id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
129093584|NCT04240886|464634195|FG000|Treatment Phase|Death|4|||
129093585|NCT04240886|464634195|FG000|Treatment Phase|Discontinuation by Subject|1|||
129093586|NCT04240886|464634195|FG000|Treatment Phase|Adverse Event|5|||
129093587|NCT04240886|464634195|FG000|Follow-up Phase|Withdrawal by Subject|1|||
129093588|NCT04240886|464634195|FG000|Follow-up Phase|Discontinuation by Subject|1|||
129093589|NCT04240886|464634195|FG000|Follow-up Phase|Death|2|||
129093590|NCT01250171|464634196|FG000|Overall Study|Administrative reasons|1|||
129093591|NCT01250171|464634197|FG001|Overall Study|Administrative reasons|0|||
129093592|NCT01250171|464634198|FG002|Overall Study|Administrative reasons|0|||
129093593|NCT04557124|464634201|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
129093594|NCT04557124|464634202|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
129093595|NCT04557124|464634201|FG000|Mid-point (1 Month)|Missed testing|5|||
129093596|NCT04557124|464634202|FG001|Mid-point (1 Month)|Missed testing|4|||
129093597|NCT04557124|464634201|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
129093598|NCT04557124|464634202|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
129093599|NCT04557124|464634201|FG000|Post-testing (2 Months)|Missed testing|1|||
129093600|NCT04557124|464634202|FG001|Post-testing (2 Months)|Missed testing|5|||
129093601|NCT04557124|464634201|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
129093602|NCT04557124|464634202|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
129093603|NCT04557124|464634201|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
129093604|NCT04557124|464634202|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
129093605|NCT05128773|464634203|FG000|Overall Study|Sponsor decision to terminate study|3|||
129093606|NCT04250714|464634204|FG000|Overall Study|Treatment - withdrawal by subject|14|||
129093607|NCT04250714|464634204|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
129093608|NCT04250714|464634204|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
129093609|NCT04250714|464634204|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
129093610|NCT04250714|464634204|FG000|Overall Study|Treatment - Death|1|||
129093611|NCT04250714|464634204|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
129093612|NCT04250714|464634204|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
129093613|NCT04250714|464634204|FG000|Overall Study|Attempt|2|||
129093614|NCT04250714|464634204|FG000|Overall Study|Intent|7|||
129093615|NCT04676412|464634205|FG000|Overall Study|Death|28|||
129093616|NCT04676412|464634206|FG001|Overall Study|Death|31|||
129093617|NCT04676412|464634205|FG000|Overall Study|Lost to Follow-up|1|||
129093618|NCT04676412|464634206|FG001|Overall Study|Lost to Follow-up|2|||
129093619|NCT04676412|464634205|FG000|Overall Study|Sponsor Decision|20|||
129093620|NCT04676412|464634206|FG001|Overall Study|Sponsor Decision|23|||
129093621|NCT04676412|464634205|FG000|Overall Study|Withdrawal by Subject|0|||
129093622|NCT04676412|464634206|FG001|Overall Study|Withdrawal by Subject|2|||
129093623|NCT04697056|464634207|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
129093624|NCT04697056|464634208|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
129093625|NCT04550832|464634209|FG000|Overall Study|Adverse Event|0|||
129093626|NCT04550832|464634210|FG001|Overall Study|Adverse Event|0|||
129093627|NCT04550832|464634211|FG002|Overall Study|Adverse Event|2|||
129093628|NCT04550832|464634212|FG003|Overall Study|Adverse Event|0|||
129093629|NCT04550832|464634213|FG004|Overall Study|Adverse Event|1|||
129093630|NCT04823130|464634214|FG000|Overall Study|Withdrawal by Subject|2|||
129093631|NCT04823130|464634215|FG001|Overall Study|Withdrawal by Subject|3|||
129093632|NCT04823130|464634214|FG000|Overall Study|Failure to meet inclusion criteria|6|||
129093633|NCT04823130|464634215|FG001|Overall Study|Failure to meet inclusion criteria|4|||
129093634|NCT04823130|464634214|FG000|Overall Study|Other-unspecified|1|||
129093635|NCT04823130|464634215|FG001|Overall Study|Other-unspecified|0|||
129093636|NCT03315455|464634217|FG000|Overall Study|Ongoing in the Study|13|||
129093637|NCT03315455|464634218|FG001|Overall Study|Ongoing in the Study|24|||
129093638|NCT03315455|464634219|FG002|Overall Study|Ongoing in the Study|17|||
129093639|NCT03315455|464634220|FG003|Overall Study|Ongoing in the Study|15|||
129093640|NCT03315455|464634217|FG000|Overall Study|Withdrawal by Subject|0|||
129093641|NCT03315455|464634218|FG001|Overall Study|Withdrawal by Subject|1|||
129093642|NCT03315455|464634219|FG002|Overall Study|Withdrawal by Subject|0|||
129093643|NCT03315455|464634220|FG003|Overall Study|Withdrawal by Subject|0|||
129093644|NCT04439357|464634224|FG000|Overall Study|Disease Progression|4|||
129093645|NCT05906836|464634227|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
129093646|NCT05906836|464634227|FG000|Overall Study|Lost to Follow-up|1|||
129093647|NCT03030118|464634228|FG000|Overall Study|Achieved SLE Diagnosis|11|||
129093648|NCT03030118|464634229|FG001|Overall Study|Achieved SLE Diagnosis|10|||
129093649|NCT03030118|464634228|FG000|Overall Study|Adverse Event|1|||
129093650|NCT03030118|464634229|FG001|Overall Study|Adverse Event|1|||
129093651|NCT03030118|464634228|FG000|Overall Study|Pregnancy|2|||
128759551|NCT02240108|463410108|FG000|Overall Study|Other than specified|8|||
129093652|NCT03030118|464634229|FG001|Overall Study|Pregnancy|2|||
128759552|NCT02240108|463410109|FG001|Overall Study|Other than specified|6|||
129093653|NCT03030118|464634228|FG000|Overall Study|Lost to Follow-up|5|||
129093654|NCT03030118|464634229|FG001|Overall Study|Lost to Follow-up|6|||
129093655|NCT03030118|464634228|FG000|Overall Study|Concomitant Medications|1|||
129093656|NCT03030118|464634229|FG001|Overall Study|Concomitant Medications|1|||
129093657|NCT03030118|464634228|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
129093658|NCT03030118|464634229|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
129093659|NCT03030118|464634228|FG000|Overall Study|Other|2|||
129093660|NCT03030118|464634229|FG001|Overall Study|Other|0|||
129093661|NCT03030118|464634228|FG000|Overall Study|Withdrawal by Subject|26|||
129093662|NCT03030118|464634229|FG001|Overall Study|Withdrawal by Subject|21|||
129093663|NCT03030118|464634228|FG000|Overall Study|Protocol Violation|1|||
129093664|NCT03030118|464634229|FG001|Overall Study|Protocol Violation|6|||
129093665|NCT04529850|464634230|FG000|Overall Study|Death|2|||
129093666|NCT04529850|464634230|FG000|Overall Study|Physician Decision|1|||
129093667|NCT04529850|464634230|FG000|Overall Study|Withdrawal by Subject|2|||
129093668|NCT01911780|464634231|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
128759553|NCT02240108|463410108|FG000|Overall Study|Adverse Event|1|||
128759554|NCT02240108|463410109|FG001|Overall Study|Adverse Event|9|||
128759555|NCT02240108|463410108|FG000|Overall Study|Pregnancy|1|||
128759556|NCT02240108|463410109|FG001|Overall Study|Pregnancy|0|||
128759557|NCT02240108|463410108|FG000|Overall Study|Withdrawal by Subject|4|||
128759558|NCT02240108|463410109|FG001|Overall Study|Withdrawal by Subject|9|||
128759559|NCT02240108|463410108|FG000|Overall Study|StudyTerminated by Sponsor|0|||
128759560|NCT02240108|463410109|FG001|Overall Study|StudyTerminated by Sponsor|1|||
128759561|NCT01345630|463410110|FG000|Overall Study|Adverse Event|22|||
128759562|NCT01345630|463410111|FG001|Overall Study|Adverse Event|23|||
128759563|NCT01345630|463410110|FG000|Overall Study|Lost to Follow-up|17|||
128759564|NCT01345630|463410111|FG001|Overall Study|Lost to Follow-up|16|||
128759565|NCT01345630|463410110|FG000|Overall Study|Protocol Violation|4|||
128759566|NCT01345630|463410111|FG001|Overall Study|Protocol Violation|1|||
128759567|NCT01345630|463410110|FG000|Overall Study|Medication error without associated AE|0|||
128759568|NCT01345630|463410111|FG001|Overall Study|Medication error without associated AE|1|||
128759569|NCT01345630|463410110|FG000|Overall Study|Study terminated by sponsor|254|||
128759570|NCT01345630|463410111|FG001|Overall Study|Study terminated by sponsor|285|||
128759571|NCT01345630|463410110|FG000|Overall Study|Other reasons|6|||
128759572|NCT01345630|463410111|FG001|Overall Study|Other reasons|8|||
128759573|NCT01345630|463410110|FG000|Overall Study|Withdrawn due to pregnancy|1|||
128759574|NCT01345630|463410111|FG001|Overall Study|Withdrawn due to pregnancy|2|||
128759575|NCT01345630|463410110|FG000|Overall Study|No longer willing to participate|9|||
128759576|NCT01345630|463410111|FG001|Overall Study|No longer willing to participate|12|||
128759577|NCT01345630|463410110|FG000|Overall Study|Insufficient clinical response|48|||
128759578|NCT01345630|463410111|FG001|Overall Study|Insufficient clinical response|11|||
128759579|NCT01090310|463410112|FG000|Core Study|Adverse Event|2|||
128759580|NCT01090310|463410113|FG001|Core Study|Adverse Event|2|||
128759581|NCT01090310|463410114|FG002|Core Study|Adverse Event|1|||
128759582|NCT01090310|463410115|FG003|Core Study|Adverse Event|1|||
128759583|NCT01090310|463410112|FG000|Core Study|Subject withdrew consent|0|||
128759584|NCT01090310|463410113|FG001|Core Study|Subject withdrew consent|3|||
128759585|NCT01090310|463410114|FG002|Core Study|Subject withdrew consent|1|||
128759586|NCT01090310|463410115|FG003|Core Study|Subject withdrew consent|1|||
128759587|NCT01090310|463410112|FG000|Core Study|Abnormal test procedure result|0|||
128759588|NCT01090310|463410113|FG001|Core Study|Abnormal test procedure result|0|||
128759589|NCT01090310|463410114|FG002|Core Study|Abnormal test procedure result|1|||
128759590|NCT01090310|463410115|FG003|Core Study|Abnormal test procedure result|0|||
128759591|NCT01090310|463410112|FG000|Core Study|Administrative reasons|5|||
128759592|NCT01090310|463410113|FG001|Core Study|Administrative reasons|6|||
128759593|NCT01090310|463410114|FG002|Core Study|Administrative reasons|4|||
128759594|NCT01090310|463410115|FG003|Core Study|Administrative reasons|4|||
128759595|NCT01090310|463410112|FG000|Core Study|Protocol deviation|1|||
128759596|NCT01090310|463410113|FG001|Core Study|Protocol deviation|0|||
128759597|NCT01090310|463410114|FG002|Core Study|Protocol deviation|0|||
128759598|NCT01090310|463410115|FG003|Core Study|Protocol deviation|1|||
128759599|NCT01090310|463410112|FG000|Extension Study|Aministrative problems|13|||
128759600|NCT01090310|463410113|FG001|Extension Study|Aministrative problems|15|||
128759601|NCT01090310|463410114|FG002|Extension Study|Aministrative problems|14|||
128759602|NCT01090310|463410115|FG003|Extension Study|Aministrative problems|18|||
128759603|NCT01090310|463410112|FG000|Extension Study|Adverse Event|0|||
128759604|NCT01090310|463410113|FG001|Extension Study|Adverse Event|0|||
128759605|NCT01090310|463410114|FG002|Extension Study|Adverse Event|0|||
128759606|NCT01090310|463410115|FG003|Extension Study|Adverse Event|1|||
128759607|NCT01090310|463410112|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
128759608|NCT01090310|463410113|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
128759609|NCT01090310|463410114|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
128759610|NCT01090310|463410115|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
128759611|NCT01090310|463410112|FG000|Extension Study|Subject withdrew consent|0|||
128759612|NCT01090310|463410113|FG001|Extension Study|Subject withdrew consent|1|||
128982149|NCT02926833|464220980|FG000|Overall Study|Death|1|||
129093669|NCT01911780|464634232|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
129093670|NCT01911780|464634231|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
128759613|NCT01090310|463410114|FG002|Extension Study|Subject withdrew consent|0|||
129093671|NCT01911780|464634232|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
128759614|NCT01090310|463410115|FG003|Extension Study|Subject withdrew consent|0|||
128759615|NCT00949884|463410119|FG000|Overall Study|Adverse Event|14|||
128759616|NCT00949884|463410120|FG001|Overall Study|Adverse Event|3|||
128759617|NCT00949884|463410121|FG002|Overall Study|Adverse Event|12|||
128759618|NCT00949884|463410119|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
128759619|NCT00949884|463410120|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
129093672|NCT01911780|464634231|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
129093673|NCT01911780|464634232|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
129093674|NCT01911780|464634231|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
129093675|NCT01911780|464634232|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
129093676|NCT01911780|464634231|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
129093677|NCT01911780|464634232|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
129093678|NCT01911780|464634231|FG000|Extension Period (52 Weeks)|Personal reason|1|||
129093679|NCT01911780|464634232|FG001|Extension Period (52 Weeks)|Personal reason|1|||
129093680|NCT03385304|464634236|FG000|Overall Study|Death|19|||
129093681|NCT03385304|464634237|FG001|Overall Study|Death|7|||
129093682|NCT03385304|464634236|FG000|Overall Study|Lost to Follow-up|17|||
129093683|NCT03385304|464634237|FG001|Overall Study|Lost to Follow-up|14|||
129093684|NCT03385304|464634236|FG000|Overall Study|Withdrawal by Subject|3|||
129093685|NCT03385304|464634237|FG001|Overall Study|Withdrawal by Subject|2|||
128759620|NCT00949884|463410121|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
128759621|NCT00949884|463410119|FG000|Overall Study|Lost to Follow-up|7|||
128759622|NCT00949884|463410120|FG001|Overall Study|Lost to Follow-up|5|||
128759623|NCT00949884|463410121|FG002|Overall Study|Lost to Follow-up|5|||
129204980|NCT00383552|465047813|FG000|Overall Study|Adverse Event|7|||
129204981|NCT00383552|465047814|FG001|Overall Study|Adverse Event|6|||
129204982|NCT00383552|465047815|FG002|Overall Study|Adverse Event|9|||
129204983|NCT00383552|465047816|FG003|Overall Study|Adverse Event|6|||
129204984|NCT00383552|465047813|FG000|Overall Study|Lack of Efficacy|4|||
129204985|NCT00383552|465047814|FG001|Overall Study|Lack of Efficacy|13|||
129204986|NCT00383552|465047815|FG002|Overall Study|Lack of Efficacy|29|||
129204987|NCT00383552|465047816|FG003|Overall Study|Lack of Efficacy|42|||
129204988|NCT00383552|465047813|FG000|Overall Study|Lost to Follow-up|0|||
129204989|NCT00383552|465047814|FG001|Overall Study|Lost to Follow-up|1|||
129204990|NCT00383552|465047815|FG002|Overall Study|Lost to Follow-up|5|||
129204991|NCT00383552|465047816|FG003|Overall Study|Lost to Follow-up|1|||
129204992|NCT00383552|465047813|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
129204993|NCT00383552|465047814|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
129204994|NCT00383552|465047815|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
128759624|NCT00949884|463410119|FG000|Overall Study|Physician Decision|5|||
128759625|NCT00949884|463410120|FG001|Overall Study|Physician Decision|0|||
128759626|NCT00949884|463410121|FG002|Overall Study|Physician Decision|6|||
128759627|NCT00949884|463410119|FG000|Overall Study|Treatment non-compliance|5|||
128759628|NCT00949884|463410120|FG001|Overall Study|Treatment non-compliance|0|||
128759629|NCT00949884|463410121|FG002|Overall Study|Treatment non-compliance|8|||
128759630|NCT00949884|463410119|FG000|Overall Study|Withdrawal by Subject|13|||
128759631|NCT00949884|463410120|FG001|Overall Study|Withdrawal by Subject|4|||
128759632|NCT00949884|463410121|FG002|Overall Study|Withdrawal by Subject|16|||
128759633|NCT00949884|463410119|FG000|Overall Study|Lack of Efficacy|4|||
128759634|NCT00949884|463410120|FG001|Overall Study|Lack of Efficacy|2|||
128759635|NCT00949884|463410121|FG002|Overall Study|Lack of Efficacy|7|||
128759636|NCT00949884|463410119|FG000|Overall Study|Study terminated by sponsor|0|||
128759637|NCT00949884|463410120|FG001|Overall Study|Study terminated by sponsor|0|||
128759638|NCT00949884|463410121|FG002|Overall Study|Study terminated by sponsor|1|||
128759639|NCT03092375|463410122|FG000|Overall Study|Lack of Efficacy|0|||
128759640|NCT03092375|463410123|FG001|Overall Study|Lack of Efficacy|1|||
128759641|NCT03092375|463410124|FG002|Overall Study|Lack of Efficacy|1|||
128759642|NCT03092375|463410125|FG003|Overall Study|Lack of Efficacy|0|||
128759643|NCT00861614|463410126|FG000|Overall Study|Disease Progression|182|||
128759644|NCT00861614|463410127|FG001|Overall Study|Disease Progression|263|||
128759645|NCT00861614|463410126|FG000|Overall Study|Study Drug Toxicity|79|||
128759646|NCT00861614|463410127|FG001|Overall Study|Study Drug Toxicity|6|||
128759647|NCT00861614|463410126|FG000|Overall Study|Death|32|||
128759648|NCT00861614|463410127|FG001|Overall Study|Death|19|||
128759649|NCT00861614|463410126|FG000|Overall Study|Adverse Event|27|||
128759650|NCT00861614|463410127|FG001|Overall Study|Adverse Event|23|||
128759651|NCT00861614|463410126|FG000|Overall Study|Withdrawal by Subject|34|||
128759652|NCT00861614|463410127|FG001|Overall Study|Withdrawal by Subject|35|||
128759653|NCT00861614|463410126|FG000|Overall Study|Other|17|||
129093686|NCT03385304|464634236|FG000|Overall Study|Incarceration|2|||
129204995|NCT00383552|465047816|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
128759654|NCT00861614|463410127|FG001|Overall Study|Other|22|||
128759655|NCT01255592|463410128|FG000|Overall Study|Adverse Event|5|||
128759656|NCT01255592|463410129|FG001|Overall Study|Adverse Event|0|||
128759657|NCT01255592|463410128|FG000|Overall Study|Withdrawal by Subject|1|||
128759658|NCT01255592|463410129|FG001|Overall Study|Withdrawal by Subject|0|||
128759659|NCT01255592|463410128|FG000|Overall Study|Other|0|||
128759660|NCT01255592|463410129|FG001|Overall Study|Other|1|||
128759661|NCT01083641|463410130|FG000|Overall Study|Withdrawal by Subject|2|||
128759662|NCT01777321|463410131|FG000|Overall Study|Withdrawal by Subject|0|||
128759663|NCT01777321|463410132|FG001|Overall Study|Withdrawal by Subject|1|||
129093687|NCT03385304|464634237|FG001|Overall Study|Incarceration|3|||
129093688|NCT02720744|464634238|FG000|Overall Study|Protocol Violation|0|||
128759664|NCT00089141|463410135|FG000|Overall Study|Termination of trial|18|||
129093689|NCT02720744|464634239|FG001|Overall Study|Protocol Violation|2|||
129093690|NCT02720744|464634238|FG000|Overall Study|Pregnancy|2|||
129093691|NCT02720744|464634239|FG001|Overall Study|Pregnancy|0|||
128759665|NCT00089141|463410136|FG001|Overall Study|Termination of trial|24|||
128759666|NCT05131165|463410137|FG000|Overall Study|Death|1|||
128759667|NCT05131165|463410138|FG001|Overall Study|Death|1|||
128759668|NCT05131165|463410139|FG002|Overall Study|Death|0|||
128759669|NCT05131165|463410137|FG000|Overall Study|Lost to Follow-up|2|||
128759670|NCT05131165|463410138|FG001|Overall Study|Lost to Follow-up|2|||
128759671|NCT05131165|463410139|FG002|Overall Study|Lost to Follow-up|5|||
128759672|NCT05131165|463410137|FG000|Overall Study|Transferred out of clinic|1|||
128759673|NCT05131165|463410138|FG001|Overall Study|Transferred out of clinic|0|||
128759674|NCT05131165|463410139|FG002|Overall Study|Transferred out of clinic|3|||
129093692|NCT02720744|464634238|FG000|Overall Study|Lack of Efficacy|2|||
129093693|NCT02720744|464634239|FG001|Overall Study|Lack of Efficacy|8|||
129093694|NCT02720744|464634238|FG000|Overall Study|Adverse Event|21|||
129093695|NCT02720744|464634239|FG001|Overall Study|Adverse Event|3|||
129093696|NCT02720744|464634238|FG000|Overall Study|Withdrawal by Subject|11|||
129093697|NCT02720744|464634239|FG001|Overall Study|Withdrawal by Subject|11|||
129093698|NCT02720744|464634238|FG000|Overall Study|Lost to follow up|2|||
129093699|NCT02720744|464634239|FG001|Overall Study|Lost to follow up|0|||
129093700|NCT02720744|464634238|FG000|Overall Study|Non Compliance with Investigational Product|0|||
129093701|NCT02720744|464634239|FG001|Overall Study|Non Compliance with Investigational Product|1|||
129093702|NCT02720744|464634238|FG000|Overall Study|Excluded Concomitant Medication|0|||
129093703|NCT02720744|464634239|FG001|Overall Study|Excluded Concomitant Medication|1|||
128759675|NCT05131165|463410137|FG000|Overall Study|Dropped out|1|||
128759676|NCT05131165|463410138|FG001|Overall Study|Dropped out|2|||
129093704|NCT00980174|464634240|FG000|Overall Study|Withdrawal by Subject|1|||
129093705|NCT00980174|464634241|FG001|Overall Study|Withdrawal by Subject|4|||
129093706|NCT00980174|464634240|FG000|Overall Study|Adverse Event|0|||
129093707|NCT00980174|464634241|FG001|Overall Study|Adverse Event|3|||
129093708|NCT00980174|464634240|FG000|Overall Study|Ineligibility determined|2|||
129093709|NCT00980174|464634241|FG001|Overall Study|Ineligibility determined|1|||
129093710|NCT00980174|464634240|FG000|Overall Study|Death|1|||
129093711|NCT00980174|464634241|FG001|Overall Study|Death|1|||
129093712|NCT00980174|464634240|FG000|Overall Study|Other|0|||
129093713|NCT00980174|464634241|FG001|Overall Study|Other|1|||
129093714|NCT00783224|464634244|FG000|Overall Study|Adverse Event|0|||
129093715|NCT00783224|464634245|FG001|Overall Study|Adverse Event|0|||
129093716|NCT00783224|464634246|FG002|Overall Study|Adverse Event|1|||
129093717|NCT00783224|464634247|FG003|Overall Study|Adverse Event|0|||
129093718|NCT00783224|464634244|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
129093719|NCT00783224|464634245|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
129093720|NCT00783224|464634246|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
129093721|NCT00783224|464634247|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
128759677|NCT05131165|463410139|FG002|Overall Study|Dropped out|0|||
128759678|NCT05168579|463410145|FG000|Overall Study|Lack of Consent|1|||
128759679|NCT05168579|463410146|FG001|Overall Study|Lack of Consent|0|||
129093722|NCT00783224|464634244|FG000|Overall Study|Inappropriate as a study subject|0|||
129093723|NCT00783224|464634245|FG001|Overall Study|Inappropriate as a study subject|0|||
129093724|NCT00783224|464634246|FG002|Overall Study|Inappropriate as a study subject|0|||
129093725|NCT00783224|464634247|FG003|Overall Study|Inappropriate as a study subject|1|||
129093726|NCT04631107|464634250|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
129093727|NCT04631107|464634250|FG000|Second Intervention (1 Night)|Adverse Event|1|||
129093728|NCT04631107|464634250|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
129093729|NCT04631107|464634250|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
129093730|NCT05385224|464634254|FG000|Overall Study|Unable to swallow capsule|2|||
129093731|NCT05385224|464634254|FG000|Overall Study|Withdrawal by Subject|2|||
129093732|NCT05385224|464634254|FG000|Overall Study|Did not meet study criteria|1|||
129093733|NCT00551161|464634255|FG000|Overall Study|Withdrawal by Subject|1|||
128759680|NCT05168579|463410145|FG000|Overall Study|Conflicts with time|2|||
128759681|NCT05168579|463410146|FG001|Overall Study|Conflicts with time|0|||
129093734|NCT01935700|464634256|FG000|Overall Study|Withdrawal by Subject|1|||
129093735|NCT01935700|464634257|FG001|Overall Study|Withdrawal by Subject|0|||
128759682|NCT05168579|463410145|FG000|Overall Study|Time slots were full|3|||
128759683|NCT05168579|463410146|FG001|Overall Study|Time slots were full|0|||
128759684|NCT05168579|463410145|FG000|Overall Study|Lost to Follow-up|0|||
128759685|NCT05168579|463410146|FG001|Overall Study|Lost to Follow-up|15|||
129093736|NCT01935700|464634256|FG000|Overall Study|Physician Decision|4|||
129093737|NCT01935700|464634257|FG001|Overall Study|Physician Decision|0|||
129093738|NCT00096993|464634258|FG000|Overall Study|Death|1|||
129093739|NCT00096993|464634259|FG001|Overall Study|Death|0|||
128759686|NCT00840801|463410147|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
129093740|NCT00096993|464634258|FG000|Overall Study|Disease progression|56|||
129093741|NCT00096993|464634259|FG001|Overall Study|Disease progression|53|||
129093742|NCT00096993|464634258|FG000|Overall Study|Adverse Event|2|||
129093743|NCT00096993|464634259|FG001|Overall Study|Adverse Event|8|||
129093744|NCT00096993|464634258|FG000|Overall Study|Subject's decision|3|||
129093745|NCT00096993|464634259|FG001|Overall Study|Subject's decision|1|||
129093746|NCT00096993|464634258|FG000|Overall Study|Physician Decision|2|||
129093747|NCT00096993|464634259|FG001|Overall Study|Physician Decision|1|||
129093748|NCT00096993|464634258|FG000|Overall Study|Non-compliance|0|||
129093749|NCT00096993|464634259|FG001|Overall Study|Non-compliance|1|||
129093750|NCT00096993|464634258|FG000|Overall Study|Other unspecified|1|||
129093751|NCT00096993|464634259|FG001|Overall Study|Other unspecified|1|||
129093752|NCT01935128|464634260|FG000|Overall Study|Death|1|||
129093753|NCT01935128|464634260|FG000|Overall Study|Adverse Event|6|||
129093754|NCT00772005|464634261|FG000|Overall Study|Adverse Event|9|||
129093755|NCT00772005|464634262|FG001|Overall Study|Adverse Event|14|||
129093756|NCT00772005|464634263|FG002|Overall Study|Adverse Event|10|||
129093757|NCT00772005|464634264|FG003|Overall Study|Adverse Event|13|||
129093758|NCT00772005|464634261|FG000|Overall Study|Lack of Efficacy|0|||
129093759|NCT00772005|464634262|FG001|Overall Study|Lack of Efficacy|1|||
129093760|NCT00772005|464634263|FG002|Overall Study|Lack of Efficacy|0|||
129093761|NCT00772005|464634264|FG003|Overall Study|Lack of Efficacy|0|||
129093762|NCT00772005|464634261|FG000|Overall Study|Withdrawal by Subject|3|||
129093763|NCT00772005|464634262|FG001|Overall Study|Withdrawal by Subject|7|||
129093764|NCT00772005|464634263|FG002|Overall Study|Withdrawal by Subject|10|||
129093765|NCT00772005|464634264|FG003|Overall Study|Withdrawal by Subject|2|||
129093766|NCT00772005|464634261|FG000|Overall Study|Protocol Violation|2|||
129093767|NCT00772005|464634262|FG001|Overall Study|Protocol Violation|4|||
129093768|NCT00772005|464634263|FG002|Overall Study|Protocol Violation|1|||
129093769|NCT00772005|464634264|FG003|Overall Study|Protocol Violation|6|||
129093770|NCT00772005|464634261|FG000|Overall Study|Lost to Follow-up|7|||
129093771|NCT00772005|464634262|FG001|Overall Study|Lost to Follow-up|3|||
129093772|NCT00772005|464634263|FG002|Overall Study|Lost to Follow-up|6|||
129093773|NCT00772005|464634264|FG003|Overall Study|Lost to Follow-up|3|||
129093774|NCT00772005|464634261|FG000|Overall Study|Non-compliance with study procedures|1|||
129093775|NCT00772005|464634262|FG001|Overall Study|Non-compliance with study procedures|1|||
129093776|NCT00772005|464634263|FG002|Overall Study|Non-compliance with study procedures|0|||
129093777|NCT00772005|464634264|FG003|Overall Study|Non-compliance with study procedures|1|||
129093778|NCT00772005|464634261|FG000|Overall Study|Non-compliance with drug administration|3|||
129093779|NCT00772005|464634262|FG001|Overall Study|Non-compliance with drug administration|0|||
129093780|NCT00772005|464634263|FG002|Overall Study|Non-compliance with drug administration|1|||
129093781|NCT00772005|464634264|FG003|Overall Study|Non-compliance with drug administration|1|||
129093782|NCT01440569|464634268|FG000|Main Study|Enrolled but not treated|1|||
129093783|NCT01440569|464634269|FG001|Main Study|Enrolled but not treated|0|||
129093784|NCT01440569|464634268|FG000|Main Study|Adverse Event|9|||
129093785|NCT01440569|464634269|FG001|Main Study|Adverse Event|0|||
129093786|NCT01440569|464634268|FG000|Main Study|Pregnancy|1|||
129093787|NCT01440569|464634269|FG001|Main Study|Pregnancy|0|||
129093788|NCT01440569|464634268|FG000|Main Study|Investigator's Discretion|1|||
129093789|NCT01440569|464634269|FG001|Main Study|Investigator's Discretion|1|||
129093790|NCT01440569|464634268|FG000|Main Study|Withdrew Consent|7|||
129093791|NCT01440569|464634269|FG001|Main Study|Withdrew Consent|1|||
129093792|NCT01440569|464634268|FG000|Main Study|Lost to Follow-up|13|||
129204996|NCT00383552|465047813|FG000|Overall Study|Did not wish to continue (related)|1|||
129204997|NCT00383552|465047814|FG001|Overall Study|Did not wish to continue (related)|0|||
128759687|NCT00840801|463410148|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
128759688|NCT00840801|463410149|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
128759689|NCT00840801|463410147|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
128759690|NCT00840801|463410148|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
128759691|NCT00840801|463410149|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
128759692|NCT00840801|463410147|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
128759693|NCT00840801|463410148|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
128759694|NCT00840801|463410149|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
128759695|NCT00840801|463410147|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
128982150|NCT02926833|464220981|FG001|Overall Study|Death|1|||
129093793|NCT01440569|464634269|FG001|Main Study|Lost to Follow-up|2|||
129093794|NCT01440569|464634268|FG000|Main Study|Subject Non-Compliance|3|||
129093795|NCT01440569|464634269|FG001|Main Study|Subject Non-Compliance|0|||
129093796|NCT01440569|464634268|FG000|Main Study|Protocol Violation|1|||
129093797|NCT01440569|464634269|FG001|Main Study|Protocol Violation|0|||
129093798|NCT01440569|464634268|FG000|Open-Label Rollover Phase|Adverse Event|3|||
129093799|NCT01440569|464634269|FG001|Open-Label Rollover Phase|Adverse Event|0|||
129093800|NCT01440569|464634268|FG000|Open-Label Rollover Phase|Pregnancy|1|||
129093801|NCT01440569|464634269|FG001|Open-Label Rollover Phase|Pregnancy|0|||
129093802|NCT01440569|464634268|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
129093803|NCT01440569|464634269|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
129093804|NCT01440569|464634268|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
129093805|NCT01440569|464634269|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
129093806|NCT01440569|464634268|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
129093807|NCT01440569|464634269|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
129093808|NCT01440569|464634268|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
129093809|NCT01440569|464634269|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
129093810|NCT01440569|464634268|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
129093811|NCT01440569|464634269|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
128759696|NCT00840801|463410148|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
128759697|NCT00840801|463410149|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
128759698|NCT01424930|463410152|FG000|Overall Study|Adverse Event|0|||
128759699|NCT01424930|463410153|FG001|Overall Study|Adverse Event|1|||
128759700|NCT01424930|463410152|FG000|Overall Study|Death|1|||
128759701|NCT01424930|463410153|FG001|Overall Study|Death|0|||
128759702|NCT01424930|463410152|FG000|Overall Study|Progressive Disease|3|||
128759703|NCT01424930|463410153|FG001|Overall Study|Progressive Disease|6|||
129093812|NCT02431806|464634272|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
129093813|NCT02431806|464634273|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
128759704|NCT01424930|463410152|FG000|Overall Study|Screen Failure|0|||
128759705|NCT01424930|463410153|FG001|Overall Study|Screen Failure|1|||
128759706|NCT01424930|463410152|FG000|Overall Study|Reason not specified|0|||
128759707|NCT01424930|463410153|FG001|Overall Study|Reason not specified|6|||
128759708|NCT00454571|463410159|FG000|Overall Study|Adverse Event|2|||
129093814|NCT02431806|464634274|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
129093815|NCT02431806|464634275|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
129093816|NCT02431806|464634272|FG000|Double-blind Treatment Period|Adverse Event|4|||
129093817|NCT02431806|464634273|FG001|Double-blind Treatment Period|Adverse Event|7|||
129093818|NCT02431806|464634274|FG002|Double-blind Treatment Period|Adverse Event|11|||
129093819|NCT02431806|464634275|FG003|Double-blind Treatment Period|Adverse Event|7|||
129093820|NCT02431806|464634272|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
129093821|NCT02431806|464634273|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129093822|NCT02431806|464634274|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
129093823|NCT02431806|464634275|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
129093824|NCT02431806|464634272|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
129093825|NCT02431806|464634273|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
129093826|NCT02431806|464634274|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
129093827|NCT02431806|464634275|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
129093828|NCT02431806|464634272|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
129093829|NCT02431806|464634273|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
129093830|NCT02431806|464634274|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
129093831|NCT02431806|464634275|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
129093832|NCT02431806|464634272|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
129093833|NCT02431806|464634273|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
129093834|NCT02431806|464634274|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
129093835|NCT02431806|464634275|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
129093836|NCT02431806|464634272|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
129093837|NCT02431806|464634273|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
129093838|NCT02431806|464634274|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
129093839|NCT02431806|464634275|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
129093840|NCT03627416|464634276|FG000|Overall Study|Adverse Event|0|||
129093841|NCT03627416|464634277|FG001|Overall Study|Adverse Event|1|||
129093842|NCT01294371|464634278|FG000|Overall Study|Adverse Event|1|||
129093843|NCT01294371|464634278|FG000|Overall Study|Withdrawal by Subject|12|||
129093844|NCT01294371|464634278|FG000|Overall Study|Lost to Follow-up|6|||
129093845|NCT01294371|464634278|FG000|Overall Study|Administrative Reason|1|||
129093846|NCT01294371|464634278|FG000|Overall Study|Other|14|||
128759709|NCT00454571|463410160|FG001|Overall Study|Adverse Event|0|||
128759710|NCT00454571|463410159|FG000|Overall Study|Physician Decision|0|||
128759711|NCT00454571|463410160|FG001|Overall Study|Physician Decision|1|||
128759712|NCT00454571|463410159|FG000|Overall Study|Protocol Violation|1|||
128759713|NCT00454571|463410160|FG001|Overall Study|Protocol Violation|0|||
128759714|NCT00454571|463410159|FG000|Overall Study|Withdrawal by Subject|10|||
129093847|NCT05619536|464634279|FG000|Overall Study|Withdrawal by Subject|0|||
129093848|NCT05619536|464634280|FG001|Overall Study|Withdrawal by Subject|1|||
129093849|NCT05619536|464634281|FG002|Overall Study|Withdrawal by Subject|0|||
129093850|NCT05619536|464634282|FG003|Overall Study|Withdrawal by Subject|1|||
129093851|NCT05619536|464634279|FG000|Overall Study|Lost to Follow-up|0|||
128759715|NCT00454571|463410160|FG001|Overall Study|Withdrawal by Subject|5|||
128759716|NCT01089374|463410161|FG000|Overall Study|Lost to Follow-up|3|||
128759717|NCT01089374|463410162|FG001|Overall Study|Lost to Follow-up|0|||
129093852|NCT05619536|464634280|FG001|Overall Study|Lost to Follow-up|1|||
129093853|NCT05619536|464634281|FG002|Overall Study|Lost to Follow-up|1|||
129093854|NCT05619536|464634282|FG003|Overall Study|Lost to Follow-up|0|||
129093855|NCT03619902|464634283|FG000|Overall Study|Termination of Study by Investigator|1|||
129093856|NCT03619902|464634283|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
129093857|NCT02923245|464634284|FG000|Overall Study|ultrasound order was cancelled|2|||
129093858|NCT02923245|464634285|FG001|Overall Study|ultrasound order was cancelled|1|||
129093859|NCT02520427|464634286|FG000|Overall Study|Decision by sponsor|0|||
129093860|NCT02520427|464634287|FG001|Overall Study|Decision by sponsor|0|||
129093861|NCT02520427|464634288|FG002|Overall Study|Decision by sponsor|0|||
129093862|NCT02520427|464634289|FG003|Overall Study|Decision by sponsor|0|||
129093863|NCT02520427|464634290|FG004|Overall Study|Decision by sponsor|0|||
129093864|NCT02520427|464634291|FG005|Overall Study|Decision by sponsor|0|||
129093865|NCT02520427|464634292|FG006|Overall Study|Decision by sponsor|0|||
129093866|NCT02520427|464634293|FG007|Overall Study|Decision by sponsor|0|||
129093867|NCT02520427|464634294|FG008|Overall Study|Decision by sponsor|1|||
129093868|NCT02520427|464634295|FG009|Overall Study|Decision by sponsor|1|||
129093869|NCT02520427|464634296|FG010|Overall Study|Decision by sponsor|0|||
129093870|NCT02520427|464634297|FG011|Overall Study|Decision by sponsor|0|||
129093871|NCT02520427|464634298|FG012|Overall Study|Decision by sponsor|0|||
129093872|NCT02520427|464634299|FG013|Overall Study|Decision by sponsor|0|||
129093873|NCT02520427|464634300|FG014|Overall Study|Decision by sponsor|0|||
129093874|NCT02520427|464634301|FG015|Overall Study|Decision by sponsor|0|||
129093875|NCT02520427|464634302|FG016|Overall Study|Decision by sponsor|0|||
129093876|NCT02520427|464634303|FG017|Overall Study|Decision by sponsor|0|||
129093877|NCT02520427|464634304|FG018|Overall Study|Decision by sponsor|0|||
129093878|NCT02520427|464634305|FG019|Overall Study|Decision by sponsor|0|||
129093879|NCT02520427|464634306|FG020|Overall Study|Decision by sponsor|0|||
129093880|NCT02520427|464634307|FG021|Overall Study|Decision by sponsor|0|||
129093881|NCT02520427|464634308|FG022|Overall Study|Decision by sponsor|0|||
129093882|NCT02520427|464634309|FG023|Overall Study|Decision by sponsor|0|||
129093883|NCT02520427|464634310|FG024|Overall Study|Decision by sponsor|0|||
129093884|NCT02520427|464634311|FG025|Overall Study|Decision by sponsor|0|||
129093885|NCT02520427|464634286|FG000|Overall Study|Withdrawal by Subject|0|||
129093886|NCT02520427|464634287|FG001|Overall Study|Withdrawal by Subject|0|||
129093887|NCT02520427|464634288|FG002|Overall Study|Withdrawal by Subject|1|||
129093888|NCT02520427|464634289|FG003|Overall Study|Withdrawal by Subject|0|||
129093889|NCT02520427|464634290|FG004|Overall Study|Withdrawal by Subject|0|||
129093890|NCT02520427|464634291|FG005|Overall Study|Withdrawal by Subject|0|||
129093891|NCT02520427|464634292|FG006|Overall Study|Withdrawal by Subject|0|||
129093892|NCT02520427|464634293|FG007|Overall Study|Withdrawal by Subject|0|||
129093893|NCT02520427|464634294|FG008|Overall Study|Withdrawal by Subject|0|||
129093894|NCT02520427|464634295|FG009|Overall Study|Withdrawal by Subject|0|||
129093895|NCT02520427|464634296|FG010|Overall Study|Withdrawal by Subject|0|||
129093896|NCT02520427|464634297|FG011|Overall Study|Withdrawal by Subject|0|||
129093897|NCT02520427|464634298|FG012|Overall Study|Withdrawal by Subject|1|||
129093898|NCT02520427|464634299|FG013|Overall Study|Withdrawal by Subject|1|||
129093899|NCT02520427|464634300|FG014|Overall Study|Withdrawal by Subject|1|||
129093900|NCT02520427|464634301|FG015|Overall Study|Withdrawal by Subject|0|||
129093901|NCT02520427|464634302|FG016|Overall Study|Withdrawal by Subject|1|||
129093902|NCT02520427|464634303|FG017|Overall Study|Withdrawal by Subject|0|||
129093903|NCT02520427|464634304|FG018|Overall Study|Withdrawal by Subject|0|||
129093904|NCT02520427|464634305|FG019|Overall Study|Withdrawal by Subject|3|||
129093905|NCT02520427|464634306|FG020|Overall Study|Withdrawal by Subject|2|||
129093906|NCT02520427|464634307|FG021|Overall Study|Withdrawal by Subject|0|||
129093907|NCT02520427|464634308|FG022|Overall Study|Withdrawal by Subject|0|||
129093908|NCT02520427|464634309|FG023|Overall Study|Withdrawal by Subject|0|||
129093909|NCT02520427|464634310|FG024|Overall Study|Withdrawal by Subject|0|||
129093910|NCT02520427|464634311|FG025|Overall Study|Withdrawal by Subject|0|||
129093911|NCT02520427|464634286|FG000|Overall Study|Death|1|||
129093912|NCT02520427|464634287|FG001|Overall Study|Death|0|||
129093913|NCT02520427|464634288|FG002|Overall Study|Death|0|||
129093914|NCT02520427|464634289|FG003|Overall Study|Death|0|||
129093915|NCT02520427|464634290|FG004|Overall Study|Death|0|||
129093916|NCT02520427|464634291|FG005|Overall Study|Death|0|||
129093917|NCT02520427|464634292|FG006|Overall Study|Death|0|||
129093918|NCT02520427|464634293|FG007|Overall Study|Death|0|||
129093919|NCT02520427|464634294|FG008|Overall Study|Death|0|||
129093920|NCT02520427|464634295|FG009|Overall Study|Death|0|||
129093921|NCT02520427|464634296|FG010|Overall Study|Death|0|||
129093922|NCT02520427|464634297|FG011|Overall Study|Death|0|||
129093923|NCT02520427|464634298|FG012|Overall Study|Death|0|||
129093924|NCT02520427|464634299|FG013|Overall Study|Death|0|||
129093925|NCT02520427|464634300|FG014|Overall Study|Death|0|||
129093926|NCT02520427|464634301|FG015|Overall Study|Death|0|||
129093927|NCT02520427|464634302|FG016|Overall Study|Death|2|||
129093928|NCT02520427|464634303|FG017|Overall Study|Death|1|||
129093929|NCT02520427|464634304|FG018|Overall Study|Death|3|||
129093930|NCT02520427|464634305|FG019|Overall Study|Death|2|||
129093931|NCT02520427|464634306|FG020|Overall Study|Death|0|||
129093932|NCT02520427|464634307|FG021|Overall Study|Death|0|||
129093933|NCT02520427|464634308|FG022|Overall Study|Death|1|||
129093934|NCT02520427|464634309|FG023|Overall Study|Death|0|||
129093935|NCT02520427|464634310|FG024|Overall Study|Death|1|||
129093936|NCT02520427|464634311|FG025|Overall Study|Death|0|||
129093937|NCT02987972|464634315|FG000|Overall Study|Adverse Event|1|||
129093938|NCT02987972|464634316|FG001|Overall Study|Adverse Event|1|||
129093939|NCT02987972|464634317|FG002|Overall Study|Adverse Event|0|||
129093940|NCT02987972|464634315|FG000|Overall Study|Death|1|||
129093941|NCT02987972|464634316|FG001|Overall Study|Death|0|||
129093942|NCT02987972|464634317|FG002|Overall Study|Death|0|||
129093943|NCT02987972|464634315|FG000|Overall Study|Lack of Efficacy|9|||
129093944|NCT02987972|464634316|FG001|Overall Study|Lack of Efficacy|12|||
129093945|NCT02987972|464634317|FG002|Overall Study|Lack of Efficacy|12|||
129093946|NCT02987972|464634315|FG000|Overall Study|Lost to Follow-up|7|||
129093947|NCT02987972|464634316|FG001|Overall Study|Lost to Follow-up|8|||
129093948|NCT02987972|464634317|FG002|Overall Study|Lost to Follow-up|4|||
129093949|NCT02987972|464634315|FG000|Overall Study|Physician Decision|1|||
129093950|NCT02987972|464634316|FG001|Overall Study|Physician Decision|6|||
129093951|NCT02987972|464634317|FG002|Overall Study|Physician Decision|0|||
129093952|NCT02987972|464634315|FG000|Overall Study|Protocol Violation|2|||
129093953|NCT02987972|464634316|FG001|Overall Study|Protocol Violation|1|||
129093954|NCT02987972|464634317|FG002|Overall Study|Protocol Violation|5|||
129093955|NCT02987972|464634315|FG000|Overall Study|Withdrawal by Subject|22|||
129093956|NCT02987972|464634316|FG001|Overall Study|Withdrawal by Subject|17|||
129093957|NCT02987972|464634317|FG002|Overall Study|Withdrawal by Subject|21|||
129093958|NCT00073983|464634318|FG000|Overall Study|not evaluable|1|||
129093959|NCT03800836|464634319|FG000|Overall Study|Other|2|||
129093960|NCT03800836|464634320|FG001|Overall Study|Other|1|||
129093961|NCT03800836|464634321|FG002|Overall Study|Other|0|||
129093962|NCT03800836|464634322|FG003|Overall Study|Other|2|||
129093963|NCT03800836|464634323|FG004|Overall Study|Other|0|||
129093964|NCT03800836|464634324|FG005|Overall Study|Other|1|||
129093965|NCT03800836|464634319|FG000|Overall Study|Lost to Follow-up|2|||
129093966|NCT03800836|464634320|FG001|Overall Study|Lost to Follow-up|0|||
129093967|NCT03800836|464634321|FG002|Overall Study|Lost to Follow-up|1|||
129093968|NCT03800836|464634322|FG003|Overall Study|Lost to Follow-up|1|||
129093969|NCT03800836|464634323|FG004|Overall Study|Lost to Follow-up|3|||
129093970|NCT03800836|464634324|FG005|Overall Study|Lost to Follow-up|0|||
129093971|NCT03800836|464634319|FG000|Overall Study|Withdrawal by Subject|1|||
129093972|NCT03800836|464634320|FG001|Overall Study|Withdrawal by Subject|0|||
129093973|NCT03800836|464634321|FG002|Overall Study|Withdrawal by Subject|0|||
129093974|NCT03800836|464634322|FG003|Overall Study|Withdrawal by Subject|0|||
129093975|NCT03800836|464634323|FG004|Overall Study|Withdrawal by Subject|0|||
129093976|NCT03800836|464634324|FG005|Overall Study|Withdrawal by Subject|0|||
129093977|NCT03800836|464634319|FG000|Overall Study|Physician Decision|31|||
129093978|NCT03800836|464634320|FG001|Overall Study|Physician Decision|3|||
129093979|NCT03800836|464634321|FG002|Overall Study|Physician Decision|6|||
129093980|NCT03800836|464634322|FG003|Overall Study|Physician Decision|4|||
129093981|NCT03800836|464634323|FG004|Overall Study|Physician Decision|4|||
129093982|NCT03800836|464634324|FG005|Overall Study|Physician Decision|5|||
129093983|NCT03800836|464634319|FG000|Overall Study|Death|34|||
129093984|NCT03800836|464634320|FG001|Overall Study|Death|16|||
129093985|NCT03800836|464634321|FG002|Overall Study|Death|5|||
129093986|NCT03800836|464634322|FG003|Overall Study|Death|5|||
129093987|NCT03800836|464634323|FG004|Overall Study|Death|10|||
129093988|NCT03800836|464634324|FG005|Overall Study|Death|0|||
129093989|NCT03800836|464634319|FG000|Overall Study|Symptomatic Deterioration|1|||
129093990|NCT03800836|464634320|FG001|Overall Study|Symptomatic Deterioration|0|||
129093991|NCT03800836|464634321|FG002|Overall Study|Symptomatic Deterioration|1|||
129093992|NCT03800836|464634322|FG003|Overall Study|Symptomatic Deterioration|0|||
129093993|NCT03800836|464634323|FG004|Overall Study|Symptomatic Deterioration|0|||
129093994|NCT03800836|464634324|FG005|Overall Study|Symptomatic Deterioration|0|||
129132878|NCT04270760|464778553|FG002|Overall Study|Lost to Follow-up|1|||
129132879|NCT04270760|464778554|FG003|Overall Study|Lost to Follow-up|0|||
129132880|NCT04270760|464778555|FG004|Overall Study|Lost to Follow-up|0|||
129132881|NCT04270760|464778551|FG000|Overall Study|Death|0|||
129132882|NCT04270760|464778552|FG001|Overall Study|Death|0|||
129132883|NCT04270760|464778553|FG002|Overall Study|Death|0|||
129132884|NCT04270760|464778554|FG003|Overall Study|Death|0|||
129132885|NCT04270760|464778555|FG004|Overall Study|Death|1|||
129132886|NCT02070991|464778556|FG000|Overall Study|Death|2|||
129132887|NCT02070991|464778557|FG001|Overall Study|Death|0|||
129132888|NCT02070991|464778556|FG000|Overall Study|Withdrawal by Subject|1|||
129132889|NCT02070991|464778557|FG001|Overall Study|Withdrawal by Subject|0|||
129132890|NCT00827242|464778558|FG000|Overall Study|Withdrawal by Subject|2|||
129132891|NCT00827242|464778559|FG001|Overall Study|Withdrawal by Subject|4|||
129132892|NCT00827242|464778558|FG000|Overall Study|Protocol Violation|1|||
129132893|NCT00827242|464778559|FG001|Overall Study|Protocol Violation|3|||
129132894|NCT00827242|464778558|FG000|Overall Study|Lost to Follow-up|0|||
129132895|NCT00827242|464778559|FG001|Overall Study|Lost to Follow-up|3|||
129132896|NCT00827242|464778558|FG000|Overall Study|Adverse Event Excluding Death|2|||
129093995|NCT05072106|464635977|FG000|Overall Study|Progressive disease|3|||
129093996|NCT05072106|464635978|FG001|Overall Study|Progressive disease|3|||
129093997|NCT05072106|464635977|FG000|Overall Study|Compassionate use|3|||
129093998|NCT05072106|464635978|FG001|Overall Study|Compassionate use|1|||
129093999|NCT05072106|464635977|FG000|Overall Study|Withdrawal by Subject|1|||
129094000|NCT05072106|464635978|FG001|Overall Study|Withdrawal by Subject|0|||
129094001|NCT03839459|464635979|FG000|Overall Study|Withdrawal by Subject|2|||
129094002|NCT03839459|464635979|FG000|Overall Study|progression of disease|3|||
129094003|NCT02542293|464635984|FG000|Overall Study|Death|367|||
129094004|NCT02542293|464635985|FG001|Overall Study|Death|377|||
129094005|NCT02542293|464635984|FG000|Overall Study|Withdrawal by Subject|8|||
129094006|NCT02542293|464635985|FG001|Overall Study|Withdrawal by Subject|19|||
129094007|NCT01458951|464635988|FG000|Overall Study|Other|1|||
129094008|NCT01458951|464635989|FG001|Overall Study|Other|0|||
129094009|NCT01458951|464635990|FG002|Overall Study|Other|0|||
129094010|NCT01458951|464635988|FG000|Overall Study|Protocol Violation|5|||
129094011|NCT01458951|464635989|FG001|Overall Study|Protocol Violation|1|||
129094012|NCT01458951|464635990|FG002|Overall Study|Protocol Violation|0|||
129094013|NCT01458951|464635988|FG000|Overall Study|Withdrawal by Subject|2|||
129094014|NCT01458951|464635989|FG001|Overall Study|Withdrawal by Subject|0|||
129094015|NCT01458951|464635990|FG002|Overall Study|Withdrawal by Subject|2|||
129094016|NCT01458951|464635988|FG000|Overall Study|Adverse Event|7|||
129094017|NCT01458951|464635989|FG001|Overall Study|Adverse Event|0|||
129094018|NCT01458951|464635990|FG002|Overall Study|Adverse Event|2|||
129094019|NCT01458951|464635988|FG000|Overall Study|Insufficient Clinical Response|17|||
128759718|NCT01089374|463410161|FG000|Overall Study|Withdrawal by Subject|1|||
128759719|NCT01089374|463410162|FG001|Overall Study|Withdrawal by Subject|0|||
128759720|NCT01089374|463410161|FG000|Overall Study|Study closed early - low accrual|6|||
128759721|NCT01089374|463410162|FG001|Overall Study|Study closed early - low accrual|0|||
128759722|NCT02657317|463410163|FG000|Overall Study|Withdrawal by Subject|2|||
128759723|NCT02657317|463410164|FG001|Overall Study|Withdrawal by Subject|0|||
128759724|NCT02657317|463410163|FG000|Overall Study|Lost to Follow-up|3|||
128759725|NCT02657317|463410164|FG001|Overall Study|Lost to Follow-up|3|||
128759726|NCT01201811|463410165|FG000|Overall Study|Adverse Event|6|||
128759727|NCT01201811|463410165|FG000|Overall Study|Disease progression|3|||
128759728|NCT01201811|463410165|FG000|Overall Study|Withdrawal by Subject|3|||
128759729|NCT01201811|463410165|FG000|Overall Study|Death|4|||
128759730|NCT01201811|463410165|FG000|Overall Study|Treatment Failure|2|||
128759731|NCT01201811|463410165|FG000|Overall Study|Physician Decision|1|||
128759732|NCT02856113|463410166|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
128759733|NCT02856113|463410167|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
128759734|NCT02856113|463410166|FG000|Overall Study|Significant Protocol Deviation|1|||
128759735|NCT02856113|463410167|FG001|Overall Study|Significant Protocol Deviation|0|||
128759736|NCT02856113|463410166|FG000|Overall Study|Lost to Follow-up|3|||
128759737|NCT02856113|463410167|FG001|Overall Study|Lost to Follow-up|5|||
128759738|NCT02856113|463410166|FG000|Overall Study|Voluntary Withdrawal|3|||
128759739|NCT02856113|463410167|FG001|Overall Study|Voluntary Withdrawal|5|||
128759740|NCT02856113|463410166|FG000|Overall Study|Pregnancy|0|||
128759741|NCT02856113|463410167|FG001|Overall Study|Pregnancy|1|||
128759742|NCT02856113|463410166|FG000|Overall Study|Principal Investigator Discretion|2|||
128759743|NCT02856113|463410167|FG001|Overall Study|Principal Investigator Discretion|1|||
128759744|NCT02856113|463410166|FG000|Overall Study|Randomized but not Treated|1|||
128759745|NCT02856113|463410167|FG001|Overall Study|Randomized but not Treated|0|||
128759746|NCT02856113|463410166|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
128759747|NCT02856113|463410167|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
128759748|NCT03494166|463410168|FG000|Overall Study|Death|0|||
128759749|NCT03494166|463410169|FG001|Overall Study|Death|0|||
128759750|NCT03494166|463410170|FG002|Overall Study|Death|0|||
128759751|NCT03494166|463410171|FG003|Overall Study|Death|1|||
128759752|NCT03494166|463410172|FG004|Overall Study|Death|3|||
128759753|NCT03494166|463410173|FG005|Overall Study|Death|0|||
128759754|NCT03494166|463410168|FG000|Overall Study|Lost to Follow-up|2|||
128759755|NCT03494166|463410169|FG001|Overall Study|Lost to Follow-up|2|||
128759756|NCT03494166|463410170|FG002|Overall Study|Lost to Follow-up|2|||
128759757|NCT03494166|463410171|FG003|Overall Study|Lost to Follow-up|2|||
128759758|NCT03494166|463410172|FG004|Overall Study|Lost to Follow-up|14|||
128759759|NCT03494166|463410173|FG005|Overall Study|Lost to Follow-up|0|||
129204998|NCT00383552|465047815|FG002|Overall Study|Did not wish to continue (related)|2|||
128759760|NCT03494166|463410168|FG000|Overall Study|Withdrawal by Subject|10|||
128759761|NCT03494166|463410169|FG001|Overall Study|Withdrawal by Subject|7|||
128982151|NCT02926833|464220982|FG002|Overall Study|Death|2|||
129094020|NCT01458951|464635989|FG001|Overall Study|Insufficient Clinical Response|0|||
128759762|NCT03494166|463410170|FG002|Overall Study|Withdrawal by Subject|0|||
128759763|NCT03494166|463410171|FG003|Overall Study|Withdrawal by Subject|5|||
128759764|NCT03494166|463410172|FG004|Overall Study|Withdrawal by Subject|3|||
128759765|NCT03494166|463410173|FG005|Overall Study|Withdrawal by Subject|17|||
128982152|NCT02926833|464220983|FG003|Overall Study|Death|13|||
129094021|NCT01458951|464635990|FG002|Overall Study|Insufficient Clinical Response|11|||
129094022|NCT02963558|464635993|FG000|Overall Study|Withdrawn by investigator|1|||
129094023|NCT02963558|464635994|FG001|Overall Study|Withdrawn by investigator|0|||
129094024|NCT02963558|464635993|FG000|Overall Study|Withdrawal by Subject|0|||
129094025|NCT02963558|464635994|FG001|Overall Study|Withdrawal by Subject|1|||
129094026|NCT01573767|464635995|FG000|Overall Study|Adverse Event|0|||
129094027|NCT01573767|464635996|FG001|Overall Study|Adverse Event|1|||
129094028|NCT01573767|464635997|FG002|Overall Study|Adverse Event|0|||
129094029|NCT01573767|464635998|FG003|Overall Study|Adverse Event|1|||
129094030|NCT01573767|464635995|FG000|Overall Study|Lack of Efficacy|18|||
128759766|NCT03494166|463410168|FG000|Overall Study|Screen failure|1|||
128759767|NCT03494166|463410169|FG001|Overall Study|Screen failure|0|||
128759768|NCT03494166|463410170|FG002|Overall Study|Screen failure|0|||
128759769|NCT03494166|463410171|FG003|Overall Study|Screen failure|0|||
129094031|NCT01573767|464635996|FG001|Overall Study|Lack of Efficacy|15|||
129094032|NCT01573767|464635997|FG002|Overall Study|Lack of Efficacy|12|||
129094033|NCT01573767|464635998|FG003|Overall Study|Lack of Efficacy|17|||
129094034|NCT01573767|464635995|FG000|Overall Study|Protocol Violation|3|||
129204999|NCT00383552|465047816|FG003|Overall Study|Did not wish to continue (related)|3|||
129205000|NCT00383552|465047813|FG000|Overall Study|Noncompliance with the protocol|11|||
129205001|NCT00383552|465047814|FG001|Overall Study|Noncompliance with the protocol|6|||
129205002|NCT00383552|465047815|FG002|Overall Study|Noncompliance with the protocol|8|||
129094035|NCT01573767|464635996|FG001|Overall Study|Protocol Violation|1|||
129094036|NCT01573767|464635997|FG002|Overall Study|Protocol Violation|1|||
129094037|NCT01573767|464635998|FG003|Overall Study|Protocol Violation|3|||
129094038|NCT01573767|464635995|FG000|Overall Study|Lost to Follow-up|0|||
129094039|NCT01573767|464635996|FG001|Overall Study|Lost to Follow-up|1|||
129094040|NCT01573767|464635997|FG002|Overall Study|Lost to Follow-up|1|||
129094041|NCT01573767|464635998|FG003|Overall Study|Lost to Follow-up|1|||
129094042|NCT01573767|464635995|FG000|Overall Study|Physician Decision|1|||
129094043|NCT01573767|464635996|FG001|Overall Study|Physician Decision|2|||
129094044|NCT01573767|464635997|FG002|Overall Study|Physician Decision|0|||
128759770|NCT03494166|463410172|FG004|Overall Study|Screen failure|1|||
128759771|NCT03494166|463410173|FG005|Overall Study|Screen failure|0|||
128759772|NCT02857426|463410174|FG000|Overall Study|Disease progression|34|||
128759773|NCT02857426|463410175|FG001|Overall Study|Disease progression|13|||
128759774|NCT02857426|463410174|FG000|Overall Study|Study drug toxicity|4|||
128759775|NCT02857426|463410175|FG001|Overall Study|Study drug toxicity|1|||
129094045|NCT01573767|464635998|FG003|Overall Study|Physician Decision|2|||
129094046|NCT01573767|464635995|FG000|Overall Study|Withdrawal by Subject|0|||
129094047|NCT01573767|464635996|FG001|Overall Study|Withdrawal by Subject|1|||
129094048|NCT01573767|464635997|FG002|Overall Study|Withdrawal by Subject|0|||
129094049|NCT01573767|464635998|FG003|Overall Study|Withdrawal by Subject|0|||
129094050|NCT01371877|464636001|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
129094051|NCT01371877|464636002|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
129094052|NCT00869557|464636003|FG000|Randomized Phase|Lost to Follow-up|2|||
129094053|NCT00869557|464636004|FG001|Randomized Phase|Lost to Follow-up|1|||
129094054|NCT00869557|464636003|FG000|Randomized Phase|Investigator's Discretion|1|||
128759776|NCT02857426|463410174|FG000|Overall Study|Death|1|||
128759777|NCT02857426|463410175|FG001|Overall Study|Death|0|||
128759778|NCT02857426|463410174|FG000|Overall Study|Adverse event unrelated to study drug|6|||
128759779|NCT02857426|463410175|FG001|Overall Study|Adverse event unrelated to study drug|2|||
128759780|NCT02857426|463410174|FG000|Overall Study|Participant withdrew consent|1|||
128759781|NCT02857426|463410175|FG001|Overall Study|Participant withdrew consent|1|||
128759782|NCT02857426|463410174|FG000|Overall Study|Maximum clinical benefit|1|||
128759783|NCT02857426|463410175|FG001|Overall Study|Maximum clinical benefit|0|||
128759784|NCT02857426|463410174|FG000|Overall Study|Completed treatment|0|||
129094055|NCT00869557|464636004|FG001|Randomized Phase|Investigator's Discretion|0|||
129094056|NCT00869557|464636003|FG000|Randomized Phase|Withdrew Consent|0|||
129205003|NCT00383552|465047816|FG003|Overall Study|Noncompliance with the protocol|10|||
129205004|NCT00383552|465047813|FG000|Overall Study|Did not meet protocol eligibility|8|||
129205005|NCT00383552|465047814|FG001|Overall Study|Did not meet protocol eligibility|6|||
129205006|NCT00383552|465047815|FG002|Overall Study|Did not meet protocol eligibility|2|||
128759785|NCT02857426|463410175|FG001|Overall Study|Completed treatment|2|||
128759786|NCT02831257|463410179|FG000|Overall Study|Lack of Efficacy|3|||
129205007|NCT00383552|465047816|FG003|Overall Study|Did not meet protocol eligibility|3|||
129205008|NCT00383552|465047813|FG000|Overall Study|Administrative|1|||
129205009|NCT00383552|465047814|FG001|Overall Study|Administrative|0|||
128759787|NCT02831257|463410179|FG000|Overall Study|Adverse Event|2|||
129205010|NCT00383552|465047815|FG002|Overall Study|Administrative|1|||
129205011|NCT00383552|465047816|FG003|Overall Study|Administrative|1|||
129205012|NCT00966654|465047817|FG000|Overall Study|Study was terminated,PI left institution|12|||
129205013|NCT01381016|465047818|FG000|Overall Study|Lost to Follow-up|1|||
129205014|NCT01381016|465047819|FG001|Overall Study|Lost to Follow-up|1|||
129205015|NCT01381016|465047818|FG000|Overall Study|Screen Failure|2|||
128759788|NCT02831257|463410179|FG000|Overall Study|Physician Decision|1|||
129094057|NCT00869557|464636004|FG001|Randomized Phase|Withdrew Consent|1|||
129094058|NCT00869557|464636003|FG000|Extension Phase|Adverse Event|2|||
129094059|NCT00869557|464636004|FG001|Extension Phase|Adverse Event|2|||
129094060|NCT00869557|464636003|FG000|Extension Phase|Lack of Efficacy|1|||
129094061|NCT00869557|464636004|FG001|Extension Phase|Lack of Efficacy|0|||
129094062|NCT00869557|464636003|FG000|Extension Phase|Lost to Follow-up|3|||
129094063|NCT00869557|464636004|FG001|Extension Phase|Lost to Follow-up|1|||
129094064|NCT00869557|464636003|FG000|Extension Phase|Investigator's Discretion|2|||
129094065|NCT00869557|464636004|FG001|Extension Phase|Investigator's Discretion|0|||
129094066|NCT00869557|464636003|FG000|Extension Phase|Withdrew Consent|2|||
129094067|NCT00869557|464636004|FG001|Extension Phase|Withdrew Consent|0|||
129094068|NCT01143064|464636007|FG000|Overall Study|Death|109|||
129094069|NCT01143064|464636008|FG001|Overall Study|Death|91|||
129094070|NCT01143064|464636007|FG000|Overall Study|Adverse Event|0|||
129094071|NCT01143064|464636008|FG001|Overall Study|Adverse Event|1|||
129094072|NCT01143064|464636007|FG000|Overall Study|Withdrawal by Subject|7|||
129094073|NCT01143064|464636008|FG001|Overall Study|Withdrawal by Subject|5|||
129094074|NCT01143064|464636007|FG000|Overall Study|Lost to Follow-up|17|||
129094075|NCT01143064|464636008|FG001|Overall Study|Lost to Follow-up|14|||
129094076|NCT01143064|464636007|FG000|Overall Study|Physician Decision|0|||
129094077|NCT01143064|464636008|FG001|Overall Study|Physician Decision|4|||
129094078|NCT02255552|464636011|FG000|Overall Study|Participants enrolled into another study|0|||
129094079|NCT02255552|464636012|FG001|Overall Study|Participants enrolled into another study|11|||
129094080|NCT02255552|464636011|FG000|Overall Study|Withdrawal by Subject|1|||
129094081|NCT02255552|464636012|FG001|Overall Study|Withdrawal by Subject|4|||
129094082|NCT01199822|464636016|FG000|Overall Study|Investigator discontinued therapy|0|||
129094083|NCT01199822|464636017|FG001|Overall Study|Investigator discontinued therapy|1|||
129094084|NCT01199822|464636018|FG002|Overall Study|Investigator discontinued therapy|0|||
129094085|NCT00480493|464636019|FG000|Overall Study|moved|2|||
129094086|NCT00480493|464636020|FG001|Overall Study|moved|7|||
129094087|NCT03747302|464636021|FG000|Overall Study|Withdrawal by Subject|1|||
129094088|NCT03747302|464636022|FG001|Overall Study|Withdrawal by Subject|2|||
129094089|NCT04027075|464636023|FG000|Overall Study|Lost to Follow-up|41|||
129094090|NCT04027075|464636024|FG001|Overall Study|Lost to Follow-up|22|||
129094091|NCT03769675|464636025|FG000|Overall Study|Lost to Follow-up|1|||
129094092|NCT01032070|464636028|FG000|Overall Study|Disease progression|13|||
129094093|NCT01032070|464636029|FG001|Overall Study|Disease progression|8|||
129094094|NCT01032070|464636028|FG000|Overall Study|Medical or ethical reasons|0|||
129094095|NCT01032070|464636029|FG001|Overall Study|Medical or ethical reasons|2|||
129094096|NCT01032070|464636028|FG000|Overall Study|Withdrawal by Subject|0|||
129094097|NCT01032070|464636029|FG001|Overall Study|Withdrawal by Subject|2|||
129094098|NCT02772276|464636030|FG000|Overall Study|Lost to Follow-up|0|||
129094099|NCT02772276|464636031|FG001|Overall Study|Lost to Follow-up|0|||
129094100|NCT02772276|464636032|FG002|Overall Study|Lost to Follow-up|0|||
129094101|NCT02772276|464636033|FG003|Overall Study|Lost to Follow-up|0|||
129094102|NCT02772276|464636034|FG004|Overall Study|Lost to Follow-up|0|||
129094103|NCT02772276|464636035|FG005|Overall Study|Lost to Follow-up|0|||
129094104|NCT02772276|464636036|FG006|Overall Study|Lost to Follow-up|1|||
129094105|NCT02772276|464636037|FG007|Overall Study|Lost to Follow-up|0|||
129094106|NCT02772276|464636038|FG008|Overall Study|Lost to Follow-up|0|||
129094107|NCT02772276|464636039|FG009|Overall Study|Lost to Follow-up|0|||
129094108|NCT02772276|464636040|FG010|Overall Study|Lost to Follow-up|0|||
129094109|NCT02772276|464636041|FG011|Overall Study|Lost to Follow-up|0|||
129094110|NCT02772276|464636042|FG012|Overall Study|Lost to Follow-up|0|||
129094111|NCT02772276|464636030|FG000|Overall Study|Withdrew consent|0|||
129094112|NCT02772276|464636031|FG001|Overall Study|Withdrew consent|0|||
129094113|NCT02772276|464636032|FG002|Overall Study|Withdrew consent|0|||
129094114|NCT02772276|464636033|FG003|Overall Study|Withdrew consent|0|||
129094115|NCT02772276|464636034|FG004|Overall Study|Withdrew consent|0|||
129094116|NCT02772276|464636035|FG005|Overall Study|Withdrew consent|0|||
129094117|NCT02772276|464636036|FG006|Overall Study|Withdrew consent|0|||
129094118|NCT02772276|464636037|FG007|Overall Study|Withdrew consent|1|||
129094119|NCT02772276|464636038|FG008|Overall Study|Withdrew consent|0|||
129094120|NCT02772276|464636039|FG009|Overall Study|Withdrew consent|0|||
129094121|NCT02772276|464636040|FG010|Overall Study|Withdrew consent|0|||
129094122|NCT02772276|464636041|FG011|Overall Study|Withdrew consent|0|||
129094123|NCT02772276|464636042|FG012|Overall Study|Withdrew consent|0|||
129094124|NCT00426660|464636043|FG000|Overall Study|Death|14|||
129094125|NCT00426660|464636043|FG000|Overall Study|Adverse Event|23|||
129094126|NCT00426660|464636043|FG000|Overall Study|Insufficient Clinical Response|22|||
129094127|NCT00426660|464636043|FG000|Overall Study|Lost to Follow-up|15|||
129094128|NCT00426660|464636043|FG000|Overall Study|Other|23|||
129094129|NCT00426660|464636043|FG000|Overall Study|Withdrawal by Subject|18|||
129094130|NCT00426660|464636043|FG000|Overall Study|Protocol Violation|1|||
129094131|NCT00426660|464636043|FG000|Overall Study|Enrolled Not Treated|15|||
128759789|NCT02831257|463410179|FG000|Overall Study|Withdrawal by Subject|6|||
129094132|NCT00738062|464636044|FG000|Open Label Treatment|Lack of Efficacy|5|||
129094133|NCT00738062|464636045|FG001|Open Label Treatment|Lack of Efficacy|0|||
129094134|NCT00738062|464636046|FG002|Open Label Treatment|Lack of Efficacy|0|||
129094135|NCT00738062|464636044|FG000|Open Label Treatment|Adverse Event|11|||
129094136|NCT00738062|464636045|FG001|Open Label Treatment|Adverse Event|0|||
129094137|NCT00738062|464636046|FG002|Open Label Treatment|Adverse Event|0|||
129094138|NCT00738062|464636044|FG000|Open Label Treatment|Protocol Violation|2|||
129094139|NCT00738062|464636045|FG001|Open Label Treatment|Protocol Violation|0|||
129094140|NCT00738062|464636046|FG002|Open Label Treatment|Protocol Violation|0|||
129094141|NCT00738062|464636044|FG000|Open Label Treatment|Withdrawal by Subject|9|||
129094142|NCT00738062|464636045|FG001|Open Label Treatment|Withdrawal by Subject|0|||
129094143|NCT00738062|464636046|FG002|Open Label Treatment|Withdrawal by Subject|0|||
129094144|NCT00738062|464636044|FG000|Open Label Treatment|Investigator Decision|1|||
129094145|NCT00738062|464636045|FG001|Open Label Treatment|Investigator Decision|0|||
129094146|NCT00738062|464636046|FG002|Open Label Treatment|Investigator Decision|0|||
129094147|NCT00738062|464636044|FG000|Open-Label Extension|Adverse Event|5|||
129094148|NCT00738062|464636045|FG001|Open-Label Extension|Adverse Event|0|||
129094149|NCT00738062|464636046|FG002|Open-Label Extension|Adverse Event|0|||
129094150|NCT00738062|464636044|FG000|Open-Label Extension|Physician Decision|1|||
129094151|NCT00738062|464636045|FG001|Open-Label Extension|Physician Decision|0|||
129094152|NCT00738062|464636046|FG002|Open-Label Extension|Physician Decision|0|||
129094153|NCT00738062|464636044|FG000|Open-Label Extension|Lack of Efficacy|2|||
129094154|NCT00738062|464636045|FG001|Open-Label Extension|Lack of Efficacy|0|||
129094155|NCT00738062|464636046|FG002|Open-Label Extension|Lack of Efficacy|0|||
129094156|NCT00738062|464636044|FG000|Open-Label Extension|Withdrawal by Subject|6|||
129094157|NCT00738062|464636045|FG001|Open-Label Extension|Withdrawal by Subject|0|||
129094158|NCT00738062|464636046|FG002|Open-Label Extension|Withdrawal by Subject|0|||
129094159|NCT00738062|464636044|FG000|Open-Label Extension|Protocol Violation|1|||
129094160|NCT00738062|464636045|FG001|Open-Label Extension|Protocol Violation|0|||
129094161|NCT00738062|464636046|FG002|Open-Label Extension|Protocol Violation|0|||
129094162|NCT00738062|464636044|FG000|Open-Label Extension|Study Terminated|2|||
129094163|NCT00738062|464636045|FG001|Open-Label Extension|Study Terminated|0|||
129205016|NCT01381016|465047819|FG001|Overall Study|Screen Failure|2|||
129205017|NCT01381016|465047818|FG000|Overall Study|Withdrawal by Subject|0|||
129205018|NCT01381016|465047819|FG001|Overall Study|Withdrawal by Subject|1|||
129205019|NCT01381016|465047818|FG000|Overall Study|Physician Decision|0|||
129205020|NCT01381016|465047819|FG001|Overall Study|Physician Decision|2|||
129205021|NCT01631435|465047820|FG000|Overall Study|Adverse Event|2|||
129205022|NCT01631435|465047820|FG000|Overall Study|Withdrawal by Subject|2|||
129205023|NCT01631435|465047820|FG000|Overall Study|incomplete study procedure|5|||
129205024|NCT01005251|465047824|FG000|Overall Study|Withdrawal by Subject|2|||
129205025|NCT01005251|465047825|FG001|Overall Study|Withdrawal by Subject|5|||
129205026|NCT01005251|465047826|FG002|Overall Study|Withdrawal by Subject|3|||
129205027|NCT01005251|465047827|FG003|Overall Study|Withdrawal by Subject|4|||
129205028|NCT01005251|465047828|FG004|Overall Study|Withdrawal by Subject|9|||
129205029|NCT01005251|465047824|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
129205030|NCT01005251|465047825|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129205031|NCT01005251|465047826|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
129205032|NCT01005251|465047827|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129205033|NCT01005251|465047828|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129205034|NCT01005251|465047824|FG000|Overall Study|Adverse Event|2|||
129205035|NCT01005251|465047825|FG001|Overall Study|Adverse Event|6|||
129205036|NCT01005251|465047826|FG002|Overall Study|Adverse Event|8|||
129205037|NCT01005251|465047827|FG003|Overall Study|Adverse Event|5|||
129205038|NCT01005251|465047828|FG004|Overall Study|Adverse Event|4|||
129205039|NCT01005251|465047824|FG000|Overall Study|Protocol Violation|1|||
129205040|NCT01005251|465047825|FG001|Overall Study|Protocol Violation|0|||
129205041|NCT01005251|465047826|FG002|Overall Study|Protocol Violation|0|||
129205042|NCT01005251|465047827|FG003|Overall Study|Protocol Violation|0|||
129205043|NCT01005251|465047828|FG004|Overall Study|Protocol Violation|2|||
129205044|NCT01005251|465047824|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
129205045|NCT01005251|465047825|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
129205046|NCT01005251|465047826|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
129205047|NCT01005251|465047827|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
129205048|NCT01005251|465047828|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
129205049|NCT01005251|465047824|FG000|Overall Study|Lost to Follow-up|1|||
129205050|NCT01005251|465047825|FG001|Overall Study|Lost to Follow-up|4|||
129205051|NCT01005251|465047826|FG002|Overall Study|Lost to Follow-up|2|||
129205052|NCT01005251|465047827|FG003|Overall Study|Lost to Follow-up|0|||
129205053|NCT01005251|465047828|FG004|Overall Study|Lost to Follow-up|0|||
129205054|NCT01005251|465047824|FG000|Overall Study|Physician Decision|0|||
129205055|NCT01005251|465047825|FG001|Overall Study|Physician Decision|0|||
129205056|NCT01005251|465047826|FG002|Overall Study|Physician Decision|0|||
129205057|NCT01005251|465047827|FG003|Overall Study|Physician Decision|0|||
129205058|NCT01005251|465047828|FG004|Overall Study|Physician Decision|2|||
128759790|NCT00855595|463410180|FG000|Overall Study|Withdrawal by Subject|1|||
129205059|NCT01005251|465047824|FG000|Overall Study|Patient moved|1|||
129205060|NCT01005251|465047825|FG001|Overall Study|Patient moved|0|||
129205061|NCT01005251|465047826|FG002|Overall Study|Patient moved|0|||
129205062|NCT01005251|465047827|FG003|Overall Study|Patient moved|0|||
129205063|NCT01005251|465047828|FG004|Overall Study|Patient moved|0|||
129205064|NCT01005251|465047824|FG000|Overall Study|Wrong drug dispensed|0|||
129205065|NCT01005251|465047825|FG001|Overall Study|Wrong drug dispensed|1|||
129205066|NCT01005251|465047826|FG002|Overall Study|Wrong drug dispensed|0|||
129205067|NCT01005251|465047827|FG003|Overall Study|Wrong drug dispensed|0|||
129205068|NCT01005251|465047828|FG004|Overall Study|Wrong drug dispensed|0|||
129205069|NCT01005251|465047824|FG000|Overall Study|Randomized in error|0|||
129205070|NCT01005251|465047825|FG001|Overall Study|Randomized in error|0|||
129205071|NCT01005251|465047826|FG002|Overall Study|Randomized in error|1|||
129205072|NCT01005251|465047827|FG003|Overall Study|Randomized in error|1|||
129205073|NCT01005251|465047828|FG004|Overall Study|Randomized in error|0|||
129205074|NCT01005251|465047824|FG000|Overall Study|Lack of Efficacy|0|||
129205075|NCT01005251|465047825|FG001|Overall Study|Lack of Efficacy|0|||
129205076|NCT01005251|465047826|FG002|Overall Study|Lack of Efficacy|1|||
129205077|NCT01005251|465047827|FG003|Overall Study|Lack of Efficacy|1|||
129205078|NCT01005251|465047828|FG004|Overall Study|Lack of Efficacy|0|||
129205079|NCT00141453|465047835|FG000|Overall Study|Protocol Violation|6|||
129205080|NCT00141453|465047836|FG001|Overall Study|Protocol Violation|5|||
129205081|NCT02055898|465047837|FG000|First Intervention (5 Days)|Physician Decision|2|||
129205082|NCT02055898|465047838|FG001|First Intervention (5 Days)|Physician Decision|0|||
129205083|NCT02055898|465047837|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
129205084|NCT02055898|465047838|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
129205085|NCT01620060|465047839|FG000|Overall Study|Adverse Event|9|||
129205086|NCT01620060|465047839|FG000|Overall Study|Protocol Violation|1|||
129205087|NCT01620060|465047839|FG000|Overall Study|Withdrawal by Subject|1|||
129205088|NCT01620060|465047839|FG000|Overall Study|Did not comply with Study Produre|1|||
129205089|NCT01620060|465047839|FG000|Overall Study|Family emergency|1|||
129205090|NCT01620060|465047839|FG000|Overall Study|Per Sponsor Decision|2|||
129205091|NCT00231777|465047840|FG000|Overall Study|Lost to Follow-up|3|||
129205092|NCT00231777|465047841|FG001|Overall Study|Lost to Follow-up|0|||
129205093|NCT00231777|465047840|FG000|Overall Study|Other|3|||
129205094|NCT00231777|465047841|FG001|Overall Study|Other|2|||
129205095|NCT04551989|465047844|FG000|Overall Study|Adverse Event|4|||
129205096|NCT04551989|465047844|FG000|Overall Study|Protocol Violation|3|||
129205097|NCT04551989|465047844|FG000|Overall Study|Lost to Follow-up|1|||
129205098|NCT04551989|465047844|FG000|Overall Study|Physician Decision|3|||
129205099|NCT04698343|465047845|FG000|Overall Study|Withdrawal by Subject|6|||
129205100|NCT04698343|465047845|FG000|Overall Study|Physician Decision|2|||
129205101|NCT04698343|465047845|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
129205102|NCT04698343|465047845|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
129205103|NCT04698343|465047845|FG000|Overall Study|Personal reasons|3|||
129205104|NCT04698343|465047845|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
129205105|NCT00088530|465047846|FG000|Overall Study|Progressive/Relapsed Disease|28|||
129205106|NCT00088530|465047847|FG001|Overall Study|Progressive/Relapsed Disease|39|||
129205107|NCT00088530|465047846|FG000|Overall Study|Adverse Event|15|||
129205108|NCT00088530|465047847|FG001|Overall Study|Adverse Event|9|||
129205109|NCT00088530|465047846|FG000|Overall Study|Withdrawal by Subject|2|||
129205110|NCT00088530|465047847|FG001|Overall Study|Withdrawal by Subject|5|||
129205111|NCT00088530|465047846|FG000|Overall Study|Lost to Follow-up|2|||
129205112|NCT00088530|465047847|FG001|Overall Study|Lost to Follow-up|0|||
129205113|NCT00088530|465047846|FG000|Overall Study|Physician Decision|2|||
129205114|NCT00088530|465047847|FG001|Overall Study|Physician Decision|0|||
129205115|NCT00088530|465047846|FG000|Overall Study|Sponsor decision|0|||
129205116|NCT00088530|465047847|FG001|Overall Study|Sponsor decision|1|||
129205117|NCT00088530|465047846|FG000|Overall Study|Patient never treated|1|||
129205118|NCT00088530|465047847|FG001|Overall Study|Patient never treated|0|||
129205119|NCT00739401|465047848|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
129205120|NCT00739401|465047848|FG000|Overall Study|Death|3|||
129205121|NCT00739401|465047848|FG000|Overall Study|Withdrawal by Subject|4|||
129205122|NCT04575155|465047849|FG000|2 Month|Withdrawal by Subject|1|||
129205123|NCT04575155|465047850|FG001|2 Month|Withdrawal by Subject|1|||
129205124|NCT04575155|465047849|FG000|2 Month|Lost to Follow-up|5|||
129094164|NCT00738062|464636046|FG002|Open-Label Extension|Study Terminated|0|||
129094165|NCT00455520|464636047|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
129205125|NCT04575155|465047850|FG001|2 Month|Lost to Follow-up|3|||
129205126|NCT04575155|465047849|FG000|2 Month|Ineligible|1|||
129205127|NCT04575155|465047850|FG001|2 Month|Ineligible|0|||
128982153|NCT02926833|464220980|FG000|Overall Study|Lost to Follow-up|1|||
129205128|NCT00660192|465047851|FG000|Overall Study|Lost to Follow-up|2|||
129205129|NCT00660192|465047852|FG001|Overall Study|Lost to Follow-up|3|||
129205130|NCT00982735|465047853|FG000|Overall Study|Lost to Follow-up|6|||
129205131|NCT00982735|465047853|FG000|Overall Study|Patient ineligible for trial|224|||
129205132|NCT01601535|465047856|FG000|Phase 1|Adverse Event|1|||
129205133|NCT01601535|465047857|FG001|Phase 1|Adverse Event|0|||
129205134|NCT01601535|465047858|FG002|Phase 1|Adverse Event|2|||
129205135|NCT01601535|465047859|FG003|Phase 1|Adverse Event|1|||
129205136|NCT01601535|465047860|FG004|Phase 1|Adverse Event|0|||
129205137|NCT01601535|465047861|FG005|Phase 1|Adverse Event|0|||
129205138|NCT01601535|465047856|FG000|Phase 1|Withdrawal by Subject|2|||
129205139|NCT01601535|465047857|FG001|Phase 1|Withdrawal by Subject|1|||
129205140|NCT01601535|465047858|FG002|Phase 1|Withdrawal by Subject|1|||
129205141|NCT01601535|465047859|FG003|Phase 1|Withdrawal by Subject|2|||
129205142|NCT01601535|465047860|FG004|Phase 1|Withdrawal by Subject|0|||
129205143|NCT01601535|465047861|FG005|Phase 1|Withdrawal by Subject|0|||
129205144|NCT01601535|465047856|FG000|Phase 1|Progressive Disease|2|||
129205145|NCT01601535|465047857|FG001|Phase 1|Progressive Disease|3|||
129205146|NCT01601535|465047858|FG002|Phase 1|Progressive Disease|2|||
129205147|NCT01601535|465047859|FG003|Phase 1|Progressive Disease|1|||
129205148|NCT01601535|465047860|FG004|Phase 1|Progressive Disease|0|||
129205149|NCT01601535|465047861|FG005|Phase 1|Progressive Disease|0|||
129205150|NCT01601535|465047856|FG000|Phase 1|Started Another Treatment|1|||
129205151|NCT01601535|465047857|FG001|Phase 1|Started Another Treatment|2|||
129205152|NCT01601535|465047858|FG002|Phase 1|Started Another Treatment|0|||
129205153|NCT01601535|465047859|FG003|Phase 1|Started Another Treatment|0|||
129205154|NCT01601535|465047860|FG004|Phase 1|Started Another Treatment|0|||
129205155|NCT01601535|465047861|FG005|Phase 1|Started Another Treatment|0|||
129205156|NCT01601535|465047856|FG000|Phase 2|Adverse Event|0|||
129205157|NCT01601535|465047857|FG001|Phase 2|Adverse Event|0|||
129205158|NCT01601535|465047858|FG002|Phase 2|Adverse Event|0|||
129205159|NCT01601535|465047859|FG003|Phase 2|Adverse Event|0|||
129205160|NCT01601535|465047860|FG004|Phase 2|Adverse Event|5|||
129205161|NCT01601535|465047861|FG005|Phase 2|Adverse Event|1|||
129205162|NCT01601535|465047856|FG000|Phase 2|Withdrawal by Subject|0|||
129205163|NCT01601535|465047857|FG001|Phase 2|Withdrawal by Subject|0|||
129205164|NCT01601535|465047858|FG002|Phase 2|Withdrawal by Subject|0|||
129205165|NCT01601535|465047859|FG003|Phase 2|Withdrawal by Subject|0|||
129205166|NCT01601535|465047860|FG004|Phase 2|Withdrawal by Subject|8|||
129205167|NCT01601535|465047861|FG005|Phase 2|Withdrawal by Subject|2|||
129205168|NCT01601535|465047856|FG000|Phase 2|Progressive Disease|0|||
129205169|NCT01601535|465047857|FG001|Phase 2|Progressive Disease|0|||
129205170|NCT01601535|465047858|FG002|Phase 2|Progressive Disease|0|||
129205171|NCT01601535|465047859|FG003|Phase 2|Progressive Disease|0|||
129205172|NCT01601535|465047860|FG004|Phase 2|Progressive Disease|5|||
129205173|NCT01601535|465047861|FG005|Phase 2|Progressive Disease|7|||
129205174|NCT01601535|465047856|FG000|Phase 2|Started Another Treatment|0|||
129205175|NCT01601535|465047857|FG001|Phase 2|Started Another Treatment|0|||
128759791|NCT00855595|463410181|FG001|Overall Study|Withdrawal by Subject|2|||
128759792|NCT00855595|463410180|FG000|Overall Study|Lost to Follow-up|3|||
128759793|NCT00855595|463410181|FG001|Overall Study|Lost to Follow-up|3|||
128759794|NCT00855595|463410180|FG000|Overall Study|Adverse Event|1|||
129205176|NCT01601535|465047858|FG002|Phase 2|Started Another Treatment|0|||
129205177|NCT01601535|465047859|FG003|Phase 2|Started Another Treatment|0|||
129205178|NCT01601535|465047860|FG004|Phase 2|Started Another Treatment|1|||
129205179|NCT01601535|465047861|FG005|Phase 2|Started Another Treatment|2|||
129205180|NCT01787461|465047864|FG000|Overall Study|Adverse Event|4|||
129205181|NCT01787461|465047865|FG001|Overall Study|Adverse Event|3|||
129205182|NCT01787461|465047864|FG000|Overall Study|Lost to Follow-up|3|||
129205183|NCT01787461|465047865|FG001|Overall Study|Lost to Follow-up|2|||
129205184|NCT01787461|465047864|FG000|Overall Study|No longer met eligibility criteria|1|||
129205185|NCT01787461|465047865|FG001|Overall Study|No longer met eligibility criteria|0|||
129205186|NCT01787461|465047864|FG000|Overall Study|Withdrawal by Subject|3|||
129205187|NCT01787461|465047865|FG001|Overall Study|Withdrawal by Subject|4|||
129205188|NCT01787461|465047864|FG000|Overall Study|Protocol Violation|3|||
129205189|NCT01787461|465047865|FG001|Overall Study|Protocol Violation|0|||
129205190|NCT04879628|465047866|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
129205191|NCT04879628|465047867|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
129205192|NCT04879628|465047868|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
129205193|NCT04879628|465047869|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
129205194|NCT04879628|465047866|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
128982154|NCT02926833|464220981|FG001|Overall Study|Lost to Follow-up|2|||
129205195|NCT04879628|465047867|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
129205196|NCT04879628|465047868|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
129205197|NCT04879628|465047869|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
129205198|NCT04879628|465047866|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
129205199|NCT04879628|465047867|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
129205200|NCT04879628|465047868|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
129205201|NCT04879628|465047869|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
129205202|NCT04879628|465047866|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
129205203|NCT04879628|465047867|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
129205204|NCT04879628|465047868|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
129205205|NCT04879628|465047869|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
129205206|NCT03649074|465047870|FG000|Overall Study|Lost to Follow-up|2|||
129205207|NCT03649074|465047871|FG001|Overall Study|Lost to Follow-up|1|||
128759795|NCT00855595|463410181|FG001|Overall Study|Adverse Event|1|||
129205208|NCT03649074|465047870|FG000|Overall Study|Adverse Event|1|||
129205209|NCT03649074|465047871|FG001|Overall Study|Adverse Event|0|||
129205210|NCT03649074|465047870|FG000|Overall Study|Physician Decision|1|||
129205211|NCT03649074|465047871|FG001|Overall Study|Physician Decision|0|||
129205212|NCT03649074|465047870|FG000|Overall Study|Withdrawal by Subject|0|||
129205213|NCT03649074|465047871|FG001|Overall Study|Withdrawal by Subject|2|||
129205214|NCT03649074|465047870|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
129205215|NCT03649074|465047871|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
129205216|NCT03649074|465047870|FG000|Overall Study|Other|1|||
129205217|NCT03649074|465047871|FG001|Overall Study|Other|0|||
129205218|NCT00556894|465047872|FG000|Overall Study|Adverse Event|2|||
129205219|NCT00556894|465047873|FG001|Overall Study|Adverse Event|3|||
129205220|NCT00556894|465047874|FG002|Overall Study|Adverse Event|3|||
129205221|NCT00556894|465047872|FG000|Overall Study|Death|1|||
129205222|NCT00556894|465047873|FG001|Overall Study|Death|0|||
129205223|NCT00556894|465047874|FG002|Overall Study|Death|0|||
129205224|NCT00556894|465047872|FG000|Overall Study|regulatory decision in Bulgaria|10|||
129205225|NCT00556894|465047873|FG001|Overall Study|regulatory decision in Bulgaria|14|||
129205226|NCT00556894|465047874|FG002|Overall Study|regulatory decision in Bulgaria|13|||
129205227|NCT00556894|465047872|FG000|Overall Study|Change in therapy|2|||
129205228|NCT00556894|465047873|FG001|Overall Study|Change in therapy|1|||
129205229|NCT00556894|465047874|FG002|Overall Study|Change in therapy|2|||
129205230|NCT00556894|465047872|FG000|Overall Study|Withdrawal by Subject|1|||
129205231|NCT00556894|465047873|FG001|Overall Study|Withdrawal by Subject|1|||
129205232|NCT00556894|465047874|FG002|Overall Study|Withdrawal by Subject|1|||
129205233|NCT04612725|465047877|FG000|Overall Study|Adverse Event|1|||
129205234|NCT04612725|465047878|FG001|Overall Study|Adverse Event|3|||
129205235|NCT04612725|465047879|FG002|Overall Study|Adverse Event|1|||
129205236|NCT04612725|465047880|FG003|Overall Study|Adverse Event|0|||
129205237|NCT04612725|465047881|FG004|Overall Study|Adverse Event|1|||
129205238|NCT04612725|465047877|FG000|Overall Study|Lost to Follow-up|0|||
129205239|NCT04612725|465047878|FG001|Overall Study|Lost to Follow-up|1|||
129205240|NCT04612725|465047879|FG002|Overall Study|Lost to Follow-up|0|||
129205241|NCT04612725|465047880|FG003|Overall Study|Lost to Follow-up|0|||
129205242|NCT04612725|465047881|FG004|Overall Study|Lost to Follow-up|0|||
129205243|NCT04612725|465047877|FG000|Overall Study|Physician Decision|2|||
129205244|NCT04612725|465047878|FG001|Overall Study|Physician Decision|0|||
129205245|NCT04612725|465047879|FG002|Overall Study|Physician Decision|0|||
129205246|NCT04612725|465047880|FG003|Overall Study|Physician Decision|0|||
129205247|NCT04612725|465047881|FG004|Overall Study|Physician Decision|0|||
129205248|NCT04612725|465047877|FG000|Overall Study|Study terminated by sponsor|3|||
129205249|NCT04612725|465047878|FG001|Overall Study|Study terminated by sponsor|1|||
129205250|NCT04612725|465047879|FG002|Overall Study|Study terminated by sponsor|2|||
129205251|NCT04612725|465047880|FG003|Overall Study|Study terminated by sponsor|4|||
129205252|NCT04612725|465047881|FG004|Overall Study|Study terminated by sponsor|5|||
129205253|NCT04612725|465047877|FG000|Overall Study|Withdrawal by Subject|8|||
129205254|NCT04612725|465047878|FG001|Overall Study|Withdrawal by Subject|3|||
129205255|NCT04612725|465047879|FG002|Overall Study|Withdrawal by Subject|5|||
129205256|NCT04612725|465047880|FG003|Overall Study|Withdrawal by Subject|1|||
129205257|NCT04612725|465047881|FG004|Overall Study|Withdrawal by Subject|9|||
129205258|NCT04612725|465047877|FG000|Overall Study|Other|0|||
129205259|NCT04612725|465047878|FG001|Overall Study|Other|0|||
129205260|NCT04612725|465047879|FG002|Overall Study|Other|0|||
129205261|NCT04612725|465047880|FG003|Overall Study|Other|0|||
129205262|NCT04612725|465047881|FG004|Overall Study|Other|1|||
129205263|NCT05190120|465047882|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
129205264|NCT05190120|465047883|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
129205265|NCT05190120|465047884|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
129205266|NCT05190120|465047885|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
129205267|NCT05190120|465047882|FG000|Overall Study|Lost to Follow-up|5|||
129205268|NCT05190120|465047883|FG001|Overall Study|Lost to Follow-up|0|||
129205269|NCT05190120|465047884|FG002|Overall Study|Lost to Follow-up|2|||
129205270|NCT05190120|465047885|FG003|Overall Study|Lost to Follow-up|3|||
129205271|NCT02354235|465047886|FG000|Overall Study|Adverse Event|2|||
129205272|NCT02354235|465047887|FG001|Overall Study|Adverse Event|2|||
129205273|NCT02354235|465047886|FG000|Overall Study|Physician Decision|0|||
129205274|NCT02354235|465047887|FG001|Overall Study|Physician Decision|1|||
129205275|NCT02354235|465047886|FG000|Overall Study|Withdrawal by Subject|1|||
129205276|NCT02354235|465047887|FG001|Overall Study|Withdrawal by Subject|3|||
129205277|NCT02354235|465047886|FG000|Overall Study|Conflict with the stopping criteria|0|||
129205278|NCT02354235|465047887|FG001|Overall Study|Conflict with the stopping criteria|1|||
129205279|NCT03069352|465047888|FG000|Overall Study|Ongoing|12|||
129205280|NCT03069352|465047889|FG001|Overall Study|Ongoing|40|||
129205281|NCT02621424|465047890|FG000|Overall Study|Withdrawal by Subject|1|||
129205282|NCT02621424|465047891|FG001|Overall Study|Withdrawal by Subject|2|||
129205283|NCT04750642|465047894|FG000|Overall Study|Adverse Event|1|||
129094166|NCT00455520|464636048|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
129205284|NCT04750642|465047895|FG001|Overall Study|Adverse Event|0|||
129205285|NCT04750642|465047894|FG000|Overall Study|Withdrawal by Subject|0|||
129205286|NCT04750642|465047895|FG001|Overall Study|Withdrawal by Subject|1|||
129205287|NCT04750642|465047894|FG000|Overall Study|Protocol Violation|0|||
129205288|NCT04750642|465047895|FG001|Overall Study|Protocol Violation|1|||
129205289|NCT00336024|465047897|FG000|Overall Study|Death|2|||
129205290|NCT00336024|465047898|FG001|Overall Study|Death|1|||
129205291|NCT00336024|465047897|FG000|Overall Study|Physician Decision|4|||
129205292|NCT00336024|465047898|FG001|Overall Study|Physician Decision|1|||
129205293|NCT00336024|465047897|FG000|Overall Study|Protocol Violation|1|||
129205294|NCT00336024|465047898|FG001|Overall Study|Protocol Violation|0|||
129205295|NCT00336024|465047897|FG000|Overall Study|Withdrawal by Subject|1|||
129205296|NCT00336024|465047898|FG001|Overall Study|Withdrawal by Subject|2|||
129205297|NCT00336024|465047897|FG000|Overall Study|Failure to fulfill consolidation|1|||
129205298|NCT00336024|465047898|FG001|Overall Study|Failure to fulfill consolidation|1|||
129205299|NCT00336024|465047897|FG000|Overall Study|Progressive Disease|4|||
129205300|NCT00336024|465047898|FG001|Overall Study|Progressive Disease|7|||
129205301|NCT00336024|465047897|FG000|Overall Study|Ineligible|7|||
129205302|NCT00336024|465047898|FG001|Overall Study|Ineligible|7|||
129222100|NCT03184870|465116025|FG009|Initial Treatment|Death|2|||
129222101|NCT03184870|465116026|FG010|Initial Treatment|Death|26|||
129222102|NCT03184870|465116027|FG011|Initial Treatment|Death|28|||
129222103|NCT03184870|465116028|FG012|Initial Treatment|Death|10|||
129222104|NCT03184870|465116029|FG013|Initial Treatment|Death|33|||
129222105|NCT03184870|465116030|FG014|Initial Treatment|Death|34|||
129222106|NCT03184870|465116031|FG015|Initial Treatment|Death|26|||
129222107|NCT03184870|465116032|FG016|Initial Treatment|Death|20|||
129222108|NCT03184870|465116033|FG017|Initial Treatment|Death|18|||
129222109|NCT03184870|465116016|FG000|Initial Treatment|Other Reasons|2|||
129222110|NCT03184870|465116017|FG001|Initial Treatment|Other Reasons|2|||
129222111|NCT03184870|465116018|FG002|Initial Treatment|Other Reasons|0|||
129222112|NCT03184870|465116019|FG003|Initial Treatment|Other Reasons|1|||
129222113|NCT03184870|465116020|FG004|Initial Treatment|Other Reasons|0|||
129222114|NCT03184870|465116021|FG005|Initial Treatment|Other Reasons|0|||
129222115|NCT03184870|465116022|FG006|Initial Treatment|Other Reasons|0|||
129222116|NCT03184870|465116023|FG007|Initial Treatment|Other Reasons|2|||
129222117|NCT03184870|465116024|FG008|Initial Treatment|Other Reasons|0|||
129222118|NCT03184870|465116025|FG009|Initial Treatment|Other Reasons|0|||
129222119|NCT03184870|465116026|FG010|Initial Treatment|Other Reasons|4|||
129222120|NCT03184870|465116027|FG011|Initial Treatment|Other Reasons|2|||
129222121|NCT03184870|465116028|FG012|Initial Treatment|Other Reasons|2|||
129222122|NCT03184870|465116029|FG013|Initial Treatment|Other Reasons|0|||
129222123|NCT03184870|465116030|FG014|Initial Treatment|Other Reasons|0|||
129222124|NCT03184870|465116031|FG015|Initial Treatment|Other Reasons|1|||
129222125|NCT03184870|465116032|FG016|Initial Treatment|Other Reasons|0|||
129222126|NCT03184870|465116033|FG017|Initial Treatment|Other Reasons|2|||
129222127|NCT03184870|465116016|FG000|Initial Treatment|Lost to Follow-up|2|||
129222128|NCT03184870|465116017|FG001|Initial Treatment|Lost to Follow-up|0|||
129222129|NCT03184870|465116018|FG002|Initial Treatment|Lost to Follow-up|0|||
129222130|NCT03184870|465116019|FG003|Initial Treatment|Lost to Follow-up|1|||
129222131|NCT03184870|465116020|FG004|Initial Treatment|Lost to Follow-up|1|||
129222132|NCT03184870|465116021|FG005|Initial Treatment|Lost to Follow-up|1|||
129222133|NCT03184870|465116022|FG006|Initial Treatment|Lost to Follow-up|0|||
129222134|NCT03184870|465116023|FG007|Initial Treatment|Lost to Follow-up|2|||
129222135|NCT03184870|465116024|FG008|Initial Treatment|Lost to Follow-up|0|||
129222136|NCT03184870|465116025|FG009|Initial Treatment|Lost to Follow-up|0|||
129222137|NCT03184870|465116026|FG010|Initial Treatment|Lost to Follow-up|2|||
129222138|NCT03184870|465116027|FG011|Initial Treatment|Lost to Follow-up|0|||
129222139|NCT03184870|465116028|FG012|Initial Treatment|Lost to Follow-up|2|||
129222140|NCT03184870|465116029|FG013|Initial Treatment|Lost to Follow-up|2|||
129222141|NCT03184870|465116030|FG014|Initial Treatment|Lost to Follow-up|0|||
129222142|NCT03184870|465116031|FG015|Initial Treatment|Lost to Follow-up|0|||
129222143|NCT03184870|465116032|FG016|Initial Treatment|Lost to Follow-up|2|||
129222144|NCT03184870|465116033|FG017|Initial Treatment|Lost to Follow-up|2|||
129222145|NCT03184870|465116016|FG000|Initial Treatment|Withdrawal by Subject|0|||
129222146|NCT03184870|465116017|FG001|Initial Treatment|Withdrawal by Subject|0|||
129222147|NCT03184870|465116018|FG002|Initial Treatment|Withdrawal by Subject|2|||
129222148|NCT03184870|465116019|FG003|Initial Treatment|Withdrawal by Subject|1|||
129094167|NCT00455520|464636047|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
129222149|NCT03184870|465116020|FG004|Initial Treatment|Withdrawal by Subject|1|||
129222150|NCT03184870|465116021|FG005|Initial Treatment|Withdrawal by Subject|0|||
129222151|NCT03184870|465116022|FG006|Initial Treatment|Withdrawal by Subject|1|||
129222152|NCT03184870|465116023|FG007|Initial Treatment|Withdrawal by Subject|0|||
129222153|NCT03184870|465116024|FG008|Initial Treatment|Withdrawal by Subject|0|||
129222154|NCT03184870|465116025|FG009|Initial Treatment|Withdrawal by Subject|0|||
129222155|NCT03184870|465116026|FG010|Initial Treatment|Withdrawal by Subject|0|||
129222156|NCT03184870|465116027|FG011|Initial Treatment|Withdrawal by Subject|2|||
129222157|NCT03184870|465116028|FG012|Initial Treatment|Withdrawal by Subject|3|||
129205303|NCT01519323|465049801|FG000|Overall Study|Death|3|||
129205304|NCT01519323|465049802|FG001|Overall Study|Death|2|||
129205305|NCT01519323|465049801|FG000|Overall Study|Study terminated by sponsor|0|||
129205306|NCT01519323|465049802|FG001|Overall Study|Study terminated by sponsor|1|||
129205307|NCT03096834|465049805|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
129205308|NCT03096834|465049806|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
129205309|NCT03096834|465049807|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
129205310|NCT03096834|465049808|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
129205311|NCT03096834|465049805|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
129205312|NCT03096834|465049806|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
129205313|NCT03096834|465049807|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
129205314|NCT03096834|465049808|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
129205315|NCT03096834|465049805|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
129205316|NCT03096834|465049806|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
129205317|NCT03096834|465049807|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
129205318|NCT03096834|465049808|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
129205319|NCT03096834|465049805|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
129205320|NCT03096834|465049806|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
129205321|NCT03096834|465049807|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
129205322|NCT03096834|465049808|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
129205323|NCT03096834|465049805|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
129205324|NCT03096834|465049806|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
129205325|NCT03096834|465049807|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
129205326|NCT03096834|465049808|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
129205327|NCT03096834|465049805|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
129205328|NCT03096834|465049806|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
129205329|NCT03096834|465049807|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
129205330|NCT03096834|465049808|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
129205331|NCT03096834|465049805|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
129205332|NCT03096834|465049806|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
129205333|NCT03096834|465049807|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
129205334|NCT03096834|465049808|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
129205335|NCT03096834|465049805|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
129205336|NCT03096834|465049806|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
129205337|NCT03096834|465049807|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
129205338|NCT03096834|465049808|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
129205339|NCT03096834|465049805|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
129205340|NCT03096834|465049806|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
129205341|NCT03096834|465049807|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
129205342|NCT03096834|465049808|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
129205343|NCT03096834|465049805|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
129205344|NCT03096834|465049806|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
129205345|NCT03096834|465049807|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
129205346|NCT03096834|465049808|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
129205347|NCT03096834|465049805|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
129205348|NCT03096834|465049806|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
129205349|NCT03096834|465049807|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
129205350|NCT03096834|465049808|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
129205351|NCT03096834|465049805|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
129205352|NCT03096834|465049806|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
129205353|NCT03096834|465049807|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
129205354|NCT03096834|465049808|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
129205355|NCT04416204|465049809|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
129205356|NCT04416204|465049810|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
129205357|NCT04416204|465049811|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
129205358|NCT04416204|465049812|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
129205359|NCT04456504|465049813|FG000|Overall Study|Lost to Follow-up|2|||
129205360|NCT01451723|465049817|FG000|Overall Study|study halted|6|||
129205361|NCT01451723|465049818|FG001|Overall Study|study halted|5|||
129205362|NCT00443040|465049821|FG000|Overall Study|Withdrawal by Subject|1|||
129205363|NCT00443040|465049822|FG001|Overall Study|Withdrawal by Subject|0|||
129205364|NCT00443040|465049823|FG002|Overall Study|Withdrawal by Subject|0|||
129205365|NCT00443040|465049821|FG000|Overall Study|Converted to an open laparotomy|3|||
129205366|NCT00443040|465049822|FG001|Overall Study|Converted to an open laparotomy|0|||
129205367|NCT00443040|465049823|FG002|Overall Study|Converted to an open laparotomy|1|||
128759796|NCT00855595|463410180|FG000|Overall Study|patient moved out of state|1|||
129205368|NCT04245111|465049824|FG000|Overall Study|Lost to Follow-up|5|||
129205369|NCT04245111|465049825|FG001|Overall Study|Lost to Follow-up|1|||
129205370|NCT04245111|465049826|FG002|Overall Study|Lost to Follow-up|1|||
129205371|NCT03192176|465049827|FG000|Overall Study|Adverse Event|1|||
129205372|NCT03192176|465049828|FG001|Overall Study|Adverse Event|0|||
129205373|NCT03192176|465049829|FG002|Overall Study|Adverse Event|4|||
129205374|NCT03192176|465049830|FG003|Overall Study|Adverse Event|5|||
129205375|NCT03192176|465049831|FG004|Overall Study|Adverse Event|3|||
129205376|NCT03192176|465049832|FG005|Overall Study|Adverse Event|2|||
129205377|NCT03192176|465049833|FG006|Overall Study|Adverse Event|3|||
129205378|NCT03192176|465049834|FG007|Overall Study|Adverse Event|3|||
129205379|NCT03192176|465049827|FG000|Overall Study|Lost to Follow-up|0|||
129205380|NCT03192176|465049828|FG001|Overall Study|Lost to Follow-up|0|||
129205381|NCT03192176|465049829|FG002|Overall Study|Lost to Follow-up|1|||
129205382|NCT03192176|465049830|FG003|Overall Study|Lost to Follow-up|2|||
129205383|NCT03192176|465049831|FG004|Overall Study|Lost to Follow-up|3|||
129205384|NCT03192176|465049832|FG005|Overall Study|Lost to Follow-up|1|||
129205385|NCT03192176|465049833|FG006|Overall Study|Lost to Follow-up|1|||
129205386|NCT03192176|465049834|FG007|Overall Study|Lost to Follow-up|1|||
129205387|NCT03192176|465049827|FG000|Overall Study|Physician Decision|1|||
129205388|NCT03192176|465049828|FG001|Overall Study|Physician Decision|0|||
129205389|NCT03192176|465049829|FG002|Overall Study|Physician Decision|0|||
129205390|NCT03192176|465049830|FG003|Overall Study|Physician Decision|0|||
129205391|NCT03192176|465049831|FG004|Overall Study|Physician Decision|0|||
129205392|NCT03192176|465049832|FG005|Overall Study|Physician Decision|2|||
129205393|NCT03192176|465049833|FG006|Overall Study|Physician Decision|1|||
129205394|NCT03192176|465049834|FG007|Overall Study|Physician Decision|0|||
129205395|NCT03192176|465049827|FG000|Overall Study|Protocol Deviation|1|||
129205396|NCT03192176|465049828|FG001|Overall Study|Protocol Deviation|1|||
129205397|NCT03192176|465049829|FG002|Overall Study|Protocol Deviation|0|||
129205398|NCT03192176|465049830|FG003|Overall Study|Protocol Deviation|0|||
129205399|NCT03192176|465049831|FG004|Overall Study|Protocol Deviation|2|||
129205400|NCT03192176|465049832|FG005|Overall Study|Protocol Deviation|0|||
129205401|NCT03192176|465049833|FG006|Overall Study|Protocol Deviation|0|||
129205402|NCT03192176|465049834|FG007|Overall Study|Protocol Deviation|0|||
129205403|NCT03192176|465049827|FG000|Overall Study|Withdrawal by Subject|3|||
129205404|NCT03192176|465049828|FG001|Overall Study|Withdrawal by Subject|4|||
129205405|NCT03192176|465049829|FG002|Overall Study|Withdrawal by Subject|0|||
129205406|NCT03192176|465049830|FG003|Overall Study|Withdrawal by Subject|4|||
129205407|NCT03192176|465049831|FG004|Overall Study|Withdrawal by Subject|3|||
129205408|NCT03192176|465049832|FG005|Overall Study|Withdrawal by Subject|4|||
129205409|NCT03192176|465049833|FG006|Overall Study|Withdrawal by Subject|4|||
129205410|NCT03192176|465049834|FG007|Overall Study|Withdrawal by Subject|2|||
129205411|NCT03192176|465049827|FG000|Overall Study|Miscellaneous|1|||
129205412|NCT03192176|465049828|FG001|Overall Study|Miscellaneous|0|||
129205413|NCT03192176|465049829|FG002|Overall Study|Miscellaneous|1|||
129205414|NCT03192176|465049830|FG003|Overall Study|Miscellaneous|1|||
129205415|NCT03192176|465049831|FG004|Overall Study|Miscellaneous|1|||
129205416|NCT03192176|465049832|FG005|Overall Study|Miscellaneous|2|||
129205417|NCT03192176|465049833|FG006|Overall Study|Miscellaneous|0|||
129205418|NCT03192176|465049834|FG007|Overall Study|Miscellaneous|1|||
129205419|NCT03532542|465049837|FG000|Overall Study|Death|1|||
129205420|NCT03532542|465049838|FG001|Overall Study|Death|0|||
129205421|NCT03532542|465049837|FG000|Overall Study|Study Terminated by Sponsor|41|||
129205422|NCT03532542|465049838|FG001|Overall Study|Study Terminated by Sponsor|65|||
129205423|NCT03532542|465049837|FG000|Overall Study|Withdrawal by Subject|6|||
129205424|NCT03532542|465049838|FG001|Overall Study|Withdrawal by Subject|5|||
129205425|NCT00718510|465049840|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
129205426|NCT00718510|465049841|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129205427|NCT00718510|465049840|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
129205428|NCT00718510|465049841|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
129205429|NCT02314052|465049842|FG000|Cycle One|Adverse Event|0|||
129205430|NCT02314052|465049843|FG001|Cycle One|Adverse Event|0|||
129205431|NCT02314052|465049844|FG002|Cycle One|Adverse Event|0|||
129205432|NCT02314052|465049845|FG003|Cycle One|Adverse Event|1|||
129205433|NCT02314052|465049846|FG004|Cycle One|Adverse Event|0|||
129205434|NCT02314052|465049847|FG005|Cycle One|Adverse Event|0|||
129205435|NCT00117637|465049848|FG000|First Intervention (Period 1)|Adverse Event|11|||
129205436|NCT00117637|465049849|FG001|First Intervention (Period 1)|Adverse Event|16|||
129205437|NCT00117637|465049848|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
129205438|NCT00117637|465049849|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
129205439|NCT00117637|465049848|FG000|First Intervention (Period 1)|Protocol Violation|1|||
129205440|NCT00117637|465049849|FG001|First Intervention (Period 1)|Protocol Violation|0|||
129205441|NCT00117637|465049848|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
129205442|NCT00117637|465049849|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
129205443|NCT00117637|465049848|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
129205444|NCT00117637|465049849|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
128982155|NCT02926833|464220982|FG002|Overall Study|Lost to Follow-up|0|||
129205445|NCT00117637|465049848|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
129205446|NCT00117637|465049849|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
129205447|NCT00117637|465049848|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
129205448|NCT00117637|465049849|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
129205449|NCT00117637|465049848|FG000|First Intervention (Period 1)|reason not reported|0|||
129205450|NCT00117637|465049849|FG001|First Intervention (Period 1)|reason not reported|1|||
129205451|NCT00117637|465049848|FG000|Second Intervention (Period 2)|Adverse Event|0|||
129205452|NCT00117637|465049849|FG001|Second Intervention (Period 2)|Adverse Event|9|||
129205453|NCT00117637|465049848|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
129205454|NCT00117637|465049849|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
129205455|NCT00117637|465049848|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
129205456|NCT00117637|465049849|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
129205457|NCT00117637|465049848|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
129205458|NCT00117637|465049849|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
129205459|NCT00117637|465049848|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
129205460|NCT00117637|465049849|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
129205461|NCT00117637|465049848|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
129205462|NCT00117637|465049849|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
129205463|NCT00117637|465049848|FG000|Second Intervention (Period 2)|reason not reported|1|||
129205464|NCT00117637|465049849|FG001|Second Intervention (Period 2)|reason not reported|0|||
129205465|NCT01582061|465049850|FG000|Overall Study|Lack of Efficacy|3|||
129205466|NCT01582061|465049851|FG001|Overall Study|Lack of Efficacy|23|||
129205467|NCT01582061|465049850|FG000|Overall Study|Adverse Event|12|||
129205468|NCT01582061|465049851|FG001|Overall Study|Adverse Event|8|||
129205469|NCT01582061|465049850|FG000|Overall Study|Withdrawal by Subject|10|||
129205470|NCT01582061|465049851|FG001|Overall Study|Withdrawal by Subject|4|||
129205471|NCT01582061|465049850|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129205472|NCT01582061|465049851|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129205473|NCT01582061|465049850|FG000|Overall Study|Death|0|||
129205474|NCT01582061|465049851|FG001|Overall Study|Death|1|||
129205475|NCT01582061|465049850|FG000|Overall Study|condition no longer requires study drug|1|||
129094168|NCT00455520|464636048|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
129094169|NCT00455520|464636047|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
129094170|NCT00455520|464636048|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
129094171|NCT00455520|464636047|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
129094172|NCT00455520|464636048|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
129094173|NCT00455520|464636047|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
129094174|NCT00455520|464636048|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
129094175|NCT00455520|464636047|FG000|Open Label Tapentadol Extended Release|All other|33|||
129094176|NCT00455520|464636048|FG001|Open Label Tapentadol Extended Release|All other|0|||
129094177|NCT00455520|464636047|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
129094178|NCT00455520|464636048|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
129094179|NCT00455520|464636047|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
129094180|NCT00455520|464636048|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
129094181|NCT00455520|464636047|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
129094182|NCT00455520|464636048|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
129094183|NCT00455520|464636047|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
129094184|NCT00455520|464636048|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
129094185|NCT00455520|464636047|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
129094186|NCT00455520|464636048|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
129094187|NCT00455520|464636047|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
129094188|NCT00455520|464636048|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
129094189|NCT03448939|464636052|FG000|Overall Study|Adverse Event|5|||
129094190|NCT03448939|464636053|FG001|Overall Study|Adverse Event|1|||
129094191|NCT03448939|464636052|FG000|Overall Study|Lost to Follow-up|6|||
129094192|NCT03448939|464636053|FG001|Overall Study|Lost to Follow-up|6|||
129094193|NCT03448939|464636052|FG000|Overall Study|Pregnancy|1|||
129094194|NCT03448939|464636053|FG001|Overall Study|Pregnancy|1|||
129094195|NCT03448939|464636052|FG000|Overall Study|Withdrawal by Subject|9|||
129094196|NCT03448939|464636053|FG001|Overall Study|Withdrawal by Subject|3|||
129094197|NCT00894790|464636054|FG000|Overall Study|Protocol Violation|0|||
129094198|NCT00894790|464636055|FG001|Overall Study|Protocol Violation|1|||
129094199|NCT00894790|464636054|FG000|Overall Study|Lost to Follow-up|0|||
129094200|NCT00894790|464636055|FG001|Overall Study|Lost to Follow-up|1|||
129094201|NCT00894790|464636054|FG000|Overall Study|Did not meet entrance criteria|1|||
129094202|NCT00894790|464636055|FG001|Overall Study|Did not meet entrance criteria|0|||
129094203|NCT01472965|464636056|FG000|Overall Study|Withdrawal by Subject|1|||
129094204|NCT01472965|464636057|FG001|Overall Study|Withdrawal by Subject|0|||
128759797|NCT00855595|463410181|FG001|Overall Study|patient moved out of state|0|||
128759798|NCT00855595|463410180|FG000|Overall Study|patient left country|0|||
128759799|NCT00855595|463410181|FG001|Overall Study|patient left country|1|||
129094205|NCT00628095|464636058|FG000|Overall Study|Adverse Event|5|||
129094206|NCT00628095|464636059|FG001|Overall Study|Adverse Event|3|||
129094207|NCT00628095|464636058|FG000|Overall Study|Lack of Efficacy|0|||
129094208|NCT00628095|464636059|FG001|Overall Study|Lack of Efficacy|3|||
129094209|NCT00628095|464636058|FG000|Overall Study|Withdrawal by Subject|2|||
129094210|NCT00628095|464636059|FG001|Overall Study|Withdrawal by Subject|0|||
129094211|NCT00628095|464636058|FG000|Overall Study|Other|0|||
129094212|NCT00628095|464636059|FG001|Overall Study|Other|1|||
129094213|NCT03235115|464636063|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129094214|NCT03235115|464636064|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129094215|NCT03235115|464636065|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129094216|NCT03235115|464636066|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129094217|NCT03235115|464636067|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129205476|NCT01582061|465049851|FG001|Overall Study|condition no longer requires study drug|0|||
129205477|NCT01582061|465049850|FG000|Overall Study|Lost to Follow-up|1|||
129205478|NCT01582061|465049851|FG001|Overall Study|Lost to Follow-up|0|||
129205479|NCT02756338|465049852|FG000|Overall Study|Withdrawn by Investigator|1|||
129205480|NCT02756338|465049852|FG000|Overall Study|Device Replaced with Pacemaker|4|||
129205481|NCT00300755|465049857|FG000|Overall Study|Adverse Event|1|||
128759800|NCT01780935|463410182|FG000|Overall Study|Admin problems due to early termination|321|||
128759801|NCT01780935|463410183|FG001|Overall Study|Admin problems due to early termination|309|||
128759802|NCT01780935|463410182|FG000|Overall Study|Adverse Event|2|||
128759803|NCT01780935|463410183|FG001|Overall Study|Adverse Event|4|||
128759804|NCT01780935|463410182|FG000|Overall Study|Death|1|||
128759805|NCT01780935|463410183|FG001|Overall Study|Death|6|||
128759806|NCT01780935|463410182|FG000|Overall Study|Lost to Follow-up|2|||
128759807|NCT01780935|463410183|FG001|Overall Study|Lost to Follow-up|6|||
128759808|NCT01780935|463410182|FG000|Overall Study|Physician Decision|1|||
128759809|NCT01780935|463410183|FG001|Overall Study|Physician Decision|1|||
128759810|NCT01780935|463410182|FG000|Overall Study|Protocol deviation|0|||
128759811|NCT01780935|463410183|FG001|Overall Study|Protocol deviation|1|||
128759812|NCT01780935|463410182|FG000|Overall Study|Patient withdrew consent|8|||
128759813|NCT01780935|463410183|FG001|Overall Study|Patient withdrew consent|9|||
128759814|NCT00166296|463410184|FG000|Overall Study|Withdrawal by Subject|1|||
128759815|NCT00166296|463410185|FG001|Overall Study|Withdrawal by Subject|3|||
128759816|NCT00166296|463410184|FG000|Overall Study|Adverse Event|2|||
128759817|NCT00166296|463410185|FG001|Overall Study|Adverse Event|4|||
128759818|NCT00166296|463410184|FG000|Overall Study|Lost to Follow-up|4|||
128759819|NCT00166296|463410185|FG001|Overall Study|Lost to Follow-up|2|||
128759820|NCT04035200|463410191|FG000|Overall Study|Lost to Follow-up|0|||
128759821|NCT04035200|463410192|FG001|Overall Study|Lost to Follow-up|1|||
128759822|NCT04035200|463410193|FG002|Overall Study|Lost to Follow-up|0|||
128759823|NCT04035200|463410191|FG000|Overall Study|Withdrawal by Subject|1|||
128759824|NCT04035200|463410192|FG001|Overall Study|Withdrawal by Subject|4|||
128759825|NCT04035200|463410193|FG002|Overall Study|Withdrawal by Subject|4|||
128759826|NCT04035200|463410191|FG000|Overall Study|COVID-19|1|||
128759827|NCT04035200|463410192|FG001|Overall Study|COVID-19|0|||
128759828|NCT04035200|463410193|FG002|Overall Study|COVID-19|0|||
128759829|NCT04035200|463410191|FG000|Overall Study|Early Termination|0|||
128759830|NCT04035200|463410192|FG001|Overall Study|Early Termination|1|||
128759831|NCT04035200|463410193|FG002|Overall Study|Early Termination|0|||
128759832|NCT04035200|463410191|FG000|Overall Study|Non-compliance|0|||
128759833|NCT04035200|463410192|FG001|Overall Study|Non-compliance|1|||
128759834|NCT04035200|463410193|FG002|Overall Study|Non-compliance|0|||
128759835|NCT03033225|463410194|FG000|Overall Study|Withdrawal by Subject|5|||
128759836|NCT00386022|463410198|FG000|Plus Estrogen|Lost to Follow-up|2|||
128759837|NCT00386022|463410199|FG001|Plus Estrogen|Lost to Follow-up|0|||
128759838|NCT00386022|463410198|FG000|Plus Estrogen|Adverse Event|0|||
128759839|NCT00386022|463410199|FG001|Plus Estrogen|Adverse Event|1|||
128759840|NCT00168038|463410207|FG000|Overall Study|Adverse Event|1|||
128759841|NCT00168038|463410207|FG000|Overall Study|Therapy failure|1|||
128759842|NCT01685138|463410210|FG000|Overall Study|Lost to Follow-up|1|||
128759843|NCT01685138|463410210|FG000|Overall Study|Protocol Violation|1|||
128759844|NCT01685138|463410210|FG000|Overall Study|No longer requires treatment|1|||
128759845|NCT01685138|463410210|FG000|Overall Study|Subject/guardian decision|2|||
128759846|NCT01685138|463410210|FG000|Overall Study|Physician Decision|6|||
128759847|NCT01685138|463410210|FG000|Overall Study|Death|10|||
128759848|NCT01685138|463410210|FG000|Overall Study|Adverse Event|18|||
129094218|NCT03235115|464636068|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
129094219|NCT00006305|464636071|FG000|Overall Study|Withdrawal by Subject|17|||
129094220|NCT00006305|464636072|FG001|Overall Study|Withdrawal by Subject|10|||
129094221|NCT00006305|464636073|FG002|Overall Study|Withdrawal by Subject|15|||
129094222|NCT00006305|464636074|FG003|Overall Study|Withdrawal by Subject|14|||
129094223|NCT00662558|464636075|FG000|Overall Study|Adverse Event|21|||
129205482|NCT00300755|465049858|FG001|Overall Study|Adverse Event|2|||
129205483|NCT00300755|465049859|FG002|Overall Study|Adverse Event|1|||
128759849|NCT01685138|463410210|FG000|Overall Study|Progressive disease|53|||
128759850|NCT00689026|463410215|FG000|Overall Study|Withdrawal by Subject|13|||
128759851|NCT00689026|463410216|FG001|Overall Study|Withdrawal by Subject|6|||
128759852|NCT01648348|463410221|FG000|Overall Study|Cancel|1|||
129094224|NCT00662558|464636076|FG001|Overall Study|Adverse Event|59|||
129094225|NCT00662558|464636075|FG000|Overall Study|Lack of Efficacy|4|||
128759853|NCT01648348|463410222|FG001|Overall Study|Cancel|0|||
128759854|NCT01648348|463410223|FG002|Overall Study|Cancel|0|||
128759855|NCT01648348|463410224|FG003|Overall Study|Cancel|0|||
128759856|NCT01648348|463410225|FG004|Overall Study|Cancel|3|||
128759857|NCT01648348|463410226|FG005|Overall Study|Cancel|6|||
128759858|NCT01648348|463410221|FG000|Overall Study|Replaced for MTD analysis|1|||
129094226|NCT00662558|464636076|FG001|Overall Study|Lack of Efficacy|7|||
129094227|NCT00662558|464636075|FG000|Overall Study|Lost to Follow-up|13|||
129094228|NCT00662558|464636076|FG001|Overall Study|Lost to Follow-up|10|||
129094229|NCT00662558|464636075|FG000|Overall Study|Other|9|||
129094230|NCT00662558|464636076|FG001|Overall Study|Other|14|||
129094231|NCT00662558|464636075|FG000|Overall Study|Withdrawal by Subject|7|||
129094232|NCT00662558|464636076|FG001|Overall Study|Withdrawal by Subject|12|||
129205484|NCT00300755|465049857|FG000|Overall Study|Withdrawal by Subject|0|||
129205485|NCT00300755|465049858|FG001|Overall Study|Withdrawal by Subject|2|||
129205486|NCT00300755|465049859|FG002|Overall Study|Withdrawal by Subject|0|||
129205487|NCT00300755|465049857|FG000|Overall Study|Protocol Violation|0|||
129205488|NCT00300755|465049858|FG001|Overall Study|Protocol Violation|0|||
129205489|NCT00300755|465049859|FG002|Overall Study|Protocol Violation|1|||
129205490|NCT02694744|465049863|FG000|Overall Study|Adverse Event|2|||
129205491|NCT02694744|465049864|FG001|Overall Study|Adverse Event|1|||
129205492|NCT02694744|465049863|FG000|Overall Study|Withdrawal by Subject|2|||
129205493|NCT02694744|465049864|FG001|Overall Study|Withdrawal by Subject|1|||
129205494|NCT02694744|465049863|FG000|Overall Study|Physician Decision|1|||
129205495|NCT02694744|465049864|FG001|Overall Study|Physician Decision|2|||
129205496|NCT02694744|465049863|FG000|Overall Study|Lost to Follow-up|1|||
129205497|NCT02694744|465049864|FG001|Overall Study|Lost to Follow-up|0|||
129205498|NCT02694744|465049863|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
129205499|NCT02694744|465049864|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
129205500|NCT00686777|465049865|FG000|Overall Study|Adverse Event|2|||
129205501|NCT00686777|465049865|FG000|Overall Study|Pregnancy|1|||
129205502|NCT00686777|465049865|FG000|Overall Study|Withdrawal by Subject|2|||
129205503|NCT00686777|465049865|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
129205504|NCT00686777|465049865|FG000|Overall Study|No Visit|1|||
129205505|NCT01945021|465049866|FG000|Overall Study|Adverse Event|1|||
129205506|NCT01945021|465049866|FG000|Overall Study|Withdrawal of consent|12|||
129205507|NCT01945021|465049866|FG000|Overall Study|Lost to Follow-up|5|||
129205508|NCT01945021|465049866|FG000|Overall Study|Death|65|||
129205509|NCT03582215|465049867|FG000|Overall Study|Adverse Event|1|||
129205510|NCT03582215|465049868|FG001|Overall Study|Adverse Event|0|||
129205511|NCT03582215|465049869|FG002|Overall Study|Adverse Event|0|||
129205512|NCT03582215|465049870|FG003|Overall Study|Adverse Event|0|||
129205513|NCT03582215|465049871|FG004|Overall Study|Adverse Event|0|||
129205514|NCT03582215|465049872|FG005|Overall Study|Adverse Event|0|||
129205515|NCT03582215|465049873|FG006|Overall Study|Adverse Event|2|||
129205516|NCT03582215|465049874|FG007|Overall Study|Adverse Event|2|||
129205517|NCT02163902|465049875|FG000|Overall Study|Subject's Request|3|||
129205518|NCT02163902|465049876|FG001|Overall Study|Subject's Request|4|||
129205519|NCT02163902|465049875|FG000|Overall Study|Lost to Follow-up|6|||
129205520|NCT02163902|465049876|FG001|Overall Study|Lost to Follow-up|7|||
129205521|NCT02163902|465049875|FG000|Overall Study|Administrative Decision|2|||
129205522|NCT02163902|465049876|FG001|Overall Study|Administrative Decision|2|||
129205523|NCT02174731|465049877|FG000|Overall Study|Participant decision|67|||
129205524|NCT02174731|465049878|FG001|Overall Study|Participant decision|64|||
129205525|NCT02174731|465049877|FG000|Overall Study|Incorrect enrolment before randomization|0|||
129205526|NCT02174731|465049878|FG001|Overall Study|Incorrect enrolment before randomization|1|||
129205527|NCT02174731|465049877|FG000|Overall Study|Missing|2|||
129205528|NCT02174731|465049878|FG001|Overall Study|Missing|0|||
129205529|NCT03119259|465049879|FG000|Overall Study|Withdrawn as no longer eligible|1|||
129205530|NCT03119259|465049880|FG001|Overall Study|Withdrawn as no longer eligible|0|||
129205531|NCT03119259|465049879|FG000|Overall Study|Withdrawal by Subject|4|||
129205532|NCT03119259|465049880|FG001|Overall Study|Withdrawal by Subject|2|||
129205533|NCT03119259|465049879|FG000|Overall Study|Lost to Follow-up|0|||
129205534|NCT03119259|465049880|FG001|Overall Study|Lost to Follow-up|1|||
129205535|NCT00467740|465049885|FG000|Overall Study|Adverse Event|0|||
129205536|NCT00467740|465049886|FG001|Overall Study|Adverse Event|0|||
128759859|NCT01648348|463410222|FG001|Overall Study|Replaced for MTD analysis|0|||
128759860|NCT01648348|463410223|FG002|Overall Study|Replaced for MTD analysis|1|||
129205537|NCT00467740|465049887|FG002|Overall Study|Adverse Event|1|||
129205538|NCT00467740|465049888|FG003|Overall Study|Adverse Event|0|||
129205539|NCT00467740|465049889|FG004|Overall Study|Adverse Event|0|||
128759861|NCT01648348|463410224|FG003|Overall Study|Replaced for MTD analysis|0|||
129094233|NCT00662558|464636075|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
129094234|NCT00662558|464636076|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
129205540|NCT00467740|465049885|FG000|Overall Study|Protocol Violation|0|||
129094235|NCT01711619|464636077|FG000|Overall Study|Early study termination|10|||
129205541|NCT00467740|465049886|FG001|Overall Study|Protocol Violation|0|||
129205542|NCT00467740|465049887|FG002|Overall Study|Protocol Violation|1|||
129205543|NCT00467740|465049888|FG003|Overall Study|Protocol Violation|0|||
129205544|NCT00467740|465049889|FG004|Overall Study|Protocol Violation|0|||
129205545|NCT00467740|465049885|FG000|Overall Study|Lost to Follow-up|0|||
129205546|NCT00467740|465049886|FG001|Overall Study|Lost to Follow-up|1|||
129205547|NCT00467740|465049887|FG002|Overall Study|Lost to Follow-up|0|||
129205548|NCT00467740|465049888|FG003|Overall Study|Lost to Follow-up|0|||
129205549|NCT00467740|465049889|FG004|Overall Study|Lost to Follow-up|0|||
129205550|NCT00467740|465049885|FG000|Overall Study|Withdrawal by Subject|1|||
129205551|NCT00467740|465049886|FG001|Overall Study|Withdrawal by Subject|1|||
129205552|NCT00467740|465049887|FG002|Overall Study|Withdrawal by Subject|0|||
128759862|NCT01648348|463410225|FG004|Overall Study|Replaced for MTD analysis|0|||
128759863|NCT01648348|463410226|FG005|Overall Study|Replaced for MTD analysis|0|||
128759864|NCT01951638|463410227|FG000|Treatment Period|Protocol Violation|0|||
128759865|NCT01951638|463410228|FG001|Treatment Period|Protocol Violation|0|||
128759866|NCT01951638|463410229|FG002|Treatment Period|Protocol Violation|0|||
128759867|NCT01951638|463410230|FG003|Treatment Period|Protocol Violation|2|||
128759868|NCT01951638|463410231|FG004|Treatment Period|Protocol Violation|0|||
128759869|NCT01951638|463410227|FG000|Treatment Period|Protocol-driven decision point|1|||
128759870|NCT01951638|463410228|FG001|Treatment Period|Protocol-driven decision point|3|||
128759871|NCT01951638|463410229|FG002|Treatment Period|Protocol-driven decision point|0|||
128759872|NCT01951638|463410230|FG003|Treatment Period|Protocol-driven decision point|0|||
128759873|NCT01951638|463410231|FG004|Treatment Period|Protocol-driven decision point|0|||
128759874|NCT01951638|463410227|FG000|Treatment Period|Logistical difficulties|0|||
128759875|NCT01951638|463410228|FG001|Treatment Period|Logistical difficulties|1|||
128759876|NCT01951638|463410229|FG002|Treatment Period|Logistical difficulties|1|||
128759877|NCT01951638|463410230|FG003|Treatment Period|Logistical difficulties|0|||
128759878|NCT01951638|463410231|FG004|Treatment Period|Logistical difficulties|0|||
128759879|NCT01951638|463410227|FG000|Treatment Period|Withdrawal by Subject|9|||
128759880|NCT01951638|463410228|FG001|Treatment Period|Withdrawal by Subject|6|||
128759881|NCT01951638|463410229|FG002|Treatment Period|Withdrawal by Subject|4|||
128759882|NCT01951638|463410230|FG003|Treatment Period|Withdrawal by Subject|5|||
128759883|NCT01951638|463410231|FG004|Treatment Period|Withdrawal by Subject|4|||
128759884|NCT01951638|463410227|FG000|Treatment Period|Death|0|||
128759885|NCT01951638|463410228|FG001|Treatment Period|Death|0|||
128759886|NCT01951638|463410229|FG002|Treatment Period|Death|0|||
128759887|NCT01951638|463410230|FG003|Treatment Period|Death|3|||
128759888|NCT01951638|463410231|FG004|Treatment Period|Death|1|||
128759889|NCT01951638|463410227|FG000|Treatment Period|Adverse Event|3|||
128759890|NCT01951638|463410228|FG001|Treatment Period|Adverse Event|4|||
128759891|NCT01951638|463410229|FG002|Treatment Period|Adverse Event|8|||
128759892|NCT01951638|463410230|FG003|Treatment Period|Adverse Event|6|||
128759893|NCT01951638|463410231|FG004|Treatment Period|Adverse Event|5|||
128759894|NCT01951638|463410227|FG000|Follow-up Period|Protocol Violation|0|||
128759895|NCT01951638|463410228|FG001|Follow-up Period|Protocol Violation|0|||
128759896|NCT01951638|463410229|FG002|Follow-up Period|Protocol Violation|0|||
128759897|NCT01951638|463410230|FG003|Follow-up Period|Protocol Violation|1|||
128759898|NCT01951638|463410231|FG004|Follow-up Period|Protocol Violation|0|||
128759899|NCT01951638|463410227|FG000|Follow-up Period|Logistical difficulties|0|||
128759900|NCT01951638|463410228|FG001|Follow-up Period|Logistical difficulties|2|||
128759901|NCT01951638|463410229|FG002|Follow-up Period|Logistical difficulties|0|||
128759902|NCT01951638|463410230|FG003|Follow-up Period|Logistical difficulties|0|||
128759903|NCT01951638|463410231|FG004|Follow-up Period|Logistical difficulties|1|||
128759904|NCT01951638|463410227|FG000|Follow-up Period|Withdrawal by Subject|1|||
128759905|NCT01951638|463410228|FG001|Follow-up Period|Withdrawal by Subject|5|||
128759906|NCT01951638|463410229|FG002|Follow-up Period|Withdrawal by Subject|2|||
128759907|NCT01951638|463410230|FG003|Follow-up Period|Withdrawal by Subject|1|||
128759908|NCT01951638|463410231|FG004|Follow-up Period|Withdrawal by Subject|2|||
128759909|NCT01951638|463410227|FG000|Follow-up Period|Lost to Follow-up|0|||
128759910|NCT01951638|463410228|FG001|Follow-up Period|Lost to Follow-up|1|||
128759911|NCT01951638|463410229|FG002|Follow-up Period|Lost to Follow-up|0|||
128759912|NCT01951638|463410230|FG003|Follow-up Period|Lost to Follow-up|1|||
129205553|NCT00467740|465049888|FG003|Overall Study|Withdrawal by Subject|1|||
128759913|NCT01951638|463410231|FG004|Follow-up Period|Lost to Follow-up|0|||
128759914|NCT01951638|463410227|FG000|Follow-up Period|Death|1|||
128759915|NCT01951638|463410228|FG001|Follow-up Period|Death|0|||
128759916|NCT01951638|463410229|FG002|Follow-up Period|Death|1|||
128759917|NCT01951638|463410230|FG003|Follow-up Period|Death|4|||
128759918|NCT01951638|463410231|FG004|Follow-up Period|Death|1|||
129205554|NCT00467740|465049889|FG004|Overall Study|Withdrawal by Subject|0|||
129205555|NCT00467740|465049885|FG000|Overall Study|Lack of Efficacy|0|||
128759919|NCT01951638|463410227|FG000|Follow-up Period|Adverse Event|0|||
128759920|NCT01951638|463410228|FG001|Follow-up Period|Adverse Event|1|||
128759921|NCT01951638|463410229|FG002|Follow-up Period|Adverse Event|2|||
128759922|NCT01951638|463410230|FG003|Follow-up Period|Adverse Event|1|||
128759923|NCT01951638|463410231|FG004|Follow-up Period|Adverse Event|1|||
128759924|NCT00459342|463410232|FG000|Overall Study|Not eligible|1|||
128759925|NCT02686034|463410233|FG000|Run-In Period 1|Eligibility|12|||
128759926|NCT02686034|463410234|FG001|Run-In Period 1|Eligibility|10|||
129205556|NCT00467740|465049886|FG001|Overall Study|Lack of Efficacy|1|||
129205557|NCT00467740|465049887|FG002|Overall Study|Lack of Efficacy|0|||
129205558|NCT00467740|465049888|FG003|Overall Study|Lack of Efficacy|0|||
129205559|NCT00467740|465049889|FG004|Overall Study|Lack of Efficacy|0|||
129205560|NCT02903160|465049890|FG000|Overall Study|Adverse Event|2|||
129205561|NCT02903160|465049890|FG000|Overall Study|Death|1|||
129205562|NCT02903160|465049890|FG000|Overall Study|Lost to Follow-up|2|||
129205563|NCT02903160|465049890|FG000|Overall Study|Withdrawal by Subject|1|||
129205564|NCT02903160|465049890|FG000|Overall Study|Medical Insurance Barriers|1|||
129205565|NCT00730158|465049897|FG000|Overall Study|Withdrawal by Subject|1|||
129205566|NCT00730158|465049898|FG001|Overall Study|Withdrawal by Subject|1|||
129205567|NCT04678115|465049899|FG000|Overall Study|Lost to Follow-up|1|||
129205568|NCT04678115|465049900|FG001|Overall Study|Lost to Follow-up|0|||
129205569|NCT01168349|465049901|FG000|Overall Study|Death|157|||
129205570|NCT01168349|465049901|FG000|Overall Study|Lost to Follow-up|34|||
129205571|NCT01168349|465049901|FG000|Overall Study|Withdrawal by Subject|9|||
129205572|NCT01168349|465049901|FG000|Overall Study|Kidney transplantation|3|||
129205573|NCT01168349|465049901|FG000|Overall Study|Other|22|||
129205574|NCT01168349|465049901|FG000|Overall Study|Protocol Violation|76|||
129205575|NCT03535974|465049902|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
129205576|NCT03535974|465049903|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
129205577|NCT03535974|465049904|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
129205578|NCT03535974|465049902|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
129205579|NCT03535974|465049903|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
129205580|NCT03535974|465049904|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
129205581|NCT00844376|465049905|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
129205582|NCT00844376|465049906|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
129205583|NCT04059549|465049907|FG000|Overall Study|Withdrawal by Subject|2|||
129205584|NCT04059549|465049908|FG001|Overall Study|Withdrawal by Subject|0|||
129205585|NCT02678351|465049910|FG000|Overall Study|Withdrawal by Subject|1|||
129205586|NCT00988884|465049911|FG000|Overall Study|Adverse Event|0|||
129205587|NCT00988884|465049912|FG001|Overall Study|Adverse Event|1|||
129205588|NCT00988884|465049911|FG000|Overall Study|Lost to Follow-up|20|||
129205589|NCT00988884|465049912|FG001|Overall Study|Lost to Follow-up|16|||
129205590|NCT00988884|465049911|FG000|Overall Study|Protocol Violation|0|||
129205591|NCT00988884|465049912|FG001|Overall Study|Protocol Violation|1|||
129205592|NCT00988884|465049911|FG000|Overall Study|Withdrawal by Subject|15|||
129205593|NCT00988884|465049912|FG001|Overall Study|Withdrawal by Subject|18|||
129205594|NCT01919229|465049913|FG000|Overall Study|Subject/guardian decision|0|||
129205595|NCT01919229|465049914|FG001|Overall Study|Subject/guardian decision|0|||
129205596|NCT01919229|465049915|FG002|Overall Study|Subject/guardian decision|1|||
128759927|NCT02686034|463410233|FG000|Run-In Period 1|Withdrawal by Subject|4|||
128759928|NCT02686034|463410234|FG001|Run-In Period 1|Withdrawal by Subject|3|||
128759929|NCT02686034|463410233|FG000|Run-In Period 1|Lost to Follow-up|4|||
128759930|NCT02686034|463410234|FG001|Run-In Period 1|Lost to Follow-up|4|||
128759931|NCT02686034|463410233|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
128759932|NCT02686034|463410234|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
128759933|NCT02686034|463410233|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
128759934|NCT02686034|463410234|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
128759935|NCT02686034|463410233|FG000|Randomized Controlled Period 2|Adverse Event|0|||
128759936|NCT02686034|463410234|FG001|Randomized Controlled Period 2|Adverse Event|2|||
128759937|NCT02686034|463410233|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
128759938|NCT02686034|463410234|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
128759939|NCT02686034|463410233|FG000|Open Label Period 3|Lost to Follow-up|0|||
128759940|NCT02686034|463410234|FG001|Open Label Period 3|Lost to Follow-up|1|||
128759941|NCT03017079|463410235|FG000|Overall Study|Physician Decision|1|||
128759942|NCT03017079|463410236|FG001|Overall Study|Physician Decision|1|||
128759943|NCT03017079|463410235|FG000|Overall Study|Death|3|||
128759944|NCT03017079|463410236|FG001|Overall Study|Death|2|||
128759945|NCT03017079|463410235|FG000|Overall Study|Lack of Efficacy|2|||
128759946|NCT03017079|463410236|FG001|Overall Study|Lack of Efficacy|2|||
128759947|NCT03017079|463410235|FG000|Overall Study|Protocol Violation|0|||
128759948|NCT03017079|463410236|FG001|Overall Study|Protocol Violation|1|||
128759949|NCT04233372|463411346|FG000|Overall Study|Lost to Follow-up|104|||
128759950|NCT04233372|463411346|FG000|Overall Study|Adverse Event|8|||
128759951|NCT04233372|463411346|FG000|Overall Study|Withdrawal by Subject|2|||
128759952|NCT03938454|463411347|FG000|Overall Study|Protocol Violation|1|||
129205597|NCT00626275|465049916|FG000|Part A - Treatment Period 1|Adverse Event|1|||
129205598|NCT00626275|465049917|FG001|Part A - Treatment Period 1|Adverse Event|0|||
129205599|NCT00626275|465049918|FG002|Part A - Treatment Period 1|Adverse Event|0|||
129205600|NCT00626275|465049919|FG003|Part A - Treatment Period 1|Adverse Event|0|||
128759953|NCT03938454|463411347|FG000|Overall Study|Withdrawal by Subject|2|||
129205601|NCT00626275|465049920|FG004|Part A - Treatment Period 1|Adverse Event|0|||
128759954|NCT03938454|463411347|FG000|Overall Study|Lost to Follow-up|3|||
129205602|NCT00626275|465049921|FG005|Part A - Treatment Period 1|Adverse Event|0|||
129205603|NCT00626275|465049922|FG006|Part A - Treatment Period 1|Adverse Event|0|||
128759955|NCT01142388|463411348|FG000|Overall Study|Lack of Efficacy|21|||
128759956|NCT01142388|463411349|FG001|Overall Study|Lack of Efficacy|31|||
128759957|NCT01142388|463411348|FG000|Overall Study|Adverse Event|9|||
128759958|NCT01142388|463411349|FG001|Overall Study|Adverse Event|5|||
128759959|NCT01142388|463411348|FG000|Overall Study|Death|3|||
128759960|NCT01142388|463411349|FG001|Overall Study|Death|2|||
128759961|NCT01142388|463411348|FG000|Overall Study|Withdrawal by Subject|5|||
128759962|NCT01142388|463411349|FG001|Overall Study|Withdrawal by Subject|3|||
128759963|NCT01142388|463411348|FG000|Overall Study|Alternative therapy|1|||
128759964|NCT01142388|463411349|FG001|Overall Study|Alternative therapy|0|||
128759965|NCT01142388|463411348|FG000|Overall Study|Other complications|0|||
128759966|NCT01142388|463411349|FG001|Overall Study|Other complications|2|||
128759967|NCT01142388|463411348|FG000|Overall Study|Other|1|||
128759968|NCT01142388|463411349|FG001|Overall Study|Other|1|||
128759969|NCT01142388|463411348|FG000|Overall Study|Never started therapy|7|||
128759970|NCT01142388|463411349|FG001|Overall Study|Never started therapy|3|||
128759971|NCT00695786|463411350|FG000|Overall Study|Adverse Event|0|||
128759972|NCT00695786|463411351|FG001|Overall Study|Adverse Event|3|||
128759973|NCT00695786|463411352|FG002|Overall Study|Adverse Event|4|||
129094236|NCT01711619|464636078|FG001|Overall Study|Early study termination|14|||
129094237|NCT01711619|464636077|FG000|Overall Study|Withdrawal by Subject|3|||
129094238|NCT01711619|464636078|FG001|Overall Study|Withdrawal by Subject|7|||
129094239|NCT01711619|464636077|FG000|Overall Study|Protocol Violation|2|||
129094240|NCT01711619|464636078|FG001|Overall Study|Protocol Violation|3|||
129094241|NCT01711619|464636077|FG000|Overall Study|Adverse Event|2|||
129094242|NCT01711619|464636078|FG001|Overall Study|Adverse Event|0|||
129094243|NCT01711619|464636077|FG000|Overall Study|Lost to Follow-up|1|||
129094244|NCT01711619|464636078|FG001|Overall Study|Lost to Follow-up|0|||
129094245|NCT00503997|464636079|FG000|Overall Study|disease progression|1|||
129094246|NCT00503997|464636079|FG000|Overall Study|Adverse Event|5|||
129094247|NCT00503997|464636079|FG000|Overall Study|Death|1|||
129094248|NCT00503997|464636079|FG000|Overall Study|Withdrawal by Subject|1|||
129094249|NCT01195844|464636080|FG000|Overall Study|Fecal sample not collected|40|||
129094250|NCT01432275|464636084|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
129094251|NCT01432275|464636085|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
129205604|NCT00626275|465049923|FG007|Part A - Treatment Period 1|Adverse Event|0|||
129205605|NCT00626275|465049916|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129094252|NCT01432275|464636084|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
129094253|NCT01432275|464636085|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
129094254|NCT01432275|464636084|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
129094255|NCT01432275|464636085|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
129094256|NCT01432275|464636084|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
129094257|NCT01432275|464636085|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
129205606|NCT00626275|465049917|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129205607|NCT00626275|465049918|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
129205608|NCT00626275|465049919|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129205609|NCT00626275|465049920|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129205610|NCT00626275|465049921|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129205611|NCT00626275|465049922|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129205612|NCT00626275|465049923|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129205613|NCT00626275|465049916|FG000|Part B|Lost to Follow-up|0|||
129205614|NCT00626275|465049917|FG001|Part B|Lost to Follow-up|0|||
129205615|NCT00626275|465049918|FG002|Part B|Lost to Follow-up|0|||
129205616|NCT00626275|465049919|FG003|Part B|Lost to Follow-up|0|||
129205617|NCT00626275|465049920|FG004|Part B|Lost to Follow-up|0|||
129205618|NCT00626275|465049921|FG005|Part B|Lost to Follow-up|0|||
129205619|NCT00626275|465049922|FG006|Part B|Lost to Follow-up|1|||
129205620|NCT00626275|465049923|FG007|Part B|Lost to Follow-up|0|||
129205621|NCT00626275|465049916|FG000|Part B|Withdrawal by Subject|0|||
129205622|NCT00626275|465049917|FG001|Part B|Withdrawal by Subject|0|||
129205623|NCT00626275|465049918|FG002|Part B|Withdrawal by Subject|0|||
129205624|NCT00626275|465049919|FG003|Part B|Withdrawal by Subject|0|||
129205625|NCT00626275|465049920|FG004|Part B|Withdrawal by Subject|0|||
129205626|NCT00626275|465049921|FG005|Part B|Withdrawal by Subject|0|||
129205627|NCT00626275|465049922|FG006|Part B|Withdrawal by Subject|0|||
129205628|NCT00626275|465049923|FG007|Part B|Withdrawal by Subject|1|||
129205629|NCT04999839|465049924|FG000|Overall Study|Adverse Event|1|||
129205630|NCT04999839|465049925|FG001|Overall Study|Adverse Event|1|||
129205631|NCT04999839|465049926|FG002|Overall Study|Adverse Event|1|||
129205632|NCT04999839|465049927|FG003|Overall Study|Adverse Event|1|||
128759974|NCT00695786|463411353|FG003|Overall Study|Adverse Event|2|||
128759975|NCT00695786|463411350|FG000|Overall Study|Lost to Follow-up|0|||
128759976|NCT00695786|463411351|FG001|Overall Study|Lost to Follow-up|5|||
128982156|NCT02926833|464220983|FG003|Overall Study|Lost to Follow-up|3|||
129205633|NCT04999839|465049928|FG004|Overall Study|Adverse Event|1|||
128759977|NCT00695786|463411352|FG002|Overall Study|Lost to Follow-up|1|||
128759978|NCT00695786|463411353|FG003|Overall Study|Lost to Follow-up|1|||
129205634|NCT04999839|465049924|FG000|Overall Study|Lost to Follow-up|2|||
129205635|NCT04999839|465049925|FG001|Overall Study|Lost to Follow-up|0|||
128759979|NCT00695786|463411350|FG000|Overall Study|Withdrawal by Subject|0|||
128759980|NCT00695786|463411351|FG001|Overall Study|Withdrawal by Subject|4|||
128759981|NCT00695786|463411352|FG002|Overall Study|Withdrawal by Subject|3|||
128759982|NCT00695786|463411353|FG003|Overall Study|Withdrawal by Subject|1|||
128759983|NCT00695786|463411350|FG000|Overall Study|Deemed Ineligible|1|||
128759984|NCT00695786|463411351|FG001|Overall Study|Deemed Ineligible|0|||
128759985|NCT00695786|463411352|FG002|Overall Study|Deemed Ineligible|0|||
128759986|NCT00695786|463411353|FG003|Overall Study|Deemed Ineligible|0|||
128759987|NCT00695786|463411350|FG000|Overall Study|Lack of Efficacy|0|||
128759988|NCT00695786|463411351|FG001|Overall Study|Lack of Efficacy|0|||
128759989|NCT00695786|463411352|FG002|Overall Study|Lack of Efficacy|0|||
128759990|NCT00695786|463411353|FG003|Overall Study|Lack of Efficacy|4|||
128759991|NCT01364922|463411357|FG000|Open-label (OL) Period|Adverse Event|7|||
128759992|NCT01364922|463411358|FG001|Open-label (OL) Period|Adverse Event|0|||
128759993|NCT01364922|463411359|FG002|Open-label (OL) Period|Adverse Event|0|||
128759994|NCT01364922|463411357|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
128759995|NCT01364922|463411358|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
128759996|NCT01364922|463411359|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
128759997|NCT01364922|463411357|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
128759998|NCT01364922|463411358|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
128759999|NCT01364922|463411359|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
128760000|NCT01364922|463411357|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
128760001|NCT01364922|463411358|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
128760002|NCT01364922|463411359|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
128760003|NCT01364922|463411357|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
128760004|NCT01364922|463411358|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
128760005|NCT01364922|463411359|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
128760006|NCT01364922|463411357|FG000|Open-label (OL) Period|Other, Unspecified|1|||
128760007|NCT01364922|463411358|FG001|Open-label (OL) Period|Other, Unspecified|0|||
128760008|NCT01364922|463411359|FG002|Open-label (OL) Period|Other, Unspecified|0|||
128760009|NCT01364922|463411357|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
128760010|NCT01364922|463411358|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
128760011|NCT01364922|463411359|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
128760012|NCT01364922|463411357|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
128760013|NCT01364922|463411358|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
128760014|NCT01364922|463411359|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
128760015|NCT01364922|463411357|FG000|Double-Blind (DB) Period|Adverse Event|0|||
128760016|NCT01364922|463411358|FG001|Double-Blind (DB) Period|Adverse Event|0|||
128760017|NCT01364922|463411359|FG002|Double-Blind (DB) Period|Adverse Event|1|||
128760018|NCT01364922|463411357|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
128760019|NCT01364922|463411358|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
128760020|NCT01364922|463411359|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
128760021|NCT04244396|463411360|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
129094258|NCT01432275|464636084|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
129094259|NCT01432275|464636085|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
129094260|NCT01432275|464636084|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
129094261|NCT01432275|464636085|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
129094262|NCT01432275|464636084|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
129094263|NCT01432275|464636085|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
129094264|NCT01432275|464636084|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
129094265|NCT01432275|464636085|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
129094266|NCT01432275|464636084|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
129094267|NCT01432275|464636085|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
129094268|NCT02565706|464636086|FG000|Overall Study|Withdrawal by Subject|5|||
129094269|NCT02565706|464636087|FG001|Overall Study|Withdrawal by Subject|7|||
129094270|NCT02565706|464636088|FG002|Overall Study|Withdrawal by Subject|7|||
129094271|NCT02565706|464636089|FG003|Overall Study|Withdrawal by Subject|11|||
129094272|NCT02565706|464636086|FG000|Overall Study|Lost to Follow-up|72|||
129094273|NCT02565706|464636087|FG001|Overall Study|Lost to Follow-up|75|||
129094274|NCT02565706|464636088|FG002|Overall Study|Lost to Follow-up|82|||
129094275|NCT02565706|464636089|FG003|Overall Study|Lost to Follow-up|74|||
129094276|NCT05020899|464636095|FG000|8 Week Follow-up|Lost to Follow-up|3|||
129094277|NCT05020899|464636096|FG001|8 Week Follow-up|Lost to Follow-up|6|||
129094278|NCT05020899|464636095|FG000|12 Week Follow-up|Lost to Follow-up|1|||
129094279|NCT05020899|464636096|FG001|12 Week Follow-up|Lost to Follow-up|0|||
128760022|NCT04244396|463411360|FG000|Overall Study|Withdrawal by Subject|2|||
128760023|NCT04244396|463411360|FG000|Overall Study|Study termination|37|||
128760024|NCT01787097|463411361|FG000|Overall Study|Withdrawal by Subject|1|||
128760025|NCT01787097|463411362|FG001|Overall Study|Withdrawal by Subject|0|||
128760026|NCT01787097|463411363|FG002|Overall Study|Withdrawal by Subject|0|||
128760027|NCT01787097|463411364|FG003|Overall Study|Withdrawal by Subject|0|||
129094280|NCT05020899|464636095|FG000|12 Week Follow-up|Death|0|||
129094281|NCT05020899|464636096|FG001|12 Week Follow-up|Death|1|||
129094282|NCT02124759|464636097|FG000|Overall Study|Withdrawal by Subject|3|||
129094283|NCT02124759|464636098|FG001|Overall Study|Withdrawal by Subject|1|||
129094284|NCT02124759|464636099|FG002|Overall Study|Withdrawal by Subject|1|||
129094285|NCT02124759|464636097|FG000|Overall Study|Screen Fail|2|||
129094286|NCT02124759|464636098|FG001|Overall Study|Screen Fail|2|||
129094287|NCT02124759|464636099|FG002|Overall Study|Screen Fail|3|||
129094288|NCT01068626|464636102|FG000|Overall Study|Adverse Event|3|||
129094289|NCT01068626|464636103|FG001|Overall Study|Adverse Event|0|||
129094290|NCT01068626|464636102|FG000|Overall Study|Withdrawal by Subject|0|||
129094291|NCT01068626|464636103|FG001|Overall Study|Withdrawal by Subject|2|||
129094292|NCT01785849|464636104|FG000|Overall Study|Death|7|||
129094293|NCT01785849|464636105|FG001|Overall Study|Death|9|||
129094294|NCT01785849|464636104|FG000|Overall Study|Protocol Specified Criteria|29|||
129205636|NCT04999839|465049926|FG002|Overall Study|Lost to Follow-up|2|||
128760028|NCT00553501|463411371|FG000|Overall Study|Adverse Event|2|||
128760029|NCT00553501|463411371|FG000|Overall Study|Death|1|||
128760030|NCT00553501|463411371|FG000|Overall Study|Progression|1|||
128760031|NCT02293395|463411372|FG000|Overall Study|Lost to Follow-up|1|||
128760032|NCT02293395|463411373|FG001|Overall Study|Lost to Follow-up|0|||
128760033|NCT02293395|463411372|FG000|Overall Study|Withdrawal by Subject|8|||
128760034|NCT02293395|463411373|FG001|Overall Study|Withdrawal by Subject|7|||
128760035|NCT01464021|463411374|FG000|Overall Study|Withdrawal by Subject|13|||
128760036|NCT01464021|463411374|FG000|Overall Study|Lost to Follow-up|1|||
128760037|NCT01464021|463411374|FG000|Overall Study|Lack of Efficacy|1|||
128760038|NCT01464021|463411374|FG000|Overall Study|various|11|||
128760039|NCT03391765|463411375|FG000|Overall Study|Adverse Event|2|||
128760040|NCT03391765|463411376|FG001|Overall Study|Adverse Event|0|||
128760041|NCT03391765|463411377|FG002|Overall Study|Adverse Event|0|||
128760042|NCT03391765|463411378|FG003|Overall Study|Adverse Event|2|||
128760043|NCT03391765|463411375|FG000|Overall Study|Withdrew consent|5|||
128760044|NCT03391765|463411376|FG001|Overall Study|Withdrew consent|7|||
128760045|NCT03391765|463411377|FG002|Overall Study|Withdrew consent|2|||
128760046|NCT03391765|463411378|FG003|Overall Study|Withdrew consent|5|||
128760047|NCT03391765|463411375|FG000|Overall Study|Other, not specified|44|||
128760048|NCT03391765|463411376|FG001|Overall Study|Other, not specified|38|||
129094295|NCT01785849|464636105|FG001|Overall Study|Protocol Specified Criteria|1|||
129094296|NCT01785849|464636104|FG000|Overall Study|Withdrawal by Subject|15|||
129094297|NCT01785849|464636105|FG001|Overall Study|Withdrawal by Subject|12|||
129094298|NCT01785849|464636104|FG000|Overall Study|Sponsor Decision|0|||
129094299|NCT01785849|464636105|FG001|Overall Study|Sponsor Decision|1|||
129094300|NCT01785849|464636104|FG000|Overall Study|Lost to Follow-up|10|||
129094301|NCT01785849|464636105|FG001|Overall Study|Lost to Follow-up|11|||
129094302|NCT04340843|464636106|FG000|Overall Study|Adverse Event|0|||
129094303|NCT04340843|464636107|FG001|Overall Study|Adverse Event|2|||
129094304|NCT04340843|464636106|FG000|Overall Study|Withdrawal by Subject|0|||
129094305|NCT04340843|464636107|FG001|Overall Study|Withdrawal by Subject|2|||
129094306|NCT04249622|464636108|FG000|Overall Study|Withdrawal by Subject|1|||
129094307|NCT04249622|464636109|FG001|Overall Study|Withdrawal by Subject|1|||
129094308|NCT04249622|464636108|FG000|Overall Study|Alternative therapy|1|||
129094309|NCT04249622|464636109|FG001|Overall Study|Alternative therapy|0|||
129094310|NCT04249622|464636108|FG000|Overall Study|Discontinuation of pertuzumab|1|||
129094311|NCT04249622|464636109|FG001|Overall Study|Discontinuation of pertuzumab|0|||
129094312|NCT01634659|464636113|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
129094313|NCT01634659|464636114|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
129094314|NCT01634659|464636113|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
129094315|NCT01634659|464636114|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
129094316|NCT00793624|464636115|FG000|Overall Study|Adverse Event|18|||
129094317|NCT00793624|464636116|FG001|Overall Study|Adverse Event|16|||
129094318|NCT00793624|464636117|FG002|Overall Study|Adverse Event|15|||
129094319|NCT00793624|464636118|FG003|Overall Study|Adverse Event|20|||
129094320|NCT00793624|464636115|FG000|Overall Study|Lost to Follow-up|2|||
129094321|NCT00793624|464636116|FG001|Overall Study|Lost to Follow-up|2|||
129094322|NCT00793624|464636117|FG002|Overall Study|Lost to Follow-up|4|||
129094323|NCT00793624|464636118|FG003|Overall Study|Lost to Follow-up|0|||
129094324|NCT00793624|464636115|FG000|Overall Study|Withdrawal by Subject|20|||
129205637|NCT04999839|465049927|FG003|Overall Study|Lost to Follow-up|4|||
129205638|NCT04999839|465049928|FG004|Overall Study|Lost to Follow-up|1|||
128760049|NCT03391765|463411377|FG002|Overall Study|Other, not specified|21|||
128760050|NCT03391765|463411378|FG003|Overall Study|Other, not specified|16|||
128760051|NCT00944658|463411379|FG000|Treatment 12 Weeks|Adverse Event|0|||
128760052|NCT00944658|463411380|FG001|Treatment 12 Weeks|Adverse Event|2|||
128760053|NCT02832622|463411386|FG000|Overall Study|MPP not programmed|1259|||
128760054|NCT02832622|463411386|FG000|Overall Study|Withdrawal by Subject|123|||
129094325|NCT00793624|464636116|FG001|Overall Study|Withdrawal by Subject|9|||
129094326|NCT00793624|464636117|FG002|Overall Study|Withdrawal by Subject|11|||
129094327|NCT00793624|464636118|FG003|Overall Study|Withdrawal by Subject|14|||
129094328|NCT00793624|464636115|FG000|Overall Study|Lack of Efficacy|9|||
129094329|NCT00793624|464636116|FG001|Overall Study|Lack of Efficacy|2|||
128760055|NCT02832622|463411386|FG000|Overall Study|Death|119|||
128760056|NCT02832622|463411386|FG000|Overall Study|Unsuccessful CRT implant|93|||
128760057|NCT02832622|463411386|FG000|Overall Study|Lost to Follow-up|45|||
128760058|NCT02832622|463411386|FG000|Overall Study|Patient non-compliance|42|||
128760059|NCT02832622|463411386|FG000|Overall Study|Withdrawal by other reasons|25|||
128760060|NCT02832622|463411386|FG000|Overall Study|System explant|24|||
128760061|NCT02832622|463411386|FG000|Overall Study|Physician Decision|6|||
128760062|NCT02472652|463411387|FG000|Overall Study|Lost to Follow-up|1|||
128760063|NCT03185832|463411388|FG000|Overall Study|Death|9|||
128760064|NCT03185832|463411389|FG001|Overall Study|Death|14|||
128760065|NCT03185832|463411390|FG002|Overall Study|Death|9|||
128760066|NCT03185832|463411391|FG003|Overall Study|Death|7|||
128760067|NCT03185832|463411388|FG000|Overall Study|Withdrawn - vital status available|0|||
128760068|NCT03185832|463411389|FG001|Overall Study|Withdrawn - vital status available|1|||
128760069|NCT03185832|463411390|FG002|Overall Study|Withdrawn - vital status available|1|||
128760070|NCT03185832|463411391|FG003|Overall Study|Withdrawn - vital status available|4|||
128760071|NCT01493687|463411394|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
128760072|NCT01493687|463411395|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
128760073|NCT01493687|463411394|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
128760074|NCT01493687|463411395|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
128760075|NCT01493687|463411394|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
128760076|NCT01493687|463411395|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
128760077|NCT01493687|463411394|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
128760078|NCT01493687|463411395|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
128760079|NCT01493687|463411394|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
128760080|NCT01493687|463411395|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
128760081|NCT01493687|463411394|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
128760082|NCT01493687|463411395|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
128760083|NCT01493687|463411394|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
128760084|NCT01493687|463411395|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
128760085|NCT01493687|463411394|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
128760086|NCT01493687|463411395|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
128760087|NCT01493687|463411394|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
128760088|NCT01493687|463411395|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
128760089|NCT01493687|463411394|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
128760090|NCT01493687|463411395|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
128760091|NCT01493687|463411394|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
128760092|NCT01493687|463411395|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
128760093|NCT01493687|463411394|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
128760094|NCT01493687|463411395|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
129094330|NCT00793624|464636117|FG002|Overall Study|Lack of Efficacy|1|||
129094331|NCT00793624|464636118|FG003|Overall Study|Lack of Efficacy|3|||
129205639|NCT04999839|465049924|FG000|Overall Study|Withdrawal by Subject|6|||
129205640|NCT04999839|465049925|FG001|Overall Study|Withdrawal by Subject|5|||
129205641|NCT04999839|465049926|FG002|Overall Study|Withdrawal by Subject|3|||
129205642|NCT04999839|465049927|FG003|Overall Study|Withdrawal by Subject|2|||
129205643|NCT04999839|465049928|FG004|Overall Study|Withdrawal by Subject|2|||
129205644|NCT04999839|465049924|FG000|Overall Study|Lack of Efficacy|0|||
129205645|NCT04999839|465049925|FG001|Overall Study|Lack of Efficacy|1|||
129205646|NCT04999839|465049926|FG002|Overall Study|Lack of Efficacy|0|||
129205647|NCT04999839|465049927|FG003|Overall Study|Lack of Efficacy|0|||
129205648|NCT04999839|465049928|FG004|Overall Study|Lack of Efficacy|0|||
129205649|NCT04999839|465049924|FG000|Overall Study|Physician Decision|0|||
129205650|NCT04999839|465049925|FG001|Overall Study|Physician Decision|0|||
129205651|NCT04999839|465049926|FG002|Overall Study|Physician Decision|0|||
129205652|NCT04999839|465049927|FG003|Overall Study|Physician Decision|0|||
129205653|NCT04999839|465049928|FG004|Overall Study|Physician Decision|1|||
129205654|NCT04999839|465049924|FG000|Overall Study|Sponsor request|0|||
129205655|NCT04999839|465049925|FG001|Overall Study|Sponsor request|1|||
129205656|NCT04999839|465049926|FG002|Overall Study|Sponsor request|0|||
129205657|NCT04999839|465049927|FG003|Overall Study|Sponsor request|0|||
129205658|NCT04999839|465049928|FG004|Overall Study|Sponsor request|0|||
129205659|NCT04999839|465049924|FG000|Overall Study|Other|0|||
129205660|NCT04999839|465049925|FG001|Overall Study|Other|0|||
129205661|NCT04999839|465049926|FG002|Overall Study|Other|1|||
129205662|NCT04999839|465049927|FG003|Overall Study|Other|0|||
129205663|NCT04999839|465049928|FG004|Overall Study|Other|0|||
129205664|NCT01362348|465049929|FG000|Overall Study|Protocol-defined stopping criteria|9|||
129205665|NCT01362348|465049929|FG000|Overall Study|Study closed/terminated|5|||
129205666|NCT02734693|465049932|FG000|Overall Study|Adverse Event|1|||
129205667|NCT02734693|465049933|FG001|Overall Study|Adverse Event|3|||
129205668|NCT02734693|465049934|FG002|Overall Study|Adverse Event|3|||
129205669|NCT02734693|465049932|FG000|Overall Study|Lack of Efficacy|1|||
129205670|NCT02734693|465049933|FG001|Overall Study|Lack of Efficacy|0|||
129205671|NCT02734693|465049934|FG002|Overall Study|Lack of Efficacy|0|||
129205672|NCT02734693|465049932|FG000|Overall Study|Lost to Follow-up|2|||
129205673|NCT02734693|465049933|FG001|Overall Study|Lost to Follow-up|0|||
129205674|NCT02734693|465049934|FG002|Overall Study|Lost to Follow-up|0|||
129205675|NCT02734693|465049932|FG000|Overall Study|Protocol Violation|1|||
129205676|NCT02734693|465049933|FG001|Overall Study|Protocol Violation|0|||
129205677|NCT02734693|465049934|FG002|Overall Study|Protocol Violation|0|||
129205678|NCT02734693|465049932|FG000|Overall Study|Withdrawal by Subject|1|||
129205679|NCT02734693|465049933|FG001|Overall Study|Withdrawal by Subject|0|||
129205680|NCT02734693|465049934|FG002|Overall Study|Withdrawal by Subject|0|||
129205681|NCT02898454|465049940|FG000|Overall Study|Adverse Event|4|||
129205682|NCT02898454|465049941|FG001|Overall Study|Adverse Event|1|||
129205683|NCT02898454|465049942|FG002|Overall Study|Adverse Event|2|||
129205684|NCT02898454|465049940|FG000|Overall Study|Protocol Violation|1|||
129205685|NCT02898454|465049941|FG001|Overall Study|Protocol Violation|0|||
129205686|NCT02898454|465049942|FG002|Overall Study|Protocol Violation|1|||
129205687|NCT02898454|465049940|FG000|Overall Study|Lack of Efficacy|4|||
129205688|NCT02898454|465049941|FG001|Overall Study|Lack of Efficacy|1|||
129205689|NCT02898454|465049942|FG002|Overall Study|Lack of Efficacy|0|||
128760095|NCT01493687|463411394|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
128760096|NCT01493687|463411395|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
128760097|NCT01493687|463411394|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
128760098|NCT01493687|463411395|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
129205690|NCT02898454|465049940|FG000|Overall Study|Withdrawal by Subject|6|||
129205691|NCT02898454|465049941|FG001|Overall Study|Withdrawal by Subject|3|||
129205692|NCT02898454|465049942|FG002|Overall Study|Withdrawal by Subject|3|||
129205693|NCT02898454|465049940|FG000|Overall Study|Lost to Follow-up|1|||
129205694|NCT02898454|465049941|FG001|Overall Study|Lost to Follow-up|0|||
129205695|NCT02898454|465049942|FG002|Overall Study|Lost to Follow-up|0|||
129205696|NCT02898454|465049940|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
129205697|NCT02898454|465049941|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
129205698|NCT02898454|465049942|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
129205699|NCT00647296|465049943|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
129205700|NCT00647296|465049944|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
129205701|NCT00647296|465049945|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
129205702|NCT00647296|465049946|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
129205703|NCT00647296|465049943|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
129205704|NCT00647296|465049944|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
129205705|NCT00647296|465049945|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
129205706|NCT00647296|465049946|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
129205707|NCT00647296|465049943|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
129205708|NCT00647296|465049944|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
129205709|NCT00647296|465049945|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
129205710|NCT00647296|465049946|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
129205711|NCT00647296|465049943|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
129205712|NCT00647296|465049944|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
129205713|NCT00647296|465049945|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
129205714|NCT00647296|465049946|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
129205715|NCT00647296|465049943|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
129205716|NCT00647296|465049944|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
129205717|NCT00647296|465049945|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
129205718|NCT00647296|465049946|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
129205719|NCT00647296|465049943|FG000|Part 2: 4-week Placebo Washout|Death|3|||
129205720|NCT00647296|465049944|FG001|Part 2: 4-week Placebo Washout|Death|0|||
129205721|NCT00647296|465049945|FG002|Part 2: 4-week Placebo Washout|Death|0|||
129205722|NCT00647296|465049946|FG003|Part 2: 4-week Placebo Washout|Death|0|||
129205723|NCT00647296|465049943|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
129205724|NCT00647296|465049944|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
129205725|NCT00647296|465049945|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
129205726|NCT00647296|465049946|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
129205727|NCT00647296|465049943|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
129205728|NCT00647296|465049944|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
129205729|NCT00647296|465049945|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
129205730|NCT00647296|465049946|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
129205731|NCT00647296|465049943|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
128760099|NCT01493687|463411394|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
128760100|NCT01493687|463411395|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
128760101|NCT02364180|463411399|FG000|Overall Study|Screen Fail|1|||
128760102|NCT02323646|463411400|FG000|Treatment Course 1|Adverse Event|1|||
128760103|NCT02323646|463411401|FG001|Treatment Course 1|Adverse Event|0|||
128760104|NCT02323646|463411402|FG002|Treatment Course 1|Adverse Event|1|||
128760105|NCT02323646|463411400|FG000|Treatment Course 1|Heavy Bleeding|1|||
128760106|NCT02323646|463411401|FG001|Treatment Course 1|Heavy Bleeding|1|||
128760107|NCT02323646|463411402|FG002|Treatment Course 1|Heavy Bleeding|0|||
129205732|NCT00647296|465049944|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
129205733|NCT00647296|465049945|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
129205734|NCT00647296|465049946|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
129205735|NCT00647296|465049943|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
129205736|NCT00647296|465049944|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
129205737|NCT00647296|465049945|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
129205738|NCT00647296|465049946|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
129205739|NCT00647296|465049943|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
129205740|NCT00647296|465049944|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
129205741|NCT00647296|465049945|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
129205742|NCT00647296|465049946|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
129205743|NCT03883581|465049947|FG000|Overall Study|Withdrawal by Subject|4|||
129205744|NCT04875195|465049948|FG000|Overall Study|Death|9|||
129205745|NCT04875195|465049949|FG001|Overall Study|Death|3|||
129205746|NCT04875195|465049948|FG000|Overall Study|Withdrawal by Subject|2|||
129205747|NCT04875195|465049949|FG001|Overall Study|Withdrawal by Subject|1|||
129205748|NCT04875195|465049948|FG000|Overall Study|Ongoing in study|49|||
129205749|NCT04875195|465049949|FG001|Overall Study|Ongoing in study|2|||
129205750|NCT02926638|465049950|FG000|Overall Study|Progression|2|||
129205751|NCT02926638|465049951|FG001|Overall Study|Progression|5|||
129205752|NCT02926638|465049950|FG000|Overall Study|Ineligible|1|||
129205753|NCT02926638|465049951|FG001|Overall Study|Ineligible|0|||
129205754|NCT02926638|465049950|FG000|Overall Study|Not protocol specified|1|||
129205755|NCT02926638|465049951|FG001|Overall Study|Not protocol specified|0|||
129205756|NCT00644423|465051330|FG000|Overall Study|Lost to Follow-up|1|||
129205757|NCT00644423|465051331|FG001|Overall Study|Lost to Follow-up|1|||
129205758|NCT01908426|465051332|FG000|Overall Study|Adverse Event|98|||
129205759|NCT01908426|465051333|FG001|Overall Study|Adverse Event|11|||
129205760|NCT01908426|465051332|FG000|Overall Study|Clinical Deterioration|72|||
129205761|NCT01908426|465051333|FG001|Overall Study|Clinical Deterioration|38|||
129205762|NCT01908426|465051332|FG000|Overall Study|Lack of Efficacy|3|||
129205763|NCT01908426|465051333|FG001|Overall Study|Lack of Efficacy|0|||
129205764|NCT01908426|465051332|FG000|Overall Study|Lost to Follow-up|0|||
129205765|NCT01908426|465051333|FG001|Overall Study|Lost to Follow-up|1|||
129205766|NCT01908426|465051332|FG000|Overall Study|Physician Decision|3|||
129205767|NCT01908426|465051333|FG001|Overall Study|Physician Decision|3|||
129205768|NCT01908426|465051332|FG000|Overall Study|Withdrawal by Subject|11|||
129205769|NCT01908426|465051333|FG001|Overall Study|Withdrawal by Subject|6|||
129205770|NCT01908426|465051332|FG000|Overall Study|Progressive Disease|206|||
129205771|NCT01908426|465051333|FG001|Overall Study|Progressive Disease|152|||
129205772|NCT01908426|465051332|FG000|Overall Study|Protocol Violation|1|||
129205773|NCT01908426|465051333|FG001|Overall Study|Protocol Violation|0|||
129205774|NCT01908426|465051332|FG000|Overall Study|No Study Treatment Given|3|||
129205775|NCT01908426|465051333|FG001|Overall Study|No Study Treatment Given|0|||
129205776|NCT02426580|465051338|FG000|Overall Study|Death|2|||
129205777|NCT02426580|465051339|FG001|Overall Study|Death|2|||
128760108|NCT02323646|463411400|FG000|Treatment Course 1|Lost to Follow-up|1|||
128760109|NCT02323646|463411401|FG001|Treatment Course 1|Lost to Follow-up|0|||
128760110|NCT02323646|463411402|FG002|Treatment Course 1|Lost to Follow-up|2|||
128760111|NCT02323646|463411400|FG000|Treatment Course 1|Withdrawal by Subject|0|||
128760112|NCT02323646|463411401|FG001|Treatment Course 1|Withdrawal by Subject|2|||
128760113|NCT02323646|463411402|FG002|Treatment Course 1|Withdrawal by Subject|0|||
128760114|NCT02323646|463411400|FG000|Treatment Course 2|Adverse Event|1|||
128760115|NCT02323646|463411401|FG001|Treatment Course 2|Adverse Event|0|||
128760116|NCT02323646|463411402|FG002|Treatment Course 2|Adverse Event|1|||
128760117|NCT02323646|463411400|FG000|Treatment Course 2|Lost to Follow-up|0|||
128760118|NCT02323646|463411401|FG001|Treatment Course 2|Lost to Follow-up|0|||
128760119|NCT02323646|463411402|FG002|Treatment Course 2|Lost to Follow-up|1|||
128760120|NCT02323646|463411400|FG000|Treatment Course 2|Non-compliance|0|||
128760121|NCT02323646|463411401|FG001|Treatment Course 2|Non-compliance|1|||
128760122|NCT02323646|463411402|FG002|Treatment Course 2|Non-compliance|1|||
128760123|NCT00521144|463411403|FG000|Overall Study|Not Treated|0|||
128760124|NCT00521144|463411404|FG001|Overall Study|Not Treated|0|||
128760125|NCT00521144|463411405|FG002|Overall Study|Not Treated|0|||
129205778|NCT02426580|465051338|FG000|Overall Study|Lost to Follow-up|0|||
129205779|NCT02426580|465051339|FG001|Overall Study|Lost to Follow-up|9|||
129205780|NCT02426580|465051338|FG000|Overall Study|transfer to hemodialysis|5|||
129205781|NCT02426580|465051339|FG001|Overall Study|transfer to hemodialysis|5|||
128760126|NCT00521144|463411406|FG003|Overall Study|Not Treated|1|||
128760127|NCT00521144|463411407|FG004|Overall Study|Not Treated|0|||
129094332|NCT00793624|464636115|FG000|Overall Study|Non compliance with protocol|2|||
128760128|NCT00521144|463411403|FG000|Overall Study|Adverse Event|0|||
129205782|NCT02426580|465051338|FG000|Overall Study|Kidney transplant|3|||
129205783|NCT02426580|465051339|FG001|Overall Study|Kidney transplant|0|||
129205784|NCT02426580|465051338|FG000|Overall Study|Allergic to egg white|1|||
128760129|NCT00521144|463411404|FG001|Overall Study|Adverse Event|1|||
129205785|NCT02426580|465051339|FG001|Overall Study|Allergic to egg white|0|||
128760130|NCT00521144|463411405|FG002|Overall Study|Adverse Event|0|||
128760131|NCT00521144|463411406|FG003|Overall Study|Adverse Event|0|||
128760132|NCT00521144|463411407|FG004|Overall Study|Adverse Event|1|||
128760133|NCT00521144|463411403|FG000|Overall Study|Progressive Disease|4|||
128760134|NCT00521144|463411404|FG001|Overall Study|Progressive Disease|2|||
128760135|NCT00521144|463411405|FG002|Overall Study|Progressive Disease|2|||
128760136|NCT00521144|463411406|FG003|Overall Study|Progressive Disease|0|||
128760137|NCT00521144|463411407|FG004|Overall Study|Progressive Disease|6|||
128760138|NCT01370525|463411408|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
128760139|NCT01370525|463411409|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
128760140|NCT01370525|463411408|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
128760141|NCT01370525|463411409|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128760142|NCT01370525|463411408|FG000|Overall Study|Adverse Event|0|||
128760143|NCT01370525|463411409|FG001|Overall Study|Adverse Event|1|||
128760144|NCT01370525|463411408|FG000|Overall Study|Protocol Violation|2|||
128760145|NCT01370525|463411409|FG001|Overall Study|Protocol Violation|1|||
128760146|NCT01370525|463411408|FG000|Overall Study|Lost to follow up|2|||
128760147|NCT01370525|463411409|FG001|Overall Study|Lost to follow up|6|||
128760148|NCT01750879|463411417|FG000|Overall Study|Adverse Event|8|||
128760149|NCT01750879|463411418|FG001|Overall Study|Adverse Event|0|||
128760150|NCT01750879|463411417|FG000|Overall Study|Lack of Efficacy|1|||
128760151|NCT01750879|463411418|FG001|Overall Study|Lack of Efficacy|0|||
128760152|NCT01750879|463411417|FG000|Overall Study|Withdrawal by Subject|1|||
128760153|NCT01750879|463411418|FG001|Overall Study|Withdrawal by Subject|0|||
128760154|NCT01750879|463411417|FG000|Overall Study|Did not complete per protocol|0|||
128760155|NCT01750879|463411418|FG001|Overall Study|Did not complete per protocol|3|||
128760156|NCT02093663|463411423|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
128760157|NCT02093663|463411424|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
128760158|NCT02093663|463411425|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
128760159|NCT02093663|463411426|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
128760160|NCT02093663|463411427|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
128760161|NCT02093663|463411423|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
128760162|NCT02093663|463411424|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760163|NCT02093663|463411425|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760164|NCT02093663|463411426|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760165|NCT02093663|463411427|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760166|NCT02093663|463411423|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
128760167|NCT02093663|463411424|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
128760168|NCT02093663|463411425|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
128760169|NCT02093663|463411426|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
128760170|NCT02093663|463411427|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
128760171|NCT02093663|463411423|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
128760172|NCT02093663|463411424|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
128760173|NCT02093663|463411425|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
128760174|NCT02093663|463411426|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
128760175|NCT02093663|463411427|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
128760176|NCT02093663|463411423|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760177|NCT02093663|463411424|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760178|NCT02093663|463411425|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
128760179|NCT02093663|463411426|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760180|NCT02093663|463411427|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
128760181|NCT02093663|463411423|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
128760182|NCT02093663|463411424|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
128760183|NCT02093663|463411425|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
128760184|NCT02093663|463411426|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
128760185|NCT02093663|463411427|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
128760186|NCT02093663|463411423|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
128760187|NCT02093663|463411424|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
128760188|NCT02093663|463411425|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
128760189|NCT02093663|463411426|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
128760190|NCT02093663|463411427|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
128760191|NCT02093663|463411423|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
128982157|NCT02926833|464220980|FG000|Overall Study|Full Consent Withdrawal|0|||
129205786|NCT01131507|465051348|FG000|Overall Study|Adverse Event|1|||
128760192|NCT02093663|463411424|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
129205787|NCT01131507|465051348|FG000|Overall Study|Lost to Follow-up|1|||
128760193|NCT02093663|463411425|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
128760194|NCT02093663|463411426|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
128982158|NCT02926833|464220981|FG001|Overall Study|Full Consent Withdrawal|0|||
129040259|NCT03314662|464438807|FG000|Overall Study|Death|2|||
128760195|NCT02093663|463411427|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
128760196|NCT02093663|463411423|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
128760197|NCT02093663|463411424|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
128760198|NCT02093663|463411425|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
128760199|NCT02093663|463411426|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
128760200|NCT02093663|463411427|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
128760201|NCT00508404|463411428|FG000|Overall Study|Ongoing at Data Cut-off|12|||
128760202|NCT00508404|463411428|FG000|Overall Study|Adverse Event|2|||
128760203|NCT00508404|463411428|FG000|Overall Study|Death|16|||
128760204|NCT00508404|463411428|FG000|Overall Study|Physician Decision|2|||
128760205|NCT00508404|463411428|FG000|Overall Study|Withdrawal by Subject|3|||
128760206|NCT00508404|463411428|FG000|Overall Study|Protocol-specified Criteria|2|||
128760207|NCT00508404|463411428|FG000|Overall Study|Lost to Follow-up|2|||
128760208|NCT00508404|463411428|FG000|Overall Study|Other - Not Specified|3|||
128760209|NCT01059643|463411434|FG000|Overall Study|Adverse Event|3|||
128760210|NCT01059643|463411434|FG000|Overall Study|Withdrawal by Subject|2|||
129205788|NCT01131507|465051348|FG000|Overall Study|Withdrawal by Subject|1|||
129205789|NCT01393158|465051355|FG000|Overall Study|Adverse Event|1|||
128760211|NCT01059643|463411434|FG000|Overall Study|Physician Decision|1|||
128760212|NCT00643123|463411444|FG000|Overall Study|Lost to Follow-up|4|||
128760213|NCT00643123|463411445|FG001|Overall Study|Lost to Follow-up|0|||
128760214|NCT00643123|463411444|FG000|Overall Study|Withdrawal by Subject|1|||
128760215|NCT00643123|463411445|FG001|Overall Study|Withdrawal by Subject|1|||
128760216|NCT01591382|463411448|FG000|Overall Study|Discharged Prior to Study Completion|2|||
129205790|NCT01393158|465051356|FG001|Overall Study|Adverse Event|0|||
129205791|NCT00762359|465051357|FG000|Overall Study|Adverse Event|20|||
128760217|NCT01591382|463411449|FG001|Overall Study|Discharged Prior to Study Completion|1|||
128760218|NCT01591382|463411448|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
128760219|NCT01591382|463411449|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
128760220|NCT00855062|463411457|FG000|Step1|Early Study Closure|5|||
128760221|NCT00855062|463411458|FG001|Step1|Early Study Closure|7|||
128982159|NCT02926833|464220982|FG002|Overall Study|Full Consent Withdrawal|0|||
128982160|NCT02926833|464220983|FG003|Overall Study|Full Consent Withdrawal|2|||
128982161|NCT02926833|464220980|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
128982162|NCT02926833|464220981|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
128760222|NCT00855062|463411457|FG000|Step1|Adverse Event|1|||
128760223|NCT00855062|463411458|FG001|Step1|Adverse Event|1|||
128760224|NCT00855062|463411457|FG000|Step1|Protocol Violation|1|||
128760225|NCT00855062|463411458|FG001|Step1|Protocol Violation|0|||
128760226|NCT00855062|463411457|FG000|Step1|Pregnancy|1|||
128982163|NCT02926833|464220982|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
128982164|NCT02926833|464220983|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
128982165|NCT02926833|464220980|FG000|Overall Study|Investigator Decision|0|||
128982166|NCT02926833|464220981|FG001|Overall Study|Investigator Decision|1|||
128982167|NCT02926833|464220982|FG002|Overall Study|Investigator Decision|0|||
128982168|NCT02926833|464220983|FG003|Overall Study|Investigator Decision|0|||
128982169|NCT02926833|464220980|FG000|Overall Study|Adverse Event|0|||
128982170|NCT02926833|464220981|FG001|Overall Study|Adverse Event|0|||
128982171|NCT02926833|464220982|FG002|Overall Study|Adverse Event|1|||
128982172|NCT02926833|464220983|FG003|Overall Study|Adverse Event|0|||
128982173|NCT02926833|464220980|FG000|Overall Study|Partial Withdrawal of Consent|0|||
128982174|NCT02926833|464220981|FG001|Overall Study|Partial Withdrawal of Consent|0|||
128982175|NCT02926833|464220982|FG002|Overall Study|Partial Withdrawal of Consent|0|||
128982176|NCT02926833|464220983|FG003|Overall Study|Partial Withdrawal of Consent|1|||
128982177|NCT01189201|464220986|FG000|Overall Study|Adverse Event|1|||
128982178|NCT01277757|464220987|FG000|Overall Study|Disease Progression|1|||
128982179|NCT01277757|464220987|FG000|Overall Study|Withdrawal by Subject|1|||
128982180|NCT04308668|464220988|FG000|Overall Study|Lost to Follow-up|32|||
128982181|NCT04308668|464220989|FG001|Overall Study|Lost to Follow-up|38|||
128982182|NCT04308668|464220988|FG000|Overall Study|Withdrawal by Subject|4|||
128982183|NCT04308668|464220989|FG001|Overall Study|Withdrawal by Subject|4|||
128982184|NCT03808298|464220990|FG000|Overall Study|Adverse Event|3|||
128982185|NCT03808298|464220990|FG000|Overall Study|Physician Decision|1|||
128982186|NCT03808298|464220990|FG000|Overall Study|Withdrawal by Subject|1|||
128982187|NCT03808298|464220990|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
128717711|NCT02337907|463263984|FG005|Overall Study|Lost to Follow-up|1|||
128982188|NCT01674010|464220991|FG000|Open Treatment Phase 1|Adverse Event|10|||
128982189|NCT01674010|464220992|FG001|Open Treatment Phase 1|Adverse Event|0|||
128982190|NCT01674010|464220993|FG002|Open Treatment Phase 1|Adverse Event|0|||
128982191|NCT01674010|464220991|FG000|Open Treatment Phase 1|Death|1|||
128982192|NCT01674010|464220992|FG001|Open Treatment Phase 1|Death|0|||
128982193|NCT01674010|464220993|FG002|Open Treatment Phase 1|Death|0|||
128982194|NCT01674010|464220991|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
128982195|NCT01674010|464220992|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
128982196|NCT01674010|464220993|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
129205792|NCT00762359|465051358|FG001|Overall Study|Adverse Event|23|||
128760227|NCT00855062|463411458|FG001|Step1|Pregnancy|0|||
128760228|NCT00855062|463411457|FG000|Step1|Withdrawal by Subject|2|||
128760229|NCT00855062|463411458|FG001|Step1|Withdrawal by Subject|3|||
128760230|NCT00855062|463411457|FG000|Step2|Early Study Closure|6|||
128760231|NCT00855062|463411458|FG001|Step2|Early Study Closure|2|||
128760232|NCT00855062|463411457|FG000|Step2|Adverse Event|0|||
128760233|NCT00855062|463411458|FG001|Step2|Adverse Event|3|||
128760234|NCT00855062|463411457|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
128760235|NCT00855062|463411458|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
128760236|NCT01960725|463411461|FG000|Overall Study|Lost to Follow-up|4|||
128760237|NCT01960725|463411462|FG001|Overall Study|Lost to Follow-up|3|||
128760238|NCT01960725|463411461|FG000|Overall Study|Withdrawal by Subject|1|||
128760239|NCT01960725|463411462|FG001|Overall Study|Withdrawal by Subject|0|||
128760240|NCT01960725|463411461|FG000|Overall Study|unable to obtain blood sample|1|||
128760241|NCT01960725|463411462|FG001|Overall Study|unable to obtain blood sample|2|||
128760242|NCT02110901|463411463|FG000|Overall Study|Death|6|||
128760243|NCT02110901|463411464|FG001|Overall Study|Death|3|||
128760244|NCT02110901|463411463|FG000|Overall Study|Lost to Follow-up|12|||
128760245|NCT02110901|463411464|FG001|Overall Study|Lost to Follow-up|8|||
128760246|NCT02110901|463411463|FG000|Overall Study|Withdrawal by Subject|7|||
128760247|NCT02110901|463411464|FG001|Overall Study|Withdrawal by Subject|3|||
128760248|NCT02110901|463411463|FG000|Overall Study|received a kidney transplant|5|||
128760249|NCT02110901|463411464|FG001|Overall Study|received a kidney transplant|0|||
128760250|NCT00758459|463411465|FG000|Overall Study|Adverse Event|3|||
128760251|NCT00758459|463411466|FG001|Overall Study|Adverse Event|2|||
128760252|NCT00758459|463411465|FG000|Overall Study|Protocol Violation|0|||
128760253|NCT00758459|463411466|FG001|Overall Study|Protocol Violation|1|||
128760254|NCT00758459|463411465|FG000|Overall Study|Withdrawal by Subject|0|||
128760255|NCT00758459|463411466|FG001|Overall Study|Withdrawal by Subject|1|||
128760256|NCT01281202|463411470|FG000|Overall Study|Adverse Event|2|||
128760257|NCT01281202|463411471|FG001|Overall Study|Adverse Event|0|||
128760258|NCT01281202|463411470|FG000|Overall Study|Withdrawal by Subject|2|||
128760259|NCT01281202|463411471|FG001|Overall Study|Withdrawal by Subject|2|||
128760260|NCT01281202|463411470|FG000|Overall Study|Protocol Violation|11|||
128760261|NCT01281202|463411471|FG001|Overall Study|Protocol Violation|10|||
128760262|NCT01281202|463411470|FG000|Overall Study|Administrative|2|||
128760263|NCT01281202|463411471|FG001|Overall Study|Administrative|8|||
128760264|NCT01281202|463411470|FG000|Overall Study|Lost to Follow-up|11|||
128760265|NCT01281202|463411471|FG001|Overall Study|Lost to Follow-up|13|||
128760266|NCT01281202|463411470|FG000|Overall Study|Incarceration|0|||
128760267|NCT01281202|463411471|FG001|Overall Study|Incarceration|3|||
128760268|NCT04252742|463411476|FG000|Overall Study|Decision by sponsor|0|||
128760269|NCT04252742|463411477|FG001|Overall Study|Decision by sponsor|2|||
128760270|NCT04252742|463411476|FG000|Overall Study|Withdrawal by Subject|15|||
128760271|NCT04252742|463411477|FG001|Overall Study|Withdrawal by Subject|9|||
128760272|NCT04252742|463411476|FG000|Overall Study|Lost to Follow-up|0|||
128760273|NCT04252742|463411477|FG001|Overall Study|Lost to Follow-up|1|||
128760274|NCT01784068|463411480|FG000|NTCS Phase|Adverse Event|5|||
128760275|NCT01784068|463411481|FG001|NTCS Phase|Adverse Event|0|||
128760276|NCT01784068|463411480|FG000|NTCS Phase|Physician Decision|2|||
128760277|NCT01784068|463411481|FG001|NTCS Phase|Physician Decision|0|||
128760278|NCT01784068|463411480|FG000|NTCS Phase|Patient/guardian decision|3|||
128760279|NCT01784068|463411481|FG001|NTCS Phase|Patient/guardian decision|0|||
128760280|NCT01784068|463411480|FG000|NTCS Phase|Death|2|||
128760281|NCT01784068|463411481|FG001|NTCS Phase|Death|0|||
128760282|NCT01784068|463411480|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
128760283|NCT01784068|463411481|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
128760284|NCT01784068|463411480|FG000|TFR Phase|Physician Decision|0|||
128760285|NCT01784068|463411481|FG001|TFR Phase|Physician Decision|1|||
128760286|NCT01784068|463411480|FG000|TFR Phase|Patient/guardian decision|0|||
128760287|NCT01784068|463411481|FG001|TFR Phase|Patient/guardian decision|3|||
128760288|NCT01784068|463411480|FG000|TFR Phase|Death|0|||
128760289|NCT01784068|463411481|FG001|TFR Phase|Death|1|||
128760290|NCT01784068|463411480|FG000|TFR Phase|Lack of Efficacy|0|||
128760291|NCT01784068|463411481|FG001|TFR Phase|Lack of Efficacy|88|||
128760292|NCT00946296|463411482|FG000|Overall Study|Physician Decision|3|||
128760293|NCT00946296|463411483|FG001|Overall Study|Physician Decision|0|||
128760294|NCT02068495|463411487|FG000|Overall Study|Case Report Forms Uncollected|60|||
128760295|NCT02068495|463411487|FG000|Overall Study|Protocol Deviation|49|||
128760296|NCT02703922|463411489|FG000|Overall Study|Death|5|||
128760297|NCT02703922|463411490|FG001|Overall Study|Death|8|||
128760298|NCT02703922|463411489|FG000|Overall Study|Lost to Follow-up|10|||
128760299|NCT02703922|463411490|FG001|Overall Study|Lost to Follow-up|10|||
128760300|NCT00394355|463411492|FG000|Overall Study|Adverse Event|10|||
128760301|NCT00394355|463411493|FG001|Overall Study|Adverse Event|6|||
128760302|NCT00394355|463411494|FG002|Overall Study|Adverse Event|7|||
128760303|NCT00394355|463411495|FG003|Overall Study|Adverse Event|8|||
128760304|NCT00394355|463411492|FG000|Overall Study|Did not meet protocol eligibility|1|||
128760305|NCT00394355|463411493|FG001|Overall Study|Did not meet protocol eligibility|5|||
128760306|NCT00394355|463411494|FG002|Overall Study|Did not meet protocol eligibility|4|||
128760307|NCT00394355|463411495|FG003|Overall Study|Did not meet protocol eligibility|2|||
128760308|NCT00394355|463411492|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
128760309|NCT00394355|463411493|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
128760310|NCT00394355|463411494|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
128760311|NCT00394355|463411495|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
128760312|NCT00394355|463411492|FG000|Overall Study|Subject withdrawal - related to drug|1|||
128760313|NCT00394355|463411493|FG001|Overall Study|Subject withdrawal - related to drug|0|||
128760314|NCT00394355|463411494|FG002|Overall Study|Subject withdrawal - related to drug|0|||
128760315|NCT00394355|463411495|FG003|Overall Study|Subject withdrawal - related to drug|0|||
128760316|NCT00394355|463411492|FG000|Overall Study|Lost to Follow-up|7|||
128760317|NCT00394355|463411493|FG001|Overall Study|Lost to Follow-up|5|||
128760318|NCT00394355|463411494|FG002|Overall Study|Lost to Follow-up|4|||
128760319|NCT00394355|463411495|FG003|Overall Study|Lost to Follow-up|3|||
128760320|NCT00394355|463411492|FG000|Overall Study|Noncompliance with protocol|4|||
128760321|NCT00394355|463411493|FG001|Overall Study|Noncompliance with protocol|3|||
128760322|NCT00394355|463411494|FG002|Overall Study|Noncompliance with protocol|10|||
128760323|NCT00394355|463411495|FG003|Overall Study|Noncompliance with protocol|8|||
128760324|NCT00394355|463411492|FG000|Overall Study|Administrative|0|||
128760325|NCT00394355|463411493|FG001|Overall Study|Administrative|1|||
128760326|NCT00394355|463411494|FG002|Overall Study|Administrative|1|||
128760327|NCT00394355|463411495|FG003|Overall Study|Administrative|1|||
128760328|NCT00394355|463411492|FG000|Overall Study|Lack of Efficacy|0|||
128760329|NCT00394355|463411493|FG001|Overall Study|Lack of Efficacy|0|||
128760330|NCT00394355|463411494|FG002|Overall Study|Lack of Efficacy|2|||
128760331|NCT00394355|463411495|FG003|Overall Study|Lack of Efficacy|3|||
128760332|NCT03538951|463411497|FG000|Overall Study|Withdrawal by Subject|1|||
128760333|NCT03538951|463411498|FG001|Overall Study|Withdrawal by Subject|2|||
128760334|NCT01289418|463412769|FG000|Day 8 Survey|email address invalid|283|||
128760335|NCT01289418|463412769|FG000|Day 8 Survey|participants did not complete the survey|1935|||
128760336|NCT01289418|463412769|FG000|Day 29 Survey|email address invalid|283|||
128760337|NCT01289418|463412769|FG000|Day 29 Survey|participants did not complete the survey|2185|||
128760338|NCT05050578|463412773|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
128760339|NCT05050578|463412774|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
128760340|NCT05050578|463412773|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
128760341|NCT05050578|463412774|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
128760342|NCT05050578|463412773|FG000|Period 2, 30 Days|Protocol Violation|0|||
128760343|NCT05050578|463412774|FG001|Period 2, 30 Days|Protocol Violation|1|||
128760344|NCT02243280|463412775|FG000|Treated|Adverse Event|1|||
128760345|NCT02243280|463412776|FG001|Treated|Adverse Event|0|||
128760346|NCT02243280|463412777|FG002|Treated|Adverse Event|0|||
128760347|NCT02243280|463412778|FG003|Treated|Adverse Event|0|||
128760348|NCT02243280|463412779|FG004|Treated|Adverse Event|0|||
128760349|NCT02243280|463412780|FG005|Treated|Adverse Event|0|||
128760350|NCT02243280|463412781|FG006|Treated|Adverse Event|0|||
128760351|NCT02243280|463412782|FG007|Treated|Adverse Event|0|||
128760352|NCT02243280|463412783|FG008|Treated|Adverse Event|0|||
128760353|NCT02243280|463412784|FG009|Treated|Adverse Event|0|||
128760354|NCT02243280|463412785|FG010|Treated|Adverse Event|1|||
128760355|NCT02243280|463412775|FG000|Treated|Lost to Follow-up|0|||
128760356|NCT02243280|463412776|FG001|Treated|Lost to Follow-up|0|||
128760357|NCT02243280|463412777|FG002|Treated|Lost to Follow-up|0|||
128870885|NCT03843554|463822120|FG000|Overall Study|Physician Decision|0|||
128870886|NCT03843554|463822121|FG001|Overall Study|Physician Decision|2|||
128870887|NCT04396366|463822124|FG000|Overall Study|Adverse Event|1|||
128870888|NCT04396366|463822125|FG001|Overall Study|Adverse Event|0|||
128870889|NCT00166712|463822127|FG000|Overall Study|Death|0|||
128870890|NCT00166712|463822128|FG001|Overall Study|Death|1|||
128760358|NCT02243280|463412778|FG003|Treated|Lost to Follow-up|0|||
128760359|NCT02243280|463412779|FG004|Treated|Lost to Follow-up|0|||
128760360|NCT02243280|463412780|FG005|Treated|Lost to Follow-up|0|||
128760361|NCT02243280|463412781|FG006|Treated|Lost to Follow-up|0|||
128760362|NCT02243280|463412782|FG007|Treated|Lost to Follow-up|0|||
128760363|NCT02243280|463412783|FG008|Treated|Lost to Follow-up|1|||
128760364|NCT02243280|463412784|FG009|Treated|Lost to Follow-up|0|||
128760365|NCT02243280|463412785|FG010|Treated|Lost to Follow-up|2|||
129205793|NCT00762359|465051357|FG000|Overall Study|Protocol Violation|21|||
128717712|NCT02337907|463263979|FG000|Overall Study|Adverse Event|1|||
128760366|NCT00998400|463412790|FG000|Overall Study|Lack of interest/motivation|1|||
128760367|NCT00998400|463412791|FG001|Overall Study|Lack of interest/motivation|2|||
128760368|NCT00998400|463412790|FG000|Overall Study|Logistical problems|1|||
128760369|NCT00998400|463412791|FG001|Overall Study|Logistical problems|0|||
128760370|NCT03386032|463412798|FG000|Overall Study|Lack of Efficacy|6|||
128760371|NCT03386032|463412799|FG001|Overall Study|Lack of Efficacy|2|||
128760372|NCT03386032|463412800|FG002|Overall Study|Lack of Efficacy|0|||
128870891|NCT00166712|463822127|FG000|Overall Study|Adverse Event|1|||
128717713|NCT02337907|463263980|FG001|Overall Study|Adverse Event|1|||
128717714|NCT02337907|463263981|FG002|Overall Study|Adverse Event|1|||
128717715|NCT02337907|463263982|FG003|Overall Study|Adverse Event|1|||
128760373|NCT03386032|463412798|FG000|Overall Study|Adverse Event|2|||
128760374|NCT03386032|463412799|FG001|Overall Study|Adverse Event|2|||
128760375|NCT03386032|463412800|FG002|Overall Study|Adverse Event|0|||
128760376|NCT03386032|463412798|FG000|Overall Study|Withdrawal by Subject|1|||
128760377|NCT03386032|463412799|FG001|Overall Study|Withdrawal by Subject|0|||
128760378|NCT03386032|463412800|FG002|Overall Study|Withdrawal by Subject|0|||
128760379|NCT03386032|463412798|FG000|Overall Study|Lost to Follow-up|9|||
128760380|NCT03386032|463412799|FG001|Overall Study|Lost to Follow-up|3|||
128760381|NCT03386032|463412800|FG002|Overall Study|Lost to Follow-up|0|||
128760382|NCT01807156|463412805|FG000|Overall Study|Physician Decision|1|||
128760383|NCT03122119|463412806|FG000|Overall Study|Did not meet eligibility critria|1|||
128760384|NCT00335452|463412815|FG000|Overall Study|Death|156|||
128760385|NCT00335452|463412816|FG001|Overall Study|Death|144|||
128760386|NCT00335452|463412817|FG002|Overall Study|Death|158|||
128760387|NCT00335452|463412818|FG003|Overall Study|Death|129|||
128760388|NCT00335452|463412815|FG000|Overall Study|Lost to Follow-up|2|||
128760389|NCT00335452|463412816|FG001|Overall Study|Lost to Follow-up|3|||
128760390|NCT00335452|463412817|FG002|Overall Study|Lost to Follow-up|1|||
128760391|NCT00335452|463412818|FG003|Overall Study|Lost to Follow-up|2|||
128760392|NCT02940574|463412830|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
128760393|NCT02940574|463412831|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
128760394|NCT02940574|463412830|FG000|1-year Follow-up|Lost to Follow-up|3|||
128760395|NCT02940574|463412831|FG001|1-year Follow-up|Lost to Follow-up|4|||
128760396|NCT00387894|463412832|FG000|Overall Study|Withdrawal by Subject|1|||
128760397|NCT02421666|463412835|FG000|6-month Follow-up|Lost to Follow-up|8|||
128760398|NCT02421666|463412836|FG001|6-month Follow-up|Lost to Follow-up|7|||
128760399|NCT02421666|463412835|FG000|6-month Follow-up|Withdrawal by Subject|5|||
128760400|NCT02421666|463412836|FG001|6-month Follow-up|Withdrawal by Subject|6|||
128760401|NCT02421666|463412835|FG000|12-month Follow-up|Lost to Follow-up|5|||
128760402|NCT02421666|463412836|FG001|12-month Follow-up|Lost to Follow-up|5|||
128760403|NCT02421666|463412835|FG000|12-month Follow-up|Withdrawal by Subject|6|||
128760404|NCT02421666|463412836|FG001|12-month Follow-up|Withdrawal by Subject|11|||
128760405|NCT01119768|463412837|FG000|Treatment Period|Lack of Efficacy|18|||
128760406|NCT01119768|463412838|FG001|Treatment Period|Lack of Efficacy|25|||
128760407|NCT02923739|463412845|FG000|Overall Study|Withdrawal by Subject|2|||
128760408|NCT02923739|463412846|FG001|Overall Study|Withdrawal by Subject|0|||
128760409|NCT02923739|463412847|FG002|Overall Study|Withdrawal by Subject|0|||
128760410|NCT02923739|463412848|FG003|Overall Study|Withdrawal by Subject|0|||
128760411|NCT02923739|463412845|FG000|Overall Study|Failed Screening|3|||
128760412|NCT02923739|463412846|FG001|Overall Study|Failed Screening|0|||
128760413|NCT02923739|463412847|FG002|Overall Study|Failed Screening|0|||
128760414|NCT02923739|463412848|FG003|Overall Study|Failed Screening|0|||
128760415|NCT02634788|463412851|FG000|Overall Study|Adverse Event|0|||
128760416|NCT02634788|463412852|FG001|Overall Study|Adverse Event|8|||
128760417|NCT02634788|463412853|FG002|Overall Study|Adverse Event|3|||
128760418|NCT02634788|463412854|FG003|Overall Study|Adverse Event|1|||
128982197|NCT01674010|464220991|FG000|Open Treatment Phase 1|Physician Decision|9|||
128982198|NCT01674010|464220992|FG001|Open Treatment Phase 1|Physician Decision|0|||
128982199|NCT01674010|464220993|FG002|Open Treatment Phase 1|Physician Decision|0|||
128982200|NCT01674010|464220991|FG000|Open Treatment Phase 1|Protocol Violation|7|||
128982201|NCT01674010|464220992|FG001|Open Treatment Phase 1|Protocol Violation|0|||
128982202|NCT01674010|464220993|FG002|Open Treatment Phase 1|Protocol Violation|0|||
128982203|NCT01674010|464220991|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
128982204|NCT01674010|464220992|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
129205794|NCT00762359|465051358|FG001|Overall Study|Protocol Violation|13|||
129205795|NCT00762359|465051357|FG000|Overall Study|Withdrawal by Subject|13|||
128982205|NCT01674010|464220993|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
128982206|NCT01674010|464220991|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
128982207|NCT01674010|464220992|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
128982208|NCT01674010|464220993|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
128982209|NCT01674010|464220991|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
128982210|NCT01674010|464220992|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
128760419|NCT02634788|463412851|FG000|Overall Study|Lack of Efficacy|4|||
128760420|NCT02634788|463412852|FG001|Overall Study|Lack of Efficacy|0|||
129205796|NCT00762359|465051358|FG001|Overall Study|Withdrawal by Subject|10|||
128760421|NCT02634788|463412853|FG002|Overall Study|Lack of Efficacy|1|||
128760422|NCT02634788|463412854|FG003|Overall Study|Lack of Efficacy|4|||
128760423|NCT02634788|463412851|FG000|Overall Study|Lost to Follow-up|0|||
128760424|NCT02634788|463412852|FG001|Overall Study|Lost to Follow-up|1|||
128760425|NCT02634788|463412853|FG002|Overall Study|Lost to Follow-up|0|||
128760426|NCT02634788|463412854|FG003|Overall Study|Lost to Follow-up|0|||
128760427|NCT02634788|463412851|FG000|Overall Study|Withdrawal by Subject|0|||
128760428|NCT02634788|463412852|FG001|Overall Study|Withdrawal by Subject|1|||
128760429|NCT02634788|463412853|FG002|Overall Study|Withdrawal by Subject|1|||
128870892|NCT00166712|463822128|FG001|Overall Study|Adverse Event|0|||
128982211|NCT01674010|464220993|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
129205797|NCT00762359|465051357|FG000|Overall Study|Lack of Efficacy|0|||
128760430|NCT02634788|463412854|FG003|Overall Study|Withdrawal by Subject|0|||
128760431|NCT02496767|463412866|FG000|Open-label Lead-in Phase|Adverse Event|176|||
128760432|NCT02496767|463412867|FG001|Open-label Lead-in Phase|Adverse Event|0|||
128760433|NCT02496767|463412868|FG002|Open-label Lead-in Phase|Adverse Event|0|||
128760434|NCT02496767|463412869|FG003|Open-label Lead-in Phase|Adverse Event|0|||
128760435|NCT02496767|463412870|FG004|Open-label Lead-in Phase|Adverse Event|0|||
128760436|NCT02496767|463412871|FG005|Open-label Lead-in Phase|Adverse Event|0|||
128760437|NCT02496767|463412872|FG006|Open-label Lead-in Phase|Adverse Event|0|||
128760438|NCT02496767|463412873|FG007|Open-label Lead-in Phase|Adverse Event|0|||
128760439|NCT02496767|463412866|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
128760440|NCT02496767|463412867|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
128760441|NCT02496767|463412868|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
128760442|NCT02496767|463412869|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
128760443|NCT02496767|463412870|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
128760444|NCT02496767|463412871|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
128760445|NCT02496767|463412872|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
128760446|NCT02496767|463412873|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
128760447|NCT02496767|463412866|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
128760448|NCT02496767|463412867|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
128760449|NCT02496767|463412868|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
128760450|NCT02496767|463412869|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
128760451|NCT02496767|463412870|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
128760452|NCT02496767|463412871|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
128760453|NCT02496767|463412872|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
128760454|NCT02496767|463412873|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
128760455|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
128760456|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
128760457|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
128760458|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
128760459|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
128760460|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
128760461|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
128760462|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
128760463|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
128760464|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
128977744|NCT00775138|464205194|FG002|Overall Study|Adverse Event|1|||
128977745|NCT00775138|464205195|FG003|Overall Study|Adverse Event|0|||
128977746|NCT04880642|464205196|FG000|Randomization|Withdrawal by Subject|2|||
128977747|NCT04880642|464205197|FG001|Randomization|Withdrawal by Subject|3|||
128977748|NCT04880642|464205196|FG000|Treatment Period|Adverse Event|0|||
128977749|NCT04880642|464205197|FG001|Treatment Period|Adverse Event|1|||
128977750|NCT04880642|464205196|FG000|Treatment Period|Death|6|||
128977751|NCT04880642|464205197|FG001|Treatment Period|Death|6|||
128977752|NCT04880642|464205196|FG000|Treatment Period|Lost to Follow-up|1|||
128977753|NCT04880642|464205197|FG001|Treatment Period|Lost to Follow-up|0|||
128977754|NCT04880642|464205196|FG000|Treatment Period|Protocol Violation|0|||
128977755|NCT04880642|464205197|FG001|Treatment Period|Protocol Violation|1|||
128977756|NCT04880642|464205196|FG000|Treatment Period|Withdrawal by Subject|5|||
128977757|NCT04880642|464205197|FG001|Treatment Period|Withdrawal by Subject|3|||
128977758|NCT04880642|464205196|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
128977759|NCT04880642|464205197|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
128977760|NCT04880642|464205196|FG000|Follow-up|Death|4|||
128977761|NCT04880642|464205197|FG001|Follow-up|Death|3|||
128977762|NCT04880642|464205196|FG000|Follow-up|Withdrawal by Subject|1|||
128977763|NCT04880642|464205197|FG001|Follow-up|Withdrawal by Subject|0|||
128977764|NCT00104299|464205198|FG000|Overall Study|Adverse Event|3|||
128977765|NCT00104299|464205199|FG001|Overall Study|Adverse Event|1|||
128977766|NCT00104299|464205198|FG000|Overall Study|Death|2|||
128977767|NCT00104299|464205199|FG001|Overall Study|Death|2|||
128977768|NCT00104299|464205198|FG000|Overall Study|Withdrawal by Subject|2|||
128977769|NCT00104299|464205199|FG001|Overall Study|Withdrawal by Subject|6|||
128977770|NCT00104299|464205198|FG000|Overall Study|Physician Decision|1|||
128977771|NCT00104299|464205199|FG001|Overall Study|Physician Decision|1|||
128977772|NCT00104299|464205198|FG000|Overall Study|To have renal transplant|1|||
128977773|NCT00104299|464205199|FG001|Overall Study|To have renal transplant|0|||
128977774|NCT02906644|464205200|FG000|First 2 Weeks|Withdrawal by Subject|0|||
128977775|NCT02906644|464205201|FG001|First 2 Weeks|Withdrawal by Subject|2|||
128977776|NCT02906644|464205200|FG000|First 2 Weeks|Physician Decision|1|||
128977777|NCT02906644|464205201|FG001|First 2 Weeks|Physician Decision|1|||
128977778|NCT02906644|464205200|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
128977779|NCT02906644|464205201|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
128977780|NCT02906644|464205200|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
128977781|NCT02906644|464205201|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
128760465|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
128760466|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
128760467|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
128760468|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
128760469|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
128760470|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
128760471|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
128760472|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
128760473|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
128760474|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
128760475|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
128760476|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
128982212|NCT01674010|464220991|FG000|Randomization Phase 2|Adverse Event|0|||
128982213|NCT01674010|464220992|FG001|Randomization Phase 2|Adverse Event|1|||
128982214|NCT01674010|464220993|FG002|Randomization Phase 2|Adverse Event|1|||
128982215|NCT01674010|464220991|FG000|Randomization Phase 2|Lost to Follow-up|0|||
128982216|NCT01674010|464220992|FG001|Randomization Phase 2|Lost to Follow-up|1|||
128982217|NCT01674010|464220993|FG002|Randomization Phase 2|Lost to Follow-up|2|||
128982218|NCT01674010|464220991|FG000|Randomization Phase 2|Mood episode recurrence|0|||
128982219|NCT01674010|464220992|FG001|Randomization Phase 2|Mood episode recurrence|8|||
128982220|NCT01674010|464220993|FG002|Randomization Phase 2|Mood episode recurrence|2|||
128982221|NCT01674010|464220991|FG000|Randomization Phase 2|Physician Decision|0|||
128982222|NCT01674010|464220992|FG001|Randomization Phase 2|Physician Decision|0|||
128982223|NCT01674010|464220993|FG002|Randomization Phase 2|Physician Decision|2|||
128982224|NCT01674010|464220991|FG000|Randomization Phase 2|Pregnancy|0|||
128982225|NCT01674010|464220992|FG001|Randomization Phase 2|Pregnancy|1|||
128982226|NCT01674010|464220993|FG002|Randomization Phase 2|Pregnancy|1|||
128982227|NCT01674010|464220991|FG000|Randomization Phase 2|Protocol Violation|0|||
128982228|NCT01674010|464220992|FG001|Randomization Phase 2|Protocol Violation|1|||
129205798|NCT00762359|465051358|FG001|Overall Study|Lack of Efficacy|4|||
129205799|NCT00762359|465051357|FG000|Overall Study|Institution closed|2|||
129205800|NCT00762359|465051358|FG001|Overall Study|Institution closed|3|||
129205801|NCT00762359|465051357|FG000|Overall Study|Physician Decision|2|||
129205802|NCT00762359|465051358|FG001|Overall Study|Physician Decision|3|||
129205803|NCT00762359|465051357|FG000|Overall Study|Removal|0|||
128982229|NCT01674010|464220993|FG002|Randomization Phase 2|Protocol Violation|1|||
128982230|NCT01674010|464220991|FG000|Randomization Phase 2|Sponsor Decision|0|||
128982231|NCT01674010|464220992|FG001|Randomization Phase 2|Sponsor Decision|42|||
128982232|NCT01674010|464220993|FG002|Randomization Phase 2|Sponsor Decision|45|||
128982233|NCT01674010|464220991|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
128982234|NCT01674010|464220992|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
128982235|NCT01674010|464220993|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
128982236|NCT01801475|464220997|FG000|Overall Study|Withdrawal by Subject|0|||
128982237|NCT01801475|464220998|FG001|Overall Study|Withdrawal by Subject|0|||
128982238|NCT01801475|464220999|FG002|Overall Study|Withdrawal by Subject|0|||
128982239|NCT01801475|464221000|FG003|Overall Study|Withdrawal by Subject|0|||
128982240|NCT01801475|464221001|FG004|Overall Study|Withdrawal by Subject|1|||
128982241|NCT00421928|464221002|FG000|Overall Study|Adverse Event|61|||
128982242|NCT00421928|464221003|FG001|Overall Study|Adverse Event|140|||
128982243|NCT00421928|464221004|FG002|Overall Study|Adverse Event|22|||
128982244|NCT00421928|464221002|FG000|Overall Study|Lost to Follow-up|5|||
128982245|NCT00421928|464221003|FG001|Overall Study|Lost to Follow-up|0|||
128982246|NCT00421928|464221004|FG002|Overall Study|Lost to Follow-up|3|||
128982247|NCT00421928|464221002|FG000|Overall Study|Withdrawal by Subject|50|||
128982248|NCT00421928|464221003|FG001|Overall Study|Withdrawal by Subject|48|||
128982249|NCT00421928|464221004|FG002|Overall Study|Withdrawal by Subject|43|||
128982250|NCT00421928|464221002|FG000|Overall Study|Lack of Efficacy|15|||
128982251|NCT00421928|464221003|FG001|Overall Study|Lack of Efficacy|7|||
128982252|NCT00421928|464221004|FG002|Overall Study|Lack of Efficacy|35|||
128982253|NCT00421928|464221002|FG000|Overall Study|Study drug non-compliant|6|||
128982254|NCT00421928|464221003|FG001|Overall Study|Study drug non-compliant|7|||
128982255|NCT00421928|464221004|FG002|Overall Study|Study drug non-compliant|4|||
128982256|NCT00421928|464221002|FG000|Overall Study|All other|26|||
128760477|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
128982257|NCT00421928|464221003|FG001|Overall Study|All other|21|||
128982258|NCT00421928|464221004|FG002|Overall Study|All other|27|||
128982259|NCT00421928|464221002|FG000|Overall Study|Death|0|||
128982260|NCT00421928|464221003|FG001|Overall Study|Death|1|||
128982261|NCT00421928|464221004|FG002|Overall Study|Death|0|||
128982262|NCT05056311|464221011|FG000|Overall Study|Lost to Follow-up|14|||
128982263|NCT05056311|464221011|FG000|Overall Study|Withdrawal by Subject|1|||
128982264|NCT05056311|464221011|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
128982265|NCT03799198|464221012|FG000|Overall Study|Lost to Follow-up|4|||
128982266|NCT03799198|464221013|FG001|Overall Study|Lost to Follow-up|8|||
129205804|NCT00762359|465051358|FG001|Overall Study|Removal|1|||
128982267|NCT03799198|464221012|FG000|Overall Study|Death|0|||
128982268|NCT03799198|464221013|FG001|Overall Study|Death|1|||
128982269|NCT00548340|464221016|FG000|Overall Study|Protocol Violation|2|||
128982270|NCT00548340|464221017|FG001|Overall Study|Protocol Violation|3|||
128982271|NCT00548340|464221018|FG002|Overall Study|Protocol Violation|3|||
128982272|NCT00548340|464221016|FG000|Overall Study|Adverse Event|2|||
128982273|NCT00548340|464221017|FG001|Overall Study|Adverse Event|2|||
128982274|NCT00548340|464221018|FG002|Overall Study|Adverse Event|2|||
128982275|NCT00548340|464221016|FG000|Overall Study|Lost to Follow-up|1|||
128982276|NCT00548340|464221017|FG001|Overall Study|Lost to Follow-up|1|||
128982277|NCT00548340|464221018|FG002|Overall Study|Lost to Follow-up|0|||
128982278|NCT00548340|464221016|FG000|Overall Study|Withdrawal by Subject|2|||
128982279|NCT00548340|464221017|FG001|Overall Study|Withdrawal by Subject|4|||
128982280|NCT00548340|464221018|FG002|Overall Study|Withdrawal by Subject|3|||
129205805|NCT00762359|465051357|FG000|Overall Study|Withdrew consent|1|||
129205806|NCT00762359|465051358|FG001|Overall Study|Withdrew consent|0|||
129205807|NCT01453049|465051359|FG000|Overall Study|Protocol Violation|2|||
129205808|NCT01453049|465051360|FG001|Overall Study|Protocol Violation|5|||
129205809|NCT01453049|465051359|FG000|Overall Study|Lost to Follow-up|2|||
129205810|NCT01453049|465051360|FG001|Overall Study|Lost to Follow-up|1|||
129205811|NCT01453049|465051359|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
129205812|NCT01453049|465051360|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
129205813|NCT01453049|465051359|FG000|Overall Study|Withdrawal by Subject|1|||
129205814|NCT01453049|465051360|FG001|Overall Study|Withdrawal by Subject|0|||
129205815|NCT01453049|465051359|FG000|Overall Study|Randomized in Error|1|||
129205816|NCT01453049|465051360|FG001|Overall Study|Randomized in Error|0|||
129205817|NCT00882440|465051361|FG000|Overall Study|Adverse Event|2|||
129205818|NCT00882440|465051362|FG001|Overall Study|Adverse Event|2|||
129205819|NCT00882440|465051363|FG002|Overall Study|Adverse Event|2|||
129205820|NCT00882440|465051364|FG003|Overall Study|Adverse Event|1|||
129205821|NCT00882440|465051365|FG004|Overall Study|Adverse Event|1|||
129205822|NCT00882440|465051366|FG005|Overall Study|Adverse Event|4|||
129205823|NCT00882440|465051367|FG006|Overall Study|Adverse Event|2|||
129205824|NCT00882440|465051361|FG000|Overall Study|Lack of Efficacy|3|||
129205825|NCT00882440|465051362|FG001|Overall Study|Lack of Efficacy|5|||
129205826|NCT00882440|465051363|FG002|Overall Study|Lack of Efficacy|2|||
129205827|NCT00882440|465051364|FG003|Overall Study|Lack of Efficacy|0|||
129205828|NCT00882440|465051365|FG004|Overall Study|Lack of Efficacy|0|||
129205829|NCT00882440|465051366|FG005|Overall Study|Lack of Efficacy|3|||
129205830|NCT00882440|465051367|FG006|Overall Study|Lack of Efficacy|0|||
129205831|NCT00882440|465051361|FG000|Overall Study|Lost to Follow-up|2|||
129205832|NCT00882440|465051362|FG001|Overall Study|Lost to Follow-up|0|||
129205833|NCT00882440|465051363|FG002|Overall Study|Lost to Follow-up|1|||
129205834|NCT00882440|465051364|FG003|Overall Study|Lost to Follow-up|1|||
129205835|NCT00882440|465051365|FG004|Overall Study|Lost to Follow-up|1|||
129205836|NCT00882440|465051366|FG005|Overall Study|Lost to Follow-up|0|||
129205837|NCT00882440|465051367|FG006|Overall Study|Lost to Follow-up|1|||
129205838|NCT00882440|465051361|FG000|Overall Study|Protocol Violation|0|||
129205839|NCT00882440|465051362|FG001|Overall Study|Protocol Violation|0|||
129205840|NCT00882440|465051363|FG002|Overall Study|Protocol Violation|1|||
129205841|NCT00882440|465051364|FG003|Overall Study|Protocol Violation|1|||
129205842|NCT00882440|465051365|FG004|Overall Study|Protocol Violation|1|||
129205843|NCT00882440|465051366|FG005|Overall Study|Protocol Violation|0|||
129205844|NCT00882440|465051367|FG006|Overall Study|Protocol Violation|0|||
129205845|NCT00882440|465051361|FG000|Overall Study|Withdrawal by Subject|2|||
129205846|NCT00882440|465051362|FG001|Overall Study|Withdrawal by Subject|1|||
129205847|NCT00882440|465051363|FG002|Overall Study|Withdrawal by Subject|1|||
129205848|NCT00882440|465051364|FG003|Overall Study|Withdrawal by Subject|0|||
129205849|NCT00882440|465051365|FG004|Overall Study|Withdrawal by Subject|6|||
129205850|NCT00882440|465051366|FG005|Overall Study|Withdrawal by Subject|0|||
129205851|NCT00882440|465051367|FG006|Overall Study|Withdrawal by Subject|1|||
129205852|NCT00882440|465051361|FG000|Overall Study|Patient Uncooperative|2|||
129205853|NCT00882440|465051362|FG001|Overall Study|Patient Uncooperative|0|||
129205854|NCT00882440|465051363|FG002|Overall Study|Patient Uncooperative|0|||
129205855|NCT00882440|465051364|FG003|Overall Study|Patient Uncooperative|0|||
129205856|NCT00882440|465051365|FG004|Overall Study|Patient Uncooperative|1|||
129205857|NCT00882440|465051366|FG005|Overall Study|Patient Uncooperative|0|||
129205858|NCT00882440|465051367|FG006|Overall Study|Patient Uncooperative|0|||
128982281|NCT00548340|464221016|FG000|Overall Study|Other|1|||
128982282|NCT00548340|464221017|FG001|Overall Study|Other|1|||
128982283|NCT00548340|464221018|FG002|Overall Study|Other|1|||
128982284|NCT01096017|464221019|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
129040260|NCT03314662|464438808|FG001|Overall Study|Death|0|||
129205859|NCT05482308|465051371|FG000|Overall Study|Withdrawal by Subject|1|||
129205860|NCT05482308|465051372|FG001|Overall Study|Withdrawal by Subject|0|||
129205861|NCT05482308|465051371|FG000|Overall Study|No longer meets eligibility criteria|0|||
129205862|NCT05482308|465051372|FG001|Overall Study|No longer meets eligibility criteria|1|||
129205863|NCT00416624|465051381|FG000|Overall Study|Withdrawal by Subject|1|||
129205864|NCT00416624|465051382|FG001|Overall Study|Withdrawal by Subject|6|||
129205865|NCT00416624|465051383|FG002|Overall Study|Withdrawal by Subject|4|||
129205866|NCT00416624|465051384|FG003|Overall Study|Withdrawal by Subject|9|||
129205867|NCT00416624|465051381|FG000|Overall Study|Death|4|||
129205868|NCT00416624|465051382|FG001|Overall Study|Death|7|||
129205869|NCT00416624|465051383|FG002|Overall Study|Death|7|||
129205870|NCT00416624|465051384|FG003|Overall Study|Death|1|||
129205871|NCT00416624|465051381|FG000|Overall Study|Adverse Event|8|||
129205872|NCT00416624|465051382|FG001|Overall Study|Adverse Event|3|||
129205873|NCT00416624|465051383|FG002|Overall Study|Adverse Event|2|||
129205874|NCT00416624|465051384|FG003|Overall Study|Adverse Event|2|||
129205875|NCT00416624|465051381|FG000|Overall Study|Other|8|||
129205876|NCT00416624|465051382|FG001|Overall Study|Other|11|||
129205877|NCT00416624|465051383|FG002|Overall Study|Other|5|||
129205878|NCT00416624|465051384|FG003|Overall Study|Other|5|||
129205879|NCT00416624|465051381|FG000|Overall Study|Cancel|1|||
129205880|NCT00416624|465051382|FG001|Overall Study|Cancel|0|||
129205881|NCT00416624|465051383|FG002|Overall Study|Cancel|0|||
129205882|NCT00416624|465051384|FG003|Overall Study|Cancel|0|||
129205883|NCT00768989|465051387|FG000|Prior to Week 24|Withdrawal by Subject|1|||
129205884|NCT00768989|465051388|FG001|Prior to Week 24|Withdrawal by Subject|0|||
129205885|NCT00768989|465051387|FG000|Prior to Week 24|Adverse Event|3|||
129205886|NCT00768989|465051388|FG001|Prior to Week 24|Adverse Event|0|||
129205887|NCT00768989|465051387|FG000|Prior to Week 24|Lost to Follow-up|0|||
129205888|NCT00768989|465051388|FG001|Prior to Week 24|Lost to Follow-up|1|||
129205889|NCT00768989|465051387|FG000|Prior to Week 24|Protocol Violation|0|||
129205890|NCT00768989|465051388|FG001|Prior to Week 24|Protocol Violation|2|||
129205891|NCT00768989|465051387|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
129205892|NCT00768989|465051388|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
129205893|NCT00768989|465051387|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
129205894|NCT00768989|465051388|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
129205895|NCT00768989|465051387|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
129205896|NCT00768989|465051388|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
129205897|NCT00768989|465051387|FG000|On or After Week 36|Lack of Efficacy|1|||
129205898|NCT00768989|465051388|FG001|On or After Week 36|Lack of Efficacy|0|||
129205899|NCT00768989|465051387|FG000|On or After Week 36|Adverse Event|0|||
129205900|NCT00768989|465051388|FG001|On or After Week 36|Adverse Event|1|||
129205901|NCT00768989|465051387|FG000|On or After Week 36|Lost to Follow-up|1|||
129205902|NCT00768989|465051388|FG001|On or After Week 36|Lost to Follow-up|0|||
129205903|NCT00768989|465051387|FG000|On or After Week 36|Poor Compliance|1|||
129205904|NCT00768989|465051388|FG001|On or After Week 36|Poor Compliance|0|||
129205905|NCT00768989|465051387|FG000|On or After Week 36|Protocol Violation|1|||
129205906|NCT00768989|465051388|FG001|On or After Week 36|Protocol Violation|0|||
129205907|NCT00768989|465051387|FG000|On or After Week 36|Did not attend termination visit|2|||
129205908|NCT00768989|465051388|FG001|On or After Week 36|Did not attend termination visit|0|||
129205909|NCT00768989|465051387|FG000|On or After Week 36|Sponsor Termination|45|||
129205910|NCT00768989|465051388|FG001|On or After Week 36|Sponsor Termination|26|||
129205911|NCT03661723|465051397|FG000|Overall Study|Disease Progression|4|||
129205912|NCT03661723|465051398|FG001|Overall Study|Disease Progression|24|||
129205913|NCT03661723|465051399|FG002|Overall Study|Disease Progression|4|||
129205914|NCT03661723|465051400|FG003|Overall Study|Disease Progression|19|||
129205915|NCT03661723|465051397|FG000|Overall Study|Withdrawal by Subject|1|||
129205916|NCT03661723|465051398|FG001|Overall Study|Withdrawal by Subject|0|||
129205917|NCT03661723|465051399|FG002|Overall Study|Withdrawal by Subject|2|||
129205918|NCT03661723|465051400|FG003|Overall Study|Withdrawal by Subject|4|||
129205919|NCT03661723|465051397|FG000|Overall Study|Physician Decision|1|||
129205920|NCT03661723|465051398|FG001|Overall Study|Physician Decision|0|||
129205921|NCT03661723|465051399|FG002|Overall Study|Physician Decision|0|||
129205922|NCT03661723|465051400|FG003|Overall Study|Physician Decision|0|||
129205923|NCT03661723|465051397|FG000|Overall Study|Clinical Deterioration|0|||
129205924|NCT03661723|465051398|FG001|Overall Study|Clinical Deterioration|0|||
129205925|NCT03661723|465051399|FG002|Overall Study|Clinical Deterioration|0|||
129205926|NCT03661723|465051400|FG003|Overall Study|Clinical Deterioration|1|||
129205927|NCT00667888|465051403|FG000|Overall Study|Death|1|||
129205928|NCT00667888|465051404|FG001|Overall Study|Death|1|||
129205929|NCT00667888|465051403|FG000|Overall Study|Withdrawal by Subject|6|||
129205930|NCT00667888|465051404|FG001|Overall Study|Withdrawal by Subject|3|||
129205931|NCT00667888|465051403|FG000|Overall Study|Proceed with other treatment|3|||
129205932|NCT00667888|465051404|FG001|Overall Study|Proceed with other treatment|3|||
128982285|NCT01096017|464221020|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
129205933|NCT00667888|465051403|FG000|Overall Study|Ineligible after SIM|0|||
129205934|NCT00667888|465051404|FG001|Overall Study|Ineligible after SIM|2|||
129205935|NCT00499681|465051405|FG000|Overall Study|toxicity|0|||
129205936|NCT00499681|465051406|FG001|Overall Study|toxicity|1|||
129205937|NCT00499681|465051405|FG000|Overall Study|disease progression|0|||
129205938|NCT00499681|465051406|FG001|Overall Study|disease progression|1|||
129205939|NCT00325897|465051407|FG000|Overall Study|Lost to Follow-up|12|||
129205940|NCT00325897|465051408|FG001|Overall Study|Lost to Follow-up|13|||
129205941|NCT03915717|465051411|FG000|Overall Study|EchoMark Not Implanted|6|||
129205942|NCT03748823|465051413|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
129205943|NCT03748823|465051414|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
129205944|NCT03748823|465051413|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
129205945|NCT03748823|465051414|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
129205946|NCT03748823|465051413|FG000|Extension Period|Withdrawal by Subject|9|||
129205947|NCT03748823|465051414|FG001|Extension Period|Withdrawal by Subject|12|||
129205948|NCT03748823|465051413|FG000|Extension Period|Death|2|||
129205949|NCT03748823|465051414|FG001|Extension Period|Death|2|||
129205950|NCT03748823|465051413|FG000|Extension Period|Other than Specified|0|||
129205951|NCT03748823|465051414|FG001|Extension Period|Other than Specified|1|||
129205952|NCT03748823|465051413|FG000|Extension Period|Protocol Violation|1|||
129205953|NCT03748823|465051414|FG001|Extension Period|Protocol Violation|0|||
129205954|NCT03748823|465051413|FG000|Extension Period|Lost to Follow-up|0|||
129205955|NCT03748823|465051414|FG001|Extension Period|Lost to Follow-up|1|||
129205956|NCT03748823|465051413|FG000|Extension Period|Lack of Efficacy|0|||
129205957|NCT03748823|465051414|FG001|Extension Period|Lack of Efficacy|1|||
129205958|NCT03748823|465051413|FG000|Extension Period|Physician Decision|1|||
129205959|NCT03748823|465051414|FG001|Extension Period|Physician Decision|2|||
129205960|NCT01664910|465051418|FG000|Overall Study|Adverse Event|0|||
129205961|NCT01664910|465051419|FG001|Overall Study|Adverse Event|0|||
129205962|NCT01664910|465051420|FG002|Overall Study|Adverse Event|1|||
129205963|NCT01011673|465051421|FG000|Randomized|Secondary headache|2|||
129205964|NCT01011673|465051422|FG001|Randomized|Secondary headache|1|||
129205965|NCT01011673|465051421|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
129205966|NCT01011673|465051422|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
129205967|NCT01632020|465051423|FG000|Overall Study|Withdrawal by Subject|1|||
129205968|NCT01632020|465051424|FG001|Overall Study|Withdrawal by Subject|0|||
129205969|NCT01632020|465051423|FG000|Overall Study|Adverse Event|1|||
129205970|NCT01632020|465051424|FG001|Overall Study|Adverse Event|0|||
129205971|NCT00549640|465051426|FG000|Overall Study|Withdrawal by Subject|6|||
129205972|NCT00549640|465051427|FG001|Overall Study|Withdrawal by Subject|12|||
129205973|NCT00549640|465051426|FG000|Overall Study|Adverse Event|5|||
129205974|NCT00549640|465051427|FG001|Overall Study|Adverse Event|0|||
129205975|NCT00549640|465051426|FG000|Overall Study|Lost to Follow-up|7|||
129205976|NCT00549640|465051427|FG001|Overall Study|Lost to Follow-up|4|||
129205977|NCT00399516|465051436|FG000|Overall Study|Lost to Follow-up|2|||
129205978|NCT00539981|465051439|FG000|Overall Study|Adverse events (AE)|3|||
129205979|NCT00539981|465051440|FG001|Overall Study|Adverse events (AE)|3|||
129205980|NCT00539981|465051439|FG000|Overall Study|Lost to Follow-up|260|||
129205981|NCT00539981|465051440|FG001|Overall Study|Lost to Follow-up|251|||
129205982|NCT00539981|465051439|FG000|Overall Study|Withdrew consent|22|||
129205983|NCT00539981|465051440|FG001|Overall Study|Withdrew consent|14|||
129205984|NCT00539981|465051439|FG000|Overall Study|Death|1|||
129205985|NCT00539981|465051440|FG001|Overall Study|Death|1|||
129205986|NCT00539981|465051439|FG000|Overall Study|Other reason-unspecified|9|||
129205987|NCT00539981|465051440|FG001|Overall Study|Other reason-unspecified|13|||
129205988|NCT02675907|465051441|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
129205989|NCT02675907|465051442|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
129205990|NCT02675907|465051441|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
129205991|NCT02675907|465051442|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
129205992|NCT02675907|465051441|FG000|Study Overall|Lack of Efficacy|1|||
129205993|NCT02675907|465051442|FG001|Study Overall|Lack of Efficacy|0|||
129205994|NCT02675907|465051441|FG000|Study Overall|Withdrawal by Subject|2|||
129205995|NCT02675907|465051442|FG001|Study Overall|Withdrawal by Subject|2|||
129205996|NCT02675907|465051441|FG000|Study Overall|Lost to Follow-up|0|||
129205997|NCT02675907|465051442|FG001|Study Overall|Lost to Follow-up|2|||
129205998|NCT01611792|465051443|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
129205999|NCT01611792|465051444|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
129206000|NCT01611792|465051443|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
129206001|NCT01611792|465051444|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
129206002|NCT01129622|465051445|FG000|Overall Study|Withdrawal by Subject|2|||
129206003|NCT00591006|465051446|FG000|Overall Study|Withdrawal by Subject|0|||
129206004|NCT00591006|465051447|FG001|Overall Study|Withdrawal by Subject|0|||
129206005|NCT00591006|465051448|FG002|Overall Study|Withdrawal by Subject|0|||
129206006|NCT00591006|465051449|FG003|Overall Study|Withdrawal by Subject|0|||
129206007|NCT00591006|465051450|FG004|Overall Study|Withdrawal by Subject|0|||
129206008|NCT00591006|465051451|FG005|Overall Study|Withdrawal by Subject|0|||
128760478|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
128760479|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
129206009|NCT00591006|465051452|FG006|Overall Study|Withdrawal by Subject|0|||
129206010|NCT00591006|465051453|FG007|Overall Study|Withdrawal by Subject|0|||
128760480|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
129206011|NCT00591006|465051454|FG008|Overall Study|Withdrawal by Subject|0|||
129206012|NCT00591006|465051455|FG009|Overall Study|Withdrawal by Subject|0|||
129206013|NCT00591006|465051456|FG010|Overall Study|Withdrawal by Subject|0|||
129206014|NCT00591006|465051457|FG011|Overall Study|Withdrawal by Subject|0|||
128760481|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
128760482|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
128760483|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
128760484|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
128760485|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
128760486|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
128760487|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129206015|NCT00591006|465051458|FG012|Overall Study|Withdrawal by Subject|0|||
129206016|NCT00591006|465051459|FG013|Overall Study|Withdrawal by Subject|0|||
129206017|NCT00591006|465051460|FG014|Overall Study|Withdrawal by Subject|0|||
129206018|NCT00591006|465051461|FG015|Overall Study|Withdrawal by Subject|1|||
129206019|NCT00591006|465051462|FG016|Overall Study|Withdrawal by Subject|0|||
128760488|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
128760489|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
128760490|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
128760491|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
128760492|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129206020|NCT00591006|465051463|FG017|Overall Study|Withdrawal by Subject|0|||
128760493|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
128760494|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
128760495|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
128760496|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
128760497|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
128760498|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
128760499|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
128760500|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
128760501|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
128760502|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
128760503|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
128760504|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
129206021|NCT00591006|465051464|FG018|Overall Study|Withdrawal by Subject|0|||
129206022|NCT00591006|465051465|FG019|Overall Study|Withdrawal by Subject|0|||
129206023|NCT00591006|465051466|FG020|Overall Study|Withdrawal by Subject|0|||
129206024|NCT00591006|465051467|FG021|Overall Study|Withdrawal by Subject|0|||
129206025|NCT00591006|465051468|FG022|Overall Study|Withdrawal by Subject|0|||
129206026|NCT00591006|465051469|FG023|Overall Study|Withdrawal by Subject|1|||
129206027|NCT00591006|465051446|FG000|Overall Study|Adverse Event|0|||
129206028|NCT00591006|465051447|FG001|Overall Study|Adverse Event|0|||
129206029|NCT00591006|465051448|FG002|Overall Study|Adverse Event|0|||
129206030|NCT00591006|465051449|FG003|Overall Study|Adverse Event|0|||
129206031|NCT00591006|465051450|FG004|Overall Study|Adverse Event|0|||
129206032|NCT00591006|465051451|FG005|Overall Study|Adverse Event|0|||
129206033|NCT00591006|465051452|FG006|Overall Study|Adverse Event|0|||
129206034|NCT00591006|465051453|FG007|Overall Study|Adverse Event|0|||
129206035|NCT00591006|465051454|FG008|Overall Study|Adverse Event|0|||
129206036|NCT00591006|465051455|FG009|Overall Study|Adverse Event|0|||
129206037|NCT00591006|465051456|FG010|Overall Study|Adverse Event|0|||
129206038|NCT00591006|465051457|FG011|Overall Study|Adverse Event|0|||
129206039|NCT00591006|465051458|FG012|Overall Study|Adverse Event|0|||
129206040|NCT00591006|465051459|FG013|Overall Study|Adverse Event|0|||
129206041|NCT00591006|465051460|FG014|Overall Study|Adverse Event|0|||
129206042|NCT00591006|465051461|FG015|Overall Study|Adverse Event|0|||
129206043|NCT00591006|465051462|FG016|Overall Study|Adverse Event|0|||
129206044|NCT00591006|465051463|FG017|Overall Study|Adverse Event|0|||
129206045|NCT00591006|465051464|FG018|Overall Study|Adverse Event|0|||
129206046|NCT00591006|465051465|FG019|Overall Study|Adverse Event|0|||
129206047|NCT00591006|465051466|FG020|Overall Study|Adverse Event|0|||
129206048|NCT00591006|465051467|FG021|Overall Study|Adverse Event|0|||
129206049|NCT00591006|465051468|FG022|Overall Study|Adverse Event|1|||
129206050|NCT00591006|465051469|FG023|Overall Study|Adverse Event|0|||
129206051|NCT00689390|465051470|FG000|Overall Study|Adverse Event|19|||
129206052|NCT00689390|465051471|FG001|Overall Study|Adverse Event|0|||
129206053|NCT00689390|465051470|FG000|Overall Study|Lost to Follow-up|179|||
129206054|NCT00689390|465051471|FG001|Overall Study|Lost to Follow-up|7|||
129206055|NCT00689390|465051470|FG000|Overall Study|Withdrawal by Subject|117|||
129206056|NCT00689390|465051471|FG001|Overall Study|Withdrawal by Subject|3|||
129206057|NCT00689390|465051470|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
129206058|NCT00689390|465051471|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
129206059|NCT00689390|465051470|FG000|Overall Study|Non-Compliance With Protocol|21|||
129206060|NCT00689390|465051471|FG001|Overall Study|Non-Compliance With Protocol|0|||
129206061|NCT00689390|465051470|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
129206062|NCT00689390|465051471|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
129206063|NCT00689390|465051470|FG000|Overall Study|Administrative|37|||
129206064|NCT00689390|465051471|FG001|Overall Study|Administrative|0|||
129206065|NCT02343263|465051472|FG000|Overall Study|Physician Decision|5|||
129206066|NCT02343263|465051473|FG001|Overall Study|Physician Decision|3|||
129206067|NCT02343263|465051474|FG002|Overall Study|Physician Decision|1|||
129206068|NCT00525512|465051488|FG000|Double-Blind Phase|Adverse Event|48|||
129206069|NCT00525512|465051489|FG001|Double-Blind Phase|Adverse Event|28|||
129206070|NCT00525512|465051490|FG002|Double-Blind Phase|Adverse Event|0|||
129206071|NCT00525512|465051491|FG003|Double-Blind Phase|Adverse Event|0|||
129206072|NCT00525512|465051488|FG000|Double-Blind Phase|Protocol Violation|3|||
129206073|NCT00525512|465051489|FG001|Double-Blind Phase|Protocol Violation|1|||
129206074|NCT00525512|465051490|FG002|Double-Blind Phase|Protocol Violation|0|||
129206075|NCT00525512|465051491|FG003|Double-Blind Phase|Protocol Violation|0|||
129206076|NCT00525512|465051488|FG000|Double-Blind Phase|Lost to Follow-up|3|||
129206077|NCT00525512|465051489|FG001|Double-Blind Phase|Lost to Follow-up|7|||
129206078|NCT00525512|465051490|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129206079|NCT00525512|465051491|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129206080|NCT00525512|465051488|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
129206081|NCT00525512|465051489|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
129206082|NCT00525512|465051490|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129206083|NCT00525512|465051491|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129206084|NCT00525512|465051488|FG000|Double-Blind Phase|Lack of Efficacy|13|||
129206085|NCT00525512|465051489|FG001|Double-Blind Phase|Lack of Efficacy|5|||
129206086|NCT00525512|465051490|FG002|Double-Blind Phase|Lack of Efficacy|0|||
129206087|NCT00525512|465051491|FG003|Double-Blind Phase|Lack of Efficacy|0|||
129206088|NCT00525512|465051488|FG000|Double-Blind Phase|Other reason (not specified)|12|||
129206089|NCT00525512|465051489|FG001|Double-Blind Phase|Other reason (not specified)|13|||
129206090|NCT00525512|465051490|FG002|Double-Blind Phase|Other reason (not specified)|0|||
129206091|NCT00525512|465051491|FG003|Double-Blind Phase|Other reason (not specified)|0|||
129206092|NCT00525512|465051488|FG000|Open-Label Phase|Adverse Event|0|||
129206093|NCT00525512|465051489|FG001|Open-Label Phase|Adverse Event|0|||
129206094|NCT00525512|465051490|FG002|Open-Label Phase|Adverse Event|1|||
129206095|NCT00525512|465051491|FG003|Open-Label Phase|Adverse Event|0|||
129206096|NCT00525512|465051488|FG000|Open-Label Phase|Lost to Follow-up|0|||
129206097|NCT00525512|465051489|FG001|Open-Label Phase|Lost to Follow-up|0|||
129206098|NCT00525512|465051490|FG002|Open-Label Phase|Lost to Follow-up|1|||
129206099|NCT00525512|465051491|FG003|Open-Label Phase|Lost to Follow-up|0|||
129206100|NCT00525512|465051488|FG000|Open-Label Phase|Other reason (not specified)|0|||
129206101|NCT00525512|465051489|FG001|Open-Label Phase|Other reason (not specified)|0|||
129206102|NCT00525512|465051490|FG002|Open-Label Phase|Other reason (not specified)|4|||
129206103|NCT00525512|465051491|FG003|Open-Label Phase|Other reason (not specified)|5|||
129206104|NCT03289208|465051496|FG000|Overall Study|Adverse Event|1|||
129206105|NCT03289208|465051497|FG001|Overall Study|Adverse Event|0|||
129206106|NCT03289208|465051498|FG002|Overall Study|Adverse Event|0|||
129206107|NCT03353675|465051503|FG000|Overall Study|Adverse Event|4|||
129206108|NCT03346434|465053313|FG000|Overall Study|Randomized in Error|0|||
129206109|NCT03346434|465053314|FG001|Overall Study|Randomized in Error|0|||
129206110|NCT03346434|465053315|FG002|Overall Study|Randomized in Error|0|||
129206111|NCT03346434|465053316|FG003|Overall Study|Randomized in Error|0|||
129206112|NCT03346434|465053317|FG004|Overall Study|Randomized in Error|1|||
129206113|NCT03346434|465053318|FG005|Overall Study|Randomized in Error|0|||
129206114|NCT03346434|465053313|FG000|Overall Study|Withdrawal by Subject|0|||
129206115|NCT03346434|465053314|FG001|Overall Study|Withdrawal by Subject|0|||
129206116|NCT03346434|465053315|FG002|Overall Study|Withdrawal by Subject|1|||
129206117|NCT03346434|465053316|FG003|Overall Study|Withdrawal by Subject|0|||
129206118|NCT03346434|465053317|FG004|Overall Study|Withdrawal by Subject|1|||
129206119|NCT03346434|465053318|FG005|Overall Study|Withdrawal by Subject|0|||
129206120|NCT03346434|465053313|FG000|Overall Study|Lost to Follow-up|0|||
129206121|NCT03346434|465053314|FG001|Overall Study|Lost to Follow-up|0|||
129206122|NCT03346434|465053315|FG002|Overall Study|Lost to Follow-up|0|||
129206123|NCT03346434|465053316|FG003|Overall Study|Lost to Follow-up|0|||
129206124|NCT03346434|465053317|FG004|Overall Study|Lost to Follow-up|1|||
129206125|NCT03346434|465053318|FG005|Overall Study|Lost to Follow-up|1|||
129206126|NCT03346434|465053313|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129206127|NCT03346434|465053314|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129206128|NCT03346434|465053315|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129206129|NCT03346434|465053316|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129206130|NCT03346434|465053317|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
128760505|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129206131|NCT03346434|465053318|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
129206132|NCT03525444|465053319|FG000|Overall Study|Adverse Event|0|||
129206133|NCT03525444|465053320|FG001|Overall Study|Adverse Event|1|||
129206134|NCT03525444|465053319|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129206135|NCT03525444|465053320|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
129206136|NCT03525444|465053319|FG000|Overall Study|Other|0|||
129206137|NCT03525444|465053320|FG001|Overall Study|Other|1|||
129206138|NCT01419236|465053324|FG000|Overall Study|Adverse Event|1|||
129206139|NCT01419236|465053325|FG001|Overall Study|Adverse Event|0|||
129206140|NCT01419236|465053324|FG000|Overall Study|Lack of Efficacy|0|||
129206141|NCT01419236|465053325|FG001|Overall Study|Lack of Efficacy|1|||
129206142|NCT01419236|465053324|FG000|Overall Study|Lost to Follow-up|1|||
129206143|NCT01419236|465053325|FG001|Overall Study|Lost to Follow-up|0|||
129206144|NCT01419236|465053324|FG000|Overall Study|Physician Decision|1|||
129206145|NCT01419236|465053325|FG001|Overall Study|Physician Decision|0|||
129206146|NCT01419236|465053324|FG000|Overall Study|Withdrawal by Subject|1|||
129206147|NCT01419236|465053325|FG001|Overall Study|Withdrawal by Subject|4|||
129206148|NCT01419236|465053324|FG000|Overall Study|Entry Criteria Not Met|1|||
129206149|NCT01419236|465053325|FG001|Overall Study|Entry Criteria Not Met|0|||
129206150|NCT02250326|465053326|FG000|Treatment|Death|1|||
129206151|NCT02250326|465053327|FG001|Treatment|Death|13|||
129206152|NCT02250326|465053328|FG002|Treatment|Death|2|||
129206153|NCT02250326|465053326|FG000|Treatment|Adverse Event|8|||
129206154|NCT02250326|465053327|FG001|Treatment|Adverse Event|8|||
129206155|NCT02250326|465053328|FG002|Treatment|Adverse Event|9|||
129206156|NCT02250326|465053326|FG000|Treatment|Progressive Disease|42|||
129206157|NCT02250326|465053327|FG001|Treatment|Progressive Disease|40|||
129206158|NCT02250326|465053328|FG002|Treatment|Progressive Disease|47|||
129206159|NCT02250326|465053326|FG000|Treatment|Symptomatic Deterioration|9|||
129206160|NCT02250326|465053327|FG001|Treatment|Symptomatic Deterioration|4|||
129206161|NCT02250326|465053328|FG002|Treatment|Symptomatic Deterioration|10|||
129206162|NCT02250326|465053326|FG000|Treatment|Withdrawal by Subject|11|||
129206163|NCT02250326|465053327|FG001|Treatment|Withdrawal by Subject|6|||
129206164|NCT02250326|465053328|FG002|Treatment|Withdrawal by Subject|4|||
129206165|NCT02250326|465053326|FG000|Treatment|Other reasons|8|||
129206166|NCT02250326|465053327|FG001|Treatment|Other reasons|7|||
129206167|NCT02250326|465053328|FG002|Treatment|Other reasons|7|||
129206168|NCT02250326|465053326|FG000|Extension Period|Progressive Disease|0|||
129206169|NCT02250326|465053327|FG001|Extension Period|Progressive Disease|2|||
129206170|NCT02250326|465053328|FG002|Extension Period|Progressive Disease|0|||
129206171|NCT02250326|465053326|FG000|Extension Period|Withdrawal by Subject|0|||
129206172|NCT02250326|465053327|FG001|Extension Period|Withdrawal by Subject|1|||
129206173|NCT02250326|465053328|FG002|Extension Period|Withdrawal by Subject|0|||
129206174|NCT02250326|465053326|FG000|Extension Period|Withdrawal by investigator|0|||
129206175|NCT02250326|465053327|FG001|Extension Period|Withdrawal by investigator|1|||
129206176|NCT02250326|465053328|FG002|Extension Period|Withdrawal by investigator|0|||
129206177|NCT00866177|465053329|FG000|Overall Study|Withdrawal by Subject|1|||
129206178|NCT00866177|465053329|FG000|Overall Study|Not Treated|151|||
129206179|NCT03585660|465053330|FG000|Overall Study|operator error|1|||
129206180|NCT03585660|465053330|FG000|Overall Study|technical error|2|||
129206181|NCT03585660|465053330|FG000|Overall Study|hip prosthesis|2|||
129206182|NCT03585660|465053330|FG000|Overall Study|did not undergo biopsy|8|||
129206183|NCT03585660|465053330|FG000|Overall Study|scanner problem|2|||
129206184|NCT00435409|465053331|FG000|Overall Study|Protocol Violation|1|||
129206185|NCT00435409|465053332|FG001|Overall Study|Protocol Violation|2|||
129206186|NCT00435409|465053333|FG002|Overall Study|Protocol Violation|0|||
129206187|NCT00435409|465053331|FG000|Overall Study|Lost to Follow-up|1|||
129206188|NCT00435409|465053332|FG001|Overall Study|Lost to Follow-up|2|||
129206189|NCT00435409|465053333|FG002|Overall Study|Lost to Follow-up|0|||
129206190|NCT00435409|465053331|FG000|Overall Study|Death|8|||
129206191|NCT00435409|465053332|FG001|Overall Study|Death|6|||
129206192|NCT00435409|465053333|FG002|Overall Study|Death|6|||
129206193|NCT00435409|465053331|FG000|Overall Study|Objective progression or relapse|158|||
129206194|NCT00435409|465053332|FG001|Overall Study|Objective progression or relapse|93|||
129206195|NCT00435409|465053333|FG002|Overall Study|Objective progression or relapse|58|||
129206196|NCT00435409|465053331|FG000|Overall Study|Global deterioration of health status|0|||
129206197|NCT00435409|465053332|FG001|Overall Study|Global deterioration of health status|0|||
129206198|NCT00435409|465053333|FG002|Overall Study|Global deterioration of health status|4|||
129206199|NCT00435409|465053331|FG000|Overall Study|Withdrawal by Subject|8|||
129206200|NCT00435409|465053332|FG001|Overall Study|Withdrawal by Subject|7|||
129206201|NCT00435409|465053333|FG002|Overall Study|Withdrawal by Subject|1|||
129206202|NCT00435409|465053331|FG000|Overall Study|Other|45|||
129206203|NCT00435409|465053332|FG001|Overall Study|Other|30|||
129206204|NCT00435409|465053333|FG002|Overall Study|Other|1|||
129206205|NCT00435409|465053331|FG000|Overall Study|Adverse Event|0|||
129206206|NCT00435409|465053332|FG001|Overall Study|Adverse Event|0|||
129206207|NCT00435409|465053333|FG002|Overall Study|Adverse Event|8|||
129206208|NCT00435409|465053331|FG000|Overall Study|Sponsor decision|0|||
129206209|NCT00435409|465053332|FG001|Overall Study|Sponsor decision|3|||
129206210|NCT00435409|465053333|FG002|Overall Study|Sponsor decision|0|||
129206211|NCT05635461|465053336|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129206212|NCT05635461|465053337|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129206213|NCT05635461|465053338|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129206214|NCT05635461|465053339|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129206215|NCT05635461|465053340|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
129206216|NCT05635461|465053341|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
128760506|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
128760507|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
129206217|NCT05635461|465053336|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129206218|NCT05635461|465053337|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
129206219|NCT05635461|465053338|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129206220|NCT05635461|465053339|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129206221|NCT05635461|465053340|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129206222|NCT05635461|465053341|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129206223|NCT05635461|465053336|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129206224|NCT05635461|465053337|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129206225|NCT05635461|465053338|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129206226|NCT05635461|465053339|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
129206227|NCT05635461|465053340|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129206228|NCT05635461|465053341|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129206229|NCT03760029|465053344|FG000|Overall Study|Death|1|||
129206230|NCT03760029|465053345|FG001|Overall Study|Death|0|||
129206231|NCT03760029|465053346|FG002|Overall Study|Death|0|||
129206232|NCT03760029|465053344|FG000|Overall Study|Lost to Follow-up|0|||
129206233|NCT03760029|465053345|FG001|Overall Study|Lost to Follow-up|2|||
129206234|NCT03760029|465053346|FG002|Overall Study|Lost to Follow-up|1|||
129206235|NCT03760029|465053344|FG000|Overall Study|Withdrawal by Subject|1|||
129206236|NCT03760029|465053345|FG001|Overall Study|Withdrawal by Subject|4|||
129206237|NCT03760029|465053346|FG002|Overall Study|Withdrawal by Subject|1|||
129206238|NCT03760029|465053344|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129206239|NCT03760029|465053345|FG001|Overall Study|Withdrawal by parent/guardian|4|||
128760508|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
128760509|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
128760510|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
128760511|NCT02496767|463412866|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
128760512|NCT02496767|463412867|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
128760513|NCT02496767|463412868|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129206240|NCT03760029|465053346|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129206241|NCT03760029|465053344|FG000|Overall Study|Other|2|||
129206242|NCT03760029|465053345|FG001|Overall Study|Other|1|||
129206243|NCT03760029|465053346|FG002|Overall Study|Other|0|||
129206244|NCT04890652|465053350|FG000|Overall Study|Withdrawal by Subject|2|||
129206245|NCT02269124|465053353|FG000|Overall Study|Lost to Follow-up|1|||
129206246|NCT02269124|465053354|FG001|Overall Study|Lost to Follow-up|0|||
129206247|NCT02269124|465053353|FG000|Overall Study|Withdrawal by Subject|0|||
129206248|NCT02269124|465053354|FG001|Overall Study|Withdrawal by Subject|2|||
129206249|NCT00614575|465053355|FG000|Overall Study|Adverse Event|106|||
129206250|NCT00614575|465053355|FG000|Overall Study|Lost to Follow-up|55|||
129206251|NCT00614575|465053355|FG000|Overall Study|Lack of Efficacy|14|||
128977782|NCT02452034|464205202|FG000|Overall Study|Adverse Event|0|||
128977783|NCT02452034|464205203|FG001|Overall Study|Adverse Event|0|||
129206252|NCT00614575|465053355|FG000|Overall Study|Withdrawal by Subject|6|||
128977784|NCT02452034|464205204|FG002|Overall Study|Adverse Event|0|||
128977785|NCT02452034|464205205|FG003|Overall Study|Adverse Event|0|||
128977786|NCT02452034|464205206|FG004|Overall Study|Adverse Event|0|||
128977787|NCT02452034|464205207|FG005|Overall Study|Adverse Event|1|||
128977788|NCT02452034|464205202|FG000|Overall Study|Death|0|||
128977789|NCT02452034|464205203|FG001|Overall Study|Death|0|||
128977790|NCT02452034|464205204|FG002|Overall Study|Death|0|||
128977791|NCT02452034|464205205|FG003|Overall Study|Death|0|||
128977792|NCT02452034|464205206|FG004|Overall Study|Death|1|||
128977793|NCT02452034|464205207|FG005|Overall Study|Death|1|||
128977794|NCT02452034|464205202|FG000|Overall Study|Physician Decision|0|||
128977795|NCT02452034|464205203|FG001|Overall Study|Physician Decision|1|||
128977796|NCT02452034|464205204|FG002|Overall Study|Physician Decision|1|||
128977797|NCT02452034|464205205|FG003|Overall Study|Physician Decision|0|||
128977798|NCT02452034|464205206|FG004|Overall Study|Physician Decision|0|||
128977799|NCT02452034|464205207|FG005|Overall Study|Physician Decision|0|||
128977800|NCT02452034|464205202|FG000|Overall Study|Protocol Violation|0|||
128977801|NCT02452034|464205203|FG001|Overall Study|Protocol Violation|0|||
128977802|NCT02452034|464205204|FG002|Overall Study|Protocol Violation|0|||
128977803|NCT02452034|464205205|FG003|Overall Study|Protocol Violation|0|||
128977804|NCT02452034|464205206|FG004|Overall Study|Protocol Violation|0|||
128977805|NCT02452034|464205207|FG005|Overall Study|Protocol Violation|1|||
128977806|NCT02452034|464205202|FG000|Overall Study|Screen Failure|1|||
128977807|NCT02452034|464205203|FG001|Overall Study|Screen Failure|0|||
128977808|NCT02452034|464205204|FG002|Overall Study|Screen Failure|0|||
128977809|NCT02452034|464205205|FG003|Overall Study|Screen Failure|1|||
128977810|NCT02452034|464205206|FG004|Overall Study|Screen Failure|0|||
128977811|NCT02452034|464205207|FG005|Overall Study|Screen Failure|0|||
128977812|NCT02452034|464205202|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
128977813|NCT02452034|464205203|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
129206253|NCT00614575|465053355|FG000|Overall Study|Death|3|||
129206254|NCT00614575|465053355|FG000|Overall Study|Physician Decision|2|||
129206255|NCT00614575|465053355|FG000|Overall Study|No data were collected.|18|||
128982286|NCT02322866|464221029|FG000|Overall Study|Adverse Event|6|||
128982287|NCT02322866|464221030|FG001|Overall Study|Adverse Event|11|||
128982288|NCT02322866|464221029|FG000|Overall Study|Withdrawal of Consent|16|||
128982289|NCT02322866|464221030|FG001|Overall Study|Withdrawal of Consent|25|||
128982290|NCT02322866|464221029|FG000|Overall Study|Lost to Follow-up|36|||
128982291|NCT02322866|464221030|FG001|Overall Study|Lost to Follow-up|39|||
128982292|NCT02322866|464221029|FG000|Overall Study|Protocol Violation|1|||
128982293|NCT02322866|464221030|FG001|Overall Study|Protocol Violation|0|||
128982294|NCT02322866|464221029|FG000|Overall Study|Noncompliance with Treatment|3|||
128982295|NCT02322866|464221030|FG001|Overall Study|Noncompliance with Treatment|4|||
128982296|NCT02322866|464221029|FG000|Overall Study|Lack of Efficacy|3|||
128982297|NCT02322866|464221030|FG001|Overall Study|Lack of Efficacy|1|||
128982298|NCT02322866|464221029|FG000|Overall Study|Other Miscellaneous Reasons|6|||
128982299|NCT02322866|464221030|FG001|Overall Study|Other Miscellaneous Reasons|6|||
128982300|NCT06045026|464221038|FG000|Overall Study|Lost to Follow-up|60|||
128982301|NCT06045026|464221038|FG000|Overall Study|Adverse Event|12|||
128982302|NCT06045026|464221038|FG000|Overall Study|Withdrawal by Subject|3|||
128982303|NCT06045026|464221038|FG000|Overall Study|Enrollment closed|1|||
128982304|NCT01928758|464221044|FG000|Overall Study|Lost to Follow-up|14|||
128982305|NCT01928758|464221045|FG001|Overall Study|Lost to Follow-up|9|||
128982306|NCT01928758|464221044|FG000|Overall Study|Withdrawal by Subject|5|||
128982307|NCT01928758|464221045|FG001|Overall Study|Withdrawal by Subject|2|||
128982308|NCT01928758|464221044|FG000|Overall Study|Adverse Event|3|||
128982309|NCT01928758|464221045|FG001|Overall Study|Adverse Event|5|||
128982310|NCT01928758|464221044|FG000|Overall Study|Protocol Violation|3|||
128982311|NCT01928758|464221045|FG001|Overall Study|Protocol Violation|4|||
128982312|NCT00719706|464221046|FG000|Overall Study|Adverse Event|5|||
128982313|NCT00719706|464221047|FG001|Overall Study|Adverse Event|4|||
128982314|NCT00719706|464221046|FG000|Overall Study|Withdrawal by Subject|1|||
128982315|NCT00719706|464221047|FG001|Overall Study|Withdrawal by Subject|2|||
128982316|NCT00719706|464221046|FG000|Overall Study|Protocol Violation|3|||
128982317|NCT00719706|464221047|FG001|Overall Study|Protocol Violation|0|||
128982318|NCT01980056|464221048|FG000|Overall Study|Death|1|||
128982319|NCT01980056|464221049|FG001|Overall Study|Death|1|||
128982320|NCT01980056|464221050|FG002|Overall Study|Death|0|||
128982321|NCT00351611|464221051|FG000|Overall Study|Adverse Event|11|||
128982322|NCT00351611|464221052|FG001|Overall Study|Adverse Event|3|||
128982323|NCT00351611|464221051|FG000|Overall Study|Death|1|||
128982324|NCT00351611|464221052|FG001|Overall Study|Death|0|||
128982325|NCT00351611|464221051|FG000|Overall Study|Lost to Follow-up|1|||
128982326|NCT00351611|464221052|FG001|Overall Study|Lost to Follow-up|0|||
128982327|NCT00351611|464221051|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
128982328|NCT00351611|464221052|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
128982329|NCT00351611|464221051|FG000|Overall Study|Other|1|||
128982330|NCT00351611|464221052|FG001|Overall Study|Other|0|||
128760514|NCT02496767|463412869|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
128760515|NCT02496767|463412870|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
128760516|NCT02496767|463412871|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
128760517|NCT02496767|463412872|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
128760518|NCT02496767|463412873|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
128760519|NCT02496767|463412866|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
128760520|NCT02496767|463412867|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
128760521|NCT02496767|463412868|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
128760522|NCT02496767|463412869|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
128760523|NCT02496767|463412870|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
128760524|NCT02496767|463412871|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
128982331|NCT00351611|464221051|FG000|Overall Study|Protocol Violation|0|||
128982332|NCT00351611|464221052|FG001|Overall Study|Protocol Violation|2|||
128982333|NCT00408408|464221053|FG000|Overall Study|No follow up data|2|||
128982334|NCT00408408|464221054|FG001|Overall Study|No follow up data|3|||
128982335|NCT00408408|464221055|FG002|Overall Study|No follow up data|0|||
128982336|NCT00408408|464221056|FG003|Overall Study|No follow up data|7|||
128982337|NCT00408408|464221057|FG004|Overall Study|No follow up data|5|||
128982338|NCT00408408|464221058|FG005|Overall Study|No follow up data|3|||
128982339|NCT00267202|464221061|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
129206256|NCT00614575|465053355|FG000|Overall Study|Irregularly enrolled patients|23|||
129206257|NCT00614575|465053355|FG000|Overall Study|No treatment|1|||
129206258|NCT03452540|465053357|FG000|Overall Study|Adverse Event|1|||
129206259|NCT03452540|465053357|FG000|Overall Study|Withdrawal by Subject|1|||
129206260|NCT03452540|465053357|FG000|Overall Study|Other SAE and AE|2|||
129206261|NCT01045460|465053360|FG000|Overall Study|Physician Decision|3|||
129206262|NCT01045460|465053361|FG001|Overall Study|Physician Decision|2|||
128982340|NCT00267202|464221062|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129206263|NCT01045460|465053360|FG000|Overall Study|Lost to Follow-up|0|||
129206264|NCT01045460|465053361|FG001|Overall Study|Lost to Follow-up|1|||
128982341|NCT00267202|464221061|FG000|Overall Study|Withdrawal by Subject|12|||
128982342|NCT00267202|464221062|FG001|Overall Study|Withdrawal by Subject|15|||
128982343|NCT00267202|464221061|FG000|Overall Study|Adverse Event|13|||
128982344|NCT00267202|464221062|FG001|Overall Study|Adverse Event|7|||
128982345|NCT00267202|464221061|FG000|Overall Study|Protocol Violation|2|||
128982346|NCT00267202|464221062|FG001|Overall Study|Protocol Violation|3|||
128982347|NCT00267202|464221061|FG000|Overall Study|Administrative problems|2|||
128982348|NCT00267202|464221062|FG001|Overall Study|Administrative problems|1|||
128982349|NCT00267202|464221061|FG000|Overall Study|Lost to Follow-up|3|||
128982350|NCT00267202|464221062|FG001|Overall Study|Lost to Follow-up|0|||
128982351|NCT03457701|464221067|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
128982352|NCT03457701|464221068|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
128982353|NCT03457701|464221067|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
128982354|NCT03457701|464221068|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
128982355|NCT02243306|464221069|FG000|Overall Study|Adverse Event|0|||
128982356|NCT02243306|464221070|FG001|Overall Study|Adverse Event|1|||
128982357|NCT02243306|464221069|FG000|Overall Study|Other: Reached stopping criteria|0|||
128982358|NCT02243306|464221070|FG001|Overall Study|Other: Reached stopping criteria|1|||
128982359|NCT02243306|464221069|FG000|Overall Study|Physician Decision|0|||
128760525|NCT02496767|463412872|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
128760526|NCT02496767|463412873|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
128760527|NCT02496767|463412866|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
128760528|NCT02496767|463412867|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
128760529|NCT02496767|463412868|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
128760530|NCT02496767|463412869|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
128760531|NCT02496767|463412870|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
128760532|NCT02496767|463412871|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
128760533|NCT02496767|463412872|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
128760534|NCT02496767|463412873|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
128760535|NCT02496767|463412866|FG000|Double-blind, Withdrawal Phase|Death|0|||
128760536|NCT02496767|463412867|FG001|Double-blind, Withdrawal Phase|Death|0|||
128760537|NCT02496767|463412868|FG002|Double-blind, Withdrawal Phase|Death|0|||
128760538|NCT02496767|463412869|FG003|Double-blind, Withdrawal Phase|Death|0|||
128760539|NCT02496767|463412870|FG004|Double-blind, Withdrawal Phase|Death|0|||
128760540|NCT02496767|463412871|FG005|Double-blind, Withdrawal Phase|Death|0|||
128760541|NCT02496767|463412872|FG006|Double-blind, Withdrawal Phase|Death|1|||
128760542|NCT02496767|463412873|FG007|Double-blind, Withdrawal Phase|Death|2|||
128760543|NCT02496767|463412866|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
128760544|NCT02496767|463412867|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
128760545|NCT02496767|463412868|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
128760546|NCT02496767|463412869|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
128760547|NCT02496767|463412870|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
128760548|NCT02496767|463412871|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
128760549|NCT02496767|463412872|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
128760550|NCT02496767|463412873|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
128760551|NCT02277990|463412874|FG000|Overall Study|Death|170|||
128982360|NCT02243306|464221070|FG001|Overall Study|Physician Decision|1|||
128982361|NCT00606931|464221076|FG000|Overall Study|Withdrawal by Subject|3|||
128982362|NCT01348828|464221093|FG000|Overall Study|Death|20|||
128982363|NCT01348828|464221093|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
128982364|NCT01348828|464221093|FG000|Overall Study|Conversion|2|||
128982365|NCT01348828|464221093|FG000|Overall Study|missed visit|1|||
128982366|NCT00302731|464221097|FG000|Overall Study|Lost to Follow-up|1|||
128982367|NCT00302731|464221098|FG001|Overall Study|Lost to Follow-up|2|||
128982368|NCT00302731|464221099|FG002|Overall Study|Lost to Follow-up|0|||
128982369|NCT00302731|464221100|FG003|Overall Study|Lost to Follow-up|0|||
128982370|NCT00302731|464221097|FG000|Overall Study|Adverse Event|0|||
128982371|NCT00302731|464221098|FG001|Overall Study|Adverse Event|2|||
128982372|NCT00302731|464221099|FG002|Overall Study|Adverse Event|2|||
128982373|NCT00302731|464221100|FG003|Overall Study|Adverse Event|0|||
128982374|NCT00302731|464221097|FG000|Overall Study|Withdrawal by Subject|1|||
128982375|NCT00302731|464221098|FG001|Overall Study|Withdrawal by Subject|1|||
128982376|NCT00302731|464221099|FG002|Overall Study|Withdrawal by Subject|0|||
128982377|NCT00302731|464221100|FG003|Overall Study|Withdrawal by Subject|0|||
128982378|NCT00302731|464221097|FG000|Overall Study|Protocol Violation|1|||
128982379|NCT00302731|464221098|FG001|Overall Study|Protocol Violation|0|||
128982380|NCT00302731|464221099|FG002|Overall Study|Protocol Violation|0|||
128982381|NCT00302731|464221100|FG003|Overall Study|Protocol Violation|0|||
128982382|NCT00302731|464221097|FG000|Overall Study|cancer unrelated to study discovered|1|||
128982383|NCT00302731|464221098|FG001|Overall Study|cancer unrelated to study discovered|0|||
128982384|NCT00302731|464221099|FG002|Overall Study|cancer unrelated to study discovered|1|||
128982385|NCT00302731|464221100|FG003|Overall Study|cancer unrelated to study discovered|0|||
128982386|NCT01000311|464221101|FG000|Overall Study|Adverse Event|2|||
128982387|NCT01000311|464221102|FG001|Overall Study|Adverse Event|5|||
128982388|NCT01000311|464221101|FG000|Overall Study|Withdrawal by Subject|16|||
128982389|NCT01000311|464221102|FG001|Overall Study|Withdrawal by Subject|24|||
128982390|NCT01000311|464221101|FG000|Overall Study|Lost to Follow-up|15|||
128982391|NCT01000311|464221102|FG001|Overall Study|Lost to Follow-up|24|||
128982392|NCT01000311|464221101|FG000|Overall Study|Protocol Violation|1|||
128982393|NCT01000311|464221102|FG001|Overall Study|Protocol Violation|2|||
128982394|NCT01000311|464221101|FG000|Overall Study|Inappropriate enrollment|2|||
128982395|NCT01000311|464221102|FG001|Overall Study|Inappropriate enrollment|0|||
128982396|NCT01000311|464221101|FG000|Overall Study|Administrative reason|9|||
128982397|NCT01000311|464221102|FG001|Overall Study|Administrative reason|15|||
128982398|NCT01610752|464221105|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
128982399|NCT01610752|464221106|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
128982400|NCT01610752|464221107|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
128982401|NCT01411917|464221108|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
128982402|NCT01411917|464221109|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
128982403|NCT02815670|464221110|FG000|Overall Study|Prematurely discontinued of the trial|1|||
128982404|NCT02354599|464221116|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
128982405|NCT02354599|464221117|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
128982406|NCT02354599|464221118|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
128982407|NCT02354599|464221119|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
128982408|NCT02354599|464221120|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
128982409|NCT02354599|464221121|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
128982410|NCT02354599|464221116|FG000|Overall Study|Withdrawal by Subject|1|||
128982411|NCT02354599|464221117|FG001|Overall Study|Withdrawal by Subject|1|||
128982412|NCT02354599|464221118|FG002|Overall Study|Withdrawal by Subject|0|||
128982413|NCT02354599|464221119|FG003|Overall Study|Withdrawal by Subject|0|||
128982414|NCT02354599|464221120|FG004|Overall Study|Withdrawal by Subject|0|||
128982415|NCT02354599|464221121|FG005|Overall Study|Withdrawal by Subject|0|||
128982416|NCT01087944|464221141|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
128982417|NCT01087944|464221142|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
128982418|NCT01087944|464221141|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
128982419|NCT01087944|464221142|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
128982420|NCT01159665|464221143|FG000|Overall Study|Withdrawal by Subject|0|||
128982421|NCT01159665|464221144|FG001|Overall Study|Withdrawal by Subject|1|||
129206265|NCT01045460|465053360|FG000|Overall Study|Lack of Efficacy|3|||
129206266|NCT01045460|465053361|FG001|Overall Study|Lack of Efficacy|0|||
129206267|NCT00524485|465053362|FG000|Overall Study|Withdrawal by Subject|5|||
129206268|NCT01600885|465053363|FG000|First Period|Adverse Event|1|||
129206269|NCT01600885|465053364|FG001|First Period|Adverse Event|1|||
129206270|NCT01600885|465053363|FG000|First Period|moved out of area|1|||
129206271|NCT01600885|465053364|FG001|First Period|moved out of area|0|||
129206272|NCT00436332|465053365|FG000|Overall Study|Adverse Event|9|||
129206273|NCT00436332|465053365|FG000|Overall Study|Withdrawal by Subject|2|||
129206274|NCT00436332|465053365|FG000|Overall Study|Progression|59|||
129206275|NCT00436332|465053365|FG000|Overall Study|Death|2|||
129206276|NCT00436332|465053365|FG000|Overall Study|Not Protocol Specified|6|||
129206277|NCT00436332|465053365|FG000|Overall Study|Ineligible|2|||
129206278|NCT00436332|465053365|FG000|Overall Study|Never Received Treatment|3|||
129206279|NCT00472108|465053366|FG000|Overall Study|Lost to Follow-up|0|||
129206280|NCT00472108|465053367|FG001|Overall Study|Lost to Follow-up|1|||
129206281|NCT00005906|465053376|FG000|Overall Study|Lack of Efficacy|3|||
129206282|NCT01339689|465053377|FG000|Overall Study|Adverse Event|1|||
129206283|NCT01339689|465053378|FG001|Overall Study|Adverse Event|2|||
129206284|NCT01339689|465053377|FG000|Overall Study|Lost to Follow-up|9|||
129206285|NCT01339689|465053378|FG001|Overall Study|Lost to Follow-up|3|||
129206286|NCT01339689|465053377|FG000|Overall Study|Withdrawal by Subject|3|||
129206287|NCT01339689|465053378|FG001|Overall Study|Withdrawal by Subject|0|||
129206288|NCT01339689|465053377|FG000|Overall Study|Noncompliance|1|||
129206289|NCT01339689|465053378|FG001|Overall Study|Noncompliance|0|||
129206290|NCT01339689|465053377|FG000|Overall Study|Relocated out of area|0|||
129206291|NCT01339689|465053378|FG001|Overall Study|Relocated out of area|1|||
129206292|NCT01339689|465053377|FG000|Overall Study|Other|2|||
128982422|NCT01159665|464221145|FG002|Overall Study|Withdrawal by Subject|0|||
128982423|NCT01159665|464221146|FG003|Overall Study|Withdrawal by Subject|0|||
128982424|NCT01159665|464221147|FG004|Overall Study|Withdrawal by Subject|0|||
128982425|NCT01159665|464221148|FG005|Overall Study|Withdrawal by Subject|0|||
128982426|NCT00540228|464221150|FG000|Overall Study|Adverse Event|2|||
128982427|NCT00540228|464221151|FG001|Overall Study|Adverse Event|0|||
129206293|NCT01339689|465053378|FG001|Overall Study|Other|2|||
129206294|NCT01339689|465053377|FG000|Overall Study|multiple reasons|1|||
128982428|NCT00540228|464221152|FG002|Overall Study|Adverse Event|0|||
129206295|NCT01339689|465053378|FG001|Overall Study|multiple reasons|1|||
129206296|NCT00883779|465053379|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
128982429|NCT00540228|464221153|FG003|Overall Study|Adverse Event|0|||
128982430|NCT00540228|464221154|FG004|Overall Study|Adverse Event|0|||
128982431|NCT00540228|464221150|FG000|Overall Study|Lost to Follow-up|1|||
128982432|NCT00540228|464221151|FG001|Overall Study|Lost to Follow-up|1|||
128982433|NCT00540228|464221152|FG002|Overall Study|Lost to Follow-up|0|||
129206297|NCT00883779|465053380|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
129206298|NCT00883779|465053379|FG000|Primary Study Treatment Phase|Disease progression|75|||
129206299|NCT00883779|465053380|FG001|Primary Study Treatment Phase|Disease progression|59|||
129206300|NCT00883779|465053379|FG000|Primary Study Treatment Phase|Adverse Event|16|||
129206301|NCT00883779|465053380|FG001|Primary Study Treatment Phase|Adverse Event|16|||
129206302|NCT00883779|465053379|FG000|Primary Study Treatment Phase|Death|2|||
129206303|NCT00883779|465053380|FG001|Primary Study Treatment Phase|Death|3|||
129206304|NCT00883779|465053379|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
129206305|NCT00883779|465053380|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
129206306|NCT00883779|465053379|FG000|Primary Study Treatment Phase|Other|3|||
129206307|NCT00883779|465053380|FG001|Primary Study Treatment Phase|Other|0|||
129206308|NCT00883779|465053379|FG000|Post-Study Treatment Phase|Adverse Event|2|||
129206309|NCT00883779|465053380|FG001|Post-Study Treatment Phase|Adverse Event|3|||
129206310|NCT00883779|465053379|FG000|Post-Study Treatment Phase|Death|1|||
129206311|NCT00883779|465053380|FG001|Post-Study Treatment Phase|Death|3|||
129206312|NCT00883779|465053379|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
129206313|NCT00883779|465053380|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
129206314|NCT00883779|465053379|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
129206315|NCT00883779|465053380|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
129206316|NCT00883779|465053379|FG000|Post-Study Treatment Phase|Disease progression|103|||
129206317|NCT00883779|465053380|FG001|Post-Study Treatment Phase|Disease progression|122|||
129206318|NCT00883779|465053379|FG000|Post-Study Treatment Phase|Other|3|||
129206319|NCT00883779|465053380|FG001|Post-Study Treatment Phase|Other|0|||
129206320|NCT00883779|465053379|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
129206321|NCT00883779|465053380|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
129206322|NCT00883779|465053379|FG000|Off-study Phase|Death|185|||
129206323|NCT00883779|465053380|FG001|Off-study Phase|Death|174|||
129206324|NCT00883779|465053379|FG000|Off-study Phase|Refused treatment|1|||
129206325|NCT00883779|465053380|FG001|Off-study Phase|Refused treatment|1|||
129206326|NCT00883779|465053379|FG000|Off-study Phase|Failure to return|5|||
129206327|NCT00883779|465053380|FG001|Off-study Phase|Failure to return|6|||
129206328|NCT00883779|465053379|FG000|Off-study Phase|Other|18|||
129206329|NCT00883779|465053380|FG001|Off-study Phase|Other|21|||
129206330|NCT02140047|465053381|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129206331|NCT02140047|465053382|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129206332|NCT02140047|465053383|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129206333|NCT00079040|465053384|FG000|Overall Study|Withdrew before treatment|1|||
129206334|NCT00079040|465053384|FG000|Overall Study|Ineligible|1|||
129206335|NCT00292942|465053385|FG000|Overall Study|Withdrawal by Subject|0|||
129206336|NCT00292942|465053386|FG001|Overall Study|Withdrawal by Subject|0|||
129206337|NCT00292942|465053387|FG002|Overall Study|Withdrawal by Subject|1|||
129206338|NCT00292942|465053388|FG003|Overall Study|Withdrawal by Subject|0|||
129206339|NCT00292942|465053385|FG000|Overall Study|Adverse Event|0|||
128982434|NCT00540228|464221153|FG003|Overall Study|Lost to Follow-up|0|||
128982435|NCT00540228|464221154|FG004|Overall Study|Lost to Follow-up|0|||
128982436|NCT01377194|464221155|FG000|Overall Study|Adverse Event|3|||
128982437|NCT01377194|464221156|FG001|Overall Study|Adverse Event|12|||
128982438|NCT01377194|464221157|FG002|Overall Study|Adverse Event|19|||
128982439|NCT01377194|464221155|FG000|Overall Study|Lack of Efficacy|3|||
128982440|NCT01377194|464221156|FG001|Overall Study|Lack of Efficacy|3|||
128982441|NCT01377194|464221157|FG002|Overall Study|Lack of Efficacy|3|||
128982442|NCT01377194|464221155|FG000|Overall Study|Protocol Violation|4|||
128982443|NCT01377194|464221156|FG001|Overall Study|Protocol Violation|10|||
128982444|NCT01377194|464221157|FG002|Overall Study|Protocol Violation|6|||
128982445|NCT01377194|464221155|FG000|Overall Study|Withdrawal by Subject|8|||
128982446|NCT01377194|464221156|FG001|Overall Study|Withdrawal by Subject|10|||
128982447|NCT01377194|464221157|FG002|Overall Study|Withdrawal by Subject|7|||
128982448|NCT01377194|464221155|FG000|Overall Study|Lost to Follow-up|14|||
129206340|NCT00292942|465053386|FG001|Overall Study|Adverse Event|0|||
128982449|NCT01377194|464221156|FG001|Overall Study|Lost to Follow-up|8|||
129206341|NCT00292942|465053387|FG002|Overall Study|Adverse Event|0|||
129206342|NCT00292942|465053388|FG003|Overall Study|Adverse Event|1|||
129206343|NCT00651924|465053389|FG000|Overall Study|Withdrawal by PI|0|||
129206344|NCT00651924|465053390|FG001|Overall Study|Withdrawal by PI|2|||
129206345|NCT00651924|465053389|FG000|Overall Study|Withdrawal by Subject|0|||
129206346|NCT00651924|465053390|FG001|Overall Study|Withdrawal by Subject|5|||
129206347|NCT00960063|465053391|FG000|Overall Study|Adverse Event|1|||
129206348|NCT00960063|465053392|FG001|Overall Study|Adverse Event|0|||
129206349|NCT00960063|465053393|FG002|Overall Study|Adverse Event|0|||
129206350|NCT00960063|465053391|FG000|Overall Study|Progression of Disease|0|||
128982450|NCT01377194|464221157|FG002|Overall Study|Lost to Follow-up|11|||
128982451|NCT02451137|464221160|FG000|Overall Study|Randomized but not treated|19|||
128982452|NCT02451137|464221161|FG001|Overall Study|Randomized but not treated|27|||
129206351|NCT00960063|465053392|FG001|Overall Study|Progression of Disease|0|||
129206352|NCT00960063|465053393|FG002|Overall Study|Progression of Disease|3|||
129206353|NCT05083351|465053395|FG000|Overall Study|Adverse Event|3|||
129206354|NCT05083351|465053395|FG000|Overall Study|Did not meet data inclusion criteria|8|||
129206355|NCT05083351|465053395|FG000|Overall Study|Did not meet eligibility criteria|19|||
129206356|NCT05083351|465053395|FG000|Overall Study|Study Staff Decision|19|||
129206357|NCT01759420|465053397|FG000|Overall Study|Screen failure|5|||
129206358|NCT01759420|465053397|FG000|Overall Study|Inaccurate EKG machine readings|1|||
129206359|NCT04258423|465053404|FG000|Overall Study|Study Closure|2|||
129206360|NCT04258423|465053405|FG001|Overall Study|Study Closure|2|||
129206361|NCT03309020|465053406|FG000|Overall Study|Death|1|||
129206362|NCT03309020|465053407|FG001|Overall Study|Death|0|||
129206363|NCT03309020|465053406|FG000|Overall Study|Did not undergo surgery|2|||
129206364|NCT03309020|465053407|FG001|Overall Study|Did not undergo surgery|1|||
129206365|NCT02362724|465053408|FG000|Overall Study|Withdrawal by Subject|3|||
129206366|NCT02362724|465053409|FG001|Overall Study|Withdrawal by Subject|1|||
129206367|NCT02362724|465053408|FG000|Overall Study|Adverse Event|3|||
129206368|NCT02362724|465053409|FG001|Overall Study|Adverse Event|0|||
129206369|NCT00402168|465053410|FG000|Randomized|Lost to Follow-up|1|||
129206370|NCT00402168|465053411|FG001|Randomized|Lost to Follow-up|0|||
129206371|NCT00402168|465053410|FG000|Randomized|Withdrawal by Subject|0|||
129206372|NCT00402168|465053411|FG001|Randomized|Withdrawal by Subject|1|||
129206373|NCT00402168|465053410|FG000|Treatment (up to 12 Months)|Death|0|||
129206374|NCT00402168|465053411|FG001|Treatment (up to 12 Months)|Death|1|||
129206375|NCT00402168|465053410|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
129206376|NCT00402168|465053411|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
129206377|NCT00402168|465053410|FG000|Treatment (up to 12 Months)|non-specified|0|||
129206378|NCT00402168|465053411|FG001|Treatment (up to 12 Months)|non-specified|1|||
129206379|NCT00402168|465053410|FG000|Long Term (LT)|Adverse Event|1|||
129206380|NCT00402168|465053411|FG001|Long Term (LT)|Adverse Event|5|||
129206381|NCT00402168|465053410|FG000|Long Term (LT)|Withdrawal by Subject|4|||
129206382|NCT00402168|465053411|FG001|Long Term (LT)|Withdrawal by Subject|7|||
129206383|NCT00402168|465053410|FG000|Long Term (LT)|Pregnancy|0|||
129206384|NCT00402168|465053411|FG001|Long Term (LT)|Pregnancy|1|||
129206385|NCT00402168|465053410|FG000|Long Term (LT)|Lost to Follow-up|1|||
129206386|NCT00402168|465053411|FG001|Long Term (LT)|Lost to Follow-up|0|||
129206387|NCT00402168|465053410|FG000|Long Term (LT)|Death|4|||
129206388|NCT00402168|465053411|FG001|Long Term (LT)|Death|0|||
129206389|NCT00402168|465053410|FG000|Long Term (LT)|Lack of Efficacy|0|||
129206390|NCT00402168|465053411|FG001|Long Term (LT)|Lack of Efficacy|2|||
129206391|NCT00402168|465053410|FG000|Long Term (LT)|non-specified|1|||
129206392|NCT00402168|465053411|FG001|Long Term (LT)|non-specified|2|||
129206393|NCT00402168|465053410|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
129206394|NCT00402168|465053411|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
129206395|NCT00402168|465053410|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
129206396|NCT00402168|465053411|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
129206397|NCT02025179|465053412|FG000|Overall Study|Lost to Follow-up|0|||
129206398|NCT02025179|465053413|FG001|Overall Study|Lost to Follow-up|0|||
129206399|NCT02025179|465053414|FG002|Overall Study|Lost to Follow-up|1|||
129206400|NCT00395746|465053420|FG000|Overall Study|Adverse Event|5|||
129206401|NCT00395746|465053421|FG001|Overall Study|Adverse Event|2|||
129206402|NCT00395746|465053422|FG002|Overall Study|Adverse Event|2|||
129206403|NCT00395746|465053420|FG000|Overall Study|Protocol Violation|0|||
129206404|NCT00395746|465053421|FG001|Overall Study|Protocol Violation|1|||
129206405|NCT00395746|465053422|FG002|Overall Study|Protocol Violation|0|||
129206406|NCT00395746|465053420|FG000|Overall Study|Lack of Efficacy|2|||
129206407|NCT00395746|465053421|FG001|Overall Study|Lack of Efficacy|0|||
129206408|NCT00395746|465053422|FG002|Overall Study|Lack of Efficacy|17|||
129206409|NCT00395746|465053420|FG000|Overall Study|Hypoglycaemia|2|||
129206410|NCT00395746|465053421|FG001|Overall Study|Hypoglycaemia|1|||
129206411|NCT00395746|465053422|FG002|Overall Study|Hypoglycaemia|0|||
129206412|NCT00395746|465053420|FG000|Overall Study|Subject decision|0|||
129206413|NCT00395746|465053421|FG001|Overall Study|Subject decision|0|||
129206414|NCT00395746|465053422|FG002|Overall Study|Subject decision|1|||
129206415|NCT00395746|465053420|FG000|Overall Study|Withdrawal of consent|0|||
129206416|NCT00395746|465053421|FG001|Overall Study|Withdrawal of consent|0|||
129206417|NCT00395746|465053422|FG002|Overall Study|Withdrawal of consent|1|||
129206418|NCT00395746|465053420|FG000|Overall Study|Difficultulty in use of device|0|||
129206419|NCT00395746|465053421|FG001|Overall Study|Difficultulty in use of device|0|||
129206420|NCT00395746|465053422|FG002|Overall Study|Difficultulty in use of device|1|||
129206421|NCT00395746|465053420|FG000|Overall Study|Unable to visit site on schedule|1|||
129206422|NCT00395746|465053421|FG001|Overall Study|Unable to visit site on schedule|0|||
129206423|NCT00395746|465053422|FG002|Overall Study|Unable to visit site on schedule|0|||
129206424|NCT03137992|465053427|FG000|Washout Period 1|Adverse Event|1|||
129206425|NCT03137992|465053428|FG001|Washout Period 1|Adverse Event|1|||
129206426|NCT03137992|465053429|FG002|Washout Period 1|Adverse Event|0|||
129206427|NCT03137992|465053430|FG003|Washout Period 1|Adverse Event|0|||
129206428|NCT03137992|465053431|FG004|Washout Period 1|Adverse Event|0|||
129206429|NCT03137992|465053432|FG005|Washout Period 1|Adverse Event|1|||
129206430|NCT03137992|465053427|FG000|Washout Period 1|Withdrawal by Subject|0|||
129206431|NCT03137992|465053428|FG001|Washout Period 1|Withdrawal by Subject|1|||
129206432|NCT03137992|465053429|FG002|Washout Period 1|Withdrawal by Subject|1|||
129206433|NCT03137992|465053430|FG003|Washout Period 1|Withdrawal by Subject|0|||
129206434|NCT03137992|465053431|FG004|Washout Period 1|Withdrawal by Subject|0|||
129206435|NCT03137992|465053432|FG005|Washout Period 1|Withdrawal by Subject|0|||
129206436|NCT03137992|465053427|FG000|Washout Period 1|Principal Investigator Discretion|0|||
129206437|NCT03137992|465053428|FG001|Washout Period 1|Principal Investigator Discretion|1|||
129206438|NCT03137992|465053429|FG002|Washout Period 1|Principal Investigator Discretion|0|||
129206439|NCT03137992|465053430|FG003|Washout Period 1|Principal Investigator Discretion|0|||
129206440|NCT03137992|465053431|FG004|Washout Period 1|Principal Investigator Discretion|0|||
129206441|NCT03137992|465053432|FG005|Washout Period 1|Principal Investigator Discretion|0|||
129206442|NCT03137992|465053427|FG000|Washout Period 1|COPD Exacerbation|1|||
129206443|NCT03137992|465053428|FG001|Washout Period 1|COPD Exacerbation|1|||
129206444|NCT03137992|465053429|FG002|Washout Period 1|COPD Exacerbation|1|||
129206445|NCT03137992|465053430|FG003|Washout Period 1|COPD Exacerbation|0|||
129206446|NCT03137992|465053431|FG004|Washout Period 1|COPD Exacerbation|1|||
129206447|NCT03137992|465053432|FG005|Washout Period 1|COPD Exacerbation|1|||
129206448|NCT03137992|465053427|FG000|Washout Period 1|Subject Noncompliance|1|||
129206449|NCT03137992|465053428|FG001|Washout Period 1|Subject Noncompliance|0|||
129206450|NCT03137992|465053429|FG002|Washout Period 1|Subject Noncompliance|0|||
129206451|NCT03137992|465053430|FG003|Washout Period 1|Subject Noncompliance|0|||
129206452|NCT03137992|465053431|FG004|Washout Period 1|Subject Noncompliance|1|||
129206453|NCT03137992|465053432|FG005|Washout Period 1|Subject Noncompliance|0|||
129206454|NCT03137992|465053427|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
129206455|NCT03137992|465053428|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
128717716|NCT02337907|463263983|FG004|Overall Study|Adverse Event|4|||
128717717|NCT02337907|463263984|FG005|Overall Study|Adverse Event|0|||
128717718|NCT01592344|463263988|FG000|Overall Study|Adverse Event|1|||
128717719|NCT01592344|463263989|FG001|Overall Study|Adverse Event|1|||
128717720|NCT01592344|463263988|FG000|Overall Study|Lack of Efficacy|1|||
128717721|NCT01592344|463263989|FG001|Overall Study|Lack of Efficacy|0|||
128717722|NCT01592344|463263988|FG000|Overall Study|not available at primary outcome visit|2|||
128717723|NCT01592344|463263989|FG001|Overall Study|not available at primary outcome visit|4|||
128717724|NCT00099437|463263991|FG000|Overall Study|Lost to Follow-up|30|||
128717725|NCT00099437|463263992|FG001|Overall Study|Lost to Follow-up|33|||
128717726|NCT00099437|463263991|FG000|Overall Study|Death|293|||
128717727|NCT00099437|463263992|FG001|Overall Study|Death|261|||
128717728|NCT00099437|463263991|FG000|Overall Study|Withdrawal by Subject|6|||
128717729|NCT00099437|463263992|FG001|Overall Study|Withdrawal by Subject|10|||
128717730|NCT00099437|463263991|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
128717731|NCT00099437|463263992|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
128717732|NCT02488681|463263995|FG000|Overall Study|Implant unsuccessful|7|||
128717733|NCT02809677|463263996|FG000|Overall Study|Withdrawal by Subject|8|||
128717734|NCT04969224|463263997|FG000|Overall Study|Adverse Event|1|||
128717735|NCT04969224|463263997|FG000|Overall Study|Enrolled but never dosed|1|||
128717736|NCT03165110|463263998|FG000|Overall Study|Anroid phone software incompatibility|1|||
128717737|NCT05533632|463263999|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
128717738|NCT05533632|463263999|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
128717739|NCT05533632|463263999|FG000|Overall Study|Lost to Follow-up|1|||
128717740|NCT05533632|463263999|FG000|Overall Study|Withdrawal by Subject|4|||
128717741|NCT05533632|463263999|FG000|Overall Study|Adverse Event|4|||
128717742|NCT00613015|463264000|FG000|Overall Study|Lost to Follow-up|0|||
128717743|NCT00613015|463264001|FG001|Overall Study|Lost to Follow-up|1|||
128717744|NCT00613015|463264002|FG002|Overall Study|Lost to Follow-up|3|||
128717745|NCT00613015|463264003|FG003|Overall Study|Lost to Follow-up|3|||
128717746|NCT00613015|463264004|FG004|Overall Study|Lost to Follow-up|2|||
128717747|NCT00613015|463264005|FG005|Overall Study|Lost to Follow-up|3|||
128717748|NCT04327388|463264008|FG000|Overall Study|Adverse Event|17|||
128717749|NCT04327388|463264009|FG001|Overall Study|Adverse Event|18|||
128717750|NCT04327388|463264010|FG002|Overall Study|Adverse Event|9|||
128717751|NCT04327388|463264008|FG000|Overall Study|Other|1|||
128717752|NCT04327388|463264009|FG001|Overall Study|Other|2|||
128717753|NCT04327388|463264010|FG002|Overall Study|Other|0|||
128717754|NCT04327388|463264008|FG000|Overall Study|Randomized and not treated|2|||
128717755|NCT04327388|463264009|FG001|Overall Study|Randomized and not treated|0|||
128717756|NCT04327388|463264010|FG002|Overall Study|Randomized and not treated|2|||
128717757|NCT04120974|463264011|FG000|Overall Study|Death|1|||
128717758|NCT04120974|463264011|FG000|Overall Study|Physician Decision|1|||
128717759|NCT04120974|463264011|FG000|Overall Study|Lost to Follow-up|6|||
128717760|NCT03338062|463264012|FG000|Overall Study|Alternative Therapy|1|||
128717761|NCT03338062|463264013|FG001|Overall Study|Alternative Therapy|0|||
128717762|NCT04340362|463264014|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
128717763|NCT01170091|463264015|FG000|Overall Study|Missing efficacy evaluation|3|||
128717764|NCT01170091|463264015|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
129206456|NCT03137992|465053429|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
129206457|NCT03137992|465053430|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
129206458|NCT03137992|465053431|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
129206459|NCT03137992|465053432|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
129206460|NCT03137992|465053427|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
129206461|NCT03137992|465053428|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
129206462|NCT03137992|465053429|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
129206463|NCT03137992|465053430|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
129206464|NCT03137992|465053431|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
129206465|NCT03137992|465053432|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
129206466|NCT03137992|465053427|FG000|Period 2 (Visit 3)|Adverse Event|0|||
129206467|NCT03137992|465053428|FG001|Period 2 (Visit 3)|Adverse Event|1|||
129206468|NCT03137992|465053429|FG002|Period 2 (Visit 3)|Adverse Event|0|||
129206469|NCT03137992|465053430|FG003|Period 2 (Visit 3)|Adverse Event|0|||
129206470|NCT03137992|465053431|FG004|Period 2 (Visit 3)|Adverse Event|0|||
129206471|NCT03137992|465053432|FG005|Period 2 (Visit 3)|Adverse Event|0|||
129206472|NCT03137992|465053427|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
129206473|NCT03137992|465053428|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
129206474|NCT03137992|465053429|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
129206475|NCT03137992|465053430|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
129206476|NCT03137992|465053431|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
129206477|NCT03137992|465053432|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
129206478|NCT03137992|465053427|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129206479|NCT03137992|465053428|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
129206480|NCT03137992|465053429|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129206481|NCT03137992|465053430|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129206482|NCT03137992|465053431|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
129206483|NCT03137992|465053432|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129206484|NCT03137992|465053427|FG000|Washout Period 2|COPD Exacerbation|1|||
129206485|NCT03137992|465053428|FG001|Washout Period 2|COPD Exacerbation|1|||
129206486|NCT03137992|465053429|FG002|Washout Period 2|COPD Exacerbation|0|||
129206487|NCT03137992|465053430|FG003|Washout Period 2|COPD Exacerbation|0|||
129206488|NCT03137992|465053431|FG004|Washout Period 2|COPD Exacerbation|1|||
129206489|NCT03137992|465053432|FG005|Washout Period 2|COPD Exacerbation|0|||
129206490|NCT03137992|465053427|FG000|Washout Period 2|Subject Non-compliance|0|||
129206491|NCT03137992|465053428|FG001|Washout Period 2|Subject Non-compliance|1|||
129206492|NCT03137992|465053429|FG002|Washout Period 2|Subject Non-compliance|0|||
129206493|NCT03137992|465053430|FG003|Washout Period 2|Subject Non-compliance|0|||
129206494|NCT03137992|465053431|FG004|Washout Period 2|Subject Non-compliance|0|||
129206495|NCT03137992|465053432|FG005|Washout Period 2|Subject Non-compliance|0|||
129206496|NCT03137992|465053427|FG000|Washout Period 2|Adverse Event|0|||
129206497|NCT03137992|465053428|FG001|Washout Period 2|Adverse Event|0|||
129206498|NCT03137992|465053429|FG002|Washout Period 2|Adverse Event|0|||
129206499|NCT03137992|465053430|FG003|Washout Period 2|Adverse Event|1|||
129206500|NCT03137992|465053431|FG004|Washout Period 2|Adverse Event|1|||
129206501|NCT03137992|465053432|FG005|Washout Period 2|Adverse Event|0|||
129206502|NCT03137992|465053427|FG000|Washout Period 2|Withdrawal by Subject|1|||
129206503|NCT03137992|465053428|FG001|Washout Period 2|Withdrawal by Subject|0|||
129206504|NCT03137992|465053429|FG002|Washout Period 2|Withdrawal by Subject|0|||
129206505|NCT03137992|465053430|FG003|Washout Period 2|Withdrawal by Subject|0|||
129206506|NCT03137992|465053431|FG004|Washout Period 2|Withdrawal by Subject|1|||
129206507|NCT03137992|465053432|FG005|Washout Period 2|Withdrawal by Subject|0|||
129206508|NCT03137992|465053427|FG000|Washout Period 2|Sponsor Decision|0|||
129206509|NCT03137992|465053428|FG001|Washout Period 2|Sponsor Decision|0|||
129206510|NCT03137992|465053429|FG002|Washout Period 2|Sponsor Decision|0|||
129206511|NCT03137992|465053430|FG003|Washout Period 2|Sponsor Decision|0|||
129206512|NCT03137992|465053431|FG004|Washout Period 2|Sponsor Decision|0|||
129206513|NCT03137992|465053432|FG005|Washout Period 2|Sponsor Decision|1|||
129206514|NCT03137992|465053427|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
129206515|NCT03137992|465053428|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
129206516|NCT03137992|465053429|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
129206517|NCT03137992|465053430|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
129206518|NCT03137992|465053431|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
129206519|NCT03137992|465053432|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
129206520|NCT03137992|465053427|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
129206521|NCT03137992|465053428|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
129206522|NCT03137992|465053429|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
129206523|NCT03137992|465053430|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
129206524|NCT03137992|465053431|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
129206525|NCT03137992|465053432|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
129206526|NCT03137992|465053427|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
129206527|NCT03137992|465053428|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129206528|NCT03137992|465053429|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
129206529|NCT03137992|465053430|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129206530|NCT03137992|465053431|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129206531|NCT03137992|465053432|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129206532|NCT03137992|465053427|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129206533|NCT03137992|465053428|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129206534|NCT03137992|465053429|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129206535|NCT03137992|465053430|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
129206536|NCT03137992|465053431|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129206537|NCT03137992|465053432|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129206538|NCT03137992|465053427|FG000|Part 2 (Open-label Extension)|Per study team|1|||
129206539|NCT03137992|465053428|FG001|Part 2 (Open-label Extension)|Per study team|0|||
129206540|NCT03137992|465053429|FG002|Part 2 (Open-label Extension)|Per study team|0|||
129206541|NCT03137992|465053430|FG003|Part 2 (Open-label Extension)|Per study team|0|||
129206542|NCT03137992|465053431|FG004|Part 2 (Open-label Extension)|Per study team|0|||
129206543|NCT03137992|465053432|FG005|Part 2 (Open-label Extension)|Per study team|0|||
129206544|NCT03137992|465053427|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129206545|NCT03137992|465053428|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129206546|NCT03137992|465053429|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129206547|NCT03137992|465053430|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129206548|NCT03137992|465053431|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129206549|NCT03137992|465053432|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
129206550|NCT02370420|465053433|FG000|Overall Study|Physician Decision|3|||
129206551|NCT02370420|465053434|FG001|Overall Study|Physician Decision|3|||
129206552|NCT02370420|465053433|FG000|Overall Study|Lost to Follow-up|11|||
129206553|NCT02370420|465053434|FG001|Overall Study|Lost to Follow-up|9|||
129206554|NCT03077542|465053435|FG000|Overall Study|Death|4|||
129206555|NCT03077542|465053436|FG001|Overall Study|Death|0|||
129206556|NCT03077542|465053435|FG000|Overall Study|Physician Decision|6|||
129206557|NCT03077542|465053436|FG001|Overall Study|Physician Decision|1|||
129206558|NCT03077542|465053435|FG000|Overall Study|Withdrawal by Subject|0|||
129206559|NCT03077542|465053436|FG001|Overall Study|Withdrawal by Subject|1|||
129206560|NCT00795704|465053437|FG000|Overall Study|Withdrawal by Subject|3|||
129206561|NCT00795704|465053438|FG001|Overall Study|Withdrawal by Subject|2|||
129206562|NCT00795704|465053437|FG000|Overall Study|Adverse Event|1|||
129206563|NCT00795704|465053438|FG001|Overall Study|Adverse Event|1|||
129206564|NCT03980730|465053439|FG000|Overall Study|Study Terminated by Sponsor|0|||
129206565|NCT03980730|465053440|FG001|Overall Study|Study Terminated by Sponsor|3|||
129206566|NCT03980730|465053439|FG000|Overall Study|Adverse Event|2|||
129206567|NCT03980730|465053440|FG001|Overall Study|Adverse Event|0|||
129206568|NCT03980730|465053439|FG000|Overall Study|Sponsor Request|0|||
129206569|NCT03980730|465053440|FG001|Overall Study|Sponsor Request|1|||
129206570|NCT01300728|465053441|FG000|Overall Study|Withdrawal by Subject|1|||
129206571|NCT01300728|465053442|FG001|Overall Study|Withdrawal by Subject|1|||
129206572|NCT01300728|465053441|FG000|Overall Study|Physician Decision|1|||
129206573|NCT01300728|465053442|FG001|Overall Study|Physician Decision|0|||
129206574|NCT00880620|465053445|FG000|Overall Study|Adverse Event|4|||
129206575|NCT00880620|465053446|FG001|Overall Study|Adverse Event|5|||
129206576|NCT00880620|465053447|FG002|Overall Study|Adverse Event|15|||
129206577|NCT00880620|465053448|FG003|Overall Study|Adverse Event|15|||
129206578|NCT00880620|465053445|FG000|Overall Study|Death|0|||
129206579|NCT00880620|465053446|FG001|Overall Study|Death|0|||
129206580|NCT00880620|465053447|FG002|Overall Study|Death|1|||
129206581|NCT00880620|465053448|FG003|Overall Study|Death|0|||
129206582|NCT00880620|465053445|FG000|Overall Study|Lack of Efficacy|12|||
129206583|NCT00880620|465053446|FG001|Overall Study|Lack of Efficacy|4|||
129206584|NCT00880620|465053447|FG002|Overall Study|Lack of Efficacy|0|||
129206585|NCT00880620|465053448|FG003|Overall Study|Lack of Efficacy|1|||
129206586|NCT00880620|465053445|FG000|Overall Study|Lost to Follow-up|0|||
129206587|NCT00880620|465053446|FG001|Overall Study|Lost to Follow-up|1|||
129206588|NCT00880620|465053447|FG002|Overall Study|Lost to Follow-up|1|||
129206589|NCT00880620|465053448|FG003|Overall Study|Lost to Follow-up|0|||
129206590|NCT00880620|465053445|FG000|Overall Study|Protocol Violation|0|||
129206591|NCT00880620|465053446|FG001|Overall Study|Protocol Violation|1|||
129206592|NCT00880620|465053447|FG002|Overall Study|Protocol Violation|0|||
129206593|NCT00880620|465053448|FG003|Overall Study|Protocol Violation|2|||
129206594|NCT00880620|465053445|FG000|Overall Study|Withdrawal by Subject|4|||
129206595|NCT00880620|465053446|FG001|Overall Study|Withdrawal by Subject|3|||
129206596|NCT00880620|465053447|FG002|Overall Study|Withdrawal by Subject|1|||
129206597|NCT00880620|465053448|FG003|Overall Study|Withdrawal by Subject|3|||
129206598|NCT00880620|465053445|FG000|Overall Study|Noncompliance|0|||
129206599|NCT00880620|465053446|FG001|Overall Study|Noncompliance|0|||
129206600|NCT00880620|465053447|FG002|Overall Study|Noncompliance|1|||
129206601|NCT00880620|465053448|FG003|Overall Study|Noncompliance|1|||
129206602|NCT00880620|465053445|FG000|Overall Study|Other|1|||
129206603|NCT00880620|465053446|FG001|Overall Study|Other|1|||
129206604|NCT00880620|465053447|FG002|Overall Study|Other|2|||
129206605|NCT00880620|465053448|FG003|Overall Study|Other|2|||
129206606|NCT00301808|465053452|FG000|Overall Study|Adverse Event|5|||
129206607|NCT00301808|465053452|FG000|Overall Study|Death|3|||
129206608|NCT00301808|465053452|FG000|Overall Study|Lack of Efficacy|4|||
129206609|NCT05893862|465053456|FG000|Overall Study|Physician Decision|0|||
129206610|NCT05893862|465053457|FG001|Overall Study|Physician Decision|1|||
129206611|NCT05893862|465053458|FG002|Overall Study|Physician Decision|0|||
129206612|NCT05893862|465053459|FG003|Overall Study|Physician Decision|0|||
129206613|NCT05893862|465053460|FG004|Overall Study|Physician Decision|1|||
129206614|NCT05893862|465053461|FG005|Overall Study|Physician Decision|0|||
129206615|NCT05893862|465053456|FG000|Overall Study|Withdrawal by Subject|1|||
129206616|NCT05893862|465053457|FG001|Overall Study|Withdrawal by Subject|7|||
129206617|NCT05893862|465053458|FG002|Overall Study|Withdrawal by Subject|1|||
129206618|NCT05893862|465053459|FG003|Overall Study|Withdrawal by Subject|3|||
129206619|NCT05893862|465053460|FG004|Overall Study|Withdrawal by Subject|3|||
129206620|NCT05893862|465053461|FG005|Overall Study|Withdrawal by Subject|2|||
129206621|NCT05893862|465053456|FG000|Overall Study|Adverse Event|1|||
129206622|NCT05893862|465053457|FG001|Overall Study|Adverse Event|4|||
129206623|NCT05893862|465053458|FG002|Overall Study|Adverse Event|2|||
129206624|NCT05893862|465053459|FG003|Overall Study|Adverse Event|2|||
129206625|NCT05893862|465053460|FG004|Overall Study|Adverse Event|1|||
129206626|NCT05893862|465053461|FG005|Overall Study|Adverse Event|0|||
129206627|NCT02919761|465053462|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
129206628|NCT02919761|465053463|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
129206629|NCT02919761|465053464|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
129206630|NCT02919761|465053462|FG000|Part 1: Open Label|Adverse Event|1|||
129206631|NCT02919761|465053463|FG001|Part 1: Open Label|Adverse Event|0|||
129206632|NCT02919761|465053464|FG002|Part 1: Open Label|Adverse Event|0|||
129206633|NCT02919761|465053462|FG000|Part 1: Open Label|Lost to Follow-up|1|||
129206634|NCT02919761|465053463|FG001|Part 1: Open Label|Lost to Follow-up|0|||
129206635|NCT02919761|465053464|FG002|Part 1: Open Label|Lost to Follow-up|0|||
129206636|NCT02919761|465053462|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
129206637|NCT02919761|465053463|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
129206638|NCT02919761|465053464|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
129206639|NCT02919761|465053462|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
129206640|NCT02919761|465053463|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
129206641|NCT02919761|465053464|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
129206642|NCT02919761|465053462|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
129206643|NCT02919761|465053463|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
129206644|NCT02919761|465053464|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
129206645|NCT02919761|465053462|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
129206646|NCT02919761|465053463|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
129206647|NCT02919761|465053464|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
129206648|NCT02919761|465053462|FG000|Part 1: Open Label|Termination by Sponsor|1|||
129206649|NCT02919761|465053463|FG001|Part 1: Open Label|Termination by Sponsor|0|||
129206650|NCT02919761|465053464|FG002|Part 1: Open Label|Termination by Sponsor|0|||
129206651|NCT02919761|465053462|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
129206652|NCT02919761|465053463|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
129206653|NCT02919761|465053464|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
129206654|NCT02919761|465053462|FG000|Part 2: Double-blind|Adverse Event|0|||
129206655|NCT02919761|465053463|FG001|Part 2: Double-blind|Adverse Event|1|||
129206656|NCT02919761|465053464|FG002|Part 2: Double-blind|Adverse Event|0|||
129206657|NCT02919761|465053462|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
129206658|NCT02919761|465053463|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
129206659|NCT02919761|465053464|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
129206660|NCT02919761|465053462|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
129206661|NCT02919761|465053463|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
129206662|NCT02919761|465053464|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
129206663|NCT02919761|465053462|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
129206664|NCT02919761|465053463|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
129206665|NCT02919761|465053464|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
129206666|NCT02919761|465053462|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
129206667|NCT02919761|465053463|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
129206668|NCT02919761|465053464|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
129206669|NCT02919761|465053462|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
129206670|NCT02919761|465053463|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
129206671|NCT02919761|465053464|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
129206672|NCT02919761|465053462|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
129206673|NCT02919761|465053463|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
129206674|NCT02919761|465053464|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
129206675|NCT02429830|465053465|FG000|Overall Study|Lost to Follow-up|1|||
129206676|NCT02429830|465053465|FG000|Overall Study|Device Explant|2|||
129206677|NCT03287791|465054923|FG000|Overall Study|Insufficient Therapeutic Response|0|||
129206678|NCT03287791|465054924|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129206679|NCT03287791|465054925|FG002|Overall Study|Insufficient Therapeutic Response|1|||
129206680|NCT03287791|465054923|FG000|Overall Study|Adverse Event|0|||
129206681|NCT03287791|465054924|FG001|Overall Study|Adverse Event|4|||
129206682|NCT03287791|465054925|FG002|Overall Study|Adverse Event|3|||
129206683|NCT03287791|465054923|FG000|Overall Study|Withdrawal by Subject|12|||
129206684|NCT03287791|465054924|FG001|Overall Study|Withdrawal by Subject|12|||
129206685|NCT03287791|465054925|FG002|Overall Study|Withdrawal by Subject|17|||
129206686|NCT03287791|465054923|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
129206687|NCT03287791|465054924|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
129206688|NCT03287791|465054925|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
129206689|NCT03287791|465054923|FG000|Overall Study|Lost to Follow-up|8|||
129206690|NCT03287791|465054924|FG001|Overall Study|Lost to Follow-up|14|||
129206691|NCT03287791|465054925|FG002|Overall Study|Lost to Follow-up|11|||
129206692|NCT03287791|465054923|FG000|Overall Study|Protocol Violation|7|||
129206693|NCT03287791|465054924|FG001|Overall Study|Protocol Violation|2|||
129206694|NCT03287791|465054925|FG002|Overall Study|Protocol Violation|1|||
129206695|NCT03287791|465054923|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
129206696|NCT03287791|465054924|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
129206697|NCT03287791|465054925|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
129206698|NCT03287791|465054923|FG000|Overall Study|Too much time between 2 visits|0|||
128982453|NCT02451137|464221160|FG000|Overall Study|Adverse Event|43|||
129206699|NCT03287791|465054924|FG001|Overall Study|Too much time between 2 visits|1|||
129206700|NCT03287791|465054925|FG002|Overall Study|Too much time between 2 visits|0|||
129206701|NCT03287791|465054923|FG000|Overall Study|Non-compliance|0|||
129206702|NCT03287791|465054924|FG001|Overall Study|Non-compliance|1|||
129206703|NCT03287791|465054925|FG002|Overall Study|Non-compliance|0|||
129206704|NCT03287791|465054923|FG000|Overall Study|Did not meet inclusion criteria|1|||
129206705|NCT03287791|465054924|FG001|Overall Study|Did not meet inclusion criteria|0|||
129206706|NCT03287791|465054925|FG002|Overall Study|Did not meet inclusion criteria|0|||
129206707|NCT03095651|465054927|FG000|Overall Study|Lost to Follow-up|1|||
129206708|NCT03095651|465054928|FG001|Overall Study|Lost to Follow-up|1|||
129206709|NCT03095651|465054929|FG002|Overall Study|Lost to Follow-up|0|||
129206710|NCT03095651|465054930|FG003|Overall Study|Lost to Follow-up|1|||
129206711|NCT03095651|465054931|FG004|Overall Study|Lost to Follow-up|0|||
129206712|NCT03095651|465054932|FG005|Overall Study|Lost to Follow-up|0|||
129206713|NCT03095651|465054933|FG006|Overall Study|Lost to Follow-up|0|||
129206714|NCT03095651|465054934|FG007|Overall Study|Lost to Follow-up|0|||
129206715|NCT03095651|465054927|FG000|Overall Study|Withdrawal by Subject|0|||
129206716|NCT03095651|465054928|FG001|Overall Study|Withdrawal by Subject|0|||
129206717|NCT03095651|465054929|FG002|Overall Study|Withdrawal by Subject|0|||
129206718|NCT03095651|465054930|FG003|Overall Study|Withdrawal by Subject|0|||
129206719|NCT03095651|465054931|FG004|Overall Study|Withdrawal by Subject|0|||
129206720|NCT03095651|465054932|FG005|Overall Study|Withdrawal by Subject|1|||
129206721|NCT03095651|465054933|FG006|Overall Study|Withdrawal by Subject|0|||
129206722|NCT03095651|465054934|FG007|Overall Study|Withdrawal by Subject|0|||
129206723|NCT04247347|465054941|FG000|Overall Study|Withdrawal by Subject|2|||
129206724|NCT04247347|465054942|FG001|Overall Study|Withdrawal by Subject|3|||
129094333|NCT00793624|464636116|FG001|Overall Study|Non compliance with protocol|3|||
129094334|NCT00793624|464636117|FG002|Overall Study|Non compliance with protocol|2|||
129206725|NCT04247347|465054943|FG002|Overall Study|Withdrawal by Subject|3|||
129206726|NCT04247347|465054941|FG000|Overall Study|Lost to Follow-up|1|||
129206727|NCT04247347|465054942|FG001|Overall Study|Lost to Follow-up|1|||
129206728|NCT04247347|465054943|FG002|Overall Study|Lost to Follow-up|1|||
129206729|NCT03562195|465054944|FG000|Overall Study|Adverse Event|0|||
129206730|NCT03562195|465054945|FG001|Overall Study|Adverse Event|6|||
129206731|NCT03562195|465054944|FG000|Overall Study|Lack of Efficacy|0|||
129206732|NCT03562195|465054945|FG001|Overall Study|Lack of Efficacy|5|||
129206733|NCT03562195|465054944|FG000|Overall Study|Protocol Violation|0|||
129206734|NCT03562195|465054945|FG001|Overall Study|Protocol Violation|1|||
129206735|NCT03562195|465054944|FG000|Overall Study|Lost to Follow-up|0|||
129206736|NCT03562195|465054945|FG001|Overall Study|Lost to Follow-up|1|||
129206737|NCT03562195|465054944|FG000|Overall Study|Physician Decision|1|||
129206738|NCT03562195|465054945|FG001|Overall Study|Physician Decision|0|||
129206739|NCT03562195|465054944|FG000|Overall Study|Withdrawal by Subject|3|||
129206740|NCT03562195|465054945|FG001|Overall Study|Withdrawal by Subject|0|||
129206741|NCT02529852|465054946|FG000|Overall Study|Withdrawal by Subject|2|||
129206742|NCT04664153|465054951|FG000|Overall Study|Lack of Efficacy|0|||
129206743|NCT04664153|465054952|FG001|Overall Study|Lack of Efficacy|0|||
129206744|NCT04664153|465054953|FG002|Overall Study|Lack of Efficacy|1|||
129206745|NCT04664153|465054954|FG003|Overall Study|Lack of Efficacy|0|||
129206746|NCT04664153|465054951|FG000|Overall Study|Physician Decision|0|||
129206747|NCT04664153|465054952|FG001|Overall Study|Physician Decision|0|||
129206748|NCT04664153|465054953|FG002|Overall Study|Physician Decision|1|||
129206749|NCT04664153|465054954|FG003|Overall Study|Physician Decision|0|||
129206750|NCT04664153|465054951|FG000|Overall Study|Withdrawal by Subject|3|||
129206751|NCT04664153|465054952|FG001|Overall Study|Withdrawal by Subject|2|||
129206752|NCT04664153|465054953|FG002|Overall Study|Withdrawal by Subject|1|||
129206753|NCT04664153|465054954|FG003|Overall Study|Withdrawal by Subject|2|||
129206754|NCT04664153|465054951|FG000|Overall Study|Other|0|||
129206755|NCT04664153|465054952|FG001|Overall Study|Other|1|||
129206756|NCT04664153|465054953|FG002|Overall Study|Other|0|||
129206757|NCT04664153|465054954|FG003|Overall Study|Other|0|||
129206758|NCT04664153|465054951|FG000|Overall Study|Adverse Event|4|||
129206759|NCT04664153|465054952|FG001|Overall Study|Adverse Event|0|||
129206760|NCT04664153|465054953|FG002|Overall Study|Adverse Event|1|||
129206761|NCT04664153|465054954|FG003|Overall Study|Adverse Event|0|||
129206762|NCT00097500|465054955|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
129206763|NCT00097500|465054956|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
129206764|NCT00097500|465054955|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
129206765|NCT00097500|465054956|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
129206766|NCT00097500|465054955|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
129206767|NCT00097500|465054956|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
129206768|NCT00097500|465054955|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129206769|NCT00097500|465054956|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
129206770|NCT00097500|465054955|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
129206771|NCT00097500|465054956|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
129206772|NCT00097500|465054955|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
129206773|NCT00097500|465054956|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
129206774|NCT00097500|465054955|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
129206775|NCT00097500|465054956|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
129206776|NCT00642356|465054962|FG000|Overall Study|Adverse Event|1|||
129206777|NCT00642356|465054963|FG001|Overall Study|Adverse Event|0|||
129206778|NCT00642356|465054962|FG000|Overall Study|Protocol Violation|0|||
129206779|NCT00642356|465054963|FG001|Overall Study|Protocol Violation|3|||
129206780|NCT00642356|465054962|FG000|Overall Study|Lack of Efficacy|1|||
129206781|NCT00642356|465054963|FG001|Overall Study|Lack of Efficacy|0|||
129206782|NCT01009060|465054964|FG000|Overall Study|Adverse Event|1|||
129206783|NCT01009060|465054965|FG001|Overall Study|Adverse Event|2|||
129206784|NCT01009060|465054964|FG000|Overall Study|Protocol Violation|0|||
129206785|NCT01009060|465054965|FG001|Overall Study|Protocol Violation|1|||
129206786|NCT01009060|465054964|FG000|Overall Study|Lost to Follow-up|1|||
129206787|NCT01009060|465054965|FG001|Overall Study|Lost to Follow-up|0|||
129206788|NCT01009060|465054964|FG000|Overall Study|Physician Decision|1|||
129206789|NCT01009060|465054965|FG001|Overall Study|Physician Decision|1|||
129206790|NCT01009060|465054964|FG000|Overall Study|Withdrawal by Subject|1|||
129206791|NCT01009060|465054965|FG001|Overall Study|Withdrawal by Subject|1|||
129206792|NCT00265564|465054966|FG000|Overall Study|Lost to Follow-up|5|||
128982454|NCT02451137|464221161|FG001|Overall Study|Adverse Event|42|||
128982455|NCT02451137|464221160|FG000|Overall Study|Lack of Efficacy|4|||
128982456|NCT02451137|464221161|FG001|Overall Study|Lack of Efficacy|9|||
128982457|NCT02451137|464221160|FG000|Overall Study|Participant decision:discontinue insulin|41|||
129206793|NCT00265564|465054967|FG001|Overall Study|Lost to Follow-up|7|||
129206794|NCT00265564|465054966|FG000|Overall Study|met exclusion criteria|5|||
129206795|NCT00265564|465054967|FG001|Overall Study|met exclusion criteria|2|||
129206796|NCT00286442|465054972|FG000|Overall Study|Hyperglycemic Rescue|19|||
129206797|NCT00286442|465054973|FG001|Overall Study|Hyperglycemic Rescue|17|||
129206798|NCT00286442|465054974|FG002|Overall Study|Hyperglycemic Rescue|25|||
129206799|NCT00286442|465054972|FG000|Overall Study|Adverse Event|7|||
129206800|NCT00286442|465054973|FG001|Overall Study|Adverse Event|6|||
129206801|NCT00286442|465054974|FG002|Overall Study|Adverse Event|1|||
129206802|NCT00286442|465054972|FG000|Overall Study|Protocol Violation|2|||
129206803|NCT00286442|465054973|FG001|Overall Study|Protocol Violation|4|||
129206804|NCT00286442|465054974|FG002|Overall Study|Protocol Violation|2|||
129206805|NCT00286442|465054972|FG000|Overall Study|Lost to Follow-up|5|||
129206806|NCT00286442|465054973|FG001|Overall Study|Lost to Follow-up|2|||
129206807|NCT00286442|465054974|FG002|Overall Study|Lost to Follow-up|1|||
129206808|NCT00286442|465054972|FG000|Overall Study|Physician Decision|1|||
129206809|NCT00286442|465054973|FG001|Overall Study|Physician Decision|1|||
129206810|NCT00286442|465054974|FG002|Overall Study|Physician Decision|1|||
129206811|NCT00286442|465054972|FG000|Overall Study|Administrative Error|1|||
129206812|NCT00286442|465054973|FG001|Overall Study|Administrative Error|1|||
129206813|NCT00286442|465054974|FG002|Overall Study|Administrative Error|0|||
128760552|NCT02277990|463412875|FG001|Overall Study|Death|188|||
128760553|NCT02277990|463412874|FG000|Overall Study|Withdrawal by Subject|64|||
128760554|NCT02277990|463412875|FG001|Overall Study|Withdrawal by Subject|53|||
128760555|NCT02277990|463412874|FG000|Overall Study|Physician Decision|40|||
128760556|NCT02277990|463412875|FG001|Overall Study|Physician Decision|34|||
128760557|NCT02277990|463412874|FG000|Overall Study|Lost to Follow-up|66|||
128760558|NCT02277990|463412875|FG001|Overall Study|Lost to Follow-up|69|||
128760559|NCT02277990|463412874|FG000|Overall Study|Had other reason|26|||
128760560|NCT02277990|463412875|FG001|Overall Study|Had other reason|32|||
128760561|NCT04711603|463412876|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
128760562|NCT04711603|463412877|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
128760563|NCT04711603|463412878|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
128760564|NCT04711603|463412879|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
128760565|NCT04711603|463412876|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
128760566|NCT04711603|463412877|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
128760567|NCT04711603|463412878|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
128760568|NCT04711603|463412879|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
128760569|NCT04711603|463412876|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
128760570|NCT04711603|463412877|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
128760571|NCT04711603|463412878|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
128760572|NCT04711603|463412879|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
128760573|NCT04711603|463412876|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
128760574|NCT04711603|463412877|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
128760575|NCT04711603|463412878|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
128760576|NCT04711603|463412879|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
128760577|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
128760578|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
128760579|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
128760580|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
128760581|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
128760582|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
128760583|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
128760584|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
128760585|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
128760586|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
128760587|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
128760588|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
128760589|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
128760590|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
128760591|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
128760592|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
128760593|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
128760594|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
128760595|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
128760596|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
128760597|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
128760598|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
128760599|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
128760600|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
128760601|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
128760602|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
128774770|NCT01216293|463466660|FG000|Main Study|Randomized, Not Treated|1|||
128760603|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
128760604|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
128982458|NCT02451137|464221161|FG001|Overall Study|Participant decision:discontinue insulin|43|||
128982459|NCT02451137|464221160|FG000|Overall Study|Hypoglycemia|2|||
128982460|NCT02451137|464221161|FG001|Overall Study|Hypoglycemia|1|||
128982461|NCT02451137|464221160|FG000|Overall Study|Investigator's decision|23|||
128760605|NCT04711603|463412876|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
128760606|NCT04711603|463412877|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
128760607|NCT04711603|463412878|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
128760608|NCT04711603|463412879|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
128760609|NCT04270747|463412884|FG000|Through Week 16|Adverse Event|1|||
128760610|NCT04270747|463412885|FG001|Through Week 16|Adverse Event|2|||
128760611|NCT04270747|463412886|FG002|Through Week 16|Adverse Event|0|||
128760612|NCT04270747|463412884|FG000|Through Week 16|Death|0|||
128760613|NCT04270747|463412885|FG001|Through Week 16|Death|2|||
128760614|NCT04270747|463412886|FG002|Through Week 16|Death|0|||
128760615|NCT04270747|463412884|FG000|Through Week 16|Consent Withdrawn|3|||
128760616|NCT04270747|463412885|FG001|Through Week 16|Consent Withdrawn|3|||
128760617|NCT04270747|463412886|FG002|Through Week 16|Consent Withdrawn|0|||
128760618|NCT04270747|463412884|FG000|Through Week 16|Physician Decision|1|||
128760619|NCT04270747|463412885|FG001|Through Week 16|Physician Decision|1|||
128760620|NCT04270747|463412886|FG002|Through Week 16|Physician Decision|0|||
128760621|NCT04270747|463412884|FG000|Through Week 16|Lost to Follow-up|2|||
128760622|NCT04270747|463412885|FG001|Through Week 16|Lost to Follow-up|0|||
128760623|NCT04270747|463412886|FG002|Through Week 16|Lost to Follow-up|0|||
128760624|NCT04270747|463412884|FG000|Through Week 16|Protocol Violation|1|||
128760625|NCT04270747|463412885|FG001|Through Week 16|Protocol Violation|2|||
128760626|NCT04270747|463412886|FG002|Through Week 16|Protocol Violation|0|||
128760627|NCT04270747|463412884|FG000|Through Week 16|Protocol Specified Criteria|6|||
128760628|NCT04270747|463412885|FG001|Through Week 16|Protocol Specified Criteria|7|||
128760629|NCT04270747|463412886|FG002|Through Week 16|Protocol Specified Criteria|0|||
128760630|NCT04270747|463412884|FG000|Through Week 16|Miscellaneous|1|||
128760631|NCT04270747|463412885|FG001|Through Week 16|Miscellaneous|1|||
128760632|NCT04270747|463412886|FG002|Through Week 16|Miscellaneous|0|||
128760633|NCT04270747|463412884|FG000|Post Week 16|Adverse Event|7|||
128760634|NCT04270747|463412885|FG001|Post Week 16|Adverse Event|5|||
128760635|NCT04270747|463412886|FG002|Post Week 16|Adverse Event|1|||
128760636|NCT04270747|463412884|FG000|Post Week 16|Death|2|||
128760637|NCT04270747|463412885|FG001|Post Week 16|Death|0|||
128760638|NCT04270747|463412886|FG002|Post Week 16|Death|2|||
128760639|NCT04270747|463412884|FG000|Post Week 16|Consent Withdrawn|4|||
128760640|NCT04270747|463412885|FG001|Post Week 16|Consent Withdrawn|3|||
128760641|NCT04270747|463412886|FG002|Post Week 16|Consent Withdrawn|6|||
128760642|NCT04270747|463412884|FG000|Post Week 16|Physician Decision|3|||
128760643|NCT04270747|463412885|FG001|Post Week 16|Physician Decision|1|||
128760644|NCT04270747|463412886|FG002|Post Week 16|Physician Decision|1|||
128760645|NCT04270747|463412884|FG000|Post Week 16|Lost to Follow-up|2|||
128760646|NCT04270747|463412885|FG001|Post Week 16|Lost to Follow-up|1|||
128760647|NCT04270747|463412886|FG002|Post Week 16|Lost to Follow-up|0|||
128760648|NCT04270747|463412884|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
128760649|NCT04270747|463412885|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
128760650|NCT04270747|463412886|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
128760651|NCT04270747|463412884|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
128760652|NCT04270747|463412885|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
128760653|NCT04270747|463412886|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
128760654|NCT04270747|463412884|FG000|Post Week 16|Miscellaneous|1|||
128760655|NCT04270747|463412885|FG001|Post Week 16|Miscellaneous|0|||
128760656|NCT04270747|463412886|FG002|Post Week 16|Miscellaneous|1|||
128760657|NCT05614089|463412888|FG000|Overall Study|Pregnancy|5|||
128760658|NCT05614089|463412889|FG001|Overall Study|Pregnancy|2|||
128760659|NCT05614089|463412888|FG000|Overall Study|Lost to Follow-up|5|||
128760660|NCT05614089|463412889|FG001|Overall Study|Lost to Follow-up|1|||
128760661|NCT05614089|463412888|FG000|Overall Study|Death|0|||
128760662|NCT05614089|463412889|FG001|Overall Study|Death|1|||
128760663|NCT05614089|463412888|FG000|Overall Study|Adverse Event|1|||
128760664|NCT05614089|463412889|FG001|Overall Study|Adverse Event|0|||
128760665|NCT00701038|463412901|FG000|Overall Study|study amended pilot group of patients|4|||
128760666|NCT00701038|463412902|FG001|Overall Study|study amended pilot group of patients|4|||
128760667|NCT01064297|463412905|FG000|Overall Study|Lost to Follow-up|791|||
128760668|NCT01064297|463412906|FG001|Overall Study|Lost to Follow-up|48|||
128760669|NCT01064297|463412907|FG002|Overall Study|Lost to Follow-up|133|||
128760670|NCT04992546|463412912|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
128760671|NCT04992546|463412912|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
128760672|NCT04992546|463412912|FG000|Open-Label Treatment Period|Adverse Event|3|||
128760673|NCT04992546|463412912|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
128760674|NCT04058353|463412916|FG000|Overall Study|Adverse Event|2|||
128760675|NCT04058353|463412917|FG001|Overall Study|Adverse Event|1|||
128760676|NCT04058353|463412916|FG000|Overall Study|Physician Decision|1|||
128760677|NCT04058353|463412917|FG001|Overall Study|Physician Decision|0|||
128760678|NCT04058353|463412916|FG000|Overall Study|Other|1|||
128760679|NCT04058353|463412917|FG001|Overall Study|Other|0|||
128760680|NCT02618616|463412918|FG000|Overall Study|Lack of Efficacy|4|||
128760681|NCT02618616|463412919|FG001|Overall Study|Lack of Efficacy|0|||
128760682|NCT02618616|463412918|FG000|Overall Study|Pregnancy|0|||
128760683|NCT02618616|463412919|FG001|Overall Study|Pregnancy|1|||
128760684|NCT02618616|463412918|FG000|Overall Study|Adverse Event|8|||
128760685|NCT02618616|463412919|FG001|Overall Study|Adverse Event|0|||
128760686|NCT02618616|463412918|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
128760687|NCT02618616|463412919|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
128760688|NCT02618616|463412918|FG000|Overall Study|Consent withdrawn by subject|8|||
128760689|NCT02618616|463412919|FG001|Overall Study|Consent withdrawn by subject|5|||
128760690|NCT02618616|463412918|FG000|Overall Study|Lost to Follow-up|0|||
128760691|NCT02618616|463412919|FG001|Overall Study|Lost to Follow-up|1|||
128760692|NCT04225988|463412921|FG000|Overall Study|Withdrawal by Subject|2|||
128760693|NCT04225988|463412922|FG001|Overall Study|Withdrawal by Subject|0|||
128760694|NCT03444376|463412929|FG000|Part A|Disease relapse or Progression|1|||
128760695|NCT03444376|463412929|FG000|Part A|Withdrawal by Subject|2|||
128760696|NCT03444376|463412929|FG000|Part A|Adverse Event|1|||
128760697|NCT03444376|463412929|FG000|Part B|Disease relapse or Progression|18|||
128760698|NCT03444376|463412929|FG000|Part B|Withdrawal by Subject|2|||
128760699|NCT03444376|463412929|FG000|Part B|Adverse Event|2|||
128760700|NCT03444376|463412929|FG000|Part B|Physician Decision|1|||
128760701|NCT03444376|463412929|FG000|Part C|Disease relapse or Progression|43|||
128760702|NCT03444376|463412929|FG000|Part C|Withdrawal by Subject|5|||
128760703|NCT03444376|463412929|FG000|Part C|Adverse Event|2|||
128760704|NCT03444376|463412929|FG000|Part C|Physician Decision|2|||
128760705|NCT03444376|463412929|FG000|Part C|Death|1|||
128760706|NCT00766675|463414580|FG000|Overall Study|Adverse Event|16|||
128760707|NCT00766675|463414580|FG000|Overall Study|Lost to Follow-up|2|||
128760708|NCT00766675|463414580|FG000|Overall Study|Withdrawal by Subject|11|||
128760709|NCT00766675|463414580|FG000|Overall Study|Protocol Violation|8|||
128760710|NCT00766675|463414580|FG000|Overall Study|Participant took prohibited medication|1|||
128760711|NCT00766675|463414580|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
128760712|NCT00766675|463414580|FG000|Overall Study|Insufficient therapy|1|||
128760713|NCT00847405|463414581|FG000|First Intervention|Adverse Event|0|||
128760714|NCT00847405|463414582|FG001|First Intervention|Adverse Event|1|||
128760715|NCT00847405|463414581|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
128760716|NCT00847405|463414582|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
128760717|NCT01352585|463414583|FG000|Overall Study|Adverse Event|2|||
128760718|NCT01352585|463414584|FG001|Overall Study|Adverse Event|1|||
128760719|NCT01352585|463414583|FG000|Overall Study|Lost to Follow-up|1|||
128760720|NCT01352585|463414584|FG001|Overall Study|Lost to Follow-up|0|||
128760721|NCT01352585|463414583|FG000|Overall Study|Other|5|||
128760722|NCT01352585|463414584|FG001|Overall Study|Other|2|||
128760723|NCT03928028|463414587|FG000|Overall Study|Physician Decision|9|||
128760724|NCT03928028|463414588|FG001|Overall Study|Physician Decision|6|||
128760725|NCT03928028|463414589|FG002|Overall Study|Physician Decision|3|||
128760726|NCT03928028|463414587|FG000|Overall Study|Withdrawal by Subject|12|||
128760727|NCT03928028|463414588|FG001|Overall Study|Withdrawal by Subject|3|||
128760728|NCT03928028|463414589|FG002|Overall Study|Withdrawal by Subject|3|||
128760729|NCT02710292|463414590|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
128760730|NCT02710292|463414591|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
128760731|NCT02710292|463414590|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
128760732|NCT02710292|463414591|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
128760733|NCT04525547|463414592|FG000|Overall Study|Not treated with Ofev|2|||
128760734|NCT04525547|463414592|FG000|Overall Study|Off-label use|2|||
128760735|NCT04525547|463414592|FG000|Overall Study|Lost to Follow-up|1|||
128760736|NCT00800202|463414593|FG000|Overall Study|Adverse Event|7|||
128760737|NCT00800202|463414594|FG001|Overall Study|Adverse Event|6|||
128760738|NCT00800202|463414593|FG000|Overall Study|Death|1|||
128760739|NCT00800202|463414594|FG001|Overall Study|Death|0|||
128760740|NCT00800202|463414593|FG000|Overall Study|Other|5|||
128760741|NCT00800202|463414594|FG001|Overall Study|Other|0|||
128760742|NCT00800202|463414593|FG000|Overall Study|Disease Progression|54|||
128760743|NCT00800202|463414594|FG001|Overall Study|Disease Progression|18|||
128760744|NCT04425902|463414595|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
128760745|NCT02901626|463414601|FG000|Overall Study|Lost to Follow-up|1|||
128760746|NCT02901626|463414602|FG001|Overall Study|Lost to Follow-up|1|||
128760747|NCT00331344|463414603|FG000|Phase I|Adverse Event|0|||
128760748|NCT00331344|463414604|FG001|Phase I|Adverse Event|0|||
128760749|NCT00331344|463414605|FG002|Phase I|Adverse Event|0|||
128760750|NCT00331344|463414606|FG003|Phase I|Adverse Event|1|||
128760751|NCT00331344|463414607|FG004|Phase I|Adverse Event|2|||
128760752|NCT00331344|463414608|FG005|Phase I|Adverse Event|2|||
128760753|NCT00331344|463414609|FG006|Phase I|Adverse Event|0|||
128760754|NCT00331344|463414610|FG007|Phase I|Adverse Event|1|||
128760755|NCT00331344|463414611|FG008|Phase I|Adverse Event|0|||
128760756|NCT00331344|463414603|FG000|Phase II|Death|0|||
128760757|NCT00331344|463414604|FG001|Phase II|Death|0|||
128760758|NCT00331344|463414605|FG002|Phase II|Death|0|||
128760759|NCT00331344|463414606|FG003|Phase II|Death|0|||
128760760|NCT00331344|463414607|FG004|Phase II|Death|0|||
128760761|NCT00331344|463414608|FG005|Phase II|Death|0|||
128760762|NCT00331344|463414609|FG006|Phase II|Death|0|||
128760763|NCT00331344|463414610|FG007|Phase II|Death|0|||
128760764|NCT00331344|463414611|FG008|Phase II|Death|4|||
128760765|NCT01373931|463414612|FG000|Lead-in Period|Adverse Event|2|||
128760766|NCT01373931|463414613|FG001|Lead-in Period|Adverse Event|0|||
128760767|NCT01373931|463414612|FG000|Period 1|Adverse Event|2|||
128760768|NCT01373931|463414613|FG001|Period 1|Adverse Event|0|||
128760769|NCT01373931|463414612|FG000|Period 1|Withdrawal by Subject|0|||
128760770|NCT01373931|463414613|FG001|Period 1|Withdrawal by Subject|2|||
128760771|NCT04857034|463414614|FG000|Placebo-Controlled Period|Request to discontinue|2|||
128760772|NCT04857034|463414615|FG001|Placebo-Controlled Period|Request to discontinue|2|||
128760773|NCT04857034|463414616|FG002|Placebo-Controlled Period|Request to discontinue|0|||
128760774|NCT04857034|463414617|FG003|Placebo-Controlled Period|Request to discontinue|0|||
128760775|NCT04857034|463414618|FG004|Placebo-Controlled Period|Request to discontinue|0|||
128760776|NCT04857034|463414614|FG000|Placebo-Controlled Period|withdrew consent|1|||
128760777|NCT04857034|463414615|FG001|Placebo-Controlled Period|withdrew consent|1|||
128760778|NCT04857034|463414616|FG002|Placebo-Controlled Period|withdrew consent|2|||
128760779|NCT04857034|463414617|FG003|Placebo-Controlled Period|withdrew consent|0|||
128760780|NCT04857034|463414618|FG004|Placebo-Controlled Period|withdrew consent|0|||
128760781|NCT04857034|463414614|FG000|Placebo-Controlled Period|Pregnancy|1|||
128760782|NCT04857034|463414615|FG001|Placebo-Controlled Period|Pregnancy|1|||
128760783|NCT04857034|463414616|FG002|Placebo-Controlled Period|Pregnancy|0|||
128760784|NCT04857034|463414617|FG003|Placebo-Controlled Period|Pregnancy|0|||
128760785|NCT04857034|463414618|FG004|Placebo-Controlled Period|Pregnancy|0|||
128760786|NCT04857034|463414614|FG000|Placebo-Controlled Period|Ongoing study period|0|||
128760787|NCT04857034|463414615|FG001|Placebo-Controlled Period|Ongoing study period|1|||
128760788|NCT04857034|463414616|FG002|Placebo-Controlled Period|Ongoing study period|0|||
128760789|NCT04857034|463414617|FG003|Placebo-Controlled Period|Ongoing study period|0|||
128760790|NCT04857034|463414618|FG004|Placebo-Controlled Period|Ongoing study period|0|||
128760791|NCT04857034|463414614|FG000|Active Treatment Period|Lack of Efficacy|1|||
128760792|NCT04857034|463414615|FG001|Active Treatment Period|Lack of Efficacy|0|||
128760793|NCT04857034|463414616|FG002|Active Treatment Period|Lack of Efficacy|0|||
128760794|NCT04857034|463414617|FG003|Active Treatment Period|Lack of Efficacy|0|||
128760795|NCT04857034|463414618|FG004|Active Treatment Period|Lack of Efficacy|0|||
128760796|NCT04857034|463414614|FG000|Active Treatment Period|request to discontinue|0|||
128760797|NCT04857034|463414615|FG001|Active Treatment Period|request to discontinue|1|||
128760798|NCT04857034|463414616|FG002|Active Treatment Period|request to discontinue|0|||
128760799|NCT04857034|463414617|FG003|Active Treatment Period|request to discontinue|1|||
128760800|NCT04857034|463414618|FG004|Active Treatment Period|request to discontinue|0|||
128760801|NCT04857034|463414614|FG000|Active Treatment Period|administrative reason by sponsor|1|||
128760802|NCT04857034|463414615|FG001|Active Treatment Period|administrative reason by sponsor|5|||
128760803|NCT04857034|463414616|FG002|Active Treatment Period|administrative reason by sponsor|0|||
128760804|NCT04857034|463414617|FG003|Active Treatment Period|administrative reason by sponsor|2|||
128760805|NCT04857034|463414618|FG004|Active Treatment Period|administrative reason by sponsor|2|||
128760806|NCT04857034|463414614|FG000|Active Treatment Period|other reasons|1|||
128760807|NCT04857034|463414615|FG001|Active Treatment Period|other reasons|1|||
128760808|NCT04857034|463414616|FG002|Active Treatment Period|other reasons|0|||
128760809|NCT04857034|463414617|FG003|Active Treatment Period|other reasons|0|||
128760810|NCT04857034|463414618|FG004|Active Treatment Period|other reasons|1|||
128760811|NCT04857034|463414614|FG000|Active Treatment Period|Ongoing Study Period|2|||
128760812|NCT04857034|463414615|FG001|Active Treatment Period|Ongoing Study Period|4|||
128760813|NCT04857034|463414616|FG002|Active Treatment Period|Ongoing Study Period|0|||
128760814|NCT04857034|463414617|FG003|Active Treatment Period|Ongoing Study Period|1|||
128760815|NCT04857034|463414618|FG004|Active Treatment Period|Ongoing Study Period|0|||
128760816|NCT00659490|463414619|FG000|Overall Study|Lost to Follow-up|2|||
128760817|NCT00659490|463414620|FG001|Overall Study|Lost to Follow-up|0|||
128760818|NCT00659490|463414621|FG002|Overall Study|Lost to Follow-up|1|||
128760819|NCT00827541|463414622|FG000|Overall Study|Exitus|1|||
128760820|NCT00827541|463414623|FG001|Overall Study|Exitus|8|||
128760821|NCT00827541|463414622|FG000|Overall Study|Other|1|||
128760822|NCT00827541|463414623|FG001|Overall Study|Other|3|||
128760823|NCT00827541|463414622|FG000|Overall Study|Pathogen not susceptible|1|||
128760824|NCT00827541|463414623|FG001|Overall Study|Pathogen not susceptible|0|||
128760825|NCT00827541|463414622|FG000|Overall Study|Lack of effectiveness|1|||
128760826|NCT00827541|463414623|FG001|Overall Study|Lack of effectiveness|0|||
128760827|NCT01649232|463414624|FG000|Overall Study|Physician Decision|2|||
128760828|NCT01649232|463414625|FG001|Overall Study|Physician Decision|0|||
128760829|NCT02228967|463414626|FG000|Overall Study|Lost to Follow-up|146|||
128760830|NCT02228967|463414627|FG001|Overall Study|Lost to Follow-up|142|||
128760831|NCT02228967|463414626|FG000|Overall Study|Withdrawal by Subject|13|||
128760832|NCT02228967|463414627|FG001|Overall Study|Withdrawal by Subject|18|||
128760833|NCT01059630|463414628|FG000|Overall Study|Death|100|||
128760834|NCT01059630|463414629|FG001|Overall Study|Death|84|||
128760835|NCT01059630|463414628|FG000|Overall Study|Lost to Follow-up|4|||
128760836|NCT01059630|463414629|FG001|Overall Study|Lost to Follow-up|1|||
128760837|NCT01059630|463414628|FG000|Overall Study|Physician Decision|2|||
128760838|NCT01059630|463414629|FG001|Overall Study|Physician Decision|4|||
128760839|NCT01059630|463414628|FG000|Overall Study|Withdrawal by Subject|21|||
128760840|NCT01059630|463414629|FG001|Overall Study|Withdrawal by Subject|14|||
128760841|NCT02889133|463414631|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
128760842|NCT02889133|463414632|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
128760843|NCT02889133|463414631|FG000|Completed Primary Outcome|Manufacturing error|3|||
128760844|NCT02889133|463414632|FG001|Completed Primary Outcome|Manufacturing error|8|||
128760845|NCT02889133|463414631|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
128760846|NCT02889133|463414632|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
128760847|NCT02889133|463414631|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
128760848|NCT02889133|463414632|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
128760849|NCT02889133|463414631|FG000|Completed Primary Outcome|Protocol Violation|1|||
128760850|NCT02889133|463414632|FG001|Completed Primary Outcome|Protocol Violation|0|||
128760851|NCT02889133|463414631|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
128760852|NCT02889133|463414632|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
128760853|NCT02889133|463414631|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
128760854|NCT02889133|463414632|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
128760855|NCT02889133|463414631|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
128760856|NCT02889133|463414632|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
128760857|NCT02889133|463414631|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
128760858|NCT02889133|463414632|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
128760859|NCT02889133|463414631|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
128760860|NCT02889133|463414632|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
128760861|NCT03351738|463414633|FG000|Overall Study|Withdrawal by Subject|0|||
128760862|NCT03351738|463414634|FG001|Overall Study|Withdrawal by Subject|1|||
128760863|NCT03351738|463414635|FG002|Overall Study|Withdrawal by Subject|0|||
128760864|NCT03351738|463414636|FG003|Overall Study|Withdrawal by Subject|1|||
128760865|NCT03351738|463414637|FG004|Overall Study|Withdrawal by Subject|0|||
128760866|NCT03351738|463414638|FG005|Overall Study|Withdrawal by Subject|0|||
128760867|NCT01375205|463414641|FG000|Overall Study|Lost to Follow-up|15|||
128760868|NCT01375205|463414642|FG001|Overall Study|Lost to Follow-up|12|||
128760869|NCT01375205|463414641|FG000|Overall Study|Withdrawal by Subject|6|||
128760870|NCT01375205|463414642|FG001|Overall Study|Withdrawal by Subject|1|||
128760871|NCT05687032|463414643|FG000|Treatment Phase|Adverse Event|13|||
128760872|NCT05687032|463414643|FG000|Treatment Phase|Death|1|||
128760873|NCT05687032|463414643|FG000|Treatment Phase|Physician Decision|3|||
128760874|NCT05687032|463414643|FG000|Treatment Phase|Progressive disease|9|||
128760875|NCT05687032|463414643|FG000|Treatment Phase|Withdrawal by Subject|5|||
128760876|NCT05687032|463414643|FG000|Follow-Up Phase|Death|16|||
128760877|NCT05687032|463414643|FG000|Follow-Up Phase|Ongoing|26|||
128760878|NCT05479604|463414646|FG000|Overall Study|Lost to Follow-up|1|||
128760879|NCT05479604|463414647|FG001|Overall Study|Lost to Follow-up|5|||
128760880|NCT03138733|463414648|FG000|Overall Study|Death|17|||
128760881|NCT03138733|463414649|FG001|Overall Study|Death|18|||
128760882|NCT03138733|463414648|FG000|Overall Study|Withdrawal by Subject|11|||
128760883|NCT03138733|463414649|FG001|Overall Study|Withdrawal by Subject|6|||
128760884|NCT03138733|463414648|FG000|Overall Study|Lost to Follow-up|3|||
128760885|NCT03138733|463414649|FG001|Overall Study|Lost to Follow-up|2|||
128760886|NCT03138733|463414648|FG000|Overall Study|Adverse Event|1|||
128760887|NCT03138733|463414649|FG001|Overall Study|Adverse Event|0|||
128760888|NCT03138733|463414648|FG000|Overall Study|Protocol Violation|1|||
128760889|NCT03138733|463414649|FG001|Overall Study|Protocol Violation|3|||
128760890|NCT03138733|463414648|FG000|Overall Study|Administrative or logistical reason|1|||
128760891|NCT03138733|463414649|FG001|Overall Study|Administrative or logistical reason|0|||
128760892|NCT03138733|463414648|FG000|Overall Study|The patient was transferred to another hospital|1|||
128760893|NCT03138733|463414649|FG001|Overall Study|The patient was transferred to another hospital|0|||
128760894|NCT00504426|463414654|FG000|Overall Study|Adverse Event|0|||
128760895|NCT00504426|463414655|FG001|Overall Study|Adverse Event|0|||
128760896|NCT00504426|463414656|FG002|Overall Study|Adverse Event|2|||
128760897|NCT00504426|463414657|FG003|Overall Study|Adverse Event|0|||
128760898|NCT00504426|463414654|FG000|Overall Study|Protocol Violation|1|||
128760899|NCT00504426|463414655|FG001|Overall Study|Protocol Violation|1|||
128760900|NCT00504426|463414656|FG002|Overall Study|Protocol Violation|2|||
128760901|NCT00504426|463414657|FG003|Overall Study|Protocol Violation|0|||
128760902|NCT00504426|463414654|FG000|Overall Study|Withdrawal by Subject|2|||
128760903|NCT00504426|463414655|FG001|Overall Study|Withdrawal by Subject|0|||
128760904|NCT00504426|463414656|FG002|Overall Study|Withdrawal by Subject|0|||
128760905|NCT00504426|463414657|FG003|Overall Study|Withdrawal by Subject|0|||
128760906|NCT00633464|463414659|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
128760907|NCT00633464|463414660|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
128760908|NCT00633464|463414659|FG000|Overall Study|Never Treated (Randomized in error)|0|||
128760909|NCT00633464|463414660|FG001|Overall Study|Never Treated (Randomized in error)|1|||
128760910|NCT02612064|463414661|FG000|Overall Study|Withdrawal by Subject|1|||
128760911|NCT02612064|463414662|FG001|Overall Study|Withdrawal by Subject|1|||
128760912|NCT02612064|463414661|FG000|Overall Study|Other|0|||
128760913|NCT02612064|463414662|FG001|Overall Study|Other|2|||
128760914|NCT01669798|463414663|FG000|Overall Study|Physician Decision|5|||
128760915|NCT00717860|463414665|FG000|Overall Study|Clinical adverse experience|5|||
128760916|NCT00717860|463414666|FG001|Overall Study|Clinical adverse experience|9|||
128760917|NCT00717860|463414665|FG000|Overall Study|Laboratory adverse experience|2|||
128760918|NCT00717860|463414666|FG001|Overall Study|Laboratory adverse experience|2|||
128760919|NCT00717860|463414665|FG000|Overall Study|Lack of Efficacy|7|||
128760920|NCT00717860|463414666|FG001|Overall Study|Lack of Efficacy|13|||
128760921|NCT00717860|463414665|FG000|Overall Study|Discontinued for other reason|6|||
128760922|NCT00717860|463414666|FG001|Overall Study|Discontinued for other reason|1|||
128760923|NCT00717860|463414665|FG000|Overall Study|Withdrew consent|7|||
128760924|NCT00717860|463414666|FG001|Overall Study|Withdrew consent|3|||
128760925|NCT00698646|463414667|FG000|Overall Study|Adverse Event|8|||
128760926|NCT00698646|463414668|FG001|Overall Study|Adverse Event|7|||
128760927|NCT00698646|463414669|FG002|Overall Study|Adverse Event|8|||
128760928|NCT00698646|463414667|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
128760929|NCT00698646|463414668|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
128760930|NCT00698646|463414669|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
128760931|NCT00698646|463414667|FG000|Overall Study|Protocol Deviation|6|||
128760932|NCT00698646|463414668|FG001|Overall Study|Protocol Deviation|2|||
128760933|NCT00698646|463414669|FG002|Overall Study|Protocol Deviation|3|||
128760934|NCT00698646|463414667|FG000|Overall Study|Withdrawal by Subject|10|||
128760935|NCT00698646|463414668|FG001|Overall Study|Withdrawal by Subject|11|||
128760936|NCT00698646|463414669|FG002|Overall Study|Withdrawal by Subject|8|||
128760937|NCT00698646|463414667|FG000|Overall Study|Lost to Follow-up|0|||
128760938|NCT00698646|463414668|FG001|Overall Study|Lost to Follow-up|0|||
128760939|NCT00698646|463414669|FG002|Overall Study|Lost to Follow-up|2|||
128760940|NCT00698646|463414667|FG000|Overall Study|Administrative problems|1|||
128760941|NCT00698646|463414668|FG001|Overall Study|Administrative problems|0|||
128760942|NCT00698646|463414669|FG002|Overall Study|Administrative problems|1|||
128760943|NCT00279201|463414670|FG000|Initiation|Death|1|||
128760944|NCT00279201|463414671|FG001|Initiation|Death|5|||
128760945|NCT00279201|463414672|FG002|Initiation|Death|0|||
128760946|NCT00279201|463414673|FG003|Initiation|Death|0|||
128760947|NCT00279201|463414674|FG004|Initiation|Death|0|||
128760948|NCT00279201|463414675|FG005|Initiation|Death|0|||
128760949|NCT00279201|463414670|FG000|Initiation|Adverse Event|6|||
128760950|NCT00279201|463414671|FG001|Initiation|Adverse Event|15|||
128760951|NCT00279201|463414672|FG002|Initiation|Adverse Event|0|||
128760952|NCT00279201|463414673|FG003|Initiation|Adverse Event|0|||
128760953|NCT00279201|463414674|FG004|Initiation|Adverse Event|0|||
128760954|NCT00279201|463414675|FG005|Initiation|Adverse Event|0|||
128760955|NCT00279201|463414670|FG000|Initiation|Lost to Follow-up|42|||
128760956|NCT00279201|463414671|FG001|Initiation|Lost to Follow-up|41|||
128760957|NCT00279201|463414672|FG002|Initiation|Lost to Follow-up|0|||
128760958|NCT00279201|463414673|FG003|Initiation|Lost to Follow-up|0|||
128760959|NCT00279201|463414674|FG004|Initiation|Lost to Follow-up|0|||
128760960|NCT00279201|463414675|FG005|Initiation|Lost to Follow-up|0|||
128760961|NCT00279201|463414670|FG000|Initiation|Entry Criteria Exclusion|7|||
128760962|NCT00279201|463414671|FG001|Initiation|Entry Criteria Exclusion|9|||
128760963|NCT00279201|463414672|FG002|Initiation|Entry Criteria Exclusion|0|||
128760964|NCT00279201|463414673|FG003|Initiation|Entry Criteria Exclusion|0|||
128760965|NCT00279201|463414674|FG004|Initiation|Entry Criteria Exclusion|0|||
128760966|NCT00279201|463414675|FG005|Initiation|Entry Criteria Exclusion|0|||
128760967|NCT00279201|463414670|FG000|Initiation|Protocol Violation|9|||
128760968|NCT00279201|463414671|FG001|Initiation|Protocol Violation|10|||
128760969|NCT00279201|463414672|FG002|Initiation|Protocol Violation|0|||
128760970|NCT00279201|463414673|FG003|Initiation|Protocol Violation|0|||
128760971|NCT00279201|463414674|FG004|Initiation|Protocol Violation|0|||
128760972|NCT00279201|463414675|FG005|Initiation|Protocol Violation|0|||
128760973|NCT00279201|463414670|FG000|Initiation|Withdrawal by Subject|35|||
128760974|NCT00279201|463414671|FG001|Initiation|Withdrawal by Subject|41|||
128760975|NCT00279201|463414672|FG002|Initiation|Withdrawal by Subject|0|||
128760976|NCT00279201|463414673|FG003|Initiation|Withdrawal by Subject|0|||
128760977|NCT00279201|463414674|FG004|Initiation|Withdrawal by Subject|0|||
128760978|NCT00279201|463414675|FG005|Initiation|Withdrawal by Subject|0|||
128760979|NCT00279201|463414670|FG000|Initiation|Physician Decision|15|||
128760980|NCT00279201|463414671|FG001|Initiation|Physician Decision|18|||
128760981|NCT00279201|463414672|FG002|Initiation|Physician Decision|0|||
128760982|NCT00279201|463414673|FG003|Initiation|Physician Decision|0|||
128760983|NCT00279201|463414674|FG004|Initiation|Physician Decision|0|||
128760984|NCT00279201|463414675|FG005|Initiation|Physician Decision|0|||
128760985|NCT00279201|463414670|FG000|Initiation|Sponsor Decision|13|||
128760986|NCT00279201|463414671|FG001|Initiation|Sponsor Decision|5|||
128760987|NCT00279201|463414672|FG002|Initiation|Sponsor Decision|0|||
128760988|NCT00279201|463414673|FG003|Initiation|Sponsor Decision|0|||
128760989|NCT00279201|463414674|FG004|Initiation|Sponsor Decision|0|||
128760990|NCT00279201|463414675|FG005|Initiation|Sponsor Decision|0|||
128760991|NCT00279201|463414670|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
128760992|NCT00279201|463414671|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
128760993|NCT00279201|463414672|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
128760994|NCT00279201|463414673|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
128760995|NCT00279201|463414674|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
128760996|NCT00279201|463414675|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
128760997|NCT00279201|463414670|FG000|Maintenance|Lack of Efficacy|32|||
128760998|NCT00279201|463414671|FG001|Maintenance|Lack of Efficacy|30|||
128760999|NCT00279201|463414672|FG002|Maintenance|Lack of Efficacy|0|||
128761000|NCT00279201|463414673|FG003|Maintenance|Lack of Efficacy|0|||
128761001|NCT00279201|463414674|FG004|Maintenance|Lack of Efficacy|0|||
128761002|NCT00279201|463414675|FG005|Maintenance|Lack of Efficacy|0|||
128761003|NCT00279201|463414670|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
128761004|NCT00279201|463414671|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
128761005|NCT00279201|463414672|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
128761006|NCT00279201|463414673|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
128761007|NCT00279201|463414674|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
128761008|NCT00279201|463414675|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
128761009|NCT00279201|463414670|FG000|Maintenance|Adverse Event|4|||
128761010|NCT00279201|463414671|FG001|Maintenance|Adverse Event|4|||
128761011|NCT00279201|463414672|FG002|Maintenance|Adverse Event|0|||
128761012|NCT00279201|463414673|FG003|Maintenance|Adverse Event|0|||
128761013|NCT00279201|463414674|FG004|Maintenance|Adverse Event|0|||
128761014|NCT00279201|463414675|FG005|Maintenance|Adverse Event|0|||
128761015|NCT00279201|463414670|FG000|Maintenance|Death|4|||
128761016|NCT00279201|463414671|FG001|Maintenance|Death|4|||
128761017|NCT00279201|463414672|FG002|Maintenance|Death|0|||
128761018|NCT00279201|463414673|FG003|Maintenance|Death|0|||
128761019|NCT00279201|463414674|FG004|Maintenance|Death|0|||
128761020|NCT00279201|463414675|FG005|Maintenance|Death|0|||
128761021|NCT00279201|463414670|FG000|Maintenance|Lost to Follow-up|17|||
128761022|NCT00279201|463414671|FG001|Maintenance|Lost to Follow-up|13|||
128761023|NCT00279201|463414672|FG002|Maintenance|Lost to Follow-up|0|||
128761024|NCT00279201|463414673|FG003|Maintenance|Lost to Follow-up|0|||
128761025|NCT00279201|463414674|FG004|Maintenance|Lost to Follow-up|0|||
128761026|NCT00279201|463414675|FG005|Maintenance|Lost to Follow-up|0|||
128761027|NCT00279201|463414670|FG000|Maintenance|Entry Criteria Exclusion|1|||
128982462|NCT02451137|464221161|FG001|Overall Study|Investigator's decision|19|||
128982463|NCT02451137|464221160|FG000|Overall Study|Lost to Follow-up|53|||
128982464|NCT02451137|464221161|FG001|Overall Study|Lost to Follow-up|61|||
128982465|NCT02451137|464221160|FG000|Overall Study|Physician Decision|6|||
128982466|NCT02451137|464221161|FG001|Overall Study|Physician Decision|5|||
128982467|NCT02451137|464221160|FG000|Overall Study|Sponsor decision|13|||
128982468|NCT02451137|464221161|FG001|Overall Study|Sponsor decision|25|||
128982469|NCT02451137|464221160|FG000|Overall Study|Withdrawal by Subject|40|||
128982470|NCT02451137|464221161|FG001|Overall Study|Withdrawal by Subject|63|||
128982471|NCT02451137|464221160|FG000|Overall Study|Other than specified above|2|||
128982472|NCT02451137|464221161|FG001|Overall Study|Other than specified above|3|||
128982473|NCT01977573|464221164|FG000|Overall Study|Adverse Event|7|||
128982474|NCT01977573|464221165|FG001|Overall Study|Adverse Event|0|||
128982475|NCT01977573|464221166|FG002|Overall Study|Adverse Event|2|||
128982476|NCT01977573|464221167|FG003|Overall Study|Adverse Event|1|||
128982477|NCT01977573|464221164|FG000|Overall Study|Lost to Follow-up|1|||
128982478|NCT01977573|464221165|FG001|Overall Study|Lost to Follow-up|0|||
128982479|NCT01977573|464221166|FG002|Overall Study|Lost to Follow-up|0|||
128982480|NCT01977573|464221167|FG003|Overall Study|Lost to Follow-up|1|||
128982481|NCT01977573|464221164|FG000|Overall Study|Physician Decision|1|||
128761028|NCT00279201|463414671|FG001|Maintenance|Entry Criteria Exclusion|4|||
128761029|NCT00279201|463414672|FG002|Maintenance|Entry Criteria Exclusion|0|||
128761030|NCT00279201|463414673|FG003|Maintenance|Entry Criteria Exclusion|0|||
128761031|NCT00279201|463414674|FG004|Maintenance|Entry Criteria Exclusion|0|||
128761032|NCT00279201|463414675|FG005|Maintenance|Entry Criteria Exclusion|0|||
128761033|NCT00279201|463414670|FG000|Maintenance|Protocol Violation|16|||
128761034|NCT00279201|463414671|FG001|Maintenance|Protocol Violation|24|||
128982482|NCT01977573|464221165|FG001|Overall Study|Physician Decision|0|||
128982483|NCT01977573|464221166|FG002|Overall Study|Physician Decision|0|||
128761035|NCT00279201|463414672|FG002|Maintenance|Protocol Violation|0|||
128761036|NCT00279201|463414673|FG003|Maintenance|Protocol Violation|0|||
128982484|NCT01977573|464221167|FG003|Overall Study|Physician Decision|0|||
128982485|NCT01977573|464221164|FG000|Overall Study|Protocol Violation|3|||
128982486|NCT01977573|464221165|FG001|Overall Study|Protocol Violation|1|||
128982487|NCT01977573|464221166|FG002|Overall Study|Protocol Violation|0|||
128761037|NCT00279201|463414674|FG004|Maintenance|Protocol Violation|0|||
128761038|NCT00279201|463414675|FG005|Maintenance|Protocol Violation|0|||
128761039|NCT00279201|463414670|FG000|Maintenance|Withdrawal by Subject|18|||
128761040|NCT00279201|463414671|FG001|Maintenance|Withdrawal by Subject|18|||
128761041|NCT00279201|463414672|FG002|Maintenance|Withdrawal by Subject|0|||
128761042|NCT00279201|463414673|FG003|Maintenance|Withdrawal by Subject|0|||
128761043|NCT00279201|463414674|FG004|Maintenance|Withdrawal by Subject|0|||
128982488|NCT01977573|464221167|FG003|Overall Study|Protocol Violation|0|||
128982489|NCT01977573|464221164|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
128982490|NCT01977573|464221165|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
128982491|NCT01977573|464221166|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
128982492|NCT01977573|464221167|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
128982493|NCT01977573|464221164|FG000|Overall Study|Withdrawal by Subject|6|||
128982494|NCT01977573|464221165|FG001|Overall Study|Withdrawal by Subject|1|||
128982495|NCT01977573|464221166|FG002|Overall Study|Withdrawal by Subject|1|||
128982496|NCT01977573|464221167|FG003|Overall Study|Withdrawal by Subject|1|||
128982497|NCT01266967|464222997|FG000|Overall Study|Death|69|||
128982498|NCT01266967|464222998|FG001|Overall Study|Death|61|||
128982499|NCT01266967|464222997|FG000|Overall Study|Study Closed/Terminated|15|||
128982500|NCT01266967|464222998|FG001|Overall Study|Study Closed/Terminated|17|||
128982501|NCT01266967|464222997|FG000|Overall Study|Lost to Follow-up|2|||
128982502|NCT01266967|464222998|FG001|Overall Study|Lost to Follow-up|1|||
128982503|NCT01266967|464222997|FG000|Overall Study|Physician Decision|0|||
128761044|NCT00279201|463414675|FG005|Maintenance|Withdrawal by Subject|0|||
128761045|NCT00279201|463414670|FG000|Maintenance|Physician Decision|9|||
128761046|NCT00279201|463414671|FG001|Maintenance|Physician Decision|9|||
128761047|NCT00279201|463414672|FG002|Maintenance|Physician Decision|0|||
128761048|NCT00279201|463414673|FG003|Maintenance|Physician Decision|0|||
128761049|NCT00279201|463414674|FG004|Maintenance|Physician Decision|0|||
128761050|NCT00279201|463414675|FG005|Maintenance|Physician Decision|0|||
128761051|NCT00279201|463414670|FG000|Maintenance|Sponsor Decision|4|||
128761052|NCT00279201|463414671|FG001|Maintenance|Sponsor Decision|0|||
128761053|NCT00279201|463414672|FG002|Maintenance|Sponsor Decision|0|||
128761054|NCT00279201|463414673|FG003|Maintenance|Sponsor Decision|0|||
128761055|NCT00279201|463414674|FG004|Maintenance|Sponsor Decision|0|||
128761056|NCT00279201|463414675|FG005|Maintenance|Sponsor Decision|0|||
128761057|NCT00279201|463414670|FG000|Maintenance|HbA1c>7.5%|123|||
128761058|NCT00279201|463414671|FG001|Maintenance|HbA1c>7.5%|126|||
128761059|NCT00279201|463414672|FG002|Maintenance|HbA1c>7.5%|0|||
128761060|NCT00279201|463414673|FG003|Maintenance|HbA1c>7.5%|0|||
128761061|NCT00279201|463414674|FG004|Maintenance|HbA1c>7.5%|0|||
128761062|NCT00279201|463414675|FG005|Maintenance|HbA1c>7.5%|0|||
128761063|NCT00279201|463414670|FG000|Intensification Addendum|Withdrawal by Subject|0|||
128761064|NCT00279201|463414671|FG001|Intensification Addendum|Withdrawal by Subject|0|||
128761065|NCT00279201|463414672|FG002|Intensification Addendum|Withdrawal by Subject|12|||
128761066|NCT00279201|463414673|FG003|Intensification Addendum|Withdrawal by Subject|14|||
128761067|NCT00279201|463414674|FG004|Intensification Addendum|Withdrawal by Subject|9|||
128761068|NCT00279201|463414675|FG005|Intensification Addendum|Withdrawal by Subject|18|||
128761069|NCT00279201|463414670|FG000|Intensification Addendum|Lost to Follow-up|0|||
128761070|NCT00279201|463414671|FG001|Intensification Addendum|Lost to Follow-up|0|||
128761071|NCT00279201|463414672|FG002|Intensification Addendum|Lost to Follow-up|4|||
128761072|NCT00279201|463414673|FG003|Intensification Addendum|Lost to Follow-up|6|||
128761073|NCT00279201|463414674|FG004|Intensification Addendum|Lost to Follow-up|7|||
128761074|NCT00279201|463414675|FG005|Intensification Addendum|Lost to Follow-up|7|||
128761075|NCT00279201|463414670|FG000|Intensification Addendum|Protocol Violation|0|||
128761076|NCT00279201|463414671|FG001|Intensification Addendum|Protocol Violation|0|||
128761077|NCT00279201|463414672|FG002|Intensification Addendum|Protocol Violation|2|||
128761078|NCT00279201|463414673|FG003|Intensification Addendum|Protocol Violation|2|||
128761079|NCT00279201|463414674|FG004|Intensification Addendum|Protocol Violation|6|||
128761080|NCT00279201|463414675|FG005|Intensification Addendum|Protocol Violation|6|||
128761081|NCT00279201|463414670|FG000|Intensification Addendum|Adverse Event|0|||
128761082|NCT00279201|463414671|FG001|Intensification Addendum|Adverse Event|0|||
128761083|NCT00279201|463414672|FG002|Intensification Addendum|Adverse Event|0|||
128761084|NCT00279201|463414673|FG003|Intensification Addendum|Adverse Event|4|||
128761085|NCT00279201|463414674|FG004|Intensification Addendum|Adverse Event|1|||
128761086|NCT00279201|463414675|FG005|Intensification Addendum|Adverse Event|3|||
128761087|NCT00279201|463414670|FG000|Intensification Addendum|Physician Decision|0|||
128761088|NCT00279201|463414671|FG001|Intensification Addendum|Physician Decision|0|||
128761089|NCT00279201|463414672|FG002|Intensification Addendum|Physician Decision|4|||
128761090|NCT00279201|463414673|FG003|Intensification Addendum|Physician Decision|1|||
128761091|NCT00279201|463414674|FG004|Intensification Addendum|Physician Decision|3|||
128761092|NCT00279201|463414675|FG005|Intensification Addendum|Physician Decision|2|||
128761093|NCT00279201|463414670|FG000|Intensification Addendum|Sponsor Decision|0|||
128761094|NCT00279201|463414671|FG001|Intensification Addendum|Sponsor Decision|0|||
128761095|NCT00279201|463414672|FG002|Intensification Addendum|Sponsor Decision|0|||
128761096|NCT00279201|463414673|FG003|Intensification Addendum|Sponsor Decision|0|||
128761097|NCT00279201|463414674|FG004|Intensification Addendum|Sponsor Decision|1|||
128982504|NCT01266967|464222998|FG001|Overall Study|Physician Decision|1|||
128761098|NCT00279201|463414675|FG005|Intensification Addendum|Sponsor Decision|1|||
128761099|NCT00279201|463414670|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
128761100|NCT00279201|463414671|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
128761101|NCT00279201|463414672|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
128761102|NCT00279201|463414673|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
128761103|NCT00279201|463414674|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
128761104|NCT00279201|463414675|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
128761105|NCT00279201|463414670|FG000|Intensification Addendum|Lack of Efficacy|0|||
128761106|NCT00279201|463414671|FG001|Intensification Addendum|Lack of Efficacy|0|||
128761107|NCT00279201|463414672|FG002|Intensification Addendum|Lack of Efficacy|0|||
128761108|NCT00279201|463414673|FG003|Intensification Addendum|Lack of Efficacy|1|||
128761109|NCT00279201|463414674|FG004|Intensification Addendum|Lack of Efficacy|1|||
128761110|NCT00279201|463414675|FG005|Intensification Addendum|Lack of Efficacy|0|||
128761111|NCT00279201|463414670|FG000|Intensification Addendum|Death|0|||
128761112|NCT00279201|463414671|FG001|Intensification Addendum|Death|0|||
128761113|NCT00279201|463414672|FG002|Intensification Addendum|Death|0|||
128761114|NCT00279201|463414673|FG003|Intensification Addendum|Death|0|||
128761115|NCT00279201|463414674|FG004|Intensification Addendum|Death|1|||
128761116|NCT00279201|463414675|FG005|Intensification Addendum|Death|0|||
128761117|NCT02390531|463414678|FG000|Overall Study|Death|0|||
128761118|NCT02390531|463414679|FG001|Overall Study|Death|2|||
128761119|NCT02390531|463414680|FG002|Overall Study|Death|0|||
128761120|NCT02390531|463414681|FG003|Overall Study|Death|1|||
128761121|NCT02390531|463414682|FG004|Overall Study|Death|0|||
128761122|NCT02390531|463414683|FG005|Overall Study|Death|0|||
128761123|NCT02390531|463414684|FG006|Overall Study|Death|0|||
128761124|NCT02390531|463414685|FG007|Overall Study|Death|1|||
128761125|NCT02390531|463414678|FG000|Overall Study|Protocol Violation|0|||
128761126|NCT02390531|463414679|FG001|Overall Study|Protocol Violation|0|||
128761127|NCT02390531|463414680|FG002|Overall Study|Protocol Violation|0|||
128761128|NCT02390531|463414681|FG003|Overall Study|Protocol Violation|0|||
128761129|NCT02390531|463414682|FG004|Overall Study|Protocol Violation|1|||
128761130|NCT02390531|463414683|FG005|Overall Study|Protocol Violation|0|||
128761131|NCT02390531|463414684|FG006|Overall Study|Protocol Violation|2|||
128761132|NCT02390531|463414685|FG007|Overall Study|Protocol Violation|0|||
128761133|NCT00511875|463414686|FG000|Overall Study|Lost to Follow-up|4|||
128761134|NCT00511875|463414687|FG001|Overall Study|Lost to Follow-up|0|||
128761135|NCT00511875|463414686|FG000|Overall Study|Missing variables|1|||
128761136|NCT00511875|463414687|FG001|Overall Study|Missing variables|0|||
128761137|NCT00542880|463414688|FG000|Period 1|Eligibility criteria not fulfilled|2|||
128761138|NCT00542880|463414689|FG001|Period 1|Eligibility criteria not fulfilled|6|||
128761139|NCT00542880|463414688|FG000|Period 1|Adverse Event|2|||
128761140|NCT00542880|463414689|FG001|Period 1|Adverse Event|2|||
128761141|NCT00542880|463414688|FG000|Period 1|Development of study-specific criteria|1|||
128761142|NCT00542880|463414689|FG001|Period 1|Development of study-specific criteria|2|||
128761143|NCT00542880|463414688|FG000|Period 1|Withdrawal by Subject|1|||
128761144|NCT00542880|463414689|FG001|Period 1|Withdrawal by Subject|1|||
128761145|NCT00542880|463414688|FG000|Period 1|Protocol Violation|0|||
128761146|NCT00542880|463414689|FG001|Period 1|Protocol Violation|1|||
128761147|NCT00542880|463414688|FG000|Period 2|Adverse Event|5|||
128761148|NCT00542880|463414689|FG001|Period 2|Adverse Event|7|||
128761149|NCT00542880|463414688|FG000|Period 2|Eligibility not fulfilled|0|||
128761150|NCT00542880|463414689|FG001|Period 2|Eligibility not fulfilled|1|||
128761151|NCT00542880|463414688|FG000|Period 2|Discontinuation criteria|2|||
128761152|NCT00542880|463414689|FG001|Period 2|Discontinuation criteria|0|||
128761153|NCT00542880|463414688|FG000|Period 2|Severe non-compliance|0|||
128761154|NCT00542880|463414689|FG001|Period 2|Severe non-compliance|1|||
128761155|NCT00542880|463414688|FG000|Period 2|Other|0|||
128761156|NCT00542880|463414689|FG001|Period 2|Other|1|||
128761157|NCT00542880|463414688|FG000|Period 3|Adverse Event|0|||
128761158|NCT00542880|463414689|FG001|Period 3|Adverse Event|2|||
128761159|NCT00696384|463414690|FG000|Open Label Phase|Adverse Event|27|||
128761160|NCT00696384|463414691|FG001|Open Label Phase|Adverse Event|0|||
128761161|NCT00696384|463414692|FG002|Open Label Phase|Adverse Event|0|||
128761162|NCT00696384|463414690|FG000|Open Label Phase|Protocol Violation|18|||
128761163|NCT00696384|463414691|FG001|Open Label Phase|Protocol Violation|0|||
128761164|NCT00696384|463414692|FG002|Open Label Phase|Protocol Violation|0|||
128761165|NCT00696384|463414690|FG000|Open Label Phase|Lost to Follow-up|24|||
128761166|NCT00696384|463414691|FG001|Open Label Phase|Lost to Follow-up|0|||
128761167|NCT00696384|463414692|FG002|Open Label Phase|Lost to Follow-up|0|||
128761168|NCT00696384|463414690|FG000|Open Label Phase|Withdrawal by Subject|37|||
128761169|NCT00696384|463414691|FG001|Open Label Phase|Withdrawal by Subject|0|||
128761170|NCT00696384|463414692|FG002|Open Label Phase|Withdrawal by Subject|0|||
128761171|NCT00696384|463414690|FG000|Open Label Phase|Other|6|||
128761172|NCT00696384|463414691|FG001|Open Label Phase|Other|0|||
128761173|NCT00696384|463414692|FG002|Open Label Phase|Other|0|||
128761174|NCT00696384|463414690|FG000|Open Label Phase|Lack of Efficacy|3|||
128761175|NCT00696384|463414691|FG001|Open Label Phase|Lack of Efficacy|0|||
128761176|NCT00696384|463414692|FG002|Open Label Phase|Lack of Efficacy|0|||
128761177|NCT00696384|463414690|FG000|Open Label Phase|Physician Decision|4|||
128761178|NCT00696384|463414691|FG001|Open Label Phase|Physician Decision|0|||
128761179|NCT00696384|463414692|FG002|Open Label Phase|Physician Decision|0|||
128761180|NCT00696384|463414690|FG000|Double Blind Phase|Adverse Event|0|||
128761181|NCT00696384|463414691|FG001|Double Blind Phase|Adverse Event|2|||
128761182|NCT00696384|463414692|FG002|Double Blind Phase|Adverse Event|2|||
128761183|NCT00696384|463414690|FG000|Double Blind Phase|Lost to Follow-up|0|||
128761184|NCT00696384|463414691|FG001|Double Blind Phase|Lost to Follow-up|2|||
128761185|NCT00696384|463414692|FG002|Double Blind Phase|Lost to Follow-up|1|||
128761186|NCT00696384|463414690|FG000|Double Blind Phase|Withdrawal by Subject|0|||
128761187|NCT00696384|463414691|FG001|Double Blind Phase|Withdrawal by Subject|4|||
128761188|NCT00696384|463414692|FG002|Double Blind Phase|Withdrawal by Subject|3|||
128761189|NCT00696384|463414690|FG000|Double Blind Phase|Lack of Efficacy|0|||
128761190|NCT00696384|463414691|FG001|Double Blind Phase|Lack of Efficacy|1|||
128761191|NCT00696384|463414692|FG002|Double Blind Phase|Lack of Efficacy|0|||
128761192|NCT00696384|463414690|FG000|Double Blind Phase|Physician Decision|0|||
128761193|NCT00696384|463414691|FG001|Double Blind Phase|Physician Decision|2|||
128761194|NCT00696384|463414692|FG002|Double Blind Phase|Physician Decision|0|||
128761195|NCT01678131|463414693|FG000|Overall Study|Adverse Event|0|||
128761196|NCT01678131|463414694|FG001|Overall Study|Adverse Event|1|||
128761197|NCT01678131|463414695|FG002|Overall Study|Adverse Event|0|||
128761198|NCT01678131|463414693|FG000|Overall Study|Withdrawal by Subject|0|||
128761199|NCT01678131|463414694|FG001|Overall Study|Withdrawal by Subject|0|||
128761200|NCT01678131|463414695|FG002|Overall Study|Withdrawal by Subject|2|||
128761201|NCT02027402|463414697|FG000|Overall Study|Withdrawal by Subject|4|||
128761202|NCT02027402|463414698|FG001|Overall Study|Withdrawal by Subject|1|||
128761203|NCT00941798|463414702|FG000|Overall Study|Withdrawal by Subject|72|||
128761204|NCT00941798|463414703|FG001|Overall Study|Withdrawal by Subject|74|||
128761205|NCT00941798|463414702|FG000|Overall Study|Adverse Event|43|||
128761206|NCT00941798|463414703|FG001|Overall Study|Adverse Event|23|||
128761207|NCT00941798|463414702|FG000|Overall Study|Lost to Follow-up|29|||
128761208|NCT00941798|463414703|FG001|Overall Study|Lost to Follow-up|23|||
128761209|NCT00941798|463414702|FG000|Overall Study|Protocol Violation|17|||
128761210|NCT00941798|463414703|FG001|Overall Study|Protocol Violation|20|||
128761211|NCT00941798|463414702|FG000|Overall Study|Administrative problems|13|||
128761212|NCT00941798|463414703|FG001|Overall Study|Administrative problems|23|||
128761213|NCT00941798|463414702|FG000|Overall Study|Lack of Efficacy|10|||
128761214|NCT00941798|463414703|FG001|Overall Study|Lack of Efficacy|17|||
128761215|NCT00941798|463414702|FG000|Overall Study|Patient's inability to use device|6|||
128761216|NCT00941798|463414703|FG001|Overall Study|Patient's inability to use device|1|||
128761217|NCT00941798|463414702|FG000|Overall Study|Abnormal test procedure results|3|||
128761218|NCT00941798|463414703|FG001|Overall Study|Abnormal test procedure results|1|||
128761219|NCT00941798|463414702|FG000|Overall Study|Abnormal laboratory values|1|||
128761220|NCT00941798|463414703|FG001|Overall Study|Abnormal laboratory values|2|||
128761221|NCT00941798|463414702|FG000|Overall Study|Death|0|||
128761222|NCT00941798|463414703|FG001|Overall Study|Death|1|||
128761223|NCT04179721|463414706|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
128761224|NCT04179721|463414707|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
128761225|NCT04179721|463414706|FG000|Overall Study|Lost to Follow-up|0|||
128761226|NCT04179721|463414707|FG001|Overall Study|Lost to Follow-up|1|||
128761227|NCT00112580|463414708|FG000|Overall Study|Adverse Event|1|||
128761228|NCT00112580|463414709|FG001|Overall Study|Adverse Event|2|||
128761229|NCT00112580|463414708|FG000|Overall Study|Disease progression|5|||
128761230|NCT00112580|463414709|FG001|Overall Study|Disease progression|16|||
128761231|NCT00112580|463414708|FG000|Overall Study|Participant withdrew consent|2|||
128761232|NCT00112580|463414709|FG001|Overall Study|Participant withdrew consent|1|||
128761233|NCT05619003|463414710|FG000|Overall Study|Adverse Event|1|||
128761234|NCT01984697|463416325|FG000|Overall Study|Adverse Event|0|||
128761235|NCT01984697|463416326|FG001|Overall Study|Adverse Event|0|||
128761236|NCT01984697|463416327|FG002|Overall Study|Adverse Event|2|||
128761237|NCT01984697|463416328|FG003|Overall Study|Adverse Event|0|||
128761238|NCT01984697|463416329|FG004|Overall Study|Adverse Event|0|||
128761239|NCT01984697|463416325|FG000|Overall Study|Lost to Follow-up|14|||
128761240|NCT01984697|463416326|FG001|Overall Study|Lost to Follow-up|5|||
128761241|NCT01984697|463416327|FG002|Overall Study|Lost to Follow-up|10|||
128761242|NCT01984697|463416328|FG003|Overall Study|Lost to Follow-up|6|||
129094335|NCT00793624|464636118|FG003|Overall Study|Non compliance with protocol|3|||
128761243|NCT01984697|463416329|FG004|Overall Study|Lost to Follow-up|21|||
128761244|NCT01984697|463416325|FG000|Overall Study|Physician Decision|3|||
128761245|NCT01984697|463416326|FG001|Overall Study|Physician Decision|0|||
128761246|NCT01984697|463416327|FG002|Overall Study|Physician Decision|0|||
128761247|NCT01984697|463416328|FG003|Overall Study|Physician Decision|1|||
128761248|NCT01984697|463416329|FG004|Overall Study|Physician Decision|0|||
128761249|NCT01984697|463416325|FG000|Overall Study|Protocol Violation|8|||
128761250|NCT01984697|463416326|FG001|Overall Study|Protocol Violation|5|||
128761251|NCT01984697|463416327|FG002|Overall Study|Protocol Violation|3|||
128761252|NCT01984697|463416328|FG003|Overall Study|Protocol Violation|2|||
128761253|NCT01984697|463416329|FG004|Overall Study|Protocol Violation|0|||
128761254|NCT01984697|463416325|FG000|Overall Study|Withdrawal by Subject|15|||
128761255|NCT01984697|463416326|FG001|Overall Study|Withdrawal by Subject|21|||
128761256|NCT01984697|463416327|FG002|Overall Study|Withdrawal by Subject|13|||
128761257|NCT01984697|463416328|FG003|Overall Study|Withdrawal by Subject|11|||
128761258|NCT01984697|463416329|FG004|Overall Study|Withdrawal by Subject|13|||
128761259|NCT01984697|463416325|FG000|Overall Study|Missed last follow-up visit|1|||
128761260|NCT01984697|463416326|FG001|Overall Study|Missed last follow-up visit|0|||
128761261|NCT01984697|463416327|FG002|Overall Study|Missed last follow-up visit|0|||
128761262|NCT01984697|463416328|FG003|Overall Study|Missed last follow-up visit|0|||
128761263|NCT01984697|463416329|FG004|Overall Study|Missed last follow-up visit|0|||
128761264|NCT01984697|463416325|FG000|Overall Study|Death|0|||
128761265|NCT01984697|463416326|FG001|Overall Study|Death|0|||
128761266|NCT01984697|463416327|FG002|Overall Study|Death|0|||
128761267|NCT01984697|463416328|FG003|Overall Study|Death|1|||
128761268|NCT01984697|463416329|FG004|Overall Study|Death|0|||
128761269|NCT01984697|463416325|FG000|Overall Study|Pregnancy|2|||
128761270|NCT01984697|463416326|FG001|Overall Study|Pregnancy|0|||
128761271|NCT01984697|463416327|FG002|Overall Study|Pregnancy|1|||
128761272|NCT01984697|463416328|FG003|Overall Study|Pregnancy|0|||
128761273|NCT01984697|463416329|FG004|Overall Study|Pregnancy|1|||
128761274|NCT03308825|463416330|FG000|Overall Study|Lost to Follow-up|2|||
128761275|NCT03308825|463416331|FG001|Overall Study|Lost to Follow-up|2|||
128761276|NCT03308825|463416332|FG002|Overall Study|Lost to Follow-up|1|||
128761277|NCT03308825|463416333|FG003|Overall Study|Lost to Follow-up|0|||
128761278|NCT03308825|463416330|FG000|Overall Study|Protocol Violation|0|||
128761279|NCT03308825|463416331|FG001|Overall Study|Protocol Violation|2|||
128761280|NCT03308825|463416332|FG002|Overall Study|Protocol Violation|0|||
128761281|NCT03308825|463416333|FG003|Overall Study|Protocol Violation|0|||
128761282|NCT04737109|463416334|FG000|Study Treatment|Disease Progression|5|||
128761283|NCT04737109|463416335|FG001|Study Treatment|Disease Progression|0|||
128761284|NCT04737109|463416336|FG002|Study Treatment|Disease Progression|0|||
128761285|NCT04737109|463416337|FG003|Study Treatment|Disease Progression|0|||
128761286|NCT04737109|463416334|FG000|Study Treatment|Death on study|1|||
128761287|NCT04737109|463416335|FG001|Study Treatment|Death on study|0|||
128761288|NCT04737109|463416336|FG002|Study Treatment|Death on study|0|||
128761289|NCT04737109|463416337|FG003|Study Treatment|Death on study|0|||
128761290|NCT00949715|463416338|FG000|Overall Study|Physician Decision|1|||
128761291|NCT00949715|463416339|FG001|Overall Study|Physician Decision|0|||
128761292|NCT00949715|463416338|FG000|Overall Study|Lost to Follow-up|1|||
128761293|NCT00949715|463416339|FG001|Overall Study|Lost to Follow-up|0|||
128761294|NCT00949715|463416338|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
128761295|NCT00949715|463416339|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
128761296|NCT02259517|463416341|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
128761297|NCT02259517|463416342|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
128761298|NCT02259517|463416343|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
128761299|NCT02259517|463416341|FG000|Overall Study|Withdrawal by Subject|0|||
128761300|NCT02259517|463416342|FG001|Overall Study|Withdrawal by Subject|0|||
128761301|NCT02259517|463416343|FG002|Overall Study|Withdrawal by Subject|3|||
128761302|NCT02276066|463416344|FG000|Overall Study|Lost to Follow-up|21|||
128761303|NCT02276066|463416345|FG001|Overall Study|Lost to Follow-up|11|||
128761304|NCT04669600|463416346|FG000|Overall Study|Withdrawal by Subject|1|||
128761305|NCT04669600|463416346|FG000|Overall Study|Other|6|||
128761306|NCT00710606|463416349|FG000|Overall Study|Adverse Event|0|||
128761307|NCT00710606|463416350|FG001|Overall Study|Adverse Event|2|||
128761308|NCT00514683|463416351|FG000|Overall Study|Not treated|2|||
128761309|NCT00514683|463416352|FG001|Overall Study|Not treated|1|||
128761310|NCT00514683|463416353|FG002|Overall Study|Not treated|0|||
128761311|NCT00514683|463416354|FG003|Overall Study|Not treated|0|||
128761312|NCT00514683|463416355|FG004|Overall Study|Not treated|1|||
128761313|NCT00514683|463416351|FG000|Overall Study|Adverse Event|21|||
128761314|NCT00514683|463416352|FG001|Overall Study|Adverse Event|20|||
129094336|NCT00793624|464636115|FG000|Overall Study|Other reason not described above|6|||
128761315|NCT00514683|463416353|FG002|Overall Study|Adverse Event|15|||
128761316|NCT00514683|463416354|FG003|Overall Study|Adverse Event|13|||
128761317|NCT00514683|463416355|FG004|Overall Study|Adverse Event|27|||
128761318|NCT00514683|463416351|FG000|Overall Study|Protocol Violation|1|||
128761319|NCT00514683|463416352|FG001|Overall Study|Protocol Violation|1|||
128761320|NCT00514683|463416353|FG002|Overall Study|Protocol Violation|0|||
128761321|NCT00514683|463416354|FG003|Overall Study|Protocol Violation|1|||
128761322|NCT00514683|463416355|FG004|Overall Study|Protocol Violation|0|||
128761323|NCT00514683|463416351|FG000|Overall Study|Withdrawal by Subject|2|||
128761324|NCT00514683|463416352|FG001|Overall Study|Withdrawal by Subject|2|||
128761325|NCT00514683|463416353|FG002|Overall Study|Withdrawal by Subject|1|||
128761326|NCT00514683|463416354|FG003|Overall Study|Withdrawal by Subject|0|||
128761327|NCT00514683|463416355|FG004|Overall Study|Withdrawal by Subject|4|||
128761328|NCT00514683|463416351|FG000|Overall Study|Reason other than listed above|0|||
128761329|NCT00514683|463416352|FG001|Overall Study|Reason other than listed above|1|||
128761330|NCT00514683|463416353|FG002|Overall Study|Reason other than listed above|2|||
128761331|NCT00514683|463416354|FG003|Overall Study|Reason other than listed above|0|||
128761332|NCT00514683|463416355|FG004|Overall Study|Reason other than listed above|1|||
128761333|NCT02736825|463416356|FG000|Overall Study|Lost to Follow-up|10|||
128761334|NCT02736825|463416357|FG001|Overall Study|Lost to Follow-up|11|||
128761335|NCT02736825|463416356|FG000|Overall Study|Early Termination|0|||
128761336|NCT02736825|463416357|FG001|Overall Study|Early Termination|1|||
128761337|NCT00790452|463416358|FG000|Overall Study|Drug supply issue|1|||
128761338|NCT00790452|463416359|FG001|Overall Study|Drug supply issue|0|||
128761339|NCT01564368|463416360|FG000|Overall Study|Ineligible|18|||
128761340|NCT01564368|463416360|FG000|Overall Study|Not Randomized in Parent study|116|||
128761341|NCT01564368|463416360|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
128761342|NCT01564368|463416360|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
128761343|NCT04082884|463416361|FG000|Overall Study|Withdrawal by Subject|1|||
128761344|NCT05674890|463416366|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
128761345|NCT05674890|463416367|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
128761346|NCT05674890|463416366|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
128761347|NCT05674890|463416367|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
128761348|NCT05674890|463416366|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
128761349|NCT05674890|463416367|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
128761350|NCT00520975|463416368|FG000|Overall Study|Disease progression|31|||
128761351|NCT00520975|463416369|FG001|Overall Study|Disease progression|23|||
128761352|NCT00520975|463416368|FG000|Overall Study|Adverse Event|7|||
128761353|NCT00520975|463416369|FG001|Overall Study|Adverse Event|10|||
128761354|NCT00520975|463416368|FG000|Overall Study|Death|0|||
128761355|NCT00520975|463416369|FG001|Overall Study|Death|2|||
128761356|NCT00520975|463416368|FG000|Overall Study|Withdrawal by Subject|3|||
128761357|NCT00520975|463416369|FG001|Overall Study|Withdrawal by Subject|5|||
128761358|NCT00520975|463416368|FG000|Overall Study|Other therapy|2|||
128761359|NCT00520975|463416369|FG001|Overall Study|Other therapy|4|||
128761360|NCT00520975|463416368|FG000|Overall Study|Other reasons|4|||
128761361|NCT00520975|463416369|FG001|Overall Study|Other reasons|2|||
128761362|NCT00520975|463416368|FG000|Overall Study|Not start protocol therapy|1|||
128761363|NCT00520975|463416369|FG001|Overall Study|Not start protocol therapy|2|||
128761364|NCT04810221|463416370|FG000|Overall Study|Physician Decision|3|||
128761365|NCT03642938|463416371|FG000|Overall Study|Withdrawal by Subject|0|||
128761366|NCT03642938|463416372|FG001|Overall Study|Withdrawal by Subject|0|||
128761367|NCT03642938|463416373|FG002|Overall Study|Withdrawal by Subject|0|||
128761368|NCT03642938|463416374|FG003|Overall Study|Withdrawal by Subject|1|||
128761369|NCT00105235|463416375|FG000|Overall Study|Death|4|||
128761370|NCT00105235|463416375|FG000|Overall Study|Physician Decision|1|||
128761371|NCT00105235|463416375|FG000|Overall Study|Withdrawal by Subject|2|||
128761372|NCT01964326|463416376|FG000|Overall Study|Adverse Event|48|||
128761373|NCT01964326|463416376|FG000|Overall Study|Death|2|||
128761374|NCT01964326|463416376|FG000|Overall Study|Protocol Violation|4|||
128761375|NCT01964326|463416376|FG000|Overall Study|Lost to Follow-up|88|||
128761376|NCT01964326|463416376|FG000|Overall Study|Withdrawal by Subject|87|||
128761377|NCT01964326|463416376|FG000|Overall Study|Pregnancy|1|||
128761378|NCT01964326|463416376|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
128761379|NCT01964326|463416376|FG000|Overall Study|Physician Decision|55|||
128761380|NCT01964326|463416376|FG000|Overall Study|Investigator Discretion|1|||
128761381|NCT01964326|463416376|FG000|Overall Study|Other|9|||
128761382|NCT01964326|463416376|FG000|Overall Study|Did not meet eligibility criteria|1|||
128761383|NCT02347657|463416377|FG000|Overall Study|Physician Decision|0|||
128761384|NCT02347657|463416378|FG001|Overall Study|Physician Decision|1|||
128761385|NCT02347657|463416377|FG000|Overall Study|Adverse Event|8|||
128761386|NCT02347657|463416378|FG001|Overall Study|Adverse Event|4|||
128761387|NCT02347657|463416377|FG000|Overall Study|Withdrawal by Subject|6|||
128761388|NCT02347657|463416378|FG001|Overall Study|Withdrawal by Subject|7|||
128761389|NCT02347657|463416377|FG000|Overall Study|Randomized but not treated|1|||
128761390|NCT02347657|463416378|FG001|Overall Study|Randomized but not treated|0|||
128761391|NCT02347657|463416377|FG000|Overall Study|Other|3|||
128761392|NCT02347657|463416378|FG001|Overall Study|Other|3|||
128761393|NCT01995539|463416379|FG000|Overall Study|Screening Failure|1|||
128761394|NCT01995539|463416379|FG000|Overall Study|Withdrawal by Investigator|15|||
128761395|NCT01995539|463416379|FG000|Overall Study|Withdrawal by Subject|11|||
128761396|NCT01995539|463416379|FG000|Overall Study|Lost to Follow-up|5|||
128761397|NCT01995539|463416379|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
128761398|NCT00261495|463416380|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
128761399|NCT00261495|463416381|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
128761400|NCT00261495|463416380|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
128761401|NCT00261495|463416381|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
128761402|NCT00261495|463416380|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
128761403|NCT00261495|463416381|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
128761404|NCT00261495|463416380|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
128761405|NCT00261495|463416381|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
128761406|NCT00261495|463416380|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
128761407|NCT00261495|463416381|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
128761408|NCT00261495|463416380|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
128761409|NCT00261495|463416381|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
128761410|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
128761411|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
128761412|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
128761413|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
128761414|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
128761415|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
128761416|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
128761417|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
128982505|NCT01266967|464222997|FG000|Overall Study|Withdrawal by Subject|3|||
128982506|NCT01266967|464222998|FG001|Overall Study|Withdrawal by Subject|3|||
128982507|NCT01945866|464222999|FG000|Overall Study|Eyes did not complete or were dropped|2|||
128982508|NCT01945866|464223000|FG001|Overall Study|Eyes did not complete or were dropped|0|||
128982509|NCT04398030|464223001|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
128982510|NCT04398030|464223002|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
128982511|NCT04398030|464223001|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
128982512|NCT04398030|464223002|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
128982513|NCT03159455|464223005|FG000|Overall Study|Adverse Event|0|||
128982514|NCT03159455|464223006|FG001|Overall Study|Adverse Event|0|||
128982515|NCT03159455|464223007|FG002|Overall Study|Adverse Event|0|||
128982516|NCT03159455|464223008|FG003|Overall Study|Adverse Event|0|||
128982517|NCT03159455|464223009|FG004|Overall Study|Adverse Event|0|||
128982518|NCT03159455|464223010|FG005|Overall Study|Adverse Event|1|||
128982519|NCT02713490|464223017|FG000|Overall Study|Withdrawal by Subject|2|||
128982520|NCT02713490|464223018|FG001|Overall Study|Withdrawal by Subject|1|||
128982521|NCT02713490|464223017|FG000|Overall Study|Did not receive study drug|1|||
128982522|NCT02713490|464223018|FG001|Overall Study|Did not receive study drug|0|||
128982523|NCT02713490|464223017|FG000|Overall Study|Met exclusion criteria|0|||
128982524|NCT02713490|464223018|FG001|Overall Study|Met exclusion criteria|1|||
128982525|NCT00346775|464223019|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
128982526|NCT00346775|464223020|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
128982527|NCT00346775|464223019|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
128982528|NCT00346775|464223020|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
128982529|NCT00346775|464223019|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
128982530|NCT00346775|464223020|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
128982531|NCT02946515|464223021|FG000|Overall Study|Lost to Follow-up|2|||
128982532|NCT02946515|464223022|FG001|Overall Study|Lost to Follow-up|1|||
128761418|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
128982533|NCT00960869|464223026|FG000|Overall Study|Adverse Event|17|||
128982534|NCT00960869|464223027|FG001|Overall Study|Adverse Event|26|||
128982535|NCT00960869|464223026|FG000|Overall Study|Withdrawal by Subject|16|||
128982536|NCT00960869|464223027|FG001|Overall Study|Withdrawal by Subject|14|||
128982537|NCT00960869|464223026|FG000|Overall Study|Lost to Follow-up|1|||
128982538|NCT00960869|464223027|FG001|Overall Study|Lost to Follow-up|4|||
128982539|NCT00960869|464223026|FG000|Overall Study|Misc|19|||
128982540|NCT00960869|464223027|FG001|Overall Study|Misc|18|||
128982541|NCT01714726|464223028|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
128982542|NCT01714726|464223029|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
128982543|NCT01714726|464223030|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
128982544|NCT01714726|464223031|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
128982545|NCT01714726|464223028|FG000|Double-Blinded Induction Period|Adverse Event|0|||
128982546|NCT01714726|464223029|FG001|Double-Blinded Induction Period|Adverse Event|1|||
128982547|NCT01714726|464223030|FG002|Double-Blinded Induction Period|Adverse Event|0|||
128982548|NCT01714726|464223031|FG003|Double-Blinded Induction Period|Adverse Event|0|||
128982549|NCT01714726|464223028|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
128982550|NCT01714726|464223029|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
128982551|NCT01714726|464223030|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
128982552|NCT01714726|464223031|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
128982553|NCT01714726|464223028|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
128982554|NCT01714726|464223029|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
128982555|NCT01714726|464223030|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
128982556|NCT01714726|464223031|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
128982557|NCT01714726|464223028|FG000|Open-Label Period|Other|0|||
128982558|NCT01714726|464223029|FG001|Open-Label Period|Other|0|||
128982559|NCT01714726|464223030|FG002|Open-Label Period|Other|1|||
128982560|NCT01714726|464223031|FG003|Open-Label Period|Other|3|||
128982561|NCT01714726|464223028|FG000|Open-Label Period|Adverse Event|0|||
128982562|NCT01714726|464223029|FG001|Open-Label Period|Adverse Event|0|||
128761419|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
128982563|NCT01714726|464223030|FG002|Open-Label Period|Adverse Event|1|||
128761420|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
128761421|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
128761422|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
128761423|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
128761424|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
128761425|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
128761426|NCT00261495|463416380|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
128761427|NCT00261495|463416381|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
128761428|NCT00261495|463416380|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
128761429|NCT00261495|463416381|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
128761430|NCT00261495|463416380|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
128761431|NCT00261495|463416381|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
128761432|NCT00261495|463416380|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
128761433|NCT00261495|463416381|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
128761434|NCT00261495|463416380|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
128761435|NCT00261495|463416381|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
128761436|NCT00261495|463416380|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
128761437|NCT00261495|463416381|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
128761438|NCT00261495|463416380|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
128761439|NCT00261495|463416381|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
128761440|NCT00642902|463416382|FG000|Overall Study|Adverse Event|0|||
128761441|NCT00642902|463416383|FG001|Overall Study|Adverse Event|1|||
128761442|NCT00642902|463416384|FG002|Overall Study|Adverse Event|3|||
128761443|NCT00642902|463416385|FG003|Overall Study|Adverse Event|1|||
128761444|NCT00642902|463416382|FG000|Overall Study|Lost to Follow-up|1|||
128761445|NCT00642902|463416383|FG001|Overall Study|Lost to Follow-up|1|||
128761446|NCT00642902|463416384|FG002|Overall Study|Lost to Follow-up|0|||
128761447|NCT00642902|463416385|FG003|Overall Study|Lost to Follow-up|0|||
128761448|NCT00642902|463416382|FG000|Overall Study|Lack of Efficacy|0|||
128761449|NCT00642902|463416383|FG001|Overall Study|Lack of Efficacy|3|||
128761450|NCT00642902|463416384|FG002|Overall Study|Lack of Efficacy|3|||
128761451|NCT00642902|463416385|FG003|Overall Study|Lack of Efficacy|0|||
128761452|NCT00642902|463416382|FG000|Overall Study|Death|1|||
128761453|NCT00642902|463416383|FG001|Overall Study|Death|0|||
128761454|NCT00642902|463416384|FG002|Overall Study|Death|0|||
128761455|NCT00642902|463416385|FG003|Overall Study|Death|0|||
128761456|NCT00642902|463416382|FG000|Overall Study|Premature termination of clinical trial|37|||
128761457|NCT00642902|463416383|FG001|Overall Study|Premature termination of clinical trial|32|||
128761458|NCT00642902|463416384|FG002|Overall Study|Premature termination of clinical trial|35|||
128761459|NCT00642902|463416385|FG003|Overall Study|Premature termination of clinical trial|35|||
128761460|NCT00642902|463416382|FG000|Overall Study|Randomized, but not treated|0|||
128761461|NCT00642902|463416383|FG001|Overall Study|Randomized, but not treated|0|||
128761462|NCT00642902|463416384|FG002|Overall Study|Randomized, but not treated|1|||
128761463|NCT00642902|463416385|FG003|Overall Study|Randomized, but not treated|0|||
128761464|NCT00642902|463416382|FG000|Overall Study|Other|1|||
128761465|NCT00642902|463416383|FG001|Overall Study|Other|5|||
128761466|NCT00642902|463416384|FG002|Overall Study|Other|1|||
128761467|NCT00642902|463416385|FG003|Overall Study|Other|4|||
128761468|NCT03953898|463416386|FG000|Overall Study|Lack of Efficacy|8|||
128761469|NCT03953898|463416386|FG000|Overall Study|Death|3|||
128761470|NCT03953898|463416386|FG000|Overall Study|Withdrawal by Subject|2|||
128761471|NCT03953898|463416386|FG000|Overall Study|Adverse Event|1|||
128761472|NCT01538472|463416388|FG000|Overall Study|Disease Progression|3|||
128761473|NCT01538472|463416388|FG000|Overall Study|Death|1|||
128761474|NCT02309112|463416389|FG000|Overall Study|Withdrawal by Subject|1|||
128761475|NCT02309112|463416390|FG001|Overall Study|Withdrawal by Subject|0|||
128761476|NCT02309112|463416391|FG002|Overall Study|Withdrawal by Subject|1|||
128761477|NCT02309112|463416389|FG000|Overall Study|Lost to Follow-up|0|||
128761478|NCT02309112|463416390|FG001|Overall Study|Lost to Follow-up|1|||
128761479|NCT02309112|463416391|FG002|Overall Study|Lost to Follow-up|0|||
128761480|NCT03170375|463416392|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
128761481|NCT03170375|463416393|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
128761482|NCT03170375|463416394|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
128761483|NCT03170375|463416392|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
128761484|NCT03170375|463416393|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
128761485|NCT03170375|463416394|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
128761486|NCT00763958|463416395|FG000|Overall Study|did not meet final criteria|4|||
128761487|NCT00763958|463416396|FG001|Overall Study|did not meet final criteria|4|||
128761488|NCT00763958|463416395|FG000|Overall Study|Lost to Follow-up|10|||
128761489|NCT00763958|463416396|FG001|Overall Study|Lost to Follow-up|2|||
128982564|NCT01714726|464223031|FG003|Open-Label Period|Adverse Event|0|||
128982565|NCT01714726|464223028|FG000|Open-Label Period|Withdrawal by Subject|0|||
128761490|NCT00763958|463416395|FG000|Overall Study|Believed they were receiving placebo|0|||
128761491|NCT00763958|463416396|FG001|Overall Study|Believed they were receiving placebo|5|||
128761492|NCT01376323|463416397|FG000|Overall Study|Adverse Event|1|||
128761493|NCT01376323|463416398|FG001|Overall Study|Adverse Event|0|||
128761494|NCT01376323|463416399|FG002|Overall Study|Adverse Event|0|||
128761495|NCT01376323|463416400|FG003|Overall Study|Adverse Event|2|||
128761496|NCT01376323|463416401|FG004|Overall Study|Adverse Event|0|||
128761497|NCT01376323|463416397|FG000|Overall Study|Lost to Follow-up|0|||
128761498|NCT01376323|463416398|FG001|Overall Study|Lost to Follow-up|0|||
128761499|NCT01376323|463416399|FG002|Overall Study|Lost to Follow-up|0|||
128761500|NCT01376323|463416400|FG003|Overall Study|Lost to Follow-up|2|||
128761501|NCT01376323|463416401|FG004|Overall Study|Lost to Follow-up|0|||
128761502|NCT01376323|463416397|FG000|Overall Study|Physician Decision|1|||
128761503|NCT01376323|463416398|FG001|Overall Study|Physician Decision|0|||
128761504|NCT01376323|463416399|FG002|Overall Study|Physician Decision|2|||
128761505|NCT01376323|463416400|FG003|Overall Study|Physician Decision|1|||
128761506|NCT01376323|463416401|FG004|Overall Study|Physician Decision|1|||
128761507|NCT01376323|463416397|FG000|Overall Study|Withdrawal by Subject|0|||
128761508|NCT01376323|463416398|FG001|Overall Study|Withdrawal by Subject|1|||
128761509|NCT01376323|463416399|FG002|Overall Study|Withdrawal by Subject|1|||
128761510|NCT01376323|463416400|FG003|Overall Study|Withdrawal by Subject|0|||
128761511|NCT01376323|463416401|FG004|Overall Study|Withdrawal by Subject|0|||
128761512|NCT04681729|463416402|FG000|Overall Study|Lack of Efficacy|2|||
128761513|NCT04681729|463416403|FG001|Overall Study|Lack of Efficacy|2|||
128761514|NCT04681729|463416402|FG000|Overall Study|Withdrawal by Subject|8|||
128761515|NCT04681729|463416403|FG001|Overall Study|Withdrawal by Subject|9|||
128761516|NCT02535364|463416407|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
128761517|NCT02535364|463416407|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
128761518|NCT02535364|463416407|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
128761519|NCT02535364|463416407|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
128761520|NCT02535364|463416407|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
128761521|NCT02535364|463416407|FG000|Part B Screening|Death|2|||
128761522|NCT02535364|463416407|FG000|Part B Screening|Physician Decision|1|||
128761523|NCT02535364|463416407|FG000|Part B Screening|Withdrawal by Subject|1|||
128761524|NCT02535364|463416407|FG000|Part B Screening|Adverse Event|1|||
128761525|NCT02535364|463416407|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
128761526|NCT02535364|463416407|FG000|Study Treatment|Death|1|||
128761527|NCT02535364|463416407|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
128761528|NCT02535364|463416407|FG000|12-Month Follow-up Period|Disease progression|22|||
128761529|NCT02535364|463416407|FG000|12-Month Follow-up Period|Death|5|||
128761530|NCT02535364|463416407|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
128761531|NCT02535364|463416407|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
128761532|NCT02535364|463416407|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
128761533|NCT00499863|463416408|FG000|Overall Study|Lack of Efficacy|21|||
128761534|NCT00499863|463416409|FG001|Overall Study|Lack of Efficacy|27|||
128761535|NCT00499863|463416408|FG000|Overall Study|Protocol Violation|12|||
128761536|NCT00499863|463416409|FG001|Overall Study|Protocol Violation|7|||
128761537|NCT00499863|463416408|FG000|Overall Study|Withdrawal by Subject|6|||
128761538|NCT00499863|463416409|FG001|Overall Study|Withdrawal by Subject|4|||
128761539|NCT00499863|463416408|FG000|Overall Study|Adverse Event|8|||
128761540|NCT00499863|463416409|FG001|Overall Study|Adverse Event|2|||
128761541|NCT00499863|463416408|FG000|Overall Study|Sponsor decision|2|||
128761542|NCT00499863|463416409|FG001|Overall Study|Sponsor decision|2|||
128761543|NCT00499863|463416408|FG000|Overall Study|Lost to Follow-up|1|||
128761544|NCT00499863|463416409|FG001|Overall Study|Lost to Follow-up|1|||
128761545|NCT00571701|463416410|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
128761546|NCT00571701|463416411|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
128761547|NCT00571701|463416410|FG000|First Intervention 12 Months|Death|1|||
128761548|NCT00571701|463416411|FG001|First Intervention 12 Months|Death|0|||
128761549|NCT00571701|463416410|FG000|Second Intervention 12 Months|Adverse Event|0|||
128761550|NCT00571701|463416411|FG001|Second Intervention 12 Months|Adverse Event|1|||
128761551|NCT00571701|463416410|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
128761552|NCT00571701|463416411|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
128761553|NCT04766086|463416415|FG000|Overall Study|Lost to Follow-up|3|||
128761554|NCT04766086|463416416|FG001|Overall Study|Lost to Follow-up|5|||
128761555|NCT04766086|463416417|FG002|Overall Study|Lost to Follow-up|3|||
128761556|NCT04766086|463416415|FG000|Overall Study|Withdrawal by Subject|1|||
128761557|NCT04766086|463416416|FG001|Overall Study|Withdrawal by Subject|1|||
128761558|NCT04766086|463416417|FG002|Overall Study|Withdrawal by Subject|2|||
128761559|NCT04766086|463416415|FG000|Overall Study|Other|0|||
128761560|NCT04766086|463416416|FG001|Overall Study|Other|0|||
128761561|NCT04766086|463416417|FG002|Overall Study|Other|1|||
128761562|NCT03759834|463416418|FG000|Overall Study|Withdrawal by Subject|1|||
128761563|NCT05701995|463416419|FG000|Pre-Treatment|Randomization Error|1|||
128761564|NCT05701995|463416420|FG001|Pre-Treatment|Randomization Error|1|||
128761565|NCT05701995|463416419|FG000|Treatment|Withdrawal by Subject|8|||
128761566|NCT05701995|463416420|FG001|Treatment|Withdrawal by Subject|4|||
128761567|NCT05701995|463416419|FG000|Treatment|Lost to Follow-up|2|||
128761568|NCT05701995|463416420|FG001|Treatment|Lost to Follow-up|3|||
128761569|NCT05701995|463416419|FG000|Treatment|Adverse Event|3|||
128761570|NCT05701995|463416420|FG001|Treatment|Adverse Event|1|||
128761571|NCT05701995|463416419|FG000|Treatment|Other Reason|1|||
128761572|NCT05701995|463416420|FG001|Treatment|Other Reason|1|||
128761573|NCT05701995|463416419|FG000|Treatment|Death|1|||
128761574|NCT05701995|463416420|FG001|Treatment|Death|0|||
128761575|NCT05701995|463416419|FG000|Treatment|Physician Decision|0|||
128761576|NCT05701995|463416420|FG001|Treatment|Physician Decision|1|||
128761577|NCT04987762|463416421|FG000|Overall Study|Study was Terminated by Sponsor|103|||
128870893|NCT00166712|463822127|FG000|Overall Study|Withdrawal by Subject|1|||
128870894|NCT00166712|463822128|FG001|Overall Study|Withdrawal by Subject|2|||
128870895|NCT00166712|463822127|FG000|Overall Study|Physician Decision|0|||
128870896|NCT00166712|463822128|FG001|Overall Study|Physician Decision|2|||
128870897|NCT03986944|463822129|FG000|Overall Study|Adverse Event|1|||
128870898|NCT03986944|463822130|FG001|Overall Study|Adverse Event|2|||
128870899|NCT03986944|463822131|FG002|Overall Study|Adverse Event|3|||
128870900|NCT03986944|463822129|FG000|Overall Study|Protocol Violation|0|||
128870901|NCT03986944|463822130|FG001|Overall Study|Protocol Violation|1|||
128870902|NCT03986944|463822131|FG002|Overall Study|Protocol Violation|1|||
128761588|NCT03988166|463416428|FG000|Overall Study|Lost to Follow-up|2|||
128761589|NCT03988166|463416428|FG000|Overall Study|Death|1|||
128761590|NCT03248375|463416429|FG000|Overall Study|Lost to Follow-up|5|||
128761591|NCT00316173|463416434|FG000|Run-in Phase|Adverse Event|1|||
128761592|NCT00316173|463416435|FG001|Run-in Phase|Adverse Event|0|||
128761593|NCT00316173|463416434|FG000|Run-in Phase|Protocol Violation|1|||
128761594|NCT00316173|463416435|FG001|Run-in Phase|Protocol Violation|0|||
128761595|NCT00316173|463416434|FG000|Run-in Phase|Study Follow-up Stopped|5|||
128761596|NCT00316173|463416435|FG001|Run-in Phase|Study Follow-up Stopped|0|||
128761597|NCT00316173|463416434|FG000|Treatment Phase|Adverse Event|0|||
128761598|NCT00316173|463416435|FG001|Treatment Phase|Adverse Event|1|||
128761599|NCT00316173|463416434|FG000|Treatment Phase|Lack of Efficacy|0|||
128761600|NCT00316173|463416435|FG001|Treatment Phase|Lack of Efficacy|3|||
128982566|NCT01714726|464223029|FG001|Open-Label Period|Withdrawal by Subject|0|||
128982567|NCT01714726|464223030|FG002|Open-Label Period|Withdrawal by Subject|9|||
128982568|NCT01714726|464223031|FG003|Open-Label Period|Withdrawal by Subject|19|||
128982569|NCT01714726|464223028|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
128982570|NCT01714726|464223029|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
128982571|NCT01714726|464223030|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
128982572|NCT01714726|464223031|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
128982573|NCT01714726|464223028|FG000|Open-Label Period|Lost to Follow-up|0|||
128982574|NCT01714726|464223029|FG001|Open-Label Period|Lost to Follow-up|0|||
128982575|NCT01714726|464223030|FG002|Open-Label Period|Lost to Follow-up|3|||
128982576|NCT01714726|464223031|FG003|Open-Label Period|Lost to Follow-up|4|||
128982577|NCT02501642|464223032|FG000|Overall Study|Lost to Follow-up|7|||
128982578|NCT02501642|464223033|FG001|Overall Study|Lost to Follow-up|11|||
128982579|NCT01846442|464223037|FG000|Overall Study|Adverse Event|2|||
128982580|NCT01846442|464223038|FG001|Overall Study|Adverse Event|4|||
128982581|NCT01846442|464223039|FG002|Overall Study|Adverse Event|2|||
128982582|NCT01846442|464223040|FG003|Overall Study|Adverse Event|1|||
128982583|NCT01846442|464223037|FG000|Overall Study|Lost to Follow-up|0|||
128982584|NCT01846442|464223038|FG001|Overall Study|Lost to Follow-up|0|||
128982585|NCT01846442|464223039|FG002|Overall Study|Lost to Follow-up|1|||
128982586|NCT01846442|464223040|FG003|Overall Study|Lost to Follow-up|0|||
128982587|NCT01846442|464223037|FG000|Overall Study|Withdrawal by Subject|3|||
128982588|NCT01846442|464223038|FG001|Overall Study|Withdrawal by Subject|2|||
128982589|NCT01846442|464223039|FG002|Overall Study|Withdrawal by Subject|0|||
128982590|NCT01846442|464223040|FG003|Overall Study|Withdrawal by Subject|1|||
128982591|NCT01846442|464223037|FG000|Overall Study|Left the city/Lost medication|1|||
128982592|NCT01846442|464223038|FG001|Overall Study|Left the city/Lost medication|0|||
128982593|NCT01846442|464223039|FG002|Overall Study|Left the city/Lost medication|1|||
128982594|NCT01846442|464223040|FG003|Overall Study|Left the city/Lost medication|1|||
128982595|NCT02600559|464223051|FG000|Overall Study|Withdrawal by Subject|3|||
128982596|NCT02600559|464223051|FG000|Overall Study|Lost to Follow-up|20|||
128982597|NCT01153971|464223054|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
128982598|NCT01153971|464223054|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
128982599|NCT01153971|464223054|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
128982600|NCT01153971|464223054|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
128761601|NCT00316173|463416434|FG000|Treatment Phase|Lost to Follow-up|0|||
128761602|NCT00316173|463416435|FG001|Treatment Phase|Lost to Follow-up|3|||
128761603|NCT00316173|463416434|FG000|Treatment Phase|Withdrawal by Subject|0|||
128761604|NCT00316173|463416435|FG001|Treatment Phase|Withdrawal by Subject|1|||
128761605|NCT00316173|463416434|FG000|Treatment Phase|Study Follow-up Stopped|0|||
128761606|NCT00316173|463416435|FG001|Treatment Phase|Study Follow-up Stopped|34|||
128761607|NCT03764072|463416436|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
128761608|NCT03764072|463416437|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
128761609|NCT03764072|463416438|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
128761610|NCT03764072|463416439|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
128761611|NCT03764072|463416440|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
128761612|NCT03764072|463416441|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
128761613|NCT03764072|463416436|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
128761614|NCT03764072|463416437|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
128761615|NCT03764072|463416438|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
128761616|NCT03764072|463416439|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
128761617|NCT03764072|463416440|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
128761618|NCT03764072|463416441|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
128761619|NCT03764072|463416436|FG000|Overall Study|Lost to Follow-up|0|||
128761620|NCT03764072|463416437|FG001|Overall Study|Lost to Follow-up|0|||
128761621|NCT03764072|463416438|FG002|Overall Study|Lost to Follow-up|0|||
128761622|NCT03764072|463416439|FG003|Overall Study|Lost to Follow-up|0|||
128761623|NCT03764072|463416440|FG004|Overall Study|Lost to Follow-up|1|||
128761624|NCT03764072|463416441|FG005|Overall Study|Lost to Follow-up|0|||
128761625|NCT00558064|463416442|FG000|Overall Study|Adverse Event|3|||
128761626|NCT00558064|463416443|FG001|Overall Study|Adverse Event|2|||
128761627|NCT00558064|463416442|FG000|Overall Study|Lack of Efficacy|0|||
128761628|NCT00558064|463416443|FG001|Overall Study|Lack of Efficacy|1|||
128761629|NCT00558064|463416442|FG000|Overall Study|Protocol Violation|1|||
128761630|NCT00558064|463416443|FG001|Overall Study|Protocol Violation|0|||
128761631|NCT00558064|463416442|FG000|Overall Study|Lost to Follow-up|0|||
128761632|NCT00558064|463416443|FG001|Overall Study|Lost to Follow-up|1|||
128761633|NCT00558064|463416442|FG000|Overall Study|Withdrawal by Subject|0|||
128761634|NCT00558064|463416443|FG001|Overall Study|Withdrawal by Subject|1|||
128761635|NCT00558064|463416442|FG000|Overall Study|No visit within allowance period|1|||
128761636|NCT00558064|463416443|FG001|Overall Study|No visit within allowance period|0|||
128761637|NCT00982930|463416446|FG000|Overall Study|Adverse Event|1|||
128761638|NCT00982930|463416446|FG000|Overall Study|Withdrawal by Subject|1|||
128761639|NCT00982930|463416446|FG000|Overall Study|Administrative Problems|2|||
128761640|NCT01489189|463416447|FG000|Overall Study|Withdrawal by Subject|20|||
128761641|NCT01489189|463416448|FG001|Overall Study|Withdrawal by Subject|23|||
128761642|NCT01489189|463416447|FG000|Overall Study|Death|10|||
128761643|NCT01489189|463416448|FG001|Overall Study|Death|8|||
128761644|NCT01489189|463416447|FG000|Overall Study|Missed Visit|1|||
128761645|NCT01489189|463416448|FG001|Overall Study|Missed Visit|4|||
128761646|NCT05597722|463416449|FG000|Overall Study|Study was terminated|6|||
128761647|NCT05597722|463416450|FG001|Overall Study|Study was terminated|1|||
128761648|NCT04108000|463416451|FG000|Overall Study|Death of patient|1|||
128761649|NCT04108000|463416452|FG001|Overall Study|Death of patient|0|||
128761650|NCT04108000|463416453|FG002|Overall Study|Death of patient|1|||
128761651|NCT04108000|463416454|FG003|Overall Study|Death of patient|0|||
128761652|NCT04108000|463416451|FG000|Overall Study|Withdrawal by Subject|2|||
128761653|NCT04108000|463416452|FG001|Overall Study|Withdrawal by Subject|2|||
128761654|NCT04108000|463416453|FG002|Overall Study|Withdrawal by Subject|0|||
128761655|NCT04108000|463416454|FG003|Overall Study|Withdrawal by Subject|0|||
128761656|NCT04108000|463416451|FG000|Overall Study|Death of surrogate partner|0|||
128761657|NCT04108000|463416452|FG001|Overall Study|Death of surrogate partner|1|||
128761658|NCT04108000|463416453|FG002|Overall Study|Death of surrogate partner|0|||
128761659|NCT04108000|463416454|FG003|Overall Study|Death of surrogate partner|1|||
128761660|NCT03881696|463416456|FG000|Overall Study|Adverse Event|2|||
128761661|NCT03881696|463416457|FG001|Overall Study|Adverse Event|0|||
128761662|NCT03881696|463416456|FG000|Overall Study|Withdrawal by Subject|2|||
128761663|NCT03881696|463416457|FG001|Overall Study|Withdrawal by Subject|0|||
128761664|NCT03881696|463416456|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
128761665|NCT03881696|463416457|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
128761666|NCT03881696|463416456|FG000|Overall Study|Failure to meet continuation criteria|1|||
128761667|NCT03881696|463416457|FG001|Overall Study|Failure to meet continuation criteria|0|||
128774771|NCT01216293|463466661|FG001|Main Study|Randomized, Not Treated|0|||
128774772|NCT01216293|463466662|FG002|Main Study|Randomized, Not Treated|0|||
128774773|NCT01216293|463466660|FG000|Calcium Absorption Substudy|Adverse Event|0|||
128774774|NCT01216293|463466661|FG001|Calcium Absorption Substudy|Adverse Event|2|||
128774775|NCT01216293|463466662|FG002|Calcium Absorption Substudy|Adverse Event|0|||
128774776|NCT01216293|463466660|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
128774777|NCT01216293|463466661|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
128774778|NCT01216293|463466662|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
128774779|NCT01216293|463466660|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
128774780|NCT01216293|463466661|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
128774781|NCT01216293|463466662|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
128774782|NCT01349829|463468336|FG000|Overall Study|Lost to Follow-up|4|||
128774783|NCT01349829|463468337|FG001|Overall Study|Lost to Follow-up|8|||
128774784|NCT01349829|463468336|FG000|Overall Study|Consent withdrawal|3|||
128774785|NCT01349829|463468337|FG001|Overall Study|Consent withdrawal|8|||
128774786|NCT01349829|463468336|FG000|Overall Study|Migrated/moved|2|||
128761668|NCT00685945|463417677|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
128761669|NCT03183388|463417678|FG000|Overall Study|Lost to Follow-up|3|||
128761670|NCT03183388|463417679|FG001|Overall Study|Lost to Follow-up|5|||
128761671|NCT03183388|463417678|FG000|Overall Study|Physician Decision|1|||
128761672|NCT03183388|463417679|FG001|Overall Study|Physician Decision|4|||
128761673|NCT03183388|463417678|FG000|Overall Study|Withdrawal by Subject|4|||
128761674|NCT03183388|463417679|FG001|Overall Study|Withdrawal by Subject|1|||
128761675|NCT03183388|463417678|FG000|Overall Study|Moved|1|||
128761676|NCT03183388|463417679|FG001|Overall Study|Moved|0|||
128761677|NCT03183388|463417678|FG000|Overall Study|Met Exclusion Criteria|2|||
128761678|NCT03183388|463417679|FG001|Overall Study|Met Exclusion Criteria|2|||
128761679|NCT03183388|463417678|FG000|Overall Study|COVID Pandemic Related|2|||
128761680|NCT03183388|463417679|FG001|Overall Study|COVID Pandemic Related|4|||
128761681|NCT01728792|463417680|FG000|Overall Study|Withdrawal of Consent|1|||
128761682|NCT01728792|463417681|FG001|Overall Study|Withdrawal of Consent|1|||
128761683|NCT01728792|463417682|FG002|Overall Study|Withdrawal of Consent|0|||
128761684|NCT01728792|463417683|FG003|Overall Study|Withdrawal of Consent|1|||
128761685|NCT01728792|463417684|FG004|Overall Study|Withdrawal of Consent|0|||
128761686|NCT01728792|463417680|FG000|Overall Study|Lost to Follow-up|2|||
128761687|NCT01728792|463417681|FG001|Overall Study|Lost to Follow-up|1|||
128761688|NCT01728792|463417682|FG002|Overall Study|Lost to Follow-up|4|||
128761689|NCT01728792|463417683|FG003|Overall Study|Lost to Follow-up|2|||
128761690|NCT01728792|463417684|FG004|Overall Study|Lost to Follow-up|0|||
128761691|NCT04277455|463417687|FG000|Overall Study|Lost to Follow-up|1|||
128761692|NCT01582789|463417691|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
128761693|NCT01582789|463417692|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
128761694|NCT01191840|463417704|FG000|Overall Study|withdrew consent|2|||
128761695|NCT01191840|463417705|FG001|Overall Study|withdrew consent|1|||
128761696|NCT01191840|463417704|FG000|Overall Study|Subject discontinued treatment|1|||
128761697|NCT01191840|463417705|FG001|Overall Study|Subject discontinued treatment|2|||
128761698|NCT01191840|463417704|FG000|Overall Study|Lost to Follow-up|4|||
128761699|NCT01191840|463417705|FG001|Overall Study|Lost to Follow-up|6|||
128761700|NCT01191840|463417704|FG000|Overall Study|Non Staph Infection|4|||
128761701|NCT01191840|463417705|FG001|Overall Study|Non Staph Infection|3|||
128761702|NCT01191840|463417704|FG000|Overall Study|ineligible at enrollment|1|||
128761703|NCT01191840|463417705|FG001|Overall Study|ineligible at enrollment|0|||
128761704|NCT01191840|463417704|FG000|Overall Study|IRB approval lapse|0|||
128761705|NCT01191840|463417705|FG001|Overall Study|IRB approval lapse|2|||
128761706|NCT01191840|463417704|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
128761707|NCT01191840|463417705|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
128761708|NCT01191840|463417704|FG000|Overall Study|Withdrawal by Subject|2|||
128761709|NCT01191840|463417705|FG001|Overall Study|Withdrawal by Subject|0|||
128761710|NCT01392300|463417706|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
128761711|NCT01392300|463417707|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
128761712|NCT01392300|463417708|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
128761713|NCT01392300|463417706|FG000|Main Period (MP)|Withdrawal by Subject|5|||
128761714|NCT01392300|463417707|FG001|Main Period (MP)|Withdrawal by Subject|1|||
128761715|NCT01392300|463417708|FG002|Main Period (MP)|Withdrawal by Subject|0|||
128761716|NCT01392300|463417706|FG000|Main Period (MP)|Lost to Follow-up|3|||
128761717|NCT01392300|463417707|FG001|Main Period (MP)|Lost to Follow-up|3|||
128761718|NCT01392300|463417708|FG002|Main Period (MP)|Lost to Follow-up|0|||
128761719|NCT01392300|463417706|FG000|Main Period (MP)|Non-compliance|1|||
128761720|NCT01392300|463417707|FG001|Main Period (MP)|Non-compliance|0|||
128761721|NCT01392300|463417708|FG002|Main Period (MP)|Non-compliance|0|||
128761722|NCT01392300|463417706|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
128761723|NCT01392300|463417707|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
128761724|NCT01392300|463417708|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
128761725|NCT01392300|463417706|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
128761726|NCT01392300|463417707|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
128761727|NCT01392300|463417708|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
128761728|NCT01392300|463417706|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
128982601|NCT01153971|464223054|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
128982602|NCT01153971|464223054|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
128761729|NCT01392300|463417707|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
128761730|NCT01392300|463417708|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
128761731|NCT01392300|463417706|FG000|Open Label Extension (OLEX) Period|Death|0|||
128761732|NCT01392300|463417707|FG001|Open Label Extension (OLEX) Period|Death|0|||
128761733|NCT01392300|463417708|FG002|Open Label Extension (OLEX) Period|Death|4|||
128761734|NCT01392300|463417706|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
128761735|NCT01392300|463417707|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
128761736|NCT01392300|463417708|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
128761737|NCT01392300|463417706|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
128761738|NCT01392300|463417707|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
128761739|NCT01392300|463417708|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
128761740|NCT01392300|463417706|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
128761741|NCT01392300|463417707|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
128761742|NCT01392300|463417708|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
128761743|NCT01802437|463417713|FG000|Overall Study|Lost to Follow-up|1|||
128761744|NCT01802437|463417714|FG001|Overall Study|Lost to Follow-up|0|||
128761745|NCT01802437|463417713|FG000|Overall Study|Withdrawal by Subject|3|||
128761746|NCT01802437|463417714|FG001|Overall Study|Withdrawal by Subject|4|||
128761747|NCT01682213|463417722|FG000|Overall Study|Withdrawal by Subject|2|||
128761748|NCT00742079|463417723|FG000|Overall Study|Lost to Follow-up|0|||
128761749|NCT00742079|463417724|FG001|Overall Study|Lost to Follow-up|1|||
128761750|NCT01181726|463417725|FG000|First Intervention|Adverse Event|1|||
128761751|NCT01181726|463417726|FG001|First Intervention|Adverse Event|0|||
128761752|NCT01264380|463417727|FG000|Period C|Disease Progression|0|||
128761753|NCT01264380|463417728|FG001|Period C|Disease Progression|0|||
128761754|NCT01264380|463417729|FG002|Period C|Disease Progression|4|||
128761755|NCT01264380|463417727|FG000|Period C|Death|0|||
128761756|NCT01264380|463417728|FG001|Period C|Death|0|||
128761757|NCT01264380|463417729|FG002|Period C|Death|2|||
128761758|NCT01264380|463417727|FG000|Period C|Follow-up for survival status|0|||
128761759|NCT01264380|463417728|FG001|Period C|Follow-up for survival status|0|||
128761760|NCT01264380|463417729|FG002|Period C|Follow-up for survival status|6|||
128761761|NCT01264380|463417727|FG000|Period C|Withdrawal by Subject|0|||
128761762|NCT01264380|463417728|FG001|Period C|Withdrawal by Subject|0|||
128761763|NCT01264380|463417729|FG002|Period C|Withdrawal by Subject|1|||
128761764|NCT01264380|463417727|FG000|Period C|Adverse Event|0|||
128761765|NCT01264380|463417728|FG001|Period C|Adverse Event|0|||
128761766|NCT01264380|463417729|FG002|Period C|Adverse Event|1|||
128761767|NCT01147822|463417730|FG000|Overall Study|Lost to Follow-up|14|||
128761768|NCT01147822|463417731|FG001|Overall Study|Lost to Follow-up|6|||
128761769|NCT01147822|463417730|FG000|Overall Study|Withdrawal by Subject|10|||
128761770|NCT01147822|463417731|FG001|Overall Study|Withdrawal by Subject|16|||
128761771|NCT01147822|463417730|FG000|Overall Study|Physician Decision|9|||
128761772|NCT01147822|463417731|FG001|Overall Study|Physician Decision|8|||
128761773|NCT01147822|463417730|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
128761774|NCT01147822|463417731|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
128761775|NCT01147822|463417730|FG000|Overall Study|Protocol Violation|1|||
128761776|NCT01147822|463417731|FG001|Overall Study|Protocol Violation|1|||
128761777|NCT00429663|463417734|FG000|Overall Study|Lost to Follow-up|24|||
128761778|NCT00429663|463417735|FG001|Overall Study|Lost to Follow-up|31|||
128761779|NCT00429663|463417734|FG000|Overall Study|Physician Decision|6|||
128761780|NCT00429663|463417735|FG001|Overall Study|Physician Decision|3|||
128761781|NCT00429663|463417734|FG000|Overall Study|Withdrawal by Subject|2|||
128761782|NCT00429663|463417735|FG001|Overall Study|Withdrawal by Subject|5|||
128761783|NCT00429663|463417734|FG000|Overall Study|Death|4|||
128761784|NCT00429663|463417735|FG001|Overall Study|Death|0|||
128761785|NCT01932697|463417738|FG000|Overall Study|Received a different amount of tx|1|||
128761786|NCT01932697|463417739|FG001|Overall Study|Received a different amount of tx|0|||
128761787|NCT01932697|463417738|FG000|Overall Study|Ineligible|1|||
128761788|NCT01932697|463417739|FG001|Overall Study|Ineligible|0|||
128761789|NCT01226511|463417740|FG000|Acute Treatment Period|Adverse Event|7|||
128761790|NCT01226511|463417741|FG001|Acute Treatment Period|Adverse Event|6|||
128761791|NCT01226511|463417740|FG000|Acute Treatment Period|Lack of Efficacy|2|||
128761792|NCT01226511|463417741|FG001|Acute Treatment Period|Lack of Efficacy|1|||
128761793|NCT01226511|463417740|FG000|Acute Treatment Period|Lost to Follow-up|3|||
128761794|NCT01226511|463417741|FG001|Acute Treatment Period|Lost to Follow-up|6|||
128761795|NCT01226511|463417740|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
128761796|NCT01226511|463417741|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
128761797|NCT01226511|463417740|FG000|Acute Treatment Period|Protocol Violation|5|||
128761798|NCT01226511|463417741|FG001|Acute Treatment Period|Protocol Violation|5|||
128761799|NCT01226511|463417740|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
128761800|NCT01226511|463417741|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
128761801|NCT01226511|463417740|FG000|Extension Treatment Period|Adverse Event|8|||
128761802|NCT01226511|463417741|FG001|Extension Treatment Period|Adverse Event|8|||
128761803|NCT01226511|463417740|FG000|Extension Treatment Period|Lack of Efficacy|3|||
128761804|NCT01226511|463417741|FG001|Extension Treatment Period|Lack of Efficacy|2|||
128761805|NCT01226511|463417740|FG000|Extension Treatment Period|Lost to Follow-up|4|||
128761806|NCT01226511|463417741|FG001|Extension Treatment Period|Lost to Follow-up|3|||
128761807|NCT01226511|463417740|FG000|Extension Treatment Period|Protocol Violation|2|||
128761808|NCT01226511|463417741|FG001|Extension Treatment Period|Protocol Violation|2|||
128761809|NCT01226511|463417740|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
128761810|NCT01226511|463417741|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
128761811|NCT01226511|463417740|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
128761812|NCT01226511|463417741|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
128761813|NCT01226511|463417740|FG000|Extension Treatment Period|Sponsor Decision|1|||
128761814|NCT01226511|463417741|FG001|Extension Treatment Period|Sponsor Decision|1|||
128761815|NCT01226511|463417740|FG000|Taper Period|Adverse Event|1|||
128761816|NCT01226511|463417741|FG001|Taper Period|Adverse Event|0|||
128761817|NCT01226511|463417740|FG000|Taper Period|Lost to Follow-up|2|||
128761818|NCT01226511|463417741|FG001|Taper Period|Lost to Follow-up|2|||
128761819|NCT01226511|463417740|FG000|Taper Period|Protocol Violation|1|||
128761820|NCT01226511|463417741|FG001|Taper Period|Protocol Violation|0|||
128761821|NCT01226511|463417740|FG000|Taper Period|Parent/Caregiver Decision|1|||
128761822|NCT01226511|463417741|FG001|Taper Period|Parent/Caregiver Decision|1|||
128761823|NCT01337986|463417742|FG000|Overall Study|Adverse Event|2|||
128761824|NCT01337986|463417743|FG001|Overall Study|Adverse Event|2|||
128761825|NCT01337986|463417742|FG000|Overall Study|Lost to Follow-up|1|||
128761826|NCT01337986|463417743|FG001|Overall Study|Lost to Follow-up|0|||
128761827|NCT01337986|463417742|FG000|Overall Study|Protocol Violation|0|||
128761828|NCT01337986|463417743|FG001|Overall Study|Protocol Violation|3|||
128761829|NCT01520402|463417746|FG000|Overall Study|Withdrawal by Subject|2|||
128761830|NCT01520402|463417746|FG000|Overall Study|Physician Decision|3|||
128761831|NCT01722162|463417748|FG000|Overall Study|Withdrawal by Subject|1|||
128761832|NCT01722162|463417749|FG001|Overall Study|Withdrawal by Subject|1|||
128761833|NCT01722162|463417748|FG000|Overall Study|Found ineligible|1|||
128761834|NCT01722162|463417749|FG001|Overall Study|Found ineligible|0|||
128761835|NCT01722162|463417748|FG000|Overall Study|Unrelated to study adverse event|2|||
128761836|NCT01722162|463417749|FG001|Overall Study|Unrelated to study adverse event|2|||
128761837|NCT01722162|463417748|FG000|Overall Study|Adverse Event|1|||
128761838|NCT01722162|463417749|FG001|Overall Study|Adverse Event|1|||
128761839|NCT01722162|463417748|FG000|Overall Study|Insurance denial post enrollment|0|||
128761840|NCT01722162|463417749|FG001|Overall Study|Insurance denial post enrollment|1|||
128761841|NCT01722162|463417748|FG000|Overall Study|Noncompliance|0|||
128761842|NCT01722162|463417749|FG001|Overall Study|Noncompliance|1|||
128761843|NCT03124199|463417750|FG000|Overall Study|Lost to Follow-up|4|||
128761844|NCT03056534|463417763|FG000|Overall Study|Participant withdrew consent|8|||
128761845|NCT03056534|463417763|FG000|Overall Study|Participant not able to return|6|||
128761846|NCT03056534|463417763|FG000|Overall Study|Lost to Follow-up|37|||
128761847|NCT03056534|463417763|FG000|Overall Study|Investigator judgment|1|||
128761848|NCT03056534|463417763|FG000|Overall Study|Death|4|||
128761849|NCT03056534|463417763|FG000|Overall Study|Adverse Event|1|||
128761850|NCT03056534|463417763|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
128761851|NCT03815019|463417764|FG000|Overall Study|Withdrawal by Subject|6|||
128761852|NCT03815019|463417765|FG001|Overall Study|Withdrawal by Subject|8|||
128761853|NCT00532155|463417766|FG000|Overall Study|Adverse Event|66|||
128761854|NCT00532155|463417767|FG001|Overall Study|Adverse Event|123|||
128761855|NCT00532155|463417766|FG000|Overall Study|Lack of Efficacy|332|||
128761856|NCT00532155|463417767|FG001|Overall Study|Lack of Efficacy|255|||
128761857|NCT00532155|463417766|FG000|Overall Study|Protocol Violation|1|||
128761858|NCT00532155|463417767|FG001|Overall Study|Protocol Violation|3|||
128761859|NCT00532155|463417766|FG000|Overall Study|Lost to Follow-up|2|||
128761860|NCT00532155|463417767|FG001|Overall Study|Lost to Follow-up|0|||
128761861|NCT00532155|463417766|FG000|Overall Study|Physician Decision|16|||
128761862|NCT00532155|463417767|FG001|Overall Study|Physician Decision|15|||
128761863|NCT00532155|463417766|FG000|Overall Study|Withdrawal by Subject|23|||
128761864|NCT00532155|463417767|FG001|Overall Study|Withdrawal by Subject|44|||
128761865|NCT00532155|463417766|FG000|Overall Study|Consent withdrawn|5|||
128761866|NCT00532155|463417767|FG001|Overall Study|Consent withdrawn|7|||
128761867|NCT00532155|463417766|FG000|Overall Study|Moved|1|||
128761868|NCT00532155|463417767|FG001|Overall Study|Moved|0|||
128761869|NCT00532155|463417766|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
128761870|NCT00532155|463417767|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
128761871|NCT00532155|463417766|FG000|Overall Study|Occurence of a second cancer|0|||
128761872|NCT00532155|463417767|FG001|Overall Study|Occurence of a second cancer|1|||
128761873|NCT00532155|463417766|FG000|Overall Study|Occurence of a secondary cancer|0|||
128761874|NCT00532155|463417767|FG001|Overall Study|Occurence of a secondary cancer|1|||
128761875|NCT00532155|463417766|FG000|Overall Study|Promotor ended study|1|||
128761876|NCT00532155|463417767|FG001|Overall Study|Promotor ended study|0|||
128761877|NCT00532155|463417766|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
128761878|NCT00532155|463417767|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
128761879|NCT00532155|463417766|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
128761880|NCT00532155|463417767|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
128761881|NCT00532155|463417766|FG000|Overall Study|Study stopped|1|||
128761882|NCT00532155|463417767|FG001|Overall Study|Study stopped|0|||
128761883|NCT00532155|463417766|FG000|Overall Study|Study terminated by sponsor|1|||
128761884|NCT00532155|463417767|FG001|Overall Study|Study terminated by sponsor|0|||
128761885|NCT00532155|463417766|FG000|Overall Study|Study termination stop further treatment|4|||
128761886|NCT00532155|463417767|FG001|Overall Study|Study termination stop further treatment|0|||
129040261|NCT03314662|464438809|FG002|Overall Study|Death|0|||
128761887|NCT00532155|463417766|FG000|Overall Study|Did not receive study medication|2|||
128761888|NCT00532155|463417767|FG001|Overall Study|Did not receive study medication|6|||
128761889|NCT02134925|463417768|FG000|Overall Study|Withdrawal by Subject|1|||
128761890|NCT02134925|463417769|FG001|Overall Study|Withdrawal by Subject|0|||
128761891|NCT02134925|463417768|FG000|Overall Study|Cancel|1|||
128761892|NCT02134925|463417769|FG001|Overall Study|Cancel|6|||
128761893|NCT00654901|463417772|FG000|Overall Study|Lost to Follow-up|1|||
128761894|NCT00654901|463417773|FG001|Overall Study|Lost to Follow-up|0|||
128761895|NCT00654901|463417774|FG002|Overall Study|Lost to Follow-up|1|||
128761896|NCT00654901|463417775|FG003|Overall Study|Lost to Follow-up|0|||
128761897|NCT00654901|463417772|FG000|Overall Study|Withdrawal by Subject|3|||
128761898|NCT00654901|463417773|FG001|Overall Study|Withdrawal by Subject|0|||
128761899|NCT00654901|463417774|FG002|Overall Study|Withdrawal by Subject|1|||
128761900|NCT00654901|463417775|FG003|Overall Study|Withdrawal by Subject|0|||
128761901|NCT04241094|463417779|FG000|Overall Study|Dropped out of treatment|4|||
128761902|NCT04241094|463417779|FG000|Overall Study|Ineligible after clinical assessment|2|||
128761903|NCT04241094|463417779|FG000|Overall Study|Lost to Follow-up|2|||
128761904|NCT02332590|463417780|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
128761905|NCT02332590|463417781|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
128761906|NCT02332590|463417780|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
128761907|NCT02332590|463417781|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
128761908|NCT02332590|463417780|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
128761909|NCT02332590|463417781|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
128761910|NCT02332590|463417780|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
128761911|NCT02332590|463417781|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
128761912|NCT02332590|463417780|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
128761913|NCT02332590|463417781|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
128761914|NCT02332590|463417780|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
128761915|NCT02332590|463417781|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
128761916|NCT02332590|463417780|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
128761917|NCT02332590|463417781|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
128761918|NCT02332590|463417780|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
128761919|NCT02332590|463417781|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
128761920|NCT02332590|463417780|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
128761921|NCT02332590|463417781|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
128761922|NCT03261271|463418966|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
128761923|NCT03261271|463418967|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
128761924|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
128761925|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
128761926|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
128761927|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
128761928|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
128761929|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
128761930|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
128761931|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
128761932|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
128761933|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
128761934|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
128761935|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
128761936|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
128761937|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
128761938|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
128761939|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
128761940|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
128761941|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
128761942|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
128761943|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
128761944|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Death|2|||
128761945|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Death|2|||
128761946|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Death|0|||
128761947|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Death|0|||
128761948|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Death|0|||
128761949|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
128761950|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
128761951|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
128761952|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
128761953|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
128761954|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
128761955|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
128761956|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
128761957|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
128761958|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
128761959|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
128761960|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
128761961|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
128761962|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
128761963|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
128761964|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
128761965|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
128761966|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
128761967|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
128761968|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
128761969|NCT03420781|463418968|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
128761970|NCT03420781|463418969|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
128761971|NCT03420781|463418970|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
128761972|NCT03420781|463418971|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
128761973|NCT03420781|463418972|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
128761974|NCT03420781|463418968|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
128761975|NCT03420781|463418969|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
128761976|NCT03420781|463418970|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
128761977|NCT03420781|463418971|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
128761978|NCT03420781|463418972|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
128761979|NCT03420781|463418968|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
128761980|NCT03420781|463418969|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
128761981|NCT03420781|463418970|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
128761982|NCT03420781|463418971|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
128761983|NCT03420781|463418972|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
128761984|NCT03420781|463418968|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
128761985|NCT03420781|463418969|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
128761986|NCT03420781|463418970|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
128761987|NCT03420781|463418971|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
128761988|NCT03420781|463418972|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
128761989|NCT00246337|463418973|FG000|Overall Study|Lost to Follow-up|3|||
128761990|NCT00246337|463418974|FG001|Overall Study|Lost to Follow-up|0|||
128761991|NCT00246337|463418975|FG002|Overall Study|Lost to Follow-up|0|||
128761992|NCT00246337|463418976|FG003|Overall Study|Lost to Follow-up|0|||
128761993|NCT00246337|463418977|FG004|Overall Study|Lost to Follow-up|2|||
128761994|NCT00246337|463418978|FG005|Overall Study|Lost to Follow-up|2|||
128761995|NCT00246337|463418979|FG006|Overall Study|Lost to Follow-up|1|||
128761996|NCT00246337|463418980|FG007|Overall Study|Lost to Follow-up|2|||
128761997|NCT00246337|463418981|FG008|Overall Study|Lost to Follow-up|0|||
128761998|NCT00246337|463418973|FG000|Overall Study|Protocol Violation|1|||
128761999|NCT00246337|463418974|FG001|Overall Study|Protocol Violation|0|||
128762000|NCT00246337|463418975|FG002|Overall Study|Protocol Violation|0|||
128762001|NCT00246337|463418976|FG003|Overall Study|Protocol Violation|0|||
128762002|NCT00246337|463418977|FG004|Overall Study|Protocol Violation|1|||
128762003|NCT00246337|463418978|FG005|Overall Study|Protocol Violation|0|||
128762004|NCT00246337|463418979|FG006|Overall Study|Protocol Violation|1|||
128762005|NCT00246337|463418980|FG007|Overall Study|Protocol Violation|1|||
128762006|NCT00246337|463418981|FG008|Overall Study|Protocol Violation|0|||
128762007|NCT00246337|463418973|FG000|Overall Study|Withdrawal by Subject|2|||
128762008|NCT00246337|463418974|FG001|Overall Study|Withdrawal by Subject|0|||
128762009|NCT00246337|463418975|FG002|Overall Study|Withdrawal by Subject|0|||
128762010|NCT00246337|463418976|FG003|Overall Study|Withdrawal by Subject|0|||
128762011|NCT00246337|463418977|FG004|Overall Study|Withdrawal by Subject|0|||
128762012|NCT00246337|463418978|FG005|Overall Study|Withdrawal by Subject|0|||
128762013|NCT00246337|463418979|FG006|Overall Study|Withdrawal by Subject|1|||
128762014|NCT00246337|463418980|FG007|Overall Study|Withdrawal by Subject|1|||
128762015|NCT00246337|463418981|FG008|Overall Study|Withdrawal by Subject|0|||
128762016|NCT00246337|463418973|FG000|Overall Study|Lack of Qualifying Event|8|||
128762017|NCT00246337|463418974|FG001|Overall Study|Lack of Qualifying Event|2|||
128762018|NCT00246337|463418975|FG002|Overall Study|Lack of Qualifying Event|1|||
128762019|NCT00246337|463418976|FG003|Overall Study|Lack of Qualifying Event|1|||
128762020|NCT00246337|463418977|FG004|Overall Study|Lack of Qualifying Event|1|||
128762021|NCT00246337|463418978|FG005|Overall Study|Lack of Qualifying Event|3|||
128762022|NCT00246337|463418979|FG006|Overall Study|Lack of Qualifying Event|3|||
128762023|NCT00246337|463418980|FG007|Overall Study|Lack of Qualifying Event|2|||
128762024|NCT00246337|463418981|FG008|Overall Study|Lack of Qualifying Event|5|||
128762025|NCT00246337|463418973|FG000|Overall Study|Site Terminated|10|||
128762026|NCT00246337|463418974|FG001|Overall Study|Site Terminated|0|||
128762027|NCT00246337|463418975|FG002|Overall Study|Site Terminated|0|||
128762028|NCT00246337|463418976|FG003|Overall Study|Site Terminated|0|||
128762029|NCT00246337|463418977|FG004|Overall Study|Site Terminated|0|||
128762030|NCT00246337|463418978|FG005|Overall Study|Site Terminated|7|||
128762031|NCT00246337|463418979|FG006|Overall Study|Site Terminated|1|||
128762032|NCT00246337|463418980|FG007|Overall Study|Site Terminated|6|||
128762033|NCT00246337|463418981|FG008|Overall Study|Site Terminated|2|||
128762034|NCT00246337|463418973|FG000|Overall Study|Abnormal baseline lab values|7|||
128762035|NCT00246337|463418974|FG001|Overall Study|Abnormal baseline lab values|0|||
128762036|NCT00246337|463418975|FG002|Overall Study|Abnormal baseline lab values|2|||
128762037|NCT00246337|463418976|FG003|Overall Study|Abnormal baseline lab values|0|||
128762038|NCT00246337|463418977|FG004|Overall Study|Abnormal baseline lab values|0|||
128762039|NCT00246337|463418978|FG005|Overall Study|Abnormal baseline lab values|2|||
128762040|NCT00246337|463418979|FG006|Overall Study|Abnormal baseline lab values|2|||
128762041|NCT00246337|463418980|FG007|Overall Study|Abnormal baseline lab values|0|||
128762042|NCT00246337|463418981|FG008|Overall Study|Abnormal baseline lab values|4|||
128762043|NCT00246337|463418973|FG000|Overall Study|Overwhelmed|0|||
128762044|NCT00246337|463418974|FG001|Overall Study|Overwhelmed|0|||
128762045|NCT00246337|463418975|FG002|Overall Study|Overwhelmed|0|||
128762046|NCT00246337|463418976|FG003|Overall Study|Overwhelmed|0|||
128762047|NCT00246337|463418977|FG004|Overall Study|Overwhelmed|0|||
128762048|NCT00246337|463418978|FG005|Overall Study|Overwhelmed|1|||
128762049|NCT00246337|463418979|FG006|Overall Study|Overwhelmed|0|||
128762050|NCT00246337|463418980|FG007|Overall Study|Overwhelmed|0|||
128762051|NCT00246337|463418981|FG008|Overall Study|Overwhelmed|0|||
128762052|NCT00246337|463418973|FG000|Overall Study|Protocol Violator|1|||
128762053|NCT00246337|463418974|FG001|Overall Study|Protocol Violator|0|||
128762054|NCT00246337|463418975|FG002|Overall Study|Protocol Violator|0|||
128762055|NCT00246337|463418976|FG003|Overall Study|Protocol Violator|0|||
128762056|NCT00246337|463418977|FG004|Overall Study|Protocol Violator|0|||
128762057|NCT00246337|463418978|FG005|Overall Study|Protocol Violator|0|||
128762058|NCT00246337|463418979|FG006|Overall Study|Protocol Violator|0|||
128762059|NCT00246337|463418980|FG007|Overall Study|Protocol Violator|0|||
128762060|NCT00246337|463418981|FG008|Overall Study|Protocol Violator|0|||
128762061|NCT00246337|463418973|FG000|Overall Study|Reported as completing trial in error|0|||
128762062|NCT00246337|463418974|FG001|Overall Study|Reported as completing trial in error|0|||
128762063|NCT00246337|463418975|FG002|Overall Study|Reported as completing trial in error|0|||
128762064|NCT00246337|463418976|FG003|Overall Study|Reported as completing trial in error|0|||
128762065|NCT00246337|463418977|FG004|Overall Study|Reported as completing trial in error|0|||
128762066|NCT00246337|463418978|FG005|Overall Study|Reported as completing trial in error|0|||
128762067|NCT00246337|463418979|FG006|Overall Study|Reported as completing trial in error|0|||
128762068|NCT00246337|463418980|FG007|Overall Study|Reported as completing trial in error|1|||
128762069|NCT00246337|463418981|FG008|Overall Study|Reported as completing trial in error|0|||
128762070|NCT00185640|463418983|FG000|Overall Study|Not Eligible|4|||
128762071|NCT00185640|463418983|FG000|Overall Study|Withdrawal by Subject|3|||
128762072|NCT00185640|463418983|FG000|Overall Study|Death|138|||
128762073|NCT00058422|463418984|FG000|Overall Study|Not treated|2|||
128762074|NCT03086018|463418985|FG000|Final Testing for End of Trial|Adverse Event|1|||
128762075|NCT03086018|463418985|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
128762076|NCT02748694|463418986|FG000|Overall Study|Voluntary Withdrawal|0|||
128762077|NCT02748694|463418987|FG001|Overall Study|Voluntary Withdrawal|0|||
128762078|NCT02748694|463418988|FG002|Overall Study|Voluntary Withdrawal|0|||
128762079|NCT02748694|463418989|FG003|Overall Study|Voluntary Withdrawal|0|||
128762080|NCT02748694|463418990|FG004|Overall Study|Voluntary Withdrawal|0|||
128762081|NCT02748694|463418991|FG005|Overall Study|Voluntary Withdrawal|0|||
128762082|NCT02748694|463418992|FG006|Overall Study|Voluntary Withdrawal|0|||
128762083|NCT02748694|463418993|FG007|Overall Study|Voluntary Withdrawal|0|||
128762084|NCT02748694|463418994|FG008|Overall Study|Voluntary Withdrawal|0|||
128762085|NCT02748694|463418995|FG009|Overall Study|Voluntary Withdrawal|0|||
128762086|NCT02748694|463418996|FG010|Overall Study|Voluntary Withdrawal|0|||
128762087|NCT02748694|463418997|FG011|Overall Study|Voluntary Withdrawal|0|||
128762088|NCT02748694|463418998|FG012|Overall Study|Voluntary Withdrawal|0|||
128762089|NCT02748694|463418999|FG013|Overall Study|Voluntary Withdrawal|0|||
128762090|NCT02748694|463419000|FG014|Overall Study|Voluntary Withdrawal|2|||
128762091|NCT00077064|463419001|FG000|Overall Study|Adverse Event|0|||
128762092|NCT00077064|463419002|FG001|Overall Study|Adverse Event|4|||
128762093|NCT00077064|463419001|FG000|Overall Study|Patient refusal|0|||
128762094|NCT00077064|463419002|FG001|Overall Study|Patient refusal|2|||
128762095|NCT00621543|463419003|FG000|Overall Study|Lost to Follow-up|23|||
128762096|NCT02192970|463419006|FG000|Overall Study|Lost to Follow-up|6|||
128762097|NCT02192970|463419007|FG001|Overall Study|Lost to Follow-up|0|||
128762098|NCT04074590|463419008|FG000|Overall Study|Adverse Event|1|||
128762099|NCT04074590|463419009|FG001|Overall Study|Adverse Event|0|||
128762100|NCT04074590|463419008|FG000|Overall Study|Physician Decision|1|||
128762101|NCT04074590|463419009|FG001|Overall Study|Physician Decision|0|||
128762102|NCT04074590|463419008|FG000|Overall Study|Withdrawal by Subject|2|||
128762103|NCT04074590|463419009|FG001|Overall Study|Withdrawal by Subject|0|||
128762104|NCT00691132|463419010|FG000|Overall Study|Adverse Event|2|||
128762105|NCT00691132|463419011|FG001|Overall Study|Adverse Event|3|||
128762106|NCT00691132|463419010|FG000|Overall Study|Withdrawal by Subject|10|||
128762107|NCT00691132|463419011|FG001|Overall Study|Withdrawal by Subject|10|||
128762108|NCT03954743|463419012|FG000|Overall Study|Adverse Event|1|||
128762109|NCT03954743|463419013|FG001|Overall Study|Adverse Event|0|||
128762110|NCT03954743|463419012|FG000|Overall Study|Lost to Follow-up|6|||
128762111|NCT03954743|463419013|FG001|Overall Study|Lost to Follow-up|4|||
128762112|NCT03954743|463419012|FG000|Overall Study|Protocol Violation|1|||
128762113|NCT03954743|463419013|FG001|Overall Study|Protocol Violation|0|||
128762114|NCT03954743|463419012|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
128762115|NCT03954743|463419013|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
128762116|NCT03954743|463419012|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
128762117|NCT03954743|463419013|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128762118|NCT02387996|463419018|FG000|Overall Study|Disease Progression|167|||
128762119|NCT02387996|463419018|FG000|Overall Study|Study Drug Toxicity|31|||
128762120|NCT02387996|463419018|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
128762121|NCT02387996|463419018|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
128762122|NCT02387996|463419018|FG000|Overall Study|Subject Withdrew Consent|5|||
128762123|NCT02387996|463419018|FG000|Overall Study|Lost to Follow-up|1|||
128762124|NCT02387996|463419018|FG000|Overall Study|Poor/Non-Compliance|1|||
128762125|NCT02387996|463419018|FG000|Overall Study|Other Reasons|5|||
128762126|NCT02387996|463419018|FG000|Overall Study|Death|1|||
128762127|NCT05375955|463419027|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
128762128|NCT05375955|463419028|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
128762129|NCT05375955|463419029|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
128762130|NCT05375955|463419030|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
128762131|NCT05375955|463419031|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
128762132|NCT05375955|463419032|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
128762133|NCT05375955|463419033|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
128762134|NCT05375955|463419027|FG000|Treatment (12 Weeks)|Physician Decision|4|||
128762135|NCT05375955|463419028|FG001|Treatment (12 Weeks)|Physician Decision|1|||
128762136|NCT05375955|463419029|FG002|Treatment (12 Weeks)|Physician Decision|3|||
128762137|NCT05375955|463419030|FG003|Treatment (12 Weeks)|Physician Decision|0|||
128762138|NCT05375955|463419031|FG004|Treatment (12 Weeks)|Physician Decision|0|||
128762139|NCT05375955|463419032|FG005|Treatment (12 Weeks)|Physician Decision|1|||
128762140|NCT05375955|463419033|FG006|Treatment (12 Weeks)|Physician Decision|0|||
128762141|NCT05375955|463419027|FG000|Treatment (12 Weeks)|Other|0|||
128762142|NCT05375955|463419028|FG001|Treatment (12 Weeks)|Other|1|||
128762143|NCT05375955|463419029|FG002|Treatment (12 Weeks)|Other|0|||
128762144|NCT05375955|463419030|FG003|Treatment (12 Weeks)|Other|0|||
128762145|NCT05375955|463419031|FG004|Treatment (12 Weeks)|Other|0|||
128762146|NCT05375955|463419032|FG005|Treatment (12 Weeks)|Other|0|||
128762147|NCT05375955|463419033|FG006|Treatment (12 Weeks)|Other|0|||
128762148|NCT05375955|463419027|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
128762149|NCT05375955|463419028|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
128762150|NCT05375955|463419029|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
128762151|NCT05375955|463419030|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
128762152|NCT05375955|463419031|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
128762153|NCT05375955|463419032|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
128762154|NCT05375955|463419033|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
128762155|NCT05375955|463419027|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
128762156|NCT05375955|463419028|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
128762157|NCT05375955|463419029|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
128762158|NCT05375955|463419030|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
128762159|NCT05375955|463419031|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
128762160|NCT05375955|463419032|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
128762161|NCT05375955|463419033|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
128762162|NCT05375955|463419027|FG000|Treatment (12 Weeks)|Pregnancy|0|||
128762163|NCT05375955|463419028|FG001|Treatment (12 Weeks)|Pregnancy|0|||
128870903|NCT03986944|463822129|FG000|Overall Study|Withdrawal by Subject|3|||
128870904|NCT03986944|463822130|FG001|Overall Study|Withdrawal by Subject|5|||
128870905|NCT03986944|463822131|FG002|Overall Study|Withdrawal by Subject|5|||
128870906|NCT03986944|463822129|FG000|Overall Study|Study termination|10|||
128870907|NCT03986944|463822130|FG001|Overall Study|Study termination|10|||
129040262|NCT00440115|464438815|FG000|Overall Study|Death|7|||
128870908|NCT03986944|463822131|FG002|Overall Study|Study termination|10|||
128870909|NCT03986944|463822129|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
128977814|NCT02452034|464205204|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
128977815|NCT02452034|464205205|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
128977816|NCT02452034|464205206|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
128977817|NCT02452034|464205207|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
128977818|NCT00561795|464205208|FG000|Overall Study|Adverse Event|3|||
128977819|NCT00561795|464205209|FG001|Overall Study|Adverse Event|3|||
128977820|NCT00561795|464205210|FG002|Overall Study|Adverse Event|0|||
128977821|NCT00561795|464205211|FG003|Overall Study|Adverse Event|0|||
128977822|NCT00561795|464205208|FG000|Overall Study|Study Closed/Terminated|0|||
128977823|NCT00561795|464205209|FG001|Overall Study|Study Closed/Terminated|3|||
128977824|NCT00561795|464205210|FG002|Overall Study|Study Closed/Terminated|0|||
128982603|NCT01153971|464223054|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
128982604|NCT03410693|464223055|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
128982605|NCT03410693|464223056|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
128982606|NCT03410693|464223055|FG000|Overall Study|Disc trt: Lost to follow up|0|||
128982607|NCT03410693|464223056|FG001|Overall Study|Disc trt: Lost to follow up|1|||
128982608|NCT03410693|464223055|FG000|Overall Study|Disc trt: radiological progression|58|||
128982609|NCT03410693|464223056|FG001|Overall Study|Disc trt: radiological progression|50|||
128982610|NCT03410693|464223055|FG000|Overall Study|Disc trt: Other|1|||
128982611|NCT03410693|464223056|FG001|Overall Study|Disc trt: Other|0|||
128982612|NCT03410693|464223055|FG000|Overall Study|Study drug never administered|1|||
128982613|NCT03410693|464223056|FG001|Overall Study|Study drug never administered|6|||
128982614|NCT03410693|464223055|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
128982615|NCT03410693|464223056|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
128982616|NCT03410693|464223055|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
128982617|NCT03410693|464223056|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
128982618|NCT03410693|464223055|FG000|Overall Study|Disc trt: Physician decision|0|||
128982619|NCT03410693|464223056|FG001|Overall Study|Disc trt: Physician decision|5|||
128982620|NCT03410693|464223055|FG000|Overall Study|Disc trt: clinical progression|1|||
128982621|NCT03410693|464223056|FG001|Overall Study|Disc trt: clinical progression|5|||
128982622|NCT03410693|464223055|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
128982623|NCT03410693|464223056|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
128982624|NCT00953576|464223057|FG000|Overall Study|Adverse Event|0|||
128982625|NCT00953576|464223058|FG001|Overall Study|Adverse Event|1|||
128982626|NCT00953576|464223057|FG000|Overall Study|Ineligible after Consent|2|||
128982627|NCT00953576|464223058|FG001|Overall Study|Ineligible after Consent|0|||
128982628|NCT03628781|464223063|FG000|Overall Study|Lost to Follow-up|16|||
128982629|NCT03628781|464223064|FG001|Overall Study|Lost to Follow-up|8|||
128982630|NCT03628781|464223063|FG000|Overall Study|Withdrawal by Subject|16|||
128982631|NCT03628781|464223064|FG001|Overall Study|Withdrawal by Subject|1|||
128982632|NCT01545375|464223067|FG000|Overall Study|Adverse Event|2|||
128982633|NCT01545375|464223068|FG001|Overall Study|Adverse Event|1|||
128982634|NCT01545375|464223067|FG000|Overall Study|Lost to Follow-up|34|||
128982635|NCT01545375|464223068|FG001|Overall Study|Lost to Follow-up|31|||
128982636|NCT01545375|464223067|FG000|Overall Study|Protocol Violation|3|||
128982637|NCT01545375|464223068|FG001|Overall Study|Protocol Violation|3|||
128982638|NCT01545375|464223067|FG000|Overall Study|Withdrawal by Subject|58|||
128982639|NCT01545375|464223068|FG001|Overall Study|Withdrawal by Subject|55|||
128982640|NCT02687815|464223069|FG000|Overall Study|Lost to Follow-up|2|||
128982641|NCT02687815|464223070|FG001|Overall Study|Lost to Follow-up|4|||
128982642|NCT02687815|464223069|FG000|Overall Study|Withdrawal by Subject|2|||
128982643|NCT02687815|464223070|FG001|Overall Study|Withdrawal by Subject|4|||
128982644|NCT01846039|464223071|FG000|Overall Study|Protocol Violation|1|||
128982645|NCT01846039|464223071|FG000|Overall Study|Subject Withdrew Consent|1|||
128982646|NCT04854421|464223072|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
128982647|NCT04854421|464223073|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
128982648|NCT03472586|464223079|FG000|Overall Study|Physician Decision|6|||
128982649|NCT03472586|464223079|FG000|Overall Study|Death|6|||
128982650|NCT03472586|464223079|FG000|Overall Study|Adverse Event|1|||
128982651|NCT02528331|464223080|FG000|Overall Study|Withdrawal by Subject|2|||
128982652|NCT01399619|464223081|FG000|Overall Study|Adverse Event|10|||
128982653|NCT01399619|464223082|FG001|Overall Study|Adverse Event|0|||
128982654|NCT01399619|464223083|FG002|Overall Study|Adverse Event|4|||
128982655|NCT01399619|464223084|FG003|Overall Study|Adverse Event|10|||
128982656|NCT01399619|464223081|FG000|Overall Study|Lack of Efficacy|9|||
128982657|NCT01399619|464223082|FG001|Overall Study|Lack of Efficacy|0|||
128982658|NCT01399619|464223083|FG002|Overall Study|Lack of Efficacy|5|||
128982659|NCT01399619|464223084|FG003|Overall Study|Lack of Efficacy|0|||
128982660|NCT01399619|464223081|FG000|Overall Study|Withdrawal by Subject|6|||
128982661|NCT01399619|464223082|FG001|Overall Study|Withdrawal by Subject|0|||
128982662|NCT01399619|464223083|FG002|Overall Study|Withdrawal by Subject|3|||
128982663|NCT01399619|464223084|FG003|Overall Study|Withdrawal by Subject|4|||
128982664|NCT01399619|464223081|FG000|Overall Study|Protocol Violation|0|||
128982665|NCT01399619|464223082|FG001|Overall Study|Protocol Violation|0|||
128982666|NCT01399619|464223083|FG002|Overall Study|Protocol Violation|0|||
128982667|NCT01399619|464223084|FG003|Overall Study|Protocol Violation|1|||
128982668|NCT01399619|464223081|FG000|Overall Study|Not treated|0|||
128982669|NCT01399619|464223082|FG001|Overall Study|Not treated|0|||
128982670|NCT01399619|464223083|FG002|Overall Study|Not treated|0|||
128982671|NCT01399619|464223084|FG003|Overall Study|Not treated|2|||
128982672|NCT00462501|464223085|FG000|Overall Study|Not treated|3|||
128982673|NCT00462501|464223085|FG000|Overall Study|Adverse Event|2|||
128982674|NCT00998166|464223086|FG000|Overall Study|Early Study Termination|8|||
128762164|NCT05375955|463419029|FG002|Treatment (12 Weeks)|Pregnancy|1|||
128982675|NCT04988035|464223089|FG000|Overall Study|Death|19|||
128762165|NCT05375955|463419030|FG003|Treatment (12 Weeks)|Pregnancy|0|||
128762166|NCT05375955|463419031|FG004|Treatment (12 Weeks)|Pregnancy|0|||
128982676|NCT04988035|464223090|FG001|Overall Study|Death|13|||
128982677|NCT04988035|464223089|FG000|Overall Study|Lost to Follow-up|12|||
128982678|NCT04988035|464223090|FG001|Overall Study|Lost to Follow-up|6|||
128982679|NCT04988035|464223089|FG000|Overall Study|Protocol Violation|0|||
128982680|NCT04988035|464223090|FG001|Overall Study|Protocol Violation|1|||
128982681|NCT04988035|464223089|FG000|Overall Study|Withdrawal by Subject|2|||
128982682|NCT04988035|464223090|FG001|Overall Study|Withdrawal by Subject|4|||
128982683|NCT04988035|464223089|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
128982684|NCT04988035|464223090|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
128982685|NCT00399542|464223091|FG000|Overall Study|Adverse Event|18|||
128982686|NCT00399542|464223092|FG001|Overall Study|Adverse Event|15|||
128982687|NCT00399542|464223091|FG000|Overall Study|Protocol Violation|13|||
128982688|NCT00399542|464223092|FG001|Overall Study|Protocol Violation|3|||
128982689|NCT00399542|464223091|FG000|Overall Study|Withdrawal by Subject|28|||
128982690|NCT00399542|464223092|FG001|Overall Study|Withdrawal by Subject|10|||
128982691|NCT00399542|464223091|FG000|Overall Study|Lack of Efficacy|18|||
128982692|NCT00399542|464223092|FG001|Overall Study|Lack of Efficacy|8|||
128982693|NCT00399542|464223091|FG000|Overall Study|Lost to Follow-up|6|||
128982694|NCT00399542|464223092|FG001|Overall Study|Lost to Follow-up|6|||
128982695|NCT00399542|464223091|FG000|Overall Study|Other|1|||
128982696|NCT00399542|464223092|FG001|Overall Study|Other|0|||
128982697|NCT00399542|464223091|FG000|Overall Study|Physician Decision|0|||
128982698|NCT00399542|464223092|FG001|Overall Study|Physician Decision|1|||
128982699|NCT03172026|464223093|FG000|Overall Study|Withdrawal by Subject|1|||
128982700|NCT03172026|464223094|FG001|Overall Study|Withdrawal by Subject|0|||
128762167|NCT05375955|463419032|FG005|Treatment (12 Weeks)|Pregnancy|0|||
128762168|NCT05375955|463419033|FG006|Treatment (12 Weeks)|Pregnancy|0|||
128762169|NCT05375955|463419027|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
128762170|NCT05375955|463419028|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
128982701|NCT03172026|464223093|FG000|Overall Study|COVID restrictions|1|||
128982702|NCT03172026|464223094|FG001|Overall Study|COVID restrictions|0|||
128982703|NCT00612456|464223095|FG000|Overall Study|Adverse Event|1|||
128982704|NCT00612456|464223096|FG001|Overall Study|Adverse Event|0|||
128982705|NCT00612456|464223097|FG002|Overall Study|Adverse Event|0|||
128982706|NCT00612456|464223095|FG000|Overall Study|Lack of Efficacy|1|||
128982707|NCT00612456|464223096|FG001|Overall Study|Lack of Efficacy|1|||
128982708|NCT00612456|464223097|FG002|Overall Study|Lack of Efficacy|0|||
128982709|NCT00612456|464223095|FG000|Overall Study|Withdrawal by Subject|0|||
128982710|NCT00612456|464223096|FG001|Overall Study|Withdrawal by Subject|1|||
128982711|NCT00612456|464223097|FG002|Overall Study|Withdrawal by Subject|0|||
128982712|NCT00265109|464223098|FG000|Overall Study|Withdrawal by Subject|5|||
128982713|NCT00265109|464223098|FG000|Overall Study|Adverse Event|1|||
128982714|NCT00920582|464223099|FG000|Overall Study|Lost to Follow-up|5|||
128982715|NCT00920582|464223100|FG001|Overall Study|Lost to Follow-up|1|||
128982716|NCT00920582|464223101|FG002|Overall Study|Lost to Follow-up|2|||
128982717|NCT00920582|464223102|FG003|Overall Study|Lost to Follow-up|0|||
128982718|NCT00920582|464223099|FG000|Overall Study|Withdrawal by Subject|5|||
128982719|NCT00920582|464223100|FG001|Overall Study|Withdrawal by Subject|4|||
128982720|NCT00920582|464223101|FG002|Overall Study|Withdrawal by Subject|6|||
128982721|NCT00920582|464223102|FG003|Overall Study|Withdrawal by Subject|3|||
128982722|NCT00920582|464223099|FG000|Overall Study|Protocol Violation|1|||
128982723|NCT00920582|464223100|FG001|Overall Study|Protocol Violation|0|||
128982724|NCT00920582|464223101|FG002|Overall Study|Protocol Violation|0|||
128982725|NCT00920582|464223102|FG003|Overall Study|Protocol Violation|0|||
128982726|NCT00920582|464223099|FG000|Overall Study|Other|2|||
128982727|NCT00920582|464223100|FG001|Overall Study|Other|1|||
128982728|NCT00920582|464223101|FG002|Overall Study|Other|3|||
128982729|NCT00920582|464223102|FG003|Overall Study|Other|2|||
128982730|NCT02924129|464223105|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
129040263|NCT00440115|464438816|FG001|Overall Study|Death|9|||
128762171|NCT05375955|463419029|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
128762172|NCT05375955|463419030|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
128762173|NCT05375955|463419031|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
128762174|NCT05375955|463419032|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
128762175|NCT05375955|463419033|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
128762176|NCT05375955|463419027|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
128762177|NCT05375955|463419028|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
128762178|NCT05375955|463419029|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
128762179|NCT05375955|463419030|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
128762180|NCT05375955|463419031|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
128762181|NCT05375955|463419032|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
128762182|NCT05375955|463419033|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
128762183|NCT05375955|463419027|FG000|Follow-up (up to 5 Weeks)|Other|0|||
128762184|NCT05375955|463419028|FG001|Follow-up (up to 5 Weeks)|Other|1|||
128762185|NCT05375955|463419029|FG002|Follow-up (up to 5 Weeks)|Other|0|||
128762186|NCT05375955|463419030|FG003|Follow-up (up to 5 Weeks)|Other|0|||
128762187|NCT05375955|463419031|FG004|Follow-up (up to 5 Weeks)|Other|0|||
128982731|NCT02924129|464223106|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
128982732|NCT02924129|464223105|FG000|Overall Study|Withdrawal by Subject|2|||
128982733|NCT02924129|464223106|FG001|Overall Study|Withdrawal by Subject|2|||
128982734|NCT02924129|464223105|FG000|Overall Study|Physician Decision|1|||
128982735|NCT02924129|464223106|FG001|Overall Study|Physician Decision|0|||
128982736|NCT02924129|464223105|FG000|Overall Study|Missed Visit|0|||
128982737|NCT02924129|464223106|FG001|Overall Study|Missed Visit|1|||
128982738|NCT00656669|464224781|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
128982739|NCT00656669|464224781|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
128982740|NCT00656669|464224781|FG000|AC (Cycles 6-9)|Adverse Event|1|||
128982741|NCT00656669|464224781|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
128982742|NCT03778021|464224782|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
128982743|NCT03778021|464224783|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
128982744|NCT00679042|464224784|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
128982745|NCT00679042|464224784|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
128982746|NCT00679042|464224784|FG000|5-Year Follow Up|Death|1|||
128982747|NCT00679042|464224784|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
128982748|NCT00679042|464224784|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
128982749|NCT01224171|464224785|FG000|Overall Study|Adverse Event|8|||
128982750|NCT01224171|464224786|FG001|Overall Study|Adverse Event|4|||
128982751|NCT01224171|464224785|FG000|Overall Study|Protocol Violation|0|||
128982752|NCT01224171|464224786|FG001|Overall Study|Protocol Violation|1|||
128982753|NCT01224171|464224785|FG000|Overall Study|Lack of Efficacy|5|||
128982754|NCT01224171|464224786|FG001|Overall Study|Lack of Efficacy|1|||
128982755|NCT01224171|464224785|FG000|Overall Study|Withdrawal of Consent|2|||
128982756|NCT01224171|464224786|FG001|Overall Study|Withdrawal of Consent|4|||
128982757|NCT01224171|464224785|FG000|Overall Study|Lost to Follow-up|0|||
128982758|NCT01224171|464224786|FG001|Overall Study|Lost to Follow-up|3|||
128982759|NCT03737812|464224787|FG000|Overall Study|Withdrawal by Subject|1|||
128982760|NCT03737812|464224788|FG001|Overall Study|Withdrawal by Subject|2|||
128982761|NCT03737812|464224789|FG002|Overall Study|Withdrawal by Subject|1|||
128982762|NCT03737812|464224787|FG000|Overall Study|Sponsor Discontinued the Study|4|||
128982763|NCT03737812|464224788|FG001|Overall Study|Sponsor Discontinued the Study|3|||
128982764|NCT03737812|464224789|FG002|Overall Study|Sponsor Discontinued the Study|2|||
128982765|NCT03737812|464224787|FG000|Overall Study|Adverse Event|0|||
128982766|NCT03737812|464224788|FG001|Overall Study|Adverse Event|1|||
128982767|NCT03737812|464224789|FG002|Overall Study|Adverse Event|0|||
128982768|NCT03737812|464224787|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
128982769|NCT03737812|464224788|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
128982770|NCT03737812|464224789|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
128982771|NCT02624713|464224790|FG000|Overall Study|Lost to Follow-up|14|||
128982772|NCT02624713|464224791|FG001|Overall Study|Lost to Follow-up|0|||
128982773|NCT00285857|464224795|FG000|Overall Study|Withdrawal by Subject|2|||
128982774|NCT00285857|464224795|FG000|Overall Study|Inadequate initial breast cytology|1|||
128982775|NCT00285857|464224795|FG000|Overall Study|Adverse Event|1|||
128982776|NCT01161173|464224801|FG000|Overall Study|Protocol Violation|13|||
128982777|NCT01161173|464224801|FG000|Overall Study|Lost to Follow-up|7|||
128982778|NCT01161173|464224801|FG000|Overall Study|Progressive Disease|82|||
128982779|NCT01161173|464224801|FG000|Overall Study|Withdrawal of Consent|5|||
128982780|NCT01161173|464224801|FG000|Overall Study|Unacceptable Toxicity|21|||
128982781|NCT01161173|464224801|FG000|Overall Study|Death|194|||
128982782|NCT01161173|464224801|FG000|Overall Study|End of Study|2|||
128982783|NCT01161173|464224801|FG000|Overall Study|Reasons Not Specified|23|||
128982784|NCT00792467|464224804|FG000|Overall Study|progression of disease|17|||
128982785|NCT00792467|464224804|FG000|Overall Study|Adverse Event|1|||
128982786|NCT00792467|464224804|FG000|Overall Study|patient request|1|||
128982787|NCT00792467|464224804|FG000|Overall Study|Lost to Follow-up|1|||
128982788|NCT00792467|464224804|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
128982789|NCT00792467|464224804|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
128982790|NCT03911401|464224805|FG000|Overall Study|Adverse Event|1|||
128982791|NCT03911401|464224806|FG001|Overall Study|Adverse Event|2|||
128982792|NCT03911401|464224807|FG002|Overall Study|Adverse Event|5|||
128982793|NCT03911401|464224805|FG000|Overall Study|Lack of Efficacy|1|||
128982794|NCT03911401|464224806|FG001|Overall Study|Lack of Efficacy|1|||
128982795|NCT03911401|464224807|FG002|Overall Study|Lack of Efficacy|8|||
128982796|NCT03911401|464224805|FG000|Overall Study|Physician Decision|0|||
128982797|NCT03911401|464224806|FG001|Overall Study|Physician Decision|0|||
128982798|NCT03911401|464224807|FG002|Overall Study|Physician Decision|1|||
128982799|NCT03911401|464224805|FG000|Overall Study|Withdrawal by Subject|1|||
128982800|NCT03911401|464224806|FG001|Overall Study|Withdrawal by Subject|2|||
128982801|NCT03911401|464224807|FG002|Overall Study|Withdrawal by Subject|0|||
128982802|NCT03911401|464224805|FG000|Overall Study|Withdrawal by parent/guardian|4|||
128982803|NCT03911401|464224806|FG001|Overall Study|Withdrawal by parent/guardian|4|||
128982804|NCT03911401|464224807|FG002|Overall Study|Withdrawal by parent/guardian|11|||
129094337|NCT00793624|464636116|FG001|Overall Study|Other reason not described above|4|||
128762188|NCT05375955|463419032|FG005|Follow-up (up to 5 Weeks)|Other|0|||
128762189|NCT05375955|463419033|FG006|Follow-up (up to 5 Weeks)|Other|0|||
128762190|NCT05375955|463419027|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
128762191|NCT05375955|463419028|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
128762192|NCT05375955|463419029|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
128762193|NCT05375955|463419030|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
128762194|NCT05375955|463419031|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
128762195|NCT05375955|463419032|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
128762196|NCT05375955|463419033|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
128762197|NCT05375955|463419027|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
128762198|NCT05375955|463419028|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
128762199|NCT05375955|463419029|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
128762200|NCT05375955|463419030|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
128762201|NCT05375955|463419031|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
128762202|NCT05375955|463419032|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
128762203|NCT05375955|463419033|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
128762204|NCT01320943|463419034|FG000|Overall Study|Lost to Follow-up|1|||
128762205|NCT01320943|463419035|FG001|Overall Study|Lost to Follow-up|0|||
128762206|NCT01320943|463419034|FG000|Overall Study|Physician Decision|0|||
128762207|NCT01320943|463419035|FG001|Overall Study|Physician Decision|1|||
128762208|NCT01320943|463419034|FG000|Overall Study|Randomized but not Treated|0|||
128982805|NCT02918968|464224808|FG000|1st Line AAT|Progressive disease|9|||
128982806|NCT02918968|464224809|FG001|1st Line AAT|Progressive disease|4|||
128982807|NCT02918968|464224808|FG000|1st Line AAT|Adverse Event|12|||
128762209|NCT01320943|463419035|FG001|Overall Study|Randomized but not Treated|1|||
128762210|NCT02063828|463419038|FG000|Overall Study|Withdrawal by Subject|4|||
128762211|NCT02063828|463419039|FG001|Overall Study|Withdrawal by Subject|6|||
128982808|NCT02918968|464224809|FG001|1st Line AAT|Adverse Event|3|||
128982809|NCT02918968|464224808|FG000|1st Line AAT|Physician Decision|4|||
128982810|NCT02918968|464224809|FG001|1st Line AAT|Physician Decision|2|||
128982811|NCT02918968|464224808|FG000|1st Line AAT|Withdrawal by Subject|2|||
128982812|NCT02918968|464224809|FG001|1st Line AAT|Withdrawal by Subject|1|||
128982813|NCT02918968|464224808|FG000|1st Line AAT|Lost to Follow-up|0|||
128982814|NCT02918968|464224809|FG001|1st Line AAT|Lost to Follow-up|1|||
128982815|NCT02918968|464224808|FG000|1st Line AAT|Death|1|||
128982816|NCT02918968|464224809|FG001|1st Line AAT|Death|0|||
128982817|NCT02918968|464224808|FG000|1st Line AAT|Miscellaneous|1|||
128982818|NCT02918968|464224809|FG001|1st Line AAT|Miscellaneous|0|||
128982819|NCT02918968|464224808|FG000|2nd Line AAT|Progressive disease|21|||
128982820|NCT02918968|464224809|FG001|2nd Line AAT|Progressive disease|3|||
128982821|NCT02918968|464224808|FG000|2nd Line AAT|Adverse Event|2|||
128982822|NCT02918968|464224809|FG001|2nd Line AAT|Adverse Event|5|||
128982823|NCT02918968|464224808|FG000|2nd Line AAT|Physician Decision|0|||
128982824|NCT02918968|464224809|FG001|2nd Line AAT|Physician Decision|1|||
128982825|NCT02918968|464224808|FG000|2nd Line AAT|Withdrawal by Subject|2|||
128982826|NCT02918968|464224809|FG001|2nd Line AAT|Withdrawal by Subject|2|||
128982827|NCT02918968|464224808|FG000|2nd Line AAT|Death|0|||
128982828|NCT02918968|464224809|FG001|2nd Line AAT|Death|1|||
128982829|NCT03781167|464224819|FG000|Overall Study|Adverse Event|23|||
128982830|NCT03781167|464224820|FG001|Overall Study|Adverse Event|25|||
128982831|NCT03781167|464224819|FG000|Overall Study|Withdrew consent|16|||
128982832|NCT03781167|464224820|FG001|Overall Study|Withdrew consent|12|||
128982833|NCT03781167|464224819|FG000|Overall Study|Lost to Follow-up|0|||
128982834|NCT03781167|464224820|FG001|Overall Study|Lost to Follow-up|1|||
128982835|NCT03781167|464224819|FG000|Overall Study|Lack of Efficacy|4|||
128982836|NCT03781167|464224820|FG001|Overall Study|Lack of Efficacy|5|||
128982837|NCT03781167|464224819|FG000|Overall Study|Difficulty with drug delivery system|2|||
128982838|NCT03781167|464224820|FG001|Overall Study|Difficulty with drug delivery system|3|||
128982839|NCT03781167|464224819|FG000|Overall Study|Other, not specified|2|||
128982840|NCT03781167|464224820|FG001|Overall Study|Other, not specified|2|||
128762212|NCT02063828|463419040|FG002|Overall Study|Withdrawal by Subject|3|||
128762213|NCT02063828|463419038|FG000|Overall Study|Death|0|||
128762214|NCT02063828|463419039|FG001|Overall Study|Death|0|||
128762215|NCT02063828|463419040|FG002|Overall Study|Death|1|||
128762216|NCT03937219|463419041|FG000|Overall Study|Death|223|||
128982841|NCT01590628|464224822|FG000|Overall Study|Death|2|||
128982842|NCT01590628|464224823|FG001|Overall Study|Death|0|||
128982843|NCT00475657|464224824|FG000|Overall Study|Death|1|||
128982844|NCT00475657|464224824|FG000|Overall Study|Sponsor's Decision|3|||
128982845|NCT00381680|464224825|FG000|Overall Study|Adverse Event|9|||
128982846|NCT00381680|464224826|FG001|Overall Study|Adverse Event|3|||
128982847|NCT00381680|464224825|FG000|Overall Study|Death|10|||
128982848|NCT00381680|464224826|FG001|Overall Study|Death|7|||
128982849|NCT00381680|464224825|FG000|Overall Study|Lost to Follow-up|3|||
128982850|NCT00381680|464224826|FG001|Overall Study|Lost to Follow-up|2|||
128982851|NCT00381680|464224825|FG000|Overall Study|Physician Decision|25|||
128982852|NCT00381680|464224826|FG001|Overall Study|Physician Decision|6|||
128982853|NCT00381680|464224825|FG000|Overall Study|Withdrawal by Subject|3|||
129040264|NCT00440115|464438817|FG002|Overall Study|Death|5|||
128982854|NCT00381680|464224826|FG001|Overall Study|Withdrawal by Subject|1|||
129094338|NCT00793624|464636117|FG002|Overall Study|Other reason not described above|6|||
129094339|NCT00793624|464636118|FG003|Overall Study|Other reason not described above|3|||
129094340|NCT03309696|464637281|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
129094341|NCT03309696|464637282|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
129094342|NCT03309696|464637283|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
129094343|NCT03309696|464637284|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
129094344|NCT05940077|464637285|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
129094345|NCT00328094|464637286|FG000|Overall Study|Physician Decision|3|||
129094346|NCT00328094|464637287|FG001|Overall Study|Physician Decision|3|||
129094347|NCT02368210|464637288|FG000|Overall Study|Withdrawal by Subject|1|||
129094348|NCT02368210|464637289|FG001|Overall Study|Withdrawal by Subject|0|||
129094349|NCT02368210|464637288|FG000|Overall Study|Adverse Event|0|||
129094350|NCT02368210|464637289|FG001|Overall Study|Adverse Event|1|||
129094351|NCT00078949|464637290|FG000|Overall Study|No treated|4|||
129094352|NCT00078949|464637291|FG001|Overall Study|No treated|5|||
129094353|NCT00078949|464637292|FG002|Overall Study|No treated|3|||
129094354|NCT00078949|464637293|FG003|Overall Study|No treated|3|||
129094355|NCT02309723|464637294|FG000|Overall Study|Withdrawal by Subject|24|||
129094356|NCT02309723|464637295|FG001|Overall Study|Withdrawal by Subject|23|||
129094357|NCT02309723|464637296|FG002|Overall Study|Withdrawal by Subject|24|||
129094358|NCT01565668|464637297|FG000|Overall Study|Death|2|||
129094359|NCT01565668|464637298|FG001|Overall Study|Death|1|||
129094360|NCT01565668|464637297|FG000|Overall Study|Lack of Efficacy|4|||
129040265|NCT00440115|464438815|FG000|Overall Study|Incarceration|0|||
129040266|NCT00440115|464438816|FG001|Overall Study|Incarceration|2|||
129040267|NCT00440115|464438817|FG002|Overall Study|Incarceration|1|||
129040268|NCT00206102|464438819|FG000|Overall Study|Adverse Event|119|||
129040269|NCT00206102|464438820|FG001|Overall Study|Adverse Event|82|||
129040270|NCT00206102|464438819|FG000|Overall Study|Protocol Violation|0|||
129040271|NCT00206102|464438820|FG001|Overall Study|Protocol Violation|2|||
129040272|NCT00206102|464438819|FG000|Overall Study|Lack of therapeutic response|16|||
129040273|NCT00206102|464438820|FG001|Overall Study|Lack of therapeutic response|11|||
129040274|NCT00206102|464438819|FG000|Overall Study|Lost to Follow-up|95|||
129040275|NCT00206102|464438820|FG001|Overall Study|Lost to Follow-up|66|||
129040276|NCT00206102|464438819|FG000|Overall Study|Withdrawal by Subject|118|||
129040277|NCT00206102|464438820|FG001|Overall Study|Withdrawal by Subject|101|||
129040278|NCT00206102|464438819|FG000|Overall Study|Study-specific discontinuation criteria|18|||
129040279|NCT00206102|464438820|FG001|Overall Study|Study-specific discontinuation criteria|17|||
129040280|NCT00206102|464438819|FG000|Overall Study|None of those categories|42|||
129040281|NCT00206102|464438820|FG001|Overall Study|None of those categories|36|||
129040282|NCT03366194|464438824|FG000|Overall Study|Lost to Follow-up|2|||
129040283|NCT03123783|464438825|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129040284|NCT03123783|464438826|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
129040285|NCT03123783|464438827|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129040286|NCT03123783|464438828|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129040287|NCT03123783|464438829|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129040288|NCT03123783|464438830|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129040289|NCT03123783|464438831|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129040290|NCT03123783|464438825|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
129040291|NCT03123783|464438826|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
129040292|NCT03123783|464438827|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
129040293|NCT03123783|464438828|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
129040294|NCT03123783|464438829|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
129040295|NCT03123783|464438830|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
129040296|NCT03123783|464438831|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
129040297|NCT03123783|464438825|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
129040298|NCT03123783|464438826|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
129040299|NCT03123783|464438827|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
129040300|NCT03123783|464438828|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
129040301|NCT03123783|464438829|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
129040302|NCT03123783|464438830|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
129040303|NCT03123783|464438831|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
129040304|NCT03123783|464438825|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129040305|NCT03123783|464438826|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129040306|NCT03123783|464438827|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129040307|NCT03123783|464438828|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
128982855|NCT00381680|464224825|FG000|Overall Study|Entry onto another COG Trial|1|||
128982856|NCT00381680|464224826|FG001|Overall Study|Entry onto another COG Trial|2|||
128982857|NCT00381680|464224825|FG000|Overall Study|Alternative Therapy|11|||
128982858|NCT00381680|464224826|FG001|Overall Study|Alternative Therapy|5|||
128982859|NCT00381680|464224825|FG000|Overall Study|Secondary Malignancy|3|||
128982860|NCT00381680|464224826|FG001|Overall Study|Secondary Malignancy|0|||
128982861|NCT00381680|464224825|FG000|Overall Study|Delay initiation|1|||
128982862|NCT00381680|464224826|FG001|Overall Study|Delay initiation|0|||
128982863|NCT00381680|464224825|FG000|Overall Study|Stem Cell Transplant|26|||
128982864|NCT00381680|464224826|FG001|Overall Study|Stem Cell Transplant|10|||
128982865|NCT00381680|464224825|FG000|Overall Study|Relapse|18|||
128982866|NCT00381680|464224826|FG001|Overall Study|Relapse|9|||
128982867|NCT00381680|464224825|FG000|Overall Study|Induction Failure|4|||
128982868|NCT00381680|464224826|FG001|Overall Study|Induction Failure|1|||
128982869|NCT00381680|464224825|FG000|Overall Study|Progression|1|||
128982870|NCT00381680|464224826|FG001|Overall Study|Progression|1|||
128982871|NCT00381680|464224825|FG000|Overall Study|Other not otherwise specified|7|||
128982872|NCT00381680|464224826|FG001|Overall Study|Other not otherwise specified|2|||
128982873|NCT00381680|464224825|FG000|Overall Study|Ineligible|3|||
128982874|NCT00381680|464224826|FG001|Overall Study|Ineligible|1|||
128982875|NCT00933543|464224842|FG000|Overall Study|Adverse Event|2|||
128982876|NCT00933543|464224843|FG001|Overall Study|Adverse Event|1|||
128982877|NCT00933543|464224842|FG000|Overall Study|Lost to Follow-up|0|||
128982878|NCT00933543|464224843|FG001|Overall Study|Lost to Follow-up|1|||
128982879|NCT00933543|464224842|FG000|Overall Study|Withdrawal by Subject|0|||
128982880|NCT00933543|464224843|FG001|Overall Study|Withdrawal by Subject|1|||
128982881|NCT00933543|464224842|FG000|Overall Study|Lack of Efficacy|0|||
128982882|NCT00933543|464224843|FG001|Overall Study|Lack of Efficacy|3|||
128982883|NCT00933543|464224842|FG000|Overall Study|Other|1|||
128982884|NCT00933543|464224843|FG001|Overall Study|Other|1|||
128982885|NCT04626947|464224844|FG000|Overall Study|Study terminated|14|||
128982886|NCT02463097|464224845|FG000|Overall Study|Withdrawal by Subject|1|||
128982887|NCT01757821|464224846|FG000|Overall Study|Adverse Event|1|||
128982888|NCT00334893|464224847|FG000|Overall Study|Not Treated|1|||
128982889|NCT00334893|464224848|FG001|Overall Study|Not Treated|0|||
128982890|NCT01258803|464224849|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
128982891|NCT01258803|464224850|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
128982892|NCT01258803|464224851|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
128982893|NCT01258803|464224852|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
128982894|NCT01258803|464224853|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
128982895|NCT01258803|464224854|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
128982896|NCT01258803|464224849|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
128982897|NCT01258803|464224850|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
128982898|NCT01258803|464224851|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
128982899|NCT01258803|464224852|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
128982900|NCT01258803|464224853|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
128982901|NCT01258803|464224854|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
128982902|NCT01258803|464224849|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
128982903|NCT01258803|464224850|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
128982904|NCT01258803|464224851|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
128982905|NCT01258803|464224852|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
128982906|NCT01258803|464224853|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
128982907|NCT01258803|464224854|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
128982908|NCT01552408|464224863|FG000|Overall Study|Lost to Follow-up|2|||
128982909|NCT01552408|464224864|FG001|Overall Study|Lost to Follow-up|0|||
128982910|NCT01552408|464224863|FG000|Overall Study|Relocation|0|||
128982911|NCT01552408|464224864|FG001|Overall Study|Relocation|1|||
128982912|NCT01552408|464224863|FG000|Overall Study|Withdrawal by Subject|2|||
128982913|NCT01552408|464224864|FG001|Overall Study|Withdrawal by Subject|1|||
128982914|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Adverse Event|6|||
128982915|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Adverse Event|6|||
128982916|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Death|14|||
128982917|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Death|11|||
128982918|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
128982919|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
128982920|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
128982921|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
128982922|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
128982923|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
128982924|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Disease Progression|1|||
128982925|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Disease Progression|0|||
128982926|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
128982927|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
128982928|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
128982929|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
128982930|NCT04419558|464224865|FG000|DB Period (48 Weeks)|Participant Decision|4|||
128982931|NCT04419558|464224866|FG001|DB Period (48 Weeks)|Participant Decision|3|||
128982932|NCT04419558|464224865|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
128762217|NCT03937219|463419042|FG001|Overall Study|Death|211|||
128762218|NCT03937219|463419041|FG000|Overall Study|Withdrawal by Subject|17|||
128762219|NCT03937219|463419042|FG001|Overall Study|Withdrawal by Subject|25|||
128762220|NCT03937219|463419041|FG000|Overall Study|Lost to Follow-up|3|||
128762221|NCT03937219|463419042|FG001|Overall Study|Lost to Follow-up|4|||
128762222|NCT03483038|463419043|FG000|Overall Study|Subjects still in follow-up|18|||
128762223|NCT02158884|463419046|FG000|Baseline Assessment|Missed performance assessment|3|||
128762224|NCT02158884|463419046|FG000|Baseline Assessment|Missed SMFA|1|||
128762225|NCT02158884|463419046|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
128762226|NCT02158884|463419046|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
128762227|NCT02158884|463419046|FG000|6 Month Assessment|Missed SMFA|20|||
128762228|NCT02158884|463419046|FG000|12 Month Assessment|Missed SMFA|17|||
128762229|NCT01313286|463419051|FG000|Period 1|Withdrawal by Subject|2|||
128762230|NCT01313286|463419052|FG001|Period 1|Withdrawal by Subject|0|||
128762231|NCT00733980|463419055|FG000|Overall Study|Adverse Event|5|||
128762232|NCT00733980|463419056|FG001|Overall Study|Adverse Event|2|||
128762233|NCT00733980|463419055|FG000|Overall Study|Lack of Efficacy|0|||
128762234|NCT00733980|463419056|FG001|Overall Study|Lack of Efficacy|1|||
128762235|NCT00733980|463419055|FG000|Overall Study|Protocol Violation|2|||
128762236|NCT00733980|463419056|FG001|Overall Study|Protocol Violation|1|||
128762237|NCT00733980|463419055|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
128762238|NCT00733980|463419056|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
128762239|NCT00733980|463419055|FG000|Overall Study|Lost to Follow-up|6|||
128762240|NCT00733980|463419056|FG001|Overall Study|Lost to Follow-up|11|||
128762241|NCT00733980|463419055|FG000|Overall Study|Physician Decision|2|||
128762242|NCT00733980|463419056|FG001|Overall Study|Physician Decision|3|||
128762243|NCT00733980|463419055|FG000|Overall Study|Withdrawal by Subject|6|||
128762244|NCT00733980|463419056|FG001|Overall Study|Withdrawal by Subject|2|||
128762245|NCT02010632|463419057|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
128982933|NCT04419558|464224866|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
128982934|NCT04419558|464224865|FG000|OLE Period (48 Weeks)|Death|4|||
128982935|NCT04419558|464224866|FG001|OLE Period (48 Weeks)|Death|6|||
128982936|NCT04419558|464224865|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
128982937|NCT04419558|464224866|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
128982938|NCT04419558|464224865|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
128982939|NCT04419558|464224866|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
128982940|NCT00383292|464224867|FG000|Overall Study|Adverse Event|4|||
128762246|NCT02010632|463419058|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
128762247|NCT00404495|463419064|FG000|Overall Study|Death|37|||
128762248|NCT00404495|463419065|FG001|Overall Study|Death|11|||
128762249|NCT00404495|463419064|FG000|Overall Study|Lost to Follow-up|5|||
128762250|NCT00404495|463419065|FG001|Overall Study|Lost to Follow-up|0|||
128762251|NCT00404495|463419064|FG000|Overall Study|Other|1|||
128762252|NCT00404495|463419065|FG001|Overall Study|Other|0|||
128762253|NCT00404495|463419064|FG000|Overall Study|Withdrawal by Subject|1|||
128762254|NCT00404495|463419065|FG001|Overall Study|Withdrawal by Subject|0|||
128762255|NCT03750006|463419068|FG000|Overall Study|Withdrawal by Subject|8|||
128762256|NCT03750006|463419068|FG000|Overall Study|COVID PANDEMIC|11|||
128762257|NCT04739761|463419070|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
128762258|NCT04739761|463419071|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
128762259|NCT04739761|463419070|FG000|Overall Study|By complete response from the participant|1|||
128762260|NCT04739761|463419071|FG001|Overall Study|By complete response from the participant|0|||
128762261|NCT04739761|463419070|FG000|Overall Study|Lost to Follow-up|3|||
128762262|NCT04739761|463419071|FG001|Overall Study|Lost to Follow-up|3|||
128762263|NCT04739761|463419070|FG000|Overall Study|Death|13|||
128762264|NCT04739761|463419071|FG001|Overall Study|Death|13|||
128762265|NCT04739761|463419070|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
128762266|NCT04739761|463419071|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
128762267|NCT04739761|463419070|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
128762268|NCT04739761|463419071|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
128762269|NCT04739761|463419070|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
128762270|NCT04739761|463419071|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
128762271|NCT04739761|463419070|FG000|Overall Study|Adverse Event|0|||
128982941|NCT00383292|464224868|FG001|Overall Study|Adverse Event|1|||
128762272|NCT04739761|463419071|FG001|Overall Study|Adverse Event|3|||
128762273|NCT04739761|463419070|FG000|Overall Study|Participant decision|1|||
128762274|NCT04739761|463419071|FG001|Overall Study|Participant decision|0|||
128774787|NCT01349829|463468337|FG001|Overall Study|Migrated/moved|7|||
128982942|NCT00383292|464224869|FG002|Overall Study|Adverse Event|2|||
128982943|NCT00383292|464224867|FG000|Overall Study|Death|3|||
128982944|NCT00383292|464224868|FG001|Overall Study|Death|3|||
128982945|NCT00383292|464224869|FG002|Overall Study|Death|3|||
128762275|NCT04739761|463419070|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
128762276|NCT04739761|463419071|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
128762277|NCT04739761|463419070|FG000|Overall Study|Participant immediately started next line of treatment|1|||
128762278|NCT04739761|463419071|FG001|Overall Study|Participant immediately started next line of treatment|0|||
128762279|NCT04739761|463419070|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
128762280|NCT04739761|463419071|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
128762281|NCT04739761|463419070|FG000|Overall Study|Lack of clinical benefit|1|||
128762282|NCT04739761|463419071|FG001|Overall Study|Lack of clinical benefit|0|||
128762283|NCT04739761|463419070|FG000|Overall Study|Disease progression|5|||
128762284|NCT04739761|463419071|FG001|Overall Study|Disease progression|5|||
128762285|NCT04739761|463419070|FG000|Overall Study|Withdrawal by Subject|14|||
128762286|NCT04739761|463419071|FG001|Overall Study|Withdrawal by Subject|13|||
128762287|NCT04739761|463419070|FG000|Overall Study|Protocol Violation|1|||
128762288|NCT04739761|463419071|FG001|Overall Study|Protocol Violation|0|||
128762289|NCT04739761|463419070|FG000|Overall Study|Physician Decision|2|||
128982946|NCT00383292|464224867|FG000|Overall Study|Physician Decision|4|||
128982947|NCT00383292|464224868|FG001|Overall Study|Physician Decision|0|||
128982948|NCT00383292|464224869|FG002|Overall Study|Physician Decision|1|||
128982949|NCT00383292|464224867|FG000|Overall Study|Withdrawal by Subject|3|||
128982950|NCT00383292|464224868|FG001|Overall Study|Withdrawal by Subject|2|||
128762290|NCT04739761|463419071|FG001|Overall Study|Physician Decision|0|||
128762291|NCT01061333|463419075|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
128762292|NCT01061333|463419076|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
128762293|NCT02044848|463420697|FG000|Overall Study|Administrative Problems|2|||
128762294|NCT02044848|463420698|FG001|Overall Study|Administrative Problems|3|||
128762295|NCT01493960|463420699|FG000|Overall Study|Adverse Event|0|||
128762296|NCT01493960|463420700|FG001|Overall Study|Adverse Event|1|||
128762297|NCT01493960|463420699|FG000|Overall Study|Lack of Efficacy|15|||
128762298|NCT01493960|463420700|FG001|Overall Study|Lack of Efficacy|9|||
128982951|NCT00383292|464224869|FG002|Overall Study|Withdrawal by Subject|2|||
128982952|NCT00383292|464224867|FG000|Overall Study|Other|1|||
128982953|NCT00383292|464224868|FG001|Overall Study|Other|0|||
128982954|NCT00383292|464224869|FG002|Overall Study|Other|0|||
128982955|NCT01016912|464224870|FG000|End of Treatment Period|Lack of Efficacy|0|||
128982956|NCT01016912|464224871|FG001|End of Treatment Period|Lack of Efficacy|1|||
128982957|NCT01016912|464224872|FG002|End of Treatment Period|Lack of Efficacy|0|||
128982958|NCT01016912|464224873|FG003|End of Treatment Period|Lack of Efficacy|4|||
128982959|NCT01016912|464224874|FG004|End of Treatment Period|Lack of Efficacy|4|||
128982960|NCT01016912|464224870|FG000|End of Treatment Period|Adverse Event|0|||
128982961|NCT01016912|464224871|FG001|End of Treatment Period|Adverse Event|1|||
128982962|NCT01016912|464224872|FG002|End of Treatment Period|Adverse Event|1|||
128982963|NCT01016912|464224873|FG003|End of Treatment Period|Adverse Event|0|||
128982964|NCT01016912|464224874|FG004|End of Treatment Period|Adverse Event|0|||
128982965|NCT01016912|464224870|FG000|End of Treatment Period|Completed double-blind period only|0|||
128982966|NCT01016912|464224871|FG001|End of Treatment Period|Completed double-blind period only|1|||
128982967|NCT01016912|464224872|FG002|End of Treatment Period|Completed double-blind period only|0|||
128982968|NCT01016912|464224873|FG003|End of Treatment Period|Completed double-blind period only|0|||
128982969|NCT01016912|464224874|FG004|End of Treatment Period|Completed double-blind period only|0|||
128982970|NCT01016912|464224870|FG000|Follow-up Period|Other reason|0|||
128982971|NCT01016912|464224871|FG001|Follow-up Period|Other reason|0|||
128982972|NCT01016912|464224872|FG002|Follow-up Period|Other reason|1|||
128982973|NCT01016912|464224873|FG003|Follow-up Period|Other reason|1|||
128982974|NCT01016912|464224874|FG004|Follow-up Period|Other reason|0|||
128982975|NCT02221882|464224875|FG000|Overall Study|Withdrawal by Subject|0|||
128982976|NCT02221882|464224876|FG001|Overall Study|Withdrawal by Subject|0|||
128982977|NCT02221882|464224877|FG002|Overall Study|Withdrawal by Subject|4|||
128982978|NCT02221882|464224878|FG003|Overall Study|Withdrawal by Subject|2|||
128982979|NCT02221882|464224879|FG004|Overall Study|Withdrawal by Subject|2|||
128982980|NCT02221882|464224880|FG005|Overall Study|Withdrawal by Subject|2|||
128982981|NCT02221882|464224875|FG000|Overall Study|Death|0|||
128982982|NCT02221882|464224876|FG001|Overall Study|Death|1|||
128982983|NCT02221882|464224877|FG002|Overall Study|Death|0|||
128982984|NCT02221882|464224878|FG003|Overall Study|Death|0|||
128982985|NCT02221882|464224879|FG004|Overall Study|Death|0|||
128982986|NCT02221882|464224880|FG005|Overall Study|Death|0|||
128982987|NCT05664672|464224881|FG000|Overall Study|Adverse Event|0|||
128982988|NCT05664672|464224882|FG001|Overall Study|Adverse Event|0|||
128982989|NCT05664672|464224883|FG002|Overall Study|Adverse Event|0|||
128982990|NCT05664672|464224884|FG003|Overall Study|Adverse Event|0|||
128982991|NCT05664672|464224885|FG004|Overall Study|Adverse Event|0|||
128982992|NCT05664672|464224886|FG005|Overall Study|Adverse Event|1|||
128982993|NCT05664672|464224881|FG000|Overall Study|Withdrawal by Subject|0|||
128982994|NCT05664672|464224882|FG001|Overall Study|Withdrawal by Subject|1|||
128982995|NCT05664672|464224883|FG002|Overall Study|Withdrawal by Subject|3|||
128982996|NCT05664672|464224884|FG003|Overall Study|Withdrawal by Subject|0|||
128762299|NCT01493960|463420699|FG000|Overall Study|Protocol Violation|3|||
128982997|NCT05664672|464224885|FG004|Overall Study|Withdrawal by Subject|5|||
128982998|NCT05664672|464224886|FG005|Overall Study|Withdrawal by Subject|6|||
128982999|NCT05664672|464224881|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
128762300|NCT01493960|463420700|FG001|Overall Study|Protocol Violation|0|||
128762301|NCT01493960|463420699|FG000|Overall Study|Withdrawal by Subject|10|||
128762302|NCT01493960|463420700|FG001|Overall Study|Withdrawal by Subject|4|||
128762303|NCT01493960|463420699|FG000|Overall Study|Non-specified|4|||
128762304|NCT01493960|463420700|FG001|Overall Study|Non-specified|4|||
128762305|NCT01679236|463420705|FG000|Overall Study|Lost to Follow-up|15|||
128762306|NCT01679236|463420706|FG001|Overall Study|Lost to Follow-up|15|||
128762307|NCT03559218|463420709|FG000|Overall Study|Withdrawal by Subject|1|||
128762308|NCT03559218|463420710|FG001|Overall Study|Withdrawal by Subject|0|||
128762309|NCT03237858|463420711|FG000|Overall Study|Death|19|||
128762310|NCT03237858|463420711|FG000|Overall Study|Withdrawal by Subject|37|||
128762311|NCT01160484|463420712|FG000|Overall Study|Lack of Efficacy|9|||
128762312|NCT01160484|463420712|FG000|Overall Study|Adverse Event|6|||
128762313|NCT01160484|463420712|FG000|Overall Study|Withdrawal by Subject|2|||
128762314|NCT01160484|463420712|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
128762315|NCT00803101|463420713|FG000|Overall Study|Death / Serious Adverse Event|4|||
128762316|NCT00803101|463420714|FG001|Overall Study|Death / Serious Adverse Event|6|||
128762317|NCT00803101|463420713|FG000|Overall Study|Withdrawal by Subject|6|||
128762318|NCT00803101|463420714|FG001|Overall Study|Withdrawal by Subject|4|||
128762319|NCT00803101|463420713|FG000|Overall Study|Lost to Follow-up|2|||
128762320|NCT00803101|463420714|FG001|Overall Study|Lost to Follow-up|2|||
128762321|NCT00803101|463420713|FG000|Overall Study|Protocol Violation|1|||
128762322|NCT00803101|463420714|FG001|Overall Study|Protocol Violation|7|||
128762323|NCT00803101|463420713|FG000|Overall Study|Surgery finished outside protocol window|1|||
128762324|NCT00803101|463420714|FG001|Overall Study|Surgery finished outside protocol window|1|||
128762325|NCT00803101|463420713|FG000|Overall Study|Patient died outside SAE report period|1|||
128762326|NCT00803101|463420714|FG001|Overall Study|Patient died outside SAE report period|0|||
128762327|NCT00803101|463420713|FG000|Overall Study|Patient did not attend scheduled visit|2|||
128762328|NCT00803101|463420714|FG001|Overall Study|Patient did not attend scheduled visit|1|||
128762329|NCT00803101|463420713|FG000|Overall Study|Patient did not have surgery|1|||
128762330|NCT00803101|463420714|FG001|Overall Study|Patient did not have surgery|1|||
128762331|NCT01782742|463420715|FG000|Double-blind Treatment Phase|Adverse Event|1|||
128762332|NCT01782742|463420716|FG001|Double-blind Treatment Phase|Adverse Event|0|||
128762333|NCT01679301|463420719|FG000|Screening Period|screen failure|3|||
128762334|NCT01679301|463420720|FG001|Screening Period|screen failure|0|||
128983000|NCT05664672|464224882|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
128983001|NCT05664672|464224883|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
128983002|NCT05664672|464224884|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
128983003|NCT05664672|464224885|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
128983004|NCT05664672|464224886|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
128983005|NCT05664672|464224881|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
128983006|NCT05664672|464224882|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
128983007|NCT05664672|464224883|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
128983008|NCT05664672|464224884|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
128983009|NCT05664672|464224885|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
128983010|NCT05664672|464224886|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
128983011|NCT02370173|464224897|FG000|Overall Study|Protocol Violation|1|||
128983012|NCT02370173|464224898|FG001|Overall Study|Protocol Violation|1|||
128983013|NCT02370173|464224897|FG000|Overall Study|Withdrawal by Subject|2|||
128983014|NCT02370173|464224898|FG001|Overall Study|Withdrawal by Subject|2|||
128983015|NCT04236986|464224899|FG000|Overall Study|Withdrawal by Subject|3|||
128983016|NCT04236986|464224900|FG001|Overall Study|Withdrawal by Subject|1|||
128983017|NCT04034225|464224901|FG000|Overall Study|Death|3|||
128983018|NCT04034225|464224901|FG000|Overall Study|Withdrawal by Subject|2|||
128983019|NCT04034225|464224901|FG000|Overall Study|Study termination by Sponsor|18|||
128983020|NCT04034225|464224901|FG000|Overall Study|Physician Decision|1|||
128983021|NCT04034225|464224901|FG000|Overall Study|Lack of Efficacy|1|||
128983022|NCT01326481|464224907|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
128983023|NCT00307736|464224908|FG000|Overall Study|Adverse Event|0|||
128983024|NCT00307736|464224909|FG001|Overall Study|Adverse Event|0|||
128983025|NCT00307736|464224910|FG002|Overall Study|Adverse Event|1|||
128983026|NCT00307736|464224911|FG003|Overall Study|Adverse Event|3|||
128983027|NCT00307736|464224908|FG000|Overall Study|Withdrawal by Subject|0|||
128983028|NCT00307736|464224909|FG001|Overall Study|Withdrawal by Subject|0|||
128983029|NCT00307736|464224910|FG002|Overall Study|Withdrawal by Subject|2|||
128983030|NCT00307736|464224911|FG003|Overall Study|Withdrawal by Subject|0|||
129094361|NCT01565668|464637298|FG001|Overall Study|Lack of Efficacy|2|||
128983031|NCT02260791|464224914|FG000|Overall Study|Lost to Follow-up|4|||
128983032|NCT02260791|464224915|FG001|Overall Study|Lost to Follow-up|4|||
128983033|NCT02260791|464224914|FG000|Overall Study|Lack of Efficacy|2|||
128762335|NCT01679301|463420721|FG002|Screening Period|screen failure|0|||
128762336|NCT04858802|463420722|FG000|Overall Study|Lost to Follow-up|1|||
128762337|NCT04858802|463420723|FG001|Overall Study|Lost to Follow-up|1|||
128762338|NCT04858802|463420722|FG000|Overall Study|Withdrawal by Subject|1|||
128762339|NCT04858802|463420723|FG001|Overall Study|Withdrawal by Subject|1|||
128762340|NCT02026232|463420724|FG000|Overall Study|incomplete visit/missing data|3|||
128762341|NCT02026232|463420725|FG001|Overall Study|incomplete visit/missing data|2|||
128762342|NCT01529008|463420726|FG000|Bone Marrow Harvesting|Physician Decision|1|||
128762343|NCT01529008|463420727|FG001|Bone Marrow Harvesting|Physician Decision|1|||
128762344|NCT01529008|463420726|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
128762345|NCT01529008|463420727|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
128762346|NCT01529008|463420726|FG000|Treatment|Adverse Event|6|||
128762347|NCT01529008|463420727|FG001|Treatment|Adverse Event|0|||
128762348|NCT01529008|463420726|FG000|Treatment|Other|3|||
128762349|NCT01529008|463420727|FG001|Treatment|Other|1|||
128762350|NCT01529008|463420726|FG000|Efficacy Analysis|Protocol Violation|2|||
128762351|NCT01529008|463420727|FG001|Efficacy Analysis|Protocol Violation|0|||
128762352|NCT01529008|463420726|FG000|Efficacy Analysis|Physician Decision|0|||
128762353|NCT01529008|463420727|FG001|Efficacy Analysis|Physician Decision|1|||
128762354|NCT01529008|463420726|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
128762355|NCT01529008|463420727|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
128762356|NCT01382602|463420728|FG000|Overall Study|Protocol Violation|0|||
128762357|NCT01382602|463420729|FG001|Overall Study|Protocol Violation|3|||
128762358|NCT01382602|463420728|FG000|Overall Study|Withdrawal by Subject|0|||
128762359|NCT01382602|463420729|FG001|Overall Study|Withdrawal by Subject|1|||
128762360|NCT02305381|463420730|FG000|Overall Study|Unclassified|5|||
128762361|NCT02305381|463420731|FG001|Overall Study|Unclassified|5|||
128762362|NCT02305381|463420732|FG002|Overall Study|Unclassified|7|||
128762363|NCT02487498|463420734|FG000|Period: Period 1|Adverse Event|2|||
128762364|NCT02487498|463420735|FG001|Period: Period 1|Adverse Event|4|||
128762365|NCT02487498|463420734|FG000|Period: Period 1|Subject/guardian decision|2|||
128762366|NCT02487498|463420735|FG001|Period: Period 1|Subject/guardian decision|4|||
128983034|NCT02260791|464224915|FG001|Overall Study|Lack of Efficacy|1|||
128983035|NCT02260791|464224914|FG000|Overall Study|Adverse Event|13|||
128983036|NCT02260791|464224915|FG001|Overall Study|Adverse Event|9|||
128983037|NCT02260791|464224914|FG000|Overall Study|Death|1|||
128983038|NCT02260791|464224915|FG001|Overall Study|Death|0|||
128983039|NCT02260791|464224914|FG000|Overall Study|Withdrawal by Subject|11|||
128983040|NCT02260791|464224915|FG001|Overall Study|Withdrawal by Subject|16|||
128983041|NCT02260791|464224914|FG000|Overall Study|Screen failure|0|||
128983042|NCT02260791|464224915|FG001|Overall Study|Screen failure|1|||
128983043|NCT02260791|464224914|FG000|Overall Study|Protocol deviation|2|||
128983044|NCT02260791|464224915|FG001|Overall Study|Protocol deviation|3|||
128983045|NCT04246996|464224917|FG000|Overall Study|Physician Decision|1|||
128983046|NCT04246996|464224918|FG001|Overall Study|Physician Decision|1|||
128983047|NCT04246996|464224917|FG000|Overall Study|Did not meet eligibility criteria|1|||
128983048|NCT04246996|464224918|FG001|Overall Study|Did not meet eligibility criteria|4|||
128983049|NCT02442284|464224919|FG000|Overall Study|Adverse Event|1|||
128983050|NCT02442284|464224919|FG000|Overall Study|Withdrew Consent|2|||
128983051|NCT02442284|464224919|FG000|Overall Study|Lost to Follow-up|3|||
128983052|NCT02442284|464224919|FG000|Overall Study|Other|1|||
128983053|NCT01365182|464224920|FG000|Overall Study|Withdrawal by Subject|10|||
128983054|NCT01365182|464224921|FG001|Overall Study|Withdrawal by Subject|13|||
128983055|NCT01365182|464224922|FG002|Overall Study|Withdrawal by Subject|12|||
128983056|NCT04604015|464224925|FG000|Overall Study|Incomplete Data Collection|33|||
128983057|NCT01231620|464224926|FG000|Overall Study|Physician Decision|3|||
128983058|NCT01231620|464224927|FG001|Overall Study|Physician Decision|5|||
128983059|NCT01231620|464224928|FG002|Overall Study|Physician Decision|10|||
128983060|NCT01231620|464224926|FG000|Overall Study|Death|12|||
128983061|NCT01231620|464224927|FG001|Overall Study|Death|14|||
128983062|NCT01231620|464224928|FG002|Overall Study|Death|11|||
128983063|NCT01231620|464224926|FG000|Overall Study|Adverse Event|2|||
128983064|NCT01231620|464224927|FG001|Overall Study|Adverse Event|2|||
128983065|NCT01231620|464224928|FG002|Overall Study|Adverse Event|1|||
128983066|NCT01231620|464224926|FG000|Overall Study|Withdrawal by Subject|6|||
128983067|NCT01231620|464224927|FG001|Overall Study|Withdrawal by Subject|6|||
128762367|NCT02487498|463420734|FG000|Period: Period 1|Lost to Follow-up|0|||
128762368|NCT02487498|463420735|FG001|Period: Period 1|Lost to Follow-up|2|||
128762369|NCT02487498|463420734|FG000|Period: Period 1|Lack of Efficacy|1|||
128762370|NCT02487498|463420735|FG001|Period: Period 1|Lack of Efficacy|0|||
128983068|NCT01231620|464224928|FG002|Overall Study|Withdrawal by Subject|8|||
128983069|NCT01231620|464224926|FG000|Overall Study|Lost to Follow-up|3|||
128983070|NCT01231620|464224927|FG001|Overall Study|Lost to Follow-up|4|||
128983071|NCT01231620|464224928|FG002|Overall Study|Lost to Follow-up|9|||
128983072|NCT02576652|464224931|FG000|Overall Study|Withdrawal by Subject|2|||
129040308|NCT03123783|464438829|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
129040309|NCT03123783|464438830|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
128762371|NCT02487498|463420734|FG000|Period: Period 1|Physician Decision|0|||
128762372|NCT02487498|463420735|FG001|Period: Period 1|Physician Decision|1|||
128762373|NCT02487498|463420734|FG000|Period: Period 1|Protocol deviation|1|||
128762374|NCT02487498|463420735|FG001|Period: Period 1|Protocol deviation|0|||
128762375|NCT02487498|463420734|FG000|Period: Washout|Subject/guardian decision|0|||
128762376|NCT02487498|463420735|FG001|Period: Washout|Subject/guardian decision|5|||
128762377|NCT02487498|463420734|FG000|Period: Washout|Lack of Efficacy|1|||
128762378|NCT02487498|463420735|FG001|Period: Washout|Lack of Efficacy|1|||
128762379|NCT02487498|463420734|FG000|Period: Washout|Physician Decision|1|||
128762380|NCT02487498|463420735|FG001|Period: Washout|Physician Decision|0|||
128762381|NCT02487498|463420734|FG000|Period: Washout|Non-compliance with study treatment|0|||
128762382|NCT02487498|463420735|FG001|Period: Washout|Non-compliance with study treatment|1|||
128762383|NCT02487498|463420734|FG000|Period: Period 2|Adverse Event|2|||
128762384|NCT02487498|463420735|FG001|Period: Period 2|Adverse Event|2|||
128762385|NCT02487498|463420734|FG000|Period: Period 2|Subject/guardian decision|2|||
128762386|NCT02487498|463420735|FG001|Period: Period 2|Subject/guardian decision|1|||
128762387|NCT02487498|463420734|FG000|Period: Period 2|Lost to Follow-up|1|||
128762388|NCT02487498|463420735|FG001|Period: Period 2|Lost to Follow-up|1|||
128762389|NCT02487498|463420734|FG000|Period: Period 2|Death|0|||
128762390|NCT02487498|463420735|FG001|Period: Period 2|Death|1|||
128762391|NCT02487498|463420734|FG000|Period: Period 2|Physician Decision|1|||
128762392|NCT02487498|463420735|FG001|Period: Period 2|Physician Decision|0|||
128762393|NCT05056870|463420736|FG000|Period 1|Site COVID-19 Related|3|||
128762394|NCT05056870|463420737|FG001|Period 1|Site COVID-19 Related|3|||
128762395|NCT05056870|463420736|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
128762396|NCT05056870|463420737|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
128762397|NCT05056870|463420736|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
128762398|NCT05056870|463420737|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
128762399|NCT05056870|463420736|FG000|Period 2|COVID-19 Related|1|||
128762400|NCT05056870|463420737|FG001|Period 2|COVID-19 Related|0|||
128762401|NCT05056870|463420736|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
128762402|NCT05056870|463420737|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
128762403|NCT00676130|463420740|FG000|Overall Study|Lost to Follow-up|0|||
128762404|NCT00676130|463420741|FG001|Overall Study|Lost to Follow-up|1|||
128762405|NCT00676130|463420740|FG000|Overall Study|Found ineligible|3|||
128762406|NCT00676130|463420741|FG001|Overall Study|Found ineligible|2|||
128762407|NCT00676130|463420740|FG000|Overall Study|Withdrawal by Subject|0|||
128762408|NCT00676130|463420741|FG001|Overall Study|Withdrawal by Subject|1|||
128762409|NCT05044325|463420742|FG000|Part A:Treatment Period 1|Adverse Event|0|||
128762410|NCT05044325|463420743|FG001|Part A:Treatment Period 1|Adverse Event|0|||
128762411|NCT05044325|463420744|FG002|Part A:Treatment Period 1|Adverse Event|0|||
128762412|NCT05044325|463420745|FG003|Part A:Treatment Period 1|Adverse Event|0|||
128762413|NCT05044325|463420746|FG004|Part A:Treatment Period 1|Adverse Event|0|||
128762414|NCT05044325|463420747|FG005|Part A:Treatment Period 1|Adverse Event|1|||
128762415|NCT05044325|463420748|FG006|Part A:Treatment Period 1|Adverse Event|0|||
128762416|NCT05044325|463420749|FG007|Part A:Treatment Period 1|Adverse Event|1|||
128762417|NCT05044325|463420750|FG008|Part A:Treatment Period 1|Adverse Event|0|||
128762418|NCT05044325|463420751|FG009|Part A:Treatment Period 1|Adverse Event|0|||
128762419|NCT05044325|463420742|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
128762420|NCT05044325|463420743|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
128762421|NCT05044325|463420744|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
128762422|NCT05044325|463420745|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
128762423|NCT05044325|463420746|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
128762424|NCT05044325|463420747|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
128762425|NCT05044325|463420748|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
128762426|NCT05044325|463420749|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
128762427|NCT05044325|463420750|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
128762428|NCT05044325|463420751|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
128762429|NCT05044325|463420742|FG000|Part A:Treatment Period 1|Physician Decision|0|||
128762430|NCT05044325|463420743|FG001|Part A:Treatment Period 1|Physician Decision|0|||
128762431|NCT05044325|463420744|FG002|Part A:Treatment Period 1|Physician Decision|0|||
128762432|NCT05044325|463420745|FG003|Part A:Treatment Period 1|Physician Decision|0|||
128762433|NCT05044325|463420746|FG004|Part A:Treatment Period 1|Physician Decision|0|||
128762434|NCT05044325|463420747|FG005|Part A:Treatment Period 1|Physician Decision|0|||
128762435|NCT05044325|463420748|FG006|Part A:Treatment Period 1|Physician Decision|1|||
128762436|NCT05044325|463420749|FG007|Part A:Treatment Period 1|Physician Decision|0|||
128762437|NCT05044325|463420750|FG008|Part A:Treatment Period 1|Physician Decision|0|||
128762438|NCT05044325|463420751|FG009|Part A:Treatment Period 1|Physician Decision|0|||
128762439|NCT05044325|463420742|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762440|NCT05044325|463420743|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762441|NCT05044325|463420744|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
128762442|NCT05044325|463420745|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762443|NCT05044325|463420746|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762444|NCT05044325|463420747|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762445|NCT05044325|463420748|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762446|NCT05044325|463420749|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762447|NCT05044325|463420750|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762448|NCT05044325|463420751|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
128762449|NCT05044325|463420742|FG000|Part A:Treatment Period 2|Adverse Event|0|||
128762450|NCT05044325|463420743|FG001|Part A:Treatment Period 2|Adverse Event|1|||
128762451|NCT05044325|463420744|FG002|Part A:Treatment Period 2|Adverse Event|0|||
128762452|NCT05044325|463420745|FG003|Part A:Treatment Period 2|Adverse Event|0|||
128762453|NCT05044325|463420746|FG004|Part A:Treatment Period 2|Adverse Event|1|||
128762454|NCT05044325|463420747|FG005|Part A:Treatment Period 2|Adverse Event|1|||
128762455|NCT05044325|463420748|FG006|Part A:Treatment Period 2|Adverse Event|0|||
128762456|NCT05044325|463420749|FG007|Part A:Treatment Period 2|Adverse Event|0|||
128762457|NCT05044325|463420750|FG008|Part A:Treatment Period 2|Adverse Event|0|||
128762458|NCT05044325|463420751|FG009|Part A:Treatment Period 2|Adverse Event|0|||
128762459|NCT05044325|463420742|FG000|Part A:Treatment Period 2|Physician Decision|0|||
128762460|NCT05044325|463420743|FG001|Part A:Treatment Period 2|Physician Decision|0|||
128762461|NCT05044325|463420744|FG002|Part A:Treatment Period 2|Physician Decision|0|||
128762462|NCT05044325|463420745|FG003|Part A:Treatment Period 2|Physician Decision|0|||
128762463|NCT05044325|463420746|FG004|Part A:Treatment Period 2|Physician Decision|0|||
128762464|NCT05044325|463420747|FG005|Part A:Treatment Period 2|Physician Decision|1|||
128762465|NCT05044325|463420748|FG006|Part A:Treatment Period 2|Physician Decision|0|||
128762466|NCT05044325|463420749|FG007|Part A:Treatment Period 2|Physician Decision|0|||
128762467|NCT05044325|463420750|FG008|Part A:Treatment Period 2|Physician Decision|0|||
128762468|NCT05044325|463420751|FG009|Part A:Treatment Period 2|Physician Decision|0|||
128762469|NCT05044325|463420742|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762470|NCT05044325|463420743|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762471|NCT05044325|463420744|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762472|NCT05044325|463420745|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
128762473|NCT05044325|463420746|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
128762474|NCT05044325|463420747|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762475|NCT05044325|463420748|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762476|NCT05044325|463420749|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762477|NCT05044325|463420750|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762478|NCT05044325|463420751|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
128762479|NCT00755222|463420752|FG000|Overall Study|Withdrawal by Subject|4|||
128762480|NCT00755222|463420753|FG001|Overall Study|Withdrawal by Subject|2|||
128762481|NCT00755222|463420752|FG000|Overall Study|Adverse Event|2|||
128762482|NCT00755222|463420753|FG001|Overall Study|Adverse Event|0|||
128762483|NCT00755222|463420752|FG000|Overall Study|Protocol Violation|2|||
128762484|NCT00755222|463420753|FG001|Overall Study|Protocol Violation|0|||
128762485|NCT04207840|463420759|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
128762486|NCT04207840|463420760|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
128762487|NCT04207840|463420761|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
128762488|NCT04207840|463420759|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
128762489|NCT04207840|463420760|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
128762490|NCT04207840|463420761|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
128762491|NCT01114204|463420762|FG000|Overall Study|Adverse Event|3|||
128762492|NCT01114204|463420763|FG001|Overall Study|Adverse Event|2|||
128762493|NCT01114204|463420762|FG000|Overall Study|Lost to Follow-up|1|||
128762494|NCT01114204|463420763|FG001|Overall Study|Lost to Follow-up|0|||
128762495|NCT01114204|463420762|FG000|Overall Study|Withdrawal by Subject|10|||
128762496|NCT01114204|463420763|FG001|Overall Study|Withdrawal by Subject|6|||
128762497|NCT01114204|463420762|FG000|Overall Study|Death|1|||
128762498|NCT01114204|463420763|FG001|Overall Study|Death|0|||
128762499|NCT01114204|463420762|FG000|Overall Study|Other-Personal reasons|2|||
128762500|NCT01114204|463420763|FG001|Overall Study|Other-Personal reasons|0|||
128762501|NCT01114204|463420762|FG000|Overall Study|Other-Medical monitor request|1|||
128762502|NCT01114204|463420763|FG001|Overall Study|Other-Medical monitor request|0|||
128762503|NCT01114204|463420762|FG000|Overall Study|Other-Participant request|2|||
128762504|NCT01114204|463420763|FG001|Overall Study|Other-Participant request|0|||
128762505|NCT01114204|463420762|FG000|Overall Study|Other-Protocol Violation|1|||
128762506|NCT01114204|463420763|FG001|Overall Study|Other-Protocol Violation|0|||
128762507|NCT02801669|463420768|FG000|Overall Study|Death|66|||
128762508|NCT02801669|463420769|FG001|Overall Study|Death|69|||
128762509|NCT02801669|463420768|FG000|Overall Study|Withdrawal by Subject|81|||
128983073|NCT02985541|464226124|FG000|Overall Study|Withdrawal by Subject|33|||
128983074|NCT02985541|464226124|FG000|Overall Study|Lost to Follow-up|26|||
128762510|NCT02801669|463420769|FG001|Overall Study|Withdrawal by Subject|77|||
128762511|NCT02801669|463420768|FG000|Overall Study|Other|4|||
128762512|NCT02801669|463420769|FG001|Overall Study|Other|6|||
128983075|NCT02985541|464226124|FG000|Overall Study|Adverse Event|27|||
128762513|NCT02696564|463420770|FG000|Overall Study|Death|1|||
128762514|NCT02696564|463420771|FG001|Overall Study|Death|2|||
128762515|NCT02696564|463420770|FG000|Overall Study|Withdrawal by Subject|3|||
128762516|NCT02696564|463420771|FG001|Overall Study|Withdrawal by Subject|2|||
128762517|NCT02696564|463420770|FG000|Overall Study|Lost to Follow-up|3|||
128762518|NCT02696564|463420771|FG001|Overall Study|Lost to Follow-up|3|||
128762519|NCT02696564|463420770|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
128762520|NCT02696564|463420771|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
128762521|NCT02696564|463420770|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
128762522|NCT02696564|463420771|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
128762523|NCT02696564|463420770|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
128762524|NCT02696564|463420771|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
128762525|NCT02696564|463420770|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
128762526|NCT02696564|463420771|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
128762527|NCT02696564|463420770|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
128762528|NCT02696564|463420771|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
128762529|NCT03633929|463420773|FG000|Overall Study|Lost to Follow-up|1|||
128762530|NCT03633929|463420773|FG000|Overall Study|Did not login to software. Did not participate|3|||
128762531|NCT04461795|463420774|FG000|Overall Study|Lost to Follow-up|2|||
128762532|NCT04461795|463420774|FG000|Overall Study|Withdrawal by Subject|2|||
128762533|NCT04461795|463420774|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
128762534|NCT02287584|463420775|FG000|the Double-blind Phase|Adverse Event|17|||
128762535|NCT02287584|463420776|FG001|the Double-blind Phase|Adverse Event|17|||
128762536|NCT02287584|463420777|FG002|the Double-blind Phase|Adverse Event|12|||
128762537|NCT02287584|463420778|FG003|the Double-blind Phase|Adverse Event|0|||
128762538|NCT02287584|463420779|FG004|the Double-blind Phase|Adverse Event|0|||
128762539|NCT02287584|463420780|FG005|the Double-blind Phase|Adverse Event|0|||
128762540|NCT02287584|463420775|FG000|the Double-blind Phase|Lack of Efficacy|18|||
128762541|NCT02287584|463420776|FG001|the Double-blind Phase|Lack of Efficacy|8|||
128762542|NCT02287584|463420777|FG002|the Double-blind Phase|Lack of Efficacy|8|||
128762543|NCT02287584|463420778|FG003|the Double-blind Phase|Lack of Efficacy|0|||
128762544|NCT02287584|463420779|FG004|the Double-blind Phase|Lack of Efficacy|0|||
128762545|NCT02287584|463420780|FG005|the Double-blind Phase|Lack of Efficacy|0|||
128762546|NCT02287584|463420775|FG000|the Double-blind Phase|Lost to Follow-up|0|||
128762547|NCT02287584|463420776|FG001|the Double-blind Phase|Lost to Follow-up|1|||
128762548|NCT02287584|463420777|FG002|the Double-blind Phase|Lost to Follow-up|1|||
128762549|NCT02287584|463420778|FG003|the Double-blind Phase|Lost to Follow-up|0|||
128762550|NCT02287584|463420779|FG004|the Double-blind Phase|Lost to Follow-up|0|||
128762551|NCT02287584|463420780|FG005|the Double-blind Phase|Lost to Follow-up|0|||
128762552|NCT02287584|463420775|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
128762553|NCT02287584|463420776|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
128762554|NCT02287584|463420777|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
128762555|NCT02287584|463420778|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
128762556|NCT02287584|463420779|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
128762557|NCT02287584|463420780|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
128762558|NCT02287584|463420775|FG000|the Double-blind Phase|Pregnancy|0|||
128762559|NCT02287584|463420776|FG001|the Double-blind Phase|Pregnancy|1|||
128762560|NCT02287584|463420777|FG002|the Double-blind Phase|Pregnancy|0|||
128762561|NCT02287584|463420778|FG003|the Double-blind Phase|Pregnancy|0|||
128762562|NCT02287584|463420779|FG004|the Double-blind Phase|Pregnancy|0|||
128762563|NCT02287584|463420780|FG005|the Double-blind Phase|Pregnancy|0|||
128762564|NCT02287584|463420775|FG000|the Double-blind Phase|Protocol Violation|0|||
128762565|NCT02287584|463420776|FG001|the Double-blind Phase|Protocol Violation|3|||
128762566|NCT02287584|463420777|FG002|the Double-blind Phase|Protocol Violation|0|||
128762567|NCT02287584|463420778|FG003|the Double-blind Phase|Protocol Violation|0|||
128762568|NCT02287584|463420779|FG004|the Double-blind Phase|Protocol Violation|0|||
128762569|NCT02287584|463420780|FG005|the Double-blind Phase|Protocol Violation|0|||
128762570|NCT02287584|463420775|FG000|the Double-blind Phase|other reasons|0|||
128762571|NCT02287584|463420776|FG001|the Double-blind Phase|other reasons|0|||
128762572|NCT02287584|463420777|FG002|the Double-blind Phase|other reasons|1|||
128762573|NCT02287584|463420778|FG003|the Double-blind Phase|other reasons|0|||
128762574|NCT02287584|463420779|FG004|the Double-blind Phase|other reasons|0|||
128762575|NCT02287584|463420780|FG005|the Double-blind Phase|other reasons|0|||
128762576|NCT02287584|463420775|FG000|the Open-label Phase|Did not receive drug|0|||
128762577|NCT02287584|463420776|FG001|the Open-label Phase|Did not receive drug|0|||
128762578|NCT02287584|463420777|FG002|the Open-label Phase|Did not receive drug|0|||
128762579|NCT02287584|463420778|FG003|the Open-label Phase|Did not receive drug|7|||
128762580|NCT02287584|463420779|FG004|the Open-label Phase|Did not receive drug|6|||
128762581|NCT02287584|463420780|FG005|the Open-label Phase|Did not receive drug|4|||
128762582|NCT02287584|463420775|FG000|the Open-label Phase|Adverse Event|0|||
128762583|NCT02287584|463420776|FG001|the Open-label Phase|Adverse Event|0|||
128762584|NCT02287584|463420777|FG002|the Open-label Phase|Adverse Event|0|||
128762585|NCT02287584|463420778|FG003|the Open-label Phase|Adverse Event|15|||
128762586|NCT02287584|463420779|FG004|the Open-label Phase|Adverse Event|12|||
128762587|NCT02287584|463420780|FG005|the Open-label Phase|Adverse Event|16|||
128762588|NCT02287584|463420775|FG000|the Open-label Phase|Lack of Efficacy|0|||
128762589|NCT02287584|463420776|FG001|the Open-label Phase|Lack of Efficacy|0|||
128762590|NCT02287584|463420777|FG002|the Open-label Phase|Lack of Efficacy|0|||
128762591|NCT02287584|463420778|FG003|the Open-label Phase|Lack of Efficacy|8|||
128762592|NCT02287584|463420779|FG004|the Open-label Phase|Lack of Efficacy|3|||
128762593|NCT02287584|463420780|FG005|the Open-label Phase|Lack of Efficacy|7|||
128762594|NCT02287584|463420775|FG000|the Open-label Phase|Lost to Follow-up|0|||
128762595|NCT02287584|463420776|FG001|the Open-label Phase|Lost to Follow-up|0|||
128762596|NCT02287584|463420777|FG002|the Open-label Phase|Lost to Follow-up|0|||
128762597|NCT02287584|463420778|FG003|the Open-label Phase|Lost to Follow-up|4|||
128762598|NCT02287584|463420779|FG004|the Open-label Phase|Lost to Follow-up|1|||
128762599|NCT02287584|463420780|FG005|the Open-label Phase|Lost to Follow-up|2|||
128762600|NCT02287584|463420775|FG000|the Open-label Phase|Withdrawal by Subject|0|||
128762601|NCT02287584|463420776|FG001|the Open-label Phase|Withdrawal by Subject|0|||
128762602|NCT02287584|463420777|FG002|the Open-label Phase|Withdrawal by Subject|0|||
128762603|NCT02287584|463420778|FG003|the Open-label Phase|Withdrawal by Subject|18|||
128762604|NCT02287584|463420779|FG004|the Open-label Phase|Withdrawal by Subject|29|||
128762605|NCT02287584|463420780|FG005|the Open-label Phase|Withdrawal by Subject|21|||
128762606|NCT02287584|463420775|FG000|the Open-label Phase|non-compliance|0|||
128762607|NCT02287584|463420776|FG001|the Open-label Phase|non-compliance|0|||
128762608|NCT02287584|463420777|FG002|the Open-label Phase|non-compliance|0|||
128762609|NCT02287584|463420778|FG003|the Open-label Phase|non-compliance|2|||
128762610|NCT02287584|463420779|FG004|the Open-label Phase|non-compliance|5|||
128762611|NCT02287584|463420780|FG005|the Open-label Phase|non-compliance|1|||
128762612|NCT02287584|463420775|FG000|the Open-label Phase|other reasons|0|||
128762613|NCT02287584|463420776|FG001|the Open-label Phase|other reasons|0|||
128762614|NCT02287584|463420777|FG002|the Open-label Phase|other reasons|0|||
128762615|NCT02287584|463420778|FG003|the Open-label Phase|other reasons|3|||
128762616|NCT02287584|463420779|FG004|the Open-label Phase|other reasons|6|||
128762617|NCT02287584|463420780|FG005|the Open-label Phase|other reasons|6|||
128762618|NCT03430063|463420785|FG000|Overall Study|Adverse Event|0|||
128762619|NCT03430063|463420786|FG001|Overall Study|Adverse Event|1|||
128762620|NCT03430063|463420787|FG002|Overall Study|Adverse Event|0|||
128762621|NCT03430063|463420785|FG000|Overall Study|Death|3|||
128762622|NCT03430063|463420786|FG001|Overall Study|Death|2|||
128762623|NCT03430063|463420787|FG002|Overall Study|Death|3|||
128762624|NCT03430063|463420785|FG000|Overall Study|Lost to Follow-up|0|||
128762625|NCT03430063|463420786|FG001|Overall Study|Lost to Follow-up|1|||
128762626|NCT03430063|463420787|FG002|Overall Study|Lost to Follow-up|0|||
128762627|NCT03430063|463420785|FG000|Overall Study|Withdrawal by Subject|0|||
128762628|NCT03430063|463420786|FG001|Overall Study|Withdrawal by Subject|0|||
128762629|NCT03430063|463420787|FG002|Overall Study|Withdrawal by Subject|1|||
128762630|NCT03430063|463420785|FG000|Overall Study|Withdrawal of consent|3|||
128762631|NCT03430063|463420786|FG001|Overall Study|Withdrawal of consent|1|||
128762632|NCT03430063|463420787|FG002|Overall Study|Withdrawal of consent|2|||
128762633|NCT03430063|463420785|FG000|Overall Study|Progressive disease|1|||
128762634|NCT03430063|463420786|FG001|Overall Study|Progressive disease|2|||
128762635|NCT03430063|463420787|FG002|Overall Study|Progressive disease|1|||
128762636|NCT03430063|463420785|FG000|Overall Study|Other un-specified|1|||
128762637|NCT03430063|463420786|FG001|Overall Study|Other un-specified|1|||
128762638|NCT03430063|463420787|FG002|Overall Study|Other un-specified|0|||
128762639|NCT03430063|463420785|FG000|Overall Study|Randomized, but never treated|0|||
128762640|NCT03430063|463420786|FG001|Overall Study|Randomized, but never treated|0|||
128762641|NCT03430063|463420787|FG002|Overall Study|Randomized, but never treated|1|||
128762642|NCT02798211|463420788|FG000|Period 1|Adverse Event|1|||
128762643|NCT02798211|463420789|FG001|Period 1|Adverse Event|1|||
128762644|NCT02798211|463420790|FG002|Period 1|Adverse Event|0|||
128762645|NCT02798211|463420791|FG003|Period 1|Adverse Event|0|||
128762646|NCT02798211|463420792|FG004|Period 1|Adverse Event|0|||
128762647|NCT02798211|463420793|FG005|Period 1|Adverse Event|0|||
128762648|NCT02798211|463420788|FG000|Period 1|Lost to Follow-up|2|||
128762649|NCT02798211|463420789|FG001|Period 1|Lost to Follow-up|1|||
128762650|NCT02798211|463420790|FG002|Period 1|Lost to Follow-up|0|||
128762651|NCT02798211|463420791|FG003|Period 1|Lost to Follow-up|0|||
128762652|NCT02798211|463420792|FG004|Period 1|Lost to Follow-up|0|||
128762653|NCT02798211|463420793|FG005|Period 1|Lost to Follow-up|0|||
128762654|NCT02798211|463420788|FG000|Period 1|Protocol Violation|0|||
128762655|NCT02798211|463420789|FG001|Period 1|Protocol Violation|0|||
128762656|NCT02798211|463420790|FG002|Period 1|Protocol Violation|2|||
128762657|NCT02798211|463420791|FG003|Period 1|Protocol Violation|0|||
128762658|NCT02798211|463420792|FG004|Period 1|Protocol Violation|0|||
128762659|NCT02798211|463420793|FG005|Period 1|Protocol Violation|0|||
128762660|NCT02798211|463420788|FG000|Period 1|Withdrawal by Subject|1|||
128762661|NCT02798211|463420789|FG001|Period 1|Withdrawal by Subject|1|||
128762662|NCT02798211|463420790|FG002|Period 1|Withdrawal by Subject|0|||
128762663|NCT02798211|463420791|FG003|Period 1|Withdrawal by Subject|0|||
128762664|NCT02798211|463420792|FG004|Period 1|Withdrawal by Subject|0|||
128762665|NCT02798211|463420793|FG005|Period 1|Withdrawal by Subject|0|||
128762666|NCT02798211|463420788|FG000|Period 1|Death|0|||
128762667|NCT02798211|463420789|FG001|Period 1|Death|0|||
128762668|NCT02798211|463420790|FG002|Period 1|Death|1|||
128762669|NCT02798211|463420791|FG003|Period 1|Death|0|||
128762670|NCT02798211|463420792|FG004|Period 1|Death|0|||
128762671|NCT02798211|463420793|FG005|Period 1|Death|0|||
128762672|NCT02798211|463420788|FG000|Period 1|Withdrawal of Informed Consent|2|||
128762673|NCT02798211|463420789|FG001|Period 1|Withdrawal of Informed Consent|7|||
128762674|NCT02798211|463420790|FG002|Period 1|Withdrawal of Informed Consent|3|||
128762675|NCT02798211|463420791|FG003|Period 1|Withdrawal of Informed Consent|0|||
128762676|NCT02798211|463420792|FG004|Period 1|Withdrawal of Informed Consent|0|||
128762677|NCT02798211|463420793|FG005|Period 1|Withdrawal of Informed Consent|0|||
128762678|NCT02798211|463420788|FG000|Period 2|Withdrawal by Subject|2|||
128762679|NCT02798211|463420789|FG001|Period 2|Withdrawal by Subject|0|||
128762680|NCT02798211|463420790|FG002|Period 2|Withdrawal by Subject|0|||
128762681|NCT02798211|463420791|FG003|Period 2|Withdrawal by Subject|0|||
128762682|NCT02798211|463420792|FG004|Period 2|Withdrawal by Subject|2|||
128762683|NCT02798211|463420793|FG005|Period 2|Withdrawal by Subject|2|||
128762684|NCT02798211|463420788|FG000|Period 2|Adverse Event|5|||
128762685|NCT02798211|463420789|FG001|Period 2|Adverse Event|0|||
128762686|NCT02798211|463420790|FG002|Period 2|Adverse Event|0|||
128762687|NCT02798211|463420791|FG003|Period 2|Adverse Event|0|||
128762688|NCT02798211|463420792|FG004|Period 2|Adverse Event|1|||
128762689|NCT02798211|463420793|FG005|Period 2|Adverse Event|0|||
128762690|NCT02798211|463420788|FG000|Period 2|Lack of Efficacy|1|||
128762691|NCT02798211|463420789|FG001|Period 2|Lack of Efficacy|0|||
128762692|NCT02798211|463420790|FG002|Period 2|Lack of Efficacy|0|||
128762693|NCT02798211|463420791|FG003|Period 2|Lack of Efficacy|1|||
128762694|NCT02798211|463420792|FG004|Period 2|Lack of Efficacy|0|||
128762695|NCT02798211|463420793|FG005|Period 2|Lack of Efficacy|1|||
128762696|NCT02798211|463420788|FG000|Period 2|Lost to Follow-up|3|||
128762697|NCT02798211|463420789|FG001|Period 2|Lost to Follow-up|0|||
128762698|NCT02798211|463420790|FG002|Period 2|Lost to Follow-up|0|||
128762699|NCT02798211|463420791|FG003|Period 2|Lost to Follow-up|0|||
128762700|NCT02798211|463420792|FG004|Period 2|Lost to Follow-up|2|||
128762701|NCT02798211|463420793|FG005|Period 2|Lost to Follow-up|0|||
128762702|NCT02798211|463420788|FG000|Period 2|Physician Decision|1|||
128762703|NCT02798211|463420789|FG001|Period 2|Physician Decision|0|||
128762704|NCT02798211|463420790|FG002|Period 2|Physician Decision|0|||
128762705|NCT02798211|463420791|FG003|Period 2|Physician Decision|1|||
128762706|NCT02798211|463420792|FG004|Period 2|Physician Decision|1|||
128762707|NCT02798211|463420793|FG005|Period 2|Physician Decision|0|||
128762708|NCT02798211|463420788|FG000|Period 2|Pregnancy|0|||
128762709|NCT02798211|463420789|FG001|Period 2|Pregnancy|0|||
128762710|NCT02798211|463420790|FG002|Period 2|Pregnancy|0|||
128762711|NCT02798211|463420791|FG003|Period 2|Pregnancy|2|||
128762712|NCT02798211|463420792|FG004|Period 2|Pregnancy|0|||
128762713|NCT02798211|463420793|FG005|Period 2|Pregnancy|0|||
128762714|NCT02798211|463420788|FG000|Period 2|Technical problems|1|||
128762715|NCT02798211|463420789|FG001|Period 2|Technical problems|0|||
128762716|NCT02798211|463420790|FG002|Period 2|Technical problems|0|||
128762717|NCT02798211|463420791|FG003|Period 2|Technical problems|1|||
128762718|NCT02798211|463420792|FG004|Period 2|Technical problems|0|||
128762719|NCT02798211|463420793|FG005|Period 2|Technical problems|0|||
128762720|NCT02798211|463420788|FG000|Period 2|Withdrawal of Informed Consent|1|||
128762721|NCT02798211|463420789|FG001|Period 2|Withdrawal of Informed Consent|0|||
128762722|NCT02798211|463420790|FG002|Period 2|Withdrawal of Informed Consent|0|||
128762723|NCT02798211|463420791|FG003|Period 2|Withdrawal of Informed Consent|2|||
128762724|NCT02798211|463420792|FG004|Period 2|Withdrawal of Informed Consent|2|||
128762725|NCT02798211|463420793|FG005|Period 2|Withdrawal of Informed Consent|3|||
128762726|NCT01982435|463420794|FG000|Overall Study|Adverse Event|1|||
128762727|NCT01982435|463420795|FG001|Overall Study|Adverse Event|0|||
128762728|NCT05292534|463420796|FG000|Overall Study|Protocol Violation|3|||
128762729|NCT05292534|463420797|FG001|Overall Study|Protocol Violation|4|||
128762730|NCT05292534|463420796|FG000|Overall Study|Withdrawal by Subject|0|||
128762731|NCT05292534|463420797|FG001|Overall Study|Withdrawal by Subject|1|||
128762732|NCT01782872|463420799|FG000|Overall Study|Protocol Violation|0|||
128762733|NCT01782872|463420800|FG001|Overall Study|Protocol Violation|0|||
128762734|NCT01782872|463420801|FG002|Overall Study|Protocol Violation|0|||
128762735|NCT01782872|463420802|FG003|Overall Study|Protocol Violation|1|||
128762736|NCT01782872|463420799|FG000|Overall Study|Withdrawal by Subject|0|||
128762737|NCT01782872|463420800|FG001|Overall Study|Withdrawal by Subject|1|||
128762738|NCT01782872|463420801|FG002|Overall Study|Withdrawal by Subject|0|||
128762739|NCT01782872|463420802|FG003|Overall Study|Withdrawal by Subject|0|||
128762740|NCT01892345|463420803|FG000|Overall Study|Adverse Event|0|||
128762741|NCT01892345|463420804|FG001|Overall Study|Adverse Event|2|||
128762742|NCT01892345|463420803|FG000|Overall Study|Death|1|||
128762743|NCT01892345|463420804|FG001|Overall Study|Death|0|||
128983076|NCT02985541|464226124|FG000|Overall Study|Physician Decision|2|||
128983077|NCT02985541|464226124|FG000|Overall Study|Pregnancy|2|||
129094362|NCT01565668|464637297|FG000|Overall Study|Participant went on Hospice Care|1|||
128762744|NCT01892345|463420803|FG000|Overall Study|Lost to Follow-up|3|||
128762745|NCT01892345|463420804|FG001|Overall Study|Lost to Follow-up|0|||
128762746|NCT01892345|463420803|FG000|Overall Study|Withdrawal by Subject|12|||
128762747|NCT01892345|463420804|FG001|Overall Study|Withdrawal by Subject|1|||
128762748|NCT01473381|463420805|FG000|Overall Study|Adverse Event|8|||
128762749|NCT01473381|463420806|FG001|Overall Study|Adverse Event|20|||
128762750|NCT01473381|463420807|FG002|Overall Study|Adverse Event|25|||
128762751|NCT01473381|463420808|FG003|Overall Study|Adverse Event|17|||
128762752|NCT01473381|463420805|FG000|Overall Study|Insufficient Therapeutic Response|10|||
128762753|NCT01473381|463420806|FG001|Overall Study|Insufficient Therapeutic Response|1|||
128762754|NCT01473381|463420807|FG002|Overall Study|Insufficient Therapeutic Response|2|||
128762755|NCT01473381|463420808|FG003|Overall Study|Insufficient Therapeutic Response|3|||
128762756|NCT01473381|463420805|FG000|Overall Study|Protocol Violation|17|||
128762757|NCT01473381|463420806|FG001|Overall Study|Protocol Violation|23|||
128762758|NCT01473381|463420807|FG002|Overall Study|Protocol Violation|19|||
128762759|NCT01473381|463420808|FG003|Overall Study|Protocol Violation|17|||
128762760|NCT01473381|463420805|FG000|Overall Study|Withdrawal of Consent|20|||
128762761|NCT01473381|463420806|FG001|Overall Study|Withdrawal of Consent|21|||
128762762|NCT01473381|463420807|FG002|Overall Study|Withdrawal of Consent|20|||
128762763|NCT01473381|463420808|FG003|Overall Study|Withdrawal of Consent|26|||
128762764|NCT01473381|463420805|FG000|Overall Study|Lost to Follow-up|25|||
128762765|NCT01473381|463420806|FG001|Overall Study|Lost to Follow-up|28|||
128762766|NCT01473381|463420807|FG002|Overall Study|Lost to Follow-up|35|||
128762767|NCT01473381|463420808|FG003|Overall Study|Lost to Follow-up|23|||
128762768|NCT01473381|463420805|FG000|Overall Study|Other Reasons|0|||
128762769|NCT01473381|463420806|FG001|Overall Study|Other Reasons|0|||
128762770|NCT01473381|463420807|FG002|Overall Study|Other Reasons|1|||
128762771|NCT01473381|463420808|FG003|Overall Study|Other Reasons|3|||
128762772|NCT04026165|463420812|FG000|Run-in Placebo Period|Enrollment Error|13|||
128762773|NCT04026165|463420813|FG001|Run-in Placebo Period|Enrollment Error|0|||
128762774|NCT04026165|463420814|FG002|Run-in Placebo Period|Enrollment Error|0|||
128762775|NCT04026165|463420815|FG003|Run-in Placebo Period|Enrollment Error|0|||
128762776|NCT04026165|463420812|FG000|Run-in Placebo Period|Run-in Failure|4|||
128762777|NCT04026165|463420813|FG001|Run-in Placebo Period|Run-in Failure|0|||
128762778|NCT04026165|463420814|FG002|Run-in Placebo Period|Run-in Failure|0|||
128762779|NCT04026165|463420815|FG003|Run-in Placebo Period|Run-in Failure|0|||
128762780|NCT04026165|463420812|FG000|Run-in Placebo Period|Protocol Violation|2|||
128762781|NCT04026165|463420813|FG001|Run-in Placebo Period|Protocol Violation|0|||
128762782|NCT04026165|463420814|FG002|Run-in Placebo Period|Protocol Violation|0|||
128762783|NCT04026165|463420815|FG003|Run-in Placebo Period|Protocol Violation|0|||
128762784|NCT04026165|463420812|FG000|Run-in Placebo Period|Withdrew Consent|2|||
128762785|NCT04026165|463420813|FG001|Run-in Placebo Period|Withdrew Consent|0|||
128762786|NCT04026165|463420814|FG002|Run-in Placebo Period|Withdrew Consent|0|||
128762787|NCT04026165|463420815|FG003|Run-in Placebo Period|Withdrew Consent|0|||
128762788|NCT04026165|463420812|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
128762789|NCT04026165|463420813|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
128762790|NCT04026165|463420814|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
128762791|NCT04026165|463420815|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
128762792|NCT04026165|463420812|FG000|Run-in SEL Period|Run-in Failure|0|||
128762793|NCT04026165|463420813|FG001|Run-in SEL Period|Run-in Failure|26|||
128762794|NCT04026165|463420814|FG002|Run-in SEL Period|Run-in Failure|0|||
128762795|NCT04026165|463420815|FG003|Run-in SEL Period|Run-in Failure|0|||
128762796|NCT04026165|463420812|FG000|Run-in SEL Period|Withdrew Consent|0|||
128762797|NCT04026165|463420813|FG001|Run-in SEL Period|Withdrew Consent|10|||
128762798|NCT04026165|463420814|FG002|Run-in SEL Period|Withdrew Consent|0|||
128762799|NCT04026165|463420815|FG003|Run-in SEL Period|Withdrew Consent|0|||
128762800|NCT04026165|463420812|FG000|Run-in SEL Period|Enrollment Error|0|||
128762801|NCT04026165|463420813|FG001|Run-in SEL Period|Enrollment Error|4|||
128762802|NCT04026165|463420814|FG002|Run-in SEL Period|Enrollment Error|0|||
128762803|NCT04026165|463420815|FG003|Run-in SEL Period|Enrollment Error|0|||
128762804|NCT04026165|463420812|FG000|Run-in SEL Period|Protocol Violation|0|||
128762805|NCT04026165|463420813|FG001|Run-in SEL Period|Protocol Violation|3|||
128762806|NCT04026165|463420814|FG002|Run-in SEL Period|Protocol Violation|0|||
128762807|NCT04026165|463420815|FG003|Run-in SEL Period|Protocol Violation|0|||
128762808|NCT04026165|463420812|FG000|Run-in SEL Period|Investigator's Discretion|0|||
128762809|NCT04026165|463420813|FG001|Run-in SEL Period|Investigator's Discretion|2|||
128762810|NCT04026165|463420814|FG002|Run-in SEL Period|Investigator's Discretion|0|||
128762811|NCT04026165|463420815|FG003|Run-in SEL Period|Investigator's Discretion|0|||
128762812|NCT04026165|463420812|FG000|Run-in SEL Period|Death|0|||
128762813|NCT04026165|463420813|FG001|Run-in SEL Period|Death|1|||
128762814|NCT04026165|463420814|FG002|Run-in SEL Period|Death|0|||
128762815|NCT04026165|463420815|FG003|Run-in SEL Period|Death|0|||
128983078|NCT02985541|464226124|FG000|Overall Study|Wish for pregnancy|44|||
128762816|NCT04026165|463420812|FG000|Randomized Period|Withdrew Consent|0|||
128762817|NCT04026165|463420813|FG001|Randomized Period|Withdrew Consent|0|||
128762818|NCT04026165|463420814|FG002|Randomized Period|Withdrew Consent|5|||
128762819|NCT04026165|463420815|FG003|Randomized Period|Withdrew Consent|8|||
128762820|NCT04026165|463420812|FG000|Randomized Period|Death|0|||
128762821|NCT04026165|463420813|FG001|Randomized Period|Death|0|||
128762822|NCT04026165|463420814|FG002|Randomized Period|Death|5|||
128762823|NCT04026165|463420815|FG003|Randomized Period|Death|7|||
128762824|NCT04026165|463420812|FG000|Randomized Period|Investigator's Discretion|0|||
128762825|NCT04026165|463420813|FG001|Randomized Period|Investigator's Discretion|0|||
128762826|NCT04026165|463420814|FG002|Randomized Period|Investigator's Discretion|2|||
128762827|NCT04026165|463420815|FG003|Randomized Period|Investigator's Discretion|2|||
128762828|NCT04026165|463420812|FG000|Randomized Period|Lost to Follow-up|0|||
128762829|NCT04026165|463420813|FG001|Randomized Period|Lost to Follow-up|0|||
128762830|NCT04026165|463420814|FG002|Randomized Period|Lost to Follow-up|2|||
128762831|NCT04026165|463420815|FG003|Randomized Period|Lost to Follow-up|2|||
128762832|NCT02487810|463420816|FG000|Overall Study|Withdrawal by Subject|1|||
128762833|NCT02487810|463420817|FG001|Overall Study|Withdrawal by Subject|0|||
128762834|NCT01889186|463420818|FG000|Overall Study|Adverse event- not related to progression|18|||
128762835|NCT01889186|463420819|FG001|Overall Study|Adverse event- not related to progression|5|||
128762836|NCT01889186|463420818|FG000|Overall Study|Adverse event- related to progression|7|||
128762837|NCT01889186|463420819|FG001|Overall Study|Adverse event- related to progression|2|||
128762838|NCT01889186|463420818|FG000|Overall Study|COVID-19 logistical restrictions|1|||
128762839|NCT01889186|463420819|FG001|Overall Study|COVID-19 logistical restrictions|0|||
128762840|NCT01889186|463420818|FG000|Overall Study|Investigator request|1|||
128762841|NCT01889186|463420819|FG001|Overall Study|Investigator request|1|||
128762842|NCT01889186|463420818|FG000|Overall Study|Progressive disease- Richter's|12|||
128762843|NCT01889186|463420819|FG001|Overall Study|Progressive disease- Richter's|7|||
128762844|NCT01889186|463420818|FG000|Overall Study|Progressive disease per protocol|46|||
128762845|NCT01889186|463420819|FG001|Overall Study|Progressive disease per protocol|17|||
128762846|NCT01889186|463420818|FG000|Overall Study|Stem cell transplant|2|||
128762847|NCT01889186|463420819|FG001|Overall Study|Stem cell transplant|1|||
128762848|NCT01889186|463420818|FG000|Overall Study|Withdrew consent|2|||
128762849|NCT01889186|463420819|FG001|Overall Study|Withdrew consent|3|||
128762850|NCT01889186|463420818|FG000|Overall Study|Other, not specified|18|||
128762851|NCT01889186|463420819|FG001|Overall Study|Other, not specified|15|||
128762852|NCT00441701|463420822|FG000|Overall Study|Adverse Event|3|||
128762853|NCT00441701|463420823|FG001|Overall Study|Adverse Event|2|||
128762854|NCT00441701|463420824|FG002|Overall Study|Adverse Event|1|||
128762855|NCT00441701|463420825|FG003|Overall Study|Adverse Event|0|||
128762856|NCT00441701|463420826|FG004|Overall Study|Adverse Event|2|||
128762857|NCT00441701|463420827|FG005|Overall Study|Adverse Event|2|||
128762858|NCT00441701|463420828|FG006|Overall Study|Adverse Event|0|||
128762859|NCT00441701|463420829|FG007|Overall Study|Adverse Event|0|||
128762860|NCT00441701|463420830|FG008|Overall Study|Adverse Event|0|||
128870910|NCT03986944|463822130|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
128870911|NCT03986944|463822131|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
128870912|NCT03986944|463822129|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
128870913|NCT03986944|463822130|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
128870914|NCT03986944|463822131|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
128870915|NCT01015560|463822133|FG000|Overall Study|Adverse Event|1|||
128870916|NCT01015560|463822133|FG000|Overall Study|Not protocol specified|1|||
128870917|NCT01015560|463822133|FG000|Overall Study|Withdrawal by Subject|1|||
128870918|NCT00640133|463822134|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
128870919|NCT00640133|463822135|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
128870920|NCT00640133|463822134|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
128870921|NCT00640133|463822135|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
128870922|NCT00640133|463822134|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
128870923|NCT00640133|463822135|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
128870924|NCT00128102|463822138|FG000|Overall Study|Site Discontinued|3|||
128870925|NCT00128102|463822139|FG001|Overall Study|Site Discontinued|6|||
128870926|NCT00128102|463822138|FG000|Overall Study|Other|0|||
128870927|NCT00128102|463822139|FG001|Overall Study|Other|1|||
128870928|NCT00128102|463822138|FG000|Overall Study|Progressive Disease|255|||
128870929|NCT00128102|463822139|FG001|Overall Study|Progressive Disease|285|||
128870930|NCT00128102|463822138|FG000|Overall Study|Adverse Event|34|||
128870931|NCT00128102|463822139|FG001|Overall Study|Adverse Event|11|||
128870932|NCT00128102|463822138|FG000|Overall Study|Death|12|||
128870933|NCT00128102|463822139|FG001|Overall Study|Death|13|||
128870934|NCT00128102|463822138|FG000|Overall Study|Physician Decision|3|||
128870935|NCT00128102|463822139|FG001|Overall Study|Physician Decision|3|||
128870936|NCT00128102|463822138|FG000|Overall Study|Withdrawal by Subject|19|||
128870937|NCT00128102|463822139|FG001|Overall Study|Withdrawal by Subject|11|||
128870938|NCT00128102|463822138|FG000|Overall Study|Protocol Violation|2|||
128870939|NCT00128102|463822139|FG001|Overall Study|Protocol Violation|2|||
128870940|NCT01202903|463822140|FG000|Overall Study|Administrative Probelms|1|||
128870941|NCT01202903|463822141|FG001|Overall Study|Administrative Probelms|4|||
128870942|NCT01202903|463822140|FG000|Overall Study|Protocol Violation|0|||
128870943|NCT01202903|463822141|FG001|Overall Study|Protocol Violation|1|||
128870944|NCT01202903|463822140|FG000|Overall Study|Death|1|||
128870945|NCT01202903|463822141|FG001|Overall Study|Death|0|||
128870946|NCT01202903|463822140|FG000|Overall Study|Lost to Follow-up|1|||
128870947|NCT01202903|463822141|FG001|Overall Study|Lost to Follow-up|1|||
128870948|NCT01202903|463822140|FG000|Overall Study|Lack of Efficacy|1|||
128870949|NCT01202903|463822141|FG001|Overall Study|Lack of Efficacy|3|||
128870950|NCT01202903|463822140|FG000|Overall Study|Adverse Event|3|||
128870951|NCT01202903|463822141|FG001|Overall Study|Adverse Event|3|||
128870952|NCT01202903|463822140|FG000|Overall Study|Withdrawal by Subject|4|||
128870953|NCT01202903|463822141|FG001|Overall Study|Withdrawal by Subject|4|||
128870954|NCT03339245|463822142|FG000|Overall Study|Adverse Event|1|||
128870955|NCT03339245|463822143|FG001|Overall Study|Adverse Event|1|||
128870956|NCT03339245|463822142|FG000|Overall Study|Withdrawal by Subject|1|||
128870957|NCT03339245|463822143|FG001|Overall Study|Withdrawal by Subject|0|||
128870958|NCT00837694|463822144|FG000|Overall Study|Lost to Follow-up|2|||
128870959|NCT00837694|463822145|FG001|Overall Study|Lost to Follow-up|0|||
128870960|NCT00837694|463822146|FG002|Overall Study|Lost to Follow-up|2|||
128870961|NCT00837694|463822147|FG003|Overall Study|Lost to Follow-up|1|||
128870962|NCT00837694|463822148|FG004|Overall Study|Lost to Follow-up|1|||
128870963|NCT00837694|463822149|FG005|Overall Study|Lost to Follow-up|1|||
128870964|NCT00306670|463822156|FG000|Overall Study|patients recruited; Genentech, the st|0|||
128870965|NCT00306670|463822157|FG001|Overall Study|patients recruited; Genentech, the st|2|||
128870966|NCT02731690|463822161|FG000|Overall Study|Adverse Event|1|||
128870967|NCT02731690|463822161|FG000|Overall Study|Withdrawal by Subject|3|||
128870968|NCT02731690|463822161|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
128870969|NCT01262677|463822162|FG000|Overall Study|Does not meet entrance criteria|0|||
128870970|NCT01262677|463822163|FG001|Overall Study|Does not meet entrance criteria|2|||
128870971|NCT01262677|463822164|FG002|Overall Study|Does not meet entrance criteria|0|||
128870972|NCT01262677|463822162|FG000|Overall Study|Insufficient clinical response|0|||
128870973|NCT01262677|463822163|FG001|Overall Study|Insufficient clinical response|0|||
128870974|NCT01262677|463822164|FG002|Overall Study|Insufficient clinical response|1|||
128870975|NCT01262677|463822162|FG000|Overall Study|Lost to Follow-up|1|||
128870976|NCT01262677|463822163|FG001|Overall Study|Lost to Follow-up|0|||
128870977|NCT01262677|463822164|FG002|Overall Study|Lost to Follow-up|2|||
128870978|NCT01262677|463822162|FG000|Overall Study|No longer willing to participate|3|||
128870979|NCT01262677|463822163|FG001|Overall Study|No longer willing to participate|3|||
128870980|NCT01262677|463822164|FG002|Overall Study|No longer willing to participate|2|||
128870981|NCT01262677|463822162|FG000|Overall Study|Reason not provided|2|||
128870982|NCT01262677|463822163|FG001|Overall Study|Reason not provided|1|||
128870983|NCT01262677|463822164|FG002|Overall Study|Reason not provided|3|||
128870984|NCT01262677|463822162|FG000|Overall Study|Protocol Violation|0|||
128870985|NCT01262677|463822163|FG001|Overall Study|Protocol Violation|1|||
128870986|NCT01262677|463822164|FG002|Overall Study|Protocol Violation|1|||
128870987|NCT01262677|463822162|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
128870988|NCT01262677|463822163|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
128870989|NCT01262677|463822164|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
128870990|NCT00201643|463822172|FG000|Overall Study|Withdrawal by Subject|5|||
128870991|NCT00201643|463822173|FG001|Overall Study|Withdrawal by Subject|4|||
128870992|NCT03446781|463822182|FG000|Overall Study|Lost to Follow-up|11|||
128870993|NCT03446781|463822183|FG001|Overall Study|Lost to Follow-up|5|||
128870994|NCT03446781|463822182|FG000|Overall Study|Withdrawal by Subject|9|||
128870995|NCT03446781|463822183|FG001|Overall Study|Withdrawal by Subject|7|||
128870996|NCT03446781|463822182|FG000|Overall Study|Adverse Event|8|||
128870997|NCT03446781|463822183|FG001|Overall Study|Adverse Event|2|||
128870998|NCT03446781|463822182|FG000|Overall Study|Protocol Violation|0|||
128870999|NCT03446781|463822183|FG001|Overall Study|Protocol Violation|3|||
128871000|NCT00996476|463822184|FG000|Overall Study|Withdrawal by Subject|1|||
128871001|NCT00996476|463822185|FG001|Overall Study|Withdrawal by Subject|2|||
128871002|NCT00996476|463822186|FG002|Overall Study|Withdrawal by Subject|1|||
128871003|NCT00996476|463822187|FG003|Overall Study|Withdrawal by Subject|0|||
128871004|NCT00996476|463822188|FG004|Overall Study|Withdrawal by Subject|1|||
128871005|NCT00996476|463822184|FG000|Overall Study|Adverse Event|0|||
128871006|NCT00996476|463822185|FG001|Overall Study|Adverse Event|1|||
128871007|NCT00996476|463822186|FG002|Overall Study|Adverse Event|0|||
128871008|NCT00996476|463822187|FG003|Overall Study|Adverse Event|0|||
128871009|NCT00996476|463822188|FG004|Overall Study|Adverse Event|1|||
128871010|NCT05540717|463822189|FG000|Overall Study|Lost to Follow-up|2|||
128871011|NCT05540717|463822190|FG001|Overall Study|Lost to Follow-up|5|||
128871012|NCT05540717|463822189|FG000|Overall Study|Withdrawal by Subject|6|||
128871013|NCT05540717|463822190|FG001|Overall Study|Withdrawal by Subject|6|||
128871014|NCT05540717|463822189|FG000|Overall Study|Sponsor request|1|||
128983079|NCT02985541|464226124|FG000|Overall Study|Other reason|5|||
128983080|NCT02985541|464226124|FG000|Overall Study|Not valid for analysis|2|||
128983081|NCT00247416|464226127|FG000|Overall Study|3 patients were found to be ineligible|1|||
128983082|NCT00247416|464226128|FG001|Overall Study|3 patients were found to be ineligible|2|||
128983083|NCT00798161|464226129|FG000|Overall Study|Adverse Event|3|||
128983084|NCT00798161|464226130|FG001|Overall Study|Adverse Event|4|||
128983085|NCT00798161|464226131|FG002|Overall Study|Adverse Event|6|||
128983086|NCT00798161|464226132|FG003|Overall Study|Adverse Event|6|||
128983087|NCT00798161|464226133|FG004|Overall Study|Adverse Event|5|||
128983088|NCT00798161|464226134|FG005|Overall Study|Adverse Event|2|||
128983089|NCT00798161|464226135|FG006|Overall Study|Adverse Event|4|||
128983090|NCT00798161|464226129|FG000|Overall Study|Protocol Violation|2|||
128983091|NCT00798161|464226130|FG001|Overall Study|Protocol Violation|1|||
128983092|NCT00798161|464226131|FG002|Overall Study|Protocol Violation|3|||
128983093|NCT00798161|464226132|FG003|Overall Study|Protocol Violation|3|||
128983094|NCT00798161|464226133|FG004|Overall Study|Protocol Violation|3|||
128983095|NCT00798161|464226134|FG005|Overall Study|Protocol Violation|2|||
128983096|NCT00798161|464226135|FG006|Overall Study|Protocol Violation|0|||
128983097|NCT00798161|464226129|FG000|Overall Study|Lost to Follow-up|1|||
128983098|NCT00798161|464226130|FG001|Overall Study|Lost to Follow-up|3|||
128983099|NCT00798161|464226131|FG002|Overall Study|Lost to Follow-up|4|||
128983100|NCT00798161|464226132|FG003|Overall Study|Lost to Follow-up|3|||
128983101|NCT00798161|464226133|FG004|Overall Study|Lost to Follow-up|4|||
128762861|NCT00441701|463420831|FG009|Overall Study|Adverse Event|0|||
128762862|NCT00441701|463420822|FG000|Overall Study|Lack of Efficacy|2|||
128762863|NCT00441701|463420823|FG001|Overall Study|Lack of Efficacy|0|||
128762864|NCT00441701|463420824|FG002|Overall Study|Lack of Efficacy|2|||
128762865|NCT00441701|463420825|FG003|Overall Study|Lack of Efficacy|2|||
128762866|NCT00441701|463420826|FG004|Overall Study|Lack of Efficacy|0|||
128762867|NCT00441701|463420827|FG005|Overall Study|Lack of Efficacy|1|||
128762868|NCT00441701|463420828|FG006|Overall Study|Lack of Efficacy|0|||
128762869|NCT00441701|463420829|FG007|Overall Study|Lack of Efficacy|0|||
128762870|NCT00441701|463420830|FG008|Overall Study|Lack of Efficacy|0|||
128762871|NCT00441701|463420831|FG009|Overall Study|Lack of Efficacy|0|||
128762872|NCT00441701|463420822|FG000|Overall Study|Withdrawal by Subject|0|||
128762873|NCT00441701|463420823|FG001|Overall Study|Withdrawal by Subject|2|||
128762874|NCT00441701|463420824|FG002|Overall Study|Withdrawal by Subject|1|||
128762875|NCT00441701|463420825|FG003|Overall Study|Withdrawal by Subject|1|||
128762876|NCT00441701|463420826|FG004|Overall Study|Withdrawal by Subject|0|||
128762877|NCT00441701|463420827|FG005|Overall Study|Withdrawal by Subject|0|||
128762878|NCT00441701|463420828|FG006|Overall Study|Withdrawal by Subject|0|||
128762879|NCT00441701|463420829|FG007|Overall Study|Withdrawal by Subject|0|||
128762880|NCT00441701|463420830|FG008|Overall Study|Withdrawal by Subject|0|||
128762881|NCT00441701|463420831|FG009|Overall Study|Withdrawal by Subject|0|||
128762882|NCT04710927|463420832|FG000|Overall Study|Lost to Follow-up|7|||
128762883|NCT04710927|463420833|FG001|Overall Study|Lost to Follow-up|6|||
128762884|NCT04710927|463420834|FG002|Overall Study|Lost to Follow-up|5|||
128762885|NCT02007434|463420836|FG000|Overall Study|Lost to Follow-up|0|||
128762886|NCT02007434|463420837|FG001|Overall Study|Lost to Follow-up|1|||
128762887|NCT02007434|463420838|FG002|Overall Study|Lost to Follow-up|0|||
128762888|NCT02007434|463420839|FG003|Overall Study|Lost to Follow-up|0|||
128762889|NCT02007434|463420840|FG004|Overall Study|Lost to Follow-up|0|||
128762890|NCT02007434|463420841|FG005|Overall Study|Lost to Follow-up|0|||
128762891|NCT02007434|463420842|FG006|Overall Study|Lost to Follow-up|0|||
128762892|NCT02007434|463420843|FG007|Overall Study|Lost to Follow-up|0|||
128762893|NCT02007434|463420836|FG000|Overall Study|Non-compliance|1|||
128762894|NCT02007434|463420837|FG001|Overall Study|Non-compliance|0|||
128762895|NCT02007434|463420838|FG002|Overall Study|Non-compliance|1|||
128762896|NCT02007434|463420839|FG003|Overall Study|Non-compliance|0|||
128762897|NCT02007434|463420840|FG004|Overall Study|Non-compliance|0|||
128762898|NCT02007434|463420841|FG005|Overall Study|Non-compliance|0|||
128762899|NCT02007434|463420842|FG006|Overall Study|Non-compliance|0|||
128762900|NCT02007434|463420843|FG007|Overall Study|Non-compliance|0|||
128762901|NCT01287611|463420844|FG000|Overall Study|Lost to Follow-up|29|||
128762902|NCT01287611|463420845|FG001|Overall Study|Lost to Follow-up|16|||
128762903|NCT01287611|463420844|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
128762904|NCT01287611|463420845|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
128762905|NCT03299686|463420856|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
128762906|NCT03299686|463420857|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
128871015|NCT05540717|463822190|FG001|Overall Study|Sponsor request|0|||
128983102|NCT00798161|464226134|FG005|Overall Study|Lost to Follow-up|0|||
128983103|NCT00798161|464226135|FG006|Overall Study|Lost to Follow-up|0|||
128983104|NCT00798161|464226129|FG000|Overall Study|Withdrawal by Subject|5|||
128983105|NCT00798161|464226130|FG001|Overall Study|Withdrawal by Subject|4|||
128983106|NCT00798161|464226131|FG002|Overall Study|Withdrawal by Subject|5|||
128983107|NCT00798161|464226132|FG003|Overall Study|Withdrawal by Subject|4|||
128983108|NCT00798161|464226133|FG004|Overall Study|Withdrawal by Subject|2|||
128983109|NCT00798161|464226134|FG005|Overall Study|Withdrawal by Subject|3|||
128983110|NCT00798161|464226135|FG006|Overall Study|Withdrawal by Subject|1|||
128762907|NCT03299686|463420856|FG000|Treatment Epoch|Physician Decision|1|||
128762908|NCT03299686|463420857|FG001|Treatment Epoch|Physician Decision|0|||
128762909|NCT03299686|463420856|FG000|Treatment Epoch|Adverse Event|8|||
128762910|NCT03299686|463420857|FG001|Treatment Epoch|Adverse Event|4|||
128762911|NCT03299686|463420856|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
128762912|NCT03299686|463420857|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
128762913|NCT03745222|463420858|FG000|Overall Study|Withdrawal by Subject|0|||
128762914|NCT03745222|463420859|FG001|Overall Study|Withdrawal by Subject|1|||
128762915|NCT03745222|463420860|FG002|Overall Study|Withdrawal by Subject|0|||
128762916|NCT02709005|463420861|FG000|Overall Study|Lost to Follow-up|1|||
128762917|NCT02709005|463420862|FG001|Overall Study|Lost to Follow-up|1|||
128762918|NCT02709005|463420861|FG000|Overall Study|Withdrawal by Subject|3|||
128762919|NCT02709005|463420862|FG001|Overall Study|Withdrawal by Subject|0|||
128762920|NCT01959347|463420863|FG000|Overall Study|Protocol Violation|9|||
128762921|NCT01959347|463420864|FG001|Overall Study|Protocol Violation|7|||
128871016|NCT05540717|463822189|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
128871017|NCT05540717|463822190|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
128871018|NCT05540717|463822189|FG000|Overall Study|Other|0|||
128871019|NCT05540717|463822190|FG001|Overall Study|Other|1|||
128871020|NCT00473265|463822191|FG000|Overall Study|Unrelated adverse event|5|||
128871021|NCT00473265|463822191|FG000|Overall Study|Off treatment early|15|||
128871022|NCT01940939|463822196|FG000|Overall Study|Withdrawal by Subject|2|||
128871023|NCT01940939|463822197|FG001|Overall Study|Withdrawal by Subject|8|||
128871024|NCT01470001|463822198|FG000|Overall Study|Lost to Follow-up|1|||
128871025|NCT01470001|463822199|FG001|Overall Study|Lost to Follow-up|1|||
128871026|NCT01470001|463822198|FG000|Overall Study|Physician Decision|2|||
128871027|NCT01470001|463822199|FG001|Overall Study|Physician Decision|0|||
128871028|NCT01470001|463822198|FG000|Overall Study|Withdrawal by Subject|2|||
128871029|NCT01470001|463822199|FG001|Overall Study|Withdrawal by Subject|1|||
128871030|NCT01895101|463822200|FG000|Overall Study|OPCAB procedure|1|||
128871031|NCT01895101|463822201|FG001|Overall Study|OPCAB procedure|1|||
128871032|NCT01895101|463822202|FG002|Overall Study|OPCAB procedure|3|||
128871033|NCT01895101|463822200|FG000|Overall Study|Withdrawal by Subject|0|||
128871034|NCT01895101|463822201|FG001|Overall Study|Withdrawal by Subject|1|||
128871035|NCT01895101|463822202|FG002|Overall Study|Withdrawal by Subject|2|||
128871036|NCT01895101|463822200|FG000|Overall Study|another study, enrolled in other study|0|||
128871037|NCT01895101|463822201|FG001|Overall Study|another study, enrolled in other study|1|||
128871038|NCT01895101|463822202|FG002|Overall Study|another study, enrolled in other study|0|||
128871039|NCT01895101|463822200|FG000|Overall Study|Death|0|||
128871040|NCT01895101|463822201|FG001|Overall Study|Death|1|||
128871041|NCT01895101|463822202|FG002|Overall Study|Death|0|||
128871042|NCT01895101|463822200|FG000|Overall Study|coagulation disorder|0|||
128871043|NCT01895101|463822201|FG001|Overall Study|coagulation disorder|1|||
128871044|NCT01895101|463822202|FG002|Overall Study|coagulation disorder|0|||
128871045|NCT00370682|463822203|FG000|Overall Study|Moved from area|0|||
128871046|NCT00370682|463822204|FG001|Overall Study|Moved from area|2|||
128871047|NCT00370682|463822205|FG002|Overall Study|Moved from area|0|||
128871048|NCT00370682|463822203|FG000|Overall Study|Lost to Follow-up|0|||
128871049|NCT00370682|463822204|FG001|Overall Study|Lost to Follow-up|1|||
128871050|NCT00370682|463822205|FG002|Overall Study|Lost to Follow-up|1|||
128871051|NCT00127205|463822206|FG000|Overall Study|Adverse Event|228|||
128871052|NCT00127205|463822207|FG001|Overall Study|Adverse Event|387|||
128871053|NCT00127205|463822208|FG002|Overall Study|Adverse Event|273|||
128871054|NCT00127205|463822206|FG000|Overall Study|Death|8|||
128871055|NCT00127205|463822207|FG001|Overall Study|Death|6|||
128871056|NCT00127205|463822208|FG002|Overall Study|Death|5|||
128871057|NCT00127205|463822206|FG000|Overall Study|Withdrawal by Subject|318|||
128871058|NCT00127205|463822207|FG001|Overall Study|Withdrawal by Subject|310|||
128871059|NCT00127205|463822208|FG002|Overall Study|Withdrawal by Subject|172|||
128871060|NCT00127205|463822206|FG000|Overall Study|Other-non protocol specified|142|||
128871061|NCT00127205|463822207|FG001|Overall Study|Other-non protocol specified|129|||
128871062|NCT00127205|463822208|FG002|Overall Study|Other-non protocol specified|77|||
128871063|NCT00127205|463822206|FG000|Overall Study|Data not reported|6|||
128871064|NCT00127205|463822207|FG001|Overall Study|Data not reported|10|||
128871065|NCT00127205|463822208|FG002|Overall Study|Data not reported|1|||
128871066|NCT00127205|463822206|FG000|Overall Study|Progression|127|||
128871067|NCT00127205|463822207|FG001|Overall Study|Progression|131|||
128871068|NCT00127205|463822208|FG002|Overall Study|Progression|84|||
128871069|NCT01280357|463822213|FG000|Overall Study|Excluded no internal monitoring|14|||
128871070|NCT01280357|463822213|FG000|Overall Study|IInsufficient data/No data supplied|12|||
128871071|NCT01259089|463822214|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
128762922|NCT01282801|463420865|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
128871072|NCT01259089|463822215|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
128871073|NCT01259089|463822216|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
128871074|NCT01259089|463822217|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
128871075|NCT01259089|463822218|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
128871076|NCT01259089|463822219|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
128871077|NCT01259089|463822214|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
128871078|NCT01259089|463822215|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
128871079|NCT01259089|463822216|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
128871080|NCT01259089|463822217|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
128871081|NCT01259089|463822218|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
128871082|NCT01259089|463822219|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
128871083|NCT01259089|463822214|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
128871084|NCT01259089|463822215|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
128871085|NCT01259089|463822216|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
128871086|NCT01259089|463822217|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
128871087|NCT01259089|463822218|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
128871088|NCT01259089|463822219|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
128871089|NCT01259089|463822214|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
128871090|NCT01259089|463822215|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
128871091|NCT01259089|463822216|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
128871092|NCT01259089|463822217|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
128871093|NCT01259089|463822218|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
128871094|NCT01259089|463822219|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
128871095|NCT01259089|463822214|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
128871096|NCT01259089|463822215|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
128871097|NCT01259089|463822216|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
128871098|NCT01259089|463822217|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
128871099|NCT01259089|463822218|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
128871100|NCT01259089|463822219|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
128871101|NCT01259089|463822214|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
128871102|NCT01259089|463822215|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
128871103|NCT01259089|463822216|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
128871104|NCT01259089|463822217|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
128871105|NCT01259089|463822218|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
128871106|NCT01259089|463822219|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
128871107|NCT01259089|463822214|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
128871108|NCT01259089|463822215|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
128983111|NCT00798161|464226129|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
128983112|NCT00798161|464226130|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
128871109|NCT01259089|463822216|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
128871110|NCT01259089|463822217|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
128871111|NCT01259089|463822218|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
128871112|NCT01259089|463822219|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
128871113|NCT01259089|463822214|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
128871114|NCT01259089|463822215|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
128871115|NCT01259089|463822216|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
128871116|NCT01259089|463822217|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
128871117|NCT01259089|463822218|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
128871118|NCT01259089|463822219|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
128871119|NCT01259089|463822214|FG000|Survival Follow up for Two Years|Death|3|||
128871120|NCT01259089|463822215|FG001|Survival Follow up for Two Years|Death|2|||
128871121|NCT01259089|463822216|FG002|Survival Follow up for Two Years|Death|2|||
128871122|NCT01259089|463822217|FG003|Survival Follow up for Two Years|Death|3|||
128871123|NCT01259089|463822218|FG004|Survival Follow up for Two Years|Death|6|||
128871124|NCT01259089|463822219|FG005|Survival Follow up for Two Years|Death|13|||
128871125|NCT01259089|463822214|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
128871126|NCT01259089|463822215|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
128871127|NCT01259089|463822216|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
128871128|NCT01259089|463822217|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
128871129|NCT01259089|463822218|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
128871130|NCT01259089|463822219|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
128871131|NCT01259089|463822214|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
128871132|NCT01259089|463822215|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
128871133|NCT01259089|463822216|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
128871134|NCT01259089|463822217|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
128871135|NCT01259089|463822218|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
128871136|NCT01259089|463822219|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
128871137|NCT00886795|463822224|FG000|Overall Study|Lack of Efficacy|1|||
128871138|NCT02310100|463822225|FG000|Overall Study|Physician Decision|3|||
128871139|NCT02310100|463822225|FG000|Overall Study|Withdrawal by Subject|10|||
128871140|NCT02310100|463822225|FG000|Overall Study|Enrollment closure|1|||
128871141|NCT02310100|463822225|FG000|Overall Study|Unapproved ablation operator|1|||
128871142|NCT02310100|463822225|FG000|Overall Study|Visit compliance|1|||
128871143|NCT02310100|463822225|FG000|Overall Study|Lost to Follow-up|2|||
128871144|NCT00688870|463822228|FG000|Infant Series|Parent or legal guardian request|4|||
128871145|NCT00688870|463822229|FG001|Infant Series|Parent or legal guardian request|0|||
128871146|NCT01253018|463822240|FG000|Overall Study|Lost to Follow-up|1|||
128871147|NCT01253018|463822241|FG001|Overall Study|Lost to Follow-up|1|||
128871148|NCT01253018|463822240|FG000|Overall Study|Robot Repair Issues|2|||
128871149|NCT01253018|463822241|FG001|Overall Study|Robot Repair Issues|0|||
128871150|NCT01253018|463822240|FG000|Overall Study|Withdrawal by Subject|1|||
128871151|NCT01253018|463822241|FG001|Overall Study|Withdrawal by Subject|1|||
128871152|NCT03449901|463822242|FG000|Overall Study|Progression|57|||
128871153|NCT03449901|463822243|FG001|Overall Study|Progression|12|||
128871154|NCT03449901|463822242|FG000|Overall Study|Adverse Event|3|||
128871155|NCT03449901|463822243|FG001|Overall Study|Adverse Event|0|||
128871156|NCT03449901|463822242|FG000|Overall Study|Death|6|||
128871157|NCT03449901|463822243|FG001|Overall Study|Death|2|||
128871158|NCT03449901|463822242|FG000|Overall Study|Withdrawal by Subject|12|||
128871159|NCT03449901|463822243|FG001|Overall Study|Withdrawal by Subject|1|||
128871160|NCT03449901|463822242|FG000|Overall Study|Physician Decision|1|||
128871161|NCT03449901|463822243|FG001|Overall Study|Physician Decision|0|||
128871162|NCT03449901|463822242|FG000|Overall Study|Patient elected for surgical intervention|1|||
128871163|NCT03449901|463822243|FG001|Overall Study|Patient elected for surgical intervention|0|||
128871164|NCT03449901|463822242|FG000|Overall Study|Patient off for other complicating disease|1|||
128871165|NCT03449901|463822243|FG001|Overall Study|Patient off for other complicating disease|0|||
128871166|NCT03466073|463822244|FG000|Overall Study|Death|1|||
128871167|NCT03466073|463822245|FG001|Overall Study|Death|0|||
128871168|NCT03466073|463822246|FG002|Overall Study|Death|0|||
128871169|NCT03466073|463822247|FG003|Overall Study|Death|0|||
128871170|NCT03466073|463822248|FG004|Overall Study|Death|0|||
128871171|NCT03466073|463822249|FG005|Overall Study|Death|1|||
128871172|NCT00744757|463822250|FG000|Overall Study|Objective disease progression|7|||
128871173|NCT00744757|463822250|FG000|Overall Study|Physician Decision|5|||
128871174|NCT00744757|463822250|FG000|Overall Study|Withdrawal by Subject|1|||
128871175|NCT00744757|463822250|FG000|Overall Study|Death|6|||
128871176|NCT00744757|463822250|FG000|Overall Study|Adverse Event|2|||
128871177|NCT03682302|463822251|FG000|Overall Study|Lost to Follow-up|1|||
128871178|NCT03682302|463822252|FG001|Overall Study|Lost to Follow-up|2|||
128871179|NCT03682302|463822253|FG002|Overall Study|Lost to Follow-up|0|||
128871180|NCT03682302|463822254|FG003|Overall Study|Lost to Follow-up|1|||
128871181|NCT03682302|463822251|FG000|Overall Study|Study drug was not administered|0|||
128871182|NCT03682302|463822252|FG001|Overall Study|Study drug was not administered|0|||
128871183|NCT03682302|463822253|FG002|Overall Study|Study drug was not administered|1|||
128871184|NCT03682302|463822254|FG003|Overall Study|Study drug was not administered|1|||
128871185|NCT05051462|463822255|FG000|Overall Study|Lost to Follow-up|1|||
128871186|NCT05051462|463822256|FG001|Overall Study|Lost to Follow-up|8|||
128871187|NCT05051462|463822255|FG000|Overall Study|Withdrawal by Subject|1|||
128871188|NCT05051462|463822256|FG001|Overall Study|Withdrawal by Subject|0|||
128871189|NCT05051462|463822255|FG000|Overall Study|Protocol Violation|0|||
128871190|NCT05051462|463822256|FG001|Overall Study|Protocol Violation|2|||
128871191|NCT05260021|463822261|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
128871192|NCT05260021|463822262|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
128871193|NCT05260021|463822263|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
128983113|NCT00798161|464226131|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
128983114|NCT00798161|464226132|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
128983115|NCT00798161|464226133|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
128983116|NCT00798161|464226134|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
128983117|NCT00798161|464226135|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
128983118|NCT00761761|464226136|FG000|Overall Study|Lost to Follow-up|3|||
128983119|NCT00761761|464226137|FG001|Overall Study|Lost to Follow-up|1|||
128983120|NCT00761761|464226136|FG000|Overall Study|Withdrawal by Subject|3|||
128983121|NCT00761761|464226137|FG001|Overall Study|Withdrawal by Subject|0|||
128983122|NCT04511533|464226143|FG000|Treatment|Other|2|||
128983123|NCT04511533|464226143|FG000|Treatment|Withdrawal by Subject|11|||
128983124|NCT04511533|464226143|FG000|Treatment|Death|5|||
128983125|NCT04511533|464226143|FG000|Treatment|Physician Decision|1|||
128983126|NCT04511533|464226143|FG000|Treatment|Progressive Disease|61|||
128983127|NCT04511533|464226143|FG000|Follow-Up|Other|7|||
128983128|NCT04511533|464226143|FG000|Follow-Up|Withdrawal by Subject|5|||
128983129|NCT04511533|464226143|FG000|Follow-Up|Lost to Follow-up|2|||
128983130|NCT04511533|464226143|FG000|Follow-Up|Death|4|||
128983131|NCT04576702|464226144|FG000|Overall Study|Death|1|||
128983132|NCT04576702|464226145|FG001|Overall Study|Death|0|||
128983133|NCT04576702|464226146|FG002|Overall Study|Death|0|||
129094363|NCT01565668|464637298|FG001|Overall Study|Participant went on Hospice Care|0|||
128871194|NCT05260021|463822261|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
128983134|NCT04576702|464226147|FG003|Overall Study|Death|0|||
128983135|NCT04576702|464226144|FG000|Overall Study|Withdrawal by Subject|0|||
128983136|NCT04576702|464226145|FG001|Overall Study|Withdrawal by Subject|2|||
128983137|NCT04576702|464226146|FG002|Overall Study|Withdrawal by Subject|1|||
128983138|NCT04576702|464226147|FG003|Overall Study|Withdrawal by Subject|0|||
128983139|NCT04576702|464226144|FG000|Overall Study|Lost to Follow-up|3|||
128983140|NCT04576702|464226145|FG001|Overall Study|Lost to Follow-up|3|||
128983141|NCT04576702|464226146|FG002|Overall Study|Lost to Follow-up|3|||
128983142|NCT04576702|464226147|FG003|Overall Study|Lost to Follow-up|4|||
128983143|NCT01319422|464226150|FG000|Overall Study|Withdrawal by Subject|1|||
128983144|NCT01319422|464226151|FG001|Overall Study|Withdrawal by Subject|0|||
128983145|NCT06104423|464226154|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
128983146|NCT06104423|464226155|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
128871195|NCT05260021|463822262|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
128871196|NCT05260021|463822263|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
128871197|NCT05260021|463822261|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
128871198|NCT05260021|463822262|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
128983147|NCT06104423|464226156|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
128983148|NCT06104423|464226154|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
128983149|NCT06104423|464226155|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
128983150|NCT06104423|464226156|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
128983151|NCT00727246|464226157|FG000|Overall Study|could not complete MRI|0|||
128983152|NCT00727246|464226158|FG001|Overall Study|could not complete MRI|1|||
128983153|NCT00727246|464226159|FG002|Overall Study|could not complete MRI|0|||
128983154|NCT00727246|464226160|FG003|Overall Study|could not complete MRI|1|||
128983155|NCT00727246|464226157|FG000|Overall Study|incidental finding|0|||
128983156|NCT00727246|464226158|FG001|Overall Study|incidental finding|0|||
128983157|NCT00727246|464226159|FG002|Overall Study|incidental finding|0|||
128983158|NCT00727246|464226160|FG003|Overall Study|incidental finding|1|||
128983159|NCT00727246|464226157|FG000|Overall Study|withdrawn|0|||
128983160|NCT00727246|464226158|FG001|Overall Study|withdrawn|0|||
128983161|NCT00727246|464226159|FG002|Overall Study|withdrawn|1|||
128983162|NCT00727246|464226160|FG003|Overall Study|withdrawn|0|||
128983163|NCT02696382|464226163|FG000|Overall Study|Death|7|||
128983164|NCT02696382|464226164|FG001|Overall Study|Death|2|||
128871199|NCT05260021|463822263|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
128871200|NCT05260021|463822261|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
128871201|NCT05260021|463822262|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
128871202|NCT05260021|463822263|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
128871203|NCT05260021|463822261|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
128871204|NCT05260021|463822262|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
128871205|NCT05260021|463822263|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
128871206|NCT03842358|463822264|FG000|Overall Study|Poor DOT probe contact with breast|2|||
128983165|NCT02696382|464226163|FG000|Overall Study|Withdrawal by Subject|5|||
128983166|NCT02696382|464226164|FG001|Overall Study|Withdrawal by Subject|12|||
128983167|NCT02696382|464226163|FG000|Overall Study|Lost to Follow-up|4|||
128871207|NCT03842358|463822264|FG000|Overall Study|DOT system problem|1|||
128871208|NCT03842358|463822264|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
128871209|NCT03842358|463822264|FG000|Overall Study|No biopsy after physician review|4|||
128871210|NCT03842358|463822264|FG000|Overall Study|Patient withdrew|2|||
128871211|NCT03333876|463824399|FG000|Screening Period|Screen Failure|4|||
128871212|NCT03333876|463824399|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
128871213|NCT03333876|463824399|FG000|Mandibular Advancement|Adverse Event|2|||
128871214|NCT03333876|463824399|FG000|Mandibular Advancement|Product Damage|2|||
128871215|NCT00095498|463824400|FG000|Overall Study|Physician Decision|9|||
128871216|NCT00095498|463824401|FG001|Overall Study|Physician Decision|10|||
128983168|NCT02696382|464226164|FG001|Overall Study|Lost to Follow-up|7|||
128983169|NCT01428882|464226174|FG000|Overall Study|Lack of Efficacy|2|||
128983170|NCT01428882|464226175|FG001|Overall Study|Lack of Efficacy|7|||
128983171|NCT01428882|464226174|FG000|Overall Study|Protocol Violation|4|||
128983172|NCT01428882|464226175|FG001|Overall Study|Protocol Violation|3|||
128983173|NCT00429026|464226178|FG000|Overall Study|Inevaluable for response.|40|||
128871217|NCT00095498|463824402|FG002|Overall Study|Physician Decision|8|||
128871218|NCT00095498|463824400|FG000|Overall Study|Adverse Event|1|||
128871219|NCT00095498|463824401|FG001|Overall Study|Adverse Event|0|||
128871220|NCT00095498|463824402|FG002|Overall Study|Adverse Event|1|||
128871221|NCT00095498|463824400|FG000|Overall Study|Withdrawal by Subject|15|||
128871222|NCT00095498|463824401|FG001|Overall Study|Withdrawal by Subject|16|||
128871223|NCT00095498|463824402|FG002|Overall Study|Withdrawal by Subject|15|||
128871224|NCT00095498|463824400|FG000|Overall Study|Disease progression|0|||
128983174|NCT03831282|464226179|FG000|Overall Study|Could not place sensor|1|||
129094364|NCT01565668|464637297|FG000|Overall Study|Adverse Event|6|||
128871225|NCT00095498|463824401|FG001|Overall Study|Disease progression|1|||
128871226|NCT00095498|463824402|FG002|Overall Study|Disease progression|1|||
128871227|NCT00095498|463824400|FG000|Overall Study|Ineligibility determined|3|||
128871228|NCT00095498|463824401|FG001|Overall Study|Ineligibility determined|0|||
128983175|NCT04652245|464226182|FG000|Wash-Out Period|Adverse Event|0|||
128871229|NCT00095498|463824402|FG002|Overall Study|Ineligibility determined|2|||
128871230|NCT00095498|463824400|FG000|Overall Study|Lost to Follow-up|1|||
128871231|NCT00095498|463824401|FG001|Overall Study|Lost to Follow-up|1|||
128871232|NCT00095498|463824402|FG002|Overall Study|Lost to Follow-up|2|||
128871233|NCT00095498|463824400|FG000|Overall Study|Noncompliance|1|||
128871234|NCT00095498|463824401|FG001|Overall Study|Noncompliance|0|||
128871235|NCT00095498|463824402|FG002|Overall Study|Noncompliance|1|||
128871236|NCT00095498|463824400|FG000|Overall Study|Other|6|||
128871237|NCT00095498|463824401|FG001|Overall Study|Other|7|||
128871238|NCT00095498|463824402|FG002|Overall Study|Other|6|||
128871239|NCT00095498|463824400|FG000|Overall Study|Protocol Violation|0|||
128871240|NCT00095498|463824401|FG001|Overall Study|Protocol Violation|0|||
128871241|NCT00095498|463824402|FG002|Overall Study|Protocol Violation|1|||
128871242|NCT00095498|463824400|FG000|Overall Study|Requirement for alternative therapy|1|||
128871243|NCT00095498|463824401|FG001|Overall Study|Requirement for alternative therapy|0|||
128871244|NCT00095498|463824402|FG002|Overall Study|Requirement for alternative therapy|2|||
128871245|NCT04684394|463824403|FG000|Overall Study|Death|1|||
128871246|NCT04684394|463824404|FG001|Overall Study|Death|2|||
128871247|NCT04684394|463824403|FG000|Overall Study|Lost to Follow-up|1|||
128871248|NCT04684394|463824404|FG001|Overall Study|Lost to Follow-up|0|||
128871249|NCT04684394|463824403|FG000|Overall Study|Withdrawal by Subject|2|||
128871250|NCT04684394|463824404|FG001|Overall Study|Withdrawal by Subject|0|||
128871251|NCT04684394|463824403|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
128871252|NCT04684394|463824404|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
128871253|NCT00591370|463824406|FG000|Overall Study|Not Treated|2|||
128871254|NCT04410523|463824410|FG000|Overall Study|Study terminated by sponsor|1|||
128871255|NCT04410523|463824411|FG001|Overall Study|Study terminated by sponsor|3|||
128871256|NCT04410523|463824412|FG002|Overall Study|Study terminated by sponsor|2|||
128871257|NCT04410523|463824413|FG003|Overall Study|Study terminated by sponsor|6|||
128871258|NCT04410523|463824414|FG004|Overall Study|Study terminated by sponsor|3|||
128871259|NCT04410523|463824415|FG005|Overall Study|Study terminated by sponsor|4|||
128871260|NCT04410523|463824410|FG000|Overall Study|Adverse Event|1|||
128871261|NCT04410523|463824411|FG001|Overall Study|Adverse Event|0|||
128871262|NCT04410523|463824412|FG002|Overall Study|Adverse Event|0|||
128871263|NCT04410523|463824413|FG003|Overall Study|Adverse Event|0|||
128871264|NCT04410523|463824414|FG004|Overall Study|Adverse Event|0|||
128871265|NCT04410523|463824415|FG005|Overall Study|Adverse Event|2|||
128871266|NCT04410523|463824410|FG000|Overall Study|Lost to Follow-up|0|||
128871267|NCT04410523|463824411|FG001|Overall Study|Lost to Follow-up|1|||
128871268|NCT04410523|463824412|FG002|Overall Study|Lost to Follow-up|0|||
128871269|NCT04410523|463824413|FG003|Overall Study|Lost to Follow-up|0|||
128871270|NCT04410523|463824414|FG004|Overall Study|Lost to Follow-up|0|||
128871271|NCT04410523|463824415|FG005|Overall Study|Lost to Follow-up|0|||
128871272|NCT04410523|463824410|FG000|Overall Study|Physician Decision|0|||
128871273|NCT04410523|463824411|FG001|Overall Study|Physician Decision|1|||
128983176|NCT04652245|464226183|FG001|Wash-Out Period|Adverse Event|2|||
128983177|NCT04652245|464226182|FG000|Wash-Out Period|Withdrawal by Subject|0|||
128983178|NCT04652245|464226183|FG001|Wash-Out Period|Withdrawal by Subject|2|||
128983179|NCT03556202|464226186|FG000|Extension Treatment Period|Adverse Event|18|||
128983180|NCT03556202|464226187|FG001|Extension Treatment Period|Adverse Event|14|||
128983181|NCT03556202|464226188|FG002|Extension Treatment Period|Adverse Event|9|||
128983182|NCT03556202|464226186|FG000|Extension Treatment Period|Death|2|||
128983183|NCT03556202|464226187|FG001|Extension Treatment Period|Death|6|||
128983184|NCT03556202|464226188|FG002|Extension Treatment Period|Death|0|||
128983185|NCT03556202|464226186|FG000|Extension Treatment Period|Lack of Efficacy|5|||
128871274|NCT04410523|463824412|FG002|Overall Study|Physician Decision|0|||
128871275|NCT04410523|463824413|FG003|Overall Study|Physician Decision|0|||
128871276|NCT04410523|463824414|FG004|Overall Study|Physician Decision|0|||
128871277|NCT04410523|463824415|FG005|Overall Study|Physician Decision|0|||
128871278|NCT04410523|463824410|FG000|Overall Study|Pregnancy|0|||
128871279|NCT04410523|463824411|FG001|Overall Study|Pregnancy|0|||
128871280|NCT04410523|463824412|FG002|Overall Study|Pregnancy|0|||
128871281|NCT04410523|463824413|FG003|Overall Study|Pregnancy|0|||
128871282|NCT04410523|463824414|FG004|Overall Study|Pregnancy|0|||
128871283|NCT04410523|463824415|FG005|Overall Study|Pregnancy|1|||
128871284|NCT04410523|463824410|FG000|Overall Study|Protocol deviation|0|||
128871285|NCT04410523|463824411|FG001|Overall Study|Protocol deviation|0|||
128871286|NCT04410523|463824412|FG002|Overall Study|Protocol deviation|0|||
128871287|NCT04410523|463824413|FG003|Overall Study|Protocol deviation|0|||
128871288|NCT04410523|463824414|FG004|Overall Study|Protocol deviation|0|||
128871289|NCT04410523|463824415|FG005|Overall Study|Protocol deviation|2|||
128871290|NCT04410523|463824410|FG000|Overall Study|Subject decision|2|||
128871291|NCT04410523|463824411|FG001|Overall Study|Subject decision|0|||
128871292|NCT04410523|463824412|FG002|Overall Study|Subject decision|0|||
128871293|NCT04410523|463824413|FG003|Overall Study|Subject decision|1|||
128871294|NCT04410523|463824414|FG004|Overall Study|Subject decision|0|||
128871295|NCT04410523|463824415|FG005|Overall Study|Subject decision|1|||
128871296|NCT00490490|463824416|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
128871297|NCT00490490|463824416|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
128871298|NCT03651622|463824417|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
128871299|NCT03651622|463824418|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
128871300|NCT03651622|463824419|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
128871301|NCT03651622|463824417|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
128983186|NCT03556202|464226187|FG001|Extension Treatment Period|Lack of Efficacy|12|||
128983187|NCT03556202|464226188|FG002|Extension Treatment Period|Lack of Efficacy|18|||
128983188|NCT03556202|464226186|FG000|Extension Treatment Period|Lost to Follow-up|9|||
128983189|NCT03556202|464226187|FG001|Extension Treatment Period|Lost to Follow-up|20|||
128983190|NCT03556202|464226188|FG002|Extension Treatment Period|Lost to Follow-up|2|||
128983191|NCT03556202|464226186|FG000|Extension Treatment Period|Pregnancy|2|||
128983192|NCT03556202|464226187|FG001|Extension Treatment Period|Pregnancy|4|||
128983193|NCT03556202|464226188|FG002|Extension Treatment Period|Pregnancy|3|||
128983194|NCT03556202|464226186|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
128983195|NCT03556202|464226187|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
128983196|NCT03556202|464226188|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
128983197|NCT03556202|464226186|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
128983198|NCT03556202|464226187|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
128871302|NCT03651622|463824418|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
128871303|NCT03651622|463824419|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
128871304|NCT03651622|463824417|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
128871305|NCT03651622|463824418|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
128871306|NCT03651622|463824419|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
128871307|NCT03651622|463824417|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
128871308|NCT03651622|463824418|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
128871309|NCT03651622|463824419|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
128871310|NCT03651622|463824417|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
128871311|NCT03651622|463824418|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
128871312|NCT03651622|463824419|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
128871313|NCT01519089|463824420|FG000|Overall Study|Adverse Event|4|||
128871314|NCT01519089|463824421|FG001|Overall Study|Adverse Event|4|||
128871315|NCT01519089|463824420|FG000|Overall Study|Lack of Efficacy|0|||
128871316|NCT01519089|463824421|FG001|Overall Study|Lack of Efficacy|2|||
128871317|NCT01519089|463824420|FG000|Overall Study|Lost to Follow-up|1|||
128871318|NCT01519089|463824421|FG001|Overall Study|Lost to Follow-up|0|||
128871319|NCT01519089|463824420|FG000|Overall Study|Withdrawal by Subject|0|||
128871320|NCT01519089|463824421|FG001|Overall Study|Withdrawal by Subject|2|||
128871321|NCT01519089|463824420|FG000|Overall Study|Other|2|||
128871322|NCT01519089|463824421|FG001|Overall Study|Other|6|||
128871323|NCT01519089|463824420|FG000|Overall Study|Not received study drug|0|||
128871324|NCT01519089|463824421|FG001|Overall Study|Not received study drug|1|||
128871325|NCT03582943|463824424|FG000|Allocated to Groups|Withdrawal by Subject|1|||
128871326|NCT03582943|463824425|FG001|Allocated to Groups|Withdrawal by Subject|1|||
128871327|NCT03582943|463824424|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
128871328|NCT03582943|463824425|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
128871329|NCT03582943|463824424|FG000|Analyzed|Protocol Violation|4|||
128871330|NCT03582943|463824425|FG001|Analyzed|Protocol Violation|1|||
128871331|NCT05032872|463824428|FG000|Overall Study|Adverse Event|1|||
128871332|NCT05032872|463824429|FG001|Overall Study|Adverse Event|0|||
128871333|NCT05032872|463824428|FG000|Overall Study|Lost to Follow-up|2|||
128871334|NCT05032872|463824429|FG001|Overall Study|Lost to Follow-up|4|||
128871335|NCT05032872|463824428|FG000|Overall Study|Withdrawal by Subject|4|||
128871336|NCT05032872|463824429|FG001|Overall Study|Withdrawal by Subject|3|||
128871337|NCT05870228|463824430|FG000|Overall Study|Lost to Follow-up|2|||
128871338|NCT05870228|463824431|FG001|Overall Study|Lost to Follow-up|0|||
128871339|NCT05870228|463824430|FG000|Overall Study|Withdrawal by Subject|1|||
128871340|NCT05870228|463824431|FG001|Overall Study|Withdrawal by Subject|0|||
128871341|NCT00488475|463824432|FG000|Overall Study|Other|1754|||
128871342|NCT01769326|463824453|FG000|Overall Study|Lost to Follow-up|1|||
128871343|NCT01769326|463824454|FG001|Overall Study|Lost to Follow-up|2|||
128871344|NCT01769326|463824455|FG002|Overall Study|Lost to Follow-up|0|||
128871345|NCT01769326|463824456|FG003|Overall Study|Lost to Follow-up|0|||
128871346|NCT01769326|463824453|FG000|Overall Study|unrelated injry|1|||
128871347|NCT01769326|463824454|FG001|Overall Study|unrelated injry|1|||
128871348|NCT01769326|463824455|FG002|Overall Study|unrelated injry|0|||
128871349|NCT01769326|463824456|FG003|Overall Study|unrelated injry|0|||
128871350|NCT01769326|463824453|FG000|Overall Study|got a job|0|||
128871351|NCT01769326|463824454|FG001|Overall Study|got a job|1|||
128871352|NCT01769326|463824455|FG002|Overall Study|got a job|0|||
128871353|NCT01769326|463824456|FG003|Overall Study|got a job|0|||
128871354|NCT01769326|463824453|FG000|Overall Study|Got sick and could not complete study|0|||
128871355|NCT01769326|463824454|FG001|Overall Study|Got sick and could not complete study|0|||
128871356|NCT01769326|463824455|FG002|Overall Study|Got sick and could not complete study|1|||
128871357|NCT01769326|463824456|FG003|Overall Study|Got sick and could not complete study|0|||
128871358|NCT01278173|463824457|FG000|Overall Study|Lack of Efficacy|13|||
128983199|NCT03556202|464226188|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
128983200|NCT03556202|464226186|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
128983201|NCT03556202|464226187|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
128983202|NCT03556202|464226188|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
128983203|NCT03556202|464226186|FG000|Extension Treatment Period|Physician Decision|0|||
128983204|NCT03556202|464226187|FG001|Extension Treatment Period|Physician Decision|8|||
128983205|NCT03556202|464226188|FG002|Extension Treatment Period|Physician Decision|2|||
128983206|NCT03556202|464226186|FG000|Extension Treatment Period|Protocol Violation|0|||
128983207|NCT03556202|464226187|FG001|Extension Treatment Period|Protocol Violation|1|||
128983208|NCT03556202|464226188|FG002|Extension Treatment Period|Protocol Violation|1|||
128983209|NCT03556202|464226186|FG000|Extension Treatment Period|Sponsor Decision|0|||
128983210|NCT03556202|464226187|FG001|Extension Treatment Period|Sponsor Decision|1|||
128983211|NCT03556202|464226188|FG002|Extension Treatment Period|Sponsor Decision|0|||
128983212|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
128983213|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
128983214|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
128983215|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Death|1|||
128983216|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Death|0|||
128983217|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Death|0|||
128983218|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
128983219|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
128983220|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
128983221|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
128983222|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
128983223|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
128983224|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
128983225|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
128983226|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
128983227|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
128983228|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
128983229|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
128983230|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
128983231|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
128983232|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
128983233|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
128983234|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
128983235|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
128983236|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
128983237|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
128983238|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
128983239|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
128983240|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
128983241|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
128983242|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
128983243|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
128983244|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
128983245|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
128983246|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
128983247|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
128983248|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
128983249|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
128983250|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
128983251|NCT03556202|464226186|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
128983252|NCT03556202|464226187|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
128983253|NCT03556202|464226188|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
128983254|NCT00903357|464226189|FG000|First Intervention|Withdrawal by Subject|5|||
128983255|NCT00903357|464226190|FG001|First Intervention|Withdrawal by Subject|3|||
128983256|NCT00903357|464226189|FG000|First Intervention|Flu|0|||
128983257|NCT00903357|464226190|FG001|First Intervention|Flu|1|||
128983258|NCT00903357|464226189|FG000|Wash Out Period of 2 Weeks|Flu|0|||
128983259|NCT00903357|464226190|FG001|Wash Out Period of 2 Weeks|Flu|1|||
128983260|NCT00903357|464226189|FG000|Second Intervention|Lost to Follow-up|1|||
128983261|NCT00903357|464226190|FG001|Second Intervention|Lost to Follow-up|0|||
128983262|NCT01539512|464226191|FG000|Overall Study|Adverse Event|9|||
128983263|NCT01539512|464226192|FG001|Overall Study|Adverse Event|7|||
128983264|NCT01539512|464226191|FG000|Overall Study|Physician Decision|1|||
128983265|NCT01539512|464226192|FG001|Overall Study|Physician Decision|1|||
128983266|NCT01539512|464226191|FG000|Overall Study|Withdrawal by Subject|12|||
128983267|NCT01539512|464226192|FG001|Overall Study|Withdrawal by Subject|5|||
128983268|NCT01539512|464226191|FG000|Overall Study|Richter's Transformation|1|||
128983269|NCT01539512|464226192|FG001|Overall Study|Richter's Transformation|0|||
128983270|NCT05146999|464226193|FG000|Overall Study|Withdrew consent|6|||
128983271|NCT05146999|464226194|FG001|Overall Study|Withdrew consent|1|||
128983272|NCT05146999|464226193|FG000|Overall Study|Lost to Follow-up|3|||
128983273|NCT05146999|464226194|FG001|Overall Study|Lost to Follow-up|2|||
128983274|NCT05146999|464226193|FG000|Overall Study|Other|1|||
128983275|NCT05146999|464226194|FG001|Overall Study|Other|3|||
128983276|NCT04668157|464226195|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
128983277|NCT04668157|464226196|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
128983278|NCT04668157|464226195|FG000|Treatment Period (52 Weeks)|Other|0|||
128983279|NCT04668157|464226196|FG001|Treatment Period (52 Weeks)|Other|2|||
128983280|NCT04479358|464226203|FG000|Overall Study|Withdrawal by Subject|0|||
128983281|NCT04479358|464226204|FG001|Overall Study|Withdrawal by Subject|0|||
128983282|NCT04479358|464226205|FG002|Overall Study|Withdrawal by Subject|1|||
128983283|NCT04479358|464226206|FG003|Overall Study|Withdrawal by Subject|0|||
128983284|NCT04479358|464226207|FG004|Overall Study|Withdrawal by Subject|0|||
128983285|NCT04479358|464226208|FG005|Overall Study|Withdrawal by Subject|1|||
128983286|NCT00764465|464226209|FG000|Overall Study|Adverse Event|2|||
128983287|NCT00764465|464226210|FG001|Overall Study|Adverse Event|0|||
128983288|NCT00764465|464226211|FG002|Overall Study|Adverse Event|0|||
128983289|NCT00764465|464226212|FG003|Overall Study|Adverse Event|1|||
128983290|NCT00764465|464226213|FG004|Overall Study|Adverse Event|1|||
128983291|NCT00764465|464226214|FG005|Overall Study|Adverse Event|1|||
128983292|NCT00764465|464226209|FG000|Overall Study|Withdrawal by Subject|0|||
128983293|NCT00764465|464226210|FG001|Overall Study|Withdrawal by Subject|1|||
128983294|NCT00764465|464226211|FG002|Overall Study|Withdrawal by Subject|1|||
128983295|NCT00764465|464226212|FG003|Overall Study|Withdrawal by Subject|0|||
128983296|NCT00764465|464226213|FG004|Overall Study|Withdrawal by Subject|0|||
128983297|NCT00764465|464226214|FG005|Overall Study|Withdrawal by Subject|0|||
128983298|NCT01333501|464226215|FG000|Overall Study|Adverse Event|3|||
128983299|NCT01333501|464226216|FG001|Overall Study|Adverse Event|1|||
128983300|NCT01333501|464226215|FG000|Overall Study|Abnormal laboratory value|2|||
128983301|NCT01333501|464226216|FG001|Overall Study|Abnormal laboratory value|1|||
128983302|NCT01333501|464226215|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128983303|NCT01333501|464226216|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
128983304|NCT01333501|464226215|FG000|Overall Study|Withdrawn consent|3|||
128983305|NCT01333501|464226216|FG001|Overall Study|Withdrawn consent|12|||
128983306|NCT00674440|464226217|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
128983307|NCT00674440|464226217|FG000|Overall Study|did not have surgery, so unevaluable|7|||
128983308|NCT00674440|464226217|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
128983309|NCT03329404|464226218|FG000|Overall Study|The study was suspended.|1|||
128983310|NCT03329404|464226219|FG001|Overall Study|The study was suspended.|4|||
128983311|NCT00914940|464226220|FG000|D0 to D100 Post-transplant|Death|2|||
128983312|NCT00914940|464226220|FG000|D101 to 2 Years Post-transplant|Death|8|||
128983313|NCT00914940|464226220|FG000|2 Years to 5 Years Post-transplant|Death|3|||
128983314|NCT00796367|464226221|FG000|Overall Study|Adverse Event|6|||
128983315|NCT00796367|464226222|FG001|Overall Study|Adverse Event|4|||
128983316|NCT00796367|464226223|FG002|Overall Study|Adverse Event|7|||
128983317|NCT00796367|464226221|FG000|Overall Study|Lost to Follow-up|5|||
128983318|NCT00796367|464226222|FG001|Overall Study|Lost to Follow-up|4|||
128983319|NCT00796367|464226223|FG002|Overall Study|Lost to Follow-up|21|||
128983320|NCT00796367|464226221|FG000|Overall Study|Withdrawal by Subject|9|||
128983321|NCT00796367|464226222|FG001|Overall Study|Withdrawal by Subject|11|||
128983322|NCT00796367|464226223|FG002|Overall Study|Withdrawal by Subject|12|||
128983323|NCT00796367|464226221|FG000|Overall Study|Lack of Efficacy|2|||
128983324|NCT00796367|464226222|FG001|Overall Study|Lack of Efficacy|1|||
128983325|NCT00796367|464226223|FG002|Overall Study|Lack of Efficacy|0|||
128983326|NCT00796367|464226221|FG000|Overall Study|non compliance|3|||
128983327|NCT00796367|464226222|FG001|Overall Study|non compliance|1|||
128983328|NCT00796367|464226223|FG002|Overall Study|non compliance|1|||
128983329|NCT00796367|464226221|FG000|Overall Study|Pregnancy|1|||
128983330|NCT00796367|464226222|FG001|Overall Study|Pregnancy|0|||
128983331|NCT00796367|464226223|FG002|Overall Study|Pregnancy|1|||
128983332|NCT00796367|464226221|FG000|Overall Study|Requirement for restricted medication|2|||
128983333|NCT00796367|464226222|FG001|Overall Study|Requirement for restricted medication|0|||
128983334|NCT00796367|464226223|FG002|Overall Study|Requirement for restricted medication|2|||
128983335|NCT00796367|464226221|FG000|Overall Study|other|2|||
128983336|NCT00796367|464226222|FG001|Overall Study|other|4|||
128983337|NCT00796367|464226223|FG002|Overall Study|other|3|||
128983338|NCT01728194|464226228|FG000|Overall Study|Lost to Follow-up|4|||
129094365|NCT01565668|464637298|FG001|Overall Study|Adverse Event|1|||
128983339|NCT01728194|464226229|FG001|Overall Study|Lost to Follow-up|3|||
128983340|NCT01728194|464226228|FG000|Overall Study|Physician Decision|4|||
128983341|NCT01728194|464226229|FG001|Overall Study|Physician Decision|0|||
128983342|NCT01728194|464226228|FG000|Overall Study|Withdrawal by Subject|7|||
128983343|NCT01728194|464226229|FG001|Overall Study|Withdrawal by Subject|3|||
128983344|NCT01728194|464226228|FG000|Overall Study|Perceived Medication Side Effects|4|||
128983345|NCT01728194|464226229|FG001|Overall Study|Perceived Medication Side Effects|0|||
128983346|NCT01728194|464226228|FG000|Overall Study|Family Member Request|1|||
128983347|NCT01728194|464226229|FG001|Overall Study|Family Member Request|0|||
128983348|NCT02129192|464226231|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
128983349|NCT02129192|464226232|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
128983350|NCT01078974|464226233|FG000|Overall Study|Adverse Event|3|||
128983351|NCT03575975|464226235|FG000|Overall Study|Lost to Follow-up|1|||
128983352|NCT03575975|464226236|FG001|Overall Study|Lost to Follow-up|0|||
128983353|NCT03575975|464226237|FG002|Overall Study|Lost to Follow-up|0|||
128983354|NCT00495794|464226238|FG000|Overall Study|Pharmacist did not activate patient|522|||
128983355|NCT00495794|464226239|FG001|Overall Study|Pharmacist did not activate patient|0|||
128983356|NCT03039699|464226241|FG000|Overall Study|Incorrect inclusion|5|||
128983357|NCT03039699|464226242|FG001|Overall Study|Incorrect inclusion|4|||
128983358|NCT03039699|464226241|FG000|Overall Study|Lack of data to assess study endpoint|5|||
128983359|NCT03039699|464226242|FG001|Overall Study|Lack of data to assess study endpoint|3|||
128983360|NCT03039699|464226241|FG000|Overall Study|Bacterial infection|12|||
128983361|NCT03039699|464226242|FG001|Overall Study|Bacterial infection|28|||
128983362|NCT00129220|464226243|FG000|Study Period II|Adverse Event|9|||
128983363|NCT00129220|464226244|FG001|Study Period II|Adverse Event|5|||
128983364|NCT00129220|464226245|FG002|Study Period II|Adverse Event|7|||
128983365|NCT00129220|464226243|FG000|Study Period II|Lack of Efficacy|15|||
128983366|NCT00129220|464226244|FG001|Study Period II|Lack of Efficacy|1|||
128983367|NCT00129220|464226245|FG002|Study Period II|Lack of Efficacy|28|||
128983368|NCT00129220|464226243|FG000|Study Period II|Entry Criteria Not Met|2|||
128983369|NCT00129220|464226244|FG001|Study Period II|Entry Criteria Not Met|0|||
128983370|NCT00129220|464226245|FG002|Study Period II|Entry Criteria Not Met|2|||
128983371|NCT00129220|464226243|FG000|Study Period II|Protocol Violation|4|||
128983372|NCT00129220|464226244|FG001|Study Period II|Protocol Violation|2|||
128983373|NCT00129220|464226245|FG002|Study Period II|Protocol Violation|1|||
128983374|NCT00129220|464226243|FG000|Study Period II|Physician Decision|0|||
128983375|NCT00129220|464226244|FG001|Study Period II|Physician Decision|1|||
128983376|NCT00129220|464226245|FG002|Study Period II|Physician Decision|0|||
128983377|NCT00129220|464226243|FG000|Study Period II|Withdrawal by Subject|1|||
128983378|NCT00129220|464226244|FG001|Study Period II|Withdrawal by Subject|3|||
128983379|NCT00129220|464226245|FG002|Study Period II|Withdrawal by Subject|4|||
128983380|NCT00129220|464226243|FG000|Study Period II|Reason Not Specified|2|||
128983381|NCT00129220|464226244|FG001|Study Period II|Reason Not Specified|0|||
128983382|NCT00129220|464226245|FG002|Study Period II|Reason Not Specified|5|||
128983383|NCT00129220|464226243|FG000|Study Period III|Adverse Event|1|||
128983384|NCT00129220|464226244|FG001|Study Period III|Adverse Event|0|||
128983385|NCT00129220|464226245|FG002|Study Period III|Adverse Event|3|||
128983386|NCT00129220|464226243|FG000|Study Period III|Protocol Violation|1|||
128983387|NCT00129220|464226244|FG001|Study Period III|Protocol Violation|1|||
128983388|NCT00129220|464226245|FG002|Study Period III|Protocol Violation|2|||
128983389|NCT00129220|464226243|FG000|Study Period III|Withdrawal by Subject|1|||
128983390|NCT00129220|464226244|FG001|Study Period III|Withdrawal by Subject|0|||
128983391|NCT00129220|464226245|FG002|Study Period III|Withdrawal by Subject|3|||
128983392|NCT00129220|464226243|FG000|Study Period III|Sponsor Decision|1|||
128983393|NCT00129220|464226244|FG001|Study Period III|Sponsor Decision|0|||
128983394|NCT00129220|464226245|FG002|Study Period III|Sponsor Decision|0|||
128983395|NCT00129220|464226243|FG000|Study Period III|Reason Not Specified|9|||
128983396|NCT00129220|464226244|FG001|Study Period III|Reason Not Specified|0|||
128983397|NCT00129220|464226245|FG002|Study Period III|Reason Not Specified|2|||
128983398|NCT01883362|464226246|FG000|Treatment|Adverse Event|1|||
128983399|NCT01883362|464226247|FG001|Treatment|Adverse Event|8|||
128983400|NCT01883362|464226246|FG000|Treatment|Withdrawal by Subject|6|||
128983401|NCT01883362|464226247|FG001|Treatment|Withdrawal by Subject|2|||
128983402|NCT01883362|464226246|FG000|Treatment|Administrative problems|4|||
128983403|NCT01883362|464226247|FG001|Treatment|Administrative problems|1|||
128983404|NCT01883362|464226246|FG000|Treatment|Relapse|4|||
128983405|NCT01883362|464226247|FG001|Treatment|Relapse|2|||
128983406|NCT01883362|464226246|FG000|Treatment|Randomized, not treated|1|||
128983407|NCT01883362|464226247|FG001|Treatment|Randomized, not treated|1|||
128983408|NCT01883362|464226246|FG000|Post Treatment Follow-up|Protocol Violation|0|||
128983409|NCT01883362|464226247|FG001|Post Treatment Follow-up|Protocol Violation|1|||
128983410|NCT01883362|464226246|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
128983411|NCT01883362|464226247|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
128983412|NCT01883362|464226246|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
128983413|NCT01883362|464226247|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
128983414|NCT01883362|464226246|FG000|Post Treatment Follow-up|Administrative problems|2|||
128983415|NCT01883362|464226247|FG001|Post Treatment Follow-up|Administrative problems|0|||
128983416|NCT01883362|464226246|FG000|Post Treatment Follow-up|Death|8|||
128983417|NCT01883362|464226247|FG001|Post Treatment Follow-up|Death|4|||
128983418|NCT01883362|464226246|FG000|Post Treatment Follow-up|Relapse|1|||
128983419|NCT01883362|464226247|FG001|Post Treatment Follow-up|Relapse|2|||
128983420|NCT02911285|464226248|FG000|Overall Study|Lost to Follow-up|8|||
128983421|NCT02911285|464226249|FG001|Overall Study|Lost to Follow-up|5|||
128983422|NCT02911285|464226248|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
128983423|NCT02911285|464226249|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
128983424|NCT01230489|464226250|FG000|Overall Study|Death|2|||
128983425|NCT01230489|464226250|FG000|Overall Study|Adverse Event|2|||
128983426|NCT01230489|464226250|FG000|Overall Study|Treatment modality changed|1|||
128983427|NCT01791543|464226251|FG000|Overall Study|Lost to Follow-up|1|||
128983428|NCT01791543|464226251|FG000|Overall Study|Adverse Event|1|||
128983429|NCT03996694|464227944|FG000|First Washout (7 Days)|positive urine drug screen|0|||
128983430|NCT03996694|464227945|FG001|First Washout (7 Days)|positive urine drug screen|0|||
128983431|NCT03996694|464227946|FG002|First Washout (7 Days)|positive urine drug screen|1|||
128983432|NCT03996694|464227947|FG003|First Washout (7 Days)|positive urine drug screen|0|||
128983433|NCT03996694|464227948|FG004|First Washout (7 Days)|positive urine drug screen|0|||
128983434|NCT03996694|464227949|FG005|First Washout (7 Days)|positive urine drug screen|0|||
128983435|NCT03996694|464227944|FG000|First Washout (7 Days)|Adverse Event|0|||
128983436|NCT03996694|464227945|FG001|First Washout (7 Days)|Adverse Event|1|||
128983437|NCT03996694|464227946|FG002|First Washout (7 Days)|Adverse Event|0|||
128983438|NCT03996694|464227947|FG003|First Washout (7 Days)|Adverse Event|0|||
128983439|NCT03996694|464227948|FG004|First Washout (7 Days)|Adverse Event|0|||
128983440|NCT03996694|464227949|FG005|First Washout (7 Days)|Adverse Event|0|||
128983441|NCT03996694|464227944|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
128983442|NCT03996694|464227945|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
128983443|NCT03996694|464227946|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
128983444|NCT03996694|464227947|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
128983445|NCT03996694|464227948|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
128983446|NCT03996694|464227949|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
128983447|NCT03996694|464227944|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
128983448|NCT03996694|464227945|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
128983449|NCT03996694|464227946|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
128983450|NCT03996694|464227947|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
128983451|NCT03996694|464227948|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
128983452|NCT03996694|464227949|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
128983453|NCT01458535|464227952|FG000|Overall Study|Other|0|||
128983454|NCT01458535|464227953|FG001|Overall Study|Other|0|||
128983455|NCT01458535|464227954|FG002|Overall Study|Other|0|||
128983456|NCT01458535|464227955|FG003|Overall Study|Other|0|||
128983457|NCT01458535|464227956|FG004|Overall Study|Other|1|||
128983458|NCT01458535|464227957|FG005|Overall Study|Other|1|||
128983459|NCT01458535|464227952|FG000|Overall Study|Withdrawal by Subject|0|||
128983460|NCT01458535|464227953|FG001|Overall Study|Withdrawal by Subject|0|||
128983461|NCT01458535|464227954|FG002|Overall Study|Withdrawal by Subject|2|||
128983462|NCT01458535|464227955|FG003|Overall Study|Withdrawal by Subject|0|||
128983463|NCT01458535|464227956|FG004|Overall Study|Withdrawal by Subject|1|||
128983464|NCT01458535|464227957|FG005|Overall Study|Withdrawal by Subject|1|||
128983465|NCT01458535|464227952|FG000|Overall Study|Lost to Follow-up|0|||
128983466|NCT01458535|464227953|FG001|Overall Study|Lost to Follow-up|2|||
128983467|NCT01458535|464227954|FG002|Overall Study|Lost to Follow-up|0|||
128983468|NCT01458535|464227955|FG003|Overall Study|Lost to Follow-up|3|||
128983469|NCT01458535|464227956|FG004|Overall Study|Lost to Follow-up|2|||
128983470|NCT01458535|464227957|FG005|Overall Study|Lost to Follow-up|2|||
128983471|NCT01458535|464227952|FG000|Overall Study|Adverse Event|0|||
128983472|NCT01458535|464227953|FG001|Overall Study|Adverse Event|0|||
128983473|NCT01458535|464227954|FG002|Overall Study|Adverse Event|0|||
128983474|NCT01458535|464227955|FG003|Overall Study|Adverse Event|1|||
128983475|NCT01458535|464227956|FG004|Overall Study|Adverse Event|0|||
128983476|NCT01458535|464227957|FG005|Overall Study|Adverse Event|0|||
128983477|NCT01238861|464227958|FG000|Overall Study|Lost to Follow-up|4|||
129094366|NCT01565668|464637297|FG000|Overall Study|Randomized, but never received drug|0|||
129094367|NCT01565668|464637298|FG001|Overall Study|Randomized, but never received drug|2|||
129094368|NCT01565668|464637297|FG000|Overall Study|Progressive disease|13|||
129094369|NCT01565668|464637298|FG001|Overall Study|Progressive disease|14|||
129094370|NCT01565668|464637297|FG000|Overall Study|Withdrawal by Subject|1|||
129094371|NCT01565668|464637298|FG001|Overall Study|Withdrawal by Subject|3|||
129094372|NCT01565668|464637297|FG000|Overall Study|HSCT Transplant|11|||
128983478|NCT01238861|464227959|FG001|Overall Study|Lost to Follow-up|2|||
128983479|NCT01238861|464227960|FG002|Overall Study|Lost to Follow-up|3|||
128983480|NCT01238861|464227961|FG003|Overall Study|Lost to Follow-up|1|||
128983481|NCT01238861|464227962|FG004|Overall Study|Lost to Follow-up|1|||
128983482|NCT01238861|464227963|FG005|Overall Study|Lost to Follow-up|2|||
128983483|NCT01238861|464227958|FG000|Overall Study|Unplanned surgery|1|||
128983484|NCT01238861|464227959|FG001|Overall Study|Unplanned surgery|0|||
128983485|NCT01238861|464227960|FG002|Overall Study|Unplanned surgery|0|||
128983486|NCT01238861|464227961|FG003|Overall Study|Unplanned surgery|0|||
128983487|NCT01238861|464227962|FG004|Overall Study|Unplanned surgery|0|||
128983488|NCT01238861|464227963|FG005|Overall Study|Unplanned surgery|0|||
128983489|NCT01238861|464227958|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
129094373|NCT01565668|464637298|FG001|Overall Study|HSCT Transplant|15|||
129094374|NCT04093492|464637299|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
129094375|NCT04093492|464637300|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
129094376|NCT04093492|464637301|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
129094377|NCT04093492|464637302|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
129094378|NCT04093492|464637299|FG000|25 Weeks Gestational Age (GA)|No response|5|||
129094379|NCT04093492|464637300|FG001|25 Weeks Gestational Age (GA)|No response|5|||
129094380|NCT04093492|464637301|FG002|25 Weeks Gestational Age (GA)|No response|5|||
129094381|NCT04093492|464637302|FG003|25 Weeks Gestational Age (GA)|No response|2|||
129094382|NCT04093492|464637299|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
129094383|NCT04093492|464637300|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
129094384|NCT04093492|464637301|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
129094385|NCT04093492|464637302|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
129094386|NCT04093492|464637299|FG000|30 Weeks GA|Delivered before assessment|1|||
129094387|NCT04093492|464637300|FG001|30 Weeks GA|Delivered before assessment|2|||
129094388|NCT04093492|464637301|FG002|30 Weeks GA|Delivered before assessment|0|||
129094389|NCT04093492|464637302|FG003|30 Weeks GA|Delivered before assessment|0|||
129094390|NCT04093492|464637299|FG000|30 Weeks GA|No response|7|||
129094391|NCT04093492|464637300|FG001|30 Weeks GA|No response|5|||
129094392|NCT04093492|464637301|FG002|30 Weeks GA|No response|5|||
129094393|NCT04093492|464637302|FG003|30 Weeks GA|No response|2|||
129094394|NCT04093492|464637299|FG000|30 Weeks GA|Lost to Follow-up|0|||
129094395|NCT04093492|464637300|FG001|30 Weeks GA|Lost to Follow-up|1|||
129094396|NCT04093492|464637301|FG002|30 Weeks GA|Lost to Follow-up|0|||
129094397|NCT04093492|464637302|FG003|30 Weeks GA|Lost to Follow-up|0|||
129094398|NCT04093492|464637299|FG000|34 Weeks GA|Delivered before assessment|6|||
129094399|NCT04093492|464637300|FG001|34 Weeks GA|Delivered before assessment|3|||
129094400|NCT04093492|464637301|FG002|34 Weeks GA|Delivered before assessment|0|||
129094401|NCT04093492|464637302|FG003|34 Weeks GA|Delivered before assessment|0|||
129094402|NCT04093492|464637299|FG000|34 Weeks GA|No response|0|||
129094403|NCT04093492|464637300|FG001|34 Weeks GA|No response|7|||
129094404|NCT04093492|464637301|FG002|34 Weeks GA|No response|5|||
129094405|NCT04093492|464637302|FG003|34 Weeks GA|No response|3|||
129094406|NCT04093492|464637299|FG000|34 Weeks GA|Lost to Follow-up|0|||
129094407|NCT04093492|464637300|FG001|34 Weeks GA|Lost to Follow-up|1|||
129094408|NCT04093492|464637301|FG002|34 Weeks GA|Lost to Follow-up|0|||
129094409|NCT04093492|464637302|FG003|34 Weeks GA|Lost to Follow-up|0|||
129094410|NCT00329641|464637303|FG000|Overall Study|Did not start treatment|1|||
129094411|NCT00329641|464637303|FG000|Overall Study|Not eligible|1|||
129094412|NCT00329641|464637303|FG000|Overall Study|Adverse Event|3|||
129094413|NCT00329641|464637303|FG000|Overall Study|Other reason, not protocol specified|1|||
129094414|NCT03422159|464637304|FG000|Overall Study|Exclusion due to terminal disease|2|||
129094415|NCT03422159|464637305|FG001|Overall Study|Exclusion due to terminal disease|1|||
129094416|NCT00980018|464637311|FG000|Overall Study|Adverse Event|8|||
129094417|NCT00980018|464637311|FG000|Overall Study|Patient withdrew consent|3|||
129094418|NCT00980018|464637311|FG000|Overall Study|Lost to Follow-up|1|||
129094419|NCT00087126|464637312|FG000|Overall Study|Ineligible - second primary|1|||
129094420|NCT00087126|464637312|FG000|Overall Study|Never treated|1|||
129094421|NCT01832818|464637313|FG000|Overall Study|Lost to Follow-up|6|||
129094422|NCT00934856|464637316|FG000|Feasibility Part|Progressive disease|4|||
129094423|NCT00934856|464637317|FG001|Feasibility Part|Progressive disease|4|||
129094424|NCT00934856|464637318|FG002|Feasibility Part|Progressive disease|2|||
129094425|NCT00934856|464637319|FG003|Feasibility Part|Progressive disease|3|||
129094426|NCT00934856|464637320|FG004|Feasibility Part|Progressive disease|0|||
129094427|NCT00934856|464637321|FG005|Feasibility Part|Progressive disease|0|||
129094428|NCT00934856|464637316|FG000|Feasibility Part|Physician Decision|0|||
129094429|NCT00934856|464637317|FG001|Feasibility Part|Physician Decision|0|||
129094430|NCT00934856|464637318|FG002|Feasibility Part|Physician Decision|1|||
129094431|NCT00934856|464637319|FG003|Feasibility Part|Physician Decision|0|||
129094432|NCT00934856|464637320|FG004|Feasibility Part|Physician Decision|0|||
129094433|NCT00934856|464637321|FG005|Feasibility Part|Physician Decision|0|||
129094434|NCT00934856|464637316|FG000|Feasibility Part|Adverse Event|1|||
129094435|NCT00934856|464637317|FG001|Feasibility Part|Adverse Event|1|||
129094436|NCT00934856|464637318|FG002|Feasibility Part|Adverse Event|0|||
129094437|NCT00934856|464637319|FG003|Feasibility Part|Adverse Event|1|||
129094438|NCT00934856|464637320|FG004|Feasibility Part|Adverse Event|0|||
129094439|NCT00934856|464637321|FG005|Feasibility Part|Adverse Event|2|||
129094440|NCT00934856|464637316|FG000|Feasibility Part|Withdrawal by Subject|0|||
129094441|NCT00934856|464637317|FG001|Feasibility Part|Withdrawal by Subject|0|||
129094442|NCT00934856|464637318|FG002|Feasibility Part|Withdrawal by Subject|0|||
129094443|NCT00934856|464637319|FG003|Feasibility Part|Withdrawal by Subject|1|||
128871359|NCT01278173|463824457|FG000|Overall Study|Adverse Event|8|||
128871360|NCT01278173|463824457|FG000|Overall Study|Administrative or other reason|4|||
128871361|NCT01278173|463824457|FG000|Overall Study|Protocol Violation|1|||
129094444|NCT00934856|464637320|FG004|Feasibility Part|Withdrawal by Subject|0|||
129094445|NCT00934856|464637321|FG005|Feasibility Part|Withdrawal by Subject|1|||
129094446|NCT00934856|464637316|FG000|Extension Part|Adverse Event|0|||
128983490|NCT01238861|464227959|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
128983491|NCT01238861|464227960|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
128983492|NCT01238861|464227961|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
128983493|NCT01238861|464227962|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
128983494|NCT01238861|464227963|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
128983495|NCT01238861|464227958|FG000|Overall Study|Incorrect enrollment/randomization|0|||
128983496|NCT01238861|464227959|FG001|Overall Study|Incorrect enrollment/randomization|0|||
128983497|NCT01238861|464227960|FG002|Overall Study|Incorrect enrollment/randomization|1|||
128983498|NCT01238861|464227961|FG003|Overall Study|Incorrect enrollment/randomization|0|||
128983499|NCT01238861|464227962|FG004|Overall Study|Incorrect enrollment/randomization|1|||
128983500|NCT01238861|464227963|FG005|Overall Study|Incorrect enrollment/randomization|0|||
128983501|NCT01238861|464227958|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
128983502|NCT01238861|464227959|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
128983503|NCT01238861|464227960|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
128983504|NCT01238861|464227961|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
128983505|NCT01238861|464227962|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
128983506|NCT01238861|464227963|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
128983507|NCT01238861|464227958|FG000|Overall Study|Subject moved out of state/area|0|||
128983508|NCT01238861|464227959|FG001|Overall Study|Subject moved out of state/area|0|||
128983509|NCT01238861|464227960|FG002|Overall Study|Subject moved out of state/area|1|||
128983510|NCT01238861|464227961|FG003|Overall Study|Subject moved out of state/area|1|||
128983511|NCT01238861|464227962|FG004|Overall Study|Subject moved out of state/area|0|||
128983512|NCT01238861|464227963|FG005|Overall Study|Subject moved out of state/area|0|||
128983513|NCT01238861|464227958|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
128983514|NCT01238861|464227959|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
128983515|NCT01238861|464227960|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
128983516|NCT01238861|464227961|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
128983517|NCT01238861|464227962|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
128983518|NCT01238861|464227963|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
128983519|NCT01238861|464227958|FG000|Overall Study|Personal problems|0|||
128983520|NCT01238861|464227959|FG001|Overall Study|Personal problems|0|||
128983521|NCT01238861|464227960|FG002|Overall Study|Personal problems|0|||
128983522|NCT01238861|464227961|FG003|Overall Study|Personal problems|1|||
128983523|NCT01238861|464227962|FG004|Overall Study|Personal problems|0|||
128983524|NCT01238861|464227963|FG005|Overall Study|Personal problems|0|||
128983525|NCT01238861|464227958|FG000|Overall Study|Unable to continue visits|0|||
128983526|NCT01238861|464227959|FG001|Overall Study|Unable to continue visits|0|||
128983527|NCT01238861|464227960|FG002|Overall Study|Unable to continue visits|0|||
128983528|NCT01238861|464227961|FG003|Overall Study|Unable to continue visits|1|||
128983529|NCT01238861|464227962|FG004|Overall Study|Unable to continue visits|0|||
128983530|NCT01238861|464227963|FG005|Overall Study|Unable to continue visits|1|||
128983531|NCT01238861|464227958|FG000|Overall Study|Serious adverse event|0|||
128983532|NCT01238861|464227959|FG001|Overall Study|Serious adverse event|0|||
128983533|NCT01238861|464227960|FG002|Overall Study|Serious adverse event|0|||
128983534|NCT01238861|464227961|FG003|Overall Study|Serious adverse event|0|||
128983535|NCT01238861|464227962|FG004|Overall Study|Serious adverse event|0|||
128983536|NCT01238861|464227963|FG005|Overall Study|Serious adverse event|1|||
128983537|NCT01238861|464227958|FG000|Overall Study|Lack of compliance|0|||
128983538|NCT01238861|464227959|FG001|Overall Study|Lack of compliance|0|||
128983539|NCT01238861|464227960|FG002|Overall Study|Lack of compliance|0|||
128983540|NCT01238861|464227961|FG003|Overall Study|Lack of compliance|0|||
128983541|NCT01238861|464227962|FG004|Overall Study|Lack of compliance|0|||
128983542|NCT01238861|464227963|FG005|Overall Study|Lack of compliance|1|||
128983543|NCT01238861|464227958|FG000|Overall Study|Adverse Event|0|||
128983544|NCT01238861|464227959|FG001|Overall Study|Adverse Event|1|||
128983545|NCT01238861|464227960|FG002|Overall Study|Adverse Event|0|||
128983546|NCT01238861|464227961|FG003|Overall Study|Adverse Event|0|||
128983547|NCT01238861|464227962|FG004|Overall Study|Adverse Event|0|||
128983548|NCT01238861|464227963|FG005|Overall Study|Adverse Event|0|||
128983549|NCT01238861|464227958|FG000|Overall Study|Withdrawal by Subject|6|||
128983550|NCT01238861|464227959|FG001|Overall Study|Withdrawal by Subject|5|||
128983551|NCT01238861|464227960|FG002|Overall Study|Withdrawal by Subject|4|||
128983552|NCT01238861|464227961|FG003|Overall Study|Withdrawal by Subject|8|||
128983553|NCT01238861|464227962|FG004|Overall Study|Withdrawal by Subject|10|||
128983554|NCT01238861|464227963|FG005|Overall Study|Withdrawal by Subject|9|||
128983555|NCT01269346|464227964|FG000|Treatment Phase|Disease progression|3|||
128983556|NCT01269346|464227964|FG000|Treatment Phase|Adverse Event|3|||
128983557|NCT01269346|464227964|FG000|Treatment Phase|Withdrawal by Subject|1|||
128983558|NCT01269346|464227964|FG000|Treatment Phase|Other|2|||
128983559|NCT01269346|464227964|FG000|Extension Phase|Adverse Event|6|||
128983560|NCT01269346|464227964|FG000|Extension Phase|Withdrawal by Subject|4|||
128983561|NCT01269346|464227964|FG000|Extension Phase|Disease progression|22|||
128983562|NCT01269346|464227964|FG000|Extension Phase|Physician decision or participant choice|9|||
128983563|NCT01269346|464227964|FG000|Extension Phase|Clinical progression|1|||
128983564|NCT01269346|464227964|FG000|Extension Phase|Started a prohibited con med|1|||
128983565|NCT01855607|464227965|FG000|Overall Study|Withdrawal by Subject|1|||
128983566|NCT01855607|464227965|FG000|Overall Study|Study was terminated|11|||
128983567|NCT04001790|464227970|FG000|Overall Study|Withdrawal by Subject|1|||
128983568|NCT04001790|464227971|FG001|Overall Study|Withdrawal by Subject|2|||
128983569|NCT02706327|464227972|FG000|Overall Study|Lost to Follow-up|1|||
128983570|NCT02706327|464227973|FG001|Overall Study|Lost to Follow-up|1|||
128983571|NCT02706327|464227974|FG002|Overall Study|Lost to Follow-up|2|||
128983572|NCT03471507|464227977|FG000|Overall Study|Lost to Follow-up|1|||
128983573|NCT03471507|464227978|FG001|Overall Study|Lost to Follow-up|3|||
128983574|NCT03471507|464227977|FG000|Overall Study|Physician Decision|0|||
128983575|NCT03471507|464227978|FG001|Overall Study|Physician Decision|1|||
128983576|NCT03471507|464227977|FG000|Overall Study|Withdrawal by Subject|2|||
128983577|NCT03471507|464227978|FG001|Overall Study|Withdrawal by Subject|1|||
128983578|NCT03417245|464227979|FG000|Overall Study|Adverse Event|1|||
128983579|NCT03417245|464227980|FG001|Overall Study|Adverse Event|0|||
128983580|NCT03417245|464227979|FG000|Overall Study|Protocol Violation|1|||
128983581|NCT03417245|464227980|FG001|Overall Study|Protocol Violation|0|||
128983582|NCT03417245|464227979|FG000|Overall Study|Withdrawal by Subject|1|||
128983583|NCT03417245|464227980|FG001|Overall Study|Withdrawal by Subject|1|||
128983584|NCT02708524|464227988|FG000|Overall Study|Adverse Event|0|||
128983585|NCT02708524|464227989|FG001|Overall Study|Adverse Event|1|||
128983586|NCT02708524|464227990|FG002|Overall Study|Adverse Event|0|||
128983587|NCT02708524|464227991|FG003|Overall Study|Adverse Event|0|||
128983588|NCT02708524|464227988|FG000|Overall Study|Lens Discomfort|1|||
128983589|NCT02708524|464227989|FG001|Overall Study|Lens Discomfort|0|||
128983590|NCT02708524|464227990|FG002|Overall Study|Lens Discomfort|1|||
128983591|NCT02708524|464227991|FG003|Overall Study|Lens Discomfort|0|||
128983592|NCT02708524|464227988|FG000|Overall Study|Lost to Follow-up|1|||
128983593|NCT02708524|464227989|FG001|Overall Study|Lost to Follow-up|1|||
128983594|NCT02708524|464227990|FG002|Overall Study|Lost to Follow-up|1|||
128983595|NCT02708524|464227991|FG003|Overall Study|Lost to Follow-up|0|||
128983596|NCT02708524|464227988|FG000|Overall Study|Protocol Violation|0|||
128983597|NCT02708524|464227989|FG001|Overall Study|Protocol Violation|1|||
128983598|NCT02708524|464227990|FG002|Overall Study|Protocol Violation|0|||
128983599|NCT02708524|464227991|FG003|Overall Study|Protocol Violation|0|||
128983600|NCT02708524|464227988|FG000|Overall Study|Withdrawal by Subject|1|||
128983601|NCT02708524|464227989|FG001|Overall Study|Withdrawal by Subject|1|||
128983602|NCT02708524|464227990|FG002|Overall Study|Withdrawal by Subject|0|||
128983603|NCT02708524|464227991|FG003|Overall Study|Withdrawal by Subject|0|||
128983604|NCT02708524|464227988|FG000|Overall Study|Dispensed incorrect study lens|0|||
128983605|NCT02708524|464227989|FG001|Overall Study|Dispensed incorrect study lens|1|||
128983606|NCT02708524|464227990|FG002|Overall Study|Dispensed incorrect study lens|1|||
128983607|NCT02708524|464227991|FG003|Overall Study|Dispensed incorrect study lens|0|||
128983608|NCT02708524|464227988|FG000|Overall Study|Did not wear lens at final visit|0|||
128983609|NCT02708524|464227989|FG001|Overall Study|Did not wear lens at final visit|1|||
128983610|NCT02708524|464227990|FG002|Overall Study|Did not wear lens at final visit|0|||
128983611|NCT02708524|464227991|FG003|Overall Study|Did not wear lens at final visit|0|||
128983612|NCT02708524|464227988|FG000|Overall Study|Subject lost study lens|1|||
128983613|NCT02708524|464227989|FG001|Overall Study|Subject lost study lens|0|||
128983614|NCT02708524|464227990|FG002|Overall Study|Subject lost study lens|0|||
128983615|NCT02708524|464227991|FG003|Overall Study|Subject lost study lens|0|||
128983616|NCT00229931|464227998|FG000|Overall Study|Death|1|||
128983617|NCT00229931|464227999|FG001|Overall Study|Death|0|||
128983618|NCT00229931|464227998|FG000|Overall Study|Lost to Follow-up|3|||
128983619|NCT00229931|464227999|FG001|Overall Study|Lost to Follow-up|2|||
128983620|NCT02992743|464228000|FG000|Overall Study|Withdrawal by Subject|1|||
128983621|NCT02992743|464228001|FG001|Overall Study|Withdrawal by Subject|1|||
128983622|NCT02992743|464228000|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
128983623|NCT02992743|464228001|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
128983624|NCT02992743|464228000|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
128983625|NCT02992743|464228001|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
128983626|NCT02992743|464228000|FG000|Overall Study|No measurable disease|1|||
128983627|NCT02992743|464228001|FG001|Overall Study|No measurable disease|0|||
128983628|NCT02992743|464228000|FG000|Overall Study|Lost to Follow-up|0|||
128983629|NCT02992743|464228001|FG001|Overall Study|Lost to Follow-up|1|||
128983630|NCT00761735|464228002|FG000|Overall Study|Lost to Follow-up|6|||
128983631|NCT00761735|464228002|FG000|Overall Study|Withdrawal by Subject|6|||
128983632|NCT00761735|464228002|FG000|Overall Study|Non-compliance with protocol|1|||
128983633|NCT00761735|464228002|FG000|Overall Study|Administrative|1|||
128983634|NCT03290131|464228003|FG000|Overall Study|Adverse Event|22|||
128983635|NCT03290131|464228004|FG001|Overall Study|Adverse Event|57|||
128983636|NCT03290131|464228005|FG002|Overall Study|Adverse Event|11|||
128983637|NCT03290131|464228003|FG000|Overall Study|Withdrawal by Subject|18|||
128983638|NCT03290131|464228004|FG001|Overall Study|Withdrawal by Subject|13|||
128983639|NCT03290131|464228005|FG002|Overall Study|Withdrawal by Subject|8|||
128983640|NCT03290131|464228003|FG000|Overall Study|MS Relapse|2|||
129094447|NCT00934856|464637317|FG001|Extension Part|Adverse Event|0|||
129094448|NCT00934856|464637318|FG002|Extension Part|Adverse Event|0|||
129094449|NCT00934856|464637319|FG003|Extension Part|Adverse Event|1|||
129094450|NCT00934856|464637320|FG004|Extension Part|Adverse Event|4|||
129094451|NCT00934856|464637321|FG005|Extension Part|Adverse Event|4|||
129094452|NCT00934856|464637316|FG000|Extension Part|Progressive disease|0|||
129094453|NCT00934856|464637317|FG001|Extension Part|Progressive disease|0|||
129094454|NCT00934856|464637318|FG002|Extension Part|Progressive disease|0|||
129094455|NCT00934856|464637319|FG003|Extension Part|Progressive disease|1|||
129094456|NCT00934856|464637320|FG004|Extension Part|Progressive disease|0|||
129094457|NCT00934856|464637321|FG005|Extension Part|Progressive disease|0|||
129094458|NCT00934856|464637316|FG000|Extension Part|Non-compliance with drug|0|||
129094459|NCT00934856|464637317|FG001|Extension Part|Non-compliance with drug|0|||
129094460|NCT00934856|464637318|FG002|Extension Part|Non-compliance with drug|0|||
129094461|NCT00934856|464637319|FG003|Extension Part|Non-compliance with drug|0|||
129094462|NCT00934856|464637320|FG004|Extension Part|Non-compliance with drug|0|||
129094463|NCT00934856|464637321|FG005|Extension Part|Non-compliance with drug|1|||
129094464|NCT01256385|464637322|FG000|Overall Study|Physician Decision|1|||
129094465|NCT01256385|464637323|FG001|Overall Study|Physician Decision|1|||
129094466|NCT01256385|464637322|FG000|Overall Study|Withdrawal by Subject|2|||
129094467|NCT01256385|464637323|FG001|Overall Study|Withdrawal by Subject|2|||
129094468|NCT00401960|464637326|FG000|Overall Study|Lost to Follow-up|3|||
129094469|NCT00401960|464637327|FG001|Overall Study|Lost to Follow-up|0|||
129094470|NCT00401960|464637326|FG000|Overall Study|Death|2|||
129094471|NCT00401960|464637327|FG001|Overall Study|Death|0|||
129094472|NCT02649426|464637328|FG000|Overall Study|Follow-up on going|1|||
129094473|NCT02649426|464637329|FG001|Overall Study|Follow-up on going|26|||
129094474|NCT02649426|464637330|FG002|Overall Study|Follow-up on going|28|||
129094475|NCT02649426|464637331|FG003|Overall Study|Follow-up on going|31|||
129094476|NCT01606202|464637332|FG000|Overall Study|Adverse Event|5|||
129094477|NCT01606202|464637333|FG001|Overall Study|Adverse Event|0|||
129094478|NCT01606202|464637332|FG000|Overall Study|Withdrawal by Subject|2|||
129094479|NCT01606202|464637333|FG001|Overall Study|Withdrawal by Subject|1|||
129094480|NCT01606202|464637332|FG000|Overall Study|Personal problems|0|||
129094481|NCT01606202|464637333|FG001|Overall Study|Personal problems|1|||
129094482|NCT01606202|464637332|FG000|Overall Study|Problems with administration|0|||
129094483|NCT01606202|464637333|FG001|Overall Study|Problems with administration|1|||
129094484|NCT02584959|464637334|FG000|Period 1|Withdrawn from study|3|||
129094485|NCT02584959|464637335|FG001|Period 1|Withdrawn from study|4|||
129094486|NCT02584959|464637336|FG002|Period 1|Withdrawn from study|0|||
129094487|NCT02584959|464637334|FG000|Period 2|Withdrawn from study|6|||
129094488|NCT02584959|464637335|FG001|Period 2|Withdrawn from study|1|||
129094489|NCT02584959|464637336|FG002|Period 2|Withdrawn from study|2|||
129094490|NCT00195494|464637341|FG000|Year 1|Adverse Event|0|||
129094491|NCT00195494|464637342|FG001|Year 1|Adverse Event|0|||
129094492|NCT00195494|464637343|FG002|Year 1|Adverse Event|0|||
129094493|NCT00195494|464637344|FG003|Year 1|Adverse Event|0|||
129094494|NCT00195494|464637345|FG004|Year 1|Adverse Event|34|||
129094495|NCT00195494|464637346|FG005|Year 1|Adverse Event|27|||
129094496|NCT00195494|464637341|FG000|Year 1|System Toxicity|0|||
129094497|NCT00195494|464637342|FG001|Year 1|System Toxicity|0|||
129094498|NCT00195494|464637343|FG002|Year 1|System Toxicity|0|||
129094499|NCT00195494|464637344|FG003|Year 1|System Toxicity|0|||
129094500|NCT00195494|464637345|FG004|Year 1|System Toxicity|0|||
129094501|NCT00195494|464637346|FG005|Year 1|System Toxicity|1|||
129094502|NCT00195494|464637341|FG000|Year 1|Lack of Efficacy|0|||
129094503|NCT00195494|464637342|FG001|Year 1|Lack of Efficacy|0|||
129094504|NCT00195494|464637343|FG002|Year 1|Lack of Efficacy|0|||
129094505|NCT00195494|464637344|FG003|Year 1|Lack of Efficacy|0|||
129094506|NCT00195494|464637345|FG004|Year 1|Lack of Efficacy|24|||
129094507|NCT00195494|464637346|FG005|Year 1|Lack of Efficacy|9|||
129094508|NCT00195494|464637341|FG000|Year 1|Compliance|0|||
129094509|NCT00195494|464637342|FG001|Year 1|Compliance|0|||
129094510|NCT00195494|464637343|FG002|Year 1|Compliance|0|||
129094511|NCT00195494|464637344|FG003|Year 1|Compliance|0|||
129094512|NCT00195494|464637345|FG004|Year 1|Compliance|5|||
129094513|NCT00195494|464637346|FG005|Year 1|Compliance|1|||
129094514|NCT00195494|464637341|FG000|Year 1|Lost to Follow-up|0|||
129094515|NCT00195494|464637342|FG001|Year 1|Lost to Follow-up|0|||
129094516|NCT00195494|464637343|FG002|Year 1|Lost to Follow-up|0|||
129094517|NCT00195494|464637344|FG003|Year 1|Lost to Follow-up|0|||
129094518|NCT00195494|464637345|FG004|Year 1|Lost to Follow-up|1|||
129094519|NCT00195494|464637346|FG005|Year 1|Lost to Follow-up|0|||
129094520|NCT00195494|464637341|FG000|Year 1|Missed >4 consecutive doses|0|||
129094521|NCT00195494|464637342|FG001|Year 1|Missed >4 consecutive doses|0|||
129094522|NCT00195494|464637343|FG002|Year 1|Missed >4 consecutive doses|0|||
129094523|NCT00195494|464637344|FG003|Year 1|Missed >4 consecutive doses|0|||
129094524|NCT00195494|464637345|FG004|Year 1|Missed >4 consecutive doses|3|||
129094525|NCT00195494|464637346|FG005|Year 1|Missed >4 consecutive doses|2|||
129094526|NCT00195494|464637341|FG000|Year 1|Protocol deviation|0|||
129094527|NCT00195494|464637342|FG001|Year 1|Protocol deviation|0|||
129094528|NCT00195494|464637343|FG002|Year 1|Protocol deviation|0|||
129094529|NCT00195494|464637344|FG003|Year 1|Protocol deviation|0|||
129094530|NCT00195494|464637345|FG004|Year 1|Protocol deviation|2|||
129094531|NCT00195494|464637346|FG005|Year 1|Protocol deviation|3|||
129094532|NCT00195494|464637341|FG000|Year 1|Physician Decision|0|||
129094533|NCT00195494|464637342|FG001|Year 1|Physician Decision|0|||
129094534|NCT00195494|464637343|FG002|Year 1|Physician Decision|0|||
129094535|NCT00195494|464637344|FG003|Year 1|Physician Decision|0|||
129094536|NCT00195494|464637345|FG004|Year 1|Physician Decision|1|||
129094537|NCT00195494|464637346|FG005|Year 1|Physician Decision|0|||
129094538|NCT00195494|464637341|FG000|Year 1|Withdrawal by Subject|0|||
129094539|NCT00195494|464637342|FG001|Year 1|Withdrawal by Subject|0|||
129094540|NCT00195494|464637343|FG002|Year 1|Withdrawal by Subject|0|||
129094541|NCT00195494|464637344|FG003|Year 1|Withdrawal by Subject|0|||
129094542|NCT00195494|464637345|FG004|Year 1|Withdrawal by Subject|8|||
129094543|NCT00195494|464637346|FG005|Year 1|Withdrawal by Subject|9|||
129094544|NCT00195494|464637341|FG000|Year 1|Protocol Violation|0|||
129094545|NCT00195494|464637342|FG001|Year 1|Protocol Violation|0|||
129094546|NCT00195494|464637343|FG002|Year 1|Protocol Violation|0|||
129094547|NCT00195494|464637344|FG003|Year 1|Protocol Violation|0|||
129094548|NCT00195494|464637345|FG004|Year 1|Protocol Violation|1|||
129094549|NCT00195494|464637346|FG005|Year 1|Protocol Violation|1|||
129094550|NCT00195494|464637341|FG000|Year 2|Adverse Event|3|||
129094551|NCT00195494|464637342|FG001|Year 2|Adverse Event|7|||
129094552|NCT00195494|464637343|FG002|Year 2|Adverse Event|5|||
129094553|NCT00195494|464637344|FG003|Year 2|Adverse Event|9|||
129094554|NCT00195494|464637345|FG004|Year 2|Adverse Event|0|||
129094555|NCT00195494|464637346|FG005|Year 2|Adverse Event|0|||
129094556|NCT00195494|464637341|FG000|Year 2|Lack of Efficacy|0|||
129094557|NCT00195494|464637342|FG001|Year 2|Lack of Efficacy|1|||
129094558|NCT00195494|464637343|FG002|Year 2|Lack of Efficacy|7|||
129094559|NCT00195494|464637344|FG003|Year 2|Lack of Efficacy|7|||
129094560|NCT00195494|464637345|FG004|Year 2|Lack of Efficacy|0|||
129094561|NCT00195494|464637346|FG005|Year 2|Lack of Efficacy|0|||
129094562|NCT00195494|464637341|FG000|Year 2|Compliance|1|||
129094563|NCT00195494|464637342|FG001|Year 2|Compliance|0|||
129094564|NCT00195494|464637343|FG002|Year 2|Compliance|0|||
129094565|NCT00195494|464637344|FG003|Year 2|Compliance|2|||
129094566|NCT00195494|464637345|FG004|Year 2|Compliance|0|||
129094567|NCT00195494|464637346|FG005|Year 2|Compliance|0|||
129094568|NCT00195494|464637341|FG000|Year 2|Lost to Follow-up|0|||
129094569|NCT00195494|464637342|FG001|Year 2|Lost to Follow-up|0|||
129094570|NCT00195494|464637343|FG002|Year 2|Lost to Follow-up|1|||
129094571|NCT00195494|464637344|FG003|Year 2|Lost to Follow-up|1|||
129094572|NCT00195494|464637345|FG004|Year 2|Lost to Follow-up|0|||
129094573|NCT00195494|464637346|FG005|Year 2|Lost to Follow-up|0|||
129094574|NCT00195494|464637341|FG000|Year 2|Missed >4 consecutive doses|1|||
129094575|NCT00195494|464637342|FG001|Year 2|Missed >4 consecutive doses|1|||
129094576|NCT00195494|464637343|FG002|Year 2|Missed >4 consecutive doses|1|||
129094577|NCT00195494|464637344|FG003|Year 2|Missed >4 consecutive doses|0|||
129094578|NCT00195494|464637345|FG004|Year 2|Missed >4 consecutive doses|0|||
129094579|NCT00195494|464637346|FG005|Year 2|Missed >4 consecutive doses|0|||
129094580|NCT00195494|464637341|FG000|Year 2|Protocol deviation|0|||
129094581|NCT00195494|464637342|FG001|Year 2|Protocol deviation|1|||
129094582|NCT00195494|464637343|FG002|Year 2|Protocol deviation|0|||
129094583|NCT00195494|464637344|FG003|Year 2|Protocol deviation|0|||
129094584|NCT00195494|464637345|FG004|Year 2|Protocol deviation|0|||
129094585|NCT00195494|464637346|FG005|Year 2|Protocol deviation|0|||
129094586|NCT00195494|464637341|FG000|Year 2|Physician Decision|1|||
129094587|NCT00195494|464637342|FG001|Year 2|Physician Decision|1|||
129094588|NCT00195494|464637343|FG002|Year 2|Physician Decision|0|||
129094589|NCT00195494|464637344|FG003|Year 2|Physician Decision|0|||
129094590|NCT00195494|464637345|FG004|Year 2|Physician Decision|0|||
129094591|NCT00195494|464637346|FG005|Year 2|Physician Decision|0|||
129094592|NCT00195494|464637341|FG000|Year 2|Withdrawal by Subject|1|||
129094593|NCT00195494|464637342|FG001|Year 2|Withdrawal by Subject|5|||
129094594|NCT00195494|464637343|FG002|Year 2|Withdrawal by Subject|4|||
129094595|NCT00195494|464637344|FG003|Year 2|Withdrawal by Subject|3|||
129094596|NCT00195494|464637345|FG004|Year 2|Withdrawal by Subject|0|||
129094597|NCT00195494|464637346|FG005|Year 2|Withdrawal by Subject|0|||
129094598|NCT00195494|464637341|FG000|Year 2|System toxicity|0|||
129094599|NCT00195494|464637342|FG001|Year 2|System toxicity|0|||
129094600|NCT00195494|464637343|FG002|Year 2|System toxicity|0|||
129094601|NCT00195494|464637344|FG003|Year 2|System toxicity|1|||
129094602|NCT00195494|464637345|FG004|Year 2|System toxicity|0|||
129094603|NCT00195494|464637346|FG005|Year 2|System toxicity|0|||
129094604|NCT02020512|464637347|FG000|Overall Study|Adverse Event|1|||
129094605|NCT02020512|464637347|FG000|Overall Study|Lost to Follow-up|3|||
129094606|NCT02020512|464637347|FG000|Overall Study|Protocol Violation|4|||
129094607|NCT00835679|464637355|FG000|Overall Study|Withdrawal by Subject|1|||
129094608|NCT00835679|464637356|FG001|Overall Study|Withdrawal by Subject|0|||
129094609|NCT00835679|464637357|FG002|Overall Study|Withdrawal by Subject|0|||
129094610|NCT00835679|464637358|FG003|Overall Study|Withdrawal by Subject|0|||
129094611|NCT03802565|464637362|FG000|Overall Study|Adverse Event|0|||
129094612|NCT03802565|464637363|FG001|Overall Study|Adverse Event|1|||
129094613|NCT03802565|464637364|FG002|Overall Study|Adverse Event|2|||
129094614|NCT03802565|464637365|FG003|Overall Study|Adverse Event|1|||
129094615|NCT03802565|464637366|FG004|Overall Study|Adverse Event|1|||
129094616|NCT03802565|464637362|FG000|Overall Study|Withdrawal by Subject|2|||
129094617|NCT03802565|464637363|FG001|Overall Study|Withdrawal by Subject|2|||
129094618|NCT03802565|464637364|FG002|Overall Study|Withdrawal by Subject|2|||
129094619|NCT03802565|464637365|FG003|Overall Study|Withdrawal by Subject|0|||
129094620|NCT03802565|464637366|FG004|Overall Study|Withdrawal by Subject|1|||
129094621|NCT03802565|464637362|FG000|Overall Study|Protocol Violation|2|||
129094622|NCT03802565|464637363|FG001|Overall Study|Protocol Violation|1|||
129094623|NCT03802565|464637364|FG002|Overall Study|Protocol Violation|4|||
129094624|NCT03802565|464637365|FG003|Overall Study|Protocol Violation|5|||
129094625|NCT03802565|464637366|FG004|Overall Study|Protocol Violation|1|||
129094626|NCT03802565|464637362|FG000|Overall Study|Lost to Follow-up|0|||
129094627|NCT03802565|464637363|FG001|Overall Study|Lost to Follow-up|0|||
129094628|NCT03802565|464637364|FG002|Overall Study|Lost to Follow-up|1|||
129094629|NCT03802565|464637365|FG003|Overall Study|Lost to Follow-up|0|||
129094630|NCT03802565|464637366|FG004|Overall Study|Lost to Follow-up|0|||
129094631|NCT03802565|464637362|FG000|Overall Study|Subjects Related to Each Other|1|||
129094632|NCT03802565|464637363|FG001|Overall Study|Subjects Related to Each Other|0|||
129094633|NCT03802565|464637364|FG002|Overall Study|Subjects Related to Each Other|0|||
129094634|NCT03802565|464637365|FG003|Overall Study|Subjects Related to Each Other|2|||
129094635|NCT03802565|464637366|FG004|Overall Study|Subjects Related to Each Other|1|||
129094636|NCT03802565|464637362|FG000|Overall Study|Elevated Enzymes|0|||
129094637|NCT03802565|464637363|FG001|Overall Study|Elevated Enzymes|0|||
129094638|NCT03802565|464637364|FG002|Overall Study|Elevated Enzymes|0|||
129094639|NCT03802565|464637365|FG003|Overall Study|Elevated Enzymes|0|||
129094640|NCT03802565|464637366|FG004|Overall Study|Elevated Enzymes|2|||
129094641|NCT04769739|464637367|FG000|Overall Study|Colorectal cancer obstruction|2|||
129094642|NCT04769739|464637368|FG001|Overall Study|Colorectal cancer obstruction|0|||
129094643|NCT04769739|464637369|FG002|Overall Study|Colorectal cancer obstruction|0|||
129094644|NCT04769739|464637370|FG003|Overall Study|Colorectal cancer obstruction|0|||
129094645|NCT04769739|464637367|FG000|Overall Study|Failed cecal intubation|1|||
129094646|NCT04769739|464637368|FG001|Overall Study|Failed cecal intubation|0|||
129094647|NCT04769739|464637369|FG002|Overall Study|Failed cecal intubation|0|||
129094648|NCT04769739|464637370|FG003|Overall Study|Failed cecal intubation|1|||
129094649|NCT04769739|464637367|FG000|Overall Study|Poor bowel preparation|0|||
129094650|NCT04769739|464637368|FG001|Overall Study|Poor bowel preparation|0|||
129094651|NCT04769739|464637369|FG002|Overall Study|Poor bowel preparation|0|||
129094652|NCT04769739|464637370|FG003|Overall Study|Poor bowel preparation|1|||
129094653|NCT03689543|464637371|FG000|Overall Study|Adverse Event|0|||
129094654|NCT03689543|464637372|FG001|Overall Study|Adverse Event|0|||
129094655|NCT03689543|464637373|FG002|Overall Study|Adverse Event|1|||
129094656|NCT00932451|464637374|FG000|Overall Study|Withdrawal by Subject|69|||
129094657|NCT00932451|464637374|FG000|Overall Study|Lost to Follow-up|22|||
129094658|NCT00932451|464637374|FG000|Overall Study|Death|726|||
129094659|NCT00932451|464637374|FG000|Overall Study|Other reasons|5|||
129094660|NCT02968433|464637392|FG000|Overall Study|Withdrawal by Subject|1|||
129094661|NCT00875433|464637393|FG000|Overall Study|Progressive disease|41|||
129094662|NCT00875433|464637393|FG000|Overall Study|Other Adverse Event|14|||
129094663|NCT00875433|464637393|FG000|Overall Study|Withdrawal by Subject|2|||
129094664|NCT00875433|464637393|FG000|Overall Study|Other|3|||
129094665|NCT00637806|464637394|FG000|Double-blind Phase|Study Discontinued|2|||
129094666|NCT00637806|464637395|FG001|Double-blind Phase|Study Discontinued|0|||
129094667|NCT00637806|464637396|FG002|Double-blind Phase|Study Discontinued|1|||
129094668|NCT00637806|464637397|FG003|Double-blind Phase|Study Discontinued|0|||
129094669|NCT00637806|464637394|FG000|Extension Phase|Study Discontinued|0|||
129094670|NCT00637806|464637395|FG001|Extension Phase|Study Discontinued|0|||
129094671|NCT00637806|464637396|FG002|Extension Phase|Study Discontinued|0|||
129094672|NCT00637806|464637397|FG003|Extension Phase|Study Discontinued|1|||
129094673|NCT00622336|464637398|FG000|Treatment Phase|Progression of Disease|181|||
129094674|NCT00622336|464637398|FG000|Treatment Phase|Adverse Event|46|||
129094675|NCT00622336|464637398|FG000|Treatment Phase|Other|40|||
129094676|NCT00622336|464637398|FG000|Treatment Phase|Death|14|||
129094677|NCT00622336|464637398|FG000|Treatment Phase|Lack of therapeutic effect|13|||
129094678|NCT00622336|464637398|FG000|Treatment Phase|Withdrawal by Subject|13|||
129094679|NCT00622336|464637398|FG000|Treatment Phase|Lost to Follow-up|2|||
129094680|NCT00622336|464637398|FG000|Extension Phase|Adverse Event|2|||
129094681|NCT00622336|464637398|FG000|Extension Phase|Progressive Disease|6|||
129094682|NCT00622336|464637398|FG000|Extension Phase|Lack of therapeutic effect|2|||
129094683|NCT00622336|464637398|FG000|Extension Phase|Withdrawal by Subject|1|||
129094684|NCT00622336|464637398|FG000|Extension Phase|Lost to Follow-up|1|||
129094685|NCT00622336|464637398|FG000|Extension Phase|Other|9|||
129094686|NCT04506905|464637401|FG000|Overall Study|Lost to Follow-up|1|||
129094687|NCT04506905|464637402|FG001|Overall Study|Lost to Follow-up|0|||
129094688|NCT04506905|464637403|FG002|Overall Study|Lost to Follow-up|0|||
129094689|NCT04506905|464637404|FG003|Overall Study|Lost to Follow-up|1|||
129094690|NCT04506905|464637405|FG004|Overall Study|Lost to Follow-up|0|||
129094691|NCT04506905|464637406|FG005|Overall Study|Lost to Follow-up|0|||
129094692|NCT04506905|464637407|FG006|Overall Study|Lost to Follow-up|0|||
129094693|NCT04506905|464637408|FG007|Overall Study|Lost to Follow-up|0|||
129094694|NCT04506905|464637409|FG008|Overall Study|Lost to Follow-up|0|||
129094695|NCT04506905|464637401|FG000|Overall Study|Withdrawal by Subject|0|||
129094696|NCT04506905|464637402|FG001|Overall Study|Withdrawal by Subject|0|||
129094697|NCT04506905|464637403|FG002|Overall Study|Withdrawal by Subject|0|||
129094698|NCT04506905|464637404|FG003|Overall Study|Withdrawal by Subject|2|||
129094699|NCT04506905|464637405|FG004|Overall Study|Withdrawal by Subject|0|||
129094700|NCT04506905|464637406|FG005|Overall Study|Withdrawal by Subject|0|||
129094701|NCT04506905|464637407|FG006|Overall Study|Withdrawal by Subject|0|||
129094702|NCT04506905|464637408|FG007|Overall Study|Withdrawal by Subject|0|||
129094703|NCT04506905|464637409|FG008|Overall Study|Withdrawal by Subject|0|||
129094704|NCT02921750|464638378|FG000|Overall Study|Adverse Event|1|||
129094705|NCT02921750|464638379|FG001|Overall Study|Adverse Event|2|||
129094706|NCT02921750|464638378|FG000|Overall Study|Withdrawal by Subject|1|||
129094707|NCT02921750|464638379|FG001|Overall Study|Withdrawal by Subject|1|||
129094708|NCT02921750|464638378|FG000|Overall Study|Lost to Follow-up|3|||
129094709|NCT02921750|464638379|FG001|Overall Study|Lost to Follow-up|3|||
129094710|NCT02921750|464638378|FG000|Overall Study|Wound healed|3|||
129094711|NCT02921750|464638379|FG001|Overall Study|Wound healed|3|||
129094712|NCT02921750|464638378|FG000|Overall Study|Serious Adverse Event|1|||
128983641|NCT03290131|464228004|FG001|Overall Study|MS Relapse|1|||
128983642|NCT03290131|464228005|FG002|Overall Study|MS Relapse|0|||
128983643|NCT03290131|464228003|FG000|Overall Study|Unknown reason|0|||
128983644|NCT03290131|464228004|FG001|Overall Study|Unknown reason|1|||
128983645|NCT03290131|464228005|FG002|Overall Study|Unknown reason|0|||
128983646|NCT00483574|464228006|FG000|Overall Study|Adverse Event|6|||
128983647|NCT00483574|464228007|FG001|Overall Study|Adverse Event|0|||
128983648|NCT00483574|464228006|FG000|Overall Study|Protocol Violation|28|||
128983649|NCT00483574|464228007|FG001|Overall Study|Protocol Violation|9|||
128983650|NCT00483574|464228006|FG000|Overall Study|Lost to Follow-up|16|||
128983651|NCT00483574|464228007|FG001|Overall Study|Lost to Follow-up|4|||
128983652|NCT00483574|464228006|FG000|Overall Study|Withdrawal by Subject|52|||
128983653|NCT00483574|464228007|FG001|Overall Study|Withdrawal by Subject|0|||
128983654|NCT00465101|464228008|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
128983655|NCT00465101|464228008|FG000|Overall Study|Change in health precluded follow up|4|||
128983656|NCT00465101|464228008|FG000|Overall Study|Did not meet study criteria|4|||
128983657|NCT00465101|464228008|FG000|Overall Study|Lost to Follow-up|5|||
128983658|NCT00465101|464228008|FG000|Overall Study|Other|6|||
128983659|NCT00465101|464228008|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
128983660|NCT00465101|464228008|FG000|Overall Study|Patient postponed procedure|1|||
128983661|NCT00465101|464228008|FG000|Overall Study|Site closed due to IRB expiration|1|||
128983662|NCT00465101|464228008|FG000|Overall Study|Unable to obtain IRB approval|1|||
128983663|NCT00465101|464228008|FG000|Overall Study|Death|3|||
128983664|NCT00465101|464228008|FG000|Overall Study|Withdrawal by Subject|25|||
128983665|NCT00465101|464228008|FG000|Overall Study|Physician Decision|1|||
128983666|NCT00465101|464228008|FG000|Overall Study|Withdrew consent prior to procedure|3|||
128983667|NCT03099096|464228009|FG000|Overall Study|Adverse Event|1|||
128983668|NCT03099096|464228009|FG000|Overall Study|Physician Decision|1|||
128983669|NCT00361504|464228012|FG000|Overall Study|Withdrawal by Subject|94|||
128983670|NCT00361504|464228013|FG001|Overall Study|Withdrawal by Subject|31|||
128983671|NCT00361504|464228012|FG000|Overall Study|Lost to Follow-up|40|||
128983672|NCT00361504|464228013|FG001|Overall Study|Lost to Follow-up|7|||
128983673|NCT00361504|464228012|FG000|Overall Study|Adverse Event|203|||
128983674|NCT00361504|464228013|FG001|Overall Study|Adverse Event|82|||
128983675|NCT00361504|464228012|FG000|Overall Study|Lack of Efficacy|72|||
128983676|NCT00361504|464228013|FG001|Overall Study|Lack of Efficacy|7|||
128983677|NCT00361504|464228012|FG000|Overall Study|Resolution of Pain|2|||
128983678|NCT00361504|464228013|FG001|Overall Study|Resolution of Pain|0|||
128983679|NCT00361504|464228012|FG000|Overall Study|Study medication non compliant|42|||
128983680|NCT00361504|464228013|FG001|Overall Study|Study medication non compliant|15|||
128983681|NCT00361504|464228012|FG000|Overall Study|All other|28|||
128983682|NCT00361504|464228013|FG001|Overall Study|All other|3|||
128983683|NCT00450814|464228016|FG000|Overall Study|Failed to complete the initial therapy|0|||
129094713|NCT02921750|464638379|FG001|Overall Study|Serious Adverse Event|2|||
128983684|NCT00450814|464228017|FG001|Overall Study|Failed to complete the initial therapy|0|||
128983685|NCT00450814|464228018|FG002|Overall Study|Failed to complete the initial therapy|0|||
128983686|NCT00450814|464228019|FG003|Overall Study|Failed to complete the initial therapy|1|||
128983687|NCT00450814|464228020|FG004|Overall Study|Failed to complete the initial therapy|1|||
128983688|NCT00450814|464228021|FG005|Overall Study|Failed to complete the initial therapy|1|||
128983689|NCT00450814|464228022|FG006|Overall Study|Failed to complete the initial therapy|0|||
129094714|NCT03605849|464638380|FG000|Overall Study|Adverse Event|20|||
129094715|NCT03605849|464638381|FG001|Overall Study|Adverse Event|21|||
129094716|NCT03605849|464638382|FG002|Overall Study|Adverse Event|29|||
128983690|NCT00450814|464228023|FG007|Overall Study|Failed to complete the initial therapy|0|||
128983691|NCT00450814|464228024|FG008|Overall Study|Failed to complete the initial therapy|0|||
129094717|NCT03605849|464638383|FG003|Overall Study|Adverse Event|11|||
129094718|NCT03605849|464638380|FG000|Overall Study|Lack of Efficacy|4|||
129094719|NCT03605849|464638381|FG001|Overall Study|Lack of Efficacy|7|||
129094720|NCT03605849|464638382|FG002|Overall Study|Lack of Efficacy|9|||
129094721|NCT03605849|464638383|FG003|Overall Study|Lack of Efficacy|2|||
129094722|NCT03605849|464638380|FG000|Overall Study|Lost to Follow-up|8|||
129094723|NCT03605849|464638381|FG001|Overall Study|Lost to Follow-up|8|||
129094724|NCT03605849|464638382|FG002|Overall Study|Lost to Follow-up|14|||
129094725|NCT03605849|464638383|FG003|Overall Study|Lost to Follow-up|11|||
129094726|NCT03605849|464638380|FG000|Overall Study|Non-compliance With IMP|6|||
129094727|NCT03605849|464638381|FG001|Overall Study|Non-compliance With IMP|5|||
129094728|NCT03605849|464638382|FG002|Overall Study|Non-compliance With IMP|2|||
129094729|NCT03605849|464638383|FG003|Overall Study|Non-compliance With IMP|1|||
129094730|NCT03605849|464638380|FG000|Overall Study|Protocol Deviation|1|||
129094731|NCT03605849|464638381|FG001|Overall Study|Protocol Deviation|2|||
129094732|NCT03605849|464638382|FG002|Overall Study|Protocol Deviation|1|||
129094733|NCT03605849|464638383|FG003|Overall Study|Protocol Deviation|3|||
129094734|NCT03605849|464638380|FG000|Overall Study|Withdrawal by Subject|33|||
129094735|NCT03605849|464638381|FG001|Overall Study|Withdrawal by Subject|28|||
129094736|NCT03605849|464638382|FG002|Overall Study|Withdrawal by Subject|30|||
129094737|NCT03605849|464638383|FG003|Overall Study|Withdrawal by Subject|28|||
129094738|NCT03605849|464638380|FG000|Overall Study|Site Terminated by Sponsor|0|||
129094739|NCT03605849|464638381|FG001|Overall Study|Site Terminated by Sponsor|0|||
129094740|NCT03605849|464638382|FG002|Overall Study|Site Terminated by Sponsor|0|||
129094741|NCT03605849|464638383|FG003|Overall Study|Site Terminated by Sponsor|1|||
129094742|NCT03605849|464638380|FG000|Overall Study|Physician Decision|2|||
129094743|NCT03605849|464638381|FG001|Overall Study|Physician Decision|1|||
129094744|NCT03605849|464638382|FG002|Overall Study|Physician Decision|2|||
129094745|NCT03605849|464638383|FG003|Overall Study|Physician Decision|1|||
129094746|NCT03605849|464638380|FG000|Overall Study|Enrolled, but not Treated|2|||
129094747|NCT03605849|464638381|FG001|Overall Study|Enrolled, but not Treated|2|||
129094748|NCT03605849|464638382|FG002|Overall Study|Enrolled, but not Treated|3|||
129094749|NCT03605849|464638383|FG003|Overall Study|Enrolled, but not Treated|2|||
129094750|NCT03605849|464638380|FG000|Overall Study|Other (COVID-19 Related)|0|||
129094751|NCT03605849|464638381|FG001|Overall Study|Other (COVID-19 Related)|1|||
129094752|NCT03605849|464638382|FG002|Overall Study|Other (COVID-19 Related)|1|||
129094753|NCT03605849|464638383|FG003|Overall Study|Other (COVID-19 Related)|0|||
129094754|NCT03605849|464638380|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
129094755|NCT03605849|464638381|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
129094756|NCT03605849|464638382|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
129094757|NCT03605849|464638383|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
129094758|NCT00590538|464638384|FG000|Overall Study|Study terminated before completed|2|||
129094759|NCT03570554|464638385|FG000|Overall Study|Non-compliance with study drug|0|||
129094760|NCT03570554|464638386|FG001|Overall Study|Non-compliance with study drug|0|||
129094761|NCT03570554|464638387|FG002|Overall Study|Non-compliance with study drug|1|||
129094762|NCT03570554|464638388|FG003|Overall Study|Non-compliance with study drug|0|||
129094763|NCT03570554|464638385|FG000|Overall Study|Adverse Event|0|||
129094764|NCT03570554|464638386|FG001|Overall Study|Adverse Event|0|||
129094765|NCT03570554|464638387|FG002|Overall Study|Adverse Event|0|||
129094766|NCT03570554|464638388|FG003|Overall Study|Adverse Event|1|||
129094767|NCT03738800|464638393|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
129094768|NCT03738800|464638394|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129094769|NCT03738800|464638395|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129094770|NCT03738800|464638393|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
129094771|NCT03738800|464638394|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
129094772|NCT03738800|464638395|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
129094773|NCT03738800|464638393|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
129094774|NCT03738800|464638394|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129094775|NCT03738800|464638395|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
129094776|NCT00766467|464638396|FG000|Overall Study|Withdrawal by Subject|7|||
129094777|NCT00766467|464638397|FG001|Overall Study|Withdrawal by Subject|2|||
129094778|NCT00766467|464638396|FG000|Overall Study|Adverse Event|1|||
129094779|NCT00766467|464638397|FG001|Overall Study|Adverse Event|1|||
129094780|NCT00766467|464638396|FG000|Overall Study|Protocol Violation|2|||
129094781|NCT00766467|464638397|FG001|Overall Study|Protocol Violation|4|||
129094782|NCT00766467|464638396|FG000|Overall Study|Tumor Progression on Study|0|||
129094783|NCT00766467|464638397|FG001|Overall Study|Tumor Progression on Study|1|||
129094784|NCT00766467|464638396|FG000|Overall Study|Physician Decision|1|||
129094785|NCT00766467|464638397|FG001|Overall Study|Physician Decision|0|||
129094786|NCT02604550|464638405|FG000|Overall Study|Lost to Follow-up|7|||
129094787|NCT02604550|464638406|FG001|Overall Study|Lost to Follow-up|6|||
129094788|NCT02604550|464638405|FG000|Overall Study|Withdrawal by Subject|0|||
129094789|NCT02604550|464638406|FG001|Overall Study|Withdrawal by Subject|1|||
129094790|NCT02604550|464638405|FG000|Overall Study|Incomplete data using paper journal|18|||
129094791|NCT02604550|464638406|FG001|Overall Study|Incomplete data using paper journal|19|||
129094792|NCT01404208|464638407|FG000|Overall Study|Discontinued|3|||
129094793|NCT01404208|464638408|FG001|Overall Study|Discontinued|0|||
129094794|NCT00033657|464638412|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
129094795|NCT00033657|464638413|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
129094796|NCT00033657|464638412|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
129094797|NCT00033657|464638413|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
129094798|NCT00033657|464638412|FG000|Neoadjuvant Chemotherapy|Death|1|||
129094799|NCT00033657|464638413|FG001|Neoadjuvant Chemotherapy|Death|1|||
129094800|NCT00033657|464638412|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
129094801|NCT00033657|464638413|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
129094802|NCT00033657|464638412|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
129094803|NCT00033657|464638413|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
129094804|NCT00033657|464638412|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
129094805|NCT00033657|464638413|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
129094806|NCT00033657|464638412|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
129094807|NCT00033657|464638413|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
129094808|NCT00033657|464638412|FG000|Surgical Resection|not complete resection|0|||
129094809|NCT00033657|464638413|FG001|Surgical Resection|not complete resection|3|||
129094810|NCT00033657|464638412|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
129094811|NCT00033657|464638413|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
129094812|NCT00033657|464638412|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
129094813|NCT00033657|464638413|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
129094814|NCT00033657|464638412|FG000|Adjuvant Chemotherapy|Death|2|||
129094815|NCT00033657|464638413|FG001|Adjuvant Chemotherapy|Death|1|||
129094816|NCT00033657|464638412|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
129094817|NCT00033657|464638413|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
129094818|NCT00033657|464638412|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
129094819|NCT00033657|464638413|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
129094820|NCT00033657|464638412|FG000|Adjuvant Chemotherapy|Other|0|||
129094821|NCT00033657|464638413|FG001|Adjuvant Chemotherapy|Other|2|||
129094822|NCT02945254|464638416|FG000|Overall Study|Lost to Follow-up|1|||
129094823|NCT02945254|464638417|FG001|Overall Study|Lost to Follow-up|0|||
129094824|NCT02945254|464638416|FG000|Overall Study|Withdrawal by Subject|1|||
129094825|NCT02945254|464638417|FG001|Overall Study|Withdrawal by Subject|0|||
129094826|NCT02631070|464638422|FG000|Overall Study|Withdrawal by Subject|35|||
129094827|NCT02631070|464638423|FG001|Overall Study|Withdrawal by Subject|13|||
129094828|NCT02631070|464638422|FG000|Overall Study|Death|45|||
128871362|NCT01278173|463824457|FG000|Overall Study|Withdrawal by Subject|1|||
128871363|NCT04662931|463824459|FG000|Overall Study|Withdrawal by Subject|17|||
129094829|NCT02631070|464638423|FG001|Overall Study|Death|24|||
129094830|NCT02631070|464638422|FG000|Overall Study|Lost to Follow-up|5|||
129094831|NCT02631070|464638423|FG001|Overall Study|Lost to Follow-up|1|||
129094832|NCT02631070|464638422|FG000|Overall Study|Transition to rollover protocol|52|||
129094833|NCT02631070|464638423|FG001|Overall Study|Transition to rollover protocol|21|||
129094834|NCT02631070|464638422|FG000|Overall Study|Other reasons|12|||
129094835|NCT02631070|464638423|FG001|Overall Study|Other reasons|5|||
129094836|NCT01522235|464638425|FG000|Overall Study|Physician Decision|1|||
129094837|NCT01522235|464638426|FG001|Overall Study|Physician Decision|1|||
129094838|NCT01870297|464638429|FG000|Overall Study|Adverse Event|0|||
129094839|NCT01870297|464638430|FG001|Overall Study|Adverse Event|0|||
129094840|NCT01870297|464638431|FG002|Overall Study|Adverse Event|0|||
129094841|NCT01870297|464638432|FG003|Overall Study|Adverse Event|0|||
129094842|NCT01870297|464638433|FG004|Overall Study|Adverse Event|2|||
129094843|NCT01870297|464638434|FG005|Overall Study|Adverse Event|0|||
129094844|NCT01870297|464638435|FG006|Overall Study|Adverse Event|0|||
129094845|NCT01870297|464638429|FG000|Overall Study|Lost to Follow-up|0|||
129094846|NCT01870297|464638430|FG001|Overall Study|Lost to Follow-up|1|||
129094847|NCT01870297|464638431|FG002|Overall Study|Lost to Follow-up|1|||
129094848|NCT01870297|464638432|FG003|Overall Study|Lost to Follow-up|0|||
129094849|NCT01870297|464638433|FG004|Overall Study|Lost to Follow-up|0|||
129094850|NCT01870297|464638434|FG005|Overall Study|Lost to Follow-up|0|||
129094851|NCT01870297|464638435|FG006|Overall Study|Lost to Follow-up|0|||
129094852|NCT01870297|464638429|FG000|Overall Study|Withdrawal by Subject|0|||
129094853|NCT01870297|464638430|FG001|Overall Study|Withdrawal by Subject|0|||
129094854|NCT01870297|464638431|FG002|Overall Study|Withdrawal by Subject|0|||
129094855|NCT01870297|464638432|FG003|Overall Study|Withdrawal by Subject|0|||
129094856|NCT01870297|464638433|FG004|Overall Study|Withdrawal by Subject|1|||
129094857|NCT01870297|464638434|FG005|Overall Study|Withdrawal by Subject|1|||
129094858|NCT01870297|464638435|FG006|Overall Study|Withdrawal by Subject|1|||
129094859|NCT01870297|464638429|FG000|Overall Study|Sponsor Decision|0|||
129094860|NCT01870297|464638430|FG001|Overall Study|Sponsor Decision|6|||
129094861|NCT01870297|464638431|FG002|Overall Study|Sponsor Decision|0|||
129094862|NCT01870297|464638432|FG003|Overall Study|Sponsor Decision|0|||
129094863|NCT01870297|464638433|FG004|Overall Study|Sponsor Decision|0|||
129094864|NCT01870297|464638434|FG005|Overall Study|Sponsor Decision|0|||
129094865|NCT01870297|464638435|FG006|Overall Study|Sponsor Decision|1|||
129094866|NCT00337779|464638436|FG000|Overall Study|Withdrawal by Subject|10|||
129094867|NCT00337779|464638437|FG001|Overall Study|Withdrawal by Subject|12|||
129094868|NCT00337779|464638436|FG000|Overall Study|Sponsor decision|1|||
129094869|NCT00337779|464638437|FG001|Overall Study|Sponsor decision|1|||
129094870|NCT00337779|464638436|FG000|Overall Study|Physician Decision|3|||
129094871|NCT00337779|464638437|FG001|Overall Study|Physician Decision|6|||
129094872|NCT00337779|464638436|FG000|Overall Study|Protocol Violation|1|||
129094873|NCT00337779|464638437|FG001|Overall Study|Protocol Violation|1|||
129094874|NCT00337779|464638436|FG000|Overall Study|Lost to Follow-up|6|||
129094875|NCT00337779|464638437|FG001|Overall Study|Lost to Follow-up|5|||
129094876|NCT00337779|464638436|FG000|Overall Study|Adverse Event|28|||
129094877|NCT00337779|464638437|FG001|Overall Study|Adverse Event|51|||
129094878|NCT00337779|464638436|FG000|Overall Study|Pregnancy|3|||
129094879|NCT00337779|464638437|FG001|Overall Study|Pregnancy|2|||
129094880|NCT00337779|464638436|FG000|Overall Study|Death|0|||
129094881|NCT00337779|464638437|FG001|Overall Study|Death|1|||
129094882|NCT03008278|464638438|FG000|Overall Study|Progressive Disease|0|||
129094883|NCT03008278|464638439|FG001|Overall Study|Progressive Disease|0|||
129094884|NCT03008278|464638440|FG002|Overall Study|Progressive Disease|32|||
129094885|NCT03008278|464638438|FG000|Overall Study|Adverse Event|0|||
129094886|NCT03008278|464638439|FG001|Overall Study|Adverse Event|0|||
129094887|NCT03008278|464638440|FG002|Overall Study|Adverse Event|4|||
129094888|NCT03008278|464638438|FG000|Overall Study|Withdrawal by Subject|0|||
129094889|NCT03008278|464638439|FG001|Overall Study|Withdrawal by Subject|0|||
129094890|NCT03008278|464638440|FG002|Overall Study|Withdrawal by Subject|3|||
129094891|NCT03008278|464638438|FG000|Overall Study|Physician Decision|0|||
129094892|NCT03008278|464638439|FG001|Overall Study|Physician Decision|2|||
129094893|NCT03008278|464638440|FG002|Overall Study|Physician Decision|0|||
129094894|NCT00513357|464638441|FG000|Overall Study|did not receive allocated placebo|2|||
129094895|NCT00513357|464638442|FG001|Overall Study|did not receive allocated placebo|3|||
129094896|NCT00513357|464638441|FG000|Overall Study|Adverse Event|4|||
129094897|NCT00513357|464638442|FG001|Overall Study|Adverse Event|2|||
129094898|NCT00513357|464638441|FG000|Overall Study|Death|2|||
129094899|NCT00513357|464638442|FG001|Overall Study|Death|0|||
129094900|NCT00513357|464638441|FG000|Overall Study|Withdrawal by Subject|5|||
129094901|NCT00513357|464638442|FG001|Overall Study|Withdrawal by Subject|4|||
129094902|NCT00513357|464638441|FG000|Overall Study|Disease Progression|2|||
129094903|NCT00513357|464638442|FG001|Overall Study|Disease Progression|1|||
129094904|NCT01162122|464638443|FG000|Overall Study|Withdrawal by Subject|52|||
129094905|NCT01162122|464638444|FG001|Overall Study|Withdrawal by Subject|43|||
129094906|NCT01162122|464638443|FG000|Overall Study|Lost to Follow-up|73|||
129094907|NCT01162122|464638444|FG001|Overall Study|Lost to Follow-up|91|||
129094908|NCT01162122|464638443|FG000|Overall Study|Adverse Event|3|||
129094909|NCT01162122|464638444|FG001|Overall Study|Adverse Event|2|||
129094910|NCT01162122|464638443|FG000|Overall Study|Death|51|||
129094911|NCT01162122|464638444|FG001|Overall Study|Death|46|||
129094912|NCT01162122|464638443|FG000|Overall Study|Protocol Violation|2|||
129094913|NCT01162122|464638444|FG001|Overall Study|Protocol Violation|2|||
129094914|NCT01162122|464638443|FG000|Overall Study|Inappropriate enrollment|5|||
129094915|NCT01162122|464638444|FG001|Overall Study|Inappropriate enrollment|4|||
129094916|NCT01162122|464638443|FG000|Overall Study|Administrative reason|1|||
129094917|NCT01162122|464638444|FG001|Overall Study|Administrative reason|1|||
129094918|NCT01162122|464638443|FG000|Overall Study|Unable to classify|3|||
129094919|NCT01162122|464638444|FG001|Overall Study|Unable to classify|7|||
129094920|NCT01162122|464638443|FG000|Overall Study|Missing primary reason|1|||
129094921|NCT01162122|464638444|FG001|Overall Study|Missing primary reason|0|||
129094922|NCT00422422|464638448|FG000|Overall Study|Lack of Efficacy|1|||
129094923|NCT00422422|464638448|FG000|Overall Study|Protocol Violation|1|||
129094924|NCT00422422|464638448|FG000|Overall Study|Withdrawal by Subject|2|||
129094925|NCT00422422|464638448|FG000|Overall Study|SAE, non-fatal|1|||
129094926|NCT00422422|464638448|FG000|Overall Study|AE, non-serious non-fatal|5|||
129094927|NCT03313310|464638449|FG000|Phase 2|Lost to Follow-up|4|||
129094928|NCT03313310|464638450|FG001|Phase 2|Lost to Follow-up|0|||
129094929|NCT03313310|464638449|FG000|Phase 3|Lost to Follow-up|0|||
129094930|NCT03313310|464638450|FG001|Phase 3|Lost to Follow-up|1|||
129094931|NCT01217385|464638451|FG000|Overall Study|Withdrawal by Subject|3|||
129094932|NCT01217385|464638451|FG000|Overall Study|DOSI not performed/not eval|12|||
129094933|NCT01217385|464638451|FG000|Overall Study|Central Path not Available|1|||
129094934|NCT01217385|464638451|FG000|Overall Study|Normal Breast TOI not available|10|||
129094935|NCT00090987|464638452|FG000|Overall Study|Adverse Event|5|||
129094936|NCT00090987|464638452|FG000|Overall Study|Lack of Efficacy|7|||
129094937|NCT00090987|464638452|FG000|Overall Study|Withdrawal by Subject|3|||
129094938|NCT00090987|464638452|FG000|Overall Study|alternative therapy|1|||
129094939|NCT00090987|464638452|FG000|Overall Study|Non-compliance|4|||
129094940|NCT00090987|464638452|FG000|Overall Study|Incarcerated|1|||
129094941|NCT02079636|464638454|FG000|Overall Study|Death|2|||
129094942|NCT02079636|464638455|FG001|Overall Study|Death|1|||
129094943|NCT02079636|464638456|FG002|Overall Study|Death|0|||
129094944|NCT02079636|464638457|FG003|Overall Study|Death|5|||
129094945|NCT02079636|464638458|FG004|Overall Study|Death|1|||
129094946|NCT02079636|464638459|FG005|Overall Study|Death|2|||
129094947|NCT02079636|464638460|FG006|Overall Study|Death|1|||
129094948|NCT02079636|464638461|FG007|Overall Study|Death|0|||
129094949|NCT02079636|464638462|FG008|Overall Study|Death|0|||
129094950|NCT02079636|464638463|FG009|Overall Study|Death|0|||
129094951|NCT02079636|464638464|FG010|Overall Study|Death|0|||
129094952|NCT02079636|464638465|FG011|Overall Study|Death|1|||
129094953|NCT02079636|464638466|FG012|Overall Study|Death|1|||
129094954|NCT02079636|464638467|FG013|Overall Study|Death|0|||
129094955|NCT02079636|464638468|FG014|Overall Study|Death|2|||
129094956|NCT02079636|464638454|FG000|Overall Study|Adverse Event|1|||
129094957|NCT02079636|464638455|FG001|Overall Study|Adverse Event|1|||
129094958|NCT02079636|464638456|FG002|Overall Study|Adverse Event|0|||
129094959|NCT02079636|464638457|FG003|Overall Study|Adverse Event|1|||
129094960|NCT02079636|464638458|FG004|Overall Study|Adverse Event|1|||
129094961|NCT02079636|464638459|FG005|Overall Study|Adverse Event|2|||
129094962|NCT02079636|464638460|FG006|Overall Study|Adverse Event|0|||
129094963|NCT02079636|464638461|FG007|Overall Study|Adverse Event|0|||
129094964|NCT02079636|464638462|FG008|Overall Study|Adverse Event|0|||
129094965|NCT02079636|464638463|FG009|Overall Study|Adverse Event|0|||
129094966|NCT02079636|464638464|FG010|Overall Study|Adverse Event|0|||
129094967|NCT02079636|464638465|FG011|Overall Study|Adverse Event|0|||
129094968|NCT02079636|464638466|FG012|Overall Study|Adverse Event|0|||
129094969|NCT02079636|464638467|FG013|Overall Study|Adverse Event|0|||
129094970|NCT02079636|464638468|FG014|Overall Study|Adverse Event|0|||
129094971|NCT02079636|464638454|FG000|Overall Study|Progressive disease|0|||
129094972|NCT02079636|464638455|FG001|Overall Study|Progressive disease|0|||
129094973|NCT02079636|464638456|FG002|Overall Study|Progressive disease|0|||
129094974|NCT02079636|464638457|FG003|Overall Study|Progressive disease|2|||
129094975|NCT02079636|464638458|FG004|Overall Study|Progressive disease|0|||
129094976|NCT02079636|464638459|FG005|Overall Study|Progressive disease|0|||
129094977|NCT02079636|464638460|FG006|Overall Study|Progressive disease|0|||
129094978|NCT02079636|464638461|FG007|Overall Study|Progressive disease|0|||
129094979|NCT02079636|464638462|FG008|Overall Study|Progressive disease|0|||
129094980|NCT02079636|464638463|FG009|Overall Study|Progressive disease|0|||
129094981|NCT02079636|464638464|FG010|Overall Study|Progressive disease|0|||
129094982|NCT02079636|464638465|FG011|Overall Study|Progressive disease|0|||
129094983|NCT02079636|464638466|FG012|Overall Study|Progressive disease|1|||
129094984|NCT02079636|464638467|FG013|Overall Study|Progressive disease|0|||
129094985|NCT02079636|464638468|FG014|Overall Study|Progressive disease|0|||
129094986|NCT02079636|464638454|FG000|Overall Study|Withdrawal by Subject|0|||
129094987|NCT02079636|464638455|FG001|Overall Study|Withdrawal by Subject|0|||
129094988|NCT02079636|464638456|FG002|Overall Study|Withdrawal by Subject|0|||
129094989|NCT02079636|464638457|FG003|Overall Study|Withdrawal by Subject|4|||
129094990|NCT02079636|464638458|FG004|Overall Study|Withdrawal by Subject|0|||
129094991|NCT02079636|464638459|FG005|Overall Study|Withdrawal by Subject|1|||
129094992|NCT02079636|464638460|FG006|Overall Study|Withdrawal by Subject|0|||
129094993|NCT02079636|464638461|FG007|Overall Study|Withdrawal by Subject|0|||
129094994|NCT02079636|464638462|FG008|Overall Study|Withdrawal by Subject|0|||
129094995|NCT02079636|464638463|FG009|Overall Study|Withdrawal by Subject|2|||
129094996|NCT02079636|464638464|FG010|Overall Study|Withdrawal by Subject|1|||
129094997|NCT02079636|464638465|FG011|Overall Study|Withdrawal by Subject|1|||
129094998|NCT02079636|464638466|FG012|Overall Study|Withdrawal by Subject|1|||
129094999|NCT02079636|464638467|FG013|Overall Study|Withdrawal by Subject|0|||
129095000|NCT02079636|464638468|FG014|Overall Study|Withdrawal by Subject|2|||
129095001|NCT02079636|464638454|FG000|Overall Study|Physician Decision|0|||
129095002|NCT02079636|464638455|FG001|Overall Study|Physician Decision|0|||
129095003|NCT02079636|464638456|FG002|Overall Study|Physician Decision|0|||
129095004|NCT02079636|464638457|FG003|Overall Study|Physician Decision|0|||
129095005|NCT02079636|464638458|FG004|Overall Study|Physician Decision|0|||
129095006|NCT02079636|464638459|FG005|Overall Study|Physician Decision|1|||
129095007|NCT02079636|464638460|FG006|Overall Study|Physician Decision|0|||
129095008|NCT02079636|464638461|FG007|Overall Study|Physician Decision|0|||
129095009|NCT02079636|464638462|FG008|Overall Study|Physician Decision|0|||
129095010|NCT02079636|464638463|FG009|Overall Study|Physician Decision|1|||
129095011|NCT02079636|464638464|FG010|Overall Study|Physician Decision|1|||
129095012|NCT02079636|464638465|FG011|Overall Study|Physician Decision|0|||
129095013|NCT02079636|464638466|FG012|Overall Study|Physician Decision|0|||
129095014|NCT02079636|464638467|FG013|Overall Study|Physician Decision|0|||
129095015|NCT02079636|464638468|FG014|Overall Study|Physician Decision|1|||
129095016|NCT02079636|464638454|FG000|Overall Study|Lost to Follow-up|0|||
129095017|NCT02079636|464638455|FG001|Overall Study|Lost to Follow-up|0|||
129095018|NCT02079636|464638456|FG002|Overall Study|Lost to Follow-up|0|||
129095019|NCT02079636|464638457|FG003|Overall Study|Lost to Follow-up|0|||
129095020|NCT02079636|464638458|FG004|Overall Study|Lost to Follow-up|0|||
129095021|NCT02079636|464638459|FG005|Overall Study|Lost to Follow-up|0|||
129095022|NCT02079636|464638460|FG006|Overall Study|Lost to Follow-up|0|||
129095023|NCT02079636|464638461|FG007|Overall Study|Lost to Follow-up|1|||
129095024|NCT02079636|464638462|FG008|Overall Study|Lost to Follow-up|0|||
129095025|NCT02079636|464638463|FG009|Overall Study|Lost to Follow-up|0|||
129095026|NCT02079636|464638464|FG010|Overall Study|Lost to Follow-up|0|||
129095027|NCT02079636|464638465|FG011|Overall Study|Lost to Follow-up|0|||
129095028|NCT02079636|464638466|FG012|Overall Study|Lost to Follow-up|0|||
129095029|NCT02079636|464638467|FG013|Overall Study|Lost to Follow-up|0|||
129095030|NCT02079636|464638468|FG014|Overall Study|Lost to Follow-up|0|||
129095031|NCT00725101|464638469|FG000|Overall Study|Death|3|||
129095032|NCT00725101|464638469|FG000|Overall Study|Lost to Follow-up|353|||
129095033|NCT00725101|464638469|FG000|Overall Study|Protocol Violation|1|||
129095034|NCT00725101|464638469|FG000|Overall Study|Withdrawal by Subject|127|||
129095035|NCT00725101|464638469|FG000|Overall Study|not specified/no reason given|11|||
129095036|NCT01592292|464638470|FG000|Overall Study|Follow-up loss|3|||
129095037|NCT01592292|464638471|FG001|Overall Study|Follow-up loss|3|||
129095038|NCT01592292|464638472|FG002|Overall Study|Follow-up loss|1|||
129095039|NCT01592292|464638473|FG003|Overall Study|Follow-up loss|0|||
129095040|NCT01592292|464638470|FG000|Overall Study|Withdrew consent|2|||
129095041|NCT01592292|464638471|FG001|Overall Study|Withdrew consent|1|||
129095042|NCT01592292|464638472|FG002|Overall Study|Withdrew consent|0|||
129095043|NCT01592292|464638473|FG003|Overall Study|Withdrew consent|0|||
129095044|NCT01592292|464638470|FG000|Overall Study|Other|1|||
129095045|NCT01592292|464638471|FG001|Overall Study|Other|1|||
129095046|NCT01592292|464638472|FG002|Overall Study|Other|2|||
129095047|NCT01592292|464638473|FG003|Overall Study|Other|1|||
129095048|NCT04148287|464638475|FG000|Overall Study|Death|2|||
129095049|NCT03164265|464638476|FG000|Overall Study|Physician Decision|3|||
129095050|NCT03912428|464638479|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
129095051|NCT03912428|464638480|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
129095052|NCT03912428|464638481|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
129095053|NCT03912428|464638482|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
129095054|NCT03912428|464638479|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
129095055|NCT03912428|464638480|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
129095056|NCT03912428|464638481|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
129095057|NCT03912428|464638482|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
129095058|NCT03912428|464638479|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
129095059|NCT03912428|464638480|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
129095060|NCT03912428|464638481|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
129095061|NCT03912428|464638482|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
129095062|NCT03233204|464638483|FG000|Overall Study|Adverse Event|1|||
129095063|NCT03233204|464638483|FG000|Overall Study|Death|1|||
129095064|NCT03233204|464638483|FG000|Overall Study|Withdrawal by Subject|1|||
129095065|NCT03233204|464638483|FG000|Overall Study|Progressive Disease|3|||
129095066|NCT02680834|464638484|FG000|Overall Study|Physician Decision|5|||
129095067|NCT02680834|464638485|FG001|Overall Study|Physician Decision|2|||
129095068|NCT02680834|464638484|FG000|Overall Study|Withdrawal by Subject|6|||
129095069|NCT02680834|464638485|FG001|Overall Study|Withdrawal by Subject|0|||
129095070|NCT02680834|464638484|FG000|Overall Study|Lost to Follow-up|0|||
129095071|NCT02680834|464638485|FG001|Overall Study|Lost to Follow-up|1|||
129095072|NCT02889835|464638486|FG000|Overall Study|Lost to Follow-up|13|||
129095073|NCT02889835|464638487|FG001|Overall Study|Lost to Follow-up|13|||
129095074|NCT02889835|464638488|FG002|Overall Study|Lost to Follow-up|13|||
129095075|NCT02889835|464638486|FG000|Overall Study|Withdrawal by Subject|2|||
129095076|NCT02889835|464638487|FG001|Overall Study|Withdrawal by Subject|2|||
129095077|NCT02889835|464638488|FG002|Overall Study|Withdrawal by Subject|2|||
129095078|NCT02889835|464638486|FG000|Overall Study|Protocol Violation|1|||
129095079|NCT02889835|464638487|FG001|Overall Study|Protocol Violation|1|||
129095080|NCT02889835|464638488|FG002|Overall Study|Protocol Violation|1|||
129095081|NCT02889835|464638486|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
129095082|NCT02889835|464638487|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
129095083|NCT02889835|464638488|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
129095084|NCT02889835|464638486|FG000|Overall Study|Death|1|||
129095085|NCT02889835|464638487|FG001|Overall Study|Death|1|||
129095086|NCT02889835|464638488|FG002|Overall Study|Death|1|||
129095087|NCT01777139|464640137|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
129095088|NCT01777139|464640138|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
129095089|NCT01777139|464640137|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
129095090|NCT01777139|464640138|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
129095091|NCT01777139|464640137|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
129095092|NCT01777139|464640138|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
129095093|NCT01777139|464640137|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
129095094|NCT01777139|464640138|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
129095095|NCT01777139|464640137|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
129095096|NCT01777139|464640138|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
129095097|NCT01777139|464640137|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
129095098|NCT01777139|464640138|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
129095099|NCT01777139|464640137|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
129095100|NCT01777139|464640138|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
129095101|NCT01777139|464640137|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
128871364|NCT04662931|463824459|FG000|Overall Study|Death|3|||
129095102|NCT01777139|464640138|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
129095103|NCT05625477|464640139|FG000|Overall Study|Lost to Follow-up|2|||
129095104|NCT05625477|464640140|FG001|Overall Study|Lost to Follow-up|2|||
129095105|NCT05625477|464640141|FG002|Overall Study|Lost to Follow-up|1|||
129095106|NCT05625477|464640142|FG003|Overall Study|Lost to Follow-up|1|||
129095107|NCT05625477|464640143|FG004|Overall Study|Lost to Follow-up|0|||
129095108|NCT05625477|464640139|FG000|Overall Study|Covid quarantine|1|||
129095109|NCT05625477|464640140|FG001|Overall Study|Covid quarantine|0|||
129095110|NCT05625477|464640141|FG002|Overall Study|Covid quarantine|0|||
129095111|NCT05625477|464640142|FG003|Overall Study|Covid quarantine|0|||
129095112|NCT05625477|464640143|FG004|Overall Study|Covid quarantine|0|||
129095113|NCT02502266|464640144|FG000|Overall Study|Adverse Event|0|||
129095114|NCT02502266|464640145|FG001|Overall Study|Adverse Event|0|||
129095115|NCT02502266|464640146|FG002|Overall Study|Adverse Event|0|||
129095116|NCT02502266|464640147|FG003|Overall Study|Adverse Event|0|||
129095117|NCT02502266|464640148|FG004|Overall Study|Adverse Event|1|||
129095118|NCT02502266|464640149|FG005|Overall Study|Adverse Event|1|||
129095119|NCT02502266|464640150|FG006|Overall Study|Adverse Event|1|||
129095120|NCT02502266|464640144|FG000|Overall Study|Withdrawal by Subject|30|||
129095121|NCT02502266|464640145|FG001|Overall Study|Withdrawal by Subject|15|||
129095122|NCT02502266|464640146|FG002|Overall Study|Withdrawal by Subject|16|||
129095123|NCT02502266|464640147|FG003|Overall Study|Withdrawal by Subject|0|||
129095124|NCT02502266|464640148|FG004|Overall Study|Withdrawal by Subject|0|||
129095125|NCT02502266|464640149|FG005|Overall Study|Withdrawal by Subject|0|||
129095126|NCT02502266|464640150|FG006|Overall Study|Withdrawal by Subject|0|||
129095127|NCT02502266|464640144|FG000|Overall Study|Still on Treatment|0|||
129095128|NCT02502266|464640145|FG001|Overall Study|Still on Treatment|0|||
129095129|NCT02502266|464640146|FG002|Overall Study|Still on Treatment|1|||
129095130|NCT02502266|464640147|FG003|Overall Study|Still on Treatment|0|||
129095131|NCT02502266|464640148|FG004|Overall Study|Still on Treatment|0|||
129095132|NCT02502266|464640149|FG005|Overall Study|Still on Treatment|0|||
129095133|NCT02502266|464640150|FG006|Overall Study|Still on Treatment|0|||
129095134|NCT02502266|464640144|FG000|Overall Study|Other Reasons|19|||
129095135|NCT02502266|464640145|FG001|Overall Study|Other Reasons|6|||
129095136|NCT02502266|464640146|FG002|Overall Study|Other Reasons|14|||
129095137|NCT02502266|464640147|FG003|Overall Study|Other Reasons|0|||
129095138|NCT02502266|464640148|FG004|Overall Study|Other Reasons|1|||
129095139|NCT02502266|464640149|FG005|Overall Study|Other Reasons|1|||
129095140|NCT02502266|464640150|FG006|Overall Study|Other Reasons|0|||
129095141|NCT02502266|464640144|FG000|Overall Study|Arm 4 Discontinued|0|||
129095142|NCT02502266|464640145|FG001|Overall Study|Arm 4 Discontinued|0|||
129095143|NCT02502266|464640146|FG002|Overall Study|Arm 4 Discontinued|0|||
129095144|NCT02502266|464640147|FG003|Overall Study|Arm 4 Discontinued|52|||
129095145|NCT02502266|464640148|FG004|Overall Study|Arm 4 Discontinued|0|||
129095146|NCT02502266|464640149|FG005|Overall Study|Arm 4 Discontinued|0|||
129095147|NCT02502266|464640150|FG006|Overall Study|Arm 4 Discontinued|0|||
129095148|NCT02502266|464640144|FG000|Overall Study|Never treated|0|||
129095149|NCT02502266|464640145|FG001|Overall Study|Never treated|0|||
129095150|NCT02502266|464640146|FG002|Overall Study|Never treated|0|||
129095151|NCT02502266|464640147|FG003|Overall Study|Never treated|0|||
129095152|NCT02502266|464640148|FG004|Overall Study|Never treated|0|||
129095153|NCT02502266|464640149|FG005|Overall Study|Never treated|1|||
129095154|NCT02502266|464640150|FG006|Overall Study|Never treated|0|||
129095155|NCT00308750|464640154|FG000|Overall Study|Adverse Event|9|||
129095156|NCT00308750|464640155|FG001|Overall Study|Adverse Event|9|||
129095157|NCT00308750|464640156|FG002|Overall Study|Adverse Event|13|||
129095158|NCT00308750|464640154|FG000|Overall Study|Withdrawal by Subject|6|||
129095159|NCT00308750|464640155|FG001|Overall Study|Withdrawal by Subject|2|||
129095160|NCT00308750|464640156|FG002|Overall Study|Withdrawal by Subject|3|||
129095161|NCT00308750|464640154|FG000|Overall Study|Physician Decision|3|||
129095162|NCT00308750|464640155|FG001|Overall Study|Physician Decision|4|||
129095163|NCT00308750|464640156|FG002|Overall Study|Physician Decision|3|||
129095164|NCT00308750|464640154|FG000|Overall Study|Sponsor Decision|1|||
129095165|NCT00308750|464640155|FG001|Overall Study|Sponsor Decision|0|||
129095166|NCT00308750|464640156|FG002|Overall Study|Sponsor Decision|0|||
129095167|NCT00308750|464640154|FG000|Overall Study|Disease Progression|47|||
129095168|NCT00308750|464640155|FG001|Overall Study|Disease Progression|24|||
129095169|NCT00308750|464640156|FG002|Overall Study|Disease Progression|28|||
129095170|NCT00308750|464640154|FG000|Overall Study|Unrelated Complication|3|||
129095171|NCT00308750|464640155|FG001|Overall Study|Unrelated Complication|0|||
129095172|NCT00308750|464640156|FG002|Overall Study|Unrelated Complication|1|||
129095173|NCT00308750|464640154|FG000|Overall Study|Death|1|||
129095174|NCT00308750|464640155|FG001|Overall Study|Death|0|||
129095175|NCT00308750|464640156|FG002|Overall Study|Death|1|||
129095176|NCT00308750|464640154|FG000|Overall Study|Protocol Violation|1|||
129095177|NCT00308750|464640155|FG001|Overall Study|Protocol Violation|0|||
129095178|NCT00308750|464640156|FG002|Overall Study|Protocol Violation|0|||
129095179|NCT00308750|464640154|FG000|Overall Study|New Primary Disease Identified|1|||
129095180|NCT00308750|464640155|FG001|Overall Study|New Primary Disease Identified|1|||
129095181|NCT00308750|464640156|FG002|Overall Study|New Primary Disease Identified|0|||
129095182|NCT02304380|464640157|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129095183|NCT02304380|464640158|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129095184|NCT02304380|464640159|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129095185|NCT02304380|464640160|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
129095186|NCT02304380|464640161|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129095187|NCT02304380|464640162|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129095188|NCT01125813|464640163|FG000|Overall Study|Death|1|||
129095189|NCT01125813|464640163|FG000|Overall Study|Withdrawal by Subject|1|||
129095190|NCT01125813|464640163|FG000|Overall Study|Screen Failures|4|||
129095191|NCT00985426|464640164|FG000|Overall Study|Adverse Event|0|||
129095192|NCT00985426|464640165|FG001|Overall Study|Adverse Event|1|||
129095193|NCT00985426|464640164|FG000|Overall Study|Subject Non-Compliance|3|||
129095194|NCT00985426|464640165|FG001|Overall Study|Subject Non-Compliance|3|||
129095195|NCT00985426|464640164|FG000|Overall Study|Withdrawal by Subject|12|||
129095196|NCT00985426|464640165|FG001|Overall Study|Withdrawal by Subject|16|||
129095197|NCT00985426|464640164|FG000|Overall Study|Lost to Follow-up|8|||
129095198|NCT00985426|464640165|FG001|Overall Study|Lost to Follow-up|10|||
129095199|NCT00985426|464640164|FG000|Overall Study|Death|7|||
129095200|NCT00985426|464640165|FG001|Overall Study|Death|3|||
129095201|NCT00985426|464640164|FG000|Overall Study|Protocol Violation|2|||
129095202|NCT00985426|464640165|FG001|Overall Study|Protocol Violation|0|||
129095203|NCT00985426|464640164|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
129095204|NCT00985426|464640165|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
129095205|NCT02327013|464640166|FG000|Overall Study|Adverse Event|4|||
129095206|NCT02327013|464640167|FG001|Overall Study|Adverse Event|4|||
129095207|NCT02327013|464640168|FG002|Overall Study|Adverse Event|3|||
129095208|NCT02327013|464640169|FG003|Overall Study|Adverse Event|0|||
129095209|NCT02327013|464640170|FG004|Overall Study|Adverse Event|1|||
129095210|NCT02327013|464640166|FG000|Overall Study|Lack of Efficacy|2|||
129095211|NCT02327013|464640167|FG001|Overall Study|Lack of Efficacy|0|||
129095212|NCT02327013|464640168|FG002|Overall Study|Lack of Efficacy|5|||
129095213|NCT02327013|464640169|FG003|Overall Study|Lack of Efficacy|0|||
129095214|NCT02327013|464640170|FG004|Overall Study|Lack of Efficacy|1|||
129095215|NCT02327013|464640166|FG000|Overall Study|Non-compliance with IMP|1|||
129095216|NCT02327013|464640167|FG001|Overall Study|Non-compliance with IMP|2|||
129095217|NCT02327013|464640168|FG002|Overall Study|Non-compliance with IMP|7|||
129095218|NCT02327013|464640169|FG003|Overall Study|Non-compliance with IMP|0|||
129095219|NCT02327013|464640170|FG004|Overall Study|Non-compliance with IMP|0|||
129095220|NCT02327013|464640166|FG000|Overall Study|Withdrawal of Consent|1|||
129095221|NCT02327013|464640167|FG001|Overall Study|Withdrawal of Consent|0|||
129095222|NCT02327013|464640168|FG002|Overall Study|Withdrawal of Consent|3|||
129095223|NCT02327013|464640169|FG003|Overall Study|Withdrawal of Consent|0|||
129095224|NCT02327013|464640170|FG004|Overall Study|Withdrawal of Consent|0|||
129095225|NCT02327013|464640166|FG000|Overall Study|Lost to Follow-up|2|||
129095226|NCT02327013|464640167|FG001|Overall Study|Lost to Follow-up|4|||
129095227|NCT02327013|464640168|FG002|Overall Study|Lost to Follow-up|5|||
129095228|NCT02327013|464640169|FG003|Overall Study|Lost to Follow-up|0|||
129095229|NCT02327013|464640170|FG004|Overall Study|Lost to Follow-up|0|||
129095230|NCT02327013|464640166|FG000|Overall Study|Administrative or other reason(s)|1|||
129095231|NCT02327013|464640167|FG001|Overall Study|Administrative or other reason(s)|5|||
129095232|NCT02327013|464640168|FG002|Overall Study|Administrative or other reason(s)|11|||
129095233|NCT02327013|464640169|FG003|Overall Study|Administrative or other reason(s)|1|||
129095234|NCT02327013|464640170|FG004|Overall Study|Administrative or other reason(s)|1|||
129095235|NCT02327013|464640166|FG000|Overall Study|Protocol Violation|0|||
129095236|NCT02327013|464640167|FG001|Overall Study|Protocol Violation|0|||
129095237|NCT02327013|464640168|FG002|Overall Study|Protocol Violation|3|||
129095238|NCT02327013|464640169|FG003|Overall Study|Protocol Violation|0|||
129095239|NCT02327013|464640170|FG004|Overall Study|Protocol Violation|1|||
129095240|NCT02327013|464640166|FG000|Overall Study|Withdrawal before treatment|2|||
129095241|NCT02327013|464640167|FG001|Overall Study|Withdrawal before treatment|1|||
129095242|NCT02327013|464640168|FG002|Overall Study|Withdrawal before treatment|5|||
129095243|NCT02327013|464640169|FG003|Overall Study|Withdrawal before treatment|0|||
129095244|NCT02327013|464640170|FG004|Overall Study|Withdrawal before treatment|0|||
129095245|NCT02971800|464640171|FG000|Overall Study|Protocol Violation|1|||
129095246|NCT02971800|464640171|FG000|Overall Study|Withdrawal by Subject|1|||
129095247|NCT02971800|464640171|FG000|Overall Study|Exclusion criteria prior intervention|1|||
129095248|NCT02971800|464640171|FG000|Overall Study|Number evaluable participant already reached|4|||
129095249|NCT04258254|464640172|FG000|Overall Study|Withdrawal by Subject|0|||
129095250|NCT04258254|464640173|FG001|Overall Study|Withdrawal by Subject|1|||
129095251|NCT04258254|464640174|FG002|Overall Study|Withdrawal by Subject|0|||
129095252|NCT04829331|464640175|FG000|Overall Study|Lost to Follow-up|1|||
129095253|NCT04829331|464640176|FG001|Overall Study|Lost to Follow-up|0|||
129095254|NCT01149421|464640178|FG000|Overall Study|Adverse Event|22|||
129095255|NCT01149421|464640179|FG001|Overall Study|Adverse Event|6|||
129095256|NCT01149421|464640180|FG002|Overall Study|Adverse Event|11|||
129095257|NCT01149421|464640178|FG000|Overall Study|Withdrawal by Subject|20|||
129095258|NCT01149421|464640179|FG001|Overall Study|Withdrawal by Subject|12|||
129095259|NCT01149421|464640180|FG002|Overall Study|Withdrawal by Subject|13|||
129095260|NCT01149421|464640178|FG000|Overall Study|Sponsor Decision|0|||
129095261|NCT01149421|464640179|FG001|Overall Study|Sponsor Decision|1|||
129095262|NCT01149421|464640180|FG002|Overall Study|Sponsor Decision|1|||
128871365|NCT04662931|463824459|FG000|Overall Study|Lost to Follow-up|3|||
128871366|NCT04662931|463824459|FG000|Overall Study|Guardian Decision|1|||
129095263|NCT01149421|464640178|FG000|Overall Study|Lost to Follow-up|2|||
129095264|NCT01149421|464640179|FG001|Overall Study|Lost to Follow-up|4|||
129095265|NCT01149421|464640180|FG002|Overall Study|Lost to Follow-up|5|||
129095266|NCT01149421|464640178|FG000|Overall Study|Physician Decision|5|||
129095267|NCT01149421|464640179|FG001|Overall Study|Physician Decision|3|||
129095268|NCT01149421|464640180|FG002|Overall Study|Physician Decision|6|||
129095269|NCT01149421|464640178|FG000|Overall Study|Entry Criteria Not Met|1|||
129095270|NCT01149421|464640179|FG001|Overall Study|Entry Criteria Not Met|1|||
129095271|NCT01149421|464640180|FG002|Overall Study|Entry Criteria Not Met|2|||
129095272|NCT01149421|464640178|FG000|Overall Study|Protocol Violation|2|||
129095273|NCT01149421|464640179|FG001|Overall Study|Protocol Violation|2|||
129095274|NCT01149421|464640180|FG002|Overall Study|Protocol Violation|6|||
129095275|NCT00616603|464640181|FG000|Overall Study|Physician Decision|2|||
129095276|NCT00616603|464640182|FG001|Overall Study|Physician Decision|0|||
129095277|NCT00616603|464640183|FG002|Overall Study|Physician Decision|2|||
129095278|NCT02956057|464640194|FG000|Overall Study|Discontinued intervention|14|||
129095279|NCT02956057|464640195|FG001|Overall Study|Discontinued intervention|10|||
129095280|NCT02956057|464640196|FG002|Overall Study|Discontinued intervention|7|||
129095281|NCT02956057|464640197|FG003|Overall Study|Discontinued intervention|14|||
129095282|NCT02956057|464640198|FG004|Overall Study|Discontinued intervention|4|||
129095283|NCT02956057|464640199|FG005|Overall Study|Discontinued intervention|17|||
129095284|NCT02956057|464640194|FG000|Overall Study|Lost to Follow-up|0|||
129095285|NCT02956057|464640195|FG001|Overall Study|Lost to Follow-up|2|||
129095286|NCT02956057|464640196|FG002|Overall Study|Lost to Follow-up|1|||
129095287|NCT02956057|464640197|FG003|Overall Study|Lost to Follow-up|1|||
129095288|NCT02956057|464640198|FG004|Overall Study|Lost to Follow-up|1|||
129095289|NCT02956057|464640199|FG005|Overall Study|Lost to Follow-up|0|||
129095290|NCT00908076|464640202|FG000|Overall Study|Lack of Efficacy|1|||
129095291|NCT00908076|464640203|FG001|Overall Study|Lack of Efficacy|1|||
129095292|NCT02382796|464640204|FG000|Overall Study|Global deterioration of health status|1|||
129095293|NCT02382796|464640204|FG000|Overall Study|Objective progression or relapse|3|||
129095294|NCT02382796|464640204|FG000|Overall Study|Commercial dacomitinib became available|3|||
129095295|NCT04007107|464640211|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
129095296|NCT04007107|464640212|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
129095297|NCT04007107|464640213|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
129095298|NCT04007107|464640214|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
129095299|NCT04068688|464640220|FG000|Overall Study|Lost to Follow-up|1|||
129095300|NCT04068688|464640221|FG001|Overall Study|Lost to Follow-up|1|||
129095301|NCT04068688|464640222|FG002|Overall Study|Lost to Follow-up|0|||
129095302|NCT04068688|464640223|FG003|Overall Study|Lost to Follow-up|0|||
129095303|NCT04068688|464640224|FG004|Overall Study|Lost to Follow-up|5|||
129095304|NCT04068688|464640225|FG005|Overall Study|Lost to Follow-up|5|||
129095305|NCT04068688|464640226|FG006|Overall Study|Lost to Follow-up|0|||
129095306|NCT04068688|464640227|FG007|Overall Study|Lost to Follow-up|0|||
129095307|NCT04068688|464640228|FG008|Overall Study|Lost to Follow-up|1|||
129095308|NCT04068688|464640229|FG009|Overall Study|Lost to Follow-up|0|||
129095309|NCT04068688|464640220|FG000|Overall Study|Withdrawal by Subject|1|||
129095310|NCT04068688|464640221|FG001|Overall Study|Withdrawal by Subject|1|||
129095311|NCT04068688|464640222|FG002|Overall Study|Withdrawal by Subject|0|||
129095312|NCT04068688|464640223|FG003|Overall Study|Withdrawal by Subject|0|||
129095313|NCT04068688|464640224|FG004|Overall Study|Withdrawal by Subject|0|||
129095314|NCT04068688|464640225|FG005|Overall Study|Withdrawal by Subject|0|||
129095315|NCT04068688|464640226|FG006|Overall Study|Withdrawal by Subject|0|||
129095316|NCT04068688|464640227|FG007|Overall Study|Withdrawal by Subject|0|||
129095317|NCT04068688|464640228|FG008|Overall Study|Withdrawal by Subject|0|||
129095318|NCT04068688|464640229|FG009|Overall Study|Withdrawal by Subject|0|||
129095319|NCT04068688|464640220|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
129095320|NCT04068688|464640221|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
129095321|NCT04068688|464640222|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095322|NCT04068688|464640223|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095323|NCT04068688|464640224|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095324|NCT04068688|464640225|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095325|NCT04068688|464640226|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095326|NCT04068688|464640227|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095327|NCT04068688|464640228|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095328|NCT04068688|464640229|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129095329|NCT04679051|464640230|FG000|Overall Study|felt tired after restricted time in bed|3|||
129095330|NCT04679051|464640231|FG001|Overall Study|felt tired after restricted time in bed|0|||
129095331|NCT04679051|464640230|FG000|Overall Study|discomfort with blood pressure cuff|2|||
129095332|NCT04679051|464640231|FG001|Overall Study|discomfort with blood pressure cuff|0|||
129095333|NCT04679051|464640230|FG000|Overall Study|scheduling conflict|1|||
129095334|NCT04679051|464640231|FG001|Overall Study|scheduling conflict|1|||
129095335|NCT04679051|464640230|FG000|Overall Study|Protocol Violation|0|||
129095336|NCT04679051|464640231|FG001|Overall Study|Protocol Violation|4|||
129095337|NCT02554318|464640232|FG000|Overall Study|Withdrawal by Subject|10|||
129095338|NCT02554318|464640233|FG001|Overall Study|Withdrawal by Subject|8|||
129095339|NCT01273155|464640238|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
129095340|NCT01273155|464640239|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
129095341|NCT01273155|464640240|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
129095342|NCT01273155|464640241|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
129095343|NCT01273155|464640242|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
129095344|NCT01273155|464640243|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
129095345|NCT01273155|464640244|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
129095346|NCT01273155|464640238|FG000|Overall Study|Change in liver function/no longer eval.|0|||
129095347|NCT01273155|464640239|FG001|Overall Study|Change in liver function/no longer eval.|1|||
129095348|NCT01273155|464640240|FG002|Overall Study|Change in liver function/no longer eval.|0|||
129095349|NCT01273155|464640241|FG003|Overall Study|Change in liver function/no longer eval.|0|||
129095350|NCT01273155|464640242|FG004|Overall Study|Change in liver function/no longer eval.|1|||
129095351|NCT01273155|464640243|FG005|Overall Study|Change in liver function/no longer eval.|0|||
129095352|NCT01273155|464640244|FG006|Overall Study|Change in liver function/no longer eval.|0|||
129095353|NCT01273155|464640238|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
129095354|NCT01273155|464640239|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
129095355|NCT01273155|464640240|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
129095356|NCT01273155|464640241|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
129095357|NCT01273155|464640242|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
129095358|NCT01273155|464640243|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
129095359|NCT01273155|464640244|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
129095360|NCT01273155|464640238|FG000|Overall Study|Died during Cycle 1|0|||
129095361|NCT01273155|464640239|FG001|Overall Study|Died during Cycle 1|0|||
129095362|NCT01273155|464640240|FG002|Overall Study|Died during Cycle 1|1|||
129095363|NCT01273155|464640241|FG003|Overall Study|Died during Cycle 1|1|||
129095364|NCT01273155|464640242|FG004|Overall Study|Died during Cycle 1|0|||
129095365|NCT01273155|464640243|FG005|Overall Study|Died during Cycle 1|2|||
129095366|NCT01273155|464640244|FG006|Overall Study|Died during Cycle 1|2|||
129095367|NCT01273155|464640238|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
129095368|NCT01273155|464640239|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
129095369|NCT01273155|464640240|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
129095370|NCT01273155|464640241|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
129095371|NCT01273155|464640242|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
129095372|NCT01273155|464640243|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
129095373|NCT01273155|464640244|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
129095374|NCT01438814|464640250|FG000|Overall Study|Adverse Event|3|||
129095375|NCT01438814|464640251|FG001|Overall Study|Adverse Event|3|||
129095376|NCT01438814|464640250|FG000|Overall Study|Protocol Violation|1|||
129095377|NCT01438814|464640251|FG001|Overall Study|Protocol Violation|2|||
129095378|NCT01438814|464640250|FG000|Overall Study|Lost to Follow-up|4|||
129095379|NCT01438814|464640251|FG001|Overall Study|Lost to Follow-up|3|||
129095380|NCT01438814|464640250|FG000|Overall Study|Withdrawal by Subject|4|||
129095381|NCT01438814|464640251|FG001|Overall Study|Withdrawal by Subject|2|||
129095382|NCT01438814|464640250|FG000|Overall Study|Other|2|||
129095383|NCT01438814|464640251|FG001|Overall Study|Other|4|||
129095384|NCT00990665|464640252|FG000|Overall Study|Unsuccessful Implant|8|||
129095385|NCT00990665|464640252|FG000|Overall Study|Death|29|||
129095386|NCT00990665|464640252|FG000|Overall Study|Heart Transplant|1|||
129095387|NCT00990665|464640252|FG000|Overall Study|Withdrawal by Subject|6|||
129095388|NCT00990665|464640252|FG000|Overall Study|Lost to Follow-up|1|||
129095389|NCT00990665|464640252|FG000|Overall Study|System Explant|3|||
129095390|NCT00672841|464640253|FG000|Overall Study|Comfort care|1|||
129095391|NCT00672841|464640254|FG001|Overall Study|Comfort care|4|||
129095392|NCT00672841|464640253|FG000|Overall Study|icteric specimens|0|||
129095393|NCT00672841|464640254|FG001|Overall Study|icteric specimens|3|||
129095394|NCT00672841|464640253|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
129095395|NCT00672841|464640254|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
129095396|NCT00672841|464640253|FG000|Overall Study|Adverse Event|0|||
129095397|NCT00672841|464640254|FG001|Overall Study|Adverse Event|3|||
129095398|NCT00672841|464640253|FG000|Overall Study|Pregnancy|0|||
129095399|NCT00672841|464640254|FG001|Overall Study|Pregnancy|1|||
129095400|NCT03578146|464640255|FG000|Overall Study|Did Not Receive Treatment|1|||
129095401|NCT03578146|464640256|FG001|Overall Study|Did Not Receive Treatment|0|||
129095402|NCT03578146|464640257|FG002|Overall Study|Did Not Receive Treatment|0|||
129095403|NCT03578146|464640258|FG003|Overall Study|Did Not Receive Treatment|0|||
129095404|NCT03578146|464640259|FG004|Overall Study|Did Not Receive Treatment|0|||
129095405|NCT03578146|464640260|FG005|Overall Study|Did Not Receive Treatment|2|||
129095406|NCT03578146|464640255|FG000|Overall Study|Lost to Follow-up|0|||
129095407|NCT03578146|464640256|FG001|Overall Study|Lost to Follow-up|1|||
129095408|NCT03578146|464640257|FG002|Overall Study|Lost to Follow-up|1|||
129095409|NCT03578146|464640258|FG003|Overall Study|Lost to Follow-up|0|||
129095410|NCT03578146|464640259|FG004|Overall Study|Lost to Follow-up|0|||
129095411|NCT03578146|464640260|FG005|Overall Study|Lost to Follow-up|1|||
129095412|NCT01717391|464640261|FG000|Overall Study|Withdrawal by Subject|5|||
129095413|NCT01717391|464640261|FG000|Overall Study|Physician Decision|1|||
129095414|NCT01717391|464640261|FG000|Overall Study|FLT technical failure|3|||
129095415|NCT03677934|464640262|FG000|Overall Study|Adverse Event|1|||
129095416|NCT03677934|464640263|FG001|Overall Study|Adverse Event|1|||
129095417|NCT03677934|464640262|FG000|Overall Study|Death|8|||
129095418|NCT03677934|464640263|FG001|Overall Study|Death|4|||
129095419|NCT03677934|464640262|FG000|Overall Study|Lost to Follow-up|3|||
129095420|NCT03677934|464640263|FG001|Overall Study|Lost to Follow-up|0|||
129095421|NCT03677934|464640262|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129095422|NCT03677934|464640263|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129095423|NCT03677934|464640262|FG000|Overall Study|Physician Decision|0|||
129095424|NCT03677934|464640263|FG001|Overall Study|Physician Decision|1|||
129095425|NCT03677934|464640262|FG000|Overall Study|Withdrawal by Subject|1|||
129095426|NCT03677934|464640263|FG001|Overall Study|Withdrawal by Subject|7|||
129095427|NCT01731470|464640265|FG000|Overall Study|Withdrawal by Subject|1|||
129095428|NCT01731470|464640265|FG000|Overall Study|Did not meet study criteria|1|||
129095429|NCT00335959|464640266|FG000|Overall Study|Adverse Event|2|||
129095430|NCT00335959|464640266|FG000|Overall Study|Ineligible|1|||
129095431|NCT02450552|464640268|FG000|Overall Study|Withdrawal by Subject|4|||
129095432|NCT02450552|464640269|FG001|Overall Study|Withdrawal by Subject|0|||
129095433|NCT02450552|464640270|FG002|Overall Study|Withdrawal by Subject|4|||
129095434|NCT02450552|464640268|FG000|Overall Study|Physician Decision|1|||
129095435|NCT02450552|464640269|FG001|Overall Study|Physician Decision|0|||
129095436|NCT02450552|464640270|FG002|Overall Study|Physician Decision|1|||
129095437|NCT01876979|464640273|FG000|Overall Study|Physician Decision|2|||
129095438|NCT01876979|464640274|FG001|Overall Study|Physician Decision|3|||
129095439|NCT00948506|464640275|FG000|Overall Study|Withdrawal by Subject|3|||
129095440|NCT00948506|464640276|FG001|Overall Study|Withdrawal by Subject|1|||
129095441|NCT00824382|464640277|FG000|Overall Study|Adverse Event|4|||
129095442|NCT00824382|464640278|FG001|Overall Study|Adverse Event|1|||
129095443|NCT00824382|464640279|FG002|Overall Study|Adverse Event|1|||
129095444|NCT00824382|464640280|FG003|Overall Study|Adverse Event|4|||
129095445|NCT00824382|464640277|FG000|Overall Study|Protocol Violation|1|||
129095446|NCT00824382|464640278|FG001|Overall Study|Protocol Violation|0|||
129095447|NCT00824382|464640279|FG002|Overall Study|Protocol Violation|0|||
129095448|NCT00824382|464640280|FG003|Overall Study|Protocol Violation|1|||
129095449|NCT00824382|464640277|FG000|Overall Study|Investigator's decision|0|||
129095450|NCT00824382|464640278|FG001|Overall Study|Investigator's decision|1|||
129095451|NCT00824382|464640279|FG002|Overall Study|Investigator's decision|2|||
129095452|NCT00824382|464640280|FG003|Overall Study|Investigator's decision|0|||
129095453|NCT00721279|464640281|FG000|Overall Study|Lack of Efficacy|6|||
129095454|NCT00721279|464640282|FG001|Overall Study|Lack of Efficacy|3|||
129095455|NCT00721279|464640281|FG000|Overall Study|Tolerability insufficient|5|||
129095456|NCT00721279|464640282|FG001|Overall Study|Tolerability insufficient|2|||
129095457|NCT00721279|464640281|FG000|Overall Study|Withdrawal by Subject|13|||
129095458|NCT00721279|464640282|FG001|Overall Study|Withdrawal by Subject|3|||
129095459|NCT00721279|464640281|FG000|Overall Study|Other|12|||
129095460|NCT00721279|464640282|FG001|Overall Study|Other|16|||
129095461|NCT03467763|464640283|FG000|Overall Study|Lost to Follow-up|1|||
129095462|NCT03467763|464640283|FG000|Overall Study|Protocol Violation|2|||
129095463|NCT02407054|464640284|FG000|Overall Study|Adverse Event|1|||
129095464|NCT02407054|464640285|FG001|Overall Study|Adverse Event|4|||
129095465|NCT02407054|464640286|FG002|Overall Study|Adverse Event|1|||
129095466|NCT02407054|464640284|FG000|Overall Study|Non-compliance with Study|0|||
129095467|NCT02407054|464640285|FG001|Overall Study|Non-compliance with Study|2|||
129095468|NCT02407054|464640286|FG002|Overall Study|Non-compliance with Study|1|||
129095469|NCT02407054|464640284|FG000|Overall Study|Physician Decision|1|||
129095470|NCT02407054|464640285|FG001|Overall Study|Physician Decision|3|||
129095471|NCT02407054|464640286|FG002|Overall Study|Physician Decision|3|||
129095472|NCT02407054|464640284|FG000|Overall Study|Withdrawal by Subject|5|||
129095473|NCT02407054|464640285|FG001|Overall Study|Withdrawal by Subject|9|||
129095474|NCT02407054|464640286|FG002|Overall Study|Withdrawal by Subject|2|||
129095475|NCT04608344|464640287|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
129095476|NCT04608344|464640288|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
129095477|NCT04608344|464640287|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
129095478|NCT04608344|464640288|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
129095479|NCT00131365|464640289|FG000|Overall Study|Withdrawal by Subject|1|||
129095480|NCT00131365|464640289|FG000|Overall Study|Alternative treatment|3|||
129095481|NCT02044874|464640290|FG000|Overall Study|Adverse Event|5|||
129095482|NCT02044874|464640291|FG001|Overall Study|Adverse Event|6|||
129095483|NCT02044874|464640292|FG002|Overall Study|Adverse Event|6|||
129095484|NCT02044874|464640290|FG000|Overall Study|Withdrawal by Subject|8|||
129095485|NCT02044874|464640291|FG001|Overall Study|Withdrawal by Subject|16|||
129095486|NCT02044874|464640292|FG002|Overall Study|Withdrawal by Subject|23|||
129095487|NCT02044874|464640290|FG000|Overall Study|Physician Decision|0|||
129095488|NCT02044874|464640291|FG001|Overall Study|Physician Decision|2|||
129095489|NCT02044874|464640292|FG002|Overall Study|Physician Decision|1|||
129095490|NCT02044874|464640290|FG000|Overall Study|Lost to Follow-up|10|||
129095491|NCT02044874|464640291|FG001|Overall Study|Lost to Follow-up|27|||
129095492|NCT02044874|464640292|FG002|Overall Study|Lost to Follow-up|21|||
129095493|NCT02044874|464640290|FG000|Overall Study|Sponsor Decision|0|||
129095494|NCT02044874|464640291|FG001|Overall Study|Sponsor Decision|1|||
129095495|NCT02044874|464640292|FG002|Overall Study|Sponsor Decision|1|||
129095496|NCT02044874|464640290|FG000|Overall Study|Other|7|||
129095497|NCT02044874|464640291|FG001|Overall Study|Other|3|||
129095498|NCT02044874|464640292|FG002|Overall Study|Other|8|||
129095499|NCT00415597|464640293|FG000|Enrollment|Withdrawal by Subject|1|||
129095500|NCT00415597|464640293|FG000|Enrollment|Protocol Violation|1|||
129095501|NCT00415597|464640293|FG000|Treatment|Adverse Event|110|||
129095502|NCT00415597|464640293|FG000|Treatment|Lack of Efficacy|39|||
129095503|NCT00415597|464640293|FG000|Treatment|Protocol Violation|67|||
129095504|NCT00415597|464640293|FG000|Treatment|Physician Decision|3|||
129095505|NCT00415597|464640293|FG000|Treatment|Withdrawal by Subject|51|||
129095506|NCT00415597|464640293|FG000|Treatment|Lost to Follow-up|28|||
129095507|NCT00415597|464640293|FG000|Treatment|Drug Screen|2|||
129095508|NCT00415597|464640293|FG000|Treatment|Administrative|3|||
129095509|NCT00415597|464640293|FG000|Treatment|Sponsor Decision|1|||
129095510|NCT00415597|464640293|FG000|Treatment|Multiple Reasons|1|||
129095511|NCT01447927|464640294|FG000|Overall Study|Adverse Event|4|||
129095512|NCT01447927|464640295|FG001|Overall Study|Adverse Event|3|||
129095513|NCT01447927|464640294|FG000|Overall Study|Withdrawal by Subject|1|||
129095514|NCT01447927|464640295|FG001|Overall Study|Withdrawal by Subject|0|||
129095515|NCT04102865|464640297|FG000|Overall Study|Adverse Event|4|||
129095516|NCT04102865|464640298|FG001|Overall Study|Adverse Event|0|||
129095517|NCT04102865|464640297|FG000|Overall Study|Lost to Follow-up|1|||
129095518|NCT04102865|464640298|FG001|Overall Study|Lost to Follow-up|0|||
129095519|NCT04102865|464640297|FG000|Overall Study|Withdrawal by Subject|2|||
129095520|NCT04102865|464640298|FG001|Overall Study|Withdrawal by Subject|0|||
129095521|NCT01764997|464640299|FG000|Run-in Period|Adverse Event|15|||
129095522|NCT01764997|464640300|FG001|Run-in Period|Adverse Event|0|||
129095523|NCT01764997|464640301|FG002|Run-in Period|Adverse Event|0|||
129095524|NCT01764997|464640302|FG003|Run-in Period|Adverse Event|0|||
129095525|NCT01764997|464640303|FG004|Run-in Period|Adverse Event|0|||
129095526|NCT01764997|464640299|FG000|Run-in Period|Lack of Efficacy|5|||
129095527|NCT01764997|464640300|FG001|Run-in Period|Lack of Efficacy|0|||
129095528|NCT01764997|464640301|FG002|Run-in Period|Lack of Efficacy|0|||
129095529|NCT01764997|464640302|FG003|Run-in Period|Lack of Efficacy|0|||
129095530|NCT01764997|464640303|FG004|Run-in Period|Lack of Efficacy|0|||
129095531|NCT01764997|464640299|FG000|Run-in Period|Poor compliance to protocol|1|||
129095532|NCT01764997|464640300|FG001|Run-in Period|Poor compliance to protocol|0|||
129095533|NCT01764997|464640301|FG002|Run-in Period|Poor compliance to protocol|0|||
129095534|NCT01764997|464640302|FG003|Run-in Period|Poor compliance to protocol|0|||
129095535|NCT01764997|464640303|FG004|Run-in Period|Poor compliance to protocol|0|||
129095536|NCT01764997|464640299|FG000|Run-in Period|Other than specified above|17|||
129095537|NCT01764997|464640300|FG001|Run-in Period|Other than specified above|0|||
129095538|NCT01764997|464640301|FG002|Run-in Period|Other than specified above|0|||
129095539|NCT01764997|464640302|FG003|Run-in Period|Other than specified above|0|||
129095540|NCT01764997|464640303|FG004|Run-in Period|Other than specified above|0|||
129095541|NCT01764997|464640299|FG000|Study Drug Treatment Period|Adverse Event|0|||
129095542|NCT01764997|464640300|FG001|Study Drug Treatment Period|Adverse Event|1|||
129095543|NCT01764997|464640301|FG002|Study Drug Treatment Period|Adverse Event|0|||
129095544|NCT01764997|464640302|FG003|Study Drug Treatment Period|Adverse Event|0|||
129095545|NCT01764997|464640303|FG004|Study Drug Treatment Period|Adverse Event|24|||
129095546|NCT01764997|464640299|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
129095547|NCT01764997|464640300|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
129095548|NCT01764997|464640301|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
129095549|NCT01764997|464640302|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
129095550|NCT01764997|464640303|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
129095551|NCT01764997|464640299|FG000|Study Drug Treatment Period|Other than specified above|0|||
129095552|NCT01764997|464640300|FG001|Study Drug Treatment Period|Other than specified above|0|||
129095553|NCT01764997|464640301|FG002|Study Drug Treatment Period|Other than specified above|0|||
129095554|NCT01764997|464640302|FG003|Study Drug Treatment Period|Other than specified above|0|||
129095555|NCT01764997|464640303|FG004|Study Drug Treatment Period|Other than specified above|10|||
129095556|NCT04438499|464640312|FG000|Overall Study|Lack of Efficacy|3|||
129095557|NCT04918355|464640313|FG000|Overall Study|no qualifying health encounter|497|||
129095558|NCT04918355|464640314|FG001|Overall Study|no qualifying health encounter|192|||
129095559|NCT04918355|464640315|FG002|Overall Study|no qualifying health encounter|438|||
129095560|NCT04918355|464640316|FG003|Overall Study|no qualifying health encounter|424|||
129095561|NCT04683939|464640318|FG000|Overall Study|Study termination by the sponsor|0|||
129095562|NCT04683939|464640319|FG001|Overall Study|Study termination by the sponsor|1|||
129095563|NCT04683939|464640320|FG002|Overall Study|Study termination by the sponsor|2|||
129095564|NCT04683939|464640321|FG003|Overall Study|Study termination by the sponsor|2|||
129095565|NCT04683939|464640318|FG000|Overall Study|Death|1|||
129095566|NCT04683939|464640319|FG001|Overall Study|Death|1|||
129095567|NCT04683939|464640320|FG002|Overall Study|Death|2|||
129095568|NCT04683939|464640321|FG003|Overall Study|Death|1|||
129095569|NCT04683939|464640318|FG000|Overall Study|Withdrawal by Subject|1|||
129095570|NCT04683939|464640319|FG001|Overall Study|Withdrawal by Subject|0|||
129095571|NCT04683939|464640320|FG002|Overall Study|Withdrawal by Subject|0|||
129095572|NCT04683939|464640321|FG003|Overall Study|Withdrawal by Subject|0|||
129095573|NCT04683939|464640318|FG000|Overall Study|Physician Decision|1|||
129095574|NCT04683939|464640319|FG001|Overall Study|Physician Decision|0|||
129095575|NCT04683939|464640320|FG002|Overall Study|Physician Decision|0|||
129095576|NCT04683939|464640321|FG003|Overall Study|Physician Decision|0|||
129095577|NCT04683939|464640318|FG000|Overall Study|Lost to Follow-up|0|||
129095578|NCT04683939|464640319|FG001|Overall Study|Lost to Follow-up|1|||
129095579|NCT04683939|464640320|FG002|Overall Study|Lost to Follow-up|0|||
129095580|NCT04683939|464640321|FG003|Overall Study|Lost to Follow-up|0|||
129095581|NCT00224406|464642596|FG000|Overall Study|Re-transplant|0|||
129095582|NCT00224406|464642597|FG001|Overall Study|Re-transplant|2|||
129095583|NCT00224406|464642596|FG000|Overall Study|Death|0|||
129095584|NCT00224406|464642597|FG001|Overall Study|Death|1|||
129095585|NCT00224406|464642596|FG000|Overall Study|Transplant cancelled|0|||
129095586|NCT00224406|464642597|FG001|Overall Study|Transplant cancelled|4|||
129095587|NCT00224406|464642596|FG000|Overall Study|Drug not delivered|2|||
129095588|NCT00224406|464642597|FG001|Overall Study|Drug not delivered|0|||
129095589|NCT00224406|464642596|FG000|Overall Study|Other|4|||
129095590|NCT00224406|464642597|FG001|Overall Study|Other|0|||
129095591|NCT00224406|464642596|FG000|Overall Study|Transplant cancelled|3|||
129095592|NCT00224406|464642597|FG001|Overall Study|Transplant cancelled|0|||
129095593|NCT01556997|464642598|FG000|Overall Study|Adverse Event|10|||
129095594|NCT01556997|464642599|FG001|Overall Study|Adverse Event|12|||
129095595|NCT01556997|464642600|FG002|Overall Study|Adverse Event|12|||
129095596|NCT01556997|464642598|FG000|Overall Study|Lost to Follow-up|6|||
129095597|NCT01556997|464642599|FG001|Overall Study|Lost to Follow-up|6|||
129095598|NCT01556997|464642600|FG002|Overall Study|Lost to Follow-up|4|||
129095599|NCT01556997|464642598|FG000|Overall Study|Physician Decision|1|||
129095600|NCT01556997|464642599|FG001|Overall Study|Physician Decision|1|||
129095601|NCT01556997|464642600|FG002|Overall Study|Physician Decision|1|||
129095602|NCT01556997|464642598|FG000|Overall Study|Withdrawal by Subject|7|||
129095603|NCT01556997|464642599|FG001|Overall Study|Withdrawal by Subject|6|||
129095604|NCT01556997|464642600|FG002|Overall Study|Withdrawal by Subject|8|||
129095605|NCT01556997|464642598|FG000|Overall Study|Other|2|||
129095606|NCT01556997|464642599|FG001|Overall Study|Other|3|||
129095607|NCT01556997|464642600|FG002|Overall Study|Other|7|||
129095608|NCT05459558|464642612|FG000|Overall Study|Adverse Event|1|||
129095609|NCT05459558|464642613|FG001|Overall Study|Adverse Event|0|||
129095610|NCT05459558|464642614|FG002|Overall Study|Adverse Event|0|||
129095611|NCT05459558|464642612|FG000|Overall Study|Scheduling issue|0|||
129095612|NCT05459558|464642613|FG001|Overall Study|Scheduling issue|1|||
129095613|NCT05459558|464642614|FG002|Overall Study|Scheduling issue|3|||
129095614|NCT05459558|464642612|FG000|Overall Study|Withdrawal by Subject|0|||
129095615|NCT05459558|464642613|FG001|Overall Study|Withdrawal by Subject|0|||
129095616|NCT05459558|464642614|FG002|Overall Study|Withdrawal by Subject|2|||
129095617|NCT01092637|464642615|FG000|Overall Study|Death|47|||
129095618|NCT01092637|464642616|FG001|Overall Study|Death|49|||
129095619|NCT03292458|464642618|FG000|Period 1|Adverse Event|2|||
129095620|NCT03292458|464642619|FG001|Period 1|Adverse Event|0|||
129095621|NCT00593606|464642620|FG000|Overall Study|Adverse Event|13|||
129095622|NCT00593606|464642620|FG000|Overall Study|Withdrawal by Subject|1|||
129095623|NCT00593606|464642620|FG000|Overall Study|Protocol Violation|3|||
129095624|NCT00593606|464642620|FG000|Overall Study|Lost to Follow-up|2|||
129095625|NCT00593606|464642620|FG000|Overall Study|Run-In Failure|5|||
129095626|NCT00593606|464642620|FG000|Overall Study|Screen Failure|3|||
129095627|NCT02278367|464642621|FG000|Overall Study|Physician Decision|5|||
129095628|NCT02278367|464642622|FG001|Overall Study|Physician Decision|0|||
129095629|NCT02278367|464642621|FG000|Overall Study|Withdrawal by Subject|5|||
129095630|NCT02278367|464642622|FG001|Overall Study|Withdrawal by Subject|0|||
129095631|NCT04643964|464642623|FG000|Overall Study|Lost to Follow-up|55|||
129095632|NCT04643964|464642624|FG001|Overall Study|Lost to Follow-up|59|||
129095633|NCT04643964|464642625|FG002|Overall Study|Lost to Follow-up|54|||
129095634|NCT04643964|464642626|FG003|Overall Study|Lost to Follow-up|129|||
129095635|NCT04643964|464642627|FG004|Overall Study|Lost to Follow-up|48|||
129095636|NCT04643964|464642623|FG000|Overall Study|Failed attention check|1|||
129095637|NCT04643964|464642624|FG001|Overall Study|Failed attention check|8|||
129095638|NCT04643964|464642625|FG002|Overall Study|Failed attention check|2|||
129095639|NCT04643964|464642626|FG003|Overall Study|Failed attention check|14|||
129095640|NCT04643964|464642627|FG004|Overall Study|Failed attention check|11|||
129095641|NCT05932225|464642628|FG000|Overall Study|Lost to Follow-up|0|||
129095642|NCT05932225|464642629|FG001|Overall Study|Lost to Follow-up|1|||
129095643|NCT05932225|464642630|FG002|Overall Study|Lost to Follow-up|0|||
129095644|NCT05932225|464642628|FG000|Overall Study|Withdrawal by Subject|1|||
129095645|NCT05932225|464642629|FG001|Overall Study|Withdrawal by Subject|0|||
129095646|NCT05932225|464642630|FG002|Overall Study|Withdrawal by Subject|0|||
129095647|NCT05932225|464642628|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
129095648|NCT05932225|464642629|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
128871367|NCT00680992|463824463|FG000|Overall Study|Complete Resection (as per protocol)|25|||
129095649|NCT05932225|464642630|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
129095650|NCT02638129|464642631|FG000|Overall Study|Study terminated|28|||
129095651|NCT02638129|464642632|FG001|Overall Study|Study terminated|30|||
129095652|NCT02949908|464642633|FG000|Overall Study|Study termination|2|||
129095653|NCT01472939|464642634|FG000|Overall Study|Adverse Event|3|||
129095654|NCT01472939|464642635|FG001|Overall Study|Adverse Event|7|||
129095655|NCT01472939|464642636|FG002|Overall Study|Adverse Event|7|||
129095656|NCT01472939|464642637|FG003|Overall Study|Adverse Event|14|||
129095657|NCT01472939|464642634|FG000|Overall Study|Lack of Efficacy|1|||
129095658|NCT01472939|464642635|FG001|Overall Study|Lack of Efficacy|0|||
129095659|NCT01472939|464642636|FG002|Overall Study|Lack of Efficacy|0|||
129095660|NCT01472939|464642637|FG003|Overall Study|Lack of Efficacy|1|||
129095661|NCT01472939|464642634|FG000|Overall Study|Lost to Follow-up|3|||
129095662|NCT01472939|464642635|FG001|Overall Study|Lost to Follow-up|0|||
129095663|NCT01472939|464642636|FG002|Overall Study|Lost to Follow-up|2|||
129095664|NCT01472939|464642637|FG003|Overall Study|Lost to Follow-up|0|||
129095665|NCT01472939|464642634|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
129095666|NCT01472939|464642635|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
129095667|NCT01472939|464642636|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
129095668|NCT01472939|464642637|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
129095669|NCT01472939|464642634|FG000|Overall Study|Prohibited Medication|0|||
129095670|NCT01472939|464642635|FG001|Overall Study|Prohibited Medication|1|||
128983692|NCT00450814|464228025|FG009|Overall Study|Failed to complete the initial therapy|0|||
129095671|NCT01472939|464642636|FG002|Overall Study|Prohibited Medication|0|||
129095672|NCT01472939|464642637|FG003|Overall Study|Prohibited Medication|0|||
129095673|NCT01472939|464642634|FG000|Overall Study|Withdrawal By PI|1|||
129095674|NCT01472939|464642635|FG001|Overall Study|Withdrawal By PI|0|||
129095675|NCT01472939|464642636|FG002|Overall Study|Withdrawal By PI|0|||
129095676|NCT01472939|464642637|FG003|Overall Study|Withdrawal By PI|0|||
129095677|NCT01472939|464642634|FG000|Overall Study|Protocol Violation|3|||
129095678|NCT01472939|464642635|FG001|Overall Study|Protocol Violation|3|||
129095679|NCT01472939|464642636|FG002|Overall Study|Protocol Violation|0|||
129095680|NCT01472939|464642637|FG003|Overall Study|Protocol Violation|1|||
129095681|NCT01472939|464642634|FG000|Overall Study|Withdrawal by Subject|9|||
129095682|NCT01472939|464642635|FG001|Overall Study|Withdrawal by Subject|3|||
129095683|NCT01472939|464642636|FG002|Overall Study|Withdrawal by Subject|1|||
129095684|NCT01472939|464642637|FG003|Overall Study|Withdrawal by Subject|4|||
129095685|NCT00114738|464642638|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
129095686|NCT00114738|464642639|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
129095687|NCT00114738|464642640|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
129095688|NCT00114738|464642638|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
129095689|NCT00114738|464642639|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
129095690|NCT00114738|464642640|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
129095691|NCT00114738|464642638|FG000|Screening for Randomization|Neuropathy|17|||
129095692|NCT00114738|464642639|FG001|Screening for Randomization|Neuropathy|0|||
129095693|NCT00114738|464642640|FG002|Screening for Randomization|Neuropathy|0|||
129095694|NCT00114738|464642638|FG000|Screening for Randomization|Progressive disease|2|||
129095695|NCT00114738|464642639|FG001|Screening for Randomization|Progressive disease|0|||
129095696|NCT00114738|464642640|FG002|Screening for Randomization|Progressive disease|0|||
129095697|NCT00114738|464642638|FG000|Screening for Randomization|CNS Hemorrhage|1|||
128762923|NCT01282801|463420866|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
128762924|NCT01060553|463420867|FG000|Overall Study|Lost to Follow-up|3|||
128762925|NCT01060553|463420868|FG001|Overall Study|Lost to Follow-up|5|||
128762926|NCT01060553|463420867|FG000|Overall Study|Withdrawal by Subject|5|||
128762927|NCT01060553|463420868|FG001|Overall Study|Withdrawal by Subject|5|||
128762928|NCT01060553|463420867|FG000|Overall Study|Lack of Efficacy|1|||
128762929|NCT01060553|463420868|FG001|Overall Study|Lack of Efficacy|0|||
128762930|NCT04707196|463420870|FG000|Overall Study|Withdrawal by Subject|9|||
128762931|NCT04707196|463420871|FG001|Overall Study|Withdrawal by Subject|6|||
128762932|NCT04707196|463420870|FG000|Overall Study|Lost to Follow-up|1|||
128762933|NCT04707196|463420871|FG001|Overall Study|Lost to Follow-up|0|||
128762934|NCT04707196|463420870|FG000|Overall Study|Protocol Violation|4|||
128762935|NCT04707196|463420871|FG001|Overall Study|Protocol Violation|1|||
128762936|NCT04707196|463420870|FG000|Overall Study|Adverse Event|2|||
128762937|NCT04707196|463420871|FG001|Overall Study|Adverse Event|2|||
128762938|NCT04707196|463420870|FG000|Overall Study|Death|3|||
128762939|NCT04707196|463420871|FG001|Overall Study|Death|1|||
128762940|NCT04707196|463420870|FG000|Overall Study|Non-compliance with study drug|1|||
128762941|NCT04707196|463420871|FG001|Overall Study|Non-compliance with study drug|0|||
128762942|NCT04707196|463420870|FG000|Overall Study|Progressive disease|9|||
128762943|NCT04707196|463420871|FG001|Overall Study|Progressive disease|10|||
128762944|NCT01862796|463420872|FG000|Overall Study|Prohibited medications|0|||
128762945|NCT01862796|463420873|FG001|Overall Study|Prohibited medications|0|||
128762946|NCT01862796|463420874|FG002|Overall Study|Prohibited medications|1|||
128762947|NCT00779779|463420879|FG000|Overall Study|Adverse Event|1|||
128762948|NCT00779779|463420879|FG000|Overall Study|Protocol Violation|14|||
128762949|NCT00779779|463420879|FG000|Overall Study|Withdrawal by Subject|4|||
128762950|NCT00779779|463420879|FG000|Overall Study|Lost to Follow-up|5|||
128762951|NCT06387472|463420882|FG000|Overall Study|Withdrawal by Subject|1|||
128762952|NCT06387472|463420882|FG000|Overall Study|Lost to Follow-up|2|||
128762953|NCT06387472|463420882|FG000|Overall Study|Physician Decision|1|||
128762954|NCT03935217|463422646|FG000|Overall Study|Adverse Event|1|||
128762955|NCT03935217|463422647|FG001|Overall Study|Adverse Event|0|||
128762956|NCT03935217|463422646|FG000|Overall Study|Lost to Follow-up|0|||
128762957|NCT03935217|463422647|FG001|Overall Study|Lost to Follow-up|1|||
128762958|NCT03935217|463422646|FG000|Overall Study|Withdrawal by Subject|0|||
128983693|NCT00450814|464228026|FG010|Overall Study|Failed to complete the initial therapy|0|||
128983694|NCT00450814|464228016|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
128762959|NCT03935217|463422647|FG001|Overall Study|Withdrawal by Subject|2|||
128762960|NCT01862991|463422655|FG000|Overall Study|Lost to Follow-up|2|||
128762961|NCT01862991|463422656|FG001|Overall Study|Lost to Follow-up|1|||
128762962|NCT01862991|463422657|FG002|Overall Study|Lost to Follow-up|1|||
128762963|NCT01862991|463422655|FG000|Overall Study|Protocol Violation|1|||
129095698|NCT00114738|464642639|FG001|Screening for Randomization|CNS Hemorrhage|0|||
129095699|NCT00114738|464642640|FG002|Screening for Randomization|CNS Hemorrhage|0|||
129095700|NCT00114738|464642638|FG000|Screening for Randomization|Other|1|||
129095701|NCT00114738|464642639|FG001|Screening for Randomization|Other|0|||
129095702|NCT00114738|464642640|FG002|Screening for Randomization|Other|0|||
129095703|NCT01358578|464642645|FG000|Induction Period|Adverse Event|2|||
129095704|NCT01358578|464642646|FG001|Induction Period|Adverse Event|4|||
129095705|NCT01358578|464642647|FG002|Induction Period|Adverse Event|2|||
129095706|NCT01358578|464642648|FG003|Induction Period|Adverse Event|6|||
129095707|NCT01358578|464642649|FG004|Induction Period|Adverse Event|0|||
129095708|NCT01358578|464642650|FG005|Induction Period|Adverse Event|0|||
129095709|NCT01358578|464642645|FG000|Induction Period|Lack of Efficacy|0|||
129095710|NCT01358578|464642646|FG001|Induction Period|Lack of Efficacy|0|||
129095711|NCT01358578|464642647|FG002|Induction Period|Lack of Efficacy|9|||
129095712|NCT01358578|464642648|FG003|Induction Period|Lack of Efficacy|1|||
129095713|NCT01358578|464642649|FG004|Induction Period|Lack of Efficacy|0|||
129095714|NCT01358578|464642650|FG005|Induction Period|Lack of Efficacy|0|||
129095715|NCT01358578|464642645|FG000|Induction Period|Lost to Follow-up|0|||
129095716|NCT01358578|464642646|FG001|Induction Period|Lost to Follow-up|0|||
129095717|NCT01358578|464642647|FG002|Induction Period|Lost to Follow-up|1|||
129095718|NCT01358578|464642648|FG003|Induction Period|Lost to Follow-up|4|||
129095719|NCT01358578|464642649|FG004|Induction Period|Lost to Follow-up|0|||
129095720|NCT01358578|464642650|FG005|Induction Period|Lost to Follow-up|0|||
129095721|NCT01358578|464642645|FG000|Induction Period|Physician Decision|2|||
129095722|NCT01358578|464642646|FG001|Induction Period|Physician Decision|1|||
129095723|NCT01358578|464642647|FG002|Induction Period|Physician Decision|2|||
129095724|NCT01358578|464642648|FG003|Induction Period|Physician Decision|0|||
129095725|NCT01358578|464642649|FG004|Induction Period|Physician Decision|0|||
129095726|NCT01358578|464642650|FG005|Induction Period|Physician Decision|0|||
129095727|NCT01358578|464642645|FG000|Induction Period|Protocol Deviation|3|||
129095728|NCT01358578|464642646|FG001|Induction Period|Protocol Deviation|5|||
129095729|NCT01358578|464642647|FG002|Induction Period|Protocol Deviation|0|||
129095730|NCT01358578|464642648|FG003|Induction Period|Protocol Deviation|3|||
129095731|NCT01358578|464642649|FG004|Induction Period|Protocol Deviation|0|||
129095732|NCT01358578|464642650|FG005|Induction Period|Protocol Deviation|0|||
129095733|NCT01358578|464642645|FG000|Induction Period|technical problems|0|||
129095734|NCT01358578|464642646|FG001|Induction Period|technical problems|0|||
129095735|NCT01358578|464642647|FG002|Induction Period|technical problems|1|||
129095736|NCT01358578|464642648|FG003|Induction Period|technical problems|1|||
129095737|NCT01358578|464642649|FG004|Induction Period|technical problems|0|||
129095738|NCT01358578|464642650|FG005|Induction Period|technical problems|0|||
129095739|NCT01358578|464642645|FG000|Induction Period|Withdrawal by Subject|5|||
129095740|NCT01358578|464642646|FG001|Induction Period|Withdrawal by Subject|5|||
129095741|NCT01358578|464642647|FG002|Induction Period|Withdrawal by Subject|10|||
129095742|NCT01358578|464642648|FG003|Induction Period|Withdrawal by Subject|6|||
129095743|NCT01358578|464642649|FG004|Induction Period|Withdrawal by Subject|0|||
129095744|NCT01358578|464642650|FG005|Induction Period|Withdrawal by Subject|0|||
129095745|NCT01358578|464642645|FG000|Maintenance Period|Adverse Event|2|||
129095746|NCT01358578|464642646|FG001|Maintenance Period|Adverse Event|7|||
129095747|NCT01358578|464642647|FG002|Maintenance Period|Adverse Event|0|||
129095748|NCT01358578|464642648|FG003|Maintenance Period|Adverse Event|6|||
129095749|NCT01358578|464642649|FG004|Maintenance Period|Adverse Event|4|||
129095750|NCT01358578|464642650|FG005|Maintenance Period|Adverse Event|3|||
129095751|NCT01358578|464642645|FG000|Maintenance Period|Lack of Efficacy|10|||
129095752|NCT01358578|464642646|FG001|Maintenance Period|Lack of Efficacy|2|||
129095753|NCT01358578|464642647|FG002|Maintenance Period|Lack of Efficacy|0|||
129095754|NCT01358578|464642648|FG003|Maintenance Period|Lack of Efficacy|11|||
129095755|NCT01358578|464642649|FG004|Maintenance Period|Lack of Efficacy|3|||
129095756|NCT01358578|464642650|FG005|Maintenance Period|Lack of Efficacy|0|||
129095757|NCT01358578|464642645|FG000|Maintenance Period|Lost to Follow-up|4|||
129095758|NCT01358578|464642646|FG001|Maintenance Period|Lost to Follow-up|0|||
129095759|NCT01358578|464642647|FG002|Maintenance Period|Lost to Follow-up|0|||
129095760|NCT01358578|464642648|FG003|Maintenance Period|Lost to Follow-up|5|||
129095761|NCT01358578|464642649|FG004|Maintenance Period|Lost to Follow-up|1|||
129095762|NCT01358578|464642650|FG005|Maintenance Period|Lost to Follow-up|1|||
129095763|NCT01358578|464642645|FG000|Maintenance Period|Non-compliance with study treatment|3|||
129095764|NCT01358578|464642646|FG001|Maintenance Period|Non-compliance with study treatment|1|||
129095765|NCT01358578|464642647|FG002|Maintenance Period|Non-compliance with study treatment|0|||
129095766|NCT01358578|464642648|FG003|Maintenance Period|Non-compliance with study treatment|2|||
129095767|NCT01358578|464642649|FG004|Maintenance Period|Non-compliance with study treatment|1|||
129095768|NCT01358578|464642650|FG005|Maintenance Period|Non-compliance with study treatment|2|||
129095769|NCT01358578|464642645|FG000|Maintenance Period|Physician Decision|0|||
129095770|NCT01358578|464642646|FG001|Maintenance Period|Physician Decision|1|||
129095771|NCT01358578|464642647|FG002|Maintenance Period|Physician Decision|0|||
129095772|NCT01358578|464642648|FG003|Maintenance Period|Physician Decision|1|||
129095773|NCT01358578|464642649|FG004|Maintenance Period|Physician Decision|0|||
129095774|NCT01358578|464642650|FG005|Maintenance Period|Physician Decision|0|||
129095775|NCT01358578|464642645|FG000|Maintenance Period|Pregnancy|1|||
129095776|NCT01358578|464642646|FG001|Maintenance Period|Pregnancy|0|||
129095777|NCT01358578|464642647|FG002|Maintenance Period|Pregnancy|0|||
129095778|NCT01358578|464642648|FG003|Maintenance Period|Pregnancy|0|||
129095779|NCT01358578|464642649|FG004|Maintenance Period|Pregnancy|0|||
129095780|NCT01358578|464642650|FG005|Maintenance Period|Pregnancy|0|||
129095781|NCT01358578|464642645|FG000|Maintenance Period|Protocol deviation|7|||
129095782|NCT01358578|464642646|FG001|Maintenance Period|Protocol deviation|4|||
129095783|NCT01358578|464642647|FG002|Maintenance Period|Protocol deviation|0|||
129095784|NCT01358578|464642648|FG003|Maintenance Period|Protocol deviation|2|||
129095785|NCT01358578|464642649|FG004|Maintenance Period|Protocol deviation|2|||
129095786|NCT01358578|464642650|FG005|Maintenance Period|Protocol deviation|2|||
129095787|NCT01358578|464642645|FG000|Maintenance Period|Withdrawal by Subject|12|||
129095788|NCT01358578|464642646|FG001|Maintenance Period|Withdrawal by Subject|7|||
129095789|NCT01358578|464642647|FG002|Maintenance Period|Withdrawal by Subject|2|||
129095790|NCT01358578|464642648|FG003|Maintenance Period|Withdrawal by Subject|15|||
129095791|NCT01358578|464642649|FG004|Maintenance Period|Withdrawal by Subject|6|||
129095792|NCT01358578|464642650|FG005|Maintenance Period|Withdrawal by Subject|3|||
129095793|NCT01358578|464642645|FG000|Follow-up Period|Adverse Event|1|||
129095794|NCT01358578|464642646|FG001|Follow-up Period|Adverse Event|1|||
129095795|NCT01358578|464642647|FG002|Follow-up Period|Adverse Event|0|||
129095796|NCT01358578|464642648|FG003|Follow-up Period|Adverse Event|0|||
129095797|NCT01358578|464642649|FG004|Follow-up Period|Adverse Event|0|||
129095798|NCT01358578|464642650|FG005|Follow-up Period|Adverse Event|0|||
129095799|NCT01358578|464642645|FG000|Follow-up Period|Lack of Efficacy|3|||
129095800|NCT01358578|464642646|FG001|Follow-up Period|Lack of Efficacy|0|||
129095801|NCT01358578|464642647|FG002|Follow-up Period|Lack of Efficacy|4|||
129095802|NCT01358578|464642648|FG003|Follow-up Period|Lack of Efficacy|1|||
129095803|NCT01358578|464642649|FG004|Follow-up Period|Lack of Efficacy|0|||
129095804|NCT01358578|464642650|FG005|Follow-up Period|Lack of Efficacy|0|||
129095805|NCT01358578|464642645|FG000|Follow-up Period|Lost to Follow-up|0|||
129095806|NCT01358578|464642646|FG001|Follow-up Period|Lost to Follow-up|1|||
129095807|NCT01358578|464642647|FG002|Follow-up Period|Lost to Follow-up|0|||
129095808|NCT01358578|464642648|FG003|Follow-up Period|Lost to Follow-up|4|||
129095809|NCT01358578|464642649|FG004|Follow-up Period|Lost to Follow-up|0|||
129095810|NCT01358578|464642650|FG005|Follow-up Period|Lost to Follow-up|0|||
129095811|NCT01358578|464642645|FG000|Follow-up Period|non- compliance with study treatment|1|||
129095812|NCT01358578|464642646|FG001|Follow-up Period|non- compliance with study treatment|0|||
129095813|NCT01358578|464642647|FG002|Follow-up Period|non- compliance with study treatment|0|||
129095814|NCT01358578|464642648|FG003|Follow-up Period|non- compliance with study treatment|0|||
129095815|NCT01358578|464642649|FG004|Follow-up Period|non- compliance with study treatment|0|||
129095816|NCT01358578|464642650|FG005|Follow-up Period|non- compliance with study treatment|0|||
129095817|NCT01358578|464642645|FG000|Follow-up Period|Pregnancy|1|||
129095818|NCT01358578|464642646|FG001|Follow-up Period|Pregnancy|0|||
129095819|NCT01358578|464642647|FG002|Follow-up Period|Pregnancy|0|||
129095820|NCT01358578|464642648|FG003|Follow-up Period|Pregnancy|0|||
129095821|NCT01358578|464642649|FG004|Follow-up Period|Pregnancy|0|||
129095822|NCT01358578|464642650|FG005|Follow-up Period|Pregnancy|0|||
129095823|NCT01358578|464642645|FG000|Follow-up Period|Withdrawal by Subject|3|||
129095824|NCT01358578|464642646|FG001|Follow-up Period|Withdrawal by Subject|3|||
129095825|NCT01358578|464642647|FG002|Follow-up Period|Withdrawal by Subject|1|||
129095826|NCT01358578|464642648|FG003|Follow-up Period|Withdrawal by Subject|12|||
129095827|NCT01358578|464642649|FG004|Follow-up Period|Withdrawal by Subject|0|||
129095828|NCT01358578|464642650|FG005|Follow-up Period|Withdrawal by Subject|0|||
129095829|NCT01358578|464642645|FG000|Follow-up Period|Physician Decision|1|||
129095830|NCT01358578|464642646|FG001|Follow-up Period|Physician Decision|1|||
129095831|NCT01358578|464642647|FG002|Follow-up Period|Physician Decision|0|||
129095832|NCT01358578|464642648|FG003|Follow-up Period|Physician Decision|2|||
129095833|NCT01358578|464642649|FG004|Follow-up Period|Physician Decision|0|||
129095834|NCT01358578|464642650|FG005|Follow-up Period|Physician Decision|0|||
129095835|NCT00388297|464642651|FG000|Overall Study|Lost to Follow-up|16|||
129095836|NCT00388297|464642652|FG001|Overall Study|Lost to Follow-up|12|||
129095837|NCT00388297|464642653|FG002|Overall Study|Lost to Follow-up|11|||
129095838|NCT00388297|464642654|FG003|Overall Study|Lost to Follow-up|8|||
129095839|NCT02607280|464642655|FG000|Overall Study|Adverse Event|4|||
129095840|NCT02607280|464642656|FG001|Overall Study|Adverse Event|0|||
129095841|NCT02607280|464642655|FG000|Overall Study|Decrease in CrCl <15|0|||
129095842|NCT02607280|464642656|FG001|Overall Study|Decrease in CrCl <15|1|||
129095843|NCT00577005|464642657|FG000|Overall Study|Lost to Follow-up|3|||
129095844|NCT00577005|464642658|FG001|Overall Study|Lost to Follow-up|2|||
129095845|NCT00577005|464642657|FG000|Overall Study|Withdrawal by Subject|2|||
129095846|NCT00577005|464642658|FG001|Overall Study|Withdrawal by Subject|1|||
129095847|NCT01004432|464642659|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
129095848|NCT01004432|464642660|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129095849|NCT01004432|464642661|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129095850|NCT01004432|464642662|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129095851|NCT01004432|464642663|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129095852|NCT01004432|464642659|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
129095853|NCT01004432|464642660|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129095854|NCT01004432|464642661|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129095855|NCT01004432|464642662|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129095856|NCT01004432|464642663|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129095857|NCT01004432|464642659|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
129095858|NCT01004432|464642660|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
129095859|NCT01004432|464642661|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
128871368|NCT00680992|463824464|FG001|Overall Study|Complete Resection (as per protocol)|121|||
128871369|NCT00680992|463824465|FG002|Overall Study|Complete Resection (as per protocol)|0|||
129095860|NCT01004432|464642662|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
129095861|NCT01004432|464642663|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
129095862|NCT01004432|464642659|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
129095863|NCT01004432|464642660|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
129095864|NCT01004432|464642661|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
129095865|NCT01004432|464642662|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
128871370|NCT00680992|463824463|FG000|Overall Study|Administrative Decision|83|||
128871371|NCT00680992|463824464|FG001|Overall Study|Administrative Decision|42|||
128871372|NCT00680992|463824465|FG002|Overall Study|Administrative Decision|5|||
128871373|NCT00680992|463824463|FG000|Overall Study|End of Trial|32|||
128871374|NCT00680992|463824464|FG001|Overall Study|End of Trial|12|||
128871375|NCT00680992|463824465|FG002|Overall Study|End of Trial|3|||
128871376|NCT00680992|463824463|FG000|Overall Study|Withdrawal by Subject|33|||
128871377|NCT00680992|463824464|FG001|Overall Study|Withdrawal by Subject|11|||
128871378|NCT00680992|463824465|FG002|Overall Study|Withdrawal by Subject|1|||
128871379|NCT00680992|463824463|FG000|Overall Study|Adverse Event|21|||
128871380|NCT00680992|463824464|FG001|Overall Study|Adverse Event|19|||
128871381|NCT00680992|463824465|FG002|Overall Study|Adverse Event|1|||
128871382|NCT00680992|463824463|FG000|Overall Study|Other|19|||
128871383|NCT00680992|463824464|FG001|Overall Study|Other|14|||
128871384|NCT00680992|463824465|FG002|Overall Study|Other|1|||
128871385|NCT00680992|463824463|FG000|Overall Study|Disease Progression|21|||
128871386|NCT00680992|463824464|FG001|Overall Study|Disease Progression|9|||
128871387|NCT00680992|463824465|FG002|Overall Study|Disease Progression|0|||
129095866|NCT01004432|464642663|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
129095867|NCT01004432|464642659|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
129095868|NCT01004432|464642660|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129095869|NCT01004432|464642661|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129095870|NCT01004432|464642662|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129095871|NCT01004432|464642663|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129095872|NCT01004432|464642659|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
129095873|NCT01004432|464642660|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
129095874|NCT01004432|464642661|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
129095875|NCT01004432|464642662|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
129095876|NCT01004432|464642663|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
129095877|NCT01004432|464642659|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
129095878|NCT01004432|464642660|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
129095879|NCT01004432|464642661|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
129095880|NCT01004432|464642662|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
129095881|NCT01004432|464642663|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
129095882|NCT01004432|464642659|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
129095883|NCT01004432|464642660|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
129095884|NCT01004432|464642661|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
128871388|NCT00680992|463824463|FG000|Overall Study|Lost to Follow-up|12|||
128871389|NCT00680992|463824464|FG001|Overall Study|Lost to Follow-up|14|||
128871390|NCT00680992|463824465|FG002|Overall Study|Lost to Follow-up|0|||
129095885|NCT01004432|464642662|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
129095886|NCT01004432|464642663|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
129095887|NCT01004432|464642659|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129095888|NCT01004432|464642660|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129095889|NCT01004432|464642661|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129095890|NCT01004432|464642662|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
129095891|NCT01004432|464642663|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129095892|NCT01004432|464642659|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
129095893|NCT01004432|464642660|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
129095894|NCT01004432|464642661|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
129095895|NCT01004432|464642662|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
129095896|NCT01004432|464642663|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
128871391|NCT00680992|463824463|FG000|Overall Study|Noncompliance|4|||
128871392|NCT00680992|463824464|FG001|Overall Study|Noncompliance|6|||
128871393|NCT00680992|463824465|FG002|Overall Study|Noncompliance|0|||
128871394|NCT00680992|463824463|FG000|Overall Study|Requirement for Alternative Therapy|8|||
128871395|NCT00680992|463824464|FG001|Overall Study|Requirement for Alternative Therapy|2|||
128871396|NCT00680992|463824465|FG002|Overall Study|Requirement for Alternative Therapy|0|||
128871397|NCT00680992|463824463|FG000|Overall Study|Pregnancy|5|||
128871398|NCT00680992|463824464|FG001|Overall Study|Pregnancy|0|||
128762964|NCT01862991|463422656|FG001|Overall Study|Protocol Violation|0|||
128762965|NCT01862991|463422657|FG002|Overall Study|Protocol Violation|0|||
128762966|NCT00332332|463422658|FG000|Overall Study|Adverse Event|13|||
128762967|NCT00332332|463422658|FG000|Overall Study|Death|1|||
128762968|NCT00332332|463422658|FG000|Overall Study|Withdrawal by Subject|8|||
129095897|NCT01004432|464642659|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
129095898|NCT01004432|464642660|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
129095899|NCT01004432|464642661|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
129095900|NCT01004432|464642662|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
129095901|NCT01004432|464642663|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
129095902|NCT01004432|464642659|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
129095903|NCT01004432|464642660|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
128871399|NCT00680992|463824465|FG002|Overall Study|Pregnancy|1|||
128871400|NCT00680992|463824463|FG000|Overall Study|Death|5|||
128871401|NCT00680992|463824464|FG001|Overall Study|Death|1|||
128871402|NCT00680992|463824465|FG002|Overall Study|Death|0|||
128871403|NCT00680992|463824463|FG000|Overall Study|Ineligibility Determined|0|||
128871404|NCT00680992|463824464|FG001|Overall Study|Ineligibility Determined|1|||
128871405|NCT00680992|463824465|FG002|Overall Study|Ineligibility Determined|0|||
128871406|NCT01585155|463824466|FG000|Overall Study|Adverse Event|1|||
128871407|NCT01585155|463824466|FG000|Overall Study|Lack of Efficacy|2|||
128871408|NCT01585155|463824466|FG000|Overall Study|Worsening ulcerative colitis|2|||
128871409|NCT01397422|463824471|FG000|Overall Study|Adverse Event|0|||
128762969|NCT00332332|463422658|FG000|Overall Study|Physician Decision|1|||
128762970|NCT00332332|463422658|FG000|Overall Study|Lost to Follow-up|3|||
128762971|NCT00332332|463422658|FG000|Overall Study|Protocol deviation|4|||
128762972|NCT00332332|463422658|FG000|Overall Study|Noncompliance|2|||
128871410|NCT01397422|463824472|FG001|Overall Study|Adverse Event|3|||
128871411|NCT01397422|463824473|FG002|Overall Study|Adverse Event|3|||
128871412|NCT01397422|463824474|FG003|Overall Study|Adverse Event|8|||
128871413|NCT01397422|463824471|FG000|Overall Study|Withdrawal by Subject|1|||
128871414|NCT01397422|463824472|FG001|Overall Study|Withdrawal by Subject|0|||
128871415|NCT01397422|463824473|FG002|Overall Study|Withdrawal by Subject|0|||
128871416|NCT01397422|463824474|FG003|Overall Study|Withdrawal by Subject|0|||
128871417|NCT01397422|463824471|FG000|Overall Study|Increased bradykinesia related to PD|1|||
128871418|NCT01397422|463824472|FG001|Overall Study|Increased bradykinesia related to PD|0|||
128871419|NCT01397422|463824473|FG002|Overall Study|Increased bradykinesia related to PD|0|||
128871420|NCT01397422|463824474|FG003|Overall Study|Increased bradykinesia related to PD|0|||
128871421|NCT03772587|463824475|FG000|Overall Study|COVID-19|0|||
128871422|NCT03772587|463824476|FG001|Overall Study|COVID-19|0|||
128871423|NCT03772587|463824477|FG002|Overall Study|COVID-19|1|||
128871424|NCT03772587|463824478|FG003|Overall Study|COVID-19|1|||
128871425|NCT03772587|463824479|FG004|Overall Study|COVID-19|0|||
128871426|NCT03772587|463824475|FG000|Overall Study|Withdrawal by Subject|1|||
128871427|NCT03772587|463824476|FG001|Overall Study|Withdrawal by Subject|0|||
128871428|NCT03772587|463824477|FG002|Overall Study|Withdrawal by Subject|0|||
128871429|NCT03772587|463824478|FG003|Overall Study|Withdrawal by Subject|0|||
128871430|NCT03772587|463824479|FG004|Overall Study|Withdrawal by Subject|0|||
128871431|NCT06665919|463824481|FG000|Overall Study|Withdrawal by Subject|4|||
128871432|NCT06665919|463824482|FG001|Overall Study|Withdrawal by Subject|4|||
128871433|NCT06665919|463824483|FG002|Overall Study|Withdrawal by Subject|4|||
128871434|NCT06665919|463824481|FG000|Overall Study|Non-compliance to Treatment|4|||
128871435|NCT06665919|463824482|FG001|Overall Study|Non-compliance to Treatment|1|||
128871436|NCT06665919|463824483|FG002|Overall Study|Non-compliance to Treatment|6|||
128871437|NCT06665919|463824481|FG000|Overall Study|Lost to Follow-up|3|||
128871438|NCT06665919|463824482|FG001|Overall Study|Lost to Follow-up|0|||
128871439|NCT06665919|463824483|FG002|Overall Study|Lost to Follow-up|2|||
128871440|NCT06665919|463824481|FG000|Overall Study|Physician Decision|4|||
128871441|NCT06665919|463824482|FG001|Overall Study|Physician Decision|0|||
128871442|NCT06665919|463824483|FG002|Overall Study|Physician Decision|1|||
128871443|NCT05148962|463824484|FG000|Overall Study|Withdrawal by Subject|1|||
128871444|NCT05148962|463824485|FG001|Overall Study|Withdrawal by Subject|1|||
128871445|NCT05148962|463824486|FG002|Overall Study|Withdrawal by Subject|0|||
128871446|NCT05148962|463824487|FG003|Overall Study|Withdrawal by Subject|1|||
128871447|NCT05148962|463824488|FG004|Overall Study|Withdrawal by Subject|0|||
128871448|NCT05148962|463824484|FG000|Overall Study|Participant was early terminated per protocol|0|||
128871449|NCT05148962|463824485|FG001|Overall Study|Participant was early terminated per protocol|0|||
128871450|NCT05148962|463824486|FG002|Overall Study|Participant was early terminated per protocol|3|||
128871451|NCT05148962|463824487|FG003|Overall Study|Participant was early terminated per protocol|5|||
128871452|NCT05148962|463824488|FG004|Overall Study|Participant was early terminated per protocol|2|||
128871453|NCT05148962|463824484|FG000|Overall Study|Miscellaneous|0|||
128871454|NCT05148962|463824485|FG001|Overall Study|Miscellaneous|0|||
128871455|NCT05148962|463824486|FG002|Overall Study|Miscellaneous|0|||
128871456|NCT05148962|463824487|FG003|Overall Study|Miscellaneous|1|||
128871457|NCT05148962|463824488|FG004|Overall Study|Miscellaneous|0|||
128871458|NCT01525238|463824489|FG000|Overall Study|Withdrawal by Subject|1|||
128871459|NCT01525238|463824490|FG001|Overall Study|Withdrawal by Subject|0|||
128871460|NCT01525238|463824491|FG002|Overall Study|Withdrawal by Subject|0|||
128871461|NCT00151281|463824492|FG000|Overall Study|Not evaluable|3|||
128871462|NCT01133418|463824493|FG000|Overall Study|Lost to Follow-up|5|||
128762973|NCT00332332|463422658|FG000|Overall Study|Disease progression|2|||
128762974|NCT00332332|463422658|FG000|Overall Study|Other|18|||
128762975|NCT00332332|463422658|FG000|Overall Study|Did not receive study treatment|16|||
128762976|NCT01108458|463422659|FG000|Overall Study|Withdrawal by Subject|1|||
128762977|NCT02790073|463422660|FG000|Overall Study|Death|1|||
128762978|NCT02790073|463422660|FG000|Overall Study|Withdrawal from HD|1|||
128762979|NCT02790073|463422660|FG000|Overall Study|Withdrawal by Subject|1|||
128762980|NCT04170686|463422661|FG000|Screening|Physician Decision|12|||
128762981|NCT04170686|463422662|FG001|Screening|Physician Decision|13|||
128762982|NCT04170686|463422661|FG000|Randomization and Treatment|Lost to Follow-up|26|||
128762983|NCT04170686|463422662|FG001|Randomization and Treatment|Lost to Follow-up|15|||
128762984|NCT03328143|463422663|FG000|Overall Study|Declined|3|||
128762985|NCT03328143|463422663|FG000|Overall Study|Required increased sedation|4|||
128762986|NCT03328143|463422663|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
128762987|NCT03328143|463422663|FG000|Overall Study|Surgery cancelled|1|||
128762988|NCT02243202|463422666|FG000|Overall Study|Adverse Event|5|||
128762989|NCT02243202|463422667|FG001|Overall Study|Adverse Event|6|||
128762990|NCT02243202|463422668|FG002|Overall Study|Adverse Event|10|||
128762991|NCT02243202|463422669|FG003|Overall Study|Adverse Event|4|||
128762992|NCT02243202|463422666|FG000|Overall Study|Lost to Follow-up|9|||
128762993|NCT02243202|463422667|FG001|Overall Study|Lost to Follow-up|9|||
128762994|NCT02243202|463422668|FG002|Overall Study|Lost to Follow-up|14|||
128762995|NCT02243202|463422669|FG003|Overall Study|Lost to Follow-up|11|||
128762996|NCT02243202|463422666|FG000|Overall Study|Protocol Violation|3|||
128762997|NCT02243202|463422667|FG001|Overall Study|Protocol Violation|1|||
128762998|NCT02243202|463422668|FG002|Overall Study|Protocol Violation|2|||
128762999|NCT02243202|463422669|FG003|Overall Study|Protocol Violation|1|||
128763000|NCT02243202|463422666|FG000|Overall Study|Withdrawal by Subject|7|||
128763001|NCT02243202|463422667|FG001|Overall Study|Withdrawal by Subject|6|||
128763002|NCT02243202|463422668|FG002|Overall Study|Withdrawal by Subject|4|||
128763003|NCT02243202|463422669|FG003|Overall Study|Withdrawal by Subject|4|||
128763004|NCT02243202|463422666|FG000|Overall Study|Other|1|||
128763005|NCT02243202|463422667|FG001|Overall Study|Other|3|||
128763006|NCT02243202|463422668|FG002|Overall Study|Other|1|||
128763007|NCT02243202|463422669|FG003|Overall Study|Other|2|||
128763008|NCT02243202|463422666|FG000|Overall Study|Randomized but not received treatment|0|||
128871463|NCT01133418|463824494|FG001|Overall Study|Lost to Follow-up|6|||
128983695|NCT00450814|464228017|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
128763009|NCT02243202|463422667|FG001|Overall Study|Randomized but not received treatment|0|||
128763010|NCT02243202|463422668|FG002|Overall Study|Randomized but not received treatment|0|||
128871464|NCT04150068|463824495|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
128871465|NCT04150068|463824496|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
128871466|NCT04150068|463824497|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
128871467|NCT04150068|463824495|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
128983696|NCT00450814|464228018|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
128983697|NCT00450814|464228019|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
128983698|NCT00450814|464228020|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
128983699|NCT00450814|464228021|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
128983700|NCT00450814|464228022|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
128983701|NCT00450814|464228023|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
128983702|NCT00450814|464228024|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
128983703|NCT00450814|464228025|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
128983704|NCT00450814|464228026|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
128983705|NCT02067728|464228027|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
128983706|NCT02067728|464228028|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
128983707|NCT02067728|464228027|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
128983708|NCT02067728|464228028|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
128983709|NCT02067728|464228027|FG000|6 Month Measurements|Unable to attend|114|||
128983710|NCT02067728|464228028|FG001|6 Month Measurements|Unable to attend|97|||
128983711|NCT03602976|464228032|FG000|Overall Study|Withdrawal by Subject|1|||
128983712|NCT04837807|464228033|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
128983713|NCT04837807|464228034|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
128983714|NCT02190604|464228035|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983715|NCT02190604|464228036|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983716|NCT02190604|464228037|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983717|NCT02190604|464228038|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983718|NCT02190604|464228039|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983719|NCT02190604|464228040|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983720|NCT02190604|464228041|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983721|NCT02190604|464228042|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983722|NCT02190604|464228043|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983723|NCT02190604|464228044|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983724|NCT02190604|464228045|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983725|NCT02190604|464228046|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983726|NCT02190604|464228047|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983727|NCT02190604|464228048|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983728|NCT02190604|464228049|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
128983729|NCT02190604|464228050|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983730|NCT02190604|464228051|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983731|NCT02190604|464228052|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983732|NCT02190604|464228053|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
128983733|NCT02190604|464228035|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983734|NCT02190604|464228036|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983735|NCT02190604|464228037|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983736|NCT02190604|464228038|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983737|NCT02190604|464228039|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983738|NCT02190604|464228040|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983739|NCT02190604|464228041|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983740|NCT02190604|464228042|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983741|NCT02190604|464228043|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983742|NCT02190604|464228044|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983743|NCT02190604|464228045|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983744|NCT02190604|464228046|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983745|NCT02190604|464228047|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983746|NCT02190604|464228048|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
128983747|NCT02190604|464228049|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983748|NCT02190604|464228050|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983749|NCT02190604|464228051|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983750|NCT02190604|464228052|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983751|NCT02190604|464228053|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
128983752|NCT01484691|464228056|FG000|Overall Study|Withdrawal by Subject|1|||
128983753|NCT01484691|464228057|FG001|Overall Study|Withdrawal by Subject|1|||
128983754|NCT01484691|464228058|FG002|Overall Study|Withdrawal by Subject|1|||
128983755|NCT01484691|464228056|FG000|Overall Study|Physician Decision|0|||
128983756|NCT01484691|464228057|FG001|Overall Study|Physician Decision|2|||
128983757|NCT01484691|464228058|FG002|Overall Study|Physician Decision|1|||
128983758|NCT04095039|464228061|FG000|Overall Study|Withdrawal by Subject|2|||
128983759|NCT04095039|464228062|FG001|Overall Study|Withdrawal by Subject|16|||
128983760|NCT04095039|464228061|FG000|Overall Study|Transplanted|21|||
128983761|NCT04095039|464228062|FG001|Overall Study|Transplanted|24|||
128983762|NCT04095039|464228061|FG000|Overall Study|Transferred to Non-study Facility|47|||
128983763|NCT04095039|464228062|FG001|Overall Study|Transferred to Non-study Facility|44|||
128983764|NCT04095039|464228061|FG000|Overall Study|Withdrawal from internvention target|0|||
128871468|NCT04150068|463824496|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
128871469|NCT04150068|463824497|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
128871470|NCT05316701|463824498|FG000|Overall Study|Adverse Event|0|||
128871471|NCT05316701|463824499|FG001|Overall Study|Adverse Event|1|||
128871472|NCT05316701|463824498|FG000|Overall Study|Death|3|||
128871473|NCT05316701|463824499|FG001|Overall Study|Death|9|||
129095904|NCT01004432|464642661|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
129095905|NCT01004432|464642662|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
128871474|NCT05316701|463824498|FG000|Overall Study|Lost to Follow-up|1|||
128871475|NCT05316701|463824499|FG001|Overall Study|Lost to Follow-up|0|||
128871476|NCT05316701|463824498|FG000|Overall Study|Physician Decision|1|||
128871477|NCT05316701|463824499|FG001|Overall Study|Physician Decision|4|||
128871478|NCT05316701|463824498|FG000|Overall Study|Withdrawal by Subject|3|||
128871479|NCT05316701|463824499|FG001|Overall Study|Withdrawal by Subject|5|||
128871480|NCT05316701|463824498|FG000|Overall Study|Progression/Relapse|14|||
128871481|NCT05316701|463824499|FG001|Overall Study|Progression/Relapse|9|||
128871482|NCT05316701|463824498|FG000|Overall Study|Received Standard of Care|1|||
129095906|NCT01004432|464642663|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
129095907|NCT01004432|464642659|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129095908|NCT01004432|464642660|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129095909|NCT01004432|464642661|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129095910|NCT01004432|464642662|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129095911|NCT01004432|464642663|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
129095912|NCT01004432|464642659|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129095913|NCT01004432|464642660|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129095914|NCT01004432|464642661|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129095915|NCT01004432|464642662|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129095916|NCT01004432|464642663|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
129095917|NCT01004432|464642659|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129095918|NCT01004432|464642660|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129095919|NCT01004432|464642661|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129095920|NCT01004432|464642662|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129095921|NCT01004432|464642663|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
129095922|NCT02667626|464642664|FG000|Overall Study|Withdrawal by Subject|0|||
129095923|NCT02667626|464642665|FG001|Overall Study|Withdrawal by Subject|1|||
129095924|NCT02539134|464642667|FG000|Overall Study|Lost to Follow-up|1|||
129095925|NCT02539134|464642668|FG001|Overall Study|Lost to Follow-up|0|||
129095926|NCT02539134|464642669|FG002|Overall Study|Lost to Follow-up|0|||
129095927|NCT02539134|464642670|FG003|Overall Study|Lost to Follow-up|0|||
129095928|NCT02539134|464642671|FG004|Overall Study|Lost to Follow-up|0|||
129095929|NCT02539134|464642672|FG005|Overall Study|Lost to Follow-up|0|||
129095930|NCT02223819|464642679|FG000|Overall Study|Lost to Follow-up|2|||
129095931|NCT03435224|464642685|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
129095932|NCT00367484|464642686|FG000|Overall Study|Adverse Event|7|||
129095933|NCT00367484|464642686|FG000|Overall Study|Withdrew informed consent|5|||
129095934|NCT00367484|464642686|FG000|Overall Study|Travel to USA|1|||
129095935|NCT00367484|464642686|FG000|Overall Study|Lost to Follow-up|1|||
129095936|NCT00367484|464642686|FG000|Overall Study|Protocol Violation|1|||
129095937|NCT00367484|464642686|FG000|Overall Study|The choice of the patient|1|||
129095938|NCT00367484|464642686|FG000|Overall Study|Lack of Efficacy|1|||
129095939|NCT04472026|464642687|FG000|Overall Study|Lost to Follow-up|5|||
129095940|NCT01777295|464642688|FG000|Overall Study|Withdrawal by Subject|2|||
129095941|NCT01777295|464642689|FG001|Overall Study|Withdrawal by Subject|2|||
129095942|NCT01777295|464642688|FG000|Overall Study|Pregnancy|0|||
129095943|NCT01777295|464642689|FG001|Overall Study|Pregnancy|1|||
128983765|NCT04095039|464228062|FG001|Overall Study|Withdrawal from internvention target|2|||
128983766|NCT04095039|464228061|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
128871483|NCT05316701|463824499|FG001|Overall Study|Received Standard of Care|0|||
128871484|NCT05316701|463824498|FG000|Overall Study|Ongoing|70|||
128983767|NCT04095039|464228062|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
128871485|NCT05316701|463824499|FG001|Overall Study|Ongoing|64|||
128871486|NCT04696653|463824500|FG000|Overall Study|left organization|18|||
128871487|NCT04696653|463824500|FG000|Overall Study|Lost to Follow-up|3|||
128871488|NCT04625413|463824501|FG000|Overall Study|Hospice|2|||
128871489|NCT04625413|463824501|FG000|Overall Study|Distress|1|||
128871490|NCT04625413|463824501|FG000|Overall Study|Not feeling well|1|||
128871491|NCT04679935|463824502|FG000|Overall Study|Death|0|||
128871492|NCT04679935|463824503|FG001|Overall Study|Death|1|||
128871493|NCT02993146|463824504|FG000|Overall Study|Withdrawal by Subject|0|||
128871494|NCT02993146|463824505|FG001|Overall Study|Withdrawal by Subject|0|||
128871495|NCT02993146|463824506|FG002|Overall Study|Withdrawal by Subject|1|||
128871496|NCT02993146|463824507|FG003|Overall Study|Withdrawal by Subject|1|||
128871497|NCT04362189|463824508|FG000|Overall Study|Lost to Follow-up|0|||
128871498|NCT04362189|463824509|FG001|Overall Study|Lost to Follow-up|1|||
128871499|NCT04362189|463824508|FG000|Overall Study|Withdrawal by Subject|1|||
128871500|NCT04362189|463824509|FG001|Overall Study|Withdrawal by Subject|0|||
128871501|NCT04362189|463824508|FG000|Overall Study|FDA Clinical Hold|7|||
128871502|NCT04362189|463824509|FG001|Overall Study|FDA Clinical Hold|2|||
128871503|NCT04362189|463824508|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
128871504|NCT04362189|463824509|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
128871505|NCT04362189|463824508|FG000|Overall Study|Adverse Event|0|||
128871506|NCT04362189|463824509|FG001|Overall Study|Adverse Event|2|||
128871507|NCT04362189|463824508|FG000|Overall Study|Death|4|||
128871508|NCT04362189|463824509|FG001|Overall Study|Death|1|||
128871509|NCT02111681|463824510|FG000|Overall Study|Death|5|||
128871510|NCT02111681|463824510|FG000|Overall Study|Lack of Efficacy|2|||
128871511|NCT02111681|463824510|FG000|Overall Study|Progression of disease|4|||
128871512|NCT04349631|463824517|FG000|Overall Study|Lost to Follow-up|3|||
128871513|NCT04349631|463824517|FG000|Overall Study|Withdrawal by Subject|7|||
128871514|NCT01982448|463824518|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
128871515|NCT01982448|463824519|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
128871516|NCT01982448|463824518|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
128871517|NCT01982448|463824519|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
128871518|NCT01982448|463824518|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
128871519|NCT01982448|463824519|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
128871520|NCT01982448|463824518|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
128871521|NCT01982448|463824519|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
128871522|NCT01077271|463825940|FG000|Overall Study|Parental desire|8|||
128871523|NCT01077271|463825940|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
128871524|NCT01077271|463825940|FG000|Overall Study|Noncompliance|2|||
128871525|NCT01077271|463825940|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
128871526|NCT01077271|463825940|FG000|Overall Study|Changed doctors|2|||
128871527|NCT01077271|463825940|FG000|Overall Study|Parents thought too many injections|2|||
128871528|NCT01077271|463825940|FG000|Overall Study|End of RSV season nearly reached|1|||
128871529|NCT01077271|463825940|FG000|Overall Study|Mother unconvinced of the necessity|1|||
128871530|NCT05020327|463825941|FG000|Overall Study|Physician Decision|3|||
128871531|NCT05020327|463825942|FG001|Overall Study|Physician Decision|0|||
128871532|NCT05020327|463825943|FG002|Overall Study|Physician Decision|0|||
128871533|NCT05020327|463825941|FG000|Overall Study|Withdrawal by Subject|1|||
128871534|NCT05020327|463825942|FG001|Overall Study|Withdrawal by Subject|1|||
128871535|NCT05020327|463825943|FG002|Overall Study|Withdrawal by Subject|0|||
128871536|NCT05020327|463825941|FG000|Overall Study|personal/cultural, ineligible|12|||
128871537|NCT05020327|463825942|FG001|Overall Study|personal/cultural, ineligible|0|||
128871538|NCT05020327|463825943|FG002|Overall Study|personal/cultural, ineligible|0|||
128871539|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
128871540|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
128871541|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
128871542|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
128871543|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
128871544|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
128871545|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
128871546|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
128871547|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
128871548|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
128871549|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
128871550|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
128871551|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Death|1|||
128871552|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Death|2|||
128871553|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Death|2|||
128871554|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Death|0|||
128871555|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Death|0|||
128871556|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Death|0|||
128871557|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
128871558|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
128871559|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
128871560|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
128871561|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
128871562|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
128871563|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
128871564|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
128871565|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
128871566|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
128871567|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
128871568|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
128871569|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
128871570|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
128871571|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
128871572|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
128871573|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
128871574|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
128871575|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
128871576|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
128871577|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
128871578|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
128871579|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
128871580|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
128871581|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
128871582|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
128871583|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
128871584|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
128871585|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
128871586|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
128871587|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
128871588|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
128871589|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
128871590|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
128871591|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
128871592|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
128871593|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
128871594|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
128871595|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
128871596|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
128871597|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
128871598|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
128871599|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Site closure|0|||
128871600|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Site closure|0|||
128871601|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Site closure|1|||
128871602|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Site closure|0|||
128871603|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Site closure|0|||
128871604|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Site closure|0|||
128871605|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
128871606|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
128871607|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
128871608|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
128871609|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
128871610|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
128871611|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
128871612|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
128871613|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
128871614|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
128871615|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
128871616|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
128871617|NCT03439254|463825944|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
128871618|NCT03439254|463825945|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
128871619|NCT03439254|463825946|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
128871620|NCT03439254|463825947|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
128871621|NCT03439254|463825948|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
128871622|NCT03439254|463825949|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
128871623|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
128871624|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
128871625|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
128871626|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
128871627|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
128871628|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
128871629|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
128871630|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
128871631|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
128871632|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
128871633|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
128871634|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
128871635|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
128871636|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
128871637|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
128871638|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
128871639|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
128871640|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
128871641|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
128871642|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
128871643|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
128871644|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
128871645|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
128871646|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
128871647|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
128871648|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
128871649|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
128871650|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
128871651|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
128871652|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
128871653|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
128871654|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
128871655|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
128871656|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
128871657|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
128871658|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
128871659|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
128871660|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
128871661|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
128871662|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
128871663|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
128871664|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
128871665|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
128871666|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
128871667|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
128871668|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
128871669|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
128871670|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
128871671|NCT03439254|463825944|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
128871672|NCT03439254|463825945|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
128871673|NCT03439254|463825946|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
128871674|NCT03439254|463825947|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
128871675|NCT03439254|463825948|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
128871676|NCT03439254|463825949|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
128871677|NCT02075476|463825951|FG000|Overall Study|Death|2|||
128871678|NCT02075476|463825952|FG001|Overall Study|Death|2|||
128871679|NCT02075476|463825951|FG000|Overall Study|Lost to Follow-up|1|||
128871680|NCT02075476|463825952|FG001|Overall Study|Lost to Follow-up|3|||
128871681|NCT00095056|463825953|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
128871682|NCT00095056|463825954|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
128871683|NCT00095056|463825953|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
128871684|NCT00095056|463825954|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
128871685|NCT00095056|463825953|FG000|Phase A (Weeks 0-12)|Death|1|||
128871686|NCT00095056|463825954|FG001|Phase A (Weeks 0-12)|Death|0|||
128871687|NCT00095056|463825953|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
128871688|NCT00095056|463825954|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
128871689|NCT00095056|463825953|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
128983768|NCT04095039|464228061|FG000|Overall Study|Cacliphylaxis|0|||
128983769|NCT04095039|464228062|FG001|Overall Study|Cacliphylaxis|1|||
128983770|NCT04095039|464228061|FG000|Overall Study|Pregnancy|1|||
128983771|NCT04095039|464228062|FG001|Overall Study|Pregnancy|0|||
128983772|NCT03205605|464228063|FG000|Overall Study|Withdrawal by Subject|1|||
128983773|NCT03328325|464228064|FG000|Overall Study|Lost to Follow-up|4|||
128983774|NCT03328325|464228064|FG000|Overall Study|Physician Decision|1|||
128983775|NCT03328325|464228064|FG000|Overall Study|Withdrawal by Subject|3|||
128983776|NCT03328325|464228064|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
128983777|NCT00736840|464228066|FG000|Overall Study|Lost to Follow-up|13|||
128983778|NCT01990339|464228069|FG000|Overall Study|Data Not Available|49|||
128983779|NCT01990339|464228069|FG000|Overall Study|Voluntary Withdrawal|1402|||
128983780|NCT01990339|464228069|FG000|Overall Study|Lost to Follow-up|861|||
128983781|NCT01038609|464228070|FG000|Overall Study|Adverse Event|0|||
128983782|NCT01038609|464228071|FG001|Overall Study|Adverse Event|0|||
128983783|NCT01038609|464228072|FG002|Overall Study|Adverse Event|1|||
128983784|NCT01038609|464228073|FG003|Overall Study|Adverse Event|0|||
128983785|NCT01038609|464228074|FG004|Overall Study|Adverse Event|0|||
128983786|NCT01038609|464228070|FG000|Overall Study|Dosing Error|0|||
128983787|NCT01038609|464228071|FG001|Overall Study|Dosing Error|0|||
128983788|NCT01038609|464228072|FG002|Overall Study|Dosing Error|0|||
128983789|NCT01038609|464228073|FG003|Overall Study|Dosing Error|1|||
128983790|NCT01038609|464228074|FG004|Overall Study|Dosing Error|1|||
128983791|NCT01038609|464228070|FG000|Overall Study|Death in the Family|1|||
128983792|NCT01038609|464228071|FG001|Overall Study|Death in the Family|0|||
128983793|NCT01038609|464228072|FG002|Overall Study|Death in the Family|0|||
128983794|NCT01038609|464228073|FG003|Overall Study|Death in the Family|0|||
128983795|NCT01038609|464228074|FG004|Overall Study|Death in the Family|0|||
128983796|NCT01038609|464228070|FG000|Overall Study|Refusal of Blood Draws|0|||
128983797|NCT01038609|464228071|FG001|Overall Study|Refusal of Blood Draws|1|||
128983798|NCT01038609|464228072|FG002|Overall Study|Refusal of Blood Draws|0|||
128983799|NCT01038609|464228073|FG003|Overall Study|Refusal of Blood Draws|0|||
128983800|NCT01038609|464228074|FG004|Overall Study|Refusal of Blood Draws|0|||
128983801|NCT02309372|464228075|FG000|Overall Study|Lost to Follow-up|3|||
128983802|NCT02309372|464228076|FG001|Overall Study|Lost to Follow-up|2|||
128983803|NCT01590810|464228078|FG000|Overall Study|Physician Decision|0|||
128983804|NCT01590810|464228079|FG001|Overall Study|Physician Decision|1|||
128983805|NCT01590810|464228080|FG002|Overall Study|Physician Decision|1|||
128983806|NCT01590810|464228081|FG003|Overall Study|Physician Decision|0|||
128983807|NCT01590810|464228082|FG004|Overall Study|Physician Decision|0|||
128983808|NCT02400281|464228083|FG000|Overall Study|Adverse Event|0|||
128983809|NCT02400281|464228084|FG001|Overall Study|Adverse Event|0|||
128983810|NCT02400281|464228085|FG002|Overall Study|Adverse Event|1|||
128983811|NCT02400281|464228086|FG003|Overall Study|Adverse Event|0|||
128983812|NCT02400281|464228087|FG004|Overall Study|Adverse Event|1|||
128983813|NCT02400281|464228088|FG005|Overall Study|Adverse Event|0|||
128871690|NCT00095056|463825954|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
128871691|NCT00095056|463825953|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
128871692|NCT00095056|463825954|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
128871693|NCT00095056|463825953|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
128871694|NCT00095056|463825954|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
128871695|NCT00095056|463825953|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
128871696|NCT00095056|463825954|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
128871697|NCT00095056|463825953|FG000|Phase B (Weeks 12-54)|Death|3|||
128871698|NCT00095056|463825954|FG001|Phase B (Weeks 12-54)|Death|1|||
128871699|NCT00095056|463825953|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
128871700|NCT00095056|463825954|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
128871701|NCT00095056|463825953|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
128871702|NCT00095056|463825954|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
128871703|NCT00923260|463825960|FG000|Overall Study|Lost to Follow-up|1|||
128871704|NCT00923260|463825961|FG001|Overall Study|Lost to Follow-up|1|||
128871705|NCT00836745|463825965|FG000|Overall Study|Death|2|||
128871706|NCT00836745|463825965|FG000|Overall Study|Lost to Follow-up|10|||
128871707|NCT00836745|463825965|FG000|Overall Study|Adverse Event|3|||
128871708|NCT00836745|463825965|FG000|Overall Study|Objective progression or relapse|4|||
128871709|NCT00836745|463825965|FG000|Overall Study|Other|2|||
128871710|NCT02898077|463825967|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
128871711|NCT02898077|463825968|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
128871712|NCT02898077|463825967|FG000|Overall Study|Lost to Follow-up|4|||
128871713|NCT02898077|463825968|FG001|Overall Study|Lost to Follow-up|3|||
128871714|NCT02898077|463825967|FG000|Overall Study|Physician Decision|0|||
128871715|NCT02898077|463825968|FG001|Overall Study|Physician Decision|2|||
128871716|NCT02898077|463825967|FG000|Overall Study|Sponsor Decision|32|||
128871717|NCT02898077|463825968|FG001|Overall Study|Sponsor Decision|13|||
128871718|NCT02898077|463825967|FG000|Overall Study|Withdrawal by Subject|6|||
128871719|NCT02898077|463825968|FG001|Overall Study|Withdrawal by Subject|3|||
128871720|NCT02898077|463825967|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
128871721|NCT02898077|463825968|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
128871722|NCT02898077|463825967|FG000|Overall Study|Ended extension period|3|||
128871723|NCT02898077|463825968|FG001|Overall Study|Ended extension period|0|||
128871724|NCT00621777|463825969|FG000|Open Phase|Adverse Event|20|||
128871725|NCT00621777|463825970|FG001|Open Phase|Adverse Event|0|||
128871726|NCT00621777|463825969|FG000|Open Phase|Did not abstain during open phase|56|||
128871727|NCT00621777|463825970|FG001|Open Phase|Did not abstain during open phase|0|||
128871728|NCT00621777|463825969|FG000|Open Phase|Withdrawal by Subject|17|||
128871729|NCT00621777|463825970|FG001|Open Phase|Withdrawal by Subject|0|||
128871730|NCT00621777|463825969|FG000|Open Phase|administrative|13|||
128871731|NCT00621777|463825970|FG001|Open Phase|administrative|0|||
128871732|NCT00621777|463825969|FG000|Open Phase|Lost to Follow-up|10|||
128871733|NCT00621777|463825970|FG001|Open Phase|Lost to Follow-up|0|||
128871734|NCT00621777|463825969|FG000|Randomized Phase|Adverse Event|3|||
128871735|NCT00621777|463825970|FG001|Randomized Phase|Adverse Event|3|||
128871736|NCT00621777|463825969|FG000|Randomized Phase|Lost to Follow-up|3|||
128871737|NCT00621777|463825970|FG001|Randomized Phase|Lost to Follow-up|3|||
128871738|NCT00621777|463825969|FG000|Randomized Phase|Withdrawal by Subject|1|||
128871739|NCT00621777|463825970|FG001|Randomized Phase|Withdrawal by Subject|9|||
128871740|NCT00621777|463825969|FG000|Randomized Phase|administrative|0|||
128871741|NCT00621777|463825970|FG001|Randomized Phase|administrative|3|||
128871742|NCT00621777|463825969|FG000|Randomized Phase|Death|0|||
128871743|NCT00621777|463825970|FG001|Randomized Phase|Death|1|||
128871744|NCT01239043|463825971|FG000|Overall Study|Protocol Violation|2|||
128871745|NCT01239043|463825972|FG001|Overall Study|Protocol Violation|1|||
128871746|NCT02121301|463825975|FG000|Overall Study|Protocol Violation|1|||
128871747|NCT02121301|463825976|FG001|Overall Study|Protocol Violation|4|||
128871748|NCT02121301|463825977|FG002|Overall Study|Protocol Violation|1|||
128871749|NCT02663518|463825981|FG000|Part 1: Phase 1a Escalation|Death|0|||
128871750|NCT02663518|463825982|FG001|Part 1: Phase 1a Escalation|Death|0|||
128871751|NCT02663518|463825983|FG002|Part 1: Phase 1a Escalation|Death|1|||
128871752|NCT02663518|463825984|FG003|Part 1: Phase 1a Escalation|Death|0|||
128871753|NCT02663518|463825985|FG004|Part 1: Phase 1a Escalation|Death|0|||
128871754|NCT02663518|463825986|FG005|Part 1: Phase 1a Escalation|Death|0|||
128871755|NCT02663518|463825987|FG006|Part 1: Phase 1a Escalation|Death|0|||
128871756|NCT02663518|463825988|FG007|Part 1: Phase 1a Escalation|Death|0|||
128871757|NCT02663518|463825989|FG008|Part 1: Phase 1a Escalation|Death|0|||
128871758|NCT02663518|463825990|FG009|Part 1: Phase 1a Escalation|Death|0|||
128871759|NCT02663518|463825991|FG010|Part 1: Phase 1a Escalation|Death|0|||
128871760|NCT02663518|463825992|FG011|Part 1: Phase 1a Escalation|Death|0|||
128871761|NCT02663518|463825993|FG012|Part 1: Phase 1a Escalation|Death|0|||
128871762|NCT02663518|463825994|FG013|Part 1: Phase 1a Escalation|Death|0|||
128871763|NCT02663518|463825981|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871764|NCT02663518|463825982|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871765|NCT02663518|463825983|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
128871766|NCT02663518|463825984|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871767|NCT02663518|463825985|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128983814|NCT02400281|464228083|FG000|Overall Study|Physician Decision|0|||
128983815|NCT02400281|464228084|FG001|Overall Study|Physician Decision|0|||
128983816|NCT02400281|464228085|FG002|Overall Study|Physician Decision|1|||
128983817|NCT02400281|464228086|FG003|Overall Study|Physician Decision|0|||
128871768|NCT02663518|463825986|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871769|NCT02663518|463825987|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871770|NCT02663518|463825988|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871771|NCT02663518|463825989|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871772|NCT02663518|463825990|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871773|NCT02663518|463825991|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871774|NCT02663518|463825992|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871775|NCT02663518|463825993|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871776|NCT02663518|463825994|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
128871777|NCT02663518|463825981|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
128871778|NCT02663518|463825982|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
128871779|NCT02663518|463825983|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
128871780|NCT02663518|463825984|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
128871781|NCT02663518|463825985|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871782|NCT02663518|463825986|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871783|NCT02663518|463825987|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871784|NCT02663518|463825988|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871785|NCT02663518|463825989|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128983818|NCT02400281|464228087|FG004|Overall Study|Physician Decision|0|||
128983819|NCT02400281|464228088|FG005|Overall Study|Physician Decision|0|||
128983820|NCT00412360|464228089|FG000|Overall Study|Lost to Follow-up|0|||
128983821|NCT00412360|464228090|FG001|Overall Study|Lost to Follow-up|1|||
128983822|NCT00412360|464228089|FG000|Overall Study|Not Transplanted|1|||
128983823|NCT00412360|464228090|FG001|Overall Study|Not Transplanted|2|||
128983824|NCT03655951|464228092|FG000|Overall Study|Lost to Follow-up|39|||
128983825|NCT03655951|464228093|FG001|Overall Study|Lost to Follow-up|20|||
128983826|NCT03655951|464228092|FG000|Overall Study|Withdrawal by Subject|0|||
128983827|NCT03655951|464228093|FG001|Overall Study|Withdrawal by Subject|1|||
128983828|NCT02811640|464228094|FG000|Overall Study|Technology malfunction|2|||
128983829|NCT00553319|464228096|FG000|Overall Study|Lost to Follow-up|10|||
128983830|NCT00553319|464228097|FG001|Overall Study|Lost to Follow-up|9|||
128983831|NCT00553319|464228098|FG002|Overall Study|Lost to Follow-up|5|||
128983832|NCT00553319|464228096|FG000|Overall Study|wanted treatment elsewhere|2|||
128983833|NCT00553319|464228097|FG001|Overall Study|wanted treatment elsewhere|1|||
128983834|NCT00553319|464228098|FG002|Overall Study|wanted treatment elsewhere|1|||
128983835|NCT00553319|464228096|FG000|Overall Study|non-compliance|0|||
128983836|NCT00553319|464228097|FG001|Overall Study|non-compliance|0|||
128983837|NCT00553319|464228098|FG002|Overall Study|non-compliance|2|||
128983838|NCT00553319|464228096|FG000|Overall Study|incarceration|1|||
128983839|NCT00553319|464228097|FG001|Overall Study|incarceration|0|||
128983840|NCT00553319|464228098|FG002|Overall Study|incarceration|0|||
128983841|NCT00553319|464228096|FG000|Overall Study|moved|1|||
128983842|NCT00553319|464228097|FG001|Overall Study|moved|0|||
128983843|NCT00553319|464228098|FG002|Overall Study|moved|1|||
128983844|NCT02441517|464228105|FG000|Overall Study|Lost to Follow-up|1|||
128983845|NCT02441517|464228105|FG000|Overall Study|Withdrawal by Subject|2|||
128983846|NCT02441517|464228105|FG000|Overall Study|Study Terminated by Sponsor|1|||
128983847|NCT01393444|464228106|FG000|Overall Study|Withdrawal by Subject|1|||
128983848|NCT01393444|464228106|FG000|Overall Study|Determined ineligible during screening.|2|||
128983849|NCT02569996|464228107|FG000|Overall Study|Adverse Event|6|||
128983850|NCT02569996|464228107|FG000|Overall Study|Physician Decision|3|||
128983851|NCT02569996|464228107|FG000|Overall Study|Progression of the disease|18|||
128983852|NCT02569996|464228107|FG000|Overall Study|New anti-lymphoma treatment|1|||
128983853|NCT02569996|464228107|FG000|Overall Study|Non-compliance|9|||
128983854|NCT02569996|464228107|FG000|Overall Study|Withdrawal by Subject|5|||
128983855|NCT02569996|464228107|FG000|Overall Study|Lost to Follow-up|5|||
128983856|NCT02569996|464228107|FG000|Overall Study|Complete remission|7|||
128983857|NCT02569996|464228107|FG000|Overall Study|Unknown reason|1|||
128983858|NCT01349816|464228110|FG000|Overall Study|Withdrawal by Subject|4|||
128983859|NCT01349816|464228110|FG000|Overall Study|Physician Decision|1|||
128983860|NCT01349816|464228110|FG000|Overall Study|Adverse Event|14|||
128983861|NCT01349816|464228110|FG000|Overall Study|Lost to Follow-up|2|||
128871786|NCT02663518|463825990|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128983862|NCT01349816|464228110|FG000|Overall Study|Protocol Violation|1|||
128983863|NCT01349816|464228110|FG000|Overall Study|Protocol-specified criteria|8|||
128983864|NCT01397409|464228113|FG000|Stage 2|Adverse Event|0|||
128983865|NCT01397409|464228114|FG001|Stage 2|Adverse Event|0|||
128983866|NCT01397409|464228115|FG002|Stage 2|Adverse Event|0|||
128983867|NCT01397409|464228116|FG003|Stage 2|Adverse Event|0|||
128983868|NCT01397409|464228117|FG004|Stage 2|Adverse Event|6|||
128983869|NCT01397409|464228118|FG005|Stage 2|Adverse Event|3|||
128983870|NCT01397409|464228119|FG006|Stage 2|Adverse Event|0|||
128983871|NCT01397409|464228120|FG007|Stage 2|Adverse Event|0|||
128983872|NCT01397409|464228121|FG008|Stage 2|Adverse Event|0|||
128871787|NCT02663518|463825991|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871788|NCT02663518|463825992|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871789|NCT02663518|463825993|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871790|NCT02663518|463825994|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
128871791|NCT02663518|463825981|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
128871792|NCT02663518|463825982|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871793|NCT02663518|463825983|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
128871794|NCT02663518|463825984|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
128871795|NCT02663518|463825985|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871796|NCT02663518|463825986|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871797|NCT02663518|463825987|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871798|NCT02663518|463825988|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871799|NCT02663518|463825989|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871800|NCT02663518|463825990|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871801|NCT02663518|463825991|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871802|NCT02663518|463825992|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871803|NCT02663518|463825993|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871804|NCT02663518|463825994|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
128871805|NCT02663518|463825981|FG000|Part 1: Phase 1a Escalation|Other|0|||
128871806|NCT02663518|463825982|FG001|Part 1: Phase 1a Escalation|Other|0|||
128871807|NCT02663518|463825983|FG002|Part 1: Phase 1a Escalation|Other|2|||
128871808|NCT02663518|463825984|FG003|Part 1: Phase 1a Escalation|Other|0|||
128871809|NCT02663518|463825985|FG004|Part 1: Phase 1a Escalation|Other|0|||
128871810|NCT02663518|463825986|FG005|Part 1: Phase 1a Escalation|Other|0|||
128871811|NCT02663518|463825987|FG006|Part 1: Phase 1a Escalation|Other|0|||
128871812|NCT02663518|463825988|FG007|Part 1: Phase 1a Escalation|Other|0|||
128871813|NCT02663518|463825989|FG008|Part 1: Phase 1a Escalation|Other|0|||
128871814|NCT02663518|463825990|FG009|Part 1: Phase 1a Escalation|Other|0|||
128871815|NCT02663518|463825991|FG010|Part 1: Phase 1a Escalation|Other|0|||
128871816|NCT02663518|463825992|FG011|Part 1: Phase 1a Escalation|Other|0|||
128871817|NCT02663518|463825993|FG012|Part 1: Phase 1a Escalation|Other|0|||
128871818|NCT02663518|463825994|FG013|Part 1: Phase 1a Escalation|Other|0|||
128871819|NCT02663518|463825981|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871820|NCT02663518|463825982|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871821|NCT02663518|463825983|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871822|NCT02663518|463825984|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871823|NCT02663518|463825985|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
128871824|NCT02663518|463825986|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871825|NCT02663518|463825987|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
128871826|NCT02663518|463825988|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
128871827|NCT02663518|463825989|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871828|NCT02663518|463825990|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871829|NCT02663518|463825991|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871830|NCT02663518|463825992|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871831|NCT02663518|463825993|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871832|NCT02663518|463825994|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
128871833|NCT02663518|463825981|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871834|NCT02663518|463825982|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871835|NCT02663518|463825983|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871836|NCT02663518|463825984|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871837|NCT02663518|463825985|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
128871838|NCT02663518|463825986|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871839|NCT02663518|463825987|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
128871840|NCT02663518|463825988|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
128871841|NCT02663518|463825989|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871842|NCT02663518|463825990|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871843|NCT02663518|463825991|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871844|NCT02663518|463825992|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871845|NCT02663518|463825993|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871846|NCT02663518|463825994|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
128871847|NCT02663518|463825981|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871848|NCT02663518|463825982|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871849|NCT02663518|463825983|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871850|NCT02663518|463825984|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871851|NCT02663518|463825985|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
128871852|NCT02663518|463825986|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871853|NCT02663518|463825987|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871854|NCT02663518|463825988|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871855|NCT02663518|463825989|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871856|NCT02663518|463825990|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871857|NCT02663518|463825991|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871858|NCT02663518|463825992|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871859|NCT02663518|463825993|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871860|NCT02663518|463825994|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
128871861|NCT02663518|463825981|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871862|NCT02663518|463825982|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871863|NCT02663518|463825983|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871864|NCT02663518|463825984|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871865|NCT02663518|463825985|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
128871866|NCT02663518|463825986|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
128871867|NCT02663518|463825987|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
128871868|NCT02663518|463825988|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
128871869|NCT02663518|463825989|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871870|NCT02663518|463825990|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871871|NCT02663518|463825991|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871872|NCT02663518|463825992|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871873|NCT02663518|463825993|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871874|NCT02663518|463825994|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
128871875|NCT02663518|463825981|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871876|NCT02663518|463825982|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871877|NCT02663518|463825983|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871878|NCT02663518|463825984|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871879|NCT02663518|463825985|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
128871880|NCT02663518|463825986|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871881|NCT02663518|463825987|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
128871882|NCT02663518|463825988|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871883|NCT02663518|463825989|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871884|NCT02663518|463825990|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871885|NCT02663518|463825991|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871886|NCT02663518|463825992|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871887|NCT02663518|463825993|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871888|NCT02663518|463825994|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
128871889|NCT02663518|463825981|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871890|NCT02663518|463825982|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871891|NCT02663518|463825983|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871892|NCT02663518|463825984|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871893|NCT02663518|463825985|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871894|NCT02663518|463825986|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871895|NCT02663518|463825987|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
128871896|NCT02663518|463825988|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871897|NCT02663518|463825989|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871898|NCT02663518|463825990|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871899|NCT02663518|463825991|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871900|NCT02663518|463825992|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871901|NCT02663518|463825993|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871902|NCT02663518|463825994|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
128871903|NCT02663518|463825981|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
128871904|NCT02663518|463825982|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
128871905|NCT02663518|463825983|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
128871906|NCT02663518|463825984|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
128871907|NCT02663518|463825985|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
128871908|NCT02663518|463825986|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
128871909|NCT02663518|463825987|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
128871910|NCT02663518|463825988|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
128871911|NCT02663518|463825989|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
128871912|NCT02663518|463825990|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
128871913|NCT02663518|463825991|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
128871914|NCT02663518|463825992|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
128871915|NCT02663518|463825993|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
128871916|NCT02663518|463825994|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
128871917|NCT02663518|463825981|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871918|NCT02663518|463825982|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871919|NCT02663518|463825983|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871920|NCT02663518|463825984|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871921|NCT02663518|463825985|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871922|NCT02663518|463825986|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871923|NCT02663518|463825987|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128983873|NCT01397409|464228122|FG009|Stage 2|Adverse Event|0|||
128983874|NCT01397409|464228113|FG000|Stage 2|Personal Reasons|0|||
128983875|NCT01397409|464228114|FG001|Stage 2|Personal Reasons|0|||
128983876|NCT01397409|464228115|FG002|Stage 2|Personal Reasons|0|||
128983877|NCT01397409|464228116|FG003|Stage 2|Personal Reasons|0|||
128983878|NCT01397409|464228117|FG004|Stage 2|Personal Reasons|1|||
128983879|NCT01397409|464228118|FG005|Stage 2|Personal Reasons|0|||
128983880|NCT01397409|464228119|FG006|Stage 2|Personal Reasons|0|||
128983881|NCT01397409|464228120|FG007|Stage 2|Personal Reasons|0|||
128871924|NCT02663518|463825988|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128983882|NCT01397409|464228121|FG008|Stage 2|Personal Reasons|0|||
128983883|NCT01397409|464228122|FG009|Stage 2|Personal Reasons|0|||
128983884|NCT01397409|464228113|FG000|Stage 2|Other Miscellaneous Reasons|0|||
128983885|NCT01397409|464228114|FG001|Stage 2|Other Miscellaneous Reasons|0|||
128983886|NCT01397409|464228115|FG002|Stage 2|Other Miscellaneous Reasons|0|||
128983887|NCT01397409|464228116|FG003|Stage 2|Other Miscellaneous Reasons|0|||
128983888|NCT01397409|464228117|FG004|Stage 2|Other Miscellaneous Reasons|1|||
128983889|NCT01397409|464228118|FG005|Stage 2|Other Miscellaneous Reasons|1|||
128983890|NCT01397409|464228119|FG006|Stage 2|Other Miscellaneous Reasons|0|||
128983891|NCT01397409|464228120|FG007|Stage 2|Other Miscellaneous Reasons|0|||
128983892|NCT01397409|464228121|FG008|Stage 2|Other Miscellaneous Reasons|0|||
128983893|NCT01397409|464228122|FG009|Stage 2|Other Miscellaneous Reasons|0|||
128983894|NCT01397409|464228113|FG000|Stage 3|Adverse Event|0|||
128983895|NCT01397409|464228114|FG001|Stage 3|Adverse Event|0|||
128983896|NCT01397409|464228115|FG002|Stage 3|Adverse Event|0|||
128983897|NCT01397409|464228116|FG003|Stage 3|Adverse Event|0|||
128871925|NCT02663518|463825989|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871926|NCT02663518|463825990|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871927|NCT02663518|463825991|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871928|NCT02663518|463825992|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871929|NCT02663518|463825993|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
128871930|NCT02663518|463825994|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
128871931|NCT02663518|463825981|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871932|NCT02663518|463825982|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871933|NCT02663518|463825983|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871934|NCT02663518|463825984|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871935|NCT02663518|463825985|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871936|NCT02663518|463825986|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871937|NCT02663518|463825987|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871938|NCT02663518|463825988|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871939|NCT02663518|463825989|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871940|NCT02663518|463825990|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871941|NCT02663518|463825991|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871942|NCT02663518|463825992|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
128871943|NCT02663518|463825993|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871944|NCT02663518|463825994|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
128871945|NCT02663518|463825981|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871946|NCT02663518|463825982|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871947|NCT02663518|463825983|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871948|NCT02663518|463825984|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871949|NCT02663518|463825985|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871950|NCT02663518|463825986|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871951|NCT02663518|463825987|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871952|NCT02663518|463825988|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871953|NCT02663518|463825989|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871954|NCT02663518|463825990|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
128871955|NCT02663518|463825991|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
128871956|NCT02663518|463825992|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
128871957|NCT02663518|463825993|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
128871958|NCT02663518|463825994|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
128871959|NCT02663518|463825981|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
128983898|NCT01397409|464228117|FG004|Stage 3|Adverse Event|0|||
128983899|NCT01397409|464228118|FG005|Stage 3|Adverse Event|0|||
128983900|NCT01397409|464228119|FG006|Stage 3|Adverse Event|0|||
128983901|NCT01397409|464228120|FG007|Stage 3|Adverse Event|1|||
128871960|NCT02663518|463825982|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
128871961|NCT02663518|463825983|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
128871962|NCT02663518|463825984|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
128871963|NCT02663518|463825985|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
128983902|NCT01397409|464228121|FG008|Stage 3|Adverse Event|0|||
128983903|NCT01397409|464228122|FG009|Stage 3|Adverse Event|0|||
128983904|NCT01397409|464228113|FG000|Stage 3|Other Miscellaneous Reasons|0|||
128871964|NCT02663518|463825986|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
128871965|NCT02663518|463825987|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
128871966|NCT02663518|463825988|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
128871967|NCT02663518|463825989|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
128871968|NCT02663518|463825990|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
128871969|NCT02663518|463825991|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
128871970|NCT02663518|463825992|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
128871971|NCT02663518|463825993|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
128871972|NCT02663518|463825994|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
128871973|NCT02663518|463825981|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871974|NCT02663518|463825982|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871975|NCT02663518|463825983|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871976|NCT02663518|463825984|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871977|NCT02663518|463825985|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871978|NCT02663518|463825986|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871979|NCT02663518|463825987|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871980|NCT02663518|463825988|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871981|NCT02663518|463825989|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871982|NCT02663518|463825990|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871983|NCT02663518|463825991|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871984|NCT02663518|463825992|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871985|NCT02663518|463825993|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
128871986|NCT02663518|463825994|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
128871987|NCT03896152|463826000|FG000|Overall Study|Patient/guardian decision|1|||
128871988|NCT03896152|463826001|FG001|Overall Study|Patient/guardian decision|1|||
128871989|NCT03896152|463826000|FG000|Overall Study|Adverse Event|0|||
128871990|NCT03896152|463826001|FG001|Overall Study|Adverse Event|1|||
128871991|NCT03896152|463826000|FG000|Overall Study|Physician Decision|1|||
128871992|NCT03896152|463826001|FG001|Overall Study|Physician Decision|0|||
128871993|NCT03896152|463826000|FG000|Overall Study|Technical problems|1|||
128871994|NCT03896152|463826001|FG001|Overall Study|Technical problems|0|||
128871995|NCT00436852|463826002|FG000|Overall Study|Death|23|||
128871996|NCT00436852|463826003|FG001|Overall Study|Death|34|||
128871997|NCT00436852|463826002|FG000|Overall Study|Lack of Efficacy|9|||
128871998|NCT00436852|463826003|FG001|Overall Study|Lack of Efficacy|7|||
128871999|NCT00436852|463826002|FG000|Overall Study|Withdrawal by Subject|2|||
128872000|NCT00436852|463826003|FG001|Overall Study|Withdrawal by Subject|4|||
128872001|NCT00436852|463826002|FG000|Overall Study|Ineligible|1|||
128872002|NCT00436852|463826003|FG001|Overall Study|Ineligible|0|||
128872003|NCT00943852|463826004|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872004|NCT00943852|463826005|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872005|NCT00943852|463826006|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872006|NCT00943852|463826007|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
128872007|NCT00943852|463826008|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872008|NCT00943852|463826009|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872009|NCT00943852|463826010|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872010|NCT00943852|463826011|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872011|NCT00943852|463826012|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872012|NCT00943852|463826013|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
128872013|NCT00943852|463826004|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872014|NCT00943852|463826005|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872015|NCT00943852|463826006|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872016|NCT00943852|463826007|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872017|NCT00943852|463826008|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872018|NCT00943852|463826009|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
128872019|NCT00943852|463826010|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872020|NCT00943852|463826011|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872021|NCT00943852|463826012|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872022|NCT00943852|463826013|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
128872023|NCT00943852|463826004|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128872024|NCT00943852|463826005|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128872025|NCT00943852|463826006|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128983905|NCT01397409|464228114|FG001|Stage 3|Other Miscellaneous Reasons|0|||
128872026|NCT00943852|463826007|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128872027|NCT00943852|463826008|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129095944|NCT01777295|464642688|FG000|Overall Study|Personal problem|1|||
128983906|NCT01397409|464228115|FG002|Stage 3|Other Miscellaneous Reasons|0|||
128983907|NCT01397409|464228116|FG003|Stage 3|Other Miscellaneous Reasons|0|||
128983908|NCT01397409|464228117|FG004|Stage 3|Other Miscellaneous Reasons|0|||
128983909|NCT01397409|464228118|FG005|Stage 3|Other Miscellaneous Reasons|0|||
128983910|NCT01397409|464228119|FG006|Stage 3|Other Miscellaneous Reasons|0|||
128983911|NCT01397409|464228120|FG007|Stage 3|Other Miscellaneous Reasons|1|||
128983912|NCT01397409|464228121|FG008|Stage 3|Other Miscellaneous Reasons|0|||
128983913|NCT01397409|464228122|FG009|Stage 3|Other Miscellaneous Reasons|0|||
128983914|NCT01207427|464228123|FG000|Double-blind Treatment Period|Adverse Event|0|||
128983915|NCT01207427|464228124|FG001|Double-blind Treatment Period|Adverse Event|1|||
128983916|NCT01207427|464228125|FG002|Double-blind Treatment Period|Adverse Event|0|||
128983917|NCT01207427|464228123|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
128983918|NCT01207427|464228124|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
128983919|NCT01207427|464228125|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
128983920|NCT01207427|464228123|FG000|Double-blind Treatment Period|Protocol Violation|2|||
128983921|NCT01207427|464228124|FG001|Double-blind Treatment Period|Protocol Violation|1|||
128983922|NCT01207427|464228125|FG002|Double-blind Treatment Period|Protocol Violation|1|||
128983923|NCT01207427|464228123|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
128983924|NCT01207427|464228124|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
128983925|NCT01207427|464228125|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
128983926|NCT01018680|464229389|FG000|Overall Study|Adverse Event|23|||
128983927|NCT01018680|464229390|FG001|Overall Study|Adverse Event|40|||
128983928|NCT01018680|464229389|FG000|Overall Study|Withdrawal by Subject|10|||
128983929|NCT01018680|464229390|FG001|Overall Study|Withdrawal by Subject|10|||
128983930|NCT01018680|464229389|FG000|Overall Study|Protocol Violation|5|||
128983931|NCT01018680|464229390|FG001|Overall Study|Protocol Violation|8|||
128983932|NCT01018680|464229389|FG000|Overall Study|Sponsor Decision|6|||
128983933|NCT01018680|464229390|FG001|Overall Study|Sponsor Decision|7|||
128983934|NCT01018680|464229389|FG000|Overall Study|Lack of Efficacy|8|||
128983935|NCT01018680|464229390|FG001|Overall Study|Lack of Efficacy|2|||
128983936|NCT01018680|464229389|FG000|Overall Study|Lost to Follow-up|5|||
128983937|NCT01018680|464229390|FG001|Overall Study|Lost to Follow-up|3|||
128983938|NCT01018680|464229389|FG000|Overall Study|Entry Criteria Not Met|1|||
128983939|NCT01018680|464229390|FG001|Overall Study|Entry Criteria Not Met|4|||
128983940|NCT01018680|464229389|FG000|Overall Study|Physician Decision|3|||
128983941|NCT01018680|464229390|FG001|Overall Study|Physician Decision|1|||
128983942|NCT02930889|464229391|FG000|Overall Study|Lost to Follow-up|2|||
128983943|NCT02930889|464229391|FG000|Overall Study|Withdrawal by Subject|6|||
128983944|NCT02930889|464229391|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
128983945|NCT00198107|464229397|FG000|Double-Blind Period|Adverse Event|1|||
128983946|NCT00198107|464229398|FG001|Double-Blind Period|Adverse Event|1|||
128983947|NCT00198107|464229399|FG002|Double-Blind Period|Adverse Event|0|||
128983948|NCT00198107|464229397|FG000|Double-Blind Period|Lack of Efficacy|2|||
128983949|NCT00198107|464229398|FG001|Double-Blind Period|Lack of Efficacy|0|||
128983950|NCT00198107|464229399|FG002|Double-Blind Period|Lack of Efficacy|0|||
128983951|NCT00198107|464229397|FG000|Double-Blind Period|Lost to Follow-up|2|||
128983952|NCT00198107|464229398|FG001|Double-Blind Period|Lost to Follow-up|1|||
128983953|NCT00198107|464229399|FG002|Double-Blind Period|Lost to Follow-up|0|||
128872028|NCT00943852|463826009|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128872029|NCT00943852|463826010|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
128872030|NCT00943852|463826011|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128872031|NCT00943852|463826012|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128872032|NCT00943852|463826013|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
128872033|NCT00943852|463826004|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872034|NCT00943852|463826005|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128983954|NCT00198107|464229397|FG000|Double-Blind Period|Physician Decision|1|||
128983955|NCT00198107|464229398|FG001|Double-Blind Period|Physician Decision|0|||
128983956|NCT00198107|464229399|FG002|Double-Blind Period|Physician Decision|0|||
128983957|NCT00198107|464229397|FG000|Double-Blind Period|Withdrawal by Subject|0|||
128983958|NCT00198107|464229398|FG001|Double-Blind Period|Withdrawal by Subject|1|||
128983959|NCT00198107|464229399|FG002|Double-Blind Period|Withdrawal by Subject|0|||
128983960|NCT00198107|464229397|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
128983961|NCT00198107|464229398|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
128983962|NCT00198107|464229399|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
128983963|NCT02383966|464229405|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
128983964|NCT02383966|464229406|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
128983965|NCT02383966|464229405|FG000|Overall Study|Randomized, but not treated|1|||
128983966|NCT02383966|464229406|FG001|Overall Study|Randomized, but not treated|3|||
128983967|NCT02163759|464229407|FG000|Overall Study|Withdrawal by Subject|1|||
128983968|NCT02163759|464229408|FG001|Overall Study|Withdrawal by Subject|5|||
128983969|NCT02163759|464229409|FG002|Overall Study|Withdrawal by Subject|1|||
128983970|NCT02163759|464229407|FG000|Overall Study|Adverse Event|0|||
128872035|NCT00943852|463826006|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872036|NCT00943852|463826007|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872037|NCT00943852|463826008|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872038|NCT00943852|463826009|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872039|NCT00943852|463826010|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872040|NCT00943852|463826011|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
128872041|NCT00943852|463826012|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872042|NCT00943852|463826013|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
128872043|NCT00943852|463826004|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
128872044|NCT00943852|463826005|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
128872045|NCT00943852|463826006|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
128872046|NCT00943852|463826007|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
128872047|NCT00943852|463826008|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
128872048|NCT00943852|463826009|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
128872049|NCT00943852|463826010|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
128872050|NCT00943852|463826011|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
128872051|NCT00943852|463826012|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
128872052|NCT00943852|463826013|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
128872053|NCT02141620|463826014|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
128872054|NCT02141620|463826015|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
128872055|NCT03377699|463826019|FG000|Overall Study|Withdrawal by Subject|2|||
128872056|NCT03377699|463826020|FG001|Overall Study|Withdrawal by Subject|9|||
128872057|NCT03377699|463826019|FG000|Overall Study|Lost to Follow-up|1|||
128872058|NCT03377699|463826020|FG001|Overall Study|Lost to Follow-up|1|||
128872059|NCT03377699|463826019|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
128872060|NCT03377699|463826020|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
128872061|NCT03377699|463826019|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
128872062|NCT03377699|463826020|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
128872063|NCT03377699|463826019|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
128872064|NCT03377699|463826020|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
128872065|NCT03377699|463826019|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
128872066|NCT03377699|463826020|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
128872067|NCT00307684|463826021|FG000|Open Label Phase|Lack of Efficacy|0|||
128872068|NCT00307684|463826022|FG001|Open Label Phase|Lack of Efficacy|0|||
128872069|NCT00307684|463826023|FG002|Open Label Phase|Lack of Efficacy|3|||
128872070|NCT00307684|463826021|FG000|Open Label Phase|Adverse Event|0|||
128872071|NCT00307684|463826022|FG001|Open Label Phase|Adverse Event|0|||
128872072|NCT00307684|463826023|FG002|Open Label Phase|Adverse Event|16|||
128872073|NCT00307684|463826021|FG000|Open Label Phase|Withdrawal by Subject|0|||
128872074|NCT00307684|463826022|FG001|Open Label Phase|Withdrawal by Subject|0|||
128872075|NCT00307684|463826023|FG002|Open Label Phase|Withdrawal by Subject|15|||
128872076|NCT00307684|463826021|FG000|Open Label Phase|Lost to Follow-up|0|||
128872077|NCT00307684|463826022|FG001|Open Label Phase|Lost to Follow-up|0|||
128872078|NCT00307684|463826023|FG002|Open Label Phase|Lost to Follow-up|11|||
128872079|NCT00307684|463826021|FG000|Open Label Phase|non compliance|0|||
128872080|NCT00307684|463826022|FG001|Open Label Phase|non compliance|0|||
128872081|NCT00307684|463826023|FG002|Open Label Phase|non compliance|5|||
128872082|NCT00307684|463826021|FG000|Open Label Phase|other|0|||
128872083|NCT00307684|463826022|FG001|Open Label Phase|other|0|||
128872084|NCT00307684|463826023|FG002|Open Label Phase|other|6|||
128872085|NCT00307684|463826021|FG000|Double Blind Phase|Lack of Efficacy|2|||
128872086|NCT00307684|463826022|FG001|Double Blind Phase|Lack of Efficacy|5|||
128872087|NCT00307684|463826023|FG002|Double Blind Phase|Lack of Efficacy|0|||
128872088|NCT02580305|463826024|FG000|Overall Study|Adverse Event|15|||
128872089|NCT02580305|463826025|FG001|Overall Study|Adverse Event|19|||
128872090|NCT02580305|463826026|FG002|Overall Study|Adverse Event|10|||
128872091|NCT02580305|463826024|FG000|Overall Study|Lack of Efficacy|5|||
128872092|NCT02580305|463826025|FG001|Overall Study|Lack of Efficacy|0|||
128872093|NCT02580305|463826026|FG002|Overall Study|Lack of Efficacy|2|||
128872094|NCT02580305|463826024|FG000|Overall Study|Protocol Violation|4|||
128872095|NCT02580305|463826025|FG001|Overall Study|Protocol Violation|9|||
128872096|NCT02580305|463826026|FG002|Overall Study|Protocol Violation|6|||
128872097|NCT02580305|463826024|FG000|Overall Study|Lost to Follow-up|4|||
128872098|NCT02580305|463826025|FG001|Overall Study|Lost to Follow-up|4|||
128872099|NCT02580305|463826026|FG002|Overall Study|Lost to Follow-up|2|||
128872100|NCT02580305|463826024|FG000|Overall Study|Withdrawal by Subject|11|||
128872101|NCT02580305|463826025|FG001|Overall Study|Withdrawal by Subject|9|||
128872102|NCT02580305|463826026|FG002|Overall Study|Withdrawal by Subject|7|||
128983971|NCT02163759|464229408|FG001|Overall Study|Adverse Event|0|||
129095945|NCT01777295|464642689|FG001|Overall Study|Personal problem|0|||
128872103|NCT02580305|463826024|FG000|Overall Study|Randomized in error and never treated|4|||
128872104|NCT02580305|463826025|FG001|Overall Study|Randomized in error and never treated|8|||
128872105|NCT02580305|463826026|FG002|Overall Study|Randomized in error and never treated|5|||
128872106|NCT00224887|463826027|FG000|Overall Study|Pregnancy|6|||
128872107|NCT00224887|463826028|FG001|Overall Study|Pregnancy|6|||
128872108|NCT00798590|463826031|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
128872109|NCT00798590|463826032|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
128872110|NCT01163292|463826038|FG000|Overall Study|Lack of Efficacy|9|||
128872111|NCT01163292|463826039|FG001|Overall Study|Lack of Efficacy|0|||
128872112|NCT01163292|463826038|FG000|Overall Study|Adverse Event|6|||
128872113|NCT01163292|463826039|FG001|Overall Study|Adverse Event|0|||
128872114|NCT01163292|463826038|FG000|Overall Study|Initiation of biological therapy|0|||
128872115|NCT01163292|463826039|FG001|Overall Study|Initiation of biological therapy|15|||
128872116|NCT01163292|463826038|FG000|Overall Study|Sufficient response to adalimumab|8|||
128872117|NCT01163292|463826039|FG001|Overall Study|Sufficient response to adalimumab|0|||
128872118|NCT01163292|463826038|FG000|Overall Study|Refusal to receive adalimumab|7|||
128872119|NCT01163292|463826039|FG001|Overall Study|Refusal to receive adalimumab|0|||
128872120|NCT01163292|463826038|FG000|Overall Study|Economic reasons|6|||
128872121|NCT01163292|463826039|FG001|Overall Study|Economic reasons|0|||
128872122|NCT01163292|463826038|FG000|Overall Study|No further visits|5|||
128872123|NCT01163292|463826039|FG001|Overall Study|No further visits|7|||
128872124|NCT03223662|463826040|FG000|Overall Study|Physician Decision|1|||
128872125|NCT03223662|463826040|FG000|Overall Study|Study closure|1|||
128872126|NCT02217475|463826041|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
128872127|NCT02217475|463826042|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
128872128|NCT02217475|463826043|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
128872129|NCT02217475|463826041|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
128983972|NCT02163759|464229409|FG002|Overall Study|Adverse Event|1|||
128983973|NCT02163759|464229407|FG000|Overall Study|Death|0|||
128983974|NCT02163759|464229408|FG001|Overall Study|Death|0|||
128983975|NCT02163759|464229409|FG002|Overall Study|Death|1|||
128983976|NCT00451191|464229421|FG000|Overall Study|withdrawal or received alternate tx|15|||
128983977|NCT00451191|464229422|FG001|Overall Study|withdrawal or received alternate tx|11|||
128983978|NCT03575806|464229434|FG000|Overall Study|Withdrawal by Subject|0|||
128983979|NCT03575806|464229435|FG001|Overall Study|Withdrawal by Subject|2|||
128983980|NCT03575806|464229434|FG000|Overall Study|Protocol Violation|0|||
128983981|NCT03575806|464229435|FG001|Overall Study|Protocol Violation|2|||
128983982|NCT00219349|464229436|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
128983983|NCT00219349|464229436|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
128983984|NCT00219349|464229436|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
128983985|NCT00219349|464229436|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
128983986|NCT02777554|464229438|FG000|Overall Study|Adverse Event|4|||
128983987|NCT02777554|464229439|FG001|Overall Study|Adverse Event|4|||
128983988|NCT02777554|464229440|FG002|Overall Study|Adverse Event|0|||
128983989|NCT02777554|464229441|FG003|Overall Study|Adverse Event|1|||
128983990|NCT02777554|464229442|FG004|Overall Study|Adverse Event|0|||
128983991|NCT02777554|464229443|FG005|Overall Study|Adverse Event|0|||
128983992|NCT02777554|464229438|FG000|Overall Study|Withdrawal by Subject|3|||
128983993|NCT02777554|464229439|FG001|Overall Study|Withdrawal by Subject|1|||
128983994|NCT02777554|464229440|FG002|Overall Study|Withdrawal by Subject|1|||
128983995|NCT02777554|464229441|FG003|Overall Study|Withdrawal by Subject|0|||
128983996|NCT02777554|464229442|FG004|Overall Study|Withdrawal by Subject|0|||
128983997|NCT02777554|464229443|FG005|Overall Study|Withdrawal by Subject|0|||
128983998|NCT02777554|464229438|FG000|Overall Study|Discharged early due to hurricane|22|||
128983999|NCT02777554|464229439|FG001|Overall Study|Discharged early due to hurricane|20|||
128984000|NCT02777554|464229440|FG002|Overall Study|Discharged early due to hurricane|0|||
128984001|NCT02777554|464229441|FG003|Overall Study|Discharged early due to hurricane|0|||
128984002|NCT02777554|464229442|FG004|Overall Study|Discharged early due to hurricane|0|||
128984003|NCT02777554|464229443|FG005|Overall Study|Discharged early due to hurricane|0|||
128984004|NCT02777554|464229438|FG000|Overall Study|Other - Miscellaneous|1|||
128984005|NCT02777554|464229439|FG001|Overall Study|Other - Miscellaneous|0|||
128984006|NCT02777554|464229440|FG002|Overall Study|Other - Miscellaneous|0|||
128984007|NCT02777554|464229441|FG003|Overall Study|Other - Miscellaneous|0|||
128984008|NCT02777554|464229442|FG004|Overall Study|Other - Miscellaneous|0|||
128984009|NCT02777554|464229443|FG005|Overall Study|Other - Miscellaneous|0|||
128984010|NCT00270205|464229444|FG000|Overall Study|Lost to Follow-up|1|||
128984011|NCT00270205|464229445|FG001|Overall Study|Lost to Follow-up|0|||
128984012|NCT00270205|464229446|FG002|Overall Study|Lost to Follow-up|0|||
128984013|NCT00270205|464229447|FG003|Overall Study|Lost to Follow-up|1|||
129095946|NCT01777295|464642688|FG000|Overall Study|Investigator call for AEs check|1|||
129095947|NCT01777295|464642689|FG001|Overall Study|Investigator call for AEs check|0|||
128984014|NCT00066573|464229448|FG000|Overall Study|Did not received protocol treatment|28|||
129095948|NCT01069419|464642690|FG000|Overall Study|Adverse Event|233|||
128872130|NCT02217475|463826042|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
128872131|NCT02217475|463826043|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
128872132|NCT02217475|463826041|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
128872133|NCT02217475|463826042|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
128872134|NCT02217475|463826043|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
128872135|NCT02217475|463826041|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
128872136|NCT02217475|463826042|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
128872137|NCT02217475|463826043|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
128872138|NCT02217475|463826041|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
128872139|NCT02217475|463826042|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
128872140|NCT02217475|463826043|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
128872141|NCT02217475|463826041|FG000|Discontinued After Period 1|Adverse Event|1|||
128872142|NCT02217475|463826042|FG001|Discontinued After Period 1|Adverse Event|2|||
128872143|NCT02217475|463826043|FG002|Discontinued After Period 1|Adverse Event|0|||
128872144|NCT02217475|463826041|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
128872145|NCT02217475|463826042|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
128872146|NCT02217475|463826043|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
128872147|NCT02217475|463826041|FG000|Discontinued After Period 1|Physician Decision|0|||
128872148|NCT02217475|463826042|FG001|Discontinued After Period 1|Physician Decision|0|||
128872149|NCT02217475|463826043|FG002|Discontinued After Period 1|Physician Decision|1|||
128872150|NCT02217475|463826041|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
128872151|NCT02217475|463826042|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
128872152|NCT02217475|463826043|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
128872153|NCT02217475|463826041|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
128872154|NCT02217475|463826042|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
128872155|NCT02217475|463826043|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
128872156|NCT02217475|463826041|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
128872157|NCT02217475|463826042|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
128872158|NCT02217475|463826043|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
128872159|NCT02217475|463826041|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
128872160|NCT02217475|463826042|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
128872161|NCT02217475|463826043|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
128872162|NCT02217475|463826041|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
128872163|NCT02217475|463826042|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
128872164|NCT02217475|463826043|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
128872165|NCT02643472|463826044|FG000|Overall Study|Death|2|||
128872166|NCT02643472|463826045|FG001|Overall Study|Death|5|||
128872167|NCT02643472|463826044|FG000|Overall Study|Withdrawal by Subject|3|||
128872168|NCT02643472|463826045|FG001|Overall Study|Withdrawal by Subject|2|||
128872169|NCT02643472|463826044|FG000|Overall Study|Protocol Violation|0|||
128872170|NCT02643472|463826045|FG001|Overall Study|Protocol Violation|1|||
128872171|NCT02643472|463826044|FG000|Overall Study|Lost to Follow-up|22|||
128872172|NCT02643472|463826045|FG001|Overall Study|Lost to Follow-up|26|||
128872173|NCT01215188|463826046|FG000|Overall Study|Lost to Follow-up|22|||
128872174|NCT01215188|463826047|FG001|Overall Study|Lost to Follow-up|22|||
128872175|NCT01215188|463826048|FG002|Overall Study|Lost to Follow-up|16|||
128872176|NCT01215188|463826046|FG000|Overall Study|Adverse Event|1|||
128872177|NCT01215188|463826047|FG001|Overall Study|Adverse Event|1|||
128872178|NCT01215188|463826048|FG002|Overall Study|Adverse Event|3|||
128872179|NCT01215188|463826046|FG000|Overall Study|Physician Decision|2|||
128872180|NCT01215188|463826047|FG001|Overall Study|Physician Decision|1|||
128872181|NCT01215188|463826048|FG002|Overall Study|Physician Decision|0|||
128872182|NCT01215188|463826046|FG000|Overall Study|Lack of Efficacy|0|||
128872183|NCT01215188|463826047|FG001|Overall Study|Lack of Efficacy|0|||
128872184|NCT01215188|463826048|FG002|Overall Study|Lack of Efficacy|1|||
128872185|NCT01215188|463826046|FG000|Overall Study|Protocol Violation|1|||
128872186|NCT01215188|463826047|FG001|Overall Study|Protocol Violation|1|||
128872187|NCT01215188|463826048|FG002|Overall Study|Protocol Violation|1|||
128872188|NCT01215188|463826046|FG000|Overall Study|Withdrawal by Subject|32|||
128872189|NCT01215188|463826047|FG001|Overall Study|Withdrawal by Subject|34|||
128872190|NCT01215188|463826048|FG002|Overall Study|Withdrawal by Subject|31|||
128872191|NCT01012414|463826049|FG000|Overall Study|Withdrawal by Subject|2|||
128872192|NCT01012414|463826049|FG000|Overall Study|Lost to Follow-up|1|||
128872193|NCT01012414|463826049|FG000|Overall Study|Trial was stopped before completed|7|||
128872194|NCT00506441|463826050|FG000|Period 1; Open-label Period|Adverse Event|21|||
128872195|NCT00506441|463826051|FG001|Period 1; Open-label Period|Adverse Event|0|||
128872196|NCT00506441|463826050|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
128872197|NCT00506441|463826051|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
128872198|NCT00506441|463826050|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
128872199|NCT00506441|463826051|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
128872200|NCT00506441|463826050|FG000|Period 1; Open-label Period|Physician Decision|5|||
129095949|NCT01069419|464642690|FG000|Overall Study|Lack of Efficacy|332|||
129095950|NCT01069419|464642690|FG000|Overall Study|Lost to Follow-up|49|||
129095951|NCT01069419|464642690|FG000|Overall Study|Remission of disease|11|||
129095952|NCT01069419|464642690|FG000|Overall Study|Withdrawal by Subject|34|||
129095953|NCT01069419|464642690|FG000|Overall Study|Other Reason|43|||
129095954|NCT01069419|464642690|FG000|Overall Study|Missing termination information|13|||
129095955|NCT04526574|464642691|FG000|Overall Study|Protocol Violation|3|||
129095956|NCT04526574|464642692|FG001|Overall Study|Protocol Violation|1|||
129095957|NCT04526574|464642691|FG000|Overall Study|Withdrawal by Subject|12|||
129095958|NCT04526574|464642692|FG001|Overall Study|Withdrawal by Subject|9|||
129095959|NCT04526574|464642691|FG000|Overall Study|Other|1|||
129095960|NCT04526574|464642692|FG001|Overall Study|Other|2|||
129095961|NCT04526574|464642691|FG000|Overall Study|Adverse Event|1|||
129095962|NCT04526574|464642692|FG001|Overall Study|Adverse Event|1|||
129095963|NCT04526574|464642691|FG000|Overall Study|Death|2|||
129095964|NCT04526574|464642692|FG001|Overall Study|Death|3|||
129095965|NCT04526574|464642691|FG000|Overall Study|Lost to Follow-up|9|||
129095966|NCT04526574|464642692|FG001|Overall Study|Lost to Follow-up|9|||
129095967|NCT04526574|464642691|FG000|Overall Study|No longer meets eligibility criteria|8|||
129095968|NCT04526574|464642692|FG001|Overall Study|No longer meets eligibility criteria|8|||
129095969|NCT02248974|464642695|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
129095970|NCT02248974|464642696|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
129095971|NCT02248974|464642695|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
129095972|NCT02248974|464642696|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
129095973|NCT02248974|464642695|FG000|1-Day Follow-Up|Enrolled in another study|1|||
129095974|NCT02248974|464642696|FG001|1-Day Follow-Up|Enrolled in another study|0|||
129095975|NCT02248974|464642695|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
129095976|NCT02248974|464642696|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
129095977|NCT02248974|464642695|FG000|1-Week Follow-Up|Enrolled in another study|1|||
129095978|NCT02248974|464642696|FG001|1-Week Follow-Up|Enrolled in another study|1|||
129095979|NCT02248974|464642695|FG000|1-Week Follow-Up|Transferred to another facility|1|||
129095980|NCT02248974|464642696|FG001|1-Week Follow-Up|Transferred to another facility|0|||
129095981|NCT02248974|464642695|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
129095982|NCT02248974|464642696|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
129095983|NCT02248974|464642695|FG000|1-Week Follow-Up|Death|1|||
129095984|NCT02248974|464642696|FG001|1-Week Follow-Up|Death|1|||
129095985|NCT02248974|464642695|FG000|1-Week Follow-Up|Excluded because of age|0|||
129095986|NCT02248974|464642696|FG001|1-Week Follow-Up|Excluded because of age|1|||
129095987|NCT02248974|464642695|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
129095988|NCT02248974|464642696|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
129095989|NCT02248974|464642695|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
129095990|NCT02248974|464642696|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
129095991|NCT02248974|464642695|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
129095992|NCT02248974|464642696|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
129095993|NCT02248974|464642695|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
129095994|NCT02248974|464642696|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
129095995|NCT02248974|464642695|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
128872201|NCT00506441|463826051|FG001|Period 1; Open-label Period|Physician Decision|0|||
128872202|NCT00506441|463826050|FG000|Period 1; Open-label Period|Protocol Violation|9|||
128872203|NCT00506441|463826051|FG001|Period 1; Open-label Period|Protocol Violation|0|||
128872204|NCT00506441|463826050|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
128872205|NCT00506441|463826051|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
128872206|NCT00506441|463826050|FG000|Period 1; Open-label Period|Other Reasons|13|||
128872207|NCT00506441|463826051|FG001|Period 1; Open-label Period|Other Reasons|0|||
128872208|NCT00506441|463826050|FG000|Period 2; Double-blind Period|Adverse Event|0|||
128872209|NCT00506441|463826051|FG001|Period 2; Double-blind Period|Adverse Event|1|||
128872210|NCT00506441|463826050|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
128872211|NCT00506441|463826051|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
128872212|NCT00506441|463826050|FG000|Period 2; Double-blind Period|Physician Decision|1|||
128872213|NCT00506441|463826051|FG001|Period 2; Double-blind Period|Physician Decision|1|||
128872214|NCT00506441|463826050|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
128872215|NCT00506441|463826051|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
128872216|NCT00506441|463826050|FG000|Period 2; Double-blind Period|Other Reason|1|||
128872217|NCT00506441|463826051|FG001|Period 2; Double-blind Period|Other Reason|1|||
128872218|NCT00528931|463826053|FG000|Overall Study|Lost to Follow-up|1|||
128872219|NCT00291642|463826056|FG000|Overall Study|Adverse Event|1|||
128872220|NCT00291642|463826057|FG001|Overall Study|Adverse Event|0|||
128872221|NCT00291642|463826058|FG002|Overall Study|Adverse Event|1|||
129095996|NCT02248974|464642696|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
129095997|NCT02332239|464642697|FG000|Overall Study|Lost to Follow-up|4|||
129095998|NCT02332239|464642698|FG001|Overall Study|Lost to Follow-up|6|||
129095999|NCT00115037|464642699|FG000|Phase1|Lost to Follow-up|16|||
129096000|NCT00115037|464642700|FG001|Phase1|Lost to Follow-up|23|||
129096001|NCT00115037|464642701|FG002|Phase1|Lost to Follow-up|0|||
129096002|NCT00115037|464642702|FG003|Phase1|Lost to Follow-up|0|||
129096003|NCT00115037|464642703|FG004|Phase1|Lost to Follow-up|0|||
129096004|NCT00115037|464642704|FG005|Phase1|Lost to Follow-up|0|||
129096005|NCT00115037|464642699|FG000|Phase1|Withdrawal by Subject|9|||
128872222|NCT00291642|463826059|FG003|Overall Study|Adverse Event|0|||
128872223|NCT00291642|463826060|FG004|Overall Study|Adverse Event|1|||
128872224|NCT00291642|463826056|FG000|Overall Study|Patient missed visit|0|||
128872225|NCT00291642|463826057|FG001|Overall Study|Patient missed visit|0|||
128872226|NCT00291642|463826058|FG002|Overall Study|Patient missed visit|1|||
128872227|NCT00291642|463826059|FG003|Overall Study|Patient missed visit|0|||
128872228|NCT00291642|463826060|FG004|Overall Study|Patient missed visit|0|||
128872229|NCT00291642|463826056|FG000|Overall Study|Intake of prohibited medication|1|||
128872230|NCT00291642|463826057|FG001|Overall Study|Intake of prohibited medication|0|||
128872231|NCT00291642|463826058|FG002|Overall Study|Intake of prohibited medication|0|||
128872232|NCT00291642|463826059|FG003|Overall Study|Intake of prohibited medication|0|||
128872233|NCT00291642|463826060|FG004|Overall Study|Intake of prohibited medication|0|||
128872234|NCT02576587|463826065|FG000|Baseline|Equipment failure|0|||
128872235|NCT02576587|463826066|FG001|Baseline|Equipment failure|1|||
128872236|NCT02576587|463826065|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
128872237|NCT02576587|463826066|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
128872238|NCT02576587|463826065|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
128872239|NCT02576587|463826066|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
128872240|NCT02576587|463826065|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
128872241|NCT02576587|463826066|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
128872242|NCT00532493|463826067|FG000|Overall Study|Death|1|||
128872243|NCT00532493|463826068|FG001|Overall Study|Death|1|||
128872244|NCT00532493|463826067|FG000|Overall Study|Lost to Follow-up|10|||
128872245|NCT00532493|463826068|FG001|Overall Study|Lost to Follow-up|7|||
128872246|NCT00532493|463826067|FG000|Overall Study|Withdrawal by Subject|7|||
128872247|NCT00532493|463826068|FG001|Overall Study|Withdrawal by Subject|9|||
128872248|NCT00532493|463826067|FG000|Overall Study|Physician Decision|1|||
128872249|NCT00532493|463826068|FG001|Overall Study|Physician Decision|6|||
128872250|NCT00532493|463826067|FG000|Overall Study|Adverse Event|6|||
128872251|NCT00532493|463826068|FG001|Overall Study|Adverse Event|5|||
128872252|NCT00532493|463826067|FG000|Overall Study|Protocol Deviation|1|||
128872253|NCT00532493|463826068|FG001|Overall Study|Protocol Deviation|0|||
128872254|NCT00532493|463826067|FG000|Overall Study|Subject Moved Away|3|||
128872255|NCT00532493|463826068|FG001|Overall Study|Subject Moved Away|1|||
128872256|NCT00532493|463826067|FG000|Overall Study|Contraindicative Medication|1|||
128872257|NCT00532493|463826068|FG001|Overall Study|Contraindicative Medication|0|||
128872258|NCT00513305|463826069|FG000|Overall Study|Adverse Event|6|||
128872259|NCT00513305|463826070|FG001|Overall Study|Adverse Event|2|||
128872260|NCT00513305|463826069|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
128872261|NCT00513305|463826070|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
128872262|NCT00513305|463826069|FG000|Overall Study|Lack of Efficacy|8|||
128872263|NCT00513305|463826070|FG001|Overall Study|Lack of Efficacy|13|||
128872264|NCT00513305|463826069|FG000|Overall Study|Withdrawal by Subject|1|||
128872265|NCT00513305|463826070|FG001|Overall Study|Withdrawal by Subject|2|||
128872266|NCT00513305|463826069|FG000|Overall Study|Disease progression|8|||
128872267|NCT00513305|463826070|FG001|Overall Study|Disease progression|5|||
128872268|NCT00513305|463826069|FG000|Overall Study|Eligible for stem cell transplant|1|||
128872269|NCT00513305|463826070|FG001|Overall Study|Eligible for stem cell transplant|0|||
128872270|NCT00513305|463826069|FG000|Overall Study|Hematologic counts did not recover|1|||
128872271|NCT00513305|463826070|FG001|Overall Study|Hematologic counts did not recover|0|||
128872272|NCT00513305|463826069|FG000|Overall Study|Physician Decision|1|||
128872273|NCT00513305|463826070|FG001|Overall Study|Physician Decision|0|||
128872274|NCT00513305|463826069|FG000|Overall Study|Persistent hypocellularity|0|||
128872275|NCT00513305|463826070|FG001|Overall Study|Persistent hypocellularity|1|||
128872276|NCT00513305|463826069|FG000|Overall Study|Sponsor Decision|0|||
128872277|NCT00513305|463826070|FG001|Overall Study|Sponsor Decision|2|||
128872278|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
128872279|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
128872280|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
128872281|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
128872282|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
128872283|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
128872284|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
128872285|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
128872286|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
128872287|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
128872288|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
128872289|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
128872290|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
128872291|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
128872292|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
128872293|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
128872294|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
128872295|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
128872296|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
128872297|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
128872298|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
128872299|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
128872300|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
128872301|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
128872302|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
128872303|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
128872304|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
128872305|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
128872306|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
128872307|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
128872308|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
128872309|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
128872310|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
128872311|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
128872312|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
128872313|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
128872314|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
128872315|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129096006|NCT00115037|464642700|FG001|Phase1|Withdrawal by Subject|4|||
129096007|NCT00115037|464642701|FG002|Phase1|Withdrawal by Subject|0|||
129096008|NCT00115037|464642702|FG003|Phase1|Withdrawal by Subject|0|||
129096009|NCT00115037|464642703|FG004|Phase1|Withdrawal by Subject|0|||
129096010|NCT00115037|464642704|FG005|Phase1|Withdrawal by Subject|0|||
129096011|NCT00115037|464642699|FG000|Phase2|Death|0|||
129096012|NCT00115037|464642700|FG001|Phase2|Death|0|||
129096013|NCT00115037|464642701|FG002|Phase2|Death|1|||
129096014|NCT00115037|464642702|FG003|Phase2|Death|0|||
129096015|NCT00115037|464642703|FG004|Phase2|Death|0|||
129096016|NCT00115037|464642704|FG005|Phase2|Death|1|||
129096017|NCT00115037|464642699|FG000|Phase2|Withdrawal by Subject|0|||
129096018|NCT00115037|464642700|FG001|Phase2|Withdrawal by Subject|0|||
129096019|NCT00115037|464642701|FG002|Phase2|Withdrawal by Subject|2|||
129096020|NCT00115037|464642702|FG003|Phase2|Withdrawal by Subject|1|||
129096021|NCT00115037|464642703|FG004|Phase2|Withdrawal by Subject|2|||
128872316|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
128872317|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
128872318|NCT00700427|463827577|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
128872319|NCT00700427|463827578|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
128872320|NCT00700427|463827579|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
128872321|NCT00700427|463827580|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
128872322|NCT00700427|463827581|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
128872323|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
128872324|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
128872325|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
128872326|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
128872327|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
128872328|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
128872329|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
128872330|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
128872331|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
128872332|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129096022|NCT00115037|464642704|FG005|Phase2|Withdrawal by Subject|1|||
129096023|NCT00115037|464642699|FG000|Phase2|Lost to Follow-up|0|||
129096024|NCT00115037|464642700|FG001|Phase2|Lost to Follow-up|0|||
129096025|NCT00115037|464642701|FG002|Phase2|Lost to Follow-up|12|||
129096026|NCT00115037|464642702|FG003|Phase2|Lost to Follow-up|14|||
129096027|NCT00115037|464642703|FG004|Phase2|Lost to Follow-up|4|||
129096028|NCT00115037|464642704|FG005|Phase2|Lost to Follow-up|10|||
129096029|NCT00396877|464642705|FG000|Overall Study|Lost to Follow-up|2|||
129096030|NCT00396877|464642706|FG001|Overall Study|Lost to Follow-up|1|||
129096031|NCT00396877|464642705|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
129096032|NCT00396877|464642706|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
129096033|NCT00334802|464642707|FG000|Overall Study|Progressive Disease|2|||
129096034|NCT00334802|464642708|FG001|Overall Study|Progressive Disease|24|||
129096035|NCT00334802|464642707|FG000|Overall Study|Toxicity|1|||
129096036|NCT00334802|464642708|FG001|Overall Study|Toxicity|5|||
129096037|NCT00334802|464642707|FG000|Overall Study|Lack of Efficacy|1|||
128872333|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
128872334|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
128872335|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
128872336|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
128872337|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
128872338|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
128872339|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
128872340|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
128872341|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
128872342|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
128872343|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
128872344|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
128872345|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
128872346|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129096038|NCT00334802|464642708|FG001|Overall Study|Lack of Efficacy|3|||
129096039|NCT00334802|464642707|FG000|Overall Study|Patient Condition Aggrevated|1|||
129096040|NCT00334802|464642708|FG001|Overall Study|Patient Condition Aggrevated|0|||
129096041|NCT00334802|464642707|FG000|Overall Study|Physician Decision|1|||
129096042|NCT00334802|464642708|FG001|Overall Study|Physician Decision|0|||
129096043|NCT00334802|464642707|FG000|Overall Study|Withdrawal by Subject|0|||
129096044|NCT00334802|464642708|FG001|Overall Study|Withdrawal by Subject|4|||
129096045|NCT00334802|464642707|FG000|Overall Study|Adverse Event|0|||
129096046|NCT00334802|464642708|FG001|Overall Study|Adverse Event|3|||
129096047|NCT00334802|464642707|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
129096048|NCT00334802|464642708|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
129096049|NCT03436199|464642709|FG000|Overall Study|Adverse Event|15|||
129096050|NCT03436199|464642710|FG001|Overall Study|Adverse Event|40|||
129096051|NCT03436199|464642711|FG002|Overall Study|Adverse Event|7|||
129096052|NCT03436199|464642709|FG000|Overall Study|Withdrawal by Subject|4|||
129096053|NCT03436199|464642710|FG001|Overall Study|Withdrawal by Subject|10|||
129096054|NCT03436199|464642711|FG002|Overall Study|Withdrawal by Subject|3|||
129096055|NCT03436199|464642709|FG000|Overall Study|Lost to Follow-up|1|||
129096056|NCT03436199|464642710|FG001|Overall Study|Lost to Follow-up|0|||
129096057|NCT03436199|464642711|FG002|Overall Study|Lost to Follow-up|2|||
129096058|NCT03436199|464642709|FG000|Overall Study|Protocol Violation|1|||
129096059|NCT03436199|464642710|FG001|Overall Study|Protocol Violation|1|||
129096060|NCT03436199|464642711|FG002|Overall Study|Protocol Violation|0|||
129096061|NCT03436199|464642709|FG000|Overall Study|Physician Decision|0|||
129096062|NCT03436199|464642710|FG001|Overall Study|Physician Decision|1|||
129096063|NCT03436199|464642711|FG002|Overall Study|Physician Decision|0|||
129096064|NCT03436199|464642709|FG000|Overall Study|Could not return to clinic|1|||
129096065|NCT03436199|464642710|FG001|Overall Study|Could not return to clinic|0|||
129096066|NCT03436199|464642711|FG002|Overall Study|Could not return to clinic|0|||
129096067|NCT03436199|464642709|FG000|Overall Study|Withdrawn per physician|0|||
129096068|NCT03436199|464642710|FG001|Overall Study|Withdrawn per physician|1|||
129096069|NCT03436199|464642711|FG002|Overall Study|Withdrawn per physician|0|||
129096070|NCT00085098|464642712|FG000|Overall Study|Withdrawal by Subject|0|||
129096071|NCT00085098|464642713|FG001|Overall Study|Withdrawal by Subject|1|||
129096072|NCT00085098|464642712|FG000|Overall Study|Ineligible|1|||
129096073|NCT00085098|464642713|FG001|Overall Study|Ineligible|1|||
129096074|NCT03515629|464642714|FG000|Overall Study|Death|0|||
129096075|NCT03515629|464642715|FG001|Overall Study|Death|1|||
129096076|NCT03515629|464642716|FG002|Overall Study|Death|1|||
129096077|NCT03515629|464642714|FG000|Overall Study|Progressive disease|0|||
129096078|NCT03515629|464642715|FG001|Overall Study|Progressive disease|1|||
129096079|NCT03515629|464642716|FG002|Overall Study|Progressive disease|0|||
129096080|NCT01886781|464642717|FG000|Overall Study|Protocol Violation|5|||
129096081|NCT01886781|464642718|FG001|Overall Study|Protocol Violation|0|||
129096082|NCT01886781|464642717|FG000|Overall Study|Adverse Event|1|||
129096083|NCT01886781|464642718|FG001|Overall Study|Adverse Event|0|||
129096084|NCT01886781|464642717|FG000|Overall Study|Lost to Follow-up|5|||
129096085|NCT01886781|464642718|FG001|Overall Study|Lost to Follow-up|0|||
128872347|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129096086|NCT01886781|464642717|FG000|Overall Study|Withdrawal by Subject|2|||
129096087|NCT01886781|464642718|FG001|Overall Study|Withdrawal by Subject|1|||
129096088|NCT01886781|464642717|FG000|Overall Study|Worsening of symptoms|1|||
129096089|NCT01886781|464642718|FG001|Overall Study|Worsening of symptoms|1|||
129096090|NCT00424021|464642719|FG000|NCT00046319 Study Period|Adverse Event|1|||
129096091|NCT00424021|464642720|FG001|NCT00046319 Study Period|Adverse Event|0|||
129096092|NCT00424021|464642721|FG002|NCT00046319 Study Period|Adverse Event|1|||
129096093|NCT00424021|464642722|FG003|NCT00046319 Study Period|Adverse Event|1|||
129096094|NCT00424021|464642719|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
129096095|NCT00424021|464642720|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
129096096|NCT00424021|464642721|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
128872348|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
128872349|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
128872350|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
128872351|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
128872352|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
128872353|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
128872354|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
129096097|NCT00424021|464642722|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
129096098|NCT00424021|464642719|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
129096099|NCT00424021|464642720|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
129096100|NCT00424021|464642721|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
129096101|NCT00424021|464642722|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
129096102|NCT00424021|464642719|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
129096103|NCT00424021|464642720|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
129096104|NCT00424021|464642721|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
129096105|NCT00424021|464642722|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
129096106|NCT00424021|464642719|FG000|AMB-220-E Study Period|Adverse Event|1|||
129096107|NCT00424021|464642720|FG001|AMB-220-E Study Period|Adverse Event|1|||
129096108|NCT00424021|464642721|FG002|AMB-220-E Study Period|Adverse Event|3|||
129096109|NCT00424021|464642722|FG003|AMB-220-E Study Period|Adverse Event|7|||
129096110|NCT00424021|464642719|FG000|AMB-220-E Study Period|Death|0|||
129096111|NCT00424021|464642720|FG001|AMB-220-E Study Period|Death|0|||
129096112|NCT00424021|464642721|FG002|AMB-220-E Study Period|Death|1|||
129096113|NCT00424021|464642722|FG003|AMB-220-E Study Period|Death|1|||
129096114|NCT00424021|464642719|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
129096115|NCT00424021|464642720|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
129096116|NCT00424021|464642721|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
129096117|NCT00424021|464642722|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
129096118|NCT00424021|464642719|FG000|AMB-220-E Study Period|Physician Decision|0|||
129096119|NCT00424021|464642720|FG001|AMB-220-E Study Period|Physician Decision|0|||
129096120|NCT00424021|464642721|FG002|AMB-220-E Study Period|Physician Decision|0|||
129096121|NCT00424021|464642722|FG003|AMB-220-E Study Period|Physician Decision|1|||
129096122|NCT03769194|464642723|FG000|Overall Study|Withdrawal by Subject|0|||
129096123|NCT03769194|464642724|FG001|Overall Study|Withdrawal by Subject|7|||
129096124|NCT03769194|464642725|FG002|Overall Study|Withdrawal by Subject|4|||
129096125|NCT03769194|464642726|FG003|Overall Study|Withdrawal by Subject|1|||
129096126|NCT03769194|464642723|FG000|Overall Study|moved from study area|0|||
129096127|NCT03769194|464642724|FG001|Overall Study|moved from study area|2|||
129096128|NCT03769194|464642725|FG002|Overall Study|moved from study area|1|||
129096129|NCT03769194|464642726|FG003|Overall Study|moved from study area|1|||
129096130|NCT03769194|464642723|FG000|Overall Study|Lost to Follow-up|3|||
129096131|NCT03769194|464642724|FG001|Overall Study|Lost to Follow-up|6|||
129096132|NCT03769194|464642725|FG002|Overall Study|Lost to Follow-up|3|||
129096133|NCT03769194|464642726|FG003|Overall Study|Lost to Follow-up|6|||
129096134|NCT03769194|464642723|FG000|Overall Study|other|1|||
129096135|NCT03769194|464642724|FG001|Overall Study|other|3|||
129096136|NCT03769194|464642725|FG002|Overall Study|other|0|||
129096137|NCT03769194|464642726|FG003|Overall Study|other|1|||
129096138|NCT03597022|464642729|FG000|Overall Study|Premature termination of the study|7|||
129096139|NCT03597022|464642730|FG001|Overall Study|Premature termination of the study|7|||
129096140|NCT03597022|464642731|FG002|Overall Study|Premature termination of the study|8|||
129096141|NCT03597022|464642729|FG000|Overall Study|Serious adverse event|1|||
129096142|NCT03597022|464642730|FG001|Overall Study|Serious adverse event|1|||
128872355|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
128872356|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
128872357|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
128872358|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
128872359|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
128872360|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
128872361|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
128872362|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129096143|NCT03597022|464642731|FG002|Overall Study|Serious adverse event|0|||
129096144|NCT01672294|464642733|FG000|Overall Study|Withdrawal by Subject|4|||
129096145|NCT01672294|464642734|FG001|Overall Study|Withdrawal by Subject|4|||
129096146|NCT01672294|464642735|FG002|Overall Study|Withdrawal by Subject|4|||
129096147|NCT01672294|464642736|FG003|Overall Study|Withdrawal by Subject|4|||
129096148|NCT01672294|464642733|FG000|Overall Study|Excluded by study|1|||
129096149|NCT01672294|464642734|FG001|Overall Study|Excluded by study|1|||
129096150|NCT01672294|464642735|FG002|Overall Study|Excluded by study|0|||
129096151|NCT01672294|464642736|FG003|Overall Study|Excluded by study|0|||
129096152|NCT01672294|464642733|FG000|Overall Study|Lost to Follow-up|1|||
129096153|NCT01672294|464642734|FG001|Overall Study|Lost to Follow-up|16|||
129096154|NCT01672294|464642735|FG002|Overall Study|Lost to Follow-up|7|||
129096155|NCT01672294|464642736|FG003|Overall Study|Lost to Follow-up|9|||
128872363|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
128872364|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
128872365|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
128872366|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
128872367|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
128872368|NCT00700427|463827577|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
128872369|NCT00700427|463827578|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
128872370|NCT00700427|463827579|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
128872371|NCT00700427|463827580|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
128872372|NCT00700427|463827581|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
128872373|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
128872374|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
128872375|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
128872376|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
128872377|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
128872378|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
128872379|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
128872380|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
128872381|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
128872382|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
128872383|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
128872384|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
128872385|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
128872386|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
128872387|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
128872388|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
128872389|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
128872390|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
128872391|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
128872392|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
128872393|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
128872394|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
128872395|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
128872396|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
128872397|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
128872398|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
128872399|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
128872400|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
128872401|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
128872402|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
128872403|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
128872404|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
128872405|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
128872406|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
128872407|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
128872408|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
128872409|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
128872410|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
128872411|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
128872412|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
128872413|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
128872414|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
128872415|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
128872416|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
128872417|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
128872418|NCT00700427|463827577|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
128872419|NCT00700427|463827578|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
128872420|NCT00700427|463827579|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
128872421|NCT00700427|463827580|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
128872422|NCT00700427|463827581|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
128872423|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
128872424|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
128872425|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129096156|NCT03887117|464642737|FG000|Overall Study|Discontinued prematurely|0|||
128872426|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129096157|NCT03887117|464642738|FG001|Overall Study|Discontinued prematurely|1|||
129096158|NCT03887117|464642739|FG002|Overall Study|Discontinued prematurely|1|||
129096159|NCT03887117|464642740|FG003|Overall Study|Discontinued prematurely|2|||
129096160|NCT01739764|464642741|FG000|Overall Study|Adverse Event|0|||
129096161|NCT01739764|464642742|FG001|Overall Study|Adverse Event|3|||
129096162|NCT01739764|464642743|FG002|Overall Study|Adverse Event|4|||
129096163|NCT01739764|464642741|FG000|Overall Study|Death|4|||
129096164|NCT01739764|464642742|FG001|Overall Study|Death|6|||
129096165|NCT01739764|464642743|FG002|Overall Study|Death|38|||
129096166|NCT01739764|464642741|FG000|Overall Study|Lost to Follow-up|0|||
129096167|NCT01739764|464642742|FG001|Overall Study|Lost to Follow-up|0|||
129096168|NCT01739764|464642743|FG002|Overall Study|Lost to Follow-up|5|||
129096169|NCT01739764|464642741|FG000|Overall Study|Non-Compliance|0|||
129096170|NCT01739764|464642742|FG001|Overall Study|Non-Compliance|0|||
129096171|NCT01739764|464642743|FG002|Overall Study|Non-Compliance|1|||
129096172|NCT01739764|464642741|FG000|Overall Study|Multiple Reasons|3|||
129096173|NCT01739764|464642742|FG001|Overall Study|Multiple Reasons|2|||
129096174|NCT01739764|464642743|FG002|Overall Study|Multiple Reasons|3|||
129096175|NCT01739764|464642741|FG000|Overall Study|Physician Decision|2|||
129096176|NCT01739764|464642742|FG001|Overall Study|Physician Decision|2|||
129096177|NCT01739764|464642743|FG002|Overall Study|Physician Decision|4|||
129096178|NCT01739764|464642741|FG000|Overall Study|Progressive Disease|3|||
129096179|NCT01739764|464642742|FG001|Overall Study|Progressive Disease|5|||
129096180|NCT01739764|464642743|FG002|Overall Study|Progressive Disease|16|||
129096181|NCT01739764|464642741|FG000|Overall Study|Protocol Violation|0|||
129096182|NCT01739764|464642742|FG001|Overall Study|Protocol Violation|0|||
129096183|NCT01739764|464642743|FG002|Overall Study|Protocol Violation|2|||
129096184|NCT01739764|464642741|FG000|Overall Study|Study Terminated by Sponsor|8|||
129096185|NCT01739764|464642742|FG001|Overall Study|Study Terminated by Sponsor|13|||
129096186|NCT01739764|464642743|FG002|Overall Study|Study Terminated by Sponsor|26|||
129096187|NCT01739764|464642741|FG000|Overall Study|Withdrawal by Subject|6|||
129096188|NCT01739764|464642742|FG001|Overall Study|Withdrawal by Subject|5|||
129096189|NCT01739764|464642743|FG002|Overall Study|Withdrawal by Subject|27|||
129096190|NCT01389258|464642744|FG000|Overall Study|Lost to Follow-up|5|||
129096191|NCT00926536|464642745|FG000|Overall Study|Physician Decision|1|||
129096192|NCT00926536|464642746|FG001|Overall Study|Physician Decision|2|||
129096193|NCT03013985|464642747|FG000|Overall Study|Protocol Violation|2|||
129096194|NCT03013985|464642748|FG001|Overall Study|Protocol Violation|2|||
129096195|NCT03013985|464642747|FG000|Overall Study|Withdrawal by Subject|14|||
129096196|NCT03013985|464642748|FG001|Overall Study|Withdrawal by Subject|17|||
129096197|NCT01080391|464642749|FG000|Overall Study|Randomized but not treated|7|||
129096198|NCT01080391|464642750|FG001|Overall Study|Randomized but not treated|4|||
129096199|NCT01534208|464642751|FG000|Overall Study|Lost to Follow-up|19|||
129096200|NCT01534208|464642752|FG001|Overall Study|Lost to Follow-up|14|||
129096201|NCT01534208|464642751|FG000|Overall Study|Withdrawal by Subject|6|||
129096202|NCT01534208|464642752|FG001|Overall Study|Withdrawal by Subject|20|||
129096203|NCT01534208|464642751|FG000|Overall Study|Adverse Event|15|||
129096204|NCT01534208|464642752|FG001|Overall Study|Adverse Event|8|||
129096205|NCT01534208|464642751|FG000|Overall Study|Physician Decision|2|||
129096206|NCT01534208|464642752|FG001|Overall Study|Physician Decision|0|||
129096207|NCT01534208|464642751|FG000|Overall Study|Lack of Efficacy|0|||
129096208|NCT01534208|464642752|FG001|Overall Study|Lack of Efficacy|3|||
129096209|NCT01534208|464642751|FG000|Overall Study|Protocol Violation|2|||
129096210|NCT01534208|464642752|FG001|Overall Study|Protocol Violation|2|||
129096211|NCT01534208|464642751|FG000|Overall Study|Sponsor decision|4|||
129096212|NCT01534208|464642752|FG001|Overall Study|Sponsor decision|1|||
129096213|NCT01534208|464642751|FG000|Overall Study|Subject relocation|2|||
129096214|NCT01534208|464642752|FG001|Overall Study|Subject relocation|0|||
129096215|NCT01534208|464642751|FG000|Overall Study|Lab assessment|2|||
129096216|NCT01534208|464642752|FG001|Overall Study|Lab assessment|1|||
129096217|NCT01534208|464642751|FG000|Overall Study|Eligibility error|3|||
129096218|NCT01534208|464642752|FG001|Overall Study|Eligibility error|0|||
129096219|NCT01534208|464642751|FG000|Overall Study|PCP decision|1|||
129096220|NCT01534208|464642752|FG001|Overall Study|PCP decision|0|||
129096221|NCT01534208|464642751|FG000|Overall Study|Needed prohibited meds|1|||
129096222|NCT01534208|464642752|FG001|Overall Study|Needed prohibited meds|0|||
129096223|NCT01904903|464642753|FG000|Overall Study|Withdrawal by Subject|1|||
129096224|NCT01260584|464642754|FG000|Period 1|Protocol Violation|0|||
129096225|NCT01260584|464642755|FG001|Period 1|Protocol Violation|0|||
129096226|NCT01260584|464642756|FG002|Period 1|Protocol Violation|1|||
129096227|NCT01260584|464642757|FG003|Period 1|Protocol Violation|1|||
129096228|NCT01260584|464642754|FG000|Period 1|Adverse Event|0|||
129096229|NCT01260584|464642755|FG001|Period 1|Adverse Event|0|||
129096230|NCT01260584|464642756|FG002|Period 1|Adverse Event|1|||
129096231|NCT01260584|464642757|FG003|Period 1|Adverse Event|0|||
128872427|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
129096232|NCT01260584|464642754|FG000|Period 2|Protocol Violation|0|||
129096233|NCT01260584|464642755|FG001|Period 2|Protocol Violation|2|||
129096234|NCT01260584|464642756|FG002|Period 2|Protocol Violation|3|||
128872428|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
128872429|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
128872430|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
128872431|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
128872432|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
128872433|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
128872434|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
128872435|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
128872436|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
128872437|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
128872438|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
128872439|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
128872440|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
128872441|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
128872442|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
128872443|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
128872444|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
128872445|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
128872446|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
128872447|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
129096235|NCT01260584|464642757|FG003|Period 2|Protocol Violation|1|||
129096236|NCT01260584|464642754|FG000|Period 2|Adverse Event|1|||
129096237|NCT01260584|464642755|FG001|Period 2|Adverse Event|0|||
129096238|NCT01260584|464642756|FG002|Period 2|Adverse Event|2|||
129096239|NCT01260584|464642757|FG003|Period 2|Adverse Event|0|||
129096240|NCT01260584|464642754|FG000|Period 2|Withdrawal by Subject|0|||
129096241|NCT01260584|464642755|FG001|Period 2|Withdrawal by Subject|1|||
129096242|NCT01260584|464642756|FG002|Period 2|Withdrawal by Subject|0|||
129096243|NCT01260584|464642757|FG003|Period 2|Withdrawal by Subject|0|||
129096244|NCT00586508|464642762|FG000|Overall Study|Progressive disease|52|||
129096245|NCT00586508|464642763|FG001|Overall Study|Progressive disease|8|||
129096246|NCT00586508|464642762|FG000|Overall Study|Death|0|||
129096247|NCT00586508|464642763|FG001|Overall Study|Death|1|||
129096248|NCT00586508|464642762|FG000|Overall Study|Adverse Event|12|||
129096249|NCT00586508|464642763|FG001|Overall Study|Adverse Event|4|||
129096250|NCT00586508|464642762|FG000|Overall Study|Withdrawal by Subject|4|||
129096251|NCT00586508|464642763|FG001|Overall Study|Withdrawal by Subject|0|||
129096252|NCT03434249|464642764|FG000|Overall Study|Adverse Event|1|||
129096253|NCT03434249|464642765|FG001|Overall Study|Adverse Event|0|||
129096254|NCT03434249|464642764|FG000|Overall Study|Lost to Follow-up|0|||
129096255|NCT03434249|464642765|FG001|Overall Study|Lost to Follow-up|1|||
129096256|NCT03434249|464642764|FG000|Overall Study|Non-compliance of family|2|||
129096257|NCT03434249|464642765|FG001|Overall Study|Non-compliance of family|1|||
129096258|NCT03434249|464642764|FG000|Overall Study|Difficulties in completing daily diary|2|||
129096259|NCT03434249|464642765|FG001|Overall Study|Difficulties in completing daily diary|1|||
129096260|NCT00561470|464642766|FG000|Overall Study|Adverse Event|74|||
129096261|NCT00561470|464642767|FG001|Overall Study|Adverse Event|163|||
129096262|NCT00561470|464642766|FG000|Overall Study|Disease progression|437|||
129096263|NCT00561470|464642767|FG001|Overall Study|Disease progression|305|||
129096264|NCT00561470|464642766|FG000|Overall Study|poor compliance to protocol|4|||
129096265|NCT00561470|464642767|FG001|Overall Study|poor compliance to protocol|4|||
129096266|NCT00561470|464642766|FG000|Overall Study|Lost to Follow-up|2|||
129096267|NCT00561470|464642767|FG001|Overall Study|Lost to Follow-up|0|||
129096268|NCT00561470|464642766|FG000|Overall Study|Physician Decision|21|||
129096269|NCT00561470|464642767|FG001|Overall Study|Physician Decision|20|||
129096270|NCT00561470|464642766|FG000|Overall Study|Consent Withdrawn|2|||
129096271|NCT00561470|464642767|FG001|Overall Study|Consent Withdrawn|6|||
129096272|NCT00561470|464642766|FG000|Overall Study|Subject request|43|||
129096273|NCT00561470|464642767|FG001|Overall Study|Subject request|77|||
129096274|NCT00561470|464642766|FG000|Overall Study|Metastatic surgery|10|||
129096275|NCT00561470|464642767|FG001|Overall Study|Metastatic surgery|12|||
129096276|NCT00561470|464642766|FG000|Overall Study|Unauthorized procedure|3|||
129096277|NCT00561470|464642767|FG001|Overall Study|Unauthorized procedure|1|||
129096278|NCT00561470|464642766|FG000|Overall Study|Randomized but not treated|5|||
129096279|NCT00561470|464642767|FG001|Overall Study|Randomized but not treated|5|||
129096280|NCT00561470|464642766|FG000|Overall Study|Missed visit window|1|||
128872448|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
128872449|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129096281|NCT00561470|464642767|FG001|Overall Study|Missed visit window|4|||
129096282|NCT00561470|464642766|FG000|Overall Study|Planning surgery|1|||
129096283|NCT00561470|464642767|FG001|Overall Study|Planning surgery|1|||
129096284|NCT00561470|464642766|FG000|Overall Study|Ongoing Treatment|11|||
129096285|NCT00561470|464642767|FG001|Overall Study|Ongoing Treatment|14|||
129096286|NCT02918552|464642768|FG000|Overall Study|Failed Pharmacokinetics|1|||
129096287|NCT02918552|464642769|FG001|Overall Study|Failed Pharmacokinetics|0|||
129096288|NCT02918552|464642768|FG000|Overall Study|Withdrawal by Subject|0|||
129096289|NCT02918552|464642769|FG001|Overall Study|Withdrawal by Subject|1|||
129096290|NCT02918552|464642768|FG000|Overall Study|Lost to Follow-up|0|||
129096291|NCT02918552|464642769|FG001|Overall Study|Lost to Follow-up|1|||
129096292|NCT03325894|464642770|FG000|Overall Study|Adverse Event|2|||
129096293|NCT03325894|464642771|FG001|Overall Study|Adverse Event|3|||
129096294|NCT03325894|464642770|FG000|Overall Study|Protocol Violation|1|||
129096295|NCT03325894|464642771|FG001|Overall Study|Protocol Violation|2|||
129096296|NCT03325894|464642770|FG000|Overall Study|Withdrawal by Subject|10|||
129096297|NCT03325894|464642771|FG001|Overall Study|Withdrawal by Subject|6|||
129096298|NCT03325894|464642770|FG000|Overall Study|Lost to Follow-up|4|||
128872450|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
128872451|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129096299|NCT03325894|464642771|FG001|Overall Study|Lost to Follow-up|9|||
129096300|NCT03325894|464642770|FG000|Overall Study|Lack of Efficacy|8|||
129096301|NCT03325894|464642771|FG001|Overall Study|Lack of Efficacy|14|||
128872452|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
129096302|NCT03325894|464642770|FG000|Overall Study|Study Terminated by Sponsor|38|||
129096303|NCT03325894|464642771|FG001|Overall Study|Study Terminated by Sponsor|43|||
129096304|NCT03325894|464642770|FG000|Overall Study|Other (Not received Treatment)|1|||
129096305|NCT03325894|464642771|FG001|Overall Study|Other (Not received Treatment)|0|||
129096306|NCT04395274|464642772|FG000|Overall Study|Lost to Follow-up|20|||
129096307|NCT04395274|464642773|FG001|Overall Study|Lost to Follow-up|11|||
129096308|NCT04395274|464642772|FG000|Overall Study|Withdrawal by Subject|13|||
129096309|NCT04395274|464642773|FG001|Overall Study|Withdrawal by Subject|10|||
129096310|NCT04395274|464642772|FG000|Overall Study|Moved Abroad|0|||
129096311|NCT04395274|464642773|FG001|Overall Study|Moved Abroad|1|||
129096312|NCT03673345|464642782|FG000|Overall Study|Lost to Follow-up|1|||
129096313|NCT03673345|464642783|FG001|Overall Study|Lost to Follow-up|0|||
129096314|NCT03673345|464642784|FG002|Overall Study|Lost to Follow-up|3|||
129096315|NCT03673345|464642785|FG003|Overall Study|Lost to Follow-up|3|||
129096316|NCT03673345|464642786|FG004|Overall Study|Lost to Follow-up|2|||
129096317|NCT03673345|464642787|FG005|Overall Study|Lost to Follow-up|1|||
129096318|NCT03673345|464642788|FG006|Overall Study|Lost to Follow-up|0|||
129096319|NCT03673345|464642789|FG007|Overall Study|Lost to Follow-up|0|||
129096320|NCT03673345|464642782|FG000|Overall Study|Withdrawal by Subject|1|||
129096321|NCT03673345|464642783|FG001|Overall Study|Withdrawal by Subject|0|||
128872453|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
128872454|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
128872455|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
128872456|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
128872457|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
128872458|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
128872459|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
128872460|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
128872461|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
128872462|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
128872463|NCT00700427|463827577|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
128872464|NCT00700427|463827578|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
128872465|NCT00700427|463827579|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
128872466|NCT00700427|463827580|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
128872467|NCT00700427|463827581|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
128872468|NCT00941070|463827583|FG000|Overall Study|Patient non-compliant|1|||
128872469|NCT04075994|463827584|FG000|Overall Study|Withdrawal by Subject|8|||
128872470|NCT04075994|463827585|FG001|Overall Study|Withdrawal by Subject|9|||
128872471|NCT04075994|463827584|FG000|Overall Study|Adverse Event|2|||
128872472|NCT04075994|463827585|FG001|Overall Study|Adverse Event|2|||
128872473|NCT04075994|463827584|FG000|Overall Study|Investigator withdrew|3|||
128872474|NCT04075994|463827585|FG001|Overall Study|Investigator withdrew|1|||
128872475|NCT01125514|463827595|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
128872476|NCT01125514|463827595|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
128872477|NCT01125514|463827595|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
128872478|NCT01125514|463827595|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
128872479|NCT01125514|463827595|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
129096322|NCT03673345|464642784|FG002|Overall Study|Withdrawal by Subject|4|||
129096323|NCT03673345|464642785|FG003|Overall Study|Withdrawal by Subject|2|||
129096324|NCT03673345|464642786|FG004|Overall Study|Withdrawal by Subject|0|||
129096325|NCT03673345|464642787|FG005|Overall Study|Withdrawal by Subject|0|||
129096326|NCT03673345|464642788|FG006|Overall Study|Withdrawal by Subject|0|||
129096327|NCT03673345|464642789|FG007|Overall Study|Withdrawal by Subject|0|||
129096328|NCT03673345|464642782|FG000|Overall Study|Physician Decision|0|||
129096329|NCT03673345|464642783|FG001|Overall Study|Physician Decision|0|||
129096330|NCT03673345|464642784|FG002|Overall Study|Physician Decision|2|||
129096331|NCT03673345|464642785|FG003|Overall Study|Physician Decision|0|||
128872480|NCT01125514|463827595|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
128872481|NCT00858364|463827598|FG000|Overall Study|Administrative Decision|3|||
128872482|NCT00858364|463827599|FG001|Overall Study|Administrative Decision|2|||
128872483|NCT00858364|463827598|FG000|Overall Study|Adverse Event|5|||
128872484|NCT00858364|463827599|FG001|Overall Study|Adverse Event|2|||
128872485|NCT00858364|463827598|FG000|Overall Study|Withdrawal by Subject|44|||
128872486|NCT00858364|463827599|FG001|Overall Study|Withdrawal by Subject|118|||
128872487|NCT00858364|463827598|FG000|Overall Study|Ineligibility Determined|1|||
129096332|NCT03673345|464642786|FG004|Overall Study|Physician Decision|0|||
129096333|NCT03673345|464642787|FG005|Overall Study|Physician Decision|0|||
129096334|NCT03673345|464642788|FG006|Overall Study|Physician Decision|0|||
129096335|NCT03673345|464642789|FG007|Overall Study|Physician Decision|0|||
129096336|NCT01362244|464642790|FG000|Overall Study|Adverse Event|3|||
129096337|NCT01362244|464642791|FG001|Overall Study|Adverse Event|5|||
129096338|NCT01362244|464642790|FG000|Overall Study|Lack of Efficacy|5|||
129096339|NCT01362244|464642791|FG001|Overall Study|Lack of Efficacy|11|||
129096340|NCT01362244|464642790|FG000|Overall Study|Lost to Follow-up|0|||
129096341|NCT01362244|464642791|FG001|Overall Study|Lost to Follow-up|2|||
129096342|NCT01362244|464642790|FG000|Overall Study|Protocol Violation|5|||
129096343|NCT01362244|464642791|FG001|Overall Study|Protocol Violation|1|||
129096344|NCT01362244|464642790|FG000|Overall Study|Withdrawal by Subject|2|||
129096345|NCT01362244|464642791|FG001|Overall Study|Withdrawal by Subject|1|||
129096346|NCT01362244|464642790|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
129096347|NCT01362244|464642791|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
129096348|NCT01362244|464642790|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
129096349|NCT01362244|464642791|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
129096350|NCT02000882|464644427|FG000|Overall Study|Adverse Event|3|||
129096351|NCT02000882|464644427|FG000|Overall Study|Physician Decision|2|||
129096352|NCT02000882|464644427|FG000|Overall Study|Withdrawal by Subject|1|||
129096353|NCT00549601|464644428|FG000|Randomized|Protocol Violation|0|||
129096354|NCT00549601|464644429|FG001|Randomized|Protocol Violation|0|||
129096355|NCT00549601|464644430|FG002|Randomized|Protocol Violation|1|||
129096356|NCT00549601|464644428|FG000|Randomized|Withdrawal by Subject|0|||
129096357|NCT00549601|464644429|FG001|Randomized|Withdrawal by Subject|1|||
129096358|NCT00549601|464644430|FG002|Randomized|Withdrawal by Subject|1|||
129096359|NCT00549601|464644428|FG000|Received Study Drug|Adverse Event|2|||
129096360|NCT00549601|464644429|FG001|Received Study Drug|Adverse Event|5|||
129096361|NCT00549601|464644430|FG002|Received Study Drug|Adverse Event|1|||
129096362|NCT00549601|464644428|FG000|Received Study Drug|Death|0|||
129096363|NCT00549601|464644429|FG001|Received Study Drug|Death|1|||
129096364|NCT00549601|464644430|FG002|Received Study Drug|Death|0|||
129096365|NCT00549601|464644428|FG000|Received Study Drug|Lost to Follow-up|0|||
129096366|NCT00549601|464644429|FG001|Received Study Drug|Lost to Follow-up|1|||
129096367|NCT00549601|464644430|FG002|Received Study Drug|Lost to Follow-up|1|||
129096368|NCT00549601|464644428|FG000|Received Study Drug|Protocol Violation|3|||
129096369|NCT00549601|464644429|FG001|Received Study Drug|Protocol Violation|4|||
129096370|NCT00549601|464644430|FG002|Received Study Drug|Protocol Violation|1|||
129096371|NCT00549601|464644428|FG000|Received Study Drug|Withdrawal by Subject|2|||
129096372|NCT00549601|464644429|FG001|Received Study Drug|Withdrawal by Subject|0|||
129096373|NCT00549601|464644430|FG002|Received Study Drug|Withdrawal by Subject|1|||
129096374|NCT01492101|464644436|FG000|Overall Study|Death|323|||
129096375|NCT01492101|464644437|FG001|Overall Study|Death|322|||
129096376|NCT01492101|464644436|FG000|Overall Study|Withdrawal by Subject|14|||
129096377|NCT01492101|464644437|FG001|Overall Study|Withdrawal by Subject|18|||
129096378|NCT01492101|464644436|FG000|Overall Study|Lost to Follow-up|0|||
129096379|NCT01492101|464644437|FG001|Overall Study|Lost to Follow-up|2|||
129096380|NCT02696434|464644438|FG000|Overall Study|Adverse Event|3|||
129096381|NCT02696434|464644439|FG001|Overall Study|Adverse Event|1|||
129096382|NCT02696434|464644438|FG000|Overall Study|Lost to Follow-up|5|||
129096383|NCT02696434|464644439|FG001|Overall Study|Lost to Follow-up|4|||
129096384|NCT02696434|464644438|FG000|Overall Study|Withdrawal by Subject|14|||
129096385|NCT02696434|464644439|FG001|Overall Study|Withdrawal by Subject|12|||
129096386|NCT02696434|464644438|FG000|Overall Study|Physician Decision|0|||
129096387|NCT02696434|464644439|FG001|Overall Study|Physician Decision|1|||
129096388|NCT00316914|464644458|FG000|Overall Study|Withdrawal by Subject|5|||
128872488|NCT00858364|463827599|FG001|Overall Study|Ineligibility Determined|10|||
128872489|NCT00858364|463827598|FG000|Overall Study|Lost to Follow-up|24|||
128872490|NCT00858364|463827599|FG001|Overall Study|Lost to Follow-up|54|||
128872491|NCT00858364|463827598|FG000|Overall Study|Noncompliance|3|||
129096389|NCT00316914|464644459|FG001|Overall Study|Withdrawal by Subject|3|||
128872492|NCT00858364|463827599|FG001|Overall Study|Noncompliance|4|||
129096390|NCT00316914|464644458|FG000|Overall Study|Adverse Event|8|||
129096391|NCT00316914|464644459|FG001|Overall Study|Adverse Event|7|||
129096392|NCT00316914|464644458|FG000|Overall Study|Other Problems|6|||
129096393|NCT00316914|464644459|FG001|Overall Study|Other Problems|11|||
129096394|NCT00316914|464644458|FG000|Overall Study|Missing end of treatment documentation|14|||
129096395|NCT00316914|464644459|FG001|Overall Study|Missing end of treatment documentation|15|||
129096396|NCT04105010|464644460|FG000|Overall Study|Death|3|||
128872493|NCT00858364|463827598|FG000|Overall Study|Protocol Deviation|0|||
128872494|NCT00858364|463827599|FG001|Overall Study|Protocol Deviation|2|||
128872495|NCT00858364|463827598|FG000|Overall Study|Other|9|||
128872496|NCT00858364|463827599|FG001|Overall Study|Other|17|||
128872497|NCT00858364|463827598|FG000|Overall Study|Missing|1|||
128872498|NCT00858364|463827599|FG001|Overall Study|Missing|1|||
128872499|NCT00858364|463827598|FG000|Overall Study|Still on-study|114|||
128872500|NCT00858364|463827599|FG001|Overall Study|Still on-study|247|||
128872501|NCT02755818|463827600|FG000|Overall Study|Withdrawal by Subject|0|||
128872502|NCT02755818|463827601|FG001|Overall Study|Withdrawal by Subject|0|||
128872503|NCT02755818|463827602|FG002|Overall Study|Withdrawal by Subject|0|||
128872504|NCT02755818|463827603|FG003|Overall Study|Withdrawal by Subject|2|||
128872505|NCT02755818|463827600|FG000|Overall Study|withdrawal by PI|0|||
128872506|NCT02755818|463827601|FG001|Overall Study|withdrawal by PI|0|||
128872507|NCT02755818|463827602|FG002|Overall Study|withdrawal by PI|1|||
128872508|NCT02755818|463827603|FG003|Overall Study|withdrawal by PI|1|||
128872509|NCT02535091|463827606|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
128872510|NCT02535091|463827607|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
128872511|NCT02535091|463827608|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
128872512|NCT02535091|463827606|FG000|Overall Study|Withdrawal by Subject|14|||
128872513|NCT02535091|463827607|FG001|Overall Study|Withdrawal by Subject|5|||
128872514|NCT02535091|463827608|FG002|Overall Study|Withdrawal by Subject|121|||
128872515|NCT02535091|463827606|FG000|Overall Study|Adverse Event|9|||
128872516|NCT02535091|463827607|FG001|Overall Study|Adverse Event|4|||
128872517|NCT02535091|463827608|FG002|Overall Study|Adverse Event|170|||
128872518|NCT02535091|463827606|FG000|Overall Study|Other|4|||
128872519|NCT02535091|463827607|FG001|Overall Study|Other|3|||
128872520|NCT02535091|463827608|FG002|Overall Study|Other|81|||
128872521|NCT02535091|463827606|FG000|Overall Study|Lost to Follow-up|0|||
128872522|NCT02535091|463827607|FG001|Overall Study|Lost to Follow-up|1|||
128872523|NCT02535091|463827608|FG002|Overall Study|Lost to Follow-up|19|||
128872524|NCT02535091|463827606|FG000|Overall Study|Protocol Violation|0|||
128872525|NCT02535091|463827607|FG001|Overall Study|Protocol Violation|1|||
128872526|NCT02535091|463827608|FG002|Overall Study|Protocol Violation|11|||
128872527|NCT02535091|463827606|FG000|Overall Study|Pregnancy|0|||
128872528|NCT02535091|463827607|FG001|Overall Study|Pregnancy|0|||
128872529|NCT02535091|463827608|FG002|Overall Study|Pregnancy|7|||
128872530|NCT02601300|463827609|FG000|Induction Phase|Lack of Efficacy|2|||
128872531|NCT02601300|463827609|FG000|Induction Phase|Protocol Violation|1|||
128872532|NCT02601300|463827609|FG000|Extension Phase|Withdrawal by Subject|3|||
128872533|NCT02601300|463827609|FG000|Extension Phase|Adverse Event|4|||
128872534|NCT02601300|463827609|FG000|Extension Phase|Lack of Efficacy|10|||
128872535|NCT01127763|463827612|FG000|Overall Study|Adverse Event|2|||
128872536|NCT01127763|463827612|FG000|Overall Study|Withdrawal by Subject|1|||
128872537|NCT01127763|463827612|FG000|Overall Study|Physician Decision|2|||
128872538|NCT00992225|463827613|FG000|Overall Study|Entry Criteria Not Met|8|||
128872539|NCT00992225|463827613|FG000|Overall Study|Adverse Event|2|||
128872540|NCT02153073|463827614|FG000|Overall Study|Case Report Forms Uncollected|230|||
128872541|NCT02153073|463827614|FG000|Overall Study|Protocol Deviation|68|||
128872542|NCT00738894|463827615|FG000|Overall Study|Lost to Follow-up|23|||
128872543|NCT00738894|463827616|FG001|Overall Study|Lost to Follow-up|13|||
128872544|NCT00738894|463827615|FG000|Overall Study|Withdrawal by Subject|10|||
128872545|NCT00738894|463827616|FG001|Overall Study|Withdrawal by Subject|15|||
128872546|NCT00738894|463827615|FG000|Overall Study|Physician Decision|4|||
128872547|NCT00738894|463827616|FG001|Overall Study|Physician Decision|5|||
128872548|NCT00738894|463827615|FG000|Overall Study|Death|2|||
128872549|NCT00738894|463827616|FG001|Overall Study|Death|0|||
128872550|NCT01081665|463827617|FG000|Overall Study|Death|41|||
128872551|NCT01081665|463827617|FG000|Overall Study|Lost to Follow-up|18|||
128872552|NCT01081665|463827617|FG000|Overall Study|Withdrawal by Subject|17|||
128872553|NCT01081665|463827617|FG000|Overall Study|Change of dialysis unit|10|||
128872554|NCT01081665|463827617|FG000|Overall Study|Regulation of iPTH|5|||
128872555|NCT01081665|463827617|FG000|Overall Study|Change in renal replacement therapy|2|||
128872556|NCT01081665|463827617|FG000|Overall Study|Adverse Event|1|||
129096397|NCT04105010|464644461|FG001|Overall Study|Death|1|||
129096398|NCT04105010|464644462|FG002|Overall Study|Death|1|||
129096399|NCT04105010|464644463|FG003|Overall Study|Death|54|||
128872557|NCT01081665|463827617|FG000|Overall Study|Lack of Efficacy|1|||
128872558|NCT02546921|463827627|FG000|Overall Study|Adverse Event|0|||
128872559|NCT02546921|463827628|FG001|Overall Study|Adverse Event|5|||
128872560|NCT02546921|463827629|FG002|Overall Study|Adverse Event|2|||
128872561|NCT02546921|463827630|FG003|Overall Study|Adverse Event|0|||
128872562|NCT02546921|463827631|FG004|Overall Study|Adverse Event|0|||
128872563|NCT02546921|463827632|FG005|Overall Study|Adverse Event|0|||
128872564|NCT02546921|463827633|FG006|Overall Study|Adverse Event|0|||
128872565|NCT02546921|463827627|FG000|Overall Study|Evidence of Disease Progression|1|||
128872566|NCT02546921|463827628|FG001|Overall Study|Evidence of Disease Progression|0|||
128872567|NCT02546921|463827629|FG002|Overall Study|Evidence of Disease Progression|0|||
129096400|NCT04105010|464644460|FG000|Overall Study|Lost to Follow-up|0|||
129096401|NCT04105010|464644461|FG001|Overall Study|Lost to Follow-up|0|||
128872568|NCT02546921|463827630|FG003|Overall Study|Evidence of Disease Progression|0|||
128872569|NCT02546921|463827631|FG004|Overall Study|Evidence of Disease Progression|1|||
128872570|NCT02546921|463827632|FG005|Overall Study|Evidence of Disease Progression|0|||
128872571|NCT02546921|463827633|FG006|Overall Study|Evidence of Disease Progression|0|||
128872572|NCT02546921|463827627|FG000|Overall Study|Patient Choice|0|||
128872573|NCT02546921|463827628|FG001|Overall Study|Patient Choice|1|||
128872574|NCT02546921|463827629|FG002|Overall Study|Patient Choice|0|||
128872575|NCT02546921|463827630|FG003|Overall Study|Patient Choice|0|||
128872576|NCT02546921|463827631|FG004|Overall Study|Patient Choice|0|||
128872577|NCT02546921|463827632|FG005|Overall Study|Patient Choice|1|||
128872578|NCT02546921|463827633|FG006|Overall Study|Patient Choice|0|||
128872579|NCT03026075|463827637|FG000|Overall Study|Physician Decision|1|||
128872580|NCT00293059|463827638|FG000|Overall Study|Adverse Event|12|||
128872581|NCT00293059|463827639|FG001|Overall Study|Adverse Event|4|||
128872582|NCT00293059|463827638|FG000|Overall Study|Lack of Efficacy|2|||
128872583|NCT00293059|463827639|FG001|Overall Study|Lack of Efficacy|0|||
128872584|NCT00293059|463827638|FG000|Overall Study|Lost to Follow-up|2|||
128872585|NCT00293059|463827639|FG001|Overall Study|Lost to Follow-up|3|||
128872586|NCT00293059|463827638|FG000|Overall Study|Pregnancy|1|||
128872587|NCT00293059|463827639|FG001|Overall Study|Pregnancy|1|||
128872588|NCT00293059|463827638|FG000|Overall Study|Protocol Violation|2|||
128872589|NCT00293059|463827639|FG001|Overall Study|Protocol Violation|0|||
128872590|NCT00293059|463827638|FG000|Overall Study|Withdrawal by Subject|11|||
128872591|NCT00293059|463827639|FG001|Overall Study|Withdrawal by Subject|5|||
128872592|NCT00293059|463827638|FG000|Overall Study|Participant moved out of state|1|||
128872593|NCT00293059|463827639|FG001|Overall Study|Participant moved out of state|0|||
128872594|NCT00293059|463827638|FG000|Overall Study|Participant stopped study drug|1|||
128872595|NCT00293059|463827639|FG001|Overall Study|Participant stopped study drug|0|||
128872596|NCT00293059|463827638|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
128872597|NCT00293059|463827639|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
128872598|NCT00293059|463827638|FG000|Overall Study|missing|3|||
128872599|NCT00293059|463827639|FG001|Overall Study|missing|5|||
128872600|NCT02227199|463827651|FG000|Overall Study|Physician Decision|0|||
128872601|NCT02227199|463827652|FG001|Overall Study|Physician Decision|0|||
128872602|NCT02227199|463827653|FG002|Overall Study|Physician Decision|1|||
128872603|NCT02227199|463827651|FG000|Overall Study|Adverse Event|0|||
128872604|NCT02227199|463827652|FG001|Overall Study|Adverse Event|0|||
128872605|NCT02227199|463827653|FG002|Overall Study|Adverse Event|3|||
128872606|NCT05597787|463827654|FG000|Overall Study|Withdrawal by Subject|0|||
128872607|NCT05597787|463827655|FG001|Overall Study|Withdrawal by Subject|0|||
128872608|NCT05597787|463827656|FG002|Overall Study|Withdrawal by Subject|1|||
128872609|NCT05453201|463827658|FG000|Overall Study|Withdrawal by Subject|1|||
128872610|NCT01934790|463827659|FG000|Treatment|Adverse Event|3|||
128872611|NCT01934790|463827659|FG000|Treatment|Clinical progression|6|||
128872612|NCT01934790|463827659|FG000|Treatment|Radiological progression|4|||
128872613|NCT01934790|463827659|FG000|Treatment|Withdrawal by Subject|2|||
128872614|NCT01934790|463827659|FG000|Treatment|Study drug never administered|1|||
128872615|NCT01934790|463827659|FG000|Active Follow up|Death|20|||
128872616|NCT01934790|463827659|FG000|Active Follow up|Physician Decision|2|||
128872617|NCT01934790|463827659|FG000|Active Follow up|Progressive disease|1|||
128872618|NCT01934790|463827659|FG000|Active Follow up|Other reason|1|||
128872619|NCT03798691|463827660|FG000|Overall Study|Lost to Follow-up|2|||
128872620|NCT03798691|463827661|FG001|Overall Study|Lost to Follow-up|2|||
128872621|NCT01200290|463827662|FG000|Treatment Period|Adverse Event|1|||
128872622|NCT01200290|463827662|FG000|Post-Treatment Follow-Up Period|Death|2|||
128872623|NCT01144377|463827668|FG000|52 Week Treatment Period|Adverse Event|0|||
128872624|NCT01144377|463827669|FG001|52 Week Treatment Period|Adverse Event|0|||
128872625|NCT01144377|463827670|FG002|52 Week Treatment Period|Adverse Event|3|||
128872626|NCT01144377|463827671|FG003|52 Week Treatment Period|Adverse Event|2|||
128872627|NCT01144377|463827672|FG004|52 Week Treatment Period|Adverse Event|1|||
128872628|NCT01144377|463827668|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
128872629|NCT01144377|463827669|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
128872630|NCT01144377|463827670|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
128872631|NCT01144377|463827671|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
128872632|NCT01144377|463827672|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
128872633|NCT01144377|463827668|FG000|52 Week Treatment Period|Protocol Violation|0|||
128872634|NCT01144377|463827669|FG001|52 Week Treatment Period|Protocol Violation|0|||
128872635|NCT01144377|463827670|FG002|52 Week Treatment Period|Protocol Violation|0|||
128872636|NCT01144377|463827671|FG003|52 Week Treatment Period|Protocol Violation|0|||
128872637|NCT01144377|463827672|FG004|52 Week Treatment Period|Protocol Violation|1|||
128872638|NCT01144377|463827668|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
128872639|NCT01144377|463827669|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
128872640|NCT01144377|463827670|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
128872641|NCT01144377|463827671|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
128872642|NCT01144377|463827672|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
128872643|NCT01144377|463827668|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
128872644|NCT01144377|463827669|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
128872645|NCT01144377|463827670|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
128872646|NCT01144377|463827671|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
128872647|NCT01144377|463827672|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
128872648|NCT01144377|463827668|FG000|52 Week Treatment Period|Sponsor Decision|0|||
128872649|NCT01144377|463827669|FG001|52 Week Treatment Period|Sponsor Decision|0|||
128872650|NCT01144377|463827670|FG002|52 Week Treatment Period|Sponsor Decision|0|||
128872651|NCT01144377|463827671|FG003|52 Week Treatment Period|Sponsor Decision|0|||
128872652|NCT01144377|463827672|FG004|52 Week Treatment Period|Sponsor Decision|1|||
128872653|NCT01144377|463827668|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
128872654|NCT01144377|463827669|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
128872655|NCT01144377|463827670|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
128872656|NCT01144377|463827671|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
128872657|NCT01144377|463827672|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
128872658|NCT01144377|463827668|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
128872659|NCT01144377|463827669|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
128872660|NCT01144377|463827670|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
128872661|NCT01144377|463827671|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
128872662|NCT01144377|463827672|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
128872663|NCT01144377|463827668|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
128872664|NCT01144377|463827669|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
128872665|NCT01144377|463827670|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
128872666|NCT01144377|463827671|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
128872667|NCT01144377|463827672|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
128872668|NCT02489968|463827675|FG000|Open-label Treatment Period|Adverse Event|14|||
128872669|NCT02489968|463827676|FG001|Open-label Treatment Period|Adverse Event|7|||
128872670|NCT02489968|463827677|FG002|Open-label Treatment Period|Adverse Event|0|||
128872671|NCT02489968|463827678|FG003|Open-label Treatment Period|Adverse Event|0|||
128872672|NCT02489968|463827679|FG004|Open-label Treatment Period|Adverse Event|0|||
128872673|NCT02489968|463827680|FG005|Open-label Treatment Period|Adverse Event|0|||
128872674|NCT02489968|463827675|FG000|Open-label Treatment Period|Protocol Violation|2|||
128872675|NCT02489968|463827676|FG001|Open-label Treatment Period|Protocol Violation|2|||
128872676|NCT02489968|463827677|FG002|Open-label Treatment Period|Protocol Violation|0|||
128872677|NCT02489968|463827678|FG003|Open-label Treatment Period|Protocol Violation|0|||
128872678|NCT02489968|463827679|FG004|Open-label Treatment Period|Protocol Violation|0|||
128872679|NCT02489968|463827680|FG005|Open-label Treatment Period|Protocol Violation|0|||
128872680|NCT02489968|463827675|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
128872681|NCT02489968|463827676|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
128872682|NCT02489968|463827677|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
128872683|NCT02489968|463827678|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
128872684|NCT02489968|463827679|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
128872685|NCT02489968|463827680|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
128872686|NCT02489968|463827675|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
128872687|NCT02489968|463827676|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
128872688|NCT02489968|463827677|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
128872689|NCT02489968|463827678|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
128872690|NCT02489968|463827679|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
128872691|NCT02489968|463827680|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
128872692|NCT02489968|463827675|FG000|Open-label Treatment Period|Other than specified above|204|||
128872693|NCT02489968|463827676|FG001|Open-label Treatment Period|Other than specified above|189|||
128872694|NCT02489968|463827677|FG002|Open-label Treatment Period|Other than specified above|0|||
128872695|NCT02489968|463827678|FG003|Open-label Treatment Period|Other than specified above|0|||
128872696|NCT02489968|463827679|FG004|Open-label Treatment Period|Other than specified above|0|||
128872697|NCT02489968|463827680|FG005|Open-label Treatment Period|Other than specified above|0|||
128872698|NCT02489968|463827675|FG000|Double-blind Treatment Period|Adverse Event|0|||
128872699|NCT02489968|463827676|FG001|Double-blind Treatment Period|Adverse Event|0|||
128872700|NCT02489968|463827677|FG002|Double-blind Treatment Period|Adverse Event|2|||
128872701|NCT02489968|463827678|FG003|Double-blind Treatment Period|Adverse Event|6|||
128872702|NCT02489968|463827679|FG004|Double-blind Treatment Period|Adverse Event|4|||
128872703|NCT02489968|463827680|FG005|Double-blind Treatment Period|Adverse Event|5|||
128872704|NCT02489968|463827675|FG000|Double-blind Treatment Period|Protocol Violation|0|||
128872705|NCT02489968|463827676|FG001|Double-blind Treatment Period|Protocol Violation|0|||
128872706|NCT02489968|463827677|FG002|Double-blind Treatment Period|Protocol Violation|0|||
128872707|NCT02489968|463827678|FG003|Double-blind Treatment Period|Protocol Violation|0|||
128872708|NCT02489968|463827679|FG004|Double-blind Treatment Period|Protocol Violation|1|||
128872709|NCT02489968|463827680|FG005|Double-blind Treatment Period|Protocol Violation|1|||
128872710|NCT02489968|463827675|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
128872711|NCT02489968|463827676|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
128872712|NCT02489968|463827677|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
128872713|NCT02489968|463827678|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
128872714|NCT02489968|463827679|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
128872715|NCT02489968|463827680|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
128872716|NCT02489968|463827675|FG000|Double-blind Treatment Period|Other than specified above|0|||
128872717|NCT02489968|463827676|FG001|Double-blind Treatment Period|Other than specified above|0|||
128872718|NCT02489968|463827677|FG002|Double-blind Treatment Period|Other than specified above|0|||
128872719|NCT02489968|463827678|FG003|Double-blind Treatment Period|Other than specified above|0|||
128872720|NCT02489968|463827679|FG004|Double-blind Treatment Period|Other than specified above|1|||
128872721|NCT02489968|463827680|FG005|Double-blind Treatment Period|Other than specified above|0|||
128872722|NCT00607724|463827682|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
128872723|NCT00607724|463827683|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
128872724|NCT00607724|463827684|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
128872725|NCT00607724|463827685|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
128872726|NCT00607724|463827686|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
128872727|NCT00607724|463827687|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
128872728|NCT00607724|463827688|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
128872729|NCT00607724|463827682|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
128872730|NCT00607724|463827683|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
128872731|NCT00607724|463827684|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
128872732|NCT00607724|463827685|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
128872733|NCT00607724|463827686|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
128872734|NCT00607724|463827687|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
128872735|NCT00607724|463827688|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
128872736|NCT00607724|463827682|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
128872737|NCT00607724|463827683|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
128872738|NCT00607724|463827684|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
128872739|NCT00607724|463827685|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
128872740|NCT00607724|463827686|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
128872741|NCT00607724|463827687|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
128872742|NCT00607724|463827688|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
128872743|NCT00607724|463827682|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
128872744|NCT00607724|463827683|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
128872745|NCT00607724|463827684|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
128872746|NCT00607724|463827685|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
128872747|NCT00607724|463827686|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
128872748|NCT00607724|463827687|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
128872749|NCT00607724|463827688|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
128872750|NCT00607724|463827682|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
128872751|NCT00607724|463827683|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
128872752|NCT00607724|463827684|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
128872753|NCT00607724|463827685|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
128872754|NCT00607724|463827686|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
128872755|NCT00607724|463827687|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
128872756|NCT00607724|463827688|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
128872757|NCT03738423|463827689|FG000|Overall Study|Withdrawal by Subject|9|||
128872758|NCT03738423|463827690|FG001|Overall Study|Withdrawal by Subject|12|||
128872759|NCT03738423|463827691|FG002|Overall Study|Withdrawal by Subject|9|||
128872760|NCT03738423|463827692|FG003|Overall Study|Withdrawal by Subject|12|||
128872761|NCT03738423|463827693|FG004|Overall Study|Withdrawal by Subject|10|||
128872762|NCT03738423|463827689|FG000|Overall Study|Lack of Efficacy|3|||
128872763|NCT03738423|463827690|FG001|Overall Study|Lack of Efficacy|1|||
128872764|NCT03738423|463827691|FG002|Overall Study|Lack of Efficacy|1|||
128872765|NCT03738423|463827692|FG003|Overall Study|Lack of Efficacy|1|||
128872766|NCT03738423|463827693|FG004|Overall Study|Lack of Efficacy|2|||
128872767|NCT03738423|463827689|FG000|Overall Study|Lost to Follow-up|1|||
128872768|NCT03738423|463827690|FG001|Overall Study|Lost to Follow-up|0|||
128872769|NCT03738423|463827691|FG002|Overall Study|Lost to Follow-up|1|||
128872770|NCT03738423|463827692|FG003|Overall Study|Lost to Follow-up|1|||
129096402|NCT04105010|464644462|FG002|Overall Study|Lost to Follow-up|0|||
129096403|NCT04105010|464644463|FG003|Overall Study|Lost to Follow-up|4|||
128872771|NCT03738423|463827693|FG004|Overall Study|Lost to Follow-up|0|||
128872772|NCT03738423|463827689|FG000|Overall Study|Protocol Violation|1|||
128872773|NCT03738423|463827690|FG001|Overall Study|Protocol Violation|0|||
128872774|NCT03738423|463827691|FG002|Overall Study|Protocol Violation|0|||
128872775|NCT03738423|463827692|FG003|Overall Study|Protocol Violation|0|||
128872776|NCT03738423|463827693|FG004|Overall Study|Protocol Violation|1|||
128872777|NCT03738423|463827689|FG000|Overall Study|Physician Decision|0|||
128872778|NCT03738423|463827690|FG001|Overall Study|Physician Decision|0|||
128872779|NCT03738423|463827691|FG002|Overall Study|Physician Decision|1|||
128872780|NCT03738423|463827692|FG003|Overall Study|Physician Decision|0|||
129096404|NCT04105010|464644460|FG000|Overall Study|Withdrawal by Subject|8|||
128872781|NCT03738423|463827693|FG004|Overall Study|Physician Decision|1|||
128872782|NCT03738423|463827689|FG000|Overall Study|Death|0|||
128872783|NCT03738423|463827690|FG001|Overall Study|Death|0|||
128872784|NCT03738423|463827691|FG002|Overall Study|Death|0|||
128872785|NCT03738423|463827692|FG003|Overall Study|Death|0|||
128872786|NCT03738423|463827693|FG004|Overall Study|Death|1|||
128872787|NCT03738423|463827689|FG000|Overall Study|Randomized but never treated|0|||
128872788|NCT03738423|463827690|FG001|Overall Study|Randomized but never treated|0|||
128872789|NCT03738423|463827691|FG002|Overall Study|Randomized but never treated|1|||
128872790|NCT03738423|463827692|FG003|Overall Study|Randomized but never treated|1|||
128872791|NCT03738423|463827693|FG004|Overall Study|Randomized but never treated|0|||
128872792|NCT01241604|463827694|FG000|Screening Period|Screen Failure|3|||
128872793|NCT01241604|463827695|FG001|Screening Period|Screen Failure|0|||
128872794|NCT01241604|463827696|FG002|Screening Period|Screen Failure|0|||
128872795|NCT01865747|463827698|FG000|Overall Study (ITT)|Adverse Event|32|||
128872796|NCT01865747|463827699|FG001|Overall Study (ITT)|Adverse Event|31|||
128872797|NCT01865747|463827698|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
128872798|NCT01865747|463827699|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
128872799|NCT01865747|463827698|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
128872800|NCT01865747|463827699|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
128872801|NCT01865747|463827698|FG000|Overall Study (ITT)|Protocol Violation|1|||
128872802|NCT01865747|463827699|FG001|Overall Study (ITT)|Protocol Violation|1|||
128872803|NCT01865747|463827698|FG000|Overall Study (ITT)|Physician Decision|5|||
128872804|NCT01865747|463827699|FG001|Overall Study (ITT)|Physician Decision|2|||
128872805|NCT01865747|463827698|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
128872806|NCT01865747|463827699|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
128872807|NCT01865747|463827698|FG000|Overall Study (ITT)|Sponsor Decision|0|||
128872808|NCT01865747|463827699|FG001|Overall Study (ITT)|Sponsor Decision|1|||
128872809|NCT01865747|463827698|FG000|Overall Study (ITT)|Progressive Disease|122|||
128872810|NCT01865747|463827699|FG001|Overall Study (ITT)|Progressive Disease|158|||
128872811|NCT01865747|463827698|FG000|Overall Study (ITT)|Reason Not Provided|0|||
128872812|NCT01865747|463827699|FG001|Overall Study (ITT)|Reason Not Provided|1|||
128872813|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
128872814|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
128872815|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
128872816|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
128872817|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
128872818|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
128872819|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
128872820|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
128872821|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
128872822|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
128872823|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
128872824|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
128872825|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
128872826|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
128872827|NCT01865747|463827698|FG000|Primary Intent to Treat (PITT)|Other|0|||
128872828|NCT01865747|463827699|FG001|Primary Intent to Treat (PITT)|Other|1|||
128872829|NCT02592876|463827700|FG000|Overall Study|Withdrawal by Subject|3|||
128872830|NCT02592876|463827701|FG001|Overall Study|Withdrawal by Subject|3|||
128872831|NCT02592876|463827700|FG000|Overall Study|Study Termination by Sponsor|32|||
128872832|NCT02592876|463827701|FG001|Overall Study|Study Termination by Sponsor|27|||
128872833|NCT02592876|463827700|FG000|Overall Study|Lost to Follow-up|0|||
128872834|NCT02592876|463827701|FG001|Overall Study|Lost to Follow-up|1|||
128872835|NCT02592876|463827700|FG000|Overall Study|Death|6|||
128872836|NCT02592876|463827701|FG001|Overall Study|Death|9|||
128872837|NCT00611975|463827706|FG000|Overall Study|Withdrawal by Subject|3|||
128872838|NCT00611975|463827707|FG001|Overall Study|Withdrawal by Subject|7|||
128872839|NCT00611975|463827706|FG000|Overall Study|Pregnancy|2|||
128872840|NCT00611975|463827707|FG001|Overall Study|Pregnancy|1|||
128872841|NCT03465904|463827708|FG000|Overall Study|Withdrawal by Subject|9|||
128872842|NCT03465904|463827709|FG001|Overall Study|Withdrawal by Subject|5|||
128872843|NCT03465904|463827708|FG000|Overall Study|Lost to Follow-up|11|||
128872844|NCT03465904|463827709|FG001|Overall Study|Lost to Follow-up|9|||
128872845|NCT03465904|463827708|FG000|Overall Study|Protocol Violation|20|||
128872846|NCT03465904|463827709|FG001|Overall Study|Protocol Violation|15|||
128872847|NCT01305200|463827711|FG000|Overall Study|Physician Decision|4|||
128872848|NCT01305200|463827712|FG001|Overall Study|Physician Decision|6|||
128872849|NCT01305200|463827713|FG002|Overall Study|Physician Decision|1|||
128872850|NCT01305200|463827711|FG000|Overall Study|Withdrawal by Subject|24|||
128872851|NCT01305200|463827712|FG001|Overall Study|Withdrawal by Subject|21|||
128872852|NCT01305200|463827713|FG002|Overall Study|Withdrawal by Subject|1|||
128872853|NCT01305200|463827711|FG000|Overall Study|Ineligible|1|||
128872854|NCT01305200|463827712|FG001|Overall Study|Ineligible|2|||
128872855|NCT01305200|463827713|FG002|Overall Study|Ineligible|1|||
128872856|NCT01305200|463827711|FG000|Overall Study|Death|0|||
128872857|NCT01305200|463827712|FG001|Overall Study|Death|2|||
128872858|NCT01305200|463827713|FG002|Overall Study|Death|0|||
128872859|NCT01198756|463829041|FG000|Overall Study|Adverse Event|0|||
128872860|NCT01198756|463829042|FG001|Overall Study|Adverse Event|0|||
128872861|NCT01198756|463829043|FG002|Overall Study|Adverse Event|0|||
128872862|NCT01198756|463829044|FG003|Overall Study|Adverse Event|1|||
128872863|NCT01198756|463829041|FG000|Overall Study|Protocol Violation|0|||
128872864|NCT01198756|463829042|FG001|Overall Study|Protocol Violation|0|||
128872865|NCT01198756|463829043|FG002|Overall Study|Protocol Violation|0|||
128872866|NCT01198756|463829044|FG003|Overall Study|Protocol Violation|2|||
128872867|NCT01198756|463829041|FG000|Overall Study|Withdrawal by Subject|9|||
128872868|NCT01198756|463829042|FG001|Overall Study|Withdrawal by Subject|4|||
128872869|NCT01198756|463829043|FG002|Overall Study|Withdrawal by Subject|7|||
128872870|NCT01198756|463829044|FG003|Overall Study|Withdrawal by Subject|5|||
128872871|NCT01198756|463829041|FG000|Overall Study|Lost to Follow-up|29|||
128872872|NCT01198756|463829042|FG001|Overall Study|Lost to Follow-up|36|||
128872873|NCT01198756|463829043|FG002|Overall Study|Lost to Follow-up|23|||
128872874|NCT01198756|463829044|FG003|Overall Study|Lost to Follow-up|18|||
128872875|NCT05816330|463829050|FG000|Overall Study|Withdrawal by Subject|4|||
128872876|NCT05816330|463829051|FG001|Overall Study|Withdrawal by Subject|1|||
128872877|NCT01353859|463829052|FG000|Overall Study|Adverse Event|3|||
128872878|NCT01353859|463829052|FG000|Overall Study|Lack of Efficacy|1|||
128872879|NCT03231800|463829053|FG000|Overall Study|Lost to Follow-up|0|||
128872880|NCT03231800|463829054|FG001|Overall Study|Lost to Follow-up|2|||
128872881|NCT03231800|463829053|FG000|Overall Study|Protocol Violation|1|||
128872882|NCT03231800|463829054|FG001|Overall Study|Protocol Violation|1|||
128872883|NCT03231800|463829053|FG000|Overall Study|reason not provided|2|||
128872884|NCT03231800|463829054|FG001|Overall Study|reason not provided|0|||
128872885|NCT00859222|463829055|FG000|Overall Study|Adverse Event|2|||
128872886|NCT00859222|463829056|FG001|Overall Study|Adverse Event|3|||
128872887|NCT00859222|463829057|FG002|Overall Study|Adverse Event|6|||
128872888|NCT00859222|463829058|FG003|Overall Study|Adverse Event|24|||
128872889|NCT00859222|463829059|FG004|Overall Study|Adverse Event|15|||
128872890|NCT00859222|463829055|FG000|Overall Study|DLT|1|||
128872891|NCT00859222|463829056|FG001|Overall Study|DLT|0|||
128872892|NCT00859222|463829057|FG002|Overall Study|DLT|0|||
128872893|NCT00859222|463829058|FG003|Overall Study|DLT|0|||
128872894|NCT00859222|463829059|FG004|Overall Study|DLT|0|||
128872895|NCT00400725|463829060|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
128872896|NCT00400725|463829061|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
128872897|NCT00400725|463829062|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
128872898|NCT00400725|463829060|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
128872899|NCT00400725|463829061|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
128872900|NCT00400725|463829062|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
128872901|NCT00400725|463829060|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
128872902|NCT00400725|463829061|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
128872903|NCT00400725|463829062|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
128872904|NCT00400725|463829060|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
128872905|NCT00400725|463829061|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
128872906|NCT00400725|463829062|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
128872907|NCT00400725|463829060|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
128872908|NCT00400725|463829061|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
128872909|NCT00400725|463829062|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
128872910|NCT00400725|463829060|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
128872911|NCT00400725|463829061|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
128872912|NCT00400725|463829062|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
128872913|NCT00400725|463829060|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
128872914|NCT00400725|463829061|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
128872915|NCT00400725|463829062|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
128872916|NCT00400725|463829060|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
128872917|NCT00400725|463829061|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
128872918|NCT00400725|463829062|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
128872919|NCT00400725|463829060|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
128872920|NCT00400725|463829061|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
128872921|NCT00400725|463829062|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
128872922|NCT01941719|463829063|FG000|Overall Study|Lost to Follow-up|20|||
128872923|NCT01941719|463829064|FG001|Overall Study|Lost to Follow-up|19|||
128872924|NCT00252577|463829065|FG000|Overall Study|Lost to Follow-up|20|||
128872925|NCT01744392|463829066|FG000|Overall Study|Physician Decision|1|||
128872926|NCT01416389|463829067|FG000|Overall Study|Lost to Follow-up|1|||
128872927|NCT01416389|463829068|FG001|Overall Study|Lost to Follow-up|0|||
128872928|NCT01416389|463829067|FG000|Overall Study|Started New Therapy|2|||
128872929|NCT01416389|463829068|FG001|Overall Study|Started New Therapy|0|||
128872930|NCT03980808|463829075|FG000|Overall Study|Lost to Follow-up|2|||
128872931|NCT03980808|463829076|FG001|Overall Study|Lost to Follow-up|2|||
128872932|NCT01655693|463829077|FG000|Overall Study|Progression of Disease|92|||
128872933|NCT01655693|463829078|FG001|Overall Study|Progression of Disease|76|||
128872934|NCT01655693|463829079|FG002|Overall Study|Progression of Disease|58|||
128872935|NCT01655693|463829077|FG000|Overall Study|Death|8|||
128872936|NCT01655693|463829078|FG001|Overall Study|Death|9|||
128872937|NCT01655693|463829079|FG002|Overall Study|Death|12|||
128872938|NCT01655693|463829077|FG000|Overall Study|Serious Adverse Event|3|||
128872939|NCT01655693|463829078|FG001|Overall Study|Serious Adverse Event|15|||
128872940|NCT01655693|463829079|FG002|Overall Study|Serious Adverse Event|11|||
128872941|NCT01655693|463829077|FG000|Overall Study|Withdrawal by Subject|3|||
128872942|NCT01655693|463829078|FG001|Overall Study|Withdrawal by Subject|2|||
128872943|NCT01655693|463829079|FG002|Overall Study|Withdrawal by Subject|20|||
128872944|NCT01655693|463829077|FG000|Overall Study|Adverse Event|3|||
128872945|NCT01655693|463829078|FG001|Overall Study|Adverse Event|11|||
128872946|NCT01655693|463829079|FG002|Overall Study|Adverse Event|3|||
128872947|NCT01655693|463829077|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
128872948|NCT01655693|463829078|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
128872949|NCT01655693|463829079|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
128872950|NCT01655693|463829077|FG000|Overall Study|Non-Compliance|0|||
128872951|NCT01655693|463829078|FG001|Overall Study|Non-Compliance|0|||
128872952|NCT01655693|463829079|FG002|Overall Study|Non-Compliance|7|||
128872953|NCT01655693|463829077|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
128872954|NCT01655693|463829078|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
128872955|NCT01655693|463829079|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
128872956|NCT01655693|463829077|FG000|Overall Study|Protocol Violation|1|||
128872957|NCT01655693|463829078|FG001|Overall Study|Protocol Violation|0|||
128872958|NCT01655693|463829079|FG002|Overall Study|Protocol Violation|3|||
128872959|NCT01655693|463829077|FG000|Overall Study|Lost to Follow-up|1|||
128872960|NCT01655693|463829078|FG001|Overall Study|Lost to Follow-up|0|||
128872961|NCT01655693|463829079|FG002|Overall Study|Lost to Follow-up|1|||
128872962|NCT01655693|463829077|FG000|Overall Study|Screening Failure|1|||
128872963|NCT01655693|463829078|FG001|Overall Study|Screening Failure|0|||
128872964|NCT01655693|463829079|FG002|Overall Study|Screening Failure|0|||
128872965|NCT01655693|463829077|FG000|Overall Study|Other|8|||
128872966|NCT01655693|463829078|FG001|Overall Study|Other|6|||
128872967|NCT01655693|463829079|FG002|Overall Study|Other|15|||
128872968|NCT00929110|463829082|FG000|Overall Study|Adverse Event|40|||
128872969|NCT00929110|463829083|FG001|Overall Study|Adverse Event|29|||
128872970|NCT00929110|463829084|FG002|Overall Study|Adverse Event|18|||
128872971|NCT00929110|463829082|FG000|Overall Study|Subject withdrew consent|40|||
128872972|NCT00929110|463829083|FG001|Overall Study|Subject withdrew consent|23|||
128872973|NCT00929110|463829084|FG002|Overall Study|Subject withdrew consent|26|||
128872974|NCT00929110|463829082|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
128872975|NCT00929110|463829083|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
128872976|NCT00929110|463829084|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
128872977|NCT00929110|463829082|FG000|Overall Study|Lost to Follow-up|7|||
128872978|NCT00929110|463829083|FG001|Overall Study|Lost to Follow-up|7|||
128872979|NCT00929110|463829084|FG002|Overall Study|Lost to Follow-up|3|||
128872980|NCT00929110|463829082|FG000|Overall Study|Protocol deviation|5|||
128872981|NCT00929110|463829083|FG001|Overall Study|Protocol deviation|2|||
128872982|NCT00929110|463829084|FG002|Overall Study|Protocol deviation|4|||
128872983|NCT00929110|463829082|FG000|Overall Study|Administrative problems|4|||
128872984|NCT00929110|463829083|FG001|Overall Study|Administrative problems|1|||
128872985|NCT00929110|463829084|FG002|Overall Study|Administrative problems|2|||
128872986|NCT00929110|463829082|FG000|Overall Study|Death|2|||
128872987|NCT00929110|463829083|FG001|Overall Study|Death|2|||
128872988|NCT00929110|463829084|FG002|Overall Study|Death|2|||
128872989|NCT00929110|463829082|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128872990|NCT00929110|463829083|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128872991|NCT00929110|463829084|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128872992|NCT00929110|463829082|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128872993|NCT00929110|463829083|FG001|Overall Study|Abnormal test procedure result(s)|1|||
128872994|NCT00929110|463829084|FG002|Overall Study|Abnormal test procedure result(s)|1|||
128872995|NCT00929110|463829082|FG000|Overall Study|Patient inability to use the device|0|||
128872996|NCT00929110|463829083|FG001|Overall Study|Patient inability to use the device|1|||
128872997|NCT00929110|463829084|FG002|Overall Study|Patient inability to use the device|0|||
128872998|NCT00620282|463829085|FG000|Overall Study|Adverse Event|0|||
128872999|NCT00620282|463829086|FG001|Overall Study|Adverse Event|1|||
128873000|NCT00620282|463829087|FG002|Overall Study|Adverse Event|0|||
129096405|NCT04105010|464644461|FG001|Overall Study|Withdrawal by Subject|1|||
129096406|NCT04105010|464644462|FG002|Overall Study|Withdrawal by Subject|1|||
129096407|NCT04105010|464644463|FG003|Overall Study|Withdrawal by Subject|4|||
129096408|NCT04105010|464644460|FG000|Overall Study|Other reason|4|||
128873001|NCT00620282|463829085|FG000|Overall Study|Arterial line unable to be placed|0|||
128873002|NCT00620282|463829086|FG001|Overall Study|Arterial line unable to be placed|0|||
128873003|NCT00620282|463829087|FG002|Overall Study|Arterial line unable to be placed|1|||
128873004|NCT00620282|463829085|FG000|Overall Study|Withdrawal by Subject|0|||
129096409|NCT04105010|464644461|FG001|Overall Study|Other reason|7|||
128873005|NCT00620282|463829086|FG001|Overall Study|Withdrawal by Subject|1|||
128873006|NCT00620282|463829087|FG002|Overall Study|Withdrawal by Subject|0|||
128873007|NCT02703259|463829088|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
128873008|NCT02703259|463829089|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
128873009|NCT02703259|463829088|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
128873010|NCT02703259|463829089|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
128873011|NCT02703259|463829088|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
128873012|NCT02703259|463829089|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
128873013|NCT02285153|463829094|FG000|Overall Study|Adverse Event|1|||
128873014|NCT02285153|463829095|FG001|Overall Study|Adverse Event|0|||
128873015|NCT02544451|463829096|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
128873016|NCT02544451|463829097|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
128873017|NCT02544451|463829098|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
128873018|NCT02544451|463829099|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
128873019|NCT02544451|463829096|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
128873020|NCT02544451|463829097|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
128873021|NCT02544451|463829098|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
128873022|NCT02544451|463829099|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
128873023|NCT02544451|463829096|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
128873024|NCT02544451|463829097|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
128873025|NCT02544451|463829098|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
128873026|NCT02544451|463829099|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
128873027|NCT02544451|463829096|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
128873028|NCT02544451|463829097|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
128873029|NCT02544451|463829098|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
128873030|NCT02544451|463829099|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
128873031|NCT02544451|463829096|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
128873032|NCT02544451|463829097|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
128873033|NCT02544451|463829098|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
128873034|NCT02544451|463829099|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
128873035|NCT02544451|463829096|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
128873036|NCT02544451|463829097|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
128873037|NCT02544451|463829098|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
128873038|NCT02544451|463829099|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
128873039|NCT03001076|463829100|FG000|Overall Study|Withdrawal by patient|2|||
128873040|NCT03001076|463829101|FG001|Overall Study|Withdrawal by patient|0|||
128873041|NCT03001076|463829100|FG000|Overall Study|Other|1|||
128873042|NCT03001076|463829101|FG001|Overall Study|Other|0|||
128873043|NCT03001076|463829100|FG000|Overall Study|Adverse Event|3|||
128873044|NCT03001076|463829101|FG001|Overall Study|Adverse Event|3|||
128873045|NCT03001076|463829100|FG000|Overall Study|Sponsor decision|1|||
128873046|NCT03001076|463829101|FG001|Overall Study|Sponsor decision|0|||
128873047|NCT03001076|463829100|FG000|Overall Study|Lost to Follow-up|0|||
128873048|NCT03001076|463829101|FG001|Overall Study|Lost to Follow-up|2|||
128873049|NCT00948766|463829102|FG000|Core Study|Adverse Event|73|||
128873050|NCT00948766|463829103|FG001|Core Study|Adverse Event|51|||
128873051|NCT00948766|463829102|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
128873052|NCT00948766|463829103|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
128873053|NCT00948766|463829102|FG000|Core Study|Patient Withdrew Consent|27|||
128873054|NCT00948766|463829103|FG001|Core Study|Patient Withdrew Consent|46|||
128873055|NCT00948766|463829102|FG000|Core Study|Lost to Follow-up|3|||
128873056|NCT00948766|463829103|FG001|Core Study|Lost to Follow-up|2|||
128873057|NCT00948766|463829102|FG000|Core Study|Administrative Problems|2|||
128873058|NCT00948766|463829103|FG001|Core Study|Administrative Problems|2|||
128873059|NCT00948766|463829102|FG000|Core Study|Death|1|||
128873060|NCT00948766|463829103|FG001|Core Study|Death|1|||
128873061|NCT00948766|463829102|FG000|Core Study|Protocol Deviation|8|||
128873062|NCT00948766|463829103|FG001|Core Study|Protocol Deviation|10|||
128873063|NCT00948766|463829102|FG000|Extension Study|Adverse Event|43|||
128873064|NCT00948766|463829103|FG001|Extension Study|Adverse Event|0|||
128873065|NCT00948766|463829102|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
128873066|NCT00948766|463829103|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
128873067|NCT00948766|463829102|FG000|Extension Study|Study Drug No Longer Required|1|||
128873068|NCT00948766|463829103|FG001|Extension Study|Study Drug No Longer Required|0|||
128873069|NCT00948766|463829102|FG000|Extension Study|Patient Withdrew Consent|32|||
128873070|NCT00948766|463829103|FG001|Extension Study|Patient Withdrew Consent|0|||
128873071|NCT00948766|463829102|FG000|Extension Study|Lost to Follow-up|8|||
129096410|NCT04105010|464644462|FG002|Overall Study|Other reason|0|||
129096411|NCT04105010|464644463|FG003|Overall Study|Other reason|19|||
128873072|NCT00948766|463829103|FG001|Extension Study|Lost to Follow-up|0|||
128873073|NCT00948766|463829102|FG000|Extension Study|Administrative Problems|1|||
128873074|NCT00948766|463829103|FG001|Extension Study|Administrative Problems|0|||
129096412|NCT01675154|464644464|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
129096413|NCT01675154|464644465|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
129096414|NCT01675154|464644466|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
129096415|NCT01675154|464644467|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
129096416|NCT00427999|464644468|FG000|Overall Study|Adverse Event|6|||
129096417|NCT00427999|464644468|FG000|Overall Study|Abnormal laboratory values|1|||
129096418|NCT00427999|464644468|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
129096419|NCT00427999|464644468|FG000|Overall Study|Protocol Violation|2|||
129096420|NCT00427999|464644468|FG000|Overall Study|Withdrawal by Subject|9|||
129096421|NCT00427999|464644468|FG000|Overall Study|Death|1|||
129096422|NCT02380859|464644469|FG000|Overall Study|Withdrawal by Subject|2|||
129096423|NCT02380859|464644470|FG001|Overall Study|Withdrawal by Subject|0|||
129096424|NCT02284568|464644471|FG000|Overall Study|Adverse Event|2|||
129096425|NCT02284568|464644472|FG001|Overall Study|Adverse Event|9|||
129096426|NCT02284568|464644473|FG002|Overall Study|Adverse Event|4|||
129096427|NCT02284568|464644471|FG000|Overall Study|Withdrawal by Subject|22|||
129096428|NCT02284568|464644472|FG001|Overall Study|Withdrawal by Subject|21|||
129096429|NCT02284568|464644473|FG002|Overall Study|Withdrawal by Subject|1|||
129096430|NCT02284568|464644471|FG000|Overall Study|Noncompliance with study drug admin|1|||
129096431|NCT02284568|464644472|FG001|Overall Study|Noncompliance with study drug admin|2|||
129096432|NCT02284568|464644473|FG002|Overall Study|Noncompliance with study drug admin|0|||
129096433|NCT02284568|464644471|FG000|Overall Study|Noncompliance|1|||
129096434|NCT02284568|464644472|FG001|Overall Study|Noncompliance|0|||
129096435|NCT02284568|464644473|FG002|Overall Study|Noncompliance|0|||
129096436|NCT02284568|464644471|FG000|Overall Study|Protocol Violation|0|||
129096437|NCT02284568|464644472|FG001|Overall Study|Protocol Violation|1|||
129096438|NCT02284568|464644473|FG002|Overall Study|Protocol Violation|0|||
129096439|NCT02284568|464644471|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
129096440|NCT02284568|464644472|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
129096441|NCT02284568|464644473|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
129096442|NCT02284568|464644471|FG000|Overall Study|Lost to Follow-up|0|||
129096443|NCT02284568|464644472|FG001|Overall Study|Lost to Follow-up|3|||
129096444|NCT02284568|464644473|FG002|Overall Study|Lost to Follow-up|0|||
129096445|NCT02284568|464644471|FG000|Overall Study|Lack of Efficacy|4|||
129096446|NCT02284568|464644472|FG001|Overall Study|Lack of Efficacy|7|||
129096447|NCT02284568|464644473|FG002|Overall Study|Lack of Efficacy|0|||
129096448|NCT02284568|464644471|FG000|Overall Study|Other|1|||
129096449|NCT02284568|464644472|FG001|Overall Study|Other|2|||
129096450|NCT02284568|464644473|FG002|Overall Study|Other|0|||
129096451|NCT02284568|464644471|FG000|Overall Study|Withdrew before taking study drug|0|||
129096452|NCT02284568|464644472|FG001|Overall Study|Withdrew before taking study drug|1|||
129096453|NCT02284568|464644473|FG002|Overall Study|Withdrew before taking study drug|0|||
129096454|NCT05323994|464644474|FG000|Overall Study|Protocol Violation|1|||
129096455|NCT01420679|464644480|FG000|Overall Study|Disease Progression|3|||
129096456|NCT01420679|464644481|FG001|Overall Study|Disease Progression|2|||
129096457|NCT01420679|464644480|FG000|Overall Study|Adverse Event|4|||
129096458|NCT01420679|464644481|FG001|Overall Study|Adverse Event|0|||
129096459|NCT01420679|464644480|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
129096460|NCT01420679|464644481|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
129096461|NCT01420679|464644480|FG000|Overall Study|Patient Decision|1|||
129096462|NCT01420679|464644481|FG001|Overall Study|Patient Decision|0|||
129096463|NCT01420679|464644480|FG000|Overall Study|Investigator Decision|1|||
129096464|NCT01420679|464644481|FG001|Overall Study|Investigator Decision|2|||
129096465|NCT01420679|464644480|FG000|Overall Study|Sponsor Decision|3|||
129096466|NCT01420679|464644481|FG001|Overall Study|Sponsor Decision|3|||
129096467|NCT01420679|464644480|FG000|Overall Study|Other|1|||
129096468|NCT01420679|464644481|FG001|Overall Study|Other|0|||
129096469|NCT00943670|464644482|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
129096470|NCT00943670|464644482|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
129096471|NCT00943670|464644482|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
129096472|NCT00943670|464644482|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
129096473|NCT00943670|464644482|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
129096474|NCT00943670|464644482|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
129096475|NCT00943670|464644482|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
129096476|NCT00943670|464644482|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
129096477|NCT00943670|464644482|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
129096478|NCT00943670|464644482|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
129096479|NCT03956615|464644483|FG000|Overall Study|No multiple myeloma confirmed|2|||
129096480|NCT03956615|464644483|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
129096481|NCT03956615|464644483|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
129096482|NCT03956615|464644483|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
129096483|NCT03000530|464644494|FG000|Overall Study|Adverse Event|0|||
129096484|NCT03000530|464644495|FG001|Overall Study|Adverse Event|0|||
129096485|NCT03000530|464644496|FG002|Overall Study|Adverse Event|2|||
129096486|NCT03000530|464644494|FG000|Overall Study|Lost to Follow-up|0|||
128873075|NCT00948766|463829102|FG000|Extension Study|Death|4|||
128873076|NCT00948766|463829103|FG001|Extension Study|Death|0|||
128873077|NCT01036438|463829107|FG000|Overall Study|Adverse Event|7|||
128873078|NCT01036438|463829108|FG001|Overall Study|Adverse Event|8|||
128873079|NCT01036438|463829107|FG000|Overall Study|Death|0|||
128873080|NCT01036438|463829108|FG001|Overall Study|Death|1|||
128873081|NCT01036438|463829107|FG000|Overall Study|No effect of study treatment|3|||
128873082|NCT01036438|463829108|FG001|Overall Study|No effect of study treatment|1|||
128873083|NCT00888927|463829109|FG000|Overall Study|Adverse Event|0|||
128873084|NCT00888927|463829110|FG001|Overall Study|Adverse Event|0|||
128873085|NCT00888927|463829111|FG002|Overall Study|Adverse Event|0|||
128873086|NCT00888927|463829112|FG003|Overall Study|Adverse Event|1|||
128873087|NCT00888927|463829109|FG000|Overall Study|Withdrawal of consent|0|||
128873088|NCT00888927|463829110|FG001|Overall Study|Withdrawal of consent|0|||
128873089|NCT00888927|463829111|FG002|Overall Study|Withdrawal of consent|0|||
128873090|NCT00888927|463829112|FG003|Overall Study|Withdrawal of consent|1|||
128873091|NCT03459443|463829113|FG000|Overall Study|Lack of Efficacy|3|||
128873092|NCT03459443|463829113|FG000|Overall Study|Adverse Event|1|||
128873093|NCT03459443|463829113|FG000|Overall Study|Sponsor's decision to close the study|18|||
128873094|NCT03189745|463829114|FG000|Overall Study|Conflict in work schedule of participant|1|||
128873095|NCT03189745|463829115|FG001|Overall Study|Conflict in work schedule of participant|1|||
128873096|NCT03702231|463829116|FG000|Overall Study|Withdrawal by Subject|1|||
128873097|NCT03702231|463829117|FG001|Overall Study|Withdrawal by Subject|0|||
128873098|NCT03702231|463829118|FG002|Overall Study|Withdrawal by Subject|0|||
128873099|NCT03702231|463829116|FG000|Overall Study|Protocol Violation|0|||
128873100|NCT03702231|463829117|FG001|Overall Study|Protocol Violation|0|||
128873101|NCT03702231|463829118|FG002|Overall Study|Protocol Violation|1|||
128873102|NCT03702231|463829116|FG000|Overall Study|Change in CLL Treatment|0|||
128873103|NCT03702231|463829117|FG001|Overall Study|Change in CLL Treatment|0|||
128873104|NCT03702231|463829118|FG002|Overall Study|Change in CLL Treatment|1|||
128873105|NCT03702231|463829116|FG000|Overall Study|COVID Pandemic|1|||
128873106|NCT03702231|463829117|FG001|Overall Study|COVID Pandemic|4|||
128873107|NCT03702231|463829118|FG002|Overall Study|COVID Pandemic|1|||
128873108|NCT03702231|463829116|FG000|Overall Study|Non-compliance|0|||
128873109|NCT03702231|463829117|FG001|Overall Study|Non-compliance|0|||
128873110|NCT03702231|463829118|FG002|Overall Study|Non-compliance|1|||
128873111|NCT03592745|463829119|FG000|Overall Study|Adverse Event|0|||
128873112|NCT03592745|463829120|FG001|Overall Study|Adverse Event|2|||
128873113|NCT03592745|463829119|FG000|Overall Study|Lost to Follow-up|2|||
128873114|NCT03592745|463829120|FG001|Overall Study|Lost to Follow-up|0|||
128873115|NCT03592745|463829119|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
128873116|NCT03592745|463829120|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
128873117|NCT03590366|463829121|FG000|Overall Study|Adverse Event|0|||
128873118|NCT03590366|463829122|FG001|Overall Study|Adverse Event|3|||
128873119|NCT03590366|463829121|FG000|Overall Study|Lost to Follow-up|3|||
128873120|NCT03590366|463829122|FG001|Overall Study|Lost to Follow-up|3|||
128873121|NCT03590366|463829121|FG000|Overall Study|Withdrawal by Subject|0|||
128873122|NCT03590366|463829122|FG001|Overall Study|Withdrawal by Subject|2|||
128873123|NCT01413503|463829124|FG000|Overall Study|Lost to Follow-up|1|||
128873124|NCT01373151|463829125|FG000|Period 1|Lack of Efficacy|3|||
128873125|NCT01373151|463829126|FG001|Period 1|Lack of Efficacy|0|||
128873126|NCT01373151|463829127|FG002|Period 1|Lack of Efficacy|0|||
128873127|NCT01373151|463829128|FG003|Period 1|Lack of Efficacy|0|||
128873128|NCT01373151|463829129|FG004|Period 1|Lack of Efficacy|1|||
128873129|NCT01373151|463829130|FG005|Period 1|Lack of Efficacy|0|||
128873130|NCT01373151|463829131|FG006|Period 1|Lack of Efficacy|0|||
128873131|NCT01373151|463829125|FG000|Period 1|Adverse Event|0|||
128873132|NCT01373151|463829126|FG001|Period 1|Adverse Event|0|||
128873133|NCT01373151|463829127|FG002|Period 1|Adverse Event|1|||
128873134|NCT01373151|463829128|FG003|Period 1|Adverse Event|0|||
128873135|NCT01373151|463829129|FG004|Period 1|Adverse Event|4|||
128873136|NCT01373151|463829130|FG005|Period 1|Adverse Event|3|||
128873137|NCT01373151|463829131|FG006|Period 1|Adverse Event|0|||
128873138|NCT01373151|463829125|FG000|Period 1|Withdrawal by Subject|2|||
128873139|NCT01373151|463829126|FG001|Period 1|Withdrawal by Subject|0|||
128873140|NCT01373151|463829127|FG002|Period 1|Withdrawal by Subject|3|||
128873141|NCT01373151|463829128|FG003|Period 1|Withdrawal by Subject|1|||
128873142|NCT01373151|463829129|FG004|Period 1|Withdrawal by Subject|0|||
128873143|NCT01373151|463829130|FG005|Period 1|Withdrawal by Subject|1|||
128873144|NCT01373151|463829131|FG006|Period 1|Withdrawal by Subject|0|||
128873145|NCT01373151|463829125|FG000|Period 2|Lack of Efficacy|9|||
128873146|NCT01373151|463829126|FG001|Period 2|Lack of Efficacy|0|||
128873147|NCT01373151|463829127|FG002|Period 2|Lack of Efficacy|0|||
128873148|NCT01373151|463829128|FG003|Period 2|Lack of Efficacy|1|||
128873149|NCT01373151|463829129|FG004|Period 2|Lack of Efficacy|2|||
128873150|NCT01373151|463829130|FG005|Period 2|Lack of Efficacy|0|||
128873151|NCT01373151|463829131|FG006|Period 2|Lack of Efficacy|3|||
128873152|NCT01373151|463829125|FG000|Period 2|Adverse Event|0|||
128873153|NCT01373151|463829126|FG001|Period 2|Adverse Event|0|||
128873154|NCT01373151|463829127|FG002|Period 2|Adverse Event|3|||
128873155|NCT01373151|463829128|FG003|Period 2|Adverse Event|3|||
128873156|NCT01373151|463829129|FG004|Period 2|Adverse Event|0|||
128873157|NCT01373151|463829130|FG005|Period 2|Adverse Event|0|||
128873158|NCT01373151|463829131|FG006|Period 2|Adverse Event|1|||
128873159|NCT01373151|463829125|FG000|Period 2|subject request to discontinue|0|||
128873160|NCT01373151|463829126|FG001|Period 2|subject request to discontinue|1|||
128873161|NCT01373151|463829127|FG002|Period 2|subject request to discontinue|0|||
128873162|NCT01373151|463829128|FG003|Period 2|subject request to discontinue|0|||
128873163|NCT01373151|463829129|FG004|Period 2|subject request to discontinue|0|||
128873164|NCT01373151|463829130|FG005|Period 2|subject request to discontinue|0|||
128873165|NCT01373151|463829131|FG006|Period 2|subject request to discontinue|0|||
128873166|NCT01373151|463829125|FG000|Period 2|Withdrawal by Subject|0|||
128873167|NCT01373151|463829126|FG001|Period 2|Withdrawal by Subject|0|||
128873168|NCT01373151|463829127|FG002|Period 2|Withdrawal by Subject|0|||
128873169|NCT01373151|463829128|FG003|Period 2|Withdrawal by Subject|1|||
128873170|NCT01373151|463829129|FG004|Period 2|Withdrawal by Subject|0|||
128873171|NCT01373151|463829130|FG005|Period 2|Withdrawal by Subject|0|||
128873172|NCT01373151|463829131|FG006|Period 2|Withdrawal by Subject|0|||
128873173|NCT01373151|463829125|FG000|Period 2|Other|0|||
128873174|NCT01373151|463829126|FG001|Period 2|Other|0|||
128873175|NCT01373151|463829127|FG002|Period 2|Other|1|||
128873176|NCT01373151|463829128|FG003|Period 2|Other|0|||
128873177|NCT01373151|463829129|FG004|Period 2|Other|0|||
128873178|NCT01373151|463829130|FG005|Period 2|Other|0|||
128873179|NCT01373151|463829131|FG006|Period 2|Other|1|||
128873180|NCT03381339|463829132|FG000|Overall Study|Protocol Violation|4|||
128873181|NCT03381339|463829133|FG001|Overall Study|Protocol Violation|3|||
128873182|NCT03381339|463829132|FG000|Overall Study|Lost to Follow-up|0|||
128873183|NCT03381339|463829133|FG001|Overall Study|Lost to Follow-up|1|||
128873184|NCT03117998|463829135|FG000|Overall Study|Adverse Event|1|||
128873185|NCT03117998|463829136|FG001|Overall Study|Adverse Event|0|||
128873186|NCT03117998|463829137|FG002|Overall Study|Adverse Event|0|||
128873187|NCT03117998|463829138|FG003|Overall Study|Adverse Event|0|||
128873188|NCT03117998|463829139|FG004|Overall Study|Adverse Event|0|||
128873189|NCT03117998|463829140|FG005|Overall Study|Adverse Event|0|||
128873190|NCT03117998|463829135|FG000|Overall Study|Withdrawal by Subject|0|||
128873191|NCT03117998|463829136|FG001|Overall Study|Withdrawal by Subject|0|||
128873192|NCT03117998|463829137|FG002|Overall Study|Withdrawal by Subject|2|||
128873193|NCT03117998|463829138|FG003|Overall Study|Withdrawal by Subject|3|||
128873194|NCT03117998|463829139|FG004|Overall Study|Withdrawal by Subject|3|||
128873195|NCT03117998|463829140|FG005|Overall Study|Withdrawal by Subject|0|||
128873196|NCT03117998|463829135|FG000|Overall Study|Physician Decision|0|||
128873197|NCT03117998|463829136|FG001|Overall Study|Physician Decision|1|||
128873198|NCT03117998|463829137|FG002|Overall Study|Physician Decision|1|||
128873199|NCT03117998|463829138|FG003|Overall Study|Physician Decision|0|||
128873200|NCT03117998|463829139|FG004|Overall Study|Physician Decision|0|||
128873201|NCT03117998|463829140|FG005|Overall Study|Physician Decision|0|||
128873202|NCT03117998|463829135|FG000|Overall Study|Lost to Follow-up|0|||
128873203|NCT03117998|463829136|FG001|Overall Study|Lost to Follow-up|0|||
128873204|NCT03117998|463829137|FG002|Overall Study|Lost to Follow-up|0|||
128873205|NCT03117998|463829138|FG003|Overall Study|Lost to Follow-up|1|||
128873206|NCT03117998|463829139|FG004|Overall Study|Lost to Follow-up|4|||
128873207|NCT03117998|463829140|FG005|Overall Study|Lost to Follow-up|0|||
128873208|NCT03117998|463829135|FG000|Overall Study|Subject noncompliance|0|||
128873209|NCT03117998|463829136|FG001|Overall Study|Subject noncompliance|0|||
128873210|NCT03117998|463829137|FG002|Overall Study|Subject noncompliance|1|||
128873211|NCT03117998|463829138|FG003|Overall Study|Subject noncompliance|0|||
128873212|NCT03117998|463829139|FG004|Overall Study|Subject noncompliance|0|||
128873213|NCT03117998|463829140|FG005|Overall Study|Subject noncompliance|2|||
128873214|NCT03117998|463829135|FG000|Overall Study|Protocol Violation|0|||
128873215|NCT03117998|463829136|FG001|Overall Study|Protocol Violation|0|||
128873216|NCT03117998|463829137|FG002|Overall Study|Protocol Violation|0|||
128873217|NCT03117998|463829138|FG003|Overall Study|Protocol Violation|0|||
128873218|NCT03117998|463829139|FG004|Overall Study|Protocol Violation|0|||
128873219|NCT03117998|463829140|FG005|Overall Study|Protocol Violation|1|||
128873220|NCT04927247|463829141|FG000|Overall Study|Other|2|||
128873221|NCT04927247|463829142|FG001|Overall Study|Other|1|||
128873222|NCT04927247|463829141|FG000|Overall Study|Physician Decision|0|||
128873223|NCT04927247|463829142|FG001|Overall Study|Physician Decision|1|||
128873224|NCT04927247|463829141|FG000|Overall Study|Adverse Event|1|||
128873225|NCT04927247|463829142|FG001|Overall Study|Adverse Event|0|||
128873226|NCT00438672|463829146|FG000|Overall Study|Lost to Follow-up|7|||
128873227|NCT00438672|463829147|FG001|Overall Study|Lost to Follow-up|9|||
128873228|NCT01468181|463829151|FG000|Overall Study|Adverse Event|8|||
128873229|NCT01468181|463829152|FG001|Overall Study|Adverse Event|1|||
128873230|NCT01468181|463829153|FG002|Overall Study|Adverse Event|6|||
128873231|NCT01468181|463829154|FG003|Overall Study|Adverse Event|2|||
128873232|NCT01468181|463829155|FG004|Overall Study|Adverse Event|2|||
128873233|NCT01468181|463829151|FG000|Overall Study|Protocol Violation|2|||
128873234|NCT01468181|463829152|FG001|Overall Study|Protocol Violation|0|||
128873235|NCT01468181|463829153|FG002|Overall Study|Protocol Violation|1|||
129096487|NCT03000530|464644495|FG001|Overall Study|Lost to Follow-up|3|||
129096488|NCT03000530|464644496|FG002|Overall Study|Lost to Follow-up|1|||
129096489|NCT03000530|464644494|FG000|Overall Study|Withdrawal by Subject|0|||
128873236|NCT01468181|463829154|FG003|Overall Study|Protocol Violation|0|||
128873237|NCT01468181|463829155|FG004|Overall Study|Protocol Violation|1|||
128873238|NCT01468181|463829151|FG000|Overall Study|Physician Decision|0|||
128873239|NCT01468181|463829152|FG001|Overall Study|Physician Decision|0|||
128873240|NCT01468181|463829153|FG002|Overall Study|Physician Decision|0|||
128873241|NCT01468181|463829154|FG003|Overall Study|Physician Decision|1|||
128873242|NCT01468181|463829155|FG004|Overall Study|Physician Decision|1|||
128873243|NCT01468181|463829151|FG000|Overall Study|Lost to Follow-up|0|||
128873244|NCT01468181|463829152|FG001|Overall Study|Lost to Follow-up|0|||
128873245|NCT01468181|463829153|FG002|Overall Study|Lost to Follow-up|1|||
128873246|NCT01468181|463829154|FG003|Overall Study|Lost to Follow-up|0|||
128873247|NCT01468181|463829155|FG004|Overall Study|Lost to Follow-up|1|||
128873248|NCT01468181|463829151|FG000|Overall Study|Withdrawal by Subject|0|||
128873249|NCT01468181|463829152|FG001|Overall Study|Withdrawal by Subject|1|||
128873250|NCT01468181|463829153|FG002|Overall Study|Withdrawal by Subject|0|||
128873251|NCT01468181|463829154|FG003|Overall Study|Withdrawal by Subject|0|||
128873252|NCT01468181|463829155|FG004|Overall Study|Withdrawal by Subject|0|||
128873253|NCT04828837|463829156|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
128873254|NCT04828837|463829157|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
128873255|NCT04828837|463829156|FG000|Overall Study|Lost to Follow-up|2|||
128873256|NCT04828837|463829157|FG001|Overall Study|Lost to Follow-up|6|||
128873257|NCT04828837|463829156|FG000|Overall Study|Lack of Efficacy|1|||
128873258|NCT04828837|463829157|FG001|Overall Study|Lack of Efficacy|0|||
128873259|NCT04828837|463829156|FG000|Overall Study|Admitted due to pneumothorax.|1|||
128873260|NCT04828837|463829157|FG001|Overall Study|Admitted due to pneumothorax.|0|||
128873261|NCT04828837|463829156|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
128873262|NCT04828837|463829157|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
128873263|NCT00545753|463829158|FG000|Overall Study|Withdrawal by Subject|0|||
128873264|NCT00545753|463829159|FG001|Overall Study|Withdrawal by Subject|1|||
128873265|NCT00545753|463829160|FG002|Overall Study|Withdrawal by Subject|10|||
128873266|NCT00545753|463829158|FG000|Overall Study|Lost to Follow-up|13|||
128873267|NCT00545753|463829159|FG001|Overall Study|Lost to Follow-up|3|||
128873268|NCT00545753|463829160|FG002|Overall Study|Lost to Follow-up|12|||
128873269|NCT00545753|463829158|FG000|Overall Study|Protocol Violation|3|||
128873270|NCT00545753|463829159|FG001|Overall Study|Protocol Violation|1|||
128873271|NCT00545753|463829160|FG002|Overall Study|Protocol Violation|4|||
128873272|NCT02297139|463829161|FG000|Overall Study|Disease progression|0|||
128873273|NCT02297139|463829162|FG001|Overall Study|Disease progression|1|||
128873274|NCT02297139|463829161|FG000|Overall Study|Study drug toxicity|0|||
128873275|NCT02297139|463829162|FG001|Overall Study|Study drug toxicity|4|||
128873276|NCT02297139|463829161|FG000|Overall Study|Participant request to discontinue study treatment|0|||
128873277|NCT02297139|463829162|FG001|Overall Study|Participant request to discontinue study treatment|1|||
128873278|NCT02297139|463829161|FG000|Overall Study|Maximum clinical benefit|1|||
128873279|NCT02297139|463829162|FG001|Overall Study|Maximum clinical benefit|0|||
128873280|NCT02297139|463829161|FG000|Overall Study|Administrative reason by sponsor|0|||
128873281|NCT02297139|463829162|FG001|Overall Study|Administrative reason by sponsor|2|||
128873282|NCT02297139|463829161|FG000|Overall Study|Other reasons|0|||
128873283|NCT02297139|463829162|FG001|Overall Study|Other reasons|8|||
128873284|NCT01942785|463829163|FG000|Overall Study|Adverse Event|2|||
128873285|NCT01942785|463829163|FG000|Overall Study|Withdrawal by Subject|1|||
128873286|NCT01942785|463829163|FG000|Overall Study|Protocol Violation|1|||
128873287|NCT00552929|463829166|FG000|Overall Study|Lost to Follow-up|0|||
128873288|NCT00552929|463829167|FG001|Overall Study|Lost to Follow-up|0|||
128873289|NCT00552929|463829168|FG002|Overall Study|Lost to Follow-up|0|||
128873290|NCT00552929|463829169|FG003|Overall Study|Lost to Follow-up|0|||
128873291|NCT00552929|463829170|FG004|Overall Study|Lost to Follow-up|0|||
128873292|NCT00552929|463829171|FG005|Overall Study|Lost to Follow-up|0|||
128873293|NCT00552929|463829172|FG006|Overall Study|Lost to Follow-up|0|||
128873294|NCT00552929|463829173|FG007|Overall Study|Lost to Follow-up|0|||
128873295|NCT00552929|463829174|FG008|Overall Study|Lost to Follow-up|1|||
128873296|NCT00552929|463829175|FG009|Overall Study|Lost to Follow-up|0|||
128873297|NCT00552929|463829166|FG000|Overall Study|Not Eligible|0|||
128873298|NCT00552929|463829167|FG001|Overall Study|Not Eligible|0|||
128873299|NCT00552929|463829168|FG002|Overall Study|Not Eligible|0|||
128873300|NCT00552929|463829169|FG003|Overall Study|Not Eligible|0|||
128873301|NCT00552929|463829170|FG004|Overall Study|Not Eligible|0|||
128873302|NCT00552929|463829171|FG005|Overall Study|Not Eligible|1|||
128873303|NCT00552929|463829172|FG006|Overall Study|Not Eligible|0|||
128873304|NCT00552929|463829173|FG007|Overall Study|Not Eligible|0|||
128873305|NCT00552929|463829174|FG008|Overall Study|Not Eligible|0|||
128873306|NCT00552929|463829175|FG009|Overall Study|Not Eligible|0|||
128873307|NCT01147536|463829179|FG000|Overall Study|Administrative study close|2|||
128873308|NCT01147536|463829179|FG000|Overall Study|Death|1|||
128873309|NCT04577001|463829180|FG000|Overall Study|Subject became ineligible|0|||
128873310|NCT04577001|463829181|FG001|Overall Study|Subject became ineligible|1|||
128873311|NCT05110690|463829182|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
128873312|NCT05110690|463829182|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
128873313|NCT05110690|463829182|FG000|Completion of Intervention|Lost to Follow-up|1|||
128873314|NCT05110690|463829182|FG000|Completion of Intervention|Death|1|||
128873315|NCT05110690|463829182|FG000|Completion of Intervention|Withdrawal by Subject|2|||
128873316|NCT03973931|463829185|FG000|Overall Study|Lost to Follow-up|47|||
128873317|NCT03973931|463829186|FG001|Overall Study|Lost to Follow-up|63|||
128873318|NCT03973931|463829187|FG002|Overall Study|Lost to Follow-up|51|||
128873319|NCT03973931|463829188|FG003|Overall Study|Lost to Follow-up|54|||
128873320|NCT03973931|463829185|FG000|Overall Study|opted out|6|||
128873321|NCT03973931|463829186|FG001|Overall Study|opted out|5|||
128873322|NCT03973931|463829187|FG002|Overall Study|opted out|5|||
128873323|NCT03973931|463829188|FG003|Overall Study|opted out|1|||
128873324|NCT00925353|463829189|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
128977825|NCT00561795|464205211|FG003|Overall Study|Study Closed/Terminated|0|||
128977826|NCT00561795|464205208|FG000|Overall Study|Physician Decision|1|||
128977827|NCT00561795|464205209|FG001|Overall Study|Physician Decision|0|||
128977828|NCT00561795|464205210|FG002|Overall Study|Physician Decision|0|||
128977829|NCT00561795|464205211|FG003|Overall Study|Physician Decision|0|||
128977830|NCT03672006|464205213|FG000|Overall Study|exclusion criteria met|0|||
128977831|NCT03672006|464205214|FG001|Overall Study|exclusion criteria met|1|||
128977832|NCT01453439|464205215|FG000|Treatment Phase|Withdrawal by Subject|13|||
128977833|NCT01453439|464205216|FG001|Treatment Phase|Withdrawal by Subject|10|||
128977834|NCT01453439|464205215|FG000|Treatment Phase|Suicidal Ideation|2|||
128977835|NCT01453439|464205216|FG001|Treatment Phase|Suicidal Ideation|0|||
128977836|NCT01453439|464205215|FG000|Treatment Phase|Need for higher level of care|1|||
128977837|NCT01453439|464205216|FG001|Treatment Phase|Need for higher level of care|1|||
128977838|NCT01453439|464205215|FG000|Treatment Phase|Therapist conflict of interest|1|||
128977839|NCT01453439|464205216|FG001|Treatment Phase|Therapist conflict of interest|0|||
128977840|NCT01453439|464205215|FG000|Follow-up|Withdrawal by Subject|0|||
128977841|NCT01453439|464205216|FG001|Follow-up|Withdrawal by Subject|1|||
128977842|NCT01453439|464205215|FG000|Follow-up|Lost to Follow-up|5|||
128977843|NCT01453439|464205216|FG001|Follow-up|Lost to Follow-up|10|||
128977844|NCT02135848|464205222|FG000|Overall Study|Adverse Event|2|||
128977845|NCT02135848|464205223|FG001|Overall Study|Adverse Event|0|||
128977846|NCT02135848|464205222|FG000|Overall Study|Withdrawal by Subject|1|||
128977847|NCT02135848|464205223|FG001|Overall Study|Withdrawal by Subject|1|||
128977848|NCT00089505|464205224|FG000|Overall Study|Death|4|||
128977849|NCT00089505|464205225|FG001|Overall Study|Death|1|||
128977850|NCT00089505|464205226|FG002|Overall Study|Death|5|||
128977851|NCT00089505|464205227|FG003|Overall Study|Death|8|||
128977852|NCT00089505|464205224|FG000|Overall Study|Withdrawal by Subject|3|||
128977853|NCT00089505|464205225|FG001|Overall Study|Withdrawal by Subject|0|||
128977854|NCT00089505|464205226|FG002|Overall Study|Withdrawal by Subject|6|||
128977855|NCT00089505|464205227|FG003|Overall Study|Withdrawal by Subject|6|||
128977856|NCT00089505|464205224|FG000|Overall Study|Lost to Follow-up|1|||
128977857|NCT00089505|464205225|FG001|Overall Study|Lost to Follow-up|1|||
128977858|NCT00089505|464205226|FG002|Overall Study|Lost to Follow-up|9|||
128977859|NCT00089505|464205227|FG003|Overall Study|Lost to Follow-up|7|||
128977860|NCT00089505|464205224|FG000|Overall Study|Physician Decision|1|||
128977861|NCT00089505|464205225|FG001|Overall Study|Physician Decision|0|||
128977862|NCT00089505|464205226|FG002|Overall Study|Physician Decision|0|||
128977863|NCT00089505|464205227|FG003|Overall Study|Physician Decision|0|||
128977864|NCT00089505|464205224|FG000|Overall Study|Protocol Violation|0|||
128977865|NCT00089505|464205225|FG001|Overall Study|Protocol Violation|0|||
128977866|NCT00089505|464205226|FG002|Overall Study|Protocol Violation|1|||
128977867|NCT00089505|464205227|FG003|Overall Study|Protocol Violation|0|||
128977868|NCT02177942|464205236|FG000|Overall Study|Adverse Event|1|||
128977869|NCT02177942|464205237|FG001|Overall Study|Adverse Event|0|||
128977870|NCT02177942|464205236|FG000|Overall Study|Lost to Follow-up|1|||
128977871|NCT02177942|464205237|FG001|Overall Study|Lost to Follow-up|1|||
128977872|NCT02177942|464205236|FG000|Overall Study|Protocol Violation|4|||
128977873|NCT02177942|464205237|FG001|Overall Study|Protocol Violation|6|||
128977874|NCT02177942|464205236|FG000|Overall Study|Withdrawal by Subject|71|||
128977875|NCT02177942|464205237|FG001|Overall Study|Withdrawal by Subject|81|||
128977876|NCT01351415|464205238|FG000|Overall Study|Withdrawal by Subject|15|||
128977877|NCT01351415|464205239|FG001|Overall Study|Withdrawal by Subject|17|||
128977878|NCT01351415|464205238|FG000|Overall Study|Trial termination by the Sponsor|28|||
128977879|NCT01351415|464205239|FG001|Overall Study|Trial termination by the Sponsor|19|||
128977880|NCT01351415|464205238|FG000|Overall Study|Lost to Follow-up|5|||
128977881|NCT01351415|464205239|FG001|Overall Study|Lost to Follow-up|7|||
128977882|NCT01351415|464205238|FG000|Overall Study|Death|190|||
128977883|NCT01351415|464205239|FG001|Overall Study|Death|187|||
128977884|NCT01351415|464205238|FG000|Overall Study|Physician Decision|2|||
128977885|NCT01351415|464205239|FG001|Overall Study|Physician Decision|3|||
128977886|NCT01351415|464205238|FG000|Overall Study|Reason unknown|0|||
128977887|NCT01351415|464205239|FG001|Overall Study|Reason unknown|2|||
128977888|NCT01351415|464205238|FG000|Overall Study|Never Started|5|||
128977889|NCT01351415|464205239|FG001|Overall Study|Never Started|5|||
128977890|NCT00699582|464205244|FG000|Overall Study|Adverse Event|4|||
128977891|NCT00699582|464205245|FG001|Overall Study|Adverse Event|11|||
128873325|NCT01290315|463830856|FG000|Overall Study|Adverse Event|0|||
128873326|NCT01290315|463830857|FG001|Overall Study|Adverse Event|0|||
128873327|NCT01290315|463830858|FG002|Overall Study|Adverse Event|0|||
128873328|NCT01290315|463830859|FG003|Overall Study|Adverse Event|3|||
128873329|NCT01290315|463830856|FG000|Overall Study|Selection criteria/compliance|2|||
128873330|NCT01290315|463830857|FG001|Overall Study|Selection criteria/compliance|1|||
128873331|NCT01290315|463830858|FG002|Overall Study|Selection criteria/compliance|0|||
128873332|NCT01290315|463830859|FG003|Overall Study|Selection criteria/compliance|2|||
128873333|NCT01290315|463830856|FG000|Overall Study|Lost to Follow-up|0|||
128873334|NCT01290315|463830857|FG001|Overall Study|Lost to Follow-up|1|||
128873335|NCT01290315|463830858|FG002|Overall Study|Lost to Follow-up|0|||
128873336|NCT01290315|463830859|FG003|Overall Study|Lost to Follow-up|0|||
128873337|NCT01290315|463830856|FG000|Overall Study|Withdrawal by Subject|1|||
128873338|NCT01290315|463830857|FG001|Overall Study|Withdrawal by Subject|1|||
128873339|NCT01290315|463830858|FG002|Overall Study|Withdrawal by Subject|0|||
128873340|NCT01290315|463830859|FG003|Overall Study|Withdrawal by Subject|0|||
128873341|NCT00591721|463830860|FG000|Overall Study|Withdrawal by Subject|10|||
128873342|NCT00591721|463830861|FG001|Overall Study|Withdrawal by Subject|10|||
128873343|NCT00591721|463830860|FG000|Overall Study|Lost to Follow-up|1|||
128873344|NCT00591721|463830861|FG001|Overall Study|Lost to Follow-up|4|||
128873345|NCT00591721|463830860|FG000|Overall Study|Intervention not received|10|||
128873346|NCT00591721|463830861|FG001|Overall Study|Intervention not received|8|||
128873347|NCT00901186|463830864|FG000|Overall Study|Lack of Efficacy|0|||
128873348|NCT00901186|463830865|FG001|Overall Study|Lack of Efficacy|1|||
128873349|NCT00901186|463830864|FG000|Overall Study|Abnormal laboratory values|0|||
128873350|NCT00901186|463830865|FG001|Overall Study|Abnormal laboratory values|1|||
128873351|NCT00901186|463830864|FG000|Overall Study|Lost to Follow-up|2|||
128873352|NCT00901186|463830865|FG001|Overall Study|Lost to Follow-up|0|||
128873353|NCT00901186|463830864|FG000|Overall Study|Adverse Event|2|||
128873354|NCT00901186|463830865|FG001|Overall Study|Adverse Event|4|||
128873355|NCT00901186|463830864|FG000|Overall Study|Administration problems|0|||
128873356|NCT00901186|463830865|FG001|Overall Study|Administration problems|1|||
128873357|NCT00901186|463830864|FG000|Overall Study|Protocol deviations|5|||
128873358|NCT00901186|463830865|FG001|Overall Study|Protocol deviations|4|||
128873359|NCT00581555|463830866|FG000|Overall Study|Adverse Event|4|||
128873360|NCT00581555|463830867|FG001|Overall Study|Adverse Event|3|||
128873361|NCT00581555|463830866|FG000|Overall Study|Physician Decision|3|||
128873362|NCT00581555|463830867|FG001|Overall Study|Physician Decision|2|||
128873363|NCT00581555|463830866|FG000|Overall Study|Withdrawal by Subject|18|||
128873364|NCT00581555|463830867|FG001|Overall Study|Withdrawal by Subject|9|||
128873365|NCT00581555|463830866|FG000|Overall Study|Lost to Follow-up|2|||
128873366|NCT00581555|463830867|FG001|Overall Study|Lost to Follow-up|2|||
128873367|NCT00581555|463830866|FG000|Overall Study|Other reasons|16|||
128873368|NCT00581555|463830867|FG001|Overall Study|Other reasons|4|||
128873369|NCT03828747|463830868|FG000|Double-Blind Treatment Period|Adverse Event|6|||
128873370|NCT03828747|463830869|FG001|Double-Blind Treatment Period|Adverse Event|6|||
128873371|NCT03828747|463830868|FG000|Double-Blind Treatment Period|Death|1|||
128873372|NCT03828747|463830869|FG001|Double-Blind Treatment Period|Death|1|||
128873373|NCT03828747|463830868|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128873374|NCT03828747|463830869|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
128873375|NCT03828747|463830868|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
128873376|NCT03828747|463830869|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
128873377|NCT03828747|463830868|FG000|Double-Blind Treatment Period|Physician Decision|1|||
128873378|NCT03828747|463830869|FG001|Double-Blind Treatment Period|Physician Decision|4|||
128873379|NCT03828747|463830868|FG000|Double-Blind Treatment Period|Various reasons|5|||
128873380|NCT03828747|463830869|FG001|Double-Blind Treatment Period|Various reasons|3|||
128873381|NCT03828747|463830868|FG000|Open-Label Extension|Adverse Event|9|||
128873382|NCT03828747|463830869|FG001|Open-Label Extension|Adverse Event|7|||
128873383|NCT03828747|463830868|FG000|Open-Label Extension|Death|0|||
128873384|NCT03828747|463830869|FG001|Open-Label Extension|Death|2|||
128873385|NCT03828747|463830868|FG000|Open-Label Extension|Lost to Follow-up|4|||
128873386|NCT03828747|463830869|FG001|Open-Label Extension|Lost to Follow-up|0|||
128873387|NCT03828747|463830868|FG000|Open-Label Extension|Withdrawal by Subject|31|||
128873388|NCT03828747|463830869|FG001|Open-Label Extension|Withdrawal by Subject|30|||
128873389|NCT03828747|463830868|FG000|Open-Label Extension|Various reasons|4|||
128873390|NCT03828747|463830869|FG001|Open-Label Extension|Various reasons|4|||
128873391|NCT03828747|463830868|FG000|Open-Label Extension|Physician Decision|6|||
128873392|NCT03828747|463830869|FG001|Open-Label Extension|Physician Decision|2|||
128873393|NCT03900416|463830870|FG000|Six Week Follow-up|Lost to Follow-up|1|||
128873394|NCT03900416|463830871|FG001|Six Week Follow-up|Lost to Follow-up|0|||
128873395|NCT03900416|463830870|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
128873396|NCT03900416|463830871|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
128873397|NCT03900416|463830870|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
128873398|NCT03900416|463830871|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
128873399|NCT03900416|463830870|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
128873400|NCT03900416|463830871|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
128873401|NCT03900416|463830870|FG000|Twelve Week Follow-up|Adverse Event|1|||
128873402|NCT03900416|463830871|FG001|Twelve Week Follow-up|Adverse Event|1|||
128873403|NCT03900416|463830870|FG000|Six Month Follow-up|Lost to Follow-up|4|||
128873404|NCT03900416|463830871|FG001|Six Month Follow-up|Lost to Follow-up|3|||
128873405|NCT03900416|463830870|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
128873406|NCT03900416|463830871|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
128873407|NCT00772330|463830872|FG000|Overall Study|Lost to Follow-up|3|||
128873408|NCT00424385|463830873|FG000|Cohort 0|Withdrawal by Subject|5|||
128873409|NCT00424385|463830873|FG000|Cohort 0|Physician Decision|1|||
128873410|NCT00424385|463830873|FG000|Cohort 1|Withdrawal by Subject|1|||
128873411|NCT02683876|463830874|FG000|Overall Study|samples damaged during shipping|2|||
128873412|NCT02683876|463830875|FG001|Overall Study|samples damaged during shipping|0|||
128873413|NCT00560066|463830893|FG000|Overall Study|Death|2|||
128873414|NCT00560066|463830894|FG001|Overall Study|Death|1|||
128873415|NCT00560066|463830893|FG000|Overall Study|Withdrawal by Subject|0|||
128873416|NCT00560066|463830894|FG001|Overall Study|Withdrawal by Subject|3|||
128873417|NCT00560066|463830893|FG000|Overall Study|Lost to Follow-up|4|||
128873418|NCT00560066|463830894|FG001|Overall Study|Lost to Follow-up|10|||
128873419|NCT00560066|463830893|FG000|Overall Study|Protocol Violation|0|||
128873420|NCT00560066|463830894|FG001|Overall Study|Protocol Violation|1|||
128873421|NCT00560066|463830893|FG000|Overall Study|Administrative reason|0|||
128873422|NCT00560066|463830894|FG001|Overall Study|Administrative reason|5|||
128873423|NCT00560066|463830893|FG000|Overall Study|Missing primary reason|0|||
128873424|NCT00560066|463830894|FG001|Overall Study|Missing primary reason|2|||
128873425|NCT01258595|463830901|FG000|Overall Study|Lost to Follow-up|1|||
128873426|NCT01258595|463830902|FG001|Overall Study|Lost to Follow-up|0|||
128873427|NCT01258595|463830901|FG000|Overall Study|Withdrawal by Subject|0|||
128873428|NCT01258595|463830902|FG001|Overall Study|Withdrawal by Subject|1|||
128873429|NCT04738292|463830903|FG000|Overall Study|Death|1|||
128873430|NCT03122223|463830904|FG000|Overall Study|Withdrawal by Subject|2|||
128873431|NCT03122223|463830905|FG001|Overall Study|Withdrawal by Subject|2|||
128873432|NCT03122223|463830906|FG002|Overall Study|Withdrawal by Subject|1|||
128873433|NCT03122223|463830907|FG003|Overall Study|Withdrawal by Subject|0|||
128873434|NCT03122223|463830904|FG000|Overall Study|Lost to Follow-up|0|||
128873435|NCT03122223|463830905|FG001|Overall Study|Lost to Follow-up|2|||
128873436|NCT03122223|463830906|FG002|Overall Study|Lost to Follow-up|2|||
128873437|NCT03122223|463830907|FG003|Overall Study|Lost to Follow-up|0|||
128763011|NCT02243202|463422669|FG003|Overall Study|Randomized but not received treatment|1|||
128763012|NCT04382924|463422673|FG000|Overall Study|Death|2|||
128763013|NCT04382924|463422674|FG001|Overall Study|Death|5|||
128763014|NCT04382924|463422675|FG002|Overall Study|Death|4|||
128763015|NCT04382924|463422673|FG000|Overall Study|Protocol Violation|0|||
128763016|NCT04382924|463422674|FG001|Overall Study|Protocol Violation|1|||
128763017|NCT04382924|463422675|FG002|Overall Study|Protocol Violation|1|||
128763018|NCT04382924|463422673|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
128763019|NCT04382924|463422674|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
128763020|NCT04382924|463422675|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
128763021|NCT04382924|463422673|FG000|Overall Study|Withdrawal by Subject|6|||
128763022|NCT04382924|463422674|FG001|Overall Study|Withdrawal by Subject|3|||
128763023|NCT04382924|463422675|FG002|Overall Study|Withdrawal by Subject|6|||
128763024|NCT02013388|463422679|FG000|Overall Study|work emergency|1|||
128763025|NCT02013388|463422680|FG001|Overall Study|work emergency|0|||
128763026|NCT02013388|463422681|FG002|Overall Study|work emergency|0|||
128763027|NCT02013388|463422682|FG003|Overall Study|work emergency|0|||
128763028|NCT02013388|463422683|FG004|Overall Study|work emergency|1|||
128763029|NCT02013388|463422684|FG005|Overall Study|work emergency|0|||
128763030|NCT02013388|463422685|FG006|Overall Study|work emergency|0|||
128763031|NCT02013388|463422686|FG007|Overall Study|work emergency|0|||
128763032|NCT03243422|463422687|FG000|Overall Study|Death|20|||
128763033|NCT03243422|463422688|FG001|Overall Study|Death|21|||
128763034|NCT03243422|463422687|FG000|Overall Study|Lost to Follow-up|9|||
128763035|NCT03243422|463422688|FG001|Overall Study|Lost to Follow-up|21|||
128763036|NCT03243422|463422687|FG000|Overall Study|Withdrawal by Subject|22|||
128763037|NCT03243422|463422688|FG001|Overall Study|Withdrawal by Subject|8|||
128763038|NCT02173054|463422689|FG000|Overall Study|lack of compliance|1|||
128763039|NCT02173054|463422690|FG001|Overall Study|lack of compliance|0|||
128763040|NCT02173054|463422691|FG002|Overall Study|lack of compliance|0|||
128763041|NCT02173054|463422689|FG000|Overall Study|Withdrawal by Subject|0|||
128763042|NCT02173054|463422690|FG001|Overall Study|Withdrawal by Subject|0|||
128763043|NCT02173054|463422691|FG002|Overall Study|Withdrawal by Subject|1|||
128763044|NCT01559454|463422692|FG000|Overall Study|Lost to Follow-up|3|||
128763045|NCT01559454|463422693|FG001|Overall Study|Lost to Follow-up|2|||
128873438|NCT03122223|463830904|FG000|Overall Study|Participant unable to adhere|1|||
128873439|NCT03122223|463830905|FG001|Overall Study|Participant unable to adhere|1|||
128873440|NCT03122223|463830906|FG002|Overall Study|Participant unable to adhere|1|||
128873441|NCT03122223|463830907|FG003|Overall Study|Participant unable to adhere|0|||
128873442|NCT01820585|463830909|FG000|Overall Study|Adverse Event|9|||
128873443|NCT01820585|463830910|FG001|Overall Study|Adverse Event|13|||
128873444|NCT01820585|463830911|FG002|Overall Study|Adverse Event|23|||
128873445|NCT01820585|463830912|FG003|Overall Study|Adverse Event|34|||
128873446|NCT01820585|463830909|FG000|Overall Study|Lack of Efficacy|9|||
128873447|NCT01820585|463830910|FG001|Overall Study|Lack of Efficacy|7|||
128873448|NCT01820585|463830911|FG002|Overall Study|Lack of Efficacy|5|||
128873449|NCT01820585|463830912|FG003|Overall Study|Lack of Efficacy|1|||
128873450|NCT01820585|463830909|FG000|Overall Study|Withdrawal by Subject|3|||
128873451|NCT01820585|463830910|FG001|Overall Study|Withdrawal by Subject|7|||
128873452|NCT01820585|463830911|FG002|Overall Study|Withdrawal by Subject|3|||
128873453|NCT01820585|463830912|FG003|Overall Study|Withdrawal by Subject|8|||
128873454|NCT01820585|463830909|FG000|Overall Study|Lost to Follow-up|3|||
128873455|NCT01820585|463830910|FG001|Overall Study|Lost to Follow-up|3|||
128873456|NCT01820585|463830911|FG002|Overall Study|Lost to Follow-up|0|||
128873457|NCT01820585|463830912|FG003|Overall Study|Lost to Follow-up|3|||
128873458|NCT01820585|463830909|FG000|Overall Study|Protocol Violation|3|||
128873459|NCT01820585|463830910|FG001|Overall Study|Protocol Violation|1|||
128873460|NCT01820585|463830911|FG002|Overall Study|Protocol Violation|1|||
128873461|NCT01820585|463830912|FG003|Overall Study|Protocol Violation|1|||
128873462|NCT01820585|463830909|FG000|Overall Study|Subject non-compliance|0|||
128873463|NCT01820585|463830910|FG001|Overall Study|Subject non-compliance|0|||
128873464|NCT01820585|463830911|FG002|Overall Study|Subject non-compliance|1|||
128873465|NCT01820585|463830912|FG003|Overall Study|Subject non-compliance|2|||
128873466|NCT01820585|463830909|FG000|Overall Study|at sponsor request|0|||
128873467|NCT01820585|463830910|FG001|Overall Study|at sponsor request|0|||
128873468|NCT01820585|463830911|FG002|Overall Study|at sponsor request|1|||
128873469|NCT01820585|463830912|FG003|Overall Study|at sponsor request|0|||
128873470|NCT01820585|463830909|FG000|Overall Study|Pregnancy|0|||
128873471|NCT01820585|463830910|FG001|Overall Study|Pregnancy|1|||
128873472|NCT01820585|463830911|FG002|Overall Study|Pregnancy|0|||
128873473|NCT01820585|463830912|FG003|Overall Study|Pregnancy|0|||
128873474|NCT01712659|463830913|FG000|Dose Escalation|Physician Decision|0|||
128873475|NCT01712659|463830914|FG001|Dose Escalation|Physician Decision|1|||
128873476|NCT01712659|463830915|FG002|Dose Escalation|Physician Decision|0|||
128873477|NCT01712659|463830916|FG003|Dose Escalation|Physician Decision|0|||
128873478|NCT01712659|463830917|FG004|Dose Escalation|Physician Decision|0|||
128873479|NCT01712659|463830913|FG000|Dose Escalation|Unable to take study drug|0|||
128873480|NCT01712659|463830914|FG001|Dose Escalation|Unable to take study drug|1|||
128873481|NCT01712659|463830915|FG002|Dose Escalation|Unable to take study drug|0|||
128873482|NCT01712659|463830916|FG003|Dose Escalation|Unable to take study drug|0|||
128873483|NCT01712659|463830917|FG004|Dose Escalation|Unable to take study drug|0|||
128873484|NCT01712659|463830913|FG000|Dose Expansion|Early disease progression|1|||
128873485|NCT01712659|463830914|FG001|Dose Expansion|Early disease progression|0|||
128873486|NCT01712659|463830915|FG002|Dose Expansion|Early disease progression|0|||
128873487|NCT01712659|463830916|FG003|Dose Expansion|Early disease progression|0|||
128873488|NCT01712659|463830917|FG004|Dose Expansion|Early disease progression|0|||
128873489|NCT01712659|463830913|FG000|Dose Expansion|Physician Decision|1|||
128873490|NCT01712659|463830914|FG001|Dose Expansion|Physician Decision|0|||
128873491|NCT01712659|463830915|FG002|Dose Expansion|Physician Decision|0|||
128873492|NCT01712659|463830916|FG003|Dose Expansion|Physician Decision|0|||
128873493|NCT01712659|463830917|FG004|Dose Expansion|Physician Decision|0|||
128873494|NCT00548262|463830918|FG000|Overall Study|Death|21|||
128873495|NCT00548262|463830918|FG000|Overall Study|Adverse Event|2|||
128873496|NCT00548262|463830918|FG000|Overall Study|Lack of Efficacy|4|||
128873497|NCT00548262|463830918|FG000|Overall Study|Lost to Follow-up|1|||
128873498|NCT00548262|463830918|FG000|Overall Study|Other|3|||
128873499|NCT00548262|463830918|FG000|Overall Study|Withdrawal by Subject|1|||
128873500|NCT01489891|463830923|FG000|Overall Study|Endoscopy failure|1|||
128873501|NCT01489891|463830924|FG001|Overall Study|Endoscopy failure|0|||
128873502|NCT00998790|463830925|FG000|Overall Study|Withdrawal by Subject|21|||
128873503|NCT01056718|463830926|FG000|Overall Study|Withdrawal by Subject|2|||
128873504|NCT01056718|463830926|FG000|Overall Study|Ischemia on baseline stress test|1|||
128873505|NCT05086276|463830927|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
128873506|NCT05086276|463830928|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
128873507|NCT00895154|463830929|FG000|Overall Study|Lost to Follow-up|1|||
128873508|NCT00895154|463830930|FG001|Overall Study|Lost to Follow-up|1|||
128873509|NCT00895154|463830929|FG000|Overall Study|Withdrawal by Subject|0|||
128873510|NCT00895154|463830930|FG001|Overall Study|Withdrawal by Subject|1|||
128873511|NCT00777088|463830931|FG000|Overall Study|PED Treatment not attempted|1|||
128873512|NCT00287690|463830932|FG000|Overall Study|Protocol Violation|20|||
128873513|NCT00287690|463830933|FG001|Overall Study|Protocol Violation|26|||
128873514|NCT02729831|463830935|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
128873515|NCT02729831|463830936|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
128873516|NCT02729831|463830937|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
128873517|NCT02729831|463830938|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
128873518|NCT02729831|463830935|FG000|1 Week Post-visit|Lost to Follow-up|43|||
128873519|NCT02729831|463830936|FG001|1 Week Post-visit|Lost to Follow-up|40|||
128873520|NCT02729831|463830937|FG002|1 Week Post-visit|Lost to Follow-up|38|||
128873521|NCT02729831|463830938|FG003|1 Week Post-visit|Lost to Follow-up|36|||
128873522|NCT02729831|463830935|FG000|6 Month Follow-up|Lost to Follow-up|54|||
128873523|NCT02729831|463830936|FG001|6 Month Follow-up|Lost to Follow-up|51|||
128873524|NCT02729831|463830937|FG002|6 Month Follow-up|Lost to Follow-up|48|||
128873525|NCT02729831|463830938|FG003|6 Month Follow-up|Lost to Follow-up|42|||
128873526|NCT02729831|463830935|FG000|6 Month Follow-up|Death|1|||
128873527|NCT02729831|463830936|FG001|6 Month Follow-up|Death|3|||
128873528|NCT02729831|463830937|FG002|6 Month Follow-up|Death|0|||
128873529|NCT02729831|463830938|FG003|6 Month Follow-up|Death|1|||
128873530|NCT05017103|463830939|FG000|Overall Study|Death|2|||
128873531|NCT01747551|463830940|FG000|Overall Study|Progressive Disease|24|||
128873532|NCT01747551|463830941|FG001|Overall Study|Progressive Disease|17|||
128873533|NCT01747551|463830940|FG000|Overall Study|Death|3|||
128873534|NCT01747551|463830941|FG001|Overall Study|Death|1|||
128873535|NCT01747551|463830940|FG000|Overall Study|Adverse Event|7|||
128873536|NCT01747551|463830941|FG001|Overall Study|Adverse Event|1|||
128873537|NCT01747551|463830940|FG000|Overall Study|Prolonged Treatment Delay|2|||
128873538|NCT01747551|463830941|FG001|Overall Study|Prolonged Treatment Delay|0|||
128873539|NCT01747551|463830940|FG000|Overall Study|Withdrawal by Subject|3|||
128873540|NCT01747551|463830941|FG001|Overall Study|Withdrawal by Subject|1|||
128873541|NCT01747551|463830940|FG000|Overall Study|Physician Decision|2|||
128873542|NCT01747551|463830941|FG001|Overall Study|Physician Decision|1|||
128873543|NCT01747551|463830940|FG000|Overall Study|Other|2|||
128873544|NCT01747551|463830941|FG001|Overall Study|Other|0|||
128873545|NCT01142115|463830942|FG000|First Intervention|Lack of Efficacy|1|||
128873546|NCT01142115|463830943|FG001|First Intervention|Lack of Efficacy|1|||
128873547|NCT01142115|463830942|FG000|First Intervention|Adverse Event|1|||
128873548|NCT01142115|463830943|FG001|First Intervention|Adverse Event|0|||
128873549|NCT03406078|463830944|FG000|Overall Study|Death|1|||
128873550|NCT03406078|463830945|FG001|Overall Study|Death|0|||
128873551|NCT03406078|463830944|FG000|Overall Study|Lost to Follow-up|0|||
128873552|NCT03406078|463830945|FG001|Overall Study|Lost to Follow-up|1|||
128873553|NCT03406078|463830944|FG000|Overall Study|Withdrawal by Subject|5|||
128873554|NCT03406078|463830945|FG001|Overall Study|Withdrawal by Subject|2|||
128873555|NCT02091206|463830946|FG000|Treatment Period|Adverse Event|0|||
128873556|NCT02091206|463830947|FG001|Treatment Period|Adverse Event|1|||
128873557|NCT02091206|463830948|FG002|Treatment Period|Adverse Event|0|||
128873558|NCT02091206|463830949|FG003|Treatment Period|Adverse Event|0|||
128873559|NCT02091206|463830946|FG000|Treatment Period|Met withdrawal criteria|0|||
128873560|NCT02091206|463830947|FG001|Treatment Period|Met withdrawal criteria|0|||
128873561|NCT02091206|463830948|FG002|Treatment Period|Met withdrawal criteria|1|||
128873562|NCT02091206|463830949|FG003|Treatment Period|Met withdrawal criteria|0|||
128873563|NCT02091206|463830946|FG000|Taper Period|Participant refused study drug|1|||
128873564|NCT02091206|463830947|FG001|Taper Period|Participant refused study drug|0|||
128873565|NCT02091206|463830948|FG002|Taper Period|Participant refused study drug|0|||
128873566|NCT02091206|463830949|FG003|Taper Period|Participant refused study drug|1|||
128873567|NCT02091206|463830946|FG000|Taper Period|Lost to Follow-up|0|||
128873568|NCT02091206|463830947|FG001|Taper Period|Lost to Follow-up|0|||
128873569|NCT02091206|463830948|FG002|Taper Period|Lost to Follow-up|0|||
128873570|NCT02091206|463830949|FG003|Taper Period|Lost to Follow-up|1|||
128873571|NCT00700778|463830950|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
128873572|NCT00350103|463830953|FG000|Overall Study|Adverse Event|12|||
128873573|NCT00350103|463830954|FG001|Overall Study|Adverse Event|29|||
128873574|NCT00350103|463830955|FG002|Overall Study|Adverse Event|17|||
128873575|NCT00350103|463830953|FG000|Overall Study|Lack of Efficacy|5|||
128873576|NCT00350103|463830954|FG001|Overall Study|Lack of Efficacy|1|||
128873577|NCT00350103|463830955|FG002|Overall Study|Lack of Efficacy|3|||
128873578|NCT00350103|463830953|FG000|Overall Study|Withdrawal by Subject|6|||
128873579|NCT00350103|463830954|FG001|Overall Study|Withdrawal by Subject|6|||
128873580|NCT00350103|463830955|FG002|Overall Study|Withdrawal by Subject|8|||
128873581|NCT00350103|463830953|FG000|Overall Study|Protocol Violation|0|||
128873582|NCT00350103|463830954|FG001|Overall Study|Protocol Violation|0|||
128873583|NCT00350103|463830955|FG002|Overall Study|Protocol Violation|1|||
128873584|NCT00350103|463830953|FG000|Overall Study|Unsatisfactory Compliance|2|||
128873585|NCT00350103|463830954|FG001|Overall Study|Unsatisfactory Compliance|2|||
128873586|NCT00350103|463830955|FG002|Overall Study|Unsatisfactory Compliance|1|||
128873587|NCT00350103|463830953|FG000|Overall Study|Investigator´s decision|1|||
128873588|NCT00350103|463830954|FG001|Overall Study|Investigator´s decision|1|||
128873589|NCT00350103|463830955|FG002|Overall Study|Investigator´s decision|0|||
128873590|NCT00350103|463830953|FG000|Overall Study|Exclusion criteria met|0|||
128873591|NCT00350103|463830954|FG001|Overall Study|Exclusion criteria met|0|||
128873592|NCT00350103|463830955|FG002|Overall Study|Exclusion criteria met|1|||
128873593|NCT00350103|463830953|FG000|Overall Study|Patient relocated|0|||
128873594|NCT00350103|463830954|FG001|Overall Study|Patient relocated|0|||
128873595|NCT00350103|463830955|FG002|Overall Study|Patient relocated|1|||
128873596|NCT00350103|463830953|FG000|Overall Study|Need for prohibited medication|1|||
128873597|NCT00350103|463830954|FG001|Overall Study|Need for prohibited medication|0|||
128873598|NCT00350103|463830955|FG002|Overall Study|Need for prohibited medication|0|||
128873599|NCT00350103|463830953|FG000|Overall Study|Personal reasons|0|||
128873600|NCT00350103|463830954|FG001|Overall Study|Personal reasons|0|||
128873601|NCT00350103|463830955|FG002|Overall Study|Personal reasons|1|||
128873602|NCT00350103|463830953|FG000|Overall Study|Patient stopped feeling pain|1|||
128873603|NCT00350103|463830954|FG001|Overall Study|Patient stopped feeling pain|0|||
128873604|NCT00350103|463830955|FG002|Overall Study|Patient stopped feeling pain|0|||
128873605|NCT00350103|463830953|FG000|Overall Study|PR greater than 250ms|0|||
128873606|NCT00350103|463830954|FG001|Overall Study|PR greater than 250ms|0|||
128873607|NCT00350103|463830955|FG002|Overall Study|PR greater than 250ms|1|||
128873608|NCT00350103|463830953|FG000|Overall Study|Wrong calculation of QT interval|0|||
128873609|NCT00350103|463830954|FG001|Overall Study|Wrong calculation of QT interval|0|||
128873610|NCT00350103|463830955|FG002|Overall Study|Wrong calculation of QT interval|1|||
128873611|NCT00350103|463830953|FG000|Overall Study|Sponsor mistake|1|||
128873612|NCT00350103|463830954|FG001|Overall Study|Sponsor mistake|0|||
128873613|NCT00350103|463830955|FG002|Overall Study|Sponsor mistake|0|||
128873614|NCT00350103|463830953|FG000|Overall Study|Randomization mistake|0|||
128873615|NCT00350103|463830954|FG001|Overall Study|Randomization mistake|1|||
128873616|NCT00350103|463830955|FG002|Overall Study|Randomization mistake|1|||
128873617|NCT00350103|463830953|FG000|Overall Study|Sponsor´s decision|0|||
128873618|NCT00350103|463830954|FG001|Overall Study|Sponsor´s decision|1|||
128873619|NCT00350103|463830955|FG002|Overall Study|Sponsor´s decision|0|||
128873620|NCT00350103|463830953|FG000|Overall Study|Lost, Reason unknown|1|||
128873621|NCT00350103|463830954|FG001|Overall Study|Lost, Reason unknown|1|||
128873622|NCT00350103|463830955|FG002|Overall Study|Lost, Reason unknown|0|||
128873623|NCT02712905|463830956|FG000|Monotherapy|Death|2|||
128873624|NCT02712905|463830957|FG001|Monotherapy|Death|5|||
128873625|NCT02712905|463830958|FG002|Monotherapy|Death|0|||
128873626|NCT02712905|463830959|FG003|Monotherapy|Death|3|||
128873627|NCT02712905|463830960|FG004|Monotherapy|Death|15|||
128873628|NCT02712905|463830961|FG005|Monotherapy|Death|1|||
128873629|NCT02712905|463830962|FG006|Monotherapy|Death|3|||
128873630|NCT02712905|463830963|FG007|Monotherapy|Death|3|||
128873631|NCT02712905|463830964|FG008|Monotherapy|Death|0|||
128873632|NCT02712905|463830965|FG009|Monotherapy|Death|27|||
128873633|NCT02712905|463830966|FG010|Monotherapy|Death|2|||
128873634|NCT02712905|463830967|FG011|Monotherapy|Death|5|||
128873635|NCT02712905|463830968|FG012|Monotherapy|Death|0|||
128873636|NCT02712905|463830969|FG013|Monotherapy|Death|0|||
128873637|NCT02712905|463830970|FG014|Monotherapy|Death|0|||
128873638|NCT02712905|463830971|FG015|Monotherapy|Death|0|||
128873639|NCT02712905|463830972|FG016|Monotherapy|Death|0|||
128873640|NCT02712905|463830973|FG017|Monotherapy|Death|0|||
128873641|NCT02712905|463830956|FG000|Monotherapy|Lost to Follow-up|0|||
128873642|NCT02712905|463830957|FG001|Monotherapy|Lost to Follow-up|1|||
128873643|NCT02712905|463830958|FG002|Monotherapy|Lost to Follow-up|0|||
128873644|NCT02712905|463830959|FG003|Monotherapy|Lost to Follow-up|1|||
128873645|NCT02712905|463830960|FG004|Monotherapy|Lost to Follow-up|0|||
128873646|NCT02712905|463830961|FG005|Monotherapy|Lost to Follow-up|0|||
128873647|NCT02712905|463830962|FG006|Monotherapy|Lost to Follow-up|0|||
128873648|NCT02712905|463830963|FG007|Monotherapy|Lost to Follow-up|0|||
128873649|NCT02712905|463830964|FG008|Monotherapy|Lost to Follow-up|0|||
128873650|NCT02712905|463830965|FG009|Monotherapy|Lost to Follow-up|2|||
128873651|NCT02712905|463830966|FG010|Monotherapy|Lost to Follow-up|0|||
128873652|NCT02712905|463830967|FG011|Monotherapy|Lost to Follow-up|0|||
128873653|NCT02712905|463830968|FG012|Monotherapy|Lost to Follow-up|0|||
128873654|NCT02712905|463830969|FG013|Monotherapy|Lost to Follow-up|0|||
128873655|NCT02712905|463830970|FG014|Monotherapy|Lost to Follow-up|0|||
128873656|NCT02712905|463830971|FG015|Monotherapy|Lost to Follow-up|0|||
128873657|NCT02712905|463830972|FG016|Monotherapy|Lost to Follow-up|0|||
128873658|NCT02712905|463830973|FG017|Monotherapy|Lost to Follow-up|0|||
128873659|NCT02712905|463830956|FG000|Monotherapy|Physician Decision|1|||
128873660|NCT02712905|463830957|FG001|Monotherapy|Physician Decision|0|||
128873661|NCT02712905|463830958|FG002|Monotherapy|Physician Decision|0|||
128873662|NCT02712905|463830959|FG003|Monotherapy|Physician Decision|1|||
128873663|NCT02712905|463830960|FG004|Monotherapy|Physician Decision|0|||
128873664|NCT02712905|463830961|FG005|Monotherapy|Physician Decision|0|||
128873665|NCT02712905|463830962|FG006|Monotherapy|Physician Decision|0|||
128873666|NCT02712905|463830963|FG007|Monotherapy|Physician Decision|0|||
128873667|NCT02712905|463830964|FG008|Monotherapy|Physician Decision|0|||
128873668|NCT02712905|463830965|FG009|Monotherapy|Physician Decision|1|||
128873669|NCT02712905|463830966|FG010|Monotherapy|Physician Decision|0|||
128873670|NCT02712905|463830967|FG011|Monotherapy|Physician Decision|0|||
128873671|NCT02712905|463830968|FG012|Monotherapy|Physician Decision|0|||
128873672|NCT02712905|463830969|FG013|Monotherapy|Physician Decision|0|||
129096490|NCT03000530|464644495|FG001|Overall Study|Withdrawal by Subject|2|||
128873673|NCT02712905|463830970|FG014|Monotherapy|Physician Decision|0|||
128873674|NCT02712905|463830971|FG015|Monotherapy|Physician Decision|0|||
128873675|NCT02712905|463830972|FG016|Monotherapy|Physician Decision|0|||
128873676|NCT02712905|463830973|FG017|Monotherapy|Physician Decision|0|||
128873677|NCT02712905|463830956|FG000|Monotherapy|Study Terminated by Sponsor|0|||
128873678|NCT02712905|463830957|FG001|Monotherapy|Study Terminated by Sponsor|0|||
128873679|NCT02712905|463830958|FG002|Monotherapy|Study Terminated by Sponsor|0|||
128873680|NCT02712905|463830959|FG003|Monotherapy|Study Terminated by Sponsor|0|||
128873681|NCT02712905|463830960|FG004|Monotherapy|Study Terminated by Sponsor|1|||
128873682|NCT02712905|463830961|FG005|Monotherapy|Study Terminated by Sponsor|0|||
128873683|NCT02712905|463830962|FG006|Monotherapy|Study Terminated by Sponsor|0|||
128873684|NCT02712905|463830963|FG007|Monotherapy|Study Terminated by Sponsor|0|||
128873685|NCT02712905|463830964|FG008|Monotherapy|Study Terminated by Sponsor|0|||
128873686|NCT02712905|463830965|FG009|Monotherapy|Study Terminated by Sponsor|2|||
128873687|NCT02712905|463830966|FG010|Monotherapy|Study Terminated by Sponsor|0|||
128873688|NCT02712905|463830967|FG011|Monotherapy|Study Terminated by Sponsor|0|||
128873689|NCT02712905|463830968|FG012|Monotherapy|Study Terminated by Sponsor|0|||
128873690|NCT02712905|463830969|FG013|Monotherapy|Study Terminated by Sponsor|0|||
128873691|NCT02712905|463830970|FG014|Monotherapy|Study Terminated by Sponsor|0|||
128873692|NCT02712905|463830971|FG015|Monotherapy|Study Terminated by Sponsor|0|||
128873693|NCT02712905|463830972|FG016|Monotherapy|Study Terminated by Sponsor|0|||
128873694|NCT02712905|463830973|FG017|Monotherapy|Study Terminated by Sponsor|0|||
128873695|NCT02712905|463830956|FG000|Monotherapy|Withdrawal by Subject|0|||
128873696|NCT02712905|463830957|FG001|Monotherapy|Withdrawal by Subject|0|||
128873697|NCT02712905|463830958|FG002|Monotherapy|Withdrawal by Subject|1|||
128873698|NCT02712905|463830959|FG003|Monotherapy|Withdrawal by Subject|0|||
128873699|NCT02712905|463830960|FG004|Monotherapy|Withdrawal by Subject|2|||
128873700|NCT02712905|463830961|FG005|Monotherapy|Withdrawal by Subject|0|||
128873701|NCT02712905|463830962|FG006|Monotherapy|Withdrawal by Subject|0|||
128873702|NCT02712905|463830963|FG007|Monotherapy|Withdrawal by Subject|0|||
128873703|NCT02712905|463830964|FG008|Monotherapy|Withdrawal by Subject|0|||
128873704|NCT02712905|463830965|FG009|Monotherapy|Withdrawal by Subject|4|||
128873705|NCT02712905|463830966|FG010|Monotherapy|Withdrawal by Subject|1|||
128873706|NCT02712905|463830967|FG011|Monotherapy|Withdrawal by Subject|2|||
128873707|NCT02712905|463830968|FG012|Monotherapy|Withdrawal by Subject|0|||
128873708|NCT02712905|463830969|FG013|Monotherapy|Withdrawal by Subject|0|||
128873709|NCT02712905|463830970|FG014|Monotherapy|Withdrawal by Subject|0|||
128873710|NCT02712905|463830971|FG015|Monotherapy|Withdrawal by Subject|0|||
128873711|NCT02712905|463830972|FG016|Monotherapy|Withdrawal by Subject|0|||
128873712|NCT02712905|463830973|FG017|Monotherapy|Withdrawal by Subject|0|||
128873713|NCT02712905|463830956|FG000|Monotherapy|Started New Cancer Drug|0|||
128873714|NCT02712905|463830957|FG001|Monotherapy|Started New Cancer Drug|0|||
128873715|NCT02712905|463830958|FG002|Monotherapy|Started New Cancer Drug|0|||
128873716|NCT02712905|463830959|FG003|Monotherapy|Started New Cancer Drug|0|||
128873717|NCT02712905|463830960|FG004|Monotherapy|Started New Cancer Drug|0|||
128873718|NCT02712905|463830961|FG005|Monotherapy|Started New Cancer Drug|1|||
128873719|NCT02712905|463830962|FG006|Monotherapy|Started New Cancer Drug|0|||
128873720|NCT02712905|463830963|FG007|Monotherapy|Started New Cancer Drug|0|||
128873721|NCT02712905|463830964|FG008|Monotherapy|Started New Cancer Drug|0|||
128873722|NCT02712905|463830965|FG009|Monotherapy|Started New Cancer Drug|0|||
128873723|NCT02712905|463830966|FG010|Monotherapy|Started New Cancer Drug|0|||
128873724|NCT02712905|463830967|FG011|Monotherapy|Started New Cancer Drug|0|||
128873725|NCT02712905|463830968|FG012|Monotherapy|Started New Cancer Drug|0|||
128873726|NCT02712905|463830969|FG013|Monotherapy|Started New Cancer Drug|0|||
128873727|NCT02712905|463830970|FG014|Monotherapy|Started New Cancer Drug|0|||
128873728|NCT02712905|463830971|FG015|Monotherapy|Started New Cancer Drug|0|||
128873729|NCT02712905|463830972|FG016|Monotherapy|Started New Cancer Drug|0|||
128873730|NCT02712905|463830973|FG017|Monotherapy|Started New Cancer Drug|0|||
128873731|NCT02712905|463830956|FG000|Monotherapy|Adverse Event|0|||
128873732|NCT02712905|463830957|FG001|Monotherapy|Adverse Event|0|||
128873733|NCT02712905|463830958|FG002|Monotherapy|Adverse Event|0|||
128873734|NCT02712905|463830959|FG003|Monotherapy|Adverse Event|0|||
128873735|NCT02712905|463830960|FG004|Monotherapy|Adverse Event|0|||
128873736|NCT02712905|463830961|FG005|Monotherapy|Adverse Event|0|||
128873737|NCT02712905|463830962|FG006|Monotherapy|Adverse Event|0|||
128873738|NCT02712905|463830963|FG007|Monotherapy|Adverse Event|0|||
128873739|NCT02712905|463830964|FG008|Monotherapy|Adverse Event|1|||
128873740|NCT02712905|463830965|FG009|Monotherapy|Adverse Event|0|||
128873741|NCT02712905|463830966|FG010|Monotherapy|Adverse Event|0|||
128873742|NCT02712905|463830967|FG011|Monotherapy|Adverse Event|0|||
128873743|NCT02712905|463830968|FG012|Monotherapy|Adverse Event|0|||
128873744|NCT02712905|463830969|FG013|Monotherapy|Adverse Event|0|||
128873745|NCT02712905|463830970|FG014|Monotherapy|Adverse Event|0|||
128873746|NCT02712905|463830971|FG015|Monotherapy|Adverse Event|0|||
128873747|NCT02712905|463830972|FG016|Monotherapy|Adverse Event|0|||
128873748|NCT02712905|463830973|FG017|Monotherapy|Adverse Event|0|||
128873749|NCT02712905|463830956|FG000|Combination Therapy|Death|0|||
128984015|NCT00066573|464229449|FG001|Overall Study|Did not received protocol treatment|28|||
128873750|NCT02712905|463830957|FG001|Combination Therapy|Death|0|||
128873751|NCT02712905|463830958|FG002|Combination Therapy|Death|0|||
128984016|NCT00869362|464229450|FG000|Overall Study|Death|0|||
128873752|NCT02712905|463830959|FG003|Combination Therapy|Death|0|||
128873753|NCT02712905|463830960|FG004|Combination Therapy|Death|0|||
128873754|NCT02712905|463830961|FG005|Combination Therapy|Death|0|||
128873755|NCT02712905|463830962|FG006|Combination Therapy|Death|0|||
128873756|NCT02712905|463830963|FG007|Combination Therapy|Death|0|||
128984017|NCT00869362|464229451|FG001|Overall Study|Death|2|||
128873757|NCT02712905|463830964|FG008|Combination Therapy|Death|0|||
128873758|NCT02712905|463830965|FG009|Combination Therapy|Death|0|||
128873759|NCT02712905|463830966|FG010|Combination Therapy|Death|0|||
128873760|NCT02712905|463830967|FG011|Combination Therapy|Death|0|||
128873761|NCT02712905|463830968|FG012|Combination Therapy|Death|5|||
128873762|NCT02712905|463830969|FG013|Combination Therapy|Death|6|||
128873763|NCT02712905|463830970|FG014|Combination Therapy|Death|1|||
128873764|NCT02712905|463830971|FG015|Combination Therapy|Death|3|||
128873765|NCT02712905|463830972|FG016|Combination Therapy|Death|1|||
128873766|NCT02712905|463830973|FG017|Combination Therapy|Death|3|||
128873767|NCT02712905|463830956|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
128873768|NCT02712905|463830957|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
128873769|NCT02712905|463830958|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
128873770|NCT02712905|463830959|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
128873771|NCT02712905|463830960|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
128873772|NCT02712905|463830961|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
128873773|NCT02712905|463830962|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
128873774|NCT02712905|463830963|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
128873775|NCT02712905|463830964|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
128873776|NCT02712905|463830965|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
128873777|NCT02712905|463830966|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
128873778|NCT02712905|463830967|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
128873779|NCT02712905|463830968|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
128873780|NCT02712905|463830969|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
128873781|NCT02712905|463830970|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
128873782|NCT02712905|463830971|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
128873783|NCT02712905|463830972|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
128873784|NCT02712905|463830973|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
128873785|NCT02712905|463830956|FG000|Combination Therapy|Withdrawal by Subject|0|||
128873786|NCT02712905|463830957|FG001|Combination Therapy|Withdrawal by Subject|0|||
128873787|NCT02712905|463830958|FG002|Combination Therapy|Withdrawal by Subject|0|||
128873788|NCT02712905|463830959|FG003|Combination Therapy|Withdrawal by Subject|0|||
128873789|NCT02712905|463830960|FG004|Combination Therapy|Withdrawal by Subject|0|||
128873790|NCT02712905|463830961|FG005|Combination Therapy|Withdrawal by Subject|0|||
128873791|NCT02712905|463830962|FG006|Combination Therapy|Withdrawal by Subject|0|||
128873792|NCT02712905|463830963|FG007|Combination Therapy|Withdrawal by Subject|0|||
128873793|NCT02712905|463830964|FG008|Combination Therapy|Withdrawal by Subject|0|||
128873794|NCT02712905|463830965|FG009|Combination Therapy|Withdrawal by Subject|0|||
128873795|NCT02712905|463830966|FG010|Combination Therapy|Withdrawal by Subject|0|||
128873796|NCT02712905|463830967|FG011|Combination Therapy|Withdrawal by Subject|0|||
128873797|NCT02712905|463830968|FG012|Combination Therapy|Withdrawal by Subject|0|||
128873798|NCT02712905|463830969|FG013|Combination Therapy|Withdrawal by Subject|0|||
128873799|NCT02712905|463830970|FG014|Combination Therapy|Withdrawal by Subject|0|||
128873800|NCT02712905|463830971|FG015|Combination Therapy|Withdrawal by Subject|1|||
128873801|NCT02712905|463830972|FG016|Combination Therapy|Withdrawal by Subject|0|||
128873802|NCT02712905|463830973|FG017|Combination Therapy|Withdrawal by Subject|2|||
128873803|NCT02712905|463830956|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873804|NCT02712905|463830957|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873805|NCT02712905|463830958|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873806|NCT02712905|463830959|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129096491|NCT03000530|464644496|FG002|Overall Study|Withdrawal by Subject|1|||
129096492|NCT00312572|464644497|FG000|Overall Study|Adverse Event|10|||
129096493|NCT00312572|464644498|FG001|Overall Study|Adverse Event|16|||
128873807|NCT02712905|463830960|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873808|NCT02712905|463830961|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873809|NCT02712905|463830962|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873810|NCT02712905|463830963|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873811|NCT02712905|463830964|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873812|NCT02712905|463830965|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873813|NCT02712905|463830966|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873814|NCT02712905|463830967|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873815|NCT02712905|463830968|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873816|NCT02712905|463830969|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873817|NCT02712905|463830970|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873818|NCT02712905|463830971|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
129096494|NCT00312572|464644497|FG000|Overall Study|Lost to Follow-up|1|||
129096495|NCT00312572|464644498|FG001|Overall Study|Lost to Follow-up|1|||
128873819|NCT02712905|463830972|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873820|NCT02712905|463830973|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
128873821|NCT00320528|463830974|FG000|Study Period II|Adverse Event|3|||
128873822|NCT00320528|463830975|FG001|Study Period II|Adverse Event|4|||
128873823|NCT00320528|463830976|FG002|Study Period II|Adverse Event|8|||
128873824|NCT00320528|463830974|FG000|Study Period II|Parent/Caregiver Decision|8|||
128873825|NCT00320528|463830975|FG001|Study Period II|Parent/Caregiver Decision|3|||
128873826|NCT00320528|463830976|FG002|Study Period II|Parent/Caregiver Decision|11|||
128873827|NCT00320528|463830974|FG000|Study Period II|Withdrawal by Subject|0|||
128873828|NCT00320528|463830975|FG001|Study Period II|Withdrawal by Subject|1|||
128873829|NCT00320528|463830976|FG002|Study Period II|Withdrawal by Subject|1|||
128984018|NCT00869362|464229450|FG000|Overall Study|Lost to Follow-up|1|||
128984019|NCT00869362|464229451|FG001|Overall Study|Lost to Follow-up|3|||
128984020|NCT03053102|464229452|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
128984021|NCT03053102|464229452|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
128984022|NCT04963231|464229453|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
128984023|NCT04963231|464229454|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
128984024|NCT04963231|464229455|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
128984025|NCT04963231|464229453|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
128984026|NCT04963231|464229454|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
128984027|NCT04963231|464229455|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
128984028|NCT04963231|464229453|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
128984029|NCT04963231|464229454|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
128984030|NCT04963231|464229455|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
128984031|NCT04963231|464229453|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
128984032|NCT04963231|464229454|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
128984033|NCT04963231|464229455|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
128984034|NCT04963231|464229453|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
128984035|NCT04963231|464229454|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
128984036|NCT04963231|464229455|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
128984037|NCT04963231|464229453|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
128984038|NCT04963231|464229454|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
128984039|NCT04963231|464229455|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
128984040|NCT04963231|464229453|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
128984041|NCT04963231|464229454|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
128984042|NCT04963231|464229455|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
128984043|NCT01982942|464229456|FG000|Overall Study|Adverse Event|10|||
128984044|NCT01982942|464229457|FG001|Overall Study|Adverse Event|5|||
128984045|NCT01982942|464229456|FG000|Overall Study|Lost to Follow-up|4|||
128984046|NCT01982942|464229457|FG001|Overall Study|Lost to Follow-up|3|||
128984047|NCT01982942|464229456|FG000|Overall Study|Multiple sclerosis progression|3|||
128984048|NCT01982942|464229457|FG001|Overall Study|Multiple sclerosis progression|2|||
128984049|NCT01982942|464229456|FG000|Overall Study|Wanted to try therapy not permitted|1|||
128984050|NCT01982942|464229457|FG001|Overall Study|Wanted to try therapy not permitted|0|||
128984051|NCT01982942|464229456|FG000|Overall Study|Subject declined future visits|0|||
128984052|NCT01982942|464229457|FG001|Overall Study|Subject declined future visits|1|||
128984053|NCT01982942|464229456|FG000|Overall Study|Left geographical area|2|||
128984054|NCT01982942|464229457|FG001|Overall Study|Left geographical area|0|||
128984055|NCT01982942|464229456|FG000|Overall Study|Too many pills|1|||
128984056|NCT01982942|464229457|FG001|Overall Study|Too many pills|0|||
128984057|NCT01982942|464229456|FG000|Overall Study|MS Relapse|0|||
128984058|NCT01982942|464229457|FG001|Overall Study|MS Relapse|1|||
128984059|NCT01982942|464229456|FG000|Overall Study|Chose to join a stem cell trial|0|||
128984060|NCT01982942|464229457|FG001|Overall Study|Chose to join a stem cell trial|1|||
128984061|NCT01982942|464229456|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
128984062|NCT01982942|464229457|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
128984063|NCT02213666|464229458|FG000|Overall Study|Withdrawal by Subject|1|||
128984064|NCT00750061|464229462|FG000|Overall Study|Adverse Event|2|||
128984065|NCT00750061|464229463|FG001|Overall Study|Adverse Event|0|||
128984066|NCT00750061|464229462|FG000|Overall Study|Withdrawal by Subject|0|||
128984067|NCT00750061|464229463|FG001|Overall Study|Withdrawal by Subject|1|||
128984068|NCT00750061|464229462|FG000|Overall Study|Physician Decision|0|||
128984069|NCT00750061|464229463|FG001|Overall Study|Physician Decision|1|||
128984070|NCT03246152|464229464|FG000|Overall Study|Lost to Follow-up|2|||
128984071|NCT03246152|464229464|FG000|Overall Study|Protocol Violation|1|||
128984072|NCT01374516|464229467|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
128984073|NCT01374516|464229468|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
128984074|NCT01374516|464229467|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
128984075|NCT01374516|464229468|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
128984076|NCT01374516|464229467|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
128873830|NCT00320528|463830974|FG000|Study Period II|Entry Criteria Exclusion|0|||
128873831|NCT00320528|463830975|FG001|Study Period II|Entry Criteria Exclusion|2|||
128873832|NCT00320528|463830976|FG002|Study Period II|Entry Criteria Exclusion|2|||
128873833|NCT00320528|463830974|FG000|Study Period III|Adverse Event|1|||
128873834|NCT00320528|463830975|FG001|Study Period III|Adverse Event|0|||
128873835|NCT00320528|463830976|FG002|Study Period III|Adverse Event|0|||
128873836|NCT00320528|463830974|FG000|Study Period III|Lost to Follow-up|1|||
128873837|NCT00320528|463830975|FG001|Study Period III|Lost to Follow-up|0|||
128873838|NCT00320528|463830976|FG002|Study Period III|Lost to Follow-up|0|||
128873839|NCT00320528|463830974|FG000|Study Period III|Withdrawal by Subject|1|||
128873840|NCT00320528|463830975|FG001|Study Period III|Withdrawal by Subject|1|||
128873841|NCT00320528|463830976|FG002|Study Period III|Withdrawal by Subject|2|||
128873842|NCT00320528|463830974|FG000|Study Period III|Lack of Efficacy|2|||
128873843|NCT00320528|463830975|FG001|Study Period III|Lack of Efficacy|0|||
128873844|NCT00320528|463830976|FG002|Study Period III|Lack of Efficacy|0|||
128873845|NCT00320528|463830974|FG000|Study Period III|Parent/Caregiver Decision|14|||
128873846|NCT00320528|463830975|FG001|Study Period III|Parent/Caregiver Decision|3|||
128873847|NCT00320528|463830976|FG002|Study Period III|Parent/Caregiver Decision|11|||
128873848|NCT00320528|463830974|FG000|Study Period III|Protocol Violation|0|||
128873849|NCT00320528|463830975|FG001|Study Period III|Protocol Violation|1|||
128873850|NCT00320528|463830976|FG002|Study Period III|Protocol Violation|0|||
128873851|NCT00320528|463830974|FG000|Study Period III|Physician Decision|0|||
128873852|NCT00320528|463830975|FG001|Study Period III|Physician Decision|1|||
128873853|NCT00320528|463830976|FG002|Study Period III|Physician Decision|2|||
128873854|NCT00320528|463830974|FG000|Study Period III|Sponsor Decision|0|||
128873855|NCT00320528|463830975|FG001|Study Period III|Sponsor Decision|0|||
128873856|NCT00320528|463830976|FG002|Study Period III|Sponsor Decision|1|||
128873857|NCT00320528|463830974|FG000|Study Period III|Atomoxetine Commercially Available|68|||
128873858|NCT00320528|463830975|FG001|Study Period III|Atomoxetine Commercially Available|25|||
128873859|NCT00320528|463830976|FG002|Study Period III|Atomoxetine Commercially Available|90|||
128873860|NCT04664400|463830977|FG000|Overall Study|Withdrawal by Subject|2|||
128873861|NCT01011153|463830982|FG000|Overall Study|Less than 78 cases completed|8|||
128873862|NCT01011153|463830983|FG001|Overall Study|Less than 78 cases completed|11|||
128873863|NCT01011153|463830984|FG002|Overall Study|Less than 78 cases completed|9|||
128873864|NCT03014479|463830985|FG000|Overall Study|Adverse Event|0|||
128873865|NCT03014479|463830986|FG001|Overall Study|Adverse Event|1|||
128873866|NCT03014479|463830985|FG000|Overall Study|Voluntary Withdrawal|0|||
128873867|NCT03014479|463830986|FG001|Overall Study|Voluntary Withdrawal|2|||
128873868|NCT03014479|463830985|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
128873869|NCT03014479|463830986|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
128873870|NCT01394978|463830992|FG000|Overall Study|Withdrawal by Subject|2|||
128873871|NCT01394978|463830993|FG001|Overall Study|Withdrawal by Subject|4|||
128873872|NCT01394978|463830992|FG000|Overall Study|Lost to Follow-up|13|||
128873873|NCT01394978|463830993|FG001|Overall Study|Lost to Follow-up|20|||
128873874|NCT01394978|463830992|FG000|Overall Study|Death|6|||
128873875|NCT01394978|463830993|FG001|Overall Study|Death|7|||
128873876|NCT01081132|463830994|FG000|Overall Study|Lack of Efficacy|25|||
128873877|NCT01081132|463830995|FG001|Overall Study|Lack of Efficacy|9|||
128873878|NCT01081132|463830994|FG000|Overall Study|Withdrawal by Subject|13|||
128873879|NCT01081132|463830995|FG001|Overall Study|Withdrawal by Subject|16|||
128873880|NCT01081132|463830994|FG000|Overall Study|Lost to Follow-up|4|||
128873881|NCT01081132|463830995|FG001|Overall Study|Lost to Follow-up|11|||
128873882|NCT01081132|463830994|FG000|Overall Study|Adverse Event|3|||
128873883|NCT01081132|463830995|FG001|Overall Study|Adverse Event|9|||
128873884|NCT01081132|463830994|FG000|Overall Study|Non Compliance|4|||
128873885|NCT01081132|463830995|FG001|Overall Study|Non Compliance|2|||
128873886|NCT01081132|463830994|FG000|Overall Study|Lack Of Compliance|0|||
128873887|NCT01081132|463830995|FG001|Overall Study|Lack Of Compliance|1|||
128873888|NCT01081132|463830994|FG000|Overall Study|Missed Visits|1|||
128873889|NCT01081132|463830995|FG001|Overall Study|Missed Visits|1|||
128873890|NCT01081132|463830994|FG000|Overall Study|Stopped Taking Meds|2|||
128873891|NCT01081132|463830995|FG001|Overall Study|Stopped Taking Meds|0|||
128873892|NCT01081132|463830994|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
128873893|NCT01081132|463830995|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
128873894|NCT01081132|463830994|FG000|Overall Study|Declined Taper Phase|0|||
128873895|NCT01081132|463830995|FG001|Overall Study|Declined Taper Phase|1|||
128873896|NCT01081132|463830994|FG000|Overall Study|Protocol Violation|3|||
128873897|NCT01081132|463830995|FG001|Overall Study|Protocol Violation|1|||
128873898|NCT02019667|463830996|FG000|First Intervention (6 Months)|Adverse Event|0|||
128873899|NCT02019667|463830997|FG001|First Intervention (6 Months)|Adverse Event|1|||
128873900|NCT02019667|463830996|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
128873901|NCT02019667|463830997|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
128873902|NCT02019667|463830996|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
128873903|NCT02019667|463830997|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
128873904|NCT02101385|463831000|FG000|Study Treatment|Disease Progression|9|||
128873905|NCT02101385|463831001|FG001|Study Treatment|Disease Progression|3|||
128873906|NCT02101385|463831000|FG000|Study Treatment|Alternative therapy|0|||
128873907|NCT02101385|463831001|FG001|Study Treatment|Alternative therapy|1|||
128873908|NCT02101385|463831000|FG000|Study Treatment|No treatment, per protocol criteria|0|||
128873909|NCT02101385|463831001|FG001|Study Treatment|No treatment, per protocol criteria|4|||
128873910|NCT02101385|463831000|FG000|Study Treatment|Patient Non compliance|0|||
128873911|NCT02101385|463831001|FG001|Study Treatment|Patient Non compliance|2|||
128873912|NCT02101385|463831000|FG000|Study Treatment|Withdrawal by Subject|5|||
128873913|NCT02101385|463831001|FG001|Study Treatment|Withdrawal by Subject|2|||
128873914|NCT02101385|463831000|FG000|Study Treatment|screen failure|1|||
128873915|NCT02101385|463831001|FG001|Study Treatment|screen failure|0|||
128873916|NCT02101385|463831000|FG000|Study Treatment|AE/Side Effects/Complications|8|||
128873917|NCT02101385|463831001|FG001|Study Treatment|AE/Side Effects/Complications|0|||
128873918|NCT02101385|463831000|FG000|Study Treatment|Lost to Follow-up|1|||
128873919|NCT02101385|463831001|FG001|Study Treatment|Lost to Follow-up|0|||
128873920|NCT02101385|463831000|FG000|Study Treatment|Disease Progression before treatment|1|||
128873921|NCT02101385|463831001|FG001|Study Treatment|Disease Progression before treatment|0|||
128873922|NCT02101385|463831000|FG000|Study Treatment|Death|1|||
128873923|NCT02101385|463831001|FG001|Study Treatment|Death|0|||
128873924|NCT02101385|463831000|FG000|Follow up|Lost to Follow-up|4|||
128873925|NCT02101385|463831001|FG001|Follow up|Lost to Follow-up|9|||
128873926|NCT02101385|463831000|FG000|Follow up|Refused to follow up|5|||
128873927|NCT02101385|463831001|FG001|Follow up|Refused to follow up|4|||
128873928|NCT02101385|463831000|FG000|Follow up|Death|21|||
128873929|NCT02101385|463831001|FG001|Follow up|Death|39|||
128873930|NCT02101385|463831000|FG000|Follow up|study completed|33|||
128873931|NCT02101385|463831001|FG001|Follow up|study completed|52|||
128873932|NCT02101385|463831000|FG000|Follow up|screen failure|2|||
128873933|NCT02101385|463831001|FG001|Follow up|screen failure|0|||
128873934|NCT02101385|463831000|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
128873935|NCT02101385|463831001|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
128873936|NCT02101385|463831000|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
128873937|NCT02101385|463831001|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
128873938|NCT02101385|463831000|FG000|Follow up|Withdrawal by Subject|2|||
128873939|NCT02101385|463831001|FG001|Follow up|Withdrawal by Subject|2|||
128873940|NCT02101385|463831000|FG000|Follow up|PI requested closure of site|0|||
128873941|NCT02101385|463831001|FG001|Follow up|PI requested closure of site|5|||
128873942|NCT02432196|463831002|FG000|Overall Study|Exit - did not receive study device|1|||
128873943|NCT02432196|463831002|FG000|Overall Study|Death|2|||
128873944|NCT02432196|463831002|FG000|Overall Study|Reoperation|3|||
128873945|NCT05038163|463831003|FG000|Stage 1|Did not complete survey|374|||
128873946|NCT05038163|463831004|FG001|Stage 1|Did not complete survey|0|||
128873947|NCT05038163|463831005|FG002|Stage 1|Did not complete survey|0|||
128873948|NCT05038163|463831006|FG003|Stage 1|Did not complete survey|0|||
128873949|NCT05038163|463831007|FG004|Stage 1|Did not complete survey|0|||
128873950|NCT05038163|463831008|FG005|Stage 1|Did not complete survey|0|||
128873951|NCT05038163|463831003|FG000|Stage 2|Did not complete Stage 2 survey|0|||
128873952|NCT05038163|463831004|FG001|Stage 2|Did not complete Stage 2 survey|29|||
128873953|NCT05038163|463831005|FG002|Stage 2|Did not complete Stage 2 survey|30|||
128873954|NCT05038163|463831006|FG003|Stage 2|Did not complete Stage 2 survey|24|||
128873955|NCT05038163|463831007|FG004|Stage 2|Did not complete Stage 2 survey|21|||
128873956|NCT05038163|463831008|FG005|Stage 2|Did not complete Stage 2 survey|100|||
128873957|NCT01905150|463831009|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
128873958|NCT01905150|463831010|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
128873959|NCT03762200|463831015|FG000|Overall Study|Death|2|||
128873960|NCT02631577|463831016|FG000|Overall Study|Death|1|||
128873961|NCT02631577|463831017|FG001|Overall Study|Death|7|||
128873962|NCT02631577|463831016|FG000|Overall Study|Withdrawal by Subject|0|||
128873963|NCT02631577|463831017|FG001|Overall Study|Withdrawal by Subject|3|||
128873964|NCT01593787|463831018|FG000|Overall Study|Adverse Event|1|||
128873965|NCT01593787|463831019|FG001|Overall Study|Adverse Event|0|||
128873966|NCT01593787|463831020|FG002|Overall Study|Adverse Event|0|||
128873967|NCT02980731|463832651|FG000|Overall Study|Death|63|||
128873968|NCT02980731|463832651|FG000|Overall Study|Withdrawal by Subject|6|||
128873969|NCT02980731|463832651|FG000|Overall Study|Lost to Follow-up|5|||
128873970|NCT02980731|463832651|FG000|Overall Study|Study terminated by Sponsor|4|||
128873971|NCT02980731|463832651|FG000|Overall Study|Completed survival follow-up period|65|||
128873972|NCT02980731|463832651|FG000|Overall Study|COVID-19 infection|1|||
128873973|NCT02980731|463832651|FG000|Overall Study|Other, not specified|66|||
128873974|NCT03037931|463832652|FG000|Overall Study|Death|354|||
128873975|NCT03037931|463832653|FG001|Overall Study|Death|367|||
128873976|NCT03037931|463832652|FG000|Overall Study|Lost to Follow-up|7|||
128873977|NCT03037931|463832653|FG001|Overall Study|Lost to Follow-up|4|||
128873978|NCT03037931|463832652|FG000|Overall Study|Withdrawal by Subject|48|||
128873979|NCT03037931|463832653|FG001|Overall Study|Withdrawal by Subject|41|||
128873980|NCT00605215|463832654|FG000|Overall Study|Death|0|||
129096496|NCT00312572|464644497|FG000|Overall Study|Administrative|4|||
129096497|NCT00312572|464644498|FG001|Overall Study|Administrative|2|||
129096498|NCT00312572|464644497|FG000|Overall Study|Lack of Efficacy|1|||
129096499|NCT00312572|464644498|FG001|Overall Study|Lack of Efficacy|2|||
129096500|NCT02614131|464644499|FG000|Overall Study|Withdrawal by Subject|1|||
129096501|NCT02614131|464644500|FG001|Overall Study|Withdrawal by Subject|0|||
128873981|NCT00605215|463832655|FG001|Overall Study|Death|0|||
128873982|NCT00605215|463832656|FG002|Overall Study|Death|1|||
128873983|NCT00605215|463832654|FG000|Overall Study|Adverse Event|19|||
128873984|NCT00605215|463832655|FG001|Overall Study|Adverse Event|21|||
128873985|NCT00605215|463832656|FG002|Overall Study|Adverse Event|26|||
128873986|NCT00605215|463832654|FG000|Overall Study|Refusal to sign the re-consent form|8|||
128873987|NCT00605215|463832655|FG001|Overall Study|Refusal to sign the re-consent form|3|||
128873988|NCT00605215|463832656|FG002|Overall Study|Refusal to sign the re-consent form|3|||
128873989|NCT00605215|463832654|FG000|Overall Study|Withdrawal by Subject|39|||
128873990|NCT00605215|463832655|FG001|Overall Study|Withdrawal by Subject|37|||
128873991|NCT00605215|463832656|FG002|Overall Study|Withdrawal by Subject|27|||
128873992|NCT00605215|463832654|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
128873993|NCT00605215|463832655|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
128873994|NCT00605215|463832656|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
128873995|NCT00605215|463832654|FG000|Overall Study|Protocol Violation|3|||
128873996|NCT00605215|463832655|FG001|Overall Study|Protocol Violation|4|||
128873997|NCT00605215|463832656|FG002|Overall Study|Protocol Violation|1|||
128873998|NCT00605215|463832654|FG000|Overall Study|Pregnancy|8|||
128873999|NCT00605215|463832655|FG001|Overall Study|Pregnancy|5|||
128874000|NCT00605215|463832656|FG002|Overall Study|Pregnancy|4|||
128874001|NCT00605215|463832654|FG000|Overall Study|Lost to Follow-up|8|||
128874002|NCT00605215|463832655|FG001|Overall Study|Lost to Follow-up|5|||
128874003|NCT00605215|463832656|FG002|Overall Study|Lost to Follow-up|2|||
128874004|NCT00605215|463832654|FG000|Overall Study|Other than specified|0|||
128874005|NCT00605215|463832655|FG001|Overall Study|Other than specified|2|||
128874006|NCT00605215|463832656|FG002|Overall Study|Other than specified|1|||
128874007|NCT02914275|463832659|FG000|Overall Study|Lost to Follow-up|84|||
128874008|NCT02914275|463832660|FG001|Overall Study|Lost to Follow-up|29|||
128874009|NCT02914275|463832659|FG000|Overall Study|Withdrawal by Subject|26|||
128874010|NCT02914275|463832660|FG001|Overall Study|Withdrawal by Subject|10|||
128874011|NCT02914275|463832659|FG000|Overall Study|Protocol Violation|1|||
128874012|NCT02914275|463832660|FG001|Overall Study|Protocol Violation|1|||
128874013|NCT02914275|463832659|FG000|Overall Study|Physician Decision|3|||
128874014|NCT02914275|463832660|FG001|Overall Study|Physician Decision|1|||
128874015|NCT02914275|463832659|FG000|Overall Study|Other|4|||
128874016|NCT02914275|463832660|FG001|Overall Study|Other|1|||
128874017|NCT02914275|463832659|FG000|Overall Study|Excluded due to invalid informed consent|3|||
128874018|NCT02914275|463832660|FG001|Overall Study|Excluded due to invalid informed consent|0|||
128874019|NCT01302067|463832665|FG000|Overall Study|Death|0|||
128874020|NCT01302067|463832666|FG001|Overall Study|Death|0|||
128874021|NCT01302067|463832667|FG002|Overall Study|Death|1|||
128874022|NCT01302067|463832665|FG000|Overall Study|Physician Decision|9|||
128874023|NCT01302067|463832666|FG001|Overall Study|Physician Decision|5|||
128874024|NCT01302067|463832667|FG002|Overall Study|Physician Decision|14|||
128874025|NCT01302067|463832665|FG000|Overall Study|Lack of Efficacy|8|||
128874026|NCT01302067|463832666|FG001|Overall Study|Lack of Efficacy|4|||
128874027|NCT01302067|463832667|FG002|Overall Study|Lack of Efficacy|2|||
128874028|NCT01302067|463832665|FG000|Overall Study|Lost to Follow-up|9|||
128874029|NCT01302067|463832666|FG001|Overall Study|Lost to Follow-up|4|||
128874030|NCT01302067|463832667|FG002|Overall Study|Lost to Follow-up|15|||
128874031|NCT01302067|463832665|FG000|Overall Study|Withdrawal by Subject|13|||
128874032|NCT01302067|463832666|FG001|Overall Study|Withdrawal by Subject|6|||
128874033|NCT01302067|463832667|FG002|Overall Study|Withdrawal by Subject|10|||
128874034|NCT01302067|463832665|FG000|Overall Study|Other|1|||
128874035|NCT01302067|463832666|FG001|Overall Study|Other|1|||
128874036|NCT01302067|463832667|FG002|Overall Study|Other|3|||
128874037|NCT01302067|463832665|FG000|Overall Study|Protocol Violation|11|||
128874038|NCT01302067|463832666|FG001|Overall Study|Protocol Violation|0|||
128874039|NCT01302067|463832667|FG002|Overall Study|Protocol Violation|8|||
128874040|NCT01302067|463832665|FG000|Overall Study|Adverse Event|27|||
128874041|NCT01302067|463832666|FG001|Overall Study|Adverse Event|14|||
128874042|NCT01302067|463832667|FG002|Overall Study|Adverse Event|45|||
128874043|NCT02738203|463832669|FG000|Overall Study|Failed IUD Insertion|2|||
128874044|NCT02738203|463832670|FG001|Overall Study|Failed IUD Insertion|2|||
128874045|NCT02738203|463832669|FG000|Overall Study|Protocol Violation|0|||
128874046|NCT02738203|463832670|FG001|Overall Study|Protocol Violation|1|||
128874047|NCT03241927|463832671|FG000|Overall Study|study terminated|1|||
129096502|NCT02614131|464644501|FG002|Overall Study|Withdrawal by Subject|0|||
128874048|NCT03241927|463832672|FG001|Overall Study|study terminated|0|||
128874049|NCT02704754|463832673|FG000|Overall Study|Lost to Follow-up|1|||
128874050|NCT02704754|463832674|FG001|Overall Study|Lost to Follow-up|1|||
128874051|NCT02704754|463832673|FG000|Overall Study|Lack of Efficacy|1|||
128874052|NCT02704754|463832674|FG001|Overall Study|Lack of Efficacy|0|||
128874053|NCT02704754|463832673|FG000|Overall Study|Withdrawal by Subject|1|||
128874054|NCT02704754|463832674|FG001|Overall Study|Withdrawal by Subject|0|||
128874055|NCT00423943|463832675|FG000|Overall Study|Withdrawal by Subject|3|||
128874056|NCT00423943|463832676|FG001|Overall Study|Withdrawal by Subject|1|||
128874057|NCT03809429|463832680|FG000|Overall Study|Withdrawal by Subject|7|||
128874058|NCT03809429|463832681|FG001|Overall Study|Withdrawal by Subject|3|||
128874059|NCT03809429|463832680|FG000|Overall Study|Adverse Event|6|||
128874060|NCT03809429|463832681|FG001|Overall Study|Adverse Event|9|||
128874061|NCT03809429|463832680|FG000|Overall Study|COVID-19|3|||
128874062|NCT03809429|463832681|FG001|Overall Study|COVID-19|1|||
128874063|NCT03809429|463832680|FG000|Overall Study|Participant was discontinued by investigator|12|||
128874064|NCT03809429|463832681|FG001|Overall Study|Participant was discontinued by investigator|7|||
128874065|NCT02383056|463832683|FG000|Overall Study|Adverse Event|1|||
128874066|NCT02383056|463832684|FG001|Overall Study|Adverse Event|0|||
128874067|NCT02383056|463832683|FG000|Overall Study|Lost to Follow-up|0|||
128874068|NCT02383056|463832684|FG001|Overall Study|Lost to Follow-up|2|||
128874069|NCT04214600|463832685|FG000|Overall Study|Lost to Follow-up|9|||
128874070|NCT04214600|463832686|FG001|Overall Study|Lost to Follow-up|14|||
128874071|NCT03245151|463832687|FG000|Overall Study|Withdrawal by Subject|2|||
128874072|NCT03245151|463832688|FG001|Overall Study|Withdrawal by Subject|0|||
128874073|NCT03245151|463832689|FG002|Overall Study|Withdrawal by Subject|0|||
128874074|NCT03245151|463832690|FG003|Overall Study|Withdrawal by Subject|2|||
128874075|NCT03245151|463832691|FG004|Overall Study|Withdrawal by Subject|1|||
128874076|NCT03245151|463832687|FG000|Overall Study|Death|3|||
128874077|NCT03245151|463832688|FG001|Overall Study|Death|14|||
128874078|NCT03245151|463832689|FG002|Overall Study|Death|9|||
128874079|NCT03245151|463832690|FG003|Overall Study|Death|16|||
128874080|NCT03245151|463832691|FG004|Overall Study|Death|7|||
128874081|NCT03245151|463832687|FG000|Overall Study|Sponsor's decision|0|||
128874082|NCT03245151|463832688|FG001|Overall Study|Sponsor's decision|1|||
128874083|NCT03245151|463832689|FG002|Overall Study|Sponsor's decision|0|||
128874084|NCT03245151|463832690|FG003|Overall Study|Sponsor's decision|0|||
128874085|NCT03245151|463832691|FG004|Overall Study|Sponsor's decision|0|||
128874086|NCT03507777|463832692|FG000|Overall Study|Lost to Follow-up|5|||
128874087|NCT03507777|463832693|FG001|Overall Study|Lost to Follow-up|7|||
128874088|NCT03507777|463832692|FG000|Overall Study|Withdrawal by Subject|6|||
128874089|NCT03507777|463832693|FG001|Overall Study|Withdrawal by Subject|11|||
128874090|NCT03507777|463832692|FG000|Overall Study|Death|30|||
128874091|NCT03507777|463832693|FG001|Overall Study|Death|44|||
128874092|NCT03507777|463832692|FG000|Overall Study|Other Reasons|3|||
128874093|NCT03507777|463832693|FG001|Overall Study|Other Reasons|8|||
128874094|NCT01144052|463832694|FG000|Overall Study|Withdrawal by Subject|1|||
128874095|NCT01144052|463832695|FG001|Overall Study|Withdrawal by Subject|1|||
128874096|NCT02947087|463832696|FG000|Overall Study|Withdrawal by Subject|3|||
128874097|NCT02947087|463832697|FG001|Overall Study|Withdrawal by Subject|2|||
128874098|NCT01879722|463832701|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
128874099|NCT01879722|463832702|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
128874100|NCT01879722|463832703|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
128874101|NCT01879722|463832704|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
128874102|NCT01879722|463832705|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
128874103|NCT01879722|463832706|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
128874104|NCT01879722|463832707|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
128874105|NCT01879722|463832708|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
128874106|NCT01879722|463832709|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
128874107|NCT01879722|463832710|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
128874108|NCT01879722|463832701|FG000|Overall Study|Voluntary Withdrawal|0|||
128874109|NCT01879722|463832702|FG001|Overall Study|Voluntary Withdrawal|0|||
128874110|NCT01879722|463832703|FG002|Overall Study|Voluntary Withdrawal|0|||
128874111|NCT01879722|463832704|FG003|Overall Study|Voluntary Withdrawal|0|||
128874112|NCT01879722|463832705|FG004|Overall Study|Voluntary Withdrawal|0|||
128874113|NCT01879722|463832706|FG005|Overall Study|Voluntary Withdrawal|0|||
128874114|NCT01879722|463832707|FG006|Overall Study|Voluntary Withdrawal|0|||
128874115|NCT01879722|463832708|FG007|Overall Study|Voluntary Withdrawal|0|||
128874116|NCT01879722|463832709|FG008|Overall Study|Voluntary Withdrawal|1|||
128874117|NCT01879722|463832710|FG009|Overall Study|Voluntary Withdrawal|0|||
128874118|NCT01327495|463832711|FG000|Overall Study|Adverse Event|2|||
128874119|NCT01327495|463832712|FG001|Overall Study|Adverse Event|1|||
128984077|NCT01374516|464229468|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
128984078|NCT01374516|464229467|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
128984079|NCT01374516|464229468|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
128984080|NCT01374516|464229467|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
128874120|NCT01327495|463832713|FG002|Overall Study|Adverse Event|1|||
128874121|NCT01327495|463832714|FG003|Overall Study|Adverse Event|0|||
128874122|NCT01327495|463832715|FG004|Overall Study|Adverse Event|0|||
128874123|NCT01327495|463832716|FG005|Overall Study|Adverse Event|2|||
128874124|NCT01327495|463832711|FG000|Overall Study|Withdrawal by Subject|0|||
128874125|NCT01327495|463832712|FG001|Overall Study|Withdrawal by Subject|1|||
128874126|NCT01327495|463832713|FG002|Overall Study|Withdrawal by Subject|1|||
128874127|NCT01327495|463832714|FG003|Overall Study|Withdrawal by Subject|0|||
128874128|NCT01327495|463832715|FG004|Overall Study|Withdrawal by Subject|1|||
128874129|NCT01327495|463832716|FG005|Overall Study|Withdrawal by Subject|0|||
128874130|NCT01327495|463832711|FG000|Overall Study|Physician Decision|0|||
128874131|NCT01327495|463832712|FG001|Overall Study|Physician Decision|0|||
128874132|NCT01327495|463832713|FG002|Overall Study|Physician Decision|0|||
128874133|NCT01327495|463832714|FG003|Overall Study|Physician Decision|0|||
128874134|NCT01327495|463832715|FG004|Overall Study|Physician Decision|2|||
128874135|NCT01327495|463832716|FG005|Overall Study|Physician Decision|0|||
128874136|NCT00006011|463832717|FG000|Overall Study|Disease progression|13|||
128874137|NCT00006011|463832718|FG001|Overall Study|Disease progression|6|||
128874138|NCT00006011|463832719|FG002|Overall Study|Disease progression|26|||
128874139|NCT00006011|463832717|FG000|Overall Study|Refused further treatment|15|||
128874140|NCT00006011|463832718|FG001|Overall Study|Refused further treatment|13|||
128874141|NCT00006011|463832719|FG002|Overall Study|Refused further treatment|26|||
128874142|NCT00006011|463832717|FG000|Overall Study|Adverse Event|15|||
128874143|NCT00006011|463832718|FG001|Overall Study|Adverse Event|39|||
128874144|NCT00006011|463832719|FG002|Overall Study|Adverse Event|5|||
128874145|NCT00006011|463832717|FG000|Overall Study|Death|0|||
128874146|NCT00006011|463832718|FG001|Overall Study|Death|1|||
128874147|NCT00006011|463832719|FG002|Overall Study|Death|2|||
128874148|NCT00006011|463832717|FG000|Overall Study|Other|4|||
128874149|NCT00006011|463832718|FG001|Overall Study|Other|2|||
128874150|NCT00006011|463832719|FG002|Overall Study|Other|5|||
128874151|NCT00006011|463832717|FG000|Overall Study|Ineligible|18|||
128874152|NCT00006011|463832718|FG001|Overall Study|Ineligible|16|||
128874153|NCT00006011|463832719|FG002|Overall Study|Ineligible|9|||
128874154|NCT00774930|463832723|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
128874155|NCT00774930|463832724|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
128874156|NCT00774930|463832723|FG000|DB Phase|Adverse Event|1|||
128874157|NCT00774930|463832724|FG001|DB Phase|Adverse Event|2|||
128874158|NCT00774930|463832723|FG000|DB Phase|Subject Decision|1|||
128874159|NCT00774930|463832724|FG001|DB Phase|Subject Decision|5|||
128874160|NCT00774930|463832723|FG000|DB Phase|Sponsor Decision|0|||
128874161|NCT00774930|463832724|FG001|DB Phase|Sponsor Decision|1|||
128874162|NCT00774930|463832723|FG000|DB Phase|Disease Progression|1|||
128874163|NCT00774930|463832724|FG001|DB Phase|Disease Progression|1|||
128874164|NCT00774930|463832723|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
128874165|NCT00774930|463832724|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
128874166|NCT00774930|463832723|FG000|IOL Phase|Adverse Event|1|||
128874167|NCT00774930|463832724|FG001|IOL Phase|Adverse Event|1|||
128874168|NCT00774930|463832723|FG000|IOL Phase|Subject Decision|4|||
128874169|NCT00774930|463832724|FG001|IOL Phase|Subject Decision|3|||
128874170|NCT00774930|463832723|FG000|IOL Phase|Physician Decision|3|||
128874171|NCT00774930|463832724|FG001|IOL Phase|Physician Decision|2|||
128874172|NCT00774930|463832723|FG000|IOL Phase|Sponsor Decision|1|||
128874173|NCT00774930|463832724|FG001|IOL Phase|Sponsor Decision|0|||
128874174|NCT00774930|463832723|FG000|IOL Phase|Disease Progression|2|||
128874175|NCT00774930|463832724|FG001|IOL Phase|Disease Progression|1|||
128874176|NCT00774930|463832723|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
128874177|NCT00774930|463832724|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
129096503|NCT02614131|464644502|FG003|Overall Study|Withdrawal by Subject|0|||
129096504|NCT02614131|464644503|FG004|Overall Study|Withdrawal by Subject|0|||
129096505|NCT02614131|464644504|FG005|Overall Study|Withdrawal by Subject|0|||
129096506|NCT02614131|464644505|FG006|Overall Study|Withdrawal by Subject|0|||
129096507|NCT02614131|464644499|FG000|Overall Study|Adverse Event|0|||
129096508|NCT02614131|464644500|FG001|Overall Study|Adverse Event|0|||
129096509|NCT02614131|464644501|FG002|Overall Study|Adverse Event|0|||
129096510|NCT02614131|464644502|FG003|Overall Study|Adverse Event|0|||
129096511|NCT02614131|464644503|FG004|Overall Study|Adverse Event|0|||
129096512|NCT02614131|464644504|FG005|Overall Study|Adverse Event|0|||
129096513|NCT02614131|464644505|FG006|Overall Study|Adverse Event|1|||
129096514|NCT01285492|464644510|FG000|Overall Study|Adverse Event|11|||
129096515|NCT01285492|464644511|FG001|Overall Study|Adverse Event|0|||
129096516|NCT01285492|464644510|FG000|Overall Study|Protocol Violation|3|||
129096517|NCT01285492|464644511|FG001|Overall Study|Protocol Violation|0|||
128874178|NCT00774930|463832723|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
128874179|NCT00774930|463832724|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
128874180|NCT00774930|463832723|FG000|IOL Phase|Other|1|||
129096518|NCT01285492|464644510|FG000|Overall Study|Withdrawal by Subject|2|||
129096519|NCT01285492|464644511|FG001|Overall Study|Withdrawal by Subject|1|||
129096520|NCT01285492|464644510|FG000|Overall Study|Death|1|||
128874181|NCT00774930|463832724|FG001|IOL Phase|Other|0|||
128874182|NCT00774930|463832723|FG000|IOL Phase|Brain radiation|0|||
128874183|NCT00774930|463832724|FG001|IOL Phase|Brain radiation|1|||
128874184|NCT00774930|463832723|FG000|LTOLE Phase|Adverse Event|7|||
128874185|NCT00774930|463832724|FG001|LTOLE Phase|Adverse Event|3|||
128874186|NCT00774930|463832723|FG000|LTOLE Phase|Subject decision|0|||
129096521|NCT01285492|464644511|FG001|Overall Study|Death|0|||
129096522|NCT01797094|464644512|FG000|Overall Study|Adverse Event|1|||
129096523|NCT01797094|464644513|FG001|Overall Study|Adverse Event|1|||
129096524|NCT01797094|464644512|FG000|Overall Study|Personal Reasons|4|||
129096525|NCT01797094|464644513|FG001|Overall Study|Personal Reasons|0|||
129096526|NCT01797094|464644512|FG000|Overall Study|Protocol Violation|0|||
129096527|NCT01797094|464644513|FG001|Overall Study|Protocol Violation|1|||
129096528|NCT01797094|464644512|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129096529|NCT01797094|464644513|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129096530|NCT03217968|464644516|FG000|Overall Study|Withdrawal by Subject|4|||
129096531|NCT03217968|464644516|FG000|Overall Study|Lost to Follow-up|1|||
129096532|NCT03217968|464644516|FG000|Overall Study|Protocol Violation|6|||
129096533|NCT00634049|464644528|FG000|Overall Study|Never received study drug|1|||
129096534|NCT00634049|464644528|FG000|Overall Study|Died prior to receiving study drug|1|||
129096535|NCT00634049|464644528|FG000|Overall Study|Screening failure|1|||
129096536|NCT00314132|464644529|FG000|Overall Study|Lost to Follow-up|3|||
129096537|NCT00314132|464644530|FG001|Overall Study|Lost to Follow-up|13|||
129096538|NCT00314132|464644529|FG000|Overall Study|Withdrawal by Subject|3|||
129096539|NCT00314132|464644530|FG001|Overall Study|Withdrawal by Subject|5|||
129096540|NCT00314132|464644529|FG000|Overall Study|Adverse Event|1|||
129096541|NCT00314132|464644530|FG001|Overall Study|Adverse Event|0|||
129096542|NCT00314132|464644529|FG000|Overall Study|Physician Decision|1|||
129096543|NCT00314132|464644530|FG001|Overall Study|Physician Decision|0|||
129096544|NCT00045734|464644531|FG000|Overall Study|Protocol Violation|1|||
129096545|NCT03482167|464644532|FG000|Allocated to Intervention|Physician Decision|1|||
129096546|NCT03482167|464644533|FG001|Allocated to Intervention|Physician Decision|2|||
129096547|NCT03482167|464644532|FG000|Received Intervention|Adverse Event|3|||
129096548|NCT03482167|464644533|FG001|Received Intervention|Adverse Event|1|||
129096549|NCT03482167|464644532|FG000|Received Intervention|Physician Decision|1|||
129096550|NCT03482167|464644533|FG001|Received Intervention|Physician Decision|1|||
129096551|NCT03482167|464644532|FG000|Received Intervention|Withdrawal by Subject|1|||
129096552|NCT03482167|464644533|FG001|Received Intervention|Withdrawal by Subject|0|||
129096553|NCT01001598|464644535|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
129096554|NCT01001598|464644535|FG000|Overall Study|Adverse Event|1|||
129096555|NCT05079230|464644547|FG000|Overall Study|Study Terminated by Sponsor|101|||
129096556|NCT05079230|464644548|FG001|Overall Study|Study Terminated by Sponsor|102|||
129096557|NCT05079230|464644547|FG000|Overall Study|Death|72|||
129096558|NCT05079230|464644548|FG001|Overall Study|Death|66|||
129096559|NCT05079230|464644547|FG000|Overall Study|Withdrew Consent|16|||
129096560|NCT05079230|464644548|FG001|Overall Study|Withdrew Consent|18|||
129096561|NCT05079230|464644547|FG000|Overall Study|Lost to Follow-up|0|||
129096562|NCT05079230|464644548|FG001|Overall Study|Lost to Follow-up|3|||
129096563|NCT01524783|464644549|FG000|Blinded Period|Adverse Event|64|||
129096564|NCT01524783|464644550|FG001|Blinded Period|Adverse Event|7|||
129096565|NCT01524783|464644551|FG002|Blinded Period|Adverse Event|0|||
129096566|NCT01524783|464644549|FG000|Blinded Period|Disease Progression|89|||
129096567|NCT01524783|464644550|FG001|Blinded Period|Disease Progression|75|||
129096568|NCT01524783|464644551|FG002|Blinded Period|Disease Progression|0|||
129096569|NCT01524783|464644549|FG000|Blinded Period|Withdrawal by Subject|19|||
129096570|NCT01524783|464644550|FG001|Blinded Period|Withdrawal by Subject|6|||
129096571|NCT01524783|464644551|FG002|Blinded Period|Withdrawal by Subject|0|||
129096572|NCT01524783|464644549|FG000|Blinded Period|Protocol deviation|2|||
129096573|NCT01524783|464644550|FG001|Blinded Period|Protocol deviation|1|||
129096574|NCT01524783|464644551|FG002|Blinded Period|Protocol deviation|0|||
129096575|NCT01524783|464644549|FG000|Blinded Period|Death|5|||
129096576|NCT01524783|464644550|FG001|Blinded Period|Death|2|||
129096577|NCT01524783|464644551|FG002|Blinded Period|Death|0|||
129096578|NCT01524783|464644549|FG000|Open-label Period|Disease progression|13|||
129096579|NCT01524783|464644550|FG001|Open-label Period|Disease progression|0|||
129096580|NCT01524783|464644551|FG002|Open-label Period|Disease progression|2|||
129096581|NCT01524783|464644549|FG000|Open-label Period|Administrative problems|5|||
129096582|NCT01524783|464644550|FG001|Open-label Period|Administrative problems|0|||
129096583|NCT01524783|464644551|FG002|Open-label Period|Administrative problems|2|||
129096584|NCT01524783|464644549|FG000|Open-label Period|Adverse Event|5|||
129096585|NCT01524783|464644550|FG001|Open-label Period|Adverse Event|0|||
129096586|NCT01524783|464644551|FG002|Open-label Period|Adverse Event|1|||
129096587|NCT01524783|464644549|FG000|Open-label Period|Withdrawal by Subject|2|||
129096588|NCT01524783|464644550|FG001|Open-label Period|Withdrawal by Subject|0|||
129096589|NCT01524783|464644551|FG002|Open-label Period|Withdrawal by Subject|1|||
129096590|NCT01524783|464644549|FG000|Open-label Period|Protocol deviation|1|||
129096591|NCT01524783|464644550|FG001|Open-label Period|Protocol deviation|0|||
129096592|NCT01524783|464644551|FG002|Open-label Period|Protocol deviation|0|||
129096593|NCT02920177|464644553|FG000|Overall Study|Withdrawal by Subject|1|||
129096594|NCT02920177|464644554|FG001|Overall Study|Withdrawal by Subject|1|||
129096595|NCT02920177|464644553|FG000|Overall Study|Physician Decision|1|||
129096596|NCT02920177|464644554|FG001|Overall Study|Physician Decision|0|||
129096597|NCT02920177|464644553|FG000|Overall Study|Lost to Follow-up|0|||
129096598|NCT02920177|464644554|FG001|Overall Study|Lost to Follow-up|1|||
129096599|NCT02054910|464644555|FG000|Overall Study|Lost to Follow-up|4|||
129096600|NCT02054910|464644556|FG001|Overall Study|Lost to Follow-up|1|||
129096601|NCT01096589|464644558|FG000|Overall Study|Adverse Event|2|||
129096602|NCT01096589|464644559|FG001|Overall Study|Adverse Event|1|||
129096603|NCT01096589|464644560|FG002|Overall Study|Adverse Event|2|||
129096604|NCT01096589|464644561|FG003|Overall Study|Adverse Event|1|||
129096605|NCT01096589|464644558|FG000|Overall Study|Withdrawal by Subject|2|||
129096606|NCT01096589|464644559|FG001|Overall Study|Withdrawal by Subject|1|||
129096607|NCT01096589|464644560|FG002|Overall Study|Withdrawal by Subject|1|||
129096608|NCT01096589|464644561|FG003|Overall Study|Withdrawal by Subject|1|||
129096609|NCT01096589|464644558|FG000|Overall Study|Compliance with protocol|0|||
129096610|NCT01096589|464644559|FG001|Overall Study|Compliance with protocol|0|||
129096611|NCT01096589|464644560|FG002|Overall Study|Compliance with protocol|1|||
129096612|NCT01096589|464644561|FG003|Overall Study|Compliance with protocol|0|||
129096613|NCT01096589|464644558|FG000|Overall Study|found treatment exhausting|0|||
129096614|NCT01096589|464644559|FG001|Overall Study|found treatment exhausting|0|||
129096615|NCT01096589|464644560|FG002|Overall Study|found treatment exhausting|0|||
129096616|NCT01096589|464644561|FG003|Overall Study|found treatment exhausting|1|||
129096617|NCT05153148|464644564|FG000|Overall Study|Adverse Event|1|||
129096618|NCT05153148|464644565|FG001|Overall Study|Adverse Event|0|||
129096619|NCT05153148|464644566|FG002|Overall Study|Adverse Event|3|||
129096620|NCT05153148|464644567|FG003|Overall Study|Adverse Event|5|||
129096621|NCT05153148|464644564|FG000|Overall Study|Lost to Follow-up|1|||
129096622|NCT05153148|464644565|FG001|Overall Study|Lost to Follow-up|1|||
129096623|NCT05153148|464644566|FG002|Overall Study|Lost to Follow-up|2|||
129096624|NCT05153148|464644567|FG003|Overall Study|Lost to Follow-up|0|||
129096625|NCT05153148|464644564|FG000|Overall Study|Withdrawal by Subject|6|||
129096626|NCT05153148|464644565|FG001|Overall Study|Withdrawal by Subject|8|||
129096627|NCT05153148|464644566|FG002|Overall Study|Withdrawal by Subject|6|||
129096628|NCT05153148|464644567|FG003|Overall Study|Withdrawal by Subject|8|||
129096629|NCT05153148|464644564|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
129096630|NCT05153148|464644565|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
129096631|NCT05153148|464644566|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
129096632|NCT05153148|464644567|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
129096633|NCT05153148|464644564|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
129096634|NCT05153148|464644565|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
129096635|NCT05153148|464644566|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
129096636|NCT05153148|464644567|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
129096637|NCT05153148|464644564|FG000|Overall Study|Reason not Specified|1|||
129096638|NCT05153148|464644565|FG001|Overall Study|Reason not Specified|1|||
129096639|NCT05153148|464644566|FG002|Overall Study|Reason not Specified|1|||
129096640|NCT05153148|464644567|FG003|Overall Study|Reason not Specified|1|||
129096641|NCT01732471|464644568|FG000|Overall Study|Withdrawal by Subject|1|||
129096642|NCT01712334|464644569|FG000|Treatment Period 1|Randomized in Error|0|||
129096643|NCT01712334|464644570|FG001|Treatment Period 1|Randomized in Error|2|||
129096644|NCT01253174|464644571|FG000|Period 1|Randomized but not treated|0|||
129096645|NCT01253174|464644572|FG001|Period 1|Randomized but not treated|1|||
129096646|NCT01253174|464644573|FG002|Period 1|Randomized but not treated|1|||
129096647|NCT01253174|464644574|FG003|Period 1|Randomized but not treated|0|||
129096648|NCT01253174|464644575|FG004|Period 1|Randomized but not treated|1|||
129096649|NCT01253174|464644576|FG005|Period 1|Randomized but not treated|0|||
129096650|NCT01253174|464644571|FG000|Period 2|Adverse Event|0|||
129096651|NCT01253174|464644572|FG001|Period 2|Adverse Event|0|||
129096652|NCT01253174|464644573|FG002|Period 2|Adverse Event|1|||
129096653|NCT01253174|464644574|FG003|Period 2|Adverse Event|0|||
129096654|NCT01253174|464644575|FG004|Period 2|Adverse Event|0|||
129096655|NCT01253174|464644576|FG005|Period 2|Adverse Event|0|||
129096656|NCT01253174|464644571|FG000|Period 3|Withdrawal by Subject|0|||
129096657|NCT01253174|464644572|FG001|Period 3|Withdrawal by Subject|1|||
129096658|NCT01253174|464644573|FG002|Period 3|Withdrawal by Subject|0|||
129096659|NCT01253174|464644574|FG003|Period 3|Withdrawal by Subject|0|||
129096660|NCT01253174|464644575|FG004|Period 3|Withdrawal by Subject|1|||
129096661|NCT01253174|464644576|FG005|Period 3|Withdrawal by Subject|0|||
129096662|NCT01253174|464644571|FG000|Period 3|Pregnancy|0|||
129096663|NCT01253174|464644572|FG001|Period 3|Pregnancy|0|||
129096664|NCT01253174|464644573|FG002|Period 3|Pregnancy|1|||
129096665|NCT01253174|464644574|FG003|Period 3|Pregnancy|0|||
129096666|NCT01253174|464644575|FG004|Period 3|Pregnancy|0|||
129096667|NCT01253174|464644576|FG005|Period 3|Pregnancy|0|||
129096668|NCT02267135|464644577|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
129096669|NCT02267135|464644578|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
129096670|NCT02267135|464644577|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
129096671|NCT02267135|464644578|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
129096672|NCT02267135|464644577|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
129096673|NCT02267135|464644578|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
129096674|NCT02267135|464644577|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
129096675|NCT02267135|464644578|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
129096676|NCT02267135|464644577|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
129096677|NCT02267135|464644578|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
129096678|NCT02892513|464644579|FG000|Overall Study|Withdrawal by Subject|0|||
129096679|NCT02892513|464644580|FG001|Overall Study|Withdrawal by Subject|1|||
129096680|NCT03806231|464644581|FG000|Overall Study|Physician Decision|1|||
129096681|NCT03806231|464644582|FG001|Overall Study|Physician Decision|0|||
129096682|NCT03806231|464644581|FG000|Overall Study|Withdrawal by Subject|1|||
129096683|NCT03806231|464644582|FG001|Overall Study|Withdrawal by Subject|0|||
129096684|NCT00900731|464644583|FG000|Overall Study|Adverse Event|31|||
129096685|NCT00900731|464644584|FG001|Overall Study|Adverse Event|27|||
129096686|NCT00900731|464644583|FG000|Overall Study|Withdrawal by Subject|8|||
129096687|NCT00900731|464644584|FG001|Overall Study|Withdrawal by Subject|7|||
129096688|NCT00900731|464644583|FG000|Overall Study|Protocol Deviation|8|||
129096689|NCT00900731|464644584|FG001|Overall Study|Protocol Deviation|11|||
129096690|NCT00900731|464644583|FG000|Overall Study|Administrative Problems|5|||
129096691|NCT00900731|464644584|FG001|Overall Study|Administrative Problems|4|||
129096692|NCT00900731|464644583|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
129096693|NCT00900731|464644584|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129096694|NCT00900731|464644583|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
129096695|NCT00900731|464644584|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
129096696|NCT00900731|464644583|FG000|Overall Study|Lost to Follow-up|2|||
129096697|NCT00900731|464644584|FG001|Overall Study|Lost to Follow-up|3|||
129096698|NCT00900731|464644583|FG000|Overall Study|Lack of Efficacy|1|||
129096699|NCT00900731|464644584|FG001|Overall Study|Lack of Efficacy|3|||
129096700|NCT00900731|464644583|FG000|Overall Study|Death|0|||
129096701|NCT00900731|464644584|FG001|Overall Study|Death|2|||
129096702|NCT02919267|464644585|FG000|Overall Study|Protocol Violation|0|||
129096703|NCT02919267|464644586|FG001|Overall Study|Protocol Violation|3|||
129096704|NCT02919267|464644587|FG002|Overall Study|Protocol Violation|3|||
129096705|NCT02919267|464644588|FG003|Overall Study|Protocol Violation|4|||
129096706|NCT00628927|464644589|FG000|Overall Study|Problems performing blood draw|6|||
129096707|NCT00628927|464644590|FG001|Overall Study|Problems performing blood draw|0|||
129096708|NCT00628927|464644589|FG000|Overall Study|Lost to Follow-up|1|||
129096709|NCT00628927|464644590|FG001|Overall Study|Lost to Follow-up|0|||
129096710|NCT00628927|464644589|FG000|Overall Study|Equipment failure|1|||
129096711|NCT00628927|464644590|FG001|Overall Study|Equipment failure|0|||
129096712|NCT02093390|464644591|FG000|Overall Study|Withdrawal by Subject|0|||
129096713|NCT02093390|464644592|FG001|Overall Study|Withdrawal by Subject|1|||
129096714|NCT00908596|464646416|FG000|Overall Study|Other reasons|46|||
129096715|NCT00908596|464646417|FG001|Overall Study|Other reasons|6|||
129096716|NCT00908596|464646418|FG002|Overall Study|Other reasons|2|||
129096717|NCT00908596|464646419|FG003|Overall Study|Other reasons|0|||
129096718|NCT00908596|464646416|FG000|Overall Study|Lost to Follow-up|0|||
129096719|NCT00908596|464646417|FG001|Overall Study|Lost to Follow-up|1|||
129096720|NCT00908596|464646418|FG002|Overall Study|Lost to Follow-up|12|||
129096721|NCT00908596|464646419|FG003|Overall Study|Lost to Follow-up|4|||
129096722|NCT00908596|464646416|FG000|Overall Study|Death|0|||
129096723|NCT00908596|464646417|FG001|Overall Study|Death|5|||
129096724|NCT00908596|464646418|FG002|Overall Study|Death|57|||
129096725|NCT00908596|464646419|FG003|Overall Study|Death|32|||
129096726|NCT00908596|464646416|FG000|Overall Study|Protocol Violation|1|||
129096727|NCT00908596|464646417|FG001|Overall Study|Protocol Violation|0|||
129096728|NCT00908596|464646418|FG002|Overall Study|Protocol Violation|0|||
129096729|NCT00908596|464646419|FG003|Overall Study|Protocol Violation|0|||
129096730|NCT00908596|464646416|FG000|Overall Study|Withdrawal by Subject|0|||
129096731|NCT00908596|464646417|FG001|Overall Study|Withdrawal by Subject|1|||
129096732|NCT00908596|464646418|FG002|Overall Study|Withdrawal by Subject|3|||
129096733|NCT00908596|464646419|FG003|Overall Study|Withdrawal by Subject|1|||
129096734|NCT02437188|464646422|FG000|Overall Study|Randomized but did not receive surgery|4|||
129096735|NCT02437188|464646423|FG001|Overall Study|Randomized but did not receive surgery|8|||
129096736|NCT02437188|464646422|FG000|Overall Study|Adverse Event|0|||
129096737|NCT02437188|464646423|FG001|Overall Study|Adverse Event|1|||
129096738|NCT01709864|464646424|FG000|Overall Study|Physician Decision|0|||
129096739|NCT01709864|464646425|FG001|Overall Study|Physician Decision|1|||
129096740|NCT01709864|464646424|FG000|Overall Study|subject/guardian decision|5|||
129096741|NCT01709864|464646425|FG001|Overall Study|subject/guardian decision|6|||
129096742|NCT01709864|464646424|FG000|Overall Study|Lost to Follow-up|1|||
129096743|NCT01709864|464646425|FG001|Overall Study|Lost to Follow-up|0|||
129096744|NCT01709864|464646424|FG000|Overall Study|non-compliance with study treatment|1|||
129096745|NCT01709864|464646425|FG001|Overall Study|non-compliance with study treatment|1|||
129096746|NCT01709864|464646424|FG000|Overall Study|Adverse Event|0|||
129096747|NCT01709864|464646425|FG001|Overall Study|Adverse Event|2|||
129096748|NCT01709864|464646424|FG000|Overall Study|Death|0|||
129096749|NCT01709864|464646425|FG001|Overall Study|Death|1|||
129096750|NCT01172808|464646428|FG000|Overall Study|Adverse Event|8|||
129096751|NCT01172808|464646429|FG001|Overall Study|Adverse Event|4|||
129096752|NCT01172808|464646430|FG002|Overall Study|Adverse Event|8|||
129096753|NCT01172808|464646431|FG003|Overall Study|Adverse Event|3|||
129096754|NCT01172808|464646428|FG000|Overall Study|Lack of Efficacy|1|||
129096755|NCT01172808|464646429|FG001|Overall Study|Lack of Efficacy|0|||
129096756|NCT01172808|464646430|FG002|Overall Study|Lack of Efficacy|0|||
129096757|NCT01172808|464646431|FG003|Overall Study|Lack of Efficacy|0|||
129096758|NCT01172808|464646428|FG000|Overall Study|Protocol Violation|2|||
129096759|NCT01172808|464646429|FG001|Overall Study|Protocol Violation|2|||
129096760|NCT01172808|464646430|FG002|Overall Study|Protocol Violation|2|||
129096761|NCT01172808|464646431|FG003|Overall Study|Protocol Violation|0|||
129096762|NCT01172808|464646428|FG000|Overall Study|Lost to Follow-up|0|||
129096763|NCT01172808|464646429|FG001|Overall Study|Lost to Follow-up|1|||
129096764|NCT01172808|464646430|FG002|Overall Study|Lost to Follow-up|1|||
129096765|NCT01172808|464646431|FG003|Overall Study|Lost to Follow-up|3|||
129096766|NCT01172808|464646428|FG000|Overall Study|Withdrawal by Subject|4|||
129096767|NCT01172808|464646429|FG001|Overall Study|Withdrawal by Subject|1|||
129096768|NCT01172808|464646430|FG002|Overall Study|Withdrawal by Subject|3|||
129096769|NCT01172808|464646431|FG003|Overall Study|Withdrawal by Subject|2|||
129096770|NCT01172808|464646428|FG000|Overall Study|Other|6|||
129096771|NCT01172808|464646429|FG001|Overall Study|Other|5|||
129096772|NCT01172808|464646430|FG002|Overall Study|Other|9|||
129096773|NCT01172808|464646431|FG003|Overall Study|Other|7|||
129096774|NCT02661061|464646432|FG000|Overall Study|Lack of Efficacy|1|||
129096775|NCT02661061|464646433|FG001|Overall Study|Lack of Efficacy|1|||
129096776|NCT02661061|464646432|FG000|Overall Study|Withdrawal by Subject|1|||
129096777|NCT02661061|464646433|FG001|Overall Study|Withdrawal by Subject|1|||
129096778|NCT03246061|464646434|FG000|Overall Study|Still in follow-up|15|||
129096779|NCT03246061|464646435|FG001|Overall Study|Still in follow-up|21|||
129096780|NCT01937715|464646436|FG000|Overall Study|Death|0|||
129096781|NCT01937715|464646437|FG001|Overall Study|Death|0|||
129096782|NCT01937715|464646438|FG002|Overall Study|Death|0|||
129096783|NCT01937715|464646439|FG003|Overall Study|Death|1|||
129096784|NCT01937715|464646440|FG004|Overall Study|Death|0|||
129096785|NCT01937715|464646436|FG000|Overall Study|Withdrawal by Subject|0|||
129096786|NCT01937715|464646437|FG001|Overall Study|Withdrawal by Subject|1|||
129096787|NCT01937715|464646438|FG002|Overall Study|Withdrawal by Subject|0|||
129096788|NCT01937715|464646439|FG003|Overall Study|Withdrawal by Subject|0|||
129096789|NCT01937715|464646440|FG004|Overall Study|Withdrawal by Subject|2|||
129096790|NCT01937715|464646436|FG000|Overall Study|Other|0|||
129096791|NCT01937715|464646437|FG001|Overall Study|Other|0|||
129096792|NCT01937715|464646438|FG002|Overall Study|Other|0|||
129096793|NCT01937715|464646439|FG003|Overall Study|Other|3|||
129096794|NCT01937715|464646440|FG004|Overall Study|Other|0|||
129096795|NCT02864316|464646441|FG000|Overall Study|Progressive Disease|2|||
129096796|NCT02864316|464646442|FG001|Overall Study|Progressive Disease|1|||
129096797|NCT02864316|464646441|FG000|Overall Study|Adverse Event|0|||
129096798|NCT02864316|464646442|FG001|Overall Study|Adverse Event|1|||
129096799|NCT01887288|464646443|FG000|Overall Study|The study was terminated and the PI has|16|||
129096800|NCT03114657|464646445|FG000|Overall Study|Adverse Event|9|||
129096801|NCT03114657|464646446|FG001|Overall Study|Adverse Event|6|||
129096802|NCT03114657|464646445|FG000|Overall Study|Death|4|||
129096803|NCT03114657|464646446|FG001|Overall Study|Death|0|||
129096804|NCT03114657|464646445|FG000|Overall Study|Multiple Reasons|1|||
129096805|NCT03114657|464646446|FG001|Overall Study|Multiple Reasons|2|||
129096806|NCT03114657|464646445|FG000|Overall Study|Physician Decision|2|||
129096807|NCT03114657|464646446|FG001|Overall Study|Physician Decision|2|||
129096808|NCT03114657|464646445|FG000|Overall Study|Study Terminated By Sponsor|355|||
129096809|NCT03114657|464646446|FG001|Overall Study|Study Terminated By Sponsor|374|||
129096810|NCT03114657|464646445|FG000|Overall Study|Symptomatic Deterioration|0|||
129096811|NCT03114657|464646446|FG001|Overall Study|Symptomatic Deterioration|1|||
129096812|NCT03114657|464646445|FG000|Overall Study|Withdrawal by Subject|28|||
129096813|NCT03114657|464646446|FG001|Overall Study|Withdrawal by Subject|22|||
129096814|NCT01179737|464646448|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
129096815|NCT01179737|464646449|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
129096816|NCT01179737|464646450|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
129096817|NCT01179737|464646451|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
129096818|NCT01179737|464646448|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
129096819|NCT01179737|464646449|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
129096820|NCT01179737|464646450|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
129096821|NCT01179737|464646451|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
129096822|NCT01179737|464646448|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
129096823|NCT01179737|464646449|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
129096824|NCT01179737|464646450|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
129096825|NCT01179737|464646451|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
129096826|NCT01179737|464646448|FG000|Cohort 1 & Cohort 2|Death|0|||
129096827|NCT01179737|464646449|FG001|Cohort 1 & Cohort 2|Death|0|||
129096828|NCT01179737|464646450|FG002|Cohort 1 & Cohort 2|Death|1|||
129096829|NCT01179737|464646451|FG003|Cohort 1 & Cohort 2|Death|0|||
129096830|NCT01179737|464646448|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
129096831|NCT01179737|464646449|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
129096832|NCT01179737|464646450|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
129096833|NCT01179737|464646451|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
129096834|NCT01179737|464646448|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
129096835|NCT01179737|464646449|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
129096836|NCT01179737|464646450|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
129096837|NCT01179737|464646451|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
129096838|NCT01179737|464646448|FG000|Extension|The study was terminated|3|||
129096839|NCT01179737|464646449|FG001|Extension|The study was terminated|0|||
129096840|NCT01179737|464646450|FG002|Extension|The study was terminated|0|||
129096841|NCT01179737|464646451|FG003|Extension|The study was terminated|0|||
129096842|NCT01546038|464646452|FG000|Overall Study|Death|15|||
129096843|NCT01546038|464646453|FG001|Overall Study|Death|6|||
129096844|NCT01546038|464646454|FG002|Overall Study|Death|4|||
129096845|NCT01546038|464646455|FG003|Overall Study|Death|2|||
129096846|NCT01546038|464646456|FG004|Overall Study|Death|9|||
129096847|NCT01546038|464646457|FG005|Overall Study|Death|3|||
129096848|NCT01546038|464646458|FG006|Overall Study|Death|46|||
129096849|NCT01546038|464646459|FG007|Overall Study|Death|76|||
129096850|NCT01546038|464646460|FG008|Overall Study|Death|39|||
129096851|NCT01546038|464646452|FG000|Overall Study|Lost to Follow-up|0|||
129096852|NCT01546038|464646453|FG001|Overall Study|Lost to Follow-up|0|||
129096853|NCT01546038|464646454|FG002|Overall Study|Lost to Follow-up|0|||
129096854|NCT01546038|464646455|FG003|Overall Study|Lost to Follow-up|0|||
129096855|NCT01546038|464646456|FG004|Overall Study|Lost to Follow-up|1|||
129096856|NCT01546038|464646457|FG005|Overall Study|Lost to Follow-up|0|||
129096857|NCT01546038|464646458|FG006|Overall Study|Lost to Follow-up|2|||
129096858|NCT01546038|464646459|FG007|Overall Study|Lost to Follow-up|1|||
129096859|NCT01546038|464646460|FG008|Overall Study|Lost to Follow-up|0|||
129096860|NCT01546038|464646452|FG000|Overall Study|Withdrawal by Subject|1|||
129096861|NCT01546038|464646453|FG001|Overall Study|Withdrawal by Subject|0|||
129096862|NCT01546038|464646454|FG002|Overall Study|Withdrawal by Subject|0|||
129096863|NCT01546038|464646455|FG003|Overall Study|Withdrawal by Subject|1|||
129096864|NCT01546038|464646456|FG004|Overall Study|Withdrawal by Subject|0|||
129096865|NCT01546038|464646457|FG005|Overall Study|Withdrawal by Subject|1|||
129096866|NCT01546038|464646458|FG006|Overall Study|Withdrawal by Subject|3|||
129096867|NCT01546038|464646459|FG007|Overall Study|Withdrawal by Subject|3|||
129096868|NCT01546038|464646460|FG008|Overall Study|Withdrawal by Subject|1|||
129096869|NCT01546038|464646452|FG000|Overall Study|: Randomized, not treated|0|||
129096870|NCT01546038|464646453|FG001|Overall Study|: Randomized, not treated|0|||
129096871|NCT01546038|464646454|FG002|Overall Study|: Randomized, not treated|0|||
129096872|NCT01546038|464646455|FG003|Overall Study|: Randomized, not treated|0|||
129096873|NCT01546038|464646456|FG004|Overall Study|: Randomized, not treated|0|||
129096874|NCT01546038|464646457|FG005|Overall Study|: Randomized, not treated|0|||
129096875|NCT01546038|464646458|FG006|Overall Study|: Randomized, not treated|2|||
129096876|NCT01546038|464646459|FG007|Overall Study|: Randomized, not treated|4|||
129096877|NCT01546038|464646460|FG008|Overall Study|: Randomized, not treated|3|||
129096878|NCT04245202|464646461|FG000|Overall Study|Lack of Efficacy|10|||
129096879|NCT04245202|464646462|FG001|Overall Study|Lack of Efficacy|1|||
129096880|NCT00717275|464646463|FG000|Overall Study|Premature study termination.|3|||
129096881|NCT03329248|464646466|FG000|Overall Study|Progressive Disease|6|||
129096882|NCT01254721|464646471|FG000|Overall Study|Lost to Follow-up|0|||
129096883|NCT01254721|464646472|FG001|Overall Study|Lost to Follow-up|4|||
129096884|NCT01254721|464646471|FG000|Overall Study|Lack of Efficacy|4|||
129096885|NCT01254721|464646472|FG001|Overall Study|Lack of Efficacy|2|||
129096886|NCT01254721|464646471|FG000|Overall Study|Death|0|||
129096887|NCT01254721|464646472|FG001|Overall Study|Death|1|||
129096888|NCT01254721|464646471|FG000|Overall Study|technical problum|1|||
129096889|NCT01254721|464646472|FG001|Overall Study|technical problum|0|||
129096890|NCT01254721|464646471|FG000|Overall Study|Adverse Event|2|||
129096891|NCT01254721|464646472|FG001|Overall Study|Adverse Event|3|||
129096892|NCT01254721|464646471|FG000|Overall Study|Withdrawal by Subject|8|||
129096893|NCT01254721|464646472|FG001|Overall Study|Withdrawal by Subject|11|||
129096894|NCT01254721|464646471|FG000|Overall Study|Wrongly randomization|0|||
129096895|NCT01254721|464646472|FG001|Overall Study|Wrongly randomization|1|||
129096896|NCT00987402|464646473|FG000|Overall Study|Insufficient data entry|86|||
129096897|NCT00987402|464646474|FG001|Overall Study|Insufficient data entry|98|||
129096898|NCT01430624|464646475|FG000|Overall Study|Lost to Follow-up|23|||
129096899|NCT01430624|464646476|FG001|Overall Study|Lost to Follow-up|29|||
129096900|NCT01430624|464646477|FG002|Overall Study|Lost to Follow-up|27|||
129096901|NCT01430624|464646475|FG000|Overall Study|technical or eligibility|5|||
129096902|NCT01430624|464646476|FG001|Overall Study|technical or eligibility|5|||
129096903|NCT01430624|464646477|FG002|Overall Study|technical or eligibility|2|||
129096904|NCT01362517|464646482|FG000|Overall Study|Protocol Violation|1|||
129096905|NCT01362517|464646482|FG000|Overall Study|Lost to Follow-up|1|||
129096906|NCT01121536|464646484|FG000|Overall Study|Adverse Event|63|||
128763046|NCT01559454|463422692|FG000|Overall Study|Withdrawal by Subject|0|||
129096907|NCT01121536|464646484|FG000|Overall Study|Lack of Efficacy|35|||
129096908|NCT01121536|464646484|FG000|Overall Study|Withdrawal by Subject|65|||
129096909|NCT01121536|464646484|FG000|Overall Study|Protocol Violation|20|||
129096910|NCT01121536|464646484|FG000|Overall Study|Noncompliance with study medication|12|||
129096911|NCT01121536|464646484|FG000|Overall Study|Noncompliance with study procedures|9|||
129096912|NCT01121536|464646484|FG000|Overall Study|Lost to Follow-up|39|||
129096913|NCT01121536|464646484|FG000|Overall Study|Other|118|||
129096914|NCT00568334|464646485|FG000|Overall Study|Withdrawal by Subject|0|||
129096915|NCT00568334|464646486|FG001|Overall Study|Withdrawal by Subject|1|||
129096916|NCT00568334|464646485|FG000|Overall Study|Lost to Follow-up|1|||
129096917|NCT00568334|464646486|FG001|Overall Study|Lost to Follow-up|0|||
129096918|NCT00306787|464646487|FG000|Overall Study|Discontinued without taking study drug|208|||
129096919|NCT00306787|464646488|FG001|Overall Study|Discontinued without taking study drug|215|||
129096920|NCT00306787|464646487|FG000|Overall Study|Adverse Event|1|||
129096921|NCT00306787|464646488|FG001|Overall Study|Adverse Event|1|||
129096922|NCT00306787|464646487|FG000|Overall Study|Lack of Efficacy|1|||
129096923|NCT00306787|464646488|FG001|Overall Study|Lack of Efficacy|0|||
129096924|NCT00306787|464646487|FG000|Overall Study|Protocol Violation|8|||
129096925|NCT00306787|464646488|FG001|Overall Study|Protocol Violation|10|||
129096926|NCT00306787|464646487|FG000|Overall Study|Withdrawal by Subject|2|||
129096927|NCT00306787|464646488|FG001|Overall Study|Withdrawal by Subject|9|||
129096928|NCT00306787|464646487|FG000|Overall Study|Lost to Follow-up|9|||
129096929|NCT00306787|464646488|FG001|Overall Study|Lost to Follow-up|6|||
129096930|NCT00306787|464646487|FG000|Overall Study|Administrative problems|4|||
129096931|NCT00306787|464646488|FG001|Overall Study|Administrative problems|0|||
129096932|NCT00306787|464646487|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129096933|NCT00306787|464646488|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129096934|NCT02273908|464646489|FG000|Overall Study|Adverse Event|16|||
129096935|NCT02273908|464646490|FG001|Overall Study|Adverse Event|0|||
129096936|NCT02273908|464646489|FG000|Overall Study|Lost to Follow-up|10|||
129096937|NCT02273908|464646490|FG001|Overall Study|Lost to Follow-up|1|||
129096938|NCT02273908|464646489|FG000|Overall Study|Did not meet entrance criteria|3|||
129096939|NCT02273908|464646490|FG001|Overall Study|Did not meet entrance criteria|2|||
129096940|NCT02273908|464646489|FG000|Overall Study|Withdrawal by Subject|4|||
129096941|NCT02273908|464646490|FG001|Overall Study|Withdrawal by Subject|2|||
129096942|NCT04908475|464646491|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
129096943|NCT04908475|464646492|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129096944|NCT04908475|464646493|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129096945|NCT04908475|464646494|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129096946|NCT04908475|464646495|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129096947|NCT04908475|464646496|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129096948|NCT04908475|464646491|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
129096949|NCT04908475|464646492|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129096950|NCT04908475|464646493|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129096951|NCT04908475|464646494|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129096952|NCT04908475|464646495|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129096953|NCT04908475|464646496|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129096954|NCT04908475|464646491|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
129096955|NCT04908475|464646492|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129096956|NCT04908475|464646493|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129096957|NCT04908475|464646494|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129096958|NCT04908475|464646495|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129096959|NCT04908475|464646496|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129096960|NCT04908475|464646491|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129096961|NCT04908475|464646492|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
129096962|NCT04908475|464646493|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
129096963|NCT04908475|464646494|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
129096964|NCT04908475|464646495|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129096965|NCT04908475|464646496|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129096966|NCT04908475|464646491|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
129096967|NCT04908475|464646492|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
129096968|NCT04908475|464646493|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
129096969|NCT04908475|464646494|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
129096970|NCT04908475|464646495|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
129096971|NCT04908475|464646496|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
129096972|NCT04908475|464646491|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
129096973|NCT04908475|464646492|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
129096974|NCT04908475|464646493|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
129096975|NCT04908475|464646494|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
129096976|NCT04908475|464646495|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
129096977|NCT04908475|464646496|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
129096978|NCT03913104|464646499|FG000|Overall Study|Lost to Follow-up|20|||
129096979|NCT03913104|464646499|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
129096980|NCT03913104|464646499|FG000|Overall Study|Withdrawal by Subject|2|||
129096981|NCT01074255|464646500|FG000|Overall Study|Did not receive EMEND|2|||
129096982|NCT01593254|464646501|FG000|Overall Study|Disease progression|2|||
129096983|NCT01593254|464646502|FG001|Overall Study|Disease progression|7|||
129096984|NCT01593254|464646501|FG000|Overall Study|Study drug toxicity|6|||
129096985|NCT01593254|464646502|FG001|Overall Study|Study drug toxicity|20|||
129096986|NCT01593254|464646501|FG000|Overall Study|Death|3|||
129096987|NCT01593254|464646502|FG001|Overall Study|Death|3|||
129096988|NCT01593254|464646501|FG000|Overall Study|AE unrelated to study drug|0|||
129096989|NCT01593254|464646502|FG001|Overall Study|AE unrelated to study drug|1|||
129096990|NCT01593254|464646501|FG000|Overall Study|participant request to discontinue study treatment|1|||
129096991|NCT01593254|464646502|FG001|Overall Study|participant request to discontinue study treatment|3|||
129096992|NCT01593254|464646501|FG000|Overall Study|participant withdrew consent|0|||
129096993|NCT01593254|464646502|FG001|Overall Study|participant withdrew consent|9|||
129096994|NCT01593254|464646501|FG000|Overall Study|lost to follow up|1|||
129096995|NCT01593254|464646502|FG001|Overall Study|lost to follow up|6|||
129096996|NCT01593254|464646501|FG000|Overall Study|maximum clinical benefit|1|||
129096997|NCT01593254|464646502|FG001|Overall Study|maximum clinical benefit|2|||
129096998|NCT01593254|464646501|FG000|Overall Study|Poor/non compliance|1|||
129096999|NCT01593254|464646502|FG001|Overall Study|Poor/non compliance|1|||
129097000|NCT01593254|464646501|FG000|Overall Study|Pregnancy|0|||
129097001|NCT01593254|464646502|FG001|Overall Study|Pregnancy|3|||
129097002|NCT01593254|464646501|FG000|Overall Study|participant no longer meets study criteria|1|||
129097003|NCT01593254|464646502|FG001|Overall Study|participant no longer meets study criteria|1|||
129097004|NCT01593254|464646501|FG000|Overall Study|Admin reason by sponsor|7|||
129097005|NCT01593254|464646502|FG001|Overall Study|Admin reason by sponsor|3|||
129097006|NCT01593254|464646501|FG000|Overall Study|Imatinib treatment failure|2|||
129097007|NCT01593254|464646502|FG001|Overall Study|Imatinib treatment failure|0|||
129097008|NCT01593254|464646501|FG000|Overall Study|Other Reasons|61|||
129097009|NCT01593254|464646502|FG001|Overall Study|Other Reasons|115|||
129097010|NCT01887678|464646503|FG000|Overall Study|Adverse Event|4|||
129097011|NCT01887678|464646504|FG001|Overall Study|Adverse Event|6|||
129097012|NCT01887678|464646503|FG000|Overall Study|Exceeded rescue medication dosage|4|||
129097013|NCT01887678|464646504|FG001|Overall Study|Exceeded rescue medication dosage|5|||
129097014|NCT01887678|464646503|FG000|Overall Study|Withdrawal of consent|3|||
129097015|NCT01887678|464646504|FG001|Overall Study|Withdrawal of consent|4|||
129097016|NCT01887678|464646503|FG000|Overall Study|Lost to Follow-up|4|||
129097017|NCT01887678|464646504|FG001|Overall Study|Lost to Follow-up|2|||
129097018|NCT01887678|464646503|FG000|Overall Study|Deterioration of clinical condition|0|||
129097019|NCT01887678|464646504|FG001|Overall Study|Deterioration of clinical condition|4|||
129097020|NCT01887678|464646503|FG000|Overall Study|Lack of Efficacy|1|||
129097021|NCT01887678|464646504|FG001|Overall Study|Lack of Efficacy|2|||
129097022|NCT01887678|464646503|FG000|Overall Study|Non-compliance|0|||
129097023|NCT01887678|464646504|FG001|Overall Study|Non-compliance|3|||
129097024|NCT01887678|464646503|FG000|Overall Study|Specified|1|||
129097025|NCT01887678|464646504|FG001|Overall Study|Specified|2|||
129097026|NCT00791492|464646505|FG000|Overall Study|Withdrawal by Subject|1|||
129097027|NCT00791492|464646506|FG001|Overall Study|Withdrawal by Subject|2|||
129097028|NCT00791492|464646505|FG000|Overall Study|Liver transplantation|5|||
129097029|NCT00791492|464646506|FG001|Overall Study|Liver transplantation|1|||
129097030|NCT00076999|464646507|FG000|Overall Study|Adverse Event|2|||
129097031|NCT00076999|464646508|FG001|Overall Study|Adverse Event|8|||
129097032|NCT00076999|464646509|FG002|Overall Study|Adverse Event|6|||
129097033|NCT00076999|464646510|FG003|Overall Study|Adverse Event|0|||
129097034|NCT00076999|464646511|FG004|Overall Study|Adverse Event|2|||
129097035|NCT00076999|464646507|FG000|Overall Study|Protocol Violation|0|||
129097036|NCT00076999|464646508|FG001|Overall Study|Protocol Violation|3|||
129097037|NCT00076999|464646509|FG002|Overall Study|Protocol Violation|4|||
129097038|NCT00076999|464646510|FG003|Overall Study|Protocol Violation|0|||
129097039|NCT00076999|464646511|FG004|Overall Study|Protocol Violation|9|||
129097040|NCT00076999|464646507|FG000|Overall Study|Lost to Follow-up|2|||
129097041|NCT00076999|464646508|FG001|Overall Study|Lost to Follow-up|1|||
129097042|NCT00076999|464646509|FG002|Overall Study|Lost to Follow-up|0|||
129097043|NCT00076999|464646510|FG003|Overall Study|Lost to Follow-up|0|||
129097044|NCT00076999|464646511|FG004|Overall Study|Lost to Follow-up|0|||
129097045|NCT00076999|464646507|FG000|Overall Study|Withdrawal by Subject|0|||
129097046|NCT00076999|464646508|FG001|Overall Study|Withdrawal by Subject|4|||
129097047|NCT00076999|464646509|FG002|Overall Study|Withdrawal by Subject|3|||
129097048|NCT00076999|464646510|FG003|Overall Study|Withdrawal by Subject|0|||
129097049|NCT00076999|464646511|FG004|Overall Study|Withdrawal by Subject|1|||
129097050|NCT00076999|464646507|FG000|Overall Study|Other reason (not specified)|8|||
129097051|NCT00076999|464646508|FG001|Overall Study|Other reason (not specified)|8|||
129097052|NCT00076999|464646509|FG002|Overall Study|Other reason (not specified)|4|||
129097053|NCT00076999|464646510|FG003|Overall Study|Other reason (not specified)|1|||
129097054|NCT00076999|464646511|FG004|Overall Study|Other reason (not specified)|13|||
129097055|NCT02603562|464646524|FG000|Overall Study|Lost to Follow-up|1|||
129097056|NCT01380691|464646539|FG000|Washout (7 Days)|Protocol Violation|0|||
129097057|NCT01380691|464646540|FG001|Washout (7 Days)|Protocol Violation|0|||
129097058|NCT01380691|464646541|FG002|Washout (7 Days)|Protocol Violation|0|||
129097059|NCT01380691|464646542|FG003|Washout (7 Days)|Protocol Violation|1|||
129097060|NCT01380691|464646539|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
129097061|NCT01380691|464646540|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
129097062|NCT01380691|464646541|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
129097063|NCT01380691|464646542|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
129097064|NCT01987232|464646543|FG000|Overall Study|Ongoing in Study|0|||
129097065|NCT01987232|464646544|FG001|Overall Study|Ongoing in Study|0|||
129097066|NCT01987232|464646545|FG002|Overall Study|Ongoing in Study|0|||
129097067|NCT01987232|464646546|FG003|Overall Study|Ongoing in Study|1|||
129097068|NCT01987232|464646547|FG004|Overall Study|Ongoing in Study|0|||
129097069|NCT00232596|464646554|FG000|6-Week Titration Phase|Adverse Event|6|||
129097070|NCT00232596|464646555|FG001|6-Week Titration Phase|Adverse Event|19|||
129097071|NCT00232596|464646554|FG000|6-Week Titration Phase|Failed to Return|2|||
129097072|NCT00232596|464646555|FG001|6-Week Titration Phase|Failed to Return|1|||
129097073|NCT00232596|464646554|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
129097074|NCT00232596|464646555|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
129097075|NCT00232596|464646554|FG000|6-Week Titration Phase|Protocol Violation|1|||
129097076|NCT00232596|464646555|FG001|6-Week Titration Phase|Protocol Violation|3|||
129097077|NCT00232596|464646554|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
129097078|NCT00232596|464646555|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
129097079|NCT00232596|464646554|FG000|6-Week Titration Phase|Other|3|||
129097080|NCT00232596|464646555|FG001|6-Week Titration Phase|Other|3|||
129097081|NCT00232596|464646554|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
129097082|NCT00232596|464646555|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
129097083|NCT00232596|464646554|FG000|12-Week Maintenance Phase|Adverse Event|7|||
129097084|NCT00232596|464646555|FG001|12-Week Maintenance Phase|Adverse Event|22|||
129097085|NCT00232596|464646554|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
129097086|NCT00232596|464646555|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
129097087|NCT00232596|464646554|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
129097088|NCT00232596|464646555|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
129097089|NCT00232596|464646554|FG000|12-Week Maintenance Phase|Other|1|||
129097090|NCT00232596|464646555|FG001|12-Week Maintenance Phase|Other|3|||
129097091|NCT03426436|464646556|FG000|Overall Study|Incorrect lead placement|12|||
129097092|NCT03426436|464646556|FG000|Overall Study|Withdrawal by Subject|2|||
129097093|NCT03426436|464646556|FG000|Overall Study|Consent issue|1|||
129097094|NCT03426436|464646556|FG000|Overall Study|ECGs not saved|4|||
129097095|NCT00932698|464646557|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
129097096|NCT00932698|464646558|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
129097097|NCT00932698|464646559|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
129097098|NCT00932698|464646560|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
129097099|NCT00932698|464646561|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
129097100|NCT00932698|464646562|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
129097101|NCT00932698|464646563|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
129097102|NCT00932698|464646564|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
129097103|NCT00932698|464646565|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
129097104|NCT00932698|464646566|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
129097105|NCT00932698|464646567|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
129097106|NCT00932698|464646557|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129097107|NCT00932698|464646558|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129097108|NCT00932698|464646559|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129097109|NCT00932698|464646560|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129097110|NCT00932698|464646561|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129097111|NCT00932698|464646562|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129097112|NCT00932698|464646563|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129097113|NCT00932698|464646564|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129097114|NCT00932698|464646565|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129097115|NCT00932698|464646566|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129097116|NCT00932698|464646567|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129097117|NCT00932698|464646557|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
129097118|NCT00932698|464646558|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
129097119|NCT00932698|464646559|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
129097120|NCT00932698|464646560|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
129097121|NCT00932698|464646561|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
129097122|NCT00932698|464646562|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
129097123|NCT00932698|464646563|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
129097124|NCT00932698|464646564|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
129097125|NCT00932698|464646565|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
129097126|NCT00932698|464646566|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
129097127|NCT00932698|464646567|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
128874187|NCT00774930|463832724|FG001|LTOLE Phase|Subject decision|5|||
129097128|NCT00932698|464646557|FG000|Part 1 (Dose Escalation)|Other|0|||
129097129|NCT00932698|464646558|FG001|Part 1 (Dose Escalation)|Other|0|||
129097130|NCT00932698|464646559|FG002|Part 1 (Dose Escalation)|Other|1|||
129097131|NCT00932698|464646560|FG003|Part 1 (Dose Escalation)|Other|0|||
129097132|NCT00932698|464646561|FG004|Part 1 (Dose Escalation)|Other|0|||
129097133|NCT00932698|464646562|FG005|Part 1 (Dose Escalation)|Other|0|||
129097134|NCT00932698|464646563|FG006|Part 1 (Dose Escalation)|Other|1|||
129097135|NCT00932698|464646564|FG007|Part 1 (Dose Escalation)|Other|0|||
129097136|NCT00932698|464646565|FG008|Part 1 (Dose Escalation)|Other|0|||
129097137|NCT00932698|464646566|FG009|Part 1 (Dose Escalation)|Other|0|||
129097138|NCT00932698|464646567|FG010|Part 1 (Dose Escalation)|Other|0|||
129097139|NCT00932698|464646557|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
129097140|NCT00932698|464646558|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
129097141|NCT00932698|464646559|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
129097142|NCT00932698|464646560|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
129097143|NCT00932698|464646561|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
129097144|NCT00932698|464646562|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
129097145|NCT00932698|464646563|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
129097146|NCT00932698|464646564|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
129097147|NCT00932698|464646565|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
129097148|NCT00932698|464646566|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
129097149|NCT00932698|464646567|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
129097150|NCT00932698|464646557|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097151|NCT00932698|464646558|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097152|NCT00932698|464646559|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097153|NCT00932698|464646560|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097154|NCT00932698|464646561|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097155|NCT00932698|464646562|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097156|NCT00932698|464646563|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097157|NCT00932698|464646564|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
129097158|NCT00932698|464646565|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
129097159|NCT00932698|464646566|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
129097160|NCT00932698|464646567|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129097161|NCT00932698|464646557|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
129097162|NCT00932698|464646558|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
129097163|NCT00932698|464646559|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
129097164|NCT00932698|464646560|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
129097165|NCT00932698|464646561|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
129097166|NCT00932698|464646562|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
129097167|NCT00932698|464646563|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
129097168|NCT00932698|464646564|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
129097169|NCT00932698|464646565|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
129097170|NCT00932698|464646566|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
129097171|NCT00932698|464646567|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
129097172|NCT00655681|464646568|FG000|Overall Study|Lost to Follow-up|1|||
129097173|NCT00655681|464646569|FG001|Overall Study|Lost to Follow-up|1|||
129097174|NCT02429310|464646570|FG000|Overall Study|Lost to Follow-up|1|||
129097175|NCT02429310|464646571|FG001|Overall Study|Lost to Follow-up|2|||
129097176|NCT02429310|464646570|FG000|Overall Study|Protocol Violation|1|||
129097177|NCT02429310|464646571|FG001|Overall Study|Protocol Violation|1|||
129097178|NCT00394433|464646572|FG000|Overall Study|Adverse Event|2|||
129097179|NCT00394433|464646572|FG000|Overall Study|Alternative Therapy|1|||
129097180|NCT01554176|464646573|FG000|Treatment Phase|Protocol Violation|1|||
129097181|NCT01554176|464646574|FG001|Treatment Phase|Protocol Violation|2|||
129097182|NCT01554176|464646575|FG002|Treatment Phase|Protocol Violation|0|||
129097183|NCT01554176|464646576|FG003|Treatment Phase|Protocol Violation|0|||
129097184|NCT01554176|464646577|FG004|Treatment Phase|Protocol Violation|0|||
129097185|NCT01554176|464646573|FG000|Treatment Phase|Physician Decision|1|||
129097186|NCT01554176|464646574|FG001|Treatment Phase|Physician Decision|1|||
129097187|NCT01554176|464646575|FG002|Treatment Phase|Physician Decision|0|||
129097188|NCT01554176|464646576|FG003|Treatment Phase|Physician Decision|0|||
129097189|NCT01554176|464646577|FG004|Treatment Phase|Physician Decision|0|||
129097190|NCT01554176|464646573|FG000|Treatment Phase|Lack of Efficacy|0|||
129097191|NCT01554176|464646574|FG001|Treatment Phase|Lack of Efficacy|1|||
129097192|NCT01554176|464646575|FG002|Treatment Phase|Lack of Efficacy|0|||
129097193|NCT01554176|464646576|FG003|Treatment Phase|Lack of Efficacy|0|||
129097194|NCT01554176|464646577|FG004|Treatment Phase|Lack of Efficacy|0|||
129097195|NCT01554176|464646573|FG000|Treatment Phase|Adverse event, non-fatal|1|||
129097196|NCT01554176|464646574|FG001|Treatment Phase|Adverse event, non-fatal|1|||
129097197|NCT01554176|464646575|FG002|Treatment Phase|Adverse event, non-fatal|0|||
129097198|NCT01554176|464646576|FG003|Treatment Phase|Adverse event, non-fatal|0|||
129097199|NCT01554176|464646577|FG004|Treatment Phase|Adverse event, non-fatal|0|||
129097200|NCT01554176|464646573|FG000|Treatment Phase|Non-compliance with study drug|1|||
129097201|NCT01554176|464646574|FG001|Treatment Phase|Non-compliance with study drug|0|||
129097202|NCT01554176|464646575|FG002|Treatment Phase|Non-compliance with study drug|0|||
129097203|NCT01554176|464646576|FG003|Treatment Phase|Non-compliance with study drug|0|||
129097204|NCT01554176|464646577|FG004|Treatment Phase|Non-compliance with study drug|0|||
129097205|NCT01554176|464646573|FG000|Treatment Phase|Withdrawal by Subject|1|||
129097206|NCT01554176|464646574|FG001|Treatment Phase|Withdrawal by Subject|0|||
129097207|NCT01554176|464646575|FG002|Treatment Phase|Withdrawal by Subject|0|||
129097208|NCT01554176|464646576|FG003|Treatment Phase|Withdrawal by Subject|0|||
129097209|NCT01554176|464646577|FG004|Treatment Phase|Withdrawal by Subject|0|||
129097210|NCT01554176|464646573|FG000|Treatment Phase|Lost to Follow-up|3|||
129097211|NCT01554176|464646574|FG001|Treatment Phase|Lost to Follow-up|0|||
129097212|NCT01554176|464646575|FG002|Treatment Phase|Lost to Follow-up|0|||
129097213|NCT01554176|464646576|FG003|Treatment Phase|Lost to Follow-up|0|||
129097214|NCT01554176|464646577|FG004|Treatment Phase|Lost to Follow-up|0|||
129097215|NCT01554176|464646573|FG000|Run-out Phase|Protocol Violation|0|||
129097216|NCT01554176|464646574|FG001|Run-out Phase|Protocol Violation|0|||
129097217|NCT01554176|464646575|FG002|Run-out Phase|Protocol Violation|0|||
129097218|NCT01554176|464646576|FG003|Run-out Phase|Protocol Violation|1|||
129097219|NCT01554176|464646577|FG004|Run-out Phase|Protocol Violation|0|||
129097220|NCT01298141|464646578|FG000|Overall Study|Adverse Event|3|||
129097221|NCT01298141|464646578|FG000|Overall Study|Refusal of Required Study Procedures|1|||
129097222|NCT01298141|464646578|FG000|Overall Study|Withdrawal by Subject|6|||
129097223|NCT01298141|464646578|FG000|Overall Study|Termination of Study by the Investigator|5|||
129097224|NCT01298141|464646578|FG000|Overall Study|Other|5|||
129097225|NCT01298141|464646578|FG000|Overall Study|Lost to Follow-up|1|||
129097226|NCT01298141|464646578|FG000|Overall Study|Death|6|||
129097227|NCT01298141|464646578|FG000|Overall Study|Not treated|4|||
129097228|NCT01854879|464646582|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
129097229|NCT01854879|464646582|FG000|Overall Study|screen fail|3|||
129097230|NCT01854879|464646582|FG000|Overall Study|incomplete data set|1|||
129097231|NCT01211483|464648528|FG000|Phase 1b|Death|6|||
129097232|NCT01211483|464648529|FG001|Phase 1b|Death|0|||
129097233|NCT01211483|464648530|FG002|Phase 1b|Death|0|||
129097234|NCT01211483|464648531|FG003|Phase 1b|Death|0|||
129097235|NCT01211483|464648528|FG000|Phase 1b|Withdrawal by Subject|1|||
129097236|NCT01211483|464648529|FG001|Phase 1b|Withdrawal by Subject|0|||
129097237|NCT01211483|464648530|FG002|Phase 1b|Withdrawal by Subject|0|||
129097238|NCT01211483|464648531|FG003|Phase 1b|Withdrawal by Subject|0|||
129097239|NCT01211483|464648528|FG000|Phase 2|Lost to Follow-up|0|||
129097240|NCT01211483|464648529|FG001|Phase 2|Lost to Follow-up|1|||
129097241|NCT01211483|464648530|FG002|Phase 2|Lost to Follow-up|1|||
129097242|NCT01211483|464648531|FG003|Phase 2|Lost to Follow-up|2|||
129097243|NCT01211483|464648528|FG000|Phase 2|Death|0|||
129097244|NCT01211483|464648529|FG001|Phase 2|Death|64|||
129097245|NCT01211483|464648530|FG002|Phase 2|Death|53|||
129097246|NCT01211483|464648531|FG003|Phase 2|Death|53|||
129097247|NCT01211483|464648528|FG000|Phase 2|Withdrawal by Subject|0|||
129097248|NCT01211483|464648529|FG001|Phase 2|Withdrawal by Subject|1|||
129097249|NCT01211483|464648530|FG002|Phase 2|Withdrawal by Subject|10|||
129097250|NCT01211483|464648531|FG003|Phase 2|Withdrawal by Subject|5|||
129097251|NCT01211483|464648528|FG000|Phase 2|Study terminated by Sponsor|0|||
129097252|NCT01211483|464648529|FG001|Phase 2|Study terminated by Sponsor|6|||
129097253|NCT01211483|464648530|FG002|Phase 2|Study terminated by Sponsor|8|||
129097254|NCT01211483|464648531|FG003|Phase 2|Study terminated by Sponsor|11|||
129097255|NCT00460265|464648532|FG000|Overall Study|Lost to Follow-up|14|||
129097256|NCT00460265|464648533|FG001|Overall Study|Lost to Follow-up|15|||
129097257|NCT00460265|464648532|FG000|Overall Study|Physician Decision|1|||
129097258|NCT00460265|464648533|FG001|Overall Study|Physician Decision|2|||
129097259|NCT00460265|464648532|FG000|Overall Study|Withdrawal by Subject|10|||
129097260|NCT00460265|464648533|FG001|Overall Study|Withdrawal by Subject|25|||
129097261|NCT00460265|464648532|FG000|Overall Study|Ongoing|60|||
129097262|NCT00460265|464648533|FG001|Overall Study|Ongoing|47|||
129097263|NCT02719353|464648534|FG000|First Intervention|Physician Decision|0|||
129097264|NCT02719353|464648535|FG001|First Intervention|Physician Decision|1|||
129097265|NCT01917344|464648537|FG000|Overall Study|Withdrawal by Subject|1|||
129097266|NCT00412217|464648538|FG000|Overall Study|Insufficient Data Available|8|||
129097267|NCT00412217|464648539|FG001|Overall Study|Insufficient Data Available|3|||
129097268|NCT00412217|464648538|FG000|Overall Study|Death|5|||
129097269|NCT00412217|464648539|FG001|Overall Study|Death|4|||
129097270|NCT00412217|464648538|FG000|Overall Study|Disease Progression|2|||
129097271|NCT00412217|464648539|FG001|Overall Study|Disease Progression|3|||
129097272|NCT00412217|464648538|FG000|Overall Study|Investigator Decision|1|||
129097273|NCT00412217|464648539|FG001|Overall Study|Investigator Decision|0|||
129097274|NCT00412217|464648538|FG000|Overall Study|Withdrawal by Subject|2|||
129097275|NCT00412217|464648539|FG001|Overall Study|Withdrawal by Subject|0|||
129097276|NCT00412217|464648538|FG000|Overall Study|Lost to Follow-up|1|||
129097277|NCT00412217|464648539|FG001|Overall Study|Lost to Follow-up|4|||
129097278|NCT00412217|464648538|FG000|Overall Study|Study Terminated by Sponsor|26|||
129097279|NCT00412217|464648539|FG001|Overall Study|Study Terminated by Sponsor|33|||
129097280|NCT00412217|464648538|FG000|Overall Study|Other|1|||
129097281|NCT00412217|464648539|FG001|Overall Study|Other|1|||
129097282|NCT01398410|464648541|FG000|Overall Study|Adverse Event|12|||
129097283|NCT01398410|464648542|FG001|Overall Study|Adverse Event|16|||
129097284|NCT01398410|464648541|FG000|Overall Study|Participants Choice|8|||
129097285|NCT01398410|464648542|FG001|Overall Study|Participants Choice|11|||
129097286|NCT01398410|464648541|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
129097287|NCT01398410|464648542|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
129097288|NCT01398410|464648541|FG000|Overall Study|Other|36|||
129097289|NCT01398410|464648542|FG001|Overall Study|Other|29|||
129097290|NCT02470403|464648543|FG000|Overall Study|Adverse Event|1|||
129097291|NCT02470403|464648544|FG001|Overall Study|Adverse Event|0|||
129097292|NCT02470403|464648545|FG002|Overall Study|Adverse Event|0|||
129097293|NCT02470403|464648546|FG003|Overall Study|Adverse Event|0|||
129097294|NCT02470403|464648547|FG004|Overall Study|Adverse Event|0|||
129097295|NCT02470403|464648543|FG000|Overall Study|Lost to Follow-up|0|||
129097296|NCT02470403|464648544|FG001|Overall Study|Lost to Follow-up|1|||
129097297|NCT02470403|464648545|FG002|Overall Study|Lost to Follow-up|0|||
129097298|NCT02470403|464648546|FG003|Overall Study|Lost to Follow-up|0|||
129097299|NCT02470403|464648547|FG004|Overall Study|Lost to Follow-up|0|||
129097300|NCT02470403|464648543|FG000|Overall Study|Subject/guardian decision|1|||
129097301|NCT02470403|464648544|FG001|Overall Study|Subject/guardian decision|0|||
129097302|NCT02470403|464648545|FG002|Overall Study|Subject/guardian decision|0|||
129097303|NCT02470403|464648546|FG003|Overall Study|Subject/guardian decision|4|||
129097304|NCT02470403|464648547|FG004|Overall Study|Subject/guardian decision|0|||
129097305|NCT03209518|464648550|FG000|Overall Study|Case Report Forms Uncollected|1|||
129097306|NCT03209518|464648550|FG000|Overall Study|Protocol Deviation|1|||
129097307|NCT00236899|464648551|FG000|Overall Study|Adverse Event (Study Related)|1|||
129097308|NCT00236899|464648552|FG001|Overall Study|Adverse Event (Study Related)|1|||
129097309|NCT00236899|464648553|FG002|Overall Study|Adverse Event (Study Related)|2|||
129097310|NCT00236899|464648554|FG003|Overall Study|Adverse Event (Study Related)|1|||
129097311|NCT00236899|464648551|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
129097312|NCT00236899|464648552|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
129097313|NCT00236899|464648553|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
129097314|NCT00236899|464648554|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
129097315|NCT00236899|464648551|FG000|Overall Study|Death (Study Disease)|1|||
129097316|NCT00236899|464648552|FG001|Overall Study|Death (Study Disease)|4|||
129097317|NCT00236899|464648553|FG002|Overall Study|Death (Study Disease)|0|||
129097318|NCT00236899|464648554|FG003|Overall Study|Death (Study Disease)|0|||
129097319|NCT00236899|464648551|FG000|Overall Study|Death (Not Study Related)|2|||
129097320|NCT00236899|464648552|FG001|Overall Study|Death (Not Study Related)|0|||
129097321|NCT00236899|464648553|FG002|Overall Study|Death (Not Study Related)|0|||
129097322|NCT00236899|464648554|FG003|Overall Study|Death (Not Study Related)|0|||
129097323|NCT00236899|464648551|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
129097324|NCT00236899|464648552|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
129097325|NCT00236899|464648553|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
129097326|NCT00236899|464648554|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
129097327|NCT00236899|464648551|FG000|Overall Study|Lost to Follow-up|0|||
129097328|NCT00236899|464648552|FG001|Overall Study|Lost to Follow-up|1|||
129097329|NCT00236899|464648553|FG002|Overall Study|Lost to Follow-up|0|||
129097330|NCT00236899|464648554|FG003|Overall Study|Lost to Follow-up|0|||
129097331|NCT00236899|464648551|FG000|Overall Study|Entry Criteria Exclusion|0|||
129097332|NCT00236899|464648552|FG001|Overall Study|Entry Criteria Exclusion|1|||
129097333|NCT00236899|464648553|FG002|Overall Study|Entry Criteria Exclusion|1|||
129097334|NCT00236899|464648554|FG003|Overall Study|Entry Criteria Exclusion|0|||
129097335|NCT00236899|464648551|FG000|Overall Study|Protocol Violation|1|||
129097336|NCT00236899|464648552|FG001|Overall Study|Protocol Violation|0|||
129097337|NCT00236899|464648553|FG002|Overall Study|Protocol Violation|0|||
129097338|NCT00236899|464648554|FG003|Overall Study|Protocol Violation|0|||
129097339|NCT00236899|464648551|FG000|Overall Study|Withdrawal by Subject|6|||
129097340|NCT00236899|464648552|FG001|Overall Study|Withdrawal by Subject|4|||
129097341|NCT00236899|464648553|FG002|Overall Study|Withdrawal by Subject|5|||
129097342|NCT00236899|464648554|FG003|Overall Study|Withdrawal by Subject|2|||
129097343|NCT00236899|464648551|FG000|Overall Study|Physician Decision|7|||
129097344|NCT00236899|464648552|FG001|Overall Study|Physician Decision|8|||
129097345|NCT00236899|464648553|FG002|Overall Study|Physician Decision|7|||
129097346|NCT00236899|464648554|FG003|Overall Study|Physician Decision|6|||
129097347|NCT00236899|464648551|FG000|Overall Study|Satisfactory Response|2|||
129097348|NCT00236899|464648552|FG001|Overall Study|Satisfactory Response|0|||
129097349|NCT00236899|464648553|FG002|Overall Study|Satisfactory Response|0|||
129097350|NCT00236899|464648554|FG003|Overall Study|Satisfactory Response|1|||
129097351|NCT00236899|464648551|FG000|Overall Study|Lack of Efficacy|18|||
129097352|NCT00236899|464648552|FG001|Overall Study|Lack of Efficacy|18|||
129097353|NCT00236899|464648553|FG002|Overall Study|Lack of Efficacy|25|||
129097354|NCT00236899|464648554|FG003|Overall Study|Lack of Efficacy|23|||
129097355|NCT03379792|464648555|FG000|Overall Study|Physician Decision|0|||
129097356|NCT03379792|464648556|FG001|Overall Study|Physician Decision|0|||
129097357|NCT03379792|464648557|FG002|Overall Study|Physician Decision|0|||
129097358|NCT03379792|464648558|FG003|Overall Study|Physician Decision|1|||
129097359|NCT03379792|464648559|FG004|Overall Study|Physician Decision|0|||
129097360|NCT03379792|464648560|FG005|Overall Study|Physician Decision|0|||
129097361|NCT03379792|464648555|FG000|Overall Study|Withdrawal by Subject|0|||
129097362|NCT03379792|464648556|FG001|Overall Study|Withdrawal by Subject|0|||
129097363|NCT03379792|464648557|FG002|Overall Study|Withdrawal by Subject|0|||
129097364|NCT03379792|464648558|FG003|Overall Study|Withdrawal by Subject|0|||
129097365|NCT03379792|464648559|FG004|Overall Study|Withdrawal by Subject|1|||
129097366|NCT03379792|464648560|FG005|Overall Study|Withdrawal by Subject|1|||
129097367|NCT02854605|464648561|FG000|Overall Study|Adverse Event|1|||
129097368|NCT02854605|464648562|FG001|Overall Study|Adverse Event|5|||
129097369|NCT02854605|464648563|FG002|Overall Study|Adverse Event|2|||
129097370|NCT02854605|464648561|FG000|Overall Study|Lost to Follow-up|0|||
129097371|NCT02854605|464648562|FG001|Overall Study|Lost to Follow-up|2|||
129097372|NCT02854605|464648563|FG002|Overall Study|Lost to Follow-up|0|||
129097373|NCT02854605|464648561|FG000|Overall Study|Withdrew Consent|1|||
129097374|NCT02854605|464648562|FG001|Overall Study|Withdrew Consent|0|||
129097375|NCT02854605|464648563|FG002|Overall Study|Withdrew Consent|1|||
129097376|NCT02854605|464648561|FG000|Overall Study|Investigator's Discretion|1|||
129097377|NCT02854605|464648562|FG001|Overall Study|Investigator's Discretion|0|||
129097378|NCT02854605|464648563|FG002|Overall Study|Investigator's Discretion|0|||
129097379|NCT02854605|464648561|FG000|Overall Study|Protocol Violation|0|||
129097380|NCT02854605|464648562|FG001|Overall Study|Protocol Violation|0|||
129097381|NCT02854605|464648563|FG002|Overall Study|Protocol Violation|1|||
129097382|NCT01897571|464648568|FG000|Overall Study|Lost to Follow-up|3|||
129097383|NCT01897571|464648569|FG001|Overall Study|Lost to Follow-up|0|||
129097384|NCT01897571|464648570|FG002|Overall Study|Lost to Follow-up|0|||
129097385|NCT01897571|464648571|FG003|Overall Study|Lost to Follow-up|0|||
129097386|NCT01897571|464648572|FG004|Overall Study|Lost to Follow-up|2|||
129097387|NCT01897571|464648573|FG005|Overall Study|Lost to Follow-up|0|||
129097388|NCT01897571|464648574|FG006|Overall Study|Lost to Follow-up|0|||
129097389|NCT01897571|464648575|FG007|Overall Study|Lost to Follow-up|0|||
129097390|NCT01897571|464648576|FG008|Overall Study|Lost to Follow-up|1|||
129097391|NCT01897571|464648577|FG009|Overall Study|Lost to Follow-up|2|||
129097392|NCT01897571|464648578|FG010|Overall Study|Lost to Follow-up|4|||
129097393|NCT01897571|464648568|FG000|Overall Study|Withdrawal by Subject|0|||
129097394|NCT01897571|464648569|FG001|Overall Study|Withdrawal by Subject|0|||
129097395|NCT01897571|464648570|FG002|Overall Study|Withdrawal by Subject|0|||
129097396|NCT01897571|464648571|FG003|Overall Study|Withdrawal by Subject|0|||
129097397|NCT01897571|464648572|FG004|Overall Study|Withdrawal by Subject|0|||
129097398|NCT01897571|464648573|FG005|Overall Study|Withdrawal by Subject|0|||
129097399|NCT01897571|464648574|FG006|Overall Study|Withdrawal by Subject|0|||
129097400|NCT01897571|464648575|FG007|Overall Study|Withdrawal by Subject|1|||
129097401|NCT01897571|464648576|FG008|Overall Study|Withdrawal by Subject|4|||
129097402|NCT01897571|464648577|FG009|Overall Study|Withdrawal by Subject|3|||
129097403|NCT01897571|464648578|FG010|Overall Study|Withdrawal by Subject|1|||
129097404|NCT01897571|464648568|FG000|Overall Study|Other|1|||
129097405|NCT01897571|464648569|FG001|Overall Study|Other|0|||
129097406|NCT01897571|464648570|FG002|Overall Study|Other|0|||
129097407|NCT01897571|464648571|FG003|Overall Study|Other|3|||
129097408|NCT01897571|464648572|FG004|Overall Study|Other|3|||
129097409|NCT01897571|464648573|FG005|Overall Study|Other|4|||
129097410|NCT01897571|464648574|FG006|Overall Study|Other|7|||
129097411|NCT01897571|464648575|FG007|Overall Study|Other|0|||
129097412|NCT01897571|464648576|FG008|Overall Study|Other|0|||
129097413|NCT01897571|464648577|FG009|Overall Study|Other|0|||
129097414|NCT01897571|464648578|FG010|Overall Study|Other|0|||
129097415|NCT01897571|464648568|FG000|Overall Study|Enrolled in rollover study|0|||
129097416|NCT01897571|464648569|FG001|Overall Study|Enrolled in rollover study|0|||
129097417|NCT01897571|464648570|FG002|Overall Study|Enrolled in rollover study|0|||
129097418|NCT01897571|464648571|FG003|Overall Study|Enrolled in rollover study|0|||
129097419|NCT01897571|464648572|FG004|Overall Study|Enrolled in rollover study|0|||
129097420|NCT01897571|464648573|FG005|Overall Study|Enrolled in rollover study|0|||
129097421|NCT01897571|464648574|FG006|Overall Study|Enrolled in rollover study|0|||
129097422|NCT01897571|464648575|FG007|Overall Study|Enrolled in rollover study|9|||
129097423|NCT01897571|464648576|FG008|Overall Study|Enrolled in rollover study|7|||
129097424|NCT01897571|464648577|FG009|Overall Study|Enrolled in rollover study|9|||
129097425|NCT01897571|464648578|FG010|Overall Study|Enrolled in rollover study|1|||
129097426|NCT01897571|464648568|FG000|Overall Study|Death|2|||
129097427|NCT01897571|464648569|FG001|Overall Study|Death|2|||
129097428|NCT01897571|464648570|FG002|Overall Study|Death|3|||
129097429|NCT01897571|464648571|FG003|Overall Study|Death|6|||
129097430|NCT01897571|464648572|FG004|Overall Study|Death|7|||
129097431|NCT01897571|464648573|FG005|Overall Study|Death|9|||
129097432|NCT01897571|464648574|FG006|Overall Study|Death|5|||
129097433|NCT01897571|464648575|FG007|Overall Study|Death|22|||
129097434|NCT01897571|464648576|FG008|Overall Study|Death|23|||
129097435|NCT01897571|464648577|FG009|Overall Study|Death|129|||
129097436|NCT01897571|464648578|FG010|Overall Study|Death|59|||
129097437|NCT00089635|464648580|FG000|Overall Study|Adverse Event|2|||
129097438|NCT00089635|464648580|FG000|Overall Study|Death|17|||
129097439|NCT00089635|464648580|FG000|Overall Study|Disease Progression|12|||
129097440|NCT00089635|464648580|FG000|Overall Study|Lost to Follow-up|3|||
129097441|NCT00089635|464648580|FG000|Overall Study|Withdrawal by Subject|6|||
129097442|NCT00089635|464648580|FG000|Overall Study|Ineligibility determined|1|||
129097443|NCT00089635|464648580|FG000|Overall Study|Other|2|||
129097444|NCT02943785|464648581|FG000|Overall Study|Adverse Event|112|||
129097445|NCT02943785|464648582|FG001|Overall Study|Adverse Event|97|||
129097446|NCT02943785|464648581|FG000|Overall Study|Withdrawal by Subject|63|||
129097447|NCT02943785|464648582|FG001|Overall Study|Withdrawal by Subject|126|||
129097448|NCT02943785|464648581|FG000|Overall Study|Physician Decision|23|||
129097449|NCT02943785|464648582|FG001|Overall Study|Physician Decision|47|||
129097450|NCT02943785|464648581|FG000|Overall Study|Death|46|||
129097451|NCT02943785|464648582|FG001|Overall Study|Death|46|||
129097452|NCT02943785|464648581|FG000|Overall Study|Lost to Follow-up|1|||
129097453|NCT02943785|464648582|FG001|Overall Study|Lost to Follow-up|0|||
129097454|NCT02943785|464648581|FG000|Overall Study|Other|16|||
129097455|NCT02943785|464648582|FG001|Overall Study|Other|19|||
129097456|NCT02943785|464648581|FG000|Overall Study|Did not receive any study medication|21|||
129097457|NCT02943785|464648582|FG001|Overall Study|Did not receive any study medication|28|||
129097458|NCT00821015|464648586|FG000|Overall Study|Lost to Follow-up|12|||
129097459|NCT03170609|464648587|FG000|Overall Study|Death|0|||
129097460|NCT03170609|464648588|FG001|Overall Study|Death|0|||
129097461|NCT03170609|464648589|FG002|Overall Study|Death|1|||
129097462|NCT03170609|464648590|FG003|Overall Study|Death|0|||
129097463|NCT03170609|464648591|FG004|Overall Study|Death|0|||
129097464|NCT03170609|464648592|FG005|Overall Study|Death|0|||
129097465|NCT03170609|464648593|FG006|Overall Study|Death|0|||
129097466|NCT03170609|464648587|FG000|Overall Study|Withdrawal by Subject|1|||
129097467|NCT03170609|464648588|FG001|Overall Study|Withdrawal by Subject|2|||
129097468|NCT03170609|464648589|FG002|Overall Study|Withdrawal by Subject|0|||
129097469|NCT03170609|464648590|FG003|Overall Study|Withdrawal by Subject|0|||
129097470|NCT03170609|464648591|FG004|Overall Study|Withdrawal by Subject|0|||
129097471|NCT03170609|464648592|FG005|Overall Study|Withdrawal by Subject|0|||
129097472|NCT03170609|464648593|FG006|Overall Study|Withdrawal by Subject|1|||
129097473|NCT03170609|464648587|FG000|Overall Study|Lost to Follow-up|1|||
129097474|NCT03170609|464648588|FG001|Overall Study|Lost to Follow-up|0|||
129097475|NCT03170609|464648589|FG002|Overall Study|Lost to Follow-up|5|||
129097476|NCT03170609|464648590|FG003|Overall Study|Lost to Follow-up|2|||
129097477|NCT03170609|464648591|FG004|Overall Study|Lost to Follow-up|1|||
129097478|NCT03170609|464648592|FG005|Overall Study|Lost to Follow-up|1|||
129097479|NCT03170609|464648593|FG006|Overall Study|Lost to Follow-up|0|||
129097480|NCT03170609|464648587|FG000|Overall Study|Other|1|||
129097481|NCT03170609|464648588|FG001|Overall Study|Other|0|||
129097482|NCT03170609|464648589|FG002|Overall Study|Other|0|||
129097483|NCT03170609|464648590|FG003|Overall Study|Other|0|||
129097484|NCT03170609|464648591|FG004|Overall Study|Other|0|||
129097485|NCT03170609|464648592|FG005|Overall Study|Other|1|||
129097486|NCT03170609|464648593|FG006|Overall Study|Other|0|||
129097487|NCT01281956|464648594|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
129097488|NCT01281956|464648595|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
129097489|NCT01857102|464648608|FG000|Period 1|No longer meets Eligibility Criteria|0|||
129097490|NCT01857102|464648609|FG001|Period 1|No longer meets Eligibility Criteria|2|||
129097491|NCT01857102|464648608|FG000|Period 1|Lost to Follow-up|0|||
129097492|NCT01857102|464648609|FG001|Period 1|Lost to Follow-up|3|||
129097493|NCT01857102|464648608|FG000|Period 1|Unsatisfactory Lens Fit|1|||
129097494|NCT01857102|464648609|FG001|Period 1|Unsatisfactory Lens Fit|0|||
129097495|NCT01857102|464648608|FG000|Period 1|Unsatisfactory Visual Response|1|||
129097496|NCT01857102|464648609|FG001|Period 1|Unsatisfactory Visual Response|0|||
129097497|NCT01857102|464648608|FG000|Period 1|Physician Decision|1|||
129097498|NCT01857102|464648609|FG001|Period 1|Physician Decision|0|||
129097499|NCT01857102|464648608|FG000|Period 2|Lens Discomfort|1|||
129097500|NCT01857102|464648609|FG001|Period 2|Lens Discomfort|0|||
129097501|NCT01857102|464648608|FG000|Period 2|Unsatisfactory Lens Fit|1|||
129097502|NCT01857102|464648609|FG001|Period 2|Unsatisfactory Lens Fit|0|||
129097503|NCT01490697|464648610|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
129097504|NCT01490697|464648611|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
129097505|NCT00090584|464648612|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
129097506|NCT00090584|464648613|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
129097507|NCT00090584|464648612|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
129097508|NCT00090584|464648613|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
129097509|NCT02117713|464648622|FG000|Week 48|Adverse Event|4|||
129097510|NCT02117713|464648622|FG000|Week 48|Withdrawal by caregiver|2|||
129097511|NCT02117713|464648622|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
129097512|NCT02117713|464648622|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
129097513|NCT02117713|464648622|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
129097514|NCT02117713|464648622|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
129097515|NCT02028169|464648624|FG000|Overall Study|Lost to Follow-up|21|||
129097516|NCT02028169|464648624|FG000|Overall Study|Lack of Efficacy|2|||
129097517|NCT02028169|464648624|FG000|Overall Study|Withdrawal by Subject|2|||
129097518|NCT02028169|464648624|FG000|Overall Study|Adverse Event|1|||
129097519|NCT02028169|464648624|FG000|Overall Study|Cessation of Drug|1|||
129097520|NCT02028169|464648624|FG000|Overall Study|Concomitant Medication Usage|1|||
129097521|NCT03168919|464648625|FG000|Overall Study|Withdrawal by Subject|2|||
129097522|NCT01085136|464648626|FG000|Part A|Other Adverse event|223|||
129097523|NCT01085136|464648627|FG001|Part A|Other Adverse event|0|||
129097524|NCT01085136|464648628|FG002|Part A|Other Adverse event|0|||
129097525|NCT01085136|464648626|FG000|Part A|Protocol Violation|3|||
129097526|NCT01085136|464648627|FG001|Part A|Protocol Violation|0|||
129097527|NCT01085136|464648628|FG002|Part A|Protocol Violation|0|||
129097528|NCT01085136|464648626|FG000|Part A|Lost to Follow-up|3|||
129097529|NCT01085136|464648627|FG001|Part A|Lost to Follow-up|0|||
129097530|NCT01085136|464648628|FG002|Part A|Lost to Follow-up|0|||
129097531|NCT01085136|464648626|FG000|Part A|Refusal to continue trial medication|64|||
129097532|NCT01085136|464648627|FG001|Part A|Refusal to continue trial medication|0|||
129097533|NCT01085136|464648628|FG002|Part A|Refusal to continue trial medication|0|||
129097534|NCT01085136|464648626|FG000|Part A|Other reason not defined above|30|||
129097535|NCT01085136|464648627|FG001|Part A|Other reason not defined above|0|||
129097536|NCT01085136|464648628|FG002|Part A|Other reason not defined above|0|||
129097537|NCT01085136|464648626|FG000|Part B|Other AE|0|||
129097538|NCT01085136|464648627|FG001|Part B|Other AE|29|||
129097539|NCT01085136|464648628|FG002|Part B|Other AE|8|||
129097540|NCT01085136|464648626|FG000|Part B|Refusal to continue trial medication|0|||
129097541|NCT01085136|464648627|FG001|Part B|Refusal to continue trial medication|12|||
129097542|NCT01085136|464648628|FG002|Part B|Refusal to continue trial medication|7|||
129097543|NCT01085136|464648626|FG000|Part B|Not treated|0|||
129097544|NCT01085136|464648627|FG001|Part B|Not treated|4|||
129097545|NCT01085136|464648628|FG002|Part B|Not treated|8|||
129097546|NCT01085136|464648626|FG000|Part B|Other reason not defined above|0|||
129097547|NCT01085136|464648627|FG001|Part B|Other reason not defined above|6|||
129097548|NCT01085136|464648628|FG002|Part B|Other reason not defined above|3|||
129097549|NCT00386425|464648630|FG000|Overall Study|Physician Decision|3|||
129097550|NCT00386425|464648631|FG001|Overall Study|Physician Decision|0|||
129097551|NCT00386425|464648632|FG002|Overall Study|Physician Decision|0|||
129097552|NCT00386425|464648630|FG000|Overall Study|Withdrawal by Subject|0|||
129097553|NCT00386425|464648631|FG001|Overall Study|Withdrawal by Subject|1|||
129097554|NCT00386425|464648632|FG002|Overall Study|Withdrawal by Subject|0|||
129097555|NCT02678000|464648633|FG000|PART 2|Adverse Event|0|||
129097556|NCT02678000|464648634|FG001|PART 2|Adverse Event|0|||
129097557|NCT02678000|464648635|FG002|PART 2|Adverse Event|2|||
129097558|NCT02678000|464648636|FG003|PART 2|Adverse Event|1|||
129097559|NCT02678000|464648637|FG004|PART 2|Adverse Event|0|||
129097560|NCT02678000|464648633|FG000|PART 2|Withdrawal by Subject|0|||
129097561|NCT02678000|464648634|FG001|PART 2|Withdrawal by Subject|0|||
129097562|NCT02678000|464648635|FG002|PART 2|Withdrawal by Subject|1|||
129097563|NCT02678000|464648636|FG003|PART 2|Withdrawal by Subject|0|||
129097564|NCT02678000|464648637|FG004|PART 2|Withdrawal by Subject|0|||
129097565|NCT03053427|464648638|FG000|Overall Study|Adverse Event|4|||
129097566|NCT03053427|464648639|FG001|Overall Study|Adverse Event|4|||
129097567|NCT03053427|464648638|FG000|Overall Study|Lack of Efficacy|1|||
129097568|NCT03053427|464648639|FG001|Overall Study|Lack of Efficacy|3|||
129097569|NCT03053427|464648638|FG000|Overall Study|Lost to Follow-up|2|||
129097570|NCT03053427|464648639|FG001|Overall Study|Lost to Follow-up|2|||
129097571|NCT03053427|464648638|FG000|Overall Study|Worsening of the target disease|0|||
129097572|NCT03053427|464648639|FG001|Overall Study|Worsening of the target disease|1|||
129097573|NCT03053427|464648638|FG000|Overall Study|Protocol Deviation|3|||
129097574|NCT03053427|464648639|FG001|Overall Study|Protocol Deviation|3|||
129097575|NCT03053427|464648638|FG000|Overall Study|Withdrawal by Subject|3|||
129097576|NCT03053427|464648639|FG001|Overall Study|Withdrawal by Subject|2|||
129097577|NCT03053427|464648638|FG000|Overall Study|Miscellaneous|0|||
129097578|NCT03053427|464648639|FG001|Overall Study|Miscellaneous|1|||
129097579|NCT02172040|464648644|FG000|Overall Study|Adverse Event|0|||
129097580|NCT02172040|464648645|FG001|Overall Study|Adverse Event|2|||
129097581|NCT02172040|464648646|FG002|Overall Study|Adverse Event|0|||
129097582|NCT02172040|464648647|FG003|Overall Study|Adverse Event|0|||
129097583|NCT02172040|464648644|FG000|Overall Study|Protocol Violation|0|||
129097584|NCT02172040|464648645|FG001|Overall Study|Protocol Violation|1|||
129097585|NCT02172040|464648646|FG002|Overall Study|Protocol Violation|0|||
129097586|NCT02172040|464648647|FG003|Overall Study|Protocol Violation|0|||
129097587|NCT02172040|464648644|FG000|Overall Study|Withdrawal by Subject|0|||
129097588|NCT02172040|464648645|FG001|Overall Study|Withdrawal by Subject|0|||
129097589|NCT02172040|464648646|FG002|Overall Study|Withdrawal by Subject|1|||
129097590|NCT02172040|464648647|FG003|Overall Study|Withdrawal by Subject|0|||
129097591|NCT02172040|464648644|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
129097592|NCT02172040|464648645|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
129097593|NCT02172040|464648646|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
129097594|NCT02172040|464648647|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
129097595|NCT02172040|464648644|FG000|Overall Study|Family emergency abroad|0|||
129097596|NCT02172040|464648645|FG001|Overall Study|Family emergency abroad|0|||
129097597|NCT02172040|464648646|FG002|Overall Study|Family emergency abroad|0|||
129097598|NCT02172040|464648647|FG003|Overall Study|Family emergency abroad|1|||
129097599|NCT01324570|464648654|FG000|Overall Study|Adverse Event|4|||
129097600|NCT01324570|464648655|FG001|Overall Study|Adverse Event|7|||
129097601|NCT01324570|464648654|FG000|Overall Study|Withdrawal by Subject|0|||
129097602|NCT01324570|464648655|FG001|Overall Study|Withdrawal by Subject|3|||
129097603|NCT01324570|464648654|FG000|Overall Study|Lack of Efficacy|0|||
129097604|NCT01324570|464648655|FG001|Overall Study|Lack of Efficacy|1|||
129097605|NCT01324570|464648654|FG000|Overall Study|Confirmed or suspected diversion|0|||
129097606|NCT01324570|464648655|FG001|Overall Study|Confirmed or suspected diversion|1|||
129097607|NCT01324570|464648654|FG000|Overall Study|Administrative|0|||
129097608|NCT01324570|464648655|FG001|Overall Study|Administrative|2|||
129097609|NCT02607306|464648656|FG000|Overall Study|Adverse Event|8|||
129097610|NCT02607306|464648657|FG001|Overall Study|Adverse Event|6|||
129097611|NCT02607306|464648658|FG002|Overall Study|Adverse Event|6|||
129097612|NCT02607306|464648656|FG000|Overall Study|Unclassified|1|||
129097613|NCT02607306|464648657|FG001|Overall Study|Unclassified|4|||
128984081|NCT01374516|464229468|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
128984082|NCT01374516|464229467|FG000|Surveillance Expansion Period|Protocol Violation|386|||
128984083|NCT01374516|464229468|FG001|Surveillance Expansion Period|Protocol Violation|217|||
128984084|NCT01374516|464229467|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
128984085|NCT01374516|464229468|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
128984086|NCT01374516|464229467|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
128984087|NCT01374516|464229468|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
128984088|NCT01374516|464229467|FG000|Surveillance Expansion Period|Serious adverse event|20|||
128984089|NCT01374516|464229468|FG001|Surveillance Expansion Period|Serious adverse event|5|||
128984090|NCT03219372|464229469|FG000|Overall Study|Withdrawal by Subject|1|||
128984091|NCT03219372|464229470|FG001|Overall Study|Withdrawal by Subject|0|||
128984092|NCT04145531|464229474|FG000|Part A|Adverse Event|2|||
128984093|NCT04145531|464229475|FG001|Part A|Adverse Event|12|||
128984094|NCT04145531|464229476|FG002|Part A|Adverse Event|6|||
128984095|NCT04145531|464229477|FG003|Part A|Adverse Event|0|||
128984096|NCT04145531|464229474|FG000|Part A|Death|1|||
128984097|NCT04145531|464229475|FG001|Part A|Death|2|||
128984098|NCT04145531|464229476|FG002|Part A|Death|0|||
128984099|NCT04145531|464229477|FG003|Part A|Death|0|||
128984100|NCT04145531|464229474|FG000|Part A|Physician Decision|2|||
128984101|NCT04145531|464229475|FG001|Part A|Physician Decision|5|||
128984102|NCT04145531|464229476|FG002|Part A|Physician Decision|2|||
128984103|NCT04145531|464229477|FG003|Part A|Physician Decision|0|||
128984104|NCT04145531|464229474|FG000|Part A|Progressive disease|0|||
128984105|NCT04145531|464229475|FG001|Part A|Progressive disease|2|||
128984106|NCT04145531|464229476|FG002|Part A|Progressive disease|1|||
128984107|NCT04145531|464229477|FG003|Part A|Progressive disease|0|||
128984108|NCT04145531|464229474|FG000|Part A|Protocol deviation|0|||
128984109|NCT04145531|464229475|FG001|Part A|Protocol deviation|0|||
128984110|NCT04145531|464229476|FG002|Part A|Protocol deviation|1|||
128984111|NCT04145531|464229477|FG003|Part A|Protocol deviation|0|||
128984112|NCT04145531|464229474|FG000|Part A|Withdrawal by parent or guardian|1|||
128984113|NCT04145531|464229475|FG001|Part A|Withdrawal by parent or guardian|0|||
128984114|NCT04145531|464229476|FG002|Part A|Withdrawal by parent or guardian|0|||
128984115|NCT04145531|464229477|FG003|Part A|Withdrawal by parent or guardian|0|||
128984116|NCT04145531|464229474|FG000|Part A|Withdrawal by participant|0|||
128984117|NCT04145531|464229475|FG001|Part A|Withdrawal by participant|0|||
128984118|NCT04145531|464229476|FG002|Part A|Withdrawal by participant|1|||
128984119|NCT04145531|464229477|FG003|Part A|Withdrawal by participant|0|||
128984120|NCT04145531|464229474|FG000|Part A|Other|0|||
128984121|NCT04145531|464229475|FG001|Part A|Other|0|||
128984122|NCT04145531|464229476|FG002|Part A|Other|1|||
128984123|NCT04145531|464229477|FG003|Part A|Other|0|||
128984124|NCT04145531|464229474|FG000|Part B|Adverse Event|0|||
128984125|NCT04145531|464229475|FG001|Part B|Adverse Event|0|||
128984126|NCT04145531|464229476|FG002|Part B|Adverse Event|0|||
128984127|NCT04145531|464229477|FG003|Part B|Adverse Event|21|||
128984128|NCT04145531|464229474|FG000|Part B|Physician Decision|0|||
129097614|NCT02607306|464648658|FG002|Overall Study|Unclassified|0|||
129097615|NCT02607306|464648656|FG000|Overall Study|Withdrawal by Subject|8|||
128984129|NCT04145531|464229475|FG001|Part B|Physician Decision|0|||
128984130|NCT04145531|464229476|FG002|Part B|Physician Decision|0|||
128984131|NCT04145531|464229477|FG003|Part B|Physician Decision|7|||
128984132|NCT04145531|464229474|FG000|Part B|Progressive disease|0|||
129097616|NCT02607306|464648657|FG001|Overall Study|Withdrawal by Subject|10|||
129097617|NCT02607306|464648658|FG002|Overall Study|Withdrawal by Subject|2|||
129097618|NCT02607306|464648656|FG000|Overall Study|Lack of Efficacy|0|||
129097619|NCT02607306|464648657|FG001|Overall Study|Lack of Efficacy|1|||
129097620|NCT02607306|464648658|FG002|Overall Study|Lack of Efficacy|1|||
129097621|NCT02607306|464648656|FG000|Overall Study|Protocol Violation|4|||
129097622|NCT02607306|464648657|FG001|Overall Study|Protocol Violation|2|||
129097623|NCT02607306|464648658|FG002|Overall Study|Protocol Violation|1|||
129097624|NCT02360475|464648661|FG000|Overall Study|Lost to Follow-up|4|||
129097625|NCT02360475|464648662|FG001|Overall Study|Lost to Follow-up|12|||
129097626|NCT02360475|464648663|FG002|Overall Study|Lost to Follow-up|6|||
129097627|NCT02360475|464648664|FG003|Overall Study|Lost to Follow-up|4|||
129097628|NCT02360475|464648661|FG000|Overall Study|Withdrawal by Subject|0|||
129097629|NCT02360475|464648662|FG001|Overall Study|Withdrawal by Subject|1|||
129097630|NCT02360475|464648663|FG002|Overall Study|Withdrawal by Subject|2|||
129097631|NCT02360475|464648664|FG003|Overall Study|Withdrawal by Subject|0|||
129097632|NCT02360475|464648661|FG000|Overall Study|Migrated/moved from study area|0|||
129097633|NCT02360475|464648662|FG001|Overall Study|Migrated/moved from study area|0|||
129097634|NCT02360475|464648663|FG002|Overall Study|Migrated/moved from study area|0|||
129097635|NCT02360475|464648664|FG003|Overall Study|Migrated/moved from study area|1|||
129097636|NCT03759366|464648666|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
129097637|NCT03759366|464648666|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
129097638|NCT03759366|464648666|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
129097639|NCT03759366|464648666|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
129097640|NCT03759366|464648666|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
129097641|NCT03759366|464648666|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
129097642|NCT03759366|464648666|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
129097643|NCT00539032|464648670|FG000|Overall Study|Withdrawal by Subject|2|||
129097644|NCT00539032|464648671|FG001|Overall Study|Withdrawal by Subject|1|||
129097645|NCT00435019|464648672|FG000|Overall Study|Adverse Event|1|||
129097646|NCT00435019|464648673|FG001|Overall Study|Adverse Event|0|||
129097647|NCT00435019|464648672|FG000|Overall Study|Lack of Efficacy|1|||
129097648|NCT00435019|464648673|FG001|Overall Study|Lack of Efficacy|2|||
129097649|NCT00435019|464648672|FG000|Overall Study|Protocol Violation|3|||
129097650|NCT00435019|464648673|FG001|Overall Study|Protocol Violation|1|||
129097651|NCT00435019|464648672|FG000|Overall Study|Personal reasons for withdrawal|8|||
129097652|NCT00435019|464648673|FG001|Overall Study|Personal reasons for withdrawal|7|||
129097653|NCT01764659|464648679|FG000|Overall Study|Death|1|||
129097654|NCT01764659|464648679|FG000|Overall Study|Physician Decision|1|||
129097655|NCT01210352|464648680|FG000|Overall Study|Adverse Event|0|||
129097656|NCT01210352|464648681|FG001|Overall Study|Adverse Event|0|||
129097657|NCT01210352|464648682|FG002|Overall Study|Adverse Event|0|||
129097658|NCT01210352|464648683|FG003|Overall Study|Adverse Event|0|||
129097659|NCT01210352|464648684|FG004|Overall Study|Adverse Event|0|||
129097660|NCT01210352|464648685|FG005|Overall Study|Adverse Event|0|||
129097661|NCT01210352|464648686|FG006|Overall Study|Adverse Event|0|||
129097662|NCT01210352|464648687|FG007|Overall Study|Adverse Event|2|||
129097663|NCT01210352|464648688|FG008|Overall Study|Adverse Event|1|||
129097664|NCT01210352|464648680|FG000|Overall Study|Lack of Efficacy|0|||
129097665|NCT01210352|464648681|FG001|Overall Study|Lack of Efficacy|0|||
129097666|NCT01210352|464648682|FG002|Overall Study|Lack of Efficacy|0|||
129097667|NCT01210352|464648683|FG003|Overall Study|Lack of Efficacy|0|||
129097668|NCT01210352|464648684|FG004|Overall Study|Lack of Efficacy|0|||
129097669|NCT01210352|464648685|FG005|Overall Study|Lack of Efficacy|0|||
129097670|NCT01210352|464648686|FG006|Overall Study|Lack of Efficacy|1|||
129097671|NCT01210352|464648687|FG007|Overall Study|Lack of Efficacy|0|||
129097672|NCT01210352|464648688|FG008|Overall Study|Lack of Efficacy|0|||
129097673|NCT01210352|464648680|FG000|Overall Study|Physician Decision|0|||
129097674|NCT01210352|464648681|FG001|Overall Study|Physician Decision|0|||
129097675|NCT01210352|464648682|FG002|Overall Study|Physician Decision|0|||
129097676|NCT01210352|464648683|FG003|Overall Study|Physician Decision|0|||
129097677|NCT01210352|464648684|FG004|Overall Study|Physician Decision|0|||
129097678|NCT01210352|464648685|FG005|Overall Study|Physician Decision|0|||
129097679|NCT01210352|464648686|FG006|Overall Study|Physician Decision|0|||
129097680|NCT01210352|464648687|FG007|Overall Study|Physician Decision|1|||
129097681|NCT01210352|464648688|FG008|Overall Study|Physician Decision|2|||
129097682|NCT01210352|464648680|FG000|Overall Study|Withdrawal by Subject|0|||
129097683|NCT01210352|464648681|FG001|Overall Study|Withdrawal by Subject|0|||
129097684|NCT01210352|464648682|FG002|Overall Study|Withdrawal by Subject|1|||
129097685|NCT01210352|464648683|FG003|Overall Study|Withdrawal by Subject|0|||
129097686|NCT01210352|464648684|FG004|Overall Study|Withdrawal by Subject|0|||
129097687|NCT01210352|464648685|FG005|Overall Study|Withdrawal by Subject|0|||
129097688|NCT01210352|464648686|FG006|Overall Study|Withdrawal by Subject|1|||
129097689|NCT01210352|464648687|FG007|Overall Study|Withdrawal by Subject|0|||
129097690|NCT01210352|464648688|FG008|Overall Study|Withdrawal by Subject|1|||
129097691|NCT01210352|464648680|FG000|Overall Study|Patient Discharged Early|0|||
129097692|NCT01210352|464648681|FG001|Overall Study|Patient Discharged Early|0|||
129097693|NCT01210352|464648682|FG002|Overall Study|Patient Discharged Early|1|||
129097694|NCT01210352|464648683|FG003|Overall Study|Patient Discharged Early|0|||
129097695|NCT01210352|464648684|FG004|Overall Study|Patient Discharged Early|0|||
129097696|NCT01210352|464648685|FG005|Overall Study|Patient Discharged Early|0|||
129097697|NCT01210352|464648686|FG006|Overall Study|Patient Discharged Early|0|||
129097698|NCT01210352|464648687|FG007|Overall Study|Patient Discharged Early|0|||
129097699|NCT01210352|464648688|FG008|Overall Study|Patient Discharged Early|0|||
129097700|NCT00422292|464648689|FG000|Overall Study|Serious adverse events|1|||
129097701|NCT00422292|464648690|FG001|Overall Study|Serious adverse events|4|||
129097702|NCT00422292|464648691|FG002|Overall Study|Serious adverse events|0|||
129097703|NCT00422292|464648692|FG003|Overall Study|Serious adverse events|0|||
129097704|NCT00422292|464648689|FG000|Overall Study|Adverse Event|1|||
129097705|NCT00422292|464648690|FG001|Overall Study|Adverse Event|0|||
129097706|NCT00422292|464648691|FG002|Overall Study|Adverse Event|1|||
129097707|NCT00422292|464648692|FG003|Overall Study|Adverse Event|0|||
129097708|NCT00422292|464648689|FG000|Overall Study|Protocol Violation|4|||
129097709|NCT00422292|464648690|FG001|Overall Study|Protocol Violation|25|||
129097710|NCT00422292|464648691|FG002|Overall Study|Protocol Violation|8|||
129097711|NCT00422292|464648692|FG003|Overall Study|Protocol Violation|5|||
129097712|NCT00422292|464648689|FG000|Overall Study|Lost to Follow-up|6|||
129097713|NCT00422292|464648690|FG001|Overall Study|Lost to Follow-up|12|||
129097714|NCT00422292|464648691|FG002|Overall Study|Lost to Follow-up|6|||
129097715|NCT00422292|464648692|FG003|Overall Study|Lost to Follow-up|6|||
129097716|NCT00422292|464648689|FG000|Overall Study|Withdrawal by Subject|6|||
129097717|NCT00422292|464648690|FG001|Overall Study|Withdrawal by Subject|25|||
129097718|NCT00422292|464648691|FG002|Overall Study|Withdrawal by Subject|7|||
129097719|NCT00422292|464648692|FG003|Overall Study|Withdrawal by Subject|13|||
129097720|NCT02440854|464648693|FG000|Overall Study|Relocation of patient|1|||
129097721|NCT02440854|464648693|FG000|Overall Study|Death|6|||
129097722|NCT02440854|464648693|FG000|Overall Study|Lost to Follow-up|10|||
129097723|NCT02440854|464648693|FG000|Overall Study|Afatinib discontinuation|46|||
129097724|NCT02440854|464648693|FG000|Overall Study|stopped study at earlier timepoint|14|||
129097725|NCT02440854|464648693|FG000|Overall Study|Study medication not received|1|||
129097726|NCT02440854|464648693|FG000|Overall Study|Violation of inclusion criteria|2|||
129097727|NCT02243046|464648694|FG000|Overall Study|Lost to Follow-up|1|||
129097728|NCT02243046|464648695|FG001|Overall Study|Lost to Follow-up|1|||
129097729|NCT02243046|464648696|FG002|Overall Study|Lost to Follow-up|4|||
129097730|NCT03338569|464648697|FG000|Overall Study|Physician Decision|8|||
129097731|NCT03338569|464648698|FG001|Overall Study|Physician Decision|3|||
129097732|NCT03338569|464648697|FG000|Overall Study|Withdrawal by Subject|0|||
129097733|NCT03338569|464648698|FG001|Overall Study|Withdrawal by Subject|1|||
129097734|NCT03338569|464648697|FG000|Overall Study|Lost to Follow-up|0|||
129097735|NCT03338569|464648698|FG001|Overall Study|Lost to Follow-up|1|||
129097736|NCT02669082|464648699|FG000|Overall Study|Adverse Event|1|||
129097737|NCT04852276|464648700|FG000|Overall Study|Death|2|||
129097738|NCT04852276|464648701|FG001|Overall Study|Death|0|||
129097739|NCT04852276|464648700|FG000|Overall Study|Lost to Follow-up|15|||
129097740|NCT04852276|464648701|FG001|Overall Study|Lost to Follow-up|9|||
129097741|NCT04852276|464648700|FG000|Overall Study|Withdrawal by Subject|26|||
129097742|NCT04852276|464648701|FG001|Overall Study|Withdrawal by Subject|6|||
129097743|NCT02824562|464650621|FG000|Overall Study|Lost to Follow-up|3|||
129097744|NCT02824562|464650622|FG001|Overall Study|Lost to Follow-up|4|||
129097745|NCT02824562|464650621|FG000|Overall Study|Death|0|||
129097746|NCT02824562|464650622|FG001|Overall Study|Death|1|||
129097747|NCT02168777|464650623|FG000|Overall Study|Withdrawal by Subject|1|||
129097748|NCT02168777|464650624|FG001|Overall Study|Withdrawal by Subject|0|||
129097749|NCT02168777|464650625|FG002|Overall Study|Withdrawal by Subject|2|||
129097750|NCT02168777|464650623|FG000|Overall Study|Adverse Event|1|||
129097751|NCT02168777|464650624|FG001|Overall Study|Adverse Event|0|||
129097752|NCT02168777|464650625|FG002|Overall Study|Adverse Event|1|||
129097753|NCT02168777|464650623|FG000|Overall Study|Disease recurrence|0|||
129097754|NCT02168777|464650624|FG001|Overall Study|Disease recurrence|0|||
129097755|NCT02168777|464650625|FG002|Overall Study|Disease recurrence|1|||
129097756|NCT02168777|464650623|FG000|Overall Study|Radiological disease progression|0|||
129097757|NCT02168777|464650624|FG001|Overall Study|Radiological disease progression|5|||
129097758|NCT02168777|464650625|FG002|Overall Study|Radiological disease progression|5|||
129097759|NCT02168777|464650623|FG000|Overall Study|Clinical disease progression|0|||
129097760|NCT02168777|464650624|FG001|Overall Study|Clinical disease progression|1|||
129097761|NCT02168777|464650625|FG002|Overall Study|Clinical disease progression|2|||
129097762|NCT02168777|464650623|FG000|Overall Study|Other reason|0|||
129097763|NCT02168777|464650624|FG001|Overall Study|Other reason|1|||
129097764|NCT02168777|464650625|FG002|Overall Study|Other reason|0|||
129097765|NCT05243563|464650626|FG000|Overall Study|Withdrawal by Subject|1|||
129097766|NCT05243563|464650627|FG001|Overall Study|Withdrawal by Subject|0|||
129097767|NCT05243563|464650626|FG000|Overall Study|Physician Decision|1|||
129097768|NCT05243563|464650627|FG001|Overall Study|Physician Decision|0|||
129097769|NCT01066793|464650628|FG000|Overall Study|Death|4|||
129097770|NCT01066793|464650629|FG001|Overall Study|Death|1|||
129097771|NCT01066793|464650630|FG002|Overall Study|Death|1|||
129097772|NCT01066793|464650631|FG003|Overall Study|Death|0|||
129097773|NCT01066793|464650632|FG004|Overall Study|Death|0|||
129097774|NCT01066793|464650633|FG005|Overall Study|Death|0|||
129097775|NCT01066793|464650628|FG000|Overall Study|Lack of Efficacy|2|||
129097776|NCT01066793|464650629|FG001|Overall Study|Lack of Efficacy|1|||
129097777|NCT01066793|464650630|FG002|Overall Study|Lack of Efficacy|0|||
129097778|NCT01066793|464650631|FG003|Overall Study|Lack of Efficacy|0|||
129097779|NCT01066793|464650632|FG004|Overall Study|Lack of Efficacy|0|||
129097780|NCT01066793|464650633|FG005|Overall Study|Lack of Efficacy|0|||
129097781|NCT01066793|464650628|FG000|Overall Study|Lost to Follow-up|180|||
129097782|NCT01066793|464650629|FG001|Overall Study|Lost to Follow-up|39|||
129097783|NCT01066793|464650630|FG002|Overall Study|Lost to Follow-up|82|||
129097784|NCT01066793|464650631|FG003|Overall Study|Lost to Follow-up|16|||
129097785|NCT01066793|464650632|FG004|Overall Study|Lost to Follow-up|0|||
129097786|NCT01066793|464650633|FG005|Overall Study|Lost to Follow-up|1|||
129097787|NCT01066793|464650628|FG000|Overall Study|Physician Decision|3|||
129097788|NCT01066793|464650629|FG001|Overall Study|Physician Decision|0|||
129097789|NCT01066793|464650630|FG002|Overall Study|Physician Decision|0|||
129097790|NCT01066793|464650631|FG003|Overall Study|Physician Decision|0|||
129097791|NCT01066793|464650632|FG004|Overall Study|Physician Decision|0|||
129097792|NCT01066793|464650633|FG005|Overall Study|Physician Decision|0|||
129097793|NCT01066793|464650628|FG000|Overall Study|Protocol Violation|3|||
129097794|NCT01066793|464650629|FG001|Overall Study|Protocol Violation|2|||
129097795|NCT01066793|464650630|FG002|Overall Study|Protocol Violation|2|||
129097796|NCT01066793|464650631|FG003|Overall Study|Protocol Violation|0|||
129097797|NCT01066793|464650632|FG004|Overall Study|Protocol Violation|0|||
129097798|NCT01066793|464650633|FG005|Overall Study|Protocol Violation|0|||
129097799|NCT01066793|464650628|FG000|Overall Study|Withdrawal by Subject|7|||
129097800|NCT01066793|464650629|FG001|Overall Study|Withdrawal by Subject|4|||
129097801|NCT01066793|464650630|FG002|Overall Study|Withdrawal by Subject|1|||
129097802|NCT01066793|464650631|FG003|Overall Study|Withdrawal by Subject|0|||
129097803|NCT01066793|464650632|FG004|Overall Study|Withdrawal by Subject|0|||
129097804|NCT01066793|464650633|FG005|Overall Study|Withdrawal by Subject|0|||
129097805|NCT01066793|464650628|FG000|Overall Study|Early Termination|3|||
129097806|NCT01066793|464650629|FG001|Overall Study|Early Termination|0|||
129097807|NCT01066793|464650630|FG002|Overall Study|Early Termination|0|||
129097808|NCT01066793|464650631|FG003|Overall Study|Early Termination|0|||
129097809|NCT01066793|464650632|FG004|Overall Study|Early Termination|0|||
129097810|NCT01066793|464650633|FG005|Overall Study|Early Termination|0|||
129097811|NCT01066793|464650628|FG000|Overall Study|Lab test not done|7|||
129097812|NCT01066793|464650629|FG001|Overall Study|Lab test not done|0|||
129097813|NCT01066793|464650630|FG002|Overall Study|Lab test not done|0|||
129097814|NCT01066793|464650631|FG003|Overall Study|Lab test not done|1|||
129097815|NCT01066793|464650632|FG004|Overall Study|Lab test not done|0|||
129097816|NCT01066793|464650633|FG005|Overall Study|Lab test not done|0|||
129097817|NCT01066793|464650628|FG000|Overall Study|Miscellaneous|4|||
129097818|NCT01066793|464650629|FG001|Overall Study|Miscellaneous|5|||
129097819|NCT01066793|464650630|FG002|Overall Study|Miscellaneous|6|||
129097820|NCT01066793|464650631|FG003|Overall Study|Miscellaneous|0|||
129097821|NCT01066793|464650632|FG004|Overall Study|Miscellaneous|0|||
129097822|NCT01066793|464650633|FG005|Overall Study|Miscellaneous|0|||
129097823|NCT01066793|464650628|FG000|Overall Study|Non-responders|104|||
129097824|NCT01066793|464650629|FG001|Overall Study|Non-responders|5|||
129097825|NCT01066793|464650630|FG002|Overall Study|Non-responders|11|||
129097826|NCT01066793|464650631|FG003|Overall Study|Non-responders|25|||
129097827|NCT01066793|464650632|FG004|Overall Study|Non-responders|0|||
129097828|NCT01066793|464650633|FG005|Overall Study|Non-responders|0|||
129097829|NCT01066793|464650628|FG000|Overall Study|Other|15|||
129097830|NCT01066793|464650629|FG001|Overall Study|Other|5|||
129097831|NCT01066793|464650630|FG002|Overall Study|Other|6|||
129097832|NCT01066793|464650631|FG003|Overall Study|Other|2|||
129097833|NCT01066793|464650632|FG004|Overall Study|Other|0|||
129097834|NCT01066793|464650633|FG005|Overall Study|Other|0|||
129097835|NCT01066793|464650628|FG000|Overall Study|Relapse|20|||
129097836|NCT01066793|464650629|FG001|Overall Study|Relapse|8|||
129097837|NCT01066793|464650630|FG002|Overall Study|Relapse|2|||
129097838|NCT01066793|464650631|FG003|Overall Study|Relapse|3|||
129097839|NCT01066793|464650632|FG004|Overall Study|Relapse|0|||
129097840|NCT01066793|464650633|FG005|Overall Study|Relapse|0|||
129097841|NCT01066793|464650628|FG000|Overall Study|Result Not Available|1|||
129097842|NCT01066793|464650629|FG001|Overall Study|Result Not Available|0|||
129097843|NCT01066793|464650630|FG002|Overall Study|Result Not Available|0|||
129097844|NCT01066793|464650631|FG003|Overall Study|Result Not Available|0|||
129097845|NCT01066793|464650632|FG004|Overall Study|Result Not Available|0|||
129097846|NCT01066793|464650633|FG005|Overall Study|Result Not Available|0|||
129097847|NCT01066793|464650628|FG000|Overall Study|Treatment Interrupted|1|||
129097848|NCT01066793|464650629|FG001|Overall Study|Treatment Interrupted|1|||
129097849|NCT01066793|464650630|FG002|Overall Study|Treatment Interrupted|0|||
129097850|NCT01066793|464650631|FG003|Overall Study|Treatment Interrupted|0|||
129097851|NCT01066793|464650632|FG004|Overall Study|Treatment Interrupted|0|||
129097852|NCT01066793|464650633|FG005|Overall Study|Treatment Interrupted|0|||
129097853|NCT01066793|464650628|FG000|Overall Study|Treatment Never Started|18|||
129097854|NCT01066793|464650629|FG001|Overall Study|Treatment Never Started|5|||
129097855|NCT01066793|464650630|FG002|Overall Study|Treatment Never Started|4|||
129097856|NCT01066793|464650631|FG003|Overall Study|Treatment Never Started|1|||
129097857|NCT01066793|464650632|FG004|Overall Study|Treatment Never Started|0|||
129097858|NCT01066793|464650633|FG005|Overall Study|Treatment Never Started|0|||
129097859|NCT01066793|464650628|FG000|Overall Study|Treatment Stopped|2|||
129097860|NCT01066793|464650629|FG001|Overall Study|Treatment Stopped|1|||
129097861|NCT01066793|464650630|FG002|Overall Study|Treatment Stopped|0|||
129097862|NCT01066793|464650631|FG003|Overall Study|Treatment Stopped|1|||
129097863|NCT01066793|464650632|FG004|Overall Study|Treatment Stopped|0|||
129097864|NCT01066793|464650633|FG005|Overall Study|Treatment Stopped|0|||
129097865|NCT01698268|464650637|FG000|Overall Study|Physician Decision|2|||
129097866|NCT01698268|464650638|FG001|Overall Study|Physician Decision|1|||
129097867|NCT00298363|464650639|FG000|Overall Study|Lost to Follow-up|0|||
129097868|NCT00298363|464650640|FG001|Overall Study|Lost to Follow-up|0|||
129097869|NCT00298363|464650641|FG002|Overall Study|Lost to Follow-up|1|||
129097870|NCT00298363|464650639|FG000|Overall Study|Physician Decision|4|||
129097871|NCT00298363|464650640|FG001|Overall Study|Physician Decision|1|||
129097872|NCT00298363|464650641|FG002|Overall Study|Physician Decision|0|||
129097873|NCT00298363|464650639|FG000|Overall Study|Protocol Violation|1|||
129097874|NCT00298363|464650640|FG001|Overall Study|Protocol Violation|1|||
129097875|NCT00298363|464650641|FG002|Overall Study|Protocol Violation|0|||
129097876|NCT00298363|464650639|FG000|Overall Study|Withdrawal by Subject|5|||
129097877|NCT00298363|464650640|FG001|Overall Study|Withdrawal by Subject|1|||
129097878|NCT00298363|464650641|FG002|Overall Study|Withdrawal by Subject|3|||
129097879|NCT00298363|464650639|FG000|Overall Study|Adverse Event|5|||
129097880|NCT00298363|464650640|FG001|Overall Study|Adverse Event|2|||
129097881|NCT00298363|464650641|FG002|Overall Study|Adverse Event|2|||
129097882|NCT00298363|464650639|FG000|Overall Study|Lack of Efficacy|2|||
129097883|NCT00298363|464650640|FG001|Overall Study|Lack of Efficacy|3|||
129097884|NCT00298363|464650641|FG002|Overall Study|Lack of Efficacy|0|||
129097885|NCT04710368|464650642|FG000|Overall Study|Withdrawal by Subject|9|||
129097886|NCT04710368|464650642|FG000|Overall Study|Lost to Follow-up|4|||
129097887|NCT04710368|464650642|FG000|Overall Study|Death|2|||
129097888|NCT04710368|464650642|FG000|Overall Study|Patient preference|11|||
129097889|NCT04710368|464650642|FG000|Overall Study|Treatment discontinuation|1|||
129097890|NCT00135356|464650643|FG000|Overall Study|Adverse Event|6|||
129097891|NCT00135356|464650644|FG001|Overall Study|Adverse Event|2|||
129097892|NCT00135356|464650643|FG000|Overall Study|Lack of Efficacy|2|||
129097893|NCT00135356|464650644|FG001|Overall Study|Lack of Efficacy|0|||
129097894|NCT00135356|464650643|FG000|Overall Study|Lost to Follow-up|3|||
129097895|NCT00135356|464650644|FG001|Overall Study|Lost to Follow-up|1|||
129097896|NCT00135356|464650643|FG000|Overall Study|Surgery for abdominal fat|1|||
129097897|NCT00135356|464650644|FG001|Overall Study|Surgery for abdominal fat|0|||
129097898|NCT00135356|464650643|FG000|Overall Study|Change in antiviral regimen|0|||
129097899|NCT00135356|464650644|FG001|Overall Study|Change in antiviral regimen|1|||
129097900|NCT00135356|464650643|FG000|Overall Study|Poor/noncompliance|1|||
129097901|NCT00135356|464650644|FG001|Overall Study|Poor/noncompliance|1|||
129097902|NCT00135356|464650643|FG000|Overall Study|No longer meets study criteria|2|||
129097903|NCT00135356|464650644|FG001|Overall Study|No longer meets study criteria|0|||
129097904|NCT00135356|464650643|FG000|Overall Study|Withdrawal by Subject|2|||
129097905|NCT00135356|464650644|FG001|Overall Study|Withdrawal by Subject|4|||
129097906|NCT00153816|464650645|FG000|Overall Study|Death|6|||
129097907|NCT00153816|464650646|FG001|Overall Study|Death|5|||
129097908|NCT00153816|464650647|FG002|Overall Study|Death|4|||
129097909|NCT00153816|464650648|FG003|Overall Study|Death|6|||
129097910|NCT00153816|464650649|FG004|Overall Study|Death|0|||
129097911|NCT00153816|464650650|FG005|Overall Study|Death|2|||
129097912|NCT00153816|464650645|FG000|Overall Study|Lost to Follow-up|7|||
129097913|NCT00153816|464650646|FG001|Overall Study|Lost to Follow-up|8|||
129097914|NCT00153816|464650647|FG002|Overall Study|Lost to Follow-up|5|||
129097915|NCT00153816|464650648|FG003|Overall Study|Lost to Follow-up|8|||
129097916|NCT00153816|464650649|FG004|Overall Study|Lost to Follow-up|7|||
129097917|NCT00153816|464650650|FG005|Overall Study|Lost to Follow-up|9|||
129097918|NCT00153816|464650645|FG000|Overall Study|Withdrawal by Subject|9|||
129097919|NCT00153816|464650646|FG001|Overall Study|Withdrawal by Subject|9|||
129097920|NCT00153816|464650647|FG002|Overall Study|Withdrawal by Subject|9|||
129097921|NCT00153816|464650648|FG003|Overall Study|Withdrawal by Subject|4|||
129097922|NCT00153816|464650649|FG004|Overall Study|Withdrawal by Subject|1|||
129097923|NCT00153816|464650650|FG005|Overall Study|Withdrawal by Subject|5|||
129097924|NCT00153816|464650645|FG000|Overall Study|Follow-up exam not done|8|||
129097925|NCT00153816|464650646|FG001|Overall Study|Follow-up exam not done|7|||
129097926|NCT00153816|464650647|FG002|Overall Study|Follow-up exam not done|11|||
129097927|NCT00153816|464650648|FG003|Overall Study|Follow-up exam not done|10|||
129097928|NCT00153816|464650649|FG004|Overall Study|Follow-up exam not done|8|||
129097929|NCT00153816|464650650|FG005|Overall Study|Follow-up exam not done|9|||
129097930|NCT00153816|464650645|FG000|Overall Study|Follow-up exam done, histology missing|2|||
129097931|NCT00153816|464650646|FG001|Overall Study|Follow-up exam done, histology missing|3|||
129097932|NCT00153816|464650647|FG002|Overall Study|Follow-up exam done, histology missing|3|||
129097933|NCT00153816|464650648|FG003|Overall Study|Follow-up exam done, histology missing|3|||
129097934|NCT00153816|464650649|FG004|Overall Study|Follow-up exam done, histology missing|1|||
129097935|NCT00153816|464650650|FG005|Overall Study|Follow-up exam done, histology missing|2|||
129097936|NCT01533688|464650651|FG000|Overall Study|Withdrawal by Subject|5|||
129097937|NCT01533688|464650652|FG001|Overall Study|Withdrawal by Subject|4|||
129097938|NCT01533688|464650653|FG002|Overall Study|Withdrawal by Subject|3|||
129097939|NCT01533688|464650651|FG000|Overall Study|Medically unstable|1|||
129097940|NCT01533688|464650652|FG001|Overall Study|Medically unstable|3|||
129097941|NCT01533688|464650653|FG002|Overall Study|Medically unstable|3|||
129097942|NCT01533688|464650651|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
129097943|NCT01533688|464650652|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
129097944|NCT01533688|464650653|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
129097945|NCT02509078|464650658|FG000|Overall Study|Protocol Violation|1|||
129097946|NCT02509078|464650659|FG001|Overall Study|Protocol Violation|1|||
129097947|NCT00253370|464650660|FG000|Overall Study|Adverse Event|18|||
129097948|NCT00253370|464650660|FG000|Overall Study|Disease progression|13|||
129097949|NCT00253370|464650660|FG000|Overall Study|Death|2|||
129097950|NCT00253370|464650660|FG000|Overall Study|Withdrawal by Subject|6|||
129097951|NCT00253370|464650660|FG000|Overall Study|Non-protocol therapy|1|||
129097952|NCT00253370|464650660|FG000|Overall Study|Physician Decision|1|||
129097953|NCT00253370|464650660|FG000|Overall Study|Protocol Violation|1|||
129097954|NCT00253370|464650660|FG000|Overall Study|Abdominal pain due to disease|1|||
129097955|NCT05916131|464650661|FG000|Overall Study|Lost to Follow-up|0|||
129097956|NCT05916131|464650662|FG001|Overall Study|Lost to Follow-up|0|||
129097957|NCT05916131|464650663|FG002|Overall Study|Lost to Follow-up|1|||
129097958|NCT05916131|464650664|FG003|Overall Study|Lost to Follow-up|0|||
129097959|NCT00904839|464650667|FG000|Overall Study|Adverse Event|0|||
129097960|NCT00904839|464650668|FG001|Overall Study|Adverse Event|5|||
129097961|NCT00904839|464650669|FG002|Overall Study|Adverse Event|4|||
129097962|NCT00904839|464650667|FG000|Overall Study|Protocol Violation|0|||
129097963|NCT00904839|464650668|FG001|Overall Study|Protocol Violation|1|||
129097964|NCT00904839|464650669|FG002|Overall Study|Protocol Violation|1|||
129097965|NCT00904839|464650667|FG000|Overall Study|Lost to Follow-up|0|||
129097966|NCT00904839|464650668|FG001|Overall Study|Lost to Follow-up|1|||
129097967|NCT00904839|464650669|FG002|Overall Study|Lost to Follow-up|2|||
129097968|NCT00904839|464650667|FG000|Overall Study|Withdrawal by Subject|0|||
129097969|NCT00904839|464650668|FG001|Overall Study|Withdrawal by Subject|2|||
129097970|NCT00904839|464650669|FG002|Overall Study|Withdrawal by Subject|0|||
129097971|NCT00904839|464650667|FG000|Overall Study|Not treated|1|||
129097972|NCT00904839|464650668|FG001|Overall Study|Not treated|0|||
129097973|NCT00904839|464650669|FG002|Overall Study|Not treated|1|||
129097974|NCT00904839|464650667|FG000|Overall Study|Other than above|0|||
129097975|NCT00904839|464650668|FG001|Overall Study|Other than above|9|||
129097976|NCT00904839|464650669|FG002|Overall Study|Other than above|7|||
129097977|NCT00553358|464650672|FG000|Overall Study|Randomized but did not receive treatment|3|||
129097978|NCT00553358|464650673|FG001|Overall Study|Randomized but did not receive treatment|3|||
129097979|NCT00553358|464650674|FG002|Overall Study|Randomized but did not receive treatment|1|||
129097980|NCT00553358|464650672|FG000|Overall Study|Lost to Follow-up|22|||
129097981|NCT00553358|464650673|FG001|Overall Study|Lost to Follow-up|26|||
129097982|NCT00553358|464650674|FG002|Overall Study|Lost to Follow-up|18|||
129097983|NCT00553358|464650672|FG000|Overall Study|Withdrew completely|23|||
129097984|NCT00553358|464650673|FG001|Overall Study|Withdrew completely|33|||
129097985|NCT00553358|464650674|FG002|Overall Study|Withdrew completely|34|||
129097986|NCT00553358|464650672|FG000|Overall Study|Died during clinical follow-up|25|||
129097987|NCT00553358|464650673|FG001|Overall Study|Died during clinical follow-up|29|||
129097988|NCT00553358|464650674|FG002|Overall Study|Died during clinical follow-up|32|||
129097989|NCT00553358|464650672|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
129097990|NCT00553358|464650673|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
129097991|NCT00553358|464650674|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
129097992|NCT00553358|464650672|FG000|Overall Study|Died after clinical follow-up ended|1|||
129097993|NCT00553358|464650673|FG001|Overall Study|Died after clinical follow-up ended|2|||
129097994|NCT00553358|464650674|FG002|Overall Study|Died after clinical follow-up ended|0|||
129097995|NCT00553358|464650672|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
129097996|NCT00553358|464650673|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
129097997|NCT00553358|464650674|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
129097998|NCT05268016|464650676|FG000|Overall Study|Unacceptable toxicity or AE|2|||
129097999|NCT05268016|464650677|FG001|Overall Study|Unacceptable toxicity or AE|2|||
129098000|NCT05268016|464650678|FG002|Overall Study|Unacceptable toxicity or AE|4|||
129098001|NCT05268016|464650679|FG003|Overall Study|Unacceptable toxicity or AE|3|||
129098002|NCT05268016|464650680|FG004|Overall Study|Unacceptable toxicity or AE|1|||
129098003|NCT05268016|464650676|FG000|Overall Study|Withdrawal by Subject|1|||
129098004|NCT05268016|464650677|FG001|Overall Study|Withdrawal by Subject|3|||
129098005|NCT05268016|464650678|FG002|Overall Study|Withdrawal by Subject|2|||
129098006|NCT05268016|464650679|FG003|Overall Study|Withdrawal by Subject|2|||
129098007|NCT05268016|464650680|FG004|Overall Study|Withdrawal by Subject|1|||
129098008|NCT05268016|464650676|FG000|Overall Study|Lost to Follow-up|4|||
129098009|NCT05268016|464650677|FG001|Overall Study|Lost to Follow-up|7|||
129098010|NCT05268016|464650678|FG002|Overall Study|Lost to Follow-up|1|||
129098011|NCT05268016|464650679|FG003|Overall Study|Lost to Follow-up|3|||
129098012|NCT05268016|464650680|FG004|Overall Study|Lost to Follow-up|5|||
129098013|NCT05268016|464650676|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
129098014|NCT05268016|464650677|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
129098015|NCT05268016|464650678|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
129098016|NCT05268016|464650679|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
129098017|NCT05268016|464650680|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
129098018|NCT05268016|464650676|FG000|Overall Study|Lack of Efficacy|0|||
129098019|NCT05268016|464650677|FG001|Overall Study|Lack of Efficacy|0|||
129098020|NCT05268016|464650678|FG002|Overall Study|Lack of Efficacy|0|||
129098021|NCT05268016|464650679|FG003|Overall Study|Lack of Efficacy|0|||
129098022|NCT05268016|464650680|FG004|Overall Study|Lack of Efficacy|4|||
129098023|NCT05268016|464650676|FG000|Overall Study|Physician Decision|0|||
129098024|NCT05268016|464650677|FG001|Overall Study|Physician Decision|0|||
129098025|NCT05268016|464650678|FG002|Overall Study|Physician Decision|0|||
129098026|NCT05268016|464650679|FG003|Overall Study|Physician Decision|1|||
129098027|NCT05268016|464650680|FG004|Overall Study|Physician Decision|0|||
129098028|NCT05268016|464650676|FG000|Overall Study|Other|1|||
129098029|NCT05268016|464650677|FG001|Overall Study|Other|0|||
129098030|NCT05268016|464650678|FG002|Overall Study|Other|1|||
129098031|NCT05268016|464650679|FG003|Overall Study|Other|2|||
129098032|NCT05268016|464650680|FG004|Overall Study|Other|0|||
129098033|NCT00404924|464650681|FG000|Overall Study|Adverse Event|75|||
129098034|NCT00404924|464650682|FG001|Overall Study|Adverse Event|16|||
129098035|NCT00404924|464650681|FG000|Overall Study|Condition under investigation worsened|475|||
129098036|NCT00404924|464650682|FG001|Overall Study|Condition under investigation worsened|264|||
129098037|NCT00404924|464650681|FG000|Overall Study|Lost to Follow-up|1|||
129098038|NCT00404924|464650682|FG001|Overall Study|Lost to Follow-up|1|||
129098039|NCT00404924|464650681|FG000|Overall Study|Withdrawal by Subject|26|||
129098040|NCT00404924|464650682|FG001|Overall Study|Withdrawal by Subject|13|||
129098041|NCT00404924|464650681|FG000|Overall Study|Other|25|||
129098042|NCT00404924|464650682|FG001|Overall Study|Other|11|||
129098043|NCT00404924|464650681|FG000|Overall Study|Randomised but not received treatment|1|||
129098044|NCT00404924|464650682|FG001|Overall Study|Randomised but not received treatment|1|||
129098045|NCT00187278|464650691|FG000|Overall Study|Protocol Violation|10|||
129098046|NCT00187278|464650692|FG001|Overall Study|Protocol Violation|13|||
129098047|NCT00803205|464650693|FG000|Overall Study|Adverse Event|7|||
129098048|NCT00803205|464650694|FG001|Overall Study|Adverse Event|2|||
129098049|NCT00803205|464650693|FG000|Overall Study|Lost to Follow-up|1|||
129098050|NCT00803205|464650694|FG001|Overall Study|Lost to Follow-up|0|||
129098051|NCT00803205|464650693|FG000|Overall Study|Withdrawal by Subject|9|||
129098052|NCT00803205|464650694|FG001|Overall Study|Withdrawal by Subject|9|||
129098053|NCT00803205|464650693|FG000|Overall Study|Physician Decision|1|||
129098054|NCT00803205|464650694|FG001|Overall Study|Physician Decision|0|||
129098055|NCT00803205|464650693|FG000|Overall Study|Protocol Violation|1|||
129098056|NCT00803205|464650694|FG001|Overall Study|Protocol Violation|1|||
129098057|NCT00803205|464650693|FG000|Overall Study|Medical Monitor Decision|1|||
129098058|NCT00803205|464650694|FG001|Overall Study|Medical Monitor Decision|0|||
129098059|NCT00803205|464650693|FG000|Overall Study|Acquired a Lung Infection|0|||
129098060|NCT00803205|464650694|FG001|Overall Study|Acquired a Lung Infection|1|||
129098061|NCT00803205|464650693|FG000|Overall Study|Sponsor Decision|0|||
129098062|NCT00803205|464650694|FG001|Overall Study|Sponsor Decision|1|||
129098063|NCT00270231|464650696|FG000|First Intervention|Lost to Follow-up|1|||
129098064|NCT00270231|464650697|FG001|First Intervention|Lost to Follow-up|1|||
129098065|NCT00270231|464650696|FG000|Washout Period|Lost to Follow-up|1|||
129098066|NCT00270231|464650697|FG001|Washout Period|Lost to Follow-up|0|||
129098067|NCT00270231|464650696|FG000|Second Intervention|Lost to Follow-up|0|||
129098068|NCT00270231|464650697|FG001|Second Intervention|Lost to Follow-up|1|||
129098069|NCT02735096|464650698|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
129098070|NCT00379808|464650699|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
129098071|NCT00379808|464650700|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
129098072|NCT04299048|464650706|FG000|Overall Study|Death|1|||
129098073|NCT04299048|464650706|FG000|Overall Study|Global deterioration of health status|2|||
129098074|NCT04299048|464650706|FG000|Overall Study|Enrolled and not treated|1|||
129098075|NCT00508157|464650708|FG000|Overall Study|Adverse Event|0|||
129098076|NCT00508157|464650709|FG001|Overall Study|Adverse Event|1|||
129098077|NCT00508157|464650708|FG000|Overall Study|Subject Withdrew Consent|1|||
129098078|NCT00508157|464650709|FG001|Overall Study|Subject Withdrew Consent|0|||
129098079|NCT00508157|464650708|FG000|Overall Study|Lost to Follow-up|1|||
129098080|NCT00508157|464650709|FG001|Overall Study|Lost to Follow-up|0|||
129206814|NCT00286442|465054972|FG000|Overall Study|Withdrawal by Subject|2|||
129206815|NCT00286442|465054973|FG001|Overall Study|Withdrawal by Subject|14|||
128874188|NCT00774930|463832723|FG000|LTOLE Phase|Physician Decision|4|||
129098081|NCT00508157|464650708|FG000|Overall Study|Subject no longer met study criteria|0|||
129098082|NCT00508157|464650709|FG001|Overall Study|Subject no longer met study criteria|1|||
129098083|NCT00508157|464650708|FG000|Overall Study|Other known cause|0|||
129098084|NCT00508157|464650709|FG001|Overall Study|Other known cause|1|||
129098085|NCT02069093|464650710|FG000|Overall Study|Disease progression|14|||
129098086|NCT02069093|464650710|FG000|Overall Study|New cancer therapy|1|||
129098087|NCT02069093|464650710|FG000|Overall Study|Death|1|||
129098088|NCT02069093|464650710|FG000|Overall Study|Administrative problems|1|||
129098089|NCT02069093|464650710|FG000|Overall Study|Withdrawal by Subject|2|||
129098090|NCT02069093|464650710|FG000|Overall Study|Abnormal laboratory values|1|||
129098091|NCT02069093|464650710|FG000|Overall Study|Adverse Event|10|||
129098092|NCT03564795|464650711|FG000|Overall Study|Withdrawal by Subject|3|||
129098093|NCT03564795|464650711|FG000|Overall Study|Lost to Follow-up|6|||
129098094|NCT03564795|464650711|FG000|Overall Study|Physician Decision|2|||
129098095|NCT02906033|464650712|FG000|Baseline|Protocol Violation|37|||
129098096|NCT02906033|464650713|FG001|Baseline|Protocol Violation|33|||
129098097|NCT02906033|464650712|FG000|Follow-up|Lost to Follow-up|46|||
129098098|NCT02906033|464650713|FG001|Follow-up|Lost to Follow-up|62|||
129098099|NCT01333956|464650724|FG000|Overall Study|Lost to Follow-up|1|||
129098100|NCT01333956|464650725|FG001|Overall Study|Lost to Follow-up|2|||
129098101|NCT01333956|464650726|FG002|Overall Study|Lost to Follow-up|0|||
129098102|NCT01333956|464650727|FG003|Overall Study|Lost to Follow-up|1|||
129098103|NCT01333956|464650724|FG000|Overall Study|Unable to complete study procedure|1|||
129098104|NCT01333956|464650725|FG001|Overall Study|Unable to complete study procedure|0|||
129098105|NCT01333956|464650726|FG002|Overall Study|Unable to complete study procedure|0|||
129098106|NCT01333956|464650727|FG003|Overall Study|Unable to complete study procedure|1|||
129098107|NCT01333956|464650724|FG000|Overall Study|Withdrawal by Subject|0|||
129098108|NCT01333956|464650725|FG001|Overall Study|Withdrawal by Subject|2|||
129098109|NCT01333956|464650726|FG002|Overall Study|Withdrawal by Subject|1|||
129098110|NCT01333956|464650727|FG003|Overall Study|Withdrawal by Subject|0|||
129098111|NCT02240069|464650728|FG000|Overall Study|Withdrawal by Subject|5|||
129098112|NCT02240069|464650729|FG001|Overall Study|Withdrawal by Subject|5|||
129098113|NCT02240069|464650730|FG002|Overall Study|Withdrawal by Subject|2|||
129098114|NCT04907227|464650731|FG000|Overall Study|Death|12|||
129098115|NCT04907227|464650732|FG001|Overall Study|Death|8|||
129098116|NCT04907227|464650731|FG000|Overall Study|Withdrawal by Subject|2|||
129098117|NCT04907227|464650732|FG001|Overall Study|Withdrawal by Subject|2|||
129098118|NCT04907227|464650731|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
129098119|NCT04907227|464650732|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
129098120|NCT04907227|464650731|FG000|Overall Study|Sponsor Decision|25|||
129098121|NCT04907227|464650732|FG001|Overall Study|Sponsor Decision|30|||
129098122|NCT04907227|464650731|FG000|Overall Study|Physician Decision|1|||
129098123|NCT04907227|464650732|FG001|Overall Study|Physician Decision|0|||
129098124|NCT03723070|464650733|FG000|Overall Study|Lost to Follow-up|2|||
129098125|NCT03723070|464650733|FG000|Overall Study|Physician Decision|1|||
129098126|NCT03723070|464650733|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
129098127|NCT02208050|464650734|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
129098128|NCT02208050|464650735|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
129098129|NCT00474786|464650737|FG000|Overall Study|Not Meeting Study Criteria|0|||
129098130|NCT00474786|464650738|FG001|Overall Study|Not Meeting Study Criteria|1|||
129098131|NCT00474786|464650737|FG000|Overall Study|Investigator Request|2|||
129098132|NCT00474786|464650738|FG001|Overall Study|Investigator Request|1|||
129098133|NCT00474786|464650737|FG000|Overall Study|Death|189|||
129098134|NCT00474786|464650738|FG001|Overall Study|Death|170|||
129098135|NCT00474786|464650737|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
129098136|NCT00474786|464650738|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
129098137|NCT00474786|464650737|FG000|Overall Study|Lost to Follow-up|4|||
129098138|NCT00474786|464650738|FG001|Overall Study|Lost to Follow-up|7|||
129098139|NCT00474786|464650737|FG000|Overall Study|Protocol Violation|2|||
129098140|NCT00474786|464650738|FG001|Overall Study|Protocol Violation|0|||
129098141|NCT00474786|464650737|FG000|Overall Study|Withdrawal by Subject|15|||
129098142|NCT00474786|464650738|FG001|Overall Study|Withdrawal by Subject|15|||
129098143|NCT00474786|464650737|FG000|Overall Study|Other|5|||
129098144|NCT00474786|464650738|FG001|Overall Study|Other|0|||
129098145|NCT00432276|464650741|FG000|Overall Study|Hyperglycemic Rescue|44|||
129098146|NCT00432276|464650742|FG001|Overall Study|Hyperglycemic Rescue|87|||
129098147|NCT00432276|464650741|FG000|Overall Study|Adverse Event|13|||
129098148|NCT00432276|464650742|FG001|Overall Study|Adverse Event|16|||
129098149|NCT00432276|464650741|FG000|Overall Study|Protocol Violation|25|||
129098150|NCT00432276|464650742|FG001|Overall Study|Protocol Violation|20|||
129098151|NCT00432276|464650741|FG000|Overall Study|Lost to Follow-up|6|||
129098152|NCT00432276|464650742|FG001|Overall Study|Lost to Follow-up|2|||
129098153|NCT00432276|464650741|FG000|Overall Study|Withdrawal by Subject|25|||
129098154|NCT00432276|464650742|FG001|Overall Study|Withdrawal by Subject|20|||
129098155|NCT00432276|464650741|FG000|Overall Study|Physician Decision|6|||
129098156|NCT00432276|464650742|FG001|Overall Study|Physician Decision|8|||
129098157|NCT00432276|464650741|FG000|Overall Study|Other|2|||
129098158|NCT00432276|464650742|FG001|Overall Study|Other|3|||
129098159|NCT00467961|464650743|FG000|Overall Study|Technical Failures|5|||
129098160|NCT00467961|464650743|FG000|Overall Study|Disease Progression|2|||
129098161|NCT05249127|464650744|FG000|Overall Study|Protocol Violation|13|||
129098162|NCT05249127|464650744|FG000|Overall Study|Physician Decision|4|||
129098163|NCT05249127|464650744|FG000|Overall Study|Withdrawal by Subject|2|||
129098164|NCT05249127|464650744|FG000|Overall Study|Participant Non-compliance|1|||
129098165|NCT02073565|464650746|FG000|Cohort A|Withdrawal by Subject|1|||
129098166|NCT02073565|464650747|FG001|Cohort A|Withdrawal by Subject|0|||
129098167|NCT02073565|464650746|FG000|Cohort B|Withdrawal by Subject|1|||
129098168|NCT02073565|464650747|FG001|Cohort B|Withdrawal by Subject|2|||
129098169|NCT02073565|464650746|FG000|Cohort C|Withdrawal by Subject|0|||
129098170|NCT02073565|464650747|FG001|Cohort C|Withdrawal by Subject|2|||
129098171|NCT02073565|464650746|FG000|Cohort C|Lost to Follow-up|0|||
129098172|NCT02073565|464650747|FG001|Cohort C|Lost to Follow-up|2|||
129098173|NCT03646305|464650748|FG000|Overall Study|Lost to Follow-up|4|||
129098174|NCT03646305|464650749|FG001|Overall Study|Lost to Follow-up|2|||
129098175|NCT03646305|464650750|FG002|Overall Study|Lost to Follow-up|2|||
129098176|NCT03646305|464650751|FG003|Overall Study|Lost to Follow-up|1|||
129098177|NCT03646305|464650748|FG000|Overall Study|Withdrawal by Subject|1|||
129098178|NCT03646305|464650749|FG001|Overall Study|Withdrawal by Subject|0|||
129098179|NCT03646305|464650750|FG002|Overall Study|Withdrawal by Subject|0|||
129098180|NCT03646305|464650751|FG003|Overall Study|Withdrawal by Subject|1|||
129098181|NCT03417024|464650754|FG000|Overall Study|Study Termination prior to follow-up|11|||
129098182|NCT03417024|464650754|FG000|Overall Study|Physician Decision|2|||
129098183|NCT02655419|464650755|FG000|Overall Study|Enrolled but not treated|1|||
128874189|NCT00774930|463832724|FG001|LTOLE Phase|Physician Decision|1|||
128874190|NCT00774930|463832723|FG000|LTOLE Phase|Sponsor decision|2|||
128874191|NCT00774930|463832724|FG001|LTOLE Phase|Sponsor decision|1|||
128874192|NCT00774930|463832723|FG000|LTOLE Phase|Disease Progression|2|||
128874193|NCT00774930|463832724|FG001|LTOLE Phase|Disease Progression|5|||
128874194|NCT00774930|463832723|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
128874195|NCT00774930|463832724|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
128874196|NCT00774930|463832723|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
128874197|NCT00774930|463832724|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
128874198|NCT00766363|463832725|FG000|Overall Study|Withdrawal by Subject|1|||
128874199|NCT00766363|463832726|FG001|Overall Study|Withdrawal by Subject|0|||
128874200|NCT00766363|463832727|FG002|Overall Study|Withdrawal by Subject|0|||
128874201|NCT00766363|463832728|FG003|Overall Study|Withdrawal by Subject|0|||
128874202|NCT00766363|463832725|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
128874203|NCT00766363|463832726|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
128874204|NCT00766363|463832727|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
128874205|NCT00766363|463832728|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
129098184|NCT02655419|464650756|FG001|Overall Study|Enrolled but not treated|5|||
129098185|NCT02655419|464650755|FG000|Overall Study|Withdrawal by Subject|4|||
129098186|NCT02655419|464650756|FG001|Overall Study|Withdrawal by Subject|1|||
129098187|NCT02655419|464650755|FG000|Overall Study|Other|0|||
129098188|NCT02655419|464650756|FG001|Overall Study|Other|1|||
129098189|NCT00207727|464650757|FG000|Overall Study|Withdrawal by Subject|0|||
129098190|NCT00207727|464650758|FG001|Overall Study|Withdrawal by Subject|0|||
129098191|NCT00207727|464650759|FG002|Overall Study|Withdrawal by Subject|0|||
129098192|NCT00207727|464650760|FG003|Overall Study|Withdrawal by Subject|0|||
129098193|NCT00207727|464650761|FG004|Overall Study|Withdrawal by Subject|1|||
129098194|NCT00207727|464650757|FG000|Overall Study|Lost to Follow-up|0|||
129098195|NCT00207727|464650758|FG001|Overall Study|Lost to Follow-up|1|||
128874206|NCT03020576|463832733|FG000|Overall Study|Withdrawal by Subject|1|||
129098196|NCT00207727|464650759|FG002|Overall Study|Lost to Follow-up|0|||
129098197|NCT00207727|464650760|FG003|Overall Study|Lost to Follow-up|0|||
128874207|NCT03020576|463832734|FG001|Overall Study|Withdrawal by Subject|2|||
128874208|NCT01153321|463832735|FG000|Overall Study|Development of study withdrawal criteria|0|||
128874209|NCT01153321|463832736|FG001|Overall Study|Development of study withdrawal criteria|1|||
128874210|NCT01153321|463832735|FG000|Overall Study|Withdrawal by Subject|0|||
128874211|NCT01153321|463832736|FG001|Overall Study|Withdrawal by Subject|1|||
128874212|NCT01153321|463832735|FG000|Overall Study|Adverse Event|1|||
128874213|NCT01153321|463832736|FG001|Overall Study|Adverse Event|1|||
128874214|NCT01177800|463832738|FG000|Overall Study|Adverse Event|9|||
128874215|NCT01177800|463832739|FG001|Overall Study|Adverse Event|3|||
128874216|NCT01177800|463832738|FG000|Overall Study|Protocol Violation|0|||
128874217|NCT01177800|463832739|FG001|Overall Study|Protocol Violation|1|||
128874218|NCT01177800|463832738|FG000|Overall Study|Physician Decision|1|||
128874219|NCT01177800|463832739|FG001|Overall Study|Physician Decision|0|||
128874220|NCT01177800|463832738|FG000|Overall Study|Withdrawal of informed consent|0|||
128874221|NCT01177800|463832739|FG001|Overall Study|Withdrawal of informed consent|1|||
128874222|NCT03527550|463832740|FG000|Overall Study|Lost to Follow-up|4|||
128874223|NCT03527550|463832741|FG001|Overall Study|Lost to Follow-up|2|||
128874224|NCT03527550|463832740|FG000|Overall Study|Withdrawal by Subject|4|||
128874225|NCT03527550|463832741|FG001|Overall Study|Withdrawal by Subject|1|||
128874226|NCT03527550|463832740|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
128874227|NCT03527550|463832741|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
128874228|NCT00911937|463832742|FG000|Overall Study|Death|1|||
128874229|NCT00911937|463832743|FG001|Overall Study|Death|0|||
128874230|NCT00911937|463832742|FG000|Overall Study|Lost to Follow-up|8|||
128874231|NCT00911937|463832743|FG001|Overall Study|Lost to Follow-up|5|||
128874232|NCT00911937|463832742|FG000|Overall Study|Withdrawal by Subject|10|||
128874233|NCT00911937|463832743|FG001|Overall Study|Withdrawal by Subject|7|||
128874234|NCT00911937|463832742|FG000|Overall Study|Withdrawn due to pregnancy|1|||
128874235|NCT00911937|463832743|FG001|Overall Study|Withdrawn due to pregnancy|0|||
128874236|NCT00911937|463832742|FG000|Overall Study|Adverse Event|11|||
128874237|NCT00911937|463832743|FG001|Overall Study|Adverse Event|25|||
128874238|NCT00911937|463832742|FG000|Overall Study|Lack of Efficacy|11|||
128874239|NCT00911937|463832743|FG001|Overall Study|Lack of Efficacy|6|||
128874240|NCT00911937|463832742|FG000|Overall Study|Did not meet inclusion criteria|9|||
128874241|NCT00911937|463832743|FG001|Overall Study|Did not meet inclusion criteria|11|||
128874242|NCT00911937|463832742|FG000|Overall Study|Protocol Violation|14|||
128874243|NCT00911937|463832743|FG001|Overall Study|Protocol Violation|23|||
128874244|NCT00911937|463832742|FG000|Overall Study|Randomized but not treated|13|||
128874245|NCT00911937|463832743|FG001|Overall Study|Randomized but not treated|13|||
128874246|NCT00911937|463832742|FG000|Overall Study|Other|9|||
128874247|NCT00911937|463832743|FG001|Overall Study|Other|5|||
128874248|NCT01498679|463832748|FG000|Overall Study|Adverse Event|1|||
128874249|NCT01498679|463832749|FG001|Overall Study|Adverse Event|4|||
128874250|NCT01498679|463832748|FG000|Overall Study|Lack of Efficacy|72|||
128874251|NCT01498679|463832749|FG001|Overall Study|Lack of Efficacy|12|||
128874252|NCT01498679|463832748|FG000|Overall Study|Protocol Violation|4|||
128874253|NCT01498679|463832749|FG001|Overall Study|Protocol Violation|0|||
128874254|NCT01498679|463832748|FG000|Overall Study|Physician Decision|0|||
128874255|NCT01498679|463832749|FG001|Overall Study|Physician Decision|2|||
128874256|NCT01498679|463832748|FG000|Overall Study|Withdrawal by Subject|12|||
128874257|NCT01498679|463832749|FG001|Overall Study|Withdrawal by Subject|4|||
128874258|NCT03212989|463832751|FG000|Overall Study|Physician Decision|8|||
128874259|NCT01844687|463832754|FG000|Visit 1|Protocol Violation|3|||
128874260|NCT01844687|463832754|FG000|Visit 1|Lost to Follow-up|5|||
128874261|NCT01844687|463832754|FG000|Visit 2|Withdrawal by Subject|1|||
128874262|NCT01844687|463832754|FG000|Visit 2|Protocol Violation|1|||
128874263|NCT01844687|463832754|FG000|Visit 3|Lost to Follow-up|1|||
128874264|NCT01844687|463832754|FG000|Visit 3|Withdrawal by Subject|3|||
128874265|NCT01844687|463832754|FG000|Visit 3|child care problems|1|||
128874266|NCT01844687|463832754|FG000|Visit 4|Pregnancy|1|||
128874267|NCT01844687|463832754|FG000|Visit 4|Lost to Follow-up|1|||
129098198|NCT00207727|464650761|FG004|Overall Study|Lost to Follow-up|0|||
129098199|NCT00207727|464650757|FG000|Overall Study|Other|38|||
129098200|NCT00207727|464650758|FG001|Overall Study|Other|41|||
128874268|NCT01844687|463832754|FG000|Visit 4|Withdrawal by Subject|2|||
128874269|NCT03047395|463832757|FG000|Overall Study|Adverse Event|142|||
128874270|NCT03047395|463832757|FG000|Overall Study|Withdrawal by Subject|155|||
128874271|NCT03047395|463832757|FG000|Overall Study|Lost to Follow-up|144|||
129098201|NCT00207727|464650759|FG002|Overall Study|Other|41|||
128874272|NCT03047395|463832757|FG000|Overall Study|COVID-19 Infection|2|||
128874273|NCT03047395|463832757|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
128874274|NCT03047395|463832757|FG000|Overall Study|Other, Not Specified|117|||
128874275|NCT00635427|463832762|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
128874276|NCT00635427|463832763|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
128874277|NCT00635427|463832764|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
128874278|NCT00635427|463832765|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
128874279|NCT00635427|463832766|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129098202|NCT00207727|464650760|FG003|Overall Study|Other|37|||
128874280|NCT00635427|463832762|FG000|Overall Study|Death|0|||
128874281|NCT00635427|463832763|FG001|Overall Study|Death|0|||
128874282|NCT00635427|463832764|FG002|Overall Study|Death|0|||
128874283|NCT00635427|463832765|FG003|Overall Study|Death|1|||
128874284|NCT00635427|463832766|FG004|Overall Study|Death|0|||
128874285|NCT00635427|463832762|FG000|Overall Study|Termination Of Study By Sponsor|12|||
128874286|NCT00635427|463832763|FG001|Overall Study|Termination Of Study By Sponsor|6|||
128874287|NCT00635427|463832764|FG002|Overall Study|Termination Of Study By Sponsor|10|||
128874288|NCT00635427|463832765|FG003|Overall Study|Termination Of Study By Sponsor|6|||
128874289|NCT00635427|463832766|FG004|Overall Study|Termination Of Study By Sponsor|6|||
128874290|NCT00635427|463832762|FG000|Overall Study|Withdrawal Of Consent|0|||
128874291|NCT00635427|463832763|FG001|Overall Study|Withdrawal Of Consent|0|||
128874292|NCT00635427|463832764|FG002|Overall Study|Withdrawal Of Consent|0|||
128874293|NCT00635427|463832765|FG003|Overall Study|Withdrawal Of Consent|2|||
128874294|NCT00635427|463832766|FG004|Overall Study|Withdrawal Of Consent|2|||
128874295|NCT03484273|463832769|FG000|Overall Study|Equipment Malfunction|1|||
128874296|NCT03484273|463832769|FG000|Overall Study|Data excluded from analysis|1|||
128874297|NCT02706899|463832774|FG000|Overall Study|Withdrawal by Subject|1|||
128874298|NCT02706899|463832775|FG001|Overall Study|Withdrawal by Subject|0|||
128874299|NCT02706899|463832774|FG000|Overall Study|Death|8|||
128874300|NCT02706899|463832775|FG001|Overall Study|Death|0|||
128874301|NCT02706899|463832774|FG000|Overall Study|Study Termination by Sponsor|4|||
128874302|NCT02706899|463832775|FG001|Overall Study|Study Termination by Sponsor|6|||
128874303|NCT00324675|463832776|FG000|Overall Study|Adverse Event|1|||
128874304|NCT00324675|463832777|FG001|Overall Study|Adverse Event|0|||
128874305|NCT01080716|463832779|FG000|Part 1|Physician Decision|1|||
128874306|NCT01080716|463832780|FG001|Part 1|Physician Decision|0|||
128874307|NCT01080716|463832781|FG002|Part 1|Physician Decision|0|||
128874308|NCT01080716|463832782|FG003|Part 1|Physician Decision|0|||
128874309|NCT01993927|463832783|FG000|Overall Study|Case Report Forms Uncollected|18|||
128874310|NCT01993927|463832783|FG000|Overall Study|Protocol Violation|11|||
128874311|NCT00760474|463832784|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
128874312|NCT00760474|463832785|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
128874313|NCT00760474|463832784|FG000|Placebo Washout Period|Other|0|||
128874314|NCT00760474|463832785|FG001|Placebo Washout Period|Other|1|||
128874315|NCT00760474|463832784|FG000|Period 2 (P2)|Lost to Follow-up|1|||
128874316|NCT00760474|463832785|FG001|Period 2 (P2)|Lost to Follow-up|0|||
128874317|NCT00760474|463832784|FG000|Period 2 (P2)|Adverse Event|0|||
128874318|NCT00760474|463832785|FG001|Period 2 (P2)|Adverse Event|1|||
128874319|NCT03981861|463832786|FG000|Overall Study|Withdrawal by Subject|3|||
128874320|NCT05618912|463832787|FG000|Overall Study|Lost to Follow-up|14|||
128874321|NCT05618912|463832788|FG001|Overall Study|Lost to Follow-up|19|||
128874322|NCT01022112|463832789|FG000|Overall Study|Adverse Event|1|||
128874323|NCT01022112|463832790|FG001|Overall Study|Adverse Event|2|||
128874324|NCT01022112|463832791|FG002|Overall Study|Adverse Event|0|||
128874325|NCT01022112|463832792|FG003|Overall Study|Adverse Event|1|||
128874326|NCT01022112|463832793|FG004|Overall Study|Adverse Event|0|||
128874327|NCT01022112|463832789|FG000|Overall Study|Lack of Efficacy|1|||
128874328|NCT01022112|463832790|FG001|Overall Study|Lack of Efficacy|0|||
128874329|NCT01022112|463832791|FG002|Overall Study|Lack of Efficacy|0|||
128874330|NCT01022112|463832792|FG003|Overall Study|Lack of Efficacy|0|||
128874331|NCT01022112|463832793|FG004|Overall Study|Lack of Efficacy|1|||
128874332|NCT01022112|463832789|FG000|Overall Study|Physician Decision|0|||
128874333|NCT01022112|463832790|FG001|Overall Study|Physician Decision|0|||
128874334|NCT01022112|463832791|FG002|Overall Study|Physician Decision|1|||
128874335|NCT01022112|463832792|FG003|Overall Study|Physician Decision|0|||
128874336|NCT01022112|463832793|FG004|Overall Study|Physician Decision|1|||
128874337|NCT01022112|463832789|FG000|Overall Study|Withdrawal by Subject|0|||
128874338|NCT01022112|463832790|FG001|Overall Study|Withdrawal by Subject|1|||
128874339|NCT01022112|463832791|FG002|Overall Study|Withdrawal by Subject|2|||
128874340|NCT01022112|463832792|FG003|Overall Study|Withdrawal by Subject|2|||
128874341|NCT01022112|463832793|FG004|Overall Study|Withdrawal by Subject|1|||
128874342|NCT01022112|463832789|FG000|Overall Study|Fasting plasma glucose level increased|1|||
128874343|NCT01022112|463832790|FG001|Overall Study|Fasting plasma glucose level increased|0|||
128874344|NCT01022112|463832791|FG002|Overall Study|Fasting plasma glucose level increased|0|||
128874345|NCT01022112|463832792|FG003|Overall Study|Fasting plasma glucose level increased|0|||
128874346|NCT01022112|463832793|FG004|Overall Study|Fasting plasma glucose level increased|7|||
128874347|NCT00432666|463834526|FG000|Main Period|Adverse Event|1|||
128874348|NCT00432666|463834527|FG001|Main Period|Adverse Event|1|||
128874349|NCT00432666|463834526|FG000|Main Period|Consent Withdrawn|1|||
129098203|NCT00207727|464650761|FG004|Overall Study|Other|33|||
128874350|NCT00432666|463834527|FG001|Main Period|Consent Withdrawn|0|||
128874351|NCT00432666|463834526|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
128874352|NCT00432666|463834527|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
128874353|NCT00432666|463834526|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
128874354|NCT00432666|463834527|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
128874355|NCT00432666|463834526|FG000|Open-Label Extension Period|Adverse Event|5|||
128874356|NCT00432666|463834527|FG001|Open-Label Extension Period|Adverse Event|0|||
128874357|NCT00432666|463834526|FG000|Open-Label Extension Period|Consent withdrawn|10|||
128874358|NCT00432666|463834527|FG001|Open-Label Extension Period|Consent withdrawn|0|||
128874359|NCT00432666|463834526|FG000|Open-Label Extension Period|Physician Decision|3|||
128874360|NCT00432666|463834527|FG001|Open-Label Extension Period|Physician Decision|0|||
128874361|NCT00978627|463834528|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
128874362|NCT00978627|463834529|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
128874363|NCT00978627|463834528|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
128874364|NCT00978627|463834529|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
128874365|NCT00978627|463834528|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
128874366|NCT00978627|463834529|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
128874367|NCT00978627|463834528|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
128874368|NCT00978627|463834529|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
128874369|NCT00978627|463834528|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
128874370|NCT00978627|463834529|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
128874371|NCT00978627|463834528|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
128874372|NCT00978627|463834529|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
128874373|NCT00978627|463834528|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
128874374|NCT00978627|463834529|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
128874375|NCT00978627|463834528|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
128874376|NCT00978627|463834529|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
128874377|NCT00978627|463834528|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
128874378|NCT00978627|463834529|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
128874379|NCT02516332|463834532|FG000|Overall Study|Withdrawal by Subject|2|||
128874380|NCT02516332|463834533|FG001|Overall Study|Withdrawal by Subject|1|||
128874381|NCT02516332|463834534|FG002|Overall Study|Withdrawal by Subject|2|||
128874382|NCT01342341|463834535|FG000|Overall Study|Lost to Follow-up|4|||
128874383|NCT01342341|463834536|FG001|Overall Study|Lost to Follow-up|4|||
128874384|NCT02245737|463834543|FG000|Overall Study|Adverse Event|23|||
128874385|NCT02245737|463834544|FG001|Overall Study|Adverse Event|26|||
128874386|NCT02245737|463834545|FG002|Overall Study|Adverse Event|33|||
128874387|NCT02245737|463834543|FG000|Overall Study|Condition Worsened|9|||
128874388|NCT02245737|463834544|FG001|Overall Study|Condition Worsened|10|||
128874389|NCT02245737|463834545|FG002|Overall Study|Condition Worsened|9|||
128874390|NCT02245737|463834543|FG000|Overall Study|Death|2|||
128874391|NCT02245737|463834544|FG001|Overall Study|Death|4|||
128874392|NCT02245737|463834545|FG002|Overall Study|Death|4|||
128874393|NCT02245737|463834543|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
128874394|NCT02245737|463834544|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
128874395|NCT02245737|463834545|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
128874396|NCT02245737|463834543|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
128874397|NCT02245737|463834544|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
128874398|NCT02245737|463834545|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
128874399|NCT02245737|463834543|FG000|Overall Study|Lost to Follow-up|2|||
128874400|NCT02245737|463834544|FG001|Overall Study|Lost to Follow-up|5|||
128874401|NCT02245737|463834545|FG002|Overall Study|Lost to Follow-up|4|||
128874402|NCT02245737|463834543|FG000|Overall Study|Other-determined by Investigator|9|||
128874403|NCT02245737|463834544|FG001|Overall Study|Other-determined by Investigator|10|||
128874404|NCT02245737|463834545|FG002|Overall Study|Other-determined by Investigator|10|||
128874405|NCT02245737|463834543|FG000|Overall Study|Physician Decision|6|||
128874406|NCT02245737|463834544|FG001|Overall Study|Physician Decision|3|||
128874407|NCT02245737|463834545|FG002|Overall Study|Physician Decision|6|||
128874408|NCT02245737|463834543|FG000|Overall Study|Protocol Violation|3|||
128874409|NCT02245737|463834544|FG001|Overall Study|Protocol Violation|2|||
128874410|NCT02245737|463834545|FG002|Overall Study|Protocol Violation|3|||
128874411|NCT02245737|463834543|FG000|Overall Study|Withdrawal by Subject|40|||
128874412|NCT02245737|463834544|FG001|Overall Study|Withdrawal by Subject|41|||
128874413|NCT02245737|463834545|FG002|Overall Study|Withdrawal by Subject|44|||
128874414|NCT02245737|463834543|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
128874415|NCT02245737|463834544|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
128874416|NCT02245737|463834545|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
128874417|NCT02245737|463834543|FG000|Overall Study|Sponsor Decision|445|||
128874418|NCT02245737|463834544|FG001|Overall Study|Sponsor Decision|430|||
128874419|NCT02245737|463834545|FG002|Overall Study|Sponsor Decision|432|||
128874420|NCT02366468|463834546|FG000|Overall Study|Adverse Event|2|||
128874421|NCT02366468|463834547|FG001|Overall Study|Adverse Event|0|||
129098204|NCT04226495|464650762|FG000|Overall Study|Withdrawal by Subject|3|||
129098205|NCT04226495|464650763|FG001|Overall Study|Withdrawal by Subject|3|||
129098206|NCT04226495|464650762|FG000|Overall Study|PI discretion|3|||
128874422|NCT02366468|463834546|FG000|Overall Study|Withdrawal by Subject|1|||
128874423|NCT02366468|463834547|FG001|Overall Study|Withdrawal by Subject|5|||
128874424|NCT02366468|463834546|FG000|Overall Study|Lost to Follow-up|2|||
129098207|NCT04226495|464650763|FG001|Overall Study|PI discretion|4|||
129098208|NCT02474355|464652287|FG000|Overall Study|Other|43|||
128874425|NCT02366468|463834547|FG001|Overall Study|Lost to Follow-up|0|||
128874426|NCT02366468|463834546|FG000|Overall Study|Death|1|||
128874427|NCT02366468|463834547|FG001|Overall Study|Death|2|||
128874428|NCT02366468|463834546|FG000|Overall Study|Other|0|||
128874429|NCT02366468|463834547|FG001|Overall Study|Other|2|||
128874430|NCT01552603|463834548|FG000|Overall Study|Physician Decision|1|||
128874431|NCT04797650|463834553|FG000|Overall Study|Reason Not Specified|5|||
128874432|NCT04797650|463834554|FG001|Overall Study|Reason Not Specified|12|||
128874433|NCT04797650|463834555|FG002|Overall Study|Reason Not Specified|5|||
128874434|NCT04797650|463834553|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
128874435|NCT04797650|463834554|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
128874436|NCT04797650|463834555|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
128874437|NCT04797650|463834553|FG000|Overall Study|Lack of Efficacy|1|||
128874438|NCT04797650|463834554|FG001|Overall Study|Lack of Efficacy|0|||
128874439|NCT04797650|463834555|FG002|Overall Study|Lack of Efficacy|1|||
128874440|NCT04797650|463834553|FG000|Overall Study|Non-compliance with Study Drug|0|||
128874441|NCT04797650|463834554|FG001|Overall Study|Non-compliance with Study Drug|0|||
128874442|NCT04797650|463834555|FG002|Overall Study|Non-compliance with Study Drug|2|||
128874443|NCT04797650|463834553|FG000|Overall Study|Lost to Follow-up|4|||
128874444|NCT04797650|463834554|FG001|Overall Study|Lost to Follow-up|6|||
128874445|NCT04797650|463834555|FG002|Overall Study|Lost to Follow-up|1|||
128874446|NCT00446043|463834556|FG000|Overall Study|Adverse Event|9|||
128874447|NCT00446043|463834556|FG000|Overall Study|Withdrawal by Subject|70|||
128874448|NCT00446043|463834556|FG000|Overall Study|Protocol Violation|2|||
128874449|NCT00446043|463834556|FG000|Overall Study|Lost to Follow-up|42|||
128874450|NCT00446043|463834556|FG000|Overall Study|Pregnancy|2|||
128874451|NCT00657020|463834559|FG000|PERIOD 1|Adverse Event|0|||
128874452|NCT00657020|463834560|FG001|PERIOD 1|Adverse Event|1|||
128874453|NCT04772898|463834563|FG000|Overall Study|Withdrawal by Subject|0|||
128874454|NCT04772898|463834564|FG001|Overall Study|Withdrawal by Subject|1|||
128874455|NCT01983254|463834566|FG000|Overall Study|Death|6|||
128874456|NCT01983254|463834567|FG001|Overall Study|Death|6|||
128874457|NCT01983254|463834566|FG000|Overall Study|Lost to Follow-up|17|||
128874458|NCT01983254|463834567|FG001|Overall Study|Lost to Follow-up|16|||
128874459|NCT01983254|463834566|FG000|Overall Study|too ill|11|||
128874460|NCT01983254|463834567|FG001|Overall Study|too ill|8|||
128874461|NCT00434213|463834570|FG000|Overall Study|Adverse Event|12|||
128874462|NCT00434213|463834570|FG000|Overall Study|Lack of Efficacy|9|||
128874463|NCT00434213|463834570|FG000|Overall Study|Lost to Follow-up|14|||
128874464|NCT00434213|463834570|FG000|Overall Study|Withdrawal by Subject|7|||
128874465|NCT00434213|463834570|FG000|Overall Study|Protocol Violation|3|||
128874466|NCT00434213|463834570|FG000|Overall Study|Unable to comply with study visit window|2|||
128874467|NCT00434213|463834570|FG000|Overall Study|Application site reaction|1|||
128874468|NCT00434213|463834570|FG000|Overall Study|Non-compliant to study schedule|1|||
128874469|NCT04988867|463834573|FG000|Overall Study|Study terminated by Sponsor|12|||
128874470|NCT04988867|463834573|FG000|Overall Study|Adverse Event|2|||
128874471|NCT04988867|463834573|FG000|Overall Study|Study drug noncompliance|1|||
128874472|NCT01253304|463834574|FG000|Overall Study|Adverse Event|0|||
128874473|NCT01253304|463834575|FG001|Overall Study|Adverse Event|0|||
128874474|NCT01253304|463834576|FG002|Overall Study|Adverse Event|0|||
128874475|NCT01253304|463834577|FG003|Overall Study|Adverse Event|1|||
128874476|NCT01699503|463834580|FG000|Overall Study|Death|31|||
128874477|NCT01699503|463834581|FG001|Overall Study|Death|40|||
128874478|NCT01699503|463834580|FG000|Overall Study|Withdrawal by Subject|65|||
128874479|NCT01699503|463834581|FG001|Overall Study|Withdrawal by Subject|57|||
128874480|NCT01699503|463834580|FG000|Overall Study|Lost to Follow-up|121|||
128874481|NCT01699503|463834581|FG001|Overall Study|Lost to Follow-up|117|||
128874482|NCT01699503|463834580|FG000|Overall Study|Excluded due to quality|783|||
128874483|NCT01699503|463834581|FG001|Overall Study|Excluded due to quality|791|||
128874484|NCT01631227|463834587|FG000|Overall Study|withdrawn consent|27|||
128874485|NCT01631227|463834588|FG001|Overall Study|withdrawn consent|21|||
128874486|NCT01631227|463834587|FG000|Overall Study|Adverse Event|1|||
128874487|NCT01631227|463834588|FG001|Overall Study|Adverse Event|0|||
128874488|NCT01631227|463834587|FG000|Overall Study|administrative|2|||
128874489|NCT01631227|463834588|FG001|Overall Study|administrative|1|||
128874490|NCT00768079|463834591|FG000|Overall Study|Lost to Follow-up|2|||
128874491|NCT00768079|463834592|FG001|Overall Study|Lost to Follow-up|0|||
128874492|NCT00768079|463834593|FG002|Overall Study|Lost to Follow-up|4|||
128874493|NCT00768079|463834591|FG000|Overall Study|Participant incarcerated|0|||
128874494|NCT00768079|463834592|FG001|Overall Study|Participant incarcerated|1|||
128874495|NCT00768079|463834593|FG002|Overall Study|Participant incarcerated|0|||
128874496|NCT01097707|463834594|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
128874497|NCT01097707|463834595|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
128874498|NCT01097707|463834596|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
128874499|NCT01097707|463834597|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
128874500|NCT01097707|463834598|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
128874501|NCT01097707|463834594|FG000|Overall Study|Adverse Event|4|||
128874502|NCT01097707|463834595|FG001|Overall Study|Adverse Event|2|||
128874503|NCT01097707|463834596|FG002|Overall Study|Adverse Event|3|||
128874504|NCT01097707|463834597|FG003|Overall Study|Adverse Event|1|||
128874505|NCT01097707|463834598|FG004|Overall Study|Adverse Event|3|||
128874506|NCT01097707|463834594|FG000|Overall Study|Entry Criteria Not Met|2|||
128874507|NCT01097707|463834595|FG001|Overall Study|Entry Criteria Not Met|1|||
128874508|NCT01097707|463834596|FG002|Overall Study|Entry Criteria Not Met|1|||
128874509|NCT01097707|463834597|FG003|Overall Study|Entry Criteria Not Met|0|||
128874510|NCT01097707|463834598|FG004|Overall Study|Entry Criteria Not Met|1|||
128874511|NCT01097707|463834594|FG000|Overall Study|Lack of Efficacy|1|||
128874512|NCT01097707|463834595|FG001|Overall Study|Lack of Efficacy|0|||
128874513|NCT01097707|463834596|FG002|Overall Study|Lack of Efficacy|0|||
128874514|NCT01097707|463834597|FG003|Overall Study|Lack of Efficacy|1|||
128874515|NCT01097707|463834598|FG004|Overall Study|Lack of Efficacy|0|||
128874516|NCT01097707|463834594|FG000|Overall Study|Lost to Follow-up|1|||
128874517|NCT01097707|463834595|FG001|Overall Study|Lost to Follow-up|1|||
128874518|NCT01097707|463834596|FG002|Overall Study|Lost to Follow-up|2|||
128874519|NCT01097707|463834597|FG003|Overall Study|Lost to Follow-up|0|||
128874520|NCT01097707|463834598|FG004|Overall Study|Lost to Follow-up|3|||
128874521|NCT01097707|463834594|FG000|Overall Study|Protocol Violation|2|||
128874522|NCT01097707|463834595|FG001|Overall Study|Protocol Violation|2|||
128874523|NCT01097707|463834596|FG002|Overall Study|Protocol Violation|3|||
128874524|NCT01097707|463834597|FG003|Overall Study|Protocol Violation|2|||
128874525|NCT01097707|463834598|FG004|Overall Study|Protocol Violation|2|||
128874526|NCT01097707|463834594|FG000|Overall Study|Sponsor Decision|31|||
128874527|NCT01097707|463834595|FG001|Overall Study|Sponsor Decision|31|||
128874528|NCT01097707|463834596|FG002|Overall Study|Sponsor Decision|34|||
128874529|NCT01097707|463834597|FG003|Overall Study|Sponsor Decision|35|||
128874530|NCT01097707|463834598|FG004|Overall Study|Sponsor Decision|36|||
128874531|NCT01097707|463834594|FG000|Overall Study|Withdrawal by Subject|3|||
128874532|NCT01097707|463834595|FG001|Overall Study|Withdrawal by Subject|6|||
128874533|NCT01097707|463834596|FG002|Overall Study|Withdrawal by Subject|1|||
128874534|NCT01097707|463834597|FG003|Overall Study|Withdrawal by Subject|4|||
128874535|NCT01097707|463834598|FG004|Overall Study|Withdrawal by Subject|3|||
128874536|NCT01097707|463834594|FG000|Overall Study|Reason unknown|0|||
128874537|NCT01097707|463834595|FG001|Overall Study|Reason unknown|0|||
128874538|NCT01097707|463834596|FG002|Overall Study|Reason unknown|0|||
128874539|NCT01097707|463834597|FG003|Overall Study|Reason unknown|0|||
128874540|NCT01097707|463834598|FG004|Overall Study|Reason unknown|1|||
128874541|NCT02207569|463834600|FG000|1-Month|Death|6|||
128874542|NCT02207569|463834600|FG000|1-Month|Withdrawal by Subject|2|||
128874543|NCT02207569|463834600|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
128874544|NCT02207569|463834600|FG000|6-Month|Death|8|||
128874545|NCT02207569|463834600|FG000|6-Month|Withdrawal by Subject|2|||
128874546|NCT02207569|463834600|FG000|12-Month|Death|14|||
128874547|NCT02207569|463834600|FG000|12-Month|Withdrawal by Subject|2|||
128874548|NCT02207569|463834600|FG000|24-Month|Death|23|||
128874549|NCT02207569|463834600|FG000|24-Month|Withdrawal by Subject|3|||
128874550|NCT02207569|463834600|FG000|36-Month|Death|23|||
128874551|NCT02207569|463834600|FG000|36-Month|Withdrawal by Subject|4|||
128874552|NCT02207569|463834600|FG000|48-Month|Death|25|||
128874553|NCT02207569|463834600|FG000|48-Month|Withdrawal by Subject|2|||
128874554|NCT02207569|463834600|FG000|48-Month|Lost to Follow-up|4|||
128874555|NCT02207569|463834600|FG000|60-Month|Death|1|||
128874556|NCT02207569|463834600|FG000|60-Month|Lost to Follow-up|1|||
128874557|NCT02207569|463834600|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
128874558|NCT02207569|463834600|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
128874559|NCT01236534|463834601|FG000|Overall Study|Adverse Event|3|||
128874560|NCT01236534|463834602|FG001|Overall Study|Adverse Event|0|||
128874561|NCT05383508|463834611|FG000|Overall Study|Withdrawal by Subject|1|||
128874562|NCT05383508|463834612|FG001|Overall Study|Withdrawal by Subject|0|||
128874563|NCT05383508|463834613|FG002|Overall Study|Withdrawal by Subject|1|||
128874564|NCT05383508|463834614|FG003|Overall Study|Withdrawal by Subject|1|||
128874565|NCT05383508|463834615|FG004|Overall Study|Withdrawal by Subject|2|||
128874566|NCT05383508|463834616|FG005|Overall Study|Withdrawal by Subject|0|||
128874567|NCT03412747|463834619|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
128874568|NCT03412747|463834620|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
128874569|NCT03412747|463834621|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
128874570|NCT03412747|463834619|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
128874571|NCT03412747|463834620|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
128874572|NCT03412747|463834621|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
128874573|NCT03412747|463834619|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
128874574|NCT03412747|463834620|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
128874575|NCT03412747|463834621|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
128874576|NCT03412747|463834619|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
128874577|NCT03412747|463834620|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
128874578|NCT03412747|463834621|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
128874579|NCT03412747|463834619|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
128874580|NCT03412747|463834620|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
128874581|NCT03412747|463834621|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
128874582|NCT03412747|463834619|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
128874583|NCT03412747|463834620|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
128874584|NCT03412747|463834621|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
128874585|NCT03412747|463834619|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
128874586|NCT03412747|463834620|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
128874587|NCT03412747|463834621|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
128874588|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
128874589|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
128874590|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
128874591|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
128874592|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
128874593|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
128874594|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
128874595|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
128874596|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
128874597|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
128874598|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
128874599|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
128874600|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
128874601|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
128874602|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
128874603|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
128874604|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
128874605|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
128874606|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
128874607|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
128874608|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
128874609|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
128874610|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
128874611|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
128874612|NCT03412747|463834619|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
128874613|NCT03412747|463834620|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
128874614|NCT03412747|463834621|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
128874615|NCT02081417|463834622|FG000|Overall Study|Lost to Follow-up|26|||
128874616|NCT02081417|463834623|FG001|Overall Study|Lost to Follow-up|23|||
128874617|NCT02081417|463834622|FG000|Overall Study|Moved Away|1|||
128874618|NCT02081417|463834623|FG001|Overall Study|Moved Away|2|||
128874619|NCT02081417|463834622|FG000|Overall Study|Incarcerated|2|||
128874620|NCT02081417|463834623|FG001|Overall Study|Incarcerated|2|||
128874621|NCT02081417|463834622|FG000|Overall Study|Death|4|||
128874622|NCT02081417|463834623|FG001|Overall Study|Death|3|||
128874623|NCT02081417|463834622|FG000|Overall Study|Withdrawal by Subject|4|||
128874624|NCT02081417|463834623|FG001|Overall Study|Withdrawal by Subject|0|||
128874625|NCT02081417|463834622|FG000|Overall Study|Admitted to Residential Treatment|2|||
128874626|NCT02081417|463834623|FG001|Overall Study|Admitted to Residential Treatment|0|||
128874627|NCT02081417|463834622|FG000|Overall Study|Did not start treatment|17|||
128874628|NCT02081417|463834623|FG001|Overall Study|Did not start treatment|21|||
128874629|NCT01157676|463834626|FG000|Randomization|Death|1|||
128874630|NCT01157676|463834627|FG001|Randomization|Death|1|||
128874631|NCT01157676|463834626|FG000|Randomization|unresectable|2|||
128874632|NCT01157676|463834627|FG001|Randomization|unresectable|3|||
128874633|NCT01157676|463834626|FG000|Randomization|Withdrawal by Subject|17|||
128874634|NCT01157676|463834627|FG001|Randomization|Withdrawal by Subject|13|||
128874635|NCT01157676|463834626|FG000|Randomization|Physician Decision|1|||
128874636|NCT01157676|463834627|FG001|Randomization|Physician Decision|0|||
128874637|NCT01157676|463834626|FG000|Surgery|underwent open cystectomy|0|||
128874638|NCT01157676|463834627|FG001|Surgery|underwent open cystectomy|4|||
128874639|NCT01157676|463834626|FG000|Surgery|converted to open procedure|0|||
128874640|NCT01157676|463834627|FG001|Surgery|converted to open procedure|5|||
128874641|NCT01157676|463834626|FG000|Surgery|underwent robotic cystectomy|1|||
128874642|NCT01157676|463834627|FG001|Surgery|underwent robotic cystectomy|0|||
128874643|NCT01801735|463834633|FG000|Overall Study|Adverse Event|79|||
128874644|NCT01801735|463834633|FG000|Overall Study|Lack of Efficacy|28|||
128874645|NCT01801735|463834633|FG000|Overall Study|Withdrawal by Subject|27|||
128874646|NCT01801735|463834633|FG000|Overall Study|Protocol Violation|25|||
128874647|NCT01801735|463834633|FG000|Overall Study|Lost to Follow-up|15|||
128874648|NCT01801735|463834633|FG000|Overall Study|Non-compliance with Trial Drug|13|||
128874649|NCT01801735|463834633|FG000|Overall Study|Physician Decision|3|||
128874650|NCT01801735|463834633|FG000|Overall Study|Death|1|||
128874651|NCT01801735|463834633|FG000|Overall Study|Other, including site closure|19|||
128874652|NCT01435616|463834634|FG000|Overall Study|Adverse Event|39|||
128874653|NCT01435616|463834635|FG001|Overall Study|Adverse Event|21|||
128874654|NCT01435616|463834634|FG000|Overall Study|Death|7|||
128874655|NCT01435616|463834635|FG001|Overall Study|Death|2|||
128874656|NCT01435616|463834634|FG000|Overall Study|Lost to Follow-up|22|||
128874657|NCT01435616|463834635|FG001|Overall Study|Lost to Follow-up|13|||
128874658|NCT01435616|463834634|FG000|Overall Study|Protocol Violation|16|||
128874659|NCT01435616|463834635|FG001|Overall Study|Protocol Violation|13|||
128874660|NCT01435616|463834634|FG000|Overall Study|Withdrawal by Subject|66|||
128874661|NCT01435616|463834635|FG001|Overall Study|Withdrawal by Subject|24|||
128874662|NCT01435616|463834634|FG000|Overall Study|Physician Decision|20|||
128874663|NCT01435616|463834635|FG001|Overall Study|Physician Decision|7|||
128874664|NCT01435616|463834634|FG000|Overall Study|Sponsor Decision|1|||
128874665|NCT01435616|463834635|FG001|Overall Study|Sponsor Decision|0|||
128874666|NCT04860297|463834636|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
128874667|NCT04860297|463834637|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
128874668|NCT04860297|463834638|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
128874669|NCT04860297|463834639|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
128874670|NCT04860297|463834640|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
128874671|NCT04860297|463834641|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
128874672|NCT04860297|463834642|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
128874673|NCT04860297|463834643|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
128874674|NCT04860297|463834636|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
128874675|NCT04860297|463834637|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
128874676|NCT04860297|463834638|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
128874677|NCT04860297|463834639|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
128874678|NCT04860297|463834640|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
128874679|NCT04860297|463834641|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
128874680|NCT04860297|463834642|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
128874681|NCT04860297|463834643|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
128874682|NCT04860297|463834636|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
128874683|NCT04860297|463834637|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
128874684|NCT04860297|463834638|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
128874685|NCT04860297|463834639|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
128874686|NCT04860297|463834640|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
128874687|NCT04860297|463834641|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
128874688|NCT04860297|463834642|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
128874689|NCT04860297|463834643|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
128874690|NCT04860297|463834636|FG000|Part B (Booster Dose)|Other Than Specified|0|||
128874691|NCT04860297|463834637|FG001|Part B (Booster Dose)|Other Than Specified|0|||
128874692|NCT04860297|463834638|FG002|Part B (Booster Dose)|Other Than Specified|0|||
128874693|NCT04860297|463834639|FG003|Part B (Booster Dose)|Other Than Specified|0|||
128874694|NCT04860297|463834640|FG004|Part B (Booster Dose)|Other Than Specified|0|||
128874695|NCT04860297|463834641|FG005|Part B (Booster Dose)|Other Than Specified|1|||
128874696|NCT04860297|463834642|FG006|Part B (Booster Dose)|Other Than Specified|1|||
128874697|NCT04860297|463834643|FG007|Part B (Booster Dose)|Other Than Specified|0|||
128874698|NCT04860297|463834636|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
128874699|NCT04860297|463834637|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
128874700|NCT04860297|463834638|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
128874701|NCT04860297|463834639|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
128874702|NCT04860297|463834640|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
128874703|NCT04860297|463834641|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
128874704|NCT04860297|463834642|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
128874705|NCT04860297|463834643|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
128874706|NCT04860297|463834636|FG000|Part B (Booster Dose)|Death|0|||
128874707|NCT04860297|463834637|FG001|Part B (Booster Dose)|Death|0|||
128874708|NCT04860297|463834638|FG002|Part B (Booster Dose)|Death|0|||
128874709|NCT04860297|463834639|FG003|Part B (Booster Dose)|Death|0|||
128874710|NCT04860297|463834640|FG004|Part B (Booster Dose)|Death|1|||
128874711|NCT04860297|463834641|FG005|Part B (Booster Dose)|Death|2|||
128984133|NCT04145531|464229475|FG001|Part B|Progressive disease|0|||
129098209|NCT02474355|464652287|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
129098210|NCT02474355|464652287|FG000|Overall Study|Lost to Follow-up|98|||
129098211|NCT02474355|464652287|FG000|Overall Study|Withdrawal by Subject|124|||
128874712|NCT04860297|463834642|FG006|Part B (Booster Dose)|Death|1|||
128874713|NCT04860297|463834643|FG007|Part B (Booster Dose)|Death|0|||
128874714|NCT04860297|463834636|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
128874715|NCT04860297|463834637|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
128874716|NCT04860297|463834638|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
128874717|NCT04860297|463834639|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
128874718|NCT04860297|463834640|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
128874719|NCT04860297|463834641|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
128874720|NCT04860297|463834642|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
129098212|NCT02474355|464652287|FG000|Overall Study|Death|1361|||
129098213|NCT01911793|464652288|FG000|Overall Study|Physician Decision|1|||
128874721|NCT04860297|463834643|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
128874722|NCT04811131|463834647|FG000|Overall Study|Adverse Event|0|||
128874723|NCT04811131|463834648|FG001|Overall Study|Adverse Event|0|||
128874724|NCT04811131|463834649|FG002|Overall Study|Adverse Event|1|||
128874725|NCT04811131|463834650|FG003|Overall Study|Adverse Event|0|||
128874726|NCT04811131|463834647|FG000|Overall Study|Lack of Efficacy|0|||
128874727|NCT04811131|463834648|FG001|Overall Study|Lack of Efficacy|0|||
128874728|NCT04811131|463834649|FG002|Overall Study|Lack of Efficacy|0|||
128874729|NCT04811131|463834650|FG003|Overall Study|Lack of Efficacy|1|||
128874730|NCT04811131|463834647|FG000|Overall Study|Lost to Follow-up|0|||
128874731|NCT04811131|463834648|FG001|Overall Study|Lost to Follow-up|1|||
128874732|NCT04811131|463834649|FG002|Overall Study|Lost to Follow-up|0|||
128874733|NCT04811131|463834650|FG003|Overall Study|Lost to Follow-up|0|||
128874734|NCT04811131|463834647|FG000|Overall Study|Sponsor request|31|||
128874735|NCT04811131|463834648|FG001|Overall Study|Sponsor request|35|||
128874736|NCT04811131|463834649|FG002|Overall Study|Sponsor request|27|||
128874737|NCT04811131|463834650|FG003|Overall Study|Sponsor request|10|||
128874738|NCT04811131|463834647|FG000|Overall Study|Withdrawal by Subject|3|||
128874739|NCT04811131|463834648|FG001|Overall Study|Withdrawal by Subject|1|||
128874740|NCT04811131|463834649|FG002|Overall Study|Withdrawal by Subject|3|||
128874741|NCT04811131|463834650|FG003|Overall Study|Withdrawal by Subject|1|||
128874742|NCT00371683|463834652|FG000|DB Treatment Period-Randomized Patients|Death|1|||
128874743|NCT00371683|463834653|FG001|DB Treatment Period-Randomized Patients|Death|1|||
128874744|NCT00371683|463834652|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
128874745|NCT00371683|463834653|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
128874746|NCT00371683|463834652|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
128874747|NCT00371683|463834653|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
128874748|NCT00371683|463834652|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
128874749|NCT00371683|463834653|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
128874750|NCT00371683|463834652|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
128874751|NCT00371683|463834653|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
128874752|NCT00371683|463834652|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
128874753|NCT00371683|463834653|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
128874754|NCT00371683|463834652|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
128874755|NCT00371683|463834653|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
128874756|NCT00371683|463834652|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
128874757|NCT00371683|463834653|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
128874758|NCT00371683|463834652|FG000|Follow-Up Period - Randomized Patients|Death|0|||
128874759|NCT00371683|463834653|FG001|Follow-Up Period - Randomized Patients|Death|2|||
128874760|NCT00371683|463834652|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
128874761|NCT00371683|463834653|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
128874762|NCT00371683|463834652|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
128874763|NCT00371683|463834653|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
128874764|NCT03181789|463834655|FG000|Overall Study|Withdrawal by Subject|0|||
128874765|NCT03181789|463834656|FG001|Overall Study|Withdrawal by Subject|1|||
128874766|NCT03181789|463834657|FG002|Overall Study|Withdrawal by Subject|1|||
128874767|NCT03181789|463834658|FG003|Overall Study|Withdrawal by Subject|0|||
128874768|NCT03181789|463834655|FG000|Overall Study|Lost to Follow-up|7|||
128874769|NCT03181789|463834656|FG001|Overall Study|Lost to Follow-up|1|||
128874770|NCT03181789|463834657|FG002|Overall Study|Lost to Follow-up|0|||
128874771|NCT03181789|463834658|FG003|Overall Study|Lost to Follow-up|0|||
128874772|NCT03181789|463834655|FG000|Overall Study|Participant unable to adhere to visit|0|||
128874773|NCT03181789|463834656|FG001|Overall Study|Participant unable to adhere to visit|1|||
128874774|NCT03181789|463834657|FG002|Overall Study|Participant unable to adhere to visit|0|||
128874775|NCT03181789|463834658|FG003|Overall Study|Participant unable to adhere to visit|0|||
128874776|NCT01151410|463834659|FG000|Overall Study|Withdrawal by Subject|3|||
128874777|NCT01151410|463834660|FG001|Overall Study|Withdrawal by Subject|5|||
128874778|NCT01151410|463834659|FG000|Overall Study|Lost to Follow-up|3|||
128874779|NCT01151410|463834660|FG001|Overall Study|Lost to Follow-up|4|||
128874780|NCT01151410|463834659|FG000|Overall Study|Adverse Event|1|||
128874781|NCT01151410|463834660|FG001|Overall Study|Adverse Event|2|||
128874782|NCT01151410|463834659|FG000|Overall Study|Protocol deviation|2|||
128874783|NCT01151410|463834660|FG001|Overall Study|Protocol deviation|1|||
128874784|NCT01151410|463834659|FG000|Overall Study|Administrative problems|1|||
128874785|NCT01151410|463834660|FG001|Overall Study|Administrative problems|1|||
129098214|NCT01911793|464652289|FG001|Overall Study|Physician Decision|5|||
129098215|NCT03334422|464652290|FG000|Overall Study|Adverse Event|1|||
128874786|NCT01151410|463834659|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128874787|NCT01151410|463834660|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128874788|NCT01151410|463834659|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128874789|NCT01151410|463834660|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128874790|NCT00735475|463834661|FG000|Overall Study|Adverse Event|0|||
129098216|NCT03334422|464652291|FG001|Overall Study|Adverse Event|3|||
129098217|NCT03334422|464652292|FG002|Overall Study|Adverse Event|2|||
129098218|NCT03334422|464652293|FG003|Overall Study|Adverse Event|2|||
129098219|NCT03334422|464652290|FG000|Overall Study|Lack of Efficacy|10|||
129098220|NCT03334422|464652291|FG001|Overall Study|Lack of Efficacy|2|||
129098221|NCT03334422|464652292|FG002|Overall Study|Lack of Efficacy|7|||
129098222|NCT03334422|464652293|FG003|Overall Study|Lack of Efficacy|3|||
129098223|NCT03334422|464652290|FG000|Overall Study|Withdrawal by Subject|8|||
129098224|NCT03334422|464652291|FG001|Overall Study|Withdrawal by Subject|3|||
129098225|NCT03334422|464652292|FG002|Overall Study|Withdrawal by Subject|1|||
129098226|NCT03334422|464652293|FG003|Overall Study|Withdrawal by Subject|0|||
129098227|NCT03334422|464652290|FG000|Overall Study|Lost to Follow-up|0|||
129098228|NCT03334422|464652291|FG001|Overall Study|Lost to Follow-up|0|||
129098229|NCT03334422|464652292|FG002|Overall Study|Lost to Follow-up|0|||
129098230|NCT03334422|464652293|FG003|Overall Study|Lost to Follow-up|1|||
129098231|NCT03334422|464652290|FG000|Overall Study|Inability to obtain laboratory samples|0|||
129098232|NCT03334422|464652291|FG001|Overall Study|Inability to obtain laboratory samples|1|||
129098233|NCT03334422|464652292|FG002|Overall Study|Inability to obtain laboratory samples|0|||
129098234|NCT03334422|464652293|FG003|Overall Study|Inability to obtain laboratory samples|0|||
129098235|NCT03334422|464652290|FG000|Overall Study|Pregnancy|0|||
129098236|NCT03334422|464652291|FG001|Overall Study|Pregnancy|1|||
129098237|NCT03334422|464652292|FG002|Overall Study|Pregnancy|0|||
129098238|NCT03334422|464652293|FG003|Overall Study|Pregnancy|0|||
129098239|NCT02697916|464652294|FG000|Overall Study|Death|357|||
129098240|NCT02697916|464652295|FG001|Overall Study|Death|315|||
129098241|NCT02697916|464652294|FG000|Overall Study|Withdrawal by Subject|221|||
129098242|NCT02697916|464652295|FG001|Overall Study|Withdrawal by Subject|393|||
129098243|NCT03774394|464652296|FG000|Overall Study|Withdrawal by Subject|2|||
129098244|NCT03774394|464652297|FG001|Overall Study|Withdrawal by Subject|0|||
129098245|NCT01313221|464652300|FG000|Overall Study|Protocol Violation|0|||
129098246|NCT01313221|464652301|FG001|Overall Study|Protocol Violation|1|||
129098247|NCT01313221|464652302|FG002|Overall Study|Protocol Violation|1|||
129098248|NCT01313221|464652300|FG000|Overall Study|Non-compliance|3|||
129098249|NCT01313221|464652301|FG001|Overall Study|Non-compliance|0|||
129098250|NCT01313221|464652302|FG002|Overall Study|Non-compliance|2|||
129098251|NCT01313221|464652300|FG000|Overall Study|Withdrawal by Subject|2|||
129098252|NCT01313221|464652301|FG001|Overall Study|Withdrawal by Subject|3|||
129098253|NCT01313221|464652302|FG002|Overall Study|Withdrawal by Subject|5|||
129098254|NCT01313221|464652300|FG000|Overall Study|Requirement for alternative therapy|0|||
129098255|NCT01313221|464652301|FG001|Overall Study|Requirement for alternative therapy|1|||
129098256|NCT01313221|464652302|FG002|Overall Study|Requirement for alternative therapy|1|||
129098257|NCT01313221|464652300|FG000|Overall Study|Lost to Follow-up|6|||
129098258|NCT01313221|464652301|FG001|Overall Study|Lost to Follow-up|3|||
129098259|NCT01313221|464652302|FG002|Overall Study|Lost to Follow-up|1|||
129098260|NCT01313221|464652300|FG000|Overall Study|Other|1|||
129098261|NCT01313221|464652301|FG001|Overall Study|Other|0|||
129098262|NCT01313221|464652302|FG002|Overall Study|Other|0|||
129098263|NCT01313221|464652300|FG000|Overall Study|Adverse Event|0|||
129098264|NCT01313221|464652301|FG001|Overall Study|Adverse Event|0|||
129098265|NCT01313221|464652302|FG002|Overall Study|Adverse Event|7|||
129098266|NCT01313221|464652300|FG000|Overall Study|Disease progression|0|||
129098267|NCT01313221|464652301|FG001|Overall Study|Disease progression|0|||
129098268|NCT01313221|464652302|FG002|Overall Study|Disease progression|2|||
129098269|NCT01313221|464652300|FG000|Overall Study|Physician Decision|0|||
129098270|NCT01313221|464652301|FG001|Overall Study|Physician Decision|0|||
129098271|NCT01313221|464652302|FG002|Overall Study|Physician Decision|2|||
129098272|NCT01313221|464652300|FG000|Overall Study|Pregnancy|0|||
129098273|NCT01313221|464652301|FG001|Overall Study|Pregnancy|0|||
129098274|NCT01313221|464652302|FG002|Overall Study|Pregnancy|2|||
129098275|NCT00994214|464652303|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
129098276|NCT00994214|464652304|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
129098277|NCT00994214|464652305|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
129098278|NCT00994214|464652306|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
129098279|NCT00994214|464652303|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
129098280|NCT00994214|464652304|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
129098281|NCT00994214|464652305|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
129098282|NCT00994214|464652306|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
129098283|NCT00994214|464652303|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
129098284|NCT00994214|464652304|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
129098285|NCT00994214|464652305|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
129098286|NCT00994214|464652306|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
129098287|NCT00994214|464652303|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
129098288|NCT00994214|464652304|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
129098289|NCT00994214|464652305|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
129098290|NCT00994214|464652306|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
128874791|NCT00735475|463834662|FG001|Overall Study|Adverse Event|1|||
128874792|NCT00735475|463834661|FG000|Overall Study|Death|1|||
128874793|NCT00735475|463834662|FG001|Overall Study|Death|1|||
128874794|NCT00735475|463834661|FG000|Overall Study|Lost to Follow-up|3|||
128874795|NCT00735475|463834662|FG001|Overall Study|Lost to Follow-up|3|||
128874796|NCT00735475|463834661|FG000|Overall Study|Physician Decision|0|||
128874797|NCT00735475|463834662|FG001|Overall Study|Physician Decision|1|||
128874798|NCT00735475|463834661|FG000|Overall Study|Withdrawal by Subject|4|||
128874799|NCT00735475|463834662|FG001|Overall Study|Withdrawal by Subject|5|||
128874800|NCT02442336|463834663|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
128874801|NCT02442336|463834663|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
128874802|NCT02442336|463834663|FG000|Overall Study|Lost to Follow-up|11|||
128874803|NCT00844532|463834665|FG000|Overall Study|Death|16|||
128874804|NCT00844532|463834665|FG000|Overall Study|Withdrawal by Subject|16|||
128874805|NCT00844532|463834665|FG000|Overall Study|Lost to Follow-up|7|||
128874806|NCT01237587|463834668|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
128874807|NCT01237587|463834669|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
128874808|NCT01237587|463834668|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
128874809|NCT01237587|463834669|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
128874810|NCT01237587|463834668|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
128874811|NCT01237587|463834669|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
128874812|NCT01237587|463834668|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
128874813|NCT01237587|463834669|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
128874814|NCT01237587|463834668|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
128874815|NCT01237587|463834669|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
128874816|NCT01237587|463834668|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
128874817|NCT01237587|463834669|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
128874818|NCT01237587|463834668|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
128874819|NCT01237587|463834669|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
128874820|NCT01237587|463834668|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
128874821|NCT01237587|463834669|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
128874822|NCT01237587|463834668|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
128874823|NCT01237587|463834669|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
128874824|NCT01237587|463834668|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
128874825|NCT01237587|463834669|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
128874826|NCT01237587|463834668|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
128874827|NCT01237587|463834669|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
128874828|NCT01237587|463834668|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
128874829|NCT01237587|463834669|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
128874830|NCT01237587|463834668|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
128874831|NCT01237587|463834669|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
128874832|NCT01237587|463834668|FG000|Taper Phase|Adverse Event|0|||
128874833|NCT01237587|463834669|FG001|Taper Phase|Adverse Event|2|||
128874834|NCT01237587|463834668|FG000|Taper Phase|Protocol Violation|2|||
128874835|NCT01237587|463834669|FG001|Taper Phase|Protocol Violation|0|||
128874836|NCT01237587|463834668|FG000|Taper Phase|Lack of Efficacy|2|||
128874837|NCT01237587|463834669|FG001|Taper Phase|Lack of Efficacy|5|||
128874838|NCT01237587|463834668|FG000|Taper Phase|Parent/Guardian Decision|0|||
128874839|NCT01237587|463834669|FG001|Taper Phase|Parent/Guardian Decision|2|||
128874840|NCT01237587|463834668|FG000|Taper Phase|Sponsor Decision|1|||
128874841|NCT01237587|463834669|FG001|Taper Phase|Sponsor Decision|0|||
128874842|NCT01237587|463834668|FG000|Taper Phase|Withdrawal by Subject|0|||
128874843|NCT01237587|463834669|FG001|Taper Phase|Withdrawal by Subject|1|||
128874844|NCT03208036|463834674|FG000|Baseline Assessment|Withdrawal by Subject|1|||
128874845|NCT03208036|463834675|FG001|Baseline Assessment|Withdrawal by Subject|1|||
128874846|NCT03208036|463834674|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
128874847|NCT03208036|463834675|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
128874848|NCT03208036|463834674|FG000|Intervention|Withdrawal by Subject|3|||
128874849|NCT03208036|463834675|FG001|Intervention|Withdrawal by Subject|2|||
128874850|NCT03208036|463834674|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
128874851|NCT03208036|463834675|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
128874852|NCT02217501|463834681|FG000|Overall Study|Death|3|||
128874853|NCT02217501|463834682|FG001|Overall Study|Death|4|||
128874854|NCT00266227|463836265|FG000|Initial Treatment|Adverse Event|0|||
128874855|NCT00266227|463836266|FG001|Initial Treatment|Adverse Event|0|||
128874856|NCT00266227|463836267|FG002|Initial Treatment|Adverse Event|13|||
128874857|NCT00266227|463836265|FG000|Initial Treatment|Lost to Follow-up|0|||
128874858|NCT00266227|463836266|FG001|Initial Treatment|Lost to Follow-up|0|||
128874859|NCT00266227|463836267|FG002|Initial Treatment|Lost to Follow-up|6|||
128874860|NCT00266227|463836265|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
128874861|NCT00266227|463836266|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
128874862|NCT00266227|463836267|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
128874863|NCT00266227|463836265|FG000|Initial Treatment|Physician decision to withdraw|0|||
128874864|NCT00266227|463836266|FG001|Initial Treatment|Physician decision to withdraw|0|||
128874865|NCT00266227|463836267|FG002|Initial Treatment|Physician decision to withdraw|12|||
128874866|NCT00266227|463836265|FG000|Initial Treatment|Pregnancy|0|||
128874867|NCT00266227|463836266|FG001|Initial Treatment|Pregnancy|0|||
128874868|NCT00266227|463836267|FG002|Initial Treatment|Pregnancy|1|||
128874869|NCT00266227|463836265|FG000|Retreatment: Up to Week 48|Death|1|||
128874870|NCT00266227|463836266|FG001|Retreatment: Up to Week 48|Death|0|||
128874871|NCT00266227|463836267|FG002|Retreatment: Up to Week 48|Death|0|||
128874872|NCT00266227|463836265|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
128874873|NCT00266227|463836266|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
128874874|NCT00266227|463836267|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
128874875|NCT00266227|463836265|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
128874876|NCT00266227|463836266|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
128874877|NCT00266227|463836267|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
128874878|NCT00266227|463836265|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
128874879|NCT00266227|463836266|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
128874880|NCT00266227|463836267|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
128874881|NCT00266227|463836265|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
128874882|NCT00266227|463836266|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
128874883|NCT00266227|463836267|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
128874884|NCT00266227|463836265|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
128874885|NCT00266227|463836266|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
128874886|NCT00266227|463836267|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
128874887|NCT00266227|463836265|FG000|Retreatment: Week 48 to Week 72|Death|1|||
128874888|NCT00266227|463836266|FG001|Retreatment: Week 48 to Week 72|Death|1|||
128874889|NCT00266227|463836267|FG002|Retreatment: Week 48 to Week 72|Death|0|||
128874890|NCT00266227|463836265|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
128874891|NCT00266227|463836266|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
128874892|NCT00266227|463836267|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
128874893|NCT00266227|463836265|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
128874894|NCT00266227|463836266|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
128874895|NCT00266227|463836267|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
128874896|NCT00266227|463836265|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
128874897|NCT00266227|463836266|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
128874898|NCT00266227|463836267|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
128874899|NCT00266227|463836265|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
128874900|NCT00266227|463836266|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
128874901|NCT00266227|463836267|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
128874902|NCT00468104|463836272|FG000|First Intervention|Protocol Violation|2|||
129098291|NCT00994214|464652303|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
129098292|NCT00994214|464652304|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
129098293|NCT00994214|464652305|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
129098294|NCT00994214|464652306|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
129098295|NCT00994214|464652303|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
129098296|NCT00994214|464652304|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
128874903|NCT00468104|463836273|FG001|First Intervention|Protocol Violation|1|||
128874904|NCT00468104|463836272|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
128874905|NCT00468104|463836273|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
128874906|NCT00468104|463836272|FG000|First Intervention|died within 3 weeks|1|||
128874907|NCT00468104|463836273|FG001|First Intervention|died within 3 weeks|0|||
128874908|NCT00468104|463836272|FG000|First Intervention|malposition/blocked chest tube tube|2|||
128874909|NCT00468104|463836273|FG001|First Intervention|malposition/blocked chest tube tube|0|||
128874910|NCT00468104|463836272|FG000|First Intervention|large lung mass with minimal effusion|1|||
128874911|NCT00468104|463836273|FG001|First Intervention|large lung mass with minimal effusion|0|||
129098297|NCT00994214|464652305|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
129098298|NCT00994214|464652306|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
129098299|NCT01716520|464652308|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
128874912|NCT00468104|463836272|FG000|First Intervention|associated prolonged pneumothorax|1|||
128874913|NCT00468104|463836273|FG001|First Intervention|associated prolonged pneumothorax|0|||
128874914|NCT00468104|463836272|FG000|First Intervention|trapped lung|1|||
128874915|NCT00468104|463836273|FG001|First Intervention|trapped lung|0|||
128874916|NCT00468104|463836272|FG000|Second Intervention|Withdrawal by Subject|5|||
128874917|NCT00468104|463836273|FG001|Second Intervention|Withdrawal by Subject|2|||
128874918|NCT00468104|463836272|FG000|Second Intervention|discarded for malposition of chest tube|0|||
128874919|NCT00468104|463836273|FG001|Second Intervention|discarded for malposition of chest tube|2|||
128874920|NCT01263665|463836274|FG000|Overall Study|Withdrew Consent|1|||
128874921|NCT01263665|463836274|FG000|Overall Study|Lost to Follow-up|3|||
128874922|NCT01263665|463836274|FG000|Overall Study|Death|2|||
128874923|NCT01263665|463836274|FG000|Overall Study|Amputation above the ankle|1|||
128874924|NCT01263665|463836274|FG000|Overall Study|Surgical Bypass|2|||
128874925|NCT00381615|463836277|FG000|Overall Study|Withdrawal by Subject|1|||
128874926|NCT00381615|463836278|FG001|Overall Study|Withdrawal by Subject|3|||
128874927|NCT00381615|463836279|FG002|Overall Study|Withdrawal by Subject|0|||
128874928|NCT00381615|463836280|FG003|Overall Study|Withdrawal by Subject|1|||
128874929|NCT00381615|463836277|FG000|Overall Study|Lost to Follow-up|3|||
128874930|NCT00381615|463836278|FG001|Overall Study|Lost to Follow-up|2|||
128874931|NCT00381615|463836279|FG002|Overall Study|Lost to Follow-up|0|||
128874932|NCT00381615|463836280|FG003|Overall Study|Lost to Follow-up|1|||
128874933|NCT00381615|463836277|FG000|Overall Study|Protocol Violation|0|||
128874934|NCT00381615|463836278|FG001|Overall Study|Protocol Violation|0|||
128874935|NCT00381615|463836279|FG002|Overall Study|Protocol Violation|1|||
128874936|NCT00381615|463836280|FG003|Overall Study|Protocol Violation|0|||
128874937|NCT01528345|463836286|FG000|Overall Study|Adverse Event|10|||
128874938|NCT01528345|463836287|FG001|Overall Study|Adverse Event|1|||
128874939|NCT01528345|463836286|FG000|Overall Study|Death|1|||
128874940|NCT01528345|463836287|FG001|Overall Study|Death|1|||
128874941|NCT01528345|463836286|FG000|Overall Study|Non-compliance with study treatment|1|||
128874942|NCT01528345|463836287|FG001|Overall Study|Non-compliance with study treatment|0|||
128874943|NCT01528345|463836286|FG000|Overall Study|Progressive Disease|26|||
128874944|NCT01528345|463836287|FG001|Overall Study|Progressive Disease|40|||
128874945|NCT01528345|463836286|FG000|Overall Study|Study Terminated by Sponsor|4|||
128874946|NCT01528345|463836287|FG001|Overall Study|Study Terminated by Sponsor|8|||
128874947|NCT01528345|463836286|FG000|Overall Study|Subject/Guardian Decision|5|||
128874948|NCT01528345|463836287|FG001|Overall Study|Subject/Guardian Decision|0|||
128874949|NCT02624791|463836288|FG000|Overall Study|Withdrawal by Subject|2|||
128874950|NCT02624791|463836289|FG001|Overall Study|Withdrawal by Subject|0|||
128874951|NCT02624791|463836290|FG002|Overall Study|Withdrawal by Subject|0|||
128874952|NCT02624791|463836291|FG003|Overall Study|Withdrawal by Subject|0|||
128874953|NCT02624791|463836292|FG004|Overall Study|Withdrawal by Subject|0|||
128874954|NCT02624791|463836293|FG005|Overall Study|Withdrawal by Subject|0|||
128874955|NCT01131182|463836294|FG000|Overall Study|Withdrawal by Subject|1|||
128874956|NCT01131182|463836295|FG001|Overall Study|Withdrawal by Subject|1|||
128874957|NCT01131182|463836294|FG000|Overall Study|Lost to Follow-up|14|||
128874958|NCT01131182|463836295|FG001|Overall Study|Lost to Follow-up|15|||
128874959|NCT01131182|463836294|FG000|Overall Study|Other Reason|1|||
128874960|NCT01131182|463836295|FG001|Overall Study|Other Reason|0|||
128874961|NCT01146782|463836300|FG000|Screening Cohort|Screen Failure|187|||
128874962|NCT01146782|463836300|FG000|Screening Cohort|Lost to Follow-up|4|||
128874963|NCT01146782|463836300|FG000|Screening Cohort|Physician Decision|1|||
128874964|NCT01146782|463836300|FG000|Screening Cohort|Withdrawal by Subject|29|||
128874965|NCT01146782|463836300|FG000|Safety Cohort|Screen Failure|61|||
128874966|NCT01146782|463836300|FG000|Safety Cohort|Withdrawal by Subject|4|||
128874967|NCT01146782|463836300|FG000|Safety Cohort|Control AHI <5|4|||
128874968|NCT01146782|463836300|FG000|Safety Cohort|TST <4 hrs|14|||
128874969|NCT01146782|463836300|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
128874970|NCT01146782|463836300|FG000|Primary Endpoint Cohort|Physician Decision|1|||
128874971|NCT02270515|463836301|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
128874972|NCT02270515|463836301|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
128874973|NCT02270515|463836301|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
128874974|NCT02270515|463836301|FG000|Intervention Period 1: 0-6 Months|Death|7|||
128874975|NCT02270515|463836301|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
129098300|NCT01716520|464652309|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129098301|NCT01716520|464652310|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
129098302|NCT01716520|464652311|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
128874976|NCT02270515|463836301|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
128874977|NCT02270515|463836301|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
128874978|NCT02270515|463836301|FG000|Intervention Period 2: 6-12 Months|Death|5|||
128874979|NCT02270515|463836301|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
128874980|NCT02270515|463836301|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
128874981|NCT02270515|463836301|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
128874982|NCT02270515|463836301|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
128874983|NCT02270515|463836301|FG000|Intervention Period 3: 12-18 Months|Death|3|||
128874984|NCT02270515|463836301|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
128874985|NCT02656329|463836303|FG000|Overall Study|Lost to Follow-up|2|||
128874986|NCT02656329|463836304|FG001|Overall Study|Lost to Follow-up|3|||
128874987|NCT02656329|463836303|FG000|Overall Study|Withdrawal by Subject|7|||
128874988|NCT02656329|463836304|FG001|Overall Study|Withdrawal by Subject|6|||
128874989|NCT02656329|463836303|FG000|Overall Study|Study termination by Sponsor|150|||
128874990|NCT02656329|463836304|FG001|Overall Study|Study termination by Sponsor|142|||
128874991|NCT02656329|463836303|FG000|Overall Study|Other than specified above|5|||
128874992|NCT02656329|463836304|FG001|Overall Study|Other than specified above|6|||
128874993|NCT01139580|463836305|FG000|Overall Study|Adverse Event|5|||
128874994|NCT01139580|463836306|FG001|Overall Study|Adverse Event|4|||
128874995|NCT01139580|463836305|FG000|Overall Study|Lost to Follow-up|9|||
128874996|NCT01139580|463836306|FG001|Overall Study|Lost to Follow-up|1|||
128874997|NCT01139580|463836305|FG000|Overall Study|Lack of Efficacy|0|||
128874998|NCT01139580|463836306|FG001|Overall Study|Lack of Efficacy|2|||
128874999|NCT01139580|463836305|FG000|Overall Study|Withdrawal by Subject|6|||
128875000|NCT01139580|463836306|FG001|Overall Study|Withdrawal by Subject|9|||
128875001|NCT01139580|463836305|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
128875002|NCT01139580|463836306|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
128875003|NCT01139580|463836305|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
128875004|NCT01139580|463836306|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
128875005|NCT01139580|463836305|FG000|Overall Study|Misrandomized|1|||
128875006|NCT01139580|463836306|FG001|Overall Study|Misrandomized|0|||
128875007|NCT01139580|463836305|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
128875008|NCT01139580|463836306|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
128875009|NCT01139580|463836305|FG000|Overall Study|Participant Randomization in Error|0|||
128875010|NCT01139580|463836306|FG001|Overall Study|Participant Randomization in Error|1|||
128875011|NCT00633880|463836307|FG000|Open Label Titration|Lack of Efficacy|1|||
128875012|NCT00633880|463836308|FG001|Open Label Titration|Lack of Efficacy|0|||
128875013|NCT00633880|463836309|FG002|Open Label Titration|Lack of Efficacy|0|||
128875014|NCT00633880|463836307|FG000|Open Label Titration|Adverse Event|13|||
128875015|NCT00633880|463836308|FG001|Open Label Titration|Adverse Event|0|||
128875016|NCT00633880|463836309|FG002|Open Label Titration|Adverse Event|0|||
128875017|NCT00633880|463836307|FG000|Open Label Titration|Treatment Failure|55|||
128875018|NCT00633880|463836308|FG001|Open Label Titration|Treatment Failure|0|||
128875019|NCT00633880|463836309|FG002|Open Label Titration|Treatment Failure|0|||
128875020|NCT00633880|463836307|FG000|Open Label Titration|Protocol Violation|6|||
128875021|NCT00633880|463836308|FG001|Open Label Titration|Protocol Violation|0|||
128875022|NCT00633880|463836309|FG002|Open Label Titration|Protocol Violation|0|||
128875023|NCT00633880|463836307|FG000|Open Label Titration|Physician Decision|1|||
128875024|NCT00633880|463836308|FG001|Open Label Titration|Physician Decision|0|||
128875025|NCT00633880|463836309|FG002|Open Label Titration|Physician Decision|0|||
128875026|NCT00633880|463836307|FG000|Open Label Titration|Withdrawal by Subject|4|||
128875027|NCT00633880|463836308|FG001|Open Label Titration|Withdrawal by Subject|0|||
128875028|NCT00633880|463836309|FG002|Open Label Titration|Withdrawal by Subject|0|||
128875029|NCT01879553|463836315|FG000|Overall Study|Withdrawal by Subject|1|||
128875030|NCT01879553|463836316|FG001|Overall Study|Withdrawal by Subject|0|||
128875031|NCT00591851|463836317|FG000|Overall Study|Withdrawal by Subject|3|||
128875032|NCT00591851|463836317|FG000|Overall Study|Adverse Event|2|||
128875033|NCT00591851|463836317|FG000|Overall Study|Progressive Disease|1|||
128875034|NCT02559895|463836319|FG000|Overall Study|Adverse Event|3|||
128875035|NCT02559895|463836320|FG001|Overall Study|Adverse Event|3|||
128875036|NCT02559895|463836321|FG002|Overall Study|Adverse Event|2|||
128875037|NCT02559895|463836322|FG003|Overall Study|Adverse Event|1|||
128875038|NCT02559895|463836319|FG000|Overall Study|Lack of Efficacy|2|||
128875039|NCT02559895|463836320|FG001|Overall Study|Lack of Efficacy|3|||
128875040|NCT02559895|463836321|FG002|Overall Study|Lack of Efficacy|2|||
128875041|NCT02559895|463836322|FG003|Overall Study|Lack of Efficacy|8|||
128875042|NCT02559895|463836319|FG000|Overall Study|Lost to Follow-up|22|||
128875043|NCT02559895|463836320|FG001|Overall Study|Lost to Follow-up|16|||
128875044|NCT02559895|463836321|FG002|Overall Study|Lost to Follow-up|12|||
128875045|NCT02559895|463836322|FG003|Overall Study|Lost to Follow-up|17|||
128875046|NCT02559895|463836319|FG000|Overall Study|Physician Decision|1|||
128875047|NCT02559895|463836320|FG001|Overall Study|Physician Decision|1|||
128875048|NCT02559895|463836321|FG002|Overall Study|Physician Decision|3|||
128875049|NCT02559895|463836322|FG003|Overall Study|Physician Decision|0|||
128875050|NCT02559895|463836319|FG000|Overall Study|Withdrawal by Subject|16|||
128875051|NCT02559895|463836320|FG001|Overall Study|Withdrawal by Subject|9|||
128875052|NCT02559895|463836321|FG002|Overall Study|Withdrawal by Subject|20|||
128875053|NCT02559895|463836322|FG003|Overall Study|Withdrawal by Subject|9|||
128875054|NCT02559895|463836319|FG000|Overall Study|Study Burden|10|||
129098303|NCT01716520|464652312|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
128875055|NCT02559895|463836320|FG001|Overall Study|Study Burden|16|||
128875056|NCT02559895|463836321|FG002|Overall Study|Study Burden|12|||
128875057|NCT02559895|463836322|FG003|Overall Study|Study Burden|22|||
128875058|NCT02559895|463836319|FG000|Overall Study|Other|1|||
128875059|NCT02559895|463836320|FG001|Overall Study|Other|5|||
128875060|NCT02559895|463836321|FG002|Overall Study|Other|3|||
128875061|NCT02559895|463836322|FG003|Overall Study|Other|3|||
128875062|NCT00515853|463836330|FG000|Overall Study|Lost to Follow-up|9|||
128875063|NCT00515853|463836331|FG001|Overall Study|Lost to Follow-up|13|||
128875064|NCT00515853|463836330|FG000|Overall Study|Withdrawal by Subject|6|||
128875065|NCT00515853|463836331|FG001|Overall Study|Withdrawal by Subject|4|||
128875066|NCT01262027|463836332|FG000|Overall Study|Adverse Event|1|||
128875067|NCT01262027|463836332|FG000|Overall Study|Withdrawal by Subject|3|||
128875068|NCT01262027|463836332|FG000|Overall Study|Protocol Violation|1|||
128875069|NCT00589121|463836336|FG000|Overall Study|Protocol Violation|2|||
128875070|NCT00589121|463836337|FG001|Overall Study|Protocol Violation|6|||
128875071|NCT00589121|463836336|FG000|Overall Study|No protocol treatment received|0|||
128875072|NCT00589121|463836337|FG001|Overall Study|No protocol treatment received|1|||
128875073|NCT00847808|463836339|FG000|Overall Study|Adverse Event|7|||
128875074|NCT00847808|463836339|FG000|Overall Study|Protocol Violation|1|||
128875075|NCT00847808|463836339|FG000|Overall Study|Lost to Follow-up|1|||
128875076|NCT00847808|463836339|FG000|Overall Study|Withdrawal by Subject|4|||
128875077|NCT00847808|463836339|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
128875078|NCT00847808|463836339|FG000|Overall Study|Participant Took Excluded Medication|1|||
128875079|NCT01758900|463836346|FG000|Overall Study|difficulty for further intubation|7|||
128875080|NCT01758900|463836347|FG001|Overall Study|difficulty for further intubation|8|||
128875081|NCT01892540|463836349|FG000|Overall Study|Did not complete PET/MRI|0|||
128875082|NCT01892540|463836350|FG001|Overall Study|Did not complete PET/MRI|0|||
128875083|NCT01892540|463836351|FG002|Overall Study|Did not complete PET/MRI|2|||
128875084|NCT01892540|463836349|FG000|Overall Study|Did not fit in scanner|0|||
128875085|NCT01892540|463836350|FG001|Overall Study|Did not fit in scanner|0|||
128875086|NCT01892540|463836351|FG002|Overall Study|Did not fit in scanner|1|||
128875087|NCT01370590|463836352|FG000|Period 1|Adverse Event|8|||
128875088|NCT01370590|463836353|FG001|Period 1|Adverse Event|4|||
128875089|NCT01370590|463836352|FG000|Period 1|Lost to Follow-up|2|||
128875090|NCT01370590|463836353|FG001|Period 1|Lost to Follow-up|2|||
128875091|NCT01370590|463836352|FG000|Period 1|Protocol Violation|2|||
128875092|NCT01370590|463836353|FG001|Period 1|Protocol Violation|2|||
128875093|NCT01370590|463836352|FG000|Period 1|Withdrawal by Subject|4|||
128875094|NCT01370590|463836353|FG001|Period 1|Withdrawal by Subject|2|||
128875095|NCT01370590|463836352|FG000|Period 1|Could not access randomization system|0|||
128875096|NCT01370590|463836353|FG001|Period 1|Could not access randomization system|1|||
128875097|NCT01370590|463836352|FG000|Crossover Washout Period|Adverse Event|1|||
128875098|NCT01370590|463836353|FG001|Crossover Washout Period|Adverse Event|4|||
128875099|NCT01370590|463836352|FG000|Crossover Washout Period|Lost to Follow-up|2|||
128875100|NCT01370590|463836353|FG001|Crossover Washout Period|Lost to Follow-up|0|||
128875101|NCT01370590|463836352|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
128875102|NCT01370590|463836353|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
128875103|NCT01370590|463836352|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
128875104|NCT01370590|463836353|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
128875105|NCT01370590|463836352|FG000|Period 2|Adverse Event|0|||
128875106|NCT01370590|463836353|FG001|Period 2|Adverse Event|1|||
128875107|NCT01370590|463836352|FG000|Period 2|Withdrawal by Subject|1|||
128875108|NCT01370590|463836353|FG001|Period 2|Withdrawal by Subject|1|||
128875109|NCT05172050|463836354|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
128875110|NCT05172050|463836355|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
128875111|NCT05172050|463836356|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
128875112|NCT05172050|463836354|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
128875113|NCT05172050|463836355|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
128875114|NCT05172050|463836356|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
128875115|NCT05172050|463836354|FG000|Overall Study|Other|2|||
128875116|NCT05172050|463836355|FG001|Overall Study|Other|2|||
128875117|NCT05172050|463836356|FG002|Overall Study|Other|1|||
128875118|NCT00604825|463836357|FG000|Overall Study|Adverse Event|2|||
128875119|NCT00604825|463836358|FG001|Overall Study|Adverse Event|6|||
128875120|NCT00604825|463836359|FG002|Overall Study|Adverse Event|7|||
128875121|NCT00604825|463836360|FG003|Overall Study|Adverse Event|4|||
128875122|NCT00604825|463836357|FG000|Overall Study|Lost to Follow-up|0|||
128875123|NCT00604825|463836358|FG001|Overall Study|Lost to Follow-up|3|||
128875124|NCT00604825|463836359|FG002|Overall Study|Lost to Follow-up|1|||
128875125|NCT00604825|463836360|FG003|Overall Study|Lost to Follow-up|0|||
128875126|NCT00604825|463836357|FG000|Overall Study|Protocol Violation|0|||
128875127|NCT00604825|463836358|FG001|Overall Study|Protocol Violation|1|||
128875128|NCT00604825|463836359|FG002|Overall Study|Protocol Violation|0|||
128875129|NCT00604825|463836360|FG003|Overall Study|Protocol Violation|0|||
128875130|NCT00604825|463836357|FG000|Overall Study|Withdrawal by Subject|4|||
128875131|NCT00604825|463836358|FG001|Overall Study|Withdrawal by Subject|3|||
128875132|NCT00604825|463836359|FG002|Overall Study|Withdrawal by Subject|5|||
128875133|NCT00604825|463836360|FG003|Overall Study|Withdrawal by Subject|5|||
128875134|NCT00604825|463836357|FG000|Overall Study|Lack of Efficacy|3|||
128875135|NCT00604825|463836358|FG001|Overall Study|Lack of Efficacy|2|||
128875136|NCT00604825|463836359|FG002|Overall Study|Lack of Efficacy|1|||
128875137|NCT00604825|463836360|FG003|Overall Study|Lack of Efficacy|0|||
128875138|NCT00604825|463836357|FG000|Overall Study|Did not meet eligibility criteria|0|||
128875139|NCT00604825|463836358|FG001|Overall Study|Did not meet eligibility criteria|0|||
128875140|NCT00604825|463836359|FG002|Overall Study|Did not meet eligibility criteria|2|||
128875141|NCT00604825|463836360|FG003|Overall Study|Did not meet eligibility criteria|0|||
128875142|NCT00604825|463836357|FG000|Overall Study|Physician Decision|0|||
128875143|NCT00604825|463836358|FG001|Overall Study|Physician Decision|0|||
128875144|NCT00604825|463836359|FG002|Overall Study|Physician Decision|0|||
128875145|NCT00604825|463836360|FG003|Overall Study|Physician Decision|1|||
128875146|NCT00604825|463836357|FG000|Overall Study|Exclusion criterion met|0|||
128875147|NCT00604825|463836358|FG001|Overall Study|Exclusion criterion met|0|||
128875148|NCT00604825|463836359|FG002|Overall Study|Exclusion criterion met|0|||
128875149|NCT00604825|463836360|FG003|Overall Study|Exclusion criterion met|1|||
128875150|NCT04617275|463836361|FG000|Treatment Period|Adverse Event|1|||
128875151|NCT04617275|463836362|FG001|Treatment Period|Adverse Event|6|||
128875152|NCT04617275|463836363|FG002|Treatment Period|Adverse Event|4|||
128875153|NCT04617275|463836364|FG003|Treatment Period|Adverse Event|6|||
128875154|NCT04617275|463836365|FG004|Treatment Period|Adverse Event|7|||
128875155|NCT04617275|463836366|FG005|Treatment Period|Adverse Event|8|||
128875156|NCT04617275|463836367|FG006|Treatment Period|Adverse Event|0|||
128875157|NCT04617275|463836368|FG007|Treatment Period|Adverse Event|12|||
128875158|NCT04617275|463836361|FG000|Treatment Period|Lost to Follow-up|0|||
128875159|NCT04617275|463836362|FG001|Treatment Period|Lost to Follow-up|0|||
128875160|NCT04617275|463836363|FG002|Treatment Period|Lost to Follow-up|2|||
128875161|NCT04617275|463836364|FG003|Treatment Period|Lost to Follow-up|0|||
128875162|NCT04617275|463836365|FG004|Treatment Period|Lost to Follow-up|0|||
128875163|NCT04617275|463836366|FG005|Treatment Period|Lost to Follow-up|3|||
128875164|NCT04617275|463836367|FG006|Treatment Period|Lost to Follow-up|0|||
128875165|NCT04617275|463836368|FG007|Treatment Period|Lost to Follow-up|2|||
128875166|NCT04617275|463836361|FG000|Treatment Period|No longer meets eligibility criteria|0|||
128875167|NCT04617275|463836362|FG001|Treatment Period|No longer meets eligibility criteria|0|||
128875168|NCT04617275|463836363|FG002|Treatment Period|No longer meets eligibility criteria|0|||
128875169|NCT04617275|463836364|FG003|Treatment Period|No longer meets eligibility criteria|1|||
128875170|NCT04617275|463836365|FG004|Treatment Period|No longer meets eligibility criteria|0|||
128875171|NCT04617275|463836366|FG005|Treatment Period|No longer meets eligibility criteria|0|||
128875172|NCT04617275|463836367|FG006|Treatment Period|No longer meets eligibility criteria|0|||
128875173|NCT04617275|463836368|FG007|Treatment Period|No longer meets eligibility criteria|0|||
128875174|NCT04617275|463836361|FG000|Treatment Period|Other|0|||
128875175|NCT04617275|463836362|FG001|Treatment Period|Other|1|||
128875176|NCT04617275|463836363|FG002|Treatment Period|Other|0|||
128875177|NCT04617275|463836364|FG003|Treatment Period|Other|0|||
128875178|NCT04617275|463836365|FG004|Treatment Period|Other|0|||
128875179|NCT04617275|463836366|FG005|Treatment Period|Other|0|||
128875180|NCT04617275|463836367|FG006|Treatment Period|Other|0|||
128875181|NCT04617275|463836368|FG007|Treatment Period|Other|0|||
128875182|NCT04617275|463836361|FG000|Treatment Period|Withdrawal by Subject|2|||
128875183|NCT04617275|463836362|FG001|Treatment Period|Withdrawal by Subject|0|||
128875184|NCT04617275|463836363|FG002|Treatment Period|Withdrawal by Subject|0|||
128875185|NCT04617275|463836364|FG003|Treatment Period|Withdrawal by Subject|2|||
128875186|NCT04617275|463836365|FG004|Treatment Period|Withdrawal by Subject|2|||
128875187|NCT04617275|463836366|FG005|Treatment Period|Withdrawal by Subject|0|||
128875188|NCT04617275|463836367|FG006|Treatment Period|Withdrawal by Subject|1|||
128875189|NCT04617275|463836368|FG007|Treatment Period|Withdrawal by Subject|2|||
128875190|NCT04617275|463836361|FG000|Follow-up Period|Adverse Event|1|||
128875191|NCT04617275|463836362|FG001|Follow-up Period|Adverse Event|1|||
128875192|NCT04617275|463836363|FG002|Follow-up Period|Adverse Event|2|||
128875193|NCT04617275|463836364|FG003|Follow-up Period|Adverse Event|3|||
128875194|NCT04617275|463836365|FG004|Follow-up Period|Adverse Event|4|||
128875195|NCT04617275|463836366|FG005|Follow-up Period|Adverse Event|3|||
128875196|NCT04617275|463836367|FG006|Follow-up Period|Adverse Event|0|||
128875197|NCT04617275|463836368|FG007|Follow-up Period|Adverse Event|3|||
128875198|NCT04617275|463836361|FG000|Follow-up Period|Lost to Follow-up|0|||
128875199|NCT04617275|463836362|FG001|Follow-up Period|Lost to Follow-up|1|||
128875200|NCT04617275|463836363|FG002|Follow-up Period|Lost to Follow-up|2|||
128875201|NCT04617275|463836364|FG003|Follow-up Period|Lost to Follow-up|0|||
128875202|NCT04617275|463836365|FG004|Follow-up Period|Lost to Follow-up|0|||
128875203|NCT04617275|463836366|FG005|Follow-up Period|Lost to Follow-up|4|||
128875204|NCT04617275|463836367|FG006|Follow-up Period|Lost to Follow-up|0|||
128875205|NCT04617275|463836368|FG007|Follow-up Period|Lost to Follow-up|3|||
128875206|NCT04617275|463836361|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
128875207|NCT04617275|463836362|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
128875208|NCT04617275|463836363|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
128875209|NCT04617275|463836364|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
128875210|NCT04617275|463836365|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
128875211|NCT04617275|463836366|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
128875212|NCT04617275|463836367|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
128875213|NCT04617275|463836368|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
128875214|NCT04617275|463836361|FG000|Follow-up Period|Other|0|||
128875215|NCT04617275|463836362|FG001|Follow-up Period|Other|1|||
128875216|NCT04617275|463836363|FG002|Follow-up Period|Other|0|||
128875217|NCT04617275|463836364|FG003|Follow-up Period|Other|0|||
128875218|NCT04617275|463836365|FG004|Follow-up Period|Other|0|||
128875219|NCT04617275|463836366|FG005|Follow-up Period|Other|0|||
128875220|NCT04617275|463836367|FG006|Follow-up Period|Other|0|||
128875221|NCT04617275|463836368|FG007|Follow-up Period|Other|0|||
128875222|NCT04617275|463836361|FG000|Follow-up Period|Withdrawal by Subject|2|||
128875223|NCT04617275|463836362|FG001|Follow-up Period|Withdrawal by Subject|0|||
128875224|NCT04617275|463836363|FG002|Follow-up Period|Withdrawal by Subject|0|||
128875225|NCT04617275|463836364|FG003|Follow-up Period|Withdrawal by Subject|2|||
128875226|NCT04617275|463836365|FG004|Follow-up Period|Withdrawal by Subject|2|||
128875227|NCT04617275|463836366|FG005|Follow-up Period|Withdrawal by Subject|0|||
128875228|NCT04617275|463836367|FG006|Follow-up Period|Withdrawal by Subject|1|||
128875229|NCT04617275|463836368|FG007|Follow-up Period|Withdrawal by Subject|2|||
128875230|NCT04927884|463836376|FG000|Overall Study|Progressive Disease|2|||
128875231|NCT05593445|463836377|FG000|12-Week DBVC Period|Adverse Event|1|||
128875232|NCT05593445|463836378|FG001|12-Week DBVC Period|Adverse Event|0|||
128875233|NCT05593445|463836379|FG002|12-Week DBVC Period|Adverse Event|0|||
128875234|NCT05593445|463836380|FG003|12-Week DBVC Period|Adverse Event|0|||
128875235|NCT05593445|463836377|FG000|12-Week DBVC Period|Physician Decision|0|||
128875236|NCT05593445|463836378|FG001|12-Week DBVC Period|Physician Decision|1|||
128875237|NCT05593445|463836379|FG002|12-Week DBVC Period|Physician Decision|0|||
128875238|NCT05593445|463836380|FG003|12-Week DBVC Period|Physician Decision|0|||
128875239|NCT05593445|463836377|FG000|12-Week DBVC Period|Protocol Violation|0|||
128875240|NCT05593445|463836378|FG001|12-Week DBVC Period|Protocol Violation|1|||
128875241|NCT05593445|463836379|FG002|12-Week DBVC Period|Protocol Violation|0|||
128875242|NCT05593445|463836380|FG003|12-Week DBVC Period|Protocol Violation|0|||
128875243|NCT05593445|463836377|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
128875244|NCT05593445|463836378|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
128875245|NCT05593445|463836379|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
128875246|NCT05593445|463836380|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
128875247|NCT05593445|463836377|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
128875248|NCT05593445|463836378|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
128875249|NCT05593445|463836379|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
128875250|NCT05593445|463836380|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
128875251|NCT05593445|463836377|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
128875252|NCT05593445|463836378|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
128875253|NCT05593445|463836379|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
128875254|NCT05593445|463836380|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
128875255|NCT05593445|463836377|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
128875256|NCT05593445|463836378|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
128875257|NCT05593445|463836379|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
128875258|NCT05593445|463836380|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
128875259|NCT05593445|463836377|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128875260|NCT05593445|463836378|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128875261|NCT05593445|463836379|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
128875262|NCT05593445|463836380|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128875263|NCT05559476|463836381|FG000|Overall Study|Adverse Event|2|||
128875264|NCT05559476|463836382|FG001|Overall Study|Adverse Event|0|||
128875265|NCT05559476|463836381|FG000|Overall Study|Lost to Follow-up|13|||
128875266|NCT05559476|463836382|FG001|Overall Study|Lost to Follow-up|12|||
128875267|NCT05559476|463836381|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
128875268|NCT05559476|463836382|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
128875269|NCT05559476|463836381|FG000|Overall Study|Other|0|||
128875270|NCT05559476|463836382|FG001|Overall Study|Other|2|||
128875271|NCT00727311|463836383|FG000|Overall Study|Did not receive drug|316|||
128875272|NCT00727311|463836383|FG000|Overall Study|Missing end of therapy data|205|||
128875273|NCT00727311|463836383|FG000|Overall Study|Adverse Event|58|||
128875274|NCT00727311|463836383|FG000|Overall Study|Lack of Efficacy|242|||
128875275|NCT00727311|463836383|FG000|Overall Study|Lost to Follow-up|73|||
128875276|NCT00727311|463836383|FG000|Overall Study|Withdrawal by Subject|77|||
128875277|NCT00727311|463836383|FG000|Overall Study|Other|97|||
128875278|NCT00727311|463836383|FG000|Overall Study|Multiple reasons|39|||
128875279|NCT00565851|463837509|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
128875280|NCT00565851|463837510|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
128875281|NCT00565851|463837511|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
128875282|NCT00565851|463837512|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
128875283|NCT00565851|463837513|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
128875284|NCT00565851|463837514|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
128875285|NCT00565851|463837515|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
128875286|NCT00565851|463837516|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
128875287|NCT00565851|463837509|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
128875288|NCT00565851|463837510|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
128875289|NCT00565851|463837511|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
128875290|NCT00565851|463837512|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
128875291|NCT00565851|463837513|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
128875292|NCT00565851|463837514|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
128875293|NCT00565851|463837515|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
128875294|NCT00565851|463837516|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
128875295|NCT00775463|463837519|FG000|Overall Study|Withdrawal by Subject|0|||
128875296|NCT00775463|463837520|FG001|Overall Study|Withdrawal by Subject|1|||
128875297|NCT00775463|463837519|FG000|Overall Study|Adverse Event|7|||
128875298|NCT00775463|463837520|FG001|Overall Study|Adverse Event|9|||
128875299|NCT00775463|463837519|FG000|Overall Study|Protocol Violation|2|||
128875300|NCT00775463|463837520|FG001|Overall Study|Protocol Violation|2|||
128875301|NCT00775463|463837519|FG000|Overall Study|Lost to Follow-up|1|||
128875302|NCT00775463|463837520|FG001|Overall Study|Lost to Follow-up|0|||
128875303|NCT00775463|463837519|FG000|Overall Study|Lack of Efficacy|1|||
128875304|NCT00775463|463837520|FG001|Overall Study|Lack of Efficacy|1|||
128875305|NCT00969709|463837521|FG000|Overall Study|Adverse Event|3|||
128875306|NCT00969709|463837522|FG001|Overall Study|Adverse Event|13|||
128875307|NCT00969709|463837523|FG002|Overall Study|Adverse Event|26|||
128875308|NCT00969709|463837524|FG003|Overall Study|Adverse Event|12|||
128875309|NCT00969709|463837521|FG000|Overall Study|Lack of Efficacy|7|||
128875310|NCT00969709|463837522|FG001|Overall Study|Lack of Efficacy|4|||
128875311|NCT00969709|463837523|FG002|Overall Study|Lack of Efficacy|1|||
128875312|NCT00969709|463837524|FG003|Overall Study|Lack of Efficacy|3|||
128875313|NCT00969709|463837521|FG000|Overall Study|Protocol Violation|9|||
128875314|NCT00969709|463837522|FG001|Overall Study|Protocol Violation|5|||
128875315|NCT00969709|463837523|FG002|Overall Study|Protocol Violation|9|||
128875316|NCT00969709|463837524|FG003|Overall Study|Protocol Violation|10|||
128875317|NCT00969709|463837521|FG000|Overall Study|Withdrawal by Subject|9|||
128875318|NCT00969709|463837522|FG001|Overall Study|Withdrawal by Subject|12|||
128875319|NCT00969709|463837523|FG002|Overall Study|Withdrawal by Subject|11|||
128875320|NCT00969709|463837524|FG003|Overall Study|Withdrawal by Subject|23|||
128875321|NCT00969709|463837521|FG000|Overall Study|Lost to Follow-up|10|||
128875322|NCT00969709|463837522|FG001|Overall Study|Lost to Follow-up|14|||
128875323|NCT00969709|463837523|FG002|Overall Study|Lost to Follow-up|8|||
128875324|NCT00969709|463837524|FG003|Overall Study|Lost to Follow-up|15|||
128875325|NCT00969709|463837521|FG000|Overall Study|Other reasons|0|||
128875326|NCT00969709|463837522|FG001|Overall Study|Other reasons|0|||
128875327|NCT00969709|463837523|FG002|Overall Study|Other reasons|3|||
128875328|NCT00969709|463837524|FG003|Overall Study|Other reasons|0|||
128875329|NCT03695237|463837525|FG000|Overall Study|Withdrawal by Subject|1|||
128875330|NCT03695237|463837526|FG001|Overall Study|Withdrawal by Subject|3|||
128875331|NCT03695237|463837525|FG000|Overall Study|Lost to Follow-up|1|||
128875332|NCT03695237|463837526|FG001|Overall Study|Lost to Follow-up|2|||
128875333|NCT03695237|463837525|FG000|Overall Study|Other, Not Specified|8|||
128875334|NCT03695237|463837526|FG001|Overall Study|Other, Not Specified|2|||
128875335|NCT01789567|463837529|FG000|Overall Study|Death|6|||
128875336|NCT00091169|463837530|FG000|Overall Study|Disease progression|3|||
128875337|NCT00091169|463837531|FG001|Overall Study|Disease progression|1|||
128875338|NCT00091169|463837530|FG000|Overall Study|Adverse Event|11|||
128875339|NCT00091169|463837531|FG001|Overall Study|Adverse Event|17|||
128875340|NCT00091169|463837530|FG000|Overall Study|Death|4|||
128875341|NCT00091169|463837531|FG001|Overall Study|Death|1|||
128875342|NCT00091169|463837530|FG000|Overall Study|Withdrawal by Subject|10|||
128875343|NCT00091169|463837531|FG001|Overall Study|Withdrawal by Subject|13|||
128875344|NCT00091169|463837530|FG000|Overall Study|Other|3|||
128875345|NCT00091169|463837531|FG001|Overall Study|Other|4|||
128875346|NCT00091169|463837530|FG000|Overall Study|Not start protocol therapy|26|||
128875347|NCT00091169|463837531|FG001|Overall Study|Not start protocol therapy|17|||
128875348|NCT00872989|463837532|FG000|Overall Study|Adverse Event|7|||
128875349|NCT00872989|463837533|FG001|Overall Study|Adverse Event|15|||
128875350|NCT00872989|463837532|FG000|Overall Study|Withdrawal by Subject|8|||
128875351|NCT00872989|463837533|FG001|Overall Study|Withdrawal by Subject|5|||
128875352|NCT00872989|463837532|FG000|Overall Study|Progression/relapse|47|||
128875353|NCT00872989|463837533|FG001|Overall Study|Progression/relapse|35|||
128875354|NCT00872989|463837532|FG000|Overall Study|Not protocol specified|3|||
128875355|NCT00872989|463837533|FG001|Overall Study|Not protocol specified|8|||
128875356|NCT01238900|463837534|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
128875357|NCT01238900|463837534|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
128875358|NCT03725085|463837535|FG000|Overall Study|Lost to Follow-up|2|||
129098304|NCT01716520|464652313|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
129098305|NCT01716520|464652308|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
129098306|NCT01716520|464652309|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
128875359|NCT01227577|463837536|FG000|Overall Study|Protocol deviation|3|||
128875360|NCT01227577|463837536|FG000|Overall Study|Death|3|||
128875361|NCT01227577|463837536|FG000|Overall Study|Administrative problems|2|||
128875362|NCT01227577|463837536|FG000|Overall Study|Lost to Follow-up|1|||
128875363|NCT01227577|463837536|FG000|Overall Study|Withdrawal by Subject|4|||
128875364|NCT01227577|463837536|FG000|Overall Study|Lack of Efficacy|5|||
128875365|NCT01227577|463837536|FG000|Overall Study|Adverse Event|17|||
128875366|NCT00852540|463837537|FG000|Overall Study|Adverse Event|10|||
128875367|NCT00852540|463837538|FG001|Overall Study|Adverse Event|3|||
128875368|NCT00852540|463837537|FG000|Overall Study|Lack of Efficacy|15|||
128875369|NCT00852540|463837538|FG001|Overall Study|Lack of Efficacy|3|||
128875370|NCT00852540|463837537|FG000|Overall Study|Protocol Violation|1|||
128875371|NCT00852540|463837538|FG001|Overall Study|Protocol Violation|2|||
128875372|NCT00852540|463837537|FG000|Overall Study|Lost to Follow-up|2|||
128875373|NCT00852540|463837538|FG001|Overall Study|Lost to Follow-up|3|||
128875374|NCT00852540|463837537|FG000|Overall Study|Investigator Discretion|2|||
128875375|NCT00852540|463837538|FG001|Overall Study|Investigator Discretion|3|||
128875376|NCT00852540|463837537|FG000|Overall Study|Withdrawal by Subject|3|||
128875377|NCT00852540|463837538|FG001|Overall Study|Withdrawal by Subject|1|||
128875378|NCT00852540|463837537|FG000|Overall Study|Did Not Receive Study Drug|3|||
128875379|NCT00852540|463837538|FG001|Overall Study|Did Not Receive Study Drug|3|||
128875380|NCT01639495|463837539|FG000|Overall Study|Lost to Follow-up|6|||
128875381|NCT01639495|463837539|FG000|Overall Study|Consented but didn't have study catheter|4|||
128875382|NCT01639495|463837539|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
128875383|NCT01639495|463837539|FG000|Overall Study|No radiofrequency energy applied|2|||
128875384|NCT01119105|463837540|FG000|Overall Study|Withdrawal by Subject|1|||
128875385|NCT01119105|463837541|FG001|Overall Study|Withdrawal by Subject|1|||
128875386|NCT01119105|463837542|FG002|Overall Study|Withdrawal by Subject|1|||
128875387|NCT01119105|463837540|FG000|Overall Study|Lost to Follow-up|0|||
128875388|NCT01119105|463837541|FG001|Overall Study|Lost to Follow-up|2|||
128875389|NCT01119105|463837542|FG002|Overall Study|Lost to Follow-up|5|||
128875390|NCT01119105|463837540|FG000|Overall Study|Adverse Event|1|||
128875391|NCT01119105|463837541|FG001|Overall Study|Adverse Event|0|||
128875392|NCT01119105|463837542|FG002|Overall Study|Adverse Event|1|||
128875393|NCT01119105|463837540|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
128875394|NCT01119105|463837541|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
128875395|NCT01119105|463837542|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
128875396|NCT01119105|463837540|FG000|Overall Study|Other|1|||
128875397|NCT01119105|463837541|FG001|Overall Study|Other|1|||
128875398|NCT01119105|463837542|FG002|Overall Study|Other|0|||
128875399|NCT01775475|463837543|FG000|Overall Study|Death|3|||
128875400|NCT01775475|463837544|FG001|Overall Study|Death|3|||
128875401|NCT00618618|463837545|FG000|Overall Study|Patient Request|0|||
128875402|NCT00618618|463837546|FG001|Overall Study|Patient Request|0|||
128875403|NCT00618618|463837547|FG002|Overall Study|Patient Request|2|||
128875404|NCT00618618|463837548|FG003|Overall Study|Patient Request|0|||
128875405|NCT00618618|463837545|FG000|Overall Study|Inability to Complete Study Procedures|0|||
128875406|NCT00618618|463837546|FG001|Overall Study|Inability to Complete Study Procedures|1|||
128875407|NCT00618618|463837547|FG002|Overall Study|Inability to Complete Study Procedures|0|||
128875408|NCT00618618|463837548|FG003|Overall Study|Inability to Complete Study Procedures|0|||
128875409|NCT00618618|463837545|FG000|Overall Study|Lost to Follow-up|3|||
128875410|NCT00618618|463837546|FG001|Overall Study|Lost to Follow-up|0|||
128875411|NCT00618618|463837547|FG002|Overall Study|Lost to Follow-up|0|||
128875412|NCT00618618|463837548|FG003|Overall Study|Lost to Follow-up|1|||
128875413|NCT00618618|463837545|FG000|Overall Study|Non-compliance|1|||
128875414|NCT00618618|463837546|FG001|Overall Study|Non-compliance|1|||
128875415|NCT00618618|463837547|FG002|Overall Study|Non-compliance|0|||
128875416|NCT00618618|463837548|FG003|Overall Study|Non-compliance|0|||
128875417|NCT00618618|463837545|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
128875418|NCT00618618|463837546|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
128875419|NCT00618618|463837547|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
128875420|NCT00618618|463837548|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
128875421|NCT00618618|463837545|FG000|Overall Study|Death|0|||
128875422|NCT00618618|463837546|FG001|Overall Study|Death|1|||
128875423|NCT00618618|463837547|FG002|Overall Study|Death|0|||
128875424|NCT00618618|463837548|FG003|Overall Study|Death|0|||
128875425|NCT02929329|463837549|FG000|Overall Study|Withdrawal by Subject|24|||
128875426|NCT02929329|463837550|FG001|Overall Study|Withdrawal by Subject|21|||
128875427|NCT02929329|463837549|FG000|Overall Study|Lost to Follow-up|26|||
128875428|NCT02929329|463837550|FG001|Overall Study|Lost to Follow-up|20|||
128875429|NCT02929329|463837549|FG000|Overall Study|Death|1054|||
128875430|NCT02929329|463837550|FG001|Overall Study|Death|1051|||
128875431|NCT01183234|463837551|FG000|First Intervention|Adverse Event|1|||
128875432|NCT01183234|463837552|FG001|First Intervention|Adverse Event|0|||
128875433|NCT00309959|463837561|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
128875434|NCT03836716|463837564|FG000|Overall Study|Adverse Event|3|||
128875435|NCT03836716|463837564|FG000|Overall Study|Death|22|||
128875436|NCT03836716|463837564|FG000|Overall Study|Withdrawal by Subject|8|||
128875437|NCT03836716|463837564|FG000|Overall Study|Study terminated by sponsor|87|||
128875438|NCT00037830|463837565|FG000|Overall Study|Adverse Event|2|||
128875439|NCT00037830|463837566|FG001|Overall Study|Adverse Event|0|||
128875440|NCT00037830|463837567|FG002|Overall Study|Adverse Event|0|||
128875441|NCT00037830|463837565|FG000|Overall Study|Withdrawal by Subject|4|||
128875442|NCT00037830|463837566|FG001|Overall Study|Withdrawal by Subject|5|||
128875443|NCT00037830|463837567|FG002|Overall Study|Withdrawal by Subject|1|||
128875444|NCT00037830|463837565|FG000|Overall Study|Protocol Violation|2|||
128875445|NCT00037830|463837566|FG001|Overall Study|Protocol Violation|2|||
128875446|NCT00037830|463837567|FG002|Overall Study|Protocol Violation|0|||
128875447|NCT00037830|463837565|FG000|Overall Study|Unrelated Medical Problem|2|||
128875448|NCT00037830|463837566|FG001|Overall Study|Unrelated Medical Problem|0|||
128875449|NCT00037830|463837567|FG002|Overall Study|Unrelated Medical Problem|0|||
128875450|NCT03292432|463837570|FG000|Overall Study|Lost to Follow-up|11|||
128875451|NCT03292432|463837571|FG001|Overall Study|Lost to Follow-up|8|||
128875452|NCT03292432|463837570|FG000|Overall Study|Death|2|||
128875453|NCT03292432|463837571|FG001|Overall Study|Death|1|||
128875454|NCT03292432|463837570|FG000|Overall Study|Withdrawal by Subject|1|||
128875455|NCT03292432|463837571|FG001|Overall Study|Withdrawal by Subject|2|||
128875456|NCT03292432|463837570|FG000|Overall Study|Site closed before any data collected|1|||
128875457|NCT03292432|463837571|FG001|Overall Study|Site closed before any data collected|0|||
128875458|NCT01014143|463837575|FG000|Second Intervention|Lost to Follow-up|2|||
128875459|NCT01014143|463837576|FG001|Second Intervention|Lost to Follow-up|0|||
128875460|NCT01014143|463837577|FG002|Second Intervention|Lost to Follow-up|0|||
128875461|NCT04638920|463837582|FG000|Overall Study|Withdrawal by Subject|5|||
128875462|NCT03775434|463837583|FG000|Overall Study|Adverse Event|2|||
128875463|NCT03775434|463837583|FG000|Overall Study|Withdrawal by Subject|1|||
128875464|NCT01859988|463837584|FG000|Overall Study|Withdrawal by Subject|6|||
128875465|NCT01859988|463837585|FG001|Overall Study|Withdrawal by Subject|3|||
128875466|NCT01859988|463837586|FG002|Overall Study|Withdrawal by Subject|4|||
128875467|NCT01859988|463837587|FG003|Overall Study|Withdrawal by Subject|3|||
128875468|NCT01859988|463837588|FG004|Overall Study|Withdrawal by Subject|2|||
128875469|NCT01859988|463837589|FG005|Overall Study|Withdrawal by Subject|2|||
128875470|NCT01859988|463837584|FG000|Overall Study|Lack of Efficacy|1|||
128875471|NCT01859988|463837585|FG001|Overall Study|Lack of Efficacy|1|||
128875472|NCT01859988|463837586|FG002|Overall Study|Lack of Efficacy|5|||
128875473|NCT01859988|463837587|FG003|Overall Study|Lack of Efficacy|0|||
128875474|NCT01859988|463837588|FG004|Overall Study|Lack of Efficacy|7|||
128875475|NCT01859988|463837589|FG005|Overall Study|Lack of Efficacy|9|||
128875476|NCT01859988|463837584|FG000|Overall Study|Physician Decision|1|||
128875477|NCT01859988|463837585|FG001|Overall Study|Physician Decision|3|||
128875478|NCT01859988|463837586|FG002|Overall Study|Physician Decision|1|||
128875479|NCT01859988|463837587|FG003|Overall Study|Physician Decision|3|||
128875480|NCT01859988|463837588|FG004|Overall Study|Physician Decision|4|||
128875481|NCT01859988|463837589|FG005|Overall Study|Physician Decision|1|||
128875482|NCT01859988|463837584|FG000|Overall Study|Adverse Event|2|||
128875483|NCT01859988|463837585|FG001|Overall Study|Adverse Event|1|||
128875484|NCT01859988|463837586|FG002|Overall Study|Adverse Event|3|||
128875485|NCT01859988|463837587|FG003|Overall Study|Adverse Event|1|||
128875486|NCT01859988|463837588|FG004|Overall Study|Adverse Event|2|||
128875487|NCT01859988|463837589|FG005|Overall Study|Adverse Event|2|||
128875488|NCT01859988|463837584|FG000|Overall Study|Lost to Follow-up|1|||
128875489|NCT01859988|463837585|FG001|Overall Study|Lost to Follow-up|2|||
128875490|NCT01859988|463837586|FG002|Overall Study|Lost to Follow-up|3|||
128875491|NCT01859988|463837587|FG003|Overall Study|Lost to Follow-up|0|||
128875492|NCT01859988|463837588|FG004|Overall Study|Lost to Follow-up|3|||
128875493|NCT01859988|463837589|FG005|Overall Study|Lost to Follow-up|2|||
128875494|NCT01859988|463837584|FG000|Overall Study|Protocol Violation|0|||
128875495|NCT01859988|463837585|FG001|Overall Study|Protocol Violation|0|||
128875496|NCT01859988|463837586|FG002|Overall Study|Protocol Violation|1|||
128875497|NCT01859988|463837587|FG003|Overall Study|Protocol Violation|0|||
128875498|NCT01859988|463837588|FG004|Overall Study|Protocol Violation|0|||
128875499|NCT01859988|463837589|FG005|Overall Study|Protocol Violation|0|||
128875500|NCT01859988|463837584|FG000|Overall Study|Other than specified above|0|||
128875501|NCT01859988|463837585|FG001|Overall Study|Other than specified above|2|||
128875502|NCT01859988|463837586|FG002|Overall Study|Other than specified above|11|||
128875503|NCT01859988|463837587|FG003|Overall Study|Other than specified above|3|||
128875504|NCT01859988|463837588|FG004|Overall Study|Other than specified above|5|||
128875505|NCT01859988|463837589|FG005|Overall Study|Other than specified above|3|||
128875506|NCT01871805|463837592|FG000|Phase I|Death|7|||
128875507|NCT01871805|463837593|FG001|Phase I|Death|4|||
128875508|NCT01871805|463837594|FG002|Phase I|Death|6|||
128875509|NCT01871805|463837595|FG003|Phase I|Death|2|||
128875510|NCT01871805|463837596|FG004|Phase I|Death|9|||
128875511|NCT01871805|463837597|FG005|Phase I|Death|0|||
128875512|NCT01871805|463837592|FG000|Phase I|Alive in Survival Follow-up|0|||
128875513|NCT01871805|463837593|FG001|Phase I|Alive in Survival Follow-up|2|||
128875514|NCT01871805|463837594|FG002|Phase I|Alive in Survival Follow-up|4|||
128875515|NCT01871805|463837595|FG003|Phase I|Alive in Survival Follow-up|5|||
128875516|NCT01871805|463837596|FG004|Phase I|Alive in Survival Follow-up|4|||
128875517|NCT01871805|463837597|FG005|Phase I|Alive in Survival Follow-up|0|||
128875518|NCT01871805|463837592|FG000|Phase I|Lost to Follow-up|0|||
128875519|NCT01871805|463837593|FG001|Phase I|Lost to Follow-up|1|||
128875520|NCT01871805|463837594|FG002|Phase I|Lost to Follow-up|3|||
128875521|NCT01871805|463837595|FG003|Phase I|Lost to Follow-up|0|||
128875522|NCT01871805|463837596|FG004|Phase I|Lost to Follow-up|0|||
128875523|NCT01871805|463837597|FG005|Phase I|Lost to Follow-up|0|||
128875524|NCT01871805|463837592|FG000|Phase II|Death|0|||
128875525|NCT01871805|463837593|FG001|Phase II|Death|0|||
128875526|NCT01871805|463837594|FG002|Phase II|Death|0|||
128875527|NCT01871805|463837595|FG003|Phase II|Death|0|||
128875528|NCT01871805|463837596|FG004|Phase II|Death|0|||
128875529|NCT01871805|463837597|FG005|Phase II|Death|45|||
128875530|NCT01871805|463837592|FG000|Phase II|Alive in Survival Follow-up|0|||
128875531|NCT01871805|463837593|FG001|Phase II|Alive in Survival Follow-up|0|||
128875532|NCT01871805|463837594|FG002|Phase II|Alive in Survival Follow-up|0|||
128875533|NCT01871805|463837595|FG003|Phase II|Alive in Survival Follow-up|0|||
128875534|NCT01871805|463837596|FG004|Phase II|Alive in Survival Follow-up|0|||
128875535|NCT01871805|463837597|FG005|Phase II|Alive in Survival Follow-up|29|||
128875536|NCT01871805|463837592|FG000|Phase II|Lost to Follow-up|0|||
128875537|NCT01871805|463837593|FG001|Phase II|Lost to Follow-up|0|||
128875538|NCT01871805|463837594|FG002|Phase II|Lost to Follow-up|0|||
128875539|NCT01871805|463837595|FG003|Phase II|Lost to Follow-up|0|||
128875540|NCT01871805|463837596|FG004|Phase II|Lost to Follow-up|0|||
128875541|NCT01871805|463837597|FG005|Phase II|Lost to Follow-up|13|||
128875542|NCT00468559|463837600|FG000|Open-label Treatment Phase|Adverse Event|5|||
128875543|NCT00468559|463837601|FG001|Open-label Treatment Phase|Adverse Event|0|||
128875544|NCT00468559|463837602|FG002|Open-label Treatment Phase|Adverse Event|0|||
128875545|NCT00468559|463837600|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
128875546|NCT00468559|463837601|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
128875547|NCT00468559|463837602|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
128875548|NCT00468559|463837600|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
128875549|NCT00468559|463837601|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
128875550|NCT00468559|463837602|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
128875551|NCT00468559|463837600|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
128875552|NCT00468559|463837601|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
128875553|NCT00468559|463837602|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
128875554|NCT00468559|463837600|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
128875555|NCT00468559|463837601|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
128875556|NCT00468559|463837602|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
128875557|NCT04602221|463837605|FG000|Overall Study|Discontinuation of trial treatment|0|||
128875558|NCT04602221|463837606|FG001|Overall Study|Discontinuation of trial treatment|0|||
128875559|NCT04602221|463837607|FG002|Overall Study|Discontinuation of trial treatment|1|||
128875560|NCT04602221|463837608|FG003|Overall Study|Discontinuation of trial treatment|0|||
128875561|NCT04602221|463837609|FG004|Overall Study|Discontinuation of trial treatment|0|||
128875562|NCT04602221|463837610|FG005|Overall Study|Discontinuation of trial treatment|0|||
128875563|NCT04602221|463837611|FG006|Overall Study|Discontinuation of trial treatment|0|||
128875564|NCT04602221|463837612|FG007|Overall Study|Discontinuation of trial treatment|0|||
128875565|NCT04602221|463837613|FG008|Overall Study|Discontinuation of trial treatment|0|||
128875566|NCT04602221|463837614|FG009|Overall Study|Discontinuation of trial treatment|0|||
128875567|NCT04602221|463837615|FG010|Overall Study|Discontinuation of trial treatment|0|||
128875568|NCT04602221|463837616|FG011|Overall Study|Discontinuation of trial treatment|0|||
128875569|NCT04602221|463837617|FG012|Overall Study|Discontinuation of trial treatment|0|||
128875570|NCT04602221|463837618|FG013|Overall Study|Discontinuation of trial treatment|0|||
128875571|NCT04602221|463837619|FG014|Overall Study|Discontinuation of trial treatment|0|||
128875572|NCT04602221|463837620|FG015|Overall Study|Discontinuation of trial treatment|0|||
128875573|NCT04602221|463837621|FG016|Overall Study|Discontinuation of trial treatment|0|||
128875574|NCT04602221|463837622|FG017|Overall Study|Discontinuation of trial treatment|0|||
128875575|NCT04602221|463837605|FG000|Overall Study|Other than listed|0|||
128875576|NCT04602221|463837606|FG001|Overall Study|Other than listed|0|||
128875577|NCT04602221|463837607|FG002|Overall Study|Other than listed|0|||
128875578|NCT04602221|463837608|FG003|Overall Study|Other than listed|0|||
128875579|NCT04602221|463837609|FG004|Overall Study|Other than listed|0|||
128875580|NCT04602221|463837610|FG005|Overall Study|Other than listed|0|||
128875581|NCT04602221|463837611|FG006|Overall Study|Other than listed|0|||
128875582|NCT04602221|463837612|FG007|Overall Study|Other than listed|0|||
128875583|NCT04602221|463837613|FG008|Overall Study|Other than listed|0|||
128875584|NCT04602221|463837614|FG009|Overall Study|Other than listed|0|||
128875585|NCT04602221|463837615|FG010|Overall Study|Other than listed|0|||
129098307|NCT01716520|464652310|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
128875586|NCT04602221|463837616|FG011|Overall Study|Other than listed|0|||
128875587|NCT04602221|463837617|FG012|Overall Study|Other than listed|0|||
128875588|NCT04602221|463837618|FG013|Overall Study|Other than listed|0|||
128875589|NCT04602221|463837619|FG014|Overall Study|Other than listed|0|||
128875590|NCT04602221|463837620|FG015|Overall Study|Other than listed|1|||
128875591|NCT04602221|463837621|FG016|Overall Study|Other than listed|0|||
128875592|NCT04602221|463837622|FG017|Overall Study|Other than listed|1|||
128875593|NCT04602221|463837605|FG000|Overall Study|Withdrawal by Subject|0|||
128875594|NCT04602221|463837606|FG001|Overall Study|Withdrawal by Subject|0|||
128875595|NCT04602221|463837607|FG002|Overall Study|Withdrawal by Subject|0|||
128875596|NCT04602221|463837608|FG003|Overall Study|Withdrawal by Subject|0|||
128875597|NCT04602221|463837609|FG004|Overall Study|Withdrawal by Subject|0|||
128875598|NCT04602221|463837610|FG005|Overall Study|Withdrawal by Subject|0|||
128875599|NCT04602221|463837611|FG006|Overall Study|Withdrawal by Subject|0|||
128875600|NCT04602221|463837612|FG007|Overall Study|Withdrawal by Subject|0|||
128875601|NCT04602221|463837613|FG008|Overall Study|Withdrawal by Subject|0|||
128875602|NCT04602221|463837614|FG009|Overall Study|Withdrawal by Subject|0|||
128875603|NCT04602221|463837615|FG010|Overall Study|Withdrawal by Subject|0|||
128875604|NCT04602221|463837616|FG011|Overall Study|Withdrawal by Subject|0|||
128875605|NCT04602221|463837617|FG012|Overall Study|Withdrawal by Subject|1|||
128875606|NCT04602221|463837618|FG013|Overall Study|Withdrawal by Subject|0|||
128875607|NCT04602221|463837619|FG014|Overall Study|Withdrawal by Subject|0|||
128875608|NCT04602221|463837620|FG015|Overall Study|Withdrawal by Subject|0|||
128875609|NCT04602221|463837621|FG016|Overall Study|Withdrawal by Subject|0|||
128875610|NCT04602221|463837622|FG017|Overall Study|Withdrawal by Subject|0|||
128875611|NCT04602221|463837605|FG000|Overall Study|Lost to Follow-up|0|||
128875612|NCT04602221|463837606|FG001|Overall Study|Lost to Follow-up|0|||
128875613|NCT04602221|463837607|FG002|Overall Study|Lost to Follow-up|0|||
128875614|NCT04602221|463837608|FG003|Overall Study|Lost to Follow-up|0|||
128875615|NCT04602221|463837609|FG004|Overall Study|Lost to Follow-up|0|||
128875616|NCT04602221|463837610|FG005|Overall Study|Lost to Follow-up|1|||
128875617|NCT04602221|463837611|FG006|Overall Study|Lost to Follow-up|0|||
128875618|NCT04602221|463837612|FG007|Overall Study|Lost to Follow-up|0|||
128875619|NCT04602221|463837613|FG008|Overall Study|Lost to Follow-up|0|||
128875620|NCT04602221|463837614|FG009|Overall Study|Lost to Follow-up|0|||
128875621|NCT04602221|463837615|FG010|Overall Study|Lost to Follow-up|0|||
128875622|NCT04602221|463837616|FG011|Overall Study|Lost to Follow-up|0|||
128875623|NCT04602221|463837617|FG012|Overall Study|Lost to Follow-up|0|||
128875624|NCT04602221|463837618|FG013|Overall Study|Lost to Follow-up|0|||
128875625|NCT04602221|463837619|FG014|Overall Study|Lost to Follow-up|0|||
128875626|NCT04602221|463837620|FG015|Overall Study|Lost to Follow-up|0|||
128875627|NCT04602221|463837621|FG016|Overall Study|Lost to Follow-up|0|||
128875628|NCT04602221|463837622|FG017|Overall Study|Lost to Follow-up|0|||
128875629|NCT00911768|463837623|FG000|Overall Study|Protocol Violation|5|||
128875630|NCT00911768|463837624|FG001|Overall Study|Protocol Violation|4|||
128875631|NCT00911768|463837623|FG000|Overall Study|Withdrawal by Subject|1|||
128875632|NCT00911768|463837624|FG001|Overall Study|Withdrawal by Subject|0|||
128875633|NCT03538301|463837625|FG000|Overall Study|Adverse Event|1|||
128875634|NCT03538301|463837626|FG001|Overall Study|Adverse Event|4|||
128875635|NCT03538301|463837627|FG002|Overall Study|Adverse Event|4|||
128875636|NCT03538301|463837625|FG000|Overall Study|Death|1|||
128875637|NCT03538301|463837626|FG001|Overall Study|Death|1|||
128875638|NCT03538301|463837627|FG002|Overall Study|Death|0|||
128875639|NCT03538301|463837625|FG000|Overall Study|Physician Decision|0|||
128875640|NCT03538301|463837626|FG001|Overall Study|Physician Decision|1|||
128875641|NCT03538301|463837627|FG002|Overall Study|Physician Decision|0|||
128875642|NCT03538301|463837625|FG000|Overall Study|Protocol Violation|0|||
128875643|NCT03538301|463837626|FG001|Overall Study|Protocol Violation|0|||
128875644|NCT03538301|463837627|FG002|Overall Study|Protocol Violation|1|||
128875645|NCT03538301|463837625|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
128875646|NCT03538301|463837626|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
128875647|NCT03538301|463837627|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
128875648|NCT02842151|463837628|FG000|Overall Study|Adverse Event|1|||
128875649|NCT02842151|463837628|FG000|Overall Study|Subject moved too far away|1|||
128875650|NCT04540887|463837629|FG000|Overall Study|Withdrawal by Subject|2|||
128875651|NCT05180500|463837632|FG000|Overall Study|Adverse Event|1|||
128875652|NCT05180500|463837633|FG001|Overall Study|Adverse Event|0|||
128875653|NCT05180500|463837632|FG000|Overall Study|Withdrawal by Subject|2|||
128875654|NCT05180500|463837633|FG001|Overall Study|Withdrawal by Subject|0|||
128875655|NCT00867308|463837634|FG000|Overall Study|Death|1|||
128875656|NCT00867308|463837635|FG001|Overall Study|Death|0|||
128875657|NCT00867308|463837634|FG000|Overall Study|Adverse Event|1|||
128875658|NCT00867308|463837635|FG001|Overall Study|Adverse Event|4|||
128875659|NCT00867308|463837634|FG000|Overall Study|Lack of Efficacy|6|||
128875660|NCT00867308|463837635|FG001|Overall Study|Lack of Efficacy|12|||
128875661|NCT00867308|463837634|FG000|Overall Study|Withdrawal by Subject|1|||
128875662|NCT00867308|463837635|FG001|Overall Study|Withdrawal by Subject|2|||
129098308|NCT01716520|464652311|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
128875663|NCT05917470|463837641|FG000|Overall Study|Progressive Disease|1|||
128875664|NCT05917470|463837642|FG001|Overall Study|Progressive Disease|1|||
128875665|NCT05917470|463837643|FG002|Overall Study|Progressive Disease|2|||
128875666|NCT05917470|463837644|FG003|Overall Study|Progressive Disease|3|||
128875667|NCT05917470|463837645|FG004|Overall Study|Progressive Disease|1|||
128875668|NCT05917470|463837646|FG005|Overall Study|Progressive Disease|1|||
128875669|NCT05917470|463837647|FG006|Overall Study|Progressive Disease|0|||
128875670|NCT05917470|463837648|FG007|Overall Study|Progressive Disease|0|||
128875671|NCT05917470|463837641|FG000|Overall Study|Withdrawal by Subject|0|||
128875672|NCT05917470|463837642|FG001|Overall Study|Withdrawal by Subject|0|||
128875673|NCT05917470|463837643|FG002|Overall Study|Withdrawal by Subject|1|||
128875674|NCT05917470|463837644|FG003|Overall Study|Withdrawal by Subject|0|||
128875675|NCT05917470|463837645|FG004|Overall Study|Withdrawal by Subject|0|||
128875676|NCT05917470|463837646|FG005|Overall Study|Withdrawal by Subject|0|||
128875677|NCT05917470|463837647|FG006|Overall Study|Withdrawal by Subject|0|||
128875678|NCT05917470|463837648|FG007|Overall Study|Withdrawal by Subject|0|||
128875679|NCT05917470|463837641|FG000|Overall Study|Sponsor Decision|0|||
128875680|NCT05917470|463837642|FG001|Overall Study|Sponsor Decision|0|||
128875681|NCT05917470|463837643|FG002|Overall Study|Sponsor Decision|1|||
128875682|NCT05917470|463837644|FG003|Overall Study|Sponsor Decision|0|||
128875683|NCT05917470|463837645|FG004|Overall Study|Sponsor Decision|2|||
128875684|NCT05917470|463837646|FG005|Overall Study|Sponsor Decision|1|||
128875685|NCT05917470|463837647|FG006|Overall Study|Sponsor Decision|3|||
128875686|NCT05917470|463837648|FG007|Overall Study|Sponsor Decision|3|||
128875687|NCT05917470|463837641|FG000|Overall Study|Adverse Event|0|||
129098309|NCT01716520|464652312|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
129098310|NCT01716520|464652313|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
129098311|NCT01716520|464652308|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129098312|NCT01716520|464652309|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129098313|NCT01716520|464652310|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129098314|NCT01716520|464652311|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129098315|NCT01716520|464652312|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129098316|NCT01716520|464652313|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129098317|NCT01716520|464652308|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
129098318|NCT01716520|464652309|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
129098319|NCT01716520|464652310|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
128875688|NCT05917470|463837642|FG001|Overall Study|Adverse Event|0|||
128875689|NCT05917470|463837643|FG002|Overall Study|Adverse Event|0|||
128875690|NCT05917470|463837644|FG003|Overall Study|Adverse Event|0|||
128875691|NCT05917470|463837645|FG004|Overall Study|Adverse Event|0|||
128875692|NCT05917470|463837646|FG005|Overall Study|Adverse Event|1|||
128875693|NCT05917470|463837647|FG006|Overall Study|Adverse Event|0|||
128875694|NCT05917470|463837648|FG007|Overall Study|Adverse Event|0|||
128875695|NCT02317432|463837649|FG000|Overall Study|Death|4|||
128875696|NCT02317432|463837650|FG001|Overall Study|Death|1|||
128875697|NCT02317432|463837649|FG000|Overall Study|Lost to Follow-up|0|||
128875698|NCT02317432|463837650|FG001|Overall Study|Lost to Follow-up|5|||
128875699|NCT02317432|463837649|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
128875700|NCT02317432|463837650|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
128875701|NCT03992846|463837655|FG000|Overall Study|Adverse Event|8|||
128875702|NCT03992846|463837656|FG001|Overall Study|Adverse Event|6|||
128875703|NCT03992846|463837657|FG002|Overall Study|Adverse Event|3|||
128875704|NCT03992846|463837655|FG000|Overall Study|Lost to Follow-up|0|||
128875705|NCT03992846|463837656|FG001|Overall Study|Lost to Follow-up|1|||
128875706|NCT03992846|463837657|FG002|Overall Study|Lost to Follow-up|1|||
128875707|NCT03992846|463837655|FG000|Overall Study|Pregnancy|2|||
128875708|NCT03992846|463837656|FG001|Overall Study|Pregnancy|0|||
128875709|NCT03992846|463837657|FG002|Overall Study|Pregnancy|1|||
128875710|NCT03992846|463837655|FG000|Overall Study|Protocol Violation|1|||
128875711|NCT03992846|463837656|FG001|Overall Study|Protocol Violation|2|||
128875712|NCT03992846|463837657|FG002|Overall Study|Protocol Violation|0|||
128875713|NCT03992846|463837655|FG000|Overall Study|Withdrawal by Subject|8|||
128875714|NCT03992846|463837656|FG001|Overall Study|Withdrawal by Subject|10|||
128875715|NCT03992846|463837657|FG002|Overall Study|Withdrawal by Subject|20|||
128875716|NCT03992846|463837655|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
128875717|NCT03992846|463837656|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
128875718|NCT03992846|463837657|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
128875719|NCT02407990|463839265|FG000|Overall Study|Death|2|||
128875720|NCT02407990|463839266|FG001|Overall Study|Death|22|||
128875721|NCT02407990|463839267|FG002|Overall Study|Death|23|||
128875722|NCT02407990|463839268|FG003|Overall Study|Death|7|||
128875723|NCT02407990|463839269|FG004|Overall Study|Death|17|||
128875724|NCT02407990|463839270|FG005|Overall Study|Death|16|||
128875725|NCT02407990|463839271|FG006|Overall Study|Death|10|||
128875726|NCT02407990|463839272|FG007|Overall Study|Death|248|||
129098320|NCT01716520|464652311|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
128875727|NCT02407990|463839265|FG000|Overall Study|Lost to Follow-up|0|||
128875728|NCT02407990|463839266|FG001|Overall Study|Lost to Follow-up|1|||
128875729|NCT02407990|463839267|FG002|Overall Study|Lost to Follow-up|0|||
128875730|NCT02407990|463839268|FG003|Overall Study|Lost to Follow-up|0|||
128875731|NCT02407990|463839269|FG004|Overall Study|Lost to Follow-up|0|||
128875732|NCT02407990|463839270|FG005|Overall Study|Lost to Follow-up|0|||
128875733|NCT02407990|463839271|FG006|Overall Study|Lost to Follow-up|0|||
128875734|NCT02407990|463839272|FG007|Overall Study|Lost to Follow-up|17|||
128875735|NCT02407990|463839265|FG000|Overall Study|Progressive Disease|0|||
128875736|NCT02407990|463839266|FG001|Overall Study|Progressive Disease|0|||
128875737|NCT02407990|463839267|FG002|Overall Study|Progressive Disease|0|||
129098321|NCT01716520|464652312|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
128875738|NCT02407990|463839268|FG003|Overall Study|Progressive Disease|0|||
128875739|NCT02407990|463839269|FG004|Overall Study|Progressive Disease|0|||
128875740|NCT02407990|463839270|FG005|Overall Study|Progressive Disease|0|||
128875741|NCT02407990|463839271|FG006|Overall Study|Progressive Disease|0|||
128875742|NCT02407990|463839272|FG007|Overall Study|Progressive Disease|1|||
128875743|NCT02407990|463839265|FG000|Overall Study|Withdrawal by Subject|0|||
128875744|NCT02407990|463839266|FG001|Overall Study|Withdrawal by Subject|0|||
128875745|NCT02407990|463839267|FG002|Overall Study|Withdrawal by Subject|0|||
128875746|NCT02407990|463839268|FG003|Overall Study|Withdrawal by Subject|0|||
128875747|NCT02407990|463839269|FG004|Overall Study|Withdrawal by Subject|1|||
128875748|NCT02407990|463839270|FG005|Overall Study|Withdrawal by Subject|0|||
128875749|NCT02407990|463839271|FG006|Overall Study|Withdrawal by Subject|0|||
128875750|NCT02407990|463839272|FG007|Overall Study|Withdrawal by Subject|30|||
128875751|NCT02407990|463839265|FG000|Overall Study|Study Terminated by Sponsor|1|||
128875752|NCT02407990|463839266|FG001|Overall Study|Study Terminated by Sponsor|3|||
128875753|NCT02407990|463839267|FG002|Overall Study|Study Terminated by Sponsor|3|||
128875754|NCT02407990|463839268|FG003|Overall Study|Study Terminated by Sponsor|0|||
128875755|NCT02407990|463839269|FG004|Overall Study|Study Terminated by Sponsor|3|||
128875756|NCT02407990|463839270|FG005|Overall Study|Study Terminated by Sponsor|4|||
128875757|NCT02407990|463839271|FG006|Overall Study|Study Terminated by Sponsor|3|||
128875758|NCT02407990|463839272|FG007|Overall Study|Study Terminated by Sponsor|37|||
128875759|NCT02407990|463839265|FG000|Overall Study|Logistics|0|||
128875760|NCT02407990|463839266|FG001|Overall Study|Logistics|0|||
128875761|NCT02407990|463839267|FG002|Overall Study|Logistics|0|||
128875762|NCT02407990|463839268|FG003|Overall Study|Logistics|0|||
128875763|NCT02407990|463839269|FG004|Overall Study|Logistics|0|||
128875764|NCT02407990|463839270|FG005|Overall Study|Logistics|0|||
128875765|NCT02407990|463839271|FG006|Overall Study|Logistics|0|||
128875766|NCT02407990|463839272|FG007|Overall Study|Logistics|1|||
128875767|NCT02407990|463839265|FG000|Overall Study|Rolled into long-term extension study|0|||
128875768|NCT02407990|463839266|FG001|Overall Study|Rolled into long-term extension study|0|||
128875769|NCT02407990|463839267|FG002|Overall Study|Rolled into long-term extension study|0|||
128875770|NCT02407990|463839268|FG003|Overall Study|Rolled into long-term extension study|0|||
128875771|NCT02407990|463839269|FG004|Overall Study|Rolled into long-term extension study|0|||
128875772|NCT02407990|463839270|FG005|Overall Study|Rolled into long-term extension study|0|||
128875773|NCT02407990|463839271|FG006|Overall Study|Rolled into long-term extension study|0|||
128875774|NCT02407990|463839272|FG007|Overall Study|Rolled into long-term extension study|1|||
128875775|NCT00734097|463839273|FG000|Screening|Protocol Violation|12|||
128875776|NCT00734097|463839273|FG000|Screening|Withdrawal by Subject|5|||
128875777|NCT00734097|463839273|FG000|Screening|Lost to Follow-up|2|||
128875778|NCT00734097|463839273|FG000|Screening|Unconfirmed pregnancy|1|||
128875779|NCT00734097|463839273|FG000|Open Label|Lost to Follow-up|7|||
128875780|NCT00734097|463839273|FG000|Open Label|Withdrawal by Subject|5|||
128875781|NCT00734097|463839273|FG000|Open Label|Protocol Violation|4|||
128875782|NCT02233543|463839278|FG000|Period 1|Withdrawal by Subject|1|||
128875783|NCT02233543|463839279|FG001|Period 1|Withdrawal by Subject|0|||
128875784|NCT02233543|463839278|FG000|Period 1|Participants required other treatment.|2|||
128875785|NCT02233543|463839279|FG001|Period 1|Participants required other treatment.|3|||
128875786|NCT02233543|463839278|FG000|Period 2|Adverse Event|1|||
128875787|NCT02233543|463839279|FG001|Period 2|Adverse Event|0|||
128875788|NCT02233543|463839278|FG000|Period 2|Participant required other treatment.|0|||
128875789|NCT02233543|463839279|FG001|Period 2|Participant required other treatment.|1|||
128875790|NCT02233543|463839278|FG000|Period 2|COPD exacerbation|1|||
128875791|NCT02233543|463839279|FG001|Period 2|COPD exacerbation|0|||
128875792|NCT00603304|463839280|FG000|Overall Study|Lost to Follow-up|5|||
128875793|NCT00603304|463839281|FG001|Overall Study|Lost to Follow-up|7|||
128875794|NCT00603304|463839280|FG000|Overall Study|Withdrawal by Subject|8|||
128875795|NCT00603304|463839281|FG001|Overall Study|Withdrawal by Subject|5|||
128875796|NCT00603304|463839280|FG000|Overall Study|Protocol Violation|1|||
128875797|NCT00603304|463839281|FG001|Overall Study|Protocol Violation|0|||
128875798|NCT00603304|463839280|FG000|Overall Study|Adverse Event|4|||
128875799|NCT00603304|463839281|FG001|Overall Study|Adverse Event|2|||
128875800|NCT00603304|463839280|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
128875801|NCT00603304|463839281|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
128875802|NCT00603304|463839280|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
128875803|NCT00603304|463839281|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
128875804|NCT00603304|463839280|FG000|Overall Study|Exclusionary Medication|2|||
128875805|NCT00603304|463839281|FG001|Overall Study|Exclusionary Medication|3|||
128875806|NCT00603304|463839280|FG000|Overall Study|Non-Compliant|0|||
128875807|NCT00603304|463839281|FG001|Overall Study|Non-Compliant|1|||
128875808|NCT00603304|463839280|FG000|Overall Study|Moved Away|0|||
128875809|NCT00603304|463839281|FG001|Overall Study|Moved Away|2|||
128875810|NCT00603304|463839280|FG000|Overall Study|Other|2|||
128875811|NCT00603304|463839281|FG001|Overall Study|Other|0|||
128875812|NCT00603304|463839280|FG000|Overall Study|Patient Decision|2|||
128875813|NCT00603304|463839281|FG001|Overall Study|Patient Decision|0|||
128875814|NCT00616902|463839282|FG000|Overall Study|Termination of study|6|||
128875815|NCT00616902|463839283|FG001|Overall Study|Termination of study|6|||
128875816|NCT03573583|463839284|FG000|Overall Study|Lost to Follow-up|1|||
128875817|NCT03573583|463839285|FG001|Overall Study|Lost to Follow-up|0|||
128875818|NCT03573583|463839284|FG000|Overall Study|Withdrawal by Subject|1|||
128875819|NCT03573583|463839285|FG001|Overall Study|Withdrawal by Subject|1|||
128875820|NCT04343872|463839290|FG000|Overall Study|Lost to Follow-up|6|||
128875821|NCT04343872|463839291|FG001|Overall Study|Lost to Follow-up|3|||
128875822|NCT03730480|463839292|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
128875823|NCT02480153|463839293|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
128875824|NCT02480153|463839294|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
128875825|NCT02480153|463839295|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
128875826|NCT02480153|463839293|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
128875827|NCT02480153|463839294|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
128875828|NCT02480153|463839295|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
128875829|NCT02480153|463839293|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
128875830|NCT02480153|463839294|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
128875831|NCT02480153|463839295|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
128875832|NCT02480153|463839293|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
128875833|NCT02480153|463839294|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
128875834|NCT02480153|463839295|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
128875835|NCT02480153|463839293|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
128875836|NCT02480153|463839294|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
128875837|NCT02480153|463839295|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
128875838|NCT02480153|463839293|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
128875839|NCT02480153|463839294|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
128875840|NCT02480153|463839295|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
128875841|NCT02480153|463839293|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
128875842|NCT02480153|463839294|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
128875843|NCT02480153|463839295|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
128875844|NCT02480153|463839293|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
128875845|NCT02480153|463839294|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
128875846|NCT02480153|463839295|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
128875847|NCT02480153|463839293|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
128875848|NCT02480153|463839294|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
128875849|NCT02480153|463839295|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
128875850|NCT02480153|463839293|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
128875851|NCT02480153|463839294|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
128875852|NCT02480153|463839295|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
128875853|NCT02480153|463839293|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
128875854|NCT02480153|463839294|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
128875855|NCT02480153|463839295|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
128875856|NCT02480153|463839293|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
128875857|NCT02480153|463839294|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
128875858|NCT02480153|463839295|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
128875859|NCT02480153|463839293|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
128875860|NCT02480153|463839294|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
128875861|NCT02480153|463839295|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
128875862|NCT02480153|463839293|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
128875863|NCT02480153|463839294|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
128875864|NCT02480153|463839295|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
128875865|NCT02480153|463839293|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
128875866|NCT02480153|463839294|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
128875867|NCT02480153|463839295|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
128875868|NCT02480153|463839293|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
128875869|NCT02480153|463839294|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
128875870|NCT02480153|463839295|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
128875871|NCT02480153|463839293|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
128875872|NCT02480153|463839294|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
128875873|NCT02480153|463839295|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
128875874|NCT02480153|463839293|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
128875875|NCT02480153|463839294|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
129098322|NCT01716520|464652313|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
129098323|NCT01716520|464652308|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
128875876|NCT02480153|463839295|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
128875877|NCT00512317|463839296|FG000|Overall Study|Insufficient clinical response|36|||
128875878|NCT00512317|463839296|FG000|Overall Study|Withdrawal by Subject|23|||
128875879|NCT00512317|463839296|FG000|Overall Study|Sponsor closure of study|21|||
128875880|NCT00512317|463839296|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
128875881|NCT00512317|463839296|FG000|Overall Study|Adverse Event|13|||
128875882|NCT00512317|463839296|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
128875883|NCT00512317|463839296|FG000|Overall Study|Lost to Follow-up|2|||
128875884|NCT00512317|463839296|FG000|Overall Study|Other|2|||
128875885|NCT04433585|463839297|FG000|Overall Study|Withdrawal by Subject|15|||
128875886|NCT04433585|463839298|FG001|Overall Study|Withdrawal by Subject|3|||
128875887|NCT04433585|463839299|FG002|Overall Study|Withdrawal by Subject|15|||
128875888|NCT04433585|463839300|FG003|Overall Study|Withdrawal by Subject|6|||
128875889|NCT04433585|463839297|FG000|Overall Study|Adverse Event|10|||
128875890|NCT04433585|463839298|FG001|Overall Study|Adverse Event|4|||
128875891|NCT04433585|463839299|FG002|Overall Study|Adverse Event|1|||
128875892|NCT04433585|463839300|FG003|Overall Study|Adverse Event|0|||
128875893|NCT04433585|463839297|FG000|Overall Study|Due to the conflict in Ukraine|2|||
128984134|NCT04145531|464229476|FG002|Part B|Progressive disease|0|||
128984135|NCT04145531|464229477|FG003|Part B|Progressive disease|1|||
128984136|NCT04145531|464229474|FG000|Part B|Recurrent disease|0|||
128984137|NCT04145531|464229475|FG001|Part B|Recurrent disease|0|||
128984138|NCT04145531|464229476|FG002|Part B|Recurrent disease|0|||
128984139|NCT04145531|464229477|FG003|Part B|Recurrent disease|1|||
128984140|NCT04145531|464229474|FG000|Part B|Withdrawal by parent or guardian|0|||
128984141|NCT04145531|464229475|FG001|Part B|Withdrawal by parent or guardian|0|||
128984142|NCT04145531|464229476|FG002|Part B|Withdrawal by parent or guardian|0|||
128984143|NCT04145531|464229477|FG003|Part B|Withdrawal by parent or guardian|3|||
128984144|NCT04145531|464229474|FG000|Part B|Withdrawal by participant|0|||
128984145|NCT04145531|464229475|FG001|Part B|Withdrawal by participant|0|||
128984146|NCT04145531|464229476|FG002|Part B|Withdrawal by participant|0|||
128984147|NCT04145531|464229477|FG003|Part B|Withdrawal by participant|1|||
128984148|NCT04145531|464229474|FG000|Part B|Other|0|||
128984149|NCT04145531|464229475|FG001|Part B|Other|0|||
128984150|NCT04145531|464229476|FG002|Part B|Other|0|||
128984151|NCT04145531|464229477|FG003|Part B|Other|1|||
128984152|NCT04629534|464229478|FG000|Overall Study|Physician Decision|1|||
128984153|NCT04629534|464229479|FG001|Overall Study|Physician Decision|0|||
128984154|NCT04629534|464229478|FG000|Overall Study|Protocol Violation|0|||
128984155|NCT04629534|464229479|FG001|Overall Study|Protocol Violation|2|||
128984156|NCT02797951|464229480|FG000|Overall Study|Adverse Event|4|||
128984157|NCT02797951|464229480|FG000|Overall Study|Death|1|||
128984158|NCT02797951|464229480|FG000|Overall Study|Lack of Efficacy|19|||
128984159|NCT02797951|464229480|FG000|Overall Study|Lost to Follow-up|4|||
128984160|NCT02797951|464229480|FG000|Overall Study|Physician Decision|6|||
128984161|NCT02797951|464229480|FG000|Overall Study|Withdrawal by Subject|15|||
128984162|NCT00814502|464229481|FG000|Overall Study|Adverse Event|1|||
128984163|NCT00814502|464229482|FG001|Overall Study|Adverse Event|0|||
128984164|NCT00814502|464229481|FG000|Overall Study|Withdrawal by Subject|0|||
128875894|NCT04433585|463839298|FG001|Overall Study|Due to the conflict in Ukraine|1|||
128875895|NCT04433585|463839299|FG002|Overall Study|Due to the conflict in Ukraine|1|||
128875896|NCT04433585|463839300|FG003|Overall Study|Due to the conflict in Ukraine|2|||
128875897|NCT04433585|463839297|FG000|Overall Study|Physician Decision|1|||
128875898|NCT04433585|463839298|FG001|Overall Study|Physician Decision|2|||
128875899|NCT04433585|463839299|FG002|Overall Study|Physician Decision|0|||
128875900|NCT04433585|463839300|FG003|Overall Study|Physician Decision|0|||
128875901|NCT04433585|463839297|FG000|Overall Study|Lost to Follow-up|1|||
128875902|NCT04433585|463839298|FG001|Overall Study|Lost to Follow-up|1|||
128875903|NCT04433585|463839299|FG002|Overall Study|Lost to Follow-up|1|||
128875904|NCT04433585|463839300|FG003|Overall Study|Lost to Follow-up|0|||
128875905|NCT04433585|463839297|FG000|Overall Study|Lack of Efficacy|0|||
128875906|NCT04433585|463839298|FG001|Overall Study|Lack of Efficacy|1|||
128875907|NCT04433585|463839299|FG002|Overall Study|Lack of Efficacy|1|||
128875908|NCT04433585|463839300|FG003|Overall Study|Lack of Efficacy|1|||
128875909|NCT04433585|463839297|FG000|Overall Study|Death|0|||
128875910|NCT04433585|463839298|FG001|Overall Study|Death|1|||
128875911|NCT04433585|463839299|FG002|Overall Study|Death|0|||
128875912|NCT04433585|463839300|FG003|Overall Study|Death|0|||
128875913|NCT04875676|463839301|FG000|Overall Study|Lost to Follow-up|1|||
128984165|NCT00814502|464229482|FG001|Overall Study|Withdrawal by Subject|2|||
128984166|NCT00234533|464229490|FG000|Overall Study|Withdrawal by Subject|6|||
128984167|NCT00234533|464229490|FG000|Overall Study|Adverse Event|2|||
128984168|NCT00234533|464229490|FG000|Overall Study|Enrolled but not treated|3|||
128875914|NCT04875676|463839302|FG001|Overall Study|Lost to Follow-up|0|||
128875915|NCT04875676|463839303|FG002|Overall Study|Lost to Follow-up|0|||
128875916|NCT02937454|463839304|FG000|Overall Study|Adverse Event|0|||
128875917|NCT02937454|463839305|FG001|Overall Study|Adverse Event|1|||
128875918|NCT02937454|463839304|FG000|Overall Study|Death|98|||
128984169|NCT00945815|464229493|FG000|Overall Study|Death|3|||
128984170|NCT00945815|464229493|FG000|Overall Study|Not protocol specified|1|||
129098324|NCT01716520|464652309|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
128984171|NCT00945815|464229493|FG000|Overall Study|Ineligible|3|||
128984172|NCT00945815|464229493|FG000|Overall Study|Did not begin protocol therapy|1|||
128875919|NCT02937454|463839305|FG001|Overall Study|Death|95|||
128875920|NCT02937454|463839304|FG000|Overall Study|Lost to Follow-up|1|||
128875921|NCT02937454|463839305|FG001|Overall Study|Lost to Follow-up|1|||
128875922|NCT02937454|463839304|FG000|Overall Study|Physician Decision|0|||
128875923|NCT02937454|463839305|FG001|Overall Study|Physician Decision|1|||
128875924|NCT02937454|463839304|FG000|Overall Study|Protocol Violation|6|||
128875925|NCT02937454|463839305|FG001|Overall Study|Protocol Violation|10|||
128875926|NCT02937454|463839304|FG000|Overall Study|Withdrawal by Subject|27|||
128875927|NCT02937454|463839305|FG001|Overall Study|Withdrawal by Subject|15|||
128875928|NCT02937454|463839304|FG000|Overall Study|Other|8|||
128875929|NCT02937454|463839305|FG001|Overall Study|Other|5|||
128875930|NCT01004848|463839306|FG000|Overall Study|Lost to Follow-up|55|||
128875931|NCT01004848|463839307|FG001|Overall Study|Lost to Follow-up|45|||
128875932|NCT00495586|463839309|FG000|Overall Study|Withdrawal by Subject|4|||
128875933|NCT00495586|463839310|FG001|Overall Study|Withdrawal by Subject|4|||
128875934|NCT02038543|463839311|FG000|Overall Study|Screen Failure|0|||
128875935|NCT02038543|463839312|FG001|Overall Study|Screen Failure|0|||
128875936|NCT02038543|463839313|FG002|Overall Study|Screen Failure|0|||
128875937|NCT02038543|463839314|FG003|Overall Study|Screen Failure|1|||
128875938|NCT02038543|463839311|FG000|Overall Study|Withdrawal by Subject|0|||
128875939|NCT02038543|463839312|FG001|Overall Study|Withdrawal by Subject|0|||
128875940|NCT02038543|463839313|FG002|Overall Study|Withdrawal by Subject|0|||
128875941|NCT02038543|463839314|FG003|Overall Study|Withdrawal by Subject|1|||
128875942|NCT00158860|463839315|FG000|Overall Study|Adverse Event|3|||
128875943|NCT00158860|463839316|FG001|Overall Study|Adverse Event|6|||
128875944|NCT00158860|463839315|FG000|Overall Study|Lost to Follow-up|11|||
128875945|NCT00158860|463839316|FG001|Overall Study|Lost to Follow-up|17|||
128875946|NCT00158860|463839315|FG000|Overall Study|Protocol Violation|8|||
128875947|NCT00158860|463839316|FG001|Overall Study|Protocol Violation|23|||
128875948|NCT00158860|463839315|FG000|Overall Study|Withdrawal by Subject|7|||
128875949|NCT00158860|463839316|FG001|Overall Study|Withdrawal by Subject|17|||
128875950|NCT00158860|463839315|FG000|Overall Study|MOVING OUT OF STATE|1|||
128875951|NCT00158860|463839316|FG001|Overall Study|MOVING OUT OF STATE|0|||
128875952|NCT00158860|463839315|FG000|Overall Study|Pregnancy|3|||
128875953|NCT00158860|463839316|FG001|Overall Study|Pregnancy|3|||
128875954|NCT00158860|463839315|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
128875955|NCT00158860|463839316|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
128875956|NCT00158860|463839315|FG000|Overall Study|SPONSOR REQUEST|0|||
128875957|NCT00158860|463839316|FG001|Overall Study|SPONSOR REQUEST|1|||
128875958|NCT00158860|463839315|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
128875959|NCT00158860|463839316|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
128875960|NCT00158860|463839315|FG000|Overall Study|Closed per sponsor|0|||
128875961|NCT00158860|463839316|FG001|Overall Study|Closed per sponsor|1|||
128875962|NCT01029652|463839317|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
128875963|NCT01029652|463839318|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
128875964|NCT01029652|463839317|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
128875965|NCT01029652|463839318|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
128875966|NCT01029652|463839317|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
128875967|NCT01029652|463839318|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
128875968|NCT01029652|463839317|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
128875969|NCT01029652|463839318|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
128875970|NCT01029652|463839317|FG000|Core Study (0-12 Weeks)|Death|0|||
128875971|NCT01029652|463839318|FG001|Core Study (0-12 Weeks)|Death|1|||
128875972|NCT01029652|463839317|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
128875973|NCT01029652|463839318|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
128875974|NCT01029652|463839317|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
128875975|NCT01029652|463839318|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
128875976|NCT01029652|463839317|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
128875977|NCT01029652|463839318|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
128875978|NCT01029652|463839317|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
128875979|NCT01029652|463839318|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
128875980|NCT01029652|463839317|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
128875981|NCT01029652|463839318|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
128875982|NCT01029652|463839317|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
128875983|NCT01029652|463839318|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
128875984|NCT01029652|463839317|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
128875985|NCT01029652|463839318|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
128875986|NCT02095951|463839319|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
128875987|NCT02095951|463839320|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
128875988|NCT00964886|463839321|FG000|Overall Study|Lost to Follow-up|2|||
128875989|NCT00964886|463839322|FG001|Overall Study|Lost to Follow-up|2|||
128875990|NCT00964886|463839323|FG002|Overall Study|Lost to Follow-up|6|||
128875991|NCT00964886|463839324|FG003|Overall Study|Lost to Follow-up|4|||
128875992|NCT00964886|463839321|FG000|Overall Study|Withdrawal by Subject|6|||
128875993|NCT00964886|463839322|FG001|Overall Study|Withdrawal by Subject|2|||
128875994|NCT00964886|463839323|FG002|Overall Study|Withdrawal by Subject|5|||
128875995|NCT00964886|463839324|FG003|Overall Study|Withdrawal by Subject|3|||
128875996|NCT00964886|463839321|FG000|Overall Study|Adverse Event|3|||
128875997|NCT00964886|463839322|FG001|Overall Study|Adverse Event|1|||
128875998|NCT00964886|463839323|FG002|Overall Study|Adverse Event|5|||
128875999|NCT00964886|463839324|FG003|Overall Study|Adverse Event|2|||
128876000|NCT00964886|463839321|FG000|Overall Study|Protocol Violation|0|||
128876001|NCT00964886|463839322|FG001|Overall Study|Protocol Violation|2|||
128876002|NCT00964886|463839323|FG002|Overall Study|Protocol Violation|0|||
128984173|NCT01314261|464229496|FG000|Overall Study|Adverse Event|1|||
128984174|NCT01314261|464229497|FG001|Overall Study|Adverse Event|0|||
128984175|NCT01314261|464229498|FG002|Overall Study|Adverse Event|0|||
128984176|NCT01314261|464229499|FG003|Overall Study|Adverse Event|0|||
128984177|NCT01314261|464229496|FG000|Overall Study|Withdrawal by Subject|0|||
128984178|NCT01314261|464229497|FG001|Overall Study|Withdrawal by Subject|3|||
128984179|NCT01314261|464229498|FG002|Overall Study|Withdrawal by Subject|1|||
128984180|NCT01314261|464229499|FG003|Overall Study|Withdrawal by Subject|0|||
128984181|NCT01314261|464229496|FG000|Overall Study|Lost to Follow-up|1|||
128984182|NCT01314261|464229497|FG001|Overall Study|Lost to Follow-up|0|||
128984183|NCT01314261|464229498|FG002|Overall Study|Lost to Follow-up|2|||
128984184|NCT01314261|464229499|FG003|Overall Study|Lost to Follow-up|2|||
128984185|NCT01314261|464229496|FG000|Overall Study|Virologic Failure|0|||
128984186|NCT01314261|464229497|FG001|Overall Study|Virologic Failure|1|||
128876003|NCT00964886|463839324|FG003|Overall Study|Protocol Violation|0|||
128876004|NCT01621568|463839328|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
128876005|NCT01621568|463839329|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
128876006|NCT01621568|463839328|FG000|Week 5-6 No Treatment|Death|1|||
128876007|NCT01621568|463839329|FG001|Week 5-6 No Treatment|Death|0|||
128876008|NCT02334423|463839330|FG000|Overall Study|Protocol Violation|10|||
128876009|NCT02334423|463839331|FG001|Overall Study|Protocol Violation|3|||
128876010|NCT02930226|463839332|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
128876011|NCT02930226|463839333|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
128876012|NCT02930226|463839334|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
128876013|NCT02930226|463839335|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
128876014|NCT02930226|463839336|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
128984187|NCT01314261|464229498|FG002|Overall Study|Virologic Failure|0|||
128984188|NCT01314261|464229499|FG003|Overall Study|Virologic Failure|1|||
128984189|NCT04524507|464229500|FG000|Overall Study|Lost to Follow-up|2|||
128984190|NCT04524507|464229501|FG001|Overall Study|Lost to Follow-up|4|||
128984191|NCT04524507|464229500|FG000|Overall Study|Withdrawal by Subject|2|||
128984192|NCT04524507|464229501|FG001|Overall Study|Withdrawal by Subject|9|||
128984193|NCT04524507|464229500|FG000|Overall Study|Death|2|||
129098325|NCT01716520|464652310|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129098326|NCT01716520|464652311|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
128876015|NCT02930226|463839337|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
128876016|NCT00652327|463839338|FG000|Overall Study|Adverse Event|0|||
128876017|NCT00652327|463839339|FG001|Overall Study|Adverse Event|2|||
128876018|NCT00652327|463839338|FG000|Overall Study|Lost to Follow-up|0|||
128876019|NCT00652327|463839339|FG001|Overall Study|Lost to Follow-up|3|||
128876020|NCT01076647|463839340|FG000|Overall Study|Adverse Event|4|||
128876021|NCT01076647|463839341|FG001|Overall Study|Adverse Event|1|||
128876022|NCT01076647|463839340|FG000|Overall Study|Lack of Efficacy|0|||
128876023|NCT01076647|463839341|FG001|Overall Study|Lack of Efficacy|1|||
128876024|NCT01076647|463839340|FG000|Overall Study|Protocol Violation|7|||
128876025|NCT01076647|463839341|FG001|Overall Study|Protocol Violation|9|||
128876026|NCT01076647|463839340|FG000|Overall Study|Withdrawal criteria|2|||
128876027|NCT01076647|463839341|FG001|Overall Study|Withdrawal criteria|2|||
128876028|NCT01076647|463839340|FG000|Overall Study|Unclassified|12|||
128876029|NCT01076647|463839341|FG001|Overall Study|Unclassified|12|||
128876030|NCT00564889|463839347|FG000|Overall Study|Death|7|||
128876031|NCT00564889|463839347|FG000|Overall Study|Adverse Event|12|||
129098327|NCT01716520|464652312|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129098328|NCT01716520|464652313|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
129098329|NCT01716520|464652308|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
128876032|NCT00564889|463839347|FG000|Overall Study|Alternative treatment|3|||
128876033|NCT00564889|463839347|FG000|Overall Study|Disease progression|3|||
128876034|NCT00564889|463839347|FG000|Overall Study|Other, not specified|4|||
128876035|NCT03500159|463839348|FG000|Overall Study|Study Terminated|2|||
128876036|NCT03500159|463839349|FG001|Overall Study|Study Terminated|1|||
128876037|NCT02292927|463839354|FG000|Overall Study|Protocol Violation|13|||
128876038|NCT02292927|463839355|FG001|Overall Study|Protocol Violation|7|||
128876039|NCT00141219|463839359|FG000|Overall Study|Protocol violations|5|||
128876040|NCT00141219|463839360|FG001|Overall Study|Protocol violations|4|||
128876041|NCT00141219|463839359|FG000|Overall Study|Adverse Event|8|||
128876042|NCT00141219|463839360|FG001|Overall Study|Adverse Event|6|||
128984194|NCT04524507|464229501|FG001|Overall Study|Death|10|||
128984195|NCT01383317|464229502|FG000|Overall Study|Lost to Follow-up|2|||
128876043|NCT00141219|463839359|FG000|Overall Study|Lack of Efficacy|5|||
128876044|NCT00141219|463839360|FG001|Overall Study|Lack of Efficacy|4|||
128876045|NCT00141219|463839359|FG000|Overall Study|Withdrawal by Subject|6|||
128876046|NCT00141219|463839360|FG001|Overall Study|Withdrawal by Subject|2|||
128876047|NCT02224690|463839361|FG000|Overall Study|Adverse Event|8|||
128876048|NCT02224690|463839362|FG001|Overall Study|Adverse Event|1|||
128876049|NCT02224690|463839361|FG000|Overall Study|Met Withdrawal Criteria|4|||
128876050|NCT02224690|463839362|FG001|Overall Study|Met Withdrawal Criteria|0|||
128876051|NCT02224690|463839361|FG000|Overall Study|Use of G-tube|1|||
128876052|NCT02224690|463839362|FG001|Overall Study|Use of G-tube|0|||
128876053|NCT02224690|463839361|FG000|Overall Study|Did not meet eligibility criteria|1|||
128876054|NCT02224690|463839362|FG001|Overall Study|Did not meet eligibility criteria|0|||
128876055|NCT00122460|463839364|FG000|Overall Study|investigational study phase ongoing|7|||
128876056|NCT00122460|463839365|FG001|Overall Study|investigational study phase ongoing|1|||
128876057|NCT02595073|463839366|FG000|Overall Study|Progressive Disease|0|||
128876058|NCT02595073|463839367|FG001|Overall Study|Progressive Disease|1|||
128876059|NCT02595073|463839366|FG000|Overall Study|Protocol Violation|2|||
128876060|NCT02595073|463839367|FG001|Overall Study|Protocol Violation|0|||
128876061|NCT02962960|463839368|FG000|Overall Study|Withdrawal by Subject|1|||
128876062|NCT02962960|463839369|FG001|Overall Study|Withdrawal by Subject|1|||
128876063|NCT02962960|463839370|FG002|Overall Study|Withdrawal by Subject|0|||
128876064|NCT02962960|463839368|FG000|Overall Study|Adverse Event|1|||
128876065|NCT02962960|463839369|FG001|Overall Study|Adverse Event|1|||
128876066|NCT02962960|463839370|FG002|Overall Study|Adverse Event|0|||
128876067|NCT02962960|463839368|FG000|Overall Study|Protocol Violation|1|||
128876068|NCT02962960|463839369|FG001|Overall Study|Protocol Violation|0|||
128876069|NCT02962960|463839370|FG002|Overall Study|Protocol Violation|0|||
128876070|NCT00470366|463839371|FG000|Overall Study|Adverse Event|3|||
128876071|NCT00470366|463839371|FG000|Overall Study|Poor compliance|1|||
128876072|NCT02996474|463839372|FG000|Overall Study|Physician Decision|5|||
128876073|NCT04493502|463839373|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
128876074|NCT04493502|463839374|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
128876075|NCT04493502|463839373|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
128876076|NCT04493502|463839374|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
128876077|NCT04493502|463839373|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
128876078|NCT04493502|463839374|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
128876079|NCT04493502|463839373|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
128876080|NCT04493502|463839374|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
128876081|NCT04493502|463839373|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
128876082|NCT04493502|463839374|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
128876083|NCT04493502|463839373|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
128876084|NCT04493502|463839374|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
128876085|NCT04493502|463839373|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
128876086|NCT04493502|463839374|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
128876087|NCT04493502|463839373|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
128984196|NCT01383317|464229503|FG001|Overall Study|Lost to Follow-up|1|||
128984197|NCT01383317|464229502|FG000|Overall Study|Death|1|||
128984198|NCT01383317|464229503|FG001|Overall Study|Death|0|||
128984199|NCT01383317|464229502|FG000|Overall Study|Adverse Event|0|||
128984200|NCT01383317|464229503|FG001|Overall Study|Adverse Event|1|||
128984201|NCT00422227|464229504|FG000|Overall Study|Adverse Event|3|||
128984202|NCT00422227|464229505|FG001|Overall Study|Adverse Event|8|||
128984203|NCT00422227|464229504|FG000|Overall Study|Lost to Follow-up|1|||
128984204|NCT00422227|464229505|FG001|Overall Study|Lost to Follow-up|3|||
128984205|NCT00422227|464229504|FG000|Overall Study|Withdrawal by Subject|0|||
128984206|NCT00422227|464229505|FG001|Overall Study|Withdrawal by Subject|4|||
128984207|NCT01790633|464229506|FG000|Overall Study|Protocol Violation|1|||
128984208|NCT01790633|464229507|FG001|Overall Study|Protocol Violation|2|||
128984209|NCT01790633|464229506|FG000|Overall Study|Did not have serology performed|47|||
128984210|NCT01790633|464229507|FG001|Overall Study|Did not have serology performed|0|||
128984211|NCT01790633|464229506|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
128984212|NCT01790633|464229507|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
128984213|NCT00157157|464229508|FG000|Overall Study|Withdrawal by Subject|6|||
129098330|NCT01716520|464652309|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
128876088|NCT04493502|463839374|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
128876089|NCT04493502|463839373|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
128876090|NCT04493502|463839374|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
128876091|NCT04493502|463839373|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
128876092|NCT04493502|463839374|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
128876093|NCT04493502|463839373|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
128984214|NCT00157157|464229508|FG000|Overall Study|Physician Decision|1|||
128984215|NCT00157157|464229508|FG000|Overall Study|Lost to Follow-up|1|||
128984216|NCT00157157|464229508|FG000|Overall Study|Enrolled in another study|1|||
128876094|NCT04493502|463839374|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
128876095|NCT04493502|463839373|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
128876096|NCT04493502|463839374|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
128876097|NCT04493502|463839373|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
128876098|NCT04493502|463839374|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
128876099|NCT00540046|463839375|FG000|Overall Study|Lost to Follow-up|33|||
128876100|NCT00540046|463839376|FG001|Overall Study|Lost to Follow-up|23|||
128876101|NCT02891837|463839377|FG000|Overall Study|Lost to Follow-up|2|||
128876102|NCT02891837|463839378|FG001|Overall Study|Lost to Follow-up|0|||
128876103|NCT02891837|463839377|FG000|Overall Study|Withdrawal by Subject|1|||
128876104|NCT02891837|463839378|FG001|Overall Study|Withdrawal by Subject|0|||
128876105|NCT01021215|463839386|FG000|Overall Study|Lost to Follow-up|3|||
128876106|NCT01021215|463839387|FG001|Overall Study|Lost to Follow-up|0|||
128876107|NCT02751320|463839388|FG000|Overall Study|Adverse Event|2|||
128876108|NCT02751320|463839388|FG000|Overall Study|Withdrawal by Subject|1|||
128876109|NCT02549196|463839389|FG000|Overall Study|Protocol Violation|0|||
128876110|NCT02549196|463839390|FG001|Overall Study|Protocol Violation|0|||
128876111|NCT02549196|463839391|FG002|Overall Study|Protocol Violation|0|||
128876112|NCT02549196|463839392|FG003|Overall Study|Protocol Violation|1|||
128876113|NCT02549196|463839389|FG000|Overall Study|Withdrawal by Subject|1|||
128876114|NCT02549196|463839390|FG001|Overall Study|Withdrawal by Subject|0|||
128876115|NCT02549196|463839391|FG002|Overall Study|Withdrawal by Subject|1|||
128876116|NCT02549196|463839392|FG003|Overall Study|Withdrawal by Subject|0|||
128876117|NCT00185965|463839395|FG000|Overall Study|Adverse Event|0|||
128876118|NCT00185965|463839396|FG001|Overall Study|Adverse Event|1|||
128876119|NCT01103362|463839397|FG000|Overall Study|study terminated|596|||
128984217|NCT00157157|464229508|FG000|Overall Study|Met exclusion criteria|1|||
128984218|NCT00157157|464229508|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
128984219|NCT01241591|464231556|FG000|Overall Study|Lack of Efficacy|5|||
128984220|NCT01241591|464231557|FG001|Overall Study|Lack of Efficacy|2|||
128984221|NCT01241591|464231558|FG002|Overall Study|Lack of Efficacy|2|||
128984222|NCT01241591|464231559|FG003|Overall Study|Lack of Efficacy|3|||
128984223|NCT01241591|464231556|FG000|Overall Study|Protocol Violation|5|||
128984224|NCT01241591|464231557|FG001|Overall Study|Protocol Violation|2|||
128984225|NCT01241591|464231558|FG002|Overall Study|Protocol Violation|3|||
128984226|NCT01241591|464231559|FG003|Overall Study|Protocol Violation|0|||
128984227|NCT01241591|464231556|FG000|Overall Study|Lost to Follow-up|1|||
128984228|NCT01241591|464231557|FG001|Overall Study|Lost to Follow-up|2|||
128984229|NCT01241591|464231558|FG002|Overall Study|Lost to Follow-up|2|||
128984230|NCT01241591|464231559|FG003|Overall Study|Lost to Follow-up|2|||
128984231|NCT01241591|464231556|FG000|Overall Study|Screen Failure|3|||
128984232|NCT01241591|464231557|FG001|Overall Study|Screen Failure|2|||
128984233|NCT01241591|464231558|FG002|Overall Study|Screen Failure|1|||
128984234|NCT01241591|464231559|FG003|Overall Study|Screen Failure|0|||
128984235|NCT01241591|464231556|FG000|Overall Study|Withdrawal by Subject|6|||
128984236|NCT01241591|464231557|FG001|Overall Study|Withdrawal by Subject|4|||
128984237|NCT01241591|464231558|FG002|Overall Study|Withdrawal by Subject|2|||
128984238|NCT01241591|464231559|FG003|Overall Study|Withdrawal by Subject|2|||
128984239|NCT01241591|464231556|FG000|Overall Study|Other|0|||
128984240|NCT01241591|464231557|FG001|Overall Study|Other|1|||
128984241|NCT01241591|464231558|FG002|Overall Study|Other|0|||
128984242|NCT01241591|464231559|FG003|Overall Study|Other|1|||
128984243|NCT01241591|464231556|FG000|Overall Study|Adverse Event|3|||
128984244|NCT01241591|464231557|FG001|Overall Study|Adverse Event|11|||
128984245|NCT01241591|464231558|FG002|Overall Study|Adverse Event|12|||
128984246|NCT01241591|464231559|FG003|Overall Study|Adverse Event|4|||
128984247|NCT01945034|464231560|FG000|Overall Study|Medication Error|0|||
128984248|NCT01945034|464231561|FG001|Overall Study|Medication Error|1|||
128984249|NCT01945034|464231562|FG002|Overall Study|Medication Error|0|||
128984250|NCT01945034|464231560|FG000|Overall Study|Withdrawal by Subject|0|||
128984251|NCT01945034|464231561|FG001|Overall Study|Withdrawal by Subject|3|||
128984252|NCT01945034|464231562|FG002|Overall Study|Withdrawal by Subject|1|||
128984253|NCT01945034|464231560|FG000|Overall Study|Other|0|||
128984254|NCT01945034|464231561|FG001|Overall Study|Other|1|||
128984255|NCT01945034|464231562|FG002|Overall Study|Other|3|||
128984256|NCT01945034|464231560|FG000|Overall Study|Lost to Follow-up|0|||
128984257|NCT01945034|464231561|FG001|Overall Study|Lost to Follow-up|0|||
128984258|NCT01945034|464231562|FG002|Overall Study|Lost to Follow-up|2|||
128984259|NCT01945034|464231560|FG000|Overall Study|Protocol Violation|1|||
128876120|NCT02533531|463839398|FG000|Overall Study|Device did not turn on|1|||
128876121|NCT02047903|463839399|FG000|Overall Study|Adverse Event|14|||
128876122|NCT02047903|463839399|FG000|Overall Study|Serious adverse event|10|||
128876123|NCT02047903|463839399|FG000|Overall Study|Withdrawal by Subject|16|||
128876124|NCT02047903|463839399|FG000|Overall Study|Lost to Follow-up|4|||
128984260|NCT01945034|464231561|FG001|Overall Study|Protocol Violation|0|||
128984261|NCT01945034|464231562|FG002|Overall Study|Protocol Violation|1|||
128984262|NCT02147132|464231563|FG000|Overall Study|Lost to Follow-up|1|||
128984263|NCT02147132|464231564|FG001|Overall Study|Lost to Follow-up|0|||
128984264|NCT02147132|464231565|FG002|Overall Study|Lost to Follow-up|0|||
128984265|NCT02147132|464231566|FG003|Overall Study|Lost to Follow-up|0|||
128984266|NCT01798056|464231567|FG000|Overall Study|Serious Adverse Event|13|||
128984267|NCT01798056|464231568|FG001|Overall Study|Serious Adverse Event|12|||
128984268|NCT01798056|464231567|FG000|Overall Study|Withdrawal by Subject|12|||
128984269|NCT01798056|464231568|FG001|Overall Study|Withdrawal by Subject|9|||
128984270|NCT01798056|464231567|FG000|Overall Study|Migrated/moved from study area|1|||
128984271|NCT01798056|464231568|FG001|Overall Study|Migrated/moved from study area|1|||
128984272|NCT01798056|464231567|FG000|Overall Study|Lost to Follow-up|1|||
128984273|NCT01798056|464231568|FG001|Overall Study|Lost to Follow-up|1|||
128984274|NCT01798056|464231567|FG000|Overall Study|Other|0|||
128984275|NCT01798056|464231568|FG001|Overall Study|Other|2|||
128984276|NCT02842736|464231571|FG000|Overall Study|Lost to Follow-up|13|||
128984277|NCT02842736|464231571|FG000|Overall Study|Intervention for menstrual bleeding|17|||
128984278|NCT02842736|464231571|FG000|Overall Study|Withdrawal by Subject|4|||
128984279|NCT02842736|464231571|FG000|Overall Study|Pregnancy|3|||
128876125|NCT02047903|463839399|FG000|Overall Study|Reason not listed|6|||
128876126|NCT02047903|463839399|FG000|Overall Study|Not Treated|9|||
128876127|NCT01011387|463839403|FG000|Overall Study|Withdrawal by Subject|3|||
128876128|NCT01011387|463839403|FG000|Overall Study|Adverse Event|2|||
128876129|NCT01011387|463839403|FG000|Overall Study|Protocol Violation|1|||
128876130|NCT02665338|463839405|FG000|Overall Study|Withdrawal by Subject|0|||
128876131|NCT02665338|463839406|FG001|Overall Study|Withdrawal by Subject|1|||
128876132|NCT05326815|463839410|FG000|Overall Study|Withdrawal by Subject|3|||
128876133|NCT05326815|463839410|FG000|Overall Study|Did not complete required labs|6|||
128876134|NCT05326815|463839410|FG000|Overall Study|Screen fail- abnormal labs|5|||
128984280|NCT02842736|464231571|FG000|Overall Study|Hysterectomy for fibroids|2|||
128984281|NCT02842736|464231571|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
128984282|NCT02842736|464231571|FG000|Overall Study|IUD: Mirena|1|||
128984283|NCT03323034|464231573|FG000|Overall Study|Lack of Efficacy|5|||
128984284|NCT03323034|464231574|FG001|Overall Study|Lack of Efficacy|5|||
128984285|NCT03323034|464231575|FG002|Overall Study|Lack of Efficacy|6|||
128984286|NCT03323034|464231576|FG003|Overall Study|Lack of Efficacy|5|||
128984287|NCT03323034|464231577|FG004|Overall Study|Lack of Efficacy|5|||
128984288|NCT03323034|464231573|FG000|Overall Study|Physician Decision|0|||
128984289|NCT03323034|464231574|FG001|Overall Study|Physician Decision|0|||
128984290|NCT03323034|464231575|FG002|Overall Study|Physician Decision|0|||
128984291|NCT03323034|464231576|FG003|Overall Study|Physician Decision|0|||
128984292|NCT03323034|464231577|FG004|Overall Study|Physician Decision|1|||
128984293|NCT03323034|464231573|FG000|Overall Study|Withdrawal by Subject|1|||
128984294|NCT03323034|464231574|FG001|Overall Study|Withdrawal by Subject|1|||
128984295|NCT03323034|464231575|FG002|Overall Study|Withdrawal by Subject|0|||
128984296|NCT03323034|464231576|FG003|Overall Study|Withdrawal by Subject|1|||
128984297|NCT03323034|464231577|FG004|Overall Study|Withdrawal by Subject|0|||
128984298|NCT02646566|464231578|FG000|Overall Study|Lost to Follow-up|5|||
128984299|NCT02646566|464231579|FG001|Overall Study|Lost to Follow-up|4|||
128984300|NCT02646566|464231580|FG002|Overall Study|Lost to Follow-up|5|||
128984301|NCT02646566|464231578|FG000|Overall Study|Treatment failure|1|||
128984302|NCT02646566|464231579|FG001|Overall Study|Treatment failure|0|||
128984303|NCT02646566|464231580|FG002|Overall Study|Treatment failure|0|||
128984304|NCT02815540|464231583|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
128984305|NCT02222246|464231584|FG000|Overall Study|No Emergency Department Visits|27|||
128984306|NCT02222246|464231585|FG001|Overall Study|No Emergency Department Visits|26|||
128984307|NCT02222246|464231584|FG000|Overall Study|Physician Decision|0|||
128984308|NCT02222246|464231585|FG001|Overall Study|Physician Decision|1|||
128984309|NCT02660489|464231586|FG000|Overall Study|Lost to Follow-up|1|||
128984310|NCT02660489|464231587|FG001|Overall Study|Lost to Follow-up|1|||
128984311|NCT02660489|464231586|FG000|Overall Study|Adverse Event|1|||
128984312|NCT02660489|464231587|FG001|Overall Study|Adverse Event|3|||
128984313|NCT02660489|464231586|FG000|Overall Study|no rhinovirus infection|4|||
128984314|NCT02660489|464231587|FG001|Overall Study|no rhinovirus infection|4|||
128984315|NCT02064231|464231588|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
128984316|NCT02064231|464231589|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
128984317|NCT02064231|464231590|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
128984318|NCT02064231|464231591|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
128984319|NCT02064231|464231588|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
128984320|NCT02064231|464231589|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
128984321|NCT02064231|464231590|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
128984322|NCT02064231|464231591|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
128984323|NCT02064231|464231588|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
128876135|NCT03562975|463839411|FG000|Overall Study|Death|1|||
128984324|NCT02064231|464231589|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
128984325|NCT02064231|464231590|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
128876136|NCT03562975|463839411|FG000|Overall Study|Lost to Follow-up|1|||
128876137|NCT03562975|463839411|FG000|Overall Study|Withdrawal by Subject|1|||
129098331|NCT01716520|464652310|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
129098332|NCT01716520|464652311|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
129098333|NCT01716520|464652312|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
129098334|NCT01716520|464652313|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
129098335|NCT01716520|464652308|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
129098336|NCT01716520|464652309|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
129098337|NCT01716520|464652310|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
129098338|NCT01716520|464652311|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
129098339|NCT01716520|464652312|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
129098340|NCT01716520|464652313|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
129098341|NCT01716520|464652308|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129098342|NCT01716520|464652309|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129098343|NCT01716520|464652310|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129098344|NCT01716520|464652311|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129098345|NCT01716520|464652312|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129098346|NCT01716520|464652313|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129098347|NCT01716520|464652308|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129098348|NCT01716520|464652309|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129098349|NCT01716520|464652310|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129098350|NCT01716520|464652311|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
129098351|NCT01716520|464652312|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129098352|NCT01716520|464652313|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129098353|NCT01716520|464652308|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
129098354|NCT01716520|464652309|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
129098355|NCT01716520|464652310|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
129098356|NCT01716520|464652311|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
129098357|NCT01716520|464652312|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
129098358|NCT01716520|464652313|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
129098359|NCT01716520|464652308|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
129098360|NCT01716520|464652309|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129098361|NCT01716520|464652310|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129098362|NCT01716520|464652311|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129098363|NCT01716520|464652312|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129098364|NCT01716520|464652313|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129098365|NCT01716520|464652308|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129098366|NCT01716520|464652309|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129098367|NCT01716520|464652310|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129098368|NCT01716520|464652311|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129098369|NCT01716520|464652312|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129098370|NCT01716520|464652313|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
129098371|NCT01716520|464652308|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129098372|NCT01716520|464652309|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
129098373|NCT01716520|464652310|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129098374|NCT01716520|464652311|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129098375|NCT01716520|464652312|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129098376|NCT01716520|464652313|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129098377|NCT01716520|464652308|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129098378|NCT01716520|464652309|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
128876138|NCT02545933|463839412|FG000|Overall Study|Adverse Event|3|||
128876139|NCT02545933|463839413|FG001|Overall Study|Adverse Event|0|||
128876140|NCT02545933|463839414|FG002|Overall Study|Adverse Event|0|||
128876141|NCT02545933|463839412|FG000|Overall Study|Withdrawal by Subject|2|||
128876142|NCT02545933|463839413|FG001|Overall Study|Withdrawal by Subject|3|||
128876143|NCT02545933|463839414|FG002|Overall Study|Withdrawal by Subject|3|||
128876144|NCT02545933|463839412|FG000|Overall Study|Protocol Violation|1|||
128876145|NCT02545933|463839413|FG001|Overall Study|Protocol Violation|0|||
128876146|NCT02545933|463839414|FG002|Overall Study|Protocol Violation|1|||
128876147|NCT00935818|463839417|FG000|Overall Study|Withdrawal by Subject|45|||
128876148|NCT00935818|463839418|FG001|Overall Study|Withdrawal by Subject|50|||
128876149|NCT00935818|463839417|FG000|Overall Study|Lost to Follow-up|40|||
128876150|NCT00935818|463839418|FG001|Overall Study|Lost to Follow-up|42|||
128876151|NCT00935818|463839417|FG000|Overall Study|Adverse Event|6|||
128876152|NCT00935818|463839418|FG001|Overall Study|Adverse Event|7|||
128876153|NCT00935818|463839417|FG000|Overall Study|Physician Decision|0|||
128876154|NCT00935818|463839418|FG001|Overall Study|Physician Decision|1|||
128876155|NCT00979134|463839419|FG000|Overall Study|Disease progression|18|||
128876156|NCT00979134|463839420|FG001|Overall Study|Disease progression|2|||
128876157|NCT00979134|463839421|FG002|Overall Study|Disease progression|5|||
128876158|NCT00979134|463839419|FG000|Overall Study|Adverse Event|0|||
128876159|NCT00979134|463839420|FG001|Overall Study|Adverse Event|0|||
129098379|NCT01716520|464652310|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129098380|NCT01716520|464652311|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129098381|NCT01716520|464652312|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129098382|NCT01716520|464652313|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
129098383|NCT01716520|464652308|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129098384|NCT01716520|464652309|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129098385|NCT01716520|464652310|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
129098386|NCT01716520|464652311|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129098387|NCT01716520|464652312|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129098388|NCT01716520|464652313|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129098389|NCT02636699|464652322|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
129098390|NCT02636699|464652323|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
129098391|NCT02636699|464652324|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
129098392|NCT02636699|464652322|FG000|Screening Period|Withdrawal by Subject|0|||
129098393|NCT02636699|464652323|FG001|Screening Period|Withdrawal by Subject|0|||
129098394|NCT02636699|464652324|FG002|Screening Period|Withdrawal by Subject|23|||
129098395|NCT02636699|464652322|FG000|Screening Period|Adverse Event|0|||
129098396|NCT02636699|464652323|FG001|Screening Period|Adverse Event|0|||
129098397|NCT02636699|464652324|FG002|Screening Period|Adverse Event|1|||
129098398|NCT02636699|464652322|FG000|Screening Period|Other not specified|0|||
129098399|NCT02636699|464652323|FG001|Screening Period|Other not specified|0|||
129098400|NCT02636699|464652324|FG002|Screening Period|Other not specified|3|||
129098401|NCT02636699|464652322|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
129098402|NCT02636699|464652323|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
129098403|NCT02636699|464652324|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
129098404|NCT02636699|464652322|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
129098405|NCT02636699|464652323|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
129098406|NCT02636699|464652324|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
129098407|NCT02636699|464652322|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
129098408|NCT02636699|464652323|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
129098409|NCT02636699|464652324|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
129098410|NCT02636699|464652322|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
129098411|NCT02636699|464652323|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
129098412|NCT02636699|464652324|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
129098413|NCT02636699|464652322|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
129098414|NCT02636699|464652323|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
129098415|NCT02636699|464652324|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
129098416|NCT02636699|464652322|FG000|Treatment and Follow-up Periods|Other|3|||
129098417|NCT02636699|464652323|FG001|Treatment and Follow-up Periods|Other|1|||
129098418|NCT02636699|464652324|FG002|Treatment and Follow-up Periods|Other|0|||
129098419|NCT02305446|464652333|FG000|Overall Study|Adverse Event|1|||
129098420|NCT01636947|464652334|FG000|Overall Study|Not Treated|2|||
129098421|NCT01636947|464652335|FG001|Overall Study|Not Treated|2|||
129098422|NCT01636947|464652334|FG000|Overall Study|Lost to Follow-up|4|||
129098423|NCT01636947|464652335|FG001|Overall Study|Lost to Follow-up|0|||
129098424|NCT01636947|464652334|FG000|Overall Study|Protocol Violation|1|||
129098425|NCT01636947|464652335|FG001|Overall Study|Protocol Violation|1|||
129098426|NCT01636947|464652334|FG000|Overall Study|Withdrawal by Subject|3|||
129098427|NCT01636947|464652335|FG001|Overall Study|Withdrawal by Subject|3|||
129098428|NCT01636947|464652334|FG000|Overall Study|Adverse Event|1|||
129098429|NCT01636947|464652335|FG001|Overall Study|Adverse Event|1|||
129098430|NCT01636947|464652334|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129098431|NCT01636947|464652335|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
129098432|NCT00957424|464652336|FG000|Overall Study|Lost to Follow-up|19|||
129098433|NCT00957424|464652336|FG000|Overall Study|Protocol Violation|3|||
129098434|NCT00957424|464652336|FG000|Overall Study|Withdrawal by Subject|1|||
129098435|NCT01167634|464652345|FG000|Overall Study|Lost to Follow-up|1|||
129098436|NCT01167634|464652346|FG001|Overall Study|Lost to Follow-up|3|||
129098437|NCT01167634|464652347|FG002|Overall Study|Lost to Follow-up|3|||
129098438|NCT01167634|464652348|FG003|Overall Study|Lost to Follow-up|4|||
129098439|NCT01167634|464652345|FG000|Overall Study|Withdrawal by Subject|1|||
129098440|NCT01167634|464652346|FG001|Overall Study|Withdrawal by Subject|1|||
129098441|NCT01167634|464652347|FG002|Overall Study|Withdrawal by Subject|0|||
129098442|NCT01167634|464652348|FG003|Overall Study|Withdrawal by Subject|0|||
129098443|NCT00369161|464652349|FG000|Overall Study|Adverse Event|15|||
129098444|NCT00369161|464652350|FG001|Overall Study|Adverse Event|13|||
129098445|NCT00369161|464652349|FG000|Overall Study|Abnormal laboratory value|0|||
129098446|NCT00369161|464652350|FG001|Overall Study|Abnormal laboratory value|1|||
129098447|NCT00369161|464652349|FG000|Overall Study|Lack of Efficacy|3|||
129098448|NCT00369161|464652350|FG001|Overall Study|Lack of Efficacy|1|||
129098449|NCT00369161|464652349|FG000|Overall Study|Protocol Violation|0|||
129098450|NCT00369161|464652350|FG001|Overall Study|Protocol Violation|2|||
129098451|NCT00369161|464652349|FG000|Overall Study|Withdrawal by Subject|2|||
129098452|NCT00369161|464652350|FG001|Overall Study|Withdrawal by Subject|3|||
129098453|NCT00369161|464652349|FG000|Overall Study|Death|1|||
129098454|NCT00369161|464652350|FG001|Overall Study|Death|2|||
129098455|NCT00369161|464652349|FG000|Overall Study|Graft loss|4|||
129098456|NCT00369161|464652350|FG001|Overall Study|Graft loss|0|||
129098457|NCT00369161|464652349|FG000|Overall Study|Administrative Problem|2|||
129098458|NCT00369161|464652350|FG001|Overall Study|Administrative Problem|2|||
129098459|NCT02147067|464652353|FG000|Overall Study|Withdrawal by Subject|2|||
129098460|NCT02147067|464652354|FG001|Overall Study|Withdrawal by Subject|2|||
129098461|NCT02603107|464652355|FG000|Randomized Phase|Withdrew consent|8|||
129098462|NCT02603107|464652356|FG001|Randomized Phase|Withdrew consent|15|||
129098463|NCT02603107|464652355|FG000|Randomized Phase|Lost to Follow-up|1|||
129098464|NCT02603107|464652356|FG001|Randomized Phase|Lost to Follow-up|3|||
129098465|NCT02603107|464652355|FG000|Randomized Phase|Adverse Event|2|||
129098466|NCT02603107|464652356|FG001|Randomized Phase|Adverse Event|0|||
129098467|NCT02603107|464652355|FG000|Randomized Phase|Death|1|||
129098468|NCT02603107|464652356|FG001|Randomized Phase|Death|1|||
129098469|NCT02603107|464652355|FG000|Randomized Phase|Non-compliance with study drug|1|||
129098470|NCT02603107|464652356|FG001|Randomized Phase|Non-compliance with study drug|1|||
129098471|NCT02603107|464652355|FG000|Randomized Phase|Investigator's discretion|0|||
129098472|NCT02603107|464652356|FG001|Randomized Phase|Investigator's discretion|1|||
129098473|NCT02603107|464652355|FG000|Randomized Phase|Lack of Efficacy|1|||
129098474|NCT02603107|464652356|FG001|Randomized Phase|Lack of Efficacy|0|||
129098475|NCT02603107|464652355|FG000|Randomized Phase|Protocol Violation|1|||
129098476|NCT02603107|464652356|FG001|Randomized Phase|Protocol Violation|0|||
129098477|NCT02603107|464652355|FG000|Optional Extension Phase|Lost to Follow-up|3|||
129098478|NCT02603107|464652356|FG001|Optional Extension Phase|Lost to Follow-up|3|||
129098479|NCT02603107|464652355|FG000|Optional Extension Phase|Withdrew consent|3|||
129098480|NCT02603107|464652356|FG001|Optional Extension Phase|Withdrew consent|2|||
129098481|NCT02603107|464652355|FG000|Optional Extension Phase|Investigator's discretion|2|||
129098482|NCT02603107|464652356|FG001|Optional Extension Phase|Investigator's discretion|2|||
129098483|NCT02603107|464652355|FG000|Optional Extension Phase|Pregnancy|0|||
129098484|NCT02603107|464652356|FG001|Optional Extension Phase|Pregnancy|3|||
129098485|NCT02603107|464652355|FG000|Optional Extension Phase|Adverse Event|0|||
129098486|NCT02603107|464652356|FG001|Optional Extension Phase|Adverse Event|2|||
129098487|NCT02603107|464652355|FG000|Optional Extension Phase|Not treated in extension phase|0|||
129098488|NCT02603107|464652356|FG001|Optional Extension Phase|Not treated in extension phase|1|||
129098489|NCT02603107|464652355|FG000|Optional Extension Phase|Protocol Violation|1|||
129098490|NCT02603107|464652356|FG001|Optional Extension Phase|Protocol Violation|0|||
129098491|NCT01404949|464652357|FG000|Overall Study|Not Treated|1|||
129098492|NCT03411902|464652358|FG000|Overall Study|Lost to Follow-up|3|||
129098493|NCT03411902|464652359|FG001|Overall Study|Lost to Follow-up|0|||
129098494|NCT00419159|464652360|FG000|Overall Study|Adverse Event|7|||
129098495|NCT00419159|464652361|FG001|Overall Study|Adverse Event|15|||
129098496|NCT00419159|464652360|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129098497|NCT00419159|464652361|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129098498|NCT00419159|464652360|FG000|Overall Study|Subject's no longer requires study drug|0|||
129098499|NCT00419159|464652361|FG001|Overall Study|Subject's no longer requires study drug|1|||
129098500|NCT00419159|464652360|FG000|Overall Study|Protocol Violation|1|||
129098501|NCT00419159|464652361|FG001|Overall Study|Protocol Violation|0|||
129098502|NCT00419159|464652360|FG000|Overall Study|Withdrawal by Subject|10|||
129098503|NCT00419159|464652361|FG001|Overall Study|Withdrawal by Subject|3|||
128984326|NCT02064231|464231591|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
128984327|NCT02064231|464231588|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
128984328|NCT02064231|464231589|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
128984329|NCT02064231|464231590|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
128984330|NCT02064231|464231591|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
128984331|NCT04887922|464231592|FG000|1st Randomization|Decided not to have surgery|0|||
128984332|NCT04887922|464231593|FG001|1st Randomization|Decided not to have surgery|1|||
128984333|NCT04887922|464231594|FG002|1st Randomization|Decided not to have surgery|0|||
128984334|NCT04887922|464231595|FG003|1st Randomization|Decided not to have surgery|0|||
128984335|NCT04887922|464231596|FG004|1st Randomization|Decided not to have surgery|0|||
128984336|NCT02985996|464231597|FG000|Overall Study|Withdrawal by Subject|0|||
128984337|NCT02985996|464231598|FG001|Overall Study|Withdrawal by Subject|0|||
128984338|NCT02985996|464231599|FG002|Overall Study|Withdrawal by Subject|1|||
129098504|NCT00419159|464652360|FG000|Overall Study|Lost to Follow-up|0|||
129098505|NCT00419159|464652361|FG001|Overall Study|Lost to Follow-up|1|||
129098506|NCT00419159|464652360|FG000|Overall Study|Death|2|||
129098507|NCT00419159|464652361|FG001|Overall Study|Death|2|||
129098508|NCT00419159|464652360|FG000|Overall Study|Disease progression|79|||
129098509|NCT00419159|464652361|FG001|Overall Study|Disease progression|76|||
129098510|NCT01017601|464652362|FG000|Overall Study|Disease Progression|12|||
129098511|NCT01017601|464652363|FG001|Overall Study|Disease Progression|12|||
129098512|NCT01017601|464652362|FG000|Overall Study|Withdrawal by Subject|0|||
129098513|NCT01017601|464652363|FG001|Overall Study|Withdrawal by Subject|1|||
128984339|NCT02985996|464231600|FG003|Overall Study|Withdrawal by Subject|0|||
128984340|NCT02985996|464231601|FG004|Overall Study|Withdrawal by Subject|0|||
128984341|NCT02985996|464231597|FG000|Overall Study|Protocol Violation|0|||
129098514|NCT02638259|464652365|FG000|Treatment Period 1|Adverse Event|1|||
129098515|NCT02638259|464652366|FG001|Treatment Period 1|Adverse Event|5|||
129098516|NCT02638259|464652365|FG000|Treatment Period 1|Death|0|||
129098517|NCT02638259|464652366|FG001|Treatment Period 1|Death|1|||
129098518|NCT02638259|464652365|FG000|Treatment Period 1|Lack of Efficacy|0|||
129098519|NCT02638259|464652366|FG001|Treatment Period 1|Lack of Efficacy|1|||
129098520|NCT02638259|464652365|FG000|Treatment Period 1|Protocol Violation|0|||
129098521|NCT02638259|464652366|FG001|Treatment Period 1|Protocol Violation|3|||
129098522|NCT02638259|464652365|FG000|Treatment Period 1|Withdrawal by Subject|4|||
129098523|NCT02638259|464652366|FG001|Treatment Period 1|Withdrawal by Subject|6|||
129098524|NCT02638259|464652365|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
129206816|NCT00286442|465054974|FG002|Overall Study|Withdrawal by Subject|2|||
129206817|NCT04571944|465054979|FG000|Overall Study|Death|1|||
129206818|NCT04571944|465054980|FG001|Overall Study|Death|0|||
129206819|NCT04571944|465054979|FG000|Overall Study|Withdrawal by Subject|3|||
129206820|NCT04571944|465054980|FG001|Overall Study|Withdrawal by Subject|0|||
129206821|NCT04571944|465054979|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
129206822|NCT04571944|465054980|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
129206823|NCT04913610|465054983|FG000|Randomized Participants|Did Not Receive Treatment|0|||
129206824|NCT04913610|465054984|FG001|Randomized Participants|Did Not Receive Treatment|0|||
129206825|NCT04913610|465054985|FG002|Randomized Participants|Did Not Receive Treatment|1|||
129206826|NCT04913610|465054986|FG003|Randomized Participants|Did Not Receive Treatment|1|||
129206827|NCT04913610|465054987|FG004|Randomized Participants|Did Not Receive Treatment|0|||
129206828|NCT04913610|465054983|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
129206829|NCT04913610|465054984|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
129206830|NCT04913610|465054985|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
129206831|NCT04913610|465054986|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
129206832|NCT04913610|465054987|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
129206833|NCT00659061|465054988|FG000|Overall Study|Migration due to political unrest|21|||
129206834|NCT00659061|465054989|FG001|Overall Study|Migration due to political unrest|15|||
129206835|NCT01277744|465054992|FG000|Overall Study|Physician Decision|2|||
129206836|NCT01650558|465054995|FG000|Overall Study|Migration out of study area|61|||
129206837|NCT01650558|465054996|FG001|Overall Study|Migration out of study area|71|||
129206838|NCT01650558|465054997|FG002|Overall Study|Migration out of study area|56|||
129206839|NCT01650558|465054995|FG000|Overall Study|Lost to Follow-up|10|||
129206840|NCT01650558|465054996|FG001|Overall Study|Lost to Follow-up|13|||
129206841|NCT01650558|465054997|FG002|Overall Study|Lost to Follow-up|6|||
129206842|NCT01650558|465054995|FG000|Overall Study|Death|10|||
129206843|NCT01650558|465054996|FG001|Overall Study|Death|6|||
129206844|NCT01650558|465054997|FG002|Overall Study|Death|8|||
129206845|NCT01650558|465054995|FG000|Overall Study|Withdrawal by Subject|1|||
129206846|NCT01650558|465054996|FG001|Overall Study|Withdrawal by Subject|1|||
128984342|NCT02985996|464231598|FG001|Overall Study|Protocol Violation|1|||
128984343|NCT02985996|464231599|FG002|Overall Study|Protocol Violation|0|||
128984344|NCT02985996|464231600|FG003|Overall Study|Protocol Violation|0|||
128984345|NCT02985996|464231601|FG004|Overall Study|Protocol Violation|0|||
128984346|NCT00401726|464231602|FG000|Overall Study|Adverse Event|34|||
128984347|NCT00401726|464231603|FG001|Overall Study|Adverse Event|45|||
128984348|NCT00401726|464231602|FG000|Overall Study|Death|0|||
128984349|NCT00401726|464231603|FG001|Overall Study|Death|3|||
128984350|NCT00401726|464231602|FG000|Overall Study|Sponsor Request|0|||
128984351|NCT00401726|464231603|FG001|Overall Study|Sponsor Request|1|||
128984352|NCT00401726|464231602|FG000|Overall Study|Physician Decision|3|||
128984353|NCT00401726|464231603|FG001|Overall Study|Physician Decision|6|||
128984354|NCT00401726|464231602|FG000|Overall Study|Lost to Follow-up|23|||
128984355|NCT00401726|464231603|FG001|Overall Study|Lost to Follow-up|20|||
128984356|NCT00401726|464231602|FG000|Overall Study|Protocol Violation|6|||
128984357|NCT00401726|464231603|FG001|Overall Study|Protocol Violation|3|||
128984358|NCT00401726|464231602|FG000|Overall Study|Withdrawal by Subject|18|||
128984359|NCT00401726|464231603|FG001|Overall Study|Withdrawal by Subject|24|||
129206847|NCT01650558|465054997|FG002|Overall Study|Withdrawal by Subject|3|||
129206848|NCT01650558|465054995|FG000|Overall Study|Non-compliant participant|1|||
129206849|NCT01650558|465054996|FG001|Overall Study|Non-compliant participant|0|||
129206850|NCT01650558|465054997|FG002|Overall Study|Non-compliant participant|2|||
129206851|NCT01650558|465054995|FG000|Overall Study|Physician Decision|0|||
129206852|NCT01650558|465054996|FG001|Overall Study|Physician Decision|1|||
129206853|NCT01650558|465054997|FG002|Overall Study|Physician Decision|0|||
129206854|NCT03740048|465054999|FG000|Overall Study|Withdrawal by Subject|1|||
128984360|NCT00401726|464231602|FG000|Overall Study|Lack of Efficacy|4|||
128984361|NCT00401726|464231603|FG001|Overall Study|Lack of Efficacy|6|||
128984362|NCT00401726|464231602|FG000|Overall Study|Protocol Deviation|9|||
128984363|NCT00401726|464231603|FG001|Overall Study|Protocol Deviation|4|||
128984364|NCT00442572|464231604|FG000|Overall Study|Relapse|8|||
129206855|NCT03740048|465055000|FG001|Overall Study|Withdrawal by Subject|1|||
129206856|NCT03740048|465054999|FG000|Overall Study|Death|1|||
129206857|NCT03740048|465055000|FG001|Overall Study|Death|6|||
129206858|NCT03740048|465054999|FG000|Overall Study|Switched to thrice-weekly HD|2|||
129206859|NCT03740048|465055000|FG001|Overall Study|Switched to thrice-weekly HD|0|||
129206860|NCT03740048|465054999|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
129206861|NCT03740048|465055000|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
129206862|NCT03740048|465054999|FG000|Overall Study|Lost to Follow-up|0|||
128876160|NCT00979134|463839421|FG002|Overall Study|Adverse Event|2|||
129206863|NCT03740048|465055000|FG001|Overall Study|Lost to Follow-up|1|||
129206864|NCT03740048|465054999|FG000|Overall Study|Non-compliance with HD|0|||
128876161|NCT00979134|463839419|FG000|Overall Study|Withdrawal by Subject|1|||
128876162|NCT00979134|463839420|FG001|Overall Study|Withdrawal by Subject|1|||
128876163|NCT00979134|463839421|FG002|Overall Study|Withdrawal by Subject|2|||
128876164|NCT00979134|463839419|FG000|Overall Study|Lost to Follow-up|2|||
128876165|NCT00979134|463839420|FG001|Overall Study|Lost to Follow-up|2|||
128876166|NCT00979134|463839421|FG002|Overall Study|Lost to Follow-up|0|||
128876167|NCT00979134|463839419|FG000|Overall Study|Death|4|||
128876168|NCT00979134|463839420|FG001|Overall Study|Death|0|||
128876169|NCT00979134|463839421|FG002|Overall Study|Death|26|||
128876170|NCT00979134|463839419|FG000|Overall Study|Other|8|||
128876171|NCT00979134|463839420|FG001|Overall Study|Other|1|||
128876172|NCT00979134|463839421|FG002|Overall Study|Other|5|||
128876173|NCT03647488|463842308|FG000|Overall Study|Progressive disease|10|||
128876174|NCT03647488|463842309|FG001|Overall Study|Progressive disease|0|||
128876175|NCT03647488|463842310|FG002|Overall Study|Progressive disease|0|||
128876176|NCT03647488|463842308|FG000|Overall Study|Adverse Event|5|||
128876177|NCT03647488|463842309|FG001|Overall Study|Adverse Event|0|||
128876178|NCT03647488|463842310|FG002|Overall Study|Adverse Event|0|||
128876179|NCT03647488|463842308|FG000|Overall Study|Clinical progression|2|||
128876180|NCT03647488|463842309|FG001|Overall Study|Clinical progression|0|||
128876181|NCT03647488|463842310|FG002|Overall Study|Clinical progression|0|||
128876182|NCT03647488|463842308|FG000|Overall Study|Participant refused to take investigational product|1|||
128876183|NCT03647488|463842309|FG001|Overall Study|Participant refused to take investigational product|0|||
128876184|NCT03647488|463842310|FG002|Overall Study|Participant refused to take investigational product|0|||
128876185|NCT03694275|463842311|FG000|Overall Study|Adverse Event|0|||
128876186|NCT03694275|463842312|FG001|Overall Study|Adverse Event|1|||
128876187|NCT03694275|463842311|FG000|Overall Study|Reason not Specified|0|||
128876188|NCT03694275|463842312|FG001|Overall Study|Reason not Specified|1|||
128876189|NCT03541174|463842313|FG000|Part 1 Double-Blind|Adverse Event|6|||
128876190|NCT03541174|463842314|FG001|Part 1 Double-Blind|Adverse Event|5|||
128876191|NCT03541174|463842315|FG002|Part 1 Double-Blind|Adverse Event|2|||
128876192|NCT03541174|463842316|FG003|Part 1 Double-Blind|Adverse Event|0|||
128876193|NCT03541174|463842317|FG004|Part 1 Double-Blind|Adverse Event|0|||
128876194|NCT03541174|463842318|FG005|Part 1 Double-Blind|Adverse Event|0|||
128876195|NCT03541174|463842313|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
128876196|NCT03541174|463842314|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
128876197|NCT03541174|463842315|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
128876198|NCT03541174|463842316|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
128876199|NCT03541174|463842317|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
128876200|NCT03541174|463842318|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
128876201|NCT03541174|463842313|FG000|Part 1 Double-Blind|Other reasons|3|||
128876202|NCT03541174|463842314|FG001|Part 1 Double-Blind|Other reasons|2|||
128876203|NCT03541174|463842315|FG002|Part 1 Double-Blind|Other reasons|3|||
128876204|NCT03541174|463842316|FG003|Part 1 Double-Blind|Other reasons|0|||
128876205|NCT03541174|463842317|FG004|Part 1 Double-Blind|Other reasons|0|||
128876206|NCT03541174|463842318|FG005|Part 1 Double-Blind|Other reasons|0|||
128876207|NCT03541174|463842313|FG000|Part 2 Single-Blind|Adverse Event|0|||
128876208|NCT03541174|463842314|FG001|Part 2 Single-Blind|Adverse Event|0|||
128876209|NCT03541174|463842315|FG002|Part 2 Single-Blind|Adverse Event|0|||
128876210|NCT03541174|463842316|FG003|Part 2 Single-Blind|Adverse Event|25|||
128876211|NCT03541174|463842317|FG004|Part 2 Single-Blind|Adverse Event|0|||
128876212|NCT03541174|463842318|FG005|Part 2 Single-Blind|Adverse Event|0|||
128876213|NCT03541174|463842313|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
128876214|NCT03541174|463842314|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
128876215|NCT03541174|463842315|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
128876216|NCT03541174|463842316|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
128876217|NCT03541174|463842317|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
128876218|NCT03541174|463842318|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
128876219|NCT03541174|463842313|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
128876220|NCT03541174|463842314|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
128876221|NCT03541174|463842315|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
128876222|NCT03541174|463842316|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
128876223|NCT03541174|463842317|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
128876224|NCT03541174|463842318|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
129206865|NCT03740048|465055000|FG001|Overall Study|Non-compliance with HD|1|||
129206866|NCT01476722|465055001|FG000|Overall Study|Adverse Event|1|||
129206867|NCT03261336|465055002|FG000|Overall Study|Adverse Event|1|||
129206868|NCT01069484|465055004|FG000|Overall Study|Death-in-near-family|1|||
129206869|NCT01069484|465055005|FG001|Overall Study|Death-in-near-family|0|||
129206870|NCT01069484|465055004|FG000|Overall Study|No specific reason|8|||
129206871|NCT01069484|465055005|FG001|Overall Study|No specific reason|2|||
129206872|NCT01069484|465055004|FG000|Overall Study|Illness mother or child|3|||
129206873|NCT01069484|465055005|FG001|Overall Study|Illness mother or child|1|||
129206874|NCT00644358|465055007|FG000|Overall Study|Adverse Event|124|||
129206875|NCT00644358|465055007|FG000|Overall Study|Lost to Follow-up|105|||
129206876|NCT00644358|465055007|FG000|Overall Study|Consent Withdrawal|64|||
129206877|NCT00644358|465055007|FG000|Overall Study|Lack of Effectiveness|39|||
129206878|NCT00644358|465055007|FG000|Overall Study|Protocol Violation|5|||
129206879|NCT00644358|465055007|FG000|Overall Study|Noncompliance|14|||
129206880|NCT00644358|465055007|FG000|Overall Study|Other Unspecified|11|||
129206881|NCT00758771|465055014|FG000|Overall Study|Withdrawal by Subject|1|||
129206882|NCT00758771|465055015|FG001|Overall Study|Withdrawal by Subject|1|||
129206883|NCT00758771|465055014|FG000|Overall Study|Did not meet eligibility criteria|2|||
129206884|NCT00758771|465055015|FG001|Overall Study|Did not meet eligibility criteria|4|||
129206885|NCT00528957|465055016|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
129206886|NCT00528957|465055017|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
129206887|NCT00528957|465055016|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
129206888|NCT00528957|465055017|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
129206889|NCT00528957|465055016|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
129206890|NCT00528957|465055017|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
129206891|NCT00528957|465055016|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
129206892|NCT00528957|465055017|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
129206893|NCT00528957|465055016|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
129206894|NCT00528957|465055017|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
129206895|NCT00528957|465055016|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
129206896|NCT00528957|465055017|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
129206897|NCT00528957|465055016|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
129206898|NCT00528957|465055017|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
129206899|NCT00528957|465055016|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
129206900|NCT00528957|465055017|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
129206901|NCT00528957|465055016|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
129206902|NCT00528957|465055017|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
129206903|NCT00528957|465055016|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
129206904|NCT00528957|465055017|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
129206905|NCT00528957|465055016|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
128984365|NCT00442572|464231605|FG001|Overall Study|Relapse|1|||
128984366|NCT00442572|464231604|FG000|Overall Study|Lost to Follow-up|0|||
128984367|NCT00442572|464231605|FG001|Overall Study|Lost to Follow-up|1|||
128984368|NCT00442572|464231604|FG000|Overall Study|Withdrawal by Subject|0|||
128984369|NCT00442572|464231605|FG001|Overall Study|Withdrawal by Subject|1|||
128984370|NCT03732534|464231606|FG000|Overall Study|Study terminated by Sponsor|6|||
128984371|NCT03735849|464231610|FG000|Overall Study|Lost to Follow-up|1|||
128984372|NCT03735849|464231611|FG001|Overall Study|Lost to Follow-up|0|||
128984373|NCT03735849|464231612|FG002|Overall Study|Lost to Follow-up|0|||
128984374|NCT03735849|464231610|FG000|Overall Study|Participant unable to adhere to visit|1|||
128984375|NCT03735849|464231611|FG001|Overall Study|Participant unable to adhere to visit|0|||
128984376|NCT03735849|464231612|FG002|Overall Study|Participant unable to adhere to visit|0|||
128984377|NCT03735849|464231610|FG000|Overall Study|Not Randomized|0|||
128984378|NCT03735849|464231611|FG001|Overall Study|Not Randomized|0|||
128984379|NCT03735849|464231612|FG002|Overall Study|Not Randomized|4|||
128984380|NCT04585906|464231613|FG000|Overall Study|Lost to Follow-up|8|||
128984381|NCT04585906|464231614|FG001|Overall Study|Lost to Follow-up|5|||
128984382|NCT01050998|464231616|FG000|Overall Study|Adverse Event|1|||
128984383|NCT01050998|464231617|FG001|Overall Study|Adverse Event|0|||
128984384|NCT01050998|464231618|FG002|Overall Study|Adverse Event|1|||
128984385|NCT01050998|464231619|FG003|Overall Study|Adverse Event|0|||
128984386|NCT01050998|464231620|FG004|Overall Study|Adverse Event|2|||
128984387|NCT01050998|464231616|FG000|Overall Study|Withdrawal by Subject|0|||
128984388|NCT01050998|464231617|FG001|Overall Study|Withdrawal by Subject|0|||
129206906|NCT00528957|465055017|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
129206907|NCT00528957|465055016|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
129206908|NCT00528957|465055017|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
128984389|NCT01050998|464231618|FG002|Overall Study|Withdrawal by Subject|0|||
128984390|NCT01050998|464231619|FG003|Overall Study|Withdrawal by Subject|1|||
129206909|NCT00528957|465055016|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
129206910|NCT00528957|465055017|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
129206911|NCT00528957|465055016|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
129206912|NCT00528957|465055017|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
129206913|NCT00528957|465055016|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
129206914|NCT00528957|465055017|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
129206915|NCT00528957|465055016|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
129206916|NCT00528957|465055017|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
129206917|NCT02051764|465055022|FG000|Overall Study|Study terminated by sponsor|0|||
129206918|NCT02051764|465055023|FG001|Overall Study|Study terminated by sponsor|7|||
129206919|NCT03624881|465055024|FG000|Overall Study|Screen Failure|14|||
129206920|NCT03624881|465055025|FG001|Overall Study|Screen Failure|0|||
129206921|NCT03624881|465055024|FG000|Overall Study|No Catheter Inserted|6|||
129206922|NCT03624881|465055025|FG001|Overall Study|No Catheter Inserted|1|||
129206923|NCT03624881|465055024|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
129206924|NCT03624881|465055025|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
129206925|NCT03624881|465055024|FG000|Overall Study|Death|2|||
129206926|NCT03624881|465055025|FG001|Overall Study|Death|0|||
129206927|NCT03624881|465055024|FG000|Overall Study|Lost to Follow-up|10|||
129206928|NCT03624881|465055025|FG001|Overall Study|Lost to Follow-up|4|||
129206929|NCT03624881|465055024|FG000|Overall Study|Withdrawal by Subject|12|||
129206930|NCT03624881|465055025|FG001|Overall Study|Withdrawal by Subject|1|||
129206931|NCT03155724|465055031|FG000|Overall Study|Death|3|||
129206932|NCT03155724|465055031|FG000|Overall Study|Physician Decision|1|||
129206933|NCT03155724|465055031|FG000|Overall Study|Study closure|7|||
129206934|NCT00321789|465055033|FG000|Overall Study|Lost to Follow-up|4|||
129206935|NCT00321789|465055034|FG001|Overall Study|Lost to Follow-up|7|||
129206936|NCT00321789|465055033|FG000|Overall Study|Withdrawal by Subject|6|||
129206937|NCT00321789|465055034|FG001|Overall Study|Withdrawal by Subject|6|||
129206938|NCT00321789|465055033|FG000|Overall Study|Protocol Violation|5|||
129206939|NCT00321789|465055034|FG001|Overall Study|Protocol Violation|3|||
129206940|NCT00601835|465055037|FG000|Overall Study|Withdrawal by Subject|9|||
129206941|NCT00601835|465055038|FG001|Overall Study|Withdrawal by Subject|6|||
129206942|NCT00601835|465055037|FG000|Overall Study|Physician Decision|1|||
129206943|NCT00601835|465055038|FG001|Overall Study|Physician Decision|0|||
129206944|NCT00601835|465055037|FG000|Overall Study|Lost to Follow-up|37|||
129206945|NCT00601835|465055038|FG001|Overall Study|Lost to Follow-up|5|||
129206946|NCT00601835|465055037|FG000|Overall Study|Adverse Event|1|||
129206947|NCT00601835|465055038|FG001|Overall Study|Adverse Event|1|||
129206948|NCT00601835|465055037|FG000|Overall Study|Relocate|12|||
129206949|NCT00601835|465055038|FG001|Overall Study|Relocate|2|||
129206950|NCT01400698|465055040|FG000|Overall Study|Lost to Follow-up|2|||
129206951|NCT01400698|465055041|FG001|Overall Study|Lost to Follow-up|5|||
129206952|NCT01400698|465055042|FG002|Overall Study|Lost to Follow-up|2|||
129206953|NCT01400698|465055043|FG003|Overall Study|Lost to Follow-up|1|||
129206954|NCT01400698|465055044|FG004|Overall Study|Lost to Follow-up|4|||
129206955|NCT01400698|465055045|FG005|Overall Study|Lost to Follow-up|3|||
129206956|NCT01400698|465055040|FG000|Overall Study|Withdrawal by Subject|8|||
129206957|NCT01400698|465055041|FG001|Overall Study|Withdrawal by Subject|2|||
129206958|NCT01400698|465055042|FG002|Overall Study|Withdrawal by Subject|0|||
129206959|NCT01400698|465055043|FG003|Overall Study|Withdrawal by Subject|4|||
129206960|NCT01400698|465055044|FG004|Overall Study|Withdrawal by Subject|1|||
129206961|NCT01400698|465055045|FG005|Overall Study|Withdrawal by Subject|3|||
129206962|NCT01400698|465055040|FG000|Overall Study|Protocol Violation|0|||
129206963|NCT01400698|465055041|FG001|Overall Study|Protocol Violation|1|||
129206964|NCT01400698|465055042|FG002|Overall Study|Protocol Violation|0|||
129206965|NCT01400698|465055043|FG003|Overall Study|Protocol Violation|0|||
129206966|NCT01400698|465055044|FG004|Overall Study|Protocol Violation|1|||
129206967|NCT01400698|465055045|FG005|Overall Study|Protocol Violation|0|||
129206968|NCT01400698|465055040|FG000|Overall Study|Non-compliance|0|||
129206969|NCT01400698|465055041|FG001|Overall Study|Non-compliance|1|||
129206970|NCT01400698|465055042|FG002|Overall Study|Non-compliance|0|||
129206971|NCT01400698|465055043|FG003|Overall Study|Non-compliance|1|||
129206972|NCT01400698|465055044|FG004|Overall Study|Non-compliance|0|||
129206973|NCT01400698|465055045|FG005|Overall Study|Non-compliance|0|||
129206974|NCT01400698|465055040|FG000|Overall Study|Adverse Event|1|||
129206975|NCT01400698|465055041|FG001|Overall Study|Adverse Event|0|||
129206976|NCT01400698|465055042|FG002|Overall Study|Adverse Event|0|||
129206977|NCT01400698|465055043|FG003|Overall Study|Adverse Event|0|||
129206978|NCT01400698|465055044|FG004|Overall Study|Adverse Event|0|||
129206979|NCT01400698|465055045|FG005|Overall Study|Adverse Event|0|||
129206980|NCT01400698|465055040|FG000|Overall Study|Other|4|||
129206981|NCT01400698|465055041|FG001|Overall Study|Other|2|||
128977892|NCT00699582|464205246|FG002|Overall Study|Adverse Event|23|||
129206982|NCT01400698|465055042|FG002|Overall Study|Other|0|||
129206983|NCT01400698|465055043|FG003|Overall Study|Other|2|||
129206984|NCT01400698|465055044|FG004|Overall Study|Other|1|||
129206985|NCT01400698|465055045|FG005|Overall Study|Other|0|||
129206986|NCT00948064|465056786|FG000|Phase I|No treatment received|1|||
129206987|NCT00948064|465056787|FG001|Phase I|No treatment received|0|||
129206988|NCT00948064|465056788|FG002|Phase I|No treatment received|0|||
129206989|NCT00948064|465056786|FG000|Phase II|Physician Decision|0|||
129206990|NCT00948064|465056787|FG001|Phase II|Physician Decision|0|||
129206991|NCT00948064|465056788|FG002|Phase II|Physician Decision|1|||
129206992|NCT00948064|465056786|FG000|Phase II|Withdrawal by Subject|0|||
129206993|NCT00948064|465056787|FG001|Phase II|Withdrawal by Subject|1|||
129206994|NCT00948064|465056788|FG002|Phase II|Withdrawal by Subject|0|||
129206995|NCT02741128|465056799|FG000|Overall Study|Protocol Violation|4|||
129206996|NCT02741128|465056800|FG001|Overall Study|Protocol Violation|1|||
129206997|NCT02741128|465056799|FG000|Overall Study|Withdrawal by Subject|2|||
129206998|NCT02741128|465056800|FG001|Overall Study|Withdrawal by Subject|0|||
129206999|NCT02741128|465056799|FG000|Overall Study|Lost to Follow-up|1|||
129207000|NCT02741128|465056800|FG001|Overall Study|Lost to Follow-up|0|||
129207001|NCT02973100|465056801|FG000|Overall Study|Adverse Event|1|||
129207002|NCT02973100|465056802|FG001|Overall Study|Adverse Event|2|||
129207003|NCT02973100|465056803|FG002|Overall Study|Adverse Event|1|||
129207004|NCT02973100|465056804|FG003|Overall Study|Adverse Event|2|||
129207005|NCT02973100|465056801|FG000|Overall Study|Lost to Follow-up|3|||
129207006|NCT02973100|465056802|FG001|Overall Study|Lost to Follow-up|1|||
129207007|NCT02973100|465056803|FG002|Overall Study|Lost to Follow-up|1|||
129207008|NCT02973100|465056804|FG003|Overall Study|Lost to Follow-up|0|||
129207009|NCT02973100|465056801|FG000|Overall Study|Withdrawal by Subject|3|||
129207010|NCT02973100|465056802|FG001|Overall Study|Withdrawal by Subject|5|||
129207011|NCT02973100|465056803|FG002|Overall Study|Withdrawal by Subject|1|||
129207012|NCT02973100|465056804|FG003|Overall Study|Withdrawal by Subject|4|||
129207013|NCT02973100|465056801|FG000|Overall Study|Notification of change in address|0|||
129207014|NCT02973100|465056802|FG001|Overall Study|Notification of change in address|0|||
129207015|NCT02973100|465056803|FG002|Overall Study|Notification of change in address|0|||
129207016|NCT02973100|465056804|FG003|Overall Study|Notification of change in address|1|||
129207017|NCT02973100|465056801|FG000|Overall Study|Failed to attend Safety followup period|0|||
129207018|NCT02973100|465056802|FG001|Overall Study|Failed to attend Safety followup period|0|||
129207019|NCT02973100|465056803|FG002|Overall Study|Failed to attend Safety followup period|1|||
129207020|NCT02973100|465056804|FG003|Overall Study|Failed to attend Safety followup period|0|||
129207021|NCT01419769|465056805|FG000|Overall Study|Did not receive the AXIOS stent|3|||
129207022|NCT01419769|465056805|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
129207023|NCT00878501|465056806|FG000|Overall Study|Adverse Event|11|||
129207024|NCT00878501|465056807|FG001|Overall Study|Adverse Event|3|||
129207025|NCT00878501|465056808|FG002|Overall Study|Adverse Event|3|||
129207026|NCT00878501|465056806|FG000|Overall Study|Lack of Efficacy|2|||
129207027|NCT00878501|465056807|FG001|Overall Study|Lack of Efficacy|1|||
129207028|NCT00878501|465056808|FG002|Overall Study|Lack of Efficacy|0|||
129207029|NCT00878501|465056806|FG000|Overall Study|Withdrawal by Subject|2|||
129098525|NCT02638259|464652366|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
129098526|NCT02638259|464652365|FG000|Treatment Period 2|Adverse Event|5|||
129098527|NCT02638259|464652366|FG001|Treatment Period 2|Adverse Event|4|||
129098528|NCT02638259|464652365|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129098529|NCT02638259|464652366|FG001|Treatment Period 2|Withdrawal by Subject|7|||
129098530|NCT01706575|464652367|FG000|Overall Study|Participant Withdrew Consent|4|||
129098531|NCT01706575|464652367|FG000|Overall Study|Lost to Follow-up|2|||
129098532|NCT01706575|464652367|FG000|Overall Study|Started but not Treated|6|||
129098533|NCT00957905|464652368|FG000|Part B|Not Treated|0|||
129098534|NCT00957905|464652369|FG001|Part B|Not Treated|1|||
129098535|NCT00957905|464652368|FG000|Part B|Physician Decision|0|||
129098536|NCT00957905|464652369|FG001|Part B|Physician Decision|1|||
129207030|NCT00878501|465056807|FG001|Overall Study|Withdrawal by Subject|1|||
128984391|NCT01050998|464231620|FG004|Overall Study|Withdrawal by Subject|3|||
128984392|NCT01050998|464231616|FG000|Overall Study|Other|3|||
129207031|NCT00878501|465056808|FG002|Overall Study|Withdrawal by Subject|2|||
129207032|NCT00878501|465056806|FG000|Overall Study|Protocol Violation|0|||
129207033|NCT00878501|465056807|FG001|Overall Study|Protocol Violation|0|||
129207034|NCT00878501|465056808|FG002|Overall Study|Protocol Violation|1|||
129207035|NCT00878501|465056806|FG000|Overall Study|Incorrect enrolment|1|||
129207036|NCT00878501|465056807|FG001|Overall Study|Incorrect enrolment|2|||
129207037|NCT00878501|465056808|FG002|Overall Study|Incorrect enrolment|0|||
129207038|NCT00878501|465056806|FG000|Overall Study|Intake of prohibited concom. medication|0|||
129207039|NCT00878501|465056807|FG001|Overall Study|Intake of prohibited concom. medication|0|||
129207040|NCT00878501|465056808|FG002|Overall Study|Intake of prohibited concom. medication|1|||
129207041|NCT00878501|465056806|FG000|Overall Study|Mis-randomisation of patient|1|||
129207042|NCT00878501|465056807|FG001|Overall Study|Mis-randomisation of patient|0|||
129207043|NCT00878501|465056808|FG002|Overall Study|Mis-randomisation of patient|0|||
129098537|NCT00957905|464652368|FG000|Part B|Death|0|||
129098538|NCT00957905|464652369|FG001|Part B|Death|1|||
129207044|NCT00878501|465056806|FG000|Overall Study|Administrative|0|||
129207045|NCT00878501|465056807|FG001|Overall Study|Administrative|0|||
128984393|NCT01050998|464231617|FG001|Overall Study|Other|2|||
128984394|NCT01050998|464231618|FG002|Overall Study|Other|1|||
128984395|NCT01050998|464231619|FG003|Overall Study|Other|1|||
128984396|NCT01050998|464231620|FG004|Overall Study|Other|5|||
128984397|NCT01050998|464231616|FG000|Overall Study|Data integrity issues|0|||
128984398|NCT01050998|464231617|FG001|Overall Study|Data integrity issues|0|||
128984399|NCT01050998|464231618|FG002|Overall Study|Data integrity issues|1|||
128984400|NCT01050998|464231619|FG003|Overall Study|Data integrity issues|1|||
128984401|NCT01050998|464231620|FG004|Overall Study|Data integrity issues|4|||
128984402|NCT04246593|464231627|FG000|Overall Study|Withdrawal by Subject|14|||
128984403|NCT04246593|464231628|FG001|Overall Study|Withdrawal by Subject|13|||
128984404|NCT04246593|464231627|FG000|Overall Study|Lost to Follow-up|124|||
128984405|NCT04246593|464231628|FG001|Overall Study|Lost to Follow-up|71|||
128984406|NCT04246593|464231627|FG000|Overall Study|Moved out of area/became ineligible|3|||
128984407|NCT04246593|464231628|FG001|Overall Study|Moved out of area/became ineligible|1|||
128984408|NCT04246593|464231627|FG000|Overall Study|Reason unknown|4|||
128984409|NCT04246593|464231628|FG001|Overall Study|Reason unknown|2|||
128984410|NCT02369874|464231630|FG000|Overall Study|Lost to Follow-up|2|||
128984411|NCT02369874|464231631|FG001|Overall Study|Lost to Follow-up|2|||
128984412|NCT02369874|464231632|FG002|Overall Study|Lost to Follow-up|2|||
128984413|NCT02369874|464231630|FG000|Overall Study|Withdrawal by Subject|7|||
128984414|NCT02369874|464231631|FG001|Overall Study|Withdrawal by Subject|9|||
128984415|NCT02369874|464231632|FG002|Overall Study|Withdrawal by Subject|27|||
128984416|NCT02369874|464231630|FG000|Overall Study|Miscellaneous|1|||
128984417|NCT02369874|464231631|FG001|Overall Study|Miscellaneous|1|||
128984418|NCT02369874|464231632|FG002|Overall Study|Miscellaneous|0|||
128984419|NCT02369874|464231630|FG000|Overall Study|On Treatment/Off Study|34|||
128984420|NCT02369874|464231631|FG001|Overall Study|On Treatment/Off Study|45|||
128984421|NCT02369874|464231632|FG002|Overall Study|On Treatment/Off Study|32|||
128984422|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
128984423|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
128984424|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
128984425|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
128984426|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
128984427|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Death|1|||
128984428|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Death|0|||
128984429|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Death|0|||
128984430|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Death|0|||
128984431|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Death|0|||
128984432|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
128984433|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
128984434|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
128984435|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
128984436|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
128984437|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
128984438|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
128984439|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
128984440|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
128984441|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
128984442|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
128984443|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
128984444|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
128984445|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
128984446|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
128984447|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
128984448|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
128984449|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
128984450|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
128984451|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
128984452|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
128984453|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
128984454|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
128984455|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
128984456|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
128984457|NCT00634933|464231635|FG000|Part A: Baseline to Week 24|Other|1|||
128984458|NCT00634933|464231636|FG001|Part A: Baseline to Week 24|Other|8|||
128984459|NCT00634933|464231637|FG002|Part A: Baseline to Week 24|Other|5|||
128984460|NCT00634933|464231638|FG003|Part A: Baseline to Week 24|Other|0|||
128984461|NCT00634933|464231639|FG004|Part A: Baseline to Week 24|Other|0|||
128984462|NCT00634933|464231635|FG000|Between Part A and Part B|Physician Decision|0|||
128984463|NCT00634933|464231636|FG001|Between Part A and Part B|Physician Decision|1|||
128984464|NCT00634933|464231637|FG002|Between Part A and Part B|Physician Decision|0|||
128984465|NCT00634933|464231638|FG003|Between Part A and Part B|Physician Decision|0|||
128984466|NCT00634933|464231639|FG004|Between Part A and Part B|Physician Decision|0|||
128984467|NCT00634933|464231635|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
129098539|NCT00957905|464652368|FG000|Part B|Protocol Violation|0|||
129098540|NCT00957905|464652369|FG001|Part B|Protocol Violation|1|||
129098541|NCT02073656|464652386|FG000|Primary Study|Lost to Follow-up|6|||
129098542|NCT02073656|464652386|FG000|Primary Study|Death|1|||
129098543|NCT02073656|464652386|FG000|Primary Study|Withdrew Consent|1|||
129098544|NCT02536781|464652387|FG000|Overall Study|Lost to Follow-up|2|||
129098545|NCT02536781|464652388|FG001|Overall Study|Lost to Follow-up|0|||
129098546|NCT03423147|464652389|FG000|Overall Study|Lost to Follow-up|5|||
129098547|NCT03423147|464652390|FG001|Overall Study|Lost to Follow-up|8|||
129098548|NCT03423147|464652389|FG000|Overall Study|Withdrawal by Subject|1|||
129098549|NCT03423147|464652390|FG001|Overall Study|Withdrawal by Subject|0|||
129098550|NCT03423147|464652389|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
129098551|NCT03423147|464652390|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
129098552|NCT03423147|464652389|FG000|Overall Study|Age < 18|1|||
129098553|NCT03423147|464652390|FG001|Overall Study|Age < 18|0|||
129098554|NCT03423147|464652389|FG000|Overall Study|No Trial of Labor|0|||
129098555|NCT03423147|464652390|FG001|Overall Study|No Trial of Labor|1|||
129098556|NCT01048099|464652391|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
129098557|NCT01048099|464652391|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
129098558|NCT02258334|464652394|FG000|Overall Study|Adverse Event|1|||
129098559|NCT02258334|464652395|FG001|Overall Study|Adverse Event|0|||
129098560|NCT02258334|464652396|FG002|Overall Study|Adverse Event|0|||
129098561|NCT02258334|464652397|FG003|Overall Study|Adverse Event|0|||
129098562|NCT01969084|464652398|FG000|Overall Study|Adverse Event|0|||
129098563|NCT01969084|464652399|FG001|Overall Study|Adverse Event|1|||
129098564|NCT00862459|464652402|FG000|Overall Study|Lost to Follow-up|1|||
129098565|NCT00862459|464652403|FG001|Overall Study|Lost to Follow-up|2|||
129098566|NCT00862459|464652404|FG002|Overall Study|Lost to Follow-up|2|||
129098567|NCT00862459|464652402|FG000|Overall Study|Protocol Violation|1|||
129098568|NCT00862459|464652403|FG001|Overall Study|Protocol Violation|0|||
129098569|NCT00862459|464652404|FG002|Overall Study|Protocol Violation|0|||
129098570|NCT00862459|464652402|FG000|Overall Study|Withdrawal by Subject|1|||
129098571|NCT00862459|464652403|FG001|Overall Study|Withdrawal by Subject|1|||
129098572|NCT00862459|464652404|FG002|Overall Study|Withdrawal by Subject|3|||
129098573|NCT00862459|464652402|FG000|Overall Study|Adverse Event|0|||
129098574|NCT00862459|464652403|FG001|Overall Study|Adverse Event|1|||
129098575|NCT00862459|464652404|FG002|Overall Study|Adverse Event|0|||
129098576|NCT00862459|464652402|FG000|Overall Study|Personal reasons|1|||
129098577|NCT00862459|464652403|FG001|Overall Study|Personal reasons|0|||
129098578|NCT00862459|464652404|FG002|Overall Study|Personal reasons|0|||
129098579|NCT00862459|464652402|FG000|Overall Study|Operation|1|||
129098580|NCT00862459|464652403|FG001|Overall Study|Operation|1|||
129098581|NCT00862459|464652404|FG002|Overall Study|Operation|0|||
129098582|NCT00862459|464652402|FG000|Overall Study|Intravenous (IV) site problems|1|||
129098583|NCT00862459|464652403|FG001|Overall Study|Intravenous (IV) site problems|0|||
129098584|NCT00862459|464652404|FG002|Overall Study|Intravenous (IV) site problems|1|||
129098585|NCT00862459|464652402|FG000|Overall Study|Unable to hold still for imaging|0|||
129098586|NCT00862459|464652403|FG001|Overall Study|Unable to hold still for imaging|1|||
129098587|NCT00862459|464652404|FG002|Overall Study|Unable to hold still for imaging|0|||
129098588|NCT00862459|464652402|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
129098589|NCT00862459|464652403|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
129098590|NCT00862459|464652404|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
129098591|NCT00862459|464652402|FG000|Overall Study|Administrative problems|0|||
129098592|NCT00862459|464652403|FG001|Overall Study|Administrative problems|1|||
129098593|NCT00862459|464652404|FG002|Overall Study|Administrative problems|0|||
129098594|NCT04015518|464652409|FG000|Overall Study|Adverse Event|6|||
129098595|NCT04015518|464652410|FG001|Overall Study|Adverse Event|1|||
129098596|NCT04015518|464652411|FG002|Overall Study|Adverse Event|1|||
129098597|NCT04015518|464652412|FG003|Overall Study|Adverse Event|3|||
129098598|NCT04015518|464652413|FG004|Overall Study|Adverse Event|3|||
129098599|NCT04015518|464652409|FG000|Overall Study|Lack of Efficacy|1|||
129098600|NCT04015518|464652410|FG001|Overall Study|Lack of Efficacy|0|||
129098601|NCT04015518|464652411|FG002|Overall Study|Lack of Efficacy|1|||
129098602|NCT04015518|464652412|FG003|Overall Study|Lack of Efficacy|0|||
129098603|NCT04015518|464652413|FG004|Overall Study|Lack of Efficacy|4|||
129098604|NCT04015518|464652409|FG000|Overall Study|Lost to Follow-up|0|||
129098605|NCT04015518|464652410|FG001|Overall Study|Lost to Follow-up|0|||
129098606|NCT04015518|464652411|FG002|Overall Study|Lost to Follow-up|0|||
129098607|NCT04015518|464652412|FG003|Overall Study|Lost to Follow-up|0|||
129098608|NCT04015518|464652413|FG004|Overall Study|Lost to Follow-up|1|||
129098609|NCT04015518|464652409|FG000|Overall Study|Withdrawal by Subject|0|||
129098610|NCT04015518|464652410|FG001|Overall Study|Withdrawal by Subject|1|||
129098611|NCT04015518|464652411|FG002|Overall Study|Withdrawal by Subject|0|||
129098612|NCT04015518|464652412|FG003|Overall Study|Withdrawal by Subject|1|||
129098613|NCT04015518|464652413|FG004|Overall Study|Withdrawal by Subject|1|||
129207046|NCT00878501|465056808|FG002|Overall Study|Administrative|1|||
129207047|NCT00812708|465056811|FG000|Overall Study|Device could not be implanted|2|||
129207048|NCT00812708|465056811|FG000|Overall Study|Lack of medical insurance|1|||
129207049|NCT00812708|465056811|FG000|Overall Study|Switched to another study|1|||
129207050|NCT00812708|465056811|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
129207051|NCT00812708|465056811|FG000|Overall Study|Signed consent but later withdrew|3|||
129207052|NCT01959503|465056812|FG000|Overall Study|Death|2|||
129207053|NCT01959503|465056813|FG001|Overall Study|Death|1|||
129207054|NCT01959503|465056812|FG000|Overall Study|Randomized but not treated|1|||
129207055|NCT01959503|465056813|FG001|Overall Study|Randomized but not treated|1|||
129207056|NCT01600326|465056814|FG000|Overall Study|Lost to Follow-up|1|||
129207057|NCT01600326|465056815|FG001|Overall Study|Lost to Follow-up|1|||
129207058|NCT03224130|465056816|FG000|Overall Study|consent issue|0|||
129207059|NCT03224130|465056817|FG001|Overall Study|consent issue|1|||
129207060|NCT02587520|465056825|FG000|Overall Study|Protocol Violation|2|||
129207061|NCT02587520|465056826|FG001|Overall Study|Protocol Violation|0|||
129207062|NCT02587520|465056827|FG002|Overall Study|Protocol Violation|0|||
129207063|NCT02587520|465056828|FG003|Overall Study|Protocol Violation|2|||
129207064|NCT02587520|465056829|FG004|Overall Study|Protocol Violation|0|||
129207065|NCT02587520|465056830|FG005|Overall Study|Protocol Violation|1|||
129207066|NCT02587520|465056831|FG006|Overall Study|Protocol Violation|1|||
129207067|NCT02587520|465056832|FG007|Overall Study|Protocol Violation|1|||
129207068|NCT02587520|465056833|FG008|Overall Study|Protocol Violation|3|||
129207069|NCT02587520|465056834|FG009|Overall Study|Protocol Violation|3|||
129207070|NCT02587520|465056835|FG010|Overall Study|Protocol Violation|1|||
129207071|NCT02587520|465056836|FG011|Overall Study|Protocol Violation|2|||
129207072|NCT02587520|465056837|FG012|Overall Study|Protocol Violation|0|||
129207073|NCT02587520|465056838|FG013|Overall Study|Protocol Violation|0|||
129207074|NCT02587520|465056839|FG014|Overall Study|Protocol Violation|0|||
129207075|NCT02587520|465056840|FG015|Overall Study|Protocol Violation|0|||
129207076|NCT02587520|465056841|FG016|Overall Study|Protocol Violation|0|||
129207077|NCT02587520|465056842|FG017|Overall Study|Protocol Violation|0|||
129207078|NCT02587520|465056825|FG000|Overall Study|Adverse Event|0|||
129207079|NCT02587520|465056826|FG001|Overall Study|Adverse Event|0|||
129207080|NCT02587520|465056827|FG002|Overall Study|Adverse Event|0|||
129207081|NCT02587520|465056828|FG003|Overall Study|Adverse Event|0|||
129207082|NCT02587520|465056829|FG004|Overall Study|Adverse Event|0|||
129207083|NCT02587520|465056830|FG005|Overall Study|Adverse Event|0|||
129207084|NCT02587520|465056831|FG006|Overall Study|Adverse Event|0|||
129207085|NCT02587520|465056832|FG007|Overall Study|Adverse Event|0|||
129207086|NCT02587520|465056833|FG008|Overall Study|Adverse Event|0|||
129207087|NCT02587520|465056834|FG009|Overall Study|Adverse Event|0|||
129207088|NCT02587520|465056835|FG010|Overall Study|Adverse Event|0|||
129207089|NCT02587520|465056836|FG011|Overall Study|Adverse Event|1|||
129207090|NCT02587520|465056837|FG012|Overall Study|Adverse Event|0|||
129207091|NCT02587520|465056838|FG013|Overall Study|Adverse Event|0|||
129207092|NCT02587520|465056839|FG014|Overall Study|Adverse Event|0|||
129207093|NCT02587520|465056840|FG015|Overall Study|Adverse Event|0|||
129207094|NCT02587520|465056841|FG016|Overall Study|Adverse Event|0|||
129207095|NCT02587520|465056842|FG017|Overall Study|Adverse Event|0|||
129207096|NCT02587520|465056825|FG000|Overall Study|Withdrawal by Subject|0|||
129207097|NCT02587520|465056826|FG001|Overall Study|Withdrawal by Subject|0|||
129207098|NCT02587520|465056827|FG002|Overall Study|Withdrawal by Subject|1|||
129207099|NCT02587520|465056828|FG003|Overall Study|Withdrawal by Subject|1|||
129207100|NCT02587520|465056829|FG004|Overall Study|Withdrawal by Subject|0|||
129207101|NCT02587520|465056830|FG005|Overall Study|Withdrawal by Subject|1|||
129207102|NCT02587520|465056831|FG006|Overall Study|Withdrawal by Subject|1|||
129207103|NCT02587520|465056832|FG007|Overall Study|Withdrawal by Subject|0|||
129207104|NCT02587520|465056833|FG008|Overall Study|Withdrawal by Subject|0|||
129207105|NCT02587520|465056834|FG009|Overall Study|Withdrawal by Subject|0|||
129207106|NCT02587520|465056835|FG010|Overall Study|Withdrawal by Subject|0|||
129207107|NCT02587520|465056836|FG011|Overall Study|Withdrawal by Subject|0|||
129207108|NCT02587520|465056837|FG012|Overall Study|Withdrawal by Subject|0|||
129207109|NCT02587520|465056838|FG013|Overall Study|Withdrawal by Subject|1|||
129207110|NCT02587520|465056839|FG014|Overall Study|Withdrawal by Subject|0|||
129207111|NCT02587520|465056840|FG015|Overall Study|Withdrawal by Subject|0|||
129207112|NCT02587520|465056841|FG016|Overall Study|Withdrawal by Subject|0|||
129207113|NCT02587520|465056842|FG017|Overall Study|Withdrawal by Subject|0|||
129207114|NCT02587520|465056825|FG000|Overall Study|Lost to Follow-up|0|||
129207115|NCT02587520|465056826|FG001|Overall Study|Lost to Follow-up|2|||
129207116|NCT02587520|465056827|FG002|Overall Study|Lost to Follow-up|0|||
129207117|NCT02587520|465056828|FG003|Overall Study|Lost to Follow-up|2|||
129207118|NCT02587520|465056829|FG004|Overall Study|Lost to Follow-up|0|||
129207119|NCT02587520|465056830|FG005|Overall Study|Lost to Follow-up|1|||
129207120|NCT02587520|465056831|FG006|Overall Study|Lost to Follow-up|1|||
129207121|NCT02587520|465056832|FG007|Overall Study|Lost to Follow-up|1|||
129207122|NCT02587520|465056833|FG008|Overall Study|Lost to Follow-up|0|||
129207123|NCT02587520|465056834|FG009|Overall Study|Lost to Follow-up|2|||
129207124|NCT02587520|465056835|FG010|Overall Study|Lost to Follow-up|2|||
128984468|NCT00634933|464231636|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
128984469|NCT00634933|464231637|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
128984470|NCT00634933|464231638|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
128984471|NCT00634933|464231639|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
128984472|NCT00634933|464231635|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
128984473|NCT00634933|464231636|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
128984474|NCT00634933|464231637|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
128984475|NCT00634933|464231638|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
128984476|NCT00634933|464231639|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
128984477|NCT00634933|464231635|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
128984478|NCT00634933|464231636|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
128984479|NCT00634933|464231637|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
128984480|NCT00634933|464231638|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
128984481|NCT00634933|464231639|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
128984482|NCT00634933|464231635|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
128984483|NCT00634933|464231636|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
128984484|NCT00634933|464231637|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
128984485|NCT00634933|464231638|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
128984486|NCT00634933|464231639|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
128984487|NCT00634933|464231635|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
128984488|NCT00634933|464231636|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
128984489|NCT00634933|464231637|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
128984490|NCT00634933|464231638|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
128984491|NCT00634933|464231639|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
128984492|NCT00634933|464231635|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
128984493|NCT00634933|464231636|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
128984494|NCT00634933|464231637|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
128984495|NCT00634933|464231638|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
128984496|NCT00634933|464231639|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
128984497|NCT00634933|464231635|FG000|Part B: Week 24 to Week 52|Other|0|||
128984498|NCT00634933|464231636|FG001|Part B: Week 24 to Week 52|Other|0|||
128984499|NCT00634933|464231637|FG002|Part B: Week 24 to Week 52|Other|5|||
128984500|NCT00634933|464231638|FG003|Part B: Week 24 to Week 52|Other|0|||
128984501|NCT00634933|464231639|FG004|Part B: Week 24 to Week 52|Other|1|||
128984502|NCT02058849|464231640|FG000|Overall Study|Hospitalization|1|||
128984503|NCT02058849|464231641|FG001|Overall Study|Hospitalization|1|||
128984504|NCT02058849|464231640|FG000|Overall Study|Death|1|||
128984505|NCT02058849|464231641|FG001|Overall Study|Death|0|||
128984506|NCT02058849|464231640|FG000|Overall Study|Lost to Follow-up|1|||
128984507|NCT02058849|464231641|FG001|Overall Study|Lost to Follow-up|0|||
128984508|NCT02058849|464231640|FG000|Overall Study|Withdrawal by Subject|4|||
128984509|NCT02058849|464231641|FG001|Overall Study|Withdrawal by Subject|0|||
128984510|NCT01049360|464231642|FG000|Period 1|Adverse Event|0|||
128984511|NCT01049360|464231643|FG001|Period 1|Adverse Event|1|||
128984512|NCT01049360|464231644|FG002|Period 1|Adverse Event|0|||
128984513|NCT01049360|464231645|FG003|Period 1|Adverse Event|1|||
128984514|NCT01049360|464231646|FG004|Period 1|Adverse Event|0|||
128984515|NCT01049360|464231647|FG005|Period 1|Adverse Event|0|||
128984516|NCT01049360|464231648|FG006|Period 1|Adverse Event|0|||
128984517|NCT01049360|464231649|FG007|Period 1|Adverse Event|1|||
128984518|NCT01049360|464231650|FG008|Period 1|Adverse Event|0|||
128984519|NCT01049360|464231651|FG009|Period 1|Adverse Event|0|||
128984520|NCT01049360|464231652|FG010|Period 1|Adverse Event|0|||
128984521|NCT01049360|464231653|FG011|Period 1|Adverse Event|0|||
128984522|NCT01049360|464231654|FG012|Period 1|Adverse Event|1|||
128984523|NCT01049360|464231655|FG013|Period 1|Adverse Event|1|||
128984524|NCT01049360|464231656|FG014|Period 1|Adverse Event|0|||
128984525|NCT01049360|464231657|FG015|Period 1|Adverse Event|0|||
128984526|NCT01049360|464231658|FG016|Period 1|Adverse Event|1|||
128984527|NCT01049360|464231659|FG017|Period 1|Adverse Event|0|||
128984528|NCT01049360|464231660|FG018|Period 1|Adverse Event|1|||
128984529|NCT01049360|464231661|FG019|Period 1|Adverse Event|0|||
128984530|NCT01049360|464231642|FG000|Period 1|Did not meet inc/exc criteria|0|||
128984531|NCT01049360|464231643|FG001|Period 1|Did not meet inc/exc criteria|0|||
128984532|NCT01049360|464231644|FG002|Period 1|Did not meet inc/exc criteria|0|||
128984533|NCT01049360|464231645|FG003|Period 1|Did not meet inc/exc criteria|0|||
128984534|NCT01049360|464231646|FG004|Period 1|Did not meet inc/exc criteria|0|||
128984535|NCT01049360|464231647|FG005|Period 1|Did not meet inc/exc criteria|0|||
128984536|NCT01049360|464231648|FG006|Period 1|Did not meet inc/exc criteria|0|||
128984537|NCT01049360|464231649|FG007|Period 1|Did not meet inc/exc criteria|1|||
128984538|NCT01049360|464231650|FG008|Period 1|Did not meet inc/exc criteria|1|||
128984539|NCT01049360|464231651|FG009|Period 1|Did not meet inc/exc criteria|0|||
128984540|NCT01049360|464231652|FG010|Period 1|Did not meet inc/exc criteria|0|||
128984541|NCT01049360|464231653|FG011|Period 1|Did not meet inc/exc criteria|0|||
128984542|NCT01049360|464231654|FG012|Period 1|Did not meet inc/exc criteria|0|||
128984543|NCT01049360|464231655|FG013|Period 1|Did not meet inc/exc criteria|0|||
129207125|NCT02587520|465056836|FG011|Overall Study|Lost to Follow-up|1|||
129207126|NCT02587520|465056837|FG012|Overall Study|Lost to Follow-up|0|||
129207127|NCT02587520|465056838|FG013|Overall Study|Lost to Follow-up|0|||
129207128|NCT02587520|465056839|FG014|Overall Study|Lost to Follow-up|0|||
129207129|NCT02587520|465056840|FG015|Overall Study|Lost to Follow-up|0|||
129207130|NCT02587520|465056841|FG016|Overall Study|Lost to Follow-up|0|||
129207131|NCT02587520|465056842|FG017|Overall Study|Lost to Follow-up|0|||
129207132|NCT03924622|465056843|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
129207133|NCT03924622|465056844|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129207134|NCT03924622|465056845|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129207135|NCT03924622|465056846|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
129207136|NCT03924622|465056847|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129207137|NCT03924622|465056848|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129207138|NCT02412306|465056850|FG000|Overall Study|Lost to Follow-up|0|||
129207139|NCT02412306|465056851|FG001|Overall Study|Lost to Follow-up|1|||
129207140|NCT02412306|465056852|FG002|Overall Study|Lost to Follow-up|0|||
129207141|NCT02412306|465056853|FG003|Overall Study|Lost to Follow-up|0|||
129207142|NCT02412306|465056854|FG004|Overall Study|Lost to Follow-up|0|||
129207143|NCT02412306|465056850|FG000|Overall Study|Withdrawal by Subject|0|||
129207144|NCT02412306|465056851|FG001|Overall Study|Withdrawal by Subject|0|||
129207145|NCT02412306|465056852|FG002|Overall Study|Withdrawal by Subject|1|||
129207146|NCT02412306|465056853|FG003|Overall Study|Withdrawal by Subject|0|||
129207147|NCT02412306|465056854|FG004|Overall Study|Withdrawal by Subject|0|||
129207148|NCT02412306|465056850|FG000|Overall Study|Death|5|||
129207149|NCT02412306|465056851|FG001|Overall Study|Death|7|||
129207150|NCT02412306|465056852|FG002|Overall Study|Death|15|||
129207151|NCT02412306|465056853|FG003|Overall Study|Death|0|||
129207152|NCT02412306|465056854|FG004|Overall Study|Death|2|||
129207153|NCT03547518|465056857|FG000|Overall Study|Lost to Follow-up|2|||
129207154|NCT03547518|465056858|FG001|Overall Study|Lost to Follow-up|0|||
129207155|NCT04349891|465056864|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
129207156|NCT04349891|465056865|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
129207157|NCT04349891|465056864|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
129207158|NCT04349891|465056865|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
129207159|NCT04349891|465056864|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
129207160|NCT04349891|465056865|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
129207161|NCT04349891|465056864|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
129207162|NCT04349891|465056865|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
129207163|NCT02927301|465056868|FG000|Overall Study|Death|39|||
129207164|NCT02927301|465056868|FG000|Overall Study|Lost to Follow-up|8|||
129207165|NCT02927301|465056868|FG000|Overall Study|Physician Decision|2|||
129207166|NCT02927301|465056868|FG000|Overall Study|Withdrawal by Subject|12|||
129207167|NCT02927301|465056868|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
129207168|NCT02201524|465056871|FG000|Overall Study|Adverse Event|0|||
129207169|NCT02201524|465056872|FG001|Overall Study|Adverse Event|2|||
129207170|NCT02201524|465056873|FG002|Overall Study|Adverse Event|1|||
129207171|NCT02201524|465056874|FG003|Overall Study|Adverse Event|0|||
129207172|NCT02201524|465056871|FG000|Overall Study|Insufficient clinical response|1|||
129207173|NCT02201524|465056872|FG001|Overall Study|Insufficient clinical response|0|||
129207174|NCT02201524|465056873|FG002|Overall Study|Insufficient clinical response|0|||
129207175|NCT02201524|465056874|FG003|Overall Study|Insufficient clinical response|0|||
129207176|NCT02201524|465056871|FG000|Overall Study|Lost to Follow-up|0|||
129207177|NCT02201524|465056872|FG001|Overall Study|Lost to Follow-up|0|||
129207178|NCT02201524|465056873|FG002|Overall Study|Lost to Follow-up|2|||
129207179|NCT02201524|465056874|FG003|Overall Study|Lost to Follow-up|0|||
129207180|NCT02201524|465056871|FG000|Overall Study|No longer meets eligibility criteria|0|||
129207181|NCT02201524|465056872|FG001|Overall Study|No longer meets eligibility criteria|0|||
129207182|NCT02201524|465056873|FG002|Overall Study|No longer meets eligibility criteria|0|||
129207183|NCT02201524|465056874|FG003|Overall Study|No longer meets eligibility criteria|2|||
129207184|NCT02201524|465056871|FG000|Overall Study|Protocol Violation|0|||
129207185|NCT02201524|465056872|FG001|Overall Study|Protocol Violation|0|||
129207186|NCT02201524|465056873|FG002|Overall Study|Protocol Violation|0|||
129207187|NCT02201524|465056874|FG003|Overall Study|Protocol Violation|1|||
129207188|NCT02201524|465056871|FG000|Overall Study|Withdrawal by Subject|0|||
129207189|NCT02201524|465056872|FG001|Overall Study|Withdrawal by Subject|0|||
129207190|NCT02201524|465056873|FG002|Overall Study|Withdrawal by Subject|1|||
129207191|NCT02201524|465056874|FG003|Overall Study|Withdrawal by Subject|1|||
129207192|NCT02201524|465056871|FG000|Overall Study|Other|1|||
129207193|NCT02201524|465056872|FG001|Overall Study|Other|1|||
129207194|NCT02201524|465056873|FG002|Overall Study|Other|0|||
129207195|NCT02201524|465056874|FG003|Overall Study|Other|0|||
129207196|NCT02914639|465056876|FG000|Overall Study|Withdrawal by Subject|0|||
129207197|NCT02914639|465056877|FG001|Overall Study|Withdrawal by Subject|2|||
129207198|NCT01018030|465056878|FG000|Overall Study|Adverse Event|10|||
129207199|NCT01018030|465056879|FG001|Overall Study|Adverse Event|5|||
129207200|NCT01018030|465056880|FG002|Overall Study|Adverse Event|5|||
129207201|NCT01018030|465056878|FG000|Overall Study|Withdrawal by Subject|2|||
129207202|NCT01018030|465056879|FG001|Overall Study|Withdrawal by Subject|2|||
129207203|NCT01018030|465056880|FG002|Overall Study|Withdrawal by Subject|4|||
129207204|NCT01018030|465056878|FG000|Overall Study|Lost to Follow-up|2|||
129207205|NCT01018030|465056879|FG001|Overall Study|Lost to Follow-up|0|||
129207206|NCT01018030|465056880|FG002|Overall Study|Lost to Follow-up|3|||
129207207|NCT01018030|465056878|FG000|Overall Study|Protocol Violation|2|||
129207208|NCT01018030|465056879|FG001|Overall Study|Protocol Violation|1|||
129207209|NCT01018030|465056880|FG002|Overall Study|Protocol Violation|0|||
129207210|NCT01018030|465056878|FG000|Overall Study|Physician Decision|1|||
129207211|NCT01018030|465056879|FG001|Overall Study|Physician Decision|0|||
129207212|NCT01018030|465056880|FG002|Overall Study|Physician Decision|1|||
129207213|NCT01018030|465056878|FG000|Overall Study|Lack of Efficacy|1|||
129207214|NCT01018030|465056879|FG001|Overall Study|Lack of Efficacy|0|||
129207215|NCT01018030|465056880|FG002|Overall Study|Lack of Efficacy|0|||
129207216|NCT01018030|465056878|FG000|Overall Study|Did Not Receive Study Drug|1|||
129207217|NCT01018030|465056879|FG001|Overall Study|Did Not Receive Study Drug|3|||
129207218|NCT01018030|465056880|FG002|Overall Study|Did Not Receive Study Drug|0|||
129207219|NCT03617172|465056881|FG000|Overall Study|Lost to Follow-up|1|||
129207220|NCT03617172|465056882|FG001|Overall Study|Lost to Follow-up|0|||
129207221|NCT00189540|465056883|FG000|Overall Study|Withdrawal by Subject|3|||
129207222|NCT00189540|465056884|FG001|Overall Study|Withdrawal by Subject|0|||
129207223|NCT00189540|465056883|FG000|Overall Study|Death|4|||
129207224|NCT00189540|465056884|FG001|Overall Study|Death|1|||
129207225|NCT01089504|465056885|FG000|Overall Study|Lost to Follow-up|1|||
129207226|NCT01089504|465056886|FG001|Overall Study|Lost to Follow-up|1|||
129207227|NCT01089504|465056885|FG000|Overall Study|Withdrawal by Subject|2|||
129207228|NCT01089504|465056886|FG001|Overall Study|Withdrawal by Subject|0|||
129207229|NCT01924845|465056887|FG000|Overall Study|Adverse Event|3|||
129207230|NCT01924845|465056887|FG000|Overall Study|Withdrawal by Subject|2|||
129207231|NCT01924845|465056887|FG000|Overall Study|Protocol Violation|1|||
129207232|NCT00062439|465056888|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
129207233|NCT00062439|465056888|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
129207234|NCT00062439|465056888|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
129207235|NCT00062439|465056888|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
129207236|NCT00062439|465056888|FG000|Post Chemoradiation Assessment|Death|1|||
129207237|NCT00062439|465056888|FG000|Post Chemoradiation Assessment|Disease progression|2|||
129207238|NCT00062439|465056888|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
129207239|NCT00062439|465056888|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
129207240|NCT00062439|465056888|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
129207241|NCT00062439|465056888|FG000|Surgery|Physician Decision|4|||
129207242|NCT00062439|465056888|FG000|Surgery|Death|1|||
129207243|NCT00062439|465056888|FG000|Surgery|Adverse Event|2|||
129207244|NCT00062439|465056888|FG000|Consolidation Chemotherapy|Adverse Event|2|||
129207245|NCT00001832|465056892|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
129207246|NCT00001832|465056893|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
129207247|NCT00001832|465056894|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
129207248|NCT00001832|465056895|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
129207249|NCT00001832|465056896|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
129207250|NCT00001832|465056897|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
129207251|NCT00001832|465056898|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
129207252|NCT00001832|465056899|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
129207253|NCT00001832|465056900|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
129207254|NCT00001832|465056901|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
129207255|NCT00001832|465056902|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
129207256|NCT00001832|465056903|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
129207257|NCT00001832|465056904|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
129207258|NCT00001832|465056905|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
129207259|NCT00001832|465056906|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
129207260|NCT00001832|465056892|FG000|Treatment Period|Death during treatment|0|||
129207261|NCT00001832|465056893|FG001|Treatment Period|Death during treatment|0|||
129207262|NCT00001832|465056894|FG002|Treatment Period|Death during treatment|0|||
129207263|NCT00001832|465056895|FG003|Treatment Period|Death during treatment|0|||
129207264|NCT00001832|465056896|FG004|Treatment Period|Death during treatment|0|||
129207265|NCT00001832|465056897|FG005|Treatment Period|Death during treatment|1|||
129207266|NCT00001832|465056898|FG006|Treatment Period|Death during treatment|0|||
129207267|NCT00001832|465056899|FG007|Treatment Period|Death during treatment|0|||
129207268|NCT00001832|465056900|FG008|Treatment Period|Death during treatment|0|||
129207269|NCT00001832|465056901|FG009|Treatment Period|Death during treatment|0|||
129207270|NCT00001832|465056902|FG010|Treatment Period|Death during treatment|0|||
129207271|NCT00001832|465056903|FG011|Treatment Period|Death during treatment|0|||
129207272|NCT00001832|465056904|FG012|Treatment Period|Death during treatment|0|||
129207273|NCT00001832|465056905|FG013|Treatment Period|Death during treatment|0|||
129207274|NCT00001832|465056906|FG014|Treatment Period|Death during treatment|0|||
129207275|NCT00001832|465056892|FG000|Treatment Period|Not treated|0|||
129207276|NCT00001832|465056893|FG001|Treatment Period|Not treated|0|||
129207277|NCT00001832|465056894|FG002|Treatment Period|Not treated|0|||
129207278|NCT00001832|465056895|FG003|Treatment Period|Not treated|0|||
129207279|NCT00001832|465056896|FG004|Treatment Period|Not treated|0|||
129207280|NCT00001832|465056897|FG005|Treatment Period|Not treated|0|||
129207281|NCT00001832|465056898|FG006|Treatment Period|Not treated|0|||
129207282|NCT00001832|465056899|FG007|Treatment Period|Not treated|1|||
129207283|NCT00001832|465056900|FG008|Treatment Period|Not treated|0|||
129207284|NCT00001832|465056901|FG009|Treatment Period|Not treated|0|||
129207285|NCT00001832|465056902|FG010|Treatment Period|Not treated|0|||
129207286|NCT00001832|465056903|FG011|Treatment Period|Not treated|0|||
129207287|NCT00001832|465056904|FG012|Treatment Period|Not treated|0|||
129207288|NCT00001832|465056905|FG013|Treatment Period|Not treated|0|||
129207289|NCT00001832|465056906|FG014|Treatment Period|Not treated|0|||
129207290|NCT02546609|465056907|FG000|Overall Study|Withdrawal by Subject|0|||
129207291|NCT02546609|465056908|FG001|Overall Study|Withdrawal by Subject|1|||
129207292|NCT02546609|465056909|FG002|Overall Study|Withdrawal by Subject|2|||
129207293|NCT02546609|465056907|FG000|Overall Study|Adverse Event|0|||
129207294|NCT02546609|465056908|FG001|Overall Study|Adverse Event|6|||
129207295|NCT02546609|465056909|FG002|Overall Study|Adverse Event|1|||
129207296|NCT02546609|465056907|FG000|Overall Study|Protocol Violation|0|||
129207297|NCT02546609|465056908|FG001|Overall Study|Protocol Violation|1|||
129207298|NCT02546609|465056909|FG002|Overall Study|Protocol Violation|1|||
129207299|NCT02546609|465056907|FG000|Overall Study|Lost to Follow-up|2|||
129207300|NCT02546609|465056908|FG001|Overall Study|Lost to Follow-up|3|||
129207301|NCT02546609|465056909|FG002|Overall Study|Lost to Follow-up|1|||
129207302|NCT02546609|465056907|FG000|Overall Study|travel or work schedule restriction|0|||
129207303|NCT02546609|465056908|FG001|Overall Study|travel or work schedule restriction|0|||
129207304|NCT02546609|465056909|FG002|Overall Study|travel or work schedule restriction|2|||
129207305|NCT00914849|465056910|FG000|Overall Study|Withdrawal by Subject|1|||
129207306|NCT00914849|465056911|FG001|Overall Study|Withdrawal by Subject|0|||
129207307|NCT00914849|465056910|FG000|Overall Study|Not eligible|0|||
129207308|NCT00914849|465056911|FG001|Overall Study|Not eligible|1|||
129207309|NCT05106959|465056912|FG000|Overall Study|Lost to Follow-up|1|||
129207310|NCT01292486|465056913|FG000|Overall Study|Protocol Violation|2|||
129207311|NCT01292486|465056913|FG000|Overall Study|Did not meet screening criteria|2|||
129207312|NCT01292486|465056913|FG000|Overall Study|Adverse Event|1|||
129207313|NCT01292486|465056913|FG000|Overall Study|Physician Decision|1|||
129207314|NCT04602390|465056914|FG000|Overall Study|Withdrawal by Subject|0|||
129207315|NCT04602390|465056915|FG001|Overall Study|Withdrawal by Subject|0|||
129207316|NCT04602390|465056916|FG002|Overall Study|Withdrawal by Subject|0|||
129207317|NCT04602390|465056917|FG003|Overall Study|Withdrawal by Subject|0|||
129207318|NCT04602390|465056918|FG004|Overall Study|Withdrawal by Subject|1|||
129207319|NCT04602390|465056919|FG005|Overall Study|Withdrawal by Subject|0|||
129207320|NCT04602390|465056914|FG000|Overall Study|Adverse Event|0|||
129207321|NCT04602390|465056915|FG001|Overall Study|Adverse Event|0|||
129207322|NCT04602390|465056916|FG002|Overall Study|Adverse Event|0|||
128984544|NCT01049360|464231656|FG014|Period 1|Did not meet inc/exc criteria|0|||
129207323|NCT04602390|465056917|FG003|Overall Study|Adverse Event|0|||
129207324|NCT04602390|465056918|FG004|Overall Study|Adverse Event|0|||
129207325|NCT04602390|465056919|FG005|Overall Study|Adverse Event|1|||
129207326|NCT01553084|465056920|FG000|Overall Study|Withdrawal by Subject|15|||
129207327|NCT01553084|465056921|FG001|Overall Study|Withdrawal by Subject|13|||
129207328|NCT01553084|465056922|FG002|Overall Study|Withdrawal by Subject|35|||
129207329|NCT03988400|465056923|FG000|Overall Study|Adverse Event|1|||
129207330|NCT03988400|465056924|FG001|Overall Study|Adverse Event|0|||
129207331|NCT03988400|465056923|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
128984545|NCT01049360|464231657|FG015|Period 1|Did not meet inc/exc criteria|0|||
128984546|NCT01049360|464231658|FG016|Period 1|Did not meet inc/exc criteria|0|||
128984547|NCT01049360|464231659|FG017|Period 1|Did not meet inc/exc criteria|0|||
129207332|NCT03988400|465056924|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
129207333|NCT03988400|465056923|FG000|Overall Study|Lost to Follow-up|0|||
129207334|NCT03988400|465056924|FG001|Overall Study|Lost to Follow-up|1|||
129207335|NCT04201431|465056926|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
129207336|NCT04201431|465056927|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
129207337|NCT04201431|465056928|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
129207338|NCT01546857|465056929|FG000|Overall Study|Withdrawal by Subject|2|||
129207339|NCT01546857|465056930|FG001|Overall Study|Withdrawal by Subject|3|||
129207340|NCT02358473|465056931|FG000|Overall Study|Disease Progession|6|||
129207341|NCT02358473|465056931|FG000|Overall Study|Adverse Event|3|||
129207342|NCT02358473|465056931|FG000|Overall Study|Withdrawal by Subject|2|||
129207343|NCT02358473|465056931|FG000|Overall Study|Physician Decision|2|||
129207344|NCT02240485|465056932|FG000|3 Months Post-admission|Lost to Follow-up|1|||
129207345|NCT02240485|465056933|FG001|3 Months Post-admission|Lost to Follow-up|5|||
129207346|NCT02240485|465056932|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
129207347|NCT02240485|465056933|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
129207348|NCT02240485|465056932|FG000|9 Months Post-admission|Lost to Follow-up|3|||
129207349|NCT02240485|465056933|FG001|9 Months Post-admission|Lost to Follow-up|1|||
129207350|NCT02240485|465056932|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
129207351|NCT02240485|465056933|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
129207352|NCT02240485|465056932|FG000|18 Months Post-admission|Lost to Follow-up|1|||
129207353|NCT02240485|465056933|FG001|18 Months Post-admission|Lost to Follow-up|1|||
129207354|NCT02240485|465056932|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
129207355|NCT02240485|465056933|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
129207356|NCT00953667|465056934|FG000|Overall Study|Lost to Follow-up|11|||
129207357|NCT00953667|465056934|FG000|Overall Study|Physician Decision|35|||
129207358|NCT00953667|465056934|FG000|Overall Study|Withdrawal by Subject|63|||
129207359|NCT00953667|465056934|FG000|Overall Study|Adverse Event|10|||
129207360|NCT00953667|465056934|FG000|Overall Study|poor venous access,unable to draw blood|4|||
129207361|NCT04819945|465056935|FG000|Overall Study|Lost to Follow-up|1|||
129207362|NCT00475670|465056936|FG000|Overall Study|Death|0|||
129207363|NCT00475670|465056937|FG001|Overall Study|Death|1|||
129207364|NCT00475670|465056936|FG000|Overall Study|Lack of Efficacy|3|||
129207365|NCT00475670|465056937|FG001|Overall Study|Lack of Efficacy|34|||
129207366|NCT00475670|465056936|FG000|Overall Study|Refused treatment|0|||
129207367|NCT00475670|465056937|FG001|Overall Study|Refused treatment|2|||
129207368|NCT00475670|465056936|FG000|Overall Study|Failure to Return|0|||
129207369|NCT00475670|465056937|FG001|Overall Study|Failure to Return|1|||
129207370|NCT00475670|465056936|FG000|Overall Study|Other|0|||
129207371|NCT00475670|465056937|FG001|Overall Study|Other|3|||
129207372|NCT04949191|465056938|FG000|Overall Study|Non-compliance with Study Drug|1|||
129207373|NCT04949191|465056939|FG001|Overall Study|Non-compliance with Study Drug|0|||
129207374|NCT04949191|465056940|FG002|Overall Study|Non-compliance with Study Drug|0|||
129207375|NCT04949191|465056941|FG003|Overall Study|Non-compliance with Study Drug|0|||
129207376|NCT04949191|465056938|FG000|Overall Study|Progressive Disease|0|||
129207377|NCT04949191|465056939|FG001|Overall Study|Progressive Disease|1|||
129207378|NCT04949191|465056940|FG002|Overall Study|Progressive Disease|0|||
129207379|NCT04949191|465056941|FG003|Overall Study|Progressive Disease|0|||
129207380|NCT04949191|465056938|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
129207381|NCT04949191|465056939|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
129207382|NCT04949191|465056940|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
129207383|NCT04949191|465056941|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
129207384|NCT04949191|465056938|FG000|Overall Study|Sponsor Terminated Study|0|||
129207385|NCT04949191|465056939|FG001|Overall Study|Sponsor Terminated Study|0|||
129207386|NCT04949191|465056940|FG002|Overall Study|Sponsor Terminated Study|1|||
129207387|NCT04949191|465056941|FG003|Overall Study|Sponsor Terminated Study|1|||
129207388|NCT01046565|465056946|FG000|Overall Study|Adverse Event|2|||
129207389|NCT01046565|465056946|FG000|Overall Study|Withdrawal by Subject|7|||
129207390|NCT00918385|465056947|FG000|Monotherapy|Adverse Event|1|||
129207391|NCT00918385|465056948|FG001|Monotherapy|Adverse Event|6|||
129207392|NCT00918385|465056947|FG000|Monotherapy|Complicating illness|1|||
129207393|NCT00918385|465056948|FG001|Monotherapy|Complicating illness|0|||
129207394|NCT00918385|465056947|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
129207395|NCT00918385|465056948|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
129207396|NCT00918385|465056947|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
129207397|NCT00918385|465056948|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
129207398|NCT00918385|465056947|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
129207399|NCT00918385|465056948|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
129207400|NCT00918385|465056947|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
129207401|NCT00918385|465056948|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
129207402|NCT00771914|465056951|FG000|Overall Study|Physician Decision|0|||
129207403|NCT00771914|465056952|FG001|Overall Study|Physician Decision|0|||
129207404|NCT00771914|465056953|FG002|Overall Study|Physician Decision|0|||
129207405|NCT00771914|465056954|FG003|Overall Study|Physician Decision|1|||
129207406|NCT00771914|465056951|FG000|Overall Study|Lost to Follow-up|0|||
129207407|NCT00771914|465056952|FG001|Overall Study|Lost to Follow-up|0|||
129207408|NCT00771914|465056953|FG002|Overall Study|Lost to Follow-up|0|||
129207409|NCT00771914|465056954|FG003|Overall Study|Lost to Follow-up|1|||
129207410|NCT02978417|465056957|FG000|Overall Study|Lost to Follow-up|2|||
129207411|NCT02978417|465056958|FG001|Overall Study|Lost to Follow-up|2|||
129207412|NCT03416868|465056966|FG000|Overall Study|Withdrawal by Subject|2|||
129207413|NCT03416868|465056966|FG000|Overall Study|Lost to Follow-up|1|||
129207414|NCT01323582|465056967|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
129207415|NCT01323582|465056968|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
129207416|NCT01323582|465056967|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
129207417|NCT01323582|465056968|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
129207418|NCT01323582|465056967|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
129207419|NCT01323582|465056968|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
129207420|NCT00960375|465056971|FG000|Overall Study|Lost to Follow-up|20|||
129207421|NCT00960375|465056972|FG001|Overall Study|Lost to Follow-up|22|||
129207422|NCT03557970|465056973|FG000|Overall Study|Study closure|1|||
129207423|NCT03557970|465056974|FG001|Overall Study|Study closure|0|||
129207424|NCT03557970|465056973|FG000|Overall Study|Physician Decision|0|||
129207425|NCT03557970|465056974|FG001|Overall Study|Physician Decision|1|||
129207426|NCT03557970|465056973|FG000|Overall Study|Death|0|||
129207427|NCT03557970|465056974|FG001|Overall Study|Death|1|||
129207428|NCT00112736|465056975|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
129207429|NCT00112736|465056976|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
129207430|NCT05435339|465056977|FG000|Overall Study|Death|1|||
129207431|NCT05435339|465056978|FG001|Overall Study|Death|0|||
129207432|NCT05435339|465056979|FG002|Overall Study|Death|3|||
129207433|NCT05435339|465056980|FG003|Overall Study|Death|1|||
129207434|NCT05435339|465056981|FG004|Overall Study|Death|3|||
129207435|NCT05435339|465056982|FG005|Overall Study|Death|2|||
129207436|NCT05435339|465056983|FG006|Overall Study|Death|4|||
129207437|NCT05435339|465056984|FG007|Overall Study|Death|6|||
129207438|NCT05435339|465056977|FG000|Overall Study|Sponsor Decision|0|||
129207439|NCT05435339|465056978|FG001|Overall Study|Sponsor Decision|1|||
129207440|NCT05435339|465056979|FG002|Overall Study|Sponsor Decision|0|||
129207441|NCT05435339|465056980|FG003|Overall Study|Sponsor Decision|0|||
129207442|NCT05435339|465056981|FG004|Overall Study|Sponsor Decision|2|||
129207443|NCT05435339|465056982|FG005|Overall Study|Sponsor Decision|1|||
129207444|NCT05435339|465056983|FG006|Overall Study|Sponsor Decision|2|||
129207445|NCT05435339|465056984|FG007|Overall Study|Sponsor Decision|2|||
129207446|NCT05435339|465056977|FG000|Overall Study|Withdrawal by Subject|0|||
129207447|NCT05435339|465056978|FG001|Overall Study|Withdrawal by Subject|0|||
129207448|NCT05435339|465056979|FG002|Overall Study|Withdrawal by Subject|0|||
129207449|NCT05435339|465056980|FG003|Overall Study|Withdrawal by Subject|0|||
129207450|NCT05435339|465056981|FG004|Overall Study|Withdrawal by Subject|1|||
129207451|NCT05435339|465056982|FG005|Overall Study|Withdrawal by Subject|0|||
129207452|NCT05435339|465056983|FG006|Overall Study|Withdrawal by Subject|1|||
129207453|NCT05435339|465056984|FG007|Overall Study|Withdrawal by Subject|1|||
129207454|NCT03473236|465056986|FG000|Overall Study|Withdrawal by Subject|0|||
129207455|NCT03473236|465056987|FG001|Overall Study|Withdrawal by Subject|0|||
129207456|NCT03473236|465056988|FG002|Overall Study|Withdrawal by Subject|0|||
129207457|NCT03473236|465056989|FG003|Overall Study|Withdrawal by Subject|0|||
129207458|NCT03473236|465056990|FG004|Overall Study|Withdrawal by Subject|0|||
129207459|NCT03473236|465056991|FG005|Overall Study|Withdrawal by Subject|1|||
129207460|NCT03473236|465056992|FG006|Overall Study|Withdrawal by Subject|0|||
129207461|NCT03473236|465056993|FG007|Overall Study|Withdrawal by Subject|0|||
129207462|NCT03473236|465056994|FG008|Overall Study|Withdrawal by Subject|1|||
129207463|NCT03473236|465056995|FG009|Overall Study|Withdrawal by Subject|0|||
129207464|NCT00849940|465056996|FG000|Overall Study|Physician Decision|4|||
129207465|NCT01927497|465056997|FG000|Overall Study|Death|0|||
129207466|NCT01927497|465056998|FG001|Overall Study|Death|1|||
129207467|NCT01927497|465056997|FG000|Overall Study|Protocol Violation|2|||
129207468|NCT01927497|465056998|FG001|Overall Study|Protocol Violation|0|||
129207469|NCT03409796|465059008|FG000|Overall Study|Adverse Event|2|||
129207470|NCT03409796|465059009|FG001|Overall Study|Adverse Event|0|||
129207471|NCT03409796|465059008|FG000|Overall Study|Other|0|||
129207472|NCT03409796|465059009|FG001|Overall Study|Other|1|||
129207473|NCT00740220|465059010|FG000|Overall Study|screen failures (non-COPD patients)|9|||
129207474|NCT01602224|465059011|FG000|Overall Study|Adverse Event|0|||
129207475|NCT01602224|465059012|FG001|Overall Study|Adverse Event|1|||
129207476|NCT01602224|465059013|FG002|Overall Study|Adverse Event|0|||
129207477|NCT01602224|465059011|FG000|Overall Study|Investigator Decison|1|||
129207478|NCT01602224|465059012|FG001|Overall Study|Investigator Decison|0|||
129207479|NCT01602224|465059013|FG002|Overall Study|Investigator Decison|0|||
129207480|NCT01602224|465059011|FG000|Overall Study|Lost to Follow-up|0|||
129207481|NCT01602224|465059012|FG001|Overall Study|Lost to Follow-up|0|||
129207482|NCT01602224|465059013|FG002|Overall Study|Lost to Follow-up|1|||
129207483|NCT01602224|465059011|FG000|Overall Study|Protocol Violation|0|||
129207484|NCT01602224|465059012|FG001|Overall Study|Protocol Violation|1|||
129207485|NCT01602224|465059013|FG002|Overall Study|Protocol Violation|0|||
129207486|NCT01602224|465059011|FG000|Overall Study|Sponsor Decision|2|||
129207487|NCT01602224|465059012|FG001|Overall Study|Sponsor Decision|3|||
129207488|NCT01602224|465059013|FG002|Overall Study|Sponsor Decision|2|||
129207489|NCT01602224|465059011|FG000|Overall Study|Withdrawal by Subject|5|||
129207490|NCT01602224|465059012|FG001|Overall Study|Withdrawal by Subject|3|||
129207491|NCT01602224|465059013|FG002|Overall Study|Withdrawal by Subject|3|||
129207492|NCT01352117|465059014|FG000|Overall Study|Death|15|||
129207493|NCT01352117|465059015|FG001|Overall Study|Death|16|||
129207494|NCT01352117|465059014|FG000|Overall Study|Withdrawal by Subject|1|||
129207495|NCT01352117|465059015|FG001|Overall Study|Withdrawal by Subject|0|||
129207496|NCT01352117|465059014|FG000|Overall Study|Lost to Follow-up|2|||
129207497|NCT01352117|465059015|FG001|Overall Study|Lost to Follow-up|7|||
129207498|NCT01352117|465059014|FG000|Overall Study|Non-adherent to study requirements|1|||
129207499|NCT01352117|465059015|FG001|Overall Study|Non-adherent to study requirements|1|||
129207500|NCT01352117|465059014|FG000|Overall Study|Did not initiate study treatment|1|||
129207501|NCT01352117|465059015|FG001|Overall Study|Did not initiate study treatment|0|||
129207502|NCT01352117|465059014|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
129207503|NCT01352117|465059015|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
129207504|NCT00633477|465059016|FG000|Overall Study|Death|1|||
129207505|NCT00633477|465059017|FG001|Overall Study|Death|0|||
129207506|NCT00633477|465059016|FG000|Overall Study|Randomized but not treated|1|||
129207507|NCT00633477|465059017|FG001|Overall Study|Randomized but not treated|0|||
129207508|NCT00770653|465059021|FG000|Overall Study|Adverse Event|13|||
129207509|NCT00770653|465059022|FG001|Overall Study|Adverse Event|5|||
129207510|NCT00770653|465059021|FG000|Overall Study|Protocol Violation|8|||
129207511|NCT00770653|465059022|FG001|Overall Study|Protocol Violation|6|||
129207512|NCT00770653|465059021|FG000|Overall Study|Withdrawal by Subject|4|||
129207513|NCT00770653|465059022|FG001|Overall Study|Withdrawal by Subject|7|||
129207514|NCT00770653|465059021|FG000|Overall Study|Lack of Compliance|1|||
129207515|NCT00770653|465059022|FG001|Overall Study|Lack of Compliance|4|||
129207516|NCT00770653|465059021|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
129207517|NCT00770653|465059022|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
129207518|NCT00770653|465059021|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
129207519|NCT00770653|465059022|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
129207520|NCT00770653|465059021|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
129207521|NCT00770653|465059022|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
129207522|NCT00770653|465059021|FG000|Overall Study|Lost to Follow-up|1|||
129207523|NCT00770653|465059022|FG001|Overall Study|Lost to Follow-up|2|||
129207524|NCT00770653|465059021|FG000|Overall Study|Physician Decision|1|||
129207525|NCT00770653|465059022|FG001|Overall Study|Physician Decision|0|||
129207526|NCT04906499|465059028|FG000|Overall Study|Lack of time|1|||
129207527|NCT00179621|465059029|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
129207528|NCT00179621|465059030|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
129207529|NCT00179621|465059031|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
129207530|NCT00179621|465059032|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
129207531|NCT00179621|465059029|FG000|Double-Blind Period|Adverse Event|2|||
129207532|NCT00179621|465059030|FG001|Double-Blind Period|Adverse Event|7|||
129207533|NCT00179621|465059031|FG002|Double-Blind Period|Adverse Event|4|||
129207534|NCT00179621|465059032|FG003|Double-Blind Period|Adverse Event|0|||
129207535|NCT00179621|465059029|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129207536|NCT00179621|465059030|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129207537|NCT00179621|465059031|FG002|Double-Blind Period|Withdrawal by Subject|3|||
129207538|NCT00179621|465059032|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129207539|NCT00179621|465059029|FG000|Double-Blind Period|Death|0|||
129207540|NCT00179621|465059030|FG001|Double-Blind Period|Death|1|||
129207541|NCT00179621|465059031|FG002|Double-Blind Period|Death|2|||
129207542|NCT00179621|465059032|FG003|Double-Blind Period|Death|0|||
129207543|NCT00179621|465059029|FG000|Double-Blind Period|Protocol Violation|1|||
129207544|NCT00179621|465059030|FG001|Double-Blind Period|Protocol Violation|0|||
129207545|NCT00179621|465059031|FG002|Double-Blind Period|Protocol Violation|0|||
129207546|NCT00179621|465059032|FG003|Double-Blind Period|Protocol Violation|0|||
129207547|NCT00179621|465059029|FG000|Double-Blind Period|Other|0|||
129207548|NCT00179621|465059030|FG001|Double-Blind Period|Other|2|||
129207549|NCT00179621|465059031|FG002|Double-Blind Period|Other|2|||
129207550|NCT00179621|465059032|FG003|Double-Blind Period|Other|0|||
129207551|NCT00179621|465059029|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
129207552|NCT00179621|465059030|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
129207553|NCT00179621|465059031|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
129207554|NCT00179621|465059032|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
129207555|NCT00179621|465059029|FG000|Open-Label Period|Adverse Event|0|||
129207556|NCT00179621|465059030|FG001|Open-Label Period|Adverse Event|6|||
129207557|NCT00179621|465059031|FG002|Open-Label Period|Adverse Event|5|||
129207558|NCT00179621|465059032|FG003|Open-Label Period|Adverse Event|6|||
129207559|NCT00179621|465059029|FG000|Open-Label Period|Withdrawal by Subject|0|||
129207560|NCT00179621|465059030|FG001|Open-Label Period|Withdrawal by Subject|2|||
129207561|NCT00179621|465059031|FG002|Open-Label Period|Withdrawal by Subject|2|||
129207562|NCT00179621|465059032|FG003|Open-Label Period|Withdrawal by Subject|2|||
129207563|NCT00179621|465059029|FG000|Open-Label Period|Death|0|||
129207564|NCT00179621|465059030|FG001|Open-Label Period|Death|0|||
129207565|NCT00179621|465059031|FG002|Open-Label Period|Death|1|||
129207566|NCT00179621|465059032|FG003|Open-Label Period|Death|2|||
129207567|NCT00179621|465059029|FG000|Open-Label Period|Other|0|||
129207568|NCT00179621|465059030|FG001|Open-Label Period|Other|1|||
129207569|NCT00179621|465059031|FG002|Open-Label Period|Other|1|||
129207570|NCT00179621|465059032|FG003|Open-Label Period|Other|2|||
129207571|NCT00262860|465059039|FG000|Overall Study|Adverse Event|2|||
129207572|NCT02891174|465059051|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
129207573|NCT02891174|465059052|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
129207574|NCT02891174|465059051|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
129207575|NCT02891174|465059052|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
129207576|NCT02891174|465059051|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
129207577|NCT02891174|465059052|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
129207578|NCT02891174|465059051|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
129207579|NCT02891174|465059052|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
129207580|NCT02891174|465059051|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
129207581|NCT02891174|465059052|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
129207582|NCT02891174|465059051|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
129207583|NCT02891174|465059052|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
129207584|NCT02891174|465059051|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
129207585|NCT02891174|465059052|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
129207586|NCT04124939|465059053|FG000|Overall Study|Lost to Follow-up|1|||
129207587|NCT04124939|465059054|FG001|Overall Study|Lost to Follow-up|3|||
129207588|NCT04235140|465059055|FG000|Overall Study|Adverse Event|2|||
129207589|NCT04235140|465059055|FG000|Overall Study|Lost to Follow-up|1|||
129207590|NCT04235140|465059055|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
129207591|NCT04235140|465059055|FG000|Overall Study|Commercial drug is available for participants|7|||
129207592|NCT00672555|465059057|FG000|Overall Study|Lost to Follow-up|4|||
129207593|NCT00672555|465059057|FG000|Overall Study|Did not want to answer questionnaire|2|||
129207594|NCT00419393|465059058|FG000|Overall Study|Adverse Event|5|||
129207595|NCT00419393|465059058|FG000|Overall Study|Protocol Violation|5|||
129207596|NCT00419393|465059058|FG000|Overall Study|Withdrawal by Subject|7|||
129207597|NCT00419393|465059058|FG000|Overall Study|Other: Sponsor request|3|||
129207598|NCT00419393|465059058|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
129207599|NCT00419393|465059058|FG000|Overall Study|Other: Site closure|1|||
129207600|NCT00419393|465059058|FG000|Overall Study|Other: Other health problems|1|||
129207601|NCT00419393|465059058|FG000|Overall Study|Other: Investigator decision|1|||
129207602|NCT04516746|465059061|FG000|Overall Study|Randomized but not Treated|51|||
129207603|NCT04516746|465059062|FG001|Overall Study|Randomized but not Treated|19|||
129207604|NCT04516746|465059061|FG000|Overall Study|Adverse Event|0|||
129207605|NCT04516746|465059062|FG001|Overall Study|Adverse Event|1|||
129207606|NCT04516746|465059061|FG000|Overall Study|Death|62|||
129207607|NCT04516746|465059062|FG001|Overall Study|Death|32|||
129207608|NCT04516746|465059061|FG000|Overall Study|Lost to Follow-up|3431|||
129207609|NCT04516746|465059062|FG001|Overall Study|Lost to Follow-up|1831|||
129207610|NCT04516746|465059061|FG000|Overall Study|Withdrawal by Subject|1946|||
129207611|NCT04516746|465059062|FG001|Overall Study|Withdrawal by Subject|1696|||
129207612|NCT04516746|465059061|FG000|Overall Study|Physician Decision|10|||
129207613|NCT04516746|465059062|FG001|Overall Study|Physician Decision|8|||
129207614|NCT04516746|465059061|FG000|Overall Study|Other|35|||
129207615|NCT04516746|465059062|FG001|Overall Study|Other|16|||
129207616|NCT01751061|465059063|FG000|Overall Study|Death|1|||
129207617|NCT01751061|465059064|FG001|Overall Study|Death|0|||
129207618|NCT01751061|465059063|FG000|Overall Study|patient death|5|||
129207619|NCT01751061|465059064|FG001|Overall Study|patient death|0|||
129207620|NCT01751061|465059063|FG000|Overall Study|Lost to Follow-up|40|||
129207621|NCT01751061|465059064|FG001|Overall Study|Lost to Follow-up|25|||
129207622|NCT01751061|465059063|FG000|Overall Study|patient regained decisional capacity|4|||
129207623|NCT01751061|465059064|FG001|Overall Study|patient regained decisional capacity|8|||
129207624|NCT01751061|465059063|FG000|Overall Study|Withdrawal by Subject|4|||
129207625|NCT01751061|465059064|FG001|Overall Study|Withdrawal by Subject|1|||
129207626|NCT01751061|465059063|FG000|Overall Study|Physician Decision|2|||
129207627|NCT01751061|465059064|FG001|Overall Study|Physician Decision|0|||
129207628|NCT00446849|465059068|FG000|Acute Phase|Lack of Efficacy|64|||
129207629|NCT00446849|465059068|FG000|Acute Phase|Protocol Violation|10|||
129207630|NCT00446849|465059068|FG000|Acute Phase|Consent withdrawn|4|||
129207631|NCT00446849|465059068|FG000|Acute Phase|Lost to Follow-up|2|||
129207632|NCT00446849|465059068|FG000|Acute Phase|Physician Decision|1|||
129207633|NCT00446849|465059068|FG000|Acute Phase|noncompliance|1|||
129207634|NCT00446849|465059068|FG000|Maintenance Phase|Lack of Efficacy|40|||
129207635|NCT00446849|465059068|FG000|Maintenance Phase|Protocol Violation|7|||
129207636|NCT00446849|465059068|FG000|Maintenance Phase|Adverse Event|6|||
129207637|NCT00446849|465059068|FG000|Maintenance Phase|Consent withdrawn|5|||
129207638|NCT00446849|465059068|FG000|Maintenance Phase|Lost to Follow-up|3|||
129207639|NCT00446849|465059068|FG000|Maintenance Phase|Pregnancy|1|||
129207640|NCT00446849|465059068|FG000|Maintenance Phase|noncompliance|2|||
129207641|NCT00446849|465059068|FG000|Maintenance Phase|prohibited medication use|2|||
129207642|NCT00446849|465059068|FG000|Maintenance Phase|antibiotic use|1|||
129207643|NCT00446849|465059068|FG000|Maintenance Phase|study closure|1|||
129207644|NCT00446849|465059068|FG000|Maintenance Phase|hydrocodone use|1|||
129207645|NCT00446849|465059068|FG000|Maintenance Phase|concomitant medication use|1|||
129207646|NCT01194830|465059071|FG000|Overall Study|Adverse Event|3|||
129207647|NCT01194830|465059072|FG001|Overall Study|Adverse Event|2|||
129207648|NCT01194830|465059071|FG000|Overall Study|Protocol Violation|5|||
129207649|NCT01194830|465059072|FG001|Overall Study|Protocol Violation|4|||
129207650|NCT01194830|465059071|FG000|Overall Study|Lost to Follow-up|9|||
129207651|NCT01194830|465059072|FG001|Overall Study|Lost to Follow-up|7|||
129207652|NCT01194830|465059071|FG000|Overall Study|Withdrawal by Subject|2|||
128984548|NCT01049360|464231660|FG018|Period 1|Did not meet inc/exc criteria|0|||
128984549|NCT01049360|464231661|FG019|Period 1|Did not meet inc/exc criteria|0|||
128984550|NCT01049360|464231642|FG000|Period 1|Withdrawal by Subject|0|||
128984551|NCT01049360|464231643|FG001|Period 1|Withdrawal by Subject|0|||
128984552|NCT01049360|464231644|FG002|Period 1|Withdrawal by Subject|0|||
128984553|NCT01049360|464231645|FG003|Period 1|Withdrawal by Subject|0|||
128984554|NCT01049360|464231646|FG004|Period 1|Withdrawal by Subject|0|||
128984555|NCT01049360|464231647|FG005|Period 1|Withdrawal by Subject|0|||
128984556|NCT01049360|464231648|FG006|Period 1|Withdrawal by Subject|0|||
128984557|NCT01049360|464231649|FG007|Period 1|Withdrawal by Subject|0|||
128984558|NCT01049360|464231650|FG008|Period 1|Withdrawal by Subject|1|||
128984559|NCT01049360|464231651|FG009|Period 1|Withdrawal by Subject|0|||
128984560|NCT01049360|464231652|FG010|Period 1|Withdrawal by Subject|1|||
128984561|NCT01049360|464231653|FG011|Period 1|Withdrawal by Subject|0|||
128984562|NCT01049360|464231654|FG012|Period 1|Withdrawal by Subject|1|||
128984563|NCT01049360|464231655|FG013|Period 1|Withdrawal by Subject|0|||
128984564|NCT01049360|464231656|FG014|Period 1|Withdrawal by Subject|0|||
128984565|NCT01049360|464231657|FG015|Period 1|Withdrawal by Subject|0|||
128984566|NCT01049360|464231658|FG016|Period 1|Withdrawal by Subject|0|||
128984567|NCT01049360|464231659|FG017|Period 1|Withdrawal by Subject|0|||
128984568|NCT01049360|464231660|FG018|Period 1|Withdrawal by Subject|0|||
128984569|NCT01049360|464231661|FG019|Period 1|Withdrawal by Subject|0|||
128984570|NCT01049360|464231642|FG000|Period 2|Protocol Violation|0|||
128984571|NCT01049360|464231643|FG001|Period 2|Protocol Violation|0|||
128984572|NCT01049360|464231644|FG002|Period 2|Protocol Violation|0|||
128984573|NCT01049360|464231645|FG003|Period 2|Protocol Violation|1|||
128984574|NCT01049360|464231646|FG004|Period 2|Protocol Violation|0|||
128984575|NCT01049360|464231647|FG005|Period 2|Protocol Violation|0|||
128984576|NCT01049360|464231648|FG006|Period 2|Protocol Violation|0|||
128984577|NCT01049360|464231649|FG007|Period 2|Protocol Violation|0|||
128984578|NCT01049360|464231650|FG008|Period 2|Protocol Violation|0|||
128984579|NCT01049360|464231651|FG009|Period 2|Protocol Violation|0|||
128984580|NCT01049360|464231652|FG010|Period 2|Protocol Violation|0|||
128984581|NCT01049360|464231653|FG011|Period 2|Protocol Violation|0|||
128984582|NCT01049360|464231654|FG012|Period 2|Protocol Violation|0|||
128984583|NCT01049360|464231655|FG013|Period 2|Protocol Violation|0|||
128984584|NCT01049360|464231656|FG014|Period 2|Protocol Violation|1|||
128984585|NCT01049360|464231657|FG015|Period 2|Protocol Violation|1|||
128984586|NCT01049360|464231658|FG016|Period 2|Protocol Violation|0|||
128984587|NCT01049360|464231659|FG017|Period 2|Protocol Violation|0|||
128984588|NCT01049360|464231660|FG018|Period 2|Protocol Violation|0|||
129207653|NCT01194830|465059072|FG001|Overall Study|Withdrawal by Subject|1|||
129207654|NCT01194830|465059071|FG000|Overall Study|Lack of Efficacy|1|||
129207655|NCT01194830|465059072|FG001|Overall Study|Lack of Efficacy|1|||
129207656|NCT01194830|465059071|FG000|Overall Study|Non-compliance issues|4|||
128984589|NCT01049360|464231661|FG019|Period 2|Protocol Violation|0|||
128984590|NCT01049360|464231642|FG000|Period 2|Adverse Event|0|||
128984591|NCT01049360|464231643|FG001|Period 2|Adverse Event|1|||
128984592|NCT01049360|464231644|FG002|Period 2|Adverse Event|0|||
128984593|NCT01049360|464231645|FG003|Period 2|Adverse Event|0|||
128984594|NCT01049360|464231646|FG004|Period 2|Adverse Event|0|||
128984595|NCT01049360|464231647|FG005|Period 2|Adverse Event|0|||
128984596|NCT01049360|464231648|FG006|Period 2|Adverse Event|0|||
128984597|NCT01049360|464231649|FG007|Period 2|Adverse Event|0|||
128984598|NCT01049360|464231650|FG008|Period 2|Adverse Event|1|||
128984599|NCT01049360|464231651|FG009|Period 2|Adverse Event|0|||
128984600|NCT01049360|464231652|FG010|Period 2|Adverse Event|0|||
128984601|NCT01049360|464231653|FG011|Period 2|Adverse Event|0|||
128984602|NCT01049360|464231654|FG012|Period 2|Adverse Event|0|||
128984603|NCT01049360|464231655|FG013|Period 2|Adverse Event|0|||
128984604|NCT01049360|464231656|FG014|Period 2|Adverse Event|0|||
128984605|NCT01049360|464231657|FG015|Period 2|Adverse Event|0|||
128984606|NCT01049360|464231658|FG016|Period 2|Adverse Event|0|||
128984607|NCT01049360|464231659|FG017|Period 2|Adverse Event|0|||
129207657|NCT01194830|465059072|FG001|Overall Study|Non-compliance issues|4|||
129207658|NCT01194830|465059071|FG000|Overall Study|Other Reason|12|||
129207659|NCT01194830|465059072|FG001|Overall Study|Other Reason|8|||
129207660|NCT03115359|465059073|FG000|Overall Study|Withdrawal by Subject|29|||
129207661|NCT03115359|465059074|FG001|Overall Study|Withdrawal by Subject|39|||
128984608|NCT01049360|464231660|FG018|Period 2|Adverse Event|0|||
128984609|NCT01049360|464231661|FG019|Period 2|Adverse Event|1|||
128984610|NCT01049360|464231642|FG000|Period 2|Withdrawal by Subject|0|||
128984611|NCT01049360|464231643|FG001|Period 2|Withdrawal by Subject|0|||
128984612|NCT01049360|464231644|FG002|Period 2|Withdrawal by Subject|0|||
128984613|NCT01049360|464231645|FG003|Period 2|Withdrawal by Subject|1|||
128984614|NCT01049360|464231646|FG004|Period 2|Withdrawal by Subject|0|||
128984615|NCT01049360|464231647|FG005|Period 2|Withdrawal by Subject|0|||
128984616|NCT01049360|464231648|FG006|Period 2|Withdrawal by Subject|0|||
128984617|NCT01049360|464231649|FG007|Period 2|Withdrawal by Subject|0|||
128984618|NCT01049360|464231650|FG008|Period 2|Withdrawal by Subject|0|||
128984619|NCT01049360|464231651|FG009|Period 2|Withdrawal by Subject|0|||
128984620|NCT01049360|464231652|FG010|Period 2|Withdrawal by Subject|0|||
129207662|NCT03115359|465059073|FG000|Overall Study|Scheduling conflict|25|||
129207663|NCT03115359|465059074|FG001|Overall Study|Scheduling conflict|23|||
129207664|NCT03115359|465059073|FG000|Overall Study|Personal reasons including health|12|||
129207665|NCT03115359|465059074|FG001|Overall Study|Personal reasons including health|9|||
129207666|NCT03115359|465059073|FG000|Overall Study|Transportation barriers|3|||
129207667|NCT03115359|465059074|FG001|Overall Study|Transportation barriers|0|||
129207668|NCT03115359|465059073|FG000|Overall Study|No longer interested|5|||
129207669|NCT03115359|465059074|FG001|Overall Study|No longer interested|4|||
129207670|NCT03115359|465059073|FG000|Overall Study|No reason provided|45|||
129207671|NCT03115359|465059074|FG001|Overall Study|No reason provided|47|||
129207672|NCT01815918|465059077|FG000|Overall Study|Patient samples not analyzable|3|||
129207673|NCT01815918|465059078|FG001|Overall Study|Patient samples not analyzable|4|||
129207674|NCT01815918|465059077|FG000|Overall Study|Lack of Efficacy|15|||
129207675|NCT01815918|465059078|FG001|Overall Study|Lack of Efficacy|15|||
129207676|NCT03284710|465059081|FG000|Overall Study|Withdrawal by Subject|1|||
129207677|NCT03284710|465059082|FG001|Overall Study|Withdrawal by Subject|0|||
129207678|NCT03284710|465059083|FG002|Overall Study|Withdrawal by Subject|1|||
129207679|NCT03284710|465059084|FG003|Overall Study|Withdrawal by Subject|6|||
129207680|NCT03284710|465059081|FG000|Overall Study|Lost to Follow-up|3|||
129207681|NCT03284710|465059082|FG001|Overall Study|Lost to Follow-up|3|||
129207682|NCT03284710|465059083|FG002|Overall Study|Lost to Follow-up|1|||
129207683|NCT03284710|465059084|FG003|Overall Study|Lost to Follow-up|0|||
129207684|NCT03284710|465059081|FG000|Overall Study|Physician Decision|1|||
129207685|NCT03284710|465059082|FG001|Overall Study|Physician Decision|0|||
129207686|NCT03284710|465059083|FG002|Overall Study|Physician Decision|0|||
129207687|NCT03284710|465059084|FG003|Overall Study|Physician Decision|0|||
129207688|NCT03284710|465059081|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
129207689|NCT03284710|465059082|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129207690|NCT03284710|465059083|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129207691|NCT03284710|465059084|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
129207692|NCT03284710|465059081|FG000|Overall Study|HIV Infection|0|||
129207693|NCT03284710|465059082|FG001|Overall Study|HIV Infection|2|||
129207694|NCT03284710|465059083|FG002|Overall Study|HIV Infection|2|||
129207695|NCT03284710|465059084|FG003|Overall Study|HIV Infection|1|||
129207696|NCT02814916|465059093|FG000|Overall Study|Withdrawal of consent|0|||
129207697|NCT02814916|465059094|FG001|Overall Study|Withdrawal of consent|2|||
129207698|NCT02814916|465059095|FG002|Overall Study|Withdrawal of consent|0|||
129207699|NCT02814916|465059093|FG000|Overall Study|Lost to Follow-up|0|||
129207700|NCT02814916|465059094|FG001|Overall Study|Lost to Follow-up|1|||
129207701|NCT02814916|465059095|FG002|Overall Study|Lost to Follow-up|0|||
129207702|NCT02814916|465059093|FG000|Overall Study|Other, not specified|0|||
129207703|NCT02814916|465059094|FG001|Overall Study|Other, not specified|1|||
129207704|NCT02814916|465059095|FG002|Overall Study|Other, not specified|0|||
129207705|NCT05543265|465059106|FG000|Overall Study|Lost to Follow-up|3|||
129207706|NCT05543265|465059107|FG001|Overall Study|Lost to Follow-up|3|||
129207707|NCT05543265|465059106|FG000|Overall Study|Withdrawal by Subject|0|||
129207708|NCT05543265|465059107|FG001|Overall Study|Withdrawal by Subject|1|||
129207709|NCT05316597|465059108|FG000|First Session|Withdrawal by Subject|0|||
129207710|NCT05316597|465059109|FG001|First Session|Withdrawal by Subject|1|||
129207711|NCT05316597|465059108|FG000|Washout Period|Lost to Follow-up|1|||
129207712|NCT05316597|465059109|FG001|Washout Period|Lost to Follow-up|2|||
129207713|NCT05316597|465059108|FG000|Washout Period|Physician Decision|1|||
129207714|NCT05316597|465059109|FG001|Washout Period|Physician Decision|1|||
129207715|NCT05316597|465059108|FG000|Washout Period|Excluded before second session|1|||
129207716|NCT05316597|465059109|FG001|Washout Period|Excluded before second session|1|||
129207717|NCT05316597|465059108|FG000|Washout Period|Withdrawal by Subject|0|||
129207718|NCT05316597|465059109|FG001|Washout Period|Withdrawal by Subject|4|||
129207719|NCT05526716|465059110|FG000|Overall Study|Death|1|||
129207720|NCT05526716|465059111|FG001|Overall Study|Death|2|||
129207721|NCT05526716|465059110|FG000|Overall Study|Lost to Follow-up|17|||
129207722|NCT05526716|465059111|FG001|Overall Study|Lost to Follow-up|15|||
129207723|NCT05526716|465059110|FG000|Overall Study|Physician Decision|0|||
129207724|NCT05526716|465059111|FG001|Overall Study|Physician Decision|1|||
129207725|NCT05526716|465059110|FG000|Overall Study|Randomized by mistake without study treatment|0|||
129207726|NCT05526716|465059111|FG001|Overall Study|Randomized by mistake without study treatment|1|||
129207727|NCT05526716|465059110|FG000|Overall Study|Withdrawal by Subject|12|||
129207728|NCT05526716|465059111|FG001|Overall Study|Withdrawal by Subject|12|||
129207729|NCT05526716|465059110|FG000|Overall Study|Not reported|0|||
129207730|NCT05526716|465059111|FG001|Overall Study|Not reported|2|||
129207731|NCT04750824|465059113|FG000|Overall Study|Toxicity/intolerability|3|||
129207732|NCT04750824|465059114|FG001|Overall Study|Toxicity/intolerability|1|||
129207733|NCT04750824|465059113|FG000|Overall Study|Death|1|||
129207734|NCT04750824|465059114|FG001|Overall Study|Death|3|||
129207735|NCT04750824|465059113|FG000|Overall Study|Scheduled duration of therapy complete|1|||
129207736|NCT04750824|465059114|FG001|Overall Study|Scheduled duration of therapy complete|9|||
129207737|NCT04750824|465059113|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
129207738|NCT04750824|465059114|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
129207739|NCT00807911|465059117|FG000|Overall Study|Withdrawal by Subject|12|||
129207740|NCT00807911|465059118|FG001|Overall Study|Withdrawal by Subject|10|||
129207741|NCT00807911|465059117|FG000|Overall Study|Ineligible|0|||
129207742|NCT00807911|465059118|FG001|Overall Study|Ineligible|4|||
129207743|NCT01706458|465059121|FG000|Overall Study|Physician Decision|3|||
129207744|NCT01706458|465059122|FG001|Overall Study|Physician Decision|4|||
129207745|NCT02384551|465059127|FG000|Overall Study|Lost to Follow-up|13|||
129207746|NCT02384551|465059128|FG001|Overall Study|Lost to Follow-up|14|||
129207747|NCT02384551|465059129|FG002|Overall Study|Lost to Follow-up|14|||
129207748|NCT02384551|465059130|FG003|Overall Study|Lost to Follow-up|14|||
129207749|NCT04742556|465059133|FG000|Overall Study|Withdrawal by Subject|0|||
129207750|NCT04742556|465059134|FG001|Overall Study|Withdrawal by Subject|1|||
129207751|NCT04742556|465059135|FG002|Overall Study|Withdrawal by Subject|0|||
129207752|NCT04742556|465059133|FG000|Overall Study|Adverse Event|0|||
129207753|NCT04742556|465059134|FG001|Overall Study|Adverse Event|0|||
129207754|NCT04742556|465059135|FG002|Overall Study|Adverse Event|2|||
129207755|NCT04742556|465059133|FG000|Overall Study|Clinical disease progression|0|||
129207756|NCT04742556|465059134|FG001|Overall Study|Clinical disease progression|1|||
129207757|NCT04742556|465059135|FG002|Overall Study|Clinical disease progression|2|||
129207758|NCT04742556|465059133|FG000|Overall Study|Objective disease progression|3|||
129207759|NCT04742556|465059134|FG001|Overall Study|Objective disease progression|2|||
129207760|NCT04742556|465059135|FG002|Overall Study|Objective disease progression|4|||
129207761|NCT02542865|465059141|FG000|Overall Study|Identified as screen failure|1|||
129207762|NCT02542865|465059142|FG001|Overall Study|Identified as screen failure|0|||
129207763|NCT02542865|465059141|FG000|Overall Study|Withdrawal by Subject|16|||
129207764|NCT02542865|465059142|FG001|Overall Study|Withdrawal by Subject|0|||
129207765|NCT02913482|465059143|FG000|Overall Study|Death|0|||
129207766|NCT02913482|465059144|FG001|Overall Study|Death|2|||
129207767|NCT02913482|465059145|FG002|Overall Study|Death|2|||
129207768|NCT02913482|465059143|FG000|Overall Study|Progressive Disease|1|||
129207769|NCT02913482|465059144|FG001|Overall Study|Progressive Disease|1|||
129207770|NCT02913482|465059145|FG002|Overall Study|Progressive Disease|1|||
129207771|NCT02913482|465059143|FG000|Overall Study|Reason not specified|0|||
129207772|NCT02913482|465059144|FG001|Overall Study|Reason not specified|0|||
129207773|NCT02913482|465059145|FG002|Overall Study|Reason not specified|1|||
129207774|NCT02913482|465059143|FG000|Overall Study|Withdrawal by Subject|0|||
129207775|NCT02913482|465059144|FG001|Overall Study|Withdrawal by Subject|1|||
129207776|NCT02913482|465059145|FG002|Overall Study|Withdrawal by Subject|1|||
129207777|NCT00083889|465059147|FG000|Overall Study|Adverse Event|76|||
129207778|NCT00083889|465059148|FG001|Overall Study|Adverse Event|86|||
129207779|NCT00083889|465059147|FG000|Overall Study|Protocol Violation|2|||
129207780|NCT00083889|465059148|FG001|Overall Study|Protocol Violation|2|||
129207781|NCT00083889|465059147|FG000|Overall Study|Withdrawal by Subject|22|||
129207782|NCT00083889|465059148|FG001|Overall Study|Withdrawal by Subject|24|||
129207783|NCT00083889|465059147|FG000|Overall Study|Lack of Efficacy|240|||
129207784|NCT00083889|465059148|FG001|Overall Study|Lack of Efficacy|219|||
129207785|NCT00083889|465059147|FG000|Overall Study|Decision of sponsor|32|||
129207786|NCT00083889|465059148|FG001|Overall Study|Decision of sponsor|4|||
129207787|NCT00083889|465059147|FG000|Overall Study|Randomized: did not take study drug|0|||
129207788|NCT00083889|465059148|FG001|Overall Study|Randomized: did not take study drug|15|||
129207789|NCT00083889|465059147|FG000|Overall Study|Completed on marketed sunitinub|3|||
129207790|NCT00083889|465059148|FG001|Overall Study|Completed on marketed sunitinub|0|||
129207791|NCT00083889|465059147|FG000|Overall Study|Crossover to SU011248|0|||
129207792|NCT00083889|465059148|FG001|Overall Study|Crossover to SU011248|25|||
129207793|NCT01247324|465059152|FG000|Overall Study|Death|6|||
129207794|NCT01247324|465059153|FG001|Overall Study|Death|10|||
129207795|NCT01247324|465059152|FG000|Overall Study|Physician Decision|2|||
129207796|NCT01247324|465059153|FG001|Overall Study|Physician Decision|3|||
129207797|NCT01247324|465059152|FG000|Overall Study|Non-compliance with study drug|3|||
129207798|NCT01247324|465059153|FG001|Overall Study|Non-compliance with study drug|0|||
129207799|NCT01247324|465059152|FG000|Overall Study|Lack of Efficacy|24|||
129207800|NCT01247324|465059153|FG001|Overall Study|Lack of Efficacy|14|||
129207801|NCT01247324|465059152|FG000|Overall Study|Non-compliance|3|||
129207802|NCT01247324|465059153|FG001|Overall Study|Non-compliance|2|||
129207803|NCT01247324|465059152|FG000|Overall Study|Pregnancy|5|||
129207804|NCT01247324|465059153|FG001|Overall Study|Pregnancy|10|||
129207805|NCT01247324|465059152|FG000|Overall Study|Protocol Violation|1|||
129207806|NCT01247324|465059153|FG001|Overall Study|Protocol Violation|1|||
129207807|NCT01247324|465059152|FG000|Overall Study|Reason not specified|42|||
129207808|NCT01247324|465059153|FG001|Overall Study|Reason not specified|32|||
129207809|NCT01247324|465059152|FG000|Overall Study|Consent withdrawn by participant|41|||
129207810|NCT01247324|465059153|FG001|Overall Study|Consent withdrawn by participant|56|||
129207811|NCT01247324|465059152|FG000|Overall Study|Adverse Event|49|||
129207812|NCT01247324|465059153|FG001|Overall Study|Adverse Event|35|||
129207813|NCT01247324|465059152|FG000|Overall Study|Lost to Follow-up|3|||
129207814|NCT01247324|465059153|FG001|Overall Study|Lost to Follow-up|6|||
129207815|NCT01247324|465059152|FG000|Overall Study|Study Terminated by Sponsor|4|||
129207816|NCT01247324|465059153|FG001|Overall Study|Study Terminated by Sponsor|1|||
129207817|NCT01247324|465059152|FG000|Overall Study|Missing|2|||
129207818|NCT01247324|465059153|FG001|Overall Study|Missing|1|||
129207819|NCT03035032|465061011|FG000|Overall Study|Adverse Event|2|||
129207820|NCT03035032|465061011|FG000|Overall Study|Death|9|||
129207821|NCT03035032|465061011|FG000|Overall Study|Lost to Follow-up|1|||
129207822|NCT03035032|465061011|FG000|Overall Study|Progressive Disease|22|||
129207823|NCT03035032|465061011|FG000|Overall Study|Protocol Violation|2|||
129207824|NCT03035032|465061011|FG000|Overall Study|Withdrawal by Subject|2|||
129207825|NCT03035032|465061011|FG000|Overall Study|Physician Decision|5|||
129207826|NCT00836589|465061012|FG000|Overall Study|Lost to Follow-up|246|||
129207827|NCT00836589|465061012|FG000|Overall Study|Death|429|||
129207828|NCT00836589|465061012|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
129207829|NCT02399215|465061034|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
129207830|NCT02399215|465061034|FG000|Overall Study|Withdrawal by Subject|1|||
129207831|NCT01903356|465061035|FG000|Overall Study|Lost to Follow-up|7|||
129207832|NCT01903356|465061035|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
129207833|NCT01903356|465061035|FG000|Overall Study|Violated the dosage and administration|3|||
129207834|NCT04529083|465061036|FG000|Overall Study|Withdrawal by Subject|3|||
129207835|NCT04196686|465061041|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
129207836|NCT04196686|465061042|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
129207837|NCT03448406|465061046|FG000|Overall Study|Noncompliance of scheduled visits|1|||
129207838|NCT03448406|465061047|FG001|Overall Study|Noncompliance of scheduled visits|2|||
129207839|NCT03448406|465061046|FG000|Overall Study|Withdrawal by Subject|1|||
129207840|NCT03448406|465061047|FG001|Overall Study|Withdrawal by Subject|2|||
129207841|NCT03448406|465061046|FG000|Overall Study|Protocol Violation|1|||
129207842|NCT03448406|465061047|FG001|Overall Study|Protocol Violation|0|||
129207843|NCT03448406|465061046|FG000|Overall Study|Adverse Event|8|||
129207844|NCT03448406|465061047|FG001|Overall Study|Adverse Event|9|||
129207845|NCT01176032|465061056|FG000|Overall Study|Adverse Event|1|||
129207846|NCT01176032|465061057|FG001|Overall Study|Adverse Event|0|||
129207847|NCT01176032|465061056|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129207848|NCT01176032|465061057|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129207849|NCT01176032|465061056|FG000|Overall Study|Protocol Violation|1|||
129207850|NCT01176032|465061057|FG001|Overall Study|Protocol Violation|0|||
129207851|NCT01176032|465061056|FG000|Overall Study|Informed consent withdrawn|3|||
129207852|NCT01176032|465061057|FG001|Overall Study|Informed consent withdrawn|0|||
129207853|NCT01176032|465061056|FG000|Overall Study|Other|1|||
129207854|NCT01176032|465061057|FG001|Overall Study|Other|0|||
129207855|NCT01469221|465061058|FG000|Double Blind Phase|Protocol Violation|1|||
129207856|NCT01469221|465061059|FG001|Double Blind Phase|Protocol Violation|0|||
129207857|NCT01469221|465061060|FG002|Double Blind Phase|Protocol Violation|0|||
129207858|NCT01469221|465061058|FG000|Double Blind Phase|Physician Decision|1|||
129207859|NCT01469221|465061059|FG001|Double Blind Phase|Physician Decision|1|||
129207860|NCT01469221|465061060|FG002|Double Blind Phase|Physician Decision|0|||
129207861|NCT01469221|465061058|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
129207862|NCT01469221|465061059|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
129207863|NCT01469221|465061060|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
129207864|NCT03186209|465061066|FG000|Overall Study|Withdrawal by Subject|11|||
129207865|NCT03186209|465061067|FG001|Overall Study|Withdrawal by Subject|22|||
129207866|NCT03186209|465061066|FG000|Overall Study|Pregnancy|1|||
129207867|NCT03186209|465061067|FG001|Overall Study|Pregnancy|0|||
129207868|NCT03186209|465061066|FG000|Overall Study|Adverse Event|4|||
129207869|NCT03186209|465061067|FG001|Overall Study|Adverse Event|0|||
129207870|NCT03186209|465061066|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
129207871|NCT03186209|465061067|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
129207872|NCT03186209|465061066|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
129207873|NCT03186209|465061067|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
129207874|NCT03186209|465061066|FG000|Overall Study|Fail to meet randomization criteria|0|||
129207875|NCT03186209|465061067|FG001|Overall Study|Fail to meet randomization criteria|1|||
129207876|NCT03186209|465061066|FG000|Overall Study|Lost to Follow-up|0|||
129207877|NCT03186209|465061067|FG001|Overall Study|Lost to Follow-up|1|||
129207878|NCT04739982|465061073|FG000|Overall Study|Lost to Follow-up|176|||
129207879|NCT04739982|465061074|FG001|Overall Study|Lost to Follow-up|65|||
129207880|NCT04739982|465061073|FG000|Overall Study|Withdrawal by Subject|19|||
129207881|NCT04739982|465061074|FG001|Overall Study|Withdrawal by Subject|0|||
129207882|NCT04739982|465061073|FG000|Overall Study|Protocol Violation|0|||
129207883|NCT04739982|465061074|FG001|Overall Study|Protocol Violation|5|||
129207884|NCT04079296|465061075|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
129207885|NCT04079296|465061076|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
129207886|NCT04079296|465061077|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
129207887|NCT04079296|465061078|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
129207888|NCT04079296|465061079|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
129207889|NCT04079296|465061075|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
129207890|NCT04079296|465061076|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
129207891|NCT04079296|465061077|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
129207892|NCT04079296|465061078|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
129207893|NCT04079296|465061079|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
129207894|NCT04079296|465061075|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129207895|NCT04079296|465061076|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129207896|NCT04079296|465061077|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129207897|NCT04079296|465061078|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129207898|NCT04079296|465061079|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
129207899|NCT04079296|465061075|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129207900|NCT04079296|465061076|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129207901|NCT04079296|465061077|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129207902|NCT04079296|465061078|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129207903|NCT04079296|465061079|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
129207904|NCT04079296|465061075|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129207905|NCT04079296|465061076|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129207906|NCT04079296|465061077|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129207907|NCT04079296|465061078|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
129207908|NCT04079296|465061079|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129207909|NCT04079296|465061075|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
129207910|NCT04079296|465061076|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
129207911|NCT04079296|465061077|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
129207912|NCT04079296|465061078|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
129207913|NCT04079296|465061079|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
129207914|NCT04079296|465061075|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
129207915|NCT04079296|465061076|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
129207916|NCT04079296|465061077|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
129207917|NCT04079296|465061078|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
129207918|NCT04079296|465061079|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
129207919|NCT04079296|465061075|FG000|Dose Expansion Phase (168 Days)|Death|0|||
129207920|NCT04079296|465061076|FG001|Dose Expansion Phase (168 Days)|Death|0|||
129207921|NCT04079296|465061077|FG002|Dose Expansion Phase (168 Days)|Death|0|||
129207922|NCT04079296|465061078|FG003|Dose Expansion Phase (168 Days)|Death|1|||
129207923|NCT04079296|465061079|FG004|Dose Expansion Phase (168 Days)|Death|0|||
129207924|NCT01346358|465061092|FG000|Overall Study|Withdrawal by Subject|1|||
129207925|NCT01346358|465061093|FG001|Overall Study|Withdrawal by Subject|0|||
129207926|NCT01346358|465061094|FG002|Overall Study|Withdrawal by Subject|1|||
129207927|NCT01346358|465061095|FG003|Overall Study|Withdrawal by Subject|1|||
129207928|NCT01346358|465061096|FG004|Overall Study|Withdrawal by Subject|0|||
129207929|NCT01346358|465061097|FG005|Overall Study|Withdrawal by Subject|2|||
129207930|NCT01346358|465061098|FG006|Overall Study|Withdrawal by Subject|1|||
129207931|NCT01346358|465061099|FG007|Overall Study|Withdrawal by Subject|1|||
129207932|NCT01346358|465061100|FG008|Overall Study|Withdrawal by Subject|1|||
129207933|NCT01346358|465061092|FG000|Overall Study|Adverse Event|1|||
129207934|NCT01346358|465061093|FG001|Overall Study|Adverse Event|0|||
128984621|NCT01049360|464231653|FG011|Period 2|Withdrawal by Subject|0|||
129207935|NCT01346358|465061094|FG002|Overall Study|Adverse Event|0|||
129207936|NCT01346358|465061095|FG003|Overall Study|Adverse Event|0|||
129207937|NCT01346358|465061096|FG004|Overall Study|Adverse Event|1|||
129207938|NCT01346358|465061097|FG005|Overall Study|Adverse Event|0|||
129207939|NCT01346358|465061098|FG006|Overall Study|Adverse Event|0|||
129207940|NCT01346358|465061099|FG007|Overall Study|Adverse Event|0|||
129207941|NCT01346358|465061100|FG008|Overall Study|Adverse Event|1|||
129207942|NCT01346358|465061092|FG000|Overall Study|Non-Compliance|0|||
129207943|NCT01346358|465061093|FG001|Overall Study|Non-Compliance|0|||
129207944|NCT01346358|465061094|FG002|Overall Study|Non-Compliance|0|||
129207945|NCT01346358|465061095|FG003|Overall Study|Non-Compliance|0|||
129207946|NCT01346358|465061096|FG004|Overall Study|Non-Compliance|0|||
129207947|NCT01346358|465061097|FG005|Overall Study|Non-Compliance|0|||
129207948|NCT01346358|465061098|FG006|Overall Study|Non-Compliance|0|||
129207949|NCT01346358|465061099|FG007|Overall Study|Non-Compliance|2|||
128984622|NCT01049360|464231654|FG012|Period 2|Withdrawal by Subject|0|||
128984623|NCT01049360|464231655|FG013|Period 2|Withdrawal by Subject|0|||
129207950|NCT01346358|465061100|FG008|Overall Study|Non-Compliance|0|||
129207951|NCT01346358|465061092|FG000|Overall Study|Physician Decision|0|||
129207952|NCT01346358|465061093|FG001|Overall Study|Physician Decision|1|||
129207953|NCT01346358|465061094|FG002|Overall Study|Physician Decision|0|||
129207954|NCT01346358|465061095|FG003|Overall Study|Physician Decision|0|||
129207955|NCT01346358|465061096|FG004|Overall Study|Physician Decision|0|||
129207956|NCT01346358|465061097|FG005|Overall Study|Physician Decision|0|||
129207957|NCT01346358|465061098|FG006|Overall Study|Physician Decision|0|||
128984624|NCT01049360|464231656|FG014|Period 2|Withdrawal by Subject|1|||
129207958|NCT01346358|465061099|FG007|Overall Study|Physician Decision|1|||
129207959|NCT01346358|465061100|FG008|Overall Study|Physician Decision|1|||
129207960|NCT00702702|465061103|FG000|Overall Study|Study prematurely terminated|56|||
129207961|NCT02004236|465061104|FG000|Overall Study|Lack of Efficacy|0|||
129207962|NCT02004236|465061105|FG001|Overall Study|Lack of Efficacy|0|||
129207963|NCT02004236|465061106|FG002|Overall Study|Lack of Efficacy|16|||
129207964|NCT05121766|465061107|FG000|Overall Study|Covid reinfection|3|||
129207965|NCT05121766|465061108|FG001|Overall Study|Covid reinfection|0|||
129207966|NCT05121766|465061107|FG000|Overall Study|Withdrawal by Subject|3|||
129207967|NCT05121766|465061108|FG001|Overall Study|Withdrawal by Subject|1|||
129207968|NCT05121766|465061107|FG000|Overall Study|Adverse Event|2|||
129207969|NCT05121766|465061108|FG001|Overall Study|Adverse Event|4|||
129207970|NCT05121766|465061107|FG000|Overall Study|Lost to Follow-up|0|||
129207971|NCT05121766|465061108|FG001|Overall Study|Lost to Follow-up|1|||
129207972|NCT02960217|465061110|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
129207973|NCT02960217|465061111|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
129207974|NCT02960217|465061110|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
129207975|NCT02960217|465061111|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
129207976|NCT02960217|465061110|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
129207977|NCT02960217|465061111|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
129207978|NCT02960217|465061110|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
129207979|NCT02960217|465061111|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
129207980|NCT02960217|465061110|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
129207981|NCT02960217|465061111|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
129207982|NCT02960217|465061110|FG000|Open-Label Extension Phase|Adverse Event|1|||
129207983|NCT02960217|465061111|FG001|Open-Label Extension Phase|Adverse Event|0|||
129207984|NCT02960217|465061110|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
129207985|NCT02960217|465061111|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
129207986|NCT02960217|465061110|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
129207987|NCT02960217|465061111|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
129207988|NCT02960217|465061110|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
129207989|NCT02960217|465061111|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
129207990|NCT00918281|465061114|FG000|Overall Study|Physician Decision|29|||
129207991|NCT01743469|465061115|FG000|Active Treatment Phase|Adverse Event|10|||
129207992|NCT01743469|465061116|FG001|Active Treatment Phase|Adverse Event|5|||
129207993|NCT01743469|465061117|FG002|Active Treatment Phase|Adverse Event|8|||
129207994|NCT01743469|465061118|FG003|Active Treatment Phase|Adverse Event|1|||
129207995|NCT01743469|465061115|FG000|Active Treatment Phase|Disease Progression|40|||
129207996|NCT01743469|465061116|FG001|Active Treatment Phase|Disease Progression|47|||
129207997|NCT01743469|465061117|FG002|Active Treatment Phase|Disease Progression|30|||
129207998|NCT01743469|465061118|FG003|Active Treatment Phase|Disease Progression|20|||
129207999|NCT01743469|465061115|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
129208000|NCT01743469|465061116|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
129208001|NCT01743469|465061117|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
129208002|NCT01743469|465061118|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
129208003|NCT01743469|465061115|FG000|Active Treatment Phase|Missing|1|||
129208004|NCT01743469|465061116|FG001|Active Treatment Phase|Missing|0|||
129208005|NCT01743469|465061117|FG002|Active Treatment Phase|Missing|0|||
129208006|NCT01743469|465061118|FG003|Active Treatment Phase|Missing|0|||
129208007|NCT01743469|465061115|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
129208008|NCT01743469|465061116|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
129208009|NCT01743469|465061117|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
129208010|NCT01743469|465061118|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
129208011|NCT01743469|465061115|FG000|Follow-up Period - Post-Treatment|Death|43|||
129208012|NCT01743469|465061116|FG001|Follow-up Period - Post-Treatment|Death|47|||
129208013|NCT01743469|465061117|FG002|Follow-up Period - Post-Treatment|Death|22|||
129208014|NCT01743469|465061118|FG003|Follow-up Period - Post-Treatment|Death|16|||
129208015|NCT01743469|465061115|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
129208016|NCT01743469|465061116|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
129208017|NCT01743469|465061117|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
129208018|NCT01743469|465061118|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
129208019|NCT00317473|465061119|FG000|Overall Study|Withdrawal by Subject|2|||
129208020|NCT00317473|465061120|FG001|Overall Study|Withdrawal by Subject|1|||
129208021|NCT00317473|465061121|FG002|Overall Study|Withdrawal by Subject|2|||
129208022|NCT00317473|465061122|FG003|Overall Study|Withdrawal by Subject|1|||
129208023|NCT00317473|465061123|FG004|Overall Study|Withdrawal by Subject|3|||
129208024|NCT00317473|465061124|FG005|Overall Study|Withdrawal by Subject|1|||
129208025|NCT00317473|465061119|FG000|Overall Study|Relocation|1|||
129208026|NCT00317473|465061120|FG001|Overall Study|Relocation|0|||
128984625|NCT01049360|464231657|FG015|Period 2|Withdrawal by Subject|0|||
129208027|NCT00317473|465061121|FG002|Overall Study|Relocation|1|||
129208028|NCT00317473|465061122|FG003|Overall Study|Relocation|1|||
129208029|NCT00317473|465061123|FG004|Overall Study|Relocation|5|||
129208030|NCT00317473|465061124|FG005|Overall Study|Relocation|2|||
129208031|NCT00317473|465061119|FG000|Overall Study|Death|1|||
129208032|NCT00317473|465061120|FG001|Overall Study|Death|0|||
129208033|NCT00317473|465061121|FG002|Overall Study|Death|0|||
129208034|NCT00317473|465061122|FG003|Overall Study|Death|0|||
129208035|NCT00317473|465061123|FG004|Overall Study|Death|0|||
129208036|NCT00317473|465061124|FG005|Overall Study|Death|0|||
129208037|NCT00317473|465061119|FG000|Overall Study|Other|0|||
129208038|NCT00317473|465061120|FG001|Overall Study|Other|2|||
129208039|NCT00317473|465061121|FG002|Overall Study|Other|0|||
129208040|NCT00317473|465061122|FG003|Overall Study|Other|0|||
129208041|NCT00317473|465061123|FG004|Overall Study|Other|0|||
129208042|NCT00317473|465061124|FG005|Overall Study|Other|0|||
129208043|NCT00388349|465061125|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
129208044|NCT00388349|465061126|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
129208045|NCT00168844|465061127|FG000|Overall Study|Adverse Event|31|||
129208046|NCT00168844|465061128|FG001|Overall Study|Adverse Event|32|||
129208047|NCT00168844|465061129|FG002|Overall Study|Adverse Event|48|||
129208048|NCT00168844|465061127|FG000|Overall Study|Lost to Follow-up|4|||
129208049|NCT00168844|465061128|FG001|Overall Study|Lost to Follow-up|5|||
129208050|NCT00168844|465061129|FG002|Overall Study|Lost to Follow-up|11|||
129208051|NCT00168844|465061127|FG000|Overall Study|Withdrawal by Subject|12|||
129208052|NCT00168844|465061128|FG001|Overall Study|Withdrawal by Subject|9|||
129208053|NCT00168844|465061129|FG002|Overall Study|Withdrawal by Subject|19|||
129208054|NCT00168844|465061127|FG000|Overall Study|Protocol Violation|2|||
129208055|NCT00168844|465061128|FG001|Overall Study|Protocol Violation|2|||
129208056|NCT00168844|465061129|FG002|Overall Study|Protocol Violation|4|||
129208057|NCT00168844|465061127|FG000|Overall Study|Other|6|||
129208058|NCT00168844|465061128|FG001|Overall Study|Other|7|||
129208059|NCT00168844|465061129|FG002|Overall Study|Other|9|||
129208060|NCT02138890|465061138|FG000|Overall Study|Adverse Event|1|||
129208061|NCT02138890|465061139|FG001|Overall Study|Adverse Event|0|||
129208062|NCT01446159|465061142|FG000|Overall Study|Withdrawal by Subject|1|||
129208063|NCT01446159|465061143|FG001|Overall Study|Withdrawal by Subject|0|||
129208064|NCT01446159|465061144|FG002|Overall Study|Withdrawal by Subject|14|||
129208065|NCT01446159|465061145|FG003|Overall Study|Withdrawal by Subject|11|||
129208066|NCT01446159|465061142|FG000|Overall Study|Lost to Follow-up|0|||
129208067|NCT01446159|465061143|FG001|Overall Study|Lost to Follow-up|0|||
129208068|NCT01446159|465061144|FG002|Overall Study|Lost to Follow-up|1|||
129208069|NCT01446159|465061145|FG003|Overall Study|Lost to Follow-up|2|||
129208070|NCT01446159|465061142|FG000|Overall Study|Death|2|||
129208071|NCT01446159|465061143|FG001|Overall Study|Death|3|||
129208072|NCT01446159|465061144|FG002|Overall Study|Death|43|||
129208073|NCT01446159|465061145|FG003|Overall Study|Death|36|||
129208074|NCT01446159|465061142|FG000|Overall Study|Other|0|||
129208075|NCT01446159|465061143|FG001|Overall Study|Other|0|||
129208076|NCT01446159|465061144|FG002|Overall Study|Other|13|||
129208077|NCT01446159|465061145|FG003|Overall Study|Other|13|||
129208078|NCT00537394|465061146|FG000|First Year of Follow-up|Death|7|||
129208079|NCT00537394|465061147|FG001|First Year of Follow-up|Death|0|||
129208080|NCT00537394|465061148|FG002|First Year of Follow-up|Death|0|||
129208081|NCT00537394|465061146|FG000|First Year of Follow-up|Severe debilitation|1|||
129208082|NCT00537394|465061147|FG001|First Year of Follow-up|Severe debilitation|0|||
129208083|NCT00537394|465061148|FG002|First Year of Follow-up|Severe debilitation|1|||
129208084|NCT00537394|465061146|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
129208085|NCT00537394|465061147|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
129208086|NCT00537394|465061148|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
129208087|NCT00537394|465061146|FG000|First Year of Follow-up|Lost to Follow-up|1|||
129208088|NCT00537394|465061147|FG001|First Year of Follow-up|Lost to Follow-up|5|||
129208089|NCT00537394|465061148|FG002|First Year of Follow-up|Lost to Follow-up|1|||
129208090|NCT00537394|465061146|FG000|2nd Year of Follow-up|Death|4|||
129208091|NCT00537394|465061147|FG001|2nd Year of Follow-up|Death|1|||
129208092|NCT00537394|465061148|FG002|2nd Year of Follow-up|Death|2|||
129208093|NCT00537394|465061146|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
129208094|NCT00537394|465061147|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
129208095|NCT00537394|465061148|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
129208096|NCT00537394|465061146|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
129208097|NCT00537394|465061147|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
129208098|NCT00537394|465061148|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
129208099|NCT00537394|465061146|FG000|2nd Year of Follow-up|Clinic site closure|1|||
129208100|NCT00537394|465061147|FG001|2nd Year of Follow-up|Clinic site closure|0|||
129208101|NCT00537394|465061148|FG002|2nd Year of Follow-up|Clinic site closure|0|||
129208102|NCT00685165|465061150|FG000|Washout Period of 14 Days|Adverse Event|1|||
129208103|NCT00685165|465061151|FG001|Washout Period of 14 Days|Adverse Event|0|||
129208104|NCT00795535|465061160|FG000|Overall Study|incomplete data and technical problems|20|||
129208105|NCT05135871|465061161|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
129208106|NCT05135871|465061162|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
129208107|NCT05135871|465061163|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
129208108|NCT05135871|465061164|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
129208109|NCT00556075|465061165|FG000|Overall Study|Lost to Follow-up|3|||
129208110|NCT00556075|465061166|FG001|Overall Study|Lost to Follow-up|0|||
129208111|NCT00556075|465061167|FG002|Overall Study|Lost to Follow-up|3|||
129208112|NCT00556075|465061165|FG000|Overall Study|Withdrawal by Subject|3|||
129208113|NCT00556075|465061166|FG001|Overall Study|Withdrawal by Subject|3|||
129208114|NCT00556075|465061167|FG002|Overall Study|Withdrawal by Subject|0|||
129208115|NCT00556075|465061165|FG000|Overall Study|Protocol Violation|1|||
129208116|NCT00556075|465061166|FG001|Overall Study|Protocol Violation|1|||
129208117|NCT00556075|465061167|FG002|Overall Study|Protocol Violation|3|||
129208118|NCT00556075|465061165|FG000|Overall Study|Not eligible|1|||
129208119|NCT00556075|465061166|FG001|Overall Study|Not eligible|1|||
129208120|NCT00556075|465061167|FG002|Overall Study|Not eligible|2|||
129208121|NCT00556075|465061165|FG000|Overall Study|Adverse Event|1|||
129208122|NCT00556075|465061166|FG001|Overall Study|Adverse Event|2|||
129208123|NCT00556075|465061167|FG002|Overall Study|Adverse Event|0|||
129208124|NCT00556075|465061165|FG000|Overall Study|Personal issues|4|||
129208125|NCT00556075|465061166|FG001|Overall Study|Personal issues|1|||
129208126|NCT00556075|465061167|FG002|Overall Study|Personal issues|0|||
129208127|NCT00556075|465061165|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
129208128|NCT00556075|465061166|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
129208129|NCT00556075|465061167|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
129208130|NCT03914417|465061168|FG000|Overall Study|Withdrawal by Subject|2|||
129208131|NCT01420861|465061171|FG000|Overall Study|Adverse Event|2|||
129208132|NCT01420861|465061171|FG000|Overall Study|Study terminated by Sponsor|7|||
129208133|NCT01420861|465061171|FG000|Overall Study|Screen failure|7|||
129208134|NCT01420861|465061171|FG000|Overall Study|Randomized not Treated|2|||
129208135|NCT03361137|465061172|FG000|Overall Study|Reason not specified|1|||
129208136|NCT03361137|465061173|FG001|Overall Study|Reason not specified|0|||
129208137|NCT03361137|465061174|FG002|Overall Study|Reason not specified|0|||
129208138|NCT03361137|465061175|FG003|Overall Study|Reason not specified|0|||
129208139|NCT03361137|465061176|FG004|Overall Study|Reason not specified|0|||
129208140|NCT03009058|465061177|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
129208141|NCT01486966|465061178|FG000|Overall Study|Adverse Event|0|||
129208142|NCT01486966|465061179|FG001|Overall Study|Adverse Event|1|||
129208143|NCT01486966|465061178|FG000|Overall Study|Withdrawal by Subject|0|||
129208144|NCT01486966|465061179|FG001|Overall Study|Withdrawal by Subject|1|||
129208145|NCT02153086|465063231|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
129208146|NCT02153086|465063231|FG000|Overall Study|Other|2|||
129208147|NCT01317472|465063232|FG000|Overall Study|Withdrawal by Subject|1|||
129208148|NCT01317472|465063233|FG001|Overall Study|Withdrawal by Subject|0|||
129208149|NCT01317472|465063232|FG000|Overall Study|Unrelated hospitalization|1|||
129208150|NCT01317472|465063233|FG001|Overall Study|Unrelated hospitalization|0|||
129208151|NCT05546476|465063234|FG000|Period 1: Part A|Adverse Event|2|||
129208152|NCT05546476|465063235|FG001|Period 1: Part A|Adverse Event|0|||
129208153|NCT05546476|465063236|FG002|Period 1: Part A|Adverse Event|0|||
129208154|NCT05546476|465063237|FG003|Period 1: Part A|Adverse Event|1|||
129208155|NCT05546476|465063234|FG000|Period 1: Part A|Death|4|||
129208156|NCT05546476|465063235|FG001|Period 1: Part A|Death|4|||
129208157|NCT05546476|465063236|FG002|Period 1: Part A|Death|5|||
129208158|NCT05546476|465063237|FG003|Period 1: Part A|Death|6|||
129208159|NCT05546476|465063234|FG000|Period 1: Part A|Lack of Efficacy|0|||
129208160|NCT05546476|465063235|FG001|Period 1: Part A|Lack of Efficacy|0|||
129208161|NCT05546476|465063236|FG002|Period 1: Part A|Lack of Efficacy|0|||
129208162|NCT05546476|465063237|FG003|Period 1: Part A|Lack of Efficacy|1|||
129208163|NCT05546476|465063234|FG000|Period 1: Part A|Lost to Follow-up|0|||
129208164|NCT05546476|465063235|FG001|Period 1: Part A|Lost to Follow-up|0|||
129208165|NCT05546476|465063236|FG002|Period 1: Part A|Lost to Follow-up|0|||
129208166|NCT05546476|465063237|FG003|Period 1: Part A|Lost to Follow-up|1|||
129208167|NCT05546476|465063234|FG000|Period 1: Part A|Physician Decision|1|||
129208168|NCT05546476|465063235|FG001|Period 1: Part A|Physician Decision|0|||
129208169|NCT05546476|465063236|FG002|Period 1: Part A|Physician Decision|0|||
129208170|NCT05546476|465063237|FG003|Period 1: Part A|Physician Decision|0|||
129208171|NCT05546476|465063234|FG000|Period 1: Part A|Progressive disease|3|||
129208172|NCT05546476|465063235|FG001|Period 1: Part A|Progressive disease|5|||
129208173|NCT05546476|465063236|FG002|Period 1: Part A|Progressive disease|0|||
129208174|NCT05546476|465063237|FG003|Period 1: Part A|Progressive disease|1|||
129208175|NCT05546476|465063234|FG000|Period 1: Part A|Withdrawal by Subject|1|||
129208176|NCT05546476|465063235|FG001|Period 1: Part A|Withdrawal by Subject|1|||
129208177|NCT05546476|465063236|FG002|Period 1: Part A|Withdrawal by Subject|1|||
129208178|NCT05546476|465063237|FG003|Period 1: Part A|Withdrawal by Subject|2|||
129208179|NCT05546476|465063234|FG000|Period 1: Part A|Global deterioration of health status|2|||
129208180|NCT05546476|465063235|FG001|Period 1: Part A|Global deterioration of health status|2|||
128876225|NCT03541174|463842313|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
128876226|NCT03541174|463842314|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
129208181|NCT05546476|465063236|FG002|Period 1: Part A|Global deterioration of health status|1|||
129208182|NCT05546476|465063237|FG003|Period 1: Part A|Global deterioration of health status|4|||
129208183|NCT05546476|465063234|FG000|Period 1: Part A|Other: Unspecified|0|||
129208184|NCT05546476|465063235|FG001|Period 1: Part A|Other: Unspecified|2|||
129208185|NCT05546476|465063236|FG002|Period 1: Part A|Other: Unspecified|0|||
129208186|NCT05546476|465063237|FG003|Period 1: Part A|Other: Unspecified|0|||
129208187|NCT05546476|465063234|FG000|Period 2: Part B|Ongoing|26|||
129208188|NCT05546476|465063235|FG001|Period 2: Part B|Ongoing|27|||
129208189|NCT05546476|465063236|FG002|Period 2: Part B|Ongoing|35|||
129208190|NCT05546476|465063237|FG003|Period 2: Part B|Ongoing|29|||
129208191|NCT02953652|465063238|FG000|Overall Study|Adverse Event|18|||
129208192|NCT02953652|465063238|FG000|Overall Study|Withdrawal by Subject|6|||
129208193|NCT02953652|465063238|FG000|Overall Study|Protocol Violation|1|||
129208194|NCT02953652|465063238|FG000|Overall Study|Disease Progression|27|||
129208195|NCT00772538|465063239|FG000|Overall Study|Adverse Event|6|||
129208196|NCT00772538|465063240|FG001|Overall Study|Adverse Event|6|||
129208197|NCT00772538|465063239|FG000|Overall Study|Protocol Violation|3|||
129208198|NCT00772538|465063240|FG001|Overall Study|Protocol Violation|3|||
129208199|NCT00772538|465063239|FG000|Overall Study|Lost to Follow-up|1|||
129208200|NCT00772538|465063240|FG001|Overall Study|Lost to Follow-up|1|||
129208201|NCT00772538|465063239|FG000|Overall Study|Withdrawal by Subject|3|||
129208202|NCT00772538|465063240|FG001|Overall Study|Withdrawal by Subject|8|||
129208203|NCT00772538|465063239|FG000|Overall Study|Lack of Efficacy|0|||
129208204|NCT00772538|465063240|FG001|Overall Study|Lack of Efficacy|1|||
129208205|NCT00772538|465063239|FG000|Overall Study|Other|7|||
129208206|NCT00772538|465063240|FG001|Overall Study|Other|7|||
129208207|NCT00713609|465063243|FG000|Overall Study|Adverse Event|2|||
129208208|NCT00713609|465063244|FG001|Overall Study|Adverse Event|0|||
129208209|NCT00713609|465063245|FG002|Overall Study|Adverse Event|2|||
129208210|NCT00713609|465063246|FG003|Overall Study|Adverse Event|2|||
129208211|NCT00713609|465063247|FG004|Overall Study|Adverse Event|3|||
129208212|NCT00713609|465063248|FG005|Overall Study|Adverse Event|1|||
129208213|NCT00713609|465063243|FG000|Overall Study|Lost to Follow-up|5|||
129208214|NCT00713609|465063244|FG001|Overall Study|Lost to Follow-up|7|||
129208215|NCT00713609|465063245|FG002|Overall Study|Lost to Follow-up|5|||
129208216|NCT00713609|465063246|FG003|Overall Study|Lost to Follow-up|5|||
129208217|NCT00713609|465063247|FG004|Overall Study|Lost to Follow-up|7|||
129208218|NCT00713609|465063248|FG005|Overall Study|Lost to Follow-up|0|||
129208219|NCT00713609|465063243|FG000|Overall Study|Lack of Efficacy|1|||
129208220|NCT00713609|465063244|FG001|Overall Study|Lack of Efficacy|3|||
129208221|NCT00713609|465063245|FG002|Overall Study|Lack of Efficacy|0|||
129208222|NCT00713609|465063246|FG003|Overall Study|Lack of Efficacy|0|||
129208223|NCT00713609|465063247|FG004|Overall Study|Lack of Efficacy|1|||
129208224|NCT00713609|465063248|FG005|Overall Study|Lack of Efficacy|0|||
129208225|NCT00713609|465063243|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
129208226|NCT00713609|465063244|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
129208227|NCT00713609|465063245|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
129208228|NCT00713609|465063246|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
129208229|NCT00713609|465063247|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
129208230|NCT00713609|465063248|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
129208231|NCT00713609|465063243|FG000|Overall Study|Withdrawal by Subject|6|||
129208232|NCT00713609|465063244|FG001|Overall Study|Withdrawal by Subject|1|||
129208233|NCT00713609|465063245|FG002|Overall Study|Withdrawal by Subject|5|||
129208234|NCT00713609|465063246|FG003|Overall Study|Withdrawal by Subject|1|||
129208235|NCT00713609|465063247|FG004|Overall Study|Withdrawal by Subject|5|||
129208236|NCT00713609|465063248|FG005|Overall Study|Withdrawal by Subject|7|||
128984626|NCT01049360|464231658|FG016|Period 2|Withdrawal by Subject|0|||
129208237|NCT00713609|465063243|FG000|Overall Study|Protocol Violation|6|||
128984627|NCT01049360|464231659|FG017|Period 2|Withdrawal by Subject|0|||
128984628|NCT01049360|464231660|FG018|Period 2|Withdrawal by Subject|0|||
128984629|NCT01049360|464231661|FG019|Period 2|Withdrawal by Subject|1|||
128984630|NCT01049360|464231642|FG000|Period 2|Lack of Efficacy|0|||
129208238|NCT00713609|465063244|FG001|Overall Study|Protocol Violation|3|||
128984631|NCT01049360|464231643|FG001|Period 2|Lack of Efficacy|0|||
128984632|NCT01049360|464231644|FG002|Period 2|Lack of Efficacy|0|||
129208239|NCT00713609|465063245|FG002|Overall Study|Protocol Violation|1|||
128984633|NCT01049360|464231645|FG003|Period 2|Lack of Efficacy|0|||
129208240|NCT00713609|465063246|FG003|Overall Study|Protocol Violation|1|||
129208241|NCT00713609|465063247|FG004|Overall Study|Protocol Violation|2|||
129208242|NCT00713609|465063248|FG005|Overall Study|Protocol Violation|0|||
128984634|NCT01049360|464231646|FG004|Period 2|Lack of Efficacy|0|||
129208243|NCT03780452|465063249|FG000|Overall Study|Screening failure|2|||
129208244|NCT01001221|465063250|FG000|Overall Study|Adverse Event|1|||
129208245|NCT01001221|465063251|FG001|Overall Study|Adverse Event|2|||
129208246|NCT01001221|465063252|FG002|Overall Study|Adverse Event|0|||
129208247|NCT01001221|465063253|FG003|Overall Study|Adverse Event|2|||
129208248|NCT01001221|465063254|FG004|Overall Study|Adverse Event|0|||
129208249|NCT01001221|465063250|FG000|Overall Study|Disease progression|3|||
129208250|NCT01001221|465063251|FG001|Overall Study|Disease progression|2|||
129208251|NCT01001221|465063252|FG002|Overall Study|Disease progression|2|||
129208252|NCT01001221|465063253|FG003|Overall Study|Disease progression|4|||
129208253|NCT01001221|465063254|FG004|Overall Study|Disease progression|0|||
129208254|NCT01001221|465063250|FG000|Overall Study|Other|1|||
129208255|NCT01001221|465063251|FG001|Overall Study|Other|1|||
128984635|NCT01049360|464231647|FG005|Period 2|Lack of Efficacy|1|||
128984636|NCT01049360|464231648|FG006|Period 2|Lack of Efficacy|0|||
128984637|NCT01049360|464231649|FG007|Period 2|Lack of Efficacy|0|||
128984638|NCT01049360|464231650|FG008|Period 2|Lack of Efficacy|0|||
128984639|NCT01049360|464231651|FG009|Period 2|Lack of Efficacy|0|||
128984640|NCT01049360|464231652|FG010|Period 2|Lack of Efficacy|0|||
128984641|NCT01049360|464231653|FG011|Period 2|Lack of Efficacy|0|||
128984642|NCT01049360|464231654|FG012|Period 2|Lack of Efficacy|0|||
128984643|NCT01049360|464231655|FG013|Period 2|Lack of Efficacy|0|||
128984644|NCT01049360|464231656|FG014|Period 2|Lack of Efficacy|0|||
128984645|NCT01049360|464231657|FG015|Period 2|Lack of Efficacy|0|||
128984646|NCT01049360|464231658|FG016|Period 2|Lack of Efficacy|0|||
128984647|NCT01049360|464231659|FG017|Period 2|Lack of Efficacy|0|||
128984648|NCT01049360|464231660|FG018|Period 2|Lack of Efficacy|0|||
128984649|NCT01049360|464231661|FG019|Period 2|Lack of Efficacy|0|||
128984650|NCT01049360|464231642|FG000|Period 4|Protocol Violation|0|||
128984651|NCT01049360|464231643|FG001|Period 4|Protocol Violation|0|||
128984652|NCT01049360|464231644|FG002|Period 4|Protocol Violation|0|||
128984653|NCT01049360|464231645|FG003|Period 4|Protocol Violation|0|||
128984654|NCT01049360|464231646|FG004|Period 4|Protocol Violation|0|||
128984655|NCT01049360|464231647|FG005|Period 4|Protocol Violation|0|||
128984656|NCT01049360|464231648|FG006|Period 4|Protocol Violation|0|||
128984657|NCT01049360|464231649|FG007|Period 4|Protocol Violation|0|||
128984658|NCT01049360|464231650|FG008|Period 4|Protocol Violation|0|||
128984659|NCT01049360|464231651|FG009|Period 4|Protocol Violation|0|||
128984660|NCT01049360|464231652|FG010|Period 4|Protocol Violation|0|||
128984661|NCT01049360|464231653|FG011|Period 4|Protocol Violation|0|||
128984662|NCT01049360|464231654|FG012|Period 4|Protocol Violation|0|||
128984663|NCT01049360|464231655|FG013|Period 4|Protocol Violation|0|||
128984664|NCT01049360|464231656|FG014|Period 4|Protocol Violation|0|||
128984665|NCT01049360|464231657|FG015|Period 4|Protocol Violation|0|||
129208256|NCT01001221|465063252|FG002|Overall Study|Other|0|||
129208257|NCT01001221|465063253|FG003|Overall Study|Other|0|||
129208258|NCT01001221|465063254|FG004|Overall Study|Other|0|||
129208259|NCT01001221|465063250|FG000|Overall Study|Not treated; protocol exclusion|0|||
129208260|NCT01001221|465063251|FG001|Overall Study|Not treated; protocol exclusion|0|||
129208261|NCT01001221|465063252|FG002|Overall Study|Not treated; protocol exclusion|1|||
129208262|NCT01001221|465063253|FG003|Overall Study|Not treated; protocol exclusion|0|||
129208263|NCT01001221|465063254|FG004|Overall Study|Not treated; protocol exclusion|0|||
129208264|NCT01791244|465063256|FG000|Overall Study|Adverse Event|5|||
128984666|NCT01049360|464231658|FG016|Period 4|Protocol Violation|0|||
128984667|NCT01049360|464231659|FG017|Period 4|Protocol Violation|1|||
128984668|NCT01049360|464231660|FG018|Period 4|Protocol Violation|0|||
128984669|NCT01049360|464231661|FG019|Period 4|Protocol Violation|0|||
128984670|NCT01049360|464231642|FG000|Period 4|Withdrawal by Subject|0|||
128984671|NCT01049360|464231643|FG001|Period 4|Withdrawal by Subject|0|||
128984672|NCT01049360|464231644|FG002|Period 4|Withdrawal by Subject|0|||
128984673|NCT01049360|464231645|FG003|Period 4|Withdrawal by Subject|1|||
128984674|NCT01049360|464231646|FG004|Period 4|Withdrawal by Subject|0|||
128984675|NCT01049360|464231647|FG005|Period 4|Withdrawal by Subject|0|||
128984676|NCT01049360|464231648|FG006|Period 4|Withdrawal by Subject|0|||
128984677|NCT01049360|464231649|FG007|Period 4|Withdrawal by Subject|0|||
128984678|NCT01049360|464231650|FG008|Period 4|Withdrawal by Subject|0|||
128984679|NCT01049360|464231651|FG009|Period 4|Withdrawal by Subject|0|||
128984680|NCT01049360|464231652|FG010|Period 4|Withdrawal by Subject|0|||
128984681|NCT01049360|464231653|FG011|Period 4|Withdrawal by Subject|0|||
128984682|NCT01049360|464231654|FG012|Period 4|Withdrawal by Subject|0|||
128984683|NCT01049360|464231655|FG013|Period 4|Withdrawal by Subject|0|||
128984684|NCT01049360|464231656|FG014|Period 4|Withdrawal by Subject|0|||
129208265|NCT01791244|465063257|FG001|Overall Study|Adverse Event|7|||
129208266|NCT01791244|465063256|FG000|Overall Study|Insufficient clinical response|10|||
129208267|NCT01791244|465063257|FG001|Overall Study|Insufficient clinical response|10|||
129208268|NCT01791244|465063256|FG000|Overall Study|Laboratory Abnormality|0|||
128984685|NCT01049360|464231657|FG015|Period 4|Withdrawal by Subject|0|||
128984686|NCT01049360|464231658|FG016|Period 4|Withdrawal by Subject|0|||
128984687|NCT01049360|464231659|FG017|Period 4|Withdrawal by Subject|0|||
128984688|NCT01049360|464231660|FG018|Period 4|Withdrawal by Subject|0|||
128984689|NCT01049360|464231661|FG019|Period 4|Withdrawal by Subject|0|||
128984690|NCT01694849|464231662|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
128984691|NCT01694849|464231663|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
128984692|NCT01694849|464231664|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
128984693|NCT01694849|464231662|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
128984694|NCT01694849|464231663|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
128984695|NCT01694849|464231664|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
128984696|NCT01694849|464231662|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
128984697|NCT01694849|464231663|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
128984698|NCT01694849|464231664|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
128984699|NCT01694849|464231662|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
128984700|NCT01694849|464231663|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
128984701|NCT01694849|464231664|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
128984702|NCT01694849|464231662|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
128984703|NCT01694849|464231663|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
128984704|NCT01694849|464231664|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
128984705|NCT01694849|464231662|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
128984706|NCT01694849|464231663|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
128984707|NCT01694849|464231664|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
128984708|NCT01694849|464231662|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
128984709|NCT01694849|464231663|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
128984710|NCT01694849|464231664|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
128984711|NCT01694849|464231662|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
128984712|NCT01694849|464231663|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
128984713|NCT01694849|464231664|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
128984714|NCT01012765|464231665|FG000|Treatment Period 1|Adverse Event|1|||
128984715|NCT01012765|464231666|FG001|Treatment Period 1|Adverse Event|0|||
128984716|NCT01012765|464231667|FG002|Treatment Period 1|Adverse Event|1|||
128984717|NCT01012765|464231668|FG003|Treatment Period 1|Adverse Event|0|||
128984718|NCT01012765|464231669|FG004|Treatment Period 1|Adverse Event|0|||
128984719|NCT01012765|464231670|FG005|Treatment Period 1|Adverse Event|0|||
128984720|NCT01012765|464231665|FG000|Treatment Period 1|Withdrawal by Subject|2|||
128984721|NCT01012765|464231666|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128984722|NCT01012765|464231667|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128984723|NCT01012765|464231668|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128984724|NCT01012765|464231669|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128984725|NCT01012765|464231670|FG005|Treatment Period 1|Withdrawal by Subject|0|||
128984726|NCT01012765|464231665|FG000|Treatment Period 1|Administrative problems|0|||
128984727|NCT01012765|464231666|FG001|Treatment Period 1|Administrative problems|0|||
128984728|NCT01012765|464231667|FG002|Treatment Period 1|Administrative problems|1|||
128984729|NCT01012765|464231668|FG003|Treatment Period 1|Administrative problems|1|||
128984730|NCT01012765|464231669|FG004|Treatment Period 1|Administrative problems|1|||
128984731|NCT01012765|464231670|FG005|Treatment Period 1|Administrative problems|0|||
128984732|NCT01012765|464231665|FG000|Treatment Period 1|Protocol Violation|0|||
128984733|NCT01012765|464231666|FG001|Treatment Period 1|Protocol Violation|0|||
128984734|NCT01012765|464231667|FG002|Treatment Period 1|Protocol Violation|0|||
128984735|NCT01012765|464231668|FG003|Treatment Period 1|Protocol Violation|2|||
128984736|NCT01012765|464231669|FG004|Treatment Period 1|Protocol Violation|1|||
128984737|NCT01012765|464231670|FG005|Treatment Period 1|Protocol Violation|0|||
128984738|NCT01012765|464231665|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
128984739|NCT01012765|464231666|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
128984740|NCT01012765|464231667|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
128984741|NCT01012765|464231668|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
128984742|NCT01012765|464231669|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
128984743|NCT01012765|464231670|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
128984744|NCT01012765|464231665|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128984745|NCT01012765|464231666|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128984746|NCT01012765|464231667|FG002|Treatment Period 2|Withdrawal by Subject|1|||
128984747|NCT01012765|464231668|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128984748|NCT01012765|464231669|FG004|Treatment Period 2|Withdrawal by Subject|1|||
128984749|NCT01012765|464231670|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128984750|NCT01012765|464231665|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
128984751|NCT01012765|464231666|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
128984752|NCT01012765|464231667|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
128984753|NCT01012765|464231668|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
128984754|NCT01012765|464231669|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
128984755|NCT01012765|464231670|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
128984756|NCT01012765|464231665|FG000|Treatment Period 2|Adverse Event|0|||
128984757|NCT01012765|464231666|FG001|Treatment Period 2|Adverse Event|1|||
128984758|NCT01012765|464231667|FG002|Treatment Period 2|Adverse Event|1|||
128984759|NCT01012765|464231668|FG003|Treatment Period 2|Adverse Event|0|||
129208269|NCT01791244|465063257|FG001|Overall Study|Laboratory Abnormality|1|||
128984760|NCT01012765|464231669|FG004|Treatment Period 2|Adverse Event|0|||
129208270|NCT01383928|465063258|FG000|Overall Study|Initiation of ASCT|2|||
128984761|NCT01012765|464231670|FG005|Treatment Period 2|Adverse Event|0|||
128984762|NCT01012765|464231665|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
128984763|NCT01012765|464231666|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
128984764|NCT01012765|464231667|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
128984765|NCT01012765|464231668|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
128984766|NCT01012765|464231669|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
128984767|NCT01012765|464231670|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
128984768|NCT01326312|464231671|FG000|Overall Study|Adverse Event|11|||
128984769|NCT01326312|464231672|FG001|Overall Study|Adverse Event|11|||
128984770|NCT01326312|464231673|FG002|Overall Study|Adverse Event|1|||
128984771|NCT01326312|464231671|FG000|Overall Study|Withdrawal by Subject|1|||
128984772|NCT01326312|464231672|FG001|Overall Study|Withdrawal by Subject|2|||
128984773|NCT01326312|464231673|FG002|Overall Study|Withdrawal by Subject|1|||
128984774|NCT01326312|464231671|FG000|Overall Study|Protocol Violation|0|||
128984775|NCT01326312|464231672|FG001|Overall Study|Protocol Violation|1|||
128984776|NCT01326312|464231673|FG002|Overall Study|Protocol Violation|0|||
128984777|NCT01326312|464231671|FG000|Overall Study|Lack of Efficacy|13|||
128984778|NCT01326312|464231672|FG001|Overall Study|Lack of Efficacy|7|||
128984779|NCT01326312|464231673|FG002|Overall Study|Lack of Efficacy|1|||
128984780|NCT01326312|464231671|FG000|Overall Study|Death|1|||
128984781|NCT01326312|464231672|FG001|Overall Study|Death|0|||
128984782|NCT01326312|464231673|FG002|Overall Study|Death|1|||
128984783|NCT01326312|464231671|FG000|Overall Study|progressive disease|0|||
128984784|NCT01326312|464231672|FG001|Overall Study|progressive disease|1|||
128984785|NCT01326312|464231673|FG002|Overall Study|progressive disease|1|||
128984786|NCT01326312|464231671|FG000|Overall Study|Study terminated by Sponsor|8|||
128984787|NCT01326312|464231672|FG001|Overall Study|Study terminated by Sponsor|32|||
128984788|NCT01326312|464231673|FG002|Overall Study|Study terminated by Sponsor|46|||
128984789|NCT01326312|464231671|FG000|Overall Study|Treatment arm terminated|19|||
128984790|NCT01326312|464231672|FG001|Overall Study|Treatment arm terminated|0|||
128984791|NCT01326312|464231673|FG002|Overall Study|Treatment arm terminated|0|||
128984792|NCT01326312|464231671|FG000|Overall Study|QTc > 500|0|||
128984793|NCT01326312|464231672|FG001|Overall Study|QTc > 500|1|||
128984794|NCT01326312|464231673|FG002|Overall Study|QTc > 500|0|||
128984795|NCT02219477|464231674|FG000|Overall Study|Adverse Event|0|||
128984796|NCT02219477|464231675|FG001|Overall Study|Adverse Event|1|||
128984797|NCT02219477|464231676|FG002|Overall Study|Adverse Event|1|||
128984798|NCT02219477|464231674|FG000|Overall Study|Withdrawal by Subject|0|||
128984799|NCT02219477|464231675|FG001|Overall Study|Withdrawal by Subject|1|||
128984800|NCT02219477|464231676|FG002|Overall Study|Withdrawal by Subject|0|||
128984801|NCT00499694|464231683|FG000|Overall Study|Patient never received treatment.|1|||
128984802|NCT02304484|464231684|FG000|Overall Study|Death|9|||
128984803|NCT02304484|464231684|FG000|Overall Study|Withdrawal by Subject|14|||
128984804|NCT02304484|464231684|FG000|Overall Study|Lost to Follow-up|2|||
128984805|NCT04338685|464231685|FG000|Overall Study|Death|3|||
128984806|NCT04338685|464231686|FG001|Overall Study|Death|4|||
128984807|NCT04338685|464231687|FG002|Overall Study|Death|2|||
128984808|NCT04338685|464231688|FG003|Overall Study|Death|4|||
128984809|NCT04338685|464231689|FG004|Overall Study|Death|4|||
128984810|NCT04338685|464231690|FG005|Overall Study|Death|8|||
128984811|NCT04338685|464231691|FG006|Overall Study|Death|1|||
128984812|NCT04338685|464231692|FG007|Overall Study|Death|0|||
128984813|NCT04338685|464231693|FG008|Overall Study|Death|0|||
128984814|NCT04338685|464231685|FG000|Overall Study|Study terminated by Sponsor|0|||
128984815|NCT04338685|464231686|FG001|Overall Study|Study terminated by Sponsor|0|||
128984816|NCT04338685|464231687|FG002|Overall Study|Study terminated by Sponsor|1|||
128984817|NCT04338685|464231688|FG003|Overall Study|Study terminated by Sponsor|4|||
128984818|NCT04338685|464231689|FG004|Overall Study|Study terminated by Sponsor|0|||
128984819|NCT04338685|464231690|FG005|Overall Study|Study terminated by Sponsor|5|||
128984820|NCT04338685|464231691|FG006|Overall Study|Study terminated by Sponsor|2|||
128984821|NCT04338685|464231692|FG007|Overall Study|Study terminated by Sponsor|4|||
128984822|NCT04338685|464231693|FG008|Overall Study|Study terminated by Sponsor|1|||
128984823|NCT04338685|464231685|FG000|Overall Study|Withdrawal by Subject|1|||
128984824|NCT04338685|464231686|FG001|Overall Study|Withdrawal by Subject|2|||
128984825|NCT04338685|464231687|FG002|Overall Study|Withdrawal by Subject|0|||
128984826|NCT04338685|464231688|FG003|Overall Study|Withdrawal by Subject|2|||
128984827|NCT04338685|464231689|FG004|Overall Study|Withdrawal by Subject|0|||
128984828|NCT04338685|464231690|FG005|Overall Study|Withdrawal by Subject|5|||
128984829|NCT04338685|464231691|FG006|Overall Study|Withdrawal by Subject|1|||
128984830|NCT04338685|464231692|FG007|Overall Study|Withdrawal by Subject|1|||
128984831|NCT04338685|464231693|FG008|Overall Study|Withdrawal by Subject|0|||
128984832|NCT02967055|464231694|FG000|Overall Study|Excluded|40|||
128984833|NCT02967055|464231694|FG000|Overall Study|Screen fail|3|||
128984834|NCT02967055|464231694|FG000|Overall Study|Lost to Follow-up|2|||
128984835|NCT02967055|464231694|FG000|Overall Study|Stopped due to side effects|3|||
128984836|NCT02967055|464231694|FG000|Overall Study|Stopped due to drug cost|1|||
128984837|NCT00145795|464231695|FG000|Overall Study|Adverse Event|1|||
128984838|NCT00145795|464231696|FG001|Overall Study|Adverse Event|0|||
128984839|NCT00976989|464231697|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
128984840|NCT00976989|464231698|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
128984841|NCT00976989|464231699|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
128984842|NCT00976989|464231697|FG000|Overall Study|Death|5|||
128984843|NCT00976989|464231698|FG001|Overall Study|Death|7|||
128984844|NCT00976989|464231699|FG002|Overall Study|Death|10|||
128984845|NCT00976989|464231697|FG000|Overall Study|Refused Treatment|4|||
128984846|NCT00976989|464231698|FG001|Overall Study|Refused Treatment|3|||
128984847|NCT00976989|464231699|FG002|Overall Study|Refused Treatment|5|||
128984848|NCT00976989|464231697|FG000|Overall Study|Failure to Return|2|||
128984849|NCT00976989|464231698|FG001|Overall Study|Failure to Return|1|||
128984850|NCT00976989|464231699|FG002|Overall Study|Failure to Return|0|||
128984851|NCT00976989|464231697|FG000|Overall Study|Recurrence of Disease|0|||
128984852|NCT00976989|464231698|FG001|Overall Study|Recurrence of Disease|1|||
128984853|NCT00976989|464231699|FG002|Overall Study|Recurrence of Disease|0|||
128984854|NCT00976989|464231697|FG000|Overall Study|Other|1|||
128984855|NCT00976989|464231698|FG001|Overall Study|Other|0|||
128984856|NCT00976989|464231699|FG002|Overall Study|Other|1|||
128984857|NCT00570492|464231700|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
128984858|NCT00570492|464231701|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
128984859|NCT00570492|464231702|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
128984860|NCT00570492|464231700|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
128984861|NCT00570492|464231701|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
128984862|NCT00570492|464231702|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
128984863|NCT00570492|464231700|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
128984864|NCT00570492|464231701|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
128984865|NCT00570492|464231702|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
128984866|NCT00570492|464231700|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
128984867|NCT00570492|464231701|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
128984868|NCT00570492|464231702|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
128984869|NCT00570492|464231700|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
128984870|NCT00570492|464231701|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
128984871|NCT00570492|464231702|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
128984872|NCT00570492|464231700|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
128984873|NCT00570492|464231701|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
128984874|NCT00570492|464231702|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
128984875|NCT00570492|464231700|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
128984876|NCT00570492|464231701|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
128984877|NCT00570492|464231702|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
128984878|NCT00570492|464231700|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
128984879|NCT00570492|464231701|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
128984880|NCT00570492|464231702|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
128984881|NCT00570492|464231700|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
128984882|NCT00570492|464231701|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
128984883|NCT00570492|464231702|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
128984884|NCT00570492|464231700|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
128984885|NCT00570492|464231701|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
128984886|NCT00570492|464231702|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
128984887|NCT00570492|464231700|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
128984888|NCT00570492|464231701|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
128984889|NCT00570492|464231702|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
128984890|NCT00570492|464231700|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
128984891|NCT00570492|464231701|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
128984892|NCT00570492|464231702|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
128984893|NCT00570492|464231700|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
128984894|NCT00570492|464231701|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
128984895|NCT00570492|464231702|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
128984896|NCT00570492|464231700|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
128984897|NCT00570492|464231701|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
128984898|NCT00570492|464231702|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
128984899|NCT03958045|464231704|FG000|Overall Study|Withdrawal by Subject|1|||
128984900|NCT04409262|464231705|FG000|Overall Study|Adverse Event|0|||
128984901|NCT04409262|464231706|FG001|Overall Study|Adverse Event|2|||
128984902|NCT04409262|464231705|FG000|Overall Study|Death|55|||
128984903|NCT04409262|464231706|FG001|Overall Study|Death|97|||
128984904|NCT04409262|464231705|FG000|Overall Study|Lost to Follow-up|12|||
128984905|NCT04409262|464231706|FG001|Overall Study|Lost to Follow-up|23|||
128984906|NCT04409262|464231705|FG000|Overall Study|Lack of Staff|0|||
128984907|NCT04409262|464231706|FG001|Overall Study|Lack of Staff|1|||
129208271|NCT01383928|465063259|FG001|Overall Study|Initiation of ASCT|1|||
129208272|NCT01383928|465063260|FG002|Overall Study|Initiation of ASCT|18|||
128984908|NCT04409262|464231705|FG000|Overall Study|Protocol Violation|3|||
128984909|NCT04409262|464231706|FG001|Overall Study|Protocol Violation|1|||
128984910|NCT04409262|464231705|FG000|Overall Study|Withdrawal by Subject|5|||
129208273|NCT01383928|465063258|FG000|Overall Study|Adverse Event|1|||
128984911|NCT04409262|464231706|FG001|Overall Study|Withdrawal by Subject|10|||
128984912|NCT02500732|464231707|FG000|Overall Study|Physician Decision|0|||
128984913|NCT02500732|464231708|FG001|Overall Study|Physician Decision|1|||
128984914|NCT03759340|464231709|FG000|Overall Study|Adverse Event|2|||
128984915|NCT03759340|464231709|FG000|Overall Study|Lost to Follow-up|1|||
128984916|NCT03759340|464231709|FG000|Overall Study|Withdrawal by Subject|15|||
128984917|NCT03759340|464231709|FG000|Overall Study|Study Terminated by Sponsor|38|||
128984918|NCT03289676|464231710|FG000|Overall Study|Withdrawal by Subject|2|||
128984919|NCT03289676|464231711|FG001|Overall Study|Withdrawal by Subject|0|||
128984920|NCT03289676|464231710|FG000|Overall Study|Protocol Violation|2|||
128984921|NCT03289676|464231711|FG001|Overall Study|Protocol Violation|0|||
128984922|NCT03289676|464231710|FG000|Overall Study|Lost to Follow-up|0|||
128984923|NCT03289676|464231711|FG001|Overall Study|Lost to Follow-up|1|||
128984924|NCT02711306|464231712|FG000|Overall Study|Withdrawal by Subject|2|||
128984925|NCT02711306|464231713|FG001|Overall Study|Withdrawal by Subject|2|||
128984926|NCT02260804|464231720|FG000|Induction Study Period|Protocol Violation|2|||
128984927|NCT02260804|464231721|FG001|Induction Study Period|Protocol Violation|0|||
128984928|NCT02260804|464231720|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
128984929|NCT02260804|464231721|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
128984930|NCT02260804|464231720|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
128984931|NCT02260804|464231721|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
128984932|NCT02260804|464231720|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
128984933|NCT02260804|464231721|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
128984934|NCT02260804|464231720|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
128984935|NCT02260804|464231721|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
128984936|NCT02260804|464231720|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
128984937|NCT02260804|464231721|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
128984938|NCT02260804|464231720|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
128984939|NCT02260804|464231721|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
128984940|NCT02260804|464231720|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
128984941|NCT02260804|464231721|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
128984942|NCT02260804|464231720|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
128984943|NCT02260804|464231721|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
128984944|NCT02260804|464231720|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
128984945|NCT02260804|464231721|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
128984946|NCT02260804|464231720|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
128984947|NCT02260804|464231721|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
128984948|NCT00344968|464232948|FG000|Overall Study|Adverse Event|5|||
128984949|NCT00344968|464232949|FG001|Overall Study|Adverse Event|4|||
128984950|NCT00344968|464232950|FG002|Overall Study|Adverse Event|15|||
128984951|NCT00344968|464232948|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
128984952|NCT00344968|464232949|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
128984953|NCT00344968|464232950|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
128984954|NCT00344968|464232948|FG000|Overall Study|Protocol Violation|2|||
128984955|NCT00344968|464232949|FG001|Overall Study|Protocol Violation|2|||
128984956|NCT00344968|464232950|FG002|Overall Study|Protocol Violation|5|||
128984957|NCT00344968|464232948|FG000|Overall Study|Withdrawal by Subject|14|||
128984958|NCT00344968|464232949|FG001|Overall Study|Withdrawal by Subject|31|||
128984959|NCT00344968|464232950|FG002|Overall Study|Withdrawal by Subject|27|||
128984960|NCT00344968|464232948|FG000|Overall Study|Lost to Follow-up|24|||
128984961|NCT00344968|464232949|FG001|Overall Study|Lost to Follow-up|37|||
128984962|NCT00344968|464232950|FG002|Overall Study|Lost to Follow-up|37|||
128984963|NCT00344968|464232948|FG000|Overall Study|Death|11|||
128984964|NCT00344968|464232949|FG001|Overall Study|Death|27|||
128984965|NCT00344968|464232950|FG002|Overall Study|Death|31|||
128984966|NCT00344968|464232948|FG000|Overall Study|Other|0|||
128984967|NCT00344968|464232949|FG001|Overall Study|Other|1|||
128984968|NCT00344968|464232950|FG002|Overall Study|Other|0|||
128984969|NCT01422876|464232951|FG000|Week 24|Lost to Follow-up|1|||
128984970|NCT01422876|464232952|FG001|Week 24|Lost to Follow-up|1|||
128984971|NCT01422876|464232953|FG002|Week 24|Lost to Follow-up|2|||
128984972|NCT01422876|464232954|FG003|Week 24|Lost to Follow-up|4|||
128984973|NCT01422876|464232955|FG004|Week 24|Lost to Follow-up|2|||
128984974|NCT01422876|464232956|FG005|Week 24|Lost to Follow-up|0|||
128984975|NCT01422876|464232957|FG006|Week 24|Lost to Follow-up|1|||
128984976|NCT01422876|464232958|FG007|Week 24|Lost to Follow-up|3|||
128984977|NCT01422876|464232959|FG008|Week 24|Lost to Follow-up|3|||
128984978|NCT01422876|464232960|FG009|Week 24|Lost to Follow-up|4|||
128984979|NCT01422876|464232951|FG000|Week 24|Consent withdrawn|5|||
128984980|NCT01422876|464232952|FG001|Week 24|Consent withdrawn|1|||
128984981|NCT01422876|464232953|FG002|Week 24|Consent withdrawn|3|||
128984982|NCT01422876|464232954|FG003|Week 24|Consent withdrawn|4|||
128984983|NCT01422876|464232955|FG004|Week 24|Consent withdrawn|5|||
128984984|NCT01422876|464232956|FG005|Week 24|Consent withdrawn|6|||
128984985|NCT01422876|464232957|FG006|Week 24|Consent withdrawn|5|||
128984986|NCT01422876|464232958|FG007|Week 24|Consent withdrawn|4|||
128984987|NCT01422876|464232959|FG008|Week 24|Consent withdrawn|3|||
128984988|NCT01422876|464232960|FG009|Week 24|Consent withdrawn|6|||
128984989|NCT01422876|464232951|FG000|Week 24|Death|0|||
128984990|NCT01422876|464232952|FG001|Week 24|Death|1|||
128984991|NCT01422876|464232953|FG002|Week 24|Death|0|||
128984992|NCT01422876|464232954|FG003|Week 24|Death|0|||
128984993|NCT01422876|464232955|FG004|Week 24|Death|0|||
128984994|NCT01422876|464232956|FG005|Week 24|Death|0|||
128984995|NCT01422876|464232957|FG006|Week 24|Death|0|||
128984996|NCT01422876|464232958|FG007|Week 24|Death|0|||
128984997|NCT01422876|464232959|FG008|Week 24|Death|0|||
128984998|NCT01422876|464232960|FG009|Week 24|Death|0|||
128984999|NCT01422876|464232951|FG000|Week 52|Lost to Follow-up|3|||
128985000|NCT01422876|464232952|FG001|Week 52|Lost to Follow-up|5|||
128985001|NCT01422876|464232953|FG002|Week 52|Lost to Follow-up|7|||
128985002|NCT01422876|464232954|FG003|Week 52|Lost to Follow-up|5|||
128985003|NCT01422876|464232955|FG004|Week 52|Lost to Follow-up|8|||
128985004|NCT01422876|464232956|FG005|Week 52|Lost to Follow-up|5|||
128985005|NCT01422876|464232957|FG006|Week 52|Lost to Follow-up|5|||
128985006|NCT01422876|464232958|FG007|Week 52|Lost to Follow-up|8|||
128985007|NCT01422876|464232959|FG008|Week 52|Lost to Follow-up|7|||
128985008|NCT01422876|464232960|FG009|Week 52|Lost to Follow-up|8|||
128985009|NCT01422876|464232951|FG000|Week 52|Consent withdrawn|9|||
128985010|NCT01422876|464232952|FG001|Week 52|Consent withdrawn|4|||
128985011|NCT01422876|464232953|FG002|Week 52|Consent withdrawn|6|||
128985012|NCT01422876|464232954|FG003|Week 52|Consent withdrawn|12|||
128985013|NCT01422876|464232955|FG004|Week 52|Consent withdrawn|7|||
128985014|NCT01422876|464232956|FG005|Week 52|Consent withdrawn|12|||
128985015|NCT01422876|464232957|FG006|Week 52|Consent withdrawn|10|||
128985016|NCT01422876|464232958|FG007|Week 52|Consent withdrawn|12|||
128985017|NCT01422876|464232959|FG008|Week 52|Consent withdrawn|13|||
128985018|NCT01422876|464232960|FG009|Week 52|Consent withdrawn|9|||
128985019|NCT01422876|464232951|FG000|Week 52|Death|0|||
128985020|NCT01422876|464232952|FG001|Week 52|Death|1|||
128985021|NCT01422876|464232953|FG002|Week 52|Death|0|||
128985022|NCT01422876|464232954|FG003|Week 52|Death|1|||
128985023|NCT01422876|464232955|FG004|Week 52|Death|0|||
128985024|NCT01422876|464232956|FG005|Week 52|Death|0|||
128985025|NCT01422876|464232957|FG006|Week 52|Death|1|||
128985026|NCT01422876|464232958|FG007|Week 52|Death|3|||
128985027|NCT01422876|464232959|FG008|Week 52|Death|1|||
128985028|NCT01422876|464232960|FG009|Week 52|Death|0|||
128985029|NCT00536991|464232969|FG000|Overall Study|Withdrawal by Subject|10|||
128985030|NCT00536991|464232969|FG000|Overall Study|Physician Decision|1|||
128985031|NCT00536991|464232969|FG000|Overall Study|patient ineligible|2|||
128985032|NCT00054639|464232970|FG000|Overall Study|Lack of Efficacy|1|||
128985033|NCT00054639|464232970|FG000|Overall Study|Physician Decision|1|||
128985034|NCT01600755|464232971|FG000|Overall Study|Withdrawal by Subject|6|||
128985035|NCT04621227|464232980|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
128985036|NCT04621227|464232980|FG000|Period 3 (29 Days)|Adverse Event|1|||
128985037|NCT04621227|464232980|FG000|Period 8 (2 Days)|Adverse Event|1|||
128985038|NCT02204449|464232983|FG000|Overall Study|Lost to Follow-up|7|||
128985039|NCT02204449|464232984|FG001|Overall Study|Lost to Follow-up|9|||
128985040|NCT02204449|464232983|FG000|Overall Study|Death|0|||
128985041|NCT02204449|464232984|FG001|Overall Study|Death|1|||
128985042|NCT02204449|464232983|FG000|Overall Study|Withdrawal by Subject|0|||
128985043|NCT02204449|464232984|FG001|Overall Study|Withdrawal by Subject|1|||
128985044|NCT01342445|464232985|FG000|Overall Study|Experienced side effects|0|||
128985045|NCT01342445|464232986|FG001|Overall Study|Experienced side effects|2|||
128985046|NCT05299359|464232987|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
128985047|NCT05299359|464232988|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
128985048|NCT05299359|464232987|FG000|Main Part: Day 1 up to Day 366|Other|2|||
128985049|NCT05299359|464232988|FG001|Main Part: Day 1 up to Day 366|Other|0|||
128985050|NCT05299359|464232987|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
128985051|NCT05299359|464232988|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
128985052|NCT05299359|464232987|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
128985053|NCT05299359|464232988|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
128985054|NCT05299359|464232987|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
128985055|NCT05299359|464232988|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
128985056|NCT05299359|464232987|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
128985057|NCT05299359|464232988|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
128985058|NCT05299359|464232987|FG000|Extension Part: Day 1 to Day 366|Other|0|||
128985059|NCT05299359|464232988|FG001|Extension Part: Day 1 to Day 366|Other|1|||
129098614|NCT04015518|464652409|FG000|Overall Study|Patient did not come for consecutive visits|0|||
128985060|NCT02392078|464232989|FG000|Overall Study|Did not have procedure|32|||
128985061|NCT02392078|464232990|FG001|Overall Study|Did not have procedure|43|||
128985062|NCT02392078|464232991|FG002|Overall Study|Did not have procedure|20|||
128985063|NCT02392078|464232992|FG003|Overall Study|Did not have procedure|1|||
128985064|NCT02652793|464232995|FG000|Overall Study|Adverse Event|1|||
128985065|NCT02652793|464232995|FG000|Overall Study|Lost to Follow-up|2|||
128985066|NCT02652793|464232995|FG000|Overall Study|Withdrawal by Subject|1|||
128985067|NCT03868410|464232996|FG000|Overall Study|Physician Decision|0|||
128985068|NCT03868410|464232997|FG001|Overall Study|Physician Decision|1|||
128985069|NCT01059175|464232998|FG000|Overall Study|Death|17|||
128985070|NCT01059175|464232999|FG001|Overall Study|Death|17|||
128985071|NCT01059175|464232998|FG000|Overall Study|Adverse Event|4|||
128985072|NCT01059175|464232999|FG001|Overall Study|Adverse Event|2|||
128985073|NCT01059175|464232998|FG000|Overall Study|Lost to Follow-up|0|||
128985074|NCT01059175|464232999|FG001|Overall Study|Lost to Follow-up|1|||
128985075|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Adverse Event|4|||
128985076|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Adverse Event|3|||
128985077|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Adverse Event|0|||
128985078|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Adverse Event|0|||
128985079|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Death|24|||
128985080|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Death|9|||
128985081|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Death|0|||
128985082|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Death|0|||
128985083|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
128985084|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
128985085|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
128985086|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
128985087|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Physician Decision|4|||
128985088|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Physician Decision|1|||
128985089|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Physician Decision|0|||
128985090|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Physician Decision|0|||
128985091|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Progressive disease|1|||
128985092|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Progressive disease|0|||
128985093|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Progressive disease|0|||
128985094|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Progressive disease|0|||
128985095|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
128985096|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
128985097|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
128985098|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
128985099|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
128985100|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
128985101|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
128985102|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
128985103|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
128985104|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
128985105|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
128985106|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
128985107|NCT04579666|464233000|FG000|RTP (Up to Week 52)|Other|2|||
128985108|NCT04579666|464233001|FG001|RTP (Up to Week 52)|Other|0|||
128985109|NCT04579666|464233002|FG002|RTP (Up to Week 52)|Other|0|||
128985110|NCT04579666|464233003|FG003|RTP (Up to Week 52)|Other|0|||
128985111|NCT04579666|464233000|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
128985112|NCT04579666|464233001|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
128985113|NCT04579666|464233002|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
128985114|NCT04579666|464233003|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
128985115|NCT04579666|464233000|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
128985116|NCT04579666|464233001|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
128985117|NCT04579666|464233002|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
128985118|NCT04579666|464233003|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
128985119|NCT04579666|464233000|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
128985120|NCT04579666|464233001|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
128985121|NCT04579666|464233002|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
128985122|NCT04579666|464233003|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
128985123|NCT04579666|464233000|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
129208274|NCT01383928|465063259|FG001|Overall Study|Adverse Event|2|||
129208275|NCT01383928|465063260|FG002|Overall Study|Adverse Event|8|||
129208276|NCT01383928|465063258|FG000|Overall Study|Other|1|||
129208277|NCT01383928|465063259|FG001|Overall Study|Other|3|||
129208278|NCT01383928|465063260|FG002|Overall Study|Other|4|||
129208279|NCT01383928|465063258|FG000|Overall Study|Progressive Disease|1|||
129208280|NCT01383928|465063259|FG001|Overall Study|Progressive Disease|1|||
129208281|NCT01383928|465063260|FG002|Overall Study|Progressive Disease|5|||
128985124|NCT04579666|464233001|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
128985125|NCT04579666|464233002|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
128985126|NCT04579666|464233003|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
128985127|NCT04579666|464233000|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
128985128|NCT04579666|464233001|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
128985129|NCT04579666|464233002|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
128985130|NCT04579666|464233003|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
128985131|NCT05450198|464233004|FG000|Overall Study|Withdrawal by Subject|1|||
129208282|NCT01383928|465063258|FG000|Overall Study|Withdrawal by Subject|0|||
129208283|NCT01383928|465063259|FG001|Overall Study|Withdrawal by Subject|0|||
129208284|NCT01383928|465063260|FG002|Overall Study|Withdrawal by Subject|4|||
129208285|NCT01383928|465063258|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
129208286|NCT01383928|465063259|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
129208287|NCT01383928|465063260|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
129208288|NCT01149096|465063262|FG000|Overall Study|Lost to Follow-up|0|||
129208289|NCT01149096|465063263|FG001|Overall Study|Lost to Follow-up|1|||
129208290|NCT03651765|465063267|FG000|Overall Study|Adverse Event|6|||
129208291|NCT03651765|465063267|FG000|Overall Study|Lack of Efficacy|18|||
129208292|NCT03651765|465063267|FG000|Overall Study|Lost to Follow-up|5|||
128985132|NCT05450198|464233005|FG001|Overall Study|Withdrawal by Subject|1|||
128985133|NCT05450198|464233006|FG002|Overall Study|Withdrawal by Subject|2|||
128985134|NCT05450198|464233007|FG003|Overall Study|Withdrawal by Subject|0|||
128985135|NCT05450198|464233004|FG000|Overall Study|Lost to Follow-up|1|||
128985136|NCT05450198|464233005|FG001|Overall Study|Lost to Follow-up|0|||
128985137|NCT05450198|464233006|FG002|Overall Study|Lost to Follow-up|2|||
128985138|NCT05450198|464233007|FG003|Overall Study|Lost to Follow-up|1|||
128985139|NCT01243762|464233017|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
128985140|NCT01243762|464233018|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
129208293|NCT03651765|465063267|FG000|Overall Study|Non-Compliance with Study Drug|4|||
129208294|NCT03651765|465063267|FG000|Overall Study|Physician Decision|6|||
129208295|NCT03651765|465063267|FG000|Overall Study|Pregnancy|1|||
129208296|NCT03651765|465063267|FG000|Overall Study|Discontinued by Sponsor|40|||
128985141|NCT01243762|464233019|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
128985142|NCT01243762|464233020|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
128985143|NCT01243762|464233021|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
128985144|NCT01243762|464233022|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
128985145|NCT01243762|464233023|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
128985146|NCT01243762|464233017|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
128985147|NCT01243762|464233018|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
128985148|NCT01243762|464233019|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
128985149|NCT01243762|464233020|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
128985150|NCT01243762|464233021|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
128985151|NCT01243762|464233022|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
128985152|NCT01243762|464233023|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
128985153|NCT01243762|464233017|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
128985154|NCT01243762|464233018|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
128985155|NCT01243762|464233019|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
128985156|NCT01243762|464233020|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
128985157|NCT01243762|464233021|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
128985158|NCT01243762|464233022|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
128985159|NCT01243762|464233023|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
128985160|NCT01243762|464233017|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
128985161|NCT01243762|464233018|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
128985162|NCT01243762|464233019|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
128985163|NCT01243762|464233020|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
128985164|NCT01243762|464233021|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
128985165|NCT01243762|464233022|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
128985166|NCT01243762|464233023|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
128985167|NCT01243762|464233017|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
128985168|NCT01243762|464233018|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
128985169|NCT01243762|464233019|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
128985170|NCT01243762|464233020|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
128985171|NCT01243762|464233021|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
128985172|NCT01243762|464233022|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
128985173|NCT01243762|464233023|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
128985174|NCT01243762|464233017|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
128985175|NCT01243762|464233018|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
128985176|NCT01243762|464233019|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
128985177|NCT01243762|464233020|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
128985178|NCT01243762|464233021|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
128985179|NCT01243762|464233022|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
128985180|NCT01243762|464233023|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
129208297|NCT03651765|465063267|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
129208298|NCT03651765|465063267|FG000|Overall Study|Withdrawal by Subject|24|||
128985181|NCT01243762|464233017|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
128985182|NCT01243762|464233018|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
128985183|NCT01243762|464233019|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
129208299|NCT03651765|465063267|FG000|Overall Study|Miscellaneous|6|||
129208300|NCT05058365|465063273|FG000|Overall Study|Migration|1|||
129208301|NCT05058365|465063274|FG001|Overall Study|Migration|1|||
129208302|NCT04038359|465063275|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
128985184|NCT01243762|464233020|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
128985185|NCT01243762|464233021|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
128985186|NCT01243762|464233022|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
128985187|NCT01243762|464233023|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
128985188|NCT01243762|464233017|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
128985189|NCT01243762|464233018|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
128985190|NCT01243762|464233019|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
128985191|NCT01243762|464233020|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
128985192|NCT01243762|464233021|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
128985193|NCT01243762|464233022|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
128985194|NCT01243762|464233023|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
128985195|NCT02059265|464233024|FG000|Overall Study|Ineligible|4|||
128985196|NCT04359758|464233029|FG000|Overall Study|Protocol Violation|3|||
128985197|NCT04359758|464233030|FG001|Overall Study|Protocol Violation|2|||
128985198|NCT03605758|464233031|FG000|Overall Study|Lost to Follow-up|2|||
128985199|NCT03605758|464233032|FG001|Overall Study|Lost to Follow-up|1|||
128985200|NCT03605758|464233031|FG000|Overall Study|Illness|0|||
128985201|NCT03605758|464233032|FG001|Overall Study|Illness|1|||
128985202|NCT03605758|464233031|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
128985203|NCT03605758|464233032|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
128985204|NCT04753606|464233033|FG000|Overall Study|Adverse Event|1|||
128985205|NCT04753606|464233034|FG001|Overall Study|Adverse Event|0|||
128985206|NCT04753606|464233035|FG002|Overall Study|Adverse Event|0|||
128985207|NCT00489411|464233036|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
128985208|NCT00489411|464233037|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
128985209|NCT00489411|464233036|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
128985210|NCT00489411|464233037|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
128985211|NCT00489411|464233036|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
128985212|NCT00489411|464233037|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
128985213|NCT00489411|464233036|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
128985214|NCT00489411|464233037|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
128985215|NCT00489411|464233036|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
128985216|NCT00489411|464233037|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
128985217|NCT01748162|464233038|FG000|Overall Study|no additional croup episodes to evaluate|2|||
128985218|NCT01748162|464233039|FG001|Overall Study|no additional croup episodes to evaluate|2|||
128985219|NCT01748162|464233038|FG000|Overall Study|participant consented but did not begin|0|||
128985220|NCT01748162|464233039|FG001|Overall Study|participant consented but did not begin|1|||
128985221|NCT01748162|464233038|FG000|Overall Study|reasons not available|3|||
128985222|NCT01748162|464233039|FG001|Overall Study|reasons not available|2|||
128985223|NCT03841331|464233040|FG000|Overall Study|Withdrawal by Subject|4|||
128985224|NCT03841331|464233041|FG001|Overall Study|Withdrawal by Subject|9|||
128985225|NCT03841331|464233040|FG000|Overall Study|Lost to Follow-up|5|||
128985226|NCT03841331|464233041|FG001|Overall Study|Lost to Follow-up|1|||
128985227|NCT02743117|464233042|FG000|Overall Study|Lost to Follow-up|0|||
128985228|NCT02743117|464233043|FG001|Overall Study|Lost to Follow-up|1|||
128985229|NCT02743117|464233042|FG000|Overall Study|Other|1|||
128985230|NCT02743117|464233043|FG001|Overall Study|Other|0|||
128985231|NCT01207219|464233044|FG000|Overall Study|changed diagnosis during study period|5|||
128985232|NCT01207219|464233045|FG001|Overall Study|changed diagnosis during study period|3|||
128985233|NCT01207219|464233046|FG002|Overall Study|changed diagnosis during study period|1|||
128985234|NCT01207219|464233044|FG000|Overall Study|Lost to Follow-up|6|||
128985235|NCT01207219|464233045|FG001|Overall Study|Lost to Follow-up|8|||
128985236|NCT01207219|464233046|FG002|Overall Study|Lost to Follow-up|6|||
128985237|NCT03532048|464233049|FG000|Overall Study|Lost to Follow-up|12|||
128985238|NCT03532048|464233050|FG001|Overall Study|Lost to Follow-up|17|||
128985239|NCT03532048|464233049|FG000|Overall Study|Withdrawal by Subject|7|||
128985240|NCT03532048|464233050|FG001|Overall Study|Withdrawal by Subject|0|||
128985241|NCT01901393|464233053|FG000|Overall Study|Adverse Event|1|||
128985242|NCT01901393|464233054|FG001|Overall Study|Adverse Event|0|||
128985243|NCT00596466|464233059|FG000|Overall Study|Lack of Efficacy|5|||
128985244|NCT00596466|464233059|FG000|Overall Study|Adverse Event|4|||
128985245|NCT00596466|464233059|FG000|Overall Study|Withdrawal by Subject|2|||
128985246|NCT00596466|464233059|FG000|Overall Study|Protocol Violation|2|||
128985247|NCT00596466|464233059|FG000|Overall Study|Unpecified|2|||
128985248|NCT00596466|464233059|FG000|Overall Study|Enrolled, not treated|2|||
128985249|NCT00908375|464233060|FG000|Overall Study|Withdrawal by Subject|2|||
128985250|NCT00908375|464233061|FG001|Overall Study|Withdrawal by Subject|4|||
128985251|NCT00908375|464233060|FG000|Overall Study|Lost to Follow-up|8|||
128985252|NCT00908375|464233061|FG001|Overall Study|Lost to Follow-up|6|||
128985253|NCT00752206|464233062|FG000|Overall Study|Disease progression|8|||
128985254|NCT00752206|464233063|FG001|Overall Study|Disease progression|11|||
128985255|NCT00752206|464233062|FG000|Overall Study|Pregnancy|1|||
128985256|NCT00752206|464233063|FG001|Overall Study|Pregnancy|0|||
128985257|NCT00678652|464233064|FG000|Overall Study|Protocol Violation|2|||
128985258|NCT00678652|464233065|FG001|Overall Study|Protocol Violation|0|||
128985259|NCT00678652|464233066|FG002|Overall Study|Protocol Violation|0|||
128985260|NCT00678652|464233067|FG003|Overall Study|Protocol Violation|0|||
128985261|NCT00678652|464233064|FG000|Overall Study|Pregnancy|0|||
128985262|NCT00678652|464233065|FG001|Overall Study|Pregnancy|0|||
128985263|NCT00678652|464233066|FG002|Overall Study|Pregnancy|1|||
128985264|NCT00678652|464233067|FG003|Overall Study|Pregnancy|0|||
128985265|NCT00678652|464233064|FG000|Overall Study|Relocation|1|||
128985266|NCT00678652|464233065|FG001|Overall Study|Relocation|0|||
128985267|NCT00678652|464233066|FG002|Overall Study|Relocation|0|||
128985268|NCT00678652|464233067|FG003|Overall Study|Relocation|0|||
128985269|NCT02283411|464233070|FG000|Overall Study|Withdrawal by Subject|3|||
128985270|NCT02283411|464233070|FG000|Overall Study|Screen Failed|28|||
128985271|NCT01298323|464233072|FG000|Overall Study|Adverse Event|2|||
128985272|NCT01298323|464233073|FG001|Overall Study|Adverse Event|4|||
128985273|NCT01298323|464233072|FG000|Overall Study|Death|11|||
128985274|NCT01298323|464233073|FG001|Overall Study|Death|16|||
128985275|NCT01298323|464233072|FG000|Overall Study|Lost to Follow-up|1|||
128985276|NCT01298323|464233073|FG001|Overall Study|Lost to Follow-up|0|||
128985277|NCT01298323|464233072|FG000|Overall Study|Withdrawal by Subject|6|||
128985278|NCT01298323|464233073|FG001|Overall Study|Withdrawal by Subject|3|||
128985279|NCT01298323|464233072|FG000|Overall Study|Protocol Violation|1|||
128985280|NCT01298323|464233073|FG001|Overall Study|Protocol Violation|0|||
128985281|NCT01298323|464233072|FG000|Overall Study|Other|10|||
128985282|NCT01298323|464233073|FG001|Overall Study|Other|9|||
128985283|NCT01298323|464233072|FG000|Overall Study|Ongoing|55|||
128985284|NCT01298323|464233073|FG001|Overall Study|Ongoing|55|||
128985285|NCT01298323|464233072|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128985286|NCT01298323|464233073|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
128985287|NCT02396849|464233075|FG000|Overall Study|Lost to Follow-up|1|||
128985288|NCT02396849|464233076|FG001|Overall Study|Lost to Follow-up|1|||
128985289|NCT02396849|464233075|FG000|Overall Study|Did not tolerate intervention|1|||
128985290|NCT02396849|464233076|FG001|Overall Study|Did not tolerate intervention|1|||
128985291|NCT04794491|464233081|FG000|Overall Study|Adverse Event|1|||
128985292|NCT04794491|464233081|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
128985293|NCT04794491|464233081|FG000|Overall Study|Noncompliance With Study Intervention|1|||
128985294|NCT04794491|464233081|FG000|Overall Study|Withdrawal by Subject|2|||
128985295|NCT00931515|464233082|FG000|Overall Study|Lost to Follow-up|2|||
128985296|NCT00931515|464233083|FG001|Overall Study|Lost to Follow-up|5|||
128985297|NCT02950831|464233084|FG000|Overall Study|Lost to Follow-up|1|||
128985298|NCT02950831|464233084|FG000|Overall Study|Withdrawal by Subject|3|||
128985299|NCT02950831|464233084|FG000|Overall Study|stimulation trail failure|5|||
128985300|NCT01965600|464233085|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
128985301|NCT01965600|464233086|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
128985302|NCT01965600|464233087|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
128985303|NCT01965600|464233088|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
128985304|NCT01965600|464233085|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
128985305|NCT01965600|464233086|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
128985306|NCT01965600|464233087|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
128985307|NCT01965600|464233088|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
128985308|NCT01965600|464233085|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
128985309|NCT01965600|464233086|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
128985310|NCT01965600|464233087|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
128985311|NCT01965600|464233088|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
128985312|NCT01965600|464233085|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
128985313|NCT01965600|464233086|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
128985314|NCT01965600|464233087|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
128985315|NCT01965600|464233088|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
128985316|NCT01965600|464233085|FG000|Second Intervention|Study terminated by Sponsor|0|||
128985317|NCT01965600|464233086|FG001|Second Intervention|Study terminated by Sponsor|0|||
128985318|NCT01965600|464233087|FG002|Second Intervention|Study terminated by Sponsor|2|||
128985319|NCT01965600|464233088|FG003|Second Intervention|Study terminated by Sponsor|2|||
128985320|NCT03418727|464233096|FG000|Overall Study|Adverse Event|1|||
128985321|NCT03418727|464233097|FG001|Overall Study|Adverse Event|2|||
128985322|NCT03418727|464233098|FG002|Overall Study|Adverse Event|0|||
128985323|NCT03418727|464233096|FG000|Overall Study|Withdrawal by Subject|0|||
128985324|NCT03418727|464233097|FG001|Overall Study|Withdrawal by Subject|0|||
128985325|NCT03418727|464233098|FG002|Overall Study|Withdrawal by Subject|2|||
128985326|NCT00686894|464233103|FG000|Overall Study|Relapse|2|||
128985327|NCT00686894|464233103|FG000|Overall Study|Protocol Violation|4|||
128985328|NCT01396434|464233104|FG000|Overall Study|Lost to Follow-up|1|||
128985329|NCT01396434|464233105|FG001|Overall Study|Lost to Follow-up|0|||
128985330|NCT01396434|464233106|FG002|Overall Study|Lost to Follow-up|0|||
128985331|NCT01396434|464233104|FG000|Overall Study|Other|10|||
128985332|NCT01396434|464233105|FG001|Overall Study|Other|0|||
128985333|NCT01396434|464233106|FG002|Overall Study|Other|0|||
128985334|NCT04678557|464233107|FG000|Overall Study|Withdrawal by Subject|1|||
128985335|NCT04678557|464233108|FG001|Overall Study|Withdrawal by Subject|0|||
128985336|NCT04678557|464233107|FG000|Overall Study|Lack of Efficacy|0|||
128985337|NCT04678557|464233108|FG001|Overall Study|Lack of Efficacy|13|||
128985338|NCT04678557|464233107|FG000|Overall Study|Safety Evaluation|0|||
128985339|NCT04678557|464233108|FG001|Overall Study|Safety Evaluation|1|||
128985340|NCT02207413|464233109|FG000|Overall Study|Withdrawal by Subject|1|||
128985341|NCT02207413|464233110|FG001|Overall Study|Withdrawal by Subject|0|||
128985342|NCT02207413|464233111|FG002|Overall Study|Withdrawal by Subject|0|||
128985343|NCT02207413|464233112|FG003|Overall Study|Withdrawal by Subject|0|||
128985344|NCT02207413|464233113|FG004|Overall Study|Withdrawal by Subject|3|||
128985345|NCT02207413|464233114|FG005|Overall Study|Withdrawal by Subject|7|||
128985346|NCT02207413|464233109|FG000|Overall Study|Lost to Follow-up|0|||
128985347|NCT02207413|464233110|FG001|Overall Study|Lost to Follow-up|0|||
128985348|NCT02207413|464233111|FG002|Overall Study|Lost to Follow-up|0|||
128985349|NCT02207413|464233112|FG003|Overall Study|Lost to Follow-up|1|||
128985350|NCT02207413|464233113|FG004|Overall Study|Lost to Follow-up|1|||
128985351|NCT02207413|464233114|FG005|Overall Study|Lost to Follow-up|5|||
128985352|NCT02207413|464233109|FG000|Overall Study|Adverse Event|0|||
128985353|NCT02207413|464233110|FG001|Overall Study|Adverse Event|0|||
128985354|NCT02207413|464233111|FG002|Overall Study|Adverse Event|0|||
128985355|NCT02207413|464233112|FG003|Overall Study|Adverse Event|0|||
128985356|NCT02207413|464233113|FG004|Overall Study|Adverse Event|2|||
128985357|NCT02207413|464233114|FG005|Overall Study|Adverse Event|1|||
128985358|NCT02207413|464233109|FG000|Overall Study|Migrated/moved from study area|0|||
128985359|NCT02207413|464233110|FG001|Overall Study|Migrated/moved from study area|0|||
128985360|NCT02207413|464233111|FG002|Overall Study|Migrated/moved from study area|0|||
128985361|NCT02207413|464233112|FG003|Overall Study|Migrated/moved from study area|0|||
128985362|NCT02207413|464233113|FG004|Overall Study|Migrated/moved from study area|1|||
128985363|NCT02207413|464233114|FG005|Overall Study|Migrated/moved from study area|0|||
128985364|NCT02513732|464235153|FG000|Overall Study|Lost to Follow-up|11|||
128985365|NCT02513732|464235153|FG000|Overall Study|Death|9|||
128985366|NCT02513732|464235153|FG000|Overall Study|Changing hospital|2|||
128985367|NCT01740297|464235154|FG000|Overall Study|Withdrawal by Subject|4|||
128985368|NCT01740297|464235155|FG001|Overall Study|Withdrawal by Subject|16|||
128985369|NCT01740297|464235156|FG002|Overall Study|Withdrawal by Subject|17|||
128985370|NCT01740297|464235154|FG000|Overall Study|Death|8|||
128985371|NCT01740297|464235155|FG001|Overall Study|Death|46|||
128985372|NCT01740297|464235156|FG002|Overall Study|Death|40|||
128985373|NCT01740297|464235154|FG000|Overall Study|Lost to Follow-up|1|||
128985374|NCT01740297|464235155|FG001|Overall Study|Lost to Follow-up|2|||
128985375|NCT01740297|464235156|FG002|Overall Study|Lost to Follow-up|4|||
128985376|NCT00761462|464235161|FG000|Treatment|Subjects never received study medication|23|||
128985377|NCT00761462|464235162|FG001|Treatment|Subjects never received study medication|12|||
128985378|NCT00761462|464235161|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
128985379|NCT00761462|464235162|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
128985380|NCT00761462|464235161|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
128985381|NCT00761462|464235162|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
128985382|NCT00761462|464235161|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
128985383|NCT00761462|464235162|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
128985384|NCT01479777|464235163|FG000|Overall Study|Physician Decision|2|||
128985385|NCT01013207|464235167|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
128985386|NCT01541644|464235172|FG000|Overall Study|Withdrawal by Subject|3|||
128985387|NCT02389621|464235175|FG000|Treatment Period|Withdrawal by Subject|1|||
128985388|NCT02389621|464235176|FG001|Treatment Period|Withdrawal by Subject|1|||
128985389|NCT02389621|464235175|FG000|Posttreatment Period|Adverse Event|3|||
128985390|NCT02389621|464235176|FG001|Posttreatment Period|Adverse Event|1|||
128985391|NCT02389621|464235175|FG000|Posttreatment Period|Withdrawal by Subject|3|||
128985392|NCT02389621|464235176|FG001|Posttreatment Period|Withdrawal by Subject|2|||
128985393|NCT02389621|464235175|FG000|Posttreatment Period|Lost to Follow-up|1|||
128985394|NCT02389621|464235176|FG001|Posttreatment Period|Lost to Follow-up|1|||
129208303|NCT04038359|465063276|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
128985395|NCT02389621|464235175|FG000|Posttreatment Period|Other - Miscellaneous|2|||
128985396|NCT02389621|464235176|FG001|Posttreatment Period|Other - Miscellaneous|0|||
128985397|NCT00953017|464235194|FG000|Overall Study|DId not show up for colonoscopy|4|||
128985398|NCT00953017|464235195|FG001|Overall Study|DId not show up for colonoscopy|4|||
129208304|NCT04038359|465063275|FG000|Overall Study|Death|8|||
129208305|NCT04038359|465063276|FG001|Overall Study|Death|7|||
128985399|NCT00953017|464235196|FG002|Overall Study|DId not show up for colonoscopy|5|||
128985400|NCT00953017|464235197|FG003|Overall Study|DId not show up for colonoscopy|4|||
128985401|NCT00953017|464235194|FG000|Overall Study|Incomplete data|1|||
128985402|NCT00953017|464235195|FG001|Overall Study|Incomplete data|1|||
128985403|NCT00953017|464235196|FG002|Overall Study|Incomplete data|0|||
128985404|NCT00953017|464235197|FG003|Overall Study|Incomplete data|0|||
128985405|NCT00953017|464235194|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
128985406|NCT00953017|464235195|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
128985407|NCT00953017|464235196|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
128985408|NCT00953017|464235197|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
128985409|NCT00953017|464235194|FG000|Overall Study|Brown stool prior to procedure|0|||
128985410|NCT00953017|464235195|FG001|Overall Study|Brown stool prior to procedure|0|||
128985411|NCT00953017|464235196|FG002|Overall Study|Brown stool prior to procedure|1|||
128985412|NCT00953017|464235197|FG003|Overall Study|Brown stool prior to procedure|0|||
128985413|NCT00718809|464235200|FG000|Overall Study|Disease progression|9|||
128985414|NCT00718809|464235201|FG001|Overall Study|Disease progression|7|||
128985415|NCT00718809|464235200|FG000|Overall Study|Adverse Event|1|||
128985416|NCT00718809|464235201|FG001|Overall Study|Adverse Event|1|||
128985417|NCT00718809|464235200|FG000|Overall Study|Withdrawal by Subject|0|||
128985418|NCT00718809|464235201|FG001|Overall Study|Withdrawal by Subject|1|||
128985419|NCT00718809|464235200|FG000|Overall Study|Lost to Follow-up|1|||
128985420|NCT00718809|464235201|FG001|Overall Study|Lost to Follow-up|0|||
128985421|NCT00718809|464235200|FG000|Overall Study|Noncompliance|1|||
128985422|NCT00718809|464235201|FG001|Overall Study|Noncompliance|0|||
128985423|NCT00463385|464235202|FG000|Overall Study|Other|4|||
128985424|NCT00463385|464235203|FG001|Overall Study|Other|3|||
128985425|NCT00463385|464235204|FG002|Overall Study|Other|6|||
128985426|NCT00463385|464235205|FG003|Overall Study|Other|4|||
128985427|NCT00463385|464235202|FG000|Overall Study|Adverse Event|5|||
128985428|NCT00463385|464235203|FG001|Overall Study|Adverse Event|8|||
128985429|NCT00463385|464235204|FG002|Overall Study|Adverse Event|4|||
128985430|NCT00463385|464235205|FG003|Overall Study|Adverse Event|2|||
128985431|NCT00463385|464235202|FG000|Overall Study|Lack of Efficacy|6|||
128985432|NCT00463385|464235203|FG001|Overall Study|Lack of Efficacy|6|||
128985433|NCT00463385|464235204|FG002|Overall Study|Lack of Efficacy|7|||
128985434|NCT00463385|464235205|FG003|Overall Study|Lack of Efficacy|9|||
128985435|NCT00463385|464235202|FG000|Overall Study|Withdrawal by Subject|3|||
128985436|NCT00463385|464235203|FG001|Overall Study|Withdrawal by Subject|3|||
128985437|NCT00463385|464235204|FG002|Overall Study|Withdrawal by Subject|3|||
128985438|NCT00463385|464235205|FG003|Overall Study|Withdrawal by Subject|4|||
128985439|NCT00463385|464235202|FG000|Overall Study|Lost to Follow-up|0|||
128985440|NCT00463385|464235203|FG001|Overall Study|Lost to Follow-up|0|||
128985441|NCT00463385|464235204|FG002|Overall Study|Lost to Follow-up|0|||
128985442|NCT00463385|464235205|FG003|Overall Study|Lost to Follow-up|1|||
128985443|NCT00463385|464235202|FG000|Overall Study|Death|2|||
128985444|NCT00463385|464235203|FG001|Overall Study|Death|1|||
128985445|NCT00463385|464235204|FG002|Overall Study|Death|2|||
128985446|NCT00463385|464235205|FG003|Overall Study|Death|0|||
128985447|NCT00463385|464235202|FG000|Overall Study|Missing|2|||
128985448|NCT00463385|464235203|FG001|Overall Study|Missing|0|||
128985449|NCT00463385|464235204|FG002|Overall Study|Missing|0|||
128985450|NCT00463385|464235205|FG003|Overall Study|Missing|2|||
128985451|NCT00463385|464235202|FG000|Overall Study|1 participant received commercial drug|0|||
128985452|NCT00463385|464235203|FG001|Overall Study|1 participant received commercial drug|1|||
128985453|NCT00463385|464235204|FG002|Overall Study|1 participant received commercial drug|0|||
128985454|NCT00463385|464235205|FG003|Overall Study|1 participant received commercial drug|0|||
128985455|NCT00449761|464235206|FG000|Overall Study|Disease progression|12|||
128985456|NCT00449761|464235206|FG000|Overall Study|Death|5|||
128985457|NCT00449761|464235206|FG000|Overall Study|New cancer therapy|1|||
128985458|NCT03735680|464235207|FG000|Overall Study|Withdrawal by Subject|0|||
128985459|NCT03735680|464235208|FG001|Overall Study|Withdrawal by Subject|1|||
128985460|NCT03735680|464235209|FG002|Overall Study|Withdrawal by Subject|0|||
128985461|NCT03735680|464235210|FG003|Overall Study|Withdrawal by Subject|0|||
128985462|NCT03735680|464235211|FG004|Overall Study|Withdrawal by Subject|0|||
128985463|NCT03735680|464235212|FG005|Overall Study|Withdrawal by Subject|1|||
128985464|NCT03735680|464235207|FG000|Overall Study|Patient unable or unwilling to continue|0|||
128985465|NCT03735680|464235208|FG001|Overall Study|Patient unable or unwilling to continue|0|||
128985466|NCT03735680|464235209|FG002|Overall Study|Patient unable or unwilling to continue|1|||
129208306|NCT04038359|465063275|FG000|Overall Study|Lost to Follow-up|3|||
129208307|NCT04038359|465063276|FG001|Overall Study|Lost to Follow-up|0|||
128985467|NCT03735680|464235210|FG003|Overall Study|Patient unable or unwilling to continue|0|||
128985468|NCT03735680|464235211|FG004|Overall Study|Patient unable or unwilling to continue|0|||
128985469|NCT03735680|464235212|FG005|Overall Study|Patient unable or unwilling to continue|0|||
128985470|NCT01548573|464235217|FG000|Overall Study|Death|3|||
128985471|NCT01548573|464235217|FG000|Overall Study|Withdrawal by Subject|2|||
128985472|NCT01366846|464235218|FG000|Overall Study|Withdrawal by Subject|2|||
128985473|NCT01366846|464235219|FG001|Overall Study|Withdrawal by Subject|0|||
128985474|NCT01366846|464235220|FG002|Overall Study|Withdrawal by Subject|0|||
129208308|NCT04038359|465063275|FG000|Overall Study|Participant Moved|1|||
128985475|NCT01366846|464235221|FG003|Overall Study|Withdrawal by Subject|0|||
128985476|NCT01366846|464235218|FG000|Overall Study|Communication Difficulties|1|||
128985477|NCT01366846|464235219|FG001|Overall Study|Communication Difficulties|4|||
128985478|NCT01366846|464235220|FG002|Overall Study|Communication Difficulties|0|||
128985479|NCT01366846|464235221|FG003|Overall Study|Communication Difficulties|1|||
128985480|NCT01366846|464235218|FG000|Overall Study|Scheduling Conflicts|0|||
128985481|NCT01366846|464235219|FG001|Overall Study|Scheduling Conflicts|0|||
128985482|NCT01366846|464235220|FG002|Overall Study|Scheduling Conflicts|1|||
128985483|NCT01366846|464235221|FG003|Overall Study|Scheduling Conflicts|0|||
128985484|NCT00558831|464235227|FG000|Overall Study|Lost to Follow-up|1|||
128985485|NCT00447265|464235228|FG000|Overall Study|Physician Decision|1|||
128985486|NCT00447265|464235229|FG001|Overall Study|Physician Decision|0|||
128985487|NCT00503035|464235232|FG000|Overall Study|Lost to Follow-up|2|||
128985488|NCT00503035|464235232|FG000|Overall Study|Physician Decision|3|||
128985489|NCT00503035|464235232|FG000|Overall Study|Ineligible|15|||
128985490|NCT05028816|464235235|FG000|Overall Study|Lost to Follow-up|5|||
128985491|NCT05028816|464235236|FG001|Overall Study|Lost to Follow-up|3|||
128985492|NCT05028816|464235235|FG000|Overall Study|Withdrawal by Subject|4|||
128985493|NCT05028816|464235236|FG001|Overall Study|Withdrawal by Subject|1|||
128985494|NCT05028816|464235235|FG000|Overall Study|Physician Decision|1|||
128985495|NCT05028816|464235236|FG001|Overall Study|Physician Decision|0|||
128985496|NCT05064436|464235237|FG000|Overall Study|Other Reasons|1|||
128985497|NCT05064436|464235238|FG001|Overall Study|Other Reasons|0|||
128985498|NCT01711736|464235240|FG000|Overall Study|Lost to Follow-up|4|||
128985499|NCT01711736|464235241|FG001|Overall Study|Lost to Follow-up|1|||
128985500|NCT01711736|464235240|FG000|Overall Study|Withdrawal by Subject|6|||
128985501|NCT01711736|464235241|FG001|Overall Study|Withdrawal by Subject|6|||
128985502|NCT01711736|464235240|FG000|Overall Study|Migrated/moved from study area|2|||
128985503|NCT01711736|464235241|FG001|Overall Study|Migrated/moved from study area|1|||
128985504|NCT02957149|464235242|FG000|Overall Study|Withdrawal by Subject|5|||
128985505|NCT00643006|464235243|FG000|Overall Study|Lost to Follow-up|5|||
128985506|NCT00643006|464235244|FG001|Overall Study|Lost to Follow-up|4|||
128985507|NCT02506101|464235245|FG000|Overall Study|Transportation issues|1|||
128985508|NCT02506101|464235246|FG001|Overall Study|Transportation issues|0|||
128985509|NCT02506101|464235245|FG000|Overall Study|No enrollment and staff unavailability|1|||
128985510|NCT02506101|464235246|FG001|Overall Study|No enrollment and staff unavailability|0|||
128985511|NCT01151085|464235248|FG000|Overall Study|Lost to Follow-up|31|||
128985512|NCT01151085|464235248|FG000|Overall Study|Protocol Violation|25|||
128985513|NCT01308476|464235249|FG000|Overall Study|Lost to Follow-up|2|||
128985514|NCT01308476|464235250|FG001|Overall Study|Lost to Follow-up|2|||
128985515|NCT01308476|464235249|FG000|Overall Study|Other|1|||
128985516|NCT01308476|464235250|FG001|Overall Study|Other|0|||
128985517|NCT00812968|464235251|FG000|Overall Study|Relapse after erythroid response|6|||
128985518|NCT00812968|464235251|FG000|Overall Study|Disease progression|1|||
128985519|NCT00812968|464235251|FG000|Overall Study|No further treatment required|1|||
128985520|NCT00812968|464235251|FG000|Overall Study|Study closed due to marketing approval|3|||
128985521|NCT04196023|464235253|FG000|Overall Study|Withdrawal by Subject|0|||
128985522|NCT04196023|464235254|FG001|Overall Study|Withdrawal by Subject|1|||
128985523|NCT04196023|464235253|FG000|Overall Study|Adverse Event|3|||
128985524|NCT04196023|464235254|FG001|Overall Study|Adverse Event|1|||
128985525|NCT04196023|464235253|FG000|Overall Study|Lost to Follow-up|0|||
128985526|NCT04196023|464235254|FG001|Overall Study|Lost to Follow-up|1|||
128985527|NCT03358407|464235255|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985528|NCT03358407|464235256|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985529|NCT03358407|464235257|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
128985530|NCT03358407|464235258|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985531|NCT03358407|464235259|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985532|NCT03358407|464235260|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985533|NCT03358407|464235261|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985534|NCT03358407|464235262|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985535|NCT03358407|464235263|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985536|NCT03358407|464235264|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
128985537|NCT03358407|464235255|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985538|NCT03358407|464235256|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985539|NCT03358407|464235257|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985540|NCT03358407|464235258|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985541|NCT03358407|464235259|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
128985542|NCT03358407|464235260|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129208309|NCT04038359|465063276|FG001|Overall Study|Participant Moved|0|||
128985543|NCT03358407|464235261|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985544|NCT03358407|464235262|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985545|NCT03358407|464235263|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985546|NCT03358407|464235264|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985547|NCT03358407|464235255|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985548|NCT03358407|464235256|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985549|NCT03358407|464235257|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985550|NCT03358407|464235258|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985551|NCT03358407|464235259|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985552|NCT03358407|464235260|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
128985553|NCT03358407|464235261|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985554|NCT03358407|464235262|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
128985555|NCT03358407|464235263|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985556|NCT03358407|464235264|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
128985557|NCT03358407|464235255|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985558|NCT03358407|464235256|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985559|NCT03358407|464235257|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985560|NCT03358407|464235258|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985561|NCT03358407|464235259|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985562|NCT03358407|464235260|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
128985563|NCT03358407|464235261|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985564|NCT03358407|464235262|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
128985565|NCT03358407|464235263|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985566|NCT03358407|464235264|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
128985567|NCT03358407|464235255|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985568|NCT03358407|464235256|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985569|NCT03358407|464235257|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985570|NCT03358407|464235258|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985571|NCT03358407|464235259|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985572|NCT03358407|464235260|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
128985573|NCT03358407|464235261|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
128985574|NCT03358407|464235262|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985575|NCT03358407|464235263|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985576|NCT03358407|464235264|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
128985577|NCT03358407|464235255|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
128985578|NCT03358407|464235256|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
128985579|NCT03358407|464235257|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
128985580|NCT03358407|464235258|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
128985581|NCT03358407|464235259|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
128985582|NCT03358407|464235260|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
128985583|NCT03358407|464235261|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
128985584|NCT03358407|464235262|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
128985585|NCT03358407|464235263|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
128985586|NCT03358407|464235264|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
128985587|NCT01283009|464235265|FG000|Overall Study|Death|83|||
128985588|NCT01283009|464235266|FG001|Overall Study|Death|78|||
128985589|NCT01283009|464235265|FG000|Overall Study|Study ended early|23|||
128985590|NCT01283009|464235266|FG001|Overall Study|Study ended early|26|||
128985591|NCT01283009|464235265|FG000|Overall Study|Withdrawal by Subject|10|||
128985592|NCT01283009|464235266|FG001|Overall Study|Withdrawal by Subject|8|||
128985593|NCT01283009|464235265|FG000|Overall Study|Physician Decision|1|||
128985594|NCT01283009|464235266|FG001|Overall Study|Physician Decision|1|||
128985595|NCT01283009|464235265|FG000|Overall Study|Lost to Follow-up|1|||
128985596|NCT01283009|464235266|FG001|Overall Study|Lost to Follow-up|0|||
128985597|NCT01283009|464235265|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
128985598|NCT01283009|464235266|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
128985599|NCT00505765|464235269|FG000|Overall Study|Withdrawal by Subject|1|||
128985600|NCT00505765|464235270|FG001|Overall Study|Withdrawal by Subject|0|||
128985601|NCT00505765|464235271|FG002|Overall Study|Withdrawal by Subject|0|||
128985602|NCT00505765|464235269|FG000|Overall Study|Adverse Event|1|||
128985603|NCT00505765|464235270|FG001|Overall Study|Adverse Event|2|||
128985604|NCT00505765|464235271|FG002|Overall Study|Adverse Event|0|||
128985605|NCT00505765|464235269|FG000|Overall Study|Noncompliance|0|||
128985606|NCT00505765|464235270|FG001|Overall Study|Noncompliance|1|||
128985607|NCT00505765|464235271|FG002|Overall Study|Noncompliance|3|||
128985608|NCT00779857|464235272|FG000|Overall Study|Death|1|||
128985609|NCT00779857|464235272|FG000|Overall Study|Withdrawal by Subject|3|||
128985610|NCT00779857|464235272|FG000|Overall Study|Missed Visit|2|||
128985611|NCT04640168|464235273|FG000|Overall Study|Withdrawal by Subject|8|||
128985612|NCT04640168|464235274|FG001|Overall Study|Withdrawal by Subject|7|||
128985613|NCT04640168|464235273|FG000|Overall Study|Lost to Follow-up|1|||
129208310|NCT04038359|465063275|FG000|Overall Study|Withdrawal by Subject|4|||
129208311|NCT04038359|465063276|FG001|Overall Study|Withdrawal by Subject|3|||
129208312|NCT04038359|465063275|FG000|Overall Study|Physician Decision|3|||
129208313|NCT04038359|465063276|FG001|Overall Study|Physician Decision|2|||
129208314|NCT04038359|465063275|FG000|Overall Study|Adverse Event|0|||
128985614|NCT04640168|464235274|FG001|Overall Study|Lost to Follow-up|0|||
128985615|NCT04640168|464235273|FG000|Overall Study|Enrolled but not treated|12|||
128985616|NCT04640168|464235274|FG001|Overall Study|Enrolled but not treated|12|||
128985617|NCT04366258|464235282|FG000|Baseline Assessments|Screen Failure|21|||
128985618|NCT04366258|464235282|FG000|Baseline Assessments|Early Termination|3|||
128985619|NCT01725217|464235283|FG000|Overall Study|Withdrawal by Subject|1|||
128985620|NCT01725217|464235284|FG001|Overall Study|Withdrawal by Subject|0|||
128985621|NCT01725217|464235285|FG002|Overall Study|Withdrawal by Subject|0|||
128985622|NCT00308555|464235286|FG000|Overall Study|Withdrawal by Subject|1|||
128985623|NCT00308555|464235287|FG001|Overall Study|Withdrawal by Subject|0|||
128985624|NCT00308555|464235286|FG000|Overall Study|Physician Decision|2|||
128985625|NCT00308555|464235287|FG001|Overall Study|Physician Decision|0|||
128985626|NCT00276458|464235288|FG000|Overall Study|Adverse Event|0|||
128985627|NCT00276458|464235289|FG001|Overall Study|Adverse Event|2|||
128985628|NCT00276458|464235288|FG000|Overall Study|Lost to Follow-up|2|||
128985629|NCT00276458|464235289|FG001|Overall Study|Lost to Follow-up|2|||
128985630|NCT00276458|464235288|FG000|Overall Study|Protocol Violation|4|||
128985631|NCT00276458|464235289|FG001|Overall Study|Protocol Violation|3|||
128985632|NCT02940392|464235292|FG000|Overall Study|Lost to Follow-up|3|||
128985633|NCT02940392|464235292|FG000|Overall Study|Retreatment|3|||
128985634|NCT02940392|464235292|FG000|Overall Study|Death|2|||
128985635|NCT00480077|464235293|FG000|Overall Study|Death|19|||
128985636|NCT00480077|464235294|FG001|Overall Study|Death|15|||
128985637|NCT00480077|464235293|FG000|Overall Study|early exit|12|||
128985638|NCT00480077|464235294|FG001|Overall Study|early exit|11|||
128985639|NCT04298229|464235299|FG000|Overall Study|Physician Decision|1|||
128985640|NCT04298229|464235300|FG001|Overall Study|Physician Decision|1|||
128985641|NCT04298229|464235299|FG000|Overall Study|Withdrawal by Subject|1|||
128985642|NCT04298229|464235300|FG001|Overall Study|Withdrawal by Subject|1|||
128985643|NCT04298229|464235299|FG000|Overall Study|Did not receive IV loop diuretics|2|||
128985644|NCT04298229|464235300|FG001|Overall Study|Did not receive IV loop diuretics|0|||
128985645|NCT00262119|464235302|FG000|Overall Study|Lost to Follow-up|38|||
128985646|NCT00262119|464235303|FG001|Overall Study|Lost to Follow-up|51|||
128985647|NCT00262119|464235304|FG002|Overall Study|Lost to Follow-up|42|||
128985648|NCT00262119|464235302|FG000|Overall Study|Death|20|||
128985649|NCT00262119|464235303|FG001|Overall Study|Death|19|||
128985650|NCT00262119|464235304|FG002|Overall Study|Death|16|||
128985651|NCT00859313|464235305|FG000|Overall Study|Lack of Efficacy|2|||
128985652|NCT00859313|464235305|FG000|Overall Study|Adverse Event|1|||
128985653|NCT00859313|464235305|FG000|Overall Study|staff error|1|||
128985654|NCT05570604|464235306|FG000|Overall Study|Lost to Follow-up|1|||
128985655|NCT05570604|464235307|FG001|Overall Study|Lost to Follow-up|5|||
128985656|NCT05570604|464235306|FG000|Overall Study|Illness|2|||
128985657|NCT05570604|464235307|FG001|Overall Study|Illness|2|||
128985658|NCT00145119|464235310|FG000|Overall Study|Death|45|||
128985659|NCT05437211|464235317|FG000|Overall Study|Patient's decision|1|||
128985660|NCT05437211|464235318|FG001|Overall Study|Patient's decision|1|||
128985661|NCT04410991|464235320|FG000|Overall Study|Poor compliance to protocol|5|||
128985662|NCT04410991|464235321|FG001|Overall Study|Poor compliance to protocol|4|||
128985663|NCT04410991|464235320|FG000|Overall Study|Withdrawal by Subject|59|||
128985664|NCT04410991|464235321|FG001|Overall Study|Withdrawal by Subject|55|||
128985665|NCT04410991|464235320|FG000|Overall Study|Other|10|||
128985666|NCT04410991|464235321|FG001|Overall Study|Other|4|||
128985667|NCT01463631|464235329|FG000|Overall Study|Withdrawal by Subject|0|||
128985668|NCT01463631|464235330|FG001|Overall Study|Withdrawal by Subject|0|||
128985669|NCT01463631|464235331|FG002|Overall Study|Withdrawal by Subject|0|||
128985670|NCT01463631|464235332|FG003|Overall Study|Withdrawal by Subject|1|||
128985671|NCT01463631|464235329|FG000|Overall Study|Death|0|||
128985672|NCT01463631|464235330|FG001|Overall Study|Death|0|||
128985673|NCT01463631|464235331|FG002|Overall Study|Death|1|||
128985674|NCT01463631|464235332|FG003|Overall Study|Death|0|||
128985675|NCT01463631|464235329|FG000|Overall Study|Progressive Disease|0|||
128985676|NCT01463631|464235330|FG001|Overall Study|Progressive Disease|0|||
128985677|NCT01463631|464235331|FG002|Overall Study|Progressive Disease|0|||
128985678|NCT01463631|464235332|FG003|Overall Study|Progressive Disease|5|||
128985679|NCT05966129|464235333|FG000|Overall Study|Death|1|||
128985680|NCT05966129|464235334|FG001|Overall Study|Death|2|||
128985681|NCT05966129|464235333|FG000|Overall Study|Lost to Follow-up|63|||
128985682|NCT05966129|464235334|FG001|Overall Study|Lost to Follow-up|66|||
128985683|NCT05966129|464235333|FG000|Overall Study|Protocol Violation|1|||
128985684|NCT05966129|464235334|FG001|Overall Study|Protocol Violation|0|||
128985685|NCT05966129|464235333|FG000|Overall Study|Withdrawal by Subject|26|||
128985686|NCT05966129|464235334|FG001|Overall Study|Withdrawal by Subject|25|||
128985687|NCT05966129|464235333|FG000|Overall Study|Surgery not completed|63|||
128985688|NCT05966129|464235334|FG001|Overall Study|Surgery not completed|69|||
128985689|NCT05966129|464235333|FG000|Overall Study|Surgery logistics issue|2|||
128985690|NCT05966129|464235334|FG001|Overall Study|Surgery logistics issue|1|||
128985691|NCT03145207|464235335|FG000|Overall Study|volunteer started taking allergy shots|1|||
128985692|NCT03145207|464235335|FG000|Overall Study|baseline blood pressure high|1|||
128985693|NCT00620776|464236968|FG000|Overall Study|Did not receive treatment|3|||
128985694|NCT00620776|464236969|FG001|Overall Study|Did not receive treatment|5|||
128985695|NCT00620776|464236968|FG000|Overall Study|Adverse Event|2|||
128985696|NCT00620776|464236969|FG001|Overall Study|Adverse Event|3|||
128985697|NCT00620776|464236968|FG000|Overall Study|Lack of Efficacy|2|||
128985698|NCT00620776|464236969|FG001|Overall Study|Lack of Efficacy|1|||
128985699|NCT00620776|464236968|FG000|Overall Study|Lost to Follow-up|2|||
128985700|NCT00620776|464236969|FG001|Overall Study|Lost to Follow-up|5|||
128985701|NCT00620776|464236968|FG000|Overall Study|Withdrawal by Subject|3|||
128985702|NCT00620776|464236969|FG001|Overall Study|Withdrawal by Subject|2|||
128985703|NCT03205046|464236971|FG000|Overall Study|Death|10|||
128985704|NCT03205046|464236972|FG001|Overall Study|Death|6|||
128985705|NCT03205046|464236971|FG000|Overall Study|Withdrawal by Subject|1|||
128985706|NCT03205046|464236972|FG001|Overall Study|Withdrawal by Subject|2|||
128985707|NCT03205046|464236971|FG000|Overall Study|Lost to Follow-up|0|||
128985708|NCT03205046|464236972|FG001|Overall Study|Lost to Follow-up|1|||
128985709|NCT03205046|464236971|FG000|Overall Study|Study terminated by sponsor|2|||
128985710|NCT03205046|464236972|FG001|Overall Study|Study terminated by sponsor|1|||
128985711|NCT01023815|464236973|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
128985712|NCT01023815|464236974|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
128985713|NCT01023815|464236975|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
128985714|NCT01023815|464236976|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
128985715|NCT01023815|464236973|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
128985716|NCT01023815|464236974|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
128985717|NCT01023815|464236975|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
128985718|NCT01023815|464236976|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
128985719|NCT01023815|464236973|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
128985720|NCT01023815|464236974|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
129208315|NCT04038359|465063276|FG001|Overall Study|Adverse Event|2|||
129208316|NCT04038359|465063275|FG000|Overall Study|Progressive Disease|0|||
129208317|NCT04038359|465063276|FG001|Overall Study|Progressive Disease|1|||
129208318|NCT00703014|465063277|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
129208319|NCT00703014|465063278|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
129208320|NCT00703014|465063279|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129208321|NCT00703014|465063280|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129208322|NCT00703014|465063277|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129208323|NCT00703014|465063278|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129208324|NCT00703014|465063279|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
129208325|NCT00703014|465063280|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
129208326|NCT03259230|465063284|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
128876227|NCT03541174|463842315|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
128876228|NCT03541174|463842316|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
128876229|NCT03541174|463842317|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
128876230|NCT03541174|463842318|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
128876231|NCT03541174|463842313|FG000|Part 2 Single-Blind|Death|0|||
128876232|NCT03541174|463842314|FG001|Part 2 Single-Blind|Death|0|||
128876233|NCT03541174|463842315|FG002|Part 2 Single-Blind|Death|0|||
128876234|NCT03541174|463842316|FG003|Part 2 Single-Blind|Death|5|||
128876235|NCT03541174|463842317|FG004|Part 2 Single-Blind|Death|0|||
128876236|NCT03541174|463842318|FG005|Part 2 Single-Blind|Death|0|||
128876237|NCT03541174|463842313|FG000|Part 2 Single-Blind|Pregnancy|0|||
128876238|NCT03541174|463842314|FG001|Part 2 Single-Blind|Pregnancy|0|||
128876239|NCT03541174|463842315|FG002|Part 2 Single-Blind|Pregnancy|0|||
128876240|NCT03541174|463842316|FG003|Part 2 Single-Blind|Pregnancy|1|||
128876241|NCT03541174|463842317|FG004|Part 2 Single-Blind|Pregnancy|0|||
128876242|NCT03541174|463842318|FG005|Part 2 Single-Blind|Pregnancy|0|||
128876243|NCT03541174|463842313|FG000|Part 2 Single-Blind|Other reasons|0|||
128876244|NCT03541174|463842314|FG001|Part 2 Single-Blind|Other reasons|0|||
128876245|NCT03541174|463842315|FG002|Part 2 Single-Blind|Other reasons|0|||
128876246|NCT03541174|463842316|FG003|Part 2 Single-Blind|Other reasons|32|||
128876247|NCT03541174|463842317|FG004|Part 2 Single-Blind|Other reasons|0|||
128876248|NCT03541174|463842318|FG005|Part 2 Single-Blind|Other reasons|0|||
128876249|NCT03541174|463842313|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
128876250|NCT03541174|463842314|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
128876251|NCT03541174|463842315|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
128876252|NCT03541174|463842316|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
128876253|NCT03541174|463842317|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
128876254|NCT03541174|463842318|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
128876255|NCT03541174|463842313|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
128985721|NCT01023815|464236975|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
128985722|NCT01023815|464236976|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
128876256|NCT03541174|463842314|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
128985723|NCT01023815|464236973|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
128985724|NCT01023815|464236974|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
128985725|NCT01023815|464236975|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
128985726|NCT01023815|464236976|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
128985727|NCT01023815|464236973|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
128985728|NCT01023815|464236974|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
128985729|NCT01023815|464236975|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
128985730|NCT01023815|464236976|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
128985731|NCT03253809|464236979|FG000|Overall Study|Unable to obtain study related data|14|||
128985732|NCT03992456|464236980|FG000|Overall Study|Withdrawal by Subject|1|||
128985733|NCT03992456|464236981|FG001|Overall Study|Withdrawal by Subject|0|||
128985734|NCT03992456|464236980|FG000|Overall Study|Disease progression|4|||
128985735|NCT03992456|464236981|FG001|Overall Study|Disease progression|5|||
128985736|NCT03992456|464236980|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
128985737|NCT03992456|464236981|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
128985738|NCT00910000|464236985|FG000|Overall Study|Adverse Event|0|||
128985739|NCT00910000|464236986|FG001|Overall Study|Adverse Event|3|||
128985740|NCT00910000|464236987|FG002|Overall Study|Adverse Event|2|||
128985741|NCT00910000|464236988|FG003|Overall Study|Adverse Event|2|||
128985742|NCT00910000|464236989|FG004|Overall Study|Adverse Event|0|||
128985743|NCT00910000|464236990|FG005|Overall Study|Adverse Event|1|||
128985744|NCT00910000|464236985|FG000|Overall Study|Withdrawal by Subject|0|||
128985745|NCT00910000|464236986|FG001|Overall Study|Withdrawal by Subject|0|||
128985746|NCT00910000|464236987|FG002|Overall Study|Withdrawal by Subject|1|||
128985747|NCT00910000|464236988|FG003|Overall Study|Withdrawal by Subject|0|||
128985748|NCT00910000|464236989|FG004|Overall Study|Withdrawal by Subject|1|||
128985749|NCT00910000|464236990|FG005|Overall Study|Withdrawal by Subject|0|||
128985750|NCT01977625|464236991|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
128985751|NCT01977625|464236992|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
128985752|NCT01977625|464236991|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
128985753|NCT01977625|464236992|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
128985754|NCT04113746|464236993|FG000|Overall Study|Lost to Follow-up|4|||
128985755|NCT04113746|464236994|FG001|Overall Study|Lost to Follow-up|4|||
128985756|NCT02594384|464236995|FG000|Overall Study|Disease Progression|3|||
128985757|NCT02594384|464236996|FG001|Overall Study|Disease Progression|7|||
128985758|NCT02594384|464236997|FG002|Overall Study|Disease Progression|0|||
128985759|NCT02594384|464236998|FG003|Overall Study|Disease Progression|2|||
128985760|NCT02594384|464236999|FG004|Overall Study|Disease Progression|2|||
128985761|NCT02594384|464237000|FG005|Overall Study|Disease Progression|12|||
128985762|NCT02594384|464237001|FG006|Overall Study|Disease Progression|5|||
128985763|NCT02594384|464237002|FG007|Overall Study|Disease Progression|5|||
128985764|NCT02594384|464236995|FG000|Overall Study|Adverse Event|0|||
128985765|NCT02594384|464236996|FG001|Overall Study|Adverse Event|1|||
128985766|NCT02594384|464236997|FG002|Overall Study|Adverse Event|4|||
128985767|NCT02594384|464236998|FG003|Overall Study|Adverse Event|1|||
128985768|NCT02594384|464236999|FG004|Overall Study|Adverse Event|0|||
128985769|NCT02594384|464237000|FG005|Overall Study|Adverse Event|6|||
128985770|NCT02594384|464237001|FG006|Overall Study|Adverse Event|1|||
128985771|NCT02594384|464237002|FG007|Overall Study|Adverse Event|1|||
128985772|NCT02594384|464236995|FG000|Overall Study|Withdrawal by Subject|0|||
128985773|NCT02594384|464236996|FG001|Overall Study|Withdrawal by Subject|0|||
128985774|NCT02594384|464236997|FG002|Overall Study|Withdrawal by Subject|0|||
128985775|NCT02594384|464236998|FG003|Overall Study|Withdrawal by Subject|1|||
128985776|NCT02594384|464236999|FG004|Overall Study|Withdrawal by Subject|0|||
128985777|NCT02594384|464237000|FG005|Overall Study|Withdrawal by Subject|0|||
128985778|NCT02594384|464237001|FG006|Overall Study|Withdrawal by Subject|0|||
128985779|NCT02594384|464237002|FG007|Overall Study|Withdrawal by Subject|1|||
128985780|NCT02594384|464236995|FG000|Overall Study|Physician Decision|0|||
128985781|NCT02594384|464236996|FG001|Overall Study|Physician Decision|0|||
128985782|NCT02594384|464236997|FG002|Overall Study|Physician Decision|0|||
129208327|NCT03259230|465063285|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
129208328|NCT01033240|465063286|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
128985783|NCT02594384|464236998|FG003|Overall Study|Physician Decision|0|||
129208329|NCT01033240|465063287|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
129208330|NCT01033240|465063288|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
129208331|NCT01033240|465063286|FG000|Overall Study|Death|2|||
128985784|NCT02594384|464236999|FG004|Overall Study|Physician Decision|0|||
128985785|NCT02594384|464237000|FG005|Overall Study|Physician Decision|1|||
128985786|NCT02594384|464237001|FG006|Overall Study|Physician Decision|2|||
128985787|NCT02594384|464237002|FG007|Overall Study|Physician Decision|0|||
128985788|NCT02594384|464236995|FG000|Overall Study|Progressive Leukocytosis|0|||
128985789|NCT02594384|464236996|FG001|Overall Study|Progressive Leukocytosis|0|||
128985790|NCT02594384|464236997|FG002|Overall Study|Progressive Leukocytosis|1|||
128985791|NCT02594384|464236998|FG003|Overall Study|Progressive Leukocytosis|0|||
128985792|NCT02594384|464236999|FG004|Overall Study|Progressive Leukocytosis|0|||
128985793|NCT02594384|464237000|FG005|Overall Study|Progressive Leukocytosis|0|||
128985794|NCT02594384|464237001|FG006|Overall Study|Progressive Leukocytosis|0|||
128985795|NCT02594384|464237002|FG007|Overall Study|Progressive Leukocytosis|0|||
128985796|NCT02594384|464236995|FG000|Overall Study|Lack of Efficacy|0|||
128985797|NCT02594384|464236996|FG001|Overall Study|Lack of Efficacy|0|||
128985798|NCT02594384|464236997|FG002|Overall Study|Lack of Efficacy|0|||
128985799|NCT02594384|464236998|FG003|Overall Study|Lack of Efficacy|0|||
128985800|NCT02594384|464236999|FG004|Overall Study|Lack of Efficacy|1|||
128985801|NCT02594384|464237000|FG005|Overall Study|Lack of Efficacy|0|||
128985802|NCT02594384|464237001|FG006|Overall Study|Lack of Efficacy|0|||
128985803|NCT02594384|464237002|FG007|Overall Study|Lack of Efficacy|0|||
128985804|NCT02594384|464236995|FG000|Overall Study|Substantial noncompliance|0|||
128985805|NCT02594384|464236996|FG001|Overall Study|Substantial noncompliance|0|||
128985806|NCT02594384|464236997|FG002|Overall Study|Substantial noncompliance|0|||
128985807|NCT02594384|464236998|FG003|Overall Study|Substantial noncompliance|0|||
128985808|NCT02594384|464236999|FG004|Overall Study|Substantial noncompliance|0|||
128985809|NCT02594384|464237000|FG005|Overall Study|Substantial noncompliance|0|||
128985810|NCT02594384|464237001|FG006|Overall Study|Substantial noncompliance|1|||
128985811|NCT02594384|464237002|FG007|Overall Study|Substantial noncompliance|0|||
128985812|NCT03919669|464237005|FG000|Overall Study|Withdrawal by Subject|1|||
128985813|NCT03919669|464237006|FG001|Overall Study|Withdrawal by Subject|0|||
128985814|NCT03919669|464237007|FG002|Overall Study|Withdrawal by Subject|0|||
128876257|NCT03541174|463842315|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
128876258|NCT03541174|463842316|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
128876259|NCT03541174|463842317|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
128876260|NCT03541174|463842318|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
128876261|NCT03541174|463842313|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
128876262|NCT03541174|463842314|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
128876263|NCT03541174|463842315|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
128876264|NCT03541174|463842316|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
128876265|NCT03541174|463842317|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
128876266|NCT03541174|463842318|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
128876267|NCT03541174|463842313|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
128876268|NCT03541174|463842314|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
128876269|NCT03541174|463842315|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
128876270|NCT03541174|463842316|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
128876271|NCT03541174|463842317|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
128876272|NCT03541174|463842318|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
128876273|NCT03541174|463842313|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
128876274|NCT03541174|463842314|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
128876275|NCT03541174|463842315|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
128876276|NCT03541174|463842316|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
128876277|NCT03541174|463842317|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
128876278|NCT03541174|463842318|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
128876279|NCT02217332|463842321|FG000|Overall Study|Adverse Event|3|||
128876280|NCT02217332|463842321|FG000|Overall Study|Dose interruption >1 month|1|||
128876281|NCT02217332|463842321|FG000|Overall Study|Protocol Violation (eligibility)|1|||
128876282|NCT02217332|463842321|FG000|Overall Study|Withdrawal by Subject|1|||
128985815|NCT03125382|464237008|FG000|Randomization|screening failure|1|||
128985816|NCT03125382|464237009|FG001|Randomization|screening failure|4|||
128985817|NCT03125382|464237010|FG002|Randomization|screening failure|2|||
128985818|NCT03125382|464237011|FG003|Randomization|screening failure|0|||
128985819|NCT03125382|464237008|FG000|Follow-up|Death|1|||
129098615|NCT04015518|464652410|FG001|Overall Study|Patient did not come for consecutive visits|1|||
129098616|NCT04015518|464652411|FG002|Overall Study|Patient did not come for consecutive visits|0|||
129098617|NCT04015518|464652412|FG003|Overall Study|Patient did not come for consecutive visits|0|||
129098618|NCT04015518|464652413|FG004|Overall Study|Patient did not come for consecutive visits|0|||
129098619|NCT04015518|464652409|FG000|Overall Study|not willing to travel due to Covid-19|0|||
129098620|NCT04015518|464652410|FG001|Overall Study|not willing to travel due to Covid-19|0|||
129098621|NCT04015518|464652411|FG002|Overall Study|not willing to travel due to Covid-19|1|||
129098622|NCT04015518|464652412|FG003|Overall Study|not willing to travel due to Covid-19|0|||
129098623|NCT04015518|464652413|FG004|Overall Study|not willing to travel due to Covid-19|0|||
129098624|NCT04015518|464652409|FG000|Overall Study|Patient wants to discontinue treatment|0|||
129098625|NCT04015518|464652410|FG001|Overall Study|Patient wants to discontinue treatment|0|||
129098626|NCT04015518|464652411|FG002|Overall Study|Patient wants to discontinue treatment|0|||
129098627|NCT04015518|464652412|FG003|Overall Study|Patient wants to discontinue treatment|1|||
129098628|NCT04015518|464652413|FG004|Overall Study|Patient wants to discontinue treatment|0|||
129098629|NCT04015518|464652409|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
129098630|NCT04015518|464652410|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
129098631|NCT04015518|464652411|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
128985820|NCT03125382|464237009|FG001|Follow-up|Death|2|||
128985821|NCT03125382|464237010|FG002|Follow-up|Death|1|||
128985822|NCT03125382|464237011|FG003|Follow-up|Death|2|||
128985823|NCT03125382|464237008|FG000|Follow-up|Lost to Follow-up|1|||
128985824|NCT03125382|464237009|FG001|Follow-up|Lost to Follow-up|4|||
128985825|NCT03125382|464237010|FG002|Follow-up|Lost to Follow-up|3|||
128985826|NCT03125382|464237011|FG003|Follow-up|Lost to Follow-up|1|||
128985827|NCT04964960|464237012|FG000|Overall Study|Withdrawal by Subject|1|||
128985828|NCT02686749|464237013|FG000|Overall Study|terminated for poor enrollment|2|||
128985829|NCT02686749|464237014|FG001|Overall Study|terminated for poor enrollment|2|||
128985830|NCT02319642|464237015|FG000|Overall Study|Adverse Event|2|||
129208332|NCT01033240|465063287|FG001|Overall Study|Death|0|||
129208333|NCT01033240|465063288|FG002|Overall Study|Death|0|||
129208334|NCT01033240|465063286|FG000|Overall Study|Withdrew Consent|2|||
129208335|NCT01033240|465063287|FG001|Overall Study|Withdrew Consent|9|||
129208336|NCT01033240|465063288|FG002|Overall Study|Withdrew Consent|2|||
129208337|NCT01033240|465063286|FG000|Overall Study|Disease Progression|35|||
129208338|NCT01033240|465063287|FG001|Overall Study|Disease Progression|32|||
129208339|NCT01033240|465063288|FG002|Overall Study|Disease Progression|41|||
129208340|NCT01033240|465063286|FG000|Overall Study|Investigator Discretion|0|||
129208341|NCT01033240|465063287|FG001|Overall Study|Investigator Discretion|0|||
129208342|NCT01033240|465063288|FG002|Overall Study|Investigator Discretion|2|||
129208343|NCT01033240|465063286|FG000|Overall Study|Other|0|||
129208344|NCT01033240|465063287|FG001|Overall Study|Other|1|||
129208345|NCT01033240|465063288|FG002|Overall Study|Other|2|||
129208346|NCT05468814|465063289|FG000|Overall Study|Lost to Follow-up|5|||
129208347|NCT05468814|465063290|FG001|Overall Study|Lost to Follow-up|6|||
129208348|NCT04716426|465063291|FG000|Overall Study|Vaccination|1|||
129208349|NCT04716426|465063292|FG001|Overall Study|Vaccination|1|||
129208350|NCT04716426|465063291|FG000|Overall Study|Contamination|1|||
129208351|NCT04716426|465063292|FG001|Overall Study|Contamination|0|||
129208352|NCT00625131|465063293|FG000|Overall Study|Lost to Follow-up|3|||
129208353|NCT00625131|465063294|FG001|Overall Study|Lost to Follow-up|2|||
129208354|NCT00625131|465063295|FG002|Overall Study|Lost to Follow-up|0|||
129208355|NCT00625131|465063293|FG000|Overall Study|Withdrawal by Subject|1|||
129208356|NCT00625131|465063294|FG001|Overall Study|Withdrawal by Subject|0|||
129208357|NCT00625131|465063295|FG002|Overall Study|Withdrawal by Subject|5|||
129208358|NCT01844765|465063297|FG000|Overall Study|Adverse Event|6|||
129208359|NCT01844765|465063298|FG001|Overall Study|Adverse Event|8|||
129208360|NCT01844765|465063297|FG000|Overall Study|Withdrawal by Subject|2|||
129208361|NCT01844765|465063298|FG001|Overall Study|Withdrawal by Subject|3|||
129208362|NCT01844765|465063297|FG000|Overall Study|Disease progression|1|||
129208363|NCT01844765|465063298|FG001|Overall Study|Disease progression|0|||
129208364|NCT01844765|465063297|FG000|Overall Study|Administrative problems|3|||
129208365|NCT01844765|465063298|FG001|Overall Study|Administrative problems|4|||
129208366|NCT01844765|465063297|FG000|Overall Study|Protocol deviation|2|||
129208367|NCT01844765|465063298|FG001|Overall Study|Protocol deviation|0|||
129208368|NCT01844765|465063297|FG000|Overall Study|Untreated|1|||
129208369|NCT01844765|465063298|FG001|Overall Study|Untreated|0|||
129208370|NCT02485691|465063299|FG000|Overall Study|Adverse Event|25|||
129208371|NCT02485691|465063300|FG001|Overall Study|Adverse Event|11|||
129208372|NCT02485691|465063299|FG000|Overall Study|Poor compliance to protocol|0|||
129208373|NCT02485691|465063300|FG001|Overall Study|Poor compliance to protocol|1|||
129208374|NCT02485691|465063299|FG000|Overall Study|Disease progression|57|||
129208375|NCT02485691|465063300|FG001|Overall Study|Disease progression|92|||
129208376|NCT02485691|465063299|FG000|Overall Study|Investigator's decision|23|||
129208377|NCT02485691|465063300|FG001|Overall Study|Investigator's decision|5|||
129208378|NCT02485691|465063299|FG000|Overall Study|Participant's request|13|||
129208379|NCT02485691|465063300|FG001|Overall Study|Participant's request|6|||
129208380|NCT02485691|465063299|FG000|Overall Study|Other reason|8|||
129208381|NCT02485691|465063300|FG001|Overall Study|Other reason|9|||
129208382|NCT02485691|465063299|FG000|Overall Study|Randomized and not treated|3|||
129208383|NCT02485691|465063300|FG001|Overall Study|Randomized and not treated|2|||
128985831|NCT02319642|464237016|FG001|Overall Study|Adverse Event|4|||
128985832|NCT02319642|464237015|FG000|Overall Study|Lack of Efficacy|1|||
128985833|NCT02319642|464237016|FG001|Overall Study|Lack of Efficacy|1|||
128985834|NCT02319642|464237015|FG000|Overall Study|Withdrawal by Subject|1|||
129208384|NCT03836625|465063301|FG000|Overall Study|Lost to Follow-up|9|||
129208385|NCT03836625|465063302|FG001|Overall Study|Lost to Follow-up|9|||
129208386|NCT03836625|465063301|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
129208387|NCT03836625|465063302|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
129208388|NCT03836625|465063301|FG000|Overall Study|Death|0|||
129208389|NCT03836625|465063302|FG001|Overall Study|Death|1|||
129208390|NCT03836625|465063301|FG000|Overall Study|Refused follow-up|0|||
129208391|NCT03836625|465063302|FG001|Overall Study|Refused follow-up|1|||
129208392|NCT04764162|465063305|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
128985835|NCT02319642|464237016|FG001|Overall Study|Withdrawal by Subject|1|||
129208393|NCT04764162|465063306|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
129208394|NCT03413891|465063307|FG000|Overall Study|Lost to Follow-up|2|||
129208395|NCT03413891|465063308|FG001|Overall Study|Lost to Follow-up|1|||
129208396|NCT03413891|465063307|FG000|Overall Study|Protocol Violation|0|||
129208397|NCT03413891|465063308|FG001|Overall Study|Protocol Violation|1|||
129208398|NCT04905134|465063311|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
129208399|NCT04905134|465063311|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
129208400|NCT05556265|465063312|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
129208401|NCT05556265|465063313|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
128985836|NCT04668066|464237017|FG000|Part 1: Treatment Phase|Adverse Event|0|||
128985837|NCT04668066|464237018|FG001|Part 1: Treatment Phase|Adverse Event|0|||
128985838|NCT04668066|464237019|FG002|Part 1: Treatment Phase|Adverse Event|0|||
128985839|NCT04668066|464237020|FG003|Part 1: Treatment Phase|Adverse Event|0|||
128985840|NCT04668066|464237021|FG004|Part 1: Treatment Phase|Adverse Event|0|||
128985841|NCT04668066|464237022|FG005|Part 1: Treatment Phase|Adverse Event|0|||
128985842|NCT04668066|464237023|FG006|Part 1: Treatment Phase|Adverse Event|0|||
128985843|NCT04668066|464237024|FG007|Part 1: Treatment Phase|Adverse Event|0|||
128985844|NCT04668066|464237025|FG008|Part 1: Treatment Phase|Adverse Event|0|||
128985845|NCT04668066|464237026|FG009|Part 1: Treatment Phase|Adverse Event|0|||
128985846|NCT04668066|464237027|FG010|Part 1: Treatment Phase|Adverse Event|0|||
128985847|NCT04668066|464237028|FG011|Part 1: Treatment Phase|Adverse Event|1|||
128985848|NCT04668066|464237029|FG012|Part 1: Treatment Phase|Adverse Event|1|||
128985849|NCT04668066|464237030|FG013|Part 1: Treatment Phase|Adverse Event|0|||
128985850|NCT04668066|464237031|FG014|Part 1: Treatment Phase|Adverse Event|0|||
128985851|NCT04668066|464237032|FG015|Part 1: Treatment Phase|Adverse Event|0|||
128985852|NCT04668066|464237033|FG016|Part 1: Treatment Phase|Adverse Event|0|||
128985853|NCT04668066|464237034|FG017|Part 1: Treatment Phase|Adverse Event|0|||
128985854|NCT04668066|464237035|FG018|Part 1: Treatment Phase|Adverse Event|0|||
128985855|NCT04668066|464237017|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985856|NCT04668066|464237018|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985857|NCT04668066|464237019|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
128985858|NCT04668066|464237020|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985859|NCT04668066|464237021|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985860|NCT04668066|464237022|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985861|NCT04668066|464237023|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985862|NCT04668066|464237024|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985863|NCT04668066|464237025|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985864|NCT04668066|464237026|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985865|NCT04668066|464237027|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985866|NCT04668066|464237028|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985867|NCT04668066|464237029|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985868|NCT04668066|464237030|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985869|NCT04668066|464237031|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985870|NCT04668066|464237032|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985871|NCT04668066|464237033|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985872|NCT04668066|464237034|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985873|NCT04668066|464237035|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
128985874|NCT04668066|464237017|FG000|Part 1: Treatment Phase|Other|0|||
128985875|NCT04668066|464237018|FG001|Part 1: Treatment Phase|Other|0|||
128985876|NCT04668066|464237019|FG002|Part 1: Treatment Phase|Other|0|||
128985877|NCT04668066|464237020|FG003|Part 1: Treatment Phase|Other|0|||
128985878|NCT04668066|464237021|FG004|Part 1: Treatment Phase|Other|0|||
128985879|NCT04668066|464237022|FG005|Part 1: Treatment Phase|Other|0|||
128985880|NCT04668066|464237023|FG006|Part 1: Treatment Phase|Other|0|||
128985881|NCT04668066|464237024|FG007|Part 1: Treatment Phase|Other|0|||
128985882|NCT04668066|464237025|FG008|Part 1: Treatment Phase|Other|0|||
128985883|NCT04668066|464237026|FG009|Part 1: Treatment Phase|Other|0|||
128985884|NCT04668066|464237027|FG010|Part 1: Treatment Phase|Other|0|||
128985885|NCT04668066|464237028|FG011|Part 1: Treatment Phase|Other|1|||
128985886|NCT04668066|464237029|FG012|Part 1: Treatment Phase|Other|0|||
128985887|NCT04668066|464237030|FG013|Part 1: Treatment Phase|Other|0|||
128985888|NCT04668066|464237031|FG014|Part 1: Treatment Phase|Other|0|||
128985889|NCT04668066|464237032|FG015|Part 1: Treatment Phase|Other|0|||
128985890|NCT04668066|464237033|FG016|Part 1: Treatment Phase|Other|0|||
128985891|NCT04668066|464237034|FG017|Part 1: Treatment Phase|Other|0|||
128985892|NCT04668066|464237035|FG018|Part 1: Treatment Phase|Other|0|||
129208402|NCT05556265|465063314|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
128985893|NCT04668066|464237017|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985894|NCT04668066|464237018|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985895|NCT04668066|464237019|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985896|NCT04668066|464237020|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985897|NCT04668066|464237021|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985898|NCT04668066|464237022|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985899|NCT04668066|464237023|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985900|NCT04668066|464237024|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985901|NCT04668066|464237025|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985902|NCT04668066|464237026|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985903|NCT04668066|464237027|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985904|NCT04668066|464237028|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985905|NCT04668066|464237029|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
128985906|NCT04668066|464237030|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985907|NCT04668066|464237031|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985908|NCT04668066|464237032|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
128985909|NCT04668066|464237033|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985910|NCT04668066|464237034|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985911|NCT04668066|464237035|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
128985912|NCT04668066|464237017|FG000|Part 1: Follow-Up|Adverse Event|0|||
128985913|NCT04668066|464237018|FG001|Part 1: Follow-Up|Adverse Event|0|||
128985914|NCT04668066|464237019|FG002|Part 1: Follow-Up|Adverse Event|0|||
128985915|NCT04668066|464237020|FG003|Part 1: Follow-Up|Adverse Event|0|||
128985916|NCT04668066|464237021|FG004|Part 1: Follow-Up|Adverse Event|0|||
128985917|NCT04668066|464237022|FG005|Part 1: Follow-Up|Adverse Event|0|||
128985918|NCT04668066|464237023|FG006|Part 1: Follow-Up|Adverse Event|0|||
128985919|NCT04668066|464237024|FG007|Part 1: Follow-Up|Adverse Event|0|||
128985920|NCT04668066|464237025|FG008|Part 1: Follow-Up|Adverse Event|0|||
128985921|NCT04668066|464237026|FG009|Part 1: Follow-Up|Adverse Event|0|||
128985922|NCT04668066|464237027|FG010|Part 1: Follow-Up|Adverse Event|0|||
128985923|NCT04668066|464237028|FG011|Part 1: Follow-Up|Adverse Event|1|||
128985924|NCT04668066|464237029|FG012|Part 1: Follow-Up|Adverse Event|0|||
128985925|NCT04668066|464237030|FG013|Part 1: Follow-Up|Adverse Event|0|||
128985926|NCT04668066|464237031|FG014|Part 1: Follow-Up|Adverse Event|0|||
128985927|NCT04668066|464237032|FG015|Part 1: Follow-Up|Adverse Event|0|||
128985928|NCT04668066|464237033|FG016|Part 1: Follow-Up|Adverse Event|0|||
128985929|NCT04668066|464237034|FG017|Part 1: Follow-Up|Adverse Event|0|||
128985930|NCT04668066|464237035|FG018|Part 1: Follow-Up|Adverse Event|0|||
128985931|NCT04668066|464237017|FG000|Part 1: Follow-Up|Other|0|||
128985932|NCT04668066|464237018|FG001|Part 1: Follow-Up|Other|0|||
128985933|NCT04668066|464237019|FG002|Part 1: Follow-Up|Other|0|||
128985934|NCT04668066|464237020|FG003|Part 1: Follow-Up|Other|0|||
128985935|NCT04668066|464237021|FG004|Part 1: Follow-Up|Other|0|||
128985936|NCT04668066|464237022|FG005|Part 1: Follow-Up|Other|0|||
128985937|NCT04668066|464237023|FG006|Part 1: Follow-Up|Other|0|||
128985938|NCT04668066|464237024|FG007|Part 1: Follow-Up|Other|0|||
128985939|NCT04668066|464237025|FG008|Part 1: Follow-Up|Other|0|||
128985940|NCT04668066|464237026|FG009|Part 1: Follow-Up|Other|0|||
128985941|NCT04668066|464237027|FG010|Part 1: Follow-Up|Other|0|||
128985942|NCT04668066|464237028|FG011|Part 1: Follow-Up|Other|1|||
128985943|NCT04668066|464237029|FG012|Part 1: Follow-Up|Other|1|||
128985944|NCT04668066|464237030|FG013|Part 1: Follow-Up|Other|0|||
128985945|NCT04668066|464237031|FG014|Part 1: Follow-Up|Other|0|||
129208403|NCT05556265|465063315|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
129208404|NCT05556265|465063316|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
129208405|NCT05556265|465063312|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129208406|NCT05556265|465063313|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
129208407|NCT05556265|465063314|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129208408|NCT05556265|465063315|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129208409|NCT05556265|465063316|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129208410|NCT05556265|465063312|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129208411|NCT05556265|465063313|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
129208412|NCT05556265|465063314|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129208413|NCT05556265|465063315|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129208414|NCT05556265|465063316|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129208415|NCT05556265|465063312|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
129208416|NCT05556265|465063313|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
128985946|NCT04668066|464237032|FG015|Part 1: Follow-Up|Other|0|||
128985947|NCT04668066|464237033|FG016|Part 1: Follow-Up|Other|0|||
128985948|NCT04668066|464237034|FG017|Part 1: Follow-Up|Other|0|||
128985949|NCT04668066|464237035|FG018|Part 1: Follow-Up|Other|0|||
129208417|NCT05556265|465063314|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
128985950|NCT04668066|464237017|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985951|NCT04668066|464237018|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985952|NCT04668066|464237019|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985953|NCT04668066|464237020|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985954|NCT04668066|464237021|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985955|NCT04668066|464237022|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985956|NCT04668066|464237023|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985957|NCT04668066|464237024|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985958|NCT04668066|464237025|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985959|NCT04668066|464237026|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985960|NCT04668066|464237027|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985961|NCT04668066|464237028|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985962|NCT04668066|464237029|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
128985963|NCT04668066|464237030|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985964|NCT04668066|464237031|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
129208418|NCT05556265|465063315|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
129208419|NCT05556265|465063316|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
129208420|NCT05556265|465063312|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
129208421|NCT05556265|465063313|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
128985965|NCT04668066|464237032|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
128985966|NCT04668066|464237033|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985967|NCT04668066|464237034|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985968|NCT04668066|464237035|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
128985969|NCT04668066|464237017|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985970|NCT04668066|464237018|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985971|NCT04668066|464237019|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985972|NCT04668066|464237020|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985973|NCT04668066|464237021|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985974|NCT04668066|464237022|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985975|NCT04668066|464237023|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985976|NCT04668066|464237024|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985977|NCT04668066|464237025|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985978|NCT04668066|464237026|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985979|NCT04668066|464237027|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985980|NCT04668066|464237028|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985981|NCT04668066|464237029|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985982|NCT04668066|464237030|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129208422|NCT05556265|465063314|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
129208423|NCT05556265|465063315|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
129208424|NCT05556265|465063316|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
129208425|NCT05556265|465063312|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
129208426|NCT05556265|465063313|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
129208427|NCT05556265|465063314|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
129208428|NCT05556265|465063315|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
129208429|NCT05556265|465063316|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
129208430|NCT05556265|465063312|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
129208431|NCT05556265|465063313|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
129208432|NCT05556265|465063314|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
129208433|NCT05556265|465063315|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
129208434|NCT05556265|465063316|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
129208435|NCT05556265|465063312|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
129208436|NCT05556265|465063313|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
129208437|NCT05556265|465063314|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
129208438|NCT05556265|465063315|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
129208439|NCT05556265|465063316|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
129208440|NCT05556265|465063312|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
129208441|NCT05556265|465063313|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
129208442|NCT05556265|465063314|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
129208443|NCT05556265|465063315|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
129208444|NCT05556265|465063316|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
129208445|NCT03221556|465063319|FG000|Allocation|post-randomization exclusion|0|||
129208446|NCT03221556|465063320|FG001|Allocation|post-randomization exclusion|1|||
129208447|NCT03221556|465063319|FG000|Follow-Up|Withdrawal by Subject|0|||
129208448|NCT03221556|465063320|FG001|Follow-Up|Withdrawal by Subject|1|||
129208449|NCT00506350|465063321|FG000|Overall Study|Serious Adverse Event|1|||
129208450|NCT00506350|465063322|FG001|Overall Study|Serious Adverse Event|0|||
129208451|NCT00506350|465063323|FG002|Overall Study|Serious Adverse Event|0|||
129208452|NCT00506350|465063324|FG003|Overall Study|Serious Adverse Event|0|||
129208453|NCT00506350|465063325|FG004|Overall Study|Serious Adverse Event|0|||
129208454|NCT00506350|465063326|FG005|Overall Study|Serious Adverse Event|0|||
129208455|NCT00506350|465063327|FG006|Overall Study|Serious Adverse Event|0|||
129208456|NCT00506350|465063328|FG007|Overall Study|Serious Adverse Event|0|||
129208457|NCT00506350|465063329|FG008|Overall Study|Serious Adverse Event|0|||
129208458|NCT00506350|465063321|FG000|Overall Study|Adverse Event|0|||
129208459|NCT00506350|465063322|FG001|Overall Study|Adverse Event|0|||
128985983|NCT04668066|464237031|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129208460|NCT00506350|465063323|FG002|Overall Study|Adverse Event|0|||
129208461|NCT00506350|465063324|FG003|Overall Study|Adverse Event|0|||
128985984|NCT04668066|464237032|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129208462|NCT00506350|465063325|FG004|Overall Study|Adverse Event|0|||
129208463|NCT00506350|465063326|FG005|Overall Study|Adverse Event|0|||
129208464|NCT00506350|465063327|FG006|Overall Study|Adverse Event|0|||
129208465|NCT00506350|465063328|FG007|Overall Study|Adverse Event|1|||
129208466|NCT00506350|465063329|FG008|Overall Study|Adverse Event|1|||
129208467|NCT00506350|465063321|FG000|Overall Study|Protocol Violation|0|||
129208468|NCT00506350|465063322|FG001|Overall Study|Protocol Violation|0|||
129208469|NCT00506350|465063323|FG002|Overall Study|Protocol Violation|1|||
129208470|NCT00506350|465063324|FG003|Overall Study|Protocol Violation|0|||
129208471|NCT00506350|465063325|FG004|Overall Study|Protocol Violation|0|||
129208472|NCT00506350|465063326|FG005|Overall Study|Protocol Violation|0|||
129208473|NCT00506350|465063327|FG006|Overall Study|Protocol Violation|1|||
128985985|NCT04668066|464237033|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985986|NCT04668066|464237034|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
128985987|NCT04668066|464237035|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
128985988|NCT04668066|464237017|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985989|NCT04668066|464237018|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985990|NCT04668066|464237019|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985991|NCT04668066|464237020|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985992|NCT04668066|464237021|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985993|NCT04668066|464237022|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
129208474|NCT00506350|465063328|FG007|Overall Study|Protocol Violation|0|||
129208475|NCT00506350|465063329|FG008|Overall Study|Protocol Violation|0|||
128985994|NCT04668066|464237023|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
129208476|NCT00506350|465063321|FG000|Overall Study|Withdrawal by Subject|0|||
129208477|NCT00506350|465063322|FG001|Overall Study|Withdrawal by Subject|1|||
128985995|NCT04668066|464237024|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985996|NCT04668066|464237025|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985997|NCT04668066|464237026|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985998|NCT04668066|464237027|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
128985999|NCT04668066|464237028|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
128986000|NCT04668066|464237029|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
128986001|NCT04668066|464237030|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
128986002|NCT04668066|464237031|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
128986003|NCT04668066|464237032|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
128986004|NCT04668066|464237033|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
128986005|NCT04668066|464237034|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
128986006|NCT04668066|464237035|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
128986007|NCT04668066|464237017|FG000|Part 2: Treatment Phase|Other|0|||
128986008|NCT04668066|464237018|FG001|Part 2: Treatment Phase|Other|0|||
128986009|NCT04668066|464237019|FG002|Part 2: Treatment Phase|Other|0|||
128986010|NCT04668066|464237020|FG003|Part 2: Treatment Phase|Other|0|||
129208478|NCT00506350|465063323|FG002|Overall Study|Withdrawal by Subject|1|||
129208479|NCT00506350|465063324|FG003|Overall Study|Withdrawal by Subject|1|||
129208480|NCT00506350|465063325|FG004|Overall Study|Withdrawal by Subject|4|||
129208481|NCT00506350|465063326|FG005|Overall Study|Withdrawal by Subject|1|||
128986011|NCT04668066|464237021|FG004|Part 2: Treatment Phase|Other|0|||
128986012|NCT04668066|464237022|FG005|Part 2: Treatment Phase|Other|0|||
128986013|NCT04668066|464237023|FG006|Part 2: Treatment Phase|Other|0|||
128986014|NCT04668066|464237024|FG007|Part 2: Treatment Phase|Other|0|||
128986015|NCT04668066|464237025|FG008|Part 2: Treatment Phase|Other|0|||
128986016|NCT04668066|464237026|FG009|Part 2: Treatment Phase|Other|0|||
129208482|NCT00506350|465063327|FG006|Overall Study|Withdrawal by Subject|1|||
129208483|NCT00506350|465063328|FG007|Overall Study|Withdrawal by Subject|2|||
129208484|NCT00506350|465063329|FG008|Overall Study|Withdrawal by Subject|0|||
129208485|NCT00506350|465063321|FG000|Overall Study|Lost to Follow-up|1|||
129208486|NCT00506350|465063322|FG001|Overall Study|Lost to Follow-up|1|||
129208487|NCT00506350|465063323|FG002|Overall Study|Lost to Follow-up|1|||
129208488|NCT00506350|465063324|FG003|Overall Study|Lost to Follow-up|1|||
129208489|NCT00506350|465063325|FG004|Overall Study|Lost to Follow-up|2|||
129208490|NCT00506350|465063326|FG005|Overall Study|Lost to Follow-up|1|||
129208491|NCT00506350|465063327|FG006|Overall Study|Lost to Follow-up|0|||
129208492|NCT00506350|465063328|FG007|Overall Study|Lost to Follow-up|0|||
129208493|NCT00506350|465063329|FG008|Overall Study|Lost to Follow-up|2|||
129208494|NCT00506350|465063321|FG000|Overall Study|Medical Reason|0|||
129208495|NCT00506350|465063322|FG001|Overall Study|Medical Reason|0|||
128986017|NCT04668066|464237027|FG010|Part 2: Treatment Phase|Other|0|||
128986018|NCT04668066|464237028|FG011|Part 2: Treatment Phase|Other|0|||
128986019|NCT04668066|464237029|FG012|Part 2: Treatment Phase|Other|0|||
128986020|NCT04668066|464237030|FG013|Part 2: Treatment Phase|Other|0|||
129208496|NCT00506350|465063323|FG002|Overall Study|Medical Reason|0|||
129208497|NCT00506350|465063324|FG003|Overall Study|Medical Reason|0|||
128986021|NCT04668066|464237031|FG014|Part 2: Treatment Phase|Other|0|||
128986022|NCT04668066|464237032|FG015|Part 2: Treatment Phase|Other|0|||
128986023|NCT04668066|464237033|FG016|Part 2: Treatment Phase|Other|0|||
128986024|NCT04668066|464237034|FG017|Part 2: Treatment Phase|Other|0|||
129208498|NCT00506350|465063325|FG004|Overall Study|Medical Reason|1|||
129208499|NCT00506350|465063326|FG005|Overall Study|Medical Reason|0|||
129208500|NCT00506350|465063327|FG006|Overall Study|Medical Reason|0|||
129208501|NCT00506350|465063328|FG007|Overall Study|Medical Reason|0|||
129208502|NCT00506350|465063329|FG008|Overall Study|Medical Reason|0|||
129208503|NCT00506350|465063321|FG000|Overall Study|Other|1|||
129208504|NCT00506350|465063322|FG001|Overall Study|Other|1|||
129208505|NCT00506350|465063323|FG002|Overall Study|Other|3|||
128986025|NCT04668066|464237035|FG018|Part 2: Treatment Phase|Other|1|||
128986026|NCT04668066|464237017|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
129208506|NCT00506350|465063324|FG003|Overall Study|Other|0|||
129208507|NCT00506350|465063325|FG004|Overall Study|Other|3|||
129208508|NCT00506350|465063326|FG005|Overall Study|Other|0|||
129208509|NCT00506350|465063327|FG006|Overall Study|Other|0|||
128986027|NCT04668066|464237018|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986028|NCT04668066|464237019|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986029|NCT04668066|464237020|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986030|NCT04668066|464237021|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986031|NCT04668066|464237022|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986032|NCT04668066|464237023|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986033|NCT04668066|464237024|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986034|NCT04668066|464237025|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986035|NCT04668066|464237026|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986036|NCT04668066|464237027|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986037|NCT04668066|464237028|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986038|NCT04668066|464237029|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986039|NCT04668066|464237030|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986040|NCT04668066|464237031|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986041|NCT04668066|464237032|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986042|NCT04668066|464237033|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986043|NCT04668066|464237034|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
128986044|NCT04668066|464237035|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
128986045|NCT05147311|464237038|FG000|Overall Study|Did not complete survey|2|||
128986046|NCT05147311|464237039|FG001|Overall Study|Did not complete survey|1|||
128986047|NCT05147311|464237038|FG000|Overall Study|Patient too sick|1|||
128986048|NCT05147311|464237039|FG001|Overall Study|Patient too sick|2|||
128986049|NCT05147311|464237038|FG000|Overall Study|Death|0|||
129208510|NCT00506350|465063328|FG007|Overall Study|Other|2|||
129208511|NCT00506350|465063329|FG008|Overall Study|Other|2|||
129208512|NCT01691794|465063330|FG000|Overall Study|Poor/Non-Compliance|1|||
129208513|NCT01691794|465063331|FG001|Overall Study|Poor/Non-Compliance|4|||
129208514|NCT01691794|465063332|FG002|Overall Study|Poor/Non-Compliance|1|||
129208515|NCT01691794|465063330|FG000|Overall Study|Death|0|||
129208516|NCT01691794|465063331|FG001|Overall Study|Death|0|||
129208517|NCT01691794|465063332|FG002|Overall Study|Death|1|||
129208518|NCT01691794|465063330|FG000|Overall Study|Lack of Efficacy|0|||
129208519|NCT01691794|465063331|FG001|Overall Study|Lack of Efficacy|7|||
129208520|NCT01691794|465063332|FG002|Overall Study|Lack of Efficacy|1|||
129208521|NCT01691794|465063330|FG000|Overall Study|Participant request to discontinue|0|||
129208522|NCT01691794|465063331|FG001|Overall Study|Participant request to discontinue|1|||
129208523|NCT01691794|465063332|FG002|Overall Study|Participant request to discontinue|0|||
129208524|NCT01691794|465063330|FG000|Overall Study|Adverse Event|0|||
129208525|NCT01691794|465063331|FG001|Overall Study|Adverse Event|1|||
129208526|NCT01691794|465063332|FG002|Overall Study|Adverse Event|1|||
129208527|NCT01691794|465063330|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
129208528|NCT01691794|465063331|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
129208529|NCT01691794|465063332|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
128986050|NCT05147311|464237039|FG001|Overall Study|Death|1|||
128986051|NCT05147311|464237038|FG000|Overall Study|Declined survey|1|||
128986052|NCT05147311|464237039|FG001|Overall Study|Declined survey|0|||
128986053|NCT04505592|464237041|FG000|Overall Study|Death|2|||
128986054|NCT04505592|464237042|FG001|Overall Study|Death|1|||
128986055|NCT01015118|464237047|FG000|Overall Study|Protocol Violation|5|||
129208530|NCT01691794|465063330|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
129208531|NCT01691794|465063331|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
129208532|NCT01691794|465063332|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
128986056|NCT01015118|464237048|FG001|Overall Study|Protocol Violation|6|||
128986057|NCT01015118|464237047|FG000|Overall Study|Withdrawal by Subject|103|||
128986058|NCT01015118|464237048|FG001|Overall Study|Withdrawal by Subject|27|||
128986059|NCT01015118|464237047|FG000|Overall Study|Other Adverse Event (AE)|141|||
129208533|NCT04972786|465063333|FG000|First Intervention (1 Day)|Adverse Event|1|||
129208534|NCT04972786|465063334|FG001|First Intervention (1 Day)|Adverse Event|0|||
128986060|NCT01015118|464237048|FG001|Overall Study|Other Adverse Event (AE)|33|||
128986061|NCT01015118|464237047|FG000|Overall Study|Worsening or AE of underlying disease|5|||
128986062|NCT01015118|464237048|FG001|Overall Study|Worsening or AE of underlying disease|4|||
129208535|NCT00844844|465063335|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
129208536|NCT00844844|465063335|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
129208537|NCT00844844|465063335|FG000|Extension Treatment Period|Adverse Event|2|||
129208538|NCT00844844|465063335|FG000|Post Treatment Period|Withdrawal by Subject|1|||
128986063|NCT01015118|464237047|FG000|Overall Study|Progressive disease|364|||
128986064|NCT01015118|464237048|FG001|Overall Study|Progressive disease|229|||
128986065|NCT01015118|464237047|FG000|Overall Study|Not treated|9|||
128986066|NCT01015118|464237048|FG001|Overall Study|Not treated|5|||
128986067|NCT01015118|464237047|FG000|Overall Study|Other than stated above|42|||
128986068|NCT01015118|464237048|FG001|Overall Study|Other than stated above|23|||
128986069|NCT03522506|464237049|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128986070|NCT03522506|464237050|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128986071|NCT03522506|464237051|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128986072|NCT03522506|464237052|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
128986073|NCT03522506|464237049|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
128986074|NCT03522506|464237050|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
128986075|NCT03522506|464237051|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
128986076|NCT03522506|464237052|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
128986077|NCT02388906|464237054|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
128986078|NCT02388906|464237055|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
128986079|NCT02388906|464237054|FG000|Treatment Period|Disease progression|121|||
128986080|NCT02388906|464237055|FG001|Treatment Period|Disease progression|100|||
128986081|NCT02388906|464237054|FG000|Treatment Period|Study drug toxicity|41|||
128986082|NCT02388906|464237055|FG001|Treatment Period|Study drug toxicity|208|||
128986083|NCT02388906|464237054|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
128986084|NCT02388906|464237055|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
128986085|NCT02388906|464237054|FG000|Treatment Period|Participant request to stop treatment|5|||
128986086|NCT02388906|464237055|FG001|Treatment Period|Participant request to stop treatment|9|||
128986087|NCT02388906|464237054|FG000|Treatment Period|Participant withdrew consent|2|||
128986088|NCT02388906|464237055|FG001|Treatment Period|Participant withdrew consent|3|||
128986089|NCT02388906|464237054|FG000|Treatment Period|Poor/non-compliance|0|||
128986090|NCT02388906|464237055|FG001|Treatment Period|Poor/non-compliance|1|||
128986091|NCT02388906|464237054|FG000|Treatment Period|Participant no longer meets study criteria|0|||
128986092|NCT02388906|464237055|FG001|Treatment Period|Participant no longer meets study criteria|1|||
128986093|NCT02388906|464237054|FG000|Treatment Period|Other reasons|3|||
128986094|NCT02388906|464237055|FG001|Treatment Period|Other reasons|3|||
128986095|NCT04365387|464237056|FG000|Overall Study|Adverse Event|4|||
128986096|NCT04365387|464237057|FG001|Overall Study|Adverse Event|2|||
128986097|NCT04365387|464237056|FG000|Overall Study|Participants request|14|||
128986098|NCT04365387|464237057|FG001|Overall Study|Participants request|14|||
128986099|NCT04365387|464237056|FG000|Overall Study|Lost to Follow-up|8|||
128986100|NCT04365387|464237057|FG001|Overall Study|Lost to Follow-up|5|||
128986101|NCT04365387|464237056|FG000|Overall Study|Protocol deviation|3|||
128986102|NCT04365387|464237057|FG001|Overall Study|Protocol deviation|4|||
128986103|NCT04365387|464237056|FG000|Overall Study|Participant compliance with visit schedule|1|||
128986104|NCT04365387|464237057|FG001|Overall Study|Participant compliance with visit schedule|0|||
128986105|NCT04365387|464237056|FG000|Overall Study|Participant incarcerated|1|||
128986106|NCT04365387|464237057|FG001|Overall Study|Participant incarcerated|0|||
128986107|NCT04365387|464237056|FG000|Overall Study|Participant moved out of town (relocated)|0|||
128986108|NCT04365387|464237057|FG001|Overall Study|Participant moved out of town (relocated)|1|||
128986109|NCT04365387|464237056|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
128986110|NCT04365387|464237057|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
128986111|NCT04365387|464237056|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
128986112|NCT04365387|464237057|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
128986113|NCT04784455|464237058|FG000|Overall Study|Death|4|||
128986114|NCT01683565|464237061|FG000|Overall Study|Lost to Follow-up|2|||
128986115|NCT01683565|464237062|FG001|Overall Study|Lost to Follow-up|0|||
128986116|NCT01683565|464237061|FG000|Overall Study|Discontinued Intervention|1|||
128986117|NCT01683565|464237062|FG001|Overall Study|Discontinued Intervention|1|||
128986118|NCT00071006|464237063|FG000|Overall Study|Lack of Efficacy|7|||
128986119|NCT00071006|464237063|FG000|Overall Study|Adverse Event|1|||
128986120|NCT00071006|464237063|FG000|Overall Study|Withdrawal by Subject|1|||
128986121|NCT00071006|464237063|FG000|Overall Study|Other|3|||
128986122|NCT05261126|464237064|FG000|Overall Study|Death|0|||
128986123|NCT05261126|464237065|FG001|Overall Study|Death|0|||
128986124|NCT05261126|464237066|FG002|Overall Study|Death|1|||
128986125|NCT05261126|464237067|FG003|Overall Study|Death|0|||
128986126|NCT05261126|464237068|FG004|Overall Study|Death|0|||
128986127|NCT05261126|464237064|FG000|Overall Study|Lost to Follow-up|0|||
128986128|NCT05261126|464237065|FG001|Overall Study|Lost to Follow-up|0|||
128986129|NCT05261126|464237066|FG002|Overall Study|Lost to Follow-up|0|||
128986130|NCT05261126|464237067|FG003|Overall Study|Lost to Follow-up|0|||
128986131|NCT05261126|464237068|FG004|Overall Study|Lost to Follow-up|1|||
128986132|NCT05261126|464237064|FG000|Overall Study|Physician Decision|1|||
128986133|NCT05261126|464237065|FG001|Overall Study|Physician Decision|0|||
128986134|NCT05261126|464237066|FG002|Overall Study|Physician Decision|0|||
128986135|NCT05261126|464237067|FG003|Overall Study|Physician Decision|0|||
128986136|NCT05261126|464237068|FG004|Overall Study|Physician Decision|0|||
128986137|NCT05261126|464237064|FG000|Overall Study|Screen Failure|0|||
128986138|NCT05261126|464237065|FG001|Overall Study|Screen Failure|0|||
128986139|NCT05261126|464237066|FG002|Overall Study|Screen Failure|0|||
128986140|NCT05261126|464237067|FG003|Overall Study|Screen Failure|0|||
128986141|NCT05261126|464237068|FG004|Overall Study|Screen Failure|1|||
128986142|NCT05261126|464237064|FG000|Overall Study|Withdrawal by Subject|1|||
128986143|NCT05261126|464237065|FG001|Overall Study|Withdrawal by Subject|0|||
128986144|NCT05261126|464237066|FG002|Overall Study|Withdrawal by Subject|1|||
128986145|NCT05261126|464237067|FG003|Overall Study|Withdrawal by Subject|1|||
128986146|NCT05261126|464237068|FG004|Overall Study|Withdrawal by Subject|0|||
128986147|NCT05261126|464237064|FG000|Overall Study|Not Recorded|0|||
128986148|NCT05261126|464237065|FG001|Overall Study|Not Recorded|0|||
128986149|NCT05261126|464237066|FG002|Overall Study|Not Recorded|0|||
128986150|NCT05261126|464237067|FG003|Overall Study|Not Recorded|1|||
128986151|NCT05261126|464237068|FG004|Overall Study|Not Recorded|0|||
128986152|NCT03901274|464237069|FG000|Overall Study|Lost to Follow-up|120|||
128986153|NCT03901274|464237070|FG001|Overall Study|Lost to Follow-up|124|||
128986154|NCT03901274|464237069|FG000|Overall Study|Withdrawal by Subject|0|||
128986155|NCT03901274|464237070|FG001|Overall Study|Withdrawal by Subject|6|||
128986156|NCT04527380|464237071|FG000|Overall Study|Lack of Efficacy|0|||
128986157|NCT04527380|464237072|FG001|Overall Study|Lack of Efficacy|1|||
128986158|NCT04527380|464237071|FG000|Overall Study|Withdrawal by Subject|1|||
128986159|NCT04527380|464237072|FG001|Overall Study|Withdrawal by Subject|0|||
128986160|NCT04411641|464237073|FG000|DB Period|Other|7|||
128986161|NCT04411641|464237074|FG001|DB Period|Other|27|||
128986162|NCT04411641|464237075|FG002|DB Period|Other|0|||
128986163|NCT04411641|464237076|FG003|DB Period|Other|0|||
128986164|NCT04411641|464237073|FG000|DB Period|Withdrawal by Subject|67|||
128986165|NCT04411641|464237074|FG001|DB Period|Withdrawal by Subject|122|||
128986166|NCT04411641|464237075|FG002|DB Period|Withdrawal by Subject|0|||
128986167|NCT04411641|464237076|FG003|DB Period|Withdrawal by Subject|0|||
128986168|NCT04411641|464237073|FG000|DB Period|Progressive disease|76|||
128986169|NCT04411641|464237074|FG001|DB Period|Progressive disease|116|||
128986170|NCT04411641|464237075|FG002|DB Period|Progressive disease|0|||
128986171|NCT04411641|464237076|FG003|DB Period|Progressive disease|0|||
128986172|NCT04411641|464237073|FG000|DB Period|Poor compliance to protocol|1|||
128986173|NCT04411641|464237074|FG001|DB Period|Poor compliance to protocol|5|||
128986174|NCT04411641|464237075|FG002|DB Period|Poor compliance to protocol|0|||
128986175|NCT04411641|464237076|FG003|DB Period|Poor compliance to protocol|0|||
128986176|NCT04411641|464237073|FG000|DB Period|Lack of Efficacy|19|||
128986177|NCT04411641|464237074|FG001|DB Period|Lack of Efficacy|19|||
128986178|NCT04411641|464237075|FG002|DB Period|Lack of Efficacy|0|||
128986179|NCT04411641|464237076|FG003|DB Period|Lack of Efficacy|0|||
128986180|NCT04411641|464237073|FG000|DB Period|Adverse Event|13|||
128986181|NCT04411641|464237074|FG001|DB Period|Adverse Event|29|||
128986182|NCT04411641|464237075|FG002|DB Period|Adverse Event|0|||
128986183|NCT04411641|464237076|FG003|DB Period|Adverse Event|0|||
128986184|NCT04411641|464237073|FG000|DB Period|Randomized and not treated|2|||
128986185|NCT04411641|464237074|FG001|DB Period|Randomized and not treated|2|||
128986186|NCT04411641|464237075|FG002|DB Period|Randomized and not treated|0|||
128986187|NCT04411641|464237076|FG003|DB Period|Randomized and not treated|0|||
128986188|NCT04411641|464237073|FG000|OL|Withdrawal by Subject|0|||
128986189|NCT04411641|464237074|FG001|OL|Withdrawal by Subject|0|||
128986190|NCT04411641|464237075|FG002|OL|Withdrawal by Subject|6|||
128986191|NCT04411641|464237076|FG003|OL|Withdrawal by Subject|17|||
128986192|NCT04411641|464237073|FG000|OL|Progressive disease|0|||
128986193|NCT04411641|464237074|FG001|OL|Progressive disease|0|||
128986194|NCT04411641|464237075|FG002|OL|Progressive disease|1|||
128986195|NCT04411641|464237076|FG003|OL|Progressive disease|2|||
128986196|NCT04411641|464237073|FG000|OL|Poor compliance to protocol|0|||
128986197|NCT04411641|464237074|FG001|OL|Poor compliance to protocol|0|||
128986198|NCT04411641|464237075|FG002|OL|Poor compliance to protocol|1|||
128986199|NCT04411641|464237076|FG003|OL|Poor compliance to protocol|0|||
128986200|NCT04411641|464237073|FG000|OL|Adverse Event|0|||
129208539|NCT03905096|465063336|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
129208540|NCT03905096|465063337|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
128986201|NCT04411641|464237074|FG001|OL|Adverse Event|0|||
128986202|NCT04411641|464237075|FG002|OL|Adverse Event|1|||
128986203|NCT04411641|464237076|FG003|OL|Adverse Event|0|||
128986204|NCT04411641|464237073|FG000|OL|Other|0|||
128986205|NCT04411641|464237074|FG001|OL|Other|0|||
128986206|NCT04411641|464237075|FG002|OL|Other|0|||
128986207|NCT04411641|464237076|FG003|OL|Other|6|||
128986208|NCT03282123|464237081|FG000|Overall Study|Withdrawal by Subject|5|||
128986209|NCT01195662|464237084|FG000|Double Blind Treatment Period|Adverse Event|4|||
128986210|NCT01195662|464237085|FG001|Double Blind Treatment Period|Adverse Event|1|||
128986211|NCT01195662|464237086|FG002|Double Blind Treatment Period|Adverse Event|2|||
128986212|NCT01195662|464237084|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
128986213|NCT01195662|464237085|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
128986214|NCT01195662|464237086|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
128986215|NCT01195662|464237084|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
128986216|NCT01195662|464237085|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
128986217|NCT01195662|464237086|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
128986218|NCT01195662|464237084|FG000|Double Blind Treatment Period|Administrative reason|2|||
128986219|NCT01195662|464237085|FG001|Double Blind Treatment Period|Administrative reason|1|||
128986220|NCT01195662|464237086|FG002|Double Blind Treatment Period|Administrative reason|1|||
128986221|NCT01195662|464237084|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
128986222|NCT01195662|464237085|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
128986223|NCT01195662|464237086|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
128986224|NCT01195662|464237084|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
128986225|NCT01195662|464237085|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
128986226|NCT01195662|464237086|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
128986227|NCT01195662|464237084|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
128986228|NCT01195662|464237085|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
128986229|NCT01195662|464237086|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
128986230|NCT01195662|464237084|FG000|Double Blind Treatment Period|Non-specified|3|||
128986231|NCT01195662|464237085|FG001|Double Blind Treatment Period|Non-specified|0|||
128986232|NCT01195662|464237086|FG002|Double Blind Treatment Period|Non-specified|0|||
128986233|NCT01195662|464237084|FG000|Double Blind Treatment Period|Missing disposition information|0|||
128986234|NCT01195662|464237085|FG001|Double Blind Treatment Period|Missing disposition information|1|||
128986235|NCT01195662|464237086|FG002|Double Blind Treatment Period|Missing disposition information|1|||
128986236|NCT01195662|464237084|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
128986237|NCT01195662|464237085|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
128986238|NCT01195662|464237086|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
128986239|NCT01195662|464237084|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
128986240|NCT01195662|464237085|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
128986241|NCT01195662|464237086|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
128986242|NCT01215968|464237087|FG000|Overall Study|Adverse Event|0|||
128986243|NCT01215968|464237088|FG001|Overall Study|Adverse Event|2|||
128986244|NCT01215968|464237087|FG000|Overall Study|Protocol Violation|2|||
128986245|NCT01215968|464237088|FG001|Overall Study|Protocol Violation|4|||
128986246|NCT01215968|464237087|FG000|Overall Study|Not received study drug|0|||
128986247|NCT01215968|464237088|FG001|Overall Study|Not received study drug|1|||
128986248|NCT05643573|464237090|FG000|Overall Study|Adverse Event|117|||
128986249|NCT05643573|464237091|FG001|Overall Study|Adverse Event|90|||
128986250|NCT05643573|464237090|FG000|Overall Study|Death|53|||
128986251|NCT05643573|464237091|FG001|Overall Study|Death|57|||
128986252|NCT05643573|464237090|FG000|Overall Study|Lost to Follow-up|6|||
128986253|NCT05643573|464237091|FG001|Overall Study|Lost to Follow-up|3|||
128986254|NCT05643573|464237090|FG000|Overall Study|Other|18|||
128986255|NCT05643573|464237091|FG001|Overall Study|Other|15|||
128986256|NCT05643573|464237090|FG000|Overall Study|Outcome event|64|||
128986257|NCT05643573|464237091|FG001|Overall Study|Outcome event|36|||
128986258|NCT05643573|464237090|FG000|Overall Study|Physician Decision|33|||
128986259|NCT05643573|464237091|FG001|Overall Study|Physician Decision|19|||
128986260|NCT05643573|464237090|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
128986261|NCT05643573|464237091|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
128986262|NCT05643573|464237090|FG000|Overall Study|Site terminated by sponsor|10|||
128986263|NCT05643573|464237091|FG001|Overall Study|Site terminated by sponsor|10|||
128986264|NCT05643573|464237090|FG000|Overall Study|Study terminated by sponsor|1|||
128986265|NCT05643573|464237091|FG001|Overall Study|Study terminated by sponsor|0|||
128986266|NCT05643573|464237090|FG000|Overall Study|Withdrawal by Subject|178|||
128986267|NCT05643573|464237091|FG001|Overall Study|Withdrawal by Subject|130|||
128986268|NCT04768881|464237094|FG000|Overall Study|Completed Study Follow-up|0|||
128986269|NCT04768881|464237095|FG001|Overall Study|Completed Study Follow-up|2|||
128986270|NCT04768881|464237094|FG000|Overall Study|Death|3|||
128986271|NCT04768881|464237095|FG001|Overall Study|Death|2|||
128986272|NCT04768881|464237094|FG000|Overall Study|Study Terminated by Sponsor|2|||
128986273|NCT04768881|464237095|FG001|Overall Study|Study Terminated by Sponsor|2|||
128986274|NCT04768881|464237094|FG000|Overall Study|Withdrawal by Subject|2|||
128986275|NCT04768881|464237095|FG001|Overall Study|Withdrawal by Subject|0|||
128986276|NCT04768881|464237094|FG000|Overall Study|Other|2|||
128986277|NCT04768881|464237095|FG001|Overall Study|Other|0|||
128986278|NCT04089566|464237097|FG000|Overall Study|Death|0|||
129208541|NCT02016781|465063339|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
128986279|NCT04089566|464237098|FG001|Overall Study|Death|6|||
128986280|NCT04089566|464237099|FG002|Overall Study|Death|10|||
128986281|NCT04089566|464237100|FG003|Overall Study|Death|0|||
128986282|NCT04089566|464237101|FG004|Overall Study|Death|0|||
128986283|NCT04089566|464237102|FG005|Overall Study|Death|0|||
128986284|NCT04089566|464237097|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
128986285|NCT04089566|464237098|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
128986286|NCT04089566|464237099|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
128986287|NCT04089566|464237100|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
129208542|NCT02016781|465063340|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
128986288|NCT04089566|464237101|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
128986289|NCT04089566|464237102|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
129208543|NCT02016781|465063339|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
129208544|NCT02016781|465063340|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
129208545|NCT02016781|465063339|FG000|Final Database Lock|Withdrawal by Subject|2|||
129208546|NCT02016781|465063340|FG001|Final Database Lock|Withdrawal by Subject|1|||
129208547|NCT02016781|465063339|FG000|Final Database Lock|Lost to Follow-up|11|||
129208548|NCT02016781|465063340|FG001|Final Database Lock|Lost to Follow-up|4|||
129208549|NCT02016781|465063339|FG000|Final Database Lock|Missing data|0|||
129208550|NCT02016781|465063340|FG001|Final Database Lock|Missing data|3|||
129208551|NCT04886154|465063341|FG000|Overall Study|Adverse Event|0|||
129208552|NCT04886154|465063342|FG001|Overall Study|Adverse Event|0|||
129208553|NCT04886154|465063343|FG002|Overall Study|Adverse Event|0|||
129208554|NCT04886154|465063344|FG003|Overall Study|Adverse Event|0|||
129208555|NCT04886154|465063345|FG004|Overall Study|Adverse Event|1|||
129208556|NCT04886154|465063346|FG005|Overall Study|Adverse Event|0|||
128986290|NCT04089566|464237097|FG000|Overall Study|Reason not Specified|0|||
128986291|NCT04089566|464237098|FG001|Overall Study|Reason not Specified|4|||
128986292|NCT04089566|464237099|FG002|Overall Study|Reason not Specified|4|||
128986293|NCT04089566|464237100|FG003|Overall Study|Reason not Specified|1|||
128986294|NCT04089566|464237101|FG004|Overall Study|Reason not Specified|0|||
128986295|NCT04089566|464237102|FG005|Overall Study|Reason not Specified|0|||
128986296|NCT01958619|464237108|FG000|Overall Study|Protocol Violation|2|||
128986297|NCT01958619|464237109|FG001|Overall Study|Protocol Violation|0|||
128986298|NCT01958619|464237110|FG002|Overall Study|Protocol Violation|1|||
128986299|NCT01958619|464237111|FG003|Overall Study|Protocol Violation|0|||
128986300|NCT01875731|464237116|FG000|Overall Study|Fail to obtain lab sample|1|||
128986301|NCT01875731|464237117|FG001|Overall Study|Fail to obtain lab sample|0|||
128986302|NCT00157820|464237120|FG000|Randomized|Physician Decision|4|||
128986303|NCT00157820|464237121|FG001|Randomized|Physician Decision|2|||
128986304|NCT00157820|464237122|FG002|Randomized|Physician Decision|3|||
128986305|NCT00157820|464237120|FG000|Randomized|Withdrawal by Subject|1|||
128986306|NCT00157820|464237121|FG001|Randomized|Withdrawal by Subject|2|||
128986307|NCT00157820|464237122|FG002|Randomized|Withdrawal by Subject|3|||
128986308|NCT00157820|464237120|FG000|Randomized|Protocol Violation|2|||
128986309|NCT00157820|464237121|FG001|Randomized|Protocol Violation|1|||
128986310|NCT00157820|464237122|FG002|Randomized|Protocol Violation|2|||
128986311|NCT00157820|464237120|FG000|1st 8 Month|Death|7|||
128986312|NCT00157820|464237121|FG001|1st 8 Month|Death|8|||
128986313|NCT00157820|464237122|FG002|1st 8 Month|Death|3|||
128986314|NCT00157820|464237120|FG000|1st 8 Month|Lost to Follow-up|1|||
128986315|NCT00157820|464237121|FG001|1st 8 Month|Lost to Follow-up|2|||
128986316|NCT00157820|464237122|FG002|1st 8 Month|Lost to Follow-up|1|||
128986317|NCT00157820|464237120|FG000|1st 8 Month|Premature cross-over|0|||
128986318|NCT00157820|464237121|FG001|1st 8 Month|Premature cross-over|2|||
128986319|NCT00157820|464237122|FG002|1st 8 Month|Premature cross-over|2|||
128986320|NCT00157820|464237120|FG000|2nd 8 Months|Death|3|||
128986321|NCT00157820|464237121|FG001|2nd 8 Months|Death|1|||
128986322|NCT00157820|464237122|FG002|2nd 8 Months|Death|3|||
128986323|NCT00157820|464237120|FG000|2nd 8 Months|Lost to Follow-up|1|||
128986324|NCT00157820|464237121|FG001|2nd 8 Months|Lost to Follow-up|5|||
128986325|NCT00157820|464237122|FG002|2nd 8 Months|Lost to Follow-up|2|||
128986326|NCT00157820|464237120|FG000|2nd 8 Months|Premature cross-over|1|||
129208557|NCT04886154|465063347|FG006|Overall Study|Adverse Event|0|||
129208558|NCT04886154|465063348|FG007|Overall Study|Adverse Event|1|||
129208559|NCT04886154|465063349|FG008|Overall Study|Adverse Event|1|||
129208560|NCT04886154|465063350|FG009|Overall Study|Adverse Event|0|||
129208561|NCT04886154|465063351|FG010|Overall Study|Adverse Event|0|||
129208562|NCT04886154|465063352|FG011|Overall Study|Adverse Event|1|||
129208563|NCT04886154|465063353|FG012|Overall Study|Adverse Event|0|||
129208564|NCT04886154|465063354|FG013|Overall Study|Adverse Event|0|||
129208565|NCT04886154|465063355|FG014|Overall Study|Adverse Event|3|||
129208566|NCT04886154|465063341|FG000|Overall Study|Lost to Follow-up|1|||
129208567|NCT04886154|465063342|FG001|Overall Study|Lost to Follow-up|0|||
129208568|NCT04886154|465063343|FG002|Overall Study|Lost to Follow-up|2|||
129208569|NCT04886154|465063344|FG003|Overall Study|Lost to Follow-up|0|||
128986327|NCT00157820|464237121|FG001|2nd 8 Months|Premature cross-over|7|||
128986328|NCT00157820|464237122|FG002|2nd 8 Months|Premature cross-over|9|||
128986329|NCT00223990|464237125|FG000|Overall Study|Moved from area|2|||
128986330|NCT00223990|464237126|FG001|Overall Study|Moved from area|1|||
128986331|NCT00223990|464237125|FG000|Overall Study|Withdrawal by Subject|4|||
128986332|NCT00223990|464237126|FG001|Overall Study|Withdrawal by Subject|8|||
128986333|NCT00223990|464237125|FG000|Overall Study|Lost to Follow-up|1|||
128986334|NCT00223990|464237126|FG001|Overall Study|Lost to Follow-up|0|||
129208570|NCT04886154|465063345|FG004|Overall Study|Lost to Follow-up|17|||
129208571|NCT04886154|465063346|FG005|Overall Study|Lost to Follow-up|7|||
129208572|NCT04886154|465063347|FG006|Overall Study|Lost to Follow-up|8|||
129208573|NCT04886154|465063348|FG007|Overall Study|Lost to Follow-up|7|||
129208574|NCT04886154|465063349|FG008|Overall Study|Lost to Follow-up|8|||
129208575|NCT04886154|465063350|FG009|Overall Study|Lost to Follow-up|0|||
128986335|NCT01302366|464238912|FG000|Overall Study|patient choice or noncompliance|5|||
128986336|NCT00509223|464238915|FG000|Overall Study|Lost to Follow-up|1|||
128986337|NCT00509223|464238916|FG001|Overall Study|Lost to Follow-up|1|||
128986338|NCT00509223|464238915|FG000|Overall Study|Adverse Event|1|||
128986339|NCT00509223|464238916|FG001|Overall Study|Adverse Event|1|||
128986340|NCT00509223|464238915|FG000|Overall Study|Withdrawal by Subject|25|||
128986341|NCT00509223|464238916|FG001|Overall Study|Withdrawal by Subject|6|||
128986342|NCT00509223|464238915|FG000|Overall Study|Including: subject change of address|5|||
128986343|NCT00509223|464238916|FG001|Overall Study|Including: subject change of address|2|||
128986344|NCT00509223|464238915|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
128986345|NCT00509223|464238916|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
128986346|NCT00467051|464238917|FG000|Overall Study|Adverse Event|2|||
128986347|NCT00934661|464238918|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
128986348|NCT00934661|464238919|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
128986349|NCT00437294|464238923|FG000|Overall Study|Adverse Event|5|||
128986350|NCT00437294|464238924|FG001|Overall Study|Adverse Event|4|||
128986351|NCT00437294|464238923|FG000|Overall Study|Death|5|||
128986352|NCT00437294|464238924|FG001|Overall Study|Death|2|||
128986353|NCT00437294|464238923|FG000|Overall Study|Physician Decision|0|||
128986354|NCT00437294|464238924|FG001|Overall Study|Physician Decision|3|||
128986355|NCT00437294|464238923|FG000|Overall Study|Withdrawal by Subject|5|||
128986356|NCT00437294|464238924|FG001|Overall Study|Withdrawal by Subject|0|||
128986357|NCT00437294|464238923|FG000|Overall Study|Progressive Disease|19|||
128986358|NCT00437294|464238924|FG001|Overall Study|Progressive Disease|23|||
128986359|NCT00437294|464238923|FG000|Overall Study|Sponsor Decision|8|||
128986360|NCT00437294|464238924|FG001|Overall Study|Sponsor Decision|9|||
128986361|NCT00437294|464238923|FG000|Overall Study|Protocol Violation|0|||
128986362|NCT00437294|464238924|FG001|Overall Study|Protocol Violation|1|||
128986363|NCT00437294|464238923|FG000|Overall Study|Entry criteria not met|1|||
128986364|NCT00437294|464238924|FG001|Overall Study|Entry criteria not met|1|||
128986365|NCT01473602|464238929|FG000|Overall Study|Adverse Event|1|||
128986366|NCT01473602|464238930|FG001|Overall Study|Adverse Event|2|||
128986367|NCT01473602|464238929|FG000|Overall Study|Death|0|||
128986368|NCT01473602|464238930|FG001|Overall Study|Death|1|||
128986369|NCT01473602|464238929|FG000|Overall Study|Lost to Follow-up|1|||
128986370|NCT01473602|464238930|FG001|Overall Study|Lost to Follow-up|1|||
128986371|NCT01473602|464238929|FG000|Overall Study|Withdrawal by Subject|5|||
128986372|NCT01473602|464238930|FG001|Overall Study|Withdrawal by Subject|4|||
128986373|NCT01473602|464238929|FG000|Overall Study|Physician Decision|1|||
128986374|NCT01473602|464238930|FG001|Overall Study|Physician Decision|0|||
128986375|NCT02674568|464238933|FG000|Overall Study|Withdrawal by Subject|5|||
128986376|NCT02674568|464238933|FG000|Overall Study|Death|303|||
128986377|NCT02674568|464238933|FG000|Overall Study|Physician Decision|2|||
128986378|NCT02674568|464238933|FG000|Overall Study|Lost to Follow-up|9|||
128986379|NCT02674568|464238933|FG000|Overall Study|Other, Not Specified|20|||
128986380|NCT00968539|464238934|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
128986381|NCT00968539|464238935|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
128986382|NCT00457249|464238936|FG000|Overall Study|Lost to Follow-up|3|||
128986383|NCT00457249|464238937|FG001|Overall Study|Lost to Follow-up|0|||
128986384|NCT00457249|464238936|FG000|Overall Study|Protocol Violation|4|||
128986385|NCT00457249|464238937|FG001|Overall Study|Protocol Violation|1|||
128986386|NCT00457249|464238936|FG000|Overall Study|Withdrawal by Subject|3|||
128986387|NCT00457249|464238937|FG001|Overall Study|Withdrawal by Subject|1|||
128986388|NCT00457249|464238936|FG000|Overall Study|Serious Adverse Events|2|||
128986389|NCT00457249|464238937|FG001|Overall Study|Serious Adverse Events|0|||
128986390|NCT00396318|464238938|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
128986391|NCT00326118|464238939|FG000|Active Phase|Withdrawal by Subject|4|||
128986392|NCT00326118|464238940|FG001|Active Phase|Withdrawal by Subject|1|||
128986393|NCT00938392|464238941|FG000|Overall Study|Adverse Event|0|||
128986394|NCT00938392|464238942|FG001|Overall Study|Adverse Event|1|||
128986395|NCT00938392|464238941|FG000|Overall Study|Withdrawal by Subject|0|||
128986396|NCT00938392|464238942|FG001|Overall Study|Withdrawal by Subject|1|||
128986397|NCT00938392|464238941|FG000|Overall Study|Lost to Follow-up|2|||
128986398|NCT00938392|464238942|FG001|Overall Study|Lost to Follow-up|2|||
129208576|NCT04886154|465063351|FG010|Overall Study|Lost to Follow-up|2|||
128986399|NCT03526549|464238943|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
128986400|NCT03526549|464238944|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
128986401|NCT03526549|464238943|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
128986402|NCT03526549|464238944|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
128986403|NCT03526549|464238943|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
128986404|NCT03526549|464238944|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
128986405|NCT03526549|464238943|FG000|Open-label Phase|Adverse Event|4|||
128986406|NCT03526549|464238944|FG001|Open-label Phase|Adverse Event|0|||
128986407|NCT03526549|464238943|FG000|Open-label Phase|Withdrawal by Subject|54|||
128986408|NCT03526549|464238944|FG001|Open-label Phase|Withdrawal by Subject|0|||
129208577|NCT04886154|465063352|FG011|Overall Study|Lost to Follow-up|0|||
128986409|NCT03526549|464238943|FG000|Open-label Phase|Lost to Follow-up|35|||
128986410|NCT03526549|464238944|FG001|Open-label Phase|Lost to Follow-up|0|||
128986411|NCT03526549|464238943|FG000|Open-label Phase|Other than Specified|5|||
128986412|NCT03526549|464238944|FG001|Open-label Phase|Other than Specified|0|||
128986413|NCT05981365|464238951|FG000|Period 1|Adverse Event|1|||
128986414|NCT05981365|464238952|FG001|Period 1|Adverse Event|0|||
128986415|NCT04780776|464238953|FG000|Titration Week 1-5|Lost to Follow-up|2|||
128986416|NCT04780776|464238954|FG001|Titration Week 1-5|Lost to Follow-up|8|||
128986417|NCT04780776|464238953|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
128986418|NCT04780776|464238954|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
128986419|NCT04780776|464238953|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
128986420|NCT04780776|464238954|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
128986421|NCT03113760|464238955|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
128986422|NCT03113760|464238956|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
128986423|NCT03113760|464238957|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
128986424|NCT03113760|464238958|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
128986425|NCT03113760|464238955|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
128986426|NCT03113760|464238956|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
128986427|NCT03113760|464238957|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
128986428|NCT03113760|464238958|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
128986429|NCT03113760|464238955|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
128986430|NCT03113760|464238956|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
128986431|NCT03113760|464238957|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
128986432|NCT03113760|464238958|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
128986433|NCT03927989|464238959|FG000|Overall Study|Withdrawal by Subject|0|||
128986434|NCT03927989|464238960|FG001|Overall Study|Withdrawal by Subject|1|||
128986435|NCT00003526|464238961|FG000|Overall Study|Not evaluable|6|||
128986436|NCT01453296|464238964|FG000|Treatment Period 1|Adverse Event|0|||
128986437|NCT01453296|464238965|FG001|Treatment Period 1|Adverse Event|1|||
128986438|NCT01453296|464238964|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
128986439|NCT01453296|464238965|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
128986440|NCT01453296|464238964|FG000|Treatment Period 2|Adverse Event|1|||
128986441|NCT01453296|464238965|FG001|Treatment Period 2|Adverse Event|0|||
128986442|NCT01453296|464238964|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128986443|NCT01453296|464238965|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128986444|NCT03480243|464238973|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
128986445|NCT03480243|464238973|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
128986446|NCT05770401|464238989|FG000|Overall Study|Lost to Follow-up|5|||
128986447|NCT05770401|464238990|FG001|Overall Study|Lost to Follow-up|4|||
128986448|NCT00402298|464238991|FG000|Overall Study|Withdrawal by Subject|1|||
128986449|NCT00402298|464238992|FG001|Overall Study|Withdrawal by Subject|0|||
128986450|NCT05048875|464238993|FG000|Overall Study|Withdrawal by Subject|1|||
128986451|NCT05048875|464238994|FG001|Overall Study|Withdrawal by Subject|0|||
128986452|NCT05048875|464238995|FG002|Overall Study|Withdrawal by Subject|0|||
128986453|NCT05048875|464238996|FG003|Overall Study|Withdrawal by Subject|0|||
128986454|NCT05048875|464238997|FG004|Overall Study|Withdrawal by Subject|0|||
128986455|NCT05048875|464238998|FG005|Overall Study|Withdrawal by Subject|0|||
128986456|NCT05048875|464238999|FG006|Overall Study|Withdrawal by Subject|0|||
128986457|NCT05048875|464239000|FG007|Overall Study|Withdrawal by Subject|0|||
128986458|NCT05048875|464238993|FG000|Overall Study|Adverse Event|0|||
128986459|NCT05048875|464238994|FG001|Overall Study|Adverse Event|0|||
128986460|NCT05048875|464238995|FG002|Overall Study|Adverse Event|0|||
128986461|NCT05048875|464238996|FG003|Overall Study|Adverse Event|1|||
128986462|NCT05048875|464238997|FG004|Overall Study|Adverse Event|0|||
128986463|NCT05048875|464238998|FG005|Overall Study|Adverse Event|0|||
128986464|NCT05048875|464238999|FG006|Overall Study|Adverse Event|0|||
128986465|NCT05048875|464239000|FG007|Overall Study|Adverse Event|0|||
128986466|NCT02255422|464239005|FG000|Overall Study|Withdrawal by Subject|0|||
128986467|NCT02255422|464239006|FG001|Overall Study|Withdrawal by Subject|0|||
128986468|NCT02255422|464239007|FG002|Overall Study|Withdrawal by Subject|0|||
128986469|NCT02255422|464239008|FG003|Overall Study|Withdrawal by Subject|0|||
128986470|NCT02255422|464239009|FG004|Overall Study|Withdrawal by Subject|0|||
128986471|NCT02255422|464239010|FG005|Overall Study|Withdrawal by Subject|0|||
128986472|NCT02255422|464239011|FG006|Overall Study|Withdrawal by Subject|2|||
128986473|NCT02255422|464239005|FG000|Overall Study|Lost to Follow-up|0|||
128986474|NCT02255422|464239006|FG001|Overall Study|Lost to Follow-up|0|||
128986475|NCT02255422|464239007|FG002|Overall Study|Lost to Follow-up|1|||
128986476|NCT02255422|464239008|FG003|Overall Study|Lost to Follow-up|0|||
128986477|NCT02255422|464239009|FG004|Overall Study|Lost to Follow-up|0|||
128986478|NCT02255422|464239010|FG005|Overall Study|Lost to Follow-up|0|||
128986479|NCT02255422|464239011|FG006|Overall Study|Lost to Follow-up|0|||
128986480|NCT00938366|464239012|FG000|Overall Study|Withdrawal by Subject|1|||
128986481|NCT00938366|464239013|FG001|Overall Study|Withdrawal by Subject|0|||
128986482|NCT01250418|464239020|FG000|Overall Study|monitor data failure|1|||
128986483|NCT01250418|464239021|FG001|Overall Study|monitor data failure|1|||
128986484|NCT01761565|464239022|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
128986485|NCT05182840|464239024|FG000|Run-in Period|Not treated|0|||
128986486|NCT05182840|464239025|FG001|Run-in Period|Not treated|1|||
128986487|NCT05182840|464239026|FG002|Run-in Period|Not treated|0|||
129208578|NCT04886154|465063353|FG012|Overall Study|Lost to Follow-up|0|||
129208579|NCT04886154|465063354|FG013|Overall Study|Lost to Follow-up|0|||
129208580|NCT04886154|465063355|FG014|Overall Study|Lost to Follow-up|0|||
129208581|NCT04886154|465063341|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208582|NCT04886154|465063342|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208583|NCT04886154|465063343|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208584|NCT04886154|465063344|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208585|NCT04886154|465063345|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208586|NCT04886154|465063346|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208587|NCT04886154|465063347|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
129208588|NCT04886154|465063348|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208589|NCT04886154|465063349|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
128986488|NCT05182840|464239027|FG003|Run-in Period|Not treated|0|||
128986489|NCT05182840|464239028|FG004|Run-in Period|Not treated|0|||
128986490|NCT05182840|464239029|FG005|Run-in Period|Not treated|0|||
128986491|NCT05182840|464239030|FG006|Run-in Period|Not treated|0|||
128986492|NCT05182840|464239031|FG007|Run-in Period|Not treated|0|||
128986493|NCT05182840|464239032|FG008|Run-in Period|Not treated|0|||
128986494|NCT05182840|464239033|FG009|Run-in Period|Not treated|0|||
128986495|NCT05182840|464239024|FG000|Run-in Period|Other reason but not sponsor termination|14|||
128986496|NCT05182840|464239025|FG001|Run-in Period|Other reason but not sponsor termination|18|||
128986497|NCT05182840|464239026|FG002|Run-in Period|Other reason but not sponsor termination|0|||
128986498|NCT05182840|464239027|FG003|Run-in Period|Other reason but not sponsor termination|0|||
128986499|NCT05182840|464239028|FG004|Run-in Period|Other reason but not sponsor termination|0|||
128986500|NCT05182840|464239029|FG005|Run-in Period|Other reason but not sponsor termination|0|||
128986501|NCT05182840|464239030|FG006|Run-in Period|Other reason but not sponsor termination|0|||
128986502|NCT05182840|464239031|FG007|Run-in Period|Other reason but not sponsor termination|0|||
128986503|NCT05182840|464239032|FG008|Run-in Period|Other reason but not sponsor termination|0|||
128986504|NCT05182840|464239033|FG009|Run-in Period|Other reason but not sponsor termination|0|||
128986505|NCT05182840|464239024|FG000|Run-in Period|No reason available|2|||
128986506|NCT05182840|464239025|FG001|Run-in Period|No reason available|2|||
128986507|NCT05182840|464239026|FG002|Run-in Period|No reason available|0|||
128986508|NCT05182840|464239027|FG003|Run-in Period|No reason available|0|||
128986509|NCT05182840|464239028|FG004|Run-in Period|No reason available|0|||
128986510|NCT05182840|464239029|FG005|Run-in Period|No reason available|0|||
128986511|NCT05182840|464239030|FG006|Run-in Period|No reason available|0|||
128986512|NCT05182840|464239031|FG007|Run-in Period|No reason available|0|||
128986513|NCT05182840|464239032|FG008|Run-in Period|No reason available|0|||
128986514|NCT05182840|464239033|FG009|Run-in Period|No reason available|0|||
128986515|NCT05182840|464239024|FG000|Run-in Period|Burden of study procedures|2|||
128986516|NCT05182840|464239025|FG001|Run-in Period|Burden of study procedures|2|||
128986517|NCT05182840|464239026|FG002|Run-in Period|Burden of study procedures|0|||
128986518|NCT05182840|464239027|FG003|Run-in Period|Burden of study procedures|0|||
128986519|NCT05182840|464239028|FG004|Run-in Period|Burden of study procedures|0|||
128986520|NCT05182840|464239029|FG005|Run-in Period|Burden of study procedures|0|||
128986521|NCT05182840|464239030|FG006|Run-in Period|Burden of study procedures|0|||
128986522|NCT05182840|464239031|FG007|Run-in Period|Burden of study procedures|0|||
128986523|NCT05182840|464239032|FG008|Run-in Period|Burden of study procedures|0|||
128986524|NCT05182840|464239033|FG009|Run-in Period|Burden of study procedures|0|||
128986525|NCT05182840|464239024|FG000|Run-in Period|Change of residence|1|||
128986526|NCT05182840|464239025|FG001|Run-in Period|Change of residence|0|||
128986527|NCT05182840|464239026|FG002|Run-in Period|Change of residence|0|||
128986528|NCT05182840|464239027|FG003|Run-in Period|Change of residence|0|||
128986529|NCT05182840|464239028|FG004|Run-in Period|Change of residence|0|||
128986530|NCT05182840|464239029|FG005|Run-in Period|Change of residence|0|||
129208590|NCT04886154|465063350|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
128986531|NCT05182840|464239030|FG006|Run-in Period|Change of residence|0|||
128986532|NCT05182840|464239031|FG007|Run-in Period|Change of residence|0|||
128986533|NCT05182840|464239032|FG008|Run-in Period|Change of residence|0|||
128986534|NCT05182840|464239033|FG009|Run-in Period|Change of residence|0|||
128986535|NCT05182840|464239024|FG000|Run-in Period|Adverse Event|5|||
128986536|NCT05182840|464239025|FG001|Run-in Period|Adverse Event|5|||
128986537|NCT05182840|464239026|FG002|Run-in Period|Adverse Event|0|||
128986538|NCT05182840|464239027|FG003|Run-in Period|Adverse Event|0|||
129208591|NCT04886154|465063351|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
128986539|NCT05182840|464239028|FG004|Run-in Period|Adverse Event|0|||
128986540|NCT05182840|464239029|FG005|Run-in Period|Adverse Event|0|||
128986541|NCT05182840|464239030|FG006|Run-in Period|Adverse Event|0|||
128986542|NCT05182840|464239031|FG007|Run-in Period|Adverse Event|0|||
128986543|NCT05182840|464239032|FG008|Run-in Period|Adverse Event|0|||
128986544|NCT05182840|464239033|FG009|Run-in Period|Adverse Event|0|||
129208592|NCT04886154|465063352|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
128876283|NCT02217332|463842321|FG000|Overall Study|Lost to Follow-up|1|||
128876284|NCT04058366|463842322|FG000|Overall Study|Adverse Event|14|||
128876285|NCT04058366|463842322|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
128876286|NCT04058366|463842322|FG000|Overall Study|Commercial drug is available for participants|6|||
128876287|NCT04058366|463842322|FG000|Overall Study|Death|1|||
128876288|NCT04058366|463842322|FG000|Overall Study|Other non-compliance|2|||
128876289|NCT04058366|463842322|FG000|Overall Study|Other|6|||
128876290|NCT00759915|463842323|FG000|Overall Study|Withdrawal by Subject|1|||
128876291|NCT00759915|463842324|FG001|Overall Study|Withdrawal by Subject|0|||
128876292|NCT00759915|463842323|FG000|Overall Study|Adverse Event|0|||
128876293|NCT00759915|463842324|FG001|Overall Study|Adverse Event|1|||
128876294|NCT02074553|463842325|FG000|Intervention Period 1|Family Emergency|0|||
128876295|NCT02074553|463842326|FG001|Intervention Period 1|Family Emergency|0|||
128876296|NCT02074553|463842327|FG002|Intervention Period 1|Family Emergency|0|||
128876297|NCT02074553|463842328|FG003|Intervention Period 1|Family Emergency|1|||
128876298|NCT02074553|463842329|FG004|Intervention Period 1|Family Emergency|0|||
128876299|NCT02074553|463842330|FG005|Intervention Period 1|Family Emergency|0|||
128876300|NCT02074553|463842331|FG006|Intervention Period 1|Family Emergency|0|||
128876301|NCT02074553|463842332|FG007|Intervention Period 1|Family Emergency|0|||
128876302|NCT02074553|463842325|FG000|Washout Period 1|Adverse Event|1|||
128876303|NCT02074553|463842326|FG001|Washout Period 1|Adverse Event|0|||
128876304|NCT02074553|463842327|FG002|Washout Period 1|Adverse Event|0|||
128876305|NCT02074553|463842328|FG003|Washout Period 1|Adverse Event|0|||
128876306|NCT02074553|463842329|FG004|Washout Period 1|Adverse Event|0|||
128876307|NCT02074553|463842330|FG005|Washout Period 1|Adverse Event|0|||
128876308|NCT02074553|463842331|FG006|Washout Period 1|Adverse Event|0|||
128876309|NCT02074553|463842332|FG007|Washout Period 1|Adverse Event|0|||
128876310|NCT02074553|463842325|FG000|Washout Period 1|Physician Decision|0|||
128876311|NCT02074553|463842326|FG001|Washout Period 1|Physician Decision|0|||
128876312|NCT02074553|463842327|FG002|Washout Period 1|Physician Decision|0|||
128876313|NCT02074553|463842328|FG003|Washout Period 1|Physician Decision|1|||
128876314|NCT02074553|463842329|FG004|Washout Period 1|Physician Decision|0|||
128876315|NCT02074553|463842330|FG005|Washout Period 1|Physician Decision|0|||
128876316|NCT02074553|463842331|FG006|Washout Period 1|Physician Decision|0|||
128876317|NCT02074553|463842332|FG007|Washout Period 1|Physician Decision|0|||
128876318|NCT02074553|463842325|FG000|Washout Period 1|Other|0|||
128876319|NCT02074553|463842326|FG001|Washout Period 1|Other|0|||
128876320|NCT02074553|463842327|FG002|Washout Period 1|Other|0|||
128876321|NCT02074553|463842328|FG003|Washout Period 1|Other|0|||
128876322|NCT02074553|463842329|FG004|Washout Period 1|Other|0|||
128876323|NCT02074553|463842330|FG005|Washout Period 1|Other|1|||
128876324|NCT02074553|463842331|FG006|Washout Period 1|Other|0|||
128876325|NCT02074553|463842332|FG007|Washout Period 1|Other|0|||
128876326|NCT02074553|463842325|FG000|Washout Period 2|Adverse Event|0|||
128876327|NCT02074553|463842326|FG001|Washout Period 2|Adverse Event|0|||
128876328|NCT02074553|463842327|FG002|Washout Period 2|Adverse Event|0|||
128876329|NCT02074553|463842328|FG003|Washout Period 2|Adverse Event|0|||
128876330|NCT02074553|463842329|FG004|Washout Period 2|Adverse Event|0|||
128876331|NCT02074553|463842330|FG005|Washout Period 2|Adverse Event|0|||
128876332|NCT02074553|463842331|FG006|Washout Period 2|Adverse Event|1|||
128876333|NCT02074553|463842332|FG007|Washout Period 2|Adverse Event|0|||
128876334|NCT02074553|463842325|FG000|Washout Period 2|Physician Decision|0|||
128876335|NCT02074553|463842326|FG001|Washout Period 2|Physician Decision|0|||
128876336|NCT02074553|463842327|FG002|Washout Period 2|Physician Decision|0|||
128876337|NCT02074553|463842328|FG003|Washout Period 2|Physician Decision|0|||
128876338|NCT02074553|463842329|FG004|Washout Period 2|Physician Decision|0|||
128876339|NCT02074553|463842330|FG005|Washout Period 2|Physician Decision|1|||
128876340|NCT02074553|463842331|FG006|Washout Period 2|Physician Decision|0|||
128876341|NCT02074553|463842332|FG007|Washout Period 2|Physician Decision|0|||
128876342|NCT02074553|463842325|FG000|Washout Period 2|Lost to Follow-up|0|||
128876343|NCT02074553|463842326|FG001|Washout Period 2|Lost to Follow-up|0|||
128876344|NCT02074553|463842327|FG002|Washout Period 2|Lost to Follow-up|1|||
128876345|NCT02074553|463842328|FG003|Washout Period 2|Lost to Follow-up|0|||
128876346|NCT02074553|463842329|FG004|Washout Period 2|Lost to Follow-up|0|||
128876347|NCT02074553|463842330|FG005|Washout Period 2|Lost to Follow-up|0|||
128876348|NCT02074553|463842331|FG006|Washout Period 2|Lost to Follow-up|0|||
128876349|NCT02074553|463842332|FG007|Washout Period 2|Lost to Follow-up|0|||
128876350|NCT02074553|463842325|FG000|Washout Period 3|Physician Decision|0|||
128876351|NCT02074553|463842326|FG001|Washout Period 3|Physician Decision|0|||
128876352|NCT02074553|463842327|FG002|Washout Period 3|Physician Decision|0|||
128876353|NCT02074553|463842328|FG003|Washout Period 3|Physician Decision|0|||
128876354|NCT02074553|463842329|FG004|Washout Period 3|Physician Decision|0|||
128876355|NCT02074553|463842330|FG005|Washout Period 3|Physician Decision|0|||
128876356|NCT02074553|463842331|FG006|Washout Period 3|Physician Decision|0|||
128876357|NCT02074553|463842332|FG007|Washout Period 3|Physician Decision|1|||
128986545|NCT05182840|464239024|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
128986546|NCT05182840|464239025|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
128986547|NCT05182840|464239026|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986548|NCT05182840|464239027|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986549|NCT05182840|464239028|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986550|NCT05182840|464239029|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986551|NCT05182840|464239030|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986552|NCT05182840|464239031|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986553|NCT05182840|464239032|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986554|NCT05182840|464239033|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
128986555|NCT05182840|464239024|FG000|Treatment Period|Reason missing|0|||
128986556|NCT05182840|464239025|FG001|Treatment Period|Reason missing|0|||
128986557|NCT05182840|464239026|FG002|Treatment Period|Reason missing|1|||
128986558|NCT05182840|464239027|FG003|Treatment Period|Reason missing|0|||
128986559|NCT05182840|464239028|FG004|Treatment Period|Reason missing|0|||
128986560|NCT05182840|464239029|FG005|Treatment Period|Reason missing|0|||
128986561|NCT05182840|464239030|FG006|Treatment Period|Reason missing|0|||
128986562|NCT05182840|464239031|FG007|Treatment Period|Reason missing|0|||
128986563|NCT05182840|464239032|FG008|Treatment Period|Reason missing|0|||
128986564|NCT05182840|464239033|FG009|Treatment Period|Reason missing|0|||
128986565|NCT05182840|464239024|FG000|Treatment Period|Other but not sponsor termination|0|||
128986566|NCT05182840|464239025|FG001|Treatment Period|Other but not sponsor termination|0|||
128986567|NCT05182840|464239026|FG002|Treatment Period|Other but not sponsor termination|8|||
128986568|NCT05182840|464239027|FG003|Treatment Period|Other but not sponsor termination|6|||
128986569|NCT05182840|464239028|FG004|Treatment Period|Other but not sponsor termination|6|||
128986570|NCT05182840|464239029|FG005|Treatment Period|Other but not sponsor termination|7|||
128986571|NCT05182840|464239030|FG006|Treatment Period|Other but not sponsor termination|5|||
128986572|NCT05182840|464239031|FG007|Treatment Period|Other but not sponsor termination|8|||
128986573|NCT05182840|464239032|FG008|Treatment Period|Other but not sponsor termination|7|||
128986574|NCT05182840|464239033|FG009|Treatment Period|Other but not sponsor termination|2|||
128986575|NCT05182840|464239024|FG000|Treatment Period|Protocol deviation|0|||
128986576|NCT05182840|464239025|FG001|Treatment Period|Protocol deviation|0|||
128986577|NCT05182840|464239026|FG002|Treatment Period|Protocol deviation|0|||
128986578|NCT05182840|464239027|FG003|Treatment Period|Protocol deviation|0|||
128986579|NCT05182840|464239028|FG004|Treatment Period|Protocol deviation|0|||
129208593|NCT04886154|465063353|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208594|NCT04886154|465063354|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208595|NCT04886154|465063355|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129208596|NCT04886154|465063341|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208597|NCT04886154|465063342|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208598|NCT04886154|465063343|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208599|NCT04886154|465063344|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208600|NCT04886154|465063345|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129208601|NCT04886154|465063346|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208602|NCT04886154|465063347|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129208603|NCT04886154|465063348|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129208604|NCT04886154|465063349|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208605|NCT04886154|465063350|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208606|NCT04886154|465063351|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208607|NCT04886154|465063352|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208608|NCT04886154|465063353|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208609|NCT04886154|465063354|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129208610|NCT04886154|465063355|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129208611|NCT04886154|465063341|FG000|Overall Study|Other, Not Specified|0|||
129208612|NCT04886154|465063342|FG001|Overall Study|Other, Not Specified|0|||
129208613|NCT04886154|465063343|FG002|Overall Study|Other, Not Specified|0|||
129208614|NCT04886154|465063344|FG003|Overall Study|Other, Not Specified|0|||
129208615|NCT04886154|465063345|FG004|Overall Study|Other, Not Specified|11|||
129208616|NCT04886154|465063346|FG005|Overall Study|Other, Not Specified|8|||
129208617|NCT04886154|465063347|FG006|Overall Study|Other, Not Specified|9|||
129208618|NCT04886154|465063348|FG007|Overall Study|Other, Not Specified|10|||
129208619|NCT04886154|465063349|FG008|Overall Study|Other, Not Specified|6|||
129208620|NCT04886154|465063350|FG009|Overall Study|Other, Not Specified|1|||
129208621|NCT04886154|465063351|FG010|Overall Study|Other, Not Specified|1|||
129208622|NCT04886154|465063352|FG011|Overall Study|Other, Not Specified|2|||
129208623|NCT04886154|465063353|FG012|Overall Study|Other, Not Specified|1|||
129208624|NCT04886154|465063354|FG013|Overall Study|Other, Not Specified|2|||
129208625|NCT04886154|465063355|FG014|Overall Study|Other, Not Specified|3|||
129208626|NCT02336282|465063370|FG000|Overall Study|Unrelated illness|1|||
129208627|NCT02336282|465063370|FG000|Overall Study|Uncomfortable with technology|1|||
129208628|NCT02336282|465063370|FG000|Overall Study|Lost to Follow-up|1|||
129208629|NCT02336282|465063370|FG000|Overall Study|Not enough time to complete sessions|2|||
129208630|NCT03724942|465063372|FG000|Overall Study|Adverse Event|20|||
129208631|NCT03724942|465063373|FG001|Overall Study|Adverse Event|14|||
129208632|NCT03724942|465063372|FG000|Overall Study|Lack of Efficacy|0|||
129208633|NCT03724942|465063373|FG001|Overall Study|Lack of Efficacy|1|||
129208634|NCT03724942|465063372|FG000|Overall Study|Physician Decision|5|||
129208635|NCT03724942|465063373|FG001|Overall Study|Physician Decision|2|||
129208636|NCT03724942|465063372|FG000|Overall Study|Protocol Violation|1|||
129208637|NCT03724942|465063373|FG001|Overall Study|Protocol Violation|0|||
129208638|NCT03724942|465063372|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
129208639|NCT03724942|465063373|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
129208640|NCT03724942|465063372|FG000|Overall Study|Withdrawal by Legal Representative|3|||
129208641|NCT03724942|465063373|FG001|Overall Study|Withdrawal by Legal Representative|0|||
129208642|NCT00668148|465063387|FG000|Overall Study|Adverse Event|5|||
129208643|NCT00668148|465063387|FG000|Overall Study|Subject Non-compliance|1|||
129208644|NCT00668148|465063387|FG000|Overall Study|Progressive Disease Before Treatment|2|||
129208645|NCT00668148|465063387|FG000|Overall Study|Withdrawal of Consent|2|||
129208646|NCT04875975|465063390|FG000|Overall Study|Adverse Event|1|||
129208647|NCT04875975|465063391|FG001|Overall Study|Adverse Event|2|||
129208648|NCT04875975|465063390|FG000|Overall Study|Lack of Efficacy|2|||
129208649|NCT04875975|465063391|FG001|Overall Study|Lack of Efficacy|2|||
129208650|NCT04875975|465063390|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
129208651|NCT04875975|465063391|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
129208652|NCT04875975|465063390|FG000|Overall Study|Relapse With Insults|0|||
129208653|NCT04875975|465063391|FG001|Overall Study|Relapse With Insults|1|||
129208654|NCT04875975|465063390|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
129208655|NCT04875975|465063391|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
129208656|NCT05472090|465063392|FG000|Overall Study|Adverse Event|2|||
129208657|NCT05472090|465063393|FG001|Overall Study|Adverse Event|3|||
129208658|NCT05472090|465063392|FG000|Overall Study|Lack of Efficacy|1|||
129208659|NCT05472090|465063393|FG001|Overall Study|Lack of Efficacy|0|||
128876358|NCT01658150|463842333|FG000|Overall Study|Withdrawal by Subject|1|||
128876359|NCT04187989|463842334|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
128876360|NCT04187989|463842335|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
128876361|NCT04187989|463842334|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
128876362|NCT04187989|463842335|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
128876363|NCT03602066|463842336|FG000|Overall Study|Withdrawal by Subject|2|||
128876364|NCT03602066|463842337|FG001|Overall Study|Withdrawal by Subject|0|||
128876365|NCT03602066|463842336|FG000|Overall Study|Physician Decision|1|||
128876366|NCT03602066|463842337|FG001|Overall Study|Physician Decision|0|||
128876367|NCT00092495|463842338|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
128876368|NCT00092495|463842339|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
128876369|NCT00092495|463842340|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
128876370|NCT00092495|463842341|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
128876371|NCT00092495|463842342|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
128876372|NCT00092495|463842338|FG000|Base Study Vaccination Period|Extended|0|||
128876373|NCT00092495|463842339|FG001|Base Study Vaccination Period|Extended|0|||
128876374|NCT00092495|463842340|FG002|Base Study Vaccination Period|Extended|0|||
128876375|NCT00092495|463842341|FG003|Base Study Vaccination Period|Extended|1|||
128876376|NCT00092495|463842342|FG004|Base Study Vaccination Period|Extended|0|||
128876377|NCT00092495|463842338|FG000|Base Study Vaccination Period|*Clinical AE|1|||
128876378|NCT00092495|463842339|FG001|Base Study Vaccination Period|*Clinical AE|0|||
128876379|NCT00092495|463842340|FG002|Base Study Vaccination Period|*Clinical AE|1|||
128876380|NCT00092495|463842341|FG003|Base Study Vaccination Period|*Clinical AE|2|||
128876381|NCT00092495|463842342|FG004|Base Study Vaccination Period|*Clinical AE|0|||
128876382|NCT00092495|463842338|FG000|Base Study Vaccination Period|*Other reasons|1|||
128876383|NCT00092495|463842339|FG001|Base Study Vaccination Period|*Other reasons|0|||
128876384|NCT00092495|463842340|FG002|Base Study Vaccination Period|*Other reasons|0|||
128876385|NCT00092495|463842341|FG003|Base Study Vaccination Period|*Other reasons|1|||
128876386|NCT00092495|463842342|FG004|Base Study Vaccination Period|*Other reasons|0|||
128876387|NCT00092495|463842338|FG000|Base Study Vaccination Period|*Pregnancy|0|||
128876388|NCT00092495|463842339|FG001|Base Study Vaccination Period|*Pregnancy|2|||
128876389|NCT00092495|463842340|FG002|Base Study Vaccination Period|*Pregnancy|5|||
129208660|NCT05472090|465063392|FG000|Overall Study|Physician Decision|1|||
129208661|NCT05472090|465063393|FG001|Overall Study|Physician Decision|0|||
129208662|NCT05472090|465063392|FG000|Overall Study|Withdrawal by Subject|2|||
128986580|NCT05182840|464239029|FG005|Treatment Period|Protocol deviation|0|||
128986581|NCT05182840|464239030|FG006|Treatment Period|Protocol deviation|0|||
128986582|NCT05182840|464239031|FG007|Treatment Period|Protocol deviation|0|||
128986583|NCT05182840|464239032|FG008|Treatment Period|Protocol deviation|1|||
128986584|NCT05182840|464239033|FG009|Treatment Period|Protocol deviation|0|||
128986585|NCT05182840|464239024|FG000|Treatment Period|No reason available|0|||
128986586|NCT05182840|464239025|FG001|Treatment Period|No reason available|0|||
128986587|NCT05182840|464239026|FG002|Treatment Period|No reason available|0|||
128986588|NCT05182840|464239027|FG003|Treatment Period|No reason available|1|||
128986589|NCT05182840|464239028|FG004|Treatment Period|No reason available|0|||
128986590|NCT05182840|464239029|FG005|Treatment Period|No reason available|2|||
128986591|NCT05182840|464239030|FG006|Treatment Period|No reason available|0|||
128986592|NCT05182840|464239031|FG007|Treatment Period|No reason available|1|||
128986593|NCT05182840|464239032|FG008|Treatment Period|No reason available|0|||
128986594|NCT05182840|464239033|FG009|Treatment Period|No reason available|0|||
128986595|NCT05182840|464239024|FG000|Treatment Period|Burden of study procedures|0|||
128986596|NCT05182840|464239025|FG001|Treatment Period|Burden of study procedures|0|||
128986597|NCT05182840|464239026|FG002|Treatment Period|Burden of study procedures|0|||
128986598|NCT05182840|464239027|FG003|Treatment Period|Burden of study procedures|0|||
128986599|NCT05182840|464239028|FG004|Treatment Period|Burden of study procedures|1|||
128986600|NCT05182840|464239029|FG005|Treatment Period|Burden of study procedures|0|||
128986601|NCT05182840|464239030|FG006|Treatment Period|Burden of study procedures|0|||
128986602|NCT05182840|464239031|FG007|Treatment Period|Burden of study procedures|0|||
128986603|NCT05182840|464239032|FG008|Treatment Period|Burden of study procedures|0|||
128986604|NCT05182840|464239033|FG009|Treatment Period|Burden of study procedures|0|||
128986605|NCT05182840|464239024|FG000|Treatment Period|Change of residence|0|||
128986606|NCT05182840|464239025|FG001|Treatment Period|Change of residence|0|||
128986607|NCT05182840|464239026|FG002|Treatment Period|Change of residence|0|||
128986608|NCT05182840|464239027|FG003|Treatment Period|Change of residence|0|||
128986609|NCT05182840|464239028|FG004|Treatment Period|Change of residence|0|||
128986610|NCT05182840|464239029|FG005|Treatment Period|Change of residence|1|||
128986611|NCT05182840|464239030|FG006|Treatment Period|Change of residence|0|||
128986612|NCT05182840|464239031|FG007|Treatment Period|Change of residence|0|||
128986613|NCT05182840|464239032|FG008|Treatment Period|Change of residence|0|||
128986614|NCT05182840|464239033|FG009|Treatment Period|Change of residence|0|||
128986615|NCT05182840|464239024|FG000|Treatment Period|Adverse Event|0|||
128986616|NCT05182840|464239025|FG001|Treatment Period|Adverse Event|0|||
128986617|NCT05182840|464239026|FG002|Treatment Period|Adverse Event|4|||
128986618|NCT05182840|464239027|FG003|Treatment Period|Adverse Event|16|||
128986619|NCT05182840|464239028|FG004|Treatment Period|Adverse Event|12|||
128986620|NCT05182840|464239029|FG005|Treatment Period|Adverse Event|6|||
128986621|NCT05182840|464239030|FG006|Treatment Period|Adverse Event|4|||
128986622|NCT05182840|464239031|FG007|Treatment Period|Adverse Event|8|||
128986623|NCT05182840|464239032|FG008|Treatment Period|Adverse Event|16|||
128986624|NCT05182840|464239033|FG009|Treatment Period|Adverse Event|5|||
128986625|NCT05182840|464239024|FG000|Treatment Period|Not treated with study drug|0|||
128986626|NCT05182840|464239025|FG001|Treatment Period|Not treated with study drug|0|||
128986627|NCT05182840|464239026|FG002|Treatment Period|Not treated with study drug|0|||
128986628|NCT05182840|464239027|FG003|Treatment Period|Not treated with study drug|1|||
128986629|NCT05182840|464239028|FG004|Treatment Period|Not treated with study drug|0|||
128986630|NCT05182840|464239029|FG005|Treatment Period|Not treated with study drug|0|||
128986631|NCT05182840|464239030|FG006|Treatment Period|Not treated with study drug|1|||
128986632|NCT05182840|464239031|FG007|Treatment Period|Not treated with study drug|1|||
128986633|NCT05182840|464239032|FG008|Treatment Period|Not treated with study drug|0|||
128986634|NCT05182840|464239033|FG009|Treatment Period|Not treated with study drug|0|||
128986635|NCT02161380|464239034|FG000|Overall Study|Lost to Follow-up|0|||
128986636|NCT02161380|464239035|FG001|Overall Study|Lost to Follow-up|1|||
128986637|NCT02161380|464239036|FG002|Overall Study|Lost to Follow-up|0|||
128986638|NCT02161380|464239037|FG003|Overall Study|Lost to Follow-up|0|||
128986639|NCT02268214|464239044|FG000|Overall Study|Subject no longer meets study criteria|0|||
128986640|NCT02268214|464239045|FG001|Overall Study|Subject no longer meets study criteria|2|||
128986641|NCT02268214|464239046|FG002|Overall Study|Subject no longer meets study criteria|0|||
128986642|NCT02268214|464239044|FG000|Overall Study|Pregnancy|2|||
128986643|NCT02268214|464239045|FG001|Overall Study|Pregnancy|2|||
128986644|NCT02268214|464239046|FG002|Overall Study|Pregnancy|1|||
128986645|NCT02268214|464239044|FG000|Overall Study|Lost to Follow-up|3|||
128986646|NCT02268214|464239045|FG001|Overall Study|Lost to Follow-up|3|||
128986647|NCT02268214|464239046|FG002|Overall Study|Lost to Follow-up|4|||
128986648|NCT02268214|464239044|FG000|Overall Study|Lack of Efficacy|1|||
128986649|NCT02268214|464239045|FG001|Overall Study|Lack of Efficacy|0|||
128986650|NCT02268214|464239046|FG002|Overall Study|Lack of Efficacy|2|||
128986651|NCT02268214|464239044|FG000|Overall Study|Adverse Event|11|||
128986652|NCT02268214|464239045|FG001|Overall Study|Adverse Event|14|||
128986653|NCT02268214|464239046|FG002|Overall Study|Adverse Event|9|||
128986654|NCT02268214|464239044|FG000|Overall Study|Withdrawal by Subject|4|||
128986655|NCT02268214|464239045|FG001|Overall Study|Withdrawal by Subject|5|||
128986656|NCT02268214|464239046|FG002|Overall Study|Withdrawal by Subject|10|||
128986657|NCT02268214|464239044|FG000|Overall Study|Subject request to discontinue treatment|10|||
128986658|NCT02268214|464239045|FG001|Overall Study|Subject request to discontinue treatment|8|||
129208663|NCT05472090|465063393|FG001|Overall Study|Withdrawal by Subject|0|||
128876390|NCT00092495|463842341|FG003|Base Study Vaccination Period|*Pregnancy|7|||
128876391|NCT00092495|463842342|FG004|Base Study Vaccination Period|*Pregnancy|0|||
128876392|NCT00092495|463842338|FG000|Base Study Vaccination Period|Adverse Event|1|||
128876393|NCT00092495|463842339|FG001|Base Study Vaccination Period|Adverse Event|0|||
128876394|NCT00092495|463842340|FG002|Base Study Vaccination Period|Adverse Event|0|||
128876395|NCT00092495|463842341|FG003|Base Study Vaccination Period|Adverse Event|3|||
128876396|NCT00092495|463842342|FG004|Base Study Vaccination Period|Adverse Event|0|||
128876397|NCT00092495|463842338|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
128876398|NCT00092495|463842339|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
128876399|NCT00092495|463842340|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
128876400|NCT00092495|463842341|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
128876401|NCT00092495|463842342|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
128876402|NCT00092495|463842338|FG000|Base Study Vaccination Period|Moved|3|||
128876403|NCT00092495|463842339|FG001|Base Study Vaccination Period|Moved|1|||
128876404|NCT00092495|463842340|FG002|Base Study Vaccination Period|Moved|2|||
128876405|NCT00092495|463842341|FG003|Base Study Vaccination Period|Moved|2|||
128876406|NCT00092495|463842342|FG004|Base Study Vaccination Period|Moved|0|||
128876407|NCT00092495|463842338|FG000|Base Study Vaccination Period|Other|1|||
128876408|NCT00092495|463842339|FG001|Base Study Vaccination Period|Other|1|||
128876409|NCT00092495|463842340|FG002|Base Study Vaccination Period|Other|0|||
128876410|NCT00092495|463842341|FG003|Base Study Vaccination Period|Other|2|||
128876411|NCT00092495|463842342|FG004|Base Study Vaccination Period|Other|0|||
128876412|NCT00092495|463842338|FG000|Base Study Vaccination Period|Pregnancy|2|||
128876413|NCT00092495|463842339|FG001|Base Study Vaccination Period|Pregnancy|0|||
128876414|NCT00092495|463842340|FG002|Base Study Vaccination Period|Pregnancy|0|||
128876415|NCT00092495|463842341|FG003|Base Study Vaccination Period|Pregnancy|0|||
128876416|NCT00092495|463842342|FG004|Base Study Vaccination Period|Pregnancy|0|||
128876417|NCT00092495|463842338|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
128876418|NCT00092495|463842339|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
128876419|NCT00092495|463842340|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
128876420|NCT00092495|463842341|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
128876421|NCT00092495|463842342|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
128876422|NCT00092495|463842338|FG000|Base Study Vaccination Period|Protocol Violation|1|||
128876423|NCT00092495|463842339|FG001|Base Study Vaccination Period|Protocol Violation|0|||
128876424|NCT00092495|463842340|FG002|Base Study Vaccination Period|Protocol Violation|0|||
128876425|NCT00092495|463842341|FG003|Base Study Vaccination Period|Protocol Violation|0|||
128876426|NCT00092495|463842342|FG004|Base Study Vaccination Period|Protocol Violation|0|||
128876427|NCT00092495|463842338|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
128876428|NCT00092495|463842339|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
128876429|NCT00092495|463842340|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
128876430|NCT00092495|463842341|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
128876431|NCT00092495|463842342|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
128876432|NCT00092495|463842338|FG000|Base Study Follow-up Period|Extended|0|||
128876433|NCT00092495|463842339|FG001|Base Study Follow-up Period|Extended|0|||
128876434|NCT00092495|463842340|FG002|Base Study Follow-up Period|Extended|1|||
128876435|NCT00092495|463842341|FG003|Base Study Follow-up Period|Extended|2|||
128876436|NCT00092495|463842342|FG004|Base Study Follow-up Period|Extended|0|||
128876437|NCT00092495|463842338|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
128876438|NCT00092495|463842339|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
128876439|NCT00092495|463842340|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
128876440|NCT00092495|463842341|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
128876441|NCT00092495|463842342|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
128876442|NCT00092495|463842338|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
128876443|NCT00092495|463842339|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
128876444|NCT00092495|463842340|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
128876445|NCT00092495|463842341|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
128876446|NCT00092495|463842342|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
128876447|NCT01639560|463842345|FG000|Overall Study|Withdrawal by Subject|9|||
128876448|NCT01639560|463842346|FG001|Overall Study|Withdrawal by Subject|14|||
128876449|NCT01639560|463842345|FG000|Overall Study|Lack of Efficacy|1|||
128876450|NCT01639560|463842346|FG001|Overall Study|Lack of Efficacy|2|||
128876451|NCT01639560|463842345|FG000|Overall Study|Lost to Follow-up|9|||
128876452|NCT01639560|463842346|FG001|Overall Study|Lost to Follow-up|11|||
128876453|NCT01639560|463842345|FG000|Overall Study|Adverse Event|0|||
128876454|NCT01639560|463842346|FG001|Overall Study|Adverse Event|2|||
128876455|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
129208664|NCT05472090|465063392|FG000|Overall Study|Lost to Follow-up|0|||
128986659|NCT02268214|464239046|FG002|Overall Study|Subject request to discontinue treatment|6|||
128986660|NCT02268214|464239044|FG000|Overall Study|Poor/non-compliance|2|||
128986661|NCT02268214|464239045|FG001|Overall Study|Poor/non-compliance|1|||
128986662|NCT02268214|464239046|FG002|Overall Study|Poor/non-compliance|2|||
128986663|NCT02268214|464239044|FG000|Overall Study|Other reasons|7|||
128986664|NCT02268214|464239045|FG001|Overall Study|Other reasons|3|||
128986665|NCT02268214|464239046|FG002|Overall Study|Other reasons|3|||
129208665|NCT05472090|465063393|FG001|Overall Study|Lost to Follow-up|3|||
129208666|NCT01350999|465063395|FG000|Overall Study|Adverse Event|4|||
129208667|NCT01350999|465063396|FG001|Overall Study|Adverse Event|9|||
129208668|NCT01350999|465063397|FG002|Overall Study|Adverse Event|10|||
129208669|NCT01350999|465063395|FG000|Overall Study|Voluntary withdrawal|3|||
129208670|NCT01350999|465063396|FG001|Overall Study|Voluntary withdrawal|4|||
129208671|NCT01350999|465063397|FG002|Overall Study|Voluntary withdrawal|6|||
129208672|NCT01350999|465063395|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
129208673|NCT01350999|465063396|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
129208674|NCT01350999|465063397|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
129208675|NCT01766050|465064677|FG000|Overall Study|Adverse Event|1|||
129208676|NCT01766050|465064677|FG000|Overall Study|Lost to Follow-up|1|||
129208677|NCT01766050|465064677|FG000|Overall Study|Withdrawal by Subject|2|||
129208678|NCT00089297|465064679|FG000|Overall Study|Adverse Event|9|||
129208679|NCT00089297|465064679|FG000|Overall Study|Death|1|||
129208680|NCT00089297|465064679|FG000|Overall Study|Withdrawal by Subject|12|||
129208681|NCT00089297|465064679|FG000|Overall Study|Disease progression|2|||
129208682|NCT00089297|465064679|FG000|Overall Study|Ineligible|11|||
129208683|NCT00089297|465064679|FG000|Overall Study|Secondary malignancy|1|||
129208684|NCT00089297|465064679|FG000|Overall Study|IRB approval not ready|1|||
129208685|NCT00089297|465064679|FG000|Overall Study|Non-compliance|1|||
129208686|NCT01910298|465064682|FG000|Overall Study|Adverse Event|1|||
129208687|NCT01910298|465064683|FG001|Overall Study|Adverse Event|0|||
129208688|NCT01910298|465064682|FG000|Overall Study|Withdrawal by Subject|2|||
129208689|NCT01910298|465064683|FG001|Overall Study|Withdrawal by Subject|7|||
129208690|NCT01910298|465064682|FG000|Overall Study|Protocol Deviation|0|||
129208691|NCT01910298|465064683|FG001|Overall Study|Protocol Deviation|5|||
129208692|NCT01910298|465064682|FG000|Overall Study|Lost to Follow-up|1|||
129208693|NCT01910298|465064683|FG001|Overall Study|Lost to Follow-up|1|||
129208694|NCT01910298|465064682|FG000|Overall Study|Study Terminated by Sponsor|1|||
129208695|NCT01910298|465064683|FG001|Overall Study|Study Terminated by Sponsor|17|||
129208696|NCT01910298|465064682|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129208697|NCT01910298|465064683|FG001|Overall Study|Other Miscellaneous Reasons|2|||
129208698|NCT01021020|465064688|FG000|Period I|Protocol Violation|1|||
129208699|NCT01021020|465064688|FG000|Period I|Withdrawal by Subject|1|||
129208700|NCT01021020|465064688|FG000|14 Day Washout Period A|Physician Decision|1|||
129208701|NCT01838694|465064691|FG000|Overall Study|Adverse Event|0|||
129208702|NCT01838694|465064692|FG001|Overall Study|Adverse Event|1|||
129208703|NCT03623243|465064693|FG000|Overall Study|Adverse Event|15|||
129208704|NCT03623243|465064693|FG000|Overall Study|Guardian Decision|1|||
129208705|NCT03623243|465064693|FG000|Overall Study|New Therapy for Study Indication|1|||
129208706|NCT03623243|465064693|FG000|Overall Study|Protocol Deviation|3|||
129208707|NCT03623243|465064693|FG000|Overall Study|Physician Decision|4|||
129208708|NCT03623243|465064693|FG000|Overall Study|Patient Decision|15|||
129208709|NCT02177695|465064697|FG000|ITT Analysis|Ineligible|5|||
128986666|NCT02268214|464239044|FG000|Overall Study|Not entering long-term period|2|||
128986667|NCT02268214|464239045|FG001|Overall Study|Not entering long-term period|3|||
128986668|NCT02268214|464239046|FG002|Overall Study|Not entering long-term period|5|||
128986669|NCT04342390|464239047|FG000|Overall Study|Lost to Follow-up|3|||
128986670|NCT04342390|464239048|FG001|Overall Study|Lost to Follow-up|0|||
128986671|NCT01083121|464239060|FG000|Overall Study|Use of Humira outside the approved label|81|||
128986672|NCT05403502|464239061|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
128986673|NCT05403502|464239061|FG000|Humalog Lead-In Period|Physician Decision|2|||
128986674|NCT05403502|464239061|FG000|Humalog Lead-In Period|Protocol Violation|1|||
128986675|NCT05403502|464239061|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
128986676|NCT05403502|464239061|FG000|Lyumjev Treatment Period|Physician Decision|2|||
128986677|NCT01054443|464239062|FG000|Overall Study|Withdrawal by Subject|0|||
129208710|NCT02177695|465064698|FG001|ITT Analysis|Ineligible|5|||
129208711|NCT02177695|465064697|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
129208712|NCT02177695|465064698|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
129208713|NCT02177695|465064697|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
129208714|NCT02177695|465064698|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
129208715|NCT02177695|465064697|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
129208716|NCT02177695|465064698|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
129208717|NCT00979901|465064699|FG000|Overall Study|Adverse Event|1|||
129208718|NCT00979901|465064700|FG001|Overall Study|Adverse Event|3|||
129208719|NCT00979901|465064701|FG002|Overall Study|Adverse Event|9|||
129208720|NCT00979901|465064702|FG003|Overall Study|Adverse Event|2|||
129208721|NCT00979901|465064699|FG000|Overall Study|Lack of Efficacy|8|||
129208722|NCT00979901|465064700|FG001|Overall Study|Lack of Efficacy|4|||
129208723|NCT00979901|465064701|FG002|Overall Study|Lack of Efficacy|9|||
129208724|NCT00979901|465064702|FG003|Overall Study|Lack of Efficacy|0|||
129208725|NCT00979901|465064699|FG000|Overall Study|Lost to Follow-up|1|||
129208726|NCT00979901|465064700|FG001|Overall Study|Lost to Follow-up|1|||
129208727|NCT00979901|465064701|FG002|Overall Study|Lost to Follow-up|2|||
129208728|NCT00979901|465064702|FG003|Overall Study|Lost to Follow-up|0|||
129208729|NCT00979901|465064699|FG000|Overall Study|Protocol Violation|2|||
129208730|NCT00979901|465064700|FG001|Overall Study|Protocol Violation|2|||
129208731|NCT00979901|465064701|FG002|Overall Study|Protocol Violation|7|||
129208732|NCT00979901|465064702|FG003|Overall Study|Protocol Violation|1|||
129208733|NCT00979901|465064699|FG000|Overall Study|Withdrawal by Subject|2|||
129208734|NCT00979901|465064700|FG001|Overall Study|Withdrawal by Subject|1|||
129208735|NCT00979901|465064701|FG002|Overall Study|Withdrawal by Subject|1|||
129208736|NCT00979901|465064702|FG003|Overall Study|Withdrawal by Subject|1|||
129208737|NCT00979901|465064699|FG000|Overall Study|Noncompliance|1|||
129208738|NCT00979901|465064700|FG001|Overall Study|Noncompliance|0|||
129208739|NCT00979901|465064701|FG002|Overall Study|Noncompliance|0|||
129208740|NCT00979901|465064702|FG003|Overall Study|Noncompliance|0|||
129208741|NCT00979901|465064699|FG000|Overall Study|out-of-state|1|||
129208742|NCT00979901|465064700|FG001|Overall Study|out-of-state|0|||
129208743|NCT00979901|465064701|FG002|Overall Study|out-of-state|0|||
129208744|NCT00979901|465064702|FG003|Overall Study|out-of-state|0|||
129208745|NCT00979901|465064699|FG000|Overall Study|vacation|1|||
129208746|NCT00979901|465064700|FG001|Overall Study|vacation|0|||
129208747|NCT00979901|465064701|FG002|Overall Study|vacation|0|||
129208748|NCT00979901|465064702|FG003|Overall Study|vacation|0|||
129208749|NCT00979901|465064699|FG000|Overall Study|elevated lab values pre-randomization|1|||
129208750|NCT00979901|465064700|FG001|Overall Study|elevated lab values pre-randomization|0|||
129208751|NCT00979901|465064701|FG002|Overall Study|elevated lab values pre-randomization|0|||
129208752|NCT00979901|465064702|FG003|Overall Study|elevated lab values pre-randomization|0|||
129208753|NCT00979901|465064699|FG000|Overall Study|Discontinued in Error|0|||
129208754|NCT00979901|465064700|FG001|Overall Study|Discontinued in Error|1|||
129208755|NCT00979901|465064701|FG002|Overall Study|Discontinued in Error|0|||
129208756|NCT00979901|465064702|FG003|Overall Study|Discontinued in Error|0|||
129208757|NCT00979901|465064699|FG000|Overall Study|Left Country|0|||
129208758|NCT00979901|465064700|FG001|Overall Study|Left Country|0|||
129208759|NCT00979901|465064701|FG002|Overall Study|Left Country|1|||
129208760|NCT00979901|465064702|FG003|Overall Study|Left Country|0|||
129208761|NCT00979901|465064699|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
129208762|NCT00979901|465064700|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
129208763|NCT00979901|465064701|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
129208764|NCT00979901|465064702|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
129208765|NCT02182895|465064713|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
129208766|NCT02182895|465064714|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
129208767|NCT03305666|465064715|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
129208768|NCT03305666|465064716|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
129208769|NCT02230410|465064718|FG000|Overall Study|Screen Failure|3|||
129208770|NCT02587221|465064723|FG000|Overall Study|Adverse Event|3|||
129208771|NCT02587221|465064724|FG001|Overall Study|Adverse Event|3|||
129208772|NCT02587221|465064723|FG000|Overall Study|Death|33|||
129208773|NCT02587221|465064724|FG001|Overall Study|Death|34|||
129208774|NCT02587221|465064723|FG000|Overall Study|Withdrawal by Subject|66|||
129208775|NCT02587221|465064724|FG001|Overall Study|Withdrawal by Subject|61|||
129208776|NCT02587221|465064723|FG000|Overall Study|Lost to Follow-up|21|||
129208777|NCT02587221|465064724|FG001|Overall Study|Lost to Follow-up|19|||
129208778|NCT02587221|465064723|FG000|Overall Study|Protocol Violation|6|||
129208779|NCT02587221|465064724|FG001|Overall Study|Protocol Violation|5|||
129208780|NCT02587221|465064723|FG000|Overall Study|Other Reason or Unspecified|2|||
129208781|NCT02587221|465064724|FG001|Overall Study|Other Reason or Unspecified|1|||
129208782|NCT02388269|465064730|FG000|Overall Study|Adverse Event|2|||
129208783|NCT02388269|465064731|FG001|Overall Study|Adverse Event|0|||
128876456|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
128876457|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129208784|NCT02388269|465064732|FG002|Overall Study|Adverse Event|0|||
129208785|NCT02388269|465064730|FG000|Overall Study|Withdrawal by Subject|1|||
129208786|NCT02388269|465064731|FG001|Overall Study|Withdrawal by Subject|2|||
129208787|NCT02388269|465064732|FG002|Overall Study|Withdrawal by Subject|0|||
129208788|NCT02388269|465064730|FG000|Overall Study|less than 50% stimulations|1|||
129208789|NCT02388269|465064731|FG001|Overall Study|less than 50% stimulations|0|||
129208790|NCT02388269|465064732|FG002|Overall Study|less than 50% stimulations|0|||
129208791|NCT02388269|465064730|FG000|Overall Study|no diary data|3|||
129208792|NCT02388269|465064731|FG001|Overall Study|no diary data|0|||
129208793|NCT02388269|465064732|FG002|Overall Study|no diary data|0|||
129208794|NCT02388269|465064730|FG000|Overall Study|Protocol Violation|2|||
128876458|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129208795|NCT02388269|465064731|FG001|Overall Study|Protocol Violation|0|||
129208796|NCT02388269|465064732|FG002|Overall Study|Protocol Violation|0|||
129208797|NCT02388269|465064730|FG000|Overall Study|Screen Failure|0|||
129208798|NCT02388269|465064731|FG001|Overall Study|Screen Failure|0|||
129208799|NCT02388269|465064732|FG002|Overall Study|Screen Failure|10|||
129208800|NCT02242942|465064735|FG000|Overall Study|Death|17|||
129208801|NCT02242942|465064736|FG001|Overall Study|Death|20|||
129208802|NCT02242942|465064737|FG002|Overall Study|Death|2|||
129208803|NCT02242942|465064735|FG000|Overall Study|Physician Decision|1|||
129208804|NCT02242942|465064736|FG001|Overall Study|Physician Decision|0|||
129208805|NCT02242942|465064737|FG002|Overall Study|Physician Decision|0|||
129208806|NCT02242942|465064735|FG000|Overall Study|Withdrawal by Subject|8|||
129208807|NCT02242942|465064736|FG001|Overall Study|Withdrawal by Subject|10|||
129208808|NCT02242942|465064737|FG002|Overall Study|Withdrawal by Subject|0|||
129208809|NCT02242942|465064735|FG000|Overall Study|On-going in Study|190|||
129208810|NCT02242942|465064736|FG001|Overall Study|On-going in Study|186|||
129208811|NCT02242942|465064737|FG002|Overall Study|On-going in Study|11|||
129208812|NCT00551759|465064738|FG000|Overall Study|Adverse Event|7|||
129208813|NCT00551759|465064738|FG000|Overall Study|Death|5|||
129208814|NCT00551759|465064738|FG000|Overall Study|Ineligible|1|||
129208815|NCT01451606|465064743|FG000|Overall Study|Withdrawal by Subject|4|||
129208816|NCT01451606|465064744|FG001|Overall Study|Withdrawal by Subject|3|||
129208817|NCT02163538|465064747|FG000|Overall Study|Protocol Violation|1|||
129208818|NCT02163538|465064748|FG001|Overall Study|Protocol Violation|0|||
129208819|NCT02163538|465064747|FG000|Overall Study|Physician Decision|0|||
129208820|NCT02163538|465064748|FG001|Overall Study|Physician Decision|1|||
129208821|NCT01283139|465064749|FG000|Overall Study|Lost to Follow-up|5|||
129208822|NCT01283139|465064750|FG001|Overall Study|Lost to Follow-up|2|||
129208823|NCT01283139|465064751|FG002|Overall Study|Lost to Follow-up|3|||
129208824|NCT01283139|465064752|FG003|Overall Study|Lost to Follow-up|1|||
129208825|NCT01283139|465064749|FG000|Overall Study|Withdrawal by Subject|8|||
129208826|NCT01283139|465064750|FG001|Overall Study|Withdrawal by Subject|8|||
129208827|NCT01283139|465064751|FG002|Overall Study|Withdrawal by Subject|6|||
129208828|NCT01283139|465064752|FG003|Overall Study|Withdrawal by Subject|8|||
129208829|NCT01283139|465064749|FG000|Overall Study|Death|2|||
129208830|NCT01283139|465064750|FG001|Overall Study|Death|0|||
129208831|NCT01283139|465064751|FG002|Overall Study|Death|2|||
129208832|NCT01283139|465064752|FG003|Overall Study|Death|2|||
129208833|NCT01283139|465064749|FG000|Overall Study|Lack of Efficacy|1|||
129208834|NCT01283139|465064750|FG001|Overall Study|Lack of Efficacy|2|||
129208835|NCT01283139|465064751|FG002|Overall Study|Lack of Efficacy|2|||
129208836|NCT01283139|465064752|FG003|Overall Study|Lack of Efficacy|1|||
129208837|NCT01283139|465064749|FG000|Overall Study|Early termination due to AE/SAE|1|||
129208838|NCT01283139|465064750|FG001|Overall Study|Early termination due to AE/SAE|1|||
129208839|NCT01283139|465064751|FG002|Overall Study|Early termination due to AE/SAE|0|||
129208840|NCT01283139|465064752|FG003|Overall Study|Early termination due to AE/SAE|0|||
129208841|NCT01283139|465064749|FG000|Overall Study|Participant's refusal to continue|0|||
129208842|NCT01283139|465064750|FG001|Overall Study|Participant's refusal to continue|3|||
129208843|NCT01283139|465064751|FG002|Overall Study|Participant's refusal to continue|1|||
129208844|NCT01283139|465064752|FG003|Overall Study|Participant's refusal to continue|1|||
129208845|NCT01283139|465064749|FG000|Overall Study|Pregnancy|0|||
129208846|NCT01283139|465064750|FG001|Overall Study|Pregnancy|1|||
129208847|NCT01283139|465064751|FG002|Overall Study|Pregnancy|1|||
129208848|NCT01283139|465064752|FG003|Overall Study|Pregnancy|0|||
129208849|NCT01283139|465064749|FG000|Overall Study|Missed follow-up visit|0|||
129208850|NCT01283139|465064750|FG001|Overall Study|Missed follow-up visit|1|||
129208851|NCT01283139|465064751|FG002|Overall Study|Missed follow-up visit|2|||
129208852|NCT01283139|465064752|FG003|Overall Study|Missed follow-up visit|2|||
129208853|NCT01283139|465064749|FG000|Overall Study|Participant randomized in error|0|||
129208854|NCT01283139|465064750|FG001|Overall Study|Participant randomized in error|0|||
129208855|NCT01283139|465064751|FG002|Overall Study|Participant randomized in error|1|||
129208856|NCT01283139|465064752|FG003|Overall Study|Participant randomized in error|0|||
129208857|NCT03668873|465064753|FG000|Overall Study|Lost to Follow-up|6|||
129208858|NCT03668873|465064754|FG001|Overall Study|Lost to Follow-up|3|||
129208859|NCT01521117|465064755|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
129208860|NCT01521117|465064756|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129208861|NCT01521117|465064755|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
128986678|NCT01054443|464239063|FG001|Overall Study|Withdrawal by Subject|0|||
129208862|NCT01521117|465064756|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
129208863|NCT01521117|465064755|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129208864|NCT01521117|465064756|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
129208865|NCT00784563|465064757|FG000|Years 1 & 2|Withdrawal by Subject|3|||
129208866|NCT00784563|465064758|FG001|Years 1 & 2|Withdrawal by Subject|2|||
129208867|NCT00784563|465064759|FG002|Years 1 & 2|Withdrawal by Subject|0|||
129208868|NCT00784563|465064757|FG000|Years 1 & 2|Adverse Event|0|||
129208869|NCT00784563|465064758|FG001|Years 1 & 2|Adverse Event|3|||
129208870|NCT00784563|465064759|FG002|Years 1 & 2|Adverse Event|0|||
129208871|NCT00784563|465064757|FG000|Year 3|Withdrawal by Subject|0|||
129208872|NCT00784563|465064758|FG001|Year 3|Withdrawal by Subject|0|||
129208873|NCT00784563|465064759|FG002|Year 3|Withdrawal by Subject|2|||
129208874|NCT00784563|465064757|FG000|Year 3|Adverse Event|0|||
129208875|NCT00784563|465064758|FG001|Year 3|Adverse Event|0|||
129208876|NCT00784563|465064759|FG002|Year 3|Adverse Event|1|||
129208877|NCT00762164|465064760|FG000|Overall Study|Lost to Follow-up|1|||
129208878|NCT00762164|465064761|FG001|Overall Study|Lost to Follow-up|1|||
129208879|NCT00762164|465064760|FG000|Overall Study|Discontinued medication|2|||
129208880|NCT00762164|465064761|FG001|Overall Study|Discontinued medication|0|||
129208881|NCT00762164|465064760|FG000|Overall Study|Withdrawal by Subject|0|||
129208882|NCT00762164|465064761|FG001|Overall Study|Withdrawal by Subject|1|||
129208883|NCT02954536|465064764|FG000|Overall Study|Adverse Event|2|||
129208884|NCT02954536|465064764|FG000|Overall Study|Death|12|||
129208885|NCT00374140|465064769|FG000|Overall Study|Lost to Follow-up|1|||
129208886|NCT00374140|465064769|FG000|Overall Study|Protocol Violation|1|||
129208887|NCT04576988|465064770|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
129208888|NCT04576988|465064771|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
129208889|NCT04576988|465064770|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
129208890|NCT04576988|465064771|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
129208891|NCT04576988|465064770|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
129208892|NCT04576988|465064771|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
129208893|NCT04576988|465064770|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
129208894|NCT04576988|465064771|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
129208895|NCT04576988|465064770|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
129208896|NCT04576988|465064771|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
129208897|NCT04576988|465064770|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
129208898|NCT04576988|465064771|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
129208899|NCT04576988|465064770|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
129208900|NCT04576988|465064771|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
129208901|NCT04576988|465064770|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
129208902|NCT04576988|465064771|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
129208903|NCT04576988|465064770|FG000|Long Term Double Blind (LTDB)|Death|2|||
129208904|NCT04576988|465064771|FG001|Long Term Double Blind (LTDB)|Death|1|||
129208905|NCT04576988|465064770|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
129208906|NCT04576988|465064771|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
129208907|NCT00617734|465064772|FG000|Overall Study|Withdrew Consent|2|||
129208908|NCT00617734|465064773|FG001|Overall Study|Withdrew Consent|0|||
129208909|NCT00617734|465064772|FG000|Overall Study|Adverse Event|4|||
129208910|NCT00617734|465064773|FG001|Overall Study|Adverse Event|1|||
129208911|NCT00617734|465064772|FG000|Overall Study|Protocol Violation|1|||
129208912|NCT00617734|465064773|FG001|Overall Study|Protocol Violation|0|||
129208913|NCT00617734|465064772|FG000|Overall Study|Found Ineligible After Randomization|1|||
129208914|NCT00617734|465064773|FG001|Overall Study|Found Ineligible After Randomization|4|||
129208915|NCT00617734|465064772|FG000|Overall Study|Lost to Follow-up|0|||
129208916|NCT00617734|465064773|FG001|Overall Study|Lost to Follow-up|1|||
129208917|NCT00604565|465064782|FG000|Overall Study|Study terminated|0|||
129208918|NCT00604565|465064783|FG001|Overall Study|Study terminated|3|||
129208919|NCT04292535|465064785|FG000|Overall Study|Withdrawal by Subject|0|||
129208920|NCT04292535|465064786|FG001|Overall Study|Withdrawal by Subject|0|||
129208921|NCT04292535|465064787|FG002|Overall Study|Withdrawal by Subject|0|||
129208922|NCT04292535|465064788|FG003|Overall Study|Withdrawal by Subject|0|||
129208923|NCT04292535|465064789|FG004|Overall Study|Withdrawal by Subject|0|||
129208924|NCT04292535|465064790|FG005|Overall Study|Withdrawal by Subject|0|||
129208925|NCT04292535|465064791|FG006|Overall Study|Withdrawal by Subject|0|||
129208926|NCT04292535|465064792|FG007|Overall Study|Withdrawal by Subject|1|||
129208927|NCT04292535|465064793|FG008|Overall Study|Withdrawal by Subject|0|||
129208928|NCT04292535|465064794|FG009|Overall Study|Withdrawal by Subject|0|||
129208929|NCT04292535|465064795|FG010|Overall Study|Withdrawal by Subject|0|||
129208930|NCT04292535|465064796|FG011|Overall Study|Withdrawal by Subject|0|||
129208931|NCT04292535|465064797|FG012|Overall Study|Withdrawal by Subject|0|||
129208932|NCT04292535|465064798|FG013|Overall Study|Withdrawal by Subject|0|||
129208933|NCT04292535|465064785|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208934|NCT04292535|465064786|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208935|NCT04292535|465064787|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208936|NCT04292535|465064788|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208937|NCT04292535|465064789|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208938|NCT04292535|465064790|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208939|NCT04292535|465064791|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208940|NCT04292535|465064792|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
129208941|NCT04292535|465064793|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208942|NCT04292535|465064794|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208943|NCT04292535|465064795|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208944|NCT04292535|465064796|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129208945|NCT04292535|465064797|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
129208946|NCT04292535|465064798|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
129208947|NCT04292535|465064785|FG000|Overall Study|Report of Dizziness|0|||
129208948|NCT04292535|465064786|FG001|Overall Study|Report of Dizziness|0|||
129208949|NCT04292535|465064787|FG002|Overall Study|Report of Dizziness|0|||
129208950|NCT04292535|465064788|FG003|Overall Study|Report of Dizziness|0|||
129208951|NCT04292535|465064789|FG004|Overall Study|Report of Dizziness|0|||
129208952|NCT04292535|465064790|FG005|Overall Study|Report of Dizziness|0|||
129208953|NCT04292535|465064791|FG006|Overall Study|Report of Dizziness|0|||
129208954|NCT04292535|465064792|FG007|Overall Study|Report of Dizziness|0|||
129208955|NCT04292535|465064793|FG008|Overall Study|Report of Dizziness|0|||
129208956|NCT04292535|465064794|FG009|Overall Study|Report of Dizziness|0|||
129208957|NCT04292535|465064795|FG010|Overall Study|Report of Dizziness|0|||
129208958|NCT04292535|465064796|FG011|Overall Study|Report of Dizziness|0|||
129208959|NCT04292535|465064797|FG012|Overall Study|Report of Dizziness|0|||
129208960|NCT04292535|465064798|FG013|Overall Study|Report of Dizziness|1|||
129208961|NCT04292535|465064785|FG000|Overall Study|Equipment Failure|0|||
129208962|NCT04292535|465064786|FG001|Overall Study|Equipment Failure|0|||
129208963|NCT04292535|465064787|FG002|Overall Study|Equipment Failure|0|||
129208964|NCT04292535|465064788|FG003|Overall Study|Equipment Failure|0|||
129208965|NCT04292535|465064789|FG004|Overall Study|Equipment Failure|0|||
129208966|NCT04292535|465064790|FG005|Overall Study|Equipment Failure|0|||
129208967|NCT04292535|465064791|FG006|Overall Study|Equipment Failure|0|||
129208968|NCT04292535|465064792|FG007|Overall Study|Equipment Failure|0|||
129208969|NCT04292535|465064793|FG008|Overall Study|Equipment Failure|0|||
129208970|NCT04292535|465064794|FG009|Overall Study|Equipment Failure|0|||
129208971|NCT04292535|465064795|FG010|Overall Study|Equipment Failure|0|||
129208972|NCT04292535|465064796|FG011|Overall Study|Equipment Failure|1|||
129208973|NCT04292535|465064797|FG012|Overall Study|Equipment Failure|0|||
129208974|NCT04292535|465064798|FG013|Overall Study|Equipment Failure|0|||
129208975|NCT00517296|465064799|FG000|Overall Study|Withdrawal by Subject|1|||
129208976|NCT00517296|465064800|FG001|Overall Study|Withdrawal by Subject|0|||
129208977|NCT01253291|465064801|FG000|Overall Study|Withdrawal by Subject|1|||
129208978|NCT01253291|465064802|FG001|Overall Study|Withdrawal by Subject|1|||
129208979|NCT01253291|465064803|FG002|Overall Study|Withdrawal by Subject|0|||
129208980|NCT01253291|465064804|FG003|Overall Study|Withdrawal by Subject|0|||
129208981|NCT01253291|465064805|FG004|Overall Study|Withdrawal by Subject|0|||
129208982|NCT01253291|465064801|FG000|Overall Study|Adverse Event|0|||
129208983|NCT01253291|465064802|FG001|Overall Study|Adverse Event|1|||
129208984|NCT01253291|465064803|FG002|Overall Study|Adverse Event|0|||
129208985|NCT01253291|465064804|FG003|Overall Study|Adverse Event|0|||
129208986|NCT01253291|465064805|FG004|Overall Study|Adverse Event|0|||
129208987|NCT01253291|465064801|FG000|Overall Study|Lack of Efficacy|1|||
129208988|NCT01253291|465064802|FG001|Overall Study|Lack of Efficacy|0|||
129208989|NCT01253291|465064803|FG002|Overall Study|Lack of Efficacy|0|||
129208990|NCT01253291|465064804|FG003|Overall Study|Lack of Efficacy|0|||
129208991|NCT01253291|465064805|FG004|Overall Study|Lack of Efficacy|0|||
129208992|NCT01253291|465064801|FG000|Overall Study|Physician Decision|2|||
129208993|NCT01253291|465064802|FG001|Overall Study|Physician Decision|0|||
129208994|NCT01253291|465064803|FG002|Overall Study|Physician Decision|0|||
129208995|NCT01253291|465064804|FG003|Overall Study|Physician Decision|0|||
129208996|NCT01253291|465064805|FG004|Overall Study|Physician Decision|2|||
129208997|NCT03037385|465067032|FG000|Overall Study|Adverse Event|0|||
129208998|NCT03037385|465067033|FG001|Overall Study|Adverse Event|0|||
129208999|NCT03037385|465067034|FG002|Overall Study|Adverse Event|1|||
129209000|NCT03037385|465067035|FG003|Overall Study|Adverse Event|0|||
129209001|NCT03037385|465067036|FG004|Overall Study|Adverse Event|0|||
129209002|NCT03037385|465067037|FG005|Overall Study|Adverse Event|0|||
128876459|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
128876460|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
128876461|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
128876462|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
128876463|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
128876464|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
128876465|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129209003|NCT03037385|465067038|FG006|Overall Study|Adverse Event|0|||
129209004|NCT03037385|465067039|FG007|Overall Study|Adverse Event|0|||
128876466|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129209005|NCT03037385|465067040|FG008|Overall Study|Adverse Event|0|||
129209006|NCT03037385|465067041|FG009|Overall Study|Adverse Event|6|||
129209007|NCT03037385|465067032|FG000|Overall Study|Death|1|||
129209008|NCT03037385|465067033|FG001|Overall Study|Death|4|||
129209009|NCT03037385|465067034|FG002|Overall Study|Death|2|||
129209010|NCT03037385|465067035|FG003|Overall Study|Death|2|||
129209011|NCT03037385|465067036|FG004|Overall Study|Death|5|||
129209012|NCT03037385|465067037|FG005|Overall Study|Death|2|||
129209013|NCT03037385|465067038|FG006|Overall Study|Death|1|||
129209014|NCT03037385|465067039|FG007|Overall Study|Death|4|||
129209015|NCT03037385|465067040|FG008|Overall Study|Death|3|||
129209016|NCT03037385|465067041|FG009|Overall Study|Death|240|||
129209017|NCT03037385|465067032|FG000|Overall Study|Initiation of Another Therapy|1|||
129209018|NCT03037385|465067033|FG001|Overall Study|Initiation of Another Therapy|0|||
129209019|NCT03037385|465067034|FG002|Overall Study|Initiation of Another Therapy|0|||
129209020|NCT03037385|465067035|FG003|Overall Study|Initiation of Another Therapy|0|||
129209021|NCT03037385|465067036|FG004|Overall Study|Initiation of Another Therapy|0|||
129209022|NCT03037385|465067037|FG005|Overall Study|Initiation of Another Therapy|0|||
129209023|NCT03037385|465067038|FG006|Overall Study|Initiation of Another Therapy|0|||
129209024|NCT03037385|465067039|FG007|Overall Study|Initiation of Another Therapy|1|||
129209025|NCT03037385|465067040|FG008|Overall Study|Initiation of Another Therapy|0|||
129209026|NCT03037385|465067041|FG009|Overall Study|Initiation of Another Therapy|2|||
129209027|NCT03037385|465067032|FG000|Overall Study|Lost to Follow-up|0|||
129209028|NCT03037385|465067033|FG001|Overall Study|Lost to Follow-up|0|||
129209029|NCT03037385|465067034|FG002|Overall Study|Lost to Follow-up|0|||
129209030|NCT03037385|465067035|FG003|Overall Study|Lost to Follow-up|0|||
129209031|NCT03037385|465067036|FG004|Overall Study|Lost to Follow-up|0|||
129209032|NCT03037385|465067037|FG005|Overall Study|Lost to Follow-up|1|||
129209033|NCT03037385|465067038|FG006|Overall Study|Lost to Follow-up|0|||
129209034|NCT03037385|465067039|FG007|Overall Study|Lost to Follow-up|0|||
129209035|NCT03037385|465067040|FG008|Overall Study|Lost to Follow-up|0|||
129209036|NCT03037385|465067041|FG009|Overall Study|Lost to Follow-up|16|||
129209037|NCT03037385|465067032|FG000|Overall Study|Physician Decision|0|||
129209038|NCT03037385|465067033|FG001|Overall Study|Physician Decision|0|||
129209039|NCT03037385|465067034|FG002|Overall Study|Physician Decision|0|||
129209040|NCT03037385|465067035|FG003|Overall Study|Physician Decision|0|||
129209041|NCT03037385|465067036|FG004|Overall Study|Physician Decision|0|||
129209042|NCT03037385|465067037|FG005|Overall Study|Physician Decision|0|||
129209043|NCT03037385|465067038|FG006|Overall Study|Physician Decision|0|||
129209044|NCT03037385|465067039|FG007|Overall Study|Physician Decision|0|||
129209045|NCT03037385|465067040|FG008|Overall Study|Physician Decision|0|||
129209046|NCT03037385|465067041|FG009|Overall Study|Physician Decision|1|||
129209047|NCT03037385|465067032|FG000|Overall Study|Progressive Disease|0|||
129209048|NCT03037385|465067033|FG001|Overall Study|Progressive Disease|1|||
129209049|NCT03037385|465067034|FG002|Overall Study|Progressive Disease|1|||
129209050|NCT03037385|465067035|FG003|Overall Study|Progressive Disease|5|||
129209051|NCT03037385|465067036|FG004|Overall Study|Progressive Disease|2|||
129209052|NCT03037385|465067037|FG005|Overall Study|Progressive Disease|0|||
129209053|NCT03037385|465067038|FG006|Overall Study|Progressive Disease|1|||
129209054|NCT03037385|465067039|FG007|Overall Study|Progressive Disease|0|||
129209055|NCT03037385|465067040|FG008|Overall Study|Progressive Disease|0|||
129209056|NCT03037385|465067041|FG009|Overall Study|Progressive Disease|30|||
129209057|NCT03037385|465067032|FG000|Overall Study|Withdrawal by Subject|0|||
129209058|NCT03037385|465067033|FG001|Overall Study|Withdrawal by Subject|0|||
129209059|NCT03037385|465067034|FG002|Overall Study|Withdrawal by Subject|1|||
129209060|NCT03037385|465067035|FG003|Overall Study|Withdrawal by Subject|2|||
129209061|NCT03037385|465067036|FG004|Overall Study|Withdrawal by Subject|1|||
129209062|NCT03037385|465067037|FG005|Overall Study|Withdrawal by Subject|3|||
129209063|NCT03037385|465067038|FG006|Overall Study|Withdrawal by Subject|0|||
129209064|NCT03037385|465067039|FG007|Overall Study|Withdrawal by Subject|0|||
129209065|NCT03037385|465067040|FG008|Overall Study|Withdrawal by Subject|0|||
129209066|NCT03037385|465067041|FG009|Overall Study|Withdrawal by Subject|52|||
129209067|NCT03037385|465067032|FG000|Overall Study|Reason Not Specified|0|||
129209068|NCT03037385|465067033|FG001|Overall Study|Reason Not Specified|1|||
129209069|NCT03037385|465067034|FG002|Overall Study|Reason Not Specified|0|||
129209070|NCT03037385|465067035|FG003|Overall Study|Reason Not Specified|4|||
129209071|NCT03037385|465067036|FG004|Overall Study|Reason Not Specified|3|||
129209072|NCT03037385|465067037|FG005|Overall Study|Reason Not Specified|6|||
129209073|NCT03037385|465067038|FG006|Overall Study|Reason Not Specified|2|||
129209074|NCT03037385|465067039|FG007|Overall Study|Reason Not Specified|0|||
129209075|NCT03037385|465067040|FG008|Overall Study|Reason Not Specified|1|||
129209076|NCT03037385|465067041|FG009|Overall Study|Reason Not Specified|181|||
129209077|NCT04515771|465067042|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
129209078|NCT04515771|465067043|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
129209079|NCT04515771|465067042|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
128763047|NCT01559454|463422693|FG001|Overall Study|Withdrawal by Subject|1|||
129209080|NCT04515771|465067043|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
129209081|NCT04515771|465067042|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
129209082|NCT04515771|465067043|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
129209083|NCT00948246|465067045|FG000|Overall Study|Lost to Follow-up|11|||
129209084|NCT00948246|465067045|FG000|Overall Study|Adverse Event|11|||
129209085|NCT00948246|465067045|FG000|Overall Study|Death|1|||
129209086|NCT00948246|465067045|FG000|Overall Study|Withdrawal by Subject|1|||
129209087|NCT03598036|465067048|FG000|Overall Study|Withdrawal by Subject|1|||
129209088|NCT03598036|465067049|FG001|Overall Study|Withdrawal by Subject|0|||
129209089|NCT04607668|465067053|FG000|Overall Study|Death|49|||
129209090|NCT04607668|465067054|FG001|Overall Study|Death|26|||
129209091|NCT04607668|465067053|FG000|Overall Study|Lost to Follow-up|3|||
129209092|NCT04607668|465067054|FG001|Overall Study|Lost to Follow-up|4|||
129209093|NCT04607668|465067053|FG000|Overall Study|Study terminated by Sponsor|92|||
129209094|NCT04607668|465067054|FG001|Overall Study|Study terminated by Sponsor|114|||
129209095|NCT04607668|465067053|FG000|Overall Study|Withdrawal by Subject|12|||
129209096|NCT04607668|465067054|FG001|Overall Study|Withdrawal by Subject|11|||
129209097|NCT04607668|465067053|FG000|Overall Study|Other, unspecified|8|||
129209098|NCT04607668|465067054|FG001|Overall Study|Other, unspecified|7|||
129209099|NCT04199351|465067055|FG000|Overall Study|Decision by sponsor|0|||
129209100|NCT04199351|465067056|FG001|Overall Study|Decision by sponsor|0|||
129209101|NCT04199351|465067057|FG002|Overall Study|Decision by sponsor|0|||
129209102|NCT04199351|465067058|FG003|Overall Study|Decision by sponsor|2|||
129209103|NCT04199351|465067059|FG004|Overall Study|Decision by sponsor|0|||
129209104|NCT04199351|465067060|FG005|Overall Study|Decision by sponsor|0|||
129209105|NCT04199351|465067061|FG006|Overall Study|Decision by sponsor|0|||
129209106|NCT04199351|465067062|FG007|Overall Study|Decision by sponsor|0|||
129209107|NCT04199351|465067063|FG008|Overall Study|Decision by sponsor|0|||
129209108|NCT04199351|465067064|FG009|Overall Study|Decision by sponsor|6|||
129209109|NCT04199351|465067055|FG000|Overall Study|Lost to Follow-up|0|||
129209110|NCT04199351|465067056|FG001|Overall Study|Lost to Follow-up|0|||
129209111|NCT04199351|465067057|FG002|Overall Study|Lost to Follow-up|1|||
129209112|NCT04199351|465067058|FG003|Overall Study|Lost to Follow-up|0|||
129209113|NCT04199351|465067059|FG004|Overall Study|Lost to Follow-up|0|||
129209114|NCT04199351|465067060|FG005|Overall Study|Lost to Follow-up|1|||
129209115|NCT04199351|465067061|FG006|Overall Study|Lost to Follow-up|0|||
129209116|NCT04199351|465067062|FG007|Overall Study|Lost to Follow-up|0|||
129209117|NCT04199351|465067063|FG008|Overall Study|Lost to Follow-up|0|||
129209118|NCT04199351|465067064|FG009|Overall Study|Lost to Follow-up|0|||
129209119|NCT04199351|465067055|FG000|Overall Study|Withdrawal by Subject|0|||
129209120|NCT04199351|465067056|FG001|Overall Study|Withdrawal by Subject|1|||
129209121|NCT04199351|465067057|FG002|Overall Study|Withdrawal by Subject|0|||
129209122|NCT04199351|465067058|FG003|Overall Study|Withdrawal by Subject|0|||
129209123|NCT04199351|465067059|FG004|Overall Study|Withdrawal by Subject|1|||
129209124|NCT04199351|465067060|FG005|Overall Study|Withdrawal by Subject|4|||
129209125|NCT04199351|465067061|FG006|Overall Study|Withdrawal by Subject|2|||
129209126|NCT04199351|465067062|FG007|Overall Study|Withdrawal by Subject|0|||
129209127|NCT04199351|465067063|FG008|Overall Study|Withdrawal by Subject|3|||
129209128|NCT04199351|465067064|FG009|Overall Study|Withdrawal by Subject|0|||
129209129|NCT00474487|465067065|FG000|Overall Study|Withdrawal by Subject|6|||
129209130|NCT00474487|465067066|FG001|Overall Study|Withdrawal by Subject|0|||
129209131|NCT00474487|465067067|FG002|Overall Study|Withdrawal by Subject|0|||
129209132|NCT00474487|465067068|FG003|Overall Study|Withdrawal by Subject|0|||
129209133|NCT00474487|465067065|FG000|Overall Study|Lost to Follow-up|20|||
129209134|NCT00474487|465067066|FG001|Overall Study|Lost to Follow-up|1|||
129209135|NCT00474487|465067067|FG002|Overall Study|Lost to Follow-up|7|||
129209136|NCT00474487|465067068|FG003|Overall Study|Lost to Follow-up|0|||
129209137|NCT00474487|465067065|FG000|Overall Study|Inappropriate enrollment|4|||
129209138|NCT00474487|465067066|FG001|Overall Study|Inappropriate enrollment|0|||
129209139|NCT00474487|465067067|FG002|Overall Study|Inappropriate enrollment|7|||
129209140|NCT00474487|465067068|FG003|Overall Study|Inappropriate enrollment|0|||
129209141|NCT00474487|465067065|FG000|Overall Study|Death|0|||
129209142|NCT00474487|465067066|FG001|Overall Study|Death|1|||
129209143|NCT00474487|465067067|FG002|Overall Study|Death|0|||
129209144|NCT00474487|465067068|FG003|Overall Study|Death|0|||
129209145|NCT00286468|465067069|FG000|Overall Study|Hyperglycemic Rescue|28|||
129209146|NCT00286468|465067070|FG001|Overall Study|Hyperglycemic Rescue|30|||
129209147|NCT00286468|465067071|FG002|Overall Study|Hyperglycemic Rescue|31|||
129209148|NCT00286468|465067069|FG000|Overall Study|Adverse Event|2|||
129209149|NCT00286468|465067070|FG001|Overall Study|Adverse Event|6|||
129209150|NCT00286468|465067071|FG002|Overall Study|Adverse Event|4|||
129209151|NCT00286468|465067069|FG000|Overall Study|Protocol Violation|0|||
129209152|NCT00286468|465067070|FG001|Overall Study|Protocol Violation|3|||
129209153|NCT00286468|465067071|FG002|Overall Study|Protocol Violation|1|||
128986679|NCT01054443|464239064|FG002|Overall Study|Withdrawal by Subject|0|||
128986680|NCT01054443|464239065|FG003|Overall Study|Withdrawal by Subject|1|||
129209154|NCT00286468|465067069|FG000|Overall Study|Lost to Follow-up|1|||
129209155|NCT00286468|465067070|FG001|Overall Study|Lost to Follow-up|1|||
129209156|NCT00286468|465067071|FG002|Overall Study|Lost to Follow-up|2|||
129209157|NCT00286468|465067069|FG000|Overall Study|Withdrawal by Subject|3|||
129209158|NCT00286468|465067070|FG001|Overall Study|Withdrawal by Subject|8|||
129209159|NCT00286468|465067071|FG002|Overall Study|Withdrawal by Subject|11|||
129209160|NCT00286468|465067069|FG000|Overall Study|Physician Decision|3|||
129209161|NCT00286468|465067070|FG001|Overall Study|Physician Decision|2|||
129209162|NCT00286468|465067071|FG002|Overall Study|Physician Decision|1|||
129209163|NCT01488045|465067072|FG000|Overall Study|Withdrawal by Subject|6|||
129209164|NCT01488045|465067073|FG001|Overall Study|Withdrawal by Subject|11|||
129209165|NCT01488045|465067072|FG000|Overall Study|Failure to present for colonoscopy|3|||
129209166|NCT01488045|465067073|FG001|Overall Study|Failure to present for colonoscopy|6|||
129209167|NCT01488045|465067072|FG000|Overall Study|Failure to report exclusion criteria|0|||
129209168|NCT01488045|465067073|FG001|Overall Study|Failure to report exclusion criteria|1|||
129209169|NCT05365217|465067075|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129209170|NCT05365217|465067076|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129209171|NCT03405792|465067080|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
129209172|NCT03405792|465067081|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
129209173|NCT03405792|465067080|FG000|Overall Study|o Did not receive pembrolizumab|1|||
129209174|NCT03405792|465067081|FG001|Overall Study|o Did not receive pembrolizumab|0|||
129209175|NCT03962491|465067082|FG000|Overall Study|Lost to Follow-up|4|||
129209176|NCT03962491|465067083|FG001|Overall Study|Lost to Follow-up|5|||
129209177|NCT03882021|465067084|FG000|Enrollment|Procedure aborted/cancelled|2|||
129209178|NCT03882021|465067084|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
129209179|NCT03882021|465067084|FG000|Enrollment to 3-Month|Death|1|||
129209180|NCT03882021|465067084|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
129209181|NCT03882021|465067084|FG000|Enrollment to 3-Month|Missed Visit|4|||
129209182|NCT03882021|465067084|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
129209183|NCT03882021|465067084|FG000|6-Month to 12-Month Visit|Death|1|||
129209184|NCT03882021|465067084|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
129209185|NCT03796728|465067086|FG000|Overall Study|Lost to Follow-up|8|||
129209186|NCT03796728|465067086|FG000|Overall Study|Reason not Specified|16|||
129209187|NCT00333775|465067087|FG000|Overall Study|Death|144|||
129209188|NCT00333775|465067088|FG001|Overall Study|Death|149|||
129209189|NCT00333775|465067089|FG002|Overall Study|Death|143|||
129209190|NCT00333775|465067087|FG000|Overall Study|In Follow-up When Study Stopped|87|||
129209191|NCT00333775|465067088|FG001|Overall Study|In Follow-up When Study Stopped|92|||
129209192|NCT00333775|465067089|FG002|Overall Study|In Follow-up When Study Stopped|96|||
129209193|NCT00333775|465067087|FG000|Overall Study|Lost to Follow-up|10|||
129209194|NCT00333775|465067088|FG001|Overall Study|Lost to Follow-up|7|||
129209195|NCT00333775|465067089|FG002|Overall Study|Lost to Follow-up|8|||
129209196|NCT02476617|465067093|FG000|Overall Study|Adverse Event|1|||
129209197|NCT02476617|465067093|FG000|Overall Study|Lost to Follow-up|1|||
129209198|NCT03486912|465067094|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
129209199|NCT03486912|465067095|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
129209200|NCT03486912|465067096|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
129209201|NCT03486912|465067097|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
129209202|NCT03486912|465067094|FG000|Treatment Period|Withdrawal by Subject|3|||
129209203|NCT03486912|465067095|FG001|Treatment Period|Withdrawal by Subject|3|||
129209204|NCT03486912|465067096|FG002|Treatment Period|Withdrawal by Subject|3|||
129209205|NCT03486912|465067097|FG003|Treatment Period|Withdrawal by Subject|2|||
129209206|NCT03486912|465067094|FG000|Treatment Period|Other Reasons|0|||
129209207|NCT03486912|465067095|FG001|Treatment Period|Other Reasons|2|||
129209208|NCT03486912|465067096|FG002|Treatment Period|Other Reasons|1|||
129209209|NCT03486912|465067097|FG003|Treatment Period|Other Reasons|1|||
129209210|NCT03486912|465067094|FG000|Treatment Period|Adverse Event|0|||
129209211|NCT03486912|465067095|FG001|Treatment Period|Adverse Event|1|||
129209212|NCT03486912|465067096|FG002|Treatment Period|Adverse Event|1|||
129209213|NCT03486912|465067097|FG003|Treatment Period|Adverse Event|0|||
129209214|NCT03486912|465067094|FG000|Treatment Period|Lost to Follow-up|1|||
129209215|NCT03486912|465067095|FG001|Treatment Period|Lost to Follow-up|0|||
129209216|NCT03486912|465067096|FG002|Treatment Period|Lost to Follow-up|0|||
129209217|NCT03486912|465067097|FG003|Treatment Period|Lost to Follow-up|2|||
129209218|NCT02491684|465067098|FG000|Treatment Phase|Adverse Event|2|||
129209219|NCT02491684|465067099|FG001|Treatment Phase|Adverse Event|2|||
129209220|NCT02491684|465067098|FG000|Treatment Phase|Incorrect randomisation|1|||
129209221|NCT02491684|465067099|FG001|Treatment Phase|Incorrect randomisation|0|||
129209222|NCT02491684|465067098|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
129209223|NCT02491684|465067099|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
129209224|NCT01263769|465067100|FG000|Overall Study|Non-Compliant with treatment|1|||
129209225|NCT04842747|465067105|FG000|Overall Study|Withdrawal by Subject|6|||
129209226|NCT04842747|465067106|FG001|Overall Study|Withdrawal by Subject|2|||
129209227|NCT04842747|465067105|FG000|Overall Study|Lost to Follow-up|1|||
129209228|NCT04842747|465067106|FG001|Overall Study|Lost to Follow-up|2|||
129209229|NCT04842747|465067105|FG000|Overall Study|Physician Decision|1|||
129209230|NCT04842747|465067106|FG001|Overall Study|Physician Decision|0|||
129209231|NCT04842747|465067105|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
129209232|NCT04842747|465067106|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
129209233|NCT02559622|465067107|FG000|Overall Study|Progressive disease|0|||
129209234|NCT02559622|465067108|FG001|Overall Study|Progressive disease|1|||
129209235|NCT02559622|465067109|FG002|Overall Study|Progressive disease|0|||
129209236|NCT02559622|465067110|FG003|Overall Study|Progressive disease|0|||
129209237|NCT02559622|465067107|FG000|Overall Study|Adverse Event|0|||
129209238|NCT02559622|465067108|FG001|Overall Study|Adverse Event|2|||
129209239|NCT02559622|465067109|FG002|Overall Study|Adverse Event|2|||
129209240|NCT02559622|465067110|FG003|Overall Study|Adverse Event|2|||
129209241|NCT02559622|465067107|FG000|Overall Study|Patient/guardian decision|1|||
129209242|NCT02559622|465067108|FG001|Overall Study|Patient/guardian decision|2|||
129209243|NCT02559622|465067109|FG002|Overall Study|Patient/guardian decision|0|||
129209244|NCT02559622|465067110|FG003|Overall Study|Patient/guardian decision|1|||
129209245|NCT04011540|465067116|FG000|Overall Study|Lost to Follow-up|9|||
129209246|NCT04011540|465067117|FG001|Overall Study|Lost to Follow-up|6|||
129209247|NCT03019406|465067118|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
129209248|NCT03019406|465067119|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
129209249|NCT03019406|465067120|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
129209250|NCT03019406|465067121|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
129209251|NCT01339832|465067124|FG000|Overall Study|Lost to Follow-up|3|||
129209252|NCT01339832|465067124|FG000|Overall Study|Death|11|||
129209253|NCT00231816|465067125|FG000|Overall Study|Adverse Event|1|||
129209254|NCT00231816|465067126|FG001|Overall Study|Adverse Event|0|||
129209255|NCT00231816|465067125|FG000|Overall Study|Lost to Follow-up|8|||
129209256|NCT00231816|465067126|FG001|Overall Study|Lost to Follow-up|5|||
129209257|NCT00231816|465067125|FG000|Overall Study|Protocol Violation|2|||
129209258|NCT00231816|465067126|FG001|Overall Study|Protocol Violation|3|||
129209259|NCT00231816|465067125|FG000|Overall Study|Withdrawal by Subject|3|||
129209260|NCT00231816|465067126|FG001|Overall Study|Withdrawal by Subject|3|||
129209261|NCT00231816|465067125|FG000|Overall Study|Other|2|||
129209262|NCT00231816|465067126|FG001|Overall Study|Other|1|||
129209263|NCT00468169|465067127|FG000|Overall Study|Withdrawal by Subject|1|||
129209264|NCT00468169|465067128|FG001|Overall Study|Withdrawal by Subject|0|||
129209265|NCT01126749|465067133|FG000|Phase 1b|Other|0|||
129209266|NCT01126749|465067134|FG001|Phase 1b|Other|1|||
129209267|NCT01126749|465067135|FG002|Phase 1b|Other|0|||
129209268|NCT01126749|465067136|FG003|Phase 1b|Other|0|||
129209269|NCT01126749|465067133|FG000|Phase 1b|Withdrawal by Subject|0|||
129209270|NCT01126749|465067134|FG001|Phase 1b|Withdrawal by Subject|1|||
129209271|NCT01126749|465067135|FG002|Phase 1b|Withdrawal by Subject|0|||
129209272|NCT01126749|465067136|FG003|Phase 1b|Withdrawal by Subject|0|||
129209273|NCT01126749|465067133|FG000|Phase 1b|Death|3|||
129209274|NCT01126749|465067134|FG001|Phase 1b|Death|4|||
129209275|NCT01126749|465067135|FG002|Phase 1b|Death|0|||
129209276|NCT01126749|465067136|FG003|Phase 1b|Death|0|||
129209277|NCT01126749|465067133|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
129209278|NCT01126749|465067134|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
129209279|NCT01126749|465067135|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
129209280|NCT01126749|465067136|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
129209281|NCT01126749|465067133|FG000|Phase 2|Study Termination by Sponsor|0|||
129209282|NCT01126749|465067134|FG001|Phase 2|Study Termination by Sponsor|0|||
129209283|NCT01126749|465067135|FG002|Phase 2|Study Termination by Sponsor|12|||
129209284|NCT01126749|465067136|FG003|Phase 2|Study Termination by Sponsor|6|||
129209285|NCT01126749|465067133|FG000|Phase 2|Other|0|||
129209286|NCT01126749|465067134|FG001|Phase 2|Other|0|||
129209287|NCT01126749|465067135|FG002|Phase 2|Other|4|||
129209288|NCT01126749|465067136|FG003|Phase 2|Other|2|||
129209289|NCT01126749|465067133|FG000|Phase 2|Withdrawal by Subject|0|||
129209290|NCT01126749|465067134|FG001|Phase 2|Withdrawal by Subject|0|||
129209291|NCT01126749|465067135|FG002|Phase 2|Withdrawal by Subject|0|||
129209292|NCT01126749|465067136|FG003|Phase 2|Withdrawal by Subject|2|||
129209293|NCT01126749|465067133|FG000|Phase 2|Lost to Follow-up|0|||
129209294|NCT01126749|465067134|FG001|Phase 2|Lost to Follow-up|0|||
129209295|NCT01126749|465067135|FG002|Phase 2|Lost to Follow-up|0|||
129209296|NCT01126749|465067136|FG003|Phase 2|Lost to Follow-up|1|||
129209297|NCT01126749|465067133|FG000|Phase 2|Death|0|||
129209298|NCT01126749|465067134|FG001|Phase 2|Death|0|||
129209299|NCT01126749|465067135|FG002|Phase 2|Death|22|||
129209300|NCT01126749|465067136|FG003|Phase 2|Death|22|||
129209301|NCT01126749|465067133|FG000|Phase 2|Adverse Event|0|||
129209302|NCT01126749|465067134|FG001|Phase 2|Adverse Event|0|||
129209303|NCT01126749|465067135|FG002|Phase 2|Adverse Event|0|||
129209304|NCT01126749|465067136|FG003|Phase 2|Adverse Event|1|||
129209305|NCT02183675|465067138|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
129209306|NCT02183675|465067139|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
129209307|NCT02183675|465067140|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
129209308|NCT02183675|465067141|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
129209309|NCT02183675|465067142|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
129209310|NCT02183675|465067143|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
129209311|NCT01614249|465067148|FG000|Overall Study|Lost to Follow-up|11|||
129209312|NCT01614249|465067149|FG001|Overall Study|Lost to Follow-up|23|||
129209313|NCT05498649|465067150|FG000|Overall Study|Lost to Follow-up|1|||
129209314|NCT02946580|465067154|FG000|Overall Study|Withdrawal by Subject|1|||
129209315|NCT02946580|465067155|FG001|Overall Study|Withdrawal by Subject|2|||
129209316|NCT02946580|465067154|FG000|Overall Study|Adverse Event|0|||
129209317|NCT02946580|465067155|FG001|Overall Study|Adverse Event|2|||
129209318|NCT02946580|465067154|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
129209319|NCT02946580|465067155|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
129209320|NCT02761330|465067156|FG000|Treatment Week 1|Withdrawal by Subject|0|||
129209321|NCT02761330|465067157|FG001|Treatment Week 1|Withdrawal by Subject|0|||
129209322|NCT02761330|465067158|FG002|Treatment Week 1|Withdrawal by Subject|0|||
129209323|NCT02761330|465067159|FG003|Treatment Week 1|Withdrawal by Subject|1|||
129209324|NCT02761330|465067160|FG004|Treatment Week 1|Withdrawal by Subject|0|||
129209325|NCT02761330|465067161|FG005|Treatment Week 1|Withdrawal by Subject|1|||
129209326|NCT03043313|465067164|FG000|Overall Study|Withdrawal by Subject|5|||
129209327|NCT03043313|465067165|FG001|Overall Study|Withdrawal by Subject|1|||
129209328|NCT03043313|465067166|FG002|Overall Study|Withdrawal by Subject|1|||
129209329|NCT03043313|465067164|FG000|Overall Study|Lost to Follow-up|1|||
129209330|NCT03043313|465067165|FG001|Overall Study|Lost to Follow-up|1|||
129209331|NCT03043313|465067166|FG002|Overall Study|Lost to Follow-up|0|||
129209332|NCT03043313|465067164|FG000|Overall Study|Death|28|||
129209333|NCT03043313|465067165|FG001|Overall Study|Death|26|||
129209334|NCT03043313|465067166|FG002|Overall Study|Death|17|||
129209335|NCT03043313|465067164|FG000|Overall Study|Participation terminated by sponsor|11|||
129209336|NCT03043313|465067165|FG001|Overall Study|Participation terminated by sponsor|13|||
129209337|NCT03043313|465067166|FG002|Overall Study|Participation terminated by sponsor|13|||
129209338|NCT00980954|465067167|FG000|Overall Study|Protocol Violation|9|||
129209339|NCT00980954|465067168|FG001|Overall Study|Protocol Violation|15|||
129209340|NCT02657889|465067169|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
129209341|NCT02657889|465067170|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
129209342|NCT02657889|465067171|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
129209343|NCT02657889|465067172|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
129209344|NCT02657889|465067169|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
129209345|NCT02657889|465067170|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
129209346|NCT02657889|465067171|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
129209347|NCT02657889|465067172|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
129209348|NCT02657889|465067169|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
129209349|NCT02657889|465067170|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
129209350|NCT02657889|465067171|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
129209351|NCT02657889|465067172|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
129209352|NCT02657889|465067169|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
129209353|NCT02657889|465067170|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
129209354|NCT02657889|465067171|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
129209355|NCT02657889|465067172|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
129209356|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
129209357|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
129209358|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
129209359|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
129209360|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
129209361|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
129209362|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
129209363|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
129209364|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
129209365|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
129209366|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
129209367|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
129209368|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
129209369|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
129209370|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
129209371|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
129209372|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
129209373|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
129209374|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
129209375|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
129209376|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
129209377|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
129209378|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
129209379|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
129209380|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
129209381|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
129209382|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
129209383|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
129209384|NCT02657889|465067169|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
129209385|NCT02657889|465067170|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
129209386|NCT02657889|465067171|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
129209387|NCT02657889|465067172|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
129209388|NCT01576341|465067173|FG000|Overall Study|Withdrawal by Subject|24|||
129209389|NCT01576341|465067173|FG000|Overall Study|Adverse Event|10|||
129209390|NCT01576341|465067173|FG000|Overall Study|Death|21|||
129209391|NCT01576341|465067173|FG000|Overall Study|Physician Decision|2|||
129209392|NCT01576341|465067173|FG000|Overall Study|Lost to Follow-up|2|||
129209393|NCT01576341|465067173|FG000|Overall Study|Kidney transplantation|10|||
129209394|NCT01576341|465067173|FG000|Overall Study|Protocol Violation|12|||
129209395|NCT01576341|465067173|FG000|Overall Study|Other|12|||
129209396|NCT03341299|465067174|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
129209397|NCT03341299|465067175|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
129209398|NCT03341299|465067176|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
129209399|NCT03341299|465067177|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
129209400|NCT00791934|465067179|FG000|Overall Study|Withdrawal by Subject|2|||
129209401|NCT00791934|465067179|FG000|Overall Study|Did not consent for extended follow-up|13|||
129209402|NCT02018562|465067181|FG000|Overall Study|Withdrawal by Subject|2|||
129209403|NCT02018562|465067182|FG001|Overall Study|Withdrawal by Subject|0|||
129209404|NCT02018562|465067181|FG000|Overall Study|Discharged prior to study completion|1|||
129209405|NCT02018562|465067182|FG001|Overall Study|Discharged prior to study completion|0|||
129209406|NCT05194124|465067184|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209407|NCT05194124|465067185|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209408|NCT05194124|465067186|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209409|NCT05194124|465067187|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
129209410|NCT05194124|465067188|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209411|NCT05194124|465067189|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
129209412|NCT05194124|465067190|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209413|NCT05194124|465067191|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209414|NCT05194124|465067192|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209415|NCT05194124|465067193|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129209416|NCT05194124|465067184|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209417|NCT05194124|465067185|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209418|NCT05194124|465067186|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209419|NCT05194124|465067187|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209420|NCT05194124|465067188|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209421|NCT05194124|465067189|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209422|NCT05194124|465067190|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209423|NCT05194124|465067191|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209424|NCT05194124|465067192|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129209425|NCT05194124|465067193|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
129209426|NCT03642873|465067194|FG000|Third Intervention (1 Day)|Screen failure|0|||
129209427|NCT03642873|465067195|FG001|Third Intervention (1 Day)|Screen failure|0|||
129209428|NCT03642873|465067196|FG002|Third Intervention (1 Day)|Screen failure|0|||
129209429|NCT03642873|465067197|FG003|Third Intervention (1 Day)|Screen failure|0|||
129209430|NCT03642873|465067198|FG004|Third Intervention (1 Day)|Screen failure|1|||
129209431|NCT03642873|465067199|FG005|Third Intervention (1 Day)|Screen failure|0|||
129209432|NCT04609319|465067200|FG000|Overall Study|Death|64|||
129209433|NCT04609319|465067201|FG001|Overall Study|Death|49|||
129209434|NCT04609319|465067202|FG002|Overall Study|Death|1|||
129209435|NCT04609319|465067200|FG000|Overall Study|Withdrawal of consent|15|||
129209436|NCT04609319|465067201|FG001|Overall Study|Withdrawal of consent|3|||
129209437|NCT04609319|465067202|FG002|Overall Study|Withdrawal of consent|0|||
128876467|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
128876468|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
128876469|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
128876470|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
128876471|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
128876472|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
128876473|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
128876474|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
128876475|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
128876476|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
128876477|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
128876478|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
128876479|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
128986681|NCT00985114|464239066|FG000|Overall Study|Adverse Event|1|||
129209438|NCT04609319|465067200|FG000|Overall Study|Lost to Follow-up|20|||
129209439|NCT04609319|465067201|FG001|Overall Study|Lost to Follow-up|33|||
129209440|NCT04609319|465067202|FG002|Overall Study|Lost to Follow-up|0|||
129209441|NCT04609319|465067200|FG000|Overall Study|Alive until end of follow-up|60|||
129209442|NCT04609319|465067201|FG001|Overall Study|Alive until end of follow-up|53|||
129209443|NCT04609319|465067202|FG002|Overall Study|Alive until end of follow-up|1|||
129209444|NCT02234843|465067213|FG000|Overall Study|Death|1|||
129209445|NCT02234843|465067214|FG001|Overall Study|Death|0|||
129209446|NCT02234843|465067215|FG002|Overall Study|Death|0|||
129209447|NCT02234843|465067216|FG003|Overall Study|Death|0|||
129209448|NCT02234843|465067217|FG004|Overall Study|Death|0|||
129209449|NCT02234843|465067218|FG005|Overall Study|Death|0|||
129209450|NCT02234843|465067219|FG006|Overall Study|Death|0|||
129209451|NCT02234843|465067220|FG007|Overall Study|Death|0|||
129209452|NCT02234843|465067221|FG008|Overall Study|Death|0|||
129209453|NCT02234843|465067222|FG009|Overall Study|Death|0|||
129209454|NCT02234843|465067213|FG000|Overall Study|Protocol Violation|1|||
129209455|NCT02234843|465067214|FG001|Overall Study|Protocol Violation|0|||
129209456|NCT02234843|465067215|FG002|Overall Study|Protocol Violation|1|||
129209457|NCT02234843|465067216|FG003|Overall Study|Protocol Violation|0|||
129209458|NCT02234843|465067217|FG004|Overall Study|Protocol Violation|0|||
129209459|NCT02234843|465067218|FG005|Overall Study|Protocol Violation|0|||
129209460|NCT02234843|465067219|FG006|Overall Study|Protocol Violation|0|||
129209461|NCT02234843|465067220|FG007|Overall Study|Protocol Violation|0|||
129209462|NCT02234843|465067221|FG008|Overall Study|Protocol Violation|0|||
128986682|NCT00985114|464239067|FG001|Overall Study|Adverse Event|0|||
129209463|NCT02234843|465067222|FG009|Overall Study|Protocol Violation|0|||
129209464|NCT02234843|465067213|FG000|Overall Study|Efficacy outcome reached|2|||
129209465|NCT02234843|465067214|FG001|Overall Study|Efficacy outcome reached|0|||
129209466|NCT02234843|465067215|FG002|Overall Study|Efficacy outcome reached|0|||
129209467|NCT02234843|465067216|FG003|Overall Study|Efficacy outcome reached|0|||
129209468|NCT02234843|465067217|FG004|Overall Study|Efficacy outcome reached|0|||
129209469|NCT02234843|465067218|FG005|Overall Study|Efficacy outcome reached|2|||
129209470|NCT02234843|465067219|FG006|Overall Study|Efficacy outcome reached|0|||
129209471|NCT02234843|465067220|FG007|Overall Study|Efficacy outcome reached|0|||
129209472|NCT02234843|465067221|FG008|Overall Study|Efficacy outcome reached|0|||
129209473|NCT02234843|465067222|FG009|Overall Study|Efficacy outcome reached|0|||
129209474|NCT02234843|465067213|FG000|Overall Study|Patient convenience|2|||
129209475|NCT02234843|465067214|FG001|Overall Study|Patient convenience|0|||
129209476|NCT02234843|465067215|FG002|Overall Study|Patient convenience|0|||
129209477|NCT02234843|465067216|FG003|Overall Study|Patient convenience|0|||
129209478|NCT02234843|465067217|FG004|Overall Study|Patient convenience|0|||
129209479|NCT02234843|465067218|FG005|Overall Study|Patient convenience|1|||
129209480|NCT02234843|465067219|FG006|Overall Study|Patient convenience|0|||
129209481|NCT02234843|465067220|FG007|Overall Study|Patient convenience|0|||
129209482|NCT02234843|465067221|FG008|Overall Study|Patient convenience|0|||
129209483|NCT02234843|465067222|FG009|Overall Study|Patient convenience|0|||
129209484|NCT02234843|465067213|FG000|Overall Study|Withdrawal by Subject|5|||
129209485|NCT02234843|465067214|FG001|Overall Study|Withdrawal by Subject|1|||
129209486|NCT02234843|465067215|FG002|Overall Study|Withdrawal by Subject|1|||
129209487|NCT02234843|465067216|FG003|Overall Study|Withdrawal by Subject|0|||
129209488|NCT02234843|465067217|FG004|Overall Study|Withdrawal by Subject|0|||
129209489|NCT02234843|465067218|FG005|Overall Study|Withdrawal by Subject|7|||
129209490|NCT02234843|465067219|FG006|Overall Study|Withdrawal by Subject|0|||
129209491|NCT02234843|465067220|FG007|Overall Study|Withdrawal by Subject|0|||
129209492|NCT02234843|465067221|FG008|Overall Study|Withdrawal by Subject|0|||
129209493|NCT02234843|465067222|FG009|Overall Study|Withdrawal by Subject|0|||
129209494|NCT02234843|465067213|FG000|Overall Study|Recovery|1|||
129209495|NCT02234843|465067214|FG001|Overall Study|Recovery|0|||
129209496|NCT02234843|465067215|FG002|Overall Study|Recovery|0|||
129209497|NCT02234843|465067216|FG003|Overall Study|Recovery|0|||
129209498|NCT02234843|465067217|FG004|Overall Study|Recovery|0|||
129209499|NCT02234843|465067218|FG005|Overall Study|Recovery|0|||
129209500|NCT02234843|465067219|FG006|Overall Study|Recovery|0|||
129209501|NCT02234843|465067220|FG007|Overall Study|Recovery|0|||
129209502|NCT02234843|465067221|FG008|Overall Study|Recovery|0|||
129209503|NCT02234843|465067222|FG009|Overall Study|Recovery|0|||
129209504|NCT02234843|465067213|FG000|Overall Study|Other|0|||
129209505|NCT02234843|465067214|FG001|Overall Study|Other|2|||
129209506|NCT02234843|465067215|FG002|Overall Study|Other|0|||
129209507|NCT02234843|465067216|FG003|Overall Study|Other|1|||
129209508|NCT02234843|465067217|FG004|Overall Study|Other|0|||
129209509|NCT02234843|465067218|FG005|Overall Study|Other|1|||
129209510|NCT02234843|465067219|FG006|Overall Study|Other|0|||
129209511|NCT02234843|465067220|FG007|Overall Study|Other|1|||
129209512|NCT02234843|465067221|FG008|Overall Study|Other|0|||
129209513|NCT02234843|465067222|FG009|Overall Study|Other|0|||
129209514|NCT02234843|465067213|FG000|Overall Study|Physician Decision|4|||
129209515|NCT02234843|465067214|FG001|Overall Study|Physician Decision|1|||
129209516|NCT02234843|465067215|FG002|Overall Study|Physician Decision|0|||
128763048|NCT01559454|463422692|FG000|Overall Study|Physician Decision|0|||
129209517|NCT02234843|465067216|FG003|Overall Study|Physician Decision|1|||
129209518|NCT02234843|465067217|FG004|Overall Study|Physician Decision|0|||
129209519|NCT02234843|465067218|FG005|Overall Study|Physician Decision|0|||
129209520|NCT02234843|465067219|FG006|Overall Study|Physician Decision|0|||
129209521|NCT02234843|465067220|FG007|Overall Study|Physician Decision|1|||
129209522|NCT02234843|465067221|FG008|Overall Study|Physician Decision|0|||
129209523|NCT02234843|465067222|FG009|Overall Study|Physician Decision|0|||
129209524|NCT02234843|465067213|FG000|Overall Study|Adverse Event|5|||
129209525|NCT02234843|465067214|FG001|Overall Study|Adverse Event|1|||
129209526|NCT02234843|465067215|FG002|Overall Study|Adverse Event|1|||
129209527|NCT02234843|465067216|FG003|Overall Study|Adverse Event|3|||
129209528|NCT02234843|465067217|FG004|Overall Study|Adverse Event|2|||
129209529|NCT02234843|465067218|FG005|Overall Study|Adverse Event|1|||
129209530|NCT02234843|465067219|FG006|Overall Study|Adverse Event|0|||
129209531|NCT02234843|465067220|FG007|Overall Study|Adverse Event|0|||
129209532|NCT02234843|465067221|FG008|Overall Study|Adverse Event|1|||
129209533|NCT02234843|465067222|FG009|Overall Study|Adverse Event|0|||
129209534|NCT02234843|465067213|FG000|Overall Study|Non-compliance with study drug|1|||
129209535|NCT02234843|465067214|FG001|Overall Study|Non-compliance with study drug|0|||
129209536|NCT02234843|465067215|FG002|Overall Study|Non-compliance with study drug|0|||
129209537|NCT02234843|465067216|FG003|Overall Study|Non-compliance with study drug|0|||
129209538|NCT02234843|465067217|FG004|Overall Study|Non-compliance with study drug|0|||
129209539|NCT02234843|465067218|FG005|Overall Study|Non-compliance with study drug|1|||
129209540|NCT02234843|465067219|FG006|Overall Study|Non-compliance with study drug|1|||
129209541|NCT02234843|465067220|FG007|Overall Study|Non-compliance with study drug|0|||
129209542|NCT02234843|465067221|FG008|Overall Study|Non-compliance with study drug|0|||
129209543|NCT02234843|465067222|FG009|Overall Study|Non-compliance with study drug|0|||
129209544|NCT02234843|465067213|FG000|Overall Study|Lost to Follow-up|0|||
129209545|NCT02234843|465067214|FG001|Overall Study|Lost to Follow-up|1|||
129209546|NCT02234843|465067215|FG002|Overall Study|Lost to Follow-up|0|||
129209547|NCT02234843|465067216|FG003|Overall Study|Lost to Follow-up|0|||
129209548|NCT02234843|465067217|FG004|Overall Study|Lost to Follow-up|0|||
129209549|NCT02234843|465067218|FG005|Overall Study|Lost to Follow-up|0|||
129209550|NCT02234843|465067219|FG006|Overall Study|Lost to Follow-up|1|||
129209551|NCT02234843|465067220|FG007|Overall Study|Lost to Follow-up|0|||
129209552|NCT02234843|465067221|FG008|Overall Study|Lost to Follow-up|0|||
129209553|NCT02234843|465067222|FG009|Overall Study|Lost to Follow-up|0|||
129209554|NCT01607957|465067225|FG000|Overall Study|Not treated|1|||
129209555|NCT01607957|465067226|FG001|Overall Study|Not treated|1|||
129209556|NCT01607957|465067225|FG000|Overall Study|Death|367|||
129209557|NCT01607957|465067226|FG001|Overall Study|Death|211|||
129209558|NCT01607957|465067225|FG000|Overall Study|Lost to Follow-up|3|||
129209559|NCT01607957|465067226|FG001|Overall Study|Lost to Follow-up|3|||
129209560|NCT01607957|465067225|FG000|Overall Study|Participant refusal|1|||
129209561|NCT01607957|465067226|FG001|Overall Study|Participant refusal|0|||
129209562|NCT00945009|465067233|FG000|Overall Study|Lack of Efficacy|10|||
129209563|NCT00945009|465067234|FG001|Overall Study|Lack of Efficacy|0|||
129209564|NCT00945009|465067235|FG002|Overall Study|Lack of Efficacy|0|||
129209565|NCT00945009|465067233|FG000|Overall Study|Physician Decision|21|||
129209566|NCT00945009|465067234|FG001|Overall Study|Physician Decision|4|||
129209567|NCT00945009|465067235|FG002|Overall Study|Physician Decision|3|||
129209568|NCT00945009|465067233|FG000|Overall Study|Protocol Violation|6|||
129209569|NCT00945009|465067234|FG001|Overall Study|Protocol Violation|1|||
129209570|NCT00945009|465067235|FG002|Overall Study|Protocol Violation|0|||
129209571|NCT00945009|465067233|FG000|Overall Study|Withdrawal by Subject|1|||
129209572|NCT00945009|465067234|FG001|Overall Study|Withdrawal by Subject|0|||
129209573|NCT00945009|465067235|FG002|Overall Study|Withdrawal by Subject|0|||
129209574|NCT00945009|465067233|FG000|Overall Study|Ineligible|6|||
129209575|NCT00945009|465067234|FG001|Overall Study|Ineligible|1|||
129209576|NCT00945009|465067235|FG002|Overall Study|Ineligible|0|||
129209577|NCT00945009|465067233|FG000|Overall Study|Inevaluable|0|||
129209578|NCT00945009|465067234|FG001|Overall Study|Inevaluable|1|||
129209579|NCT00945009|465067235|FG002|Overall Study|Inevaluable|0|||
129209580|NCT00945009|465067233|FG000|Overall Study|Refusal of further protocol|1|||
129209581|NCT00945009|465067234|FG001|Overall Study|Refusal of further protocol|0|||
129209582|NCT00945009|465067235|FG002|Overall Study|Refusal of further protocol|0|||
129209583|NCT03919773|465067236|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
129209584|NCT03919773|465067237|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
129209585|NCT03919773|465067236|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
129209586|NCT03919773|465067237|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
129209587|NCT04659044|465067238|FG000|Induction|Physician Decision|1|||
129209588|NCT04659044|465067238|FG000|Induction|Adverse Event|2|||
129209589|NCT03589859|465067239|FG000|Overall Study|Withdrawal by Subject|0|||
129209590|NCT03589859|465067240|FG001|Overall Study|Withdrawal by Subject|6|||
129209591|NCT04966013|465067241|FG000|Overall Study|Withdrawal by Subject|0|||
129209592|NCT04966013|465067242|FG001|Overall Study|Withdrawal by Subject|2|||
129209593|NCT04966013|465067243|FG002|Overall Study|Withdrawal by Subject|1|||
129209594|NCT04966013|465067241|FG000|Overall Study|Adverse Event|2|||
129209595|NCT04966013|465067242|FG001|Overall Study|Adverse Event|1|||
129209596|NCT04966013|465067243|FG002|Overall Study|Adverse Event|1|||
129209597|NCT03518086|465067247|FG000|Overall Study|Adverse Event|23|||
129209598|NCT03518086|465067248|FG001|Overall Study|Adverse Event|15|||
129209599|NCT03518086|465067249|FG002|Overall Study|Adverse Event|3|||
129209600|NCT03518086|465067250|FG003|Overall Study|Adverse Event|2|||
129209601|NCT03518086|465067247|FG000|Overall Study|Withdrawal by Subject|8|||
129209602|NCT03518086|465067248|FG001|Overall Study|Withdrawal by Subject|5|||
129209603|NCT03518086|465067249|FG002|Overall Study|Withdrawal by Subject|1|||
129209604|NCT03518086|465067250|FG003|Overall Study|Withdrawal by Subject|0|||
129209605|NCT03518086|465067247|FG000|Overall Study|Lack of Efficacy|5|||
129209606|NCT03518086|465067248|FG001|Overall Study|Lack of Efficacy|5|||
129209607|NCT03518086|465067249|FG002|Overall Study|Lack of Efficacy|0|||
129209608|NCT03518086|465067250|FG003|Overall Study|Lack of Efficacy|2|||
129209609|NCT03518086|465067247|FG000|Overall Study|Protocol Violation|1|||
129209610|NCT03518086|465067248|FG001|Overall Study|Protocol Violation|5|||
129209611|NCT03518086|465067249|FG002|Overall Study|Protocol Violation|1|||
129209612|NCT03518086|465067250|FG003|Overall Study|Protocol Violation|3|||
128986683|NCT00985114|464239066|FG000|Overall Study|Withdrawal by Subject|0|||
129209613|NCT03518086|465067247|FG000|Overall Study|Lost to Follow-up|0|||
129209614|NCT03518086|465067248|FG001|Overall Study|Lost to Follow-up|3|||
129209615|NCT03518086|465067249|FG002|Overall Study|Lost to Follow-up|0|||
129209616|NCT03518086|465067250|FG003|Overall Study|Lost to Follow-up|0|||
129209617|NCT03518086|465067247|FG000|Overall Study|Insufficient Diary Data|0|||
129209618|NCT03518086|465067248|FG001|Overall Study|Insufficient Diary Data|2|||
129209619|NCT03518086|465067249|FG002|Overall Study|Insufficient Diary Data|0|||
129209620|NCT03518086|465067250|FG003|Overall Study|Insufficient Diary Data|0|||
129209621|NCT03518086|465067247|FG000|Overall Study|Non- compliance to Protocol|0|||
129209622|NCT03518086|465067248|FG001|Overall Study|Non- compliance to Protocol|1|||
129209623|NCT03518086|465067249|FG002|Overall Study|Non- compliance to Protocol|0|||
129209624|NCT03518086|465067250|FG003|Overall Study|Non- compliance to Protocol|0|||
129209625|NCT03518086|465067247|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
129209626|NCT03518086|465067248|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
129209627|NCT03518086|465067249|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
129209628|NCT03518086|465067250|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
129209629|NCT03518086|465067247|FG000|Overall Study|Site Terminated by Sponsor|0|||
129209630|NCT03518086|465067248|FG001|Overall Study|Site Terminated by Sponsor|1|||
129209631|NCT03518086|465067249|FG002|Overall Study|Site Terminated by Sponsor|0|||
129209632|NCT03518086|465067250|FG003|Overall Study|Site Terminated by Sponsor|0|||
129209633|NCT03518086|465067247|FG000|Overall Study|Pregnancy|0|||
129209634|NCT03518086|465067248|FG001|Overall Study|Pregnancy|0|||
129209635|NCT03518086|465067249|FG002|Overall Study|Pregnancy|0|||
129209636|NCT03518086|465067250|FG003|Overall Study|Pregnancy|2|||
129209637|NCT05967260|465067251|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
129209638|NCT05967260|465067252|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
129209639|NCT02994108|465069054|FG000|Intervention Messages|Withdrawal by Subject|2|||
129209640|NCT02994108|465069055|FG001|Intervention Messages|Withdrawal by Subject|0|||
129209641|NCT02994108|465069054|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
129209642|NCT02994108|465069055|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
129209643|NCT02994108|465069054|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
129209644|NCT02994108|465069055|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
129209645|NCT02994108|465069054|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
129209646|NCT02994108|465069055|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
129209647|NCT02081677|465069056|FG000|Overall Study|Adverse Event|0|||
129209648|NCT02081677|465069057|FG001|Overall Study|Adverse Event|0|||
129209649|NCT02081677|465069058|FG002|Overall Study|Adverse Event|1|||
129209650|NCT02081677|465069059|FG003|Overall Study|Adverse Event|0|||
129209651|NCT02081677|465069056|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129209652|NCT02081677|465069057|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129209653|NCT02081677|465069058|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
129209654|NCT02081677|465069059|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129209655|NCT02081677|465069056|FG000|Overall Study|Not comfortable with lens care system|1|||
129209656|NCT02081677|465069057|FG001|Overall Study|Not comfortable with lens care system|0|||
129209657|NCT02081677|465069058|FG002|Overall Study|Not comfortable with lens care system|0|||
129209658|NCT02081677|465069059|FG003|Overall Study|Not comfortable with lens care system|0|||
129209659|NCT02081677|465069056|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129209660|NCT02081677|465069057|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129209661|NCT02081677|465069058|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
129209662|NCT02081677|465069059|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
129209663|NCT01097668|465069060|FG000|Overall Study|Withdrawal by Subject|1|||
129209664|NCT01097668|465069061|FG001|Overall Study|Withdrawal by Subject|2|||
129209665|NCT01097668|465069060|FG000|Overall Study|Lost to Follow-up|1|||
129209666|NCT01097668|465069061|FG001|Overall Study|Lost to Follow-up|0|||
129209667|NCT01428258|465069062|FG000|Intervention 1|Withdrawal by Subject|2|||
129209668|NCT01428258|465069063|FG001|Intervention 1|Withdrawal by Subject|0|||
129209669|NCT00248625|465069064|FG000|Overall Study|Withdrawal by Subject|0|||
129209670|NCT00248625|465069065|FG001|Overall Study|Withdrawal by Subject|2|||
129209671|NCT02443688|465069068|FG000|Overall Study|Adverse Event|2|||
128986684|NCT00985114|464239067|FG001|Overall Study|Withdrawal by Subject|2|||
129209672|NCT02443688|465069069|FG001|Overall Study|Adverse Event|3|||
129209673|NCT02443688|465069070|FG002|Overall Study|Adverse Event|2|||
129209674|NCT02443688|465069068|FG000|Overall Study|Lost to Follow-up|1|||
129209675|NCT02443688|465069069|FG001|Overall Study|Lost to Follow-up|0|||
129209676|NCT02443688|465069070|FG002|Overall Study|Lost to Follow-up|0|||
129209677|NCT02443688|465069068|FG000|Overall Study|Physician Decision|3|||
129209678|NCT02443688|465069069|FG001|Overall Study|Physician Decision|0|||
129209679|NCT02443688|465069070|FG002|Overall Study|Physician Decision|1|||
129209680|NCT02443688|465069068|FG000|Overall Study|Pregnancy|0|||
129209681|NCT02443688|465069069|FG001|Overall Study|Pregnancy|0|||
129209682|NCT02443688|465069070|FG002|Overall Study|Pregnancy|1|||
129209683|NCT02443688|465069068|FG000|Overall Study|Withdrawal by Subject|3|||
129209684|NCT02443688|465069069|FG001|Overall Study|Withdrawal by Subject|3|||
129209685|NCT02443688|465069070|FG002|Overall Study|Withdrawal by Subject|4|||
129209686|NCT02443688|465069068|FG000|Overall Study|Non-compliance with study drug|1|||
129209687|NCT02443688|465069069|FG001|Overall Study|Non-compliance with study drug|2|||
129209688|NCT02443688|465069070|FG002|Overall Study|Non-compliance with study drug|4|||
129209689|NCT02443688|465069068|FG000|Overall Study|Sponsor Request|2|||
129209690|NCT02443688|465069069|FG001|Overall Study|Sponsor Request|1|||
129209691|NCT02443688|465069070|FG002|Overall Study|Sponsor Request|0|||
129209692|NCT03182374|465069071|FG000|Overall Study|Lost to Follow-up|3|||
129209693|NCT03182374|465069072|FG001|Overall Study|Lost to Follow-up|2|||
129209694|NCT03182374|465069071|FG000|Overall Study|Lack of Efficacy|8|||
129209695|NCT03182374|465069072|FG001|Overall Study|Lack of Efficacy|14|||
129209696|NCT03182374|465069071|FG000|Overall Study|Withdrawal by Subject|1|||
129209697|NCT03182374|465069072|FG001|Overall Study|Withdrawal by Subject|1|||
129209698|NCT03182374|465069071|FG000|Overall Study|exit for non-compliance|1|||
129209699|NCT03182374|465069072|FG001|Overall Study|exit for non-compliance|1|||
129209700|NCT03182374|465069071|FG000|Overall Study|one subject was randomized but not treated|1|||
129209701|NCT03182374|465069072|FG001|Overall Study|one subject was randomized but not treated|0|||
129209702|NCT03182374|465069071|FG000|Overall Study|Other reasons|0|||
129209703|NCT03182374|465069072|FG001|Overall Study|Other reasons|3|||
129209704|NCT03085095|465069073|FG000|Overall Study|Adverse Event|23|||
129209705|NCT03085095|465069074|FG001|Overall Study|Adverse Event|8|||
129209706|NCT03085095|465069073|FG000|Overall Study|Protocol Violation|0|||
129209707|NCT03085095|465069074|FG001|Overall Study|Protocol Violation|1|||
129209708|NCT03085095|465069073|FG000|Overall Study|Lost to Follow-up|2|||
129209709|NCT03085095|465069074|FG001|Overall Study|Lost to Follow-up|1|||
129209710|NCT03085095|465069073|FG000|Overall Study|Withdrawal by Subject|17|||
129209711|NCT03085095|465069074|FG001|Overall Study|Withdrawal by Subject|6|||
129209712|NCT03085095|465069073|FG000|Overall Study|Physician Decision|9|||
129209713|NCT03085095|465069074|FG001|Overall Study|Physician Decision|3|||
129209714|NCT03085095|465069073|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
129209715|NCT03085095|465069074|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
129209716|NCT03085095|465069073|FG000|Overall Study|Did not Receive Study Drug|2|||
129209717|NCT03085095|465069074|FG001|Overall Study|Did not Receive Study Drug|2|||
129209718|NCT03085095|465069073|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
129209719|NCT03085095|465069074|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
129209720|NCT00408317|465069075|FG000|First Intervention Period|Adverse Event|0|||
129209721|NCT00408317|465069076|FG001|First Intervention Period|Adverse Event|1|||
129209722|NCT00408317|465069075|FG000|Second Intervention Period|Adverse Event|2|||
129209723|NCT00408317|465069076|FG001|Second Intervention Period|Adverse Event|0|||
129209724|NCT00408317|465069075|FG000|Second Intervention Period|Protocol Violation|0|||
129209725|NCT00408317|465069076|FG001|Second Intervention Period|Protocol Violation|1|||
129209726|NCT00408317|465069075|FG000|Second Intervention Period|Withdrawal of consent|0|||
129209727|NCT00408317|465069076|FG001|Second Intervention Period|Withdrawal of consent|1|||
129209728|NCT03822117|465069077|FG000|Overall Study|Death|18|||
129209729|NCT03822117|465069078|FG001|Overall Study|Death|17|||
129209730|NCT03822117|465069079|FG002|Overall Study|Death|12|||
129209731|NCT03822117|465069080|FG003|Overall Study|Death|4|||
129209732|NCT03822117|465069077|FG000|Overall Study|Lost to Follow-up|1|||
129209733|NCT03822117|465069078|FG001|Overall Study|Lost to Follow-up|2|||
129209734|NCT03822117|465069079|FG002|Overall Study|Lost to Follow-up|3|||
129209735|NCT03822117|465069080|FG003|Overall Study|Lost to Follow-up|0|||
129209736|NCT03822117|465069077|FG000|Overall Study|Study Terminated by Sponsor|25|||
129209737|NCT03822117|465069078|FG001|Overall Study|Study Terminated by Sponsor|11|||
129209738|NCT03822117|465069079|FG002|Overall Study|Study Terminated by Sponsor|6|||
129209739|NCT03822117|465069080|FG003|Overall Study|Study Terminated by Sponsor|0|||
129209740|NCT03822117|465069077|FG000|Overall Study|Withdrawal by Subject|4|||
129209741|NCT03822117|465069078|FG001|Overall Study|Withdrawal by Subject|0|||
129209742|NCT03822117|465069079|FG002|Overall Study|Withdrawal by Subject|3|||
129209743|NCT03822117|465069080|FG003|Overall Study|Withdrawal by Subject|0|||
129209744|NCT03822117|465069077|FG000|Overall Study|Disease Progression|1|||
129209745|NCT03822117|465069078|FG001|Overall Study|Disease Progression|2|||
129209746|NCT03822117|465069079|FG002|Overall Study|Disease Progression|1|||
129209747|NCT03822117|465069080|FG003|Overall Study|Disease Progression|0|||
129209748|NCT03822117|465069077|FG000|Overall Study|Never Returned to Hospital|0|||
129209749|NCT03822117|465069078|FG001|Overall Study|Never Returned to Hospital|0|||
128986685|NCT01119118|464239068|FG000|Overall Study|Adverse Event|1|||
128986686|NCT01003691|464239070|FG000|Overall Study|Adverse Event|0|||
128986687|NCT01003691|464239071|FG001|Overall Study|Adverse Event|0|||
128986688|NCT01003691|464239072|FG002|Overall Study|Adverse Event|0|||
128986689|NCT01003691|464239073|FG003|Overall Study|Adverse Event|1|||
128986690|NCT00167414|464239074|FG000|Overall Study|Death|10|||
128986691|NCT01593761|464239077|FG000|Overall Study|Lost to Follow-up|1|||
128986692|NCT01593761|464239077|FG000|Overall Study|culture negative for MRSA at baseline|5|||
128986693|NCT01593761|464239077|FG000|Overall Study|positive for hepatitis C virus|1|||
128986694|NCT01593761|464239077|FG000|Overall Study|secondary cellulitis|1|||
128986695|NCT00560573|464241453|FG000|Overall Study|Death|4|||
128986696|NCT00560573|464241454|FG001|Overall Study|Death|1|||
128986697|NCT00560573|464241455|FG002|Overall Study|Death|4|||
128986698|NCT00560573|464241456|FG003|Overall Study|Death|5|||
128986699|NCT00560573|464241457|FG004|Overall Study|Death|1|||
128986700|NCT00560573|464241458|FG005|Overall Study|Death|10|||
128986701|NCT00560573|464241453|FG000|Overall Study|Lost to Follow-up|0|||
128986702|NCT00560573|464241454|FG001|Overall Study|Lost to Follow-up|0|||
128986703|NCT00560573|464241455|FG002|Overall Study|Lost to Follow-up|0|||
128986704|NCT00560573|464241456|FG003|Overall Study|Lost to Follow-up|1|||
128986705|NCT00560573|464241457|FG004|Overall Study|Lost to Follow-up|1|||
128986706|NCT00560573|464241458|FG005|Overall Study|Lost to Follow-up|0|||
128986707|NCT00560573|464241453|FG000|Overall Study|Withdrawal by Subject|0|||
128986708|NCT00560573|464241454|FG001|Overall Study|Withdrawal by Subject|0|||
128986709|NCT00560573|464241455|FG002|Overall Study|Withdrawal by Subject|0|||
128986710|NCT00560573|464241456|FG003|Overall Study|Withdrawal by Subject|1|||
128986711|NCT00560573|464241457|FG004|Overall Study|Withdrawal by Subject|1|||
128986712|NCT00560573|464241458|FG005|Overall Study|Withdrawal by Subject|0|||
128986713|NCT00560573|464241453|FG000|Overall Study|Other|2|||
128986714|NCT00560573|464241454|FG001|Overall Study|Other|2|||
128986715|NCT00560573|464241455|FG002|Overall Study|Other|2|||
128986716|NCT00560573|464241456|FG003|Overall Study|Other|3|||
128986717|NCT00560573|464241457|FG004|Overall Study|Other|3|||
128986718|NCT00560573|464241458|FG005|Overall Study|Other|3|||
128986719|NCT00560573|464241453|FG000|Overall Study|Enrolled, not treated|0|||
128986720|NCT00560573|464241454|FG001|Overall Study|Enrolled, not treated|0|||
128986721|NCT00560573|464241455|FG002|Overall Study|Enrolled, not treated|0|||
128986722|NCT00560573|464241456|FG003|Overall Study|Enrolled, not treated|0|||
128986723|NCT00560573|464241457|FG004|Overall Study|Enrolled, not treated|1|||
128986724|NCT00560573|464241458|FG005|Overall Study|Enrolled, not treated|0|||
128986725|NCT02916056|464241460|FG000|Overall Study|Adverse Event|6|||
128986726|NCT02916056|464241460|FG000|Overall Study|Lost to Follow-up|1|||
128986727|NCT02916056|464241460|FG000|Overall Study|Other|12|||
128986728|NCT02916056|464241460|FG000|Overall Study|Protocol Violation|1|||
128986729|NCT02916056|464241460|FG000|Overall Study|Withdrawal by Subject|8|||
128986730|NCT02916056|464241460|FG000|Overall Study|Study Terminated by Sponsor|269|||
128986731|NCT00290511|464241461|FG000|Overall Study|Adverse Event|1|||
128986732|NCT00290511|464241461|FG000|Overall Study|Death|1|||
128986733|NCT00290511|464241461|FG000|Overall Study|Physician Decision|1|||
128986734|NCT00290511|464241461|FG000|Overall Study|Withdrawal by Subject|1|||
128986735|NCT00124709|464241462|FG000|Overall Study|Randomized but did not take medication|3|||
128986736|NCT00124709|464241463|FG001|Overall Study|Randomized but did not take medication|1|||
128986737|NCT00124709|464241462|FG000|Overall Study|Adverse Event|3|||
128986738|NCT00124709|464241463|FG001|Overall Study|Adverse Event|0|||
128986739|NCT00124709|464241462|FG000|Overall Study|Lack of Efficacy|5|||
128986740|NCT00124709|464241463|FG001|Overall Study|Lack of Efficacy|10|||
128986741|NCT00124709|464241462|FG000|Overall Study|Protocol Violation|3|||
128986742|NCT00124709|464241463|FG001|Overall Study|Protocol Violation|5|||
128986743|NCT00124709|464241462|FG000|Overall Study|Withdrawal by Subject|127|||
128986744|NCT00124709|464241463|FG001|Overall Study|Withdrawal by Subject|136|||
128986745|NCT00124709|464241462|FG000|Overall Study|Lost to Follow-up|114|||
128986746|NCT00124709|464241463|FG001|Overall Study|Lost to Follow-up|120|||
128986747|NCT00122954|464241464|FG000|Overall Study|Withdrawal by Subject|2|||
128986748|NCT00122954|464241465|FG001|Overall Study|Withdrawal by Subject|2|||
128986749|NCT00122954|464241464|FG000|Overall Study|Protocol Violation|0|||
128986750|NCT00122954|464241465|FG001|Overall Study|Protocol Violation|1|||
128986751|NCT01728376|464241466|FG000|Overall Study|Adverse Event|1|||
128986752|NCT01728376|464241467|FG001|Overall Study|Adverse Event|1|||
128986753|NCT01728376|464241468|FG002|Overall Study|Adverse Event|1|||
128986754|NCT01728376|464241469|FG003|Overall Study|Adverse Event|1|||
128986755|NCT01728376|464241470|FG004|Overall Study|Adverse Event|1|||
128986756|NCT01728376|464241471|FG005|Overall Study|Adverse Event|0|||
128986757|NCT01728376|464241466|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
128986758|NCT01728376|464241467|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
128986759|NCT01728376|464241468|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
128986760|NCT01728376|464241469|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
129209750|NCT03822117|465069079|FG002|Overall Study|Never Returned to Hospital|1|||
129209751|NCT03822117|465069080|FG003|Overall Study|Never Returned to Hospital|0|||
129209752|NCT01074502|465069081|FG000|Overall Study|Withdrawal by Subject|1|||
129209753|NCT03198715|465069082|FG000|Overall Study|Death|0|||
129209754|NCT03198715|465069083|FG001|Overall Study|Death|0|||
129209755|NCT03198715|465069084|FG002|Overall Study|Death|1|||
129209756|NCT03198715|465069085|FG003|Overall Study|Death|0|||
129209757|NCT03198715|465069086|FG004|Overall Study|Death|2|||
129209758|NCT03198715|465069082|FG000|Overall Study|Other|0|||
129209759|NCT03198715|465069083|FG001|Overall Study|Other|1|||
129209760|NCT03198715|465069084|FG002|Overall Study|Other|1|||
129209761|NCT03198715|465069085|FG003|Overall Study|Other|0|||
129209762|NCT03198715|465069086|FG004|Overall Study|Other|0|||
129209763|NCT00616759|465069087|FG000|Overall Study|Physician Decision|2|||
129209764|NCT00616759|465069088|FG001|Overall Study|Physician Decision|0|||
129209765|NCT00616759|465069087|FG000|Overall Study|Withdrawal by Subject|1|||
129209766|NCT00616759|465069088|FG001|Overall Study|Withdrawal by Subject|2|||
129209767|NCT00726063|465069092|FG000|Overall Study|Adverse Event|9|||
129209768|NCT00726063|465069093|FG001|Overall Study|Adverse Event|7|||
129209769|NCT02007096|465069094|FG000|Overall Study|medication not available|2|||
129209770|NCT02007096|465069095|FG001|Overall Study|medication not available|0|||
129209771|NCT02007096|465069094|FG000|Overall Study|did not inject saline|0|||
129209772|NCT02007096|465069095|FG001|Overall Study|did not inject saline|3|||
129209773|NCT02007096|465069094|FG000|Overall Study|did not follow postoperative protocol|8|||
129209774|NCT02007096|465069095|FG001|Overall Study|did not follow postoperative protocol|11|||
129209775|NCT02007096|465069094|FG000|Overall Study|converted to open surgery|1|||
129209776|NCT02007096|465069095|FG001|Overall Study|converted to open surgery|1|||
129209777|NCT02007096|465069094|FG000|Overall Study|no mesh placed|0|||
129209778|NCT02007096|465069095|FG001|Overall Study|no mesh placed|1|||
129209779|NCT05176314|465069097|FG000|Overall Study|Lost to Follow-up|2|||
129209780|NCT05176314|465069097|FG000|Overall Study|Physician Decision|1|||
129209781|NCT05176314|465069097|FG000|Overall Study|Adverse Event|1|||
129209782|NCT01231984|465069098|FG000|Study Period 1|Withdrawal by Subject|0|||
129209783|NCT01231984|465069099|FG001|Study Period 1|Withdrawal by Subject|0|||
129209784|NCT01231984|465069100|FG002|Study Period 1|Withdrawal by Subject|0|||
129209785|NCT01231984|465069101|FG003|Study Period 1|Withdrawal by Subject|1|||
129209786|NCT01231984|465069098|FG000|Study Period 1|Lost to Follow-up|1|||
129209787|NCT01231984|465069099|FG001|Study Period 1|Lost to Follow-up|1|||
129209788|NCT01231984|465069100|FG002|Study Period 1|Lost to Follow-up|1|||
129209789|NCT01231984|465069101|FG003|Study Period 1|Lost to Follow-up|0|||
129209790|NCT01231984|465069098|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
129209791|NCT01231984|465069099|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
129209792|NCT01231984|465069100|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
129209793|NCT01231984|465069101|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
129209794|NCT01231984|465069098|FG000|Study Period 1|Screen Failure|0|||
129209795|NCT01231984|465069099|FG001|Study Period 1|Screen Failure|0|||
129209796|NCT01231984|465069100|FG002|Study Period 1|Screen Failure|0|||
129209797|NCT01231984|465069101|FG003|Study Period 1|Screen Failure|1|||
129209798|NCT01231984|465069098|FG000|Study Period 1|Non-compliance with study requirements|5|||
129209799|NCT01231984|465069099|FG001|Study Period 1|Non-compliance with study requirements|0|||
129209800|NCT01231984|465069100|FG002|Study Period 1|Non-compliance with study requirements|2|||
129209801|NCT01231984|465069101|FG003|Study Period 1|Non-compliance with study requirements|1|||
129209802|NCT01231984|465069098|FG000|Study Period 1|Protocol Violation|3|||
129209803|NCT01231984|465069099|FG001|Study Period 1|Protocol Violation|4|||
129209804|NCT01231984|465069100|FG002|Study Period 1|Protocol Violation|2|||
129209805|NCT01231984|465069101|FG003|Study Period 1|Protocol Violation|3|||
129209806|NCT01231984|465069098|FG000|Study Period 1|Adverse Event|1|||
129209807|NCT01231984|465069099|FG001|Study Period 1|Adverse Event|0|||
129209808|NCT01231984|465069100|FG002|Study Period 1|Adverse Event|0|||
129209809|NCT01231984|465069101|FG003|Study Period 1|Adverse Event|0|||
129209810|NCT01231984|465069098|FG000|Study Period 1|Other|0|||
129209811|NCT01231984|465069099|FG001|Study Period 1|Other|0|||
129209812|NCT01231984|465069100|FG002|Study Period 1|Other|0|||
129209813|NCT01231984|465069101|FG003|Study Period 1|Other|1|||
129209814|NCT01231984|465069098|FG000|Study Period 2|Withdrawal by Subject|1|||
129209815|NCT01231984|465069099|FG001|Study Period 2|Withdrawal by Subject|1|||
129209816|NCT01231984|465069100|FG002|Study Period 2|Withdrawal by Subject|0|||
129209817|NCT01231984|465069101|FG003|Study Period 2|Withdrawal by Subject|0|||
129209818|NCT01231984|465069098|FG000|Study Period 2|Lost to Follow-up|1|||
129209819|NCT01231984|465069099|FG001|Study Period 2|Lost to Follow-up|0|||
129209820|NCT01231984|465069100|FG002|Study Period 2|Lost to Follow-up|0|||
129209821|NCT01231984|465069101|FG003|Study Period 2|Lost to Follow-up|3|||
129209822|NCT01231984|465069098|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
129209823|NCT01231984|465069099|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
129209824|NCT01231984|465069100|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
129209825|NCT01231984|465069101|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
129209826|NCT02766023|465069104|FG000|Overall Study|Lost to Follow-up|23|||
129209827|NCT02766023|465069105|FG001|Overall Study|Lost to Follow-up|11|||
129209828|NCT02766023|465069104|FG000|Overall Study|Pregnancy|1|||
129209829|NCT02766023|465069105|FG001|Overall Study|Pregnancy|0|||
129209830|NCT02766023|465069104|FG000|Overall Study|Adverse Event|1|||
129209831|NCT02766023|465069105|FG001|Overall Study|Adverse Event|0|||
129209832|NCT02766023|465069104|FG000|Overall Study|Withdrawal by Subject|4|||
129209833|NCT02766023|465069105|FG001|Overall Study|Withdrawal by Subject|5|||
129209834|NCT02766023|465069104|FG000|Overall Study|Physician Decision|1|||
129209835|NCT02766023|465069105|FG001|Overall Study|Physician Decision|0|||
129209836|NCT02766023|465069104|FG000|Overall Study|Not Eligible at Enrollment|0|||
129209837|NCT02766023|465069105|FG001|Overall Study|Not Eligible at Enrollment|1|||
129209838|NCT02923726|465069108|FG000|Overall Study|Death|196|||
129209839|NCT02923726|465069109|FG001|Overall Study|Death|175|||
129209840|NCT02923726|465069108|FG000|Overall Study|Withdrawal by Subject|337|||
129209841|NCT02923726|465069109|FG001|Overall Study|Withdrawal by Subject|307|||
129209842|NCT01680341|465069112|FG000|Overall Study|Adverse Event|3|||
129209843|NCT01680341|465069113|FG001|Overall Study|Adverse Event|2|||
129209844|NCT01680341|465069112|FG000|Overall Study|Unclassified|18|||
129209845|NCT01680341|465069113|FG001|Overall Study|Unclassified|15|||
129209846|NCT00481832|465069114|FG000|Enrollment|Physician Decision|8|||
129209847|NCT00481832|465069114|FG000|Enrollment|Unable to collect enough stem cells|2|||
129209848|NCT00481832|465069114|FG000|Inter-transplant Period|Adverse Event|4|||
129209849|NCT00481832|465069114|FG000|Inter-transplant Period|Death|3|||
129209850|NCT00481832|465069114|FG000|Inter-transplant Period|Physician Decision|4|||
129209851|NCT00481832|465069114|FG000|Inter-transplant Period|Disease relapse|11|||
129209852|NCT00481832|465069114|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
129209853|NCT02558894|465069117|FG000|Overall Study|Death; any cause, entire study duration|28|||
129209854|NCT02558894|465069118|FG001|Overall Study|Death; any cause, entire study duration|31|||
129209855|NCT02558894|465069117|FG000|Overall Study|Withdrawal by Subject|2|||
129209856|NCT02558894|465069118|FG001|Overall Study|Withdrawal by Subject|1|||
129209857|NCT02558894|465069117|FG000|Overall Study|Closure of Part A|2|||
129209858|NCT02558894|465069118|FG001|Overall Study|Closure of Part A|1|||
129209859|NCT02992288|465069119|FG000|Overall Study|Adverse Event|8|||
129209860|NCT02992288|465069120|FG001|Overall Study|Adverse Event|2|||
129209861|NCT02992288|465069121|FG002|Overall Study|Adverse Event|2|||
129209862|NCT02992288|465069122|FG003|Overall Study|Adverse Event|2|||
129209863|NCT02992288|465069123|FG004|Overall Study|Adverse Event|2|||
129209864|NCT02992288|465069124|FG005|Overall Study|Adverse Event|7|||
129209865|NCT02992288|465069119|FG000|Overall Study|Non-compliance with study drug|0|||
129209866|NCT02992288|465069120|FG001|Overall Study|Non-compliance with study drug|1|||
129209867|NCT02992288|465069121|FG002|Overall Study|Non-compliance with study drug|1|||
129209868|NCT02992288|465069122|FG003|Overall Study|Non-compliance with study drug|0|||
129209869|NCT02992288|465069123|FG004|Overall Study|Non-compliance with study drug|1|||
129209870|NCT02992288|465069124|FG005|Overall Study|Non-compliance with study drug|0|||
129209871|NCT02992288|465069119|FG000|Overall Study|Physician Decision|3|||
129209872|NCT02992288|465069120|FG001|Overall Study|Physician Decision|0|||
129209873|NCT02992288|465069121|FG002|Overall Study|Physician Decision|1|||
129209874|NCT02992288|465069122|FG003|Overall Study|Physician Decision|0|||
129209875|NCT02992288|465069123|FG004|Overall Study|Physician Decision|0|||
129209876|NCT02992288|465069124|FG005|Overall Study|Physician Decision|1|||
129209877|NCT02992288|465069119|FG000|Overall Study|Death|2|||
129209878|NCT02992288|465069120|FG001|Overall Study|Death|0|||
129209879|NCT02992288|465069121|FG002|Overall Study|Death|2|||
129209880|NCT02992288|465069122|FG003|Overall Study|Death|1|||
129209881|NCT02992288|465069123|FG004|Overall Study|Death|2|||
129209882|NCT02992288|465069124|FG005|Overall Study|Death|0|||
129209883|NCT02992288|465069119|FG000|Overall Study|Lost to Follow-up|0|||
129209884|NCT02992288|465069120|FG001|Overall Study|Lost to Follow-up|0|||
129209885|NCT02992288|465069121|FG002|Overall Study|Lost to Follow-up|0|||
129209886|NCT02992288|465069122|FG003|Overall Study|Lost to Follow-up|1|||
129209887|NCT02992288|465069123|FG004|Overall Study|Lost to Follow-up|0|||
129209888|NCT02992288|465069124|FG005|Overall Study|Lost to Follow-up|0|||
129209889|NCT02992288|465069119|FG000|Overall Study|Protocol Violation|0|||
129209890|NCT02992288|465069120|FG001|Overall Study|Protocol Violation|0|||
129209891|NCT02992288|465069121|FG002|Overall Study|Protocol Violation|0|||
129209892|NCT02992288|465069122|FG003|Overall Study|Protocol Violation|0|||
129209893|NCT02992288|465069123|FG004|Overall Study|Protocol Violation|0|||
129209894|NCT02992288|465069124|FG005|Overall Study|Protocol Violation|1|||
129209895|NCT02992288|465069119|FG000|Overall Study|Withdrawal by Subject|4|||
129209896|NCT02992288|465069120|FG001|Overall Study|Withdrawal by Subject|2|||
129209897|NCT02992288|465069121|FG002|Overall Study|Withdrawal by Subject|1|||
129209898|NCT02992288|465069122|FG003|Overall Study|Withdrawal by Subject|5|||
129209899|NCT02992288|465069123|FG004|Overall Study|Withdrawal by Subject|3|||
129209900|NCT02992288|465069124|FG005|Overall Study|Withdrawal by Subject|4|||
129209901|NCT02006472|465069128|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
129209902|NCT02006472|465069129|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
129209903|NCT02006472|465069130|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
129209904|NCT02006472|465069131|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
129209905|NCT02006472|465069132|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
129209906|NCT02006472|465069128|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129209907|NCT02006472|465069129|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129209908|NCT02006472|465069130|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
129209909|NCT02006472|465069131|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129209910|NCT02006472|465069132|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129209911|NCT02006472|465069128|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
129209912|NCT02006472|465069129|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
129209913|NCT02006472|465069130|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
129209914|NCT02006472|465069131|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
129209915|NCT02006472|465069132|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
129209916|NCT02006472|465069128|FG000|Period 1 (Through Week 26)|Other|1|||
129209917|NCT02006472|465069129|FG001|Period 1 (Through Week 26)|Other|5|||
129209918|NCT02006472|465069130|FG002|Period 1 (Through Week 26)|Other|0|||
129209919|NCT02006472|465069131|FG003|Period 1 (Through Week 26)|Other|2|||
129209920|NCT02006472|465069132|FG004|Period 1 (Through Week 26)|Other|3|||
129209921|NCT02006472|465069128|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
129209922|NCT02006472|465069129|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
129209923|NCT02006472|465069130|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
129209924|NCT02006472|465069131|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
129209925|NCT02006472|465069132|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
129209926|NCT02006472|465069128|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
129209927|NCT02006472|465069129|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
129209928|NCT02006472|465069130|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
129209929|NCT02006472|465069131|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
129209930|NCT02006472|465069132|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
129209931|NCT02006472|465069128|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
129209932|NCT02006472|465069129|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
129209933|NCT02006472|465069130|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
129209934|NCT02006472|465069131|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
129209935|NCT02006472|465069132|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
129209936|NCT02006472|465069128|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
129209937|NCT02006472|465069129|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
129209938|NCT02006472|465069130|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
129209939|NCT02006472|465069131|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
129209940|NCT02006472|465069132|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
129209941|NCT02006472|465069128|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
129209942|NCT02006472|465069129|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
129209943|NCT02006472|465069130|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
129209944|NCT02006472|465069131|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
129209945|NCT02006472|465069132|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
129209946|NCT02006472|465069128|FG000|Period 2 (Through Week 52)|Other|0|||
129209947|NCT02006472|465069129|FG001|Period 2 (Through Week 52)|Other|1|||
129209948|NCT02006472|465069130|FG002|Period 2 (Through Week 52)|Other|0|||
129209949|NCT02006472|465069131|FG003|Period 2 (Through Week 52)|Other|1|||
129209950|NCT02006472|465069132|FG004|Period 2 (Through Week 52)|Other|0|||
129209951|NCT02006472|465069128|FG000|Period 2 (Through Week 52)|Not treated|0|||
129209952|NCT02006472|465069129|FG001|Period 2 (Through Week 52)|Not treated|0|||
129209953|NCT02006472|465069130|FG002|Period 2 (Through Week 52)|Not treated|2|||
129209954|NCT02006472|465069131|FG003|Period 2 (Through Week 52)|Not treated|0|||
129209955|NCT02006472|465069132|FG004|Period 2 (Through Week 52)|Not treated|0|||
129209956|NCT02006472|465069128|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
129209957|NCT02006472|465069129|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
129209958|NCT02006472|465069130|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
129209959|NCT02006472|465069131|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
129209960|NCT02006472|465069132|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
129209961|NCT02006472|465069128|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
129209962|NCT02006472|465069129|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
129209963|NCT02006472|465069130|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
129209964|NCT02006472|465069131|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
129209965|NCT02006472|465069132|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
129209966|NCT00499486|465069133|FG000|Overall Study|Withdrawal by Subject|16|||
129209967|NCT00656513|465069134|FG000|Overall Study|Protocol Violation|1|||
129209968|NCT00656513|465069135|FG001|Overall Study|Protocol Violation|0|||
129209969|NCT00656513|465069136|FG002|Overall Study|Protocol Violation|2|||
128876480|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
128876481|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
128876482|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
128876483|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
128876484|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
128876485|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
128876486|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
128876487|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129209970|NCT00656513|465069134|FG000|Overall Study|Withdrawal by Subject|0|||
129209971|NCT00656513|465069135|FG001|Overall Study|Withdrawal by Subject|11|||
129209972|NCT00656513|465069136|FG002|Overall Study|Withdrawal by Subject|4|||
129209973|NCT00656513|465069134|FG000|Overall Study|Death|0|||
129209974|NCT00656513|465069135|FG001|Overall Study|Death|0|||
129209975|NCT00656513|465069136|FG002|Overall Study|Death|1|||
129209976|NCT00656513|465069134|FG000|Overall Study|Missing data|0|||
129209977|NCT00656513|465069135|FG001|Overall Study|Missing data|11|||
129209978|NCT00656513|465069136|FG002|Overall Study|Missing data|9|||
129209979|NCT00656513|465069134|FG000|Overall Study|Incomplete treatment|3|||
129209980|NCT00656513|465069135|FG001|Overall Study|Incomplete treatment|0|||
129209981|NCT00656513|465069136|FG002|Overall Study|Incomplete treatment|0|||
129209982|NCT00656513|465069134|FG000|Overall Study|Treatment completed outside of timeframe|0|||
129209983|NCT00656513|465069135|FG001|Overall Study|Treatment completed outside of timeframe|3|||
129209984|NCT00656513|465069136|FG002|Overall Study|Treatment completed outside of timeframe|1|||
129209985|NCT00656513|465069134|FG000|Overall Study|Missing baseline form|0|||
129209986|NCT00656513|465069135|FG001|Overall Study|Missing baseline form|5|||
129209987|NCT00656513|465069136|FG002|Overall Study|Missing baseline form|5|||
129209988|NCT00087152|465069137|FG000|Overall Study|Ineligible|6|||
129209989|NCT01436149|465069145|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
129209990|NCT01436149|465069146|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
129209991|NCT01436149|465069147|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
129209992|NCT01436149|465069145|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
129209993|NCT01436149|465069146|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
129209994|NCT01436149|465069147|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
129209995|NCT01436149|465069145|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
129209996|NCT01436149|465069146|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129209997|NCT01436149|465069147|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129209998|NCT01436149|465069145|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
129209999|NCT01436149|465069146|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129210000|NCT01436149|465069147|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129210001|NCT01436149|465069145|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
129210002|NCT01436149|465069146|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
129210003|NCT01436149|465069147|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
129210004|NCT01436149|465069145|FG000|Antidepressant Lead-in Phase|Other|119|||
129210005|NCT01436149|465069146|FG001|Antidepressant Lead-in Phase|Other|0|||
129210006|NCT01436149|465069147|FG002|Antidepressant Lead-in Phase|Other|0|||
129210007|NCT01436149|465069145|FG000|Randomized Phase|Adverse Event|9|||
129210008|NCT01436149|465069146|FG001|Randomized Phase|Adverse Event|10|||
129210009|NCT01436149|465069147|FG002|Randomized Phase|Adverse Event|11|||
129210010|NCT01436149|465069145|FG000|Randomized Phase|Protocol Violation|4|||
129210011|NCT01436149|465069146|FG001|Randomized Phase|Protocol Violation|5|||
129210012|NCT01436149|465069147|FG002|Randomized Phase|Protocol Violation|0|||
129210013|NCT01436149|465069145|FG000|Randomized Phase|Withdrawal by Subject|16|||
129210014|NCT01436149|465069146|FG001|Randomized Phase|Withdrawal by Subject|10|||
129210015|NCT01436149|465069147|FG002|Randomized Phase|Withdrawal by Subject|10|||
129210016|NCT01436149|465069145|FG000|Randomized Phase|Lost to Follow-up|34|||
129210017|NCT01436149|465069146|FG001|Randomized Phase|Lost to Follow-up|5|||
129210018|NCT01436149|465069147|FG002|Randomized Phase|Lost to Follow-up|6|||
129210019|NCT01436149|465069145|FG000|Randomized Phase|Lack of Efficacy|0|||
129210020|NCT01436149|465069146|FG001|Randomized Phase|Lack of Efficacy|0|||
129210021|NCT01436149|465069147|FG002|Randomized Phase|Lack of Efficacy|1|||
129210022|NCT01436149|465069145|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
129210023|NCT01436149|465069146|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
129210024|NCT01436149|465069147|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
129210025|NCT01436149|465069145|FG000|Randomized Phase|Other|12|||
129210026|NCT01436149|465069146|FG001|Randomized Phase|Other|5|||
129210027|NCT01436149|465069147|FG002|Randomized Phase|Other|11|||
129210028|NCT01643668|465069151|FG000|Overall Study|Death|1|||
129210029|NCT00322881|465069152|FG000|Overall Study|Death|2|||
129210030|NCT00322881|465069152|FG000|Overall Study|Adverse Event|1|||
129210031|NCT00322881|465069152|FG000|Overall Study|Disease Progression|2|||
129210032|NCT00561652|465069153|FG000|Overall Study|Withdrawal by Subject|0|||
129210033|NCT00561652|465069154|FG001|Overall Study|Withdrawal by Subject|1|||
129210034|NCT02285855|465069157|FG000|Overall Study|Withdrawal by Subject|2|||
129210035|NCT02285855|465069158|FG001|Overall Study|Withdrawal by Subject|1|||
129210036|NCT02718898|465069159|FG000|Blinded Treatment Period|Adverse Event|5|||
129210037|NCT02718898|465069160|FG001|Blinded Treatment Period|Adverse Event|1|||
129210038|NCT02718898|465069161|FG002|Blinded Treatment Period|Adverse Event|0|||
129210039|NCT02718898|465069162|FG003|Blinded Treatment Period|Adverse Event|0|||
129210040|NCT02718898|465069163|FG004|Blinded Treatment Period|Adverse Event|0|||
129210041|NCT02718898|465069164|FG005|Blinded Treatment Period|Adverse Event|0|||
129210042|NCT02718898|465069165|FG006|Blinded Treatment Period|Adverse Event|0|||
129210043|NCT02718898|465069159|FG000|Blinded Treatment Period|Physician Decision|1|||
129210044|NCT02718898|465069160|FG001|Blinded Treatment Period|Physician Decision|0|||
129210045|NCT02718898|465069161|FG002|Blinded Treatment Period|Physician Decision|0|||
129210046|NCT02718898|465069162|FG003|Blinded Treatment Period|Physician Decision|0|||
129210047|NCT02718898|465069163|FG004|Blinded Treatment Period|Physician Decision|0|||
129210048|NCT02718898|465069164|FG005|Blinded Treatment Period|Physician Decision|0|||
129210049|NCT02718898|465069165|FG006|Blinded Treatment Period|Physician Decision|0|||
129210050|NCT02718898|465069159|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
129210051|NCT02718898|465069160|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
129210052|NCT02718898|465069161|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
129210053|NCT02718898|465069162|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
129210054|NCT02718898|465069163|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
129210055|NCT02718898|465069164|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
129210056|NCT02718898|465069165|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
129210057|NCT02718898|465069159|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
129210058|NCT02718898|465069160|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
129210059|NCT02718898|465069161|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
129210060|NCT02718898|465069162|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
129210061|NCT02718898|465069163|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
129210062|NCT02718898|465069164|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
129210063|NCT02718898|465069165|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
129210064|NCT02718898|465069159|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129210065|NCT02718898|465069160|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129210066|NCT02718898|465069161|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
129210067|NCT02718898|465069162|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
129210068|NCT02718898|465069163|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129210069|NCT02718898|465069164|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129210070|NCT02718898|465069165|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129210071|NCT02718898|465069159|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129210072|NCT02718898|465069160|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129210073|NCT02718898|465069161|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129210074|NCT02718898|465069162|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
129210075|NCT02718898|465069163|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129210076|NCT02718898|465069164|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129210077|NCT02718898|465069165|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129210078|NCT02718898|465069159|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129210079|NCT02718898|465069160|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129210080|NCT02718898|465069161|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
129210081|NCT02718898|465069162|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
129210082|NCT02718898|465069163|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129210083|NCT02718898|465069164|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129210084|NCT02718898|465069165|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129210085|NCT02718898|465069159|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129210086|NCT02718898|465069160|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129210087|NCT02718898|465069161|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
129210088|NCT02718898|465069162|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
129210089|NCT02718898|465069163|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129210090|NCT02718898|465069164|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129210091|NCT02718898|465069165|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129210092|NCT02718898|465069159|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129210093|NCT02718898|465069160|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129210094|NCT02718898|465069161|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129210095|NCT02718898|465069162|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
129210096|NCT02718898|465069163|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129210097|NCT02718898|465069164|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129210098|NCT02718898|465069165|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129210099|NCT02718898|465069159|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129210100|NCT02718898|465069160|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129210101|NCT02718898|465069161|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129210102|NCT02718898|465069162|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
129210103|NCT02718898|465069163|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129210104|NCT02718898|465069164|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129210105|NCT02718898|465069165|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129210106|NCT02718898|465069159|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
129210107|NCT02718898|465069160|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
129210108|NCT02718898|465069161|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
129210109|NCT02718898|465069162|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
129210110|NCT02718898|465069163|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
129210111|NCT02718898|465069164|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
129210112|NCT02718898|465069165|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
129210113|NCT02718898|465069159|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129210114|NCT02718898|465069160|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129210115|NCT02718898|465069161|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129210116|NCT02718898|465069162|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129210117|NCT02718898|465069163|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
129210118|NCT02718898|465069164|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
129210119|NCT02718898|465069165|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
129210120|NCT02718898|465069159|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129210121|NCT02718898|465069160|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129210122|NCT02718898|465069161|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129210123|NCT02718898|465069162|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129210124|NCT02718898|465069163|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129210125|NCT02718898|465069164|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
129210126|NCT02718898|465069165|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
129210127|NCT04484961|465069166|FG000|Overall Study|Lost to Follow-up|9|||
129210128|NCT04484961|465069167|FG001|Overall Study|Lost to Follow-up|9|||
129210129|NCT01667900|465069168|FG000|Part B|Death|0|||
129210130|NCT01667900|465069169|FG001|Part B|Death|0|||
129210131|NCT01667900|465069170|FG002|Part B|Death|0|||
129210132|NCT01667900|465069171|FG003|Part B|Death|0|||
129210133|NCT01667900|465069172|FG004|Part B|Death|0|||
129210134|NCT01667900|465069173|FG005|Part B|Death|0|||
129210135|NCT01667900|465069174|FG006|Part B|Death|0|||
129210136|NCT01667900|465069175|FG007|Part B|Death|0|||
129210137|NCT01667900|465069176|FG008|Part B|Death|0|||
129210138|NCT01667900|465069177|FG009|Part B|Death|0|||
129210139|NCT01667900|465069178|FG010|Part B|Death|0|||
129210140|NCT01667900|465069179|FG011|Part B|Death|0|||
129210141|NCT01667900|465069180|FG012|Part B|Death|0|||
129210142|NCT01667900|465069181|FG013|Part B|Death|0|||
129210143|NCT01667900|465069182|FG014|Part B|Death|0|||
129210144|NCT01667900|465069183|FG015|Part B|Death|0|||
129210145|NCT01667900|465069184|FG016|Part B|Death|1|||
129210146|NCT01667900|465069185|FG017|Part B|Death|0|||
129210147|NCT01667900|465069186|FG018|Part B|Death|0|||
129210148|NCT01667900|465069187|FG019|Part B|Death|0|||
129210149|NCT04528641|465069189|FG000|Overall Study|Withdrawal by Subject|0|||
129210150|NCT04528641|465069190|FG001|Overall Study|Withdrawal by Subject|0|||
129210151|NCT04528641|465069191|FG002|Overall Study|Withdrawal by Subject|0|||
129210152|NCT04528641|465069192|FG003|Overall Study|Withdrawal by Subject|1|||
129210153|NCT04528641|465069193|FG004|Overall Study|Withdrawal by Subject|0|||
129210154|NCT04528641|465069194|FG005|Overall Study|Withdrawal by Subject|1|||
129210155|NCT02783690|465069199|FG000|Overall Study|Withdrawal by Subject|3|||
129210156|NCT02783690|465069200|FG001|Overall Study|Withdrawal by Subject|3|||
129210157|NCT03474588|465069201|FG000|Overall Study|Withdrawal by Subject|4|||
129210158|NCT03474588|465069202|FG001|Overall Study|Withdrawal by Subject|3|||
129210159|NCT03474588|465069201|FG000|Overall Study|Death|0|||
129210160|NCT03474588|465069202|FG001|Overall Study|Death|1|||
129210161|NCT00626106|465069208|FG000|Overall Study|Withdrawal by Subject|2|||
129210162|NCT00626106|465069209|FG001|Overall Study|Withdrawal by Subject|1|||
129210163|NCT00626106|465069208|FG000|Overall Study|Lost to Follow-up|1|||
129210164|NCT00626106|465069209|FG001|Overall Study|Lost to Follow-up|4|||
129210165|NCT00626106|465069208|FG000|Overall Study|Death|64|||
129210166|NCT00626106|465069209|FG001|Overall Study|Death|19|||
129210167|NCT05417438|465069210|FG000|Overall Study|Withdrawal by Subject|3|||
129210168|NCT02702492|465069213|FG000|Overall Study|Disease progression|3|||
129210169|NCT02702492|465069214|FG001|Overall Study|Disease progression|3|||
129210170|NCT02702492|465069215|FG002|Overall Study|Disease progression|2|||
129210171|NCT02702492|465069216|FG003|Overall Study|Disease progression|4|||
129210172|NCT02702492|465069217|FG004|Overall Study|Disease progression|4|||
129210173|NCT02702492|465069218|FG005|Overall Study|Disease progression|1|||
129210174|NCT02702492|465069219|FG006|Overall Study|Disease progression|2|||
129210175|NCT02702492|465069220|FG007|Overall Study|Disease progression|8|||
129210176|NCT02702492|465069221|FG008|Overall Study|Disease progression|5|||
129210177|NCT02702492|465069222|FG009|Overall Study|Disease progression|1|||
129210178|NCT02702492|465069223|FG010|Overall Study|Disease progression|0|||
129210179|NCT02702492|465069224|FG011|Overall Study|Disease progression|3|||
129210180|NCT02702492|465069225|FG012|Overall Study|Disease progression|2|||
129210181|NCT02702492|465069213|FG000|Overall Study|Clinical progression|0|||
129210182|NCT02702492|465069214|FG001|Overall Study|Clinical progression|0|||
129210183|NCT02702492|465069215|FG002|Overall Study|Clinical progression|2|||
129210184|NCT02702492|465069216|FG003|Overall Study|Clinical progression|1|||
129210185|NCT02702492|465069217|FG004|Overall Study|Clinical progression|0|||
129210186|NCT02702492|465069218|FG005|Overall Study|Clinical progression|2|||
129210187|NCT02702492|465069219|FG006|Overall Study|Clinical progression|1|||
129210188|NCT02702492|465069220|FG007|Overall Study|Clinical progression|4|||
129210189|NCT02702492|465069221|FG008|Overall Study|Clinical progression|0|||
129210190|NCT02702492|465069222|FG009|Overall Study|Clinical progression|0|||
129210191|NCT02702492|465069223|FG010|Overall Study|Clinical progression|1|||
129210192|NCT02702492|465069224|FG011|Overall Study|Clinical progression|2|||
129210193|NCT02702492|465069225|FG012|Overall Study|Clinical progression|0|||
129210194|NCT02702492|465069213|FG000|Overall Study|Adverse Event|0|||
129210195|NCT02702492|465069214|FG001|Overall Study|Adverse Event|0|||
129210196|NCT02702492|465069215|FG002|Overall Study|Adverse Event|1|||
129210197|NCT02702492|465069216|FG003|Overall Study|Adverse Event|2|||
129210198|NCT02702492|465069217|FG004|Overall Study|Adverse Event|1|||
129210199|NCT02702492|465069218|FG005|Overall Study|Adverse Event|0|||
129210200|NCT02702492|465069219|FG006|Overall Study|Adverse Event|1|||
129210201|NCT02702492|465069220|FG007|Overall Study|Adverse Event|0|||
129210202|NCT02702492|465069221|FG008|Overall Study|Adverse Event|2|||
128986761|NCT01728376|464241470|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
128986762|NCT01728376|464241471|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
128986763|NCT01728376|464241466|FG000|Overall Study|No relevant bacteria|2|||
128986764|NCT01728376|464241467|FG001|Overall Study|No relevant bacteria|0|||
128986765|NCT01728376|464241468|FG002|Overall Study|No relevant bacteria|0|||
128986766|NCT01728376|464241469|FG003|Overall Study|No relevant bacteria|0|||
128986767|NCT01728376|464241470|FG004|Overall Study|No relevant bacteria|1|||
129210203|NCT02702492|465069222|FG009|Overall Study|Adverse Event|0|||
129210204|NCT02702492|465069223|FG010|Overall Study|Adverse Event|0|||
129210205|NCT02702492|465069224|FG011|Overall Study|Adverse Event|0|||
129210206|NCT02702492|465069225|FG012|Overall Study|Adverse Event|1|||
129210207|NCT02702492|465069213|FG000|Overall Study|Other|0|||
129210208|NCT02702492|465069214|FG001|Overall Study|Other|0|||
129210209|NCT02702492|465069215|FG002|Overall Study|Other|0|||
129210210|NCT02702492|465069216|FG003|Overall Study|Other|0|||
129210211|NCT02702492|465069217|FG004|Overall Study|Other|0|||
129210212|NCT02702492|465069218|FG005|Overall Study|Other|0|||
129210213|NCT02702492|465069219|FG006|Overall Study|Other|0|||
129210214|NCT02702492|465069220|FG007|Overall Study|Other|0|||
129210215|NCT02702492|465069221|FG008|Overall Study|Other|0|||
129210216|NCT02702492|465069222|FG009|Overall Study|Other|0|||
129210217|NCT02702492|465069223|FG010|Overall Study|Other|0|||
129210218|NCT02702492|465069224|FG011|Overall Study|Other|0|||
129210219|NCT02702492|465069225|FG012|Overall Study|Other|1|||
129210220|NCT03253393|465069226|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
129210221|NCT03253393|465069227|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
129210222|NCT03253393|465069228|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
129210223|NCT00079417|465070664|FG000|Overall Study|Physician Decision|2|||
129210224|NCT00079417|465070664|FG000|Overall Study|Ineligible|7|||
129210225|NCT02458313|465070665|FG000|Overall Study|Withdrawal by Subject|6|||
129210226|NCT02458313|465070666|FG001|Overall Study|Withdrawal by Subject|8|||
129210227|NCT02458313|465070665|FG000|Overall Study|Excluded for motion during MRI|1|||
129210228|NCT02458313|465070666|FG001|Overall Study|Excluded for motion during MRI|2|||
129210229|NCT00904969|465070667|FG000|Overall Study|Lost to Follow-up|4|||
129210230|NCT00904969|465070667|FG000|Overall Study|Withdrawal by Subject|3|||
129210231|NCT00904969|465070667|FG000|Overall Study|Additional Treatments|11|||
129210232|NCT00904969|465070667|FG000|Overall Study|Case Aborted; Subject Exited|1|||
129210233|NCT00199381|465070674|FG000|Overall Study|Withdrawal by Subject|38|||
129210234|NCT00199381|465070674|FG000|Overall Study|Adverse Event|73|||
129210235|NCT00199381|465070674|FG000|Overall Study|Protocol Violation|6|||
129210236|NCT00199381|465070674|FG000|Overall Study|Lack of Efficacy|27|||
129210237|NCT00199381|465070674|FG000|Overall Study|Not including due to early termination|37|||
129210238|NCT00199381|465070674|FG000|Overall Study|Study termination by Sponsor|323|||
129210239|NCT00385671|465070676|FG000|Overall Study|Adverse Event|14|||
129210240|NCT00385671|465070677|FG001|Overall Study|Adverse Event|27|||
129210241|NCT00385671|465070678|FG002|Overall Study|Adverse Event|18|||
129210242|NCT00385671|465070676|FG000|Overall Study|Lack of Efficacy|5|||
129210243|NCT00385671|465070677|FG001|Overall Study|Lack of Efficacy|9|||
129210244|NCT00385671|465070678|FG002|Overall Study|Lack of Efficacy|5|||
129210245|NCT00385671|465070676|FG000|Overall Study|Lost to Follow-up|6|||
129210246|NCT00385671|465070677|FG001|Overall Study|Lost to Follow-up|6|||
129210247|NCT00385671|465070678|FG002|Overall Study|Lost to Follow-up|5|||
128986768|NCT01728376|464241471|FG005|Overall Study|No relevant bacteria|1|||
128986769|NCT01728376|464241466|FG000|Overall Study|Did not receive treatment|0|||
129210248|NCT00385671|465070676|FG000|Overall Study|Physician Decision|2|||
128986770|NCT01728376|464241467|FG001|Overall Study|Did not receive treatment|1|||
129210249|NCT00385671|465070677|FG001|Overall Study|Physician Decision|1|||
129210250|NCT00385671|465070678|FG002|Overall Study|Physician Decision|2|||
129210251|NCT00385671|465070676|FG000|Overall Study|Protocol Violation|5|||
129210252|NCT00385671|465070677|FG001|Overall Study|Protocol Violation|2|||
129210253|NCT00385671|465070678|FG002|Overall Study|Protocol Violation|1|||
129210254|NCT00385671|465070676|FG000|Overall Study|Sponsor Decision|2|||
129210255|NCT00385671|465070677|FG001|Overall Study|Sponsor Decision|2|||
128986771|NCT01728376|464241468|FG002|Overall Study|Did not receive treatment|0|||
129210256|NCT00385671|465070678|FG002|Overall Study|Sponsor Decision|1|||
129210257|NCT00385671|465070676|FG000|Overall Study|Withdrawal by Subject|4|||
129210258|NCT00385671|465070677|FG001|Overall Study|Withdrawal by Subject|4|||
129210259|NCT00385671|465070678|FG002|Overall Study|Withdrawal by Subject|4|||
129210260|NCT01775501|465070679|FG000|Overall Study|Discontinued prior to treatment|1|||
129210261|NCT01280903|465070683|FG000|Overall Study|Lost to Follow-up|23|||
129210262|NCT01280903|465070684|FG001|Overall Study|Lost to Follow-up|16|||
129210263|NCT03453164|465070685|FG000|Overall Study|Lack of Efficacy|16|||
129210264|NCT03453164|465070685|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
129210265|NCT03007966|465070688|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
129210266|NCT03007966|465070689|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
129210267|NCT03459079|465070690|FG000|Overall Study|Adverse Event|4|||
129210268|NCT03459079|465070691|FG001|Overall Study|Adverse Event|2|||
129210269|NCT03459079|465070692|FG002|Overall Study|Adverse Event|0|||
129210270|NCT03459079|465070690|FG000|Overall Study|Withdrawal by Subject|2|||
129210271|NCT03459079|465070691|FG001|Overall Study|Withdrawal by Subject|2|||
129210272|NCT03459079|465070692|FG002|Overall Study|Withdrawal by Subject|0|||
129210273|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
129210274|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
129210275|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129210276|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
129210277|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
129210278|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
129210279|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129210280|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
129210281|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
129210282|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129210283|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129210284|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129210285|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
129210286|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
129210287|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
129210288|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
129210289|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
129210290|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
129210291|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
129210292|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
129210293|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
129210294|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
129210295|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129210296|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129210297|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
129210298|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
129210299|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
129210300|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
129210301|NCT04026113|465070697|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129210302|NCT04026113|465070698|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
129210303|NCT04026113|465070699|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129210304|NCT04026113|465070700|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129210305|NCT04026113|465070697|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
129210306|NCT04026113|465070698|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
129210307|NCT04026113|465070699|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
129210308|NCT04026113|465070700|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
129210309|NCT04613362|465070701|FG000|3 Month Follow-up|Lost to Follow-up|1|||
129210310|NCT04613362|465070702|FG001|3 Month Follow-up|Lost to Follow-up|2|||
129210311|NCT04613362|465070701|FG000|6 Month Follow-up|Lost to Follow-up|0|||
129210312|NCT04613362|465070702|FG001|6 Month Follow-up|Lost to Follow-up|1|||
129210313|NCT02218372|465070703|FG000|Overall Study|Adverse Event|1|||
129210314|NCT02218372|465070704|FG001|Overall Study|Adverse Event|1|||
129210315|NCT02218372|465070703|FG000|Overall Study|Miscellaneous|2|||
128986772|NCT01728376|464241469|FG003|Overall Study|Did not receive treatment|0|||
128986773|NCT01728376|464241470|FG004|Overall Study|Did not receive treatment|0|||
128986774|NCT01728376|464241471|FG005|Overall Study|Did not receive treatment|0|||
128986775|NCT01728376|464241466|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
129210316|NCT02218372|465070704|FG001|Overall Study|Miscellaneous|1|||
128986776|NCT01728376|464241467|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
129210317|NCT02218372|465070703|FG000|Overall Study|Randomized but did not receive treatment|2|||
129210318|NCT02218372|465070704|FG001|Overall Study|Randomized but did not receive treatment|3|||
129210319|NCT02218372|465070703|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129210320|NCT02218372|465070704|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129210321|NCT00074711|465070713|FG000|Overall Study|Withdrawal by Subject|1|||
129210322|NCT00074711|465070714|FG001|Overall Study|Withdrawal by Subject|1|||
129210323|NCT00074711|465070713|FG000|Overall Study|Lost to Follow-up|10|||
129210324|NCT00074711|465070714|FG001|Overall Study|Lost to Follow-up|8|||
129210325|NCT00074711|465070713|FG000|Overall Study|Participant stopped study drug|4|||
129210326|NCT00074711|465070714|FG001|Overall Study|Participant stopped study drug|6|||
129210327|NCT00671658|465070715|FG000|Overall Study|Physician Decision|5|||
129210328|NCT01921205|465070716|FG000|Overall Study|Adverse Event|12|||
129210329|NCT01921205|465070717|FG001|Overall Study|Adverse Event|7|||
129210330|NCT01921205|465070716|FG000|Overall Study|Lack of Efficacy|1|||
129210331|NCT01921205|465070717|FG001|Overall Study|Lack of Efficacy|0|||
129210332|NCT01921205|465070716|FG000|Overall Study|Protocol Violation|1|||
129210333|NCT01921205|465070717|FG001|Overall Study|Protocol Violation|3|||
129210334|NCT01921205|465070716|FG000|Overall Study|Lost to Follow-up|1|||
129210335|NCT01921205|465070717|FG001|Overall Study|Lost to Follow-up|1|||
129210336|NCT01921205|465070716|FG000|Overall Study|Withdrawal by Subject|6|||
129210337|NCT01921205|465070717|FG001|Overall Study|Withdrawal by Subject|5|||
129210338|NCT01921205|465070716|FG000|Overall Study|Use Of Prohibited Medication|0|||
129210339|NCT01921205|465070717|FG001|Overall Study|Use Of Prohibited Medication|1|||
129210340|NCT01921205|465070716|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
129210341|NCT01921205|465070717|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
129210342|NCT01921205|465070716|FG000|Overall Study|Non Compliance Of The Parent|0|||
129210343|NCT01921205|465070717|FG001|Overall Study|Non Compliance Of The Parent|1|||
129210344|NCT01921205|465070716|FG000|Overall Study|Non Compliance Of Child|0|||
129210345|NCT01921205|465070717|FG001|Overall Study|Non Compliance Of Child|1|||
129210346|NCT01527149|465070719|FG000|Overall Study|Death|2|||
129210347|NCT03125395|465070720|FG000|Overall Study|Adverse Event|2|||
129210348|NCT03125395|465070720|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129210349|NCT03125395|465070720|FG000|Overall Study|Physician Decision|2|||
129210350|NCT03125395|465070720|FG000|Overall Study|Commercial drug is available|5|||
129210351|NCT01499940|465070721|FG000|Overall Study|Study was withdrawn before completion.|9|||
129210352|NCT03279081|465070723|FG000|Overall Study|Withdrawal by Subject|12|||
129210353|NCT03279081|465070724|FG001|Overall Study|Withdrawal by Subject|20|||
129210354|NCT03279081|465070723|FG000|Overall Study|Physician Decision|4|||
129210355|NCT03279081|465070724|FG001|Overall Study|Physician Decision|1|||
129210356|NCT03279081|465070723|FG000|Overall Study|Lost to Follow-up|8|||
129210357|NCT03279081|465070724|FG001|Overall Study|Lost to Follow-up|8|||
129210358|NCT03279081|465070723|FG000|Overall Study|Death|0|||
129210359|NCT03279081|465070724|FG001|Overall Study|Death|1|||
129210360|NCT03279081|465070723|FG000|Overall Study|Adverse Event|1|||
129210361|NCT03279081|465070724|FG001|Overall Study|Adverse Event|0|||
129210362|NCT03279081|465070723|FG000|Overall Study|Reason not Specified|14|||
129210363|NCT03279081|465070724|FG001|Overall Study|Reason not Specified|4|||
129210364|NCT03521570|465070725|FG000|Overall Study|Not eligible|11|||
129210365|NCT03253796|465070736|FG000|Period 1: Run-In|Adverse Event|4|||
129210366|NCT03253796|465070737|FG001|Period 1: Run-In|Adverse Event|0|||
129210367|NCT03253796|465070738|FG002|Period 1: Run-In|Adverse Event|0|||
129210368|NCT03253796|465070739|FG003|Period 1: Run-In|Adverse Event|0|||
129210369|NCT03253796|465070740|FG004|Period 1: Run-In|Adverse Event|0|||
129210370|NCT03253796|465070736|FG000|Period 1: Run-In|Lack of Efficacy|1|||
129210371|NCT03253796|465070737|FG001|Period 1: Run-In|Lack of Efficacy|0|||
129210372|NCT03253796|465070738|FG002|Period 1: Run-In|Lack of Efficacy|0|||
129210373|NCT03253796|465070739|FG003|Period 1: Run-In|Lack of Efficacy|0|||
129210374|NCT03253796|465070740|FG004|Period 1: Run-In|Lack of Efficacy|0|||
129210375|NCT03253796|465070736|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
129210376|NCT03253796|465070737|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
129210377|NCT03253796|465070738|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
129210378|NCT03253796|465070739|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
129210379|NCT03253796|465070740|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
129210380|NCT03253796|465070736|FG000|Period 1: Run-In|Protocol Violation|5|||
129210381|NCT03253796|465070737|FG001|Period 1: Run-In|Protocol Violation|0|||
129210382|NCT03253796|465070738|FG002|Period 1: Run-In|Protocol Violation|0|||
129210383|NCT03253796|465070739|FG003|Period 1: Run-In|Protocol Violation|0|||
129210384|NCT03253796|465070740|FG004|Period 1: Run-In|Protocol Violation|0|||
129210385|NCT03253796|465070736|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
129210386|NCT03253796|465070737|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
129210387|NCT03253796|465070738|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
129210388|NCT03253796|465070739|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
129210389|NCT03253796|465070740|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
129210390|NCT03253796|465070736|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129210391|NCT03253796|465070737|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129210392|NCT03253796|465070738|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
129210393|NCT03253796|465070739|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129210394|NCT03253796|465070740|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129210395|NCT03253796|465070736|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129210396|NCT03253796|465070737|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129210397|NCT03253796|465070738|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
129210398|NCT03253796|465070739|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129210399|NCT03253796|465070740|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129210400|NCT03253796|465070736|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
129210401|NCT03253796|465070737|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
129210402|NCT03253796|465070738|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
129210403|NCT03253796|465070739|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
129210404|NCT03253796|465070740|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
129210405|NCT03253796|465070736|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129210406|NCT03253796|465070737|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129210407|NCT03253796|465070738|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
129210408|NCT03253796|465070739|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129210409|NCT03253796|465070740|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129210410|NCT03253796|465070736|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
129210411|NCT03253796|465070737|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
129210412|NCT03253796|465070738|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
129210413|NCT03253796|465070739|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
129210414|NCT03253796|465070740|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
129210415|NCT03253796|465070736|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129210416|NCT03253796|465070737|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129210417|NCT03253796|465070738|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129210418|NCT03253796|465070739|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129210419|NCT03253796|465070740|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
129210420|NCT00976274|465070744|FG000|Overall Study|Lost to Follow-up|5|||
129210421|NCT00976274|465070745|FG001|Overall Study|Lost to Follow-up|5|||
129210422|NCT00976274|465070744|FG000|Overall Study|Withdrawal by Subject|1|||
129210423|NCT00976274|465070745|FG001|Overall Study|Withdrawal by Subject|1|||
129210424|NCT00976274|465070744|FG000|Overall Study|Physician Decision|1|||
129210425|NCT00976274|465070745|FG001|Overall Study|Physician Decision|2|||
129210426|NCT01075243|465070746|FG000|Overall Study|Lost to Follow-up|5|||
129210427|NCT01075243|465070747|FG001|Overall Study|Lost to Follow-up|2|||
129210428|NCT01075243|465070748|FG002|Overall Study|Lost to Follow-up|0|||
129210429|NCT01075243|465070746|FG000|Overall Study|Withdrawal by Subject|1|||
129210430|NCT01075243|465070747|FG001|Overall Study|Withdrawal by Subject|1|||
129210431|NCT01075243|465070748|FG002|Overall Study|Withdrawal by Subject|0|||
129210432|NCT00627393|465070751|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
129210433|NCT00627393|465070752|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
129210434|NCT00627393|465070751|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
129210435|NCT00627393|465070752|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
129210436|NCT00627393|465070751|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
129210437|NCT00627393|465070752|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
129210438|NCT00627393|465070751|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
129210439|NCT00627393|465070752|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
129210440|NCT00004563|465070755|FG000|Overall Study|Withdrawal by Subject|20|||
129210441|NCT00004563|465070756|FG001|Overall Study|Withdrawal by Subject|16|||
129210442|NCT00004563|465070755|FG000|Overall Study|Lack of Efficacy|3|||
129210443|NCT00004563|465070756|FG001|Overall Study|Lack of Efficacy|5|||
129210444|NCT00004563|465070755|FG000|Overall Study|Death|2|||
129210445|NCT00004563|465070756|FG001|Overall Study|Death|3|||
129210446|NCT03337308|465070757|FG000|Overall Study|Adverse Event|2|||
129210447|NCT03337308|465070758|FG001|Overall Study|Adverse Event|3|||
129210448|NCT03337308|465070759|FG002|Overall Study|Adverse Event|3|||
129210449|NCT03337308|465070760|FG003|Overall Study|Adverse Event|1|||
129210450|NCT03337308|465070757|FG000|Overall Study|Lost to Follow-up|1|||
129210451|NCT03337308|465070758|FG001|Overall Study|Lost to Follow-up|2|||
129210452|NCT03337308|465070759|FG002|Overall Study|Lost to Follow-up|0|||
129210453|NCT03337308|465070760|FG003|Overall Study|Lost to Follow-up|0|||
129210454|NCT03337308|465070757|FG000|Overall Study|Withdrawal by Subject|2|||
129210455|NCT03337308|465070758|FG001|Overall Study|Withdrawal by Subject|1|||
129210456|NCT03337308|465070759|FG002|Overall Study|Withdrawal by Subject|2|||
129210457|NCT03337308|465070760|FG003|Overall Study|Withdrawal by Subject|1|||
129210458|NCT03337308|465070757|FG000|Overall Study|Protocol Violation|0|||
129210459|NCT03337308|465070758|FG001|Overall Study|Protocol Violation|1|||
129210460|NCT03337308|465070759|FG002|Overall Study|Protocol Violation|0|||
129210461|NCT03337308|465070760|FG003|Overall Study|Protocol Violation|0|||
129210462|NCT01056822|465070761|FG000|Overall Study|Adverse Event|0|||
129210463|NCT01056822|465070762|FG001|Overall Study|Adverse Event|1|||
129210464|NCT01056822|465070761|FG000|Overall Study|Protocol Violation|6|||
129210465|NCT01056822|465070762|FG001|Overall Study|Protocol Violation|5|||
129210466|NCT01056822|465070761|FG000|Overall Study|Withdrawal by Subject|1|||
129210467|NCT01056822|465070762|FG001|Overall Study|Withdrawal by Subject|1|||
129210468|NCT01056822|465070761|FG000|Overall Study|Lost to Follow-up|1|||
129210469|NCT01056822|465070762|FG001|Overall Study|Lost to Follow-up|0|||
129210470|NCT03094416|465070765|FG000|Run-in|Screening failure|8|||
129210471|NCT03094416|465070765|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
129210472|NCT03094416|465070765|FG000|Run-in|Withdrawal by Subject|3|||
129210473|NCT03094416|465070765|FG000|Treatment Period|Withdrawal by Subject|2|||
129210474|NCT01668784|465070766|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
129210475|NCT01668784|465070767|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
129210476|NCT01668784|465070766|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
129210477|NCT01668784|465070767|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
129210478|NCT01668784|465070766|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
129210479|NCT01668784|465070767|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
129210480|NCT01668784|465070766|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
129210481|NCT01668784|465070767|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
129210482|NCT01668784|465070766|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
129210483|NCT01668784|465070767|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
129210484|NCT01668784|465070766|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
129210485|NCT01668784|465070767|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
129210486|NCT01668784|465070766|FG000|Treatment Period|Disease Progression|316|||
129210487|NCT01668784|465070767|FG001|Treatment Period|Disease Progression|293|||
129210488|NCT01668784|465070766|FG000|Treatment Period|Study Drug Toxicity|46|||
129210489|NCT01668784|465070767|FG001|Treatment Period|Study Drug Toxicity|53|||
129210490|NCT01668784|465070766|FG000|Treatment Period|Death|1|||
129210491|NCT01668784|465070767|FG001|Treatment Period|Death|1|||
129210492|NCT01668784|465070766|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
129210493|NCT01668784|465070767|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
129210494|NCT01668784|465070766|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
129210495|NCT01668784|465070767|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
129210496|NCT01668784|465070766|FG000|Treatment Period|Withdrawal by Subject|5|||
129210497|NCT01668784|465070767|FG001|Treatment Period|Withdrawal by Subject|3|||
129210498|NCT01668784|465070766|FG000|Treatment Period|Maximal Clinical Benefit|3|||
129210499|NCT01668784|465070767|FG001|Treatment Period|Maximal Clinical Benefit|3|||
129210500|NCT01668784|465070766|FG000|Treatment Period|Other|2|||
129210501|NCT01668784|465070767|FG001|Treatment Period|Other|8|||
129210502|NCT01668784|465070766|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
129210503|NCT01668784|465070767|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
129210504|NCT04366349|465070768|FG000|Overall Study|Withdrawal by Subject|1|||
129210505|NCT04366349|465070769|FG001|Overall Study|Withdrawal by Subject|0|||
129210506|NCT04366349|465070770|FG002|Overall Study|Withdrawal by Subject|0|||
129210507|NCT04366349|465070771|FG003|Overall Study|Withdrawal by Subject|0|||
129210508|NCT04366349|465070772|FG004|Overall Study|Withdrawal by Subject|0|||
129210509|NCT04366349|465070773|FG005|Overall Study|Withdrawal by Subject|0|||
129210510|NCT03804528|465070782|FG000|Overall Study|Time Commitment|18|||
129210511|NCT03804528|465070782|FG000|Overall Study|Health Reasons|5|||
129210512|NCT04607005|465070783|FG000|Overall Study|Adverse Event|0|||
129210513|NCT04607005|465070784|FG001|Overall Study|Adverse Event|1|||
129210514|NCT04607005|465070783|FG000|Overall Study|Lack of Efficacy|1|||
129210515|NCT04607005|465070784|FG001|Overall Study|Lack of Efficacy|6|||
129210516|NCT04607005|465070783|FG000|Overall Study|Withdrawal by Subject|4|||
129210517|NCT04607005|465070784|FG001|Overall Study|Withdrawal by Subject|9|||
129210518|NCT04607005|465070783|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
129210519|NCT04607005|465070784|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
129210520|NCT02331134|465070785|FG000|Overall Study|Withdrawal by Subject|1|||
129210521|NCT04825574|465070787|FG000|Overall Study|Commercial treatment became available|1|||
129210522|NCT04825574|465070787|FG000|Overall Study|Disease progression|1|||
129210523|NCT04272242|465070790|FG000|Overall Study|Withdrawal by Subject|3|||
129210524|NCT04272242|465070790|FG000|Overall Study|Lost to Follow-up|1|||
129210525|NCT04272242|465070790|FG000|Overall Study|Adverse Event|1|||
129210526|NCT00781768|465072907|FG000|Overall Study|Not transplanted.|0|||
129210527|NCT00781768|465072908|FG001|Overall Study|Not transplanted.|2|||
129210528|NCT04944992|465072909|FG000|Overall Study|Lost to Follow-up|1|||
129210529|NCT04944992|465072910|FG001|Overall Study|Lost to Follow-up|1|||
129210530|NCT04944992|465072909|FG000|Overall Study|Physician Decision|1|||
129210531|NCT04944992|465072910|FG001|Overall Study|Physician Decision|0|||
129210532|NCT04944992|465072909|FG000|Overall Study|Withdrawal by Subject|6|||
129210533|NCT04944992|465072910|FG001|Overall Study|Withdrawal by Subject|1|||
129210534|NCT01295814|465072911|FG000|Overall Study|Lack of Efficacy|0|||
129210535|NCT01295814|465072912|FG001|Overall Study|Lack of Efficacy|2|||
129210536|NCT01295814|465072911|FG000|Overall Study|Withdrawal by Subject|2|||
129210537|NCT01295814|465072912|FG001|Overall Study|Withdrawal by Subject|0|||
129210538|NCT03414983|465072913|FG000|Pre-Treatment|Other reasons|1|||
129210539|NCT03414983|465072914|FG001|Pre-Treatment|Other reasons|0|||
129210540|NCT03414983|465072913|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129210541|NCT03414983|465072914|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
129210542|NCT03414983|465072913|FG000|Pre-Treatment|Participant withdrew consent|1|||
129210543|NCT03414983|465072914|FG001|Pre-Treatment|Participant withdrew consent|3|||
129210544|NCT03414983|465072913|FG000|Treatment|Participant withdrew consent|4|||
129210545|NCT03414983|465072914|FG001|Treatment|Participant withdrew consent|3|||
129210546|NCT03414983|465072913|FG000|Treatment|Participant request to discontinue study treatment|8|||
129210547|NCT03414983|465072914|FG001|Treatment|Participant request to discontinue study treatment|10|||
129210548|NCT03414983|465072913|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
129210549|NCT03414983|465072914|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
129210550|NCT03414983|465072913|FG000|Treatment|Death|0|||
129210551|NCT03414983|465072914|FG001|Treatment|Death|1|||
129210552|NCT03414983|465072913|FG000|Treatment|Study Drug Toxicity|10|||
129210553|NCT03414983|465072914|FG001|Treatment|Study Drug Toxicity|5|||
129210554|NCT03414983|465072913|FG000|Treatment|Disease Progression|75|||
129210555|NCT03414983|465072914|FG001|Treatment|Disease Progression|29|||
129210556|NCT03414983|465072913|FG000|Treatment|Not reported|1|||
129210557|NCT03414983|465072914|FG001|Treatment|Not reported|0|||
129210558|NCT03414983|465072913|FG000|Treatment|Other reasons|3|||
129210559|NCT03414983|465072914|FG001|Treatment|Other reasons|2|||
129210560|NCT03414983|465072913|FG000|Treatment|Poor/non-compliance|2|||
129210561|NCT03414983|465072914|FG001|Treatment|Poor/non-compliance|0|||
129210562|NCT03414983|465072913|FG000|Treatment|Maximum clinical benefit|5|||
129210563|NCT03414983|465072914|FG001|Treatment|Maximum clinical benefit|9|||
129210564|NCT03414983|465072913|FG000|Treatment|Lost to Follow-up|0|||
129210565|NCT03414983|465072914|FG001|Treatment|Lost to Follow-up|1|||
129210566|NCT03414983|465072913|FG000|Treatment|Administrative reasons by sponsor|1|||
129210567|NCT03414983|465072914|FG001|Treatment|Administrative reasons by sponsor|0|||
129210568|NCT00303069|465072915|FG000|Overall Study|Lost to Follow-up|1|||
129210569|NCT00303069|465072916|FG001|Overall Study|Lost to Follow-up|0|||
129210570|NCT00303069|465072917|FG002|Overall Study|Lost to Follow-up|0|||
129210571|NCT00303069|465072918|FG003|Overall Study|Lost to Follow-up|2|||
129210572|NCT00303069|465072915|FG000|Overall Study|subject moved|1|||
129210573|NCT00303069|465072916|FG001|Overall Study|subject moved|0|||
129210574|NCT00303069|465072917|FG002|Overall Study|subject moved|0|||
129210575|NCT00303069|465072918|FG003|Overall Study|subject moved|0|||
129210576|NCT00303069|465072915|FG000|Overall Study|Recruitment into Army Reserves|0|||
129210577|NCT00303069|465072916|FG001|Overall Study|Recruitment into Army Reserves|0|||
129210578|NCT00303069|465072917|FG002|Overall Study|Recruitment into Army Reserves|1|||
129210579|NCT00303069|465072918|FG003|Overall Study|Recruitment into Army Reserves|0|||
129210580|NCT00092417|465072919|FG000|Overall Study|Lost to Follow-up|2|||
129210581|NCT00092417|465072920|FG001|Overall Study|Lost to Follow-up|0|||
129210582|NCT00092417|465072919|FG000|Overall Study|Withdrawal by Subject|2|||
129210583|NCT00092417|465072920|FG001|Overall Study|Withdrawal by Subject|1|||
129210584|NCT00092417|465072919|FG000|Overall Study|Other|1|||
129210585|NCT00092417|465072920|FG001|Overall Study|Other|0|||
129210586|NCT00751296|465072922|FG000|Overall Study|Adverse Event|2|||
129210587|NCT03780244|465072932|FG000|Overall Study|Lost to Follow-up|1|||
129210588|NCT03780244|465072933|FG001|Overall Study|Lost to Follow-up|0|||
129210589|NCT00804908|465072936|FG000|Overall Study|Other|115|||
129210590|NCT00804908|465072937|FG001|Overall Study|Other|116|||
129210591|NCT00804908|465072938|FG002|Overall Study|Other|114|||
129210592|NCT03181932|465072939|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
129210593|NCT03181932|465072940|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
129210594|NCT03181932|465072939|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
129210595|NCT03181932|465072940|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
129210596|NCT03181932|465072939|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
129210597|NCT03181932|465072940|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
129210598|NCT03181932|465072939|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
129210599|NCT03181932|465072940|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
129210600|NCT03181932|465072939|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
129210601|NCT03181932|465072940|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
129210602|NCT03181932|465072939|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
129210603|NCT03181932|465072940|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
129210604|NCT03181932|465072939|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
129210605|NCT03181932|465072940|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
129210606|NCT03181932|465072939|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
129210607|NCT03181932|465072940|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
129210608|NCT03181932|465072939|FG000|Period 2 (Open-label Period)|Reason missing|2|||
129210609|NCT03181932|465072940|FG001|Period 2 (Open-label Period)|Reason missing|0|||
129210610|NCT02220920|465072942|FG000|Overall Study|Adverse Event|1|||
129210611|NCT02220920|465072943|FG001|Overall Study|Adverse Event|0|||
129210612|NCT02220920|465072942|FG000|Overall Study|Lack of Efficacy|0|||
129210613|NCT02220920|465072943|FG001|Overall Study|Lack of Efficacy|1|||
129210614|NCT02220920|465072942|FG000|Overall Study|Withdrawal by Subject|1|||
129210615|NCT02220920|465072943|FG001|Overall Study|Withdrawal by Subject|0|||
129210616|NCT02220920|465072942|FG000|Overall Study|Conflict with the stopping criteria|1|||
129210617|NCT02220920|465072943|FG001|Overall Study|Conflict with the stopping criteria|2|||
129210618|NCT01112917|465072944|FG000|Overall Study|Death|2|||
129210619|NCT01112917|465072945|FG001|Overall Study|Death|11|||
129210620|NCT01112917|465072944|FG000|Overall Study|Lost to Follow-up|1|||
129210621|NCT01112917|465072945|FG001|Overall Study|Lost to Follow-up|1|||
129210622|NCT01112917|465072944|FG000|Overall Study|Withdrawal by Subject|1|||
129210623|NCT01112917|465072945|FG001|Overall Study|Withdrawal by Subject|3|||
129210624|NCT01112917|465072944|FG000|Overall Study|Unable to Convert Filter|3|||
129210625|NCT01112917|465072945|FG001|Overall Study|Unable to Convert Filter|0|||
129210626|NCT02177123|465072946|FG000|Overall Study|Lost to Follow-up|6|||
129210627|NCT02177123|465072946|FG000|Overall Study|Withdrawal by Subject|4|||
129210628|NCT02177123|465072946|FG000|Overall Study|Adverse Event|4|||
129210629|NCT02177123|465072946|FG000|Overall Study|Physician Decision|3|||
129210630|NCT02177123|465072946|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
129210631|NCT02177123|465072946|FG000|Overall Study|Excluded for medical reasons|2|||
129210632|NCT02177123|465072946|FG000|Overall Study|Death|1|||
129210633|NCT02177123|465072946|FG000|Overall Study|Other|1|||
129210634|NCT02177123|465072946|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
129210635|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
129210636|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
129210637|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
129210638|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Death|9|||
129210639|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Death|0|||
129210640|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Death|0|||
129210641|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
129210642|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129210643|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129210644|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
129210645|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
129210646|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
129210647|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Other|135|||
129210648|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Other|0|||
129210649|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Other|0|||
129210650|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
129210651|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
129210652|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
129210653|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
129210654|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
129210655|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
129210656|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
129210657|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
129210658|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
129210659|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Other|3|||
129210660|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Other|0|||
129210661|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Other|0|||
129210662|NCT02118584|465072951|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
129210663|NCT02118584|465072952|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129210664|NCT02118584|465072953|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129210665|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129210666|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
129210667|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129210668|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
129210669|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
129210670|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
129210671|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
129210672|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
129210673|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
129210674|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129210675|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129210676|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
129210677|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
129210678|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
129210679|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
129210680|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
129210681|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
129210682|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
129210683|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129210684|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
129210685|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129210686|NCT02118584|465072951|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
129210687|NCT02118584|465072952|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
129210688|NCT02118584|465072953|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
129210689|NCT06271993|465072956|FG000|Overall Study|Not reactive to histamine|5|||
129210690|NCT06271993|465072957|FG001|Overall Study|Not reactive to histamine|5|||
129210691|NCT06271993|465072958|FG002|Overall Study|Not reactive to histamine|5|||
129210692|NCT03566511|465072959|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
129210693|NCT03566511|465072960|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
129210694|NCT02939287|465072966|FG000|Overall Study|met exclusion criteria|1|||
129210695|NCT02939287|465072967|FG001|Overall Study|met exclusion criteria|1|||
129210696|NCT02939287|465072968|FG002|Overall Study|met exclusion criteria|1|||
129210697|NCT02939287|465072966|FG000|Overall Study|Did not complete survey|2|||
129210698|NCT02939287|465072967|FG001|Overall Study|Did not complete survey|2|||
129210699|NCT02939287|465072968|FG002|Overall Study|Did not complete survey|0|||
129210700|NCT02939287|465072966|FG000|Overall Study|Withdrawal by Subject|1|||
129210701|NCT02939287|465072967|FG001|Overall Study|Withdrawal by Subject|1|||
129210702|NCT02939287|465072968|FG002|Overall Study|Withdrawal by Subject|0|||
129210703|NCT00981656|465072969|FG000|Overall Study|Protocol Violation|1|||
129210704|NCT00981656|465072969|FG000|Overall Study|Did not start protocol treatment|2|||
129210705|NCT00687596|465072970|FG000|Overall Study|Adverse Event (AE)|10|||
129210706|NCT00687596|465072971|FG001|Overall Study|Adverse Event (AE)|3|||
129210707|NCT00687596|465072970|FG000|Overall Study|Radiological Disease Progression|6|||
129210708|NCT00687596|465072971|FG001|Overall Study|Radiological Disease Progression|2|||
129210709|NCT00687596|465072970|FG000|Overall Study|Clinical Disease Progression|1|||
129210710|NCT00687596|465072971|FG001|Overall Study|Clinical Disease Progression|3|||
129210711|NCT00687596|465072970|FG000|Overall Study|Investigator Discretion|3|||
129210712|NCT00687596|465072971|FG001|Overall Study|Investigator Discretion|1|||
129210713|NCT00687596|465072970|FG000|Overall Study|Sponsor Terminated Study|6|||
129210714|NCT00687596|465072971|FG001|Overall Study|Sponsor Terminated Study|17|||
129210715|NCT03466658|465072974|FG000|Overall Study|Withdrawal by Subject|3|||
129210716|NCT00129402|465072975|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129210717|NCT00129402|465072976|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
129210718|NCT00129402|465072977|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
129210719|NCT00129402|465072978|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129210720|NCT00129402|465072979|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129210721|NCT00129402|465072980|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
129210722|NCT00129402|465072981|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129210723|NCT00129402|465072975|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129210724|NCT00129402|465072976|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129210725|NCT00129402|465072977|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129210726|NCT00129402|465072978|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129210727|NCT00129402|465072979|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129210728|NCT00129402|465072980|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
129210729|NCT00129402|465072981|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129210730|NCT00129402|465072975|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129210731|NCT00129402|465072976|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129210732|NCT00129402|465072977|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129210733|NCT00129402|465072978|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
129210734|NCT00129402|465072979|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129210735|NCT00129402|465072980|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129210736|NCT00129402|465072981|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129210737|NCT00129402|465072975|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129210738|NCT00129402|465072976|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129210739|NCT00129402|465072977|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
129210740|NCT00129402|465072978|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129210741|NCT00129402|465072979|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
129210742|NCT00129402|465072980|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129210743|NCT00129402|465072981|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129210744|NCT00129402|465072975|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129210745|NCT00129402|465072976|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
128986777|NCT01728376|464241468|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
128986778|NCT01728376|464241469|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
129210746|NCT00129402|465072977|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
129210747|NCT00129402|465072978|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129210748|NCT00129402|465072979|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129210749|NCT00129402|465072980|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129210750|NCT00129402|465072981|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129210751|NCT00129402|465072975|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129210752|NCT00129402|465072976|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129210753|NCT00129402|465072977|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
129210754|NCT00129402|465072978|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129210755|NCT00129402|465072979|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129210756|NCT00129402|465072980|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
129210757|NCT00129402|465072981|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129210758|NCT00129402|465072975|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129210759|NCT00129402|465072976|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129210760|NCT00129402|465072977|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
129210761|NCT00129402|465072978|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129210762|NCT00129402|465072979|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129210763|NCT00129402|465072980|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129210764|NCT00129402|465072981|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129210765|NCT00129402|465072975|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129210766|NCT00129402|465072976|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129210767|NCT00129402|465072977|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
129210768|NCT00129402|465072978|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129210769|NCT00129402|465072979|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129210770|NCT00129402|465072980|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
129210771|NCT00129402|465072981|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129210772|NCT00129402|465072975|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129210773|NCT00129402|465072976|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129210774|NCT00129402|465072977|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
129210775|NCT00129402|465072978|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129210776|NCT00129402|465072979|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129210777|NCT00129402|465072980|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
129210778|NCT00129402|465072981|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129210779|NCT00129402|465072975|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129210780|NCT00129402|465072976|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129210781|NCT00129402|465072977|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129210782|NCT00129402|465072978|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129210783|NCT00129402|465072979|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129210784|NCT00129402|465072980|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129210785|NCT00129402|465072981|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
129210786|NCT00129402|465072975|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129210787|NCT00129402|465072976|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129210788|NCT00129402|465072977|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129210789|NCT00129402|465072978|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129210790|NCT00129402|465072979|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129210791|NCT00129402|465072980|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129210792|NCT00129402|465072981|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
129210793|NCT00129402|465072975|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129210794|NCT00129402|465072976|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129210795|NCT00129402|465072977|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129210796|NCT00129402|465072978|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129210797|NCT00129402|465072979|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129210798|NCT00129402|465072980|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129210799|NCT00129402|465072981|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
129210800|NCT00129402|465072975|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129210801|NCT00129402|465072976|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129210802|NCT00129402|465072977|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129210803|NCT00129402|465072978|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129210804|NCT00129402|465072979|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129210805|NCT00129402|465072980|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129210806|NCT00129402|465072981|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
129210807|NCT00456846|465072982|FG000|Overall Study|Adverse Event|2|||
129210808|NCT00456846|465072983|FG001|Overall Study|Adverse Event|15|||
129210809|NCT00456846|465072982|FG000|Overall Study|Physician Decision|11|||
129210810|NCT00456846|465072983|FG001|Overall Study|Physician Decision|6|||
129210811|NCT00456846|465072982|FG000|Overall Study|Protocol Deviation|2|||
129210812|NCT00456846|465072983|FG001|Overall Study|Protocol Deviation|0|||
129210813|NCT00456846|465072982|FG000|Overall Study|Participant Discretion|1|||
129210814|NCT00456846|465072983|FG001|Overall Study|Participant Discretion|5|||
129210815|NCT00456846|465072982|FG000|Overall Study|Other|0|||
129210816|NCT00456846|465072983|FG001|Overall Study|Other|2|||
129210817|NCT03379818|465072984|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
129210818|NCT03379818|465072985|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
129210819|NCT03379818|465072984|FG000|Overall Study|Withdrawal by Subject|2|||
129210820|NCT03379818|465072985|FG001|Overall Study|Withdrawal by Subject|3|||
129210821|NCT03379818|465072984|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
129210822|NCT03379818|465072985|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
129210823|NCT03199976|465072987|FG000|Overall Study|Lack of Efficacy|3|||
129210824|NCT03199976|465072988|FG001|Overall Study|Lack of Efficacy|6|||
129210825|NCT03199976|465072989|FG002|Overall Study|Lack of Efficacy|13|||
129210826|NCT03199976|465072987|FG000|Overall Study|Withdrawal by Subject|1|||
129210827|NCT03199976|465072988|FG001|Overall Study|Withdrawal by Subject|0|||
129210828|NCT03199976|465072989|FG002|Overall Study|Withdrawal by Subject|0|||
129210829|NCT03199976|465072987|FG000|Overall Study|Lost to Follow-up|0|||
129210830|NCT03199976|465072988|FG001|Overall Study|Lost to Follow-up|1|||
129210831|NCT03199976|465072989|FG002|Overall Study|Lost to Follow-up|1|||
129210832|NCT01780506|465072997|FG000|Double-Blind Phase|Randomized but not Treated|3|||
129210833|NCT01780506|465072998|FG001|Double-Blind Phase|Randomized but not Treated|2|||
129210834|NCT01780506|465072997|FG000|Double-Blind Phase|Adverse Event|4|||
129210835|NCT01780506|465072998|FG001|Double-Blind Phase|Adverse Event|14|||
129210836|NCT01780506|465072997|FG000|Double-Blind Phase|Death|1|||
129210837|NCT01780506|465072998|FG001|Double-Blind Phase|Death|2|||
129210838|NCT01780506|465072997|FG000|Double-Blind Phase|Pregnancy|2|||
129210839|NCT01780506|465072998|FG001|Double-Blind Phase|Pregnancy|1|||
129210840|NCT01780506|465072997|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129210841|NCT01780506|465072998|FG001|Double-Blind Phase|Lack of Efficacy|1|||
129210842|NCT01780506|465072997|FG000|Double-Blind Phase|Investigator's Discretion|5|||
129210843|NCT01780506|465072998|FG001|Double-Blind Phase|Investigator's Discretion|2|||
129210844|NCT01780506|465072997|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
129210845|NCT01780506|465072998|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
129210846|NCT01780506|465072997|FG000|Double-Blind Phase|Protocol Violation|4|||
129210847|NCT01780506|465072998|FG001|Double-Blind Phase|Protocol Violation|3|||
129210848|NCT01780506|465072997|FG000|Double-Blind Phase|Withdrew Consent|23|||
129210849|NCT01780506|465072998|FG001|Double-Blind Phase|Withdrew Consent|24|||
129210850|NCT01780506|465072997|FG000|Double-Blind Phase|Lost to Follow-up|23|||
129210851|NCT01780506|465072998|FG001|Double-Blind Phase|Lost to Follow-up|26|||
129210852|NCT01780506|465072997|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
129210853|NCT01780506|465072998|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
129210854|NCT05236270|465072999|FG000|Overall Study|Lost to Follow-up|3|||
129210855|NCT05236270|465073000|FG001|Overall Study|Lost to Follow-up|2|||
129210856|NCT05236270|465073001|FG002|Overall Study|Lost to Follow-up|0|||
129210857|NCT05236270|465073002|FG003|Overall Study|Lost to Follow-up|0|||
129210858|NCT05236270|465073003|FG004|Overall Study|Lost to Follow-up|2|||
129210859|NCT05236270|465073004|FG005|Overall Study|Lost to Follow-up|0|||
129210860|NCT05236270|465073005|FG006|Overall Study|Lost to Follow-up|1|||
129210861|NCT05236270|465073006|FG007|Overall Study|Lost to Follow-up|3|||
129210862|NCT04030143|465073007|FG000|Overall Study|Adverse Event|5|||
129210863|NCT04030143|465073008|FG001|Overall Study|Adverse Event|10|||
129210864|NCT04030143|465073007|FG000|Overall Study|Lost to Follow-up|3|||
129210865|NCT04030143|465073008|FG001|Overall Study|Lost to Follow-up|7|||
129210866|NCT04030143|465073007|FG000|Overall Study|Protocol Deviation|2|||
129210867|NCT04030143|465073008|FG001|Overall Study|Protocol Deviation|2|||
129210868|NCT04030143|465073007|FG000|Overall Study|Withdrawal by Subject|16|||
129210869|NCT04030143|465073008|FG001|Overall Study|Withdrawal by Subject|18|||
129210870|NCT04030143|465073007|FG000|Overall Study|Physician Decision|1|||
129210871|NCT04030143|465073008|FG001|Overall Study|Physician Decision|1|||
129210872|NCT04030143|465073007|FG000|Overall Study|Due to Covid-19|2|||
129210873|NCT04030143|465073008|FG001|Overall Study|Due to Covid-19|3|||
129210874|NCT04030143|465073007|FG000|Overall Study|Not Due to Covid-19|1|||
129210875|NCT04030143|465073008|FG001|Overall Study|Not Due to Covid-19|1|||
129210876|NCT00412984|465073010|FG000|Overall Study|Death|331|||
129210877|NCT00412984|465073011|FG001|Overall Study|Death|349|||
129210878|NCT00412984|465073010|FG000|Overall Study|Adverse Event|679|||
129210879|NCT00412984|465073011|FG001|Overall Study|Adverse Event|738|||
129210880|NCT00412984|465073010|FG000|Overall Study|Withdrawal by Subject|921|||
129210881|NCT00412984|465073011|FG001|Overall Study|Withdrawal by Subject|989|||
129210882|NCT00412984|465073010|FG000|Overall Study|Lost to Follow-up|51|||
129210883|NCT00412984|465073011|FG001|Overall Study|Lost to Follow-up|39|||
129210884|NCT00412984|465073010|FG000|Overall Study|Poor/Noncompliance|57|||
129210885|NCT00412984|465073011|FG001|Overall Study|Poor/Noncompliance|77|||
129210886|NCT00412984|465073010|FG000|Overall Study|Pregnancy|1|||
129210887|NCT00412984|465073011|FG001|Overall Study|Pregnancy|0|||
129210888|NCT00412984|465073010|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
129210889|NCT00412984|465073011|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
129210890|NCT00412984|465073010|FG000|Overall Study|Administrative Reason by Sponsor|11|||
129210891|NCT00412984|465073011|FG001|Overall Study|Administrative Reason by Sponsor|8|||
129210892|NCT00412984|465073010|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
129210893|NCT00412984|465073011|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
129210894|NCT00412984|465073010|FG000|Overall Study|Other Reason|80|||
129210895|NCT00412984|465073011|FG001|Overall Study|Other Reason|92|||
129210896|NCT00412984|465073010|FG000|Overall Study|Not Reported|11|||
129210897|NCT00412984|465073011|FG001|Overall Study|Not Reported|12|||
129210898|NCT02383576|465073012|FG000|Overall Study|Death|53|||
129210899|NCT02383576|465073013|FG001|Overall Study|Death|33|||
129210900|NCT02383576|465073012|FG000|Overall Study|Lost to Follow-up|7|||
129210901|NCT02383576|465073013|FG001|Overall Study|Lost to Follow-up|1|||
129210902|NCT02383576|465073012|FG000|Overall Study|Withdrew Consent|1|||
129210903|NCT02383576|465073013|FG001|Overall Study|Withdrew Consent|6|||
129210904|NCT02383576|465073012|FG000|Overall Study|Investigator's Decision|0|||
129210905|NCT02383576|465073013|FG001|Overall Study|Investigator's Decision|1|||
129210906|NCT02383576|465073012|FG000|Overall Study|Administrative/Other|2|||
129210907|NCT02383576|465073013|FG001|Overall Study|Administrative/Other|4|||
129210908|NCT04218240|465073014|FG000|Overall Study|Withdrawal by Subject|6|||
129210909|NCT04218240|465073015|FG001|Overall Study|Withdrawal by Subject|0|||
129210910|NCT04218240|465073014|FG000|Overall Study|Lack of Efficacy|24|||
129210911|NCT04218240|465073015|FG001|Overall Study|Lack of Efficacy|19|||
129210912|NCT04218240|465073014|FG000|Overall Study|Physician Decision|0|||
129210913|NCT04218240|465073015|FG001|Overall Study|Physician Decision|1|||
129210914|NCT04218240|465073014|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
129210915|NCT04218240|465073015|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
129210916|NCT04914364|465073016|FG000|Overall Study|No longer eligible for study|1|||
129210917|NCT04914364|465073016|FG000|Overall Study|Lost to Follow-up|2|||
129210918|NCT04097678|465073017|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
129210919|NCT04097678|465073018|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
129210920|NCT03694678|465073019|FG000|Overall Study|Withdrawal by Subject|2|||
129210921|NCT03694678|465073020|FG001|Overall Study|Withdrawal by Subject|0|||
129210922|NCT03694678|465073019|FG000|Overall Study|Lost to Follow-up|2|||
129210923|NCT03694678|465073020|FG001|Overall Study|Lost to Follow-up|3|||
129210924|NCT02435212|465073021|FG000|Core Phase|Adverse Event|8|||
129210925|NCT02435212|465073022|FG001|Core Phase|Adverse Event|5|||
129210926|NCT02435212|465073021|FG000|Core Phase|Withdrawal by Subject|3|||
129210927|NCT02435212|465073022|FG001|Core Phase|Withdrawal by Subject|0|||
129210928|NCT02435212|465073021|FG000|Core Phase|Withdrawal by parent/guardian|9|||
129210929|NCT02435212|465073022|FG001|Core Phase|Withdrawal by parent/guardian|4|||
129210930|NCT02435212|465073021|FG000|Core Phase|Protocol Violation|1|||
129210931|NCT02435212|465073022|FG001|Core Phase|Protocol Violation|2|||
129210932|NCT02435212|465073021|FG000|Core Phase|Physician Decision|3|||
129210933|NCT02435212|465073022|FG001|Core Phase|Physician Decision|0|||
129210934|NCT02435212|465073021|FG000|Core Phase|Lost to Follow-up|0|||
129210935|NCT02435212|465073022|FG001|Core Phase|Lost to Follow-up|1|||
129210936|NCT02435212|465073021|FG000|Core Phase|Lack of Efficacy|0|||
129210937|NCT02435212|465073022|FG001|Core Phase|Lack of Efficacy|1|||
129210938|NCT02435212|465073021|FG000|Core Phase|Recovery|1|||
129210939|NCT02435212|465073022|FG001|Core Phase|Recovery|0|||
129210940|NCT02435212|465073021|FG000|Optional Extension Phase|Adverse Event|3|||
129210941|NCT02435212|465073022|FG001|Optional Extension Phase|Adverse Event|9|||
129210942|NCT02435212|465073021|FG000|Optional Extension Phase|Physician Decision|6|||
129210943|NCT02435212|465073022|FG001|Optional Extension Phase|Physician Decision|8|||
129210944|NCT02435212|465073021|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
129210945|NCT02435212|465073022|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
129210946|NCT02435212|465073021|FG000|Optional Extension Phase|Lack of Efficacy|2|||
129210947|NCT02435212|465073022|FG001|Optional Extension Phase|Lack of Efficacy|3|||
129210948|NCT02435212|465073021|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
129210949|NCT02435212|465073022|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
129210950|NCT02435212|465073021|FG000|Optional Extension Phase|Protocol Violation|0|||
129210951|NCT02435212|465073022|FG001|Optional Extension Phase|Protocol Violation|1|||
129210952|NCT02435212|465073021|FG000|Optional Extension Phase|Recovery|1|||
129210953|NCT02435212|465073022|FG001|Optional Extension Phase|Recovery|1|||
128763049|NCT01559454|463422693|FG001|Overall Study|Physician Decision|1|||
129210954|NCT02435212|465073021|FG000|Optional Extension Phase|Death|1|||
129210955|NCT02435212|465073022|FG001|Optional Extension Phase|Death|0|||
129210956|NCT02435212|465073021|FG000|Optional Extension Phase|Technical problems|2|||
129210957|NCT02435212|465073022|FG001|Optional Extension Phase|Technical problems|0|||
129210958|NCT05966142|465073032|FG000|Overall Study|Death|3|||
129210959|NCT05966142|465073033|FG001|Overall Study|Death|3|||
129210960|NCT05966142|465073032|FG000|Overall Study|Lost to Follow-up|55|||
129210961|NCT05966142|465073033|FG001|Overall Study|Lost to Follow-up|52|||
129210962|NCT05966142|465073032|FG000|Overall Study|Physician Decision|1|||
129210963|NCT05966142|465073033|FG001|Overall Study|Physician Decision|0|||
129210964|NCT05966142|465073032|FG000|Overall Study|Withdrawal by Subject|9|||
129210965|NCT05966142|465073033|FG001|Overall Study|Withdrawal by Subject|8|||
129210966|NCT05966142|465073032|FG000|Overall Study|Duplicate Enrollment|1|||
129210967|NCT05966142|465073033|FG001|Overall Study|Duplicate Enrollment|0|||
129210968|NCT05966142|465073032|FG000|Overall Study|Study Logistical Reason|1|||
129210969|NCT05966142|465073033|FG001|Overall Study|Study Logistical Reason|0|||
129210970|NCT05966142|465073032|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
129210971|NCT05966142|465073033|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
129210972|NCT04852302|465073039|FG000|Overall Study|Withdrawal by Subject|2|||
129210973|NCT04852302|465073039|FG000|Overall Study|Did not complete CALM therapy.|2|||
129210974|NCT04711850|465073040|FG000|Overall Study|Graft loss|2|||
129210975|NCT04711850|465073041|FG001|Overall Study|Graft loss|1|||
129210976|NCT04711850|465073040|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
129210977|NCT04711850|465073041|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
129210978|NCT04711850|465073040|FG000|Overall Study|Study terminated by sponsor|5|||
129210979|NCT04711850|465073041|FG001|Overall Study|Study terminated by sponsor|3|||
129210980|NCT04711850|465073040|FG000|Overall Study|Sponsor decision|0|||
129210981|NCT04711850|465073041|FG001|Overall Study|Sponsor decision|2|||
129210982|NCT03267277|465073042|FG000|Overall Study|Withdrawal by Subject|1|||
129210983|NCT04849364|465073043|FG000|Overall Study|Eligibility criteria not meet|0|||
129210984|NCT04849364|465073044|FG001|Overall Study|Eligibility criteria not meet|1|||
129210985|NCT04849364|465073045|FG002|Overall Study|Eligibility criteria not meet|0|||
129210986|NCT04531176|465073056|FG000|Overall Study|Study was stopped early|24|||
129210987|NCT04531176|465073057|FG001|Overall Study|Study was stopped early|26|||
129210988|NCT04531176|465073058|FG002|Overall Study|Study was stopped early|24|||
129210989|NCT00528112|465073059|FG000|Treatment up to 3 Years|Adverse Event|313|||
129210990|NCT00528112|465073060|FG001|Treatment up to 3 Years|Adverse Event|278|||
129210991|NCT00528112|465073059|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
129210992|NCT00528112|465073060|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
129210993|NCT00528112|465073059|FG000|Treatment up to 3 Years|Protocol Violation|16|||
129210994|NCT00528112|465073060|FG001|Treatment up to 3 Years|Protocol Violation|16|||
129210995|NCT00528112|465073059|FG000|Treatment up to 3 Years|Death|0|||
129210996|NCT00528112|465073060|FG001|Treatment up to 3 Years|Death|1|||
129210997|NCT00528112|465073059|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
129210998|NCT00528112|465073060|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
129210999|NCT00528112|465073059|FG000|Treatment up to 3 Years|Pregnancy|9|||
129211000|NCT00528112|465073060|FG001|Treatment up to 3 Years|Pregnancy|10|||
129211001|NCT00528112|465073059|FG000|Treatment up to 3 Years|Other reasons|186|||
129211002|NCT00528112|465073060|FG001|Treatment up to 3 Years|Other reasons|186|||
129211003|NCT00528112|465073059|FG000|Extension Phase|Withdrawal by Subject|0|||
129211004|NCT00528112|465073060|FG001|Extension Phase|Withdrawal by Subject|3|||
129211005|NCT00528112|465073059|FG000|Extension Phase|Other reasons|0|||
129211006|NCT00528112|465073060|FG001|Extension Phase|Other reasons|100|||
129211007|NCT00528112|465073059|FG000|Extension Phase|Pregnancy|0|||
129211008|NCT00528112|465073060|FG001|Extension Phase|Pregnancy|3|||
129211009|NCT00528112|465073059|FG000|Extension Phase|Lost to Follow-up|0|||
129211010|NCT00528112|465073060|FG001|Extension Phase|Lost to Follow-up|12|||
129211011|NCT00528112|465073059|FG000|Extension Phase|Death|0|||
129211012|NCT00528112|465073060|FG001|Extension Phase|Death|1|||
129211013|NCT00528112|465073059|FG000|Extension Phase|Adverse Event|0|||
129211014|NCT00528112|465073060|FG001|Extension Phase|Adverse Event|36|||
129211015|NCT00528112|465073059|FG000|Extension Phase|Protocol Violation|0|||
129211016|NCT00528112|465073060|FG001|Extension Phase|Protocol Violation|2|||
129211017|NCT00894803|465073061|FG000|Overall Study|Death|20|||
128986779|NCT01728376|464241470|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
128986780|NCT01728376|464241471|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
128986781|NCT04341727|464241483|FG000|Overall Study|Withdrawal by Subject|0|||
128986782|NCT04341727|464241484|FG001|Overall Study|Withdrawal by Subject|0|||
128986783|NCT04341727|464241485|FG002|Overall Study|Withdrawal by Subject|1|||
128986784|NCT04341727|464241486|FG003|Overall Study|Withdrawal by Subject|0|||
129211018|NCT00894803|465073062|FG001|Overall Study|Death|4|||
129211019|NCT00894803|465073061|FG000|Overall Study|Lost to Follow-up|0|||
129211020|NCT00894803|465073062|FG001|Overall Study|Lost to Follow-up|1|||
129211021|NCT01345240|465073064|FG000|Overall Study|Adverse Event|3|||
129211022|NCT01345240|465073065|FG001|Overall Study|Adverse Event|5|||
129211023|NCT01345240|465073066|FG002|Overall Study|Adverse Event|4|||
129211024|NCT01345240|465073067|FG003|Overall Study|Adverse Event|2|||
129211025|NCT01345240|465073068|FG004|Overall Study|Adverse Event|1|||
129211026|NCT01345240|465073064|FG000|Overall Study|Lost to Follow-up|8|||
129211027|NCT01345240|465073065|FG001|Overall Study|Lost to Follow-up|9|||
128986785|NCT04341727|464241483|FG000|Overall Study|Lost to Follow-up|0|||
129211028|NCT01345240|465073066|FG002|Overall Study|Lost to Follow-up|14|||
129211029|NCT01345240|465073067|FG003|Overall Study|Lost to Follow-up|7|||
129211030|NCT01345240|465073068|FG004|Overall Study|Lost to Follow-up|9|||
129211031|NCT01502293|465073069|FG000|Overall Study|Progressive Disease|20|||
129211032|NCT01502293|465073070|FG001|Overall Study|Progressive Disease|12|||
129211033|NCT01502293|465073071|FG002|Overall Study|Progressive Disease|2|||
129211034|NCT01502293|465073069|FG000|Overall Study|Withdrawal by Subject|3|||
129211035|NCT01502293|465073070|FG001|Overall Study|Withdrawal by Subject|3|||
129211036|NCT01502293|465073071|FG002|Overall Study|Withdrawal by Subject|1|||
129211037|NCT01502293|465073069|FG000|Overall Study|Adverse Event|0|||
129211038|NCT01502293|465073070|FG001|Overall Study|Adverse Event|2|||
129211039|NCT01502293|465073071|FG002|Overall Study|Adverse Event|0|||
129211040|NCT01502293|465073069|FG000|Overall Study|Reason Not Specified|2|||
129211041|NCT01502293|465073070|FG001|Overall Study|Reason Not Specified|0|||
129211042|NCT01502293|465073071|FG002|Overall Study|Reason Not Specified|0|||
129211043|NCT01502293|465073069|FG000|Overall Study|Physician Decision|0|||
129211044|NCT01502293|465073070|FG001|Overall Study|Physician Decision|0|||
129211045|NCT01502293|465073071|FG002|Overall Study|Physician Decision|1|||
129211046|NCT00774046|465073074|FG000|Screening|Not eligible|56|||
129211047|NCT00774046|465073074|FG000|Enrollment|Desired other therapy/refused|28|||
129211048|NCT00774046|465073074|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
129211049|NCT02246530|465073076|FG000|Overall Study|Lost to Follow-up|4|||
129211050|NCT02246530|465073077|FG001|Overall Study|Lost to Follow-up|0|||
129211051|NCT05138653|465073078|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
129211052|NCT05138653|465073079|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211053|NCT05138653|465073080|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211054|NCT05138653|465073081|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211055|NCT05138653|465073082|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211056|NCT05138653|465073083|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211057|NCT05138653|465073084|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211058|NCT05138653|465073085|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211059|NCT05138653|465073086|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211060|NCT05138653|465073087|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211061|NCT05138653|465073088|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211062|NCT05138653|465073089|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211063|NCT05138653|465073090|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211064|NCT05138653|465073091|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211065|NCT05138653|465073092|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211066|NCT05138653|465073093|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129211067|NCT05138653|465073078|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211068|NCT05138653|465073079|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
129211069|NCT05138653|465073080|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211070|NCT05138653|465073081|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211071|NCT05138653|465073082|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211072|NCT05138653|465073083|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211073|NCT05138653|465073084|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211074|NCT05138653|465073085|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211075|NCT05138653|465073086|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
129211076|NCT05138653|465073087|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211077|NCT05138653|465073088|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211078|NCT05138653|465073089|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211079|NCT05138653|465073090|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211080|NCT05138653|465073091|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211081|NCT05138653|465073092|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211082|NCT05138653|465073093|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129211083|NCT05138653|465073078|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211084|NCT05138653|465073079|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
129211085|NCT05138653|465073080|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211086|NCT05138653|465073081|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211087|NCT05138653|465073082|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
129211088|NCT05138653|465073083|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211089|NCT05138653|465073084|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211090|NCT05138653|465073085|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211091|NCT05138653|465073086|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211092|NCT05138653|465073087|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211093|NCT05138653|465073088|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211094|NCT05138653|465073089|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211095|NCT05138653|465073090|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
128986786|NCT04341727|464241484|FG001|Overall Study|Lost to Follow-up|0|||
129211096|NCT05138653|465073091|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211097|NCT05138653|465073092|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211098|NCT05138653|465073093|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129211099|NCT05138653|465073078|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211100|NCT05138653|465073079|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211101|NCT05138653|465073080|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211102|NCT05138653|465073081|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211103|NCT05138653|465073082|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211104|NCT05138653|465073083|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211105|NCT05138653|465073084|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
129211106|NCT05138653|465073085|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211107|NCT05138653|465073086|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211108|NCT05138653|465073087|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211109|NCT05138653|465073088|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211110|NCT05138653|465073089|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211111|NCT05138653|465073090|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211112|NCT05138653|465073091|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211113|NCT05138653|465073092|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211114|NCT05138653|465073093|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129211115|NCT05138653|465073078|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211116|NCT05138653|465073079|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211117|NCT05138653|465073080|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211118|NCT05138653|465073081|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211119|NCT05138653|465073082|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211120|NCT05138653|465073083|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211121|NCT05138653|465073084|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211122|NCT05138653|465073085|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211123|NCT05138653|465073086|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211124|NCT05138653|465073087|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211125|NCT05138653|465073088|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
129211126|NCT05138653|465073089|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211127|NCT05138653|465073090|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
129211128|NCT05138653|465073091|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211129|NCT05138653|465073092|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
129211130|NCT05138653|465073093|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129211131|NCT05138653|465073078|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211132|NCT05138653|465073079|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211133|NCT05138653|465073080|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211134|NCT05138653|465073081|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211135|NCT05138653|465073082|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211136|NCT05138653|465073083|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211137|NCT05138653|465073084|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211138|NCT05138653|465073085|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211139|NCT05138653|465073086|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211140|NCT05138653|465073087|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211141|NCT05138653|465073088|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211142|NCT05138653|465073089|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211143|NCT05138653|465073090|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211144|NCT05138653|465073091|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211145|NCT05138653|465073092|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129211146|NCT05138653|465073093|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
129211147|NCT05138653|465073078|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211148|NCT05138653|465073079|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211149|NCT05138653|465073080|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211150|NCT05138653|465073081|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211151|NCT05138653|465073082|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211152|NCT05138653|465073083|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211153|NCT05138653|465073084|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211154|NCT05138653|465073085|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211155|NCT05138653|465073086|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211156|NCT05138653|465073087|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211157|NCT05138653|465073088|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211158|NCT05138653|465073089|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
128763050|NCT01559454|463422692|FG000|Overall Study|Protocol Violation|0|||
129211159|NCT05138653|465073090|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211160|NCT05138653|465073091|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
129211161|NCT05138653|465073092|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211162|NCT05138653|465073093|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129211163|NCT02608684|465075035|FG000|Overall Study|Physician Decision|2|||
129211164|NCT02608684|465075035|FG000|Overall Study|Withdrawal by Subject|1|||
129211165|NCT01972217|465075036|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
129211166|NCT01972217|465075037|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
129211167|NCT01972217|465075038|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
129211168|NCT01972217|465075039|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
129211169|NCT01972217|465075036|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
129211170|NCT01972217|465075037|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
129211171|NCT01972217|465075038|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
129211172|NCT01972217|465075039|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
129211173|NCT01972217|465075036|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
129211174|NCT01972217|465075037|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
129211175|NCT01972217|465075038|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
129211176|NCT01972217|465075039|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
129211177|NCT01972217|465075036|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
129211178|NCT01972217|465075037|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
129211179|NCT01972217|465075038|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
129211180|NCT01972217|465075039|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
129211181|NCT01972217|465075036|FG000|Part B Double-blind, Randomised Period|Death|0|||
129211182|NCT01972217|465075037|FG001|Part B Double-blind, Randomised Period|Death|0|||
129211183|NCT01972217|465075038|FG002|Part B Double-blind, Randomised Period|Death|43|||
129211184|NCT01972217|465075039|FG003|Part B Double-blind, Randomised Period|Death|44|||
129211185|NCT01972217|465075036|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129211186|NCT01972217|465075037|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129211187|NCT01972217|465075038|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
129211188|NCT01972217|465075039|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129211189|NCT01972217|465075036|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
128986787|NCT04341727|464241485|FG002|Overall Study|Lost to Follow-up|0|||
129211190|NCT01972217|465075037|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
129211191|NCT01972217|465075038|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
129211192|NCT01972217|465075039|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
129211193|NCT01972217|465075036|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
129211194|NCT01972217|465075037|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
129211195|NCT01972217|465075038|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
129211196|NCT01972217|465075039|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
129211197|NCT01972217|465075036|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
129211198|NCT01972217|465075037|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
129211199|NCT01972217|465075038|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
129211200|NCT01972217|465075039|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
129211201|NCT02318706|465075040|FG000|Double-blind Phase|Adverse Event|7|||
129211202|NCT02318706|465075041|FG001|Double-blind Phase|Adverse Event|4|||
129211203|NCT02318706|465075042|FG002|Double-blind Phase|Adverse Event|3|||
129211204|NCT02318706|465075043|FG003|Double-blind Phase|Adverse Event|10|||
129211205|NCT02318706|465075044|FG004|Double-blind Phase|Adverse Event|0|||
129211206|NCT02318706|465075040|FG000|Double-blind Phase|Lost to Follow-up|1|||
129211207|NCT02318706|465075041|FG001|Double-blind Phase|Lost to Follow-up|0|||
129211208|NCT02318706|465075042|FG002|Double-blind Phase|Lost to Follow-up|0|||
129211209|NCT02318706|465075043|FG003|Double-blind Phase|Lost to Follow-up|0|||
129211210|NCT02318706|465075044|FG004|Double-blind Phase|Lost to Follow-up|0|||
129211211|NCT02318706|465075040|FG000|Double-blind Phase|Protocol Violation|4|||
129211212|NCT02318706|465075041|FG001|Double-blind Phase|Protocol Violation|2|||
129211213|NCT02318706|465075042|FG002|Double-blind Phase|Protocol Violation|4|||
129211214|NCT02318706|465075043|FG003|Double-blind Phase|Protocol Violation|3|||
129211215|NCT02318706|465075044|FG004|Double-blind Phase|Protocol Violation|0|||
129211216|NCT02318706|465075040|FG000|Double-blind Phase|Withdrawal by Subject|9|||
129211217|NCT02318706|465075041|FG001|Double-blind Phase|Withdrawal by Subject|5|||
129211218|NCT02318706|465075042|FG002|Double-blind Phase|Withdrawal by Subject|7|||
129211219|NCT02318706|465075043|FG003|Double-blind Phase|Withdrawal by Subject|10|||
129211220|NCT02318706|465075044|FG004|Double-blind Phase|Withdrawal by Subject|0|||
129211221|NCT02318706|465075040|FG000|Double-blind Phase|Other|4|||
129211222|NCT02318706|465075041|FG001|Double-blind Phase|Other|1|||
129211223|NCT02318706|465075042|FG002|Double-blind Phase|Other|2|||
129211224|NCT02318706|465075043|FG003|Double-blind Phase|Other|1|||
129211225|NCT02318706|465075044|FG004|Double-blind Phase|Other|0|||
129211226|NCT02318706|465075040|FG000|Double-blind Phase|Death|0|||
129211227|NCT02318706|465075041|FG001|Double-blind Phase|Death|0|||
129211228|NCT02318706|465075042|FG002|Double-blind Phase|Death|2|||
129211229|NCT02318706|465075043|FG003|Double-blind Phase|Death|0|||
129211230|NCT02318706|465075044|FG004|Double-blind Phase|Death|0|||
129211231|NCT02318706|465075040|FG000|Open-label Extension Phase|Adverse Event|0|||
129211232|NCT02318706|465075041|FG001|Open-label Extension Phase|Adverse Event|0|||
129211233|NCT02318706|465075042|FG002|Open-label Extension Phase|Adverse Event|0|||
129211234|NCT02318706|465075043|FG003|Open-label Extension Phase|Adverse Event|0|||
129211235|NCT02318706|465075044|FG004|Open-label Extension Phase|Adverse Event|21|||
129211236|NCT02318706|465075040|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
129211237|NCT02318706|465075041|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
129211238|NCT02318706|465075042|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
129211239|NCT02318706|465075043|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
129211240|NCT02318706|465075044|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
129211241|NCT02318706|465075040|FG000|Open-label Extension Phase|Death|0|||
129211242|NCT02318706|465075041|FG001|Open-label Extension Phase|Death|0|||
129211243|NCT02318706|465075042|FG002|Open-label Extension Phase|Death|0|||
129211244|NCT02318706|465075043|FG003|Open-label Extension Phase|Death|0|||
129211245|NCT02318706|465075044|FG004|Open-label Extension Phase|Death|1|||
129211246|NCT02318706|465075040|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
129211247|NCT02318706|465075041|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
129211248|NCT02318706|465075042|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
129211249|NCT02318706|465075043|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
129211250|NCT02318706|465075044|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
129211251|NCT00992108|465075050|FG000|Overall Study|Lost to Follow-up|0|||
129211252|NCT00992108|465075051|FG001|Overall Study|Lost to Follow-up|1|||
129211253|NCT04639245|465075056|FG000|Overall Study|Death|1|||
129211254|NCT01702311|465075057|FG000|Overall Study|Withdrawal by Subject|3|||
129211255|NCT01702311|465075058|FG001|Overall Study|Withdrawal by Subject|2|||
129211256|NCT01702311|465075057|FG000|Overall Study|Discharge less than 24 hours|10|||
129211257|NCT01702311|465075058|FG001|Overall Study|Discharge less than 24 hours|7|||
129211258|NCT01702311|465075057|FG000|Overall Study|Physician Decision|3|||
129211259|NCT01702311|465075058|FG001|Overall Study|Physician Decision|4|||
129211260|NCT04106557|465075062|FG000|Overall Study|Physician Decision|0|||
129211261|NCT04106557|465075063|FG001|Overall Study|Physician Decision|1|||
129211262|NCT04106557|465075064|FG002|Overall Study|Physician Decision|0|||
129211263|NCT04106557|465075062|FG000|Overall Study|Protocol Violation|0|||
129211264|NCT04106557|465075063|FG001|Overall Study|Protocol Violation|1|||
129211265|NCT04106557|465075064|FG002|Overall Study|Protocol Violation|0|||
129211266|NCT01209689|465075065|FG000|Overall Study|Insufficient Therapeutic Response|7|||
129211267|NCT01209689|465075066|FG001|Overall Study|Insufficient Therapeutic Response|2|||
129211268|NCT01209689|465075065|FG000|Overall Study|Refused Treatment|8|||
129211269|NCT01209689|465075066|FG001|Overall Study|Refused Treatment|3|||
129211270|NCT01209689|465075065|FG000|Overall Study|Adverse Event|4|||
129211271|NCT01209689|465075066|FG001|Overall Study|Adverse Event|0|||
129211272|NCT01209689|465075065|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129211273|NCT01209689|465075066|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
129211274|NCT01209689|465075065|FG000|Overall Study|Failure to Return|3|||
129211275|NCT01209689|465075066|FG001|Overall Study|Failure to Return|0|||
129211276|NCT01209689|465075065|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
129211277|NCT01209689|465075066|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
129211278|NCT03175367|465075067|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129211279|NCT03175367|465075068|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129211280|NCT03175367|465075069|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
129211281|NCT03175367|465075070|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
129211282|NCT03175367|465075071|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129211283|NCT03175367|465075072|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129211284|NCT03175367|465075073|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
129211285|NCT03175367|465075067|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129211286|NCT03175367|465075068|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129211287|NCT03175367|465075069|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129211288|NCT03175367|465075070|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129211289|NCT03175367|465075071|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
129211290|NCT03175367|465075072|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129211291|NCT03175367|465075073|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
128986788|NCT04341727|464241486|FG003|Overall Study|Lost to Follow-up|1|||
129211292|NCT03175367|465075067|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129211293|NCT03175367|465075068|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129211294|NCT03175367|465075069|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
129211295|NCT03175367|465075070|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
129211296|NCT03175367|465075071|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129211297|NCT03175367|465075072|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129211298|NCT03175367|465075073|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129211299|NCT03175367|465075067|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
129211300|NCT03175367|465075068|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
129211301|NCT03175367|465075069|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
129211302|NCT03175367|465075070|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
129211303|NCT03175367|465075071|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129211304|NCT03175367|465075072|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129211305|NCT03175367|465075073|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129211306|NCT03175367|465075067|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129211307|NCT03175367|465075068|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129211308|NCT03175367|465075069|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
129211309|NCT03175367|465075070|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129211310|NCT03175367|465075071|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
129211311|NCT03175367|465075072|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129211312|NCT03175367|465075073|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129211313|NCT03175367|465075067|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129211314|NCT03175367|465075068|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129211315|NCT03175367|465075069|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129211316|NCT03175367|465075070|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129211317|NCT03175367|465075071|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129211318|NCT03175367|465075072|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129211319|NCT03175367|465075073|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
129211320|NCT03175367|465075067|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129211321|NCT03175367|465075068|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129211322|NCT03175367|465075069|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129211323|NCT03175367|465075070|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129211324|NCT03175367|465075071|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129211325|NCT03175367|465075072|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
129211326|NCT03175367|465075073|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
129211327|NCT02151058|465075075|FG000|Overall Study|Withdrawal by Subject|1|||
129211328|NCT02151058|465075076|FG001|Overall Study|Withdrawal by Subject|1|||
129211329|NCT02151058|465075077|FG002|Overall Study|Withdrawal by Subject|3|||
129211330|NCT02151058|465075075|FG000|Overall Study|Lost to Follow-up|1|||
129211331|NCT02151058|465075076|FG001|Overall Study|Lost to Follow-up|0|||
129211332|NCT02151058|465075077|FG002|Overall Study|Lost to Follow-up|2|||
129211333|NCT03829228|465075078|FG000|Overall Study|Protocol Violation|1|||
129211334|NCT03337477|465075079|FG000|Overall Study|not categorized into the listed ones|11|||
129211335|NCT03337477|465075080|FG001|Overall Study|not categorized into the listed ones|9|||
129211336|NCT03337477|465075079|FG000|Overall Study|Withdrawal by Subject|0|||
129211337|NCT03337477|465075080|FG001|Overall Study|Withdrawal by Subject|1|||
129211338|NCT03337477|465075079|FG000|Overall Study|Death|0|||
129211339|NCT03337477|465075080|FG001|Overall Study|Death|1|||
129211340|NCT03337477|465075079|FG000|Overall Study|Lost to Follow-up|0|||
129211341|NCT03337477|465075080|FG001|Overall Study|Lost to Follow-up|2|||
129211342|NCT01462370|465075087|FG000|Overall Study|Lack of Qualifying Event|1|||
129211343|NCT01462370|465075088|FG001|Overall Study|Lack of Qualifying Event|1|||
129211344|NCT01462370|465075087|FG000|Overall Study|Physician Decision|0|||
129211345|NCT01462370|465075088|FG001|Overall Study|Physician Decision|1|||
129211346|NCT01462370|465075087|FG000|Overall Study|Withdrawal by Subject|0|||
129211347|NCT01462370|465075088|FG001|Overall Study|Withdrawal by Subject|3|||
129211348|NCT00853307|465075089|FG000|Overall Study|Adverse Event|1|||
129211349|NCT00853307|465075090|FG001|Overall Study|Adverse Event|2|||
129211350|NCT00853307|465075089|FG000|Overall Study|Withdrawal by Subject|1|||
129211351|NCT00853307|465075090|FG001|Overall Study|Withdrawal by Subject|2|||
129211352|NCT00853307|465075089|FG000|Overall Study|Reason Not Specified|0|||
129211353|NCT00853307|465075090|FG001|Overall Study|Reason Not Specified|1|||
129211354|NCT00473564|465075091|FG000|Overall Study|robot surgery aborted in OR|23|||
129211355|NCT00674817|465075092|FG000|Period 1|Withdrawal by Subject|2|||
129211356|NCT00674817|465075092|FG000|Period 1|Protocol Violation|1|||
129211357|NCT00674817|465075092|FG000|Period 3|Adverse Event|1|||
129211358|NCT00674817|465075092|FG000|Period 3|Protocol Violation|1|||
129211359|NCT00674817|465075092|FG000|Period 4|Adverse Event|1|||
129211360|NCT03103542|465075094|FG000|Overall Study|Physician Decision|2|||
129211361|NCT03103542|465075094|FG000|Overall Study|Adverse Event|2|||
129211362|NCT03103542|465075094|FG000|Overall Study|Other|2|||
129211363|NCT03103542|465075094|FG000|Overall Study|Withdrawal by Subject|1|||
129211364|NCT03406780|465075095|FG000|Overall Study|Withdrawal by Subject|1|||
129211365|NCT03406780|465075096|FG001|Overall Study|Withdrawal by Subject|1|||
129211366|NCT03406780|465075095|FG000|Overall Study|Other|0|||
129211367|NCT03406780|465075096|FG001|Overall Study|Other|2|||
129211368|NCT03044106|465075097|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
129211369|NCT03044106|465075098|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
129211370|NCT01748292|465075099|FG000|Overall Study|Adverse Event|2|||
129211371|NCT01748292|465075100|FG001|Overall Study|Adverse Event|4|||
129211372|NCT01748292|465075099|FG000|Overall Study|Lost to Follow-up|0|||
129211373|NCT01748292|465075100|FG001|Overall Study|Lost to Follow-up|3|||
129211374|NCT01748292|465075099|FG000|Overall Study|Death|0|||
129211375|NCT01748292|465075100|FG001|Overall Study|Death|3|||
129211376|NCT01748292|465075099|FG000|Overall Study|Withdrawal by Subject|0|||
129211377|NCT01748292|465075100|FG001|Overall Study|Withdrawal by Subject|2|||
129211378|NCT03697252|465075103|FG000|Overall Study|Adverse Event|3|||
129211379|NCT03697252|465075104|FG001|Overall Study|Adverse Event|2|||
129211380|NCT03697252|465075103|FG000|Overall Study|Withdrawal by Subject|14|||
129211381|NCT03697252|465075104|FG001|Overall Study|Withdrawal by Subject|14|||
129211382|NCT03697252|465075103|FG000|Overall Study|Lost to Follow-up|0|||
129211383|NCT03697252|465075104|FG001|Overall Study|Lost to Follow-up|1|||
129211384|NCT03697252|465075103|FG000|Overall Study|Physician Decision|1|||
129211385|NCT03697252|465075104|FG001|Overall Study|Physician Decision|1|||
129211386|NCT03697252|465075103|FG000|Overall Study|Other|0|||
129211387|NCT03697252|465075104|FG001|Overall Study|Other|1|||
129211388|NCT02340026|465075105|FG000|Treatment Phase|Withdrawal by Subject|2|||
129211389|NCT02340026|465075106|FG001|Treatment Phase|Withdrawal by Subject|2|||
129211390|NCT02340026|465075105|FG000|Follow-up Phase|Lost to Follow-up|1|||
129211391|NCT02340026|465075106|FG001|Follow-up Phase|Lost to Follow-up|0|||
129211392|NCT00888134|465075130|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
129211393|NCT00888134|465075130|FG000|Follow-up|being followed for long-term survival|1|||
129211394|NCT01488890|465075133|FG000|Overall Study|Serious adverse event|2|||
129211395|NCT01488890|465075134|FG001|Overall Study|Serious adverse event|0|||
129211396|NCT01488890|465075135|FG002|Overall Study|Serious adverse event|0|||
129211397|NCT01488890|465075136|FG003|Overall Study|Serious adverse event|0|||
129211398|NCT01488890|465075133|FG000|Overall Study|Protocol Violation|3|||
129211399|NCT01488890|465075134|FG001|Overall Study|Protocol Violation|0|||
129211400|NCT01488890|465075135|FG002|Overall Study|Protocol Violation|4|||
129211401|NCT01488890|465075136|FG003|Overall Study|Protocol Violation|0|||
129211402|NCT01488890|465075133|FG000|Overall Study|Lost to Follow-up|13|||
129211403|NCT01488890|465075134|FG001|Overall Study|Lost to Follow-up|10|||
129211404|NCT01488890|465075135|FG002|Overall Study|Lost to Follow-up|20|||
129211405|NCT01488890|465075136|FG003|Overall Study|Lost to Follow-up|3|||
129211406|NCT01488890|465075133|FG000|Overall Study|Withdrawal by Subject|14|||
129211407|NCT01488890|465075134|FG001|Overall Study|Withdrawal by Subject|10|||
129211408|NCT01488890|465075135|FG002|Overall Study|Withdrawal by Subject|11|||
129211409|NCT01488890|465075136|FG003|Overall Study|Withdrawal by Subject|2|||
129211410|NCT05712460|465075137|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211411|NCT05712460|465075138|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211412|NCT05712460|465075139|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211413|NCT05712460|465075140|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211414|NCT05712460|465075141|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211415|NCT05712460|465075142|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211416|NCT05712460|465075143|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211417|NCT05712460|465075144|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
129211418|NCT05712460|465075145|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211419|NCT05712460|465075146|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211420|NCT05712460|465075147|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211421|NCT05712460|465075148|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129211422|NCT00829426|465075152|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129211423|NCT00829426|465075153|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129211424|NCT05135767|465075156|FG000|Baseline|Lost to Follow-up|1|||
129211425|NCT05135767|465075157|FG001|Baseline|Lost to Follow-up|1|||
129211426|NCT05135767|465075156|FG000|Baseline|Withdrawal by Subject|0|||
129211427|NCT05135767|465075157|FG001|Baseline|Withdrawal by Subject|2|||
129211428|NCT05135767|465075156|FG000|Active Study Phase|Lost to Follow-up|2|||
129211429|NCT05135767|465075157|FG001|Active Study Phase|Lost to Follow-up|0|||
129211430|NCT02260934|465075163|FG000|Overall Study|Lost to Follow-up|2|||
128986789|NCT05604521|464241487|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
129211431|NCT02260934|465075164|FG001|Overall Study|Lost to Follow-up|1|||
129211432|NCT02260934|465075163|FG000|Overall Study|Withdrawal by Subject|0|||
129211433|NCT02260934|465075164|FG001|Overall Study|Withdrawal by Subject|2|||
129211434|NCT02260934|465075163|FG000|Overall Study|Participant Relocated|1|||
129211435|NCT02260934|465075164|FG001|Overall Study|Participant Relocated|0|||
129211436|NCT02260934|465075163|FG000|Overall Study|Site error|0|||
129211437|NCT02260934|465075164|FG001|Overall Study|Site error|1|||
129211438|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
129211439|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
129211440|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
129211441|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
129211442|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
129211443|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
129211444|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
129211445|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
129211446|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
129211447|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
129211448|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
129211449|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
129211450|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
129211451|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
129211452|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
129211453|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
129211454|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
129211455|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
129211456|NCT03605667|465075167|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
129211457|NCT03605667|465075168|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
129211458|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
129211459|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
129211460|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Other|6|||
129211461|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Other|8|||
129211462|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
129211463|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
129211464|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
129211465|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
129211466|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
129211467|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
129211468|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
129211469|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
129211470|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
129211471|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
129211472|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
129211473|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
129211474|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Death|0|||
129211475|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Death|2|||
129211476|NCT03605667|465075167|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
129211477|NCT03605667|465075168|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
129211478|NCT03597347|465075171|FG000|Overall Study|Withdrawal by Subject|1|||
129211479|NCT03597347|465075172|FG001|Overall Study|Withdrawal by Subject|1|||
129211480|NCT03597347|465075173|FG002|Overall Study|Withdrawal by Subject|0|||
129211481|NCT03597347|465075171|FG000|Overall Study|Withdrawal due to Covid-19|3|||
129211482|NCT03597347|465075172|FG001|Overall Study|Withdrawal due to Covid-19|0|||
129211483|NCT03597347|465075173|FG002|Overall Study|Withdrawal due to Covid-19|0|||
129211484|NCT03597347|465075171|FG000|Overall Study|Sponsor decision to terminate study|3|||
129211485|NCT03597347|465075172|FG001|Overall Study|Sponsor decision to terminate study|2|||
129211486|NCT03597347|465075173|FG002|Overall Study|Sponsor decision to terminate study|4|||
129211487|NCT00107653|465075174|FG000|Overall Study|Adverse Event|24|||
129211488|NCT00107653|465075175|FG001|Overall Study|Adverse Event|43|||
129211489|NCT00107653|465075174|FG000|Overall Study|Insufficient Therapeutic Response|25|||
129211490|NCT00107653|465075175|FG001|Overall Study|Insufficient Therapeutic Response|11|||
129211491|NCT00107653|465075174|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129211492|NCT00107653|465075175|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129211493|NCT00107653|465075174|FG000|Overall Study|Protocol Violation|1|||
129211494|NCT00107653|465075175|FG001|Overall Study|Protocol Violation|0|||
129211495|NCT00107653|465075174|FG000|Overall Study|Withdrawal by Subject|12|||
129211496|NCT00107653|465075175|FG001|Overall Study|Withdrawal by Subject|13|||
129211497|NCT00107653|465075174|FG000|Overall Study|Lost to Follow-up|13|||
129211498|NCT00107653|465075175|FG001|Overall Study|Lost to Follow-up|5|||
129211499|NCT00107653|465075174|FG000|Overall Study|Administrative Reasons|3|||
129211500|NCT00107653|465075175|FG001|Overall Study|Administrative Reasons|3|||
129211501|NCT02532517|465075179|FG000|Overall Study|Did not complete 24-Month visit|4|||
129211502|NCT02532517|465075179|FG000|Overall Study|Failed Angiographic eligibility|1|||
129211503|NCT02532517|465075179|FG000|Overall Study|Lost to Follow-up|4|||
129211504|NCT02532517|465075179|FG000|Overall Study|Withdrawal by Subject|4|||
129211505|NCT02532517|465075179|FG000|Overall Study|Death|4|||
129211506|NCT03312231|465075180|FG000|Overall Study|Lost to Follow-up|2|||
129211507|NCT03312231|465075181|FG001|Overall Study|Lost to Follow-up|6|||
129211508|NCT03312231|465075182|FG002|Overall Study|Lost to Follow-up|1|||
129211509|NCT03312231|465075183|FG003|Overall Study|Lost to Follow-up|3|||
129211510|NCT03312231|465075184|FG004|Overall Study|Lost to Follow-up|1|||
129211511|NCT03312231|465075180|FG000|Overall Study|Withdrawal by Subject|0|||
129211512|NCT03312231|465075181|FG001|Overall Study|Withdrawal by Subject|3|||
129211513|NCT03312231|465075182|FG002|Overall Study|Withdrawal by Subject|1|||
129211514|NCT03312231|465075183|FG003|Overall Study|Withdrawal by Subject|0|||
129211515|NCT03312231|465075184|FG004|Overall Study|Withdrawal by Subject|0|||
129211516|NCT03312231|465075180|FG000|Overall Study|Death|0|||
129211517|NCT03312231|465075181|FG001|Overall Study|Death|1|||
129211518|NCT03312231|465075182|FG002|Overall Study|Death|1|||
129211519|NCT03312231|465075183|FG003|Overall Study|Death|0|||
129211520|NCT03312231|465075184|FG004|Overall Study|Death|0|||
129211521|NCT03312231|465075180|FG000|Overall Study|Study Vaccination not Received|1|||
129211522|NCT03312231|465075181|FG001|Overall Study|Study Vaccination not Received|1|||
129211523|NCT03312231|465075182|FG002|Overall Study|Study Vaccination not Received|1|||
129211524|NCT03312231|465075183|FG003|Overall Study|Study Vaccination not Received|0|||
129211525|NCT03312231|465075184|FG004|Overall Study|Study Vaccination not Received|0|||
129211526|NCT03157830|465075185|FG000|Overall Study|Lost to Follow-up|1|||
129211527|NCT03157830|465075185|FG000|Overall Study|Withdrawal by Subject|1|||
129211528|NCT03694353|465075187|FG000|Overall Study|Withdrawal by Subject|1|||
129211529|NCT03694353|465075187|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
129211530|NCT05720897|465075188|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
129211531|NCT05720897|465075189|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
129211532|NCT00400179|465075190|FG000|Overall Study|Adverse Event|2|||
129211533|NCT00400179|465075191|FG001|Overall Study|Adverse Event|2|||
129211534|NCT00400179|465075190|FG000|Overall Study|Death|1|||
129211535|NCT00400179|465075191|FG001|Overall Study|Death|2|||
129211536|NCT00400179|465075190|FG000|Overall Study|Withdrew Consent|1|||
129211537|NCT00400179|465075191|FG001|Overall Study|Withdrew Consent|5|||
129211538|NCT00400179|465075190|FG000|Overall Study|Disease progression|1|||
129211539|NCT00400179|465075191|FG001|Overall Study|Disease progression|1|||
129211540|NCT00400179|465075190|FG000|Overall Study|Intercurrent illness|0|||
129211541|NCT00400179|465075191|FG001|Overall Study|Intercurrent illness|1|||
129211542|NCT00400179|465075190|FG000|Overall Study|Investigator judgment|0|||
129211543|NCT00400179|465075191|FG001|Overall Study|Investigator judgment|1|||
129211544|NCT00400179|465075190|FG000|Overall Study|Randomization error/patient ineligible|1|||
129211545|NCT00400179|465075191|FG001|Overall Study|Randomization error/patient ineligible|6|||
129211546|NCT04780061|465075192|FG000|Overall Study|Withdrawal by Subject|5|||
129211547|NCT04780061|465075193|FG001|Overall Study|Withdrawal by Subject|8|||
129211548|NCT04780061|465075192|FG000|Overall Study|Adverse Event|2|||
129211549|NCT04780061|465075193|FG001|Overall Study|Adverse Event|2|||
129211550|NCT04780061|465075192|FG000|Overall Study|Lost to Follow-up|1|||
129211551|NCT04780061|465075193|FG001|Overall Study|Lost to Follow-up|5|||
129211552|NCT01824836|465075194|FG000|Overall Study|Adverse Event|48|||
129211553|NCT01824836|465075194|FG000|Overall Study|Withdrawal by Subject|63|||
129211554|NCT01824836|465075194|FG000|Overall Study|Other complicating disease|116|||
129211555|NCT01824836|465075194|FG000|Overall Study|Disease progression|5|||
129211556|NCT01824836|465075194|FG000|Overall Study|Alternative therapy|2|||
129211557|NCT01824836|465075194|FG000|Overall Study|Depression|1|||
129211558|NCT01824836|465075194|FG000|Overall Study|Non-compliance|3|||
129211559|NCT01824836|465075194|FG000|Overall Study|Patient regained ovarian function|3|||
129211560|NCT01824836|465075194|FG000|Overall Study|Lost to Follow-up|8|||
129211561|NCT01824836|465075194|FG000|Overall Study|Physician Decision|2|||
129211562|NCT01824836|465075194|FG000|Overall Study|Research office was closed|3|||
129211563|NCT01824836|465075194|FG000|Overall Study|Relocation|3|||
129211564|NCT01824836|465075194|FG000|Overall Study|Insurance-related issue|1|||
129211565|NCT01824836|465075194|FG000|Overall Study|Transportation issue|1|||
129211566|NCT01824836|465075194|FG000|Overall Study|Patient transferred care|1|||
129211567|NCT01824836|465075194|FG000|Overall Study|Unknown reasons|4|||
129211568|NCT01824836|465075194|FG000|Overall Study|Never started treatment|16|||
129211569|NCT01456039|465077073|FG000|Phase 1 (First Step)|Disease Progression|1|||
129211570|NCT01456039|465077074|FG001|Phase 1 (First Step)|Disease Progression|1|||
129211571|NCT01456039|465077075|FG002|Phase 1 (First Step)|Disease Progression|0|||
129211572|NCT01456039|465077073|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
129211573|NCT01456039|465077074|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
129211574|NCT01456039|465077075|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
129211575|NCT01456039|465077073|FG000|Phase 1 (First Step)|Adverse Event|0|||
129211576|NCT01456039|465077074|FG001|Phase 1 (First Step)|Adverse Event|3|||
129211577|NCT01456039|465077075|FG002|Phase 1 (First Step)|Adverse Event|0|||
129211578|NCT01456039|465077073|FG000|Phase 1 (First Step)|Other|0|||
129211579|NCT01456039|465077074|FG001|Phase 1 (First Step)|Other|1|||
129211580|NCT01456039|465077075|FG002|Phase 1 (First Step)|Other|0|||
129211581|NCT01456039|465077073|FG000|Phase 2 (Second Step)|Disease Progression|0|||
129211582|NCT01456039|465077074|FG001|Phase 2 (Second Step)|Disease Progression|0|||
129211583|NCT01456039|465077075|FG002|Phase 2 (Second Step)|Disease Progression|17|||
129211584|NCT01456039|465077073|FG000|Phase 2 (Second Step)|Adverse Event|0|||
129211585|NCT01456039|465077074|FG001|Phase 2 (Second Step)|Adverse Event|0|||
129211586|NCT01456039|465077075|FG002|Phase 2 (Second Step)|Adverse Event|10|||
129211587|NCT01456039|465077073|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
129211588|NCT01456039|465077074|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
129211589|NCT01456039|465077075|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
129211590|NCT01456039|465077073|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
129211591|NCT01456039|465077074|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
129211592|NCT01456039|465077075|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
129211593|NCT01456039|465077073|FG000|Phase 2 (Second Step)|Other|0|||
129211594|NCT01456039|465077074|FG001|Phase 2 (Second Step)|Other|0|||
129211595|NCT01456039|465077075|FG002|Phase 2 (Second Step)|Other|1|||
129211596|NCT00755183|465077076|FG000|Overall Study|Adverse Event|5|||
129211597|NCT00755183|465077077|FG001|Overall Study|Adverse Event|2|||
129211598|NCT00755183|465077076|FG000|Overall Study|Protocol Violation|0|||
129211599|NCT00755183|465077077|FG001|Overall Study|Protocol Violation|1|||
129211600|NCT00755183|465077076|FG000|Overall Study|Withdrawal by Subject|0|||
129211601|NCT00755183|465077077|FG001|Overall Study|Withdrawal by Subject|2|||
129211602|NCT00755183|465077076|FG000|Overall Study|Administrative|2|||
129211603|NCT00755183|465077077|FG001|Overall Study|Administrative|1|||
129211604|NCT00148317|465077078|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
129211605|NCT00148317|465077078|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
129211606|NCT00148317|465077078|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
129211607|NCT00335777|465077079|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
129211608|NCT00335777|465077079|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
129211609|NCT00335777|465077079|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
129211610|NCT00335777|465077079|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
129211611|NCT00335777|465077079|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
129211612|NCT00124943|465077080|FG000|Phase II|Adverse Event|0|||
129211613|NCT00124943|465077081|FG001|Phase II|Adverse Event|2|||
129211614|NCT00124943|465077082|FG002|Phase II|Adverse Event|0|||
129211615|NCT00124943|465077083|FG003|Phase II|Adverse Event|1|||
128986790|NCT05604521|464241488|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
128986791|NCT05604521|464241487|FG000|Overall Study|Adverse Event|1|||
128986792|NCT05604521|464241488|FG001|Overall Study|Adverse Event|0|||
128986793|NCT01491737|464241492|FG000|Overall Study|Withdrawal by Subject|20|||
128986794|NCT01491737|464241493|FG001|Overall Study|Withdrawal by Subject|17|||
128986795|NCT01491737|464241492|FG000|Overall Study|Lost to Follow-up|2|||
129211616|NCT00124943|465077080|FG000|Phase II|Protocol Violation|0|||
129211617|NCT00124943|465077081|FG001|Phase II|Protocol Violation|0|||
129211618|NCT00124943|465077082|FG002|Phase II|Protocol Violation|0|||
129211619|NCT00124943|465077083|FG003|Phase II|Protocol Violation|1|||
129211620|NCT00124943|465077080|FG000|Phase II|Lost to Follow-up|0|||
129211621|NCT00124943|465077081|FG001|Phase II|Lost to Follow-up|0|||
129211622|NCT00124943|465077082|FG002|Phase II|Lost to Follow-up|0|||
129211623|NCT00124943|465077083|FG003|Phase II|Lost to Follow-up|1|||
129211624|NCT00124943|465077080|FG000|Phase II|Withdrawal by Subject|0|||
129211625|NCT00124943|465077081|FG001|Phase II|Withdrawal by Subject|0|||
129211626|NCT00124943|465077082|FG002|Phase II|Withdrawal by Subject|0|||
129211627|NCT00124943|465077083|FG003|Phase II|Withdrawal by Subject|2|||
129211628|NCT00321620|465077084|FG000|Overall Study|Death|269|||
129211629|NCT00321620|465077085|FG001|Overall Study|Death|294|||
129211630|NCT00321620|465077084|FG000|Overall Study|Withdrawal by Subject|164|||
129211631|NCT00321620|465077085|FG001|Overall Study|Withdrawal by Subject|147|||
129211632|NCT00321620|465077084|FG000|Overall Study|Disease progression|113|||
129211633|NCT00321620|465077085|FG001|Overall Study|Disease progression|117|||
129211634|NCT00321620|465077084|FG000|Overall Study|Adverse Event|43|||
129211635|NCT00321620|465077085|FG001|Overall Study|Adverse Event|56|||
129211636|NCT00321620|465077084|FG000|Overall Study|Lost to Follow-up|13|||
129211637|NCT00321620|465077085|FG001|Overall Study|Lost to Follow-up|9|||
129211638|NCT00321620|465077084|FG000|Overall Study|Physician Decision|4|||
129211639|NCT00321620|465077085|FG001|Overall Study|Physician Decision|1|||
129211640|NCT00321620|465077084|FG000|Overall Study|Noncompliance|14|||
129211641|NCT00321620|465077085|FG001|Overall Study|Noncompliance|7|||
129211642|NCT00321620|465077084|FG000|Overall Study|Protocol deviation|4|||
129211643|NCT00321620|465077085|FG001|Overall Study|Protocol deviation|3|||
129211644|NCT00321620|465077084|FG000|Overall Study|Ineligibility determined|2|||
129211645|NCT00321620|465077085|FG001|Overall Study|Ineligibility determined|3|||
129211646|NCT00321620|465077084|FG000|Overall Study|Participant request|75|||
129211647|NCT00321620|465077085|FG001|Overall Study|Participant request|52|||
129211648|NCT00321620|465077084|FG000|Overall Study|Other|42|||
129211649|NCT00321620|465077085|FG001|Overall Study|Other|33|||
129211650|NCT03304626|465077088|FG000|Overall Study|Adverse Event|1|||
129211651|NCT03304626|465077089|FG001|Overall Study|Adverse Event|0|||
128986796|NCT01491737|464241493|FG001|Overall Study|Lost to Follow-up|10|||
128986797|NCT01491737|464241492|FG000|Overall Study|Death|63|||
128986798|NCT01491737|464241493|FG001|Overall Study|Death|57|||
128986799|NCT01491737|464241492|FG000|Overall Study|Study Termination by Sponsor|36|||
129211652|NCT03304626|465077088|FG000|Overall Study|Lack of Efficacy|1|||
129211653|NCT03304626|465077089|FG001|Overall Study|Lack of Efficacy|1|||
129211654|NCT04385277|465077090|FG000|Overall Study|Physician Decision|2|||
129211655|NCT04385277|465077090|FG000|Overall Study|Ineligible|1|||
129211656|NCT04385277|465077090|FG000|Overall Study|Patient/Parent Refusal|2|||
129211657|NCT02903771|465077095|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
129211658|NCT02903771|465077096|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
129211659|NCT02903771|465077097|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
129211660|NCT02903771|465077098|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
129211661|NCT02903771|465077099|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
129211662|NCT02903771|465077100|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
129211663|NCT02903771|465077101|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
129211664|NCT02903771|465077095|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
129211665|NCT02903771|465077096|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
129211666|NCT02903771|465077097|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
129211667|NCT02903771|465077098|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
129211668|NCT02903771|465077099|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
129211669|NCT02903771|465077100|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
129211670|NCT02903771|465077101|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
129211671|NCT02903771|465077095|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129211672|NCT02903771|465077096|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129211673|NCT02903771|465077097|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
129211674|NCT02903771|465077098|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129211675|NCT02903771|465077099|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129211676|NCT02903771|465077100|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
129211677|NCT02903771|465077101|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129211678|NCT02903771|465077095|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129211679|NCT02903771|465077096|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129211680|NCT02903771|465077097|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129211681|NCT02903771|465077098|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129211682|NCT02903771|465077099|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
129211683|NCT02903771|465077100|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129211684|NCT02903771|465077101|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129211685|NCT02903771|465077095|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
129211686|NCT02903771|465077096|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
129211687|NCT02903771|465077097|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
129211688|NCT02903771|465077098|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
129211689|NCT02903771|465077099|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
129211690|NCT02903771|465077100|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
129211691|NCT02903771|465077101|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
129211692|NCT02903771|465077095|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129211693|NCT02903771|465077096|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129211694|NCT02903771|465077097|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129211695|NCT02903771|465077098|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129211696|NCT02903771|465077099|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
129211697|NCT02903771|465077100|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129211698|NCT02903771|465077101|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129211699|NCT02903771|465077095|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129211700|NCT02903771|465077096|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129211701|NCT02903771|465077097|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129211702|NCT02903771|465077098|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129211703|NCT02903771|465077099|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
129211704|NCT02903771|465077100|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129211705|NCT02903771|465077101|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129211706|NCT02903771|465077095|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129211707|NCT02903771|465077096|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129211708|NCT02903771|465077097|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129211709|NCT02903771|465077098|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129211710|NCT02903771|465077099|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
129211711|NCT02903771|465077100|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129211712|NCT02903771|465077101|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129211713|NCT02903771|465077095|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129211714|NCT02903771|465077096|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129211715|NCT02903771|465077097|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129211716|NCT02903771|465077098|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129211717|NCT02903771|465077099|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
129211718|NCT02903771|465077100|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129211719|NCT02903771|465077101|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129211720|NCT02903771|465077095|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129211721|NCT02903771|465077096|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129211722|NCT02903771|465077097|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129211723|NCT02903771|465077098|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129211724|NCT02903771|465077099|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
129211725|NCT02903771|465077100|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129211726|NCT02903771|465077101|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129211727|NCT02903771|465077095|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129211728|NCT02903771|465077096|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129211729|NCT02903771|465077097|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129211730|NCT02903771|465077098|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129211731|NCT02903771|465077099|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
129211732|NCT02903771|465077100|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129211733|NCT02903771|465077101|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129211734|NCT00837434|465077105|FG000|Overall Study|Physician Decision|3|||
129211735|NCT00837434|465077106|FG001|Overall Study|Physician Decision|0|||
129211736|NCT00837434|465077105|FG000|Overall Study|Lost to Follow-up|1|||
129211737|NCT00837434|465077106|FG001|Overall Study|Lost to Follow-up|1|||
129211738|NCT00837434|465077105|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
129211739|NCT00837434|465077106|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
129211740|NCT00837434|465077105|FG000|Overall Study|Noncompliant|2|||
129211741|NCT00837434|465077106|FG001|Overall Study|Noncompliant|0|||
129211742|NCT00837434|465077105|FG000|Overall Study|Baseline assessments not done in time|1|||
129211743|NCT00837434|465077106|FG001|Overall Study|Baseline assessments not done in time|0|||
129211744|NCT00837434|465077105|FG000|Overall Study|Unable to obtain study drug|1|||
129211745|NCT00837434|465077106|FG001|Overall Study|Unable to obtain study drug|0|||
129211746|NCT03041038|465077127|FG000|Overall Study|Withdrawal by Subject|4|||
129211747|NCT03041038|465077128|FG001|Overall Study|Withdrawal by Subject|0|||
129211748|NCT03041038|465077127|FG000|Overall Study|Lost to Follow-up|1|||
129211749|NCT03041038|465077128|FG001|Overall Study|Lost to Follow-up|1|||
129211750|NCT03041038|465077127|FG000|Overall Study|Protocol Violation|1|||
129211751|NCT03041038|465077128|FG001|Overall Study|Protocol Violation|1|||
129211752|NCT03331315|465077129|FG000|Overall Study|Physician Decision|18|||
129211753|NCT03331315|465077130|FG001|Overall Study|Physician Decision|14|||
129211754|NCT01709721|465077131|FG000|Open Label Phase|Withdrawal by Subject|0|||
129211755|NCT01709721|465077132|FG001|Open Label Phase|Withdrawal by Subject|0|||
129211756|NCT01709721|465077133|FG002|Open Label Phase|Withdrawal by Subject|5|||
129211757|NCT01709721|465077131|FG000|Open Label Phase|Adverse Event|0|||
129211758|NCT01709721|465077132|FG001|Open Label Phase|Adverse Event|0|||
129211759|NCT01709721|465077133|FG002|Open Label Phase|Adverse Event|8|||
129211760|NCT01709721|465077131|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
129211761|NCT01709721|465077132|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
129211762|NCT01709721|465077133|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
129211763|NCT01709721|465077131|FG000|Open Label Phase|Investigator Decision|0|||
129211764|NCT01709721|465077132|FG001|Open Label Phase|Investigator Decision|0|||
129211765|NCT01709721|465077133|FG002|Open Label Phase|Investigator Decision|1|||
129211766|NCT01709721|465077131|FG000|Open Label Phase|Sponsor Decision|0|||
129211767|NCT01709721|465077132|FG001|Open Label Phase|Sponsor Decision|0|||
129211768|NCT01709721|465077133|FG002|Open Label Phase|Sponsor Decision|2|||
129211769|NCT01709721|465077131|FG000|Open Label Phase|Protocol Violation|0|||
129211770|NCT01709721|465077132|FG001|Open Label Phase|Protocol Violation|0|||
129211771|NCT01709721|465077133|FG002|Open Label Phase|Protocol Violation|1|||
129211772|NCT01709721|465077131|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
129211773|NCT01709721|465077132|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
129211774|NCT01709721|465077133|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
129211775|NCT01709721|465077131|FG000|Open Label Phase|Inadequate Pain Control|0|||
129211776|NCT01709721|465077132|FG001|Open Label Phase|Inadequate Pain Control|0|||
129211777|NCT01709721|465077133|FG002|Open Label Phase|Inadequate Pain Control|37|||
129211778|NCT01709721|465077131|FG000|Open Label Phase|Other, Specify in text field in database|0|||
129211779|NCT01709721|465077132|FG001|Open Label Phase|Other, Specify in text field in database|0|||
129211780|NCT01709721|465077133|FG002|Open Label Phase|Other, Specify in text field in database|14|||
129211781|NCT01709721|465077131|FG000|Randomized Phase|Adverse Event|0|||
129211782|NCT01709721|465077132|FG001|Randomized Phase|Adverse Event|1|||
129211783|NCT01709721|465077133|FG002|Randomized Phase|Adverse Event|0|||
129211784|NCT01709721|465077131|FG000|Randomized Phase|Lost to Follow-up|1|||
129211785|NCT01709721|465077132|FG001|Randomized Phase|Lost to Follow-up|0|||
129211786|NCT01709721|465077133|FG002|Randomized Phase|Lost to Follow-up|0|||
129211787|NCT01709721|465077131|FG000|Randomized Phase|Inadequate Pain Control|1|||
129211788|NCT01709721|465077132|FG001|Randomized Phase|Inadequate Pain Control|2|||
129211789|NCT01709721|465077133|FG002|Randomized Phase|Inadequate Pain Control|0|||
129211790|NCT01709721|465077131|FG000|Randomized Phase|Other, Specify text field in database|1|||
129211791|NCT01709721|465077132|FG001|Randomized Phase|Other, Specify text field in database|3|||
129211792|NCT01709721|465077133|FG002|Randomized Phase|Other, Specify text field in database|0|||
129211793|NCT00360230|465077136|FG000|Overall Study|Withdrawal by Subject|1|||
129211794|NCT00360230|465077137|FG001|Overall Study|Withdrawal by Subject|1|||
129211795|NCT00360230|465077138|FG002|Overall Study|Withdrawal by Subject|0|||
129211796|NCT00360230|465077139|FG003|Overall Study|Withdrawal by Subject|1|||
129211797|NCT00360230|465077140|FG004|Overall Study|Withdrawal by Subject|1|||
129211798|NCT00360230|465077141|FG005|Overall Study|Withdrawal by Subject|1|||
129211799|NCT00360230|465077142|FG006|Overall Study|Withdrawal by Subject|0|||
129211800|NCT00360230|465077136|FG000|Overall Study|Migrated|4|||
129211801|NCT00360230|465077137|FG001|Overall Study|Migrated|1|||
129211802|NCT00360230|465077138|FG002|Overall Study|Migrated|3|||
129211803|NCT00360230|465077139|FG003|Overall Study|Migrated|1|||
129211804|NCT00360230|465077140|FG004|Overall Study|Migrated|4|||
129211805|NCT00360230|465077141|FG005|Overall Study|Migrated|1|||
129211806|NCT00360230|465077142|FG006|Overall Study|Migrated|1|||
129211807|NCT00360230|465077136|FG000|Overall Study|Other|1|||
129211808|NCT00360230|465077137|FG001|Overall Study|Other|0|||
129211809|NCT00360230|465077138|FG002|Overall Study|Other|0|||
129211810|NCT00360230|465077139|FG003|Overall Study|Other|0|||
129211811|NCT00360230|465077140|FG004|Overall Study|Other|0|||
129211812|NCT00360230|465077141|FG005|Overall Study|Other|0|||
129211813|NCT00360230|465077142|FG006|Overall Study|Other|0|||
129211814|NCT00360230|465077136|FG000|Overall Study|Protocol Violation|0|||
129211815|NCT00360230|465077137|FG001|Overall Study|Protocol Violation|0|||
129211816|NCT00360230|465077138|FG002|Overall Study|Protocol Violation|0|||
129211817|NCT00360230|465077139|FG003|Overall Study|Protocol Violation|0|||
129211818|NCT00360230|465077140|FG004|Overall Study|Protocol Violation|0|||
129211819|NCT00360230|465077141|FG005|Overall Study|Protocol Violation|1|||
129211820|NCT00360230|465077142|FG006|Overall Study|Protocol Violation|0|||
129211821|NCT00360230|465077136|FG000|Overall Study|Death|0|||
129211822|NCT00360230|465077137|FG001|Overall Study|Death|1|||
129211823|NCT00360230|465077138|FG002|Overall Study|Death|0|||
129211824|NCT00360230|465077139|FG003|Overall Study|Death|0|||
129211825|NCT00360230|465077140|FG004|Overall Study|Death|0|||
129211826|NCT00360230|465077141|FG005|Overall Study|Death|1|||
129211827|NCT00360230|465077142|FG006|Overall Study|Death|1|||
129211828|NCT00581308|465077143|FG000|Pre Discharge|Lost to Follow-up|1|||
129211829|NCT00581308|465077143|FG000|Pre Discharge|Device Removed|1|||
129211830|NCT00581308|465077143|FG000|Month 1|Lost to Follow-up|3|||
129211831|NCT00581308|465077143|FG000|Month 1|Withdrawal by Subject|2|||
129211832|NCT00581308|465077143|FG000|Month 1|Device Removed|2|||
129211833|NCT00581308|465077143|FG000|Month 1|Uknown|1|||
129211834|NCT00581308|465077143|FG000|Month 6|Lost to Follow-up|1|||
129211835|NCT00581308|465077143|FG000|Month 6|Withdrawal by Subject|2|||
129211836|NCT00581308|465077143|FG000|Month 12|Death|1|||
129211837|NCT00581308|465077143|FG000|Month 12|Lost to Follow-up|14|||
129211838|NCT00581308|465077143|FG000|Month 12|Withdrawal by Subject|3|||
129211839|NCT00581308|465077143|FG000|Month 12|Device Removed|1|||
129211840|NCT00581308|465077143|FG000|Month 12|Other|1|||
129211841|NCT03219723|465077144|FG000|Overall Study|Case Report Forms Uncollected|6|||
129211842|NCT03219723|465077144|FG000|Overall Study|Protocol Deviation|4|||
129211843|NCT00459316|465077145|FG000|Steps 1 & 2|Other eligibility failure|1|||
129211844|NCT00459316|465077146|FG001|Steps 1 & 2|Other eligibility failure|1|||
129211845|NCT00459316|465077147|FG002|Steps 1 & 2|Other eligibility failure|0|||
129211846|NCT00459316|465077145|FG000|Steps 1 & 2|Death|1|||
129211847|NCT00459316|465077146|FG001|Steps 1 & 2|Death|1|||
129211848|NCT00459316|465077147|FG002|Steps 1 & 2|Death|0|||
129211849|NCT00459316|465077145|FG000|Steps 1 & 2|Not able to get to clinic|7|||
129211850|NCT00459316|465077146|FG001|Steps 1 & 2|Not able to get to clinic|4|||
129211851|NCT00459316|465077147|FG002|Steps 1 & 2|Not able to get to clinic|0|||
129211852|NCT00459316|465077145|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
129211853|NCT00459316|465077146|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
129211854|NCT00459316|465077147|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
129211855|NCT00459316|465077145|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
129211856|NCT00459316|465077146|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
129211857|NCT00459316|465077147|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
129211858|NCT00459316|465077145|FG000|Steps 1 & 2|Lost to Follow-up|5|||
129211859|NCT00459316|465077146|FG001|Steps 1 & 2|Lost to Follow-up|0|||
129211860|NCT00459316|465077147|FG002|Steps 1 & 2|Lost to Follow-up|2|||
129211861|NCT00459316|465077145|FG000|Step 3|Withdrawal by Subject|3|||
129211862|NCT00459316|465077146|FG001|Step 3|Withdrawal by Subject|0|||
129211863|NCT00459316|465077147|FG002|Step 3|Withdrawal by Subject|1|||
129211864|NCT01614886|465077148|FG000|Overall Study|Adverse Event|15|||
129211865|NCT01614886|465077149|FG001|Overall Study|Adverse Event|20|||
129211866|NCT01614886|465077148|FG000|Overall Study|Withdrawal by Subject|4|||
129211867|NCT01614886|465077149|FG001|Overall Study|Withdrawal by Subject|4|||
129211868|NCT01614886|465077148|FG000|Overall Study|Death|1|||
129211869|NCT01614886|465077149|FG001|Overall Study|Death|0|||
129211870|NCT01614886|465077148|FG000|Overall Study|Protocol deviation|0|||
129211871|NCT01614886|465077149|FG001|Overall Study|Protocol deviation|2|||
129211872|NCT01207414|465077151|FG000|Overall Study|Adverse Event|25|||
129211873|NCT01207414|465077152|FG001|Overall Study|Adverse Event|39|||
129211874|NCT01207414|465077151|FG000|Overall Study|Abnormal test procedure results|0|||
129211875|NCT01207414|465077152|FG001|Overall Study|Abnormal test procedure results|1|||
129211876|NCT01207414|465077151|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129211877|NCT01207414|465077152|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129211878|NCT01207414|465077151|FG000|Overall Study|Patient withdrew consent|14|||
129211879|NCT01207414|465077152|FG001|Overall Study|Patient withdrew consent|11|||
129211880|NCT01207414|465077151|FG000|Overall Study|Lost to Follow-up|15|||
129211881|NCT01207414|465077152|FG001|Overall Study|Lost to Follow-up|17|||
129211882|NCT01207414|465077151|FG000|Overall Study|Administrative problems|1|||
129211883|NCT01207414|465077152|FG001|Overall Study|Administrative problems|1|||
129211884|NCT01207414|465077151|FG000|Overall Study|Protocol deviation|12|||
129211885|NCT01207414|465077152|FG001|Overall Study|Protocol deviation|9|||
129211886|NCT01207414|465077151|FG000|Overall Study|Randomized in error|1|||
129211887|NCT01207414|465077152|FG001|Overall Study|Randomized in error|0|||
129211888|NCT01527370|465077153|FG000|Overall Study|Withdrawal by Subject|4|||
129211889|NCT01527370|465077153|FG000|Overall Study|Physician Decision|1|||
129211890|NCT01527370|465077153|FG000|Overall Study|Death|1|||
129211891|NCT02057250|465077156|FG000|AID Assessment Phase|Adverse Event|3|||
129211892|NCT02057250|465077157|FG001|AID Assessment Phase|Adverse Event|2|||
129211893|NCT02057250|465077158|FG002|AID Assessment Phase|Adverse Event|6|||
129211894|NCT02057250|465077159|FG003|AID Assessment Phase|Adverse Event|1|||
129211895|NCT02057250|465077160|FG004|AID Assessment Phase|Adverse Event|0|||
129211896|NCT02057250|465077156|FG000|AID Assessment Phase|Other than specified above|1|||
129211897|NCT02057250|465077157|FG001|AID Assessment Phase|Other than specified above|1|||
129211898|NCT02057250|465077158|FG002|AID Assessment Phase|Other than specified above|1|||
129211899|NCT02057250|465077159|FG003|AID Assessment Phase|Other than specified above|1|||
129211900|NCT02057250|465077160|FG004|AID Assessment Phase|Other than specified above|0|||
129211901|NCT02057250|465077156|FG000|Extension Phase|Adverse Event|0|||
129211902|NCT02057250|465077157|FG001|Extension Phase|Adverse Event|0|||
129211903|NCT02057250|465077158|FG002|Extension Phase|Adverse Event|0|||
129211904|NCT02057250|465077159|FG003|Extension Phase|Adverse Event|0|||
129211905|NCT02057250|465077160|FG004|Extension Phase|Adverse Event|15|||
129211906|NCT02057250|465077156|FG000|Extension Phase|Lack of Efficacy|0|||
129211907|NCT02057250|465077157|FG001|Extension Phase|Lack of Efficacy|0|||
129211908|NCT02057250|465077158|FG002|Extension Phase|Lack of Efficacy|0|||
129211909|NCT02057250|465077159|FG003|Extension Phase|Lack of Efficacy|0|||
129211910|NCT02057250|465077160|FG004|Extension Phase|Lack of Efficacy|10|||
129211911|NCT02057250|465077156|FG000|Extension Phase|Entered in this period but not treated|0|||
129211912|NCT02057250|465077157|FG001|Extension Phase|Entered in this period but not treated|0|||
129211913|NCT02057250|465077158|FG002|Extension Phase|Entered in this period but not treated|0|||
129211914|NCT02057250|465077159|FG003|Extension Phase|Entered in this period but not treated|0|||
129211915|NCT02057250|465077160|FG004|Extension Phase|Entered in this period but not treated|4|||
129211916|NCT02057250|465077156|FG000|Extension Phase|Other than specified above|0|||
129211917|NCT02057250|465077157|FG001|Extension Phase|Other than specified above|0|||
129211918|NCT02057250|465077158|FG002|Extension Phase|Other than specified above|0|||
129211919|NCT02057250|465077159|FG003|Extension Phase|Other than specified above|0|||
129211920|NCT02057250|465077160|FG004|Extension Phase|Other than specified above|7|||
129211921|NCT01435382|465077162|FG000|Overall Study|Lost to Follow-up|1|||
129211922|NCT01435382|465077163|FG001|Overall Study|Lost to Follow-up|0|||
129211923|NCT01435382|465077164|FG002|Overall Study|Lost to Follow-up|1|||
129211924|NCT01435382|465077165|FG003|Overall Study|Lost to Follow-up|0|||
129211925|NCT01435382|465077162|FG000|Overall Study|Withdrawal by Subject|0|||
129211926|NCT01435382|465077163|FG001|Overall Study|Withdrawal by Subject|2|||
129211927|NCT01435382|465077164|FG002|Overall Study|Withdrawal by Subject|0|||
129211928|NCT01435382|465077165|FG003|Overall Study|Withdrawal by Subject|1|||
129211929|NCT02435992|465077166|FG000|Overall Study|non compliance with protocol|2|||
129211930|NCT02435992|465077167|FG001|Overall Study|non compliance with protocol|0|||
129211931|NCT02435992|465077168|FG002|Overall Study|non compliance with protocol|1|||
129211932|NCT02435992|465077169|FG003|Overall Study|non compliance with protocol|0|||
129211933|NCT02435992|465077170|FG004|Overall Study|non compliance with protocol|0|||
129211934|NCT02435992|465077166|FG000|Overall Study|Adverse Event|11|||
129211935|NCT02435992|465077167|FG001|Overall Study|Adverse Event|6|||
129211936|NCT02435992|465077168|FG002|Overall Study|Adverse Event|12|||
129211937|NCT02435992|465077169|FG003|Overall Study|Adverse Event|0|||
129211938|NCT02435992|465077170|FG004|Overall Study|Adverse Event|0|||
129211939|NCT02435992|465077166|FG000|Overall Study|Lack of Efficacy|4|||
129211940|NCT02435992|465077167|FG001|Overall Study|Lack of Efficacy|10|||
128986800|NCT01491737|464241493|FG001|Overall Study|Study Termination by Sponsor|36|||
129211941|NCT02435992|465077168|FG002|Overall Study|Lack of Efficacy|9|||
128986801|NCT01491737|464241492|FG000|Overall Study|Reason Not Specified|8|||
129211942|NCT02435992|465077169|FG003|Overall Study|Lack of Efficacy|0|||
129211943|NCT02435992|465077170|FG004|Overall Study|Lack of Efficacy|0|||
129211944|NCT02435992|465077166|FG000|Overall Study|Withdrawal by Subject|10|||
129211945|NCT02435992|465077167|FG001|Overall Study|Withdrawal by Subject|8|||
129211946|NCT02435992|465077168|FG002|Overall Study|Withdrawal by Subject|20|||
129211947|NCT02435992|465077169|FG003|Overall Study|Withdrawal by Subject|0|||
129211948|NCT02435992|465077170|FG004|Overall Study|Withdrawal by Subject|0|||
129211949|NCT02435992|465077166|FG000|Overall Study|Other Reason|1|||
129211950|NCT02435992|465077167|FG001|Overall Study|Other Reason|0|||
129211951|NCT02435992|465077168|FG002|Overall Study|Other Reason|0|||
129211952|NCT02435992|465077169|FG003|Overall Study|Other Reason|0|||
129211953|NCT02435992|465077170|FG004|Overall Study|Other Reason|0|||
129211954|NCT02435992|465077166|FG000|Overall Study|Physician Decision|0|||
129211955|NCT02435992|465077167|FG001|Overall Study|Physician Decision|0|||
129211956|NCT02435992|465077168|FG002|Overall Study|Physician Decision|1|||
129211957|NCT02435992|465077169|FG003|Overall Study|Physician Decision|0|||
129211958|NCT02435992|465077170|FG004|Overall Study|Physician Decision|0|||
129211959|NCT00260533|465077171|FG000|Overall Study|Other|3|||
129211960|NCT00260533|465077172|FG001|Overall Study|Other|3|||
129211961|NCT01761877|465077173|FG000|Overall Study|Adverse Event|7|||
129211962|NCT01761877|465077174|FG001|Overall Study|Adverse Event|0|||
129211963|NCT01761877|465077173|FG000|Overall Study|Withdrawal by Subject|6|||
129211964|NCT01761877|465077174|FG001|Overall Study|Withdrawal by Subject|4|||
129211965|NCT01761877|465077173|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
129211966|NCT01761877|465077174|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
129211967|NCT01761877|465077173|FG000|Overall Study|Death|0|||
129211968|NCT01761877|465077174|FG001|Overall Study|Death|1|||
129211969|NCT01761877|465077173|FG000|Overall Study|MRI intolerant|1|||
129211970|NCT01761877|465077174|FG001|Overall Study|MRI intolerant|6|||
129211971|NCT01310777|465077176|FG000|Overall Study|Adverse Event|23|||
129211972|NCT01310777|465077177|FG001|Overall Study|Adverse Event|1|||
129211973|NCT01310777|465077178|FG002|Overall Study|Adverse Event|15|||
129211974|NCT01310777|465077176|FG000|Overall Study|Lost to Follow-up|0|||
129211975|NCT01310777|465077177|FG001|Overall Study|Lost to Follow-up|4|||
129211976|NCT01310777|465077178|FG002|Overall Study|Lost to Follow-up|1|||
129211977|NCT01310777|465077176|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
129211978|NCT01310777|465077177|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
129211979|NCT01310777|465077178|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
129211980|NCT01310777|465077176|FG000|Overall Study|Inadequate Control of IOP|5|||
129211981|NCT01310777|465077177|FG001|Overall Study|Inadequate Control of IOP|7|||
129211982|NCT01310777|465077178|FG002|Overall Study|Inadequate Control of IOP|10|||
129211983|NCT01310777|465077176|FG000|Overall Study|Other|4|||
129211984|NCT01310777|465077177|FG001|Overall Study|Other|1|||
129211985|NCT01310777|465077178|FG002|Overall Study|Other|2|||
129211986|NCT02461758|465077180|FG000|Overall Study|Lost to Follow-up|0|||
129211987|NCT02461758|465077181|FG001|Overall Study|Lost to Follow-up|1|||
129211988|NCT02461758|465077182|FG002|Overall Study|Lost to Follow-up|1|||
129211989|NCT02461758|465077183|FG003|Overall Study|Lost to Follow-up|0|||
129211990|NCT02738801|465077186|FG000|Overall Study|Adverse Event|1|||
129211991|NCT02738801|465077187|FG001|Overall Study|Adverse Event|1|||
129211992|NCT02738801|465077186|FG000|Overall Study|Withdrawal by Subject|0|||
129211993|NCT02738801|465077187|FG001|Overall Study|Withdrawal by Subject|1|||
129211994|NCT01210313|465077188|FG000|Overall Study|Withdrawal by Subject|3|||
129211995|NCT01210313|465077188|FG000|Overall Study|Adverse Event|2|||
129211996|NCT01210313|465077188|FG000|Overall Study|Distant recurrence|4|||
129211997|NCT01210313|465077188|FG000|Overall Study|Non-compliance|7|||
129211998|NCT01710345|465077199|FG000|Overall Study|Adverse Event|0|||
129211999|NCT01710345|465077200|FG001|Overall Study|Adverse Event|2|||
129212000|NCT01710345|465077201|FG002|Overall Study|Adverse Event|0|||
129212001|NCT01710345|465077199|FG000|Overall Study|Lack of Efficacy|2|||
129212002|NCT01710345|465077200|FG001|Overall Study|Lack of Efficacy|3|||
129212003|NCT01710345|465077201|FG002|Overall Study|Lack of Efficacy|1|||
129212004|NCT01710345|465077199|FG000|Overall Study|Drug Dosing Error|1|||
129212005|NCT01710345|465077200|FG001|Overall Study|Drug Dosing Error|0|||
129212006|NCT01710345|465077201|FG002|Overall Study|Drug Dosing Error|0|||
129212007|NCT04298697|465077205|FG000|Overall Study|Lost to Follow-up|5|||
129212008|NCT04298697|465077206|FG001|Overall Study|Lost to Follow-up|5|||
129212009|NCT04298697|465077207|FG002|Overall Study|Lost to Follow-up|1|||
129212010|NCT04298697|465077208|FG003|Overall Study|Lost to Follow-up|0|||
129212011|NCT04298697|465077205|FG000|Overall Study|Withdrawal by Subject|0|||
129212012|NCT04298697|465077206|FG001|Overall Study|Withdrawal by Subject|3|||
129212013|NCT04298697|465077207|FG002|Overall Study|Withdrawal by Subject|2|||
129212014|NCT04298697|465077208|FG003|Overall Study|Withdrawal by Subject|3|||
129212015|NCT00449696|465077209|FG000|Overall Study|Other Treatment Required|6|||
129212016|NCT00449696|465077210|FG001|Overall Study|Other Treatment Required|1|||
129212017|NCT00449696|465077209|FG000|Overall Study|Withdrawal by Subject|5|||
129212018|NCT00449696|465077210|FG001|Overall Study|Withdrawal by Subject|5|||
129212019|NCT00449696|465077209|FG000|Overall Study|Lost to Follow-up|2|||
129212020|NCT00449696|465077210|FG001|Overall Study|Lost to Follow-up|3|||
129212021|NCT00449696|465077209|FG000|Overall Study|Others|7|||
129212022|NCT00449696|465077210|FG001|Overall Study|Others|0|||
129212023|NCT01903460|465077211|FG000|Overall Study|Adverse Event|0|||
129212024|NCT01903460|465077212|FG001|Overall Study|Adverse Event|0|||
129212025|NCT01903460|465077213|FG002|Overall Study|Adverse Event|0|||
129212026|NCT01903460|465077214|FG003|Overall Study|Adverse Event|1|||
129212027|NCT04973449|465077215|FG000|Overall Study|Withdrawal by Subject|3|||
129212028|NCT04973449|465077216|FG001|Overall Study|Withdrawal by Subject|3|||
129212029|NCT04973449|465077217|FG002|Overall Study|Withdrawal by Subject|2|||
128986802|NCT01491737|464241493|FG001|Overall Study|Reason Not Specified|9|||
128986803|NCT01976663|464241494|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
128986804|NCT01976663|464241494|FG000|Overall Study|Personal Reasons|6|||
128986805|NCT01976663|464241494|FG000|Overall Study|Withdrawal by Subject|4|||
128986806|NCT01976663|464241494|FG000|Overall Study|Screen Failure|3|||
128986807|NCT01976663|464241494|FG000|Overall Study|Adverse Event|2|||
128986808|NCT01976663|464241494|FG000|Overall Study|Lost to Follow-up|3|||
128986809|NCT01817764|464241495|FG000|Overall Study|Adverse Event|7|||
128986810|NCT01817764|464241496|FG001|Overall Study|Adverse Event|10|||
128986811|NCT01817764|464241495|FG000|Overall Study|Lack of Efficacy|9|||
129212030|NCT04973449|465077218|FG003|Overall Study|Withdrawal by Subject|5|||
128986812|NCT01817764|464241496|FG001|Overall Study|Lack of Efficacy|7|||
128986813|NCT01817764|464241495|FG000|Overall Study|Protocol Violation|7|||
128986814|NCT01817764|464241496|FG001|Overall Study|Protocol Violation|5|||
128986815|NCT01817764|464241495|FG000|Overall Study|Lost to Follow-up|1|||
128986816|NCT01817764|464241496|FG001|Overall Study|Lost to Follow-up|4|||
128986817|NCT01817764|464241495|FG000|Overall Study|Withdrawal by Subject|10|||
128986818|NCT01817764|464241496|FG001|Overall Study|Withdrawal by Subject|12|||
128986819|NCT00526162|464241497|FG000|Overall Study|Device not implanted|3|||
128986820|NCT05279807|464241498|FG000|Overall Study|Withdrawal by Subject|1|||
128986821|NCT05279807|464241499|FG001|Overall Study|Withdrawal by Subject|0|||
128986822|NCT05279807|464241498|FG000|Overall Study|Adverse Event|0|||
128986823|NCT05279807|464241499|FG001|Overall Study|Adverse Event|1|||
128986824|NCT05279807|464241498|FG000|Overall Study|Laboratory Abnormal Results|1|||
128986825|NCT05279807|464241499|FG001|Overall Study|Laboratory Abnormal Results|0|||
128986826|NCT05993299|464241500|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
128986827|NCT05993299|464241500|FG000|Overall Study|Ongoing|4|||
128986828|NCT03110107|464241501|FG000|Treatment Period|Disease Progression|3|||
128986829|NCT03110107|464241502|FG001|Treatment Period|Disease Progression|9|||
128986830|NCT03110107|464241503|FG002|Treatment Period|Disease Progression|8|||
128986831|NCT03110107|464241504|FG003|Treatment Period|Disease Progression|11|||
128986832|NCT03110107|464241505|FG004|Treatment Period|Disease Progression|8|||
128986833|NCT03110107|464241506|FG005|Treatment Period|Disease Progression|4|||
128986834|NCT03110107|464241507|FG006|Treatment Period|Disease Progression|6|||
128986835|NCT03110107|464241508|FG007|Treatment Period|Disease Progression|7|||
128986836|NCT03110107|464241509|FG008|Treatment Period|Disease Progression|2|||
128986837|NCT03110107|464241510|FG009|Treatment Period|Disease Progression|10|||
128986838|NCT03110107|464241511|FG010|Treatment Period|Disease Progression|5|||
128986839|NCT03110107|464241512|FG011|Treatment Period|Disease Progression|2|||
128986840|NCT03110107|464241513|FG012|Treatment Period|Disease Progression|0|||
128986841|NCT03110107|464241514|FG013|Treatment Period|Disease Progression|5|||
128986842|NCT03110107|464241515|FG014|Treatment Period|Disease Progression|14|||
128986843|NCT03110107|464241516|FG015|Treatment Period|Disease Progression|14|||
128986844|NCT03110107|464241517|FG016|Treatment Period|Disease Progression|4|||
128986845|NCT03110107|464241518|FG017|Treatment Period|Disease Progression|3|||
128986846|NCT03110107|464241519|FG018|Treatment Period|Disease Progression|16|||
128986847|NCT03110107|464241520|FG019|Treatment Period|Disease Progression|14|||
128986848|NCT03110107|464241521|FG020|Treatment Period|Disease Progression|12|||
128986849|NCT03110107|464241522|FG021|Treatment Period|Disease Progression|16|||
128986850|NCT03110107|464241523|FG022|Treatment Period|Disease Progression|18|||
128986851|NCT03110107|464241524|FG023|Treatment Period|Disease Progression|13|||
128986852|NCT03110107|464241525|FG024|Treatment Period|Disease Progression|16|||
128986853|NCT03110107|464241526|FG025|Treatment Period|Disease Progression|31|||
128986854|NCT03110107|464241501|FG000|Treatment Period|Study drug toxicity|1|||
128986855|NCT03110107|464241502|FG001|Treatment Period|Study drug toxicity|0|||
128986856|NCT03110107|464241503|FG002|Treatment Period|Study drug toxicity|1|||
129212031|NCT04973449|465077219|FG004|Overall Study|Withdrawal by Subject|5|||
129212032|NCT04973449|465077220|FG005|Overall Study|Withdrawal by Subject|4|||
129212033|NCT04973449|465077221|FG006|Overall Study|Withdrawal by Subject|7|||
129212034|NCT04973449|465077222|FG007|Overall Study|Withdrawal by Subject|5|||
129212035|NCT04973449|465077215|FG000|Overall Study|Lost to Follow-up|15|||
129212036|NCT04973449|465077216|FG001|Overall Study|Lost to Follow-up|16|||
129212037|NCT04973449|465077217|FG002|Overall Study|Lost to Follow-up|16|||
129212038|NCT04973449|465077218|FG003|Overall Study|Lost to Follow-up|13|||
129212039|NCT04973449|465077219|FG004|Overall Study|Lost to Follow-up|5|||
129212040|NCT04973449|465077220|FG005|Overall Study|Lost to Follow-up|6|||
129212041|NCT04973449|465077221|FG006|Overall Study|Lost to Follow-up|10|||
128986857|NCT03110107|464241504|FG003|Treatment Period|Study drug toxicity|2|||
128986858|NCT03110107|464241505|FG004|Treatment Period|Study drug toxicity|0|||
129212042|NCT04973449|465077222|FG007|Overall Study|Lost to Follow-up|6|||
129212043|NCT04973449|465077215|FG000|Overall Study|Death|1|||
128986859|NCT03110107|464241506|FG005|Treatment Period|Study drug toxicity|3|||
128986860|NCT03110107|464241507|FG006|Treatment Period|Study drug toxicity|1|||
128986861|NCT03110107|464241508|FG007|Treatment Period|Study drug toxicity|1|||
128986862|NCT03110107|464241509|FG008|Treatment Period|Study drug toxicity|3|||
128986863|NCT03110107|464241510|FG009|Treatment Period|Study drug toxicity|2|||
129212044|NCT04973449|465077216|FG001|Overall Study|Death|0|||
129212045|NCT04973449|465077217|FG002|Overall Study|Death|0|||
129212046|NCT04973449|465077218|FG003|Overall Study|Death|0|||
129212047|NCT04973449|465077219|FG004|Overall Study|Death|0|||
129212048|NCT04973449|465077220|FG005|Overall Study|Death|1|||
129212049|NCT04973449|465077221|FG006|Overall Study|Death|0|||
129212050|NCT04973449|465077222|FG007|Overall Study|Death|0|||
129212051|NCT04973449|465077215|FG000|Overall Study|Other|1|||
129212052|NCT04973449|465077216|FG001|Overall Study|Other|1|||
129212053|NCT04973449|465077217|FG002|Overall Study|Other|2|||
129212054|NCT04973449|465077218|FG003|Overall Study|Other|1|||
129212055|NCT04973449|465077219|FG004|Overall Study|Other|4|||
129212056|NCT04973449|465077220|FG005|Overall Study|Other|0|||
129212057|NCT04973449|465077221|FG006|Overall Study|Other|2|||
129212058|NCT04973449|465077222|FG007|Overall Study|Other|2|||
129212059|NCT00521079|465077223|FG000|Overall Study|Adverse Event|7|||
129212060|NCT00521079|465077224|FG001|Overall Study|Adverse Event|1|||
129212061|NCT00521079|465077223|FG000|Overall Study|Lost to Follow-up|2|||
129212062|NCT00521079|465077224|FG001|Overall Study|Lost to Follow-up|1|||
129212063|NCT00521079|465077223|FG000|Overall Study|Withdrawal by Subject|5|||
129212064|NCT00521079|465077224|FG001|Overall Study|Withdrawal by Subject|3|||
129212065|NCT01506596|465077226|FG000|Overall Study|ineligible pathology|1|||
129212066|NCT00888173|465077227|FG000|Overall Study|Wrong Primary|1|||
129212067|NCT00888173|465077227|FG000|Overall Study|Ineligible: required test not done|1|||
129212068|NCT05523089|465077231|FG000|Overall Study|Withdrawal by Subject|1|||
129212069|NCT05523089|465077232|FG001|Overall Study|Withdrawal by Subject|0|||
129212070|NCT05523089|465077233|FG002|Overall Study|Withdrawal by Subject|0|||
129212071|NCT05523089|465077231|FG000|Overall Study|Lost to Follow-up|1|||
129212072|NCT05523089|465077232|FG001|Overall Study|Lost to Follow-up|0|||
129212073|NCT05523089|465077233|FG002|Overall Study|Lost to Follow-up|0|||
129212074|NCT02681523|465077234|FG000|Overall Study|Adverse Event|1|||
129212075|NCT02681523|465077234|FG000|Overall Study|Patient Non-compliance|1|||
129212076|NCT04323124|465077239|FG000|Overall Study|Adverse Event|0|||
129212077|NCT04323124|465077240|FG001|Overall Study|Adverse Event|0|||
129212078|NCT04323124|465077241|FG002|Overall Study|Adverse Event|0|||
129212079|NCT04323124|465077242|FG003|Overall Study|Adverse Event|0|||
129212080|NCT04323124|465077243|FG004|Overall Study|Adverse Event|0|||
129212081|NCT04323124|465077244|FG005|Overall Study|Adverse Event|1|||
129212082|NCT04323124|465077245|FG006|Overall Study|Adverse Event|0|||
129212083|NCT04323124|465077246|FG007|Overall Study|Adverse Event|1|||
129212084|NCT04323124|465077247|FG008|Overall Study|Adverse Event|1|||
129212085|NCT04323124|465077248|FG009|Overall Study|Adverse Event|0|||
129212086|NCT04323124|465077249|FG010|Overall Study|Adverse Event|0|||
129212087|NCT04323124|465077250|FG011|Overall Study|Adverse Event|0|||
129212088|NCT04323124|465077251|FG012|Overall Study|Adverse Event|0|||
129212089|NCT04323124|465077252|FG013|Overall Study|Adverse Event|0|||
129212090|NCT04323124|465077253|FG014|Overall Study|Adverse Event|0|||
129212091|NCT04323124|465077239|FG000|Overall Study|Other|0|||
129212092|NCT04323124|465077240|FG001|Overall Study|Other|0|||
129212093|NCT04323124|465077241|FG002|Overall Study|Other|0|||
129212094|NCT04323124|465077242|FG003|Overall Study|Other|0|||
129212095|NCT04323124|465077243|FG004|Overall Study|Other|1|||
129212096|NCT04323124|465077244|FG005|Overall Study|Other|0|||
129212097|NCT04323124|465077245|FG006|Overall Study|Other|0|||
129212098|NCT04323124|465077246|FG007|Overall Study|Other|0|||
129212099|NCT04323124|465077247|FG008|Overall Study|Other|1|||
129212100|NCT04323124|465077248|FG009|Overall Study|Other|0|||
129212101|NCT04323124|465077249|FG010|Overall Study|Other|0|||
129212102|NCT04323124|465077250|FG011|Overall Study|Other|0|||
129212103|NCT04323124|465077251|FG012|Overall Study|Other|0|||
129212104|NCT04323124|465077252|FG013|Overall Study|Other|0|||
129212105|NCT04323124|465077253|FG014|Overall Study|Other|0|||
129212106|NCT04323124|465077239|FG000|Overall Study|Coming from a red zone (COVID)|0|||
129212107|NCT04323124|465077240|FG001|Overall Study|Coming from a red zone (COVID)|0|||
129212108|NCT04323124|465077241|FG002|Overall Study|Coming from a red zone (COVID)|0|||
129212109|NCT04323124|465077242|FG003|Overall Study|Coming from a red zone (COVID)|0|||
129212110|NCT04323124|465077243|FG004|Overall Study|Coming from a red zone (COVID)|1|||
129212111|NCT04323124|465077244|FG005|Overall Study|Coming from a red zone (COVID)|1|||
129212112|NCT04323124|465077245|FG006|Overall Study|Coming from a red zone (COVID)|0|||
129212113|NCT04323124|465077246|FG007|Overall Study|Coming from a red zone (COVID)|0|||
129212114|NCT04323124|465077247|FG008|Overall Study|Coming from a red zone (COVID)|0|||
129212115|NCT04323124|465077248|FG009|Overall Study|Coming from a red zone (COVID)|0|||
129212116|NCT04323124|465077249|FG010|Overall Study|Coming from a red zone (COVID)|0|||
129212117|NCT04323124|465077250|FG011|Overall Study|Coming from a red zone (COVID)|0|||
129212118|NCT04323124|465077251|FG012|Overall Study|Coming from a red zone (COVID)|0|||
129212119|NCT04323124|465077252|FG013|Overall Study|Coming from a red zone (COVID)|0|||
129212120|NCT04323124|465077253|FG014|Overall Study|Coming from a red zone (COVID)|0|||
129212121|NCT04323124|465077239|FG000|Overall Study|No longer meets eligibility criteria|0|||
129212122|NCT04323124|465077240|FG001|Overall Study|No longer meets eligibility criteria|0|||
129212123|NCT04323124|465077241|FG002|Overall Study|No longer meets eligibility criteria|0|||
128763051|NCT01559454|463422693|FG001|Overall Study|Protocol Violation|1|||
129212124|NCT04323124|465077242|FG003|Overall Study|No longer meets eligibility criteria|0|||
129212125|NCT04323124|465077243|FG004|Overall Study|No longer meets eligibility criteria|0|||
129212126|NCT04323124|465077244|FG005|Overall Study|No longer meets eligibility criteria|0|||
129212127|NCT04323124|465077245|FG006|Overall Study|No longer meets eligibility criteria|0|||
129212128|NCT04323124|465077246|FG007|Overall Study|No longer meets eligibility criteria|1|||
129212129|NCT04323124|465077247|FG008|Overall Study|No longer meets eligibility criteria|0|||
129212130|NCT04323124|465077248|FG009|Overall Study|No longer meets eligibility criteria|0|||
129212131|NCT04323124|465077249|FG010|Overall Study|No longer meets eligibility criteria|0|||
128986864|NCT03110107|464241511|FG010|Treatment Period|Study drug toxicity|0|||
128986865|NCT03110107|464241512|FG011|Treatment Period|Study drug toxicity|2|||
128986866|NCT03110107|464241513|FG012|Treatment Period|Study drug toxicity|0|||
128986867|NCT03110107|464241514|FG013|Treatment Period|Study drug toxicity|0|||
128986868|NCT03110107|464241515|FG014|Treatment Period|Study drug toxicity|2|||
128986869|NCT03110107|464241516|FG015|Treatment Period|Study drug toxicity|3|||
128986870|NCT03110107|464241517|FG016|Treatment Period|Study drug toxicity|3|||
128986871|NCT03110107|464241518|FG017|Treatment Period|Study drug toxicity|3|||
128986872|NCT03110107|464241519|FG018|Treatment Period|Study drug toxicity|1|||
128986873|NCT03110107|464241520|FG019|Treatment Period|Study drug toxicity|2|||
128986874|NCT03110107|464241521|FG020|Treatment Period|Study drug toxicity|2|||
128986875|NCT03110107|464241522|FG021|Treatment Period|Study drug toxicity|0|||
128986876|NCT03110107|464241523|FG022|Treatment Period|Study drug toxicity|2|||
128986877|NCT03110107|464241524|FG023|Treatment Period|Study drug toxicity|6|||
128986878|NCT03110107|464241525|FG024|Treatment Period|Study drug toxicity|7|||
128986879|NCT03110107|464241526|FG025|Treatment Period|Study drug toxicity|6|||
128986880|NCT03110107|464241501|FG000|Treatment Period|Death|0|||
128986881|NCT03110107|464241502|FG001|Treatment Period|Death|0|||
128986882|NCT03110107|464241503|FG002|Treatment Period|Death|0|||
128986883|NCT03110107|464241504|FG003|Treatment Period|Death|0|||
128986884|NCT03110107|464241505|FG004|Treatment Period|Death|0|||
128986885|NCT03110107|464241506|FG005|Treatment Period|Death|0|||
128986886|NCT03110107|464241507|FG006|Treatment Period|Death|0|||
128986887|NCT03110107|464241508|FG007|Treatment Period|Death|0|||
128986888|NCT03110107|464241509|FG008|Treatment Period|Death|0|||
128986889|NCT03110107|464241510|FG009|Treatment Period|Death|0|||
128986890|NCT03110107|464241511|FG010|Treatment Period|Death|0|||
128986891|NCT03110107|464241512|FG011|Treatment Period|Death|0|||
128986892|NCT03110107|464241513|FG012|Treatment Period|Death|1|||
128986893|NCT03110107|464241514|FG013|Treatment Period|Death|0|||
128986894|NCT03110107|464241515|FG014|Treatment Period|Death|0|||
128986895|NCT03110107|464241516|FG015|Treatment Period|Death|0|||
128986896|NCT03110107|464241517|FG016|Treatment Period|Death|0|||
128986897|NCT03110107|464241518|FG017|Treatment Period|Death|0|||
128986898|NCT03110107|464241519|FG018|Treatment Period|Death|0|||
128986899|NCT03110107|464241520|FG019|Treatment Period|Death|0|||
128986900|NCT03110107|464241521|FG020|Treatment Period|Death|0|||
128986901|NCT03110107|464241522|FG021|Treatment Period|Death|0|||
128986902|NCT03110107|464241523|FG022|Treatment Period|Death|0|||
128986903|NCT03110107|464241524|FG023|Treatment Period|Death|0|||
128986904|NCT03110107|464241525|FG024|Treatment Period|Death|0|||
128986905|NCT03110107|464241526|FG025|Treatment Period|Death|0|||
128986906|NCT03110107|464241501|FG000|Treatment Period|Adverse Event|0|||
128986907|NCT03110107|464241502|FG001|Treatment Period|Adverse Event|0|||
128986908|NCT03110107|464241503|FG002|Treatment Period|Adverse Event|1|||
128986909|NCT03110107|464241504|FG003|Treatment Period|Adverse Event|0|||
128986910|NCT03110107|464241505|FG004|Treatment Period|Adverse Event|0|||
129212132|NCT04323124|465077250|FG011|Overall Study|No longer meets eligibility criteria|0|||
129212133|NCT04323124|465077251|FG012|Overall Study|No longer meets eligibility criteria|0|||
129212134|NCT04323124|465077252|FG013|Overall Study|No longer meets eligibility criteria|1|||
129212135|NCT04323124|465077253|FG014|Overall Study|No longer meets eligibility criteria|1|||
129212136|NCT04323124|465077239|FG000|Overall Study|Study terminated by sponsor|0|||
129212137|NCT04323124|465077240|FG001|Overall Study|Study terminated by sponsor|0|||
129212138|NCT04323124|465077241|FG002|Overall Study|Study terminated by sponsor|0|||
129212139|NCT04323124|465077242|FG003|Overall Study|Study terminated by sponsor|0|||
129212140|NCT04323124|465077243|FG004|Overall Study|Study terminated by sponsor|0|||
129212141|NCT04323124|465077244|FG005|Overall Study|Study terminated by sponsor|0|||
129212142|NCT04323124|465077245|FG006|Overall Study|Study terminated by sponsor|0|||
129212143|NCT04323124|465077246|FG007|Overall Study|Study terminated by sponsor|0|||
129212144|NCT04323124|465077247|FG008|Overall Study|Study terminated by sponsor|0|||
128986911|NCT03110107|464241506|FG005|Treatment Period|Adverse Event|2|||
128986912|NCT03110107|464241507|FG006|Treatment Period|Adverse Event|0|||
128986913|NCT03110107|464241508|FG007|Treatment Period|Adverse Event|2|||
128986914|NCT03110107|464241509|FG008|Treatment Period|Adverse Event|0|||
129212145|NCT04323124|465077248|FG009|Overall Study|Study terminated by sponsor|0|||
128986915|NCT03110107|464241510|FG009|Treatment Period|Adverse Event|1|||
128986916|NCT03110107|464241511|FG010|Treatment Period|Adverse Event|0|||
128986917|NCT03110107|464241512|FG011|Treatment Period|Adverse Event|0|||
128986918|NCT03110107|464241513|FG012|Treatment Period|Adverse Event|0|||
128986919|NCT03110107|464241514|FG013|Treatment Period|Adverse Event|0|||
129212146|NCT04323124|465077249|FG010|Overall Study|Study terminated by sponsor|0|||
129212147|NCT04323124|465077250|FG011|Overall Study|Study terminated by sponsor|2|||
129212148|NCT04323124|465077251|FG012|Overall Study|Study terminated by sponsor|1|||
129212149|NCT04323124|465077252|FG013|Overall Study|Study terminated by sponsor|0|||
129212150|NCT04323124|465077253|FG014|Overall Study|Study terminated by sponsor|0|||
129212151|NCT00489307|465077254|FG000|Overall Study|Death|1|||
129212152|NCT00489307|465077255|FG001|Overall Study|Death|1|||
129212153|NCT00489307|465077254|FG000|Overall Study|Lost to Follow-up|2|||
129212154|NCT00489307|465077255|FG001|Overall Study|Lost to Follow-up|2|||
129212155|NCT00489307|465077254|FG000|Overall Study|Physician Decision|1|||
129212156|NCT00489307|465077255|FG001|Overall Study|Physician Decision|0|||
129212157|NCT00489307|465077254|FG000|Overall Study|Withdrawal by Subject|2|||
129212158|NCT00489307|465077255|FG001|Overall Study|Withdrawal by Subject|4|||
129212159|NCT00489307|465077254|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
129212160|NCT00489307|465077255|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
129212161|NCT00489307|465077254|FG000|Overall Study|Surgery after assignment|1|||
129212162|NCT00489307|465077255|FG001|Overall Study|Surgery after assignment|0|||
129212163|NCT00489307|465077254|FG000|Overall Study|Did not fill up the forms|2|||
129212164|NCT00489307|465077255|FG001|Overall Study|Did not fill up the forms|1|||
129212165|NCT00489307|465077254|FG000|Overall Study|Patient or family refusal|5|||
129212166|NCT00489307|465077255|FG001|Overall Study|Patient or family refusal|9|||
129212167|NCT03204188|465077258|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
129212168|NCT03204188|465077258|FG000|Immunotherapy Phase (1 Year)|Death|1|||
129212169|NCT03204188|465077258|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
129212170|NCT03204188|465077258|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
129212171|NCT01520506|465078599|FG000|Overall Study|Missed Visit|4|||
129212172|NCT01520506|465078599|FG000|Overall Study|Lost to Follow-up|1|||
129212173|NCT01520506|465078599|FG000|Overall Study|Withdrawal by Subject|1|||
129212174|NCT00425269|465078600|FG000|Overall Study|Pregnancy|5|||
129212175|NCT00425269|465078601|FG001|Overall Study|Pregnancy|7|||
129212176|NCT00425269|465078600|FG000|Overall Study|Lost to Follow-up|9|||
129212177|NCT00425269|465078601|FG001|Overall Study|Lost to Follow-up|9|||
129212178|NCT00425269|465078600|FG000|Overall Study|moved or medical reason|5|||
129212179|NCT00425269|465078601|FG001|Overall Study|moved or medical reason|4|||
129212180|NCT01084655|465078606|FG000|Overall Study|Radiographic disease progression|3|||
129212181|NCT01084655|465078607|FG001|Overall Study|Radiographic disease progression|2|||
129212182|NCT01084655|465078608|FG002|Overall Study|Radiographic disease progression|8|||
129212183|NCT01084655|465078606|FG000|Overall Study|Withdrawal by Subject|1|||
129212184|NCT01084655|465078607|FG001|Overall Study|Withdrawal by Subject|0|||
129212185|NCT01084655|465078608|FG002|Overall Study|Withdrawal by Subject|4|||
129212186|NCT01084655|465078606|FG000|Overall Study|Adverse Event|2|||
129212187|NCT01084655|465078607|FG001|Overall Study|Adverse Event|1|||
129212188|NCT01084655|465078608|FG002|Overall Study|Adverse Event|2|||
129212189|NCT01084655|465078606|FG000|Overall Study|Other|0|||
129212190|NCT01084655|465078607|FG001|Overall Study|Other|3|||
129212191|NCT01084655|465078608|FG002|Overall Study|Other|2|||
129212192|NCT01084655|465078606|FG000|Overall Study|Symptomatic deterioration|0|||
129212193|NCT01084655|465078607|FG001|Overall Study|Symptomatic deterioration|0|||
129212194|NCT01084655|465078608|FG002|Overall Study|Symptomatic deterioration|2|||
129212195|NCT01084655|465078606|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
129212196|NCT01084655|465078607|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
129212197|NCT01084655|465078608|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
129212198|NCT00535496|465078609|FG000|Overall Study|Lost to Follow-up|0|||
129212199|NCT00535496|465078610|FG001|Overall Study|Lost to Follow-up|1|||
129212200|NCT00535496|465078611|FG002|Overall Study|Lost to Follow-up|0|||
129212201|NCT00535496|465078612|FG003|Overall Study|Lost to Follow-up|0|||
129212202|NCT00535496|465078609|FG000|Overall Study|Not treated with sugammadex|0|||
129212203|NCT00535496|465078610|FG001|Overall Study|Not treated with sugammadex|1|||
129212204|NCT00535496|465078611|FG002|Overall Study|Not treated with sugammadex|0|||
129212205|NCT00535496|465078612|FG003|Overall Study|Not treated with sugammadex|0|||
129212206|NCT02326155|465078613|FG000|Overall Study|Adverse Event|21|||
129212207|NCT02326155|465078614|FG001|Overall Study|Adverse Event|5|||
129212208|NCT02326155|465078613|FG000|Overall Study|Death|3|||
129212209|NCT02326155|465078614|FG001|Overall Study|Death|0|||
129212210|NCT02326155|465078613|FG000|Overall Study|Lack of Efficacy|49|||
129212211|NCT02326155|465078614|FG001|Overall Study|Lack of Efficacy|5|||
129212212|NCT02326155|465078613|FG000|Overall Study|Lost to Follow-up|14|||
129212213|NCT02326155|465078614|FG001|Overall Study|Lost to Follow-up|3|||
129212214|NCT02326155|465078613|FG000|Overall Study|Protocol Violation|2|||
129212215|NCT02326155|465078614|FG001|Overall Study|Protocol Violation|0|||
129212216|NCT02326155|465078613|FG000|Overall Study|Withdrawal by Subject|34|||
129212217|NCT02326155|465078614|FG001|Overall Study|Withdrawal by Subject|11|||
128986920|NCT03110107|464241515|FG014|Treatment Period|Adverse Event|0|||
128986921|NCT03110107|464241516|FG015|Treatment Period|Adverse Event|2|||
129212218|NCT02326155|465078613|FG000|Overall Study|Disease progression|37|||
129212219|NCT02326155|465078614|FG001|Overall Study|Disease progression|4|||
129212220|NCT02326155|465078613|FG000|Overall Study|Study close|188|||
129212221|NCT02326155|465078614|FG001|Overall Study|Study close|21|||
129212222|NCT02326155|465078613|FG000|Overall Study|except for study close|46|||
129212223|NCT02326155|465078614|FG001|Overall Study|except for study close|13|||
129212224|NCT05024032|465078615|FG000|Overall Study|Withdrawal by Subject|0|||
129212225|NCT05024032|465078616|FG001|Overall Study|Withdrawal by Subject|3|||
129212226|NCT05024032|465078617|FG002|Overall Study|Withdrawal by Subject|4|||
129212227|NCT05024032|465078615|FG000|Overall Study|Adverse Event|0|||
129212228|NCT05024032|465078616|FG001|Overall Study|Adverse Event|1|||
129212229|NCT05024032|465078617|FG002|Overall Study|Adverse Event|0|||
129212230|NCT05024032|465078615|FG000|Overall Study|Protocol Deviation|1|||
129212231|NCT05024032|465078616|FG001|Overall Study|Protocol Deviation|0|||
129212232|NCT05024032|465078617|FG002|Overall Study|Protocol Deviation|0|||
129212233|NCT00371150|465078622|FG000|Overall Study|Lost to Follow-up|3|||
129212234|NCT00371150|465078623|FG001|Overall Study|Lost to Follow-up|2|||
129212235|NCT03714672|465078624|FG000|Overall Study|Adverse Event|0|||
129212236|NCT03714672|465078625|FG001|Overall Study|Adverse Event|0|||
129212237|NCT03714672|465078626|FG002|Overall Study|Adverse Event|3|||
129212238|NCT03714672|465078627|FG003|Overall Study|Adverse Event|0|||
129212239|NCT03714672|465078624|FG000|Overall Study|Physician Decision|0|||
129212240|NCT03714672|465078625|FG001|Overall Study|Physician Decision|1|||
129212241|NCT03714672|465078626|FG002|Overall Study|Physician Decision|0|||
129212242|NCT03714672|465078627|FG003|Overall Study|Physician Decision|0|||
129212243|NCT03714672|465078624|FG000|Overall Study|Other Reason|1|||
129212244|NCT03714672|465078625|FG001|Overall Study|Other Reason|2|||
129212245|NCT03714672|465078626|FG002|Overall Study|Other Reason|1|||
129212246|NCT03714672|465078627|FG003|Overall Study|Other Reason|1|||
129212247|NCT03714672|465078624|FG000|Overall Study|Lost to Follow-up|1|||
129212248|NCT03714672|465078625|FG001|Overall Study|Lost to Follow-up|1|||
129212249|NCT03714672|465078626|FG002|Overall Study|Lost to Follow-up|0|||
129212250|NCT03714672|465078627|FG003|Overall Study|Lost to Follow-up|0|||
129212251|NCT02345070|465078628|FG000|Overall Study|Adverse Event|12|||
129212252|NCT02345070|465078629|FG001|Overall Study|Adverse Event|8|||
129212253|NCT02345070|465078630|FG002|Overall Study|Adverse Event|16|||
129212254|NCT02345070|465078628|FG000|Overall Study|Poor compliance to protocol|2|||
129212255|NCT02345070|465078629|FG001|Overall Study|Poor compliance to protocol|0|||
129212256|NCT02345070|465078630|FG002|Overall Study|Poor compliance to protocol|0|||
129212257|NCT02345070|465078628|FG000|Overall Study|Other than specified above|6|||
129212258|NCT02345070|465078629|FG001|Overall Study|Other than specified above|3|||
129212259|NCT02345070|465078630|FG002|Overall Study|Other than specified above|7|||
129212260|NCT05101122|465078633|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
129212261|NCT05101122|465078633|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
129212262|NCT05101122|465078633|FG000|AD313 80/5|Withdrawal by Subject|1|||
129212263|NCT05101122|465078633|FG000|AD313 80/10|Physician Decision|1|||
129212264|NCT04945733|465078634|FG000|Overall Study|Physician Decision|1|||
129212265|NCT04945733|465078635|FG001|Overall Study|Physician Decision|3|||
129212266|NCT04945733|465078636|FG002|Overall Study|Physician Decision|0|||
129212267|NCT04945733|465078634|FG000|Overall Study|Withdrawal by Subject|3|||
129212268|NCT04945733|465078635|FG001|Overall Study|Withdrawal by Subject|3|||
129212269|NCT04945733|465078636|FG002|Overall Study|Withdrawal by Subject|0|||
129212270|NCT00886379|465078637|FG000|Overall Study|Transferred Schools|0|||
129212271|NCT00886379|465078638|FG001|Overall Study|Transferred Schools|0|||
129212272|NCT00886379|465078639|FG002|Overall Study|Transferred Schools|2|||
129212273|NCT00886379|465078640|FG003|Overall Study|Transferred Schools|1|||
129212274|NCT00886379|465078641|FG004|Overall Study|Transferred Schools|1|||
129212275|NCT00886379|465078637|FG000|Overall Study|Final blood draw not obtained|3|||
129212276|NCT00886379|465078638|FG001|Overall Study|Final blood draw not obtained|3|||
129212277|NCT00886379|465078639|FG002|Overall Study|Final blood draw not obtained|4|||
129212278|NCT00886379|465078640|FG003|Overall Study|Final blood draw not obtained|2|||
129212279|NCT00886379|465078641|FG004|Overall Study|Final blood draw not obtained|2|||
129212280|NCT04558125|465078642|FG000|Overall Study|Death|1|||
129212281|NCT03137381|465078643|FG000|Overall Study|Adverse Event|3|||
129212282|NCT03137381|465078644|FG001|Overall Study|Adverse Event|0|||
129212283|NCT03137381|465078645|FG002|Overall Study|Adverse Event|2|||
129212284|NCT03137381|465078646|FG003|Overall Study|Adverse Event|0|||
129212285|NCT03137381|465078643|FG000|Overall Study|Lost to Follow-up|2|||
129212286|NCT03137381|465078644|FG001|Overall Study|Lost to Follow-up|1|||
129212287|NCT03137381|465078645|FG002|Overall Study|Lost to Follow-up|1|||
129212288|NCT03137381|465078646|FG003|Overall Study|Lost to Follow-up|0|||
129212289|NCT03137381|465078643|FG000|Overall Study|Protocol deviation|1|||
129212290|NCT03137381|465078644|FG001|Overall Study|Protocol deviation|1|||
129212291|NCT03137381|465078645|FG002|Overall Study|Protocol deviation|0|||
129212292|NCT03137381|465078646|FG003|Overall Study|Protocol deviation|1|||
129212293|NCT03137381|465078643|FG000|Overall Study|Withdrawal by Investigator|0|||
129212294|NCT03137381|465078644|FG001|Overall Study|Withdrawal by Investigator|1|||
129212295|NCT03137381|465078645|FG002|Overall Study|Withdrawal by Investigator|1|||
129212296|NCT03137381|465078646|FG003|Overall Study|Withdrawal by Investigator|0|||
129212297|NCT03137381|465078643|FG000|Overall Study|Withdrawal by Subject|3|||
129212298|NCT03137381|465078644|FG001|Overall Study|Withdrawal by Subject|4|||
129212299|NCT03137381|465078645|FG002|Overall Study|Withdrawal by Subject|3|||
129212300|NCT03137381|465078646|FG003|Overall Study|Withdrawal by Subject|0|||
129212301|NCT03137381|465078643|FG000|Overall Study|Pregnancy|0|||
129212302|NCT03137381|465078644|FG001|Overall Study|Pregnancy|0|||
129212303|NCT03137381|465078645|FG002|Overall Study|Pregnancy|1|||
129212304|NCT03137381|465078646|FG003|Overall Study|Pregnancy|0|||
129212305|NCT01980017|465078651|FG000|Overall Study|Lost to Follow-up|30|||
129212306|NCT01980017|465078652|FG001|Overall Study|Lost to Follow-up|21|||
129212307|NCT01980017|465078651|FG000|Overall Study|Death|0|||
129212308|NCT01980017|465078652|FG001|Overall Study|Death|1|||
129212309|NCT00910650|465078653|FG000|Overall Study|Death|2|||
129212310|NCT03367793|465078654|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129212311|NCT03367793|465078655|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129212312|NCT03367793|465078656|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
129212313|NCT03367793|465078657|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129212314|NCT03367793|465078658|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129212315|NCT03367793|465078659|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129212316|NCT00423579|465078660|FG000|Overall Study|Lost to Follow-up|3|||
129212317|NCT00423579|465078661|FG001|Overall Study|Lost to Follow-up|0|||
129212318|NCT00423579|465078660|FG000|Overall Study|Protocol Violation|1|||
129212319|NCT00423579|465078661|FG001|Overall Study|Protocol Violation|3|||
129212320|NCT00423579|465078660|FG000|Overall Study|Diagnosis of diabetes|0|||
129212321|NCT00423579|465078661|FG001|Overall Study|Diagnosis of diabetes|1|||
129212322|NCT02224560|465078664|FG000|Overall Study|Protocol Deviation|1|||
129212323|NCT02224560|465078665|FG001|Overall Study|Protocol Deviation|0|||
129212324|NCT02224560|465078666|FG002|Overall Study|Protocol Deviation|0|||
129212325|NCT02224560|465078664|FG000|Overall Study|Withdrawal by Subject|2|||
129212326|NCT02224560|465078665|FG001|Overall Study|Withdrawal by Subject|0|||
129212327|NCT02224560|465078666|FG002|Overall Study|Withdrawal by Subject|1|||
129212328|NCT02224560|465078664|FG000|Overall Study|Met Withdrawal Criteria|1|||
129212329|NCT02224560|465078665|FG001|Overall Study|Met Withdrawal Criteria|0|||
129212330|NCT02224560|465078666|FG002|Overall Study|Met Withdrawal Criteria|0|||
129212331|NCT02224560|465078664|FG000|Overall Study|Adverse Event|4|||
129212332|NCT02224560|465078665|FG001|Overall Study|Adverse Event|1|||
129212333|NCT02224560|465078666|FG002|Overall Study|Adverse Event|1|||
129212334|NCT02224560|465078664|FG000|Overall Study|Withdrawn by Investigator|1|||
129212335|NCT02224560|465078665|FG001|Overall Study|Withdrawn by Investigator|1|||
129212336|NCT02224560|465078666|FG002|Overall Study|Withdrawn by Investigator|0|||
129212337|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
129212338|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
129212339|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
129212340|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
129212341|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
129212342|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
129212343|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
129212344|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
129212345|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
129212346|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
129212347|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
129212348|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
129212349|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
129212350|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
129212351|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
129212352|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
129212353|NCT03773978|465078670|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
129212354|NCT03773978|465078671|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
129212355|NCT03773978|465078670|FG000|DBW Period|Adverse Event|2|||
129212356|NCT03773978|465078671|FG001|DBW Period|Adverse Event|2|||
129212357|NCT03773978|465078670|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
129212358|NCT03773978|465078671|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
129212359|NCT03773978|465078670|FG000|DBW Period|Withdrawal by Subject|2|||
129212360|NCT03773978|465078671|FG001|DBW Period|Withdrawal by Subject|1|||
129212361|NCT03773978|465078670|FG000|DBW Period|Due to epidemic or pandemic|5|||
129212362|NCT03773978|465078671|FG001|DBW Period|Due to epidemic or pandemic|6|||
129212363|NCT03773978|465078670|FG000|DBW Period|Study team decision|1|||
129212364|NCT03773978|465078671|FG001|DBW Period|Study team decision|0|||
129212365|NCT01033019|465078675|FG000|Overall Study|Withdrawal by Subject|1|||
129212366|NCT01033019|465078676|FG001|Overall Study|Withdrawal by Subject|0|||
129212367|NCT03224819|465078679|FG000|Overall Study|Withdrawal by Subject|0|||
129212368|NCT03224819|465078680|FG001|Overall Study|Withdrawal by Subject|0|||
129212369|NCT03224819|465078681|FG002|Overall Study|Withdrawal by Subject|0|||
129212370|NCT03224819|465078682|FG003|Overall Study|Withdrawal by Subject|0|||
129212371|NCT03224819|465078683|FG004|Overall Study|Withdrawal by Subject|0|||
129212372|NCT03224819|465078684|FG005|Overall Study|Withdrawal by Subject|0|||
129212373|NCT03224819|465078685|FG006|Overall Study|Withdrawal by Subject|0|||
129212374|NCT03224819|465078686|FG007|Overall Study|Withdrawal by Subject|0|||
129212375|NCT03224819|465078687|FG008|Overall Study|Withdrawal by Subject|0|||
129212376|NCT03224819|465078688|FG009|Overall Study|Withdrawal by Subject|0|||
128986922|NCT03110107|464241517|FG016|Treatment Period|Adverse Event|0|||
128986923|NCT03110107|464241518|FG017|Treatment Period|Adverse Event|1|||
128986924|NCT03110107|464241519|FG018|Treatment Period|Adverse Event|2|||
128986925|NCT03110107|464241520|FG019|Treatment Period|Adverse Event|1|||
128986926|NCT03110107|464241521|FG020|Treatment Period|Adverse Event|4|||
128986927|NCT03110107|464241522|FG021|Treatment Period|Adverse Event|2|||
128986928|NCT03110107|464241523|FG022|Treatment Period|Adverse Event|2|||
128986929|NCT03110107|464241524|FG023|Treatment Period|Adverse Event|2|||
128986930|NCT03110107|464241525|FG024|Treatment Period|Adverse Event|2|||
128986931|NCT03110107|464241526|FG025|Treatment Period|Adverse Event|4|||
128986932|NCT03110107|464241501|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
128986933|NCT03110107|464241502|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
128986934|NCT03110107|464241503|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
128986935|NCT03110107|464241504|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
128986936|NCT03110107|464241505|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
128986937|NCT03110107|464241506|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
128986938|NCT03110107|464241507|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
128986939|NCT03110107|464241508|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
128986940|NCT03110107|464241509|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
128986941|NCT03110107|464241510|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
128986942|NCT03110107|464241511|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
128986943|NCT03110107|464241512|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
128986944|NCT03110107|464241513|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
128986945|NCT03110107|464241514|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
128986946|NCT03110107|464241515|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
128986947|NCT03110107|464241516|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
128986948|NCT03110107|464241517|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
128986949|NCT03110107|464241518|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
128986950|NCT03110107|464241519|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
128986951|NCT03110107|464241520|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
128986952|NCT03110107|464241521|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
128986953|NCT03110107|464241522|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
128986954|NCT03110107|464241523|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
128986955|NCT03110107|464241524|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
128986956|NCT03110107|464241525|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
128986957|NCT03110107|464241526|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
128986958|NCT03110107|464241501|FG000|Treatment Period|Participant withdrew consent|0|||
128986959|NCT03110107|464241502|FG001|Treatment Period|Participant withdrew consent|0|||
128986960|NCT03110107|464241503|FG002|Treatment Period|Participant withdrew consent|1|||
128986961|NCT03110107|464241504|FG003|Treatment Period|Participant withdrew consent|0|||
128986962|NCT03110107|464241505|FG004|Treatment Period|Participant withdrew consent|4|||
129212377|NCT03224819|465078689|FG010|Overall Study|Withdrawal by Subject|0|||
128876488|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
128876489|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
128876490|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
128876491|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
128876492|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
128876493|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
128876494|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
128876495|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
128876496|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
128876497|NCT01160289|463842347|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
128876498|NCT01160289|463842348|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
128876499|NCT01160289|463842349|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
128876500|NCT01160289|463842350|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
128876501|NCT01160289|463842351|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
128876502|NCT01160289|463842352|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
128876503|NCT01160289|463842347|FG000|Post-Randomization Period|Adverse Event|0|||
128876504|NCT01160289|463842348|FG001|Post-Randomization Period|Adverse Event|4|||
128876505|NCT01160289|463842349|FG002|Post-Randomization Period|Adverse Event|4|||
128876506|NCT01160289|463842350|FG003|Post-Randomization Period|Adverse Event|2|||
129212378|NCT03224819|465078690|FG011|Overall Study|Withdrawal by Subject|0|||
128986963|NCT03110107|464241506|FG005|Treatment Period|Participant withdrew consent|3|||
128986964|NCT03110107|464241507|FG006|Treatment Period|Participant withdrew consent|0|||
128986965|NCT03110107|464241508|FG007|Treatment Period|Participant withdrew consent|0|||
128986966|NCT03110107|464241509|FG008|Treatment Period|Participant withdrew consent|0|||
128986967|NCT03110107|464241510|FG009|Treatment Period|Participant withdrew consent|1|||
128986968|NCT03110107|464241511|FG010|Treatment Period|Participant withdrew consent|0|||
128986969|NCT03110107|464241512|FG011|Treatment Period|Participant withdrew consent|0|||
128986970|NCT03110107|464241513|FG012|Treatment Period|Participant withdrew consent|0|||
128986971|NCT03110107|464241514|FG013|Treatment Period|Participant withdrew consent|0|||
128986972|NCT03110107|464241515|FG014|Treatment Period|Participant withdrew consent|0|||
128986973|NCT03110107|464241516|FG015|Treatment Period|Participant withdrew consent|0|||
128986974|NCT03110107|464241517|FG016|Treatment Period|Participant withdrew consent|0|||
128986975|NCT03110107|464241518|FG017|Treatment Period|Participant withdrew consent|0|||
128986976|NCT03110107|464241519|FG018|Treatment Period|Participant withdrew consent|0|||
128986977|NCT03110107|464241520|FG019|Treatment Period|Participant withdrew consent|1|||
128986978|NCT03110107|464241521|FG020|Treatment Period|Participant withdrew consent|0|||
128986979|NCT03110107|464241522|FG021|Treatment Period|Participant withdrew consent|2|||
128986980|NCT03110107|464241523|FG022|Treatment Period|Participant withdrew consent|0|||
128986981|NCT03110107|464241524|FG023|Treatment Period|Participant withdrew consent|0|||
128986982|NCT03110107|464241525|FG024|Treatment Period|Participant withdrew consent|0|||
128986983|NCT03110107|464241526|FG025|Treatment Period|Participant withdrew consent|2|||
128986984|NCT03110107|464241501|FG000|Treatment Period|Participants no longer meets study criteria|0|||
128986985|NCT03110107|464241502|FG001|Treatment Period|Participants no longer meets study criteria|0|||
128986986|NCT03110107|464241503|FG002|Treatment Period|Participants no longer meets study criteria|0|||
128986987|NCT03110107|464241504|FG003|Treatment Period|Participants no longer meets study criteria|0|||
128986988|NCT03110107|464241505|FG004|Treatment Period|Participants no longer meets study criteria|0|||
128986989|NCT03110107|464241506|FG005|Treatment Period|Participants no longer meets study criteria|0|||
128986990|NCT03110107|464241507|FG006|Treatment Period|Participants no longer meets study criteria|0|||
128986991|NCT03110107|464241508|FG007|Treatment Period|Participants no longer meets study criteria|0|||
128986992|NCT03110107|464241509|FG008|Treatment Period|Participants no longer meets study criteria|0|||
128986993|NCT03110107|464241510|FG009|Treatment Period|Participants no longer meets study criteria|0|||
128986994|NCT03110107|464241511|FG010|Treatment Period|Participants no longer meets study criteria|0|||
128986995|NCT03110107|464241512|FG011|Treatment Period|Participants no longer meets study criteria|0|||
128986996|NCT03110107|464241513|FG012|Treatment Period|Participants no longer meets study criteria|0|||
128986997|NCT03110107|464241514|FG013|Treatment Period|Participants no longer meets study criteria|0|||
128986998|NCT03110107|464241515|FG014|Treatment Period|Participants no longer meets study criteria|0|||
128986999|NCT03110107|464241516|FG015|Treatment Period|Participants no longer meets study criteria|0|||
128987000|NCT03110107|464241517|FG016|Treatment Period|Participants no longer meets study criteria|0|||
128987001|NCT03110107|464241518|FG017|Treatment Period|Participants no longer meets study criteria|0|||
128987002|NCT03110107|464241519|FG018|Treatment Period|Participants no longer meets study criteria|0|||
128987003|NCT03110107|464241520|FG019|Treatment Period|Participants no longer meets study criteria|0|||
128987004|NCT03110107|464241521|FG020|Treatment Period|Participants no longer meets study criteria|0|||
128987005|NCT03110107|464241522|FG021|Treatment Period|Participants no longer meets study criteria|0|||
128987006|NCT03110107|464241523|FG022|Treatment Period|Participants no longer meets study criteria|0|||
128987007|NCT03110107|464241524|FG023|Treatment Period|Participants no longer meets study criteria|1|||
128987008|NCT03110107|464241525|FG024|Treatment Period|Participants no longer meets study criteria|0|||
128987009|NCT03110107|464241526|FG025|Treatment Period|Participants no longer meets study criteria|0|||
128987010|NCT03110107|464241501|FG000|Treatment Period|Other Reasons|0|||
128987011|NCT03110107|464241502|FG001|Treatment Period|Other Reasons|0|||
128987012|NCT03110107|464241503|FG002|Treatment Period|Other Reasons|1|||
128987013|NCT03110107|464241504|FG003|Treatment Period|Other Reasons|1|||
128987014|NCT03110107|464241505|FG004|Treatment Period|Other Reasons|0|||
128987015|NCT03110107|464241506|FG005|Treatment Period|Other Reasons|1|||
128987016|NCT03110107|464241507|FG006|Treatment Period|Other Reasons|0|||
128987017|NCT03110107|464241508|FG007|Treatment Period|Other Reasons|0|||
128987018|NCT03110107|464241509|FG008|Treatment Period|Other Reasons|0|||
128987019|NCT03110107|464241510|FG009|Treatment Period|Other Reasons|0|||
128987020|NCT03110107|464241511|FG010|Treatment Period|Other Reasons|0|||
128987021|NCT03110107|464241512|FG011|Treatment Period|Other Reasons|0|||
128987022|NCT03110107|464241513|FG012|Treatment Period|Other Reasons|0|||
128987023|NCT03110107|464241514|FG013|Treatment Period|Other Reasons|0|||
128987024|NCT03110107|464241515|FG014|Treatment Period|Other Reasons|0|||
128987025|NCT03110107|464241516|FG015|Treatment Period|Other Reasons|0|||
128987026|NCT03110107|464241517|FG016|Treatment Period|Other Reasons|0|||
128987027|NCT03110107|464241518|FG017|Treatment Period|Other Reasons|0|||
128987028|NCT03110107|464241519|FG018|Treatment Period|Other Reasons|0|||
128987029|NCT03110107|464241520|FG019|Treatment Period|Other Reasons|0|||
128763052|NCT01559454|463422692|FG000|Overall Study|Lack of Efficacy|0|||
128987030|NCT03110107|464241521|FG020|Treatment Period|Other Reasons|0|||
128987031|NCT03110107|464241522|FG021|Treatment Period|Other Reasons|0|||
128987032|NCT03110107|464241523|FG022|Treatment Period|Other Reasons|0|||
128987033|NCT03110107|464241524|FG023|Treatment Period|Other Reasons|0|||
128987034|NCT03110107|464241525|FG024|Treatment Period|Other Reasons|1|||
128987035|NCT03110107|464241526|FG025|Treatment Period|Other Reasons|0|||
128987036|NCT03586427|464241534|FG000|Overall Study|Lost to Follow-up|0|||
128987037|NCT03586427|464241535|FG001|Overall Study|Lost to Follow-up|3|||
128987038|NCT03586427|464241536|FG002|Overall Study|Lost to Follow-up|1|||
128987039|NCT03586427|464241537|FG003|Overall Study|Lost to Follow-up|3|||
128987040|NCT03586427|464241538|FG004|Overall Study|Lost to Follow-up|3|||
128987041|NCT03586427|464241534|FG000|Overall Study|Withdrawal by Subject|0|||
128987042|NCT03586427|464241535|FG001|Overall Study|Withdrawal by Subject|1|||
128987043|NCT03586427|464241536|FG002|Overall Study|Withdrawal by Subject|2|||
128987044|NCT03586427|464241537|FG003|Overall Study|Withdrawal by Subject|1|||
128987045|NCT03586427|464241538|FG004|Overall Study|Withdrawal by Subject|1|||
128987046|NCT03586427|464241534|FG000|Overall Study|Adverse Event|0|||
128987047|NCT03586427|464241535|FG001|Overall Study|Adverse Event|0|||
128987048|NCT03586427|464241536|FG002|Overall Study|Adverse Event|1|||
128987049|NCT03586427|464241537|FG003|Overall Study|Adverse Event|0|||
128987050|NCT03586427|464241538|FG004|Overall Study|Adverse Event|0|||
128987051|NCT03586427|464241534|FG000|Overall Study|Protocol Violation|0|||
128987052|NCT03586427|464241535|FG001|Overall Study|Protocol Violation|0|||
128987053|NCT03586427|464241536|FG002|Overall Study|Protocol Violation|1|||
128987054|NCT03586427|464241537|FG003|Overall Study|Protocol Violation|0|||
128987055|NCT03586427|464241538|FG004|Overall Study|Protocol Violation|1|||
128987056|NCT03586427|464241534|FG000|Overall Study|Noncompliance with study drug|0|||
128987057|NCT03586427|464241535|FG001|Overall Study|Noncompliance with study drug|0|||
128987058|NCT03586427|464241536|FG002|Overall Study|Noncompliance with study drug|1|||
128987059|NCT03586427|464241537|FG003|Overall Study|Noncompliance with study drug|0|||
128987060|NCT03586427|464241538|FG004|Overall Study|Noncompliance with study drug|0|||
128987061|NCT00494234|464241539|FG000|Overall Study|Withdrawal by Subject|1|||
128987062|NCT00494234|464241540|FG001|Overall Study|Withdrawal by Subject|0|||
128987063|NCT00494234|464241539|FG000|Overall Study|Disease progression|11|||
128987064|NCT00494234|464241540|FG001|Overall Study|Disease progression|8|||
128987065|NCT00494234|464241539|FG000|Overall Study|Death|2|||
128987066|NCT00494234|464241540|FG001|Overall Study|Death|1|||
128987067|NCT03193996|464241541|FG000|Overall Study|Withdrawal by Subject|4|||
128987068|NCT03193996|464241541|FG000|Overall Study|Lost to Follow-up|4|||
128987069|NCT03193996|464241541|FG000|Overall Study|Physician Decision|2|||
128987070|NCT03193996|464241541|FG000|Overall Study|Pregnancy|1|||
128987071|NCT03193996|464241541|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
128987072|NCT03193996|464241541|FG000|Overall Study|Complicating disease|1|||
128987073|NCT00423137|464241542|FG000|Overall Study|Lost to Follow-up|0|||
128987074|NCT00423137|464241543|FG001|Overall Study|Lost to Follow-up|0|||
128987075|NCT00423137|464241544|FG002|Overall Study|Lost to Follow-up|1|||
128987076|NCT00423137|464241545|FG003|Overall Study|Lost to Follow-up|0|||
128987077|NCT00423137|464241542|FG000|Overall Study|Protocol Violation|0|||
128987078|NCT00423137|464241543|FG001|Overall Study|Protocol Violation|0|||
128987079|NCT00423137|464241544|FG002|Overall Study|Protocol Violation|0|||
128987080|NCT00423137|464241545|FG003|Overall Study|Protocol Violation|1|||
129212379|NCT03224819|465078691|FG012|Overall Study|Withdrawal by Subject|1|||
129212380|NCT03224819|465078692|FG013|Overall Study|Withdrawal by Subject|0|||
129212381|NCT03224819|465078679|FG000|Overall Study|Sponsor Decision|0|||
129212382|NCT03224819|465078680|FG001|Overall Study|Sponsor Decision|0|||
129212383|NCT03224819|465078681|FG002|Overall Study|Sponsor Decision|0|||
129212384|NCT03224819|465078682|FG003|Overall Study|Sponsor Decision|1|||
129212385|NCT03224819|465078683|FG004|Overall Study|Sponsor Decision|1|||
129212386|NCT03224819|465078684|FG005|Overall Study|Sponsor Decision|2|||
129212387|NCT03224819|465078685|FG006|Overall Study|Sponsor Decision|1|||
129212388|NCT03224819|465078686|FG007|Overall Study|Sponsor Decision|1|||
129212389|NCT03224819|465078687|FG008|Overall Study|Sponsor Decision|1|||
129212390|NCT03224819|465078688|FG009|Overall Study|Sponsor Decision|2|||
129212391|NCT03224819|465078689|FG010|Overall Study|Sponsor Decision|1|||
129212392|NCT03224819|465078690|FG011|Overall Study|Sponsor Decision|1|||
129212393|NCT03224819|465078691|FG012|Overall Study|Sponsor Decision|1|||
129212394|NCT03224819|465078692|FG013|Overall Study|Sponsor Decision|0|||
129212395|NCT03224819|465078679|FG000|Overall Study|Lost to Follow-up|0|||
129212396|NCT03224819|465078680|FG001|Overall Study|Lost to Follow-up|0|||
129212397|NCT03224819|465078681|FG002|Overall Study|Lost to Follow-up|0|||
129212398|NCT03224819|465078682|FG003|Overall Study|Lost to Follow-up|0|||
129212399|NCT03224819|465078683|FG004|Overall Study|Lost to Follow-up|0|||
129212400|NCT03224819|465078684|FG005|Overall Study|Lost to Follow-up|0|||
128987081|NCT00423137|464241542|FG000|Overall Study|Adverse Event Study disease worse|1|||
128987082|NCT00423137|464241543|FG001|Overall Study|Adverse Event Study disease worse|0|||
128987083|NCT00423137|464241544|FG002|Overall Study|Adverse Event Study disease worse|3|||
128987084|NCT00423137|464241545|FG003|Overall Study|Adverse Event Study disease worse|1|||
128987085|NCT00423137|464241542|FG000|Overall Study|Adverse Event Other|0|||
129212401|NCT03224819|465078685|FG006|Overall Study|Lost to Follow-up|0|||
129212402|NCT03224819|465078686|FG007|Overall Study|Lost to Follow-up|0|||
129212403|NCT03224819|465078687|FG008|Overall Study|Lost to Follow-up|1|||
128987086|NCT00423137|464241543|FG001|Overall Study|Adverse Event Other|0|||
128987087|NCT00423137|464241544|FG002|Overall Study|Adverse Event Other|2|||
128987088|NCT00423137|464241545|FG003|Overall Study|Adverse Event Other|0|||
128987089|NCT00593385|464241547|FG000|Overall Study|Death|14|||
128987090|NCT00593385|464241547|FG000|Overall Study|Lost to Follow-up|17|||
128987091|NCT00593385|464241547|FG000|Overall Study|Withdrawal by Subject|9|||
128987092|NCT01471197|464241548|FG000|Overall Study|Disease Progression|4|||
128987093|NCT01471197|464241549|FG001|Overall Study|Disease Progression|2|||
128987094|NCT01471197|464241548|FG000|Overall Study|Death|1|||
128987095|NCT01471197|464241549|FG001|Overall Study|Death|0|||
128987096|NCT01471197|464241548|FG000|Overall Study|Study Drug Toxicity|1|||
128987097|NCT01471197|464241549|FG001|Overall Study|Study Drug Toxicity|0|||
128987098|NCT00924313|464241555|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
128987099|NCT01012609|464241556|FG000|Overall Study|Withdrawal by Subject|1|||
128987100|NCT01012609|464241557|FG001|Overall Study|Withdrawal by Subject|1|||
128987101|NCT03557775|464241558|FG000|Overall Study|Withdrawal by Subject|1|||
128987102|NCT03557775|464241559|FG001|Overall Study|Withdrawal by Subject|2|||
128987103|NCT03557775|464241560|FG002|Overall Study|Withdrawal by Subject|4|||
128987104|NCT03557775|464241558|FG000|Overall Study|Physician Decision|0|||
128987105|NCT03557775|464241559|FG001|Overall Study|Physician Decision|1|||
128987106|NCT03557775|464241560|FG002|Overall Study|Physician Decision|0|||
128987107|NCT00483119|464241561|FG000|Overall Study|Adverse Event|0|||
128987108|NCT00483119|464241562|FG001|Overall Study|Adverse Event|1|||
128987109|NCT00483119|464241561|FG000|Overall Study|Physician Decision|1|||
128987110|NCT00483119|464241562|FG001|Overall Study|Physician Decision|0|||
128987111|NCT03426995|464241563|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987112|NCT03426995|464241564|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987113|NCT03426995|464241565|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
128987114|NCT03426995|464241566|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987115|NCT03426995|464241567|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987116|NCT03426995|464241568|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987117|NCT03426995|464241569|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987118|NCT03426995|464241570|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987119|NCT03426995|464241571|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987120|NCT03426995|464241572|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987121|NCT03426995|464241573|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987122|NCT03426995|464241574|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987123|NCT03426995|464241575|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129212404|NCT03224819|465078688|FG009|Overall Study|Lost to Follow-up|0|||
129212405|NCT03224819|465078689|FG010|Overall Study|Lost to Follow-up|0|||
129212406|NCT03224819|465078690|FG011|Overall Study|Lost to Follow-up|0|||
129212407|NCT03224819|465078691|FG012|Overall Study|Lost to Follow-up|0|||
129212408|NCT03224819|465078692|FG013|Overall Study|Lost to Follow-up|0|||
129212409|NCT03224819|465078679|FG000|Overall Study|Death|0|||
129212410|NCT03224819|465078680|FG001|Overall Study|Death|1|||
129212411|NCT03224819|465078681|FG002|Overall Study|Death|0|||
129212412|NCT03224819|465078682|FG003|Overall Study|Death|0|||
129212413|NCT03224819|465078683|FG004|Overall Study|Death|0|||
129212414|NCT03224819|465078684|FG005|Overall Study|Death|0|||
129212415|NCT03224819|465078685|FG006|Overall Study|Death|0|||
129212416|NCT03224819|465078686|FG007|Overall Study|Death|1|||
129212417|NCT03224819|465078687|FG008|Overall Study|Death|0|||
129212418|NCT03224819|465078688|FG009|Overall Study|Death|0|||
129212419|NCT03224819|465078689|FG010|Overall Study|Death|0|||
129212420|NCT03224819|465078690|FG011|Overall Study|Death|1|||
129212421|NCT03224819|465078691|FG012|Overall Study|Death|0|||
129212422|NCT03224819|465078692|FG013|Overall Study|Death|0|||
129212423|NCT00651742|465078710|FG000|Overall Study|Objective Disease Progression|22|||
129212424|NCT00651742|465078710|FG000|Overall Study|Toxicity|3|||
129212425|NCT00651742|465078710|FG000|Overall Study|Investigator Judgment|1|||
129212426|NCT00651742|465078710|FG000|Overall Study|Withdrawal of Consent|1|||
128987124|NCT03426995|464241576|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987125|NCT03426995|464241577|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987126|NCT03426995|464241578|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987127|NCT03426995|464241579|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987128|NCT03426995|464241580|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129212427|NCT00651742|465078710|FG000|Overall Study|Enrolled but not treated|1|||
129212428|NCT04050553|465078711|FG000|Period 1|Physician Decision|2|||
129212429|NCT04050553|465078712|FG001|Period 1|Physician Decision|2|||
129212430|NCT04050553|465078711|FG000|Period 1|Adverse Event|1|||
128763053|NCT01559454|463422693|FG001|Overall Study|Lack of Efficacy|1|||
129212431|NCT04050553|465078712|FG001|Period 1|Adverse Event|1|||
129212432|NCT04050553|465078711|FG000|Period 1|Withdrawal by Subject|0|||
129212433|NCT04050553|465078712|FG001|Period 1|Withdrawal by Subject|1|||
129212434|NCT04050553|465078711|FG000|Wash-out|Adverse Event|0|||
128987129|NCT03426995|464241581|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
128987130|NCT03426995|464241563|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987131|NCT03426995|464241564|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987132|NCT03426995|464241565|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987133|NCT03426995|464241566|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987134|NCT03426995|464241567|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987135|NCT03426995|464241568|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
128987136|NCT03426995|464241569|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987137|NCT03426995|464241570|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987138|NCT03426995|464241571|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987139|NCT03426995|464241572|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987140|NCT03426995|464241573|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987141|NCT03426995|464241574|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987142|NCT03426995|464241575|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987143|NCT03426995|464241576|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987144|NCT03426995|464241577|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987145|NCT03426995|464241578|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987146|NCT03426995|464241579|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987147|NCT03426995|464241580|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987148|NCT03426995|464241581|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
128987149|NCT03426995|464241563|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987150|NCT03426995|464241564|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987151|NCT03426995|464241565|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987152|NCT03426995|464241566|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987153|NCT03426995|464241567|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
128987154|NCT03426995|464241568|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
128987155|NCT03426995|464241569|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987156|NCT03426995|464241570|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987157|NCT03426995|464241571|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987158|NCT03426995|464241572|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987159|NCT03426995|464241573|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987160|NCT03426995|464241574|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987161|NCT03426995|464241575|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987162|NCT03426995|464241576|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987163|NCT03426995|464241577|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987164|NCT03426995|464241578|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987165|NCT03426995|464241579|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987166|NCT03426995|464241580|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987167|NCT03426995|464241581|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
128987168|NCT03426995|464241563|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987169|NCT03426995|464241564|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987170|NCT03426995|464241565|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987171|NCT03426995|464241566|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987172|NCT03426995|464241567|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987173|NCT03426995|464241568|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987174|NCT03426995|464241569|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987175|NCT03426995|464241570|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987176|NCT03426995|464241571|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987177|NCT03426995|464241572|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987178|NCT03426995|464241573|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
128987179|NCT03426995|464241574|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987180|NCT03426995|464241575|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987181|NCT03426995|464241576|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987182|NCT03426995|464241577|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987183|NCT03426995|464241578|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987184|NCT03426995|464241579|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987185|NCT03426995|464241580|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987186|NCT03426995|464241581|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
128987187|NCT03426995|464241563|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987188|NCT03426995|464241564|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987189|NCT03426995|464241565|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987190|NCT03426995|464241566|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987191|NCT03426995|464241567|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987192|NCT03426995|464241568|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987193|NCT03426995|464241569|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987194|NCT03426995|464241570|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
128987195|NCT03426995|464241571|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987196|NCT03426995|464241572|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987197|NCT03426995|464241573|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987198|NCT03426995|464241574|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987199|NCT03426995|464241575|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987200|NCT03426995|464241576|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987201|NCT03426995|464241577|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987202|NCT03426995|464241578|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987203|NCT03426995|464241579|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987204|NCT03426995|464241580|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987205|NCT03426995|464241581|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
128987206|NCT03426995|464241563|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987207|NCT03426995|464241564|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987208|NCT03426995|464241565|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987209|NCT03426995|464241566|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987210|NCT03426995|464241567|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987211|NCT03426995|464241568|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987212|NCT03426995|464241569|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987213|NCT03426995|464241570|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987214|NCT03426995|464241571|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987215|NCT03426995|464241572|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987216|NCT03426995|464241573|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987217|NCT03426995|464241574|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987218|NCT03426995|464241575|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987219|NCT03426995|464241576|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987220|NCT03426995|464241577|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
128987221|NCT03426995|464241578|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
128987222|NCT03426995|464241579|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987223|NCT03426995|464241580|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987224|NCT03426995|464241581|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
128987225|NCT03426995|464241563|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987226|NCT03426995|464241564|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987227|NCT03426995|464241565|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987228|NCT03426995|464241566|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987229|NCT03426995|464241567|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987230|NCT03426995|464241568|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987231|NCT03426995|464241569|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987232|NCT03426995|464241570|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987233|NCT03426995|464241571|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987234|NCT03426995|464241572|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987235|NCT03426995|464241573|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987236|NCT03426995|464241574|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987237|NCT03426995|464241575|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987238|NCT03426995|464241576|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987239|NCT03426995|464241577|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
128987240|NCT03426995|464241578|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
128987241|NCT03426995|464241579|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987242|NCT03426995|464241580|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987243|NCT03426995|464241581|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
128987244|NCT05939388|464241582|FG000|Overall Study|Lost to Follow-up|1|||
128987245|NCT00602667|464241583|FG000|Overall Study|Still on Therapy|0|||
128987246|NCT00602667|464241584|FG001|Overall Study|Still on Therapy|2|||
128987247|NCT00602667|464241585|FG002|Overall Study|Still on Therapy|2|||
128987248|NCT00602667|464241583|FG000|Overall Study|Death|0|||
128987249|NCT00602667|464241584|FG001|Overall Study|Death|1|||
128987250|NCT00602667|464241585|FG002|Overall Study|Death|1|||
128987251|NCT00602667|464241583|FG000|Overall Study|Family request|3|||
128987252|NCT00602667|464241584|FG001|Overall Study|Family request|25|||
128987253|NCT00602667|464241585|FG002|Overall Study|Family request|6|||
128987254|NCT00602667|464241583|FG000|Overall Study|Excessive toxicity|1|||
128987255|NCT00602667|464241584|FG001|Overall Study|Excessive toxicity|1|||
128987256|NCT00602667|464241585|FG002|Overall Study|Excessive toxicity|0|||
128987257|NCT00602667|464241583|FG000|Overall Study|Second malignancy|0|||
128987258|NCT00602667|464241584|FG001|Overall Study|Second malignancy|1|||
128987259|NCT00602667|464241585|FG002|Overall Study|Second malignancy|0|||
128987260|NCT00602667|464241583|FG000|Overall Study|Physician Decision|2|||
129212435|NCT04050553|465078712|FG001|Wash-out|Adverse Event|1|||
129212436|NCT04050553|465078711|FG000|Wash-out|Withdrawal by Subject|0|||
129212437|NCT04050553|465078712|FG001|Wash-out|Withdrawal by Subject|1|||
129212438|NCT01535040|465078713|FG000|Overall Study|Physician Decision|0|||
128987261|NCT00602667|464241584|FG001|Overall Study|Physician Decision|3|||
128987262|NCT00602667|464241585|FG002|Overall Study|Physician Decision|8|||
128987263|NCT00602667|464241583|FG000|Overall Study|Progressive disease|13|||
128987264|NCT00602667|464241584|FG001|Overall Study|Progressive disease|48|||
128987265|NCT00602667|464241585|FG002|Overall Study|Progressive disease|45|||
128987266|NCT00602667|464241583|FG000|Overall Study|Progressive disease prior to therapy|0|||
128987267|NCT00602667|464241584|FG001|Overall Study|Progressive disease prior to therapy|0|||
128987268|NCT00602667|464241585|FG002|Overall Study|Progressive disease prior to therapy|1|||
128987269|NCT04410978|464241591|FG000|Overall Study|Poor compliance to protocol|2|||
128987270|NCT04410978|464241592|FG001|Overall Study|Poor compliance to protocol|4|||
128987271|NCT04410978|464241591|FG000|Overall Study|Withdrawal by Subject|64|||
128987272|NCT04410978|464241592|FG001|Overall Study|Withdrawal by Subject|66|||
128987273|NCT04410978|464241591|FG000|Overall Study|Other|6|||
128987274|NCT04410978|464241592|FG001|Overall Study|Other|7|||
128987275|NCT04410978|464241591|FG000|Overall Study|Missing study status|1|||
128987276|NCT04410978|464241592|FG001|Overall Study|Missing study status|0|||
128987277|NCT00885677|464241599|FG000|Overall Study|Death|40|||
128987278|NCT00885677|464241600|FG001|Overall Study|Death|34|||
128987279|NCT00885677|464241599|FG000|Overall Study|Lost to Follow-up|15|||
128987280|NCT00885677|464241600|FG001|Overall Study|Lost to Follow-up|13|||
128987281|NCT00885677|464241599|FG000|Overall Study|Protocol Violation|54|||
128987282|NCT00885677|464241600|FG001|Overall Study|Protocol Violation|54|||
128987283|NCT00885677|464241599|FG000|Overall Study|premature study closure|41|||
128987284|NCT00885677|464241600|FG001|Overall Study|premature study closure|44|||
128987285|NCT00885677|464241599|FG000|Overall Study|device/lead revision or replacement|7|||
128987286|NCT00885677|464241600|FG001|Overall Study|device/lead revision or replacement|6|||
128987287|NCT00885677|464241599|FG000|Overall Study|Heart transplantation|1|||
128987288|NCT00885677|464241600|FG001|Overall Study|Heart transplantation|0|||
128987289|NCT00885677|464241599|FG000|Overall Study|Inclusion/exclusion not met|25|||
128987290|NCT00885677|464241600|FG001|Overall Study|Inclusion/exclusion not met|27|||
128987291|NCT00972309|464241601|FG000|Overall Study|Switched to alternative treatment|0|||
128987292|NCT00972309|464241602|FG001|Overall Study|Switched to alternative treatment|2|||
128987293|NCT00972309|464241601|FG000|Overall Study|Refused further treatment|0|||
128987294|NCT00972309|464241602|FG001|Overall Study|Refused further treatment|1|||
128987295|NCT00972309|464241601|FG000|Overall Study|Late determination of ineligibility|0|||
128987296|NCT00972309|464241602|FG001|Overall Study|Late determination of ineligibility|1|||
128987297|NCT00972309|464241601|FG000|Overall Study|Second malignancy|1|||
128987298|NCT00972309|464241602|FG001|Overall Study|Second malignancy|1|||
128987299|NCT00972309|464241601|FG000|Overall Study|Visa issues|0|||
128987300|NCT00972309|464241602|FG001|Overall Study|Visa issues|1|||
128987301|NCT00972309|464241601|FG000|Overall Study|Secondary cancer (SCC)|0|||
128987302|NCT00972309|464241602|FG001|Overall Study|Secondary cancer (SCC)|1|||
128987303|NCT00972309|464241601|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
128987304|NCT00972309|464241602|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
128987305|NCT00972309|464241601|FG000|Overall Study|Lost to Follow-up|1|||
128987306|NCT00972309|464241602|FG001|Overall Study|Lost to Follow-up|1|||
128987307|NCT00972309|464241601|FG000|Overall Study|Disease progression on study|10|||
128987308|NCT00972309|464241602|FG001|Overall Study|Disease progression on study|4|||
128987309|NCT00948896|464241603|FG000|Randomization to 24 Months of Age|Death|1|||
128987310|NCT00948896|464241604|FG001|Randomization to 24 Months of Age|Death|0|||
128987311|NCT00948896|464241605|FG002|Randomization to 24 Months of Age|Death|0|||
128987312|NCT00948896|464241606|FG003|Randomization to 24 Months of Age|Death|0|||
128987313|NCT00948896|464241607|FG004|Randomization to 24 Months of Age|Death|2|||
128987314|NCT00948896|464241608|FG005|Randomization to 24 Months of Age|Death|1|||
128987315|NCT00948896|464241609|FG006|Randomization to 24 Months of Age|Death|2|||
128987316|NCT00948896|464241610|FG007|Randomization to 24 Months of Age|Death|1|||
128987317|NCT00948896|464241603|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
129212439|NCT01535040|465078714|FG001|Overall Study|Physician Decision|1|||
129212440|NCT01535040|465078713|FG000|Overall Study|Withdrawal by Subject|13|||
128987318|NCT00948896|464241604|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
128987319|NCT00948896|464241605|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
129212441|NCT01535040|465078714|FG001|Overall Study|Withdrawal by Subject|10|||
128987320|NCT00948896|464241606|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
128987321|NCT00948896|464241607|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
129212442|NCT01535040|465078713|FG000|Overall Study|Never Started|9|||
129212443|NCT01535040|465078714|FG001|Overall Study|Never Started|4|||
129212444|NCT01535040|465078713|FG000|Overall Study|Toxicity|7|||
128987322|NCT00948896|464241608|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
128987323|NCT00948896|464241609|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
128987324|NCT00948896|464241610|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
129212445|NCT01535040|465078714|FG001|Overall Study|Toxicity|5|||
129212446|NCT01535040|465078713|FG000|Overall Study|Multiple Reasons|1|||
129212447|NCT01535040|465078714|FG001|Overall Study|Multiple Reasons|1|||
129212448|NCT01074970|465078716|FG000|Overall Study|Never Treated|0|||
129212449|NCT01074970|465078717|FG001|Overall Study|Never Treated|0|||
129212450|NCT01074970|465078718|FG002|Overall Study|Never Treated|8|||
129212451|NCT01074970|465078719|FG003|Overall Study|Never Treated|1|||
129212452|NCT01074970|465078716|FG000|Overall Study|Adverse Event|1|||
129212453|NCT01074970|465078717|FG001|Overall Study|Adverse Event|0|||
129212454|NCT01074970|465078718|FG002|Overall Study|Adverse Event|4|||
129212455|NCT01074970|465078719|FG003|Overall Study|Adverse Event|3|||
129212456|NCT01074970|465078716|FG000|Overall Study|Disease progression during treatment|3|||
129212457|NCT01074970|465078717|FG001|Overall Study|Disease progression during treatment|1|||
129212458|NCT01074970|465078718|FG002|Overall Study|Disease progression during treatment|2|||
129212459|NCT01074970|465078719|FG003|Overall Study|Disease progression during treatment|9|||
129212460|NCT01074970|465078716|FG000|Overall Study|Lost to Follow-up|0|||
129212461|NCT01074970|465078717|FG001|Overall Study|Lost to Follow-up|0|||
129212462|NCT01074970|465078718|FG002|Overall Study|Lost to Follow-up|1|||
129212463|NCT01074970|465078719|FG003|Overall Study|Lost to Follow-up|0|||
129212464|NCT01074970|465078716|FG000|Overall Study|Withdrawal by Subject|0|||
129212465|NCT01074970|465078717|FG001|Overall Study|Withdrawal by Subject|0|||
129212466|NCT01074970|465078718|FG002|Overall Study|Withdrawal by Subject|6|||
129212467|NCT01074970|465078719|FG003|Overall Study|Withdrawal by Subject|4|||
129212468|NCT05430854|465078720|FG000|Overall Study|Trial terminated by Sponsor|39|||
129212469|NCT05430854|465078721|FG001|Overall Study|Trial terminated by Sponsor|50|||
129212470|NCT05430854|465078722|FG002|Overall Study|Trial terminated by Sponsor|46|||
129212471|NCT05430854|465078720|FG000|Overall Study|Withdrawal by Subject|0|||
129212472|NCT05430854|465078721|FG001|Overall Study|Withdrawal by Subject|3|||
129212473|NCT05430854|465078722|FG002|Overall Study|Withdrawal by Subject|0|||
129212474|NCT00734149|465078723|FG000|Overall Study|Withdrawal by Subject|1|||
129212475|NCT04314284|465078724|FG000|Overall Study|Withdrawal by Subject|4|||
129212476|NCT04314284|465078725|FG001|Overall Study|Withdrawal by Subject|7|||
129212477|NCT04314284|465078724|FG000|Overall Study|Consented but did not complete survey|0|||
129212478|NCT04314284|465078725|FG001|Overall Study|Consented but did not complete survey|6|||
129212479|NCT01652235|465078728|FG000|Overall Study|Death|9|||
129212480|NCT01652235|465078728|FG000|Overall Study|Lost to Follow-up|5|||
129212481|NCT01652235|465078728|FG000|Overall Study|Withdrawal by Subject|2|||
129212482|NCT02023086|465078731|FG000|Overall Study|Withdrawal by Subject|2|||
129212483|NCT02023086|465078732|FG001|Overall Study|Withdrawal by Subject|0|||
129212484|NCT03472885|465078733|FG000|24-Week Treatment Period|Adverse Event|1|||
129212485|NCT02201953|465078734|FG000|Overall Study|Randomized but Never Treated|1|||
129212486|NCT02201953|465078735|FG001|Overall Study|Randomized but Never Treated|5|||
129212487|NCT02201953|465078734|FG000|Overall Study|Lack of Efficacy|9|||
129212488|NCT02201953|465078735|FG001|Overall Study|Lack of Efficacy|30|||
129212489|NCT02201953|465078734|FG000|Overall Study|Lost to Follow-up|8|||
129212490|NCT02201953|465078735|FG001|Overall Study|Lost to Follow-up|8|||
129212491|NCT02201953|465078734|FG000|Overall Study|Withdrew Consent|2|||
129212492|NCT02201953|465078735|FG001|Overall Study|Withdrew Consent|5|||
129212493|NCT02201953|465078734|FG000|Overall Study|Adverse Event|0|||
128876507|NCT01160289|463842351|FG004|Post-Randomization Period|Adverse Event|0|||
128876508|NCT01160289|463842352|FG005|Post-Randomization Period|Adverse Event|0|||
129212494|NCT02201953|465078735|FG001|Overall Study|Adverse Event|5|||
129212495|NCT02201953|465078734|FG000|Overall Study|Death|0|||
129212496|NCT02201953|465078735|FG001|Overall Study|Death|3|||
129212497|NCT02638220|465078736|FG000|Overall Study|Lost to Follow-up|6|||
129212498|NCT02638220|465078736|FG000|Overall Study|Withdrawal by Subject|3|||
129212499|NCT02638220|465078736|FG000|Overall Study|Physician Decision|1|||
129212500|NCT02638220|465078736|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
129212501|NCT01615939|465079880|FG000|Overall Study|Lost to Follow-up|5|||
129212502|NCT01615939|465079881|FG001|Overall Study|Lost to Follow-up|0|||
129212503|NCT02892344|465079885|FG000|Overall Study|Protocol deviation|3|||
129212504|NCT02892344|465079886|FG001|Overall Study|Protocol deviation|4|||
129212505|NCT02892344|465079885|FG000|Overall Study|Adverse Event|1|||
129212506|NCT02892344|465079886|FG001|Overall Study|Adverse Event|8|||
129212507|NCT02892344|465079885|FG000|Overall Study|Lost to Follow-up|0|||
129212508|NCT02892344|465079886|FG001|Overall Study|Lost to Follow-up|1|||
129212509|NCT02892344|465079885|FG000|Overall Study|Non-compliance with study treatment|0|||
129212510|NCT02892344|465079886|FG001|Overall Study|Non-compliance with study treatment|1|||
129212511|NCT02892344|465079885|FG000|Overall Study|Physician Decision|0|||
129212512|NCT02892344|465079886|FG001|Overall Study|Physician Decision|2|||
129212513|NCT02892344|465079885|FG000|Overall Study|Subject/guardian decision|0|||
129212514|NCT02892344|465079886|FG001|Overall Study|Subject/guardian decision|4|||
129212515|NCT02892344|465079885|FG000|Overall Study|Technical problems|0|||
129212516|NCT02892344|465079886|FG001|Overall Study|Technical problems|1|||
129212517|NCT03591406|465079888|FG000|Overall Study|Adverse Event|5|||
129212518|NCT03591406|465079889|FG001|Overall Study|Adverse Event|3|||
129212519|NCT03591406|465079888|FG000|Overall Study|Protocol Violation|2|||
128876509|NCT01160289|463842347|FG000|Post-Randomization Period|Death|0|||
129212520|NCT03591406|465079889|FG001|Overall Study|Protocol Violation|1|||
129212521|NCT03591406|465079888|FG000|Overall Study|Withdrawal by Subject|0|||
129212522|NCT03591406|465079889|FG001|Overall Study|Withdrawal by Subject|5|||
129212523|NCT02066181|465079890|FG000|Overall Study|Withdrawal by Subject|1|||
129212524|NCT02066181|465079891|FG001|Overall Study|Withdrawal by Subject|1|||
129212525|NCT01083771|465079892|FG000|Overall Study|non-compliant|2|||
129212526|NCT01083771|465079892|FG000|Overall Study|Withdrawal by Subject|3|||
129212527|NCT00939393|465079895|FG000|Overall Study|Withdrawal by Subject|1|||
129212528|NCT00939393|465079896|FG001|Overall Study|Withdrawal by Subject|0|||
129212529|NCT00939393|465079895|FG000|Overall Study|Lost to Follow-up|3|||
129212530|NCT00939393|465079896|FG001|Overall Study|Lost to Follow-up|0|||
129212531|NCT02851615|465079897|FG000|Overall Study|Cognitive Issue|1|||
129212532|NCT02851615|465079898|FG001|Overall Study|Cognitive Issue|0|||
129212533|NCT02851615|465079897|FG000|Overall Study|Lost to Follow-up|0|||
129212534|NCT02851615|465079898|FG001|Overall Study|Lost to Follow-up|4|||
129212535|NCT01747876|465079908|FG000|Overall Study|Adverse Event|1|||
129212536|NCT01747876|465079909|FG001|Overall Study|Adverse Event|0|||
129212537|NCT01747876|465079910|FG002|Overall Study|Adverse Event|2|||
129212538|NCT01747876|465079908|FG000|Overall Study|Withdrawal by Subject|0|||
129212539|NCT01747876|465079909|FG001|Overall Study|Withdrawal by Subject|1|||
129212540|NCT01747876|465079910|FG002|Overall Study|Withdrawal by Subject|1|||
129212541|NCT01747876|465079908|FG000|Overall Study|Disease progression|4|||
129212542|NCT01747876|465079909|FG001|Overall Study|Disease progression|13|||
129212543|NCT01747876|465079910|FG002|Overall Study|Disease progression|8|||
129212544|NCT01747876|465079908|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
129212545|NCT01747876|465079909|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
129212546|NCT01747876|465079910|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
129212547|NCT02379728|465079913|FG000|Overall Study|Lost to Follow-up|1|||
129212548|NCT02379728|465079914|FG001|Overall Study|Lost to Follow-up|0|||
129212549|NCT02379728|465079915|FG002|Overall Study|Lost to Follow-up|3|||
129212550|NCT02379728|465079916|FG003|Overall Study|Lost to Follow-up|0|||
129212551|NCT02379728|465079913|FG000|Overall Study|Withdrawal by Subject|5|||
129212552|NCT02379728|465079914|FG001|Overall Study|Withdrawal by Subject|0|||
129212553|NCT02379728|465079915|FG002|Overall Study|Withdrawal by Subject|5|||
129212554|NCT02379728|465079916|FG003|Overall Study|Withdrawal by Subject|3|||
129212555|NCT02379728|465079913|FG000|Overall Study|Protocol Violation|0|||
129212556|NCT02379728|465079914|FG001|Overall Study|Protocol Violation|0|||
129212557|NCT02379728|465079915|FG002|Overall Study|Protocol Violation|2|||
129212558|NCT02379728|465079916|FG003|Overall Study|Protocol Violation|0|||
129212559|NCT03131219|465079918|FG000|Initial Evaluation Period|Adverse Event|2|||
129212560|NCT03131219|465079919|FG001|Initial Evaluation Period|Adverse Event|0|||
129212561|NCT03131219|465079918|FG000|Initial Evaluation Period|Protocol Violation|1|||
129212562|NCT03131219|465079919|FG001|Initial Evaluation Period|Protocol Violation|0|||
129212563|NCT03131219|465079918|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
129212564|NCT03131219|465079919|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
129212565|NCT03131219|465079918|FG000|Initial Evaluation Period|Physician Decision|1|||
129212566|NCT03131219|465079919|FG001|Initial Evaluation Period|Physician Decision|0|||
129212567|NCT03131219|465079918|FG000|Extension Period|Physician Decision|1|||
129212568|NCT03131219|465079919|FG001|Extension Period|Physician Decision|0|||
129212569|NCT01391546|465079923|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
129212570|NCT01391546|465079924|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
129212571|NCT05660577|465079927|FG000|Overall Study|Discontinued|9|||
129212572|NCT03363841|465079930|FG000|Overall Study|Adverse Event|1|||
129212573|NCT03363841|465079930|FG000|Overall Study|Withdrawal by Subject|1|||
129212574|NCT03363841|465079930|FG000|Overall Study|Death|7|||
129212575|NCT03363841|465079930|FG000|Overall Study|Physician Decision|1|||
129212576|NCT02156076|465079931|FG000|Treatment Period|no longer meets study criteria|0|||
129212577|NCT02156076|465079932|FG001|Treatment Period|no longer meets study criteria|0|||
129212578|NCT02156076|465079933|FG002|Treatment Period|no longer meets study criteria|1|||
129212579|NCT02156076|465079934|FG003|Treatment Period|no longer meets study criteria|0|||
129212580|NCT02156076|465079931|FG000|Treatment Period|Poor/non-compliance|0|||
129212581|NCT02156076|465079932|FG001|Treatment Period|Poor/non-compliance|1|||
129212582|NCT02156076|465079933|FG002|Treatment Period|Poor/non-compliance|0|||
129212583|NCT02156076|465079934|FG003|Treatment Period|Poor/non-compliance|0|||
129212584|NCT02156076|465079931|FG000|Treatment Period|Lost to Follow-up|0|||
129212585|NCT02156076|465079932|FG001|Treatment Period|Lost to Follow-up|0|||
129212586|NCT02156076|465079933|FG002|Treatment Period|Lost to Follow-up|0|||
129212587|NCT02156076|465079934|FG003|Treatment Period|Lost to Follow-up|1|||
129212588|NCT02156076|465079931|FG000|Treatment Period|Withdrawal by Subject|0|||
129212589|NCT02156076|465079932|FG001|Treatment Period|Withdrawal by Subject|0|||
129212590|NCT02156076|465079933|FG002|Treatment Period|Withdrawal by Subject|1|||
129212591|NCT02156076|465079934|FG003|Treatment Period|Withdrawal by Subject|0|||
129212592|NCT02156076|465079931|FG000|Treatment Period|Subject request to discontinue treatment|0|||
129212593|NCT02156076|465079932|FG001|Treatment Period|Subject request to discontinue treatment|1|||
129212594|NCT02156076|465079933|FG002|Treatment Period|Subject request to discontinue treatment|0|||
129212595|NCT02156076|465079934|FG003|Treatment Period|Subject request to discontinue treatment|0|||
129212596|NCT02156076|465079931|FG000|Treatment Period|Adverse Event|0|||
129212597|NCT02156076|465079932|FG001|Treatment Period|Adverse Event|0|||
129212598|NCT02156076|465079933|FG002|Treatment Period|Adverse Event|0|||
128987325|NCT00948896|464241603|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
128987326|NCT00948896|464241604|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
128987327|NCT00948896|464241605|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
128987328|NCT00948896|464241606|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
128987329|NCT00948896|464241607|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
128987330|NCT00948896|464241608|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
129212599|NCT02156076|465079934|FG003|Treatment Period|Adverse Event|1|||
129212600|NCT02156076|465079931|FG000|Follow-up Period|Withdrawal by Subject|1|||
129212601|NCT02156076|465079932|FG001|Follow-up Period|Withdrawal by Subject|0|||
129212602|NCT02156076|465079933|FG002|Follow-up Period|Withdrawal by Subject|0|||
129212603|NCT02156076|465079934|FG003|Follow-up Period|Withdrawal by Subject|0|||
129212604|NCT00003475|465079937|FG000|Overall Study|Not evaluable|13|||
129212605|NCT00106704|465079938|FG000|Overall Study|Adverse Event|10|||
129212606|NCT00106704|465079939|FG001|Overall Study|Adverse Event|7|||
129212607|NCT00106704|465079938|FG000|Overall Study|Death|2|||
129212608|NCT00106704|465079939|FG001|Overall Study|Death|1|||
129212609|NCT00106704|465079938|FG000|Overall Study|Lack of Efficacy|67|||
129212610|NCT00106704|465079939|FG001|Overall Study|Lack of Efficacy|69|||
129212611|NCT00106704|465079938|FG000|Overall Study|Lost to Follow-up|7|||
129212612|NCT00106704|465079939|FG001|Overall Study|Lost to Follow-up|3|||
129212613|NCT00106704|465079938|FG000|Overall Study|Pregnancy|1|||
129212614|NCT00106704|465079939|FG001|Overall Study|Pregnancy|0|||
129212615|NCT00106704|465079938|FG000|Overall Study|Protocol Violation|4|||
129212616|NCT00106704|465079939|FG001|Overall Study|Protocol Violation|7|||
129212617|NCT00106704|465079938|FG000|Overall Study|Withdrawal by Subject|14|||
129212618|NCT00106704|465079939|FG001|Overall Study|Withdrawal by Subject|21|||
129212619|NCT00106704|465079938|FG000|Overall Study|Patient moved|1|||
129212620|NCT00106704|465079939|FG001|Overall Study|Patient moved|0|||
129212621|NCT00106704|465079938|FG000|Overall Study|Site terminated|0|||
129212622|NCT00106704|465079939|FG001|Overall Study|Site terminated|1|||
129212623|NCT00106704|465079938|FG000|Overall Study|Planned major surgery|1|||
129212624|NCT00106704|465079939|FG001|Overall Study|Planned major surgery|0|||
129212625|NCT00106704|465079938|FG000|Overall Study|Patient Received Glycemic Medication|22|||
129212626|NCT00106704|465079939|FG001|Overall Study|Patient Received Glycemic Medication|41|||
129212627|NCT00106704|465079938|FG000|Overall Study|Unable to re-enter US|1|||
129212628|NCT00106704|465079939|FG001|Overall Study|Unable to re-enter US|0|||
129212629|NCT00106704|465079938|FG000|Overall Study|Laboratory test|1|||
129212630|NCT00106704|465079939|FG001|Overall Study|Laboratory test|1|||
129212631|NCT01498068|465079945|FG000|Overall Study|Withdrawal by Subject|1|||
129212632|NCT01498068|465079946|FG001|Overall Study|Withdrawal by Subject|1|||
129212633|NCT01353898|465079948|FG000|Overall Study|Study site terminated|0|||
129212634|NCT01353898|465079949|FG001|Overall Study|Study site terminated|0|||
129212635|NCT01353898|465079950|FG002|Overall Study|Study site terminated|0|||
129212636|NCT01353898|465079951|FG003|Overall Study|Study site terminated|0|||
129212637|NCT01353898|465079952|FG004|Overall Study|Study site terminated|0|||
129212638|NCT01353898|465079953|FG005|Overall Study|Study site terminated|1|||
129212639|NCT03558737|465079954|FG000|Overall Study|Death|1|||
129212640|NCT03558737|465079955|FG001|Overall Study|Death|1|||
129212641|NCT01318915|465079956|FG000|Overall Study|Lost to Follow-up|1|||
129212642|NCT00453206|465079958|FG000|Overall Study|Death|1|||
129212643|NCT05386329|465079959|FG000|Overall Study|Lost to Follow-up|3|||
129212644|NCT03041181|465079961|FG000|Overall Study|Disease Progression|1|||
129212645|NCT03041181|465079962|FG001|Overall Study|Disease Progression|2|||
129212646|NCT03104868|465079963|FG000|6 Week Follow up|Lost to Follow-up|5|||
129212647|NCT03104868|465079964|FG001|6 Week Follow up|Lost to Follow-up|8|||
129212648|NCT03104868|465079963|FG000|6 Week Follow up|Death|1|||
129212649|NCT03104868|465079964|FG001|6 Week Follow up|Death|1|||
129212650|NCT03104868|465079963|FG000|6 Week Follow up|Withdrawal by Subject|7|||
129212651|NCT03104868|465079964|FG001|6 Week Follow up|Withdrawal by Subject|6|||
129212652|NCT03104868|465079963|FG000|6 Week Follow up|Completed Later Timepoint|24|||
129212653|NCT03104868|465079964|FG001|6 Week Follow up|Completed Later Timepoint|22|||
129212654|NCT03104868|465079963|FG000|6 Month Follow up|Lost to Follow-up|2|||
129212655|NCT03104868|465079964|FG001|6 Month Follow up|Lost to Follow-up|2|||
129212656|NCT03104868|465079963|FG000|6 Month Follow up|Death|0|||
129212657|NCT03104868|465079964|FG001|6 Month Follow up|Death|1|||
129212658|NCT03104868|465079963|FG000|6 Month Follow up|Completed Later Timepoint|22|||
128987331|NCT00948896|464241609|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
129212659|NCT03104868|465079964|FG001|6 Month Follow up|Completed Later Timepoint|32|||
129212660|NCT03104868|465079963|FG000|12 Month Follow up|Lost to Follow-up|1|||
129212661|NCT03104868|465079964|FG001|12 Month Follow up|Lost to Follow-up|2|||
129212662|NCT03104868|465079963|FG000|12 Month Follow up|Death|0|||
129212663|NCT03104868|465079964|FG001|12 Month Follow up|Death|1|||
129212664|NCT03104868|465079963|FG000|12 Month Follow up|Withdrawal by Subject|0|||
129212665|NCT03104868|465079964|FG001|12 Month Follow up|Withdrawal by Subject|3|||
129212666|NCT03104868|465079963|FG000|12 Month Follow up|Completed Later Timepoint|32|||
129212667|NCT03104868|465079964|FG001|12 Month Follow up|Completed Later Timepoint|29|||
129212668|NCT03104868|465079963|FG000|18 Month Follow up|Lost to Follow-up|7|||
129212669|NCT03104868|465079964|FG001|18 Month Follow up|Lost to Follow-up|11|||
129212670|NCT03104868|465079963|FG000|18 Month Follow up|Death|2|||
129212671|NCT03104868|465079964|FG001|18 Month Follow up|Death|1|||
129212672|NCT03104868|465079963|FG000|18 Month Follow up|Withdrawal by Subject|1|||
129212673|NCT03104868|465079964|FG001|18 Month Follow up|Withdrawal by Subject|2|||
129212674|NCT03104868|465079963|FG000|18 Month Follow up|Graft Loss|1|||
129212675|NCT03104868|465079964|FG001|18 Month Follow up|Graft Loss|1|||
129212676|NCT03104868|465079963|FG000|18 Month Follow up|Completed Later Timepoint|19|||
129212677|NCT03104868|465079964|FG001|18 Month Follow up|Completed Later Timepoint|20|||
129212678|NCT03104868|465079963|FG000|24 Month Follow up|Lost to Follow-up|15|||
129212679|NCT03104868|465079964|FG001|24 Month Follow up|Lost to Follow-up|16|||
129212680|NCT03104868|465079963|FG000|24 Month Follow up|Death|3|||
129212681|NCT03104868|465079964|FG001|24 Month Follow up|Death|2|||
129212682|NCT03104868|465079963|FG000|24 Month Follow up|Withdrawal by Subject|1|||
129212683|NCT03104868|465079964|FG001|24 Month Follow up|Withdrawal by Subject|0|||
129212684|NCT03104868|465079963|FG000|24 Month Follow up|Graft Loss|2|||
129212685|NCT03104868|465079964|FG001|24 Month Follow up|Graft Loss|0|||
129212686|NCT03050801|465079967|FG000|Experiment 1|Lost to Follow-up|0|||
129212687|NCT03050801|465079968|FG001|Experiment 1|Lost to Follow-up|1|||
129212688|NCT03050801|465079969|FG002|Experiment 1|Lost to Follow-up|0|||
129212689|NCT03050801|465079970|FG003|Experiment 1|Lost to Follow-up|0|||
129212690|NCT03050801|465079971|FG004|Experiment 1|Lost to Follow-up|0|||
129212691|NCT03050801|465079972|FG005|Experiment 1|Lost to Follow-up|0|||
129212692|NCT03050801|465079967|FG000|Experiment 1|Physician Decision|0|||
129212693|NCT03050801|465079968|FG001|Experiment 1|Physician Decision|3|||
129212694|NCT03050801|465079969|FG002|Experiment 1|Physician Decision|0|||
129212695|NCT03050801|465079970|FG003|Experiment 1|Physician Decision|0|||
129212696|NCT03050801|465079971|FG004|Experiment 1|Physician Decision|0|||
129212697|NCT03050801|465079972|FG005|Experiment 1|Physician Decision|0|||
129212698|NCT03050801|465079967|FG000|Experiment 1|Change of experimental design|0|||
129212699|NCT03050801|465079968|FG001|Experiment 1|Change of experimental design|3|||
129212700|NCT03050801|465079969|FG002|Experiment 1|Change of experimental design|0|||
129212701|NCT03050801|465079970|FG003|Experiment 1|Change of experimental design|0|||
129212702|NCT03050801|465079971|FG004|Experiment 1|Change of experimental design|0|||
129212703|NCT03050801|465079972|FG005|Experiment 1|Change of experimental design|0|||
129212704|NCT03050801|465079967|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
129212705|NCT03050801|465079968|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
129212706|NCT03050801|465079969|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
128987332|NCT00948896|464241610|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
128987333|NCT00948896|464241603|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
128987334|NCT00948896|464241604|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
129212707|NCT03050801|465079970|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
129212708|NCT03050801|465079971|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
128987335|NCT00948896|464241605|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
128987336|NCT00948896|464241606|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
129212709|NCT03050801|465079972|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
129212710|NCT03050801|465079967|FG000|Experiment 2|Lost to Follow-up|0|||
129212711|NCT03050801|465079968|FG001|Experiment 2|Lost to Follow-up|0|||
129212712|NCT03050801|465079969|FG002|Experiment 2|Lost to Follow-up|0|||
129212713|NCT03050801|465079970|FG003|Experiment 2|Lost to Follow-up|1|||
129212714|NCT03050801|465079971|FG004|Experiment 2|Lost to Follow-up|1|||
129212715|NCT03050801|465079972|FG005|Experiment 2|Lost to Follow-up|0|||
129212716|NCT03050801|465079967|FG000|Experiment 2|Physician Decision|0|||
129212717|NCT03050801|465079968|FG001|Experiment 2|Physician Decision|0|||
129212718|NCT03050801|465079969|FG002|Experiment 2|Physician Decision|0|||
129212719|NCT03050801|465079970|FG003|Experiment 2|Physician Decision|0|||
128987337|NCT00948896|464241607|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
128987338|NCT00948896|464241608|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
128987339|NCT00948896|464241609|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
128987340|NCT00948896|464241610|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
128987341|NCT00948896|464241603|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
128987342|NCT00948896|464241604|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
129212720|NCT03050801|465079971|FG004|Experiment 2|Physician Decision|1|||
129212721|NCT03050801|465079972|FG005|Experiment 2|Physician Decision|0|||
128763054|NCT00991341|463422700|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
129212722|NCT03050801|465079967|FG000|Experiment 2|Pregnancy|0|||
129212723|NCT03050801|465079968|FG001|Experiment 2|Pregnancy|0|||
129212724|NCT03050801|465079969|FG002|Experiment 2|Pregnancy|0|||
129212725|NCT03050801|465079970|FG003|Experiment 2|Pregnancy|0|||
129212726|NCT03050801|465079971|FG004|Experiment 2|Pregnancy|1|||
129212727|NCT03050801|465079972|FG005|Experiment 2|Pregnancy|0|||
129212728|NCT03050801|465079967|FG000|Experiment 2|Withdrawal by Subject|0|||
129212729|NCT03050801|465079968|FG001|Experiment 2|Withdrawal by Subject|0|||
129212730|NCT03050801|465079969|FG002|Experiment 2|Withdrawal by Subject|0|||
129212731|NCT03050801|465079970|FG003|Experiment 2|Withdrawal by Subject|1|||
129212732|NCT03050801|465079971|FG004|Experiment 2|Withdrawal by Subject|0|||
129212733|NCT03050801|465079972|FG005|Experiment 2|Withdrawal by Subject|0|||
129212734|NCT03050801|465079967|FG000|Experiment 2|Poor data quality|0|||
129212735|NCT03050801|465079968|FG001|Experiment 2|Poor data quality|0|||
129212736|NCT03050801|465079969|FG002|Experiment 2|Poor data quality|0|||
129212737|NCT03050801|465079970|FG003|Experiment 2|Poor data quality|4|||
129212738|NCT03050801|465079971|FG004|Experiment 2|Poor data quality|1|||
129212739|NCT03050801|465079972|FG005|Experiment 2|Poor data quality|0|||
129212740|NCT03050801|465079967|FG000|Experiment 2|Discomfort during stimulation|0|||
129212741|NCT03050801|465079968|FG001|Experiment 2|Discomfort during stimulation|0|||
129212742|NCT03050801|465079969|FG002|Experiment 2|Discomfort during stimulation|0|||
129212743|NCT03050801|465079970|FG003|Experiment 2|Discomfort during stimulation|0|||
129212744|NCT03050801|465079971|FG004|Experiment 2|Discomfort during stimulation|0|||
129212745|NCT03050801|465079972|FG005|Experiment 2|Discomfort during stimulation|2|||
129212746|NCT00005780|465079973|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
129212747|NCT03600909|465079974|FG000|Overall Study|Not treated|0|||
129212748|NCT03600909|465079975|FG001|Overall Study|Not treated|3|||
129212749|NCT03600909|465079976|FG002|Overall Study|Not treated|0|||
129212750|NCT02651675|465079977|FG000|Overall Study|Death|0|||
129212751|NCT02651675|465079978|FG001|Overall Study|Death|0|||
129212752|NCT02651675|465079979|FG002|Overall Study|Death|1|||
129212753|NCT03674411|465079980|FG000|Overall Study|Non-treatment|4|||
129212754|NCT04408989|465079981|FG000|Overall Study|Lost to Follow-up|0|||
129212755|NCT04408989|465079982|FG001|Overall Study|Lost to Follow-up|0|||
129212756|NCT04408989|465079983|FG002|Overall Study|Lost to Follow-up|1|||
129212757|NCT04408989|465079981|FG000|Overall Study|Withdrawal by Subject|0|||
129212758|NCT04408989|465079982|FG001|Overall Study|Withdrawal by Subject|0|||
129212759|NCT04408989|465079983|FG002|Overall Study|Withdrawal by Subject|2|||
128876510|NCT01160289|463842348|FG001|Post-Randomization Period|Death|0|||
128876511|NCT01160289|463842349|FG002|Post-Randomization Period|Death|0|||
128876512|NCT01160289|463842350|FG003|Post-Randomization Period|Death|1|||
128876513|NCT01160289|463842351|FG004|Post-Randomization Period|Death|0|||
128876514|NCT01160289|463842352|FG005|Post-Randomization Period|Death|0|||
128876515|NCT01160289|463842347|FG000|Post-Randomization Period|Lack of Efficacy|0|||
128876516|NCT01160289|463842348|FG001|Post-Randomization Period|Lack of Efficacy|1|||
128876517|NCT01160289|463842349|FG002|Post-Randomization Period|Lack of Efficacy|0|||
128876518|NCT01160289|463842350|FG003|Post-Randomization Period|Lack of Efficacy|3|||
128876519|NCT01160289|463842351|FG004|Post-Randomization Period|Lack of Efficacy|0|||
128876520|NCT01160289|463842352|FG005|Post-Randomization Period|Lack of Efficacy|0|||
128876521|NCT01160289|463842347|FG000|Post-Randomization Period|Lost to Follow-up|0|||
128876522|NCT01160289|463842348|FG001|Post-Randomization Period|Lost to Follow-up|3|||
128876523|NCT01160289|463842349|FG002|Post-Randomization Period|Lost to Follow-up|2|||
128876524|NCT01160289|463842350|FG003|Post-Randomization Period|Lost to Follow-up|5|||
128876525|NCT01160289|463842351|FG004|Post-Randomization Period|Lost to Follow-up|3|||
128876526|NCT01160289|463842352|FG005|Post-Randomization Period|Lost to Follow-up|4|||
128876527|NCT01160289|463842347|FG000|Post-Randomization Period|Physician Decision|0|||
128876528|NCT01160289|463842348|FG001|Post-Randomization Period|Physician Decision|0|||
128876529|NCT01160289|463842349|FG002|Post-Randomization Period|Physician Decision|1|||
128876530|NCT01160289|463842350|FG003|Post-Randomization Period|Physician Decision|0|||
128876531|NCT01160289|463842351|FG004|Post-Randomization Period|Physician Decision|0|||
128876532|NCT01160289|463842352|FG005|Post-Randomization Period|Physician Decision|0|||
128876533|NCT01160289|463842347|FG000|Post-Randomization Period|Protocol Violation|0|||
128876534|NCT01160289|463842348|FG001|Post-Randomization Period|Protocol Violation|4|||
128876535|NCT01160289|463842349|FG002|Post-Randomization Period|Protocol Violation|2|||
128876536|NCT01160289|463842350|FG003|Post-Randomization Period|Protocol Violation|0|||
128876537|NCT01160289|463842351|FG004|Post-Randomization Period|Protocol Violation|1|||
128876538|NCT01160289|463842352|FG005|Post-Randomization Period|Protocol Violation|3|||
128876539|NCT01160289|463842347|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
128876540|NCT01160289|463842348|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
128876541|NCT01160289|463842349|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
128876542|NCT01160289|463842350|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
128876543|NCT01160289|463842351|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
128876544|NCT01160289|463842352|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
128876545|NCT01160289|463842347|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
128876546|NCT01160289|463842348|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
128876547|NCT01160289|463842349|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
128876548|NCT01160289|463842350|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
129212760|NCT05082857|465079984|FG000|Overall Study|participants relocated and could not continue|2|||
129212761|NCT05082857|465079985|FG001|Overall Study|participants relocated and could not continue|1|||
129212762|NCT05082857|465079984|FG000|Overall Study|Lost to Follow-up|1|||
129212763|NCT05082857|465079985|FG001|Overall Study|Lost to Follow-up|3|||
129212764|NCT04672239|465079986|FG000|Week 2 Survey|Failed survey check items|1|||
129212765|NCT04672239|465079987|FG001|Week 2 Survey|Failed survey check items|2|||
129212766|NCT04672239|465079988|FG002|Week 2 Survey|Failed survey check items|3|||
129212767|NCT04672239|465079986|FG000|Week 2 Survey|Partially completed survey|7|||
129212768|NCT04672239|465079987|FG001|Week 2 Survey|Partially completed survey|1|||
129212769|NCT04672239|465079988|FG002|Week 2 Survey|Partially completed survey|4|||
129212770|NCT04672239|465079986|FG000|Week 2 Survey|Withdrawal by Subject|0|||
129212771|NCT04672239|465079987|FG001|Week 2 Survey|Withdrawal by Subject|1|||
129212772|NCT04672239|465079988|FG002|Week 2 Survey|Withdrawal by Subject|0|||
129212773|NCT04672239|465079986|FG000|Week 2 Survey|Lost to Follow-up|3|||
129212774|NCT04672239|465079987|FG001|Week 2 Survey|Lost to Follow-up|2|||
129212775|NCT04672239|465079988|FG002|Week 2 Survey|Lost to Follow-up|5|||
129212776|NCT04672239|465079986|FG000|Week 6 Survey|Failed survey check items|2|||
129212777|NCT04672239|465079987|FG001|Week 6 Survey|Failed survey check items|2|||
129212778|NCT04672239|465079988|FG002|Week 6 Survey|Failed survey check items|2|||
129212779|NCT04672239|465079986|FG000|Week 6 Survey|Partially completed survey|3|||
129212780|NCT04672239|465079987|FG001|Week 6 Survey|Partially completed survey|3|||
129212781|NCT04672239|465079988|FG002|Week 6 Survey|Partially completed survey|2|||
129212782|NCT04672239|465079986|FG000|Week 6 Survey|Withdrawal by Subject|1|||
129212783|NCT04672239|465079987|FG001|Week 6 Survey|Withdrawal by Subject|1|||
129212784|NCT04672239|465079988|FG002|Week 6 Survey|Withdrawal by Subject|1|||
129212785|NCT04672239|465079986|FG000|Week 6 Survey|Withdrawn by PI|0|||
129212786|NCT04672239|465079987|FG001|Week 6 Survey|Withdrawn by PI|1|||
129212787|NCT04672239|465079988|FG002|Week 6 Survey|Withdrawn by PI|0|||
129212788|NCT04672239|465079986|FG000|Week 6 Survey|Lost to Follow-up|12|||
129212789|NCT04672239|465079987|FG001|Week 6 Survey|Lost to Follow-up|2|||
129212790|NCT04672239|465079988|FG002|Week 6 Survey|Lost to Follow-up|5|||
129212791|NCT04672239|465079986|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
129212792|NCT04672239|465079987|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
129212793|NCT04672239|465079988|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
129212794|NCT04672239|465079986|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
129212795|NCT04672239|465079987|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
129212796|NCT04672239|465079988|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
129212797|NCT04672239|465079986|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
129212798|NCT04672239|465079987|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
129212799|NCT04672239|465079988|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
129212800|NCT04672239|465079986|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
129212801|NCT04672239|465079987|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
129212802|NCT04672239|465079988|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
129212803|NCT04672239|465079986|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
129212804|NCT04672239|465079987|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
129212805|NCT04672239|465079988|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
129212806|NCT04672239|465079986|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
129212807|NCT04672239|465079987|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
129212808|NCT04672239|465079988|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
129212809|NCT04672239|465079986|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
129212810|NCT04672239|465079987|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
129212811|NCT04672239|465079988|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
129212812|NCT04606134|465079989|FG000|Overall Study|Adverse Event|0|||
129212813|NCT04606134|465079990|FG001|Overall Study|Adverse Event|1|||
129212814|NCT01099267|465079992|FG000|MDS-003 Study|Adverse Event|37|||
129212815|NCT01099267|465079992|FG000|MDS-003 Study|Lack of Efficacy|52|||
129212816|NCT01099267|465079992|FG000|MDS-003 Study|Withdrawal by Subject|8|||
129212817|NCT01099267|465079992|FG000|MDS-003 Study|Lost to Follow-up|1|||
129212818|NCT01099267|465079992|FG000|MDS-003 Study|Death|11|||
129212819|NCT01099267|465079992|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
129212820|NCT01099267|465079992|FG000|MDS-003 Study|Disease Progression|7|||
129212821|NCT01099267|465079992|FG000|MDS-003 Study|Investigator Decision|2|||
129212822|NCT01099267|465079992|FG000|MDS-003 Study|Non-Compliance|2|||
129212823|NCT01099267|465079992|FG000|MDS-003 Study|Loss of Response|1|||
129212824|NCT01099267|465079992|FG000|MDS-003 Study|Secondary Malign Disease|1|||
129212825|NCT01838395|465079999|FG000|Overall Study|Withdrawal by Subject|0|||
129212826|NCT01838395|465080000|FG001|Overall Study|Withdrawal by Subject|0|||
129212827|NCT01838395|465080001|FG002|Overall Study|Withdrawal by Subject|0|||
129212828|NCT01838395|465080002|FG003|Overall Study|Withdrawal by Subject|0|||
129212829|NCT01838395|465080003|FG004|Overall Study|Withdrawal by Subject|1|||
129212830|NCT01838395|465080004|FG005|Overall Study|Withdrawal by Subject|0|||
129212831|NCT01838395|465079999|FG000|Overall Study|Death|0|||
129212832|NCT01838395|465080000|FG001|Overall Study|Death|0|||
129212833|NCT01838395|465080001|FG002|Overall Study|Death|1|||
129212834|NCT01838395|465080002|FG003|Overall Study|Death|0|||
129212835|NCT01838395|465080003|FG004|Overall Study|Death|0|||
129212836|NCT01838395|465080004|FG005|Overall Study|Death|0|||
129212837|NCT01838395|465079999|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129212838|NCT01838395|465080000|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
129212839|NCT01838395|465080001|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129212840|NCT01838395|465080002|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129212841|NCT01838395|465080003|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129212842|NCT01838395|465080004|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129212843|NCT04586205|465080009|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
129212844|NCT04586205|465080010|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
129212845|NCT04328077|465082163|FG000|Overall Study|Lost to Follow-up|0|||
129212846|NCT04328077|465082164|FG001|Overall Study|Lost to Follow-up|1|||
129212847|NCT04328077|465082165|FG002|Overall Study|Lost to Follow-up|0|||
129212848|NCT04328077|465082166|FG003|Overall Study|Lost to Follow-up|0|||
129212849|NCT04328077|465082163|FG000|Overall Study|Withdrawal by Subject|0|||
129212850|NCT04328077|465082164|FG001|Overall Study|Withdrawal by Subject|1|||
129212851|NCT04328077|465082165|FG002|Overall Study|Withdrawal by Subject|1|||
129212852|NCT04328077|465082166|FG003|Overall Study|Withdrawal by Subject|3|||
129212853|NCT02419001|465082167|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
129212854|NCT02419001|465082168|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
129212855|NCT00744497|465082171|FG000|Overall Study|Withdrawal by Subject|21|||
129212856|NCT00744497|465082172|FG001|Overall Study|Withdrawal by Subject|18|||
129212857|NCT00744497|465082171|FG000|Overall Study|Death|11|||
129212858|NCT00744497|465082172|FG001|Overall Study|Death|9|||
129212859|NCT00744497|465082171|FG000|Overall Study|Lost to Follow-up|4|||
129212860|NCT00744497|465082172|FG001|Overall Study|Lost to Follow-up|2|||
129212861|NCT00744497|465082171|FG000|Overall Study|Poor compliance/noncompliance|9|||
129212862|NCT00744497|465082172|FG001|Overall Study|Poor compliance/noncompliance|5|||
129212863|NCT00744497|465082171|FG000|Overall Study|No longer meets study criteria|7|||
129212864|NCT00744497|465082172|FG001|Overall Study|No longer meets study criteria|3|||
129212865|NCT00744497|465082171|FG000|Overall Study|Administrative Reason By Sponsor|25|||
129212866|NCT00744497|465082172|FG001|Overall Study|Administrative Reason By Sponsor|8|||
129212867|NCT00744497|465082171|FG000|Overall Study|Disease progression|312|||
129212868|NCT00744497|465082172|FG001|Overall Study|Disease progression|219|||
129212869|NCT00744497|465082171|FG000|Overall Study|Study drug toxicity|68|||
129212870|NCT00744497|465082172|FG001|Overall Study|Study drug toxicity|141|||
129212871|NCT00744497|465082171|FG000|Overall Study|Adverse event unrelated to study drug|78|||
129212872|NCT00744497|465082172|FG001|Overall Study|Adverse event unrelated to study drug|122|||
129212873|NCT00744497|465082171|FG000|Overall Study|Patient requested to stop study drug|65|||
129212874|NCT00744497|465082172|FG001|Overall Study|Patient requested to stop study drug|80|||
129212875|NCT00744497|465082171|FG000|Overall Study|Maximum clinical benefit|141|||
129212876|NCT00744497|465082172|FG001|Overall Study|Maximum clinical benefit|142|||
129212877|NCT00744497|465082171|FG000|Overall Study|Not defined|19|||
129212878|NCT00744497|465082172|FG001|Overall Study|Not defined|13|||
129212879|NCT03819114|465082207|FG000|Overall Study|Protocol Violation|0|||
129212880|NCT03819114|465082208|FG001|Overall Study|Protocol Violation|1|||
129212881|NCT03819114|465082209|FG002|Overall Study|Protocol Violation|1|||
129212882|NCT03819114|465082210|FG003|Overall Study|Protocol Violation|0|||
129212883|NCT03819114|465082207|FG000|Overall Study|Lost to Follow-up|0|||
129212884|NCT03819114|465082208|FG001|Overall Study|Lost to Follow-up|0|||
129212885|NCT03819114|465082209|FG002|Overall Study|Lost to Follow-up|1|||
129212886|NCT03819114|465082210|FG003|Overall Study|Lost to Follow-up|0|||
129212887|NCT01744977|465082211|FG000|Overall Study|Withdrawal by Subject|1|||
129212888|NCT01744977|465082212|FG001|Overall Study|Withdrawal by Subject|2|||
129212889|NCT01744977|465082211|FG000|Overall Study|Death|2|||
129212890|NCT01744977|465082212|FG001|Overall Study|Death|3|||
129212891|NCT01744977|465082211|FG000|Overall Study|Lost to Follow-up|2|||
129212892|NCT01744977|465082212|FG001|Overall Study|Lost to Follow-up|0|||
129212893|NCT01744977|465082211|FG000|Overall Study|No longer meets inclusion|6|||
129212894|NCT01744977|465082212|FG001|Overall Study|No longer meets inclusion|0|||
129212895|NCT04225897|465082220|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212896|NCT04225897|465082221|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
129212897|NCT04225897|465082222|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212898|NCT04225897|465082223|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212899|NCT04225897|465082224|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212900|NCT04225897|465082225|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212901|NCT04225897|465082226|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212902|NCT04225897|465082227|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212903|NCT04225897|465082228|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212904|NCT04225897|465082229|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212905|NCT04225897|465082230|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212906|NCT04225897|465082231|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129212907|NCT04225897|465082220|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212908|NCT04225897|465082221|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212909|NCT04225897|465082222|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
129212910|NCT04225897|465082223|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212911|NCT04225897|465082224|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
128987343|NCT00948896|464241605|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
129212912|NCT04225897|465082225|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212913|NCT04225897|465082226|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212914|NCT04225897|465082227|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212915|NCT04225897|465082228|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212916|NCT04225897|465082229|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212917|NCT04225897|465082230|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212918|NCT04225897|465082231|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129212919|NCT04225897|465082220|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212920|NCT04225897|465082221|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212921|NCT04225897|465082222|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
129212922|NCT04225897|465082223|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212923|NCT04225897|465082224|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212924|NCT04225897|465082225|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212925|NCT04225897|465082226|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212926|NCT04225897|465082227|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212927|NCT04225897|465082228|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212928|NCT04225897|465082229|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212929|NCT04225897|465082230|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212930|NCT04225897|465082231|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129212931|NCT04225897|465082220|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212932|NCT04225897|465082221|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212933|NCT04225897|465082222|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212934|NCT04225897|465082223|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212935|NCT04225897|465082224|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212936|NCT04225897|465082225|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212937|NCT04225897|465082226|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212938|NCT04225897|465082227|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
129212939|NCT04225897|465082228|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212940|NCT04225897|465082229|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212941|NCT04225897|465082230|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212942|NCT04225897|465082231|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129212943|NCT02703597|465082232|FG000|Assignment to Baseline|Lost to Follow-up|17|||
129212944|NCT02703597|465082233|FG001|Assignment to Baseline|Lost to Follow-up|16|||
129212945|NCT02703597|465082232|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
129212946|NCT02703597|465082233|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
129212947|NCT02703597|465082232|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
129212948|NCT02703597|465082233|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
129212949|NCT02703597|465082232|FG000|First Post-test to First Follow-up|Site drop out|0|||
129212950|NCT02703597|465082233|FG001|First Post-test to First Follow-up|Site drop out|58|||
129212951|NCT02703597|465082232|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
129212952|NCT02703597|465082233|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
129212953|NCT02703597|465082232|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
129212954|NCT02703597|465082233|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
129212955|NCT02703597|465082232|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
129212956|NCT02703597|465082233|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
129212957|NCT02131259|465082234|FG000|Overall Study|Progressive disease|751|||
129212958|NCT02131259|465082234|FG000|Overall Study|Adverse Event|341|||
129212959|NCT02131259|465082234|FG000|Overall Study|Lost to Follow-up|7|||
129212960|NCT02131259|465082234|FG000|Overall Study|Relocation|32|||
129212961|NCT02131259|465082234|FG000|Overall Study|Other|63|||
129212962|NCT02131259|465082234|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
129212963|NCT02131259|465082234|FG000|Overall Study|Progressive disease/relocation|1|||
129212964|NCT02131259|465082234|FG000|Overall Study|Progressive disease/other|2|||
129212965|NCT02131259|465082234|FG000|Overall Study|AE/lost to follow-up|1|||
129212966|NCT02131259|465082234|FG000|Overall Study|AE/other|1|||
129212967|NCT02131259|465082234|FG000|Overall Study|Progressive disease/AE/other|1|||
129212968|NCT02131259|465082234|FG000|Overall Study|Missing|3|||
129212969|NCT02796170|465082235|FG000|Overall Study|Lost to Follow-up|3|||
128987344|NCT00948896|464241606|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
128987345|NCT00948896|464241607|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
128987346|NCT00948896|464241608|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
129212970|NCT02796170|465082236|FG001|Overall Study|Lost to Follow-up|0|||
128987347|NCT00948896|464241609|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
128987348|NCT00948896|464241610|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
129212971|NCT03818321|465082239|FG000|Overall Study|Withdrawal by Subject|1|||
129212972|NCT03818321|465082240|FG001|Overall Study|Withdrawal by Subject|2|||
129212973|NCT01867671|465082241|FG000|Overall Study|Adverse Event|5|||
129212974|NCT01867671|465082242|FG001|Overall Study|Adverse Event|3|||
129212975|NCT01867671|465082241|FG000|Overall Study|Anaphylaxis|0|||
129212976|NCT01867671|465082242|FG001|Overall Study|Anaphylaxis|1|||
129212977|NCT01867671|465082241|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
129212978|NCT01867671|465082242|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
129212979|NCT01867671|465082241|FG000|Overall Study|Lost to Follow-up|0|||
129212980|NCT01867671|465082242|FG001|Overall Study|Lost to Follow-up|1|||
129212981|NCT01867671|465082241|FG000|Overall Study|Non-compliance with Study Drug|1|||
129212982|NCT01867671|465082242|FG001|Overall Study|Non-compliance with Study Drug|2|||
129212983|NCT01867671|465082241|FG000|Overall Study|Withdrawal by Subject|21|||
129212984|NCT01867671|465082242|FG001|Overall Study|Withdrawal by Subject|21|||
129212985|NCT01523366|465082243|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129212986|NCT01523366|465082244|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129212987|NCT01523366|465082243|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
129212988|NCT01523366|465082244|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
129212989|NCT04543279|465082249|FG000|Overall Study|Withdrawal by Subject|1|||
129212990|NCT04543279|465082250|FG001|Overall Study|Withdrawal by Subject|0|||
129212991|NCT04543279|465082249|FG000|Overall Study|Adverse Event|1|||
129212992|NCT04543279|465082250|FG001|Overall Study|Adverse Event|0|||
129212993|NCT04543279|465082249|FG000|Overall Study|Physician Decision|1|||
129212994|NCT04543279|465082250|FG001|Overall Study|Physician Decision|0|||
129212995|NCT05249582|465082254|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
129212996|NCT05249582|465082255|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
129212997|NCT05249582|465082254|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
129212998|NCT05249582|465082255|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
129212999|NCT05249582|465082254|FG000|Overall Study|Declined to use virtual reality headset|1|||
129213000|NCT05249582|465082255|FG001|Overall Study|Declined to use virtual reality headset|0|||
129213001|NCT03675126|465082256|FG000|Overall Study|Study Terminated by Sponsor|9|||
129213002|NCT03675126|465082256|FG000|Overall Study|Death|2|||
129213003|NCT03675126|465082256|FG000|Overall Study|Withdrawal by Subject|4|||
129213004|NCT00001959|465082257|FG000|Overall Study|newly diagnosed colon cancer|1|||
129213005|NCT00001959|465082257|FG000|Overall Study|disabling sedation|1|||
129213006|NCT00001959|465082257|FG000|Overall Study|non-compliance|1|||
129213007|NCT04189952|465082259|FG000|Follow-up Period|Death|1|||
129213008|NCT04189952|465082259|FG000|Follow-up Period|Withdrawal by Subject|1|||
129213009|NCT01052493|465082260|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
129213010|NCT01052493|465082261|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
129213011|NCT01052493|465082262|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
129213012|NCT00283296|465082264|FG000|Overall Study|in-home trial not completed|5|||
129213013|NCT02158442|465082267|FG000|Overall Study|Withdrawal by Subject|1|||
129213014|NCT02158442|465082268|FG001|Overall Study|Withdrawal by Subject|0|||
129213015|NCT02158442|465082267|FG000|Overall Study|Perfusion staff not available|1|||
129213016|NCT02158442|465082268|FG001|Overall Study|Perfusion staff not available|0|||
129213017|NCT00632229|465082276|FG000|Overall Study|Adverse Event|6|||
129213018|NCT00632229|465082277|FG001|Overall Study|Adverse Event|0|||
129213019|NCT00632229|465082276|FG000|Overall Study|Lost to Follow-up|0|||
129213020|NCT00632229|465082277|FG001|Overall Study|Lost to Follow-up|3|||
129213021|NCT00632229|465082276|FG000|Overall Study|Lack of Efficacy|0|||
129213022|NCT00632229|465082277|FG001|Overall Study|Lack of Efficacy|2|||
129213023|NCT00632229|465082276|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
129213024|NCT00632229|465082277|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
129213025|NCT00474812|465082284|FG000|Overall Study|Withdrawal by Subject|5|||
129213026|NCT00474812|465082284|FG000|Overall Study|No Initiation of treatment|2|||
129213027|NCT00737672|465082291|FG000|Overall Study|Graft Abandonment|48|||
129213028|NCT00737672|465082292|FG001|Overall Study|Graft Abandonment|56|||
129213029|NCT00737672|465082291|FG000|Overall Study|Death|23|||
129213030|NCT00737672|465082292|FG001|Overall Study|Death|22|||
129213031|NCT00737672|465082291|FG000|Overall Study|Withdrawal by Subject|1|||
129213032|NCT00737672|465082292|FG001|Overall Study|Withdrawal by Subject|2|||
129213033|NCT00737672|465082291|FG000|Overall Study|Lost to Follow-up|1|||
129213034|NCT00737672|465082292|FG001|Overall Study|Lost to Follow-up|0|||
129213035|NCT00737672|465082291|FG000|Overall Study|Miscellaneous|7|||
129213036|NCT00737672|465082292|FG001|Overall Study|Miscellaneous|1|||
129213037|NCT00737672|465082291|FG000|Overall Study|Physician Decision|0|||
129213038|NCT00737672|465082292|FG001|Overall Study|Physician Decision|2|||
129213039|NCT02694185|465082294|FG000|Overall Study|Withdrawal by Subject|45|||
129213040|NCT02694185|465082295|FG001|Overall Study|Withdrawal by Subject|0|||
129213041|NCT04363320|465082296|FG000|Overall Study|Lost to Follow-up|43|||
129213042|NCT04363320|465082297|FG001|Overall Study|Lost to Follow-up|42|||
129213043|NCT04363320|465082298|FG002|Overall Study|Lost to Follow-up|24|||
129213044|NCT04363320|465082299|FG003|Overall Study|Lost to Follow-up|29|||
129213045|NCT04363320|465082296|FG000|Overall Study|Death|0|||
129213046|NCT04363320|465082297|FG001|Overall Study|Death|0|||
129213047|NCT04363320|465082298|FG002|Overall Study|Death|1|||
129213048|NCT04363320|465082299|FG003|Overall Study|Death|0|||
129213049|NCT05632211|465082300|FG000|Overall Study|Withdrawal by Subject|2|||
129213050|NCT05632211|465082301|FG001|Overall Study|Withdrawal by Subject|0|||
129213051|NCT05632211|465082302|FG002|Overall Study|Withdrawal by Subject|2|||
129213052|NCT05632211|465082300|FG000|Overall Study|Other reasons|1|||
129213053|NCT05632211|465082301|FG001|Overall Study|Other reasons|1|||
129213054|NCT05632211|465082302|FG002|Overall Study|Other reasons|1|||
129213055|NCT04123470|465082303|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
129213056|NCT04123470|465082304|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
129213057|NCT04123470|465082303|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
129213058|NCT04123470|465082304|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
129213059|NCT04123470|465082303|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
129213060|NCT04123470|465082304|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
129213061|NCT04123470|465082303|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
129213062|NCT04123470|465082304|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
129213063|NCT05408429|465082316|FG000|Overall Study|Lost to Follow-up|1|||
129213064|NCT05408429|465082317|FG001|Overall Study|Lost to Follow-up|1|||
129213065|NCT05408429|465082318|FG002|Overall Study|Lost to Follow-up|0|||
129213066|NCT05408429|465082316|FG000|Overall Study|Withdrawal by Subject|5|||
129213067|NCT05408429|465082317|FG001|Overall Study|Withdrawal by Subject|0|||
129213068|NCT05408429|465082318|FG002|Overall Study|Withdrawal by Subject|1|||
129213069|NCT05972993|465082321|FG000|Overall Study|Lost to Follow-up|2|||
128987349|NCT00948896|464241603|FG000|24 Months of Age to 36 Months of Age|Death|0|||
129213070|NCT05972993|465082322|FG001|Overall Study|Lost to Follow-up|0|||
129213071|NCT05972993|465082323|FG002|Overall Study|Lost to Follow-up|1|||
129213072|NCT05972993|465082324|FG003|Overall Study|Lost to Follow-up|0|||
129213073|NCT05972993|465082325|FG004|Overall Study|Lost to Follow-up|0|||
129213074|NCT05972993|465082326|FG005|Overall Study|Lost to Follow-up|0|||
129213075|NCT05972993|465082327|FG006|Overall Study|Lost to Follow-up|0|||
129213076|NCT05972993|465082328|FG007|Overall Study|Lost to Follow-up|2|||
129213077|NCT05972993|465082329|FG008|Overall Study|Lost to Follow-up|0|||
129213078|NCT03866577|465082332|FG000|Overall Study|Protocol Violation|0|||
129213079|NCT03866577|465082333|FG001|Overall Study|Protocol Violation|0|||
129213080|NCT03866577|465082334|FG002|Overall Study|Protocol Violation|0|||
129213081|NCT03866577|465082335|FG003|Overall Study|Protocol Violation|0|||
129213082|NCT03866577|465082336|FG004|Overall Study|Protocol Violation|0|||
129213083|NCT03866577|465082337|FG005|Overall Study|Protocol Violation|0|||
129213084|NCT03866577|465082338|FG006|Overall Study|Protocol Violation|0|||
129213085|NCT03866577|465082339|FG007|Overall Study|Protocol Violation|0|||
129213086|NCT03866577|465082340|FG008|Overall Study|Protocol Violation|0|||
129213087|NCT03866577|465082341|FG009|Overall Study|Protocol Violation|0|||
129213088|NCT03866577|465082342|FG010|Overall Study|Protocol Violation|0|||
129213089|NCT03866577|465082343|FG011|Overall Study|Protocol Violation|1|||
129213090|NCT03866577|465082344|FG012|Overall Study|Protocol Violation|0|||
129213091|NCT03866577|465082332|FG000|Overall Study|Withdrawal by Subject|0|||
129213092|NCT03866577|465082333|FG001|Overall Study|Withdrawal by Subject|0|||
129213093|NCT03866577|465082334|FG002|Overall Study|Withdrawal by Subject|0|||
129213094|NCT03866577|465082335|FG003|Overall Study|Withdrawal by Subject|0|||
129213095|NCT03866577|465082336|FG004|Overall Study|Withdrawal by Subject|0|||
129213096|NCT03866577|465082337|FG005|Overall Study|Withdrawal by Subject|0|||
129213097|NCT03866577|465082338|FG006|Overall Study|Withdrawal by Subject|0|||
129213098|NCT03866577|465082339|FG007|Overall Study|Withdrawal by Subject|0|||
129213099|NCT03866577|465082340|FG008|Overall Study|Withdrawal by Subject|1|||
129213100|NCT03866577|465082341|FG009|Overall Study|Withdrawal by Subject|1|||
129213101|NCT03866577|465082342|FG010|Overall Study|Withdrawal by Subject|0|||
129213102|NCT03866577|465082343|FG011|Overall Study|Withdrawal by Subject|0|||
129213103|NCT03866577|465082344|FG012|Overall Study|Withdrawal by Subject|0|||
129213104|NCT03866577|465082332|FG000|Overall Study|Not qualified for IVIg infusion|0|||
129213105|NCT03866577|465082333|FG001|Overall Study|Not qualified for IVIg infusion|0|||
129213106|NCT03866577|465082334|FG002|Overall Study|Not qualified for IVIg infusion|0|||
129213107|NCT03866577|465082335|FG003|Overall Study|Not qualified for IVIg infusion|0|||
129213108|NCT03866577|465082336|FG004|Overall Study|Not qualified for IVIg infusion|0|||
129213109|NCT03866577|465082337|FG005|Overall Study|Not qualified for IVIg infusion|0|||
129213110|NCT03866577|465082338|FG006|Overall Study|Not qualified for IVIg infusion|0|||
129213111|NCT03866577|465082339|FG007|Overall Study|Not qualified for IVIg infusion|0|||
129213112|NCT03866577|465082340|FG008|Overall Study|Not qualified for IVIg infusion|0|||
129213113|NCT03866577|465082341|FG009|Overall Study|Not qualified for IVIg infusion|1|||
129213114|NCT03866577|465082342|FG010|Overall Study|Not qualified for IVIg infusion|0|||
129213115|NCT03866577|465082343|FG011|Overall Study|Not qualified for IVIg infusion|0|||
129213116|NCT03866577|465082344|FG012|Overall Study|Not qualified for IVIg infusion|0|||
129213117|NCT04825678|465082345|FG000|Overall Study|Decision by Sponsor|2|||
129213118|NCT04825678|465082346|FG001|Overall Study|Decision by Sponsor|3|||
129213119|NCT04825678|465082345|FG000|Overall Study|Withdrawal of Consent From Study|7|||
129213120|NCT04825678|465082346|FG001|Overall Study|Withdrawal of Consent From Study|9|||
129213121|NCT04825678|465082345|FG000|Overall Study|Lost to Follow-up|3|||
129213122|NCT04825678|465082346|FG001|Overall Study|Lost to Follow-up|4|||
129213123|NCT04825678|465082345|FG000|Overall Study|Never Received Investigational Product|1|||
129213124|NCT04825678|465082346|FG001|Overall Study|Never Received Investigational Product|1|||
129213125|NCT05530252|465082347|FG000|Overall Study|Lost to Follow-up|1|||
129213126|NCT05530252|465082348|FG001|Overall Study|Lost to Follow-up|1|||
129213127|NCT05530252|465082349|FG002|Overall Study|Lost to Follow-up|1|||
129213128|NCT03818256|465082350|FG000|Overall Study|Withdrawal by Subject|2|||
129213129|NCT03818256|465082351|FG001|Overall Study|Withdrawal by Subject|2|||
129213130|NCT03818256|465082350|FG000|Overall Study|Adverse Event|3|||
129213131|NCT03818256|465082351|FG001|Overall Study|Adverse Event|1|||
129213132|NCT03818256|465082350|FG000|Overall Study|Lost to Follow-up|0|||
129213133|NCT03818256|465082351|FG001|Overall Study|Lost to Follow-up|5|||
129213134|NCT03818256|465082350|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
129213135|NCT03818256|465082351|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
129213136|NCT03818256|465082350|FG000|Overall Study|Not reporting for scheduled visits|1|||
129213137|NCT03818256|465082351|FG001|Overall Study|Not reporting for scheduled visits|0|||
129213138|NCT03818256|465082350|FG000|Overall Study|Non-compliant with investigational product|1|||
129213139|NCT03818256|465082351|FG001|Overall Study|Non-compliant with investigational product|0|||
129213140|NCT03043794|465082357|FG000|Overall Study|Lost to Follow-up|1|||
129213141|NCT05565742|465082358|FG000|Overall Study|Withdrawal by Subject|0|||
129213142|NCT05565742|465082359|FG001|Overall Study|Withdrawal by Subject|0|||
129213143|NCT05565742|465082360|FG002|Overall Study|Withdrawal by Subject|2|||
129213144|NCT05565742|465082361|FG003|Overall Study|Withdrawal by Subject|2|||
129213145|NCT05565742|465082362|FG004|Overall Study|Withdrawal by Subject|2|||
129213146|NCT05565742|465082358|FG000|Overall Study|Death|1|||
129213147|NCT05565742|465082359|FG001|Overall Study|Death|0|||
129213148|NCT05565742|465082360|FG002|Overall Study|Death|0|||
129213149|NCT05565742|465082361|FG003|Overall Study|Death|0|||
129213150|NCT05565742|465082362|FG004|Overall Study|Death|0|||
129213151|NCT05565742|465082358|FG000|Overall Study|Participant Travelled Abroad|0|||
129213152|NCT05565742|465082359|FG001|Overall Study|Participant Travelled Abroad|0|||
129213153|NCT05565742|465082360|FG002|Overall Study|Participant Travelled Abroad|0|||
129213154|NCT05565742|465082361|FG003|Overall Study|Participant Travelled Abroad|0|||
129213155|NCT05565742|465082362|FG004|Overall Study|Participant Travelled Abroad|1|||
129213156|NCT04163341|465082363|FG000|Overall Study|Withdrawal by Subject|2|||
129213157|NCT04163341|465082364|FG001|Overall Study|Withdrawal by Subject|0|||
129213158|NCT04163341|465082363|FG000|Overall Study|Lost to Follow-up|3|||
129213159|NCT04163341|465082364|FG001|Overall Study|Lost to Follow-up|4|||
129213160|NCT02855125|465082365|FG000|Overall Study|Withdrawal by Subject|2|||
129213161|NCT02855125|465082366|FG001|Overall Study|Withdrawal by Subject|2|||
129213162|NCT02855125|465082365|FG000|Overall Study|Clinical Disease Progression|5|||
129213163|NCT02855125|465082366|FG001|Overall Study|Clinical Disease Progression|4|||
129213164|NCT02855125|465082365|FG000|Overall Study|Radiologic Disease Progression|36|||
129213165|NCT02855125|465082366|FG001|Overall Study|Radiologic Disease Progression|39|||
129213166|NCT02855125|465082365|FG000|Overall Study|Adverse Event|11|||
129213167|NCT02855125|465082366|FG001|Overall Study|Adverse Event|7|||
129213168|NCT02855125|465082365|FG000|Overall Study|Physician Decision|1|||
129213169|NCT02855125|465082366|FG001|Overall Study|Physician Decision|0|||
129213170|NCT02855125|465082365|FG000|Overall Study|On Treatment|9|||
129213171|NCT02855125|465082366|FG001|Overall Study|On Treatment|11|||
129213172|NCT02855125|465082365|FG000|Overall Study|Randomized but not treated|0|||
129213173|NCT02855125|465082366|FG001|Overall Study|Randomized but not treated|1|||
129213174|NCT04467905|465082367|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
129213175|NCT04467905|465082368|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
129213176|NCT04467905|465082369|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
129213177|NCT04467905|465082367|FG000|Overall Study|Conversion to SR|0|||
129213178|NCT04467905|465082368|FG001|Overall Study|Conversion to SR|0|||
129213179|NCT04467905|465082369|FG002|Overall Study|Conversion to SR|3|||
129213180|NCT04467905|465082367|FG000|Overall Study|Technical issue with Holter ECG|0|||
129213181|NCT04467905|465082368|FG001|Overall Study|Technical issue with Holter ECG|0|||
129213182|NCT04467905|465082369|FG002|Overall Study|Technical issue with Holter ECG|3|||
129213183|NCT04467905|465082367|FG000|Overall Study|Hemodynamic instability|0|||
129213184|NCT04467905|465082368|FG001|Overall Study|Hemodynamic instability|0|||
129213185|NCT04467905|465082369|FG002|Overall Study|Hemodynamic instability|1|||
129213186|NCT04467905|465082367|FG000|Overall Study|Site misinterpretation of protocol|0|||
129213187|NCT04467905|465082368|FG001|Overall Study|Site misinterpretation of protocol|0|||
129213188|NCT04467905|465082369|FG002|Overall Study|Site misinterpretation of protocol|1|||
129213189|NCT00911170|465082370|FG000|Treatment Period|Randomized in error|1|||
129213190|NCT00911170|465082371|FG001|Treatment Period|Randomized in error|1|||
129213191|NCT00911170|465082370|FG000|Treatment Period|Ineligibility determined|1|||
129213192|NCT00911170|465082371|FG001|Treatment Period|Ineligibility determined|3|||
129213193|NCT00911170|465082370|FG000|Treatment Period|Protocol deviation|1|||
129213194|NCT00911170|465082371|FG001|Treatment Period|Protocol deviation|2|||
129213195|NCT00911170|465082370|FG000|Treatment Period|Adverse Event|9|||
129213196|NCT00911170|465082371|FG001|Treatment Period|Adverse Event|10|||
128987350|NCT00948896|464241604|FG001|24 Months of Age to 36 Months of Age|Death|2|||
128987351|NCT00948896|464241605|FG002|24 Months of Age to 36 Months of Age|Death|2|||
128987352|NCT00948896|464241606|FG003|24 Months of Age to 36 Months of Age|Death|0|||
128987353|NCT00948896|464241607|FG004|24 Months of Age to 36 Months of Age|Death|0|||
128987354|NCT00948896|464241608|FG005|24 Months of Age to 36 Months of Age|Death|1|||
128987355|NCT00948896|464241609|FG006|24 Months of Age to 36 Months of Age|Death|0|||
128987356|NCT00948896|464241610|FG007|24 Months of Age to 36 Months of Age|Death|0|||
128987357|NCT00948896|464241603|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
128987358|NCT00948896|464241604|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
128987359|NCT00948896|464241605|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
128987360|NCT00948896|464241606|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
128987361|NCT00948896|464241607|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
128987362|NCT00948896|464241608|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
128987363|NCT00948896|464241609|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
128987364|NCT00948896|464241610|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
128987365|NCT00948896|464241603|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
128987366|NCT00948896|464241604|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
128987367|NCT00948896|464241605|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
128987368|NCT00948896|464241606|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
128987369|NCT00948896|464241607|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
128987370|NCT00948896|464241608|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
128987371|NCT00948896|464241609|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
128987372|NCT00948896|464241610|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
128987373|NCT00948896|464241603|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
128987374|NCT00948896|464241604|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
128987375|NCT00948896|464241605|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
128987376|NCT00948896|464241606|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
128987377|NCT00948896|464241607|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
128987378|NCT00948896|464241608|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
128987379|NCT00948896|464241609|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
128987380|NCT00948896|464241610|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
128987381|NCT00948896|464241603|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
128987382|NCT00948896|464241604|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
128987383|NCT00948896|464241605|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
128987384|NCT00948896|464241606|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
128987385|NCT00948896|464241607|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
128987386|NCT00948896|464241608|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
128987387|NCT00948896|464241609|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
128987388|NCT00948896|464241610|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
128987389|NCT03795233|464241611|FG000|Overall Study|Withdrawal by Subject|2|||
128987390|NCT03795233|464241612|FG001|Overall Study|Withdrawal by Subject|1|||
128987391|NCT03795233|464241611|FG000|Overall Study|Lost to Follow-up|1|||
129213197|NCT00911170|465082370|FG000|Treatment Period|Withdrawal by Subject|4|||
129213198|NCT00911170|465082371|FG001|Treatment Period|Withdrawal by Subject|4|||
129213199|NCT00911170|465082370|FG000|Treatment Period|Disease progression|0|||
129213200|NCT00911170|465082371|FG001|Treatment Period|Disease progression|2|||
129213201|NCT00911170|465082370|FG000|Treatment Period|Physician Decision|5|||
129213202|NCT00911170|465082371|FG001|Treatment Period|Physician Decision|5|||
129213203|NCT00911170|465082370|FG000|Treatment Period|Lost to Follow-up|0|||
129213204|NCT00911170|465082371|FG001|Treatment Period|Lost to Follow-up|1|||
129213205|NCT00911170|465082370|FG000|Treatment Period|Death|6|||
129213206|NCT00911170|465082371|FG001|Treatment Period|Death|9|||
129213207|NCT00911170|465082370|FG000|Long Term Follow-Up|Continuing in study|274|||
129213208|NCT00911170|465082371|FG001|Long Term Follow-Up|Continuing in study|269|||
129213209|NCT00911170|465082370|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
129213210|NCT00911170|465082371|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
129213211|NCT00911170|465082370|FG000|Long Term Follow-Up|Physician Decision|5|||
129213212|NCT00911170|465082371|FG001|Long Term Follow-Up|Physician Decision|4|||
129213213|NCT00911170|465082370|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
129213214|NCT00911170|465082371|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
129213215|NCT00911170|465082370|FG000|Long Term Follow-Up|Death|116|||
129213216|NCT00911170|465082371|FG001|Long Term Follow-Up|Death|121|||
129213217|NCT02514083|465082372|FG000|Overall Study|Adverse Event|1|||
129213218|NCT01586364|465084517|FG000|Overall Study|Withdrawal by Subject|40|||
129213219|NCT01586364|465084517|FG000|Overall Study|Adverse Event|37|||
129213220|NCT01586364|465084517|FG000|Overall Study|Lost to Follow-up|17|||
129213221|NCT01586364|465084517|FG000|Overall Study|Protocol Violation|16|||
129213222|NCT01586364|465084517|FG000|Overall Study|Lack of Efficacy|1|||
129213223|NCT01586364|465084517|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
129213224|NCT01586364|465084517|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
129213225|NCT01586364|465084517|FG000|Overall Study|Other-Site closure due to PI illness|1|||
129213226|NCT01586364|465084517|FG000|Overall Study|Other-PI discretion, site closing|2|||
129213227|NCT01586364|465084517|FG000|Overall Study|Other-Not specified|1|||
129213228|NCT02121535|465084518|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
129213229|NCT02121535|465084519|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
129213230|NCT02121535|465084518|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
129213231|NCT02121535|465084519|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
129213232|NCT00091949|465084520|FG000|Overall Study|Withdrawal by Subject|117|||
129213233|NCT00091949|465084521|FG001|Overall Study|Withdrawal by Subject|110|||
129213234|NCT00091949|465084520|FG000|Overall Study|Lost to Follow-up|58|||
129213235|NCT00091949|465084521|FG001|Overall Study|Lost to Follow-up|41|||
129213236|NCT02083354|465084522|FG000|Overall Study|Withdrawal by Subject|9|||
129213237|NCT02083354|465084522|FG000|Overall Study|Lost to Follow-up|1|||
129213238|NCT02083354|465084522|FG000|Overall Study|Adverse Event|3|||
129213239|NCT02083354|465084522|FG000|Overall Study|Disease progression|46|||
129213240|NCT02083354|465084522|FG000|Overall Study|Study closed/terminated|5|||
129213241|NCT00313014|465084533|FG000|Overall Study|Withdrawal by Subject|11|||
129213242|NCT00313014|465084534|FG001|Overall Study|Withdrawal by Subject|7|||
129213243|NCT00313014|465084535|FG002|Overall Study|Withdrawal by Subject|5|||
129213244|NCT00313014|465084533|FG000|Overall Study|Adverse Event|14|||
129213245|NCT00313014|465084534|FG001|Overall Study|Adverse Event|29|||
129213246|NCT00313014|465084535|FG002|Overall Study|Adverse Event|16|||
129213247|NCT00313014|465084533|FG000|Overall Study|Lost to Follow-up|7|||
129213248|NCT00313014|465084534|FG001|Overall Study|Lost to Follow-up|6|||
129213249|NCT00313014|465084535|FG002|Overall Study|Lost to Follow-up|10|||
129213250|NCT00313014|465084533|FG000|Overall Study|Administrative|9|||
129213251|NCT00313014|465084534|FG001|Overall Study|Administrative|6|||
129213252|NCT00313014|465084535|FG002|Overall Study|Administrative|14|||
129213253|NCT00313014|465084533|FG000|Overall Study|Lack of Efficacy|52|||
129213254|NCT00313014|465084534|FG001|Overall Study|Lack of Efficacy|25|||
129213255|NCT00313014|465084535|FG002|Overall Study|Lack of Efficacy|16|||
129213256|NCT01198795|465084536|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
129213257|NCT01198795|465084536|FG000|Overall Study|Withdrawal by Subject|17|||
129213258|NCT01198795|465084536|FG000|Overall Study|Lost to Follow-up|15|||
129213259|NCT01198795|465084536|FG000|Overall Study|Adverse Event|9|||
128876549|NCT01160289|463842351|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
128876550|NCT01160289|463842352|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
128876551|NCT01160289|463842347|FG000|Post-Randomization Period|Sponsor Decision|0|||
128876552|NCT01160289|463842348|FG001|Post-Randomization Period|Sponsor Decision|1|||
128876553|NCT01160289|463842349|FG002|Post-Randomization Period|Sponsor Decision|0|||
128876554|NCT01160289|463842350|FG003|Post-Randomization Period|Sponsor Decision|0|||
128876555|NCT01160289|463842351|FG004|Post-Randomization Period|Sponsor Decision|0|||
128876556|NCT01160289|463842352|FG005|Post-Randomization Period|Sponsor Decision|0|||
128876557|NCT01156792|463842354|FG000|Overall Study|Adverse Event|1|||
128876558|NCT01156792|463842354|FG000|Overall Study|Lack of Efficacy|36|||
128876559|NCT01156792|463842354|FG000|Overall Study|Protocol Violation|6|||
128876560|NCT01156792|463842354|FG000|Overall Study|Lost to Follow-up|3|||
128876561|NCT01156792|463842354|FG000|Overall Study|Physician Decision|3|||
128876562|NCT01156792|463842354|FG000|Overall Study|Withdrawal by Subject|9|||
128876563|NCT01156792|463842354|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
128876564|NCT01474434|463842355|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
128876565|NCT01474434|463842356|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
128876566|NCT01474434|463842357|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
128876567|NCT01474434|463842358|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
128876568|NCT01474434|463842355|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
128876569|NCT01474434|463842356|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
128876570|NCT01474434|463842357|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
128876571|NCT01474434|463842358|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
128876572|NCT01474434|463842355|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
128876573|NCT01474434|463842356|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
128876574|NCT01474434|463842357|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
128876575|NCT01474434|463842358|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
128876576|NCT00993668|463842359|FG000|Single-Blind Period|Adverse Event|1|||
128876577|NCT00993668|463842360|FG001|Single-Blind Period|Adverse Event|1|||
128876578|NCT00993668|463842359|FG000|Single-Blind Period|Lack of Efficacy|0|||
128876579|NCT00993668|463842360|FG001|Single-Blind Period|Lack of Efficacy|1|||
129213260|NCT01198795|465084536|FG000|Overall Study|Lack of Efficacy|5|||
129213261|NCT01198795|465084536|FG000|Overall Study|Protocol Violation|2|||
129213262|NCT01198795|465084536|FG000|Overall Study|Other Reason|4|||
129213263|NCT04154904|465084537|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
129213264|NCT04154904|465084538|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
129213265|NCT04154904|465084539|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
129213266|NCT00936715|465084540|FG000|Overall Study|Investigators Discretion|1|||
129213267|NCT00936715|465084540|FG000|Overall Study|Protocol Violation|1|||
129213268|NCT00936715|465084540|FG000|Overall Study|Safety or Tolerability Reasons|4|||
129213269|NCT04226742|465084541|FG000|Overall Study|Lost to Follow-up|16|||
129213270|NCT04226742|465084542|FG001|Overall Study|Lost to Follow-up|13|||
129213271|NCT04226742|465084541|FG000|Overall Study|Withdrawal by Subject|5|||
129213272|NCT04226742|465084542|FG001|Overall Study|Withdrawal by Subject|3|||
129213273|NCT02492763|465084543|FG000|Overall Study|Withdrawal by Subject|0|||
129213274|NCT02492763|465084544|FG001|Overall Study|Withdrawal by Subject|2|||
129213275|NCT02492763|465084545|FG002|Overall Study|Withdrawal by Subject|1|||
129213276|NCT02492763|465084546|FG003|Overall Study|Withdrawal by Subject|0|||
129213277|NCT02492763|465084543|FG000|Overall Study|Adverse Event|3|||
129213278|NCT02492763|465084544|FG001|Overall Study|Adverse Event|1|||
129213279|NCT02492763|465084545|FG002|Overall Study|Adverse Event|1|||
129213280|NCT02492763|465084546|FG003|Overall Study|Adverse Event|2|||
129213281|NCT02492763|465084543|FG000|Overall Study|Death|0|||
129213282|NCT02492763|465084544|FG001|Overall Study|Death|0|||
129213283|NCT02492763|465084545|FG002|Overall Study|Death|1|||
129213284|NCT02492763|465084546|FG003|Overall Study|Death|0|||
129213285|NCT02492763|465084543|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
129213286|NCT02492763|465084544|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
129213287|NCT02492763|465084545|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
129213288|NCT02492763|465084546|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
129213289|NCT02492763|465084543|FG000|Overall Study|Lost to Follow-up|0|||
129213290|NCT02492763|465084544|FG001|Overall Study|Lost to Follow-up|0|||
129213291|NCT02492763|465084545|FG002|Overall Study|Lost to Follow-up|1|||
129213292|NCT02492763|465084546|FG003|Overall Study|Lost to Follow-up|0|||
129213293|NCT02492763|465084543|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129213294|NCT02492763|465084544|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129213295|NCT02492763|465084545|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129213296|NCT02492763|465084546|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129213297|NCT02492763|465084543|FG000|Overall Study|Screen Failure|0|||
129213298|NCT02492763|465084544|FG001|Overall Study|Screen Failure|0|||
129213299|NCT02492763|465084545|FG002|Overall Study|Screen Failure|0|||
129213300|NCT02492763|465084546|FG003|Overall Study|Screen Failure|1|||
129213301|NCT02492763|465084543|FG000|Overall Study|Study Terminated by Sponsor|13|||
129213302|NCT02492763|465084544|FG001|Overall Study|Study Terminated by Sponsor|10|||
129213303|NCT02492763|465084545|FG002|Overall Study|Study Terminated by Sponsor|6|||
129213304|NCT02492763|465084546|FG003|Overall Study|Study Terminated by Sponsor|10|||
129213305|NCT00914316|465084550|FG000|Phase 1|Physician Decision|4|||
129213306|NCT00914316|465084551|FG001|Phase 1|Physician Decision|0|||
129213307|NCT00914316|465084552|FG002|Phase 1|Physician Decision|1|||
129213308|NCT00914316|465084553|FG003|Phase 1|Physician Decision|2|||
129213309|NCT00914316|465084550|FG000|Phase 1|Withdrawal by Subject|0|||
129213310|NCT00914316|465084551|FG001|Phase 1|Withdrawal by Subject|2|||
129213311|NCT00914316|465084552|FG002|Phase 1|Withdrawal by Subject|4|||
129213312|NCT00914316|465084553|FG003|Phase 1|Withdrawal by Subject|0|||
129213313|NCT00914316|465084550|FG000|Phase 1|Adverse Event|1|||
129213314|NCT00914316|465084551|FG001|Phase 1|Adverse Event|0|||
129213315|NCT00914316|465084552|FG002|Phase 1|Adverse Event|0|||
129213316|NCT00914316|465084553|FG003|Phase 1|Adverse Event|0|||
129213317|NCT00914316|465084550|FG000|Phase 2|Withdrawal by Subject|1|||
129213318|NCT00914316|465084551|FG001|Phase 2|Withdrawal by Subject|0|||
129213319|NCT00914316|465084552|FG002|Phase 2|Withdrawal by Subject|1|||
129213320|NCT00914316|465084553|FG003|Phase 2|Withdrawal by Subject|0|||
129213321|NCT01759446|465084555|FG000|Overall Study|Protocol Violation|1|||
129213322|NCT01759446|465084556|FG001|Overall Study|Protocol Violation|0|||
129213323|NCT01759446|465084557|FG002|Overall Study|Protocol Violation|1|||
129213324|NCT01759446|465084558|FG003|Overall Study|Protocol Violation|0|||
129213325|NCT01759446|465084559|FG004|Overall Study|Protocol Violation|0|||
129213326|NCT01759446|465084555|FG000|Overall Study|Withdrawal by Subject|0|||
129213327|NCT01759446|465084556|FG001|Overall Study|Withdrawal by Subject|1|||
129213328|NCT01759446|465084557|FG002|Overall Study|Withdrawal by Subject|0|||
129213329|NCT01759446|465084558|FG003|Overall Study|Withdrawal by Subject|1|||
128987392|NCT03795233|464241612|FG001|Overall Study|Lost to Follow-up|0|||
129213330|NCT01759446|465084559|FG004|Overall Study|Withdrawal by Subject|0|||
129213331|NCT01213472|465084567|FG000|Overall Study|Recurrence/Progressive disease|25|||
129213332|NCT01213472|465084567|FG000|Overall Study|Withdrawal by Subject|1|||
129213333|NCT01213472|465084567|FG000|Overall Study|Physician Decision|1|||
129213334|NCT02085460|465084568|FG000|Overall Study|Adverse Event|2|||
129213335|NCT02085460|465084569|FG001|Overall Study|Adverse Event|2|||
129213336|NCT02085460|465084570|FG002|Overall Study|Adverse Event|1|||
129213337|NCT02085460|465084568|FG000|Overall Study|Physician Decision|1|||
129213338|NCT02085460|465084569|FG001|Overall Study|Physician Decision|1|||
129213339|NCT02085460|465084570|FG002|Overall Study|Physician Decision|2|||
129213340|NCT02085460|465084568|FG000|Overall Study|Withdrawal by Subject|11|||
129213341|NCT02085460|465084569|FG001|Overall Study|Withdrawal by Subject|5|||
129213342|NCT02085460|465084570|FG002|Overall Study|Withdrawal by Subject|7|||
129213343|NCT01285323|465084571|FG000|Overall Study|Adverse Event|9|||
129213344|NCT01285323|465084572|FG001|Overall Study|Adverse Event|8|||
129213345|NCT01285323|465084571|FG000|Overall Study|Lack of Efficacy|4|||
129213346|NCT01285323|465084572|FG001|Overall Study|Lack of Efficacy|2|||
129213347|NCT01285323|465084571|FG000|Overall Study|Withdrawal by Subject|15|||
129213348|NCT01285323|465084572|FG001|Overall Study|Withdrawal by Subject|11|||
129213349|NCT01285323|465084571|FG000|Overall Study|Protocol Violation|1|||
129213350|NCT01285323|465084572|FG001|Overall Study|Protocol Violation|2|||
129213351|NCT01285323|465084571|FG000|Overall Study|Non-compliance with study procedures|2|||
129213352|NCT01285323|465084572|FG001|Overall Study|Non-compliance with study procedures|3|||
129213353|NCT01285323|465084571|FG000|Overall Study|Lost to Follow-up|1|||
129213354|NCT01285323|465084572|FG001|Overall Study|Lost to Follow-up|1|||
129213355|NCT01285323|465084571|FG000|Overall Study|Other|1|||
129213356|NCT01285323|465084572|FG001|Overall Study|Other|3|||
129213357|NCT00763035|465084573|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
129213358|NCT00763035|465084574|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
129213359|NCT00763035|465084573|FG000|First Intervention|Adverse Event|0|||
128987393|NCT03795233|464241611|FG000|Overall Study|Death|1|||
129213360|NCT00763035|465084574|FG001|First Intervention|Adverse Event|1|||
129213361|NCT00763035|465084573|FG000|Second Intervention|Adverse Event|1|||
129213362|NCT00763035|465084574|FG001|Second Intervention|Adverse Event|0|||
129213363|NCT00763035|465084573|FG000|Second Intervention|Physician Decision|2|||
129213364|NCT00763035|465084574|FG001|Second Intervention|Physician Decision|0|||
129213365|NCT02606643|465084575|FG000|Overall Study|did not meet inclusion criteria|1|||
129213366|NCT02606643|465084576|FG001|Overall Study|did not meet inclusion criteria|3|||
129213367|NCT04313244|465084582|FG000|Overall Study|Withdrawal of Consent|3|||
129213368|NCT04313244|465084583|FG001|Overall Study|Withdrawal of Consent|3|||
129213369|NCT04313244|465084582|FG000|Overall Study|Met Exclusion Criteria|1|||
129213370|NCT04313244|465084583|FG001|Overall Study|Met Exclusion Criteria|0|||
129213371|NCT04313244|465084582|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
129213372|NCT04313244|465084583|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
129213373|NCT01472289|465084586|FG000|Overall Study|Death|2|||
129213374|NCT00907335|465084587|FG000|Overall Study|Withdrawal by Subject|2|||
129213375|NCT00907335|465084588|FG001|Overall Study|Withdrawal by Subject|0|||
129213376|NCT00907335|465084587|FG000|Overall Study|Adverse Event|4|||
129213377|NCT00907335|465084588|FG001|Overall Study|Adverse Event|1|||
129213378|NCT00907335|465084587|FG000|Overall Study|Lost to Follow-up|2|||
129213379|NCT00907335|465084588|FG001|Overall Study|Lost to Follow-up|0|||
129213380|NCT03879772|465084589|FG000|Overall Study|Adverse Event|2|||
129213381|NCT03879772|465084590|FG001|Overall Study|Adverse Event|2|||
129213382|NCT03879772|465084591|FG002|Overall Study|Adverse Event|3|||
129213383|NCT03879772|465084592|FG003|Overall Study|Adverse Event|4|||
129213384|NCT03879772|465084593|FG004|Overall Study|Adverse Event|3|||
129213385|NCT03879772|465084589|FG000|Overall Study|Treatment Failure|1|||
129213386|NCT03879772|465084590|FG001|Overall Study|Treatment Failure|0|||
129213387|NCT03879772|465084591|FG002|Overall Study|Treatment Failure|0|||
129213388|NCT03879772|465084592|FG003|Overall Study|Treatment Failure|2|||
129213389|NCT03879772|465084593|FG004|Overall Study|Treatment Failure|1|||
129213390|NCT03879772|465084589|FG000|Overall Study|Lost to Follow-up|0|||
128987394|NCT03795233|464241612|FG001|Overall Study|Death|0|||
128987395|NCT01869959|464241616|FG000|Randomization Period|Physician Decision|0|||
128987396|NCT01869959|464241617|FG001|Randomization Period|Physician Decision|0|||
128987397|NCT01869959|464241618|FG002|Randomization Period|Physician Decision|0|||
128987398|NCT01869959|464241619|FG003|Randomization Period|Physician Decision|0|||
128987399|NCT01869959|464241620|FG004|Randomization Period|Physician Decision|1|||
128987400|NCT01869959|464241616|FG000|Treatment Period|Adverse Event|1|||
128987401|NCT01869959|464241617|FG001|Treatment Period|Adverse Event|0|||
128987402|NCT01869959|464241618|FG002|Treatment Period|Adverse Event|3|||
128987403|NCT01869959|464241619|FG003|Treatment Period|Adverse Event|1|||
128987404|NCT01869959|464241620|FG004|Treatment Period|Adverse Event|0|||
128987405|NCT01869959|464241616|FG000|Treatment Period|Sponsor decision|0|||
128987406|NCT01869959|464241617|FG001|Treatment Period|Sponsor decision|1|||
129213391|NCT03879772|465084590|FG001|Overall Study|Lost to Follow-up|0|||
129213392|NCT03879772|465084591|FG002|Overall Study|Lost to Follow-up|0|||
129213393|NCT03879772|465084592|FG003|Overall Study|Lost to Follow-up|0|||
129213394|NCT03879772|465084593|FG004|Overall Study|Lost to Follow-up|1|||
129213395|NCT03879772|465084589|FG000|Overall Study|Withdrawal by Subject|0|||
129213396|NCT03879772|465084590|FG001|Overall Study|Withdrawal by Subject|1|||
129213397|NCT03879772|465084591|FG002|Overall Study|Withdrawal by Subject|3|||
129213398|NCT03879772|465084592|FG003|Overall Study|Withdrawal by Subject|1|||
129213399|NCT03879772|465084593|FG004|Overall Study|Withdrawal by Subject|1|||
129213400|NCT03879772|465084589|FG000|Overall Study|Protocol Violation|0|||
128763055|NCT00991341|463422701|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
129213401|NCT03879772|465084590|FG001|Overall Study|Protocol Violation|0|||
129213402|NCT03879772|465084591|FG002|Overall Study|Protocol Violation|3|||
129213403|NCT03879772|465084592|FG003|Overall Study|Protocol Violation|1|||
128987407|NCT01869959|464241618|FG002|Treatment Period|Sponsor decision|0|||
128987408|NCT01869959|464241619|FG003|Treatment Period|Sponsor decision|1|||
129213404|NCT03879772|465084593|FG004|Overall Study|Protocol Violation|2|||
129213405|NCT03879772|465084589|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
129213406|NCT03879772|465084590|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
129213407|NCT03879772|465084591|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
129213408|NCT03879772|465084592|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
129213409|NCT03879772|465084593|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
129213410|NCT02161016|465084594|FG000|Overall Study|withdrawn by IRB|1|||
129213411|NCT00728689|465084601|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
129213412|NCT00728689|465084602|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
129213413|NCT00929695|465084603|FG000|Overall Study|Death|2|||
129213414|NCT00929695|465084604|FG001|Overall Study|Death|1|||
129213415|NCT00929695|465084603|FG000|Overall Study|Withdrawal by Subject|0|||
129213416|NCT00929695|465084604|FG001|Overall Study|Withdrawal by Subject|2|||
129213417|NCT00929695|465084603|FG000|Overall Study|discharge home|4|||
129213418|NCT00929695|465084604|FG001|Overall Study|discharge home|3|||
129213419|NCT00929695|465084603|FG000|Overall Study|incorrect stratification|2|||
129213420|NCT00929695|465084604|FG001|Overall Study|incorrect stratification|0|||
129213421|NCT03216226|465084605|FG000|Overall Study|Adverse Event|3|||
129213422|NCT03216226|465084606|FG001|Overall Study|Adverse Event|0|||
129213423|NCT03216226|465084605|FG000|Overall Study|Protocol Violation|1|||
129213424|NCT03216226|465084606|FG001|Overall Study|Protocol Violation|3|||
129213425|NCT03216226|465084605|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
129213426|NCT03216226|465084606|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
129213427|NCT03216226|465084605|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
129213428|NCT03216226|465084606|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
129213429|NCT03216226|465084605|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
129213430|NCT03216226|465084606|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
128987409|NCT01869959|464241620|FG004|Treatment Period|Sponsor decision|0|||
128987410|NCT01869959|464241616|FG000|Treatment Period|Withdrawal by Subject|0|||
128987411|NCT01869959|464241617|FG001|Treatment Period|Withdrawal by Subject|1|||
128987412|NCT01869959|464241618|FG002|Treatment Period|Withdrawal by Subject|0|||
128987413|NCT01869959|464241619|FG003|Treatment Period|Withdrawal by Subject|0|||
128987414|NCT01869959|464241620|FG004|Treatment Period|Withdrawal by Subject|0|||
128987415|NCT00828009|464241621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
128987416|NCT00828009|464241621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
128987417|NCT00828009|464241621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
128987418|NCT00828009|464241621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
129213431|NCT00887809|465084607|FG000|Overall Study|Patient Not Treated|3|||
129213432|NCT00887809|465084608|FG001|Overall Study|Patient Not Treated|0|||
129213433|NCT00887809|465084607|FG000|Overall Study|Death|1|||
129213434|NCT00887809|465084608|FG001|Overall Study|Death|0|||
129213435|NCT01352715|465084611|FG000|Overall Study|Death|3|||
129213436|NCT01352715|465084612|FG001|Overall Study|Death|3|||
129213437|NCT01352715|465084611|FG000|Overall Study|Lost to Follow-up|5|||
129213438|NCT01352715|465084612|FG001|Overall Study|Lost to Follow-up|7|||
129213439|NCT01352715|465084611|FG000|Overall Study|Withdrawal by Subject|4|||
129213440|NCT01352715|465084612|FG001|Overall Study|Withdrawal by Subject|8|||
129213441|NCT01352715|465084611|FG000|Overall Study|site closure|16|||
129213442|NCT01352715|465084612|FG001|Overall Study|site closure|15|||
129213443|NCT01352715|465084611|FG000|Overall Study|no final visit in closeout period|15|||
129213444|NCT01352715|465084612|FG001|Overall Study|no final visit in closeout period|12|||
129213445|NCT01352715|465084611|FG000|Overall Study|major ineligibility|2|||
129213446|NCT01352715|465084612|FG001|Overall Study|major ineligibility|1|||
129213447|NCT04109547|465084613|FG000|Overall Study|Withdrawal by Subject|3|||
129213448|NCT04109547|465084614|FG001|Overall Study|Withdrawal by Subject|2|||
129213449|NCT04109547|465084615|FG002|Overall Study|Withdrawal by Subject|6|||
129213450|NCT04109547|465084616|FG003|Overall Study|Withdrawal by Subject|6|||
129213451|NCT04109547|465084613|FG000|Overall Study|Lost to Follow-up|0|||
129213452|NCT04109547|465084614|FG001|Overall Study|Lost to Follow-up|0|||
129213453|NCT04109547|465084615|FG002|Overall Study|Lost to Follow-up|0|||
129213454|NCT04109547|465084616|FG003|Overall Study|Lost to Follow-up|1|||
129213455|NCT04109547|465084613|FG000|Overall Study|Physician Decision|1|||
129213456|NCT04109547|465084614|FG001|Overall Study|Physician Decision|2|||
129213457|NCT04109547|465084615|FG002|Overall Study|Physician Decision|0|||
129213458|NCT04109547|465084616|FG003|Overall Study|Physician Decision|0|||
129213459|NCT00871975|465084617|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
129213460|NCT00871975|465084617|FG000|Overall Study|Catheters could not be inserted|1|||
128987419|NCT00828009|464241621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
128987420|NCT00828009|464241621|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
128987421|NCT00828009|464241621|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
128987422|NCT00828009|464241621|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
128987423|NCT00828009|464241621|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
128987424|NCT00828009|464241621|FG000|Step 2 - Maintenance Therapy|Death|1|||
128987425|NCT00828009|464241621|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
128987426|NCT00828009|464241621|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
128987427|NCT00828009|464241621|FG000|Step 2 - Maintenance Therapy|Other|1|||
128987428|NCT00563706|464243255|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
128987429|NCT00563706|464243256|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
128987430|NCT00563706|464243257|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
128987431|NCT00563706|464243258|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
128987432|NCT00563706|464243259|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
128987433|NCT00563706|464243260|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
128987434|NCT00563706|464243261|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
128987435|NCT00563706|464243262|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
128987436|NCT00563706|464243263|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
128987437|NCT00563706|464243255|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
128987438|NCT00563706|464243256|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
128987439|NCT00563706|464243257|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
128987440|NCT00563706|464243258|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
129213461|NCT00871975|465084617|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
129213462|NCT00871975|465084617|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
129213463|NCT00870740|465084618|FG000|Overall Study|Adverse Event|2|||
129213464|NCT00870740|465084619|FG001|Overall Study|Adverse Event|1|||
129213465|NCT00870740|465084620|FG002|Overall Study|Adverse Event|3|||
129213466|NCT00870740|465084621|FG003|Overall Study|Adverse Event|2|||
129213467|NCT00870740|465084622|FG004|Overall Study|Adverse Event|1|||
129213468|NCT00870740|465084623|FG005|Overall Study|Adverse Event|6|||
129213469|NCT00870740|465084618|FG000|Overall Study|Consent Withdrawn|6|||
129213470|NCT00870740|465084619|FG001|Overall Study|Consent Withdrawn|3|||
129213471|NCT00870740|465084620|FG002|Overall Study|Consent Withdrawn|4|||
129213472|NCT00870740|465084621|FG003|Overall Study|Consent Withdrawn|6|||
129213473|NCT00870740|465084622|FG004|Overall Study|Consent Withdrawn|6|||
129213474|NCT00870740|465084623|FG005|Overall Study|Consent Withdrawn|5|||
129213475|NCT00870740|465084618|FG000|Overall Study|Investigator Decision|2|||
129213476|NCT00870740|465084619|FG001|Overall Study|Investigator Decision|0|||
129213477|NCT00870740|465084620|FG002|Overall Study|Investigator Decision|1|||
129213478|NCT00870740|465084621|FG003|Overall Study|Investigator Decision|0|||
129213479|NCT00870740|465084622|FG004|Overall Study|Investigator Decision|0|||
129213480|NCT00870740|465084623|FG005|Overall Study|Investigator Decision|0|||
129213481|NCT00870740|465084618|FG000|Overall Study|Subject Non-compliance|0|||
129213482|NCT00870740|465084619|FG001|Overall Study|Subject Non-compliance|0|||
129213483|NCT00870740|465084620|FG002|Overall Study|Subject Non-compliance|0|||
129213484|NCT00870740|465084621|FG003|Overall Study|Subject Non-compliance|0|||
129213485|NCT00870740|465084622|FG004|Overall Study|Subject Non-compliance|0|||
129213486|NCT00870740|465084623|FG005|Overall Study|Subject Non-compliance|1|||
129213487|NCT00870740|465084618|FG000|Overall Study|Death|0|||
129213488|NCT00870740|465084619|FG001|Overall Study|Death|0|||
129213489|NCT00870740|465084620|FG002|Overall Study|Death|0|||
129213490|NCT00870740|465084621|FG003|Overall Study|Death|0|||
129213491|NCT00870740|465084622|FG004|Overall Study|Death|1|||
129213492|NCT00870740|465084623|FG005|Overall Study|Death|0|||
129213493|NCT00870740|465084618|FG000|Overall Study|Other|2|||
129213494|NCT00870740|465084619|FG001|Overall Study|Other|5|||
129213495|NCT00870740|465084620|FG002|Overall Study|Other|2|||
129213496|NCT00870740|465084621|FG003|Overall Study|Other|4|||
129213497|NCT00870740|465084622|FG004|Overall Study|Other|3|||
129213498|NCT00870740|465084623|FG005|Overall Study|Other|5|||
129213499|NCT03592186|465084624|FG000|Overall Study|Withdrawal by Subject|1|||
129213500|NCT03592186|465084625|FG001|Overall Study|Withdrawal by Subject|0|||
129213501|NCT03592186|465084624|FG000|Overall Study|Lost to Follow-up|16|||
129213502|NCT03592186|465084625|FG001|Overall Study|Lost to Follow-up|11|||
129213503|NCT00307801|465084628|FG000|Overall Study|Adverse Event|12|||
129213504|NCT00307801|465084629|FG001|Overall Study|Adverse Event|4|||
129213505|NCT00307801|465084628|FG000|Overall Study|Withdrawal by Subject|9|||
128763056|NCT00991341|463422700|FG000|Overall Study|Death|3|||
128763057|NCT00991341|463422701|FG001|Overall Study|Death|0|||
128987441|NCT00563706|464243259|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
128987442|NCT00563706|464243260|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
129213506|NCT00307801|465084629|FG001|Overall Study|Withdrawal by Subject|4|||
129213507|NCT00307801|465084628|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
129213508|NCT00307801|465084629|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
129213509|NCT00307801|465084628|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
129213510|NCT00307801|465084629|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
129213511|NCT00307801|465084628|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
129213512|NCT00307801|465084629|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
128987443|NCT00563706|464243261|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
128987444|NCT00563706|464243262|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
128987445|NCT00563706|464243263|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
128987446|NCT00563706|464243255|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
128987447|NCT00563706|464243256|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
128987448|NCT00563706|464243257|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
128987449|NCT00563706|464243258|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
128987450|NCT00563706|464243259|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
128987451|NCT00563706|464243260|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
128987452|NCT00563706|464243261|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
128987453|NCT00563706|464243262|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
128987454|NCT00563706|464243263|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
128987455|NCT00563706|464243255|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
128987456|NCT00563706|464243256|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
128987457|NCT00563706|464243257|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
128987458|NCT00563706|464243258|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
128987459|NCT00563706|464243259|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
128987460|NCT00563706|464243260|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
128987461|NCT00563706|464243261|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
128987462|NCT00563706|464243262|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
128987463|NCT00563706|464243263|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
128987464|NCT00563706|464243255|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
128987465|NCT00563706|464243256|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
128987466|NCT00563706|464243257|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
128987467|NCT00563706|464243258|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
128987468|NCT00563706|464243259|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
128987469|NCT00563706|464243260|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
128987470|NCT00563706|464243261|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
128987471|NCT00563706|464243262|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
128987472|NCT00563706|464243263|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
128987473|NCT01361308|464243266|FG000|Overall Study|Withdrawal by Subject|9|||
128987474|NCT01361308|464243267|FG001|Overall Study|Withdrawal by Subject|13|||
128987475|NCT01361308|464243266|FG000|Overall Study|Physician Decision|3|||
128987476|NCT01361308|464243267|FG001|Overall Study|Physician Decision|3|||
128987477|NCT01361308|464243266|FG000|Overall Study|Lack of Efficacy|2|||
128987478|NCT01361308|464243267|FG001|Overall Study|Lack of Efficacy|0|||
128987479|NCT01361308|464243266|FG000|Overall Study|Protocol Violation|1|||
128987480|NCT01361308|464243267|FG001|Overall Study|Protocol Violation|0|||
128987481|NCT01361308|464243266|FG000|Overall Study|Lost to Follow-up|5|||
128987482|NCT01361308|464243267|FG001|Overall Study|Lost to Follow-up|4|||
128987483|NCT01361308|464243266|FG000|Overall Study|Adverse Event|8|||
128987484|NCT01361308|464243267|FG001|Overall Study|Adverse Event|4|||
128987485|NCT01361308|464243266|FG000|Overall Study|Eligibility Criteria Not Met|2|||
128987486|NCT01361308|464243267|FG001|Overall Study|Eligibility Criteria Not Met|3|||
128987487|NCT01361308|464243266|FG000|Overall Study|Failed C-SSRS|5|||
128987488|NCT01361308|464243267|FG001|Overall Study|Failed C-SSRS|2|||
128987489|NCT01361308|464243266|FG000|Overall Study|Other|0|||
128987490|NCT01361308|464243267|FG001|Overall Study|Other|1|||
128987491|NCT00700115|464243276|FG000|Overall Study|Withdrawal by Subject|1|||
128987492|NCT00700115|464243277|FG001|Overall Study|Withdrawal by Subject|0|||
128987493|NCT00700115|464243276|FG000|Overall Study|Lost to Follow-up|0|||
128987494|NCT00700115|464243277|FG001|Overall Study|Lost to Follow-up|1|||
128987495|NCT02503215|464243278|FG000|Overall Study|Unable to wear compression stockings|1|||
128987496|NCT02503215|464243278|FG000|Overall Study|Unable to use positive airway pressure|2|||
128987497|NCT02983305|464243283|FG000|Overall Study|incomplete data|2|||
128987498|NCT02983305|464243284|FG001|Overall Study|incomplete data|0|||
128987499|NCT00822237|464243285|FG000|Dose 1 Vaccination|Not vaccinated|3|||
128987500|NCT00822237|464243286|FG001|Dose 1 Vaccination|Not vaccinated|0|||
128987501|NCT00822237|464243285|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
128987502|NCT00822237|464243286|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
128987503|NCT00822237|464243285|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
128987504|NCT00822237|464243286|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
128987505|NCT00822237|464243285|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
128987506|NCT00822237|464243286|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
128987507|NCT00822237|464243285|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
128987508|NCT00822237|464243286|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
128987509|NCT01646268|464243287|FG000|Overall Study|Adverse Event|6|||
128987510|NCT01646268|464243288|FG001|Overall Study|Adverse Event|7|||
128987511|NCT01646268|464243287|FG000|Overall Study|Lack of Efficacy|1|||
128987512|NCT01646268|464243288|FG001|Overall Study|Lack of Efficacy|3|||
129213513|NCT00307801|465084628|FG000|Overall Study|Wrong Randomization|1|||
129213514|NCT00307801|465084629|FG001|Overall Study|Wrong Randomization|0|||
129213515|NCT00307801|465084628|FG000|Overall Study|Lack of Efficacy|0|||
129213516|NCT00307801|465084629|FG001|Overall Study|Lack of Efficacy|2|||
129213517|NCT00307801|465084628|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
129213518|NCT00307801|465084629|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
129213519|NCT00307801|465084628|FG000|Overall Study|Frustration with e-diary|1|||
129213520|NCT00307801|465084629|FG001|Overall Study|Frustration with e-diary|0|||
129213521|NCT00307801|465084628|FG000|Overall Study|Protocol Violation|3|||
129213522|NCT00307801|465084629|FG001|Overall Study|Protocol Violation|2|||
129213523|NCT00307801|465084628|FG000|Overall Study|No reason specified|2|||
129213524|NCT00307801|465084629|FG001|Overall Study|No reason specified|0|||
129213525|NCT00307801|465084628|FG000|Overall Study|Pregnancy|0|||
129213526|NCT00307801|465084629|FG001|Overall Study|Pregnancy|1|||
129213527|NCT00551642|465084632|FG000|Treatment Period|Protocol Deviation|6|||
129213528|NCT00551642|465084633|FG001|Treatment Period|Protocol Deviation|11|||
129213529|NCT00551642|465084632|FG000|Treatment Period|Delivery device failure|1|||
129213530|NCT00551642|465084633|FG001|Treatment Period|Delivery device failure|3|||
129213531|NCT00551642|465084632|FG000|Treatment Period|Physician Decision|0|||
129213532|NCT00551642|465084633|FG001|Treatment Period|Physician Decision|1|||
129213533|NCT00551642|465084632|FG000|Treatment Period|Death|33|||
129213534|NCT00551642|465084633|FG001|Treatment Period|Death|31|||
129213535|NCT00551642|465084632|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
129213536|NCT00551642|465084633|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
129213537|NCT00551642|465084632|FG000|Treatment Period|Adverse Event|15|||
129213538|NCT00551642|465084633|FG001|Treatment Period|Adverse Event|12|||
129213539|NCT00551642|465084632|FG000|Treatment Period|Withdrawal by Subject|2|||
129213540|NCT00551642|465084633|FG001|Treatment Period|Withdrawal by Subject|1|||
129213541|NCT03011099|465084637|FG000|Overall Study|Withdrawal by Subject|0|||
129213542|NCT03011099|465084638|FG001|Overall Study|Withdrawal by Subject|2|||
129213543|NCT02668653|465084641|FG000|Overall Study|Refractory disease|41|||
129213544|NCT02668653|465084642|FG001|Overall Study|Refractory disease|70|||
129213545|NCT02668653|465084641|FG000|Overall Study|Relapse|44|||
129213546|NCT02668653|465084642|FG001|Overall Study|Relapse|65|||
129213547|NCT02668653|465084641|FG000|Overall Study|Adverse Event|58|||
129213548|NCT02668653|465084642|FG001|Overall Study|Adverse Event|23|||
129213549|NCT02668653|465084641|FG000|Overall Study|Subject decision to stop study drug|25|||
129213550|NCT02668653|465084642|FG001|Overall Study|Subject decision to stop study drug|23|||
129213551|NCT02668653|465084641|FG000|Overall Study|Other reasons not specified|16|||
129213552|NCT02668653|465084642|FG001|Overall Study|Other reasons not specified|11|||
129213553|NCT02668653|465084641|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
129213554|NCT02668653|465084642|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
129213555|NCT02668653|465084641|FG000|Overall Study|Investigator decision|10|||
129213556|NCT02668653|465084642|FG001|Overall Study|Investigator decision|7|||
129213557|NCT02668653|465084641|FG000|Overall Study|Failure to meet continuation criteria|5|||
128876580|NCT00993668|463842359|FG000|Single-Blind Period|Lost to Follow-up|3|||
128876581|NCT00993668|463842360|FG001|Single-Blind Period|Lost to Follow-up|1|||
128876582|NCT00993668|463842359|FG000|Open-Label Period|Adverse Event|9|||
128876583|NCT00993668|463842360|FG001|Open-Label Period|Adverse Event|8|||
128876584|NCT00993668|463842359|FG000|Open-Label Period|Lack of Efficacy|4|||
128876585|NCT00993668|463842360|FG001|Open-Label Period|Lack of Efficacy|3|||
128876586|NCT00993668|463842359|FG000|Open-Label Period|Withdrawal by Subject|4|||
128876587|NCT00993668|463842360|FG001|Open-Label Period|Withdrawal by Subject|3|||
128876588|NCT00993668|463842359|FG000|Open-Label Period|Lost to Follow-up|6|||
128876589|NCT00993668|463842360|FG001|Open-Label Period|Lost to Follow-up|1|||
128876590|NCT03606668|463842363|FG000|Overall Study|Screen Failure|1|||
128876591|NCT03606668|463842363|FG000|Overall Study|Lost to Follow-up|1|||
128876592|NCT02057523|463842367|FG000|Overall Study|Withdrawal by Subject|1|||
128876593|NCT02057523|463842367|FG000|Overall Study|Lack of Efficacy|1|||
128876594|NCT03618823|463842371|FG000|Overall Study|Lost to Follow-up|63|||
128876595|NCT03618823|463842372|FG001|Overall Study|Lost to Follow-up|61|||
128876596|NCT00523640|463842373|FG000|Overall Study|Death|1|||
128876597|NCT02399254|463842374|FG000|Overall Study|Physician Decision|2|||
128876598|NCT01506609|463842375|FG000|Overall Study|Adverse Event Related to Progression|0|||
129213558|NCT02668653|465084642|FG001|Overall Study|Failure to meet continuation criteria|12|||
128876599|NCT01506609|463842376|FG001|Overall Study|Adverse Event Related to Progression|0|||
128876600|NCT01506609|463842377|FG002|Overall Study|Adverse Event Related to Progression|0|||
128987513|NCT01646268|464243287|FG000|Overall Study|Protocol Violation|0|||
129213559|NCT02668653|465084641|FG000|Overall Study|Lost to Follow-up|1|||
129213560|NCT02668653|465084642|FG001|Overall Study|Lost to Follow-up|0|||
129213561|NCT02668653|465084641|FG000|Overall Study|Pregnancy|0|||
129213562|NCT02668653|465084642|FG001|Overall Study|Pregnancy|1|||
129213563|NCT02668653|465084641|FG000|Overall Study|Death|0|||
129213564|NCT02668653|465084642|FG001|Overall Study|Death|1|||
129213565|NCT01294553|465084643|FG000|Overall Study|Duplicated Participants|1|||
129213566|NCT01294553|465084643|FG000|Overall Study|Protocol Violation|268|||
129213567|NCT01217229|465084644|FG000|Overall Study|Adverse Event|1|||
129213568|NCT01217229|465084644|FG000|Overall Study|Disease progression, deterioration|2|||
128987514|NCT01646268|464243288|FG001|Overall Study|Protocol Violation|1|||
128987515|NCT01646268|464243287|FG000|Overall Study|Withdrawal by Subject|2|||
128987516|NCT01646268|464243288|FG001|Overall Study|Withdrawal by Subject|5|||
128987517|NCT01646268|464243287|FG000|Overall Study|Other|2|||
129213569|NCT01217229|465084644|FG000|Overall Study|Disease progression, Cheson criteria|14|||
129213570|NCT01217229|465084644|FG000|Overall Study|Protocol Violation|1|||
129213571|NCT01217229|465084644|FG000|Overall Study|Disease progression not confirmed|2|||
129213572|NCT00926237|465084645|FG000|Overall Study|Withdrawal by Subject|2|||
129213573|NCT00926237|465084646|FG001|Overall Study|Withdrawal by Subject|1|||
129213574|NCT00577889|465084647|FG000|Overall Study|Withdrawal by Subject|1|||
129213575|NCT00577889|465084648|FG001|Overall Study|Withdrawal by Subject|0|||
129213576|NCT00577889|465084649|FG002|Overall Study|Withdrawal by Subject|0|||
129213577|NCT02667119|465084650|FG000|Overall Study|Lost to Follow-up|3|||
129213578|NCT02667119|465084651|FG001|Overall Study|Lost to Follow-up|0|||
129213579|NCT03783078|465084654|FG000|Overall Study|Death|31|||
129213580|NCT03783078|465084654|FG000|Overall Study|Sponsor Decision|23|||
129213581|NCT03783078|465084654|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129213582|NCT02059278|465084656|FG000|Overall Study|Adverse Event|1|||
129213583|NCT02059278|465084657|FG001|Overall Study|Adverse Event|1|||
129213584|NCT02059278|465084656|FG000|Overall Study|Lost to Follow-up|1|||
129213585|NCT02059278|465084657|FG001|Overall Study|Lost to Follow-up|0|||
129213586|NCT02059278|465084656|FG000|Overall Study|Withdrawal by Subject|0|||
129213587|NCT02059278|465084657|FG001|Overall Study|Withdrawal by Subject|3|||
129213588|NCT02059278|465084656|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
129213589|NCT02059278|465084657|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
129213590|NCT00541658|465084658|FG000|Overall Study|Adverse Event|28|||
129213591|NCT00541658|465084659|FG001|Overall Study|Adverse Event|37|||
129213592|NCT00541658|465084660|FG002|Overall Study|Adverse Event|25|||
129213593|NCT00541658|465084658|FG000|Overall Study|Physician Decision|0|||
129213594|NCT00541658|465084659|FG001|Overall Study|Physician Decision|0|||
129213595|NCT00541658|465084660|FG002|Overall Study|Physician Decision|4|||
129213596|NCT00541658|465084658|FG000|Overall Study|Lost to Follow-up|3|||
129213597|NCT00541658|465084659|FG001|Overall Study|Lost to Follow-up|3|||
129213598|NCT00541658|465084660|FG002|Overall Study|Lost to Follow-up|6|||
129213599|NCT00541658|465084658|FG000|Overall Study|Protocol Violation|0|||
129213600|NCT00541658|465084659|FG001|Overall Study|Protocol Violation|1|||
129213601|NCT00541658|465084660|FG002|Overall Study|Protocol Violation|1|||
129213602|NCT00541658|465084658|FG000|Overall Study|Withdrawal by Subject|28|||
129213603|NCT00541658|465084659|FG001|Overall Study|Withdrawal by Subject|32|||
129213604|NCT00541658|465084660|FG002|Overall Study|Withdrawal by Subject|32|||
129213605|NCT00541658|465084658|FG000|Overall Study|Took No Study Drug|1|||
129213606|NCT00541658|465084659|FG001|Overall Study|Took No Study Drug|0|||
129213607|NCT00541658|465084660|FG002|Overall Study|Took No Study Drug|0|||
129213608|NCT04482647|465084666|FG000|Overall Study|Time constraints|2|||
129213609|NCT04482647|465084666|FG000|Overall Study|Health issues|1|||
129213610|NCT04482647|465084666|FG000|Overall Study|Death in the family|1|||
129213611|NCT04482647|465084666|FG000|Overall Study|Disliked the intervention|1|||
129213612|NCT04482647|465084666|FG000|Overall Study|No reasons specified|7|||
129213613|NCT02484391|465084667|FG000|Overall Study|Lack of Efficacy|15|||
129213614|NCT02484391|465084668|FG001|Overall Study|Lack of Efficacy|14|||
129213615|NCT02484391|465084669|FG002|Overall Study|Lack of Efficacy|3|||
128987518|NCT01646268|464243288|FG001|Overall Study|Other|0|||
128987519|NCT01519635|464243293|FG000|Overall Study|Withdrawal by Subject|0|||
128987520|NCT01519635|464243294|FG001|Overall Study|Withdrawal by Subject|1|||
128987521|NCT01519635|464243293|FG000|Overall Study|No possibility to put a catheter|1|||
128987522|NCT01519635|464243294|FG001|Overall Study|No possibility to put a catheter|2|||
128987523|NCT01300741|464243295|FG000|Overall Study|Lens deposits|1|||
128987524|NCT01300741|464243295|FG000|Overall Study|Lost to Follow-up|1|||
128987525|NCT01300741|464243295|FG000|Overall Study|Discomfort|1|||
128987526|NCT02325414|464243296|FG000|Overall Study|Withdrawal by Subject|3|||
128987527|NCT02325414|464243297|FG001|Overall Study|Withdrawal by Subject|1|||
128987528|NCT02325414|464243296|FG000|Overall Study|Lost to Follow-up|5|||
128987529|NCT02325414|464243297|FG001|Overall Study|Lost to Follow-up|5|||
128987530|NCT01339273|464243298|FG000|Overall Study|Lost to Follow-up|8|||
128987531|NCT01339273|464243299|FG001|Overall Study|Lost to Follow-up|8|||
128987532|NCT00726882|464243300|FG000|Overall Study|Withdrawal by Subject|5|||
128987533|NCT00726882|464243300|FG000|Overall Study|Lost to Follow-up|7|||
129213616|NCT02484391|465084667|FG000|Overall Study|Lost to Follow-up|0|||
129213617|NCT02484391|465084668|FG001|Overall Study|Lost to Follow-up|0|||
129213618|NCT02484391|465084669|FG002|Overall Study|Lost to Follow-up|2|||
128987534|NCT00726882|464243300|FG000|Overall Study|Other|10|||
128987535|NCT00347776|464243301|FG000|1.5 Month Follow-up|Death|2|||
129213619|NCT02484391|465084667|FG000|Overall Study|Physician Decision|1|||
129213620|NCT02484391|465084668|FG001|Overall Study|Physician Decision|3|||
129213621|NCT02484391|465084669|FG002|Overall Study|Physician Decision|0|||
129213622|NCT02484391|465084667|FG000|Overall Study|Went to Transplant|5|||
129213623|NCT02484391|465084668|FG001|Overall Study|Went to Transplant|3|||
129213624|NCT02484391|465084669|FG002|Overall Study|Went to Transplant|2|||
128987536|NCT00347776|464243302|FG001|1.5 Month Follow-up|Death|0|||
128987537|NCT00347776|464243303|FG002|1.5 Month Follow-up|Death|0|||
128987538|NCT00347776|464243301|FG000|1.5 Month Follow-up|reached the endpoint|12|||
128987539|NCT00347776|464243302|FG001|1.5 Month Follow-up|reached the endpoint|8|||
128987540|NCT00347776|464243303|FG002|1.5 Month Follow-up|reached the endpoint|12|||
128987541|NCT00347776|464243301|FG000|6 Month Follow-up|Death|2|||
128987542|NCT00347776|464243302|FG001|6 Month Follow-up|Death|1|||
128987543|NCT00347776|464243303|FG002|6 Month Follow-up|Death|3|||
128987544|NCT00347776|464243301|FG000|6 Month Follow-up|reached endpont|20|||
128987545|NCT00347776|464243302|FG001|6 Month Follow-up|reached endpont|12|||
128987546|NCT00347776|464243303|FG002|6 Month Follow-up|reached endpont|15|||
128987547|NCT00347776|464243301|FG000|12 Month Follow-up|Lost to Follow-up|7|||
128987548|NCT00347776|464243302|FG001|12 Month Follow-up|Lost to Follow-up|6|||
128987549|NCT00347776|464243303|FG002|12 Month Follow-up|Lost to Follow-up|6|||
128987550|NCT00347776|464243301|FG000|12 Month Follow-up|Death|3|||
128987551|NCT00347776|464243302|FG001|12 Month Follow-up|Death|4|||
128987552|NCT00347776|464243303|FG002|12 Month Follow-up|Death|4|||
128987553|NCT00347776|464243301|FG000|12 Month Follow-up|Reached endpoint|13|||
128987554|NCT00347776|464243302|FG001|12 Month Follow-up|Reached endpoint|6|||
128987555|NCT00347776|464243303|FG002|12 Month Follow-up|Reached endpoint|9|||
128987556|NCT00299546|464243304|FG000|Overall Study|Death|3|||
128987557|NCT00299546|464243305|FG001|Overall Study|Death|2|||
128987558|NCT00299546|464243306|FG002|Overall Study|Death|0|||
128987559|NCT00299546|464243304|FG000|Overall Study|Lost to Follow-up|2|||
128987560|NCT00299546|464243305|FG001|Overall Study|Lost to Follow-up|2|||
128987561|NCT00299546|464243306|FG002|Overall Study|Lost to Follow-up|5|||
128987562|NCT00299546|464243304|FG000|Overall Study|Adverse Event|37|||
128987563|NCT00299546|464243305|FG001|Overall Study|Adverse Event|22|||
128987564|NCT00299546|464243306|FG002|Overall Study|Adverse Event|27|||
128987565|NCT00299546|464243304|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
128987566|NCT00299546|464243305|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
128987567|NCT00299546|464243306|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
128987568|NCT00299546|464243304|FG000|Overall Study|Other|24|||
128987569|NCT00299546|464243305|FG001|Overall Study|Other|26|||
128987570|NCT00299546|464243306|FG002|Overall Study|Other|19|||
128987571|NCT00299546|464243304|FG000|Overall Study|Not treated|0|||
128987572|NCT00299546|464243305|FG001|Overall Study|Not treated|1|||
128987573|NCT00299546|464243306|FG002|Overall Study|Not treated|1|||
128987574|NCT03099265|464243307|FG000|Overall Study|Adverse Event|1|||
128987575|NCT02526017|464243311|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
128987576|NCT02526017|464243312|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
128987577|NCT02526017|464243313|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
128987578|NCT02526017|464243314|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
128987579|NCT02526017|464243315|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
129213625|NCT02594124|465084670|FG000|Overall Study|Adverse Event|0|||
129213626|NCT02594124|465084671|FG001|Overall Study|Adverse Event|5|||
129213627|NCT02594124|465084672|FG002|Overall Study|Adverse Event|8|||
129213628|NCT02594124|465084673|FG003|Overall Study|Adverse Event|1|||
129213629|NCT02594124|465084674|FG004|Overall Study|Adverse Event|0|||
129213630|NCT02594124|465084675|FG005|Overall Study|Adverse Event|0|||
129213631|NCT02594124|465084676|FG006|Overall Study|Adverse Event|2|||
129213632|NCT02594124|465084677|FG007|Overall Study|Adverse Event|2|||
129213633|NCT02594124|465084678|FG008|Overall Study|Adverse Event|0|||
129213634|NCT02594124|465084670|FG000|Overall Study|Withdrawal by Subject|2|||
129213635|NCT02594124|465084671|FG001|Overall Study|Withdrawal by Subject|3|||
129213636|NCT02594124|465084672|FG002|Overall Study|Withdrawal by Subject|5|||
129213637|NCT02594124|465084673|FG003|Overall Study|Withdrawal by Subject|1|||
129213638|NCT02594124|465084674|FG004|Overall Study|Withdrawal by Subject|8|||
129213639|NCT02594124|465084675|FG005|Overall Study|Withdrawal by Subject|4|||
129213640|NCT02594124|465084676|FG006|Overall Study|Withdrawal by Subject|13|||
129213641|NCT02594124|465084677|FG007|Overall Study|Withdrawal by Subject|19|||
129213642|NCT02594124|465084678|FG008|Overall Study|Withdrawal by Subject|0|||
129213643|NCT02594124|465084670|FG000|Overall Study|Physician Decision|0|||
129213644|NCT02594124|465084671|FG001|Overall Study|Physician Decision|2|||
129213645|NCT02594124|465084672|FG002|Overall Study|Physician Decision|0|||
129213646|NCT02594124|465084673|FG003|Overall Study|Physician Decision|0|||
129213647|NCT02594124|465084674|FG004|Overall Study|Physician Decision|0|||
129213648|NCT02594124|465084675|FG005|Overall Study|Physician Decision|0|||
129213649|NCT02594124|465084676|FG006|Overall Study|Physician Decision|0|||
129213650|NCT02594124|465084677|FG007|Overall Study|Physician Decision|1|||
129213651|NCT02594124|465084678|FG008|Overall Study|Physician Decision|0|||
129213652|NCT02594124|465084670|FG000|Overall Study|Commercial drug|0|||
129213653|NCT02594124|465084671|FG001|Overall Study|Commercial drug|1|||
129213654|NCT02594124|465084672|FG002|Overall Study|Commercial drug|6|||
129213655|NCT02594124|465084673|FG003|Overall Study|Commercial drug|3|||
128987580|NCT02526017|464243316|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
128987581|NCT02526017|464243317|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
128987582|NCT02526017|464243318|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129213656|NCT02594124|465084674|FG004|Overall Study|Commercial drug|0|||
129213657|NCT02594124|465084675|FG005|Overall Study|Commercial drug|0|||
129213658|NCT02594124|465084676|FG006|Overall Study|Commercial drug|7|||
129213659|NCT02594124|465084677|FG007|Overall Study|Commercial drug|11|||
129213660|NCT02594124|465084678|FG008|Overall Study|Commercial drug|2|||
129213661|NCT02594124|465084670|FG000|Overall Study|Reason Not Specified|1|||
129213662|NCT02594124|465084671|FG001|Overall Study|Reason Not Specified|3|||
129213663|NCT02594124|465084672|FG002|Overall Study|Reason Not Specified|4|||
129213664|NCT02594124|465084673|FG003|Overall Study|Reason Not Specified|0|||
129213665|NCT02594124|465084674|FG004|Overall Study|Reason Not Specified|0|||
129213666|NCT02594124|465084675|FG005|Overall Study|Reason Not Specified|1|||
129213667|NCT02594124|465084676|FG006|Overall Study|Reason Not Specified|1|||
129213668|NCT02594124|465084677|FG007|Overall Study|Reason Not Specified|6|||
129213669|NCT02594124|465084678|FG008|Overall Study|Reason Not Specified|1|||
129213670|NCT01899040|465084683|FG000|Overall Study|Randomized in error|0|||
129213671|NCT01899040|465084684|FG001|Overall Study|Randomized in error|1|||
129213672|NCT01899040|465084685|FG002|Overall Study|Randomized in error|1|||
129213673|NCT01899040|465084683|FG000|Overall Study|Adverse Event|3|||
129213674|NCT01899040|465084684|FG001|Overall Study|Adverse Event|1|||
129213675|NCT01899040|465084685|FG002|Overall Study|Adverse Event|2|||
129213676|NCT01899040|465084683|FG000|Overall Study|Unspecified reasons|4|||
129213677|NCT01899040|465084684|FG001|Overall Study|Unspecified reasons|4|||
129213678|NCT01899040|465084685|FG002|Overall Study|Unspecified reasons|0|||
129213679|NCT01899040|465084683|FG000|Overall Study|Compliance issues|1|||
129213680|NCT01899040|465084684|FG001|Overall Study|Compliance issues|2|||
129213681|NCT01899040|465084685|FG002|Overall Study|Compliance issues|0|||
129213682|NCT00905164|465084691|FG000|Period 1|Protocol Violation|0|||
129213683|NCT00905164|465084692|FG001|Period 1|Protocol Violation|1|||
129213684|NCT01256788|465087047|FG000|Overall Study|Lost to Follow-up|5|||
129213685|NCT01256788|465087048|FG001|Overall Study|Lost to Follow-up|8|||
129213686|NCT01256788|465087049|FG002|Overall Study|Lost to Follow-up|3|||
129213687|NCT03312634|465087050|FG000|Overall Study|Adverse Event|11|||
129213688|NCT03312634|465087051|FG001|Overall Study|Adverse Event|0|||
129213689|NCT03312634|465087050|FG000|Overall Study|Sponsor request|2|||
129213690|NCT03312634|465087051|FG001|Overall Study|Sponsor request|0|||
129213691|NCT03312634|465087050|FG000|Overall Study|Withdrawal by Subject|31|||
129213692|NCT03312634|465087051|FG001|Overall Study|Withdrawal by Subject|9|||
129213693|NCT03312634|465087050|FG000|Overall Study|Enrolled in an interventional study|0|||
129213694|NCT03312634|465087051|FG001|Overall Study|Enrolled in an interventional study|52|||
129213695|NCT03312634|465087050|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
129213696|NCT03312634|465087051|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
129213697|NCT03312634|465087050|FG000|Overall Study|Death|0|||
129213698|NCT03312634|465087051|FG001|Overall Study|Death|1|||
129213699|NCT03312634|465087050|FG000|Overall Study|Non-compliance|0|||
129213700|NCT03312634|465087051|FG001|Overall Study|Non-compliance|2|||
129213701|NCT03312634|465087050|FG000|Overall Study|Lost to Follow-up|0|||
129213702|NCT03312634|465087051|FG001|Overall Study|Lost to Follow-up|1|||
129213703|NCT03312634|465087050|FG000|Overall Study|Enrolled into non-interventional study|0|||
129213704|NCT03312634|465087051|FG001|Overall Study|Enrolled into non-interventional study|5|||
129213705|NCT03312634|465087050|FG000|Overall Study|Worsening clinical condition|0|||
129213706|NCT03312634|465087051|FG001|Overall Study|Worsening clinical condition|1|||
129213707|NCT03312634|465087050|FG000|Overall Study|Participant did not want to travel|0|||
129213708|NCT03312634|465087051|FG001|Overall Study|Participant did not want to travel|1|||
129213709|NCT03312634|465087050|FG000|Overall Study|Physician Decision|1|||
129213710|NCT03312634|465087051|FG001|Overall Study|Physician Decision|0|||
129213711|NCT03312634|465087050|FG000|Overall Study|Other|13|||
129213712|NCT03312634|465087051|FG001|Overall Study|Other|0|||
129213713|NCT05366738|465087052|FG000|Overall Study|Adverse Event|0|||
129213714|NCT05366738|465087053|FG001|Overall Study|Adverse Event|1|||
129213715|NCT05366738|465087054|FG002|Overall Study|Adverse Event|0|||
129213716|NCT00906204|465087057|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
129213717|NCT00906204|465087058|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
129213718|NCT00906204|465087057|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
129213719|NCT00906204|465087058|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
129213720|NCT00906204|465087057|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
129213721|NCT00906204|465087058|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
129213722|NCT00906204|465087057|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
129213723|NCT00906204|465087058|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
129213724|NCT00906204|465087057|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
129213725|NCT00906204|465087058|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
129213726|NCT05291520|465087059|FG000|Overall Study|Lost to Follow-up|0|||
129213727|NCT05291520|465087060|FG001|Overall Study|Lost to Follow-up|0|||
129213728|NCT05291520|465087061|FG002|Overall Study|Lost to Follow-up|1|||
129213729|NCT01347112|465087062|FG000|Overall Study|Withdrawal by Subject|1|||
129213730|NCT01347112|465087063|FG001|Overall Study|Withdrawal by Subject|7|||
129213731|NCT01347112|465087062|FG000|Overall Study|Lost to Follow-up|3|||
129213732|NCT01347112|465087063|FG001|Overall Study|Lost to Follow-up|5|||
129213733|NCT00696072|465087066|FG000|Overall Study|continuing active treatment|10|||
129213734|NCT00696072|465087067|FG001|Overall Study|continuing active treatment|13|||
129213735|NCT00696072|465087066|FG000|Overall Study|Adverse Event|10|||
129213736|NCT00696072|465087067|FG001|Overall Study|Adverse Event|6|||
129213737|NCT00696072|465087066|FG000|Overall Study|Patient Request|3|||
129213738|NCT00696072|465087067|FG001|Overall Study|Patient Request|7|||
129213739|NCT00696072|465087066|FG000|Overall Study|Investigator Request|1|||
128987583|NCT02526017|464243319|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
128987584|NCT00518531|464243321|FG000|Treatment Period 1|Adverse Event|5|||
128987585|NCT00518531|464243322|FG001|Treatment Period 1|Adverse Event|0|||
128987586|NCT00518531|464243321|FG000|Treatment Period 1|Lost to Follow-up|5|||
128987587|NCT00518531|464243322|FG001|Treatment Period 1|Lost to Follow-up|3|||
128987588|NCT00518531|464243321|FG000|Treatment Period 1|Physician Decision|1|||
128987589|NCT00518531|464243322|FG001|Treatment Period 1|Physician Decision|0|||
128987590|NCT00518531|464243321|FG000|Treatment Period 1|Protocol Violation|2|||
128987591|NCT00518531|464243322|FG001|Treatment Period 1|Protocol Violation|0|||
128987592|NCT00518531|464243321|FG000|Treatment Period 1|Withdrawal by Subject|4|||
128987593|NCT00518531|464243322|FG001|Treatment Period 1|Withdrawal by Subject|6|||
128987594|NCT00518531|464243321|FG000|Treatment Period 1|Early crossover|1|||
128987595|NCT00518531|464243322|FG001|Treatment Period 1|Early crossover|3|||
128987596|NCT00518531|464243321|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128987597|NCT00518531|464243322|FG001|Treatment Period 2|Withdrawal by Subject|8|||
128987598|NCT00518531|464243321|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
128987599|NCT00518531|464243322|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
128987600|NCT00518531|464243321|FG000|Treatment Period 2|Adverse Event|1|||
128987601|NCT00518531|464243322|FG001|Treatment Period 2|Adverse Event|7|||
128987602|NCT00518531|464243321|FG000|Treatment Period 2|Protocol-specified criteria|0|||
128987603|NCT00518531|464243322|FG001|Treatment Period 2|Protocol-specified criteria|1|||
128987604|NCT00518531|464243321|FG000|Treatment Period 2|Non-compliance|1|||
128987605|NCT00518531|464243322|FG001|Treatment Period 2|Non-compliance|2|||
128987606|NCT00602927|464243325|FG000|Period 1: 13 Days|Protocol Violation|2|||
128987607|NCT00602927|464243326|FG001|Period 1: 13 Days|Protocol Violation|4|||
128987608|NCT00602927|464243325|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
128987609|NCT00602927|464243326|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
128987610|NCT00602927|464243325|FG000|Period 1: 13 Days|Time|1|||
128987611|NCT00602927|464243326|FG001|Period 1: 13 Days|Time|0|||
128987612|NCT00602927|464243325|FG000|Period 1: 13 Days|Claustrophobia|0|||
128987613|NCT00602927|464243326|FG001|Period 1: 13 Days|Claustrophobia|1|||
128987614|NCT00602927|464243325|FG000|Period 2: 14 Days|Protocol Violation|0|||
128987615|NCT00602927|464243326|FG001|Period 2: 14 Days|Protocol Violation|2|||
128987616|NCT00602927|464243325|FG000|Period 3: 13 Days|Protocol Violation|0|||
128987617|NCT00602927|464243326|FG001|Period 3: 13 Days|Protocol Violation|1|||
128987618|NCT00602927|464243325|FG000|Period 3: 13 Days|MRI data quality|2|||
128987619|NCT00602927|464243326|FG001|Period 3: 13 Days|MRI data quality|2|||
128987620|NCT04888377|464243332|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
128987621|NCT04888377|464243333|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
128987622|NCT04888377|464243332|FG000|Overall Study|Physician Decision|6|||
128987623|NCT04888377|464243333|FG001|Overall Study|Physician Decision|6|||
128987624|NCT04888377|464243332|FG000|Overall Study|Withdrawal by Subject|7|||
128987625|NCT04888377|464243333|FG001|Overall Study|Withdrawal by Subject|3|||
128987626|NCT00478933|464243334|FG000|Overall Study|Protocol Violation|22|||
128987627|NCT00478933|464243334|FG000|Overall Study|Informed consent not verified|3|||
128987628|NCT00478933|464243334|FG000|Overall Study|Inadequate data available|53|||
128987629|NCT03772574|464243335|FG000|Overall Study|Protocol Violation|2|||
128987630|NCT03772574|464243336|FG001|Overall Study|Protocol Violation|0|||
128987631|NCT03772574|464243337|FG002|Overall Study|Protocol Violation|0|||
128987632|NCT03772574|464243335|FG000|Overall Study|Discomfort|0|||
128987633|NCT03772574|464243336|FG001|Overall Study|Discomfort|5|||
128987634|NCT03772574|464243337|FG002|Overall Study|Discomfort|4|||
128987635|NCT01298362|464243341|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
129213740|NCT00696072|465087067|FG001|Overall Study|Investigator Request|4|||
129213741|NCT00696072|465087066|FG000|Overall Study|Sponsor Request|0|||
128987636|NCT01298362|464243342|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
128987637|NCT00762073|464243351|FG000|Overall Study|Lack of Efficacy|1|||
128987638|NCT00762073|464243352|FG001|Overall Study|Lack of Efficacy|1|||
128987639|NCT00762073|464243353|FG002|Overall Study|Lack of Efficacy|0|||
128987640|NCT00762073|464243354|FG003|Overall Study|Lack of Efficacy|0|||
128987641|NCT00762073|464243351|FG000|Overall Study|Adverse Event|1|||
128987642|NCT00762073|464243352|FG001|Overall Study|Adverse Event|0|||
128987643|NCT00762073|464243353|FG002|Overall Study|Adverse Event|1|||
128987644|NCT00762073|464243354|FG003|Overall Study|Adverse Event|1|||
128987645|NCT00762073|464243351|FG000|Overall Study|Significant Subject Noncompliance|0|||
128987646|NCT00762073|464243352|FG001|Overall Study|Significant Subject Noncompliance|1|||
129213742|NCT00696072|465087067|FG001|Overall Study|Sponsor Request|1|||
129213743|NCT00696072|465087066|FG000|Overall Study|Disease Progression|32|||
129213744|NCT00696072|465087067|FG001|Overall Study|Disease Progression|30|||
129213745|NCT00696072|465087066|FG000|Overall Study|Non-specified|1|||
129213746|NCT00696072|465087067|FG001|Overall Study|Non-specified|2|||
129213747|NCT01597596|465087068|FG000|Overall Study|Study terminated by sponsor|1|||
129213748|NCT01597596|465087069|FG001|Overall Study|Study terminated by sponsor|0|||
129213749|NCT01597596|465087068|FG000|Overall Study|Physician Decision|0|||
129213750|NCT01597596|465087069|FG001|Overall Study|Physician Decision|1|||
129213751|NCT02141295|465087084|FG000|Overall Study|Adverse Event|1|||
129213752|NCT02141295|465087085|FG001|Overall Study|Adverse Event|18|||
129213753|NCT02141295|465087086|FG002|Overall Study|Adverse Event|11|||
129213754|NCT02141295|465087084|FG000|Overall Study|Physician Decision|2|||
129213755|NCT02141295|465087085|FG001|Overall Study|Physician Decision|19|||
129213756|NCT02141295|465087086|FG002|Overall Study|Physician Decision|14|||
129213757|NCT02141295|465087084|FG000|Overall Study|Study terminated by sponsor|0|||
129213758|NCT02141295|465087085|FG001|Overall Study|Study terminated by sponsor|6|||
129213759|NCT02141295|465087086|FG002|Overall Study|Study terminated by sponsor|6|||
129213760|NCT02141295|465087084|FG000|Overall Study|Non-compliance|0|||
129213761|NCT02141295|465087085|FG001|Overall Study|Non-compliance|1|||
129213762|NCT02141295|465087086|FG002|Overall Study|Non-compliance|0|||
129213763|NCT02141295|465087084|FG000|Overall Study|Progressive disease|3|||
129213764|NCT02141295|465087085|FG001|Overall Study|Progressive disease|32|||
129213765|NCT02141295|465087086|FG002|Overall Study|Progressive disease|50|||
129213766|NCT02141295|465087084|FG000|Overall Study|Reason not specified|0|||
129213767|NCT02141295|465087085|FG001|Overall Study|Reason not specified|9|||
129213768|NCT02141295|465087086|FG002|Overall Study|Reason not specified|10|||
129213769|NCT02141295|465087084|FG000|Overall Study|Withdrawal by Subject|0|||
129213770|NCT02141295|465087085|FG001|Overall Study|Withdrawal by Subject|9|||
129213771|NCT02141295|465087086|FG002|Overall Study|Withdrawal by Subject|4|||
129213772|NCT01710501|465087087|FG000|Overall Study|Lost to Follow-up|2|||
129213773|NCT01710501|465087088|FG001|Overall Study|Lost to Follow-up|0|||
129213774|NCT01710501|465087089|FG002|Overall Study|Lost to Follow-up|0|||
129213775|NCT02536976|465087090|FG000|Overall Study|Physician Decision|0|||
129213776|NCT02536976|465087091|FG001|Overall Study|Physician Decision|1|||
129213777|NCT01389596|465087094|FG000|Overall Study|Protocol Violation|3|||
129213778|NCT01389596|465087095|FG001|Overall Study|Protocol Violation|4|||
129213779|NCT01389596|465087096|FG002|Overall Study|Protocol Violation|3|||
129213780|NCT01389596|465087094|FG000|Overall Study|Withdrawal by Subject|1|||
129213781|NCT01389596|465087095|FG001|Overall Study|Withdrawal by Subject|2|||
129213782|NCT01389596|465087096|FG002|Overall Study|Withdrawal by Subject|2|||
129213783|NCT01389596|465087094|FG000|Overall Study|Insufficient Clinical Response|3|||
129213784|NCT01389596|465087095|FG001|Overall Study|Insufficient Clinical Response|4|||
129213785|NCT01389596|465087096|FG002|Overall Study|Insufficient Clinical Response|5|||
129213786|NCT01389596|465087094|FG000|Overall Study|Adverse Event|1|||
129213787|NCT01389596|465087095|FG001|Overall Study|Adverse Event|4|||
129213788|NCT01389596|465087096|FG002|Overall Study|Adverse Event|0|||
128876601|NCT01506609|463842378|FG003|Overall Study|Adverse Event Related to Progression|3|||
128876602|NCT01506609|463842379|FG004|Overall Study|Adverse Event Related to Progression|7|||
129213789|NCT01389596|465087094|FG000|Overall Study|Death|0|||
129213790|NCT01389596|465087095|FG001|Overall Study|Death|1|||
129213791|NCT01389596|465087096|FG002|Overall Study|Death|0|||
129213792|NCT01389596|465087094|FG000|Overall Study|Other Unspecified|2|||
129213793|NCT01389596|465087095|FG001|Overall Study|Other Unspecified|1|||
128876603|NCT01506609|463842380|FG005|Overall Study|Adverse Event Related to Progression|3|||
128876604|NCT01506609|463842375|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
128876605|NCT01506609|463842376|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
128876606|NCT01506609|463842377|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
128876607|NCT01506609|463842378|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
128876608|NCT01506609|463842379|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
128876609|NCT01506609|463842380|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
128876610|NCT01506609|463842375|FG000|Overall Study|Withdrawal by Subject|0|||
128876611|NCT01506609|463842376|FG001|Overall Study|Withdrawal by Subject|0|||
128876612|NCT01506609|463842377|FG002|Overall Study|Withdrawal by Subject|0|||
128876613|NCT01506609|463842378|FG003|Overall Study|Withdrawal by Subject|9|||
128876614|NCT01506609|463842379|FG004|Overall Study|Withdrawal by Subject|7|||
128876615|NCT01506609|463842380|FG005|Overall Study|Withdrawal by Subject|7|||
128876616|NCT01506609|463842375|FG000|Overall Study|Lost to Follow-up|0|||
128876617|NCT01506609|463842376|FG001|Overall Study|Lost to Follow-up|0|||
128876618|NCT01506609|463842377|FG002|Overall Study|Lost to Follow-up|0|||
128876619|NCT01506609|463842378|FG003|Overall Study|Lost to Follow-up|1|||
128876620|NCT01506609|463842379|FG004|Overall Study|Lost to Follow-up|2|||
128876621|NCT01506609|463842380|FG005|Overall Study|Lost to Follow-up|0|||
128876622|NCT01506609|463842375|FG000|Overall Study|Sponsor Discontinued Study|0|||
128876623|NCT01506609|463842376|FG001|Overall Study|Sponsor Discontinued Study|0|||
128876624|NCT01506609|463842377|FG002|Overall Study|Sponsor Discontinued Study|0|||
128876625|NCT01506609|463842378|FG003|Overall Study|Sponsor Discontinued Study|2|||
129213794|NCT01389596|465087096|FG002|Overall Study|Other Unspecified|0|||
129213795|NCT01671319|465087097|FG000|Overall Study|Withdrawal by Subject|1|||
129213796|NCT01709084|465087098|FG000|Overall Study|Lost to Follow-up|4|||
129213797|NCT01709084|465087099|FG001|Overall Study|Lost to Follow-up|7|||
129213798|NCT01709084|465087098|FG000|Overall Study|Withdrawal by Subject|2|||
129213799|NCT01709084|465087099|FG001|Overall Study|Withdrawal by Subject|2|||
129213800|NCT01709084|465087098|FG000|Overall Study|Adverse Event|5|||
129213801|NCT01709084|465087099|FG001|Overall Study|Adverse Event|0|||
129213802|NCT01709084|465087098|FG000|Overall Study|Other|5|||
129213803|NCT01709084|465087099|FG001|Overall Study|Other|3|||
129213804|NCT01709084|465087098|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
129213805|NCT01709084|465087099|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
129213806|NCT01709084|465087098|FG000|Overall Study|Not Treated|0|||
129213807|NCT01709084|465087099|FG001|Overall Study|Not Treated|2|||
129213808|NCT02144610|465087100|FG000|Overall Study|Physician Decision|1|||
129213809|NCT02144610|465087101|FG001|Overall Study|Physician Decision|0|||
129213810|NCT02144610|465087100|FG000|Overall Study|Withdrawal by Subject|1|||
129213811|NCT02144610|465087101|FG001|Overall Study|Withdrawal by Subject|5|||
129213812|NCT02144610|465087100|FG000|Overall Study|Death|2|||
129213813|NCT02144610|465087101|FG001|Overall Study|Death|2|||
129213814|NCT02144610|465087100|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
128987647|NCT00762073|464243353|FG002|Overall Study|Significant Subject Noncompliance|0|||
128987648|NCT00762073|464243354|FG003|Overall Study|Significant Subject Noncompliance|1|||
128987649|NCT00762073|464243351|FG000|Overall Study|Withdrawal by Subject|1|||
128987650|NCT00762073|464243352|FG001|Overall Study|Withdrawal by Subject|2|||
128987651|NCT00762073|464243353|FG002|Overall Study|Withdrawal by Subject|1|||
128987652|NCT00762073|464243354|FG003|Overall Study|Withdrawal by Subject|1|||
128987653|NCT00762073|464243351|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
128987654|NCT00762073|464243352|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
128987655|NCT00762073|464243353|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
128987656|NCT00762073|464243354|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
128987657|NCT00491322|464243356|FG000|Overall Study|Protocol Violation|1|||
128987658|NCT00491322|464243357|FG001|Overall Study|Protocol Violation|0|||
128987659|NCT00491322|464243356|FG000|Overall Study|Pregnancy|0|||
128987660|NCT00491322|464243357|FG001|Overall Study|Pregnancy|1|||
128987661|NCT02331680|464243358|FG000|Overall Study|Adverse Event|3|||
128987662|NCT02331680|464243359|FG001|Overall Study|Adverse Event|0|||
128987663|NCT02331680|464243360|FG002|Overall Study|Adverse Event|2|||
128987664|NCT02331680|464243358|FG000|Overall Study|Physician Decision|1|||
128987665|NCT02331680|464243359|FG001|Overall Study|Physician Decision|1|||
128987666|NCT02331680|464243360|FG002|Overall Study|Physician Decision|2|||
128987667|NCT02331680|464243358|FG000|Overall Study|Withdrawal by Subject|0|||
128987668|NCT02331680|464243359|FG001|Overall Study|Withdrawal by Subject|1|||
128987669|NCT02331680|464243360|FG002|Overall Study|Withdrawal by Subject|2|||
128987670|NCT02331680|464243358|FG000|Overall Study|Met withdrawal criteria|2|||
128987671|NCT02331680|464243359|FG001|Overall Study|Met withdrawal criteria|2|||
128987672|NCT02331680|464243360|FG002|Overall Study|Met withdrawal criteria|5|||
128987673|NCT02331680|464243358|FG000|Overall Study|Non-compliance with study drug|0|||
128987674|NCT02331680|464243359|FG001|Overall Study|Non-compliance with study drug|0|||
128987675|NCT02331680|464243360|FG002|Overall Study|Non-compliance with study drug|1|||
128987676|NCT02331680|464243358|FG000|Overall Study|Protocol Violation|0|||
128987677|NCT02331680|464243359|FG001|Overall Study|Protocol Violation|0|||
128987678|NCT02331680|464243360|FG002|Overall Study|Protocol Violation|3|||
128987679|NCT02279888|464243361|FG000|Overall Study|Death|326|||
128987680|NCT02279888|464243361|FG000|Overall Study|Withdrawal by Subject|38|||
128987681|NCT02279888|464243361|FG000|Overall Study|Lost to Follow-up|21|||
128987682|NCT02279888|464243361|FG000|Overall Study|Physician Decision|62|||
128987683|NCT02279888|464243361|FG000|Overall Study|Subject Non-compliance|43|||
128987684|NCT02279888|464243361|FG000|Overall Study|Not implanted|14|||
128987685|NCT02279888|464243361|FG000|Overall Study|Visit not performed|26|||
128987686|NCT01891669|464243362|FG000|Overall Study|Death|0|||
128987687|NCT01891669|464243363|FG001|Overall Study|Death|0|||
128987688|NCT01891669|464243364|FG002|Overall Study|Death|0|||
128987689|NCT01891669|464243365|FG003|Overall Study|Death|0|||
128987690|NCT01891669|464243366|FG004|Overall Study|Death|0|||
128987691|NCT01891669|464243367|FG005|Overall Study|Death|0|||
128987692|NCT01891669|464243368|FG006|Overall Study|Death|0|||
128987693|NCT01891669|464243369|FG007|Overall Study|Death|1|||
128987694|NCT01891669|464243370|FG008|Overall Study|Death|0|||
128987695|NCT01891669|464243371|FG009|Overall Study|Death|1|||
128987696|NCT01891669|464243362|FG000|Overall Study|Withdrawal by Subject|1|||
129213815|NCT02144610|465087101|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
129213816|NCT02144610|465087100|FG000|Overall Study|Other|0|||
129213817|NCT02144610|465087101|FG001|Overall Study|Other|1|||
129213818|NCT01054885|465087102|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
128987697|NCT01891669|464243363|FG001|Overall Study|Withdrawal by Subject|1|||
128987698|NCT01891669|464243364|FG002|Overall Study|Withdrawal by Subject|0|||
128987699|NCT01891669|464243365|FG003|Overall Study|Withdrawal by Subject|0|||
128987700|NCT01891669|464243366|FG004|Overall Study|Withdrawal by Subject|0|||
129213819|NCT01054885|465087103|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
128987701|NCT01891669|464243367|FG005|Overall Study|Withdrawal by Subject|0|||
129213820|NCT01054885|465087104|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129213821|NCT01054885|465087105|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129213822|NCT01054885|465087106|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129213823|NCT01054885|465087107|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129213824|NCT01054885|465087108|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129213825|NCT01054885|465087102|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
129213826|NCT01054885|465087103|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
129213827|NCT01054885|465087104|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
129213828|NCT01054885|465087105|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
129213829|NCT01054885|465087106|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
129213830|NCT01054885|465087107|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
129213831|NCT01054885|465087108|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
129213832|NCT01054885|465087102|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
129213833|NCT01054885|465087103|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129213834|NCT01054885|465087104|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129213835|NCT01054885|465087105|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129213836|NCT01054885|465087106|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129213837|NCT01054885|465087107|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129213838|NCT01054885|465087108|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129213839|NCT01054885|465087102|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
129213840|NCT01054885|465087103|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129213841|NCT01054885|465087104|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129213842|NCT01054885|465087105|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129213843|NCT01054885|465087106|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129213844|NCT01054885|465087107|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129213845|NCT01054885|465087108|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129213846|NCT01054885|465087102|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
129213847|NCT01054885|465087103|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
129213848|NCT01054885|465087104|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
129213849|NCT01054885|465087105|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
129213850|NCT01054885|465087106|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
129213851|NCT01054885|465087107|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
129213852|NCT01054885|465087108|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
129213853|NCT01054885|465087102|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
129213854|NCT01054885|465087103|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129213855|NCT01054885|465087104|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129213856|NCT01054885|465087105|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129213857|NCT01054885|465087106|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129213858|NCT01054885|465087107|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129213859|NCT01054885|465087108|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129213860|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
129213861|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
129213862|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
129213863|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
129213864|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
129213865|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
129213866|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
129213867|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129213868|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129213869|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
129213870|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
129213871|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129222158|NCT03184870|465116029|FG013|Initial Treatment|Withdrawal by Subject|0|||
129222159|NCT03184870|465116030|FG014|Initial Treatment|Withdrawal by Subject|1|||
129222160|NCT03184870|465116031|FG015|Initial Treatment|Withdrawal by Subject|5|||
128876626|NCT01506609|463842379|FG004|Overall Study|Sponsor Discontinued Study|2|||
128876627|NCT01506609|463842380|FG005|Overall Study|Sponsor Discontinued Study|0|||
128876628|NCT01506609|463842375|FG000|Overall Study|Progressive Disease per Protocol|1|||
129222161|NCT03184870|465116032|FG016|Initial Treatment|Withdrawal by Subject|2|||
129222162|NCT03184870|465116033|FG017|Initial Treatment|Withdrawal by Subject|2|||
129222163|NCT03184870|465116016|FG000|Initial Treatment|Moved to crossover treatment|0|||
129222164|NCT03184870|465116017|FG001|Initial Treatment|Moved to crossover treatment|0|||
129222165|NCT03184870|465116018|FG002|Initial Treatment|Moved to crossover treatment|0|||
129222166|NCT03184870|465116019|FG003|Initial Treatment|Moved to crossover treatment|0|||
129222167|NCT03184870|465116020|FG004|Initial Treatment|Moved to crossover treatment|0|||
129213872|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
129213873|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
128876629|NCT01506609|463842376|FG001|Overall Study|Progressive Disease per Protocol|0|||
128876630|NCT01506609|463842377|FG002|Overall Study|Progressive Disease per Protocol|0|||
128876631|NCT01506609|463842378|FG003|Overall Study|Progressive Disease per Protocol|64|||
128876632|NCT01506609|463842379|FG004|Overall Study|Progressive Disease per Protocol|57|||
128876633|NCT01506609|463842380|FG005|Overall Study|Progressive Disease per Protocol|74|||
128876634|NCT01506609|463842375|FG000|Overall Study|Other, Not Specified|0|||
128876635|NCT01506609|463842376|FG001|Overall Study|Other, Not Specified|0|||
128876636|NCT01506609|463842377|FG002|Overall Study|Other, Not Specified|0|||
128876637|NCT01506609|463842378|FG003|Overall Study|Other, Not Specified|10|||
128876638|NCT01506609|463842379|FG004|Overall Study|Other, Not Specified|7|||
128876639|NCT01506609|463842380|FG005|Overall Study|Other, Not Specified|3|||
128876640|NCT01506609|463842375|FG000|Overall Study|Missing / Unknown Reason|1|||
128876641|NCT01506609|463842376|FG001|Overall Study|Missing / Unknown Reason|0|||
128876642|NCT01506609|463842377|FG002|Overall Study|Missing / Unknown Reason|1|||
128876643|NCT01506609|463842378|FG003|Overall Study|Missing / Unknown Reason|4|||
128876644|NCT01506609|463842379|FG004|Overall Study|Missing / Unknown Reason|4|||
128876645|NCT01506609|463842380|FG005|Overall Study|Missing / Unknown Reason|2|||
128876646|NCT00862719|463842381|FG000|Overall Study|Disease Progression|5|||
128876647|NCT00862719|463842382|FG001|Overall Study|Disease Progression|0|||
128876648|NCT00862719|463842383|FG002|Overall Study|Disease Progression|1|||
128876649|NCT00862719|463842384|FG003|Overall Study|Disease Progression|0|||
128876650|NCT00862719|463842381|FG000|Overall Study|Death|5|||
128876651|NCT00862719|463842382|FG001|Overall Study|Death|6|||
128876652|NCT00862719|463842383|FG002|Overall Study|Death|1|||
128876653|NCT00862719|463842384|FG003|Overall Study|Death|1|||
128876654|NCT00862719|463842381|FG000|Overall Study|Engraftment failure|0|||
128876655|NCT00862719|463842382|FG001|Overall Study|Engraftment failure|0|||
128876656|NCT00862719|463842383|FG002|Overall Study|Engraftment failure|1|||
128876657|NCT00862719|463842384|FG003|Overall Study|Engraftment failure|0|||
128876658|NCT00862719|463842381|FG000|Overall Study|Veno-Occlusive Disease|0|||
128876659|NCT00862719|463842382|FG001|Overall Study|Veno-Occlusive Disease|0|||
128876660|NCT00862719|463842383|FG002|Overall Study|Veno-Occlusive Disease|1|||
128876661|NCT00862719|463842384|FG003|Overall Study|Veno-Occlusive Disease|0|||
128876662|NCT00324116|463842385|FG000|Overall Study|Adverse Event|5|||
128876663|NCT00324116|463842385|FG000|Overall Study|Lack of Efficacy|17|||
128876664|NCT00324116|463842385|FG000|Overall Study|Withdrawal by Subject|5|||
128876665|NCT00324116|463842385|FG000|Overall Study|Other|5|||
128876666|NCT01737827|463842386|FG000|Overall Study|Adverse Event|3|||
128876667|NCT01737827|463842387|FG001|Overall Study|Adverse Event|6|||
128876668|NCT01737827|463842388|FG002|Overall Study|Adverse Event|0|||
128876669|NCT01737827|463842386|FG000|Overall Study|Lost to Follow-up|0|||
128876670|NCT01737827|463842387|FG001|Overall Study|Lost to Follow-up|1|||
128876671|NCT01737827|463842388|FG002|Overall Study|Lost to Follow-up|0|||
128876672|NCT01737827|463842386|FG000|Overall Study|Physician Decision|0|||
128876673|NCT01737827|463842387|FG001|Overall Study|Physician Decision|2|||
128876674|NCT01737827|463842388|FG002|Overall Study|Physician Decision|0|||
128876675|NCT01737827|463842386|FG000|Overall Study|Progressive Disease|5|||
128876676|NCT01737827|463842387|FG001|Overall Study|Progressive Disease|16|||
128876677|NCT01737827|463842388|FG002|Overall Study|Progressive Disease|2|||
128876678|NCT01737827|463842386|FG000|Overall Study|Study Terminated by Sponsor|0|||
128876679|NCT01737827|463842387|FG001|Overall Study|Study Terminated by Sponsor|1|||
128876680|NCT01737827|463842388|FG002|Overall Study|Study Terminated by Sponsor|0|||
128876681|NCT01737827|463842386|FG000|Overall Study|Subject/Guardian Decision|0|||
128876682|NCT01737827|463842387|FG001|Overall Study|Subject/Guardian Decision|2|||
128876683|NCT01737827|463842388|FG002|Overall Study|Subject/Guardian Decision|0|||
128876684|NCT01451827|463842389|FG000|Overall Study|Adverse Event|2|||
128876685|NCT01451827|463842390|FG001|Overall Study|Adverse Event|0|||
128876686|NCT01451827|463842391|FG002|Overall Study|Adverse Event|1|||
128876687|NCT01451827|463842392|FG003|Overall Study|Adverse Event|1|||
128876688|NCT01451827|463842389|FG000|Overall Study|Protocol deviation|1|||
128876689|NCT01451827|463842390|FG001|Overall Study|Protocol deviation|0|||
128876690|NCT01451827|463842391|FG002|Overall Study|Protocol deviation|0|||
128876691|NCT01451827|463842392|FG003|Overall Study|Protocol deviation|0|||
128876692|NCT01451827|463842389|FG000|Overall Study|Lost to Follow-up|0|||
128876693|NCT01451827|463842390|FG001|Overall Study|Lost to Follow-up|3|||
128876694|NCT01451827|463842391|FG002|Overall Study|Lost to Follow-up|0|||
128876695|NCT01451827|463842392|FG003|Overall Study|Lost to Follow-up|2|||
128876696|NCT01451827|463842389|FG000|Overall Study|Participant met withdrawal criteria|0|||
128876697|NCT01451827|463842390|FG001|Overall Study|Participant met withdrawal criteria|2|||
128876698|NCT01451827|463842391|FG002|Overall Study|Participant met withdrawal criteria|0|||
128876699|NCT01451827|463842392|FG003|Overall Study|Participant met withdrawal criteria|0|||
128876700|NCT01451827|463842389|FG000|Overall Study|Withdrawal by Subject|0|||
128876701|NCT01451827|463842390|FG001|Overall Study|Withdrawal by Subject|0|||
128876702|NCT01451827|463842391|FG002|Overall Study|Withdrawal by Subject|1|||
128876703|NCT01451827|463842392|FG003|Overall Study|Withdrawal by Subject|1|||
128987702|NCT01891669|464243368|FG006|Overall Study|Withdrawal by Subject|1|||
128987703|NCT01891669|464243369|FG007|Overall Study|Withdrawal by Subject|2|||
128987704|NCT01891669|464243370|FG008|Overall Study|Withdrawal by Subject|1|||
128987705|NCT01891669|464243371|FG009|Overall Study|Withdrawal by Subject|1|||
128987706|NCT01891669|464243362|FG000|Overall Study|Other|1|||
128987707|NCT01891669|464243363|FG001|Overall Study|Other|0|||
128987708|NCT01891669|464243364|FG002|Overall Study|Other|0|||
128987709|NCT01891669|464243365|FG003|Overall Study|Other|0|||
128987710|NCT01891669|464243366|FG004|Overall Study|Other|0|||
128987711|NCT01891669|464243367|FG005|Overall Study|Other|0|||
128987712|NCT01891669|464243368|FG006|Overall Study|Other|0|||
128987713|NCT01891669|464243369|FG007|Overall Study|Other|1|||
128987714|NCT01891669|464243370|FG008|Overall Study|Other|0|||
128987715|NCT01891669|464243371|FG009|Overall Study|Other|0|||
128987716|NCT05153629|464243373|FG000|Overall Study|Withdrawal by Subject|0|||
128987717|NCT05153629|464243374|FG001|Overall Study|Withdrawal by Subject|2|||
128987718|NCT03743571|464243377|FG000|Overall Study|Withdrawal by Subject|1|||
128987719|NCT03743571|464243378|FG001|Overall Study|Withdrawal by Subject|1|||
128987720|NCT03743571|464243377|FG000|Overall Study|Lost to Follow-up|1|||
128987721|NCT03743571|464243378|FG001|Overall Study|Lost to Follow-up|2|||
128987722|NCT04115488|464243379|FG000|Overall Study|Adverse Event|8|||
128987723|NCT04115488|464243380|FG001|Overall Study|Adverse Event|4|||
128987724|NCT04115488|464243379|FG000|Overall Study|Withdrawal by Subject|3|||
128987725|NCT04115488|464243380|FG001|Overall Study|Withdrawal by Subject|6|||
128987726|NCT04115488|464243379|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
128987727|NCT04115488|464243380|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
128987728|NCT04115488|464243379|FG000|Overall Study|Patient 's location change|1|||
128987729|NCT04115488|464243380|FG001|Overall Study|Patient 's location change|0|||
128987730|NCT04115488|464243379|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
128987731|NCT04115488|464243380|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
128987732|NCT02576951|464243396|FG000|Overall Study|Lost to Follow-up|0|||
128987733|NCT02576951|464243397|FG001|Overall Study|Lost to Follow-up|0|||
128987734|NCT02576951|464243398|FG002|Overall Study|Lost to Follow-up|2|||
128987735|NCT02576951|464243399|FG003|Overall Study|Lost to Follow-up|2|||
128987736|NCT02576951|464243396|FG000|Overall Study|Withdrawal by Subject|1|||
128987737|NCT02576951|464243397|FG001|Overall Study|Withdrawal by Subject|0|||
128987738|NCT02576951|464243398|FG002|Overall Study|Withdrawal by Subject|0|||
128987739|NCT02576951|464243399|FG003|Overall Study|Withdrawal by Subject|2|||
128987740|NCT02576951|464243396|FG000|Overall Study|Protocol Violation|0|||
128987741|NCT02576951|464243397|FG001|Overall Study|Protocol Violation|0|||
128987742|NCT02576951|464243398|FG002|Overall Study|Protocol Violation|0|||
128987743|NCT02576951|464243399|FG003|Overall Study|Protocol Violation|1|||
128987744|NCT03280628|464244959|FG000|Overall Study|Lost to Follow-up|8|||
128987745|NCT03280628|464244960|FG001|Overall Study|Lost to Follow-up|6|||
128987746|NCT03280628|464244961|FG002|Overall Study|Lost to Follow-up|11|||
128987747|NCT03839693|464244966|FG000|Overall Study|Lost to Follow-up|0|||
128987748|NCT03839693|464244967|FG001|Overall Study|Lost to Follow-up|2|||
128987749|NCT03839693|464244968|FG002|Overall Study|Lost to Follow-up|2|||
128987750|NCT03839693|464244966|FG000|Overall Study|Withdrawal by Subject|1|||
128987751|NCT03839693|464244967|FG001|Overall Study|Withdrawal by Subject|0|||
128987752|NCT03839693|464244968|FG002|Overall Study|Withdrawal by Subject|2|||
128987753|NCT03839693|464244966|FG000|Overall Study|subject moved out of the area|1|||
128987754|NCT03839693|464244967|FG001|Overall Study|subject moved out of the area|0|||
128987755|NCT03839693|464244968|FG002|Overall Study|subject moved out of the area|0|||
128987756|NCT03433482|464244969|FG000|Overall Study|Lost to Follow-up|1|||
128987757|NCT03433482|464244970|FG001|Overall Study|Lost to Follow-up|0|||
128987758|NCT03433482|464244971|FG002|Overall Study|Lost to Follow-up|1|||
128987759|NCT03433482|464244972|FG003|Overall Study|Lost to Follow-up|1|||
128987760|NCT03433482|464244969|FG000|Overall Study|Withdrawal by Subject|0|||
128987761|NCT03433482|464244970|FG001|Overall Study|Withdrawal by Subject|0|||
128987762|NCT03433482|464244971|FG002|Overall Study|Withdrawal by Subject|1|||
128987763|NCT03433482|464244972|FG003|Overall Study|Withdrawal by Subject|0|||
128987764|NCT03433482|464244969|FG000|Overall Study|Unknown reason|0|||
129213874|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
129213875|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
128987765|NCT03433482|464244970|FG001|Overall Study|Unknown reason|0|||
128987766|NCT03433482|464244971|FG002|Overall Study|Unknown reason|2|||
128987767|NCT03433482|464244972|FG003|Overall Study|Unknown reason|0|||
129222168|NCT03184870|465116021|FG005|Initial Treatment|Moved to crossover treatment|0|||
128987768|NCT00594568|464244973|FG000|Initial Treatment|Adverse Event|51|||
128987769|NCT00594568|464244974|FG001|Initial Treatment|Adverse Event|121|||
128987770|NCT00594568|464244975|FG002|Initial Treatment|Adverse Event|144|||
128987771|NCT00594568|464244973|FG000|Initial Treatment|Death|6|||
128987772|NCT00594568|464244974|FG001|Initial Treatment|Death|11|||
128987773|NCT00594568|464244975|FG002|Initial Treatment|Death|15|||
128987774|NCT00594568|464244973|FG000|Initial Treatment|Lost to Follow-up|4|||
128987775|NCT00594568|464244974|FG001|Initial Treatment|Lost to Follow-up|1|||
128987776|NCT00594568|464244975|FG002|Initial Treatment|Lost to Follow-up|4|||
129213876|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
129213877|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
129213878|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
129213879|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
129213880|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
129213881|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
129213882|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
129213883|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
129213884|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
129213885|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
129213886|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
129213887|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
129213888|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
129213889|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
129213890|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
128987777|NCT00594568|464244973|FG000|Initial Treatment|Physician Decision|3|||
128987778|NCT00594568|464244974|FG001|Initial Treatment|Physician Decision|2|||
128987779|NCT00594568|464244975|FG002|Initial Treatment|Physician Decision|4|||
129213891|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
129213892|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
129213893|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
129213894|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
129213895|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129213896|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129213897|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
129213898|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129213899|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129213900|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129213901|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
129213902|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129213903|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
129213904|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
129213905|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129213906|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129213907|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
129213908|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129213909|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
129213910|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
129213911|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
129213912|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
129213913|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
129213914|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
129213915|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
129213916|NCT01054885|465087102|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129213917|NCT01054885|465087103|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
129213918|NCT01054885|465087104|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129213919|NCT01054885|465087105|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
129213920|NCT01054885|465087106|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
128987780|NCT00594568|464244973|FG000|Initial Treatment|Protocol Violation|2|||
128987781|NCT00594568|464244974|FG001|Initial Treatment|Protocol Violation|2|||
128987782|NCT00594568|464244975|FG002|Initial Treatment|Protocol Violation|5|||
128987783|NCT00594568|464244973|FG000|Initial Treatment|Withdrawal by Subject|25|||
128987784|NCT00594568|464244974|FG001|Initial Treatment|Withdrawal by Subject|31|||
128987785|NCT00594568|464244975|FG002|Initial Treatment|Withdrawal by Subject|46|||
128987786|NCT00594568|464244973|FG000|Initial Treatment|Sponsor decision|193|||
128987787|NCT00594568|464244974|FG001|Initial Treatment|Sponsor decision|142|||
128987788|NCT00594568|464244975|FG002|Initial Treatment|Sponsor decision|147|||
128987789|NCT00594568|464244973|FG000|Initial Treatment|Caregiver decision|21|||
128987790|NCT00594568|464244974|FG001|Initial Treatment|Caregiver decision|36|||
128987791|NCT00594568|464244975|FG002|Initial Treatment|Caregiver decision|36|||
128987792|NCT00594568|464244973|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
128763058|NCT00991341|463422700|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
128987793|NCT00594568|464244974|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
128987794|NCT00594568|464244975|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
129213921|NCT01054885|465087107|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129213922|NCT01054885|465087108|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
129213923|NCT00214201|465087110|FG000|Overall Study|Withdrawal by Subject|2|||
129213924|NCT00214201|465087111|FG001|Overall Study|Withdrawal by Subject|0|||
129213925|NCT00214201|465087110|FG000|Overall Study|Death|0|||
129213926|NCT00214201|465087111|FG001|Overall Study|Death|2|||
129213927|NCT01399372|465087115|FG000|Overall Study|Protocol Violation|3|||
129213928|NCT01399372|465087116|FG001|Overall Study|Protocol Violation|1|||
129213929|NCT01432730|465087117|FG000|Period 1|Adverse Event|2|||
129213930|NCT01432730|465087118|FG001|Period 1|Adverse Event|0|||
129213931|NCT01432730|465087117|FG000|Period 2|Adverse Event|0|||
129213932|NCT01432730|465087118|FG001|Period 2|Adverse Event|4|||
129213933|NCT01421719|465087123|FG000|Overall Study|Withdrawal by Subject|4|||
129213934|NCT01124006|465087124|FG000|Overall Study|Withdrawal by Subject|2|||
129213935|NCT01124006|465087125|FG001|Overall Study|Withdrawal by Subject|2|||
129213936|NCT01124006|465087126|FG002|Overall Study|Withdrawal by Subject|0|||
129213937|NCT01124006|465087124|FG000|Overall Study|Lost to Follow-up|1|||
129213938|NCT01124006|465087125|FG001|Overall Study|Lost to Follow-up|0|||
129213939|NCT01124006|465087126|FG002|Overall Study|Lost to Follow-up|1|||
129213940|NCT01124006|465087124|FG000|Overall Study|Other|0|||
129213941|NCT01124006|465087125|FG001|Overall Study|Other|0|||
129213942|NCT01124006|465087126|FG002|Overall Study|Other|1|||
129213943|NCT01712399|465087132|FG000|Overall Study|Lost to Follow-up|1|||
129213944|NCT01712399|465087132|FG000|Overall Study|Withdrawal by Subject|39|||
129213945|NCT01712399|465087132|FG000|Overall Study|Death|1|||
129213946|NCT01712399|465087132|FG000|Overall Study|Adverse Event|11|||
129213947|NCT01712399|465087132|FG000|Overall Study|Study closure|345|||
129213948|NCT01942837|465087133|FG000|Overall Study|Death|1|||
129213949|NCT01942837|465087133|FG000|Overall Study|Symptomatic or radiographic progression|49|||
129213950|NCT01942837|465087133|FG000|Overall Study|Adverse Event|6|||
129213951|NCT01942837|465087133|FG000|Overall Study|Physician Decision|3|||
129213952|NCT01942837|465087133|FG000|Overall Study|Withdrawal by Subject|2|||
129213953|NCT01942837|465087133|FG000|Overall Study|Intercurrent Illness|1|||
129213954|NCT01942837|465087133|FG000|Overall Study|On treatment|3|||
129213955|NCT01942837|465087133|FG000|Overall Study|Never initiate the treatment|2|||
129213956|NCT01298648|465087134|FG000|Overall Study|Withdrawal by Subject|2|||
129213957|NCT01298648|465087134|FG000|Overall Study|Lost to Follow-up|21|||
129213958|NCT01803607|465087139|FG000|Overall Study|Adverse Event|5|||
129213959|NCT01803607|465087140|FG001|Overall Study|Adverse Event|3|||
129213960|NCT01803607|465087139|FG000|Overall Study|Lack of Efficacy|0|||
129213961|NCT01803607|465087140|FG001|Overall Study|Lack of Efficacy|1|||
129213962|NCT01803607|465087139|FG000|Overall Study|Protocol Violation|3|||
129213963|NCT01803607|465087140|FG001|Overall Study|Protocol Violation|2|||
129213964|NCT01803607|465087139|FG000|Overall Study|Study terminated by sponsor|54|||
129213965|NCT01803607|465087140|FG001|Overall Study|Study terminated by sponsor|56|||
129213966|NCT01803607|465087139|FG000|Overall Study|Withdrawal by Subject|6|||
129213967|NCT01803607|465087140|FG001|Overall Study|Withdrawal by Subject|5|||
129213968|NCT02038933|465087152|FG000|Overall Study|Disease progression|104|||
129213969|NCT02038933|465087152|FG000|Overall Study|Study drug toxicity|6|||
129213970|NCT02038933|465087152|FG000|Overall Study|Adverse event unrelated to study drug|6|||
129213971|NCT02038933|465087152|FG000|Overall Study|Participant request to discontinue treatment|2|||
129213972|NCT02038933|465087152|FG000|Overall Study|Lost to Follow-up|1|||
129213973|NCT02038933|465087152|FG000|Overall Study|Other reasons|2|||
129213974|NCT03250273|465087153|FG000|Overall Study|Disease Progression|2|||
129213975|NCT03250273|465087154|FG001|Overall Study|Disease Progression|11|||
129213976|NCT03250273|465087153|FG000|Overall Study|Death|0|||
129213977|NCT03250273|465087154|FG001|Overall Study|Death|1|||
129213978|NCT01337960|465087155|FG000|Overall Study|Lost to Follow-up|1|||
129213979|NCT01337960|465087156|FG001|Overall Study|Lost to Follow-up|0|||
129213980|NCT01337960|465087157|FG002|Overall Study|Lost to Follow-up|0|||
129213981|NCT01337960|465087155|FG000|Overall Study|Withdrawal by Subject|1|||
129213982|NCT01337960|465087156|FG001|Overall Study|Withdrawal by Subject|0|||
129213983|NCT01337960|465087157|FG002|Overall Study|Withdrawal by Subject|0|||
129213984|NCT01772316|465087158|FG000|Overall Study|Serious adverse event|1|||
129213985|NCT01772316|465087158|FG000|Overall Study|Inform consent withdrawn|1|||
129213986|NCT01772316|465087158|FG000|Overall Study|Withdrawn by sponsor decision|5|||
129213987|NCT01774721|465087161|FG000|Overall Study|Death|133|||
129213988|NCT01774721|465087162|FG001|Overall Study|Death|152|||
129213989|NCT01774721|465087161|FG000|Overall Study|Withdrawal by Subject|20|||
129213990|NCT01774721|465087162|FG001|Overall Study|Withdrawal by Subject|14|||
129213991|NCT01774721|465087161|FG000|Overall Study|Lost to Follow-up|6|||
129213992|NCT01774721|465087162|FG001|Overall Study|Lost to Follow-up|7|||
129213993|NCT01774721|465087161|FG000|Overall Study|Did not meet eligibility criteria|0|||
129213994|NCT01774721|465087162|FG001|Overall Study|Did not meet eligibility criteria|3|||
129213995|NCT01774721|465087161|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
128987795|NCT00594568|464244973|FG000|Initial Treatment|Entry criteria exclusion|0|||
128987796|NCT00594568|464244974|FG001|Initial Treatment|Entry criteria exclusion|1|||
128987797|NCT00594568|464244975|FG002|Initial Treatment|Entry criteria exclusion|1|||
128987798|NCT00594568|464244973|FG000|Delayed Start|Death|0|||
128987799|NCT00594568|464244974|FG001|Delayed Start|Death|0|||
129213996|NCT01774721|465087162|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
129213997|NCT01774721|465087161|FG000|Overall Study|Study terminated by sponsor|5|||
129213998|NCT01774721|465087162|FG001|Overall Study|Study terminated by sponsor|0|||
129213999|NCT01774721|465087161|FG000|Overall Study|Disease progression|5|||
129214000|NCT01774721|465087162|FG001|Overall Study|Disease progression|0|||
129214001|NCT00803569|465087165|FG000|Overall Study|Progressive Disease|3|||
129214002|NCT00803569|465087165|FG000|Overall Study|Noncompliance|1|||
129214003|NCT04004988|465087166|FG000|Period 1|Physician Decision|2|||
129214004|NCT04004988|465087167|FG001|Period 1|Physician Decision|0|||
129214005|NCT04004988|465087166|FG000|Period 1|Withdrawal by Subject|0|||
129214006|NCT04004988|465087167|FG001|Period 1|Withdrawal by Subject|1|||
129214007|NCT04004988|465087166|FG000|Period 1|Adverse Event|1|||
128876704|NCT02971761|463842393|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
128876705|NCT02424734|463842394|FG000|Overall Study|Treatment stopped to be discharged home|2|||
128876706|NCT02424734|463842395|FG001|Overall Study|Treatment stopped to be discharged home|2|||
128876707|NCT02424734|463842396|FG002|Overall Study|Treatment stopped to be discharged home|0|||
128876708|NCT00116753|463842397|FG000|Overall Study|Adverse Event|16|||
128876709|NCT00116753|463842398|FG001|Overall Study|Adverse Event|10|||
128876710|NCT00116753|463842399|FG002|Overall Study|Adverse Event|7|||
128876711|NCT00116753|463842397|FG000|Overall Study|Withdrawal by Subject|11|||
128876712|NCT00116753|463842398|FG001|Overall Study|Withdrawal by Subject|12|||
128876713|NCT00116753|463842399|FG002|Overall Study|Withdrawal by Subject|8|||
128876714|NCT00116753|463842397|FG000|Overall Study|Lost to Follow-up|0|||
128876715|NCT00116753|463842398|FG001|Overall Study|Lost to Follow-up|2|||
128876716|NCT00116753|463842399|FG002|Overall Study|Lost to Follow-up|1|||
128876717|NCT00116753|463842397|FG000|Overall Study|Protocol Violation|0|||
128876718|NCT00116753|463842398|FG001|Overall Study|Protocol Violation|0|||
128876719|NCT00116753|463842399|FG002|Overall Study|Protocol Violation|1|||
128987800|NCT00594568|464244975|FG002|Delayed Start|Death|1|||
129214008|NCT04004988|465087167|FG001|Period 1|Adverse Event|2|||
129214009|NCT00930046|465087168|FG000|Overall Study|Wound catheter malfunctioned|1|||
129214010|NCT00930046|465087169|FG001|Overall Study|Wound catheter malfunctioned|2|||
129214011|NCT01598532|465087170|FG000|Overall Study|Lost to Follow-up|3|||
129214012|NCT01598532|465087170|FG000|Overall Study|Did not meet inclusion criteria|8|||
129214013|NCT00912808|465087171|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
129214014|NCT00912808|465087172|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129214015|NCT00912808|465087171|FG000|Washout|Withdrawal by Subject|0|||
129214016|NCT00912808|465087172|FG001|Washout|Withdrawal by Subject|1|||
129214017|NCT00912808|465087171|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129214018|NCT00912808|465087172|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
129214019|NCT00912808|465087171|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
129214020|NCT00912808|465087172|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
129214021|NCT03873116|465087173|FG000|Part 1|Study drug discontinuation due to rash|0|||
129214022|NCT03873116|465087174|FG001|Part 1|Study drug discontinuation due to rash|0|||
129214023|NCT03873116|465087175|FG002|Part 1|Study drug discontinuation due to rash|0|||
129214024|NCT03873116|465087176|FG003|Part 1|Study drug discontinuation due to rash|0|||
129214025|NCT03873116|465087177|FG004|Part 1|Study drug discontinuation due to rash|0|||
129214026|NCT03873116|465087178|FG005|Part 1|Study drug discontinuation due to rash|1|||
129214027|NCT03873116|465087173|FG000|Part 2|Withdrawal by Subject|0|||
129214028|NCT03873116|465087174|FG001|Part 2|Withdrawal by Subject|0|||
129214029|NCT03873116|465087175|FG002|Part 2|Withdrawal by Subject|1|||
129214030|NCT03873116|465087176|FG003|Part 2|Withdrawal by Subject|0|||
129214031|NCT03873116|465087177|FG004|Part 2|Withdrawal by Subject|0|||
129214032|NCT03873116|465087178|FG005|Part 2|Withdrawal by Subject|0|||
129214033|NCT03873116|465087173|FG000|Part 2|Lab abnormality or AE|0|||
129214034|NCT03873116|465087174|FG001|Part 2|Lab abnormality or AE|0|||
129214035|NCT03873116|465087175|FG002|Part 2|Lab abnormality or AE|0|||
129214036|NCT03873116|465087176|FG003|Part 2|Lab abnormality or AE|0|||
129214037|NCT03873116|465087177|FG004|Part 2|Lab abnormality or AE|1|||
129214038|NCT03873116|465087178|FG005|Part 2|Lab abnormality or AE|0|||
129214039|NCT03873116|465087173|FG000|Part 3|Withdrawal by Subject|0|||
129214040|NCT03873116|465087174|FG001|Part 3|Withdrawal by Subject|0|||
129214041|NCT03873116|465087175|FG002|Part 3|Withdrawal by Subject|0|||
129214042|NCT03873116|465087176|FG003|Part 3|Withdrawal by Subject|0|||
129214043|NCT03873116|465087177|FG004|Part 3|Withdrawal by Subject|1|||
129214044|NCT03873116|465087178|FG005|Part 3|Withdrawal by Subject|0|||
129214045|NCT04682366|465087179|FG000|Overall Study|Lost to Follow-up|1|||
129214046|NCT04682366|465087180|FG001|Overall Study|Lost to Follow-up|1|||
129214047|NCT00702221|465087181|FG000|Overall Study|Adverse Event|4|||
129214048|NCT00702221|465087182|FG001|Overall Study|Adverse Event|3|||
129214049|NCT02531802|465087185|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
129214050|NCT02531802|465087186|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
129214051|NCT02531802|465087187|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
129214052|NCT02531802|465087188|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
129214053|NCT02531802|465087189|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
129214054|NCT02531802|465087190|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
129214055|NCT02531802|465087191|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
129214056|NCT02531802|465087192|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
128876720|NCT00116753|463842397|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
128876721|NCT00116753|463842398|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
128876722|NCT00116753|463842399|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
128876723|NCT00116753|463842397|FG000|Overall Study|Disease Progression|3|||
128876724|NCT00116753|463842398|FG001|Overall Study|Disease Progression|4|||
128876725|NCT00116753|463842399|FG002|Overall Study|Disease Progression|3|||
128876726|NCT00116753|463842397|FG000|Overall Study|Abnormal Echocardiogram|0|||
128876727|NCT00116753|463842398|FG001|Overall Study|Abnormal Echocardiogram|0|||
128876728|NCT00116753|463842399|FG002|Overall Study|Abnormal Echocardiogram|1|||
129214057|NCT02531802|465087193|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
129214058|NCT02531802|465087194|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
129214059|NCT02531802|465087195|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
129214060|NCT02531802|465087196|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
129214061|NCT02531802|465087197|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
129214062|NCT02531802|465087198|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
129214063|NCT02531802|465087199|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
128876729|NCT00116753|463842397|FG000|Overall Study|Progressive Parkinson's Disease|1|||
129214064|NCT02531802|465087200|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
129214065|NCT02531802|465087201|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
129214066|NCT02531802|465087202|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
129214067|NCT02531802|465087203|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
129214068|NCT02531802|465087204|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
129214069|NCT02531802|465087205|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
129214070|NCT02531802|465087185|FG000|Received Vaccination 2|Physician Decision|0|||
129214071|NCT02531802|465087186|FG001|Received Vaccination 2|Physician Decision|0|||
129214072|NCT02531802|465087187|FG002|Received Vaccination 2|Physician Decision|0|||
129214073|NCT02531802|465087188|FG003|Received Vaccination 2|Physician Decision|0|||
129214074|NCT02531802|465087189|FG004|Received Vaccination 2|Physician Decision|0|||
129214075|NCT02531802|465087190|FG005|Received Vaccination 2|Physician Decision|1|||
129214076|NCT02531802|465087191|FG006|Received Vaccination 2|Physician Decision|0|||
129214077|NCT02531802|465087192|FG007|Received Vaccination 2|Physician Decision|0|||
129214078|NCT02531802|465087193|FG008|Received Vaccination 2|Physician Decision|0|||
129214079|NCT02531802|465087194|FG009|Received Vaccination 2|Physician Decision|2|||
129214080|NCT02531802|465087195|FG010|Received Vaccination 2|Physician Decision|0|||
129214081|NCT02531802|465087196|FG011|Received Vaccination 2|Physician Decision|0|||
129214082|NCT02531802|465087197|FG012|Received Vaccination 2|Physician Decision|0|||
129214083|NCT02531802|465087198|FG013|Received Vaccination 2|Physician Decision|1|||
129214084|NCT02531802|465087199|FG014|Received Vaccination 2|Physician Decision|0|||
129214085|NCT02531802|465087200|FG015|Received Vaccination 2|Physician Decision|0|||
129214086|NCT02531802|465087201|FG016|Received Vaccination 2|Physician Decision|0|||
129214087|NCT02531802|465087202|FG017|Received Vaccination 2|Physician Decision|1|||
129214088|NCT02531802|465087203|FG018|Received Vaccination 2|Physician Decision|0|||
129214089|NCT02531802|465087204|FG019|Received Vaccination 2|Physician Decision|0|||
129214090|NCT02531802|465087205|FG020|Received Vaccination 2|Physician Decision|0|||
129214091|NCT02531802|465087185|FG000|Received Vaccination 2|Adverse Event|0|||
129214092|NCT02531802|465087186|FG001|Received Vaccination 2|Adverse Event|0|||
129214093|NCT02531802|465087187|FG002|Received Vaccination 2|Adverse Event|0|||
129214094|NCT02531802|465087188|FG003|Received Vaccination 2|Adverse Event|0|||
129214095|NCT02531802|465087189|FG004|Received Vaccination 2|Adverse Event|0|||
129214096|NCT02531802|465087190|FG005|Received Vaccination 2|Adverse Event|2|||
129214097|NCT02531802|465087191|FG006|Received Vaccination 2|Adverse Event|0|||
129214098|NCT02531802|465087192|FG007|Received Vaccination 2|Adverse Event|0|||
129214099|NCT02531802|465087193|FG008|Received Vaccination 2|Adverse Event|0|||
129214100|NCT02531802|465087194|FG009|Received Vaccination 2|Adverse Event|0|||
129214101|NCT02531802|465087195|FG010|Received Vaccination 2|Adverse Event|0|||
129214102|NCT02531802|465087196|FG011|Received Vaccination 2|Adverse Event|0|||
129214103|NCT02531802|465087197|FG012|Received Vaccination 2|Adverse Event|0|||
129214104|NCT02531802|465087198|FG013|Received Vaccination 2|Adverse Event|0|||
129214105|NCT02531802|465087199|FG014|Received Vaccination 2|Adverse Event|0|||
129214106|NCT02531802|465087200|FG015|Received Vaccination 2|Adverse Event|0|||
129214107|NCT02531802|465087201|FG016|Received Vaccination 2|Adverse Event|0|||
129214108|NCT02531802|465087202|FG017|Received Vaccination 2|Adverse Event|2|||
129214109|NCT02531802|465087203|FG018|Received Vaccination 2|Adverse Event|1|||
129214110|NCT02531802|465087204|FG019|Received Vaccination 2|Adverse Event|0|||
129214111|NCT02531802|465087205|FG020|Received Vaccination 2|Adverse Event|1|||
129214112|NCT02531802|465087185|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
129214113|NCT02531802|465087186|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
129214114|NCT02531802|465087187|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
129214115|NCT02531802|465087188|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
129214116|NCT02531802|465087189|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
129214117|NCT02531802|465087190|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
129214118|NCT02531802|465087191|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
129214119|NCT02531802|465087192|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
129214120|NCT02531802|465087193|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
129214121|NCT02531802|465087194|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
129214122|NCT02531802|465087195|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
129214123|NCT02531802|465087196|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
129214124|NCT02531802|465087197|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
129214125|NCT02531802|465087198|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
129214126|NCT02531802|465087199|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
129214127|NCT02531802|465087200|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
129214128|NCT02531802|465087201|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
129214129|NCT02531802|465087202|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
129214130|NCT02531802|465087203|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
129214131|NCT02531802|465087204|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
129214132|NCT02531802|465087205|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
129214133|NCT03345784|465087206|FG000|Overall Study|Withdrawal by Subject|2|||
129214134|NCT03345784|465087207|FG001|Overall Study|Withdrawal by Subject|1|||
129214135|NCT04798196|465087208|FG000|Overall Study|Lost to Follow-up|3|||
129214136|NCT04798196|465087209|FG001|Overall Study|Lost to Follow-up|1|||
129214137|NCT04798196|465087210|FG002|Overall Study|Lost to Follow-up|3|||
129214138|NCT04596267|465087217|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
129214139|NCT04596267|465087218|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
129214140|NCT04596267|465087217|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
129214141|NCT04596267|465087218|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
129214142|NCT00071058|465087219|FG000|Overall Study|brain tumor-removed from study|1|||
129214143|NCT02000440|465087220|FG000|Overall Study|Adverse Event|3|||
129214144|NCT02000440|465087220|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
129214145|NCT01550003|465087221|FG000|Overall Study|Adverse Event|0|||
129214146|NCT01550003|465087222|FG001|Overall Study|Adverse Event|9|||
129214147|NCT01550003|465087223|FG002|Overall Study|Adverse Event|15|||
129214148|NCT01550003|465087221|FG000|Overall Study|Lack of Efficacy|4|||
129214149|NCT01550003|465087222|FG001|Overall Study|Lack of Efficacy|11|||
129214150|NCT01550003|465087223|FG002|Overall Study|Lack of Efficacy|15|||
129214151|NCT01550003|465087221|FG000|Overall Study|Protocol Violation|0|||
129214152|NCT01550003|465087222|FG001|Overall Study|Protocol Violation|3|||
129214153|NCT01550003|465087223|FG002|Overall Study|Protocol Violation|2|||
129214154|NCT01550003|465087221|FG000|Overall Study|Lost to Follow-up|1|||
129214155|NCT01550003|465087222|FG001|Overall Study|Lost to Follow-up|4|||
129214156|NCT01550003|465087223|FG002|Overall Study|Lost to Follow-up|8|||
129214157|NCT01550003|465087221|FG000|Overall Study|Consent withdrawn|2|||
129214158|NCT01550003|465087222|FG001|Overall Study|Consent withdrawn|11|||
129214159|NCT01550003|465087223|FG002|Overall Study|Consent withdrawn|23|||
129214160|NCT01550003|465087221|FG000|Overall Study|Missing|1|||
129214161|NCT01550003|465087222|FG001|Overall Study|Missing|0|||
129214162|NCT01550003|465087223|FG002|Overall Study|Missing|2|||
129214163|NCT01550003|465087221|FG000|Overall Study|Study closure as announced by sponsor|7|||
129214164|NCT01550003|465087222|FG001|Overall Study|Study closure as announced by sponsor|6|||
129214165|NCT01550003|465087223|FG002|Overall Study|Study closure as announced by sponsor|24|||
129214166|NCT01550003|465087221|FG000|Overall Study|Protocol Noncompliance|1|||
129214167|NCT01550003|465087222|FG001|Overall Study|Protocol Noncompliance|0|||
129214168|NCT01550003|465087223|FG002|Overall Study|Protocol Noncompliance|0|||
129214169|NCT01550003|465087221|FG000|Overall Study|Study closure|0|||
129214170|NCT01550003|465087222|FG001|Overall Study|Study closure|1|||
129214171|NCT01550003|465087223|FG002|Overall Study|Study closure|1|||
129214172|NCT01550003|465087221|FG000|Overall Study|Patient reached adulthood|0|||
129214173|NCT01550003|465087222|FG001|Overall Study|Patient reached adulthood|1|||
129214174|NCT01550003|465087223|FG002|Overall Study|Patient reached adulthood|0|||
129214175|NCT01550003|465087221|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
129214176|NCT01550003|465087222|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
129214177|NCT01550003|465087223|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
129214178|NCT01550003|465087221|FG000|Overall Study|Sponsor's order|0|||
129214179|NCT01550003|465087222|FG001|Overall Study|Sponsor's order|3|||
129214180|NCT01550003|465087223|FG002|Overall Study|Sponsor's order|3|||
129214181|NCT01550003|465087221|FG000|Overall Study|Sponsor's decision|1|||
129214182|NCT01550003|465087222|FG001|Overall Study|Sponsor's decision|5|||
129214183|NCT01550003|465087223|FG002|Overall Study|Sponsor's decision|4|||
129214184|NCT01550003|465087221|FG000|Overall Study|Subject mother passed away|0|||
129214185|NCT01550003|465087222|FG001|Overall Study|Subject mother passed away|1|||
129214186|NCT01550003|465087223|FG002|Overall Study|Subject mother passed away|0|||
129214187|NCT01550003|465087221|FG000|Overall Study|Discontinuation|0|||
129214188|NCT01550003|465087222|FG001|Overall Study|Discontinuation|1|||
129214189|NCT01550003|465087223|FG002|Overall Study|Discontinuation|0|||
129214190|NCT01550003|465087221|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
129214191|NCT01550003|465087222|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
129214192|NCT01550003|465087223|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
129214193|NCT01550003|465087221|FG000|Overall Study|Site closure|0|||
129214194|NCT01550003|465087222|FG001|Overall Study|Site closure|2|||
129214195|NCT01550003|465087223|FG002|Overall Study|Site closure|0|||
129214196|NCT01550003|465087221|FG000|Overall Study|Pregnancy|0|||
129214197|NCT01550003|465087222|FG001|Overall Study|Pregnancy|1|||
129214198|NCT01550003|465087223|FG002|Overall Study|Pregnancy|0|||
129214199|NCT01550003|465087221|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
129214200|NCT01550003|465087222|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
129214201|NCT01550003|465087223|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
129214202|NCT01550003|465087221|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
129214203|NCT01550003|465087222|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
129214204|NCT01550003|465087223|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
129214205|NCT01550003|465087221|FG000|Overall Study|Switching to adult rheumatologist|0|||
129214206|NCT01550003|465087222|FG001|Overall Study|Switching to adult rheumatologist|0|||
129214207|NCT01550003|465087223|FG002|Overall Study|Switching to adult rheumatologist|1|||
129214208|NCT01550003|465087221|FG000|Overall Study|Patient transition to adult care|0|||
129214209|NCT01550003|465087222|FG001|Overall Study|Patient transition to adult care|0|||
129214210|NCT01550003|465087223|FG002|Overall Study|Patient transition to adult care|1|||
129214211|NCT01550003|465087221|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
129214212|NCT01550003|465087222|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
129214213|NCT01550003|465087223|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
129214214|NCT01550003|465087221|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
129214215|NCT01550003|465087222|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
129214216|NCT01550003|465087223|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
129214217|NCT01550003|465087221|FG000|Overall Study|Per Sponsor request|1|||
129214218|NCT01550003|465087222|FG001|Overall Study|Per Sponsor request|0|||
129214219|NCT01550003|465087223|FG002|Overall Study|Per Sponsor request|1|||
129214220|NCT01550003|465087221|FG000|Overall Study|Patient not compliance|0|||
129214221|NCT01550003|465087222|FG001|Overall Study|Patient not compliance|0|||
129214222|NCT01550003|465087223|FG002|Overall Study|Patient not compliance|1|||
129214223|NCT01550003|465087221|FG000|Overall Study|Non-compliance|0|||
129214224|NCT01550003|465087222|FG001|Overall Study|Non-compliance|0|||
129214225|NCT01550003|465087223|FG002|Overall Study|Non-compliance|1|||
129214226|NCT01550003|465087221|FG000|Overall Study|Study closed|0|||
129214227|NCT01550003|465087222|FG001|Overall Study|Study closed|1|||
129214228|NCT01550003|465087223|FG002|Overall Study|Study closed|0|||
129214229|NCT01550003|465087221|FG000|Overall Study|Transitioned to adult rheumatology|0|||
129214230|NCT01550003|465087222|FG001|Overall Study|Transitioned to adult rheumatology|0|||
129214231|NCT01550003|465087223|FG002|Overall Study|Transitioned to adult rheumatology|1|||
129214232|NCT01656408|465087224|FG000|Overall Study|Adverse Event|0|||
129214233|NCT01656408|465087225|FG001|Overall Study|Adverse Event|0|||
129214234|NCT01656408|465087226|FG002|Overall Study|Adverse Event|1|||
129214235|NCT01656408|465087227|FG003|Overall Study|Adverse Event|0|||
129214236|NCT01656408|465087228|FG004|Overall Study|Adverse Event|0|||
129214237|NCT01656408|465087229|FG005|Overall Study|Adverse Event|1|||
129214238|NCT01656408|465087230|FG006|Overall Study|Adverse Event|1|||
129214239|NCT01656408|465087231|FG007|Overall Study|Adverse Event|0|||
129214240|NCT01656408|465087232|FG008|Overall Study|Adverse Event|1|||
129214241|NCT01656408|465087233|FG009|Overall Study|Adverse Event|0|||
129214242|NCT01656408|465087224|FG000|Overall Study|Physician Decision|1|||
129214243|NCT01656408|465087225|FG001|Overall Study|Physician Decision|0|||
129214244|NCT01656408|465087226|FG002|Overall Study|Physician Decision|1|||
129214245|NCT01656408|465087227|FG003|Overall Study|Physician Decision|0|||
129214246|NCT01656408|465087228|FG004|Overall Study|Physician Decision|1|||
129214247|NCT01656408|465087229|FG005|Overall Study|Physician Decision|1|||
129214248|NCT01656408|465087230|FG006|Overall Study|Physician Decision|0|||
129214249|NCT01656408|465087231|FG007|Overall Study|Physician Decision|1|||
129214250|NCT01656408|465087232|FG008|Overall Study|Physician Decision|1|||
129214251|NCT01656408|465087233|FG009|Overall Study|Physician Decision|3|||
129214252|NCT03995368|465087234|FG000|Overall Study|Lost to Follow-up|1|||
129214253|NCT03995368|465087235|FG001|Overall Study|Lost to Follow-up|4|||
129214254|NCT03995368|465087236|FG002|Overall Study|Lost to Follow-up|1|||
129214255|NCT03995368|465087234|FG000|Overall Study|Did not meet inclusion criteria|1|||
129214256|NCT03995368|465087235|FG001|Overall Study|Did not meet inclusion criteria|6|||
129214257|NCT03995368|465087236|FG002|Overall Study|Did not meet inclusion criteria|3|||
129214258|NCT03995368|465087234|FG000|Overall Study|Withdrawal by Subject|0|||
129214259|NCT03995368|465087235|FG001|Overall Study|Withdrawal by Subject|1|||
129214260|NCT03995368|465087236|FG002|Overall Study|Withdrawal by Subject|1|||
129214261|NCT03755934|465087237|FG000|Overall Study|Adverse Event|4|||
129214262|NCT03755934|465087238|FG001|Overall Study|Adverse Event|1|||
129214263|NCT03755934|465087239|FG002|Overall Study|Adverse Event|1|||
129214264|NCT03755934|465087240|FG003|Overall Study|Adverse Event|3|||
129214265|NCT03755934|465087237|FG000|Overall Study|Physician Decision|2|||
129214266|NCT03755934|465087238|FG001|Overall Study|Physician Decision|0|||
129214267|NCT03755934|465087239|FG002|Overall Study|Physician Decision|0|||
129214268|NCT03755934|465087240|FG003|Overall Study|Physician Decision|1|||
129214269|NCT03755934|465087237|FG000|Overall Study|Withdrawal by Subject|5|||
129214270|NCT03755934|465087238|FG001|Overall Study|Withdrawal by Subject|0|||
129214271|NCT03755934|465087239|FG002|Overall Study|Withdrawal by Subject|0|||
129214272|NCT03755934|465087240|FG003|Overall Study|Withdrawal by Subject|1|||
129214273|NCT03755934|465087237|FG000|Overall Study|Other|3|||
129214274|NCT03755934|465087238|FG001|Overall Study|Other|1|||
129214275|NCT03755934|465087239|FG002|Overall Study|Other|3|||
129214276|NCT03755934|465087240|FG003|Overall Study|Other|1|||
129214277|NCT00361296|465087241|FG000|Overall Study|Physician Decision|1|||
129214278|NCT00361296|465087241|FG000|Overall Study|Lack of Efficacy|2|||
129214279|NCT01281124|465089297|FG000|Overall Study|Death|1|||
129214280|NCT03038100|465089298|FG000|Overall Study|Death|289|||
129214281|NCT03038100|465089299|FG001|Overall Study|Death|272|||
129214282|NCT03038100|465089298|FG000|Overall Study|Lost to Follow-up|9|||
129214283|NCT03038100|465089299|FG001|Overall Study|Lost to Follow-up|10|||
129214284|NCT03038100|465089298|FG000|Overall Study|Protocol Deviation|1|||
129214285|NCT03038100|465089299|FG001|Overall Study|Protocol Deviation|4|||
129214286|NCT03038100|465089298|FG000|Overall Study|Withdrawal by Subject|45|||
129214287|NCT03038100|465089299|FG001|Overall Study|Withdrawal by Subject|51|||
128876730|NCT00116753|463842398|FG001|Overall Study|Progressive Parkinson's Disease|0|||
128876731|NCT00116753|463842399|FG002|Overall Study|Progressive Parkinson's Disease|0|||
128876732|NCT00116753|463842397|FG000|Overall Study|Dosing Error|0|||
128876733|NCT00116753|463842398|FG001|Overall Study|Dosing Error|1|||
128876734|NCT00116753|463842399|FG002|Overall Study|Dosing Error|0|||
128876735|NCT01642251|463842400|FG000|Overall Study|Progressive disease|0|||
128876736|NCT01642251|463842401|FG001|Overall Study|Progressive disease|0|||
128876737|NCT01642251|463842402|FG002|Overall Study|Progressive disease|3|||
128876738|NCT01642251|463842403|FG003|Overall Study|Progressive disease|3|||
128876739|NCT01642251|463842400|FG000|Overall Study|Adverse Event|0|||
128876740|NCT01642251|463842401|FG001|Overall Study|Adverse Event|0|||
128876741|NCT01642251|463842402|FG002|Overall Study|Adverse Event|5|||
128876742|NCT01642251|463842403|FG003|Overall Study|Adverse Event|4|||
128876743|NCT01642251|463842400|FG000|Overall Study|Death|0|||
128876744|NCT01642251|463842401|FG001|Overall Study|Death|0|||
128876745|NCT01642251|463842402|FG002|Overall Study|Death|1|||
128876746|NCT01642251|463842403|FG003|Overall Study|Death|3|||
128876747|NCT01642251|463842400|FG000|Overall Study|Withdrawal by Subject|0|||
128876748|NCT01642251|463842401|FG001|Overall Study|Withdrawal by Subject|0|||
128876749|NCT01642251|463842402|FG002|Overall Study|Withdrawal by Subject|1|||
128876750|NCT01642251|463842403|FG003|Overall Study|Withdrawal by Subject|3|||
128876751|NCT01642251|463842400|FG000|Overall Study|Alternative therapy|0|||
128876752|NCT01642251|463842401|FG001|Overall Study|Alternative therapy|0|||
128876753|NCT01642251|463842402|FG002|Overall Study|Alternative therapy|0|||
128876754|NCT01642251|463842403|FG003|Overall Study|Alternative therapy|2|||
128876755|NCT01642251|463842400|FG000|Overall Study|Other complicating disease|0|||
128876756|NCT01642251|463842401|FG001|Overall Study|Other complicating disease|0|||
128876757|NCT01642251|463842402|FG002|Overall Study|Other complicating disease|1|||
128876758|NCT01642251|463842403|FG003|Overall Study|Other complicating disease|0|||
128876759|NCT01642251|463842400|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
128876760|NCT01642251|463842401|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
128876761|NCT01642251|463842402|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
128876762|NCT01642251|463842403|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
129214288|NCT03038100|465089298|FG000|Overall Study|Study Terminated By Sponsor|305|||
129214289|NCT03038100|465089299|FG001|Overall Study|Study Terminated By Sponsor|311|||
129214290|NCT03038100|465089298|FG000|Overall Study|Physician Decision|1|||
129214291|NCT03038100|465089299|FG001|Overall Study|Physician Decision|3|||
129214292|NCT02392624|465089300|FG000|Overall Study|Withdrawal by Subject|15|||
129214293|NCT02392624|465089301|FG001|Overall Study|Withdrawal by Subject|12|||
129214294|NCT02392624|465089302|FG002|Overall Study|Withdrawal by Subject|9|||
129214295|NCT02392624|465089300|FG000|Overall Study|Adverse Event|4|||
129214296|NCT02392624|465089301|FG001|Overall Study|Adverse Event|1|||
129214297|NCT02392624|465089302|FG002|Overall Study|Adverse Event|2|||
128876763|NCT01445301|463842404|FG000|Overall Study|Adverse Event|15|||
128876764|NCT01445301|463842405|FG001|Overall Study|Adverse Event|25|||
128876765|NCT01445301|463842406|FG002|Overall Study|Adverse Event|4|||
129214298|NCT02392624|465089300|FG000|Overall Study|Pregnancy|1|||
129214299|NCT02392624|465089301|FG001|Overall Study|Pregnancy|0|||
129214300|NCT02392624|465089302|FG002|Overall Study|Pregnancy|0|||
129214301|NCT02392624|465089300|FG000|Overall Study|Protocol Violation|0|||
129214302|NCT02392624|465089301|FG001|Overall Study|Protocol Violation|0|||
129214303|NCT02392624|465089302|FG002|Overall Study|Protocol Violation|1|||
129214304|NCT02392624|465089300|FG000|Overall Study|Sponsor/Investigator Decision|2|||
129214305|NCT02392624|465089301|FG001|Overall Study|Sponsor/Investigator Decision|1|||
129214306|NCT02392624|465089302|FG002|Overall Study|Sponsor/Investigator Decision|0|||
129214307|NCT02392624|465089300|FG000|Overall Study|Other|49|||
129214308|NCT02392624|465089301|FG001|Overall Study|Other|1|||
129214309|NCT02392624|465089302|FG002|Overall Study|Other|1|||
129214310|NCT00706238|465089303|FG000|Overall Study|Disease progression|4|||
129214311|NCT00706238|465089303|FG000|Overall Study|Other|1|||
129214312|NCT03841604|465089308|FG000|Overall Study|Withdrawal by Subject|3|||
129214313|NCT03841604|465089309|FG001|Overall Study|Withdrawal by Subject|1|||
129214314|NCT03841604|465089308|FG000|Overall Study|Adverse Event|4|||
129214315|NCT03841604|465089309|FG001|Overall Study|Adverse Event|2|||
129214316|NCT03841604|465089308|FG000|Overall Study|Physician Decision|1|||
129214317|NCT03841604|465089309|FG001|Overall Study|Physician Decision|0|||
129214318|NCT03877510|465089312|FG000|Overall Study|Death|6|||
129214319|NCT03877510|465089312|FG000|Overall Study|Lost to Follow-up|2|||
129214320|NCT03877510|465089312|FG000|Overall Study|Non-compliance with study drug|2|||
129214321|NCT03877510|465089312|FG000|Overall Study|Lack of Efficacy|14|||
129214322|NCT03877510|465089312|FG000|Overall Study|Adverse Event|20|||
129214323|NCT03877510|465089312|FG000|Overall Study|Withdrawal by Subject|22|||
129214324|NCT03877510|465089312|FG000|Overall Study|Miscellaneous|1|||
129214325|NCT01417377|465089313|FG000|Overall Study|Lost to Follow-up|12|||
129214326|NCT01417377|465089313|FG000|Overall Study|Enrolled, but not treated|1|||
129214327|NCT02113982|465089314|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
129214328|NCT02113982|465089315|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
129214329|NCT02113982|465089316|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
129214330|NCT02113982|465089317|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
129214331|NCT02113982|465089318|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
129214332|NCT02113982|465089319|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
129214333|NCT02113982|465089320|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
129214334|NCT02113982|465089321|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
129214335|NCT02113982|465089322|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
129214336|NCT02113982|465089323|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
129214337|NCT02113982|465089324|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
129214338|NCT02113982|465089325|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
129214339|NCT02113982|465089326|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
129214340|NCT02113982|465089327|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
129214341|NCT02113982|465089314|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
129214342|NCT02113982|465089315|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
129214343|NCT02113982|465089316|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
129214344|NCT02113982|465089317|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
129214345|NCT02113982|465089318|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
129214346|NCT02113982|465089319|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
129214347|NCT02113982|465089320|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
129214348|NCT02113982|465089321|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
129214349|NCT02113982|465089322|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
129214350|NCT02113982|465089323|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
129214351|NCT02113982|465089324|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
129214352|NCT02113982|465089325|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
129214353|NCT02113982|465089326|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
129214354|NCT02113982|465089327|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
129214355|NCT02113982|465089314|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214356|NCT02113982|465089315|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214357|NCT02113982|465089316|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214358|NCT02113982|465089317|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214359|NCT02113982|465089318|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214360|NCT02113982|465089319|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214361|NCT02113982|465089320|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
129214362|NCT02113982|465089321|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214363|NCT02113982|465089322|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214364|NCT02113982|465089323|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
128876766|NCT01445301|463842404|FG000|Overall Study|Lack of Efficacy|0|||
128876767|NCT01445301|463842405|FG001|Overall Study|Lack of Efficacy|1|||
128876768|NCT01445301|463842406|FG002|Overall Study|Lack of Efficacy|0|||
128876769|NCT01445301|463842404|FG000|Overall Study|Protocol Violation|1|||
128876770|NCT01445301|463842405|FG001|Overall Study|Protocol Violation|0|||
128876771|NCT01445301|463842406|FG002|Overall Study|Protocol Violation|0|||
128876772|NCT01445301|463842404|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
128876773|NCT01445301|463842405|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
128876774|NCT01445301|463842406|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
128876775|NCT01445301|463842404|FG000|Overall Study|Physician Decision|0|||
128876776|NCT01445301|463842405|FG001|Overall Study|Physician Decision|2|||
128876777|NCT01445301|463842406|FG002|Overall Study|Physician Decision|0|||
128876778|NCT01445301|463842404|FG000|Overall Study|Withdrawal by Subject|5|||
128876779|NCT01445301|463842405|FG001|Overall Study|Withdrawal by Subject|6|||
128876780|NCT01445301|463842406|FG002|Overall Study|Withdrawal by Subject|4|||
128876781|NCT00752557|463842407|FG000|Overall Study|Withdrawal by Subject|4|||
128876782|NCT00752557|463842408|FG001|Overall Study|Withdrawal by Subject|3|||
128876783|NCT00752557|463842409|FG002|Overall Study|Withdrawal by Subject|3|||
128876784|NCT00752557|463842407|FG000|Overall Study|Unspecified resaons|0|||
128876785|NCT00752557|463842408|FG001|Overall Study|Unspecified resaons|2|||
128876786|NCT00752557|463842409|FG002|Overall Study|Unspecified resaons|2|||
128876787|NCT00752557|463842407|FG000|Overall Study|Lost to Follow-up|1|||
128876788|NCT00752557|463842408|FG001|Overall Study|Lost to Follow-up|0|||
128876789|NCT00752557|463842409|FG002|Overall Study|Lost to Follow-up|1|||
128876790|NCT01605916|463842414|FG000|Overall Study|Adverse Event|1|||
128876791|NCT01605916|463842415|FG001|Overall Study|Adverse Event|0|||
128876792|NCT01605916|463842416|FG002|Overall Study|Adverse Event|0|||
128876793|NCT01605916|463842417|FG003|Overall Study|Adverse Event|1|||
128876794|NCT01605916|463842418|FG004|Overall Study|Adverse Event|0|||
128876795|NCT01605916|463842414|FG000|Overall Study|Lack of Efficacy|2|||
128876796|NCT01605916|463842415|FG001|Overall Study|Lack of Efficacy|3|||
128876797|NCT01605916|463842416|FG002|Overall Study|Lack of Efficacy|3|||
128876798|NCT01605916|463842417|FG003|Overall Study|Lack of Efficacy|5|||
128876799|NCT01605916|463842418|FG004|Overall Study|Lack of Efficacy|4|||
128876800|NCT01605916|463842414|FG000|Overall Study|Withdrawal by Subject|1|||
128876801|NCT01605916|463842415|FG001|Overall Study|Withdrawal by Subject|1|||
128876802|NCT01605916|463842416|FG002|Overall Study|Withdrawal by Subject|0|||
128876803|NCT01605916|463842417|FG003|Overall Study|Withdrawal by Subject|0|||
128876804|NCT01605916|463842418|FG004|Overall Study|Withdrawal by Subject|2|||
128876805|NCT00296400|463842424|FG000|Overall Study|Adverse Event|7|||
128876806|NCT00296400|463842425|FG001|Overall Study|Adverse Event|7|||
128876807|NCT00296400|463842426|FG002|Overall Study|Adverse Event|7|||
128876808|NCT00296400|463842424|FG000|Overall Study|Withdrawal by Subject|5|||
128876809|NCT00296400|463842425|FG001|Overall Study|Withdrawal by Subject|6|||
128876810|NCT00296400|463842426|FG002|Overall Study|Withdrawal by Subject|2|||
128876811|NCT00296400|463842424|FG000|Overall Study|Incorrect enrollment|2|||
128876812|NCT00296400|463842425|FG001|Overall Study|Incorrect enrollment|0|||
128876813|NCT00296400|463842426|FG002|Overall Study|Incorrect enrollment|0|||
128876814|NCT00296400|463842424|FG000|Overall Study|Protocol Violation|1|||
128876815|NCT00296400|463842425|FG001|Overall Study|Protocol Violation|1|||
128876816|NCT00296400|463842426|FG002|Overall Study|Protocol Violation|1|||
128876817|NCT00296400|463842424|FG000|Overall Study|Lost to Follow-up|1|||
128876818|NCT00296400|463842425|FG001|Overall Study|Lost to Follow-up|1|||
128876819|NCT00296400|463842426|FG002|Overall Study|Lost to Follow-up|2|||
128876820|NCT00296400|463842424|FG000|Overall Study|Study specific discontinuation criteria|0|||
128876821|NCT00296400|463842425|FG001|Overall Study|Study specific discontinuation criteria|0|||
128876822|NCT00296400|463842426|FG002|Overall Study|Study specific discontinuation criteria|1|||
128876823|NCT00296400|463842424|FG000|Overall Study|Visit 10 was performed earlier|0|||
128876824|NCT00296400|463842425|FG001|Overall Study|Visit 10 was performed earlier|1|||
128876825|NCT00296400|463842426|FG002|Overall Study|Visit 10 was performed earlier|0|||
128876826|NCT00296400|463842424|FG000|Overall Study|Pregnancy|1|||
128876827|NCT00296400|463842425|FG001|Overall Study|Pregnancy|2|||
128876828|NCT00296400|463842426|FG002|Overall Study|Pregnancy|0|||
128876829|NCT01014533|463842427|FG000|Overall Study|Protocol Violation|3|||
128876830|NCT01014533|463842428|FG001|Overall Study|Protocol Violation|2|||
128876831|NCT01014533|463842427|FG000|Overall Study|Withdrawal by Subject|2|||
128876832|NCT01014533|463842428|FG001|Overall Study|Withdrawal by Subject|0|||
128876833|NCT01014533|463842427|FG000|Overall Study|unable to come to appointment|0|||
128876834|NCT01014533|463842428|FG001|Overall Study|unable to come to appointment|3|||
128876835|NCT00412061|463842429|FG000|Double Blind Phase|Disease Progression|101|||
128876836|NCT00412061|463842430|FG001|Double Blind Phase|Disease Progression|154|||
128876837|NCT00412061|463842429|FG000|Double Blind Phase|Adverse Event|61|||
128876838|NCT00412061|463842430|FG001|Double Blind Phase|Adverse Event|16|||
128876839|NCT00412061|463842429|FG000|Double Blind Phase|Final Primary Analysis|26|||
128876840|NCT00412061|463842430|FG001|Double Blind Phase|Final Primary Analysis|14|||
128876841|NCT00412061|463842429|FG000|Double Blind Phase|Withdrawal by Subject|18|||
128876842|NCT00412061|463842430|FG001|Double Blind Phase|Withdrawal by Subject|20|||
128876843|NCT00412061|463842429|FG000|Double Blind Phase|Death|6|||
128876844|NCT00412061|463842430|FG001|Double Blind Phase|Death|3|||
128876845|NCT00412061|463842429|FG000|Double Blind Phase|Protocol Violation|3|||
128876846|NCT00412061|463842430|FG001|Double Blind Phase|Protocol Violation|4|||
128876847|NCT00412061|463842429|FG000|Double Blind Phase|New Cander Therapy|1|||
128876848|NCT00412061|463842430|FG001|Double Blind Phase|New Cander Therapy|1|||
128876849|NCT00412061|463842429|FG000|Double Blind Phase|Lost to Follow-up|0|||
128876850|NCT00412061|463842430|FG001|Double Blind Phase|Lost to Follow-up|1|||
128876851|NCT00412061|463842429|FG000|Open Label Phase|Disease Progression|0|||
128876852|NCT00412061|463842430|FG001|Open Label Phase|Disease Progression|86|||
128876853|NCT00412061|463842429|FG000|Open Label Phase|Adverse Event|0|||
128876854|NCT00412061|463842430|FG001|Open Label Phase|Adverse Event|46|||
128876855|NCT00412061|463842429|FG000|Open Label Phase|Withdrawal by Subject|0|||
128876856|NCT00412061|463842430|FG001|Open Label Phase|Withdrawal by Subject|15|||
128876857|NCT00412061|463842429|FG000|Open Label Phase|Administrative Problems|0|||
128876858|NCT00412061|463842430|FG001|Open Label Phase|Administrative Problems|13|||
128876859|NCT00412061|463842429|FG000|Open Label Phase|Death|0|||
128876860|NCT00412061|463842430|FG001|Open Label Phase|Death|7|||
128876861|NCT00412061|463842429|FG000|Open Label Phase|Lost to Follow-up|0|||
128876862|NCT00412061|463842430|FG001|Open Label Phase|Lost to Follow-up|2|||
128876863|NCT00412061|463842429|FG000|Open Label Phase|New Cancer Therapy|0|||
128876864|NCT00412061|463842430|FG001|Open Label Phase|New Cancer Therapy|1|||
128876865|NCT01942590|463842432|FG000|Overall Study|Withdrawal by Subject|0|||
128876866|NCT01942590|463842433|FG001|Overall Study|Withdrawal by Subject|1|||
128876867|NCT01942590|463842432|FG000|Overall Study|Adverse Event|1|||
128876868|NCT01942590|463842433|FG001|Overall Study|Adverse Event|0|||
128876869|NCT02433340|463842435|FG000|Overall Study|Adverse Event|0|||
128876870|NCT02433340|463842436|FG001|Overall Study|Adverse Event|0|||
128876871|NCT02433340|463842437|FG002|Overall Study|Adverse Event|1|||
128876872|NCT02433340|463842438|FG003|Overall Study|Adverse Event|0|||
128876873|NCT02433340|463842435|FG000|Overall Study|Withdrawal by Subject|1|||
128876874|NCT02433340|463842436|FG001|Overall Study|Withdrawal by Subject|0|||
128876875|NCT02433340|463842437|FG002|Overall Study|Withdrawal by Subject|1|||
128876876|NCT02433340|463842438|FG003|Overall Study|Withdrawal by Subject|2|||
128876877|NCT02433340|463842435|FG000|Overall Study|Lost to Follow-up|0|||
128876878|NCT02433340|463842436|FG001|Overall Study|Lost to Follow-up|1|||
128876879|NCT02433340|463842437|FG002|Overall Study|Lost to Follow-up|0|||
128876880|NCT02433340|463842438|FG003|Overall Study|Lost to Follow-up|0|||
128876881|NCT02433340|463842435|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
128876882|NCT02433340|463842436|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
128876883|NCT02433340|463842437|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
128876884|NCT02433340|463842438|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
128876885|NCT02433340|463842435|FG000|Overall Study|Other|0|||
128876886|NCT02433340|463842436|FG001|Overall Study|Other|1|||
128876887|NCT02433340|463842437|FG002|Overall Study|Other|0|||
128987801|NCT00594568|464244973|FG000|Delayed Start|Adverse Event|12|||
128987802|NCT00594568|464244974|FG001|Delayed Start|Adverse Event|2|||
128987803|NCT00594568|464244975|FG002|Delayed Start|Adverse Event|2|||
128987804|NCT00594568|464244973|FG000|Delayed Start|Withdrawal by Subject|4|||
128987805|NCT00594568|464244974|FG001|Delayed Start|Withdrawal by Subject|3|||
128987806|NCT00594568|464244975|FG002|Delayed Start|Withdrawal by Subject|0|||
128987807|NCT00594568|464244973|FG000|Delayed Start|Physician Decision|0|||
128987808|NCT00594568|464244974|FG001|Delayed Start|Physician Decision|0|||
128987809|NCT00594568|464244975|FG002|Delayed Start|Physician Decision|1|||
128987810|NCT00594568|464244973|FG000|Delayed Start|Lost to Follow-up|0|||
128987811|NCT00594568|464244974|FG001|Delayed Start|Lost to Follow-up|0|||
128987812|NCT00594568|464244975|FG002|Delayed Start|Lost to Follow-up|1|||
128987813|NCT00594568|464244973|FG000|Delayed Start|Caregiver Decision|5|||
128987814|NCT00594568|464244974|FG001|Delayed Start|Caregiver Decision|6|||
128987815|NCT00594568|464244975|FG002|Delayed Start|Caregiver Decision|2|||
128987816|NCT00594568|464244973|FG000|Delayed Start|Sponsor Decision|77|||
128987817|NCT00594568|464244974|FG001|Delayed Start|Sponsor Decision|66|||
128987818|NCT00594568|464244975|FG002|Delayed Start|Sponsor Decision|59|||
128987819|NCT00594568|464244973|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
128987820|NCT00594568|464244974|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
128987821|NCT00594568|464244975|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
128987822|NCT00594568|464244973|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
128987823|NCT00594568|464244974|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
128987824|NCT00594568|464244975|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
128987825|NCT00594568|464244973|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
128987826|NCT00594568|464244974|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
128987827|NCT00594568|464244975|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
128987828|NCT00594568|464244973|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
128987829|NCT00594568|464244974|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
128987830|NCT00594568|464244975|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
128987831|NCT00594568|464244973|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
128987832|NCT00594568|464244974|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
128987833|NCT00594568|464244975|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
128876888|NCT02433340|463842438|FG003|Overall Study|Other|0|||
128876889|NCT01178385|463842439|FG000|Overall Study|Withdrawal by Subject|2|||
128876890|NCT01178385|463842440|FG001|Overall Study|Withdrawal by Subject|0|||
128876891|NCT01226095|463842441|FG000|Overall Study|Poor compliance|1|||
128876892|NCT01688830|463842444|FG000|Overall Study|Lost to Follow-up|0|||
128876893|NCT01688830|463842445|FG001|Overall Study|Lost to Follow-up|0|||
128876894|NCT01688830|463842446|FG002|Overall Study|Lost to Follow-up|0|||
128876895|NCT01688830|463842447|FG003|Overall Study|Lost to Follow-up|0|||
128876896|NCT01688830|463842448|FG004|Overall Study|Lost to Follow-up|0|||
128876897|NCT01688830|463842449|FG005|Overall Study|Lost to Follow-up|0|||
128876898|NCT01688830|463842450|FG006|Overall Study|Lost to Follow-up|0|||
128876899|NCT01688830|463842451|FG007|Overall Study|Lost to Follow-up|0|||
128876900|NCT01688830|463842452|FG008|Overall Study|Lost to Follow-up|0|||
128876901|NCT01688830|463842453|FG009|Overall Study|Lost to Follow-up|0|||
128876902|NCT01688830|463842454|FG010|Overall Study|Lost to Follow-up|1|||
128876903|NCT01688830|463842455|FG011|Overall Study|Lost to Follow-up|0|||
128876904|NCT01688830|463842456|FG012|Overall Study|Lost to Follow-up|0|||
128987834|NCT00594568|464244973|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
128987835|NCT00594568|464244974|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
128987836|NCT00594568|464244975|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
128987837|NCT04311411|464244976|FG000|Overall Study|Adverse Event|2|||
128987838|NCT04311411|464244977|FG001|Overall Study|Adverse Event|3|||
128987839|NCT04311411|464244978|FG002|Overall Study|Adverse Event|2|||
128987840|NCT04311411|464244976|FG000|Overall Study|Withdrawal by Subject|3|||
128987841|NCT04311411|464244977|FG001|Overall Study|Withdrawal by Subject|3|||
128987842|NCT04311411|464244978|FG002|Overall Study|Withdrawal by Subject|0|||
128987843|NCT03722849|464244982|FG000|Overall Study|Withdrawal by Subject|1|||
128987844|NCT03722849|464244983|FG001|Overall Study|Withdrawal by Subject|1|||
128987845|NCT05644756|464244984|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
128987846|NCT05644756|464244984|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
128987847|NCT03985982|464244985|FG000|Double-Blind Phase|Lost to Follow-up|4|||
128987848|NCT03985982|464244986|FG001|Double-Blind Phase|Lost to Follow-up|3|||
128987849|NCT03985982|464244987|FG002|Double-Blind Phase|Lost to Follow-up|0|||
128987850|NCT03985982|464244985|FG000|Double-Blind Phase|Physician Decision|1|||
128987851|NCT03985982|464244986|FG001|Double-Blind Phase|Physician Decision|0|||
128987852|NCT03985982|464244987|FG002|Double-Blind Phase|Physician Decision|0|||
128987853|NCT03985982|464244985|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
128987854|NCT03985982|464244986|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
128987855|NCT03985982|464244987|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
128987856|NCT03985982|464244985|FG000|Double-Blind Phase|COVID-19|1|||
128987857|NCT03985982|464244986|FG001|Double-Blind Phase|COVID-19|0|||
128987858|NCT03985982|464244987|FG002|Double-Blind Phase|COVID-19|0|||
128987859|NCT03985982|464244985|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
128987860|NCT03985982|464244986|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
128987861|NCT03985982|464244987|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
128987862|NCT03985982|464244985|FG000|Open-Label Phase|Lost to Follow-up|0|||
128987863|NCT03985982|464244986|FG001|Open-Label Phase|Lost to Follow-up|0|||
128987864|NCT03985982|464244987|FG002|Open-Label Phase|Lost to Follow-up|13|||
128987865|NCT03985982|464244985|FG000|Open-Label Phase|Physician Decision|0|||
128987866|NCT03985982|464244986|FG001|Open-Label Phase|Physician Decision|0|||
128987867|NCT03985982|464244987|FG002|Open-Label Phase|Physician Decision|2|||
128987868|NCT03985982|464244985|FG000|Open-Label Phase|Withdrawal by Subject|0|||
128987869|NCT03985982|464244986|FG001|Open-Label Phase|Withdrawal by Subject|0|||
128987870|NCT03985982|464244987|FG002|Open-Label Phase|Withdrawal by Subject|11|||
128987871|NCT00348348|464244992|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
128987872|NCT00348348|464244993|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
128987873|NCT00348348|464244992|FG000|Overall Study|Lack of Efficacy|1|||
128987874|NCT00348348|464244993|FG001|Overall Study|Lack of Efficacy|1|||
128987875|NCT00348348|464244992|FG000|Overall Study|Lost to Follow-up|8|||
128987876|NCT00348348|464244993|FG001|Overall Study|Lost to Follow-up|10|||
128987877|NCT00348348|464244992|FG000|Overall Study|Withdrawal by Subject|4|||
128987878|NCT00348348|464244993|FG001|Overall Study|Withdrawal by Subject|1|||
128987879|NCT00348348|464244992|FG000|Overall Study|Other|7|||
128987880|NCT00348348|464244993|FG001|Overall Study|Other|4|||
128987881|NCT00348348|464244992|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
128987882|NCT00348348|464244993|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
128987883|NCT00348348|464244992|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
128987884|NCT00348348|464244993|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
128987885|NCT00348348|464244992|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
128987886|NCT00348348|464244993|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
128987887|NCT00348348|464244992|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
128987888|NCT00348348|464244993|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
128987889|NCT00348348|464244992|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
128987890|NCT00348348|464244993|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
128987891|NCT00348348|464244992|FG000|Overall Study|Adverse event probably related to study|1|||
128987892|NCT00348348|464244993|FG001|Overall Study|Adverse event probably related to study|0|||
128876905|NCT01688830|463842457|FG013|Overall Study|Lost to Follow-up|0|||
128876906|NCT01688830|463842458|FG014|Overall Study|Lost to Follow-up|0|||
128876907|NCT01688830|463842459|FG015|Overall Study|Lost to Follow-up|0|||
128876908|NCT01688830|463842460|FG016|Overall Study|Lost to Follow-up|0|||
128876909|NCT01688830|463842461|FG017|Overall Study|Lost to Follow-up|0|||
128876910|NCT01688830|463842462|FG018|Overall Study|Lost to Follow-up|0|||
128876911|NCT01688830|463842463|FG019|Overall Study|Lost to Follow-up|0|||
128876912|NCT01688830|463842464|FG020|Overall Study|Lost to Follow-up|0|||
128876913|NCT01285609|463842465|FG000|Randomized|Progressive Disease|41|||
128876914|NCT01285609|463842466|FG001|Randomized|Progressive Disease|61|||
128876915|NCT01285609|463842465|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
128876916|NCT01285609|463842466|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
128876917|NCT01285609|463842465|FG000|Randomized|Study Drug Toxicity|13|||
128876918|NCT01285609|463842466|FG001|Randomized|Study Drug Toxicity|14|||
128876919|NCT01285609|463842465|FG000|Randomized|Death|5|||
128876920|NCT01285609|463842466|FG001|Randomized|Death|7|||
128876921|NCT01285609|463842465|FG000|Randomized|Withdrawal by Subject|8|||
128876922|NCT01285609|463842466|FG001|Randomized|Withdrawal by Subject|11|||
128876923|NCT01285609|463842465|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
128876924|NCT01285609|463842466|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
128876925|NCT01285609|463842465|FG000|Randomized|Undisclosed Reasons|1|||
128876926|NCT01285609|463842466|FG001|Randomized|Undisclosed Reasons|0|||
128876927|NCT01285609|463842465|FG000|Randomized|Randomized but not Treated|4|||
128876928|NCT01285609|463842466|FG001|Randomized|Randomized but not Treated|4|||
128876929|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
128876930|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
128876931|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
128876932|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
128876933|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
128876934|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
128876935|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
128876936|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
128876937|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Death|11|||
128876938|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Death|3|||
128876939|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
128876940|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
128876941|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Not Reported|0|||
128876942|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Not Reported|2|||
128876943|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
128876944|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
128876945|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
128876946|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
128876947|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
128876948|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
128876949|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
128876950|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
128876951|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
128876952|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
128876953|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
128876954|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
128876955|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
128876956|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
128876957|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
128763059|NCT00991341|463422701|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
128987893|NCT01068418|464245002|FG000|Overall Study|Physician Decision|12|||
128987894|NCT03155269|464245003|FG000|Overall Study|Withdrawal by Subject|4|||
128987895|NCT03155269|464245004|FG001|Overall Study|Withdrawal by Subject|5|||
128987896|NCT03155269|464245003|FG000|Overall Study|Lost to Follow-up|1|||
128987897|NCT03155269|464245004|FG001|Overall Study|Lost to Follow-up|2|||
128987898|NCT00943826|464245005|FG000|Concurrent Phase|Adverse Event|50|||
128987899|NCT00943826|464245006|FG001|Concurrent Phase|Adverse Event|27|||
128987900|NCT00943826|464245005|FG000|Concurrent Phase|Withdrew consent|3|||
128987901|NCT00943826|464245006|FG001|Concurrent Phase|Withdrew consent|7|||
128987902|NCT00943826|464245005|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
128987903|NCT00943826|464245006|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
128987904|NCT00943826|464245005|FG000|Concurrent Phase|Administrative reasons|2|||
128987905|NCT00943826|464245006|FG001|Concurrent Phase|Administrative reasons|1|||
128987906|NCT00943826|464245005|FG000|Concurrent Phase|Protocol Violation|1|||
128987907|NCT00943826|464245006|FG001|Concurrent Phase|Protocol Violation|0|||
128987908|NCT00943826|464245005|FG000|Maintenance Phase|Adverse Event|31|||
128987909|NCT00943826|464245006|FG001|Maintenance Phase|Adverse Event|30|||
128987910|NCT00943826|464245005|FG000|Maintenance Phase|Withdrew consent|2|||
128987911|NCT00943826|464245006|FG001|Maintenance Phase|Withdrew consent|4|||
128987912|NCT00943826|464245005|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
128987913|NCT00943826|464245006|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
128987914|NCT00943826|464245005|FG000|Maintenance Phase|Administrative reasons|4|||
128987915|NCT00943826|464245006|FG001|Maintenance Phase|Administrative reasons|1|||
128987916|NCT00943826|464245005|FG000|Maintenance Phase|Failure to return|0|||
128987917|NCT00943826|464245006|FG001|Maintenance Phase|Failure to return|1|||
128987918|NCT00943826|464245005|FG000|Monotherapy Phase|Adverse Event|42|||
128987919|NCT00943826|464245006|FG001|Monotherapy Phase|Adverse Event|5|||
128987920|NCT00943826|464245005|FG000|Monotherapy Phase|Administrative reasons|11|||
128987921|NCT00943826|464245006|FG001|Monotherapy Phase|Administrative reasons|5|||
128987922|NCT00943826|464245005|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
128987923|NCT00943826|464245006|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
128987924|NCT00943826|464245005|FG000|Monotherapy Phase|Withdrew Consent|2|||
128987925|NCT00943826|464245006|FG001|Monotherapy Phase|Withdrew Consent|3|||
128987926|NCT00943826|464245005|FG000|Monotherapy Phase|Failure to return|2|||
128987927|NCT00943826|464245006|FG001|Monotherapy Phase|Failure to return|1|||
128876958|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
128876959|NCT01285609|463842465|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
128876960|NCT01285609|463842466|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
128876961|NCT01285609|463842465|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
128876962|NCT01285609|463842466|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
128876963|NCT04822597|463842467|FG000|Overall Study|Withdrawal by Subject|0|||
128876964|NCT04822597|463842468|FG001|Overall Study|Withdrawal by Subject|1|||
128876965|NCT04822597|463842469|FG002|Overall Study|Withdrawal by Subject|1|||
128876966|NCT04822597|463842470|FG003|Overall Study|Withdrawal by Subject|0|||
128876967|NCT04822597|463842467|FG000|Overall Study|Physician Decision|0|||
128876968|NCT04822597|463842468|FG001|Overall Study|Physician Decision|0|||
128876969|NCT04822597|463842469|FG002|Overall Study|Physician Decision|1|||
128876970|NCT04822597|463842470|FG003|Overall Study|Physician Decision|1|||
128876971|NCT04822597|463842467|FG000|Overall Study|Subject withdrawn after enrollment|0|||
128876972|NCT04822597|463842468|FG001|Overall Study|Subject withdrawn after enrollment|1|||
128876973|NCT04822597|463842469|FG002|Overall Study|Subject withdrawn after enrollment|0|||
128876974|NCT04822597|463842470|FG003|Overall Study|Subject withdrawn after enrollment|1|||
128876975|NCT04822597|463842467|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
128876976|NCT04822597|463842468|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
128876977|NCT04822597|463842469|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
128876978|NCT04822597|463842470|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
128876979|NCT03265938|463842480|FG000|Overall Study|Withdrawal by Subject|1|||
128876980|NCT03265938|463842480|FG000|Overall Study|Physician Decision|1|||
128876981|NCT03265938|463842480|FG000|Overall Study|friable mass|6|||
128876982|NCT02679508|463842481|FG000|Healing Phase|Protocol Violation|1|||
128876983|NCT02679508|463842482|FG001|Healing Phase|Protocol Violation|1|||
128876984|NCT02679508|463842481|FG000|Healing Phase|Lost to Follow-up|1|||
128876985|NCT02679508|463842482|FG001|Healing Phase|Lost to Follow-up|0|||
128876986|NCT02679508|463842481|FG000|Maintenance Phase|Adverse Event|12|||
128876987|NCT02679508|463842482|FG001|Maintenance Phase|Adverse Event|2|||
128876988|NCT02679508|463842481|FG000|Maintenance Phase|Lost to Follow-up|0|||
128876989|NCT02679508|463842482|FG001|Maintenance Phase|Lost to Follow-up|1|||
128876990|NCT02679508|463842481|FG000|Maintenance Phase|Withdrawal by Subject|15|||
128876991|NCT02679508|463842482|FG001|Maintenance Phase|Withdrawal by Subject|8|||
128876992|NCT02679508|463842481|FG000|Maintenance Phase|Other|5|||
128876993|NCT02679508|463842482|FG001|Maintenance Phase|Other|4|||
128876994|NCT03143166|463842483|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
128876995|NCT03616977|463842484|FG000|Period 1|Physician Decision|0|||
128876996|NCT03616977|463842485|FG001|Period 1|Physician Decision|1|||
128876997|NCT03616977|463842484|FG000|Period 3|Adverse Event|1|||
128876998|NCT03616977|463842485|FG001|Period 3|Adverse Event|1|||
128876999|NCT03683823|463842486|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
128877000|NCT03683823|463842487|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
128877001|NCT03683823|463842486|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
128877002|NCT03683823|463842487|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
128877003|NCT03683823|463842486|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
128877004|NCT03683823|463842487|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
128877005|NCT01323972|463842489|FG000|Overall Study|Withdrawal by Subject|1|||
128877006|NCT01323972|463842490|FG001|Overall Study|Withdrawal by Subject|0|||
128877007|NCT01323972|463842491|FG002|Overall Study|Withdrawal by Subject|1|||
128877008|NCT01323972|463842492|FG003|Overall Study|Withdrawal by Subject|0|||
128877009|NCT01323972|463842489|FG000|Overall Study|Migrated/moved from study area|1|||
128877010|NCT01323972|463842490|FG001|Overall Study|Migrated/moved from study area|2|||
128877011|NCT01323972|463842491|FG002|Overall Study|Migrated/moved from study area|0|||
128877012|NCT01323972|463842492|FG003|Overall Study|Migrated/moved from study area|0|||
128877013|NCT01323972|463842489|FG000|Overall Study|Lost to Follow-up|0|||
128877014|NCT01323972|463842490|FG001|Overall Study|Lost to Follow-up|1|||
128877015|NCT01323972|463842491|FG002|Overall Study|Lost to Follow-up|1|||
128877016|NCT01323972|463842492|FG003|Overall Study|Lost to Follow-up|1|||
128877017|NCT05000931|463842501|FG000|Overall Study|Lost to Follow-up|1|||
128877018|NCT00925132|463842502|FG000|Overall Study|Withdrawal by Subject|2|||
128877019|NCT00925132|463842503|FG001|Overall Study|Withdrawal by Subject|0|||
128877020|NCT00925132|463842504|FG002|Overall Study|Withdrawal by Subject|0|||
128877021|NCT00925132|463842505|FG003|Overall Study|Withdrawal by Subject|0|||
128877022|NCT00925132|463842506|FG004|Overall Study|Withdrawal by Subject|1|||
128877023|NCT00925132|463842502|FG000|Overall Study|Removed due to disease progression|0|||
128877024|NCT00925132|463842503|FG001|Overall Study|Removed due to disease progression|0|||
128877025|NCT00925132|463842504|FG002|Overall Study|Removed due to disease progression|0|||
128877026|NCT00925132|463842505|FG003|Overall Study|Removed due to disease progression|0|||
128987928|NCT00943826|464245005|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
128987929|NCT00943826|464245006|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
128987930|NCT00943826|464245005|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
128987931|NCT00943826|464245006|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
128987932|NCT00943826|464245005|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
128987933|NCT00943826|464245006|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
128987934|NCT00943826|464245005|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
128987935|NCT00943826|464245006|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
128987936|NCT00326625|464245007|FG000|Overall Study|Adverse Event|20|||
128987937|NCT00326625|464245008|FG001|Overall Study|Adverse Event|9|||
128987938|NCT00326625|464245007|FG000|Overall Study|Withdrawal by Subject|15|||
128987939|NCT00326625|464245008|FG001|Overall Study|Withdrawal by Subject|12|||
128987940|NCT00326625|464245007|FG000|Overall Study|Death|18|||
128987941|NCT00326625|464245008|FG001|Overall Study|Death|16|||
128987942|NCT00326625|464245007|FG000|Overall Study|Lost to Follow-up|1|||
128987943|NCT00326625|464245008|FG001|Overall Study|Lost to Follow-up|0|||
128987944|NCT00326625|464245007|FG000|Overall Study|prescheduled medical intervention|0|||
128987945|NCT00326625|464245008|FG001|Overall Study|prescheduled medical intervention|1|||
128763060|NCT00991341|463422700|FG000|Overall Study|Physician Decision|1|||
128763061|NCT00991341|463422701|FG001|Overall Study|Physician Decision|2|||
128763062|NCT00991341|463422700|FG000|Overall Study|Withdrawal by Subject|3|||
128763063|NCT00991341|463422701|FG001|Overall Study|Withdrawal by Subject|4|||
128763064|NCT01330316|463422720|FG000|Overall Study|Adverse Event|2|||
128763065|NCT01330316|463422721|FG001|Overall Study|Adverse Event|2|||
128763066|NCT01330316|463422720|FG000|Overall Study|Lack of Efficacy|0|||
128763067|NCT01330316|463422721|FG001|Overall Study|Lack of Efficacy|10|||
128763068|NCT01330316|463422720|FG000|Overall Study|Lost to Follow-up|0|||
128763069|NCT01330316|463422721|FG001|Overall Study|Lost to Follow-up|1|||
128763070|NCT01330316|463422720|FG000|Overall Study|Withdrawal by Subject|0|||
128987946|NCT00455923|464245013|FG000|Overall Study|Pregnancy|0|||
128987947|NCT00455923|464245014|FG001|Overall Study|Pregnancy|2|||
128763071|NCT01330316|463422721|FG001|Overall Study|Withdrawal by Subject|1|||
128763072|NCT01330316|463422720|FG000|Overall Study|other than above|0|||
128763073|NCT01330316|463422721|FG001|Overall Study|other than above|1|||
128763074|NCT00215540|463422722|FG000|Overall Study|Withdrew from study medication|1|||
128987948|NCT00455923|464245013|FG000|Overall Study|Other|3|||
128763075|NCT00215540|463422723|FG001|Overall Study|Withdrew from study medication|0|||
128763076|NCT00215540|463422724|FG002|Overall Study|Withdrew from study medication|0|||
128763077|NCT03010462|463422725|FG000|Overall Study|Withdrawal by Subject|3|||
128987949|NCT00455923|464245014|FG001|Overall Study|Other|1|||
128987950|NCT01265875|464245016|FG000|Overall Study|Uncooperative/unreliable|1|||
128987951|NCT05275673|464245017|FG000|Overall Study|Study Termination by Sponsor|2|||
128987952|NCT05275673|464245018|FG001|Overall Study|Study Termination by Sponsor|3|||
128987953|NCT05275673|464245017|FG000|Overall Study|Death|1|||
128987954|NCT05275673|464245018|FG001|Overall Study|Death|0|||
128987955|NCT05275673|464245017|FG000|Overall Study|Withdrawal by Subject|1|||
128987956|NCT05275673|464245018|FG001|Overall Study|Withdrawal by Subject|0|||
128987957|NCT02335411|464245021|FG000|Overall Study|Death|223|||
128987958|NCT02335411|464245022|FG001|Overall Study|Death|22|||
128987959|NCT02335411|464245023|FG002|Overall Study|Death|26|||
128987960|NCT02335411|464245021|FG000|Overall Study|Physician Decision|3|||
128987961|NCT02335411|464245022|FG001|Overall Study|Physician Decision|0|||
128987962|NCT02335411|464245023|FG002|Overall Study|Physician Decision|0|||
128987963|NCT02335411|464245021|FG000|Overall Study|Protocol Violation|1|||
128987964|NCT02335411|464245022|FG001|Overall Study|Protocol Violation|0|||
128987965|NCT02335411|464245023|FG002|Overall Study|Protocol Violation|0|||
128987966|NCT02335411|464245021|FG000|Overall Study|Withdrawal by Subject|11|||
128987967|NCT02335411|464245022|FG001|Overall Study|Withdrawal by Subject|0|||
128987968|NCT02335411|464245023|FG002|Overall Study|Withdrawal by Subject|3|||
128987969|NCT02335411|464245021|FG000|Overall Study|Sponsor Decision|12|||
128987970|NCT02335411|464245022|FG001|Overall Study|Sponsor Decision|3|||
128987971|NCT02335411|464245023|FG002|Overall Study|Sponsor Decision|2|||
128987972|NCT02335411|464245021|FG000|Overall Study|Adverse Event|9|||
128987973|NCT02335411|464245022|FG001|Overall Study|Adverse Event|0|||
128987974|NCT02335411|464245023|FG002|Overall Study|Adverse Event|0|||
128987975|NCT03075826|464245024|FG000|Overall Study|Withdrawal by Subject|1|||
128987976|NCT03075826|464245024|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
128987977|NCT00650806|464245025|FG000|Overall Study|Adverse Event|0|||
128987978|NCT00650806|464245026|FG001|Overall Study|Adverse Event|5|||
128987979|NCT00650806|464245027|FG002|Overall Study|Adverse Event|3|||
128987980|NCT00650806|464245028|FG003|Overall Study|Adverse Event|4|||
128987981|NCT00650806|464245025|FG000|Overall Study|Lost to Follow-up|7|||
128987982|NCT00650806|464245026|FG001|Overall Study|Lost to Follow-up|6|||
128987983|NCT00650806|464245027|FG002|Overall Study|Lost to Follow-up|11|||
128987984|NCT00650806|464245028|FG003|Overall Study|Lost to Follow-up|10|||
128987985|NCT00650806|464245025|FG000|Overall Study|Protocol Violation|0|||
128987986|NCT00650806|464245026|FG001|Overall Study|Protocol Violation|0|||
128987987|NCT00650806|464245027|FG002|Overall Study|Protocol Violation|0|||
128987988|NCT00650806|464245028|FG003|Overall Study|Protocol Violation|1|||
128987989|NCT00650806|464245025|FG000|Overall Study|Pregnancy|0|||
128987990|NCT00650806|464245026|FG001|Overall Study|Pregnancy|0|||
128987991|NCT00650806|464245027|FG002|Overall Study|Pregnancy|0|||
128987992|NCT00650806|464245028|FG003|Overall Study|Pregnancy|1|||
128987993|NCT00650806|464245025|FG000|Overall Study|Withdrawal by Subject|7|||
128987994|NCT00650806|464245026|FG001|Overall Study|Withdrawal by Subject|5|||
128987995|NCT00650806|464245027|FG002|Overall Study|Withdrawal by Subject|8|||
128987996|NCT00650806|464245028|FG003|Overall Study|Withdrawal by Subject|6|||
128987997|NCT00650806|464245025|FG000|Overall Study|Noncompliance with study drug regimen|1|||
128987998|NCT00650806|464245026|FG001|Overall Study|Noncompliance with study drug regimen|1|||
128987999|NCT00650806|464245027|FG002|Overall Study|Noncompliance with study drug regimen|0|||
128988000|NCT00650806|464245028|FG003|Overall Study|Noncompliance with study drug regimen|0|||
128988001|NCT00650806|464245025|FG000|Overall Study|Study terminated by sponsor|2|||
128988002|NCT00650806|464245026|FG001|Overall Study|Study terminated by sponsor|3|||
128717765|NCT03447990|463264019|FG000|Overall Study|Withdrawal by Subject|0|||
128988003|NCT00650806|464245027|FG002|Overall Study|Study terminated by sponsor|5|||
128988004|NCT00650806|464245028|FG003|Overall Study|Study terminated by sponsor|4|||
128988005|NCT00650806|464245025|FG000|Overall Study|Other|1|||
128988006|NCT00650806|464245026|FG001|Overall Study|Other|1|||
128988007|NCT00650806|464245027|FG002|Overall Study|Other|2|||
128988008|NCT00650806|464245028|FG003|Overall Study|Other|0|||
128988009|NCT04456998|464245029|FG000|Overall Study|Adverse Event|0|||
128988010|NCT04456998|464245030|FG001|Overall Study|Adverse Event|4|||
128988011|NCT04456998|464245029|FG000|Overall Study|Protocol Deviation|0|||
128877027|NCT00925132|463842506|FG004|Overall Study|Removed due to disease progression|4|||
128877028|NCT03141905|463842507|FG000|Overall Study|Death|3|||
128877029|NCT03141905|463842508|FG001|Overall Study|Death|2|||
128877030|NCT03141905|463842507|FG000|Overall Study|Withdrawal by Subject|1|||
128877031|NCT03141905|463842508|FG001|Overall Study|Withdrawal by Subject|0|||
128877032|NCT03141905|463842507|FG000|Overall Study|Lost to Follow-up|3|||
128877033|NCT03141905|463842508|FG001|Overall Study|Lost to Follow-up|7|||
128877034|NCT03141905|463842507|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
128877035|NCT03141905|463842508|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
128877036|NCT01034176|463844087|FG000|Overall Study|Physician Decision|2|||
128877037|NCT01034176|463844088|FG001|Overall Study|Physician Decision|0|||
128877038|NCT01034176|463844087|FG000|Overall Study|Withdrawal by Subject|0|||
128877039|NCT01034176|463844088|FG001|Overall Study|Withdrawal by Subject|1|||
128877040|NCT01034176|463844087|FG000|Overall Study|Lost to Follow-up|0|||
128877041|NCT01034176|463844088|FG001|Overall Study|Lost to Follow-up|1|||
128877042|NCT05087979|463844091|FG000|Overall Study|Converted to general anesthesia|1|||
128877043|NCT05087979|463844092|FG001|Overall Study|Converted to general anesthesia|0|||
128877044|NCT03207009|463844093|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
128877045|NCT02924428|463844094|FG000|Overall Study|Adverse Event|1|||
128877046|NCT02924428|463844095|FG001|Overall Study|Adverse Event|0|||
128877047|NCT02924428|463844094|FG000|Overall Study|Physician Decision|1|||
128877048|NCT02924428|463844095|FG001|Overall Study|Physician Decision|0|||
128877049|NCT02924428|463844094|FG000|Overall Study|Lost to Follow-up|2|||
128877050|NCT02924428|463844095|FG001|Overall Study|Lost to Follow-up|4|||
128877051|NCT02924428|463844094|FG000|Overall Study|Pregnancy|0|||
128877052|NCT02924428|463844095|FG001|Overall Study|Pregnancy|1|||
128877053|NCT01850446|463844096|FG000|Overall Study|Lack of Efficacy|1|||
128877054|NCT01850446|463844097|FG001|Overall Study|Lack of Efficacy|0|||
128877055|NCT01850446|463844096|FG000|Overall Study|Withdrawal by Subject|4|||
128877056|NCT01850446|463844097|FG001|Overall Study|Withdrawal by Subject|0|||
128877057|NCT01850446|463844096|FG000|Overall Study|Protocol Violation|0|||
128877058|NCT01850446|463844097|FG001|Overall Study|Protocol Violation|2|||
128877059|NCT01773291|463844098|FG000|Overall Study|Protocol Violation|1|||
128988012|NCT04456998|464245030|FG001|Overall Study|Protocol Deviation|1|||
128988013|NCT04456998|464245029|FG000|Overall Study|Withdrawal by Subject|0|||
128988014|NCT04456998|464245030|FG001|Overall Study|Withdrawal by Subject|1|||
128988015|NCT04882085|464245034|FG000|Overall Study|Death|6|||
128988016|NCT04882085|464245035|FG001|Overall Study|Death|9|||
128988017|NCT04882085|464245034|FG000|Overall Study|Withdrawal by Subject|0|||
128988018|NCT04882085|464245035|FG001|Overall Study|Withdrawal by Subject|3|||
128988019|NCT04882085|464245034|FG000|Overall Study|Randomized not treated|1|||
128988020|NCT04882085|464245035|FG001|Overall Study|Randomized not treated|0|||
128988021|NCT00400985|464245036|FG000|Overall Study|Withdrawal by Subject|5|||
128988022|NCT00400985|464245036|FG000|Overall Study|system modification|8|||
128988023|NCT00400985|464245036|FG000|Overall Study|Death|30|||
128988024|NCT00400985|464245036|FG000|Overall Study|Lost to Follow-up|9|||
128988025|NCT00965562|464245037|FG000|Overall Study|Lost to Follow-up|1|||
128988026|NCT00965562|464245038|FG001|Overall Study|Lost to Follow-up|2|||
128988027|NCT00965562|464245039|FG002|Overall Study|Lost to Follow-up|3|||
128988028|NCT00965562|464245037|FG000|Overall Study|Withdrawal by Subject|2|||
128988029|NCT00965562|464245038|FG001|Overall Study|Withdrawal by Subject|2|||
128988030|NCT00965562|464245039|FG002|Overall Study|Withdrawal by Subject|0|||
128988031|NCT03792633|464245044|FG000|Overall Study|Alternative Treatment|17|||
128988032|NCT03792633|464245045|FG001|Overall Study|Alternative Treatment|19|||
128988033|NCT03792633|464245044|FG000|Overall Study|Death|2|||
128988034|NCT03792633|464245045|FG001|Overall Study|Death|0|||
128988035|NCT03792633|464245044|FG000|Overall Study|Disease progression|8|||
128988036|NCT03792633|464245045|FG001|Overall Study|Disease progression|9|||
128988037|NCT03792633|464245044|FG000|Overall Study|Lost to Follow-up|1|||
128988038|NCT03792633|464245045|FG001|Overall Study|Lost to Follow-up|1|||
128988039|NCT03792633|464245044|FG000|Overall Study|Screen fail|1|||
128988040|NCT03792633|464245045|FG001|Overall Study|Screen fail|0|||
128988041|NCT03792633|464245044|FG000|Overall Study|Second malignancy|0|||
128988042|NCT03792633|464245045|FG001|Overall Study|Second malignancy|1|||
128988043|NCT03179462|464245048|FG000|Overall Study|screening failure|1|||
128988044|NCT03179462|464245049|FG001|Overall Study|screening failure|2|||
128988045|NCT03179462|464245050|FG002|Overall Study|screening failure|0|||
128988046|NCT04636437|464245051|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
128988047|NCT04636437|464245052|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
128988048|NCT04636437|464245053|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
128988049|NCT04636437|464245051|FG000|Overall Study|Started weight loss drug/program|2|||
128988050|NCT04636437|464245052|FG001|Overall Study|Started weight loss drug/program|1|||
128988051|NCT04636437|464245053|FG002|Overall Study|Started weight loss drug/program|1|||
128988052|NCT04636437|464245051|FG000|Overall Study|Lost to Follow-up|3|||
128988053|NCT04636437|464245052|FG001|Overall Study|Lost to Follow-up|1|||
128988054|NCT04636437|464245053|FG002|Overall Study|Lost to Follow-up|4|||
128988055|NCT04636437|464245051|FG000|Overall Study|Participant or physician decision|3|||
128988056|NCT04636437|464245052|FG001|Overall Study|Participant or physician decision|1|||
128988057|NCT04636437|464245053|FG002|Overall Study|Participant or physician decision|1|||
128988058|NCT00816166|464245054|FG000|Overall Study|Lost to Follow-up|6|||
128988059|NCT00816166|464245055|FG001|Overall Study|Lost to Follow-up|10|||
128988060|NCT00816166|464245054|FG000|Overall Study|Death|4|||
128988061|NCT00816166|464245055|FG001|Overall Study|Death|2|||
128988062|NCT00352664|464245056|FG000|Overall Study|Withdrawal by Subject|7|||
128988063|NCT00352664|464245057|FG001|Overall Study|Withdrawal by Subject|0|||
128988064|NCT01233284|464245058|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
128988065|NCT01233284|464245059|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128988066|NCT01233284|464245060|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128988067|NCT01233284|464245061|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128988068|NCT01233284|464245062|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128988069|NCT01233284|464245058|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
128988070|NCT01233284|464245059|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
128988071|NCT01233284|464245060|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
128988072|NCT01233284|464245061|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
128988073|NCT01233284|464245062|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
128988074|NCT01233284|464245058|FG000|Period 1 (4 Weeks)|Other|0|||
128988075|NCT01233284|464245059|FG001|Period 1 (4 Weeks)|Other|0|||
128988076|NCT01233284|464245060|FG002|Period 1 (4 Weeks)|Other|1|||
128988077|NCT01233284|464245061|FG003|Period 1 (4 Weeks)|Other|0|||
128988078|NCT01233284|464245062|FG004|Period 1 (4 Weeks)|Other|0|||
128988079|NCT01233284|464245058|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128988080|NCT01233284|464245059|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128988081|NCT01233284|464245060|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
128988082|NCT01233284|464245061|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128988083|NCT01233284|464245062|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128988084|NCT01233284|464245058|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
128988085|NCT01233284|464245059|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
128988086|NCT01233284|464245060|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
128988087|NCT01233284|464245061|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
128988088|NCT01233284|464245062|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
128988089|NCT01233284|464245058|FG000|Period 3 (4 Weeks)|Other|0|||
128988090|NCT01233284|464245059|FG001|Period 3 (4 Weeks)|Other|0|||
128988091|NCT01233284|464245060|FG002|Period 3 (4 Weeks)|Other|0|||
128988092|NCT01233284|464245061|FG003|Period 3 (4 Weeks)|Other|1|||
128988093|NCT01233284|464245062|FG004|Period 3 (4 Weeks)|Other|0|||
128988094|NCT01233284|464245058|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
128988095|NCT01233284|464245059|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
128988096|NCT01233284|464245060|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
128988097|NCT01233284|464245061|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
128988098|NCT01233284|464245062|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
128988099|NCT01233284|464245058|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
128988100|NCT01233284|464245059|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
128988101|NCT01233284|464245060|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
128988102|NCT01233284|464245061|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
128988103|NCT01233284|464245062|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
128988104|NCT01058707|464245064|FG000|Overall Study|Disease Progression|15|||
128988105|NCT01058707|464245065|FG001|Overall Study|Disease Progression|20|||
128988106|NCT01058707|464245066|FG002|Overall Study|Disease Progression|20|||
128988107|NCT01058707|464245067|FG003|Overall Study|Disease Progression|15|||
128988108|NCT01058707|464245068|FG004|Overall Study|Disease Progression|23|||
128988109|NCT01058707|464245069|FG005|Overall Study|Disease Progression|10|||
128988110|NCT01058707|464245070|FG006|Overall Study|Disease Progression|12|||
128988111|NCT01058707|464245064|FG000|Overall Study|Adverse Event|11|||
128988112|NCT01058707|464245065|FG001|Overall Study|Adverse Event|4|||
128988113|NCT01058707|464245066|FG002|Overall Study|Adverse Event|7|||
128988114|NCT01058707|464245067|FG003|Overall Study|Adverse Event|6|||
128988115|NCT01058707|464245068|FG004|Overall Study|Adverse Event|7|||
128988116|NCT01058707|464245069|FG005|Overall Study|Adverse Event|3|||
128988117|NCT01058707|464245070|FG006|Overall Study|Adverse Event|1|||
128988118|NCT01058707|464245064|FG000|Overall Study|Subject Decision|5|||
128988119|NCT01058707|464245065|FG001|Overall Study|Subject Decision|3|||
128988120|NCT01058707|464245066|FG002|Overall Study|Subject Decision|3|||
128988121|NCT01058707|464245067|FG003|Overall Study|Subject Decision|1|||
128988122|NCT01058707|464245068|FG004|Overall Study|Subject Decision|2|||
128988123|NCT01058707|464245069|FG005|Overall Study|Subject Decision|3|||
128988124|NCT01058707|464245070|FG006|Overall Study|Subject Decision|6|||
128988125|NCT01058707|464245064|FG000|Overall Study|Lost to Follow-up|0|||
128988126|NCT01058707|464245065|FG001|Overall Study|Lost to Follow-up|0|||
128988127|NCT01058707|464245066|FG002|Overall Study|Lost to Follow-up|1|||
128988128|NCT01058707|464245067|FG003|Overall Study|Lost to Follow-up|0|||
128988129|NCT01058707|464245068|FG004|Overall Study|Lost to Follow-up|0|||
128988130|NCT01058707|464245069|FG005|Overall Study|Lost to Follow-up|0|||
128988131|NCT01058707|464245070|FG006|Overall Study|Lost to Follow-up|0|||
128988132|NCT01058707|464245064|FG000|Overall Study|Reason Not Specified|0|||
128988133|NCT01058707|464245065|FG001|Overall Study|Reason Not Specified|3|||
128988134|NCT01058707|464245066|FG002|Overall Study|Reason Not Specified|2|||
128988135|NCT01058707|464245067|FG003|Overall Study|Reason Not Specified|0|||
128988136|NCT01058707|464245068|FG004|Overall Study|Reason Not Specified|7|||
128988137|NCT01058707|464245069|FG005|Overall Study|Reason Not Specified|1|||
128988138|NCT01058707|464245070|FG006|Overall Study|Reason Not Specified|7|||
128988139|NCT01821391|464245071|FG000|Overall Study|Adverse Event|1|||
128988140|NCT01821391|464245072|FG001|Overall Study|Adverse Event|0|||
128988141|NCT00795886|464245081|FG000|Overall Study|Death|10|||
128988142|NCT05554471|464245087|FG000|Overall Study|Physician Decision|2|||
128988143|NCT05554471|464245088|FG001|Overall Study|Physician Decision|1|||
128988144|NCT05554471|464245087|FG000|Overall Study|Lost to Follow-up|2|||
128988145|NCT05554471|464245088|FG001|Overall Study|Lost to Follow-up|1|||
128988146|NCT05554471|464245087|FG000|Overall Study|Death|0|||
128988147|NCT05554471|464245088|FG001|Overall Study|Death|1|||
128988148|NCT04880850|464245089|FG000|Overall Study|Death|2|||
128988149|NCT04880850|464245090|FG001|Overall Study|Death|1|||
128988150|NCT04880850|464245089|FG000|Overall Study|Lost to Follow-up|3|||
128988151|NCT04880850|464245090|FG001|Overall Study|Lost to Follow-up|6|||
128988152|NCT04880850|464245089|FG000|Overall Study|Physician Decision|2|||
128988153|NCT04880850|464245090|FG001|Overall Study|Physician Decision|1|||
128988154|NCT04880850|464245089|FG000|Overall Study|Withdrawal by Subject|9|||
128988155|NCT04880850|464245090|FG001|Overall Study|Withdrawal by Subject|10|||
128988156|NCT01608321|464245091|FG000|Overall Study|Withdrawal by Subject|1|||
128988157|NCT01608321|464245092|FG001|Overall Study|Withdrawal by Subject|0|||
128988158|NCT03417102|464245093|FG000|Overall Study|Adverse Event|0|||
128988159|NCT03417102|464245094|FG001|Overall Study|Adverse Event|1|||
128988160|NCT03417102|464245093|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
128988161|NCT03417102|464245094|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
128988162|NCT03417102|464245093|FG000|Overall Study|Other|0|||
128988163|NCT03417102|464245094|FG001|Overall Study|Other|1|||
128988164|NCT02062385|464245095|FG000|Overall Study|Adverse Event|19|||
128988165|NCT02062385|464245096|FG001|Overall Study|Adverse Event|13|||
128988166|NCT02062385|464245097|FG002|Overall Study|Adverse Event|1|||
128988167|NCT02062385|464245098|FG003|Overall Study|Adverse Event|0|||
128988168|NCT02062385|464245095|FG000|Overall Study|Protocol Violation|1|||
128988169|NCT02062385|464245096|FG001|Overall Study|Protocol Violation|0|||
128988170|NCT02062385|464245097|FG002|Overall Study|Protocol Violation|0|||
128988171|NCT02062385|464245098|FG003|Overall Study|Protocol Violation|0|||
128988172|NCT02062385|464245095|FG000|Overall Study|Incomplete EPI by database lock|2|||
128988173|NCT02062385|464245096|FG001|Overall Study|Incomplete EPI by database lock|0|||
128988174|NCT02062385|464245097|FG002|Overall Study|Incomplete EPI by database lock|0|||
128988175|NCT02062385|464245098|FG003|Overall Study|Incomplete EPI by database lock|0|||
128988176|NCT02062385|464245095|FG000|Overall Study|Moved|10|||
128988177|NCT02062385|464245096|FG001|Overall Study|Moved|11|||
128988178|NCT02062385|464245097|FG002|Overall Study|Moved|1|||
128988179|NCT02062385|464245098|FG003|Overall Study|Moved|0|||
128988180|NCT02062385|464245095|FG000|Overall Study|Withdrawn by parent/guardian|46|||
128988181|NCT02062385|464245096|FG001|Overall Study|Withdrawn by parent/guardian|41|||
128988182|NCT02062385|464245097|FG002|Overall Study|Withdrawn by parent/guardian|9|||
128988183|NCT02062385|464245098|FG003|Overall Study|Withdrawn by parent/guardian|8|||
128988184|NCT02062385|464245095|FG000|Overall Study|Death|0|||
128988185|NCT02062385|464245096|FG001|Overall Study|Death|0|||
128988186|NCT02062385|464245097|FG002|Overall Study|Death|0|||
128988187|NCT02062385|464245098|FG003|Overall Study|Death|1|||
128988188|NCT02062385|464245095|FG000|Overall Study|Lost to Follow-up|0|||
128988189|NCT02062385|464245096|FG001|Overall Study|Lost to Follow-up|0|||
128988190|NCT02062385|464245097|FG002|Overall Study|Lost to Follow-up|1|||
128988191|NCT02062385|464245098|FG003|Overall Study|Lost to Follow-up|0|||
128988192|NCT00526227|464245099|FG000|Overall Study|Device not implanted|1|||
128988193|NCT00526227|464245099|FG000|Overall Study|Death|1|||
128988194|NCT03222856|464245102|FG000|Overall Study|Adverse Event|6|||
129214365|NCT02113982|465089324|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214366|NCT02113982|465089325|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214367|NCT02113982|465089326|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214368|NCT02113982|465089327|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129214369|NCT02113982|465089314|FG000|Stage 1: Dose Escalation|Transplant|0|||
129214370|NCT02113982|465089315|FG001|Stage 1: Dose Escalation|Transplant|1|||
129214371|NCT02113982|465089316|FG002|Stage 1: Dose Escalation|Transplant|0|||
129214372|NCT02113982|465089317|FG003|Stage 1: Dose Escalation|Transplant|0|||
129214373|NCT02113982|465089318|FG004|Stage 1: Dose Escalation|Transplant|0|||
128988195|NCT03222856|464245102|FG000|Overall Study|Death|1|||
128988196|NCT01721369|464245103|FG000|Overall Study|Not initial etiological diagnosis|12|||
128988197|NCT00706901|464246481|FG000|Overall Study|Lost to Follow-up|2|||
128988198|NCT00706901|464246482|FG001|Overall Study|Lost to Follow-up|3|||
128988199|NCT00706901|464246483|FG002|Overall Study|Lost to Follow-up|2|||
128988200|NCT00706901|464246481|FG000|Overall Study|Withdrawal by Subject|4|||
128988201|NCT00706901|464246482|FG001|Overall Study|Withdrawal by Subject|2|||
128988202|NCT00706901|464246483|FG002|Overall Study|Withdrawal by Subject|5|||
128988203|NCT00706901|464246481|FG000|Overall Study|In Jail|1|||
128988204|NCT00706901|464246482|FG001|Overall Study|In Jail|0|||
128988205|NCT00706901|464246483|FG002|Overall Study|In Jail|1|||
128988206|NCT00706901|464246481|FG000|Overall Study|Death|1|||
128988207|NCT00706901|464246482|FG001|Overall Study|Death|0|||
128988208|NCT00706901|464246483|FG002|Overall Study|Death|0|||
128988209|NCT04478994|464246484|FG000|Overall Study|Withdrawal by Subject|1|||
128988210|NCT04478994|464246485|FG001|Overall Study|Withdrawal by Subject|1|||
128988211|NCT01100073|464246486|FG000|Overall Study|Lack of Efficacy|4|||
129214374|NCT02113982|465089319|FG005|Stage 1: Dose Escalation|Transplant|1|||
128988212|NCT01100073|464246486|FG000|Overall Study|Insufficient Tolerability|21|||
128877060|NCT01773291|463844099|FG001|Overall Study|Protocol Violation|0|||
128877061|NCT01773291|463844100|FG002|Overall Study|Protocol Violation|0|||
128877062|NCT01773291|463844098|FG000|Overall Study|Withdrawal by Subject|0|||
128877063|NCT01773291|463844099|FG001|Overall Study|Withdrawal by Subject|0|||
128877064|NCT01773291|463844100|FG002|Overall Study|Withdrawal by Subject|1|||
128877065|NCT00107120|463844102|FG000|Overall Study|Adverse Event|4|||
128877066|NCT00107120|463844103|FG001|Overall Study|Adverse Event|1|||
128877067|NCT00107120|463844102|FG000|Overall Study|Lack of Efficacy|5|||
128877068|NCT00107120|463844103|FG001|Overall Study|Lack of Efficacy|5|||
128877069|NCT00107120|463844102|FG000|Overall Study|Protocol Violation|3|||
128877070|NCT00107120|463844103|FG001|Overall Study|Protocol Violation|0|||
128988213|NCT01100073|464246486|FG000|Overall Study|Withdrawal by Subject|13|||
128988214|NCT01100073|464246486|FG000|Overall Study|Lost to Follow-up|39|||
128988215|NCT01100073|464246486|FG000|Overall Study|Lack of effect + patient's wish|2|||
128988216|NCT01100073|464246486|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
128988217|NCT01100073|464246486|FG000|Overall Study|Other|8|||
128988218|NCT01100073|464246486|FG000|Overall Study|Missing|5|||
128988219|NCT01656850|464246487|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
128988220|NCT01656850|464246488|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
128988221|NCT01741259|464246494|FG000|Overall Study|Protocol Violation|6|||
128988222|NCT01741259|464246495|FG001|Overall Study|Protocol Violation|4|||
128988223|NCT01741259|464246494|FG000|Overall Study|Withdrawal by Subject|0|||
128988224|NCT01741259|464246495|FG001|Overall Study|Withdrawal by Subject|2|||
128988225|NCT00057330|464246501|FG000|Overall Study|Adverse Event|9|||
128988226|NCT00057330|464246502|FG001|Overall Study|Adverse Event|12|||
128988227|NCT00057330|464246501|FG000|Overall Study|Death|1|||
128988228|NCT00057330|464246502|FG001|Overall Study|Death|0|||
128988229|NCT00057330|464246501|FG000|Overall Study|Protocol Violation|1|||
128988230|NCT00057330|464246502|FG001|Overall Study|Protocol Violation|1|||
128988231|NCT00057330|464246501|FG000|Overall Study|Withdrawal by Subject|115|||
128988232|NCT00057330|464246502|FG001|Overall Study|Withdrawal by Subject|84|||
128988233|NCT00057330|464246501|FG000|Overall Study|Lost to Follow-up|745|||
128988234|NCT00057330|464246502|FG001|Overall Study|Lost to Follow-up|617|||
128988235|NCT00057330|464246501|FG000|Overall Study|Physician Decision|1|||
128988236|NCT00057330|464246502|FG001|Overall Study|Physician Decision|0|||
128988237|NCT00057330|464246501|FG000|Overall Study|Other|260|||
128988238|NCT00057330|464246502|FG001|Overall Study|Other|206|||
128988239|NCT04633434|464246509|FG000|Overall Study|Lost to Follow-up|32|||
128988240|NCT04633434|464246510|FG001|Overall Study|Lost to Follow-up|32|||
128988241|NCT01605370|464246520|FG000|Overall Study|Adverse Event|1|||
128988242|NCT01605370|464246521|FG001|Overall Study|Adverse Event|0|||
128988243|NCT00183170|464246526|FG000|First Intervention|Did not complete study|1|||
128988244|NCT00183170|464246527|FG001|First Intervention|Did not complete study|0|||
128988245|NCT00183170|464246526|FG000|First Intervention|Did not meet targeted BrAC|1|||
128988246|NCT00183170|464246527|FG001|First Intervention|Did not meet targeted BrAC|0|||
128988247|NCT00183170|464246526|FG000|Washout 1 Week|Did not complete study|6|||
128988248|NCT00183170|464246527|FG001|Washout 1 Week|Did not complete study|8|||
128988249|NCT00183170|464246526|FG000|Second Intervention|Did not complete study|1|||
128988250|NCT00183170|464246527|FG001|Second Intervention|Did not complete study|0|||
128988251|NCT00183170|464246526|FG000|Second Intervention|Did not meet targeted BrAC|0|||
128988252|NCT00183170|464246527|FG001|Second Intervention|Did not meet targeted BrAC|2|||
128988253|NCT04983589|464246528|FG000|Overall Study|Withdrawal by Subject|0|||
128988254|NCT04983589|464246529|FG001|Overall Study|Withdrawal by Subject|3|||
128988255|NCT04983589|464246528|FG000|Overall Study|COVID-19 Infection|1|||
128988256|NCT04983589|464246529|FG001|Overall Study|COVID-19 Infection|0|||
128988257|NCT04983589|464246528|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
128988258|NCT04983589|464246529|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
128988259|NCT00924820|464246530|FG000|Overall Study|Death|2|||
128988260|NCT00924820|464246530|FG000|Overall Study|Ineligible, Screen Failure|5|||
128988261|NCT00761969|464246531|FG000|Overall Study|Death|112|||
128988262|NCT00761969|464246532|FG001|Overall Study|Death|47|||
128988263|NCT00761969|464246531|FG000|Overall Study|Lost to Follow-up|88|||
128988264|NCT00761969|464246532|FG001|Overall Study|Lost to Follow-up|93|||
128988265|NCT01353586|464246535|FG000|Overall Study|Procedure terminated prior to ablation|3|||
128988266|NCT01353586|464246536|FG001|Overall Study|Procedure terminated prior to ablation|0|||
128988267|NCT01353586|464246535|FG000|Overall Study|Never had insertion of study catheter|4|||
128988268|NCT01353586|464246536|FG001|Overall Study|Never had insertion of study catheter|1|||
128988269|NCT01353586|464246535|FG000|Overall Study|Neurological exam not done|0|||
128988270|NCT01353586|464246536|FG001|Overall Study|Neurological exam not done|1|||
128988271|NCT00585468|464246537|FG000|First Intervention|Withdrawal by Subject|1|||
128988272|NCT00585468|464246538|FG001|First Intervention|Withdrawal by Subject|1|||
128988273|NCT00978120|464246539|FG000|Overall Study|Death|0|||
128988274|NCT00978120|464246540|FG001|Overall Study|Death|0|||
128988275|NCT00978120|464246541|FG002|Overall Study|Death|0|||
128988276|NCT00978120|464246542|FG003|Overall Study|Death|1|||
128988277|NCT00978120|464246539|FG000|Overall Study|Lost to Follow-up|0|||
128988278|NCT00978120|464246540|FG001|Overall Study|Lost to Follow-up|0|||
128988279|NCT00978120|464246541|FG002|Overall Study|Lost to Follow-up|3|||
128988280|NCT00978120|464246542|FG003|Overall Study|Lost to Follow-up|0|||
128988281|NCT00978120|464246539|FG000|Overall Study|Withdrawal by Subject|2|||
128988282|NCT00978120|464246540|FG001|Overall Study|Withdrawal by Subject|0|||
128988283|NCT00978120|464246541|FG002|Overall Study|Withdrawal by Subject|0|||
128988284|NCT00978120|464246542|FG003|Overall Study|Withdrawal by Subject|0|||
128988285|NCT00978120|464246539|FG000|Overall Study|Moved out of state|0|||
128988286|NCT00978120|464246540|FG001|Overall Study|Moved out of state|0|||
128988287|NCT00978120|464246541|FG002|Overall Study|Moved out of state|0|||
128988288|NCT00978120|464246542|FG003|Overall Study|Moved out of state|1|||
128988289|NCT03733301|464246549|FG000|Overall Study|Screen Fail|1|||
128988290|NCT03733301|464246550|FG001|Overall Study|Screen Fail|0|||
128988291|NCT03733301|464246551|FG002|Overall Study|Screen Fail|0|||
128988292|NCT03733301|464246549|FG000|Overall Study|Non-compliance|1|||
128988293|NCT03733301|464246550|FG001|Overall Study|Non-compliance|0|||
128988294|NCT03733301|464246551|FG002|Overall Study|Non-compliance|0|||
128988295|NCT03733301|464246549|FG000|Overall Study|Lack of Efficacy|2|||
128988296|NCT03733301|464246550|FG001|Overall Study|Lack of Efficacy|3|||
128988297|NCT03733301|464246551|FG002|Overall Study|Lack of Efficacy|0|||
128988298|NCT03733301|464246549|FG000|Overall Study|Adverse Event|0|||
128988299|NCT03733301|464246550|FG001|Overall Study|Adverse Event|1|||
128988300|NCT03733301|464246551|FG002|Overall Study|Adverse Event|3|||
128988301|NCT03733301|464246549|FG000|Overall Study|Withdrawal by Subject|3|||
128988302|NCT03733301|464246550|FG001|Overall Study|Withdrawal by Subject|5|||
128988303|NCT03733301|464246551|FG002|Overall Study|Withdrawal by Subject|1|||
128988304|NCT00877799|464246554|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
128988305|NCT00877799|464246555|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
128988306|NCT00877799|464246556|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
128988307|NCT00877799|464246557|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
128988308|NCT00877799|464246558|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
128988309|NCT00877799|464246554|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
128988310|NCT00877799|464246555|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
128988311|NCT00877799|464246556|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
128988312|NCT00877799|464246557|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
128988313|NCT00877799|464246558|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
128988314|NCT00877799|464246554|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
128988315|NCT00877799|464246555|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
128988316|NCT00877799|464246556|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
128988317|NCT00877799|464246557|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
128988318|NCT00877799|464246558|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
128988319|NCT00877799|464246554|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
128988320|NCT00877799|464246555|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
128988321|NCT00877799|464246556|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
128988322|NCT00877799|464246557|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
128988323|NCT00877799|464246558|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
128988324|NCT00877799|464246554|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
128988325|NCT00877799|464246555|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
128988326|NCT00877799|464246556|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
128763078|NCT03010462|463422726|FG001|Overall Study|Withdrawal by Subject|1|||
128988327|NCT00877799|464246557|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
128988328|NCT00877799|464246558|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
128988329|NCT04054011|464246559|FG000|Overall Study|COVID|3|||
128988330|NCT03707145|464246560|FG000|Overall Study|Lost to Follow-up|0|||
128988331|NCT03707145|464246561|FG001|Overall Study|Lost to Follow-up|1|||
128988332|NCT03707145|464246562|FG002|Overall Study|Lost to Follow-up|1|||
128988333|NCT03707145|464246563|FG003|Overall Study|Lost to Follow-up|0|||
128988334|NCT04455620|464246567|FG000|Overall Study|Withdrawal by Subject|0|||
128988335|NCT04455620|464246568|FG001|Overall Study|Withdrawal by Subject|0|||
128988336|NCT04455620|464246569|FG002|Overall Study|Withdrawal by Subject|2|||
128988337|NCT04455620|464246570|FG003|Overall Study|Withdrawal by Subject|0|||
128988338|NCT04455620|464246571|FG004|Overall Study|Withdrawal by Subject|1|||
128988339|NCT04455620|464246567|FG000|Overall Study|Lost to Follow-up|0|||
128763079|NCT02207725|463422729|FG000|Overall Study|Did Not Receive Treatment|0|||
128988340|NCT04455620|464246568|FG001|Overall Study|Lost to Follow-up|0|||
128988341|NCT04455620|464246569|FG002|Overall Study|Lost to Follow-up|1|||
128988342|NCT04455620|464246570|FG003|Overall Study|Lost to Follow-up|1|||
128988343|NCT04455620|464246571|FG004|Overall Study|Lost to Follow-up|0|||
128988344|NCT04455620|464246567|FG000|Overall Study|Death|1|||
128988345|NCT04455620|464246568|FG001|Overall Study|Death|6|||
128988346|NCT04455620|464246569|FG002|Overall Study|Death|20|||
128988347|NCT04455620|464246570|FG003|Overall Study|Death|1|||
128988348|NCT04455620|464246571|FG004|Overall Study|Death|7|||
128988349|NCT04455620|464246567|FG000|Overall Study|Study Termination|0|||
128988350|NCT04455620|464246568|FG001|Overall Study|Study Termination|2|||
128988351|NCT04455620|464246569|FG002|Overall Study|Study Termination|1|||
128988352|NCT04455620|464246570|FG003|Overall Study|Study Termination|0|||
128988353|NCT04455620|464246571|FG004|Overall Study|Study Termination|6|||
128988354|NCT02851069|464246573|FG000|Overall Study|Failure to Return|3|||
128988355|NCT02851069|464246573|FG000|Overall Study|Other|3|||
128988356|NCT03539952|464246582|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
128988357|NCT03539952|464246583|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
128988358|NCT03539952|464246582|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
128988359|NCT03539952|464246583|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
128988360|NCT03539952|464246582|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
128988361|NCT03539952|464246583|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
128988362|NCT03539952|464246582|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
128988363|NCT03539952|464246583|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
128988364|NCT03539952|464246582|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
128988365|NCT03539952|464246583|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
128988366|NCT03539952|464246582|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
128988367|NCT03539952|464246583|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
128988368|NCT03539952|464246582|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
128988369|NCT03539952|464246583|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
128988370|NCT03075215|464246584|FG000|12-Month Primary Endpoint|Death|152|||
128988371|NCT03075215|464246584|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
128988372|NCT03075215|464246584|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
128988373|NCT03075215|464246584|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
128988374|NCT02756182|464246585|FG000|Overall Study|StudyTechnical Difficulties|4|||
128988375|NCT02146365|464246586|FG000|Overall Study|Lost to Follow-up|2|||
128988376|NCT02146365|464246587|FG001|Overall Study|Lost to Follow-up|1|||
128988377|NCT02146365|464246588|FG002|Overall Study|Lost to Follow-up|3|||
128988378|NCT02146365|464246589|FG003|Overall Study|Lost to Follow-up|3|||
128988379|NCT02146365|464246590|FG004|Overall Study|Lost to Follow-up|1|||
128988380|NCT02146365|464246591|FG005|Overall Study|Lost to Follow-up|1|||
128988381|NCT02146365|464246592|FG006|Overall Study|Lost to Follow-up|0|||
128988382|NCT02146365|464246593|FG007|Overall Study|Lost to Follow-up|1|||
128988383|NCT02146365|464246586|FG000|Overall Study|Withdrawal by Subject|1|||
128988384|NCT02146365|464246587|FG001|Overall Study|Withdrawal by Subject|2|||
128988385|NCT02146365|464246588|FG002|Overall Study|Withdrawal by Subject|1|||
128988386|NCT02146365|464246589|FG003|Overall Study|Withdrawal by Subject|5|||
128988387|NCT02146365|464246590|FG004|Overall Study|Withdrawal by Subject|1|||
128988388|NCT02146365|464246591|FG005|Overall Study|Withdrawal by Subject|0|||
128988389|NCT02146365|464246592|FG006|Overall Study|Withdrawal by Subject|0|||
128988390|NCT02146365|464246593|FG007|Overall Study|Withdrawal by Subject|0|||
128988391|NCT02146365|464246586|FG000|Overall Study|Unable to Comply with Protocol|0|||
128988392|NCT02146365|464246587|FG001|Overall Study|Unable to Comply with Protocol|1|||
128988393|NCT02146365|464246588|FG002|Overall Study|Unable to Comply with Protocol|1|||
128988394|NCT02146365|464246589|FG003|Overall Study|Unable to Comply with Protocol|0|||
128988395|NCT02146365|464246590|FG004|Overall Study|Unable to Comply with Protocol|0|||
128988396|NCT02146365|464246591|FG005|Overall Study|Unable to Comply with Protocol|0|||
128988397|NCT02146365|464246592|FG006|Overall Study|Unable to Comply with Protocol|0|||
128988398|NCT02146365|464246593|FG007|Overall Study|Unable to Comply with Protocol|0|||
128988399|NCT02146365|464246586|FG000|Overall Study|Other|1|||
128988400|NCT02146365|464246587|FG001|Overall Study|Other|0|||
128988401|NCT02146365|464246588|FG002|Overall Study|Other|2|||
128988402|NCT02146365|464246589|FG003|Overall Study|Other|1|||
128988403|NCT02146365|464246590|FG004|Overall Study|Other|0|||
128988404|NCT02146365|464246591|FG005|Overall Study|Other|0|||
128988405|NCT02146365|464246592|FG006|Overall Study|Other|0|||
128988406|NCT02146365|464246593|FG007|Overall Study|Other|0|||
128988407|NCT01843660|464246594|FG000|Overall Study|Other|30|||
128988408|NCT01977482|464246595|FG000|Overall Study|Adverse Event|0|||
128988409|NCT01977482|464246596|FG001|Overall Study|Adverse Event|1|||
128988410|NCT01977482|464246597|FG002|Overall Study|Adverse Event|1|||
128988411|NCT01977482|464246598|FG003|Overall Study|Adverse Event|0|||
128988412|NCT01977482|464246599|FG004|Overall Study|Adverse Event|2|||
128988413|NCT01977482|464246600|FG005|Overall Study|Adverse Event|0|||
128988414|NCT01977482|464246595|FG000|Overall Study|Lost to Follow-up|1|||
128988415|NCT01977482|464246596|FG001|Overall Study|Lost to Follow-up|0|||
128988416|NCT01977482|464246597|FG002|Overall Study|Lost to Follow-up|0|||
128988417|NCT01977482|464246598|FG003|Overall Study|Lost to Follow-up|0|||
128988418|NCT01977482|464246599|FG004|Overall Study|Lost to Follow-up|0|||
128988419|NCT01977482|464246600|FG005|Overall Study|Lost to Follow-up|0|||
128988420|NCT01977482|464246595|FG000|Overall Study|Physician Decision|0|||
128988421|NCT01977482|464246596|FG001|Overall Study|Physician Decision|1|||
128988422|NCT01977482|464246597|FG002|Overall Study|Physician Decision|0|||
128988423|NCT01977482|464246598|FG003|Overall Study|Physician Decision|0|||
128988424|NCT01977482|464246599|FG004|Overall Study|Physician Decision|0|||
128988425|NCT01977482|464246600|FG005|Overall Study|Physician Decision|0|||
128988426|NCT01977482|464246595|FG000|Overall Study|Protocol Violation|0|||
128988427|NCT01977482|464246596|FG001|Overall Study|Protocol Violation|0|||
128988428|NCT01977482|464246597|FG002|Overall Study|Protocol Violation|1|||
128988429|NCT01977482|464246598|FG003|Overall Study|Protocol Violation|0|||
128988430|NCT01977482|464246599|FG004|Overall Study|Protocol Violation|0|||
128988431|NCT01977482|464246600|FG005|Overall Study|Protocol Violation|0|||
128988432|NCT01977482|464246595|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
128988433|NCT01977482|464246596|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
128988434|NCT01977482|464246597|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
128988435|NCT01977482|464246598|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
128988436|NCT01977482|464246599|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
128988437|NCT01977482|464246600|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
128988438|NCT01977482|464246595|FG000|Overall Study|Withdrawal by Subject|2|||
128988439|NCT01977482|464246596|FG001|Overall Study|Withdrawal by Subject|4|||
128988440|NCT01977482|464246597|FG002|Overall Study|Withdrawal by Subject|1|||
128988441|NCT01977482|464246598|FG003|Overall Study|Withdrawal by Subject|3|||
128988442|NCT01977482|464246599|FG004|Overall Study|Withdrawal by Subject|1|||
128988443|NCT01977482|464246600|FG005|Overall Study|Withdrawal by Subject|5|||
128988444|NCT00209560|464246601|FG000|Overall Study|Lack of Efficacy|1|||
128988445|NCT00209560|464246602|FG001|Overall Study|Lack of Efficacy|0|||
128988446|NCT01319994|464247961|FG000|Overall Study|Protocol Violation|7|||
128988447|NCT01319994|464247962|FG001|Overall Study|Protocol Violation|6|||
128988448|NCT01340794|464247963|FG000|Overall Study|Withdrawal by Subject|0|||
128988449|NCT01340794|464247964|FG001|Overall Study|Withdrawal by Subject|1|||
128988450|NCT01118949|464247967|FG000|Overall Study|Adverse Event|5|||
128988451|NCT01118949|464247967|FG000|Overall Study|Withdrawal by Subject|4|||
128988452|NCT00685763|464247972|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
128988453|NCT00685763|464247972|FG000|Overall Study|Protocol Violation|1|||
128988454|NCT00698009|464247974|FG000|Overall Study|Withdrawal by Subject|1|||
128988455|NCT02856282|464247975|FG000|Overall Study|Withdrawal by Subject|1|||
128988456|NCT02074982|464247976|FG000|Overall Study|Adverse Event|15|||
128988457|NCT02074982|464247977|FG001|Overall Study|Adverse Event|7|||
128988458|NCT02074982|464247976|FG000|Overall Study|Lack of Efficacy|6|||
128988459|NCT02074982|464247977|FG001|Overall Study|Lack of Efficacy|1|||
128988460|NCT02074982|464247976|FG000|Overall Study|Lost to Follow-up|9|||
128988461|NCT02074982|464247977|FG001|Overall Study|Lost to Follow-up|10|||
128988462|NCT02074982|464247976|FG000|Overall Study|Non-compliance with study treatment|0|||
128988463|NCT02074982|464247977|FG001|Overall Study|Non-compliance with study treatment|2|||
128988464|NCT02074982|464247976|FG000|Overall Study|Physician Decision|1|||
128988465|NCT02074982|464247977|FG001|Overall Study|Physician Decision|1|||
128988466|NCT02074982|464247976|FG000|Overall Study|Pregnancy|1|||
128988467|NCT02074982|464247977|FG001|Overall Study|Pregnancy|2|||
128988468|NCT02074982|464247976|FG000|Overall Study|Protocol deviation|4|||
128988469|NCT02074982|464247977|FG001|Overall Study|Protocol deviation|3|||
128988470|NCT02074982|464247976|FG000|Overall Study|Technical problems|0|||
128988471|NCT02074982|464247977|FG001|Overall Study|Technical problems|2|||
128988472|NCT02074982|464247976|FG000|Overall Study|Subject/guardian decision|15|||
128988473|NCT02074982|464247977|FG001|Overall Study|Subject/guardian decision|24|||
128988474|NCT02074982|464247976|FG000|Overall Study|Death|0|||
128988475|NCT02074982|464247977|FG001|Overall Study|Death|2|||
128988476|NCT02094573|464247980|FG000|Overall Study|Adverse Event|4|||
128988477|NCT02094573|464247981|FG001|Overall Study|Adverse Event|14|||
128988478|NCT02094573|464247980|FG000|Overall Study|Clinical Progressive Disease|9|||
128988479|NCT02094573|464247981|FG001|Overall Study|Clinical Progressive Disease|13|||
128988480|NCT02094573|464247980|FG000|Overall Study|Death|11|||
128988481|NCT02094573|464247981|FG001|Overall Study|Death|3|||
128988482|NCT02094573|464247980|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
128988483|NCT02094573|464247981|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
128988484|NCT02094573|464247980|FG000|Overall Study|Non-compliance with Study Drug|1|||
128988485|NCT02094573|464247981|FG001|Overall Study|Non-compliance with Study Drug|1|||
128988486|NCT02094573|464247980|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
128988487|NCT02094573|464247981|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
128988488|NCT02094573|464247980|FG000|Overall Study|Physician Decision|4|||
128988489|NCT02094573|464247981|FG001|Overall Study|Physician Decision|4|||
128988490|NCT02094573|464247980|FG000|Overall Study|Site Terminated by Sponsor|10|||
128988491|NCT02094573|464247981|FG001|Overall Study|Site Terminated by Sponsor|17|||
128988492|NCT02094573|464247980|FG000|Overall Study|Withdrawal by Subject|6|||
128988493|NCT02094573|464247981|FG001|Overall Study|Withdrawal by Subject|8|||
128988494|NCT02094573|464247980|FG000|Overall Study|Randomized but not Treated|3|||
128988495|NCT02094573|464247981|FG001|Overall Study|Randomized but not Treated|0|||
128988496|NCT03606109|464247985|FG000|Overall Study|Lost to Follow-up|2|||
129214375|NCT02113982|465089320|FG006|Stage 1: Dose Escalation|Transplant|0|||
129214376|NCT02113982|465089321|FG007|Stage 1: Dose Escalation|Transplant|0|||
129214377|NCT02113982|465089322|FG008|Stage 1: Dose Escalation|Transplant|0|||
129214378|NCT02113982|465089323|FG009|Stage 1: Dose Escalation|Transplant|0|||
129214379|NCT02113982|465089324|FG010|Stage 1: Dose Escalation|Transplant|0|||
129214380|NCT02113982|465089325|FG011|Stage 1: Dose Escalation|Transplant|0|||
129214381|NCT02113982|465089326|FG012|Stage 1: Dose Escalation|Transplant|0|||
129214382|NCT02113982|465089327|FG013|Stage 1: Dose Escalation|Transplant|0|||
129214383|NCT02113982|465089314|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
129214384|NCT02113982|465089315|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
129214385|NCT02113982|465089316|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
129214386|NCT02113982|465089317|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
129214387|NCT02113982|465089318|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
129214388|NCT02113982|465089319|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
129214389|NCT02113982|465089320|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
129214390|NCT02113982|465089321|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
129214391|NCT02113982|465089322|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
129214392|NCT02113982|465089323|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
129214393|NCT02113982|465089324|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
128988497|NCT03606109|464247986|FG001|Overall Study|Lost to Follow-up|1|||
128988498|NCT03669640|464247987|FG000|Overall Study|Study Terminated by Sponsor|0|||
129214394|NCT02113982|465089325|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
129214395|NCT02113982|465089326|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
128988499|NCT03669640|464247988|FG001|Overall Study|Study Terminated by Sponsor|0|||
128988500|NCT03669640|464247989|FG002|Overall Study|Study Terminated by Sponsor|0|||
128988501|NCT03669640|464247990|FG003|Overall Study|Study Terminated by Sponsor|0|||
128988502|NCT03669640|464247991|FG004|Overall Study|Study Terminated by Sponsor|1|||
128988503|NCT03669640|464247992|FG005|Overall Study|Study Terminated by Sponsor|0|||
128988504|NCT03669640|464247987|FG000|Overall Study|Lost to Follow-up|0|||
128988505|NCT03669640|464247988|FG001|Overall Study|Lost to Follow-up|0|||
128988506|NCT03669640|464247989|FG002|Overall Study|Lost to Follow-up|2|||
128988507|NCT03669640|464247990|FG003|Overall Study|Lost to Follow-up|0|||
128988508|NCT03669640|464247991|FG004|Overall Study|Lost to Follow-up|0|||
128988509|NCT03669640|464247992|FG005|Overall Study|Lost to Follow-up|0|||
128988510|NCT03669640|464247987|FG000|Overall Study|Death|0|||
128988511|NCT03669640|464247988|FG001|Overall Study|Death|0|||
128988512|NCT03669640|464247989|FG002|Overall Study|Death|1|||
128988513|NCT03669640|464247990|FG003|Overall Study|Death|0|||
128988514|NCT03669640|464247991|FG004|Overall Study|Death|0|||
128988515|NCT03669640|464247992|FG005|Overall Study|Death|0|||
128988516|NCT03669640|464247987|FG000|Overall Study|Withdrawal by Subject|1|||
128988517|NCT03669640|464247988|FG001|Overall Study|Withdrawal by Subject|2|||
128988518|NCT03669640|464247989|FG002|Overall Study|Withdrawal by Subject|1|||
128988519|NCT03669640|464247990|FG003|Overall Study|Withdrawal by Subject|0|||
128988520|NCT03669640|464247991|FG004|Overall Study|Withdrawal by Subject|1|||
128988521|NCT03669640|464247992|FG005|Overall Study|Withdrawal by Subject|3|||
128988522|NCT03669640|464247987|FG000|Overall Study|Protocol Violation|1|||
128988523|NCT03669640|464247988|FG001|Overall Study|Protocol Violation|0|||
128988524|NCT03669640|464247989|FG002|Overall Study|Protocol Violation|0|||
128988525|NCT03669640|464247990|FG003|Overall Study|Protocol Violation|0|||
128988526|NCT03669640|464247991|FG004|Overall Study|Protocol Violation|0|||
128988527|NCT03669640|464247992|FG005|Overall Study|Protocol Violation|0|||
128988528|NCT03669640|464247987|FG000|Overall Study|Physician Decision|0|||
128988529|NCT03669640|464247988|FG001|Overall Study|Physician Decision|2|||
128988530|NCT03669640|464247989|FG002|Overall Study|Physician Decision|0|||
128988531|NCT03669640|464247990|FG003|Overall Study|Physician Decision|0|||
128988532|NCT03669640|464247991|FG004|Overall Study|Physician Decision|0|||
128988533|NCT03669640|464247992|FG005|Overall Study|Physician Decision|0|||
128988534|NCT03669640|464247987|FG000|Overall Study|Disease Relapse|1|||
128988535|NCT03669640|464247988|FG001|Overall Study|Disease Relapse|0|||
128988536|NCT03669640|464247989|FG002|Overall Study|Disease Relapse|0|||
128988537|NCT03669640|464247990|FG003|Overall Study|Disease Relapse|0|||
128988538|NCT03669640|464247991|FG004|Overall Study|Disease Relapse|0|||
128988539|NCT03669640|464247992|FG005|Overall Study|Disease Relapse|0|||
128988540|NCT03669640|464247987|FG000|Overall Study|Adverse Event|2|||
128988541|NCT03669640|464247988|FG001|Overall Study|Adverse Event|1|||
128988542|NCT03669640|464247989|FG002|Overall Study|Adverse Event|0|||
128988543|NCT03669640|464247990|FG003|Overall Study|Adverse Event|0|||
128988544|NCT03669640|464247991|FG004|Overall Study|Adverse Event|1|||
128988545|NCT03669640|464247992|FG005|Overall Study|Adverse Event|0|||
128988546|NCT00471237|464247994|FG000|Overall Study|Adverse Event|6|||
128988547|NCT00471237|464247995|FG001|Overall Study|Adverse Event|5|||
128988548|NCT00471237|464247996|FG002|Overall Study|Adverse Event|4|||
128988549|NCT00471237|464247997|FG003|Overall Study|Adverse Event|8|||
128988550|NCT00471237|464247998|FG004|Overall Study|Adverse Event|7|||
128988551|NCT00471237|464247999|FG005|Overall Study|Adverse Event|5|||
128988552|NCT00471237|464248000|FG006|Overall Study|Adverse Event|0|||
128988553|NCT00471237|464247994|FG000|Overall Study|Lost to Follow-up|1|||
128988554|NCT00471237|464247995|FG001|Overall Study|Lost to Follow-up|1|||
128988555|NCT00471237|464247996|FG002|Overall Study|Lost to Follow-up|0|||
128988556|NCT00471237|464247997|FG003|Overall Study|Lost to Follow-up|2|||
128988557|NCT00471237|464247998|FG004|Overall Study|Lost to Follow-up|3|||
128988558|NCT00471237|464247999|FG005|Overall Study|Lost to Follow-up|0|||
128988559|NCT00471237|464248000|FG006|Overall Study|Lost to Follow-up|0|||
128988560|NCT00471237|464247994|FG000|Overall Study|Protocol Violation|3|||
128988561|NCT00471237|464247995|FG001|Overall Study|Protocol Violation|6|||
128988562|NCT00471237|464247996|FG002|Overall Study|Protocol Violation|3|||
128988563|NCT00471237|464247997|FG003|Overall Study|Protocol Violation|2|||
128988564|NCT00471237|464247998|FG004|Overall Study|Protocol Violation|2|||
128988565|NCT00471237|464247999|FG005|Overall Study|Protocol Violation|4|||
128988566|NCT00471237|464248000|FG006|Overall Study|Protocol Violation|1|||
128988567|NCT00471237|464247994|FG000|Overall Study|Withdrawal by Subject|8|||
128988568|NCT00471237|464247995|FG001|Overall Study|Withdrawal by Subject|6|||
128988569|NCT00471237|464247996|FG002|Overall Study|Withdrawal by Subject|5|||
128988570|NCT00471237|464247997|FG003|Overall Study|Withdrawal by Subject|8|||
128988571|NCT00471237|464247998|FG004|Overall Study|Withdrawal by Subject|7|||
128988572|NCT00471237|464247999|FG005|Overall Study|Withdrawal by Subject|4|||
128988573|NCT00471237|464248000|FG006|Overall Study|Withdrawal by Subject|2|||
128988574|NCT00471237|464247994|FG000|Overall Study|Sponsor terminated study|20|||
128988575|NCT00471237|464247995|FG001|Overall Study|Sponsor terminated study|23|||
128988576|NCT00471237|464247996|FG002|Overall Study|Sponsor terminated study|19|||
128988577|NCT00471237|464247997|FG003|Overall Study|Sponsor terminated study|22|||
128988578|NCT00471237|464247998|FG004|Overall Study|Sponsor terminated study|18|||
128988579|NCT00471237|464247999|FG005|Overall Study|Sponsor terminated study|24|||
128988580|NCT00471237|464248000|FG006|Overall Study|Sponsor terminated study|0|||
128988581|NCT00471237|464247994|FG000|Overall Study|Non-compliance|0|||
128988582|NCT00471237|464247995|FG001|Overall Study|Non-compliance|1|||
128988583|NCT00471237|464247996|FG002|Overall Study|Non-compliance|0|||
128988584|NCT00471237|464247997|FG003|Overall Study|Non-compliance|1|||
128988585|NCT00471237|464247998|FG004|Overall Study|Non-compliance|0|||
128988586|NCT00471237|464247999|FG005|Overall Study|Non-compliance|0|||
128988587|NCT00471237|464248000|FG006|Overall Study|Non-compliance|0|||
128988588|NCT00471237|464247994|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
128988589|NCT00471237|464247995|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
128988590|NCT00471237|464247996|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
128988591|NCT00471237|464247997|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
128988592|NCT00471237|464247998|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
128988593|NCT00471237|464247999|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
128988594|NCT00471237|464248000|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
128988595|NCT00471237|464247994|FG000|Overall Study|Early stopping due to non-efficacy|1|||
128988596|NCT00471237|464247995|FG001|Overall Study|Early stopping due to non-efficacy|0|||
128988597|NCT00471237|464247996|FG002|Overall Study|Early stopping due to non-efficacy|0|||
128988598|NCT00471237|464247997|FG003|Overall Study|Early stopping due to non-efficacy|0|||
128988599|NCT00471237|464247998|FG004|Overall Study|Early stopping due to non-efficacy|1|||
128988600|NCT00471237|464247999|FG005|Overall Study|Early stopping due to non-efficacy|0|||
128988601|NCT00471237|464248000|FG006|Overall Study|Early stopping due to non-efficacy|0|||
128988602|NCT00471237|464247994|FG000|Overall Study|Participant planned to travel to abraod|1|||
128988603|NCT00471237|464247995|FG001|Overall Study|Participant planned to travel to abraod|0|||
128988604|NCT00471237|464247996|FG002|Overall Study|Participant planned to travel to abraod|0|||
128988605|NCT00471237|464247997|FG003|Overall Study|Participant planned to travel to abraod|0|||
128988606|NCT00471237|464247998|FG004|Overall Study|Participant planned to travel to abraod|0|||
128988607|NCT00471237|464247999|FG005|Overall Study|Participant planned to travel to abraod|1|||
128988608|NCT00471237|464248000|FG006|Overall Study|Participant planned to travel to abraod|0|||
128988609|NCT00471237|464247994|FG000|Overall Study|High parathyroid hormone|0|||
128988610|NCT00471237|464247995|FG001|Overall Study|High parathyroid hormone|0|||
128988611|NCT00471237|464247996|FG002|Overall Study|High parathyroid hormone|1|||
128988612|NCT00471237|464247997|FG003|Overall Study|High parathyroid hormone|0|||
128988613|NCT00471237|464247998|FG004|Overall Study|High parathyroid hormone|0|||
128988614|NCT00471237|464247999|FG005|Overall Study|High parathyroid hormone|0|||
128988615|NCT00471237|464248000|FG006|Overall Study|High parathyroid hormone|0|||
128988616|NCT00471237|464247994|FG000|Overall Study|Participant lost medication|0|||
128988617|NCT00471237|464247995|FG001|Overall Study|Participant lost medication|0|||
128988618|NCT00471237|464247996|FG002|Overall Study|Participant lost medication|0|||
128988619|NCT00471237|464247997|FG003|Overall Study|Participant lost medication|0|||
128988620|NCT00471237|464247998|FG004|Overall Study|Participant lost medication|1|||
128988621|NCT00471237|464247999|FG005|Overall Study|Participant lost medication|0|||
128988622|NCT00471237|464248000|FG006|Overall Study|Participant lost medication|0|||
128988623|NCT00471237|464247994|FG000|Overall Study|Administration of prohibited medicine|0|||
128988624|NCT00471237|464247995|FG001|Overall Study|Administration of prohibited medicine|0|||
128988625|NCT00471237|464247996|FG002|Overall Study|Administration of prohibited medicine|0|||
128988626|NCT00471237|464247997|FG003|Overall Study|Administration of prohibited medicine|0|||
128988627|NCT00471237|464247998|FG004|Overall Study|Administration of prohibited medicine|1|||
128988628|NCT00471237|464247999|FG005|Overall Study|Administration of prohibited medicine|0|||
128988629|NCT00471237|464248000|FG006|Overall Study|Administration of prohibited medicine|0|||
128988630|NCT00471237|464247994|FG000|Overall Study|Participant shifted residence|0|||
128988631|NCT00471237|464247995|FG001|Overall Study|Participant shifted residence|0|||
128988632|NCT00471237|464247996|FG002|Overall Study|Participant shifted residence|0|||
128988633|NCT00471237|464247997|FG003|Overall Study|Participant shifted residence|0|||
128988634|NCT00471237|464247998|FG004|Overall Study|Participant shifted residence|1|||
128988635|NCT00471237|464247999|FG005|Overall Study|Participant shifted residence|0|||
128988636|NCT00471237|464248000|FG006|Overall Study|Participant shifted residence|0|||
128988637|NCT00471237|464247994|FG000|Overall Study|Participant's decision|0|||
129214396|NCT02113982|465089327|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
128988638|NCT00471237|464247995|FG001|Overall Study|Participant's decision|0|||
128988639|NCT00471237|464247996|FG002|Overall Study|Participant's decision|0|||
128988640|NCT00471237|464247997|FG003|Overall Study|Participant's decision|0|||
128988641|NCT00471237|464247998|FG004|Overall Study|Participant's decision|0|||
128988642|NCT00471237|464247999|FG005|Overall Study|Participant's decision|1|||
128988643|NCT00471237|464248000|FG006|Overall Study|Participant's decision|0|||
128988644|NCT01301625|464248014|FG000|Overall Study|Death|5|||
128988645|NCT01301625|464248014|FG000|Overall Study|Not Due|21|||
128988646|NCT01301625|464248014|FG000|Overall Study|Expected|8|||
128988647|NCT01301625|464248014|FG000|Overall Study|Lost to Follow-up|1|||
128988648|NCT02684370|464248016|FG000|Part A|Adverse Event|2|||
128988649|NCT02684370|464248017|FG001|Part A|Adverse Event|0|||
128988650|NCT02684370|464248018|FG002|Part A|Adverse Event|1|||
128988651|NCT02684370|464248019|FG003|Part A|Adverse Event|0|||
128988652|NCT02684370|464248020|FG004|Part A|Adverse Event|0|||
128988653|NCT02684370|464248021|FG005|Part A|Adverse Event|0|||
128988654|NCT02684370|464248016|FG000|Part A|Lost to Follow-up|1|||
128988655|NCT02684370|464248017|FG001|Part A|Lost to Follow-up|1|||
128988656|NCT02684370|464248018|FG002|Part A|Lost to Follow-up|0|||
128988657|NCT02684370|464248019|FG003|Part A|Lost to Follow-up|0|||
128988658|NCT02684370|464248020|FG004|Part A|Lost to Follow-up|0|||
128988659|NCT02684370|464248021|FG005|Part A|Lost to Follow-up|0|||
128988660|NCT02684370|464248016|FG000|Part A|Subject Withdrawal|1|||
128988661|NCT02684370|464248017|FG001|Part A|Subject Withdrawal|0|||
128988662|NCT02684370|464248018|FG002|Part A|Subject Withdrawal|3|||
128988663|NCT02684370|464248019|FG003|Part A|Subject Withdrawal|0|||
128988664|NCT02684370|464248020|FG004|Part A|Subject Withdrawal|0|||
128988665|NCT02684370|464248021|FG005|Part A|Subject Withdrawal|0|||
128988666|NCT02684370|464248016|FG000|Part A|Other|0|||
128988667|NCT02684370|464248017|FG001|Part A|Other|0|||
128988668|NCT02684370|464248018|FG002|Part A|Other|1|||
128988669|NCT02684370|464248019|FG003|Part A|Other|0|||
128988670|NCT02684370|464248020|FG004|Part A|Other|0|||
128988671|NCT02684370|464248021|FG005|Part A|Other|0|||
128988672|NCT02684370|464248016|FG000|Part B|Adverse Event|0|||
128988673|NCT02684370|464248017|FG001|Part B|Adverse Event|0|||
128988674|NCT02684370|464248018|FG002|Part B|Adverse Event|0|||
128988675|NCT02684370|464248019|FG003|Part B|Adverse Event|0|||
128988676|NCT02684370|464248020|FG004|Part B|Adverse Event|2|||
128988677|NCT02684370|464248021|FG005|Part B|Adverse Event|1|||
128988678|NCT02684370|464248016|FG000|Part B|Lost to Follow-up|0|||
128988679|NCT02684370|464248017|FG001|Part B|Lost to Follow-up|0|||
128988680|NCT02684370|464248018|FG002|Part B|Lost to Follow-up|0|||
128988681|NCT02684370|464248019|FG003|Part B|Lost to Follow-up|1|||
128988682|NCT02684370|464248020|FG004|Part B|Lost to Follow-up|2|||
128988683|NCT02684370|464248021|FG005|Part B|Lost to Follow-up|5|||
128988684|NCT02684370|464248016|FG000|Part B|Subject Withdrawal|0|||
128988685|NCT02684370|464248017|FG001|Part B|Subject Withdrawal|0|||
128988686|NCT02684370|464248018|FG002|Part B|Subject Withdrawal|0|||
128988687|NCT02684370|464248019|FG003|Part B|Subject Withdrawal|1|||
128988688|NCT02684370|464248020|FG004|Part B|Subject Withdrawal|1|||
128988689|NCT02684370|464248021|FG005|Part B|Subject Withdrawal|2|||
128988690|NCT04221373|464248022|FG000|Overall Study|Physician Decision|4|||
128988691|NCT04221373|464248023|FG001|Overall Study|Physician Decision|0|||
128988692|NCT00627094|464248029|FG000|Overall Study|Adverse Event|8|||
128988693|NCT00627094|464248030|FG001|Overall Study|Adverse Event|7|||
128988694|NCT00627094|464248029|FG000|Overall Study|Lost to Follow-up|1|||
128988695|NCT00627094|464248030|FG001|Overall Study|Lost to Follow-up|0|||
128988696|NCT00627094|464248029|FG000|Overall Study|Withdrawal by Subject|1|||
128988697|NCT00627094|464248030|FG001|Overall Study|Withdrawal by Subject|1|||
128988698|NCT00627094|464248029|FG000|Overall Study|ulcer healed|1|||
128988699|NCT00627094|464248030|FG001|Overall Study|ulcer healed|7|||
128988700|NCT00627094|464248029|FG000|Overall Study|Other reason|1|||
128988701|NCT00627094|464248030|FG001|Overall Study|Other reason|0|||
128988702|NCT00138658|464248031|FG000|Overall Study|Adverse Event|23|||
128988703|NCT00138658|464248031|FG000|Overall Study|Death|1|||
128988704|NCT00138658|464248031|FG000|Overall Study|Disease Progression|21|||
128988705|NCT00138658|464248031|FG000|Overall Study|Physician Decision|11|||
128988706|NCT00138658|464248031|FG000|Overall Study|Withdrawal by Subject|5|||
128988707|NCT04637815|464248036|FG000|Overall Study|Death|1|||
128988708|NCT04637815|464248037|FG001|Overall Study|Death|0|||
128988709|NCT04637815|464248036|FG000|Overall Study|Lost to Follow-up|5|||
128988710|NCT04637815|464248037|FG001|Overall Study|Lost to Follow-up|2|||
128988711|NCT00320801|464248038|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
128988712|NCT00320801|464248039|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
128988713|NCT00320801|464248040|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
128988714|NCT00320801|464248041|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
128988715|NCT00320801|464248038|FG000|Open-label Run-in Period|Adverse Event|33|||
128988716|NCT00320801|464248039|FG001|Open-label Run-in Period|Adverse Event|0|||
128988717|NCT00320801|464248040|FG002|Open-label Run-in Period|Adverse Event|0|||
128988718|NCT00320801|464248041|FG003|Open-label Run-in Period|Adverse Event|0|||
128988719|NCT00320801|464248038|FG000|Open-label Run-in Period|Administrative|10|||
128988720|NCT00320801|464248039|FG001|Open-label Run-in Period|Administrative|0|||
128988721|NCT00320801|464248040|FG002|Open-label Run-in Period|Administrative|0|||
128988722|NCT00320801|464248041|FG003|Open-label Run-in Period|Administrative|0|||
128988723|NCT00320801|464248038|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
128988724|NCT00320801|464248039|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
128988725|NCT00320801|464248040|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
128988726|NCT00320801|464248041|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
128988727|NCT00320801|464248038|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
128988728|NCT00320801|464248039|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
128988729|NCT00320801|464248040|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
128988730|NCT00320801|464248041|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
128988731|NCT00320801|464248038|FG000|Open-label Run-in Period|Did not qualify|1|||
128988732|NCT00320801|464248039|FG001|Open-label Run-in Period|Did not qualify|0|||
128988733|NCT00320801|464248040|FG002|Open-label Run-in Period|Did not qualify|0|||
128988734|NCT00320801|464248041|FG003|Open-label Run-in Period|Did not qualify|0|||
128988735|NCT00320801|464248038|FG000|Double-blind Phase|Withdrawal by Subject|0|||
128988736|NCT00320801|464248039|FG001|Double-blind Phase|Withdrawal by Subject|0|||
128988737|NCT00320801|464248040|FG002|Double-blind Phase|Withdrawal by Subject|1|||
128988738|NCT00320801|464248041|FG003|Double-blind Phase|Withdrawal by Subject|0|||
128988739|NCT00320801|464248038|FG000|Double-blind Phase|Adverse Event|0|||
128988740|NCT00320801|464248039|FG001|Double-blind Phase|Adverse Event|2|||
128988741|NCT00320801|464248040|FG002|Double-blind Phase|Adverse Event|8|||
128988742|NCT00320801|464248041|FG003|Double-blind Phase|Adverse Event|0|||
128988743|NCT00320801|464248038|FG000|Double-blind Phase|Administrative|0|||
128988744|NCT00320801|464248039|FG001|Double-blind Phase|Administrative|0|||
128988745|NCT00320801|464248040|FG002|Double-blind Phase|Administrative|4|||
128988746|NCT00320801|464248041|FG003|Double-blind Phase|Administrative|0|||
128988747|NCT00320801|464248038|FG000|Double-blind Phase|Lack of Efficacy|0|||
128988748|NCT00320801|464248039|FG001|Double-blind Phase|Lack of Efficacy|9|||
128988749|NCT00320801|464248040|FG002|Double-blind Phase|Lack of Efficacy|1|||
128988750|NCT00320801|464248041|FG003|Double-blind Phase|Lack of Efficacy|0|||
128988751|NCT00320801|464248038|FG000|Extension Phase|Withdrawal by Subject|0|||
128988752|NCT00320801|464248039|FG001|Extension Phase|Withdrawal by Subject|0|||
128988753|NCT00320801|464248040|FG002|Extension Phase|Withdrawal by Subject|0|||
128988754|NCT00320801|464248041|FG003|Extension Phase|Withdrawal by Subject|6|||
128988755|NCT00320801|464248038|FG000|Extension Phase|Adverse Event|0|||
128988756|NCT00320801|464248039|FG001|Extension Phase|Adverse Event|0|||
128988757|NCT00320801|464248040|FG002|Extension Phase|Adverse Event|0|||
128988758|NCT00320801|464248041|FG003|Extension Phase|Adverse Event|8|||
128988759|NCT00320801|464248038|FG000|Extension Phase|Administrative|0|||
128988760|NCT00320801|464248039|FG001|Extension Phase|Administrative|0|||
128988761|NCT00320801|464248040|FG002|Extension Phase|Administrative|0|||
128988762|NCT00320801|464248041|FG003|Extension Phase|Administrative|29|||
128988763|NCT00320801|464248038|FG000|Extension Phase|Lack of Efficacy|0|||
128988764|NCT00320801|464248039|FG001|Extension Phase|Lack of Efficacy|0|||
128988765|NCT00320801|464248040|FG002|Extension Phase|Lack of Efficacy|0|||
128988766|NCT00320801|464248041|FG003|Extension Phase|Lack of Efficacy|2|||
128988767|NCT00320801|464248038|FG000|Extension Phase|Lost to Follow-up|0|||
128988768|NCT00320801|464248039|FG001|Extension Phase|Lost to Follow-up|0|||
128988769|NCT00320801|464248040|FG002|Extension Phase|Lost to Follow-up|0|||
128988770|NCT00320801|464248041|FG003|Extension Phase|Lost to Follow-up|3|||
128988771|NCT00337727|464248042|FG000|Overall Study|Adverse Event|5|||
128988772|NCT00337727|464248043|FG001|Overall Study|Adverse Event|3|||
128988773|NCT00337727|464248042|FG000|Overall Study|Lost to Follow-up|5|||
128988774|NCT00337727|464248043|FG001|Overall Study|Lost to Follow-up|4|||
128763080|NCT02207725|463422730|FG001|Overall Study|Did Not Receive Treatment|1|||
128988775|NCT00337727|464248042|FG000|Overall Study|Physician Decision|1|||
128988776|NCT00337727|464248043|FG001|Overall Study|Physician Decision|0|||
128988777|NCT00337727|464248042|FG000|Overall Study|Protocol Violation|4|||
128988778|NCT00337727|464248043|FG001|Overall Study|Protocol Violation|0|||
128988779|NCT00337727|464248042|FG000|Overall Study|Withdrawal by Subject|3|||
128988780|NCT00337727|464248043|FG001|Overall Study|Withdrawal by Subject|5|||
128988781|NCT00577031|464248044|FG000|Overall Study|Adverse Event|52|||
128988782|NCT00577031|464248044|FG000|Overall Study|Progression of disease|93|||
128988783|NCT00577031|464248044|FG000|Overall Study|Protocol Violation|5|||
128988784|NCT00577031|464248044|FG000|Overall Study|Participant withdrew consent|13|||
128988785|NCT00577031|464248044|FG000|Overall Study|Participant non-compliance|5|||
128988786|NCT00577031|464248044|FG000|Overall Study|Need for surgery|17|||
128988787|NCT00577031|464248044|FG000|Overall Study|Medical decision|14|||
128988788|NCT00577031|464248044|FG000|Overall Study|Death|6|||
128988789|NCT06067191|464248045|FG000|Overall Study|Withdrawal by Subject|0|||
128988790|NCT06067191|464248046|FG001|Overall Study|Withdrawal by Subject|1|||
128988791|NCT04764669|464248048|FG000|Overall Study|Adverse Event|1|||
128988792|NCT04764669|464248049|FG001|Overall Study|Adverse Event|0|||
128988793|NCT04764669|464248050|FG002|Overall Study|Adverse Event|1|||
128988794|NCT04764669|464248051|FG003|Overall Study|Adverse Event|0|||
128988795|NCT04764669|464248048|FG000|Overall Study|Subject Choice|0|||
128988796|NCT04764669|464248049|FG001|Overall Study|Subject Choice|0|||
128988797|NCT04764669|464248050|FG002|Overall Study|Subject Choice|1|||
128988798|NCT04764669|464248051|FG003|Overall Study|Subject Choice|0|||
128988799|NCT04764669|464248048|FG000|Overall Study|Withdrawal by Subject|2|||
128988800|NCT04764669|464248049|FG001|Overall Study|Withdrawal by Subject|0|||
128988801|NCT04764669|464248050|FG002|Overall Study|Withdrawal by Subject|0|||
128988802|NCT04764669|464248051|FG003|Overall Study|Withdrawal by Subject|0|||
128988803|NCT00807040|464248052|FG000|Overall Study|Death|24|||
128988804|NCT00807040|464248053|FG001|Overall Study|Death|29|||
128988805|NCT00807040|464248052|FG000|Overall Study|Withdrawal by Subject|8|||
128988806|NCT00807040|464248053|FG001|Overall Study|Withdrawal by Subject|6|||
128988807|NCT00807040|464248052|FG000|Overall Study|Lost to Follow-up|4|||
128988808|NCT00807040|464248053|FG001|Overall Study|Lost to Follow-up|6|||
128988809|NCT00625846|464248054|FG000|Overall Study|Withdrawal by Subject|2|||
128988810|NCT00625846|464248055|FG001|Overall Study|Withdrawal by Subject|0|||
128988811|NCT00625846|464248056|FG002|Overall Study|Withdrawal by Subject|1|||
128988812|NCT00625846|464248057|FG003|Overall Study|Withdrawal by Subject|2|||
128988813|NCT01067339|464248064|FG000|Overall Study|Withdrawal by Subject|6|||
128988814|NCT01067339|464248065|FG001|Overall Study|Withdrawal by Subject|5|||
128988815|NCT00890409|464248066|FG000|Overall Study|Lost to Follow-up|20|||
128988816|NCT00890409|464248067|FG001|Overall Study|Lost to Follow-up|21|||
128988817|NCT00769132|464248069|FG000|Period 1|Adverse Event|1|||
128988818|NCT00769132|464248070|FG001|Period 1|Adverse Event|0|||
128988819|NCT00769132|464248071|FG002|Period 1|Adverse Event|0|||
128988820|NCT00769132|464248072|FG003|Period 1|Adverse Event|1|||
128988821|NCT00769132|464248069|FG000|Period 2|Withdrawal by Subject|0|||
128988822|NCT00769132|464248070|FG001|Period 2|Withdrawal by Subject|0|||
128988823|NCT00769132|464248071|FG002|Period 2|Withdrawal by Subject|0|||
128988824|NCT00769132|464248072|FG003|Period 2|Withdrawal by Subject|1|||
128988825|NCT00769132|464248069|FG000|Period 3|Withdrawal by Subject|1|||
128988826|NCT00769132|464248070|FG001|Period 3|Withdrawal by Subject|0|||
128988827|NCT00769132|464248071|FG002|Period 3|Withdrawal by Subject|0|||
128988828|NCT00769132|464248072|FG003|Period 3|Withdrawal by Subject|0|||
128988829|NCT00769132|464248069|FG000|Period 4|Withdrawal by Subject|0|||
128988830|NCT00769132|464248070|FG001|Period 4|Withdrawal by Subject|1|||
128988831|NCT00769132|464248071|FG002|Period 4|Withdrawal by Subject|0|||
128988832|NCT00769132|464248072|FG003|Period 4|Withdrawal by Subject|0|||
128988833|NCT00557830|464248076|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
128988834|NCT00557830|464248077|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
128988835|NCT00557830|464248078|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
128988836|NCT00557830|464248076|FG000|Screening Treatment Phase|Adverse Event|2|||
128988837|NCT00557830|464248077|FG001|Screening Treatment Phase|Adverse Event|0|||
128988838|NCT00557830|464248078|FG002|Screening Treatment Phase|Adverse Event|0|||
128988839|NCT00557830|464248076|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
129214397|NCT02113982|465089314|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
129214398|NCT02113982|465089315|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
129214399|NCT02113982|465089316|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
129214400|NCT02113982|465089317|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
129214401|NCT02113982|465089318|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
129214402|NCT02113982|465089319|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
129214403|NCT02113982|465089320|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
129214404|NCT02113982|465089321|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
129214405|NCT02113982|465089322|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
129214406|NCT02113982|465089323|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
129214407|NCT02113982|465089324|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
129214408|NCT02113982|465089325|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
128988840|NCT00557830|464248077|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
128988841|NCT00557830|464248078|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
128988842|NCT00538473|464248079|FG000|Overall Study|Adverse Event|1|||
128988843|NCT00538473|464248080|FG001|Overall Study|Adverse Event|0|||
128988844|NCT01833897|464248081|FG000|Overall Study|Lack of Efficacy|1|||
128988845|NCT00669110|464248082|FG000|Overall Study|Adverse Event|4|||
128988846|NCT00669110|464248083|FG001|Overall Study|Adverse Event|3|||
128988847|NCT00669110|464248082|FG000|Overall Study|Caregiver request|3|||
128988848|NCT00669110|464248083|FG001|Overall Study|Caregiver request|2|||
128988849|NCT00669110|464248082|FG000|Overall Study|Physician Decision|0|||
128988850|NCT00669110|464248083|FG001|Overall Study|Physician Decision|1|||
128988851|NCT00669110|464248082|FG000|Overall Study|Lost to Follow-up|1|||
128988852|NCT00669110|464248083|FG001|Overall Study|Lost to Follow-up|0|||
128988853|NCT00669110|464248082|FG000|Overall Study|Protocol Violation|0|||
128988854|NCT00669110|464248083|FG001|Overall Study|Protocol Violation|5|||
128988855|NCT00669110|464248082|FG000|Overall Study|Withdrawal by Subject|0|||
128988856|NCT00669110|464248083|FG001|Overall Study|Withdrawal by Subject|2|||
128988857|NCT00127192|464248084|FG000|Overall Study|Adverse Event|0|||
128988858|NCT00127192|464248085|FG001|Overall Study|Adverse Event|1|||
128988859|NCT00127192|464248086|FG002|Overall Study|Adverse Event|1|||
128988860|NCT00127192|464248087|FG003|Overall Study|Adverse Event|1|||
128988861|NCT00127192|464248088|FG004|Overall Study|Adverse Event|0|||
128988862|NCT00127192|464248084|FG000|Overall Study|Lack of Efficacy|2|||
128988863|NCT00127192|464248085|FG001|Overall Study|Lack of Efficacy|0|||
128988864|NCT00127192|464248086|FG002|Overall Study|Lack of Efficacy|0|||
128988865|NCT00127192|464248087|FG003|Overall Study|Lack of Efficacy|0|||
128988866|NCT00127192|464248088|FG004|Overall Study|Lack of Efficacy|2|||
128988867|NCT00127192|464248084|FG000|Overall Study|Withdrawal by Subject|0|||
128988868|NCT00127192|464248085|FG001|Overall Study|Withdrawal by Subject|0|||
128988869|NCT00127192|464248086|FG002|Overall Study|Withdrawal by Subject|1|||
128988870|NCT00127192|464248087|FG003|Overall Study|Withdrawal by Subject|0|||
128988871|NCT00127192|464248088|FG004|Overall Study|Withdrawal by Subject|3|||
128988872|NCT00127192|464248084|FG000|Overall Study|Adverse event in pre-treatment period|1|||
128988873|NCT00127192|464248085|FG001|Overall Study|Adverse event in pre-treatment period|0|||
128988874|NCT00127192|464248086|FG002|Overall Study|Adverse event in pre-treatment period|0|||
128988875|NCT00127192|464248087|FG003|Overall Study|Adverse event in pre-treatment period|0|||
128988876|NCT00127192|464248088|FG004|Overall Study|Adverse event in pre-treatment period|0|||
128988877|NCT01870921|464248089|FG000|Overall Study|Subject decision|80|||
128988878|NCT01870921|464248089|FG000|Overall Study|Severe non-compliance to protocol|7|||
128988879|NCT01870921|464248089|FG000|Overall Study|Subject Lost to Follow up|2|||
128988880|NCT01870921|464248089|FG000|Overall Study|Other|1|||
128988881|NCT04409509|464248090|FG000|Overall Study|Failure to meet randomization requirement|1|||
128988882|NCT04409509|464248091|FG001|Overall Study|Failure to meet randomization requirement|0|||
128988883|NCT04409509|464248090|FG000|Overall Study|Adverse Event|0|||
128988884|NCT04409509|464248091|FG001|Overall Study|Adverse Event|1|||
128988885|NCT04409509|464248090|FG000|Overall Study|Death|11|||
128988886|NCT04409509|464248091|FG001|Overall Study|Death|10|||
128988887|NCT04409509|464248090|FG000|Overall Study|Non-compliance with study drug|0|||
128988888|NCT04409509|464248091|FG001|Overall Study|Non-compliance with study drug|1|||
128988889|NCT04409509|464248090|FG000|Overall Study|Lost to Follow-up|0|||
128988890|NCT04409509|464248091|FG001|Overall Study|Lost to Follow-up|3|||
128988891|NCT04409509|464248090|FG000|Overall Study|Withdrawal by Subject|0|||
128988892|NCT04409509|464248091|FG001|Overall Study|Withdrawal by Subject|3|||
128988893|NCT04409509|464248090|FG000|Overall Study|Randomized by mistake|0|||
128988894|NCT04409509|464248091|FG001|Overall Study|Randomized by mistake|1|||
128988895|NCT04409509|464248090|FG000|Overall Study|Other|1|||
128988896|NCT04409509|464248091|FG001|Overall Study|Other|1|||
128988897|NCT00077766|464248092|FG000|Overall Study|Adverse Event|1|||
128988898|NCT00077766|464248093|FG001|Overall Study|Adverse Event|1|||
128988899|NCT00077766|464248092|FG000|Overall Study|Withdrawal by Subject|4|||
128988900|NCT00077766|464248093|FG001|Overall Study|Withdrawal by Subject|3|||
128988901|NCT00077766|464248092|FG000|Overall Study|Death|12|||
128988902|NCT00077766|464248093|FG001|Overall Study|Death|10|||
128988903|NCT00077766|464248092|FG000|Overall Study|Lost to Follow-up|2|||
128988904|NCT00077766|464248093|FG001|Overall Study|Lost to Follow-up|0|||
128988905|NCT00077766|464248092|FG000|Overall Study|Protocol Violation|1|||
128988906|NCT00077766|464248093|FG001|Overall Study|Protocol Violation|0|||
128988907|NCT00077766|464248092|FG000|Overall Study|Kidney Transplantation|9|||
128988908|NCT00077766|464248093|FG001|Overall Study|Kidney Transplantation|5|||
128988909|NCT00077766|464248092|FG000|Overall Study|Transplantation|5|||
128988910|NCT00077766|464248093|FG001|Overall Study|Transplantation|1|||
128988911|NCT00077766|464248092|FG000|Overall Study|Investigators Discretion|1|||
128988912|NCT00077766|464248093|FG001|Overall Study|Investigators Discretion|0|||
128988913|NCT00077766|464248092|FG000|Overall Study|Participant's decision|1|||
128988914|NCT00077766|464248093|FG001|Overall Study|Participant's decision|0|||
128988915|NCT00077766|464248092|FG000|Overall Study|Dialysis Discontinued|1|||
128988916|NCT00077766|464248093|FG001|Overall Study|Dialysis Discontinued|0|||
128988917|NCT00077766|464248092|FG000|Overall Study|Dialysis|0|||
128988918|NCT00077766|464248093|FG001|Overall Study|Dialysis|1|||
128988919|NCT00077766|464248092|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
128988920|NCT00077766|464248093|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
128988921|NCT00077766|464248092|FG000|Overall Study|Started Nocturnal Dialysis|0|||
128988922|NCT00077766|464248093|FG001|Overall Study|Started Nocturnal Dialysis|1|||
128988923|NCT00077766|464248092|FG000|Overall Study|Stop Dialysis|0|||
128988924|NCT00077766|464248093|FG001|Overall Study|Stop Dialysis|1|||
128988925|NCT00077766|464248092|FG000|Overall Study|Participants Vacation|2|||
128988926|NCT00077766|464248093|FG001|Overall Study|Participants Vacation|1|||
128988927|NCT02184988|464248098|FG000|Overall Study|Pregnancy|2|||
128988928|NCT02184988|464248098|FG000|Overall Study|Adverse Event|2|||
128988929|NCT02184988|464248098|FG000|Overall Study|moving away/travelling/unable to complet|6|||
128988930|NCT02184988|464248098|FG000|Overall Study|work scheduling issues|4|||
128988931|NCT02184988|464248098|FG000|Overall Study|various other reasons|9|||
128988932|NCT02184988|464248098|FG000|Overall Study|Lost to Follow-up|32|||
128988933|NCT03188991|464248099|FG000|Overall Study|Withdrawal by Subject|0|||
128988934|NCT03188991|464248100|FG001|Overall Study|Withdrawal by Subject|0|||
128988935|NCT03188991|464248101|FG002|Overall Study|Withdrawal by Subject|0|||
128988936|NCT03188991|464248102|FG003|Overall Study|Withdrawal by Subject|1|||
128988937|NCT03255226|464249618|FG000|Overall Study|Adverse Event|2|||
128988938|NCT03255226|464249618|FG000|Overall Study|Physician Decision|3|||
128988939|NCT03255226|464249618|FG000|Overall Study|Withdrawal by Subject|1|||
129214409|NCT02113982|465089326|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
129214410|NCT02113982|465089327|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
129214411|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
129214412|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
129214413|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
129214414|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
128763081|NCT02207725|463422731|FG002|Overall Study|Did Not Receive Treatment|1|||
128988940|NCT03255226|464249618|FG000|Overall Study|Serum or blood sodium increased|4|||
128988941|NCT03255226|464249618|FG000|Overall Study|Serum or blood potassium increased|4|||
128988942|NCT01035229|464249619|FG000|Overall Study|Adverse Event|61|||
128988943|NCT01035229|464249620|FG001|Overall Study|Adverse Event|14|||
128988944|NCT01035229|464249619|FG000|Overall Study|Withdrawal by Subject|20|||
128988945|NCT01035229|464249620|FG001|Overall Study|Withdrawal by Subject|7|||
128988946|NCT01035229|464249619|FG000|Overall Study|Lost to Follow-up|1|||
128988947|NCT01035229|464249620|FG001|Overall Study|Lost to Follow-up|0|||
128988948|NCT01035229|464249619|FG000|Overall Study|Administrative problems|1|||
128988949|NCT01035229|464249620|FG001|Overall Study|Administrative problems|1|||
128988950|NCT01035229|464249619|FG000|Overall Study|Death|13|||
128988951|NCT01035229|464249620|FG001|Overall Study|Death|5|||
128988952|NCT01035229|464249619|FG000|Overall Study|New cancer therapy|2|||
128988953|NCT01035229|464249620|FG001|Overall Study|New cancer therapy|0|||
128988954|NCT01035229|464249619|FG000|Overall Study|Protocol Violation|0|||
128988955|NCT01035229|464249620|FG001|Overall Study|Protocol Violation|2|||
128988956|NCT01035229|464249619|FG000|Overall Study|Sponsor's decision to end study|3|||
128988957|NCT01035229|464249620|FG001|Overall Study|Sponsor's decision to end study|3|||
128988958|NCT01035229|464249619|FG000|Overall Study|Disease Progression|261|||
128988959|NCT01035229|464249620|FG001|Overall Study|Disease Progression|152|||
128988960|NCT00798707|464249621|FG000|Overall Study|Adverse Event|6|||
128988961|NCT00798707|464249622|FG001|Overall Study|Adverse Event|8|||
128988962|NCT00798707|464249623|FG002|Overall Study|Adverse Event|8|||
128988963|NCT00798707|464249621|FG000|Overall Study|Failed to return|2|||
128988964|NCT00798707|464249622|FG001|Overall Study|Failed to return|2|||
128988965|NCT00798707|464249623|FG002|Overall Study|Failed to return|0|||
128988966|NCT00798707|464249621|FG000|Overall Study|Investigator|0|||
128988967|NCT00798707|464249622|FG001|Overall Study|Investigator|1|||
128988968|NCT00798707|464249623|FG002|Overall Study|Investigator|2|||
128988969|NCT00798707|464249621|FG000|Overall Study|Lack of Efficacy|2|||
128988970|NCT00798707|464249622|FG001|Overall Study|Lack of Efficacy|2|||
128988971|NCT00798707|464249623|FG002|Overall Study|Lack of Efficacy|1|||
128988972|NCT00798707|464249621|FG000|Overall Study|Lost to Follow-up|5|||
128988973|NCT00798707|464249622|FG001|Overall Study|Lost to Follow-up|6|||
128988974|NCT00798707|464249623|FG002|Overall Study|Lost to Follow-up|6|||
128988975|NCT00798707|464249621|FG000|Overall Study|Other|0|||
128988976|NCT00798707|464249622|FG001|Overall Study|Other|1|||
128988977|NCT00798707|464249623|FG002|Overall Study|Other|0|||
128988978|NCT00798707|464249621|FG000|Overall Study|Protocol Violation|4|||
128988979|NCT00798707|464249622|FG001|Overall Study|Protocol Violation|0|||
128988980|NCT00798707|464249623|FG002|Overall Study|Protocol Violation|2|||
128988981|NCT00798707|464249621|FG000|Overall Study|Withdrawal by Subject|3|||
128988982|NCT00798707|464249622|FG001|Overall Study|Withdrawal by Subject|8|||
128988983|NCT00798707|464249623|FG002|Overall Study|Withdrawal by Subject|2|||
128988984|NCT00798707|464249621|FG000|Overall Study|Randomized not treated|4|||
128988985|NCT00798707|464249622|FG001|Overall Study|Randomized not treated|5|||
128988986|NCT00798707|464249623|FG002|Overall Study|Randomized not treated|1|||
128988987|NCT01160770|464249626|FG000|Overall Study|Adverse Event|10|||
128988988|NCT01160770|464249626|FG000|Overall Study|Protocol Violation|2|||
128988989|NCT01160770|464249626|FG000|Overall Study|Subject/parent/caregiver request|33|||
128988990|NCT01160770|464249626|FG000|Overall Study|Physician Decision|1|||
128988991|NCT01160770|464249626|FG000|Overall Study|Lost to Follow-up|7|||
128988992|NCT01160770|464249626|FG000|Overall Study|Study termination or sponsor request|1|||
128988993|NCT01160770|464249626|FG000|Overall Study|Death|9|||
128988994|NCT01160770|464249626|FG000|Overall Study|Lack of Efficacy|15|||
128988995|NCT01160770|464249626|FG000|Overall Study|Other Reasons|1|||
128988996|NCT03457727|464249627|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
128988997|NCT03457727|464249628|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
128988998|NCT03457727|464249629|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
128988999|NCT03457727|464249630|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
128989000|NCT00929201|464249631|FG000|Period 1|Withdrawal by Subject|0|||
128989001|NCT00929201|464249632|FG001|Period 1|Withdrawal by Subject|1|||
128989002|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
128989003|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
128989004|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
128989005|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
128989006|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
128989007|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
128989008|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
129214415|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
129214416|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
129214417|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
129214418|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
129214419|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
129214420|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
129214421|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
128989009|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
129214422|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
128989010|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
128989011|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
128989012|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
129214423|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
128989013|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
128989014|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
128989015|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
128989016|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
128989017|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
128989018|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
128989019|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
128989020|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
128989021|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
128989022|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
128989023|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
128989024|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
128989025|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
128989026|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
128989027|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
128989028|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
128989029|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
128989030|NCT01299272|464249635|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
128989031|NCT01299272|464249636|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
129214424|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
129214425|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
129214426|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
129214427|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
129214428|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
129214429|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
129214430|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
129214431|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
129214432|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
129214433|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
129214434|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
129214435|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
129214436|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
129214437|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
129214438|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
129214439|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214440|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214441|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214442|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214443|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214444|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214445|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214446|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
129214447|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214448|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
129214449|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
129214450|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214451|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214452|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
129214453|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214454|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214455|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214456|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214457|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214458|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214459|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214460|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
129214461|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214462|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
129214463|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214464|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214465|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214466|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129214467|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214468|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214469|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214470|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
128989032|NCT01299272|464249637|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
129214471|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214472|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214473|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
128989033|NCT01299272|464249638|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
128989034|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
128989035|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
128989036|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
128989037|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
128989038|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
128989039|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
128989040|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
128989041|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
128989042|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
128989043|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
128989044|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
128989045|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
128989046|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
128989047|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
128989048|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
128989049|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
128989050|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
128989051|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
128989052|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
128989053|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
128989054|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
128989055|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
128989056|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
128989057|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
128989058|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
128989059|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
128989060|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
128989061|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
128989062|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
128989063|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
128989064|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
128989065|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
128989066|NCT01299272|464249635|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
128989067|NCT01299272|464249636|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
128989068|NCT01299272|464249637|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
128989069|NCT01299272|464249638|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
128989070|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
128989071|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
128989072|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
128989073|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
128989074|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
128989075|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
128989076|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
128989077|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
128989078|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
128989079|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
128989080|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
128989081|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
128989082|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
128989083|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
128989084|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
128989085|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
128989086|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
128989087|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
128989088|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
128989089|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
128989090|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
128989091|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
128989092|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
128989093|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
128989094|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
128989095|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
129214474|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
128877071|NCT00107120|463844102|FG000|Overall Study|Withdrawal by Subject|8|||
128877072|NCT00107120|463844103|FG001|Overall Study|Withdrawal by Subject|9|||
128877073|NCT00107120|463844102|FG000|Overall Study|Lost to Follow-up|8|||
128877074|NCT00107120|463844103|FG001|Overall Study|Lost to Follow-up|6|||
128877075|NCT00107120|463844102|FG000|Overall Study|Pregnancy|0|||
128877076|NCT00107120|463844103|FG001|Overall Study|Pregnancy|1|||
128877077|NCT00107120|463844102|FG000|Overall Study|moving away from site|1|||
128877078|NCT00107120|463844103|FG001|Overall Study|moving away from site|1|||
128877079|NCT00107120|463844102|FG000|Overall Study|death of parent|0|||
128877080|NCT00107120|463844103|FG001|Overall Study|death of parent|1|||
128877081|NCT03241225|463844104|FG000|Overall Study|Lost to Follow-up|2|||
128877082|NCT03241225|463844105|FG001|Overall Study|Lost to Follow-up|1|||
128877083|NCT03241225|463844104|FG000|Overall Study|Protocol Violation|4|||
128877084|NCT03241225|463844105|FG001|Overall Study|Protocol Violation|1|||
128877085|NCT03241225|463844104|FG000|Overall Study|Withdrawal by Subject|1|||
128877086|NCT03241225|463844105|FG001|Overall Study|Withdrawal by Subject|0|||
128877087|NCT01635920|463844110|FG000|Overall Study|Adverse Event|1|||
128877088|NCT01635920|463844111|FG001|Overall Study|Adverse Event|0|||
128877089|NCT01635920|463844110|FG000|Overall Study|Lost to Follow-up|0|||
128877090|NCT01635920|463844111|FG001|Overall Study|Lost to Follow-up|1|||
128877091|NCT01635920|463844110|FG000|Overall Study|Subject decision|2|||
128877092|NCT01635920|463844111|FG001|Overall Study|Subject decision|0|||
128877093|NCT01813929|463844112|FG000|Overall Study|Withdrawal by Subject|0|||
128877094|NCT01813929|463844113|FG001|Overall Study|Withdrawal by Subject|1|||
128877095|NCT00007345|463844114|FG000|Overall Study|Refused further treatment|0|||
128877096|NCT00007345|463844115|FG001|Overall Study|Refused further treatment|7|||
128877097|NCT00007345|463844114|FG000|Overall Study|Switched to alternative treatment|0|||
128877098|NCT00007345|463844115|FG001|Overall Study|Switched to alternative treatment|3|||
128877099|NCT00007345|463844114|FG000|Overall Study|Intercurrent illness|1|||
128877100|NCT00007345|463844115|FG001|Overall Study|Intercurrent illness|0|||
128877101|NCT00007345|463844114|FG000|Overall Study|Death on study|1|||
128877102|NCT00007345|463844115|FG001|Overall Study|Death on study|1|||
128877103|NCT00194987|463844116|FG000|Overall Study|Withdrawal by Subject|0|||
128877104|NCT00194987|463844117|FG001|Overall Study|Withdrawal by Subject|3|||
128877105|NCT01664598|463844118|FG000|Overall Study|Sponsor Decision|1|||
128877106|NCT01664598|463844118|FG000|Overall Study|Withdrawal of Informed Consent|4|||
128877107|NCT01664598|463844118|FG000|Overall Study|Adverse Event|1|||
128877108|NCT02342743|463844119|FG000|Baseline Period|Withdrawal by Subject|3|||
128877109|NCT02342743|463844119|FG000|Baseline Period|Lost to Follow-up|2|||
128877110|NCT02342743|463844119|FG000|Baseline Period|Change in prophylactic medication|3|||
128877111|NCT02342743|463844119|FG000|Baseline Period|Screening failure regarding baseline|7|||
128877112|NCT02342743|463844119|FG000|Treatment Period|Withdrawal by Subject|2|||
128877113|NCT02342743|463844119|FG000|Treatment Period|Lost to Follow-up|8|||
128877114|NCT02342743|463844119|FG000|Treatment Period|Change in prophylactic medication|1|||
128877115|NCT03646656|463844120|FG000|Overall Study|Lost to Follow-up|1|||
128877116|NCT03646656|463844121|FG001|Overall Study|Lost to Follow-up|0|||
128877117|NCT03646656|463844120|FG000|Overall Study|Withdrawal by Subject|2|||
128877118|NCT03646656|463844121|FG001|Overall Study|Withdrawal by Subject|0|||
128877119|NCT00938470|463844126|FG000|Overall Study|Disease Progression|3|||
128877120|NCT00938470|463844127|FG001|Overall Study|Disease Progression|0|||
128877121|NCT00938470|463844126|FG000|Overall Study|Alternate Treatment|1|||
128877122|NCT00938470|463844127|FG001|Overall Study|Alternate Treatment|0|||
128877123|NCT00938470|463844126|FG000|Overall Study|Death|3|||
128877124|NCT00938470|463844127|FG001|Overall Study|Death|2|||
128877125|NCT00938470|463844126|FG000|Overall Study|Other Reason|0|||
128877126|NCT00938470|463844127|FG001|Overall Study|Other Reason|1|||
128877127|NCT02630693|463844131|FG000|Overall Study|No receive treatment|0|||
128877128|NCT02630693|463844132|FG001|Overall Study|No receive treatment|1|||
128877129|NCT03932812|463844137|FG000|Overall Study|Lost to Follow-up|12|||
128877130|NCT03932812|463844138|FG001|Overall Study|Lost to Follow-up|14|||
128877131|NCT03932812|463844137|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
128877132|NCT03932812|463844138|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
128877133|NCT02585232|463844143|FG000|Overall Study|Lost to Follow-up|8|||
128877134|NCT02585232|463844144|FG001|Overall Study|Lost to Follow-up|8|||
128877135|NCT02585232|463844143|FG000|Overall Study|Withdrawal by Subject|4|||
128877136|NCT02585232|463844144|FG001|Overall Study|Withdrawal by Subject|8|||
128877137|NCT03215810|463844145|FG000|Overall Study|Still responding to nivolumab|1|||
128877138|NCT03215810|463844145|FG000|Overall Study|Insufficient TIL growth|1|||
128877139|NCT03215810|463844145|FG000|Overall Study|Decline in performance status|1|||
128877140|NCT03215810|463844145|FG000|Overall Study|Withdrawal by Subject|1|||
128877141|NCT02313233|463844146|FG000|Overall Study|Withdrawal by Subject|1|||
128877142|NCT02313233|463844147|FG001|Overall Study|Withdrawal by Subject|2|||
128877143|NCT02313233|463844146|FG000|Overall Study|Administrative reason|1|||
128877144|NCT02313233|463844147|FG001|Overall Study|Administrative reason|1|||
128877145|NCT01656733|463844150|FG000|Overall Study|No permission to collect birth outcomes|0|||
129214475|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
128989096|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
128989097|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
128989098|NCT01299272|464249635|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
128989099|NCT01299272|464249636|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
128989100|NCT01299272|464249637|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
128989101|NCT01299272|464249638|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
128989102|NCT00464308|464249639|FG000|Overall Study|Adverse Event|22|||
128989103|NCT00464308|464249640|FG001|Overall Study|Adverse Event|27|||
128989104|NCT00464308|464249641|FG002|Overall Study|Adverse Event|16|||
129214476|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214477|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214478|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214479|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214480|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129214481|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Transplant|0|||
129214482|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Transplant|0|||
129214483|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Transplant|0|||
129214484|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Transplant|0|||
128877146|NCT01656733|463844151|FG001|Overall Study|No permission to collect birth outcomes|1|||
128877147|NCT01656733|463844150|FG000|Overall Study|Delivery at another hospital|0|||
128877148|NCT01656733|463844151|FG001|Overall Study|Delivery at another hospital|2|||
128877149|NCT01656733|463844150|FG000|Overall Study|Spontaneous abortion|0|||
128877150|NCT01656733|463844151|FG001|Overall Study|Spontaneous abortion|1|||
128877151|NCT02679573|463844155|FG000|Overall Study|Adverse Event|13|||
128877152|NCT02679573|463844156|FG001|Overall Study|Adverse Event|6|||
128877153|NCT02679573|463844155|FG000|Overall Study|Lack of Efficacy|12|||
128877154|NCT02679573|463844156|FG001|Overall Study|Lack of Efficacy|15|||
128877155|NCT02679573|463844155|FG000|Overall Study|Could not complete required study visits|6|||
128877156|NCT02679573|463844156|FG001|Overall Study|Could not complete required study visits|2|||
128877157|NCT02679573|463844155|FG000|Overall Study|Withdrawal by Subject|2|||
128877158|NCT02679573|463844156|FG001|Overall Study|Withdrawal by Subject|9|||
128877159|NCT02679573|463844155|FG000|Overall Study|Death|2|||
128877160|NCT02679573|463844156|FG001|Overall Study|Death|0|||
128877161|NCT02679573|463844155|FG000|Overall Study|Physician Decision|2|||
128877162|NCT02679573|463844156|FG001|Overall Study|Physician Decision|4|||
128877163|NCT02679573|463844155|FG000|Overall Study|Lost to Follow-up|0|||
128877164|NCT02679573|463844156|FG001|Overall Study|Lost to Follow-up|3|||
128877165|NCT00682890|463844157|FG000|Overall Study|Lost to Follow-up|1|||
128877166|NCT00682890|463844158|FG001|Overall Study|Lost to Follow-up|1|||
128877167|NCT00682890|463844157|FG000|Overall Study|subject moved away|0|||
128877168|NCT00682890|463844158|FG001|Overall Study|subject moved away|1|||
128877169|NCT00682890|463844157|FG000|Overall Study|heavy menstrual bleeding|1|||
128877170|NCT00682890|463844158|FG001|Overall Study|heavy menstrual bleeding|0|||
128877171|NCT03545503|463844159|FG000|Overall Study|Protocol Violation|14|||
128877172|NCT03545503|463844160|FG001|Overall Study|Protocol Violation|16|||
128877173|NCT01502631|463844163|FG000|Overall Study|Adverse Event|5|||
128877174|NCT01502631|463844164|FG001|Overall Study|Adverse Event|8|||
128877175|NCT01502631|463844163|FG000|Overall Study|Lost to Follow-up|2|||
128877176|NCT01502631|463844164|FG001|Overall Study|Lost to Follow-up|2|||
128877177|NCT01502631|463844163|FG000|Overall Study|Participant withdrew consent|2|||
128877178|NCT01502631|463844164|FG001|Overall Study|Participant withdrew consent|4|||
128877179|NCT01502631|463844163|FG000|Overall Study|Participant non-compliant|1|||
128877180|NCT01502631|463844164|FG001|Overall Study|Participant non-compliant|0|||
128877181|NCT01502631|463844163|FG000|Overall Study|Investigator's decision|0|||
128877182|NCT01502631|463844164|FG001|Overall Study|Investigator's decision|1|||
128877183|NCT01502631|463844163|FG000|Overall Study|Other|10|||
128877184|NCT01502631|463844164|FG001|Overall Study|Other|5|||
128877185|NCT01293487|463844165|FG000|Overall Study|Lost to Follow-up|0|||
128877186|NCT01293487|463844166|FG001|Overall Study|Lost to Follow-up|0|||
128877187|NCT01293487|463844167|FG002|Overall Study|Lost to Follow-up|0|||
128877188|NCT01293487|463844168|FG003|Overall Study|Lost to Follow-up|1|||
128877189|NCT01293487|463844169|FG004|Overall Study|Lost to Follow-up|0|||
128877190|NCT01293487|463844170|FG005|Overall Study|Lost to Follow-up|0|||
128877191|NCT01293487|463844171|FG006|Overall Study|Lost to Follow-up|0|||
128877192|NCT01293487|463844172|FG007|Overall Study|Lost to Follow-up|0|||
128877193|NCT01293487|463844165|FG000|Overall Study|Withdrawal by Subject|0|||
128877194|NCT01293487|463844166|FG001|Overall Study|Withdrawal by Subject|0|||
128877195|NCT01293487|463844167|FG002|Overall Study|Withdrawal by Subject|0|||
128877196|NCT01293487|463844168|FG003|Overall Study|Withdrawal by Subject|0|||
128877197|NCT01293487|463844169|FG004|Overall Study|Withdrawal by Subject|0|||
128989105|NCT00464308|464249639|FG000|Overall Study|Lost to Follow-up|29|||
128989106|NCT00464308|464249640|FG001|Overall Study|Lost to Follow-up|19|||
128989107|NCT00464308|464249641|FG002|Overall Study|Lost to Follow-up|20|||
128989108|NCT00464308|464249639|FG000|Overall Study|Patient discontinued and other reasons|17|||
128989109|NCT00464308|464249640|FG001|Overall Study|Patient discontinued and other reasons|17|||
128989110|NCT00464308|464249641|FG002|Overall Study|Patient discontinued and other reasons|23|||
128989111|NCT00464308|464249639|FG000|Overall Study|Physician Decision|1|||
128989112|NCT00464308|464249640|FG001|Overall Study|Physician Decision|0|||
128989113|NCT00464308|464249641|FG002|Overall Study|Physician Decision|0|||
128989114|NCT01513759|464249642|FG000|Overall Study|Protocol Violation|4|||
128989115|NCT01513759|464249642|FG000|Overall Study|Death during catheter placement|1|||
128989116|NCT00630994|464249643|FG000|Overall Study|Adverse Event|1|||
128989117|NCT00630994|464249643|FG000|Overall Study|Disease Progression|1|||
128989118|NCT00630994|464249643|FG000|Overall Study|Lack of Efficacy|1|||
128989119|NCT00630994|464249643|FG000|Overall Study|Other|1|||
128989120|NCT03533608|464249644|FG000|Overall Study|Withdrawal by Subject|3|||
128989121|NCT03533608|464249644|FG000|Overall Study|Physician Decision|2|||
128989122|NCT03286426|464249645|FG000|Overall Study|Physician Decision|3|||
128989123|NCT03514121|464249646|FG000|Overall Study|Withdrawal by Subject|0|||
128989124|NCT03514121|464249647|FG001|Overall Study|Withdrawal by Subject|0|||
128989125|NCT03514121|464249648|FG002|Overall Study|Withdrawal by Subject|0|||
128989126|NCT03514121|464249649|FG003|Overall Study|Withdrawal by Subject|0|||
128989127|NCT03514121|464249650|FG004|Overall Study|Withdrawal by Subject|1|||
128989128|NCT03514121|464249651|FG005|Overall Study|Withdrawal by Subject|2|||
128989129|NCT03514121|464249652|FG006|Overall Study|Withdrawal by Subject|1|||
128989130|NCT03514121|464249653|FG007|Overall Study|Withdrawal by Subject|1|||
128989131|NCT03514121|464249654|FG008|Overall Study|Withdrawal by Subject|7|||
128989132|NCT03514121|464249655|FG009|Overall Study|Withdrawal by Subject|2|||
128989133|NCT03514121|464249646|FG000|Overall Study|Death|0|||
128989134|NCT03514121|464249647|FG001|Overall Study|Death|0|||
128989135|NCT03514121|464249648|FG002|Overall Study|Death|0|||
128989136|NCT03514121|464249649|FG003|Overall Study|Death|0|||
128989137|NCT03514121|464249650|FG004|Overall Study|Death|0|||
128989138|NCT03514121|464249651|FG005|Overall Study|Death|3|||
128989139|NCT03514121|464249652|FG006|Overall Study|Death|2|||
128989140|NCT03514121|464249653|FG007|Overall Study|Death|1|||
128989141|NCT03514121|464249654|FG008|Overall Study|Death|26|||
128989142|NCT03514121|464249655|FG009|Overall Study|Death|3|||
128989143|NCT03514121|464249646|FG000|Overall Study|Lost to Follow-up|0|||
128989144|NCT03514121|464249647|FG001|Overall Study|Lost to Follow-up|0|||
128989145|NCT03514121|464249648|FG002|Overall Study|Lost to Follow-up|1|||
128989146|NCT03514121|464249649|FG003|Overall Study|Lost to Follow-up|0|||
128989147|NCT03514121|464249650|FG004|Overall Study|Lost to Follow-up|0|||
128989148|NCT03514121|464249651|FG005|Overall Study|Lost to Follow-up|0|||
128989149|NCT03514121|464249652|FG006|Overall Study|Lost to Follow-up|0|||
128989150|NCT03514121|464249653|FG007|Overall Study|Lost to Follow-up|0|||
128989151|NCT03514121|464249654|FG008|Overall Study|Lost to Follow-up|1|||
128989152|NCT03514121|464249655|FG009|Overall Study|Lost to Follow-up|0|||
128989153|NCT03514121|464249646|FG000|Overall Study|Adverse Event|0|||
128989154|NCT03514121|464249647|FG001|Overall Study|Adverse Event|0|||
128989155|NCT03514121|464249648|FG002|Overall Study|Adverse Event|0|||
128989156|NCT03514121|464249649|FG003|Overall Study|Adverse Event|0|||
128989157|NCT03514121|464249650|FG004|Overall Study|Adverse Event|0|||
128989158|NCT03514121|464249651|FG005|Overall Study|Adverse Event|0|||
129214485|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Transplant|0|||
129214486|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Transplant|0|||
129214487|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Transplant|0|||
129214488|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Transplant|0|||
128989159|NCT03514121|464249652|FG006|Overall Study|Adverse Event|1|||
128989160|NCT03514121|464249653|FG007|Overall Study|Adverse Event|0|||
129214489|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Transplant|0|||
128989161|NCT03514121|464249654|FG008|Overall Study|Adverse Event|0|||
128989162|NCT03514121|464249655|FG009|Overall Study|Adverse Event|0|||
128989163|NCT03514121|464249646|FG000|Overall Study|Other|0|||
129214490|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Transplant|4|||
128989164|NCT03514121|464249647|FG001|Overall Study|Other|1|||
128989165|NCT03514121|464249648|FG002|Overall Study|Other|1|||
128989166|NCT03514121|464249649|FG003|Overall Study|Other|0|||
128989167|NCT03514121|464249650|FG004|Overall Study|Other|1|||
128989168|NCT03514121|464249651|FG005|Overall Study|Other|2|||
128989169|NCT03514121|464249652|FG006|Overall Study|Other|3|||
128989170|NCT03514121|464249653|FG007|Overall Study|Other|2|||
128989171|NCT03514121|464249654|FG008|Overall Study|Other|7|||
128989172|NCT03514121|464249655|FG009|Overall Study|Other|3|||
128989173|NCT03514121|464249646|FG000|Overall Study|Study termination by Sponsor|0|||
129214491|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Transplant|2|||
128989174|NCT03514121|464249647|FG001|Overall Study|Study termination by Sponsor|0|||
128989175|NCT03514121|464249648|FG002|Overall Study|Study termination by Sponsor|0|||
128989176|NCT03514121|464249649|FG003|Overall Study|Study termination by Sponsor|0|||
129214492|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Transplant|0|||
128877198|NCT01293487|463844170|FG005|Overall Study|Withdrawal by Subject|0|||
128877199|NCT01293487|463844171|FG006|Overall Study|Withdrawal by Subject|0|||
128877200|NCT01293487|463844172|FG007|Overall Study|Withdrawal by Subject|2|||
128877201|NCT00395460|463844173|FG000|Overall Study|Withdrawal by Subject|1|||
128877202|NCT00395460|463844174|FG001|Overall Study|Withdrawal by Subject|0|||
128877203|NCT01605019|463844177|FG000|Overall Study|pt did not meet transplant endpoint|3|||
128877204|NCT01605019|463844178|FG001|Overall Study|pt did not meet transplant endpoint|0|||
128877205|NCT04223830|463844183|FG000|Overall Study|Lost to Follow-up|9|||
128877206|NCT04223830|463844183|FG000|Overall Study|Adverse Event|1|||
128877207|NCT01806623|463844184|FG000|Overall Study|Withdrawal by Subject|1|||
128877208|NCT01806623|463844184|FG000|Overall Study|Adverse Event|1|||
128877209|NCT01806623|463844184|FG000|Overall Study|Did not meet the inclusion criteria|56|||
128877210|NCT01964924|463844185|FG000|Trametinib Monotherapy|Progression|19|||
128877211|NCT01964924|463844186|FG001|Trametinib Monotherapy|Progression|0|||
128877212|NCT01153958|463844187|FG000|Overall Study|Study Terminated|36|||
128877213|NCT01153958|463844188|FG001|Overall Study|Study Terminated|32|||
128877214|NCT01034163|463844189|FG000|Overall Study|Treatment completed as per protocol|8|||
128877215|NCT01034163|463844190|FG001|Overall Study|Treatment completed as per protocol|7|||
128877216|NCT01034163|463844189|FG000|Overall Study|Withdrawal by Subject|8|||
128877217|NCT01034163|463844190|FG001|Overall Study|Withdrawal by Subject|2|||
128877218|NCT01034163|463844189|FG000|Overall Study|Protocol deviation|1|||
128877219|NCT01034163|463844190|FG001|Overall Study|Protocol deviation|0|||
128877220|NCT01034163|463844189|FG000|Overall Study|Disease progression|3|||
128877221|NCT01034163|463844190|FG001|Overall Study|Disease progression|4|||
128877222|NCT01034163|463844189|FG000|Overall Study|Adverse Event|6|||
128877223|NCT01034163|463844190|FG001|Overall Study|Adverse Event|0|||
128877224|NCT01034163|463844189|FG000|Overall Study|Administrative problems|0|||
128877225|NCT01034163|463844190|FG001|Overall Study|Administrative problems|1|||
128877226|NCT01034163|463844189|FG000|Overall Study|Abnormal laboratory value|1|||
128877227|NCT01034163|463844190|FG001|Overall Study|Abnormal laboratory value|0|||
128877228|NCT00528645|463844191|FG000|Overall Study|Adverse Event|3|||
128877229|NCT02150343|463844192|FG000|Overall Study|Adverse Event|2|||
128877230|NCT02150343|463844193|FG001|Overall Study|Adverse Event|0|||
128877231|NCT02150343|463844194|FG002|Overall Study|Adverse Event|1|||
128877232|NCT02150343|463844195|FG003|Overall Study|Adverse Event|1|||
128877233|NCT02150343|463844192|FG000|Overall Study|Withdrawal by Subject|13|||
128877234|NCT02150343|463844193|FG001|Overall Study|Withdrawal by Subject|10|||
128877235|NCT02150343|463844194|FG002|Overall Study|Withdrawal by Subject|9|||
128877236|NCT02150343|463844195|FG003|Overall Study|Withdrawal by Subject|4|||
128877237|NCT02150343|463844192|FG000|Overall Study|Lost to Follow-up|4|||
128877238|NCT02150343|463844193|FG001|Overall Study|Lost to Follow-up|4|||
128877239|NCT02150343|463844194|FG002|Overall Study|Lost to Follow-up|2|||
128877240|NCT02150343|463844195|FG003|Overall Study|Lost to Follow-up|3|||
128877241|NCT02150343|463844192|FG000|Overall Study|Other|2|||
128877242|NCT02150343|463844193|FG001|Overall Study|Other|6|||
128877243|NCT02150343|463844194|FG002|Overall Study|Other|0|||
128877244|NCT02150343|463844195|FG003|Overall Study|Other|2|||
128877245|NCT00190749|463844196|FG000|Overall Study|Lost to Follow-up|8|||
128877246|NCT00190749|463844197|FG001|Overall Study|Lost to Follow-up|11|||
128877247|NCT00190749|463844196|FG000|Overall Study|Withdrawal by Subject|10|||
128877248|NCT00190749|463844197|FG001|Overall Study|Withdrawal by Subject|6|||
128877249|NCT00190749|463844196|FG000|Overall Study|Protocol Violation|5|||
128877250|NCT00190749|463844197|FG001|Overall Study|Protocol Violation|4|||
128877251|NCT00190749|463844196|FG000|Overall Study|Adverse Event|0|||
128877252|NCT00190749|463844197|FG001|Overall Study|Adverse Event|5|||
128877253|NCT00190749|463844196|FG000|Overall Study|Lack of Efficacy|2|||
128877254|NCT00190749|463844197|FG001|Overall Study|Lack of Efficacy|3|||
128877255|NCT00190749|463844196|FG000|Overall Study|Reason Not Specified|0|||
128877256|NCT00190749|463844197|FG001|Overall Study|Reason Not Specified|2|||
128877257|NCT00190749|463844196|FG000|Overall Study|Sponsor Decision|1|||
128877258|NCT00190749|463844197|FG001|Overall Study|Sponsor Decision|0|||
128877259|NCT02729753|463844198|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
128877260|NCT02729753|463844199|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
128877261|NCT01090427|463844200|FG000|After Controlled Period|Death|0|||
128877262|NCT01090427|463844201|FG001|After Controlled Period|Death|0|||
128877263|NCT01090427|463844202|FG002|After Controlled Period|Death|0|||
128877264|NCT01090427|463844203|FG003|After Controlled Period|Death|0|||
128877265|NCT01090427|463844204|FG004|After Controlled Period|Death|0|||
128877266|NCT01090427|463844205|FG005|After Controlled Period|Death|1|||
128877267|NCT01090427|463844206|FG006|After Controlled Period|Death|0|||
128877268|NCT01090427|463844200|FG000|After Controlled Period|Lack of Efficacy|0|||
128877269|NCT01090427|463844201|FG001|After Controlled Period|Lack of Efficacy|0|||
128877270|NCT01090427|463844202|FG002|After Controlled Period|Lack of Efficacy|0|||
128877271|NCT01090427|463844203|FG003|After Controlled Period|Lack of Efficacy|0|||
128877272|NCT01090427|463844204|FG004|After Controlled Period|Lack of Efficacy|0|||
128877273|NCT01090427|463844205|FG005|After Controlled Period|Lack of Efficacy|3|||
128877274|NCT01090427|463844206|FG006|After Controlled Period|Lack of Efficacy|2|||
128877275|NCT01090427|463844200|FG000|After Controlled Period|Adverse Event|0|||
128989177|NCT03514121|464249650|FG004|Overall Study|Study termination by Sponsor|0|||
128989178|NCT03514121|464249651|FG005|Overall Study|Study termination by Sponsor|0|||
128989179|NCT03514121|464249652|FG006|Overall Study|Study termination by Sponsor|0|||
128989180|NCT03514121|464249653|FG007|Overall Study|Study termination by Sponsor|0|||
128989181|NCT03514121|464249654|FG008|Overall Study|Study termination by Sponsor|11|||
128989182|NCT03514121|464249655|FG009|Overall Study|Study termination by Sponsor|3|||
128989183|NCT03514121|464249646|FG000|Overall Study|Investigator decision|0|||
128989184|NCT03514121|464249647|FG001|Overall Study|Investigator decision|0|||
128989185|NCT03514121|464249648|FG002|Overall Study|Investigator decision|0|||
128989186|NCT03514121|464249649|FG003|Overall Study|Investigator decision|0|||
128989187|NCT03514121|464249650|FG004|Overall Study|Investigator decision|0|||
128989188|NCT03514121|464249651|FG005|Overall Study|Investigator decision|0|||
128989189|NCT03514121|464249652|FG006|Overall Study|Investigator decision|0|||
128989190|NCT03514121|464249653|FG007|Overall Study|Investigator decision|0|||
128989191|NCT03514121|464249654|FG008|Overall Study|Investigator decision|1|||
128989192|NCT03514121|464249655|FG009|Overall Study|Investigator decision|0|||
128989193|NCT05553600|464249656|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
128989194|NCT05553600|464249657|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
128989195|NCT05553600|464249658|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
128989196|NCT05553600|464249659|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
128989197|NCT05553600|464249656|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
128989198|NCT05553600|464249657|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
128989199|NCT05553600|464249658|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
128989200|NCT05553600|464249659|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
128989201|NCT05553600|464249656|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
128989202|NCT05553600|464249657|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
128989203|NCT05553600|464249658|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
128989204|NCT05553600|464249659|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
128989205|NCT05553600|464249656|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
128989206|NCT05553600|464249657|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
128989207|NCT05553600|464249658|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
128989208|NCT05553600|464249659|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
128989209|NCT05553600|464249656|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
128989210|NCT05553600|464249657|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
128989211|NCT05553600|464249658|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
128989212|NCT05553600|464249659|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
128989213|NCT05553600|464249656|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
128989214|NCT05553600|464249657|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
128989215|NCT05553600|464249658|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
128989216|NCT05553600|464249659|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
128989217|NCT05553600|464249656|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
128989218|NCT05553600|464249657|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
128989219|NCT05553600|464249658|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
128989220|NCT05553600|464249659|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
128989221|NCT05553600|464249656|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
128989222|NCT05553600|464249657|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
128989223|NCT05553600|464249658|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
128989224|NCT05553600|464249659|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
128989225|NCT05553600|464249656|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
128989226|NCT05553600|464249657|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
128989227|NCT05553600|464249658|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
128989228|NCT05553600|464249659|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
128989229|NCT05553600|464249656|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
128989230|NCT05553600|464249657|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
128989231|NCT05553600|464249658|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
128989232|NCT05553600|464249659|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
128989233|NCT05553600|464249656|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
128989234|NCT05553600|464249657|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
128989235|NCT05553600|464249658|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
128989236|NCT05553600|464249659|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
128989237|NCT05553600|464249656|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
128989238|NCT05553600|464249657|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
129214493|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Transplant|0|||
128989239|NCT05553600|464249658|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
128989240|NCT05553600|464249659|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
128989241|NCT03286400|464249663|FG000|Overall Study|Death|10|||
128989242|NCT03286400|464249663|FG000|Overall Study|Lost to Follow-up|10|||
128989243|NCT03286400|464249663|FG000|Overall Study|Physician Decision|1|||
128989244|NCT03286400|464249663|FG000|Overall Study|Scheduling difficulty|4|||
128989245|NCT00826176|464249664|FG000|Overall Study|Lost to Follow-up|1|||
128989246|NCT00826176|464249665|FG001|Overall Study|Lost to Follow-up|0|||
128989247|NCT00826176|464249664|FG000|Overall Study|Subject Withdrew Consent|3|||
128989248|NCT00826176|464249665|FG001|Overall Study|Subject Withdrew Consent|0|||
128989249|NCT00826176|464249664|FG000|Overall Study|Administrative|9|||
128989250|NCT00826176|464249665|FG001|Overall Study|Administrative|0|||
128989251|NCT00297882|464249671|FG000|Day 14|Lack of Efficacy|12|||
128989252|NCT00297882|464249672|FG001|Day 14|Lack of Efficacy|49|||
128989253|NCT00297882|464249671|FG000|Day 28|Lost to Follow-up|13|||
128989254|NCT00297882|464249672|FG001|Day 28|Lost to Follow-up|23|||
128989255|NCT00297882|464249671|FG000|Day 28|Lack of Efficacy|3|||
128989256|NCT00297882|464249672|FG001|Day 28|Lack of Efficacy|0|||
128989257|NCT04484805|464249673|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
128989258|NCT04484805|464249674|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
128989259|NCT04484805|464249673|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
128989260|NCT04484805|464249674|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
128989261|NCT04242264|464249675|FG000|Overall Study|Lost to Follow-up|2|||
128989262|NCT04242264|464249676|FG001|Overall Study|Lost to Follow-up|2|||
128989263|NCT04242264|464249677|FG002|Overall Study|Lost to Follow-up|1|||
128989264|NCT04242264|464249678|FG003|Overall Study|Lost to Follow-up|1|||
128989265|NCT04242264|464249675|FG000|Overall Study|Withdrawal by Subject|1|||
128989266|NCT04242264|464249676|FG001|Overall Study|Withdrawal by Subject|0|||
128989267|NCT04242264|464249677|FG002|Overall Study|Withdrawal by Subject|0|||
128989268|NCT04242264|464249678|FG003|Overall Study|Withdrawal by Subject|0|||
128989269|NCT02116309|464249682|FG000|Overall Study|Lost to Follow-up|0|||
128989270|NCT02116309|464249683|FG001|Overall Study|Lost to Follow-up|1|||
128989271|NCT00848965|464249684|FG000|Overall Study|Adverse Event|1|||
128989272|NCT00848965|464249684|FG000|Overall Study|Withdrawal by Subject|1|||
128989273|NCT03710824|464249685|FG000|Overall Study|Withdrawal by Subject|1|||
128989274|NCT03710824|464249685|FG000|Overall Study|Lost to Follow-up|3|||
128989275|NCT03710824|464249685|FG000|Overall Study|Adverse Event|25|||
128989276|NCT03710824|464249685|FG000|Overall Study|Treatment discontinuation|2|||
128989277|NCT02329834|464249686|FG000|Overall Study|Physician Decision|1|||
128989278|NCT02329834|464249687|FG001|Overall Study|Physician Decision|0|||
128989279|NCT00578448|464249688|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
128989280|NCT00578448|464249688|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
128989281|NCT00578448|464249688|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
128989282|NCT00578448|464249688|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
128989283|NCT01976104|464249689|FG000|Overall Study|Adverse Event|0|||
128989284|NCT01976104|464249690|FG001|Overall Study|Adverse Event|0|||
128989285|NCT01976104|464249691|FG002|Overall Study|Adverse Event|1|||
128989286|NCT01976104|464249692|FG003|Overall Study|Adverse Event|0|||
128989287|NCT01976104|464249689|FG000|Overall Study|Lost to Follow-up|3|||
128989288|NCT01976104|464249690|FG001|Overall Study|Lost to Follow-up|0|||
128989289|NCT01976104|464249691|FG002|Overall Study|Lost to Follow-up|1|||
128989290|NCT01976104|464249692|FG003|Overall Study|Lost to Follow-up|1|||
128989291|NCT01976104|464249689|FG000|Overall Study|Subject Choice|0|||
128989292|NCT01976104|464249690|FG001|Overall Study|Subject Choice|1|||
128989293|NCT01976104|464249691|FG002|Overall Study|Subject Choice|0|||
128989294|NCT01976104|464249692|FG003|Overall Study|Subject Choice|1|||
128989295|NCT01976104|464249689|FG000|Overall Study|Withdrawal by Subject|3|||
128989296|NCT01976104|464249690|FG001|Overall Study|Withdrawal by Subject|0|||
128989297|NCT01976104|464249691|FG002|Overall Study|Withdrawal by Subject|0|||
128989298|NCT01976104|464249692|FG003|Overall Study|Withdrawal by Subject|1|||
128989299|NCT01976104|464249689|FG000|Overall Study|Other|0|||
128989300|NCT01976104|464249690|FG001|Overall Study|Other|1|||
128763082|NCT02207725|463422732|FG003|Overall Study|Did Not Receive Treatment|1|||
128877276|NCT01090427|463844201|FG001|After Controlled Period|Adverse Event|0|||
128877277|NCT01090427|463844202|FG002|After Controlled Period|Adverse Event|0|||
128877278|NCT01090427|463844203|FG003|After Controlled Period|Adverse Event|2|||
128877279|NCT01090427|463844204|FG004|After Controlled Period|Adverse Event|0|||
128877280|NCT01090427|463844205|FG005|After Controlled Period|Adverse Event|1|||
128877281|NCT01090427|463844206|FG006|After Controlled Period|Adverse Event|0|||
128877282|NCT01200589|463844207|FG000|Overall Study|Withdrawal by Subject|13|||
128877283|NCT01200589|463844208|FG001|Overall Study|Withdrawal by Subject|11|||
128877284|NCT01200589|463844207|FG000|Overall Study|Physician Decision|2|||
128877285|NCT01200589|463844208|FG001|Overall Study|Physician Decision|2|||
128877286|NCT01200589|463844207|FG000|Overall Study|Lost to Follow-up|5|||
128877287|NCT01200589|463844208|FG001|Overall Study|Lost to Follow-up|4|||
128989301|NCT01976104|464249691|FG002|Overall Study|Other|0|||
128989302|NCT01976104|464249692|FG003|Overall Study|Other|0|||
128989303|NCT01317199|464249693|FG000|Dose-escalation Phase 1|Physician Decision|5|||
128989304|NCT01317199|464249694|FG001|Dose-escalation Phase 1|Physician Decision|0|||
128989305|NCT01317199|464249695|FG002|Dose-escalation Phase 1|Physician Decision|0|||
128989306|NCT01317199|464249696|FG003|Dose-escalation Phase 1|Physician Decision|0|||
128989307|NCT01317199|464249693|FG000|Dose-escalation Phase 1|Disease progression|1|||
128989308|NCT01317199|464249694|FG001|Dose-escalation Phase 1|Disease progression|0|||
128989309|NCT01317199|464249695|FG002|Dose-escalation Phase 1|Disease progression|0|||
128989310|NCT01317199|464249696|FG003|Dose-escalation Phase 1|Disease progression|0|||
128989311|NCT01317199|464249693|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
128989312|NCT01317199|464249694|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
128989313|NCT01317199|464249695|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
128989314|NCT01317199|464249696|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
128989315|NCT01317199|464249693|FG000|Randomized Phase 2|Disease progression|0|||
128989316|NCT01317199|464249694|FG001|Randomized Phase 2|Disease progression|3|||
128989317|NCT01317199|464249695|FG002|Randomized Phase 2|Disease progression|7|||
128989318|NCT01317199|464249696|FG003|Randomized Phase 2|Disease progression|5|||
128989319|NCT01317199|464249693|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
128989320|NCT01317199|464249694|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
128989321|NCT01317199|464249695|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
128989322|NCT01317199|464249696|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
128989323|NCT01317199|464249693|FG000|Randomized Phase 2|Adverse Event|0|||
128989324|NCT01317199|464249694|FG001|Randomized Phase 2|Adverse Event|0|||
128989325|NCT01317199|464249695|FG002|Randomized Phase 2|Adverse Event|0|||
128989326|NCT01317199|464249696|FG003|Randomized Phase 2|Adverse Event|1|||
128989327|NCT01317199|464249693|FG000|Randomized Phase 2|Comorbidities|0|||
128989328|NCT01317199|464249694|FG001|Randomized Phase 2|Comorbidities|2|||
128989329|NCT01317199|464249695|FG002|Randomized Phase 2|Comorbidities|2|||
128989330|NCT01317199|464249696|FG003|Randomized Phase 2|Comorbidities|2|||
128989331|NCT01317199|464249693|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
128989332|NCT01317199|464249694|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
128989333|NCT01317199|464249695|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
128989334|NCT01317199|464249696|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
128989335|NCT01317199|464249693|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
128989336|NCT01317199|464249694|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
128989337|NCT01317199|464249695|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
128989338|NCT01317199|464249696|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
128989339|NCT01317199|464249693|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
128989340|NCT01317199|464249694|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
128989341|NCT01317199|464249695|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
128989342|NCT01317199|464249696|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
128989343|NCT01317199|464249693|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
128989344|NCT01317199|464249694|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
128989345|NCT01317199|464249695|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
128989346|NCT01317199|464249696|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
128989347|NCT01353209|464249697|FG000|Overall Study|Adverse Event|1|||
128989348|NCT01353209|464249698|FG001|Overall Study|Adverse Event|1|||
128989349|NCT03237325|464249702|FG000|Overall Study|Lost to Follow-up|3|||
128877288|NCT01200589|463844207|FG000|Overall Study|Study terminated|170|||
128877289|NCT01200589|463844208|FG001|Overall Study|Study terminated|172|||
128877290|NCT01154010|463844209|FG000|Overall Study|Lost to Follow-up|0|||
128877291|NCT01154010|463844210|FG001|Overall Study|Lost to Follow-up|1|||
128877292|NCT00439231|463844211|FG000|Overall Study|Lack of Efficacy|28|||
128877293|NCT02008877|463844212|FG000|Overall Study|Inevaluable|0|||
128877294|NCT02008877|463844213|FG001|Overall Study|Inevaluable|1|||
128877295|NCT02008877|463844214|FG002|Overall Study|Inevaluable|0|||
128877296|NCT02412371|463844215|FG000|Overall Study|Withdrawal by Subject|0|||
128877297|NCT02412371|463844216|FG001|Overall Study|Withdrawal by Subject|2|||
128877298|NCT02412371|463844217|FG002|Overall Study|Withdrawal by Subject|0|||
128877299|NCT02412371|463844218|FG003|Overall Study|Withdrawal by Subject|1|||
128877300|NCT02412371|463844219|FG004|Overall Study|Withdrawal by Subject|1|||
128877301|NCT02412371|463844220|FG005|Overall Study|Withdrawal by Subject|0|||
128877302|NCT02412371|463844215|FG000|Overall Study|Sponsor Discontinued Study|1|||
128877303|NCT02412371|463844216|FG001|Overall Study|Sponsor Discontinued Study|4|||
128877304|NCT02412371|463844217|FG002|Overall Study|Sponsor Discontinued Study|6|||
128877305|NCT02412371|463844218|FG003|Overall Study|Sponsor Discontinued Study|4|||
128877306|NCT02412371|463844219|FG004|Overall Study|Sponsor Discontinued Study|5|||
128877307|NCT02412371|463844220|FG005|Overall Study|Sponsor Discontinued Study|0|||
128877308|NCT02412371|463844215|FG000|Overall Study|Death|4|||
128877309|NCT02412371|463844216|FG001|Overall Study|Death|2|||
128877310|NCT02412371|463844217|FG002|Overall Study|Death|1|||
128877311|NCT02412371|463844218|FG003|Overall Study|Death|3|||
128877312|NCT02412371|463844219|FG004|Overall Study|Death|5|||
128877313|NCT02412371|463844220|FG005|Overall Study|Death|2|||
128877314|NCT02412371|463844215|FG000|Overall Study|Other|2|||
128877315|NCT02412371|463844216|FG001|Overall Study|Other|1|||
128877316|NCT02412371|463844217|FG002|Overall Study|Other|0|||
128989350|NCT03237325|464249703|FG001|Overall Study|Lost to Follow-up|5|||
128989351|NCT03237325|464249702|FG000|Overall Study|Physician Decision|2|||
128989352|NCT03237325|464249703|FG001|Overall Study|Physician Decision|4|||
128989353|NCT03237325|464249702|FG000|Overall Study|Withdrawal by Subject|9|||
128989354|NCT03237325|464249703|FG001|Overall Study|Withdrawal by Subject|12|||
128989355|NCT03237325|464249702|FG000|Overall Study|Noncompliance with Study Procedures|1|||
128989356|NCT03237325|464249703|FG001|Overall Study|Noncompliance with Study Procedures|1|||
128989357|NCT03237325|464249702|FG000|Overall Study|Termination by Sponsor|0|||
128989358|NCT03237325|464249703|FG001|Overall Study|Termination by Sponsor|1|||
128989359|NCT03237325|464249702|FG000|Overall Study|Reason other than described|0|||
128989360|NCT03237325|464249703|FG001|Overall Study|Reason other than described|2|||
128989361|NCT05102162|464249707|FG000|Overall Study|Withdrawal by Subject|3|||
128989362|NCT05102162|464249708|FG001|Overall Study|Withdrawal by Subject|0|||
128989363|NCT05102162|464249707|FG000|Overall Study|Baseline cultures negative|4|||
128989364|NCT05102162|464249708|FG001|Overall Study|Baseline cultures negative|2|||
128989365|NCT05102162|464249707|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
128989366|NCT05102162|464249708|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
128989367|NCT05102162|464249707|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
128989368|NCT05102162|464249708|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
128989369|NCT01165424|464249709|FG000|Overall Study|Clinical adverse experiences|1|||
128989370|NCT01165424|464249709|FG000|Overall Study|Laboratory adverse experiences|1|||
128989371|NCT01165424|464249709|FG000|Overall Study|Did not meet entry criteria|1|||
128989372|NCT01165424|464249709|FG000|Overall Study|Participant moved (relocated)|1|||
128989373|NCT02181673|464249710|FG000|Up to Week 24|Adverse Event|2|||
128989374|NCT02181673|464249711|FG001|Up to Week 24|Adverse Event|0|||
128989375|NCT02181673|464249712|FG002|Up to Week 24|Adverse Event|3|||
128989376|NCT02181673|464249710|FG000|Up to Week 24|Death|1|||
128989377|NCT02181673|464249711|FG001|Up to Week 24|Death|0|||
128989378|NCT02181673|464249712|FG002|Up to Week 24|Death|0|||
128989379|NCT02181673|464249710|FG000|Up to Week 24|Lack of Efficacy|1|||
128989380|NCT02181673|464249711|FG001|Up to Week 24|Lack of Efficacy|0|||
128989381|NCT02181673|464249712|FG002|Up to Week 24|Lack of Efficacy|0|||
128989382|NCT02181673|464249710|FG000|Up to Week 24|Lost to Follow-up|1|||
128989383|NCT02181673|464249711|FG001|Up to Week 24|Lost to Follow-up|0|||
128989384|NCT02181673|464249712|FG002|Up to Week 24|Lost to Follow-up|0|||
128989385|NCT02181673|464249710|FG000|Up to Week 24|Physician Decision|0|||
128989386|NCT02181673|464249711|FG001|Up to Week 24|Physician Decision|0|||
128989387|NCT02181673|464249712|FG002|Up to Week 24|Physician Decision|3|||
128989388|NCT02181673|464249710|FG000|Up to Week 24|Withdrawal by Subject|10|||
128989389|NCT02181673|464249711|FG001|Up to Week 24|Withdrawal by Subject|0|||
128989390|NCT02181673|464249712|FG002|Up to Week 24|Withdrawal by Subject|1|||
128877317|NCT02412371|463844218|FG003|Overall Study|Other|0|||
128877318|NCT02412371|463844219|FG004|Overall Study|Other|1|||
128877319|NCT02412371|463844220|FG005|Overall Study|Other|3|||
128877320|NCT02053792|463844221|FG000|Overall Study|Physician Decision|0|||
128877321|NCT02053792|463844222|FG001|Overall Study|Physician Decision|1|||
128877322|NCT02053792|463844221|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
128877323|NCT02053792|463844222|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
128877324|NCT02053792|463844221|FG000|Overall Study|Lack of Efficacy|1|||
128877325|NCT02053792|463844222|FG001|Overall Study|Lack of Efficacy|0|||
128877326|NCT02053792|463844221|FG000|Overall Study|Adverse Event|1|||
128877327|NCT02053792|463844222|FG001|Overall Study|Adverse Event|0|||
128877328|NCT02053792|463844221|FG000|Overall Study|Withdrawal by Subject|2|||
128877329|NCT02053792|463844222|FG001|Overall Study|Withdrawal by Subject|2|||
128877330|NCT02053792|463844221|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
128877331|NCT02053792|463844222|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
128877332|NCT02053792|463844221|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
128877333|NCT02053792|463844222|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
128877334|NCT03149549|463844223|FG000|Study Discontinuation--Treatment Period|Death|0|||
128877335|NCT03149549|463844224|FG001|Study Discontinuation--Treatment Period|Death|0|||
128877336|NCT03149549|463844225|FG002|Study Discontinuation--Treatment Period|Death|0|||
128877337|NCT03149549|463844226|FG003|Study Discontinuation--Treatment Period|Death|1|||
128877338|NCT03149549|463844227|FG004|Study Discontinuation--Treatment Period|Death|2|||
128877339|NCT03149549|463844228|FG005|Study Discontinuation--Treatment Period|Death|1|||
128877340|NCT03149549|463844229|FG006|Study Discontinuation--Treatment Period|Death|1|||
128877341|NCT03149549|463844230|FG007|Study Discontinuation--Treatment Period|Death|2|||
128877342|NCT03149549|463844231|FG008|Study Discontinuation--Treatment Period|Death|4|||
128877343|NCT03149549|463844232|FG009|Study Discontinuation--Treatment Period|Death|1|||
128877344|NCT03149549|463844233|FG010|Study Discontinuation--Treatment Period|Death|0|||
128877345|NCT03149549|463844234|FG011|Study Discontinuation--Treatment Period|Death|0|||
128989391|NCT02181673|464249710|FG000|Up to Week 24|Other|2|||
128989392|NCT02181673|464249711|FG001|Up to Week 24|Other|0|||
128989393|NCT02181673|464249712|FG002|Up to Week 24|Other|3|||
128989394|NCT02181673|464249710|FG000|Up to Week 24|Randomized not Treated|0|||
128989395|NCT02181673|464249711|FG001|Up to Week 24|Randomized not Treated|0|||
128989396|NCT02181673|464249712|FG002|Up to Week 24|Randomized not Treated|1|||
128989397|NCT02181673|464249710|FG000|Week 24-Week 60|Adverse Event|0|||
128989398|NCT02181673|464249711|FG001|Week 24-Week 60|Adverse Event|4|||
128989399|NCT02181673|464249712|FG002|Week 24-Week 60|Adverse Event|10|||
128989400|NCT02181673|464249710|FG000|Week 24-Week 60|Other|0|||
128989401|NCT02181673|464249711|FG001|Week 24-Week 60|Other|2|||
128989402|NCT02181673|464249712|FG002|Week 24-Week 60|Other|1|||
128989403|NCT02181673|464249710|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
128989404|NCT02181673|464249711|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
128989405|NCT02181673|464249712|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
128989406|NCT02181673|464249710|FG000|Week 24-Week 60|Pregnancy|0|||
128989407|NCT02181673|464249711|FG001|Week 24-Week 60|Pregnancy|0|||
128989408|NCT02181673|464249712|FG002|Week 24-Week 60|Pregnancy|1|||
128989409|NCT02181673|464249710|FG000|Week 24-Week 60|Lack of Efficacy|0|||
128989410|NCT02181673|464249711|FG001|Week 24-Week 60|Lack of Efficacy|0|||
128989411|NCT02181673|464249712|FG002|Week 24-Week 60|Lack of Efficacy|1|||
128989412|NCT02181673|464249710|FG000|Week 24-Week 60|Lost to Follow-up|0|||
128989413|NCT02181673|464249711|FG001|Week 24-Week 60|Lost to Follow-up|0|||
128989414|NCT02181673|464249712|FG002|Week 24-Week 60|Lost to Follow-up|1|||
128989415|NCT02181673|464249710|FG000|Week 24-Week 60|Physician Decision|0|||
128989416|NCT02181673|464249711|FG001|Week 24-Week 60|Physician Decision|0|||
128989417|NCT02181673|464249712|FG002|Week 24-Week 60|Physician Decision|1|||
128989418|NCT00227591|464249715|FG000|Overall Study|Withdrawal by Subject|1|||
128989419|NCT01886105|464249716|FG000|Overall Study|Lack of Efficacy|3|||
128989420|NCT03843775|464249719|FG000|Overall Study|Adverse Event|1|||
128989421|NCT03843775|464249720|FG001|Overall Study|Adverse Event|1|||
128989422|NCT03843775|464249719|FG000|Overall Study|Lack of Efficacy|2|||
128989423|NCT03843775|464249720|FG001|Overall Study|Lack of Efficacy|6|||
128989424|NCT03843775|464249719|FG000|Overall Study|Withdrawal by Subject|0|||
128989425|NCT03843775|464249720|FG001|Overall Study|Withdrawal by Subject|1|||
128989426|NCT04150107|464249723|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
128989427|NCT04150107|464249724|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
128989428|NCT04150107|464249723|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
128989429|NCT04150107|464249724|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
128989430|NCT00690573|464249736|FG000|Overall Study|Lack of Efficacy|8|||
128989431|NCT00690573|464249736|FG000|Overall Study|Withdrawal by Subject|1|||
128989432|NCT03505606|464251012|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
128989433|NCT03505606|464251013|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
128989434|NCT03505606|464251014|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
128989435|NCT03505606|464251012|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
128989436|NCT03505606|464251013|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
128989437|NCT03505606|464251014|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
128989438|NCT03505606|464251012|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
128989439|NCT03505606|464251013|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
128989440|NCT03505606|464251014|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
128989441|NCT03505606|464251012|FG000|Overall Study|Poor compliance with refractive correction|0|||
128989442|NCT03505606|464251013|FG001|Overall Study|Poor compliance with refractive correction|0|||
128989443|NCT03505606|464251014|FG002|Overall Study|Poor compliance with refractive correction|1|||
128989444|NCT03505606|464251012|FG000|Overall Study|Insufficient anisometropia|0|||
128989445|NCT03505606|464251013|FG001|Overall Study|Insufficient anisometropia|0|||
128989446|NCT03505606|464251014|FG002|Overall Study|Insufficient anisometropia|2|||
128989447|NCT03505606|464251012|FG000|Overall Study|Ectopia Lentis|0|||
128989448|NCT03505606|464251013|FG001|Overall Study|Ectopia Lentis|0|||
128989449|NCT03505606|464251014|FG002|Overall Study|Ectopia Lentis|1|||
128989450|NCT03505606|464251012|FG000|Overall Study|alternation of amblyopic eye|0|||
128989451|NCT03505606|464251013|FG001|Overall Study|alternation of amblyopic eye|1|||
128989452|NCT03505606|464251014|FG002|Overall Study|alternation of amblyopic eye|0|||
128989453|NCT02087865|464251016|FG000|Overall Study|Withdrawal by Subject|6|||
128989454|NCT02087865|464251017|FG001|Overall Study|Withdrawal by Subject|0|||
128989455|NCT02087865|464251018|FG002|Overall Study|Withdrawal by Subject|1|||
128989456|NCT02087865|464251016|FG000|Overall Study|Lost to Follow-up|0|||
128989457|NCT02087865|464251017|FG001|Overall Study|Lost to Follow-up|0|||
128989458|NCT02087865|464251018|FG002|Overall Study|Lost to Follow-up|1|||
128989459|NCT02087865|464251016|FG000|Overall Study|Drug Non-compliance|0|||
128989460|NCT02087865|464251017|FG001|Overall Study|Drug Non-compliance|2|||
128989461|NCT02087865|464251018|FG002|Overall Study|Drug Non-compliance|0|||
128989462|NCT02087865|464251016|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
128989463|NCT02087865|464251017|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
128989464|NCT02087865|464251018|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
128989465|NCT01392469|464251021|FG000|Overall Study|Adverse Event|2|||
128989466|NCT01392469|464251021|FG000|Overall Study|Withdrawal by Subject|1|||
128989467|NCT01392469|464251021|FG000|Overall Study|Protocol Violation|1|||
128989468|NCT00648739|464251024|FG000|Overall Study|Adverse Event|1|||
128989469|NCT00648739|464251025|FG001|Overall Study|Adverse Event|0|||
128989470|NCT00648739|464251026|FG002|Overall Study|Adverse Event|1|||
128989471|NCT00648739|464251027|FG003|Overall Study|Adverse Event|2|||
128989472|NCT00648739|464251028|FG004|Overall Study|Adverse Event|1|||
128989473|NCT00648739|464251029|FG005|Overall Study|Adverse Event|0|||
128989474|NCT00648739|464251030|FG006|Overall Study|Adverse Event|0|||
128989475|NCT00648739|464251024|FG000|Overall Study|Withdrawal by Subject|1|||
128989476|NCT00648739|464251025|FG001|Overall Study|Withdrawal by Subject|0|||
128989477|NCT00648739|464251026|FG002|Overall Study|Withdrawal by Subject|1|||
128989478|NCT00648739|464251027|FG003|Overall Study|Withdrawal by Subject|0|||
128989479|NCT00648739|464251028|FG004|Overall Study|Withdrawal by Subject|0|||
128989480|NCT00648739|464251029|FG005|Overall Study|Withdrawal by Subject|2|||
128989481|NCT00648739|464251030|FG006|Overall Study|Withdrawal by Subject|0|||
128989482|NCT00648739|464251024|FG000|Overall Study|Lack of Efficacy|0|||
128989483|NCT00648739|464251025|FG001|Overall Study|Lack of Efficacy|0|||
128989484|NCT00648739|464251026|FG002|Overall Study|Lack of Efficacy|0|||
128989485|NCT00648739|464251027|FG003|Overall Study|Lack of Efficacy|0|||
128989486|NCT00648739|464251028|FG004|Overall Study|Lack of Efficacy|1|||
128989487|NCT00648739|464251029|FG005|Overall Study|Lack of Efficacy|2|||
128989488|NCT00648739|464251030|FG006|Overall Study|Lack of Efficacy|0|||
128989489|NCT00648739|464251024|FG000|Overall Study|Investigator Considered it Advisable|0|||
128989490|NCT00648739|464251025|FG001|Overall Study|Investigator Considered it Advisable|0|||
128989491|NCT00648739|464251026|FG002|Overall Study|Investigator Considered it Advisable|0|||
128989492|NCT00648739|464251027|FG003|Overall Study|Investigator Considered it Advisable|0|||
128989493|NCT00648739|464251028|FG004|Overall Study|Investigator Considered it Advisable|0|||
128989494|NCT00648739|464251029|FG005|Overall Study|Investigator Considered it Advisable|1|||
128989495|NCT00648739|464251030|FG006|Overall Study|Investigator Considered it Advisable|1|||
128989496|NCT00648739|464251024|FG000|Overall Study|Death|0|||
128989497|NCT00648739|464251025|FG001|Overall Study|Death|1|||
128989498|NCT00648739|464251026|FG002|Overall Study|Death|0|||
128989499|NCT00648739|464251027|FG003|Overall Study|Death|0|||
128989500|NCT00648739|464251028|FG004|Overall Study|Death|0|||
128989501|NCT00648739|464251029|FG005|Overall Study|Death|0|||
128989502|NCT00648739|464251030|FG006|Overall Study|Death|0|||
128989503|NCT00648739|464251024|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
128989504|NCT00648739|464251025|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
128989505|NCT00648739|464251026|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
128989506|NCT00648739|464251027|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
128989507|NCT00648739|464251028|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
128989508|NCT00648739|464251029|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
128989509|NCT00648739|464251030|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
128989510|NCT00648739|464251024|FG000|Overall Study|Follow-up Visits Not Completed|0|||
128989511|NCT00648739|464251025|FG001|Overall Study|Follow-up Visits Not Completed|1|||
128989512|NCT00648739|464251026|FG002|Overall Study|Follow-up Visits Not Completed|0|||
128989513|NCT00648739|464251027|FG003|Overall Study|Follow-up Visits Not Completed|0|||
128989514|NCT00648739|464251028|FG004|Overall Study|Follow-up Visits Not Completed|0|||
128989515|NCT00648739|464251029|FG005|Overall Study|Follow-up Visits Not Completed|0|||
128989516|NCT00648739|464251030|FG006|Overall Study|Follow-up Visits Not Completed|0|||
128989517|NCT00564486|464251035|FG000|Overall Study|Adverse Event|0|||
128989518|NCT00564486|464251036|FG001|Overall Study|Adverse Event|1|||
128989519|NCT00564486|464251037|FG002|Overall Study|Adverse Event|0|||
128989520|NCT00564486|464251038|FG003|Overall Study|Adverse Event|0|||
128989521|NCT00564486|464251035|FG000|Overall Study|Withdrawal by Subject|4|||
128989522|NCT00564486|464251036|FG001|Overall Study|Withdrawal by Subject|0|||
128989523|NCT00564486|464251037|FG002|Overall Study|Withdrawal by Subject|0|||
128989524|NCT00564486|464251038|FG003|Overall Study|Withdrawal by Subject|5|||
128989525|NCT00564486|464251035|FG000|Overall Study|Subject refused to have blood drawn|0|||
128989526|NCT00564486|464251036|FG001|Overall Study|Subject refused to have blood drawn|0|||
128877346|NCT03149549|463844235|FG012|Study Discontinuation--Treatment Period|Death|1|||
128877347|NCT03149549|463844223|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877348|NCT03149549|463844224|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877349|NCT03149549|463844225|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877350|NCT03149549|463844226|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877351|NCT03149549|463844227|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877352|NCT03149549|463844228|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877353|NCT03149549|463844229|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877354|NCT03149549|463844230|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
128877355|NCT03149549|463844231|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877356|NCT03149549|463844232|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877357|NCT03149549|463844233|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877358|NCT03149549|463844234|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
128877359|NCT03149549|463844235|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
128877360|NCT03149549|463844223|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877361|NCT03149549|463844224|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877362|NCT03149549|463844225|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877363|NCT03149549|463844226|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
128877364|NCT03149549|463844227|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
128877365|NCT03149549|463844228|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
128877366|NCT03149549|463844229|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
128877367|NCT03149549|463844230|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877368|NCT03149549|463844231|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
128877369|NCT03149549|463844232|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877370|NCT03149549|463844233|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877371|NCT03149549|463844234|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877372|NCT03149549|463844235|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
128877373|NCT03149549|463844223|FG000|Study Discontinuation--Treatment Period|Other|0|||
128877374|NCT03149549|463844224|FG001|Study Discontinuation--Treatment Period|Other|0|||
128877375|NCT03149549|463844225|FG002|Study Discontinuation--Treatment Period|Other|0|||
128877376|NCT03149549|463844226|FG003|Study Discontinuation--Treatment Period|Other|0|||
128877377|NCT03149549|463844227|FG004|Study Discontinuation--Treatment Period|Other|0|||
128877378|NCT03149549|463844228|FG005|Study Discontinuation--Treatment Period|Other|0|||
128877379|NCT03149549|463844229|FG006|Study Discontinuation--Treatment Period|Other|0|||
128877380|NCT03149549|463844230|FG007|Study Discontinuation--Treatment Period|Other|1|||
128877381|NCT03149549|463844231|FG008|Study Discontinuation--Treatment Period|Other|0|||
128877382|NCT03149549|463844232|FG009|Study Discontinuation--Treatment Period|Other|1|||
128877383|NCT03149549|463844233|FG010|Study Discontinuation--Treatment Period|Other|0|||
128877384|NCT03149549|463844234|FG011|Study Discontinuation--Treatment Period|Other|0|||
128877385|NCT03149549|463844235|FG012|Study Discontinuation--Treatment Period|Other|0|||
128877386|NCT03149549|463844223|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877387|NCT03149549|463844224|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877388|NCT03149549|463844225|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877389|NCT03149549|463844226|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877390|NCT03149549|463844227|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877391|NCT03149549|463844228|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
128877392|NCT03149549|463844229|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
128877393|NCT03149549|463844230|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877394|NCT03149549|463844231|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
128877395|NCT03149549|463844232|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877396|NCT03149549|463844233|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877397|NCT03149549|463844234|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128989527|NCT00564486|464251037|FG002|Overall Study|Subject refused to have blood drawn|1|||
128989528|NCT00564486|464251038|FG003|Overall Study|Subject refused to have blood drawn|0|||
128989529|NCT00564486|464251035|FG000|Overall Study|Lost to Follow-up|3|||
128989530|NCT00564486|464251036|FG001|Overall Study|Lost to Follow-up|0|||
128989531|NCT00564486|464251037|FG002|Overall Study|Lost to Follow-up|2|||
128989532|NCT00564486|464251038|FG003|Overall Study|Lost to Follow-up|2|||
128989533|NCT03862807|464251043|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
128989534|NCT04362761|464251044|FG000|Part A (48 Weeks)|Adverse Event|2|||
128989535|NCT04362761|464251044|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
128989536|NCT04362761|464251044|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
128989537|NCT04362761|464251044|FG000|Part A (48 Weeks)|Other|5|||
128989538|NCT04362761|464251044|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
128989539|NCT04362761|464251044|FG000|Part B (86 Weeks)|Other|4|||
128989540|NCT00684645|464251045|FG000|Overall Study|Death|2|||
128989541|NCT00684645|464251045|FG000|Overall Study|Progressive disease|67|||
128989542|NCT00684645|464251045|FG000|Overall Study|Adverse Event|27|||
128989543|NCT00684645|464251045|FG000|Overall Study|Lost to Follow-up|3|||
128989544|NCT00684645|464251045|FG000|Overall Study|Other|15|||
128989545|NCT02525627|464251059|FG000|Overall Study|Revision|1|||
128989546|NCT02525627|464251060|FG001|Overall Study|Revision|1|||
128989547|NCT02525627|464251059|FG000|Overall Study|Withdrawal by Subject|1|||
128989548|NCT02525627|464251060|FG001|Overall Study|Withdrawal by Subject|2|||
128989549|NCT02525627|464251059|FG000|Overall Study|Death|1|||
128989550|NCT02525627|464251060|FG001|Overall Study|Death|0|||
128989551|NCT02525627|464251059|FG000|Overall Study|Site terminated|11|||
128989552|NCT02525627|464251060|FG001|Overall Study|Site terminated|10|||
128989553|NCT03746080|464251061|FG000|Overall Study|In follow up|2|||
128989554|NCT03746080|464251061|FG000|Overall Study|Death|15|||
128989555|NCT01473589|464251062|FG000|Overall Study|Adverse Event|1|||
128989556|NCT01473589|464251063|FG001|Overall Study|Adverse Event|1|||
128989557|NCT01473589|464251062|FG000|Overall Study|Death|2|||
128989558|NCT01473589|464251063|FG001|Overall Study|Death|0|||
128989559|NCT01473589|464251062|FG000|Overall Study|Lost to Follow-up|2|||
128989560|NCT01473589|464251063|FG001|Overall Study|Lost to Follow-up|2|||
128989561|NCT01473589|464251062|FG000|Overall Study|Protocol Violation|1|||
128989562|NCT01473589|464251063|FG001|Overall Study|Protocol Violation|0|||
128989563|NCT01473589|464251062|FG000|Overall Study|Withdrawal by Subject|5|||
128989564|NCT01473589|464251063|FG001|Overall Study|Withdrawal by Subject|11|||
128989565|NCT01473589|464251062|FG000|Overall Study|Physician Decision|0|||
128989566|NCT01473589|464251063|FG001|Overall Study|Physician Decision|1|||
128989567|NCT01473589|464251062|FG000|Overall Study|Entry criteria not met|0|||
128989568|NCT01473589|464251063|FG001|Overall Study|Entry criteria not met|1|||
128989569|NCT01819467|464251064|FG000|Overall Study|Physician Decision|20|||
128989570|NCT01819467|464251065|FG001|Overall Study|Physician Decision|9|||
128989571|NCT03256526|464251067|FG000|Overall Study|Adverse Event|1|||
128989572|NCT03256526|464251068|FG001|Overall Study|Adverse Event|0|||
128989573|NCT03256526|464251069|FG002|Overall Study|Adverse Event|1|||
128989574|NCT03256526|464251067|FG000|Overall Study|Lost to Follow-up|1|||
128989575|NCT03256526|464251068|FG001|Overall Study|Lost to Follow-up|0|||
128989576|NCT03256526|464251069|FG002|Overall Study|Lost to Follow-up|2|||
128989577|NCT02875340|464251070|FG000|Overall Study|Death|2|||
128989578|NCT02875340|464251070|FG000|Overall Study|Withdrawal by Subject|2|||
128989579|NCT02875340|464251070|FG000|Overall Study|Physician Decision|3|||
128989580|NCT02875340|464251070|FG000|Overall Study|Adverse Event|1|||
128989581|NCT01607398|464251073|FG000|Overall Study|Adverse Event|0|||
128989582|NCT01607398|464251074|FG001|Overall Study|Adverse Event|2|||
128989583|NCT01607398|464251073|FG000|Overall Study|Severe COPD|2|||
128989584|NCT01607398|464251074|FG001|Overall Study|Severe COPD|0|||
128989585|NCT04930536|464251077|FG000|Overall Study|Adverse Event|1|||
128989586|NCT04930536|464251078|FG001|Overall Study|Adverse Event|0|||
128989587|NCT04930536|464251077|FG000|Overall Study|Disease Progression|2|||
128989588|NCT04930536|464251078|FG001|Overall Study|Disease Progression|0|||
128989589|NCT04930536|464251077|FG000|Overall Study|Patient Decision|4|||
128989590|NCT04930536|464251078|FG001|Overall Study|Patient Decision|2|||
128989591|NCT04930536|464251077|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
128989592|NCT04930536|464251078|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
128989593|NCT01432600|464251079|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
128989594|NCT01432600|464251080|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
128989595|NCT01432600|464251081|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
128989596|NCT04139642|464251084|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
128989597|NCT04139642|464251085|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
128989598|NCT00433771|464251087|FG000|Overall Study|screen fail|14|||
128989599|NCT00433771|464251087|FG000|Overall Study|Treated and later found to be ineligible|2|||
128989600|NCT00433771|464251087|FG000|Overall Study|Death|2|||
128989601|NCT00433771|464251087|FG000|Overall Study|Failure to deploy stent|1|||
128989602|NCT00539006|464251091|FG000|Pre-treatment|Other|0|||
128989603|NCT00539006|464251092|FG001|Pre-treatment|Other|1|||
128989604|NCT00539006|464251093|FG002|Pre-treatment|Other|0|||
128989605|NCT00539006|464251094|FG003|Pre-treatment|Other|0|||
128989606|NCT00539006|464251091|FG000|Treatment Period 1|Lost to Follow-up|0|||
128989607|NCT00539006|464251092|FG001|Treatment Period 1|Lost to Follow-up|0|||
128989608|NCT00539006|464251093|FG002|Treatment Period 1|Lost to Follow-up|1|||
128989609|NCT00539006|464251094|FG003|Treatment Period 1|Lost to Follow-up|0|||
128989610|NCT00539006|464251091|FG000|Treatment Period 1|Protocol Violation|0|||
128989611|NCT00539006|464251092|FG001|Treatment Period 1|Protocol Violation|0|||
128989612|NCT00539006|464251093|FG002|Treatment Period 1|Protocol Violation|1|||
128989613|NCT00539006|464251094|FG003|Treatment Period 1|Protocol Violation|0|||
128989614|NCT00539006|464251091|FG000|Treatment Period 1|Lack of Efficacy|0|||
128989615|NCT00539006|464251092|FG001|Treatment Period 1|Lack of Efficacy|0|||
128989616|NCT00539006|464251093|FG002|Treatment Period 1|Lack of Efficacy|0|||
128989617|NCT00539006|464251094|FG003|Treatment Period 1|Lack of Efficacy|1|||
128989618|NCT00539006|464251091|FG000|Washout|Adverse Event|2|||
128989619|NCT00539006|464251092|FG001|Washout|Adverse Event|1|||
128989620|NCT00539006|464251093|FG002|Washout|Adverse Event|0|||
128989621|NCT00539006|464251094|FG003|Washout|Adverse Event|0|||
128989622|NCT00539006|464251091|FG000|Washout|Protocol Violation|1|||
128989623|NCT00539006|464251092|FG001|Washout|Protocol Violation|1|||
128989624|NCT00539006|464251093|FG002|Washout|Protocol Violation|0|||
128989625|NCT00539006|464251094|FG003|Washout|Protocol Violation|0|||
128989626|NCT00539006|464251091|FG000|Washout|Withdrawal by Subject|0|||
128989627|NCT00539006|464251092|FG001|Washout|Withdrawal by Subject|2|||
128989628|NCT00539006|464251093|FG002|Washout|Withdrawal by Subject|0|||
128989629|NCT00539006|464251094|FG003|Washout|Withdrawal by Subject|0|||
128989630|NCT00539006|464251091|FG000|Washout|Failed to meet continuation criteria|16|||
128989631|NCT00539006|464251092|FG001|Washout|Failed to meet continuation criteria|5|||
128989632|NCT00539006|464251093|FG002|Washout|Failed to meet continuation criteria|14|||
128989633|NCT00539006|464251094|FG003|Washout|Failed to meet continuation criteria|6|||
128989634|NCT00539006|464251091|FG000|Washout|Other|1|||
128989635|NCT00539006|464251092|FG001|Washout|Other|1|||
128989636|NCT00539006|464251093|FG002|Washout|Other|2|||
128989637|NCT00539006|464251094|FG003|Washout|Other|3|||
128989638|NCT00539006|464251091|FG000|Treatment Period 2|Protocol Violation|1|||
128989639|NCT00539006|464251092|FG001|Treatment Period 2|Protocol Violation|0|||
128989640|NCT00539006|464251093|FG002|Treatment Period 2|Protocol Violation|0|||
128989641|NCT00539006|464251094|FG003|Treatment Period 2|Protocol Violation|0|||
128989642|NCT00539006|464251091|FG000|Treatment Period 2|Other|0|||
128989643|NCT00539006|464251092|FG001|Treatment Period 2|Other|1|||
128989644|NCT00539006|464251093|FG002|Treatment Period 2|Other|0|||
128989645|NCT00539006|464251094|FG003|Treatment Period 2|Other|0|||
128989646|NCT02353572|464251097|FG000|Overall Study|Withdrawal by Subject|1|||
128989647|NCT02353572|464251097|FG000|Overall Study|Study terminated|2|||
128989648|NCT02230332|464251103|FG000|Overall Study|Adverse Event|2|||
128989649|NCT02230332|464251104|FG001|Overall Study|Adverse Event|1|||
128989650|NCT02230332|464251103|FG000|Overall Study|Lost to Follow-up|1|||
128989651|NCT02230332|464251104|FG001|Overall Study|Lost to Follow-up|0|||
128989652|NCT02230332|464251103|FG000|Overall Study|Protocol Violation|1|||
128989653|NCT02230332|464251104|FG001|Overall Study|Protocol Violation|0|||
128989654|NCT01036594|464251108|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
128989655|NCT01036594|464251109|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
128989656|NCT01036594|464251108|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
128989657|NCT01036594|464251109|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
128989658|NCT01036594|464251108|FG000|Week 12 Evaluation|Adverse Event|5|||
128989659|NCT01036594|464251109|FG001|Week 12 Evaluation|Adverse Event|0|||
128989660|NCT01036594|464251108|FG000|Week 12 Evaluation|Physician Decision|1|||
128989661|NCT01036594|464251109|FG001|Week 12 Evaluation|Physician Decision|0|||
128989662|NCT01036594|464251108|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
128989663|NCT01036594|464251109|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
128989664|NCT01036594|464251108|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
128989665|NCT01036594|464251109|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
128989666|NCT01036594|464251108|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
128989667|NCT01036594|464251109|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
128989668|NCT01036594|464251108|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
128989669|NCT01036594|464251109|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
128989670|NCT01036594|464251108|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
128989671|NCT01036594|464251109|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
128989672|NCT00244881|464251114|FG000|Overall Study|Withdrawal by Subject|3|||
128989673|NCT03664024|464251115|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
128989674|NCT03664024|464251115|FG000|Overall Study|Lost to Follow-up|2|||
128989675|NCT03664024|464251115|FG000|Overall Study|Withdrawal by Subject|2|||
128989676|NCT03664024|464251115|FG000|Overall Study|Death|80|||
128989677|NCT03159611|464251116|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
128989678|NCT03159611|464251117|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
128989679|NCT03159611|464251116|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
128989680|NCT03159611|464251117|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
128989681|NCT03159611|464251116|FG000|Overall Study|Protocol Violation|7|||
128989682|NCT03159611|464251117|FG001|Overall Study|Protocol Violation|4|||
128989683|NCT03159611|464251116|FG000|Overall Study|Adverse Event|1|||
128989684|NCT03159611|464251117|FG001|Overall Study|Adverse Event|0|||
128989685|NCT03159611|464251116|FG000|Overall Study|Withdrawal by Subject|1|||
128989686|NCT03159611|464251117|FG001|Overall Study|Withdrawal by Subject|1|||
128989687|NCT03159611|464251116|FG000|Overall Study|Non-compliance with protocol requirement|3|||
128989688|NCT03159611|464251117|FG001|Overall Study|Non-compliance with protocol requirement|2|||
128989689|NCT03159611|464251116|FG000|Overall Study|Inability to perform procedures|1|||
128989690|NCT03159611|464251117|FG001|Overall Study|Inability to perform procedures|0|||
128989691|NCT02057549|464251119|FG000|Overall Study|Lost to Follow-up|1|||
128989692|NCT02057549|464251120|FG001|Overall Study|Lost to Follow-up|0|||
128989693|NCT02057549|464251119|FG000|Overall Study|Physician Decision|1|||
128989694|NCT02057549|464251120|FG001|Overall Study|Physician Decision|0|||
128989695|NCT02057549|464251119|FG000|Overall Study|Withdrawal by Subject|1|||
128989696|NCT02057549|464251120|FG001|Overall Study|Withdrawal by Subject|0|||
128989697|NCT01418365|464251121|FG000|First Intervention|Withdrawal by Subject|0|||
128989698|NCT01418365|464251122|FG001|First Intervention|Withdrawal by Subject|1|||
128989699|NCT01418365|464251121|FG000|First Intervention|Non-compliance|1|||
128989700|NCT01418365|464251122|FG001|First Intervention|Non-compliance|0|||
128989701|NCT01418365|464251121|FG000|Second Intervention|Withdrawal by Subject|0|||
128989702|NCT01418365|464251122|FG001|Second Intervention|Withdrawal by Subject|1|||
128989703|NCT00518011|464251126|FG000|Overall Study|Death|1|||
128989704|NCT00518011|464251127|FG001|Overall Study|Death|1|||
128989705|NCT00518011|464251126|FG000|Overall Study|Adverse Event|2|||
128989706|NCT00518011|464251127|FG001|Overall Study|Adverse Event|3|||
128989707|NCT00518011|464251126|FG000|Overall Study|Disease Progression|2|||
128989708|NCT00518011|464251127|FG001|Overall Study|Disease Progression|2|||
128989709|NCT00518011|464251126|FG000|Overall Study|Other Reasons|3|||
128989710|NCT00518011|464251127|FG001|Overall Study|Other Reasons|2|||
128989711|NCT00518011|464251126|FG000|Overall Study|Withdrawal by Subject|1|||
128989712|NCT00518011|464251127|FG001|Overall Study|Withdrawal by Subject|0|||
128989713|NCT03409328|464251128|FG000|Overall Study|Lost to Follow-up|6|||
128989714|NCT03409328|464251129|FG001|Overall Study|Lost to Follow-up|3|||
128989715|NCT03930615|464251132|FG000|Overall Study|Death|9|||
128989716|NCT03930615|464251133|FG001|Overall Study|Death|3|||
128989717|NCT03930615|464251132|FG000|Overall Study|Lost to Follow-up|1|||
128989718|NCT03930615|464251133|FG001|Overall Study|Lost to Follow-up|2|||
128989719|NCT03930615|464251132|FG000|Overall Study|Physician Decision|3|||
128989720|NCT03930615|464251133|FG001|Overall Study|Physician Decision|4|||
128989721|NCT03930615|464251132|FG000|Overall Study|Withdrawal by Subject|13|||
128989722|NCT03930615|464251133|FG001|Overall Study|Withdrawal by Subject|2|||
128989723|NCT03930615|464251132|FG000|Overall Study|Not treated|1|||
128989724|NCT03930615|464251133|FG001|Overall Study|Not treated|1|||
128989725|NCT04611152|464251136|FG000|Overall Study|Adverse Event|9|||
128989726|NCT04611152|464251137|FG001|Overall Study|Adverse Event|8|||
128989727|NCT04611152|464251136|FG000|Overall Study|Non-compliance with study schedule|1|||
128989728|NCT04611152|464251137|FG001|Overall Study|Non-compliance with study schedule|3|||
128989729|NCT04611152|464251136|FG000|Overall Study|Withdrawal by Subject|5|||
128989730|NCT04611152|464251137|FG001|Overall Study|Withdrawal by Subject|6|||
128989731|NCT04611152|464251136|FG000|Overall Study|Lost to Follow-up|11|||
128989732|NCT04611152|464251137|FG001|Overall Study|Lost to Follow-up|2|||
128989733|NCT03644927|464251140|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
128989734|NCT03644927|464251141|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
128989735|NCT00956813|464251145|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
128989736|NCT00956813|464251146|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
128989737|NCT00956813|464251145|FG000|Flaxseed and Placebo|Ineligible|3|||
128989738|NCT00956813|464251146|FG001|Flaxseed and Placebo|Ineligible|1|||
128989739|NCT04797637|464251147|FG000|Overall Study|Lost to Follow-up|23|||
128989740|NCT04797637|464251148|FG001|Overall Study|Lost to Follow-up|32|||
128989741|NCT04797637|464251147|FG000|Overall Study|Withdrawal by Subject|0|||
128989742|NCT04797637|464251148|FG001|Overall Study|Withdrawal by Subject|1|||
128989743|NCT01525407|464251155|FG000|Overall Study|Change in recipient treatment plan|2|||
128989744|NCT01525407|464251156|FG001|Overall Study|Change in recipient treatment plan|2|||
128989745|NCT01525407|464251155|FG000|Overall Study|Withdrawal by Subject|0|||
128989746|NCT01525407|464251156|FG001|Overall Study|Withdrawal by Subject|1|||
128989747|NCT01525407|464251155|FG000|Overall Study|Transplant was delayed|0|||
129214494|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Transplant|0|||
129214495|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
128989748|NCT01525407|464251156|FG001|Overall Study|Transplant was delayed|1|||
128989749|NCT01525407|464251155|FG000|Overall Study|Delay in Transplant|1|||
128989750|NCT01525407|464251156|FG001|Overall Study|Delay in Transplant|0|||
129214496|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
128989751|NCT04502862|464251157|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
128989752|NCT04502862|464251158|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
128989753|NCT04502862|464251157|FG000|Overall Study|Withdrawal by Subject|1|||
128989754|NCT04502862|464251158|FG001|Overall Study|Withdrawal by Subject|0|||
128989755|NCT04502862|464251157|FG000|Overall Study|Adverse Event|1|||
128989756|NCT04502862|464251158|FG001|Overall Study|Adverse Event|1|||
128989757|NCT00242567|464252445|FG000|Overall Study|Adverse Event|70|||
128989758|NCT00242567|464252446|FG001|Overall Study|Adverse Event|43|||
128989759|NCT00242567|464252445|FG000|Overall Study|Disease Progression|17|||
128989760|NCT00242567|464252446|FG001|Overall Study|Disease Progression|22|||
128989761|NCT00242567|464252445|FG000|Overall Study|Symptomatic deterioration|9|||
128989762|NCT00242567|464252446|FG001|Overall Study|Symptomatic deterioration|3|||
128989763|NCT00242567|464252445|FG000|Overall Study|Lack of Efficacy|2|||
128989764|NCT00242567|464252446|FG001|Overall Study|Lack of Efficacy|2|||
128989765|NCT00242567|464252445|FG000|Overall Study|Lost to Follow-up|9|||
128989766|NCT00242567|464252446|FG001|Overall Study|Lost to Follow-up|19|||
128989767|NCT00242567|464252445|FG000|Overall Study|Withdrawal by Subject|33|||
128989768|NCT00242567|464252446|FG001|Overall Study|Withdrawal by Subject|28|||
128989769|NCT00242567|464252445|FG000|Overall Study|Protocol Violation|12|||
128989770|NCT00242567|464252446|FG001|Overall Study|Protocol Violation|12|||
128989771|NCT00242567|464252445|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
128989772|NCT00242567|464252446|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
128989773|NCT00242567|464252445|FG000|Overall Study|Other|14|||
128989774|NCT00242567|464252446|FG001|Overall Study|Other|9|||
128989775|NCT02729545|464252449|FG000|Overall Study|Pregnancy|1|||
128989776|NCT02729545|464252450|FG001|Overall Study|Pregnancy|1|||
128989777|NCT02729545|464252449|FG000|Overall Study|Lost to Follow-up|0|||
128989778|NCT02729545|464252450|FG001|Overall Study|Lost to Follow-up|1|||
128989779|NCT02729545|464252449|FG000|Overall Study|Withdrawal by Subject|2|||
128989780|NCT02729545|464252450|FG001|Overall Study|Withdrawal by Subject|3|||
128989781|NCT03079869|464252459|FG000|Overall Study|Adverse Event|6|||
128989782|NCT03079869|464252460|FG001|Overall Study|Adverse Event|8|||
128989783|NCT03079869|464252459|FG000|Overall Study|Withdrawal by Subject|4|||
128989784|NCT03079869|464252460|FG001|Overall Study|Withdrawal by Subject|1|||
128989785|NCT03079869|464252459|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
128989786|NCT03079869|464252460|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
128989787|NCT02411110|464252461|FG000|Treatment Period 1|Adverse Event|4|||
128989788|NCT02411110|464252462|FG001|Treatment Period 1|Adverse Event|2|||
128989789|NCT02411110|464252461|FG000|Treatment Period 1|Lost to Follow-up|1|||
128989790|NCT02411110|464252462|FG001|Treatment Period 1|Lost to Follow-up|0|||
128989791|NCT02411110|464252461|FG000|Treatment Period 1|Personal Reasons|2|||
128989792|NCT02411110|464252462|FG001|Treatment Period 1|Personal Reasons|5|||
128989793|NCT02411110|464252461|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
128989794|NCT02411110|464252462|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
128989795|NCT02411110|464252461|FG000|Treatment Period 2|Adverse Event|1|||
128989796|NCT02411110|464252462|FG001|Treatment Period 2|Adverse Event|0|||
128989797|NCT02411110|464252461|FG000|Treatment Period 2|Lost to Follow-up|0|||
128989798|NCT02411110|464252462|FG001|Treatment Period 2|Lost to Follow-up|2|||
128989799|NCT02411110|464252461|FG000|Treatment Period 2|Personal Reasons|0|||
128989800|NCT02411110|464252462|FG001|Treatment Period 2|Personal Reasons|2|||
128989801|NCT02871921|464252473|FG000|Overall Study|Withdrawal by Subject|34|||
128989802|NCT02871921|464252474|FG001|Overall Study|Withdrawal by Subject|27|||
128989803|NCT02871921|464252475|FG002|Overall Study|Withdrawal by Subject|27|||
128989804|NCT02871921|464252476|FG003|Overall Study|Withdrawal by Subject|30|||
128989805|NCT03319368|464252481|FG000|Overall Study|Discharge swabs not collected from resident|57|||
128989806|NCT03319368|464252482|FG001|Overall Study|Discharge swabs not collected from resident|46|||
128989807|NCT03000075|464252483|FG000|Part A|Adverse Event|4|||
128989808|NCT03000075|464252484|FG001|Part A|Adverse Event|0|||
128989809|NCT03000075|464252485|FG002|Part A|Adverse Event|0|||
128989810|NCT03000075|464252486|FG003|Part A|Adverse Event|0|||
128989811|NCT03000075|464252487|FG004|Part A|Adverse Event|0|||
128989812|NCT03000075|464252488|FG005|Part A|Adverse Event|0|||
128989813|NCT03000075|464252489|FG006|Part A|Adverse Event|0|||
128989814|NCT03000075|464252483|FG000|Part B|Not dosed due to AE|0|||
128989815|NCT03000075|464252484|FG001|Part B|Not dosed due to AE|0|||
128989816|NCT03000075|464252485|FG002|Part B|Not dosed due to AE|0|||
128989817|NCT03000075|464252486|FG003|Part B|Not dosed due to AE|0|||
128989818|NCT03000075|464252487|FG004|Part B|Not dosed due to AE|0|||
128989819|NCT03000075|464252488|FG005|Part B|Not dosed due to AE|2|||
128989820|NCT03000075|464252489|FG006|Part B|Not dosed due to AE|1|||
128989821|NCT03000075|464252483|FG000|Part B|Adverse Event|0|||
128989822|NCT03000075|464252484|FG001|Part B|Adverse Event|0|||
128989823|NCT03000075|464252485|FG002|Part B|Adverse Event|0|||
128989824|NCT03000075|464252486|FG003|Part B|Adverse Event|0|||
128989825|NCT03000075|464252487|FG004|Part B|Adverse Event|1|||
128989826|NCT03000075|464252488|FG005|Part B|Adverse Event|0|||
128989827|NCT03000075|464252489|FG006|Part B|Adverse Event|0|||
128989828|NCT00440193|464252494|FG000|Treatment Period|Adverse Event|74|||
128989829|NCT00440193|464252495|FG001|Treatment Period|Adverse Event|67|||
128989830|NCT00440193|464252494|FG000|Treatment Period|Death|19|||
128989831|NCT00440193|464252495|FG001|Treatment Period|Death|22|||
128989832|NCT00440193|464252494|FG000|Treatment Period|Lack of Efficacy|0|||
128989833|NCT00440193|464252495|FG001|Treatment Period|Lack of Efficacy|1|||
128989834|NCT00440193|464252494|FG000|Treatment Period|Lost to Follow-up|12|||
128989835|NCT00440193|464252495|FG001|Treatment Period|Lost to Follow-up|18|||
128989836|NCT00440193|464252494|FG000|Treatment Period|Physician Decision|3|||
128989837|NCT00440193|464252495|FG001|Treatment Period|Physician Decision|6|||
128989838|NCT00440193|464252494|FG000|Treatment Period|Protocol Violation|16|||
128989839|NCT00440193|464252495|FG001|Treatment Period|Protocol Violation|19|||
128989840|NCT00440193|464252494|FG000|Treatment Period|Withdrawal by Subject|36|||
128989841|NCT00440193|464252495|FG001|Treatment Period|Withdrawal by Subject|77|||
128989842|NCT00440193|464252494|FG000|Treatment Period|Clinical endpoint reached|28|||
128989843|NCT00440193|464252495|FG001|Treatment Period|Clinical endpoint reached|25|||
128989844|NCT00440193|464252494|FG000|Treatment Period|Study terminated by sponsor|102|||
128989845|NCT00440193|464252495|FG001|Treatment Period|Study terminated by sponsor|94|||
128989846|NCT00440193|464252494|FG000|Treatment Period|Protocol driven decision point|2|||
128989847|NCT00440193|464252495|FG001|Treatment Period|Protocol driven decision point|2|||
128989848|NCT00440193|464252494|FG000|Treatment Period|Switch to commercial drug|0|||
128989849|NCT00440193|464252495|FG001|Treatment Period|Switch to commercial drug|2|||
128989850|NCT00440193|464252494|FG000|Treatment Period|Technical problems|1|||
128989851|NCT00440193|464252495|FG001|Treatment Period|Technical problems|1|||
128989852|NCT00440193|464252494|FG000|Treatment Period|Participant convenience|5|||
128989853|NCT00440193|464252495|FG001|Treatment Period|Participant convenience|2|||
128989854|NCT00440193|464252494|FG000|Treatment Period|Participant did not receive treatment|7|||
128989855|NCT00440193|464252495|FG001|Treatment Period|Participant did not receive treatment|13|||
128989856|NCT00440193|464252494|FG000|Treatment Period|Site closed by investigator|0|||
128989857|NCT00440193|464252495|FG001|Treatment Period|Site closed by investigator|2|||
128989858|NCT00440193|464252494|FG000|Observational Period|Adverse Event|2|||
128989859|NCT00440193|464252495|FG001|Observational Period|Adverse Event|2|||
128989860|NCT00440193|464252494|FG000|Observational Period|Death|15|||
128989861|NCT00440193|464252495|FG001|Observational Period|Death|20|||
128989862|NCT00440193|464252494|FG000|Observational Period|Lost to Follow-up|12|||
128989863|NCT00440193|464252495|FG001|Observational Period|Lost to Follow-up|8|||
128989864|NCT00440193|464252494|FG000|Observational Period|Protocol Violation|1|||
128989865|NCT00440193|464252495|FG001|Observational Period|Protocol Violation|0|||
128989866|NCT00440193|464252494|FG000|Observational Period|Withdrawal by Subject|11|||
128989867|NCT00440193|464252495|FG001|Observational Period|Withdrawal by Subject|8|||
128989868|NCT00440193|464252494|FG000|Observational Period|Physician Decision|1|||
128989869|NCT00440193|464252495|FG001|Observational Period|Physician Decision|0|||
128989870|NCT00440193|464252494|FG000|Observational Period|Clinical endpoint reached|1|||
128989871|NCT00440193|464252495|FG001|Observational Period|Clinical endpoint reached|0|||
128989872|NCT00440193|464252494|FG000|Observational Period|Participant convenience|2|||
128989873|NCT00440193|464252495|FG001|Observational Period|Participant convenience|0|||
128989874|NCT00824993|464252496|FG000|Overall Study|Withdrawal by Subject|1|||
128989875|NCT00824993|464252497|FG001|Overall Study|Withdrawal by Subject|1|||
128989876|NCT00824993|464252496|FG000|Overall Study|Malignancy Relapse|9|||
128989877|NCT00824993|464252497|FG001|Overall Study|Malignancy Relapse|10|||
128989878|NCT00824993|464252496|FG000|Overall Study|Rapid Bone Loss|0|||
128989879|NCT00824993|464252497|FG001|Overall Study|Rapid Bone Loss|1|||
128989880|NCT00824993|464252496|FG000|Overall Study|Non-Compliant|2|||
128989881|NCT00824993|464252497|FG001|Overall Study|Non-Compliant|1|||
128989882|NCT00824993|464252496|FG000|Overall Study|Insurance Issue|2|||
128989883|NCT00824993|464252497|FG001|Overall Study|Insurance Issue|1|||
128989884|NCT00824993|464252496|FG000|Overall Study|Death|0|||
128989885|NCT00824993|464252497|FG001|Overall Study|Death|3|||
128989886|NCT00530621|464252500|FG000|Overall Study|Adverse Event|11|||
128989887|NCT00530621|464252501|FG001|Overall Study|Adverse Event|8|||
128989888|NCT00530621|464252500|FG000|Overall Study|Physician Decision|2|||
128989889|NCT00530621|464252501|FG001|Overall Study|Physician Decision|4|||
128989890|NCT00530621|464252500|FG000|Overall Study|Progressive Disease (PD)|47|||
128989891|NCT00530621|464252501|FG001|Overall Study|Progressive Disease (PD)|40|||
128989892|NCT00530621|464252500|FG000|Overall Study|Sponsor Decision|12|||
128989893|NCT00530621|464252501|FG001|Overall Study|Sponsor Decision|15|||
128989894|NCT00530621|464252500|FG000|Overall Study|Subject Decision|4|||
128989895|NCT00530621|464252501|FG001|Overall Study|Subject Decision|7|||
128989896|NCT00530621|464252500|FG000|Overall Study|Death|3|||
128989897|NCT00530621|464252501|FG001|Overall Study|Death|6|||
128989898|NCT00530621|464252500|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
128989899|NCT00530621|464252501|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
128989900|NCT02596009|464252502|FG000|Overall Study|Administrative problems|0|||
128989901|NCT02596009|464252503|FG001|Overall Study|Administrative problems|1|||
128763083|NCT03145766|463422733|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
128877398|NCT03149549|463844235|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
128877399|NCT03149549|463844223|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877400|NCT03149549|463844224|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877401|NCT03149549|463844225|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877402|NCT03149549|463844226|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877403|NCT03149549|463844227|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
128877404|NCT03149549|463844228|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877405|NCT03149549|463844229|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877406|NCT03149549|463844230|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
128877407|NCT03149549|463844231|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
128877408|NCT03149549|463844232|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877409|NCT03149549|463844233|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
128877410|NCT03149549|463844234|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
128877411|NCT03149549|463844235|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
128877412|NCT03149549|463844223|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128877413|NCT03149549|463844224|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128877414|NCT03149549|463844225|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128877415|NCT03149549|463844226|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128877416|NCT03149549|463844227|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
128877417|NCT03149549|463844228|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128877418|NCT03149549|463844229|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128877419|NCT03149549|463844230|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
128877420|NCT03149549|463844231|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
128877421|NCT03149549|463844232|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
128877422|NCT03149549|463844233|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
128877423|NCT03149549|463844234|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
128877424|NCT03149549|463844235|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
128877425|NCT03149549|463844223|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
128877426|NCT03149549|463844224|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
128877427|NCT03149549|463844225|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
128877428|NCT03149549|463844226|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
128877429|NCT03149549|463844227|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
128877430|NCT03149549|463844228|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
128877431|NCT03149549|463844229|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
128877432|NCT03149549|463844230|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
128877433|NCT03149549|463844231|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
128877434|NCT03149549|463844232|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
128877435|NCT03149549|463844233|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
128877436|NCT03149549|463844234|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
128877437|NCT03149549|463844235|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
128877438|NCT03149549|463844223|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
128877439|NCT03149549|463844224|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
128877440|NCT03149549|463844225|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
128877441|NCT03149549|463844226|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
128877442|NCT03149549|463844227|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
128877443|NCT03149549|463844228|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
128877444|NCT03149549|463844229|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
128877445|NCT03149549|463844230|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
128877446|NCT03149549|463844231|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
128877447|NCT03149549|463844232|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
128877448|NCT03149549|463844233|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
128877449|NCT03149549|463844234|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
128877450|NCT03149549|463844235|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
128877451|NCT02502799|463846220|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
128877452|NCT02502799|463846221|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
128877453|NCT02502799|463846222|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
128877454|NCT02502799|463846223|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
128877455|NCT02502799|463846220|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
128877456|NCT02502799|463846221|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
128877457|NCT02502799|463846222|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
128877458|NCT02502799|463846223|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
128877459|NCT02502799|463846220|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
128877460|NCT02502799|463846221|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
128877461|NCT02502799|463846222|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
128989902|NCT02596009|464252504|FG002|Overall Study|Administrative problems|0|||
128989903|NCT02596009|464252505|FG003|Overall Study|Administrative problems|0|||
128989904|NCT02596009|464252506|FG004|Overall Study|Administrative problems|0|||
128989905|NCT02596009|464252507|FG005|Overall Study|Administrative problems|0|||
128989906|NCT02998645|464252508|FG000|Treatment Period 1|Adverse Event|6|||
128989907|NCT02998645|464252508|FG000|Treatment Period 1|Death|5|||
128989908|NCT02998645|464252508|FG000|Treatment Period 1|Technical Problems|4|||
128989909|NCT02998645|464252508|FG000|Treatment Period 1|Lack of Efficacy|2|||
128989910|NCT02998645|464252508|FG000|Treatment Period 1|Progressive disease|1|||
128989911|NCT02998645|464252508|FG000|Treatment Period 1|Subject/guardian decision|1|||
128989912|NCT02998645|464252508|FG000|Treatment Period 2|Lack of Efficacy|5|||
128989913|NCT02998645|464252508|FG000|Treatment Period 2|Adverse Event|2|||
128989914|NCT02998645|464252508|FG000|Treatment Period 2|Progressive disease|2|||
128989915|NCT02998645|464252508|FG000|Treatment Period 2|Physician Decision|1|||
128989916|NCT01023022|464252510|FG000|Overall Study|Death|5|||
128989917|NCT01023022|464252510|FG000|Overall Study|Lost to Follow-up|7|||
128989918|NCT01023022|464252510|FG000|Overall Study|due to technical issues|2|||
128989919|NCT03917654|464252511|FG000|Year 1|Withdrawal by Subject|1|||
128989920|NCT03917654|464252512|FG001|Year 1|Withdrawal by Subject|0|||
128989921|NCT03917654|464252513|FG002|Year 1|Withdrawal by Subject|0|||
128989922|NCT03917654|464252514|FG003|Year 1|Withdrawal by Subject|0|||
128989923|NCT03917654|464252515|FG004|Year 1|Withdrawal by Subject|0|||
128989924|NCT03917654|464252516|FG005|Year 1|Withdrawal by Subject|1|||
128989925|NCT03917654|464252517|FG006|Year 1|Withdrawal by Subject|6|||
128989926|NCT03917654|464252518|FG007|Year 1|Withdrawal by Subject|2|||
128989927|NCT03917654|464252519|FG008|Year 1|Withdrawal by Subject|5|||
128989928|NCT03917654|464252520|FG009|Year 1|Withdrawal by Subject|3|||
128989929|NCT03917654|464252521|FG010|Year 1|Withdrawal by Subject|1|||
128989930|NCT03917654|464252522|FG011|Year 1|Withdrawal by Subject|0|||
128989931|NCT03917654|464252511|FG000|Year 1|Travel|0|||
128989932|NCT03917654|464252512|FG001|Year 1|Travel|1|||
128989933|NCT03917654|464252513|FG002|Year 1|Travel|1|||
128989934|NCT03917654|464252514|FG003|Year 1|Travel|0|||
128989935|NCT03917654|464252515|FG004|Year 1|Travel|4|||
128989936|NCT03917654|464252516|FG005|Year 1|Travel|4|||
128989937|NCT03917654|464252517|FG006|Year 1|Travel|10|||
128989938|NCT03917654|464252518|FG007|Year 1|Travel|8|||
128989939|NCT03917654|464252519|FG008|Year 1|Travel|2|||
128989940|NCT03917654|464252520|FG009|Year 1|Travel|5|||
128989941|NCT03917654|464252521|FG010|Year 1|Travel|3|||
128989942|NCT03917654|464252522|FG011|Year 1|Travel|3|||
128989943|NCT03917654|464252511|FG000|Year 1|Subject moved away from site|0|||
128989944|NCT03917654|464252512|FG001|Year 1|Subject moved away from site|1|||
128989945|NCT03917654|464252513|FG002|Year 1|Subject moved away from site|0|||
128989946|NCT03917654|464252514|FG003|Year 1|Subject moved away from site|0|||
128989947|NCT03917654|464252515|FG004|Year 1|Subject moved away from site|0|||
128989948|NCT03917654|464252516|FG005|Year 1|Subject moved away from site|0|||
128989949|NCT03917654|464252517|FG006|Year 1|Subject moved away from site|1|||
128989950|NCT03917654|464252518|FG007|Year 1|Subject moved away from site|2|||
128989951|NCT03917654|464252519|FG008|Year 1|Subject moved away from site|1|||
128989952|NCT03917654|464252520|FG009|Year 1|Subject moved away from site|0|||
128989953|NCT03917654|464252521|FG010|Year 1|Subject moved away from site|0|||
128989954|NCT03917654|464252522|FG011|Year 1|Subject moved away from site|3|||
128989955|NCT03917654|464252511|FG000|Year 1|Spouse/Family member request|0|||
128989956|NCT03917654|464252512|FG001|Year 1|Spouse/Family member request|0|||
128989957|NCT03917654|464252513|FG002|Year 1|Spouse/Family member request|1|||
128989958|NCT03917654|464252514|FG003|Year 1|Spouse/Family member request|0|||
128989959|NCT03917654|464252515|FG004|Year 1|Spouse/Family member request|1|||
128989960|NCT03917654|464252516|FG005|Year 1|Spouse/Family member request|0|||
128989961|NCT03917654|464252517|FG006|Year 1|Spouse/Family member request|0|||
128989962|NCT03917654|464252518|FG007|Year 1|Spouse/Family member request|2|||
128989963|NCT03917654|464252519|FG008|Year 1|Spouse/Family member request|0|||
128989964|NCT03917654|464252520|FG009|Year 1|Spouse/Family member request|0|||
128989965|NCT03917654|464252521|FG010|Year 1|Spouse/Family member request|0|||
128989966|NCT03917654|464252522|FG011|Year 1|Spouse/Family member request|1|||
128989967|NCT03917654|464252511|FG000|Year 1|Death|0|||
128989968|NCT03917654|464252512|FG001|Year 1|Death|0|||
128763084|NCT03145766|463422734|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
128989969|NCT03917654|464252513|FG002|Year 1|Death|0|||
128989970|NCT03917654|464252514|FG003|Year 1|Death|0|||
128989971|NCT03917654|464252515|FG004|Year 1|Death|0|||
128989972|NCT03917654|464252516|FG005|Year 1|Death|0|||
128989973|NCT03917654|464252517|FG006|Year 1|Death|0|||
128989974|NCT03917654|464252518|FG007|Year 1|Death|0|||
128989975|NCT03917654|464252519|FG008|Year 1|Death|1|||
128989976|NCT03917654|464252520|FG009|Year 1|Death|1|||
128989977|NCT03917654|464252521|FG010|Year 1|Death|0|||
128989978|NCT03917654|464252522|FG011|Year 1|Death|0|||
128989979|NCT03917654|464252511|FG000|Year 1|Lost to Follow-up|0|||
128989980|NCT03917654|464252512|FG001|Year 1|Lost to Follow-up|0|||
128989981|NCT03917654|464252513|FG002|Year 1|Lost to Follow-up|0|||
128989982|NCT03917654|464252514|FG003|Year 1|Lost to Follow-up|0|||
128989983|NCT03917654|464252515|FG004|Year 1|Lost to Follow-up|0|||
128989984|NCT03917654|464252516|FG005|Year 1|Lost to Follow-up|0|||
128989985|NCT03917654|464252517|FG006|Year 1|Lost to Follow-up|2|||
128989986|NCT03917654|464252518|FG007|Year 1|Lost to Follow-up|0|||
128989987|NCT03917654|464252519|FG008|Year 1|Lost to Follow-up|0|||
128989988|NCT03917654|464252520|FG009|Year 1|Lost to Follow-up|0|||
128989989|NCT03917654|464252521|FG010|Year 1|Lost to Follow-up|0|||
128989990|NCT03917654|464252522|FG011|Year 1|Lost to Follow-up|0|||
128989991|NCT03917654|464252511|FG000|Year 1|Missed visits|0|||
128989992|NCT03917654|464252512|FG001|Year 1|Missed visits|0|||
128989993|NCT03917654|464252513|FG002|Year 1|Missed visits|0|||
128989994|NCT03917654|464252514|FG003|Year 1|Missed visits|0|||
128989995|NCT03917654|464252515|FG004|Year 1|Missed visits|0|||
128989996|NCT03917654|464252516|FG005|Year 1|Missed visits|0|||
128989997|NCT03917654|464252517|FG006|Year 1|Missed visits|0|||
128989998|NCT03917654|464252518|FG007|Year 1|Missed visits|0|||
128989999|NCT03917654|464252519|FG008|Year 1|Missed visits|0|||
128990000|NCT03917654|464252520|FG009|Year 1|Missed visits|0|||
128990001|NCT03917654|464252521|FG010|Year 1|Missed visits|1|||
128990002|NCT03917654|464252522|FG011|Year 1|Missed visits|1|||
128990003|NCT03917654|464252511|FG000|Year 1|Pregnancy|0|||
128990004|NCT03917654|464252512|FG001|Year 1|Pregnancy|0|||
128990005|NCT03917654|464252513|FG002|Year 1|Pregnancy|0|||
128990006|NCT03917654|464252514|FG003|Year 1|Pregnancy|0|||
128990007|NCT03917654|464252515|FG004|Year 1|Pregnancy|0|||
128990008|NCT03917654|464252516|FG005|Year 1|Pregnancy|0|||
128990009|NCT03917654|464252517|FG006|Year 1|Pregnancy|0|||
128990010|NCT03917654|464252518|FG007|Year 1|Pregnancy|1|||
128990011|NCT03917654|464252519|FG008|Year 1|Pregnancy|0|||
128990012|NCT03917654|464252520|FG009|Year 1|Pregnancy|1|||
128990013|NCT03917654|464252521|FG010|Year 1|Pregnancy|0|||
128990014|NCT03917654|464252522|FG011|Year 1|Pregnancy|0|||
128990015|NCT03917654|464252511|FG000|Year 2|Travel|1|||
128990016|NCT03917654|464252512|FG001|Year 2|Travel|0|||
128990017|NCT03917654|464252513|FG002|Year 2|Travel|0|||
128990018|NCT03917654|464252514|FG003|Year 2|Travel|0|||
128990019|NCT03917654|464252515|FG004|Year 2|Travel|1|||
128990020|NCT03917654|464252516|FG005|Year 2|Travel|1|||
128990021|NCT03917654|464252517|FG006|Year 2|Travel|2|||
128990022|NCT03917654|464252518|FG007|Year 2|Travel|1|||
128990023|NCT03917654|464252519|FG008|Year 2|Travel|0|||
128990024|NCT03917654|464252520|FG009|Year 2|Travel|1|||
128990025|NCT03917654|464252521|FG010|Year 2|Travel|0|||
128990026|NCT03917654|464252522|FG011|Year 2|Travel|1|||
128990027|NCT03917654|464252511|FG000|Year 2|Married|1|||
128877462|NCT02502799|463846223|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
128877463|NCT02502799|463846220|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
128877464|NCT02502799|463846221|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
128877465|NCT02502799|463846222|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
128877466|NCT02502799|463846223|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
128877467|NCT02502799|463846220|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
128877468|NCT02502799|463846221|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
128877469|NCT02502799|463846222|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
128877470|NCT02502799|463846223|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
128877471|NCT01076192|463846226|FG000|Overall Study|Other|197|||
128877472|NCT02680002|463846227|FG000|Overall Study|Lost to Follow-up|5|||
128877473|NCT02680002|463846228|FG001|Overall Study|Lost to Follow-up|1|||
128877474|NCT02680002|463846229|FG002|Overall Study|Lost to Follow-up|4|||
128877475|NCT02680002|463846230|FG003|Overall Study|Lost to Follow-up|2|||
128877476|NCT02680002|463846231|FG004|Overall Study|Lost to Follow-up|0|||
128877477|NCT02680002|463846232|FG005|Overall Study|Lost to Follow-up|2|||
128877478|NCT02680002|463846227|FG000|Overall Study|Physician Decision|5|||
128990028|NCT03917654|464252512|FG001|Year 2|Married|0|||
128990029|NCT03917654|464252513|FG002|Year 2|Married|0|||
128990030|NCT03917654|464252514|FG003|Year 2|Married|0|||
128990031|NCT03917654|464252515|FG004|Year 2|Married|0|||
128990032|NCT03917654|464252516|FG005|Year 2|Married|0|||
128990033|NCT03917654|464252517|FG006|Year 2|Married|1|||
128990034|NCT03917654|464252518|FG007|Year 2|Married|1|||
128990035|NCT03917654|464252519|FG008|Year 2|Married|0|||
128990036|NCT03917654|464252520|FG009|Year 2|Married|0|||
128990037|NCT03917654|464252521|FG010|Year 2|Married|0|||
128990038|NCT03917654|464252522|FG011|Year 2|Married|0|||
128990039|NCT03917654|464252511|FG000|Year 2|Subject moved away from site|1|||
128990040|NCT03917654|464252512|FG001|Year 2|Subject moved away from site|0|||
128990041|NCT03917654|464252513|FG002|Year 2|Subject moved away from site|0|||
128990042|NCT03917654|464252514|FG003|Year 2|Subject moved away from site|0|||
128990043|NCT03917654|464252515|FG004|Year 2|Subject moved away from site|1|||
128990044|NCT03917654|464252516|FG005|Year 2|Subject moved away from site|0|||
128990045|NCT03917654|464252517|FG006|Year 2|Subject moved away from site|2|||
128990046|NCT03917654|464252518|FG007|Year 2|Subject moved away from site|3|||
128990047|NCT03917654|464252519|FG008|Year 2|Subject moved away from site|0|||
128990048|NCT03917654|464252520|FG009|Year 2|Subject moved away from site|2|||
128990049|NCT03917654|464252521|FG010|Year 2|Subject moved away from site|0|||
128990050|NCT03917654|464252522|FG011|Year 2|Subject moved away from site|1|||
128990051|NCT03917654|464252511|FG000|Year 2|Year 2 Screening failure|0|||
128990052|NCT03917654|464252512|FG001|Year 2|Year 2 Screening failure|1|||
128990053|NCT03917654|464252513|FG002|Year 2|Year 2 Screening failure|0|||
128990054|NCT03917654|464252514|FG003|Year 2|Year 2 Screening failure|0|||
128990055|NCT03917654|464252515|FG004|Year 2|Year 2 Screening failure|2|||
128990056|NCT03917654|464252516|FG005|Year 2|Year 2 Screening failure|0|||
128990057|NCT03917654|464252517|FG006|Year 2|Year 2 Screening failure|4|||
128990058|NCT03917654|464252518|FG007|Year 2|Year 2 Screening failure|3|||
128990059|NCT03917654|464252519|FG008|Year 2|Year 2 Screening failure|10|||
128990060|NCT03917654|464252520|FG009|Year 2|Year 2 Screening failure|2|||
128990061|NCT03917654|464252521|FG010|Year 2|Year 2 Screening failure|1|||
128990062|NCT03917654|464252522|FG011|Year 2|Year 2 Screening failure|1|||
128990063|NCT03917654|464252511|FG000|Year 2|Death|0|||
128990064|NCT03917654|464252512|FG001|Year 2|Death|0|||
128990065|NCT03917654|464252513|FG002|Year 2|Death|0|||
128990066|NCT03917654|464252514|FG003|Year 2|Death|0|||
128990067|NCT03917654|464252515|FG004|Year 2|Death|0|||
128990068|NCT03917654|464252516|FG005|Year 2|Death|1|||
128990069|NCT03917654|464252517|FG006|Year 2|Death|0|||
128990070|NCT03917654|464252518|FG007|Year 2|Death|0|||
128990071|NCT03917654|464252519|FG008|Year 2|Death|1|||
128990072|NCT03917654|464252520|FG009|Year 2|Death|1|||
128990073|NCT03917654|464252521|FG010|Year 2|Death|0|||
128990074|NCT03917654|464252522|FG011|Year 2|Death|0|||
128990075|NCT03917654|464252511|FG000|Year 2|Withdrawal by Subject|0|||
128990076|NCT03917654|464252512|FG001|Year 2|Withdrawal by Subject|0|||
128990077|NCT03917654|464252513|FG002|Year 2|Withdrawal by Subject|0|||
128990078|NCT03917654|464252514|FG003|Year 2|Withdrawal by Subject|0|||
128990079|NCT03917654|464252515|FG004|Year 2|Withdrawal by Subject|0|||
128990080|NCT03917654|464252516|FG005|Year 2|Withdrawal by Subject|0|||
128990081|NCT03917654|464252517|FG006|Year 2|Withdrawal by Subject|3|||
128990082|NCT03917654|464252518|FG007|Year 2|Withdrawal by Subject|0|||
128990083|NCT03917654|464252519|FG008|Year 2|Withdrawal by Subject|2|||
128990084|NCT03917654|464252520|FG009|Year 2|Withdrawal by Subject|5|||
128990085|NCT03917654|464252521|FG010|Year 2|Withdrawal by Subject|0|||
128990086|NCT03917654|464252522|FG011|Year 2|Withdrawal by Subject|0|||
128990087|NCT03917654|464252511|FG000|Year 2|Spouse/family member request|0|||
128990088|NCT03917654|464252512|FG001|Year 2|Spouse/family member request|0|||
128990089|NCT03917654|464252513|FG002|Year 2|Spouse/family member request|0|||
128990090|NCT03917654|464252514|FG003|Year 2|Spouse/family member request|0|||
128990091|NCT03917654|464252515|FG004|Year 2|Spouse/family member request|0|||
128990092|NCT03917654|464252516|FG005|Year 2|Spouse/family member request|0|||
128990093|NCT03917654|464252517|FG006|Year 2|Spouse/family member request|1|||
128990094|NCT03917654|464252518|FG007|Year 2|Spouse/family member request|0|||
128990095|NCT03917654|464252519|FG008|Year 2|Spouse/family member request|0|||
128990096|NCT03917654|464252520|FG009|Year 2|Spouse/family member request|0|||
128990097|NCT03917654|464252521|FG010|Year 2|Spouse/family member request|0|||
128990098|NCT03917654|464252522|FG011|Year 2|Spouse/family member request|0|||
128990099|NCT03917654|464252511|FG000|Year 2|Lost to Follow-up|0|||
128990100|NCT03917654|464252512|FG001|Year 2|Lost to Follow-up|0|||
128990101|NCT03917654|464252513|FG002|Year 2|Lost to Follow-up|0|||
128990102|NCT03917654|464252514|FG003|Year 2|Lost to Follow-up|0|||
128990103|NCT03917654|464252515|FG004|Year 2|Lost to Follow-up|0|||
128990104|NCT03917654|464252516|FG005|Year 2|Lost to Follow-up|0|||
128990105|NCT03917654|464252517|FG006|Year 2|Lost to Follow-up|1|||
128990106|NCT03917654|464252518|FG007|Year 2|Lost to Follow-up|0|||
128990107|NCT03917654|464252519|FG008|Year 2|Lost to Follow-up|1|||
128990108|NCT03917654|464252520|FG009|Year 2|Lost to Follow-up|0|||
128990109|NCT03917654|464252521|FG010|Year 2|Lost to Follow-up|0|||
128990110|NCT03917654|464252522|FG011|Year 2|Lost to Follow-up|1|||
128990111|NCT03917654|464252511|FG000|Year 2|Adverse Event|0|||
128990112|NCT03917654|464252512|FG001|Year 2|Adverse Event|0|||
128990113|NCT03917654|464252513|FG002|Year 2|Adverse Event|0|||
128990114|NCT03917654|464252514|FG003|Year 2|Adverse Event|0|||
128990115|NCT03917654|464252515|FG004|Year 2|Adverse Event|0|||
128990116|NCT03917654|464252516|FG005|Year 2|Adverse Event|0|||
128990117|NCT03917654|464252517|FG006|Year 2|Adverse Event|0|||
128990118|NCT03917654|464252518|FG007|Year 2|Adverse Event|0|||
128990119|NCT03917654|464252519|FG008|Year 2|Adverse Event|0|||
128990120|NCT03917654|464252520|FG009|Year 2|Adverse Event|1|||
128990121|NCT03917654|464252521|FG010|Year 2|Adverse Event|0|||
128990122|NCT03917654|464252522|FG011|Year 2|Adverse Event|0|||
128990123|NCT00905437|464252525|FG000|Overall Study|Adverse Event|3|||
128990124|NCT00905437|464252526|FG001|Overall Study|Adverse Event|2|||
128990125|NCT00905437|464252525|FG000|Overall Study|Lost to Follow-up|0|||
128990126|NCT00905437|464252526|FG001|Overall Study|Lost to Follow-up|1|||
128990127|NCT00905437|464252525|FG000|Overall Study|Withdrawal by Subject|0|||
128990128|NCT00905437|464252526|FG001|Overall Study|Withdrawal by Subject|1|||
128990129|NCT00905437|464252525|FG000|Overall Study|Other|5|||
128990130|NCT00905437|464252526|FG001|Overall Study|Other|6|||
128990131|NCT01306968|464252529|FG000|Overall Study|Lost to Follow-up|1|||
128990132|NCT01306968|464252530|FG001|Overall Study|Lost to Follow-up|1|||
128990133|NCT01306968|464252531|FG002|Overall Study|Lost to Follow-up|0|||
128990134|NCT01306968|464252532|FG003|Overall Study|Lost to Follow-up|0|||
128990135|NCT01306968|464252529|FG000|Overall Study|Physician Decision|0|||
128990136|NCT01306968|464252530|FG001|Overall Study|Physician Decision|1|||
128990137|NCT01306968|464252531|FG002|Overall Study|Physician Decision|0|||
128990138|NCT01306968|464252532|FG003|Overall Study|Physician Decision|0|||
128990139|NCT01306968|464252529|FG000|Overall Study|Relocated and left active duty|0|||
128990140|NCT01306968|464252530|FG001|Overall Study|Relocated and left active duty|1|||
128990141|NCT01306968|464252531|FG002|Overall Study|Relocated and left active duty|1|||
128990142|NCT01306968|464252532|FG003|Overall Study|Relocated and left active duty|1|||
128990143|NCT01306968|464252529|FG000|Overall Study|Withdrew - time commitment|0|||
128990144|NCT01306968|464252530|FG001|Overall Study|Withdrew - time commitment|0|||
128990145|NCT01306968|464252531|FG002|Overall Study|Withdrew - time commitment|0|||
128990146|NCT01306968|464252532|FG003|Overall Study|Withdrew - time commitment|2|||
128990147|NCT01306968|464252529|FG000|Overall Study|Withdrew over privacy concerns|0|||
128990148|NCT01306968|464252530|FG001|Overall Study|Withdrew over privacy concerns|0|||
128990149|NCT01306968|464252531|FG002|Overall Study|Withdrew over privacy concerns|0|||
128990150|NCT01306968|464252532|FG003|Overall Study|Withdrew over privacy concerns|1|||
128990151|NCT03252015|464252535|FG000|Overall Study|Withdrawal by Subject|0|||
128990152|NCT03252015|464252536|FG001|Overall Study|Withdrawal by Subject|1|||
128990153|NCT03252015|464252537|FG002|Overall Study|Withdrawal by Subject|1|||
128990154|NCT03252015|464252538|FG003|Overall Study|Withdrawal by Subject|0|||
128990155|NCT03252015|464252535|FG000|Overall Study|Adverse Event|1|||
128990156|NCT03252015|464252536|FG001|Overall Study|Adverse Event|0|||
128990157|NCT03252015|464252537|FG002|Overall Study|Adverse Event|0|||
128990158|NCT03252015|464252538|FG003|Overall Study|Adverse Event|1|||
128990159|NCT03128931|464252539|FG000|Overall Study|Physician Decision|1|||
128990160|NCT03128931|464252539|FG000|Overall Study|Equipment Issues|3|||
128990161|NCT01329562|464252540|FG000|Overall Study|Protocol Violation|5|||
128990162|NCT01329562|464252541|FG001|Overall Study|Protocol Violation|3|||
128990163|NCT01329562|464252540|FG000|Overall Study|Lost to Follow-up|1|||
128990164|NCT01329562|464252541|FG001|Overall Study|Lost to Follow-up|1|||
128990165|NCT01329562|464252540|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
128990166|NCT01329562|464252541|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
128990167|NCT01329562|464252540|FG000|Overall Study|Physician Decision|0|||
128990168|NCT01329562|464252541|FG001|Overall Study|Physician Decision|1|||
128990169|NCT00061568|464252544|FG000|Overall Study|Lost to Follow-up|12|||
128990170|NCT00061568|464252545|FG001|Overall Study|Lost to Follow-up|0|||
128990171|NCT00061568|464252544|FG000|Overall Study|Death|6|||
128990172|NCT00061568|464252545|FG001|Overall Study|Death|0|||
128990173|NCT00061568|464252544|FG000|Overall Study|Withdrawal by Subject|1|||
128990174|NCT00061568|464252545|FG001|Overall Study|Withdrawal by Subject|0|||
128990175|NCT01071278|464252549|FG000|Overall Study|Premature Discontinuation|254|||
128990176|NCT01071278|464252549|FG000|Overall Study|Completion Status Unknown|459|||
128990177|NCT00903409|464252550|FG000|Overall Study|Adverse Event|11|||
128990178|NCT00903409|464252551|FG001|Overall Study|Adverse Event|9|||
128990179|NCT00903409|464252550|FG000|Overall Study|Non-compliance with Protocol|1|||
128990180|NCT00903409|464252551|FG001|Overall Study|Non-compliance with Protocol|1|||
128990181|NCT00903409|464252550|FG000|Overall Study|Laboratory Abnormality|2|||
128990182|NCT00903409|464252551|FG001|Overall Study|Laboratory Abnormality|0|||
128990183|NCT00903409|464252550|FG000|Overall Study|Withdrawal by Subject|8|||
128990184|NCT00903409|464252551|FG001|Overall Study|Withdrawal by Subject|8|||
128990185|NCT00903409|464252550|FG000|Overall Study|Other|2|||
128990186|NCT00903409|464252551|FG001|Overall Study|Other|3|||
128990187|NCT00903409|464252550|FG000|Overall Study|Lost to Follow-up|2|||
128990188|NCT00903409|464252551|FG001|Overall Study|Lost to Follow-up|6|||
128990189|NCT00797316|464252552|FG000|Overall Study|Administrative problems|1|||
128990190|NCT00797316|464252553|FG001|Overall Study|Administrative problems|0|||
128990191|NCT00797316|464252552|FG000|Overall Study|Adverse Event|5|||
128990192|NCT00797316|464252553|FG001|Overall Study|Adverse Event|3|||
128877479|NCT02680002|463846228|FG001|Overall Study|Physician Decision|1|||
128990193|NCT00797316|464252552|FG000|Overall Study|Lost to Follow-up|4|||
128990194|NCT00797316|464252553|FG001|Overall Study|Lost to Follow-up|8|||
128990195|NCT00797316|464252552|FG000|Overall Study|Protocol Deviation|1|||
128990196|NCT00797316|464252553|FG001|Overall Study|Protocol Deviation|2|||
128990197|NCT00797316|464252552|FG000|Overall Study|Patient withdrew consent|12|||
128990198|NCT00797316|464252553|FG001|Overall Study|Patient withdrew consent|6|||
128990199|NCT00797316|464252552|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128990200|NCT00797316|464252553|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
128990201|NCT03239340|464252556|FG000|Overall Study|Other|26|||
128990202|NCT03239340|464252556|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
128990203|NCT03239340|464252556|FG000|Overall Study|Death|40|||
128990204|NCT03239340|464252556|FG000|Overall Study|Lost to Follow-up|2|||
128990205|NCT03239340|464252556|FG000|Overall Study|Physician Decision|16|||
128990206|NCT03239340|464252556|FG000|Overall Study|Withdrawal by Subject|27|||
128990207|NCT03868059|464252559|FG000|Overall Study|Adverse Event|3|||
128990208|NCT03868059|464252559|FG000|Overall Study|Lost to Follow-up|3|||
128990209|NCT03868059|464252559|FG000|Overall Study|Withdrawal by Subject|6|||
128990210|NCT02061293|464252560|FG000|Overall Study|Elevated Blood Pressure|1|||
128990211|NCT02061293|464252561|FG001|Overall Study|Elevated Blood Pressure|1|||
128990212|NCT04066894|464252562|FG000|Overall Study|Lack of Efficacy|1|||
128990213|NCT04066894|464252562|FG000|Overall Study|Screen Failure|1|||
128990214|NCT03494816|464252564|FG000|Overall Study|Protocol Violation|2|||
128990215|NCT03494816|464252564|FG000|Overall Study|Physician Decision|2|||
128990216|NCT03494816|464252564|FG000|Overall Study|Did not start trial treatment|1|||
128990217|NCT03494816|464252564|FG000|Overall Study|Adverse Event|1|||
128990218|NCT01283282|464252565|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
128990219|NCT01283282|464252566|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
128990220|NCT01283282|464252565|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
128990221|NCT01283282|464252566|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
128990222|NCT01283282|464252565|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
128990223|NCT01283282|464252566|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
128990224|NCT00777920|464252567|FG000|Overall Study|Adverse Event|39|||
128990225|NCT00777920|464252567|FG000|Overall Study|Withdrawal of Consent|4|||
128990226|NCT00777920|464252567|FG000|Overall Study|Lost to Follow-up|1|||
128990227|NCT00777920|464252567|FG000|Overall Study|Investigator's discretion|1|||
128990228|NCT00777920|464252567|FG000|Overall Study|Clinical status did not improve|1|||
128990229|NCT00777920|464252567|FG000|Overall Study|Other, not specified|4|||
128990230|NCT00483717|464252568|FG000|Overall Study|Protocol Violation|5|||
128990231|NCT00483717|464252569|FG001|Overall Study|Protocol Violation|7|||
128990232|NCT00483717|464252568|FG000|Overall Study|Time of dosing missing|1|||
128990233|NCT00483717|464252569|FG001|Overall Study|Time of dosing missing|1|||
128990234|NCT00483717|464252568|FG000|Overall Study|No treatment for migraine|16|||
128990235|NCT00483717|464252569|FG001|Overall Study|No treatment for migraine|13|||
128990236|NCT00483717|464252568|FG000|Overall Study|Lost to Follow-up|1|||
128990237|NCT00483717|464252569|FG001|Overall Study|Lost to Follow-up|0|||
128990238|NCT00483717|464252568|FG000|Overall Study|Withdrawal by Subject|1|||
128990239|NCT00483717|464252569|FG001|Overall Study|Withdrawal by Subject|0|||
128990240|NCT03878108|464252570|FG000|Overall Study|Adverse Event|1|||
128990241|NCT03878108|464252571|FG001|Overall Study|Adverse Event|0|||
128990242|NCT01682681|464252572|FG000|Overall Study|Lack of Efficacy|62|||
128990243|NCT01682681|464252572|FG000|Overall Study|Withdrawal by Subject|1|||
128990244|NCT01682681|464252572|FG000|Overall Study|Moved to other hospital|10|||
128990245|NCT01682681|464252572|FG000|Overall Study|Lost to Follow-up|174|||
128990246|NCT01682681|464252572|FG000|Overall Study|Adverse Event|46|||
128990247|NCT01682681|464252572|FG000|Overall Study|tapering of topiramate|5|||
128990248|NCT01682681|464252572|FG000|Overall Study|Other|21|||
128990249|NCT01682681|464252572|FG000|Overall Study|Low compliance|13|||
128990250|NCT00975000|464252573|FG000|Overall Study|Other|1|||
128990251|NCT00975000|464252574|FG001|Overall Study|Other|0|||
128990252|NCT00975000|464252573|FG000|Overall Study|Adverse Event|1|||
128990253|NCT00975000|464252574|FG001|Overall Study|Adverse Event|1|||
128990254|NCT00975000|464252573|FG000|Overall Study|Withdrawal by Subject|2|||
128990255|NCT00975000|464252574|FG001|Overall Study|Withdrawal by Subject|2|||
128990256|NCT00975000|464252573|FG000|Overall Study|Lost to Follow-up|0|||
128990257|NCT00975000|464252574|FG001|Overall Study|Lost to Follow-up|1|||
128990258|NCT00975000|464252573|FG000|Overall Study|Protocol-specified Criteria|1|||
128990259|NCT00975000|464252574|FG001|Overall Study|Protocol-specified Criteria|0|||
128990260|NCT00975000|464252573|FG000|Overall Study|Non-compliance|0|||
128990261|NCT00975000|464252574|FG001|Overall Study|Non-compliance|1|||
128990262|NCT01126359|464252575|FG000|First Intervention (20-minutes)|Physician Decision|0|||
128990263|NCT01126359|464252576|FG001|First Intervention (20-minutes)|Physician Decision|1|||
128990264|NCT00902486|464252577|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
128990265|NCT00902486|464252578|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
128990266|NCT00902486|464252579|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
128990267|NCT00902486|464252580|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
128990268|NCT00902486|464252581|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
128990269|NCT00902486|464252582|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
128990270|NCT00902486|464252577|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
128990271|NCT00902486|464252578|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
128990272|NCT00902486|464252579|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
128990273|NCT00902486|464252580|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
128990274|NCT00902486|464252581|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
128990275|NCT00902486|464252582|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
128990276|NCT00902486|464252577|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
128990277|NCT00902486|464252578|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
128990278|NCT00902486|464252579|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
128990279|NCT00902486|464252580|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
128990280|NCT00902486|464252581|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
128990281|NCT00902486|464252582|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
128990282|NCT00902486|464252577|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
128990283|NCT00902486|464252578|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
128990284|NCT00902486|464252579|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
128990285|NCT00902486|464252580|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
128990286|NCT00902486|464252581|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
128990287|NCT00902486|464252582|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
128990288|NCT00902486|464252577|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
128990289|NCT00902486|464252578|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
128990290|NCT00902486|464252579|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
128990291|NCT00902486|464252580|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
128990292|NCT00902486|464252581|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
128990293|NCT00902486|464252582|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
128990294|NCT00902486|464252577|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
128990295|NCT00902486|464252578|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
128990296|NCT00902486|464252579|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
128990297|NCT00902486|464252580|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
128990298|NCT00902486|464252581|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
128990299|NCT00902486|464252582|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
128990300|NCT00902486|464252577|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
128990301|NCT00902486|464252578|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
128990302|NCT00902486|464252579|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
128990303|NCT00902486|464252580|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
128990304|NCT00902486|464252581|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
128990305|NCT00902486|464252582|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
128990306|NCT00902486|464252577|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
128990307|NCT00902486|464252578|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
128990308|NCT00902486|464252579|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
128990309|NCT00902486|464252580|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
128990310|NCT00902486|464252581|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
128990311|NCT00902486|464252582|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
128990312|NCT00902486|464252577|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
128990313|NCT00902486|464252578|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
128990314|NCT00902486|464252579|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
128990315|NCT00902486|464252580|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
128990316|NCT00902486|464252581|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
128990317|NCT00902486|464252582|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
128990318|NCT00902486|464252577|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
128990319|NCT00902486|464252578|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
128990320|NCT00902486|464252579|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
128990321|NCT00902486|464252580|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
128990322|NCT00902486|464252581|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
128990323|NCT00902486|464252582|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
128990324|NCT00902486|464252577|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
128990325|NCT00902486|464252578|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
128990326|NCT00902486|464252579|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
128990327|NCT00902486|464252580|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
128990328|NCT00902486|464252581|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
128990329|NCT00902486|464252582|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
128990330|NCT02332655|464252583|FG000|Overall Study|Lack of Efficacy|1|||
128990331|NCT01298661|464252584|FG000|Overall Study|Withdrawal by Subject|2|||
128990332|NCT01298661|464252585|FG001|Overall Study|Withdrawal by Subject|0|||
128990333|NCT01298661|464252586|FG002|Overall Study|Withdrawal by Subject|2|||
128990334|NCT01808508|464254941|FG000|Overall Study|Lost to Follow-up|1|||
128990335|NCT01808508|464254942|FG001|Overall Study|Lost to Follow-up|0|||
128990336|NCT01808508|464254943|FG002|Overall Study|Lost to Follow-up|0|||
128990337|NCT01017731|464254944|FG000|Overall Study|Lost to Follow-up|2|||
128990338|NCT01017731|464254944|FG000|Overall Study|Withdrawal by Subject|3|||
128990339|NCT01017731|464254944|FG000|Overall Study|Physician Decision|2|||
128990340|NCT01017731|464254944|FG000|Overall Study|Adverse Event|1|||
128990341|NCT01803464|464254949|FG000|Overall Study|Incomplete data|0|||
128990342|NCT01803464|464254950|FG001|Overall Study|Incomplete data|0|||
128990343|NCT01803464|464254951|FG002|Overall Study|Incomplete data|4|||
128990344|NCT01803464|464254952|FG003|Overall Study|Incomplete data|0|||
128990345|NCT01803464|464254949|FG000|Overall Study|Withdrawal by Subject|1|||
128990346|NCT01803464|464254950|FG001|Overall Study|Withdrawal by Subject|0|||
128990347|NCT01803464|464254951|FG002|Overall Study|Withdrawal by Subject|0|||
128990348|NCT01803464|464254952|FG003|Overall Study|Withdrawal by Subject|0|||
128990349|NCT02860039|464254958|FG000|Overall Study|Death|4|||
128990350|NCT02860039|464254959|FG001|Overall Study|Death|0|||
128990351|NCT02860039|464254958|FG000|Overall Study|Lost to Follow-up|2|||
128990352|NCT02860039|464254959|FG001|Overall Study|Lost to Follow-up|2|||
128990353|NCT02860039|464254958|FG000|Overall Study|Protocol Violation|3|||
128990354|NCT02860039|464254959|FG001|Overall Study|Protocol Violation|1|||
128990355|NCT02860039|464254958|FG000|Overall Study|Withdrawal by Subject|1|||
128990356|NCT02860039|464254959|FG001|Overall Study|Withdrawal by Subject|0|||
128990357|NCT02860039|464254958|FG000|Overall Study|Not otherwise eligible|1|||
128990358|NCT02860039|464254959|FG001|Overall Study|Not otherwise eligible|1|||
128990359|NCT01360021|464254960|FG000|Overall Study|Eligibility criteria + other|2|||
128990360|NCT01360021|464254961|FG001|Overall Study|Eligibility criteria + other|1|||
128990361|NCT01360021|464254962|FG002|Overall Study|Eligibility criteria + other|1|||
128990362|NCT01360021|464254960|FG000|Overall Study|Protocol Violation|0|||
128990363|NCT01360021|464254961|FG001|Overall Study|Protocol Violation|0|||
128990364|NCT01360021|464254962|FG002|Overall Study|Protocol Violation|1|||
128990365|NCT01360021|464254960|FG000|Overall Study|Withdrawal by Subject|4|||
128990366|NCT01360021|464254961|FG001|Overall Study|Withdrawal by Subject|0|||
128990367|NCT01360021|464254962|FG002|Overall Study|Withdrawal by Subject|2|||
128990368|NCT01360021|464254960|FG000|Overall Study|Adverse Event|2|||
128990369|NCT01360021|464254961|FG001|Overall Study|Adverse Event|3|||
128990370|NCT01360021|464254962|FG002|Overall Study|Adverse Event|3|||
128990371|NCT01257737|464254964|FG000|Overall Study|Lost to Follow-up|1|||
128990372|NCT01257737|464254965|FG001|Overall Study|Lost to Follow-up|2|||
128990373|NCT01257737|464254964|FG000|Overall Study|Liver transplant|1|||
128990374|NCT01257737|464254965|FG001|Overall Study|Liver transplant|0|||
128990375|NCT01257737|464254964|FG000|Overall Study|Relocation out of the country|0|||
128990376|NCT01257737|464254965|FG001|Overall Study|Relocation out of the country|1|||
128990377|NCT01257737|464254964|FG000|Overall Study|Withdrew from study|0|||
128990378|NCT01257737|464254965|FG001|Overall Study|Withdrew from study|1|||
128990379|NCT03170271|464254969|FG000|Overall Study|Adverse Event|7|||
128990380|NCT03170271|464254970|FG001|Overall Study|Adverse Event|2|||
128990381|NCT03170271|464254969|FG000|Overall Study|Lost to Follow-up|0|||
128990382|NCT03170271|464254970|FG001|Overall Study|Lost to Follow-up|1|||
128990383|NCT03170271|464254969|FG000|Overall Study|Physician Decision|1|||
128990384|NCT03170271|464254970|FG001|Overall Study|Physician Decision|0|||
128990385|NCT03170271|464254969|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
128990386|NCT03170271|464254970|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
128990387|NCT03170271|464254969|FG000|Overall Study|Withdrawal by Subject|17|||
128990388|NCT03170271|464254970|FG001|Overall Study|Withdrawal by Subject|5|||
128990389|NCT03170271|464254969|FG000|Overall Study|Other|2|||
128990390|NCT03170271|464254970|FG001|Overall Study|Other|2|||
128990391|NCT03170271|464254969|FG000|Overall Study|Randomized in error|4|||
128990392|NCT03170271|464254970|FG001|Overall Study|Randomized in error|0|||
128990393|NCT03123120|464254972|FG000|Overall Study|Lost to Follow-up|0|||
128990394|NCT03123120|464254973|FG001|Overall Study|Lost to Follow-up|1|||
128990395|NCT03123120|464254972|FG000|Overall Study|Withdrawal by Subject|0|||
128990396|NCT03123120|464254973|FG001|Overall Study|Withdrawal by Subject|1|||
128990397|NCT00806416|464254976|FG000|Period 1 - Part I|Adverse Event|0|||
128990398|NCT00806416|464254977|FG001|Period 1 - Part I|Adverse Event|1|||
128990399|NCT00806416|464254978|FG002|Period 1 - Part I|Adverse Event|0|||
128990400|NCT00806416|464254979|FG003|Period 1 - Part I|Adverse Event|0|||
128990401|NCT00806416|464254976|FG000|Period 1 - Part I|Lost to Follow-up|0|||
128990402|NCT00806416|464254977|FG001|Period 1 - Part I|Lost to Follow-up|2|||
128990403|NCT00806416|464254978|FG002|Period 1 - Part I|Lost to Follow-up|0|||
128990404|NCT00806416|464254979|FG003|Period 1 - Part I|Lost to Follow-up|0|||
128990405|NCT00806416|464254976|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
128990406|NCT00806416|464254977|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
128990407|NCT00806416|464254978|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
128990408|NCT00806416|464254979|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
128990409|NCT00806416|464254976|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
128990410|NCT00806416|464254977|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
128990411|NCT00806416|464254978|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
128990412|NCT00806416|464254979|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
128990413|NCT01244516|464254984|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
128990414|NCT01244516|464254985|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
128990415|NCT01244516|464254986|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
128990416|NCT01244516|464254984|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
128990417|NCT01244516|464254985|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
128990418|NCT01244516|464254986|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
128990419|NCT01244516|464254984|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
128990420|NCT01244516|464254985|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
128990421|NCT01244516|464254986|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
128990422|NCT01244516|464254984|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
128990423|NCT01244516|464254985|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
128990424|NCT01244516|464254986|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
128990425|NCT01244516|464254984|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
128990426|NCT01244516|464254985|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
128990427|NCT01244516|464254986|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
128990428|NCT01244516|464254984|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
128990429|NCT01244516|464254985|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
128990430|NCT01244516|464254986|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
128990431|NCT01244516|464254984|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
128990432|NCT01244516|464254985|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
128990433|NCT01244516|464254986|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
128990434|NCT03345485|464254989|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
128990435|NCT03345485|464254990|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
128990436|NCT03345485|464254991|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
128990437|NCT03345485|464254992|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
128990438|NCT03345485|464254993|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
128990439|NCT03345485|464254994|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
128990440|NCT03345485|464254995|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
128990441|NCT03345485|464254996|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
128990442|NCT03345485|464254997|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
128990443|NCT03345485|464254998|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
128990444|NCT03345485|464254999|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
128990445|NCT03345485|464255000|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
128990446|NCT03345485|464255001|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
128990447|NCT03359473|464255002|FG000|Overall Study|Adverse Event|0|||
128990448|NCT03359473|464255003|FG001|Overall Study|Adverse Event|2|||
128990449|NCT03359473|464255004|FG002|Overall Study|Adverse Event|5|||
128990450|NCT03359473|464255005|FG003|Overall Study|Adverse Event|3|||
128990451|NCT03359473|464255002|FG000|Overall Study|Lost to Follow-up|0|||
128990452|NCT03359473|464255003|FG001|Overall Study|Lost to Follow-up|1|||
128990453|NCT03359473|464255004|FG002|Overall Study|Lost to Follow-up|0|||
128990454|NCT03359473|464255005|FG003|Overall Study|Lost to Follow-up|0|||
128990455|NCT03359473|464255002|FG000|Overall Study|Physician Decision|0|||
128990456|NCT03359473|464255003|FG001|Overall Study|Physician Decision|1|||
128990457|NCT03359473|464255004|FG002|Overall Study|Physician Decision|0|||
128990458|NCT03359473|464255005|FG003|Overall Study|Physician Decision|1|||
128990459|NCT03359473|464255002|FG000|Overall Study|Withdrawal by Subject|1|||
128990460|NCT03359473|464255003|FG001|Overall Study|Withdrawal by Subject|2|||
128990461|NCT03359473|464255004|FG002|Overall Study|Withdrawal by Subject|1|||
128990462|NCT03359473|464255005|FG003|Overall Study|Withdrawal by Subject|0|||
128990463|NCT03359473|464255002|FG000|Overall Study|Protocol-defined stopping criteria|1|||
128990464|NCT03359473|464255003|FG001|Overall Study|Protocol-defined stopping criteria|0|||
128990465|NCT03359473|464255004|FG002|Overall Study|Protocol-defined stopping criteria|0|||
128990466|NCT03359473|464255005|FG003|Overall Study|Protocol-defined stopping criteria|1|||
128990467|NCT05302414|464255006|FG000|Pretest to Posttest|Lost to Follow-up|12|||
128990468|NCT05302414|464255007|FG001|Pretest to Posttest|Lost to Follow-up|8|||
128877480|NCT02680002|463846229|FG002|Overall Study|Physician Decision|1|||
128990469|NCT05302414|464255008|FG002|Pretest to Posttest|Lost to Follow-up|8|||
128990470|NCT05302414|464255006|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
128990471|NCT05302414|464255007|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
128990472|NCT05302414|464255008|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
128990473|NCT01610284|464255009|FG000|Randomization Phase|Adverse Event|1|||
128990474|NCT01610284|464255010|FG001|Randomization Phase|Adverse Event|0|||
128990475|NCT01610284|464255009|FG000|Randomization Phase|Physician Decision|1|||
128990476|NCT01610284|464255010|FG001|Randomization Phase|Physician Decision|1|||
128990477|NCT01610284|464255009|FG000|Randomization Phase|Death|0|||
128990478|NCT01610284|464255010|FG001|Randomization Phase|Death|1|||
128990479|NCT01610284|464255009|FG000|Treatment Phase|Adverse Event|80|||
128990480|NCT01610284|464255010|FG001|Treatment Phase|Adverse Event|12|||
128990481|NCT01610284|464255009|FG000|Treatment Phase|Lost to Follow-up|1|||
128990482|NCT01610284|464255010|FG001|Treatment Phase|Lost to Follow-up|0|||
128990483|NCT01610284|464255009|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
128990484|NCT01610284|464255010|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
128990485|NCT01610284|464255009|FG000|Treatment Phase|Physician Decision|27|||
128990486|NCT01610284|464255010|FG001|Treatment Phase|Physician Decision|24|||
128990487|NCT01610284|464255009|FG000|Treatment Phase|Progressive Disease|377|||
128990488|NCT01610284|464255010|FG001|Treatment Phase|Progressive Disease|486|||
128990489|NCT01610284|464255009|FG000|Treatment Phase|Protocol Deviation|2|||
128990490|NCT01610284|464255010|FG001|Treatment Phase|Protocol Deviation|3|||
128990491|NCT01610284|464255009|FG000|Treatment Phase|Study terminated by Sponsor|18|||
128990492|NCT01610284|464255010|FG001|Treatment Phase|Study terminated by Sponsor|15|||
128990493|NCT01610284|464255009|FG000|Treatment Phase|Subject/Guardian Decision|55|||
128990494|NCT01610284|464255010|FG001|Treatment Phase|Subject/Guardian Decision|23|||
128990495|NCT01610284|464255009|FG000|Treatment Phase|Death|6|||
128990496|NCT01610284|464255010|FG001|Treatment Phase|Death|5|||
128990497|NCT01610284|464255009|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
128990498|NCT01610284|464255010|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
128990499|NCT01610284|464255009|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
128990500|NCT01610284|464255010|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
128990501|NCT01610284|464255009|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
128990502|NCT01610284|464255010|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
128990503|NCT01610284|464255009|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
128990504|NCT01610284|464255010|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
128990505|NCT01610284|464255009|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
128990506|NCT01610284|464255010|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
128990507|NCT01610284|464255009|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
128990508|NCT01610284|464255010|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
128990509|NCT01102972|464255013|FG000|Overall Study|Adverse Event|8|||
128990510|NCT01102972|464255014|FG001|Overall Study|Adverse Event|2|||
128990511|NCT01102972|464255013|FG000|Overall Study|Lack of Efficacy|2|||
128990512|NCT01102972|464255014|FG001|Overall Study|Lack of Efficacy|1|||
128990513|NCT01102972|464255013|FG000|Overall Study|Protocol Violation|1|||
128990514|NCT01102972|464255014|FG001|Overall Study|Protocol Violation|0|||
128990515|NCT01102972|464255013|FG000|Overall Study|Lost to Follow-up|10|||
128990516|NCT01102972|464255014|FG001|Overall Study|Lost to Follow-up|5|||
128990517|NCT01102972|464255013|FG000|Overall Study|Investigator Discretion|2|||
128990518|NCT01102972|464255014|FG001|Overall Study|Investigator Discretion|0|||
128990519|NCT01102972|464255013|FG000|Overall Study|Withdrawal by Subject|6|||
128990520|NCT01102972|464255014|FG001|Overall Study|Withdrawal by Subject|6|||
128990521|NCT01856257|464255015|FG000|Overall Study|Death|2|||
128990522|NCT01856257|464255016|FG001|Overall Study|Death|0|||
128990523|NCT01856257|464255017|FG002|Overall Study|Death|0|||
128990524|NCT01856257|464255018|FG003|Overall Study|Death|0|||
128990525|NCT01856257|464255015|FG000|Overall Study|Physician Decision|0|||
128990526|NCT01856257|464255016|FG001|Overall Study|Physician Decision|0|||
128990527|NCT01856257|464255017|FG002|Overall Study|Physician Decision|0|||
128990528|NCT01856257|464255018|FG003|Overall Study|Physician Decision|1|||
128990529|NCT01856257|464255015|FG000|Overall Study|Withdrawal by Subject|1|||
128990530|NCT01856257|464255016|FG001|Overall Study|Withdrawal by Subject|1|||
128990531|NCT01856257|464255017|FG002|Overall Study|Withdrawal by Subject|0|||
128990532|NCT01856257|464255018|FG003|Overall Study|Withdrawal by Subject|0|||
128990533|NCT01856257|464255015|FG000|Overall Study|Donor complication|0|||
128990534|NCT01856257|464255016|FG001|Overall Study|Donor complication|0|||
128990535|NCT01856257|464255017|FG002|Overall Study|Donor complication|0|||
128990536|NCT01856257|464255018|FG003|Overall Study|Donor complication|1|||
128990537|NCT01125358|464255025|FG000|Overall Study|Adverse Event|3|||
128990538|NCT01125358|464255026|FG001|Overall Study|Adverse Event|0|||
128990539|NCT01125358|464255027|FG002|Overall Study|Adverse Event|0|||
128990540|NCT01125358|464255028|FG003|Overall Study|Adverse Event|2|||
128990541|NCT01125358|464255025|FG000|Overall Study|Perceived Lack of Efficacy|6|||
128990542|NCT01125358|464255026|FG001|Overall Study|Perceived Lack of Efficacy|3|||
128990543|NCT01125358|464255027|FG002|Overall Study|Perceived Lack of Efficacy|7|||
128990544|NCT01125358|464255028|FG003|Overall Study|Perceived Lack of Efficacy|4|||
128990545|NCT01125358|464255025|FG000|Overall Study|Protocol Violation|1|||
128990546|NCT01125358|464255026|FG001|Overall Study|Protocol Violation|0|||
128990547|NCT01125358|464255027|FG002|Overall Study|Protocol Violation|0|||
128990548|NCT01125358|464255028|FG003|Overall Study|Protocol Violation|0|||
128990549|NCT01125358|464255025|FG000|Overall Study|Sponsor Decision|0|||
128990550|NCT01125358|464255026|FG001|Overall Study|Sponsor Decision|0|||
128990551|NCT01125358|464255027|FG002|Overall Study|Sponsor Decision|1|||
128990552|NCT01125358|464255028|FG003|Overall Study|Sponsor Decision|1|||
128990553|NCT01125358|464255025|FG000|Overall Study|Withdrawal by Subject|2|||
128990554|NCT01125358|464255026|FG001|Overall Study|Withdrawal by Subject|1|||
128990555|NCT01125358|464255027|FG002|Overall Study|Withdrawal by Subject|1|||
128990556|NCT01125358|464255028|FG003|Overall Study|Withdrawal by Subject|1|||
128990557|NCT01157065|464255029|FG000|Overall Study|Death|0|||
128990558|NCT01157065|464255030|FG001|Overall Study|Death|1|||
128990559|NCT01060007|464255033|FG000|Overall Study|Withdrawal by Subject|1|||
128990560|NCT01060007|464255033|FG000|Overall Study|Inevaluable for response at surgery|3|||
128990561|NCT05168657|464255034|FG000|Overall Study|Adverse Event|0|||
128990562|NCT05168657|464255035|FG001|Overall Study|Adverse Event|0|||
128990563|NCT05168657|464255036|FG002|Overall Study|Adverse Event|1|||
128990564|NCT05168657|464255037|FG003|Overall Study|Adverse Event|0|||
128990565|NCT05168657|464255038|FG004|Overall Study|Adverse Event|0|||
128990566|NCT05168657|464255039|FG005|Overall Study|Adverse Event|0|||
128990567|NCT05168657|464255040|FG006|Overall Study|Adverse Event|0|||
128990568|NCT05168657|464255041|FG007|Overall Study|Adverse Event|0|||
128990569|NCT04935931|464255042|FG000|Overall Study|Withdrawal by Subject|1|||
128990570|NCT00962013|464255045|FG000|Overall Study|Did not have surgery|1|||
128990571|NCT00962013|464255045|FG000|Overall Study|Death|8|||
128990572|NCT00962013|464255045|FG000|Overall Study|Lost to Follow-up|12|||
128990573|NCT00962013|464255045|FG000|Overall Study|Unable/Unwilling to return|6|||
128990574|NCT00962013|464255045|FG000|Overall Study|Withdrawal by Subject|8|||
128990575|NCT00962013|464255045|FG000|Overall Study|Removal of study device|3|||
128990576|NCT00962013|464255045|FG000|Overall Study|Site Termination|24|||
128990577|NCT00962013|464255045|FG000|Overall Study|No 5 year evaluation|6|||
128990578|NCT04527549|464255046|FG000|Overall Study|Withdrawal by Subject|1|||
128990579|NCT04527549|464255047|FG001|Overall Study|Withdrawal by Subject|1|||
128990580|NCT00424632|464255048|FG000|Overall Study|Death|0|||
128990581|NCT00424632|464255049|FG001|Overall Study|Death|0|||
128990582|NCT00424632|464255050|FG002|Overall Study|Death|0|||
128990583|NCT00424632|464255051|FG003|Overall Study|Death|0|||
128990584|NCT00424632|464255052|FG004|Overall Study|Death|0|||
128990585|NCT00424632|464255053|FG005|Overall Study|Death|2|||
128990586|NCT00424632|464255054|FG006|Overall Study|Death|0|||
128990587|NCT00424632|464255055|FG007|Overall Study|Death|0|||
128990588|NCT00424632|464255056|FG008|Overall Study|Death|0|||
128990589|NCT00424632|464255057|FG009|Overall Study|Death|0|||
128990590|NCT00424632|464255048|FG000|Overall Study|Adverse Event|0|||
128990591|NCT00424632|464255049|FG001|Overall Study|Adverse Event|0|||
128990592|NCT00424632|464255050|FG002|Overall Study|Adverse Event|0|||
128990593|NCT00424632|464255051|FG003|Overall Study|Adverse Event|0|||
128990594|NCT00424632|464255052|FG004|Overall Study|Adverse Event|0|||
128990595|NCT00424632|464255053|FG005|Overall Study|Adverse Event|0|||
128990596|NCT00424632|464255054|FG006|Overall Study|Adverse Event|0|||
128990597|NCT00424632|464255055|FG007|Overall Study|Adverse Event|0|||
128990598|NCT00424632|464255056|FG008|Overall Study|Adverse Event|3|||
128990599|NCT00424632|464255057|FG009|Overall Study|Adverse Event|2|||
128990600|NCT00424632|464255048|FG000|Overall Study|Global deterioration of health status|0|||
128990601|NCT00424632|464255049|FG001|Overall Study|Global deterioration of health status|0|||
128990602|NCT00424632|464255050|FG002|Overall Study|Global deterioration of health status|0|||
128990603|NCT00424632|464255051|FG003|Overall Study|Global deterioration of health status|1|||
128990604|NCT00424632|464255052|FG004|Overall Study|Global deterioration of health status|1|||
128990605|NCT00424632|464255053|FG005|Overall Study|Global deterioration of health status|0|||
128990606|NCT00424632|464255054|FG006|Overall Study|Global deterioration of health status|0|||
128990607|NCT00424632|464255055|FG007|Overall Study|Global deterioration of health status|0|||
128990608|NCT00424632|464255056|FG008|Overall Study|Global deterioration of health status|0|||
128990609|NCT00424632|464255057|FG009|Overall Study|Global deterioration of health status|0|||
128990610|NCT00424632|464255048|FG000|Overall Study|Objective progression or relapse|1|||
128990611|NCT00424632|464255049|FG001|Overall Study|Objective progression or relapse|1|||
128990612|NCT00424632|464255050|FG002|Overall Study|Objective progression or relapse|1|||
128990613|NCT00424632|464255051|FG003|Overall Study|Objective progression or relapse|2|||
128990614|NCT00424632|464255052|FG004|Overall Study|Objective progression or relapse|2|||
128990615|NCT00424632|464255053|FG005|Overall Study|Objective progression or relapse|13|||
128990616|NCT00424632|464255054|FG006|Overall Study|Objective progression or relapse|7|||
128990617|NCT00424632|464255055|FG007|Overall Study|Objective progression or relapse|3|||
128990618|NCT00424632|464255056|FG008|Overall Study|Objective progression or relapse|12|||
128990619|NCT00424632|464255057|FG009|Overall Study|Objective progression or relapse|4|||
128990620|NCT00424632|464255048|FG000|Overall Study|Other|0|||
128990621|NCT00424632|464255049|FG001|Overall Study|Other|0|||
129214497|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
128877481|NCT02680002|463846230|FG003|Overall Study|Physician Decision|1|||
128990622|NCT00424632|464255050|FG002|Overall Study|Other|0|||
128990623|NCT00424632|464255051|FG003|Overall Study|Other|1|||
128990624|NCT00424632|464255052|FG004|Overall Study|Other|0|||
128990625|NCT00424632|464255053|FG005|Overall Study|Other|0|||
128990626|NCT00424632|464255054|FG006|Overall Study|Other|0|||
128990627|NCT00424632|464255055|FG007|Overall Study|Other|0|||
128990628|NCT00424632|464255056|FG008|Overall Study|Other|1|||
128990629|NCT00424632|464255057|FG009|Overall Study|Other|0|||
128990630|NCT00445458|464255062|FG000|Overall Study|Disease Progression|3|||
128990631|NCT00445458|464255063|FG001|Overall Study|Disease Progression|4|||
128990632|NCT00445458|464255064|FG002|Overall Study|Disease Progression|54|||
128990633|NCT00445458|464255065|FG003|Overall Study|Disease Progression|27|||
128990634|NCT00445458|464255062|FG000|Overall Study|Withdrawal by Subject|0|||
128990635|NCT00445458|464255063|FG001|Overall Study|Withdrawal by Subject|0|||
128990636|NCT00445458|464255064|FG002|Overall Study|Withdrawal by Subject|7|||
128990637|NCT00445458|464255065|FG003|Overall Study|Withdrawal by Subject|0|||
128990638|NCT00445458|464255062|FG000|Overall Study|Adverse Event|0|||
128990639|NCT00445458|464255063|FG001|Overall Study|Adverse Event|0|||
128990640|NCT00445458|464255064|FG002|Overall Study|Adverse Event|3|||
128990641|NCT00445458|464255065|FG003|Overall Study|Adverse Event|0|||
128990642|NCT00445458|464255062|FG000|Overall Study|Death|0|||
128990643|NCT00445458|464255063|FG001|Overall Study|Death|1|||
128990644|NCT00445458|464255064|FG002|Overall Study|Death|2|||
128990645|NCT00445458|464255065|FG003|Overall Study|Death|0|||
128990646|NCT00445458|464255062|FG000|Overall Study|Physician Decision|0|||
128990647|NCT00445458|464255063|FG001|Overall Study|Physician Decision|0|||
128990648|NCT00445458|464255064|FG002|Overall Study|Physician Decision|1|||
128990649|NCT00445458|464255065|FG003|Overall Study|Physician Decision|1|||
128990650|NCT00445458|464255062|FG000|Overall Study|Surgery|0|||
128990651|NCT00445458|464255063|FG001|Overall Study|Surgery|0|||
128990652|NCT00445458|464255064|FG002|Overall Study|Surgery|1|||
128990653|NCT00445458|464255065|FG003|Overall Study|Surgery|0|||
128990654|NCT00728988|464255068|FG000|Overall Study|Not Treated|2|||
128990655|NCT00728988|464255069|FG001|Overall Study|Not Treated|2|||
128990656|NCT00728988|464255068|FG000|Overall Study|Death|1|||
128990657|NCT00728988|464255069|FG001|Overall Study|Death|1|||
128990658|NCT00728988|464255068|FG000|Overall Study|Adverse Event|3|||
128990659|NCT00728988|464255069|FG001|Overall Study|Adverse Event|2|||
128990660|NCT00728988|464255068|FG000|Overall Study|Other|85|||
128990661|NCT00728988|464255069|FG001|Overall Study|Other|77|||
128990662|NCT00728988|464255068|FG000|Overall Study|Withdrawal by Subject|2|||
128990663|NCT00728988|464255069|FG001|Overall Study|Withdrawal by Subject|6|||
128990664|NCT01984229|464255072|FG000|Safety Follow-up Period|Adverse Event|1|||
128990665|NCT01984229|464255073|FG001|Safety Follow-up Period|Adverse Event|1|||
128990666|NCT01984229|464255072|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
128990667|NCT01984229|464255073|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
128990668|NCT02325739|464255076|FG000|Phase I Part|Adverse Event|1|||
128990669|NCT02325739|464255077|FG001|Phase I Part|Adverse Event|0|||
128990670|NCT02325739|464255078|FG002|Phase I Part|Adverse Event|1|||
128990671|NCT02325739|464255079|FG003|Phase I Part|Adverse Event|2|||
128990672|NCT02325739|464255080|FG004|Phase I Part|Adverse Event|3|||
128990673|NCT02325739|464255081|FG005|Phase I Part|Adverse Event|1|||
128990674|NCT02325739|464255082|FG006|Phase I Part|Adverse Event|0|||
128990675|NCT02325739|464255083|FG007|Phase I Part|Adverse Event|2|||
128990676|NCT02325739|464255084|FG008|Phase I Part|Adverse Event|0|||
128990677|NCT02325739|464255085|FG009|Phase I Part|Adverse Event|0|||
128990678|NCT02325739|464255086|FG010|Phase I Part|Adverse Event|0|||
128990679|NCT02325739|464255076|FG000|Phase I Part|Progressive disease|9|||
128990680|NCT02325739|464255077|FG001|Phase I Part|Progressive disease|6|||
128990681|NCT02325739|464255078|FG002|Phase I Part|Progressive disease|3|||
128990682|NCT02325739|464255079|FG003|Phase I Part|Progressive disease|23|||
128990683|NCT02325739|464255080|FG004|Phase I Part|Progressive disease|14|||
128990684|NCT02325739|464255081|FG005|Phase I Part|Progressive disease|6|||
128990685|NCT02325739|464255082|FG006|Phase I Part|Progressive disease|6|||
128990686|NCT02325739|464255083|FG007|Phase I Part|Progressive disease|3|||
128990687|NCT02325739|464255084|FG008|Phase I Part|Progressive disease|0|||
128990688|NCT02325739|464255085|FG009|Phase I Part|Progressive disease|0|||
128990689|NCT02325739|464255086|FG010|Phase I Part|Progressive disease|0|||
128990690|NCT02325739|464255076|FG000|Phase I Part|Subject/guardian decision|1|||
128990691|NCT02325739|464255077|FG001|Phase I Part|Subject/guardian decision|0|||
128990692|NCT02325739|464255078|FG002|Phase I Part|Subject/guardian decision|1|||
128990693|NCT02325739|464255079|FG003|Phase I Part|Subject/guardian decision|1|||
128990694|NCT02325739|464255080|FG004|Phase I Part|Subject/guardian decision|0|||
128990695|NCT02325739|464255081|FG005|Phase I Part|Subject/guardian decision|0|||
128990696|NCT02325739|464255082|FG006|Phase I Part|Subject/guardian decision|0|||
128990697|NCT02325739|464255083|FG007|Phase I Part|Subject/guardian decision|1|||
128990698|NCT02325739|464255084|FG008|Phase I Part|Subject/guardian decision|0|||
128990699|NCT02325739|464255085|FG009|Phase I Part|Subject/guardian decision|0|||
128990700|NCT02325739|464255086|FG010|Phase I Part|Subject/guardian decision|0|||
128990701|NCT02325739|464255076|FG000|Phase I Part|Death|0|||
128990702|NCT02325739|464255077|FG001|Phase I Part|Death|0|||
128990703|NCT02325739|464255078|FG002|Phase I Part|Death|0|||
128990704|NCT02325739|464255079|FG003|Phase I Part|Death|0|||
128990705|NCT02325739|464255080|FG004|Phase I Part|Death|2|||
128990706|NCT02325739|464255081|FG005|Phase I Part|Death|0|||
128990707|NCT02325739|464255082|FG006|Phase I Part|Death|0|||
128990708|NCT02325739|464255083|FG007|Phase I Part|Death|0|||
128990709|NCT02325739|464255084|FG008|Phase I Part|Death|0|||
128990710|NCT02325739|464255085|FG009|Phase I Part|Death|0|||
128990711|NCT02325739|464255086|FG010|Phase I Part|Death|0|||
128990712|NCT02325739|464255076|FG000|Phase II Part|Adverse Event|0|||
128990713|NCT02325739|464255077|FG001|Phase II Part|Adverse Event|0|||
128990714|NCT02325739|464255078|FG002|Phase II Part|Adverse Event|0|||
128990715|NCT02325739|464255079|FG003|Phase II Part|Adverse Event|0|||
128990716|NCT02325739|464255080|FG004|Phase II Part|Adverse Event|0|||
128990717|NCT02325739|464255081|FG005|Phase II Part|Adverse Event|0|||
128990718|NCT02325739|464255082|FG006|Phase II Part|Adverse Event|0|||
128990719|NCT02325739|464255083|FG007|Phase II Part|Adverse Event|0|||
128990720|NCT02325739|464255084|FG008|Phase II Part|Adverse Event|4|||
128990721|NCT02325739|464255085|FG009|Phase II Part|Adverse Event|5|||
128990722|NCT02325739|464255086|FG010|Phase II Part|Adverse Event|1|||
128990723|NCT02325739|464255076|FG000|Phase II Part|Physician Decision|0|||
128990724|NCT02325739|464255077|FG001|Phase II Part|Physician Decision|0|||
128990725|NCT02325739|464255078|FG002|Phase II Part|Physician Decision|0|||
128990726|NCT02325739|464255079|FG003|Phase II Part|Physician Decision|0|||
128990727|NCT02325739|464255080|FG004|Phase II Part|Physician Decision|0|||
128990728|NCT02325739|464255081|FG005|Phase II Part|Physician Decision|0|||
128990729|NCT02325739|464255082|FG006|Phase II Part|Physician Decision|0|||
128990730|NCT02325739|464255083|FG007|Phase II Part|Physician Decision|0|||
128990731|NCT02325739|464255084|FG008|Phase II Part|Physician Decision|0|||
128990732|NCT02325739|464255085|FG009|Phase II Part|Physician Decision|1|||
128990733|NCT02325739|464255086|FG010|Phase II Part|Physician Decision|0|||
128990734|NCT02325739|464255076|FG000|Phase II Part|Progressive disease|0|||
128990735|NCT02325739|464255077|FG001|Phase II Part|Progressive disease|0|||
128990736|NCT02325739|464255078|FG002|Phase II Part|Progressive disease|0|||
128990737|NCT02325739|464255079|FG003|Phase II Part|Progressive disease|0|||
128990738|NCT02325739|464255080|FG004|Phase II Part|Progressive disease|0|||
128990739|NCT02325739|464255081|FG005|Phase II Part|Progressive disease|0|||
128990740|NCT02325739|464255082|FG006|Phase II Part|Progressive disease|0|||
128990741|NCT02325739|464255083|FG007|Phase II Part|Progressive disease|0|||
128990742|NCT02325739|464255084|FG008|Phase II Part|Progressive disease|22|||
128990743|NCT02325739|464255085|FG009|Phase II Part|Progressive disease|29|||
128990744|NCT02325739|464255086|FG010|Phase II Part|Progressive disease|18|||
128990745|NCT02325739|464255076|FG000|Phase II Part|Subject/guardian decision|0|||
128990746|NCT02325739|464255077|FG001|Phase II Part|Subject/guardian decision|0|||
128990747|NCT02325739|464255078|FG002|Phase II Part|Subject/guardian decision|0|||
128990748|NCT02325739|464255079|FG003|Phase II Part|Subject/guardian decision|0|||
128990749|NCT02325739|464255080|FG004|Phase II Part|Subject/guardian decision|0|||
128990750|NCT02325739|464255081|FG005|Phase II Part|Subject/guardian decision|0|||
128990751|NCT02325739|464255082|FG006|Phase II Part|Subject/guardian decision|0|||
128990752|NCT02325739|464255083|FG007|Phase II Part|Subject/guardian decision|0|||
128990753|NCT02325739|464255084|FG008|Phase II Part|Subject/guardian decision|4|||
128990754|NCT02325739|464255085|FG009|Phase II Part|Subject/guardian decision|1|||
128990755|NCT02325739|464255086|FG010|Phase II Part|Subject/guardian decision|1|||
128990756|NCT03186794|464255088|FG000|Overall Study|Physician Decision|2|||
128990757|NCT03186794|464255088|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
128990758|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
128990759|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
128990760|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Death|5|||
128990761|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Death|2|||
128990762|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
128990763|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
128990764|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
128990765|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
128990766|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
128990767|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
128990768|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Relapse|1|||
128990769|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Relapse|0|||
128990770|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
128990771|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
128990772|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
128990773|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
128990774|NCT00111007|464255090|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
129214498|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
129214499|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
129214500|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
129214501|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
129214502|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
128990775|NCT00111007|464255091|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
128990776|NCT00111007|464255090|FG000|Active Follow-up|Adverse Event|1|||
128990777|NCT00111007|464255091|FG001|Active Follow-up|Adverse Event|0|||
128990778|NCT00111007|464255090|FG000|Active Follow-up|Death|2|||
128990779|NCT00111007|464255091|FG001|Active Follow-up|Death|0|||
128990780|NCT00111007|464255090|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
128990781|NCT00111007|464255091|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
128990782|NCT00111007|464255090|FG000|Long Term Follow-up|Death|34|||
128990783|NCT00111007|464255091|FG001|Long Term Follow-up|Death|39|||
128990784|NCT00111007|464255090|FG000|Long Term Follow-up|Lost to Follow-up|1|||
128990785|NCT00111007|464255091|FG001|Long Term Follow-up|Lost to Follow-up|1|||
128990786|NCT00111007|464255090|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
128990787|NCT00111007|464255091|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
128990788|NCT00111007|464255090|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
128990789|NCT00111007|464255091|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
128990790|NCT00111007|464255090|FG000|Long Term Follow-up|Missing|10|||
128990791|NCT00111007|464255091|FG001|Long Term Follow-up|Missing|3|||
128990792|NCT02380248|464255093|FG000|Overall Study|Lost to Follow-up|11|||
128990793|NCT02380248|464255093|FG000|Overall Study|Withdrawal by Subject|3|||
128990794|NCT01275170|464255094|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
128990795|NCT01275170|464255095|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
128990796|NCT01275170|464255096|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
128990797|NCT01275170|464255097|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
128990798|NCT01275170|464255098|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
128990799|NCT01275170|464255099|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
128990800|NCT01275170|464255100|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
128990801|NCT01275170|464255101|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
128990802|NCT00605839|464255102|FG000|Overall Study|Protocol Violation|1|||
128990803|NCT00605839|464255103|FG001|Overall Study|Protocol Violation|0|||
128990804|NCT00605839|464255104|FG002|Overall Study|Protocol Violation|0|||
128990805|NCT02864953|464255105|FG000|Overall Study|Adverse Event|22|||
128990806|NCT02864953|464255106|FG001|Overall Study|Adverse Event|19|||
128990807|NCT02864953|464255105|FG000|Overall Study|Withdrawal by Subject|1|||
128990808|NCT02864953|464255106|FG001|Overall Study|Withdrawal by Subject|0|||
128990809|NCT02864953|464255105|FG000|Overall Study|Physician Decision|4|||
128990810|NCT02864953|464255106|FG001|Overall Study|Physician Decision|2|||
128990811|NCT02864953|464255105|FG000|Overall Study|Death|3|||
128990812|NCT02864953|464255106|FG001|Overall Study|Death|13|||
128990813|NCT02864953|464255105|FG000|Overall Study|Reason not specified|14|||
128990814|NCT02864953|464255106|FG001|Overall Study|Reason not specified|12|||
128990815|NCT02864953|464255105|FG000|Overall Study|Withdrew Prior to Dosing|9|||
128990816|NCT02864953|464255106|FG001|Overall Study|Withdrew Prior to Dosing|8|||
128990817|NCT03728257|464255107|FG000|Overall Study|Death|3|||
128990818|NCT03728257|464255108|FG001|Overall Study|Death|0|||
128990819|NCT00621309|464255109|FG000|Overall Study|Withdrawal by Subject|2|||
128990820|NCT00621309|464255110|FG001|Overall Study|Withdrawal by Subject|0|||
128990821|NCT00621309|464255111|FG002|Overall Study|Withdrawal by Subject|1|||
128990822|NCT00621309|464255112|FG003|Overall Study|Withdrawal by Subject|1|||
128990823|NCT00621309|464255113|FG004|Overall Study|Withdrawal by Subject|1|||
128990824|NCT00621309|464255114|FG005|Overall Study|Withdrawal by Subject|1|||
128990825|NCT04993339|464255115|FG000|Overall Study|Lost to Follow-up|0|||
128990826|NCT04993339|464255116|FG001|Overall Study|Lost to Follow-up|1|||
128990827|NCT04993339|464255115|FG000|Overall Study|no MRI scan|3|||
128990828|NCT04993339|464255116|FG001|Overall Study|no MRI scan|1|||
128990829|NCT01381068|464255117|FG000|Overall Study|Death|1|||
128990830|NCT01381068|464255118|FG001|Overall Study|Death|0|||
128990831|NCT02949219|464255125|FG000|Overall Study|Withdrawal by Subject|1|||
128990832|NCT00314262|464255136|FG000|Overall Study|Adverse Event|2|||
128990833|NCT00314262|464255136|FG000|Overall Study|Withdrawal by Subject|2|||
128990834|NCT00314262|464255136|FG000|Overall Study|Physician Decision|1|||
128990835|NCT00083226|464255137|FG000|Overall Study|Lack of Efficacy|19|||
128990836|NCT00083226|464255137|FG000|Overall Study|Adverse Event|9|||
128990837|NCT00083226|464255137|FG000|Overall Study|Death|4|||
128990838|NCT00083226|464255137|FG000|Overall Study|Withdrawal by Subject|4|||
128990839|NCT00083226|464255137|FG000|Overall Study|Other|2|||
128990840|NCT00083226|464255137|FG000|Overall Study|ineligible or not receiving treatment|4|||
128990841|NCT00909857|464255138|FG000|Overall Study|Withdrawal by Subject|6|||
128990842|NCT00909857|464255139|FG001|Overall Study|Withdrawal by Subject|10|||
128990843|NCT00909857|464255138|FG000|Overall Study|Adverse Event|5|||
128990844|NCT00909857|464255139|FG001|Overall Study|Adverse Event|5|||
128990845|NCT00909857|464255138|FG000|Overall Study|Lost to Follow-up|2|||
128990846|NCT00909857|464255139|FG001|Overall Study|Lost to Follow-up|5|||
128990847|NCT00909857|464255138|FG000|Overall Study|Protocol Violation|2|||
128990848|NCT00909857|464255139|FG001|Overall Study|Protocol Violation|1|||
128990849|NCT00909857|464255138|FG000|Overall Study|Pregnancy|1|||
128990850|NCT00909857|464255139|FG001|Overall Study|Pregnancy|0|||
128990851|NCT00909857|464255138|FG000|Overall Study|Other|1|||
128877482|NCT02680002|463846231|FG004|Overall Study|Physician Decision|1|||
128877483|NCT02680002|463846232|FG005|Overall Study|Physician Decision|1|||
128877484|NCT02680002|463846227|FG000|Overall Study|Protocol Violation|1|||
128877485|NCT02680002|463846228|FG001|Overall Study|Protocol Violation|0|||
128877486|NCT02680002|463846229|FG002|Overall Study|Protocol Violation|1|||
128877487|NCT02680002|463846230|FG003|Overall Study|Protocol Violation|0|||
128877488|NCT02680002|463846231|FG004|Overall Study|Protocol Violation|1|||
128877489|NCT02680002|463846232|FG005|Overall Study|Protocol Violation|2|||
128877490|NCT02680002|463846227|FG000|Overall Study|Withdrawal by Subject|0|||
128877491|NCT02680002|463846228|FG001|Overall Study|Withdrawal by Subject|0|||
128877492|NCT02680002|463846229|FG002|Overall Study|Withdrawal by Subject|1|||
128877493|NCT02680002|463846230|FG003|Overall Study|Withdrawal by Subject|0|||
128877494|NCT02680002|463846231|FG004|Overall Study|Withdrawal by Subject|2|||
128877495|NCT02680002|463846232|FG005|Overall Study|Withdrawal by Subject|2|||
128877496|NCT02680002|463846227|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
128877497|NCT02680002|463846228|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
128877498|NCT02680002|463846229|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
128877499|NCT02680002|463846230|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
128877500|NCT02680002|463846231|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
128877501|NCT02680002|463846232|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
128877502|NCT02680002|463846227|FG000|Overall Study|Other|0|||
128877503|NCT02680002|463846228|FG001|Overall Study|Other|1|||
128877504|NCT02680002|463846229|FG002|Overall Study|Other|0|||
128877505|NCT02680002|463846230|FG003|Overall Study|Other|0|||
128877506|NCT02680002|463846231|FG004|Overall Study|Other|1|||
128877507|NCT02680002|463846232|FG005|Overall Study|Other|0|||
128877508|NCT02680002|463846227|FG000|Overall Study|Adverse Event|0|||
128877509|NCT02680002|463846228|FG001|Overall Study|Adverse Event|0|||
128877510|NCT02680002|463846229|FG002|Overall Study|Adverse Event|0|||
128877511|NCT02680002|463846230|FG003|Overall Study|Adverse Event|0|||
128877512|NCT02680002|463846231|FG004|Overall Study|Adverse Event|1|||
128877513|NCT02680002|463846232|FG005|Overall Study|Adverse Event|2|||
128877514|NCT03527173|463846235|FG000|Overall Study|Lost to Follow-up|4|||
128877515|NCT03527173|463846236|FG001|Overall Study|Lost to Follow-up|2|||
128877516|NCT03527173|463846235|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
128877517|NCT03527173|463846236|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
128877518|NCT03527173|463846235|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
128877519|NCT03527173|463846236|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
128877520|NCT03527173|463846235|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
128877521|NCT03527173|463846236|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
128877522|NCT01248780|463846241|FG000|Overall Study|Lack of Efficacy|2|||
128877523|NCT01248780|463846242|FG001|Overall Study|Lack of Efficacy|0|||
128877524|NCT01248780|463846241|FG000|Overall Study|Lost to Follow-up|0|||
128877525|NCT01248780|463846242|FG001|Overall Study|Lost to Follow-up|1|||
128877526|NCT01248780|463846241|FG000|Overall Study|Death|0|||
128877527|NCT01248780|463846242|FG001|Overall Study|Death|1|||
128877528|NCT01248780|463846241|FG000|Overall Study|Adverse Event|2|||
128877529|NCT01248780|463846242|FG001|Overall Study|Adverse Event|7|||
128877530|NCT01248780|463846241|FG000|Overall Study|Protocol Violation|1|||
128877531|NCT01248780|463846242|FG001|Overall Study|Protocol Violation|1|||
128877532|NCT01248780|463846241|FG000|Overall Study|Withdrawal by Subject|4|||
128877533|NCT01248780|463846242|FG001|Overall Study|Withdrawal by Subject|4|||
128877534|NCT01248780|463846241|FG000|Overall Study|Not treated|0|||
128877535|NCT01248780|463846242|FG001|Overall Study|Not treated|1|||
128877536|NCT02134977|463846243|FG000|Overall Study|Protocol Deviation|102|||
128877537|NCT04097301|463846244|FG000|Overall Study|Death|1|||
128877538|NCT04097301|463846244|FG000|Overall Study|Withdrawal by Subject|1|||
128877539|NCT04097301|463846244|FG000|Overall Study|Screening Failure|5|||
128877540|NCT00203476|463846245|FG000|Overall Study|Lost to Follow-up|1|||
128877541|NCT00203476|463846246|FG001|Overall Study|Lost to Follow-up|0|||
128877542|NCT00203476|463846247|FG002|Overall Study|Lost to Follow-up|0|||
128877543|NCT00203476|463846245|FG000|Overall Study|Withdrawal by Subject|0|||
128990852|NCT00909857|464255139|FG001|Overall Study|Other|0|||
128877544|NCT00203476|463846246|FG001|Overall Study|Withdrawal by Subject|1|||
128877545|NCT00203476|463846247|FG002|Overall Study|Withdrawal by Subject|0|||
128877546|NCT01190514|463846248|FG000|First Intervention (Period 1)|Adverse Event|1|||
128877547|NCT01190514|463846249|FG001|First Intervention (Period 1)|Adverse Event|0|||
128877548|NCT01190514|463846250|FG002|First Intervention (Period 1)|Adverse Event|0|||
128990853|NCT00909857|464255138|FG000|Overall Study|Did not receive study medication|19|||
128990854|NCT00909857|464255139|FG001|Overall Study|Did not receive study medication|24|||
128877549|NCT01190514|463846251|FG003|First Intervention (Period 1)|Adverse Event|0|||
128990855|NCT00604175|464255146|FG000|Entry Through Week 28|Death|2|||
128990856|NCT00604175|464255147|FG001|Entry Through Week 28|Death|0|||
128990857|NCT00604175|464255148|FG002|Entry Through Week 28|Death|0|||
128990858|NCT00604175|464255146|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
128990859|NCT00604175|464255147|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
128990860|NCT00604175|464255148|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
128990861|NCT00604175|464255146|FG000|Entry Through Week 28|Lost to Follow-up|4|||
128990862|NCT00604175|464255147|FG001|Entry Through Week 28|Lost to Follow-up|3|||
128990863|NCT00604175|464255148|FG002|Entry Through Week 28|Lost to Follow-up|0|||
128990864|NCT00604175|464255146|FG000|Entry Through Week 28|Ineligible|1|||
128990865|NCT00604175|464255147|FG001|Entry Through Week 28|Ineligible|0|||
128990866|NCT00604175|464255148|FG002|Entry Through Week 28|Ineligible|0|||
128990867|NCT00604175|464255146|FG000|Entry Through Week 28|Did not start intervention|2|||
128990868|NCT00604175|464255147|FG001|Entry Through Week 28|Did not start intervention|0|||
128990869|NCT00604175|464255148|FG002|Entry Through Week 28|Did not start intervention|1|||
128990870|NCT00604175|464255146|FG000|Week 29 Through Week 72|Death|0|||
128990871|NCT00604175|464255147|FG001|Week 29 Through Week 72|Death|0|||
128990872|NCT00604175|464255148|FG002|Week 29 Through Week 72|Death|1|||
128990873|NCT00604175|464255146|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
128990874|NCT00604175|464255147|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
128990875|NCT00604175|464255148|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
128990876|NCT00604175|464255146|FG000|Week 29 Through Week 72|Site closure|0|||
128990877|NCT00604175|464255147|FG001|Week 29 Through Week 72|Site closure|1|||
128990878|NCT00604175|464255148|FG002|Week 29 Through Week 72|Site closure|0|||
128990879|NCT00604175|464255146|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
128990880|NCT00604175|464255147|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
128990881|NCT00604175|464255148|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
128990882|NCT02044094|464255149|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
128990883|NCT02044094|464255149|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
128990884|NCT02044094|464255149|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
128990885|NCT02044094|464255149|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
128990886|NCT02044094|464255149|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
128990887|NCT02044094|464255149|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
128990888|NCT02044094|464255149|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
128990889|NCT02044094|464255149|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
128990890|NCT05378269|464256862|FG000|Overall Study|Protocol Violation|1|||
128990891|NCT05378269|464256863|FG001|Overall Study|Protocol Violation|0|||
128990892|NCT05378269|464256864|FG002|Overall Study|Protocol Violation|2|||
128990893|NCT05378269|464256865|FG003|Overall Study|Protocol Violation|0|||
128990894|NCT05378269|464256866|FG004|Overall Study|Protocol Violation|0|||
128990895|NCT01721200|464256867|FG000|Overall Study|Lost to Follow-up|3|||
128990896|NCT01721200|464256868|FG001|Overall Study|Lost to Follow-up|5|||
128990897|NCT03926728|464256869|FG000|Overall Study|Withdrawal by Subject|0|||
128990898|NCT03926728|464256870|FG001|Overall Study|Withdrawal by Subject|1|||
128990899|NCT03926728|464256871|FG002|Overall Study|Withdrawal by Subject|1|||
128990900|NCT03926728|464256872|FG003|Overall Study|Withdrawal by Subject|0|||
128990901|NCT03926728|464256873|FG004|Overall Study|Withdrawal by Subject|0|||
128990902|NCT03926728|464256874|FG005|Overall Study|Withdrawal by Subject|1|||
128990903|NCT03926728|464256875|FG006|Overall Study|Withdrawal by Subject|1|||
128990904|NCT03926728|464256876|FG007|Overall Study|Withdrawal by Subject|0|||
128990905|NCT03926728|464256877|FG008|Overall Study|Withdrawal by Subject|0|||
128990906|NCT03926728|464256878|FG009|Overall Study|Withdrawal by Subject|1|||
128990907|NCT03926728|464256879|FG010|Overall Study|Withdrawal by Subject|0|||
128990908|NCT03926728|464256880|FG011|Overall Study|Withdrawal by Subject|0|||
128990909|NCT00398632|464256881|FG000|Overall Study|Withdrawal by Subject|1|||
128990910|NCT00398632|464256881|FG000|Overall Study|Lack of Efficacy|1|||
128990911|NCT00366678|464256884|FG000|Infant Series|Withdrawal by Subject|8|||
128990912|NCT00366678|464256885|FG001|Infant Series|Withdrawal by Subject|6|||
128990913|NCT00366678|464256886|FG002|Infant Series|Withdrawal by Subject|0|||
128990914|NCT00366678|464256884|FG000|Infant Series|Protocol Violation|4|||
128990915|NCT00366678|464256885|FG001|Infant Series|Protocol Violation|3|||
128990916|NCT00366678|464256886|FG002|Infant Series|Protocol Violation|0|||
128990917|NCT00366678|464256884|FG000|Infant Series|Failed to return|1|||
128990918|NCT00366678|464256885|FG001|Infant Series|Failed to return|1|||
128990919|NCT00366678|464256886|FG002|Infant Series|Failed to return|0|||
128990920|NCT00366678|464256884|FG000|Infant Series|Adverse Event|1|||
128990921|NCT00366678|464256885|FG001|Infant Series|Adverse Event|0|||
128990922|NCT00366678|464256886|FG002|Infant Series|Adverse Event|0|||
128990923|NCT00366678|464256884|FG000|After Infant|Withdrawal by Subject|8|||
128990924|NCT00366678|464256885|FG001|After Infant|Withdrawal by Subject|4|||
128990925|NCT00366678|464256886|FG002|After Infant|Withdrawal by Subject|0|||
128990926|NCT00366678|464256884|FG000|After Infant|Lost to Follow-up|2|||
128990927|NCT00366678|464256885|FG001|After Infant|Lost to Follow-up|1|||
128990928|NCT00366678|464256886|FG002|After Infant|Lost to Follow-up|0|||
128990929|NCT00366678|464256884|FG000|After Infant|Failed to return|5|||
128990930|NCT00366678|464256885|FG001|After Infant|Failed to return|5|||
128990931|NCT00366678|464256886|FG002|After Infant|Failed to return|0|||
128990932|NCT00366678|464256884|FG000|After Infant|Adverse Event|1|||
128990933|NCT00366678|464256885|FG001|After Infant|Adverse Event|0|||
128990934|NCT00366678|464256886|FG002|After Infant|Adverse Event|0|||
128990935|NCT00366678|464256884|FG000|After Infant|Protocol Violation|1|||
128990936|NCT00366678|464256885|FG001|After Infant|Protocol Violation|0|||
128990937|NCT00366678|464256886|FG002|After Infant|Protocol Violation|0|||
128990938|NCT00366678|464256884|FG000|Toddler Dose|Protocol Violation|2|||
128990939|NCT00366678|464256885|FG001|Toddler Dose|Protocol Violation|1|||
128990940|NCT00366678|464256886|FG002|Toddler Dose|Protocol Violation|0|||
128990941|NCT00366678|464256884|FG000|Toddler Dose|Failed to return|1|||
128990942|NCT00366678|464256885|FG001|Toddler Dose|Failed to return|0|||
128990943|NCT00366678|464256886|FG002|Toddler Dose|Failed to return|0|||
128990944|NCT00366678|464256884|FG000|Toddler Dose|Withdrawal by Subject|1|||
128990945|NCT00366678|464256885|FG001|Toddler Dose|Withdrawal by Subject|0|||
128990946|NCT00366678|464256886|FG002|Toddler Dose|Withdrawal by Subject|0|||
128990947|NCT00366678|464256884|FG000|Toddler Dose|protocol deviation|1|||
128990948|NCT00366678|464256885|FG001|Toddler Dose|protocol deviation|0|||
128990949|NCT00366678|464256886|FG002|Toddler Dose|protocol deviation|0|||
128990950|NCT04292171|464256887|FG000|Overall Study|Pharmacy error|2|||
128990951|NCT04292171|464256888|FG001|Overall Study|Pharmacy error|0|||
128990952|NCT04292171|464256887|FG000|Overall Study|Delivered prior to procedure|0|||
128990953|NCT04292171|464256888|FG001|Overall Study|Delivered prior to procedure|1|||
128990954|NCT02545868|464256889|FG000|Overall Study|Lack of Efficacy|1|||
128990955|NCT02545868|464256890|FG001|Overall Study|Lack of Efficacy|1|||
128990956|NCT02545868|464256891|FG002|Overall Study|Lack of Efficacy|0|||
128990957|NCT02545868|464256889|FG000|Overall Study|Lost to Follow-up|1|||
128990958|NCT02545868|464256890|FG001|Overall Study|Lost to Follow-up|5|||
128990959|NCT02545868|464256891|FG002|Overall Study|Lost to Follow-up|1|||
128990960|NCT02545868|464256889|FG000|Overall Study|Non-compliance|1|||
128990961|NCT02545868|464256890|FG001|Overall Study|Non-compliance|1|||
128990962|NCT02545868|464256891|FG002|Overall Study|Non-compliance|1|||
128990963|NCT02545868|464256889|FG000|Overall Study|Treatment change|21|||
128990964|NCT02545868|464256890|FG001|Overall Study|Treatment change|19|||
128990965|NCT02545868|464256891|FG002|Overall Study|Treatment change|22|||
128990966|NCT02545868|464256889|FG000|Overall Study|Physician Decision|1|||
128990967|NCT02545868|464256890|FG001|Overall Study|Physician Decision|1|||
128990968|NCT02545868|464256891|FG002|Overall Study|Physician Decision|1|||
128990969|NCT02545868|464256889|FG000|Overall Study|Withdrawal by Subject|6|||
128990970|NCT02545868|464256890|FG001|Overall Study|Withdrawal by Subject|7|||
128990971|NCT02545868|464256891|FG002|Overall Study|Withdrawal by Subject|9|||
128990972|NCT04465916|464256896|FG000|Overall Study|Withdrawal by Subject|0|||
128990973|NCT04465916|464256897|FG001|Overall Study|Withdrawal by Subject|1|||
128990974|NCT03976076|464256899|FG000|Overall Study|Withdrawal by Subject|2|||
128990975|NCT01325701|464256900|FG000|Overall Study|Adverse Event|12|||
128990976|NCT01325701|464256901|FG001|Overall Study|Adverse Event|0|||
128990977|NCT01325701|464256900|FG000|Overall Study|Protocol Violation|1|||
128990978|NCT01325701|464256901|FG001|Overall Study|Protocol Violation|0|||
128990979|NCT01325701|464256900|FG000|Overall Study|Physician Decision|2|||
128990980|NCT01325701|464256901|FG001|Overall Study|Physician Decision|2|||
128990981|NCT01325701|464256900|FG000|Overall Study|Withdrawal by Subject|2|||
128990982|NCT01325701|464256901|FG001|Overall Study|Withdrawal by Subject|1|||
128990983|NCT01325701|464256900|FG000|Overall Study|Rollerover Extension Study|4|||
128990984|NCT01325701|464256901|FG001|Overall Study|Rollerover Extension Study|0|||
128990985|NCT00388674|464256906|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
128990986|NCT00388674|464256907|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
128990987|NCT00388674|464256906|FG000|Initial Treatment|Adverse Event|22|||
128990988|NCT00388674|464256907|FG001|Initial Treatment|Adverse Event|87|||
128990989|NCT00388674|464256906|FG000|Initial Treatment|Death|215|||
128990990|NCT00388674|464256907|FG001|Initial Treatment|Death|216|||
128990991|NCT00388674|464256906|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
128990992|NCT00388674|464256907|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
128990993|NCT00388674|464256906|FG000|Initial Treatment|HCC|12|||
128990994|NCT00388674|464256907|FG001|Initial Treatment|HCC|20|||
128990995|NCT00388674|464256906|FG000|Initial Treatment|Lost to Follow-up|526|||
128990996|NCT00388674|464256907|FG001|Initial Treatment|Lost to Follow-up|624|||
128990997|NCT00388674|464256906|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
128990998|NCT00388674|464256907|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
128990999|NCT00388674|464256906|FG000|Initial Treatment|Never Treated with Study Medication|1|||
128991000|NCT00388674|464256907|FG001|Initial Treatment|Never Treated with Study Medication|7|||
128991001|NCT00388674|464256906|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
128991002|NCT00388674|464256907|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
128991003|NCT00388674|464256906|FG000|Initial Treatment|Not Defined|125|||
128991004|NCT00388674|464256907|FG001|Initial Treatment|Not Defined|172|||
128991005|NCT00388674|464256906|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
128991006|NCT00388674|464256907|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
128991007|NCT00388674|464256906|FG000|Initial Treatment|Pregnancy|26|||
128991008|NCT00388674|464256907|FG001|Initial Treatment|Pregnancy|16|||
128991009|NCT00388674|464256906|FG000|Initial Treatment|Study Drug Toxicity|5|||
128991010|NCT00388674|464256907|FG001|Initial Treatment|Study Drug Toxicity|92|||
128991011|NCT00388674|464256906|FG000|Initial Treatment|Participant Request|501|||
128991012|NCT00388674|464256907|FG001|Initial Treatment|Participant Request|673|||
129214503|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
129214504|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
129214505|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
129214506|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
129214507|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
129214508|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
129214509|NCT02113982|465089314|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
129214510|NCT02113982|465089315|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
129214511|NCT02113982|465089316|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
129214512|NCT02113982|465089317|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
129214513|NCT02113982|465089318|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
129214514|NCT02113982|465089319|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
129214515|NCT02113982|465089320|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
129214516|NCT02113982|465089321|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
129214517|NCT02113982|465089322|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
129214518|NCT02113982|465089323|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
129214519|NCT02113982|465089324|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
129214520|NCT02113982|465089325|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
129214521|NCT02113982|465089326|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
129214522|NCT02113982|465089327|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
129214523|NCT02113982|465089314|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214524|NCT02113982|465089315|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214525|NCT02113982|465089316|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214526|NCT02113982|465089317|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214527|NCT02113982|465089318|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214528|NCT02113982|465089319|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214529|NCT02113982|465089320|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214530|NCT02113982|465089321|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214531|NCT02113982|465089322|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214532|NCT02113982|465089323|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214533|NCT02113982|465089324|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214534|NCT02113982|465089325|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
129214535|NCT02113982|465089326|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
128991013|NCT00388674|464256906|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
128991014|NCT00388674|464256907|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
128991015|NCT00388674|464256906|FG000|Initial Treatment|Not Reported|10|||
128991016|NCT00388674|464256907|FG001|Initial Treatment|Not Reported|12|||
128991017|NCT00388674|464256906|FG000|End of Study|Administrative Reason By Sponsor|299|||
128991018|NCT00388674|464256907|FG001|End of Study|Administrative Reason By Sponsor|253|||
128991019|NCT00388674|464256906|FG000|End of Study|Death|239|||
128991020|NCT00388674|464256907|FG001|End of Study|Death|262|||
128991021|NCT00388674|464256906|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
128991022|NCT00388674|464256907|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
128991023|NCT00388674|464256906|FG000|End of Study|HCC|8|||
128991024|NCT00388674|464256907|FG001|End of Study|HCC|7|||
128991025|NCT00388674|464256906|FG000|End of Study|Lost to Follow-up|587|||
128991026|NCT00388674|464256907|FG001|End of Study|Lost to Follow-up|715|||
128991027|NCT00388674|464256906|FG000|End of Study|Malignancy (Non-HCC)|1|||
128991028|NCT00388674|464256907|FG001|End of Study|Malignancy (Non-HCC)|1|||
128991029|NCT00388674|464256906|FG000|End of Study|Non-Study Related Comorbidities|3|||
128991030|NCT00388674|464256907|FG001|End of Study|Non-Study Related Comorbidities|4|||
128991031|NCT00388674|464256906|FG000|End of Study|Not Defined|135|||
128991032|NCT00388674|464256907|FG001|End of Study|Not Defined|214|||
128991033|NCT00388674|464256906|FG000|End of Study|Participant Withdrew Consent|437|||
128991034|NCT00388674|464256907|FG001|End of Study|Participant Withdrew Consent|673|||
128991035|NCT00388674|464256906|FG000|End of Study|No Off-Treatment Status Data|22|||
128991036|NCT00388674|464256907|FG001|End of Study|No Off-Treatment Status Data|30|||
128991037|NCT00388674|464256906|FG000|End of Study|Not Reported|0|||
128991038|NCT00388674|464256907|FG001|End of Study|Not Reported|1|||
128991039|NCT00568776|464256908|FG000|Overall Study|Adverse Event|8|||
128991040|NCT00568776|464256909|FG001|Overall Study|Adverse Event|8|||
128991041|NCT00568776|464256910|FG002|Overall Study|Adverse Event|10|||
128991042|NCT00568776|464256911|FG003|Overall Study|Adverse Event|8|||
128991043|NCT00568776|464256908|FG000|Overall Study|Death|0|||
128991044|NCT00568776|464256909|FG001|Overall Study|Death|1|||
128991045|NCT00568776|464256910|FG002|Overall Study|Death|4|||
128991046|NCT00568776|464256911|FG003|Overall Study|Death|3|||
128991047|NCT00568776|464256908|FG000|Overall Study|Physician Decision|0|||
128991048|NCT00568776|464256909|FG001|Overall Study|Physician Decision|2|||
128991049|NCT00568776|464256910|FG002|Overall Study|Physician Decision|0|||
128991050|NCT00568776|464256911|FG003|Overall Study|Physician Decision|0|||
128991051|NCT00568776|464256908|FG000|Overall Study|Lack of Efficacy|2|||
128991052|NCT00568776|464256909|FG001|Overall Study|Lack of Efficacy|2|||
128991053|NCT00568776|464256910|FG002|Overall Study|Lack of Efficacy|2|||
128991054|NCT00568776|464256911|FG003|Overall Study|Lack of Efficacy|4|||
128991055|NCT00568776|464256908|FG000|Overall Study|Lost to Follow-up|1|||
128991056|NCT00568776|464256909|FG001|Overall Study|Lost to Follow-up|1|||
128991057|NCT00568776|464256910|FG002|Overall Study|Lost to Follow-up|1|||
128991058|NCT00568776|464256911|FG003|Overall Study|Lost to Follow-up|1|||
128991059|NCT00568776|464256908|FG000|Overall Study|Protocol Violation|1|||
128991060|NCT00568776|464256909|FG001|Overall Study|Protocol Violation|0|||
128991061|NCT00568776|464256910|FG002|Overall Study|Protocol Violation|1|||
128991062|NCT00568776|464256911|FG003|Overall Study|Protocol Violation|1|||
128991063|NCT00568776|464256908|FG000|Overall Study|Withdrawal by Subject|13|||
128991064|NCT00568776|464256909|FG001|Overall Study|Withdrawal by Subject|15|||
128991065|NCT00568776|464256910|FG002|Overall Study|Withdrawal by Subject|13|||
128991066|NCT00568776|464256911|FG003|Overall Study|Withdrawal by Subject|7|||
128991067|NCT00568776|464256908|FG000|Overall Study|Loss of Caregiver|0|||
128991068|NCT00568776|464256909|FG001|Overall Study|Loss of Caregiver|2|||
128991069|NCT00568776|464256910|FG002|Overall Study|Loss of Caregiver|1|||
128991070|NCT00568776|464256911|FG003|Overall Study|Loss of Caregiver|2|||
128991071|NCT00568776|464256908|FG000|Overall Study|Sponsor Decision|2|||
128991072|NCT00568776|464256909|FG001|Overall Study|Sponsor Decision|2|||
128991073|NCT00568776|464256910|FG002|Overall Study|Sponsor Decision|41|||
128991074|NCT00568776|464256911|FG003|Overall Study|Sponsor Decision|42|||
128991075|NCT00568776|464256908|FG000|Overall Study|Miscellaeneous|3|||
128991076|NCT00568776|464256909|FG001|Overall Study|Miscellaeneous|3|||
128991077|NCT00568776|464256910|FG002|Overall Study|Miscellaeneous|1|||
128991078|NCT00568776|464256911|FG003|Overall Study|Miscellaeneous|4|||
128991079|NCT02118896|464256922|FG000|Overall Study|Death|4|||
128991080|NCT02118896|464256923|FG001|Overall Study|Death|0|||
128991081|NCT02118896|464256924|FG002|Overall Study|Death|4|||
128991082|NCT02118896|464256925|FG003|Overall Study|Death|6|||
128991083|NCT02118896|464256926|FG004|Overall Study|Death|3|||
128991084|NCT02118896|464256927|FG005|Overall Study|Death|1|||
128991085|NCT02118896|464256928|FG006|Overall Study|Death|0|||
128991086|NCT02118896|464256929|FG007|Overall Study|Death|0|||
128991087|NCT02118896|464256930|FG008|Overall Study|Death|0|||
128991088|NCT02118896|464256931|FG009|Overall Study|Death|0|||
128991089|NCT02118896|464256922|FG000|Overall Study|Adverse Event|5|||
128991090|NCT02118896|464256923|FG001|Overall Study|Adverse Event|4|||
128991091|NCT02118896|464256924|FG002|Overall Study|Adverse Event|4|||
128991092|NCT02118896|464256925|FG003|Overall Study|Adverse Event|5|||
128991093|NCT02118896|464256926|FG004|Overall Study|Adverse Event|5|||
128991094|NCT02118896|464256927|FG005|Overall Study|Adverse Event|9|||
128991095|NCT02118896|464256928|FG006|Overall Study|Adverse Event|1|||
128991096|NCT02118896|464256929|FG007|Overall Study|Adverse Event|1|||
128991097|NCT02118896|464256930|FG008|Overall Study|Adverse Event|4|||
128991098|NCT02118896|464256931|FG009|Overall Study|Adverse Event|0|||
128991099|NCT02118896|464256922|FG000|Overall Study|Consent withdrawn|2|||
128991100|NCT02118896|464256923|FG001|Overall Study|Consent withdrawn|0|||
128991101|NCT02118896|464256924|FG002|Overall Study|Consent withdrawn|3|||
128991102|NCT02118896|464256925|FG003|Overall Study|Consent withdrawn|4|||
128991103|NCT02118896|464256926|FG004|Overall Study|Consent withdrawn|1|||
128991104|NCT02118896|464256927|FG005|Overall Study|Consent withdrawn|4|||
128991105|NCT02118896|464256928|FG006|Overall Study|Consent withdrawn|0|||
128991106|NCT02118896|464256929|FG007|Overall Study|Consent withdrawn|0|||
128991107|NCT02118896|464256930|FG008|Overall Study|Consent withdrawn|0|||
128991108|NCT02118896|464256931|FG009|Overall Study|Consent withdrawn|0|||
128991109|NCT02118896|464256922|FG000|Overall Study|Non-compliance|2|||
128991110|NCT02118896|464256923|FG001|Overall Study|Non-compliance|1|||
128991111|NCT02118896|464256924|FG002|Overall Study|Non-compliance|1|||
128991112|NCT02118896|464256925|FG003|Overall Study|Non-compliance|5|||
128991113|NCT02118896|464256926|FG004|Overall Study|Non-compliance|0|||
128991114|NCT02118896|464256927|FG005|Overall Study|Non-compliance|1|||
128991115|NCT02118896|464256928|FG006|Overall Study|Non-compliance|0|||
128991116|NCT02118896|464256929|FG007|Overall Study|Non-compliance|1|||
128991117|NCT02118896|464256930|FG008|Overall Study|Non-compliance|0|||
128991118|NCT02118896|464256931|FG009|Overall Study|Non-compliance|0|||
128991119|NCT02118896|464256922|FG000|Overall Study|Pregnancy|1|||
128991120|NCT02118896|464256923|FG001|Overall Study|Pregnancy|1|||
128991121|NCT02118896|464256924|FG002|Overall Study|Pregnancy|0|||
128991122|NCT02118896|464256925|FG003|Overall Study|Pregnancy|0|||
128991123|NCT02118896|464256926|FG004|Overall Study|Pregnancy|1|||
128991124|NCT02118896|464256927|FG005|Overall Study|Pregnancy|3|||
128991125|NCT02118896|464256928|FG006|Overall Study|Pregnancy|1|||
128991126|NCT02118896|464256929|FG007|Overall Study|Pregnancy|0|||
128991127|NCT02118896|464256930|FG008|Overall Study|Pregnancy|0|||
128991128|NCT02118896|464256931|FG009|Overall Study|Pregnancy|0|||
128991129|NCT02118896|464256922|FG000|Overall Study|Lost to Follow-up|1|||
128991130|NCT02118896|464256923|FG001|Overall Study|Lost to Follow-up|2|||
128991131|NCT02118896|464256924|FG002|Overall Study|Lost to Follow-up|1|||
128991132|NCT02118896|464256925|FG003|Overall Study|Lost to Follow-up|0|||
128991133|NCT02118896|464256926|FG004|Overall Study|Lost to Follow-up|2|||
128991134|NCT02118896|464256927|FG005|Overall Study|Lost to Follow-up|1|||
128877550|NCT01190514|463846248|FG000|Third Intervention (Period 3)|Adverse Event|1|||
128991135|NCT02118896|464256928|FG006|Overall Study|Lost to Follow-up|0|||
128991136|NCT02118896|464256929|FG007|Overall Study|Lost to Follow-up|0|||
128991137|NCT02118896|464256930|FG008|Overall Study|Lost to Follow-up|0|||
128991138|NCT02118896|464256931|FG009|Overall Study|Lost to Follow-up|0|||
128991139|NCT02118896|464256922|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
128991140|NCT02118896|464256923|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
128991141|NCT02118896|464256924|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
128991142|NCT02118896|464256925|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
128991143|NCT02118896|464256926|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
128991144|NCT02118896|464256927|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
128991145|NCT02118896|464256928|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
128991146|NCT02118896|464256929|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
128991147|NCT02118896|464256930|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
128991148|NCT02118896|464256931|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
128991149|NCT02118896|464256922|FG000|Overall Study|Prohibited medication|0|||
128991150|NCT02118896|464256923|FG001|Overall Study|Prohibited medication|0|||
128991151|NCT02118896|464256924|FG002|Overall Study|Prohibited medication|0|||
128991152|NCT02118896|464256925|FG003|Overall Study|Prohibited medication|0|||
128991153|NCT02118896|464256926|FG004|Overall Study|Prohibited medication|1|||
128991154|NCT02118896|464256927|FG005|Overall Study|Prohibited medication|3|||
128991155|NCT02118896|464256928|FG006|Overall Study|Prohibited medication|0|||
128991156|NCT02118896|464256929|FG007|Overall Study|Prohibited medication|0|||
128991157|NCT02118896|464256930|FG008|Overall Study|Prohibited medication|0|||
128991158|NCT02118896|464256931|FG009|Overall Study|Prohibited medication|0|||
128991159|NCT02118896|464256922|FG000|Overall Study|Miscellaneous|1|||
128991160|NCT02118896|464256923|FG001|Overall Study|Miscellaneous|2|||
128991161|NCT02118896|464256924|FG002|Overall Study|Miscellaneous|0|||
128991162|NCT02118896|464256925|FG003|Overall Study|Miscellaneous|2|||
128991163|NCT02118896|464256926|FG004|Overall Study|Miscellaneous|0|||
128991164|NCT02118896|464256927|FG005|Overall Study|Miscellaneous|4|||
128991165|NCT02118896|464256928|FG006|Overall Study|Miscellaneous|0|||
128991166|NCT02118896|464256929|FG007|Overall Study|Miscellaneous|0|||
128991167|NCT02118896|464256930|FG008|Overall Study|Miscellaneous|0|||
128991168|NCT02118896|464256931|FG009|Overall Study|Miscellaneous|0|||
128991169|NCT03292731|464256932|FG000|Overall Study|Protocol Violation|4|||
128991170|NCT03292731|464256933|FG001|Overall Study|Protocol Violation|11|||
128991171|NCT03292731|464256934|FG002|Overall Study|Protocol Violation|1|||
128991172|NCT03901352|464256935|FG000|Double-blind Phase|Adverse Event|6|||
128991173|NCT03901352|464256936|FG001|Double-blind Phase|Adverse Event|4|||
128991174|NCT03901352|464256935|FG000|Double-blind Phase|Death|1|||
128991175|NCT03901352|464256936|FG001|Double-blind Phase|Death|0|||
128991176|NCT03901352|464256935|FG000|Double-blind Phase|Lack of Efficacy|0|||
128991177|NCT03901352|464256936|FG001|Double-blind Phase|Lack of Efficacy|1|||
128991178|NCT03901352|464256935|FG000|Double-blind Phase|Protocol Violation|0|||
128991179|NCT03901352|464256936|FG001|Double-blind Phase|Protocol Violation|1|||
128991180|NCT03901352|464256935|FG000|Double-blind Phase|Withdrawal by Subject|10|||
128991181|NCT03901352|464256936|FG001|Double-blind Phase|Withdrawal by Subject|8|||
128991182|NCT03901352|464256935|FG000|Open-label Extension Phase|Adverse Event|24|||
128991183|NCT03901352|464256936|FG001|Open-label Extension Phase|Adverse Event|0|||
128991184|NCT03901352|464256935|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
128991185|NCT03901352|464256936|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
128991186|NCT03901352|464256935|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
128991187|NCT03901352|464256936|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
128991188|NCT03901352|464256935|FG000|Open-label Extension Phase|Other|1|||
128991189|NCT03901352|464256936|FG001|Open-label Extension Phase|Other|0|||
128991190|NCT01965431|464256937|FG000|Overall Study|Adverse Event|0|||
128991191|NCT01965431|464256938|FG001|Overall Study|Adverse Event|1|||
128991192|NCT01965431|464256939|FG002|Overall Study|Adverse Event|0|||
128991193|NCT01965431|464256940|FG003|Overall Study|Adverse Event|0|||
128991194|NCT01965431|464256941|FG004|Overall Study|Adverse Event|0|||
128991195|NCT01965431|464256942|FG005|Overall Study|Adverse Event|0|||
128991196|NCT01965431|464256937|FG000|Overall Study|Other than stated above|6|||
128991197|NCT01965431|464256938|FG001|Overall Study|Other than stated above|5|||
128991198|NCT01965431|464256939|FG002|Overall Study|Other than stated above|6|||
128991199|NCT01965431|464256940|FG003|Overall Study|Other than stated above|6|||
128991200|NCT01965431|464256941|FG004|Overall Study|Other than stated above|6|||
128991201|NCT01965431|464256942|FG005|Overall Study|Other than stated above|6|||
128991202|NCT04635631|464256943|FG000|Overall Study|Adverse Event|1|||
128991203|NCT04635631|464256943|FG000|Overall Study|Progressive disease|13|||
128991204|NCT04635631|464256943|FG000|Overall Study|Withdrawal by Subject|1|||
128991205|NCT00572910|464256946|FG000|Overall Study|Adverse Event|1|||
128991206|NCT00572910|464256947|FG001|Overall Study|Adverse Event|2|||
128991207|NCT00572910|464256948|FG002|Overall Study|Adverse Event|0|||
128991208|NCT00572910|464256949|FG003|Overall Study|Adverse Event|2|||
128991209|NCT00572910|464256950|FG004|Overall Study|Adverse Event|0|||
128991210|NCT00572910|464256951|FG005|Overall Study|Adverse Event|0|||
128991211|NCT00572910|464256952|FG006|Overall Study|Adverse Event|4|||
128991212|NCT00572910|464256953|FG007|Overall Study|Adverse Event|2|||
128991213|NCT00572910|464256954|FG008|Overall Study|Adverse Event|1|||
128991214|NCT00572910|464256955|FG009|Overall Study|Adverse Event|3|||
128991215|NCT00572910|464256956|FG010|Overall Study|Adverse Event|2|||
128991216|NCT00572910|464256946|FG000|Overall Study|Lost to Follow-up|0|||
128991217|NCT00572910|464256947|FG001|Overall Study|Lost to Follow-up|1|||
128991218|NCT00572910|464256948|FG002|Overall Study|Lost to Follow-up|1|||
128991219|NCT00572910|464256949|FG003|Overall Study|Lost to Follow-up|2|||
128991220|NCT00572910|464256950|FG004|Overall Study|Lost to Follow-up|1|||
128991221|NCT00572910|464256951|FG005|Overall Study|Lost to Follow-up|0|||
128991222|NCT00572910|464256952|FG006|Overall Study|Lost to Follow-up|0|||
128991223|NCT00572910|464256953|FG007|Overall Study|Lost to Follow-up|0|||
128991224|NCT00572910|464256954|FG008|Overall Study|Lost to Follow-up|0|||
128991225|NCT00572910|464256955|FG009|Overall Study|Lost to Follow-up|1|||
128991226|NCT00572910|464256956|FG010|Overall Study|Lost to Follow-up|0|||
128991227|NCT00572910|464256946|FG000|Overall Study|Withdrawal by Subject|3|||
128991228|NCT00572910|464256947|FG001|Overall Study|Withdrawal by Subject|0|||
128991229|NCT00572910|464256948|FG002|Overall Study|Withdrawal by Subject|1|||
128991230|NCT00572910|464256949|FG003|Overall Study|Withdrawal by Subject|0|||
128991231|NCT00572910|464256950|FG004|Overall Study|Withdrawal by Subject|1|||
128991232|NCT00572910|464256951|FG005|Overall Study|Withdrawal by Subject|3|||
128991233|NCT00572910|464256952|FG006|Overall Study|Withdrawal by Subject|0|||
128991234|NCT00572910|464256953|FG007|Overall Study|Withdrawal by Subject|2|||
128991235|NCT00572910|464256954|FG008|Overall Study|Withdrawal by Subject|2|||
128991236|NCT00572910|464256955|FG009|Overall Study|Withdrawal by Subject|2|||
129214536|NCT02113982|465089327|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
129214537|NCT02113982|465089314|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214538|NCT02113982|465089315|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214539|NCT02113982|465089316|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214540|NCT02113982|465089317|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214541|NCT02113982|465089318|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214542|NCT02113982|465089319|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214543|NCT02113982|465089320|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214544|NCT02113982|465089321|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
128991237|NCT00572910|464256956|FG010|Overall Study|Withdrawal by Subject|1|||
128991238|NCT00592007|464256961|FG000|Overall Study|Withdrawal by Subject|1|||
129214545|NCT02113982|465089322|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
128991239|NCT00592007|464256961|FG000|Overall Study|patient ineligible (out of lab range)|1|||
128991240|NCT00457418|464256962|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
128991241|NCT00457418|464256962|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
128991242|NCT00457418|464256962|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
128991243|NCT00457418|464256962|FG000|Post PK Maintenance|Adverse Event|10|||
128991244|NCT00457418|464256962|FG000|Post PK Maintenance|Progression of Disease|6|||
128991245|NCT00457418|464256962|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
128991246|NCT00457418|464256962|FG000|Post PK Maintenance|Lost to Follow-up|1|||
128991247|NCT00595127|464256963|FG000|Overall Study|Death|6|||
128991248|NCT00595127|464256963|FG000|Overall Study|Relapsed|3|||
128991249|NCT00595127|464256963|FG000|Overall Study|joined another trial|1|||
128991250|NCT02086968|464256965|FG000|Overall Study|Adverse Event|1|||
128991251|NCT02086968|464256966|FG001|Overall Study|Adverse Event|5|||
128991252|NCT02086968|464256965|FG000|Overall Study|Lost to Follow-up|2|||
128991253|NCT02086968|464256966|FG001|Overall Study|Lost to Follow-up|3|||
128991254|NCT02086968|464256965|FG000|Overall Study|Study drug received outside protocol|0|||
128991255|NCT02086968|464256966|FG001|Overall Study|Study drug received outside protocol|1|||
128991256|NCT02086968|464256965|FG000|Overall Study|Physician Decision|4|||
128991257|NCT02086968|464256966|FG001|Overall Study|Physician Decision|0|||
128991258|NCT02086968|464256965|FG000|Overall Study|Withdrawal by Subject|1|||
128991259|NCT02086968|464256966|FG001|Overall Study|Withdrawal by Subject|4|||
128991260|NCT01569074|464256967|FG000|Overall Study|Study stopped|6|||
128991261|NCT01569074|464256968|FG001|Overall Study|Study stopped|6|||
128991262|NCT01569074|464256969|FG002|Overall Study|Study stopped|8|||
128991263|NCT01569074|464256970|FG003|Overall Study|Study stopped|7|||
128991264|NCT01569074|464256971|FG004|Overall Study|Study stopped|7|||
128991265|NCT01569074|464256967|FG000|Overall Study|Study-specific discontinuation criteria|0|||
128991266|NCT01569074|464256968|FG001|Overall Study|Study-specific discontinuation criteria|1|||
128991267|NCT01569074|464256969|FG002|Overall Study|Study-specific discontinuation criteria|0|||
128991268|NCT01569074|464256970|FG003|Overall Study|Study-specific discontinuation criteria|0|||
128991269|NCT01569074|464256971|FG004|Overall Study|Study-specific discontinuation criteria|0|||
128991270|NCT01569074|464256967|FG000|Overall Study|Severe non-compliance to protocol|0|||
128991271|NCT01569074|464256968|FG001|Overall Study|Severe non-compliance to protocol|0|||
128991272|NCT01569074|464256969|FG002|Overall Study|Severe non-compliance to protocol|1|||
128991273|NCT01569074|464256970|FG003|Overall Study|Severe non-compliance to protocol|0|||
128991274|NCT01569074|464256971|FG004|Overall Study|Severe non-compliance to protocol|0|||
128991275|NCT01569074|464256967|FG000|Overall Study|eg change in circumstances|0|||
128991276|NCT01569074|464256968|FG001|Overall Study|eg change in circumstances|2|||
128991277|NCT01569074|464256969|FG002|Overall Study|eg change in circumstances|0|||
128991278|NCT01569074|464256970|FG003|Overall Study|eg change in circumstances|1|||
128991279|NCT01569074|464256971|FG004|Overall Study|eg change in circumstances|1|||
128991280|NCT01569074|464256967|FG000|Overall Study|Adverse Event|1|||
128991281|NCT01569074|464256968|FG001|Overall Study|Adverse Event|0|||
128991282|NCT01569074|464256969|FG002|Overall Study|Adverse Event|3|||
128717766|NCT03447990|463264020|FG001|Overall Study|Withdrawal by Subject|0|||
128991283|NCT01569074|464256970|FG003|Overall Study|Adverse Event|0|||
128991284|NCT01569074|464256971|FG004|Overall Study|Adverse Event|0|||
128991285|NCT02723786|464256972|FG000|Overall Study|Lost to Follow-up|1|||
128991286|NCT00203892|464256973|FG000|Overall Study|Physician Decision|1|||
128991287|NCT00203892|464256974|FG001|Overall Study|Physician Decision|2|||
128991288|NCT00203892|464256975|FG002|Overall Study|Physician Decision|0|||
128877551|NCT01190514|463846249|FG001|Third Intervention (Period 3)|Adverse Event|0|||
128991289|NCT00203892|464256973|FG000|Overall Study|Death|1|||
128991290|NCT00203892|464256974|FG001|Overall Study|Death|0|||
128991291|NCT00203892|464256975|FG002|Overall Study|Death|0|||
128991292|NCT00742859|464256989|FG000|Overall Study|Adverse Event|5|||
128991293|NCT00742859|464256990|FG001|Overall Study|Adverse Event|6|||
128991294|NCT00742859|464256991|FG002|Overall Study|Adverse Event|3|||
128991295|NCT00742859|464256992|FG003|Overall Study|Adverse Event|1|||
128991296|NCT00742859|464256989|FG000|Overall Study|Death|1|||
128991297|NCT00742859|464256990|FG001|Overall Study|Death|0|||
128991298|NCT00742859|464256991|FG002|Overall Study|Death|0|||
128991299|NCT00742859|464256992|FG003|Overall Study|Death|1|||
128991300|NCT00742859|464256989|FG000|Overall Study|Physician Decision|1|||
128991301|NCT00742859|464256990|FG001|Overall Study|Physician Decision|2|||
128991302|NCT00742859|464256991|FG002|Overall Study|Physician Decision|0|||
128991303|NCT00742859|464256992|FG003|Overall Study|Physician Decision|0|||
128991304|NCT00742859|464256989|FG000|Overall Study|Withdrawal by Subject|4|||
128991305|NCT00742859|464256990|FG001|Overall Study|Withdrawal by Subject|2|||
128991306|NCT00742859|464256991|FG002|Overall Study|Withdrawal by Subject|4|||
128991307|NCT00742859|464256992|FG003|Overall Study|Withdrawal by Subject|1|||
128991308|NCT00742859|464256989|FG000|Overall Study|Endpoint|0|||
128991309|NCT00742859|464256990|FG001|Overall Study|Endpoint|1|||
129214546|NCT02113982|465089323|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214547|NCT02113982|465089324|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214548|NCT02113982|465089325|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
129214549|NCT02113982|465089326|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214550|NCT02113982|465089327|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
129214551|NCT02113982|465089314|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214552|NCT02113982|465089315|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214553|NCT02113982|465089316|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214554|NCT02113982|465089317|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214555|NCT02113982|465089318|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214556|NCT02113982|465089319|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214557|NCT02113982|465089320|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214558|NCT02113982|465089321|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214559|NCT02113982|465089322|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214560|NCT02113982|465089323|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214561|NCT02113982|465089324|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214562|NCT02113982|465089325|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
129214563|NCT02113982|465089326|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214564|NCT02113982|465089327|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129214565|NCT02113982|465089314|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
129214566|NCT02113982|465089315|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
129214567|NCT02113982|465089316|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
129214568|NCT02113982|465089317|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
129214569|NCT02113982|465089318|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
129214570|NCT02113982|465089319|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
129214571|NCT02113982|465089320|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
129214572|NCT02113982|465089321|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
129214573|NCT02113982|465089322|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
129214574|NCT02113982|465089323|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
129214575|NCT02113982|465089324|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
129214576|NCT02113982|465089325|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
129214577|NCT02113982|465089326|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
129214578|NCT02113982|465089327|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
129214579|NCT02113982|465089314|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214580|NCT02113982|465089315|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214581|NCT02113982|465089316|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214582|NCT02113982|465089317|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214583|NCT02113982|465089318|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214584|NCT02113982|465089319|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214585|NCT02113982|465089320|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214586|NCT02113982|465089321|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214587|NCT02113982|465089322|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214588|NCT02113982|465089323|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214589|NCT02113982|465089324|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214590|NCT02113982|465089325|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214591|NCT02113982|465089326|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
128877552|NCT01190514|463846250|FG002|Third Intervention (Period 3)|Adverse Event|0|||
128991310|NCT00742859|464256991|FG002|Overall Study|Endpoint|1|||
128991311|NCT00742859|464256992|FG003|Overall Study|Endpoint|2|||
128991312|NCT00742859|464256989|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
128991313|NCT00742859|464256990|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
128991314|NCT00742859|464256991|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
128991315|NCT00742859|464256992|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
128991316|NCT00742859|464256989|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
128991317|NCT00742859|464256990|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
128991318|NCT00742859|464256991|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
128991319|NCT00742859|464256992|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
128991320|NCT00742859|464256989|FG000|Overall Study|Sponsor request patient out of town|0|||
128991321|NCT00742859|464256990|FG001|Overall Study|Sponsor request patient out of town|0|||
128991322|NCT00742859|464256991|FG002|Overall Study|Sponsor request patient out of town|1|||
128991323|NCT00742859|464256992|FG003|Overall Study|Sponsor request patient out of town|1|||
128991324|NCT00742859|464256989|FG000|Overall Study|Site error|0|||
128991325|NCT00742859|464256990|FG001|Overall Study|Site error|0|||
128991326|NCT00742859|464256991|FG002|Overall Study|Site error|1|||
128991327|NCT00742859|464256992|FG003|Overall Study|Site error|1|||
128991328|NCT03972709|464257003|FG000|Overall Study|Withdrawal by Subject|18|||
128991329|NCT03972709|464257004|FG001|Overall Study|Withdrawal by Subject|7|||
128991330|NCT03972709|464257005|FG002|Overall Study|Withdrawal by Subject|14|||
128991331|NCT03972709|464257003|FG000|Overall Study|Study Terminated by Sponsor|48|||
128991332|NCT03972709|464257004|FG001|Overall Study|Study Terminated by Sponsor|25|||
128991333|NCT03972709|464257005|FG002|Overall Study|Study Terminated by Sponsor|50|||
128991334|NCT03972709|464257003|FG000|Overall Study|Physician Decision|1|||
128991335|NCT03972709|464257004|FG001|Overall Study|Physician Decision|0|||
128991336|NCT03972709|464257005|FG002|Overall Study|Physician Decision|0|||
128991337|NCT03972709|464257003|FG000|Overall Study|COVID-19|0|||
128991338|NCT03972709|464257004|FG001|Overall Study|COVID-19|1|||
128991339|NCT03972709|464257005|FG002|Overall Study|COVID-19|1|||
128991340|NCT03972709|464257003|FG000|Overall Study|Lost to Follow-up|6|||
128991341|NCT03972709|464257004|FG001|Overall Study|Lost to Follow-up|1|||
128991342|NCT03972709|464257005|FG002|Overall Study|Lost to Follow-up|2|||
128991343|NCT03972709|464257003|FG000|Overall Study|Death|5|||
128991344|NCT03972709|464257004|FG001|Overall Study|Death|1|||
128991345|NCT03972709|464257005|FG002|Overall Study|Death|4|||
128991346|NCT03972709|464257003|FG000|Overall Study|Adverse Event|3|||
128991347|NCT03972709|464257004|FG001|Overall Study|Adverse Event|1|||
128991348|NCT03972709|464257005|FG002|Overall Study|Adverse Event|4|||
128991349|NCT03972709|464257003|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
128991350|NCT03972709|464257004|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
128991351|NCT03972709|464257005|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
128991352|NCT03972709|464257003|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
128991353|NCT03972709|464257004|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
128991354|NCT03972709|464257005|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
128991355|NCT03972709|464257003|FG000|Overall Study|Subject Unable to be Contacted|0|||
128991356|NCT03972709|464257004|FG001|Overall Study|Subject Unable to be Contacted|1|||
128991357|NCT03972709|464257005|FG002|Overall Study|Subject Unable to be Contacted|0|||
128991358|NCT03972709|464257003|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
128991359|NCT03972709|464257004|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
128991360|NCT03972709|464257005|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
129214592|NCT02113982|465089327|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129214593|NCT02113982|465089314|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214594|NCT02113982|465089315|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214595|NCT02113982|465089316|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214596|NCT02113982|465089317|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214597|NCT02113982|465089318|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214598|NCT02113982|465089319|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214599|NCT02113982|465089320|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214600|NCT02113982|465089321|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214601|NCT02113982|465089322|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214602|NCT02113982|465089323|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214603|NCT02113982|465089324|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214604|NCT02113982|465089325|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129214605|NCT02113982|465089326|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
129214606|NCT02113982|465089327|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
128991361|NCT03972709|464257003|FG000|Overall Study|Subject Moved|0|||
128991362|NCT03972709|464257004|FG001|Overall Study|Subject Moved|1|||
128991363|NCT03972709|464257005|FG002|Overall Study|Subject Moved|0|||
128991364|NCT03972709|464257003|FG000|Overall Study|Missed Study Visits|1|||
128991365|NCT03972709|464257004|FG001|Overall Study|Missed Study Visits|0|||
128991366|NCT03972709|464257005|FG002|Overall Study|Missed Study Visits|0|||
128991367|NCT04278872|464257008|FG000|Overall Study|Adverse Event|1|||
128991368|NCT04278872|464257009|FG001|Overall Study|Adverse Event|0|||
128991369|NCT04278872|464257008|FG000|Overall Study|Protocol Violation|0|||
128991370|NCT04278872|464257009|FG001|Overall Study|Protocol Violation|1|||
128991371|NCT04278872|464257008|FG000|Overall Study|Study Termination|2|||
128991372|NCT04278872|464257009|FG001|Overall Study|Study Termination|0|||
128991373|NCT00752895|464257010|FG000|Overall Study|Withdrawal by Subject|8|||
128991374|NCT00752895|464257011|FG001|Overall Study|Withdrawal by Subject|3|||
128991375|NCT00096031|464257012|FG000|Overall Study|Adverse Event|3|||
128991376|NCT00096031|464257012|FG000|Overall Study|Lack of Efficacy|42|||
128991377|NCT00096031|464257012|FG000|Overall Study|Death|4|||
128991378|NCT00096031|464257012|FG000|Overall Study|Withdrawal by Subject|1|||
128991379|NCT00096031|464257012|FG000|Overall Study|Ineligible|8|||
128991380|NCT00096031|464257012|FG000|Overall Study|Not protocol specified|5|||
128991381|NCT03353415|464257015|FG000|Masked CGM Wear|Lost to Follow-up|2|||
128991382|NCT03353415|464257015|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
128991383|NCT02392377|464257016|FG000|Overall Study|Withdrawal by Subject|0|||
128991384|NCT02392377|464257017|FG001|Overall Study|Withdrawal by Subject|1|||
128991385|NCT03205163|464257020|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
128991386|NCT03205163|464257021|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
128991387|NCT05257109|464257022|FG000|Overall Study|Withdrawal by Subject|1|||
128991388|NCT05257109|464257023|FG001|Overall Study|Withdrawal by Subject|0|||
128991389|NCT05257109|464257024|FG002|Overall Study|Withdrawal by Subject|0|||
128991390|NCT05257109|464257025|FG003|Overall Study|Withdrawal by Subject|0|||
128991391|NCT00359073|464258812|FG000|Overall Study|Withdrawal by Subject|1|||
128991392|NCT00359073|464258813|FG001|Overall Study|Withdrawal by Subject|1|||
128991393|NCT00359073|464258812|FG000|Overall Study|Eligibility criteria no longer met|3|||
128991394|NCT00359073|464258813|FG001|Overall Study|Eligibility criteria no longer met|0|||
128991395|NCT00359073|464258812|FG000|Overall Study|developed RV16 antibody|0|||
128991396|NCT00359073|464258813|FG001|Overall Study|developed RV16 antibody|1|||
128991397|NCT03387423|464258814|FG000|Overall Study|Lost to Follow-up|16|||
128991398|NCT03387423|464258815|FG001|Overall Study|Lost to Follow-up|12|||
128991399|NCT03387423|464258816|FG002|Overall Study|Lost to Follow-up|1|||
128991400|NCT03387423|464258817|FG003|Overall Study|Lost to Follow-up|0|||
128991401|NCT03387423|464258814|FG000|Overall Study|Other|0|||
128991402|NCT03387423|464258815|FG001|Overall Study|Other|3|||
128991403|NCT03387423|464258816|FG002|Overall Study|Other|0|||
128991404|NCT03387423|464258817|FG003|Overall Study|Other|0|||
128991405|NCT03387423|464258814|FG000|Overall Study|Administrative Reason|166|||
128991406|NCT03387423|464258815|FG001|Overall Study|Administrative Reason|89|||
128991407|NCT03387423|464258816|FG002|Overall Study|Administrative Reason|17|||
128991408|NCT03387423|464258817|FG003|Overall Study|Administrative Reason|19|||
128991409|NCT03387423|464258814|FG000|Overall Study|Revocation Consent|76|||
128991410|NCT03387423|464258815|FG001|Overall Study|Revocation Consent|32|||
128991411|NCT03387423|464258816|FG002|Overall Study|Revocation Consent|3|||
128991412|NCT03387423|464258817|FG003|Overall Study|Revocation Consent|5|||
128991413|NCT01371006|464258818|FG000|Overall Study|Adverse Event|1|||
128991414|NCT01371006|464258819|FG001|Overall Study|Adverse Event|0|||
128991415|NCT00915473|464258820|FG000|Screening|Withdrawal by Subject|1|||
128991416|NCT00915473|464258821|FG001|Screening|Withdrawal by Subject|0|||
128991417|NCT00915473|464258820|FG000|4-week Follow Up|Lost to Follow-up|1|||
128991418|NCT00915473|464258821|FG001|4-week Follow Up|Lost to Follow-up|5|||
128991419|NCT03515837|464258822|FG000|Overall Study|Death|219|||
128991420|NCT03515837|464258823|FG001|Overall Study|Death|227|||
128991421|NCT03515837|464258822|FG000|Overall Study|Lost to Follow-up|0|||
128991422|NCT03515837|464258823|FG001|Overall Study|Lost to Follow-up|1|||
128991423|NCT03515837|464258822|FG000|Overall Study|Withdrawal by Subject|0|||
128991424|NCT03515837|464258823|FG001|Overall Study|Withdrawal by Subject|4|||
128991425|NCT03515837|464258822|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
128991426|NCT03515837|464258823|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
128991427|NCT01964898|464258824|FG000|Overall Study|ineligible post-randomization|1|||
128991428|NCT01964898|464258825|FG001|Overall Study|ineligible post-randomization|1|||
128991429|NCT01964898|464258824|FG000|Overall Study|did not receive the allocated interventi|2|||
128991430|NCT01964898|464258825|FG001|Overall Study|did not receive the allocated interventi|1|||
128991431|NCT01964898|464258824|FG000|Overall Study|Lost to Follow-up|3|||
128991432|NCT01964898|464258825|FG001|Overall Study|Lost to Follow-up|5|||
128991433|NCT01964898|464258824|FG000|Overall Study|Withdrawal by Subject|1|||
128991434|NCT01964898|464258825|FG001|Overall Study|Withdrawal by Subject|0|||
128991435|NCT02325401|464258828|FG000|Overall Study|Withdrawal by Subject|0|||
128991436|NCT02325401|464258829|FG001|Overall Study|Withdrawal by Subject|1|||
128991437|NCT02325401|464258830|FG002|Overall Study|Withdrawal by Subject|1|||
128991438|NCT03526679|464258831|FG000|Overall Study|still under treatment|2|||
128991439|NCT03443973|464258832|FG000|Double-blind Treatment Period|Adverse Event|5|||
128991440|NCT03443973|464258833|FG001|Double-blind Treatment Period|Adverse Event|19|||
128991441|NCT03443973|464258834|FG002|Double-blind Treatment Period|Adverse Event|0|||
128991442|NCT03443973|464258835|FG003|Double-blind Treatment Period|Adverse Event|0|||
128991443|NCT03443973|464258832|FG000|Double-blind Treatment Period|Death|5|||
128991444|NCT03443973|464258833|FG001|Double-blind Treatment Period|Death|7|||
128991445|NCT03443973|464258834|FG002|Double-blind Treatment Period|Death|0|||
128991446|NCT03443973|464258835|FG003|Double-blind Treatment Period|Death|0|||
128991447|NCT03443973|464258832|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
128991448|NCT03443973|464258833|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
128991449|NCT03443973|464258834|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
128991450|NCT03443973|464258835|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
128991451|NCT03443973|464258832|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
128991452|NCT03443973|464258833|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
128991453|NCT03443973|464258834|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
128991454|NCT03443973|464258835|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
128991455|NCT03443973|464258832|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
128991456|NCT03443973|464258833|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
128991457|NCT03443973|464258834|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
128991458|NCT03443973|464258835|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
128991459|NCT03443973|464258832|FG000|Double-blind Treatment Period|Physician Decision|5|||
128991460|NCT03443973|464258833|FG001|Double-blind Treatment Period|Physician Decision|6|||
128991461|NCT03443973|464258834|FG002|Double-blind Treatment Period|Physician Decision|0|||
128991462|NCT03443973|464258835|FG003|Double-blind Treatment Period|Physician Decision|0|||
128991463|NCT03443973|464258832|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
128991464|NCT03443973|464258833|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
128991465|NCT03443973|464258834|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
128991466|NCT03443973|464258835|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
128991467|NCT03443973|464258832|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
128991468|NCT03443973|464258833|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
128991469|NCT03443973|464258834|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
128991470|NCT03443973|464258835|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
128991471|NCT03443973|464258832|FG000|Open-label Extension Period|Reason Not Specified|0|||
128991472|NCT03443973|464258833|FG001|Open-label Extension Period|Reason Not Specified|0|||
128991473|NCT03443973|464258834|FG002|Open-label Extension Period|Reason Not Specified|3|||
128991474|NCT03443973|464258835|FG003|Open-label Extension Period|Reason Not Specified|0|||
128991475|NCT03443973|464258832|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
128991476|NCT03443973|464258833|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
128991477|NCT03443973|464258834|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
128991478|NCT03443973|464258835|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
128991479|NCT01956123|464258836|FG000|COS Cycle 2|Protocol Violation|8|||
128991480|NCT01956123|464258837|FG001|COS Cycle 2|Protocol Violation|3|||
128991481|NCT01956123|464258838|FG002|COS Cycle 2|Protocol Violation|0|||
128991482|NCT01956123|464258839|FG003|COS Cycle 2|Protocol Violation|0|||
128991483|NCT01956123|464258836|FG000|COS Cycle 2|Adverse Event|3|||
128991484|NCT01956123|464258837|FG001|COS Cycle 2|Adverse Event|4|||
128991485|NCT01956123|464258838|FG002|COS Cycle 2|Adverse Event|0|||
128991486|NCT01956123|464258839|FG003|COS Cycle 2|Adverse Event|0|||
128991487|NCT01956123|464258836|FG000|COS Cycle 2|Personal Reasons|2|||
128991488|NCT01956123|464258837|FG001|COS Cycle 2|Personal Reasons|0|||
128991489|NCT01956123|464258838|FG002|COS Cycle 2|Personal Reasons|0|||
128991490|NCT01956123|464258839|FG003|COS Cycle 2|Personal Reasons|0|||
128991491|NCT01956123|464258836|FG000|COS Cycle 2|Withdrawal by Subject|1|||
128991492|NCT01956123|464258837|FG001|COS Cycle 2|Withdrawal by Subject|0|||
128991493|NCT01956123|464258838|FG002|COS Cycle 2|Withdrawal by Subject|0|||
128991494|NCT01956123|464258839|FG003|COS Cycle 2|Withdrawal by Subject|0|||
128991495|NCT01956123|464258836|FG000|COS Cycle 3|Protocol Violation|0|||
128991496|NCT01956123|464258837|FG001|COS Cycle 3|Protocol Violation|0|||
128991497|NCT01956123|464258838|FG002|COS Cycle 3|Protocol Violation|2|||
128991498|NCT01956123|464258839|FG003|COS Cycle 3|Protocol Violation|1|||
128991499|NCT01956123|464258836|FG000|COS Cycle 3|Adverse Event|0|||
128991500|NCT01956123|464258837|FG001|COS Cycle 3|Adverse Event|0|||
128991501|NCT01956123|464258838|FG002|COS Cycle 3|Adverse Event|3|||
128991502|NCT01956123|464258839|FG003|COS Cycle 3|Adverse Event|0|||
128991503|NCT01956123|464258836|FG000|COS Cycle 3|Personal Reasons|0|||
128991504|NCT01956123|464258837|FG001|COS Cycle 3|Personal Reasons|0|||
128991505|NCT01956123|464258838|FG002|COS Cycle 3|Personal Reasons|1|||
128991506|NCT01956123|464258839|FG003|COS Cycle 3|Personal Reasons|0|||
128991507|NCT01956123|464258836|FG000|COS Cycle 3|Withdrawal by Subject|0|||
128991508|NCT01956123|464258837|FG001|COS Cycle 3|Withdrawal by Subject|0|||
128991509|NCT01956123|464258838|FG002|COS Cycle 3|Withdrawal by Subject|0|||
128991510|NCT01956123|464258839|FG003|COS Cycle 3|Withdrawal by Subject|1|||
128991511|NCT02209454|464258845|FG000|Second Period|Adverse Event|1|||
128991512|NCT02209454|464258846|FG001|Second Period|Adverse Event|0|||
128991513|NCT01777191|464258849|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
128991514|NCT01777191|464258850|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
128991515|NCT01777191|464258849|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
128991516|NCT01777191|464258850|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
128991517|NCT01777191|464258849|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
128991518|NCT01777191|464258850|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
128991519|NCT01777191|464258849|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
128991520|NCT01777191|464258850|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
128991521|NCT01777191|464258849|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
128991522|NCT01777191|464258850|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
128991523|NCT01777191|464258849|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
128991524|NCT01777191|464258850|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
128991525|NCT01777191|464258849|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
128991526|NCT01777191|464258850|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
128991527|NCT01777191|464258849|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
128991528|NCT01777191|464258850|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
128991529|NCT01777191|464258849|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
128991530|NCT01777191|464258850|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
128991531|NCT01777191|464258849|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
128991532|NCT01777191|464258850|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
128991533|NCT01777191|464258849|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
128991534|NCT01777191|464258850|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
128991535|NCT00468312|464258855|FG000|Overall Study|Adverse Event|2|||
128991536|NCT00468312|464258856|FG001|Overall Study|Adverse Event|1|||
128991537|NCT00468312|464258855|FG000|Overall Study|Lack of Efficacy|0|||
128991538|NCT00468312|464258856|FG001|Overall Study|Lack of Efficacy|1|||
128991539|NCT00468312|464258855|FG000|Overall Study|Withdrawal by Subject|0|||
128991540|NCT00468312|464258856|FG001|Overall Study|Withdrawal by Subject|1|||
128991541|NCT00468312|464258855|FG000|Overall Study|Protocol Violation|2|||
128991542|NCT00468312|464258856|FG001|Overall Study|Protocol Violation|1|||
128991543|NCT00468312|464258855|FG000|Overall Study|Did not meet protocol eligibility|0|||
128991544|NCT00468312|464258856|FG001|Overall Study|Did not meet protocol eligibility|1|||
128991545|NCT01052038|464258857|FG000|Overall Study|Lost to Follow-up|2|||
128991546|NCT01052038|464258858|FG001|Overall Study|Lost to Follow-up|3|||
128991547|NCT01052038|464258859|FG002|Overall Study|Lost to Follow-up|1|||
128991548|NCT01052038|464258857|FG000|Overall Study|Protocol Violation|2|||
128991549|NCT01052038|464258858|FG001|Overall Study|Protocol Violation|3|||
128991550|NCT01052038|464258859|FG002|Overall Study|Protocol Violation|3|||
128991551|NCT00734617|464258860|FG000|Overall Study|Adverse Event|4|||
128991552|NCT00734617|464258861|FG001|Overall Study|Adverse Event|7|||
128991553|NCT00734617|464258860|FG000|Overall Study|Withdrawal by Subject|103|||
128991554|NCT00734617|464258861|FG001|Overall Study|Withdrawal by Subject|95|||
128991555|NCT02367729|464258867|FG000|Overall Study|Organic disorder diagnosed|2|||
128991556|NCT02367729|464258868|FG001|Overall Study|Organic disorder diagnosed|1|||
128991557|NCT02367729|464258867|FG000|Overall Study|Adverse Event|1|||
128991558|NCT02367729|464258868|FG001|Overall Study|Adverse Event|2|||
128991559|NCT02367729|464258867|FG000|Overall Study|Withdrawal by Subject|0|||
128991560|NCT02367729|464258868|FG001|Overall Study|Withdrawal by Subject|5|||
128991561|NCT00759174|464258873|FG000|Overall Study|Other|0|||
128991562|NCT00759174|464258874|FG001|Overall Study|Other|2|||
128991563|NCT01890109|464258875|FG000|Overall Study|Withdrawal by Subject|0|||
128991564|NCT01890109|464258876|FG001|Overall Study|Withdrawal by Subject|3|||
128991565|NCT01890109|464258875|FG000|Overall Study|Lost to Follow-up|1|||
128991566|NCT01890109|464258876|FG001|Overall Study|Lost to Follow-up|2|||
128991567|NCT01643928|464258879|FG000|Overall Study|Lost to Follow-up|1|||
128991568|NCT01643928|464258880|FG001|Overall Study|Lost to Follow-up|0|||
128991569|NCT01643928|464258881|FG002|Overall Study|Lost to Follow-up|2|||
128991570|NCT01643928|464258882|FG003|Overall Study|Lost to Follow-up|0|||
128991571|NCT01643928|464258883|FG004|Overall Study|Lost to Follow-up|0|||
128991572|NCT01643928|464258879|FG000|Overall Study|Withdrawal by Subject|2|||
128991573|NCT01643928|464258880|FG001|Overall Study|Withdrawal by Subject|0|||
128991574|NCT01643928|464258881|FG002|Overall Study|Withdrawal by Subject|0|||
128991575|NCT01643928|464258882|FG003|Overall Study|Withdrawal by Subject|1|||
128991576|NCT01643928|464258883|FG004|Overall Study|Withdrawal by Subject|0|||
128991577|NCT01643928|464258879|FG000|Overall Study|Pregnancy|0|||
128991578|NCT01643928|464258880|FG001|Overall Study|Pregnancy|0|||
128991579|NCT01643928|464258881|FG002|Overall Study|Pregnancy|0|||
128991580|NCT01643928|464258882|FG003|Overall Study|Pregnancy|1|||
128991581|NCT01643928|464258883|FG004|Overall Study|Pregnancy|0|||
128991582|NCT01643928|464258879|FG000|Overall Study|Other|5|||
128991583|NCT01643928|464258880|FG001|Overall Study|Other|1|||
128991584|NCT01643928|464258881|FG002|Overall Study|Other|1|||
128991585|NCT01643928|464258882|FG003|Overall Study|Other|0|||
128991586|NCT01643928|464258883|FG004|Overall Study|Other|0|||
128991587|NCT01643928|464258879|FG000|Overall Study|Adverse Event|2|||
128991588|NCT01643928|464258880|FG001|Overall Study|Adverse Event|1|||
128991589|NCT01643928|464258881|FG002|Overall Study|Adverse Event|0|||
128991590|NCT01643928|464258882|FG003|Overall Study|Adverse Event|1|||
128991591|NCT01643928|464258883|FG004|Overall Study|Adverse Event|2|||
128991592|NCT01005680|464258884|FG000|Overall Study|Lost to Follow-up|4|||
128991593|NCT01005680|464258885|FG001|Overall Study|Lost to Follow-up|6|||
128991594|NCT01005680|464258884|FG000|Overall Study|Withdrawal by Subject|1|||
128991595|NCT01005680|464258885|FG001|Overall Study|Withdrawal by Subject|4|||
128991596|NCT01005680|464258884|FG000|Overall Study|Physician Decision|1|||
128991597|NCT01005680|464258885|FG001|Overall Study|Physician Decision|1|||
128991598|NCT03576131|464258886|FG000|Overall Study|Investigator decision|0|||
128991599|NCT03576131|464258887|FG001|Overall Study|Investigator decision|0|||
128991600|NCT03576131|464258888|FG002|Overall Study|Investigator decision|0|||
128991601|NCT03576131|464258889|FG003|Overall Study|Investigator decision|1|||
128991602|NCT03576131|464258890|FG004|Overall Study|Investigator decision|0|||
128991603|NCT03576131|464258891|FG005|Overall Study|Investigator decision|1|||
128991604|NCT03576131|464258892|FG006|Overall Study|Investigator decision|0|||
128991605|NCT03576131|464258893|FG007|Overall Study|Investigator decision|0|||
128991606|NCT03576131|464258886|FG000|Overall Study|Withdrawal by Subject|1|||
128991607|NCT03576131|464258887|FG001|Overall Study|Withdrawal by Subject|1|||
128991608|NCT03576131|464258888|FG002|Overall Study|Withdrawal by Subject|0|||
128991609|NCT03576131|464258889|FG003|Overall Study|Withdrawal by Subject|1|||
128991610|NCT03576131|464258890|FG004|Overall Study|Withdrawal by Subject|2|||
128991611|NCT03576131|464258891|FG005|Overall Study|Withdrawal by Subject|3|||
128991612|NCT03576131|464258892|FG006|Overall Study|Withdrawal by Subject|1|||
128991613|NCT03576131|464258893|FG007|Overall Study|Withdrawal by Subject|0|||
128991614|NCT03576131|464258886|FG000|Overall Study|Death|3|||
128991615|NCT03576131|464258887|FG001|Overall Study|Death|3|||
128991616|NCT03576131|464258888|FG002|Overall Study|Death|1|||
128991617|NCT03576131|464258889|FG003|Overall Study|Death|5|||
128991618|NCT03576131|464258890|FG004|Overall Study|Death|4|||
128991619|NCT03576131|464258891|FG005|Overall Study|Death|1|||
128991620|NCT03576131|464258892|FG006|Overall Study|Death|0|||
128991621|NCT03576131|464258893|FG007|Overall Study|Death|1|||
128991622|NCT03576131|464258886|FG000|Overall Study|New anti-cancer treatment|5|||
128991623|NCT03576131|464258887|FG001|Overall Study|New anti-cancer treatment|1|||
128991624|NCT03576131|464258888|FG002|Overall Study|New anti-cancer treatment|2|||
128991625|NCT03576131|464258889|FG003|Overall Study|New anti-cancer treatment|3|||
128991626|NCT03576131|464258890|FG004|Overall Study|New anti-cancer treatment|0|||
128991627|NCT03576131|464258891|FG005|Overall Study|New anti-cancer treatment|0|||
128991628|NCT03576131|464258892|FG006|Overall Study|New anti-cancer treatment|0|||
128991629|NCT03576131|464258893|FG007|Overall Study|New anti-cancer treatment|0|||
128991630|NCT03576131|464258886|FG000|Overall Study|Unspecified reason|0|||
128991631|NCT03576131|464258887|FG001|Overall Study|Unspecified reason|0|||
128991632|NCT03576131|464258888|FG002|Overall Study|Unspecified reason|1|||
128991633|NCT03576131|464258889|FG003|Overall Study|Unspecified reason|1|||
128991634|NCT03576131|464258890|FG004|Overall Study|Unspecified reason|1|||
128991635|NCT03576131|464258891|FG005|Overall Study|Unspecified reason|1|||
128991636|NCT03576131|464258892|FG006|Overall Study|Unspecified reason|0|||
128991637|NCT03576131|464258893|FG007|Overall Study|Unspecified reason|0|||
128991638|NCT03576131|464258886|FG000|Overall Study|Subject non-compliance|0|||
128991639|NCT03576131|464258887|FG001|Overall Study|Subject non-compliance|0|||
128991640|NCT03576131|464258888|FG002|Overall Study|Subject non-compliance|0|||
128991641|NCT03576131|464258889|FG003|Overall Study|Subject non-compliance|0|||
128991642|NCT03576131|464258890|FG004|Overall Study|Subject non-compliance|0|||
128991643|NCT03576131|464258891|FG005|Overall Study|Subject non-compliance|1|||
128991644|NCT03576131|464258892|FG006|Overall Study|Subject non-compliance|0|||
128991645|NCT03576131|464258893|FG007|Overall Study|Subject non-compliance|0|||
128991646|NCT00996632|464258898|FG000|Overall Study|Physician Decision|0|||
128991647|NCT00996632|464258899|FG001|Overall Study|Physician Decision|0|||
128991648|NCT03069365|464258906|FG000|Overall Study|Adverse Event|1|||
128991649|NCT02050373|464258907|FG000|Overall Study|Adverse Event|4|||
128991650|NCT02050373|464258908|FG001|Overall Study|Adverse Event|7|||
128991651|NCT02050373|464258907|FG000|Overall Study|Death|3|||
128991652|NCT02050373|464258908|FG001|Overall Study|Death|3|||
128991653|NCT03901339|464258910|FG000|Overall Study|Death|220|||
128991654|NCT03901339|464258911|FG001|Overall Study|Death|192|||
128991655|NCT03901339|464258910|FG000|Overall Study|Informed consent withdrawn|13|||
128991656|NCT03901339|464258911|FG001|Overall Study|Informed consent withdrawn|40|||
128991657|NCT03901339|464258910|FG000|Overall Study|Sponsor request|30|||
128991658|NCT03901339|464258911|FG001|Overall Study|Sponsor request|23|||
128991659|NCT03901339|464258910|FG000|Overall Study|Reason not specified|5|||
128991660|NCT03901339|464258911|FG001|Overall Study|Reason not specified|7|||
128991661|NCT03901339|464258910|FG000|Overall Study|Lost to Follow-up|4|||
128991662|NCT03901339|464258911|FG001|Overall Study|Lost to Follow-up|7|||
128991663|NCT03901339|464258910|FG000|Overall Study|Covid19|0|||
128991664|NCT03901339|464258911|FG001|Overall Study|Covid19|2|||
128991665|NCT02886494|464258912|FG000|Overall Study|Adverse Event|1|||
128991666|NCT02886494|464258913|FG001|Overall Study|Adverse Event|0|||
128991667|NCT02886494|464258912|FG000|Overall Study|Withdrawal by Subject|12|||
128991668|NCT02886494|464258913|FG001|Overall Study|Withdrawal by Subject|3|||
128991669|NCT02886494|464258912|FG000|Overall Study|Protocol Violation|4|||
128991670|NCT02886494|464258913|FG001|Overall Study|Protocol Violation|1|||
128991671|NCT02780115|464258914|FG000|Overall Study|Withdrawal by Subject|0|||
128991672|NCT02780115|464258915|FG001|Overall Study|Withdrawal by Subject|1|||
128991673|NCT02780115|464258916|FG002|Overall Study|Withdrawal by Subject|1|||
128991674|NCT02780115|464258917|FG003|Overall Study|Withdrawal by Subject|0|||
128991675|NCT02780115|464258918|FG004|Overall Study|Withdrawal by Subject|0|||
128991676|NCT02780115|464258914|FG000|Overall Study|Adverse Event|0|||
128991677|NCT02780115|464258915|FG001|Overall Study|Adverse Event|0|||
128991678|NCT02780115|464258916|FG002|Overall Study|Adverse Event|0|||
128991679|NCT02780115|464258917|FG003|Overall Study|Adverse Event|1|||
128991680|NCT02780115|464258918|FG004|Overall Study|Adverse Event|1|||
128991681|NCT01179191|464258919|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
128991682|NCT01179191|464258919|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
128991683|NCT01179191|464258919|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
128991684|NCT01179191|464258919|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
128991685|NCT01179191|464258919|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
128991686|NCT01179191|464258919|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
128991687|NCT01179191|464258919|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
128991688|NCT01179191|464258919|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
128991689|NCT01179191|464258919|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
128991690|NCT01179191|464258919|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
128991691|NCT01179191|464258919|FG000|Maintenance Phase (8 Weeks)|Other|66|||
128991692|NCT02742818|464258923|FG000|Overall Study|Adverse Event|0|||
128991693|NCT02742818|464258924|FG001|Overall Study|Adverse Event|1|||
128991694|NCT02742818|464258923|FG000|Overall Study|Protocol Violation|0|||
128991695|NCT02742818|464258924|FG001|Overall Study|Protocol Violation|1|||
128991696|NCT01785472|464258926|FG000|Overall Study|Adverse Event|5|||
128991697|NCT01785472|464258927|FG001|Overall Study|Adverse Event|4|||
128991698|NCT01785472|464258928|FG002|Overall Study|Adverse Event|6|||
128991699|NCT01785472|464258926|FG000|Overall Study|Lack of Efficacy|2|||
128991700|NCT01785472|464258927|FG001|Overall Study|Lack of Efficacy|0|||
128991701|NCT01785472|464258928|FG002|Overall Study|Lack of Efficacy|1|||
128991702|NCT01785472|464258926|FG000|Overall Study|Lost to Follow-up|1|||
128991703|NCT01785472|464258927|FG001|Overall Study|Lost to Follow-up|2|||
128991704|NCT01785472|464258928|FG002|Overall Study|Lost to Follow-up|0|||
128991705|NCT01785472|464258926|FG000|Overall Study|Physician Decision|1|||
128991706|NCT01785472|464258927|FG001|Overall Study|Physician Decision|1|||
128991707|NCT01785472|464258928|FG002|Overall Study|Physician Decision|1|||
128991708|NCT01785472|464258926|FG000|Overall Study|Protocol deviation|0|||
128991709|NCT01785472|464258927|FG001|Overall Study|Protocol deviation|2|||
128991710|NCT01785472|464258928|FG002|Overall Study|Protocol deviation|2|||
128991711|NCT01785472|464258926|FG000|Overall Study|Subject/guardian decision|15|||
129214607|NCT02113982|465089314|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214608|NCT02113982|465089315|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214609|NCT02113982|465089316|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214610|NCT02113982|465089317|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214611|NCT02113982|465089318|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214612|NCT02113982|465089319|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214613|NCT02113982|465089320|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
128991712|NCT01785472|464258927|FG001|Overall Study|Subject/guardian decision|10|||
128991713|NCT01785472|464258928|FG002|Overall Study|Subject/guardian decision|11|||
128991714|NCT01785472|464258926|FG000|Overall Study|Technical problems|0|||
128991715|NCT01785472|464258927|FG001|Overall Study|Technical problems|0|||
128991716|NCT01785472|464258928|FG002|Overall Study|Technical problems|1|||
128991717|NCT03099161|464258933|FG000|Overall Study|Adverse Event|0|||
128991718|NCT03099161|464258934|FG001|Overall Study|Adverse Event|0|||
128991719|NCT03099161|464258935|FG002|Overall Study|Adverse Event|2|||
128991720|NCT03099161|464258933|FG000|Overall Study|Physician Decision|2|||
128991721|NCT03099161|464258934|FG001|Overall Study|Physician Decision|0|||
128991722|NCT03099161|464258935|FG002|Overall Study|Physician Decision|0|||
128991723|NCT03099161|464258933|FG000|Overall Study|Progressive Disease|1|||
128991724|NCT03099161|464258934|FG001|Overall Study|Progressive Disease|4|||
128991725|NCT03099161|464258935|FG002|Overall Study|Progressive Disease|1|||
128991726|NCT00556166|464258939|FG000|Overall Study|Withdrawal by Subject|1|||
128991727|NCT02985515|464258942|FG000|Olfaction Testing|Lost to Follow-up|0|||
128991728|NCT02985515|464258943|FG001|Olfaction Testing|Lost to Follow-up|5|||
128991729|NCT02985515|464258942|FG000|Olfaction Testing|Protocol Violation|0|||
128991730|NCT02985515|464258943|FG001|Olfaction Testing|Protocol Violation|3|||
128991731|NCT01071083|464258946|FG000|Overall Study|Adverse Event|1|||
128991732|NCT01071083|464258947|FG001|Overall Study|Adverse Event|0|||
128991733|NCT01071083|464258948|FG002|Overall Study|Adverse Event|1|||
128991734|NCT01071083|464258949|FG003|Overall Study|Adverse Event|0|||
128991735|NCT01071083|464258950|FG004|Overall Study|Adverse Event|1|||
128991736|NCT01071083|464258946|FG000|Overall Study|Withdrawal by Subject|3|||
128991737|NCT01071083|464258947|FG001|Overall Study|Withdrawal by Subject|0|||
128991738|NCT01071083|464258948|FG002|Overall Study|Withdrawal by Subject|2|||
128991739|NCT01071083|464258949|FG003|Overall Study|Withdrawal by Subject|0|||
128991740|NCT01071083|464258950|FG004|Overall Study|Withdrawal by Subject|3|||
128991741|NCT01071083|464258946|FG000|Overall Study|Physician Decision|1|||
128991742|NCT01071083|464258947|FG001|Overall Study|Physician Decision|0|||
128991743|NCT01071083|464258948|FG002|Overall Study|Physician Decision|0|||
128991744|NCT01071083|464258949|FG003|Overall Study|Physician Decision|1|||
128991745|NCT01071083|464258950|FG004|Overall Study|Physician Decision|1|||
128991746|NCT01071083|464258946|FG000|Overall Study|Early Rescue|1|||
128991747|NCT01071083|464258947|FG001|Overall Study|Early Rescue|0|||
128991748|NCT01071083|464258948|FG002|Overall Study|Early Rescue|0|||
128991749|NCT01071083|464258949|FG003|Overall Study|Early Rescue|0|||
128991750|NCT01071083|464258950|FG004|Overall Study|Early Rescue|1|||
128991751|NCT01071083|464258946|FG000|Overall Study|Subject Moved|0|||
128991752|NCT01071083|464258947|FG001|Overall Study|Subject Moved|1|||
128991753|NCT01071083|464258948|FG002|Overall Study|Subject Moved|0|||
128991754|NCT01071083|464258949|FG003|Overall Study|Subject Moved|0|||
128991755|NCT01071083|464258950|FG004|Overall Study|Subject Moved|0|||
128991756|NCT01071083|464258946|FG000|Overall Study|Images Not Usable (Motion)|0|||
128991757|NCT01071083|464258947|FG001|Overall Study|Images Not Usable (Motion)|1|||
128991758|NCT01071083|464258948|FG002|Overall Study|Images Not Usable (Motion)|0|||
128991759|NCT01071083|464258949|FG003|Overall Study|Images Not Usable (Motion)|0|||
128991760|NCT01071083|464258950|FG004|Overall Study|Images Not Usable (Motion)|0|||
128991761|NCT01071083|464258946|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
128991762|NCT01071083|464258947|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
128991763|NCT01071083|464258948|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
128991764|NCT01071083|464258949|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
128991765|NCT01071083|464258950|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
128991766|NCT01071083|464258946|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
128991767|NCT01071083|464258947|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
128991768|NCT01071083|464258948|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
128991769|NCT01071083|464258949|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
128991770|NCT01071083|464258950|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
128991771|NCT01071083|464258946|FG000|Overall Study|Subject Refused to Continue|1|||
128991772|NCT01071083|464258947|FG001|Overall Study|Subject Refused to Continue|0|||
128991773|NCT01071083|464258948|FG002|Overall Study|Subject Refused to Continue|0|||
128991774|NCT01071083|464258949|FG003|Overall Study|Subject Refused to Continue|0|||
128991775|NCT01071083|464258950|FG004|Overall Study|Subject Refused to Continue|0|||
128991776|NCT00834366|464258951|FG000|Treatment Period 1|Adverse Event|1|||
128991777|NCT00834366|464258952|FG001|Treatment Period 1|Adverse Event|1|||
128991778|NCT00090259|464258953|FG000|Overall Study|Lost to Follow-up|30|||
128991779|NCT00090259|464258954|FG001|Overall Study|Lost to Follow-up|26|||
128991780|NCT00090259|464258953|FG000|Overall Study|Withdrawal by Subject|21|||
128991781|NCT00090259|464258954|FG001|Overall Study|Withdrawal by Subject|15|||
128991782|NCT00090259|464258953|FG000|Overall Study|Investigator site closed|11|||
128991783|NCT00090259|464258954|FG001|Overall Study|Investigator site closed|7|||
128991784|NCT00960687|464258955|FG000|Washout Period of 7 Days|Adverse Event|3|||
128991785|NCT00960687|464258956|FG001|Washout Period of 7 Days|Adverse Event|2|||
128991786|NCT00960687|464258955|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
128991787|NCT00960687|464258956|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
128991788|NCT02704130|464258957|FG000|Overall Study|Physician Decision|5|||
128991789|NCT02704130|464258958|FG001|Overall Study|Physician Decision|3|||
128991790|NCT02666768|464258959|FG000|Overall Study|Withdrawal by Subject|4|||
128991791|NCT00285012|464258962|FG000|Assigned to Study Treatment (Tx)|Other|2|||
128991792|NCT00285012|464258963|FG001|Assigned to Study Treatment (Tx)|Other|3|||
128991793|NCT00285012|464258962|FG000|Received Study Tx|Death|2|||
128991794|NCT00285012|464258963|FG001|Received Study Tx|Death|1|||
128991795|NCT00285012|464258962|FG000|Received Study Tx|Adverse Event|5|||
128991796|NCT00285012|464258963|FG001|Received Study Tx|Adverse Event|11|||
128991797|NCT00285012|464258962|FG000|Received Study Tx|Lack of Efficacy|0|||
128991798|NCT00285012|464258963|FG001|Received Study Tx|Lack of Efficacy|3|||
128991799|NCT00285012|464258962|FG000|Received Study Tx|Lost to Follow-up|29|||
128991800|NCT00285012|464258963|FG001|Received Study Tx|Lost to Follow-up|31|||
128991801|NCT00285012|464258962|FG000|Received Study Tx|Withdrawal by Subject|31|||
128991802|NCT00285012|464258963|FG001|Received Study Tx|Withdrawal by Subject|43|||
128991803|NCT00285012|464258962|FG000|Received Study Tx|Other|5|||
128991804|NCT00285012|464258963|FG001|Received Study Tx|Other|5|||
128991805|NCT02873195|464258966|FG000|Overall Study|Ineligible|5|||
128991806|NCT02873195|464258967|FG001|Overall Study|Ineligible|0|||
128991807|NCT05004181|464258968|FG000|Overall Study|Withdrawal of consent|0|||
128991808|NCT05004181|464258969|FG001|Overall Study|Withdrawal of consent|0|||
128991809|NCT05004181|464258970|FG002|Overall Study|Withdrawal of consent|1|||
128991810|NCT05004181|464258971|FG003|Overall Study|Withdrawal of consent|3|||
128991811|NCT05004181|464258972|FG004|Overall Study|Withdrawal of consent|3|||
128991812|NCT05004181|464258973|FG005|Overall Study|Withdrawal of consent|0|||
128991813|NCT05004181|464258974|FG006|Overall Study|Withdrawal of consent|30|||
128991814|NCT05004181|464258975|FG007|Overall Study|Withdrawal of consent|9|||
128991815|NCT05004181|464258976|FG008|Overall Study|Withdrawal of consent|3|||
128991816|NCT05004181|464258977|FG009|Overall Study|Withdrawal of consent|2|||
128991817|NCT05004181|464258978|FG010|Overall Study|Withdrawal of consent|5|||
128991818|NCT05004181|464258979|FG011|Overall Study|Withdrawal of consent|1|||
128991819|NCT05004181|464258968|FG000|Overall Study|Lost to Follow-up|2|||
128991820|NCT05004181|464258969|FG001|Overall Study|Lost to Follow-up|4|||
128991821|NCT05004181|464258970|FG002|Overall Study|Lost to Follow-up|2|||
128991822|NCT05004181|464258971|FG003|Overall Study|Lost to Follow-up|3|||
128991823|NCT05004181|464258972|FG004|Overall Study|Lost to Follow-up|5|||
128991824|NCT05004181|464258973|FG005|Overall Study|Lost to Follow-up|2|||
128991825|NCT05004181|464258974|FG006|Overall Study|Lost to Follow-up|15|||
128877553|NCT01190514|463846251|FG003|Third Intervention (Period 3)|Adverse Event|0|||
128991826|NCT05004181|464258975|FG007|Overall Study|Lost to Follow-up|12|||
128991827|NCT05004181|464258976|FG008|Overall Study|Lost to Follow-up|38|||
128991828|NCT05004181|464258977|FG009|Overall Study|Lost to Follow-up|6|||
128991829|NCT05004181|464258978|FG010|Overall Study|Lost to Follow-up|6|||
128991830|NCT05004181|464258979|FG011|Overall Study|Lost to Follow-up|0|||
128991831|NCT05004181|464258968|FG000|Overall Study|Death|0|||
128991832|NCT05004181|464258969|FG001|Overall Study|Death|0|||
128991833|NCT05004181|464258970|FG002|Overall Study|Death|0|||
128991834|NCT05004181|464258971|FG003|Overall Study|Death|0|||
128991835|NCT05004181|464258972|FG004|Overall Study|Death|0|||
128991836|NCT05004181|464258973|FG005|Overall Study|Death|0|||
128991837|NCT05004181|464258974|FG006|Overall Study|Death|1|||
128991838|NCT05004181|464258975|FG007|Overall Study|Death|0|||
128991839|NCT05004181|464258976|FG008|Overall Study|Death|2|||
128991840|NCT05004181|464258977|FG009|Overall Study|Death|0|||
128991841|NCT05004181|464258978|FG010|Overall Study|Death|0|||
128991842|NCT05004181|464258979|FG011|Overall Study|Death|0|||
128991843|NCT05004181|464258968|FG000|Overall Study|Physician Decision|0|||
128991844|NCT05004181|464258969|FG001|Overall Study|Physician Decision|0|||
128991845|NCT05004181|464258970|FG002|Overall Study|Physician Decision|0|||
128991846|NCT05004181|464258971|FG003|Overall Study|Physician Decision|0|||
128991847|NCT05004181|464258972|FG004|Overall Study|Physician Decision|0|||
128991848|NCT05004181|464258973|FG005|Overall Study|Physician Decision|0|||
128991849|NCT05004181|464258974|FG006|Overall Study|Physician Decision|2|||
128991850|NCT05004181|464258975|FG007|Overall Study|Physician Decision|0|||
128991851|NCT05004181|464258976|FG008|Overall Study|Physician Decision|7|||
128991852|NCT05004181|464258977|FG009|Overall Study|Physician Decision|0|||
128991853|NCT05004181|464258978|FG010|Overall Study|Physician Decision|0|||
128991854|NCT05004181|464258979|FG011|Overall Study|Physician Decision|0|||
128991855|NCT05004181|464258968|FG000|Overall Study|Withdrawal by Subject|2|||
128991856|NCT05004181|464258969|FG001|Overall Study|Withdrawal by Subject|3|||
128991857|NCT05004181|464258970|FG002|Overall Study|Withdrawal by Subject|2|||
128991858|NCT05004181|464258971|FG003|Overall Study|Withdrawal by Subject|2|||
128991859|NCT05004181|464258972|FG004|Overall Study|Withdrawal by Subject|4|||
128991860|NCT05004181|464258973|FG005|Overall Study|Withdrawal by Subject|2|||
128991861|NCT05004181|464258974|FG006|Overall Study|Withdrawal by Subject|4|||
128991862|NCT05004181|464258975|FG007|Overall Study|Withdrawal by Subject|22|||
128991863|NCT05004181|464258976|FG008|Overall Study|Withdrawal by Subject|8|||
128991864|NCT05004181|464258977|FG009|Overall Study|Withdrawal by Subject|1|||
128991865|NCT05004181|464258978|FG010|Overall Study|Withdrawal by Subject|3|||
128991866|NCT05004181|464258979|FG011|Overall Study|Withdrawal by Subject|2|||
128991867|NCT05004181|464258968|FG000|Overall Study|Protocol Violation|2|||
128991868|NCT05004181|464258969|FG001|Overall Study|Protocol Violation|3|||
128991869|NCT05004181|464258970|FG002|Overall Study|Protocol Violation|0|||
128991870|NCT05004181|464258971|FG003|Overall Study|Protocol Violation|0|||
128991871|NCT05004181|464258972|FG004|Overall Study|Protocol Violation|1|||
128991872|NCT05004181|464258973|FG005|Overall Study|Protocol Violation|0|||
128991873|NCT05004181|464258974|FG006|Overall Study|Protocol Violation|16|||
128991874|NCT05004181|464258975|FG007|Overall Study|Protocol Violation|18|||
128991875|NCT05004181|464258976|FG008|Overall Study|Protocol Violation|2|||
128991876|NCT05004181|464258977|FG009|Overall Study|Protocol Violation|2|||
128991877|NCT05004181|464258978|FG010|Overall Study|Protocol Violation|2|||
128991878|NCT05004181|464258979|FG011|Overall Study|Protocol Violation|1|||
128991879|NCT05004181|464258968|FG000|Overall Study|Not further specified|1|||
128991880|NCT05004181|464258969|FG001|Overall Study|Not further specified|0|||
128991881|NCT05004181|464258970|FG002|Overall Study|Not further specified|0|||
128991882|NCT05004181|464258971|FG003|Overall Study|Not further specified|0|||
128991883|NCT05004181|464258972|FG004|Overall Study|Not further specified|0|||
128991884|NCT05004181|464258973|FG005|Overall Study|Not further specified|0|||
128991885|NCT05004181|464258974|FG006|Overall Study|Not further specified|1|||
128991886|NCT05004181|464258975|FG007|Overall Study|Not further specified|0|||
128991887|NCT05004181|464258976|FG008|Overall Study|Not further specified|2|||
128991888|NCT05004181|464258977|FG009|Overall Study|Not further specified|1|||
128991889|NCT05004181|464258978|FG010|Overall Study|Not further specified|0|||
128991890|NCT05004181|464258979|FG011|Overall Study|Not further specified|1|||
128991891|NCT03993288|464260532|FG000|Overall Study|Lost to Follow-up|2|||
128991892|NCT03993288|464260533|FG001|Overall Study|Lost to Follow-up|1|||
128991893|NCT03993288|464260532|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
128991894|NCT03993288|464260533|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
128991895|NCT03993288|464260532|FG000|Overall Study|wrong randomization|0|||
128991896|NCT03993288|464260533|FG001|Overall Study|wrong randomization|1|||
128991897|NCT03993288|464260532|FG000|Overall Study|improper enrollment|0|||
128991898|NCT03993288|464260533|FG001|Overall Study|improper enrollment|1|||
128991899|NCT03993288|464260532|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
128991900|NCT03993288|464260533|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
128991901|NCT03993288|464260532|FG000|Overall Study|developed SAE|2|||
128991902|NCT03993288|464260533|FG001|Overall Study|developed SAE|0|||
128991903|NCT03993288|464260532|FG000|Overall Study|consent withdrawal|1|||
128991904|NCT03993288|464260533|FG001|Overall Study|consent withdrawal|0|||
128991905|NCT03993288|464260532|FG000|Overall Study|did not follow the treatment schedule|1|||
128991906|NCT03993288|464260533|FG001|Overall Study|did not follow the treatment schedule|0|||
128991907|NCT03993288|464260532|FG000|Overall Study|did not follow the treatment regimen|1|||
128991908|NCT03993288|464260533|FG001|Overall Study|did not follow the treatment regimen|0|||
128991909|NCT03993288|464260532|FG000|Overall Study|Adverse Event|1|||
128991910|NCT03993288|464260533|FG001|Overall Study|Adverse Event|0|||
128991911|NCT03993288|464260532|FG000|Overall Study|Withdrawal by Subject|1|||
128991912|NCT03993288|464260533|FG001|Overall Study|Withdrawal by Subject|1|||
128991913|NCT03349437|464260537|FG000|Screening|Screen Fail|4|||
128991914|NCT03349437|464260538|FG001|Screening|Screen Fail|0|||
128991915|NCT03349437|464260539|FG002|Screening|Screen Fail|0|||
128991916|NCT03349437|464260537|FG000|Screening|Withdrawn|1|||
128991917|NCT03349437|464260538|FG001|Screening|Withdrawn|0|||
128991918|NCT03349437|464260539|FG002|Screening|Withdrawn|0|||
128991919|NCT01461369|464260540|FG000|Overall Study|Lack of Efficacy|2|||
128991920|NCT01461369|464260541|FG001|Overall Study|Lack of Efficacy|0|||
128991921|NCT01461369|464260542|FG002|Overall Study|Lack of Efficacy|6|||
128991922|NCT01461369|464260540|FG000|Overall Study|Lost to Follow-up|0|||
128991923|NCT01461369|464260541|FG001|Overall Study|Lost to Follow-up|0|||
128991924|NCT01461369|464260542|FG002|Overall Study|Lost to Follow-up|3|||
128991925|NCT01461369|464260540|FG000|Overall Study|Adverse Event|9|||
128991926|NCT01461369|464260541|FG001|Overall Study|Adverse Event|12|||
128991927|NCT01461369|464260542|FG002|Overall Study|Adverse Event|4|||
128991928|NCT01461369|464260540|FG000|Overall Study|Protocol Violation|1|||
128991929|NCT01461369|464260541|FG001|Overall Study|Protocol Violation|2|||
128991930|NCT01461369|464260542|FG002|Overall Study|Protocol Violation|2|||
128991931|NCT01461369|464260540|FG000|Overall Study|Withdrawal by Subject|1|||
128991932|NCT01461369|464260541|FG001|Overall Study|Withdrawal by Subject|3|||
128991933|NCT01461369|464260542|FG002|Overall Study|Withdrawal by Subject|2|||
128991934|NCT02406742|464260545|FG000|Overall Study|Progression of Disease|5|||
128991935|NCT02406742|464260546|FG001|Overall Study|Progression of Disease|1|||
128991936|NCT02406742|464260547|FG002|Overall Study|Progression of Disease|6|||
128991937|NCT02406742|464260545|FG000|Overall Study|Adverse Event|3|||
128991938|NCT02406742|464260546|FG001|Overall Study|Adverse Event|0|||
128991939|NCT02406742|464260547|FG002|Overall Study|Adverse Event|2|||
128991940|NCT02406742|464260545|FG000|Overall Study|Death|1|||
128991941|NCT02406742|464260546|FG001|Overall Study|Death|0|||
128991942|NCT02406742|464260547|FG002|Overall Study|Death|0|||
128991943|NCT02406742|464260545|FG000|Overall Study|Lack of Efficacy|0|||
128991944|NCT02406742|464260546|FG001|Overall Study|Lack of Efficacy|0|||
128991945|NCT02406742|464260547|FG002|Overall Study|Lack of Efficacy|1|||
128991946|NCT02406742|464260545|FG000|Overall Study|Withdrawal by Participant|1|||
128991947|NCT02406742|464260546|FG001|Overall Study|Withdrawal by Participant|2|||
128991948|NCT02406742|464260547|FG002|Overall Study|Withdrawal by Participant|0|||
128991949|NCT02406742|464260545|FG000|Overall Study|Physician Decision|1|||
128991950|NCT02406742|464260546|FG001|Overall Study|Physician Decision|2|||
128991951|NCT02406742|464260547|FG002|Overall Study|Physician Decision|1|||
128991952|NCT02406742|464260545|FG000|Overall Study|Transition to other treatment|2|||
128991953|NCT02406742|464260546|FG001|Overall Study|Transition to other treatment|0|||
128991954|NCT02406742|464260547|FG002|Overall Study|Transition to other treatment|1|||
128991955|NCT02406742|464260545|FG000|Overall Study|Other Reasons|1|||
128991956|NCT02406742|464260546|FG001|Overall Study|Other Reasons|11|||
128991957|NCT02406742|464260547|FG002|Overall Study|Other Reasons|5|||
128991958|NCT03692078|464260548|FG000|Overall Study|Adverse Event|0|||
128991959|NCT03692078|464260549|FG001|Overall Study|Adverse Event|0|||
128991960|NCT03692078|464260550|FG002|Overall Study|Adverse Event|0|||
128991961|NCT03692078|464260551|FG003|Overall Study|Adverse Event|0|||
128991962|NCT03692078|464260552|FG004|Overall Study|Adverse Event|0|||
128991963|NCT03692078|464260553|FG005|Overall Study|Adverse Event|1|||
128991964|NCT03692078|464260554|FG006|Overall Study|Adverse Event|0|||
128991965|NCT03692078|464260548|FG000|Overall Study|Enrollment Closed|5|||
128991966|NCT03692078|464260549|FG001|Overall Study|Enrollment Closed|0|||
128991967|NCT03692078|464260550|FG002|Overall Study|Enrollment Closed|0|||
128991968|NCT03692078|464260551|FG003|Overall Study|Enrollment Closed|0|||
128991969|NCT03692078|464260552|FG004|Overall Study|Enrollment Closed|0|||
128991970|NCT03692078|464260553|FG005|Overall Study|Enrollment Closed|0|||
128991971|NCT03692078|464260554|FG006|Overall Study|Enrollment Closed|0|||
128991972|NCT03692078|464260548|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
128991973|NCT03692078|464260549|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
128991974|NCT03692078|464260550|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
128991975|NCT03692078|464260551|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
128991976|NCT03692078|464260552|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
128991977|NCT03692078|464260553|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
128991978|NCT03692078|464260554|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
128991979|NCT03692078|464260548|FG000|Overall Study|Withdrawal by Subject|0|||
128991980|NCT03692078|464260549|FG001|Overall Study|Withdrawal by Subject|2|||
128991981|NCT03692078|464260550|FG002|Overall Study|Withdrawal by Subject|0|||
128991982|NCT03692078|464260551|FG003|Overall Study|Withdrawal by Subject|1|||
128991983|NCT03692078|464260552|FG004|Overall Study|Withdrawal by Subject|5|||
128991984|NCT03692078|464260553|FG005|Overall Study|Withdrawal by Subject|3|||
128991985|NCT03692078|464260554|FG006|Overall Study|Withdrawal by Subject|3|||
128991986|NCT01563029|464260555|FG000|Overall Study|Adverse Event|1|||
128991987|NCT01563029|464260556|FG001|Overall Study|Adverse Event|0|||
128991988|NCT01563029|464260557|FG002|Overall Study|Adverse Event|1|||
128991989|NCT01563029|464260558|FG003|Overall Study|Adverse Event|2|||
128991990|NCT01563029|464260559|FG004|Overall Study|Adverse Event|1|||
128991991|NCT01563029|464260555|FG000|Overall Study|Lack of Efficacy|42|||
128991992|NCT01563029|464260556|FG001|Overall Study|Lack of Efficacy|16|||
128991993|NCT01563029|464260557|FG002|Overall Study|Lack of Efficacy|23|||
128991994|NCT01563029|464260558|FG003|Overall Study|Lack of Efficacy|21|||
128991995|NCT01563029|464260559|FG004|Overall Study|Lack of Efficacy|19|||
128991996|NCT01563029|464260555|FG000|Overall Study|Protocol Violation|1|||
128991997|NCT01563029|464260556|FG001|Overall Study|Protocol Violation|2|||
128991998|NCT01563029|464260557|FG002|Overall Study|Protocol Violation|3|||
128991999|NCT01563029|464260558|FG003|Overall Study|Protocol Violation|1|||
128992000|NCT01563029|464260559|FG004|Overall Study|Protocol Violation|3|||
128992001|NCT01563029|464260555|FG000|Overall Study|Protocol defined stopping criteria|1|||
128992002|NCT01563029|464260556|FG001|Overall Study|Protocol defined stopping criteria|0|||
128992003|NCT01563029|464260557|FG002|Overall Study|Protocol defined stopping criteria|0|||
128992004|NCT01563029|464260558|FG003|Overall Study|Protocol defined stopping criteria|0|||
128992005|NCT01563029|464260559|FG004|Overall Study|Protocol defined stopping criteria|0|||
128992006|NCT01563029|464260555|FG000|Overall Study|Lost to Follow-up|1|||
128992007|NCT01563029|464260556|FG001|Overall Study|Lost to Follow-up|0|||
128992008|NCT01563029|464260557|FG002|Overall Study|Lost to Follow-up|1|||
128992009|NCT01563029|464260558|FG003|Overall Study|Lost to Follow-up|1|||
128992010|NCT01563029|464260559|FG004|Overall Study|Lost to Follow-up|1|||
128992011|NCT01563029|464260555|FG000|Overall Study|Physician Decision|3|||
128992012|NCT01563029|464260556|FG001|Overall Study|Physician Decision|5|||
128992013|NCT01563029|464260557|FG002|Overall Study|Physician Decision|2|||
128992014|NCT01563029|464260558|FG003|Overall Study|Physician Decision|4|||
128992015|NCT01563029|464260559|FG004|Overall Study|Physician Decision|2|||
128992016|NCT01563029|464260555|FG000|Overall Study|Withdrawal by Subject|4|||
128992017|NCT01563029|464260556|FG001|Overall Study|Withdrawal by Subject|1|||
128992018|NCT01563029|464260557|FG002|Overall Study|Withdrawal by Subject|3|||
128992019|NCT01563029|464260558|FG003|Overall Study|Withdrawal by Subject|4|||
128992020|NCT01563029|464260559|FG004|Overall Study|Withdrawal by Subject|3|||
128992021|NCT01569594|464260560|FG000|Overall Study|Physician Decision|4|||
128992022|NCT01569594|464260560|FG000|Overall Study|Death|13|||
128992023|NCT01569594|464260560|FG000|Overall Study|Lost to Follow-up|22|||
128992024|NCT01569594|464260560|FG000|Overall Study|Adverse Event|2|||
128992025|NCT01569594|464260560|FG000|Overall Study|Withdrawal by Subject|13|||
128992026|NCT01569594|464260560|FG000|Overall Study|Other|4|||
128992027|NCT01569594|464260560|FG000|Overall Study|No ECM used|9|||
128992028|NCT01826201|464260563|FG000|Overall Study|Non compliance with protocol|4|||
128992029|NCT01615822|464260564|FG000|Period 1|Withdrawal by Subject|0|||
128992030|NCT01615822|464260565|FG001|Period 1|Withdrawal by Subject|1|||
128992031|NCT01615822|464260566|FG002|Period 1|Withdrawal by Subject|0|||
128992032|NCT01615822|464260564|FG000|Period 1|Adverse Event|1|||
128992033|NCT01615822|464260565|FG001|Period 1|Adverse Event|1|||
128877554|NCT00686725|463846252|FG000|Overall Study|Adverse Event|1|||
128992034|NCT01615822|464260566|FG002|Period 1|Adverse Event|0|||
128992035|NCT01615822|464260564|FG000|Period 2|Lost to Follow-up|0|||
128992036|NCT01615822|464260565|FG001|Period 2|Lost to Follow-up|1|||
128992037|NCT01615822|464260566|FG002|Period 2|Lost to Follow-up|2|||
128992038|NCT02861534|464260567|FG000|Overall Study|Death|541|||
128992039|NCT02861534|464260568|FG001|Overall Study|Death|552|||
128992040|NCT02861534|464260567|FG000|Overall Study|Lost to Follow-up|14|||
128992041|NCT02861534|464260568|FG001|Overall Study|Lost to Follow-up|14|||
128992042|NCT02861534|464260567|FG000|Overall Study|Site Terminated by Sponsor|4|||
128992043|NCT02861534|464260568|FG001|Overall Study|Site Terminated by Sponsor|3|||
128992044|NCT02861534|464260567|FG000|Overall Study|Withdrawal by Subject|15|||
128992045|NCT02861534|464260568|FG001|Overall Study|Withdrawal by Subject|18|||
128992046|NCT00916617|464260571|FG000|Overall Study|Adverse Event|3|||
128992047|NCT00916617|464260572|FG001|Overall Study|Adverse Event|2|||
128992048|NCT00916617|464260573|FG002|Overall Study|Adverse Event|6|||
128992049|NCT00916617|464260574|FG003|Overall Study|Adverse Event|3|||
128992050|NCT00916617|464260571|FG000|Overall Study|Withdrawal by Subject|3|||
128992051|NCT00916617|464260572|FG001|Overall Study|Withdrawal by Subject|2|||
128992052|NCT00916617|464260573|FG002|Overall Study|Withdrawal by Subject|0|||
128992053|NCT00916617|464260574|FG003|Overall Study|Withdrawal by Subject|1|||
128992054|NCT00916617|464260571|FG000|Overall Study|Caregiver Request|3|||
128992055|NCT00916617|464260572|FG001|Overall Study|Caregiver Request|2|||
128992056|NCT00916617|464260573|FG002|Overall Study|Caregiver Request|1|||
128992057|NCT00916617|464260574|FG003|Overall Study|Caregiver Request|0|||
128992058|NCT00916617|464260571|FG000|Overall Study|Physician Decision|1|||
128992059|NCT00916617|464260572|FG001|Overall Study|Physician Decision|1|||
128992060|NCT00916617|464260573|FG002|Overall Study|Physician Decision|0|||
128992061|NCT00916617|464260574|FG003|Overall Study|Physician Decision|0|||
128992062|NCT00916617|464260571|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
128992063|NCT00916617|464260572|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
128992064|NCT00916617|464260573|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
128992065|NCT00916617|464260574|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
128992066|NCT00916617|464260571|FG000|Overall Study|Lost to Follow-up|2|||
128992067|NCT00916617|464260572|FG001|Overall Study|Lost to Follow-up|1|||
128992068|NCT00916617|464260573|FG002|Overall Study|Lost to Follow-up|0|||
128992069|NCT00916617|464260574|FG003|Overall Study|Lost to Follow-up|0|||
128992070|NCT00916617|464260571|FG000|Overall Study|Lack of Efficacy|1|||
128992071|NCT00916617|464260572|FG001|Overall Study|Lack of Efficacy|0|||
128992072|NCT00916617|464260573|FG002|Overall Study|Lack of Efficacy|0|||
128992073|NCT00916617|464260574|FG003|Overall Study|Lack of Efficacy|0|||
128992074|NCT00916617|464260571|FG000|Overall Study|Other|2|||
128992075|NCT00916617|464260572|FG001|Overall Study|Other|0|||
128992076|NCT00916617|464260573|FG002|Overall Study|Other|0|||
128992077|NCT00916617|464260574|FG003|Overall Study|Other|2|||
128992078|NCT01988337|464260577|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
128992079|NCT01260194|464260578|FG000|Overall Study|Withdrawal of Consent|1|||
128992080|NCT04854707|464260581|FG000|Overall Study|Lack of Efficacy|78|||
128992081|NCT04854707|464260582|FG001|Overall Study|Lack of Efficacy|59|||
128992082|NCT04854707|464260583|FG002|Overall Study|Lack of Efficacy|30|||
128992083|NCT03466060|464260589|FG000|Period 1|Test Lens Damage|0|||
128992084|NCT03466060|464260590|FG001|Period 1|Test Lens Damage|2|||
128992085|NCT03466060|464260591|FG002|Period 1|Test Lens Damage|0|||
128992086|NCT03466060|464260592|FG003|Period 1|Test Lens Damage|0|||
128992087|NCT03466060|464260593|FG004|Period 1|Test Lens Damage|0|||
128992088|NCT03466060|464260594|FG005|Period 1|Test Lens Damage|0|||
128992089|NCT03466060|464260589|FG000|Period 1|Withdrawal by Subject|0|||
128992090|NCT03466060|464260590|FG001|Period 1|Withdrawal by Subject|0|||
128992091|NCT03466060|464260591|FG002|Period 1|Withdrawal by Subject|2|||
128992092|NCT03466060|464260592|FG003|Period 1|Withdrawal by Subject|0|||
128992093|NCT03466060|464260593|FG004|Period 1|Withdrawal by Subject|0|||
128992094|NCT03466060|464260594|FG005|Period 1|Withdrawal by Subject|0|||
128992095|NCT03466060|464260589|FG000|Period 1|Lost to Follow-up|0|||
128992096|NCT03466060|464260590|FG001|Period 1|Lost to Follow-up|0|||
128992097|NCT03466060|464260591|FG002|Period 1|Lost to Follow-up|0|||
128992098|NCT03466060|464260592|FG003|Period 1|Lost to Follow-up|1|||
128992099|NCT03466060|464260593|FG004|Period 1|Lost to Follow-up|0|||
128992100|NCT03466060|464260594|FG005|Period 1|Lost to Follow-up|0|||
128992101|NCT03466060|464260589|FG000|Period 1|Grade 2 Conjunctivitis|0|||
128992102|NCT03466060|464260590|FG001|Period 1|Grade 2 Conjunctivitis|0|||
128992103|NCT03466060|464260591|FG002|Period 1|Grade 2 Conjunctivitis|1|||
128992104|NCT03466060|464260592|FG003|Period 1|Grade 2 Conjunctivitis|0|||
128992105|NCT03466060|464260593|FG004|Period 1|Grade 2 Conjunctivitis|0|||
128992106|NCT03466060|464260594|FG005|Period 1|Grade 2 Conjunctivitis|0|||
128992107|NCT03466060|464260589|FG000|Period 2|Lens Handling Difficulties|0|||
128992108|NCT03466060|464260590|FG001|Period 2|Lens Handling Difficulties|0|||
128992109|NCT03466060|464260591|FG002|Period 2|Lens Handling Difficulties|1|||
128992110|NCT03466060|464260592|FG003|Period 2|Lens Handling Difficulties|0|||
128992111|NCT03466060|464260593|FG004|Period 2|Lens Handling Difficulties|0|||
128992112|NCT03466060|464260594|FG005|Period 2|Lens Handling Difficulties|0|||
128992113|NCT01612780|464260595|FG000|Overall Study|Treatment not completed|1|||
128992114|NCT01612780|464260595|FG000|Overall Study|Withdrawal by Subject|5|||
128992115|NCT04732728|464260599|FG000|Overall Study|Death|12|||
128992116|NCT04732728|464260599|FG000|Overall Study|Withdrawn|136|||
128992117|NCT01339000|464260602|FG000|Overall Study|study closed due to lack of drug supply|1|||
128992118|NCT01339000|464260603|FG001|Overall Study|study closed due to lack of drug supply|0|||
128992119|NCT02072174|464260604|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
128992120|NCT02072174|464260605|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
128992121|NCT02072174|464260604|FG000|Overall Study|Protocol Violation|16|||
128992122|NCT02072174|464260605|FG001|Overall Study|Protocol Violation|23|||
128992123|NCT02072174|464260604|FG000|Overall Study|Physician Decision|0|||
128992124|NCT02072174|464260605|FG001|Overall Study|Physician Decision|1|||
128992125|NCT02072174|464260604|FG000|Overall Study|Non-compliance with protocol requirement|2|||
128992126|NCT02072174|464260605|FG001|Overall Study|Non-compliance with protocol requirement|0|||
128992127|NCT05674721|464260607|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
128992128|NCT05674721|464260608|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
128992129|NCT05674721|464260607|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
128992130|NCT05674721|464260608|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
128992131|NCT05013749|464260622|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
128992132|NCT05013749|464260623|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
128992133|NCT05013749|464260622|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
128992134|NCT05013749|464260623|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
128992135|NCT02017535|464260626|FG000|Overall Study|Withdrawal by Subject|1|||
128992136|NCT02017535|464260627|FG001|Overall Study|Withdrawal by Subject|0|||
128992137|NCT02017535|464260628|FG002|Overall Study|Withdrawal by Subject|0|||
128992138|NCT02017535|464260629|FG003|Overall Study|Withdrawal by Subject|0|||
128992139|NCT01393626|464260630|FG000|Overall Study|Adverse Event|2|||
128992140|NCT01393626|464260631|FG001|Overall Study|Adverse Event|1|||
128992141|NCT01393626|464260632|FG002|Overall Study|Adverse Event|5|||
128992142|NCT01393626|464260633|FG003|Overall Study|Adverse Event|0|||
128992143|NCT01393626|464260630|FG000|Overall Study|Did not meet entrance criteria|1|||
128992144|NCT01393626|464260631|FG001|Overall Study|Did not meet entrance criteria|0|||
128992145|NCT01393626|464260632|FG002|Overall Study|Did not meet entrance criteria|0|||
128992146|NCT01393626|464260633|FG003|Overall Study|Did not meet entrance criteria|0|||
128992147|NCT01393626|464260630|FG000|Overall Study|Lack of Efficacy|6|||
128992148|NCT01393626|464260631|FG001|Overall Study|Lack of Efficacy|6|||
128992149|NCT01393626|464260632|FG002|Overall Study|Lack of Efficacy|4|||
128992150|NCT01393626|464260633|FG003|Overall Study|Lack of Efficacy|1|||
128992151|NCT01393626|464260630|FG000|Overall Study|Lost to Follow-up|1|||
128992152|NCT01393626|464260631|FG001|Overall Study|Lost to Follow-up|1|||
128992153|NCT01393626|464260632|FG002|Overall Study|Lost to Follow-up|1|||
128992154|NCT01393626|464260633|FG003|Overall Study|Lost to Follow-up|0|||
128992155|NCT01393626|464260630|FG000|Overall Study|Withdrawal by Subject|6|||
128992156|NCT01393626|464260631|FG001|Overall Study|Withdrawal by Subject|4|||
128992157|NCT01393626|464260632|FG002|Overall Study|Withdrawal by Subject|0|||
128992158|NCT01393626|464260633|FG003|Overall Study|Withdrawal by Subject|0|||
128992159|NCT01393626|464260630|FG000|Overall Study|Other|1|||
128992160|NCT01393626|464260631|FG001|Overall Study|Other|0|||
128992161|NCT01393626|464260632|FG002|Overall Study|Other|0|||
128992162|NCT01393626|464260633|FG003|Overall Study|Other|0|||
128992163|NCT01393626|464260630|FG000|Overall Study|Protocol Violation|1|||
128992164|NCT01393626|464260631|FG001|Overall Study|Protocol Violation|0|||
128992165|NCT01393626|464260632|FG002|Overall Study|Protocol Violation|2|||
128992166|NCT01393626|464260633|FG003|Overall Study|Protocol Violation|0|||
128992167|NCT02858076|464260634|FG000|Overall Study|Death|6|||
128992168|NCT02858076|464260635|FG001|Overall Study|Death|3|||
128992169|NCT02858076|464260634|FG000|Overall Study|Withdrawal by Subject|1|||
128992170|NCT02858076|464260635|FG001|Overall Study|Withdrawal by Subject|5|||
128992171|NCT02858076|464260634|FG000|Overall Study|Lost to Follow-up|2|||
128992172|NCT02858076|464260635|FG001|Overall Study|Lost to Follow-up|7|||
128992173|NCT02858076|464260634|FG000|Overall Study|Completed Out of Window|1|||
128992174|NCT02858076|464260635|FG001|Overall Study|Completed Out of Window|3|||
128992175|NCT03506425|464260636|FG000|Overall Study|Adverse Event|1|||
128992176|NCT03506425|464260637|FG001|Overall Study|Adverse Event|3|||
128992177|NCT03506425|464260638|FG002|Overall Study|Adverse Event|0|||
128992178|NCT03506425|464260636|FG000|Overall Study|Death|1|||
128992179|NCT03506425|464260637|FG001|Overall Study|Death|0|||
128992180|NCT03506425|464260638|FG002|Overall Study|Death|0|||
128992181|NCT03506425|464260636|FG000|Overall Study|Withdrawal by Subject|0|||
128992182|NCT03506425|464260637|FG001|Overall Study|Withdrawal by Subject|0|||
128992183|NCT03506425|464260638|FG002|Overall Study|Withdrawal by Subject|1|||
128992184|NCT02643394|464260641|FG000|Overall Study|Protocol Violation|4|||
128992185|NCT02643394|464260642|FG001|Overall Study|Protocol Violation|5|||
128992186|NCT04088734|464260643|FG000|Overall Study|Other, Not Specified|5|||
128992187|NCT00096200|464260644|FG000|Overall Study|Adverse Event|0|||
128992188|NCT00096200|464260645|FG001|Overall Study|Adverse Event|4|||
128992189|NCT00096200|464260646|FG002|Overall Study|Adverse Event|0|||
128992190|NCT00096200|464260644|FG000|Overall Study|Withdrawal by Subject|1|||
128992191|NCT00096200|464260645|FG001|Overall Study|Withdrawal by Subject|2|||
128992192|NCT00096200|464260646|FG002|Overall Study|Withdrawal by Subject|0|||
128992193|NCT00096200|464260644|FG000|Overall Study|Ineligible pathology|0|||
128992194|NCT00096200|464260645|FG001|Overall Study|Ineligible pathology|1|||
128992195|NCT00096200|464260646|FG002|Overall Study|Ineligible pathology|0|||
128992196|NCT00938015|464260650|FG000|Overall Study|Death|2|||
128992197|NCT00938015|464260650|FG000|Overall Study|Lost to Follow-up|32|||
128992198|NCT00938015|464260650|FG000|Overall Study|Adverse Event|32|||
128992199|NCT00938015|464260650|FG000|Overall Study|Non-responder|52|||
128992200|NCT00938015|464260650|FG000|Overall Study|Reason not related to Etanercept|29|||
128992201|NCT02341482|464260651|FG000|Overall Study|Adverse Event|1|||
128992202|NCT00664066|464260655|FG000|Overall Study|Study terminated|3|||
128992203|NCT03701516|464260656|FG000|Period 1|Lost to Follow-up|0|||
128992204|NCT03701516|464260657|FG001|Period 1|Lost to Follow-up|1|||
128992205|NCT03701516|464260656|FG000|Period 1|Adverse Event|0|||
128992206|NCT03701516|464260657|FG001|Period 1|Adverse Event|2|||
128992207|NCT03701516|464260656|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
128992208|NCT03701516|464260657|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
128992209|NCT03701516|464260656|FG000|Period 1|Non Compliance to Protocol|2|||
128992210|NCT03701516|464260657|FG001|Period 1|Non Compliance to Protocol|1|||
128992211|NCT03701516|464260656|FG000|Period 1|Withdrawal by Subject|0|||
128992212|NCT03701516|464260657|FG001|Period 1|Withdrawal by Subject|1|||
128992213|NCT03701516|464260656|FG000|Period 2|failed to meet all eligibility creiteria|1|||
128992214|NCT03701516|464260657|FG001|Period 2|failed to meet all eligibility creiteria|0|||
128992215|NCT03701516|464260656|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
128992216|NCT03701516|464260657|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
128992217|NCT03083639|464260658|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
128992218|NCT03083639|464260659|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
128992219|NCT03083639|464260658|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
128992220|NCT03083639|464260659|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
128992221|NCT01591499|464260660|FG000|Baseline Visit|Withdrawal by Subject|0|||
128992222|NCT01591499|464260661|FG001|Baseline Visit|Withdrawal by Subject|2|||
128992223|NCT01591499|464260662|FG002|Baseline Visit|Withdrawal by Subject|0|||
128992224|NCT01591499|464260663|FG003|Baseline Visit|Withdrawal by Subject|2|||
128992225|NCT01591499|464260660|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
128992226|NCT01591499|464260661|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
128992227|NCT01591499|464260662|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
128992228|NCT01591499|464260663|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
128992229|NCT01591499|464260660|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
128992230|NCT01591499|464260661|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
128877555|NCT00686725|463846253|FG001|Overall Study|Adverse Event|1|||
128992231|NCT01591499|464260662|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
128992232|NCT01591499|464260663|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
128992233|NCT00981019|464260664|FG000|Overall Study|Did not respond|65|||
128992234|NCT00981019|464260664|FG000|Overall Study|Did not match target population|94|||
128992235|NCT00981019|464260664|FG000|Overall Study|Inadvertent exclusion|239|||
128992236|NCT00981019|464260664|FG000|Overall Study|Hit the survey after closure|79|||
128992237|NCT00358670|464260665|FG000|Overall Study|Adverse Event|26|||
128992238|NCT00358670|464260666|FG001|Overall Study|Adverse Event|29|||
128992239|NCT00358670|464260665|FG000|Overall Study|Lack of Efficacy|20|||
128992240|NCT00358670|464260666|FG001|Overall Study|Lack of Efficacy|23|||
128992241|NCT00358670|464260665|FG000|Overall Study|Protocol Violation|6|||
128992242|NCT00358670|464260666|FG001|Overall Study|Protocol Violation|9|||
128992243|NCT00358670|464260665|FG000|Overall Study|Lost to Follow-up|4|||
128992244|NCT00358670|464260666|FG001|Overall Study|Lost to Follow-up|5|||
128992245|NCT00358670|464260665|FG000|Overall Study|Withdrawal by Subject|13|||
128992246|NCT00358670|464260666|FG001|Overall Study|Withdrawal by Subject|24|||
128992247|NCT00358670|464260665|FG000|Overall Study|Protocol Defined Clinical Event|0|||
128992248|NCT00358670|464260666|FG001|Overall Study|Protocol Defined Clinical Event|1|||
128992249|NCT00358670|464260665|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
128992250|NCT00358670|464260666|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
128992251|NCT00358670|464260665|FG000|Overall Study|Administrative|153|||
128992252|NCT00358670|464260666|FG001|Overall Study|Administrative|125|||
128992253|NCT05083559|464260667|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
128992254|NCT05083559|464260668|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
128992255|NCT05083559|464260667|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
128992256|NCT05083559|464260668|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
128992257|NCT05083559|464260667|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
128992258|NCT05083559|464260668|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
128992259|NCT03940742|464260670|FG000|Overall Study|Lost to Follow-up|0|||
128992260|NCT03940742|464260671|FG001|Overall Study|Lost to Follow-up|0|||
128992261|NCT03940742|464260672|FG002|Overall Study|Lost to Follow-up|0|||
128992262|NCT03940742|464260673|FG003|Overall Study|Lost to Follow-up|1|||
128992263|NCT02032823|464260674|FG000|Overall Study|Death|75|||
128992264|NCT02032823|464260675|FG001|Overall Study|Death|109|||
128992265|NCT02032823|464260674|FG000|Overall Study|Lost to Follow-up|18|||
128992266|NCT02032823|464260675|FG001|Overall Study|Lost to Follow-up|17|||
128992267|NCT02032823|464260674|FG000|Overall Study|Withdrawal by Subject|70|||
128992268|NCT02032823|464260675|FG001|Overall Study|Withdrawal by Subject|53|||
128992269|NCT02032823|464260674|FG000|Overall Study|Ongoing study at data cut-off|755|||
128992270|NCT02032823|464260675|FG001|Overall Study|Ongoing study at data cut-off|731|||
128992271|NCT02032823|464260674|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
128992272|NCT02032823|464260675|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
128992273|NCT03428217|464260676|FG000|Overall Study|Death|89|||
128992274|NCT03428217|464260677|FG001|Overall Study|Death|93|||
128992275|NCT03428217|464260676|FG000|Overall Study|Withdrawal by Subject|8|||
128992276|NCT03428217|464260677|FG001|Overall Study|Withdrawal by Subject|7|||
128992277|NCT03428217|464260676|FG000|Overall Study|Lost to Follow-up|1|||
128992278|NCT03428217|464260677|FG001|Overall Study|Lost to Follow-up|3|||
128992279|NCT03428217|464260676|FG000|Overall Study|Study terminated by sponsor|124|||
128992280|NCT03428217|464260677|FG001|Overall Study|Study terminated by sponsor|118|||
128992281|NCT03428217|464260676|FG000|Overall Study|Other, Not Specified|1|||
128992282|NCT03428217|464260677|FG001|Overall Study|Other, Not Specified|0|||
128992283|NCT03889197|464260678|FG000|Overall Study|Withdrawal by Subject|1|||
128992284|NCT03889197|464260679|FG001|Overall Study|Withdrawal by Subject|0|||
128992285|NCT03889197|464260678|FG000|Overall Study|Physician Decision|0|||
128992286|NCT03889197|464260679|FG001|Overall Study|Physician Decision|1|||
128992287|NCT03889197|464260678|FG000|Overall Study|met exclusion criteria|0|||
128992288|NCT03889197|464260679|FG001|Overall Study|met exclusion criteria|1|||
128992289|NCT03889197|464260678|FG000|Overall Study|Protocol Violation|1|||
128992290|NCT03889197|464260679|FG001|Overall Study|Protocol Violation|0|||
128992291|NCT05899218|464260680|FG000|Overall Study|Lost to Follow-up|2|||
128992292|NCT05899218|464260681|FG001|Overall Study|Lost to Follow-up|2|||
128992293|NCT05899218|464260680|FG000|Overall Study|deemed ineligible out of country|1|||
128992294|NCT05899218|464260681|FG001|Overall Study|deemed ineligible out of country|0|||
128992295|NCT05246111|464260682|FG000|Period 01|NOT ELIGIBLE IC5|1|||
128992296|NCT05246111|464260683|FG001|Period 01|NOT ELIGIBLE IC5|0|||
128992297|NCT03151226|464260684|FG000|Overall Study|Withdrawal by Subject|2|||
128992298|NCT03151226|464260684|FG000|Overall Study|not wear device correctly|1|||
128992299|NCT00891527|464262875|FG000|Overall Study|Withdrawal by Subject|2|||
128992300|NCT01186744|464262876|FG000|Overall Study|Lack of Efficacy|156|||
128992301|NCT01186744|464262877|FG001|Overall Study|Lack of Efficacy|99|||
128992302|NCT01186744|464262878|FG002|Overall Study|Lack of Efficacy|0|||
128992303|NCT01186744|464262879|FG003|Overall Study|Lack of Efficacy|2|||
128992304|NCT01186744|464262880|FG004|Overall Study|Lack of Efficacy|2|||
128992305|NCT01186744|464262881|FG005|Overall Study|Lack of Efficacy|5|||
128992306|NCT01186744|464262876|FG000|Overall Study|Protocol Violation|1|||
128992307|NCT01186744|464262877|FG001|Overall Study|Protocol Violation|2|||
128992308|NCT01186744|464262878|FG002|Overall Study|Protocol Violation|0|||
128992309|NCT01186744|464262879|FG003|Overall Study|Protocol Violation|1|||
128992310|NCT01186744|464262880|FG004|Overall Study|Protocol Violation|1|||
128992311|NCT01186744|464262881|FG005|Overall Study|Protocol Violation|2|||
128992312|NCT01186744|464262876|FG000|Overall Study|Lost to Follow-up|15|||
128992313|NCT01186744|464262877|FG001|Overall Study|Lost to Follow-up|16|||
128992314|NCT01186744|464262878|FG002|Overall Study|Lost to Follow-up|2|||
128992315|NCT01186744|464262879|FG003|Overall Study|Lost to Follow-up|1|||
128992316|NCT01186744|464262880|FG004|Overall Study|Lost to Follow-up|1|||
128992317|NCT01186744|464262881|FG005|Overall Study|Lost to Follow-up|4|||
128992318|NCT01186744|464262876|FG000|Overall Study|Screen failure|1|||
128992319|NCT01186744|464262877|FG001|Overall Study|Screen failure|1|||
128992320|NCT01186744|464262878|FG002|Overall Study|Screen failure|0|||
128992321|NCT01186744|464262879|FG003|Overall Study|Screen failure|1|||
128992322|NCT01186744|464262880|FG004|Overall Study|Screen failure|0|||
128992323|NCT01186744|464262881|FG005|Overall Study|Screen failure|0|||
128992324|NCT01186744|464262876|FG000|Overall Study|Withdrawal by Subject|14|||
128992325|NCT01186744|464262877|FG001|Overall Study|Withdrawal by Subject|10|||
128992326|NCT01186744|464262878|FG002|Overall Study|Withdrawal by Subject|2|||
128992327|NCT01186744|464262879|FG003|Overall Study|Withdrawal by Subject|5|||
128992328|NCT01186744|464262880|FG004|Overall Study|Withdrawal by Subject|0|||
128992329|NCT01186744|464262881|FG005|Overall Study|Withdrawal by Subject|6|||
128992330|NCT01186744|464262876|FG000|Overall Study|Study terminated by Sponsor|1|||
128992331|NCT01186744|464262877|FG001|Overall Study|Study terminated by Sponsor|0|||
128992332|NCT01186744|464262878|FG002|Overall Study|Study terminated by Sponsor|0|||
128992333|NCT01186744|464262879|FG003|Overall Study|Study terminated by Sponsor|0|||
128992334|NCT01186744|464262880|FG004|Overall Study|Study terminated by Sponsor|0|||
128992335|NCT01186744|464262881|FG005|Overall Study|Study terminated by Sponsor|0|||
128992336|NCT01186744|464262876|FG000|Overall Study|Other|9|||
128992337|NCT01186744|464262877|FG001|Overall Study|Other|10|||
128992338|NCT01186744|464262878|FG002|Overall Study|Other|1|||
128992339|NCT01186744|464262879|FG003|Overall Study|Other|2|||
128992340|NCT01186744|464262880|FG004|Overall Study|Other|1|||
128992341|NCT01186744|464262881|FG005|Overall Study|Other|5|||
128992342|NCT01186744|464262876|FG000|Overall Study|Adverse Event|10|||
128992343|NCT01186744|464262877|FG001|Overall Study|Adverse Event|14|||
128992344|NCT01186744|464262878|FG002|Overall Study|Adverse Event|1|||
128992345|NCT01186744|464262879|FG003|Overall Study|Adverse Event|0|||
128992346|NCT01186744|464262880|FG004|Overall Study|Adverse Event|1|||
128992347|NCT01186744|464262881|FG005|Overall Study|Adverse Event|4|||
128992348|NCT01186744|464262876|FG000|Overall Study|Death|1|||
128992349|NCT01186744|464262877|FG001|Overall Study|Death|0|||
128992350|NCT01186744|464262878|FG002|Overall Study|Death|0|||
128992351|NCT01186744|464262879|FG003|Overall Study|Death|0|||
128992352|NCT01186744|464262880|FG004|Overall Study|Death|0|||
128992353|NCT01186744|464262881|FG005|Overall Study|Death|0|||
128992354|NCT01020773|464262884|FG000|Overall Study|Withdrawal by Subject|4|||
128992355|NCT01020773|464262885|FG001|Overall Study|Withdrawal by Subject|3|||
128992356|NCT01389024|464262886|FG000|Overall Study|Withdrawal by Subject|0|||
128992357|NCT01389024|464262887|FG001|Overall Study|Withdrawal by Subject|1|||
128992358|NCT01389024|464262886|FG000|Overall Study|Lost to Follow-up|1|||
128992359|NCT01389024|464262887|FG001|Overall Study|Lost to Follow-up|0|||
128992360|NCT00819091|464262888|FG000|Overall Study|Adverse Event|3|||
128992361|NCT00819091|464262889|FG001|Overall Study|Adverse Event|5|||
128992362|NCT00819091|464262888|FG000|Overall Study|Protocol Violation|0|||
128992363|NCT00819091|464262889|FG001|Overall Study|Protocol Violation|1|||
128992364|NCT00819091|464262888|FG000|Overall Study|Lost to Follow-up|2|||
128992365|NCT00819091|464262889|FG001|Overall Study|Lost to Follow-up|0|||
128992366|NCT00819091|464262888|FG000|Overall Study|Withdrawal by Subject|1|||
128992367|NCT00819091|464262889|FG001|Overall Study|Withdrawal by Subject|2|||
128992368|NCT00819091|464262888|FG000|Overall Study|Other|1|||
128992369|NCT00819091|464262889|FG001|Overall Study|Other|2|||
128992370|NCT02675426|464262891|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
128992371|NCT02675426|464262892|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
128992372|NCT02675426|464262893|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
128992373|NCT02675426|464262894|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
128992374|NCT02675426|464262891|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
128992375|NCT02675426|464262892|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
128992376|NCT02675426|464262893|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
128992377|NCT02675426|464262894|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
128877556|NCT00686725|463846252|FG000|Overall Study|Progressive Disease|17|||
128992378|NCT02675426|464262891|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
128992379|NCT02675426|464262892|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
128992380|NCT02675426|464262893|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
128992381|NCT02675426|464262894|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
128992382|NCT02675426|464262891|FG000|Period 1: Week 1 to Week 12|Other|2|||
128992383|NCT02675426|464262892|FG001|Period 1: Week 1 to Week 12|Other|1|||
128992384|NCT02675426|464262893|FG002|Period 1: Week 1 to Week 12|Other|0|||
128992385|NCT02675426|464262894|FG003|Period 1: Week 1 to Week 12|Other|2|||
128992386|NCT02675426|464262891|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
128992387|NCT02675426|464262892|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
128992388|NCT02675426|464262893|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
128992389|NCT02675426|464262894|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
128992390|NCT02675426|464262891|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
128992391|NCT02675426|464262892|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
128992392|NCT02675426|464262893|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
128992393|NCT02675426|464262894|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
128992394|NCT02675426|464262891|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
128992395|NCT02675426|464262892|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
128992396|NCT02675426|464262893|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
128992397|NCT02675426|464262894|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
128992398|NCT02675426|464262891|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
128992399|NCT02675426|464262892|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
128992400|NCT02675426|464262893|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
128992401|NCT02675426|464262894|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
128992402|NCT02675426|464262891|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
128992403|NCT02675426|464262892|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
128992404|NCT02675426|464262893|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
128992405|NCT02675426|464262894|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
128992406|NCT02675426|464262891|FG000|Period 2: Week 12 to Week 260|Other|8|||
128992407|NCT02675426|464262892|FG001|Period 2: Week 12 to Week 260|Other|12|||
128992408|NCT02675426|464262893|FG002|Period 2: Week 12 to Week 260|Other|23|||
128992409|NCT02675426|464262894|FG003|Period 2: Week 12 to Week 260|Other|15|||
128992410|NCT02953262|464262895|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
128992411|NCT02953262|464262896|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
128992412|NCT02953262|464262897|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
128992413|NCT02953262|464262898|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
128992414|NCT01652573|464262899|FG000|Overall Study|Adverse Event|0|||
128992415|NCT01652573|464262900|FG001|Overall Study|Adverse Event|1|||
128992416|NCT00740480|464262901|FG000|Overall Study|Adverse Event|1|||
128992417|NCT00740480|464262901|FG000|Overall Study|Physician Decision|1|||
128992418|NCT00934622|464262902|FG000|Overall Study|Lost to Follow-up|7|||
128992419|NCT00934622|464262902|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
128992420|NCT01856686|464262906|FG000|Overall Study|Lost to Follow-up|5|||
128992421|NCT01856686|464262907|FG001|Overall Study|Lost to Follow-up|11|||
128992422|NCT00602979|464262910|FG000|Overall Study|Lost to Follow-up|3|||
128992423|NCT00602979|464262911|FG001|Overall Study|Lost to Follow-up|2|||
128992424|NCT00602979|464262912|FG002|Overall Study|Lost to Follow-up|3|||
128992425|NCT00602979|464262913|FG003|Overall Study|Lost to Follow-up|2|||
128992426|NCT00602979|464262914|FG004|Overall Study|Lost to Follow-up|3|||
128992427|NCT00602979|464262910|FG000|Overall Study|Failed Intubation|0|||
128992428|NCT00602979|464262911|FG001|Overall Study|Failed Intubation|1|||
128992429|NCT00602979|464262912|FG002|Overall Study|Failed Intubation|0|||
128992430|NCT00602979|464262913|FG003|Overall Study|Failed Intubation|1|||
128992431|NCT00602979|464262914|FG004|Overall Study|Failed Intubation|0|||
128992432|NCT02962739|464262919|FG000|Overall Study|Withdrawal by Subject|0|||
128992433|NCT02962739|464262920|FG001|Overall Study|Withdrawal by Subject|1|||
128992434|NCT02962739|464262921|FG002|Overall Study|Withdrawal by Subject|0|||
128992435|NCT02962739|464262922|FG003|Overall Study|Withdrawal by Subject|0|||
128992436|NCT02962739|464262923|FG004|Overall Study|Withdrawal by Subject|0|||
128992437|NCT02962739|464262924|FG005|Overall Study|Withdrawal by Subject|0|||
128992438|NCT02962739|464262919|FG000|Overall Study|Protocol Violation|0|||
128992439|NCT02962739|464262920|FG001|Overall Study|Protocol Violation|0|||
128992440|NCT02962739|464262921|FG002|Overall Study|Protocol Violation|1|||
128992441|NCT02962739|464262922|FG003|Overall Study|Protocol Violation|0|||
128992442|NCT02962739|464262923|FG004|Overall Study|Protocol Violation|1|||
128992443|NCT02962739|464262924|FG005|Overall Study|Protocol Violation|0|||
128992444|NCT03891875|464262928|FG000|Overall Study|Withdrawal by Subject|20|||
128992445|NCT03891875|464262929|FG001|Overall Study|Withdrawal by Subject|3|||
128992446|NCT03891875|464262928|FG000|Overall Study|Adverse Event|10|||
128992447|NCT03891875|464262929|FG001|Overall Study|Adverse Event|4|||
128992448|NCT03891875|464262928|FG000|Overall Study|Physician Decision|1|||
128992449|NCT03891875|464262929|FG001|Overall Study|Physician Decision|1|||
128992450|NCT03891875|464262928|FG000|Overall Study|Protocol Violation|1|||
128992451|NCT03891875|464262929|FG001|Overall Study|Protocol Violation|0|||
128992452|NCT03891875|464262928|FG000|Overall Study|Lost to Follow-up|1|||
128992453|NCT03891875|464262929|FG001|Overall Study|Lost to Follow-up|0|||
128992454|NCT03891875|464262928|FG000|Overall Study|COVID-19 infection|1|||
128992455|NCT03891875|464262929|FG001|Overall Study|COVID-19 infection|0|||
128992456|NCT02426125|464262930|FG000|Overall Study|Lost to Follow-up|14|||
128992457|NCT02426125|464262931|FG001|Overall Study|Lost to Follow-up|12|||
128992458|NCT02426125|464262930|FG000|Overall Study|Withdrawal by Subject|13|||
128992459|NCT02426125|464262931|FG001|Overall Study|Withdrawal by Subject|14|||
128992460|NCT02426125|464262930|FG000|Overall Study|Death|185|||
128992461|NCT02426125|464262931|FG001|Overall Study|Death|200|||
128992462|NCT02426125|464262930|FG000|Overall Study|Randomized, But Never Treated|5|||
128992463|NCT02426125|464262931|FG001|Overall Study|Randomized, But Never Treated|2|||
128992464|NCT00835068|464262934|FG000|Overall Study|Death|1|||
128992465|NCT00835068|464262935|FG001|Overall Study|Death|0|||
128992466|NCT00835068|464262934|FG000|Overall Study|Adverse Event|0|||
128992467|NCT00835068|464262935|FG001|Overall Study|Adverse Event|1|||
128992468|NCT00835068|464262934|FG000|Overall Study|Other|8|||
128992469|NCT00835068|464262935|FG001|Overall Study|Other|0|||
128992470|NCT00835068|464262934|FG000|Overall Study|Withdrawal by Subject|1|||
128992471|NCT00835068|464262935|FG001|Overall Study|Withdrawal by Subject|0|||
128992472|NCT02575807|464262938|FG000|Overall Study|Death|8|||
128992473|NCT02575807|464262939|FG001|Overall Study|Death|3|||
128992474|NCT02575807|464262940|FG002|Overall Study|Death|7|||
128992475|NCT02575807|464262941|FG003|Overall Study|Death|0|||
128992476|NCT02575807|464262942|FG004|Overall Study|Death|1|||
128992477|NCT02575807|464262938|FG000|Overall Study|Study terminated by Sponsor|0|||
128992478|NCT02575807|464262939|FG001|Overall Study|Study terminated by Sponsor|1|||
128992479|NCT02575807|464262940|FG002|Overall Study|Study terminated by Sponsor|7|||
128992480|NCT02575807|464262941|FG003|Overall Study|Study terminated by Sponsor|0|||
128992481|NCT02575807|464262942|FG004|Overall Study|Study terminated by Sponsor|1|||
128992482|NCT02575807|464262938|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
128877557|NCT00686725|463846253|FG001|Overall Study|Progressive Disease|23|||
128877558|NCT00686725|463846252|FG000|Overall Study|Lost to Follow-up|7|||
128877559|NCT00686725|463846253|FG001|Overall Study|Lost to Follow-up|5|||
128992483|NCT02575807|464262939|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
128992484|NCT02575807|464262940|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
128992485|NCT02575807|464262941|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
128992486|NCT02575807|464262942|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
128992487|NCT02575807|464262938|FG000|Overall Study|Terminated due to physician decision|0|||
128992488|NCT02575807|464262939|FG001|Overall Study|Terminated due to physician decision|0|||
128992489|NCT02575807|464262940|FG002|Overall Study|Terminated due to physician decision|1|||
128992490|NCT02575807|464262941|FG003|Overall Study|Terminated due to physician decision|0|||
128992491|NCT02575807|464262942|FG004|Overall Study|Terminated due to physician decision|0|||
128992492|NCT02575807|464262938|FG000|Overall Study|Subject ineligible - medical implant|0|||
128877560|NCT00686725|463846252|FG000|Overall Study|Death|6|||
128877561|NCT00686725|463846253|FG001|Overall Study|Death|3|||
128992493|NCT02575807|464262939|FG001|Overall Study|Subject ineligible - medical implant|0|||
128992494|NCT02575807|464262940|FG002|Overall Study|Subject ineligible - medical implant|0|||
128992495|NCT02575807|464262941|FG003|Overall Study|Subject ineligible - medical implant|1|||
128992496|NCT02575807|464262942|FG004|Overall Study|Subject ineligible - medical implant|0|||
128992497|NCT02575807|464262938|FG000|Overall Study|Withdrawal by Subject|0|||
128992498|NCT02575807|464262939|FG001|Overall Study|Withdrawal by Subject|0|||
128992499|NCT02575807|464262940|FG002|Overall Study|Withdrawal by Subject|1|||
128992500|NCT02575807|464262941|FG003|Overall Study|Withdrawal by Subject|1|||
128992501|NCT02575807|464262942|FG004|Overall Study|Withdrawal by Subject|2|||
128992502|NCT01495793|464262943|FG000|Overall Study|Lost to Follow-up|1|||
128992503|NCT01495793|464262943|FG000|Overall Study|Violation of inclusion criteria|1|||
128992504|NCT03014570|464262946|FG000|Overall Study|COVID-19 Restrictions|38|||
128992505|NCT03014570|464262947|FG001|Overall Study|COVID-19 Restrictions|24|||
128992506|NCT03014570|464262946|FG000|Overall Study|Death|70|||
128992507|NCT03014570|464262947|FG001|Overall Study|Death|79|||
128992508|NCT03014570|464262946|FG000|Overall Study|Transfer from facility|11|||
128992509|NCT03014570|464262947|FG001|Overall Study|Transfer from facility|14|||
128992510|NCT03014570|464262946|FG000|Overall Study|Hospitalized|5|||
128992511|NCT03014570|464262947|FG001|Overall Study|Hospitalized|3|||
128992512|NCT03014570|464262946|FG000|Overall Study|Transfer within facility|1|||
128992513|NCT03014570|464262947|FG001|Overall Study|Transfer within facility|0|||
128992514|NCT03014570|464262946|FG000|Overall Study|Site refusal|0|||
128992515|NCT03014570|464262947|FG001|Overall Study|Site refusal|11|||
128992516|NCT00478673|464262953|FG000|30-Days Post-Procedure|Death|2|||
128992517|NCT00478673|464262953|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
128992518|NCT00478673|464262953|FG000|30-Days Post-Procedure|Missed Visit|7|||
128992519|NCT00478673|464262953|FG000|12-Months Post-Procedure|Death|23|||
128992520|NCT00478673|464262953|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
128992521|NCT00478673|464262953|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
128992522|NCT00478673|464262953|FG000|12-Months Post-Procedure|Missed Visit|25|||
128992523|NCT00478673|464262953|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
128992524|NCT03332212|464262954|FG000|Overall Study|Not treated|0|||
128992525|NCT03332212|464262955|FG001|Overall Study|Not treated|1|||
128992526|NCT03332212|464262956|FG002|Overall Study|Not treated|0|||
128992527|NCT03332212|464262957|FG003|Overall Study|Not treated|0|||
128992528|NCT03332212|464262954|FG000|Overall Study|Adverse Event|0|||
128992529|NCT03332212|464262955|FG001|Overall Study|Adverse Event|0|||
128992530|NCT03332212|464262956|FG002|Overall Study|Adverse Event|0|||
128992531|NCT03332212|464262957|FG003|Overall Study|Adverse Event|1|||
128992532|NCT03332212|464262954|FG000|Overall Study|worsening of disease under study|1|||
128992533|NCT03332212|464262955|FG001|Overall Study|worsening of disease under study|1|||
128992534|NCT03332212|464262956|FG002|Overall Study|worsening of disease under study|0|||
128992535|NCT03332212|464262957|FG003|Overall Study|worsening of disease under study|0|||
128992536|NCT02125734|464262961|FG000|Period 2|Adverse Event|0|||
128992537|NCT02125734|464262962|FG001|Period 2|Adverse Event|1|||
128992538|NCT02304302|464262968|FG000|Overall Study|Adverse Event|2|||
128992539|NCT02304302|464262969|FG001|Overall Study|Adverse Event|3|||
128992540|NCT02304302|464262968|FG000|Overall Study|Lost to Follow-up|1|||
128992541|NCT02304302|464262969|FG001|Overall Study|Lost to Follow-up|4|||
128992542|NCT02304302|464262968|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
128992543|NCT02304302|464262969|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
128992544|NCT00391118|464262970|FG000|Overall Study|Adverse Event|3|||
128992545|NCT00391118|464262971|FG001|Overall Study|Adverse Event|10|||
128992546|NCT00391118|464262972|FG002|Overall Study|Adverse Event|7|||
128992547|NCT00391118|464262970|FG000|Overall Study|Lost to Follow-up|0|||
128992548|NCT00391118|464262971|FG001|Overall Study|Lost to Follow-up|2|||
128992549|NCT00391118|464262972|FG002|Overall Study|Lost to Follow-up|3|||
128992550|NCT00391118|464262970|FG000|Overall Study|Withdrawal by Subject|0|||
128992551|NCT00391118|464262971|FG001|Overall Study|Withdrawal by Subject|9|||
128992552|NCT00391118|464262972|FG002|Overall Study|Withdrawal by Subject|1|||
128992553|NCT00391118|464262970|FG000|Overall Study|Death|0|||
128992554|NCT00391118|464262971|FG001|Overall Study|Death|1|||
128992555|NCT00391118|464262972|FG002|Overall Study|Death|0|||
128992556|NCT00391118|464262970|FG000|Overall Study|Physician Decision|0|||
128992557|NCT00391118|464262971|FG001|Overall Study|Physician Decision|3|||
128992558|NCT00391118|464262972|FG002|Overall Study|Physician Decision|0|||
128992559|NCT00391118|464262970|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
128992560|NCT00391118|464262971|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
128992561|NCT00391118|464262972|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
128992562|NCT00391118|464262970|FG000|Overall Study|Progressive Disease|7|||
128992563|NCT00391118|464262971|FG001|Overall Study|Progressive Disease|26|||
128992564|NCT00391118|464262972|FG002|Overall Study|Progressive Disease|43|||
128992565|NCT00391118|464262970|FG000|Overall Study|Sponsor Decision|0|||
128992566|NCT00391118|464262971|FG001|Overall Study|Sponsor Decision|1|||
128992567|NCT00391118|464262972|FG002|Overall Study|Sponsor Decision|3|||
128992568|NCT00391118|464262970|FG000|Overall Study|Protocol Violation|1|||
128992569|NCT00391118|464262971|FG001|Overall Study|Protocol Violation|0|||
128992570|NCT00391118|464262972|FG002|Overall Study|Protocol Violation|0|||
128992571|NCT03078192|464262974|FG000|Overall Study|Withdrawal by Subject|2|||
128992572|NCT03078192|464262975|FG001|Overall Study|Withdrawal by Subject|1|||
128992573|NCT03078192|464262974|FG000|Overall Study|screen failure|0|||
128992574|NCT03078192|464262975|FG001|Overall Study|screen failure|3|||
128992575|NCT03107715|464262978|FG000|Overall Study|did not deliver at the home hospital|4|||
128992576|NCT03107715|464262979|FG001|Overall Study|did not deliver at the home hospital|6|||
128992577|NCT03107715|464262978|FG000|Overall Study|infant stillborn|0|||
128992578|NCT03107715|464262979|FG001|Overall Study|infant stillborn|1|||
128992579|NCT02508649|464262980|FG000|Overall Study|Withdrawal by Subject|4|||
128992580|NCT02508649|464262981|FG001|Overall Study|Withdrawal by Subject|6|||
128992581|NCT02508649|464262982|FG002|Overall Study|Withdrawal by Subject|5|||
128992582|NCT02508649|464262983|FG003|Overall Study|Withdrawal by Subject|6|||
128992583|NCT02508649|464262980|FG000|Overall Study|Investigator withdrew the subject|1|||
128992584|NCT02508649|464262981|FG001|Overall Study|Investigator withdrew the subject|2|||
128992585|NCT02508649|464262982|FG002|Overall Study|Investigator withdrew the subject|1|||
128992586|NCT02508649|464262983|FG003|Overall Study|Investigator withdrew the subject|0|||
128992587|NCT02508649|464262980|FG000|Overall Study|Post randomization screening failure|12|||
128992588|NCT02508649|464262981|FG001|Overall Study|Post randomization screening failure|4|||
128992589|NCT02508649|464262982|FG002|Overall Study|Post randomization screening failure|9|||
128992590|NCT02508649|464262983|FG003|Overall Study|Post randomization screening failure|3|||
128992591|NCT02508649|464262980|FG000|Overall Study|Lost to Follow-up|1|||
128992592|NCT02508649|464262981|FG001|Overall Study|Lost to Follow-up|1|||
128992593|NCT02508649|464262982|FG002|Overall Study|Lost to Follow-up|0|||
128992594|NCT02508649|464262983|FG003|Overall Study|Lost to Follow-up|1|||
128992595|NCT03594175|464262991|FG000|Overall Study|Not treated|8|||
128992596|NCT03594175|464262992|FG001|Overall Study|Not treated|1|||
128992597|NCT03594175|464262993|FG002|Overall Study|Not treated|5|||
128992598|NCT03594175|464262991|FG000|Overall Study|Adverse Event|3|||
128992599|NCT03594175|464262992|FG001|Overall Study|Adverse Event|0|||
128992600|NCT03594175|464262993|FG002|Overall Study|Adverse Event|0|||
128992601|NCT03594175|464262991|FG000|Overall Study|Withdrawal by Subject|3|||
128992602|NCT03594175|464262992|FG001|Overall Study|Withdrawal by Subject|0|||
128992603|NCT03594175|464262993|FG002|Overall Study|Withdrawal by Subject|0|||
128992604|NCT03594175|464262991|FG000|Overall Study|Protocol Violation|2|||
128992605|NCT03594175|464262992|FG001|Overall Study|Protocol Violation|2|||
128992606|NCT03594175|464262993|FG002|Overall Study|Protocol Violation|2|||
128992607|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992608|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992609|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992610|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
128992611|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
128992612|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992613|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992614|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992615|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992616|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
128992617|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992618|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992619|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
128992620|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
128992621|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
128992622|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
128992623|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
128992624|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
128992625|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
128992626|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992627|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992628|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992629|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992630|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992631|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
128992632|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992633|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992634|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992635|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
128992636|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992637|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992638|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992639|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
128992640|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
128992641|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
128992642|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
128992643|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
128992644|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
128992645|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
128992646|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992647|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992648|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992649|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992650|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
128992651|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992652|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992653|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992654|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992655|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992656|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992657|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992658|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992659|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
128992660|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992661|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992662|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
128992663|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
128992664|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992665|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992666|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992667|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992668|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992669|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992670|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992671|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992672|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992673|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992674|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
128992675|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992676|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992677|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
128992678|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992679|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992680|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
128992681|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
128992682|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
128992683|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
128992684|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
128992685|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992686|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
128992687|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992688|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992689|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
128992690|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992691|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992692|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992693|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
128992694|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992695|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
128992696|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
128992697|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
128992698|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
128992699|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
128992700|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
128992701|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
128992702|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992703|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
128992704|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
128992705|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992706|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992707|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992708|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992709|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
128992710|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
128992711|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
128992712|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992713|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
128877562|NCT00686725|463846252|FG000|Overall Study|Withdrawal by Subject|13|||
128877563|NCT00686725|463846253|FG001|Overall Study|Withdrawal by Subject|4|||
128877564|NCT00686725|463846252|FG000|Overall Study|Protocol Violation|1|||
128877565|NCT00686725|463846253|FG001|Overall Study|Protocol Violation|3|||
128877566|NCT00686725|463846252|FG000|Overall Study|Other|1|||
128877567|NCT00686725|463846253|FG001|Overall Study|Other|3|||
128877568|NCT01970345|463846254|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
128992714|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992715|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
128992716|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992717|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
128992718|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
128992719|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
128992720|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
128992721|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992722|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992723|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992724|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992725|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
128992726|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992727|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992728|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992729|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992730|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
128992731|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992732|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992733|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992734|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992735|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992736|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992737|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992738|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992739|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
128992740|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
128992741|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
128992742|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
128992743|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
128992744|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
128992745|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
128992746|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
128992747|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
128992748|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
128992749|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
128992750|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
128992751|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
128992752|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
128992753|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
128992754|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
128992755|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
128992756|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
128992757|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
128992758|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
128992759|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992760|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992761|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992762|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992763|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992764|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992765|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992766|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992767|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992768|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992769|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
128992770|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992771|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992772|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992773|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992774|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992775|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992776|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992777|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
128992778|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
128992779|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
128992780|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
128992781|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
128992782|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
128992783|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
128992784|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
128992785|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
128992786|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
128992787|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
128992788|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
128992789|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
128992790|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
128992791|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
128992792|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
128992793|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
128992794|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
128992795|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
128992796|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
128992797|NCT01915498|464262994|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
128992798|NCT01915498|464262995|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
128992799|NCT01915498|464262996|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
128992800|NCT01915498|464262997|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
128992801|NCT01915498|464262998|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
128992802|NCT01915498|464262999|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
128992803|NCT01915498|464263000|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
128992804|NCT01915498|464263001|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
128992805|NCT01915498|464263002|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
128992806|NCT01915498|464263003|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
128992807|NCT01915498|464263004|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
128992808|NCT01915498|464263005|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
128992809|NCT01915498|464263006|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
128992810|NCT01915498|464263007|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
128992811|NCT01915498|464263008|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
128992812|NCT01915498|464263009|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
128992813|NCT01915498|464263010|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
128992814|NCT01915498|464263011|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
128992815|NCT01915498|464263012|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
128992816|NCT01915498|464262994|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992817|NCT01915498|464262995|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992818|NCT01915498|464262996|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992819|NCT01915498|464262997|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992820|NCT01915498|464262998|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992821|NCT01915498|464262999|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992822|NCT01915498|464263000|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992823|NCT01915498|464263001|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992824|NCT01915498|464263002|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992825|NCT01915498|464263003|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992826|NCT01915498|464263004|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992827|NCT01915498|464263005|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992828|NCT01915498|464263006|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992829|NCT01915498|464263007|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992830|NCT01915498|464263008|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992831|NCT01915498|464263009|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992832|NCT01915498|464263010|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992833|NCT01915498|464263011|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
128992834|NCT01915498|464263012|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
128992835|NCT01915498|464262994|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992836|NCT01915498|464262995|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992837|NCT01915498|464262996|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992838|NCT01915498|464262997|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992839|NCT01915498|464262998|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992840|NCT01915498|464262999|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992841|NCT01915498|464263000|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992842|NCT01915498|464263001|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992843|NCT01915498|464263002|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992844|NCT01915498|464263003|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992845|NCT01915498|464263004|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992846|NCT01915498|464263005|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992847|NCT01915498|464263006|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992848|NCT01915498|464263007|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992849|NCT01915498|464263008|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992850|NCT01915498|464263009|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992851|NCT01915498|464263010|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992852|NCT01915498|464263011|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
128992853|NCT01915498|464263012|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
128992854|NCT01915498|464262994|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992855|NCT01915498|464262995|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992856|NCT01915498|464262996|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992857|NCT01915498|464262997|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992858|NCT01915498|464262998|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992859|NCT01915498|464262999|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992860|NCT01915498|464263000|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992861|NCT01915498|464263001|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992862|NCT01915498|464263002|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992863|NCT01915498|464263003|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992864|NCT01915498|464263004|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992865|NCT01915498|464263005|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992866|NCT01915498|464263006|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992867|NCT01915498|464263007|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992868|NCT01915498|464263008|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129214614|NCT02113982|465089321|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214615|NCT02113982|465089322|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214616|NCT02113982|465089323|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214617|NCT02113982|465089324|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214618|NCT02113982|465089325|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129214619|NCT02113982|465089326|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
129214620|NCT02113982|465089327|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
129214621|NCT02113982|465089314|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214622|NCT02113982|465089315|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214623|NCT02113982|465089316|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214624|NCT02113982|465089317|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214625|NCT02113982|465089318|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214626|NCT02113982|465089319|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214627|NCT02113982|465089320|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214628|NCT02113982|465089321|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214629|NCT02113982|465089322|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214630|NCT02113982|465089323|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214631|NCT02113982|465089324|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214632|NCT02113982|465089325|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129214633|NCT02113982|465089326|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
129214634|NCT02113982|465089327|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
129214635|NCT02113982|465089314|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214636|NCT02113982|465089315|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214637|NCT02113982|465089316|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214638|NCT02113982|465089317|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214639|NCT02113982|465089318|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214640|NCT02113982|465089319|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214641|NCT02113982|465089320|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214642|NCT02113982|465089321|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214643|NCT02113982|465089322|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214644|NCT02113982|465089323|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214645|NCT02113982|465089324|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214646|NCT02113982|465089325|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129214647|NCT02113982|465089326|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
129214648|NCT02113982|465089327|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
128992869|NCT01915498|464263009|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992870|NCT01915498|464263010|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992871|NCT01915498|464263011|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
128992872|NCT01915498|464263012|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
128992873|NCT01907516|464263013|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
128992874|NCT01907516|464263014|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
128992875|NCT01907516|464263013|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
128992876|NCT01907516|464263014|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
128992877|NCT01907516|464263013|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
128992878|NCT01907516|464263014|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
128992879|NCT01907516|464263013|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
128992880|NCT01907516|464263014|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
128992881|NCT00633217|464263017|FG000|Overall Study|Adverse Event|5|||
128992882|NCT00633217|464263018|FG001|Overall Study|Adverse Event|9|||
128992883|NCT00633217|464263017|FG000|Overall Study|Lack of Efficacy|0|||
128992884|NCT00633217|464263018|FG001|Overall Study|Lack of Efficacy|2|||
128992885|NCT00633217|464263017|FG000|Overall Study|Protocol Violation|3|||
128992886|NCT00633217|464263018|FG001|Overall Study|Protocol Violation|7|||
128992887|NCT00633217|464263017|FG000|Overall Study|Lost to Follow-up|2|||
128992888|NCT00633217|464263018|FG001|Overall Study|Lost to Follow-up|2|||
128992889|NCT00633217|464263017|FG000|Overall Study|Investigator Discretion|2|||
128992890|NCT00633217|464263018|FG001|Overall Study|Investigator Discretion|0|||
128992891|NCT00633217|464263017|FG000|Overall Study|Withdrew Consent|3|||
128992892|NCT00633217|464263018|FG001|Overall Study|Withdrew Consent|3|||
128992893|NCT04881448|464263019|FG000|Overall Study|Study cancelled by sponsor|220|||
128992894|NCT04881448|464263019|FG000|Overall Study|Withdrawal by Subject|2|||
128992895|NCT04881448|464263019|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
128992896|NCT00005879|464263024|FG000|Overall Study|Withdrawal by Subject|8|||
128992897|NCT00005879|464263025|FG001|Overall Study|Withdrawal by Subject|10|||
128992898|NCT05022121|464263029|FG000|Overall Study|Lack of Efficacy|1|||
128992899|NCT05022121|464263030|FG001|Overall Study|Lack of Efficacy|0|||
128992900|NCT05022121|464263029|FG000|Overall Study|Lost to Follow-up|0|||
128992901|NCT05022121|464263030|FG001|Overall Study|Lost to Follow-up|2|||
128992902|NCT02395536|464263035|FG000|Overall Study|Lost to Follow-up|4|||
128992903|NCT02395536|464263036|FG001|Overall Study|Lost to Follow-up|4|||
128992904|NCT02395536|464263035|FG000|Overall Study|Death|2|||
128992905|NCT02395536|464263036|FG001|Overall Study|Death|0|||
128992906|NCT02395536|464263035|FG000|Overall Study|Physician Decision|4|||
128992907|NCT02395536|464263036|FG001|Overall Study|Physician Decision|6|||
128992908|NCT02395536|464263035|FG000|Overall Study|Withdrawal by Subject|9|||
128992909|NCT02395536|464263036|FG001|Overall Study|Withdrawal by Subject|17|||
128992910|NCT02395536|464263035|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
128992911|NCT02395536|464263036|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
128992912|NCT02395536|464263035|FG000|Overall Study|Insurance issue|0|||
128992913|NCT02395536|464263036|FG001|Overall Study|Insurance issue|1|||
128992914|NCT01788163|464265461|FG000|Overall Study|Other|53|||
128992915|NCT01788163|464265462|FG001|Overall Study|Other|0|||
128992916|NCT01788163|464265463|FG002|Overall Study|Other|0|||
128992917|NCT01788163|464265464|FG003|Overall Study|Other|0|||
128992918|NCT01788163|464265465|FG004|Overall Study|Other|0|||
128992919|NCT01788163|464265466|FG005|Overall Study|Other|7|||
128992920|NCT01788163|464265467|FG006|Overall Study|Other|1|||
128992921|NCT01788163|464265468|FG007|Overall Study|Other|48|||
128992922|NCT01788163|464265469|FG008|Overall Study|Other|15|||
128992923|NCT01788163|464265461|FG000|Overall Study|Withdrawal by Subject|2|||
128992924|NCT01788163|464265462|FG001|Overall Study|Withdrawal by Subject|0|||
128992925|NCT01788163|464265463|FG002|Overall Study|Withdrawal by Subject|0|||
128992926|NCT01788163|464265464|FG003|Overall Study|Withdrawal by Subject|0|||
128992927|NCT01788163|464265465|FG004|Overall Study|Withdrawal by Subject|0|||
128992928|NCT01788163|464265466|FG005|Overall Study|Withdrawal by Subject|0|||
128992929|NCT01788163|464265467|FG006|Overall Study|Withdrawal by Subject|0|||
128992930|NCT01788163|464265468|FG007|Overall Study|Withdrawal by Subject|0|||
128992931|NCT01788163|464265469|FG008|Overall Study|Withdrawal by Subject|1|||
128992932|NCT00545441|464265470|FG000|Overall Study|Fistula draining at 6 months|2|||
128992933|NCT00545441|464265471|FG001|Overall Study|Fistula draining at 6 months|4|||
128992934|NCT00545441|464265470|FG000|Overall Study|Lost to Follow-up|9|||
128992935|NCT00545441|464265471|FG001|Overall Study|Lost to Follow-up|5|||
128992936|NCT00545441|464265470|FG000|Overall Study|Technical failure|0|||
128992937|NCT00545441|464265471|FG001|Overall Study|Technical failure|1|||
128992938|NCT00545441|464265470|FG000|Overall Study|Withdrawal by Subject|1|||
128992939|NCT00545441|464265471|FG001|Overall Study|Withdrawal by Subject|1|||
128992940|NCT00545441|464265470|FG000|Overall Study|Persistence or recurrence of fistula|5|||
128992941|NCT00545441|464265471|FG001|Overall Study|Persistence or recurrence of fistula|2|||
128992942|NCT00545441|464265470|FG000|Overall Study|Patients were not treated|1|||
128992943|NCT00545441|464265471|FG001|Overall Study|Patients were not treated|3|||
128992944|NCT00265239|464265472|FG000|Overall Study|Adverse Event|2|||
128992945|NCT00265239|464265473|FG001|Overall Study|Adverse Event|1|||
128992946|NCT02803138|464265476|FG000|Overall Study|Failure to return|38|||
128992947|NCT02803138|464265476|FG000|Overall Study|Insufficient virological response|2|||
128992948|NCT02803138|464265476|FG000|Overall Study|Withdrawn consent|1|||
128992949|NCT02803138|464265476|FG000|Overall Study|Death|1|||
128992950|NCT02803138|464265476|FG000|Overall Study|Other, not specified|28|||
128992951|NCT04071366|464265479|FG000|Part 1: Open-label (29 Days)|Death|4|||
128992952|NCT04071366|464265480|FG001|Part 1: Open-label (29 Days)|Death|2|||
128992953|NCT04071366|464265481|FG002|Part 1: Open-label (29 Days)|Death|8|||
128992954|NCT04071366|464265482|FG003|Part 1: Open-label (29 Days)|Death|0|||
128992955|NCT04071366|464265483|FG004|Part 1: Open-label (29 Days)|Death|0|||
128992956|NCT04071366|464265479|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
128992957|NCT04071366|464265480|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
128992958|NCT04071366|464265481|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
128992959|NCT04071366|464265482|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
128992960|NCT04071366|464265483|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
128992961|NCT04071366|464265479|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
128992962|NCT04071366|464265480|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
128992963|NCT04071366|464265481|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
128992964|NCT04071366|464265482|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
128992965|NCT04071366|464265483|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
128992966|NCT04071366|464265479|FG000|Part 2: Randomized (29 Days)|Death|0|||
128992967|NCT04071366|464265480|FG001|Part 2: Randomized (29 Days)|Death|0|||
128992968|NCT04071366|464265481|FG002|Part 2: Randomized (29 Days)|Death|0|||
128992969|NCT04071366|464265482|FG003|Part 2: Randomized (29 Days)|Death|2|||
128992970|NCT04071366|464265483|FG004|Part 2: Randomized (29 Days)|Death|2|||
128992971|NCT04071366|464265479|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
128992972|NCT04071366|464265480|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
128992973|NCT04071366|464265481|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
128992974|NCT04071366|464265482|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
128992975|NCT04071366|464265483|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
128992976|NCT04071366|464265479|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
128992977|NCT04071366|464265480|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
128992978|NCT04071366|464265481|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
128992979|NCT04071366|464265482|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
128992980|NCT04071366|464265483|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
128992981|NCT04071366|464265479|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
128992982|NCT04071366|464265480|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
128992983|NCT04071366|464265481|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
128992984|NCT04071366|464265482|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
128992985|NCT04071366|464265483|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
128992986|NCT04071366|464265479|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
128992987|NCT04071366|464265480|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
128992988|NCT04071366|464265481|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
128992989|NCT04071366|464265482|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
128992990|NCT04071366|464265483|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
128992991|NCT04071366|464265479|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
128992992|NCT04071366|464265480|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
128992993|NCT04071366|464265481|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
128992994|NCT04071366|464265482|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
128992995|NCT04071366|464265483|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
128992996|NCT04071366|464265479|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
128992997|NCT04071366|464265480|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
128992998|NCT04071366|464265481|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
128992999|NCT04071366|464265482|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
128993000|NCT04071366|464265483|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
128993001|NCT00021229|464265484|FG000|Overall Study|Adverse Event|10|||
128993002|NCT00021229|464265485|FG001|Overall Study|Adverse Event|5|||
128993003|NCT00021229|464265486|FG002|Overall Study|Adverse Event|2|||
128993004|NCT00021229|464265484|FG000|Overall Study|Death|0|||
128993005|NCT00021229|464265485|FG001|Overall Study|Death|1|||
128993006|NCT00021229|464265486|FG002|Overall Study|Death|0|||
128993007|NCT00021229|464265484|FG000|Overall Study|Withdrawal by Subject|7|||
128993008|NCT00021229|464265485|FG001|Overall Study|Withdrawal by Subject|7|||
128993009|NCT00021229|464265486|FG002|Overall Study|Withdrawal by Subject|1|||
128993010|NCT00021229|464265484|FG000|Overall Study|Progressive Disease|15|||
128993011|NCT00021229|464265485|FG001|Overall Study|Progressive Disease|19|||
128993012|NCT00021229|464265486|FG002|Overall Study|Progressive Disease|12|||
128993013|NCT00021229|464265484|FG000|Overall Study|Protocol Violation|1|||
128993014|NCT00021229|464265485|FG001|Overall Study|Protocol Violation|1|||
128993015|NCT00021229|464265486|FG002|Overall Study|Protocol Violation|0|||
128993016|NCT00021229|464265484|FG000|Overall Study|Physician Decision|0|||
128993017|NCT00021229|464265485|FG001|Overall Study|Physician Decision|0|||
128993018|NCT00021229|464265486|FG002|Overall Study|Physician Decision|1|||
128993019|NCT00021229|464265484|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
128993020|NCT00021229|464265485|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
128993021|NCT00021229|464265486|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
128993022|NCT02156466|464265487|FG000|Overall Study|Adverse Event|0|||
128993023|NCT02156466|464265488|FG001|Overall Study|Adverse Event|0|||
128993024|NCT02156466|464265489|FG002|Overall Study|Adverse Event|1|||
128993025|NCT02156466|464265490|FG003|Overall Study|Adverse Event|1|||
128993026|NCT02156466|464265491|FG004|Overall Study|Adverse Event|0|||
128993027|NCT02156466|464265487|FG000|Overall Study|Quantiferon Positivity|0|||
128993028|NCT02156466|464265488|FG001|Overall Study|Quantiferon Positivity|0|||
128993029|NCT02156466|464265489|FG002|Overall Study|Quantiferon Positivity|0|||
128993030|NCT02156466|464265490|FG003|Overall Study|Quantiferon Positivity|1|||
128993031|NCT02156466|464265491|FG004|Overall Study|Quantiferon Positivity|0|||
128993032|NCT02237118|464265492|FG000|Overall Study|Protocol Violation|0|||
128993033|NCT02237118|464265493|FG001|Overall Study|Protocol Violation|1|||
128993034|NCT02237118|464265492|FG000|Overall Study|consent withdrawn|1|||
128993035|NCT02237118|464265493|FG001|Overall Study|consent withdrawn|0|||
128993036|NCT00953927|464265494|FG000|Overall Study|Lost to Follow-up|61|||
128993037|NCT00953927|464265495|FG001|Overall Study|Lost to Follow-up|65|||
128993038|NCT00953927|464265494|FG000|Overall Study|Withdrawal by Subject|36|||
128993039|NCT00953927|464265495|FG001|Overall Study|Withdrawal by Subject|25|||
128993040|NCT00953927|464265494|FG000|Overall Study|Death|7|||
128993041|NCT00953927|464265495|FG001|Overall Study|Death|4|||
128993042|NCT00953927|464265494|FG000|Overall Study|Other study discontinuation|1|||
128993043|NCT00953927|464265495|FG001|Overall Study|Other study discontinuation|1|||
128993044|NCT03284424|464265497|FG000|Overall Study|Death|70|||
128993045|NCT03284424|464265498|FG001|Overall Study|Death|24|||
128993046|NCT03284424|464265497|FG000|Overall Study|Lost to Follow-up|3|||
128993047|NCT03284424|464265498|FG001|Overall Study|Lost to Follow-up|1|||
128993048|NCT03284424|464265497|FG000|Overall Study|Physician Decision|1|||
128993049|NCT03284424|464265498|FG001|Overall Study|Physician Decision|2|||
128993050|NCT03284424|464265497|FG000|Overall Study|Withdrawal by Subject|4|||
128993051|NCT03284424|464265498|FG001|Overall Study|Withdrawal by Subject|5|||
128993052|NCT03284424|464265497|FG000|Overall Study|Sponsor's decision|27|||
128993053|NCT03284424|464265498|FG001|Overall Study|Sponsor's decision|22|||
128993054|NCT01268683|464265503|FG000|Overall Study|Lost to Follow-up|1|||
128993055|NCT01268683|464265503|FG000|Overall Study|Death|1|||
128993056|NCT02216214|464265504|FG000|Overall Study|Randomized Never Received Study Drug|1|||
128993057|NCT02216214|464265505|FG001|Overall Study|Randomized Never Received Study Drug|0|||
128993058|NCT02216214|464265504|FG000|Overall Study|Adverse Event|10|||
128993059|NCT02216214|464265505|FG001|Overall Study|Adverse Event|8|||
128993060|NCT02216214|464265504|FG000|Overall Study|Lack of Efficacy|2|||
128993061|NCT02216214|464265505|FG001|Overall Study|Lack of Efficacy|2|||
128993062|NCT02216214|464265504|FG000|Overall Study|Lost to Follow-up|3|||
128993063|NCT02216214|464265505|FG001|Overall Study|Lost to Follow-up|2|||
128993064|NCT02216214|464265504|FG000|Overall Study|Protocol Violation|4|||
128993065|NCT02216214|464265505|FG001|Overall Study|Protocol Violation|2|||
128993066|NCT02216214|464265504|FG000|Overall Study|Withdrawal by Subject|22|||
128993067|NCT02216214|464265505|FG001|Overall Study|Withdrawal by Subject|20|||
128993068|NCT02216214|464265504|FG000|Overall Study|Study Terminated By Sponsor|0|||
128993069|NCT02216214|464265505|FG001|Overall Study|Study Terminated By Sponsor|1|||
128993070|NCT02216214|464265504|FG000|Overall Study|Miscellaneous|1|||
128993071|NCT02216214|464265505|FG001|Overall Study|Miscellaneous|1|||
128993072|NCT00713830|464265506|FG000|Overall Study|Adverse Event|23|||
128993073|NCT00713830|464265507|FG001|Overall Study|Adverse Event|71|||
128993074|NCT00713830|464265506|FG000|Overall Study|Lack of Efficacy|24|||
128993075|NCT00713830|464265507|FG001|Overall Study|Lack of Efficacy|16|||
128993076|NCT00713830|464265506|FG000|Overall Study|Lost to Follow-up|2|||
128993077|NCT00713830|464265507|FG001|Overall Study|Lost to Follow-up|9|||
128993078|NCT00713830|464265506|FG000|Overall Study|Withdrawal by Subject|13|||
128993079|NCT00713830|464265507|FG001|Overall Study|Withdrawal by Subject|23|||
128993080|NCT00713830|464265506|FG000|Overall Study|Poor Compliance to Protocol|7|||
128993081|NCT00713830|464265507|FG001|Overall Study|Poor Compliance to Protocol|14|||
128993082|NCT00713830|464265506|FG000|Overall Study|Familial and Personal Reasons|9|||
128993083|NCT00713830|464265507|FG001|Overall Study|Familial and Personal Reasons|34|||
128993084|NCT00713830|464265506|FG000|Overall Study|Sponsor Decision|4|||
128993085|NCT00713830|464265507|FG001|Overall Study|Sponsor Decision|10|||
128993086|NCT03981614|464265510|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
128993087|NCT03981614|464265511|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
128993088|NCT03981614|464265512|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
128993089|NCT00499252|464265513|FG000|Overall Study|Adverse Event|3|||
128993090|NCT00499252|464265513|FG000|Overall Study|Refused further treatment|2|||
128993091|NCT00499252|464265513|FG000|Overall Study|Ineligible|4|||
128993092|NCT00499252|464265513|FG000|Overall Study|<no further label>|3|||
128993093|NCT00566631|464265514|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
128993094|NCT00566631|464265514|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
128993095|NCT00566631|464265514|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
128993096|NCT00566631|464265514|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
128993097|NCT00566631|464265514|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
128993098|NCT00566631|464265514|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
128993099|NCT00566631|464265514|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
128993100|NCT00566631|464265514|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
128993101|NCT00566631|464265514|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
128993102|NCT00566631|464265514|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
128993103|NCT00566631|464265514|FG000|Part 2: Extension Phase|Adverse Event|11|||
128993104|NCT00566631|464265514|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
128993105|NCT00566631|464265514|FG000|Part 2: Extension Phase|Death|1|||
128993106|NCT00566631|464265514|FG000|Part 2: Extension Phase|Other|5|||
128993107|NCT03387735|464265515|FG000|Overall Study|Lost to Follow-up|4|||
128993108|NCT03387735|464265516|FG001|Overall Study|Lost to Follow-up|8|||
128993109|NCT03387735|464265515|FG000|Overall Study|Death|4|||
128993110|NCT03387735|464265516|FG001|Overall Study|Death|8|||
128993111|NCT00537056|464265517|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
128993112|NCT03020966|464265521|FG000|Overall Study|Withdrawal by Subject|2|||
128993113|NCT03020966|464265522|FG001|Overall Study|Withdrawal by Subject|0|||
128993114|NCT02628418|464265526|FG000|Overall Study|Lost to Follow-up|1|||
128993115|NCT02628418|464265527|FG001|Overall Study|Lost to Follow-up|2|||
128993116|NCT01215955|464265528|FG000|Overall Study|Adverse Event|1|||
128993117|NCT01215955|464265529|FG001|Overall Study|Adverse Event|4|||
128993118|NCT01215955|464265530|FG002|Overall Study|Adverse Event|2|||
128993119|NCT01215955|464265531|FG003|Overall Study|Adverse Event|3|||
128993120|NCT01215955|464265528|FG000|Overall Study|Death|2|||
128993121|NCT01215955|464265529|FG001|Overall Study|Death|0|||
128993122|NCT01215955|464265530|FG002|Overall Study|Death|1|||
128993123|NCT01215955|464265531|FG003|Overall Study|Death|3|||
128993124|NCT01215955|464265528|FG000|Overall Study|Entry Criteria Not Met|1|||
128993125|NCT01215955|464265529|FG001|Overall Study|Entry Criteria Not Met|3|||
128993126|NCT01215955|464265530|FG002|Overall Study|Entry Criteria Not Met|4|||
128993127|NCT01215955|464265531|FG003|Overall Study|Entry Criteria Not Met|7|||
128993128|NCT01215955|464265528|FG000|Overall Study|Lack of Efficacy|1|||
128993129|NCT01215955|464265529|FG001|Overall Study|Lack of Efficacy|2|||
128993130|NCT01215955|464265530|FG002|Overall Study|Lack of Efficacy|1|||
128993131|NCT01215955|464265531|FG003|Overall Study|Lack of Efficacy|0|||
128993132|NCT01215955|464265528|FG000|Overall Study|Lost to Follow-up|4|||
128993133|NCT01215955|464265529|FG001|Overall Study|Lost to Follow-up|4|||
128993134|NCT01215955|464265530|FG002|Overall Study|Lost to Follow-up|8|||
128993135|NCT01215955|464265531|FG003|Overall Study|Lost to Follow-up|9|||
128993136|NCT01215955|464265528|FG000|Overall Study|Physician Decision|4|||
128993137|NCT01215955|464265529|FG001|Overall Study|Physician Decision|10|||
128993138|NCT01215955|464265530|FG002|Overall Study|Physician Decision|8|||
128993139|NCT01215955|464265531|FG003|Overall Study|Physician Decision|11|||
128993140|NCT01215955|464265528|FG000|Overall Study|Protocol Violation|17|||
128993141|NCT01215955|464265529|FG001|Overall Study|Protocol Violation|13|||
128993142|NCT01215955|464265530|FG002|Overall Study|Protocol Violation|8|||
128993143|NCT01215955|464265531|FG003|Overall Study|Protocol Violation|8|||
128993144|NCT01215955|464265528|FG000|Overall Study|Sponsor Decision|1|||
128993145|NCT01215955|464265529|FG001|Overall Study|Sponsor Decision|2|||
128993146|NCT01215955|464265530|FG002|Overall Study|Sponsor Decision|0|||
128993147|NCT01215955|464265531|FG003|Overall Study|Sponsor Decision|1|||
128993148|NCT01215955|464265528|FG000|Overall Study|Withdrawal by Subject|14|||
128993149|NCT01215955|464265529|FG001|Overall Study|Withdrawal by Subject|15|||
128993150|NCT01215955|464265530|FG002|Overall Study|Withdrawal by Subject|13|||
128993151|NCT01215955|464265531|FG003|Overall Study|Withdrawal by Subject|9|||
128993152|NCT01215955|464265528|FG000|Overall Study|Quality Issues|0|||
128993153|NCT01215955|464265529|FG001|Overall Study|Quality Issues|0|||
128993154|NCT01215955|464265530|FG002|Overall Study|Quality Issues|3|||
128993155|NCT01215955|464265531|FG003|Overall Study|Quality Issues|2|||
128993156|NCT01523301|464265532|FG000|Overall Study|Adverse Event|25|||
128993157|NCT01523301|464265533|FG001|Overall Study|Adverse Event|16|||
128993158|NCT01523301|464265532|FG000|Overall Study|Lack of Efficacy|0|||
128993159|NCT01523301|464265533|FG001|Overall Study|Lack of Efficacy|2|||
128993160|NCT01523301|464265532|FG000|Overall Study|Protocol Violation|3|||
128993161|NCT01523301|464265533|FG001|Overall Study|Protocol Violation|4|||
128993162|NCT01523301|464265532|FG000|Overall Study|Lost to Follow-up|1|||
128993163|NCT01523301|464265533|FG001|Overall Study|Lost to Follow-up|0|||
128993164|NCT01523301|464265532|FG000|Overall Study|Withdrawal by Subject|6|||
128993165|NCT01523301|464265533|FG001|Overall Study|Withdrawal by Subject|8|||
128993166|NCT01523301|464265532|FG000|Overall Study|Other Reason|0|||
128993167|NCT01523301|464265533|FG001|Overall Study|Other Reason|2|||
128993168|NCT01447628|464265534|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
128993169|NCT01447628|464265535|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
128993170|NCT01447628|464265536|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
128993171|NCT01447628|464265537|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
128993172|NCT00185731|464265538|FG000|Overall Study|Withdrawal by Subject|1|||
128993173|NCT00185731|464265538|FG000|Overall Study|Not Eligible|1|||
128993174|NCT03087773|464265539|FG000|Overall Study|Withdrawal by Subject|8|||
128993175|NCT03087773|464265540|FG001|Overall Study|Withdrawal by Subject|4|||
128993176|NCT03087773|464265539|FG000|Overall Study|Lost to Follow-up|12|||
128993177|NCT03087773|464265540|FG001|Overall Study|Lost to Follow-up|8|||
128993178|NCT01787188|464265547|FG000|Overall Study|Adverse Event|2|||
128993179|NCT01787188|464265548|FG001|Overall Study|Adverse Event|4|||
128993180|NCT01787188|464265549|FG002|Overall Study|Adverse Event|6|||
128993181|NCT01787188|464265547|FG000|Overall Study|Lack of Efficacy|7|||
128993182|NCT01787188|464265548|FG001|Overall Study|Lack of Efficacy|3|||
128993183|NCT01787188|464265549|FG002|Overall Study|Lack of Efficacy|5|||
128993184|NCT01787188|464265547|FG000|Overall Study|Non-compliance with Study Drug|0|||
128993185|NCT01787188|464265548|FG001|Overall Study|Non-compliance with Study Drug|1|||
128993186|NCT01787188|464265549|FG002|Overall Study|Non-compliance with Study Drug|0|||
128993187|NCT01787188|464265547|FG000|Overall Study|Withdrawal by Subject|4|||
128993188|NCT01787188|464265548|FG001|Overall Study|Withdrawal by Subject|3|||
128993189|NCT01787188|464265549|FG002|Overall Study|Withdrawal by Subject|2|||
128993190|NCT01787188|464265547|FG000|Overall Study|Protocol Violation|3|||
128993191|NCT01787188|464265548|FG001|Overall Study|Protocol Violation|2|||
128993192|NCT01787188|464265549|FG002|Overall Study|Protocol Violation|3|||
128993193|NCT01787188|464265547|FG000|Overall Study|Lost to Follow-up|1|||
128993194|NCT01787188|464265548|FG001|Overall Study|Lost to Follow-up|2|||
128993195|NCT01787188|464265549|FG002|Overall Study|Lost to Follow-up|2|||
128993196|NCT01787188|464265547|FG000|Overall Study|Other, including patient moved|0|||
128993197|NCT01787188|464265548|FG001|Overall Study|Other, including patient moved|3|||
128993198|NCT01787188|464265549|FG002|Overall Study|Other, including patient moved|0|||
128993199|NCT05349188|464265552|FG000|Overall Study|Withdrawal by Subject|1|||
128993200|NCT05349188|464265553|FG001|Overall Study|Withdrawal by Subject|0|||
129214649|NCT02113982|465089314|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214650|NCT02113982|465089315|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214651|NCT02113982|465089316|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214652|NCT02113982|465089317|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214653|NCT02113982|465089318|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214654|NCT02113982|465089319|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214655|NCT02113982|465089320|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214656|NCT02113982|465089321|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214657|NCT02113982|465089322|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214658|NCT02113982|465089323|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214659|NCT02113982|465089324|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214660|NCT02113982|465089325|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214661|NCT02113982|465089326|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
129214662|NCT02113982|465089327|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129214663|NCT02113982|465089314|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214664|NCT02113982|465089315|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214665|NCT02113982|465089316|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214666|NCT02113982|465089317|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214667|NCT02113982|465089318|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214668|NCT02113982|465089319|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214669|NCT02113982|465089320|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214670|NCT02113982|465089321|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214671|NCT02113982|465089322|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214672|NCT02113982|465089323|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214673|NCT02113982|465089324|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214674|NCT02113982|465089325|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214675|NCT02113982|465089326|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
129214676|NCT02113982|465089327|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129214677|NCT02085161|465089329|FG000|Overall Study|Not Treated|1|||
129214678|NCT02085161|465089330|FG001|Overall Study|Not Treated|0|||
129214679|NCT02085161|465089331|FG002|Overall Study|Not Treated|0|||
129214680|NCT02085161|465089332|FG003|Overall Study|Not Treated|0|||
129214681|NCT02085161|465089329|FG000|Overall Study|Adverse Event|8|||
129214682|NCT02085161|465089330|FG001|Overall Study|Adverse Event|5|||
129214683|NCT02085161|465089331|FG002|Overall Study|Adverse Event|4|||
129214684|NCT02085161|465089332|FG003|Overall Study|Adverse Event|5|||
129214685|NCT02085161|465089329|FG000|Overall Study|Protocol Violation|0|||
129214686|NCT02085161|465089330|FG001|Overall Study|Protocol Violation|1|||
129214687|NCT02085161|465089331|FG002|Overall Study|Protocol Violation|0|||
129214688|NCT02085161|465089332|FG003|Overall Study|Protocol Violation|1|||
129214689|NCT02085161|465089329|FG000|Overall Study|Withdrawal by Subject|2|||
129214690|NCT02085161|465089330|FG001|Overall Study|Withdrawal by Subject|4|||
129214691|NCT02085161|465089331|FG002|Overall Study|Withdrawal by Subject|0|||
129214692|NCT02085161|465089332|FG003|Overall Study|Withdrawal by Subject|3|||
129214693|NCT02085161|465089329|FG000|Overall Study|Other Reason|1|||
129214694|NCT02085161|465089330|FG001|Overall Study|Other Reason|0|||
129214695|NCT02085161|465089331|FG002|Overall Study|Other Reason|1|||
129214696|NCT02085161|465089332|FG003|Overall Study|Other Reason|1|||
129214697|NCT01936870|465089335|FG000|Overall Study|No Visit After Treatment|176|||
129214698|NCT01936870|465089335|FG000|Overall Study|Protocol Violation|12|||
129214699|NCT01936870|465089335|FG000|Overall Study|No Drug Administration|1|||
129214700|NCT00628108|465089345|FG000|Overall Study|Adverse Event|0|||
129214701|NCT00628108|465089346|FG001|Overall Study|Adverse Event|3|||
129214702|NCT00628108|465089345|FG000|Overall Study|Withdrawal by Subject|1|||
129214703|NCT00628108|465089346|FG001|Overall Study|Withdrawal by Subject|0|||
129214704|NCT03848832|465089347|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
129214705|NCT03848832|465089348|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
129214706|NCT03848832|465089349|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
129214707|NCT03848832|465089347|FG000|Overall Study|Withdrawal by Subject|0|||
129214708|NCT03848832|465089348|FG001|Overall Study|Withdrawal by Subject|0|||
129214709|NCT03848832|465089349|FG002|Overall Study|Withdrawal by Subject|1|||
129214710|NCT03848832|465089347|FG000|Overall Study|Withdrawal (Covid-19)|0|||
129214711|NCT03848832|465089348|FG001|Overall Study|Withdrawal (Covid-19)|2|||
129214712|NCT03848832|465089349|FG002|Overall Study|Withdrawal (Covid-19)|0|||
129214713|NCT03848832|465089347|FG000|Overall Study|Physician Decision|2|||
129214714|NCT03848832|465089348|FG001|Overall Study|Physician Decision|1|||
129214715|NCT03848832|465089349|FG002|Overall Study|Physician Decision|3|||
129214716|NCT03848832|465089347|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
129214717|NCT03848832|465089348|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
129214718|NCT03848832|465089349|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
129214719|NCT03848832|465089347|FG000|Overall Study|Adverse Event|1|||
129214720|NCT03848832|465089348|FG001|Overall Study|Adverse Event|0|||
128993201|NCT02756078|464265554|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
128993202|NCT02756078|464265555|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
128993203|NCT02756078|464265554|FG000|Period 1|Lost to Follow-up|0|||
128993204|NCT02756078|464265555|FG001|Period 1|Lost to Follow-up|2|||
129214721|NCT03848832|465089349|FG002|Overall Study|Adverse Event|0|||
129214722|NCT01760733|465089350|FG000|Waiting List|Death|18|||
129214723|NCT01760733|465089350|FG000|Waiting List|Removed from waiting list|41|||
129214724|NCT01760733|465089350|FG000|Waiting List|Not received a transplant yet|13|||
129214725|NCT01760733|465089350|FG000|Transplanted|Not reached 10 years post transplant|184|||
129214726|NCT01760733|465089350|FG000|Transplanted|Death|26|||
129214727|NCT01760733|465089350|FG000|Transplanted|Graft loss|7|||
129214728|NCT02399163|465089352|FG000|Overall Study|Adverse Event|2|||
129214729|NCT02399163|465089352|FG000|Overall Study|Protocol Deviation|2|||
129214730|NCT02399163|465089352|FG000|Overall Study|Withdrawal by Participant|5|||
129214731|NCT04646044|465089354|FG000|Overall Study|Lost to Follow-up|0|||
129214732|NCT04646044|465089355|FG001|Overall Study|Lost to Follow-up|0|||
129214733|NCT04646044|465089356|FG002|Overall Study|Lost to Follow-up|1|||
129214734|NCT04646044|465089357|FG003|Overall Study|Lost to Follow-up|0|||
129214735|NCT04646044|465089354|FG000|Overall Study|Withdrawal by Subject|0|||
129214736|NCT04646044|465089355|FG001|Overall Study|Withdrawal by Subject|1|||
129214737|NCT04646044|465089356|FG002|Overall Study|Withdrawal by Subject|0|||
129214738|NCT04646044|465089357|FG003|Overall Study|Withdrawal by Subject|0|||
129214739|NCT02404025|465089358|FG000|Overall Study|Adverse Event|1|||
129214740|NCT02404025|465089358|FG000|Overall Study|Lack of Efficacy|3|||
129214741|NCT03938259|465089360|FG000|Overall Study|unable to establish baseline for ventilation|1|||
129214742|NCT03938259|465089361|FG001|Overall Study|unable to establish baseline for ventilation|1|||
129214743|NCT01907854|465089362|FG000|Overall Study|Protocol Violation|1|||
129214744|NCT01907854|465089363|FG001|Overall Study|Protocol Violation|1|||
129214745|NCT01907854|465089362|FG000|Overall Study|Withdrawal by Subject|9|||
129214746|NCT01907854|465089363|FG001|Overall Study|Withdrawal by Subject|7|||
129214747|NCT01907854|465089362|FG000|Overall Study|Lost to Follow-up|2|||
129214748|NCT01907854|465089363|FG001|Overall Study|Lost to Follow-up|2|||
129214749|NCT01907854|465089362|FG000|Overall Study|Unclassified|4|||
129214750|NCT01907854|465089363|FG001|Overall Study|Unclassified|3|||
129214751|NCT02215252|465089366|FG000|Overall Study|Adverse Event|1|||
129214752|NCT02215252|465089367|FG001|Overall Study|Adverse Event|5|||
129214753|NCT02215252|465089368|FG002|Overall Study|Adverse Event|2|||
129214754|NCT02215252|465089366|FG000|Overall Study|Lost to Follow-up|0|||
129214755|NCT02215252|465089367|FG001|Overall Study|Lost to Follow-up|0|||
129214756|NCT02215252|465089368|FG002|Overall Study|Lost to Follow-up|1|||
129214757|NCT02215252|465089366|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
129214758|NCT02215252|465089367|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
129214759|NCT02215252|465089368|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
129214760|NCT02215252|465089366|FG000|Overall Study|Protocol Violation|0|||
129214761|NCT02215252|465089367|FG001|Overall Study|Protocol Violation|1|||
129214762|NCT02215252|465089368|FG002|Overall Study|Protocol Violation|0|||
129214763|NCT02215252|465089366|FG000|Overall Study|Withdrawal by Subject|1|||
129214764|NCT02215252|465089367|FG001|Overall Study|Withdrawal by Subject|0|||
129214765|NCT02215252|465089368|FG002|Overall Study|Withdrawal by Subject|0|||
129214766|NCT02215252|465089366|FG000|Overall Study|Other|0|||
129214767|NCT02215252|465089367|FG001|Overall Study|Other|1|||
129214768|NCT02215252|465089368|FG002|Overall Study|Other|1|||
129214769|NCT02633306|465089369|FG000|Overall Study|Withdrawal by Subject|3|||
129214770|NCT03910244|465089370|FG000|Overall Study|Adverse Event|14|||
129214771|NCT03910244|465089371|FG001|Overall Study|Adverse Event|0|||
129214772|NCT03910244|465089370|FG000|Overall Study|Death|1|||
129214773|NCT03910244|465089371|FG001|Overall Study|Death|0|||
129214774|NCT03910244|465089370|FG000|Overall Study|Lost to Follow-up|0|||
129214775|NCT03910244|465089371|FG001|Overall Study|Lost to Follow-up|2|||
129214776|NCT03910244|465089370|FG000|Overall Study|Joint withdrawal decision|1|||
129214777|NCT03910244|465089371|FG001|Overall Study|Joint withdrawal decision|0|||
129214778|NCT03910244|465089370|FG000|Overall Study|Study Terminated by Sponsor|7|||
129214779|NCT03910244|465089371|FG001|Overall Study|Study Terminated by Sponsor|4|||
129214780|NCT03910244|465089370|FG000|Overall Study|Physician Decision|1|||
129214781|NCT03910244|465089371|FG001|Overall Study|Physician Decision|0|||
129214782|NCT03910244|465089370|FG000|Overall Study|Protocol Violation|1|||
129214783|NCT03910244|465089371|FG001|Overall Study|Protocol Violation|0|||
129214784|NCT03910244|465089370|FG000|Overall Study|Withdrawal by Subject|7|||
129214785|NCT03910244|465089371|FG001|Overall Study|Withdrawal by Subject|2|||
129214786|NCT01746901|465089372|FG000|Naloxone Challenge Phase|Adverse Event|2|||
128993205|NCT02756078|464265554|FG000|Period 1|Protocol Violation|0|||
128993206|NCT02756078|464265555|FG001|Period 1|Protocol Violation|1|||
128993207|NCT02756078|464265554|FG000|Period 1|Adverse Event|1|||
128993208|NCT02756078|464265555|FG001|Period 1|Adverse Event|10|||
128993209|NCT02756078|464265554|FG000|Period 1|Withdrawal by Subject|6|||
128993210|NCT02756078|464265555|FG001|Period 1|Withdrawal by Subject|6|||
128993211|NCT02756078|464265554|FG000|Period 1|Lens Discomfort|2|||
128993212|NCT02756078|464265555|FG001|Period 1|Lens Discomfort|2|||
128993213|NCT02756078|464265554|FG000|Period 2|Adverse Event|3|||
128993214|NCT02756078|464265555|FG001|Period 2|Adverse Event|5|||
128993215|NCT02756078|464265554|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
128993216|NCT02756078|464265555|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
128993217|NCT02756078|464265554|FG000|Period 2|Withdrawal by Subject|3|||
128993218|NCT02756078|464265555|FG001|Period 2|Withdrawal by Subject|1|||
128993219|NCT00943384|464265556|FG000|Overall Study|Dispositioned prior to treatment|23|||
128993220|NCT00943384|464265556|FG000|Overall Study|Treated off protocol-protocol violation|5|||
128993221|NCT00943384|464265556|FG000|Overall Study|Lost to Follow-up|16|||
128993222|NCT00943384|464265556|FG000|Overall Study|Withdrawal by Subject|5|||
128993223|NCT02180659|464265557|FG000|Overall Study|Adverse Event|1|||
128993224|NCT02180659|464265558|FG001|Overall Study|Adverse Event|0|||
128993225|NCT02180659|464265557|FG000|Overall Study|Lost to Follow-up|4|||
128993226|NCT02180659|464265558|FG001|Overall Study|Lost to Follow-up|2|||
128993227|NCT02180659|464265557|FG000|Overall Study|Subject incarcerated during conduct|1|||
128993228|NCT02180659|464265558|FG001|Overall Study|Subject incarcerated during conduct|0|||
128993229|NCT02180659|464265557|FG000|Overall Study|Withdrawal by Subject|0|||
128993230|NCT02180659|464265558|FG001|Overall Study|Withdrawal by Subject|2|||
128993231|NCT02180659|464265557|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
128993232|NCT02180659|464265558|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
128993233|NCT00481871|464265559|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
128993234|NCT00481871|464265560|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
128993235|NCT00481871|464265561|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
128993236|NCT00481871|464265562|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
128993237|NCT00481871|464265563|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
128993238|NCT01308762|464265564|FG000|Overall Study|Protocol Violation|0|||
128993239|NCT01308762|464265565|FG001|Overall Study|Protocol Violation|1|||
128993240|NCT01308762|464265566|FG002|Overall Study|Protocol Violation|0|||
128993241|NCT01216319|464265572|FG000|Overall Study|Lost to Follow-up|2|||
128993242|NCT01216319|464265572|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
128993243|NCT00929864|464265573|FG000|Overall Study|Death|1|||
128993244|NCT00929864|464265574|FG001|Overall Study|Death|1|||
128993245|NCT00929864|464265573|FG000|Overall Study|Adverse Event|11|||
128993246|NCT00929864|464265574|FG001|Overall Study|Adverse Event|30|||
128993247|NCT00929864|464265573|FG000|Overall Study|Lack of Efficacy|19|||
128993248|NCT00929864|464265574|FG001|Overall Study|Lack of Efficacy|16|||
128993249|NCT00929864|464265573|FG000|Overall Study|Lost to Follow-up|7|||
128993250|NCT00929864|464265574|FG001|Overall Study|Lost to Follow-up|12|||
128993251|NCT00929864|464265573|FG000|Overall Study|Withdrawal by Subject|20|||
128993252|NCT00929864|464265574|FG001|Overall Study|Withdrawal by Subject|9|||
128993253|NCT00929864|464265573|FG000|Overall Study|No longer met criteria|2|||
128993254|NCT00929864|464265574|FG001|Overall Study|No longer met criteria|1|||
128993255|NCT00929864|464265573|FG000|Overall Study|Poor or non-compliance|3|||
128993256|NCT00929864|464265574|FG001|Overall Study|Poor or non-compliance|3|||
128993257|NCT00929864|464265573|FG000|Overall Study|Pregnancy|0|||
128993258|NCT00929864|464265574|FG001|Overall Study|Pregnancy|3|||
128993259|NCT00929864|464265573|FG000|Overall Study|Administrative reason by Sponsor|1|||
128993260|NCT00929864|464265574|FG001|Overall Study|Administrative reason by Sponsor|1|||
128993261|NCT00929864|464265573|FG000|Overall Study|Non-specified|2|||
128993262|NCT00929864|464265574|FG001|Overall Study|Non-specified|7|||
128993263|NCT03454672|464265577|FG000|Overall Study|Adverse Event|1|||
128993264|NCT03454672|464265578|FG001|Overall Study|Adverse Event|1|||
128993265|NCT03454672|464265577|FG000|Overall Study|Lost to Follow-up|1|||
128993266|NCT03454672|464265578|FG001|Overall Study|Lost to Follow-up|3|||
128993267|NCT03454672|464265577|FG000|Overall Study|painful|1|||
128993268|NCT03454672|464265578|FG001|Overall Study|painful|2|||
128993269|NCT03454672|464265577|FG000|Overall Study|Non-compliance|2|||
128993270|NCT03454672|464265578|FG001|Overall Study|Non-compliance|4|||
128993271|NCT03454672|464265577|FG000|Overall Study|personal reasons|3|||
128993272|NCT03454672|464265578|FG001|Overall Study|personal reasons|2|||
128993273|NCT03454672|464265577|FG000|Overall Study|Withdrawal by Subject|1|||
128993274|NCT03454672|464265578|FG001|Overall Study|Withdrawal by Subject|0|||
128993275|NCT05473247|464265579|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
128993276|NCT02392559|464265580|FG000|Overall Study|Withdrawal by Subject|0|||
128993277|NCT02392559|464265581|FG001|Overall Study|Withdrawal by Subject|1|||
128993278|NCT00402779|464265582|FG000|Overall Study|Screen Failure|77|||
128993279|NCT00402779|464265583|FG001|Overall Study|Screen Failure|76|||
128993280|NCT02149199|464265585|FG000|Overall Study|Study specific withdrawal criteria|4|||
128993281|NCT02149199|464265586|FG001|Overall Study|Study specific withdrawal criteria|21|||
128993282|NCT02149199|464265587|FG002|Overall Study|Study specific withdrawal criteria|6|||
128993283|NCT02149199|464265585|FG000|Overall Study|Other|20|||
128993284|NCT02149199|464265586|FG001|Overall Study|Other|25|||
128993285|NCT02149199|464265587|FG002|Overall Study|Other|20|||
128993286|NCT02149199|464265585|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
128993287|NCT02149199|464265586|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
128993288|NCT02149199|464265587|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
128993289|NCT02149199|464265585|FG000|Overall Study|Withdrawal by Subject|75|||
128993290|NCT02149199|464265586|FG001|Overall Study|Withdrawal by Subject|93|||
128993291|NCT02149199|464265587|FG002|Overall Study|Withdrawal by Subject|77|||
128993292|NCT02149199|464265585|FG000|Overall Study|Protocol Violation|16|||
128993293|NCT02149199|464265586|FG001|Overall Study|Protocol Violation|13|||
128993294|NCT02149199|464265587|FG002|Overall Study|Protocol Violation|15|||
128993295|NCT02149199|464265585|FG000|Overall Study|Lost to Follow-up|3|||
128993296|NCT02149199|464265586|FG001|Overall Study|Lost to Follow-up|12|||
128993297|NCT02149199|464265587|FG002|Overall Study|Lost to Follow-up|11|||
128993298|NCT02149199|464265585|FG000|Overall Study|Death|0|||
128993299|NCT02149199|464265586|FG001|Overall Study|Death|0|||
128993300|NCT02149199|464265587|FG002|Overall Study|Death|1|||
128993301|NCT02149199|464265585|FG000|Overall Study|Adverse Event|6|||
128993302|NCT02149199|464265586|FG001|Overall Study|Adverse Event|15|||
128993303|NCT02149199|464265587|FG002|Overall Study|Adverse Event|9|||
128993304|NCT03252756|464265588|FG000|Overall Study|Protocol Violation|2|||
128993305|NCT03252756|464265589|FG001|Overall Study|Protocol Violation|4|||
128993306|NCT03252756|464265588|FG000|Overall Study|COVID-19 Pandemic|1|||
128993307|NCT03252756|464265589|FG001|Overall Study|COVID-19 Pandemic|1|||
128993308|NCT03252756|464265588|FG000|Overall Study|Study Drug Expiration|0|||
128993309|NCT03252756|464265589|FG001|Overall Study|Study Drug Expiration|1|||
128993310|NCT01500434|464265592|FG000|Overall Study|Death|1|||
128993311|NCT01500434|464265592|FG000|Overall Study|Withdrawal by Subject|1|||
128993312|NCT01500434|464265592|FG000|Overall Study|Missed 12-month follow-up|5|||
128993313|NCT01966107|464265596|FG000|Overall Study|excluded from FAS|21|||
128993314|NCT01966107|464265597|FG001|Overall Study|excluded from FAS|20|||
128993315|NCT01966107|464265596|FG000|Overall Study|discontinued treatment|345|||
128993316|NCT01966107|464265597|FG001|Overall Study|discontinued treatment|372|||
128993317|NCT01966107|464265596|FG000|Overall Study|due to study closure|164|||
128993318|NCT01966107|464265597|FG001|Overall Study|due to study closure|186|||
128993319|NCT01966107|464265596|FG000|Overall Study|withdrew from the study|272|||
128993320|NCT01966107|464265597|FG001|Overall Study|withdrew from the study|303|||
128993321|NCT00532779|464265598|FG000|Overall Study|Adverse Event|122|||
128993322|NCT00532779|464265599|FG001|Overall Study|Adverse Event|112|||
128993323|NCT00532779|464265600|FG002|Overall Study|Adverse Event|56|||
128993324|NCT00532779|464265598|FG000|Overall Study|Lost to Follow-up|76|||
128993325|NCT00532779|464265599|FG001|Overall Study|Lost to Follow-up|65|||
128993326|NCT00532779|464265600|FG002|Overall Study|Lost to Follow-up|66|||
128993327|NCT00532779|464265598|FG000|Overall Study|Withdrawal by Subject|63|||
128993328|NCT00532779|464265599|FG001|Overall Study|Withdrawal by Subject|60|||
128993329|NCT00532779|464265600|FG002|Overall Study|Withdrawal by Subject|90|||
128993330|NCT00532779|464265598|FG000|Overall Study|Lack of Efficacy|12|||
128993331|NCT00532779|464265599|FG001|Overall Study|Lack of Efficacy|12|||
128993332|NCT00532779|464265600|FG002|Overall Study|Lack of Efficacy|40|||
128993333|NCT00532779|464265598|FG000|Overall Study|Protocol Violation|5|||
128993334|NCT00532779|464265599|FG001|Overall Study|Protocol Violation|9|||
128993335|NCT00532779|464265600|FG002|Overall Study|Protocol Violation|7|||
128993336|NCT00532779|464265598|FG000|Overall Study|Pregnancy|2|||
128993337|NCT00532779|464265599|FG001|Overall Study|Pregnancy|5|||
128993338|NCT00532779|464265600|FG002|Overall Study|Pregnancy|3|||
128993339|NCT00532779|464265598|FG000|Overall Study|Death|0|||
128993340|NCT00532779|464265599|FG001|Overall Study|Death|1|||
128993341|NCT00532779|464265600|FG002|Overall Study|Death|0|||
128993342|NCT00532779|464265598|FG000|Overall Study|Drug noncompliance, moved, other|14|||
128993343|NCT00532779|464265599|FG001|Overall Study|Drug noncompliance, moved, other|23|||
128993344|NCT00532779|464265600|FG002|Overall Study|Drug noncompliance, moved, other|29|||
128993345|NCT02662556|464265601|FG000|Overall Study|Adverse Event|4|||
128993346|NCT02662556|464265601|FG000|Overall Study|Lack of Efficacy|4|||
128877569|NCT01970345|463846255|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
128877570|NCT01970345|463846254|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
128993347|NCT00689273|464265602|FG000|Overall Study|Adverse Event|3|||
128993348|NCT00689273|464265603|FG001|Overall Study|Adverse Event|1|||
128993349|NCT00689273|464265602|FG000|Overall Study|Lack of Efficacy|3|||
128993350|NCT00689273|464265603|FG001|Overall Study|Lack of Efficacy|0|||
128993351|NCT00689273|464265602|FG000|Overall Study|Lost to Follow-up|0|||
128993352|NCT00689273|464265603|FG001|Overall Study|Lost to Follow-up|2|||
128993353|NCT00689273|464265602|FG000|Overall Study|Other|6|||
128993354|NCT00689273|464265603|FG001|Overall Study|Other|2|||
128993355|NCT00689273|464265602|FG000|Overall Study|Randomized but not Treated|1|||
128993356|NCT00689273|464265603|FG001|Overall Study|Randomized but not Treated|0|||
128877571|NCT01970345|463846255|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
128993357|NCT01238172|464265604|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
128993358|NCT01238172|464265605|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
128993359|NCT01238172|464265604|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
128993360|NCT01238172|464265605|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
128993361|NCT01556165|464265606|FG000|Overall Study|Adverse Event|5|||
128993362|NCT01556165|464265607|FG001|Overall Study|Adverse Event|3|||
128993363|NCT01556165|464265606|FG000|Overall Study|Protocol Violation|0|||
128993364|NCT01556165|464265607|FG001|Overall Study|Protocol Violation|3|||
128993365|NCT01556165|464265606|FG000|Overall Study|Withdrawal of Consent|7|||
128993366|NCT01556165|464265607|FG001|Overall Study|Withdrawal of Consent|1|||
128993367|NCT02531698|464265608|FG000|Overall Study|Adverse Event|2|||
128993368|NCT02531698|464265609|FG001|Overall Study|Adverse Event|1|||
128993369|NCT02531698|464265608|FG000|Overall Study|Withdrawal by Subject|6|||
128993370|NCT02531698|464265609|FG001|Overall Study|Withdrawal by Subject|1|||
128993371|NCT02531698|464265608|FG000|Overall Study|Protocol Violation|2|||
128993372|NCT02531698|464265609|FG001|Overall Study|Protocol Violation|0|||
128993373|NCT02531698|464265608|FG000|Overall Study|Lost to Follow-up|1|||
128993374|NCT02531698|464265609|FG001|Overall Study|Lost to Follow-up|0|||
128993375|NCT00701558|464265610|FG000|Overall Study|Death|7|||
128993376|NCT00701558|464265610|FG000|Overall Study|Lost to Follow-up|8|||
128993377|NCT00131937|464265611|FG000|Overall Study|Adverse Event|3|||
128993378|NCT00131937|464265611|FG000|Overall Study|Withdrawal by Subject|2|||
128993379|NCT00131937|464265611|FG000|Overall Study|Physician Decision|1|||
128993380|NCT00131937|464265611|FG000|Overall Study|Disease Progression|7|||
128993381|NCT00131937|464265611|FG000|Overall Study|Alternative therapy|1|||
128993382|NCT01640964|464265612|FG000|Overall Study|Lost to Follow-up|0|||
128993383|NCT01640964|464265613|FG001|Overall Study|Lost to Follow-up|0|||
128993384|NCT01640964|464265614|FG002|Overall Study|Lost to Follow-up|1|||
128993385|NCT01640964|464265612|FG000|Overall Study|Protocol Deviation|1|||
128993386|NCT01640964|464265613|FG001|Overall Study|Protocol Deviation|1|||
128993387|NCT01640964|464265614|FG002|Overall Study|Protocol Deviation|2|||
128993388|NCT02787746|464265615|FG000|Overall Study|Adverse Event|42|||
128993389|NCT02787746|464265615|FG000|Overall Study|Withdrawal by Subject|65|||
128993390|NCT02787746|464265615|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
128993391|NCT02038959|464266778|FG000|Overall Study|Withdrawal by Subject|6|||
128993392|NCT02038959|464266779|FG001|Overall Study|Withdrawal by Subject|8|||
128993393|NCT00424515|464266787|FG000|Overall Study|Progressive Disease|10|||
128993394|NCT00424515|464266788|FG001|Overall Study|Progressive Disease|11|||
128993395|NCT00424515|464266787|FG000|Overall Study|Adverse Event|0|||
128993396|NCT00424515|464266788|FG001|Overall Study|Adverse Event|1|||
128993397|NCT00424515|464266787|FG000|Overall Study|Intercurrent Illness|0|||
128993398|NCT00424515|464266788|FG001|Overall Study|Intercurrent Illness|1|||
128993399|NCT00424515|464266787|FG000|Overall Study|Withdrawal by Subject|1|||
128993400|NCT00424515|464266788|FG001|Overall Study|Withdrawal by Subject|0|||
128993401|NCT00267020|464266789|FG000|Overall Study|Adverse Event|22|||
128993402|NCT00267020|464266790|FG001|Overall Study|Adverse Event|5|||
128993403|NCT00267020|464266789|FG000|Overall Study|Death|2|||
128993404|NCT00267020|464266790|FG001|Overall Study|Death|1|||
128993405|NCT00267020|464266789|FG000|Overall Study|Withdrawal by Subject|17|||
128993406|NCT00267020|464266790|FG001|Overall Study|Withdrawal by Subject|7|||
128993407|NCT00267020|464266789|FG000|Overall Study|Physician Decision|3|||
128993408|NCT00267020|464266790|FG001|Overall Study|Physician Decision|2|||
128993409|NCT00267020|464266789|FG000|Overall Study|Disease Progression|39|||
128993410|NCT00267020|464266790|FG001|Overall Study|Disease Progression|25|||
128993411|NCT00267020|464266789|FG000|Overall Study|Unrelated Complication|1|||
128993412|NCT00267020|464266790|FG001|Overall Study|Unrelated Complication|1|||
128993413|NCT00267020|464266789|FG000|Overall Study|Sponsor Request|1|||
128993414|NCT00267020|464266790|FG001|Overall Study|Sponsor Request|0|||
128993415|NCT00267020|464266789|FG000|Overall Study|Other|1|||
128993416|NCT00267020|464266790|FG001|Overall Study|Other|2|||
128993417|NCT02428231|464266796|FG000|Overall Study|Other|10|||
128993418|NCT02428231|464266797|FG001|Overall Study|Other|16|||
128993419|NCT02428231|464266796|FG000|Overall Study|Required Symptomatic Therapy|0|||
128993420|NCT02428231|464266797|FG001|Overall Study|Required Symptomatic Therapy|1|||
128993421|NCT02428231|464266796|FG000|Overall Study|Adverse Event|3|||
128993422|NCT02428231|464266797|FG001|Overall Study|Adverse Event|0|||
128993423|NCT01784419|464266800|FG000|Overall Study|Adverse Event|3|||
128993424|NCT02253654|464266801|FG000|Overall Study|Withdrawal by Subject|12|||
128993425|NCT02253654|464266802|FG001|Overall Study|Withdrawal by Subject|4|||
128993426|NCT02253654|464266801|FG000|Overall Study|Decision by Sponsor|1|||
128993427|NCT02253654|464266802|FG001|Overall Study|Decision by Sponsor|1|||
128993428|NCT02253654|464266801|FG000|Overall Study|Lost to Follow-up|2|||
128993429|NCT02253654|464266802|FG001|Overall Study|Lost to Follow-up|5|||
128993430|NCT02253654|464266801|FG000|Overall Study|Death|4|||
128993431|NCT02253654|464266802|FG001|Overall Study|Death|7|||
128993432|NCT02253654|464266801|FG000|Overall Study|Did Not Receive Study Treatment|4|||
128993433|NCT02253654|464266802|FG001|Overall Study|Did Not Receive Study Treatment|1|||
128993434|NCT00399490|464266805|FG000|Overall Study|Adverse Event|19|||
128993435|NCT00399490|464266805|FG000|Overall Study|Lack of Efficacy|31|||
128993436|NCT00399490|464266805|FG000|Overall Study|Lost to Follow-up|5|||
128993437|NCT00399490|464266805|FG000|Overall Study|Withdrawal by Subject|18|||
128993438|NCT00399490|464266805|FG000|Overall Study|Other|25|||
128993439|NCT00791154|464266810|FG000|Overall Study|Noncompliance|0|||
128993440|NCT00791154|464266811|FG001|Overall Study|Noncompliance|1|||
128993441|NCT00791154|464266812|FG002|Overall Study|Noncompliance|0|||
128993442|NCT00791154|464266813|FG003|Overall Study|Noncompliance|0|||
128993443|NCT00791154|464266814|FG004|Overall Study|Noncompliance|1|||
128993444|NCT00791154|464266815|FG005|Overall Study|Noncompliance|1|||
128993445|NCT00791154|464266816|FG006|Overall Study|Noncompliance|1|||
128993446|NCT00791154|464266810|FG000|Overall Study|Adverse Event|0|||
128993447|NCT00791154|464266811|FG001|Overall Study|Adverse Event|0|||
128993448|NCT00791154|464266812|FG002|Overall Study|Adverse Event|0|||
128993449|NCT00791154|464266813|FG003|Overall Study|Adverse Event|0|||
128993450|NCT00791154|464266814|FG004|Overall Study|Adverse Event|2|||
128993451|NCT00791154|464266815|FG005|Overall Study|Adverse Event|0|||
128993452|NCT00791154|464266816|FG006|Overall Study|Adverse Event|1|||
128993453|NCT00791154|464266810|FG000|Overall Study|Full Consent withdrawn|1|||
128993454|NCT00791154|464266811|FG001|Overall Study|Full Consent withdrawn|3|||
128993455|NCT00791154|464266812|FG002|Overall Study|Full Consent withdrawn|0|||
128993456|NCT00791154|464266813|FG003|Overall Study|Full Consent withdrawn|0|||
128993457|NCT00791154|464266814|FG004|Overall Study|Full Consent withdrawn|1|||
128993458|NCT00791154|464266815|FG005|Overall Study|Full Consent withdrawn|3|||
128993459|NCT00791154|464266816|FG006|Overall Study|Full Consent withdrawn|1|||
128993460|NCT00791154|464266810|FG000|Overall Study|Lost to Follow-up|0|||
128993461|NCT00791154|464266811|FG001|Overall Study|Lost to Follow-up|0|||
128993462|NCT00791154|464266812|FG002|Overall Study|Lost to Follow-up|0|||
128993463|NCT00791154|464266813|FG003|Overall Study|Lost to Follow-up|1|||
128993464|NCT00791154|464266814|FG004|Overall Study|Lost to Follow-up|2|||
128993465|NCT00791154|464266815|FG005|Overall Study|Lost to Follow-up|0|||
128993466|NCT00791154|464266816|FG006|Overall Study|Lost to Follow-up|4|||
128993467|NCT00791154|464266810|FG000|Overall Study|Death|5|||
128993468|NCT00791154|464266811|FG001|Overall Study|Death|4|||
128993469|NCT00791154|464266812|FG002|Overall Study|Death|4|||
128993470|NCT00791154|464266813|FG003|Overall Study|Death|7|||
128993471|NCT00791154|464266814|FG004|Overall Study|Death|54|||
128993472|NCT00791154|464266815|FG005|Overall Study|Death|54|||
128993473|NCT00791154|464266816|FG006|Overall Study|Death|52|||
128993474|NCT00791154|464266810|FG000|Overall Study|Other event|0|||
128993475|NCT00791154|464266811|FG001|Overall Study|Other event|0|||
128993476|NCT00791154|464266812|FG002|Overall Study|Other event|2|||
128993477|NCT00791154|464266813|FG003|Overall Study|Other event|0|||
128993478|NCT00791154|464266814|FG004|Overall Study|Other event|2|||
128993479|NCT00791154|464266815|FG005|Overall Study|Other event|4|||
128993480|NCT00791154|464266816|FG006|Overall Study|Other event|2|||
128993481|NCT00765999|464266817|FG000|Overall Study|Adverse Event|203|||
128993482|NCT00765999|464266817|FG000|Overall Study|Insufficient Therapeutic Response|100|||
128993483|NCT00765999|464266817|FG000|Overall Study|Protocol Violation|95|||
128993484|NCT00765999|464266817|FG000|Overall Study|Consent Withdrawn|202|||
128993485|NCT00765999|464266817|FG000|Overall Study|Lost to Follow-up|131|||
128993486|NCT00765999|464266817|FG000|Overall Study|Study Terminated by Sponsor|2|||
128993487|NCT00765999|464266817|FG000|Overall Study|Other Miscellaneous Reasons|51|||
128993488|NCT04840901|464266818|FG000|Overall Study|Lost to Follow-up|3|||
128993489|NCT04840901|464266819|FG001|Overall Study|Lost to Follow-up|1|||
128993490|NCT04840901|464266818|FG000|Overall Study|Moved|1|||
128993491|NCT04840901|464266819|FG001|Overall Study|Moved|0|||
128993492|NCT04840901|464266818|FG000|Overall Study|Unable to comply with study schedule|0|||
128993493|NCT04840901|464266819|FG001|Overall Study|Unable to comply with study schedule|1|||
128993494|NCT04840901|464266818|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
128993495|NCT04840901|464266819|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
128993496|NCT00902265|464266820|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
128993497|NCT00902265|464266820|FG000|Overall Study|Adverse Event|2|||
128993498|NCT00902265|464266820|FG000|Overall Study|Lack of Efficacy|2|||
128993499|NCT00902265|464266820|FG000|Overall Study|Protocol Violation|1|||
128993500|NCT04701658|464266821|FG000|Overall Study|Lost to Follow-up|6|||
128993501|NCT00110084|464266822|FG000|Overall Study|Adverse Event|9|||
128993502|NCT00110084|464266822|FG000|Overall Study|Death|1|||
128993503|NCT00110084|464266822|FG000|Overall Study|Patient Refusal|10|||
128993504|NCT00110084|464266822|FG000|Overall Study|Alternate Therapy|5|||
128993505|NCT00110084|464266822|FG000|Overall Study|Intercurrent Illness|1|||
128993506|NCT00110084|464266822|FG000|Overall Study|Other|2|||
128993507|NCT05016765|464266823|FG000|Overall Study|Lost to Follow-up|4|||
128993508|NCT01346501|464266827|FG000|Overall Study|Initiated Other Biological Agents|3|||
128993509|NCT01346501|464266828|FG001|Overall Study|Initiated Other Biological Agents|1|||
128993510|NCT01346501|464266827|FG000|Overall Study|Other|8|||
128993511|NCT01346501|464266828|FG001|Overall Study|Other|12|||
128993512|NCT04101721|464266829|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
128993513|NCT04101721|464266830|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
128993514|NCT04101721|464266829|FG000|Overall Study|Death|0|||
128993515|NCT04101721|464266830|FG001|Overall Study|Death|1|||
128993516|NCT04101721|464266829|FG000|Overall Study|Lost to Follow-up|0|||
128993517|NCT04101721|464266830|FG001|Overall Study|Lost to Follow-up|3|||
128993518|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
128993519|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
128993520|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
128993521|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
128993522|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
128993523|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
128993524|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
128993525|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
128993526|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
128993527|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
128993528|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
128993529|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
128993530|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
128993531|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
128993532|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
128993533|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
128993534|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
128993535|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
128993536|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
128993537|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
128993538|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
128993539|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
128993540|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
128993541|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
128993542|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
128993543|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
128993544|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
128993545|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
128993546|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
128993547|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
128993548|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
128993549|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
128993550|NCT03747939|464266831|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
128993551|NCT03747939|464266832|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
128993552|NCT03747939|464266833|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
128993553|NCT03747939|464266834|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
128993554|NCT03747939|464266831|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
128993555|NCT03747939|464266832|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
128993556|NCT03747939|464266833|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
128993557|NCT03747939|464266834|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
128993558|NCT03747939|464266831|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
128993559|NCT03747939|464266832|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
128993560|NCT03747939|464266833|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
128993561|NCT03747939|464266834|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
128993562|NCT03747939|464266831|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
128993563|NCT03747939|464266832|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
128993564|NCT03747939|464266833|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
128993565|NCT03747939|464266834|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
128993566|NCT03747939|464266831|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
128993567|NCT03747939|464266832|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
128993568|NCT03747939|464266833|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
128877572|NCT04279392|463846258|FG000|Overall Study|Physician Decision|1|||
128877573|NCT04279392|463846259|FG001|Overall Study|Physician Decision|0|||
128877574|NCT01171807|463846260|FG000|Overall Study|Treatment failure|2|||
128993569|NCT03747939|464266834|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
128993570|NCT03747939|464266831|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
128993571|NCT03747939|464266832|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
128993572|NCT03747939|464266833|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
128993573|NCT03747939|464266834|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
128877575|NCT01171807|463846261|FG001|Overall Study|Treatment failure|4|||
128993574|NCT02494583|464266837|FG000|Overall Study|Death|224|||
128877576|NCT01171807|463846260|FG000|Overall Study|Non compliance|1|||
128877577|NCT01171807|463846261|FG001|Overall Study|Non compliance|0|||
128877578|NCT01171807|463846260|FG000|Overall Study|Lost to Follow-up|3|||
128877579|NCT01171807|463846261|FG001|Overall Study|Lost to Follow-up|0|||
128877580|NCT04101318|463846268|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
128877581|NCT04101318|463846269|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
128877582|NCT04101318|463846268|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
128877583|NCT04101318|463846269|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
128877584|NCT04101318|463846268|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
128877585|NCT04101318|463846269|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
128877586|NCT00558259|463846270|FG000|Overall Study|Adverse Event|50|||
128877587|NCT00558259|463846271|FG001|Overall Study|Adverse Event|81|||
128877588|NCT00558259|463846270|FG000|Overall Study|Protocol Violation|9|||
128877589|NCT00558259|463846271|FG001|Overall Study|Protocol Violation|5|||
128877590|NCT00558259|463846270|FG000|Overall Study|Withdrawal by Subject|12|||
128877591|NCT00558259|463846271|FG001|Overall Study|Withdrawal by Subject|13|||
128877592|NCT04289051|463846272|FG000|Overall Study|Lost to Follow-up|0|||
128877593|NCT04289051|463846273|FG001|Overall Study|Lost to Follow-up|0|||
128877594|NCT04289051|463846274|FG002|Overall Study|Lost to Follow-up|2|||
128877595|NCT01901341|463846275|FG000|Overall Study|Adverse Event|4|||
128877596|NCT01901341|463846276|FG001|Overall Study|Adverse Event|2|||
128877597|NCT01901341|463846275|FG000|Overall Study|Lack of Efficacy|0|||
128877598|NCT01901341|463846276|FG001|Overall Study|Lack of Efficacy|2|||
128877599|NCT01901341|463846275|FG000|Overall Study|Lost to Follow-up|0|||
128877600|NCT01901341|463846276|FG001|Overall Study|Lost to Follow-up|1|||
128877601|NCT01901341|463846275|FG000|Overall Study|Protocol Violation|2|||
128877602|NCT01901341|463846276|FG001|Overall Study|Protocol Violation|0|||
128877603|NCT01901341|463846275|FG000|Overall Study|Study Terminated by Sponsor|13|||
128877604|NCT01901341|463846276|FG001|Overall Study|Study Terminated by Sponsor|15|||
128877605|NCT01901341|463846275|FG000|Overall Study|Withdrawal by Subject|1|||
128877606|NCT01901341|463846276|FG001|Overall Study|Withdrawal by Subject|1|||
128877607|NCT01981473|463846277|FG000|Overall Study|Incorrect diagnosis of RA|0|||
128877608|NCT01981473|463846278|FG001|Overall Study|Incorrect diagnosis of RA|0|||
128877609|NCT01981473|463846279|FG002|Overall Study|Incorrect diagnosis of RA|1|||
128877610|NCT01981473|463846277|FG000|Overall Study|Received treatment for < 6 months|0|||
128877611|NCT01981473|463846278|FG001|Overall Study|Received treatment for < 6 months|0|||
128877612|NCT01981473|463846279|FG002|Overall Study|Received treatment for < 6 months|1|||
128877613|NCT01981473|463846277|FG000|Overall Study|Received treatment for >24 months|2|||
128877614|NCT01981473|463846278|FG001|Overall Study|Received treatment for >24 months|0|||
128877615|NCT01981473|463846279|FG002|Overall Study|Received treatment for >24 months|6|||
128877616|NCT01888900|463846283|FG000|Overall Study|failed treatment|0|||
128877617|NCT01888900|463846284|FG001|Overall Study|failed treatment|2|||
128877618|NCT02257567|463846291|FG000|Overall Study|Adverse Event|0|||
128877619|NCT02257567|463846292|FG001|Overall Study|Adverse Event|0|||
128877620|NCT02257567|463846293|FG002|Overall Study|Adverse Event|0|||
128877621|NCT02257567|463846294|FG003|Overall Study|Adverse Event|1|||
128877622|NCT02257567|463846295|FG004|Overall Study|Adverse Event|1|||
128877623|NCT02257567|463846296|FG005|Overall Study|Adverse Event|0|||
128877624|NCT02257567|463846297|FG006|Overall Study|Adverse Event|0|||
128877625|NCT02257567|463846298|FG007|Overall Study|Adverse Event|0|||
128877626|NCT02257567|463846299|FG008|Overall Study|Adverse Event|1|||
128877627|NCT02257567|463846300|FG009|Overall Study|Adverse Event|0|||
128877628|NCT02257567|463846301|FG010|Overall Study|Adverse Event|0|||
128877629|NCT02257567|463846291|FG000|Overall Study|Death|2|||
128877630|NCT02257567|463846292|FG001|Overall Study|Death|2|||
128877631|NCT02257567|463846293|FG002|Overall Study|Death|2|||
128877632|NCT02257567|463846294|FG003|Overall Study|Death|4|||
128877633|NCT02257567|463846295|FG004|Overall Study|Death|15|||
128877634|NCT02257567|463846296|FG005|Overall Study|Death|11|||
128877635|NCT02257567|463846297|FG006|Overall Study|Death|26|||
128877636|NCT02257567|463846298|FG007|Overall Study|Death|30|||
128877637|NCT02257567|463846299|FG008|Overall Study|Death|2|||
128877638|NCT02257567|463846300|FG009|Overall Study|Death|18|||
128877639|NCT02257567|463846301|FG010|Overall Study|Death|65|||
128877640|NCT02257567|463846291|FG000|Overall Study|Lost to Follow-up|0|||
128877641|NCT02257567|463846292|FG001|Overall Study|Lost to Follow-up|0|||
128877642|NCT02257567|463846293|FG002|Overall Study|Lost to Follow-up|0|||
128877643|NCT02257567|463846294|FG003|Overall Study|Lost to Follow-up|0|||
128877644|NCT02257567|463846295|FG004|Overall Study|Lost to Follow-up|2|||
128877645|NCT02257567|463846296|FG005|Overall Study|Lost to Follow-up|2|||
128877646|NCT02257567|463846297|FG006|Overall Study|Lost to Follow-up|0|||
128877647|NCT02257567|463846298|FG007|Overall Study|Lost to Follow-up|0|||
128877648|NCT02257567|463846299|FG008|Overall Study|Lost to Follow-up|0|||
128877649|NCT02257567|463846300|FG009|Overall Study|Lost to Follow-up|1|||
128877650|NCT02257567|463846301|FG010|Overall Study|Lost to Follow-up|1|||
128877651|NCT02257567|463846291|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128993575|NCT02494583|464266838|FG001|Overall Study|Death|214|||
128993576|NCT02494583|464266839|FG002|Overall Study|Death|225|||
128993577|NCT02494583|464266837|FG000|Overall Study|Lost to Follow-up|1|||
128993578|NCT02494583|464266838|FG001|Overall Study|Lost to Follow-up|0|||
128993579|NCT02494583|464266839|FG002|Overall Study|Lost to Follow-up|0|||
128993580|NCT02494583|464266837|FG000|Overall Study|Protocol Violation|1|||
128993581|NCT02494583|464266838|FG001|Overall Study|Protocol Violation|2|||
128993582|NCT02494583|464266839|FG002|Overall Study|Protocol Violation|0|||
128993583|NCT02494583|464266837|FG000|Overall Study|Screen Failure|0|||
128993584|NCT02494583|464266838|FG001|Overall Study|Screen Failure|1|||
128993585|NCT02494583|464266839|FG002|Overall Study|Screen Failure|0|||
128993586|NCT02494583|464266837|FG000|Overall Study|Transferred to Extension Study|15|||
128993587|NCT02494583|464266838|FG001|Overall Study|Transferred to Extension Study|15|||
128993588|NCT02494583|464266839|FG002|Overall Study|Transferred to Extension Study|6|||
128993589|NCT02494583|464266837|FG000|Overall Study|Did Not Continue on Extension Study|8|||
128993590|NCT02494583|464266838|FG001|Overall Study|Did Not Continue on Extension Study|10|||
128993591|NCT02494583|464266839|FG002|Overall Study|Did Not Continue on Extension Study|4|||
128993592|NCT02494583|464266837|FG000|Overall Study|Withdrawal by Subject|7|||
128993593|NCT02494583|464266838|FG001|Overall Study|Withdrawal by Subject|15|||
128993594|NCT02494583|464266839|FG002|Overall Study|Withdrawal by Subject|15|||
128993595|NCT03151707|464266842|FG000|Overall Study|Lost to Follow-up|6|||
128993596|NCT02362646|464266846|FG000|Overall Study|Death|15|||
128993597|NCT02362646|464266847|FG001|Overall Study|Death|8|||
128993598|NCT02362646|464266846|FG000|Overall Study|Withdrawal by Subject|2|||
128993599|NCT02362646|464266847|FG001|Overall Study|Withdrawal by Subject|2|||
128993600|NCT02362646|464266846|FG000|Overall Study|received transplant|21|||
128993601|NCT02362646|464266847|FG001|Overall Study|received transplant|14|||
128993602|NCT00865306|464266848|FG000|Controlled Trial|Lost to Follow-up|1|||
128993603|NCT00865306|464266849|FG001|Controlled Trial|Lost to Follow-up|1|||
128993604|NCT00865306|464266848|FG000|Controlled Trial|Difficulty commuting|2|||
128993605|NCT00865306|464266849|FG001|Controlled Trial|Difficulty commuting|0|||
128993606|NCT00865306|464266848|FG000|Controlled Trial|Improved btw baseline and first session|1|||
128993607|NCT00865306|464266849|FG001|Controlled Trial|Improved btw baseline and first session|0|||
128993608|NCT00865306|464266848|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
128993609|NCT00865306|464266849|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
128993610|NCT00865306|464266848|FG000|Controlled Trial|Withdrawal by Subject|0|||
128993611|NCT00865306|464266849|FG001|Controlled Trial|Withdrawal by Subject|1|||
128993612|NCT02058368|464266851|FG000|Overall Study|Adverse Event|15|||
128993613|NCT02058368|464266852|FG001|Overall Study|Adverse Event|20|||
128993614|NCT02058368|464266851|FG000|Overall Study|Lack of Efficacy|0|||
128993615|NCT02058368|464266852|FG001|Overall Study|Lack of Efficacy|1|||
128993616|NCT02058368|464266851|FG000|Overall Study|Protocol Violation|0|||
128993617|NCT02058368|464266852|FG001|Overall Study|Protocol Violation|4|||
128993618|NCT02058368|464266851|FG000|Overall Study|Lost to Follow-up|2|||
128993619|NCT02058368|464266852|FG001|Overall Study|Lost to Follow-up|0|||
128993620|NCT02058368|464266851|FG000|Overall Study|Physician Decision|2|||
128993621|NCT02058368|464266852|FG001|Overall Study|Physician Decision|3|||
128993622|NCT02058368|464266851|FG000|Overall Study|Withdrawal by Subject|22|||
128993623|NCT02058368|464266852|FG001|Overall Study|Withdrawal by Subject|26|||
128993624|NCT02181842|464266853|FG000|Overall Study|Case Report Forms Uncollected|2|||
128993625|NCT01652872|464266854|FG000|Overall Study|Death|36|||
128993626|NCT01652872|464266855|FG001|Overall Study|Death|39|||
128993627|NCT01652872|464266854|FG000|Overall Study|Lost to Follow-up|28|||
128993628|NCT01652872|464266855|FG001|Overall Study|Lost to Follow-up|23|||
128993629|NCT01652872|464266854|FG000|Overall Study|Decision by sponsor|5|||
128993630|NCT01652872|464266855|FG001|Overall Study|Decision by sponsor|7|||
128993631|NCT01652872|464266854|FG000|Overall Study|Withdrawal by Subject|76|||
128993632|NCT01652872|464266855|FG001|Overall Study|Withdrawal by Subject|84|||
128993633|NCT04529096|464266856|FG000|Overall Study|Adverse Event|6|||
128993634|NCT04529096|464266857|FG001|Overall Study|Adverse Event|1|||
128993635|NCT04529096|464266856|FG000|Overall Study|Lack of Efficacy|1|||
128993636|NCT04529096|464266857|FG001|Overall Study|Lack of Efficacy|0|||
128993637|NCT04529096|464266856|FG000|Overall Study|Lost to Follow-up|1|||
128993638|NCT04529096|464266857|FG001|Overall Study|Lost to Follow-up|1|||
128993639|NCT04529096|464266856|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128993640|NCT04529096|464266857|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128993641|NCT04529096|464266856|FG000|Overall Study|Physician Decision|1|||
128993642|NCT04529096|464266857|FG001|Overall Study|Physician Decision|3|||
128993643|NCT04529096|464266856|FG000|Overall Study|Withdrawal by Subject|5|||
128993644|NCT04529096|464266857|FG001|Overall Study|Withdrawal by Subject|0|||
128993645|NCT03985293|464266868|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
128993646|NCT03985293|464266869|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
128993647|NCT03985293|464266870|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
128993648|NCT03985293|464266871|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
128993649|NCT03985293|464266872|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
128993650|NCT03985293|464266873|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
128993651|NCT03985293|464266868|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
128993652|NCT03985293|464266869|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
128993653|NCT03985293|464266870|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
128993654|NCT03985293|464266871|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
128993655|NCT03985293|464266872|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
128993656|NCT03985293|464266873|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
128993657|NCT03985293|464266868|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
128993658|NCT03985293|464266869|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
128993659|NCT03985293|464266870|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
128993660|NCT03985293|464266871|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
128993661|NCT03985293|464266872|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
128993662|NCT03985293|464266873|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
128993663|NCT03985293|464266868|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
128993664|NCT03985293|464266869|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
128993665|NCT03985293|464266870|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
128993666|NCT03985293|464266871|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
128993667|NCT03985293|464266872|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
128993668|NCT03985293|464266873|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
128993669|NCT03985293|464266868|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
128993670|NCT03985293|464266869|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
128993671|NCT03985293|464266870|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
128993672|NCT03985293|464266871|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
128993673|NCT03985293|464266872|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
128993674|NCT03985293|464266873|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
128993675|NCT03985293|464266868|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
128993676|NCT03985293|464266869|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
128993677|NCT03985293|464266870|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
128993678|NCT03985293|464266871|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
128993679|NCT03985293|464266872|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
128993680|NCT03985293|464266873|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
128993681|NCT03985293|464266868|FG000|FOLLOW-UP|Lost to Follow-up|0|||
128993682|NCT03985293|464266869|FG001|FOLLOW-UP|Lost to Follow-up|0|||
128993683|NCT03985293|464266870|FG002|FOLLOW-UP|Lost to Follow-up|1|||
128993684|NCT03985293|464266871|FG003|FOLLOW-UP|Lost to Follow-up|0|||
128993685|NCT03985293|464266872|FG004|FOLLOW-UP|Lost to Follow-up|0|||
128993686|NCT03985293|464266873|FG005|FOLLOW-UP|Lost to Follow-up|0|||
128993687|NCT00390572|464266874|FG000|Overall Study|Lost to Follow-up|8|||
128993688|NCT00390572|464266875|FG001|Overall Study|Lost to Follow-up|4|||
128993689|NCT00390572|464266874|FG000|Overall Study|health condition|0|||
128993690|NCT00390572|464266875|FG001|Overall Study|health condition|1|||
128993691|NCT01345058|464266882|FG000|Overall Study|Withdrawal by Subject|1|||
128993692|NCT01345058|464266883|FG001|Overall Study|Withdrawal by Subject|0|||
128993693|NCT01345058|464266882|FG000|Overall Study|Participant Reported Increase in Events|1|||
128993694|NCT01345058|464266883|FG001|Overall Study|Participant Reported Increase in Events|0|||
128993695|NCT01345058|464266882|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
128993696|NCT01345058|464266883|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
128993697|NCT01345058|464266882|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
128993698|NCT01345058|464266883|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
128993699|NCT01345058|464266882|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
128993700|NCT01345058|464266883|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
128993701|NCT01892020|464266890|FG000|Period 1|Adverse Event|1|||
128993702|NCT01892020|464266891|FG001|Period 1|Adverse Event|1|||
128993703|NCT01892020|464266890|FG000|Period 1|Protocol Violation|2|||
128993704|NCT01892020|464266891|FG001|Period 1|Protocol Violation|4|||
128993705|NCT01892020|464266890|FG000|Period 1|Unclassified|0|||
128993706|NCT01892020|464266891|FG001|Period 1|Unclassified|1|||
128993707|NCT01892020|464266890|FG000|Period 2|Protocol Violation|1|||
128993708|NCT01892020|464266891|FG001|Period 2|Protocol Violation|0|||
128993709|NCT00858234|464268419|FG000|Overall Study|Adverse Event|6|||
128993710|NCT00858234|464268419|FG000|Overall Study|Progressive disease|2|||
128993711|NCT00858234|464268419|FG000|Overall Study|Status unknown|1|||
128993712|NCT01678924|464268420|FG000|Overall Study|Adverse Event|1|||
128993713|NCT01678924|464268421|FG001|Overall Study|Adverse Event|1|||
128993714|NCT01678924|464268422|FG002|Overall Study|Adverse Event|0|||
128993715|NCT01678924|464268423|FG003|Overall Study|Adverse Event|1|||
128993716|NCT01678924|464268420|FG000|Overall Study|Lack of Efficacy|7|||
128993717|NCT01678924|464268421|FG001|Overall Study|Lack of Efficacy|2|||
128993718|NCT01678924|464268422|FG002|Overall Study|Lack of Efficacy|0|||
128993719|NCT01678924|464268423|FG003|Overall Study|Lack of Efficacy|5|||
128993720|NCT01678924|464268420|FG000|Overall Study|Lost to Follow-up|0|||
128993721|NCT01678924|464268421|FG001|Overall Study|Lost to Follow-up|4|||
128993722|NCT01678924|464268422|FG002|Overall Study|Lost to Follow-up|0|||
128993723|NCT01678924|464268423|FG003|Overall Study|Lost to Follow-up|2|||
128993724|NCT01678924|464268420|FG000|Overall Study|Personal Reasons|2|||
128993725|NCT01678924|464268421|FG001|Overall Study|Personal Reasons|2|||
128993726|NCT01678924|464268422|FG002|Overall Study|Personal Reasons|2|||
128993727|NCT01678924|464268423|FG003|Overall Study|Personal Reasons|7|||
128993728|NCT01678924|464268420|FG000|Overall Study|Withdrawal by Subject|0|||
128993729|NCT01678924|464268421|FG001|Overall Study|Withdrawal by Subject|3|||
128993730|NCT01678924|464268422|FG002|Overall Study|Withdrawal by Subject|0|||
128993731|NCT01678924|464268423|FG003|Overall Study|Withdrawal by Subject|2|||
128993732|NCT01678924|464268420|FG000|Overall Study|Unable to attend scheduled visits|0|||
128993733|NCT01678924|464268421|FG001|Overall Study|Unable to attend scheduled visits|0|||
128993734|NCT01678924|464268422|FG002|Overall Study|Unable to attend scheduled visits|0|||
128993735|NCT01678924|464268423|FG003|Overall Study|Unable to attend scheduled visits|1|||
128993736|NCT00640614|464268427|FG000|Overall Study|Lost to Follow-up|1|||
128993737|NCT00640614|464268428|FG001|Overall Study|Lost to Follow-up|0|||
128993738|NCT00529802|464268429|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
128993739|NCT00529802|464268429|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
128993740|NCT00529802|464268429|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
128993741|NCT00529802|464268429|FG000|Evaluable for Primary Endpoint|Death|1|||
128993742|NCT00529802|464268429|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
128993743|NCT00529802|464268429|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
128993744|NCT00529802|464268429|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
128993745|NCT01336608|464268430|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
128993746|NCT01336608|464268431|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
128993747|NCT01336608|464268432|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
128993748|NCT01336608|464268433|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
128993749|NCT01336608|464268430|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
128993750|NCT01336608|464268431|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
128993751|NCT01336608|464268432|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
128877652|NCT02257567|463846292|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877653|NCT02257567|463846293|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877654|NCT02257567|463846294|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877655|NCT02257567|463846295|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
128977893|NCT00699582|464205244|FG000|Overall Study|Withdrawal by Subject|6|||
128993752|NCT01336608|464268433|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
128993753|NCT01336608|464268430|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
128993754|NCT01336608|464268431|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
128993755|NCT01336608|464268432|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
128993756|NCT01336608|464268433|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
128993757|NCT01336608|464268430|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
128993758|NCT01336608|464268431|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
128993759|NCT01336608|464268432|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
128993760|NCT01336608|464268433|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
128993761|NCT01336608|464268430|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
128993762|NCT01336608|464268431|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
128993763|NCT01336608|464268432|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
128993764|NCT01336608|464268433|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
128993765|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
128993766|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
128993767|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
128993768|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
128993769|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
128993770|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
128993771|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
128993772|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
128993773|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
128993774|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
128993775|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
128993776|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
128993777|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
128993778|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
128993779|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
128993780|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
128993781|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
128993782|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
128993783|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
128993784|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
128993785|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128993786|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
128993787|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128993788|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128993789|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
128993790|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
128993791|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
128993792|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
128993793|NCT01336608|464268430|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
128993794|NCT01336608|464268431|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
128993795|NCT01336608|464268432|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
128993796|NCT01336608|464268433|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
128993797|NCT00080288|464268434|FG000|Overall Study|Adverse Event|7|||
128993798|NCT00080288|464268435|FG001|Overall Study|Adverse Event|4|||
128993799|NCT00080288|464268434|FG000|Overall Study|Lost to Follow-up|3|||
128993800|NCT00080288|464268435|FG001|Overall Study|Lost to Follow-up|5|||
128993801|NCT00080288|464268434|FG000|Overall Study|Physician Decision|6|||
128993802|NCT00080288|464268435|FG001|Overall Study|Physician Decision|2|||
128993803|NCT00080288|464268434|FG000|Overall Study|Withdrawal by Subject|3|||
128993804|NCT00080288|464268435|FG001|Overall Study|Withdrawal by Subject|16|||
128993805|NCT00080288|464268434|FG000|Overall Study|Miscellaneous|11|||
128993806|NCT00080288|464268435|FG001|Overall Study|Miscellaneous|11|||
128993807|NCT03044431|464268436|FG000|Overall Study|Lost to Follow-up|59|||
128993808|NCT03456726|464268437|FG000|Overall Study|Disease Progression|6|||
128993809|NCT03456726|464268438|FG001|Overall Study|Disease Progression|1|||
128993810|NCT03456726|464268437|FG000|Overall Study|Adverse Event|4|||
128993811|NCT03456726|464268438|FG001|Overall Study|Adverse Event|2|||
128993812|NCT03456726|464268437|FG000|Overall Study|Withdrawal by Subject|1|||
128993813|NCT03456726|464268438|FG001|Overall Study|Withdrawal by Subject|0|||
128993814|NCT03456726|464268437|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
128993815|NCT03456726|464268438|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
128993816|NCT04470622|464268439|FG000|Overall Study|Withdrawal by Subject|0|||
128993817|NCT04470622|464268440|FG001|Overall Study|Withdrawal by Subject|1|||
128993818|NCT04470622|464268439|FG000|Overall Study|Screen Failure|0|||
128993819|NCT04470622|464268440|FG001|Overall Study|Screen Failure|1|||
128993820|NCT04470622|464268439|FG000|Overall Study|Death|0|||
128993821|NCT04470622|464268440|FG001|Overall Study|Death|1|||
128993822|NCT02328547|464268441|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
128993823|NCT02328547|464268442|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
128993824|NCT02328547|464268441|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
128993825|NCT02328547|464268442|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
128993826|NCT02576054|464268443|FG000|Overall Study|Withdrawal by Subject|1|||
128993827|NCT01190098|464268447|FG000|Overall Study|Adverse Event|2|||
128993828|NCT01190098|464268448|FG001|Overall Study|Adverse Event|0|||
128993829|NCT01190098|464268447|FG000|Overall Study|Patient coomorbidity|0|||
128993830|NCT01190098|464268448|FG001|Overall Study|Patient coomorbidity|1|||
128993831|NCT01190098|464268447|FG000|Overall Study|Lack of transportation|1|||
128993832|NCT01190098|464268448|FG001|Overall Study|Lack of transportation|0|||
128993833|NCT01190098|464268447|FG000|Overall Study|Other|0|||
128993834|NCT01190098|464268448|FG001|Overall Study|Other|1|||
128993835|NCT00344305|464268449|FG000|Overall Study|Lost to Follow-up|2|||
128993836|NCT00344305|464268450|FG001|Overall Study|Lost to Follow-up|0|||
128993837|NCT00344305|464268449|FG000|Overall Study|Participant was not contacted in window|0|||
128993838|NCT00344305|464268450|FG001|Overall Study|Participant was not contacted in window|1|||
128993839|NCT02957682|464268451|FG000|Overall Study|Adverse Event|64|||
128993840|NCT02957682|464268452|FG001|Overall Study|Adverse Event|67|||
128993841|NCT02957682|464268451|FG000|Overall Study|Poor Compliance to Protocol|30|||
128993842|NCT02957682|464268452|FG001|Overall Study|Poor Compliance to Protocol|26|||
128993843|NCT02957682|464268451|FG000|Overall Study|Physician Decision|4|||
128993844|NCT02957682|464268452|FG001|Overall Study|Physician Decision|4|||
128993845|NCT02957682|464268451|FG000|Overall Study|Study Terminated by Sponsor|4|||
128993846|NCT02957682|464268452|FG001|Overall Study|Study Terminated by Sponsor|3|||
128993847|NCT02957682|464268451|FG000|Overall Study|Subject Moved|10|||
128993848|NCT02957682|464268452|FG001|Overall Study|Subject Moved|16|||
128993849|NCT02957682|464268451|FG000|Overall Study|Withdrawal by Subject|64|||
128993850|NCT02957682|464268452|FG001|Overall Study|Withdrawal by Subject|33|||
128993851|NCT02957682|464268451|FG000|Overall Study|Related to IMP Administration|3|||
128993852|NCT02957682|464268452|FG001|Overall Study|Related to IMP Administration|6|||
128993853|NCT02957682|464268451|FG000|Overall Study|Non-disclosed|16|||
128993854|NCT02957682|464268452|FG001|Overall Study|Non-disclosed|12|||
128993855|NCT02957682|464268451|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
128993856|NCT02957682|464268452|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
128993857|NCT02703454|464268457|FG000|Overall Study|Not treated|1|||
128993858|NCT02703454|464268458|FG001|Overall Study|Not treated|3|||
128993859|NCT02703454|464268457|FG000|Overall Study|Withdrawal by Subject|4|||
128993860|NCT02703454|464268458|FG001|Overall Study|Withdrawal by Subject|3|||
128993861|NCT02703454|464268457|FG000|Overall Study|Lost to Follow-up|1|||
128993862|NCT02703454|464268458|FG001|Overall Study|Lost to Follow-up|2|||
128993863|NCT02703454|464268457|FG000|Overall Study|Study discontinuation|5|||
128993864|NCT02703454|464268458|FG001|Overall Study|Study discontinuation|8|||
128993865|NCT02284373|464268459|FG000|Overall Study|Withdrawal by Subject|0|||
128993866|NCT02284373|464268460|FG001|Overall Study|Withdrawal by Subject|1|||
128993867|NCT02284373|464268461|FG002|Overall Study|Withdrawal by Subject|0|||
128993868|NCT02284373|464268459|FG000|Overall Study|Other|0|||
128993869|NCT02284373|464268460|FG001|Overall Study|Other|1|||
128993870|NCT02284373|464268461|FG002|Overall Study|Other|0|||
128993871|NCT02284373|464268459|FG000|Overall Study|Lost to Follow-up|0|||
128993872|NCT02284373|464268460|FG001|Overall Study|Lost to Follow-up|1|||
128993873|NCT02284373|464268461|FG002|Overall Study|Lost to Follow-up|0|||
128993874|NCT02499406|464268462|FG000|Overall Study|missed 3 treatment sessions|4|||
128993875|NCT04651218|464268463|FG000|Overall Study|Withdrawal by Subject|0|||
128993876|NCT04651218|464268464|FG001|Overall Study|Withdrawal by Subject|2|||
128993877|NCT00414011|464268465|FG000|Overall Study|Physician Decision|3|||
128993878|NCT00414011|464268465|FG000|Overall Study|Withdrawal by Subject|2|||
128993879|NCT02476851|464268466|FG000|Overall Study|Protocol Violation|1|||
128993880|NCT02476851|464268467|FG001|Overall Study|Protocol Violation|1|||
128993881|NCT01399125|464268468|FG000|Overall Study|Adverse Event|32|||
128993882|NCT01399125|464268469|FG001|Overall Study|Adverse Event|30|||
128993883|NCT01399125|464268468|FG000|Overall Study|Abnormal Lab values|0|||
128993884|NCT01399125|464268469|FG001|Overall Study|Abnormal Lab values|1|||
128993885|NCT01399125|464268468|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
128993886|NCT01399125|464268469|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
128993887|NCT01399125|464268468|FG000|Overall Study|Withdrawal by Subject|5|||
128993888|NCT01399125|464268469|FG001|Overall Study|Withdrawal by Subject|8|||
128993889|NCT01399125|464268468|FG000|Overall Study|Lost to Follow-up|2|||
128993890|NCT01399125|464268469|FG001|Overall Study|Lost to Follow-up|3|||
128993891|NCT01399125|464268468|FG000|Overall Study|Administrative Problems|7|||
128993892|NCT01399125|464268469|FG001|Overall Study|Administrative Problems|11|||
128993893|NCT01399125|464268468|FG000|Overall Study|Death|0|||
128993894|NCT01399125|464268469|FG001|Overall Study|Death|1|||
128993895|NCT01399125|464268468|FG000|Overall Study|Protocol Deviation|5|||
128993896|NCT01399125|464268469|FG001|Overall Study|Protocol Deviation|2|||
128993897|NCT00647426|464268472|FG000|Overall Study|Withdrawal by Subject|2|||
128993898|NCT03578276|464268475|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
128993899|NCT03578276|464268476|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
128993900|NCT00981409|464268477|FG000|Overall Study|Adverse Event|4|||
128993901|NCT00981409|464268478|FG001|Overall Study|Adverse Event|0|||
128993902|NCT00981409|464268477|FG000|Overall Study|Protocol Violation|0|||
128993903|NCT00981409|464268478|FG001|Overall Study|Protocol Violation|1|||
128993904|NCT00981409|464268477|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
128993905|NCT00981409|464268478|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
128993906|NCT00078312|464268487|FG000|Overall Study|Adverse Event|43|||
128993907|NCT00078312|464268487|FG000|Overall Study|Lack of Efficacy|15|||
128993908|NCT00078312|464268487|FG000|Overall Study|Lost to Follow-up|41|||
128993909|NCT00078312|464268487|FG000|Overall Study|Physician Decision|9|||
128993910|NCT00078312|464268487|FG000|Overall Study|Protocol Violation|3|||
128993911|NCT00078312|464268487|FG000|Overall Study|Withdrawal by Subject|33|||
128993912|NCT00078312|464268487|FG000|Overall Study|Miscellaneous|33|||
128993913|NCT05354206|464268488|FG000|Overall Study|Withdrawal by Subject|1|||
128993914|NCT05354206|464268489|FG001|Overall Study|Withdrawal by Subject|0|||
128993915|NCT04285983|464268490|FG000|Overall Study|Protocol Violation|6|||
128993916|NCT04936334|464268491|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
128993917|NCT00422058|464268492|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
128993918|NCT00422058|464268493|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
128993919|NCT00422058|464268494|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
128993920|NCT00422058|464268495|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
128993921|NCT00422058|464268496|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
128993922|NCT00422058|464268497|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
128993923|NCT00422058|464268492|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
128993924|NCT00422058|464268493|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
128993925|NCT00422058|464268494|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
128993926|NCT00422058|464268495|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
128993927|NCT00422058|464268496|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
128993928|NCT00422058|464268497|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
128993929|NCT00422058|464268492|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
128993930|NCT00422058|464268493|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
128993931|NCT00422058|464268494|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
128993932|NCT00422058|464268495|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
128993933|NCT00422058|464268496|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
128993934|NCT00422058|464268497|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
128993935|NCT00422058|464268492|FG000|Double-Blind, Week 0-20|Other|11|||
128993936|NCT00422058|464268493|FG001|Double-Blind, Week 0-20|Other|3|||
128993937|NCT00422058|464268494|FG002|Double-Blind, Week 0-20|Other|8|||
128993938|NCT00422058|464268495|FG003|Double-Blind, Week 0-20|Other|8|||
128993939|NCT00422058|464268496|FG004|Double-Blind, Week 0-20|Other|4|||
128993940|NCT00422058|464268497|FG005|Double-Blind, Week 0-20|Other|10|||
128993941|NCT00422058|464268492|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
128993942|NCT00422058|464268493|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
128993943|NCT00422058|464268494|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
128993944|NCT00422058|464268495|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
128993945|NCT00422058|464268496|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
128993946|NCT00422058|464268497|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
128993947|NCT00422058|464268492|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
128993948|NCT00422058|464268493|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
128993949|NCT00422058|464268494|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
128993950|NCT00422058|464268495|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
128993951|NCT00422058|464268496|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
128993952|NCT00422058|464268497|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
128993953|NCT00422058|464268492|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
128993954|NCT00422058|464268493|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
128993955|NCT00422058|464268494|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
128993956|NCT00422058|464268495|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
128993957|NCT00422058|464268496|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
128993958|NCT00422058|464268497|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
128993959|NCT00422058|464268492|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
128993960|NCT00422058|464268493|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
128993961|NCT00422058|464268494|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
128993962|NCT00422058|464268495|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
128993963|NCT00422058|464268496|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
128993964|NCT00422058|464268497|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
128993965|NCT00422058|464268492|FG000|Open-Label Extension, Week 20-104|Other|13|||
128993966|NCT00422058|464268493|FG001|Open-Label Extension, Week 20-104|Other|14|||
128993967|NCT00422058|464268494|FG002|Open-Label Extension, Week 20-104|Other|6|||
128993968|NCT00422058|464268495|FG003|Open-Label Extension, Week 20-104|Other|13|||
128993969|NCT00422058|464268496|FG004|Open-Label Extension, Week 20-104|Other|16|||
128993970|NCT00422058|464268497|FG005|Open-Label Extension, Week 20-104|Other|18|||
128993971|NCT00103259|464268503|FG000|Overall Study|Death|3|||
128993972|NCT00103259|464268504|FG001|Overall Study|Death|2|||
128993973|NCT00103259|464268503|FG000|Overall Study|Withdrawal by Subject|2|||
128993974|NCT00103259|464268504|FG001|Overall Study|Withdrawal by Subject|3|||
128993975|NCT00103259|464268503|FG000|Overall Study|alternative therapy|1|||
128993976|NCT00103259|464268504|FG001|Overall Study|alternative therapy|0|||
128993977|NCT00103259|464268503|FG000|Overall Study|other (reasons were not specified)|2|||
128993978|NCT00103259|464268504|FG001|Overall Study|other (reasons were not specified)|1|||
128993979|NCT00103259|464268503|FG000|Overall Study|ineligible/no protocol therapy|4|||
128993980|NCT00103259|464268504|FG001|Overall Study|ineligible/no protocol therapy|6|||
128993981|NCT03224234|464268509|FG000|Main Study|Lost to Follow-up|5|||
128993982|NCT03224234|464268510|FG001|Main Study|Lost to Follow-up|5|||
128993983|NCT02866695|464268511|FG000|Overall Study|Adverse Event|1|||
128993984|NCT02866695|464268511|FG000|Overall Study|Lost to Follow-up|1|||
128993985|NCT02610842|464268512|FG000|Overall Study|Lost to Follow-up|5|||
128993986|NCT00756652|464268513|FG000|Original Phase|Withdrawal by Subject|864|||
128993987|NCT00756652|464268514|FG001|Original Phase|Withdrawal by Subject|23|||
128993988|NCT00756652|464268513|FG000|Original Phase|Lost to Follow-up|601|||
128993989|NCT00756652|464268514|FG001|Original Phase|Lost to Follow-up|0|||
128993990|NCT00756652|464268513|FG000|Original Phase|Other Discontinuation|797|||
128993991|NCT00756652|464268514|FG001|Original Phase|Other Discontinuation|5|||
128993992|NCT00756652|464268513|FG000|Original Phase|Participant Noncompliance|18622|||
128993993|NCT00756652|464268514|FG001|Original Phase|Participant Noncompliance|424|||
128993994|NCT00756652|464268513|FG000|Original Phase|Unknown Discontinuation Reason|2|||
128993995|NCT00756652|464268514|FG001|Original Phase|Unknown Discontinuation Reason|0|||
128993996|NCT00756652|464268513|FG000|Original Phase|Participants without data|3259|||
128993997|NCT00756652|464268514|FG001|Original Phase|Participants without data|466|||
128993998|NCT00756652|464268513|FG000|Original Phase|Death|168|||
128993999|NCT00756652|464268514|FG001|Original Phase|Death|1|||
128994000|NCT00756652|464268513|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
128994001|NCT00756652|464268514|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
128994002|NCT00756652|464268513|FG000|Re-Op Phase|Withdrawal by Subject|62|||
128994003|NCT00756652|464268514|FG001|Re-Op Phase|Withdrawal by Subject|0|||
128994004|NCT00756652|464268513|FG000|Re-Op Phase|Death|6|||
128994005|NCT00756652|464268514|FG001|Re-Op Phase|Death|0|||
128994006|NCT00756652|464268513|FG000|Re-Op Phase|Lost to Follow-up|340|||
128994007|NCT00756652|464268514|FG001|Re-Op Phase|Lost to Follow-up|0|||
128877656|NCT02257567|463846296|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877657|NCT02257567|463846297|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
128877658|NCT02257567|463846298|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877659|NCT02257567|463846299|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877660|NCT02257567|463846300|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877661|NCT02257567|463846301|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
128877662|NCT02257567|463846291|FG000|Overall Study|Physician Decision|0|||
128877663|NCT02257567|463846292|FG001|Overall Study|Physician Decision|0|||
128877664|NCT02257567|463846293|FG002|Overall Study|Physician Decision|0|||
128877665|NCT02257567|463846294|FG003|Overall Study|Physician Decision|0|||
128877666|NCT02257567|463846295|FG004|Overall Study|Physician Decision|0|||
128877667|NCT02257567|463846296|FG005|Overall Study|Physician Decision|0|||
128877668|NCT02257567|463846297|FG006|Overall Study|Physician Decision|0|||
128877669|NCT02257567|463846298|FG007|Overall Study|Physician Decision|2|||
128877670|NCT02257567|463846299|FG008|Overall Study|Physician Decision|0|||
128877671|NCT02257567|463846300|FG009|Overall Study|Physician Decision|1|||
128877672|NCT02257567|463846301|FG010|Overall Study|Physician Decision|0|||
128877673|NCT02257567|463846291|FG000|Overall Study|Withdrawal by Subject|0|||
128877674|NCT02257567|463846292|FG001|Overall Study|Withdrawal by Subject|0|||
128877675|NCT02257567|463846293|FG002|Overall Study|Withdrawal by Subject|2|||
128877676|NCT02257567|463846294|FG003|Overall Study|Withdrawal by Subject|0|||
128877677|NCT02257567|463846295|FG004|Overall Study|Withdrawal by Subject|0|||
128877678|NCT02257567|463846296|FG005|Overall Study|Withdrawal by Subject|6|||
128877679|NCT02257567|463846297|FG006|Overall Study|Withdrawal by Subject|6|||
128877680|NCT02257567|463846298|FG007|Overall Study|Withdrawal by Subject|6|||
128877681|NCT02257567|463846299|FG008|Overall Study|Withdrawal by Subject|1|||
128877682|NCT02257567|463846300|FG009|Overall Study|Withdrawal by Subject|1|||
128877683|NCT02257567|463846301|FG010|Overall Study|Withdrawal by Subject|10|||
128877684|NCT01065844|463846310|FG000|Overall Study|Adverse Event|5|||
128877685|NCT02884908|463846313|FG000|Overall Study|Lost to Follow-up|13|||
128877686|NCT02884908|463846314|FG001|Overall Study|Lost to Follow-up|18|||
128877687|NCT02084056|463846317|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
128877688|NCT02084056|463846318|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
128877689|NCT02084056|463846319|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
128877690|NCT02084056|463846320|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
128877691|NCT02084056|463846317|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
128877692|NCT02084056|463846318|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
128877693|NCT02084056|463846319|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
128877694|NCT02084056|463846320|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
128877695|NCT02413333|463846322|FG000|Period 1|Adverse Event|1|||
128877696|NCT02413333|463846323|FG001|Period 1|Adverse Event|0|||
128877697|NCT02413333|463846322|FG000|Period 1|Reason Not Specified|0|||
128877698|NCT02413333|463846323|FG001|Period 1|Reason Not Specified|1|||
128877699|NCT02413333|463846322|FG000|Period 2|Protocol Deviation|1|||
128877700|NCT02413333|463846323|FG001|Period 2|Protocol Deviation|0|||
128877701|NCT00709852|463846324|FG000|Period 1|Adverse Event|2|||
128877702|NCT00709852|463846325|FG001|Period 1|Adverse Event|0|||
128877703|NCT00709852|463846324|FG000|Period 1|Withdrawal by Subject|4|||
128877704|NCT00709852|463846325|FG001|Period 1|Withdrawal by Subject|2|||
128877705|NCT00709852|463846324|FG000|Period 1|Protocol Violation|1|||
128877706|NCT00709852|463846325|FG001|Period 1|Protocol Violation|0|||
128877707|NCT00709852|463846324|FG000|Period 1|Defective scanner|0|||
128877708|NCT00709852|463846325|FG001|Period 1|Defective scanner|1|||
128877709|NCT00709852|463846324|FG000|Period 1|Lost to Follow-up|1|||
128877710|NCT00709852|463846325|FG001|Period 1|Lost to Follow-up|0|||
128877711|NCT00709852|463846324|FG000|Period 2|Protocol Violation|4|||
128877712|NCT00709852|463846325|FG001|Period 2|Protocol Violation|1|||
128877713|NCT00709852|463846324|FG000|Period 2|Adverse Event|1|||
128877714|NCT00709852|463846325|FG001|Period 2|Adverse Event|1|||
128877715|NCT00709852|463846324|FG000|Period 2|Lost to Follow-up|1|||
128877716|NCT00709852|463846325|FG001|Period 2|Lost to Follow-up|0|||
128877717|NCT00709852|463846324|FG000|Period 2|No 72-hour follow-up|3|||
128877718|NCT00709852|463846325|FG001|Period 2|No 72-hour follow-up|0|||
128877719|NCT02951767|463846326|FG000|Overall Study|Study Terminated By Sponsor|9|||
128877720|NCT02951767|463846326|FG000|Overall Study|Withdrawal by Subject|11|||
128877721|NCT02951767|463846326|FG000|Overall Study|Death|96|||
128877722|NCT02951767|463846326|FG000|Overall Study|Lost to Follow-up|2|||
128877723|NCT02951767|463846326|FG000|Overall Study|Physician Decision|1|||
128877724|NCT01048671|463846327|FG000|Overall Study|Protocol Violation|0|||
128877725|NCT01048671|463846328|FG001|Overall Study|Protocol Violation|1|||
128877726|NCT01048671|463846329|FG002|Overall Study|Protocol Violation|1|||
128877727|NCT03814187|463846330|FG000|Overall Study|Sponsor's Administrative Decision|0|||
128877728|NCT03814187|463846331|FG001|Overall Study|Sponsor's Administrative Decision|0|||
128877729|NCT03814187|463846332|FG002|Overall Study|Sponsor's Administrative Decision|272|||
128877730|NCT03814187|463846330|FG000|Overall Study|Death|80|||
128877731|NCT03814187|463846331|FG001|Overall Study|Death|81|||
128877732|NCT03814187|463846332|FG002|Overall Study|Death|4|||
128877733|NCT03814187|463846330|FG000|Overall Study|Withdrew Consent|77|||
128877734|NCT03814187|463846331|FG001|Overall Study|Withdrew Consent|78|||
128877735|NCT03814187|463846332|FG002|Overall Study|Withdrew Consent|2|||
128877736|NCT03814187|463846330|FG000|Overall Study|Lost to Follow-up|47|||
128877737|NCT03814187|463846331|FG001|Overall Study|Lost to Follow-up|52|||
128877738|NCT03814187|463846332|FG002|Overall Study|Lost to Follow-up|1|||
128877739|NCT03814187|463846330|FG000|Overall Study|Adverse Event|22|||
128877740|NCT03814187|463846331|FG001|Overall Study|Adverse Event|23|||
128877741|NCT03814187|463846332|FG002|Overall Study|Adverse Event|0|||
128877742|NCT03814187|463846330|FG000|Overall Study|Physician Decision|7|||
128877743|NCT03814187|463846331|FG001|Overall Study|Physician Decision|4|||
128877744|NCT03814187|463846332|FG002|Overall Study|Physician Decision|2|||
128877745|NCT03814187|463846330|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
128877746|NCT03814187|463846331|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
128877747|NCT03814187|463846332|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
128877748|NCT03814187|463846330|FG000|Overall Study|Other reasons|34|||
128877749|NCT03814187|463846331|FG001|Overall Study|Other reasons|40|||
128877750|NCT03814187|463846332|FG002|Overall Study|Other reasons|2|||
128877751|NCT00196976|463846333|FG000|Primary Study|Migrated from study area|0|||
128877752|NCT00196976|463846334|FG001|Primary Study|Migrated from study area|0|||
128877753|NCT00196976|463846335|FG002|Primary Study|Migrated from study area|0|||
128877754|NCT00196976|463846336|FG003|Primary Study|Migrated from study area|0|||
128877755|NCT00196976|463846337|FG004|Primary Study|Migrated from study area|0|||
128877756|NCT00196976|463846338|FG005|Primary Study|Migrated from study area|0|||
128877757|NCT00196976|463846339|FG006|Primary Study|Migrated from study area|0|||
128877758|NCT00196976|463846340|FG007|Primary Study|Migrated from study area|1|||
128877759|NCT00196976|463846341|FG008|Primary Study|Migrated from study area|0|||
128877760|NCT00196976|463846342|FG009|Primary Study|Migrated from study area|0|||
128877761|NCT00196976|463846343|FG010|Primary Study|Migrated from study area|0|||
128877762|NCT00196976|463846344|FG011|Primary Study|Migrated from study area|0|||
128877763|NCT00196976|463846345|FG012|Primary Study|Migrated from study area|0|||
128877764|NCT00196976|463846346|FG013|Primary Study|Migrated from study area|0|||
128877765|NCT00196976|463846333|FG000|Primary Study|Protocol Violation|0|||
128877766|NCT00196976|463846334|FG001|Primary Study|Protocol Violation|1|||
128877767|NCT00196976|463846335|FG002|Primary Study|Protocol Violation|1|||
128877768|NCT00196976|463846336|FG003|Primary Study|Protocol Violation|0|||
128877769|NCT00196976|463846337|FG004|Primary Study|Protocol Violation|0|||
128877770|NCT00196976|463846338|FG005|Primary Study|Protocol Violation|0|||
128877771|NCT00196976|463846339|FG006|Primary Study|Protocol Violation|0|||
128877772|NCT00196976|463846340|FG007|Primary Study|Protocol Violation|0|||
128877773|NCT00196976|463846341|FG008|Primary Study|Protocol Violation|0|||
128877774|NCT00196976|463846342|FG009|Primary Study|Protocol Violation|0|||
128877775|NCT00196976|463846343|FG010|Primary Study|Protocol Violation|0|||
128877776|NCT00196976|463846344|FG011|Primary Study|Protocol Violation|0|||
128877777|NCT00196976|463846345|FG012|Primary Study|Protocol Violation|0|||
128877778|NCT00196976|463846346|FG013|Primary Study|Protocol Violation|0|||
128877779|NCT00196976|463846333|FG000|Primary Study|Withdrawal by Subject|1|||
128877780|NCT00196976|463846334|FG001|Primary Study|Withdrawal by Subject|0|||
128877781|NCT00196976|463846335|FG002|Primary Study|Withdrawal by Subject|1|||
128877782|NCT00196976|463846336|FG003|Primary Study|Withdrawal by Subject|1|||
128877783|NCT00196976|463846337|FG004|Primary Study|Withdrawal by Subject|2|||
128877784|NCT00196976|463846338|FG005|Primary Study|Withdrawal by Subject|1|||
128877785|NCT00196976|463846339|FG006|Primary Study|Withdrawal by Subject|0|||
128877786|NCT00196976|463846340|FG007|Primary Study|Withdrawal by Subject|0|||
128877787|NCT00196976|463846341|FG008|Primary Study|Withdrawal by Subject|0|||
128877788|NCT00196976|463846342|FG009|Primary Study|Withdrawal by Subject|1|||
128877789|NCT00196976|463846343|FG010|Primary Study|Withdrawal by Subject|0|||
128877790|NCT00196976|463846344|FG011|Primary Study|Withdrawal by Subject|0|||
128877791|NCT00196976|463846345|FG012|Primary Study|Withdrawal by Subject|0|||
128877792|NCT00196976|463846346|FG013|Primary Study|Withdrawal by Subject|0|||
128877793|NCT00196976|463846333|FG000|Primary Study|Lost to Follow-up|0|||
128877794|NCT00196976|463846334|FG001|Primary Study|Lost to Follow-up|0|||
128877795|NCT00196976|463846335|FG002|Primary Study|Lost to Follow-up|0|||
128877796|NCT00196976|463846336|FG003|Primary Study|Lost to Follow-up|0|||
128877797|NCT00196976|463846337|FG004|Primary Study|Lost to Follow-up|1|||
128877798|NCT00196976|463846338|FG005|Primary Study|Lost to Follow-up|1|||
128877799|NCT00196976|463846339|FG006|Primary Study|Lost to Follow-up|0|||
128877800|NCT00196976|463846340|FG007|Primary Study|Lost to Follow-up|2|||
128877801|NCT00196976|463846341|FG008|Primary Study|Lost to Follow-up|0|||
128877802|NCT00196976|463846342|FG009|Primary Study|Lost to Follow-up|0|||
128877803|NCT00196976|463846343|FG010|Primary Study|Lost to Follow-up|0|||
128877804|NCT00196976|463846344|FG011|Primary Study|Lost to Follow-up|0|||
128877805|NCT00196976|463846345|FG012|Primary Study|Lost to Follow-up|0|||
128877806|NCT00196976|463846346|FG013|Primary Study|Lost to Follow-up|0|||
128877807|NCT00196976|463846333|FG000|Primary Study|Other|0|||
128994008|NCT00756652|464268513|FG000|Re-Op Phase|Site Closed|2454|||
128994009|NCT00756652|464268514|FG001|Re-Op Phase|Site Closed|0|||
128994010|NCT00756652|464268513|FG000|Re-Op Phase|Withdrawn after explant|14|||
128994011|NCT00756652|464268514|FG001|Re-Op Phase|Withdrawn after explant|0|||
128994012|NCT02564952|464268515|FG000|Overall Study|Adverse Event|6|||
128994013|NCT02564952|464268515|FG000|Overall Study|Lost to Follow-up|1|||
128994014|NCT02564952|464268515|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
128994015|NCT02564952|464268515|FG000|Overall Study|Withdrawal by Subject|1|||
128994016|NCT02564952|464268515|FG000|Overall Study|Low Efficacy|1|||
128994017|NCT02564952|464268515|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
128994018|NCT00038467|464268516|FG000|Overall Study|Adverse Event|170|||
128994019|NCT00038467|464268517|FG001|Overall Study|Adverse Event|145|||
128994020|NCT00038467|464268516|FG000|Overall Study|Withdrawal by Subject|150|||
128994021|NCT00038467|464268517|FG001|Overall Study|Withdrawal by Subject|107|||
128994022|NCT00038467|464268516|FG000|Overall Study|Protocol Violation|19|||
128994023|NCT00038467|464268517|FG001|Overall Study|Protocol Violation|22|||
128994024|NCT00038467|464268516|FG000|Overall Study|Death|22|||
128994025|NCT00038467|464268517|FG001|Overall Study|Death|16|||
128994026|NCT00038467|464268516|FG000|Overall Study|Lost to Follow-up|15|||
128994027|NCT00038467|464268517|FG001|Overall Study|Lost to Follow-up|10|||
128994028|NCT00038467|464268516|FG000|Overall Study|Recurrence|109|||
128994029|NCT00038467|464268517|FG001|Overall Study|Recurrence|179|||
128994030|NCT00038467|464268516|FG000|Overall Study|Randomized, but not treated|31|||
128994031|NCT00038467|464268517|FG001|Overall Study|Randomized, but not treated|35|||
128994032|NCT00038467|464268516|FG000|Overall Study|Other|26|||
128994033|NCT00038467|464268517|FG001|Overall Study|Other|28|||
128994034|NCT01988493|464268518|FG000|Overall Study|Randomized but not treated|0|||
128994035|NCT01988493|464268519|FG001|Overall Study|Randomized but not treated|0|||
128994036|NCT01988493|464268520|FG002|Overall Study|Randomized but not treated|0|||
128994037|NCT01988493|464268521|FG003|Overall Study|Randomized but not treated|0|||
128994038|NCT01988493|464268522|FG004|Overall Study|Randomized but not treated|1|||
128994039|NCT00627458|464268523|FG000|Overall Study|Migrated from study area|1|||
128994040|NCT00627458|464268524|FG001|Overall Study|Migrated from study area|0|||
128994041|NCT00627458|464268525|FG002|Overall Study|Migrated from study area|1|||
128994042|NCT00627458|464268523|FG000|Overall Study|Withdrawal by Subject|2|||
128994043|NCT00627458|464268524|FG001|Overall Study|Withdrawal by Subject|6|||
128994044|NCT00627458|464268525|FG002|Overall Study|Withdrawal by Subject|5|||
128994045|NCT00627458|464268523|FG000|Overall Study|Lost to Follow-up|1|||
128994046|NCT00627458|464268524|FG001|Overall Study|Lost to Follow-up|1|||
128994047|NCT00627458|464268525|FG002|Overall Study|Lost to Follow-up|0|||
128994048|NCT02617446|464268529|FG000|Overall Study|Withdrawal by Subject|0|||
128994049|NCT02617446|464268530|FG001|Overall Study|Withdrawal by Subject|2|||
128994050|NCT02617446|464268531|FG002|Overall Study|Withdrawal by Subject|0|||
128994051|NCT02617446|464268529|FG000|Overall Study|Adverse Event|1|||
128994052|NCT02617446|464268530|FG001|Overall Study|Adverse Event|0|||
128994053|NCT02617446|464268531|FG002|Overall Study|Adverse Event|5|||
128994054|NCT02617446|464268529|FG000|Overall Study|Lost to Follow-up|3|||
128994055|NCT02617446|464268530|FG001|Overall Study|Lost to Follow-up|0|||
128994056|NCT02617446|464268531|FG002|Overall Study|Lost to Follow-up|0|||
128994057|NCT02617446|464268529|FG000|Overall Study|Death|0|||
128994058|NCT02617446|464268530|FG001|Overall Study|Death|0|||
128994059|NCT02617446|464268531|FG002|Overall Study|Death|2|||
128994060|NCT00530088|464268532|FG000|Overall Study|Disease Progression|4|||
128994061|NCT00530088|464268532|FG000|Overall Study|Physician Decision|4|||
128994062|NCT00530088|464268532|FG000|Overall Study|Other Not Specified|2|||
128994063|NCT00902278|464268533|FG000|Overall Study|Physician Decision|1|||
128994064|NCT00902278|464268534|FG001|Overall Study|Physician Decision|0|||
128994065|NCT00902278|464268535|FG002|Overall Study|Physician Decision|2|||
128994066|NCT00902278|464268536|FG003|Overall Study|Physician Decision|0|||
128994067|NCT00902278|464268537|FG004|Overall Study|Physician Decision|1|||
128994068|NCT00902278|464268533|FG000|Overall Study|Lost to Follow-up|3|||
128994069|NCT00902278|464268534|FG001|Overall Study|Lost to Follow-up|2|||
128994070|NCT00902278|464268535|FG002|Overall Study|Lost to Follow-up|3|||
128994071|NCT00902278|464268536|FG003|Overall Study|Lost to Follow-up|0|||
128994072|NCT00902278|464268537|FG004|Overall Study|Lost to Follow-up|1|||
128994073|NCT04822701|464268544|FG000|Overall Study|Not treated|2|||
128994074|NCT04822701|464268545|FG001|Overall Study|Not treated|0|||
128994075|NCT04822701|464268544|FG000|Overall Study|Lost to Follow-up|1|||
128994076|NCT04822701|464268545|FG001|Overall Study|Lost to Follow-up|0|||
128994077|NCT04822701|464268544|FG000|Overall Study|Withdrawal by Subject|1|||
128994078|NCT04822701|464268545|FG001|Overall Study|Withdrawal by Subject|0|||
128994079|NCT01726335|464270046|FG000|Overall Study|Lost to Follow-up|2|||
128994080|NCT01726335|464270046|FG000|Overall Study|Withdrawal by Subject|15|||
128994081|NCT01726335|464270046|FG000|Overall Study|Adverse Event|4|||
128994082|NCT01726335|464270046|FG000|Overall Study|Lost to Follow-up|2|||
128994083|NCT01726335|464270046|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
128994084|NCT01796860|464270052|FG000|Overall Study|Withdrawal by Subject|3|||
128994085|NCT01396161|464270054|FG000|Overall Study|Withdrawal by Subject|0|||
128994086|NCT01396161|464270055|FG001|Overall Study|Withdrawal by Subject|0|||
128994087|NCT01396161|464270056|FG002|Overall Study|Withdrawal by Subject|0|||
128994088|NCT01396161|464270057|FG003|Overall Study|Withdrawal by Subject|0|||
128994089|NCT01396161|464270058|FG004|Overall Study|Withdrawal by Subject|1|||
128994090|NCT01396161|464270059|FG005|Overall Study|Withdrawal by Subject|0|||
128994091|NCT01396161|464270060|FG006|Overall Study|Withdrawal by Subject|0|||
128994092|NCT01396161|464270054|FG000|Overall Study|Other|0|||
128994093|NCT01396161|464270055|FG001|Overall Study|Other|0|||
128994094|NCT01396161|464270056|FG002|Overall Study|Other|0|||
128994095|NCT01396161|464270057|FG003|Overall Study|Other|0|||
128994096|NCT01396161|464270058|FG004|Overall Study|Other|0|||
128994097|NCT01396161|464270059|FG005|Overall Study|Other|0|||
128994098|NCT01396161|464270060|FG006|Overall Study|Other|1|||
128994099|NCT03543046|464270069|FG000|Overall Study|Adverse Event|1|||
128994100|NCT03543046|464270070|FG001|Overall Study|Adverse Event|1|||
128994101|NCT03543046|464270069|FG000|Overall Study|Physician Decision|1|||
128994102|NCT03543046|464270070|FG001|Overall Study|Physician Decision|1|||
128994103|NCT03543046|464270069|FG000|Overall Study|Protocol Violation|1|||
128994104|NCT03543046|464270070|FG001|Overall Study|Protocol Violation|0|||
128994105|NCT03869684|464270071|FG000|Overall Study|Adverse Event|0|||
128994106|NCT03869684|464270072|FG001|Overall Study|Adverse Event|3|||
128994107|NCT03869684|464270073|FG002|Overall Study|Adverse Event|1|||
128994108|NCT03869684|464270071|FG000|Overall Study|Withdrawal by Subject|1|||
128994109|NCT03869684|464270072|FG001|Overall Study|Withdrawal by Subject|0|||
128994110|NCT03869684|464270073|FG002|Overall Study|Withdrawal by Subject|0|||
128994111|NCT03869684|464270071|FG000|Overall Study|Lost to Follow-up|1|||
128994112|NCT03869684|464270072|FG001|Overall Study|Lost to Follow-up|0|||
128994113|NCT03869684|464270073|FG002|Overall Study|Lost to Follow-up|0|||
128994114|NCT03869684|464270071|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
128994115|NCT03869684|464270072|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
128994116|NCT03869684|464270073|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
128994117|NCT01227954|464270078|FG000|Overall Study|Protocol Violation|6|||
128994118|NCT01227954|464270078|FG000|Overall Study|No protocol treatment|7|||
128994119|NCT01414062|464270083|FG000|Overall Study|Lost to Follow-up|3|||
128994120|NCT01414062|464270084|FG001|Overall Study|Lost to Follow-up|2|||
128994121|NCT01414062|464270083|FG000|Overall Study|Left Country|1|||
128994122|NCT01414062|464270084|FG001|Overall Study|Left Country|1|||
128994123|NCT01414062|464270083|FG000|Overall Study|Family Disapproval|1|||
128994124|NCT01414062|464270084|FG001|Overall Study|Family Disapproval|0|||
128994125|NCT01414062|464270083|FG000|Overall Study|Withdrawal by Subject|0|||
128994126|NCT01414062|464270084|FG001|Overall Study|Withdrawal by Subject|1|||
128994127|NCT02787785|464270087|FG000|Overall Study|Death|3|||
128994128|NCT02787785|464270088|FG001|Overall Study|Death|4|||
128994129|NCT02787785|464270087|FG000|Overall Study|Lost to Follow-up|1|||
128994130|NCT02787785|464270088|FG001|Overall Study|Lost to Follow-up|1|||
128994131|NCT02787785|464270087|FG000|Overall Study|Withdrawal by Subject|0|||
128994132|NCT02787785|464270088|FG001|Overall Study|Withdrawal by Subject|5|||
128994133|NCT01850108|464270091|FG000|Overall Study|Lost to Follow-up|4|||
128994134|NCT01850108|464270091|FG000|Overall Study|Not eligible|1|||
128994135|NCT01850108|464270091|FG000|Overall Study|Failed engraftment|2|||
128994136|NCT01850108|464270091|FG000|Overall Study|Physician Decision|1|||
128994137|NCT04330482|464270096|FG000|Overall Study|Lost to Follow-up|2|||
128994138|NCT04330482|464270097|FG001|Overall Study|Lost to Follow-up|1|||
128994139|NCT04330482|464270096|FG000|Overall Study|Withdrawal by Subject|0|||
128994140|NCT04330482|464270097|FG001|Overall Study|Withdrawal by Subject|3|||
128994141|NCT05144477|464270099|FG000|Overall Study|Withdrawal by Subject|1|||
128994142|NCT05144477|464270100|FG001|Overall Study|Withdrawal by Subject|1|||
128994143|NCT04333199|464270103|FG000|Evaluated Patients|Lost to Follow-up|0|||
128994144|NCT04333199|464270104|FG001|Evaluated Patients|Lost to Follow-up|1|||
128994145|NCT04333199|464270105|FG002|Evaluated Patients|Lost to Follow-up|2|||
128994146|NCT02268045|464270114|FG000|Overall Study|Death|4|||
128994147|NCT02268045|464270115|FG001|Overall Study|Death|4|||
128994148|NCT02268045|464270114|FG000|Overall Study|Disease Progression|2|||
128994149|NCT02268045|464270115|FG001|Overall Study|Disease Progression|1|||
128994150|NCT02268045|464270114|FG000|Overall Study|Adverse Event|7|||
128994151|NCT02268045|464270115|FG001|Overall Study|Adverse Event|7|||
128994152|NCT02268045|464270114|FG000|Overall Study|Withdrawal by Subject|2|||
128994153|NCT02268045|464270115|FG001|Overall Study|Withdrawal by Subject|6|||
128994154|NCT02268045|464270114|FG000|Overall Study|Physician Decision|0|||
128994155|NCT02268045|464270115|FG001|Overall Study|Physician Decision|1|||
128994156|NCT02268045|464270114|FG000|Overall Study|Protocol Violation|1|||
128994157|NCT02268045|464270115|FG001|Overall Study|Protocol Violation|1|||
128994158|NCT01766310|464270116|FG000|Overall Study|Lost to Follow-up|1|||
128994159|NCT01766310|464270117|FG001|Overall Study|Lost to Follow-up|3|||
128994160|NCT01154673|464270118|FG000|Overall Study|Lost to Follow-up|1|||
128994161|NCT01154673|464270119|FG001|Overall Study|Lost to Follow-up|0|||
128994162|NCT01154673|464270118|FG000|Overall Study|moved out of province|1|||
128994163|NCT01154673|464270119|FG001|Overall Study|moved out of province|0|||
128994164|NCT00646282|464270120|FG000|Overall Study|Protocol terminated|4|||
128994165|NCT00646282|464270121|FG001|Overall Study|Protocol terminated|4|||
128994166|NCT01556490|464270122|FG000|Randomized Patients Summary|Protocol Violation|22|||
128994167|NCT01556490|464270123|FG001|Randomized Patients Summary|Protocol Violation|23|||
128994168|NCT01556490|464270122|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
128994169|NCT01556490|464270123|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
128994170|NCT01289990|464270127|FG000|Overall Study|Death|0|||
128994171|NCT01289990|464270128|FG001|Overall Study|Death|0|||
128994172|NCT01289990|464270129|FG002|Overall Study|Death|0|||
128994173|NCT01289990|464270130|FG003|Overall Study|Death|1|||
128994174|NCT01289990|464270131|FG004|Overall Study|Death|2|||
128994175|NCT01289990|464270132|FG005|Overall Study|Death|1|||
128994176|NCT01289990|464270133|FG006|Overall Study|Death|0|||
128994177|NCT01289990|464270134|FG007|Overall Study|Death|0|||
128994178|NCT01289990|464270135|FG008|Overall Study|Death|0|||
128994179|NCT01289990|464270136|FG009|Overall Study|Death|0|||
128994180|NCT01289990|464270137|FG010|Overall Study|Death|0|||
128994181|NCT01289990|464270138|FG011|Overall Study|Death|1|||
128994182|NCT01289990|464270139|FG012|Overall Study|Death|0|||
128994183|NCT01289990|464270127|FG000|Overall Study|Lost to Follow-up|3|||
128994184|NCT01289990|464270128|FG001|Overall Study|Lost to Follow-up|2|||
128994185|NCT01289990|464270129|FG002|Overall Study|Lost to Follow-up|5|||
128994186|NCT01289990|464270130|FG003|Overall Study|Lost to Follow-up|5|||
128994187|NCT01289990|464270131|FG004|Overall Study|Lost to Follow-up|3|||
128994188|NCT01289990|464270132|FG005|Overall Study|Lost to Follow-up|4|||
128994189|NCT01289990|464270133|FG006|Overall Study|Lost to Follow-up|2|||
128994190|NCT01289990|464270134|FG007|Overall Study|Lost to Follow-up|2|||
128994191|NCT01289990|464270135|FG008|Overall Study|Lost to Follow-up|1|||
128994192|NCT01289990|464270136|FG009|Overall Study|Lost to Follow-up|4|||
128994193|NCT01289990|464270137|FG010|Overall Study|Lost to Follow-up|2|||
128994194|NCT01289990|464270138|FG011|Overall Study|Lost to Follow-up|1|||
128994195|NCT01289990|464270139|FG012|Overall Study|Lost to Follow-up|2|||
128994196|NCT01289990|464270127|FG000|Overall Study|Withdrawal by Subject|15|||
128994197|NCT01289990|464270128|FG001|Overall Study|Withdrawal by Subject|14|||
128994198|NCT01289990|464270129|FG002|Overall Study|Withdrawal by Subject|12|||
128994199|NCT01289990|464270130|FG003|Overall Study|Withdrawal by Subject|13|||
128994200|NCT01289990|464270131|FG004|Overall Study|Withdrawal by Subject|8|||
128994201|NCT01289990|464270132|FG005|Overall Study|Withdrawal by Subject|7|||
128994202|NCT01289990|464270133|FG006|Overall Study|Withdrawal by Subject|13|||
128994203|NCT01289990|464270134|FG007|Overall Study|Withdrawal by Subject|9|||
128994204|NCT01289990|464270135|FG008|Overall Study|Withdrawal by Subject|12|||
128994205|NCT01289990|464270136|FG009|Overall Study|Withdrawal by Subject|13|||
128994206|NCT01289990|464270137|FG010|Overall Study|Withdrawal by Subject|11|||
128994207|NCT01289990|464270138|FG011|Overall Study|Withdrawal by Subject|13|||
128994208|NCT01289990|464270139|FG012|Overall Study|Withdrawal by Subject|16|||
128994209|NCT01289990|464270127|FG000|Overall Study|discontinued in preceding trial|18|||
128994210|NCT01289990|464270128|FG001|Overall Study|discontinued in preceding trial|20|||
128994211|NCT01289990|464270129|FG002|Overall Study|discontinued in preceding trial|41|||
128994212|NCT01289990|464270130|FG003|Overall Study|discontinued in preceding trial|17|||
128994213|NCT01289990|464270131|FG004|Overall Study|discontinued in preceding trial|11|||
128994214|NCT01289990|464270132|FG005|Overall Study|discontinued in preceding trial|12|||
128994215|NCT01289990|464270133|FG006|Overall Study|discontinued in preceding trial|18|||
128877808|NCT00196976|463846334|FG001|Primary Study|Other|0|||
128877809|NCT00196976|463846335|FG002|Primary Study|Other|2|||
128877810|NCT00196976|463846336|FG003|Primary Study|Other|0|||
128877811|NCT00196976|463846337|FG004|Primary Study|Other|0|||
128877812|NCT00196976|463846338|FG005|Primary Study|Other|0|||
128877813|NCT00196976|463846339|FG006|Primary Study|Other|0|||
128877814|NCT00196976|463846340|FG007|Primary Study|Other|0|||
128877815|NCT00196976|463846341|FG008|Primary Study|Other|0|||
128877816|NCT00196976|463846342|FG009|Primary Study|Other|0|||
128877817|NCT00196976|463846343|FG010|Primary Study|Other|0|||
128877818|NCT00196976|463846344|FG011|Primary Study|Other|0|||
128877819|NCT00196976|463846345|FG012|Primary Study|Other|0|||
128877820|NCT00196976|463846346|FG013|Primary Study|Other|0|||
128877821|NCT00196976|463846333|FG000|Booster Study|Withdrawal by Subject|0|||
128877822|NCT00196976|463846334|FG001|Booster Study|Withdrawal by Subject|0|||
128877823|NCT00196976|463846335|FG002|Booster Study|Withdrawal by Subject|0|||
128877824|NCT00196976|463846336|FG003|Booster Study|Withdrawal by Subject|0|||
128994216|NCT01289990|464270134|FG007|Overall Study|discontinued in preceding trial|8|||
128994217|NCT01289990|464270135|FG008|Overall Study|discontinued in preceding trial|17|||
128994218|NCT01289990|464270136|FG009|Overall Study|discontinued in preceding trial|21|||
128994219|NCT01289990|464270137|FG010|Overall Study|discontinued in preceding trial|17|||
128994220|NCT01289990|464270138|FG011|Overall Study|discontinued in preceding trial|17|||
128994221|NCT01289990|464270139|FG012|Overall Study|discontinued in preceding trial|24|||
128994222|NCT01289990|464270127|FG000|Overall Study|did not continue in extension|41|||
128994223|NCT01289990|464270128|FG001|Overall Study|did not continue in extension|45|||
128994224|NCT01289990|464270129|FG002|Overall Study|did not continue in extension|51|||
128994225|NCT01289990|464270130|FG003|Overall Study|did not continue in extension|51|||
128994226|NCT01289990|464270131|FG004|Overall Study|did not continue in extension|48|||
128994227|NCT01289990|464270132|FG005|Overall Study|did not continue in extension|50|||
128994228|NCT01289990|464270133|FG006|Overall Study|did not continue in extension|54|||
128994229|NCT01289990|464270134|FG007|Overall Study|did not continue in extension|36|||
128994230|NCT01289990|464270135|FG008|Overall Study|did not continue in extension|44|||
128994231|NCT01289990|464270136|FG009|Overall Study|did not continue in extension|48|||
128994232|NCT01289990|464270137|FG010|Overall Study|did not continue in extension|45|||
128994233|NCT01289990|464270138|FG011|Overall Study|did not continue in extension|34|||
128994234|NCT01289990|464270139|FG012|Overall Study|did not continue in extension|56|||
128994235|NCT01289990|464270127|FG000|Overall Study|Not treated|0|||
128994236|NCT01289990|464270128|FG001|Overall Study|Not treated|0|||
128994237|NCT01289990|464270129|FG002|Overall Study|Not treated|0|||
128994238|NCT01289990|464270130|FG003|Overall Study|Not treated|0|||
128994239|NCT01289990|464270131|FG004|Overall Study|Not treated|0|||
128994240|NCT01289990|464270132|FG005|Overall Study|Not treated|0|||
128994241|NCT01289990|464270133|FG006|Overall Study|Not treated|1|||
128994242|NCT01289990|464270134|FG007|Overall Study|Not treated|0|||
128994243|NCT01289990|464270135|FG008|Overall Study|Not treated|1|||
128994244|NCT01289990|464270136|FG009|Overall Study|Not treated|0|||
128994245|NCT01289990|464270137|FG010|Overall Study|Not treated|1|||
128994246|NCT01289990|464270138|FG011|Overall Study|Not treated|2|||
128994247|NCT01289990|464270139|FG012|Overall Study|Not treated|0|||
128994248|NCT00683904|464270140|FG000|Dose Level 1|Disease progression|2|||
128994249|NCT00683904|464270141|FG001|Dose Level 1|Disease progression|0|||
128994250|NCT00683904|464270140|FG000|Dose Level 1|Adverse Event|1|||
128994251|NCT00683904|464270141|FG001|Dose Level 1|Adverse Event|0|||
128994252|NCT00683904|464270140|FG000|Dose Level 2|Adverse Event|0|||
128994253|NCT00683904|464270141|FG001|Dose Level 2|Adverse Event|2|||
128994254|NCT01488071|464270142|FG000|Overall Study|Adverse Event|15|||
128994255|NCT01488071|464270143|FG001|Overall Study|Adverse Event|23|||
128994256|NCT01488071|464270142|FG000|Overall Study|Lack of Efficacy|11|||
128994257|NCT01488071|464270143|FG001|Overall Study|Lack of Efficacy|17|||
128994258|NCT01488071|464270142|FG000|Overall Study|Non-compliance with study drug|2|||
128994259|NCT01488071|464270143|FG001|Overall Study|Non-compliance with study drug|0|||
128994260|NCT01488071|464270142|FG000|Overall Study|Protocol Violation|5|||
128994261|NCT01488071|464270143|FG001|Overall Study|Protocol Violation|7|||
128994262|NCT01488071|464270142|FG000|Overall Study|Withdrawal of Consent|14|||
128994263|NCT01488071|464270143|FG001|Overall Study|Withdrawal of Consent|12|||
128994264|NCT01488071|464270142|FG000|Overall Study|Lost to Follow-up|1|||
128994265|NCT01488071|464270143|FG001|Overall Study|Lost to Follow-up|0|||
128994266|NCT01488071|464270142|FG000|Overall Study|Administrative or Other Reason(s)|5|||
128994267|NCT01488071|464270143|FG001|Overall Study|Administrative or Other Reason(s)|4|||
128994268|NCT02587325|464270144|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
128994269|NCT02587325|464270145|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
128994270|NCT02587325|464270146|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
128994271|NCT02587325|464270147|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
128994272|NCT02587325|464270148|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
128994273|NCT02587325|464270144|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
128994274|NCT02587325|464270145|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
128994275|NCT02587325|464270146|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
128994276|NCT02587325|464270147|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
128994277|NCT02587325|464270148|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
128994278|NCT02587325|464270144|FG000|32-Week Optional Extension Part|Adverse Event|0|||
128994279|NCT02587325|464270145|FG001|32-Week Optional Extension Part|Adverse Event|0|||
128994280|NCT02587325|464270146|FG002|32-Week Optional Extension Part|Adverse Event|1|||
128994281|NCT02587325|464270147|FG003|32-Week Optional Extension Part|Adverse Event|0|||
128994282|NCT02587325|464270148|FG004|32-Week Optional Extension Part|Adverse Event|0|||
128994283|NCT02587325|464270144|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
128994284|NCT02587325|464270145|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
128994285|NCT02587325|464270146|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
128994286|NCT02587325|464270147|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
128994287|NCT02587325|464270148|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
128994288|NCT01831596|464270149|FG000|Overall Study|Other|8|||
128994289|NCT02524665|464270153|FG000|Overall Study|Lost to Follow-up|1|||
128994290|NCT02602080|464270154|FG000|Overall Study|Protocol Violation|6|||
128994291|NCT02602080|464270155|FG001|Overall Study|Protocol Violation|1|||
128994292|NCT02602080|464270156|FG002|Overall Study|Protocol Violation|3|||
128994293|NCT04355767|464270162|FG000|Overall Study|Withdrawal by Subject|2|||
128994294|NCT04355767|464270163|FG001|Overall Study|Withdrawal by Subject|2|||
128994295|NCT04355767|464270162|FG000|Overall Study|Death|5|||
128994296|NCT04355767|464270163|FG001|Overall Study|Death|1|||
128994297|NCT01999322|464270164|FG000|Overall Study|Adverse Event|1|||
128994298|NCT01999322|464270165|FG001|Overall Study|Adverse Event|0|||
128994299|NCT02200614|464270166|FG000|Double Blind Treatment|Adverse Event|86|||
128994300|NCT02200614|464270167|FG001|Double Blind Treatment|Adverse Event|48|||
128994301|NCT02200614|464270166|FG000|Double Blind Treatment|Confirmed metastasis|120|||
128994302|NCT02200614|464270167|FG001|Double Blind Treatment|Confirmed metastasis|140|||
128994303|NCT02200614|464270166|FG000|Double Blind Treatment|Judgment of the investigator|59|||
128994304|NCT02200614|464270167|FG001|Double Blind Treatment|Judgment of the investigator|99|||
128994305|NCT02200614|464270166|FG000|Double Blind Treatment|Metastasis by local reading|1|||
128994306|NCT02200614|464270167|FG001|Double Blind Treatment|Metastasis by local reading|3|||
128994307|NCT02200614|464270166|FG000|Double Blind Treatment|Other reason|6|||
128994308|NCT02200614|464270167|FG001|Double Blind Treatment|Other reason|2|||
128994309|NCT02200614|464270166|FG000|Double Blind Treatment|Personal reason|77|||
128994310|NCT02200614|464270167|FG001|Double Blind Treatment|Personal reason|85|||
128994311|NCT02200614|464270166|FG000|Double Blind Treatment|Protocol deviation|14|||
128994312|NCT02200614|464270167|FG001|Double Blind Treatment|Protocol deviation|7|||
128994313|NCT02200614|464270166|FG000|Double Blind Treatment|Not treated|1|||
128994314|NCT02200614|464270167|FG001|Double Blind Treatment|Not treated|0|||
128994315|NCT02200614|464270166|FG000|Open Label|Adverse Event|41|||
128994316|NCT02200614|464270167|FG001|Open Label|Adverse Event|11|||
128994317|NCT02200614|464270166|FG000|Open Label|Confirmed metastasis|1|||
128994318|NCT02200614|464270167|FG001|Open Label|Confirmed metastasis|0|||
128994319|NCT02200614|464270166|FG000|Open Label|Judgment of the investigator|29|||
128994320|NCT02200614|464270167|FG001|Open Label|Judgment of the investigator|2|||
128994321|NCT02200614|464270166|FG000|Open Label|Metastasis by local reading|138|||
128994322|NCT02200614|464270167|FG001|Open Label|Metastasis by local reading|27|||
128994323|NCT02200614|464270166|FG000|Open Label|Other reason|22|||
128994324|NCT02200614|464270167|FG001|Open Label|Other reason|4|||
128994325|NCT02200614|464270166|FG000|Open Label|Personal reason|60|||
128994326|NCT02200614|464270167|FG001|Open Label|Personal reason|8|||
128994327|NCT02200614|464270166|FG000|Open Label|Protocol deviation|3|||
128994328|NCT02200614|464270167|FG001|Open Label|Protocol deviation|2|||
128994329|NCT02200614|464270166|FG000|Open Label|Missing|2|||
128994330|NCT02200614|464270167|FG001|Open Label|Missing|2|||
128994331|NCT03302299|464272148|FG000|Overall Study|Protocol Violation|1|||
128994332|NCT00391092|464272149|FG000|Overall Study|Death|78|||
128994333|NCT00391092|464272150|FG001|Overall Study|Death|81|||
128763085|NCT03145766|463422735|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
128763086|NCT03145766|463422736|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
128763087|NCT03145766|463422737|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
128763088|NCT03145766|463422733|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
128994334|NCT00391092|464272149|FG000|Overall Study|Lost to Follow-up|13|||
128994335|NCT00391092|464272150|FG001|Overall Study|Lost to Follow-up|18|||
128994336|NCT00391092|464272149|FG000|Overall Study|Alive on treatment|29|||
128763089|NCT03145766|463422734|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
128763090|NCT03145766|463422735|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
128763091|NCT03145766|463422736|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
128763092|NCT03145766|463422737|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
128994337|NCT00391092|464272150|FG001|Overall Study|Alive on treatment|33|||
128994338|NCT00391092|464272149|FG000|Overall Study|Alive in follow-up|88|||
128994339|NCT00391092|464272150|FG001|Overall Study|Alive in follow-up|84|||
128994340|NCT04318535|464272151|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
128994341|NCT04318535|464272152|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
128994342|NCT04318535|464272153|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
128994343|NCT01901146|464272155|FG000|Neoadjuvant Phase|Death|1|||
128994344|NCT01901146|464272156|FG001|Neoadjuvant Phase|Death|2|||
128994345|NCT01901146|464272157|FG002|Neoadjuvant Phase|Death|0|||
128994346|NCT01901146|464272158|FG003|Neoadjuvant Phase|Death|0|||
128994347|NCT01901146|464272159|FG004|Neoadjuvant Phase|Death|0|||
128994348|NCT01901146|464272155|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
128994349|NCT01901146|464272156|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
128994350|NCT01901146|464272157|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
128994351|NCT01901146|464272158|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
128994352|NCT01901146|464272159|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
128994353|NCT01901146|464272155|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
128994354|NCT01901146|464272156|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
128994355|NCT01901146|464272157|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
128994356|NCT01901146|464272158|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
128994357|NCT01901146|464272159|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
128994358|NCT01901146|464272155|FG000|Neoadjuvant Phase|Physician Decision|1|||
128994359|NCT01901146|464272156|FG001|Neoadjuvant Phase|Physician Decision|2|||
128994360|NCT01901146|464272157|FG002|Neoadjuvant Phase|Physician Decision|0|||
128994361|NCT01901146|464272158|FG003|Neoadjuvant Phase|Physician Decision|0|||
128994362|NCT01901146|464272159|FG004|Neoadjuvant Phase|Physician Decision|0|||
128994363|NCT01901146|464272155|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
128994364|NCT01901146|464272156|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
128994365|NCT01901146|464272157|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
128994366|NCT01901146|464272158|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
128994367|NCT01901146|464272159|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
128994368|NCT01901146|464272155|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
128994369|NCT01901146|464272156|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
128994370|NCT01901146|464272157|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
128994371|NCT01901146|464272158|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
128994372|NCT01901146|464272159|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
128994373|NCT01901146|464272155|FG000|Adjuvant Phase|Other|0|||
128994374|NCT01901146|464272156|FG001|Adjuvant Phase|Other|0|||
128994375|NCT01901146|464272157|FG002|Adjuvant Phase|Other|1|||
128994376|NCT01901146|464272158|FG003|Adjuvant Phase|Other|0|||
128994377|NCT01901146|464272159|FG004|Adjuvant Phase|Other|0|||
128994378|NCT01901146|464272155|FG000|Adjuvant Phase|Death|0|||
128994379|NCT01901146|464272156|FG001|Adjuvant Phase|Death|0|||
128994380|NCT01901146|464272157|FG002|Adjuvant Phase|Death|0|||
128994381|NCT01901146|464272158|FG003|Adjuvant Phase|Death|0|||
128994382|NCT01901146|464272159|FG004|Adjuvant Phase|Death|3|||
128994383|NCT01901146|464272155|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
128994384|NCT01901146|464272156|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
128994385|NCT01901146|464272157|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
128994386|NCT01901146|464272158|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
128994387|NCT01901146|464272159|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
128994388|NCT01901146|464272155|FG000|Adjuvant Phase|Physician Decision|0|||
128994389|NCT01901146|464272156|FG001|Adjuvant Phase|Physician Decision|0|||
128994390|NCT01901146|464272157|FG002|Adjuvant Phase|Physician Decision|9|||
128994391|NCT01901146|464272158|FG003|Adjuvant Phase|Physician Decision|2|||
128994392|NCT01901146|464272159|FG004|Adjuvant Phase|Physician Decision|4|||
128994393|NCT01901146|464272155|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
128994394|NCT01901146|464272156|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
128994395|NCT01901146|464272157|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
128994396|NCT01901146|464272158|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
128994397|NCT01901146|464272159|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
128994398|NCT02996448|464272162|FG000|Overall Study|Study terminated due to adverse effects|3|||
128994399|NCT00606801|464272163|FG000|Intervention|Protocol Violation|3|||
128994400|NCT00606801|464272164|FG001|Intervention|Protocol Violation|3|||
128994401|NCT00303316|464272167|FG000|Overall Study|Protocol Violation|1|||
128994402|NCT00303316|464272168|FG001|Overall Study|Protocol Violation|0|||
128994403|NCT00303316|464272167|FG000|Overall Study|Lost to Follow-up|0|||
128994404|NCT00303316|464272168|FG001|Overall Study|Lost to Follow-up|1|||
128994405|NCT00303316|464272167|FG000|Overall Study|Withdrawal by Subject|1|||
128994406|NCT00303316|464272168|FG001|Overall Study|Withdrawal by Subject|2|||
128994407|NCT01586624|464272169|FG000|Overall Study|Adverse Event|3|||
128994408|NCT01586624|464272170|FG001|Overall Study|Adverse Event|0|||
128994409|NCT01586624|464272171|FG002|Overall Study|Adverse Event|2|||
128994410|NCT01586624|464272172|FG003|Overall Study|Adverse Event|1|||
128994411|NCT01586624|464272173|FG004|Overall Study|Adverse Event|3|||
128994412|NCT01586624|464272174|FG005|Overall Study|Adverse Event|3|||
128994413|NCT01586624|464272175|FG006|Overall Study|Adverse Event|2|||
128994414|NCT01586624|464272176|FG007|Overall Study|Adverse Event|3|||
128994415|NCT01586624|464272169|FG000|Overall Study|Physician Decision|0|||
128994416|NCT01586624|464272170|FG001|Overall Study|Physician Decision|1|||
128994417|NCT01586624|464272171|FG002|Overall Study|Physician Decision|1|||
128994418|NCT01586624|464272172|FG003|Overall Study|Physician Decision|0|||
128994419|NCT01586624|464272173|FG004|Overall Study|Physician Decision|2|||
128994420|NCT01586624|464272174|FG005|Overall Study|Physician Decision|0|||
128994421|NCT01586624|464272175|FG006|Overall Study|Physician Decision|1|||
128994422|NCT01586624|464272176|FG007|Overall Study|Physician Decision|1|||
128994423|NCT01586624|464272169|FG000|Overall Study|Withdrawal by Subject|0|||
128994424|NCT01586624|464272170|FG001|Overall Study|Withdrawal by Subject|0|||
128994425|NCT01586624|464272171|FG002|Overall Study|Withdrawal by Subject|0|||
128994426|NCT01586624|464272172|FG003|Overall Study|Withdrawal by Subject|1|||
128994427|NCT01586624|464272173|FG004|Overall Study|Withdrawal by Subject|0|||
128994428|NCT01586624|464272174|FG005|Overall Study|Withdrawal by Subject|0|||
128994429|NCT01586624|464272175|FG006|Overall Study|Withdrawal by Subject|0|||
128994430|NCT01586624|464272176|FG007|Overall Study|Withdrawal by Subject|0|||
128994431|NCT01586624|464272169|FG000|Overall Study|Evidence of disease progression|1|||
128994432|NCT01586624|464272170|FG001|Overall Study|Evidence of disease progression|3|||
128994433|NCT01586624|464272171|FG002|Overall Study|Evidence of disease progression|2|||
128994434|NCT01586624|464272172|FG003|Overall Study|Evidence of disease progression|5|||
128994435|NCT01586624|464272173|FG004|Overall Study|Evidence of disease progression|3|||
128994436|NCT01586624|464272174|FG005|Overall Study|Evidence of disease progression|5|||
128994437|NCT01586624|464272175|FG006|Overall Study|Evidence of disease progression|4|||
128994438|NCT01586624|464272176|FG007|Overall Study|Evidence of disease progression|6|||
128994439|NCT01586624|464272169|FG000|Overall Study|Screen failure (no treatment received)|0|||
128994440|NCT01586624|464272170|FG001|Overall Study|Screen failure (no treatment received)|0|||
128994441|NCT01586624|464272171|FG002|Overall Study|Screen failure (no treatment received)|0|||
128994442|NCT01586624|464272172|FG003|Overall Study|Screen failure (no treatment received)|0|||
128994443|NCT01586624|464272173|FG004|Overall Study|Screen failure (no treatment received)|0|||
128994444|NCT01586624|464272174|FG005|Overall Study|Screen failure (no treatment received)|0|||
128994445|NCT01586624|464272175|FG006|Overall Study|Screen failure (no treatment received)|1|||
128994446|NCT01586624|464272176|FG007|Overall Study|Screen failure (no treatment received)|0|||
128994447|NCT01160198|464272179|FG000|Overall Study|Withdrawal by Subject|2|||
128994448|NCT01160198|464272180|FG001|Overall Study|Withdrawal by Subject|1|||
128994449|NCT01160198|464272181|FG002|Overall Study|Withdrawal by Subject|0|||
128994450|NCT01160198|464272179|FG000|Overall Study|Adverse Event|0|||
128994451|NCT01160198|464272180|FG001|Overall Study|Adverse Event|1|||
128994452|NCT01160198|464272181|FG002|Overall Study|Adverse Event|0|||
128994453|NCT01160198|464272179|FG000|Overall Study|Lost to Follow-up|0|||
128994454|NCT01160198|464272180|FG001|Overall Study|Lost to Follow-up|1|||
128994455|NCT01160198|464272181|FG002|Overall Study|Lost to Follow-up|0|||
128994456|NCT01160198|464272179|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
128994457|NCT01160198|464272180|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
128994458|NCT01160198|464272181|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
128994459|NCT02016755|464272183|FG000|Overall Study|Major amputation of index limb|2|||
128994460|NCT02016755|464272183|FG000|Overall Study|Adverse Event|2|||
128994461|NCT02016755|464272183|FG000|Overall Study|Physician Decision|1|||
128994462|NCT02016755|464272183|FG000|Overall Study|Death|2|||
128994463|NCT00306852|464272187|FG000|Overall Study|Death|14|||
128994464|NCT00306852|464272188|FG001|Overall Study|Death|14|||
128994465|NCT00306852|464272187|FG000|Overall Study|Lost to Follow-up|15|||
128994466|NCT00306852|464272188|FG001|Overall Study|Lost to Follow-up|24|||
128994467|NCT03343054|464272190|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
128994468|NCT03343054|464272191|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
128994469|NCT03343054|464272192|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
128994470|NCT03343054|464272190|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
128994471|NCT03343054|464272191|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
128994472|NCT03343054|464272192|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
128994473|NCT03343054|464272190|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
128994474|NCT03343054|464272191|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
128994475|NCT03343054|464272192|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
128994476|NCT03343054|464272190|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
128994477|NCT03343054|464272191|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
128994478|NCT03343054|464272192|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
128994479|NCT01467570|464272193|FG000|Overall Study|Lost to Follow-up|8|||
128994480|NCT01467570|464272194|FG001|Overall Study|Lost to Follow-up|9|||
128994481|NCT02626182|464272195|FG000|Overall Study|Adverse Event|2|||
128994482|NCT02626182|464272196|FG001|Overall Study|Adverse Event|0|||
128994483|NCT02766088|464272199|FG000|Overall Study|Sponsor study termination|498|||
128994484|NCT02766088|464272199|FG000|Overall Study|Migrated/moved from the study area|1|||
128994485|NCT02766088|464272199|FG000|Overall Study|Lost to Follow-up|5|||
128994486|NCT02766088|464272199|FG000|Overall Study|Other|1|||
128994487|NCT02766088|464272199|FG000|Overall Study|Death|1|||
128994488|NCT01222715|464272200|FG000|Overall Study|Adverse Event|0|||
128994489|NCT01222715|464272201|FG001|Overall Study|Adverse Event|4|||
128994490|NCT01222715|464272200|FG000|Overall Study|Death|0|||
128994491|NCT01222715|464272201|FG001|Overall Study|Death|1|||
128994492|NCT01222715|464272200|FG000|Overall Study|Lack of Efficacy|22|||
128994493|NCT01222715|464272201|FG001|Overall Study|Lack of Efficacy|14|||
128994494|NCT01222715|464272200|FG000|Overall Study|Physician Decision|12|||
128994495|NCT01222715|464272201|FG001|Overall Study|Physician Decision|2|||
128994496|NCT01222715|464272200|FG000|Overall Study|Refusal of further protocol therapy|0|||
128994497|NCT01222715|464272201|FG001|Overall Study|Refusal of further protocol therapy|4|||
128994498|NCT01222715|464272200|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
128994499|NCT01222715|464272201|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
128994500|NCT01222715|464272200|FG000|Overall Study|Ineligible|0|||
128994501|NCT01222715|464272201|FG001|Overall Study|Ineligible|1|||
128994502|NCT01222715|464272200|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
128994503|NCT01222715|464272201|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
128994504|NCT03555890|464272210|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
128994505|NCT03555890|464272211|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
128994506|NCT03555890|464272212|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
128994507|NCT03555890|464272213|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
128994508|NCT03372369|464272214|FG000|Qualification Period|Withdrawal by Subject|16|||
128994509|NCT03372369|464272215|FG001|Qualification Period|Withdrawal by Subject|13|||
128994510|NCT03372369|464272214|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
128994511|NCT03372369|464272215|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
128994512|NCT03372369|464272214|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
128994513|NCT03372369|464272215|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
128994514|NCT02239601|464272216|FG000|Overall Study|Withdrawal by Subject|3|||
128994515|NCT02239601|464272217|FG001|Overall Study|Withdrawal by Subject|4|||
128994516|NCT02239601|464272216|FG000|Overall Study|Protocol Violation|4|||
128994517|NCT02239601|464272217|FG001|Overall Study|Protocol Violation|2|||
128994518|NCT01508325|464272218|FG000|Overall Study|Withdrawal by Subject|8|||
128994519|NCT01508325|464272219|FG001|Overall Study|Withdrawal by Subject|9|||
128994520|NCT01508325|464272218|FG000|Overall Study|Protocol Violation|0|||
128994521|NCT01508325|464272219|FG001|Overall Study|Protocol Violation|3|||
128994522|NCT01508325|464272218|FG000|Overall Study|Physician Decision|2|||
128994523|NCT01508325|464272219|FG001|Overall Study|Physician Decision|1|||
128994524|NCT01508325|464272218|FG000|Overall Study|Adverse Event|1|||
128994525|NCT01508325|464272219|FG001|Overall Study|Adverse Event|0|||
128994526|NCT01508325|464272218|FG000|Overall Study|Lost to Follow-up|5|||
128994527|NCT01508325|464272219|FG001|Overall Study|Lost to Follow-up|6|||
128994528|NCT01508325|464272218|FG000|Overall Study|Other|2|||
128994529|NCT01508325|464272219|FG001|Overall Study|Other|2|||
128994530|NCT04682639|464272220|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
128994531|NCT04682639|464272221|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
128994532|NCT04682639|464272222|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
128994533|NCT04682639|464272223|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
128994534|NCT04682639|464272224|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
128994535|NCT04682639|464272220|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
128994536|NCT04682639|464272221|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
128994537|NCT04682639|464272222|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
128994538|NCT04682639|464272223|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128994539|NCT04682639|464272224|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128994540|NCT04682639|464272220|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
128994541|NCT04682639|464272221|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
128994542|NCT04682639|464272222|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128994543|NCT04682639|464272223|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128994544|NCT04682639|464272224|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128994545|NCT04682639|464272220|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
128994546|NCT04682639|464272221|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
128994547|NCT04682639|464272222|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
128994548|NCT04682639|464272223|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
128994549|NCT04682639|464272224|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
128994550|NCT04682639|464272220|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
128994551|NCT04682639|464272221|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
128994552|NCT04682639|464272222|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
128994553|NCT04682639|464272223|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
128994554|NCT04682639|464272224|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
128994555|NCT04682639|464272220|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
128994556|NCT04682639|464272221|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
128994557|NCT04682639|464272222|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
128994558|NCT04682639|464272223|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
128994559|NCT04682639|464272224|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
128994560|NCT04682639|464272220|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
128994561|NCT04682639|464272221|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
128994562|NCT04682639|464272222|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
128994563|NCT04682639|464272223|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
128994564|NCT04682639|464272224|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
128994565|NCT04682639|464272220|FG000|OLE Period (28 Weeks)|Other|1|||
128994566|NCT04682639|464272221|FG001|OLE Period (28 Weeks)|Other|2|||
128994567|NCT04682639|464272222|FG002|OLE Period (28 Weeks)|Other|0|||
128994568|NCT04682639|464272223|FG003|OLE Period (28 Weeks)|Other|0|||
128994569|NCT04682639|464272224|FG004|OLE Period (28 Weeks)|Other|1|||
128994570|NCT04682639|464272220|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
128994571|NCT04682639|464272221|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
128994572|NCT04682639|464272222|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
128994573|NCT04682639|464272223|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
128994574|NCT04682639|464272224|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
128994575|NCT04682639|464272220|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
128994576|NCT04682639|464272221|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
128994577|NCT04682639|464272222|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
128994578|NCT04682639|464272223|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
128994579|NCT04682639|464272224|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
128994580|NCT04682639|464272220|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
128994581|NCT04682639|464272221|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
128994582|NCT04682639|464272222|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
128994583|NCT04682639|464272223|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
128994584|NCT04682639|464272224|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
128994585|NCT04682639|464272220|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
128994586|NCT04682639|464272221|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
128994587|NCT04682639|464272222|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
128994588|NCT04682639|464272223|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
128994589|NCT04682639|464272224|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
128994590|NCT00883740|464272225|FG000|First Intervention|Lost to Follow-up|1|||
128994591|NCT00883740|464272226|FG001|First Intervention|Lost to Follow-up|0|||
128994592|NCT00883740|464272225|FG000|First Intervention|No longer willing to participate|2|||
128994593|NCT00883740|464272226|FG001|First Intervention|No longer willing to participate|0|||
128994594|NCT00883740|464272225|FG000|First Intervention|Protocol Violation|3|||
128994595|NCT00883740|464272226|FG001|First Intervention|Protocol Violation|6|||
128994596|NCT00883740|464272225|FG000|First Intervention|Adverse Event|1|||
128994597|NCT00883740|464272226|FG001|First Intervention|Adverse Event|2|||
128994598|NCT00883740|464272225|FG000|Second Intervention|Protocol Violation|1|||
128994599|NCT00883740|464272226|FG001|Second Intervention|Protocol Violation|0|||
128994600|NCT00883740|464272225|FG000|Second Intervention|No longer willing to participate|0|||
128994601|NCT00883740|464272226|FG001|Second Intervention|No longer willing to participate|1|||
128994602|NCT01392170|464272227|FG000|Overall Study|Withdrawal by Subject|1|||
128994603|NCT01392170|464272227|FG000|Overall Study|Ineligible|1|||
128994604|NCT04056299|464272236|FG000|Overall Study|Sponsor discontinued study|3|||
128994605|NCT04056299|464272237|FG001|Overall Study|Sponsor discontinued study|3|||
128994606|NCT03174925|464272240|FG000|Overall Study|Elastographic images not retrievable|2|||
128994607|NCT03174925|464272240|FG000|Overall Study|Elastography image not interpretable|1|||
128994608|NCT04247594|464272243|FG000|Overall Study|Withdrawal by Subject|4|||
128994609|NCT02748616|464272249|FG000|Overall Study|Lost to Follow-up|1|||
128994610|NCT02748616|464272249|FG000|Overall Study|Withdrawal by Subject|2|||
128994611|NCT02748616|464272249|FG000|Overall Study|Physician Decision|2|||
128994612|NCT02748616|464272249|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
128994613|NCT01296152|464272251|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
128994614|NCT04057118|464272254|FG000|Overall Study|Adverse Event|1|||
128994615|NCT04057118|464272255|FG001|Overall Study|Adverse Event|0|||
128994616|NCT04057118|464272256|FG002|Overall Study|Adverse Event|1|||
128994617|NCT04057118|464272257|FG003|Overall Study|Adverse Event|1|||
128994618|NCT04057118|464272254|FG000|Overall Study|Physician Decision|0|||
128994619|NCT04057118|464272255|FG001|Overall Study|Physician Decision|0|||
128994620|NCT04057118|464272256|FG002|Overall Study|Physician Decision|1|||
128994621|NCT04057118|464272257|FG003|Overall Study|Physician Decision|1|||
128994622|NCT04057118|464272254|FG000|Overall Study|Withdrawal by Subject|2|||
128994623|NCT04057118|464272255|FG001|Overall Study|Withdrawal by Subject|2|||
128994624|NCT04057118|464272256|FG002|Overall Study|Withdrawal by Subject|0|||
128994625|NCT04057118|464272257|FG003|Overall Study|Withdrawal by Subject|2|||
128994626|NCT04057118|464272254|FG000|Overall Study|Not Specific|0|||
128994627|NCT04057118|464272255|FG001|Overall Study|Not Specific|0|||
128994628|NCT04057118|464272256|FG002|Overall Study|Not Specific|1|||
128994629|NCT04057118|464272257|FG003|Overall Study|Not Specific|1|||
128994630|NCT04736576|464272258|FG000|Overall Study|Progressive disease|3|||
128994631|NCT04736576|464272259|FG001|Overall Study|Progressive disease|1|||
128994632|NCT04736576|464272258|FG000|Overall Study|Death|1|||
128994633|NCT04736576|464272259|FG001|Overall Study|Death|0|||
128994634|NCT03273712|464272260|FG000|Overall Study|Death|5|||
128994635|NCT03273712|464272260|FG000|Overall Study|Adverse Event|1|||
128994636|NCT03273712|464272260|FG000|Overall Study|Disease Progression|1|||
128994637|NCT00190684|464272261|FG000|Overall Study|Adverse Event|86|||
128994638|NCT00190684|464272261|FG000|Overall Study|Satisfactory response|80|||
128994639|NCT00190684|464272261|FG000|Overall Study|Lack of efficacy|204|||
128994640|NCT00190684|464272261|FG000|Overall Study|Lost to Follow-up|232|||
128994641|NCT00190684|464272261|FG000|Overall Study|Patient moved|60|||
128994642|NCT00190684|464272261|FG000|Overall Study|Patient Decision|432|||
128994643|NCT00190684|464272261|FG000|Overall Study|Clinical relapse|67|||
128994644|NCT00190684|464272261|FG000|Overall Study|Sponsor's decision|17|||
128994645|NCT00190684|464272261|FG000|Overall Study|Physician Decision|84|||
128994646|NCT00190684|464272261|FG000|Overall Study|Protocol Violation|123|||
128994647|NCT00190684|464272261|FG000|Overall Study|Study Period III Completed|103|||
128994648|NCT00190684|464272261|FG000|Overall Study|Study Period V Completed|1|||
128994649|NCT00829439|464272267|FG000|Overall Study|Adverse Event|0|||
128994650|NCT00829439|464272268|FG001|Overall Study|Adverse Event|0|||
128994651|NCT00829439|464272269|FG002|Overall Study|Adverse Event|1|||
128994652|NCT00829439|464272270|FG003|Overall Study|Adverse Event|0|||
128994653|NCT01155284|464272271|FG000|Overall Study|Withdrawal by Subject|4|||
128994654|NCT01155284|464272272|FG001|Overall Study|Withdrawal by Subject|3|||
128994655|NCT01155284|464272271|FG000|Overall Study|Lost to Follow-up|1|||
128994656|NCT01155284|464272272|FG001|Overall Study|Lost to Follow-up|2|||
128994657|NCT01155284|464272271|FG000|Overall Study|Physician Decision|1|||
128994658|NCT01155284|464272272|FG001|Overall Study|Physician Decision|0|||
128994659|NCT01155284|464272271|FG000|Overall Study|Adverse Event|1|||
128994660|NCT01155284|464272272|FG001|Overall Study|Adverse Event|0|||
128994661|NCT04529499|464272283|FG000|Overall Study|Withdrawal by Subject|9|||
128994662|NCT04529499|464272284|FG001|Overall Study|Withdrawal by Subject|11|||
128994663|NCT04529499|464272283|FG000|Overall Study|Physician Decision|1|||
128994664|NCT04529499|464272284|FG001|Overall Study|Physician Decision|2|||
128994665|NCT04529499|464272283|FG000|Overall Study|Adverse Event|4|||
128994666|NCT04529499|464272284|FG001|Overall Study|Adverse Event|4|||
128994667|NCT04529499|464272283|FG000|Overall Study|Death|14|||
128994668|NCT04529499|464272284|FG001|Overall Study|Death|11|||
128994669|NCT04529499|464272283|FG000|Overall Study|Lost to Follow-up|1|||
128994670|NCT04529499|464272284|FG001|Overall Study|Lost to Follow-up|1|||
128994671|NCT04529499|464272283|FG000|Overall Study|Others|7|||
128994672|NCT04529499|464272284|FG001|Overall Study|Others|11|||
128994673|NCT00758706|464272285|FG000|Overall Study|Adverse Event|4|||
128994674|NCT00758706|464272286|FG001|Overall Study|Adverse Event|4|||
128994675|NCT01494649|464272287|FG000|Overall Study|Lost to Follow-up|0|||
128994676|NCT01494649|464272288|FG001|Overall Study|Lost to Follow-up|1|||
128994677|NCT03467971|464272289|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128994678|NCT03467971|464272290|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128994679|NCT01174368|464272293|FG000|Overall Study|Withdrawal by Subject|1|||
128994680|NCT05789420|464272294|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
128994681|NCT05789420|464272294|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
128994682|NCT01220128|464272295|FG000|Overall Study|Progressive disease|0|||
128994683|NCT01220128|464272296|FG001|Overall Study|Progressive disease|0|||
128994684|NCT01220128|464272297|FG002|Overall Study|Progressive disease|2|||
128994685|NCT01220128|464272298|FG003|Overall Study|Progressive disease|0|||
128994686|NCT01220128|464272299|FG004|Overall Study|Progressive disease|0|||
128994687|NCT01220128|464272300|FG005|Overall Study|Progressive disease|0|||
128994688|NCT01220128|464272301|FG006|Overall Study|Progressive disease|0|||
128994689|NCT01220128|464272295|FG000|Overall Study|Sponsor study termination|0|||
128994690|NCT01220128|464272296|FG001|Overall Study|Sponsor study termination|1|||
128994691|NCT01220128|464272297|FG002|Overall Study|Sponsor study termination|0|||
128994692|NCT01220128|464272298|FG003|Overall Study|Sponsor study termination|0|||
128994693|NCT01220128|464272299|FG004|Overall Study|Sponsor study termination|0|||
128994694|NCT01220128|464272300|FG005|Overall Study|Sponsor study termination|0|||
128994695|NCT01220128|464272301|FG006|Overall Study|Sponsor study termination|1|||
128994696|NCT01220128|464272295|FG000|Overall Study|Adverse event, serious fatal|2|||
128994697|NCT01220128|464272296|FG001|Overall Study|Adverse event, serious fatal|0|||
128994698|NCT01220128|464272297|FG002|Overall Study|Adverse event, serious fatal|0|||
128994699|NCT01220128|464272298|FG003|Overall Study|Adverse event, serious fatal|0|||
128994700|NCT01220128|464272299|FG004|Overall Study|Adverse event, serious fatal|0|||
128994701|NCT01220128|464272300|FG005|Overall Study|Adverse event, serious fatal|0|||
128994702|NCT01220128|464272301|FG006|Overall Study|Adverse event, serious fatal|1|||
128994703|NCT01220128|464272295|FG000|Overall Study|Adverse event, non-fatal|1|||
128994704|NCT01220128|464272296|FG001|Overall Study|Adverse event, non-fatal|0|||
128994705|NCT01220128|464272297|FG002|Overall Study|Adverse event, non-fatal|0|||
128994706|NCT01220128|464272298|FG003|Overall Study|Adverse event, non-fatal|0|||
128994707|NCT01220128|464272299|FG004|Overall Study|Adverse event, non-fatal|0|||
128994708|NCT01220128|464272300|FG005|Overall Study|Adverse event, non-fatal|0|||
128994709|NCT01220128|464272301|FG006|Overall Study|Adverse event, non-fatal|3|||
128994710|NCT01220128|464272295|FG000|Overall Study|Other|0|||
128994711|NCT01220128|464272296|FG001|Overall Study|Other|0|||
128994712|NCT01220128|464272297|FG002|Overall Study|Other|1|||
128994713|NCT01220128|464272298|FG003|Overall Study|Other|0|||
128994714|NCT01220128|464272299|FG004|Overall Study|Other|0|||
128994715|NCT01220128|464272300|FG005|Overall Study|Other|0|||
128994716|NCT01220128|464272301|FG006|Overall Study|Other|0|||
128994717|NCT01220128|464272295|FG000|Overall Study|Consent withdrawn by subject|1|||
128994718|NCT01220128|464272296|FG001|Overall Study|Consent withdrawn by subject|0|||
128994719|NCT01220128|464272297|FG002|Overall Study|Consent withdrawn by subject|0|||
128994720|NCT01220128|464272298|FG003|Overall Study|Consent withdrawn by subject|0|||
128994721|NCT01220128|464272299|FG004|Overall Study|Consent withdrawn by subject|0|||
128994722|NCT01220128|464272300|FG005|Overall Study|Consent withdrawn by subject|0|||
128994723|NCT01220128|464272301|FG006|Overall Study|Consent withdrawn by subject|0|||
128994724|NCT00000135|464272324|FG000|Overall Study|Death|27|||
128994725|NCT00000135|464272325|FG001|Overall Study|Death|14|||
128994726|NCT02340078|464272326|FG000|Overall Study|Protocol Violation|1|||
128994727|NCT00567996|464272327|FG000|Overall Study|Adverse Event|18|||
128994728|NCT00567996|464272328|FG001|Overall Study|Adverse Event|16|||
128994729|NCT00567996|464272329|FG002|Overall Study|Adverse Event|13|||
128994730|NCT00567996|464272327|FG000|Overall Study|Protocol Deviation|9|||
128994731|NCT00567996|464272328|FG001|Overall Study|Protocol Deviation|11|||
128994732|NCT00567996|464272329|FG002|Overall Study|Protocol Deviation|13|||
128994733|NCT00567996|464272327|FG000|Overall Study|Withdrawal by Subject|8|||
128994734|NCT00567996|464272328|FG001|Overall Study|Withdrawal by Subject|12|||
128994735|NCT00567996|464272329|FG002|Overall Study|Withdrawal by Subject|22|||
128994736|NCT00567996|464272327|FG000|Overall Study|Abnormal Lab value(s)|2|||
128994737|NCT00567996|464272328|FG001|Overall Study|Abnormal Lab value(s)|1|||
128994738|NCT00567996|464272329|FG002|Overall Study|Abnormal Lab value(s)|2|||
128994739|NCT00567996|464272327|FG000|Overall Study|Abnormal test procedure result(s)|2|||
128994740|NCT00567996|464272328|FG001|Overall Study|Abnormal test procedure result(s)|1|||
128994741|NCT00567996|464272329|FG002|Overall Study|Abnormal test procedure result(s)|1|||
128994742|NCT00567996|464272327|FG000|Overall Study|Lost to Follow-up|2|||
128994743|NCT00567996|464272328|FG001|Overall Study|Lost to Follow-up|5|||
128994744|NCT00567996|464272329|FG002|Overall Study|Lost to Follow-up|2|||
128994745|NCT00567996|464272327|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128994746|NCT00567996|464272328|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128994747|NCT00567996|464272329|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
128994748|NCT00567996|464272327|FG000|Overall Study|Administrative problems|1|||
128994749|NCT00567996|464272328|FG001|Overall Study|Administrative problems|1|||
128994750|NCT00567996|464272329|FG002|Overall Study|Administrative problems|0|||
128994751|NCT00567996|464272327|FG000|Overall Study|Death|1|||
128994752|NCT00567996|464272328|FG001|Overall Study|Death|0|||
128994753|NCT00567996|464272329|FG002|Overall Study|Death|2|||
128994754|NCT00567996|464272327|FG000|Overall Study|Patient's inability to use the device|0|||
128994755|NCT00567996|464272328|FG001|Overall Study|Patient's inability to use the device|1|||
128994756|NCT00567996|464272329|FG002|Overall Study|Patient's inability to use the device|0|||
128994757|NCT00883129|464272330|FG000|Overall Study|Adverse Event|7|||
128994758|NCT00883129|464272331|FG001|Overall Study|Adverse Event|15|||
128994759|NCT00883129|464272330|FG000|Overall Study|Withdrawal by Subject|8|||
128994760|NCT00883129|464272331|FG001|Overall Study|Withdrawal by Subject|9|||
128994761|NCT00883129|464272330|FG000|Overall Study|Non-compliance|3|||
128994762|NCT00883129|464272331|FG001|Overall Study|Non-compliance|6|||
128994763|NCT00883129|464272330|FG000|Overall Study|Lost to Follow-up|1|||
128994764|NCT00883129|464272331|FG001|Overall Study|Lost to Follow-up|2|||
128994765|NCT00883129|464272330|FG000|Overall Study|Death|1|||
128994766|NCT00883129|464272331|FG001|Overall Study|Death|2|||
128994767|NCT00883129|464272330|FG000|Overall Study|Defined Treatment Failure|0|||
128994768|NCT00883129|464272331|FG001|Overall Study|Defined Treatment Failure|2|||
128994769|NCT01898884|464272332|FG000|Multiple Dose Period|Adverse Event|0|||
128994770|NCT01898884|464272333|FG001|Multiple Dose Period|Adverse Event|0|||
128994771|NCT01898884|464272334|FG002|Multiple Dose Period|Adverse Event|0|||
128994772|NCT01898884|464272335|FG003|Multiple Dose Period|Adverse Event|0|||
128994773|NCT01898884|464272336|FG004|Multiple Dose Period|Adverse Event|0|||
128994774|NCT01898884|464272337|FG005|Multiple Dose Period|Adverse Event|0|||
128994775|NCT01898884|464272338|FG006|Multiple Dose Period|Adverse Event|1|||
128994776|NCT01898884|464272339|FG007|Multiple Dose Period|Adverse Event|0|||
128994777|NCT01898884|464272340|FG008|Multiple Dose Period|Adverse Event|0|||
128994778|NCT01898884|464272332|FG000|Multiple Dose Period|Randomized Not Treated|0|||
128994779|NCT01898884|464272333|FG001|Multiple Dose Period|Randomized Not Treated|0|||
128994780|NCT01898884|464272334|FG002|Multiple Dose Period|Randomized Not Treated|0|||
128994781|NCT01898884|464272335|FG003|Multiple Dose Period|Randomized Not Treated|0|||
128994782|NCT01898884|464272336|FG004|Multiple Dose Period|Randomized Not Treated|0|||
128994783|NCT01898884|464272337|FG005|Multiple Dose Period|Randomized Not Treated|0|||
128994784|NCT01898884|464272338|FG006|Multiple Dose Period|Randomized Not Treated|0|||
128994785|NCT01898884|464272339|FG007|Multiple Dose Period|Randomized Not Treated|0|||
128994786|NCT01898884|464272340|FG008|Multiple Dose Period|Randomized Not Treated|1|||
128994787|NCT01614925|464273719|FG000|Overall Study|Withdrawal by Subject|1|||
128994788|NCT01614925|464273720|FG001|Overall Study|Withdrawal by Subject|0|||
128994789|NCT01614925|464273719|FG000|Overall Study|Protocol Violation|3|||
128994790|NCT01614925|464273720|FG001|Overall Study|Protocol Violation|2|||
128994791|NCT02437890|464273721|FG000|Overall Study|Non-compliance to study drug|0|||
128877825|NCT00196976|463846337|FG004|Booster Study|Withdrawal by Subject|0|||
128994792|NCT02437890|464273722|FG001|Overall Study|Non-compliance to study drug|1|||
128994793|NCT02437890|464273723|FG002|Overall Study|Non-compliance to study drug|0|||
128994794|NCT02437890|464273724|FG003|Overall Study|Non-compliance to study drug|0|||
128994795|NCT02437890|464273725|FG004|Overall Study|Non-compliance to study drug|1|||
128994796|NCT02437890|464273721|FG000|Overall Study|Sponsor's decision|1|||
128994797|NCT02437890|464273722|FG001|Overall Study|Sponsor's decision|1|||
128994798|NCT02437890|464273723|FG002|Overall Study|Sponsor's decision|4|||
128994799|NCT02437890|464273724|FG003|Overall Study|Sponsor's decision|0|||
128994800|NCT02437890|464273725|FG004|Overall Study|Sponsor's decision|2|||
128994801|NCT02437890|464273721|FG000|Overall Study|Physician Decision|0|||
128994802|NCT02437890|464273722|FG001|Overall Study|Physician Decision|0|||
128994803|NCT02437890|464273723|FG002|Overall Study|Physician Decision|0|||
128994804|NCT02437890|464273724|FG003|Overall Study|Physician Decision|1|||
128994805|NCT02437890|464273725|FG004|Overall Study|Physician Decision|0|||
128994806|NCT02437890|464273721|FG000|Overall Study|Unable to attend visit(s)|1|||
128994807|NCT02437890|464273722|FG001|Overall Study|Unable to attend visit(s)|0|||
128994808|NCT02437890|464273723|FG002|Overall Study|Unable to attend visit(s)|0|||
128994809|NCT02437890|464273724|FG003|Overall Study|Unable to attend visit(s)|0|||
128994810|NCT02437890|464273725|FG004|Overall Study|Unable to attend visit(s)|0|||
128994811|NCT02437890|464273721|FG000|Overall Study|Lack of Efficacy|1|||
128994812|NCT02437890|464273722|FG001|Overall Study|Lack of Efficacy|3|||
128994813|NCT02437890|464273723|FG002|Overall Study|Lack of Efficacy|0|||
128994814|NCT02437890|464273724|FG003|Overall Study|Lack of Efficacy|3|||
128994815|NCT02437890|464273725|FG004|Overall Study|Lack of Efficacy|1|||
128994816|NCT02437890|464273721|FG000|Overall Study|Adverse Event|4|||
128994817|NCT02437890|464273722|FG001|Overall Study|Adverse Event|9|||
128994818|NCT02437890|464273723|FG002|Overall Study|Adverse Event|5|||
128994819|NCT02437890|464273724|FG003|Overall Study|Adverse Event|11|||
128994820|NCT02437890|464273725|FG004|Overall Study|Adverse Event|7|||
128994821|NCT02437890|464273721|FG000|Overall Study|Withdrawal by Subject|1|||
128994822|NCT02437890|464273722|FG001|Overall Study|Withdrawal by Subject|2|||
128994823|NCT02437890|464273723|FG002|Overall Study|Withdrawal by Subject|6|||
128994824|NCT02437890|464273724|FG003|Overall Study|Withdrawal by Subject|5|||
128994825|NCT02437890|464273725|FG004|Overall Study|Withdrawal by Subject|5|||
128994826|NCT02437890|464273721|FG000|Overall Study|Death|0|||
128994827|NCT02437890|464273722|FG001|Overall Study|Death|0|||
128994828|NCT02437890|464273723|FG002|Overall Study|Death|0|||
128994829|NCT02437890|464273724|FG003|Overall Study|Death|2|||
128994830|NCT02437890|464273725|FG004|Overall Study|Death|0|||
128994831|NCT01422720|464273726|FG000|Overall Study|Adverse Event|16|||
128994832|NCT01422720|464273726|FG000|Overall Study|Lack of Efficacy|1|||
128994833|NCT01422720|464273726|FG000|Overall Study|Withdrawal by Subject|4|||
128994834|NCT01422720|464273726|FG000|Overall Study|Ineligibility|1|||
128994835|NCT01074307|464273728|FG000|Overall Study|No primary endpoint evaluation|14|||
128994836|NCT01074307|464273729|FG001|Overall Study|No primary endpoint evaluation|6|||
128994837|NCT01074307|464273728|FG000|Overall Study|Exclusion criterion|0|||
128994838|NCT01074307|464273729|FG001|Overall Study|Exclusion criterion|1|||
128994839|NCT01074307|464273728|FG000|Overall Study|Protocol Violation|8|||
128994840|NCT01074307|464273729|FG001|Overall Study|Protocol Violation|5|||
128994841|NCT02162511|464273734|FG000|Overall Study|Lack of Efficacy|0|||
128994842|NCT02162511|464273735|FG001|Overall Study|Lack of Efficacy|0|||
128994843|NCT02162511|464273736|FG002|Overall Study|Lack of Efficacy|2|||
128994844|NCT00802529|464273737|FG000|Overall Study|Lost to Follow-up|0|||
128994845|NCT00802529|464273738|FG001|Overall Study|Lost to Follow-up|1|||
128994846|NCT00552617|464273740|FG000|Overall Study|Not Treated|0|||
128994847|NCT00552617|464273741|FG001|Overall Study|Not Treated|0|||
128994848|NCT00552617|464273742|FG002|Overall Study|Not Treated|1|||
128994849|NCT00552617|464273743|FG003|Overall Study|Not Treated|0|||
128994850|NCT00552617|464273744|FG004|Overall Study|Not Treated|0|||
128994851|NCT00552617|464273745|FG005|Overall Study|Not Treated|0|||
128994852|NCT00552617|464273746|FG006|Overall Study|Not Treated|0|||
128994853|NCT00552617|464273747|FG007|Overall Study|Not Treated|0|||
128994854|NCT00552617|464273748|FG008|Overall Study|Not Treated|0|||
128994855|NCT00552617|464273749|FG009|Overall Study|Not Treated|1|||
128994856|NCT00552617|464273740|FG000|Overall Study|Lost to Follow-up|0|||
128994857|NCT00552617|464273741|FG001|Overall Study|Lost to Follow-up|0|||
128994858|NCT00552617|464273742|FG002|Overall Study|Lost to Follow-up|0|||
128994859|NCT00552617|464273743|FG003|Overall Study|Lost to Follow-up|1|||
128994860|NCT00552617|464273744|FG004|Overall Study|Lost to Follow-up|0|||
128994861|NCT00552617|464273745|FG005|Overall Study|Lost to Follow-up|2|||
128994862|NCT00552617|464273746|FG006|Overall Study|Lost to Follow-up|0|||
128994863|NCT00552617|464273747|FG007|Overall Study|Lost to Follow-up|0|||
128994864|NCT00552617|464273748|FG008|Overall Study|Lost to Follow-up|2|||
128994865|NCT00552617|464273749|FG009|Overall Study|Lost to Follow-up|0|||
128994866|NCT00337129|464273757|FG000|Overall Study|Adverse Event|4|||
128994867|NCT00337129|464273757|FG000|Overall Study|Withdrawal by Subject|1|||
128994868|NCT00337129|464273757|FG000|Overall Study|Lack of Efficacy|32|||
128994869|NCT00337129|464273757|FG000|Overall Study|Death|2|||
128994870|NCT00337129|464273757|FG000|Overall Study|not protocol specified|1|||
128994871|NCT00563524|464273760|FG000|Overall Study|Adverse Event|0|||
128994872|NCT00563524|464273761|FG001|Overall Study|Adverse Event|1|||
128994873|NCT00563524|464273762|FG002|Overall Study|Adverse Event|0|||
128994874|NCT00563524|464273763|FG003|Overall Study|Adverse Event|0|||
128994875|NCT00563524|464273764|FG004|Overall Study|Adverse Event|2|||
128994876|NCT00563524|464273765|FG005|Overall Study|Adverse Event|0|||
128994877|NCT00563524|464273760|FG000|Overall Study|Lost to Follow-up|1|||
128994878|NCT00563524|464273761|FG001|Overall Study|Lost to Follow-up|0|||
128994879|NCT00563524|464273762|FG002|Overall Study|Lost to Follow-up|0|||
128994880|NCT00563524|464273763|FG003|Overall Study|Lost to Follow-up|0|||
128994881|NCT00563524|464273764|FG004|Overall Study|Lost to Follow-up|0|||
128994882|NCT00563524|464273765|FG005|Overall Study|Lost to Follow-up|0|||
128994883|NCT00563524|464273760|FG000|Overall Study|Protocol Violation|0|||
128994884|NCT00563524|464273761|FG001|Overall Study|Protocol Violation|1|||
128994885|NCT00563524|464273762|FG002|Overall Study|Protocol Violation|0|||
128994886|NCT00563524|464273763|FG003|Overall Study|Protocol Violation|0|||
128994887|NCT00563524|464273764|FG004|Overall Study|Protocol Violation|0|||
128994888|NCT00563524|464273765|FG005|Overall Study|Protocol Violation|0|||
128994889|NCT00563524|464273760|FG000|Overall Study|Withdrawal by Subject|1|||
128994890|NCT00563524|464273761|FG001|Overall Study|Withdrawal by Subject|1|||
128994891|NCT00563524|464273762|FG002|Overall Study|Withdrawal by Subject|3|||
128994892|NCT00563524|464273763|FG003|Overall Study|Withdrawal by Subject|0|||
128994893|NCT00563524|464273764|FG004|Overall Study|Withdrawal by Subject|0|||
128994894|NCT00563524|464273765|FG005|Overall Study|Withdrawal by Subject|1|||
128994895|NCT02360397|464273769|FG000|Overall Study|Incomplete screening|3|||
128994896|NCT02360397|464273769|FG000|Overall Study|Adverse Event|1|||
128994897|NCT01537549|464273770|FG000|Overall Study|Lost to Follow-up|1|||
128994898|NCT01537549|464273770|FG000|Overall Study|Withdrawal by Subject|2|||
128994899|NCT01286207|464273773|FG000|Overall Study|Adverse Event|27|||
128994900|NCT01286207|464273774|FG001|Overall Study|Adverse Event|41|||
128994901|NCT01286207|464273775|FG002|Overall Study|Adverse Event|8|||
128994902|NCT01286207|464273773|FG000|Overall Study|Lost to Follow-up|49|||
128994903|NCT01286207|464273774|FG001|Overall Study|Lost to Follow-up|43|||
128994904|NCT01286207|464273775|FG002|Overall Study|Lost to Follow-up|20|||
128994905|NCT01286207|464273773|FG000|Overall Study|Withdrawal by Subject|93|||
128994906|NCT01286207|464273774|FG001|Overall Study|Withdrawal by Subject|79|||
128994907|NCT01286207|464273775|FG002|Overall Study|Withdrawal by Subject|41|||
128994908|NCT01286207|464273773|FG000|Overall Study|Lack of Response|92|||
128994909|NCT01286207|464273774|FG001|Overall Study|Lack of Response|38|||
128994910|NCT01286207|464273775|FG002|Overall Study|Lack of Response|8|||
128994911|NCT01286207|464273773|FG000|Overall Study|Other|37|||
128994912|NCT01286207|464273774|FG001|Overall Study|Other|47|||
128994913|NCT01286207|464273775|FG002|Overall Study|Other|13|||
128994914|NCT01383954|464273776|FG000|Overall Study|Lack of Efficacy|2|||
128994915|NCT01383954|464273776|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
128994916|NCT01383954|464273776|FG000|Overall Study|Adverse Event|1|||
128994917|NCT01383954|464273776|FG000|Overall Study|Reason Not Specified|9|||
128994918|NCT00450177|464273777|FG000|Overall Study|Adverse Event|7|||
128994919|NCT00450177|464273778|FG001|Overall Study|Adverse Event|4|||
128994920|NCT00450177|464273777|FG000|Overall Study|Withdrawal by Subject|1|||
128994921|NCT00450177|464273778|FG001|Overall Study|Withdrawal by Subject|6|||
128994922|NCT00450177|464273777|FG000|Overall Study|Withdrawal by Primary Team|1|||
128994923|NCT00450177|464273778|FG001|Overall Study|Withdrawal by Primary Team|1|||
128994924|NCT00763269|464273781|FG000|Overall Study|Lost to Follow-up|12|||
128994925|NCT00763269|464273782|FG001|Overall Study|Lost to Follow-up|13|||
128994926|NCT00589693|464273783|FG000|Overall Study|randomized in error|12|||
128994927|NCT00589693|464273784|FG001|Overall Study|randomized in error|6|||
128994928|NCT00589693|464273783|FG000|Overall Study|Adverse Event|4|||
128994929|NCT00589693|464273784|FG001|Overall Study|Adverse Event|4|||
128994930|NCT00589693|464273783|FG000|Overall Study|Death|26|||
128994931|NCT00589693|464273784|FG001|Overall Study|Death|16|||
128994932|NCT00589693|464273783|FG000|Overall Study|Lack of Efficacy|0|||
128994933|NCT00589693|464273784|FG001|Overall Study|Lack of Efficacy|1|||
128994934|NCT00589693|464273783|FG000|Overall Study|Lost to Follow-up|1|||
128994935|NCT00589693|464273784|FG001|Overall Study|Lost to Follow-up|0|||
128994936|NCT00589693|464273783|FG000|Overall Study|Physician Decision|0|||
128994937|NCT00589693|464273784|FG001|Overall Study|Physician Decision|1|||
128994938|NCT00589693|464273783|FG000|Overall Study|Protocol Violation|1|||
128994939|NCT00589693|464273784|FG001|Overall Study|Protocol Violation|1|||
128994940|NCT03231709|464273785|FG000|Treatment Period 1|Reason not Specified|0|||
128994941|NCT03231709|464273786|FG001|Treatment Period 1|Reason not Specified|1|||
128994942|NCT03231709|464273785|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
128994943|NCT03231709|464273786|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
128994944|NCT02609178|464273787|FG000|First Crown|Withdrawal by Subject|0|||
128994945|NCT02609178|464273788|FG001|First Crown|Withdrawal by Subject|0|||
128994946|NCT02609178|464273789|FG002|First Crown|Withdrawal by Subject|1|||
128994947|NCT02609178|464273790|FG003|First Crown|Withdrawal by Subject|1|||
128994948|NCT02609178|464273791|FG004|First Crown|Withdrawal by Subject|0|||
128994949|NCT02609178|464273792|FG005|First Crown|Withdrawal by Subject|0|||
128994950|NCT01128153|464273793|FG000|Overall Study|Adverse Event|1|||
128994951|NCT01128153|464273794|FG001|Overall Study|Adverse Event|3|||
128994952|NCT01128153|464273793|FG000|Overall Study|Condition under investigation worsened|8|||
128994953|NCT01128153|464273794|FG001|Overall Study|Condition under investigation worsened|7|||
128994954|NCT01128153|464273793|FG000|Overall Study|Withdrawal by Subject|2|||
128994955|NCT01128153|464273794|FG001|Overall Study|Withdrawal by Subject|3|||
128994956|NCT01128153|464273793|FG000|Overall Study|Incorrect enrolment to study|2|||
128994957|NCT01128153|464273794|FG001|Overall Study|Incorrect enrolment to study|1|||
128994958|NCT01128153|464273793|FG000|Overall Study|Protocol Violation|2|||
128994959|NCT01128153|464273794|FG001|Overall Study|Protocol Violation|0|||
128994960|NCT01128153|464273793|FG000|Overall Study|Developed discontinuation criteria|1|||
128994961|NCT01128153|464273794|FG001|Overall Study|Developed discontinuation criteria|1|||
128994962|NCT02419469|464273795|FG000|Overall Study|Withdrawal by Subject|1|||
128994963|NCT01682512|464273796|FG000|Overall Study|Adverse Event|6|||
128994964|NCT01682512|464273797|FG001|Overall Study|Adverse Event|5|||
128994965|NCT01682512|464273798|FG002|Overall Study|Adverse Event|2|||
128994966|NCT01682512|464273796|FG000|Overall Study|Withdrawal by Subject|2|||
128994967|NCT01682512|464273797|FG001|Overall Study|Withdrawal by Subject|6|||
128994968|NCT01682512|464273798|FG002|Overall Study|Withdrawal by Subject|3|||
128994969|NCT01682512|464273796|FG000|Overall Study|Physician Decision|0|||
128994970|NCT01682512|464273797|FG001|Overall Study|Physician Decision|2|||
128994971|NCT01682512|464273798|FG002|Overall Study|Physician Decision|0|||
128994972|NCT01682512|464273796|FG000|Overall Study|Study terminated by sponsor|46|||
128994973|NCT01682512|464273797|FG001|Overall Study|Study terminated by sponsor|43|||
128994974|NCT01682512|464273798|FG002|Overall Study|Study terminated by sponsor|0|||
128994975|NCT01682512|464273796|FG000|Overall Study|Lost to Follow-up|3|||
128994976|NCT01682512|464273797|FG001|Overall Study|Lost to Follow-up|0|||
128994977|NCT01682512|464273798|FG002|Overall Study|Lost to Follow-up|2|||
128994978|NCT01682512|464273796|FG000|Overall Study|Protocol Violation|2|||
128994979|NCT01682512|464273797|FG001|Overall Study|Protocol Violation|3|||
128994980|NCT01682512|464273798|FG002|Overall Study|Protocol Violation|2|||
128994981|NCT01682512|464273796|FG000|Overall Study|Primary lack of efficacy|10|||
128994982|NCT01682512|464273797|FG001|Overall Study|Primary lack of efficacy|7|||
128994983|NCT01682512|464273798|FG002|Overall Study|Primary lack of efficacy|7|||
128994984|NCT01682512|464273796|FG000|Overall Study|Secondary lack of efficacy|1|||
128994985|NCT01682512|464273797|FG001|Overall Study|Secondary lack of efficacy|1|||
128994986|NCT01682512|464273798|FG002|Overall Study|Secondary lack of efficacy|0|||
128994987|NCT01682512|464273796|FG000|Overall Study|Other than stated above|2|||
128994988|NCT01682512|464273797|FG001|Overall Study|Other than stated above|4|||
128994989|NCT01682512|464273798|FG002|Overall Study|Other than stated above|2|||
128994990|NCT00054275|464273801|FG000|Overall Study|Withdrawal by Subject|4|||
128994991|NCT00054275|464273801|FG000|Overall Study|Adverse Event|5|||
128994992|NCT00054275|464273801|FG000|Overall Study|Progressive disease in cycle 1|1|||
128994993|NCT00054275|464273801|FG000|Overall Study|Physician Decision|1|||
128994994|NCT02030834|464273809|FG000|Overall Study|Death|4|||
128994995|NCT02030834|464273810|FG001|Overall Study|Death|0|||
128994996|NCT02030834|464273811|FG002|Overall Study|Death|0|||
128994997|NCT02030834|464273809|FG000|Overall Study|Manufacturing failure|2|||
128994998|NCT02030834|464273810|FG001|Overall Study|Manufacturing failure|0|||
128994999|NCT02030834|464273811|FG002|Overall Study|Manufacturing failure|1|||
128995000|NCT02030834|464273809|FG000|Overall Study|Disease progression|2|||
128995001|NCT02030834|464273810|FG001|Overall Study|Disease progression|0|||
128995002|NCT02030834|464273811|FG002|Overall Study|Disease progression|2|||
128995003|NCT02030834|464273809|FG000|Overall Study|Lost to Follow-up|1|||
128995004|NCT02030834|464273810|FG001|Overall Study|Lost to Follow-up|0|||
128995005|NCT02030834|464273811|FG002|Overall Study|Lost to Follow-up|0|||
128995006|NCT02030834|464273809|FG000|Overall Study|Withdrawal by Subject|1|||
128995007|NCT02030834|464273810|FG001|Overall Study|Withdrawal by Subject|0|||
128995008|NCT02030834|464273811|FG002|Overall Study|Withdrawal by Subject|0|||
128995009|NCT02030834|464273809|FG000|Overall Study|Lack of funding|1|||
128995010|NCT02030834|464273810|FG001|Overall Study|Lack of funding|0|||
128995011|NCT02030834|464273811|FG002|Overall Study|Lack of funding|0|||
128995012|NCT00996918|464273814|FG000|Overall Study|Lack of Efficacy|1|||
128995013|NCT00996918|464273815|FG001|Overall Study|Lack of Efficacy|1|||
128995014|NCT00996918|464273816|FG002|Overall Study|Lack of Efficacy|2|||
128995015|NCT00996918|464273817|FG003|Overall Study|Lack of Efficacy|2|||
128995016|NCT00996918|464273818|FG004|Overall Study|Lack of Efficacy|0|||
128995017|NCT00996918|464273814|FG000|Overall Study|Adverse Event|2|||
128995018|NCT00996918|464273815|FG001|Overall Study|Adverse Event|5|||
128995019|NCT00996918|464273816|FG002|Overall Study|Adverse Event|2|||
128995020|NCT00996918|464273817|FG003|Overall Study|Adverse Event|6|||
128995021|NCT00996918|464273818|FG004|Overall Study|Adverse Event|0|||
128995022|NCT00996918|464273814|FG000|Overall Study|Withdrawal by Subject|1|||
128995023|NCT00996918|464273815|FG001|Overall Study|Withdrawal by Subject|4|||
128995024|NCT00996918|464273816|FG002|Overall Study|Withdrawal by Subject|3|||
128995025|NCT00996918|464273817|FG003|Overall Study|Withdrawal by Subject|3|||
128995026|NCT00996918|464273818|FG004|Overall Study|Withdrawal by Subject|2|||
128995027|NCT00996918|464273814|FG000|Overall Study|Physician Decision|1|||
128995028|NCT00996918|464273815|FG001|Overall Study|Physician Decision|0|||
128995029|NCT00996918|464273816|FG002|Overall Study|Physician Decision|0|||
128995030|NCT00996918|464273817|FG003|Overall Study|Physician Decision|0|||
128995031|NCT00996918|464273818|FG004|Overall Study|Physician Decision|0|||
128995032|NCT00996918|464273814|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
128995033|NCT00996918|464273815|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
128995034|NCT00996918|464273816|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
128995035|NCT00996918|464273817|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
128995036|NCT00996918|464273818|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
128995037|NCT00996918|464273814|FG000|Overall Study|Loss of Caregiver|0|||
128995038|NCT00996918|464273815|FG001|Overall Study|Loss of Caregiver|1|||
128995039|NCT00996918|464273816|FG002|Overall Study|Loss of Caregiver|0|||
128995040|NCT00996918|464273817|FG003|Overall Study|Loss of Caregiver|0|||
128995041|NCT00996918|464273818|FG004|Overall Study|Loss of Caregiver|0|||
128995042|NCT00996918|464273814|FG000|Overall Study|Other|3|||
128995043|NCT00996918|464273815|FG001|Overall Study|Other|1|||
128995044|NCT00996918|464273816|FG002|Overall Study|Other|0|||
128995045|NCT00996918|464273817|FG003|Overall Study|Other|0|||
128995046|NCT00996918|464273818|FG004|Overall Study|Other|0|||
128995047|NCT04440007|464273823|FG000|Overall Study|Adverse Event|0|||
128995048|NCT04440007|464273824|FG001|Overall Study|Adverse Event|1|||
128995049|NCT04440007|464273823|FG000|Overall Study|Lost to Follow-up|1|||
128995050|NCT04440007|464273824|FG001|Overall Study|Lost to Follow-up|3|||
128995051|NCT04440007|464273823|FG000|Overall Study|Death|7|||
128995052|NCT04440007|464273824|FG001|Overall Study|Death|2|||
128995053|NCT04440007|464273823|FG000|Overall Study|Physician Decision|1|||
128995054|NCT04440007|464273824|FG001|Overall Study|Physician Decision|1|||
128995055|NCT04440007|464273823|FG000|Overall Study|Withdrawal by Subject|2|||
128995056|NCT04440007|464273824|FG001|Overall Study|Withdrawal by Subject|1|||
128995057|NCT04440007|464273823|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
128995058|NCT04440007|464273824|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
128995059|NCT04440007|464273823|FG000|Overall Study|Discontinued prior to dosing|0|||
128995060|NCT04440007|464273824|FG001|Overall Study|Discontinued prior to dosing|2|||
128995061|NCT01466673|464273825|FG000|Overall Study|Non-compliance with study treatment|2|||
128995062|NCT01466673|464273826|FG001|Overall Study|Non-compliance with study treatment|0|||
128995063|NCT01466673|464273825|FG000|Overall Study|Lost to Follow-up|3|||
128995064|NCT01466673|464273826|FG001|Overall Study|Lost to Follow-up|5|||
128995065|NCT01466673|464273825|FG000|Overall Study|Adverse Event|2|||
128995066|NCT01466673|464273826|FG001|Overall Study|Adverse Event|1|||
128995067|NCT00854607|464273827|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
128995068|NCT03959137|464273830|FG000|Overall Study|Protocol Violation|6|||
128995069|NCT00995488|464273831|FG000|Overall Study|Withdrawal by Subject|1|||
128995070|NCT03611751|464273832|FG000|Pre-treatment|Randomized but not treated|1|||
128995071|NCT03611751|464273833|FG001|Pre-treatment|Randomized but not treated|1|||
128995072|NCT03611751|464273834|FG002|Pre-treatment|Randomized but not treated|0|||
128995073|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
128995074|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
128995075|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
128995076|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
128995077|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
128995078|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
128995079|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
128995080|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
128995081|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
128995082|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
128995083|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
128995084|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
128995085|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
128995086|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
128995087|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
128995088|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
128995089|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
128995090|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
128995091|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
128995092|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
128995093|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
128995094|NCT03611751|464273832|FG000|Treatment Week 0 - Week 16|Death|0|||
128995095|NCT03611751|464273833|FG001|Treatment Week 0 - Week 16|Death|0|||
128995096|NCT03611751|464273834|FG002|Treatment Week 0 - Week 16|Death|1|||
128995097|NCT03611751|464273832|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
128995098|NCT03611751|464273833|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
128995099|NCT03611751|464273834|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
128995100|NCT03611751|464273832|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
128995101|NCT03611751|464273833|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
128995102|NCT03611751|464273834|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
128995103|NCT03611751|464273832|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
128995104|NCT03611751|464273833|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
128995105|NCT03611751|464273834|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
128995106|NCT03611751|464273832|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
128995107|NCT03611751|464273833|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
128995108|NCT03611751|464273834|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
128995109|NCT03611751|464273832|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
128995110|NCT03611751|464273833|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
128995111|NCT03611751|464273834|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
128995112|NCT03611751|464273832|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
128995113|NCT03611751|464273833|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
128995114|NCT03611751|464273834|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
128995115|NCT03611751|464273832|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
128995116|NCT03611751|464273833|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
128995117|NCT03611751|464273834|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
128995118|NCT03611751|464273832|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
128995119|NCT03611751|464273833|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
128995120|NCT03611751|464273834|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
128995121|NCT03611751|464273832|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
128995122|NCT03611751|464273833|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
128995123|NCT03611751|464273834|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
128995124|NCT03611751|464273832|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
128995125|NCT03611751|464273833|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
128995126|NCT03611751|464273834|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
128995127|NCT03611751|464273832|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
128995128|NCT03611751|464273833|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
128995129|NCT03611751|464273834|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
128995130|NCT03611751|464273832|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
128995131|NCT03611751|464273833|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
128995132|NCT03611751|464273834|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
128995133|NCT03611751|464273832|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
128995134|NCT03611751|464273833|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
128995135|NCT03611751|464273834|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
128995136|NCT03611751|464273832|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
128995137|NCT03611751|464273833|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
128995138|NCT03611751|464273834|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
128995139|NCT02702271|464273835|FG000|Overall Study|Death|36|||
128995140|NCT02702271|464273836|FG001|Overall Study|Death|7|||
128995141|NCT02702271|464273835|FG000|Overall Study|Lost to Follow-up|12|||
128995142|NCT02702271|464273836|FG001|Overall Study|Lost to Follow-up|0|||
128995143|NCT02702271|464273835|FG000|Overall Study|Withdrawal by Subject|8|||
128995144|NCT02702271|464273836|FG001|Overall Study|Withdrawal by Subject|1|||
128995145|NCT02702271|464273835|FG000|Overall Study|Physician Decision|2|||
128995146|NCT02702271|464273836|FG001|Overall Study|Physician Decision|0|||
128995147|NCT02702271|464273835|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
128995148|NCT02702271|464273836|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
128995149|NCT02139306|464273839|FG000|Overall Study|Withdrawal by Subject|4|||
128995150|NCT02139306|464273840|FG001|Overall Study|Withdrawal by Subject|6|||
128995151|NCT02139306|464273839|FG000|Overall Study|Adverse Event|3|||
128995152|NCT02139306|464273840|FG001|Overall Study|Adverse Event|4|||
128995153|NCT02139306|464273839|FG000|Overall Study|Physician Decision|0|||
128995154|NCT02139306|464273840|FG001|Overall Study|Physician Decision|1|||
128995155|NCT02139306|464273839|FG000|Overall Study|Other Unspecified|2|||
128995156|NCT02139306|464273840|FG001|Overall Study|Other Unspecified|3|||
128995157|NCT02139306|464273839|FG000|Overall Study|Protocol Violation|4|||
128995158|NCT02139306|464273840|FG001|Overall Study|Protocol Violation|0|||
128995159|NCT04449354|464273841|FG000|Overall Study|Withdrawal by Subject|1|||
128995160|NCT02913261|464273842|FG000|Overall Study|Technical problems|0|||
128995161|NCT02913261|464273843|FG001|Overall Study|Technical problems|1|||
128995162|NCT02913261|464273842|FG000|Overall Study|Lack of Efficacy|32|||
128995163|NCT02913261|464273843|FG001|Overall Study|Lack of Efficacy|69|||
128995164|NCT02913261|464273842|FG000|Overall Study|Adverse Event|27|||
128995165|NCT02913261|464273843|FG001|Overall Study|Adverse Event|5|||
128995166|NCT02913261|464273842|FG000|Overall Study|Death|25|||
128995167|NCT02913261|464273843|FG001|Overall Study|Death|22|||
128995168|NCT02913261|464273842|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
128995169|NCT02913261|464273843|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
128995170|NCT02913261|464273842|FG000|Overall Study|Disease relapse|8|||
128995171|NCT02913261|464273843|FG001|Overall Study|Disease relapse|13|||
128995172|NCT02913261|464273842|FG000|Overall Study|Physician Decision|8|||
128995173|NCT02913261|464273843|FG001|Overall Study|Physician Decision|9|||
128995174|NCT02913261|464273842|FG000|Overall Study|Subject/guardian decision|4|||
128995175|NCT02913261|464273843|FG001|Overall Study|Subject/guardian decision|6|||
128995176|NCT02913261|464273842|FG000|Overall Study|Graft loss|2|||
128995177|NCT02913261|464273843|FG001|Overall Study|Graft loss|0|||
128995178|NCT01311505|464273844|FG000|First Intervention Period|Protocol Violation|0|||
128995179|NCT01311505|464273845|FG001|First Intervention Period|Protocol Violation|1|||
128995180|NCT02956005|464273846|FG000|Overall Study|Not eligible|1|||
128995181|NCT02956005|464273846|FG000|Overall Study|Withdrawal by Subject|3|||
128995182|NCT02956005|464273846|FG000|Overall Study|Physician Decision|12|||
128995183|NCT03273257|464273849|FG000|Overall Study|Death|0|||
128995184|NCT03273257|464273850|FG001|Overall Study|Death|1|||
128995185|NCT03273257|464273849|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
128995186|NCT03273257|464273850|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
128995187|NCT03273257|464273849|FG000|Overall Study|Study terminated|3|||
128995188|NCT03273257|464273850|FG001|Overall Study|Study terminated|2|||
128995189|NCT01185639|464273852|FG000|Overall Study|Progressed and didn't receive therapy|2|||
128995190|NCT00759759|464273853|FG000|Overall Study|didn't return for period 2|1|||
128995191|NCT00759759|464273854|FG001|Overall Study|didn't return for period 2|0|||
128995192|NCT00759759|464273853|FG000|Overall Study|Didn't receive drug in period 2|1|||
128995193|NCT00759759|464273854|FG001|Overall Study|Didn't receive drug in period 2|0|||
128995194|NCT00759759|464273853|FG000|Overall Study|Withdrawal by Subject|2|||
128995195|NCT00759759|464273854|FG001|Overall Study|Withdrawal by Subject|1|||
128995196|NCT01211613|464275695|FG000|Overall Study|Lost to Follow-up|2|||
128995197|NCT01211613|464275696|FG001|Overall Study|Lost to Follow-up|2|||
128995198|NCT01211613|464275697|FG002|Overall Study|Lost to Follow-up|2|||
128995199|NCT01211613|464275695|FG000|Overall Study|Withdrawal by Subject|1|||
128995200|NCT01211613|464275696|FG001|Overall Study|Withdrawal by Subject|0|||
128995201|NCT01211613|464275697|FG002|Overall Study|Withdrawal by Subject|0|||
128995202|NCT03853213|464275698|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
128995203|NCT03853213|464275699|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
128995204|NCT03853213|464275698|FG000|Overall Study|Other (e.g., too busy)|0|||
128995205|NCT03853213|464275699|FG001|Overall Study|Other (e.g., too busy)|2|||
128995206|NCT01458132|464275700|FG000|Overall Study|Other|15|||
128995207|NCT01458132|464275701|FG001|Overall Study|Other|3|||
128995208|NCT00833976|464275706|FG000|Overall Study|Withdrawal by Subject|5|||
128995209|NCT00833976|464275706|FG000|Overall Study|Lost to Follow-up|4|||
128995210|NCT00833976|464275706|FG000|Overall Study|Did not meet eligibility criteria|41|||
128995211|NCT00833976|464275706|FG000|Overall Study|Physician Decision|1|||
128995212|NCT03911960|464275707|FG000|Overall Study|Lost to Follow-up|5|||
128995213|NCT03911960|464275708|FG001|Overall Study|Lost to Follow-up|3|||
128995214|NCT02239692|464275709|FG000|Overall Study|Incomplete colonoscopy|1|||
128995215|NCT02239692|464275710|FG001|Overall Study|Incomplete colonoscopy|2|||
128995216|NCT02239692|464275709|FG000|Overall Study|Adverse Event|0|||
128995217|NCT02239692|464275710|FG001|Overall Study|Adverse Event|1|||
128995218|NCT02239692|464275709|FG000|Overall Study|Physician Decision|0|||
128995219|NCT02239692|464275710|FG001|Overall Study|Physician Decision|1|||
128995220|NCT02239692|464275709|FG000|Overall Study|Lost to Follow-up|1|||
128995221|NCT02239692|464275710|FG001|Overall Study|Lost to Follow-up|4|||
128995222|NCT02239692|464275709|FG000|Overall Study|Withdrawal by Subject|3|||
128995223|NCT02239692|464275710|FG001|Overall Study|Withdrawal by Subject|5|||
128995224|NCT02239692|464275709|FG000|Overall Study|Other reason|1|||
128995225|NCT02239692|464275710|FG001|Overall Study|Other reason|0|||
128995226|NCT00297492|464275711|FG000|Set Quit Date|Lost to Follow-up|7|||
128995227|NCT00297492|464275712|FG001|Set Quit Date|Lost to Follow-up|13|||
128995228|NCT00297492|464275713|FG002|Set Quit Date|Lost to Follow-up|5|||
128995229|NCT00297492|464275711|FG000|6 Month Follow-up|Lost to Follow-up|63|||
128995230|NCT00297492|464275712|FG001|6 Month Follow-up|Lost to Follow-up|49|||
128995231|NCT00297492|464275713|FG002|6 Month Follow-up|Lost to Follow-up|27|||
128995232|NCT02414854|464275716|FG000|Overall Study|Adverse Event|9|||
128995233|NCT02414854|464275717|FG001|Overall Study|Adverse Event|7|||
128995234|NCT02414854|464275718|FG002|Overall Study|Adverse Event|1|||
128995235|NCT02414854|464275719|FG003|Overall Study|Adverse Event|12|||
128995236|NCT02414854|464275716|FG000|Overall Study|Poor compliance to protocol|1|||
128995237|NCT02414854|464275717|FG001|Overall Study|Poor compliance to protocol|1|||
128995238|NCT02414854|464275718|FG002|Overall Study|Poor compliance to protocol|2|||
128995239|NCT02414854|464275719|FG003|Overall Study|Poor compliance to protocol|2|||
128995240|NCT02414854|464275716|FG000|Overall Study|Other than specified above|12|||
128995241|NCT02414854|464275717|FG001|Overall Study|Other than specified above|37|||
128995242|NCT02414854|464275718|FG002|Overall Study|Other than specified above|17|||
128995243|NCT02414854|464275719|FG003|Overall Study|Other than specified above|37|||
128995244|NCT04723173|464275720|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
128995245|NCT02082262|464275721|FG000|Overall Study|Withdrawal by Subject|3|||
128995246|NCT02082262|464275721|FG000|Overall Study|Adverse Event|48|||
128995247|NCT01408576|464275722|FG000|Overall Study|Lack of Efficacy|17|||
128995248|NCT01408576|464275723|FG001|Overall Study|Lack of Efficacy|30|||
128995249|NCT01408576|464275724|FG002|Overall Study|Lack of Efficacy|48|||
128995250|NCT01408576|464275722|FG000|Overall Study|Protocol Violation|1|||
128995251|NCT01408576|464275723|FG001|Overall Study|Protocol Violation|2|||
128995252|NCT01408576|464275724|FG002|Overall Study|Protocol Violation|2|||
128995253|NCT01408576|464275722|FG000|Overall Study|Lost to Follow-up|10|||
128995254|NCT01408576|464275723|FG001|Overall Study|Lost to Follow-up|9|||
128995255|NCT01408576|464275724|FG002|Overall Study|Lost to Follow-up|17|||
128995256|NCT01408576|464275722|FG000|Overall Study|Withdrawal by Subject|34|||
128995257|NCT01408576|464275723|FG001|Overall Study|Withdrawal by Subject|60|||
128995258|NCT01408576|464275724|FG002|Overall Study|Withdrawal by Subject|66|||
128995259|NCT01408576|464275722|FG000|Overall Study|Sponsor terminated study|89|||
128995260|NCT01408576|464275723|FG001|Overall Study|Sponsor terminated study|333|||
128995261|NCT01408576|464275724|FG002|Overall Study|Sponsor terminated study|330|||
128995262|NCT01408576|464275722|FG000|Overall Study|AE, serious fatal|4|||
128995263|NCT01408576|464275723|FG001|Overall Study|AE, serious fatal|4|||
128995264|NCT01408576|464275724|FG002|Overall Study|AE, serious fatal|1|||
128995265|NCT01408576|464275722|FG000|Overall Study|SAE, non-fatal|11|||
128995266|NCT01408576|464275723|FG001|Overall Study|SAE, non-fatal|23|||
128995267|NCT01408576|464275724|FG002|Overall Study|SAE, non-fatal|14|||
128995268|NCT01408576|464275722|FG000|Overall Study|AE, non-serious non-fatal|12|||
128995269|NCT01408576|464275723|FG001|Overall Study|AE, non-serious non-fatal|19|||
128995270|NCT01408576|464275724|FG002|Overall Study|AE, non-serious non-fatal|11|||
128995271|NCT01408576|464275722|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
128995272|NCT01408576|464275723|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
128995273|NCT01408576|464275724|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
128995274|NCT01408576|464275722|FG000|Overall Study|AE, unknown type|0|||
128995275|NCT01408576|464275723|FG001|Overall Study|AE, unknown type|1|||
128995276|NCT01408576|464275724|FG002|Overall Study|AE, unknown type|0|||
128995277|NCT01408576|464275722|FG000|Overall Study|Other|10|||
128995278|NCT01408576|464275723|FG001|Overall Study|Other|16|||
128995279|NCT01408576|464275724|FG002|Overall Study|Other|18|||
128995280|NCT00817778|464275726|FG000|Overall Study|Adverse Event|1|||
128995281|NCT00817778|464275727|FG001|Overall Study|Adverse Event|0|||
128995282|NCT00817778|464275726|FG000|Overall Study|Withdrawal by Subject|1|||
128995283|NCT00817778|464275727|FG001|Overall Study|Withdrawal by Subject|1|||
128995284|NCT00817778|464275726|FG000|Overall Study|Protocol Violation|0|||
128995285|NCT00817778|464275727|FG001|Overall Study|Protocol Violation|1|||
128995286|NCT00817778|464275726|FG000|Overall Study|Study-specific discontinuation criteria|0|||
128995287|NCT00817778|464275727|FG001|Overall Study|Study-specific discontinuation criteria|1|||
128995288|NCT00817778|464275726|FG000|Overall Study|Poor venous access|1|||
128995289|NCT00817778|464275727|FG001|Overall Study|Poor venous access|0|||
128995290|NCT02923115|464275733|FG000|Overall Study|Lost to Follow-up|0|||
128995291|NCT02923115|464275734|FG001|Overall Study|Lost to Follow-up|0|||
128995292|NCT02923115|464275735|FG002|Overall Study|Lost to Follow-up|0|||
128995293|NCT02923115|464275736|FG003|Overall Study|Lost to Follow-up|1|||
128995294|NCT02923115|464275737|FG004|Overall Study|Lost to Follow-up|0|||
128995295|NCT02923115|464275738|FG005|Overall Study|Lost to Follow-up|0|||
128995296|NCT02923115|464275733|FG000|Overall Study|Withdrawal by Subject|0|||
128995297|NCT02923115|464275734|FG001|Overall Study|Withdrawal by Subject|1|||
128995298|NCT02923115|464275735|FG002|Overall Study|Withdrawal by Subject|0|||
128995299|NCT02923115|464275736|FG003|Overall Study|Withdrawal by Subject|0|||
128995300|NCT02923115|464275737|FG004|Overall Study|Withdrawal by Subject|0|||
128995301|NCT02923115|464275738|FG005|Overall Study|Withdrawal by Subject|0|||
128995302|NCT02923115|464275733|FG000|Overall Study|Randomized, but not dosed|0|||
128995303|NCT02923115|464275734|FG001|Overall Study|Randomized, but not dosed|0|||
128995304|NCT02923115|464275735|FG002|Overall Study|Randomized, but not dosed|3|||
128995305|NCT02923115|464275736|FG003|Overall Study|Randomized, but not dosed|1|||
128995306|NCT02923115|464275737|FG004|Overall Study|Randomized, but not dosed|5|||
128995307|NCT02923115|464275738|FG005|Overall Study|Randomized, but not dosed|0|||
128995308|NCT01791127|464275739|FG000|Overall Study|Death|356|||
128995309|NCT01791127|464275739|FG000|Overall Study|Patient has withdrawn from study|293|||
128995310|NCT01791127|464275739|FG000|Overall Study|Lost to Follow-up|42|||
128995311|NCT01791127|464275739|FG000|Overall Study|All Siello leads are explanted|31|||
128995312|NCT01791127|464275739|FG000|Overall Study|Completion of 30 day safety registry|1|||
128995313|NCT01791127|464275739|FG000|Overall Study|Study terminated for EP Passion|749|||
128995314|NCT00520494|464275740|FG000|Overall Study|Withdrawal by Subject|1|||
128995315|NCT00068406|464275741|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
128995316|NCT00068406|464275741|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
128995317|NCT03451331|464275742|FG000|Overall Study|Withdrawal by Subject|1|||
128995318|NCT03451331|464275743|FG001|Overall Study|Withdrawal by Subject|0|||
128995319|NCT03451331|464275742|FG000|Overall Study|Unable to start treatment.|1|||
128995320|NCT03451331|464275743|FG001|Overall Study|Unable to start treatment.|1|||
128995321|NCT01875991|464275744|FG000|Overall Study|Withdrawal by Subject|6|||
128995322|NCT01875991|464275745|FG001|Overall Study|Withdrawal by Subject|6|||
128995323|NCT01875991|464275744|FG000|Overall Study|Sponsor Decision|1|||
128995324|NCT01875991|464275745|FG001|Overall Study|Sponsor Decision|0|||
128995325|NCT02454972|464275746|FG000|Overall Study|Progressive disease|17|||
128995326|NCT02454972|464275747|FG001|Overall Study|Progressive disease|16|||
128995327|NCT02454972|464275748|FG002|Overall Study|Progressive disease|59|||
128995328|NCT02454972|464275749|FG003|Overall Study|Progressive disease|23|||
128995329|NCT02454972|464275750|FG004|Overall Study|Progressive disease|16|||
128995330|NCT02454972|464275751|FG005|Overall Study|Progressive disease|12|||
128995331|NCT02454972|464275752|FG006|Overall Study|Progressive disease|19|||
128995332|NCT02454972|464275753|FG007|Overall Study|Progressive disease|27|||
128995333|NCT02454972|464275754|FG008|Overall Study|Progressive disease|0|||
128995334|NCT02454972|464275746|FG000|Overall Study|Death|0|||
128995335|NCT02454972|464275747|FG001|Overall Study|Death|0|||
128995336|NCT02454972|464275748|FG002|Overall Study|Death|5|||
128995337|NCT02454972|464275749|FG003|Overall Study|Death|1|||
128995338|NCT02454972|464275750|FG004|Overall Study|Death|0|||
128995339|NCT02454972|464275751|FG005|Overall Study|Death|0|||
128995340|NCT02454972|464275752|FG006|Overall Study|Death|0|||
128995341|NCT02454972|464275753|FG007|Overall Study|Death|0|||
128995342|NCT02454972|464275754|FG008|Overall Study|Death|95|||
128995343|NCT02454972|464275746|FG000|Overall Study|Physician Decision|0|||
128995344|NCT02454972|464275747|FG001|Overall Study|Physician Decision|1|||
128995345|NCT02454972|464275748|FG002|Overall Study|Physician Decision|2|||
128995346|NCT02454972|464275749|FG003|Overall Study|Physician Decision|1|||
128995347|NCT02454972|464275750|FG004|Overall Study|Physician Decision|2|||
128995348|NCT02454972|464275751|FG005|Overall Study|Physician Decision|0|||
128995349|NCT02454972|464275752|FG006|Overall Study|Physician Decision|0|||
128995350|NCT02454972|464275753|FG007|Overall Study|Physician Decision|1|||
128995351|NCT02454972|464275754|FG008|Overall Study|Physician Decision|0|||
128995352|NCT02454972|464275746|FG000|Overall Study|Non treatment-related adverse event|2|||
128995353|NCT02454972|464275747|FG001|Overall Study|Non treatment-related adverse event|0|||
128995354|NCT02454972|464275748|FG002|Overall Study|Non treatment-related adverse event|1|||
128995355|NCT02454972|464275749|FG003|Overall Study|Non treatment-related adverse event|0|||
128995356|NCT02454972|464275750|FG004|Overall Study|Non treatment-related adverse event|0|||
128995357|NCT02454972|464275751|FG005|Overall Study|Non treatment-related adverse event|1|||
128995358|NCT02454972|464275752|FG006|Overall Study|Non treatment-related adverse event|0|||
128995359|NCT02454972|464275753|FG007|Overall Study|Non treatment-related adverse event|1|||
128995360|NCT02454972|464275754|FG008|Overall Study|Non treatment-related adverse event|0|||
128995361|NCT02454972|464275746|FG000|Overall Study|Treatment-related adverse events|0|||
128995362|NCT02454972|464275747|FG001|Overall Study|Treatment-related adverse events|1|||
128995363|NCT02454972|464275748|FG002|Overall Study|Treatment-related adverse events|1|||
128995364|NCT02454972|464275749|FG003|Overall Study|Treatment-related adverse events|0|||
128995365|NCT02454972|464275750|FG004|Overall Study|Treatment-related adverse events|2|||
128995366|NCT02454972|464275751|FG005|Overall Study|Treatment-related adverse events|0|||
128995367|NCT02454972|464275752|FG006|Overall Study|Treatment-related adverse events|0|||
128995368|NCT02454972|464275753|FG007|Overall Study|Treatment-related adverse events|2|||
128995369|NCT02454972|464275754|FG008|Overall Study|Treatment-related adverse events|0|||
128995370|NCT02454972|464275746|FG000|Overall Study|Patient moves to compassionate use|0|||
128995371|NCT02454972|464275747|FG001|Overall Study|Patient moves to compassionate use|0|||
128995372|NCT02454972|464275748|FG002|Overall Study|Patient moves to compassionate use|0|||
128995373|NCT02454972|464275749|FG003|Overall Study|Patient moves to compassionate use|0|||
128995374|NCT02454972|464275750|FG004|Overall Study|Patient moves to compassionate use|0|||
128995375|NCT02454972|464275751|FG005|Overall Study|Patient moves to compassionate use|0|||
128995376|NCT02454972|464275752|FG006|Overall Study|Patient moves to compassionate use|2|||
128995377|NCT02454972|464275753|FG007|Overall Study|Patient moves to compassionate use|0|||
128995378|NCT02454972|464275754|FG008|Overall Study|Patient moves to compassionate use|0|||
128995379|NCT02454972|464275746|FG000|Overall Study|Withdrawal by Subject|0|||
128995380|NCT02454972|464275747|FG001|Overall Study|Withdrawal by Subject|1|||
128995381|NCT02454972|464275748|FG002|Overall Study|Withdrawal by Subject|5|||
128995382|NCT02454972|464275749|FG003|Overall Study|Withdrawal by Subject|2|||
128995383|NCT02454972|464275750|FG004|Overall Study|Withdrawal by Subject|3|||
128995384|NCT02454972|464275751|FG005|Overall Study|Withdrawal by Subject|2|||
128995385|NCT02454972|464275752|FG006|Overall Study|Withdrawal by Subject|0|||
128995386|NCT02454972|464275753|FG007|Overall Study|Withdrawal by Subject|1|||
128995387|NCT02454972|464275754|FG008|Overall Study|Withdrawal by Subject|2|||
128995388|NCT02454972|464275746|FG000|Overall Study|Multiple delay/holds on treatment|0|||
128995389|NCT02454972|464275747|FG001|Overall Study|Multiple delay/holds on treatment|0|||
128995390|NCT02454972|464275748|FG002|Overall Study|Multiple delay/holds on treatment|0|||
128995391|NCT02454972|464275749|FG003|Overall Study|Multiple delay/holds on treatment|1|||
128995392|NCT02454972|464275750|FG004|Overall Study|Multiple delay/holds on treatment|0|||
128995393|NCT02454972|464275751|FG005|Overall Study|Multiple delay/holds on treatment|0|||
128995394|NCT02454972|464275752|FG006|Overall Study|Multiple delay/holds on treatment|0|||
128995395|NCT02454972|464275753|FG007|Overall Study|Multiple delay/holds on treatment|0|||
128995396|NCT02454972|464275754|FG008|Overall Study|Multiple delay/holds on treatment|0|||
128995397|NCT02454972|464275746|FG000|Overall Study|Never treated|0|||
128995398|NCT02454972|464275747|FG001|Overall Study|Never treated|0|||
128995399|NCT02454972|464275748|FG002|Overall Study|Never treated|3|||
128995400|NCT02454972|464275749|FG003|Overall Study|Never treated|1|||
128995401|NCT02454972|464275750|FG004|Overall Study|Never treated|1|||
128995402|NCT02454972|464275751|FG005|Overall Study|Never treated|0|||
128995403|NCT02454972|464275752|FG006|Overall Study|Never treated|0|||
128995404|NCT02454972|464275753|FG007|Overall Study|Never treated|0|||
128995405|NCT02454972|464275754|FG008|Overall Study|Never treated|5|||
128995406|NCT02454972|464275746|FG000|Overall Study|Lost to Follow-up|0|||
128995407|NCT02454972|464275747|FG001|Overall Study|Lost to Follow-up|0|||
128995408|NCT02454972|464275748|FG002|Overall Study|Lost to Follow-up|0|||
128995409|NCT02454972|464275749|FG003|Overall Study|Lost to Follow-up|0|||
128995410|NCT02454972|464275750|FG004|Overall Study|Lost to Follow-up|0|||
128995411|NCT02454972|464275751|FG005|Overall Study|Lost to Follow-up|0|||
128995412|NCT02454972|464275752|FG006|Overall Study|Lost to Follow-up|0|||
128995413|NCT02454972|464275753|FG007|Overall Study|Lost to Follow-up|0|||
128995414|NCT02454972|464275754|FG008|Overall Study|Lost to Follow-up|2|||
128995415|NCT02454972|464275746|FG000|Overall Study|Study termination|0|||
128995416|NCT02454972|464275747|FG001|Overall Study|Study termination|0|||
128995417|NCT02454972|464275748|FG002|Overall Study|Study termination|0|||
128995418|NCT02454972|464275749|FG003|Overall Study|Study termination|0|||
128995419|NCT02454972|464275750|FG004|Overall Study|Study termination|0|||
128995420|NCT02454972|464275751|FG005|Overall Study|Study termination|0|||
128995421|NCT02454972|464275752|FG006|Overall Study|Study termination|0|||
128995422|NCT02454972|464275753|FG007|Overall Study|Study termination|0|||
128995423|NCT02454972|464275754|FG008|Overall Study|Study termination|6|||
128995424|NCT01377233|464275755|FG000|Open-label|Adverse Event|1|||
128995425|NCT01377233|464275756|FG001|Open-label|Adverse Event|0|||
128995426|NCT01377233|464275757|FG002|Open-label|Adverse Event|0|||
128995427|NCT01377233|464275758|FG003|Open-label|Adverse Event|0|||
128995428|NCT01377233|464275759|FG004|Open-label|Adverse Event|0|||
128995429|NCT01377233|464275755|FG000|Open-label|Withdrawal by Subject|3|||
128995430|NCT01377233|464275756|FG001|Open-label|Withdrawal by Subject|0|||
128995431|NCT01377233|464275757|FG002|Open-label|Withdrawal by Subject|0|||
128995432|NCT01377233|464275758|FG003|Open-label|Withdrawal by Subject|0|||
128995433|NCT01377233|464275759|FG004|Open-label|Withdrawal by Subject|0|||
128995434|NCT01377233|464275755|FG000|Double-blind|Adverse Event|0|||
128995435|NCT01377233|464275756|FG001|Double-blind|Adverse Event|1|||
128995436|NCT01377233|464275757|FG002|Double-blind|Adverse Event|2|||
128995437|NCT01377233|464275758|FG003|Double-blind|Adverse Event|2|||
128995438|NCT01377233|464275759|FG004|Double-blind|Adverse Event|0|||
128995439|NCT01377233|464275755|FG000|Double-blind|Protocol Violation|0|||
128995440|NCT01377233|464275756|FG001|Double-blind|Protocol Violation|0|||
128995441|NCT01377233|464275757|FG002|Double-blind|Protocol Violation|0|||
128995442|NCT01377233|464275758|FG003|Double-blind|Protocol Violation|0|||
128995443|NCT01377233|464275759|FG004|Double-blind|Protocol Violation|1|||
128995444|NCT01377233|464275755|FG000|Double-blind|Withdrawal by Subject|0|||
128995445|NCT01377233|464275756|FG001|Double-blind|Withdrawal by Subject|0|||
128995446|NCT01377233|464275757|FG002|Double-blind|Withdrawal by Subject|0|||
128995447|NCT01377233|464275758|FG003|Double-blind|Withdrawal by Subject|1|||
128995448|NCT01377233|464275759|FG004|Double-blind|Withdrawal by Subject|0|||
128995449|NCT01377233|464275755|FG000|Double-blind|Administrative or other|0|||
128995450|NCT01377233|464275756|FG001|Double-blind|Administrative or other|0|||
128995451|NCT01377233|464275757|FG002|Double-blind|Administrative or other|0|||
128995452|NCT01377233|464275758|FG003|Double-blind|Administrative or other|1|||
128995453|NCT01377233|464275759|FG004|Double-blind|Administrative or other|1|||
128995454|NCT01785875|464275760|FG000|Overall Study|Withdrawal by Subject|41|||
128995455|NCT01785875|464275761|FG001|Overall Study|Withdrawal by Subject|34|||
128995456|NCT01785875|464275762|FG002|Overall Study|Withdrawal by Subject|36|||
128995457|NCT01785875|464275760|FG000|Overall Study|Lost to Follow-up|19|||
128995458|NCT01785875|464275761|FG001|Overall Study|Lost to Follow-up|22|||
128995459|NCT01785875|464275762|FG002|Overall Study|Lost to Follow-up|6|||
128995460|NCT01785875|464275760|FG000|Overall Study|Death|27|||
128995461|NCT01785875|464275761|FG001|Overall Study|Death|16|||
128995462|NCT01785875|464275762|FG002|Overall Study|Death|7|||
128995463|NCT01785875|464275760|FG000|Overall Study|Sponsor Decision|0|||
128995464|NCT01785875|464275761|FG001|Overall Study|Sponsor Decision|2|||
128995465|NCT01785875|464275762|FG002|Overall Study|Sponsor Decision|0|||
128995466|NCT01785875|464275760|FG000|Overall Study|Protocol Specified Criteria|207|||
128995467|NCT01785875|464275761|FG001|Overall Study|Protocol Specified Criteria|214|||
128995468|NCT01785875|464275762|FG002|Overall Study|Protocol Specified Criteria|55|||
128995469|NCT01785875|464275760|FG000|Overall Study|Missing|0|||
128995470|NCT01785875|464275761|FG001|Overall Study|Missing|1|||
128995471|NCT01785875|464275762|FG002|Overall Study|Missing|3|||
128995472|NCT04991311|464275763|FG000|Overall Study|Adverse Event|1|||
128995473|NCT00755937|464275764|FG000|Recruitment|Unknown if infliximab received|164|||
128995474|NCT00755937|464275764|FG000|Observational Follow-up|Lost to Follow-up|148|||
128995475|NCT01440595|464275767|FG000|Overall Study|Lost to Follow-up|0|||
128995476|NCT01440595|464275768|FG001|Overall Study|Lost to Follow-up|1|||
128995477|NCT01440595|464275769|FG002|Overall Study|Lost to Follow-up|0|||
128995478|NCT01440595|464275767|FG000|Overall Study|Study terminated by sponsor.|1|||
128995479|NCT01440595|464275768|FG001|Overall Study|Study terminated by sponsor.|2|||
128995480|NCT01440595|464275769|FG002|Overall Study|Study terminated by sponsor.|1|||
128995481|NCT01347879|464275770|FG000|Overall Study|Adverse Event|0|||
128995482|NCT01347879|464275771|FG001|Overall Study|Adverse Event|12|||
128995483|NCT01347879|464275770|FG000|Overall Study|Lost to Follow-up|2|||
128995484|NCT01347879|464275771|FG001|Overall Study|Lost to Follow-up|0|||
128995485|NCT01347879|464275770|FG000|Overall Study|Withdrawal by Subject|3|||
128995486|NCT01347879|464275771|FG001|Overall Study|Withdrawal by Subject|2|||
128995487|NCT01347879|464275770|FG000|Overall Study|Other|2|||
128995488|NCT01347879|464275771|FG001|Overall Study|Other|3|||
128995489|NCT01223196|464275772|FG000|Overall Study|Lost to Follow-up|2|||
128995490|NCT01223196|464275773|FG001|Overall Study|Lost to Follow-up|0|||
128995491|NCT01223196|464275772|FG000|Overall Study|Physician Decision|1|||
128995492|NCT01223196|464275773|FG001|Overall Study|Physician Decision|0|||
128995493|NCT01223196|464275772|FG000|Overall Study|Withdrawal by Subject|1|||
128995494|NCT01223196|464275773|FG001|Overall Study|Withdrawal by Subject|0|||
128995495|NCT01238822|464275778|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
128995496|NCT02725671|464275784|FG000|Overall Study|Lost to Follow-up|1|||
128995497|NCT00965263|464275785|FG000|Overall Study|Physician Decision|2|||
128995498|NCT00965263|464275786|FG001|Overall Study|Physician Decision|0|||
128995499|NCT00965263|464275785|FG000|Overall Study|Family emergency|0|||
128995500|NCT00965263|464275786|FG001|Overall Study|Family emergency|1|||
128995501|NCT00965263|464275785|FG000|Overall Study|Protocol Violation|0|||
128995502|NCT00965263|464275786|FG001|Overall Study|Protocol Violation|2|||
128995503|NCT00123487|464275787|FG000|Randomized|Death prior to starting treatment|0|||
128995504|NCT00123487|464275788|FG001|Randomized|Death prior to starting treatment|1|||
128995505|NCT00123487|464275787|FG000|Randomized|SAE prior to starting treatment|1|||
128995506|NCT00123487|464275788|FG001|Randomized|SAE prior to starting treatment|0|||
128995507|NCT00123487|464275787|FG000|Treated With Study Drug|Adverse Event|23|||
128995508|NCT00123487|464275788|FG001|Treated With Study Drug|Adverse Event|22|||
128995509|NCT00123487|464275787|FG000|Treated With Study Drug|Disease Progression|141|||
128995510|NCT00123487|464275788|FG001|Treated With Study Drug|Disease Progression|122|||
128995511|NCT00123487|464275787|FG000|Treated With Study Drug|Physician Decision|8|||
128995512|NCT00123487|464275788|FG001|Treated With Study Drug|Physician Decision|9|||
128995513|NCT00123487|464275787|FG000|Treated With Study Drug|Other|59|||
128995514|NCT00123487|464275788|FG001|Treated With Study Drug|Other|58|||
128877826|NCT00196976|463846338|FG005|Booster Study|Withdrawal by Subject|0|||
128877827|NCT00196976|463846339|FG006|Booster Study|Withdrawal by Subject|0|||
128877828|NCT00196976|463846340|FG007|Booster Study|Withdrawal by Subject|0|||
128877829|NCT00196976|463846341|FG008|Booster Study|Withdrawal by Subject|0|||
128877830|NCT00196976|463846342|FG009|Booster Study|Withdrawal by Subject|0|||
128877831|NCT00196976|463846343|FG010|Booster Study|Withdrawal by Subject|1|||
128877832|NCT00196976|463846344|FG011|Booster Study|Withdrawal by Subject|0|||
128995515|NCT00123487|464275787|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
128995516|NCT00123487|464275788|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
128995517|NCT00123487|464275787|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
128995518|NCT00123487|464275788|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
128995519|NCT00123487|464275787|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
128995520|NCT00123487|464275788|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
128995521|NCT02643966|464275789|FG000|First Screening Round|ineligible|1|||
128995522|NCT02643966|464275789|FG000|First Screening Round|excluded from analysis|2|||
128877833|NCT00196976|463846345|FG012|Booster Study|Withdrawal by Subject|0|||
128995523|NCT02643966|464275789|FG000|First Screening Round|Lost to Follow-up|56|||
128995524|NCT02643966|464275789|FG000|First Screening Round|Withdrawal by Subject|28|||
128995525|NCT02643966|464275789|FG000|First Screening Round|Death|1|||
128995526|NCT02643966|464275789|FG000|Between First and Second Screening|Lost to Follow-up|65|||
128995527|NCT02643966|464275789|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
128995528|NCT02643966|464275789|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
128995529|NCT02643966|464275789|FG000|Second Screening Round|Withdrawal by Subject|20|||
128995530|NCT02643966|464275789|FG000|Second Screening Round|Lost to Follow-up|57|||
128995531|NCT02643966|464275789|FG000|Second Screening Round|Physician Decision|2|||
128995532|NCT02643966|464275789|FG000|Second Screening Round|Death|4|||
128995533|NCT02643966|464275789|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
128995534|NCT02643966|464275789|FG000|Between Second and Third Screening|Death|1|||
128995535|NCT02643966|464275789|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
128995536|NCT02643966|464275789|FG000|Third Screening Round|PI excluded|2|||
128995537|NCT02643966|464275789|FG000|Third Screening Round|Lost to Follow-up|241|||
128995538|NCT03835975|464275790|FG000|Overall Study|Lost to Follow-up|1|||
128995539|NCT03835975|464275791|FG001|Overall Study|Lost to Follow-up|1|||
128995540|NCT03835975|464275792|FG002|Overall Study|Lost to Follow-up|0|||
128995541|NCT03835975|464275793|FG003|Overall Study|Lost to Follow-up|0|||
128995542|NCT03835975|464275794|FG004|Overall Study|Lost to Follow-up|0|||
128995543|NCT03835975|464275790|FG000|Overall Study|No longer met eligibility criteria|0|||
128995544|NCT03835975|464275791|FG001|Overall Study|No longer met eligibility criteria|1|||
128995545|NCT03835975|464275792|FG002|Overall Study|No longer met eligibility criteria|0|||
128995546|NCT03835975|464275793|FG003|Overall Study|No longer met eligibility criteria|0|||
128995547|NCT03835975|464275794|FG004|Overall Study|No longer met eligibility criteria|0|||
128995548|NCT03835975|464275790|FG000|Overall Study|Protocol Violation|1|||
128995549|NCT03835975|464275791|FG001|Overall Study|Protocol Violation|1|||
128995550|NCT03835975|464275792|FG002|Overall Study|Protocol Violation|2|||
128995551|NCT03835975|464275793|FG003|Overall Study|Protocol Violation|0|||
128995552|NCT03835975|464275794|FG004|Overall Study|Protocol Violation|0|||
128995553|NCT03835975|464275790|FG000|Overall Study|Withdrawal by Subject|1|||
128995554|NCT03835975|464275791|FG001|Overall Study|Withdrawal by Subject|0|||
128995555|NCT03835975|464275792|FG002|Overall Study|Withdrawal by Subject|1|||
128995556|NCT03835975|464275793|FG003|Overall Study|Withdrawal by Subject|1|||
128995557|NCT03835975|464275794|FG004|Overall Study|Withdrawal by Subject|0|||
128995558|NCT00061945|464275795|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
128995559|NCT00061945|464275796|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
128995560|NCT00061945|464275795|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
128995561|NCT00061945|464275796|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
128995562|NCT00061945|464275795|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
128995563|NCT00061945|464275796|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
128995564|NCT00061945|464275795|FG000|Course IV: Alemtuzumab|Early exits|6|||
128995565|NCT00061945|464275796|FG001|Course IV: Alemtuzumab|Early exits|15|||
128995566|NCT01039584|464275797|FG000|Overall Study|Withdrawal by Subject|4|||
128995567|NCT01039584|464275798|FG001|Overall Study|Withdrawal by Subject|2|||
128995568|NCT01039584|464275799|FG002|Overall Study|Withdrawal by Subject|1|||
128995569|NCT01039584|464275797|FG000|Overall Study|Protocol Violation|10|||
128995570|NCT01039584|464275798|FG001|Overall Study|Protocol Violation|4|||
128995571|NCT01039584|464275799|FG002|Overall Study|Protocol Violation|6|||
128995572|NCT01039584|464275797|FG000|Overall Study|Lost to Follow-up|5|||
128995573|NCT01039584|464275798|FG001|Overall Study|Lost to Follow-up|3|||
128995574|NCT01039584|464275799|FG002|Overall Study|Lost to Follow-up|4|||
128995575|NCT01039584|464275797|FG000|Overall Study|Negative Baseline culture for Candida|59|||
128995576|NCT01039584|464275798|FG001|Overall Study|Negative Baseline culture for Candida|59|||
128995577|NCT01039584|464275799|FG002|Overall Study|Negative Baseline culture for Candida|24|||
128995578|NCT01039584|464275797|FG000|Overall Study|Lack of Efficacy|7|||
128995579|NCT01039584|464275798|FG001|Overall Study|Lack of Efficacy|6|||
128995580|NCT01039584|464275799|FG002|Overall Study|Lack of Efficacy|10|||
128995581|NCT01039584|464275797|FG000|Overall Study|other|1|||
128995582|NCT01039584|464275798|FG001|Overall Study|other|3|||
128995583|NCT01039584|464275799|FG002|Overall Study|other|1|||
128995584|NCT01039584|464275797|FG000|Overall Study|Pap smear with significant pathology|10|||
128995585|NCT01039584|464275798|FG001|Overall Study|Pap smear with significant pathology|10|||
128995586|NCT01039584|464275799|FG002|Overall Study|Pap smear with significant pathology|3|||
128995587|NCT01039584|464275797|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
128995588|NCT01039584|464275798|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
128995589|NCT01039584|464275799|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
128995590|NCT03672396|464275802|FG000|Overall Study|Withdrawal by Subject|4|||
128995591|NCT03672396|464275802|FG000|Overall Study|Physician Decision|1|||
128995592|NCT03672396|464275802|FG000|Overall Study|Adverse Event|1|||
128995593|NCT02441179|464275804|FG000|Overall Study|Withdrawal by Subject|1|||
128995594|NCT02441179|464275805|FG001|Overall Study|Withdrawal by Subject|1|||
128995595|NCT00975884|464275806|FG000|Overall Study|Adverse Event|1|||
128995596|NCT00975884|464275807|FG001|Overall Study|Adverse Event|0|||
128995597|NCT00975884|464275806|FG000|Overall Study|Lost to Follow-up|5|||
128995598|NCT00975884|464275807|FG001|Overall Study|Lost to Follow-up|3|||
128995599|NCT00975884|464275806|FG000|Overall Study|Withdrawal by Subject|9|||
128995600|NCT00975884|464275807|FG001|Overall Study|Withdrawal by Subject|9|||
128995601|NCT00975884|464275806|FG000|Overall Study|Other|1|||
128995602|NCT00975884|464275807|FG001|Overall Study|Other|3|||
128995603|NCT01656967|464275808|FG000|Overall Study|faulty monitor|1|||
128995604|NCT01656967|464275809|FG001|Overall Study|faulty monitor|0|||
128995605|NCT01656967|464275808|FG000|Overall Study|unsuccessful ETT insertion|3|||
128995606|NCT01656967|464275809|FG001|Overall Study|unsuccessful ETT insertion|2|||
128995607|NCT00051636|464275810|FG000|Period 1 - Core|Adverse Event|2|||
128995608|NCT00051636|464275811|FG001|Period 1 - Core|Adverse Event|2|||
128995609|NCT00051636|464275810|FG000|Period 1 - Core|Protocol Violation|1|||
128995610|NCT00051636|464275811|FG001|Period 1 - Core|Protocol Violation|0|||
128995611|NCT00051636|464275810|FG000|Period 1 - Core|Withdrawal by Subject|1|||
128995612|NCT00051636|464275811|FG001|Period 1 - Core|Withdrawal by Subject|2|||
128995613|NCT00051636|464275810|FG000|Period 1 - Core|Lost to Follow-up|0|||
128995614|NCT00051636|464275811|FG001|Period 1 - Core|Lost to Follow-up|2|||
128995615|NCT00051636|464275810|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
128995616|NCT00051636|464275811|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
128995617|NCT00051636|464275810|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
128995618|NCT00051636|464275811|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
128995619|NCT00051636|464275810|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
128995620|NCT00051636|464275811|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
128995621|NCT00051636|464275810|FG000|Period 2- Extended Observation Period|Death|4|||
128995622|NCT00051636|464275811|FG001|Period 2- Extended Observation Period|Death|5|||
128995623|NCT00051636|464275810|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
128995624|NCT00051636|464275811|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
128995625|NCT00479765|464275812|FG000|Overall Study|study terminated|4|||
128995626|NCT05166512|464275815|FG000|Randomized|Lost to Follow-up|2|||
128995627|NCT05166512|464275816|FG001|Randomized|Lost to Follow-up|0|||
128995628|NCT05166512|464275815|FG000|Randomized|Withdrawal by Subject|1|||
128995629|NCT05166512|464275816|FG001|Randomized|Withdrawal by Subject|0|||
128995630|NCT05166512|464275815|FG000|Baseline Data Collection|Lost to Follow-up|0|||
128995631|NCT05166512|464275816|FG001|Baseline Data Collection|Lost to Follow-up|3|||
128995632|NCT05166512|464275815|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
128995633|NCT05166512|464275816|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
128995634|NCT05166512|464275815|FG000|Baseline Data Collection|Protocol Violation|2|||
128995635|NCT05166512|464275816|FG001|Baseline Data Collection|Protocol Violation|0|||
128995636|NCT05166512|464275815|FG000|4 Month Data Collection|Lost to Follow-up|1|||
128995637|NCT05166512|464275816|FG001|4 Month Data Collection|Lost to Follow-up|0|||
128995638|NCT05166512|464275815|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
128995639|NCT05166512|464275816|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
128995640|NCT05166512|464275815|FG000|12 Month Data Collection|Lost to Follow-up|3|||
128995641|NCT05166512|464275816|FG001|12 Month Data Collection|Lost to Follow-up|1|||
128995642|NCT05166512|464275815|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
128995643|NCT05166512|464275816|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
128995644|NCT00944125|464275817|FG000|3 to 6 Months|Withdrawal by Subject|0|||
128995645|NCT00944125|464275818|FG001|3 to 6 Months|Withdrawal by Subject|2|||
128995646|NCT00944125|464275817|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
128995647|NCT00944125|464275818|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
128995648|NCT00446134|464275819|FG000|Overall Study|Adverse Event|7|||
128995649|NCT00446134|464275820|FG001|Overall Study|Adverse Event|17|||
128995650|NCT00446134|464275821|FG002|Overall Study|Adverse Event|13|||
128995651|NCT00446134|464275822|FG003|Overall Study|Adverse Event|18|||
128995652|NCT00446134|464275819|FG000|Overall Study|Lack of Efficacy|19|||
128995653|NCT00446134|464275820|FG001|Overall Study|Lack of Efficacy|19|||
128995654|NCT00446134|464275821|FG002|Overall Study|Lack of Efficacy|24|||
128995655|NCT00446134|464275822|FG003|Overall Study|Lack of Efficacy|19|||
128995656|NCT00446134|464275819|FG000|Overall Study|Protocol Violation|0|||
128995657|NCT00446134|464275820|FG001|Overall Study|Protocol Violation|2|||
128995658|NCT00446134|464275821|FG002|Overall Study|Protocol Violation|1|||
128995659|NCT00446134|464275822|FG003|Overall Study|Protocol Violation|0|||
128995660|NCT00446134|464275819|FG000|Overall Study|Lost to Follow-up|1|||
128995661|NCT00446134|464275820|FG001|Overall Study|Lost to Follow-up|3|||
128995662|NCT00446134|464275821|FG002|Overall Study|Lost to Follow-up|1|||
128995663|NCT00446134|464275822|FG003|Overall Study|Lost to Follow-up|1|||
128995664|NCT00446134|464275819|FG000|Overall Study|Withdrawal by Subject|3|||
128995665|NCT00446134|464275820|FG001|Overall Study|Withdrawal by Subject|3|||
128995666|NCT00446134|464275821|FG002|Overall Study|Withdrawal by Subject|1|||
128995667|NCT00446134|464275822|FG003|Overall Study|Withdrawal by Subject|3|||
128995668|NCT00446134|464275819|FG000|Overall Study|Physician Decision|0|||
128995669|NCT00446134|464275820|FG001|Overall Study|Physician Decision|0|||
128995670|NCT00446134|464275821|FG002|Overall Study|Physician Decision|0|||
128995671|NCT00446134|464275822|FG003|Overall Study|Physician Decision|2|||
128995672|NCT00446134|464275819|FG000|Overall Study|Adverse Event-Diarrhea|1|||
128995673|NCT00446134|464275820|FG001|Overall Study|Adverse Event-Diarrhea|1|||
128995674|NCT00446134|464275821|FG002|Overall Study|Adverse Event-Diarrhea|2|||
128995675|NCT00446134|464275822|FG003|Overall Study|Adverse Event-Diarrhea|0|||
128995676|NCT00446134|464275819|FG000|Overall Study|Reason Not Completed|3|||
128995677|NCT00446134|464275820|FG001|Overall Study|Reason Not Completed|0|||
128995678|NCT00446134|464275821|FG002|Overall Study|Reason Not Completed|1|||
128995679|NCT00446134|464275822|FG003|Overall Study|Reason Not Completed|2|||
128995680|NCT03022799|464275823|FG000|Overall Study|Adverse Event|0|||
128995681|NCT03022799|464275824|FG001|Overall Study|Adverse Event|0|||
128995682|NCT03022799|464275825|FG002|Overall Study|Adverse Event|0|||
128995683|NCT03022799|464275826|FG003|Overall Study|Adverse Event|0|||
128995684|NCT03022799|464275827|FG004|Overall Study|Adverse Event|0|||
128995685|NCT03022799|464275828|FG005|Overall Study|Adverse Event|0|||
128995686|NCT03022799|464275829|FG006|Overall Study|Adverse Event|0|||
128995687|NCT03022799|464275830|FG007|Overall Study|Adverse Event|0|||
128995688|NCT03022799|464275831|FG008|Overall Study|Adverse Event|0|||
128995689|NCT03022799|464275832|FG009|Overall Study|Adverse Event|1|||
128995690|NCT03022799|464275833|FG010|Overall Study|Adverse Event|1|||
128995691|NCT03022799|464275834|FG011|Overall Study|Adverse Event|0|||
128995692|NCT03022799|464275835|FG012|Overall Study|Adverse Event|0|||
128995693|NCT00928135|464275836|FG000|Overall Study|Withdrawal by Subject|1|||
128995694|NCT00928135|464275837|FG001|Overall Study|Withdrawal by Subject|0|||
128995695|NCT00434148|464275840|FG000|Overall Study|Adverse Event|18|||
128995696|NCT00434148|464275841|FG001|Overall Study|Adverse Event|18|||
128995697|NCT00434148|464275840|FG000|Overall Study|Lack of Efficacy|25|||
128995698|NCT00434148|464275841|FG001|Overall Study|Lack of Efficacy|28|||
128877834|NCT00196976|463846346|FG013|Booster Study|Withdrawal by Subject|0|||
128995699|NCT00434148|464275840|FG000|Overall Study|Withdrawal by Subject|15|||
128995700|NCT00434148|464275841|FG001|Overall Study|Withdrawal by Subject|15|||
128995701|NCT00434148|464275840|FG000|Overall Study|Protocol Violation|4|||
128995702|NCT00434148|464275841|FG001|Overall Study|Protocol Violation|0|||
128995703|NCT00434148|464275840|FG000|Overall Study|Administrative problems|6|||
128995704|NCT00434148|464275841|FG001|Overall Study|Administrative problems|10|||
128995705|NCT00434148|464275840|FG000|Overall Study|Lost to Follow-up|0|||
128995706|NCT00434148|464275841|FG001|Overall Study|Lost to Follow-up|1|||
128995707|NCT00434148|464275840|FG000|Overall Study|Condition no longer requires study drug|1|||
128995708|NCT00434148|464275841|FG001|Overall Study|Condition no longer requires study drug|0|||
128995709|NCT00434148|464275840|FG000|Overall Study|Abnormal test procedure result|0|||
128995710|NCT00434148|464275841|FG001|Overall Study|Abnormal test procedure result|1|||
128995711|NCT01861717|464275846|FG000|Overall Study|Lost to Follow-up|1|||
128995712|NCT01861717|464275846|FG000|Overall Study|Withdrawal by Subject|1|||
128995713|NCT03033069|464275847|FG000|Overall Study|Adverse Event|6|||
128995714|NCT03033069|464275848|FG001|Overall Study|Adverse Event|7|||
128995715|NCT03033069|464275849|FG002|Overall Study|Adverse Event|4|||
128995716|NCT03033069|464275850|FG003|Overall Study|Adverse Event|6|||
128995717|NCT03033069|464275847|FG000|Overall Study|Lack of Efficacy|0|||
128995718|NCT03033069|464275848|FG001|Overall Study|Lack of Efficacy|0|||
128995719|NCT03033069|464275849|FG002|Overall Study|Lack of Efficacy|1|||
128995720|NCT03033069|464275850|FG003|Overall Study|Lack of Efficacy|0|||
128995721|NCT03033069|464275847|FG000|Overall Study|Lost to Follow-up|6|||
128995722|NCT03033069|464275848|FG001|Overall Study|Lost to Follow-up|5|||
128995723|NCT03033069|464275849|FG002|Overall Study|Lost to Follow-up|5|||
128995724|NCT03033069|464275850|FG003|Overall Study|Lost to Follow-up|6|||
128995725|NCT03033069|464275847|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128995726|NCT03033069|464275848|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128995727|NCT03033069|464275849|FG002|Overall Study|Non-Compliance With Study Drug|1|||
128995728|NCT03033069|464275850|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128995729|NCT03033069|464275847|FG000|Overall Study|Protocol Deviation|0|||
128995730|NCT03033069|464275848|FG001|Overall Study|Protocol Deviation|1|||
128995731|NCT03033069|464275849|FG002|Overall Study|Protocol Deviation|0|||
128995732|NCT03033069|464275850|FG003|Overall Study|Protocol Deviation|0|||
128995733|NCT03033069|464275847|FG000|Overall Study|Withdrawal by Subject|10|||
128995734|NCT03033069|464275848|FG001|Overall Study|Withdrawal by Subject|10|||
128995735|NCT03033069|464275849|FG002|Overall Study|Withdrawal by Subject|11|||
128995736|NCT03033069|464275850|FG003|Overall Study|Withdrawal by Subject|6|||
128995737|NCT03033069|464275847|FG000|Overall Study|Withdrawal By Caregiver|1|||
128995738|NCT03033069|464275848|FG001|Overall Study|Withdrawal By Caregiver|0|||
128995739|NCT03033069|464275849|FG002|Overall Study|Withdrawal By Caregiver|0|||
128995740|NCT03033069|464275850|FG003|Overall Study|Withdrawal By Caregiver|0|||
128995741|NCT03033069|464275847|FG000|Overall Study|Reason not Specified|0|||
128995742|NCT03033069|464275848|FG001|Overall Study|Reason not Specified|1|||
128995743|NCT03033069|464275849|FG002|Overall Study|Reason not Specified|0|||
128995744|NCT03033069|464275850|FG003|Overall Study|Reason not Specified|1|||
128995745|NCT05458895|464275855|FG000|Overall Study|Withdrawal by Subject|8|||
128995746|NCT05458895|464275855|FG000|Overall Study|Lost to Follow-up|17|||
128995747|NCT05458895|464275855|FG000|Overall Study|Pregnancy|2|||
128995748|NCT05458895|464275855|FG000|Overall Study|Withdrawal by Study Team|1|||
128995749|NCT04639310|464275856|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
128995750|NCT04639310|464275857|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
128995751|NCT01084603|464277611|FG000|Baseline|Withdrawal by Subject|2|||
128995752|NCT01084603|464277611|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
128995753|NCT01084603|464277611|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
128995754|NCT01084603|464277611|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
128995755|NCT01084603|464277611|FG000|Washout Period 4|Adverse Event|1|||
128995756|NCT04388527|464277613|FG000|Overall Study|Death|14|||
128995757|NCT04388527|464277613|FG000|Overall Study|Withdrawal by Subject|2|||
128995758|NCT04388527|464277613|FG000|Overall Study|Lost to Follow-up|1|||
128995759|NCT03471182|464277616|FG000|Overall Study|Withdrawal by Subject|1|||
128995760|NCT03471182|464277617|FG001|Overall Study|Withdrawal by Subject|1|||
128995761|NCT03471182|464277618|FG002|Overall Study|Withdrawal by Subject|0|||
128995762|NCT03471182|464277616|FG000|Overall Study|Technical failure|2|||
128995763|NCT03471182|464277617|FG001|Overall Study|Technical failure|0|||
128995764|NCT03471182|464277618|FG002|Overall Study|Technical failure|0|||
128995765|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
128995766|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
128877835|NCT00196976|463846333|FG000|Booster Study|Lost to Follow-up|0|||
128995767|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
128995768|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
128877836|NCT00196976|463846334|FG001|Booster Study|Lost to Follow-up|0|||
128877837|NCT00196976|463846335|FG002|Booster Study|Lost to Follow-up|0|||
128877838|NCT00196976|463846336|FG003|Booster Study|Lost to Follow-up|0|||
128877839|NCT00196976|463846337|FG004|Booster Study|Lost to Follow-up|0|||
128877840|NCT00196976|463846338|FG005|Booster Study|Lost to Follow-up|0|||
128877841|NCT00196976|463846339|FG006|Booster Study|Lost to Follow-up|0|||
128877842|NCT00196976|463846340|FG007|Booster Study|Lost to Follow-up|0|||
128877843|NCT00196976|463846341|FG008|Booster Study|Lost to Follow-up|0|||
128877844|NCT00196976|463846342|FG009|Booster Study|Lost to Follow-up|0|||
128877845|NCT00196976|463846343|FG010|Booster Study|Lost to Follow-up|1|||
128995769|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
128995770|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
128995771|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
128995772|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
128995773|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
128995774|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
128995775|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
128995776|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
128995777|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
128995778|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
128995779|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
128995780|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
128763093|NCT03145766|463422733|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
128763094|NCT03145766|463422734|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
128763095|NCT03145766|463422735|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
128763096|NCT03145766|463422736|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
128763097|NCT03145766|463422737|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
128763098|NCT03145766|463422733|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
128763099|NCT03145766|463422734|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
129040374|NCT00440466|464440131|FG000|Overall Study|Withdrawal by Subject|2|||
128877846|NCT00196976|463846344|FG011|Booster Study|Lost to Follow-up|2|||
128877847|NCT00196976|463846345|FG012|Booster Study|Lost to Follow-up|0|||
128995781|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
128995782|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
128995783|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
128995784|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
128995785|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
128995786|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
128995787|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
128995788|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
128995789|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
128995790|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
128995791|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
128995792|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
128995793|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
128995794|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
128995795|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
128995796|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
128995797|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
128995798|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
128995799|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
128995800|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
128995801|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
128995802|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
128995803|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
128995804|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
128995805|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
128995806|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
128995807|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
128995808|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
128995809|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
128995810|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
128995811|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
128995812|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
128995813|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
128995814|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
128995815|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
128995816|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
128995817|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
128995818|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
128995819|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
128995820|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
128995821|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
128995822|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
128995823|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
128995824|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
128995825|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
128995826|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
128995827|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
128995828|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
128995829|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
128995830|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
128995831|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
128995832|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
128995833|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
128995834|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
128995835|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
128995836|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
128995837|NCT04440163|464277620|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
128995838|NCT04440163|464277621|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
128995839|NCT04440163|464277622|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
128995840|NCT04440163|464277623|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
128995841|NCT04440163|464277624|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
128995842|NCT04440163|464277625|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
128995843|NCT04440163|464277626|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
128995844|NCT04440163|464277627|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
128995845|NCT04440163|464277620|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
128995846|NCT04440163|464277621|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
128995847|NCT04440163|464277622|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
128995848|NCT04440163|464277623|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
128995849|NCT04440163|464277624|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
128995850|NCT04440163|464277625|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
128995851|NCT04440163|464277626|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
128995852|NCT04440163|464277627|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
128995853|NCT04440163|464277620|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
128995854|NCT04440163|464277621|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
128995855|NCT04440163|464277622|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
128995856|NCT04440163|464277623|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
128995857|NCT04440163|464277624|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
128995858|NCT04440163|464277625|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
128995859|NCT04440163|464277626|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
128995860|NCT04440163|464277627|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
128995861|NCT02018042|464277630|FG000|Overall Study|Withdrawal by Subject|1|||
128995862|NCT01954082|464277631|FG000|Overall Study|Study Suspension|42|||
128995863|NCT01954082|464277632|FG001|Overall Study|Study Suspension|36|||
128877848|NCT00196976|463846346|FG013|Booster Study|Lost to Follow-up|0|||
128995864|NCT01954082|464277631|FG000|Overall Study|Adverse Event|10|||
128995865|NCT01954082|464277632|FG001|Overall Study|Adverse Event|4|||
128995866|NCT01954082|464277631|FG000|Overall Study|Intolerance|0|||
128995867|NCT01954082|464277632|FG001|Overall Study|Intolerance|1|||
128995868|NCT01954082|464277631|FG000|Overall Study|Non-compliance|6|||
128995869|NCT01954082|464277632|FG001|Overall Study|Non-compliance|4|||
128995870|NCT01954082|464277631|FG000|Overall Study|Physician Decision|2|||
128995871|NCT01954082|464277632|FG001|Overall Study|Physician Decision|0|||
128995872|NCT01954082|464277631|FG000|Overall Study|Parent Decision|1|||
128995873|NCT01954082|464277632|FG001|Overall Study|Parent Decision|0|||
128995874|NCT01954082|464277631|FG000|Overall Study|Withdrawal by Subject|0|||
128995875|NCT01954082|464277632|FG001|Overall Study|Withdrawal by Subject|1|||
128995876|NCT01954082|464277631|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
128995877|NCT01954082|464277632|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
128995878|NCT01954082|464277631|FG000|Overall Study|Redirection of Care|0|||
128995879|NCT01954082|464277632|FG001|Overall Study|Redirection of Care|2|||
128995880|NCT01954082|464277631|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
128995881|NCT01954082|464277632|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
128995882|NCT01954082|464277631|FG000|Overall Study|Comfort Care|0|||
128995883|NCT01954082|464277632|FG001|Overall Study|Comfort Care|1|||
128995884|NCT01954082|464277631|FG000|Overall Study|Infant Moved|0|||
128995885|NCT01954082|464277632|FG001|Overall Study|Infant Moved|1|||
128995886|NCT01954082|464277631|FG000|Overall Study|Randomized not Treated|4|||
128995887|NCT01954082|464277632|FG001|Overall Study|Randomized not Treated|2|||
128995888|NCT00417027|464277635|FG000|Overall Study|Protocol Violation|0|||
128995889|NCT00417027|464277636|FG001|Overall Study|Protocol Violation|5|||
128995890|NCT00417027|464277637|FG002|Overall Study|Protocol Violation|5|||
128995891|NCT00707174|464277638|FG000|Overall Study|Adverse Event|1|||
128995892|NCT00707174|464277639|FG001|Overall Study|Adverse Event|6|||
128995893|NCT00707174|464277638|FG000|Overall Study|Withdrawal by Subject|4|||
128995894|NCT00707174|464277639|FG001|Overall Study|Withdrawal by Subject|1|||
128995895|NCT00618774|464277642|FG000|Overall Study|Adverse Event|5|||
128995896|NCT00618774|464277643|FG001|Overall Study|Adverse Event|3|||
128995897|NCT00618774|464277642|FG000|Overall Study|Withdrawal by Subject|1|||
128995898|NCT00618774|464277643|FG001|Overall Study|Withdrawal by Subject|0|||
128995899|NCT00572156|464277644|FG000|Overall Study|Adverse Event|3|||
128995900|NCT00572156|464277645|FG001|Overall Study|Adverse Event|1|||
128995901|NCT00572156|464277646|FG002|Overall Study|Adverse Event|5|||
128995902|NCT00572156|464277647|FG003|Overall Study|Adverse Event|1|||
128995903|NCT00572156|464277644|FG000|Overall Study|Lost to Follow-up|1|||
128995904|NCT00572156|464277645|FG001|Overall Study|Lost to Follow-up|1|||
128995905|NCT00572156|464277646|FG002|Overall Study|Lost to Follow-up|1|||
128995906|NCT00572156|464277647|FG003|Overall Study|Lost to Follow-up|0|||
128995907|NCT00572156|464277644|FG000|Overall Study|Protocol Violation|1|||
128995908|NCT00572156|464277645|FG001|Overall Study|Protocol Violation|2|||
128995909|NCT00572156|464277646|FG002|Overall Study|Protocol Violation|0|||
128995910|NCT00572156|464277647|FG003|Overall Study|Protocol Violation|2|||
128995911|NCT00572156|464277644|FG000|Overall Study|Patient/Parent Decision|1|||
128995912|NCT00572156|464277645|FG001|Overall Study|Patient/Parent Decision|6|||
128995913|NCT00572156|464277646|FG002|Overall Study|Patient/Parent Decision|4|||
128995914|NCT00572156|464277647|FG003|Overall Study|Patient/Parent Decision|3|||
128995915|NCT00572156|464277644|FG000|Overall Study|Sponsor Decision|20|||
128995916|NCT00572156|464277645|FG001|Overall Study|Sponsor Decision|16|||
128995917|NCT00572156|464277646|FG002|Overall Study|Sponsor Decision|17|||
128995918|NCT00572156|464277647|FG003|Overall Study|Sponsor Decision|19|||
128995919|NCT02261974|464277648|FG000|Overall Study|Withdrawal by Subject|3|||
128995920|NCT02261974|464277649|FG001|Overall Study|Withdrawal by Subject|2|||
128995921|NCT02261974|464277648|FG000|Overall Study|Pregnancy|0|||
128995922|NCT02261974|464277649|FG001|Overall Study|Pregnancy|1|||
128995923|NCT02261974|464277648|FG000|Overall Study|Missed treatment cut-off date|6|||
128995924|NCT02261974|464277649|FG001|Overall Study|Missed treatment cut-off date|3|||
128877849|NCT02689518|463846347|FG000|Overall Study|Withdrawal by Subject|3|||
128995925|NCT02261974|464277648|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
128995926|NCT02261974|464277649|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
128995927|NCT02261974|464277648|FG000|Overall Study|Lost to Follow-up|2|||
128995928|NCT02261974|464277649|FG001|Overall Study|Lost to Follow-up|0|||
128995929|NCT02261974|464277648|FG000|Overall Study|Adverse Event|1|||
128995930|NCT02261974|464277649|FG001|Overall Study|Adverse Event|0|||
128995931|NCT05180630|464277653|FG000|First Intervention|Physician Decision|0|||
128995932|NCT05180630|464277654|FG001|First Intervention|Physician Decision|0|||
128995933|NCT05180630|464277655|FG002|First Intervention|Physician Decision|3|||
128995934|NCT00709735|464277663|FG000|Overall Study|Lost to Follow-up|1|||
128995935|NCT00709735|464277664|FG001|Overall Study|Lost to Follow-up|1|||
128995936|NCT00709735|464277663|FG000|Overall Study|Relapse into Opioid Abuse|0|||
128995937|NCT00709735|464277664|FG001|Overall Study|Relapse into Opioid Abuse|1|||
128995938|NCT00709735|464277663|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
128995939|NCT00709735|464277664|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
128995940|NCT00666718|464277665|FG000|Overall Study|Adverse Event|0|||
128995941|NCT00666718|464277666|FG001|Overall Study|Adverse Event|1|||
128995942|NCT00666718|464277665|FG000|Overall Study|Death|1|||
128995943|NCT00666718|464277666|FG001|Overall Study|Death|0|||
128995944|NCT00666718|464277665|FG000|Overall Study|Lost to Follow-up|1|||
128995945|NCT00666718|464277666|FG001|Overall Study|Lost to Follow-up|0|||
128995946|NCT00666718|464277665|FG000|Overall Study|Entry Criteria Not Met|2|||
128995947|NCT00666718|464277666|FG001|Overall Study|Entry Criteria Not Met|0|||
128995948|NCT00666718|464277665|FG000|Overall Study|Protocol Violation|1|||
128995949|NCT00666718|464277666|FG001|Overall Study|Protocol Violation|3|||
128995950|NCT00666718|464277665|FG000|Overall Study|Withdrawal by Subject|7|||
128995951|NCT00666718|464277666|FG001|Overall Study|Withdrawal by Subject|12|||
128995952|NCT00666718|464277665|FG000|Overall Study|Physician Decision|0|||
128995953|NCT00666718|464277666|FG001|Overall Study|Physician Decision|2|||
128995954|NCT00963599|464277667|FG000|Overall Study|Adverse Event|2|||
128995955|NCT00963599|464277668|FG001|Overall Study|Adverse Event|0|||
128995956|NCT00963599|464277669|FG002|Overall Study|Adverse Event|1|||
128995957|NCT00963599|464277670|FG003|Overall Study|Adverse Event|2|||
128995958|NCT00963599|464277667|FG000|Overall Study|Lack of Efficacy|0|||
128995959|NCT00963599|464277668|FG001|Overall Study|Lack of Efficacy|2|||
128995960|NCT00963599|464277669|FG002|Overall Study|Lack of Efficacy|1|||
128995961|NCT00963599|464277670|FG003|Overall Study|Lack of Efficacy|4|||
128995962|NCT00963599|464277667|FG000|Overall Study|Lost to Follow-up|0|||
128995963|NCT00963599|464277668|FG001|Overall Study|Lost to Follow-up|1|||
128995964|NCT00963599|464277669|FG002|Overall Study|Lost to Follow-up|1|||
128995965|NCT00963599|464277670|FG003|Overall Study|Lost to Follow-up|1|||
128995966|NCT00963599|464277667|FG000|Overall Study|Protocol Violation|2|||
128995967|NCT00963599|464277668|FG001|Overall Study|Protocol Violation|2|||
128995968|NCT00963599|464277669|FG002|Overall Study|Protocol Violation|3|||
128995969|NCT00963599|464277670|FG003|Overall Study|Protocol Violation|4|||
128995970|NCT00963599|464277667|FG000|Overall Study|Withdrawal by Subject|2|||
128995971|NCT00963599|464277668|FG001|Overall Study|Withdrawal by Subject|1|||
128995972|NCT00963599|464277669|FG002|Overall Study|Withdrawal by Subject|3|||
128995973|NCT00963599|464277670|FG003|Overall Study|Withdrawal by Subject|3|||
128995974|NCT03496207|464277673|FG000|Base Study|Adverse Event|0|||
128995975|NCT03496207|464277674|FG001|Base Study|Adverse Event|0|||
128995976|NCT03496207|464277675|FG002|Base Study|Adverse Event|1|||
128995977|NCT03496207|464277676|FG003|Base Study|Adverse Event|1|||
128995978|NCT03496207|464277677|FG004|Base Study|Adverse Event|4|||
128995979|NCT03496207|464277673|FG000|Base Study|Death|0|||
128995980|NCT03496207|464277674|FG001|Base Study|Death|0|||
128995981|NCT03496207|464277675|FG002|Base Study|Death|0|||
128995982|NCT03496207|464277676|FG003|Base Study|Death|0|||
128995983|NCT03496207|464277677|FG004|Base Study|Death|1|||
128995984|NCT03496207|464277673|FG000|Base Study|Withdrawal by Subject|0|||
128995985|NCT03496207|464277674|FG001|Base Study|Withdrawal by Subject|0|||
128995986|NCT03496207|464277675|FG002|Base Study|Withdrawal by Subject|1|||
128995987|NCT03496207|464277676|FG003|Base Study|Withdrawal by Subject|0|||
128995988|NCT03496207|464277677|FG004|Base Study|Withdrawal by Subject|1|||
128995989|NCT03496207|464277673|FG000|Extension Period|Adverse Event|0|||
128995990|NCT03496207|464277674|FG001|Extension Period|Adverse Event|0|||
128995991|NCT03496207|464277675|FG002|Extension Period|Adverse Event|0|||
128995992|NCT03496207|464277676|FG003|Extension Period|Adverse Event|1|||
128995993|NCT03496207|464277677|FG004|Extension Period|Adverse Event|1|||
128995994|NCT03496207|464277673|FG000|Extension Period|Death|1|||
128995995|NCT03496207|464277674|FG001|Extension Period|Death|0|||
128995996|NCT03496207|464277675|FG002|Extension Period|Death|0|||
128995997|NCT03496207|464277676|FG003|Extension Period|Death|1|||
128995998|NCT03496207|464277677|FG004|Extension Period|Death|2|||
128995999|NCT03496207|464277673|FG000|Extension Period|Withdrawal by Subject|1|||
128996000|NCT03496207|464277674|FG001|Extension Period|Withdrawal by Subject|0|||
128996001|NCT03496207|464277675|FG002|Extension Period|Withdrawal by Subject|0|||
128996002|NCT03496207|464277676|FG003|Extension Period|Withdrawal by Subject|1|||
128996003|NCT03496207|464277677|FG004|Extension Period|Withdrawal by Subject|1|||
128996004|NCT03496207|464277673|FG000|Extension Period|Elevated hemoglobin levels|0|||
128996005|NCT03496207|464277674|FG001|Extension Period|Elevated hemoglobin levels|0|||
128996006|NCT03496207|464277675|FG002|Extension Period|Elevated hemoglobin levels|0|||
128996007|NCT03496207|464277676|FG003|Extension Period|Elevated hemoglobin levels|0|||
128996008|NCT03496207|464277677|FG004|Extension Period|Elevated hemoglobin levels|1|||
128996009|NCT00810615|464277680|FG000|Overall Study|Withdrawal by Subject|1|||
128996010|NCT00810615|464277681|FG001|Overall Study|Withdrawal by Subject|1|||
128996011|NCT02525562|464277682|FG000|Overall Study|Death|9|||
128996012|NCT02525562|464277683|FG001|Overall Study|Death|0|||
128996013|NCT02525562|464277684|FG002|Overall Study|Death|0|||
128996014|NCT02525562|464277682|FG000|Overall Study|Lost to Follow-up|19|||
128996015|NCT02525562|464277683|FG001|Overall Study|Lost to Follow-up|0|||
128996016|NCT02525562|464277684|FG002|Overall Study|Lost to Follow-up|0|||
128996017|NCT02525562|464277682|FG000|Overall Study|Withdrawal by Subject|37|||
128996018|NCT02525562|464277683|FG001|Overall Study|Withdrawal by Subject|0|||
128996019|NCT02525562|464277684|FG002|Overall Study|Withdrawal by Subject|0|||
128996020|NCT02525562|464277682|FG000|Overall Study|Revision/Removal of Study Device|4|||
128996021|NCT02525562|464277683|FG001|Overall Study|Revision/Removal of Study Device|0|||
128996022|NCT02525562|464277684|FG002|Overall Study|Revision/Removal of Study Device|0|||
128996023|NCT02525562|464277682|FG000|Overall Study|Study Closed by Sponsor|154|||
128996024|NCT02525562|464277683|FG001|Overall Study|Study Closed by Sponsor|0|||
128996025|NCT02525562|464277684|FG002|Overall Study|Study Closed by Sponsor|0|||
128996026|NCT02567266|464277685|FG000|Overall Study|Withdrawal by Subject|10|||
128996027|NCT02567266|464277686|FG001|Overall Study|Withdrawal by Subject|7|||
128996028|NCT02567266|464277687|FG002|Overall Study|Withdrawal by Subject|6|||
128996029|NCT02567266|464277685|FG000|Overall Study|Lost to Follow-up|13|||
128996030|NCT02567266|464277686|FG001|Overall Study|Lost to Follow-up|8|||
128996031|NCT02567266|464277687|FG002|Overall Study|Lost to Follow-up|10|||
128996032|NCT02164539|464277688|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
128996033|NCT02164539|464277689|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
128996034|NCT02164539|464277690|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
128996035|NCT02164539|464277691|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
128996036|NCT02164539|464277692|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
128996037|NCT02164539|464277693|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
128996038|NCT02164539|464277694|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
128996039|NCT02164539|464277688|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
128996040|NCT02164539|464277689|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
128996041|NCT02164539|464277690|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
128996042|NCT02164539|464277691|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
128996043|NCT02164539|464277692|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
128996044|NCT02164539|464277693|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
128996045|NCT02164539|464277694|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
128996046|NCT02164539|464277688|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
128996047|NCT02164539|464277689|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
128996048|NCT02164539|464277690|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
128996049|NCT02164539|464277691|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
128996050|NCT02164539|464277692|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
128996051|NCT02164539|464277693|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
128996052|NCT02164539|464277694|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
128996053|NCT02164539|464277688|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
128996054|NCT02164539|464277689|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
128996055|NCT02164539|464277690|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
128996056|NCT02164539|464277691|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
128996057|NCT02164539|464277692|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
128996058|NCT02164539|464277693|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
128996059|NCT02164539|464277694|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
128996060|NCT02164539|464277688|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
128996061|NCT02164539|464277689|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
128996062|NCT02164539|464277690|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
128996063|NCT02164539|464277691|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
128996064|NCT02164539|464277692|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
128996065|NCT02164539|464277693|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
128996066|NCT02164539|464277694|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
128996067|NCT02164539|464277688|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
128996068|NCT02164539|464277689|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
128996069|NCT02164539|464277690|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
128996070|NCT02164539|464277691|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
128996071|NCT02164539|464277692|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
128996072|NCT02164539|464277693|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
128996073|NCT02164539|464277694|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
128996074|NCT01255722|464277695|FG000|Overall Study|Adverse Event|0|||
128996075|NCT01255722|464277696|FG001|Overall Study|Adverse Event|1|||
128996076|NCT01255722|464277697|FG002|Overall Study|Adverse Event|1|||
128996077|NCT01255722|464277695|FG000|Overall Study|asymptomatic patient|1|||
128996078|NCT01255722|464277696|FG001|Overall Study|asymptomatic patient|0|||
128996079|NCT01255722|464277697|FG002|Overall Study|asymptomatic patient|0|||
128996080|NCT01255722|464277695|FG000|Overall Study|beta-blocker contraindicated|2|||
128996081|NCT01255722|464277696|FG001|Overall Study|beta-blocker contraindicated|0|||
128996082|NCT01255722|464277697|FG002|Overall Study|beta-blocker contraindicated|0|||
128996083|NCT01612702|464277700|FG000|Overall Study|Protocol Violation|11|||
128996084|NCT01612702|464277701|FG001|Overall Study|Protocol Violation|11|||
128877850|NCT00825825|463846352|FG000|First Medication Period (14 Days)|Adverse Event|1|||
128996085|NCT01542736|464277702|FG000|Overall Study|Death|1|||
128996086|NCT02400905|464277703|FG000|Overall Study|Death|24|||
128996087|NCT02400905|464277703|FG000|Overall Study|Lost to Follow-up|18|||
128996088|NCT02400905|464277703|FG000|Overall Study|Withdrawal by Subject|16|||
128996089|NCT02400905|464277703|FG000|Overall Study|Physician Decision|4|||
128996090|NCT02400905|464277703|FG000|Overall Study|Other|1|||
128996091|NCT03091400|464277708|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
128996092|NCT03091400|464277709|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
128996093|NCT00420849|464277712|FG000|Overall Study|Lack of Efficacy|154|||
128996094|NCT00420849|464277712|FG000|Overall Study|Adverse Event|107|||
128996095|NCT00420849|464277712|FG000|Overall Study|Withdrawal by Subject|28|||
128996096|NCT00420849|464277712|FG000|Overall Study|Death|18|||
128996097|NCT00420849|464277712|FG000|Overall Study|Other|14|||
128996098|NCT00420849|464277712|FG000|Overall Study|Transplant|8|||
128996099|NCT00420849|464277712|FG000|Overall Study|Protocol Violation|1|||
128996100|NCT00420849|464277712|FG000|Overall Study|Lost to Follow-up|1|||
128996101|NCT00743119|464277715|FG000|Overall Study|unreliable|3|||
128996102|NCT00743119|464277715|FG000|Overall Study|Withdrawal by Subject|1|||
128996103|NCT04816877|464277716|FG000|Overall Study|Withdrawal by Subject|1|||
128996104|NCT04816877|464277717|FG001|Overall Study|Withdrawal by Subject|0|||
128996105|NCT02176642|464277719|FG000|Overall Study|Withdrawal by Subject|0|||
128996106|NCT02176642|464277720|FG001|Overall Study|Withdrawal by Subject|1|||
128996107|NCT01309828|464277721|FG000|Overall Study|Adverse Event|10|||
128996108|NCT01309828|464277722|FG001|Overall Study|Adverse Event|11|||
128996109|NCT01309828|464277721|FG000|Overall Study|Voluntary Withdrawal|5|||
128996110|NCT01309828|464277722|FG001|Overall Study|Voluntary Withdrawal|4|||
128996111|NCT01309828|464277721|FG000|Overall Study|Major Protocol Deviation|0|||
128996112|NCT01309828|464277722|FG001|Overall Study|Major Protocol Deviation|1|||
128996113|NCT01309828|464277721|FG000|Overall Study|Other|1|||
128996114|NCT01309828|464277722|FG001|Overall Study|Other|0|||
128996115|NCT00295620|464277723|FG000|Overall Study|Lost to Follow-up|9|||
128996116|NCT00295620|464277724|FG001|Overall Study|Lost to Follow-up|5|||
128996117|NCT00295620|464277723|FG000|Overall Study|Withdrawal by Subject|37|||
128996118|NCT00295620|464277724|FG001|Overall Study|Withdrawal by Subject|50|||
128996119|NCT00295620|464277723|FG000|Overall Study|Death|206|||
128996120|NCT00295620|464277724|FG001|Overall Study|Death|207|||
128996121|NCT00295620|464277723|FG000|Overall Study|Other reasons|10|||
128996122|NCT00295620|464277724|FG001|Overall Study|Other reasons|9|||
128996123|NCT00295620|464277723|FG000|Overall Study|Discontinuation by sponsor|580|||
128996124|NCT00295620|464277724|FG001|Overall Study|Discontinuation by sponsor|593|||
128996125|NCT00295620|464277723|FG000|Overall Study|Protocol Violation|30|||
128996126|NCT00295620|464277724|FG001|Overall Study|Protocol Violation|32|||
128996127|NCT00217971|464277725|FG000|Overall Study|Adverse Event|1|||
128996128|NCT00217971|464277726|FG001|Overall Study|Adverse Event|1|||
128996129|NCT00217971|464277725|FG000|Overall Study|Lost to Follow-up|15|||
128996130|NCT00217971|464277726|FG001|Overall Study|Lost to Follow-up|19|||
128996131|NCT00217971|464277725|FG000|Overall Study|Physician Decision|0|||
128996132|NCT00217971|464277726|FG001|Overall Study|Physician Decision|1|||
128996133|NCT00217971|464277725|FG000|Overall Study|Withdrawal by Subject|7|||
128996134|NCT00217971|464277726|FG001|Overall Study|Withdrawal by Subject|12|||
128996135|NCT00217971|464277725|FG000|Overall Study|non compliant|1|||
128996136|NCT00217971|464277726|FG001|Overall Study|non compliant|0|||
128996137|NCT02989610|464277727|FG000|Overall Study|Withdrawal by Subject|20|||
128996138|NCT02989610|464277727|FG000|Overall Study|Departure of PI from Site|8|||
128996139|NCT02989610|464277727|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
128996140|NCT02989610|464277727|FG000|Overall Study|Lost to Follow-up|3|||
128996141|NCT02989610|464277727|FG000|Overall Study|Death|3|||
128996142|NCT02989610|464277727|FG000|Overall Study|System Explant|3|||
128996143|NCT02989610|464277727|FG000|Overall Study|Subject Non-Compliance|2|||
128996144|NCT02989610|464277727|FG000|Overall Study|System Revision|2|||
128996145|NCT02989610|464277727|FG000|Overall Study|PI Left, Study Closing|1|||
128996146|NCT02989610|464277727|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
128996147|NCT02989610|464277727|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
128996148|NCT02556632|464277732|FG000|Overall Study|Lost to Follow-up|1|||
128996149|NCT02556632|464277733|FG001|Overall Study|Lost to Follow-up|0|||
128996150|NCT02556632|464277734|FG002|Overall Study|Lost to Follow-up|0|||
128996151|NCT02556632|464277732|FG000|Overall Study|Disliked Intervention|1|||
128996152|NCT02556632|464277733|FG001|Overall Study|Disliked Intervention|1|||
128996153|NCT02556632|464277734|FG002|Overall Study|Disliked Intervention|1|||
128996154|NCT02556632|464277732|FG000|Overall Study|No Reason|1|||
128996155|NCT02556632|464277733|FG001|Overall Study|No Reason|0|||
128996156|NCT02556632|464277734|FG002|Overall Study|No Reason|1|||
128996157|NCT02556632|464277732|FG000|Overall Study|Personal Issues|0|||
128996158|NCT02556632|464277733|FG001|Overall Study|Personal Issues|1|||
128996159|NCT02556632|464277734|FG002|Overall Study|Personal Issues|1|||
128996160|NCT02556632|464277732|FG000|Overall Study|Changed Mind|0|||
128996161|NCT02556632|464277733|FG001|Overall Study|Changed Mind|1|||
128996162|NCT02556632|464277734|FG002|Overall Study|Changed Mind|0|||
128996163|NCT02556632|464277732|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
128996164|NCT02556632|464277733|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
128996165|NCT02556632|464277734|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
128996166|NCT02556632|464277732|FG000|Overall Study|Unrelated Adverse Event|1|||
128996167|NCT02556632|464277733|FG001|Overall Study|Unrelated Adverse Event|0|||
128996168|NCT02556632|464277734|FG002|Overall Study|Unrelated Adverse Event|3|||
128996169|NCT02556632|464277732|FG000|Overall Study|Related Adverse Event|0|||
128996170|NCT02556632|464277733|FG001|Overall Study|Related Adverse Event|1|||
128996171|NCT02556632|464277734|FG002|Overall Study|Related Adverse Event|0|||
128996172|NCT02556632|464277732|FG000|Overall Study|Possibly Related Adverse Event|0|||
128996173|NCT02556632|464277733|FG001|Overall Study|Possibly Related Adverse Event|0|||
128996174|NCT02556632|464277734|FG002|Overall Study|Possibly Related Adverse Event|1|||
128996175|NCT02556632|464277732|FG000|Overall Study|Did Not Start RT|0|||
128996176|NCT02556632|464277733|FG001|Overall Study|Did Not Start RT|1|||
128996177|NCT02556632|464277734|FG002|Overall Study|Did Not Start RT|0|||
128996178|NCT02556632|464277732|FG000|Overall Study|Ineligible|0|||
128996179|NCT02556632|464277733|FG001|Overall Study|Ineligible|1|||
128996180|NCT02556632|464277734|FG002|Overall Study|Ineligible|0|||
128996181|NCT02556632|464277732|FG000|Overall Study|Disliked Study Procedures|0|||
128996182|NCT02556632|464277733|FG001|Overall Study|Disliked Study Procedures|0|||
128996183|NCT02556632|464277734|FG002|Overall Study|Disliked Study Procedures|1|||
128996184|NCT02556632|464277732|FG000|Overall Study|Treatment or Change Delay|0|||
128996185|NCT02556632|464277733|FG001|Overall Study|Treatment or Change Delay|0|||
128996186|NCT02556632|464277734|FG002|Overall Study|Treatment or Change Delay|1|||
128996187|NCT00808015|464277737|FG000|Overall Study|Death|1|||
128996188|NCT00808015|464277737|FG000|Overall Study|Lack of Efficacy|58|||
128996189|NCT00808015|464277737|FG000|Overall Study|Lost to Follow-up|76|||
128996190|NCT00808015|464277737|FG000|Overall Study|Participants not willing to participate|158|||
128996191|NCT00808015|464277737|FG000|Overall Study|Adverse Event|22|||
128996192|NCT00808015|464277737|FG000|Overall Study|Other|25|||
128996193|NCT00808015|464277737|FG000|Overall Study|Enrolled but not treated|4|||
128996194|NCT02574260|464277740|FG000|Overall Study|Disease Progression|1|||
128996195|NCT01066039|464277745|FG000|Overall Study|Adverse Event|6|||
128996196|NCT01066039|464277745|FG000|Overall Study|Withdrawal by Subject|17|||
128996197|NCT01066039|464277745|FG000|Overall Study|Protocol Violation|2|||
128996198|NCT01066039|464277745|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
128996199|NCT01066039|464277745|FG000|Overall Study|Investigator's Request|1|||
128996200|NCT01066039|464277745|FG000|Overall Study|Dropout due to Insulin Administration|1|||
128996201|NCT01066039|464277745|FG000|Overall Study|Additional Antihypertensive Required|4|||
128996202|NCT01066039|464277745|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
128996203|NCT01066039|464277745|FG000|Overall Study|Failure to Control Blood Pressure|1|||
128996204|NCT01066039|464277745|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
128996205|NCT04508621|464277746|FG000|Overall Study|Adverse Event|39|||
128996206|NCT04508621|464277747|FG001|Overall Study|Adverse Event|16|||
128996207|NCT04508621|464277746|FG000|Overall Study|Lack of Efficacy|2|||
128996208|NCT04508621|464277747|FG001|Overall Study|Lack of Efficacy|8|||
128996209|NCT04508621|464277746|FG000|Overall Study|Physician Decision|0|||
128996210|NCT04508621|464277747|FG001|Overall Study|Physician Decision|1|||
128996211|NCT04508621|464277746|FG000|Overall Study|Withdrawal by Subject|10|||
128996212|NCT04508621|464277747|FG001|Overall Study|Withdrawal by Subject|14|||
128996213|NCT04508621|464277746|FG000|Overall Study|Lost to Follow-up|12|||
128996214|NCT04508621|464277747|FG001|Overall Study|Lost to Follow-up|9|||
128996215|NCT04508621|464277746|FG000|Overall Study|COVID-19 related crisis|3|||
128996216|NCT04508621|464277747|FG001|Overall Study|COVID-19 related crisis|0|||
128996217|NCT04508621|464277746|FG000|Overall Study|Subject non-compliance|1|||
128996218|NCT04508621|464277747|FG001|Overall Study|Subject non-compliance|0|||
128996219|NCT00084617|464277757|FG000|Overall Study|Withdrawal by Subject|7|||
128996220|NCT00084617|464277757|FG000|Overall Study|Lack of Efficacy|1|||
128996221|NCT00084617|464277757|FG000|Overall Study|Protocol Violation|1|||
128996222|NCT01625286|464277758|FG000|Overall Study|Adverse Event|0|||
128996223|NCT01625286|464277759|FG001|Overall Study|Adverse Event|0|||
128996224|NCT01625286|464277760|FG002|Overall Study|Adverse Event|0|||
128996225|NCT01625286|464277761|FG003|Overall Study|Adverse Event|0|||
128996226|NCT01625286|464277762|FG004|Overall Study|Adverse Event|1|||
128996227|NCT01625286|464277763|FG005|Overall Study|Adverse Event|2|||
128996228|NCT01625286|464277764|FG006|Overall Study|Adverse Event|1|||
128996229|NCT01625286|464277758|FG000|Overall Study|Death|0|||
128996230|NCT01625286|464277759|FG001|Overall Study|Death|0|||
128877851|NCT00825825|463846353|FG001|First Medication Period (14 Days)|Adverse Event|0|||
128877852|NCT00825825|463846354|FG002|First Medication Period (14 Days)|Adverse Event|0|||
128877853|NCT00825825|463846355|FG003|First Medication Period (14 Days)|Adverse Event|0|||
128877854|NCT00825825|463846356|FG004|First Medication Period (14 Days)|Adverse Event|0|||
128996231|NCT01625286|464277760|FG002|Overall Study|Death|1|||
128996232|NCT01625286|464277761|FG003|Overall Study|Death|1|||
128996233|NCT01625286|464277762|FG004|Overall Study|Death|0|||
128996234|NCT01625286|464277763|FG005|Overall Study|Death|11|||
128996235|NCT01625286|464277764|FG006|Overall Study|Death|16|||
128996236|NCT01625286|464277758|FG000|Overall Study|Withdrawal by Subject|0|||
128996237|NCT01625286|464277759|FG001|Overall Study|Withdrawal by Subject|1|||
128996238|NCT01625286|464277760|FG002|Overall Study|Withdrawal by Subject|0|||
128877855|NCT00825825|463846357|FG005|First Medication Period (14 Days)|Adverse Event|1|||
128996239|NCT01625286|464277761|FG003|Overall Study|Withdrawal by Subject|1|||
128996240|NCT01625286|464277762|FG004|Overall Study|Withdrawal by Subject|0|||
128996241|NCT01625286|464277763|FG005|Overall Study|Withdrawal by Subject|0|||
128996242|NCT01625286|464277764|FG006|Overall Study|Withdrawal by Subject|1|||
128996243|NCT01625286|464277758|FG000|Overall Study|Any reason not specifically recorded|0|||
128996244|NCT01625286|464277759|FG001|Overall Study|Any reason not specifically recorded|0|||
128996245|NCT01625286|464277760|FG002|Overall Study|Any reason not specifically recorded|0|||
128996246|NCT01625286|464277761|FG003|Overall Study|Any reason not specifically recorded|0|||
128996247|NCT01625286|464277762|FG004|Overall Study|Any reason not specifically recorded|0|||
128996248|NCT01625286|464277763|FG005|Overall Study|Any reason not specifically recorded|1|||
128996249|NCT01625286|464277764|FG006|Overall Study|Any reason not specifically recorded|0|||
128996250|NCT01625286|464277758|FG000|Overall Study|Progressive disease|6|||
128996251|NCT01625286|464277759|FG001|Overall Study|Progressive disease|3|||
128996252|NCT01625286|464277760|FG002|Overall Study|Progressive disease|4|||
128996253|NCT01625286|464277761|FG003|Overall Study|Progressive disease|5|||
128996254|NCT01625286|464277762|FG004|Overall Study|Progressive disease|5|||
128996255|NCT01625286|464277763|FG005|Overall Study|Progressive disease|0|||
128996256|NCT01625286|464277764|FG006|Overall Study|Progressive disease|0|||
128996257|NCT01625286|464277758|FG000|Overall Study|Lost to Follow-up|0|||
128996258|NCT01625286|464277759|FG001|Overall Study|Lost to Follow-up|0|||
128996259|NCT01625286|464277760|FG002|Overall Study|Lost to Follow-up|0|||
128996260|NCT01625286|464277761|FG003|Overall Study|Lost to Follow-up|0|||
128996261|NCT01625286|464277762|FG004|Overall Study|Lost to Follow-up|0|||
128996262|NCT01625286|464277763|FG005|Overall Study|Lost to Follow-up|0|||
128996263|NCT01625286|464277764|FG006|Overall Study|Lost to Follow-up|1|||
128996264|NCT03338673|464277765|FG000|Overall Study|Lost to Follow-up|1|||
128996265|NCT03338673|464277766|FG001|Overall Study|Lost to Follow-up|1|||
128996266|NCT00828516|464277768|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
128996267|NCT02623426|464277775|FG000|Overall Study|Lost to Follow-up|0|||
128996268|NCT02623426|464277776|FG001|Overall Study|Lost to Follow-up|0|||
128996269|NCT02623426|464277777|FG002|Overall Study|Lost to Follow-up|1|||
128996270|NCT02623426|464277775|FG000|Overall Study|Withdrawal by Subject|1|||
128996271|NCT02623426|464277776|FG001|Overall Study|Withdrawal by Subject|2|||
128996272|NCT02623426|464277777|FG002|Overall Study|Withdrawal by Subject|2|||
128996273|NCT03724968|464279276|FG000|Overall Study|Insurance issues|0|||
128996274|NCT03724968|464279277|FG001|Overall Study|Insurance issues|1|||
128996275|NCT03724968|464279276|FG000|Overall Study|Study closed|0|||
128996276|NCT03724968|464279277|FG001|Overall Study|Study closed|1|||
128996277|NCT01142466|464279278|FG000|Overall Study|Adverse Event|2|||
128996278|NCT01142466|464279279|FG001|Overall Study|Adverse Event|1|||
128996279|NCT01142466|464279278|FG000|Overall Study|Withdrawal by Subject|1|||
128996280|NCT01142466|464279279|FG001|Overall Study|Withdrawal by Subject|1|||
128996281|NCT00569231|464279284|FG000|Overall Study|Study unrelated surgery|1|||
128996282|NCT00569231|464279284|FG000|Overall Study|Airfare expense|2|||
128996283|NCT00569231|464279284|FG000|Overall Study|Withdrawal by Subject|1|||
128996284|NCT00569231|464279284|FG000|Overall Study|Car accident injury|1|||
128996285|NCT00569231|464279284|FG000|Overall Study|Non-compliance|2|||
128996286|NCT00700310|464279287|FG000|Overall Study|Adverse Event|6|||
128996287|NCT00700310|464279288|FG001|Overall Study|Adverse Event|10|||
128996288|NCT00700310|464279289|FG002|Overall Study|Adverse Event|5|||
128996289|NCT00700310|464279290|FG003|Overall Study|Adverse Event|11|||
128996290|NCT00700310|464279287|FG000|Overall Study|Lost to Follow-up|4|||
128996291|NCT00700310|464279288|FG001|Overall Study|Lost to Follow-up|1|||
128996292|NCT00700310|464279289|FG002|Overall Study|Lost to Follow-up|0|||
128996293|NCT00700310|464279290|FG003|Overall Study|Lost to Follow-up|1|||
128996294|NCT00700310|464279287|FG000|Overall Study|Withdrawal by Subject|8|||
128996295|NCT00700310|464279288|FG001|Overall Study|Withdrawal by Subject|9|||
128996296|NCT00700310|464279289|FG002|Overall Study|Withdrawal by Subject|8|||
128996297|NCT00700310|464279290|FG003|Overall Study|Withdrawal by Subject|8|||
128996298|NCT00700310|464279287|FG000|Overall Study|Lack of Efficacy|0|||
128996299|NCT00700310|464279288|FG001|Overall Study|Lack of Efficacy|3|||
128996300|NCT00700310|464279289|FG002|Overall Study|Lack of Efficacy|0|||
128996301|NCT00700310|464279290|FG003|Overall Study|Lack of Efficacy|1|||
128996302|NCT00700310|464279287|FG000|Overall Study|Administrative/Other|1|||
128996303|NCT00700310|464279288|FG001|Overall Study|Administrative/Other|3|||
128996304|NCT00700310|464279289|FG002|Overall Study|Administrative/Other|1|||
128996305|NCT00700310|464279290|FG003|Overall Study|Administrative/Other|3|||
128996306|NCT00700310|464279287|FG000|Overall Study|Randomized, Not Treated|2|||
128996307|NCT00700310|464279288|FG001|Overall Study|Randomized, Not Treated|0|||
128996308|NCT00700310|464279289|FG002|Overall Study|Randomized, Not Treated|2|||
128996309|NCT00700310|464279290|FG003|Overall Study|Randomized, Not Treated|2|||
128996310|NCT00681824|464279295|FG000|Overall Study|withdrawn by investigator|0|||
128996311|NCT00681824|464279296|FG001|Overall Study|withdrawn by investigator|0|||
128996312|NCT00681824|464279297|FG002|Overall Study|withdrawn by investigator|1|||
128996313|NCT00681824|464279295|FG000|Overall Study|scheduling conflict|1|||
128996314|NCT00681824|464279296|FG001|Overall Study|scheduling conflict|0|||
128996315|NCT00681824|464279297|FG002|Overall Study|scheduling conflict|0|||
128996316|NCT00681824|464279295|FG000|Overall Study|Death|0|||
128996317|NCT00681824|464279296|FG001|Overall Study|Death|1|||
128996318|NCT00681824|464279297|FG002|Overall Study|Death|0|||
128996319|NCT03724916|464279298|FG000|Overall Study|Withdrawal by Subject|0|||
128996320|NCT03724916|464279299|FG001|Overall Study|Withdrawal by Subject|1|||
128996321|NCT03724916|464279300|FG002|Overall Study|Withdrawal by Subject|1|||
128996322|NCT03724916|464279301|FG003|Overall Study|Withdrawal by Subject|2|||
128996323|NCT03724916|464279298|FG000|Overall Study|Randomized but not Treated|1|||
128996324|NCT03724916|464279299|FG001|Overall Study|Randomized but not Treated|0|||
128996325|NCT03724916|464279300|FG002|Overall Study|Randomized but not Treated|0|||
128996326|NCT03724916|464279301|FG003|Overall Study|Randomized but not Treated|0|||
128996327|NCT04575038|464279302|FG000|Overall Study|Withdrawal by Subject|1|||
128996328|NCT04575038|464279303|FG001|Overall Study|Withdrawal by Subject|1|||
128996329|NCT03591107|464279309|FG000|Overall Study|Same patient in both arms|1|||
128996330|NCT03591107|464279310|FG001|Overall Study|Same patient in both arms|1|||
128996331|NCT03591107|464279309|FG000|Overall Study|Sought care at other clinics|0|||
128996332|NCT03591107|464279310|FG001|Overall Study|Sought care at other clinics|2|||
128996333|NCT03591107|464279309|FG000|Overall Study|Discharged from clinic|0|||
128996334|NCT03591107|464279310|FG001|Overall Study|Discharged from clinic|1|||
128996335|NCT03591107|464279309|FG000|Overall Study|Withdrawal by Subject|0|||
128996336|NCT03591107|464279310|FG001|Overall Study|Withdrawal by Subject|1|||
128996337|NCT01902134|464279313|FG000|Overall Study|Adverse Event|3|||
128996338|NCT01902134|464279314|FG001|Overall Study|Adverse Event|1|||
128996339|NCT01902134|464279315|FG002|Overall Study|Adverse Event|2|||
128996340|NCT01902134|464279316|FG003|Overall Study|Adverse Event|1|||
128996341|NCT01902134|464279317|FG004|Overall Study|Adverse Event|1|||
128996342|NCT01902134|464279318|FG005|Overall Study|Adverse Event|3|||
128996343|NCT01902134|464279313|FG000|Overall Study|Lack of Efficacy|0|||
128996344|NCT01902134|464279314|FG001|Overall Study|Lack of Efficacy|0|||
128996345|NCT01902134|464279315|FG002|Overall Study|Lack of Efficacy|2|||
128996346|NCT01902134|464279316|FG003|Overall Study|Lack of Efficacy|0|||
128996347|NCT01902134|464279317|FG004|Overall Study|Lack of Efficacy|0|||
128996348|NCT01902134|464279318|FG005|Overall Study|Lack of Efficacy|1|||
128996349|NCT01902134|464279313|FG000|Overall Study|Physician Decision|0|||
128996350|NCT01902134|464279314|FG001|Overall Study|Physician Decision|1|||
128996351|NCT01902134|464279315|FG002|Overall Study|Physician Decision|0|||
128996352|NCT01902134|464279316|FG003|Overall Study|Physician Decision|0|||
128996353|NCT01902134|464279317|FG004|Overall Study|Physician Decision|0|||
128996354|NCT01902134|464279318|FG005|Overall Study|Physician Decision|0|||
128996355|NCT01902134|464279313|FG000|Overall Study|Protocol Violation|0|||
128996356|NCT01902134|464279314|FG001|Overall Study|Protocol Violation|0|||
128996357|NCT01902134|464279315|FG002|Overall Study|Protocol Violation|0|||
128996358|NCT01902134|464279316|FG003|Overall Study|Protocol Violation|0|||
128996359|NCT01902134|464279317|FG004|Overall Study|Protocol Violation|0|||
128996360|NCT01902134|464279318|FG005|Overall Study|Protocol Violation|1|||
128996361|NCT01902134|464279313|FG000|Overall Study|Withdrawal by Subject|4|||
128996362|NCT01902134|464279314|FG001|Overall Study|Withdrawal by Subject|8|||
128996363|NCT01902134|464279315|FG002|Overall Study|Withdrawal by Subject|9|||
128996364|NCT01902134|464279316|FG003|Overall Study|Withdrawal by Subject|1|||
128996365|NCT01902134|464279317|FG004|Overall Study|Withdrawal by Subject|5|||
128996366|NCT01902134|464279318|FG005|Overall Study|Withdrawal by Subject|4|||
128996367|NCT01902134|464279313|FG000|Overall Study|no compliance|1|||
128996368|NCT01902134|464279314|FG001|Overall Study|no compliance|0|||
128996369|NCT01902134|464279315|FG002|Overall Study|no compliance|0|||
128996370|NCT01902134|464279316|FG003|Overall Study|no compliance|0|||
128996371|NCT01902134|464279317|FG004|Overall Study|no compliance|0|||
128996372|NCT01902134|464279318|FG005|Overall Study|no compliance|0|||
128996373|NCT01902134|464279313|FG000|Overall Study|Other|0|||
128996374|NCT01902134|464279314|FG001|Overall Study|Other|1|||
128996375|NCT01902134|464279315|FG002|Overall Study|Other|2|||
128996376|NCT01902134|464279316|FG003|Overall Study|Other|0|||
128996377|NCT01902134|464279317|FG004|Overall Study|Other|1|||
128996378|NCT01902134|464279318|FG005|Overall Study|Other|0|||
128996379|NCT00305110|464279319|FG000|Overall Study|Missing data|29|||
128996380|NCT00678379|464279320|FG000|Overall Study|Injection performed after tonsillectomy|2|||
128996381|NCT00678379|464279321|FG001|Overall Study|Injection performed after tonsillectomy|0|||
128996382|NCT00678379|464279322|FG002|Overall Study|Injection performed after tonsillectomy|1|||
128996383|NCT00678379|464279320|FG000|Overall Study|Incomplete Data|4|||
128996384|NCT00678379|464279321|FG001|Overall Study|Incomplete Data|3|||
128996385|NCT00678379|464279322|FG002|Overall Study|Incomplete Data|3|||
128996386|NCT00350519|464279334|FG000|Overall Study|Death|0|||
128996387|NCT00350519|464279335|FG001|Overall Study|Death|1|||
128996388|NCT00350519|464279334|FG000|Overall Study|Physician Decision|0|||
128996389|NCT00350519|464279335|FG001|Overall Study|Physician Decision|1|||
128996390|NCT00350519|464279334|FG000|Overall Study|Protocol Violation|1|||
128996391|NCT00350519|464279335|FG001|Overall Study|Protocol Violation|2|||
128996392|NCT00350519|464279334|FG000|Overall Study|Withdrawal by Subject|3|||
128996393|NCT00350519|464279335|FG001|Overall Study|Withdrawal by Subject|2|||
128996394|NCT03836729|464279336|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
128996395|NCT01020305|464279346|FG000|Overall Study|Adverse Event|2|||
128996396|NCT01017029|464279350|FG000|Overall Study|Lost to Follow-up|1|||
128996397|NCT01017029|464279351|FG001|Overall Study|Lost to Follow-up|0|||
128996398|NCT01017029|464279350|FG000|Overall Study|Administrative problem|0|||
128996399|NCT01017029|464279351|FG001|Overall Study|Administrative problem|1|||
128996400|NCT01017029|464279350|FG000|Overall Study|Death|3|||
128996401|NCT01017029|464279351|FG001|Overall Study|Death|1|||
128996402|NCT02753400|464279353|FG000|Overall Study|Adverse Event|3|||
128996403|NCT02753400|464279354|FG001|Overall Study|Adverse Event|0|||
128996404|NCT02753400|464279353|FG000|Overall Study|Withdrawal by Subject|2|||
128996405|NCT02753400|464279354|FG001|Overall Study|Withdrawal by Subject|1|||
128996406|NCT01415921|464279355|FG000|Overall Study|Adverse Event|0|||
128996407|NCT01415921|464279356|FG001|Overall Study|Adverse Event|1|||
128996408|NCT01415921|464279355|FG000|Overall Study|Physician Decision|1|||
128996409|NCT01415921|464279356|FG001|Overall Study|Physician Decision|1|||
128996410|NCT01415921|464279355|FG000|Overall Study|Withdrawal by Subject|0|||
128996411|NCT01415921|464279356|FG001|Overall Study|Withdrawal by Subject|1|||
128996412|NCT01415921|464279355|FG000|Overall Study|Other|2|||
128996413|NCT01415921|464279356|FG001|Overall Study|Other|0|||
128996414|NCT01830920|464279361|FG000|Overall Study|Adverse Event|1|||
128996415|NCT01830920|464279362|FG001|Overall Study|Adverse Event|0|||
128996416|NCT01830920|464279363|FG002|Overall Study|Adverse Event|1|||
128996417|NCT01830920|464279364|FG003|Overall Study|Adverse Event|0|||
128996418|NCT01830920|464279365|FG004|Overall Study|Adverse Event|0|||
128996419|NCT01830920|464279361|FG000|Overall Study|Withdrawal by Subject|2|||
128996420|NCT01830920|464279362|FG001|Overall Study|Withdrawal by Subject|2|||
128996421|NCT01830920|464279363|FG002|Overall Study|Withdrawal by Subject|1|||
128996422|NCT01830920|464279364|FG003|Overall Study|Withdrawal by Subject|7|||
128996423|NCT01830920|464279365|FG004|Overall Study|Withdrawal by Subject|1|||
128996424|NCT01830920|464279361|FG000|Overall Study|Death|3|||
128996425|NCT01830920|464279362|FG001|Overall Study|Death|3|||
128996426|NCT01830920|464279363|FG002|Overall Study|Death|5|||
128996427|NCT01830920|464279364|FG003|Overall Study|Death|4|||
128996428|NCT01830920|464279365|FG004|Overall Study|Death|4|||
128996429|NCT01830920|464279361|FG000|Overall Study|Other|15|||
128996430|NCT01830920|464279362|FG001|Overall Study|Other|1|||
128996431|NCT01830920|464279363|FG002|Overall Study|Other|1|||
128996432|NCT01830920|464279364|FG003|Overall Study|Other|5|||
128996433|NCT01830920|464279365|FG004|Overall Study|Other|3|||
128996434|NCT03876873|464279366|FG000|Overall Study|Physician Decision|0|||
128996435|NCT03876873|464279367|FG001|Overall Study|Physician Decision|1|||
128996436|NCT03402126|464279369|FG000|Overall Study|Lost to Follow-up|6|||
128996437|NCT03402126|464279369|FG000|Overall Study|Protocol Violation|10|||
128996438|NCT03402126|464279369|FG000|Overall Study|Sponsor request/Study termination|29|||
128996439|NCT03402126|464279369|FG000|Overall Study|Study product no longer in use|1|||
128996440|NCT03402126|464279369|FG000|Overall Study|Technical problems|1|||
128996441|NCT03402126|464279369|FG000|Overall Study|Withdrawal by Subject|6|||
128996442|NCT03402126|464279369|FG000|Overall Study|Physician Decision|2|||
128996443|NCT03402126|464279369|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
128996444|NCT03402126|464279369|FG000|Overall Study|Death|4|||
128996445|NCT02117479|464279370|FG000|Overall Study|Death|13|||
128996446|NCT02117479|464279371|FG001|Overall Study|Death|8|||
128996447|NCT02117479|464279370|FG000|Overall Study|Adverse Event|8|||
128996448|NCT02117479|464279371|FG001|Overall Study|Adverse Event|16|||
128996449|NCT02117479|464279370|FG000|Overall Study|Subject decision|8|||
128996450|NCT02117479|464279371|FG001|Overall Study|Subject decision|9|||
128996451|NCT02117479|464279370|FG000|Overall Study|Disease progression|104|||
128996452|NCT02117479|464279371|FG001|Overall Study|Disease progression|108|||
128996453|NCT02117479|464279370|FG000|Overall Study|Noncompliance with study treatment|1|||
128996454|NCT02117479|464279371|FG001|Overall Study|Noncompliance with study treatment|0|||
128996455|NCT02117479|464279370|FG000|Overall Study|Study terminated by the sponsor|4|||
128996456|NCT02117479|464279371|FG001|Overall Study|Study terminated by the sponsor|6|||
128996457|NCT02117479|464279370|FG000|Overall Study|Physician Decision|7|||
128996458|NCT02117479|464279371|FG001|Overall Study|Physician Decision|2|||
128996459|NCT02117479|464279370|FG000|Overall Study|Other unspecified|11|||
128996460|NCT02117479|464279371|FG001|Overall Study|Other unspecified|7|||
128996461|NCT01959230|464279372|FG000|Overall Study|Failure to follow study procedures|0|||
128996462|NCT01959230|464279373|FG001|Overall Study|Failure to follow study procedures|1|||
128996463|NCT01959230|464279372|FG000|Overall Study|Administrative reasons|2|||
128996464|NCT01959230|464279373|FG001|Overall Study|Administrative reasons|0|||
128996465|NCT01959230|464279372|FG000|Overall Study|Withdrawal by Subject|2|||
128996466|NCT01959230|464279373|FG001|Overall Study|Withdrawal by Subject|0|||
128996467|NCT01453374|464279374|FG000|Overall Study|Adverse Event|7|||
128996468|NCT01453374|464279374|FG000|Overall Study|Lack of Efficacy|1|||
128996469|NCT01453374|464279374|FG000|Overall Study|Lost to Follow-up|3|||
128996470|NCT01453374|464279374|FG000|Overall Study|Withdrawal by Subject|5|||
128996471|NCT01453374|464279374|FG000|Overall Study|Incarcerated|2|||
128996472|NCT00720304|464279375|FG000|Overall Study|Withdrawal by Subject|14|||
128996473|NCT00720304|464279376|FG001|Overall Study|Withdrawal by Subject|1|||
128996474|NCT00720304|464279375|FG000|Overall Study|Death|1|||
128996475|NCT00720304|464279376|FG001|Overall Study|Death|0|||
128996476|NCT00720304|464279375|FG000|Overall Study|Physician Decision|5|||
128996477|NCT00720304|464279376|FG001|Overall Study|Physician Decision|2|||
128996478|NCT00720304|464279375|FG000|Overall Study|Adverse Event|3|||
128996479|NCT00720304|464279376|FG001|Overall Study|Adverse Event|1|||
128996480|NCT00720304|464279375|FG000|Overall Study|Disease progression|6|||
128996481|NCT00720304|464279376|FG001|Overall Study|Disease progression|1|||
128996482|NCT01333475|464279377|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
128996483|NCT01333475|464279378|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
128996484|NCT01333475|464279377|FG000|Overall Study|Toxicity|1|||
128996485|NCT01333475|464279378|FG001|Overall Study|Toxicity|3|||
128996486|NCT03674827|464279381|FG000|Treatment Phase|Adverse Event|0|||
128996487|NCT03674827|464279382|FG001|Treatment Phase|Adverse Event|0|||
128996488|NCT03674827|464279383|FG002|Treatment Phase|Adverse Event|0|||
128996489|NCT03674827|464279384|FG003|Treatment Phase|Adverse Event|0|||
128996490|NCT03674827|464279385|FG004|Treatment Phase|Adverse Event|0|||
128996491|NCT03674827|464279386|FG005|Treatment Phase|Adverse Event|2|||
128996492|NCT03674827|464279381|FG000|Treatment Phase|Death|2|||
128996493|NCT03674827|464279382|FG001|Treatment Phase|Death|0|||
128996494|NCT03674827|464279383|FG002|Treatment Phase|Death|0|||
128996495|NCT03674827|464279384|FG003|Treatment Phase|Death|0|||
128996496|NCT03674827|464279385|FG004|Treatment Phase|Death|1|||
128996497|NCT03674827|464279386|FG005|Treatment Phase|Death|0|||
128996498|NCT03674827|464279381|FG000|Treatment Phase|Progressive Disease|0|||
128996499|NCT03674827|464279382|FG001|Treatment Phase|Progressive Disease|4|||
128996500|NCT03674827|464279383|FG002|Treatment Phase|Progressive Disease|3|||
128996501|NCT03674827|464279384|FG003|Treatment Phase|Progressive Disease|4|||
128996502|NCT03674827|464279385|FG004|Treatment Phase|Progressive Disease|4|||
128996503|NCT03674827|464279386|FG005|Treatment Phase|Progressive Disease|9|||
128996504|NCT03674827|464279381|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
128996505|NCT03674827|464279382|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
128996506|NCT03674827|464279383|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
128996507|NCT03674827|464279384|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
128996508|NCT03674827|464279385|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
128996509|NCT03674827|464279386|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
128996510|NCT03674827|464279381|FG000|Treatment Phase|Withdrawal by Subject|0|||
128877856|NCT00825825|463846352|FG000|First Medication Period (14 Days)|Physician Decision|2|||
128877857|NCT00825825|463846353|FG001|First Medication Period (14 Days)|Physician Decision|0|||
128877858|NCT00825825|463846354|FG002|First Medication Period (14 Days)|Physician Decision|1|||
128877859|NCT00825825|463846355|FG003|First Medication Period (14 Days)|Physician Decision|0|||
128877860|NCT00825825|463846356|FG004|First Medication Period (14 Days)|Physician Decision|0|||
128877861|NCT00825825|463846357|FG005|First Medication Period (14 Days)|Physician Decision|1|||
128877862|NCT00825825|463846352|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
128877863|NCT00825825|463846353|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
128877864|NCT00825825|463846354|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
128877865|NCT00825825|463846355|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
128877866|NCT00825825|463846356|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
128877867|NCT00825825|463846357|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
128877868|NCT00825825|463846352|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
128877869|NCT00825825|463846353|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
128877870|NCT00825825|463846354|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
128877871|NCT00825825|463846355|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
128877872|NCT00825825|463846356|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
128877873|NCT00825825|463846357|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
128877874|NCT00825825|463846352|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
128877875|NCT00825825|463846353|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
128877876|NCT00825825|463846354|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
128877877|NCT00825825|463846355|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
128877878|NCT00825825|463846356|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
128877879|NCT00825825|463846357|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
128877880|NCT00825825|463846352|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
128877881|NCT00825825|463846353|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
128877882|NCT00825825|463846354|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
128877883|NCT00825825|463846355|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
128877884|NCT00825825|463846356|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
128877885|NCT00825825|463846357|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
128877886|NCT00825825|463846352|FG000|Third Medication Period (14 Days)|poor data quality|0|||
128877887|NCT00825825|463846353|FG001|Third Medication Period (14 Days)|poor data quality|1|||
128877888|NCT00825825|463846354|FG002|Third Medication Period (14 Days)|poor data quality|0|||
128877889|NCT00825825|463846355|FG003|Third Medication Period (14 Days)|poor data quality|0|||
128877890|NCT00825825|463846356|FG004|Third Medication Period (14 Days)|poor data quality|0|||
128877891|NCT00825825|463846357|FG005|Third Medication Period (14 Days)|poor data quality|0|||
128877892|NCT01920854|463846361|FG000|Overall Study|Withdrawal by Subject|1|||
128877893|NCT01920854|463846362|FG001|Overall Study|Withdrawal by Subject|0|||
128877894|NCT01920854|463846363|FG002|Overall Study|Withdrawal by Subject|0|||
128877895|NCT01920854|463846364|FG003|Overall Study|Withdrawal by Subject|0|||
128877896|NCT01920854|463846365|FG004|Overall Study|Withdrawal by Subject|1|||
128877897|NCT01920854|463846366|FG005|Overall Study|Withdrawal by Subject|0|||
128877898|NCT01920854|463846367|FG006|Overall Study|Withdrawal by Subject|1|||
128996511|NCT03674827|464279382|FG001|Treatment Phase|Withdrawal by Subject|0|||
128996512|NCT03674827|464279383|FG002|Treatment Phase|Withdrawal by Subject|0|||
128996513|NCT03674827|464279384|FG003|Treatment Phase|Withdrawal by Subject|0|||
128877899|NCT00757783|463846368|FG000|Overall Study|Adverse Event|0|||
128996514|NCT03674827|464279385|FG004|Treatment Phase|Withdrawal by Subject|0|||
128996515|NCT03674827|464279386|FG005|Treatment Phase|Withdrawal by Subject|1|||
128996516|NCT03674827|464279381|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
128996517|NCT03674827|464279382|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
128996518|NCT03674827|464279383|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
128996519|NCT03674827|464279384|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
128996520|NCT03674827|464279385|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
128996521|NCT03674827|464279386|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
128996522|NCT03674827|464279381|FG000|Treatment Phase|Other|0|||
128996523|NCT03674827|464279382|FG001|Treatment Phase|Other|1|||
128996524|NCT03674827|464279383|FG002|Treatment Phase|Other|0|||
128996525|NCT03674827|464279384|FG003|Treatment Phase|Other|0|||
128996526|NCT03674827|464279385|FG004|Treatment Phase|Other|0|||
128996527|NCT03674827|464279386|FG005|Treatment Phase|Other|1|||
128996528|NCT03674827|464279381|FG000|Long-Term Follow-up Phase|Death|2|||
128996529|NCT03674827|464279382|FG001|Long-Term Follow-up Phase|Death|4|||
128996530|NCT03674827|464279383|FG002|Long-Term Follow-up Phase|Death|2|||
128996531|NCT03674827|464279384|FG003|Long-Term Follow-up Phase|Death|3|||
128996532|NCT03674827|464279385|FG004|Long-Term Follow-up Phase|Death|2|||
128996533|NCT03674827|464279386|FG005|Long-Term Follow-up Phase|Death|6|||
128996534|NCT03674827|464279381|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
128877900|NCT00757783|463846369|FG001|Overall Study|Adverse Event|2|||
128877901|NCT00757783|463846368|FG000|Overall Study|Lost to Follow-up|1|||
128877902|NCT00757783|463846369|FG001|Overall Study|Lost to Follow-up|1|||
128877903|NCT00757783|463846368|FG000|Overall Study|Protocol Violation|1|||
128877904|NCT00757783|463846369|FG001|Overall Study|Protocol Violation|0|||
128877905|NCT00757783|463846368|FG000|Overall Study|Withdrawal by Subject|2|||
128877906|NCT00757783|463846369|FG001|Overall Study|Withdrawal by Subject|1|||
128877907|NCT00757783|463846368|FG000|Overall Study|Other|1|||
128877908|NCT00757783|463846369|FG001|Overall Study|Other|2|||
128877909|NCT01049217|463846374|FG000|Overall Study|Adverse Event|2|||
128877910|NCT01049217|463846375|FG001|Overall Study|Adverse Event|1|||
128877911|NCT01049217|463846374|FG000|Overall Study|Lack of Efficacy|1|||
128877912|NCT01049217|463846375|FG001|Overall Study|Lack of Efficacy|1|||
128877913|NCT01049217|463846374|FG000|Overall Study|Lost to Follow-up|3|||
128877914|NCT01049217|463846375|FG001|Overall Study|Lost to Follow-up|8|||
128877915|NCT01049217|463846374|FG000|Overall Study|Withdrawal by Subject|4|||
128877916|NCT01049217|463846375|FG001|Overall Study|Withdrawal by Subject|3|||
128877917|NCT01049217|463846374|FG000|Overall Study|Protocol Violation|1|||
128877918|NCT01049217|463846375|FG001|Overall Study|Protocol Violation|3|||
128877919|NCT01049217|463846374|FG000|Overall Study|Pregnancy|1|||
128877920|NCT01049217|463846375|FG001|Overall Study|Pregnancy|0|||
128877921|NCT01049217|463846374|FG000|Overall Study|Study Terminated by Sponsor|43|||
128877922|NCT01049217|463846375|FG001|Overall Study|Study Terminated by Sponsor|43|||
128877923|NCT01049217|463846374|FG000|Overall Study|Other|1|||
128877924|NCT01049217|463846375|FG001|Overall Study|Other|2|||
128877925|NCT01049217|463846374|FG000|Overall Study|Randomized but not Treated|0|||
128877926|NCT01049217|463846375|FG001|Overall Study|Randomized but not Treated|2|||
128877927|NCT00903682|463846376|FG000|Overall Study|Adverse Event|6|||
128877928|NCT00903682|463846377|FG001|Overall Study|Adverse Event|13|||
128877929|NCT00903682|463846376|FG000|Overall Study|Lost to Follow-up|1|||
128877930|NCT00903682|463846377|FG001|Overall Study|Lost to Follow-up|0|||
128877931|NCT00903682|463846376|FG000|Overall Study|Withdrawal by Subject|5|||
128877932|NCT00903682|463846377|FG001|Overall Study|Withdrawal by Subject|0|||
128877933|NCT00903682|463846376|FG000|Overall Study|Pregnancy|0|||
128877934|NCT00903682|463846377|FG001|Overall Study|Pregnancy|1|||
128877935|NCT00903682|463846376|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
128877936|NCT00903682|463846377|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
128877937|NCT00903682|463846376|FG000|Overall Study|Subject Non-Compliant|1|||
128877938|NCT00903682|463846377|FG001|Overall Study|Subject Non-Compliant|0|||
128877939|NCT00903682|463846376|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
128877940|NCT00903682|463846377|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
128877941|NCT00903682|463846376|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
128877942|NCT00903682|463846377|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
128877943|NCT02495792|463846378|FG000|Overall Study|Lost to Follow-up|5|||
128877944|NCT02495792|463846379|FG001|Overall Study|Lost to Follow-up|9|||
128877945|NCT02495792|463846378|FG000|Overall Study|Protocol Violation|32|||
128877946|NCT02495792|463846379|FG001|Overall Study|Protocol Violation|31|||
128877947|NCT01028027|463846380|FG000|Overall Study|Lost to Follow-up|4|||
128877948|NCT01028027|463846381|FG001|Overall Study|Lost to Follow-up|1|||
128877949|NCT01028027|463846380|FG000|Overall Study|Withdrawal by Subject|5|||
128877950|NCT01028027|463846381|FG001|Overall Study|Withdrawal by Subject|3|||
128996535|NCT03674827|464279382|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
128996536|NCT03674827|464279383|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
128877951|NCT01028027|463846380|FG000|Overall Study|Adverse Event|4|||
128877952|NCT01028027|463846381|FG001|Overall Study|Adverse Event|7|||
128877953|NCT01028027|463846380|FG000|Overall Study|Protocol Violation|3|||
128877954|NCT01028027|463846381|FG001|Overall Study|Protocol Violation|1|||
128877955|NCT01028027|463846380|FG000|Overall Study|Lack of Efficacy|0|||
128877956|NCT01028027|463846381|FG001|Overall Study|Lack of Efficacy|1|||
128996537|NCT03674827|464279384|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
128996538|NCT03674827|464279385|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
128996539|NCT03674827|464279386|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
128996540|NCT03674827|464279381|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
128996541|NCT03674827|464279382|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
128996542|NCT03674827|464279383|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
128996543|NCT03674827|464279384|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
128996544|NCT03674827|464279385|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
128996545|NCT03674827|464279386|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
128996546|NCT01783483|464279387|FG000|Overall Study|Death|3|||
128996547|NCT01783483|464279388|FG001|Overall Study|Death|3|||
128996548|NCT01783483|464279387|FG000|Overall Study|Lost to Follow-up|14|||
128996549|NCT01783483|464279388|FG001|Overall Study|Lost to Follow-up|10|||
128996550|NCT01783483|464279387|FG000|Overall Study|Withdrawal by Subject|2|||
128996551|NCT01783483|464279388|FG001|Overall Study|Withdrawal by Subject|1|||
128996552|NCT01783483|464279387|FG000|Overall Study|Physician Decision|1|||
128996553|NCT01783483|464279388|FG001|Overall Study|Physician Decision|1|||
128996554|NCT02624518|464279391|FG000|Overall Study|Physician Decision|1|||
128996555|NCT00370396|464279392|FG000|Overall Study|Withdrawal by Subject|0|||
128996556|NCT00370396|464279393|FG001|Overall Study|Withdrawal by Subject|0|||
128996557|NCT00370396|464279394|FG002|Overall Study|Withdrawal by Subject|1|||
128996558|NCT00370396|464279392|FG000|Overall Study|Lost to Follow-up|11|||
128996559|NCT00370396|464279393|FG001|Overall Study|Lost to Follow-up|1|||
128996560|NCT00370396|464279394|FG002|Overall Study|Lost to Follow-up|0|||
128996561|NCT01462695|464279395|FG000|Overall Study|Adverse Event|1|||
128996562|NCT01462695|464279396|FG001|Overall Study|Adverse Event|1|||
128996563|NCT01462695|464279395|FG000|Overall Study|Death|2|||
128996564|NCT01462695|464279396|FG001|Overall Study|Death|0|||
128996565|NCT01462695|464279395|FG000|Overall Study|Lack of Efficacy|6|||
128996566|NCT01462695|464279396|FG001|Overall Study|Lack of Efficacy|12|||
128996567|NCT01462695|464279395|FG000|Overall Study|Physician Decision|5|||
128996568|NCT01462695|464279396|FG001|Overall Study|Physician Decision|0|||
128996569|NCT01462695|464279395|FG000|Overall Study|Withdrawal by Subject|2|||
128996570|NCT01462695|464279396|FG001|Overall Study|Withdrawal by Subject|0|||
128996571|NCT01462695|464279395|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
128996572|NCT01462695|464279396|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
128996573|NCT01364298|464279398|FG000|Overall Study|Adverse Event|3|||
128996574|NCT01364298|464279399|FG001|Overall Study|Adverse Event|4|||
128996575|NCT01364298|464279398|FG000|Overall Study|Lack of adherence to treatment|1|||
128996576|NCT01364298|464279399|FG001|Overall Study|Lack of adherence to treatment|3|||
128996577|NCT01364298|464279398|FG000|Overall Study|Lack of Efficacy|1|||
128996578|NCT01364298|464279399|FG001|Overall Study|Lack of Efficacy|0|||
128996579|NCT01364298|464279398|FG000|Overall Study|Lost to Follow-up|5|||
128996580|NCT01364298|464279399|FG001|Overall Study|Lost to Follow-up|10|||
128996581|NCT01364298|464279398|FG000|Overall Study|Withdrawal by Subject|3|||
128996582|NCT01364298|464279399|FG001|Overall Study|Withdrawal by Subject|3|||
128996583|NCT01364298|464279398|FG000|Overall Study|Other|1|||
128996584|NCT01364298|464279399|FG001|Overall Study|Other|3|||
128996585|NCT00659581|464279402|FG000|Overall Study|Adverse Event|1006|||
128996586|NCT00659581|464279402|FG000|Overall Study|Lack of Efficacy|1183|||
128996587|NCT00659581|464279402|FG000|Overall Study|Other|6393|||
128996588|NCT03125629|464279406|FG000|Overall Study|Withdrawal by Subject|2|||
128996589|NCT03125629|464279406|FG000|Overall Study|Equipment malfunction|1|||
128996590|NCT03909971|464279407|FG000|Overall Study|Other Reasons Not Specified|0|||
128996591|NCT03909971|464279408|FG001|Overall Study|Other Reasons Not Specified|1|||
128996592|NCT03909971|464279407|FG000|Overall Study|Global Deterioration of Health Status|2|||
128996593|NCT03909971|464279408|FG001|Overall Study|Global Deterioration of Health Status|1|||
128996594|NCT03909971|464279407|FG000|Overall Study|Progressive Disease|6|||
128996595|NCT03909971|464279408|FG001|Overall Study|Progressive Disease|14|||
128996596|NCT03909971|464279407|FG000|Overall Study|Death|2|||
128996597|NCT03909971|464279408|FG001|Overall Study|Death|6|||
128996598|NCT04523831|464279414|FG000|Overall Study|Lost to Follow-up|15|||
128996599|NCT04523831|464279415|FG001|Overall Study|Lost to Follow-up|17|||
128996600|NCT04523831|464279414|FG000|Overall Study|Death|0|||
128996601|NCT04523831|464279415|FG001|Overall Study|Death|3|||
128996602|NCT04523831|464279414|FG000|Overall Study|Adverse Event|2|||
128996603|NCT04523831|464279415|FG001|Overall Study|Adverse Event|0|||
128996604|NCT00430638|464279420|FG000|Overall Study|Adverse Event|15|||
128996605|NCT00430638|464279421|FG001|Overall Study|Adverse Event|15|||
128996606|NCT00430638|464279420|FG000|Overall Study|Uncontrolled blood pressure|48|||
128996607|NCT00430638|464279421|FG001|Overall Study|Uncontrolled blood pressure|13|||
128996608|NCT00430638|464279420|FG000|Overall Study|Lost to Follow-up|1|||
128996609|NCT00430638|464279421|FG001|Overall Study|Lost to Follow-up|7|||
128996610|NCT00430638|464279420|FG000|Overall Study|Protocol Violation|6|||
128996611|NCT00430638|464279421|FG001|Overall Study|Protocol Violation|4|||
128996612|NCT00430638|464279420|FG000|Overall Study|Withdrawal by Subject|4|||
128996613|NCT00430638|464279421|FG001|Overall Study|Withdrawal by Subject|6|||
128996614|NCT00430638|464279420|FG000|Overall Study|Non-compliant|2|||
128996615|NCT00430638|464279421|FG001|Overall Study|Non-compliant|1|||
128996616|NCT00430638|464279420|FG000|Overall Study|Other|2|||
128996617|NCT00430638|464279421|FG001|Overall Study|Other|2|||
128996618|NCT03185949|464279422|FG000|ITT Analysis|Withdrawal by Subject|4|||
128996619|NCT03185949|464279423|FG001|ITT Analysis|Withdrawal by Subject|3|||
128996620|NCT03185949|464279422|FG000|PP Analysis|Protocol Violation|2|||
128996621|NCT03185949|464279423|FG001|PP Analysis|Protocol Violation|2|||
128996622|NCT03185949|464279422|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
128996623|NCT03185949|464279423|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
128996624|NCT05166421|464279432|FG000|Overall Study|Other|3|||
128996625|NCT05166421|464279433|FG001|Overall Study|Other|1|||
128996626|NCT05166421|464279434|FG002|Overall Study|Other|1|||
128996627|NCT05166421|464279432|FG000|Overall Study|Withdrawal by Subject|5|||
128996628|NCT05166421|464279433|FG001|Overall Study|Withdrawal by Subject|3|||
128996629|NCT05166421|464279434|FG002|Overall Study|Withdrawal by Subject|6|||
128996630|NCT05166421|464279432|FG000|Overall Study|Lost to Follow-up|4|||
128996631|NCT05166421|464279433|FG001|Overall Study|Lost to Follow-up|1|||
128996632|NCT05166421|464279434|FG002|Overall Study|Lost to Follow-up|7|||
128996633|NCT01858558|464281333|FG000|Overall Study|Death|1|||
128996634|NCT01858558|464281334|FG001|Overall Study|Death|1|||
128996635|NCT01858558|464281333|FG000|Overall Study|Lost to Follow-up|1|||
128996636|NCT01858558|464281334|FG001|Overall Study|Lost to Follow-up|0|||
128996637|NCT01858558|464281333|FG000|Overall Study|Disease progression|3|||
128996638|NCT01858558|464281334|FG001|Overall Study|Disease progression|1|||
128996639|NCT01858558|464281333|FG000|Overall Study|Product contamination|2|||
128996640|NCT01858558|464281334|FG001|Overall Study|Product contamination|0|||
128996641|NCT01858558|464281333|FG000|Overall Study|Failed expansion of cell product|2|||
128996642|NCT01858558|464281334|FG001|Overall Study|Failed expansion of cell product|0|||
128996643|NCT02598622|464281336|FG000|Overall Study|Withdrawal by Subject|3|||
128996644|NCT02598622|464281337|FG001|Overall Study|Withdrawal by Subject|0|||
128996645|NCT02598622|464281336|FG000|Overall Study|Physician Decision|3|||
128996646|NCT02598622|464281337|FG001|Overall Study|Physician Decision|0|||
128996647|NCT04335110|464281353|FG000|Overall Study|Withdrawal by Subject|1|||
128996648|NCT04335110|464281354|FG001|Overall Study|Withdrawal by Subject|1|||
128996649|NCT04335110|464281353|FG000|Overall Study|Death|0|||
128996650|NCT04335110|464281354|FG001|Overall Study|Death|1|||
128996651|NCT02595528|464281355|FG000|Overall Study|Withdrawal by Subject|1|||
128996652|NCT02595528|464281356|FG001|Overall Study|Withdrawal by Subject|2|||
128996653|NCT02595528|464281357|FG002|Overall Study|Withdrawal by Subject|1|||
128996654|NCT02595528|464281358|FG003|Overall Study|Withdrawal by Subject|3|||
128996655|NCT02595528|464281355|FG000|Overall Study|Lost to Follow-up|1|||
128996656|NCT02595528|464281356|FG001|Overall Study|Lost to Follow-up|1|||
128996657|NCT02595528|464281357|FG002|Overall Study|Lost to Follow-up|0|||
128996658|NCT02595528|464281358|FG003|Overall Study|Lost to Follow-up|1|||
128996659|NCT00948025|464281359|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
128996660|NCT00948025|464281360|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
128996661|NCT00948025|464281359|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
128996662|NCT00948025|464281360|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
128996663|NCT00948025|464281359|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
128996664|NCT00948025|464281360|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
128996665|NCT01637961|464281361|FG000|Overall Study|Ineligible: wrong primary|1|||
128996666|NCT01637961|464281361|FG000|Overall Study|Ineligible: inadequate pathology|1|||
128996667|NCT03101293|464281365|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
128996668|NCT03101293|464281366|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
128996669|NCT03862625|464281373|FG000|Overall Study|Lost to Follow-up|0|||
128996670|NCT03862625|464281374|FG001|Overall Study|Lost to Follow-up|1|||
128996671|NCT01270841|464281375|FG000|Overall Study|Adverse Event|0|||
128996672|NCT01270841|464281376|FG001|Overall Study|Adverse Event|1|||
128996673|NCT01270841|464281377|FG002|Overall Study|Adverse Event|0|||
128996674|NCT01270841|464281378|FG003|Overall Study|Adverse Event|3|||
128996675|NCT01270841|464281375|FG000|Overall Study|Withdrawal by Subject|3|||
128996676|NCT01270841|464281376|FG001|Overall Study|Withdrawal by Subject|2|||
128996677|NCT01270841|464281377|FG002|Overall Study|Withdrawal by Subject|3|||
128996678|NCT01270841|464281378|FG003|Overall Study|Withdrawal by Subject|3|||
128996679|NCT01270841|464281375|FG000|Overall Study|Lost to Follow-up|3|||
128996680|NCT01270841|464281376|FG001|Overall Study|Lost to Follow-up|1|||
128996681|NCT01270841|464281377|FG002|Overall Study|Lost to Follow-up|4|||
128996682|NCT01270841|464281378|FG003|Overall Study|Lost to Follow-up|2|||
128996683|NCT01270841|464281375|FG000|Overall Study|Physician Decision|0|||
128996684|NCT01270841|464281376|FG001|Overall Study|Physician Decision|1|||
128996685|NCT01270841|464281377|FG002|Overall Study|Physician Decision|0|||
128996686|NCT01270841|464281378|FG003|Overall Study|Physician Decision|0|||
128996687|NCT01270841|464281375|FG000|Overall Study|Did not qualify|6|||
128996688|NCT01270841|464281376|FG001|Overall Study|Did not qualify|3|||
128996689|NCT01270841|464281377|FG002|Overall Study|Did not qualify|4|||
128996690|NCT01270841|464281378|FG003|Overall Study|Did not qualify|5|||
128996691|NCT01270841|464281375|FG000|Overall Study|Protocol Violation|1|||
128996692|NCT01270841|464281376|FG001|Overall Study|Protocol Violation|5|||
128996693|NCT01270841|464281377|FG002|Overall Study|Protocol Violation|0|||
128996694|NCT01270841|464281378|FG003|Overall Study|Protocol Violation|0|||
128996695|NCT01270841|464281375|FG000|Overall Study|Enrolled in error|0|||
128996696|NCT01270841|464281376|FG001|Overall Study|Enrolled in error|1|||
128996697|NCT01270841|464281377|FG002|Overall Study|Enrolled in error|0|||
128996698|NCT01270841|464281378|FG003|Overall Study|Enrolled in error|0|||
128996699|NCT02082912|464281379|FG000|Overall Study|Physician Decision|0|||
128996700|NCT02082912|464281380|FG001|Overall Study|Physician Decision|1|||
128996701|NCT03333382|464281385|FG000|Overall Study|Lost to Follow-up|1|||
128996702|NCT03333382|464281386|FG001|Overall Study|Lost to Follow-up|0|||
128996703|NCT00550420|464281387|FG000|Overall Study|Adverse Event|28|||
128996704|NCT00550420|464281387|FG000|Overall Study|Lost to Follow-up|8|||
128996705|NCT00550420|464281387|FG000|Overall Study|Protocol Violation|11|||
128996706|NCT00550420|464281387|FG000|Overall Study|Withdrawal by Subject|30|||
128996707|NCT00550420|464281387|FG000|Overall Study|Still in study at termination|206|||
128996708|NCT00550420|464281387|FG000|Overall Study|Missing|2|||
128996709|NCT00550420|464281387|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
128996710|NCT00550420|464281387|FG000|Overall Study|Investigators opinion|1|||
128996711|NCT00550420|464281387|FG000|Overall Study|Lack of curative effect|1|||
128996712|NCT00550420|464281387|FG000|Overall Study|Unethical stop of enrollment|2|||
128996713|NCT00550420|464281387|FG000|Overall Study|Caregiver's decision to withdraw|1|||
128996714|NCT00550420|464281387|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
128996715|NCT00550420|464281387|FG000|Overall Study|Exclusion criteria|1|||
128996716|NCT00550420|464281387|FG000|Overall Study|Prohibited medicine|1|||
128996717|NCT02773446|464281393|FG000|First Admission|Withdrawal by Subject|0|||
128996718|NCT02773446|464281394|FG001|First Admission|Withdrawal by Subject|0|||
128996719|NCT02773446|464281395|FG002|First Admission|Withdrawal by Subject|0|||
128996720|NCT02773446|464281396|FG003|First Admission|Withdrawal by Subject|1|||
128996721|NCT02773446|464281397|FG004|First Admission|Withdrawal by Subject|0|||
128996722|NCT02773446|464281398|FG005|First Admission|Withdrawal by Subject|0|||
128996723|NCT02773446|464281393|FG000|First Admission|Lost to Follow-up|1|||
128996724|NCT02773446|464281394|FG001|First Admission|Lost to Follow-up|0|||
128996725|NCT02773446|464281395|FG002|First Admission|Lost to Follow-up|0|||
128996726|NCT02773446|464281396|FG003|First Admission|Lost to Follow-up|0|||
128996727|NCT02773446|464281397|FG004|First Admission|Lost to Follow-up|0|||
128996728|NCT02773446|464281398|FG005|First Admission|Lost to Follow-up|0|||
128996729|NCT04378010|464281399|FG000|Overall Study|Adverse Event|8|||
128996730|NCT04378010|464281400|FG001|Overall Study|Adverse Event|14|||
128996731|NCT04378010|464281401|FG002|Overall Study|Adverse Event|4|||
128996732|NCT04378010|464281399|FG000|Overall Study|Withdrawal by Subject|0|||
128996733|NCT04378010|464281400|FG001|Overall Study|Withdrawal by Subject|2|||
128996734|NCT04378010|464281401|FG002|Overall Study|Withdrawal by Subject|1|||
128996735|NCT04378010|464281399|FG000|Overall Study|Protocol Violation|2|||
128996736|NCT04378010|464281400|FG001|Overall Study|Protocol Violation|1|||
128996737|NCT04378010|464281401|FG002|Overall Study|Protocol Violation|4|||
128996738|NCT04378010|464281399|FG000|Overall Study|Study terminated by Sponsor|22|||
128996739|NCT04378010|464281400|FG001|Overall Study|Study terminated by Sponsor|16|||
128996740|NCT04378010|464281401|FG002|Overall Study|Study terminated by Sponsor|22|||
128996741|NCT04378010|464281399|FG000|Overall Study|Subject inability to complete study visit|0|||
128996742|NCT04378010|464281400|FG001|Overall Study|Subject inability to complete study visit|0|||
128996743|NCT04378010|464281401|FG002|Overall Study|Subject inability to complete study visit|1|||
128996744|NCT04378010|464281399|FG000|Overall Study|Subject never dosed|0|||
128996745|NCT04378010|464281400|FG001|Overall Study|Subject never dosed|1|||
128996746|NCT04378010|464281401|FG002|Overall Study|Subject never dosed|0|||
128996747|NCT02513459|464281402|FG000|Overall Study|Adverse Event|7|||
128996748|NCT02513459|464281402|FG000|Overall Study|Withdrew consent|5|||
128996749|NCT02513459|464281402|FG000|Overall Study|Loss of efficacy|2|||
128996750|NCT02513459|464281402|FG000|Overall Study|Pregnancy|2|||
128996751|NCT02513459|464281402|FG000|Overall Study|Subject decision|2|||
128996752|NCT02513459|464281402|FG000|Overall Study|Lack of response|1|||
128996753|NCT02513459|464281402|FG000|Overall Study|Reproductive plans|1|||
128996754|NCT02513459|464281402|FG000|Overall Study|Surgery planned-- not done|1|||
128996755|NCT03237611|464281403|FG000|Overall Study|Withdrawal by Subject|1|||
128996756|NCT03237611|464281403|FG000|Overall Study|Ineligible|1|||
128996757|NCT04023994|464281404|FG000|Overall Study|Lost to Follow-up|0|||
128996758|NCT04023994|464281405|FG001|Overall Study|Lost to Follow-up|1|||
128996759|NCT04023994|464281406|FG002|Overall Study|Lost to Follow-up|2|||
128996760|NCT04023994|464281407|FG003|Overall Study|Lost to Follow-up|0|||
128996761|NCT04023994|464281408|FG004|Overall Study|Lost to Follow-up|0|||
128996762|NCT04023994|464281409|FG005|Overall Study|Lost to Follow-up|0|||
128996763|NCT04023994|464281404|FG000|Overall Study|Withdrawal by Subject|0|||
128996764|NCT04023994|464281405|FG001|Overall Study|Withdrawal by Subject|0|||
128996765|NCT04023994|464281406|FG002|Overall Study|Withdrawal by Subject|0|||
128996766|NCT04023994|464281407|FG003|Overall Study|Withdrawal by Subject|1|||
128996767|NCT04023994|464281408|FG004|Overall Study|Withdrawal by Subject|0|||
128996768|NCT04023994|464281409|FG005|Overall Study|Withdrawal by Subject|0|||
128996769|NCT00923195|464281410|FG000|Overall Study|Death|0|||
128996770|NCT00923195|464281411|FG001|Overall Study|Death|1|||
128996771|NCT01613131|464281412|FG000|Overall Study|Withdrawal by Subject|3|||
128996772|NCT01613131|464281413|FG001|Overall Study|Withdrawal by Subject|5|||
128996773|NCT00787566|464281416|FG000|Overall Study|AE related to chemotherapy|0|||
128996774|NCT00787566|464281417|FG001|Overall Study|AE related to chemotherapy|1|||
128996775|NCT00787566|464281418|FG002|Overall Study|AE related to chemotherapy|0|||
128996776|NCT01814761|464281419|FG000|Overall Study|Other Reasons|1|||
128996777|NCT01814761|464281420|FG001|Overall Study|Other Reasons|10|||
128996778|NCT01814761|464281419|FG000|Overall Study|Ocular Adverse Event|6|||
128996779|NCT01814761|464281420|FG001|Overall Study|Ocular Adverse Event|15|||
128996780|NCT01814761|464281419|FG000|Overall Study|Lost to Follow-up|1|||
128996781|NCT01814761|464281420|FG001|Overall Study|Lost to Follow-up|5|||
128996782|NCT03137082|464281421|FG000|Overall Study|Withdrawal by Subject|1|||
128996783|NCT03137082|464281422|FG001|Overall Study|Withdrawal by Subject|1|||
128996784|NCT03137082|464281421|FG000|Overall Study|Lost to Follow-up|1|||
128996785|NCT03137082|464281422|FG001|Overall Study|Lost to Follow-up|0|||
128996786|NCT00544557|464281423|FG000|Overall Study|Adverse Event|140|||
128996787|NCT00544557|464281423|FG000|Overall Study|Lack of Efficacy|196|||
128996788|NCT00544557|464281423|FG000|Overall Study|Other|98|||
128996789|NCT00467818|464281424|FG000|Overall Study|Adverse Event|1|||
128996790|NCT00467818|464281425|FG001|Overall Study|Adverse Event|0|||
128996791|NCT00467818|464281424|FG000|Overall Study|Lost to Follow-up|2|||
128996792|NCT00467818|464281425|FG001|Overall Study|Lost to Follow-up|2|||
128996793|NCT01313728|464281426|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
128996794|NCT03547531|464281429|FG000|Overall Study|not coming in data collection : sick|2|||
128996795|NCT03547531|464281430|FG001|Overall Study|not coming in data collection : sick|2|||
128996796|NCT03547531|464281429|FG000|Overall Study|having family occasion|0|||
128996797|NCT03547531|464281430|FG001|Overall Study|having family occasion|2|||
128996798|NCT02444182|464281438|FG000|Overall Study|non-compliance|2|||
128996799|NCT02444182|464281439|FG001|Overall Study|non-compliance|1|||
128996800|NCT02444182|464281438|FG000|Overall Study|Lost to Follow-up|0|||
128996801|NCT02444182|464281439|FG001|Overall Study|Lost to Follow-up|4|||
128996802|NCT02981602|464281442|FG000|Overall Study|Adverse Event|0|||
128996803|NCT02981602|464281443|FG001|Overall Study|Adverse Event|0|||
128996804|NCT02981602|464281444|FG002|Overall Study|Adverse Event|0|||
128996805|NCT02981602|464281445|FG003|Overall Study|Adverse Event|1|||
128996806|NCT02981602|464281446|FG004|Overall Study|Adverse Event|0|||
128996807|NCT01169987|464281447|FG000|Overall Study|Withdrawal by Subject|3|||
128996808|NCT01169987|464281447|FG000|Overall Study|Lost to Follow-up|24|||
128996809|NCT01169987|464281447|FG000|Overall Study|Other|4|||
128996810|NCT00386100|464281448|FG000|Overall Study|Did not receive study medication|6|||
128996811|NCT00386100|464281449|FG001|Overall Study|Did not receive study medication|4|||
128996812|NCT00386100|464281448|FG000|Overall Study|Adverse Event|15|||
128996813|NCT00386100|464281449|FG001|Overall Study|Adverse Event|25|||
128996814|NCT00386100|464281448|FG000|Overall Study|Death|0|||
128996815|NCT00386100|464281449|FG001|Overall Study|Death|1|||
128996816|NCT00386100|464281448|FG000|Overall Study|Insufficient therapeutic effect|30|||
128996817|NCT00386100|464281449|FG001|Overall Study|Insufficient therapeutic effect|6|||
128996818|NCT00386100|464281448|FG000|Overall Study|Lost to Follow-up|29|||
128996819|NCT00386100|464281449|FG001|Overall Study|Lost to Follow-up|29|||
128996820|NCT00386100|464281448|FG000|Overall Study|Non-compliance|18|||
128996821|NCT00386100|464281449|FG001|Overall Study|Non-compliance|19|||
128996822|NCT00386100|464281448|FG000|Overall Study|Protocol Violation|5|||
128996823|NCT00386100|464281449|FG001|Overall Study|Protocol Violation|3|||
128996824|NCT00386100|464281448|FG000|Overall Study|Withdrawal by Subject|32|||
128996825|NCT00386100|464281449|FG001|Overall Study|Withdrawal by Subject|31|||
128996826|NCT00386100|464281448|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
128996827|NCT00386100|464281449|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
128996828|NCT00386100|464281448|FG000|Overall Study|BMD <2.5|1|||
128996829|NCT00386100|464281449|FG001|Overall Study|BMD <2.5|0|||
128996830|NCT00386100|464281448|FG000|Overall Study|Consecutive elevated Hba1C|1|||
128996831|NCT00386100|464281449|FG001|Overall Study|Consecutive elevated Hba1C|0|||
128996832|NCT00386100|464281448|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
128996833|NCT00386100|464281449|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
128996834|NCT00386100|464281448|FG000|Overall Study|Laboratory findings|1|||
128996835|NCT00386100|464281449|FG001|Overall Study|Laboratory findings|0|||
128996836|NCT00386100|464281448|FG000|Overall Study|Participant's concern due to CPK levels|1|||
128996837|NCT00386100|464281449|FG001|Overall Study|Participant's concern due to CPK levels|0|||
128877957|NCT00812331|463848327|FG000|Overall Study|Adverse Event|1|||
128996838|NCT00386100|464281448|FG000|Overall Study|Participant moving out of state|2|||
128996839|NCT00386100|464281449|FG001|Overall Study|Participant moving out of state|0|||
128996840|NCT00386100|464281448|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
128996841|NCT00386100|464281449|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
128996842|NCT00386100|464281448|FG000|Overall Study|Didn't meet entry criteria|1|||
128996843|NCT00386100|464281449|FG001|Overall Study|Didn't meet entry criteria|1|||
128996844|NCT00386100|464281448|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
128996845|NCT00386100|464281449|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
128996846|NCT00386100|464281448|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
128996847|NCT00386100|464281449|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
128996848|NCT00386100|464281448|FG000|Overall Study|Bad metabolic control & patient security|1|||
128996849|NCT00386100|464281449|FG001|Overall Study|Bad metabolic control & patient security|0|||
128996850|NCT00386100|464281448|FG000|Overall Study|Bone loss by DXA bone scan|1|||
128996851|NCT00386100|464281449|FG001|Overall Study|Bone loss by DXA bone scan|0|||
128996852|NCT00386100|464281448|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
128996853|NCT00386100|464281449|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
128996854|NCT00386100|464281448|FG000|Overall Study|7.6% bone loss|1|||
128996855|NCT00386100|464281449|FG001|Overall Study|7.6% bone loss|0|||
128996856|NCT00386100|464281448|FG000|Overall Study|Osteoporosis|0|||
128996857|NCT00386100|464281449|FG001|Overall Study|Osteoporosis|1|||
128996858|NCT00386100|464281448|FG000|Overall Study|Positive pregnancy test|1|||
128996859|NCT00386100|464281449|FG001|Overall Study|Positive pregnancy test|3|||
128996860|NCT00386100|464281448|FG000|Overall Study|Out of country for 5 months|1|||
128996861|NCT00386100|464281449|FG001|Overall Study|Out of country for 5 months|0|||
128996862|NCT00386100|464281448|FG000|Overall Study|Hb1Ac >8%|0|||
128996863|NCT00386100|464281449|FG001|Overall Study|Hb1Ac >8%|1|||
128996864|NCT00386100|464281448|FG000|Overall Study|Participant randomized in error|1|||
128996865|NCT00386100|464281449|FG001|Overall Study|Participant randomized in error|0|||
128996866|NCT01706770|464281452|FG000|Overall Study|Lost to Follow-up|1|||
128996867|NCT01706770|464281453|FG001|Overall Study|Lost to Follow-up|0|||
128996868|NCT01706770|464281452|FG000|Overall Study|Physician Decision|1|||
128996869|NCT01706770|464281453|FG001|Overall Study|Physician Decision|0|||
128996870|NCT00886782|464281459|FG000|Overall Study|Disease progression|3|||
128996871|NCT00886782|464281460|FG001|Overall Study|Disease progression|3|||
128996872|NCT00886782|464281461|FG002|Overall Study|Disease progression|3|||
128996873|NCT00886782|464281459|FG000|Overall Study|Study drug toxicity|0|||
128996874|NCT00886782|464281460|FG001|Overall Study|Study drug toxicity|0|||
128996875|NCT00886782|464281461|FG002|Overall Study|Study drug toxicity|1|||
128996876|NCT00886782|464281459|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
128996877|NCT00886782|464281460|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
128996878|NCT00886782|464281461|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
128996879|NCT03636542|464281462|FG000|Overall Study|Lost to Follow-up|1|||
128996880|NCT03636542|464281463|FG001|Overall Study|Lost to Follow-up|1|||
128996881|NCT03636542|464281462|FG000|Overall Study|Physician Decision|0|||
128996882|NCT03636542|464281463|FG001|Overall Study|Physician Decision|1|||
128996883|NCT03636542|464281462|FG000|Overall Study|Withdrawal by Subject|1|||
128996884|NCT03636542|464281463|FG001|Overall Study|Withdrawal by Subject|0|||
128996885|NCT04130919|464281464|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
128996886|NCT04130919|464281465|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
128996887|NCT04130919|464281466|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
128996888|NCT04130919|464281467|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
128996889|NCT04130919|464281468|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
128996890|NCT04130919|464281469|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
128996891|NCT04130919|464281464|FG000|Blinded Treatment Phase|Adverse Event|0|||
128996892|NCT04130919|464281465|FG001|Blinded Treatment Phase|Adverse Event|0|||
128996893|NCT04130919|464281466|FG002|Blinded Treatment Phase|Adverse Event|1|||
128996894|NCT04130919|464281467|FG003|Blinded Treatment Phase|Adverse Event|0|||
128996895|NCT04130919|464281468|FG004|Blinded Treatment Phase|Adverse Event|0|||
128996896|NCT04130919|464281469|FG005|Blinded Treatment Phase|Adverse Event|0|||
128996897|NCT04130919|464281464|FG000|Blinded Treatment Phase|Disease worsening|0|||
128996898|NCT04130919|464281465|FG001|Blinded Treatment Phase|Disease worsening|0|||
128996899|NCT04130919|464281466|FG002|Blinded Treatment Phase|Disease worsening|1|||
128996900|NCT04130919|464281467|FG003|Blinded Treatment Phase|Disease worsening|0|||
128996901|NCT04130919|464281468|FG004|Blinded Treatment Phase|Disease worsening|0|||
128996902|NCT04130919|464281469|FG005|Blinded Treatment Phase|Disease worsening|0|||
128996903|NCT04130919|464281464|FG000|Blinded Treatment Phase|Investigator's decision|0|||
128996904|NCT04130919|464281465|FG001|Blinded Treatment Phase|Investigator's decision|1|||
128996905|NCT04130919|464281466|FG002|Blinded Treatment Phase|Investigator's decision|0|||
128996906|NCT04130919|464281467|FG003|Blinded Treatment Phase|Investigator's decision|0|||
128996907|NCT04130919|464281468|FG004|Blinded Treatment Phase|Investigator's decision|0|||
128996908|NCT04130919|464281469|FG005|Blinded Treatment Phase|Investigator's decision|0|||
128996909|NCT04130919|464281464|FG000|Blinded Treatment Phase|Withdrew consent|1|||
128996910|NCT04130919|464281465|FG001|Blinded Treatment Phase|Withdrew consent|0|||
128996911|NCT04130919|464281466|FG002|Blinded Treatment Phase|Withdrew consent|0|||
128996912|NCT04130919|464281467|FG003|Blinded Treatment Phase|Withdrew consent|0|||
128996913|NCT04130919|464281468|FG004|Blinded Treatment Phase|Withdrew consent|0|||
128996914|NCT04130919|464281469|FG005|Blinded Treatment Phase|Withdrew consent|0|||
128996915|NCT04130919|464281464|FG000|Open-label Treatment Phase|Withdrew consent|0|||
128996916|NCT04130919|464281465|FG001|Open-label Treatment Phase|Withdrew consent|0|||
128996917|NCT04130919|464281466|FG002|Open-label Treatment Phase|Withdrew consent|0|||
128996918|NCT04130919|464281467|FG003|Open-label Treatment Phase|Withdrew consent|1|||
128996919|NCT04130919|464281468|FG004|Open-label Treatment Phase|Withdrew consent|1|||
128996920|NCT04130919|464281469|FG005|Open-label Treatment Phase|Withdrew consent|1|||
128996921|NCT04130919|464281464|FG000|Open-label Treatment Phase|Disease worsening|0|||
128996922|NCT04130919|464281465|FG001|Open-label Treatment Phase|Disease worsening|0|||
128996923|NCT04130919|464281466|FG002|Open-label Treatment Phase|Disease worsening|0|||
128996924|NCT04130919|464281467|FG003|Open-label Treatment Phase|Disease worsening|1|||
128996925|NCT04130919|464281468|FG004|Open-label Treatment Phase|Disease worsening|0|||
128996926|NCT04130919|464281469|FG005|Open-label Treatment Phase|Disease worsening|1|||
128996927|NCT04130919|464281464|FG000|Open-label Treatment Phase|Investigator's decision|0|||
128996928|NCT04130919|464281465|FG001|Open-label Treatment Phase|Investigator's decision|0|||
128996929|NCT04130919|464281466|FG002|Open-label Treatment Phase|Investigator's decision|0|||
128996930|NCT04130919|464281467|FG003|Open-label Treatment Phase|Investigator's decision|1|||
128996931|NCT04130919|464281468|FG004|Open-label Treatment Phase|Investigator's decision|0|||
128996932|NCT04130919|464281469|FG005|Open-label Treatment Phase|Investigator's decision|0|||
128996933|NCT04130919|464281464|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
128996934|NCT04130919|464281465|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
128996935|NCT04130919|464281466|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
128996936|NCT04130919|464281467|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
128996937|NCT04130919|464281468|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
128996938|NCT04130919|464281469|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
128996939|NCT04130919|464281464|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
128996940|NCT04130919|464281465|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
128996941|NCT04130919|464281466|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
128996942|NCT04130919|464281467|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
128996943|NCT04130919|464281468|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
128996944|NCT04130919|464281469|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
128996945|NCT00068237|464281471|FG000|Overall Study|Ineligible|3|||
128996946|NCT00068237|464281471|FG000|Overall Study|No protocol treatment received|2|||
128996947|NCT01358708|464281472|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
128996948|NCT01358708|464281473|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128996949|NCT01358708|464281472|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
128996950|NCT01358708|464281473|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
128996951|NCT03056001|464281474|FG000|Overall Study|Death|24|||
128996952|NCT00363129|464281477|FG000|Overall Study|Withdrawal by Subject|11|||
128996953|NCT00363129|464281478|FG001|Overall Study|Withdrawal by Subject|18|||
128996954|NCT00363129|464281477|FG000|Overall Study|Adverse Event|8|||
128996955|NCT00363129|464281478|FG001|Overall Study|Adverse Event|3|||
128996956|NCT00363129|464281477|FG000|Overall Study|Alternate Treatment|2|||
128996957|NCT00363129|464281478|FG001|Overall Study|Alternate Treatment|4|||
128996958|NCT00363129|464281477|FG000|Overall Study|Other Medical Problems|2|||
128996959|NCT00363129|464281478|FG001|Overall Study|Other Medical Problems|4|||
128996960|NCT00363129|464281477|FG000|Overall Study|Death|0|||
128996961|NCT00363129|464281478|FG001|Overall Study|Death|1|||
128996962|NCT00363129|464281477|FG000|Overall Study|Other Reasons|6|||
128996963|NCT00363129|464281478|FG001|Overall Study|Other Reasons|3|||
128996964|NCT03707522|464281479|FG000|Overall Study|Lost to Follow-up|24|||
128996965|NCT03707522|464281480|FG001|Overall Study|Lost to Follow-up|27|||
128996966|NCT03707522|464281481|FG002|Overall Study|Lost to Follow-up|41|||
128996967|NCT03707522|464281482|FG003|Overall Study|Lost to Follow-up|36|||
128996968|NCT04363736|464281483|FG000|Overall Study|Withdrawal by Subject|1|||
128996969|NCT04363736|464281484|FG001|Overall Study|Withdrawal by Subject|0|||
128996970|NCT04363736|464281483|FG000|Overall Study|Lost to Follow-up|10|||
128996971|NCT04363736|464281484|FG001|Overall Study|Lost to Follow-up|7|||
128996972|NCT04363736|464281483|FG000|Overall Study|Death|8|||
128996973|NCT04363736|464281484|FG001|Overall Study|Death|6|||
128996974|NCT03797222|464281485|FG000|Overall Study|Withdrawal by Subject|1|||
128996975|NCT00725725|464281486|FG000|Overall Study|Adverse Event|1|||
128996976|NCT00725725|464281487|FG001|Overall Study|Adverse Event|3|||
128996977|NCT00725725|464281488|FG002|Overall Study|Adverse Event|2|||
128996978|NCT00725725|464281486|FG000|Overall Study|Lost to Follow-up|2|||
128996979|NCT00725725|464281487|FG001|Overall Study|Lost to Follow-up|0|||
128996980|NCT00725725|464281488|FG002|Overall Study|Lost to Follow-up|2|||
128996981|NCT00725725|464281486|FG000|Overall Study|Withdrawal by Subject|1|||
128996982|NCT00725725|464281487|FG001|Overall Study|Withdrawal by Subject|0|||
128996983|NCT00725725|464281488|FG002|Overall Study|Withdrawal by Subject|1|||
128996984|NCT00725725|464281486|FG000|Overall Study|Protocol Violation|0|||
128996985|NCT00725725|464281487|FG001|Overall Study|Protocol Violation|1|||
128996986|NCT00725725|464281488|FG002|Overall Study|Protocol Violation|0|||
128996987|NCT01619085|464281489|FG000|Overall Study|Adverse Event|231|||
128996988|NCT01619085|464281489|FG000|Overall Study|Protocol Violation|4|||
128877958|NCT00812331|463848328|FG001|Overall Study|Adverse Event|0|||
128996989|NCT01619085|464281489|FG000|Overall Study|Lost to Follow-up|3|||
128996990|NCT01619085|464281489|FG000|Overall Study|Withdrawal by Subject|45|||
128996991|NCT01619085|464281489|FG000|Overall Study|Other than specified|96|||
128996992|NCT01619085|464281489|FG000|Overall Study|Not treated|1|||
128996993|NCT01619085|464281489|FG000|Overall Study|Death|145|||
128996994|NCT00990093|464281490|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
128996995|NCT00990093|464281491|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
128996996|NCT00990093|464281490|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
128996997|NCT00990093|464281491|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
128996998|NCT00990093|464281490|FG000|Test Period 1 (1-14 Days)|Other|1|||
128996999|NCT00990093|464281491|FG001|Test Period 1 (1-14 Days)|Other|0|||
128997000|NCT00990093|464281490|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
128997001|NCT00990093|464281491|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
128997002|NCT00990093|464281490|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
128997003|NCT00990093|464281491|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
128997004|NCT00990093|464281490|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
128997005|NCT00990093|464281491|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
128997006|NCT00990093|464281490|FG000|Test Period 2 (15-28 Days)|Other|0|||
128997007|NCT00990093|464281491|FG001|Test Period 2 (15-28 Days)|Other|1|||
128997008|NCT04556838|464281492|FG000|Overall Study|Withdrawal by Subject|3|||
128997009|NCT04556838|464281493|FG001|Overall Study|Withdrawal by Subject|1|||
128997010|NCT04556838|464281494|FG002|Overall Study|Withdrawal by Subject|2|||
128997011|NCT04556838|464281492|FG000|Overall Study|Adverse Event|0|||
128997012|NCT04556838|464281493|FG001|Overall Study|Adverse Event|1|||
128997013|NCT04556838|464281494|FG002|Overall Study|Adverse Event|1|||
128997014|NCT04556838|464281492|FG000|Overall Study|Lost to Follow-up|0|||
128997015|NCT04556838|464281493|FG001|Overall Study|Lost to Follow-up|0|||
128997016|NCT04556838|464281494|FG002|Overall Study|Lost to Follow-up|2|||
128997017|NCT04556838|464281492|FG000|Overall Study|Subject travel|0|||
128997018|NCT04556838|464281493|FG001|Overall Study|Subject travel|1|||
128997019|NCT04556838|464281494|FG002|Overall Study|Subject travel|0|||
128997020|NCT04556838|464281492|FG000|Overall Study|Physician Decision|1|||
128997021|NCT04556838|464281493|FG001|Overall Study|Physician Decision|0|||
128997022|NCT04556838|464281494|FG002|Overall Study|Physician Decision|0|||
128997023|NCT00995930|464281495|FG000|Overall Study|Protocol deviation|2|||
128997024|NCT00995930|464281496|FG001|Overall Study|Protocol deviation|5|||
128997025|NCT00995930|464281495|FG000|Overall Study|Death|0|||
128997026|NCT00995930|464281496|FG001|Overall Study|Death|1|||
128997027|NCT00995930|464281495|FG000|Overall Study|Administrative problems|4|||
128997028|NCT00995930|464281496|FG001|Overall Study|Administrative problems|2|||
128997029|NCT00995930|464281495|FG000|Overall Study|Lost to Follow-up|1|||
128997030|NCT00995930|464281496|FG001|Overall Study|Lost to Follow-up|2|||
128997031|NCT00995930|464281495|FG000|Overall Study|Withdrawal by Subject|3|||
128877959|NCT00812331|463848329|FG002|Overall Study|Adverse Event|0|||
128877960|NCT00812331|463848330|FG003|Overall Study|Adverse Event|0|||
128877961|NCT00812331|463848331|FG004|Overall Study|Adverse Event|0|||
128877962|NCT01506453|463848332|FG000|Overall Study|Withdrawal prior to treatment|0|||
128877963|NCT01506453|463848333|FG001|Overall Study|Withdrawal prior to treatment|2|||
128877964|NCT00055601|463848341|FG000|Overall Study|Protocol Violation|1|||
128877965|NCT00055601|463848342|FG001|Overall Study|Protocol Violation|1|||
128877966|NCT00055601|463848341|FG000|Overall Study|No protocol treatment received|1|||
128877967|NCT00055601|463848342|FG001|Overall Study|No protocol treatment received|1|||
128877968|NCT00117845|463848343|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
128877969|NCT01022268|463848344|FG000|Overall Study|Withdrawal by Subject|1|||
128877970|NCT01022268|463848345|FG001|Overall Study|Withdrawal by Subject|0|||
128877971|NCT01022268|463848344|FG000|Overall Study|Withdrawal by Subject|1|||
128877972|NCT01022268|463848345|FG001|Overall Study|Withdrawal by Subject|0|||
128877973|NCT00910689|463848346|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
128877974|NCT00910689|463848347|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
128877975|NCT00910689|463848348|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
128877976|NCT00910689|463848349|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
128877977|NCT00910689|463848346|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
128877978|NCT00910689|463848347|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
128877979|NCT00910689|463848348|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
128877980|NCT00910689|463848349|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
128877981|NCT00910689|463848346|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
128877982|NCT00910689|463848347|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
128877983|NCT00910689|463848348|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
128877984|NCT00910689|463848349|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
128877985|NCT00910689|463848346|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
128997032|NCT00995930|464281496|FG001|Overall Study|Withdrawal by Subject|4|||
128997033|NCT00995930|464281495|FG000|Overall Study|Adverse Event|11|||
128997034|NCT00995930|464281496|FG001|Overall Study|Adverse Event|14|||
128997035|NCT01458119|464281497|FG000|Overall Study|Physician Decision|4|||
128997036|NCT01458119|464281497|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
128997037|NCT01458119|464281497|FG000|Overall Study|Pregnancy|1|||
128997038|NCT01458119|464281497|FG000|Overall Study|Death|2|||
128997039|NCT01458119|464281497|FG000|Overall Study|Adverse Event|1|||
128997040|NCT01458119|464281497|FG000|Overall Study|Consent Withdrawn by Participant|8|||
128997041|NCT01458119|464281497|FG000|Overall Study|Non-compliance With Study Drug|3|||
128997042|NCT05003167|464281498|FG000|Overall Study|Withdrawal by Subject|1|||
128997043|NCT02367781|464281499|FG000|Overall Study|Withdrawal by Subject|20|||
128997044|NCT02367781|464281500|FG001|Overall Study|Withdrawal by Subject|13|||
128997045|NCT02367781|464281499|FG000|Overall Study|Protocol Violation|0|||
128997046|NCT02367781|464281500|FG001|Overall Study|Protocol Violation|1|||
128997047|NCT02367781|464281499|FG000|Overall Study|Physician Decision|7|||
128997048|NCT02367781|464281500|FG001|Overall Study|Physician Decision|0|||
128997049|NCT02367781|464281499|FG000|Overall Study|Randomized in Error|5|||
128997050|NCT02367781|464281500|FG001|Overall Study|Randomized in Error|4|||
128997051|NCT02367781|464281499|FG000|Overall Study|Non-Compliance|1|||
128997052|NCT02367781|464281500|FG001|Overall Study|Non-Compliance|0|||
128997053|NCT02367781|464281499|FG000|Overall Study|Lost to Follow-up|1|||
128997054|NCT02367781|464281500|FG001|Overall Study|Lost to Follow-up|2|||
128997055|NCT02367781|464281499|FG000|Overall Study|Death|330|||
128997056|NCT02367781|464281500|FG001|Overall Study|Death|176|||
128997057|NCT02367781|464281499|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
128997058|NCT02367781|464281500|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
128997059|NCT02367781|464281499|FG000|Overall Study|Prolonged Hospitalization|1|||
128997060|NCT02367781|464281500|FG001|Overall Study|Prolonged Hospitalization|0|||
128997061|NCT02367781|464281499|FG000|Overall Study|Death Prior First Dose|1|||
128997062|NCT02367781|464281500|FG001|Overall Study|Death Prior First Dose|0|||
128997063|NCT02367781|464281499|FG000|Overall Study|Administrative-Change Facility|1|||
128997064|NCT02367781|464281500|FG001|Overall Study|Administrative-Change Facility|0|||
128997065|NCT02367781|464281499|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
128997066|NCT02367781|464281500|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
128997067|NCT02367781|464281499|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
128997068|NCT02367781|464281500|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
128997069|NCT02367781|464281499|FG000|Overall Study|Study Terminated by Sponsor|3|||
128997070|NCT02367781|464281500|FG001|Overall Study|Study Terminated by Sponsor|1|||
128997071|NCT02367781|464281499|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
128997072|NCT02367781|464281500|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
128997073|NCT02367781|464281499|FG000|Overall Study|Sponsor Decision|2|||
128997074|NCT02367781|464281500|FG001|Overall Study|Sponsor Decision|0|||
128997075|NCT02367781|464281499|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
128997076|NCT02367781|464281500|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
128997077|NCT01133392|464281503|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
128997078|NCT01133392|464281504|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
128997079|NCT01133392|464281503|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
128997080|NCT01133392|464281504|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
128997081|NCT01835470|464283348|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
128997082|NCT01835470|464283348|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
128997083|NCT01272193|464283349|FG000|Overall Study|Adverse Event|1|||
128997084|NCT01272193|464283350|FG001|Overall Study|Adverse Event|1|||
128997085|NCT01272193|464283349|FG000|Overall Study|Lack of Efficacy|0|||
128997086|NCT01272193|464283350|FG001|Overall Study|Lack of Efficacy|3|||
128997087|NCT01272193|464283349|FG000|Overall Study|Withdrawal Criteria|1|||
128997088|NCT01272193|464283350|FG001|Overall Study|Withdrawal Criteria|1|||
128997089|NCT01272193|464283349|FG000|Overall Study|Unclassified|8|||
128997090|NCT01272193|464283350|FG001|Overall Study|Unclassified|7|||
128997091|NCT01440647|464283351|FG000|Overall Study|Death|2|||
128997092|NCT01440647|464283352|FG001|Overall Study|Death|3|||
128997093|NCT00096382|464283355|FG000|Overall Study|Not treated|1|||
128997094|NCT00096382|464283356|FG001|Overall Study|Not treated|0|||
128997095|NCT00096382|464283355|FG000|Overall Study|Death during treatment|1|||
128997096|NCT00096382|464283356|FG001|Overall Study|Death during treatment|0|||
128997097|NCT01326702|464283358|FG000|Overall Study|Other|1|||
128997098|NCT01326702|464283359|FG001|Overall Study|Other|0|||
128997099|NCT01326702|464283360|FG002|Overall Study|Other|0|||
128997100|NCT01326702|464283361|FG003|Overall Study|Other|0|||
128997101|NCT01326702|464283362|FG004|Overall Study|Other|0|||
128997102|NCT01326702|464283363|FG005|Overall Study|Other|1|||
128997103|NCT01326702|464283364|FG006|Overall Study|Other|0|||
128997104|NCT01326702|464283358|FG000|Overall Study|progressive disease|1|||
128997105|NCT01326702|464283359|FG001|Overall Study|progressive disease|1|||
128997106|NCT01326702|464283360|FG002|Overall Study|progressive disease|3|||
128997107|NCT01326702|464283361|FG003|Overall Study|progressive disease|1|||
128997108|NCT01326702|464283362|FG004|Overall Study|progressive disease|3|||
128997109|NCT01326702|464283363|FG005|Overall Study|progressive disease|2|||
128997110|NCT01326702|464283364|FG006|Overall Study|progressive disease|3|||
128997111|NCT01326702|464283358|FG000|Overall Study|Death|0|||
128997112|NCT01326702|464283359|FG001|Overall Study|Death|1|||
128997113|NCT01326702|464283360|FG002|Overall Study|Death|0|||
128997114|NCT01326702|464283361|FG003|Overall Study|Death|0|||
128997115|NCT01326702|464283362|FG004|Overall Study|Death|0|||
128997116|NCT01326702|464283363|FG005|Overall Study|Death|0|||
128997117|NCT01326702|464283364|FG006|Overall Study|Death|0|||
128997118|NCT01326702|464283358|FG000|Overall Study|Adverse Event|0|||
128997119|NCT01326702|464283359|FG001|Overall Study|Adverse Event|0|||
128997120|NCT01326702|464283360|FG002|Overall Study|Adverse Event|1|||
128997121|NCT01326702|464283361|FG003|Overall Study|Adverse Event|1|||
128997122|NCT01326702|464283362|FG004|Overall Study|Adverse Event|0|||
128997123|NCT01326702|464283363|FG005|Overall Study|Adverse Event|3|||
128997124|NCT01326702|464283364|FG006|Overall Study|Adverse Event|1|||
128997125|NCT01326702|464283358|FG000|Overall Study|Withdrawal by Subject|0|||
128997126|NCT01326702|464283359|FG001|Overall Study|Withdrawal by Subject|0|||
128997127|NCT01326702|464283360|FG002|Overall Study|Withdrawal by Subject|1|||
128997128|NCT01326702|464283361|FG003|Overall Study|Withdrawal by Subject|0|||
128997129|NCT01326702|464283362|FG004|Overall Study|Withdrawal by Subject|1|||
128997130|NCT01326702|464283363|FG005|Overall Study|Withdrawal by Subject|1|||
128997131|NCT01326702|464283364|FG006|Overall Study|Withdrawal by Subject|3|||
128997132|NCT01326702|464283358|FG000|Overall Study|Not Treated|0|||
128997133|NCT01326702|464283359|FG001|Overall Study|Not Treated|0|||
128997134|NCT01326702|464283360|FG002|Overall Study|Not Treated|0|||
128997135|NCT01326702|464283361|FG003|Overall Study|Not Treated|1|||
128997136|NCT01326702|464283362|FG004|Overall Study|Not Treated|0|||
128997137|NCT01326702|464283363|FG005|Overall Study|Not Treated|1|||
128997138|NCT01326702|464283364|FG006|Overall Study|Not Treated|0|||
128997139|NCT00782275|464283377|FG000|Overall Study|Adverse Event|11|||
128997140|NCT00782275|464283377|FG000|Overall Study|Withdrawal by Subject|1|||
128997141|NCT00782275|464283377|FG000|Overall Study|Progressive Disease|21|||
128997142|NCT00782275|464283377|FG000|Overall Study|Physician Decision|4|||
128997143|NCT00782275|464283377|FG000|Overall Study|Not started treatment|1|||
128997144|NCT00782275|464283377|FG000|Overall Study|Other|3|||
128997145|NCT00331773|464283380|FG000|Overall Study|Withdrawal by Subject|6|||
128997146|NCT00331773|464283381|FG001|Overall Study|Withdrawal by Subject|4|||
128997147|NCT00331773|464283380|FG000|Overall Study|Protocol Violation|10|||
128997148|NCT00331773|464283381|FG001|Overall Study|Protocol Violation|3|||
128997149|NCT00289731|464283382|FG000|Overall Study|Adverse Event|1|||
128997150|NCT00289731|464283383|FG001|Overall Study|Adverse Event|2|||
128997151|NCT00289731|464283384|FG002|Overall Study|Adverse Event|2|||
128997152|NCT00289731|464283382|FG000|Overall Study|Other|1|||
128997153|NCT00289731|464283383|FG001|Overall Study|Other|0|||
128997154|NCT00289731|464283384|FG002|Overall Study|Other|0|||
128997155|NCT02019979|464283385|FG000|Overall Study|study terminated|14|||
128997156|NCT00525031|464283393|FG000|Overall Study|Disease Progression|1|||
128997157|NCT00525031|464283394|FG001|Overall Study|Disease Progression|1|||
128997158|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
128997159|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
128997160|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
128997161|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
128997162|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
128997163|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
128997164|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
128997165|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
128997166|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
128997167|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
128997168|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
128997169|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
128997170|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
128997171|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
128997172|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
128997173|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
128997174|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
128997175|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
128997176|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
128997177|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
128997178|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
128997179|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
128997180|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
128997181|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
128997182|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
128997183|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
128997184|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
128997185|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
128997186|NCT01872689|464283395|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
128997187|NCT01872689|464283396|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
128997188|NCT01872689|464283397|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
128997189|NCT01872689|464283398|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
128997190|NCT01872689|464283395|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
128997191|NCT01872689|464283396|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
128997192|NCT01872689|464283397|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
128997193|NCT01872689|464283398|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
128997194|NCT01872689|464283395|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
128997195|NCT01872689|464283396|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
128997196|NCT01872689|464283397|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
128997197|NCT01872689|464283398|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
128997198|NCT01872689|464283395|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
128997199|NCT01872689|464283396|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
128997200|NCT01872689|464283397|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
128997201|NCT01872689|464283398|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
128997202|NCT01872689|464283395|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
128997203|NCT01872689|464283396|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
128997204|NCT01872689|464283397|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
128997205|NCT01872689|464283398|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
128997206|NCT01872689|464283395|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
128997207|NCT01872689|464283396|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
128997208|NCT01872689|464283397|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
128997209|NCT01872689|464283398|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
128997210|NCT01872689|464283395|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
128997211|NCT01872689|464283396|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
128997212|NCT01872689|464283397|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
128997213|NCT01872689|464283398|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
128997214|NCT02143947|464283403|FG000|Overall Study|Lost to Follow-up|4|||
128997215|NCT02143947|464283404|FG001|Overall Study|Lost to Follow-up|2|||
128997216|NCT01244815|464283405|FG000|Overall Study|Not Treated|0|||
128997217|NCT01244815|464283406|FG001|Overall Study|Not Treated|1|||
128997218|NCT01244815|464283407|FG002|Overall Study|Not Treated|0|||
128997219|NCT01244815|464283408|FG003|Overall Study|Not Treated|0|||
128997220|NCT01244815|464283405|FG000|Overall Study|Adverse Event|4|||
128997221|NCT01244815|464283406|FG001|Overall Study|Adverse Event|7|||
128997222|NCT01244815|464283407|FG002|Overall Study|Adverse Event|5|||
128997223|NCT01244815|464283408|FG003|Overall Study|Adverse Event|5|||
128997224|NCT01244815|464283405|FG000|Overall Study|Treatment Failure|0|||
128997225|NCT01244815|464283406|FG001|Overall Study|Treatment Failure|0|||
128997226|NCT01244815|464283407|FG002|Overall Study|Treatment Failure|0|||
128997227|NCT01244815|464283408|FG003|Overall Study|Treatment Failure|1|||
128997228|NCT01244815|464283405|FG000|Overall Study|Lost to Follow-up|3|||
128997229|NCT01244815|464283406|FG001|Overall Study|Lost to Follow-up|2|||
128997230|NCT01244815|464283407|FG002|Overall Study|Lost to Follow-up|3|||
128997231|NCT01244815|464283408|FG003|Overall Study|Lost to Follow-up|2|||
128997232|NCT01244815|464283405|FG000|Overall Study|Withdrawal by Subject|0|||
128997233|NCT01244815|464283406|FG001|Overall Study|Withdrawal by Subject|2|||
128997234|NCT01244815|464283407|FG002|Overall Study|Withdrawal by Subject|0|||
128997235|NCT01244815|464283408|FG003|Overall Study|Withdrawal by Subject|3|||
128997236|NCT01244815|464283405|FG000|Overall Study|Protocol Violation|7|||
128997237|NCT01244815|464283406|FG001|Overall Study|Protocol Violation|4|||
128997238|NCT01244815|464283407|FG002|Overall Study|Protocol Violation|3|||
128997239|NCT01244815|464283408|FG003|Overall Study|Protocol Violation|1|||
128997240|NCT01244815|464283405|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
128997241|NCT01244815|464283406|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
128997242|NCT01244815|464283407|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
128997243|NCT01244815|464283408|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
128997244|NCT00697112|464283410|FG000|Overall Study|Adverse Event|8|||
128997245|NCT00697112|464283410|FG000|Overall Study|Lost to Follow-up|1|||
128997246|NCT00697112|464283410|FG000|Overall Study|Did not meet inclusion criteria|1|||
128997247|NCT03066440|464283413|FG000|Overall Study|Physician Decision|1|||
128997248|NCT03066440|464283414|FG001|Overall Study|Physician Decision|1|||
128997249|NCT03066440|464283413|FG000|Overall Study|Protocol Violation|0|||
128997250|NCT03066440|464283414|FG001|Overall Study|Protocol Violation|2|||
128997251|NCT00736333|464283415|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
128997252|NCT00736333|464283415|FG000|Overall Study|Data Missing|2|||
128997253|NCT00736333|464283415|FG000|Overall Study|Tumor Progression|75|||
128997254|NCT00736333|464283415|FG000|Overall Study|Toxicity|6|||
128997255|NCT00736333|464283415|FG000|Overall Study|Withdrawal by Subject|10|||
128997256|NCT00736333|464283415|FG000|Overall Study|Death|7|||
128997257|NCT00736333|464283415|FG000|Overall Study|Other|4|||
128997258|NCT01106352|464283418|FG000|Overall Study|Subjects untreated|0|||
128997259|NCT01106352|464283419|FG001|Overall Study|Subjects untreated|0|||
128997260|NCT01106352|464283420|FG002|Overall Study|Subjects untreated|0|||
128997261|NCT01106352|464283421|FG003|Overall Study|Subjects untreated|3|||
128997262|NCT01106352|464283422|FG004|Overall Study|Subjects untreated|4|||
128997263|NCT01106352|464283418|FG000|Overall Study|Sponsor Decision|1|||
128997264|NCT01106352|464283419|FG001|Overall Study|Sponsor Decision|0|||
128997265|NCT01106352|464283420|FG002|Overall Study|Sponsor Decision|0|||
128997266|NCT01106352|464283421|FG003|Overall Study|Sponsor Decision|0|||
128997267|NCT01106352|464283422|FG004|Overall Study|Sponsor Decision|0|||
128997268|NCT01106352|464283418|FG000|Overall Study|Too ill to come in for the visit|0|||
128997269|NCT01106352|464283419|FG001|Overall Study|Too ill to come in for the visit|0|||
128997270|NCT01106352|464283420|FG002|Overall Study|Too ill to come in for the visit|1|||
128997271|NCT01106352|464283421|FG003|Overall Study|Too ill to come in for the visit|0|||
128997272|NCT01106352|464283422|FG004|Overall Study|Too ill to come in for the visit|0|||
128997273|NCT01106352|464283418|FG000|Overall Study|Lost to Follow-up|0|||
128997274|NCT01106352|464283419|FG001|Overall Study|Lost to Follow-up|0|||
128997275|NCT01106352|464283420|FG002|Overall Study|Lost to Follow-up|0|||
128997276|NCT01106352|464283421|FG003|Overall Study|Lost to Follow-up|0|||
128997277|NCT01106352|464283422|FG004|Overall Study|Lost to Follow-up|1|||
128997278|NCT01106352|464283418|FG000|Overall Study|Death|0|||
128997279|NCT01106352|464283419|FG001|Overall Study|Death|0|||
128997280|NCT01106352|464283420|FG002|Overall Study|Death|1|||
128997281|NCT01106352|464283421|FG003|Overall Study|Death|3|||
128997282|NCT01106352|464283422|FG004|Overall Study|Death|1|||
128997283|NCT01106352|464283418|FG000|Overall Study|Disease progression|0|||
128997284|NCT01106352|464283419|FG001|Overall Study|Disease progression|0|||
128997285|NCT01106352|464283420|FG002|Overall Study|Disease progression|0|||
128997286|NCT01106352|464283421|FG003|Overall Study|Disease progression|1|||
128997287|NCT01106352|464283422|FG004|Overall Study|Disease progression|0|||
128997288|NCT01106352|464283418|FG000|Overall Study|Withdrawal by Subject|0|||
128997289|NCT01106352|464283419|FG001|Overall Study|Withdrawal by Subject|0|||
128997290|NCT01106352|464283420|FG002|Overall Study|Withdrawal by Subject|0|||
128997291|NCT01106352|464283421|FG003|Overall Study|Withdrawal by Subject|3|||
128997292|NCT01106352|464283422|FG004|Overall Study|Withdrawal by Subject|2|||
128997293|NCT01106352|464283418|FG000|Overall Study|Went on hospice|0|||
128997294|NCT01106352|464283419|FG001|Overall Study|Went on hospice|0|||
128997295|NCT01106352|464283420|FG002|Overall Study|Went on hospice|0|||
128997296|NCT01106352|464283421|FG003|Overall Study|Went on hospice|1|||
128997297|NCT01106352|464283422|FG004|Overall Study|Went on hospice|0|||
128997298|NCT01106352|464283418|FG000|Overall Study|Subject entered hospice|0|||
128997299|NCT01106352|464283419|FG001|Overall Study|Subject entered hospice|0|||
128997300|NCT01106352|464283420|FG002|Overall Study|Subject entered hospice|0|||
128997301|NCT01106352|464283421|FG003|Overall Study|Subject entered hospice|1|||
128997302|NCT01106352|464283422|FG004|Overall Study|Subject entered hospice|0|||
128997303|NCT01106352|464283418|FG000|Overall Study|Home hospice since July 2013|0|||
128997304|NCT01106352|464283419|FG001|Overall Study|Home hospice since July 2013|0|||
128997305|NCT01106352|464283420|FG002|Overall Study|Home hospice since July 2013|0|||
128997306|NCT01106352|464283421|FG003|Overall Study|Home hospice since July 2013|1|||
128997307|NCT01106352|464283422|FG004|Overall Study|Home hospice since July 2013|0|||
128997308|NCT03944707|464283423|FG000|Overall Study|Adverse Event|0|||
128997309|NCT03944707|464283424|FG001|Overall Study|Adverse Event|2|||
128997310|NCT03944707|464283423|FG000|Overall Study|Study terminated by sponsor|12|||
128997311|NCT03944707|464283424|FG001|Overall Study|Study terminated by sponsor|7|||
128997312|NCT03944707|464283423|FG000|Overall Study|Subject decision|0|||
128997313|NCT03944707|464283424|FG001|Overall Study|Subject decision|1|||
128997314|NCT04126733|464283427|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
128997315|NCT04126733|464283427|FG000|Treatment Period|Adverse Event|8|||
128997316|NCT04126733|464283427|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
128997317|NCT04126733|464283427|FG000|Treatment Period|Physician Decision|5|||
128997318|NCT04126733|464283427|FG000|Treatment Period|Death|1|||
128997319|NCT04126733|464283427|FG000|Treatment Period|Other Reasons|2|||
128997320|NCT04126733|464283427|FG000|Active Follow-up Period|Death|13|||
128997321|NCT04126733|464283427|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
128997322|NCT04126733|464283427|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
128997323|NCT04126733|464283427|FG000|Active Follow-up Period|Other Reasons|1|||
128997324|NCT04126733|464283427|FG000|Long-term Follow-up Period|Death|22|||
128997325|NCT04126733|464283427|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
128997326|NCT04126733|464283427|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
128997327|NCT02598193|464283429|FG000|Overall Study|Adverse Event|13|||
128997328|NCT02598193|464283429|FG000|Overall Study|Withdrawal by Subject|1|||
128997329|NCT02598193|464283429|FG000|Overall Study|Listed in active lung transplant list|1|||
128997330|NCT02598193|464283429|FG000|Overall Study|Does not want to take Nintedanib|1|||
128997331|NCT02487979|464283432|FG000|Overall Study|Physician Decision|2|||
128997332|NCT02487979|464283432|FG000|Overall Study|Withdrawal by Subject|2|||
128997333|NCT02487979|464283432|FG000|Overall Study|Progressive Disease|17|||
128997334|NCT00447694|464283433|FG000|Overall Study|Adverse Event|2|||
128997335|NCT00447694|464283433|FG000|Overall Study|Abnormal laboratory value|1|||
128997336|NCT00447694|464283433|FG000|Overall Study|Abnormal test procedure result|1|||
128997337|NCT00447694|464283433|FG000|Overall Study|Withdrawal by Subject|2|||
128997338|NCT02354976|464283438|FG000|Overall Study|Other - reason not specified|1|||
128997339|NCT02354976|464283439|FG001|Overall Study|Other - reason not specified|0|||
128997340|NCT02354976|464283440|FG002|Overall Study|Other - reason not specified|1|||
128997341|NCT02354976|464283438|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
128997342|NCT02354976|464283439|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
128997343|NCT02354976|464283440|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
128997344|NCT02354976|464283438|FG000|Overall Study|Adverse Event|1|||
128997345|NCT02354976|464283439|FG001|Overall Study|Adverse Event|0|||
128997346|NCT02354976|464283440|FG002|Overall Study|Adverse Event|2|||
128997347|NCT00986154|464283441|FG000|Overall Study|Death|136|||
128997348|NCT00986154|464283442|FG001|Overall Study|Death|127|||
128997349|NCT00986154|464283441|FG000|Overall Study|Lost to Follow-up|7|||
128997350|NCT00986154|464283442|FG001|Overall Study|Lost to Follow-up|4|||
128997351|NCT00986154|464283441|FG000|Overall Study|Withdrawal by Subject|32|||
128997352|NCT00986154|464283442|FG001|Overall Study|Withdrawal by Subject|33|||
128997353|NCT00986154|464283441|FG000|Overall Study|investigator/subject decide not continue|6|||
128997354|NCT00986154|464283442|FG001|Overall Study|investigator/subject decide not continue|3|||
128997355|NCT00986154|464283441|FG000|Overall Study|never received study drug|25|||
128997356|NCT00986154|464283442|FG001|Overall Study|never received study drug|27|||
128997357|NCT03726437|464283443|FG000|Overall Study|Lost to Follow-up|85|||
128997358|NCT03726437|464283444|FG001|Overall Study|Lost to Follow-up|76|||
128997359|NCT00068445|464283445|FG000|Randomization|Cancel|1|||
128997360|NCT00068445|464283446|FG001|Randomization|Cancel|3|||
128997361|NCT00068445|464283445|FG000|Randomization|Ineligible|1|||
128997362|NCT00068445|464283446|FG001|Randomization|Ineligible|1|||
128997363|NCT00068445|464283445|FG000|Treatment|Refused Further Treatment|13|||
128997364|NCT00068445|464283446|FG001|Treatment|Refused Further Treatment|10|||
128997365|NCT00068445|464283445|FG000|Treatment|Adverse Event|7|||
128997366|NCT00068445|464283446|FG001|Treatment|Adverse Event|1|||
128997367|NCT00068445|464283445|FG000|Treatment|Other (Specifics not available)|9|||
128997368|NCT00068445|464283446|FG001|Treatment|Other (Specifics not available)|5|||
128997369|NCT01896700|464283447|FG000|Overall Study|Adverse Event|4|||
128997370|NCT01896700|464283448|FG001|Overall Study|Adverse Event|5|||
128997371|NCT01896700|464283447|FG000|Overall Study|Withdrawal by Subject|0|||
128997372|NCT01896700|464283448|FG001|Overall Study|Withdrawal by Subject|1|||
128997373|NCT00423488|464283450|FG000|Overall Study|No evidence of study drug intake|2|||
128997374|NCT00423488|464283451|FG001|Overall Study|No evidence of study drug intake|1|||
128997375|NCT00423488|464283450|FG000|Overall Study|No post baseline data|3|||
128997376|NCT00423488|464283451|FG001|Overall Study|No post baseline data|0|||
128997377|NCT03118765|464283452|FG000|Overall Study|Withdrawal by Subject|0|||
128997378|NCT03118765|464283453|FG001|Overall Study|Withdrawal by Subject|0|||
128997379|NCT03118765|464283454|FG002|Overall Study|Withdrawal by Subject|1|||
128997380|NCT03118765|464283455|FG003|Overall Study|Withdrawal by Subject|0|||
128997381|NCT03118765|464283456|FG004|Overall Study|Withdrawal by Subject|0|||
128997382|NCT03118765|464283452|FG000|Overall Study|Adverse Event|1|||
128997383|NCT03118765|464283453|FG001|Overall Study|Adverse Event|1|||
128997384|NCT03118765|464283454|FG002|Overall Study|Adverse Event|1|||
128997385|NCT03118765|464283455|FG003|Overall Study|Adverse Event|1|||
128997386|NCT03118765|464283456|FG004|Overall Study|Adverse Event|1|||
128997387|NCT03118765|464283452|FG000|Overall Study|Non compliance with Study Procedures|0|||
128997388|NCT03118765|464283453|FG001|Overall Study|Non compliance with Study Procedures|0|||
128997389|NCT03118765|464283454|FG002|Overall Study|Non compliance with Study Procedures|0|||
128997390|NCT03118765|464283455|FG003|Overall Study|Non compliance with Study Procedures|1|||
128997391|NCT03118765|464283456|FG004|Overall Study|Non compliance with Study Procedures|0|||
128997392|NCT03118765|464283452|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
128997393|NCT03118765|464283453|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
128997394|NCT03118765|464283454|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
128997395|NCT03118765|464283455|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
128997396|NCT03118765|464283456|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
128997397|NCT03118765|464283452|FG000|Overall Study|COPD Exacerbation|1|||
128997398|NCT03118765|464283453|FG001|Overall Study|COPD Exacerbation|0|||
128997399|NCT03118765|464283454|FG002|Overall Study|COPD Exacerbation|0|||
128997400|NCT03118765|464283455|FG003|Overall Study|COPD Exacerbation|1|||
128997401|NCT03118765|464283456|FG004|Overall Study|COPD Exacerbation|0|||
128997402|NCT03118765|464283452|FG000|Overall Study|Lost to Follow-up|1|||
128997403|NCT03118765|464283453|FG001|Overall Study|Lost to Follow-up|0|||
128997404|NCT03118765|464283454|FG002|Overall Study|Lost to Follow-up|1|||
128997405|NCT03118765|464283455|FG003|Overall Study|Lost to Follow-up|0|||
128997406|NCT03118765|464283456|FG004|Overall Study|Lost to Follow-up|0|||
128997407|NCT03118765|464283452|FG000|Overall Study|Sponsor Decision|1|||
128997408|NCT03118765|464283453|FG001|Overall Study|Sponsor Decision|0|||
128997409|NCT03118765|464283454|FG002|Overall Study|Sponsor Decision|1|||
128997410|NCT03118765|464283455|FG003|Overall Study|Sponsor Decision|0|||
128997411|NCT03118765|464283456|FG004|Overall Study|Sponsor Decision|1|||
128997412|NCT00849524|464283457|FG000|Overall Study|Lack of Efficacy|3|||
128997413|NCT00527397|464283460|FG000|Overall Study|Adverse Event|3|||
128997414|NCT00527397|464283460|FG000|Overall Study|Lack of Efficacy|1|||
128997415|NCT00527397|464283460|FG000|Overall Study|Protocol Violation|1|||
128997416|NCT00527397|464283460|FG000|Overall Study|Withdrawal by Subject|6|||
128997417|NCT00527397|464283460|FG000|Overall Study|Study terminated by sponsor|13|||
128997418|NCT00879970|464283466|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
128997419|NCT00879970|464283467|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
128997420|NCT00879970|464283468|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
128997421|NCT00879970|464283469|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
128997422|NCT00879970|464283470|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
128997423|NCT00879970|464283466|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
128997424|NCT00879970|464283467|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
128997425|NCT00879970|464283468|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
128997426|NCT00879970|464283469|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
128877986|NCT00910689|463848347|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
128877987|NCT00910689|463848348|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
128877988|NCT00910689|463848349|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
128877989|NCT00910689|463848346|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
128877990|NCT00910689|463848347|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
128877991|NCT00910689|463848348|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
128877992|NCT00910689|463848349|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
128877993|NCT00910689|463848346|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
128877994|NCT00910689|463848347|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
128877995|NCT00910689|463848348|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
128877996|NCT00910689|463848349|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
128877997|NCT00910689|463848346|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
128877998|NCT00910689|463848347|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
128877999|NCT00910689|463848348|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
128878000|NCT00910689|463848349|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
128878001|NCT00910689|463848346|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
128878002|NCT00910689|463848347|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
128878003|NCT00910689|463848348|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
128878004|NCT00910689|463848349|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
128878005|NCT00910689|463848346|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
128878006|NCT00910689|463848347|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
128878007|NCT00910689|463848348|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
128878008|NCT00910689|463848349|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
128878009|NCT00910689|463848346|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
128878010|NCT00910689|463848347|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
128878011|NCT00910689|463848348|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
128878012|NCT00910689|463848349|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
128878013|NCT00910689|463848346|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
128878014|NCT00910689|463848347|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
128878015|NCT00910689|463848348|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
128878016|NCT00910689|463848349|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
128878017|NCT00910689|463848346|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
128878018|NCT00910689|463848347|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
128878019|NCT00910689|463848348|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
128878020|NCT00910689|463848349|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
128878021|NCT00910689|463848346|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
128878022|NCT00910689|463848347|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
128878023|NCT00910689|463848348|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
128878024|NCT00910689|463848349|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
128878025|NCT00910689|463848346|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
128878026|NCT00910689|463848347|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
128878027|NCT00910689|463848348|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
128878028|NCT00910689|463848349|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
128878029|NCT00910689|463848346|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
128878030|NCT00910689|463848347|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
128878031|NCT00910689|463848348|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
128878032|NCT00910689|463848349|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
128878033|NCT00910689|463848346|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
128878034|NCT00910689|463848347|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
128878035|NCT00910689|463848348|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
128878036|NCT00910689|463848349|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
128878037|NCT00910689|463848346|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
128997427|NCT00879970|464283470|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
128997428|NCT00879970|464283466|FG000|Period 1 TZD Randomization|Death|2|||
128997429|NCT00879970|464283467|FG001|Period 1 TZD Randomization|Death|1|||
128878038|NCT00910689|463848347|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
128878039|NCT00910689|463848348|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
128878040|NCT00910689|463848349|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
128878041|NCT00910689|463848346|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
128878042|NCT00910689|463848347|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
128997430|NCT00879970|464283468|FG002|Period 1 TZD Randomization|Death|0|||
128997431|NCT00879970|464283469|FG003|Period 1 TZD Randomization|Death|0|||
128997432|NCT00879970|464283470|FG004|Period 1 TZD Randomization|Death|0|||
128997433|NCT00879970|464283466|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
128997434|NCT00879970|464283467|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
128997435|NCT00879970|464283468|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
128997436|NCT00879970|464283469|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
128997437|NCT00879970|464283470|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
128997438|NCT00879970|464283466|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
128997439|NCT00879970|464283467|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
128997440|NCT00879970|464283468|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
128997441|NCT00879970|464283469|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
128997442|NCT00879970|464283470|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
128997443|NCT00879970|464283466|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
128997444|NCT00879970|464283467|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
128997445|NCT00879970|464283468|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
128997446|NCT00879970|464283469|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
128997447|NCT00879970|464283470|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
128997448|NCT00879970|464283466|FG000|Period 2 Vitamin D Randomization|Death|0|||
128997449|NCT00879970|464283467|FG001|Period 2 Vitamin D Randomization|Death|0|||
128997450|NCT00879970|464283468|FG002|Period 2 Vitamin D Randomization|Death|0|||
128997451|NCT00879970|464283469|FG003|Period 2 Vitamin D Randomization|Death|2|||
128997452|NCT00879970|464283470|FG004|Period 2 Vitamin D Randomization|Death|0|||
128997453|NCT01749033|464283472|FG000|Overall Study|Did not receive allocated intervention|3|||
128997454|NCT01749033|464283473|FG001|Overall Study|Did not receive allocated intervention|3|||
128997455|NCT01749033|464283474|FG002|Overall Study|Did not receive allocated intervention|0|||
128997456|NCT01749033|464283472|FG000|Overall Study|Lost to Follow-up|0|||
128997457|NCT01749033|464283473|FG001|Overall Study|Lost to Follow-up|2|||
128997458|NCT01749033|464283474|FG002|Overall Study|Lost to Follow-up|1|||
128997459|NCT04380701|464283475|FG000|Overall Study|Pregnancy|0|||
128997460|NCT04380701|464283476|FG001|Overall Study|Pregnancy|0|||
128997461|NCT04380701|464283477|FG002|Overall Study|Pregnancy|0|||
128997462|NCT04380701|464283478|FG003|Overall Study|Pregnancy|0|||
128997463|NCT04380701|464283479|FG004|Overall Study|Pregnancy|0|||
128997464|NCT04380701|464283480|FG005|Overall Study|Pregnancy|0|||
128997465|NCT04380701|464283481|FG006|Overall Study|Pregnancy|0|||
128997466|NCT04380701|464283482|FG007|Overall Study|Pregnancy|0|||
128997467|NCT04380701|464283483|FG008|Overall Study|Pregnancy|0|||
128997468|NCT04380701|464283484|FG009|Overall Study|Pregnancy|0|||
128997469|NCT04380701|464283485|FG010|Overall Study|Pregnancy|0|||
128997470|NCT04380701|464283486|FG011|Overall Study|Pregnancy|0|||
128997471|NCT04380701|464283487|FG012|Overall Study|Pregnancy|0|||
128997472|NCT04380701|464283488|FG013|Overall Study|Pregnancy|0|||
128997473|NCT04380701|464283489|FG014|Overall Study|Pregnancy|0|||
128997474|NCT04380701|464283490|FG015|Overall Study|Pregnancy|0|||
128997475|NCT04380701|464283491|FG016|Overall Study|Pregnancy|0|||
128997476|NCT04380701|464283492|FG017|Overall Study|Pregnancy|0|||
128997477|NCT04380701|464283493|FG018|Overall Study|Pregnancy|0|||
128997478|NCT04380701|464283494|FG019|Overall Study|Pregnancy|0|||
128997479|NCT04380701|464283495|FG020|Overall Study|Pregnancy|0|||
128997480|NCT04380701|464283496|FG021|Overall Study|Pregnancy|0|||
128997481|NCT04380701|464283497|FG022|Overall Study|Pregnancy|0|||
128997482|NCT04380701|464283498|FG023|Overall Study|Pregnancy|0|||
128997483|NCT04380701|464283499|FG024|Overall Study|Pregnancy|0|||
128997484|NCT04380701|464283500|FG025|Overall Study|Pregnancy|0|||
128997485|NCT04380701|464283501|FG026|Overall Study|Pregnancy|0|||
128997486|NCT04380701|464283502|FG027|Overall Study|Pregnancy|0|||
128997487|NCT04380701|464283503|FG028|Overall Study|Pregnancy|0|||
128997488|NCT04380701|464283504|FG029|Overall Study|Pregnancy|0|||
128997489|NCT04380701|464283505|FG030|Overall Study|Pregnancy|0|||
128997490|NCT04380701|464283506|FG031|Overall Study|Pregnancy|0|||
128997491|NCT04380701|464283507|FG032|Overall Study|Pregnancy|1|||
128997492|NCT04380701|464283508|FG033|Overall Study|Pregnancy|0|||
128997493|NCT04380701|464283475|FG000|Overall Study|Lost to Follow-up|0|||
128997494|NCT04380701|464283476|FG001|Overall Study|Lost to Follow-up|0|||
128997495|NCT04380701|464283477|FG002|Overall Study|Lost to Follow-up|0|||
128997496|NCT04380701|464283478|FG003|Overall Study|Lost to Follow-up|0|||
128997497|NCT04380701|464283479|FG004|Overall Study|Lost to Follow-up|0|||
128997498|NCT04380701|464283480|FG005|Overall Study|Lost to Follow-up|0|||
128997499|NCT04380701|464283481|FG006|Overall Study|Lost to Follow-up|0|||
128997500|NCT04380701|464283482|FG007|Overall Study|Lost to Follow-up|0|||
128997501|NCT04380701|464283483|FG008|Overall Study|Lost to Follow-up|0|||
128997502|NCT04380701|464283484|FG009|Overall Study|Lost to Follow-up|0|||
128997503|NCT04380701|464283485|FG010|Overall Study|Lost to Follow-up|0|||
128997504|NCT04380701|464283486|FG011|Overall Study|Lost to Follow-up|0|||
128997505|NCT04380701|464283487|FG012|Overall Study|Lost to Follow-up|0|||
128997506|NCT04380701|464283488|FG013|Overall Study|Lost to Follow-up|0|||
128997507|NCT04380701|464283489|FG014|Overall Study|Lost to Follow-up|0|||
128997508|NCT04380701|464283490|FG015|Overall Study|Lost to Follow-up|0|||
128997509|NCT04380701|464283491|FG016|Overall Study|Lost to Follow-up|0|||
128997510|NCT04380701|464283492|FG017|Overall Study|Lost to Follow-up|0|||
128997511|NCT04380701|464283493|FG018|Overall Study|Lost to Follow-up|0|||
128997512|NCT04380701|464283494|FG019|Overall Study|Lost to Follow-up|0|||
128997513|NCT04380701|464283495|FG020|Overall Study|Lost to Follow-up|1|||
128997514|NCT04380701|464283496|FG021|Overall Study|Lost to Follow-up|0|||
128997515|NCT04380701|464283497|FG022|Overall Study|Lost to Follow-up|0|||
128997516|NCT04380701|464283498|FG023|Overall Study|Lost to Follow-up|1|||
128997517|NCT04380701|464283499|FG024|Overall Study|Lost to Follow-up|0|||
128997518|NCT04380701|464283500|FG025|Overall Study|Lost to Follow-up|0|||
128997519|NCT04380701|464283501|FG026|Overall Study|Lost to Follow-up|0|||
128997520|NCT04380701|464283502|FG027|Overall Study|Lost to Follow-up|0|||
128997521|NCT04380701|464283503|FG028|Overall Study|Lost to Follow-up|0|||
128997522|NCT04380701|464283504|FG029|Overall Study|Lost to Follow-up|1|||
128997523|NCT04380701|464283505|FG030|Overall Study|Lost to Follow-up|0|||
128997524|NCT04380701|464283506|FG031|Overall Study|Lost to Follow-up|0|||
128997525|NCT04380701|464283507|FG032|Overall Study|Lost to Follow-up|0|||
128997526|NCT04380701|464283508|FG033|Overall Study|Lost to Follow-up|1|||
128997527|NCT04380701|464283475|FG000|Overall Study|Private reason(s)|0|||
128997528|NCT04380701|464283476|FG001|Overall Study|Private reason(s)|0|||
128997529|NCT04380701|464283477|FG002|Overall Study|Private reason(s)|0|||
128997530|NCT04380701|464283478|FG003|Overall Study|Private reason(s)|0|||
128997531|NCT04380701|464283479|FG004|Overall Study|Private reason(s)|0|||
128997532|NCT04380701|464283480|FG005|Overall Study|Private reason(s)|0|||
128997533|NCT04380701|464283481|FG006|Overall Study|Private reason(s)|1|||
128997534|NCT04380701|464283482|FG007|Overall Study|Private reason(s)|0|||
128997535|NCT04380701|464283483|FG008|Overall Study|Private reason(s)|1|||
128997536|NCT04380701|464283484|FG009|Overall Study|Private reason(s)|1|||
128997537|NCT04380701|464283485|FG010|Overall Study|Private reason(s)|0|||
128997538|NCT04380701|464283486|FG011|Overall Study|Private reason(s)|0|||
128997539|NCT04380701|464283487|FG012|Overall Study|Private reason(s)|0|||
128997540|NCT04380701|464283488|FG013|Overall Study|Private reason(s)|0|||
128997541|NCT04380701|464283489|FG014|Overall Study|Private reason(s)|0|||
128997542|NCT04380701|464283490|FG015|Overall Study|Private reason(s)|0|||
128997543|NCT04380701|464283491|FG016|Overall Study|Private reason(s)|0|||
128997544|NCT04380701|464283492|FG017|Overall Study|Private reason(s)|0|||
128997545|NCT04380701|464283493|FG018|Overall Study|Private reason(s)|0|||
128997546|NCT04380701|464283494|FG019|Overall Study|Private reason(s)|0|||
128997547|NCT04380701|464283495|FG020|Overall Study|Private reason(s)|0|||
128997548|NCT04380701|464283496|FG021|Overall Study|Private reason(s)|0|||
128997549|NCT04380701|464283497|FG022|Overall Study|Private reason(s)|0|||
128997550|NCT04380701|464283498|FG023|Overall Study|Private reason(s)|1|||
128997551|NCT04380701|464283499|FG024|Overall Study|Private reason(s)|0|||
128997552|NCT04380701|464283500|FG025|Overall Study|Private reason(s)|0|||
128997553|NCT04380701|464283501|FG026|Overall Study|Private reason(s)|0|||
128997554|NCT04380701|464283502|FG027|Overall Study|Private reason(s)|0|||
128997555|NCT04380701|464283503|FG028|Overall Study|Private reason(s)|0|||
128997556|NCT04380701|464283504|FG029|Overall Study|Private reason(s)|1|||
128997557|NCT04380701|464283505|FG030|Overall Study|Private reason(s)|0|||
128997558|NCT04380701|464283506|FG031|Overall Study|Private reason(s)|0|||
128997559|NCT04380701|464283507|FG032|Overall Study|Private reason(s)|0|||
128997560|NCT04380701|464283508|FG033|Overall Study|Private reason(s)|0|||
128997561|NCT04380701|464283475|FG000|Overall Study|Withdrawal by Subject|0|||
128997562|NCT04380701|464283476|FG001|Overall Study|Withdrawal by Subject|0|||
128997563|NCT04380701|464283477|FG002|Overall Study|Withdrawal by Subject|0|||
128997564|NCT04380701|464283478|FG003|Overall Study|Withdrawal by Subject|0|||
128997565|NCT04380701|464283479|FG004|Overall Study|Withdrawal by Subject|0|||
128997566|NCT04380701|464283480|FG005|Overall Study|Withdrawal by Subject|0|||
128997567|NCT04380701|464283481|FG006|Overall Study|Withdrawal by Subject|1|||
128997568|NCT04380701|464283482|FG007|Overall Study|Withdrawal by Subject|1|||
128997569|NCT04380701|464283483|FG008|Overall Study|Withdrawal by Subject|0|||
128997570|NCT04380701|464283484|FG009|Overall Study|Withdrawal by Subject|0|||
128997571|NCT04380701|464283485|FG010|Overall Study|Withdrawal by Subject|0|||
128997572|NCT04380701|464283486|FG011|Overall Study|Withdrawal by Subject|1|||
128997573|NCT04380701|464283487|FG012|Overall Study|Withdrawal by Subject|0|||
128997574|NCT04380701|464283488|FG013|Overall Study|Withdrawal by Subject|1|||
128997575|NCT04380701|464283489|FG014|Overall Study|Withdrawal by Subject|0|||
128997576|NCT04380701|464283490|FG015|Overall Study|Withdrawal by Subject|0|||
128997577|NCT04380701|464283491|FG016|Overall Study|Withdrawal by Subject|1|||
128997578|NCT04380701|464283492|FG017|Overall Study|Withdrawal by Subject|0|||
128997579|NCT04380701|464283493|FG018|Overall Study|Withdrawal by Subject|0|||
128997580|NCT04380701|464283494|FG019|Overall Study|Withdrawal by Subject|0|||
128997581|NCT04380701|464283495|FG020|Overall Study|Withdrawal by Subject|0|||
128997582|NCT04380701|464283496|FG021|Overall Study|Withdrawal by Subject|0|||
128997583|NCT04380701|464283497|FG022|Overall Study|Withdrawal by Subject|2|||
128997584|NCT04380701|464283498|FG023|Overall Study|Withdrawal by Subject|2|||
128997585|NCT04380701|464283499|FG024|Overall Study|Withdrawal by Subject|1|||
128997586|NCT04380701|464283500|FG025|Overall Study|Withdrawal by Subject|1|||
128997587|NCT04380701|464283501|FG026|Overall Study|Withdrawal by Subject|0|||
128997588|NCT04380701|464283502|FG027|Overall Study|Withdrawal by Subject|0|||
128997589|NCT04380701|464283503|FG028|Overall Study|Withdrawal by Subject|0|||
128997590|NCT04380701|464283504|FG029|Overall Study|Withdrawal by Subject|0|||
128997591|NCT04380701|464283505|FG030|Overall Study|Withdrawal by Subject|0|||
128997592|NCT04380701|464283506|FG031|Overall Study|Withdrawal by Subject|0|||
128997593|NCT04380701|464283507|FG032|Overall Study|Withdrawal by Subject|0|||
128997594|NCT04380701|464283508|FG033|Overall Study|Withdrawal by Subject|0|||
128997595|NCT04380701|464283475|FG000|Overall Study|Adverse Event|0|||
128997596|NCT04380701|464283476|FG001|Overall Study|Adverse Event|0|||
128997597|NCT04380701|464283477|FG002|Overall Study|Adverse Event|0|||
128997598|NCT04380701|464283478|FG003|Overall Study|Adverse Event|0|||
128997599|NCT04380701|464283479|FG004|Overall Study|Adverse Event|0|||
128997600|NCT04380701|464283480|FG005|Overall Study|Adverse Event|1|||
128997601|NCT04380701|464283481|FG006|Overall Study|Adverse Event|0|||
128997602|NCT04380701|464283482|FG007|Overall Study|Adverse Event|0|||
128997603|NCT04380701|464283483|FG008|Overall Study|Adverse Event|0|||
128997604|NCT04380701|464283484|FG009|Overall Study|Adverse Event|0|||
128997605|NCT04380701|464283485|FG010|Overall Study|Adverse Event|0|||
128997606|NCT04380701|464283486|FG011|Overall Study|Adverse Event|0|||
128997607|NCT04380701|464283487|FG012|Overall Study|Adverse Event|0|||
128997608|NCT04380701|464283488|FG013|Overall Study|Adverse Event|0|||
128997609|NCT04380701|464283489|FG014|Overall Study|Adverse Event|0|||
128997610|NCT04380701|464283490|FG015|Overall Study|Adverse Event|1|||
128997611|NCT04380701|464283491|FG016|Overall Study|Adverse Event|0|||
128997612|NCT04380701|464283492|FG017|Overall Study|Adverse Event|0|||
128997613|NCT04380701|464283493|FG018|Overall Study|Adverse Event|0|||
128997614|NCT04380701|464283494|FG019|Overall Study|Adverse Event|1|||
128997615|NCT04380701|464283495|FG020|Overall Study|Adverse Event|0|||
128997616|NCT04380701|464283496|FG021|Overall Study|Adverse Event|0|||
128997617|NCT04380701|464283497|FG022|Overall Study|Adverse Event|0|||
128997618|NCT04380701|464283498|FG023|Overall Study|Adverse Event|0|||
128997619|NCT04380701|464283499|FG024|Overall Study|Adverse Event|0|||
128997620|NCT04380701|464283500|FG025|Overall Study|Adverse Event|0|||
128997621|NCT04380701|464283501|FG026|Overall Study|Adverse Event|0|||
128997622|NCT04380701|464283502|FG027|Overall Study|Adverse Event|0|||
128997623|NCT04380701|464283503|FG028|Overall Study|Adverse Event|0|||
128997624|NCT04380701|464283504|FG029|Overall Study|Adverse Event|0|||
128997625|NCT04380701|464283505|FG030|Overall Study|Adverse Event|0|||
128997626|NCT04380701|464283506|FG031|Overall Study|Adverse Event|0|||
128997627|NCT04380701|464283507|FG032|Overall Study|Adverse Event|0|||
128997628|NCT04380701|464283508|FG033|Overall Study|Adverse Event|0|||
128997629|NCT04380701|464283475|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
128997630|NCT04380701|464283476|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
128997631|NCT04380701|464283477|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
128997632|NCT04380701|464283478|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
128997633|NCT04380701|464283479|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
128997634|NCT04380701|464283480|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
128997635|NCT04380701|464283481|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
128997636|NCT04380701|464283482|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
128997637|NCT04380701|464283483|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
128997638|NCT04380701|464283484|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
128997639|NCT04380701|464283485|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
128997640|NCT04380701|464283486|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
128997641|NCT04380701|464283487|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
128997642|NCT04380701|464283488|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
128997643|NCT04380701|464283489|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
128997644|NCT04380701|464283490|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
128997645|NCT04380701|464283491|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
128997646|NCT04380701|464283492|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
128997647|NCT04380701|464283493|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
128997648|NCT04380701|464283494|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
128997649|NCT04380701|464283495|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
128997650|NCT04380701|464283496|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
128997651|NCT04380701|464283497|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
128997652|NCT04380701|464283498|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
128997653|NCT04380701|464283499|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
128997654|NCT04380701|464283500|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
128997655|NCT04380701|464283501|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
128997656|NCT04380701|464283502|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
128997657|NCT04380701|464283503|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
128997658|NCT04380701|464283504|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
128997659|NCT04380701|464283505|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
128997660|NCT04380701|464283506|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
128997661|NCT04380701|464283507|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
128997662|NCT04380701|464283508|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
128997663|NCT04380701|464283475|FG000|Overall Study|Physician Decision|0|||
128997664|NCT04380701|464283476|FG001|Overall Study|Physician Decision|0|||
128997665|NCT04380701|464283477|FG002|Overall Study|Physician Decision|0|||
128997666|NCT04380701|464283478|FG003|Overall Study|Physician Decision|0|||
128997667|NCT04380701|464283479|FG004|Overall Study|Physician Decision|0|||
128997668|NCT04380701|464283480|FG005|Overall Study|Physician Decision|0|||
128997669|NCT04380701|464283481|FG006|Overall Study|Physician Decision|0|||
128997670|NCT04380701|464283482|FG007|Overall Study|Physician Decision|0|||
128997671|NCT04380701|464283483|FG008|Overall Study|Physician Decision|0|||
128997672|NCT04380701|464283484|FG009|Overall Study|Physician Decision|0|||
128997673|NCT04380701|464283485|FG010|Overall Study|Physician Decision|0|||
128997674|NCT04380701|464283486|FG011|Overall Study|Physician Decision|0|||
128997675|NCT04380701|464283487|FG012|Overall Study|Physician Decision|0|||
128997676|NCT04380701|464283488|FG013|Overall Study|Physician Decision|0|||
128997677|NCT04380701|464283489|FG014|Overall Study|Physician Decision|0|||
128997678|NCT04380701|464283490|FG015|Overall Study|Physician Decision|0|||
128997679|NCT04380701|464283491|FG016|Overall Study|Physician Decision|0|||
128997680|NCT04380701|464283492|FG017|Overall Study|Physician Decision|0|||
128997681|NCT04380701|464283493|FG018|Overall Study|Physician Decision|0|||
128997682|NCT04380701|464283494|FG019|Overall Study|Physician Decision|0|||
128997683|NCT04380701|464283495|FG020|Overall Study|Physician Decision|0|||
128997684|NCT04380701|464283496|FG021|Overall Study|Physician Decision|0|||
128997685|NCT04380701|464283497|FG022|Overall Study|Physician Decision|0|||
128997686|NCT04380701|464283498|FG023|Overall Study|Physician Decision|0|||
128997687|NCT04380701|464283499|FG024|Overall Study|Physician Decision|2|||
128997688|NCT04380701|464283500|FG025|Overall Study|Physician Decision|0|||
128997689|NCT04380701|464283501|FG026|Overall Study|Physician Decision|0|||
128997690|NCT04380701|464283502|FG027|Overall Study|Physician Decision|0|||
128997691|NCT04380701|464283503|FG028|Overall Study|Physician Decision|0|||
128997692|NCT04380701|464283504|FG029|Overall Study|Physician Decision|0|||
128997693|NCT04380701|464283505|FG030|Overall Study|Physician Decision|0|||
128997694|NCT04380701|464283506|FG031|Overall Study|Physician Decision|0|||
128997695|NCT04380701|464283507|FG032|Overall Study|Physician Decision|0|||
128997696|NCT04380701|464283508|FG033|Overall Study|Physician Decision|0|||
128997697|NCT04380701|464283475|FG000|Overall Study|Death|0|||
128997698|NCT04380701|464283476|FG001|Overall Study|Death|0|||
128997699|NCT04380701|464283477|FG002|Overall Study|Death|0|||
128997700|NCT04380701|464283478|FG003|Overall Study|Death|0|||
128997701|NCT04380701|464283479|FG004|Overall Study|Death|0|||
128997702|NCT04380701|464283480|FG005|Overall Study|Death|0|||
128997703|NCT04380701|464283481|FG006|Overall Study|Death|0|||
128997704|NCT04380701|464283482|FG007|Overall Study|Death|0|||
128997705|NCT04380701|464283483|FG008|Overall Study|Death|0|||
128997706|NCT04380701|464283484|FG009|Overall Study|Death|0|||
128997707|NCT04380701|464283485|FG010|Overall Study|Death|0|||
128997708|NCT04380701|464283486|FG011|Overall Study|Death|0|||
128997709|NCT04380701|464283487|FG012|Overall Study|Death|0|||
128997710|NCT04380701|464283488|FG013|Overall Study|Death|0|||
128997711|NCT04380701|464283489|FG014|Overall Study|Death|0|||
128997712|NCT04380701|464283490|FG015|Overall Study|Death|0|||
128997713|NCT04380701|464283491|FG016|Overall Study|Death|0|||
128997714|NCT04380701|464283492|FG017|Overall Study|Death|0|||
128997715|NCT04380701|464283493|FG018|Overall Study|Death|0|||
128997716|NCT04380701|464283494|FG019|Overall Study|Death|0|||
128997717|NCT04380701|464283495|FG020|Overall Study|Death|0|||
128997718|NCT04380701|464283496|FG021|Overall Study|Death|0|||
128997719|NCT04380701|464283497|FG022|Overall Study|Death|0|||
128997720|NCT04380701|464283498|FG023|Overall Study|Death|0|||
128997721|NCT04380701|464283499|FG024|Overall Study|Death|1|||
128997722|NCT04380701|464283500|FG025|Overall Study|Death|0|||
128997723|NCT04380701|464283501|FG026|Overall Study|Death|0|||
128997724|NCT04380701|464283502|FG027|Overall Study|Death|0|||
128997725|NCT04380701|464283503|FG028|Overall Study|Death|0|||
128997726|NCT04380701|464283504|FG029|Overall Study|Death|0|||
128997727|NCT04380701|464283505|FG030|Overall Study|Death|0|||
128997728|NCT04380701|464283506|FG031|Overall Study|Death|0|||
128997729|NCT04380701|464283507|FG032|Overall Study|Death|0|||
128997730|NCT04380701|464283508|FG033|Overall Study|Death|0|||
128997731|NCT04380701|464283475|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997732|NCT04380701|464283476|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997733|NCT04380701|464283477|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997734|NCT04380701|464283478|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997735|NCT04380701|464283479|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997736|NCT04380701|464283480|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997737|NCT04380701|464283481|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997738|NCT04380701|464283482|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997739|NCT04380701|464283483|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997740|NCT04380701|464283484|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997741|NCT04380701|464283485|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997742|NCT04380701|464283486|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997743|NCT04380701|464283487|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997744|NCT04380701|464283488|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997745|NCT04380701|464283489|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997746|NCT04380701|464283490|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997747|NCT04380701|464283491|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997748|NCT04380701|464283492|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997749|NCT04380701|464283493|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997750|NCT04380701|464283494|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997751|NCT04380701|464283495|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997752|NCT04380701|464283496|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
128997753|NCT04380701|464283497|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
128997754|NCT04380701|464283498|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
128997755|NCT04380701|464283499|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
128997756|NCT04380701|464283500|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997757|NCT04380701|464283501|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997758|NCT04380701|464283502|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997759|NCT04380701|464283503|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997760|NCT04380701|464283504|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997761|NCT04380701|464283505|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997762|NCT04380701|464283506|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997763|NCT04380701|464283507|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997764|NCT04380701|464283508|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
128997765|NCT00383019|464283509|FG000|Overall Study|Adverse Event|5|||
128997766|NCT00383019|464283510|FG001|Overall Study|Adverse Event|1|||
128997767|NCT00383019|464283509|FG000|Overall Study|Withdrawal by Subject|0|||
128997768|NCT00383019|464283510|FG001|Overall Study|Withdrawal by Subject|1|||
128997769|NCT03125915|464283513|FG000|1 Month Follow up|Lost to Follow-up|3|||
128997770|NCT03125915|464283514|FG001|1 Month Follow up|Lost to Follow-up|3|||
128997771|NCT03125915|464283515|FG002|1 Month Follow up|Lost to Follow-up|2|||
128997772|NCT03125915|464283516|FG003|1 Month Follow up|Lost to Follow-up|3|||
128997773|NCT03125915|464283513|FG000|3 Month Follow-up|Lost to Follow-up|6|||
128997774|NCT03125915|464283514|FG001|3 Month Follow-up|Lost to Follow-up|4|||
128997775|NCT03125915|464283515|FG002|3 Month Follow-up|Lost to Follow-up|4|||
128997776|NCT03125915|464283516|FG003|3 Month Follow-up|Lost to Follow-up|2|||
128997777|NCT03125915|464283513|FG000|6 Month Follow-up|Lost to Follow-up|7|||
128997778|NCT03125915|464283514|FG001|6 Month Follow-up|Lost to Follow-up|3|||
128997779|NCT03125915|464283515|FG002|6 Month Follow-up|Lost to Follow-up|6|||
128997780|NCT03125915|464283516|FG003|6 Month Follow-up|Lost to Follow-up|3|||
128997781|NCT01123980|464283517|FG000|Overall Study|Adverse Event|1|||
128997782|NCT01123980|464283518|FG001|Overall Study|Adverse Event|1|||
128997783|NCT01123980|464283517|FG000|Overall Study|Lack of Efficacy|1|||
128997784|NCT01123980|464283518|FG001|Overall Study|Lack of Efficacy|0|||
128997785|NCT01123980|464283517|FG000|Overall Study|Physician Decision|0|||
128997786|NCT01123980|464283518|FG001|Overall Study|Physician Decision|1|||
128997787|NCT01123980|464283517|FG000|Overall Study|Lost to Follow-up|0|||
128997788|NCT01123980|464283518|FG001|Overall Study|Lost to Follow-up|6|||
128997789|NCT01123980|464283517|FG000|Overall Study|Protocol Violation|6|||
128997790|NCT01123980|464283518|FG001|Overall Study|Protocol Violation|6|||
128997791|NCT01123980|464283517|FG000|Overall Study|Withdrawal by Subject|5|||
128997792|NCT01123980|464283518|FG001|Overall Study|Withdrawal by Subject|3|||
128997793|NCT01123980|464283517|FG000|Overall Study|Unclassified|6|||
128997794|NCT01123980|464283518|FG001|Overall Study|Unclassified|7|||
128997795|NCT01225991|464283519|FG000|Overall Study|Withdrawal by Subject|6|||
128997796|NCT00789828|464283520|FG000|Core Period (48 Weeks)|Administrative problems|0|||
128997797|NCT00789828|464283521|FG001|Core Period (48 Weeks)|Administrative problems|1|||
128997798|NCT00789828|464283520|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
128997799|NCT00789828|464283521|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
128997800|NCT00789828|464283520|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
128997801|NCT00789828|464283521|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
128997802|NCT00789828|464283520|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
128997803|NCT00789828|464283521|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
128997804|NCT00789828|464283520|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
128997805|NCT00789828|464283521|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
128997806|NCT00789828|464283520|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
128997807|NCT00789828|464283521|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
128997808|NCT00789828|464283520|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
128997809|NCT00789828|464283521|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
128997810|NCT00789828|464283520|FG000|Open-label Extension Period (4 Years)|Death|1|||
128997811|NCT00789828|464283521|FG001|Open-label Extension Period (4 Years)|Death|0|||
128997812|NCT00789828|464283520|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
128997813|NCT00789828|464283521|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
128997814|NCT00789828|464283520|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
128997815|NCT00789828|464283521|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
128997816|NCT02094937|464283522|FG000|8 Weeks in Period 1|Adverse Event|9|||
128997817|NCT02094937|464283523|FG001|8 Weeks in Period 1|Adverse Event|0|||
128997818|NCT02094937|464283524|FG002|8 Weeks in Period 1|Adverse Event|0|||
128997819|NCT02094937|464283525|FG003|8 Weeks in Period 1|Adverse Event|0|||
128997820|NCT02094937|464283522|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
128997821|NCT02094937|464283523|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
128997822|NCT02094937|464283524|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
128997823|NCT02094937|464283525|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
128997824|NCT02094937|464283522|FG000|8 Weeks in Period 1|Protocol Violation|2|||
128997825|NCT02094937|464283523|FG001|8 Weeks in Period 1|Protocol Violation|0|||
128997826|NCT02094937|464283524|FG002|8 Weeks in Period 1|Protocol Violation|0|||
128997827|NCT02094937|464283525|FG003|8 Weeks in Period 1|Protocol Violation|0|||
128997828|NCT02094937|464283522|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
128997829|NCT02094937|464283523|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
128997830|NCT02094937|464283524|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
128997831|NCT02094937|464283525|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
128997832|NCT02094937|464283522|FG000|8 Weeks in Period 1|Physician Decision|1|||
128997833|NCT02094937|464283523|FG001|8 Weeks in Period 1|Physician Decision|0|||
128997834|NCT02094937|464283524|FG002|8 Weeks in Period 1|Physician Decision|0|||
128997835|NCT02094937|464283525|FG003|8 Weeks in Period 1|Physician Decision|0|||
128997836|NCT02094937|464283522|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
128997837|NCT02094937|464283523|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
128997838|NCT02094937|464283524|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
128997839|NCT02094937|464283525|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
128997840|NCT02094937|464283522|FG000|12 Weeks in Period 2|Adverse Event|0|||
128997841|NCT02094937|464283523|FG001|12 Weeks in Period 2|Adverse Event|2|||
128997842|NCT02094937|464283524|FG002|12 Weeks in Period 2|Adverse Event|4|||
128997843|NCT02094937|464283525|FG003|12 Weeks in Period 2|Adverse Event|1|||
128997844|NCT02094937|464283522|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
128997845|NCT02094937|464283523|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
128997846|NCT02094937|464283524|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
128997847|NCT02094937|464283525|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
128997848|NCT02094937|464283522|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
128997849|NCT02094937|464283523|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
128997850|NCT02094937|464283524|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
128997851|NCT02094937|464283525|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
128997852|NCT02094937|464283522|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
128997853|NCT02094937|464283523|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
128997854|NCT02094937|464283524|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
128997855|NCT02094937|464283525|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
128997856|NCT02094937|464283522|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
128997857|NCT02094937|464283523|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
128997858|NCT02094937|464283524|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
128997859|NCT02094937|464283525|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
128997860|NCT05788237|464283526|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
128997861|NCT05788237|464283527|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
128997862|NCT05788237|464283528|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
128997863|NCT05788237|464283529|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
128997864|NCT05788237|464283526|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
128997865|NCT05788237|464283527|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
128997866|NCT05788237|464283528|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
128997867|NCT05788237|464283529|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
128997868|NCT05788237|464283526|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
128997869|NCT05788237|464283527|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
128997870|NCT05788237|464283528|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
128997871|NCT05788237|464283529|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
128997872|NCT05788237|464283526|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
128997873|NCT05788237|464283527|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
128997874|NCT05788237|464283528|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
128997875|NCT05788237|464283529|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
128997876|NCT05788237|464283526|FG000|SSA (Approximately 2 Months)|Death|0|||
128997877|NCT05788237|464283527|FG001|SSA (Approximately 2 Months)|Death|1|||
128997878|NCT05788237|464283528|FG002|SSA (Approximately 2 Months)|Death|0|||
128997879|NCT05788237|464283529|FG003|SSA (Approximately 2 Months)|Death|0|||
128997880|NCT05788237|464283526|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
128997881|NCT05788237|464283527|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
128997882|NCT05788237|464283528|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
128997883|NCT05788237|464283529|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
128997884|NCT05788237|464283526|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
128997885|NCT05788237|464283527|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
128997886|NCT05788237|464283528|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
128997887|NCT05788237|464283529|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
128997888|NCT05788237|464283526|FG000|SSB (Approximately 1 Month)|Other|0|||
128997889|NCT05788237|464283527|FG001|SSB (Approximately 1 Month)|Other|0|||
128997890|NCT05788237|464283528|FG002|SSB (Approximately 1 Month)|Other|0|||
128997891|NCT05788237|464283529|FG003|SSB (Approximately 1 Month)|Other|1|||
128997892|NCT02842086|464283530|FG000|Overall Study|Randomized but Never Treated|6|||
128997893|NCT02842086|464283531|FG001|Overall Study|Randomized but Never Treated|6|||
128997894|NCT02842086|464283530|FG000|Overall Study|Still in Double-Blind Phase|7|||
128997895|NCT02842086|464283531|FG001|Overall Study|Still in Double-Blind Phase|3|||
128997896|NCT02842086|464283530|FG000|Overall Study|Adverse Event|18|||
128997897|NCT02842086|464283531|FG001|Overall Study|Adverse Event|20|||
128997898|NCT02842086|464283530|FG000|Overall Study|Death|3|||
128997899|NCT02842086|464283531|FG001|Overall Study|Death|3|||
128997900|NCT02842086|464283530|FG000|Overall Study|Investigator's Discretion|9|||
128997901|NCT02842086|464283531|FG001|Overall Study|Investigator's Discretion|13|||
128997902|NCT02842086|464283530|FG000|Overall Study|Non-Compliance with Study Drug|9|||
128997903|NCT02842086|464283531|FG001|Overall Study|Non-Compliance with Study Drug|8|||
128997904|NCT02842086|464283530|FG000|Overall Study|Protocol Violation|8|||
128997905|NCT02842086|464283531|FG001|Overall Study|Protocol Violation|4|||
128997906|NCT02842086|464283530|FG000|Overall Study|Withdrew Consent|205|||
128997907|NCT02842086|464283531|FG001|Overall Study|Withdrew Consent|194|||
128997908|NCT02842086|464283530|FG000|Overall Study|Lost to Follow-up|274|||
128997909|NCT02842086|464283531|FG001|Overall Study|Lost to Follow-up|236|||
128997910|NCT02842086|464283530|FG000|Overall Study|HIV-1 Infection|5|||
128997911|NCT02842086|464283531|FG001|Overall Study|HIV-1 Infection|6|||
128997912|NCT03751124|464283532|FG000|Overall Study|Adverse Event|4|||
128997913|NCT03751124|464283533|FG001|Overall Study|Adverse Event|3|||
128997914|NCT03751124|464283532|FG000|Overall Study|Protocol Deviation|0|||
128997915|NCT03751124|464283533|FG001|Overall Study|Protocol Deviation|1|||
128997916|NCT03751124|464283532|FG000|Overall Study|Lost to Follow-up|6|||
128997917|NCT03751124|464283533|FG001|Overall Study|Lost to Follow-up|4|||
128997918|NCT03751124|464283532|FG000|Overall Study|Withdrawal by Subject|6|||
128997919|NCT03751124|464283533|FG001|Overall Study|Withdrawal by Subject|8|||
128997920|NCT03751124|464283532|FG000|Overall Study|Lack of Efficacy|1|||
128997921|NCT03751124|464283533|FG001|Overall Study|Lack of Efficacy|1|||
128997922|NCT03751124|464283532|FG000|Overall Study|Pregnancy|0|||
128997923|NCT03751124|464283533|FG001|Overall Study|Pregnancy|1|||
128997924|NCT03751124|464283532|FG000|Overall Study|Other|9|||
128997925|NCT03751124|464283533|FG001|Overall Study|Other|9|||
128997926|NCT03751124|464283532|FG000|Overall Study|Participants who did not receive any study drug|0|||
128997927|NCT03751124|464283533|FG001|Overall Study|Participants who did not receive any study drug|1|||
128997928|NCT00555399|464283536|FG000|Overall Study|Withdrawal by Subject|0|||
128997929|NCT00555399|464283537|FG001|Overall Study|Withdrawal by Subject|0|||
128997930|NCT00555399|464283538|FG002|Overall Study|Withdrawal by Subject|1|||
128997931|NCT00555399|464283539|FG003|Overall Study|Withdrawal by Subject|0|||
128997932|NCT00555399|464283540|FG004|Overall Study|Withdrawal by Subject|0|||
128997933|NCT00555399|464283541|FG005|Overall Study|Withdrawal by Subject|0|||
128997934|NCT00555399|464283542|FG006|Overall Study|Withdrawal by Subject|0|||
128997935|NCT00555399|464283543|FG007|Overall Study|Withdrawal by Subject|0|||
128997936|NCT00555399|464283544|FG008|Overall Study|Withdrawal by Subject|0|||
128997937|NCT00555399|464283545|FG009|Overall Study|Withdrawal by Subject|0|||
128997938|NCT00555399|464283546|FG010|Overall Study|Withdrawal by Subject|0|||
128997939|NCT00555399|464283547|FG011|Overall Study|Withdrawal by Subject|1|||
128997940|NCT00555399|464283536|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
128997941|NCT00555399|464283537|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
128997942|NCT00555399|464283538|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
128997943|NCT00555399|464283539|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
128997944|NCT00555399|464283540|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
128997945|NCT00555399|464283541|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
128997946|NCT00555399|464283542|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
128997947|NCT00555399|464283543|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
128997948|NCT00555399|464283544|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
128997949|NCT00555399|464283545|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
128997950|NCT00555399|464283546|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
128997951|NCT00555399|464283547|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
128997952|NCT03053622|464284814|FG000|Overall Study|Lost to Follow-up|0|||
128997953|NCT03053622|464284815|FG001|Overall Study|Lost to Follow-up|0|||
128997954|NCT03053622|464284816|FG002|Overall Study|Lost to Follow-up|0|||
128997955|NCT03053622|464284817|FG003|Overall Study|Lost to Follow-up|1|||
128997956|NCT01355523|464284821|FG000|Overall Study|Withdrawal by Subject|1|||
128997957|NCT01355523|464284822|FG001|Overall Study|Withdrawal by Subject|4|||
128997958|NCT01355523|464284821|FG000|Overall Study|Lost to Follow-up|0|||
128997959|NCT01355523|464284822|FG001|Overall Study|Lost to Follow-up|2|||
128997960|NCT01355523|464284821|FG000|Overall Study|Protocol Violation|0|||
128997961|NCT01355523|464284822|FG001|Overall Study|Protocol Violation|2|||
128997962|NCT01355523|464284821|FG000|Overall Study|Adverse Event|0|||
128997963|NCT01355523|464284822|FG001|Overall Study|Adverse Event|2|||
128997964|NCT01011907|464284823|FG000|Overall Study|Withdrawal by Subject|13|||
128997965|NCT01011907|464284824|FG001|Overall Study|Withdrawal by Subject|11|||
128997966|NCT01011907|464284823|FG000|Overall Study|Adverse Event|1|||
128997967|NCT01011907|464284824|FG001|Overall Study|Adverse Event|4|||
128997968|NCT01406873|464284835|FG000|Overall Study|Withdrawal by Subject|1|||
128997969|NCT01406873|464284836|FG001|Overall Study|Withdrawal by Subject|1|||
128997970|NCT00207714|464284837|FG000|Overall Study|Adverse Event|6|||
128997971|NCT00207714|464284838|FG001|Overall Study|Adverse Event|2|||
128997972|NCT00207714|464284839|FG002|Overall Study|Adverse Event|4|||
128997973|NCT00207714|464284840|FG003|Overall Study|Adverse Event|3|||
128997974|NCT00207714|464284841|FG004|Overall Study|Adverse Event|1|||
128997975|NCT00207714|464284837|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
128997976|NCT00207714|464284838|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
128997977|NCT00207714|464284839|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
128997978|NCT00207714|464284840|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
128997979|NCT00207714|464284841|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
128997980|NCT00207714|464284837|FG000|Overall Study|Other|3|||
128997981|NCT00207714|464284838|FG001|Overall Study|Other|2|||
128997982|NCT00207714|464284839|FG002|Overall Study|Other|5|||
128997983|NCT00207714|464284840|FG003|Overall Study|Other|1|||
128997984|NCT00207714|464284841|FG004|Overall Study|Other|0|||
128997985|NCT03627195|464284842|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
128997986|NCT03627195|464284843|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
128997987|NCT03627195|464284844|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
128997988|NCT03627195|464284845|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
128997989|NCT03627195|464284846|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
128997990|NCT03627195|464284847|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
128997991|NCT00736099|464284850|FG000|Overall Study|Adverse Event|61|||
128997992|NCT00736099|464284851|FG001|Overall Study|Adverse Event|18|||
128997993|NCT00736099|464284850|FG000|Overall Study|Protocol Violation|10|||
128997994|NCT00736099|464284851|FG001|Overall Study|Protocol Violation|4|||
128997995|NCT00736099|464284850|FG000|Overall Study|Lost to Follow-up|12|||
128997996|NCT00736099|464284851|FG001|Overall Study|Lost to Follow-up|5|||
128997997|NCT00736099|464284850|FG000|Overall Study|Withdrawal by Subject|42|||
128997998|NCT00736099|464284851|FG001|Overall Study|Withdrawal by Subject|13|||
128997999|NCT00736099|464284850|FG000|Overall Study|Lack of Efficacy|15|||
128998000|NCT00736099|464284851|FG001|Overall Study|Lack of Efficacy|8|||
128998001|NCT00736099|464284850|FG000|Overall Study|Other reason|43|||
128998002|NCT00736099|464284851|FG001|Overall Study|Other reason|10|||
128998003|NCT00833547|464284855|FG000|Overall Study|Withdrawal by Subject|2|||
128998004|NCT00833547|464284856|FG001|Overall Study|Withdrawal by Subject|2|||
128998005|NCT00686790|464284861|FG000|Overall Study|Adverse Event|2|||
128998006|NCT00686790|464284861|FG000|Overall Study|Withdrawal by Subject|1|||
128998007|NCT00686790|464284861|FG000|Overall Study|Death|1|||
128998008|NCT00686790|464284861|FG000|Overall Study|Lost to Follow-up|12|||
128998009|NCT01835132|464284862|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
128998010|NCT00856778|464284863|FG000|Overall Study|Adverse Event|7|||
128998011|NCT00856778|464284863|FG000|Overall Study|Withdrawal by Subject|10|||
128998012|NCT00856778|464284863|FG000|Overall Study|Study deviation|2|||
128998013|NCT00856778|464284863|FG000|Overall Study|Lost to Follow-up|5|||
128998014|NCT02140164|464284864|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
128998015|NCT00686374|464284879|FG000|Overall Study|Lack of Efficacy|10|||
128998016|NCT00686374|464284879|FG000|Overall Study|Adverse Event|8|||
128998017|NCT00686374|464284879|FG000|Overall Study|Withdrew consent|5|||
128998018|NCT00686374|464284879|FG000|Overall Study|Lost to Follow-up|1|||
128998019|NCT00686374|464284879|FG000|Overall Study|Missing reason|33|||
128998020|NCT00686374|464284879|FG000|Overall Study|Other, not specified|4|||
128998021|NCT01070966|464284880|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
128998022|NCT01070966|464284880|FG000|Participants for Safety Evaluation|Off-label use|9|||
128998023|NCT01070966|464284880|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
128998024|NCT01070966|464284880|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
128998025|NCT01070966|464284880|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
128998026|NCT01070966|464284880|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
128717767|NCT03447990|463264021|FG002|Overall Study|Withdrawal by Subject|0|||
128998027|NCT01070966|464284880|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
128998028|NCT01070966|464284880|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
128998029|NCT02770716|464284881|FG000|Overall Study|Death|101|||
128998030|NCT02770716|464284882|FG001|Overall Study|Death|45|||
128998031|NCT02770716|464284881|FG000|Overall Study|Withdrawal by Subject|4|||
128998032|NCT02770716|464284882|FG001|Overall Study|Withdrawal by Subject|2|||
128998033|NCT02770716|464284881|FG000|Overall Study|Lost to Follow-up|1|||
128998034|NCT02770716|464284882|FG001|Overall Study|Lost to Follow-up|0|||
128998035|NCT02770716|464284881|FG000|Overall Study|Various reasons|6|||
128998036|NCT02770716|464284882|FG001|Overall Study|Various reasons|2|||
128998037|NCT01725113|464284883|FG000|Overall Study|Kidney Transplant|1|||
128998038|NCT01725113|464284884|FG001|Overall Study|Kidney Transplant|1|||
128998039|NCT01725113|464284883|FG000|Overall Study|Withdrawal by Subject|0|||
128998040|NCT01725113|464284884|FG001|Overall Study|Withdrawal by Subject|1|||
128998041|NCT03989115|464284885|FG000|Overall Study|Withdrawal by Subject|2|||
128998042|NCT03989115|464284886|FG001|Overall Study|Withdrawal by Subject|1|||
128998043|NCT03989115|464284887|FG002|Overall Study|Withdrawal by Subject|3|||
128998044|NCT03989115|464284888|FG003|Overall Study|Withdrawal by Subject|0|||
128998045|NCT03989115|464284889|FG004|Overall Study|Withdrawal by Subject|17|||
128998046|NCT03989115|464284890|FG005|Overall Study|Withdrawal by Subject|1|||
128998047|NCT03989115|464284891|FG006|Overall Study|Withdrawal by Subject|0|||
128998048|NCT03989115|464284892|FG007|Overall Study|Withdrawal by Subject|0|||
128998049|NCT03989115|464284885|FG000|Overall Study|Sponsor decision to terminate the study|1|||
128998050|NCT03989115|464284886|FG001|Overall Study|Sponsor decision to terminate the study|1|||
128998051|NCT03989115|464284887|FG002|Overall Study|Sponsor decision to terminate the study|0|||
128998052|NCT03989115|464284888|FG003|Overall Study|Sponsor decision to terminate the study|1|||
128998053|NCT03989115|464284889|FG004|Overall Study|Sponsor decision to terminate the study|11|||
128998054|NCT03989115|464284890|FG005|Overall Study|Sponsor decision to terminate the study|0|||
128998055|NCT03989115|464284891|FG006|Overall Study|Sponsor decision to terminate the study|2|||
128998056|NCT03989115|464284892|FG007|Overall Study|Sponsor decision to terminate the study|1|||
128998057|NCT03989115|464284885|FG000|Overall Study|Lost to Follow-up|2|||
128998058|NCT03989115|464284886|FG001|Overall Study|Lost to Follow-up|0|||
128998059|NCT03989115|464284887|FG002|Overall Study|Lost to Follow-up|0|||
128998060|NCT03989115|464284888|FG003|Overall Study|Lost to Follow-up|0|||
128998061|NCT03989115|464284889|FG004|Overall Study|Lost to Follow-up|1|||
128998062|NCT03989115|464284890|FG005|Overall Study|Lost to Follow-up|0|||
128998063|NCT03989115|464284891|FG006|Overall Study|Lost to Follow-up|0|||
128998064|NCT03989115|464284892|FG007|Overall Study|Lost to Follow-up|0|||
128998065|NCT03989115|464284885|FG000|Overall Study|Death|2|||
128998066|NCT03989115|464284886|FG001|Overall Study|Death|2|||
128998067|NCT03989115|464284887|FG002|Overall Study|Death|9|||
128998068|NCT03989115|464284888|FG003|Overall Study|Death|6|||
128998069|NCT03989115|464284889|FG004|Overall Study|Death|31|||
128998070|NCT03989115|464284890|FG005|Overall Study|Death|6|||
128998071|NCT03989115|464284891|FG006|Overall Study|Death|2|||
128998072|NCT03989115|464284892|FG007|Overall Study|Death|3|||
128998073|NCT03989115|464284885|FG000|Overall Study|Other|1|||
128998074|NCT03989115|464284886|FG001|Overall Study|Other|2|||
128998075|NCT03989115|464284887|FG002|Overall Study|Other|0|||
128998076|NCT03989115|464284888|FG003|Overall Study|Other|0|||
128998077|NCT03989115|464284889|FG004|Overall Study|Other|5|||
128998078|NCT03989115|464284890|FG005|Overall Study|Other|0|||
128998079|NCT03989115|464284891|FG006|Overall Study|Other|0|||
128998080|NCT03989115|464284892|FG007|Overall Study|Other|0|||
128998081|NCT01808209|464284893|FG000|Overall Study|Lost to Follow-up|0|||
128998082|NCT01808209|464284894|FG001|Overall Study|Lost to Follow-up|1|||
128998083|NCT02629133|464284900|FG000|Overall Study|Lost to Follow-up|3|||
128998084|NCT02629133|464284901|FG001|Overall Study|Lost to Follow-up|1|||
128998085|NCT02629133|464284900|FG000|Overall Study|Withdrawal by Subject|1|||
128998086|NCT02629133|464284901|FG001|Overall Study|Withdrawal by Subject|1|||
128998087|NCT03216954|464284902|FG000|Overall Study|Adverse Event|0|||
128998088|NCT03216954|464284903|FG001|Overall Study|Adverse Event|0|||
128998089|NCT03216954|464284904|FG002|Overall Study|Adverse Event|1|||
128998090|NCT03216954|464284905|FG003|Overall Study|Adverse Event|0|||
128998091|NCT03216954|464284906|FG004|Overall Study|Adverse Event|1|||
128998092|NCT03216954|464284902|FG000|Overall Study|Withdrawal by Subject|2|||
128998093|NCT03216954|464284903|FG001|Overall Study|Withdrawal by Subject|0|||
128998094|NCT03216954|464284904|FG002|Overall Study|Withdrawal by Subject|0|||
128998095|NCT03216954|464284905|FG003|Overall Study|Withdrawal by Subject|0|||
128998096|NCT03216954|464284906|FG004|Overall Study|Withdrawal by Subject|0|||
128998097|NCT03216954|464284902|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
128998098|NCT03216954|464284903|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
128998099|NCT03216954|464284904|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
128998100|NCT03216954|464284905|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
128998101|NCT03216954|464284906|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
128998102|NCT01507831|464284907|FG000|Overall Study|Randomized but not treated|0|||
128998103|NCT01507831|464284908|FG001|Overall Study|Randomized but not treated|3|||
128998104|NCT01507831|464284907|FG000|Overall Study|Adverse Event|48|||
128998105|NCT01507831|464284908|FG001|Overall Study|Adverse Event|113|||
128998106|NCT01507831|464284907|FG000|Overall Study|Death|6|||
128998107|NCT01507831|464284908|FG001|Overall Study|Death|2|||
128998108|NCT01507831|464284907|FG000|Overall Study|Poor compliance to protocol|38|||
128998109|NCT01507831|464284908|FG001|Overall Study|Poor compliance to protocol|60|||
128998110|NCT01507831|464284907|FG000|Overall Study|Physician Decision|0|||
128998111|NCT01507831|464284908|FG001|Overall Study|Physician Decision|4|||
128998112|NCT01507831|464284907|FG000|Overall Study|Participant moved|5|||
128998113|NCT01507831|464284908|FG001|Overall Study|Participant moved|19|||
128998114|NCT01507831|464284907|FG000|Overall Study|Consent withdrawn by participant|34|||
128998115|NCT01507831|464284908|FG001|Overall Study|Consent withdrawn by participant|72|||
128998116|NCT01507831|464284907|FG000|Overall Study|Related to study drug administration|5|||
128998117|NCT01507831|464284908|FG001|Overall Study|Related to study drug administration|14|||
128998118|NCT01507831|464284907|FG000|Overall Study|Last visit outside protocol visit window|51|||
128998119|NCT01507831|464284908|FG001|Overall Study|Last visit outside protocol visit window|143|||
128998120|NCT01507831|464284907|FG000|Overall Study|Selection criteria finally not met|0|||
128998121|NCT01507831|464284908|FG001|Overall Study|Selection criteria finally not met|1|||
128998122|NCT01507831|464284907|FG000|Overall Study|Site closure|0|||
128998123|NCT01507831|464284908|FG001|Overall Study|Site closure|3|||
128998124|NCT01507831|464284907|FG000|Overall Study|Potential lost to follow-up|3|||
128998125|NCT01507831|464284908|FG001|Overall Study|Potential lost to follow-up|0|||
128998126|NCT01507831|464284907|FG000|Overall Study|Other|3|||
128998127|NCT01507831|464284908|FG001|Overall Study|Other|6|||
128998128|NCT01610167|464284909|FG000|Overall Study|Scheduling conflict.|0|||
128998129|NCT01610167|464284910|FG001|Overall Study|Scheduling conflict.|0|||
128998130|NCT01610167|464284911|FG002|Overall Study|Scheduling conflict.|2|||
128998131|NCT03296553|464284913|FG000|Overall Study|Withdrawal by Subject|1|||
128998132|NCT03296553|464284914|FG001|Overall Study|Withdrawal by Subject|1|||
128998133|NCT03296553|464284913|FG000|Overall Study|Death|1|||
128998134|NCT03296553|464284914|FG001|Overall Study|Death|0|||
128998135|NCT02295280|464284915|FG000|Overall Study|Adverse Event|0|||
128998136|NCT02295280|464284916|FG001|Overall Study|Adverse Event|1|||
128998137|NCT02713243|464284917|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
128998138|NCT02713243|464284918|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
128998139|NCT02713243|464284917|FG000|Overall Study|Administrative problems|0|||
128998140|NCT02713243|464284918|FG001|Overall Study|Administrative problems|1|||
128998141|NCT02713243|464284917|FG000|Overall Study|Protocol deviation|0|||
128998142|NCT02713243|464284918|FG001|Overall Study|Protocol deviation|1|||
128998143|NCT00124449|464284919|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
128998144|NCT00124449|464284920|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
128998145|NCT00124449|464284919|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
128998146|NCT00124449|464284920|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
128998147|NCT00124449|464284919|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
128998148|NCT00124449|464284920|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
128998149|NCT00124449|464284919|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
128998150|NCT00124449|464284920|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
128998151|NCT00124449|464284919|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
128998152|NCT00124449|464284920|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
128998153|NCT00124449|464284919|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
128998154|NCT00124449|464284920|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
128998155|NCT00124449|464284919|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
128998156|NCT00124449|464284920|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
128998157|NCT00124449|464284919|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
128998158|NCT00124449|464284920|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
128998159|NCT00124449|464284919|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
128998160|NCT00124449|464284920|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
128998161|NCT00124449|464284919|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
128998162|NCT00124449|464284920|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
128998163|NCT00124449|464284919|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
128998164|NCT00124449|464284920|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
128998165|NCT00124449|464284919|FG000|18-Month Untreated Observation Period|Relocated|1|||
128998166|NCT00124449|464284920|FG001|18-Month Untreated Observation Period|Relocated|0|||
128998167|NCT01254045|464284921|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
128998168|NCT01254045|464284922|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
128998169|NCT01254045|464284923|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
128998170|NCT01254045|464284924|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
128998171|NCT01254045|464284925|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
128998172|NCT01254045|464284926|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
128998173|NCT02971605|464284927|FG000|Overall Study|Withdrawal by Subject|1|||
128998174|NCT01021137|464284928|FG000|Overall Study|Lost to Follow-up|9|||
128998175|NCT01021137|464284929|FG001|Overall Study|Lost to Follow-up|4|||
128998176|NCT01021137|464284930|FG002|Overall Study|Lost to Follow-up|2|||
128998177|NCT01021137|464284931|FG003|Overall Study|Lost to Follow-up|6|||
128998178|NCT01021137|464284928|FG000|Overall Study|Withdrawal by Subject|1|||
128998179|NCT01021137|464284929|FG001|Overall Study|Withdrawal by Subject|0|||
128998180|NCT01021137|464284930|FG002|Overall Study|Withdrawal by Subject|0|||
128998181|NCT01021137|464284931|FG003|Overall Study|Withdrawal by Subject|3|||
128998182|NCT03439293|464284932|FG000|Overall Study|Death|22|||
128998183|NCT03439293|464284932|FG000|Overall Study|Withdrawal by Subject|8|||
128998184|NCT03439293|464284932|FG000|Overall Study|Lost to Follow-up|2|||
128998185|NCT03439293|464284932|FG000|Overall Study|Reason Not Specified|28|||
128998186|NCT03439293|464284932|FG000|Overall Study|Missing|1|||
128998187|NCT02766400|464284935|FG000|Overall Study|Death|1|||
128998188|NCT02766400|464284936|FG001|Overall Study|Death|2|||
128998189|NCT02766400|464284935|FG000|Overall Study|Withdrawal by Subject|1|||
128998190|NCT02766400|464284936|FG001|Overall Study|Withdrawal by Subject|0|||
128998191|NCT03499249|464284943|FG000|Overall Study|Physician Decision|1|||
128998192|NCT00435825|464284944|FG000|Overall Study|Abnormality of Laboratory Test|0|||
128998193|NCT00435825|464284945|FG001|Overall Study|Abnormality of Laboratory Test|1|||
128998194|NCT00435825|464284946|FG002|Overall Study|Abnormality of Laboratory Test|0|||
128998195|NCT00435825|464284947|FG003|Overall Study|Abnormality of Laboratory Test|0|||
128998196|NCT00435825|464284944|FG000|Overall Study|Insufficient Therapeutic Response|3|||
128998197|NCT00435825|464284945|FG001|Overall Study|Insufficient Therapeutic Response|1|||
128998198|NCT00435825|464284946|FG002|Overall Study|Insufficient Therapeutic Response|0|||
128998199|NCT00435825|464284947|FG003|Overall Study|Insufficient Therapeutic Response|3|||
128998200|NCT00435825|464284944|FG000|Overall Study|Other Protocol Violation|1|||
128998201|NCT00435825|464284945|FG001|Overall Study|Other Protocol Violation|0|||
128998202|NCT00435825|464284946|FG002|Overall Study|Other Protocol Violation|0|||
128998203|NCT00435825|464284947|FG003|Overall Study|Other Protocol Violation|0|||
128998204|NCT00435825|464284944|FG000|Overall Study|Refused treatment|2|||
128998205|NCT00435825|464284945|FG001|Overall Study|Refused treatment|0|||
128998206|NCT00435825|464284946|FG002|Overall Study|Refused treatment|0|||
128998207|NCT00435825|464284947|FG003|Overall Study|Refused treatment|5|||
128998208|NCT00435825|464284944|FG000|Overall Study|Failure to return|5|||
128998209|NCT00435825|464284945|FG001|Overall Study|Failure to return|0|||
128998210|NCT00435825|464284946|FG002|Overall Study|Failure to return|4|||
128998211|NCT00435825|464284947|FG003|Overall Study|Failure to return|0|||
128998212|NCT00435825|464284944|FG000|Overall Study|Did not receive study drug|1|||
128998213|NCT00435825|464284945|FG001|Overall Study|Did not receive study drug|0|||
128998214|NCT00435825|464284946|FG002|Overall Study|Did not receive study drug|2|||
128998215|NCT00435825|464284947|FG003|Overall Study|Did not receive study drug|0|||
128998216|NCT00435825|464284944|FG000|Overall Study|Did not enter follow-up|0|||
128998217|NCT00435825|464284945|FG001|Overall Study|Did not enter follow-up|4|||
128998218|NCT00435825|464284946|FG002|Overall Study|Did not enter follow-up|1|||
128998219|NCT00435825|464284947|FG003|Overall Study|Did not enter follow-up|3|||
128998220|NCT00435825|464284944|FG000|Overall Study|Did not complete full follow-up period|6|||
128998221|NCT00435825|464284945|FG001|Overall Study|Did not complete full follow-up period|6|||
128998222|NCT00435825|464284946|FG002|Overall Study|Did not complete full follow-up period|4|||
128998223|NCT00435825|464284947|FG003|Overall Study|Did not complete full follow-up period|5|||
128998224|NCT00378482|464284948|FG000|Overall Study|Lost to Follow-up|1|||
128998225|NCT00378482|464284948|FG000|Overall Study|Lack of Efficacy|8|||
128998226|NCT00378482|464284948|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
128998227|NCT00378482|464284948|FG000|Overall Study|Withdrawal by Subject|4|||
128998228|NCT00378482|464284948|FG000|Overall Study|Adverse Event|9|||
128998229|NCT00343642|464286342|FG000|Overall Study|Lost to Follow-up|0|||
128998230|NCT00343642|464286343|FG001|Overall Study|Lost to Follow-up|1|||
128998231|NCT00343642|464286344|FG002|Overall Study|Lost to Follow-up|0|||
128998232|NCT00343642|464286342|FG000|Overall Study|Pregnancy|1|||
128998233|NCT00343642|464286343|FG001|Overall Study|Pregnancy|0|||
128998234|NCT00343642|464286344|FG002|Overall Study|Pregnancy|2|||
128998235|NCT00343642|464286342|FG000|Overall Study|Withdrawal by Subject|2|||
128998236|NCT00343642|464286343|FG001|Overall Study|Withdrawal by Subject|3|||
128998237|NCT00343642|464286344|FG002|Overall Study|Withdrawal by Subject|4|||
128998238|NCT00343642|464286342|FG000|Overall Study|Adverse Event|0|||
128998239|NCT00343642|464286343|FG001|Overall Study|Adverse Event|0|||
128998240|NCT00343642|464286344|FG002|Overall Study|Adverse Event|1|||
128998241|NCT00343642|464286342|FG000|Overall Study|Flare up|6|||
128998242|NCT00343642|464286343|FG001|Overall Study|Flare up|4|||
128998243|NCT00343642|464286344|FG002|Overall Study|Flare up|0|||
128998244|NCT00860574|464286345|FG000|Overall Study|Death|2|||
128998245|NCT00860574|464286345|FG000|Overall Study|Relapse|1|||
128998246|NCT01246986|464286346|FG000|Overall Study|Lost to Follow-up|0|||
128998247|NCT01246986|464286347|FG001|Overall Study|Lost to Follow-up|1|||
128998248|NCT01246986|464286348|FG002|Overall Study|Lost to Follow-up|3|||
128998249|NCT01246986|464286349|FG003|Overall Study|Lost to Follow-up|0|||
128998250|NCT01246986|464286350|FG004|Overall Study|Lost to Follow-up|0|||
128998251|NCT01246986|464286351|FG005|Overall Study|Lost to Follow-up|1|||
128998252|NCT01246986|464286352|FG006|Overall Study|Lost to Follow-up|0|||
128998253|NCT01246986|464286346|FG000|Overall Study|Withdrawal by Subject|3|||
128998254|NCT01246986|464286347|FG001|Overall Study|Withdrawal by Subject|4|||
128998255|NCT01246986|464286348|FG002|Overall Study|Withdrawal by Subject|3|||
128998256|NCT01246986|464286349|FG003|Overall Study|Withdrawal by Subject|0|||
128998257|NCT01246986|464286350|FG004|Overall Study|Withdrawal by Subject|4|||
128998258|NCT01246986|464286351|FG005|Overall Study|Withdrawal by Subject|0|||
128998259|NCT01246986|464286352|FG006|Overall Study|Withdrawal by Subject|0|||
128998260|NCT01416142|464286356|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
128998261|NCT01416142|464286357|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
128998262|NCT01416142|464286358|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
128998263|NCT01335399|464286359|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
128998264|NCT01335399|464286360|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
128998265|NCT01335399|464286359|FG000|Pre-treatment Period|Participant request to discontinue|0|||
128998266|NCT01335399|464286360|FG001|Pre-treatment Period|Participant request to discontinue|1|||
128998267|NCT01335399|464286359|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
128998268|NCT01335399|464286360|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
128998269|NCT01335399|464286359|FG000|Pre-treatment Period|Consent withdrawal|3|||
128998270|NCT01335399|464286360|FG001|Pre-treatment Period|Consent withdrawal|0|||
128998271|NCT01335399|464286359|FG000|Treatment Period|Disease progression|117|||
128998272|NCT01335399|464286360|FG001|Treatment Period|Disease progression|145|||
128998273|NCT01335399|464286359|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
128998274|NCT01335399|464286360|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
128998275|NCT01335399|464286359|FG000|Treatment Period|Study drug toxicity|52|||
128998276|NCT01335399|464286360|FG001|Treatment Period|Study drug toxicity|64|||
128998277|NCT01335399|464286359|FG000|Treatment Period|Participant request to discontinue|30|||
128998278|NCT01335399|464286360|FG001|Treatment Period|Participant request to discontinue|22|||
128998279|NCT01335399|464286359|FG000|Treatment Period|Other reasons|30|||
128998280|NCT01335399|464286360|FG001|Treatment Period|Other reasons|30|||
128998281|NCT01335399|464286359|FG000|Treatment Period|Consent withdrawal|10|||
128998282|NCT01335399|464286360|FG001|Treatment Period|Consent withdrawal|7|||
128998283|NCT01335399|464286359|FG000|Treatment Period|Death|7|||
128998284|NCT01335399|464286360|FG001|Treatment Period|Death|6|||
128998285|NCT01335399|464286359|FG000|Treatment Period|Poor/Non-compliance|3|||
128998286|NCT01335399|464286360|FG001|Treatment Period|Poor/Non-compliance|4|||
128998287|NCT01335399|464286359|FG000|Treatment Period|Lost to Follow-up|2|||
128998288|NCT01335399|464286360|FG001|Treatment Period|Lost to Follow-up|2|||
128998289|NCT01335399|464286359|FG000|Treatment Period|Maximum clinical benefit|1|||
128998290|NCT01335399|464286360|FG001|Treatment Period|Maximum clinical benefit|1|||
128998291|NCT01335399|464286359|FG000|Treatment Period|No longer meet study criteria|1|||
128998292|NCT01335399|464286360|FG001|Treatment Period|No longer meet study criteria|1|||
128998293|NCT01335399|464286359|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
128998294|NCT01335399|464286360|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
128998295|NCT02464059|464286361|FG000|Overall Study|Lost to Follow-up|6|||
128998296|NCT00304954|464286364|FG000|Overall Study|Withdrawal by Subject|0|||
128998297|NCT00304954|464286365|FG001|Overall Study|Withdrawal by Subject|0|||
128998298|NCT00304954|464286366|FG002|Overall Study|Withdrawal by Subject|1|||
128998299|NCT00304954|464286367|FG003|Overall Study|Withdrawal by Subject|0|||
128998300|NCT00304954|464286364|FG000|Overall Study|Adverse Event|1|||
128998301|NCT00304954|464286365|FG001|Overall Study|Adverse Event|0|||
128998302|NCT00304954|464286366|FG002|Overall Study|Adverse Event|0|||
128998303|NCT00304954|464286367|FG003|Overall Study|Adverse Event|0|||
128998304|NCT03990389|464286370|FG000|Overall Study|Lost to Follow-up|3|||
128998305|NCT03990389|464286371|FG001|Overall Study|Lost to Follow-up|0|||
128998306|NCT02290028|464286372|FG000|Overall Study|Death|217|||
128998307|NCT02290028|464286372|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
128998308|NCT02290028|464286372|FG000|Overall Study|No longer under care of study physician|76|||
128998309|NCT02290028|464286372|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
128998310|NCT02290028|464286372|FG000|Overall Study|Withdrawal by Subject|52|||
128998311|NCT02290028|464286372|FG000|Overall Study|Study site closure|44|||
128998312|NCT02290028|464286372|FG000|Overall Study|Lost to Follow-up|34|||
128998313|NCT02290028|464286372|FG000|Overall Study|Miscellaneous|10|||
128998314|NCT02290028|464286372|FG000|Overall Study|Transition to EP PASSION|1295|||
128998315|NCT02290028|464286372|FG000|Overall Study|Planned study completion at 12 months|257|||
128998316|NCT03202511|464286373|FG000|Overall Study|Withdrawal by Subject|1|||
128998317|NCT03202511|464286374|FG001|Overall Study|Withdrawal by Subject|0|||
128998318|NCT00265083|464286375|FG000|Overall Study|Adverse Event|5|||
128998319|NCT00265083|464286376|FG001|Overall Study|Adverse Event|13|||
128998320|NCT00265083|464286377|FG002|Overall Study|Adverse Event|15|||
128998321|NCT00265083|464286375|FG000|Overall Study|Lost to Follow-up|3|||
128998322|NCT00265083|464286376|FG001|Overall Study|Lost to Follow-up|4|||
128998323|NCT00265083|464286377|FG002|Overall Study|Lost to Follow-up|4|||
128998324|NCT00265083|464286375|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
128998325|NCT00265083|464286376|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
128998326|NCT00265083|464286377|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
128998327|NCT00265083|464286375|FG000|Overall Study|Other|1|||
128998328|NCT00265083|464286376|FG001|Overall Study|Other|12|||
128998329|NCT00265083|464286377|FG002|Overall Study|Other|9|||
128998330|NCT03208933|464286378|FG000|Overall Study|Death|3|||
128998331|NCT03208933|464286378|FG000|Overall Study|Withdrawal by Subject|3|||
128998332|NCT03208933|464286378|FG000|Overall Study|Adverse Event|1|||
128998333|NCT03208933|464286378|FG000|Overall Study|Lost to Follow-up|2|||
128998334|NCT03208933|464286378|FG000|Overall Study|Physician Decision|3|||
128998335|NCT03208933|464286378|FG000|Overall Study|Protocol Violation|1|||
128998336|NCT04242186|464286379|FG000|Overall Study|Death|5|||
128998337|NCT00379587|464286380|FG000|Overall Study|Lost to Follow-up|2|||
128998338|NCT00534092|464286381|FG000|Overall Study|Lost to Follow-up|1|||
128998339|NCT00534092|464286382|FG001|Overall Study|Lost to Follow-up|0|||
128998340|NCT00534092|464286381|FG000|Overall Study|personal reasons/family concerns|1|||
128998341|NCT00534092|464286382|FG001|Overall Study|personal reasons/family concerns|0|||
128998342|NCT00830063|464286389|FG000|Overall Study|Adverse Event|7|||
128998343|NCT00830063|464286390|FG001|Overall Study|Adverse Event|13|||
128998344|NCT00830063|464286391|FG002|Overall Study|Adverse Event|16|||
128998345|NCT00830063|464286392|FG003|Overall Study|Adverse Event|13|||
128998346|NCT00830063|464286389|FG000|Overall Study|Death|1|||
128998347|NCT00830063|464286390|FG001|Overall Study|Death|0|||
128998348|NCT00830063|464286391|FG002|Overall Study|Death|0|||
128998349|NCT00830063|464286392|FG003|Overall Study|Death|0|||
128998350|NCT00830063|464286389|FG000|Overall Study|Lost to Follow-up|0|||
128998351|NCT00830063|464286390|FG001|Overall Study|Lost to Follow-up|0|||
128998352|NCT00830063|464286391|FG002|Overall Study|Lost to Follow-up|3|||
128998353|NCT00830063|464286392|FG003|Overall Study|Lost to Follow-up|1|||
128998354|NCT00830063|464286389|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
128998355|NCT00830063|464286390|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
128998356|NCT00830063|464286391|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
128998357|NCT00830063|464286392|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
128998358|NCT00830063|464286389|FG000|Overall Study|Lack of Efficacy|51|||
128998359|NCT00830063|464286390|FG001|Overall Study|Lack of Efficacy|23|||
128998360|NCT00830063|464286391|FG002|Overall Study|Lack of Efficacy|25|||
128998361|NCT00830063|464286392|FG003|Overall Study|Lack of Efficacy|32|||
128998362|NCT00830063|464286389|FG000|Overall Study|Other|5|||
128998363|NCT00830063|464286390|FG001|Overall Study|Other|5|||
128998364|NCT00830063|464286391|FG002|Overall Study|Other|8|||
128998365|NCT00830063|464286392|FG003|Overall Study|Other|6|||
128998366|NCT00830063|464286389|FG000|Overall Study|Withdrawal by Subject|16|||
128998367|NCT00830063|464286390|FG001|Overall Study|Withdrawal by Subject|10|||
128998368|NCT00830063|464286391|FG002|Overall Study|Withdrawal by Subject|16|||
128998369|NCT00830063|464286392|FG003|Overall Study|Withdrawal by Subject|13|||
128998370|NCT00830063|464286389|FG000|Overall Study|Protocol Violation|1|||
128998371|NCT00830063|464286390|FG001|Overall Study|Protocol Violation|0|||
128998372|NCT00830063|464286391|FG002|Overall Study|Protocol Violation|3|||
128998373|NCT00830063|464286392|FG003|Overall Study|Protocol Violation|2|||
128998374|NCT00830063|464286389|FG000|Overall Study|Randomized But Not Treated|0|||
128998375|NCT00830063|464286390|FG001|Overall Study|Randomized But Not Treated|2|||
128998376|NCT00830063|464286391|FG002|Overall Study|Randomized But Not Treated|0|||
128998377|NCT00830063|464286392|FG003|Overall Study|Randomized But Not Treated|2|||
128998378|NCT02323295|464286393|FG000|Overall Study|Adverse Event|0|||
128998379|NCT02323295|464286394|FG001|Overall Study|Adverse Event|1|||
128998380|NCT02323295|464286393|FG000|Overall Study|Withdrawal by Subject|0|||
128998381|NCT02323295|464286394|FG001|Overall Study|Withdrawal by Subject|1|||
128998382|NCT02323295|464286393|FG000|Overall Study|Patient did not have surgery as planned.|0|||
128998383|NCT02323295|464286394|FG001|Overall Study|Patient did not have surgery as planned.|1|||
128998384|NCT00775983|464286395|FG000|Overall Study|Protocol Violation|1|||
128998385|NCT00775983|464286396|FG001|Overall Study|Protocol Violation|2|||
128998386|NCT01155063|464286397|FG000|Overall Study|Adverse Event|1|||
128998387|NCT01155063|464286397|FG000|Overall Study|Withdrawal by Subject|1|||
128998388|NCT01155063|464286397|FG000|Overall Study|Study terminated by sponsor|87|||
128998389|NCT01314703|464286398|FG000|Overall Study|screen failure and closed enrollment|8|||
128998390|NCT00881959|464286401|FG000|Overall Study|Lost to Follow-up|2|||
128998391|NCT00881959|464286402|FG001|Overall Study|Lost to Follow-up|4|||
128998392|NCT01427920|464286410|FG000|Overall Study|Adverse Event|1|||
128998393|NCT01427920|464286411|FG001|Overall Study|Adverse Event|2|||
128998394|NCT01427920|464286410|FG000|Overall Study|Lack of Efficacy|1|||
128998395|NCT01427920|464286411|FG001|Overall Study|Lack of Efficacy|0|||
128998396|NCT01427920|464286410|FG000|Overall Study|Protocol Violation|1|||
128998397|NCT01427920|464286411|FG001|Overall Study|Protocol Violation|3|||
128998398|NCT01427920|464286410|FG000|Overall Study|Withdrawal Criteria|4|||
128998399|NCT01427920|464286411|FG001|Overall Study|Withdrawal Criteria|4|||
128998400|NCT01427920|464286410|FG000|Overall Study|Unclassified|2|||
128998401|NCT01427920|464286411|FG001|Overall Study|Unclassified|8|||
128998402|NCT00751998|464286420|FG000|Overall Study|Lost to Follow-up|7|||
128998403|NCT00751998|464286420|FG000|Overall Study|Death|11|||
128998404|NCT00751998|464286420|FG000|Overall Study|Withdrawal by Subject|2|||
128998405|NCT01965535|464286421|FG000|Overall Study|Lack of Efficacy|2|||
128998406|NCT01965535|464286422|FG001|Overall Study|Lack of Efficacy|1|||
128998407|NCT02983227|464286423|FG000|Overall Study|Adverse Event|21|||
128998408|NCT02983227|464286424|FG001|Overall Study|Adverse Event|3|||
128998409|NCT02983227|464286423|FG000|Overall Study|Death|3|||
128998410|NCT02983227|464286424|FG001|Overall Study|Death|0|||
128998411|NCT02983227|464286423|FG000|Overall Study|Lack of Efficacy|8|||
128998412|NCT02983227|464286424|FG001|Overall Study|Lack of Efficacy|1|||
128998413|NCT02983227|464286423|FG000|Overall Study|Lost to Follow-up|3|||
128998414|NCT02983227|464286424|FG001|Overall Study|Lost to Follow-up|0|||
128998415|NCT02983227|464286423|FG000|Overall Study|Multiple Reasons|2|||
128998416|NCT02983227|464286424|FG001|Overall Study|Multiple Reasons|1|||
128998417|NCT02983227|464286423|FG000|Overall Study|Physician Decision|3|||
128998418|NCT02983227|464286424|FG001|Overall Study|Physician Decision|1|||
128998419|NCT02983227|464286423|FG000|Overall Study|Withdrawal by Subject|19|||
128998420|NCT02983227|464286424|FG001|Overall Study|Withdrawal by Subject|8|||
128998421|NCT01946282|464286427|FG000|Year 1|Did not return FIT kit|4186|||
128998422|NCT01946282|464286428|FG001|Year 1|Did not return FIT kit|608|||
128998423|NCT01946282|464286429|FG002|Year 1|Did not return FIT kit|654|||
128998424|NCT01946282|464286427|FG000|Year 2|Did not return FIT kit|803|||
128998425|NCT01946282|464286428|FG001|Year 2|Did not return FIT kit|131|||
128998426|NCT01946282|464286429|FG002|Year 2|Did not return FIT kit|115|||
128998427|NCT01946282|464286427|FG000|Year 3|Did not return FIT kit|288|||
128998428|NCT01946282|464286428|FG001|Year 3|Did not return FIT kit|43|||
128998429|NCT01946282|464286429|FG002|Year 3|Did not return FIT kit|30|||
128998430|NCT01493531|464286430|FG000|Overall Study|Adverse Event|4|||
128998431|NCT01493531|464286431|FG001|Overall Study|Adverse Event|12|||
128998432|NCT01493531|464286432|FG002|Overall Study|Adverse Event|9|||
128998433|NCT01493531|464286430|FG000|Overall Study|Gout flare|3|||
128998434|NCT01493531|464286431|FG001|Overall Study|Gout flare|0|||
128998435|NCT01493531|464286432|FG002|Overall Study|Gout flare|2|||
128998436|NCT01493531|464286430|FG000|Overall Study|Protocol Violation|8|||
128998437|NCT01493531|464286431|FG001|Overall Study|Protocol Violation|15|||
128998438|NCT01493531|464286432|FG002|Overall Study|Protocol Violation|12|||
128998439|NCT01493531|464286430|FG000|Overall Study|Sponsor terminated study|5|||
128998440|NCT01493531|464286431|FG001|Overall Study|Sponsor terminated study|2|||
128998441|NCT01493531|464286432|FG002|Overall Study|Sponsor terminated study|3|||
128998442|NCT01493531|464286430|FG000|Overall Study|Lost to Follow-up|5|||
128998443|NCT01493531|464286431|FG001|Overall Study|Lost to Follow-up|7|||
128998444|NCT01493531|464286432|FG002|Overall Study|Lost to Follow-up|11|||
128998445|NCT01493531|464286430|FG000|Overall Study|Withdrawal by Subject|16|||
128998446|NCT01493531|464286431|FG001|Overall Study|Withdrawal by Subject|13|||
128998447|NCT01493531|464286432|FG002|Overall Study|Withdrawal by Subject|11|||
128998448|NCT01493531|464286430|FG000|Overall Study|Death|0|||
128998449|NCT01493531|464286431|FG001|Overall Study|Death|1|||
128998450|NCT01493531|464286432|FG002|Overall Study|Death|0|||
128998451|NCT00845026|464286435|FG000|Study Period III|Adverse Event|23|||
128998452|NCT00845026|464286436|FG001|Study Period III|Adverse Event|19|||
128998453|NCT00845026|464286435|FG000|Study Period III|Perceived lack of efficacy|27|||
128998454|NCT00845026|464286436|FG001|Study Period III|Perceived lack of efficacy|15|||
128998455|NCT00845026|464286435|FG000|Study Period III|Withdrawal by Subject|19|||
128998456|NCT00845026|464286436|FG001|Study Period III|Withdrawal by Subject|15|||
128998457|NCT00845026|464286435|FG000|Study Period III|Entry Criteria not met|8|||
128998458|NCT00845026|464286436|FG001|Study Period III|Entry Criteria not met|11|||
128998459|NCT00845026|464286435|FG000|Study Period III|Lost to Follow-up|4|||
128998460|NCT00845026|464286436|FG001|Study Period III|Lost to Follow-up|5|||
128998461|NCT00845026|464286435|FG000|Study Period III|Protocol Violation|8|||
128998462|NCT00845026|464286436|FG001|Study Period III|Protocol Violation|1|||
128998463|NCT00845026|464286435|FG000|Study Period III|Scheduled conflict|3|||
128998464|NCT00845026|464286436|FG001|Study Period III|Scheduled conflict|1|||
128998465|NCT00845026|464286435|FG000|Study Period III|Subject is moving or has moved|2|||
128998466|NCT00845026|464286436|FG001|Study Period III|Subject is moving or has moved|4|||
128998467|NCT00845026|464286435|FG000|Study Period III|Transportation issues|1|||
128998468|NCT00845026|464286436|FG001|Study Period III|Transportation issues|1|||
128998469|NCT00845026|464286435|FG000|Study Period IV|Adverse Event|4|||
128998470|NCT00845026|464286436|FG001|Study Period IV|Adverse Event|0|||
128998471|NCT00845026|464286435|FG000|Study Period IV|Perceived lack of efficacy|2|||
128998472|NCT00845026|464286436|FG001|Study Period IV|Perceived lack of efficacy|1|||
128998473|NCT00845026|464286435|FG000|Study Period IV|Protocol Violation|3|||
128998474|NCT00845026|464286436|FG001|Study Period IV|Protocol Violation|1|||
128998475|NCT00845026|464286435|FG000|Study Period IV|Lost to Follow-up|1|||
128998476|NCT00845026|464286436|FG001|Study Period IV|Lost to Follow-up|0|||
128998477|NCT00845026|464286435|FG000|Study Period IV|Withdrawal by Subject|4|||
128998478|NCT00845026|464286436|FG001|Study Period IV|Withdrawal by Subject|1|||
128998479|NCT00845026|464286435|FG000|Study Period IV|Entry Criteria Not Met|1|||
128998480|NCT00845026|464286436|FG001|Study Period IV|Entry Criteria Not Met|0|||
128998481|NCT00845026|464286435|FG000|Study Period IV|Subject is moving or has moved|0|||
128998482|NCT00845026|464286436|FG001|Study Period IV|Subject is moving or has moved|1|||
128998483|NCT00845026|464286435|FG000|Study Period IV|Scheduling conflict|1|||
128998484|NCT00845026|464286436|FG001|Study Period IV|Scheduling conflict|0|||
128998485|NCT01325532|464286437|FG000|Overall Study|Withdrawal by Subject|2|||
128998486|NCT01325532|464286438|FG001|Overall Study|Withdrawal by Subject|0|||
128998487|NCT03012815|464286439|FG000|Overall Study|Lost to Follow-up|1|||
128998488|NCT03012815|464286440|FG001|Overall Study|Lost to Follow-up|0|||
128998489|NCT03012815|464286439|FG000|Overall Study|Physician Decision|3|||
128998490|NCT03012815|464286440|FG001|Overall Study|Physician Decision|2|||
128998491|NCT03012815|464286439|FG000|Overall Study|Adverse Event|1|||
128998492|NCT03012815|464286440|FG001|Overall Study|Adverse Event|0|||
128998493|NCT01252238|464286441|FG000|Overall Study|Sponsor terminated study|4|||
128998494|NCT01252238|464286442|FG001|Overall Study|Sponsor terminated study|4|||
128998495|NCT01252238|464286443|FG002|Overall Study|Sponsor terminated study|4|||
128998496|NCT00558519|464286444|FG000|Overall Study|Ph+|20|||
128998497|NCT00558519|464286444|FG000|Overall Study|Ineligible|1|||
128998498|NCT00558519|464286444|FG000|Overall Study|Insufficient data|1|||
128998499|NCT00558519|464286444|FG000|Overall Study|Never received treatment|1|||
128998500|NCT02875067|464286445|FG000|Overall Study|Withdrawal by Subject|1|||
128998501|NCT02875067|464286445|FG000|Overall Study|Withdrawal by Termination of Study|5|||
128998502|NCT00065065|464286446|FG000|Overall Study|Adverse Event|3|||
128998503|NCT00065065|464286447|FG001|Overall Study|Adverse Event|2|||
128998504|NCT00065065|464286446|FG000|Overall Study|Withdrawal by Subject|1|||
128998505|NCT00065065|464286447|FG001|Overall Study|Withdrawal by Subject|5|||
128998506|NCT00065065|464286446|FG000|Overall Study|Lack of Efficacy|4|||
128998507|NCT00065065|464286447|FG001|Overall Study|Lack of Efficacy|11|||
128998508|NCT00065065|464286446|FG000|Overall Study|Other|2|||
128998509|NCT00065065|464286447|FG001|Overall Study|Other|2|||
128998510|NCT01050673|464286450|FG000|Overall Study|Physician Decision|4|||
128998511|NCT01050673|464286451|FG001|Overall Study|Physician Decision|5|||
128998512|NCT03056352|464286452|FG000|Overall Study|Lost to Follow-up|1|||
128998513|NCT00597207|464286457|FG000|Overall Study|Lost to Follow-up|5|||
128998514|NCT00597207|464286458|FG001|Overall Study|Lost to Follow-up|7|||
128998515|NCT00520351|464286459|FG000|First Intervention|Withdrawal by Subject|1|||
128998516|NCT00520351|464286460|FG001|First Intervention|Withdrawal by Subject|1|||
128998517|NCT00869089|464286467|FG000|Overall Study|Lost to Follow-up|1|||
128998518|NCT00869089|464286467|FG000|Overall Study|Withdrawal by Subject|1|||
128998519|NCT00869089|464286467|FG000|Overall Study|Screen Fail|1|||
128998520|NCT01559818|464286473|FG000|Overall Study|Physician Decision|1|||
128998521|NCT01559818|464286473|FG000|Overall Study|Pregnancy|1|||
128998522|NCT01559818|464286473|FG000|Overall Study|Study terminated by Sponsor|4|||
128998523|NCT01559818|464286473|FG000|Overall Study|Withdrawal by Subject|1|||
128998524|NCT01374906|464286476|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128998525|NCT01374906|464286477|FG001|Overall Study|Abnormal laboratory value(s)|3|||
128998526|NCT01374906|464286476|FG000|Overall Study|Administrative problems|2|||
128998527|NCT01374906|464286477|FG001|Overall Study|Administrative problems|2|||
128998528|NCT01374906|464286476|FG000|Overall Study|Adverse Event|10|||
128998529|NCT01374906|464286477|FG001|Overall Study|Adverse Event|11|||
128998530|NCT01374906|464286476|FG000|Overall Study|Death|0|||
128998531|NCT01374906|464286477|FG001|Overall Study|Death|2|||
128998532|NCT01374906|464286476|FG000|Overall Study|Protocol Violation|2|||
128998533|NCT01374906|464286477|FG001|Overall Study|Protocol Violation|2|||
128998534|NCT01374906|464286476|FG000|Overall Study|Withdrawal by Subject|15|||
128998535|NCT01374906|464286477|FG001|Overall Study|Withdrawal by Subject|9|||
128998536|NCT01374906|464286476|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
128998537|NCT01374906|464286477|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
128998538|NCT02475980|464286480|FG000|Overall Study|Lost to Follow-up|4|||
128998539|NCT02475980|464286480|FG000|Overall Study|Withdrawal by Subject|1|||
128998540|NCT00665626|464286484|FG000|Overall Study|Lack of Efficacy|8|||
128998541|NCT00665626|464286485|FG001|Overall Study|Lack of Efficacy|5|||
128998542|NCT00665626|464286484|FG000|Overall Study|Lost to Follow-up|0|||
128998543|NCT00665626|464286485|FG001|Overall Study|Lost to Follow-up|2|||
128998544|NCT00665626|464286484|FG000|Overall Study|Withdrawal by Subject|0|||
128998545|NCT00665626|464286485|FG001|Overall Study|Withdrawal by Subject|1|||
128998546|NCT00665626|464286484|FG000|Overall Study|Protocol Violation|0|||
128998547|NCT00665626|464286485|FG001|Overall Study|Protocol Violation|2|||
128998548|NCT00665626|464286484|FG000|Overall Study|Adverse Event|1|||
128998549|NCT00665626|464286485|FG001|Overall Study|Adverse Event|9|||
128998550|NCT00665626|464286484|FG000|Overall Study|Due to exclusion criteria|0|||
128998551|NCT00665626|464286485|FG001|Overall Study|Due to exclusion criteria|1|||
128998552|NCT00665626|464286484|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
128998553|NCT00665626|464286485|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
128998554|NCT00665626|464286484|FG000|Overall Study|Unably to comply with dosing regimen|0|||
128998555|NCT00665626|464286485|FG001|Overall Study|Unably to comply with dosing regimen|1|||
128998556|NCT00665626|464286484|FG000|Overall Study|Death|1|||
128998557|NCT00665626|464286485|FG001|Overall Study|Death|0|||
128998558|NCT04147611|464286486|FG000|Overall Study|Physician Decision|0|||
128998559|NCT04147611|464286487|FG001|Overall Study|Physician Decision|1|||
128998560|NCT00530439|464286488|FG000|Overall Study|GDM|9|||
128998561|NCT00530439|464286489|FG001|Overall Study|GDM|3|||
128998562|NCT00530439|464286488|FG000|Overall Study|Withdraw|18|||
128998563|NCT00530439|464286489|FG001|Overall Study|Withdraw|14|||
128998564|NCT00530439|464286488|FG000|Overall Study|Missed abortion|1|||
128998565|NCT00530439|464286489|FG001|Overall Study|Missed abortion|4|||
128998566|NCT00530439|464286488|FG000|Overall Study|Misclassification|2|||
128998567|NCT00530439|464286489|FG001|Overall Study|Misclassification|0|||
128998568|NCT00530439|464286488|FG000|Overall Study|Twin pregnancy|0|||
128998569|NCT00530439|464286489|FG001|Overall Study|Twin pregnancy|2|||
128998570|NCT00530439|464286488|FG000|Overall Study|Severe malformation/abortion|0|||
128998571|NCT00530439|464286489|FG001|Overall Study|Severe malformation/abortion|3|||
128998572|NCT01529749|464286490|FG000|Overall Study|Lost to Follow-up|0|||
128998573|NCT01529749|464286491|FG001|Overall Study|Lost to Follow-up|1|||
128998574|NCT01529749|464286492|FG002|Overall Study|Lost to Follow-up|1|||
128998575|NCT01529749|464286493|FG003|Overall Study|Lost to Follow-up|0|||
128998576|NCT01529749|464286490|FG000|Overall Study|Physician Decision|0|||
128998577|NCT01529749|464286491|FG001|Overall Study|Physician Decision|0|||
128998578|NCT01529749|464286492|FG002|Overall Study|Physician Decision|0|||
128998579|NCT01529749|464286493|FG003|Overall Study|Physician Decision|1|||
128998580|NCT01529749|464286490|FG000|Overall Study|Withdrawal by Subject|0|||
128998581|NCT01529749|464286491|FG001|Overall Study|Withdrawal by Subject|1|||
128998582|NCT01529749|464286492|FG002|Overall Study|Withdrawal by Subject|1|||
128998583|NCT01529749|464286493|FG003|Overall Study|Withdrawal by Subject|0|||
128998584|NCT01529749|464286490|FG000|Overall Study|Protocol Violation|0|||
128998585|NCT01529749|464286491|FG001|Overall Study|Protocol Violation|0|||
128998586|NCT01529749|464286492|FG002|Overall Study|Protocol Violation|0|||
128998587|NCT01529749|464286493|FG003|Overall Study|Protocol Violation|1|||
128998588|NCT02919475|464287968|FG000|Overall Study|Adverse Event|3|||
128998589|NCT02919475|464287969|FG001|Overall Study|Adverse Event|3|||
128998590|NCT02919475|464287970|FG002|Overall Study|Adverse Event|3|||
128998591|NCT02919475|464287971|FG003|Overall Study|Adverse Event|9|||
128998592|NCT02919475|464287972|FG004|Overall Study|Adverse Event|2|||
128998593|NCT02919475|464287968|FG000|Overall Study|Death|0|||
128998594|NCT02919475|464287969|FG001|Overall Study|Death|1|||
128998595|NCT02919475|464287970|FG002|Overall Study|Death|0|||
128998596|NCT02919475|464287971|FG003|Overall Study|Death|0|||
128998597|NCT02919475|464287972|FG004|Overall Study|Death|0|||
128998598|NCT02919475|464287968|FG000|Overall Study|Lost to Follow-up|0|||
128998599|NCT02919475|464287969|FG001|Overall Study|Lost to Follow-up|0|||
128998600|NCT02919475|464287970|FG002|Overall Study|Lost to Follow-up|0|||
128998601|NCT02919475|464287971|FG003|Overall Study|Lost to Follow-up|1|||
128998602|NCT02919475|464287972|FG004|Overall Study|Lost to Follow-up|0|||
128998603|NCT02919475|464287968|FG000|Overall Study|Withdrawal by Subject|2|||
128998604|NCT02919475|464287969|FG001|Overall Study|Withdrawal by Subject|3|||
128998605|NCT02919475|464287970|FG002|Overall Study|Withdrawal by Subject|1|||
128998606|NCT02919475|464287971|FG003|Overall Study|Withdrawal by Subject|2|||
128998607|NCT02919475|464287972|FG004|Overall Study|Withdrawal by Subject|2|||
128998608|NCT02919475|464287968|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
128998609|NCT02919475|464287969|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
128998610|NCT02919475|464287970|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
128998611|NCT02919475|464287971|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
128998612|NCT02919475|464287972|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128998613|NCT02762565|464287976|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
128998614|NCT00623623|464287977|FG000|Overall Study|Previous enrolment into this study|1|||
128998615|NCT00623623|464287978|FG001|Overall Study|Previous enrolment into this study|1|||
128998616|NCT02265952|464287980|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
128998617|NCT02265952|464287981|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
128998618|NCT02265952|464287980|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
128998619|NCT02265952|464287981|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
128998620|NCT01042977|464287982|FG000|Overall Study|Adverse Event|4|||
128998621|NCT01042977|464287983|FG001|Overall Study|Adverse Event|12|||
128998622|NCT01042977|464287982|FG000|Overall Study|Death|2|||
128998623|NCT01042977|464287983|FG001|Overall Study|Death|1|||
128998624|NCT01042977|464287982|FG000|Overall Study|Withdrawal by Subject|8|||
128998625|NCT01042977|464287983|FG001|Overall Study|Withdrawal by Subject|16|||
128998626|NCT01042977|464287982|FG000|Overall Study|Lost to Follow-up|0|||
128998627|NCT01042977|464287983|FG001|Overall Study|Lost to Follow-up|2|||
128998628|NCT01042977|464287982|FG000|Overall Study|Poor/non-compliance|3|||
128998629|NCT01042977|464287983|FG001|Overall Study|Poor/non-compliance|4|||
128998630|NCT01042977|464287982|FG000|Overall Study|Subject no longer meets study criteria|15|||
128998631|NCT01042977|464287983|FG001|Overall Study|Subject no longer meets study criteria|13|||
128998632|NCT01042977|464287982|FG000|Overall Study|Incorrect enrollment|6|||
128998633|NCT01042977|464287983|FG001|Overall Study|Incorrect enrollment|4|||
128998634|NCT01042977|464287982|FG000|Overall Study|Safety|0|||
128998635|NCT01042977|464287983|FG001|Overall Study|Safety|2|||
128998636|NCT01042977|464287982|FG000|Overall Study|Administrative reason by sponsor|0|||
128998637|NCT01042977|464287983|FG001|Overall Study|Administrative reason by sponsor|1|||
128998638|NCT01042977|464287982|FG000|Overall Study|Various|3|||
128998639|NCT01042977|464287983|FG001|Overall Study|Various|0|||
128998640|NCT02499354|464287984|FG000|Overall Study|Withdrawal by Subject|1|||
128998641|NCT02499354|464287985|FG001|Overall Study|Withdrawal by Subject|0|||
128998642|NCT02424565|464287988|FG000|Period 1 (D0)|Protocol Violation|0|||
128998643|NCT02424565|464287989|FG001|Period 1 (D0)|Protocol Violation|1|||
128998644|NCT03650400|464287990|FG000|Overall Study|Study terminated by sponsor|0|||
128998645|NCT03650400|464287991|FG001|Overall Study|Study terminated by sponsor|5|||
128998646|NCT01759381|464287992|FG000|Overall Study|Death|1|||
128998647|NCT01759381|464287993|FG001|Overall Study|Death|0|||
128998648|NCT00447603|464287995|FG000|Screening|Withdrawal by Subject|1|||
128998649|NCT00447603|464287996|FG001|Screening|Withdrawal by Subject|0|||
128998650|NCT00447603|464287997|FG002|Screening|Withdrawal by Subject|0|||
128998651|NCT00447603|464287995|FG000|Screening|Protocol Violation|1|||
128998652|NCT00447603|464287996|FG001|Screening|Protocol Violation|0|||
128998653|NCT00447603|464287997|FG002|Screening|Protocol Violation|0|||
128998654|NCT00447603|464287995|FG000|Screening|Screen Failure|4|||
128998655|NCT00447603|464287996|FG001|Screening|Screen Failure|0|||
128998656|NCT00447603|464287997|FG002|Screening|Screen Failure|0|||
128998657|NCT00447603|464287995|FG000|Screening|Study Terminated by Sponsor|15|||
128998658|NCT00447603|464287996|FG001|Screening|Study Terminated by Sponsor|0|||
128998659|NCT00447603|464287997|FG002|Screening|Study Terminated by Sponsor|0|||
128998660|NCT00447603|464287995|FG000|Filter Period|Adverse Event|0|||
128998661|NCT00447603|464287996|FG001|Filter Period|Adverse Event|0|||
128998662|NCT00447603|464287997|FG002|Filter Period|Adverse Event|1|||
128998663|NCT00447603|464287995|FG000|Filter Period|Screen Failure|0|||
128998664|NCT00447603|464287996|FG001|Filter Period|Screen Failure|3|||
128998665|NCT00447603|464287997|FG002|Filter Period|Screen Failure|4|||
128998666|NCT00447603|464287995|FG000|Filter Period|Study terminated by Sponsor|0|||
128998667|NCT00447603|464287996|FG001|Filter Period|Study terminated by Sponsor|1|||
128998668|NCT00447603|464287997|FG002|Filter Period|Study terminated by Sponsor|10|||
128998669|NCT04228302|464288001|FG000|Overall Study|Adverse Event|0|||
128998670|NCT04228302|464288002|FG001|Overall Study|Adverse Event|0|||
128998671|NCT04228302|464288003|FG002|Overall Study|Adverse Event|0|||
128998672|NCT04228302|464288004|FG003|Overall Study|Adverse Event|0|||
128998673|NCT04228302|464288005|FG004|Overall Study|Adverse Event|1|||
128998674|NCT04228302|464288006|FG005|Overall Study|Adverse Event|0|||
128998675|NCT02732561|464288008|FG000|Overall Study|Lost to Follow-up|1|||
128998676|NCT02732561|464288009|FG001|Overall Study|Lost to Follow-up|1|||
128998677|NCT02732561|464288008|FG000|Overall Study|Withdrawal by Subject|1|||
128998678|NCT02732561|464288009|FG001|Overall Study|Withdrawal by Subject|0|||
128998679|NCT02410837|464288016|FG000|Overall Study|Death|387|||
128998680|NCT02410837|464288016|FG000|Overall Study|Lost to Follow-up|50|||
128998681|NCT02410837|464288016|FG000|Overall Study|Withdrawal by Subject|44|||
128998682|NCT02410837|464288016|FG000|Overall Study|Physician Decision|6|||
128998683|NCT02410837|464288016|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
128998684|NCT00837577|464288017|FG000|Double-blind Period|Clinical Adverse Event|1|||
128998685|NCT00837577|464288018|FG001|Double-blind Period|Clinical Adverse Event|0|||
128998686|NCT00837577|464288017|FG000|Double-blind Period|Withdrawal by Subject|1|||
128998687|NCT00837577|464288018|FG001|Double-blind Period|Withdrawal by Subject|0|||
128998688|NCT00837577|464288017|FG000|Open-label Period|Clinical Adverse Event|2|||
128998689|NCT00837577|464288018|FG001|Open-label Period|Clinical Adverse Event|2|||
128998690|NCT00837577|464288017|FG000|Open-label Period|Laboratory Adverse Event|0|||
128998691|NCT00837577|464288018|FG001|Open-label Period|Laboratory Adverse Event|1|||
128998692|NCT00837577|464288017|FG000|Open-label Period|Lack of Efficacy|4|||
128998693|NCT00837577|464288018|FG001|Open-label Period|Lack of Efficacy|3|||
128998694|NCT00837577|464288017|FG000|Open-label Period|Withdrawal by Subject|1|||
128998695|NCT00837577|464288018|FG001|Open-label Period|Withdrawal by Subject|2|||
128998696|NCT00837577|464288017|FG000|Open-label Period|Other Reason|1|||
128998697|NCT00837577|464288018|FG001|Open-label Period|Other Reason|1|||
128998698|NCT03031431|464288023|FG000|Overall Study|Infant removed by maternal request|1|||
128998699|NCT01205529|464288024|FG000|Overall Study|Procedure Cancelled|4|||
128998700|NCT01205529|464288024|FG000|Overall Study|Withdrawal by Subject|2|||
128998701|NCT01205529|464288024|FG000|Overall Study|Physician Decision|4|||
128998702|NCT01205529|464288024|FG000|Overall Study|Unstable post op|15|||
128998703|NCT01205529|464288024|FG000|Overall Study|No longer met criteria|30|||
128998704|NCT01027884|464288029|FG000|Overall Study|Adverse Event|2|||
128998705|NCT01027884|464288030|FG001|Overall Study|Adverse Event|1|||
128998706|NCT01027884|464288029|FG000|Overall Study|Protocol Violation|1|||
128998707|NCT01027884|464288030|FG001|Overall Study|Protocol Violation|0|||
128998708|NCT01027884|464288029|FG000|Overall Study|Non-compliance|1|||
128998709|NCT01027884|464288030|FG001|Overall Study|Non-compliance|1|||
128998710|NCT01027884|464288029|FG000|Overall Study|Withdrawal by Subject|0|||
128998711|NCT01027884|464288030|FG001|Overall Study|Withdrawal by Subject|1|||
128998712|NCT01027884|464288029|FG000|Overall Study|Lost to Follow-up|0|||
128998713|NCT01027884|464288030|FG001|Overall Study|Lost to Follow-up|1|||
128998714|NCT01027884|464288029|FG000|Overall Study|Spinal fixation surgery|0|||
128998715|NCT01027884|464288030|FG001|Overall Study|Spinal fixation surgery|3|||
128998716|NCT03670537|464288031|FG000|Overall Study|Protocol Violation|1|||
128998717|NCT02059187|464288032|FG000|Overall Study|Adverse Event|0|||
128998718|NCT02059187|464288033|FG001|Overall Study|Adverse Event|3|||
128998719|NCT02059187|464288032|FG000|Overall Study|Death|1|||
128998720|NCT02059187|464288033|FG001|Overall Study|Death|1|||
128998721|NCT02059187|464288032|FG000|Overall Study|Lost to Follow-up|9|||
128998722|NCT02059187|464288033|FG001|Overall Study|Lost to Follow-up|8|||
128998723|NCT02059187|464288032|FG000|Overall Study|Non-compliance with study drug|1|||
128998724|NCT02059187|464288033|FG001|Overall Study|Non-compliance with study drug|0|||
128998725|NCT02059187|464288032|FG000|Overall Study|Physician Decision|1|||
128998726|NCT02059187|464288033|FG001|Overall Study|Physician Decision|2|||
128998727|NCT02059187|464288032|FG000|Overall Study|Protocol Violation|1|||
128998728|NCT02059187|464288033|FG001|Overall Study|Protocol Violation|0|||
128998729|NCT02059187|464288032|FG000|Overall Study|Withdrawal by Subject|12|||
128998730|NCT02059187|464288033|FG001|Overall Study|Withdrawal by Subject|8|||
128998731|NCT03070431|464288034|FG000|Overall Study|Withdrawal by Subject|2|||
128998732|NCT03070431|464288034|FG000|Overall Study|Lost to Follow-up|2|||
128998733|NCT01889862|464288035|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
128998734|NCT01889862|464288036|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
128998735|NCT01889862|464288037|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
128998736|NCT01889862|464288038|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
128998737|NCT01889862|464288039|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
128998738|NCT01889862|464288035|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
128998739|NCT01889862|464288036|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
128998740|NCT01889862|464288037|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
128998741|NCT01889862|464288038|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
128998742|NCT01889862|464288039|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
128998743|NCT01889862|464288035|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
128998744|NCT01889862|464288036|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
128998745|NCT01889862|464288037|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
128998746|NCT01889862|464288038|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
128998747|NCT01889862|464288039|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
128998748|NCT01889862|464288035|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
128998749|NCT01889862|464288036|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
128998750|NCT01889862|464288037|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
128998751|NCT01889862|464288038|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
128998752|NCT01889862|464288039|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
128998753|NCT01889862|464288035|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
128998754|NCT01889862|464288036|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
128998755|NCT01889862|464288037|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
128998756|NCT01889862|464288038|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
128998757|NCT01889862|464288039|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
128998758|NCT01889862|464288035|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
128998759|NCT01889862|464288036|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
128998760|NCT01889862|464288037|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
128998761|NCT01889862|464288038|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
128998762|NCT01889862|464288039|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
128998763|NCT01889862|464288035|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
128998764|NCT01889862|464288036|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
128998765|NCT01889862|464288037|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
128998766|NCT01889862|464288038|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
128998767|NCT01889862|464288039|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
128998768|NCT01889862|464288035|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
128998769|NCT01889862|464288036|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
128998770|NCT01889862|464288037|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
128998771|NCT01889862|464288038|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
128998772|NCT01889862|464288039|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
128998773|NCT01889862|464288035|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
128998774|NCT01889862|464288036|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
128998775|NCT01889862|464288037|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
128998776|NCT01889862|464288038|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
128998777|NCT01889862|464288039|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
128998778|NCT01889862|464288035|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
128998779|NCT01889862|464288036|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
128998780|NCT01889862|464288037|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
128998781|NCT01889862|464288038|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
128998782|NCT01889862|464288039|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
128998783|NCT02065791|464288040|FG000|Overall Study|Closed Site|1|||
128998784|NCT02065791|464288041|FG001|Overall Study|Closed Site|1|||
128998785|NCT02065791|464288040|FG000|Overall Study|Withdrawal by Subject|11|||
128998786|NCT02065791|464288041|FG001|Overall Study|Withdrawal by Subject|5|||
128998787|NCT02065791|464288040|FG000|Overall Study|Lost to Follow-up|13|||
128998788|NCT02065791|464288041|FG001|Overall Study|Lost to Follow-up|9|||
128998789|NCT00272961|464288042|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
128998790|NCT00272961|464288043|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
128998791|NCT00272961|464288044|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
128998792|NCT00272961|464288045|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
128998793|NCT00272961|464288046|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
128998794|NCT00272961|464288042|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
128998795|NCT00272961|464288043|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
128998796|NCT00272961|464288044|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
128998797|NCT00272961|464288045|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
128998798|NCT00272961|464288046|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
128998799|NCT00272961|464288042|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
128998800|NCT00272961|464288043|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
128998801|NCT00272961|464288044|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
128998802|NCT00272961|464288045|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
128998803|NCT00272961|464288046|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
128998804|NCT00272961|464288042|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
128998805|NCT00272961|464288043|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
128998806|NCT00272961|464288044|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
128998807|NCT00272961|464288045|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
128998808|NCT00272961|464288046|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
128998809|NCT00272961|464288042|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
128998810|NCT00272961|464288043|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
128998811|NCT00272961|464288044|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
128998812|NCT00272961|464288045|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
128998813|NCT00272961|464288046|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
128998814|NCT00272961|464288042|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
128998815|NCT00272961|464288043|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
128998816|NCT00272961|464288044|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
128998817|NCT00272961|464288045|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
128998818|NCT00272961|464288046|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
128998819|NCT00272961|464288042|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
128998820|NCT00272961|464288043|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
128998821|NCT00272961|464288044|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
128998822|NCT00272961|464288045|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
128998823|NCT00272961|464288046|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
128998824|NCT00272961|464288042|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
128998825|NCT00272961|464288043|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
128998826|NCT00272961|464288044|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
128998827|NCT00272961|464288045|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
128998828|NCT00272961|464288046|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
128998829|NCT00106028|464288056|FG000|Overall Study|Adverse Event|3|||
128998830|NCT00106028|464288057|FG001|Overall Study|Adverse Event|2|||
128998831|NCT00106028|464288056|FG000|Overall Study|Protocol Violation|1|||
128998832|NCT00106028|464288057|FG001|Overall Study|Protocol Violation|1|||
128998833|NCT00106028|464288056|FG000|Overall Study|Withdrawal by Subject|2|||
128998834|NCT00106028|464288057|FG001|Overall Study|Withdrawal by Subject|8|||
128998835|NCT00106028|464288056|FG000|Overall Study|Lost to Follow-up|0|||
128998836|NCT00106028|464288057|FG001|Overall Study|Lost to Follow-up|1|||
128998837|NCT01280981|464288058|FG000|Overall Study|Withdrawal by Subject|11|||
128998838|NCT01280981|464288058|FG000|Overall Study|Protocol Violation|2|||
128998839|NCT01280981|464288058|FG000|Overall Study|Lack of Efficacy|13|||
128998840|NCT01280981|464288058|FG000|Overall Study|Lost to Follow-up|3|||
128998841|NCT01280981|464288058|FG000|Overall Study|Adverse Event|6|||
128998842|NCT01280981|464288058|FG000|Overall Study|Irregular or discontinued menses|3|||
128998843|NCT01280981|464288058|FG000|Overall Study|Failed to return|45|||
128998844|NCT01280981|464288058|FG000|Overall Study|Non-compliance with protocol|3|||
128998845|NCT01280981|464288058|FG000|Overall Study|Withdrawal of consent|3|||
128998846|NCT01280981|464288058|FG000|Overall Study|Elective surgery|2|||
128998847|NCT01280981|464288058|FG000|Overall Study|Study site closure|1|||
128998848|NCT06371079|464288060|FG000|Overall Study|Missing data|88|||
128998849|NCT06371079|464288061|FG001|Overall Study|Missing data|247|||
128998850|NCT01256398|464288062|FG000|Overall Study|Withdrawal by Subject|1|||
128998851|NCT03276962|464288064|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
128998852|NCT03276962|464288065|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
128998853|NCT03276962|464288066|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
128998854|NCT03276962|464288067|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
128998855|NCT03276962|464288068|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
128998856|NCT03276962|464288064|FG000|Overall Study|Protocol Deviation|2|||
128998857|NCT03276962|464288065|FG001|Overall Study|Protocol Deviation|0|||
128998858|NCT03276962|464288066|FG002|Overall Study|Protocol Deviation|1|||
128998859|NCT03276962|464288067|FG003|Overall Study|Protocol Deviation|2|||
128998860|NCT03276962|464288068|FG004|Overall Study|Protocol Deviation|1|||
128998861|NCT03276962|464288064|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
128998862|NCT03276962|464288065|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
128998863|NCT03276962|464288066|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
128998864|NCT03276962|464288067|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
128998865|NCT03276962|464288068|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
128998866|NCT03276962|464288064|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
128998867|NCT03276962|464288065|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
128998868|NCT03276962|464288066|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
128998869|NCT03276962|464288067|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
128998870|NCT03276962|464288068|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
128998871|NCT03276962|464288064|FG000|Overall Study|Lost to Follow-up|10|||
128998872|NCT03276962|464288065|FG001|Overall Study|Lost to Follow-up|10|||
128998873|NCT03276962|464288066|FG002|Overall Study|Lost to Follow-up|4|||
128998874|NCT03276962|464288067|FG003|Overall Study|Lost to Follow-up|6|||
128998875|NCT03276962|464288068|FG004|Overall Study|Lost to Follow-up|10|||
128998876|NCT03276962|464288064|FG000|Overall Study|Other|0|||
128998877|NCT03276962|464288065|FG001|Overall Study|Other|2|||
128998878|NCT03276962|464288066|FG002|Overall Study|Other|0|||
128998879|NCT03276962|464288067|FG003|Overall Study|Other|2|||
128998880|NCT03276962|464288068|FG004|Overall Study|Other|1|||
128998881|NCT00411762|464288069|FG000|Overall Study|Withdrawal by Subject|5|||
128998882|NCT01238211|464288070|FG000|Overall Study|Continues active treatment|31|||
128998883|NCT01238211|464288070|FG000|Overall Study|Adverse Event|7|||
128998884|NCT01238211|464288070|FG000|Overall Study|Death|4|||
128998885|NCT01238211|464288070|FG000|Overall Study|Relapse/Progression|2|||
128998886|NCT01238211|464288070|FG000|Overall Study|Withdrawal by Subject|7|||
128998887|NCT01238211|464288070|FG000|Overall Study|Non-protocol treatment|4|||
128998888|NCT01238211|464288070|FG000|Overall Study|Investigator/Patient Decision|3|||
128998889|NCT04428502|464288071|FG000|Overall Study|Did not meet entrance criteria|14|||
128998890|NCT03550794|464288082|FG000|Overall Study|No longer met inclusion criteria|1|||
128998891|NCT03550794|464288083|FG001|Overall Study|No longer met inclusion criteria|2|||
128998892|NCT03550794|464288082|FG000|Overall Study|Goals of care changed|1|||
128998893|NCT03550794|464288083|FG001|Overall Study|Goals of care changed|0|||
128998894|NCT03550794|464288082|FG000|Overall Study|Withdrawal by Subject|2|||
128998895|NCT03550794|464288083|FG001|Overall Study|Withdrawal by Subject|0|||
128998896|NCT03550794|464288082|FG000|Overall Study|Death|0|||
128998897|NCT03550794|464288083|FG001|Overall Study|Death|1|||
128998898|NCT00449930|464288084|FG000|Overall Study|Adverse Event|9|||
128998899|NCT00449930|464288085|FG001|Overall Study|Adverse Event|19|||
128998900|NCT00449930|464288084|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
128998901|NCT00449930|464288085|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
128998902|NCT00449930|464288084|FG000|Overall Study|Lack of Efficacy|10|||
128998903|NCT00449930|464288085|FG001|Overall Study|Lack of Efficacy|1|||
128998904|NCT00449930|464288084|FG000|Overall Study|Lost to Follow-up|9|||
128998905|NCT00449930|464288085|FG001|Overall Study|Lost to Follow-up|14|||
128998906|NCT00449930|464288084|FG000|Overall Study|Physician Decision|1|||
128998907|NCT00449930|464288085|FG001|Overall Study|Physician Decision|2|||
128998908|NCT00449930|464288084|FG000|Overall Study|Protocol Violation|14|||
128998909|NCT00449930|464288085|FG001|Overall Study|Protocol Violation|15|||
128998910|NCT00449930|464288084|FG000|Overall Study|Withdrawal by Subject|16|||
128998911|NCT00449930|464288085|FG001|Overall Study|Withdrawal by Subject|23|||
128998912|NCT00449930|464288084|FG000|Overall Study|Glycemic discontinuation criteria|1|||
128998913|NCT00449930|464288085|FG001|Overall Study|Glycemic discontinuation criteria|1|||
128998914|NCT01864525|464288086|FG000|Overall Study|Adverse Event|1|||
128998915|NCT01864525|464288087|FG001|Overall Study|Adverse Event|0|||
128998916|NCT01890785|464288088|FG000|Third Intervention|Withdrawal by Subject|0|||
128998917|NCT01890785|464288089|FG001|Third Intervention|Withdrawal by Subject|1|||
128998918|NCT01890785|464288090|FG002|Third Intervention|Withdrawal by Subject|0|||
128998919|NCT01890785|464288091|FG003|Third Intervention|Withdrawal by Subject|0|||
128998920|NCT01890785|464288092|FG004|Third Intervention|Withdrawal by Subject|0|||
128998921|NCT01890785|464288093|FG005|Third Intervention|Withdrawal by Subject|0|||
128998922|NCT03712228|464288094|FG000|Treatment Period 1|Lack of Efficacy|0|||
128998923|NCT03712228|464288095|FG001|Treatment Period 1|Lack of Efficacy|0|||
128998924|NCT03712228|464288096|FG002|Treatment Period 1|Lack of Efficacy|0|||
128998925|NCT03712228|464288097|FG003|Treatment Period 1|Lack of Efficacy|0|||
128998926|NCT03712228|464288098|FG004|Treatment Period 1|Lack of Efficacy|0|||
128998927|NCT03712228|464288099|FG005|Treatment Period 1|Lack of Efficacy|1|||
128998928|NCT03712228|464288094|FG000|Treatment Period 2|Pregnancy|0|||
128998929|NCT03712228|464288095|FG001|Treatment Period 2|Pregnancy|0|||
128998930|NCT03712228|464288096|FG002|Treatment Period 2|Pregnancy|0|||
128998931|NCT03712228|464288097|FG003|Treatment Period 2|Pregnancy|1|||
128998932|NCT03712228|464288098|FG004|Treatment Period 2|Pregnancy|0|||
128998933|NCT03712228|464288099|FG005|Treatment Period 2|Pregnancy|0|||
128998934|NCT03712228|464288094|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128998935|NCT03712228|464288095|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128998936|NCT03712228|464288096|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128998937|NCT03712228|464288097|FG003|Treatment Period 2|Withdrawal by Subject|1|||
128998938|NCT03712228|464288098|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128998939|NCT03712228|464288099|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128998940|NCT01964105|464288100|FG000|Overall Study|Lost to Follow-up|2|||
128998941|NCT01964105|464288101|FG001|Overall Study|Lost to Follow-up|13|||
128998942|NCT01964105|464288102|FG002|Overall Study|Lost to Follow-up|0|||
128998943|NCT03001011|464288103|FG000|Overall Study|Adverse Event|9|||
128998944|NCT03001011|464288104|FG001|Overall Study|Adverse Event|3|||
128998945|NCT03001011|464288103|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
128998946|NCT03001011|464288104|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
128998947|NCT03001011|464288103|FG000|Overall Study|Other than specified above|3|||
128998948|NCT03001011|464288104|FG001|Overall Study|Other than specified above|8|||
128998949|NCT05288673|464288106|FG000|Overall Study|Consent withdrawn by subject|0|||
128998950|NCT05288673|464288107|FG001|Overall Study|Consent withdrawn by subject|0|||
128998951|NCT05288673|464288108|FG002|Overall Study|Consent withdrawn by subject|1|||
128998952|NCT02278952|464288109|FG000|Overall Study|Insufficient Sample|6|||
128998953|NCT04071626|464288110|FG000|Overall Study|Withdrawal by Subject|1|||
128998954|NCT04071626|464288111|FG001|Overall Study|Withdrawal by Subject|1|||
128998955|NCT04071626|464288110|FG000|Overall Study|Protocol Violation|0|||
128998956|NCT04071626|464288111|FG001|Overall Study|Protocol Violation|1|||
128998957|NCT01629693|464288116|FG000|Overall Study|Lost to Follow-up|2|||
128998958|NCT01629693|464288117|FG001|Overall Study|Lost to Follow-up|4|||
128998959|NCT01629693|464288116|FG000|Overall Study|Withdrawal by Subject|2|||
128998960|NCT01629693|464288117|FG001|Overall Study|Withdrawal by Subject|2|||
128998961|NCT01629693|464288116|FG000|Overall Study|Adverse Event|1|||
128998962|NCT01629693|464288117|FG001|Overall Study|Adverse Event|0|||
128998963|NCT01629693|464288116|FG000|Overall Study|Investigator decision|0|||
128998964|NCT01629693|464288117|FG001|Overall Study|Investigator decision|1|||
128998965|NCT01629693|464288116|FG000|Overall Study|Poor comfort of study lenses|0|||
128998966|NCT01629693|464288117|FG001|Overall Study|Poor comfort of study lenses|2|||
128998967|NCT01629693|464288116|FG000|Overall Study|Subject decision unrelated to AE|0|||
128998968|NCT01629693|464288117|FG001|Overall Study|Subject decision unrelated to AE|1|||
128998969|NCT04385199|464288118|FG000|Overall Study|Withdrawal by Subject|1|||
128998970|NCT04385199|464288119|FG001|Overall Study|Withdrawal by Subject|0|||
128998971|NCT01963676|464289767|FG000|Overall Study|Withdrawal by Subject|1|||
128998972|NCT01963676|464289768|FG001|Overall Study|Withdrawal by Subject|0|||
128998973|NCT01246973|464289769|FG000|Overall Study|Other|38|||
128998974|NCT01246973|464289770|FG001|Overall Study|Other|25|||
128998975|NCT01246973|464289769|FG000|Overall Study|Adverse Event|16|||
128998976|NCT01246973|464289770|FG001|Overall Study|Adverse Event|9|||
128998977|NCT01246973|464289769|FG000|Overall Study|Withdrawal by Subject|7|||
128998978|NCT01246973|464289770|FG001|Overall Study|Withdrawal by Subject|13|||
128998979|NCT00766506|464289771|FG000|Overall Study|Use rescue medication after 3 hours|3|||
128998980|NCT00766506|464289772|FG001|Overall Study|Use rescue medication after 3 hours|0|||
128998981|NCT00766506|464289771|FG000|Overall Study|Other|2|||
128998982|NCT00766506|464289772|FG001|Overall Study|Other|2|||
128998983|NCT02496221|464289773|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
128998984|NCT02496221|464289774|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
128998985|NCT02496221|464289773|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
128998986|NCT02496221|464289774|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
128998987|NCT02496221|464289773|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
128998988|NCT02496221|464289774|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
128998989|NCT03262233|464289775|FG000|Overall Study|Withdrawal by Subject|12|||
128998990|NCT03262233|464289776|FG001|Overall Study|Withdrawal by Subject|8|||
128998991|NCT03262233|464289777|FG002|Overall Study|Withdrawal by Subject|21|||
128998992|NCT03262233|464289778|FG003|Overall Study|Withdrawal by Subject|13|||
128998993|NCT03262233|464289775|FG000|Overall Study|Declined due to shock|1|||
128998994|NCT03262233|464289776|FG001|Overall Study|Declined due to shock|2|||
128998995|NCT03262233|464289777|FG002|Overall Study|Declined due to shock|2|||
128998996|NCT03262233|464289778|FG003|Overall Study|Declined due to shock|3|||
128998997|NCT03262233|464289775|FG000|Overall Study|Protocol Violation|5|||
128998998|NCT03262233|464289776|FG001|Overall Study|Protocol Violation|10|||
128998999|NCT03262233|464289777|FG002|Overall Study|Protocol Violation|2|||
128999000|NCT03262233|464289778|FG003|Overall Study|Protocol Violation|13|||
128999001|NCT03262233|464289775|FG000|Overall Study|data collection artifact|0|||
128999002|NCT03262233|464289776|FG001|Overall Study|data collection artifact|1|||
128999003|NCT03262233|464289777|FG002|Overall Study|data collection artifact|0|||
128999004|NCT03262233|464289778|FG003|Overall Study|data collection artifact|0|||
128999005|NCT01120600|464289781|FG000|Overall Study|Adverse Event|7|||
128999006|NCT01120600|464289782|FG001|Overall Study|Adverse Event|7|||
128999007|NCT01120600|464289781|FG000|Overall Study|Excessive Bone Loss|0|||
128999008|NCT01120600|464289782|FG001|Overall Study|Excessive Bone Loss|4|||
128999009|NCT01120600|464289781|FG000|Overall Study|Lost to Follow-up|1|||
128999010|NCT01120600|464289782|FG001|Overall Study|Lost to Follow-up|3|||
128999011|NCT01120600|464289781|FG000|Overall Study|Physician Decision|1|||
128999012|NCT01120600|464289782|FG001|Overall Study|Physician Decision|3|||
128999013|NCT01120600|464289781|FG000|Overall Study|Protocol Violation|0|||
128999014|NCT01120600|464289782|FG001|Overall Study|Protocol Violation|4|||
128999015|NCT01120600|464289781|FG000|Overall Study|Withdrawal by Subject|10|||
128999016|NCT01120600|464289782|FG001|Overall Study|Withdrawal by Subject|11|||
128999017|NCT01165242|464289783|FG000|Overall Study|Unreachable Subjects|1|||
128999018|NCT01165242|464289784|FG001|Overall Study|Unreachable Subjects|0|||
128999019|NCT01165242|464289785|FG002|Overall Study|Unreachable Subjects|0|||
128999020|NCT01165242|464289783|FG000|Overall Study|Incarcerated Subjects|0|||
128999021|NCT01165242|464289784|FG001|Overall Study|Incarcerated Subjects|1|||
128999022|NCT01165242|464289785|FG002|Overall Study|Incarcerated Subjects|0|||
128999023|NCT01165242|464289783|FG000|Overall Study|Visit 2 Declined by Subject|0|||
128999024|NCT01165242|464289784|FG001|Overall Study|Visit 2 Declined by Subject|0|||
128999025|NCT01165242|464289785|FG002|Overall Study|Visit 2 Declined by Subject|1|||
128999026|NCT01165242|464289783|FG000|Overall Study|Withdrawal by Subject|0|||
128999027|NCT01165242|464289784|FG001|Overall Study|Withdrawal by Subject|2|||
128999028|NCT01165242|464289785|FG002|Overall Study|Withdrawal by Subject|2|||
128999029|NCT01165242|464289783|FG000|Overall Study|Extended Holiday|0|||
128999030|NCT01165242|464289784|FG001|Overall Study|Extended Holiday|0|||
128999031|NCT01165242|464289785|FG002|Overall Study|Extended Holiday|1|||
128999032|NCT01165242|464289783|FG000|Overall Study|Lost to Follow-up|9|||
128999033|NCT01165242|464289784|FG001|Overall Study|Lost to Follow-up|7|||
128999034|NCT01165242|464289785|FG002|Overall Study|Lost to Follow-up|10|||
128999035|NCT03770000|464289786|FG000|Overall Study|Premature discontinuation due to PD|0|||
128999036|NCT03770000|464289787|FG001|Overall Study|Premature discontinuation due to PD|0|||
128999037|NCT03770000|464289788|FG002|Overall Study|Premature discontinuation due to PD|1|||
128999038|NCT03770000|464289789|FG003|Overall Study|Premature discontinuation due to PD|3|||
128999039|NCT03770000|464289790|FG004|Overall Study|Premature discontinuation due to PD|2|||
128999040|NCT03877237|464289791|FG000|Overall Study|Adverse Event|1|||
128999041|NCT03877237|464289792|FG001|Overall Study|Adverse Event|2|||
128999042|NCT03877237|464289791|FG000|Overall Study|Death|3|||
128999043|NCT03877237|464289792|FG001|Overall Study|Death|2|||
128999044|NCT03877237|464289791|FG000|Overall Study|Physician Decision|1|||
128999045|NCT03877237|464289792|FG001|Overall Study|Physician Decision|0|||
128999046|NCT03877237|464289791|FG000|Overall Study|Withdrawal by Subject|0|||
128999047|NCT03877237|464289792|FG001|Overall Study|Withdrawal by Subject|2|||
128999048|NCT00566098|464289795|FG000|Collection of MILs|Withdrawal by Subject|1|||
128999049|NCT00566098|464289795|FG000|Collection of MILs|Relapsed|1|||
128999050|NCT00566098|464289795|FG000|Generation of MILs Product|Relapsed|1|||
128999051|NCT00566098|464289795|FG000|Administration of ASCT+MILs|Death|10|||
128999052|NCT00566098|464289795|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
128999053|NCT01690520|464289798|FG000|Overall Study|Death|25|||
128999054|NCT01690520|464289799|FG001|Overall Study|Death|21|||
128999055|NCT01690520|464289798|FG000|Overall Study|Lost to Follow-up|2|||
128999056|NCT01690520|464289799|FG001|Overall Study|Lost to Follow-up|3|||
128999057|NCT01690520|464289798|FG000|Overall Study|Withdrawal by Subject|2|||
128999058|NCT01690520|464289799|FG001|Overall Study|Withdrawal by Subject|0|||
128999059|NCT01690520|464289798|FG000|Overall Study|Relapse|0|||
128999060|NCT01690520|464289799|FG001|Overall Study|Relapse|1|||
128999061|NCT01690520|464289798|FG000|Overall Study|Other|0|||
128999062|NCT01690520|464289799|FG001|Overall Study|Other|1|||
128999063|NCT01690520|464289798|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
128999064|NCT01690520|464289799|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
128999065|NCT02236754|464289800|FG000|Overall Study|Withdrawal by Subject|1|||
128999066|NCT02236754|464289801|FG001|Overall Study|Withdrawal by Subject|0|||
128999067|NCT04006847|464289802|FG000|Overall Study|Product issue|1|||
128999068|NCT00382291|464289803|FG000|Overall Study|Adverse Event|1|||
128999069|NCT00382291|464289804|FG001|Overall Study|Adverse Event|2|||
128999070|NCT00382291|464289805|FG002|Overall Study|Adverse Event|2|||
128999071|NCT00382291|464289803|FG000|Overall Study|Protocol Violation|1|||
128999072|NCT00382291|464289804|FG001|Overall Study|Protocol Violation|0|||
128999073|NCT00382291|464289805|FG002|Overall Study|Protocol Violation|0|||
128999074|NCT00382291|464289803|FG000|Overall Study|Temporary study suspension|2|||
128999075|NCT00382291|464289804|FG001|Overall Study|Temporary study suspension|2|||
128999076|NCT00382291|464289805|FG002|Overall Study|Temporary study suspension|5|||
128999077|NCT00382291|464289803|FG000|Overall Study|Withdrawal by Subject|0|||
128999078|NCT00382291|464289804|FG001|Overall Study|Withdrawal by Subject|2|||
128999079|NCT00382291|464289805|FG002|Overall Study|Withdrawal by Subject|0|||
128999080|NCT00382291|464289803|FG000|Overall Study|Physician Decision|0|||
128999081|NCT00382291|464289804|FG001|Overall Study|Physician Decision|1|||
128999082|NCT00382291|464289805|FG002|Overall Study|Physician Decision|0|||
128999083|NCT00382291|464289803|FG000|Overall Study|Lack of Efficacy|0|||
128999084|NCT00382291|464289804|FG001|Overall Study|Lack of Efficacy|0|||
128999085|NCT00382291|464289805|FG002|Overall Study|Lack of Efficacy|1|||
128999086|NCT01375010|464289806|FG000|Overall Study|Lost to Follow-up|8|||
128999087|NCT01375010|464289807|FG001|Overall Study|Lost to Follow-up|2|||
128999088|NCT01375010|464289806|FG000|Overall Study|Withdrawal by Subject|4|||
128999089|NCT01375010|464289807|FG001|Overall Study|Withdrawal by Subject|2|||
128999090|NCT02614703|464289808|FG000|Overall Study|Withdrawal by Subject|7|||
128999091|NCT02614703|464289809|FG001|Overall Study|Withdrawal by Subject|1|||
128999092|NCT02402933|464289810|FG000|Overall Study|Withdrawal by Subject|4|||
128999093|NCT02402933|464289810|FG000|Overall Study|Discontinued; Site Termination|10|||
128999094|NCT01681771|464289815|FG000|Overall Study|Lost to Follow-up|4|||
128999095|NCT01681771|464289816|FG001|Overall Study|Lost to Follow-up|2|||
128999096|NCT02092961|464289817|FG000|Overall Study|Not reported|1|||
128999097|NCT02092961|464289818|FG001|Overall Study|Not reported|0|||
128999098|NCT02092961|464289819|FG002|Overall Study|Not reported|1|||
128999099|NCT02092961|464289817|FG000|Overall Study|Study stopped|13|||
128999100|NCT02092961|464289818|FG001|Overall Study|Study stopped|9|||
128999101|NCT02092961|464289819|FG002|Overall Study|Study stopped|12|||
128999102|NCT02092961|464289817|FG000|Overall Study|Lack of therapeutic response|2|||
128999103|NCT02092961|464289818|FG001|Overall Study|Lack of therapeutic response|1|||
128999104|NCT02092961|464289819|FG002|Overall Study|Lack of therapeutic response|3|||
128999105|NCT02092961|464289817|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
128999106|NCT02092961|464289818|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
128999107|NCT02092961|464289819|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
128999108|NCT02092961|464289817|FG000|Overall Study|Adverse Event|2|||
128999109|NCT02092961|464289818|FG001|Overall Study|Adverse Event|4|||
128999110|NCT02092961|464289819|FG002|Overall Study|Adverse Event|0|||
128999111|NCT01792284|464289826|FG000|Lead-in Period|Adverse Event|15|||
128999112|NCT01792284|464289827|FG001|Lead-in Period|Adverse Event|0|||
128999113|NCT01792284|464289828|FG002|Lead-in Period|Adverse Event|0|||
128999114|NCT01792284|464289826|FG000|Lead-in Period|Lost to Follow-up|2|||
128999115|NCT01792284|464289827|FG001|Lead-in Period|Lost to Follow-up|0|||
128999116|NCT01792284|464289828|FG002|Lead-in Period|Lost to Follow-up|0|||
128999117|NCT01792284|464289826|FG000|Lead-in Period|Protocol Violation|1|||
128999118|NCT01792284|464289827|FG001|Lead-in Period|Protocol Violation|0|||
128999119|NCT01792284|464289828|FG002|Lead-in Period|Protocol Violation|0|||
128999120|NCT01792284|464289826|FG000|Lead-in Period|Withdrawal by Subject|10|||
128999121|NCT01792284|464289827|FG001|Lead-in Period|Withdrawal by Subject|0|||
128999122|NCT01792284|464289828|FG002|Lead-in Period|Withdrawal by Subject|0|||
128999123|NCT01792284|464289826|FG000|Lead-in Period|Physician Decision|1|||
128999124|NCT01792284|464289827|FG001|Lead-in Period|Physician Decision|0|||
128999125|NCT01792284|464289828|FG002|Lead-in Period|Physician Decision|0|||
128999126|NCT01792284|464289826|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
128999127|NCT01792284|464289827|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
128999128|NCT01792284|464289828|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
128999129|NCT01792284|464289826|FG000|Randomization Period 1|Withdrawal by Subject|0|||
128999130|NCT01792284|464289827|FG001|Randomization Period 1|Withdrawal by Subject|1|||
128999131|NCT01792284|464289828|FG002|Randomization Period 1|Withdrawal by Subject|1|||
128999132|NCT01792284|464289826|FG000|Randomization Period 1|Physician Decision|0|||
128999133|NCT01792284|464289827|FG001|Randomization Period 1|Physician Decision|1|||
128999134|NCT01792284|464289828|FG002|Randomization Period 1|Physician Decision|1|||
128999135|NCT01792284|464289826|FG000|Randomization Period 1|Adverse Event|0|||
128999136|NCT01792284|464289827|FG001|Randomization Period 1|Adverse Event|0|||
128999137|NCT01792284|464289828|FG002|Randomization Period 1|Adverse Event|2|||
128999138|NCT01792284|464289826|FG000|Randomization Period 1|Lost to Follow-up|0|||
128999139|NCT01792284|464289827|FG001|Randomization Period 1|Lost to Follow-up|0|||
128999140|NCT01792284|464289828|FG002|Randomization Period 1|Lost to Follow-up|1|||
128999141|NCT01792284|464289826|FG000|Randomization Period 2|Protocol Violation|0|||
128999142|NCT01792284|464289827|FG001|Randomization Period 2|Protocol Violation|1|||
128999143|NCT01792284|464289828|FG002|Randomization Period 2|Protocol Violation|0|||
128999144|NCT01792284|464289826|FG000|Randomization Period 2|Withdrawal by Subject|0|||
128999145|NCT01792284|464289827|FG001|Randomization Period 2|Withdrawal by Subject|2|||
128999146|NCT01792284|464289828|FG002|Randomization Period 2|Withdrawal by Subject|0|||
128999147|NCT01169649|464289829|FG000|Overall Study|Patient Not Treated|3|||
128999148|NCT01847313|464289830|FG000|Overall Study|Death|0|||
128999149|NCT01847313|464289831|FG001|Overall Study|Death|1|||
128999150|NCT01847313|464289830|FG000|Overall Study|Withdrawal by Subject|0|||
128999151|NCT01847313|464289831|FG001|Overall Study|Withdrawal by Subject|1|||
128999152|NCT02962882|464289832|FG000|Overall Study|Adverse Event|2|||
128999153|NCT02962882|464289832|FG000|Overall Study|Withdrawal by Subject|2|||
128999154|NCT02962882|464289832|FG000|Overall Study|Transfer from ICU|32|||
128999155|NCT00515073|464289833|FG000|Overall Study|Withdrawal by Subject|1|||
128999156|NCT00515073|464289833|FG000|Overall Study|Physician Decision|1|||
128999157|NCT00660790|464289834|FG000|Baseline to 3 Months|Death|1|||
128999158|NCT00660790|464289834|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
128999159|NCT00660790|464289834|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
128999160|NCT02791659|464289835|FG000|Overall Study|Protocol Violation|0|||
128999161|NCT02791659|464289836|FG001|Overall Study|Protocol Violation|1|||
128999162|NCT01456052|464289837|FG000|Overall Study|Adverse Event|1|||
128999163|NCT01456052|464289838|FG001|Overall Study|Adverse Event|1|||
128999164|NCT01456052|464289839|FG002|Overall Study|Adverse Event|2|||
128999165|NCT01456052|464289837|FG000|Overall Study|Consent withdrawn|0|||
128999166|NCT01456052|464289838|FG001|Overall Study|Consent withdrawn|2|||
128999167|NCT01456052|464289839|FG002|Overall Study|Consent withdrawn|1|||
128999168|NCT01456052|464289837|FG000|Overall Study|Protocol Violation|0|||
128999169|NCT01456052|464289838|FG001|Overall Study|Protocol Violation|1|||
128999170|NCT01456052|464289839|FG002|Overall Study|Protocol Violation|0|||
128999171|NCT01456052|464289837|FG000|Overall Study|Physician Decision|1|||
128999172|NCT01456052|464289838|FG001|Overall Study|Physician Decision|0|||
128999173|NCT01456052|464289839|FG002|Overall Study|Physician Decision|1|||
128999174|NCT01456052|464289837|FG000|Overall Study|Treatment Failure|0|||
128999175|NCT01456052|464289838|FG001|Overall Study|Treatment Failure|1|||
128999176|NCT01456052|464289839|FG002|Overall Study|Treatment Failure|1|||
128999177|NCT03840811|464289840|FG000|Overall Study|Lost to Follow-up|0|||
128999178|NCT03840811|464289841|FG001|Overall Study|Lost to Follow-up|0|||
128999179|NCT03840811|464289842|FG002|Overall Study|Lost to Follow-up|1|||
128999180|NCT01904383|464289843|FG000|Overall Study|CRF not collected|117|||
128999181|NCT01904383|464289843|FG000|Overall Study|Reason not listed|147|||
128999182|NCT01904383|464289843|FG000|Overall Study|Lost to Follow-up|674|||
128999183|NCT01904383|464289843|FG000|Overall Study|Lack of Efficacy|370|||
128999184|NCT01904383|464289843|FG000|Overall Study|Improvement|141|||
128999185|NCT01904383|464289843|FG000|Overall Study|Adverse Event|271|||
128999186|NCT01904383|464289843|FG000|Overall Study|No patient visit after entry|54|||
128999187|NCT01625845|464289844|FG000|Overall Study|Adverse Event|1|||
128999188|NCT01625845|464289845|FG001|Overall Study|Adverse Event|2|||
128999189|NCT01625845|464289844|FG000|Overall Study|Lost to Follow-up|2|||
128999190|NCT01625845|464289845|FG001|Overall Study|Lost to Follow-up|1|||
128999191|NCT01625845|464289844|FG000|Overall Study|Withdrawal by Subject|2|||
128999192|NCT01625845|464289845|FG001|Overall Study|Withdrawal by Subject|0|||
128999193|NCT02853929|464289846|FG000|Overall Study|Lost to Follow-up|3|||
128999194|NCT02853929|464289847|FG001|Overall Study|Lost to Follow-up|0|||
128999195|NCT02853929|464289846|FG000|Overall Study|Withdrawal by Subject|1|||
128999196|NCT02853929|464289847|FG001|Overall Study|Withdrawal by Subject|0|||
128999197|NCT02853929|464289846|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
128999198|NCT02853929|464289847|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
128999199|NCT01294592|464289848|FG000|Overall Study|Adverse Event|28|||
128999200|NCT01294592|464289849|FG001|Overall Study|Adverse Event|13|||
128999201|NCT01294592|464289848|FG000|Overall Study|Lack of Efficacy|7|||
128999202|NCT01294592|464289849|FG001|Overall Study|Lack of Efficacy|5|||
128999203|NCT01294592|464289848|FG000|Overall Study|Protocol Violation|1|||
128999204|NCT01294592|464289849|FG001|Overall Study|Protocol Violation|7|||
128999205|NCT01294592|464289848|FG000|Overall Study|Lost to Follow-up|7|||
128999206|NCT01294592|464289849|FG001|Overall Study|Lost to Follow-up|9|||
128999207|NCT01294592|464289848|FG000|Overall Study|Physician Decision|6|||
128999208|NCT01294592|464289849|FG001|Overall Study|Physician Decision|11|||
128999209|NCT01294592|464289848|FG000|Overall Study|Withdrawal by Subject|28|||
128999210|NCT01294592|464289849|FG001|Overall Study|Withdrawal by Subject|28|||
128999211|NCT01113710|464289850|FG000|Overall Study|Adverse Event|64|||
128999212|NCT01113710|464289850|FG000|Overall Study|Lack of Efficacy|41|||
128999213|NCT01113710|464289850|FG000|Overall Study|No Information Available|40|||
128999214|NCT01113710|464289850|FG000|Overall Study|Withdrawal by Subject|28|||
128999215|NCT01113710|464289850|FG000|Overall Study|Lost to Follow-up|20|||
128999216|NCT01113710|464289850|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
128999217|NCT01113710|464289850|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
128999218|NCT01113710|464289850|FG000|Overall Study|Lack of Patient's Compliance|8|||
128999219|NCT01113710|464289850|FG000|Overall Study|Other|7|||
128999220|NCT01113710|464289850|FG000|Overall Study|Adverse Event/Other|5|||
128999221|NCT01113710|464289850|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
128999222|NCT01113710|464289850|FG000|Overall Study|Lack of Efficacy/Other|4|||
128999223|NCT01113710|464289850|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
128999224|NCT01113710|464289850|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
128999225|NCT01113710|464289850|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
128999226|NCT01113710|464289850|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
128999227|NCT01113710|464289850|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
128999228|NCT01113710|464289850|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
128999229|NCT01113710|464289850|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
128999230|NCT01113710|464289850|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
128999231|NCT01113710|464289850|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
128999232|NCT01113710|464289850|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
128999233|NCT01113710|464289850|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
128999234|NCT01113710|464289850|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
128999235|NCT01113710|464289850|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
128999236|NCT01078623|464289851|FG000|Treatment Period 1|Adverse Event|1|||
128999237|NCT01078623|464289852|FG001|Treatment Period 1|Adverse Event|1|||
128999238|NCT01078623|464289853|FG002|Treatment Period 1|Adverse Event|1|||
128999239|NCT01078623|464289854|FG003|Treatment Period 1|Adverse Event|0|||
128999240|NCT01078623|464289855|FG004|Treatment Period 1|Adverse Event|0|||
128999241|NCT01078623|464289856|FG005|Treatment Period 1|Adverse Event|0|||
128999242|NCT01078623|464289857|FG006|Treatment Period 1|Adverse Event|1|||
128999243|NCT01078623|464289858|FG007|Treatment Period 1|Adverse Event|0|||
128999244|NCT01078623|464289859|FG008|Treatment Period 1|Adverse Event|1|||
128999245|NCT01078623|464289860|FG009|Treatment Period 1|Adverse Event|1|||
128999246|NCT01078623|464289861|FG010|Treatment Period 1|Adverse Event|0|||
128999247|NCT01078623|464289862|FG011|Treatment Period 1|Adverse Event|0|||
128999248|NCT01078623|464289863|FG012|Treatment Period 1|Adverse Event|0|||
128999249|NCT01078623|464289864|FG013|Treatment Period 1|Adverse Event|0|||
128999250|NCT01078623|464289865|FG014|Treatment Period 1|Adverse Event|0|||
128999251|NCT01078623|464289866|FG015|Treatment Period 1|Adverse Event|0|||
128999252|NCT01078623|464289867|FG016|Treatment Period 1|Adverse Event|0|||
128999253|NCT01078623|464289868|FG017|Treatment Period 1|Adverse Event|0|||
128999254|NCT01078623|464289869|FG018|Treatment Period 1|Adverse Event|0|||
128999255|NCT01078623|464289870|FG019|Treatment Period 1|Adverse Event|0|||
128999256|NCT01078623|464289851|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128999257|NCT01078623|464289852|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128999258|NCT01078623|464289853|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128999259|NCT01078623|464289854|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128999260|NCT01078623|464289855|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128999261|NCT01078623|464289856|FG005|Treatment Period 1|Withdrawal by Subject|0|||
128999262|NCT01078623|464289857|FG006|Treatment Period 1|Withdrawal by Subject|0|||
128999263|NCT01078623|464289858|FG007|Treatment Period 1|Withdrawal by Subject|1|||
128999264|NCT01078623|464289859|FG008|Treatment Period 1|Withdrawal by Subject|0|||
128999265|NCT01078623|464289860|FG009|Treatment Period 1|Withdrawal by Subject|0|||
128999266|NCT01078623|464289861|FG010|Treatment Period 1|Withdrawal by Subject|1|||
128999267|NCT01078623|464289862|FG011|Treatment Period 1|Withdrawal by Subject|0|||
128999268|NCT01078623|464289863|FG012|Treatment Period 1|Withdrawal by Subject|0|||
128999269|NCT01078623|464289864|FG013|Treatment Period 1|Withdrawal by Subject|0|||
128999270|NCT01078623|464289865|FG014|Treatment Period 1|Withdrawal by Subject|0|||
128999271|NCT01078623|464289866|FG015|Treatment Period 1|Withdrawal by Subject|0|||
128999272|NCT01078623|464289867|FG016|Treatment Period 1|Withdrawal by Subject|0|||
128999273|NCT01078623|464289868|FG017|Treatment Period 1|Withdrawal by Subject|0|||
128999274|NCT01078623|464289869|FG018|Treatment Period 1|Withdrawal by Subject|0|||
128999275|NCT01078623|464289870|FG019|Treatment Period 1|Withdrawal by Subject|0|||
128999276|NCT01078623|464289851|FG000|Treatment Period 1|Protocol Violation|0|||
128999277|NCT01078623|464289852|FG001|Treatment Period 1|Protocol Violation|0|||
128999278|NCT01078623|464289853|FG002|Treatment Period 1|Protocol Violation|0|||
128999279|NCT01078623|464289854|FG003|Treatment Period 1|Protocol Violation|0|||
128999280|NCT01078623|464289855|FG004|Treatment Period 1|Protocol Violation|0|||
128999281|NCT01078623|464289856|FG005|Treatment Period 1|Protocol Violation|1|||
128878043|NCT00910689|463848348|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
128878044|NCT00910689|463848349|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
128878045|NCT00910689|463848346|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
128878046|NCT00910689|463848347|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
128878047|NCT00910689|463848348|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
128999282|NCT01078623|464289857|FG006|Treatment Period 1|Protocol Violation|0|||
128999283|NCT01078623|464289858|FG007|Treatment Period 1|Protocol Violation|0|||
128999284|NCT01078623|464289859|FG008|Treatment Period 1|Protocol Violation|0|||
128999285|NCT01078623|464289860|FG009|Treatment Period 1|Protocol Violation|0|||
128999286|NCT01078623|464289861|FG010|Treatment Period 1|Protocol Violation|0|||
128999287|NCT01078623|464289862|FG011|Treatment Period 1|Protocol Violation|0|||
128999288|NCT01078623|464289863|FG012|Treatment Period 1|Protocol Violation|0|||
128999289|NCT01078623|464289864|FG013|Treatment Period 1|Protocol Violation|0|||
128999290|NCT01078623|464289865|FG014|Treatment Period 1|Protocol Violation|0|||
128999291|NCT01078623|464289866|FG015|Treatment Period 1|Protocol Violation|0|||
128999292|NCT01078623|464289867|FG016|Treatment Period 1|Protocol Violation|0|||
128999293|NCT01078623|464289868|FG017|Treatment Period 1|Protocol Violation|0|||
128878048|NCT00910689|463848349|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
128999294|NCT01078623|464289869|FG018|Treatment Period 1|Protocol Violation|0|||
128878049|NCT00910689|463848346|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
128878050|NCT00910689|463848347|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
128878051|NCT00910689|463848348|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
128878052|NCT00910689|463848349|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
128878053|NCT00910689|463848346|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
128878054|NCT00910689|463848347|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
128878055|NCT00910689|463848348|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
128878056|NCT00910689|463848349|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
128878057|NCT00484289|463848355|FG000|Long Term Phase|Adverse Event|1|||
128878058|NCT00484289|463848356|FG001|Long Term Phase|Adverse Event|17|||
128878059|NCT00484289|463848357|FG002|Long Term Phase|Adverse Event|5|||
128878060|NCT00484289|463848355|FG000|Long Term Phase|Withdrawal by Subject|0|||
128878061|NCT00484289|463848356|FG001|Long Term Phase|Withdrawal by Subject|7|||
128878062|NCT00484289|463848357|FG002|Long Term Phase|Withdrawal by Subject|6|||
128763100|NCT03145766|463422735|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
128763101|NCT03145766|463422736|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
128763102|NCT03145766|463422737|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
128763103|NCT03145766|463422733|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
128763104|NCT03145766|463422734|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
128878063|NCT00484289|463848355|FG000|Long Term Phase|Inadequate response|2|||
128999295|NCT01078623|464289870|FG019|Treatment Period 1|Protocol Violation|0|||
128999296|NCT01078623|464289851|FG000|Treatment Period 2|Adverse Event|0|||
128999297|NCT01078623|464289852|FG001|Treatment Period 2|Adverse Event|0|||
128999298|NCT01078623|464289853|FG002|Treatment Period 2|Adverse Event|0|||
128999299|NCT01078623|464289854|FG003|Treatment Period 2|Adverse Event|0|||
128999300|NCT01078623|464289855|FG004|Treatment Period 2|Adverse Event|0|||
128999301|NCT01078623|464289856|FG005|Treatment Period 2|Adverse Event|0|||
128999302|NCT01078623|464289857|FG006|Treatment Period 2|Adverse Event|1|||
128999303|NCT01078623|464289858|FG007|Treatment Period 2|Adverse Event|0|||
128999304|NCT01078623|464289859|FG008|Treatment Period 2|Adverse Event|0|||
128999305|NCT01078623|464289860|FG009|Treatment Period 2|Adverse Event|0|||
128999306|NCT01078623|464289861|FG010|Treatment Period 2|Adverse Event|0|||
128999307|NCT01078623|464289862|FG011|Treatment Period 2|Adverse Event|0|||
128999308|NCT01078623|464289863|FG012|Treatment Period 2|Adverse Event|0|||
128999309|NCT01078623|464289864|FG013|Treatment Period 2|Adverse Event|0|||
128999310|NCT01078623|464289865|FG014|Treatment Period 2|Adverse Event|0|||
128999311|NCT01078623|464289866|FG015|Treatment Period 2|Adverse Event|0|||
128999312|NCT01078623|464289867|FG016|Treatment Period 2|Adverse Event|0|||
128999313|NCT01078623|464289868|FG017|Treatment Period 2|Adverse Event|0|||
128999314|NCT01078623|464289869|FG018|Treatment Period 2|Adverse Event|1|||
128999315|NCT01078623|464289870|FG019|Treatment Period 2|Adverse Event|0|||
128999316|NCT01078623|464289851|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128999317|NCT01078623|464289852|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128999318|NCT01078623|464289853|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128999319|NCT01078623|464289854|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128999320|NCT01078623|464289855|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128999321|NCT01078623|464289856|FG005|Treatment Period 2|Withdrawal by Subject|1|||
128999322|NCT01078623|464289857|FG006|Treatment Period 2|Withdrawal by Subject|0|||
128999323|NCT01078623|464289858|FG007|Treatment Period 2|Withdrawal by Subject|0|||
128999324|NCT01078623|464289859|FG008|Treatment Period 2|Withdrawal by Subject|0|||
128999325|NCT01078623|464289860|FG009|Treatment Period 2|Withdrawal by Subject|0|||
128999326|NCT01078623|464289861|FG010|Treatment Period 2|Withdrawal by Subject|0|||
128999327|NCT01078623|464289862|FG011|Treatment Period 2|Withdrawal by Subject|0|||
128999328|NCT01078623|464289863|FG012|Treatment Period 2|Withdrawal by Subject|0|||
128999329|NCT01078623|464289864|FG013|Treatment Period 2|Withdrawal by Subject|0|||
128999330|NCT01078623|464289865|FG014|Treatment Period 2|Withdrawal by Subject|0|||
128999331|NCT01078623|464289866|FG015|Treatment Period 2|Withdrawal by Subject|0|||
128999332|NCT01078623|464289867|FG016|Treatment Period 2|Withdrawal by Subject|0|||
128999333|NCT01078623|464289868|FG017|Treatment Period 2|Withdrawal by Subject|0|||
128878064|NCT00484289|463848356|FG001|Long Term Phase|Inadequate response|7|||
128999334|NCT01078623|464289869|FG018|Treatment Period 2|Withdrawal by Subject|0|||
128999335|NCT01078623|464289870|FG019|Treatment Period 2|Withdrawal by Subject|0|||
128999336|NCT01078623|464289851|FG000|Treatment Period 3|Adverse Event|0|||
128999337|NCT01078623|464289852|FG001|Treatment Period 3|Adverse Event|0|||
128878065|NCT00484289|463848357|FG002|Long Term Phase|Inadequate response|4|||
128999338|NCT01078623|464289853|FG002|Treatment Period 3|Adverse Event|0|||
128999339|NCT01078623|464289854|FG003|Treatment Period 3|Adverse Event|0|||
128999340|NCT01078623|464289855|FG004|Treatment Period 3|Adverse Event|1|||
128999341|NCT01078623|464289856|FG005|Treatment Period 3|Adverse Event|0|||
128999342|NCT01078623|464289857|FG006|Treatment Period 3|Adverse Event|0|||
128999343|NCT01078623|464289858|FG007|Treatment Period 3|Adverse Event|0|||
128999344|NCT01078623|464289859|FG008|Treatment Period 3|Adverse Event|0|||
128999345|NCT01078623|464289860|FG009|Treatment Period 3|Adverse Event|0|||
128999346|NCT01078623|464289861|FG010|Treatment Period 3|Adverse Event|0|||
128999347|NCT01078623|464289862|FG011|Treatment Period 3|Adverse Event|0|||
128999348|NCT01078623|464289863|FG012|Treatment Period 3|Adverse Event|0|||
128999349|NCT01078623|464289864|FG013|Treatment Period 3|Adverse Event|1|||
128999350|NCT01078623|464289865|FG014|Treatment Period 3|Adverse Event|0|||
128999351|NCT01078623|464289866|FG015|Treatment Period 3|Adverse Event|0|||
128999352|NCT01078623|464289867|FG016|Treatment Period 3|Adverse Event|0|||
128999353|NCT01078623|464289868|FG017|Treatment Period 3|Adverse Event|0|||
128999354|NCT01078623|464289869|FG018|Treatment Period 3|Adverse Event|0|||
128999355|NCT01078623|464289870|FG019|Treatment Period 3|Adverse Event|0|||
128999356|NCT01078623|464289851|FG000|Treatment Period 4|Adverse Event|0|||
128999357|NCT01078623|464289852|FG001|Treatment Period 4|Adverse Event|0|||
128999358|NCT01078623|464289853|FG002|Treatment Period 4|Adverse Event|1|||
128999359|NCT01078623|464289854|FG003|Treatment Period 4|Adverse Event|0|||
128878066|NCT00484289|463848355|FG000|Long Term Phase|Other Reason|0|||
128878067|NCT00484289|463848356|FG001|Long Term Phase|Other Reason|5|||
128999360|NCT01078623|464289855|FG004|Treatment Period 4|Adverse Event|0|||
128999361|NCT01078623|464289856|FG005|Treatment Period 4|Adverse Event|0|||
128999362|NCT01078623|464289857|FG006|Treatment Period 4|Adverse Event|0|||
128999363|NCT01078623|464289858|FG007|Treatment Period 4|Adverse Event|0|||
128999364|NCT01078623|464289859|FG008|Treatment Period 4|Adverse Event|0|||
128999365|NCT01078623|464289860|FG009|Treatment Period 4|Adverse Event|0|||
128999366|NCT01078623|464289861|FG010|Treatment Period 4|Adverse Event|0|||
128999367|NCT01078623|464289862|FG011|Treatment Period 4|Adverse Event|0|||
128999368|NCT01078623|464289863|FG012|Treatment Period 4|Adverse Event|0|||
128999369|NCT01078623|464289864|FG013|Treatment Period 4|Adverse Event|0|||
128999370|NCT01078623|464289865|FG014|Treatment Period 4|Adverse Event|0|||
128999371|NCT01078623|464289866|FG015|Treatment Period 4|Adverse Event|0|||
128999372|NCT01078623|464289867|FG016|Treatment Period 4|Adverse Event|0|||
128999373|NCT01078623|464289868|FG017|Treatment Period 4|Adverse Event|0|||
128999374|NCT01078623|464289869|FG018|Treatment Period 4|Adverse Event|0|||
128999375|NCT01078623|464289870|FG019|Treatment Period 4|Adverse Event|0|||
128999376|NCT01078623|464289851|FG000|Treatment Period 4|Withdrawal by Subject|0|||
128999377|NCT01078623|464289852|FG001|Treatment Period 4|Withdrawal by Subject|0|||
128999378|NCT01078623|464289853|FG002|Treatment Period 4|Withdrawal by Subject|0|||
128999379|NCT01078623|464289854|FG003|Treatment Period 4|Withdrawal by Subject|0|||
128999380|NCT01078623|464289855|FG004|Treatment Period 4|Withdrawal by Subject|0|||
128999381|NCT01078623|464289856|FG005|Treatment Period 4|Withdrawal by Subject|0|||
128999382|NCT01078623|464289857|FG006|Treatment Period 4|Withdrawal by Subject|0|||
128999383|NCT01078623|464289858|FG007|Treatment Period 4|Withdrawal by Subject|0|||
128999384|NCT01078623|464289859|FG008|Treatment Period 4|Withdrawal by Subject|0|||
128999385|NCT01078623|464289860|FG009|Treatment Period 4|Withdrawal by Subject|0|||
128999386|NCT01078623|464289861|FG010|Treatment Period 4|Withdrawal by Subject|0|||
129214787|NCT01746901|465089373|FG001|Naloxone Challenge Phase|Adverse Event|0|||
129214788|NCT01746901|465089374|FG002|Naloxone Challenge Phase|Adverse Event|0|||
129214789|NCT01746901|465089375|FG003|Naloxone Challenge Phase|Adverse Event|0|||
129214790|NCT01746901|465089376|FG004|Naloxone Challenge Phase|Adverse Event|0|||
129214791|NCT01746901|465089377|FG005|Naloxone Challenge Phase|Adverse Event|0|||
129214792|NCT01746901|465089378|FG006|Naloxone Challenge Phase|Adverse Event|0|||
129214793|NCT01746901|465089379|FG007|Naloxone Challenge Phase|Adverse Event|0|||
129214794|NCT01746901|465089380|FG008|Naloxone Challenge Phase|Adverse Event|0|||
129214795|NCT01746901|465089372|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
129214796|NCT01746901|465089373|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214797|NCT01746901|465089374|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214798|NCT01746901|465089375|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214799|NCT01746901|465089376|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214800|NCT01746901|465089377|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214801|NCT01746901|465089378|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214802|NCT01746901|465089379|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214803|NCT01746901|465089380|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129214804|NCT01746901|465089372|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214805|NCT01746901|465089373|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
129214806|NCT01746901|465089374|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214807|NCT01746901|465089375|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214808|NCT01746901|465089376|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214809|NCT01746901|465089377|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214810|NCT01746901|465089378|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214811|NCT01746901|465089379|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214812|NCT01746901|465089380|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129214813|NCT01746901|465089372|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129214814|NCT01746901|465089373|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
129214815|NCT01746901|465089374|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
129214816|NCT01746901|465089375|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129214817|NCT01746901|465089376|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129214818|NCT01746901|465089377|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129214819|NCT01746901|465089378|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129214820|NCT01746901|465089379|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129214821|NCT01746901|465089380|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129214822|NCT01746901|465089372|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129214823|NCT01746901|465089373|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
129214824|NCT01746901|465089374|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
129214825|NCT01746901|465089375|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129214826|NCT01746901|465089376|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129214827|NCT01746901|465089377|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129214828|NCT01746901|465089378|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129214829|NCT01746901|465089379|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129214830|NCT01746901|465089380|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129214831|NCT01746901|465089372|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129214832|NCT01746901|465089373|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
129214833|NCT01746901|465089374|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
129214834|NCT01746901|465089375|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129214835|NCT01746901|465089376|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129214836|NCT01746901|465089377|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129214837|NCT01746901|465089378|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129214838|NCT01746901|465089379|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129214839|NCT01746901|465089380|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129214840|NCT01746901|465089372|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
129214841|NCT01746901|465089373|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
129214842|NCT01746901|465089374|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
129214843|NCT01746901|465089375|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
129214844|NCT01746901|465089376|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
129214845|NCT01746901|465089377|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
128999387|NCT01078623|464289862|FG011|Treatment Period 4|Withdrawal by Subject|0|||
129214846|NCT01746901|465089378|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
129214847|NCT01746901|465089379|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
129214848|NCT01746901|465089380|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
129214849|NCT01746901|465089372|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129214850|NCT01746901|465089373|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129214851|NCT01746901|465089374|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129214852|NCT01746901|465089375|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129214853|NCT01746901|465089376|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
128999388|NCT01078623|464289863|FG012|Treatment Period 4|Withdrawal by Subject|0|||
128999389|NCT01078623|464289864|FG013|Treatment Period 4|Withdrawal by Subject|0|||
128999390|NCT01078623|464289865|FG014|Treatment Period 4|Withdrawal by Subject|0|||
128999391|NCT01078623|464289866|FG015|Treatment Period 4|Withdrawal by Subject|1|||
128999392|NCT01078623|464289867|FG016|Treatment Period 4|Withdrawal by Subject|0|||
128999393|NCT01078623|464289868|FG017|Treatment Period 4|Withdrawal by Subject|0|||
128999394|NCT01078623|464289869|FG018|Treatment Period 4|Withdrawal by Subject|0|||
128999395|NCT01078623|464289870|FG019|Treatment Period 4|Withdrawal by Subject|0|||
128999396|NCT00463866|464289871|FG000|Overall Study|Adverse Event|70|||
128999397|NCT00463866|464289872|FG001|Overall Study|Adverse Event|93|||
128999398|NCT00463866|464289871|FG000|Overall Study|Withdrawal by Subject|81|||
128999399|NCT00463866|464289872|FG001|Overall Study|Withdrawal by Subject|79|||
128999400|NCT00463866|464289871|FG000|Overall Study|Lost to Follow-up|46|||
128999401|NCT00463866|464289872|FG001|Overall Study|Lost to Follow-up|55|||
128999402|NCT00463866|464289871|FG000|Overall Study|Incorrect Enrolment|64|||
128999403|NCT00463866|464289872|FG001|Overall Study|Incorrect Enrolment|66|||
128999404|NCT00463866|464289871|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
128999405|NCT00463866|464289872|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
128999406|NCT00463866|464289871|FG000|Overall Study|Safety Reason|1|||
128999407|NCT00463866|464289872|FG001|Overall Study|Safety Reason|3|||
128999408|NCT00463866|464289871|FG000|Overall Study|Mis-Randomization of subject|0|||
128999409|NCT00463866|464289872|FG001|Overall Study|Mis-Randomization of subject|1|||
128999410|NCT00463866|464289871|FG000|Overall Study|Other|22|||
128999411|NCT00463866|464289872|FG001|Overall Study|Other|22|||
128999412|NCT01886300|464289885|FG000|Overall Study|Trial terminated by sponsor|16|||
128999413|NCT00373685|464289888|FG000|Overall Study|Death|2|||
128999414|NCT00373685|464289889|FG001|Overall Study|Death|1|||
128999415|NCT00373685|464289888|FG000|Overall Study|Adverse Event|278|||
128999416|NCT00373685|464289889|FG001|Overall Study|Adverse Event|253|||
128999417|NCT00373685|464289888|FG000|Overall Study|Insufficient clinical response|169|||
128999418|NCT00373685|464289889|FG001|Overall Study|Insufficient clinical response|119|||
128999419|NCT00373685|464289888|FG000|Overall Study|Did not meet entrance criteria|167|||
128878068|NCT00484289|463848357|FG002|Long Term Phase|Other Reason|1|||
128999420|NCT00373685|464289889|FG001|Overall Study|Did not meet entrance criteria|184|||
128999421|NCT00373685|464289888|FG000|Overall Study|Lost to follow up|83|||
128999422|NCT00373685|464289889|FG001|Overall Study|Lost to follow up|103|||
128999423|NCT00373685|464289888|FG000|Overall Study|No longer willing to participate|337|||
128999424|NCT00373685|464289889|FG001|Overall Study|No longer willing to participate|352|||
128999425|NCT00373685|464289888|FG000|Overall Study|Other|149|||
128999426|NCT00373685|464289889|FG001|Overall Study|Other|146|||
129214854|NCT01746901|465089377|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129214855|NCT01746901|465089378|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129214856|NCT01746901|465089379|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
128999427|NCT00373685|464289888|FG000|Overall Study|Protocol Violation|191|||
128999428|NCT00373685|464289889|FG001|Overall Study|Protocol Violation|182|||
128999429|NCT00373685|464289888|FG000|Overall Study|Final Status Unknown|12|||
128999430|NCT00373685|464289889|FG001|Overall Study|Final Status Unknown|4|||
128999431|NCT00373685|464289888|FG000|Overall Study|Randomized, not treated|51|||
128999432|NCT00373685|464289889|FG001|Overall Study|Randomized, not treated|77|||
128999433|NCT00575328|464289890|FG000|Overall Study|Adverse Event|1|||
128999434|NCT00575328|464289891|FG001|Overall Study|Adverse Event|1|||
128999435|NCT00575328|464289890|FG000|Overall Study|Lost to Follow-up|2|||
128999436|NCT00575328|464289891|FG001|Overall Study|Lost to Follow-up|1|||
128999437|NCT02124746|464289892|FG000|Overall Study|Adverse Event|2|||
128999438|NCT02124746|464289893|FG001|Overall Study|Adverse Event|1|||
128999439|NCT02124746|464289894|FG002|Overall Study|Adverse Event|2|||
128999440|NCT02124746|464289892|FG000|Overall Study|Death|2|||
128999441|NCT02124746|464289893|FG001|Overall Study|Death|1|||
128999442|NCT02124746|464289894|FG002|Overall Study|Death|3|||
128999443|NCT02124746|464289892|FG000|Overall Study|Lack of Efficacy|3|||
128999444|NCT02124746|464289893|FG001|Overall Study|Lack of Efficacy|2|||
128999445|NCT02124746|464289894|FG002|Overall Study|Lack of Efficacy|2|||
128999446|NCT02124746|464289892|FG000|Overall Study|Physician Decision|6|||
128999447|NCT02124746|464289893|FG001|Overall Study|Physician Decision|4|||
128999448|NCT02124746|464289894|FG002|Overall Study|Physician Decision|5|||
128999449|NCT02124746|464289892|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128999450|NCT02124746|464289893|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128999451|NCT02124746|464289894|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128999452|NCT02124746|464289892|FG000|Overall Study|Withdrawal by Subject|3|||
128999453|NCT02124746|464289893|FG001|Overall Study|Withdrawal by Subject|3|||
128999454|NCT02124746|464289894|FG002|Overall Study|Withdrawal by Subject|0|||
129214857|NCT01746901|465089380|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129214858|NCT01746901|465089372|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
129214859|NCT01746901|465089373|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
129214860|NCT01746901|465089374|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
129214861|NCT01746901|465089375|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
129214862|NCT01746901|465089376|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
129214863|NCT01746901|465089377|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
129214864|NCT01746901|465089378|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
129214865|NCT01746901|465089379|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
129214866|NCT01746901|465089380|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
129214867|NCT01746901|465089372|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214868|NCT01746901|465089373|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214869|NCT01746901|465089374|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214870|NCT01746901|465089375|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
129214871|NCT01746901|465089376|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214872|NCT01746901|465089377|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214873|NCT01746901|465089378|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214874|NCT01746901|465089379|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214875|NCT01746901|465089380|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129214876|NCT01746901|465089372|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129214877|NCT01746901|465089373|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129214878|NCT01746901|465089374|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129214879|NCT01746901|465089375|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129214880|NCT01746901|465089376|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129214881|NCT01746901|465089377|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
129214882|NCT01746901|465089378|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129214883|NCT01746901|465089379|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129214884|NCT01746901|465089380|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
129214885|NCT01746901|465089372|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129214886|NCT01746901|465089373|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129214887|NCT01746901|465089374|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129214888|NCT01746901|465089375|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129214889|NCT01746901|465089376|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129214890|NCT01746901|465089377|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129214891|NCT01746901|465089378|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
129214892|NCT01746901|465089379|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129214893|NCT01746901|465089380|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
129214894|NCT03594110|465089384|FG000|Interventional Part|Participant concerned about study treatment|23|||
129214895|NCT03594110|465089385|FG001|Interventional Part|Participant concerned about study treatment|28|||
129214896|NCT03594110|465089384|FG000|Interventional Part|Doctor advice|38|||
129214897|NCT03594110|465089385|FG001|Interventional Part|Doctor advice|40|||
129214898|NCT03594110|465089384|FG000|Interventional Part|Participants' wish|89|||
129214899|NCT03594110|465089385|FG001|Interventional Part|Participants' wish|68|||
129214900|NCT03594110|465089384|FG000|Interventional Part|Adverse event-non-fatal events|119|||
129214901|NCT03594110|465089385|FG001|Interventional Part|Adverse event-non-fatal events|116|||
129214902|NCT03594110|465089384|FG000|Interventional Part|Study drug stopped, reason missing|336|||
129214903|NCT03594110|465089385|FG001|Interventional Part|Study drug stopped, reason missing|294|||
129214904|NCT03594110|465089384|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
129214905|NCT03594110|465089385|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
129214906|NCT03594110|465089384|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
129214907|NCT03594110|465089385|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
129214908|NCT03594110|465089384|FG000|Interventional Part|Contraindicated drug started|32|||
129214909|NCT03594110|465089385|FG001|Interventional Part|Contraindicated drug started|18|||
129222169|NCT03184870|465116022|FG006|Initial Treatment|Moved to crossover treatment|0|||
128878069|NCT00484289|463848355|FG000|Post Marketing Phase|Adverse Event|0|||
128999455|NCT02124746|464289892|FG000|Overall Study|Study Terminated by Sponsor|0|||
128999456|NCT02124746|464289893|FG001|Overall Study|Study Terminated by Sponsor|0|||
128999457|NCT02124746|464289894|FG002|Overall Study|Study Terminated by Sponsor|6|||
128999458|NCT02124746|464289892|FG000|Overall Study|Disease Progression|3|||
128999459|NCT02124746|464289893|FG001|Overall Study|Disease Progression|6|||
128999460|NCT02124746|464289894|FG002|Overall Study|Disease Progression|4|||
128999461|NCT00571922|464289895|FG000|Overall Study|Completion unknown|36|||
128999462|NCT00571922|464289896|FG001|Overall Study|Completion unknown|36|||
128999463|NCT02191579|464289904|FG000|Treatment 1|Multiple Reasons Specified|27|||
128999464|NCT02191579|464289905|FG001|Treatment 1|Multiple Reasons Specified|58|||
128999465|NCT02191579|464289904|FG000|Treatment 2|Multiple Reasons Specified|0|||
128999466|NCT02191579|464289905|FG001|Treatment 2|Multiple Reasons Specified|25|||
128999467|NCT03940586|464289912|FG000|Overall Study|Death|3|||
129214910|NCT03594110|465089384|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
129214911|NCT03594110|465089385|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
129214912|NCT03594110|465089384|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
129214913|NCT03594110|465089385|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
129214914|NCT03594110|465089384|FG000|Non-interventional Part|Withdrawal by Subject|3|||
129214915|NCT03594110|465089385|FG001|Non-interventional Part|Withdrawal by Subject|4|||
129214916|NCT03594110|465089384|FG000|Non-interventional Part|Lost to Follow-up|45|||
129214917|NCT03594110|465089385|FG001|Non-interventional Part|Lost to Follow-up|41|||
129214918|NCT05029362|465089386|FG000|Overall Study|Lost to Follow-up|9|||
129214919|NCT00684021|465089392|FG000|Overall Study|MRI Contraindicated|1|||
129214920|NCT00684021|465089393|FG001|Overall Study|MRI Contraindicated|1|||
129214921|NCT00684021|465089394|FG002|Overall Study|MRI Contraindicated|1|||
129214922|NCT00684021|465089395|FG003|Overall Study|MRI Contraindicated|0|||
129214923|NCT00684021|465089392|FG000|Overall Study|MRI not performed|0|||
129214924|NCT00684021|465089393|FG001|Overall Study|MRI not performed|1|||
129214925|NCT00684021|465089394|FG002|Overall Study|MRI not performed|1|||
129214926|NCT00684021|465089395|FG003|Overall Study|MRI not performed|2|||
129214927|NCT00684021|465089392|FG000|Overall Study|Death|1|||
129214928|NCT00684021|465089393|FG001|Overall Study|Death|0|||
129214929|NCT00684021|465089394|FG002|Overall Study|Death|0|||
129214930|NCT00684021|465089395|FG003|Overall Study|Death|0|||
129214931|NCT04041414|465089396|FG000|Overall Study|Lost to Follow-up|1|||
129214932|NCT04041414|465089397|FG001|Overall Study|Lost to Follow-up|2|||
129214933|NCT01690143|465089400|FG000|Overall Study|Withdrawal by Subject|1|||
129214934|NCT00198822|465089408|FG000|Overall Study|Lost to Follow-up|14|||
129214935|NCT00198822|465089409|FG001|Overall Study|Lost to Follow-up|20|||
129214936|NCT00198822|465089410|FG002|Overall Study|Lost to Follow-up|21|||
129214937|NCT02420821|465089416|FG000|Overall Study|Lost to Follow-up|6|||
129214938|NCT02420821|465089417|FG001|Overall Study|Lost to Follow-up|6|||
129214939|NCT02420821|465089416|FG000|Overall Study|Non-compliance|0|||
129214940|NCT02420821|465089417|FG001|Overall Study|Non-compliance|2|||
129214941|NCT02420821|465089416|FG000|Overall Study|Physician Decision|6|||
129214942|NCT02420821|465089417|FG001|Overall Study|Physician Decision|2|||
129214943|NCT02420821|465089416|FG000|Overall Study|Withdrawal by Subject|32|||
129214944|NCT02420821|465089417|FG001|Overall Study|Withdrawal by Subject|25|||
129214945|NCT02420821|465089416|FG000|Overall Study|Death|270|||
129214946|NCT02420821|465089417|FG001|Overall Study|Death|263|||
129214947|NCT02420821|465089416|FG000|Overall Study|Study Terminated By Sponsor|145|||
129214948|NCT02420821|465089417|FG001|Overall Study|Study Terminated By Sponsor|149|||
129214949|NCT02420821|465089416|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
129214950|NCT02420821|465089417|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
129214951|NCT02420821|465089416|FG000|Overall Study|Adverse Event|0|||
129214952|NCT02420821|465089417|FG001|Overall Study|Adverse Event|1|||
129214953|NCT02420821|465089416|FG000|Overall Study|Protinuria|0|||
129214954|NCT02420821|465089417|FG001|Overall Study|Protinuria|1|||
129214955|NCT02420821|465089416|FG000|Overall Study|Progressive Disease|1|||
129214956|NCT02420821|465089417|FG001|Overall Study|Progressive Disease|1|||
129214957|NCT02420821|465089416|FG000|Overall Study|Disease Progression|0|||
129214958|NCT02420821|465089417|FG001|Overall Study|Disease Progression|1|||
129214959|NCT02420821|465089416|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
129214960|NCT02420821|465089417|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
129214961|NCT01409707|465089418|FG000|Overall Study|Withdrawal by Subject|5|||
129214962|NCT01409707|465089419|FG001|Overall Study|Withdrawal by Subject|17|||
129214963|NCT01409707|465089420|FG002|Overall Study|Withdrawal by Subject|16|||
129214964|NCT01658436|465089421|FG000|Overall Study|Adverse Event|6|||
129214965|NCT01658436|465089422|FG001|Overall Study|Adverse Event|5|||
129214966|NCT01658436|465089421|FG000|Overall Study|Physician Decision|1|||
129214967|NCT01658436|465089422|FG001|Overall Study|Physician Decision|0|||
129214968|NCT01658436|465089421|FG000|Overall Study|Progressive disease|12|||
128999468|NCT03940586|464289913|FG001|Overall Study|Death|2|||
129214969|NCT01658436|465089422|FG001|Overall Study|Progressive disease|4|||
129214970|NCT01658436|465089421|FG000|Overall Study|Study terminated by sponsor|0|||
129214971|NCT01658436|465089422|FG001|Overall Study|Study terminated by sponsor|1|||
129214972|NCT01658436|465089421|FG000|Overall Study|Subject/guardian decision|0|||
129214973|NCT01658436|465089422|FG001|Overall Study|Subject/guardian decision|1|||
129214974|NCT01658436|465089421|FG000|Overall Study|Death|1|||
129214975|NCT01658436|465089422|FG001|Overall Study|Death|0|||
129214976|NCT00686712|465089423|FG000|Overall Study|Protocol Violation|8|||
128999469|NCT03940586|464289914|FG002|Overall Study|Death|0|||
128999470|NCT03940586|464289912|FG000|Overall Study|Physician Decision|1|||
128999471|NCT03940586|464289913|FG001|Overall Study|Physician Decision|0|||
128999472|NCT03940586|464289914|FG002|Overall Study|Physician Decision|1|||
128999473|NCT03940586|464289912|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
128999474|NCT03940586|464289913|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
128999475|NCT03940586|464289914|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
128999476|NCT03940586|464289912|FG000|Overall Study|Not Treated|0|||
128999477|NCT03940586|464289913|FG001|Overall Study|Not Treated|2|||
128999478|NCT03940586|464289914|FG002|Overall Study|Not Treated|0|||
128999479|NCT00964223|464289915|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
128999480|NCT03077828|464289916|FG000|Treatment Cycles|Death|1|||
128999481|NCT03077828|464289916|FG000|Treatment Cycles|Withdrawal by Subject|1|||
128999482|NCT03077828|464289916|FG000|Treatment Cycles|Screen Fail|2|||
128999483|NCT03077828|464289916|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
128999484|NCT03077828|464289916|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
128999485|NCT03077828|464289916|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
128999486|NCT03077828|464289916|FG000|Follow-up|Patients still in follow-up|15|||
128999487|NCT00345683|464289920|FG000|Overall Study|Lost to Follow-up|19|||
128999488|NCT00345683|464289921|FG001|Overall Study|Lost to Follow-up|7|||
128999489|NCT00345683|464289920|FG000|Overall Study|Other|6|||
128999490|NCT00345683|464289921|FG001|Overall Study|Other|2|||
128999491|NCT04288115|464289922|FG000|Overall Study|Withdrawal by Subject|0|||
128999492|NCT04288115|464289923|FG001|Overall Study|Withdrawal by Subject|1|||
128999493|NCT04288115|464289922|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
128999494|NCT04288115|464289923|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
128999495|NCT00729365|464289925|FG000|Overall Study|Physician Decision|33|||
128999496|NCT00729365|464289926|FG001|Overall Study|Physician Decision|6|||
128999497|NCT00729365|464289927|FG002|Overall Study|Physician Decision|7|||
128999498|NCT01298596|464289930|FG000|Overall Study|Withdrawal by Subject|1|||
128999499|NCT01298596|464289931|FG001|Overall Study|Withdrawal by Subject|1|||
128999500|NCT01298596|464289930|FG000|Overall Study|Death|5|||
128999501|NCT01298596|464289931|FG001|Overall Study|Death|3|||
128999502|NCT01298596|464289930|FG000|Overall Study|Lost to Follow-up|6|||
128999503|NCT01298596|464289931|FG001|Overall Study|Lost to Follow-up|14|||
128999504|NCT01298596|464289930|FG000|Overall Study|Referred for further management|16|||
128999505|NCT01298596|464289931|FG001|Overall Study|Referred for further management|15|||
128999506|NCT04128696|464289934|FG000|Overall Study|Lost to Follow-up|3|||
128999507|NCT04128696|464289935|FG001|Overall Study|Lost to Follow-up|7|||
128999508|NCT04128696|464289934|FG000|Overall Study|Withdrawal by Subject|12|||
128999509|NCT04128696|464289935|FG001|Overall Study|Withdrawal by Subject|11|||
128999510|NCT04128696|464289934|FG000|Overall Study|Study Closed/Terminated|26|||
128999511|NCT04128696|464289935|FG001|Overall Study|Study Closed/Terminated|38|||
128999512|NCT04128696|464289934|FG000|Overall Study|Physician Decision|2|||
128999513|NCT04128696|464289935|FG001|Overall Study|Physician Decision|3|||
128999514|NCT00585039|464289936|FG000|Overall Study|medication spilled|2|||
128999515|NCT00585039|464289937|FG001|Overall Study|medication spilled|0|||
128999516|NCT01010230|464289938|FG000|Overall Study|Withdrawal by Subject|6|||
128999517|NCT01010230|464289939|FG001|Overall Study|Withdrawal by Subject|5|||
128999518|NCT01010230|464289938|FG000|Overall Study|Lost to Follow-up|4|||
128999519|NCT01010230|464289939|FG001|Overall Study|Lost to Follow-up|2|||
128999520|NCT01585831|464289946|FG000|Overall Study|Physician Decision|0|||
128999521|NCT01585831|464289947|FG001|Overall Study|Physician Decision|1|||
128999522|NCT01585831|464289946|FG000|Overall Study|Withdrawal by Subject|2|||
128999523|NCT01585831|464289947|FG001|Overall Study|Withdrawal by Subject|1|||
128999524|NCT02046369|464289948|FG000|Overall Study|Adverse Event|3|||
128999525|NCT02046369|464289949|FG001|Overall Study|Adverse Event|3|||
128999526|NCT02046369|464289948|FG000|Overall Study|Lack of Efficacy|3|||
128999527|NCT02046369|464289949|FG001|Overall Study|Lack of Efficacy|3|||
128999528|NCT02046369|464289948|FG000|Overall Study|Lost to Follow-up|3|||
128999529|NCT02046369|464289949|FG001|Overall Study|Lost to Follow-up|3|||
128999530|NCT02046369|464289948|FG000|Overall Study|Protocol Violation|1|||
128999531|NCT02046369|464289949|FG001|Overall Study|Protocol Violation|2|||
128999532|NCT02046369|464289948|FG000|Overall Study|Withdrawal by Subject|3|||
128999533|NCT02046369|464289949|FG001|Overall Study|Withdrawal by Subject|6|||
128999534|NCT02046369|464289948|FG000|Overall Study|never received study drug|0|||
128999535|NCT02046369|464289949|FG001|Overall Study|never received study drug|1|||
128999536|NCT02046369|464289948|FG000|Overall Study|non compliance|1|||
128999537|NCT02046369|464289949|FG001|Overall Study|non compliance|0|||
128999538|NCT03120520|464289950|FG000|Overall Study|Lost to Follow-up|1|||
128999539|NCT03120520|464289951|FG001|Overall Study|Lost to Follow-up|1|||
128999540|NCT03120520|464289952|FG002|Overall Study|Lost to Follow-up|1|||
128999541|NCT03120520|464289953|FG003|Overall Study|Lost to Follow-up|1|||
128999542|NCT03120520|464289950|FG000|Overall Study|Withdrawal by Subject|3|||
128999543|NCT03120520|464289951|FG001|Overall Study|Withdrawal by Subject|2|||
128999544|NCT03120520|464289952|FG002|Overall Study|Withdrawal by Subject|3|||
128999545|NCT03120520|464289953|FG003|Overall Study|Withdrawal by Subject|2|||
128999546|NCT03120520|464289950|FG000|Overall Study|Other|0|||
128999547|NCT03120520|464289951|FG001|Overall Study|Other|1|||
128999548|NCT03120520|464289952|FG002|Overall Study|Other|0|||
128999549|NCT03120520|464289953|FG003|Overall Study|Other|0|||
128999550|NCT02133352|464289957|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
128999551|NCT00579254|464289958|FG000|Overall Study|Lost to Follow-up|39|||
128999552|NCT00579254|464289958|FG000|Overall Study|Discontinued when study terminated|73|||
128999553|NCT02557672|464289959|FG000|Overall Study|Withdrawal by Subject|4|||
128999554|NCT02557672|464289960|FG001|Overall Study|Withdrawal by Subject|2|||
128999555|NCT03705169|464289961|FG000|Overall Study|Lost to Follow-up|0|||
128999556|NCT03705169|464289962|FG001|Overall Study|Lost to Follow-up|0|||
128999557|NCT03705169|464289963|FG002|Overall Study|Lost to Follow-up|0|||
128999558|NCT03705169|464289964|FG003|Overall Study|Lost to Follow-up|2|||
128999559|NCT03705169|464289965|FG004|Overall Study|Lost to Follow-up|0|||
128999560|NCT03705169|464289966|FG005|Overall Study|Lost to Follow-up|2|||
128999561|NCT03705169|464289967|FG006|Overall Study|Lost to Follow-up|1|||
128999562|NCT03705169|464289968|FG007|Overall Study|Lost to Follow-up|0|||
128999563|NCT03705169|464289969|FG008|Overall Study|Lost to Follow-up|0|||
128999564|NCT03705169|464289970|FG009|Overall Study|Lost to Follow-up|1|||
128999565|NCT03705169|464289961|FG000|Overall Study|Adverse Event|0|||
128999566|NCT03705169|464289962|FG001|Overall Study|Adverse Event|0|||
128999567|NCT03705169|464289963|FG002|Overall Study|Adverse Event|0|||
128999568|NCT03705169|464289964|FG003|Overall Study|Adverse Event|1|||
128999569|NCT03705169|464289965|FG004|Overall Study|Adverse Event|0|||
128999570|NCT03705169|464289966|FG005|Overall Study|Adverse Event|0|||
128999571|NCT03705169|464289967|FG006|Overall Study|Adverse Event|0|||
128999572|NCT03705169|464289968|FG007|Overall Study|Adverse Event|0|||
128999573|NCT03705169|464289969|FG008|Overall Study|Adverse Event|0|||
128999574|NCT03705169|464289970|FG009|Overall Study|Adverse Event|0|||
128999575|NCT03705169|464289961|FG000|Overall Study|Site Closure|0|||
128999576|NCT03705169|464289962|FG001|Overall Study|Site Closure|0|||
128999577|NCT03705169|464289963|FG002|Overall Study|Site Closure|0|||
128999578|NCT03705169|464289964|FG003|Overall Study|Site Closure|1|||
128999579|NCT03705169|464289965|FG004|Overall Study|Site Closure|0|||
128999580|NCT03705169|464289966|FG005|Overall Study|Site Closure|0|||
128999581|NCT03705169|464289967|FG006|Overall Study|Site Closure|0|||
128999582|NCT03705169|464289968|FG007|Overall Study|Site Closure|0|||
128999583|NCT03705169|464289969|FG008|Overall Study|Site Closure|0|||
128999584|NCT03705169|464289970|FG009|Overall Study|Site Closure|0|||
128999585|NCT03705169|464289961|FG000|Overall Study|Did not receive study treatment|0|||
128999586|NCT03705169|464289962|FG001|Overall Study|Did not receive study treatment|0|||
128999587|NCT03705169|464289963|FG002|Overall Study|Did not receive study treatment|0|||
128999588|NCT03705169|464289964|FG003|Overall Study|Did not receive study treatment|1|||
128999589|NCT03705169|464289965|FG004|Overall Study|Did not receive study treatment|0|||
128999590|NCT03705169|464289966|FG005|Overall Study|Did not receive study treatment|0|||
128999591|NCT03705169|464289967|FG006|Overall Study|Did not receive study treatment|0|||
128999592|NCT03705169|464289968|FG007|Overall Study|Did not receive study treatment|0|||
128999593|NCT03705169|464289969|FG008|Overall Study|Did not receive study treatment|0|||
128999594|NCT03705169|464289970|FG009|Overall Study|Did not receive study treatment|0|||
128999595|NCT03705169|464289961|FG000|Overall Study|Concerns about study visit compliance|0|||
128999596|NCT03705169|464289962|FG001|Overall Study|Concerns about study visit compliance|0|||
128999597|NCT03705169|464289963|FG002|Overall Study|Concerns about study visit compliance|0|||
128999598|NCT03705169|464289964|FG003|Overall Study|Concerns about study visit compliance|1|||
128999599|NCT03705169|464289965|FG004|Overall Study|Concerns about study visit compliance|0|||
128999600|NCT03705169|464289966|FG005|Overall Study|Concerns about study visit compliance|0|||
128999601|NCT03705169|464289967|FG006|Overall Study|Concerns about study visit compliance|0|||
128999602|NCT03705169|464289968|FG007|Overall Study|Concerns about study visit compliance|0|||
128999603|NCT03705169|464289969|FG008|Overall Study|Concerns about study visit compliance|0|||
128999604|NCT03705169|464289970|FG009|Overall Study|Concerns about study visit compliance|0|||
128999605|NCT00420290|464289971|FG000|Overall Study|Adverse Event|3|||
128999606|NCT00420290|464289972|FG001|Overall Study|Adverse Event|1|||
128999607|NCT00420290|464289971|FG000|Overall Study|Withdrawal by Subject|0|||
128999608|NCT00420290|464289972|FG001|Overall Study|Withdrawal by Subject|2|||
128999609|NCT00420290|464289971|FG000|Overall Study|did not meet inclusion/exclusion|1|||
128999610|NCT00420290|464289972|FG001|Overall Study|did not meet inclusion/exclusion|1|||
128999611|NCT01663714|464291895|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
128999612|NCT01663714|464291895|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
128999613|NCT01663714|464291895|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
128999614|NCT01663714|464291895|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
128999615|NCT01663714|464291895|FG000|Long-Term Follow-Up|Death|4|||
128999616|NCT01663714|464291895|FG000|Long-Term Follow-Up|Non-compliance|1|||
128999617|NCT00597584|464291896|FG000|Overall Study|Adverse Event|4|||
128999618|NCT00597584|464291897|FG001|Overall Study|Adverse Event|2|||
128999619|NCT00597584|464291896|FG000|Overall Study|Death|53|||
128999620|NCT00597584|464291897|FG001|Overall Study|Death|30|||
128999621|NCT00597584|464291896|FG000|Overall Study|Lack of Efficacy|1|||
128999622|NCT00597584|464291897|FG001|Overall Study|Lack of Efficacy|0|||
128999623|NCT00597584|464291896|FG000|Overall Study|Lost to Follow-up|2|||
128999624|NCT00597584|464291897|FG001|Overall Study|Lost to Follow-up|4|||
128999625|NCT00597584|464291896|FG000|Overall Study|Physician Decision|3|||
128999626|NCT00597584|464291897|FG001|Overall Study|Physician Decision|0|||
128999627|NCT00597584|464291896|FG000|Overall Study|Pregnancy|2|||
128999628|NCT00597584|464291897|FG001|Overall Study|Pregnancy|0|||
128999629|NCT00597584|464291896|FG000|Overall Study|Withdrawal by Subject|44|||
128999630|NCT00597584|464291897|FG001|Overall Study|Withdrawal by Subject|12|||
128999631|NCT00597584|464291896|FG000|Overall Study|Discontinued Dialysis|0|||
128999632|NCT00597584|464291897|FG001|Overall Study|Discontinued Dialysis|1|||
128999633|NCT00597584|464291896|FG000|Overall Study|Lost ability to consent|1|||
128999634|NCT00597584|464291897|FG001|Overall Study|Lost ability to consent|1|||
128999635|NCT00597584|464291896|FG000|Overall Study|Never dosed|1|||
128999636|NCT00597584|464291897|FG001|Overall Study|Never dosed|0|||
128999637|NCT00597584|464291896|FG000|Overall Study|Relocation|8|||
128999638|NCT00597584|464291897|FG001|Overall Study|Relocation|6|||
128999639|NCT00597584|464291896|FG000|Overall Study|Renal transplant|9|||
128999640|NCT00597584|464291897|FG001|Overall Study|Renal transplant|7|||
128999641|NCT03549130|464291898|FG000|Overall Study|Adverse Event|0|||
128999642|NCT03549130|464291899|FG001|Overall Study|Adverse Event|1|||
128999643|NCT03549130|464291898|FG000|Overall Study|Lost to Follow-up|0|||
128999644|NCT03549130|464291899|FG001|Overall Study|Lost to Follow-up|1|||
128999645|NCT04356573|464291900|FG000|Overall Study|Didn't Qualify|1|||
128999646|NCT04356573|464291901|FG001|Overall Study|Didn't Qualify|0|||
128999647|NCT03568500|464291902|FG000|Overall Study|Lost to Follow-up|1|||
128999648|NCT03568500|464291903|FG001|Overall Study|Lost to Follow-up|1|||
128999649|NCT03568500|464291904|FG002|Overall Study|Lost to Follow-up|2|||
128999650|NCT03568500|464291902|FG000|Overall Study|Adverse Event|1|||
128999651|NCT03568500|464291903|FG001|Overall Study|Adverse Event|1|||
128999652|NCT03568500|464291904|FG002|Overall Study|Adverse Event|2|||
128999653|NCT03568500|464291902|FG000|Overall Study|Physician Decision|1|||
128999654|NCT03568500|464291903|FG001|Overall Study|Physician Decision|0|||
128999655|NCT03568500|464291904|FG002|Overall Study|Physician Decision|0|||
128999656|NCT03568500|464291902|FG000|Overall Study|Withdrawal by Subject|4|||
128999657|NCT03568500|464291903|FG001|Overall Study|Withdrawal by Subject|2|||
128999658|NCT03568500|464291904|FG002|Overall Study|Withdrawal by Subject|0|||
128999659|NCT03568500|464291902|FG000|Overall Study|Technical Problems|2|||
128999660|NCT03568500|464291903|FG001|Overall Study|Technical Problems|1|||
128999661|NCT03568500|464291904|FG002|Overall Study|Technical Problems|0|||
128999662|NCT03568500|464291902|FG000|Overall Study|Participant Noncompliance|1|||
128999663|NCT03568500|464291903|FG001|Overall Study|Participant Noncompliance|1|||
128999664|NCT03568500|464291904|FG002|Overall Study|Participant Noncompliance|0|||
128999665|NCT04132232|464291912|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
128999666|NCT04132232|464291913|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
128999667|NCT04132232|464291912|FG000|Overall Study|Lost to Follow-up|6|||
128999668|NCT04132232|464291913|FG001|Overall Study|Lost to Follow-up|7|||
128999669|NCT00368537|464291914|FG000|Randomization|No study drug dosed|13|||
128999670|NCT00368537|464291915|FG001|Randomization|No study drug dosed|6|||
128999671|NCT00368537|464291914|FG000|Baseline Participants|Lost to Follow-up|16|||
128999672|NCT00368537|464291915|FG001|Baseline Participants|Lost to Follow-up|17|||
128999673|NCT00368537|464291914|FG000|Baseline Participants|Withdrawal by Subject|6|||
128999674|NCT00368537|464291915|FG001|Baseline Participants|Withdrawal by Subject|4|||
128999675|NCT00368537|464291914|FG000|Baseline Participants|Death|1|||
128999676|NCT00368537|464291915|FG001|Baseline Participants|Death|2|||
128999677|NCT00368537|464291914|FG000|Baseline Participants|No susceptibility|1|||
128999678|NCT00368537|464291915|FG001|Baseline Participants|No susceptibility|0|||
128999679|NCT00368537|464291914|FG000|Baseline Participants|Patient uncompliant|0|||
128999680|NCT00368537|464291915|FG001|Baseline Participants|Patient uncompliant|1|||
128999681|NCT01368276|464291925|FG000|Overall Study|Death|1|||
128999682|NCT01368276|464291926|FG001|Overall Study|Death|10|||
128999683|NCT02008721|464291927|FG000|Overall Study|Withdrawal by Subject|5|||
128999684|NCT02008721|464291928|FG001|Overall Study|Withdrawal by Subject|1|||
128999685|NCT02008721|464291927|FG000|Overall Study|Death|4|||
128999686|NCT02008721|464291928|FG001|Overall Study|Death|2|||
128999687|NCT02008721|464291927|FG000|Overall Study|Adverse Event|3|||
128999688|NCT02008721|464291928|FG001|Overall Study|Adverse Event|5|||
128999689|NCT02008721|464291927|FG000|Overall Study|Protocol Violation|3|||
128999690|NCT02008721|464291928|FG001|Overall Study|Protocol Violation|2|||
128999691|NCT00267007|464291929|FG000|Overall Study|Withdrawal by Subject|6|||
128999692|NCT00267007|464291930|FG001|Overall Study|Withdrawal by Subject|0|||
128999693|NCT00267007|464291929|FG000|Overall Study|Lost to Follow-up|1|||
128999694|NCT00267007|464291930|FG001|Overall Study|Lost to Follow-up|0|||
128999695|NCT00267007|464291929|FG000|Overall Study|Non-compliance|0|||
128999696|NCT00267007|464291930|FG001|Overall Study|Non-compliance|1|||
128999697|NCT00267007|464291929|FG000|Overall Study|Adverse Event|1|||
128999698|NCT00267007|464291930|FG001|Overall Study|Adverse Event|0|||
128999699|NCT01825876|464291934|FG000|Period 2|Withdrawal by Subject|0|||
128999700|NCT01825876|464291935|FG001|Period 2|Withdrawal by Subject|1|||
128999701|NCT03751020|464291938|FG000|Overall Study|Withdrawal by Subject|2|||
128999702|NCT03751020|464291939|FG001|Overall Study|Withdrawal by Subject|0|||
128999703|NCT03751020|464291940|FG002|Overall Study|Withdrawal by Subject|0|||
128999704|NCT03751020|464291938|FG000|Overall Study|Lost to Follow-up|7|||
128999705|NCT03751020|464291939|FG001|Overall Study|Lost to Follow-up|4|||
128999706|NCT03751020|464291940|FG002|Overall Study|Lost to Follow-up|10|||
128999707|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
128999708|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
128999709|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
128999710|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
128999711|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
128999712|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
128999713|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
128999714|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
128999715|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
128999716|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
128999717|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
128999718|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
128999719|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
128999720|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
128999721|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
128999722|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
128999723|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
128999724|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
128999725|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
128999726|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
128999727|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
128999728|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
128999729|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
128999730|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
128999731|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
128999732|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
128999733|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
128999734|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
128999735|NCT00528879|464291941|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
128999736|NCT00528879|464291942|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
128999737|NCT00528879|464291943|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
128999738|NCT00528879|464291944|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
128999739|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
128999740|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
128999741|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
128999742|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
128999743|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
128999744|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
128999745|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
128999746|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
128999747|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
128999748|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
128999749|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
128999750|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
128999751|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
128999752|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
128999753|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
128999754|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
128999755|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
128999756|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
128999757|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
128999758|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
128999759|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
128999760|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
128999761|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
128999762|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
128999763|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
128999764|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
128999765|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
128999766|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
128999767|NCT00528879|464291941|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
128999768|NCT00528879|464291942|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
128999769|NCT00528879|464291943|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
128999770|NCT00528879|464291944|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
128999771|NCT00078819|464291947|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
128999772|NCT00078819|464291948|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
128999773|NCT00078819|464291949|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
128999774|NCT00078819|464291950|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
128999775|NCT00078819|464291947|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
128999776|NCT00078819|464291948|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
128999777|NCT00078819|464291949|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
128999778|NCT00078819|464291950|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
128999779|NCT00078819|464291947|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
128999780|NCT00078819|464291948|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
129214977|NCT00686712|465089424|FG001|Overall Study|Protocol Violation|8|||
128999781|NCT00078819|464291949|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
128999782|NCT00078819|464291950|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
128999783|NCT00078819|464291947|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
128999784|NCT00078819|464291948|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
128999785|NCT00078819|464291949|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
128999786|NCT00078819|464291950|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
128999787|NCT00078819|464291947|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
128999788|NCT00078819|464291948|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
128999789|NCT00078819|464291949|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
128999790|NCT00078819|464291950|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
128999791|NCT00078819|464291947|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
128999792|NCT00078819|464291948|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
128999793|NCT00078819|464291949|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
128999794|NCT00078819|464291950|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
128999795|NCT00078819|464291947|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
128999796|NCT00078819|464291948|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
128999797|NCT00078819|464291949|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
128999798|NCT00078819|464291950|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
128999799|NCT00078819|464291947|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
128999800|NCT00078819|464291948|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
128999801|NCT00078819|464291949|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
128999802|NCT00078819|464291950|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
128878070|NCT00484289|463848356|FG001|Post Marketing Phase|Adverse Event|1|||
128878071|NCT00484289|463848357|FG002|Post Marketing Phase|Adverse Event|0|||
128878072|NCT02349425|463848358|FG000|Period 1|Adverse Event|1|||
128878073|NCT02349425|463848359|FG001|Period 1|Adverse Event|1|||
128999803|NCT04133519|464291951|FG000|Overall Study|Withdrawal by Subject|5|||
128878074|NCT02349425|463848360|FG002|Period 1|Adverse Event|0|||
128878075|NCT02349425|463848361|FG003|Period 1|Adverse Event|0|||
128878076|NCT02349425|463848358|FG000|Period 2|Adverse Event|0|||
128878077|NCT02349425|463848359|FG001|Period 2|Adverse Event|1|||
128999804|NCT04133519|464291952|FG001|Overall Study|Withdrawal by Subject|4|||
128999805|NCT04133519|464291951|FG000|Overall Study|Protocol Violation|0|||
128999806|NCT04133519|464291952|FG001|Overall Study|Protocol Violation|1|||
128999807|NCT04133519|464291951|FG000|Overall Study|Never started treatment|1|||
128999808|NCT04133519|464291952|FG001|Overall Study|Never started treatment|1|||
128999809|NCT00667719|464291953|FG000|Overall Study|Adverse Event|39|||
128999810|NCT00667719|464291953|FG000|Overall Study|Abnormal Test Procedure|1|||
128999811|NCT00667719|464291953|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
128999812|NCT00667719|464291953|FG000|Overall Study|Protocol Violation|3|||
128999813|NCT00667719|464291953|FG000|Overall Study|Withdrawal by Subject|17|||
128999814|NCT00667719|464291953|FG000|Overall Study|Lost to Follow-up|8|||
128999815|NCT00323609|464291954|FG000|Overall Study|Death|16|||
128999816|NCT00323609|464291955|FG001|Overall Study|Death|21|||
128999817|NCT00323609|464291956|FG002|Overall Study|Death|0|||
128999818|NCT00323609|464291957|FG003|Overall Study|Death|0|||
128999819|NCT00323609|464291954|FG000|Overall Study|Lost to Follow-up|9|||
128999820|NCT00323609|464291955|FG001|Overall Study|Lost to Follow-up|10|||
128999821|NCT00323609|464291956|FG002|Overall Study|Lost to Follow-up|0|||
128999822|NCT00323609|464291957|FG003|Overall Study|Lost to Follow-up|0|||
128999823|NCT00323609|464291954|FG000|Overall Study|Physician Decision|2|||
128999824|NCT00323609|464291955|FG001|Overall Study|Physician Decision|0|||
128999825|NCT00323609|464291956|FG002|Overall Study|Physician Decision|0|||
128999826|NCT00323609|464291957|FG003|Overall Study|Physician Decision|1|||
128999827|NCT00323609|464291954|FG000|Overall Study|Withdrawal by Subject|11|||
128999828|NCT00323609|464291955|FG001|Overall Study|Withdrawal by Subject|23|||
128999829|NCT00323609|464291956|FG002|Overall Study|Withdrawal by Subject|4|||
128999830|NCT00323609|464291957|FG003|Overall Study|Withdrawal by Subject|4|||
128999831|NCT00323609|464291954|FG000|Overall Study|Other non-VCF-related medical condition|3|||
128999832|NCT00323609|464291955|FG001|Overall Study|Other non-VCF-related medical condition|2|||
128999833|NCT00323609|464291956|FG002|Overall Study|Other non-VCF-related medical condition|0|||
128999834|NCT00323609|464291957|FG003|Overall Study|Other non-VCF-related medical condition|0|||
128999835|NCT00323609|464291954|FG000|Overall Study|Sponsor discontinued trial|29|||
128999836|NCT00323609|464291955|FG001|Overall Study|Sponsor discontinued trial|29|||
128999837|NCT00323609|464291956|FG002|Overall Study|Sponsor discontinued trial|0|||
128999838|NCT00323609|464291957|FG003|Overall Study|Sponsor discontinued trial|0|||
128999839|NCT00323609|464291954|FG000|Overall Study|Unrelenting or severe back pain|1|||
128999840|NCT00323609|464291955|FG001|Overall Study|Unrelenting or severe back pain|1|||
128999841|NCT00323609|464291956|FG002|Overall Study|Unrelenting or severe back pain|0|||
128999842|NCT00323609|464291957|FG003|Overall Study|Unrelenting or severe back pain|0|||
128999843|NCT00323609|464291954|FG000|Overall Study|Logistical withdrawal|9|||
128999844|NCT00323609|464291955|FG001|Overall Study|Logistical withdrawal|5|||
128999845|NCT00323609|464291956|FG002|Overall Study|Logistical withdrawal|0|||
128999846|NCT00323609|464291957|FG003|Overall Study|Logistical withdrawal|1|||
128999847|NCT00323609|464291954|FG000|Overall Study|Other reason|11|||
128999848|NCT00323609|464291955|FG001|Overall Study|Other reason|8|||
128999849|NCT00323609|464291956|FG002|Overall Study|Other reason|4|||
128999850|NCT00323609|464291957|FG003|Overall Study|Other reason|9|||
128999851|NCT02217345|464291961|FG000|Overall Study|Lost to Follow-up|2|||
128999852|NCT02217345|464291962|FG001|Overall Study|Lost to Follow-up|1|||
128999853|NCT02217345|464291961|FG000|Overall Study|Withdrawal by Subject|3|||
128999854|NCT02217345|464291962|FG001|Overall Study|Withdrawal by Subject|2|||
128999855|NCT02217345|464291961|FG000|Overall Study|Adverse Event|2|||
128999856|NCT02217345|464291962|FG001|Overall Study|Adverse Event|1|||
128999857|NCT02217345|464291961|FG000|Overall Study|Physician Decision|0|||
128999858|NCT02217345|464291962|FG001|Overall Study|Physician Decision|1|||
128999859|NCT00950599|464291963|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
128999860|NCT00950599|464291964|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
128999861|NCT00950599|464291965|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
128999862|NCT00950599|464291966|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
128999863|NCT00950599|464291967|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
128999864|NCT00950599|464291968|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
128999865|NCT00950599|464291969|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129214978|NCT00686712|465089425|FG002|Overall Study|Protocol Violation|10|||
129214979|NCT00686712|465089423|FG000|Overall Study|Lost to Follow-up|1|||
129214980|NCT00686712|465089424|FG001|Overall Study|Lost to Follow-up|2|||
128999866|NCT00950599|464291970|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129214981|NCT00686712|465089425|FG002|Overall Study|Lost to Follow-up|3|||
128999867|NCT00950599|464291971|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
128999868|NCT00950599|464291972|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
128999869|NCT00950599|464291963|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128999870|NCT00950599|464291964|FG001|Double-Blind Treatment Period|Adverse Event|1|||
128999871|NCT00950599|464291965|FG002|Double-Blind Treatment Period|Adverse Event|1|||
128999872|NCT00950599|464291966|FG003|Double-Blind Treatment Period|Adverse Event|1|||
128999873|NCT00950599|464291967|FG004|Double-Blind Treatment Period|Adverse Event|1|||
128999874|NCT00950599|464291968|FG005|Double-Blind Treatment Period|Adverse Event|1|||
128999875|NCT00950599|464291969|FG006|Double-Blind Treatment Period|Adverse Event|0|||
128999876|NCT00950599|464291970|FG007|Double-Blind Treatment Period|Adverse Event|0|||
128999877|NCT00950599|464291971|FG008|Double-Blind Treatment Period|Adverse Event|0|||
128999878|NCT00950599|464291972|FG009|Double-Blind Treatment Period|Adverse Event|0|||
128999879|NCT00950599|464291963|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
128999880|NCT00950599|464291964|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
128999881|NCT00950599|464291965|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
128999882|NCT00950599|464291966|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
128999883|NCT00950599|464291967|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
129214982|NCT00686712|465089423|FG000|Overall Study|Adverse Event|1|||
128999884|NCT00950599|464291968|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
128999885|NCT00950599|464291969|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
128999886|NCT00950599|464291970|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
128999887|NCT00950599|464291971|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
128999888|NCT00950599|464291972|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
128999889|NCT00950599|464291963|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128999890|NCT00950599|464291964|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
128999891|NCT00950599|464291965|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
128999892|NCT00950599|464291966|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
128999893|NCT00950599|464291967|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
128999894|NCT00950599|464291968|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
128999895|NCT00950599|464291969|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
128999896|NCT00950599|464291970|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
128999897|NCT00950599|464291971|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
128999898|NCT00950599|464291972|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
128999899|NCT00950599|464291963|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
128999900|NCT00950599|464291964|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
128999901|NCT00950599|464291965|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
128999902|NCT00950599|464291966|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
128999903|NCT00950599|464291967|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
128999904|NCT00950599|464291968|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
128999905|NCT00950599|464291969|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
128999906|NCT00950599|464291970|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
128999907|NCT00950599|464291971|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
128999908|NCT00950599|464291972|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
128999909|NCT00950599|464291963|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999910|NCT00950599|464291964|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999911|NCT00950599|464291965|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999912|NCT00950599|464291966|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999913|NCT00950599|464291967|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
128999914|NCT00950599|464291968|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
128999915|NCT00950599|464291969|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999916|NCT00950599|464291970|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999917|NCT00950599|464291971|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999918|NCT00950599|464291972|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
128999919|NCT00950599|464291963|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
128999920|NCT00950599|464291964|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
128999921|NCT00950599|464291965|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
128999922|NCT00950599|464291966|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
128999923|NCT00950599|464291967|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
128999924|NCT00950599|464291968|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
128999925|NCT00950599|464291969|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
128999926|NCT00950599|464291970|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
128999927|NCT00950599|464291971|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
128999928|NCT00950599|464291972|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
128999929|NCT00950599|464291963|FG000|Follow-Up Period|Adverse Event|0|||
128999930|NCT00950599|464291964|FG001|Follow-Up Period|Adverse Event|0|||
128999931|NCT00950599|464291965|FG002|Follow-Up Period|Adverse Event|0|||
128999932|NCT00950599|464291966|FG003|Follow-Up Period|Adverse Event|0|||
128999933|NCT00950599|464291967|FG004|Follow-Up Period|Adverse Event|0|||
128999934|NCT00950599|464291968|FG005|Follow-Up Period|Adverse Event|0|||
128999935|NCT00950599|464291969|FG006|Follow-Up Period|Adverse Event|0|||
128999936|NCT00950599|464291970|FG007|Follow-Up Period|Adverse Event|0|||
128999937|NCT00950599|464291971|FG008|Follow-Up Period|Adverse Event|1|||
128999938|NCT00950599|464291972|FG009|Follow-Up Period|Adverse Event|0|||
128999939|NCT00950599|464291963|FG000|Follow-Up Period|Lack of Efficacy|0|||
128999940|NCT00950599|464291964|FG001|Follow-Up Period|Lack of Efficacy|0|||
128999941|NCT00950599|464291965|FG002|Follow-Up Period|Lack of Efficacy|0|||
128999942|NCT00950599|464291966|FG003|Follow-Up Period|Lack of Efficacy|0|||
128999943|NCT00950599|464291967|FG004|Follow-Up Period|Lack of Efficacy|0|||
128999944|NCT00950599|464291968|FG005|Follow-Up Period|Lack of Efficacy|0|||
128999945|NCT00950599|464291969|FG006|Follow-Up Period|Lack of Efficacy|0|||
128999946|NCT00950599|464291970|FG007|Follow-Up Period|Lack of Efficacy|0|||
128999947|NCT00950599|464291971|FG008|Follow-Up Period|Lack of Efficacy|3|||
128999948|NCT00950599|464291972|FG009|Follow-Up Period|Lack of Efficacy|0|||
128999949|NCT00950599|464291963|FG000|Follow-Up Period|Lost to Follow-up|0|||
128999950|NCT00950599|464291964|FG001|Follow-Up Period|Lost to Follow-up|0|||
128999951|NCT00950599|464291965|FG002|Follow-Up Period|Lost to Follow-up|0|||
128999952|NCT00950599|464291966|FG003|Follow-Up Period|Lost to Follow-up|0|||
128999953|NCT00950599|464291967|FG004|Follow-Up Period|Lost to Follow-up|0|||
128999954|NCT00950599|464291968|FG005|Follow-Up Period|Lost to Follow-up|0|||
128999955|NCT00950599|464291969|FG006|Follow-Up Period|Lost to Follow-up|0|||
128999956|NCT00950599|464291970|FG007|Follow-Up Period|Lost to Follow-up|0|||
128999957|NCT00950599|464291971|FG008|Follow-Up Period|Lost to Follow-up|5|||
128999958|NCT00950599|464291972|FG009|Follow-Up Period|Lost to Follow-up|1|||
128999959|NCT00950599|464291963|FG000|Follow-Up Period|Physician Decision|0|||
128999960|NCT00950599|464291964|FG001|Follow-Up Period|Physician Decision|0|||
128999961|NCT00950599|464291965|FG002|Follow-Up Period|Physician Decision|0|||
128999962|NCT00950599|464291966|FG003|Follow-Up Period|Physician Decision|0|||
128999963|NCT00950599|464291967|FG004|Follow-Up Period|Physician Decision|0|||
128999964|NCT00950599|464291968|FG005|Follow-Up Period|Physician Decision|0|||
128999965|NCT00950599|464291969|FG006|Follow-Up Period|Physician Decision|0|||
128999966|NCT00950599|464291970|FG007|Follow-Up Period|Physician Decision|0|||
128999967|NCT00950599|464291971|FG008|Follow-Up Period|Physician Decision|1|||
128999968|NCT00950599|464291972|FG009|Follow-Up Period|Physician Decision|0|||
128999969|NCT00950599|464291963|FG000|Follow-Up Period|Poor/Noncompliance|0|||
128999970|NCT00950599|464291964|FG001|Follow-Up Period|Poor/Noncompliance|0|||
128999971|NCT00950599|464291965|FG002|Follow-Up Period|Poor/Noncompliance|0|||
128999972|NCT00950599|464291966|FG003|Follow-Up Period|Poor/Noncompliance|0|||
128999973|NCT00950599|464291967|FG004|Follow-Up Period|Poor/Noncompliance|0|||
128999974|NCT00950599|464291968|FG005|Follow-Up Period|Poor/Noncompliance|0|||
128999975|NCT00950599|464291969|FG006|Follow-Up Period|Poor/Noncompliance|0|||
128999976|NCT00950599|464291970|FG007|Follow-Up Period|Poor/Noncompliance|0|||
128999977|NCT00950599|464291971|FG008|Follow-Up Period|Poor/Noncompliance|1|||
128999978|NCT00950599|464291972|FG009|Follow-Up Period|Poor/Noncompliance|0|||
128999979|NCT00950599|464291963|FG000|Follow-Up Period|Subject withdrew Consent|0|||
128999980|NCT00950599|464291964|FG001|Follow-Up Period|Subject withdrew Consent|0|||
128999981|NCT00950599|464291965|FG002|Follow-Up Period|Subject withdrew Consent|0|||
128999982|NCT00950599|464291966|FG003|Follow-Up Period|Subject withdrew Consent|0|||
128999983|NCT00950599|464291967|FG004|Follow-Up Period|Subject withdrew Consent|0|||
128999984|NCT00950599|464291968|FG005|Follow-Up Period|Subject withdrew Consent|0|||
128999985|NCT00950599|464291969|FG006|Follow-Up Period|Subject withdrew Consent|0|||
128999986|NCT00950599|464291970|FG007|Follow-Up Period|Subject withdrew Consent|0|||
128999987|NCT00950599|464291971|FG008|Follow-Up Period|Subject withdrew Consent|2|||
128999988|NCT00950599|464291972|FG009|Follow-Up Period|Subject withdrew Consent|1|||
128999989|NCT00971204|464291973|FG000|Overall Study|Did not meet all criteria-not treated|14|||
128999990|NCT00971204|464291973|FG000|Overall Study|Lost to Follow-up|10|||
128999991|NCT02436135|464291974|FG000|Overall Study|Progressive Disease|3|||
128999992|NCT02436135|464291975|FG001|Overall Study|Progressive Disease|1|||
128999993|NCT02436135|464291974|FG000|Overall Study|Investigator Discretion|1|||
129214983|NCT00686712|465089424|FG001|Overall Study|Adverse Event|1|||
128878078|NCT02349425|463848360|FG002|Period 2|Adverse Event|1|||
128999994|NCT02436135|464291975|FG001|Overall Study|Investigator Discretion|2|||
128999995|NCT02436135|464291974|FG000|Overall Study|Adverse Event|1|||
128999996|NCT02436135|464291975|FG001|Overall Study|Adverse Event|0|||
128999997|NCT02436135|464291974|FG000|Overall Study|Withdrawal by Participant|1|||
128999998|NCT02436135|464291975|FG001|Overall Study|Withdrawal by Participant|0|||
128999999|NCT02436135|464291974|FG000|Overall Study|Study Terminated By Sponsor|0|||
129000000|NCT02436135|464291975|FG001|Overall Study|Study Terminated By Sponsor|1|||
129000001|NCT02729194|464291976|FG000|Overall Study|Withdrawal by Subject|3|||
129000002|NCT00475852|464291977|FG000|Overall Study|Death|444|||
129000003|NCT00475852|464291978|FG001|Overall Study|Death|456|||
129000004|NCT00475852|464291977|FG000|Overall Study|Withdrawal by Subject|19|||
129000005|NCT00475852|464291978|FG001|Overall Study|Withdrawal by Subject|24|||
129000006|NCT00475852|464291977|FG000|Overall Study|Lost to Follow-up|54|||
129000007|NCT00475852|464291978|FG001|Overall Study|Lost to Follow-up|68|||
129000008|NCT00297479|464291980|FG000|Overall Study|Lost to Follow-up|37|||
129000009|NCT00297479|464291981|FG001|Overall Study|Lost to Follow-up|54|||
129000010|NCT00297479|464291982|FG002|Overall Study|Lost to Follow-up|51|||
129000011|NCT01664494|464291985|FG000|Overall Study|Withdrawal by Subject|27|||
129000012|NCT01664494|464291985|FG000|Overall Study|Death|18|||
129000013|NCT01664494|464291985|FG000|Overall Study|Other|49|||
129000014|NCT01664494|464291985|FG000|Overall Study|Lost to Follow-up|99|||
129000015|NCT03196791|464291986|FG000|Overall Study|Protocol Violation|7|||
129000016|NCT03196791|464291987|FG001|Overall Study|Protocol Violation|3|||
129000017|NCT03196791|464291986|FG000|Overall Study|Withdrawal by Subject|3|||
129000018|NCT03196791|464291987|FG001|Overall Study|Withdrawal by Subject|2|||
129000019|NCT03063632|464291992|FG000|Overall Study|Death|4|||
129000020|NCT03063632|464291993|FG001|Overall Study|Death|6|||
129000021|NCT03063632|464291992|FG000|Overall Study|Lost to Follow-up|0|||
129000022|NCT03063632|464291993|FG001|Overall Study|Lost to Follow-up|1|||
129000023|NCT03063632|464291992|FG000|Overall Study|Withdrawal by Subject|0|||
129000024|NCT03063632|464291993|FG001|Overall Study|Withdrawal by Subject|2|||
129000025|NCT03063632|464291992|FG000|Overall Study|Physician Decision|2|||
129000026|NCT03063632|464291993|FG001|Overall Study|Physician Decision|0|||
129000027|NCT03063632|464291992|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
129000028|NCT03063632|464291993|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
129000029|NCT02570165|464291996|FG000|Overall Study|Adverse Event|1|||
129000030|NCT02570165|464291997|FG001|Overall Study|Adverse Event|0|||
129000031|NCT02570165|464291998|FG002|Overall Study|Adverse Event|2|||
129000032|NCT02570165|464291999|FG003|Overall Study|Adverse Event|0|||
129000033|NCT02570165|464292000|FG004|Overall Study|Adverse Event|0|||
129000034|NCT02570165|464292001|FG005|Overall Study|Adverse Event|0|||
129000035|NCT02570165|464292002|FG006|Overall Study|Adverse Event|0|||
129000036|NCT02570165|464291996|FG000|Overall Study|Lack of Efficacy|0|||
129000037|NCT02570165|464291997|FG001|Overall Study|Lack of Efficacy|1|||
129000038|NCT02570165|464291998|FG002|Overall Study|Lack of Efficacy|0|||
129000039|NCT02570165|464291999|FG003|Overall Study|Lack of Efficacy|0|||
129000040|NCT02570165|464292000|FG004|Overall Study|Lack of Efficacy|4|||
129000041|NCT02570165|464292001|FG005|Overall Study|Lack of Efficacy|0|||
129000042|NCT02570165|464292002|FG006|Overall Study|Lack of Efficacy|0|||
129000043|NCT02570165|464291996|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
129000044|NCT02570165|464291997|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
129000045|NCT02570165|464291998|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
129214984|NCT00686712|465089425|FG002|Overall Study|Adverse Event|0|||
129000046|NCT02570165|464291999|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
129000047|NCT02570165|464292000|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
129000048|NCT02570165|464292001|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
129000049|NCT02570165|464292002|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
129000050|NCT02570165|464291996|FG000|Overall Study|Lost to Follow-up|0|||
129000051|NCT02570165|464291997|FG001|Overall Study|Lost to Follow-up|0|||
129000052|NCT02570165|464291998|FG002|Overall Study|Lost to Follow-up|1|||
129000053|NCT02570165|464291999|FG003|Overall Study|Lost to Follow-up|1|||
129000054|NCT02570165|464292000|FG004|Overall Study|Lost to Follow-up|0|||
129000055|NCT02570165|464292001|FG005|Overall Study|Lost to Follow-up|0|||
129000056|NCT02570165|464292002|FG006|Overall Study|Lost to Follow-up|0|||
129000057|NCT02570165|464291996|FG000|Overall Study|Physician Decision|0|||
129000058|NCT02570165|464291997|FG001|Overall Study|Physician Decision|1|||
129000059|NCT02570165|464291998|FG002|Overall Study|Physician Decision|0|||
129000060|NCT02570165|464291999|FG003|Overall Study|Physician Decision|0|||
129000061|NCT02570165|464292000|FG004|Overall Study|Physician Decision|0|||
129000062|NCT02570165|464292001|FG005|Overall Study|Physician Decision|0|||
129000063|NCT02570165|464292002|FG006|Overall Study|Physician Decision|0|||
129000064|NCT02570165|464291996|FG000|Overall Study|Withdrawal by Subject|0|||
129000065|NCT02570165|464291997|FG001|Overall Study|Withdrawal by Subject|0|||
129000066|NCT02570165|464291998|FG002|Overall Study|Withdrawal by Subject|0|||
129000067|NCT02570165|464291999|FG003|Overall Study|Withdrawal by Subject|2|||
129000068|NCT02570165|464292000|FG004|Overall Study|Withdrawal by Subject|1|||
129000069|NCT02570165|464292001|FG005|Overall Study|Withdrawal by Subject|0|||
129000070|NCT02570165|464292002|FG006|Overall Study|Withdrawal by Subject|0|||
129000071|NCT02570165|464291996|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
129000072|NCT02570165|464291997|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
129000073|NCT02570165|464291998|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
129000074|NCT02570165|464291999|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
129000075|NCT02570165|464292000|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
129000076|NCT02570165|464292001|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
129000077|NCT02570165|464292002|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
129000078|NCT02570165|464291996|FG000|Overall Study|Withdrawal Request by GSK|0|||
129000079|NCT02570165|464291997|FG001|Overall Study|Withdrawal Request by GSK|0|||
129000080|NCT02570165|464291998|FG002|Overall Study|Withdrawal Request by GSK|2|||
129000081|NCT02570165|464291999|FG003|Overall Study|Withdrawal Request by GSK|0|||
129000082|NCT02570165|464292000|FG004|Overall Study|Withdrawal Request by GSK|0|||
129000083|NCT02570165|464292001|FG005|Overall Study|Withdrawal Request by GSK|0|||
129000084|NCT02570165|464292002|FG006|Overall Study|Withdrawal Request by GSK|0|||
129000085|NCT01789281|464292003|FG000|Overall Study|Disease progression|15|||
129000086|NCT01789281|464292004|FG001|Overall Study|Disease progression|4|||
129000087|NCT01789281|464292003|FG000|Overall Study|Adverse Event|5|||
129000088|NCT01789281|464292004|FG001|Overall Study|Adverse Event|5|||
129000089|NCT01789281|464292003|FG000|Overall Study|Withdrawal by Subject|1|||
129000090|NCT01789281|464292004|FG001|Overall Study|Withdrawal by Subject|0|||
129000091|NCT01789281|464292003|FG000|Overall Study|Lost to Follow-up|1|||
129000092|NCT01789281|464292004|FG001|Overall Study|Lost to Follow-up|0|||
129000093|NCT01789281|464292003|FG000|Overall Study|Administrative problems|0|||
129000094|NCT01789281|464292004|FG001|Overall Study|Administrative problems|1|||
129000095|NCT02746705|464292007|FG000|Overall Study|Physician Decision|1|||
129000096|NCT02746705|464292008|FG001|Overall Study|Physician Decision|1|||
129000097|NCT02746705|464292007|FG000|Overall Study|Lost to Follow-up|1|||
129000098|NCT02746705|464292008|FG001|Overall Study|Lost to Follow-up|0|||
129000099|NCT02746705|464292007|FG000|Overall Study|outlier scores deemed not valid|0|||
129000100|NCT02746705|464292008|FG001|Overall Study|outlier scores deemed not valid|1|||
129000101|NCT04304950|464292022|FG000|Overall Study|Lost to Follow-up|1|||
129000102|NCT04304950|464292023|FG001|Overall Study|Lost to Follow-up|1|||
129000103|NCT02418910|464292024|FG000|Overall Study|Lost to Follow-up|3|||
129000104|NCT02418910|464292024|FG000|Overall Study|Withdrawal by Subject|4|||
129000105|NCT03634488|464292026|FG000|Overall Study|Death|1|||
129000106|NCT03634488|464292027|FG001|Overall Study|Death|0|||
129000107|NCT03634488|464292028|FG002|Overall Study|Death|0|||
129000108|NCT03634488|464292026|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
129000109|NCT03634488|464292027|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
129000110|NCT03634488|464292028|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
129000111|NCT03182686|464292029|FG000|Overall Study|Lost to Follow-up|2|||
129000112|NCT03182686|464292030|FG001|Overall Study|Lost to Follow-up|0|||
129000113|NCT03182686|464292029|FG000|Overall Study|Adverse Event|2|||
129000114|NCT03182686|464292030|FG001|Overall Study|Adverse Event|0|||
129000115|NCT03182686|464292029|FG000|Overall Study|Withdrawal by Subject|3|||
129000116|NCT03182686|464292030|FG001|Overall Study|Withdrawal by Subject|0|||
129000117|NCT01154127|464292031|FG000|Period 1 (21 Days)|Adverse Event|3|||
129000118|NCT01154127|464292032|FG001|Period 1 (21 Days)|Adverse Event|4|||
129000119|NCT01154127|464292031|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
129000120|NCT01154127|464292032|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
129000121|NCT01154127|464292031|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
129000122|NCT01154127|464292032|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
129000123|NCT01154127|464292031|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
129000124|NCT01154127|464292032|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
129000125|NCT01154127|464292031|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
129000126|NCT01154127|464292032|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
129000127|NCT01697449|464292033|FG000|Overall Study|Disease progression|47|||
129000128|NCT01697449|464292033|FG000|Overall Study|Adverse Event|7|||
129000129|NCT01697449|464292033|FG000|Overall Study|Lost to Follow-up|5|||
129000130|NCT01697449|464292033|FG000|Overall Study|Withdrawal by Subject|2|||
129000131|NCT01697449|464292033|FG000|Overall Study|Physician Decision|1|||
129000132|NCT01697449|464292033|FG000|Overall Study|Death|2|||
129000133|NCT01697449|464292033|FG000|Overall Study|Other|1|||
129000134|NCT01697449|464292033|FG000|Overall Study|Missing|25|||
129000135|NCT02390219|464292034|FG000|Overall Study|Death|1|||
129000136|NCT02390219|464292034|FG000|Overall Study|Physician Decision|1|||
129000137|NCT02390219|464292034|FG000|Overall Study|Adverse Event|6|||
129000138|NCT02390219|464292034|FG000|Overall Study|Withdrawal by Subject|1|||
129000139|NCT02390219|464292034|FG000|Overall Study|Lost to Follow-up|2|||
129000140|NCT02390219|464292034|FG000|Overall Study|Other|2|||
129000141|NCT01169844|464292035|FG000|Overall Study|Adverse Event|0|||
129000142|NCT01169844|464292036|FG001|Overall Study|Adverse Event|1|||
129000143|NCT01169844|464292035|FG000|Overall Study|Patient withdrew consent|4|||
129000144|NCT01169844|464292036|FG001|Overall Study|Patient withdrew consent|0|||
129000145|NCT01169844|464292035|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129000146|NCT01169844|464292036|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129000147|NCT05037409|464292037|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
129000148|NCT05037409|464292038|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
129000149|NCT05037409|464292039|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
129000150|NCT00529568|464292040|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
129000151|NCT00529568|464292041|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
129000152|NCT00529568|464292042|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
129000153|NCT00529568|464292040|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
129000154|NCT00529568|464292041|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
129000155|NCT00529568|464292042|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
129000156|NCT00529568|464292040|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
129000157|NCT00529568|464292041|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
129000158|NCT00529568|464292042|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
129000159|NCT00529568|464292040|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
129000160|NCT00529568|464292041|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
129000161|NCT00529568|464292042|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
129000162|NCT00529568|464292040|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
129000163|NCT00529568|464292041|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
129214985|NCT03987503|465089426|FG000|Overall Study|Lost to Follow-up|20|||
129000164|NCT00529568|464292042|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
129000165|NCT00529568|464292040|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
129000166|NCT00529568|464292041|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
129000167|NCT00529568|464292042|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
129000168|NCT00529568|464292040|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
129000169|NCT00529568|464292041|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
129000170|NCT00529568|464292042|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
129000171|NCT00529568|464292040|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
129000172|NCT00529568|464292041|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
129000173|NCT00529568|464292042|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
129000174|NCT00529568|464292040|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
129000175|NCT00529568|464292041|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
129000176|NCT00529568|464292042|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
129000177|NCT00529568|464292040|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
129000178|NCT00529568|464292041|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
129000179|NCT00529568|464292042|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
129000180|NCT00529568|464292040|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
129000181|NCT00529568|464292041|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
129000182|NCT00529568|464292042|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
129000183|NCT01201356|464292043|FG000|Overall Study|Adverse Event|170|||
129000184|NCT01201356|464292043|FG000|Overall Study|Abnormal laboratory value(s)|51|||
129000185|NCT01201356|464292043|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129000186|NCT01201356|464292043|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
129000187|NCT01201356|464292043|FG000|Overall Study|Condition no longer requires study drug|12|||
129000188|NCT01201356|464292043|FG000|Overall Study|Withdrawal by Subject|144|||
129000189|NCT01201356|464292043|FG000|Overall Study|Lost to Follow-up|50|||
129000190|NCT01201356|464292043|FG000|Overall Study|administrative problems|74|||
129000191|NCT01201356|464292043|FG000|Overall Study|Death|16|||
129000192|NCT01201356|464292043|FG000|Overall Study|Protocol Violation|12|||
129000193|NCT00931385|464292044|FG000|Overall Study|Adverse Event|2|||
129000194|NCT00931385|464292045|FG001|Overall Study|Adverse Event|1|||
129000195|NCT00931385|464292046|FG002|Overall Study|Adverse Event|0|||
129000196|NCT00931385|464292047|FG003|Overall Study|Adverse Event|3|||
129000197|NCT00931385|464292044|FG000|Overall Study|Protocol Violation|0|||
129000198|NCT00931385|464292045|FG001|Overall Study|Protocol Violation|0|||
129000199|NCT00931385|464292046|FG002|Overall Study|Protocol Violation|1|||
129000200|NCT00931385|464292047|FG003|Overall Study|Protocol Violation|0|||
129000201|NCT00931385|464292044|FG000|Overall Study|Withdrawal by Subject|0|||
129000202|NCT00931385|464292045|FG001|Overall Study|Withdrawal by Subject|1|||
129000203|NCT00931385|464292046|FG002|Overall Study|Withdrawal by Subject|0|||
129000204|NCT00931385|464292047|FG003|Overall Study|Withdrawal by Subject|1|||
129000205|NCT00931385|464292044|FG000|Overall Study|Lost to Follow-up|0|||
129000206|NCT00931385|464292045|FG001|Overall Study|Lost to Follow-up|0|||
129000207|NCT00931385|464292046|FG002|Overall Study|Lost to Follow-up|0|||
129000208|NCT00931385|464292047|FG003|Overall Study|Lost to Follow-up|1|||
129000209|NCT00811070|464292049|FG000|Overall Study|Death|0|||
129000210|NCT00811070|464292050|FG001|Overall Study|Death|0|||
129000211|NCT00811070|464292051|FG002|Overall Study|Death|0|||
129000212|NCT00811070|464292052|FG003|Overall Study|Death|2|||
129000213|NCT00811070|464292053|FG004|Overall Study|Death|5|||
129000214|NCT00811070|464292054|FG005|Overall Study|Death|0|||
129000215|NCT00811070|464292049|FG000|Overall Study|Other|1|||
129000216|NCT00811070|464292050|FG001|Overall Study|Other|0|||
129000217|NCT00811070|464292051|FG002|Overall Study|Other|0|||
129000218|NCT00811070|464292052|FG003|Overall Study|Other|0|||
129000219|NCT00811070|464292053|FG004|Overall Study|Other|0|||
129000220|NCT00811070|464292054|FG005|Overall Study|Other|0|||
129000221|NCT00811070|464292049|FG000|Overall Study|Withdrawal by Subject|0|||
129000222|NCT00811070|464292050|FG001|Overall Study|Withdrawal by Subject|1|||
129000223|NCT00811070|464292051|FG002|Overall Study|Withdrawal by Subject|0|||
129000224|NCT00811070|464292052|FG003|Overall Study|Withdrawal by Subject|0|||
129000225|NCT00811070|464292053|FG004|Overall Study|Withdrawal by Subject|0|||
129000226|NCT00811070|464292054|FG005|Overall Study|Withdrawal by Subject|0|||
129000227|NCT00811070|464292049|FG000|Overall Study|Physician Decision|0|||
129000228|NCT00811070|464292050|FG001|Overall Study|Physician Decision|0|||
129000229|NCT00811070|464292051|FG002|Overall Study|Physician Decision|0|||
129000230|NCT00811070|464292052|FG003|Overall Study|Physician Decision|0|||
129000231|NCT00811070|464292053|FG004|Overall Study|Physician Decision|0|||
129000232|NCT00811070|464292054|FG005|Overall Study|Physician Decision|1|||
129000233|NCT04444752|464292058|FG000|Overall Study|Adverse Event|1|||
129000234|NCT04444752|464292059|FG001|Overall Study|Adverse Event|0|||
129000235|NCT04444752|464292060|FG002|Overall Study|Adverse Event|0|||
129000236|NCT04444752|464292061|FG003|Overall Study|Adverse Event|2|||
129000237|NCT04444752|464292058|FG000|Overall Study|Lost to Follow-up|2|||
129000238|NCT04444752|464292059|FG001|Overall Study|Lost to Follow-up|6|||
129000239|NCT04444752|464292060|FG002|Overall Study|Lost to Follow-up|2|||
129000240|NCT04444752|464292061|FG003|Overall Study|Lost to Follow-up|5|||
129000241|NCT04444752|464292058|FG000|Overall Study|Physician Decision|0|||
129000242|NCT04444752|464292059|FG001|Overall Study|Physician Decision|0|||
129000243|NCT04444752|464292060|FG002|Overall Study|Physician Decision|0|||
129000244|NCT04444752|464292061|FG003|Overall Study|Physician Decision|2|||
129000245|NCT04444752|464292058|FG000|Overall Study|Pregnancy|0|||
129000246|NCT04444752|464292059|FG001|Overall Study|Pregnancy|0|||
129000247|NCT04444752|464292060|FG002|Overall Study|Pregnancy|0|||
129000248|NCT04444752|464292061|FG003|Overall Study|Pregnancy|1|||
129000249|NCT04444752|464292058|FG000|Overall Study|Withdrawal by Subject|6|||
129000250|NCT04444752|464292059|FG001|Overall Study|Withdrawal by Subject|5|||
129000251|NCT04444752|464292060|FG002|Overall Study|Withdrawal by Subject|3|||
129000252|NCT04444752|464292061|FG003|Overall Study|Withdrawal by Subject|4|||
129000253|NCT04444752|464292058|FG000|Overall Study|Protocol Violation|1|||
129000254|NCT04444752|464292059|FG001|Overall Study|Protocol Violation|1|||
129000255|NCT04444752|464292060|FG002|Overall Study|Protocol Violation|0|||
129000256|NCT04444752|464292061|FG003|Overall Study|Protocol Violation|0|||
129000257|NCT04444752|464292058|FG000|Overall Study|Patient moving out of town|1|||
129000258|NCT04444752|464292059|FG001|Overall Study|Patient moving out of town|0|||
129000259|NCT04444752|464292060|FG002|Overall Study|Patient moving out of town|0|||
129000260|NCT04444752|464292061|FG003|Overall Study|Patient moving out of town|1|||
129000261|NCT04444752|464292058|FG000|Overall Study|Lack of Efficacy|0|||
129000262|NCT04444752|464292059|FG001|Overall Study|Lack of Efficacy|0|||
129000263|NCT04444752|464292060|FG002|Overall Study|Lack of Efficacy|0|||
129000264|NCT04444752|464292061|FG003|Overall Study|Lack of Efficacy|1|||
129000265|NCT04444752|464292058|FG000|Overall Study|Death|0|||
129000266|NCT04444752|464292059|FG001|Overall Study|Death|0|||
129000267|NCT04444752|464292060|FG002|Overall Study|Death|1|||
129000268|NCT04444752|464292061|FG003|Overall Study|Death|0|||
129000269|NCT01759537|464292062|FG000|Overall Study|Death|1|||
129000270|NCT01759537|464292063|FG001|Overall Study|Death|1|||
129000271|NCT01759537|464292062|FG000|Overall Study|Pregnancy|1|||
129000272|NCT01759537|464292063|FG001|Overall Study|Pregnancy|1|||
129000273|NCT01759537|464292062|FG000|Overall Study|Lost to Follow-up|9|||
129000274|NCT01759537|464292063|FG001|Overall Study|Lost to Follow-up|9|||
129000275|NCT01759537|464292062|FG000|Overall Study|Accident involving jaw fracture|1|||
129000276|NCT01759537|464292063|FG001|Overall Study|Accident involving jaw fracture|1|||
129000277|NCT01759537|464292062|FG000|Overall Study|Subcrestal implant too coronal|1|||
129000278|NCT01759537|464292063|FG001|Overall Study|Subcrestal implant too coronal|1|||
129000279|NCT02270983|464293253|FG000|Overall Study|Adverse Event|3|||
129000280|NCT02270983|464293254|FG001|Overall Study|Adverse Event|2|||
129000281|NCT02270983|464293255|FG002|Overall Study|Adverse Event|6|||
129000282|NCT02270983|464293253|FG000|Overall Study|Lack of Efficacy|2|||
129000283|NCT02270983|464293254|FG001|Overall Study|Lack of Efficacy|1|||
129000284|NCT02270983|464293255|FG002|Overall Study|Lack of Efficacy|1|||
129000285|NCT02270983|464293253|FG000|Overall Study|Withdrawal by Subject|1|||
129000286|NCT02270983|464293254|FG001|Overall Study|Withdrawal by Subject|0|||
129000287|NCT02270983|464293255|FG002|Overall Study|Withdrawal by Subject|2|||
129000288|NCT02270983|464293253|FG000|Overall Study|Lost to Follow-up|1|||
129000289|NCT02270983|464293254|FG001|Overall Study|Lost to Follow-up|1|||
129000290|NCT02270983|464293255|FG002|Overall Study|Lost to Follow-up|2|||
129000291|NCT02270983|464293253|FG000|Overall Study|Protocol Violation|1|||
129000292|NCT02270983|464293254|FG001|Overall Study|Protocol Violation|1|||
129000293|NCT02270983|464293255|FG002|Overall Study|Protocol Violation|1|||
129000294|NCT02270983|464293253|FG000|Overall Study|family emergency|0|||
129000295|NCT02270983|464293254|FG001|Overall Study|family emergency|1|||
129000296|NCT02270983|464293255|FG002|Overall Study|family emergency|0|||
129000297|NCT02270983|464293253|FG000|Overall Study|study procedure non-compliance|1|||
129000298|NCT02270983|464293254|FG001|Overall Study|study procedure non-compliance|0|||
129000299|NCT02270983|464293255|FG002|Overall Study|study procedure non-compliance|0|||
129000300|NCT02270983|464293253|FG000|Overall Study|moved away from study site|0|||
129000301|NCT02270983|464293254|FG001|Overall Study|moved away from study site|1|||
129000302|NCT02270983|464293255|FG002|Overall Study|moved away from study site|0|||
129000303|NCT00854620|464293258|FG000|Overall Study|Adverse Event|1|||
129000304|NCT01623830|464293262|FG000|Overall Study|Withdrawal by Subject|6|||
129000305|NCT01623830|464293263|FG001|Overall Study|Withdrawal by Subject|7|||
129000306|NCT01623830|464293262|FG000|Overall Study|Exclusion from Study|1|||
129000307|NCT01623830|464293263|FG001|Overall Study|Exclusion from Study|2|||
129000308|NCT00928252|464293264|FG000|Overall Study|Physician Decision|3|||
129000309|NCT01605461|464293267|FG000|Overall Study|Lost to Follow-up|3|||
129000310|NCT01605461|464293267|FG000|Overall Study|Withdrawal by Subject|1|||
129000311|NCT02024698|464293268|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
129000312|NCT02024698|464293269|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
129000313|NCT02370784|464293273|FG000|Overall Study|Patient started prohibited medication|0|||
129000314|NCT02370784|464293274|FG001|Overall Study|Patient started prohibited medication|1|||
129000315|NCT01312779|464293277|FG000|Overall Study|Withdrawal by Subject|2|||
129000316|NCT01312779|464293277|FG000|Overall Study|Death|3|||
129000317|NCT01312779|464293277|FG000|Overall Study|Not Implanted with Device|27|||
129000318|NCT00693784|464293280|FG000|Overall Study|Lost to Follow-up|2|||
129000319|NCT00693784|464293280|FG000|Overall Study|Withdrawal by Subject|2|||
129000320|NCT00326885|464293282|FG000|Overall Study|Adverse Event|1|||
129000321|NCT00326885|464293282|FG000|Overall Study|Withdrawal by Subject|3|||
129000322|NCT00326885|464293282|FG000|Overall Study|Physician Decision|1|||
129000323|NCT00326885|464293282|FG000|Overall Study|Hospice withdrew consent|2|||
129000324|NCT01473758|464293283|FG000|Cycle 1|Adverse Event|10|||
129000325|NCT01473758|464293284|FG001|Cycle 1|Adverse Event|2|||
129000326|NCT01473758|464293285|FG002|Cycle 1|Adverse Event|0|||
129000327|NCT01473758|464293286|FG003|Cycle 1|Adverse Event|0|||
129000328|NCT01473758|464293283|FG000|Cycle 1|Withdrawal by Subject|1|||
129000329|NCT01473758|464293284|FG001|Cycle 1|Withdrawal by Subject|1|||
129000330|NCT01473758|464293285|FG002|Cycle 1|Withdrawal by Subject|0|||
129000331|NCT01473758|464293286|FG003|Cycle 1|Withdrawal by Subject|0|||
129000332|NCT01473758|464293283|FG000|Cycle 2|Adverse Event|0|||
129000333|NCT01473758|464293284|FG001|Cycle 2|Adverse Event|0|||
129000334|NCT01473758|464293285|FG002|Cycle 2|Adverse Event|5|||
129000335|NCT01473758|464293286|FG003|Cycle 2|Adverse Event|0|||
129000336|NCT01677910|464293287|FG000|Double-Blind Treatment Period|Adverse Event|6|||
129000337|NCT01677910|464293288|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129000338|NCT01677910|464293289|FG002|Double-Blind Treatment Period|Adverse Event|3|||
129000339|NCT01677910|464293290|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129000340|NCT01677910|464293287|FG000|Double-Blind Treatment Period|Physician Decision|0|||
129000341|NCT01677910|464293288|FG001|Double-Blind Treatment Period|Physician Decision|0|||
129000342|NCT01677910|464293289|FG002|Double-Blind Treatment Period|Physician Decision|1|||
129000343|NCT01677910|464293290|FG003|Double-Blind Treatment Period|Physician Decision|0|||
129000344|NCT01677910|464293287|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
129000345|NCT01677910|464293288|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
129000346|NCT01677910|464293289|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
129000347|NCT01677910|464293290|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
129000348|NCT01677910|464293287|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
129000349|NCT01677910|464293288|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
129000350|NCT01677910|464293289|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
129000351|NCT01677910|464293290|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
129000352|NCT01677910|464293287|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
129000353|NCT01677910|464293288|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
129000354|NCT01677910|464293289|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
129000355|NCT01677910|464293290|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
129000356|NCT01677910|464293287|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129000357|NCT01677910|464293288|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129000358|NCT01677910|464293289|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129000359|NCT01677910|464293290|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
129000360|NCT01677910|464293287|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129000361|NCT01677910|464293288|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129000362|NCT01677910|464293289|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129000363|NCT01677910|464293290|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
129000364|NCT01677910|464293287|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129000365|NCT01677910|464293288|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129000366|NCT01677910|464293289|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129000367|NCT01677910|464293290|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
129000368|NCT01677910|464293287|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
129000369|NCT01677910|464293288|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
129000370|NCT01677910|464293289|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
129000371|NCT01677910|464293290|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
129000372|NCT01677910|464293287|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
129000373|NCT01677910|464293288|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
129000374|NCT01677910|464293289|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
129000375|NCT01677910|464293290|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
129000376|NCT03341273|464293293|FG000|Overall Study|Lost to Follow-up|7|||
129000377|NCT03341273|464293294|FG001|Overall Study|Lost to Follow-up|7|||
129000378|NCT03341273|464293293|FG000|Overall Study|Withdrawal by Subject|4|||
129000379|NCT03341273|464293294|FG001|Overall Study|Withdrawal by Subject|2|||
129000380|NCT03341273|464293293|FG000|Overall Study|Physician Decision|1|||
129000381|NCT03341273|464293294|FG001|Overall Study|Physician Decision|0|||
129000382|NCT03341273|464293293|FG000|Overall Study|Protocol Violation|0|||
129000383|NCT03341273|464293294|FG001|Overall Study|Protocol Violation|1|||
129000384|NCT03341273|464293293|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
129000385|NCT03341273|464293294|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
129000386|NCT03341273|464293293|FG000|Overall Study|Became ineligible after enrollment|1|||
129000387|NCT03341273|464293294|FG001|Overall Study|Became ineligible after enrollment|0|||
129000388|NCT03341273|464293293|FG000|Overall Study|Not Eligible at Enrollment|0|||
129000389|NCT03341273|464293294|FG001|Overall Study|Not Eligible at Enrollment|1|||
129000390|NCT03341273|464293293|FG000|Overall Study|Participant incarcerated|1|||
129000391|NCT03341273|464293294|FG001|Overall Study|Participant incarcerated|0|||
129000392|NCT00685919|464293295|FG000|Overall Study|Withdrawal by Subject|0|||
129000393|NCT00685919|464293296|FG001|Overall Study|Withdrawal by Subject|0|||
129000394|NCT00685919|464293297|FG002|Overall Study|Withdrawal by Subject|1|||
129000395|NCT00685919|464293298|FG003|Overall Study|Withdrawal by Subject|0|||
129000396|NCT00685919|464293295|FG000|Overall Study|Physician Decision|1|||
129000397|NCT00685919|464293296|FG001|Overall Study|Physician Decision|0|||
129000398|NCT00685919|464293297|FG002|Overall Study|Physician Decision|0|||
129000399|NCT00685919|464293298|FG003|Overall Study|Physician Decision|0|||
129000400|NCT01717456|464293299|FG000|End of Treatment|Physician Decision|0|||
129000401|NCT01717456|464293300|FG001|End of Treatment|Physician Decision|1|||
129000402|NCT01717456|464293299|FG000|End of Treatment|Lost to Follow-up|0|||
129000403|NCT01717456|464293300|FG001|End of Treatment|Lost to Follow-up|1|||
129000404|NCT01717456|464293299|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
129000405|NCT01717456|464293300|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
129000406|NCT03870997|464293303|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
129000407|NCT03870997|464293304|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
129000408|NCT03870997|464293305|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
129000409|NCT03870997|464293306|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
129000410|NCT03870997|464293307|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
129000411|NCT03870997|464293308|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
129000412|NCT00033631|464293309|FG000|Overall Study|Protocol Violation|14|||
129000413|NCT00033631|464293310|FG001|Overall Study|Protocol Violation|11|||
129000414|NCT00033631|464293309|FG000|Overall Study|Withdrawal by Subject|4|||
129000415|NCT00033631|464293310|FG001|Overall Study|Withdrawal by Subject|4|||
129000416|NCT01827371|464293311|FG000|Overall Study|Adverse Event|0|||
129000417|NCT01827371|464293312|FG001|Overall Study|Adverse Event|0|||
129000418|NCT01827371|464293313|FG002|Overall Study|Adverse Event|4|||
129000419|NCT01827371|464293314|FG003|Overall Study|Adverse Event|2|||
129000420|NCT01827371|464293311|FG000|Overall Study|Lost to Follow-up|0|||
129000421|NCT01827371|464293312|FG001|Overall Study|Lost to Follow-up|2|||
129000422|NCT01827371|464293313|FG002|Overall Study|Lost to Follow-up|0|||
129000423|NCT01827371|464293314|FG003|Overall Study|Lost to Follow-up|4|||
129000424|NCT01827371|464293311|FG000|Overall Study|Protocol Violation|1|||
129000425|NCT01827371|464293312|FG001|Overall Study|Protocol Violation|0|||
129000426|NCT01827371|464293313|FG002|Overall Study|Protocol Violation|0|||
129000427|NCT01827371|464293314|FG003|Overall Study|Protocol Violation|0|||
129000428|NCT01827371|464293311|FG000|Overall Study|Withdrawal by Subject|1|||
129000429|NCT01827371|464293312|FG001|Overall Study|Withdrawal by Subject|2|||
129000430|NCT01827371|464293313|FG002|Overall Study|Withdrawal by Subject|2|||
129000431|NCT01827371|464293314|FG003|Overall Study|Withdrawal by Subject|3|||
129000432|NCT01827371|464293311|FG000|Overall Study|Physician Decision|0|||
129000433|NCT01827371|464293312|FG001|Overall Study|Physician Decision|1|||
129000434|NCT01827371|464293313|FG002|Overall Study|Physician Decision|0|||
129000435|NCT01827371|464293314|FG003|Overall Study|Physician Decision|1|||
129000436|NCT01827371|464293311|FG000|Overall Study|Temporary study halt to vaccinations|11|||
129000437|NCT01827371|464293312|FG001|Overall Study|Temporary study halt to vaccinations|2|||
129000438|NCT01827371|464293313|FG002|Overall Study|Temporary study halt to vaccinations|5|||
129000439|NCT01827371|464293314|FG003|Overall Study|Temporary study halt to vaccinations|13|||
129000440|NCT01361607|464293322|FG000|Overall Study|Adverse Event|38|||
129000441|NCT01361607|464293323|FG001|Overall Study|Adverse Event|29|||
129000442|NCT01361607|464293322|FG000|Overall Study|Withdrawal by Subject|19|||
129000443|NCT01361607|464293323|FG001|Overall Study|Withdrawal by Subject|8|||
129000444|NCT01361607|464293322|FG000|Overall Study|Withdrawal by Investigator|5|||
129000445|NCT01361607|464293323|FG001|Overall Study|Withdrawal by Investigator|3|||
129000446|NCT01361607|464293322|FG000|Overall Study|Lost to Follow-up|1|||
129000447|NCT01361607|464293323|FG001|Overall Study|Lost to Follow-up|0|||
129000448|NCT01361607|464293322|FG000|Overall Study|Met Withdrawal Criteria|1|||
129000449|NCT01361607|464293323|FG001|Overall Study|Met Withdrawal Criteria|1|||
129000450|NCT01401478|464293324|FG000|Overall Study|Study drug not available|6|||
129000451|NCT01401478|464293324|FG000|Overall Study|Adverse Event|5|||
129000452|NCT01401478|464293324|FG000|Overall Study|Hyperphosphatemia|5|||
129000453|NCT01401478|464293324|FG000|Overall Study|Lost to Follow-up|5|||
129000454|NCT01401478|464293324|FG000|Overall Study|Kidney transplantation|3|||
129000455|NCT01401478|464293324|FG000|Overall Study|Withdrawal by Subject|3|||
129000456|NCT01401478|464293324|FG000|Overall Study|Blood samples not available|1|||
129000457|NCT01401478|464293324|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
129000458|NCT01401478|464293324|FG000|Overall Study|Low intact parathyroid hormone|1|||
129000459|NCT01401478|464293324|FG000|Overall Study|Serious adverse event|1|||
129000460|NCT01684722|464293325|FG000|Overall Study|Lost to Follow-up|78|||
129000461|NCT01684722|464293326|FG001|Overall Study|Lost to Follow-up|56|||
129000462|NCT01684722|464293327|FG002|Overall Study|Lost to Follow-up|75|||
129000463|NCT01684722|464293328|FG003|Overall Study|Lost to Follow-up|89|||
129000464|NCT01684722|464293325|FG000|Overall Study|Death|19|||
129000465|NCT01684722|464293326|FG001|Overall Study|Death|21|||
129000466|NCT01684722|464293327|FG002|Overall Study|Death|19|||
129000467|NCT01684722|464293328|FG003|Overall Study|Death|21|||
129000468|NCT01814137|464293329|FG000|Overall Study|Adverse Event|0|||
129000469|NCT01814137|464293330|FG001|Overall Study|Adverse Event|1|||
129000470|NCT01814137|464293329|FG000|Overall Study|Withdrawal by Subject|2|||
129000471|NCT01814137|464293330|FG001|Overall Study|Withdrawal by Subject|2|||
129000472|NCT01814137|464293329|FG000|Overall Study|Physician Decision|1|||
129000473|NCT01814137|464293330|FG001|Overall Study|Physician Decision|1|||
129000474|NCT01814137|464293329|FG000|Overall Study|Unclassified|2|||
129000475|NCT01814137|464293330|FG001|Overall Study|Unclassified|1|||
129000476|NCT00219557|464293331|FG000|Phase 1|Lack of Efficacy|3|||
129000477|NCT00219557|464293332|FG001|Phase 1|Lack of Efficacy|0|||
129000478|NCT00219557|464293333|FG002|Phase 1|Lack of Efficacy|0|||
129000479|NCT00219557|464293331|FG000|Phase 1|Adverse Event|2|||
129000480|NCT00219557|464293332|FG001|Phase 1|Adverse Event|0|||
129000481|NCT00219557|464293333|FG002|Phase 1|Adverse Event|0|||
129000482|NCT00219557|464293331|FG000|Phase 1|Withdrawal by Subject|1|||
129000483|NCT00219557|464293332|FG001|Phase 1|Withdrawal by Subject|0|||
129000484|NCT00219557|464293333|FG002|Phase 1|Withdrawal by Subject|0|||
129000485|NCT00219557|464293331|FG000|Phase 1|Started chemotherapy at other institute|1|||
129214986|NCT03987503|465089426|FG000|Overall Study|Withdrawal by Subject|2|||
129214987|NCT01929317|465089428|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
129214988|NCT01929317|465089429|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
129214989|NCT01929317|465089428|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
129214990|NCT01929317|465089429|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
129214991|NCT01929317|465089428|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
129214992|NCT01929317|465089429|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
129214993|NCT01929317|465089428|FG000|Long-term Phase|Adverse Event|5|||
129000486|NCT00219557|464293332|FG001|Phase 1|Started chemotherapy at other institute|0|||
129000487|NCT00219557|464293333|FG002|Phase 1|Started chemotherapy at other institute|0|||
129000488|NCT00219557|464293331|FG000|Phase 2|Lack of Efficacy|0|||
129000489|NCT00219557|464293332|FG001|Phase 2|Lack of Efficacy|21|||
129000490|NCT00219557|464293333|FG002|Phase 2|Lack of Efficacy|15|||
129000491|NCT00219557|464293331|FG000|Phase 2|Adverse Event|0|||
129000492|NCT00219557|464293332|FG001|Phase 2|Adverse Event|22|||
129000493|NCT00219557|464293333|FG002|Phase 2|Adverse Event|2|||
129000494|NCT00219557|464293331|FG000|Phase 2|Death|0|||
129000495|NCT00219557|464293332|FG001|Phase 2|Death|8|||
129000496|NCT00219557|464293333|FG002|Phase 2|Death|2|||
129000497|NCT00219557|464293331|FG000|Phase 2|Other|0|||
129000498|NCT00219557|464293332|FG001|Phase 2|Other|8|||
129000499|NCT00219557|464293333|FG002|Phase 2|Other|6|||
129000500|NCT00219557|464293331|FG000|Phase 2|Withdrawal by Subject|0|||
129000501|NCT00219557|464293332|FG001|Phase 2|Withdrawal by Subject|9|||
129000502|NCT00219557|464293333|FG002|Phase 2|Withdrawal by Subject|5|||
129000503|NCT00219557|464293331|FG000|Phase 2|Treatment not received|0|||
129000504|NCT00219557|464293332|FG001|Phase 2|Treatment not received|1|||
129000505|NCT00219557|464293333|FG002|Phase 2|Treatment not received|3|||
129000506|NCT03412019|464293334|FG000|Overall Study|Withdrawal by Subject|1|||
129000507|NCT03412019|464293335|FG001|Overall Study|Withdrawal by Subject|1|||
129000508|NCT00479401|464293340|FG000|Overall Study|Adverse Event|24|||
129000509|NCT00479401|464293341|FG001|Overall Study|Adverse Event|20|||
129000510|NCT00479401|464293342|FG002|Overall Study|Adverse Event|4|||
129000511|NCT00479401|464293340|FG000|Overall Study|Lack of Efficacy|2|||
129000512|NCT00479401|464293341|FG001|Overall Study|Lack of Efficacy|2|||
129000513|NCT00479401|464293342|FG002|Overall Study|Lack of Efficacy|4|||
129000514|NCT00479401|464293340|FG000|Overall Study|Protocol Violation|2|||
129214994|NCT01929317|465089429|FG001|Long-term Phase|Adverse Event|1|||
129214995|NCT01929317|465089428|FG000|Long-term Phase|Physician Decision|3|||
129214996|NCT01929317|465089429|FG001|Long-term Phase|Physician Decision|0|||
129214997|NCT01929317|465089428|FG000|Long-term Phase|Withdrawal by Subject|4|||
129214998|NCT01929317|465089429|FG001|Long-term Phase|Withdrawal by Subject|0|||
129214999|NCT01929317|465089428|FG000|Long-term Phase|Protocol Violation|1|||
129215000|NCT01929317|465089429|FG001|Long-term Phase|Protocol Violation|0|||
129215001|NCT01929317|465089428|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
129215002|NCT01929317|465089429|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
129215003|NCT01929317|465089428|FG000|Long-term Phase|Study Closed/Terminated|5|||
129000515|NCT00479401|464293341|FG001|Overall Study|Protocol Violation|1|||
129215004|NCT01929317|465089429|FG001|Long-term Phase|Study Closed/Terminated|3|||
129000516|NCT00479401|464293342|FG002|Overall Study|Protocol Violation|1|||
129000517|NCT00479401|464293340|FG000|Overall Study|Lost to Follow-up|1|||
129000518|NCT00479401|464293341|FG001|Overall Study|Lost to Follow-up|1|||
129000519|NCT00479401|464293342|FG002|Overall Study|Lost to Follow-up|1|||
129000520|NCT00479401|464293340|FG000|Overall Study|Withdrawal by Subject|16|||
129000521|NCT00479401|464293341|FG001|Overall Study|Withdrawal by Subject|10|||
129000522|NCT00479401|464293342|FG002|Overall Study|Withdrawal by Subject|2|||
129000523|NCT00479401|464293340|FG000|Overall Study|Exclusion criteria, relocation|4|||
129000524|NCT00479401|464293341|FG001|Overall Study|Exclusion criteria, relocation|3|||
128878079|NCT02349425|463848361|FG003|Period 2|Adverse Event|0|||
129000525|NCT00479401|464293342|FG002|Overall Study|Exclusion criteria, relocation|0|||
129000526|NCT01430104|464293345|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
129000527|NCT01571635|464293346|FG000|Overall Study|Adverse Event|3|||
129000528|NCT01571635|464293347|FG001|Overall Study|Adverse Event|0|||
129000529|NCT01571635|464293348|FG002|Overall Study|Adverse Event|2|||
129000530|NCT01571635|464293349|FG003|Overall Study|Adverse Event|3|||
129000531|NCT01571635|464293350|FG004|Overall Study|Adverse Event|5|||
129000532|NCT01571635|464293346|FG000|Overall Study|Other reasons|2|||
129000533|NCT01571635|464293347|FG001|Overall Study|Other reasons|1|||
129000534|NCT01571635|464293348|FG002|Overall Study|Other reasons|2|||
129000535|NCT01571635|464293349|FG003|Overall Study|Other reasons|2|||
129000536|NCT01571635|464293350|FG004|Overall Study|Other reasons|1|||
129000537|NCT01571635|464293346|FG000|Overall Study|Study terminated by sponsor|0|||
129000538|NCT01571635|464293347|FG001|Overall Study|Study terminated by sponsor|4|||
129000539|NCT01571635|464293348|FG002|Overall Study|Study terminated by sponsor|1|||
129000540|NCT01571635|464293349|FG003|Overall Study|Study terminated by sponsor|3|||
129000541|NCT01571635|464293350|FG004|Overall Study|Study terminated by sponsor|1|||
129000542|NCT01571635|464293346|FG000|Overall Study|Withdrew consent|1|||
129000543|NCT01571635|464293347|FG001|Overall Study|Withdrew consent|1|||
129000544|NCT01571635|464293348|FG002|Overall Study|Withdrew consent|2|||
129000545|NCT01571635|464293349|FG003|Overall Study|Withdrew consent|3|||
129000546|NCT01571635|464293350|FG004|Overall Study|Withdrew consent|0|||
129000547|NCT01571635|464293346|FG000|Overall Study|Lack of Efficacy|0|||
129000548|NCT01571635|464293347|FG001|Overall Study|Lack of Efficacy|2|||
129000549|NCT01571635|464293348|FG002|Overall Study|Lack of Efficacy|0|||
129000550|NCT01571635|464293349|FG003|Overall Study|Lack of Efficacy|1|||
129000551|NCT01571635|464293350|FG004|Overall Study|Lack of Efficacy|2|||
129000552|NCT01722266|464293351|FG000|Overall Study|Withdrawal by Subject|1|||
129000553|NCT01722266|464293352|FG001|Overall Study|Withdrawal by Subject|2|||
129000554|NCT01722266|464293353|FG002|Overall Study|Withdrawal by Subject|0|||
129000555|NCT01722266|464293354|FG003|Overall Study|Withdrawal by Subject|0|||
129000556|NCT01722266|464293351|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
129000557|NCT01722266|464293352|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
129000558|NCT01722266|464293353|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
129000559|NCT01722266|464293354|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
129000560|NCT01722266|464293351|FG000|Overall Study|Dropped out due to Nausea|0|||
129000561|NCT01722266|464293352|FG001|Overall Study|Dropped out due to Nausea|0|||
129000562|NCT01722266|464293353|FG002|Overall Study|Dropped out due to Nausea|2|||
129000563|NCT01722266|464293354|FG003|Overall Study|Dropped out due to Nausea|0|||
129000564|NCT02862535|464293355|FG000|Overall Study|Death|7|||
129000565|NCT02862535|464293356|FG001|Overall Study|Death|3|||
129000566|NCT02862535|464293357|FG002|Overall Study|Death|2|||
129000567|NCT02862535|464293358|FG003|Overall Study|Death|5|||
129000568|NCT02862535|464293355|FG000|Overall Study|Study Terminated by Sponsor|1|||
129000569|NCT02862535|464293356|FG001|Overall Study|Study Terminated by Sponsor|3|||
129000570|NCT02862535|464293357|FG002|Overall Study|Study Terminated by Sponsor|8|||
129000571|NCT02862535|464293358|FG003|Overall Study|Study Terminated by Sponsor|5|||
129000572|NCT02862535|464293355|FG000|Overall Study|Enrolled, not Treated|1|||
129000573|NCT02862535|464293356|FG001|Overall Study|Enrolled, not Treated|0|||
129000574|NCT02862535|464293357|FG002|Overall Study|Enrolled, not Treated|0|||
129000575|NCT02862535|464293358|FG003|Overall Study|Enrolled, not Treated|1|||
129000576|NCT02472977|464293364|FG000|Overall Study|Disease progression|4|||
129000577|NCT02472977|464293365|FG001|Overall Study|Disease progression|25|||
129000578|NCT02472977|464293366|FG002|Overall Study|Disease progression|6|||
129000579|NCT02472977|464293364|FG000|Overall Study|Withdrawal by Subject|0|||
129000580|NCT02472977|464293365|FG001|Overall Study|Withdrawal by Subject|1|||
129000581|NCT02472977|464293366|FG002|Overall Study|Withdrawal by Subject|0|||
129000582|NCT02472977|464293364|FG000|Overall Study|Study drug toxicity|2|||
129000583|NCT02472977|464293365|FG001|Overall Study|Study drug toxicity|0|||
129000584|NCT02472977|464293366|FG002|Overall Study|Study drug toxicity|2|||
129000585|NCT02472977|464293364|FG000|Overall Study|Subject request to discontinue treatment|0|||
129000586|NCT02472977|464293365|FG001|Overall Study|Subject request to discontinue treatment|1|||
129000587|NCT02472977|464293366|FG002|Overall Study|Subject request to discontinue treatment|0|||
129000588|NCT00738920|464293373|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
129000589|NCT00738920|464293374|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
129000590|NCT00738920|464293375|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
129000591|NCT00738920|464293373|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
129000592|NCT00738920|464293374|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
129000593|NCT00738920|464293375|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
129000594|NCT00738920|464293373|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
129000595|NCT00738920|464293374|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
129000596|NCT00738920|464293375|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
129000597|NCT00738920|464293373|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
129000598|NCT00738920|464293374|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
129000599|NCT00738920|464293375|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
129000600|NCT00738920|464293373|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
129000601|NCT00738920|464293374|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
129000602|NCT00738920|464293375|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
129000603|NCT00738920|464293373|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
129000604|NCT00738920|464293374|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
129000605|NCT00738920|464293375|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
129000606|NCT00738920|464293373|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
129000607|NCT00738920|464293374|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
129000608|NCT00738920|464293375|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
129000609|NCT00738920|464293373|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
129000610|NCT00738920|464293374|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
129000611|NCT00738920|464293375|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
129000612|NCT00738920|464293373|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
129000613|NCT00738920|464293374|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
129000614|NCT00738920|464293375|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
129000615|NCT00738920|464293373|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
129000616|NCT00738920|464293374|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
129000617|NCT00738920|464293375|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
129000618|NCT01025193|464293376|FG000|Overall Study|Protocol Violation|1|||
129000619|NCT01025193|464293376|FG000|Overall Study|Adverse Event|3|||
129000620|NCT04079842|464293377|FG000|Overall Study|Request of subject|2|||
129000621|NCT04079842|464293377|FG000|Overall Study|Unable to draw Arterial samples|1|||
129000622|NCT02904200|464293378|FG000|Overall Study|Withdrawal by Subject|1|||
129000623|NCT02904200|464293379|FG001|Overall Study|Withdrawal by Subject|0|||
129000624|NCT00185211|464293380|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
129000625|NCT00185211|464293381|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
129000626|NCT00185211|464293380|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
129000627|NCT00185211|464293381|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
129000628|NCT00185211|464293380|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
129000629|NCT00185211|464293381|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
129000630|NCT00185211|464293380|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
129000631|NCT00185211|464293381|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
129000632|NCT00185211|464293380|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
129000633|NCT00185211|464293381|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
129000634|NCT00185211|464293380|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
129000635|NCT00185211|464293381|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
129000636|NCT00185211|464293380|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
129000637|NCT00185211|464293381|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
129000638|NCT00185211|464293380|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
128878080|NCT02915302|463848362|FG000|Overall Study|Adverse Event|3|||
129000639|NCT00185211|464293381|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
129000640|NCT00185211|464293380|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
129000641|NCT00185211|464293381|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
129000642|NCT00185211|464293380|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
129000643|NCT00185211|464293381|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
129000644|NCT00185211|464293380|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
129000645|NCT00185211|464293381|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
129000646|NCT00185211|464293380|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
129000647|NCT00185211|464293381|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
129000648|NCT02544633|464295251|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
129000649|NCT02544633|464295252|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
129000650|NCT02544633|464295253|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
129000651|NCT02544633|464295254|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
129000652|NCT02544633|464295251|FG000|Treatment Period|Adverse Event|7|||
129000653|NCT02544633|464295252|FG001|Treatment Period|Adverse Event|4|||
129000654|NCT02544633|464295253|FG002|Treatment Period|Adverse Event|0|||
129000655|NCT02544633|464295254|FG003|Treatment Period|Adverse Event|5|||
129000656|NCT02544633|464295251|FG000|Treatment Period|Lack of Efficacy|17|||
129000657|NCT02544633|464295252|FG001|Treatment Period|Lack of Efficacy|11|||
129000658|NCT02544633|464295253|FG002|Treatment Period|Lack of Efficacy|5|||
129000659|NCT02544633|464295254|FG003|Treatment Period|Lack of Efficacy|5|||
129000660|NCT02544633|464295251|FG000|Treatment Period|Global Deterioration of Health|3|||
129000661|NCT02544633|464295252|FG001|Treatment Period|Global Deterioration of Health|3|||
129000662|NCT02544633|464295253|FG002|Treatment Period|Global Deterioration of Health|0|||
129000663|NCT02544633|464295254|FG003|Treatment Period|Global Deterioration of Health|1|||
129000664|NCT02544633|464295251|FG000|Treatment Period|Withdrawal by Subject|1|||
129000665|NCT02544633|464295252|FG001|Treatment Period|Withdrawal by Subject|0|||
129000666|NCT02544633|464295253|FG002|Treatment Period|Withdrawal by Subject|0|||
129000667|NCT02544633|464295254|FG003|Treatment Period|Withdrawal by Subject|0|||
129000668|NCT02544633|464295251|FG000|Treatment Period|Lost to Follow-up|0|||
129000669|NCT02544633|464295252|FG001|Treatment Period|Lost to Follow-up|1|||
129000670|NCT02544633|464295253|FG002|Treatment Period|Lost to Follow-up|0|||
129000671|NCT02544633|464295254|FG003|Treatment Period|Lost to Follow-up|0|||
129000672|NCT02544633|464295251|FG000|Treatment Period|Death|0|||
129000673|NCT02544633|464295252|FG001|Treatment Period|Death|0|||
129000674|NCT02544633|464295253|FG002|Treatment Period|Death|1|||
129000675|NCT02544633|464295254|FG003|Treatment Period|Death|0|||
129000676|NCT02544633|464295251|FG000|Treatment Period|Non-compliance|0|||
129000677|NCT02544633|464295252|FG001|Treatment Period|Non-compliance|0|||
129000678|NCT02544633|464295253|FG002|Treatment Period|Non-compliance|1|||
129000679|NCT02544633|464295254|FG003|Treatment Period|Non-compliance|0|||
129000680|NCT02544633|464295251|FG000|Treatment Period|Clinical Disease Progression|0|||
129000681|NCT02544633|464295252|FG001|Treatment Period|Clinical Disease Progression|0|||
129000682|NCT02544633|464295253|FG002|Treatment Period|Clinical Disease Progression|0|||
129000683|NCT02544633|464295254|FG003|Treatment Period|Clinical Disease Progression|1|||
129000684|NCT02544633|464295251|FG000|Survival Follow-up Period|Death|12|||
129215005|NCT04322526|465089430|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
129215006|NCT04322526|465089431|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129215007|NCT04322526|465089430|FG000|Washout (1 Week)|Lost to Follow-up|1|||
129215008|NCT04322526|465089431|FG001|Washout (1 Week)|Lost to Follow-up|2|||
129215009|NCT01523756|465089432|FG000|Baseline Period|Adverse Event|0|||
129215010|NCT01523756|465089433|FG001|Baseline Period|Adverse Event|1|||
129215011|NCT01523756|465089432|FG000|Test Period 1|Adverse Event|1|||
129215012|NCT01523756|465089433|FG001|Test Period 1|Adverse Event|0|||
129215013|NCT01523756|465089432|FG000|Test Period 2|Withdrawal by Subject|0|||
129215014|NCT01523756|465089433|FG001|Test Period 2|Withdrawal by Subject|1|||
129215015|NCT00993967|465089434|FG000|Overall Study|Adverse Event|8|||
129215016|NCT00993967|465089434|FG000|Overall Study|Death|1|||
129215017|NCT00993967|465089434|FG000|Overall Study|Lost to Follow-up|14|||
129215018|NCT00993967|465089434|FG000|Overall Study|Withdrawal by Subject|36|||
129215019|NCT00993967|465089434|FG000|Overall Study|Protocol Violation|2|||
129215020|NCT00515619|465089435|FG000|Overall Study|Adverse Event|34|||
129215021|NCT00515619|465089435|FG000|Overall Study|Lack of Efficacy|92|||
129215022|NCT00515619|465089435|FG000|Overall Study|Withdrawal by Subject|66|||
129215023|NCT00515619|465089435|FG000|Overall Study|Protocol Violation|3|||
129215024|NCT00515619|465089435|FG000|Overall Study|Lost to Follow-up|4|||
129215025|NCT00515619|465089435|FG000|Overall Study|Unsatisfactory compliance|6|||
129215026|NCT00515619|465089435|FG000|Overall Study|Other: Site discontinuing trials|2|||
129215027|NCT00515619|465089435|FG000|Overall Study|Other: Subject cannot attend visits|2|||
129215028|NCT00515619|465089435|FG000|Overall Study|Other: Subject required surgery|1|||
129215029|NCT00515619|465089435|FG000|Overall Study|Other: Subject moved to another country|1|||
129215030|NCT00515619|465089435|FG000|Overall Study|Other: Investigator decision|1|||
129215031|NCT00515619|465089435|FG000|Overall Study|Other: Subject became pregnant|1|||
129215032|NCT00515619|465089435|FG000|Overall Study|Other: Request from sponsor|1|||
129215033|NCT00515619|465089435|FG000|Overall Study|Other: Drug available on license|1|||
129215034|NCT00515619|465089435|FG000|Overall Study|Other: Subject interested in other AED|1|||
129215035|NCT02760498|465089436|FG000|Overall Study|Adverse Event|3|||
129215036|NCT02760498|465089437|FG001|Overall Study|Adverse Event|3|||
129215037|NCT02760498|465089438|FG002|Overall Study|Adverse Event|1|||
129215038|NCT02760498|465089439|FG003|Overall Study|Adverse Event|1|||
129215039|NCT02760498|465089440|FG004|Overall Study|Adverse Event|0|||
129215040|NCT02760498|465089441|FG005|Overall Study|Adverse Event|6|||
129215041|NCT02760498|465089436|FG000|Overall Study|Death|7|||
129215042|NCT02760498|465089437|FG001|Overall Study|Death|5|||
129215043|NCT02760498|465089438|FG002|Overall Study|Death|5|||
129215044|NCT02760498|465089439|FG003|Overall Study|Death|7|||
129215045|NCT02760498|465089440|FG004|Overall Study|Death|0|||
129215046|NCT02760498|465089441|FG005|Overall Study|Death|23|||
129215047|NCT02760498|465089436|FG000|Overall Study|Lost to Follow-up|0|||
129215048|NCT02760498|465089437|FG001|Overall Study|Lost to Follow-up|0|||
129215049|NCT02760498|465089438|FG002|Overall Study|Lost to Follow-up|0|||
129215050|NCT02760498|465089439|FG003|Overall Study|Lost to Follow-up|0|||
129215051|NCT02760498|465089440|FG004|Overall Study|Lost to Follow-up|0|||
129215052|NCT02760498|465089441|FG005|Overall Study|Lost to Follow-up|3|||
129215053|NCT02760498|465089436|FG000|Overall Study|Non-compliance with study drug|0|||
129215054|NCT02760498|465089437|FG001|Overall Study|Non-compliance with study drug|2|||
129215055|NCT02760498|465089438|FG002|Overall Study|Non-compliance with study drug|0|||
129215056|NCT02760498|465089439|FG003|Overall Study|Non-compliance with study drug|0|||
129215057|NCT02760498|465089440|FG004|Overall Study|Non-compliance with study drug|0|||
129215058|NCT02760498|465089441|FG005|Overall Study|Non-compliance with study drug|0|||
129215059|NCT02760498|465089436|FG000|Overall Study|Participant decision|1|||
129215060|NCT02760498|465089437|FG001|Overall Study|Participant decision|4|||
129215061|NCT02760498|465089438|FG002|Overall Study|Participant decision|2|||
129215062|NCT02760498|465089439|FG003|Overall Study|Participant decision|2|||
129215063|NCT02760498|465089440|FG004|Overall Study|Participant decision|1|||
129215064|NCT02760498|465089441|FG005|Overall Study|Participant decision|6|||
129000685|NCT02544633|464295252|FG001|Survival Follow-up Period|Death|14|||
129000686|NCT02544633|464295253|FG002|Survival Follow-up Period|Death|3|||
129000687|NCT02544633|464295254|FG003|Survival Follow-up Period|Death|9|||
129000688|NCT02544633|464295251|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
129000689|NCT02544633|464295252|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
129000690|NCT02544633|464295253|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
129000691|NCT02544633|464295254|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
129000692|NCT02544633|464295251|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
129000693|NCT02544633|464295252|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
129000694|NCT02544633|464295253|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
129000695|NCT02544633|464295254|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
129000696|NCT02544633|464295251|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
129000697|NCT02544633|464295252|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
129000698|NCT02544633|464295253|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
129000699|NCT02544633|464295254|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
129000700|NCT01977352|464295255|FG000|Overall Study|Lost to Follow-up|1|||
129000701|NCT01977352|464295256|FG001|Overall Study|Lost to Follow-up|2|||
129000702|NCT00331630|464295257|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
129000703|NCT00331630|464295257|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
129000704|NCT00331630|464295257|FG000|Follow up for 5 Years|Death|5|||
129000705|NCT00331630|464295257|FG000|Follow up for 5 Years|Data collection was stopped|24|||
129000706|NCT03763331|464295258|FG000|Overall Study|Lost to Follow-up|1|||
129000707|NCT03763331|464295259|FG001|Overall Study|Lost to Follow-up|0|||
129000708|NCT03763331|464295258|FG000|Overall Study|Withdrawal by Subject|1|||
129000709|NCT03763331|464295259|FG001|Overall Study|Withdrawal by Subject|0|||
129000710|NCT03763331|464295258|FG000|Overall Study|Non-compliance|0|||
129000711|NCT03763331|464295259|FG001|Overall Study|Non-compliance|3|||
129000712|NCT04741503|464295260|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
129000713|NCT04741503|464295261|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
129000714|NCT04741503|464295262|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
129000715|NCT04741503|464295260|FG000|Initial Enrollment|Overquotas removed|0|||
129000716|NCT04741503|464295261|FG001|Initial Enrollment|Overquotas removed|0|||
129000717|NCT04741503|464295262|FG002|Initial Enrollment|Overquotas removed|186|||
129000718|NCT04741503|464295260|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
129040375|NCT00440466|464440132|FG001|Overall Study|Withdrawal by Subject|5|||
129000719|NCT04741503|464295261|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
129000720|NCT04741503|464295262|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
129000721|NCT02280421|464295263|FG000|Washout (2 Weeks)|Adverse Event|0|||
129000722|NCT02280421|464295264|FG001|Washout (2 Weeks)|Adverse Event|1|||
129000723|NCT02280421|464295263|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129215065|NCT02760498|465089436|FG000|Overall Study|Sponsor decision|0|||
129000724|NCT02280421|464295264|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
129000725|NCT02764489|464295274|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
129000726|NCT02764489|464295275|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
129000727|NCT02764489|464295274|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
129000728|NCT02764489|464295275|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
129000729|NCT02764489|464295274|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
129000730|NCT02764489|464295275|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
129000731|NCT02764489|464295274|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
129000732|NCT02764489|464295275|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
128878081|NCT02915302|463848363|FG001|Overall Study|Adverse Event|0|||
128878082|NCT02915302|463848362|FG000|Overall Study|Protocol Violation|20|||
129000733|NCT01706198|464295278|FG000|Overall Study|Adverse Event|12|||
129000734|NCT01706198|464295279|FG001|Overall Study|Adverse Event|15|||
129000735|NCT01706198|464295278|FG000|Overall Study|Protocol Violation|7|||
129000736|NCT01706198|464295279|FG001|Overall Study|Protocol Violation|5|||
129000737|NCT01706198|464295278|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
129000738|NCT01706198|464295279|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
129000739|NCT01706198|464295278|FG000|Overall Study|Lost to Follow-up|97|||
129000740|NCT01706198|464295279|FG001|Overall Study|Lost to Follow-up|93|||
129000741|NCT01706198|464295278|FG000|Overall Study|Physician Decision|23|||
129000742|NCT01706198|464295279|FG001|Overall Study|Physician Decision|37|||
129000743|NCT01706198|464295278|FG000|Overall Study|Withdrawal by Subject|23|||
129000744|NCT01706198|464295279|FG001|Overall Study|Withdrawal by Subject|31|||
129000745|NCT04313283|464295281|FG000|Overall Study|did not complete intervention|4|||
129000746|NCT00606684|464295295|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
129000747|NCT00606684|464295296|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129000748|NCT00606684|464295297|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129000749|NCT00606684|464295298|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129000750|NCT00606684|464295299|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129000751|NCT00606684|464295300|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129000752|NCT00606684|464295301|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129215066|NCT02760498|465089437|FG001|Overall Study|Sponsor decision|0|||
128666466|NCT00539864|463077442|FG000|Overall Study|Lost to Follow-up|0|||
128666467|NCT00539864|463077443|FG001|Overall Study|Lost to Follow-up|1|||
128666468|NCT00539864|463077442|FG000|Overall Study|Withdrawal by Subject|1|||
128666469|NCT00539864|463077443|FG001|Overall Study|Withdrawal by Subject|1|||
128666470|NCT02840799|463077444|FG000|Phase 1|Physician Decision|1|||
128666471|NCT02840799|463077445|FG001|Phase 1|Physician Decision|3|||
128666472|NCT02840799|463077444|FG000|Phase 1|Withdrawal by Subject|4|||
128666473|NCT02840799|463077445|FG001|Phase 1|Withdrawal by Subject|0|||
128666474|NCT02840799|463077444|FG000|Phase 2 (Crossover)|Adverse Event|0|||
128666475|NCT02840799|463077445|FG001|Phase 2 (Crossover)|Adverse Event|1|||
128666476|NCT02840799|463077444|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
128666477|NCT02840799|463077445|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
128666478|NCT02565784|463077446|FG000|First Treatment|Adverse Event|1|||
128666479|NCT02565784|463077446|FG000|First Treatment|Withdrawal by Subject|1|||
128666480|NCT02565784|463077446|FG000|Second Treatment|Withdrawal by Subject|2|||
128666481|NCT00943072|463077454|FG000|Overall Study|Adverse Event|0|||
128666482|NCT00943072|463077455|FG001|Overall Study|Adverse Event|3|||
128666483|NCT00943072|463077454|FG000|Overall Study|Death|0|||
128666484|NCT00943072|463077455|FG001|Overall Study|Death|2|||
128666485|NCT00943072|463077454|FG000|Overall Study|Withdrawal by Subject|3|||
128666486|NCT00943072|463077455|FG001|Overall Study|Withdrawal by Subject|1|||
128666487|NCT00943072|463077454|FG000|Overall Study|Protocol Violation|0|||
128666488|NCT00943072|463077455|FG001|Overall Study|Protocol Violation|1|||
128763105|NCT03145766|463422735|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
128666489|NCT00943072|463077454|FG000|Overall Study|Lost to Follow-up|1|||
128666490|NCT00943072|463077455|FG001|Overall Study|Lost to Follow-up|2|||
128666491|NCT00943072|463077454|FG000|Overall Study|Lack of Efficacy|0|||
128666492|NCT00943072|463077455|FG001|Overall Study|Lack of Efficacy|4|||
128666493|NCT00943072|463077454|FG000|Overall Study|Other|1|||
128666494|NCT00943072|463077455|FG001|Overall Study|Other|1|||
128666495|NCT00552188|463077458|FG000|Overall Study|Adverse Event|0|||
128666496|NCT00552188|463077459|FG001|Overall Study|Adverse Event|2|||
128666497|NCT00552188|463077458|FG000|Overall Study|Lost to Follow-up|2|||
128666498|NCT00552188|463077459|FG001|Overall Study|Lost to Follow-up|1|||
128666499|NCT00552188|463077458|FG000|Overall Study|Withdrawal of consent|0|||
128666500|NCT00552188|463077459|FG001|Overall Study|Withdrawal of consent|1|||
128666501|NCT00552188|463077458|FG000|Overall Study|Subject returned to home country|0|||
128666502|NCT00552188|463077459|FG001|Overall Study|Subject returned to home country|1|||
128666503|NCT03887702|463077460|FG000|Overall Study|Study terminated|0|||
128666504|NCT03887702|463077461|FG001|Overall Study|Study terminated|0|||
128666505|NCT03887702|463077462|FG002|Overall Study|Study terminated|2|||
128666506|NCT03887702|463077463|FG003|Overall Study|Study terminated|2|||
128666507|NCT01168219|463077470|FG000|Overall Study|off study before starting treatment|2|||
128666508|NCT01168219|463077470|FG000|Overall Study|withdrew before transplant|1|||
128666509|NCT01168219|463077470|FG000|Overall Study|ineligible due to CML|2|||
128666510|NCT02600819|463077471|FG000|GEN Phase|Adverse Event|2|||
128666511|NCT02600819|463077472|FG001|GEN Phase|Adverse Event|0|||
128666512|NCT02600819|463077471|FG000|GEN Phase|Death|2|||
128666513|NCT02600819|463077472|FG001|GEN Phase|Death|0|||
128666514|NCT02600819|463077471|FG000|GEN Phase|Investigator's Discretion|4|||
128666515|NCT02600819|463077472|FG001|GEN Phase|Investigator's Discretion|0|||
128666516|NCT02600819|463077471|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
128666517|NCT02600819|463077472|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
128666518|NCT02600819|463077471|FG000|GEN Phase|Withdrew Consent|5|||
128666519|NCT02600819|463077472|FG001|GEN Phase|Withdrew Consent|0|||
128666520|NCT02600819|463077471|FG000|GEN Phase|Lost to Follow-up|2|||
128666521|NCT02600819|463077472|FG001|GEN Phase|Lost to Follow-up|0|||
128666522|NCT01088048|463077474|FG000|Overall Study|Adverse Event|7|||
128666523|NCT01088048|463077475|FG001|Overall Study|Adverse Event|9|||
128666524|NCT01088048|463077476|FG002|Overall Study|Adverse Event|7|||
128666525|NCT01088048|463077477|FG003|Overall Study|Adverse Event|5|||
128666526|NCT01088048|463077478|FG004|Overall Study|Adverse Event|6|||
128666527|NCT01088048|463077479|FG005|Overall Study|Adverse Event|3|||
128666528|NCT01088048|463077480|FG006|Overall Study|Adverse Event|3|||
128666529|NCT01088048|463077481|FG007|Overall Study|Adverse Event|0|||
128666530|NCT01088048|463077482|FG008|Overall Study|Adverse Event|2|||
128666531|NCT01088048|463077483|FG009|Overall Study|Adverse Event|2|||
128666532|NCT01088048|463077474|FG000|Overall Study|Withdrew Consent|1|||
128666533|NCT01088048|463077475|FG001|Overall Study|Withdrew Consent|1|||
128666534|NCT01088048|463077476|FG002|Overall Study|Withdrew Consent|1|||
128666535|NCT01088048|463077477|FG003|Overall Study|Withdrew Consent|1|||
128666536|NCT01088048|463077478|FG004|Overall Study|Withdrew Consent|2|||
128666537|NCT01088048|463077479|FG005|Overall Study|Withdrew Consent|1|||
128666538|NCT01088048|463077480|FG006|Overall Study|Withdrew Consent|0|||
128666539|NCT01088048|463077481|FG007|Overall Study|Withdrew Consent|2|||
128666540|NCT01088048|463077482|FG008|Overall Study|Withdrew Consent|2|||
128666541|NCT01088048|463077483|FG009|Overall Study|Withdrew Consent|1|||
128666542|NCT01088048|463077474|FG000|Overall Study|Concomitant Medication Prohibited|1|||
128666543|NCT01088048|463077475|FG001|Overall Study|Concomitant Medication Prohibited|0|||
128666544|NCT01088048|463077476|FG002|Overall Study|Concomitant Medication Prohibited|0|||
128666545|NCT01088048|463077477|FG003|Overall Study|Concomitant Medication Prohibited|0|||
128666546|NCT01088048|463077478|FG004|Overall Study|Concomitant Medication Prohibited|0|||
128666547|NCT01088048|463077479|FG005|Overall Study|Concomitant Medication Prohibited|0|||
128666548|NCT01088048|463077480|FG006|Overall Study|Concomitant Medication Prohibited|0|||
128666549|NCT01088048|463077481|FG007|Overall Study|Concomitant Medication Prohibited|0|||
128666550|NCT01088048|463077482|FG008|Overall Study|Concomitant Medication Prohibited|0|||
128666551|NCT01088048|463077483|FG009|Overall Study|Concomitant Medication Prohibited|0|||
128666552|NCT01088048|463077474|FG000|Overall Study|Investigator Request|2|||
128666553|NCT01088048|463077475|FG001|Overall Study|Investigator Request|2|||
128666554|NCT01088048|463077476|FG002|Overall Study|Investigator Request|0|||
128666555|NCT01088048|463077477|FG003|Overall Study|Investigator Request|0|||
128666556|NCT01088048|463077478|FG004|Overall Study|Investigator Request|3|||
128666557|NCT01088048|463077479|FG005|Overall Study|Investigator Request|1|||
128666558|NCT01088048|463077480|FG006|Overall Study|Investigator Request|1|||
128666559|NCT01088048|463077481|FG007|Overall Study|Investigator Request|0|||
128666560|NCT01088048|463077482|FG008|Overall Study|Investigator Request|0|||
128666561|NCT01088048|463077483|FG009|Overall Study|Investigator Request|0|||
128666562|NCT01088048|463077474|FG000|Overall Study|Patient Non-compliance|0|||
129215067|NCT02760498|465089438|FG002|Overall Study|Sponsor decision|0|||
128666563|NCT01088048|463077475|FG001|Overall Study|Patient Non-compliance|1|||
128666564|NCT01088048|463077476|FG002|Overall Study|Patient Non-compliance|0|||
128666565|NCT01088048|463077477|FG003|Overall Study|Patient Non-compliance|0|||
128666566|NCT01088048|463077478|FG004|Overall Study|Patient Non-compliance|0|||
128666567|NCT01088048|463077479|FG005|Overall Study|Patient Non-compliance|0|||
128666568|NCT01088048|463077480|FG006|Overall Study|Patient Non-compliance|0|||
128666569|NCT01088048|463077481|FG007|Overall Study|Patient Non-compliance|0|||
128666570|NCT01088048|463077482|FG008|Overall Study|Patient Non-compliance|0|||
128666571|NCT01088048|463077483|FG009|Overall Study|Patient Non-compliance|0|||
128666572|NCT01088048|463077474|FG000|Overall Study|Disease Progression|7|||
128666573|NCT01088048|463077475|FG001|Overall Study|Disease Progression|4|||
128666574|NCT01088048|463077476|FG002|Overall Study|Disease Progression|3|||
128666575|NCT01088048|463077477|FG003|Overall Study|Disease Progression|5|||
128666576|NCT01088048|463077478|FG004|Overall Study|Disease Progression|3|||
128666577|NCT01088048|463077479|FG005|Overall Study|Disease Progression|3|||
128666578|NCT01088048|463077480|FG006|Overall Study|Disease Progression|2|||
128666579|NCT01088048|463077481|FG007|Overall Study|Disease Progression|1|||
128666580|NCT01088048|463077482|FG008|Overall Study|Disease Progression|0|||
128666581|NCT01088048|463077483|FG009|Overall Study|Disease Progression|0|||
128666582|NCT01088048|463077474|FG000|Overall Study|Death|1|||
128666583|NCT01088048|463077475|FG001|Overall Study|Death|5|||
128666584|NCT01088048|463077476|FG002|Overall Study|Death|3|||
128666585|NCT01088048|463077477|FG003|Overall Study|Death|3|||
128666586|NCT01088048|463077478|FG004|Overall Study|Death|1|||
128666587|NCT01088048|463077479|FG005|Overall Study|Death|3|||
128666588|NCT01088048|463077480|FG006|Overall Study|Death|0|||
128666589|NCT01088048|463077481|FG007|Overall Study|Death|0|||
128666590|NCT01088048|463077482|FG008|Overall Study|Death|3|||
128666591|NCT01088048|463077483|FG009|Overall Study|Death|1|||
128666592|NCT01088048|463077474|FG000|Overall Study|Other|3|||
128666593|NCT01088048|463077475|FG001|Overall Study|Other|5|||
128666594|NCT01088048|463077476|FG002|Overall Study|Other|0|||
128666595|NCT01088048|463077477|FG003|Overall Study|Other|0|||
128666596|NCT01088048|463077478|FG004|Overall Study|Other|2|||
128666597|NCT01088048|463077479|FG005|Overall Study|Other|0|||
128666598|NCT01088048|463077480|FG006|Overall Study|Other|0|||
128666599|NCT01088048|463077481|FG007|Overall Study|Other|2|||
128666600|NCT01088048|463077482|FG008|Overall Study|Other|0|||
128666601|NCT01088048|463077483|FG009|Overall Study|Other|0|||
129000753|NCT00606684|464295295|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
129000754|NCT00606684|464295296|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129000755|NCT00606684|464295297|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129000756|NCT00606684|464295298|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129000757|NCT00606684|464295299|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129000758|NCT00606684|464295300|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129000759|NCT00606684|464295301|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129000760|NCT00606684|464295295|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
129000761|NCT00606684|464295296|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
129000762|NCT00606684|464295297|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
129000763|NCT00606684|464295298|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
129000764|NCT00606684|464295299|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
129000765|NCT00606684|464295300|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
129000766|NCT00606684|464295301|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
129000767|NCT00606684|464295295|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
129000768|NCT00606684|464295296|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129000769|NCT00606684|464295297|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129000770|NCT00606684|464295298|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129000771|NCT00606684|464295299|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129000772|NCT00606684|464295300|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129000773|NCT00606684|464295301|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129000774|NCT00606684|464295295|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
129000775|NCT00606684|464295296|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129000776|NCT00606684|464295297|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129000777|NCT00606684|464295298|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129000778|NCT00606684|464295299|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129000779|NCT00606684|464295300|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129000780|NCT00606684|464295301|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129000781|NCT00606684|464295295|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
129000782|NCT00606684|464295296|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
129000783|NCT00606684|464295297|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
129000784|NCT00606684|464295298|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
129000785|NCT00606684|464295299|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
129000786|NCT00606684|464295300|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
129000787|NCT00606684|464295301|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
129000788|NCT00606684|464295295|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
129000789|NCT00606684|464295296|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129000790|NCT00606684|464295297|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129000791|NCT00606684|464295298|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129000792|NCT00606684|464295299|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
128666602|NCT01621802|463077484|FG000|Overall Study|Protocol Violation|0|||
128666603|NCT01621802|463077485|FG001|Overall Study|Protocol Violation|0|||
128666604|NCT01621802|463077486|FG002|Overall Study|Protocol Violation|0|||
128666605|NCT01621802|463077487|FG003|Overall Study|Protocol Violation|0|||
128666606|NCT01621802|463077488|FG004|Overall Study|Protocol Violation|0|||
128666607|NCT01621802|463077489|FG005|Overall Study|Protocol Violation|1|||
128666608|NCT01621802|463077484|FG000|Overall Study|Withdrawal by Subject|8|||
128666609|NCT01621802|463077485|FG001|Overall Study|Withdrawal by Subject|4|||
128666610|NCT01621802|463077486|FG002|Overall Study|Withdrawal by Subject|4|||
128666611|NCT01621802|463077487|FG003|Overall Study|Withdrawal by Subject|2|||
129000793|NCT00606684|464295300|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129000794|NCT00606684|464295301|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129000795|NCT00606684|464295295|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129000796|NCT00606684|464295296|FG001|Double-Blind Treatment Period|Adverse Event|3|||
129000797|NCT00606684|464295297|FG002|Double-Blind Treatment Period|Adverse Event|2|||
129000798|NCT00606684|464295298|FG003|Double-Blind Treatment Period|Adverse Event|4|||
129000799|NCT00606684|464295299|FG004|Double-Blind Treatment Period|Adverse Event|2|||
129000800|NCT00606684|464295300|FG005|Double-Blind Treatment Period|Adverse Event|0|||
128666612|NCT01621802|463077488|FG004|Overall Study|Withdrawal by Subject|2|||
128666613|NCT01621802|463077489|FG005|Overall Study|Withdrawal by Subject|0|||
129000801|NCT00606684|464295301|FG006|Double-Blind Treatment Period|Adverse Event|1|||
129000802|NCT00606684|464295295|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129000803|NCT00606684|464295296|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
129000804|NCT00606684|464295297|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
129000805|NCT00606684|464295298|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
129000806|NCT00606684|464295299|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
129000807|NCT00606684|464295300|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
128666614|NCT01621802|463077484|FG000|Overall Study|Migrated/moved from study area|0|||
128666615|NCT01621802|463077485|FG001|Overall Study|Migrated/moved from study area|0|||
128666616|NCT01621802|463077486|FG002|Overall Study|Migrated/moved from study area|2|||
128666617|NCT01621802|463077487|FG003|Overall Study|Migrated/moved from study area|0|||
128666618|NCT01621802|463077488|FG004|Overall Study|Migrated/moved from study area|1|||
128666619|NCT01621802|463077489|FG005|Overall Study|Migrated/moved from study area|0|||
128666620|NCT01621802|463077484|FG000|Overall Study|Others|3|||
128666621|NCT01621802|463077485|FG001|Overall Study|Others|3|||
128666622|NCT01621802|463077486|FG002|Overall Study|Others|3|||
128666623|NCT01621802|463077487|FG003|Overall Study|Others|2|||
128666624|NCT01621802|463077488|FG004|Overall Study|Others|1|||
128666625|NCT01621802|463077489|FG005|Overall Study|Others|0|||
128666626|NCT01621802|463077484|FG000|Overall Study|Lost to Follow-up|36|||
128666627|NCT01621802|463077485|FG001|Overall Study|Lost to Follow-up|16|||
128666628|NCT01621802|463077486|FG002|Overall Study|Lost to Follow-up|24|||
128666629|NCT01621802|463077487|FG003|Overall Study|Lost to Follow-up|7|||
128666630|NCT01621802|463077488|FG004|Overall Study|Lost to Follow-up|31|||
128666631|NCT01621802|463077489|FG005|Overall Study|Lost to Follow-up|11|||
128666632|NCT03790696|463077491|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
128666633|NCT03790696|463077492|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
128666634|NCT01149148|463077493|FG000|Overall Study|Lost to Follow-up|1|||
128666635|NCT01149148|463077494|FG001|Overall Study|Lost to Follow-up|2|||
128666636|NCT01149148|463077493|FG000|Overall Study|Death|1|||
128666637|NCT01149148|463077494|FG001|Overall Study|Death|0|||
128666638|NCT03436082|463077495|FG000|Overall Study|Did not undergo procedure|1|||
128666639|NCT03436082|463077496|FG001|Overall Study|Did not undergo procedure|0|||
128666640|NCT00950859|463077499|FG000|Overall Study|Adverse Event|3|||
128666641|NCT00950859|463077500|FG001|Overall Study|Adverse Event|3|||
128666642|NCT00950859|463077499|FG000|Overall Study|Insufficient Viral Load Response|12|||
128666643|NCT00950859|463077500|FG001|Overall Study|Insufficient Viral Load Response|3|||
128666644|NCT00950859|463077499|FG000|Overall Study|Protocol Violation|1|||
128666645|NCT00950859|463077500|FG001|Overall Study|Protocol Violation|1|||
128666646|NCT00950859|463077499|FG000|Overall Study|Lost to Follow-up|0|||
128666647|NCT00950859|463077500|FG001|Overall Study|Lost to Follow-up|3|||
128666648|NCT04896086|463077501|FG000|Overall Study|Lost to Follow-up|0|||
128666649|NCT04896086|463077502|FG001|Overall Study|Lost to Follow-up|2|||
128666650|NCT04896086|463077503|FG002|Overall Study|Lost to Follow-up|1|||
128666651|NCT04896086|463077504|FG003|Overall Study|Lost to Follow-up|0|||
128666652|NCT04896086|463077505|FG004|Overall Study|Lost to Follow-up|0|||
128666653|NCT04896086|463077501|FG000|Overall Study|Physician Decision|0|||
128666654|NCT04896086|463077502|FG001|Overall Study|Physician Decision|1|||
128666655|NCT04896086|463077503|FG002|Overall Study|Physician Decision|0|||
128666656|NCT04896086|463077504|FG003|Overall Study|Physician Decision|0|||
128666657|NCT04896086|463077505|FG004|Overall Study|Physician Decision|0|||
128666658|NCT04896086|463077501|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
128666659|NCT04896086|463077502|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
128666660|NCT04896086|463077503|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
129000808|NCT00606684|464295301|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
129000809|NCT00606684|464295295|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
128666661|NCT04896086|463077504|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
128666662|NCT04896086|463077505|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
128666663|NCT04896086|463077501|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
128666664|NCT04896086|463077502|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
128666665|NCT04896086|463077503|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
128666666|NCT04896086|463077504|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
128666667|NCT04896086|463077505|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
128666668|NCT02249832|463077508|FG000|Overall Study|Withdrawal by Subject|3|||
128666669|NCT02249832|463077508|FG000|Overall Study|Lost to Follow-up|10|||
128666670|NCT00485134|463077509|FG000|Overall Study|Lost to Follow-up|1|||
128666671|NCT00485134|463077510|FG001|Overall Study|Lost to Follow-up|0|||
128666672|NCT00485134|463077511|FG002|Overall Study|Lost to Follow-up|0|||
128666673|NCT00485134|463077512|FG003|Overall Study|Lost to Follow-up|0|||
128666674|NCT00485134|463077513|FG004|Overall Study|Lost to Follow-up|0|||
128666675|NCT00485134|463077514|FG005|Overall Study|Lost to Follow-up|0|||
128666676|NCT00485134|463077515|FG006|Overall Study|Lost to Follow-up|0|||
128666677|NCT00485134|463077516|FG007|Overall Study|Lost to Follow-up|0|||
128666678|NCT00485134|463077509|FG000|Overall Study|Withdrawal by Subject|0|||
128666679|NCT00485134|463077510|FG001|Overall Study|Withdrawal by Subject|1|||
128666680|NCT00485134|463077511|FG002|Overall Study|Withdrawal by Subject|0|||
128666681|NCT00485134|463077512|FG003|Overall Study|Withdrawal by Subject|0|||
128666682|NCT00485134|463077513|FG004|Overall Study|Withdrawal by Subject|0|||
128666683|NCT00485134|463077514|FG005|Overall Study|Withdrawal by Subject|0|||
128666684|NCT00485134|463077515|FG006|Overall Study|Withdrawal by Subject|0|||
128666685|NCT00485134|463077516|FG007|Overall Study|Withdrawal by Subject|0|||
128666686|NCT00485134|463077509|FG000|Overall Study|Change in health status|0|||
128666687|NCT00485134|463077510|FG001|Overall Study|Change in health status|1|||
128666688|NCT00485134|463077511|FG002|Overall Study|Change in health status|2|||
128666689|NCT00485134|463077512|FG003|Overall Study|Change in health status|1|||
128666690|NCT00485134|463077513|FG004|Overall Study|Change in health status|0|||
128666691|NCT00485134|463077514|FG005|Overall Study|Change in health status|1|||
128666692|NCT00485134|463077515|FG006|Overall Study|Change in health status|0|||
128666693|NCT00485134|463077516|FG007|Overall Study|Change in health status|0|||
128666694|NCT00485134|463077509|FG000|Overall Study|Withdrew for adverse event|0|||
128666695|NCT00485134|463077510|FG001|Overall Study|Withdrew for adverse event|0|||
128666696|NCT00485134|463077511|FG002|Overall Study|Withdrew for adverse event|1|||
128666697|NCT00485134|463077512|FG003|Overall Study|Withdrew for adverse event|0|||
128666698|NCT00485134|463077513|FG004|Overall Study|Withdrew for adverse event|0|||
128666699|NCT00485134|463077514|FG005|Overall Study|Withdrew for adverse event|0|||
128666700|NCT00485134|463077515|FG006|Overall Study|Withdrew for adverse event|0|||
128666701|NCT00485134|463077516|FG007|Overall Study|Withdrew for adverse event|0|||
128666702|NCT00485134|463077509|FG000|Overall Study|Positive drug test|0|||
128666703|NCT00485134|463077510|FG001|Overall Study|Positive drug test|0|||
128666704|NCT00485134|463077511|FG002|Overall Study|Positive drug test|0|||
128666705|NCT00485134|463077512|FG003|Overall Study|Positive drug test|0|||
128666706|NCT00485134|463077513|FG004|Overall Study|Positive drug test|2|||
128666707|NCT00485134|463077514|FG005|Overall Study|Positive drug test|1|||
128666708|NCT00485134|463077515|FG006|Overall Study|Positive drug test|0|||
128666709|NCT00485134|463077516|FG007|Overall Study|Positive drug test|0|||
128666710|NCT00485134|463077509|FG000|Overall Study|Non-compliance|0|||
128666711|NCT00485134|463077510|FG001|Overall Study|Non-compliance|0|||
128666712|NCT00485134|463077511|FG002|Overall Study|Non-compliance|0|||
128666713|NCT00485134|463077512|FG003|Overall Study|Non-compliance|0|||
128666714|NCT00485134|463077513|FG004|Overall Study|Non-compliance|1|||
128666715|NCT00485134|463077514|FG005|Overall Study|Non-compliance|2|||
128666716|NCT00485134|463077515|FG006|Overall Study|Non-compliance|2|||
128666717|NCT00485134|463077516|FG007|Overall Study|Non-compliance|0|||
128666718|NCT00485134|463077509|FG000|Overall Study|Unable to comply with study schedule|0|||
128666719|NCT00485134|463077510|FG001|Overall Study|Unable to comply with study schedule|0|||
128666720|NCT00485134|463077511|FG002|Overall Study|Unable to comply with study schedule|0|||
128666721|NCT00485134|463077512|FG003|Overall Study|Unable to comply with study schedule|0|||
128666722|NCT00485134|463077513|FG004|Overall Study|Unable to comply with study schedule|0|||
128666723|NCT00485134|463077514|FG005|Overall Study|Unable to comply with study schedule|0|||
128666724|NCT00485134|463077515|FG006|Overall Study|Unable to comply with study schedule|0|||
128666725|NCT00485134|463077516|FG007|Overall Study|Unable to comply with study schedule|1|||
128666726|NCT00485134|463077509|FG000|Overall Study|Pregnancy|0|||
128666727|NCT00485134|463077510|FG001|Overall Study|Pregnancy|0|||
128666728|NCT00485134|463077511|FG002|Overall Study|Pregnancy|0|||
128666729|NCT00485134|463077512|FG003|Overall Study|Pregnancy|0|||
128666730|NCT00485134|463077513|FG004|Overall Study|Pregnancy|0|||
128666731|NCT00485134|463077514|FG005|Overall Study|Pregnancy|0|||
128666732|NCT00485134|463077515|FG006|Overall Study|Pregnancy|1|||
128666733|NCT00485134|463077516|FG007|Overall Study|Pregnancy|0|||
128666734|NCT00970684|463077517|FG000|Overall Study|Lack of Efficacy|5|||
128666735|NCT00970684|463077517|FG000|Overall Study|Adverse Event|4|||
128666736|NCT00970684|463077517|FG000|Overall Study|Withdrawal by Subject|1|||
128666737|NCT00481091|463077518|FG000|Overall Study|Withdrawal by Subject|0|||
128666738|NCT00481091|463077519|FG001|Overall Study|Withdrawal by Subject|1|||
128666739|NCT00481091|463077520|FG002|Overall Study|Withdrawal by Subject|1|||
128666740|NCT00481091|463077521|FG003|Overall Study|Withdrawal by Subject|0|||
128666741|NCT00481091|463077522|FG004|Overall Study|Withdrawal by Subject|0|||
128666742|NCT00481091|463077523|FG005|Overall Study|Withdrawal by Subject|0|||
128666743|NCT00481091|463077524|FG006|Overall Study|Withdrawal by Subject|0|||
128666744|NCT00481091|463077525|FG007|Overall Study|Withdrawal by Subject|0|||
128666745|NCT00481091|463077526|FG008|Overall Study|Withdrawal by Subject|1|||
128666746|NCT00481091|463077527|FG009|Overall Study|Withdrawal by Subject|6|||
128666747|NCT00481091|463077518|FG000|Overall Study|Other, Not Specified|0|||
128666748|NCT00481091|463077519|FG001|Overall Study|Other, Not Specified|1|||
128666749|NCT00481091|463077520|FG002|Overall Study|Other, Not Specified|1|||
128666750|NCT00481091|463077521|FG003|Overall Study|Other, Not Specified|0|||
128666751|NCT00481091|463077522|FG004|Overall Study|Other, Not Specified|0|||
128666752|NCT00481091|463077523|FG005|Overall Study|Other, Not Specified|1|||
128666753|NCT00481091|463077524|FG006|Overall Study|Other, Not Specified|0|||
128666754|NCT00481091|463077525|FG007|Overall Study|Other, Not Specified|0|||
128666755|NCT00481091|463077526|FG008|Overall Study|Other, Not Specified|0|||
128666756|NCT00481091|463077527|FG009|Overall Study|Other, Not Specified|4|||
128666757|NCT00481091|463077518|FG000|Overall Study|Adverse Event|1|||
128666758|NCT00481091|463077519|FG001|Overall Study|Adverse Event|2|||
128666759|NCT00481091|463077520|FG002|Overall Study|Adverse Event|0|||
128666760|NCT00481091|463077521|FG003|Overall Study|Adverse Event|1|||
128666761|NCT00481091|463077522|FG004|Overall Study|Adverse Event|1|||
128666762|NCT00481091|463077523|FG005|Overall Study|Adverse Event|1|||
128666763|NCT00481091|463077524|FG006|Overall Study|Adverse Event|2|||
128666764|NCT00481091|463077525|FG007|Overall Study|Adverse Event|1|||
128666765|NCT00481091|463077526|FG008|Overall Study|Adverse Event|1|||
128666766|NCT00481091|463077527|FG009|Overall Study|Adverse Event|6|||
128666767|NCT00481091|463077518|FG000|Overall Study|Progressive disease clinical|0|||
128666768|NCT00481091|463077519|FG001|Overall Study|Progressive disease clinical|0|||
128666769|NCT00481091|463077520|FG002|Overall Study|Progressive disease clinical|0|||
128666770|NCT00481091|463077521|FG003|Overall Study|Progressive disease clinical|0|||
128666771|NCT00481091|463077522|FG004|Overall Study|Progressive disease clinical|0|||
128666772|NCT00481091|463077523|FG005|Overall Study|Progressive disease clinical|0|||
128666773|NCT00481091|463077524|FG006|Overall Study|Progressive disease clinical|0|||
128666774|NCT00481091|463077525|FG007|Overall Study|Progressive disease clinical|0|||
128666775|NCT00481091|463077526|FG008|Overall Study|Progressive disease clinical|1|||
128666776|NCT00481091|463077527|FG009|Overall Study|Progressive disease clinical|7|||
128666777|NCT00481091|463077518|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
128666778|NCT00481091|463077519|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
128666779|NCT00481091|463077520|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
128666780|NCT00481091|463077521|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
128666781|NCT00481091|463077522|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
128666782|NCT00481091|463077523|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
128666783|NCT00481091|463077524|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
128666784|NCT00481091|463077525|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
128666785|NCT00481091|463077526|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
128666786|NCT00481091|463077527|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
128666787|NCT00481091|463077518|FG000|Overall Study|Progressive disease other|1|||
128666788|NCT00481091|463077519|FG001|Overall Study|Progressive disease other|1|||
128666789|NCT00481091|463077520|FG002|Overall Study|Progressive disease other|0|||
128666790|NCT00481091|463077521|FG003|Overall Study|Progressive disease other|1|||
128666791|NCT00481091|463077522|FG004|Overall Study|Progressive disease other|1|||
128666792|NCT00481091|463077523|FG005|Overall Study|Progressive disease other|1|||
128666793|NCT00481091|463077524|FG006|Overall Study|Progressive disease other|0|||
128666794|NCT00481091|463077525|FG007|Overall Study|Progressive disease other|2|||
128666795|NCT00481091|463077526|FG008|Overall Study|Progressive disease other|0|||
128666796|NCT00481091|463077527|FG009|Overall Study|Progressive disease other|0|||
128666797|NCT00481091|463077518|FG000|Overall Study|No reason given|0|||
128666798|NCT00481091|463077519|FG001|Overall Study|No reason given|0|||
128666799|NCT00481091|463077520|FG002|Overall Study|No reason given|1|||
128666800|NCT00481091|463077521|FG003|Overall Study|No reason given|1|||
128666801|NCT00481091|463077522|FG004|Overall Study|No reason given|1|||
128666802|NCT00481091|463077523|FG005|Overall Study|No reason given|0|||
128666803|NCT00481091|463077524|FG006|Overall Study|No reason given|1|||
128666804|NCT00481091|463077525|FG007|Overall Study|No reason given|1|||
128666805|NCT00481091|463077526|FG008|Overall Study|No reason given|1|||
128666806|NCT00481091|463077527|FG009|Overall Study|No reason given|4|||
128666807|NCT04294680|463077528|FG000|Overall Study|Withdrawal by Subject|2|||
128666808|NCT04294680|463077529|FG001|Overall Study|Withdrawal by Subject|1|||
128666809|NCT04294680|463077528|FG000|Overall Study|Follow-up visits completed outside of window|1|||
128666810|NCT04294680|463077529|FG001|Overall Study|Follow-up visits completed outside of window|0|||
128666811|NCT01296672|463077530|FG000|Overall Study|Lost to Follow-up|73|||
128666812|NCT01296672|463077531|FG001|Overall Study|Lost to Follow-up|18|||
128666813|NCT04027608|463077532|FG000|Overall Study|Withdrawal by Subject|13|||
128666814|NCT04027608|463077533|FG001|Overall Study|Withdrawal by Subject|2|||
128666815|NCT04027608|463077532|FG000|Overall Study|Protocol Violation|2|||
128666816|NCT04027608|463077533|FG001|Overall Study|Protocol Violation|1|||
129000810|NCT00606684|464295296|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
129000811|NCT00606684|464295297|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
129000812|NCT00606684|464295298|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
129000813|NCT00606684|464295299|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
129000814|NCT00606684|464295300|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
129000815|NCT00606684|464295301|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
129000816|NCT00606684|464295295|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
129000817|NCT00606684|464295296|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
129000818|NCT00606684|464295297|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
129000819|NCT00606684|464295298|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
129000820|NCT00606684|464295299|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
129000821|NCT00606684|464295300|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
129000822|NCT00606684|464295301|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
129000823|NCT00606684|464295295|FG000|Double-Blind Treatment Period|Physician Decision|0|||
128666817|NCT04027608|463077532|FG000|Overall Study|Physician Decision|1|||
128666818|NCT04027608|463077533|FG001|Overall Study|Physician Decision|0|||
128666819|NCT04027608|463077532|FG000|Overall Study|Lost to Follow-up|20|||
128666820|NCT04027608|463077533|FG001|Overall Study|Lost to Follow-up|4|||
128666821|NCT04661579|463077536|FG000|Overall Study|Lost to Follow-up|19|||
128666822|NCT04661579|463077537|FG001|Overall Study|Lost to Follow-up|10|||
128666823|NCT04661579|463077538|FG002|Overall Study|Lost to Follow-up|2|||
128666824|NCT04661579|463077539|FG003|Overall Study|Lost to Follow-up|7|||
129000824|NCT00606684|464295296|FG001|Double-Blind Treatment Period|Physician Decision|5|||
129000825|NCT00606684|464295297|FG002|Double-Blind Treatment Period|Physician Decision|1|||
129000826|NCT00606684|464295298|FG003|Double-Blind Treatment Period|Physician Decision|0|||
129000827|NCT00606684|464295299|FG004|Double-Blind Treatment Period|Physician Decision|3|||
129000828|NCT00606684|464295300|FG005|Double-Blind Treatment Period|Physician Decision|1|||
129000829|NCT00606684|464295301|FG006|Double-Blind Treatment Period|Physician Decision|2|||
129000830|NCT00606684|464295295|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129000831|NCT00606684|464295296|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128666825|NCT04661579|463077540|FG004|Overall Study|Lost to Follow-up|11|||
128666826|NCT04661579|463077536|FG000|Overall Study|Physician Decision|2|||
128666827|NCT04661579|463077537|FG001|Overall Study|Physician Decision|0|||
128666828|NCT04661579|463077538|FG002|Overall Study|Physician Decision|0|||
128666829|NCT04661579|463077539|FG003|Overall Study|Physician Decision|1|||
128666830|NCT04661579|463077540|FG004|Overall Study|Physician Decision|0|||
128666831|NCT04661579|463077536|FG000|Overall Study|Withdrawal by Subject|1|||
128666832|NCT04661579|463077537|FG001|Overall Study|Withdrawal by Subject|4|||
128666833|NCT04661579|463077538|FG002|Overall Study|Withdrawal by Subject|0|||
128666834|NCT04661579|463077539|FG003|Overall Study|Withdrawal by Subject|2|||
128666835|NCT04661579|463077540|FG004|Overall Study|Withdrawal by Subject|0|||
128666836|NCT04661579|463077536|FG000|Overall Study|Death|1|||
128666837|NCT04661579|463077537|FG001|Overall Study|Death|0|||
128666838|NCT04661579|463077538|FG002|Overall Study|Death|0|||
128666839|NCT04661579|463077539|FG003|Overall Study|Death|0|||
128666840|NCT04661579|463077540|FG004|Overall Study|Death|0|||
128666841|NCT04661579|463077536|FG000|Overall Study|Other|1|||
128666842|NCT04661579|463077537|FG001|Overall Study|Other|2|||
128666843|NCT04661579|463077538|FG002|Overall Study|Other|1|||
128666844|NCT04661579|463077539|FG003|Overall Study|Other|1|||
128666845|NCT04661579|463077540|FG004|Overall Study|Other|1|||
128666846|NCT04661579|463077536|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
128666847|NCT04661579|463077537|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
128666848|NCT04661579|463077538|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
128666849|NCT04661579|463077539|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
128666850|NCT04661579|463077540|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
128666851|NCT00859456|463077542|FG000|Overall Study|Adverse Event|3|||
128666852|NCT00859456|463077542|FG000|Overall Study|Progressive disease|2|||
128666853|NCT00859456|463077542|FG000|Overall Study|Non-compliance|3|||
128666854|NCT03527732|463077543|FG000|Overall Study|Lost to Follow-up|21|||
128666855|NCT03527732|463077544|FG001|Overall Study|Lost to Follow-up|23|||
128666856|NCT03527732|463077545|FG002|Overall Study|Lost to Follow-up|80|||
128666857|NCT03527732|463077546|FG003|Overall Study|Lost to Follow-up|62|||
129000832|NCT00606684|464295297|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129215068|NCT02760498|465089439|FG003|Overall Study|Sponsor decision|3|||
128666858|NCT03527732|463077547|FG004|Overall Study|Lost to Follow-up|12|||
128666859|NCT03527732|463077548|FG005|Overall Study|Lost to Follow-up|20|||
128666860|NCT02280408|463077549|FG000|Overall Study|Lost to Follow-up|0|||
128666861|NCT02280408|463077550|FG001|Overall Study|Lost to Follow-up|2|||
128666862|NCT02280408|463077551|FG002|Overall Study|Lost to Follow-up|0|||
128666863|NCT02280408|463077552|FG003|Overall Study|Lost to Follow-up|0|||
128666864|NCT03710083|463077553|FG000|Overall Study|Withdrawal by Subject|2|||
128666865|NCT03710083|463077553|FG000|Overall Study|Unsuccessful Procedure|1|||
128666866|NCT00889720|463077555|FG000|Overall Study|Withdrawal by Subject|4|||
128666867|NCT00889720|463077555|FG000|Overall Study|Other|4|||
128666868|NCT00775593|463077556|FG000|Overall Study|Unmet eligibility criteria|6|||
128666869|NCT00775593|463077556|FG000|Overall Study|Death|1|||
128666870|NCT03904693|463077557|FG000|Overall Study|Death|0|||
128666871|NCT03904693|463077558|FG001|Overall Study|Death|0|||
128666872|NCT03904693|463077559|FG002|Overall Study|Death|3|||
128666873|NCT03904693|463077557|FG000|Overall Study|Physician Decision|0|||
128666874|NCT03904693|463077558|FG001|Overall Study|Physician Decision|0|||
128666875|NCT03904693|463077559|FG002|Overall Study|Physician Decision|2|||
128666876|NCT03904693|463077557|FG000|Overall Study|Withdrawal by Subject|0|||
128666877|NCT03904693|463077558|FG001|Overall Study|Withdrawal by Subject|1|||
128666878|NCT03904693|463077559|FG002|Overall Study|Withdrawal by Subject|4|||
128666879|NCT03865381|463077562|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
128666880|NCT03865381|463077562|FG000|Overall Study|Withdrawal by Subject|2|||
128666881|NCT05626322|463077563|FG000|Overall Study|Death|2|||
128666882|NCT05626322|463077564|FG001|Overall Study|Death|0|||
128666883|NCT05626322|463077565|FG002|Overall Study|Death|0|||
128666884|NCT05626322|463077563|FG000|Overall Study|Physician Decision|1|||
128666885|NCT05626322|463077564|FG001|Overall Study|Physician Decision|0|||
128666886|NCT05626322|463077565|FG002|Overall Study|Physician Decision|0|||
128666887|NCT05626322|463077563|FG000|Overall Study|Progressive Disease|0|||
128666888|NCT05626322|463077564|FG001|Overall Study|Progressive Disease|1|||
128666889|NCT05626322|463077565|FG002|Overall Study|Progressive Disease|1|||
128666890|NCT05626322|463077563|FG000|Overall Study|Study terminated by sponsor|0|||
128666891|NCT05626322|463077564|FG001|Overall Study|Study terminated by sponsor|1|||
128666892|NCT05626322|463077565|FG002|Overall Study|Study terminated by sponsor|0|||
128666893|NCT01519167|463077570|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
128666894|NCT01519167|463077571|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
128666895|NCT01519167|463077570|FG000|Overall Study|Adverse Event|0|||
128666896|NCT01519167|463077571|FG001|Overall Study|Adverse Event|1|||
128666897|NCT01519167|463077570|FG000|Overall Study|Lack of Efficacy|0|||
128666898|NCT01519167|463077571|FG001|Overall Study|Lack of Efficacy|1|||
128666899|NCT01519167|463077570|FG000|Overall Study|Medical condition changes&deep sedation|0|||
128666900|NCT01519167|463077571|FG001|Overall Study|Medical condition changes&deep sedation|2|||
128666901|NCT01519167|463077570|FG000|Overall Study|Physician Decision|0|||
128666902|NCT01519167|463077571|FG001|Overall Study|Physician Decision|1|||
128666903|NCT04200352|463077579|FG000|Overall Study|Death|1|||
128666904|NCT04200352|463077579|FG000|Overall Study|Adverse Event|6|||
128666905|NCT04200352|463077579|FG000|Overall Study|Withdrawal by parent/guardian|6|||
128666906|NCT04200352|463077579|FG000|Overall Study|Lack of Efficacy|1|||
128666907|NCT04200352|463077579|FG000|Overall Study|Other than specified|6|||
128666908|NCT00993148|463077580|FG000|Overall Study|Lost to Follow-up|2|||
128666909|NCT00993148|463077580|FG000|Overall Study|never initiated treatment|1|||
128666910|NCT00233064|463077581|FG000|Overall Study|Lost to Follow-up|7|||
128666911|NCT00233064|463077582|FG001|Overall Study|Lost to Follow-up|7|||
128666912|NCT00233064|463077581|FG000|Overall Study|Withdrawal by Subject|5|||
128666913|NCT00233064|463077582|FG001|Overall Study|Withdrawal by Subject|3|||
128666914|NCT00233064|463077581|FG000|Overall Study|Death|0|||
128666915|NCT00233064|463077582|FG001|Overall Study|Death|1|||
128666916|NCT00233064|463077581|FG000|Overall Study|Relocation|0|||
128666917|NCT00233064|463077582|FG001|Overall Study|Relocation|1|||
128666918|NCT00233064|463077581|FG000|Overall Study|Protocol Violation|1|||
128666919|NCT00233064|463077582|FG001|Overall Study|Protocol Violation|0|||
128666920|NCT00233064|463077581|FG000|Overall Study|Moved to Dom. Republic|1|||
128666921|NCT00233064|463077582|FG001|Overall Study|Moved to Dom. Republic|0|||
128666922|NCT01120964|463077589|FG000|Overall Study|Did not receive full treatment|1|||
128666923|NCT01120964|463077590|FG001|Overall Study|Did not receive full treatment|0|||
128666924|NCT04237116|463077594|FG000|Overall Study|Adverse Event|0|||
128666925|NCT04237116|463077595|FG001|Overall Study|Adverse Event|1|||
128666926|NCT04237116|463077594|FG000|Overall Study|Study terminated by Sponsor|4|||
128666927|NCT04237116|463077595|FG001|Overall Study|Study terminated by Sponsor|1|||
128666928|NCT00829504|463077596|FG000|First Intervention|Adverse Event|1|||
128666929|NCT00829504|463077597|FG001|First Intervention|Adverse Event|0|||
128666930|NCT00829504|463077596|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
128666931|NCT00829504|463077597|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
128666932|NCT00829504|463077596|FG000|Second Intervention|Physician Decision|1|||
128666933|NCT00829504|463077597|FG001|Second Intervention|Physician Decision|0|||
128666934|NCT03212144|463077598|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
128666935|NCT03212144|463077599|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
128666936|NCT03212144|463077598|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
128666937|NCT03212144|463077599|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
128666938|NCT00599339|463077600|FG000|Overall Study|Adverse Event|79|||
128666939|NCT00599339|463077600|FG000|Overall Study|Withdrawal by Subject|137|||
128666940|NCT00599339|463077600|FG000|Overall Study|Other Reason|179|||
128666941|NCT00599339|463077600|FG000|Overall Study|Lost to Follow-up|221|||
128666942|NCT00599339|463077600|FG000|Overall Study|No valid data consent|36|||
128666943|NCT00599339|463077600|FG000|Overall Study|Study Termination Status Unknown|12|||
128666948|NCT00924027|463077607|FG000|Overall Study|Lost to Further Follow-Up|4|||
128666949|NCT00924027|463077608|FG001|Overall Study|Lost to Further Follow-Up|0|||
128666950|NCT00924027|463077609|FG002|Overall Study|Lost to Further Follow-Up|0|||
128666951|NCT00924027|463077610|FG003|Overall Study|Lost to Further Follow-Up|0|||
128666952|NCT00924027|463077607|FG000|Overall Study|Physician Decision|1|||
128666953|NCT00924027|463077608|FG001|Overall Study|Physician Decision|0|||
128666954|NCT00924027|463077609|FG002|Overall Study|Physician Decision|0|||
128666955|NCT00924027|463077610|FG003|Overall Study|Physician Decision|1|||
128666956|NCT00924027|463077607|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
128666957|NCT00924027|463077608|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
128666958|NCT00924027|463077609|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
128666959|NCT00924027|463077610|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
128666960|NCT00924027|463077607|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
128666961|NCT00924027|463077608|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
128666962|NCT00924027|463077609|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
128666963|NCT00924027|463077610|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
128666964|NCT00924027|463077607|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
128666965|NCT00924027|463077608|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
128666966|NCT00924027|463077609|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
128666967|NCT00924027|463077610|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
128666972|NCT04193189|463077613|FG000|Overall Study|Lost to Follow-up|9|||
128666973|NCT04193189|463077614|FG001|Overall Study|Lost to Follow-up|7|||
128666974|NCT04193189|463077615|FG002|Overall Study|Lost to Follow-up|9|||
128666975|NCT04193189|463077616|FG003|Overall Study|Lost to Follow-up|0|||
128666976|NCT04193189|463077613|FG000|Overall Study|Withdrawal by Subject|1|||
128666977|NCT04193189|463077614|FG001|Overall Study|Withdrawal by Subject|2|||
128666978|NCT04193189|463077615|FG002|Overall Study|Withdrawal by Subject|2|||
128666979|NCT04193189|463077616|FG003|Overall Study|Withdrawal by Subject|0|||
128666980|NCT04193189|463077613|FG000|Overall Study|Death|1|||
128666981|NCT04193189|463077614|FG001|Overall Study|Death|1|||
128666982|NCT04193189|463077615|FG002|Overall Study|Death|0|||
128666983|NCT04193189|463077616|FG003|Overall Study|Death|0|||
128666984|NCT04193189|463077613|FG000|Overall Study|Protocol Violation|0|||
128666985|NCT04193189|463077614|FG001|Overall Study|Protocol Violation|0|||
128666986|NCT04193189|463077615|FG002|Overall Study|Protocol Violation|0|||
128666987|NCT04193189|463077616|FG003|Overall Study|Protocol Violation|1|||
128667016|NCT00476008|463078993|FG000|Overall Study|Adverse Event|4|||
128667017|NCT00476008|463078994|FG001|Overall Study|Adverse Event|4|||
128667018|NCT00476008|463078993|FG000|Overall Study|Placebo concerns|2|||
128667019|NCT00476008|463078994|FG001|Overall Study|Placebo concerns|2|||
128667020|NCT00476008|463078993|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
128667021|NCT00476008|463078994|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
128667022|NCT00476008|463078993|FG000|Overall Study|Withdrawal by Subject|0|||
129000833|NCT00606684|464295298|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129000834|NCT00606684|464295299|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129000835|NCT00606684|464295300|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129000836|NCT00606684|464295301|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129000837|NCT02763579|464295302|FG000|Global Period|Death|167|||
129000838|NCT02763579|464295303|FG001|Global Period|Death|151|||
129000839|NCT02763579|464295304|FG002|Global Period|Death|0|||
129000840|NCT02763579|464295305|FG003|Global Period|Death|0|||
129000841|NCT02763579|464295302|FG000|Global Period|Lost to Follow-up|2|||
129000842|NCT02763579|464295303|FG001|Global Period|Lost to Follow-up|4|||
129000843|NCT02763579|464295304|FG002|Global Period|Lost to Follow-up|0|||
129000844|NCT02763579|464295305|FG003|Global Period|Lost to Follow-up|0|||
129000845|NCT02763579|464295302|FG000|Global Period|Physician Decision|0|||
129000846|NCT02763579|464295303|FG001|Global Period|Physician Decision|2|||
129000847|NCT02763579|464295304|FG002|Global Period|Physician Decision|0|||
129000848|NCT02763579|464295305|FG003|Global Period|Physician Decision|0|||
129000849|NCT02763579|464295302|FG000|Global Period|Study Terminated By Sponsor|21|||
129000850|NCT02763579|464295303|FG001|Global Period|Study Terminated By Sponsor|26|||
128667023|NCT00476008|463078994|FG001|Overall Study|Withdrawal by Subject|1|||
129000851|NCT02763579|464295304|FG002|Global Period|Study Terminated By Sponsor|0|||
129000852|NCT02763579|464295305|FG003|Global Period|Study Terminated By Sponsor|0|||
129000853|NCT02763579|464295302|FG000|Global Period|Withdrawal by Subject|12|||
129000854|NCT02763579|464295303|FG001|Global Period|Withdrawal by Subject|18|||
129000855|NCT02763579|464295304|FG002|Global Period|Withdrawal by Subject|0|||
129000856|NCT02763579|464295305|FG003|Global Period|Withdrawal by Subject|0|||
129000857|NCT02763579|464295302|FG000|China Period|Death|0|||
129000858|NCT02763579|464295303|FG001|China Period|Death|0|||
129000859|NCT02763579|464295304|FG002|China Period|Death|46|||
129000860|NCT02763579|464295305|FG003|China Period|Death|48|||
129000861|NCT02763579|464295302|FG000|China Period|Lost to Follow-up|0|||
129000862|NCT02763579|464295303|FG001|China Period|Lost to Follow-up|0|||
129000863|NCT02763579|464295304|FG002|China Period|Lost to Follow-up|1|||
129000864|NCT02763579|464295305|FG003|China Period|Lost to Follow-up|1|||
129000865|NCT02763579|464295302|FG000|China Period|Physician Decision|0|||
129000866|NCT02763579|464295303|FG001|China Period|Physician Decision|0|||
129000867|NCT02763579|464295304|FG002|China Period|Physician Decision|0|||
129000868|NCT02763579|464295305|FG003|China Period|Physician Decision|1|||
129000869|NCT02763579|464295302|FG000|China Period|Study Terminated By Sponsor|0|||
129000870|NCT02763579|464295303|FG001|China Period|Study Terminated By Sponsor|0|||
129000871|NCT02763579|464295304|FG002|China Period|Study Terminated By Sponsor|3|||
129000872|NCT02763579|464295305|FG003|China Period|Study Terminated By Sponsor|4|||
129000873|NCT02763579|464295302|FG000|China Period|Withdrawal by Subject|0|||
129000874|NCT02763579|464295303|FG001|China Period|Withdrawal by Subject|0|||
129000875|NCT02763579|464295304|FG002|China Period|Withdrawal by Subject|3|||
129000876|NCT02763579|464295305|FG003|China Period|Withdrawal by Subject|3|||
129000877|NCT00910858|464295311|FG000|Pharmacokinetic Phase|Adverse Event|1|||
128667024|NCT00476008|463078993|FG000|Overall Study|Death|1|||
128667025|NCT00476008|463078994|FG001|Overall Study|Death|0|||
128667026|NCT00792571|463078997|FG000|Overall Study|Death|1|||
128667027|NCT00792571|463078997|FG000|Overall Study|Adverse Event|4|||
128667028|NCT00792571|463078997|FG000|Overall Study|Withdrawal by Subject|1|||
128667029|NCT00792571|463078997|FG000|Overall Study|Other|4|||
128667030|NCT02563067|463079006|FG000|Overall Study|Subject/guardian decision|14|||
128667031|NCT02563067|463079007|FG001|Overall Study|Subject/guardian decision|20|||
128667032|NCT02563067|463079008|FG002|Overall Study|Subject/guardian decision|16|||
128667033|NCT02563067|463079006|FG000|Overall Study|Physician Decision|0|||
128667034|NCT02563067|463079007|FG001|Overall Study|Physician Decision|1|||
128667035|NCT02563067|463079008|FG002|Overall Study|Physician Decision|3|||
128667036|NCT02563067|463079006|FG000|Overall Study|Lost to Follow-up|1|||
128667037|NCT02563067|463079007|FG001|Overall Study|Lost to Follow-up|2|||
128667038|NCT02563067|463079008|FG002|Overall Study|Lost to Follow-up|0|||
128667039|NCT02563067|463079006|FG000|Overall Study|Technical problems|0|||
128667040|NCT02563067|463079007|FG001|Overall Study|Technical problems|1|||
128667041|NCT02563067|463079008|FG002|Overall Study|Technical problems|0|||
128667042|NCT02563067|463079006|FG000|Overall Study|Lack of Efficacy|1|||
128667043|NCT02563067|463079007|FG001|Overall Study|Lack of Efficacy|0|||
129000878|NCT00910858|464295312|FG001|Pharmacokinetic Phase|Adverse Event|0|||
129000879|NCT00910858|464295313|FG002|Pharmacokinetic Phase|Adverse Event|0|||
129000880|NCT00910858|464295311|FG000|Monotherapy Phase|Adverse Event|3|||
129000881|NCT00910858|464295312|FG001|Monotherapy Phase|Adverse Event|2|||
128667044|NCT02563067|463079008|FG002|Overall Study|Lack of Efficacy|0|||
128667045|NCT02563067|463079006|FG000|Overall Study|Death|0|||
129000882|NCT00910858|464295313|FG002|Monotherapy Phase|Adverse Event|0|||
129000883|NCT00910858|464295311|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
128667046|NCT02563067|463079007|FG001|Overall Study|Death|1|||
128667047|NCT02563067|463079008|FG002|Overall Study|Death|1|||
129000884|NCT00910858|464295312|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
129000885|NCT00910858|464295313|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
129000886|NCT00910858|464295311|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
128667048|NCT02563067|463079006|FG000|Overall Study|Adverse Event|2|||
128667049|NCT02563067|463079007|FG001|Overall Study|Adverse Event|1|||
128667050|NCT02563067|463079008|FG002|Overall Study|Adverse Event|0|||
128667051|NCT02563067|463079006|FG000|Overall Study|Death post Treatment/safety period|1|||
128667052|NCT02563067|463079007|FG001|Overall Study|Death post Treatment/safety period|0|||
128667053|NCT02563067|463079008|FG002|Overall Study|Death post Treatment/safety period|0|||
128667054|NCT03544333|463079018|FG000|Overall Study|Withdrawal by Subject|1|||
129000887|NCT00910858|464295312|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
128667055|NCT03544333|463079019|FG001|Overall Study|Withdrawal by Subject|0|||
128667056|NCT01039519|463079023|FG000|Treatment|Progressive disease|20|||
128667057|NCT01039519|463079023|FG000|Treatment|Treatment failure|2|||
128667058|NCT01039519|463079023|FG000|Treatment|Adverse Event|3|||
128667059|NCT01039519|463079023|FG000|Treatment|Physician Decision|2|||
128667060|NCT01039519|463079023|FG000|Survival Follow-up|Death|23|||
128667061|NCT01039519|463079023|FG000|Survival Follow-up|Sponsor decision|4|||
128667062|NCT01330108|463079026|FG000|Overall Study|Withdrawal by Subject|4|||
128667063|NCT00243269|463079027|FG000|Overall Study|Protocol Violation|2|||
128667064|NCT00243269|463079028|FG001|Overall Study|Protocol Violation|1|||
128667065|NCT00243269|463079029|FG002|Overall Study|Protocol Violation|0|||
128667066|NCT00243269|463079030|FG003|Overall Study|Protocol Violation|1|||
128667067|NCT00243269|463079027|FG000|Overall Study|Lost to Follow-up|1|||
128667068|NCT00243269|463079028|FG001|Overall Study|Lost to Follow-up|0|||
128667069|NCT00243269|463079029|FG002|Overall Study|Lost to Follow-up|1|||
128667070|NCT00243269|463079030|FG003|Overall Study|Lost to Follow-up|3|||
128667071|NCT03052400|463079031|FG000|Overall Study|Lost to Follow-up|1|||
128667072|NCT03052400|463079032|FG001|Overall Study|Lost to Follow-up|0|||
128667073|NCT03052400|463079031|FG000|Overall Study|Withdrawal by Subject|0|||
128667074|NCT03052400|463079032|FG001|Overall Study|Withdrawal by Subject|1|||
128667075|NCT00555061|463079033|FG000|Overall Study|Adverse Event|3|||
128667076|NCT00555061|463079033|FG000|Overall Study|Protocol Violation|1|||
128667077|NCT00555061|463079033|FG000|Overall Study|Lost to Follow-up|2|||
128667078|NCT00555061|463079033|FG000|Overall Study|Withdrawal by Subject|2|||
128667079|NCT00555061|463079033|FG000|Overall Study|Participant enrolled, but never treated|1|||
128667080|NCT01396447|463079035|FG000|Overall Study|Did Not Receive Treatment|3|||
128667081|NCT01396447|463079036|FG001|Overall Study|Did Not Receive Treatment|2|||
128667082|NCT01396447|463079037|FG002|Overall Study|Did Not Receive Treatment|1|||
128667083|NCT01396447|463079038|FG003|Overall Study|Did Not Receive Treatment|0|||
129000888|NCT00910858|464295313|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
129000889|NCT00910858|464295311|FG000|Monotherapy Phase|Protocol Violation|1|||
129000890|NCT00910858|464295312|FG001|Monotherapy Phase|Protocol Violation|0|||
129000891|NCT00910858|464295313|FG002|Monotherapy Phase|Protocol Violation|0|||
129000892|NCT00910858|464295311|FG000|Monotherapy Phase|Other|3|||
129000893|NCT00910858|464295312|FG001|Monotherapy Phase|Other|4|||
129000894|NCT00910858|464295313|FG002|Monotherapy Phase|Other|2|||
129000895|NCT00910858|464295311|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
129000896|NCT00910858|464295312|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
129000897|NCT00910858|464295313|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
129000898|NCT00910858|464295311|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
129000899|NCT00910858|464295312|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
129000900|NCT00910858|464295313|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
129000901|NCT00910858|464295311|FG000|Combined Treatment Phase|Protocol Violation|1|||
129000902|NCT00910858|464295312|FG001|Combined Treatment Phase|Protocol Violation|0|||
129000903|NCT00910858|464295313|FG002|Combined Treatment Phase|Protocol Violation|0|||
129000904|NCT00910858|464295311|FG000|Combined Treatment Phase|Other|0|||
129000905|NCT00910858|464295312|FG001|Combined Treatment Phase|Other|2|||
129000906|NCT00910858|464295313|FG002|Combined Treatment Phase|Other|1|||
129000907|NCT01703741|464295320|FG000|Overall Study|Withdrawal by Subject|6|||
129000908|NCT01703741|464295320|FG000|Overall Study|Adverse Event|2|||
129000909|NCT01703741|464295320|FG000|Overall Study|Physician Decision|2|||
129000910|NCT01703741|464295320|FG000|Overall Study|Protocol Violation|1|||
129000911|NCT01703741|464295320|FG000|Overall Study|Lost to Follow-up|3|||
129000912|NCT01703741|464295320|FG000|Overall Study|Subject did not want to continue|2|||
129000913|NCT01703741|464295320|FG000|Overall Study|Subject cannot comply with study visits|1|||
129000914|NCT01703741|464295320|FG000|Overall Study|Subject started testosterone injections|1|||
129000915|NCT01170364|464295321|FG000|Overall Study|Protocol Violation|4|||
129000916|NCT01170364|464295322|FG001|Overall Study|Protocol Violation|1|||
129000917|NCT01381900|464295323|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
128667084|NCT01396447|463079035|FG000|Overall Study|Adverse Event|15|||
128667085|NCT01396447|463079036|FG001|Overall Study|Adverse Event|12|||
128667086|NCT01396447|463079037|FG002|Overall Study|Adverse Event|12|||
128667087|NCT01396447|463079038|FG003|Overall Study|Adverse Event|17|||
128667088|NCT01396447|463079035|FG000|Overall Study|Insufficient Therapeutic Response|5|||
128667089|NCT01396447|463079036|FG001|Overall Study|Insufficient Therapeutic Response|5|||
128667090|NCT01396447|463079037|FG002|Overall Study|Insufficient Therapeutic Response|2|||
129000918|NCT01381900|464295324|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
129000919|NCT01381900|464295325|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
128667091|NCT01396447|463079038|FG003|Overall Study|Insufficient Therapeutic Response|4|||
128667092|NCT01396447|463079035|FG000|Overall Study|Protocol Violation|5|||
128667093|NCT01396447|463079036|FG001|Overall Study|Protocol Violation|2|||
128667094|NCT01396447|463079037|FG002|Overall Study|Protocol Violation|3|||
128667095|NCT01396447|463079038|FG003|Overall Study|Protocol Violation|7|||
128667096|NCT01396447|463079035|FG000|Overall Study|Withdrawal of Consent|11|||
128667097|NCT01396447|463079036|FG001|Overall Study|Withdrawal of Consent|9|||
128667098|NCT01396447|463079037|FG002|Overall Study|Withdrawal of Consent|4|||
128667099|NCT01396447|463079038|FG003|Overall Study|Withdrawal of Consent|15|||
128667100|NCT01396447|463079035|FG000|Overall Study|Lost to Follow-up|4|||
128667101|NCT01396447|463079036|FG001|Overall Study|Lost to Follow-up|8|||
128667102|NCT01396447|463079037|FG002|Overall Study|Lost to Follow-up|7|||
128667103|NCT01396447|463079038|FG003|Overall Study|Lost to Follow-up|9|||
128667104|NCT01396447|463079035|FG000|Overall Study|Other Miscellaneous Reasons|0|||
128667105|NCT01396447|463079036|FG001|Overall Study|Other Miscellaneous Reasons|2|||
128667106|NCT01396447|463079037|FG002|Overall Study|Other Miscellaneous Reasons|1|||
128667107|NCT01396447|463079038|FG003|Overall Study|Other Miscellaneous Reasons|0|||
128667108|NCT04881942|463079039|FG000|Overall Study|Adverse Event|0|||
128667109|NCT04881942|463079040|FG001|Overall Study|Adverse Event|0|||
128667110|NCT04881942|463079041|FG002|Overall Study|Adverse Event|0|||
128667111|NCT04881942|463079042|FG003|Overall Study|Adverse Event|0|||
128667112|NCT04881942|463079043|FG004|Overall Study|Adverse Event|1|||
128667113|NCT04881942|463079039|FG000|Overall Study|Alternates|0|||
128667114|NCT04881942|463079040|FG001|Overall Study|Alternates|0|||
128667115|NCT04881942|463079041|FG002|Overall Study|Alternates|0|||
128667116|NCT04881942|463079042|FG003|Overall Study|Alternates|0|||
128667117|NCT04881942|463079043|FG004|Overall Study|Alternates|2|||
128667118|NCT01349959|463079044|FG000|Overall Study|Adverse Event|7|||
128667119|NCT02675634|463079045|FG000|Test Period 1|Adverse Event|0|||
128667120|NCT02675634|463079046|FG001|Test Period 1|Adverse Event|1|||
128667121|NCT02675634|463079047|FG002|Test Period 1|Adverse Event|0|||
128667122|NCT02675634|463079048|FG003|Test Period 1|Adverse Event|1|||
128667123|NCT02675634|463079049|FG004|Test Period 1|Adverse Event|0|||
128667124|NCT02675634|463079050|FG005|Test Period 1|Adverse Event|0|||
128667125|NCT02675634|463079045|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
128667126|NCT02675634|463079046|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
128667127|NCT02675634|463079047|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
128667128|NCT02675634|463079048|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
128667129|NCT02675634|463079049|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
128667130|NCT02675634|463079050|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
128667131|NCT02675634|463079045|FG000|Test Period 2|Lack of Efficacy|1|||
128667132|NCT02675634|463079046|FG001|Test Period 2|Lack of Efficacy|0|||
128667133|NCT02675634|463079047|FG002|Test Period 2|Lack of Efficacy|0|||
128667134|NCT02675634|463079048|FG003|Test Period 2|Lack of Efficacy|0|||
128667135|NCT02675634|463079049|FG004|Test Period 2|Lack of Efficacy|0|||
128667136|NCT02675634|463079050|FG005|Test Period 2|Lack of Efficacy|0|||
128667137|NCT02675634|463079045|FG000|Test Period 2|Adverse Event|0|||
128667138|NCT02675634|463079046|FG001|Test Period 2|Adverse Event|0|||
128667139|NCT02675634|463079047|FG002|Test Period 2|Adverse Event|0|||
128667140|NCT02675634|463079048|FG003|Test Period 2|Adverse Event|0|||
128667141|NCT02675634|463079049|FG004|Test Period 2|Adverse Event|0|||
128667142|NCT02675634|463079050|FG005|Test Period 2|Adverse Event|1|||
128667143|NCT01652534|463079051|FG000|Overall Study|Lack of Efficacy|1|||
128667144|NCT01652534|463079052|FG001|Overall Study|Lack of Efficacy|0|||
128667145|NCT03860259|463079053|FG000|Overall Study|Lost to Follow-up|5|||
128667146|NCT03860259|463079054|FG001|Overall Study|Lost to Follow-up|5|||
128667147|NCT03860259|463079053|FG000|Overall Study|Protocol Violation|1|||
128667148|NCT03860259|463079054|FG001|Overall Study|Protocol Violation|0|||
128667149|NCT00811018|463079055|FG000|Overall Study|Additional Chronic Treatment|31|||
128667150|NCT00811018|463079055|FG000|Overall Study|Adverse Event|79|||
128667151|NCT00811018|463079055|FG000|Overall Study|Death|147|||
128667152|NCT00811018|463079055|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
128667153|NCT00811018|463079055|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
128667154|NCT00811018|463079055|FG000|Overall Study|Investigator Decision|57|||
128667155|NCT00811018|463079055|FG000|Overall Study|Lost to Follow-up|19|||
128667156|NCT00811018|463079055|FG000|Overall Study|Pregnancy|6|||
128667157|NCT00811018|463079055|FG000|Overall Study|Sponsor Decision|450|||
128667158|NCT00811018|463079055|FG000|Overall Study|Withdrawal by Subject|70|||
128667159|NCT00811018|463079055|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
128667160|NCT00811018|463079055|FG000|Overall Study|Other|26|||
128667161|NCT01092117|463079059|FG000|Index Procedure to 1 Month|Death|1|||
128667162|NCT01092117|463079059|FG000|1 Month|Death|1|||
128667163|NCT01092117|463079059|FG000|1 Month|Withdrawal by Subject|1|||
128667164|NCT01092117|463079059|FG000|1 Month|Lost to Follow-up|1|||
128667165|NCT01092117|463079059|FG000|6 Months|Death|2|||
128667166|NCT01092117|463079059|FG000|6 Months|Withdrawal by Subject|3|||
128667167|NCT01092117|463079059|FG000|12 Month|Death|11|||
128667168|NCT01092117|463079059|FG000|12 Month|Withdrawal by Subject|2|||
128667169|NCT01092117|463079059|FG000|12 Month|Lost to Follow-up|1|||
128667170|NCT01092117|463079059|FG000|Year 2|Death|5|||
128667171|NCT01092117|463079059|FG000|Year 2|Withdrawal by Subject|4|||
128667172|NCT01092117|463079059|FG000|Year 2|Lost to Follow-up|1|||
128667173|NCT01092117|463079059|FG000|Year 3|Death|7|||
128667174|NCT01092117|463079059|FG000|Year 3|Withdrawal by Subject|9|||
128667175|NCT01092117|463079059|FG000|Year 3|Lost to Follow-up|3|||
128667176|NCT01092117|463079059|FG000|Year 4|Death|8|||
128667177|NCT01092117|463079059|FG000|Year 4|Withdrawal by Subject|4|||
128667178|NCT01092117|463079059|FG000|Year 4|Lost to Follow-up|4|||
128667179|NCT01623050|463079062|FG000|Overall Study|Lost to Follow-up|9|||
128667180|NCT02147561|463079065|FG000|Overall Study|Lost to Follow-up|3|||
128667181|NCT02147561|463079065|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
128667182|NCT01191762|463079066|FG000|Overall Study|Adverse Event|1|||
128667183|NCT01191762|463079067|FG001|Overall Study|Adverse Event|0|||
128667184|NCT00393861|463079070|FG000|Overall Study|Adverse Event|2|||
128667185|NCT00393861|463079070|FG000|Overall Study|Disease Progression|24|||
128667186|NCT00459186|463079071|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
128667187|NCT00459186|463079071|FG000|PET Imaging and Assessment|Adverse Event|3|||
128667188|NCT05300763|463079072|FG000|Overall Study|Adverse Event|0|||
128667189|NCT05300763|463079073|FG001|Overall Study|Adverse Event|1|||
128667190|NCT05300763|463079072|FG000|Overall Study|Major Protocol Deviation|1|||
128667191|NCT05300763|463079073|FG001|Overall Study|Major Protocol Deviation|0|||
128667192|NCT05300763|463079072|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
128667193|NCT05300763|463079073|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
128667194|NCT03801031|463079075|FG000|Overall Study|Lost to Follow-up|1|||
128667195|NCT03801031|463079076|FG001|Overall Study|Lost to Follow-up|0|||
128667196|NCT03801031|463079075|FG000|Overall Study|Unable to comply|1|||
128667197|NCT03801031|463079076|FG001|Overall Study|Unable to comply|0|||
128667198|NCT03801031|463079075|FG000|Overall Study|Withdrawal by Subject|0|||
128667199|NCT03801031|463079076|FG001|Overall Study|Withdrawal by Subject|1|||
128667200|NCT02948088|463079077|FG000|Overall Study|Lost to Follow-up|8|||
128667201|NCT02948088|463079077|FG000|Overall Study|Death|1|||
128667202|NCT02948088|463079077|FG000|Overall Study|Withdrawal by Subject|4|||
128667203|NCT02948088|463079077|FG000|Overall Study|Other|2|||
128667204|NCT01409811|463079078|FG000|Overall Study|Insurance denial|1|||
128667205|NCT01942733|463079079|FG000|Overall Study|Lost to Follow-up|1|||
128667206|NCT01942733|463079079|FG000|Overall Study|Non-compliance with IMP|1|||
128667207|NCT01942733|463079079|FG000|Overall Study|Administrative|1|||
128667208|NCT00634101|463079080|FG000|Overall Study|Study Terminated|3|||
128667209|NCT00634101|463079081|FG001|Overall Study|Study Terminated|3|||
128667210|NCT00634101|463079080|FG000|Overall Study|Lost to Follow-up|2|||
128667211|NCT00634101|463079081|FG001|Overall Study|Lost to Follow-up|0|||
128667212|NCT00838513|463079083|FG000|Screening Period|Screen Failure|3|||
128667213|NCT00838513|463079083|FG000|Extension Treatment Period|Death|1|||
128667214|NCT00838513|463079083|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
128667215|NCT00573144|463079087|FG000|Overall Study|Withdrawal by Subject|2|||
128667216|NCT00573144|463079088|FG001|Overall Study|Withdrawal by Subject|3|||
128667217|NCT00953056|463079089|FG000|Overall Study|Withdrew Consent|0|||
128667218|NCT00953056|463079090|FG001|Overall Study|Withdrew Consent|0|||
128667219|NCT00953056|463079091|FG002|Overall Study|Withdrew Consent|0|||
128667220|NCT00953056|463079092|FG003|Overall Study|Withdrew Consent|0|||
128667221|NCT00953056|463079093|FG004|Overall Study|Withdrew Consent|2|||
128667222|NCT00953056|463079094|FG005|Overall Study|Withdrew Consent|3|||
128667223|NCT00953056|463079089|FG000|Overall Study|Serious Adverse Event|0|||
128667224|NCT00953056|463079090|FG001|Overall Study|Serious Adverse Event|0|||
128667225|NCT00953056|463079091|FG002|Overall Study|Serious Adverse Event|0|||
128667226|NCT00953056|463079092|FG003|Overall Study|Serious Adverse Event|0|||
128667227|NCT00953056|463079093|FG004|Overall Study|Serious Adverse Event|0|||
129000920|NCT01381900|464295323|FG000|Overall Study|Adverse Event|4|||
129000921|NCT01381900|464295324|FG001|Overall Study|Adverse Event|6|||
129000922|NCT01381900|464295325|FG002|Overall Study|Adverse Event|7|||
129000923|NCT01381900|464295323|FG000|Overall Study|Noncompliance with study drug|0|||
129000924|NCT01381900|464295324|FG001|Overall Study|Noncompliance with study drug|0|||
129000925|NCT01381900|464295325|FG002|Overall Study|Noncompliance with study drug|1|||
128667228|NCT00953056|463079094|FG005|Overall Study|Serious Adverse Event|1|||
128667229|NCT02367833|463079095|FG000|Overall Study|Withdrawal by Subject|1|||
129000926|NCT01381900|464295323|FG000|Overall Study|Physician Decision|0|||
129000927|NCT01381900|464295324|FG001|Overall Study|Physician Decision|1|||
129000928|NCT01381900|464295325|FG002|Overall Study|Physician Decision|1|||
129215069|NCT02760498|465089440|FG004|Overall Study|Sponsor decision|0|||
128667230|NCT02367833|463079096|FG001|Overall Study|Withdrawal by Subject|1|||
128667231|NCT02367833|463079097|FG002|Overall Study|Withdrawal by Subject|0|||
128667232|NCT01077076|463079098|FG000|First Intervention|Withdrawal by Subject|1|||
128667233|NCT01077076|463079099|FG001|First Intervention|Withdrawal by Subject|0|||
128667234|NCT01077076|463079100|FG002|First Intervention|Withdrawal by Subject|0|||
128667235|NCT01077076|463079101|FG003|First Intervention|Withdrawal by Subject|0|||
129000929|NCT01381900|464295323|FG000|Overall Study|Protocol Violation|0|||
129000930|NCT01381900|464295324|FG001|Overall Study|Protocol Violation|1|||
129215070|NCT02760498|465089441|FG005|Overall Study|Sponsor decision|0|||
129000931|NCT01381900|464295325|FG002|Overall Study|Protocol Violation|1|||
129000932|NCT01381900|464295323|FG000|Overall Study|Withdrawal by Subject|0|||
128667236|NCT01077076|463079102|FG004|First Intervention|Withdrawal by Subject|0|||
128667237|NCT01077076|463079103|FG005|First Intervention|Withdrawal by Subject|0|||
128667238|NCT01077076|463079098|FG000|Third Intervention|Death in the participant's family|0|||
128667239|NCT01077076|463079099|FG001|Third Intervention|Death in the participant's family|0|||
128667240|NCT01077076|463079100|FG002|Third Intervention|Death in the participant's family|0|||
128667241|NCT01077076|463079101|FG003|Third Intervention|Death in the participant's family|0|||
128667242|NCT01077076|463079102|FG004|Third Intervention|Death in the participant's family|0|||
128667243|NCT01077076|463079103|FG005|Third Intervention|Death in the participant's family|1|||
128667244|NCT01327482|463079104|FG000|Overall Study|Adverse Event|1|||
128667245|NCT00476229|463079105|FG000|Overall Study|Progressive shortness of breath|1|||
128667246|NCT02164461|463079106|FG000|Overall Study|Adverse Event|0|||
128667247|NCT02164461|463079107|FG001|Overall Study|Adverse Event|0|||
128667248|NCT02164461|463079108|FG002|Overall Study|Adverse Event|1|||
128667249|NCT02164461|463079106|FG000|Overall Study|Disease Progression|1|||
128667250|NCT02164461|463079107|FG001|Overall Study|Disease Progression|3|||
128667251|NCT02164461|463079108|FG002|Overall Study|Disease Progression|4|||
128667252|NCT02164461|463079106|FG000|Overall Study|Withdrawal by Subject|0|||
128667253|NCT02164461|463079107|FG001|Overall Study|Withdrawal by Subject|3|||
128667254|NCT02164461|463079108|FG002|Overall Study|Withdrawal by Subject|0|||
128667255|NCT02100696|463079110|FG000|Induction Phase|Adverse Event|0|||
128667256|NCT02100696|463079111|FG001|Induction Phase|Adverse Event|0|||
128667257|NCT02100696|463079112|FG002|Induction Phase|Adverse Event|1|||
128667258|NCT02100696|463079113|FG003|Induction Phase|Adverse Event|0|||
128667259|NCT02100696|463079114|FG004|Induction Phase|Adverse Event|0|||
129000933|NCT01381900|464295324|FG001|Overall Study|Withdrawal by Subject|0|||
129000934|NCT01381900|464295325|FG002|Overall Study|Withdrawal by Subject|1|||
129000935|NCT01381900|464295323|FG000|Overall Study|Early withdraw|3|||
129000936|NCT01381900|464295324|FG001|Overall Study|Early withdraw|1|||
129000937|NCT01381900|464295325|FG002|Overall Study|Early withdraw|1|||
129000938|NCT02041494|464295326|FG000|Overall Study|Death|1|||
129000939|NCT02041494|464295327|FG001|Overall Study|Death|3|||
129000940|NCT02041494|464295326|FG000|Overall Study|Lost to Follow-up|2|||
129000941|NCT02041494|464295327|FG001|Overall Study|Lost to Follow-up|6|||
129000942|NCT02041494|464295326|FG000|Overall Study|study terminated|16|||
129000943|NCT02041494|464295327|FG001|Overall Study|study terminated|11|||
129000944|NCT02965820|464295331|FG000|Period 2, Second 30 Days|Adverse Event|1|||
129000945|NCT02965820|464295332|FG001|Period 2, Second 30 Days|Adverse Event|1|||
129000946|NCT01967888|464295333|FG000|Overall Study|Lost to Follow-up|6|||
129000947|NCT01967888|464295334|FG001|Overall Study|Lost to Follow-up|4|||
129000948|NCT01967888|464295333|FG000|Overall Study|Withdrawal by Subject|1|||
129000949|NCT01967888|464295334|FG001|Overall Study|Withdrawal by Subject|1|||
129000950|NCT01967888|464295333|FG000|Overall Study|Did Not Have Transplant|1|||
129000951|NCT01967888|464295334|FG001|Overall Study|Did Not Have Transplant|0|||
129000952|NCT01967888|464295333|FG000|Overall Study|Research visit not done, data recorded|1|||
129000953|NCT01967888|464295334|FG001|Overall Study|Research visit not done, data recorded|0|||
129000954|NCT01967888|464295333|FG000|Overall Study|Subject excluded after randomization|1|||
129000955|NCT01967888|464295334|FG001|Overall Study|Subject excluded after randomization|0|||
129000956|NCT01967888|464295333|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
129000957|NCT01967888|464295334|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
129000958|NCT01967888|464295333|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
129000959|NCT01967888|464295334|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
129000960|NCT00553540|464295335|FG000|Overall Study|discharged after first visit|2|||
129000961|NCT00553540|464295336|FG001|Overall Study|discharged after first visit|5|||
129000962|NCT02622074|464295337|FG000|Overall Study|Death|4|||
129000963|NCT02622074|464295338|FG001|Overall Study|Death|0|||
129000964|NCT02622074|464295339|FG002|Overall Study|Death|0|||
129000965|NCT02622074|464295340|FG003|Overall Study|Death|1|||
129000966|NCT02622074|464295341|FG004|Overall Study|Death|1|||
128667260|NCT02100696|463079115|FG005|Induction Phase|Adverse Event|0|||
128667261|NCT02100696|463079110|FG000|Induction Phase|Lost to Follow-up|1|||
128667262|NCT02100696|463079111|FG001|Induction Phase|Lost to Follow-up|0|||
128667263|NCT02100696|463079112|FG002|Induction Phase|Lost to Follow-up|1|||
128667264|NCT02100696|463079113|FG003|Induction Phase|Lost to Follow-up|0|||
129000967|NCT02622074|464295342|FG005|Overall Study|Death|0|||
129000968|NCT02622074|464295337|FG000|Overall Study|Withdrawal by Subject|0|||
129000969|NCT02622074|464295338|FG001|Overall Study|Withdrawal by Subject|1|||
129215071|NCT02760498|465089436|FG000|Overall Study|Physician Decision|3|||
128667265|NCT02100696|463079114|FG004|Induction Phase|Lost to Follow-up|0|||
129000970|NCT02622074|464295339|FG002|Overall Study|Withdrawal by Subject|0|||
129000971|NCT02622074|464295340|FG003|Overall Study|Withdrawal by Subject|0|||
129000972|NCT02622074|464295341|FG004|Overall Study|Withdrawal by Subject|0|||
129000973|NCT02622074|464295342|FG005|Overall Study|Withdrawal by Subject|0|||
129000974|NCT02114931|464295343|FG000|Overall Study|Withdrawal by Subject|15|||
129000975|NCT02114931|464295344|FG001|Overall Study|Withdrawal by Subject|18|||
129000976|NCT02114931|464295343|FG000|Overall Study|Adverse Event|4|||
129000977|NCT02114931|464295344|FG001|Overall Study|Adverse Event|6|||
129000978|NCT02114931|464295343|FG000|Overall Study|Lost to Follow-up|3|||
129000979|NCT02114931|464295344|FG001|Overall Study|Lost to Follow-up|3|||
129000980|NCT02114931|464295343|FG000|Overall Study|Physician Decision|1|||
129000981|NCT02114931|464295344|FG001|Overall Study|Physician Decision|2|||
128667266|NCT02100696|463079115|FG005|Induction Phase|Lost to Follow-up|0|||
128667267|NCT02100696|463079110|FG000|Induction Phase|Protocol Violation|0|||
128667268|NCT02100696|463079111|FG001|Induction Phase|Protocol Violation|1|||
128667269|NCT02100696|463079112|FG002|Induction Phase|Protocol Violation|1|||
128667270|NCT02100696|463079113|FG003|Induction Phase|Protocol Violation|0|||
128667271|NCT02100696|463079114|FG004|Induction Phase|Protocol Violation|0|||
128667272|NCT02100696|463079115|FG005|Induction Phase|Protocol Violation|0|||
128667273|NCT02100696|463079110|FG000|Induction Phase|Withdrawal by Subject|8|||
128667274|NCT02100696|463079111|FG001|Induction Phase|Withdrawal by Subject|2|||
128667275|NCT02100696|463079112|FG002|Induction Phase|Withdrawal by Subject|13|||
128667276|NCT02100696|463079113|FG003|Induction Phase|Withdrawal by Subject|0|||
128667277|NCT02100696|463079114|FG004|Induction Phase|Withdrawal by Subject|0|||
128667278|NCT02100696|463079115|FG005|Induction Phase|Withdrawal by Subject|0|||
128667279|NCT02100696|463079110|FG000|Induction Phase|Physician Decision|1|||
128667280|NCT02100696|463079111|FG001|Induction Phase|Physician Decision|0|||
128667281|NCT02100696|463079112|FG002|Induction Phase|Physician Decision|2|||
128667282|NCT02100696|463079113|FG003|Induction Phase|Physician Decision|0|||
128667283|NCT02100696|463079114|FG004|Induction Phase|Physician Decision|0|||
128667284|NCT02100696|463079115|FG005|Induction Phase|Physician Decision|0|||
128667285|NCT02100696|463079110|FG000|Induction Phase|Multiple Reasons|5|||
128667286|NCT02100696|463079111|FG001|Induction Phase|Multiple Reasons|2|||
128667287|NCT02100696|463079112|FG002|Induction Phase|Multiple Reasons|8|||
128667288|NCT02100696|463079113|FG003|Induction Phase|Multiple Reasons|0|||
128667289|NCT02100696|463079114|FG004|Induction Phase|Multiple Reasons|0|||
128667290|NCT02100696|463079115|FG005|Induction Phase|Multiple Reasons|0|||
128667291|NCT02100696|463079110|FG000|Maintenance Phase|Adverse Event|0|||
128667292|NCT02100696|463079111|FG001|Maintenance Phase|Adverse Event|0|||
128667293|NCT02100696|463079112|FG002|Maintenance Phase|Adverse Event|0|||
128667294|NCT02100696|463079113|FG003|Maintenance Phase|Adverse Event|0|||
128667295|NCT02100696|463079114|FG004|Maintenance Phase|Adverse Event|0|||
128667296|NCT02100696|463079115|FG005|Maintenance Phase|Adverse Event|2|||
128667297|NCT02100696|463079110|FG000|Maintenance Phase|Lost to Follow-up|0|||
128667298|NCT02100696|463079111|FG001|Maintenance Phase|Lost to Follow-up|0|||
128667299|NCT02100696|463079112|FG002|Maintenance Phase|Lost to Follow-up|0|||
128667300|NCT02100696|463079113|FG003|Maintenance Phase|Lost to Follow-up|0|||
128667301|NCT02100696|463079114|FG004|Maintenance Phase|Lost to Follow-up|1|||
128667302|NCT02100696|463079115|FG005|Maintenance Phase|Lost to Follow-up|0|||
128667303|NCT02100696|463079110|FG000|Maintenance Phase|Protocol Violation|0|||
128667304|NCT02100696|463079111|FG001|Maintenance Phase|Protocol Violation|0|||
128667305|NCT02100696|463079112|FG002|Maintenance Phase|Protocol Violation|0|||
128667306|NCT02100696|463079113|FG003|Maintenance Phase|Protocol Violation|0|||
128667307|NCT02100696|463079114|FG004|Maintenance Phase|Protocol Violation|1|||
128667308|NCT02100696|463079115|FG005|Maintenance Phase|Protocol Violation|0|||
128667309|NCT02100696|463079110|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128667310|NCT02100696|463079111|FG001|Maintenance Phase|Withdrawal by Subject|0|||
128667311|NCT02100696|463079112|FG002|Maintenance Phase|Withdrawal by Subject|0|||
128667312|NCT02100696|463079113|FG003|Maintenance Phase|Withdrawal by Subject|1|||
128667313|NCT02100696|463079114|FG004|Maintenance Phase|Withdrawal by Subject|4|||
128667314|NCT02100696|463079115|FG005|Maintenance Phase|Withdrawal by Subject|2|||
128667315|NCT02100696|463079110|FG000|Maintenance Phase|Physician Decision|0|||
128667316|NCT02100696|463079111|FG001|Maintenance Phase|Physician Decision|0|||
128667317|NCT02100696|463079112|FG002|Maintenance Phase|Physician Decision|0|||
128667318|NCT02100696|463079113|FG003|Maintenance Phase|Physician Decision|0|||
128667319|NCT02100696|463079114|FG004|Maintenance Phase|Physician Decision|1|||
128667320|NCT02100696|463079115|FG005|Maintenance Phase|Physician Decision|0|||
128667321|NCT02100696|463079110|FG000|Maintenance Phase|Multiple Reasons|0|||
128667322|NCT02100696|463079111|FG001|Maintenance Phase|Multiple Reasons|0|||
128667323|NCT02100696|463079112|FG002|Maintenance Phase|Multiple Reasons|0|||
128667324|NCT02100696|463079113|FG003|Maintenance Phase|Multiple Reasons|0|||
128667325|NCT02100696|463079114|FG004|Maintenance Phase|Multiple Reasons|2|||
128667326|NCT02100696|463079115|FG005|Maintenance Phase|Multiple Reasons|1|||
128667327|NCT01668589|463079116|FG000|Overall Study|Lost to Follow-up|29|||
128667328|NCT01668589|463079117|FG001|Overall Study|Lost to Follow-up|37|||
128667329|NCT01668589|463079118|FG002|Overall Study|Lost to Follow-up|15|||
128667330|NCT01668589|463079119|FG003|Overall Study|Lost to Follow-up|5|||
128667331|NCT01668589|463079116|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
128667332|NCT01668589|463079117|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
128667333|NCT01668589|463079118|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
128763106|NCT03145766|463422736|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
128667334|NCT01668589|463079119|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
129000982|NCT02114931|464295343|FG000|Overall Study|Other|2|||
129000983|NCT02114931|464295344|FG001|Overall Study|Other|1|||
129000984|NCT03565211|464295346|FG000|Overall Study|Withdrawal by Subject|2|||
129000985|NCT03565211|464295346|FG000|Overall Study|Lost to Follow-up|1|||
129000986|NCT03565211|464295346|FG000|Overall Study|Adverse Event|44|||
129000987|NCT03565211|464295346|FG000|Overall Study|Personal issues|1|||
129000988|NCT01894984|464295350|FG000|Overall Study|Other|314|||
129000989|NCT01894984|464295351|FG001|Overall Study|Other|175|||
129000990|NCT03840135|464295353|FG000|Overall Study|Protocol Violation|6|||
129000991|NCT03840135|464295354|FG001|Overall Study|Protocol Violation|1|||
129000992|NCT03840135|464295353|FG000|Overall Study|Withdrawal by Subject|1|||
129000993|NCT03840135|464295354|FG001|Overall Study|Withdrawal by Subject|0|||
129000994|NCT01809314|464295355|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
129000995|NCT01809314|464295355|FG000|Overall Study|Adverse Event|6|||
129000996|NCT01809314|464295355|FG000|Overall Study|Insufficient Therapeutic Response|14|||
129000997|NCT01809314|464295355|FG000|Overall Study|Lost to Follow-up|724|||
129000998|NCT01427803|464295360|FG000|Overall Study|Lost to Follow-up|32|||
129000999|NCT01427803|464295361|FG001|Overall Study|Lost to Follow-up|26|||
129001000|NCT01427803|464295360|FG000|Overall Study|Withdrawal by Subject|20|||
129001001|NCT01427803|464295361|FG001|Overall Study|Withdrawal by Subject|0|||
129001002|NCT01427803|464295360|FG000|Overall Study|Unable to complete full treatment period|6|||
129001003|NCT01427803|464295361|FG001|Overall Study|Unable to complete full treatment period|0|||
128667335|NCT01668589|463079116|FG000|Overall Study|Death|12|||
128667336|NCT01668589|463079117|FG001|Overall Study|Death|3|||
128667337|NCT01668589|463079118|FG002|Overall Study|Death|2|||
128667338|NCT01668589|463079119|FG003|Overall Study|Death|11|||
129001004|NCT01427803|464295360|FG000|Overall Study|Protocol Violation|1|||
129001005|NCT01427803|464295361|FG001|Overall Study|Protocol Violation|0|||
129001006|NCT01427803|464295360|FG000|Overall Study|Physician Decision|3|||
129001007|NCT01427803|464295361|FG001|Overall Study|Physician Decision|0|||
129001008|NCT01427803|464295360|FG000|Overall Study|did not take product|1|||
129001009|NCT01427803|464295361|FG001|Overall Study|did not take product|0|||
129001010|NCT00863057|464295362|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
129001011|NCT00863057|464295363|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
129001012|NCT00863057|464295364|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
129001013|NCT00863057|464295365|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
129001014|NCT00863057|464295362|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129001015|NCT00863057|464295363|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
129001016|NCT00863057|464295364|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129001017|NCT00863057|464295365|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129001018|NCT00863057|464295362|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
129001019|NCT00863057|464295363|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
129001020|NCT00863057|464295364|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
129001021|NCT00863057|464295365|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
129001022|NCT00863057|464295362|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
129001023|NCT00863057|464295363|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
129001024|NCT00863057|464295364|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
129001025|NCT00863057|464295365|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
129001026|NCT02741271|464295368|FG000|Overall Study|Lost to Follow-up|2|||
129001027|NCT02741271|464295369|FG001|Overall Study|Lost to Follow-up|0|||
129001028|NCT02741271|464295368|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129001029|NCT02741271|464295369|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129001030|NCT01612156|464295370|FG000|Overall Study|Protocol Violation|2|||
129001031|NCT01612156|464295371|FG001|Overall Study|Protocol Violation|0|||
129001032|NCT00410410|464295372|FG000|Induction Period (IP)|Death|1|||
129001033|NCT00410410|464295373|FG001|Induction Period (IP)|Death|0|||
129001034|NCT00410410|464295374|FG002|Induction Period (IP)|Death|0|||
129001035|NCT00410410|464295375|FG003|Induction Period (IP)|Death|0|||
129001036|NCT00410410|464295376|FG004|Induction Period (IP)|Death|0|||
129001037|NCT00410410|464295377|FG005|Induction Period (IP)|Death|0|||
129001038|NCT00410410|464295378|FG006|Induction Period (IP)|Death|0|||
129001039|NCT00410410|464295379|FG007|Induction Period (IP)|Death|0|||
128667339|NCT01668589|463079116|FG000|Overall Study|Other|44|||
128667340|NCT01668589|463079117|FG001|Overall Study|Other|10|||
129001040|NCT00410410|464295380|FG008|Induction Period (IP)|Death|0|||
129001041|NCT00410410|464295372|FG000|Induction Period (IP)|Adverse Event|3|||
129001042|NCT00410410|464295373|FG001|Induction Period (IP)|Adverse Event|4|||
129001043|NCT00410410|464295374|FG002|Induction Period (IP)|Adverse Event|2|||
129001044|NCT00410410|464295375|FG003|Induction Period (IP)|Adverse Event|4|||
129001045|NCT00410410|464295376|FG004|Induction Period (IP)|Adverse Event|1|||
129001046|NCT00410410|464295377|FG005|Induction Period (IP)|Adverse Event|0|||
129001047|NCT00410410|464295378|FG006|Induction Period (IP)|Adverse Event|0|||
129001048|NCT00410410|464295379|FG007|Induction Period (IP)|Adverse Event|0|||
129001049|NCT00410410|464295380|FG008|Induction Period (IP)|Adverse Event|0|||
129001050|NCT00410410|464295372|FG000|Induction Period (IP)|Lack of Efficacy|26|||
129001051|NCT00410410|464295373|FG001|Induction Period (IP)|Lack of Efficacy|24|||
129001052|NCT00410410|464295374|FG002|Induction Period (IP)|Lack of Efficacy|8|||
128667341|NCT01668589|463079118|FG002|Overall Study|Other|7|||
128667342|NCT01668589|463079119|FG003|Overall Study|Other|15|||
128667343|NCT00472030|463079123|FG000|Overall Study|Physician Decision|1|||
128667344|NCT00472030|463079124|FG001|Overall Study|Physician Decision|0|||
128667345|NCT02260180|463081584|FG000|Overall Study|Adverse Event|2|||
128667346|NCT02260180|463081585|FG001|Overall Study|Adverse Event|0|||
128667347|NCT02260180|463081586|FG002|Overall Study|Adverse Event|1|||
128667348|NCT03860818|463081589|FG000|Overall Study|Death|144|||
129001053|NCT00410410|464295375|FG003|Induction Period (IP)|Lack of Efficacy|8|||
129001054|NCT00410410|464295376|FG004|Induction Period (IP)|Lack of Efficacy|7|||
129001055|NCT00410410|464295377|FG005|Induction Period (IP)|Lack of Efficacy|7|||
128667349|NCT03860818|463081590|FG001|Overall Study|Death|195|||
128667350|NCT03860818|463081589|FG000|Overall Study|Graft Loss|32|||
128667351|NCT03860818|463081590|FG001|Overall Study|Graft Loss|45|||
128667352|NCT01139008|463081591|FG000|Overall Study|Withdrawal by Subject|5|||
128667353|NCT01139008|463081591|FG000|Overall Study|Non-compliant, lost product|1|||
128667354|NCT01715857|463081592|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
128667355|NCT00505778|463081593|FG000|Overall Study|Adverse Event|2|||
128667356|NCT00505778|463081594|FG001|Overall Study|Adverse Event|7|||
128667357|NCT00505778|463081593|FG000|Overall Study|Physician Decision|8|||
128667358|NCT00505778|463081594|FG001|Overall Study|Physician Decision|14|||
128667359|NCT00505778|463081593|FG000|Overall Study|Lost to Follow-up|17|||
128667360|NCT00505778|463081594|FG001|Overall Study|Lost to Follow-up|23|||
128667361|NCT00505778|463081593|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
128667362|NCT00505778|463081594|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
128667363|NCT00505778|463081593|FG000|Overall Study|Protocol Violation|7|||
128667364|NCT00505778|463081594|FG001|Overall Study|Protocol Violation|9|||
128667365|NCT00505778|463081593|FG000|Overall Study|Withdrawal by Subject|29|||
129001056|NCT00410410|464295378|FG006|Induction Period (IP)|Lack of Efficacy|0|||
129001057|NCT00410410|464295379|FG007|Induction Period (IP)|Lack of Efficacy|0|||
129001058|NCT00410410|464295380|FG008|Induction Period (IP)|Lack of Efficacy|0|||
129001059|NCT00410410|464295372|FG000|Induction Period (IP)|Lost to Follow-up|2|||
129001060|NCT00410410|464295373|FG001|Induction Period (IP)|Lost to Follow-up|2|||
129001061|NCT00410410|464295374|FG002|Induction Period (IP)|Lost to Follow-up|2|||
129001062|NCT00410410|464295375|FG003|Induction Period (IP)|Lost to Follow-up|3|||
129001063|NCT00410410|464295376|FG004|Induction Period (IP)|Lost to Follow-up|0|||
129001064|NCT00410410|464295377|FG005|Induction Period (IP)|Lost to Follow-up|1|||
129001065|NCT00410410|464295378|FG006|Induction Period (IP)|Lost to Follow-up|0|||
129001066|NCT00410410|464295379|FG007|Induction Period (IP)|Lost to Follow-up|0|||
129001067|NCT00410410|464295380|FG008|Induction Period (IP)|Lost to Follow-up|0|||
129001068|NCT00410410|464295372|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
129001069|NCT00410410|464295373|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
129001070|NCT00410410|464295374|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
129001071|NCT00410410|464295375|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
129001072|NCT00410410|464295376|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
129001073|NCT00410410|464295377|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
129001074|NCT00410410|464295378|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
129001075|NCT00410410|464295379|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
129001076|NCT00410410|464295380|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
129001077|NCT00410410|464295372|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001078|NCT00410410|464295373|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001079|NCT00410410|464295374|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
129001080|NCT00410410|464295375|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001081|NCT00410410|464295376|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001082|NCT00410410|464295377|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001083|NCT00410410|464295378|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001084|NCT00410410|464295379|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001085|NCT00410410|464295380|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129001086|NCT00410410|464295372|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129001087|NCT00410410|464295373|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129001088|NCT00410410|464295374|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129001089|NCT00410410|464295375|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129001090|NCT00410410|464295376|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
128667366|NCT00505778|463081594|FG001|Overall Study|Withdrawal by Subject|14|||
128667367|NCT00505778|463081593|FG000|Overall Study|Relapse|65|||
128667368|NCT00505778|463081594|FG001|Overall Study|Relapse|65|||
128667369|NCT00505778|463081593|FG000|Overall Study|Took No Study Drug|2|||
128667370|NCT00505778|463081594|FG001|Overall Study|Took No Study Drug|2|||
128667371|NCT05367492|463081596|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
128667372|NCT05367492|463081597|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
129001091|NCT00410410|464295377|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
129001092|NCT00410410|464295378|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129001093|NCT00410410|464295379|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129001094|NCT00410410|464295380|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129001095|NCT00410410|464295372|FG000|Induction Period (IP)|Other|0|||
129001096|NCT00410410|464295373|FG001|Induction Period (IP)|Other|0|||
129001097|NCT00410410|464295374|FG002|Induction Period (IP)|Other|1|||
129001098|NCT00410410|464295375|FG003|Induction Period (IP)|Other|0|||
129001099|NCT00410410|464295376|FG004|Induction Period (IP)|Other|0|||
129001100|NCT00410410|464295377|FG005|Induction Period (IP)|Other|0|||
129001101|NCT00410410|464295378|FG006|Induction Period (IP)|Other|0|||
129001102|NCT00410410|464295379|FG007|Induction Period (IP)|Other|0|||
129001103|NCT00410410|464295380|FG008|Induction Period (IP)|Other|0|||
129001104|NCT00410410|464295372|FG000|Maintenance Period (MP)|Death|0|||
129001105|NCT00410410|464295373|FG001|Maintenance Period (MP)|Death|0|||
129001106|NCT00410410|464295374|FG002|Maintenance Period (MP)|Death|0|||
129001107|NCT00410410|464295375|FG003|Maintenance Period (MP)|Death|0|||
129001108|NCT00410410|464295376|FG004|Maintenance Period (MP)|Death|0|||
129001109|NCT00410410|464295377|FG005|Maintenance Period (MP)|Death|0|||
129001110|NCT00410410|464295378|FG006|Maintenance Period (MP)|Death|1|||
129001111|NCT00410410|464295379|FG007|Maintenance Period (MP)|Death|0|||
129001112|NCT00410410|464295380|FG008|Maintenance Period (MP)|Death|0|||
129001113|NCT00410410|464295372|FG000|Maintenance Period (MP)|Adverse Event|0|||
129001114|NCT00410410|464295373|FG001|Maintenance Period (MP)|Adverse Event|0|||
129001115|NCT00410410|464295374|FG002|Maintenance Period (MP)|Adverse Event|0|||
129001116|NCT00410410|464295375|FG003|Maintenance Period (MP)|Adverse Event|0|||
129001117|NCT00410410|464295376|FG004|Maintenance Period (MP)|Adverse Event|0|||
129001118|NCT00410410|464295377|FG005|Maintenance Period (MP)|Adverse Event|0|||
129001119|NCT00410410|464295378|FG006|Maintenance Period (MP)|Adverse Event|1|||
129001120|NCT00410410|464295379|FG007|Maintenance Period (MP)|Adverse Event|3|||
129001121|NCT00410410|464295380|FG008|Maintenance Period (MP)|Adverse Event|0|||
129001122|NCT00410410|464295372|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
129001123|NCT00410410|464295373|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
129001124|NCT00410410|464295374|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
129001125|NCT00410410|464295375|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
129001126|NCT00410410|464295376|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
129001127|NCT00410410|464295377|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
129001128|NCT00410410|464295378|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
129001129|NCT00410410|464295379|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
129001130|NCT00410410|464295380|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
129001131|NCT00410410|464295372|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
129001132|NCT00410410|464295373|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
129001133|NCT00410410|464295374|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
129001134|NCT00410410|464295375|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
129001135|NCT00410410|464295376|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
129001136|NCT00410410|464295377|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
129001137|NCT00410410|464295378|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
129001138|NCT00410410|464295379|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
129001139|NCT00410410|464295380|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
129001140|NCT00410410|464295372|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
129001141|NCT00410410|464295373|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
129001142|NCT00410410|464295374|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
129001143|NCT00410410|464295375|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
129001144|NCT00410410|464295376|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
129001145|NCT00410410|464295377|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
129001146|NCT00410410|464295378|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
129001147|NCT00410410|464295379|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
129001148|NCT00410410|464295380|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
129001149|NCT00410410|464295372|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
128667373|NCT05367492|463081598|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
128667374|NCT05367492|463081596|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
128667375|NCT05367492|463081597|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
128667376|NCT05367492|463081598|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
128667377|NCT05367492|463081596|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
128667378|NCT05367492|463081597|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
129001150|NCT00410410|464295373|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129001151|NCT00410410|464295374|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129001152|NCT00410410|464295375|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
128667379|NCT05367492|463081598|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
128667380|NCT05367492|463081596|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
129001153|NCT00410410|464295376|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129001154|NCT00410410|464295377|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129001155|NCT00410410|464295378|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
129001156|NCT00410410|464295379|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
129001157|NCT00410410|464295380|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129001158|NCT00410410|464295372|FG000|Open-Label Period (OL)|Death|0|||
129001159|NCT00410410|464295373|FG001|Open-Label Period (OL)|Death|0|||
128667381|NCT05367492|463081597|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
128667382|NCT05367492|463081598|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
128667383|NCT00808080|463081600|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
128667384|NCT00423917|463081601|FG000|Overall Study|Cancel|2|||
128667385|NCT00423917|463081601|FG000|Overall Study|Ineligible|1|||
128667386|NCT03085797|463081602|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
128667387|NCT03085797|463081603|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
128667388|NCT03085797|463081602|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
128667389|NCT03085797|463081603|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
128667390|NCT03085797|463081602|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
128667391|NCT03085797|463081603|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
128667392|NCT01175083|463081606|FG000|Primary Epoch|Withdrawal by Subject|0|||
128667393|NCT01175083|463081607|FG001|Primary Epoch|Withdrawal by Subject|0|||
128667394|NCT01175083|463081608|FG002|Primary Epoch|Withdrawal by Subject|0|||
128667395|NCT01175083|463081609|FG003|Primary Epoch|Withdrawal by Subject|0|||
128667396|NCT01175083|463081610|FG004|Primary Epoch|Withdrawal by Subject|0|||
128667397|NCT01175083|463081611|FG005|Primary Epoch|Withdrawal by Subject|2|||
128667398|NCT01175083|463081606|FG000|Primary Epoch|Lost to Follow-up|0|||
128667399|NCT01175083|463081607|FG001|Primary Epoch|Lost to Follow-up|0|||
128667400|NCT01175083|463081608|FG002|Primary Epoch|Lost to Follow-up|0|||
128667401|NCT01175083|463081609|FG003|Primary Epoch|Lost to Follow-up|0|||
128667402|NCT01175083|463081610|FG004|Primary Epoch|Lost to Follow-up|0|||
128667403|NCT01175083|463081611|FG005|Primary Epoch|Lost to Follow-up|1|||
128667404|NCT01175083|463081606|FG000|Booster Epoch|Death|0|||
128667405|NCT01175083|463081607|FG001|Booster Epoch|Death|0|||
128667406|NCT01175083|463081608|FG002|Booster Epoch|Death|1|||
128667407|NCT01175083|463081609|FG003|Booster Epoch|Death|0|||
128667408|NCT01175083|463081610|FG004|Booster Epoch|Death|0|||
128667409|NCT01175083|463081611|FG005|Booster Epoch|Death|0|||
128667410|NCT01175083|463081606|FG000|Booster Epoch|Withdrawal by Subject|0|||
128667411|NCT01175083|463081607|FG001|Booster Epoch|Withdrawal by Subject|0|||
128667412|NCT01175083|463081608|FG002|Booster Epoch|Withdrawal by Subject|0|||
128667413|NCT01175083|463081609|FG003|Booster Epoch|Withdrawal by Subject|1|||
128667414|NCT01175083|463081610|FG004|Booster Epoch|Withdrawal by Subject|0|||
128667415|NCT01175083|463081611|FG005|Booster Epoch|Withdrawal by Subject|0|||
128667416|NCT00475306|463081612|FG000|Overall Study|Protocol Violation|1|||
128667417|NCT00475306|463081613|FG001|Overall Study|Protocol Violation|1|||
128667418|NCT00475306|463081614|FG002|Overall Study|Protocol Violation|0|||
128667419|NCT00475306|463081615|FG003|Overall Study|Protocol Violation|1|||
128667420|NCT01716052|463081616|FG000|Overall Study|Withdrawal of funding|1|||
128667421|NCT01716052|463081617|FG001|Overall Study|Withdrawal of funding|1|||
128667422|NCT02405442|463081618|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
128667423|NCT02405442|463081619|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
128667424|NCT02405442|463081620|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
128667425|NCT02405442|463081621|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
128667426|NCT02405442|463081618|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
128667427|NCT02405442|463081619|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
128667428|NCT02405442|463081620|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
128667429|NCT02405442|463081621|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
128667430|NCT02405442|463081618|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
128667431|NCT02405442|463081619|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
128667432|NCT02405442|463081620|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
128667433|NCT02405442|463081621|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
128667434|NCT02405442|463081618|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
128667435|NCT02405442|463081619|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
128667436|NCT02405442|463081620|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
128667437|NCT02405442|463081621|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
128667438|NCT02405442|463081618|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
128667439|NCT02405442|463081619|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
128667440|NCT02405442|463081620|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
128667441|NCT02405442|463081621|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
128667442|NCT02405442|463081618|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
128667443|NCT02405442|463081619|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
128667444|NCT02405442|463081620|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
128667445|NCT02405442|463081621|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
128667446|NCT02405442|463081618|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
128667447|NCT02405442|463081619|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
128667448|NCT02405442|463081620|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
128667449|NCT02405442|463081621|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
128667450|NCT02405442|463081618|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
128667451|NCT02405442|463081619|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
129001160|NCT00410410|464295374|FG002|Open-Label Period (OL)|Death|0|||
129001161|NCT00410410|464295375|FG003|Open-Label Period (OL)|Death|0|||
129001162|NCT00410410|464295376|FG004|Open-Label Period (OL)|Death|0|||
129001163|NCT00410410|464295377|FG005|Open-Label Period (OL)|Death|0|||
128667452|NCT02405442|463081620|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
128667453|NCT02405442|463081621|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
128667454|NCT02405442|463081618|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
128667455|NCT02405442|463081619|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
128667456|NCT02405442|463081620|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
128667457|NCT02405442|463081621|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
128667458|NCT02405442|463081618|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
128667459|NCT02405442|463081619|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
128667460|NCT02405442|463081620|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
128667461|NCT02405442|463081621|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
128667462|NCT02405442|463081618|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
128667463|NCT02405442|463081619|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
128667464|NCT02405442|463081620|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
128667465|NCT02405442|463081621|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
128667466|NCT02405442|463081618|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
128667467|NCT02405442|463081619|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
128667468|NCT02405442|463081620|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
128667469|NCT02405442|463081621|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
128667470|NCT02405442|463081618|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
128667471|NCT02405442|463081619|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
128667472|NCT02405442|463081620|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
128667473|NCT02405442|463081621|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
128667474|NCT02405442|463081618|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
128667475|NCT02405442|463081619|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
128667476|NCT02405442|463081620|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
128667477|NCT02405442|463081621|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
128667478|NCT03275350|463081623|FG000|Overall Study|Lost to Follow-up|4|||
128667479|NCT03275350|463081624|FG001|Overall Study|Lost to Follow-up|6|||
128667480|NCT03275350|463081623|FG000|Overall Study|Death|2|||
128667481|NCT03275350|463081624|FG001|Overall Study|Death|1|||
128667482|NCT03275350|463081623|FG000|Overall Study|Physician Decision|1|||
128667483|NCT03275350|463081624|FG001|Overall Study|Physician Decision|0|||
128667484|NCT03275350|463081623|FG000|Overall Study|Incarcerated|1|||
128667485|NCT03275350|463081624|FG001|Overall Study|Incarcerated|1|||
128667486|NCT01652469|463081626|FG000|Overall Study|Withdrawal by Subject|1|||
128667487|NCT01652469|463081627|FG001|Overall Study|Withdrawal by Subject|4|||
128667488|NCT01652469|463081626|FG000|Overall Study|Lost to Follow-up|0|||
128667489|NCT01652469|463081627|FG001|Overall Study|Lost to Follow-up|2|||
128667490|NCT00796978|463081628|FG000|Overall Study|Cardiac adverse event|5|||
128667491|NCT00796978|463081628|FG000|Overall Study|Adverse Event|4|||
128667492|NCT00796978|463081628|FG000|Overall Study|Withdrawal by Subject|3|||
128667493|NCT01386970|463081629|FG000|Overall Study|Withdrawal by Subject|0|||
128667494|NCT01386970|463081630|FG001|Overall Study|Withdrawal by Subject|1|||
128667495|NCT01386970|463081629|FG000|Overall Study|Adverse Event|4|||
128667496|NCT01386970|463081630|FG001|Overall Study|Adverse Event|1|||
128667497|NCT00578292|463081631|FG000|Overall Study|Death|1|||
128667498|NCT00578292|463081631|FG000|Overall Study|Graft failure|2|||
128667499|NCT04849559|463081632|FG000|Overall Study|Withdrawal by Subject|2|||
128667500|NCT04849559|463081633|FG001|Overall Study|Withdrawal by Subject|1|||
128667501|NCT02910986|463081634|FG000|Overall Study|non-Latina|14|||
128667502|NCT02910986|463081635|FG001|Overall Study|non-Latina|13|||
128667503|NCT02910986|463081636|FG002|Overall Study|non-Latina|12|||
128667504|NCT02910986|463081634|FG000|Overall Study|Failure to return T! survey|72|||
128667505|NCT02910986|463081635|FG001|Overall Study|Failure to return T! survey|84|||
128667506|NCT02910986|463081636|FG002|Overall Study|Failure to return T! survey|72|||
128667507|NCT02910986|463081634|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
128667508|NCT02910986|463081635|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
128667509|NCT02910986|463081636|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
128667510|NCT02910986|463081634|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
128667511|NCT02910986|463081635|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
128667512|NCT02910986|463081636|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
128667513|NCT02105961|463081637|FG000|Overall Study|Adverse Event|18|||
128667514|NCT02105961|463081638|FG001|Overall Study|Adverse Event|7|||
128667515|NCT02105961|463081639|FG002|Overall Study|Adverse Event|13|||
128667516|NCT02105961|463081637|FG000|Overall Study|Lack of Efficacy|3|||
129001164|NCT00410410|464295378|FG006|Open-Label Period (OL)|Death|0|||
129001165|NCT00410410|464295379|FG007|Open-Label Period (OL)|Death|0|||
128667517|NCT02105961|463081638|FG001|Overall Study|Lack of Efficacy|0|||
128667518|NCT02105961|463081639|FG002|Overall Study|Lack of Efficacy|3|||
128667519|NCT02105961|463081637|FG000|Overall Study|Lost to Follow-up|2|||
128667520|NCT02105961|463081638|FG001|Overall Study|Lost to Follow-up|0|||
128667521|NCT02105961|463081639|FG002|Overall Study|Lost to Follow-up|1|||
128667522|NCT02105961|463081637|FG000|Overall Study|Physician Decision|3|||
128667523|NCT02105961|463081638|FG001|Overall Study|Physician Decision|3|||
128667524|NCT02105961|463081639|FG002|Overall Study|Physician Decision|2|||
128667525|NCT02105961|463081637|FG000|Overall Study|Withdrawal by Subject|15|||
128667526|NCT02105961|463081638|FG001|Overall Study|Withdrawal by Subject|7|||
128667527|NCT02105961|463081639|FG002|Overall Study|Withdrawal by Subject|11|||
128667528|NCT00934362|463081640|FG000|Overall Study|Adverse Event|1|||
128667529|NCT00934362|463081641|FG001|Overall Study|Adverse Event|0|||
128667530|NCT04380519|463081644|FG000|Overall Study|Withdrawal by Subject|4|||
128667531|NCT04380519|463081645|FG001|Overall Study|Withdrawal by Subject|0|||
128667532|NCT04380519|463081646|FG002|Overall Study|Withdrawal by Subject|1|||
128667533|NCT04380519|463081644|FG000|Overall Study|Death|14|||
128667534|NCT04380519|463081645|FG001|Overall Study|Death|9|||
128667535|NCT04380519|463081646|FG002|Overall Study|Death|6|||
128667536|NCT04380519|463081644|FG000|Overall Study|Adverse Event|0|||
128667537|NCT04380519|463081645|FG001|Overall Study|Adverse Event|1|||
128667538|NCT04380519|463081646|FG002|Overall Study|Adverse Event|0|||
128667539|NCT04380519|463081644|FG000|Overall Study|relatives' decision|0|||
128667540|NCT04380519|463081645|FG001|Overall Study|relatives' decision|1|||
128667541|NCT04380519|463081646|FG002|Overall Study|relatives' decision|0|||
128667542|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
128667543|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
128667544|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
128667545|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
128667546|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
128667547|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
128667548|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
128667549|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
128667550|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
128667551|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
128667552|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
128667553|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
128667554|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
128667555|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
128667556|NCT04173494|463081647|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
128667557|NCT04173494|463081648|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
128667558|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
128667559|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
128667560|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
128667561|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
128667562|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
128667563|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
128667564|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
128667565|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
128667566|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
128667567|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
128667568|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
128667569|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
128667570|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
128667571|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
128667572|NCT04173494|463081647|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
128667573|NCT04173494|463081648|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
128667574|NCT02474069|463081649|FG000|Selection Phase (SP)|Adverse Event|8|||
128667575|NCT02474069|463081650|FG001|Selection Phase (SP)|Adverse Event|0|||
128667576|NCT02474069|463081651|FG002|Selection Phase (SP)|Adverse Event|0|||
129001166|NCT00410410|464295380|FG008|Open-Label Period (OL)|Death|1|||
129001167|NCT00410410|464295372|FG000|Open-Label Period (OL)|Adverse Event|0|||
129001168|NCT00410410|464295373|FG001|Open-Label Period (OL)|Adverse Event|0|||
129001169|NCT00410410|464295374|FG002|Open-Label Period (OL)|Adverse Event|0|||
128667577|NCT02474069|463081649|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
128667578|NCT02474069|463081650|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
128667579|NCT02474069|463081651|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
128667580|NCT02474069|463081649|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
128667581|NCT02474069|463081650|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
128667582|NCT02474069|463081651|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
129001170|NCT00410410|464295375|FG003|Open-Label Period (OL)|Adverse Event|0|||
128667583|NCT02474069|463081649|FG000|Selection Phase (SP)|Physician Decision|1|||
129001171|NCT00410410|464295376|FG004|Open-Label Period (OL)|Adverse Event|0|||
129001172|NCT00410410|464295377|FG005|Open-Label Period (OL)|Adverse Event|0|||
129001173|NCT00410410|464295378|FG006|Open-Label Period (OL)|Adverse Event|0|||
129001174|NCT00410410|464295379|FG007|Open-Label Period (OL)|Adverse Event|0|||
129001175|NCT00410410|464295380|FG008|Open-Label Period (OL)|Adverse Event|10|||
129001176|NCT00410410|464295372|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
129001177|NCT00410410|464295373|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
129001178|NCT00410410|464295374|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
129001179|NCT00410410|464295375|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
129001180|NCT00410410|464295376|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
129001181|NCT00410410|464295377|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
129001182|NCT00410410|464295378|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
129001183|NCT00410410|464295379|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
129001184|NCT00410410|464295380|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
129001185|NCT00410410|464295372|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
129001186|NCT00410410|464295373|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
129001187|NCT00410410|464295374|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
129001188|NCT00410410|464295375|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
129001189|NCT00410410|464295376|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
129001190|NCT00410410|464295377|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
129001191|NCT00410410|464295378|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
129001192|NCT00410410|464295379|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
129001193|NCT00410410|464295380|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
129001194|NCT00410410|464295372|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001195|NCT00410410|464295373|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001196|NCT00410410|464295374|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001197|NCT00410410|464295375|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001198|NCT00410410|464295376|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001199|NCT00410410|464295377|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001200|NCT00410410|464295378|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001201|NCT00410410|464295379|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
129001202|NCT00410410|464295380|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
129001203|NCT00410410|464295372|FG000|Open-Label Period (OL)|Pregnancy|0|||
129001204|NCT00410410|464295373|FG001|Open-Label Period (OL)|Pregnancy|0|||
129001205|NCT00410410|464295374|FG002|Open-Label Period (OL)|Pregnancy|0|||
129001206|NCT00410410|464295375|FG003|Open-Label Period (OL)|Pregnancy|0|||
129001207|NCT00410410|464295376|FG004|Open-Label Period (OL)|Pregnancy|0|||
129001208|NCT00410410|464295377|FG005|Open-Label Period (OL)|Pregnancy|0|||
129001209|NCT00410410|464295378|FG006|Open-Label Period (OL)|Pregnancy|0|||
129001210|NCT00410410|464295379|FG007|Open-Label Period (OL)|Pregnancy|0|||
129001211|NCT00410410|464295380|FG008|Open-Label Period (OL)|Pregnancy|1|||
129001212|NCT00410410|464295372|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129001213|NCT00410410|464295373|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129001214|NCT00410410|464295374|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129001215|NCT00410410|464295375|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129001216|NCT00410410|464295376|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
128667584|NCT02474069|463081650|FG001|Selection Phase (SP)|Physician Decision|0|||
128667585|NCT02474069|463081651|FG002|Selection Phase (SP)|Physician Decision|0|||
128667586|NCT02474069|463081649|FG000|Selection Phase (SP)|Protocol Violation|1|||
128667587|NCT02474069|463081650|FG001|Selection Phase (SP)|Protocol Violation|0|||
128667588|NCT02474069|463081651|FG002|Selection Phase (SP)|Protocol Violation|0|||
128667589|NCT02474069|463081649|FG000|Selection Phase (SP)|No longer requires treatment|1|||
128667590|NCT02474069|463081650|FG001|Selection Phase (SP)|No longer requires treatment|0|||
128667591|NCT02474069|463081651|FG002|Selection Phase (SP)|No longer requires treatment|0|||
128667592|NCT02474069|463081649|FG000|Selection Phase (SP)|Technical Problem|1|||
128667593|NCT02474069|463081650|FG001|Selection Phase (SP)|Technical Problem|0|||
128667594|NCT02474069|463081651|FG002|Selection Phase (SP)|Technical Problem|0|||
128667595|NCT02474069|463081649|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
128667596|NCT02474069|463081650|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
128667597|NCT02474069|463081651|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
128667598|NCT02474069|463081649|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
128667599|NCT02474069|463081650|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
129001217|NCT00410410|464295377|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129001218|NCT00410410|464295378|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129001219|NCT00410410|464295379|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129001220|NCT00410410|464295380|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
129001221|NCT00410410|464295372|FG000|Open-Label Period (OL)|Other|0|||
129001222|NCT00410410|464295373|FG001|Open-Label Period (OL)|Other|0|||
129001223|NCT00410410|464295374|FG002|Open-Label Period (OL)|Other|0|||
129001224|NCT00410410|464295375|FG003|Open-Label Period (OL)|Other|0|||
128667600|NCT02474069|463081651|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
128667601|NCT02474069|463081649|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
129001225|NCT00410410|464295376|FG004|Open-Label Period (OL)|Other|0|||
128667602|NCT02474069|463081650|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
128667603|NCT02474069|463081651|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
128667604|NCT02474069|463081649|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
128667605|NCT02474069|463081650|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
128667606|NCT02474069|463081651|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
128667607|NCT02474069|463081649|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
128667608|NCT02474069|463081650|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
128667609|NCT02474069|463081651|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
128667610|NCT02474069|463081649|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
128667611|NCT02474069|463081650|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
128667612|NCT02474069|463081651|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
128667613|NCT01727024|463081652|FG000|Period 1|Lost to Follow-up|1|||
128667614|NCT01727024|463081653|FG001|Period 1|Lost to Follow-up|1|||
128667615|NCT01727024|463081652|FG000|Period 1|Withdrawal by Subject|2|||
128667616|NCT01727024|463081653|FG001|Period 1|Withdrawal by Subject|3|||
128667617|NCT01485172|463081654|FG000|Overall Study|Adverse Event|2|||
128667618|NCT01485172|463081655|FG001|Overall Study|Adverse Event|1|||
128667619|NCT01485172|463081656|FG002|Overall Study|Adverse Event|2|||
128667620|NCT01485172|463081657|FG003|Overall Study|Adverse Event|2|||
128667621|NCT01485172|463081658|FG004|Overall Study|Adverse Event|1|||
128667622|NCT01485172|463081659|FG005|Overall Study|Adverse Event|2|||
128667623|NCT01485172|463081654|FG000|Overall Study|Lack of Efficacy|2|||
128667624|NCT01485172|463081655|FG001|Overall Study|Lack of Efficacy|0|||
128667625|NCT01485172|463081656|FG002|Overall Study|Lack of Efficacy|0|||
128667626|NCT01485172|463081657|FG003|Overall Study|Lack of Efficacy|0|||
128667627|NCT01485172|463081658|FG004|Overall Study|Lack of Efficacy|0|||
128667628|NCT01485172|463081659|FG005|Overall Study|Lack of Efficacy|0|||
128667629|NCT01485172|463081654|FG000|Overall Study|Protocol Violation|0|||
128667630|NCT01485172|463081655|FG001|Overall Study|Protocol Violation|0|||
128667631|NCT01485172|463081656|FG002|Overall Study|Protocol Violation|4|||
128667632|NCT01485172|463081657|FG003|Overall Study|Protocol Violation|5|||
128667633|NCT01485172|463081658|FG004|Overall Study|Protocol Violation|1|||
128667634|NCT01485172|463081659|FG005|Overall Study|Protocol Violation|0|||
128667635|NCT01485172|463081654|FG000|Overall Study|Protocol defined stopping criteria|1|||
128667636|NCT01485172|463081655|FG001|Overall Study|Protocol defined stopping criteria|0|||
129001226|NCT00410410|464295377|FG005|Open-Label Period (OL)|Other|0|||
129001227|NCT00410410|464295378|FG006|Open-Label Period (OL)|Other|0|||
129001228|NCT00410410|464295379|FG007|Open-Label Period (OL)|Other|0|||
129001229|NCT00410410|464295380|FG008|Open-Label Period (OL)|Other|7|||
129001230|NCT01023269|464295381|FG000|Overall Study|early termination of the study|2|||
129001231|NCT01023269|464295382|FG001|Overall Study|early termination of the study|0|||
129001232|NCT00947011|464295385|FG000|Overall Study|Study was terminated,PI left institution|12|||
129001233|NCT00814658|464295386|FG000|Overall Study|Lost to Follow-up|0|||
129001234|NCT00814658|464295387|FG001|Overall Study|Lost to Follow-up|1|||
129001235|NCT00814658|464295386|FG000|Overall Study|Physician Decision|1|||
129001236|NCT00814658|464295387|FG001|Overall Study|Physician Decision|0|||
129001237|NCT00814658|464295386|FG000|Overall Study|Adverse Event|3|||
129001238|NCT00814658|464295387|FG001|Overall Study|Adverse Event|3|||
129001239|NCT05266456|464295388|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
129001240|NCT05266456|464295389|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
129001241|NCT05266456|464295390|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
129001242|NCT05266456|464295391|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
129001243|NCT05266456|464295388|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
129001244|NCT05266456|464295389|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
129001245|NCT05266456|464295390|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
129001246|NCT05266456|464295391|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
129001247|NCT05266456|464295388|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
129001248|NCT05266456|464295389|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
129001249|NCT05266456|464295390|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
129001250|NCT05266456|464295391|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
129001251|NCT05266456|464295388|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
129001252|NCT05266456|464295389|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
129001253|NCT05266456|464295390|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
129001254|NCT05266456|464295391|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
129001255|NCT05266456|464295388|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
128667637|NCT01485172|463081656|FG002|Overall Study|Protocol defined stopping criteria|0|||
128667638|NCT01485172|463081657|FG003|Overall Study|Protocol defined stopping criteria|0|||
129001256|NCT05266456|464295389|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
129001257|NCT05266456|464295390|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
128667639|NCT01485172|463081658|FG004|Overall Study|Protocol defined stopping criteria|1|||
128667640|NCT01485172|463081659|FG005|Overall Study|Protocol defined stopping criteria|0|||
128667641|NCT01485172|463081654|FG000|Overall Study|Lost to Follow-up|0|||
128667642|NCT01485172|463081655|FG001|Overall Study|Lost to Follow-up|0|||
129001258|NCT05266456|464295391|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
128667643|NCT01485172|463081656|FG002|Overall Study|Lost to Follow-up|1|||
128667644|NCT01485172|463081657|FG003|Overall Study|Lost to Follow-up|0|||
128667645|NCT01485172|463081658|FG004|Overall Study|Lost to Follow-up|0|||
128667646|NCT01485172|463081659|FG005|Overall Study|Lost to Follow-up|1|||
129001259|NCT01141283|464295392|FG000|Overall Study|Adverse Event|56|||
129001260|NCT01141283|464295392|FG000|Overall Study|Lost to Follow-up|4|||
129001261|NCT01141283|464295392|FG000|Overall Study|Withdrawal by Subject|14|||
129001262|NCT01141283|464295392|FG000|Overall Study|Administrative|4|||
129001263|NCT01141283|464295392|FG000|Overall Study|Lack of Efficacy|10|||
129001264|NCT02868281|464295393|FG000|Overall Study|Adverse Event|2|||
129001265|NCT02868281|464295394|FG001|Overall Study|Adverse Event|2|||
129001266|NCT02868281|464295393|FG000|Overall Study|Protocol Violation|13|||
129001267|NCT02868281|464295394|FG001|Overall Study|Protocol Violation|10|||
129001268|NCT02868281|464295393|FG000|Overall Study|Lost to Follow-up|3|||
129001269|NCT02868281|464295394|FG001|Overall Study|Lost to Follow-up|6|||
129001270|NCT02868281|464295393|FG000|Overall Study|Withdrawal by Subject|11|||
129001271|NCT02868281|464295394|FG001|Overall Study|Withdrawal by Subject|15|||
129001272|NCT02868281|464295393|FG000|Overall Study|Physician Decision|2|||
129001273|NCT02868281|464295394|FG001|Overall Study|Physician Decision|0|||
129001274|NCT02868281|464295393|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
129001275|NCT02868281|464295394|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
129001276|NCT02868281|464295393|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
129001277|NCT02868281|464295394|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
129001278|NCT02868281|464295393|FG000|Overall Study|Long journey/moving away|1|||
129001279|NCT02868281|464295394|FG001|Overall Study|Long journey/moving away|1|||
129001280|NCT03124381|464295395|FG000|Overall Study|Lost to Follow-up|1|||
129001281|NCT03124381|464295396|FG001|Overall Study|Lost to Follow-up|1|||
129001282|NCT03124381|464295395|FG000|Overall Study|Withdrawal by Subject|6|||
129001283|NCT03124381|464295396|FG001|Overall Study|Withdrawal by Subject|3|||
129001284|NCT03124381|464295395|FG000|Overall Study|Protocol Violation|0|||
128667647|NCT01485172|463081654|FG000|Overall Study|Physician Decision|0|||
128667648|NCT01485172|463081655|FG001|Overall Study|Physician Decision|0|||
128667649|NCT01485172|463081656|FG002|Overall Study|Physician Decision|0|||
128667650|NCT01485172|463081657|FG003|Overall Study|Physician Decision|0|||
128667651|NCT01485172|463081658|FG004|Overall Study|Physician Decision|1|||
128667652|NCT01485172|463081659|FG005|Overall Study|Physician Decision|0|||
128667653|NCT01485172|463081654|FG000|Overall Study|Withdrawal by Subject|2|||
128667654|NCT01485172|463081655|FG001|Overall Study|Withdrawal by Subject|0|||
128667655|NCT01485172|463081656|FG002|Overall Study|Withdrawal by Subject|0|||
128667656|NCT01485172|463081657|FG003|Overall Study|Withdrawal by Subject|1|||
128667657|NCT01485172|463081658|FG004|Overall Study|Withdrawal by Subject|1|||
128667658|NCT01485172|463081659|FG005|Overall Study|Withdrawal by Subject|1|||
128667659|NCT02283762|463081660|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
128667660|NCT02283762|463081661|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
128667661|NCT02283762|463081660|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
128667662|NCT02283762|463081661|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
128667663|NCT02283762|463081660|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
128667664|NCT02283762|463081661|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
128667665|NCT02283762|463081660|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
128667666|NCT02283762|463081661|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
128667667|NCT02283762|463081660|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
128667668|NCT02283762|463081661|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
128667669|NCT02283762|463081660|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
128667670|NCT02283762|463081661|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
128667671|NCT02283762|463081660|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
128667672|NCT02283762|463081661|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
128667673|NCT02283762|463081660|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
128667674|NCT02283762|463081661|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
128667675|NCT02283762|463081660|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
128667676|NCT02283762|463081661|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
128667677|NCT02283762|463081660|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
128667678|NCT02283762|463081661|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
129001285|NCT03124381|464295396|FG001|Overall Study|Protocol Violation|1|||
129001286|NCT03124381|464295395|FG000|Overall Study|Adverse Event|1|||
129001287|NCT03124381|464295396|FG001|Overall Study|Adverse Event|1|||
129001288|NCT03124381|464295395|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
129001289|NCT03124381|464295396|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
129001290|NCT02533999|464295402|FG000|Overall Study|Lost to Follow-up|3|||
129001291|NCT02533999|464295403|FG001|Overall Study|Lost to Follow-up|5|||
129001292|NCT02533999|464295402|FG000|Overall Study|Protocol Violation|3|||
128667679|NCT02283762|463081660|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
128667680|NCT02283762|463081661|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
128667681|NCT02283762|463081660|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
129001293|NCT02533999|464295403|FG001|Overall Study|Protocol Violation|0|||
128667682|NCT02283762|463081661|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
128667683|NCT02920242|463081665|FG000|Overall Study|Withdrawal by Subject|1|||
128667684|NCT02920242|463081666|FG001|Overall Study|Withdrawal by Subject|0|||
128667685|NCT02920242|463081667|FG002|Overall Study|Withdrawal by Subject|1|||
128667686|NCT02920242|463081665|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
128667687|NCT02920242|463081666|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
128667688|NCT02920242|463081667|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
128667689|NCT00202878|463081668|FG000|Overall Study|Death|964|||
128667690|NCT00202878|463081669|FG001|Overall Study|Death|968|||
128667691|NCT00202878|463081668|FG000|Overall Study|Only Vital Status Known|357|||
128667692|NCT00202878|463081669|FG001|Overall Study|Only Vital Status Known|356|||
129001294|NCT02533999|464295402|FG000|Overall Study|Adverse Event|0|||
129001295|NCT02533999|464295403|FG001|Overall Study|Adverse Event|1|||
129001296|NCT02533999|464295402|FG000|Overall Study|Randomized but intervention not received|0|||
129001297|NCT02533999|464295403|FG001|Overall Study|Randomized but intervention not received|1|||
129001298|NCT01875445|464295404|FG000|Overall Study|Lost to Follow-up|5|||
129001299|NCT01875445|464295405|FG001|Overall Study|Lost to Follow-up|0|||
129001300|NCT01875445|464295404|FG000|Overall Study|Withdrawal by Subject|2|||
129001301|NCT01875445|464295405|FG001|Overall Study|Withdrawal by Subject|0|||
129001302|NCT01328054|464295406|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
129001303|NCT01328054|464295407|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
129001304|NCT01328054|464295406|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
129001305|NCT01328054|464295407|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
129001306|NCT01328054|464295406|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
129001307|NCT01328054|464295407|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
129001308|NCT05478603|464295408|FG000|Overall Study|Withdrawal by Subject|0|||
129001309|NCT05478603|464295409|FG001|Overall Study|Withdrawal by Subject|1|||
129001310|NCT05478603|464295410|FG002|Overall Study|Withdrawal by Subject|0|||
129001311|NCT05478603|464295411|FG003|Overall Study|Withdrawal by Subject|0|||
129001312|NCT00291330|464295414|FG000|Overall Study|Adverse Event|47|||
128667693|NCT00202878|463081668|FG000|Overall Study|Lost to Follow-up|44|||
128667694|NCT00202878|463081669|FG001|Overall Study|Lost to Follow-up|49|||
128667695|NCT00202878|463081668|FG000|Overall Study|Site Closure|39|||
128667696|NCT00202878|463081669|FG001|Overall Study|Site Closure|36|||
128667697|NCT00202878|463081668|FG000|Overall Study|Withdrawal by Subject|795|||
128667698|NCT00202878|463081669|FG001|Overall Study|Withdrawal by Subject|808|||
128667699|NCT01587014|463081670|FG000|Overall Study|Death|2|||
128667700|NCT00139477|463081677|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
128667701|NCT00139477|463081678|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
128667702|NCT00139477|463081677|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
128667703|NCT00139477|463081678|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
128667704|NCT00139477|463081677|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
128667705|NCT00139477|463081678|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
128667706|NCT00139477|463081677|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
128667707|NCT00139477|463081678|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
128667708|NCT00139477|463081677|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
128667709|NCT00139477|463081678|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
128667710|NCT00139477|463081677|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
128667711|NCT00139477|463081678|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
128667712|NCT00139477|463081677|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
128667713|NCT00139477|463081678|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
128667714|NCT02625909|463081686|FG000|Overall Study|Death|2|||
128667715|NCT02625909|463081687|FG001|Overall Study|Death|0|||
128667716|NCT02625909|463081686|FG000|Overall Study|Lost to Follow-up|3|||
128667717|NCT02625909|463081687|FG001|Overall Study|Lost to Follow-up|5|||
128667718|NCT02625909|463081686|FG000|Overall Study|Lack of Efficacy|9|||
128667719|NCT02625909|463081687|FG001|Overall Study|Lack of Efficacy|2|||
128667720|NCT02625909|463081686|FG000|Overall Study|Reinfection|3|||
128667721|NCT02625909|463081687|FG001|Overall Study|Reinfection|2|||
129001313|NCT00291330|464295415|FG001|Overall Study|Adverse Event|40|||
129001314|NCT00291330|464295414|FG000|Overall Study|Protocol Violation|13|||
129001315|NCT00291330|464295415|FG001|Overall Study|Protocol Violation|20|||
129001316|NCT00291330|464295414|FG000|Overall Study|Lost to Follow-up|16|||
128667722|NCT00035932|463081692|FG000|Overall Study|Adverse Event|10|||
128667723|NCT00035932|463081693|FG001|Overall Study|Adverse Event|9|||
128667724|NCT00035932|463081694|FG002|Overall Study|Adverse Event|9|||
128667725|NCT00035932|463081692|FG000|Overall Study|Death|0|||
128667726|NCT00035932|463081693|FG001|Overall Study|Death|0|||
128667727|NCT00035932|463081694|FG002|Overall Study|Death|1|||
128667728|NCT00035932|463081692|FG000|Overall Study|Disease Progression / Relapse|1|||
129001317|NCT00291330|464295415|FG001|Overall Study|Lost to Follow-up|11|||
129001318|NCT00291330|464295414|FG000|Overall Study|Withdrawal by Subject|22|||
129001319|NCT00291330|464295415|FG001|Overall Study|Withdrawal by Subject|25|||
129001320|NCT00291330|464295414|FG000|Overall Study|Other|3|||
129001321|NCT00291330|464295415|FG001|Overall Study|Other|1|||
129001322|NCT02378506|464295420|FG000|Overall Study|Lack of Efficacy|3|||
129001323|NCT02378506|464295420|FG000|Overall Study|Withdrawal by Subject|4|||
129001324|NCT02378506|464295420|FG000|Overall Study|Protocol Violation|2|||
129001325|NCT02378506|464295420|FG000|Overall Study|Death|1|||
129001326|NCT02378506|464295420|FG000|Overall Study|Adverse Event|14|||
128667729|NCT00035932|463081693|FG001|Overall Study|Disease Progression / Relapse|1|||
128667730|NCT00035932|463081694|FG002|Overall Study|Disease Progression / Relapse|0|||
129001327|NCT02378506|464295420|FG000|Overall Study|Randomized But Not Treated|1|||
129001328|NCT01606137|464295421|FG000|Overall Study|Adverse Event|85|||
129001329|NCT01606137|464295421|FG000|Overall Study|Withdrawal by Subject|74|||
129001330|NCT01606137|464295421|FG000|Overall Study|Lack of Efficacy|56|||
129001331|NCT01606137|464295421|FG000|Overall Study|Lost to Follow-up|15|||
128667731|NCT00035932|463081692|FG000|Overall Study|Lost to Follow-up|4|||
128667732|NCT00035932|463081693|FG001|Overall Study|Lost to Follow-up|4|||
128667733|NCT00035932|463081694|FG002|Overall Study|Lost to Follow-up|3|||
128667734|NCT00035932|463081692|FG000|Overall Study|Noncompliance|6|||
128667735|NCT00035932|463081693|FG001|Overall Study|Noncompliance|7|||
128667736|NCT00035932|463081694|FG002|Overall Study|Noncompliance|6|||
128667737|NCT00035932|463081692|FG000|Overall Study|Protocol Violation While on Study|0|||
128667738|NCT00035932|463081693|FG001|Overall Study|Protocol Violation While on Study|1|||
128667739|NCT00035932|463081694|FG002|Overall Study|Protocol Violation While on Study|2|||
128667740|NCT00035932|463081692|FG000|Overall Study|Withdrawal by Subject|1|||
128667741|NCT00035932|463081693|FG001|Overall Study|Withdrawal by Subject|5|||
128667742|NCT00035932|463081694|FG002|Overall Study|Withdrawal by Subject|0|||
128667743|NCT00035932|463081692|FG000|Overall Study|Study Termination by Sponsor|1|||
128667744|NCT00035932|463081693|FG001|Overall Study|Study Termination by Sponsor|0|||
128667745|NCT00035932|463081694|FG002|Overall Study|Study Termination by Sponsor|0|||
128667746|NCT00035932|463081692|FG000|Overall Study|Lack of Efficacy|33|||
128667747|NCT00035932|463081693|FG001|Overall Study|Lack of Efficacy|33|||
128667748|NCT00035932|463081694|FG002|Overall Study|Lack of Efficacy|28|||
128667749|NCT01976741|463081695|FG000|Overall Study|Withdrawal by Subject|1|||
128667750|NCT01976741|463081696|FG001|Overall Study|Withdrawal by Subject|0|||
128667751|NCT01976741|463081697|FG002|Overall Study|Withdrawal by Subject|1|||
128667752|NCT01976741|463081698|FG003|Overall Study|Withdrawal by Subject|1|||
128667753|NCT01976741|463081699|FG004|Overall Study|Withdrawal by Subject|0|||
128667754|NCT01976741|463081700|FG005|Overall Study|Withdrawal by Subject|0|||
128667755|NCT01976741|463081701|FG006|Overall Study|Withdrawal by Subject|1|||
128667756|NCT01976741|463081702|FG007|Overall Study|Withdrawal by Subject|4|||
128667757|NCT01976741|463081703|FG008|Overall Study|Withdrawal by Subject|0|||
128667758|NCT01976741|463081704|FG009|Overall Study|Withdrawal by Subject|0|||
128667759|NCT01976741|463081695|FG000|Overall Study|Adverse Event|0|||
128667760|NCT01976741|463081696|FG001|Overall Study|Adverse Event|0|||
128667761|NCT01976741|463081697|FG002|Overall Study|Adverse Event|2|||
128667762|NCT01976741|463081698|FG003|Overall Study|Adverse Event|0|||
128667763|NCT01976741|463081699|FG004|Overall Study|Adverse Event|0|||
128667764|NCT01976741|463081700|FG005|Overall Study|Adverse Event|0|||
128667765|NCT01976741|463081701|FG006|Overall Study|Adverse Event|3|||
128667766|NCT01976741|463081702|FG007|Overall Study|Adverse Event|8|||
128667767|NCT01976741|463081703|FG008|Overall Study|Adverse Event|1|||
129001332|NCT01606137|464295421|FG000|Overall Study|Protocol Violation|1|||
129001333|NCT01606137|464295421|FG000|Overall Study|Patient non-compliance|9|||
129001334|NCT01606137|464295421|FG000|Overall Study|Death|1|||
129001335|NCT01606137|464295421|FG000|Overall Study|Decreased/no pain|4|||
129001336|NCT01606137|464295421|FG000|Overall Study|Issues with driving|4|||
129001337|NCT01606137|464295421|FG000|Overall Study|multiple sclerosis less stable|1|||
129001338|NCT01606137|464295421|FG000|Overall Study|Increased bilirubin|1|||
129001339|NCT01606137|464295421|FG000|Overall Study|Spray causes nausea|1|||
129001340|NCT01606137|464295421|FG000|Overall Study|Not enough improvement|4|||
129001341|NCT01606137|464295421|FG000|Overall Study|Wanted to try another treatment|1|||
129001342|NCT01606137|464295421|FG000|Overall Study|Patient leaving country|1|||
129001343|NCT01606137|464295421|FG000|Overall Study|Personal reasons|1|||
129001344|NCT01606137|464295421|FG000|Overall Study|Unable to tolerate study med. taste|1|||
128667768|NCT01976741|463081704|FG009|Overall Study|Adverse Event|4|||
128667769|NCT01388335|463081705|FG000|Period 1|Progressive Disease|1|||
128667770|NCT01388335|463081705|FG000|Period 2|Progressive Disease|2|||
128667771|NCT01388335|463081705|FG000|Period 2|Sponsor Decision|1|||
128667772|NCT01388335|463081705|FG000|Safety Extension|Progressive Disease|7|||
128667773|NCT00670306|463081708|FG000|Overall Study|Adverse Event|8|||
128667774|NCT00670306|463081708|FG000|Overall Study|Lack of Efficacy|10|||
128667775|NCT00670306|463081708|FG000|Overall Study|Withdrawal by Subject|9|||
128667776|NCT00670306|463081708|FG000|Overall Study|Physician Decision|1|||
128667777|NCT00670306|463081708|FG000|Overall Study|Lost to Follow-up|8|||
128667778|NCT00670306|463081708|FG000|Overall Study|incl/excl criterias did not meet|19|||
129001345|NCT01606137|464295421|FG000|Overall Study|Patient moving|1|||
129001346|NCT01606137|464295421|FG000|Overall Study|Unable to collect consistent data|1|||
129001347|NCT03372083|464297515|FG000|Overall Study|Adverse Event|3|||
129001348|NCT03372083|464297515|FG000|Overall Study|Physician Decision|1|||
128667779|NCT02167139|463081709|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
128667780|NCT02167139|463081710|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
128667781|NCT02167139|463081711|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
128667782|NCT02167139|463081712|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
128667783|NCT02167139|463081709|FG000|Randomised, Double-blind|Adverse Event|2|||
128667784|NCT02167139|463081710|FG001|Randomised, Double-blind|Adverse Event|9|||
128667785|NCT02167139|463081711|FG002|Randomised, Double-blind|Adverse Event|0|||
128667786|NCT02167139|463081712|FG003|Randomised, Double-blind|Adverse Event|0|||
128667787|NCT02167139|463081709|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
128667788|NCT02167139|463081710|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
128667789|NCT02167139|463081711|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
128667790|NCT02167139|463081712|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
128667791|NCT02167139|463081709|FG000|Randomised, Double-blind|Other|3|||
128667792|NCT02167139|463081710|FG001|Randomised, Double-blind|Other|0|||
128667793|NCT02167139|463081711|FG002|Randomised, Double-blind|Other|0|||
128667794|NCT02167139|463081712|FG003|Randomised, Double-blind|Other|0|||
128667795|NCT02167139|463081709|FG000|Transition-extension|Adverse Event|2|||
128667796|NCT02167139|463081710|FG001|Transition-extension|Adverse Event|0|||
128667797|NCT02167139|463081711|FG002|Transition-extension|Adverse Event|2|||
128667798|NCT02167139|463081712|FG003|Transition-extension|Adverse Event|3|||
128667799|NCT02167139|463081709|FG000|Transition-extension|Withdrawal by Subject|2|||
128667800|NCT02167139|463081710|FG001|Transition-extension|Withdrawal by Subject|0|||
128667801|NCT02167139|463081711|FG002|Transition-extension|Withdrawal by Subject|4|||
128667802|NCT02167139|463081712|FG003|Transition-extension|Withdrawal by Subject|1|||
128667803|NCT02167139|463081709|FG000|Transition-extension|Lack of Efficacy|0|||
128667804|NCT02167139|463081710|FG001|Transition-extension|Lack of Efficacy|0|||
128667805|NCT02167139|463081711|FG002|Transition-extension|Lack of Efficacy|1|||
128667806|NCT02167139|463081712|FG003|Transition-extension|Lack of Efficacy|1|||
128667807|NCT02167139|463081709|FG000|Transition-extension|Other|1|||
128667808|NCT02167139|463081710|FG001|Transition-extension|Other|0|||
128667809|NCT02167139|463081711|FG002|Transition-extension|Other|1|||
128667810|NCT02167139|463081712|FG003|Transition-extension|Other|0|||
128667811|NCT02167139|463081709|FG000|Transition-extension|Lost to Follow-up|1|||
128667812|NCT02167139|463081710|FG001|Transition-extension|Lost to Follow-up|0|||
128667813|NCT02167139|463081711|FG002|Transition-extension|Lost to Follow-up|0|||
128667814|NCT02167139|463081712|FG003|Transition-extension|Lost to Follow-up|0|||
128667815|NCT04413617|463081713|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
128667816|NCT04413617|463081714|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
128667817|NCT04413617|463081715|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
128667818|NCT04413617|463081716|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
128667819|NCT04413617|463081717|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
128667820|NCT04413617|463081713|FG000|Overall Study|Protocol Violation|0|||
128667821|NCT04413617|463081714|FG001|Overall Study|Protocol Violation|1|||
128667822|NCT04413617|463081715|FG002|Overall Study|Protocol Violation|0|||
128667823|NCT04413617|463081716|FG003|Overall Study|Protocol Violation|0|||
128667824|NCT04413617|463081717|FG004|Overall Study|Protocol Violation|1|||
128667825|NCT04413617|463081713|FG000|Overall Study|Lack of Efficacy|2|||
128667826|NCT04413617|463081714|FG001|Overall Study|Lack of Efficacy|0|||
128667827|NCT04413617|463081715|FG002|Overall Study|Lack of Efficacy|2|||
128667828|NCT04413617|463081716|FG003|Overall Study|Lack of Efficacy|1|||
128667829|NCT04413617|463081717|FG004|Overall Study|Lack of Efficacy|0|||
128667830|NCT04413617|463081713|FG000|Overall Study|Withdrawal by Subject|3|||
128667831|NCT04413617|463081714|FG001|Overall Study|Withdrawal by Subject|4|||
128667832|NCT04413617|463081715|FG002|Overall Study|Withdrawal by Subject|2|||
128667833|NCT04413617|463081716|FG003|Overall Study|Withdrawal by Subject|5|||
128667834|NCT04413617|463081717|FG004|Overall Study|Withdrawal by Subject|3|||
128667835|NCT04413617|463081713|FG000|Overall Study|Death|1|||
128667836|NCT04413617|463081714|FG001|Overall Study|Death|0|||
128667837|NCT04413617|463081715|FG002|Overall Study|Death|0|||
128667838|NCT04413617|463081716|FG003|Overall Study|Death|0|||
128667839|NCT04413617|463081717|FG004|Overall Study|Death|0|||
128667840|NCT04413617|463081713|FG000|Overall Study|Adverse Event|1|||
128667841|NCT04413617|463081714|FG001|Overall Study|Adverse Event|0|||
128667842|NCT04413617|463081715|FG002|Overall Study|Adverse Event|0|||
128667843|NCT04413617|463081716|FG003|Overall Study|Adverse Event|1|||
128667844|NCT04413617|463081717|FG004|Overall Study|Adverse Event|1|||
128667845|NCT04413617|463081713|FG000|Overall Study|COVID-19|0|||
128667846|NCT04413617|463081714|FG001|Overall Study|COVID-19|1|||
128667847|NCT04413617|463081715|FG002|Overall Study|COVID-19|0|||
128667848|NCT04413617|463081716|FG003|Overall Study|COVID-19|0|||
128667849|NCT04413617|463081717|FG004|Overall Study|COVID-19|0|||
128667850|NCT01192191|463081718|FG000|Overall Study|Adverse Event|7|||
128667851|NCT01192191|463081719|FG001|Overall Study|Adverse Event|12|||
128667852|NCT01192191|463081718|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
128667853|NCT01192191|463081719|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
128667854|NCT01192191|463081718|FG000|Overall Study|Lost to Follow-up|0|||
129001349|NCT03372083|464297515|FG000|Overall Study|Withdrawal by Subject|1|||
129001350|NCT02266706|464297516|FG000|Overall Study|Withdrawal by Subject|0|||
129001351|NCT02266706|464297517|FG001|Overall Study|Withdrawal by Subject|1|||
129001352|NCT02266706|464297518|FG002|Overall Study|Withdrawal by Subject|1|||
128667855|NCT01192191|463081719|FG001|Overall Study|Lost to Follow-up|1|||
128667856|NCT01192191|463081718|FG000|Overall Study|Withdrawal by Subject|1|||
128667857|NCT01192191|463081719|FG001|Overall Study|Withdrawal by Subject|6|||
128667858|NCT01583296|463081722|FG000|Overall Study|Withdrawal by Subject|11|||
128667859|NCT01583296|463081723|FG001|Overall Study|Withdrawal by Subject|10|||
128667860|NCT01047553|463081724|FG000|Overall Study|Adverse Event|10|||
128667861|NCT01047553|463081725|FG001|Overall Study|Adverse Event|5|||
128667862|NCT01047553|463081724|FG000|Overall Study|Withdrawal by Subject|4|||
128667863|NCT01047553|463081725|FG001|Overall Study|Withdrawal by Subject|2|||
128667864|NCT01047553|463081724|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
128667865|NCT01047553|463081725|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
128667866|NCT01047553|463081724|FG000|Overall Study|Lost to Follow-up|1|||
128667867|NCT01047553|463081725|FG001|Overall Study|Lost to Follow-up|0|||
128667868|NCT01047553|463081724|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
128667869|NCT01047553|463081725|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
128667870|NCT01047553|463081724|FG000|Overall Study|PI's decision|0|||
128667871|NCT01047553|463081725|FG001|Overall Study|PI's decision|1|||
128667872|NCT01063283|463081726|FG000|Cycle 1|Adverse Event|2|||
128667873|NCT01063283|463081727|FG001|Cycle 1|Adverse Event|0|||
128667874|NCT01063283|463081728|FG002|Cycle 1|Adverse Event|0|||
128667875|NCT01063283|463081726|FG000|Cycle 1|Technical failure in data collection|1|||
128667876|NCT01063283|463081727|FG001|Cycle 1|Technical failure in data collection|0|||
128667877|NCT01063283|463081728|FG002|Cycle 1|Technical failure in data collection|0|||
128667878|NCT03179319|463081729|FG000|Overall Study|Lost to Follow-up|6|||
128667879|NCT03179319|463081730|FG001|Overall Study|Lost to Follow-up|0|||
128667880|NCT01120717|463081731|FG000|Overall Study|Withdrawal by Subject|11|||
128667881|NCT01120717|463081732|FG001|Overall Study|Withdrawal by Subject|6|||
128667882|NCT01120717|463081731|FG000|Overall Study|Adverse Event|10|||
128667883|NCT01120717|463081732|FG001|Overall Study|Adverse Event|6|||
128667884|NCT01120717|463081731|FG000|Overall Study|Protocol Deviation|2|||
128667885|NCT01120717|463081732|FG001|Overall Study|Protocol Deviation|5|||
128667886|NCT01120717|463081731|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
128667887|NCT01120717|463081732|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
128667888|NCT01120717|463081731|FG000|Overall Study|Lost to Follow-up|2|||
128667889|NCT01120717|463081732|FG001|Overall Study|Lost to Follow-up|3|||
128667890|NCT01120717|463081731|FG000|Overall Study|Death|3|||
128667891|NCT01120717|463081732|FG001|Overall Study|Death|1|||
128667892|NCT01120717|463081731|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
128667893|NCT01120717|463081732|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
128667894|NCT05334212|463081739|FG000|Overall Study|Study terminated prematurely|7|||
128667895|NCT04393454|463081740|FG000|Overall Study|Death|1|||
128667896|NCT04393454|463081740|FG000|Overall Study|Lost to Follow-up|1|||
128667897|NCT03304249|463081742|FG000|Overall Study|Lost to Follow-up|8|||
128667898|NCT03304249|463081743|FG001|Overall Study|Lost to Follow-up|10|||
128667899|NCT03304249|463081742|FG000|Overall Study|Withdrawal by Subject|12|||
128667900|NCT03304249|463081743|FG001|Overall Study|Withdrawal by Subject|2|||
128667901|NCT03304249|463081742|FG000|Overall Study|Moved Out of District|4|||
128667902|NCT03304249|463081743|FG001|Overall Study|Moved Out of District|2|||
128667903|NCT04189224|463081744|FG000|Period 2|Adverse Event|0|||
128667904|NCT04189224|463081745|FG001|Period 2|Adverse Event|1|||
128667905|NCT04198714|463081746|FG000|Overall Study|Physician Decision|0|||
128667906|NCT04198714|463081747|FG001|Overall Study|Physician Decision|1|||
128667907|NCT02970942|463081748|FG000|Overall Study|Death|0|||
128667908|NCT02970942|463081749|FG001|Overall Study|Death|1|||
128667909|NCT02970942|463081750|FG002|Overall Study|Death|0|||
128667910|NCT02970942|463081751|FG003|Overall Study|Death|0|||
128667911|NCT02970942|463081748|FG000|Overall Study|Lost to Follow-up|1|||
128667912|NCT02970942|463081749|FG001|Overall Study|Lost to Follow-up|0|||
128667913|NCT02970942|463081750|FG002|Overall Study|Lost to Follow-up|2|||
128667914|NCT02970942|463081751|FG003|Overall Study|Lost to Follow-up|1|||
128667915|NCT02970942|463081748|FG000|Overall Study|Withdrawal by Subject|3|||
128667916|NCT02970942|463081749|FG001|Overall Study|Withdrawal by Subject|5|||
128667917|NCT02970942|463081750|FG002|Overall Study|Withdrawal by Subject|3|||
128667918|NCT02970942|463081751|FG003|Overall Study|Withdrawal by Subject|2|||
128667919|NCT02529553|463081752|FG000|Overall Study|Progressive Disease|1|||
128667920|NCT02529553|463081753|FG001|Overall Study|Progressive Disease|0|||
128667921|NCT02529553|463081754|FG002|Overall Study|Progressive Disease|1|||
128667922|NCT02529553|463081755|FG003|Overall Study|Progressive Disease|3|||
128667923|NCT02529553|463081756|FG004|Overall Study|Progressive Disease|2|||
128667924|NCT02529553|463081757|FG005|Overall Study|Progressive Disease|3|||
128667925|NCT02529553|463081758|FG006|Overall Study|Progressive Disease|3|||
129001353|NCT02266706|464297519|FG003|Overall Study|Withdrawal by Subject|0|||
128667926|NCT02529553|463081759|FG007|Overall Study|Progressive Disease|5|||
128667927|NCT02529553|463081760|FG008|Overall Study|Progressive Disease|3|||
128667928|NCT02529553|463081752|FG000|Overall Study|Physician Decision|0|||
128667929|NCT02529553|463081753|FG001|Overall Study|Physician Decision|1|||
128667930|NCT02529553|463081754|FG002|Overall Study|Physician Decision|0|||
128667931|NCT02529553|463081755|FG003|Overall Study|Physician Decision|0|||
128667932|NCT02529553|463081756|FG004|Overall Study|Physician Decision|1|||
128667933|NCT02529553|463081757|FG005|Overall Study|Physician Decision|0|||
128667934|NCT02529553|463081758|FG006|Overall Study|Physician Decision|0|||
128667935|NCT02529553|463081759|FG007|Overall Study|Physician Decision|0|||
128667936|NCT02529553|463081760|FG008|Overall Study|Physician Decision|0|||
128667937|NCT02529553|463081752|FG000|Overall Study|Withdrawal by Subject|0|||
128667938|NCT02529553|463081753|FG001|Overall Study|Withdrawal by Subject|0|||
128667939|NCT02529553|463081754|FG002|Overall Study|Withdrawal by Subject|0|||
128667940|NCT02529553|463081755|FG003|Overall Study|Withdrawal by Subject|0|||
128667941|NCT02529553|463081756|FG004|Overall Study|Withdrawal by Subject|0|||
128667942|NCT02529553|463081757|FG005|Overall Study|Withdrawal by Subject|1|||
128667943|NCT02529553|463081758|FG006|Overall Study|Withdrawal by Subject|0|||
128667944|NCT02529553|463081759|FG007|Overall Study|Withdrawal by Subject|1|||
128667945|NCT02529553|463081760|FG008|Overall Study|Withdrawal by Subject|0|||
128667946|NCT00488683|463081761|FG000|Overall Study|Withdrawal by Subject|1|||
128667947|NCT00488683|463081762|FG001|Overall Study|Withdrawal by Subject|2|||
128667948|NCT00488683|463081763|FG002|Overall Study|Withdrawal by Subject|2|||
128667949|NCT00488683|463081761|FG000|Overall Study|Lost to Follow-up|5|||
128667950|NCT00488683|463081762|FG001|Overall Study|Lost to Follow-up|3|||
128667951|NCT00488683|463081763|FG002|Overall Study|Lost to Follow-up|0|||
128667952|NCT00488683|463081761|FG000|Overall Study|Protocol Violation|5|||
128667953|NCT00488683|463081762|FG001|Overall Study|Protocol Violation|1|||
128667954|NCT00488683|463081763|FG002|Overall Study|Protocol Violation|0|||
128667955|NCT00488683|463081761|FG000|Overall Study|Unable to Classify|1|||
128667956|NCT00488683|463081762|FG001|Overall Study|Unable to Classify|0|||
128667957|NCT00488683|463081763|FG002|Overall Study|Unable to Classify|0|||
128667958|NCT02102204|463082953|FG000|Overall Study|Withdrawal by Subject|137|||
128667959|NCT02102204|463082953|FG000|Overall Study|Death|92|||
128667960|NCT02102204|463082953|FG000|Overall Study|Lost to Follow-up|65|||
128667961|NCT02102204|463082953|FG000|Overall Study|Sponsor Decision|5|||
128667962|NCT02102204|463082953|FG000|Overall Study|Ongoing|5|||
128667963|NCT01865552|463082954|FG000|Period 1|Adverse Event|1|||
128667964|NCT01865552|463082955|FG001|Period 1|Adverse Event|0|||
128667965|NCT01865552|463082956|FG002|Period 1|Adverse Event|0|||
128667966|NCT01865552|463082957|FG003|Period 1|Adverse Event|1|||
128667967|NCT01865552|463082958|FG004|Period 1|Adverse Event|1|||
128667968|NCT01865552|463082959|FG005|Period 1|Adverse Event|1|||
128667969|NCT01865552|463082954|FG000|Period 1|Pathological lab|0|||
128667970|NCT01865552|463082955|FG001|Period 1|Pathological lab|0|||
128667971|NCT01865552|463082956|FG002|Period 1|Pathological lab|0|||
128667972|NCT01865552|463082957|FG003|Period 1|Pathological lab|0|||
128667973|NCT01865552|463082958|FG004|Period 1|Pathological lab|1|||
128667974|NCT01865552|463082959|FG005|Period 1|Pathological lab|0|||
128667975|NCT01865552|463082954|FG000|Period 1|Other|0|||
128667976|NCT01865552|463082955|FG001|Period 1|Other|0|||
128667977|NCT01865552|463082956|FG002|Period 1|Other|0|||
128667978|NCT01865552|463082957|FG003|Period 1|Other|0|||
128667979|NCT01865552|463082958|FG004|Period 1|Other|1|||
128667980|NCT01865552|463082959|FG005|Period 1|Other|0|||
128667981|NCT02923921|463082960|FG000|Overall Study|Sponsor Decision|39|||
128667982|NCT02923921|463082961|FG001|Overall Study|Sponsor Decision|38|||
128667983|NCT02923921|463082960|FG000|Overall Study|Lost to Follow-up|1|||
128667984|NCT02923921|463082961|FG001|Overall Study|Lost to Follow-up|0|||
128667985|NCT02923921|463082960|FG000|Overall Study|Withdrawal by Subject|6|||
128667986|NCT02923921|463082961|FG001|Overall Study|Withdrawal by Subject|13|||
128667987|NCT02923921|463082960|FG000|Overall Study|Unknown, Not Collected|7|||
128667988|NCT02923921|463082961|FG001|Overall Study|Unknown, Not Collected|6|||
128667989|NCT00479687|463082962|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
128667990|NCT00479687|463082963|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
128667991|NCT00479687|463082964|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
128667992|NCT00479687|463082962|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
128667993|NCT00479687|463082963|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
128667994|NCT00479687|463082964|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
128667995|NCT00479687|463082962|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
128667996|NCT00479687|463082963|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
128667997|NCT00479687|463082964|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
128667998|NCT00479687|463082962|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
128667999|NCT00479687|463082963|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
128668000|NCT00479687|463082964|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
128668001|NCT00479687|463082962|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
128668002|NCT00479687|463082963|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
128668003|NCT00479687|463082964|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
128668004|NCT00479687|463082962|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
128668005|NCT00479687|463082963|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
129001354|NCT02266706|464297520|FG004|Overall Study|Withdrawal by Subject|0|||
129001355|NCT02266706|464297521|FG005|Overall Study|Withdrawal by Subject|1|||
129001356|NCT02266706|464297522|FG006|Overall Study|Withdrawal by Subject|0|||
129001357|NCT02266706|464297523|FG007|Overall Study|Withdrawal by Subject|0|||
129001358|NCT02266706|464297524|FG008|Overall Study|Withdrawal by Subject|0|||
129001359|NCT02266706|464297516|FG000|Overall Study|Screen failure|0|||
129001360|NCT02266706|464297517|FG001|Overall Study|Screen failure|0|||
129001361|NCT02266706|464297518|FG002|Overall Study|Screen failure|0|||
129001362|NCT02266706|464297519|FG003|Overall Study|Screen failure|0|||
129001363|NCT02266706|464297520|FG004|Overall Study|Screen failure|0|||
128668006|NCT00479687|463082964|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
128668007|NCT00479687|463082962|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
128668008|NCT00479687|463082963|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
128668009|NCT00479687|463082964|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
128668010|NCT00479687|463082962|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
128668011|NCT00479687|463082963|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
128668012|NCT00479687|463082964|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
128668013|NCT00479687|463082962|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
128668014|NCT00479687|463082963|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
128668015|NCT00479687|463082964|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
128668016|NCT00295880|463082965|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
128668017|NCT00295880|463082965|FG000|Overall Study|Unit randomization did not occur|1|||
128668018|NCT01474239|463082966|FG000|Overall Study|Disease Progression|37|||
128668019|NCT01474239|463082967|FG001|Overall Study|Disease Progression|25|||
128668020|NCT01474239|463082966|FG000|Overall Study|Adverse Event|12|||
128668021|NCT01474239|463082967|FG001|Overall Study|Adverse Event|3|||
128668022|NCT01474239|463082966|FG000|Overall Study|Withdrawal by Subject|1|||
128668023|NCT01474239|463082967|FG001|Overall Study|Withdrawal by Subject|2|||
128668024|NCT01474239|463082966|FG000|Overall Study|Death|1|||
128668025|NCT01474239|463082967|FG001|Overall Study|Death|1|||
128668026|NCT01474239|463082966|FG000|Overall Study|Clinical Disease Progression|7|||
128668027|NCT01474239|463082967|FG001|Overall Study|Clinical Disease Progression|1|||
128668028|NCT01474239|463082966|FG000|Overall Study|Withdrawal for Economic Reason|1|||
128668029|NCT01474239|463082967|FG001|Overall Study|Withdrawal for Economic Reason|0|||
128668030|NCT02175199|463082970|FG000|Overall Study|Withdrawal by Subject|1|||
128668031|NCT02175199|463082971|FG001|Overall Study|Withdrawal by Subject|5|||
128668032|NCT02175199|463082970|FG000|Overall Study|Randomized in Error|1|||
128668033|NCT02175199|463082971|FG001|Overall Study|Randomized in Error|0|||
128668034|NCT02175199|463082970|FG000|Overall Study|Sponsor Decision|1|||
128668035|NCT02175199|463082971|FG001|Overall Study|Sponsor Decision|0|||
128668036|NCT03983317|463082978|FG000|Overall Study|Physician Decision|5|||
128668037|NCT01761162|463082979|FG000|Overall Study|Withdrawal by Subject|3|||
128668038|NCT02741518|463082980|FG000|Overall Study|Withdrawal by Subject|1|||
128668039|NCT02741518|463082981|FG001|Overall Study|Withdrawal by Subject|1|||
128668040|NCT01349049|463082982|FG000|Overall Study|Disease progression|3|||
128668041|NCT01349049|463082983|FG001|Overall Study|Disease progression|5|||
128668042|NCT01349049|463082984|FG002|Overall Study|Disease progression|3|||
128668043|NCT01349049|463082985|FG003|Overall Study|Disease progression|2|||
128668044|NCT01349049|463082986|FG004|Overall Study|Disease progression|2|||
128668045|NCT01349049|463082987|FG005|Overall Study|Disease progression|2|||
128668046|NCT01349049|463082988|FG006|Overall Study|Disease progression|3|||
128668047|NCT01349049|463082989|FG007|Overall Study|Disease progression|2|||
128668048|NCT01349049|463082990|FG008|Overall Study|Disease progression|33|||
128668049|NCT01349049|463082982|FG000|Overall Study|Adverse Event|0|||
128668050|NCT01349049|463082983|FG001|Overall Study|Adverse Event|1|||
128668051|NCT01349049|463082984|FG002|Overall Study|Adverse Event|0|||
128668052|NCT01349049|463082985|FG003|Overall Study|Adverse Event|0|||
128668053|NCT01349049|463082986|FG004|Overall Study|Adverse Event|0|||
128668054|NCT01349049|463082987|FG005|Overall Study|Adverse Event|3|||
128668055|NCT01349049|463082988|FG006|Overall Study|Adverse Event|1|||
128668056|NCT01349049|463082989|FG007|Overall Study|Adverse Event|0|||
128668057|NCT01349049|463082990|FG008|Overall Study|Adverse Event|4|||
128668058|NCT01349049|463082982|FG000|Overall Study|Physician Decision|0|||
128668059|NCT01349049|463082983|FG001|Overall Study|Physician Decision|1|||
128668060|NCT01349049|463082984|FG002|Overall Study|Physician Decision|0|||
128668061|NCT01349049|463082985|FG003|Overall Study|Physician Decision|0|||
128668062|NCT01349049|463082986|FG004|Overall Study|Physician Decision|0|||
128668063|NCT01349049|463082987|FG005|Overall Study|Physician Decision|0|||
128668064|NCT01349049|463082988|FG006|Overall Study|Physician Decision|0|||
128668065|NCT01349049|463082989|FG007|Overall Study|Physician Decision|0|||
128668066|NCT01349049|463082990|FG008|Overall Study|Physician Decision|2|||
128668067|NCT01349049|463082982|FG000|Overall Study|Protocol Violation|0|||
128668068|NCT01349049|463082983|FG001|Overall Study|Protocol Violation|0|||
128668069|NCT01349049|463082984|FG002|Overall Study|Protocol Violation|0|||
129001364|NCT02266706|464297521|FG005|Overall Study|Screen failure|1|||
129001365|NCT02266706|464297522|FG006|Overall Study|Screen failure|1|||
129001366|NCT02266706|464297523|FG007|Overall Study|Screen failure|0|||
129001367|NCT02266706|464297524|FG008|Overall Study|Screen failure|0|||
129001368|NCT02266706|464297516|FG000|Overall Study|Enrollment in another study|0|||
129001369|NCT02266706|464297517|FG001|Overall Study|Enrollment in another study|0|||
129001370|NCT02266706|464297518|FG002|Overall Study|Enrollment in another study|0|||
129001371|NCT02266706|464297519|FG003|Overall Study|Enrollment in another study|1|||
129001372|NCT02266706|464297520|FG004|Overall Study|Enrollment in another study|0|||
129001373|NCT02266706|464297521|FG005|Overall Study|Enrollment in another study|0|||
129001374|NCT02266706|464297522|FG006|Overall Study|Enrollment in another study|0|||
129001375|NCT02266706|464297523|FG007|Overall Study|Enrollment in another study|0|||
129001376|NCT02266706|464297524|FG008|Overall Study|Enrollment in another study|0|||
129001377|NCT00409188|464297525|FG000|Overall Study|Ongoing at data cut-off|383|||
129001378|NCT00409188|464297526|FG001|Overall Study|Ongoing at data cut-off|175|||
129001379|NCT02257632|464297532|FG000|Overall Study|Withdrawal by Subject|0|||
129001380|NCT02257632|464297533|FG001|Overall Study|Withdrawal by Subject|1|||
129001381|NCT02257632|464297532|FG000|Overall Study|Adverse Event|1|||
129001382|NCT02257632|464297533|FG001|Overall Study|Adverse Event|2|||
129001383|NCT01393990|464297534|FG000|Overall Study|Adverse Event|0|||
129001384|NCT01393990|464297535|FG001|Overall Study|Adverse Event|0|||
129001385|NCT01393990|464297536|FG002|Overall Study|Adverse Event|0|||
129001386|NCT01393990|464297537|FG003|Overall Study|Adverse Event|0|||
129001387|NCT01393990|464297538|FG004|Overall Study|Adverse Event|0|||
129001388|NCT01393990|464297539|FG005|Overall Study|Adverse Event|0|||
129001389|NCT01393990|464297540|FG006|Overall Study|Adverse Event|0|||
129001390|NCT01393990|464297541|FG007|Overall Study|Adverse Event|0|||
129001391|NCT01393990|464297542|FG008|Overall Study|Adverse Event|0|||
129001392|NCT01393990|464297543|FG009|Overall Study|Adverse Event|0|||
129001393|NCT01393990|464297544|FG010|Overall Study|Adverse Event|0|||
129001394|NCT01393990|464297545|FG011|Overall Study|Adverse Event|0|||
129001395|NCT01393990|464297546|FG012|Overall Study|Adverse Event|0|||
129001396|NCT01393990|464297547|FG013|Overall Study|Adverse Event|0|||
129001397|NCT01393990|464297548|FG014|Overall Study|Adverse Event|1|||
129001398|NCT01393990|464297549|FG015|Overall Study|Adverse Event|1|||
129001399|NCT01393990|464297550|FG016|Overall Study|Adverse Event|0|||
129001400|NCT01393990|464297551|FG017|Overall Study|Adverse Event|0|||
129001401|NCT01393990|464297534|FG000|Overall Study|Progressive Disease|1|||
129001402|NCT01393990|464297535|FG001|Overall Study|Progressive Disease|0|||
129001403|NCT01393990|464297536|FG002|Overall Study|Progressive Disease|0|||
129001404|NCT01393990|464297537|FG003|Overall Study|Progressive Disease|1|||
129001405|NCT01393990|464297538|FG004|Overall Study|Progressive Disease|1|||
129001406|NCT01393990|464297539|FG005|Overall Study|Progressive Disease|1|||
129001407|NCT01393990|464297540|FG006|Overall Study|Progressive Disease|1|||
129001408|NCT01393990|464297541|FG007|Overall Study|Progressive Disease|1|||
129001409|NCT01393990|464297542|FG008|Overall Study|Progressive Disease|3|||
129001410|NCT01393990|464297543|FG009|Overall Study|Progressive Disease|1|||
129001411|NCT01393990|464297544|FG010|Overall Study|Progressive Disease|0|||
129001412|NCT01393990|464297545|FG011|Overall Study|Progressive Disease|0|||
128668070|NCT01349049|463082985|FG003|Overall Study|Protocol Violation|0|||
128668071|NCT01349049|463082986|FG004|Overall Study|Protocol Violation|0|||
129001413|NCT01393990|464297546|FG012|Overall Study|Progressive Disease|0|||
129001414|NCT01393990|464297547|FG013|Overall Study|Progressive Disease|1|||
129001415|NCT01393990|464297548|FG014|Overall Study|Progressive Disease|6|||
129001416|NCT01393990|464297549|FG015|Overall Study|Progressive Disease|1|||
129001417|NCT01393990|464297550|FG016|Overall Study|Progressive Disease|0|||
128668072|NCT01349049|463082987|FG005|Overall Study|Protocol Violation|0|||
128668073|NCT01349049|463082988|FG006|Overall Study|Protocol Violation|0|||
128668074|NCT01349049|463082989|FG007|Overall Study|Protocol Violation|0|||
128668075|NCT01349049|463082990|FG008|Overall Study|Protocol Violation|1|||
128668076|NCT01349049|463082982|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
128668077|NCT01349049|463082983|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
128668078|NCT01349049|463082984|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
128668079|NCT01349049|463082985|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
128668080|NCT01349049|463082986|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
128668081|NCT01349049|463082987|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
128668082|NCT01349049|463082988|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
128668083|NCT01349049|463082989|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
128668084|NCT01349049|463082990|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
128668085|NCT01349049|463082982|FG000|Overall Study|Other|0|||
129001418|NCT01393990|464297551|FG017|Overall Study|Progressive Disease|0|||
129001419|NCT01393990|464297534|FG000|Overall Study|Death|0|||
129001420|NCT01393990|464297535|FG001|Overall Study|Death|0|||
128668086|NCT01349049|463082983|FG001|Overall Study|Other|0|||
128668087|NCT01349049|463082984|FG002|Overall Study|Other|0|||
129001421|NCT01393990|464297536|FG002|Overall Study|Death|0|||
129001422|NCT01393990|464297537|FG003|Overall Study|Death|0|||
129001423|NCT01393990|464297538|FG004|Overall Study|Death|1|||
129001424|NCT01393990|464297539|FG005|Overall Study|Death|0|||
129001425|NCT01393990|464297540|FG006|Overall Study|Death|0|||
129001426|NCT01393990|464297541|FG007|Overall Study|Death|0|||
129001427|NCT01393990|464297542|FG008|Overall Study|Death|0|||
129001428|NCT01393990|464297543|FG009|Overall Study|Death|0|||
128668088|NCT01349049|463082985|FG003|Overall Study|Other|0|||
128668089|NCT01349049|463082986|FG004|Overall Study|Other|0|||
128668090|NCT01349049|463082987|FG005|Overall Study|Other|1|||
128668091|NCT01349049|463082988|FG006|Overall Study|Other|0|||
128668092|NCT01349049|463082989|FG007|Overall Study|Other|0|||
128668093|NCT01349049|463082990|FG008|Overall Study|Other|4|||
128668094|NCT01349049|463082982|FG000|Overall Study|Death|0|||
128668095|NCT01349049|463082983|FG001|Overall Study|Death|0|||
128668096|NCT01349049|463082984|FG002|Overall Study|Death|0|||
128668097|NCT01349049|463082985|FG003|Overall Study|Death|0|||
128668098|NCT01349049|463082986|FG004|Overall Study|Death|0|||
128668099|NCT01349049|463082987|FG005|Overall Study|Death|0|||
128668100|NCT01349049|463082988|FG006|Overall Study|Death|0|||
128668101|NCT01349049|463082989|FG007|Overall Study|Death|1|||
128668102|NCT01349049|463082990|FG008|Overall Study|Death|5|||
128668103|NCT01349049|463082982|FG000|Overall Study|Non-compliance|0|||
128668104|NCT01349049|463082983|FG001|Overall Study|Non-compliance|0|||
128668105|NCT01349049|463082984|FG002|Overall Study|Non-compliance|0|||
128668106|NCT01349049|463082985|FG003|Overall Study|Non-compliance|1|||
128668107|NCT01349049|463082986|FG004|Overall Study|Non-compliance|0|||
128668108|NCT01349049|463082987|FG005|Overall Study|Non-compliance|0|||
128668109|NCT01349049|463082988|FG006|Overall Study|Non-compliance|0|||
128668110|NCT01349049|463082989|FG007|Overall Study|Non-compliance|0|||
128668111|NCT01349049|463082990|FG008|Overall Study|Non-compliance|0|||
128668112|NCT01349049|463082982|FG000|Overall Study|Withdrawal by Subject|0|||
128668113|NCT01349049|463082983|FG001|Overall Study|Withdrawal by Subject|0|||
128668114|NCT01349049|463082984|FG002|Overall Study|Withdrawal by Subject|0|||
128668115|NCT01349049|463082985|FG003|Overall Study|Withdrawal by Subject|0|||
128668116|NCT01349049|463082986|FG004|Overall Study|Withdrawal by Subject|0|||
128668117|NCT01349049|463082987|FG005|Overall Study|Withdrawal by Subject|0|||
128668118|NCT01349049|463082988|FG006|Overall Study|Withdrawal by Subject|0|||
128668119|NCT01349049|463082989|FG007|Overall Study|Withdrawal by Subject|0|||
128668120|NCT01349049|463082990|FG008|Overall Study|Withdrawal by Subject|6|||
128668121|NCT04681352|463082997|FG000|Overall Study|Lost to Follow-up|2|||
128668122|NCT04681352|463082997|FG000|Overall Study|Withdrawal by Subject|22|||
128668123|NCT01643772|463082998|FG000|Overall Study|Protocol Violation|0|||
128668124|NCT01643772|463082999|FG001|Overall Study|Protocol Violation|0|||
128668125|NCT01643772|463083000|FG002|Overall Study|Protocol Violation|0|||
128668126|NCT01643772|463083001|FG003|Overall Study|Protocol Violation|1|||
128668127|NCT01643772|463082998|FG000|Overall Study|Adverse Event|0|||
128668128|NCT01643772|463082999|FG001|Overall Study|Adverse Event|0|||
128668129|NCT01643772|463083000|FG002|Overall Study|Adverse Event|0|||
128668130|NCT01643772|463083001|FG003|Overall Study|Adverse Event|1|||
128668131|NCT03126344|463083002|FG000|Overall Study|Lost to Follow-up|0|||
128668132|NCT03126344|463083003|FG001|Overall Study|Lost to Follow-up|0|||
128668133|NCT03126344|463083004|FG002|Overall Study|Lost to Follow-up|5|||
128668134|NCT01837823|463083011|FG000|Overall Study|Lost to Follow-up|6|||
128668135|NCT00436345|463083014|FG000|Overall Study|ICU resident beyond follow-up period|3|||
128668136|NCT00436345|463083015|FG001|Overall Study|ICU resident beyond follow-up period|0|||
128668137|NCT02078960|463083016|FG000|Treatment Period|Other|0|||
128668138|NCT02078960|463083017|FG001|Treatment Period|Other|0|||
128668139|NCT02078960|463083018|FG002|Treatment Period|Other|1|||
128668140|NCT02078960|463083016|FG000|Treatment Period|Lack of Efficacy|0|||
128668141|NCT02078960|463083017|FG001|Treatment Period|Lack of Efficacy|1|||
128668142|NCT02078960|463083018|FG002|Treatment Period|Lack of Efficacy|0|||
128668143|NCT02078960|463083016|FG000|Treatment Period|Disease progression - accelerated phase|0|||
128668144|NCT02078960|463083017|FG001|Treatment Period|Disease progression - accelerated phase|1|||
128668145|NCT02078960|463083018|FG002|Treatment Period|Disease progression - accelerated phase|0|||
128668146|NCT02078960|463083016|FG000|Treatment Period|Disease progression - blast phase|1|||
128668147|NCT02078960|463083017|FG001|Treatment Period|Disease progression - blast phase|0|||
128668148|NCT02078960|463083018|FG002|Treatment Period|Disease progression - blast phase|0|||
128668149|NCT02078960|463083016|FG000|Treatment Period|Withdrawal by Subject|0|||
128668150|NCT02078960|463083017|FG001|Treatment Period|Withdrawal by Subject|1|||
128668151|NCT02078960|463083018|FG002|Treatment Period|Withdrawal by Subject|1|||
128668152|NCT02078960|463083016|FG000|Treatment Period|Adverse Event|1|||
128668153|NCT02078960|463083017|FG001|Treatment Period|Adverse Event|0|||
128668154|NCT02078960|463083018|FG002|Treatment Period|Adverse Event|0|||
128668155|NCT02078960|463083016|FG000|Treatment Period|Death|0|||
128668156|NCT02078960|463083017|FG001|Treatment Period|Death|0|||
128668157|NCT02078960|463083018|FG002|Treatment Period|Death|1|||
128668158|NCT02078960|463083016|FG000|Follow-up Period|Death|2|||
128668159|NCT02078960|463083017|FG001|Follow-up Period|Death|0|||
128668160|NCT02078960|463083018|FG002|Follow-up Period|Death|0|||
128668161|NCT02078960|463083016|FG000|Follow-up Period|Lost to Follow-up|0|||
128668162|NCT02078960|463083017|FG001|Follow-up Period|Lost to Follow-up|1|||
128668163|NCT02078960|463083018|FG002|Follow-up Period|Lost to Follow-up|0|||
128668164|NCT04248491|463083019|FG000|Overall Study|Lost to Follow-up|1|||
128668165|NCT04248491|463083020|FG001|Overall Study|Lost to Follow-up|0|||
128668166|NCT00975689|463083026|FG000|Overall Study|Adverse Event|0|||
128668167|NCT00975689|463083027|FG001|Overall Study|Adverse Event|3|||
129001429|NCT01393990|464297544|FG010|Overall Study|Death|0|||
129001430|NCT01393990|464297545|FG011|Overall Study|Death|0|||
129001431|NCT01393990|464297546|FG012|Overall Study|Death|0|||
129001432|NCT01393990|464297547|FG013|Overall Study|Death|1|||
129001433|NCT01393990|464297548|FG014|Overall Study|Death|1|||
129001434|NCT01393990|464297549|FG015|Overall Study|Death|0|||
129001435|NCT01393990|464297550|FG016|Overall Study|Death|0|||
129001436|NCT01393990|464297551|FG017|Overall Study|Death|0|||
129001437|NCT01393990|464297534|FG000|Overall Study|Withdrawal by Subject|0|||
129001438|NCT01393990|464297535|FG001|Overall Study|Withdrawal by Subject|0|||
129001439|NCT01393990|464297536|FG002|Overall Study|Withdrawal by Subject|0|||
129001440|NCT01393990|464297537|FG003|Overall Study|Withdrawal by Subject|0|||
129001441|NCT01393990|464297538|FG004|Overall Study|Withdrawal by Subject|0|||
129001442|NCT01393990|464297539|FG005|Overall Study|Withdrawal by Subject|0|||
129001443|NCT01393990|464297540|FG006|Overall Study|Withdrawal by Subject|0|||
129001444|NCT01393990|464297541|FG007|Overall Study|Withdrawal by Subject|0|||
129001445|NCT01393990|464297542|FG008|Overall Study|Withdrawal by Subject|0|||
129001446|NCT01393990|464297543|FG009|Overall Study|Withdrawal by Subject|0|||
129001447|NCT01393990|464297544|FG010|Overall Study|Withdrawal by Subject|0|||
129001448|NCT01393990|464297545|FG011|Overall Study|Withdrawal by Subject|0|||
129001449|NCT01393990|464297546|FG012|Overall Study|Withdrawal by Subject|0|||
129001450|NCT01393990|464297547|FG013|Overall Study|Withdrawal by Subject|0|||
129001451|NCT01393990|464297548|FG014|Overall Study|Withdrawal by Subject|1|||
129001452|NCT01393990|464297549|FG015|Overall Study|Withdrawal by Subject|1|||
129001453|NCT01393990|464297550|FG016|Overall Study|Withdrawal by Subject|0|||
129001454|NCT01393990|464297551|FG017|Overall Study|Withdrawal by Subject|0|||
129001455|NCT00275028|464297552|FG000|Overall Study|Withdrew consent before treatment began|1|||
129001456|NCT00275028|464297552|FG000|Overall Study|Withdrawal by Subject|5|||
129001457|NCT00275028|464297552|FG000|Overall Study|Adverse Event|9|||
129001458|NCT00275028|464297552|FG000|Overall Study|Progressive Disease|30|||
129001459|NCT00275028|464297552|FG000|Overall Study|Physician Decision|2|||
129001460|NCT00720798|464297554|FG000|Overall Study|Adverse Event|304|||
129001461|NCT00720798|464297554|FG000|Overall Study|Death|39|||
129001462|NCT00720798|464297554|FG000|Overall Study|Insufficient Therapeutic Response|129|||
129001463|NCT00720798|464297554|FG000|Overall Study|Protocol Violation|4|||
129001464|NCT00720798|464297554|FG000|Overall Study|Refused Treatment|151|||
129001465|NCT00720798|464297554|FG000|Overall Study|Failure to Return|46|||
129001466|NCT00720798|464297554|FG000|Overall Study|Reason not Specified|83|||
129001467|NCT00433381|464297555|FG000|Overall Study|Ineligible / no protocol treatment|3|||
129001468|NCT00433381|464297556|FG001|Overall Study|Ineligible / no protocol treatment|3|||
129001469|NCT01059071|464297558|FG000|Overall Study|Lack of Efficacy|1|||
129001470|NCT01059071|464297559|FG001|Overall Study|Lack of Efficacy|4|||
129001471|NCT01059071|464297560|FG002|Overall Study|Lack of Efficacy|2|||
129001472|NCT01059071|464297561|FG003|Overall Study|Lack of Efficacy|3|||
129001473|NCT01059071|464297558|FG000|Overall Study|Withdrawal by Subject|1|||
129001474|NCT01059071|464297559|FG001|Overall Study|Withdrawal by Subject|0|||
129001475|NCT01059071|464297560|FG002|Overall Study|Withdrawal by Subject|0|||
129001476|NCT01059071|464297561|FG003|Overall Study|Withdrawal by Subject|2|||
129001477|NCT01059071|464297558|FG000|Overall Study|Physician Decision|0|||
129001478|NCT01059071|464297559|FG001|Overall Study|Physician Decision|0|||
129001479|NCT01059071|464297560|FG002|Overall Study|Physician Decision|0|||
129001480|NCT01059071|464297561|FG003|Overall Study|Physician Decision|1|||
129001481|NCT00936884|464297564|FG000|Double-blind|Withdrawal by Subject|6|||
129001482|NCT00936884|464297565|FG001|Double-blind|Withdrawal by Subject|4|||
129001483|NCT00936884|464297566|FG002|Double-blind|Withdrawal by Subject|0|||
129001484|NCT00936884|464297564|FG000|Double-blind|Death|2|||
129001485|NCT00936884|464297565|FG001|Double-blind|Death|1|||
129001486|NCT00936884|464297566|FG002|Double-blind|Death|0|||
129001487|NCT00936884|464297564|FG000|Double-blind|Lack of Efficacy|1|||
129001488|NCT00936884|464297565|FG001|Double-blind|Lack of Efficacy|1|||
129001489|NCT00936884|464297566|FG002|Double-blind|Lack of Efficacy|0|||
129001490|NCT00936884|464297564|FG000|Double-blind|Adverse Event|1|||
129001491|NCT00936884|464297565|FG001|Double-blind|Adverse Event|0|||
129001492|NCT00936884|464297566|FG002|Double-blind|Adverse Event|0|||
129001493|NCT00936884|464297564|FG000|Double-blind|Physician Decision|1|||
129001494|NCT00936884|464297565|FG001|Double-blind|Physician Decision|0|||
129001495|NCT00936884|464297566|FG002|Double-blind|Physician Decision|0|||
129001496|NCT00936884|464297564|FG000|Double-blind|No post baseline diary entry|1|||
129001497|NCT00936884|464297565|FG001|Double-blind|No post baseline diary entry|0|||
129001498|NCT00936884|464297566|FG002|Double-blind|No post baseline diary entry|0|||
129001499|NCT00936884|464297564|FG000|Double-blind|Did not receive study drug|0|||
129001500|NCT00936884|464297565|FG001|Double-blind|Did not receive study drug|1|||
129001501|NCT00936884|464297566|FG002|Double-blind|Did not receive study drug|0|||
129001502|NCT01859390|464297567|FG000|Overall Study|Insufficient Sputum Collected|1|||
129001503|NCT01859390|464297568|FG001|Overall Study|Insufficient Sputum Collected|3|||
129001504|NCT01859390|464297567|FG000|Overall Study|Sample Missing Collection Date|0|||
129001505|NCT01859390|464297568|FG001|Overall Study|Sample Missing Collection Date|1|||
129001506|NCT01859390|464297567|FG000|Overall Study|Tube Cracked|0|||
128668168|NCT00975689|463083026|FG000|Overall Study|Withdrawal by Subject|1|||
128668169|NCT00975689|463083027|FG001|Overall Study|Withdrawal by Subject|0|||
128668170|NCT00975689|463083026|FG000|Overall Study|Physician Decision|1|||
128668171|NCT00975689|463083027|FG001|Overall Study|Physician Decision|0|||
128668172|NCT02597478|463083031|FG000|Overall Study|Withdrawal by Subject|2|||
128668173|NCT02597478|463083032|FG001|Overall Study|Withdrawal by Subject|0|||
128668174|NCT02597478|463083031|FG000|Overall Study|Change of opioid dose|1|||
128668175|NCT02597478|463083032|FG001|Overall Study|Change of opioid dose|0|||
128668176|NCT02597478|463083031|FG000|Overall Study|Insufficient exertional dyspnea|0|||
128668177|NCT02597478|463083032|FG001|Overall Study|Insufficient exertional dyspnea|1|||
128668178|NCT01402102|463083033|FG000|Overall Study|Protocol Violation|1|||
129001507|NCT01859390|464297568|FG001|Overall Study|Tube Cracked|2|||
129001508|NCT01859390|464297567|FG000|Overall Study|Shipment Error|0|||
129001509|NCT01859390|464297568|FG001|Overall Study|Shipment Error|1|||
129001510|NCT02038634|464297570|FG000|Overall Study|Lost to Follow-up|0|||
129001511|NCT02038634|464297571|FG001|Overall Study|Lost to Follow-up|1|||
129001512|NCT01664052|464297572|FG000|Phase 1|No device placement|6|||
129001513|NCT01664052|464297573|FG001|Phase 1|No device placement|0|||
129001514|NCT01664052|464297572|FG000|Phase 1|No HSG 1 hr post placement|1|||
129001515|NCT01664052|464297573|FG001|Phase 1|No HSG 1 hr post placement|0|||
129001516|NCT01664052|464297572|FG000|Phase 2|No device placement|0|||
129001517|NCT01664052|464297573|FG001|Phase 2|No device placement|4|||
129001518|NCT01084005|464297574|FG000|Overall Study|Adverse Event|1|||
129001519|NCT01084005|464297575|FG001|Overall Study|Adverse Event|8|||
129001520|NCT01084005|464297574|FG000|Overall Study|Protocol Violation|3|||
129001521|NCT01084005|464297575|FG001|Overall Study|Protocol Violation|7|||
129001522|NCT01084005|464297574|FG000|Overall Study|Withdrawal by Subject|1|||
129001523|NCT01084005|464297575|FG001|Overall Study|Withdrawal by Subject|1|||
129001524|NCT00549198|464297576|FG000|Overall Study|Adverse Event|28|||
129001525|NCT00549198|464297577|FG001|Overall Study|Adverse Event|26|||
129001526|NCT00549198|464297576|FG000|Overall Study|Insufficient Viral Load Response|4|||
129001527|NCT00549198|464297577|FG001|Overall Study|Insufficient Viral Load Response|2|||
129001528|NCT00549198|464297576|FG000|Overall Study|Protocol-defined Virological Failure|7|||
129001529|NCT00549198|464297577|FG001|Overall Study|Protocol-defined Virological Failure|0|||
129001530|NCT00549198|464297576|FG000|Overall Study|Non-compliance|2|||
129001531|NCT00549198|464297577|FG001|Overall Study|Non-compliance|4|||
129001532|NCT00549198|464297576|FG000|Overall Study|Lost to Follow-up|7|||
129001533|NCT00549198|464297577|FG001|Overall Study|Lost to Follow-up|8|||
129001534|NCT00549198|464297576|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
129001535|NCT00549198|464297577|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129001536|NCT00549198|464297576|FG000|Overall Study|Protocol Violation|7|||
129001537|NCT00549198|464297577|FG001|Overall Study|Protocol Violation|2|||
129001538|NCT00549198|464297576|FG000|Overall Study|Investigator Decision|4|||
129001539|NCT00549198|464297577|FG001|Overall Study|Investigator Decision|3|||
129001540|NCT00549198|464297576|FG000|Overall Study|Withdrawal by Subject|7|||
129001541|NCT00549198|464297577|FG001|Overall Study|Withdrawal by Subject|7|||
129001542|NCT00549198|464297576|FG000|Overall Study|Disease Progression|1|||
129001543|NCT00549198|464297577|FG001|Overall Study|Disease Progression|0|||
129001544|NCT00549198|464297576|FG000|Overall Study|Participant Moved|2|||
129001545|NCT00549198|464297577|FG001|Overall Study|Participant Moved|0|||
129001546|NCT00549198|464297576|FG000|Overall Study|Participant not able to perform Week 96|1|||
129001547|NCT00549198|464297577|FG001|Overall Study|Participant not able to perform Week 96|0|||
129001548|NCT00549198|464297576|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
129001549|NCT00549198|464297577|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
129001550|NCT00549198|464297576|FG000|Overall Study|Prohibited Medication|1|||
129001551|NCT00549198|464297577|FG001|Overall Study|Prohibited Medication|2|||
129001552|NCT00549198|464297576|FG000|Overall Study|Participant planning pregnancy|1|||
129001553|NCT00549198|464297577|FG001|Overall Study|Participant planning pregnancy|0|||
129001554|NCT00549198|464297576|FG000|Overall Study|Participant overweight, no scan possible|1|||
129001555|NCT00549198|464297577|FG001|Overall Study|Participant overweight, no scan possible|0|||
129001556|NCT00549198|464297576|FG000|Overall Study|No scan facilities|0|||
129001557|NCT00549198|464297577|FG001|Overall Study|No scan facilities|2|||
129001558|NCT00549198|464297576|FG000|Overall Study|Pregnancy|0|||
128668179|NCT01402102|463083034|FG001|Overall Study|Protocol Violation|0|||
128668180|NCT01402102|463083033|FG000|Overall Study|Insufficiency of compliance|1|||
129001559|NCT00549198|464297577|FG001|Overall Study|Pregnancy|3|||
129001560|NCT00549198|464297576|FG000|Overall Study|Not Exposed to Study Drug|3|||
129001561|NCT00549198|464297577|FG001|Overall Study|Not Exposed to Study Drug|4|||
129001562|NCT02480010|464297578|FG000|Overall Study|Adverse Event|3|||
129001563|NCT02480010|464297579|FG001|Overall Study|Adverse Event|1|||
129001564|NCT02480010|464297578|FG000|Overall Study|Death|1|||
129001565|NCT02480010|464297579|FG001|Overall Study|Death|0|||
129001566|NCT02480010|464297578|FG000|Overall Study|Insufficient therapeutic response|31|||
129001567|NCT02480010|464297579|FG001|Overall Study|Insufficient therapeutic response|29|||
129001568|NCT02480010|464297578|FG000|Overall Study|Refused Treatment|0|||
129001569|NCT02480010|464297579|FG001|Overall Study|Refused Treatment|3|||
129001570|NCT01034137|464297581|FG000|Overall Study|Adverse Event|9|||
129001571|NCT01034137|464297582|FG001|Overall Study|Adverse Event|10|||
129001572|NCT01034137|464297583|FG002|Overall Study|Adverse Event|8|||
129001573|NCT01034137|464297581|FG000|Overall Study|Withdrawal by Subject|4|||
129001574|NCT01034137|464297582|FG001|Overall Study|Withdrawal by Subject|3|||
129001575|NCT01034137|464297583|FG002|Overall Study|Withdrawal by Subject|3|||
129001576|NCT01034137|464297581|FG000|Overall Study|Lack of Efficacy|9|||
129001577|NCT01034137|464297582|FG001|Overall Study|Lack of Efficacy|4|||
129001578|NCT01034137|464297583|FG002|Overall Study|Lack of Efficacy|13|||
129001579|NCT01034137|464297581|FG000|Overall Study|Protocol Violation|2|||
129001580|NCT01034137|464297582|FG001|Overall Study|Protocol Violation|2|||
129001581|NCT01034137|464297583|FG002|Overall Study|Protocol Violation|1|||
129001582|NCT01034137|464297581|FG000|Overall Study|Refused treatment or did not cooperate|2|||
129001583|NCT01034137|464297582|FG001|Overall Study|Refused treatment or did not cooperate|0|||
129001584|NCT01034137|464297583|FG002|Overall Study|Refused treatment or did not cooperate|1|||
129001585|NCT01034137|464297581|FG000|Overall Study|Administrative or other|2|||
129001586|NCT01034137|464297582|FG001|Overall Study|Administrative or other|3|||
129001587|NCT01034137|464297583|FG002|Overall Study|Administrative or other|4|||
129001588|NCT01764854|464297587|FG000|Overall Study|Adverse Event|0|||
129001589|NCT01764854|464297588|FG001|Overall Study|Adverse Event|0|||
129001590|NCT01764854|464297589|FG002|Overall Study|Adverse Event|2|||
129001591|NCT01764854|464297590|FG003|Overall Study|Adverse Event|0|||
129001592|NCT01764854|464297587|FG000|Overall Study|Withdrawal by Subject|0|||
129001593|NCT01764854|464297588|FG001|Overall Study|Withdrawal by Subject|0|||
129001594|NCT01764854|464297589|FG002|Overall Study|Withdrawal by Subject|1|||
129001595|NCT01764854|464297590|FG003|Overall Study|Withdrawal by Subject|0|||
129001596|NCT01764854|464297587|FG000|Overall Study|relocation|0|||
129001597|NCT01764854|464297588|FG001|Overall Study|relocation|0|||
129001598|NCT01764854|464297589|FG002|Overall Study|relocation|2|||
129001599|NCT01764854|464297590|FG003|Overall Study|relocation|0|||
129001600|NCT01764854|464297587|FG000|Overall Study|Protocol Violation|0|||
129001601|NCT01764854|464297588|FG001|Overall Study|Protocol Violation|0|||
129001602|NCT01764854|464297589|FG002|Overall Study|Protocol Violation|1|||
129001603|NCT01764854|464297590|FG003|Overall Study|Protocol Violation|2|||
129001604|NCT03377556|464297599|FG000|Overall Study|Adverse Event|5|||
129001605|NCT03377556|464297599|FG000|Overall Study|Refusal unrelated to adverse events|1|||
129001606|NCT03377556|464297599|FG000|Overall Study|Progression/relapse|38|||
129001607|NCT03377556|464297599|FG000|Overall Study|Death|3|||
129001608|NCT00472446|464297600|FG000|Overall Study|Protocol Violation|0|||
129001609|NCT00472446|464297601|FG001|Overall Study|Protocol Violation|0|||
129001610|NCT00472446|464297602|FG002|Overall Study|Protocol Violation|0|||
129001611|NCT00472446|464297603|FG003|Overall Study|Protocol Violation|1|||
129001612|NCT00472446|464297600|FG000|Overall Study|Reintervention|0|||
129001613|NCT00472446|464297601|FG001|Overall Study|Reintervention|0|||
129001614|NCT00472446|464297602|FG002|Overall Study|Reintervention|1|||
129001615|NCT00472446|464297603|FG003|Overall Study|Reintervention|1|||
129001616|NCT00472446|464297600|FG000|Overall Study|Questionnaires not returned|5|||
129001617|NCT00472446|464297601|FG001|Overall Study|Questionnaires not returned|6|||
129001618|NCT00472446|464297602|FG002|Overall Study|Questionnaires not returned|6|||
129001619|NCT00472446|464297603|FG003|Overall Study|Questionnaires not returned|4|||
129001620|NCT01165684|464297606|FG000|Overall Study|Adverse Event|1|||
129001621|NCT01165684|464297607|FG001|Overall Study|Adverse Event|1|||
129001622|NCT01165684|464297606|FG000|Overall Study|Lack of Efficacy|2|||
129001623|NCT01165684|464297607|FG001|Overall Study|Lack of Efficacy|1|||
129001624|NCT01165684|464297606|FG000|Overall Study|Protocol Violation|7|||
129001625|NCT01165684|464297607|FG001|Overall Study|Protocol Violation|15|||
129001626|NCT01165684|464297606|FG000|Overall Study|Withdrawal Criteria|2|||
129001627|NCT01165684|464297607|FG001|Overall Study|Withdrawal Criteria|13|||
129001628|NCT01165684|464297606|FG000|Overall Study|Unclassified|16|||
129001629|NCT01165684|464297607|FG001|Overall Study|Unclassified|22|||
129001630|NCT00671879|464297610|FG000|Overall Study|Withdrawal by Subject|0|||
129001631|NCT00671879|464297611|FG001|Overall Study|Withdrawal by Subject|4|||
129001632|NCT00671879|464297612|FG002|Overall Study|Withdrawal by Subject|6|||
129001633|NCT04633837|464297613|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
129001634|NCT04633837|464297614|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
129001635|NCT00901628|464297615|FG000|Overall Study|disconnection of catheter|4|||
129001636|NCT00901628|464297616|FG001|Overall Study|disconnection of catheter|8|||
129001637|NCT00901628|464297615|FG000|Overall Study|disconnection of drain|0|||
129001638|NCT00901628|464297616|FG001|Overall Study|disconnection of drain|1|||
129001639|NCT00901628|464297615|FG000|Overall Study|peroneal nerve palsy|0|||
129001640|NCT00901628|464297616|FG001|Overall Study|peroneal nerve palsy|1|||
129001641|NCT00608205|464297619|FG000|Overall Study|Adverse Event|3|||
129001642|NCT00608205|464297620|FG001|Overall Study|Adverse Event|2|||
129001643|NCT00608205|464297619|FG000|Overall Study|Patient non-compliant|0|||
129001644|NCT00608205|464297620|FG001|Overall Study|Patient non-compliant|1|||
129001645|NCT01797120|464297621|FG000|Overall Study|Disesae progression|37|||
129001646|NCT01797120|464297622|FG001|Overall Study|Disesae progression|49|||
129001647|NCT01797120|464297621|FG000|Overall Study|Adverse Event|13|||
129001648|NCT01797120|464297622|FG001|Overall Study|Adverse Event|5|||
129001649|NCT01797120|464297621|FG000|Overall Study|Withdrawal by Subject|6|||
129001650|NCT01797120|464297622|FG001|Overall Study|Withdrawal by Subject|6|||
129001651|NCT01797120|464297621|FG000|Overall Study|Symptomatic progression|2|||
129001652|NCT01797120|464297622|FG001|Overall Study|Symptomatic progression|1|||
129001653|NCT01797120|464297621|FG000|Overall Study|Non-compliance|1|||
129001654|NCT01797120|464297622|FG001|Overall Study|Non-compliance|0|||
129001655|NCT01797120|464297621|FG000|Overall Study|Physician Decision|3|||
129001656|NCT01797120|464297622|FG001|Overall Study|Physician Decision|0|||
129001657|NCT01797120|464297621|FG000|Overall Study|still on treatment|2|||
129001658|NCT01797120|464297622|FG001|Overall Study|still on treatment|4|||
129001659|NCT01797120|464297621|FG000|Overall Study|never start protocol therapy|2|||
129001660|NCT01797120|464297622|FG001|Overall Study|never start protocol therapy|0|||
129001661|NCT01909466|464297628|FG000|Overall Study|Lost to Follow-up|5|||
129001662|NCT01909466|464297629|FG001|Overall Study|Lost to Follow-up|7|||
129001663|NCT01909466|464297628|FG000|Overall Study|Adverse Event|3|||
129001664|NCT01909466|464297629|FG001|Overall Study|Adverse Event|4|||
129001665|NCT01909466|464297628|FG000|Overall Study|Met Withdrawal Criteria|0|||
129001666|NCT01909466|464297629|FG001|Overall Study|Met Withdrawal Criteria|3|||
129001667|NCT01909466|464297628|FG000|Overall Study|Physician Decision|2|||
129001668|NCT01909466|464297629|FG001|Overall Study|Physician Decision|0|||
129001669|NCT01909466|464297628|FG000|Overall Study|Withdrawal by Subject|11|||
129001670|NCT01909466|464297629|FG001|Overall Study|Withdrawal by Subject|9|||
129001671|NCT01909466|464297628|FG000|Overall Study|Lack of Efficacy|1|||
129001672|NCT01909466|464297629|FG001|Overall Study|Lack of Efficacy|0|||
129001673|NCT01339910|464297630|FG000|Overall Study|Withdrawal by Subject|1|||
129001674|NCT01339910|464297631|FG001|Overall Study|Withdrawal by Subject|0|||
129001675|NCT01339910|464297630|FG000|Overall Study|Physician Decision|1|||
129001676|NCT01339910|464297631|FG001|Overall Study|Physician Decision|0|||
129001677|NCT01339910|464297630|FG000|Overall Study|Disease relapse|1|||
129001678|NCT01339910|464297631|FG001|Overall Study|Disease relapse|4|||
129001679|NCT01567306|464297635|FG000|Overall Study|Protocol Violation|2|||
129001680|NCT01567306|464297636|FG001|Overall Study|Protocol Violation|2|||
129001681|NCT01567306|464297637|FG002|Overall Study|Protocol Violation|0|||
129001682|NCT01567306|464297638|FG003|Overall Study|Protocol Violation|3|||
129001683|NCT01567306|464297639|FG004|Overall Study|Protocol Violation|1|||
129001684|NCT01567306|464297640|FG005|Overall Study|Protocol Violation|1|||
129001685|NCT01567306|464297635|FG000|Overall Study|Change site living|1|||
129001686|NCT01567306|464297636|FG001|Overall Study|Change site living|0|||
129001687|NCT01567306|464297637|FG002|Overall Study|Change site living|0|||
129001688|NCT01567306|464297638|FG003|Overall Study|Change site living|0|||
129001689|NCT01567306|464297639|FG004|Overall Study|Change site living|0|||
129001690|NCT01567306|464297640|FG005|Overall Study|Change site living|0|||
129001691|NCT01567306|464297635|FG000|Overall Study|Adverse Event|0|||
129001692|NCT01567306|464297636|FG001|Overall Study|Adverse Event|0|||
129001693|NCT01567306|464297637|FG002|Overall Study|Adverse Event|0|||
129001694|NCT01567306|464297638|FG003|Overall Study|Adverse Event|2|||
129001695|NCT01567306|464297639|FG004|Overall Study|Adverse Event|4|||
129001696|NCT01567306|464297640|FG005|Overall Study|Adverse Event|1|||
129001697|NCT01567306|464297635|FG000|Overall Study|Lost to Follow-up|0|||
129001698|NCT01567306|464297636|FG001|Overall Study|Lost to Follow-up|0|||
129001699|NCT01567306|464297637|FG002|Overall Study|Lost to Follow-up|0|||
129001700|NCT01567306|464297638|FG003|Overall Study|Lost to Follow-up|0|||
129001701|NCT01567306|464297639|FG004|Overall Study|Lost to Follow-up|2|||
129001702|NCT01567306|464297640|FG005|Overall Study|Lost to Follow-up|0|||
129001703|NCT01567306|464297635|FG000|Overall Study|Withdrawal by Subject|0|||
129001704|NCT01567306|464297636|FG001|Overall Study|Withdrawal by Subject|0|||
129001705|NCT01567306|464297637|FG002|Overall Study|Withdrawal by Subject|0|||
129001706|NCT01567306|464297638|FG003|Overall Study|Withdrawal by Subject|0|||
129001707|NCT01567306|464297639|FG004|Overall Study|Withdrawal by Subject|0|||
129001708|NCT01567306|464297640|FG005|Overall Study|Withdrawal by Subject|1|||
129001709|NCT00738673|464297643|FG000|Overall Study|Adverse Event|1|||
129001710|NCT00738673|464297644|FG001|Overall Study|Adverse Event|0|||
129001711|NCT00738673|464297643|FG000|Overall Study|Lack of Efficacy|19|||
129001712|NCT00738673|464297644|FG001|Overall Study|Lack of Efficacy|8|||
129001713|NCT00738673|464297643|FG000|Overall Study|Protocol Violation|1|||
129001714|NCT00738673|464297644|FG001|Overall Study|Protocol Violation|2|||
129001715|NCT00738673|464297643|FG000|Overall Study|Withdrawal by Subject|3|||
129001716|NCT00738673|464297644|FG001|Overall Study|Withdrawal by Subject|1|||
129001717|NCT02736227|464297647|FG000|Overall Study|Withdrawal by Subject|0|||
129001718|NCT02736227|464297648|FG001|Overall Study|Withdrawal by Subject|0|||
129001719|NCT02736227|464297649|FG002|Overall Study|Withdrawal by Subject|1|||
129001720|NCT02736227|464297647|FG000|Overall Study|Physician Decision|0|||
129001721|NCT02736227|464297648|FG001|Overall Study|Physician Decision|0|||
129001722|NCT02736227|464297649|FG002|Overall Study|Physician Decision|5|||
129001723|NCT02736227|464297647|FG000|Overall Study|Non Compliant|0|||
129001724|NCT02736227|464297648|FG001|Overall Study|Non Compliant|0|||
129001725|NCT02736227|464297649|FG002|Overall Study|Non Compliant|2|||
129001726|NCT04120194|464297650|FG000|Overall Study|Lost to Follow-up|11|||
129001727|NCT04120194|464297651|FG001|Overall Study|Lost to Follow-up|8|||
129001728|NCT04120194|464297650|FG000|Overall Study|Adverse Event|4|||
129001729|NCT04120194|464297651|FG001|Overall Study|Adverse Event|5|||
129001730|NCT04120194|464297650|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
129001731|NCT04120194|464297651|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
129001732|NCT04120194|464297650|FG000|Overall Study|Miscellaneous|4|||
129001733|NCT04120194|464297651|FG001|Overall Study|Miscellaneous|5|||
129001734|NCT00827359|464297655|FG000|Overall Study|Progressive Diseas|19|||
129001735|NCT00827359|464297655|FG000|Overall Study|Unacceptable Toxicity|5|||
129001736|NCT00827359|464297655|FG000|Overall Study|Ineligible|1|||
129001737|NCT01159769|464297656|FG000|Overall Study|Adverse Event|1|||
129001738|NCT02555618|464297657|FG000|Overall Study|Sponsor's Circumstances|1|||
129001739|NCT02555618|464297658|FG001|Overall Study|Sponsor's Circumstances|0|||
129001740|NCT02063698|464297659|FG000|Overall Study|did not complete booklet for days 2-8|1|||
129001741|NCT02063698|464297660|FG001|Overall Study|did not complete booklet for days 2-8|2|||
129001742|NCT03652961|464297665|FG000|Overall Study|Lost to Follow-up|3|||
129001743|NCT03652961|464297665|FG000|Overall Study|Screen Failure|1|||
129001744|NCT01783496|464297666|FG000|Overall Study|Lost to Follow-up|0|||
129001745|NCT01783496|464297667|FG001|Overall Study|Lost to Follow-up|0|||
129001746|NCT01783496|464297668|FG002|Overall Study|Lost to Follow-up|0|||
129001747|NCT01783496|464297669|FG003|Overall Study|Lost to Follow-up|2|||
129001748|NCT01783496|464297670|FG004|Overall Study|Lost to Follow-up|0|||
129001749|NCT01783496|464297671|FG005|Overall Study|Lost to Follow-up|1|||
129001750|NCT01783496|464297666|FG000|Overall Study|Withdrawal by Subject|1|||
129001751|NCT01783496|464297667|FG001|Overall Study|Withdrawal by Subject|0|||
129001752|NCT01783496|464297668|FG002|Overall Study|Withdrawal by Subject|0|||
129001753|NCT01783496|464297669|FG003|Overall Study|Withdrawal by Subject|0|||
129001754|NCT01783496|464297670|FG004|Overall Study|Withdrawal by Subject|0|||
129001755|NCT01783496|464297671|FG005|Overall Study|Withdrawal by Subject|0|||
129001756|NCT01953783|464297672|FG000|Overall Study|Progressive disease|2|||
129001757|NCT00686920|464297673|FG000|Overall Study|Death|45|||
129001758|NCT00686920|464297674|FG001|Overall Study|Death|14|||
129001759|NCT00686920|464297673|FG000|Overall Study|Liver Transplant|23|||
129001760|NCT00686920|464297674|FG001|Overall Study|Liver Transplant|8|||
129001761|NCT00686920|464297673|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
129001762|NCT00686920|464297674|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
129001763|NCT00686920|464297673|FG000|Overall Study|Withdrawal by Subject|23|||
129001764|NCT00686920|464297674|FG001|Overall Study|Withdrawal by Subject|5|||
129001765|NCT00686920|464297673|FG000|Overall Study|Protocol Violation|2|||
129001766|NCT00686920|464297674|FG001|Overall Study|Protocol Violation|1|||
129001767|NCT00686920|464297673|FG000|Overall Study|Adverse Event|10|||
129001768|NCT00686920|464297674|FG001|Overall Study|Adverse Event|2|||
129001769|NCT00686920|464297673|FG000|Overall Study|Personal Reason|0|||
129001770|NCT00686920|464297674|FG001|Overall Study|Personal Reason|1|||
129001771|NCT00686920|464297673|FG000|Overall Study|Lost to Follow-up|15|||
129001772|NCT00686920|464297674|FG001|Overall Study|Lost to Follow-up|3|||
129001773|NCT00686920|464297673|FG000|Overall Study|Moved to Another State|1|||
129001774|NCT00686920|464297674|FG001|Overall Study|Moved to Another State|0|||
129001775|NCT00686920|464297673|FG000|Overall Study|Transferred to Nursing Home|1|||
129001776|NCT00686920|464297674|FG001|Overall Study|Transferred to Nursing Home|0|||
129001777|NCT00686920|464297673|FG000|Overall Study|Noncompliance|9|||
129001778|NCT00686920|464297674|FG001|Overall Study|Noncompliance|0|||
129001779|NCT00686920|464297673|FG000|Overall Study|Principal Investigator Decision|2|||
129001780|NCT00686920|464297674|FG001|Overall Study|Principal Investigator Decision|0|||
129001781|NCT00591253|464297677|FG000|Overall Study|Adverse Event|3|||
129001782|NCT00591253|464297678|FG001|Overall Study|Adverse Event|3|||
129001783|NCT00591253|464297679|FG002|Overall Study|Adverse Event|1|||
129001784|NCT00591253|464297677|FG000|Overall Study|Protocol Violation|2|||
129001785|NCT00591253|464297678|FG001|Overall Study|Protocol Violation|2|||
129001786|NCT00591253|464297679|FG002|Overall Study|Protocol Violation|2|||
129001787|NCT00591253|464297677|FG000|Overall Study|Lost to Follow-up|2|||
129001788|NCT00591253|464297678|FG001|Overall Study|Lost to Follow-up|4|||
129001789|NCT00591253|464297679|FG002|Overall Study|Lost to Follow-up|0|||
129001790|NCT00591253|464297677|FG000|Overall Study|Withdrawal by Subject|1|||
129001791|NCT00591253|464297678|FG001|Overall Study|Withdrawal by Subject|7|||
129001792|NCT00591253|464297679|FG002|Overall Study|Withdrawal by Subject|6|||
129001793|NCT00591253|464297677|FG000|Overall Study|Lack of Efficacy|1|||
129001794|NCT00591253|464297678|FG001|Overall Study|Lack of Efficacy|0|||
129001795|NCT00591253|464297679|FG002|Overall Study|Lack of Efficacy|3|||
129001796|NCT00591253|464297677|FG000|Overall Study|Other|5|||
129001797|NCT00591253|464297678|FG001|Overall Study|Other|5|||
129001798|NCT00591253|464297679|FG002|Overall Study|Other|3|||
129001799|NCT03811249|464297680|FG000|Overall Study|Withdrawal by Subject|44|||
129001800|NCT03811249|464297680|FG000|Overall Study|Missed Visit|24|||
129001801|NCT01783730|464297681|FG000|Overall Study|Failed to meet inclusion criteria|6|||
129001802|NCT01841359|464297682|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
129001803|NCT01841359|464297682|FG000|Overall Study|Concommitant medical issues|2|||
129001804|NCT01841359|464297682|FG000|Overall Study|Adverse Event|3|||
128668181|NCT01402102|463083034|FG001|Overall Study|Insufficiency of compliance|1|||
128668182|NCT01402102|463083033|FG000|Overall Study|Withdrawal by Subject|0|||
128668183|NCT01402102|463083034|FG001|Overall Study|Withdrawal by Subject|2|||
129001805|NCT01841359|464297682|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
129001806|NCT02151461|464297683|FG000|Overall Study|Adverse Event|5|||
129001807|NCT02151461|464297684|FG001|Overall Study|Adverse Event|1|||
129001808|NCT02151461|464297685|FG002|Overall Study|Adverse Event|0|||
129001809|NCT02151461|464297686|FG003|Overall Study|Adverse Event|2|||
129001810|NCT02151461|464297683|FG000|Overall Study|Lost to Follow-up|0|||
129001811|NCT02151461|464297684|FG001|Overall Study|Lost to Follow-up|0|||
129001812|NCT02151461|464297685|FG002|Overall Study|Lost to Follow-up|1|||
129001813|NCT02151461|464297686|FG003|Overall Study|Lost to Follow-up|1|||
129001814|NCT02151461|464297683|FG000|Overall Study|Withdrawal by Subject|1|||
129001815|NCT02151461|464297684|FG001|Overall Study|Withdrawal by Subject|0|||
129001816|NCT02151461|464297685|FG002|Overall Study|Withdrawal by Subject|1|||
129001817|NCT02151461|464297686|FG003|Overall Study|Withdrawal by Subject|1|||
129001818|NCT02151461|464297683|FG000|Overall Study|Treatment discontinuation|0|||
129001819|NCT02151461|464297684|FG001|Overall Study|Treatment discontinuation|0|||
129001820|NCT02151461|464297685|FG002|Overall Study|Treatment discontinuation|1|||
129001821|NCT02151461|464297686|FG003|Overall Study|Treatment discontinuation|0|||
129001822|NCT02168270|464297687|FG000|Overall Study|Lack of Efficacy|4|||
129001823|NCT01102777|464297688|FG000|Overall Study|Death|2|||
129001824|NCT01102777|464297689|FG001|Overall Study|Death|6|||
129001825|NCT01102777|464297688|FG000|Overall Study|Lost to Follow-up|7|||
129001826|NCT01102777|464297689|FG001|Overall Study|Lost to Follow-up|10|||
129001827|NCT00706706|464297690|FG000|Overall Study|Death|53|||
129001828|NCT00706706|464297690|FG000|Overall Study|Lost to Follow-up|7|||
129001829|NCT00706706|464297690|FG000|Overall Study|Study endpoint had reached|45|||
129001830|NCT05017493|464297691|FG000|Overall Study|Withdrawal by Subject|26|||
129001831|NCT05017493|464297692|FG001|Overall Study|Withdrawal by Subject|0|||
129001832|NCT05017493|464297691|FG000|Overall Study|Physician Decision|15|||
129001833|NCT05017493|464297692|FG001|Overall Study|Physician Decision|0|||
129001834|NCT05017493|464297691|FG000|Overall Study|Protocol Violation|81|||
129001835|NCT05017493|464297692|FG001|Overall Study|Protocol Violation|0|||
129001836|NCT01154153|464297699|FG000|Overall Study|Poor compliance to protocol|2|||
129001837|NCT01154153|464297700|FG001|Overall Study|Poor compliance to protocol|0|||
129001838|NCT01154153|464297699|FG000|Overall Study|Unable to use labs|2|||
129001839|NCT01154153|464297700|FG001|Overall Study|Unable to use labs|3|||
129001840|NCT01154153|464297699|FG000|Overall Study|Withdrew consent|1|||
129001841|NCT01154153|464297700|FG001|Overall Study|Withdrew consent|0|||
129001842|NCT00771901|464297701|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
129001843|NCT00771901|464297702|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
129001844|NCT00771901|464297703|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
129001845|NCT01965652|464297704|FG000|Overall Study|Adverse Event|40|||
129001846|NCT01965652|464297705|FG001|Overall Study|Adverse Event|37|||
129001847|NCT01965652|464297704|FG000|Overall Study|Withdrawal by Subject|62|||
129001848|NCT01965652|464297705|FG001|Overall Study|Withdrawal by Subject|69|||
129001849|NCT01965652|464297704|FG000|Overall Study|Lost to Follow-up|53|||
129001850|NCT01965652|464297705|FG001|Overall Study|Lost to Follow-up|40|||
129001851|NCT01965652|464297704|FG000|Overall Study|Protocol Violation|34|||
129001852|NCT01965652|464297705|FG001|Overall Study|Protocol Violation|38|||
129001853|NCT01965652|464297704|FG000|Overall Study|Death|3|||
129001854|NCT01965652|464297705|FG001|Overall Study|Death|4|||
129001855|NCT01965652|464297704|FG000|Overall Study|Other - Miscellaneous|18|||
129001856|NCT01965652|464297705|FG001|Overall Study|Other - Miscellaneous|21|||
129001857|NCT01965652|464297704|FG000|Overall Study|Pregnancy|0|||
129001858|NCT01965652|464297705|FG001|Overall Study|Pregnancy|1|||
129001859|NCT01121900|464297706|FG000|First Intervention Period|Adverse Event|1|||
129001860|NCT01121900|464297707|FG001|First Intervention Period|Adverse Event|1|||
129001861|NCT01121900|464297706|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129001862|NCT01121900|464297707|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129001863|NCT03493698|464297708|FG000|Treatment Period C|Adverse Event|1|||
129001864|NCT03493698|464297708|FG000|Treatment Period C|Withdrawal by Subject|1|||
129001865|NCT03760510|464297709|FG000|Overall Study|Not ventilated for 24 hours|105|||
129001866|NCT03760510|464297710|FG001|Overall Study|Not ventilated for 24 hours|97|||
129001867|NCT00566709|464297711|FG000|Overall Study|Protocol Violation|5|||
129001868|NCT00566709|464297712|FG001|Overall Study|Protocol Violation|0|||
129001869|NCT03443869|464297713|FG000|Overall Study|Death|3|||
129001870|NCT03443869|464297714|FG001|Overall Study|Death|3|||
129001871|NCT03443869|464297713|FG000|Overall Study|Withdrawal by Subject|34|||
129001872|NCT03443869|464297714|FG001|Overall Study|Withdrawal by Subject|22|||
128668184|NCT01305577|463083036|FG000|Overall Study|Adverse Event|2|||
129001873|NCT03443869|464297713|FG000|Overall Study|Lost to Follow-up|1|||
129001874|NCT03443869|464297714|FG001|Overall Study|Lost to Follow-up|2|||
129001875|NCT03443869|464297713|FG000|Overall Study|Physician Decision|3|||
129001876|NCT03443869|464297714|FG001|Overall Study|Physician Decision|3|||
129001877|NCT03443869|464297713|FG000|Overall Study|Other|4|||
128668185|NCT01305577|463083037|FG001|Overall Study|Adverse Event|2|||
129001878|NCT03443869|464297714|FG001|Overall Study|Other|4|||
129001879|NCT00299728|464297715|FG000|Overall Study|Lost to Follow-up|0|||
129001880|NCT00299728|464297716|FG001|Overall Study|Lost to Follow-up|1|||
129001881|NCT00299728|464297715|FG000|Overall Study|Withdrawal by Subject|0|||
129001882|NCT00299728|464297716|FG001|Overall Study|Withdrawal by Subject|1|||
129001883|NCT00299728|464297715|FG000|Overall Study|Progressive disease|0|||
129001884|NCT00299728|464297716|FG001|Overall Study|Progressive disease|1|||
129001885|NCT00827827|464299485|FG000|Overall Study|Lost to Follow-up|3|||
129001886|NCT00827827|464299486|FG001|Overall Study|Lost to Follow-up|0|||
129001887|NCT00827827|464299485|FG000|Overall Study|Fall at home- hospitalization|1|||
129001888|NCT00827827|464299486|FG001|Overall Study|Fall at home- hospitalization|0|||
129001889|NCT00827827|464299485|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
129001890|NCT00827827|464299486|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
129001891|NCT00827827|464299485|FG000|Overall Study|Gout|1|||
129001892|NCT00827827|464299486|FG001|Overall Study|Gout|0|||
129001893|NCT00827827|464299485|FG000|Overall Study|Transportation issues|1|||
129001894|NCT00827827|464299486|FG001|Overall Study|Transportation issues|0|||
129001895|NCT00827827|464299485|FG000|Overall Study|Burned with water at home|1|||
129001896|NCT00827827|464299486|FG001|Overall Study|Burned with water at home|0|||
129001897|NCT01418352|464299489|FG000|Overall Study|Lost to Follow-up|2|||
129001898|NCT01418352|464299490|FG001|Overall Study|Lost to Follow-up|0|||
129001899|NCT01418352|464299491|FG002|Overall Study|Lost to Follow-up|0|||
129001900|NCT01418352|464299492|FG003|Overall Study|Lost to Follow-up|0|||
129001901|NCT01418352|464299489|FG000|Overall Study|Adverse Event|0|||
129001902|NCT01418352|464299490|FG001|Overall Study|Adverse Event|1|||
129001903|NCT01418352|464299491|FG002|Overall Study|Adverse Event|0|||
129001904|NCT01418352|464299492|FG003|Overall Study|Adverse Event|0|||
129001905|NCT01418352|464299489|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
129001906|NCT01418352|464299490|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
128668186|NCT01305577|463083038|FG002|Overall Study|Adverse Event|1|||
129001907|NCT01418352|464299491|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
128668187|NCT01305577|463083036|FG000|Overall Study|Withdrawal by Subject|7|||
128668188|NCT01305577|463083037|FG001|Overall Study|Withdrawal by Subject|5|||
128668189|NCT01305577|463083038|FG002|Overall Study|Withdrawal by Subject|6|||
128668190|NCT01305577|463083036|FG000|Overall Study|Lost to Follow-up|4|||
128668191|NCT01305577|463083037|FG001|Overall Study|Lost to Follow-up|3|||
128668192|NCT01305577|463083038|FG002|Overall Study|Lost to Follow-up|2|||
128668193|NCT01305577|463083036|FG000|Overall Study|Protocol Deviation|0|||
128668194|NCT01305577|463083037|FG001|Overall Study|Protocol Deviation|1|||
129001908|NCT01418352|464299492|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
129001909|NCT01418352|464299489|FG000|Overall Study|Subject Withdrew Consent|0|||
129001910|NCT01418352|464299490|FG001|Overall Study|Subject Withdrew Consent|1|||
129001911|NCT01418352|464299491|FG002|Overall Study|Subject Withdrew Consent|2|||
129001912|NCT01418352|464299492|FG003|Overall Study|Subject Withdrew Consent|1|||
129001913|NCT01418352|464299489|FG000|Overall Study|Protocol Deviation|0|||
129001914|NCT01418352|464299490|FG001|Overall Study|Protocol Deviation|0|||
129001915|NCT01418352|464299491|FG002|Overall Study|Protocol Deviation|1|||
129001916|NCT01418352|464299492|FG003|Overall Study|Protocol Deviation|0|||
129001917|NCT01418352|464299489|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
129001918|NCT01418352|464299490|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
129001919|NCT01418352|464299491|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
129001920|NCT01418352|464299492|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
129001921|NCT00619619|464299493|FG000|Overall Study|Physician Decision|0|||
129001922|NCT00619619|464299494|FG001|Overall Study|Physician Decision|0|||
129001923|NCT00619619|464299495|FG002|Overall Study|Physician Decision|1|||
129001924|NCT00619619|464299496|FG003|Overall Study|Physician Decision|0|||
129001925|NCT00619619|464299497|FG004|Overall Study|Physician Decision|0|||
129001926|NCT00619619|464299498|FG005|Overall Study|Physician Decision|0|||
129001927|NCT00619619|464299499|FG006|Overall Study|Physician Decision|0|||
129001928|NCT00619619|464299500|FG007|Overall Study|Physician Decision|0|||
129001929|NCT00619619|464299493|FG000|Overall Study|Protocol Violation|0|||
129001930|NCT00619619|464299494|FG001|Overall Study|Protocol Violation|0|||
129001931|NCT00619619|464299495|FG002|Overall Study|Protocol Violation|0|||
129001932|NCT00619619|464299496|FG003|Overall Study|Protocol Violation|1|||
129001933|NCT00619619|464299497|FG004|Overall Study|Protocol Violation|0|||
129001934|NCT00619619|464299498|FG005|Overall Study|Protocol Violation|0|||
129001935|NCT00619619|464299499|FG006|Overall Study|Protocol Violation|1|||
129001936|NCT00619619|464299500|FG007|Overall Study|Protocol Violation|1|||
128668195|NCT01305577|463083038|FG002|Overall Study|Protocol Deviation|1|||
128668196|NCT00905645|463083039|FG000|Overall Study|Death (not device related)|10|||
128668197|NCT00905645|463083040|FG001|Overall Study|Death (not device related)|4|||
129001937|NCT00619619|464299493|FG000|Overall Study|Adverse Event|0|||
129001938|NCT00619619|464299494|FG001|Overall Study|Adverse Event|0|||
129001939|NCT00619619|464299495|FG002|Overall Study|Adverse Event|0|||
129001940|NCT00619619|464299496|FG003|Overall Study|Adverse Event|0|||
128668198|NCT00905645|463083041|FG002|Overall Study|Death (not device related)|15|||
129001941|NCT00619619|464299497|FG004|Overall Study|Adverse Event|2|||
129001942|NCT00619619|464299498|FG005|Overall Study|Adverse Event|0|||
129001943|NCT00619619|464299499|FG006|Overall Study|Adverse Event|0|||
129001944|NCT00619619|464299500|FG007|Overall Study|Adverse Event|2|||
129001945|NCT01092702|464299501|FG000|Overall Study|Withdrawal by Subject|7|||
129001946|NCT01092702|464299501|FG000|Overall Study|Lost to Follow-up|2|||
129001947|NCT03263819|464299502|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
129001948|NCT03263819|464299503|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
129001949|NCT01271933|464299511|FG000|Single-Blind Phase|Lack of Efficacy|37|||
129001950|NCT01271933|464299512|FG001|Single-Blind Phase|Lack of Efficacy|0|||
129001951|NCT01271933|464299513|FG002|Single-Blind Phase|Lack of Efficacy|0|||
129001952|NCT01271933|464299511|FG000|Single-Blind Phase|Lost to Follow-up|10|||
129001953|NCT01271933|464299512|FG001|Single-Blind Phase|Lost to Follow-up|0|||
129001954|NCT01271933|464299513|FG002|Single-Blind Phase|Lost to Follow-up|0|||
129001955|NCT01271933|464299511|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
129001956|NCT01271933|464299512|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
129001957|NCT01271933|464299513|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
129001958|NCT01271933|464299511|FG000|Single-Blind Phase|Protocol Violation|3|||
129001959|NCT01271933|464299512|FG001|Single-Blind Phase|Protocol Violation|0|||
129001960|NCT01271933|464299513|FG002|Single-Blind Phase|Protocol Violation|0|||
129001961|NCT01271933|464299511|FG000|Single-Blind Phase|Adverse Event|52|||
129001962|NCT01271933|464299512|FG001|Single-Blind Phase|Adverse Event|0|||
129001963|NCT01271933|464299513|FG002|Single-Blind Phase|Adverse Event|0|||
129001964|NCT01271933|464299511|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
129001965|NCT01271933|464299512|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
129001966|NCT01271933|464299513|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
129001967|NCT01271933|464299511|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
129001968|NCT01271933|464299512|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
129001969|NCT01271933|464299513|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
129001970|NCT01271933|464299511|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
129001971|NCT01271933|464299512|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
129001972|NCT01271933|464299513|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
129001973|NCT01271933|464299511|FG000|Double-Blind Phase|Randomized but not treated|0|||
129001974|NCT01271933|464299512|FG001|Double-Blind Phase|Randomized but not treated|0|||
129001975|NCT01271933|464299513|FG002|Double-Blind Phase|Randomized but not treated|1|||
129001976|NCT01271933|464299511|FG000|Double-Blind Phase|Lack of Efficacy|0|||
129001977|NCT01271933|464299512|FG001|Double-Blind Phase|Lack of Efficacy|6|||
129001978|NCT01271933|464299513|FG002|Double-Blind Phase|Lack of Efficacy|9|||
129001979|NCT01271933|464299511|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129001980|NCT01271933|464299512|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129001981|NCT01271933|464299513|FG002|Double-Blind Phase|Lost to Follow-up|1|||
129001982|NCT01271933|464299511|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129001983|NCT01271933|464299512|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
129001984|NCT01271933|464299513|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
129001985|NCT01271933|464299511|FG000|Double-Blind Phase|Adverse Event|0|||
129001986|NCT01271933|464299512|FG001|Double-Blind Phase|Adverse Event|3|||
129001987|NCT01271933|464299513|FG002|Double-Blind Phase|Adverse Event|0|||
129001988|NCT01271933|464299511|FG000|Double-Blind Phase|Participant request-personal reason|0|||
129001989|NCT01271933|464299512|FG001|Double-Blind Phase|Participant request-personal reason|1|||
128668199|NCT00905645|463083042|FG003|Overall Study|Death (not device related)|8|||
128668200|NCT00905645|463083039|FG000|Overall Study|Explantation of study device(s)|78|||
128668201|NCT00905645|463083040|FG001|Overall Study|Explantation of study device(s)|47|||
128668202|NCT00905645|463083041|FG002|Overall Study|Explantation of study device(s)|28|||
128668203|NCT00905645|463083042|FG003|Overall Study|Explantation of study device(s)|21|||
128668204|NCT00905645|463083039|FG000|Overall Study|Subject Request|41|||
128668205|NCT00905645|463083040|FG001|Overall Study|Subject Request|17|||
128668206|NCT00905645|463083041|FG002|Overall Study|Subject Request|13|||
128668207|NCT00905645|463083042|FG003|Overall Study|Subject Request|11|||
128668208|NCT00905645|463083039|FG000|Overall Study|Lost to Follow-up|299|||
128668209|NCT00905645|463083040|FG001|Overall Study|Lost to Follow-up|103|||
128668210|NCT00905645|463083041|FG002|Overall Study|Lost to Follow-up|51|||
128668211|NCT00905645|463083042|FG003|Overall Study|Lost to Follow-up|12|||
128668212|NCT02364336|463083043|FG000|Overall Study|Adverse Event|0|||
128668213|NCT02364336|463083044|FG001|Overall Study|Adverse Event|1|||
128668214|NCT01731938|463083045|FG000|Preliminary Part I|Withdrawal by Subject|2|||
128668215|NCT01731938|463083046|FG001|Preliminary Part I|Withdrawal by Subject|2|||
128668216|NCT01731938|463083045|FG000|Preliminary Part I|Physician Decision|1|||
129001990|NCT01271933|464299513|FG002|Double-Blind Phase|Participant request-personal reason|0|||
128668217|NCT01731938|463083046|FG001|Preliminary Part I|Physician Decision|0|||
129001991|NCT01138150|464299514|FG000|Overall Study|blood unable to be processed|0|||
129001992|NCT01138150|464299515|FG001|Overall Study|blood unable to be processed|1|||
128668218|NCT01731938|463083045|FG000|Preliminary Part I|Lost to Follow-up|0|||
128668219|NCT01731938|463083046|FG001|Preliminary Part I|Lost to Follow-up|3|||
128668220|NCT01731938|463083045|FG000|Preliminary Part I|Missed Week 6 visit|0|||
128668221|NCT01731938|463083046|FG001|Preliminary Part I|Missed Week 6 visit|3|||
128668222|NCT01731938|463083045|FG000|Primary Part II|Withdrawal by Subject|5|||
128668223|NCT01731938|463083046|FG001|Primary Part II|Withdrawal by Subject|4|||
128668224|NCT01731938|463083045|FG000|Primary Part II|Lost to Follow-up|4|||
128668225|NCT01731938|463083046|FG001|Primary Part II|Lost to Follow-up|5|||
128668226|NCT01731938|463083045|FG000|Primary Part II|Death|2|||
128668227|NCT01731938|463083046|FG001|Primary Part II|Death|1|||
128668228|NCT01731938|463083045|FG000|Primary Part II|Missed Week 6 visit|2|||
128668229|NCT01731938|463083046|FG001|Primary Part II|Missed Week 6 visit|3|||
128668230|NCT04931888|463083047|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
128668231|NCT04931888|463083048|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
128668232|NCT04931888|463083049|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
128668233|NCT04931888|463083050|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
128668234|NCT00771953|463083052|FG000|Overall Study|Adverse Event|5|||
128668235|NCT00771953|463083053|FG001|Overall Study|Adverse Event|3|||
129001993|NCT01138150|464299514|FG000|Overall Study|Physician Decision|1|||
129001994|NCT01138150|464299515|FG001|Overall Study|Physician Decision|0|||
129001995|NCT01620983|464299516|FG000|Overall Study|Lost to Follow-up|8|||
129001996|NCT01620983|464299517|FG001|Overall Study|Lost to Follow-up|4|||
129001997|NCT01620983|464299518|FG002|Overall Study|Lost to Follow-up|9|||
129001998|NCT01620983|464299516|FG000|Overall Study|Withdrawal by Subject|6|||
129001999|NCT01620983|464299517|FG001|Overall Study|Withdrawal by Subject|8|||
129002000|NCT01620983|464299518|FG002|Overall Study|Withdrawal by Subject|1|||
129002001|NCT01620983|464299516|FG000|Overall Study|Death|2|||
129002002|NCT01620983|464299517|FG001|Overall Study|Death|0|||
129002003|NCT01620983|464299518|FG002|Overall Study|Death|0|||
129002004|NCT01620983|464299516|FG000|Overall Study|Physician Decision|3|||
129002005|NCT01620983|464299517|FG001|Overall Study|Physician Decision|10|||
129002006|NCT01620983|464299518|FG002|Overall Study|Physician Decision|5|||
129002007|NCT05085964|464299520|FG000|Overall Study|Premature termination of study|21|||
129002008|NCT05085964|464299521|FG001|Overall Study|Premature termination of study|0|||
129002009|NCT00545233|464299522|FG000|Overall Study|Adverse Event|10|||
129002010|NCT00545233|464299523|FG001|Overall Study|Adverse Event|5|||
129002011|NCT00545233|464299522|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
129002012|NCT00545233|464299523|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129002013|NCT00545233|464299522|FG000|Overall Study|Protocol Violation|2|||
129002014|NCT00545233|464299523|FG001|Overall Study|Protocol Violation|0|||
129002015|NCT00545233|464299522|FG000|Overall Study|Refused Treatment|9|||
129002016|NCT00545233|464299523|FG001|Overall Study|Refused Treatment|7|||
129002017|NCT00545233|464299522|FG000|Overall Study|Failure to Return|4|||
129002018|NCT00545233|464299523|FG001|Overall Study|Failure to Return|6|||
129002019|NCT00545233|464299522|FG000|Overall Study|Insufficient response|14|||
129002020|NCT00545233|464299523|FG001|Overall Study|Insufficient response|15|||
129002021|NCT00545233|464299522|FG000|Overall Study|Physician Decision|2|||
129002022|NCT00545233|464299523|FG001|Overall Study|Physician Decision|1|||
129002023|NCT01208402|464299524|FG000|Overall Study|Withdrawal by Subject|1|||
129002024|NCT01208402|464299525|FG001|Overall Study|Withdrawal by Subject|0|||
129002025|NCT03156270|464299528|FG000|Overall Study|Failed pre-treatment screening|1|||
129002026|NCT03156270|464299528|FG000|Overall Study|Lost to Follow-up|1|||
129002027|NCT01504867|464299532|FG000|Overall Study|Inclusion criteria not met|2|||
129002028|NCT01504867|464299533|FG001|Overall Study|Inclusion criteria not met|2|||
129002029|NCT01504867|464299532|FG000|Overall Study|Consent revoked|5|||
129002030|NCT01504867|464299533|FG001|Overall Study|Consent revoked|1|||
129002031|NCT00871169|464299534|FG000|Overall Study|Protocol Violation|1|||
128668236|NCT00771953|463083052|FG000|Overall Study|Death|2|||
128668237|NCT00771953|463083053|FG001|Overall Study|Death|2|||
128668238|NCT00771953|463083052|FG000|Overall Study|Progression before active Tx|1|||
128668239|NCT00771953|463083053|FG001|Overall Study|Progression before active Tx|2|||
128668240|NCT00771953|463083052|FG000|Overall Study|Sponsor decision|1|||
128668241|NCT00771953|463083053|FG001|Overall Study|Sponsor decision|0|||
128668242|NCT00771953|463083052|FG000|Overall Study|Other complicating disease|1|||
128668243|NCT00771953|463083053|FG001|Overall Study|Other complicating disease|0|||
128668244|NCT00771953|463083052|FG000|Overall Study|Withdrawal by Subject|0|||
128668245|NCT00771953|463083053|FG001|Overall Study|Withdrawal by Subject|3|||
129002032|NCT00871169|464299534|FG000|Overall Study|Patient did not receive study treatment|2|||
129002033|NCT02110706|464299538|FG000|Overall Study|Adverse Event|2|||
129002034|NCT02110706|464299539|FG001|Overall Study|Adverse Event|3|||
129002035|NCT02110706|464299538|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
129002036|NCT02110706|464299539|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
128668246|NCT00856518|463083057|FG000|Overall Study|Lost to Follow-up|4|||
129002037|NCT03210259|464299540|FG000|12-Week Run-in Period|Adverse Event|1|||
129002038|NCT03210259|464299541|FG001|12-Week Run-in Period|Adverse Event|0|||
129002039|NCT03210259|464299542|FG002|12-Week Run-in Period|Adverse Event|0|||
129002040|NCT03210259|464299540|FG000|12-Week Run-in Period|Death|1|||
129002041|NCT03210259|464299541|FG001|12-Week Run-in Period|Death|0|||
129002042|NCT03210259|464299542|FG002|12-Week Run-in Period|Death|0|||
129002043|NCT03210259|464299540|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
129002044|NCT03210259|464299541|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
129002045|NCT03210259|464299542|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
129002046|NCT03210259|464299540|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
129002047|NCT03210259|464299541|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
129002048|NCT03210259|464299542|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
129002049|NCT03210259|464299540|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
129002050|NCT03210259|464299541|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
129002051|NCT03210259|464299542|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
129002052|NCT03210259|464299540|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
129002053|NCT03210259|464299541|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
129002054|NCT03210259|464299542|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
129002055|NCT03210259|464299540|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
129002056|NCT03210259|464299541|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
129002057|NCT03210259|464299542|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
129002058|NCT03210259|464299540|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
129002059|NCT03210259|464299541|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
129002060|NCT03210259|464299542|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
129002061|NCT03210259|464299540|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
129002062|NCT03210259|464299541|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
129002063|NCT03210259|464299542|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
129002064|NCT03210259|464299540|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
129002065|NCT03210259|464299541|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
129002066|NCT03210259|464299542|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
129002067|NCT03210259|464299540|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
129002068|NCT03210259|464299541|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
129002069|NCT03210259|464299542|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
129002070|NCT02087059|464299543|FG000|Overall Study|Disease Progression|1|||
129002071|NCT02087059|464299543|FG000|Overall Study|Adverse Event|5|||
129002072|NCT02087059|464299543|FG000|Overall Study|Lost to Follow-up|1|||
129002073|NCT00252187|464299544|FG000|Overall Study|Adverse Event|3|||
129002074|NCT00252187|464299545|FG001|Overall Study|Adverse Event|1|||
129002075|NCT00252187|464299544|FG000|Overall Study|Withdrawal by Subject|1|||
129002076|NCT00252187|464299545|FG001|Overall Study|Withdrawal by Subject|0|||
129002077|NCT02175966|464299548|FG000|Follow-up Period|Lack of Efficacy|10|||
129002078|NCT02175966|464299549|FG001|Follow-up Period|Lack of Efficacy|6|||
129002079|NCT00210626|464299554|FG000|Overall Study|Adverse Event|1|||
129002080|NCT00210626|464299555|FG001|Overall Study|Adverse Event|2|||
129002081|NCT00210626|464299554|FG000|Overall Study|Protocol Violation|1|||
129002082|NCT00210626|464299555|FG001|Overall Study|Protocol Violation|5|||
129002083|NCT00210626|464299554|FG000|Overall Study|Lost to Follow-up|11|||
129002084|NCT00210626|464299555|FG001|Overall Study|Lost to Follow-up|11|||
129002085|NCT00210626|464299554|FG000|Overall Study|Death|1|||
129002086|NCT00210626|464299555|FG001|Overall Study|Death|0|||
129002087|NCT00210626|464299554|FG000|Overall Study|Withdrawal by Subject|29|||
129002088|NCT00210626|464299555|FG001|Overall Study|Withdrawal by Subject|20|||
129002089|NCT00210626|464299554|FG000|Overall Study|Physician Decision|0|||
129002090|NCT00210626|464299555|FG001|Overall Study|Physician Decision|2|||
129002091|NCT00210626|464299554|FG000|Overall Study|Sponser Request|1|||
129002092|NCT00210626|464299555|FG001|Overall Study|Sponser Request|0|||
129002093|NCT00210626|464299554|FG000|Overall Study|Other|4|||
129002094|NCT00210626|464299555|FG001|Overall Study|Other|5|||
129002095|NCT02473510|464299556|FG000|Overall Study|Lost to Follow-up|1|||
129002096|NCT02473510|464299557|FG001|Overall Study|Lost to Follow-up|2|||
129002097|NCT01306253|464299558|FG000|Overall Study|Lost to Follow-up|1|||
129002098|NCT01306253|464299559|FG001|Overall Study|Lost to Follow-up|1|||
129002099|NCT01261325|464299560|FG000|Overall Study|Lack of Efficacy|1|||
129002100|NCT01261325|464299561|FG001|Overall Study|Lack of Efficacy|1|||
129002101|NCT01261325|464299562|FG002|Overall Study|Lack of Efficacy|0|||
129002102|NCT01261325|464299560|FG000|Overall Study|Withdrawal by Subject|2|||
129002103|NCT01261325|464299561|FG001|Overall Study|Withdrawal by Subject|2|||
128668247|NCT00856518|463083058|FG001|Overall Study|Lost to Follow-up|2|||
128668248|NCT00947193|463083059|FG000|Overall Study|Lost to Follow-up|1|||
128668249|NCT00947193|463083060|FG001|Overall Study|Lost to Follow-up|0|||
129002104|NCT01261325|464299562|FG002|Overall Study|Withdrawal by Subject|4|||
128668250|NCT00947193|463083059|FG000|Overall Study|Withdrawal by Subject|1|||
129002105|NCT01261325|464299560|FG000|Overall Study|SAE, non-fatal|1|||
129002106|NCT01261325|464299561|FG001|Overall Study|SAE, non-fatal|5|||
129002107|NCT01261325|464299562|FG002|Overall Study|SAE, non-fatal|1|||
129002108|NCT01261325|464299560|FG000|Overall Study|AE, non-serious non-fatal|9|||
129002109|NCT01261325|464299561|FG001|Overall Study|AE, non-serious non-fatal|15|||
129002110|NCT01261325|464299562|FG002|Overall Study|AE, non-serious non-fatal|13|||
129002111|NCT01261325|464299560|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129002112|NCT01261325|464299561|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129002113|NCT01261325|464299562|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
128668251|NCT00947193|463083060|FG001|Overall Study|Withdrawal by Subject|0|||
128668252|NCT00947193|463083059|FG000|Overall Study|Factor VIII >1%|1|||
128668253|NCT00947193|463083060|FG001|Overall Study|Factor VIII >1%|0|||
128668254|NCT00926029|463083062|FG000|Overall Study|Lost to Follow-up|2|||
128668255|NCT00926029|463083063|FG001|Overall Study|Lost to Follow-up|1|||
128668256|NCT00926029|463083064|FG002|Overall Study|Lost to Follow-up|1|||
128668257|NCT05246514|463083065|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
128668258|NCT05246514|463083065|FG000|Overall Study|Withdrawal by Subject|1|||
128668259|NCT05246514|463083065|FG000|Overall Study|Death|13|||
128668260|NCT04154189|463083066|FG000|Overall Study|Withdrawal by Subject|4|||
128668261|NCT04154189|463083067|FG001|Overall Study|Withdrawal by Subject|6|||
128668262|NCT04154189|463083066|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
128668263|NCT04154189|463083067|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
128668264|NCT04154189|463083066|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
128668265|NCT04154189|463083067|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
128668266|NCT04154189|463083066|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
128668267|NCT04154189|463083067|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
128668268|NCT04154189|463083066|FG000|Overall Study|Death|25|||
128668269|NCT04154189|463083067|FG001|Overall Study|Death|25|||
128668270|NCT00486291|463083068|FG000|Overall Study|Adverse Event|3|||
128668271|NCT00486291|463083069|FG001|Overall Study|Adverse Event|4|||
128668272|NCT00486291|463083068|FG000|Overall Study|Lost to Follow-up|3|||
128668273|NCT00486291|463083069|FG001|Overall Study|Lost to Follow-up|7|||
128668274|NCT00486291|463083068|FG000|Overall Study|protocol non-compliance|10|||
128668275|NCT00486291|463083069|FG001|Overall Study|protocol non-compliance|15|||
128668276|NCT00486291|463083068|FG000|Overall Study|requirement for restricted medication|0|||
128668277|NCT00486291|463083069|FG001|Overall Study|requirement for restricted medication|3|||
128668278|NCT00126490|463083070|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
128668279|NCT00975780|463083071|FG000|Follow Up|Death|88|||
128668280|NCT00975780|463083072|FG001|Follow Up|Death|122|||
128668281|NCT00975780|463083071|FG000|Follow Up|Facility Withdrawal|7|||
128668282|NCT00975780|463083072|FG001|Follow Up|Facility Withdrawal|23|||
128668283|NCT00975780|463083071|FG000|Follow Up|Discharged from Facility|7|||
128668284|NCT00975780|463083072|FG001|Follow Up|Discharged from Facility|12|||
128668285|NCT03051178|463083075|FG000|Overall Study|Withdrawal by Subject|5|||
128668286|NCT01598506|463083076|FG000|Overall Study|Withdrawal by Subject|2|||
128668287|NCT04080167|463083079|FG000|Overall Study|Lost to Follow-up-Patients|7|||
128668288|NCT04080167|463083080|FG001|Overall Study|Lost to Follow-up-Patients|14|||
128668289|NCT04080167|463083081|FG002|Overall Study|Lost to Follow-up-Patients|0|||
128668290|NCT04080167|463083079|FG000|Overall Study|Lost to Follow-up-Providers|2|||
128668291|NCT04080167|463083080|FG001|Overall Study|Lost to Follow-up-Providers|2|||
128668292|NCT04080167|463083081|FG002|Overall Study|Lost to Follow-up-Providers|0|||
128668293|NCT04080167|463083079|FG000|Overall Study|Withdrawal by Subject|1|||
128668294|NCT04080167|463083080|FG001|Overall Study|Withdrawal by Subject|2|||
128668295|NCT04080167|463083081|FG002|Overall Study|Withdrawal by Subject|0|||
128668296|NCT04080167|463083079|FG000|Overall Study|Withdrawal by Provider|0|||
128668297|NCT04080167|463083080|FG001|Overall Study|Withdrawal by Provider|0|||
128668298|NCT04080167|463083081|FG002|Overall Study|Withdrawal by Provider|4|||
128668299|NCT04080167|463083079|FG000|Overall Study|Death-Patient|2|||
128668300|NCT04080167|463083080|FG001|Overall Study|Death-Patient|1|||
128668301|NCT04080167|463083081|FG002|Overall Study|Death-Patient|0|||
129002114|NCT01261325|464299560|FG000|Overall Study|Non Compliance|2|||
129002115|NCT01261325|464299561|FG001|Overall Study|Non Compliance|0|||
129002116|NCT01261325|464299562|FG002|Overall Study|Non Compliance|0|||
129002117|NCT01261325|464299560|FG000|Overall Study|Patient Randomized by Mistake|0|||
129002118|NCT01261325|464299561|FG001|Overall Study|Patient Randomized by Mistake|1|||
129002119|NCT01261325|464299562|FG002|Overall Study|Patient Randomized by Mistake|0|||
129002120|NCT01261325|464299560|FG000|Overall Study|Erroneously Randomized|1|||
129002121|NCT01261325|464299561|FG001|Overall Study|Erroneously Randomized|0|||
129002122|NCT01261325|464299562|FG002|Overall Study|Erroneously Randomized|0|||
129002123|NCT01261325|464299560|FG000|Overall Study|Screen Failure|1|||
128668302|NCT04080167|463083079|FG000|Overall Study|Hydroxyurea New Starts|0|||
128668303|NCT04080167|463083080|FG001|Overall Study|Hydroxyurea New Starts|0|||
128668304|NCT04080167|463083081|FG002|Overall Study|Hydroxyurea New Starts|1|||
128668305|NCT04080167|463083079|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
128668306|NCT04080167|463083080|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
128668307|NCT04080167|463083081|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
128668308|NCT02657408|463083082|FG000|Overall Study|Adverse Event|3|||
128668309|NCT02657408|463083083|FG001|Overall Study|Adverse Event|7|||
128668310|NCT00324961|463083085|FG000|Overall Study|Adverse Event|5|||
128668311|NCT00324961|463083085|FG000|Overall Study|Consent Withdrawn|11|||
128668312|NCT00324961|463083085|FG000|Overall Study|Lost to Follow-up|22|||
128668313|NCT00324961|463083085|FG000|Overall Study|Protocol Violation|3|||
129002124|NCT01261325|464299561|FG001|Overall Study|Screen Failure|0|||
129002125|NCT01261325|464299562|FG002|Overall Study|Screen Failure|0|||
129002126|NCT01261325|464299560|FG000|Overall Study|Randomized in Error|0|||
129002127|NCT01261325|464299561|FG001|Overall Study|Randomized in Error|0|||
129002128|NCT01261325|464299562|FG002|Overall Study|Randomized in Error|1|||
129002129|NCT01261325|464299560|FG000|Overall Study|Protocol Violation|0|||
129002130|NCT01261325|464299561|FG001|Overall Study|Protocol Violation|3|||
129002131|NCT01261325|464299562|FG002|Overall Study|Protocol Violation|1|||
129002132|NCT01261325|464299560|FG000|Overall Study|Lost to Follow-up|0|||
129002133|NCT01261325|464299561|FG001|Overall Study|Lost to Follow-up|1|||
129002134|NCT01261325|464299562|FG002|Overall Study|Lost to Follow-up|3|||
129002135|NCT01261325|464299560|FG000|Overall Study|AE, serious fatal|0|||
129002136|NCT01261325|464299561|FG001|Overall Study|AE, serious fatal|0|||
129002137|NCT01261325|464299562|FG002|Overall Study|AE, serious fatal|2|||
129002138|NCT01086215|464299565|FG000|Overall Study|Death|14|||
129002139|NCT01086215|464299566|FG001|Overall Study|Death|8|||
129002140|NCT01086215|464299567|FG002|Overall Study|Death|8|||
129002141|NCT01086215|464299568|FG003|Overall Study|Death|1|||
129002142|NCT01086215|464299565|FG000|Overall Study|Lost to Follow-up|22|||
129002143|NCT01086215|464299566|FG001|Overall Study|Lost to Follow-up|39|||
129002144|NCT01086215|464299567|FG002|Overall Study|Lost to Follow-up|18|||
129002145|NCT01086215|464299568|FG003|Overall Study|Lost to Follow-up|2|||
129002146|NCT03469271|464299571|FG000|Overall Study|Withdrawal by Subject|2|||
129002147|NCT03469271|464299572|FG001|Overall Study|Withdrawal by Subject|0|||
129002148|NCT03469271|464299573|FG002|Overall Study|Withdrawal by Subject|0|||
129002149|NCT03469271|464299574|FG003|Overall Study|Withdrawal by Subject|1|||
129002150|NCT00408876|464299575|FG000|Overall Study|Adverse Event|9|||
129002151|NCT00408876|464299576|FG001|Overall Study|Adverse Event|17|||
129002152|NCT00408876|464299577|FG002|Overall Study|Adverse Event|27|||
129002153|NCT00408876|464299578|FG003|Overall Study|Adverse Event|10|||
129002154|NCT00408876|464299575|FG000|Overall Study|Withdrawal by Subject|3|||
129002155|NCT00408876|464299576|FG001|Overall Study|Withdrawal by Subject|6|||
129002156|NCT00408876|464299577|FG002|Overall Study|Withdrawal by Subject|6|||
129002157|NCT00408876|464299578|FG003|Overall Study|Withdrawal by Subject|14|||
129002158|NCT00408876|464299575|FG000|Overall Study|Lack of Efficacy|2|||
129002159|NCT00408876|464299576|FG001|Overall Study|Lack of Efficacy|4|||
129002160|NCT00408876|464299577|FG002|Overall Study|Lack of Efficacy|5|||
129002161|NCT00408876|464299578|FG003|Overall Study|Lack of Efficacy|6|||
129002162|NCT00408876|464299575|FG000|Overall Study|Lost to Follow-up|1|||
129002163|NCT00408876|464299576|FG001|Overall Study|Lost to Follow-up|6|||
129002164|NCT00408876|464299577|FG002|Overall Study|Lost to Follow-up|5|||
129002165|NCT00408876|464299578|FG003|Overall Study|Lost to Follow-up|2|||
129002166|NCT00408876|464299575|FG000|Overall Study|Protocol Violation|0|||
129002167|NCT00408876|464299576|FG001|Overall Study|Protocol Violation|3|||
129002168|NCT00408876|464299577|FG002|Overall Study|Protocol Violation|4|||
129002169|NCT00408876|464299578|FG003|Overall Study|Protocol Violation|3|||
129002170|NCT00408876|464299575|FG000|Overall Study|Physician Decision|1|||
129002171|NCT00408876|464299576|FG001|Overall Study|Physician Decision|0|||
129002172|NCT00408876|464299577|FG002|Overall Study|Physician Decision|3|||
129002173|NCT00408876|464299578|FG003|Overall Study|Physician Decision|0|||
129002174|NCT02006147|464299579|FG000|Overall Study|Protocol Violation|1|||
129002175|NCT02006147|464299580|FG001|Overall Study|Protocol Violation|1|||
129002176|NCT02006147|464299581|FG002|Overall Study|Protocol Violation|0|||
129002177|NCT02006147|464299582|FG003|Overall Study|Protocol Violation|0|||
129002178|NCT02006147|464299579|FG000|Overall Study|Withdrawal by Subject|0|||
129002179|NCT02006147|464299580|FG001|Overall Study|Withdrawal by Subject|1|||
129002180|NCT02006147|464299581|FG002|Overall Study|Withdrawal by Subject|0|||
129002181|NCT02006147|464299582|FG003|Overall Study|Withdrawal by Subject|0|||
129002182|NCT02006147|464299579|FG000|Overall Study|Withdrawal by Sponsor|1|||
129002183|NCT02006147|464299580|FG001|Overall Study|Withdrawal by Sponsor|0|||
129002184|NCT02006147|464299581|FG002|Overall Study|Withdrawal by Sponsor|0|||
129002185|NCT02006147|464299582|FG003|Overall Study|Withdrawal by Sponsor|0|||
129002186|NCT03361956|464299583|FG000|Overall Study|Adverse Event|1|||
129002187|NCT03361956|464299584|FG001|Overall Study|Adverse Event|0|||
129002188|NCT03361956|464299585|FG002|Overall Study|Adverse Event|1|||
129002189|NCT03361956|464299586|FG003|Overall Study|Adverse Event|1|||
129002190|NCT03361956|464299587|FG004|Overall Study|Adverse Event|0|||
128668314|NCT00324961|463083085|FG000|Overall Study|Other|2|||
129002191|NCT03361956|464299583|FG000|Overall Study|Other|0|||
129002192|NCT03361956|464299584|FG001|Overall Study|Other|0|||
129002193|NCT03361956|464299585|FG002|Overall Study|Other|0|||
129002194|NCT03361956|464299586|FG003|Overall Study|Other|1|||
129002195|NCT03361956|464299587|FG004|Overall Study|Other|0|||
129002196|NCT03361956|464299583|FG000|Overall Study|Withdrawal by Subject|2|||
129002197|NCT03361956|464299584|FG001|Overall Study|Withdrawal by Subject|2|||
129002198|NCT03361956|464299585|FG002|Overall Study|Withdrawal by Subject|2|||
129002199|NCT03361956|464299586|FG003|Overall Study|Withdrawal by Subject|0|||
129002200|NCT03361956|464299587|FG004|Overall Study|Withdrawal by Subject|3|||
129002201|NCT03361956|464299583|FG000|Overall Study|Disease Relapse|0|||
129002202|NCT03361956|464299584|FG001|Overall Study|Disease Relapse|0|||
129002203|NCT03361956|464299585|FG002|Overall Study|Disease Relapse|1|||
129002204|NCT03361956|464299586|FG003|Overall Study|Disease Relapse|0|||
129002205|NCT03361956|464299587|FG004|Overall Study|Disease Relapse|0|||
129002206|NCT03361956|464299583|FG000|Overall Study|Physician Decision|0|||
129002207|NCT03361956|464299584|FG001|Overall Study|Physician Decision|2|||
129002208|NCT03361956|464299585|FG002|Overall Study|Physician Decision|0|||
129002209|NCT03361956|464299586|FG003|Overall Study|Physician Decision|1|||
129002210|NCT03361956|464299587|FG004|Overall Study|Physician Decision|0|||
129002211|NCT03361956|464299583|FG000|Overall Study|Lost to Follow-up|0|||
129002212|NCT03361956|464299584|FG001|Overall Study|Lost to Follow-up|0|||
129002213|NCT03361956|464299585|FG002|Overall Study|Lost to Follow-up|1|||
129002214|NCT03361956|464299586|FG003|Overall Study|Lost to Follow-up|1|||
129002215|NCT03361956|464299587|FG004|Overall Study|Lost to Follow-up|2|||
129002216|NCT01829295|464299593|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
129002217|NCT01829295|464299594|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
129002218|NCT01829295|464299595|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
129002219|NCT01829295|464299596|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
129002220|NCT01829295|464299593|FG000|6-12 Months|Adverse Event|0|||
129002221|NCT01829295|464299594|FG001|6-12 Months|Adverse Event|0|||
129002222|NCT01829295|464299595|FG002|6-12 Months|Adverse Event|3|||
129002223|NCT01829295|464299596|FG003|6-12 Months|Adverse Event|2|||
129002224|NCT01829295|464299593|FG000|6-12 Months|Lost to Follow-up|2|||
129002225|NCT01829295|464299594|FG001|6-12 Months|Lost to Follow-up|0|||
129002226|NCT01829295|464299595|FG002|6-12 Months|Lost to Follow-up|0|||
129002227|NCT01829295|464299596|FG003|6-12 Months|Lost to Follow-up|0|||
129002228|NCT01829295|464299593|FG000|6-12 Months|Withdrawal by Subject|2|||
129002229|NCT01829295|464299594|FG001|6-12 Months|Withdrawal by Subject|2|||
129002230|NCT01829295|464299595|FG002|6-12 Months|Withdrawal by Subject|0|||
129002231|NCT01829295|464299596|FG003|6-12 Months|Withdrawal by Subject|0|||
129002232|NCT02826603|464299597|FG000|Overall Study|Adverse Event|17|||
129002233|NCT02826603|464299598|FG001|Overall Study|Adverse Event|9|||
129002234|NCT02826603|464299597|FG000|Overall Study|Lack of Efficacy|4|||
129002235|NCT02826603|464299598|FG001|Overall Study|Lack of Efficacy|9|||
129002236|NCT02826603|464299597|FG000|Overall Study|Lost to Follow-up|13|||
129002237|NCT02826603|464299598|FG001|Overall Study|Lost to Follow-up|12|||
129002238|NCT02826603|464299597|FG000|Overall Study|Noncompliance with treatment|0|||
129002239|NCT02826603|464299598|FG001|Overall Study|Noncompliance with treatment|2|||
129002240|NCT02826603|464299597|FG000|Overall Study|Physician Decision|1|||
129002241|NCT02826603|464299598|FG001|Overall Study|Physician Decision|7|||
129002242|NCT02826603|464299597|FG000|Overall Study|Pregnancy|1|||
129002243|NCT02826603|464299598|FG001|Overall Study|Pregnancy|2|||
129002244|NCT02826603|464299597|FG000|Overall Study|Protocol Violation|3|||
129002245|NCT02826603|464299598|FG001|Overall Study|Protocol Violation|3|||
129002246|NCT02826603|464299597|FG000|Overall Study|Withdrawal by Subject|20|||
129002247|NCT02826603|464299598|FG001|Overall Study|Withdrawal by Subject|19|||
129002248|NCT02826603|464299597|FG000|Overall Study|Death|2|||
129002249|NCT02826603|464299598|FG001|Overall Study|Death|0|||
129002250|NCT02826603|464299597|FG000|Overall Study|New therapy for study indication|0|||
128668315|NCT03350672|463083088|FG000|Overall Study|Withdrawal by Subject|7|||
128668316|NCT03350672|463083089|FG001|Overall Study|Withdrawal by Subject|0|||
128668317|NCT03350672|463083090|FG002|Overall Study|Withdrawal by Subject|0|||
128668318|NCT01459497|463083091|FG000|Overall Study|Inability to meet trial constraints.|1|||
128668319|NCT01459497|463083092|FG001|Overall Study|Inability to meet trial constraints.|0|||
128668320|NCT01459497|463083091|FG000|Overall Study|Physician Decision|1|||
128668321|NCT01459497|463083092|FG001|Overall Study|Physician Decision|1|||
128668322|NCT01459497|463083091|FG000|Overall Study|Hospitalization.|0|||
128668323|NCT01459497|463083092|FG001|Overall Study|Hospitalization.|3|||
128668324|NCT01459497|463083091|FG000|Overall Study|Disease progression.|0|||
128668325|NCT01459497|463083092|FG001|Overall Study|Disease progression.|1|||
128668326|NCT03530124|463083093|FG000|Overall Study|Withdrawal by Subject|0|||
128668327|NCT03530124|463083094|FG001|Overall Study|Withdrawal by Subject|1|||
128668328|NCT03530124|463083093|FG000|Overall Study|Protocol Violation|1|||
128668329|NCT03530124|463083094|FG001|Overall Study|Protocol Violation|0|||
128668330|NCT03530124|463083093|FG000|Overall Study|Discharged prior to study completion|1|||
128668331|NCT03530124|463083094|FG001|Overall Study|Discharged prior to study completion|0|||
128668332|NCT05343624|463083095|FG000|Overall Study|Chart review not completed|1|||
129002251|NCT02826603|464299598|FG001|Overall Study|New therapy for study indication|1|||
129002252|NCT01337050|464299602|FG000|Overall Study|Death|0|||
129002253|NCT01337050|464299603|FG001|Overall Study|Death|0|||
128668333|NCT02504216|463083096|FG000|Overall Study|Lost to Follow-up|3|||
128668334|NCT02504216|463083097|FG001|Overall Study|Lost to Follow-up|3|||
128668335|NCT02504216|463083096|FG000|Overall Study|Withdrawal by Subject|8|||
129002254|NCT01337050|464299604|FG002|Overall Study|Death|4|||
129002255|NCT01337050|464299602|FG000|Overall Study|Other|4|||
129002256|NCT01337050|464299603|FG001|Overall Study|Other|6|||
129002257|NCT01337050|464299604|FG002|Overall Study|Other|8|||
129002258|NCT01337050|464299602|FG000|Overall Study|Participants refused further follow-up|0|||
129002259|NCT01337050|464299603|FG001|Overall Study|Participants refused further follow-up|7|||
129002260|NCT01337050|464299604|FG002|Overall Study|Participants refused further follow-up|7|||
129002261|NCT00003102|464299605|FG000|Overall Study|Physician Decision|1|||
129002262|NCT00003102|464299606|FG001|Overall Study|Physician Decision|1|||
129002263|NCT00003102|464299607|FG002|Overall Study|Physician Decision|0|||
129002264|NCT00003102|464299605|FG000|Overall Study|Progressive Disease|0|||
129002265|NCT00003102|464299606|FG001|Overall Study|Progressive Disease|1|||
129002266|NCT00003102|464299607|FG002|Overall Study|Progressive Disease|0|||
129002267|NCT00003102|464299605|FG000|Overall Study|Adverse Event|0|||
129002268|NCT00003102|464299606|FG001|Overall Study|Adverse Event|1|||
129002269|NCT00003102|464299607|FG002|Overall Study|Adverse Event|1|||
129002270|NCT00003102|464299605|FG000|Overall Study|Death|0|||
129002271|NCT00003102|464299606|FG001|Overall Study|Death|0|||
129002272|NCT00003102|464299607|FG002|Overall Study|Death|1|||
129002273|NCT00583596|464299608|FG000|Overall Study|Lost to Follow-up|110|||
129002274|NCT00583596|464299608|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
129002275|NCT00583596|464299608|FG000|Overall Study|Death|2|||
129002276|NCT00583596|464299608|FG000|Overall Study|Withdrawal by Subject|6|||
129002277|NCT00583596|464299608|FG000|Overall Study|Lost to Follow-up|94|||
129002278|NCT00583596|464299608|FG000|Overall Study|Data not complete|1|||
129002279|NCT00583596|464299608|FG000|Overall Study|Not consented|15|||
129002280|NCT00583596|464299608|FG000|Overall Study|Outside f-up window|26|||
129002281|NCT00656019|464299609|FG000|Overall Study|Not Eligible|10|||
129002282|NCT00656019|464299610|FG001|Overall Study|Not Eligible|0|||
129002283|NCT00656019|464299611|FG002|Overall Study|Not Eligible|0|||
129002284|NCT00656019|464299612|FG003|Overall Study|Not Eligible|0|||
129002285|NCT00656019|464299609|FG000|Overall Study|Withdrawal by Subject|2|||
129002286|NCT00656019|464299610|FG001|Overall Study|Withdrawal by Subject|0|||
129002287|NCT00656019|464299611|FG002|Overall Study|Withdrawal by Subject|0|||
129002288|NCT00656019|464299612|FG003|Overall Study|Withdrawal by Subject|0|||
129002289|NCT00656019|464299609|FG000|Overall Study|Lost to Follow-up|2|||
129002290|NCT00656019|464299610|FG001|Overall Study|Lost to Follow-up|1|||
129002291|NCT00656019|464299611|FG002|Overall Study|Lost to Follow-up|0|||
129002292|NCT00656019|464299612|FG003|Overall Study|Lost to Follow-up|0|||
129002293|NCT00096486|464299613|FG000|Overall Study|Withdrawal by Subject|0|||
129002294|NCT00096486|464299614|FG001|Overall Study|Withdrawal by Subject|0|||
129002295|NCT00096486|464299615|FG002|Overall Study|Withdrawal by Subject|1|||
129002296|NCT00096486|464299616|FG003|Overall Study|Withdrawal by Subject|1|||
129002297|NCT00096486|464299613|FG000|Overall Study|Not Treated|0|||
128668336|NCT02504216|463083097|FG001|Overall Study|Withdrawal by Subject|12|||
128668337|NCT04549545|463085015|FG000|Initial Period|Withdrawal by Subject|4|||
128668338|NCT04549545|463085016|FG001|Initial Period|Withdrawal by Subject|0|||
128668339|NCT04549545|463085015|FG000|Initial Period|Additional ENT Procedure|3|||
128668340|NCT04549545|463085016|FG001|Initial Period|Additional ENT Procedure|0|||
128668341|NCT04549545|463085015|FG000|Initial Period|Lost to Follow-up|3|||
128668342|NCT04549545|463085016|FG001|Initial Period|Lost to Follow-up|1|||
128668343|NCT04549545|463085015|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
128668344|NCT04549545|463085016|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
128668345|NCT04549545|463085015|FG000|Crossover Period|Additional ENT Procedure|0|||
128668346|NCT04549545|463085016|FG001|Crossover Period|Additional ENT Procedure|6|||
128668347|NCT04549545|463085015|FG000|Crossover Period|Lost to Follow-up|0|||
128668348|NCT04549545|463085016|FG001|Crossover Period|Lost to Follow-up|1|||
128668349|NCT04549545|463085015|FG000|Crossover Period|Withdrawal by Subject|0|||
128668350|NCT04549545|463085016|FG001|Crossover Period|Withdrawal by Subject|4|||
128668351|NCT01006291|463085020|FG000|Overall Study|Adverse Event|2|||
128668352|NCT01006291|463085021|FG001|Overall Study|Adverse Event|1|||
128668353|NCT01006291|463085022|FG002|Overall Study|Adverse Event|2|||
128668354|NCT01006291|463085020|FG000|Overall Study|Lack of Efficacy|2|||
128668355|NCT01006291|463085021|FG001|Overall Study|Lack of Efficacy|2|||
128668356|NCT01006291|463085022|FG002|Overall Study|Lack of Efficacy|1|||
128668357|NCT01006291|463085020|FG000|Overall Study|Protocol Violation|3|||
128668358|NCT01006291|463085021|FG001|Overall Study|Protocol Violation|3|||
128668359|NCT01006291|463085022|FG002|Overall Study|Protocol Violation|3|||
128668360|NCT01006291|463085020|FG000|Overall Study|Withdrawal criteria|5|||
128668361|NCT01006291|463085021|FG001|Overall Study|Withdrawal criteria|4|||
128668362|NCT01006291|463085022|FG002|Overall Study|Withdrawal criteria|4|||
129002298|NCT00096486|464299614|FG001|Overall Study|Not Treated|0|||
129002299|NCT00096486|464299615|FG002|Overall Study|Not Treated|1|||
129002300|NCT00096486|464299616|FG003|Overall Study|Not Treated|1|||
129002301|NCT03558997|464299617|FG000|Overall Study|Adverse Event|0|||
129002302|NCT03558997|464299618|FG001|Overall Study|Adverse Event|2|||
128668363|NCT01006291|463085020|FG000|Overall Study|Other|14|||
129002303|NCT03558997|464299619|FG002|Overall Study|Adverse Event|5|||
129002304|NCT03558997|464299620|FG003|Overall Study|Adverse Event|1|||
128668364|NCT01006291|463085021|FG001|Overall Study|Other|14|||
128668365|NCT01006291|463085022|FG002|Overall Study|Other|17|||
129002305|NCT03558997|464299617|FG000|Overall Study|Physician Decision|0|||
129002306|NCT03558997|464299618|FG001|Overall Study|Physician Decision|0|||
129002307|NCT03558997|464299619|FG002|Overall Study|Physician Decision|1|||
129002308|NCT03558997|464299620|FG003|Overall Study|Physician Decision|0|||
129002309|NCT03558997|464299617|FG000|Overall Study|Withdrawal by Subject|1|||
129002310|NCT03558997|464299618|FG001|Overall Study|Withdrawal by Subject|0|||
129002311|NCT03558997|464299619|FG002|Overall Study|Withdrawal by Subject|1|||
129002312|NCT03558997|464299620|FG003|Overall Study|Withdrawal by Subject|1|||
129002313|NCT03558997|464299617|FG000|Overall Study|Lost to Follow-up|0|||
129002314|NCT03558997|464299618|FG001|Overall Study|Lost to Follow-up|0|||
129002315|NCT03558997|464299619|FG002|Overall Study|Lost to Follow-up|1|||
129002316|NCT03558997|464299620|FG003|Overall Study|Lost to Follow-up|0|||
129002317|NCT02230085|464299623|FG000|Overall Study|Physician Decision|1|||
129002318|NCT02230085|464299623|FG000|Overall Study|Withdrawal by Subject|3|||
129002319|NCT01360632|464299629|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
129002320|NCT01360632|464299630|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
129002321|NCT01360632|464299631|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
129002322|NCT01360632|464299632|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
129002323|NCT01360632|464299633|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
129002324|NCT01360632|464299629|FG000|Phase A (8 Weeks)|Adverse Event|60|||
129002325|NCT01360632|464299630|FG001|Phase A (8 Weeks)|Adverse Event|0|||
129002326|NCT01360632|464299631|FG002|Phase A (8 Weeks)|Adverse Event|0|||
129002327|NCT01360632|464299632|FG003|Phase A (8 Weeks)|Adverse Event|0|||
129002328|NCT01360632|464299633|FG004|Phase A (8 Weeks)|Adverse Event|0|||
129002329|NCT01360632|464299629|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
129002330|NCT01360632|464299630|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129002331|NCT01360632|464299631|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129002332|NCT01360632|464299632|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129002333|NCT01360632|464299633|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129002334|NCT01360632|464299629|FG000|Phase A (8 Weeks)|Physician Decision|10|||
129002335|NCT01360632|464299630|FG001|Phase A (8 Weeks)|Physician Decision|0|||
129002336|NCT01360632|464299631|FG002|Phase A (8 Weeks)|Physician Decision|0|||
128668366|NCT03079102|463085023|FG000|Overall Study|Physician Decision|0|||
128668367|NCT03079102|463085024|FG001|Overall Study|Physician Decision|1|||
128668368|NCT02810444|463085025|FG000|Overall Study|Screen Failures|14|||
128668369|NCT02810444|463085025|FG000|Overall Study|Withdrawal by Subject|4|||
128668370|NCT02810444|463085025|FG000|Overall Study|Adverse Event|3|||
128668371|NCT02785770|463085026|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
128668372|NCT02785770|463085027|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
128668373|NCT02785770|463085028|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
128668374|NCT02785770|463085029|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
128668375|NCT02785770|463085026|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
128668376|NCT02785770|463085027|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
129002337|NCT01360632|464299632|FG003|Phase A (8 Weeks)|Physician Decision|0|||
129002338|NCT01360632|464299633|FG004|Phase A (8 Weeks)|Physician Decision|0|||
129002339|NCT01360632|464299629|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
128668377|NCT02785770|463085028|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
129002340|NCT01360632|464299630|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
128668378|NCT02785770|463085029|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
128668379|NCT02785770|463085026|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
128668380|NCT02785770|463085027|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
128668381|NCT02785770|463085028|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
128668382|NCT02785770|463085029|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
128668383|NCT04518995|463085030|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
128668384|NCT04518995|463085031|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
128668385|NCT04518995|463085032|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
128668386|NCT04518995|463085030|FG000|Overall Study|Lack of Efficacy|2|||
128668387|NCT04518995|463085031|FG001|Overall Study|Lack of Efficacy|1|||
128668388|NCT04518995|463085032|FG002|Overall Study|Lack of Efficacy|0|||
128668389|NCT04518995|463085030|FG000|Overall Study|Non-compliance With Study Drug|0|||
128668390|NCT04518995|463085031|FG001|Overall Study|Non-compliance With Study Drug|3|||
128668391|NCT04518995|463085032|FG002|Overall Study|Non-compliance With Study Drug|2|||
128668392|NCT04518995|463085030|FG000|Overall Study|Pregnancy|0|||
128668393|NCT04518995|463085031|FG001|Overall Study|Pregnancy|0|||
128668394|NCT04518995|463085032|FG002|Overall Study|Pregnancy|1|||
128668395|NCT04518995|463085030|FG000|Overall Study|Protocol Violation|2|||
129002341|NCT01360632|464299631|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
129002342|NCT01360632|464299632|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
129002343|NCT01360632|464299633|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
128668396|NCT04518995|463085031|FG001|Overall Study|Protocol Violation|0|||
128668397|NCT04518995|463085032|FG002|Overall Study|Protocol Violation|1|||
128668398|NCT04518995|463085030|FG000|Overall Study|Reason not Specified|4|||
128668399|NCT04518995|463085031|FG001|Overall Study|Reason not Specified|11|||
128668400|NCT04518995|463085032|FG002|Overall Study|Reason not Specified|2|||
129002344|NCT01360632|464299629|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
129002345|NCT01360632|464299630|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
129002346|NCT01360632|464299631|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
129002347|NCT01360632|464299632|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
129002348|NCT01360632|464299633|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
128668401|NCT04518995|463085030|FG000|Overall Study|Lost to Follow-up|1|||
128668402|NCT04518995|463085031|FG001|Overall Study|Lost to Follow-up|10|||
128668403|NCT04518995|463085032|FG002|Overall Study|Lost to Follow-up|6|||
129002349|NCT01360632|464299629|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
129002350|NCT01360632|464299630|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
129002351|NCT01360632|464299631|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
129002352|NCT01360632|464299632|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
129002353|NCT01360632|464299633|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
129002354|NCT01360632|464299629|FG000|Phase B (6 Weeks)|Adverse Event|0|||
129002355|NCT01360632|464299630|FG001|Phase B (6 Weeks)|Adverse Event|3|||
129002356|NCT01360632|464299631|FG002|Phase B (6 Weeks)|Adverse Event|9|||
129002357|NCT01360632|464299632|FG003|Phase B (6 Weeks)|Adverse Event|3|||
129002358|NCT01360632|464299633|FG004|Phase B (6 Weeks)|Adverse Event|0|||
129002359|NCT01360632|464299629|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129002360|NCT01360632|464299630|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129002361|NCT01360632|464299631|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
129002362|NCT01360632|464299632|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
129002363|NCT01360632|464299633|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129002364|NCT01360632|464299629|FG000|Phase B (6 Weeks)|Physician Decision|0|||
129002365|NCT01360632|464299630|FG001|Phase B (6 Weeks)|Physician Decision|0|||
129002366|NCT01360632|464299631|FG002|Phase B (6 Weeks)|Physician Decision|0|||
129002367|NCT01360632|464299632|FG003|Phase B (6 Weeks)|Physician Decision|1|||
129002368|NCT01360632|464299633|FG004|Phase B (6 Weeks)|Physician Decision|0|||
129002369|NCT01360632|464299629|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
129002370|NCT01360632|464299630|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
129002371|NCT01360632|464299631|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
129002372|NCT01360632|464299632|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
129002373|NCT01360632|464299633|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
129002374|NCT01360632|464299629|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
129002375|NCT01360632|464299630|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
129002376|NCT01360632|464299631|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
129002377|NCT01360632|464299632|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
129002378|NCT01360632|464299633|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
129002379|NCT01360632|464299629|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
129002380|NCT01360632|464299630|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
129002381|NCT01360632|464299631|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
129002382|NCT01360632|464299632|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
129002383|NCT01360632|464299633|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
129002384|NCT01360632|464299629|FG000|Phase A+|Lost to Follow-up|0|||
129002385|NCT01360632|464299630|FG001|Phase A+|Lost to Follow-up|0|||
129002386|NCT01360632|464299631|FG002|Phase A+|Lost to Follow-up|0|||
129002387|NCT01360632|464299632|FG003|Phase A+|Lost to Follow-up|0|||
129002388|NCT01360632|464299633|FG004|Phase A+|Lost to Follow-up|2|||
129002389|NCT01360632|464299629|FG000|Phase A+|Adverse Event|0|||
129002390|NCT01360632|464299630|FG001|Phase A+|Adverse Event|0|||
129002391|NCT01360632|464299631|FG002|Phase A+|Adverse Event|0|||
129002392|NCT01360632|464299632|FG003|Phase A+|Adverse Event|0|||
129002393|NCT01360632|464299633|FG004|Phase A+|Adverse Event|2|||
129002394|NCT01360632|464299629|FG000|Phase A+|Met Withdrawal Criteria|0|||
128668404|NCT00545272|463085035|FG000|Overall Study|Protocol deviation|0|||
128668405|NCT00545272|463085036|FG001|Overall Study|Protocol deviation|1|||
128668406|NCT00545272|463085037|FG002|Overall Study|Protocol deviation|0|||
128668407|NCT00545272|463085038|FG003|Overall Study|Protocol deviation|1|||
128668408|NCT00545272|463085039|FG004|Overall Study|Protocol deviation|0|||
128668409|NCT00545272|463085040|FG005|Overall Study|Protocol deviation|1|||
128668410|NCT00545272|463085035|FG000|Overall Study|Adverse Event|0|||
128668411|NCT00545272|463085036|FG001|Overall Study|Adverse Event|0|||
128668412|NCT00545272|463085037|FG002|Overall Study|Adverse Event|1|||
128668413|NCT00545272|463085038|FG003|Overall Study|Adverse Event|0|||
128668414|NCT00545272|463085039|FG004|Overall Study|Adverse Event|0|||
128668415|NCT00545272|463085040|FG005|Overall Study|Adverse Event|1|||
129002395|NCT01360632|464299630|FG001|Phase A+|Met Withdrawal Criteria|0|||
129002396|NCT01360632|464299631|FG002|Phase A+|Met Withdrawal Criteria|0|||
129002397|NCT01360632|464299632|FG003|Phase A+|Met Withdrawal Criteria|0|||
129002398|NCT01360632|464299633|FG004|Phase A+|Met Withdrawal Criteria|7|||
129002399|NCT01360632|464299629|FG000|Phase A+|Physician Decision|0|||
129002400|NCT01360632|464299630|FG001|Phase A+|Physician Decision|0|||
129002401|NCT01360632|464299631|FG002|Phase A+|Physician Decision|0|||
129002402|NCT01360632|464299632|FG003|Phase A+|Physician Decision|0|||
129002403|NCT01360632|464299633|FG004|Phase A+|Physician Decision|3|||
129002404|NCT01360632|464299629|FG000|Phase A+|Withdrawal by Subject|0|||
129002405|NCT01360632|464299630|FG001|Phase A+|Withdrawal by Subject|0|||
129002406|NCT01360632|464299631|FG002|Phase A+|Withdrawal by Subject|0|||
129002407|NCT01360632|464299632|FG003|Phase A+|Withdrawal by Subject|0|||
128668416|NCT00545272|463085035|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128668417|NCT00545272|463085036|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128668418|NCT00545272|463085037|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128668419|NCT00545272|463085038|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129002408|NCT01360632|464299633|FG004|Phase A+|Withdrawal by Subject|8|||
129002409|NCT01360632|464299629|FG000|Phase A+|Protocol Deviation|0|||
129002410|NCT01360632|464299630|FG001|Phase A+|Protocol Deviation|0|||
129002411|NCT01360632|464299631|FG002|Phase A+|Protocol Deviation|0|||
129002412|NCT01360632|464299632|FG003|Phase A+|Protocol Deviation|0|||
129002413|NCT01360632|464299633|FG004|Phase A+|Protocol Deviation|3|||
129002414|NCT02173301|464299634|FG000|Overall Study|Adverse Event|7|||
129002415|NCT02173301|464299635|FG001|Overall Study|Adverse Event|8|||
129002416|NCT02173301|464299636|FG002|Overall Study|Adverse Event|13|||
129002417|NCT02173301|464299637|FG003|Overall Study|Adverse Event|5|||
129002418|NCT02173301|464299634|FG000|Overall Study|Withdrawal by Subject|8|||
129002419|NCT02173301|464299635|FG001|Overall Study|Withdrawal by Subject|10|||
129002420|NCT02173301|464299636|FG002|Overall Study|Withdrawal by Subject|4|||
129002421|NCT02173301|464299637|FG003|Overall Study|Withdrawal by Subject|8|||
129002422|NCT02173301|464299634|FG000|Overall Study|Lost to Follow-up|4|||
129002423|NCT02173301|464299635|FG001|Overall Study|Lost to Follow-up|4|||
129002424|NCT02173301|464299636|FG002|Overall Study|Lost to Follow-up|2|||
129002425|NCT02173301|464299637|FG003|Overall Study|Lost to Follow-up|2|||
129002426|NCT02173301|464299634|FG000|Overall Study|Protocol Violation|0|||
129002427|NCT02173301|464299635|FG001|Overall Study|Protocol Violation|1|||
129002428|NCT02173301|464299636|FG002|Overall Study|Protocol Violation|0|||
129002429|NCT02173301|464299637|FG003|Overall Study|Protocol Violation|0|||
129002430|NCT02173301|464299634|FG000|Overall Study|Physician Decision|0|||
129002431|NCT02173301|464299635|FG001|Overall Study|Physician Decision|0|||
129002432|NCT02173301|464299636|FG002|Overall Study|Physician Decision|1|||
129002433|NCT02173301|464299637|FG003|Overall Study|Physician Decision|0|||
129002434|NCT02173301|464299634|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
129002435|NCT02173301|464299635|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
129002436|NCT02173301|464299636|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
129002437|NCT02173301|464299637|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
129002438|NCT03016078|464299639|FG000|Overall Study|Protocol Violation|1|||
129002439|NCT03016078|464299639|FG000|Overall Study|Protocol Violation|1|||
129002440|NCT01715415|464299641|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
129002441|NCT01715415|464299642|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
129002442|NCT01715415|464299641|FG000|Double-blind Treatment|Adverse Event|3|||
129002443|NCT01715415|464299642|FG001|Double-blind Treatment|Adverse Event|0|||
129002444|NCT01715415|464299641|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
129002445|NCT01715415|464299642|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
129002446|NCT01715415|464299641|FG000|Double-blind Treatment|Other|1|||
129002447|NCT01715415|464299642|FG001|Double-blind Treatment|Other|0|||
129002448|NCT01715415|464299641|FG000|Open-label Treatment|Adverse Event|0|||
129002449|NCT01715415|464299642|FG001|Open-label Treatment|Adverse Event|1|||
129002450|NCT01715415|464299641|FG000|Open-label Treatment|Subject Noncompliant|0|||
129002451|NCT01715415|464299642|FG001|Open-label Treatment|Subject Noncompliant|1|||
129002452|NCT05028751|464299643|FG000|Overall Study|Study Terminated by Sponsor|3|||
129002453|NCT05028751|464299644|FG001|Overall Study|Study Terminated by Sponsor|0|||
129002454|NCT05028751|464299645|FG002|Overall Study|Study Terminated by Sponsor|0|||
129002455|NCT05028751|464299646|FG003|Overall Study|Study Terminated by Sponsor|0|||
129002456|NCT05028751|464299643|FG000|Overall Study|Death|9|||
129002457|NCT05028751|464299644|FG001|Overall Study|Death|3|||
129002458|NCT05028751|464299645|FG002|Overall Study|Death|2|||
129002459|NCT05028751|464299646|FG003|Overall Study|Death|4|||
129002460|NCT05028751|464299643|FG000|Overall Study|Withdrawal by Subject|0|||
129002461|NCT05028751|464299644|FG001|Overall Study|Withdrawal by Subject|0|||
129002462|NCT05028751|464299645|FG002|Overall Study|Withdrawal by Subject|1|||
129002463|NCT05028751|464299646|FG003|Overall Study|Withdrawal by Subject|0|||
129002464|NCT05028751|464299643|FG000|Overall Study|Miscellaneous|2|||
129002465|NCT05028751|464299644|FG001|Overall Study|Miscellaneous|0|||
129002466|NCT05028751|464299645|FG002|Overall Study|Miscellaneous|0|||
129002467|NCT05028751|464299646|FG003|Overall Study|Miscellaneous|0|||
129002468|NCT00598559|464301890|FG000|Overall Study|Adverse Event|11|||
129002469|NCT00598559|464301891|FG001|Overall Study|Adverse Event|7|||
129002470|NCT00598559|464301892|FG002|Overall Study|Adverse Event|0|||
129002471|NCT00598559|464301890|FG000|Overall Study|Withdrawal by Subject|2|||
129002472|NCT00598559|464301891|FG001|Overall Study|Withdrawal by Subject|2|||
129002473|NCT00598559|464301892|FG002|Overall Study|Withdrawal by Subject|0|||
129002474|NCT00598559|464301890|FG000|Overall Study|Protocol Non-compliance|1|||
129002475|NCT00598559|464301891|FG001|Overall Study|Protocol Non-compliance|0|||
129002476|NCT00598559|464301892|FG002|Overall Study|Protocol Non-compliance|0|||
129002477|NCT00598559|464301890|FG000|Overall Study|Early discharge from hospital|9|||
129002478|NCT00598559|464301891|FG001|Overall Study|Early discharge from hospital|12|||
129002479|NCT00598559|464301892|FG002|Overall Study|Early discharge from hospital|3|||
129002480|NCT00598559|464301890|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
129002481|NCT00598559|464301891|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
129002482|NCT00598559|464301892|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
129002483|NCT01907737|464301895|FG000|Overall Study|Withdrawal by Subject|1|||
129002484|NCT01772368|464301897|FG000|Overall Study|Adverse Event|1|||
129002485|NCT01772368|464301897|FG000|Overall Study|Withdrawal by Subject|3|||
128668420|NCT00545272|463085039|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129002486|NCT01772368|464301897|FG000|Overall Study|Protocol Violation|2|||
129002487|NCT01772368|464301897|FG000|Overall Study|Other|1|||
129002488|NCT01452529|464301898|FG000|Run-in Period|Adverse Event|96|||
129002489|NCT01452529|464301899|FG001|Run-in Period|Adverse Event|0|||
129002490|NCT01452529|464301900|FG002|Run-in Period|Adverse Event|0|||
129002491|NCT01452529|464301898|FG000|Run-in Period|Withdrawal by Subject|49|||
129002492|NCT01452529|464301899|FG001|Run-in Period|Withdrawal by Subject|0|||
129002493|NCT01452529|464301900|FG002|Run-in Period|Withdrawal by Subject|0|||
129002494|NCT01452529|464301898|FG000|Run-in Period|Lost to Follow-up|19|||
129002495|NCT01452529|464301899|FG001|Run-in Period|Lost to Follow-up|0|||
129002496|NCT01452529|464301900|FG002|Run-in Period|Lost to Follow-up|0|||
129002497|NCT01452529|464301898|FG000|Run-in Period|Lack of Efficacy|46|||
129002498|NCT01452529|464301899|FG001|Run-in Period|Lack of Efficacy|0|||
129002499|NCT01452529|464301900|FG002|Run-in Period|Lack of Efficacy|0|||
129002500|NCT01452529|464301898|FG000|Run-in Period|Confirmed or suspected diversion|23|||
129002501|NCT01452529|464301899|FG001|Run-in Period|Confirmed or suspected diversion|0|||
129002502|NCT01452529|464301900|FG002|Run-in Period|Confirmed or suspected diversion|0|||
129002503|NCT01452529|464301898|FG000|Run-in Period|Administrative|21|||
128668421|NCT00545272|463085040|FG005|Overall Study|Abnormal laboratory value(s)|1|||
128668422|NCT00545272|463085035|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128668423|NCT00545272|463085036|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129002504|NCT01452529|464301899|FG001|Run-in Period|Administrative|0|||
129002505|NCT01452529|464301900|FG002|Run-in Period|Administrative|0|||
129002506|NCT01452529|464301898|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
129002507|NCT01452529|464301899|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
129002508|NCT01452529|464301900|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
129002509|NCT01452529|464301898|FG000|Double-blind (DB) Period|Adverse Event|0|||
129002510|NCT01452529|464301899|FG001|Double-blind (DB) Period|Adverse Event|18|||
129002511|NCT01452529|464301900|FG002|Double-blind (DB) Period|Adverse Event|11|||
129002512|NCT01452529|464301898|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
129002513|NCT01452529|464301899|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
129002514|NCT01452529|464301900|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
129002515|NCT01452529|464301898|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
129002516|NCT01452529|464301899|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
129002517|NCT01452529|464301900|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
129002518|NCT01452529|464301898|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
129002519|NCT01452529|464301899|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
129002520|NCT01452529|464301900|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
129002521|NCT01452529|464301898|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
129002522|NCT01452529|464301899|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
129002523|NCT01452529|464301900|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
129002524|NCT01452529|464301898|FG000|Double-blind (DB) Period|Administrative|0|||
129002525|NCT01452529|464301899|FG001|Double-blind (DB) Period|Administrative|11|||
129002526|NCT01452529|464301900|FG002|Double-blind (DB) Period|Administrative|7|||
129002527|NCT02884206|464301906|FG000|Valsartan Run-in Period|Death|1|||
129002528|NCT02884206|464301907|FG001|Valsartan Run-in Period|Death|0|||
129002529|NCT02884206|464301908|FG002|Valsartan Run-in Period|Death|0|||
129002530|NCT02884206|464301906|FG000|Valsartan Run-in Period|Adverse Event|31|||
129002531|NCT02884206|464301907|FG001|Valsartan Run-in Period|Adverse Event|0|||
129002532|NCT02884206|464301908|FG002|Valsartan Run-in Period|Adverse Event|0|||
129002533|NCT02884206|464301906|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
129002534|NCT02884206|464301907|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
129002535|NCT02884206|464301908|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
129002536|NCT02884206|464301906|FG000|Valsartan Run-in Period|Protocol deviation|4|||
129002537|NCT02884206|464301907|FG001|Valsartan Run-in Period|Protocol deviation|0|||
129002538|NCT02884206|464301908|FG002|Valsartan Run-in Period|Protocol deviation|0|||
129002539|NCT02884206|464301906|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
129002540|NCT02884206|464301907|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
129002541|NCT02884206|464301908|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
129002542|NCT02884206|464301906|FG000|Valsartan Run-in Period|Physician Decision|1|||
129002543|NCT02884206|464301907|FG001|Valsartan Run-in Period|Physician Decision|0|||
129002544|NCT02884206|464301908|FG002|Valsartan Run-in Period|Physician Decision|0|||
129002545|NCT02884206|464301906|FG000|LCZ696 Run-in Period|Adverse Event|38|||
128668424|NCT00545272|463085037|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129002546|NCT02884206|464301907|FG001|LCZ696 Run-in Period|Adverse Event|0|||
129002547|NCT02884206|464301908|FG002|LCZ696 Run-in Period|Adverse Event|0|||
129002548|NCT02884206|464301906|FG000|LCZ696 Run-in Period|Death|2|||
129002549|NCT02884206|464301907|FG001|LCZ696 Run-in Period|Death|0|||
129002550|NCT02884206|464301908|FG002|LCZ696 Run-in Period|Death|0|||
128668425|NCT00545272|463085038|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129002551|NCT02884206|464301906|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
128668426|NCT00545272|463085039|FG004|Overall Study|Abnormal test procedure result(s)|1|||
128668427|NCT00545272|463085040|FG005|Overall Study|Abnormal test procedure result(s)|0|||
128668428|NCT00545272|463085035|FG000|Overall Study|Lost to Follow-up|0|||
128668429|NCT00545272|463085036|FG001|Overall Study|Lost to Follow-up|0|||
128668430|NCT00545272|463085037|FG002|Overall Study|Lost to Follow-up|0|||
128668431|NCT00545272|463085038|FG003|Overall Study|Lost to Follow-up|0|||
128668432|NCT00545272|463085039|FG004|Overall Study|Lost to Follow-up|1|||
128668433|NCT00545272|463085040|FG005|Overall Study|Lost to Follow-up|0|||
128668434|NCT04491604|463085041|FG000|Overall Study|Withdrawal by Subject|3|||
128668435|NCT00373113|463085042|FG000|Overall Study|Death|1|||
128668436|NCT00373113|463085043|FG001|Overall Study|Death|7|||
128668437|NCT00373113|463085042|FG000|Overall Study|Adverse Event|38|||
128668438|NCT00373113|463085043|FG001|Overall Study|Adverse Event|24|||
128668439|NCT00373113|463085042|FG000|Overall Study|Study terminated by sponsor|9|||
128668440|NCT00373113|463085043|FG001|Overall Study|Study terminated by sponsor|1|||
128668441|NCT00373113|463085042|FG000|Overall Study|Global deterioration of health status|10|||
128668442|NCT00373113|463085043|FG001|Overall Study|Global deterioration of health status|7|||
128668443|NCT00373113|463085042|FG000|Overall Study|Lost to Follow-up|1|||
128668444|NCT00373113|463085043|FG001|Overall Study|Lost to Follow-up|3|||
128668445|NCT00373113|463085042|FG000|Overall Study|Objective progression or relapse|150|||
128668446|NCT00373113|463085043|FG001|Overall Study|Objective progression or relapse|169|||
128668447|NCT00373113|463085042|FG000|Overall Study|Other|14|||
128668448|NCT00373113|463085043|FG001|Overall Study|Other|17|||
128668449|NCT00373113|463085042|FG000|Overall Study|Protocol Violation|5|||
128668450|NCT00373113|463085043|FG001|Overall Study|Protocol Violation|1|||
128668451|NCT00373113|463085042|FG000|Overall Study|Withdrawal by Subject|10|||
128668452|NCT00373113|463085043|FG001|Overall Study|Withdrawal by Subject|15|||
128668453|NCT02834793|463085044|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
128668454|NCT02834793|463085045|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
128668455|NCT02834793|463085046|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
129002552|NCT02884206|464301907|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
129002553|NCT02884206|464301908|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
129002554|NCT02884206|464301906|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
129002555|NCT02884206|464301907|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
129002556|NCT02884206|464301908|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
129002557|NCT02884206|464301906|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
129002558|NCT02884206|464301907|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
129002559|NCT02884206|464301908|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
129002560|NCT02884206|464301906|FG000|LCZ696 Run-in Period|Physician Decision|1|||
129002561|NCT02884206|464301907|FG001|LCZ696 Run-in Period|Physician Decision|0|||
129002562|NCT02884206|464301908|FG002|LCZ696 Run-in Period|Physician Decision|0|||
129002563|NCT02884206|464301906|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
129002564|NCT02884206|464301907|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
129002565|NCT02884206|464301908|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
129002566|NCT02884206|464301906|FG000|Double-Blind Period|Death|0|||
129002567|NCT02884206|464301907|FG001|Double-Blind Period|Death|28|||
129002568|NCT02884206|464301908|FG002|Double-Blind Period|Death|39|||
129002569|NCT02884206|464301906|FG000|Double-Blind Period|Patient/guardian decision|0|||
129002570|NCT02884206|464301907|FG001|Double-Blind Period|Patient/guardian decision|10|||
129002571|NCT02884206|464301908|FG002|Double-Blind Period|Patient/guardian decision|13|||
129002572|NCT02884206|464301906|FG000|Double-Blind Period|Lost to Follow-up|0|||
129002573|NCT02884206|464301907|FG001|Double-Blind Period|Lost to Follow-up|4|||
129002574|NCT02884206|464301908|FG002|Double-Blind Period|Lost to Follow-up|4|||
129002575|NCT02884206|464301906|FG000|Double-Blind Period|Physician Decision|0|||
129002576|NCT02884206|464301907|FG001|Double-Blind Period|Physician Decision|2|||
129002577|NCT02884206|464301908|FG002|Double-Blind Period|Physician Decision|0|||
129002578|NCT02884206|464301906|FG000|Double-Blind Period|Adverse Event|0|||
129002579|NCT02884206|464301907|FG001|Double-Blind Period|Adverse Event|0|||
129002580|NCT02884206|464301908|FG002|Double-Blind Period|Adverse Event|3|||
129002581|NCT02884206|464301906|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
129002582|NCT02884206|464301907|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
129002583|NCT02884206|464301908|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
129002584|NCT00112489|464301911|FG000|Overall Study|Refused further treatment|8|||
128668456|NCT02834793|463085047|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
129002585|NCT00112489|464301911|FG000|Overall Study|Adverse Event|12|||
129002586|NCT00112489|464301911|FG000|Overall Study|Death|2|||
129002587|NCT00112489|464301911|FG000|Overall Study|Other, Not Specified|9|||
129002588|NCT00112489|464301911|FG000|Overall Study|Patient never treated|2|||
129002589|NCT00112489|464301911|FG000|Overall Study|Ineligible|7|||
128668457|NCT02834793|463085044|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
128668458|NCT02834793|463085045|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
128668459|NCT02834793|463085046|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
128668460|NCT02834793|463085047|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
128668461|NCT02834793|463085044|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
128668462|NCT02834793|463085045|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
128668463|NCT02834793|463085046|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
128668464|NCT02834793|463085047|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
128668465|NCT02834793|463085044|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
128668466|NCT02834793|463085045|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
128668467|NCT02834793|463085046|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
128668468|NCT02834793|463085047|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
128668469|NCT02834793|463085044|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
128668470|NCT02834793|463085045|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
128668471|NCT02834793|463085046|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
128668472|NCT02834793|463085047|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
129002590|NCT05751629|464301912|FG000|Overall Study|Withdrawal by Subject|6|||
129002591|NCT05751629|464301912|FG000|Overall Study|Death|25|||
129002592|NCT05751629|464301912|FG000|Overall Study|Study Site Closed|9|||
129002593|NCT05751629|464301912|FG000|Overall Study|Physician Decision|1|||
129002594|NCT00295854|464301915|FG000|Overall Study|Adverse Event|7|||
129002595|NCT00295854|464301916|FG001|Overall Study|Adverse Event|7|||
128668473|NCT02834793|463085044|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
128668474|NCT02834793|463085045|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
128668475|NCT02834793|463085046|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
128668476|NCT02834793|463085047|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
128668477|NCT02834793|463085044|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
128668478|NCT02834793|463085045|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
128668479|NCT02834793|463085046|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
128668480|NCT02834793|463085047|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
128668481|NCT02834793|463085044|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
128668482|NCT02834793|463085045|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
128668483|NCT02834793|463085046|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
128668484|NCT02834793|463085047|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
128668485|NCT02834793|463085044|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
128668486|NCT02834793|463085045|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
128668487|NCT02834793|463085046|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
128668488|NCT02834793|463085047|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
128668489|NCT02834793|463085044|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
128668490|NCT02834793|463085045|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
128668491|NCT02834793|463085046|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
128668492|NCT02834793|463085047|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
128668493|NCT02834793|463085044|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
128668494|NCT02834793|463085045|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
128668495|NCT02834793|463085046|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
128668496|NCT02834793|463085047|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
128668497|NCT02834793|463085044|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
128668498|NCT02834793|463085045|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
128668499|NCT02834793|463085046|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
128668500|NCT02834793|463085047|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
128668501|NCT02834793|463085044|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
128668502|NCT02834793|463085045|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
128668503|NCT02834793|463085046|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
128668504|NCT02834793|463085047|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
128668505|NCT02834793|463085044|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
128668506|NCT02834793|463085045|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
128668507|NCT02834793|463085046|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
128668508|NCT02834793|463085047|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
128668509|NCT02834793|463085044|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
128668510|NCT02834793|463085045|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
128668511|NCT02834793|463085046|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
128668512|NCT02834793|463085047|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
128668513|NCT01049009|463085048|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
128668514|NCT01049009|463085049|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
128668515|NCT01049009|463085048|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128668516|NCT01049009|463085049|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
128668517|NCT01049009|463085048|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
128668518|NCT01049009|463085049|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
128668519|NCT01049009|463085048|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
128668520|NCT01049009|463085049|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
128668521|NCT02136069|463085050|FG000|Overall Study|UC flare-up|1|||
128668522|NCT02136069|463085051|FG001|Overall Study|UC flare-up|0|||
128668523|NCT02136069|463085050|FG000|Overall Study|Adverse Event|6|||
129002596|NCT00295854|464301917|FG002|Overall Study|Adverse Event|6|||
129002597|NCT00295854|464301915|FG000|Overall Study|Protocol Violation|1|||
129002598|NCT00295854|464301916|FG001|Overall Study|Protocol Violation|1|||
129002599|NCT00295854|464301917|FG002|Overall Study|Protocol Violation|1|||
129002600|NCT00295854|464301915|FG000|Overall Study|Lost to Follow-up|2|||
129002601|NCT00295854|464301916|FG001|Overall Study|Lost to Follow-up|0|||
129002602|NCT00295854|464301917|FG002|Overall Study|Lost to Follow-up|1|||
129002603|NCT00295854|464301915|FG000|Overall Study|Withdrawal by Subject|3|||
129002604|NCT00295854|464301916|FG001|Overall Study|Withdrawal by Subject|7|||
129002605|NCT00295854|464301917|FG002|Overall Study|Withdrawal by Subject|4|||
129002606|NCT00295854|464301915|FG000|Overall Study|did not continue to meet criteria|1|||
129002607|NCT00295854|464301916|FG001|Overall Study|did not continue to meet criteria|1|||
129002608|NCT00295854|464301917|FG002|Overall Study|did not continue to meet criteria|2|||
129002609|NCT00295854|464301915|FG000|Overall Study|required a prohibited medication|1|||
129002610|NCT00295854|464301916|FG001|Overall Study|required a prohibited medication|0|||
129002611|NCT00295854|464301917|FG002|Overall Study|required a prohibited medication|0|||
129002612|NCT00295854|464301915|FG000|Overall Study|Other|3|||
129002613|NCT00295854|464301916|FG001|Overall Study|Other|5|||
129002614|NCT00295854|464301917|FG002|Overall Study|Other|1|||
129002615|NCT00772577|464301918|FG000|Overall Study|Adverse Event|6|||
129002616|NCT00772577|464301919|FG001|Overall Study|Adverse Event|3|||
128668524|NCT02136069|463085051|FG001|Overall Study|Adverse Event|8|||
128668525|NCT02136069|463085050|FG000|Overall Study|Death|0|||
128668526|NCT02136069|463085051|FG001|Overall Study|Death|1|||
129002617|NCT00772577|464301918|FG000|Overall Study|Abnormal laboratory values|0|||
129002618|NCT00772577|464301919|FG001|Overall Study|Abnormal laboratory values|1|||
129002619|NCT00772577|464301918|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129002620|NCT00772577|464301919|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129002621|NCT00772577|464301918|FG000|Overall Study|Patient withdrew consent|8|||
129002622|NCT00772577|464301919|FG001|Overall Study|Patient withdrew consent|5|||
129002623|NCT00772577|464301918|FG000|Overall Study|Lost to Follow-up|4|||
129002624|NCT00772577|464301919|FG001|Overall Study|Lost to Follow-up|3|||
129002625|NCT00772577|464301918|FG000|Overall Study|Administrative problems|2|||
129002626|NCT00772577|464301919|FG001|Overall Study|Administrative problems|1|||
129002627|NCT00772577|464301918|FG000|Overall Study|Protocol Deviation|3|||
129002628|NCT00772577|464301919|FG001|Overall Study|Protocol Deviation|2|||
129002629|NCT00672620|464301920|FG000|Overall Study|Adverse Event|7|||
129002630|NCT00672620|464301921|FG001|Overall Study|Adverse Event|7|||
129002631|NCT00672620|464301922|FG002|Overall Study|Adverse Event|12|||
129002632|NCT00672620|464301923|FG003|Overall Study|Adverse Event|17|||
129002633|NCT00672620|464301920|FG000|Overall Study|Lack of Efficacy|1|||
129002634|NCT00672620|464301921|FG001|Overall Study|Lack of Efficacy|2|||
129002635|NCT00672620|464301922|FG002|Overall Study|Lack of Efficacy|2|||
129002636|NCT00672620|464301923|FG003|Overall Study|Lack of Efficacy|0|||
129002637|NCT00672620|464301920|FG000|Overall Study|Noncompliance with Study Drug|3|||
129002638|NCT00672620|464301921|FG001|Overall Study|Noncompliance with Study Drug|4|||
129002639|NCT00672620|464301922|FG002|Overall Study|Noncompliance with Study Drug|0|||
129002640|NCT00672620|464301923|FG003|Overall Study|Noncompliance with Study Drug|2|||
129002641|NCT00672620|464301920|FG000|Overall Study|Protocol Deviations|5|||
129002642|NCT00672620|464301921|FG001|Overall Study|Protocol Deviations|7|||
129002643|NCT00672620|464301922|FG002|Overall Study|Protocol Deviations|2|||
129002644|NCT00672620|464301923|FG003|Overall Study|Protocol Deviations|5|||
129002645|NCT00672620|464301920|FG000|Overall Study|Withdrawal of Consent|6|||
129002646|NCT00672620|464301921|FG001|Overall Study|Withdrawal of Consent|12|||
129002647|NCT00672620|464301922|FG002|Overall Study|Withdrawal of Consent|5|||
129002648|NCT00672620|464301923|FG003|Overall Study|Withdrawal of Consent|6|||
129002649|NCT00672620|464301920|FG000|Overall Study|Lost to Follow-up|8|||
129002650|NCT00672620|464301921|FG001|Overall Study|Lost to Follow-up|19|||
129002651|NCT00672620|464301922|FG002|Overall Study|Lost to Follow-up|8|||
129002652|NCT00672620|464301923|FG003|Overall Study|Lost to Follow-up|11|||
129002653|NCT00672620|464301920|FG000|Overall Study|Reason not Specified|3|||
129002654|NCT00672620|464301921|FG001|Overall Study|Reason not Specified|3|||
129002655|NCT00672620|464301922|FG002|Overall Study|Reason not Specified|2|||
129002656|NCT00672620|464301923|FG003|Overall Study|Reason not Specified|1|||
129002657|NCT03211156|464301924|FG000|Overall Study|Withdrawal by Subject|0|||
129002658|NCT03211156|464301925|FG001|Overall Study|Withdrawal by Subject|2|||
129002659|NCT03211156|464301924|FG000|Overall Study|Lost to Follow-up|1|||
129002660|NCT03211156|464301925|FG001|Overall Study|Lost to Follow-up|1|||
128668527|NCT02136069|463085050|FG000|Overall Study|Lack of Efficacy|10|||
129002661|NCT03211156|464301924|FG000|Overall Study|Adverse Event|1|||
129002662|NCT03211156|464301925|FG001|Overall Study|Adverse Event|0|||
129002663|NCT00829413|464301926|FG000|Overall Study|No study drug admimnistered|13|||
129002664|NCT00829413|464301926|FG000|Overall Study|Training Patients|67|||
129002665|NCT00829413|464301926|FG000|Overall Study|No truth standard procedure available|9|||
129002666|NCT00829413|464301926|FG000|Overall Study|Technically inadequate truth standard|2|||
129002667|NCT00829413|464301926|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
129002668|NCT03487796|464301928|FG000|Overall Study|Lost to Follow-up|18|||
129002669|NCT03487796|464301929|FG001|Overall Study|Lost to Follow-up|6|||
129002670|NCT04272775|464301930|FG000|Overall Study|Study Terminated by Sponsor|1|||
128668528|NCT02136069|463085051|FG001|Overall Study|Lack of Efficacy|4|||
128668529|NCT02136069|463085050|FG000|Overall Study|Lost to Follow-up|1|||
128668530|NCT02136069|463085051|FG001|Overall Study|Lost to Follow-up|0|||
128668531|NCT02136069|463085050|FG000|Overall Study|Non-Compliance|1|||
128668532|NCT02136069|463085051|FG001|Overall Study|Non-Compliance|0|||
128668533|NCT02136069|463085050|FG000|Overall Study|Physician Decision|5|||
128668534|NCT02136069|463085051|FG001|Overall Study|Physician Decision|4|||
128668535|NCT02136069|463085050|FG000|Overall Study|Withdrawal by Subject|10|||
128668536|NCT02136069|463085051|FG001|Overall Study|Withdrawal by Subject|11|||
128878083|NCT02915302|463848363|FG001|Overall Study|Protocol Violation|27|||
128878084|NCT02915302|463848362|FG000|Overall Study|Lost to Follow-up|19|||
128878085|NCT02915302|463848363|FG001|Overall Study|Lost to Follow-up|22|||
128878086|NCT02915302|463848362|FG000|Overall Study|Withdrawal by Subject|22|||
128878087|NCT02915302|463848363|FG001|Overall Study|Withdrawal by Subject|29|||
128878088|NCT02915302|463848362|FG000|Overall Study|Other|1|||
128878089|NCT02915302|463848363|FG001|Overall Study|Other|0|||
128878090|NCT03064035|463848368|FG000|Overall Study|Did not receive allocated intervention|4|||
128878091|NCT03064035|463848369|FG001|Overall Study|Did not receive allocated intervention|2|||
128878092|NCT03064035|463848368|FG000|Overall Study|Lost to Follow-up|1|||
128878093|NCT03064035|463848369|FG001|Overall Study|Lost to Follow-up|1|||
128878094|NCT03103763|463848370|FG000|Overall Study|Death|15|||
128878095|NCT03103763|463848371|FG001|Overall Study|Death|5|||
128878096|NCT03103763|463848372|FG002|Overall Study|Death|5|||
128878097|NCT03103763|463848370|FG000|Overall Study|Withdrawal by Subject|0|||
128878098|NCT03103763|463848371|FG001|Overall Study|Withdrawal by Subject|3|||
128878099|NCT03103763|463848372|FG002|Overall Study|Withdrawal by Subject|2|||
128878100|NCT01143038|463848373|FG000|Overall Study|Withdrawal by Subject|4|||
128878101|NCT01143038|463848373|FG000|Overall Study|Requirement for alternative therapy|5|||
128878102|NCT01143038|463848373|FG000|Overall Study|Adverse Event|3|||
128878103|NCT01143038|463848373|FG000|Overall Study|Lost to Follow-up|2|||
128878104|NCT01143038|463848373|FG000|Overall Study|Protocol Deviation|1|||
128878105|NCT01143038|463848373|FG000|Overall Study|Death|1|||
128878106|NCT01346475|463848377|FG000|First Intervention|Lost to Follow-up|4|||
128878107|NCT01346475|463848378|FG001|First Intervention|Lost to Follow-up|3|||
128878108|NCT02874924|463848379|FG000|Overall Study|Adverse Event|2|||
128878109|NCT02874924|463848380|FG001|Overall Study|Adverse Event|0|||
128878110|NCT02874924|463848381|FG002|Overall Study|Adverse Event|0|||
128878111|NCT02874924|463848379|FG000|Overall Study|Withdrawal by Subject|1|||
128878112|NCT02874924|463848380|FG001|Overall Study|Withdrawal by Subject|0|||
128878113|NCT02874924|463848381|FG002|Overall Study|Withdrawal by Subject|0|||
128878114|NCT02029846|463848386|FG000|Overall Study|n=1 each arm|1|||
128878115|NCT02029846|463848387|FG001|Overall Study|n=1 each arm|1|||
128878116|NCT02966301|463848388|FG000|Overall Study|Death|2|||
128878117|NCT02966301|463848388|FG000|Overall Study|Withdrawal by Subject|1|||
128878118|NCT00822172|463848392|FG000|Overall Study|Adverse Event|10|||
128878119|NCT00822172|463848393|FG001|Overall Study|Adverse Event|12|||
128878120|NCT00822172|463848392|FG000|Overall Study|Death|1|||
128878121|NCT00822172|463848393|FG001|Overall Study|Death|0|||
128878122|NCT00822172|463848392|FG000|Overall Study|Lost to Follow-up|3|||
128878123|NCT00822172|463848393|FG001|Overall Study|Lost to Follow-up|1|||
128878124|NCT00822172|463848392|FG000|Overall Study|Withdrawal by Subject|1|||
128878125|NCT00822172|463848393|FG001|Overall Study|Withdrawal by Subject|4|||
128878126|NCT00822172|463848392|FG000|Overall Study|site closed|0|||
128878127|NCT00822172|463848393|FG001|Overall Study|site closed|1|||
128878128|NCT00822172|463848392|FG000|Overall Study|Other|0|||
128878129|NCT00822172|463848393|FG001|Overall Study|Other|1|||
128878130|NCT00700258|463848394|FG000|Overall Study|Premature discontinuation of documentation|136|||
128878131|NCT00700258|463848394|FG000|Overall Study|Type of study end not documented|1|||
128878132|NCT00700258|463848394|FG000|Overall Study|Lost to Follow-up|81|||
128878133|NCT00700258|463848394|FG000|Overall Study|Premature discontinuation of therapy|1013|||
128878134|NCT00370331|463848396|FG000|Overall Study|Adverse Event|4|||
128878135|NCT00370331|463848397|FG001|Overall Study|Adverse Event|13|||
128878136|NCT00370331|463848396|FG000|Overall Study|Withdrawal by Subject|2|||
128878137|NCT00370331|463848397|FG001|Overall Study|Withdrawal by Subject|4|||
128878138|NCT00370331|463848396|FG000|Overall Study|Lost to Follow-up|0|||
128878139|NCT00370331|463848397|FG001|Overall Study|Lost to Follow-up|3|||
128878140|NCT00370331|463848396|FG000|Overall Study|Lack of Efficacy|0|||
128878141|NCT00370331|463848397|FG001|Overall Study|Lack of Efficacy|1|||
129002671|NCT04272775|464301931|FG001|Overall Study|Study Terminated by Sponsor|0|||
128668537|NCT04538144|463085052|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
128668538|NCT04538144|463085053|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
128878142|NCT00370331|463848396|FG000|Overall Study|Non-compliance|0|||
128878143|NCT00370331|463848397|FG001|Overall Study|Non-compliance|1|||
128878144|NCT00370331|463848396|FG000|Overall Study|Protocol Violation|1|||
128878145|NCT00370331|463848397|FG001|Overall Study|Protocol Violation|1|||
128878146|NCT01874431|463848398|FG000|Overall Study|Physician Decision|0|||
128878147|NCT01874431|463848399|FG001|Overall Study|Physician Decision|0|||
128878148|NCT01874431|463848400|FG002|Overall Study|Physician Decision|1|||
128878149|NCT01874431|463848401|FG003|Overall Study|Physician Decision|0|||
128878150|NCT01874431|463848402|FG004|Overall Study|Physician Decision|0|||
128668539|NCT04538144|463085054|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
128668540|NCT04538144|463085055|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
128668541|NCT01092546|463085056|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
128668542|NCT00622440|463085057|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
128668543|NCT00622440|463085058|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
128668544|NCT00622440|463085057|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
128668545|NCT00622440|463085058|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
128668546|NCT00622440|463085057|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
128668547|NCT00622440|463085058|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
128668548|NCT00622440|463085057|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
128668549|NCT00622440|463085058|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
128668550|NCT01667419|463085063|FG000|Overall Study|Reason Not Specified|1|||
128668551|NCT01667419|463085064|FG001|Overall Study|Reason Not Specified|0|||
128668552|NCT01667419|463085065|FG002|Overall Study|Reason Not Specified|0|||
128668553|NCT01667419|463085066|FG003|Overall Study|Reason Not Specified|0|||
128668554|NCT01667419|463085063|FG000|Overall Study|Withdrawal by Subject|16|||
128668555|NCT01667419|463085064|FG001|Overall Study|Withdrawal by Subject|8|||
128668556|NCT01667419|463085065|FG002|Overall Study|Withdrawal by Subject|9|||
128668557|NCT01667419|463085066|FG003|Overall Study|Withdrawal by Subject|8|||
128668558|NCT01667419|463085063|FG000|Overall Study|Non-compliance|0|||
128668559|NCT01667419|463085064|FG001|Overall Study|Non-compliance|0|||
128668560|NCT01667419|463085065|FG002|Overall Study|Non-compliance|0|||
128668561|NCT01667419|463085066|FG003|Overall Study|Non-compliance|1|||
128668562|NCT01667419|463085063|FG000|Overall Study|Protocol Violation|1|||
128668563|NCT01667419|463085064|FG001|Overall Study|Protocol Violation|0|||
128668564|NCT01667419|463085065|FG002|Overall Study|Protocol Violation|0|||
129002672|NCT04272775|464301930|FG000|Overall Study|Protocol Violation|0|||
129002673|NCT04272775|464301931|FG001|Overall Study|Protocol Violation|1|||
129002674|NCT04272775|464301930|FG000|Overall Study|Symptomatic Deterioration|1|||
129002675|NCT04272775|464301931|FG001|Overall Study|Symptomatic Deterioration|1|||
129002676|NCT04272775|464301930|FG000|Overall Study|Withdrawal by Subject|1|||
129002677|NCT04272775|464301931|FG001|Overall Study|Withdrawal by Subject|2|||
129002678|NCT04272775|464301930|FG000|Overall Study|Adverse Event|1|||
129002679|NCT04272775|464301931|FG001|Overall Study|Adverse Event|2|||
129002680|NCT04272775|464301930|FG000|Overall Study|Progressive Disease|3|||
129002681|NCT04272775|464301931|FG001|Overall Study|Progressive Disease|1|||
129002682|NCT00124020|464301932|FG000|Overall Study|Death|67|||
129002683|NCT00124020|464301933|FG001|Overall Study|Death|71|||
129002684|NCT00124020|464301932|FG000|Overall Study|Withdrawal by Subject|13|||
129002685|NCT00124020|464301933|FG001|Overall Study|Withdrawal by Subject|11|||
129002686|NCT00124020|464301932|FG000|Overall Study|Lost to Follow-up|5|||
129002687|NCT00124020|464301933|FG001|Overall Study|Lost to Follow-up|8|||
129002688|NCT00124020|464301932|FG000|Overall Study|Other|1|||
129002689|NCT00124020|464301933|FG001|Overall Study|Other|1|||
129002690|NCT00124020|464301932|FG000|Overall Study|Transfer to another hospital|2|||
129002691|NCT00124020|464301933|FG001|Overall Study|Transfer to another hospital|0|||
129002692|NCT02043366|464301934|FG000|Overall Study|Lost to Follow-up|2|||
129002693|NCT02043366|464301935|FG001|Overall Study|Lost to Follow-up|2|||
129002694|NCT02043366|464301936|FG002|Overall Study|Lost to Follow-up|2|||
129002695|NCT02043366|464301937|FG003|Overall Study|Lost to Follow-up|2|||
129002696|NCT02043366|464301938|FG004|Overall Study|Lost to Follow-up|2|||
129002697|NCT02043366|464301939|FG005|Overall Study|Lost to Follow-up|2|||
129002698|NCT00891774|464301942|FG000|Overall Study|Lost to Follow-up|5|||
129002699|NCT00891774|464301942|FG000|Overall Study|Illness (Self/Mother)|3|||
129002700|NCT00891774|464301942|FG000|Overall Study|Withdrawal by Subject|2|||
129002701|NCT00891774|464301942|FG000|Overall Study|Protocol Violation|4|||
129002702|NCT03175120|464301944|FG000|Overall Study|Adverse Event|2|||
129002703|NCT03175120|464301945|FG001|Overall Study|Adverse Event|2|||
129002704|NCT03175120|464301944|FG000|Overall Study|Protocol Violation|5|||
129002705|NCT03175120|464301945|FG001|Overall Study|Protocol Violation|2|||
129002706|NCT03175120|464301944|FG000|Overall Study|Lost to Follow-up|1|||
129002707|NCT03175120|464301945|FG001|Overall Study|Lost to Follow-up|0|||
129002708|NCT03175120|464301944|FG000|Overall Study|Withdrawal by Subject|2|||
129002709|NCT03175120|464301945|FG001|Overall Study|Withdrawal by Subject|5|||
129002710|NCT03175120|464301944|FG000|Overall Study|Other|2|||
129002711|NCT03175120|464301945|FG001|Overall Study|Other|3|||
129002712|NCT01977092|464301946|FG000|Overall Study|Death|3|||
128668565|NCT01667419|463085066|FG003|Overall Study|Protocol Violation|0|||
128668566|NCT01667419|463085063|FG000|Overall Study|Lost to Follow-up|7|||
128668567|NCT01667419|463085064|FG001|Overall Study|Lost to Follow-up|6|||
129002713|NCT01977092|464301947|FG001|Overall Study|Death|4|||
129002714|NCT01977092|464301946|FG000|Overall Study|Lost to Follow-up|23|||
129002715|NCT01977092|464301947|FG001|Overall Study|Lost to Follow-up|14|||
128668568|NCT01667419|463085065|FG002|Overall Study|Lost to Follow-up|2|||
128668569|NCT01667419|463085066|FG003|Overall Study|Lost to Follow-up|4|||
128668570|NCT01667419|463085063|FG000|Overall Study|Death|18|||
129002716|NCT01977092|464301946|FG000|Overall Study|Withdrawal by Subject|2|||
129002717|NCT01977092|464301947|FG001|Overall Study|Withdrawal by Subject|1|||
129002718|NCT01977092|464301946|FG000|Overall Study|In prison|3|||
129002719|NCT01977092|464301947|FG001|Overall Study|In prison|11|||
129002720|NCT00678392|464301948|FG000|Overall Study|Adverse Event|0|||
129002721|NCT00678392|464301949|FG001|Overall Study|Adverse Event|6|||
129002722|NCT00678392|464301948|FG000|Overall Study|Death|280|||
129002723|NCT00678392|464301949|FG001|Overall Study|Death|269|||
129002724|NCT00678392|464301948|FG000|Overall Study|Lost to Follow-up|15|||
129002725|NCT00678392|464301949|FG001|Overall Study|Lost to Follow-up|13|||
129002726|NCT00678392|464301948|FG000|Overall Study|Objective Progression or Relapse|3|||
129002727|NCT00678392|464301949|FG001|Overall Study|Objective Progression or Relapse|8|||
129002728|NCT00678392|464301948|FG000|Overall Study|Sponsor's Decision|1|||
129002729|NCT00678392|464301949|FG001|Overall Study|Sponsor's Decision|2|||
129002730|NCT00678392|464301948|FG000|Overall Study|Withdrawal by Subject|4|||
129002731|NCT00678392|464301949|FG001|Overall Study|Withdrawal by Subject|4|||
129002732|NCT00678392|464301948|FG000|Overall Study|Randomized But Not Treated|2|||
129002733|NCT00678392|464301949|FG001|Overall Study|Randomized But Not Treated|7|||
129002734|NCT00678392|464301948|FG000|Overall Study|Other|56|||
129002735|NCT00678392|464301949|FG001|Overall Study|Other|53|||
129002736|NCT03038113|464301950|FG000|Overall Study|Withdrawal by Subject|0|||
129002737|NCT03038113|464301951|FG001|Overall Study|Withdrawal by Subject|0|||
129002738|NCT03038113|464301952|FG002|Overall Study|Withdrawal by Subject|1|||
129002739|NCT03038113|464301953|FG003|Overall Study|Withdrawal by Subject|0|||
129002740|NCT03038113|464301954|FG004|Overall Study|Withdrawal by Subject|0|||
129002741|NCT03038113|464301955|FG005|Overall Study|Withdrawal by Subject|0|||
129002742|NCT03038113|464301956|FG006|Overall Study|Withdrawal by Subject|0|||
129002743|NCT03038113|464301957|FG007|Overall Study|Withdrawal by Subject|0|||
129002744|NCT03038113|464301958|FG008|Overall Study|Withdrawal by Subject|0|||
129002745|NCT03038113|464301959|FG009|Overall Study|Withdrawal by Subject|0|||
129002746|NCT03038113|464301960|FG010|Overall Study|Withdrawal by Subject|0|||
129002747|NCT03038113|464301961|FG011|Overall Study|Withdrawal by Subject|0|||
129002748|NCT03038113|464301962|FG012|Overall Study|Withdrawal by Subject|0|||
129002749|NCT03038113|464301963|FG013|Overall Study|Withdrawal by Subject|1|||
129002750|NCT03038113|464301950|FG000|Overall Study|Lost to Follow-up|0|||
129002751|NCT03038113|464301951|FG001|Overall Study|Lost to Follow-up|0|||
129002752|NCT03038113|464301952|FG002|Overall Study|Lost to Follow-up|0|||
129002753|NCT03038113|464301953|FG003|Overall Study|Lost to Follow-up|0|||
129002754|NCT03038113|464301954|FG004|Overall Study|Lost to Follow-up|0|||
129002755|NCT03038113|464301955|FG005|Overall Study|Lost to Follow-up|0|||
129002756|NCT03038113|464301956|FG006|Overall Study|Lost to Follow-up|1|||
129002757|NCT03038113|464301957|FG007|Overall Study|Lost to Follow-up|0|||
129002758|NCT03038113|464301958|FG008|Overall Study|Lost to Follow-up|0|||
129002759|NCT03038113|464301959|FG009|Overall Study|Lost to Follow-up|0|||
129002760|NCT03038113|464301960|FG010|Overall Study|Lost to Follow-up|0|||
129002761|NCT03038113|464301961|FG011|Overall Study|Lost to Follow-up|0|||
129002762|NCT03038113|464301962|FG012|Overall Study|Lost to Follow-up|0|||
129002763|NCT03038113|464301963|FG013|Overall Study|Lost to Follow-up|0|||
129002764|NCT03341507|464301964|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
129002765|NCT02927847|464301966|FG000|Overall Study|Lost to Follow-up|1|||
128668571|NCT01667419|463085064|FG001|Overall Study|Death|33|||
128668572|NCT01667419|463085065|FG002|Overall Study|Death|25|||
128668573|NCT01667419|463085066|FG003|Overall Study|Death|26|||
128668574|NCT04364984|463085067|FG000|Overall Study|Death|2|||
128668575|NCT04364984|463085068|FG001|Overall Study|Death|2|||
129002766|NCT02927847|464301967|FG001|Overall Study|Lost to Follow-up|0|||
129002767|NCT02927847|464301966|FG000|Overall Study|Withdrawal by Subject|4|||
129002768|NCT02927847|464301967|FG001|Overall Study|Withdrawal by Subject|2|||
129002769|NCT02927847|464301966|FG000|Overall Study|PI withdrawn due to missed visits|1|||
129002770|NCT02927847|464301967|FG001|Overall Study|PI withdrawn due to missed visits|1|||
129002771|NCT00723554|464301968|FG000|Overall Study|Adverse Event|12|||
129002772|NCT00723554|464301968|FG000|Overall Study|Investigator's judgement|5|||
129002773|NCT00723554|464301968|FG000|Overall Study|Inhaled medication other than iloprost|4|||
129002774|NCT00723554|464301968|FG000|Overall Study|Withdrawal of consent|3|||
129002775|NCT00723554|464301968|FG000|Overall Study|Other|3|||
129002776|NCT00723554|464301968|FG000|Overall Study|Lost to Follow-up|1|||
129002777|NCT00723554|464301968|FG000|Overall Study|Non-compliance|1|||
129002778|NCT01405820|464301969|FG000|Randomized Treatment Period|Adverse Event|3|||
129002779|NCT01405820|464301970|FG001|Randomized Treatment Period|Adverse Event|3|||
129002780|NCT01405820|464301971|FG002|Randomized Treatment Period|Adverse Event|3|||
128668576|NCT04364984|463085069|FG002|Overall Study|Death|0|||
129002781|NCT01405820|464301972|FG003|Randomized Treatment Period|Adverse Event|0|||
129002782|NCT01405820|464301973|FG004|Randomized Treatment Period|Adverse Event|2|||
129002783|NCT01405820|464301974|FG005|Randomized Treatment Period|Adverse Event|1|||
129002784|NCT01405820|464301969|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
128878151|NCT01874431|463848403|FG005|Overall Study|Physician Decision|0|||
129002785|NCT01405820|464301970|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
128668577|NCT01941186|463085070|FG000|Follow-up|Lost to Follow-up|1|||
128668578|NCT01941186|463085071|FG001|Follow-up|Lost to Follow-up|0|||
129002786|NCT01405820|464301971|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
129002787|NCT01405820|464301972|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
129002788|NCT01405820|464301973|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
129002789|NCT01405820|464301974|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
129002790|NCT01405820|464301969|FG000|Randomized Treatment Period|Other|2|||
129002791|NCT01405820|464301970|FG001|Randomized Treatment Period|Other|2|||
129002792|NCT01405820|464301971|FG002|Randomized Treatment Period|Other|1|||
129002793|NCT01405820|464301972|FG003|Randomized Treatment Period|Other|1|||
129002794|NCT01405820|464301973|FG004|Randomized Treatment Period|Other|0|||
129002795|NCT01405820|464301974|FG005|Randomized Treatment Period|Other|0|||
129002796|NCT01405820|464301969|FG000|Randomized Treatment Period|Physician Decision|0|||
129002797|NCT01405820|464301970|FG001|Randomized Treatment Period|Physician Decision|2|||
129002798|NCT01405820|464301971|FG002|Randomized Treatment Period|Physician Decision|1|||
129002799|NCT01405820|464301972|FG003|Randomized Treatment Period|Physician Decision|0|||
129002800|NCT01405820|464301973|FG004|Randomized Treatment Period|Physician Decision|0|||
129002801|NCT01405820|464301974|FG005|Randomized Treatment Period|Physician Decision|0|||
129002802|NCT01405820|464301969|FG000|Randomized Treatment Period|Rescue|0|||
129002803|NCT01405820|464301970|FG001|Randomized Treatment Period|Rescue|1|||
129002804|NCT01405820|464301971|FG002|Randomized Treatment Period|Rescue|13|||
129002805|NCT01405820|464301972|FG003|Randomized Treatment Period|Rescue|10|||
129002806|NCT01405820|464301973|FG004|Randomized Treatment Period|Rescue|8|||
129002807|NCT01405820|464301974|FG005|Randomized Treatment Period|Rescue|8|||
129002808|NCT01405820|464301969|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
129002809|NCT01405820|464301970|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
129002810|NCT01405820|464301971|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
129002811|NCT01405820|464301972|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
129002812|NCT01405820|464301973|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
129002813|NCT01405820|464301974|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
129002814|NCT01405820|464301969|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
129002815|NCT01405820|464301970|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
129002816|NCT01405820|464301971|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
129002817|NCT01405820|464301972|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
129002818|NCT01405820|464301973|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
129002819|NCT01405820|464301974|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
129002820|NCT01405820|464301969|FG000|Randomized Treatment Period|Death|0|||
129002821|NCT01405820|464301970|FG001|Randomized Treatment Period|Death|0|||
129002822|NCT01405820|464301971|FG002|Randomized Treatment Period|Death|0|||
129002823|NCT01405820|464301972|FG003|Randomized Treatment Period|Death|1|||
129002824|NCT01405820|464301973|FG004|Randomized Treatment Period|Death|0|||
129002825|NCT01405820|464301974|FG005|Randomized Treatment Period|Death|0|||
129002826|NCT01405820|464301969|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129002827|NCT01405820|464301970|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129002828|NCT01405820|464301971|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129002829|NCT01405820|464301972|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
129002830|NCT01405820|464301973|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129002831|NCT01405820|464301974|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129002832|NCT01405820|464301969|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
129002833|NCT01405820|464301970|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
129002834|NCT01405820|464301971|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
129002835|NCT01405820|464301972|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
129002836|NCT01405820|464301973|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
129002837|NCT01405820|464301974|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
129002838|NCT01405820|464301969|FG000|Open-Label Treatment Period|Other|1|||
129002839|NCT01405820|464301970|FG001|Open-Label Treatment Period|Other|1|||
129002840|NCT01405820|464301971|FG002|Open-Label Treatment Period|Other|1|||
129002841|NCT01405820|464301972|FG003|Open-Label Treatment Period|Other|1|||
128668579|NCT01068600|463085072|FG000|Overall Study|Withdrawal by Subject|5|||
128668580|NCT01068600|463085073|FG001|Overall Study|Withdrawal by Subject|6|||
128668581|NCT01068600|463085072|FG000|Overall Study|Adverse Event|3|||
128668582|NCT01068600|463085073|FG001|Overall Study|Adverse Event|3|||
128668583|NCT01068600|463085072|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128668584|NCT01068600|463085073|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128668585|NCT01068600|463085072|FG000|Overall Study|Lost to Follow-up|1|||
128668586|NCT01068600|463085073|FG001|Overall Study|Lost to Follow-up|2|||
129002842|NCT01405820|464301973|FG004|Open-Label Treatment Period|Other|1|||
129002843|NCT01405820|464301974|FG005|Open-Label Treatment Period|Other|1|||
129002844|NCT01405820|464301969|FG000|Open-Label Treatment Period|Physician Decision|0|||
129002845|NCT01405820|464301970|FG001|Open-Label Treatment Period|Physician Decision|0|||
128668587|NCT01068600|463085072|FG000|Overall Study|Protocol deviation|1|||
128668588|NCT01068600|463085073|FG001|Overall Study|Protocol deviation|1|||
129002846|NCT01405820|464301971|FG002|Open-Label Treatment Period|Physician Decision|1|||
128668589|NCT01068600|463085072|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128668590|NCT01068600|463085073|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129002847|NCT01405820|464301972|FG003|Open-Label Treatment Period|Physician Decision|2|||
129002848|NCT01405820|464301973|FG004|Open-Label Treatment Period|Physician Decision|1|||
129002849|NCT01405820|464301974|FG005|Open-Label Treatment Period|Physician Decision|0|||
129002850|NCT01405820|464301969|FG000|Open-Label Treatment Period|Adverse Event|0|||
129002851|NCT01405820|464301970|FG001|Open-Label Treatment Period|Adverse Event|0|||
129002852|NCT01405820|464301971|FG002|Open-Label Treatment Period|Adverse Event|0|||
129002853|NCT01405820|464301972|FG003|Open-Label Treatment Period|Adverse Event|1|||
129002854|NCT01405820|464301973|FG004|Open-Label Treatment Period|Adverse Event|0|||
129002855|NCT01405820|464301974|FG005|Open-Label Treatment Period|Adverse Event|0|||
129002856|NCT02280356|464301982|FG000|Overall Study|Not Treated|2|||
129002857|NCT02280356|464301982|FG000|Overall Study|Withdrawal by Subject|1|||
129002858|NCT02280356|464301982|FG000|Overall Study|Not evaluable|2|||
129002859|NCT00871728|464301990|FG000|Overall Study|Adverse Event|1|||
129002860|NCT00871728|464301990|FG000|Overall Study|Protocol Violation|7|||
128668591|NCT01068600|463085072|FG000|Overall Study|Administrative problems|0|||
128668592|NCT01068600|463085073|FG001|Overall Study|Administrative problems|1|||
128668593|NCT03023813|463085076|FG000|Overall Study|Lost to Follow-up|1|||
129002861|NCT00871728|464301990|FG000|Overall Study|Lost to Follow-up|2|||
129002862|NCT00871728|464301990|FG000|Overall Study|Failed to Visit Hospital|4|||
129002863|NCT00871728|464301990|FG000|Overall Study|Participant Non-compliance|1|||
129002864|NCT00871728|464301990|FG000|Overall Study|Withdrawal of Informed Consent|5|||
129002865|NCT04147715|464301991|FG000|Overall Study|Adverse Event|0|||
129002866|NCT04147715|464301992|FG001|Overall Study|Adverse Event|0|||
129002867|NCT04147715|464301993|FG002|Overall Study|Adverse Event|0|||
129002868|NCT04147715|464301994|FG003|Overall Study|Adverse Event|0|||
129002869|NCT04147715|464301995|FG004|Overall Study|Adverse Event|0|||
129002870|NCT04147715|464301996|FG005|Overall Study|Adverse Event|0|||
129002871|NCT04147715|464301997|FG006|Overall Study|Adverse Event|0|||
129002872|NCT04147715|464301998|FG007|Overall Study|Adverse Event|2|||
128668594|NCT03023813|463085077|FG001|Overall Study|Lost to Follow-up|2|||
128668595|NCT03023813|463085078|FG002|Overall Study|Lost to Follow-up|0|||
128668596|NCT00312195|463085085|FG000|Overall Study|Adverse Event|4|||
128668597|NCT00312195|463085086|FG001|Overall Study|Adverse Event|6|||
128668598|NCT00312195|463085085|FG000|Overall Study|Lost to Follow-up|1|||
128668599|NCT00312195|463085086|FG001|Overall Study|Lost to Follow-up|0|||
128668600|NCT00312195|463085085|FG000|Overall Study|Protocol Violation|1|||
128668601|NCT00312195|463085086|FG001|Overall Study|Protocol Violation|0|||
128668602|NCT00862082|463085090|FG000|Overall Study|Sponsor decision to terminate the study|5|||
128668603|NCT00862082|463085091|FG001|Overall Study|Sponsor decision to terminate the study|0|||
128668604|NCT00862082|463085090|FG000|Overall Study|Withdrawal by Subject|0|||
128668605|NCT00862082|463085091|FG001|Overall Study|Withdrawal by Subject|1|||
128668606|NCT00223080|463085092|FG000|Overall Study|Withdrawal by Subject|253|||
128668607|NCT00223080|463085093|FG001|Overall Study|Withdrawal by Subject|232|||
128668608|NCT00223080|463085092|FG000|Overall Study|Required contraindicated med|0|||
128668609|NCT00223080|463085093|FG001|Overall Study|Required contraindicated med|1|||
128668610|NCT00223080|463085092|FG000|Overall Study|Non-compliant|7|||
128668611|NCT00223080|463085093|FG001|Overall Study|Non-compliant|7|||
128668612|NCT00223080|463085092|FG000|Overall Study|Moved from study area|37|||
128668613|NCT00223080|463085093|FG001|Overall Study|Moved from study area|47|||
128668614|NCT00223080|463085092|FG000|Overall Study|Lost to Follow-up|259|||
128668615|NCT00223080|463085093|FG001|Overall Study|Lost to Follow-up|284|||
128668616|NCT00223080|463085092|FG000|Overall Study|Death|85|||
128668617|NCT00223080|463085093|FG001|Overall Study|Death|74|||
128668618|NCT00223080|463085092|FG000|Overall Study|Other|14|||
128668619|NCT00223080|463085093|FG001|Overall Study|Other|11|||
129002873|NCT04147715|464301999|FG008|Overall Study|Adverse Event|1|||
129002874|NCT04147715|464302000|FG009|Overall Study|Adverse Event|0|||
129002875|NCT04147715|464302001|FG010|Overall Study|Adverse Event|0|||
129002876|NCT04147715|464302002|FG011|Overall Study|Adverse Event|0|||
129002877|NCT03404206|464302003|FG000|Overall Study|Withdrawal by Subject|1|||
129002878|NCT03404206|464302004|FG001|Overall Study|Withdrawal by Subject|1|||
129002879|NCT03404206|464302005|FG002|Overall Study|Withdrawal by Subject|0|||
129002880|NCT03404206|464302003|FG000|Overall Study|Lost to Follow-up|3|||
128668620|NCT00223080|463085092|FG000|Overall Study|Reason not provided|141|||
128668621|NCT00223080|463085093|FG001|Overall Study|Reason not provided|140|||
128668622|NCT00223080|463085092|FG000|Overall Study|Adverse Event|0|||
128668623|NCT00223080|463085093|FG001|Overall Study|Adverse Event|1|||
128668624|NCT02598583|463085094|FG000|Extension Period|Withdrawal by Subject|1|||
128668625|NCT02598583|463085095|FG001|Extension Period|Withdrawal by Subject|0|||
128668626|NCT03237286|463085096|FG000|Overall Study|Withdrawal by Subject|1|||
128668627|NCT03237286|463085097|FG001|Overall Study|Withdrawal by Subject|0|||
128668628|NCT03237286|463085098|FG002|Overall Study|Withdrawal by Subject|2|||
128668629|NCT03237286|463085096|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
129002881|NCT03404206|464302004|FG001|Overall Study|Lost to Follow-up|1|||
129002882|NCT03404206|464302005|FG002|Overall Study|Lost to Follow-up|0|||
129002883|NCT01626859|464302014|FG000|Overall Study|Adverse Event|1|||
129002884|NCT01626859|464302015|FG001|Overall Study|Adverse Event|3|||
129002885|NCT01626859|464302016|FG002|Overall Study|Adverse Event|2|||
128668630|NCT03237286|463085097|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
128668631|NCT03237286|463085098|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
128668632|NCT00948441|463085106|FG000|Overall Study|no longer meet inclusion criteria|1|||
128668633|NCT00948441|463085107|FG001|Overall Study|no longer meet inclusion criteria|4|||
128668634|NCT00947882|463085110|FG000|Overall Study|Adverse Event|0|||
128668635|NCT00947882|463085111|FG001|Overall Study|Adverse Event|1|||
128668636|NCT00947882|463085112|FG002|Overall Study|Adverse Event|4|||
128668637|NCT00947882|463085113|FG003|Overall Study|Adverse Event|4|||
128668638|NCT00947882|463085110|FG000|Overall Study|Withdrawal by Subject|2|||
128668639|NCT00947882|463085111|FG001|Overall Study|Withdrawal by Subject|0|||
128668640|NCT00947882|463085112|FG002|Overall Study|Withdrawal by Subject|8|||
128668641|NCT00947882|463085113|FG003|Overall Study|Withdrawal by Subject|2|||
128668642|NCT00947882|463085110|FG000|Overall Study|Protocol Violation|0|||
128668643|NCT00947882|463085111|FG001|Overall Study|Protocol Violation|0|||
128668644|NCT00947882|463085112|FG002|Overall Study|Protocol Violation|1|||
128668645|NCT00947882|463085113|FG003|Overall Study|Protocol Violation|0|||
128668646|NCT00947882|463085110|FG000|Overall Study|Lost to Follow-up|0|||
128668647|NCT00947882|463085111|FG001|Overall Study|Lost to Follow-up|2|||
128668648|NCT00947882|463085112|FG002|Overall Study|Lost to Follow-up|1|||
128668649|NCT00947882|463085113|FG003|Overall Study|Lost to Follow-up|0|||
129002886|NCT01626859|464302014|FG000|Overall Study|Physician Decision|0|||
129002887|NCT01626859|464302015|FG001|Overall Study|Physician Decision|1|||
129002888|NCT01626859|464302016|FG002|Overall Study|Physician Decision|0|||
129002889|NCT01626859|464302014|FG000|Overall Study|Withdrawal by Subject|1|||
129002890|NCT01626859|464302015|FG001|Overall Study|Withdrawal by Subject|4|||
129002891|NCT01626859|464302016|FG002|Overall Study|Withdrawal by Subject|2|||
129002892|NCT02629965|464302017|FG000|Period 1|Adverse Event|1|||
129002893|NCT02629965|464302018|FG001|Period 1|Adverse Event|0|||
129002894|NCT02629965|464302017|FG000|Period 1|Unexpected worsening of disease|2|||
129002895|NCT02629965|464302018|FG001|Period 1|Unexpected worsening of disease|0|||
129002896|NCT02629965|464302017|FG000|Period 1|Other than listed above|1|||
129002897|NCT02629965|464302018|FG001|Period 1|Other than listed above|2|||
129002898|NCT02629965|464302017|FG000|Period 2|Adverse Event|1|||
129002899|NCT02629965|464302018|FG001|Period 2|Adverse Event|0|||
129002900|NCT02330081|464302019|FG000|Overall Study|Adverse Event|1|||
129002901|NCT02330081|464302019|FG000|Overall Study|Donation did not meet criteria|1|||
129002902|NCT02330081|464302019|FG000|Overall Study|Protocol Violation|6|||
129002903|NCT00905489|464302022|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
129002904|NCT00905489|464302022|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
129002905|NCT00905489|464302022|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
129002906|NCT02668302|464302026|FG000|Overall Study|Withdrawal by Subject|1|||
129002907|NCT02668302|464302027|FG001|Overall Study|Withdrawal by Subject|0|||
129002908|NCT00895583|464302032|FG000|Overall Study|Adverse Event|28|||
129002909|NCT00895583|464302033|FG001|Overall Study|Adverse Event|4|||
129002910|NCT00895583|464302032|FG000|Overall Study|Death|2|||
129002911|NCT00895583|464302033|FG001|Overall Study|Death|1|||
129002912|NCT00895583|464302032|FG000|Overall Study|Physician Decision|3|||
129002913|NCT00895583|464302033|FG001|Overall Study|Physician Decision|1|||
129002914|NCT00895583|464302032|FG000|Overall Study|Lost to Follow-up|1|||
129002915|NCT00895583|464302033|FG001|Overall Study|Lost to Follow-up|3|||
129002916|NCT00895583|464302032|FG000|Overall Study|Protocol Violation|1|||
129002917|NCT00895583|464302033|FG001|Overall Study|Protocol Violation|0|||
129002918|NCT00895583|464302032|FG000|Overall Study|Withdrawal by Subject|4|||
129002919|NCT00895583|464302033|FG001|Overall Study|Withdrawal by Subject|2|||
129002920|NCT00895583|464302032|FG000|Overall Study|Lack of Efficacy|5|||
129002921|NCT00895583|464302033|FG001|Overall Study|Lack of Efficacy|0|||
129002922|NCT00895583|464302032|FG000|Overall Study|Other|0|||
129002923|NCT00895583|464302033|FG001|Overall Study|Other|1|||
129002924|NCT00616928|464302034|FG000|Overall Study|Adverse Event|6|||
129002925|NCT00616928|464302035|FG001|Overall Study|Adverse Event|3|||
129002926|NCT00616928|464302036|FG002|Overall Study|Adverse Event|2|||
129002927|NCT00616928|464302037|FG003|Overall Study|Adverse Event|2|||
129002928|NCT00616928|464302034|FG000|Overall Study|Other|51|||
129002929|NCT00616928|464302035|FG001|Overall Study|Other|8|||
129002930|NCT00616928|464302036|FG002|Overall Study|Other|15|||
129002931|NCT00616928|464302037|FG003|Overall Study|Other|5|||
129002932|NCT00616928|464302034|FG000|Overall Study|Lost to Follow-up|5|||
129002933|NCT00616928|464302035|FG001|Overall Study|Lost to Follow-up|7|||
129002934|NCT00616928|464302036|FG002|Overall Study|Lost to Follow-up|0|||
129002935|NCT00616928|464302037|FG003|Overall Study|Lost to Follow-up|0|||
129002936|NCT04535583|464302038|FG000|Overall Study|Lost to Follow-up|1|||
128668650|NCT00947882|463085110|FG000|Overall Study|Other/Unknown|10|||
129002937|NCT04535583|464302038|FG000|Overall Study|Physician Decision|1|||
129002938|NCT04535583|464302038|FG000|Overall Study|Withdrawal by Subject|1|||
128668651|NCT00947882|463085111|FG001|Overall Study|Other/Unknown|13|||
128668652|NCT00947882|463085112|FG002|Overall Study|Other/Unknown|3|||
129002939|NCT01078090|464302039|FG000|Overall Study|Lost to Follow-up|2363|||
129002940|NCT01078090|464302039|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
129002941|NCT01078090|464302039|FG000|Overall Study|Lack of Efficacy|1193|||
128668653|NCT00947882|463085113|FG003|Overall Study|Other/Unknown|6|||
128668654|NCT00947882|463085110|FG000|Overall Study|Trial Terminated by Sponsor|62|||
128668655|NCT00947882|463085111|FG001|Overall Study|Trial Terminated by Sponsor|61|||
128878152|NCT01874431|463848404|FG006|Overall Study|Physician Decision|0|||
128878153|NCT01874431|463848405|FG007|Overall Study|Physician Decision|0|||
128878154|NCT01874431|463848398|FG000|Overall Study|Adverse Event|5|||
128878155|NCT01874431|463848399|FG001|Overall Study|Adverse Event|4|||
128878156|NCT01874431|463848400|FG002|Overall Study|Adverse Event|6|||
128878157|NCT01874431|463848401|FG003|Overall Study|Adverse Event|5|||
128878158|NCT01874431|463848402|FG004|Overall Study|Adverse Event|2|||
128878159|NCT01874431|463848403|FG005|Overall Study|Adverse Event|8|||
128878160|NCT01874431|463848404|FG006|Overall Study|Adverse Event|2|||
128878161|NCT01874431|463848405|FG007|Overall Study|Adverse Event|3|||
128878162|NCT01874431|463848398|FG000|Overall Study|Protocol Violation|1|||
128878163|NCT01874431|463848399|FG001|Overall Study|Protocol Violation|1|||
128878164|NCT01874431|463848400|FG002|Overall Study|Protocol Violation|1|||
128878165|NCT01874431|463848401|FG003|Overall Study|Protocol Violation|0|||
128878166|NCT01874431|463848402|FG004|Overall Study|Protocol Violation|3|||
128878167|NCT01874431|463848403|FG005|Overall Study|Protocol Violation|2|||
128878168|NCT01874431|463848404|FG006|Overall Study|Protocol Violation|1|||
128878169|NCT01874431|463848405|FG007|Overall Study|Protocol Violation|1|||
128878170|NCT01874431|463848398|FG000|Overall Study|Non-compliance|0|||
128878171|NCT01874431|463848399|FG001|Overall Study|Non-compliance|0|||
128878172|NCT01874431|463848400|FG002|Overall Study|Non-compliance|0|||
128878173|NCT01874431|463848401|FG003|Overall Study|Non-compliance|0|||
128878174|NCT01874431|463848402|FG004|Overall Study|Non-compliance|1|||
128878175|NCT01874431|463848403|FG005|Overall Study|Non-compliance|0|||
128878176|NCT01874431|463848404|FG006|Overall Study|Non-compliance|1|||
128878177|NCT01874431|463848405|FG007|Overall Study|Non-compliance|0|||
128878178|NCT01874431|463848398|FG000|Overall Study|Logistical difficulties|0|||
128878179|NCT01874431|463848399|FG001|Overall Study|Logistical difficulties|0|||
128878180|NCT01874431|463848400|FG002|Overall Study|Logistical difficulties|0|||
128878181|NCT01874431|463848401|FG003|Overall Study|Logistical difficulties|0|||
128878182|NCT01874431|463848402|FG004|Overall Study|Logistical difficulties|0|||
128878183|NCT01874431|463848403|FG005|Overall Study|Logistical difficulties|0|||
128878184|NCT01874431|463848404|FG006|Overall Study|Logistical difficulties|1|||
128878185|NCT01874431|463848405|FG007|Overall Study|Logistical difficulties|0|||
128878186|NCT01874431|463848398|FG000|Overall Study|Withdrawal by Subject|0|||
128878187|NCT01874431|463848399|FG001|Overall Study|Withdrawal by Subject|0|||
128878188|NCT01874431|463848400|FG002|Overall Study|Withdrawal by Subject|1|||
128878189|NCT01874431|463848401|FG003|Overall Study|Withdrawal by Subject|2|||
128878190|NCT01874431|463848402|FG004|Overall Study|Withdrawal by Subject|1|||
128878191|NCT01874431|463848403|FG005|Overall Study|Withdrawal by Subject|1|||
128878192|NCT01874431|463848404|FG006|Overall Study|Withdrawal by Subject|3|||
128878193|NCT01874431|463848405|FG007|Overall Study|Withdrawal by Subject|0|||
128878194|NCT01874431|463848398|FG000|Overall Study|Sponsor decision|0|||
128878195|NCT01874431|463848399|FG001|Overall Study|Sponsor decision|0|||
128878196|NCT01874431|463848400|FG002|Overall Study|Sponsor decision|0|||
128878197|NCT01874431|463848401|FG003|Overall Study|Sponsor decision|0|||
128878198|NCT01874431|463848402|FG004|Overall Study|Sponsor decision|1|||
128878199|NCT01874431|463848403|FG005|Overall Study|Sponsor decision|0|||
128878200|NCT01874431|463848404|FG006|Overall Study|Sponsor decision|0|||
128878201|NCT01874431|463848405|FG007|Overall Study|Sponsor decision|0|||
128878202|NCT01874431|463848398|FG000|Overall Study|Lost to Follow-up|0|||
128878203|NCT01874431|463848399|FG001|Overall Study|Lost to Follow-up|0|||
128878204|NCT01874431|463848400|FG002|Overall Study|Lost to Follow-up|1|||
128878205|NCT01874431|463848401|FG003|Overall Study|Lost to Follow-up|0|||
128878206|NCT01874431|463848402|FG004|Overall Study|Lost to Follow-up|0|||
128878207|NCT01874431|463848403|FG005|Overall Study|Lost to Follow-up|0|||
128878208|NCT01874431|463848404|FG006|Overall Study|Lost to Follow-up|0|||
128878209|NCT01874431|463848405|FG007|Overall Study|Lost to Follow-up|0|||
128878210|NCT00738582|463848408|FG000|Combination Therapy|Completed Combination Therapy|1|||
128878211|NCT00738582|463848409|FG001|Combination Therapy|Completed Combination Therapy|0|||
128878212|NCT00738582|463848408|FG000|Combination Therapy|Physician Decision|1|||
128878213|NCT00738582|463848409|FG001|Combination Therapy|Physician Decision|0|||
128878214|NCT00738582|463848408|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
128878215|NCT00738582|463848409|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
128878216|NCT00738582|463848408|FG000|Combination Therapy|Other|5|||
128878217|NCT00738582|463848409|FG001|Combination Therapy|Other|0|||
128878218|NCT00738582|463848408|FG000|Combination Therapy|Adverse Event|16|||
128878219|NCT00738582|463848409|FG001|Combination Therapy|Adverse Event|0|||
128878220|NCT00738582|463848408|FG000|Combination Therapy|Progressive Disease|9|||
128878221|NCT00738582|463848409|FG001|Combination Therapy|Progressive Disease|0|||
128878222|NCT00738582|463848408|FG000|Maintenance Therapy|Other|0|||
128878223|NCT00738582|463848409|FG001|Maintenance Therapy|Other|2|||
128878224|NCT00738582|463848408|FG000|Maintenance Therapy|Adverse Event|0|||
128878225|NCT00738582|463848409|FG001|Maintenance Therapy|Adverse Event|6|||
128878226|NCT00738582|463848408|FG000|Maintenance Therapy|Progressive Disease|0|||
128878227|NCT00738582|463848409|FG001|Maintenance Therapy|Progressive Disease|47|||
129002942|NCT01078090|464302039|FG000|Overall Study|ADR and lack of efficacy|61|||
129002943|NCT01078090|464302039|FG000|Overall Study|Other|523|||
128878228|NCT00738582|463848408|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
129002944|NCT04049552|464302041|FG000|Overall Study|Lost to Follow-up|1|||
129002945|NCT02123459|464302044|FG000|Washout Period (1 Day)|Adverse Event|1|||
129002946|NCT02123459|464302045|FG001|Washout Period (1 Day)|Adverse Event|0|||
129002947|NCT02196506|464302050|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
129002948|NCT02196506|464302051|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
129002949|NCT02196506|464302052|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
129002950|NCT02196506|464302053|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
129002951|NCT02196506|464302050|FG000|Phase A|Withdrawal by Subject|34|||
129002952|NCT02196506|464302051|FG001|Phase A|Withdrawal by Subject|0|||
129002953|NCT02196506|464302052|FG002|Phase A|Withdrawal by Subject|0|||
129002954|NCT02196506|464302053|FG003|Phase A|Withdrawal by Subject|0|||
129002955|NCT02196506|464302050|FG000|Phase A|Adverse Event|22|||
129002956|NCT02196506|464302051|FG001|Phase A|Adverse Event|0|||
129002957|NCT02196506|464302052|FG002|Phase A|Adverse Event|0|||
129002958|NCT02196506|464302053|FG003|Phase A|Adverse Event|0|||
129002959|NCT02196506|464302050|FG000|Phase A|Lost to Follow-up|9|||
129002960|NCT02196506|464302051|FG001|Phase A|Lost to Follow-up|0|||
129002961|NCT02196506|464302052|FG002|Phase A|Lost to Follow-up|0|||
129002962|NCT02196506|464302053|FG003|Phase A|Lost to Follow-up|0|||
129002963|NCT02196506|464302050|FG000|Phase A|Protocol deviation|12|||
129002964|NCT02196506|464302051|FG001|Phase A|Protocol deviation|0|||
129002965|NCT02196506|464302052|FG002|Phase A|Protocol deviation|0|||
129002966|NCT02196506|464302053|FG003|Phase A|Protocol deviation|0|||
129002967|NCT02196506|464302050|FG000|Phase A|Participant withdrawn by investigator|10|||
129002968|NCT02196506|464302051|FG001|Phase A|Participant withdrawn by investigator|0|||
129002969|NCT02196506|464302052|FG002|Phase A|Participant withdrawn by investigator|0|||
129002970|NCT02196506|464302053|FG003|Phase A|Participant withdrawn by investigator|0|||
129002971|NCT02196506|464302050|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
129002972|NCT02196506|464302051|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
129002973|NCT02196506|464302052|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
129002974|NCT02196506|464302053|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
129002975|NCT02196506|464302050|FG000|Phase B|Lack of Efficacy|0|||
129002976|NCT02196506|464302051|FG001|Phase B|Lack of Efficacy|1|||
129002977|NCT02196506|464302052|FG002|Phase B|Lack of Efficacy|2|||
129002978|NCT02196506|464302053|FG003|Phase B|Lack of Efficacy|0|||
129002979|NCT02196506|464302050|FG000|Phase B|Withdrawal by Participant|0|||
129002980|NCT02196506|464302051|FG001|Phase B|Withdrawal by Participant|8|||
129002981|NCT02196506|464302052|FG002|Phase B|Withdrawal by Participant|1|||
129002982|NCT02196506|464302053|FG003|Phase B|Withdrawal by Participant|0|||
129002983|NCT02196506|464302050|FG000|Phase B|Adverse Event|0|||
129002984|NCT02196506|464302051|FG001|Phase B|Adverse Event|4|||
129002985|NCT02196506|464302052|FG002|Phase B|Adverse Event|1|||
129002986|NCT02196506|464302053|FG003|Phase B|Adverse Event|0|||
129002987|NCT02196506|464302050|FG000|Phase B|Lost to Follow-up|0|||
129002988|NCT02196506|464302051|FG001|Phase B|Lost to Follow-up|2|||
129002989|NCT02196506|464302052|FG002|Phase B|Lost to Follow-up|1|||
129002990|NCT02196506|464302053|FG003|Phase B|Lost to Follow-up|0|||
129002991|NCT02196506|464302050|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
129002992|NCT02196506|464302051|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
129002993|NCT02196506|464302052|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
129002994|NCT02196506|464302053|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
129002995|NCT02196506|464302050|FG000|Phase A+|Withdrawal by Participant|0|||
129002996|NCT02196506|464302051|FG001|Phase A+|Withdrawal by Participant|0|||
129002997|NCT02196506|464302052|FG002|Phase A+|Withdrawal by Participant|0|||
129002998|NCT02196506|464302053|FG003|Phase A+|Withdrawal by Participant|5|||
129002999|NCT02196506|464302050|FG000|Phase A+|Adverse Event|0|||
129003000|NCT02196506|464302051|FG001|Phase A+|Adverse Event|0|||
129003001|NCT02196506|464302052|FG002|Phase A+|Adverse Event|0|||
129003002|NCT02196506|464302053|FG003|Phase A+|Adverse Event|1|||
129003003|NCT02196506|464302050|FG000|Phase A+|Lost to Follow-up|0|||
129003004|NCT02196506|464302051|FG001|Phase A+|Lost to Follow-up|0|||
129003005|NCT02196506|464302052|FG002|Phase A+|Lost to Follow-up|0|||
129003006|NCT02196506|464302053|FG003|Phase A+|Lost to Follow-up|6|||
129003007|NCT02196506|464302050|FG000|Phase A+|Participant withdrawn by investigator|0|||
129003008|NCT02196506|464302051|FG001|Phase A+|Participant withdrawn by investigator|0|||
129003009|NCT02196506|464302052|FG002|Phase A+|Participant withdrawn by investigator|0|||
129003010|NCT02196506|464302053|FG003|Phase A+|Participant withdrawn by investigator|1|||
129003011|NCT00254397|464302054|FG000|Overall Study|Disease Progression|4|||
129003012|NCT00254397|464302055|FG001|Overall Study|Disease Progression|1|||
129003013|NCT00254397|464302056|FG002|Overall Study|Disease Progression|16|||
129003014|NCT00254397|464302057|FG003|Overall Study|Disease Progression|23|||
129003015|NCT00254397|464302054|FG000|Overall Study|Non-Compliant|0|||
129003016|NCT00254397|464302055|FG001|Overall Study|Non-Compliant|0|||
129003017|NCT00254397|464302056|FG002|Overall Study|Non-Compliant|0|||
129003018|NCT00254397|464302057|FG003|Overall Study|Non-Compliant|1|||
129003019|NCT00254397|464302054|FG000|Overall Study|Adverse Event|2|||
129003020|NCT00254397|464302055|FG001|Overall Study|Adverse Event|0|||
129003021|NCT00254397|464302056|FG002|Overall Study|Adverse Event|3|||
129003022|NCT00254397|464302057|FG003|Overall Study|Adverse Event|1|||
129003023|NCT01015612|464302068|FG000|Overall Study|Death|113|||
129003024|NCT01015612|464302068|FG000|Overall Study|Withdrawal by Subject|40|||
129003025|NCT00066807|464302069|FG000|Overall Study|Study was terminated early|14|||
129003026|NCT00066807|464302070|FG001|Overall Study|Study was terminated early|15|||
129003027|NCT03586830|464302072|FG000|Overall Study|Site terminated by Sponsor|1|||
129003028|NCT03586830|464302073|FG001|Overall Study|Site terminated by Sponsor|4|||
129003029|NCT03586830|464302074|FG002|Overall Study|Site terminated by Sponsor|3|||
129003030|NCT03586830|464302075|FG003|Overall Study|Site terminated by Sponsor|3|||
129003031|NCT03586830|464302072|FG000|Overall Study|Lost to Follow-up|0|||
129003032|NCT03586830|464302073|FG001|Overall Study|Lost to Follow-up|2|||
129003033|NCT03586830|464302074|FG002|Overall Study|Lost to Follow-up|2|||
129003034|NCT03586830|464302075|FG003|Overall Study|Lost to Follow-up|1|||
129003035|NCT03586830|464302072|FG000|Overall Study|Withdrawal by Subject|1|||
129003036|NCT03586830|464302073|FG001|Overall Study|Withdrawal by Subject|0|||
129003037|NCT03586830|464302074|FG002|Overall Study|Withdrawal by Subject|3|||
129003038|NCT03586830|464302075|FG003|Overall Study|Withdrawal by Subject|1|||
129003039|NCT04578548|464302076|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129003040|NCT04578548|464302077|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129003041|NCT04578548|464302076|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
129003042|NCT04578548|464302077|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
129003043|NCT04578548|464302076|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
129003044|NCT04578548|464302077|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
129003045|NCT04578548|464302076|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
129003046|NCT04578548|464302077|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
129003047|NCT04578548|464302076|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
129003048|NCT04578548|464302077|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
129003049|NCT04578548|464302076|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
129003050|NCT04578548|464302077|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
129003051|NCT00395083|464302080|FG000|Overall Study|Withdrawal by Subject|6|||
129003052|NCT00395083|464302081|FG001|Overall Study|Withdrawal by Subject|5|||
129003053|NCT00395083|464302080|FG000|Overall Study|Developed another disease|4|||
129003054|NCT00395083|464302081|FG001|Overall Study|Developed another disease|3|||
129003055|NCT00972153|464302082|FG000|Overall Study|Equipment malfunction during case|0|||
129003056|NCT00972153|464302083|FG001|Overall Study|Equipment malfunction during case|1|||
129003057|NCT00972153|464302084|FG002|Overall Study|Equipment malfunction during case|0|||
129003058|NCT04136626|464302085|FG000|Treatment Phase|Withdrawal by Subject|1|||
129003059|NCT04136626|464302086|FG001|Treatment Phase|Withdrawal by Subject|9|||
129003060|NCT04136626|464302085|FG000|Treatment Phase|Adverse Event|1|||
129003061|NCT04136626|464302086|FG001|Treatment Phase|Adverse Event|0|||
129003062|NCT04136626|464302085|FG000|Treatment Phase|Lost to Follow-up|1|||
129003063|NCT04136626|464302086|FG001|Treatment Phase|Lost to Follow-up|5|||
129003064|NCT04136626|464302085|FG000|12-month Follow-up|Lost to Follow-up|8|||
129003065|NCT04136626|464302086|FG001|12-month Follow-up|Lost to Follow-up|7|||
129003066|NCT00628745|464302087|FG000|Overall Study|Withdrawal by Subject|63|||
129003067|NCT00628745|464302088|FG001|Overall Study|Withdrawal by Subject|3|||
129003068|NCT00628745|464302089|FG002|Overall Study|Withdrawal by Subject|9|||
129003069|NCT00628745|464302090|FG003|Overall Study|Withdrawal by Subject|2|||
129003070|NCT00628745|464302091|FG004|Overall Study|Withdrawal by Subject|69|||
129003071|NCT00628745|464302087|FG000|Overall Study|Does not meet inclusion criteria|0|||
129003072|NCT00628745|464302088|FG001|Overall Study|Does not meet inclusion criteria|12|||
129003073|NCT00628745|464302089|FG002|Overall Study|Does not meet inclusion criteria|0|||
129003074|NCT00628745|464302090|FG003|Overall Study|Does not meet inclusion criteria|0|||
129003075|NCT00628745|464302091|FG004|Overall Study|Does not meet inclusion criteria|18|||
129003076|NCT00628745|464302087|FG000|Overall Study|Participation in an interventional clinical trial|81|||
129003077|NCT00628745|464302088|FG001|Overall Study|Participation in an interventional clinical trial|4|||
129003078|NCT00628745|464302089|FG002|Overall Study|Participation in an interventional clinical trial|7|||
128668656|NCT00947882|463085112|FG002|Overall Study|Trial Terminated by Sponsor|62|||
128668657|NCT00947882|463085113|FG003|Overall Study|Trial Terminated by Sponsor|70|||
128668658|NCT00329797|463085114|FG000|Overall Study|Protocol Violation|1|||
129003079|NCT00628745|464302090|FG003|Overall Study|Participation in an interventional clinical trial|0|||
129003080|NCT00628745|464302091|FG004|Overall Study|Participation in an interventional clinical trial|63|||
129003081|NCT00628745|464302087|FG000|Overall Study|Physician Decision|8|||
129003082|NCT00628745|464302088|FG001|Overall Study|Physician Decision|4|||
128668659|NCT00329797|463085115|FG001|Overall Study|Protocol Violation|0|||
128668660|NCT00329797|463085114|FG000|Overall Study|Withdrawal by Subject|6|||
129003083|NCT00628745|464302089|FG002|Overall Study|Physician Decision|3|||
129003084|NCT00628745|464302090|FG003|Overall Study|Physician Decision|0|||
129003085|NCT00628745|464302091|FG004|Overall Study|Physician Decision|30|||
129003086|NCT00628745|464302087|FG000|Overall Study|Lost to Follow-up|109|||
128668661|NCT00329797|463085115|FG001|Overall Study|Withdrawal by Subject|6|||
128668662|NCT01262820|463085116|FG000|Overall Study|Adverse Event|5|||
128668663|NCT01262820|463085116|FG000|Overall Study|Lack of Efficacy|9|||
128668664|NCT01262820|463085116|FG000|Overall Study|Drug held for 21+ days|1|||
128668665|NCT00104520|463085117|FG000|Overall Study|Unrelated adverse event|34|||
128668666|NCT00104520|463085118|FG001|Overall Study|Unrelated adverse event|47|||
128668667|NCT00104520|463085117|FG000|Overall Study|Study drug intolerance|0|||
128668668|NCT00104520|463085118|FG001|Overall Study|Study drug intolerance|1|||
128668669|NCT00104520|463085117|FG000|Overall Study|Related adverse event|13|||
128668670|NCT00104520|463085118|FG001|Overall Study|Related adverse event|15|||
129003087|NCT00628745|464302088|FG001|Overall Study|Lost to Follow-up|7|||
129003088|NCT00628745|464302089|FG002|Overall Study|Lost to Follow-up|7|||
129003089|NCT00628745|464302090|FG003|Overall Study|Lost to Follow-up|0|||
129003090|NCT00628745|464302091|FG004|Overall Study|Lost to Follow-up|498|||
129003091|NCT00628745|464302087|FG000|Overall Study|Death|197|||
129003092|NCT00628745|464302088|FG001|Overall Study|Death|81|||
129003093|NCT00628745|464302089|FG002|Overall Study|Death|12|||
129003094|NCT00628745|464302090|FG003|Overall Study|Death|4|||
129003095|NCT00628745|464302091|FG004|Overall Study|Death|939|||
129003096|NCT00628745|464302087|FG000|Overall Study|Participant transferred to another THAOS site|6|||
129003097|NCT00628745|464302088|FG001|Overall Study|Participant transferred to another THAOS site|0|||
129003098|NCT00628745|464302089|FG002|Overall Study|Participant transferred to another THAOS site|0|||
129003099|NCT00628745|464302090|FG003|Overall Study|Participant transferred to another THAOS site|0|||
129003100|NCT00628745|464302091|FG004|Overall Study|Participant transferred to another THAOS site|7|||
129003101|NCT00628745|464302087|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
129003102|NCT00628745|464302088|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
129003103|NCT00628745|464302089|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
129003104|NCT00628745|464302090|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
129003105|NCT00628745|464302091|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
129003106|NCT00628745|464302087|FG000|Overall Study|Site closure|152|||
129003107|NCT00628745|464302088|FG001|Overall Study|Site closure|146|||
129003108|NCT00628745|464302089|FG002|Overall Study|Site closure|6|||
129003109|NCT00628745|464302090|FG003|Overall Study|Site closure|8|||
129003110|NCT00628745|464302091|FG004|Overall Study|Site closure|691|||
129003111|NCT00628745|464302087|FG000|Overall Study|Duplicate participant|0|||
129003112|NCT00628745|464302088|FG001|Overall Study|Duplicate participant|0|||
129003113|NCT00628745|464302089|FG002|Overall Study|Duplicate participant|0|||
129003114|NCT00628745|464302090|FG003|Overall Study|Duplicate participant|0|||
129003115|NCT00628745|464302091|FG004|Overall Study|Duplicate participant|1|||
129003116|NCT00628745|464302087|FG000|Overall Study|Missing|4|||
129003117|NCT00628745|464302088|FG001|Overall Study|Missing|3|||
129003118|NCT00628745|464302089|FG002|Overall Study|Missing|0|||
129003119|NCT00628745|464302090|FG003|Overall Study|Missing|0|||
129003120|NCT00628745|464302091|FG004|Overall Study|Missing|10|||
129003121|NCT00628745|464302087|FG000|Overall Study|Othe reasons|987|||
129003122|NCT00628745|464302088|FG001|Overall Study|Othe reasons|373|||
129003123|NCT00628745|464302089|FG002|Overall Study|Othe reasons|105|||
129003124|NCT00628745|464302090|FG003|Overall Study|Othe reasons|1|||
129003125|NCT00628745|464302091|FG004|Overall Study|Othe reasons|1772|||
129003126|NCT03322462|464303550|FG000|Overall Study|Technical difficulties|2|||
129003127|NCT03322462|464303550|FG000|Overall Study|Other|1|||
129003128|NCT03381248|464303551|FG000|0-6 Months|Withdrawal by Subject|4|||
129003129|NCT03381248|464303552|FG001|0-6 Months|Withdrawal by Subject|1|||
129003130|NCT03381248|464303551|FG000|0-6 Months|Lost to Follow-up|3|||
129003131|NCT03381248|464303552|FG001|0-6 Months|Lost to Follow-up|2|||
129003132|NCT03381248|464303551|FG000|0-6 Months|Lack of Efficacy|1|||
129003133|NCT03381248|464303552|FG001|0-6 Months|Lack of Efficacy|0|||
129003134|NCT03381248|464303551|FG000|0-6 Months|Adverse Event|1|||
129003135|NCT03381248|464303552|FG001|0-6 Months|Adverse Event|0|||
129003136|NCT03381248|464303551|FG000|0-6 Months|Protocol Violation|2|||
129003137|NCT03381248|464303552|FG001|0-6 Months|Protocol Violation|1|||
129003138|NCT03381248|464303551|FG000|0-6 Months|Physician Decision|1|||
129003139|NCT03381248|464303552|FG001|0-6 Months|Physician Decision|0|||
129003140|NCT03381248|464303551|FG000|0-6 Months|Planning another procedure|1|||
129003141|NCT03381248|464303552|FG001|0-6 Months|Planning another procedure|2|||
129003142|NCT03381248|464303551|FG000|6-12 Months|Withdrawal by Subject|1|||
129003143|NCT03381248|464303552|FG001|6-12 Months|Withdrawal by Subject|3|||
129003144|NCT03381248|464303551|FG000|6-12 Months|Lost to Follow-up|0|||
128668671|NCT00104520|463085117|FG000|Overall Study|Lost to Follow-up|1|||
128668672|NCT00104520|463085118|FG001|Overall Study|Lost to Follow-up|0|||
129003145|NCT03381248|464303552|FG001|6-12 Months|Lost to Follow-up|2|||
129003146|NCT03381248|464303551|FG000|6-12 Months|Protocol Violation|3|||
129003147|NCT03381248|464303552|FG001|6-12 Months|Protocol Violation|2|||
129003148|NCT03381248|464303551|FG000|6-12 Months|Planning another procedure|6|||
129003149|NCT03381248|464303552|FG001|6-12 Months|Planning another procedure|2|||
129003150|NCT03381248|464303551|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
129003151|NCT03381248|464303552|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
129003152|NCT03381248|464303551|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
129003153|NCT03381248|464303552|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
129003154|NCT03381248|464303551|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
129003155|NCT03381248|464303552|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
129003156|NCT03572933|464303559|FG000|Overall Study|Adverse Event|4|||
129003157|NCT03572933|464303560|FG001|Overall Study|Adverse Event|1|||
128668673|NCT00104520|463085117|FG000|Overall Study|Noncompliance|0|||
128668674|NCT00104520|463085118|FG001|Overall Study|Noncompliance|2|||
128668675|NCT00104520|463085117|FG000|Overall Study|Personal/administrative|1|||
128668676|NCT00104520|463085118|FG001|Overall Study|Personal/administrative|1|||
128668677|NCT00104520|463085117|FG000|Overall Study|Other|1|||
128668678|NCT00104520|463085118|FG001|Overall Study|Other|5|||
128668679|NCT01026324|463085120|FG000|Follow up/Survival|Withdrawal by Subject|1|||
128668680|NCT01026324|463085121|FG001|Follow up/Survival|Withdrawal by Subject|0|||
128668681|NCT01026324|463085122|FG002|Follow up/Survival|Withdrawal by Subject|0|||
128668682|NCT05188053|463085123|FG000|Overall Study|Lost to Follow-up|23|||
128668683|NCT05188053|463085124|FG001|Overall Study|Lost to Follow-up|30|||
128668684|NCT05188053|463085123|FG000|Overall Study|Protocol Violation|16|||
128668685|NCT05188053|463085124|FG001|Overall Study|Protocol Violation|16|||
128668686|NCT05188053|463085123|FG000|Overall Study|Physician Decision|3|||
128668687|NCT05188053|463085124|FG001|Overall Study|Physician Decision|0|||
128668688|NCT05188053|463085123|FG000|Overall Study|Withdrawal by Subject|0|||
128668689|NCT05188053|463085124|FG001|Overall Study|Withdrawal by Subject|1|||
128668690|NCT02447302|463085136|FG000|Overall Study|Physician Decision|1|||
128668691|NCT02447302|463085137|FG001|Overall Study|Physician Decision|0|||
128668692|NCT02447302|463085138|FG002|Overall Study|Physician Decision|0|||
128668693|NCT02447302|463085136|FG000|Overall Study|Adverse Event|4|||
128668694|NCT02447302|463085137|FG001|Overall Study|Adverse Event|3|||
128668695|NCT02447302|463085138|FG002|Overall Study|Adverse Event|0|||
128668696|NCT02447302|463085136|FG000|Overall Study|Withdrawal by Subject|0|||
128668697|NCT02447302|463085137|FG001|Overall Study|Withdrawal by Subject|1|||
128668698|NCT02447302|463085138|FG002|Overall Study|Withdrawal by Subject|5|||
128668699|NCT02447302|463085136|FG000|Overall Study|Sponsor Decision|0|||
128668700|NCT02447302|463085137|FG001|Overall Study|Sponsor Decision|0|||
128668701|NCT02447302|463085138|FG002|Overall Study|Sponsor Decision|1|||
128668702|NCT01456897|463085143|FG000|Overall Study|Adverse Event|19|||
128668703|NCT01456897|463085144|FG001|Overall Study|Adverse Event|22|||
128668704|NCT01456897|463085143|FG000|Overall Study|Protocol Violation|3|||
128668705|NCT01456897|463085144|FG001|Overall Study|Protocol Violation|4|||
128668706|NCT01456897|463085143|FG000|Overall Study|Physician Decision|5|||
128668707|NCT01456897|463085144|FG001|Overall Study|Physician Decision|3|||
128668708|NCT01456897|463085143|FG000|Overall Study|Withdrawal by Subject|44|||
128668709|NCT01456897|463085144|FG001|Overall Study|Withdrawal by Subject|17|||
128668710|NCT01456897|463085143|FG000|Overall Study|Lack of Efficacy|4|||
128668711|NCT01456897|463085144|FG001|Overall Study|Lack of Efficacy|11|||
128668712|NCT01396070|463085151|FG000|Overall Study|Withdrawal by Subject|2|||
128668713|NCT01396070|463085151|FG000|Overall Study|Death|2|||
128668714|NCT01396070|463085151|FG000|Overall Study|Adverse Event|8|||
128668715|NCT01396070|463085151|FG000|Overall Study|Physician Decision|3|||
128668716|NCT01396070|463085151|FG000|Overall Study|Lack of Efficacy|4|||
128668717|NCT01561313|463085152|FG000|Overall Study|Withdrawal by Subject|1|||
128668718|NCT01561313|463085153|FG001|Overall Study|Withdrawal by Subject|0|||
128668719|NCT01561313|463085152|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
128668720|NCT01561313|463085153|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
128668721|NCT04254913|463085154|FG000|Overall Study|Adverse Event|1|||
128668722|NCT01396057|463085155|FG000|Overall Study|Adverse Event|2|||
128668723|NCT01396057|463085156|FG001|Overall Study|Adverse Event|6|||
128668724|NCT01396057|463085155|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128668725|NCT01396057|463085156|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
128668726|NCT01396057|463085155|FG000|Overall Study|Protocol deviation|4|||
128668727|NCT01396057|463085156|FG001|Overall Study|Protocol deviation|4|||
128668728|NCT01396057|463085155|FG000|Overall Study|Consent withdrawn|3|||
128668729|NCT01396057|463085156|FG001|Overall Study|Consent withdrawn|2|||
128668730|NCT04535453|463085157|FG000|Overall Study|Death|0|||
128668731|NCT04535453|463085158|FG001|Overall Study|Death|1|||
128668732|NCT04535453|463085159|FG002|Overall Study|Death|0|||
128668733|NCT04535453|463085160|FG003|Overall Study|Death|0|||
128668734|NCT04535453|463085161|FG004|Overall Study|Death|0|||
128668735|NCT04535453|463085162|FG005|Overall Study|Death|0|||
128668736|NCT04535453|463085163|FG006|Overall Study|Death|0|||
128668737|NCT04535453|463085164|FG007|Overall Study|Death|0|||
128668738|NCT04535453|463085165|FG008|Overall Study|Death|0|||
128668739|NCT04535453|463085166|FG009|Overall Study|Death|0|||
128668740|NCT04535453|463085167|FG010|Overall Study|Death|0|||
128668741|NCT04535453|463085168|FG011|Overall Study|Death|0|||
128668742|NCT04535453|463085157|FG000|Overall Study|Lost to Follow-up|1|||
128668743|NCT04535453|463085158|FG001|Overall Study|Lost to Follow-up|1|||
128668744|NCT04535453|463085159|FG002|Overall Study|Lost to Follow-up|1|||
128668745|NCT04535453|463085160|FG003|Overall Study|Lost to Follow-up|0|||
128668746|NCT04535453|463085161|FG004|Overall Study|Lost to Follow-up|3|||
128668747|NCT04535453|463085162|FG005|Overall Study|Lost to Follow-up|1|||
128668748|NCT04535453|463085163|FG006|Overall Study|Lost to Follow-up|0|||
128668749|NCT04535453|463085164|FG007|Overall Study|Lost to Follow-up|0|||
128668750|NCT04535453|463085165|FG008|Overall Study|Lost to Follow-up|1|||
128668751|NCT04535453|463085166|FG009|Overall Study|Lost to Follow-up|1|||
128668752|NCT04535453|463085167|FG010|Overall Study|Lost to Follow-up|0|||
128668753|NCT04535453|463085168|FG011|Overall Study|Lost to Follow-up|0|||
128668754|NCT04535453|463085157|FG000|Overall Study|Physician Decision|0|||
128668755|NCT04535453|463085158|FG001|Overall Study|Physician Decision|0|||
128668756|NCT04535453|463085159|FG002|Overall Study|Physician Decision|0|||
128668757|NCT04535453|463085160|FG003|Overall Study|Physician Decision|1|||
128668758|NCT04535453|463085161|FG004|Overall Study|Physician Decision|0|||
128668759|NCT04535453|463085162|FG005|Overall Study|Physician Decision|0|||
128668760|NCT04535453|463085163|FG006|Overall Study|Physician Decision|0|||
128668761|NCT04535453|463085164|FG007|Overall Study|Physician Decision|0|||
128668762|NCT04535453|463085165|FG008|Overall Study|Physician Decision|0|||
128668763|NCT04535453|463085166|FG009|Overall Study|Physician Decision|0|||
128668764|NCT04535453|463085167|FG010|Overall Study|Physician Decision|0|||
128668765|NCT04535453|463085168|FG011|Overall Study|Physician Decision|0|||
128668766|NCT04535453|463085157|FG000|Overall Study|Withdrawal by Subject|3|||
128668767|NCT04535453|463085158|FG001|Overall Study|Withdrawal by Subject|6|||
128668768|NCT04535453|463085159|FG002|Overall Study|Withdrawal by Subject|3|||
128668769|NCT04535453|463085160|FG003|Overall Study|Withdrawal by Subject|3|||
128668770|NCT04535453|463085161|FG004|Overall Study|Withdrawal by Subject|2|||
128668771|NCT04535453|463085162|FG005|Overall Study|Withdrawal by Subject|1|||
129003158|NCT03572933|464303559|FG000|Overall Study|Withdrawal by Subject|0|||
128668772|NCT04535453|463085163|FG006|Overall Study|Withdrawal by Subject|1|||
128668773|NCT04535453|463085164|FG007|Overall Study|Withdrawal by Subject|1|||
128668774|NCT04535453|463085165|FG008|Overall Study|Withdrawal by Subject|1|||
128668775|NCT04535453|463085166|FG009|Overall Study|Withdrawal by Subject|1|||
128668776|NCT04535453|463085167|FG010|Overall Study|Withdrawal by Subject|0|||
128668777|NCT04535453|463085168|FG011|Overall Study|Withdrawal by Subject|1|||
128668778|NCT04535453|463085157|FG000|Overall Study|Other|0|||
128668779|NCT04535453|463085158|FG001|Overall Study|Other|0|||
128668780|NCT04535453|463085159|FG002|Overall Study|Other|1|||
128668781|NCT04535453|463085160|FG003|Overall Study|Other|0|||
128668782|NCT04535453|463085161|FG004|Overall Study|Other|1|||
128668783|NCT04535453|463085162|FG005|Overall Study|Other|0|||
128668784|NCT04535453|463085163|FG006|Overall Study|Other|1|||
128668785|NCT04535453|463085164|FG007|Overall Study|Other|1|||
129003159|NCT03572933|464303560|FG001|Overall Study|Withdrawal by Subject|1|||
129003160|NCT01405950|464303563|FG000|Overall Study|Withdrawal by Subject|1|||
129003161|NCT01405950|464303564|FG001|Overall Study|Withdrawal by Subject|0|||
129003162|NCT01405950|464303565|FG002|Overall Study|Withdrawal by Subject|0|||
129003163|NCT01405950|464303566|FG003|Overall Study|Withdrawal by Subject|0|||
129003164|NCT02410252|464303567|FG000|Overall Study|Withdrawal by Subject|4|||
129003165|NCT02410252|464303567|FG000|Overall Study|Physician Decision|2|||
129003166|NCT00387712|464303570|FG000|Overall Study|Physician Decision|6|||
129003167|NCT00387712|464303571|FG001|Overall Study|Physician Decision|4|||
129003168|NCT00387712|464303570|FG000|Overall Study|Lost to Follow-up|17|||
129003169|NCT00387712|464303571|FG001|Overall Study|Lost to Follow-up|20|||
129003170|NCT00387712|464303570|FG000|Overall Study|Withdrawal by Subject|6|||
129003171|NCT00387712|464303571|FG001|Overall Study|Withdrawal by Subject|12|||
129003172|NCT03551730|464303580|FG000|Overall Study|Adverse Event|1|||
129003173|NCT03551730|464303581|FG001|Overall Study|Adverse Event|0|||
129003174|NCT03551730|464303582|FG002|Overall Study|Adverse Event|0|||
129003175|NCT03551730|464303583|FG003|Overall Study|Adverse Event|0|||
129003176|NCT03347695|464303587|FG000|Overall Study|Death|0|||
129003177|NCT03347695|464303588|FG001|Overall Study|Death|4|||
129003178|NCT03347695|464303587|FG000|Overall Study|Lost to Follow-up|0|||
129003179|NCT03347695|464303588|FG001|Overall Study|Lost to Follow-up|1|||
129003180|NCT02668783|464303607|FG000|Overall Study|Pregnancy|0|||
129003181|NCT02668783|464303608|FG001|Overall Study|Pregnancy|1|||
129003182|NCT02668783|464303607|FG000|Overall Study|Protocol Violation|2|||
128668786|NCT04535453|463085165|FG008|Overall Study|Other|1|||
128668787|NCT04535453|463085166|FG009|Overall Study|Other|0|||
128668788|NCT04535453|463085167|FG010|Overall Study|Other|0|||
128668789|NCT04535453|463085168|FG011|Overall Study|Other|0|||
128668790|NCT03500224|463085169|FG000|Overall Study|Withdrawal by Subject|2|||
128668791|NCT01324401|463085172|FG000|Overall Study|Withdrawn before any treatment|0|||
128668792|NCT01324401|463085173|FG001|Overall Study|Withdrawn before any treatment|3|||
128668793|NCT01324401|463085172|FG000|Overall Study|Adverse Event|1|||
128668794|NCT01324401|463085173|FG001|Overall Study|Adverse Event|3|||
128668795|NCT01708902|463085175|FG000|Overall Study|Adverse Event|3|||
128668796|NCT01708902|463085176|FG001|Overall Study|Adverse Event|4|||
128668797|NCT01708902|463085177|FG002|Overall Study|Adverse Event|9|||
128668798|NCT01708902|463085178|FG003|Overall Study|Adverse Event|2|||
129003183|NCT02668783|464303608|FG001|Overall Study|Protocol Violation|1|||
128668799|NCT01708902|463085179|FG004|Overall Study|Adverse Event|7|||
128668800|NCT01708902|463085180|FG005|Overall Study|Adverse Event|3|||
128878229|NCT00738582|463848409|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
128878230|NCT00642772|463848410|FG000|Overall Study|Lost to Follow-up|3|||
128878231|NCT00642772|463848410|FG000|Overall Study|Withdrawal by Subject|7|||
128878232|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
128878233|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
128878234|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
128878235|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
128878236|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
128878237|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
128878238|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
128878239|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
128878240|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
128878241|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
128878242|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
128878243|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
128878244|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
128878245|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
128878246|NCT00757588|463848411|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
128878247|NCT00757588|463848412|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
128878248|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
128878249|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
128878250|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
128878251|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
128878252|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
128878253|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
128878254|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
128878255|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
128878256|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
128878257|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
128878258|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
128878259|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
128878260|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
128878261|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
128878262|NCT00757588|463848411|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
128878263|NCT00757588|463848412|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
128878264|NCT00545051|463848413|FG000|Overall Study|Adverse Event|7|||
128878265|NCT00545051|463848414|FG001|Overall Study|Adverse Event|3|||
128878266|NCT00545051|463848413|FG000|Overall Study|Death|1|||
128878267|NCT00545051|463848414|FG001|Overall Study|Death|0|||
128878268|NCT00545051|463848413|FG000|Overall Study|Violation of inclusion/exclusion|0|||
128878269|NCT00545051|463848414|FG001|Overall Study|Violation of inclusion/exclusion|2|||
128878270|NCT00545051|463848413|FG000|Overall Study|Protocol Violation|1|||
128878271|NCT00545051|463848414|FG001|Overall Study|Protocol Violation|0|||
128878272|NCT00545051|463848413|FG000|Overall Study|Withdrawal by Subject|0|||
128878273|NCT00545051|463848414|FG001|Overall Study|Withdrawal by Subject|1|||
128878274|NCT00545051|463848413|FG000|Overall Study|Administrative reasons|0|||
128878275|NCT00545051|463848414|FG001|Overall Study|Administrative reasons|1|||
128878276|NCT00903006|463848415|FG000|Overall Study|Withdrawal by Subject|2|||
128878277|NCT00903006|463848416|FG001|Overall Study|Withdrawal by Subject|0|||
128878278|NCT00903006|463848417|FG002|Overall Study|Withdrawal by Subject|0|||
128878279|NCT00903006|463848418|FG003|Overall Study|Withdrawal by Subject|0|||
128878280|NCT00903006|463848415|FG000|Overall Study|Progressive Disease|0|||
128878281|NCT00903006|463848416|FG001|Overall Study|Progressive Disease|3|||
128878282|NCT00903006|463848417|FG002|Overall Study|Progressive Disease|1|||
128878283|NCT00903006|463848418|FG003|Overall Study|Progressive Disease|0|||
128878284|NCT03271021|463848422|FG000|Overall Study|Adverse Event|3|||
128878285|NCT03271021|463848423|FG001|Overall Study|Adverse Event|2|||
128878286|NCT03271021|463848422|FG000|Overall Study|Withdrawal by Subject|36|||
128878287|NCT03271021|463848423|FG001|Overall Study|Withdrawal by Subject|53|||
128878288|NCT03271021|463848422|FG000|Overall Study|Lost to Follow-up|34|||
128878289|NCT03271021|463848423|FG001|Overall Study|Lost to Follow-up|39|||
128878290|NCT03271021|463848422|FG000|Overall Study|Protocol Violation|6|||
128878291|NCT03271021|463848423|FG001|Overall Study|Protocol Violation|4|||
128878292|NCT03271021|463848422|FG000|Overall Study|Abnormal Lab Results|1|||
128878293|NCT03271021|463848423|FG001|Overall Study|Abnormal Lab Results|0|||
128878294|NCT03271021|463848422|FG000|Overall Study|Miscellaneous|9|||
128878295|NCT03271021|463848423|FG001|Overall Study|Miscellaneous|8|||
128878296|NCT01383499|463848424|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
128878297|NCT01383499|463848425|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
128668801|NCT01708902|463085181|FG006|Overall Study|Adverse Event|5|||
129003184|NCT02668783|464303607|FG000|Overall Study|Study terminated by sponsor|9|||
129003185|NCT02668783|464303608|FG001|Overall Study|Study terminated by sponsor|10|||
129003186|NCT02668783|464303607|FG000|Overall Study|Subject moved|1|||
129003187|NCT02668783|464303608|FG001|Overall Study|Subject moved|0|||
129003188|NCT02668783|464303607|FG000|Overall Study|Withdrawal by Subject|1|||
129003189|NCT02668783|464303608|FG001|Overall Study|Withdrawal by Subject|0|||
129003190|NCT01003886|464303609|FG000|Overall Study|Lack of Efficacy|5|||
129003191|NCT01003886|464303609|FG000|Overall Study|Lost to Follow-up|169|||
129003192|NCT01003886|464303609|FG000|Overall Study|Withdrawal by Subject|39|||
129003193|NCT01003886|464303609|FG000|Overall Study|Other|14|||
129003194|NCT01003886|464303609|FG000|Overall Study|Adverse Event|3|||
129003195|NCT04467697|464303610|FG000|Overall Study|Adverse Event|2|||
129003196|NCT04467697|464303610|FG000|Overall Study|Lost to Follow-up|6|||
129003197|NCT04467697|464303610|FG000|Overall Study|Withdrawal by Subject|9|||
129003198|NCT04467697|464303610|FG000|Overall Study|Protocol Violation|3|||
129003199|NCT00909727|464303613|FG000|Overall Study|Adverse Event|1|||
129003200|NCT00909727|464303614|FG001|Overall Study|Adverse Event|0|||
129003201|NCT00909727|464303613|FG000|Overall Study|Wrong Genotype|1|||
129003202|NCT00909727|464303614|FG001|Overall Study|Wrong Genotype|0|||
129003203|NCT00909727|464303613|FG000|Overall Study|Withdrawal of Consent|1|||
129003204|NCT00909727|464303614|FG001|Overall Study|Withdrawal of Consent|0|||
129003205|NCT00909727|464303613|FG000|Overall Study|Prohibited Medication|1|||
129003206|NCT00909727|464303614|FG001|Overall Study|Prohibited Medication|0|||
129003207|NCT02231710|464303615|FG000|Overall Study|Physician Decision|1|||
129003208|NCT04081337|464303616|FG000|Overall Study|Adverse Event|0|||
129003209|NCT04081337|464303617|FG001|Overall Study|Adverse Event|1|||
129003210|NCT04081337|464303616|FG000|Overall Study|Withdrawal by Subject|2|||
129003211|NCT04081337|464303617|FG001|Overall Study|Withdrawal by Subject|0|||
129003212|NCT04081337|464303616|FG000|Overall Study|Physician Decision|1|||
129003213|NCT04081337|464303617|FG001|Overall Study|Physician Decision|2|||
129003214|NCT04081337|464303616|FG000|Overall Study|Lost to Follow-up|1|||
129003215|NCT04081337|464303617|FG001|Overall Study|Lost to Follow-up|0|||
129003216|NCT00673361|464303622|FG000|Overall Study|Screen Failure|2|||
129003217|NCT01799590|464303625|FG000|Overall Study|Adverse Event|13|||
129003218|NCT01799590|464303626|FG001|Overall Study|Adverse Event|7|||
129003219|NCT01799590|464303627|FG002|Overall Study|Adverse Event|5|||
129003220|NCT01799590|464303625|FG000|Overall Study|Pregnancy|2|||
129003221|NCT01799590|464303626|FG001|Overall Study|Pregnancy|0|||
129003222|NCT01799590|464303627|FG002|Overall Study|Pregnancy|0|||
129003223|NCT01799590|464303625|FG000|Overall Study|Lack of Efficacy|3|||
129003224|NCT01799590|464303626|FG001|Overall Study|Lack of Efficacy|1|||
129003225|NCT01799590|464303627|FG002|Overall Study|Lack of Efficacy|3|||
129003226|NCT01799590|464303625|FG000|Overall Study|Participants convenience|4|||
129003227|NCT01799590|464303626|FG001|Overall Study|Participants convenience|4|||
129003228|NCT01799590|464303627|FG002|Overall Study|Participants convenience|2|||
129003229|NCT01799590|464303625|FG000|Overall Study|Aggravation of complications|0|||
129003230|NCT01799590|464303626|FG001|Overall Study|Aggravation of complications|1|||
129003231|NCT01799590|464303627|FG002|Overall Study|Aggravation of complications|1|||
129003232|NCT01799590|464303625|FG000|Overall Study|Using drugs with restricted days of use|0|||
129003233|NCT01799590|464303626|FG001|Overall Study|Using drugs with restricted days of use|3|||
129003234|NCT01799590|464303627|FG002|Overall Study|Using drugs with restricted days of use|2|||
129003235|NCT01799590|464303625|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
129003236|NCT01799590|464303626|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
129003237|NCT01799590|464303627|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
129003238|NCT01799590|464303625|FG000|Overall Study|Other|3|||
129003239|NCT01799590|464303626|FG001|Overall Study|Other|0|||
129003240|NCT01799590|464303627|FG002|Overall Study|Other|1|||
129003241|NCT01489956|464303628|FG000|Overall Study|Lost to Follow-up|1|||
129003242|NCT01489956|464303629|FG001|Overall Study|Lost to Follow-up|0|||
129003243|NCT01489956|464303630|FG002|Overall Study|Lost to Follow-up|0|||
129003244|NCT01489956|464303628|FG000|Overall Study|Withdrawal by Subject|0|||
129003245|NCT01489956|464303629|FG001|Overall Study|Withdrawal by Subject|0|||
129003246|NCT01489956|464303630|FG002|Overall Study|Withdrawal by Subject|1|||
128668802|NCT01708902|463085175|FG000|Overall Study|Lack of Efficacy|3|||
129003247|NCT03255031|464303633|FG000|Overall Study|Adverse Event|5|||
129003248|NCT03255031|464303634|FG001|Overall Study|Adverse Event|3|||
128668803|NCT01708902|463085176|FG001|Overall Study|Lack of Efficacy|1|||
128668804|NCT01708902|463085177|FG002|Overall Study|Lack of Efficacy|0|||
129003249|NCT03255031|464303633|FG000|Overall Study|Physician Decision|2|||
129003250|NCT03255031|464303634|FG001|Overall Study|Physician Decision|1|||
129003251|NCT03255031|464303633|FG000|Overall Study|Withdrawal by Subject|9|||
129003252|NCT03255031|464303634|FG001|Overall Study|Withdrawal by Subject|3|||
129003253|NCT01689974|464303636|FG000|Overall Study|Termination of Study|5|||
129003254|NCT01689974|464303637|FG001|Overall Study|Termination of Study|5|||
128668805|NCT01708902|463085178|FG003|Overall Study|Lack of Efficacy|0|||
129003255|NCT00415532|464303641|FG000|Treatment Period|Adverse Event|2|||
129003256|NCT00415532|464303642|FG001|Treatment Period|Adverse Event|3|||
129003257|NCT00415532|464303641|FG000|Treatment Period|Death|2|||
129003258|NCT00415532|464303642|FG001|Treatment Period|Death|1|||
129003259|NCT00415532|464303641|FG000|Treatment Period|Lost to Follow-up|1|||
129003260|NCT00415532|464303642|FG001|Treatment Period|Lost to Follow-up|1|||
129003261|NCT00415532|464303641|FG000|Treatment Period|Protocol Violation|1|||
129003262|NCT00415532|464303642|FG001|Treatment Period|Protocol Violation|0|||
129003263|NCT00415532|464303641|FG000|Treatment Period|Withdrawal by Subject|6|||
129003264|NCT00415532|464303642|FG001|Treatment Period|Withdrawal by Subject|6|||
129003265|NCT00415532|464303641|FG000|Treatment Period|Other|2|||
129003266|NCT00415532|464303642|FG001|Treatment Period|Other|2|||
129003267|NCT00415532|464303641|FG000|Treatment Period|Ineligibility determined|1|||
129003268|NCT00415532|464303642|FG001|Treatment Period|Ineligibility determined|1|||
129003269|NCT00415532|464303641|FG000|Treatment Period|Noncompliance|1|||
129003270|NCT00415532|464303642|FG001|Treatment Period|Noncompliance|1|||
129003271|NCT00415532|464303641|FG000|Treatment Period|Requirement for alternative therapy|1|||
129003272|NCT00415532|464303642|FG001|Treatment Period|Requirement for alternative therapy|0|||
129003273|NCT00415532|464303641|FG000|Safety Follow Up Period|Adverse Event|1|||
129003274|NCT00415532|464303642|FG001|Safety Follow Up Period|Adverse Event|3|||
129003275|NCT00415532|464303641|FG000|Safety Follow Up Period|Death|3|||
129003276|NCT00415532|464303642|FG001|Safety Follow Up Period|Death|0|||
129003277|NCT00415532|464303641|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
129003278|NCT00415532|464303642|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
129003279|NCT00415532|464303641|FG000|Safety Follow Up Period|Other|1|||
129003280|NCT00415532|464303642|FG001|Safety Follow Up Period|Other|4|||
129003281|NCT00415532|464303641|FG000|Safety Follow Up Period|Ineligibility determined|1|||
129003282|NCT00415532|464303642|FG001|Safety Follow Up Period|Ineligibility determined|1|||
129003283|NCT00415532|464303641|FG000|Safety Follow Up Period|Noncompliance|1|||
129003284|NCT00415532|464303642|FG001|Safety Follow Up Period|Noncompliance|0|||
129003285|NCT00415532|464303641|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
129003286|NCT00415532|464303642|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
129003287|NCT01698320|464303643|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
129003288|NCT01698320|464303644|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
129003289|NCT01698320|464303645|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
129003290|NCT01698320|464303643|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
129003291|NCT01698320|464303644|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
129003292|NCT01698320|464303645|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
129003293|NCT01698320|464303643|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
129003294|NCT01698320|464303644|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
129003295|NCT01698320|464303645|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
129003296|NCT01698320|464303643|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
129003297|NCT01698320|464303644|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
129003298|NCT01698320|464303645|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
129003299|NCT01698320|464303643|FG000|12-Week Double-Blind Period|Adverse Event|0|||
129003300|NCT01698320|464303644|FG001|12-Week Double-Blind Period|Adverse Event|1|||
129003301|NCT01698320|464303645|FG002|12-Week Double-Blind Period|Adverse Event|1|||
129003302|NCT01698320|464303643|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
129003303|NCT01698320|464303644|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
129003304|NCT01698320|464303645|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
129003305|NCT01698320|464303643|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
129003306|NCT01698320|464303644|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
129003307|NCT01698320|464303645|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
129003308|NCT01698320|464303643|FG000|12-Week Double-Blind Period|Pregnancy|0|||
129003309|NCT01698320|464303644|FG001|12-Week Double-Blind Period|Pregnancy|1|||
129003310|NCT01698320|464303645|FG002|12-Week Double-Blind Period|Pregnancy|1|||
129003311|NCT01698320|464303643|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
128668806|NCT01708902|463085179|FG004|Overall Study|Lack of Efficacy|0|||
128668807|NCT01708902|463085180|FG005|Overall Study|Lack of Efficacy|1|||
128668808|NCT01708902|463085181|FG006|Overall Study|Lack of Efficacy|0|||
128668809|NCT01708902|463085175|FG000|Overall Study|Non compliance with protocol|0|||
128668810|NCT01708902|463085176|FG001|Overall Study|Non compliance with protocol|2|||
128668811|NCT01708902|463085177|FG002|Overall Study|Non compliance with protocol|1|||
129003312|NCT01698320|464303644|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
129003313|NCT01698320|464303645|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
129003314|NCT01698320|464303643|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
129003315|NCT01698320|464303644|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
129003316|NCT01698320|464303645|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
129003317|NCT01698320|464303643|FG000|40-Week Open-Label Period|Adverse Event|0|||
129003318|NCT01698320|464303644|FG001|40-Week Open-Label Period|Adverse Event|3|||
129003319|NCT01698320|464303645|FG002|40-Week Open-Label Period|Adverse Event|2|||
129003320|NCT01698320|464303643|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
129003321|NCT01698320|464303644|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
129003322|NCT01698320|464303645|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
128668812|NCT01708902|463085178|FG003|Overall Study|Non compliance with protocol|3|||
128668813|NCT01708902|463085179|FG004|Overall Study|Non compliance with protocol|0|||
128668814|NCT01708902|463085180|FG005|Overall Study|Non compliance with protocol|0|||
128668815|NCT01708902|463085181|FG006|Overall Study|Non compliance with protocol|0|||
128668816|NCT01708902|463085175|FG000|Overall Study|Lost to Follow-up|2|||
128668817|NCT01708902|463085176|FG001|Overall Study|Lost to Follow-up|1|||
128668818|NCT01708902|463085177|FG002|Overall Study|Lost to Follow-up|2|||
128668819|NCT01708902|463085178|FG003|Overall Study|Lost to Follow-up|2|||
128668820|NCT01708902|463085179|FG004|Overall Study|Lost to Follow-up|0|||
128668821|NCT01708902|463085180|FG005|Overall Study|Lost to Follow-up|0|||
128668822|NCT01708902|463085181|FG006|Overall Study|Lost to Follow-up|1|||
128668823|NCT01708902|463085175|FG000|Overall Study|Refused to continue trial medication|8|||
128668824|NCT01708902|463085176|FG001|Overall Study|Refused to continue trial medication|0|||
129003323|NCT01698320|464303643|FG000|40-Week Open-Label Period|Pregnancy|0|||
129003324|NCT01698320|464303644|FG001|40-Week Open-Label Period|Pregnancy|2|||
128668825|NCT01708902|463085177|FG002|Overall Study|Refused to continue trial medication|4|||
128668826|NCT01708902|463085178|FG003|Overall Study|Refused to continue trial medication|2|||
128668827|NCT01708902|463085179|FG004|Overall Study|Refused to continue trial medication|8|||
128668828|NCT01708902|463085180|FG005|Overall Study|Refused to continue trial medication|1|||
128668829|NCT01708902|463085181|FG006|Overall Study|Refused to continue trial medication|1|||
128668830|NCT01708902|463085175|FG000|Overall Study|Other Reason|1|||
128668831|NCT01708902|463085176|FG001|Overall Study|Other Reason|0|||
128668832|NCT01708902|463085177|FG002|Overall Study|Other Reason|1|||
128668833|NCT01708902|463085178|FG003|Overall Study|Other Reason|1|||
128668834|NCT01708902|463085179|FG004|Overall Study|Other Reason|1|||
128668835|NCT01708902|463085180|FG005|Overall Study|Other Reason|2|||
128668836|NCT01708902|463085181|FG006|Overall Study|Other Reason|0|||
128668837|NCT02152956|463085182|FG000|Overall Study|Adverse Event|0|||
128668838|NCT02152956|463085183|FG001|Overall Study|Adverse Event|0|||
128668839|NCT02152956|463085184|FG002|Overall Study|Adverse Event|0|||
128668840|NCT02152956|463085185|FG003|Overall Study|Adverse Event|0|||
128668841|NCT02152956|463085186|FG004|Overall Study|Adverse Event|0|||
128668842|NCT02152956|463085187|FG005|Overall Study|Adverse Event|0|||
128668843|NCT02152956|463085188|FG006|Overall Study|Adverse Event|0|||
128668844|NCT02152956|463085189|FG007|Overall Study|Adverse Event|0|||
128668845|NCT02152956|463085190|FG008|Overall Study|Adverse Event|0|||
128668846|NCT02152956|463085191|FG009|Overall Study|Adverse Event|0|||
128668847|NCT02152956|463085192|FG010|Overall Study|Adverse Event|0|||
128668848|NCT02152956|463085193|FG011|Overall Study|Adverse Event|4|||
128668849|NCT02152956|463085194|FG012|Overall Study|Adverse Event|0|||
128668850|NCT02152956|463085182|FG000|Overall Study|Death|0|||
128668851|NCT02152956|463085183|FG001|Overall Study|Death|3|||
128668852|NCT02152956|463085184|FG002|Overall Study|Death|3|||
128668853|NCT02152956|463085185|FG003|Overall Study|Death|4|||
128668854|NCT02152956|463085186|FG004|Overall Study|Death|1|||
128668855|NCT02152956|463085187|FG005|Overall Study|Death|2|||
128668856|NCT02152956|463085188|FG006|Overall Study|Death|6|||
128668857|NCT02152956|463085189|FG007|Overall Study|Death|6|||
128668858|NCT02152956|463085190|FG008|Overall Study|Death|4|||
128668859|NCT02152956|463085191|FG009|Overall Study|Death|5|||
128668860|NCT02152956|463085192|FG010|Overall Study|Death|3|||
129003325|NCT01698320|464303645|FG002|40-Week Open-Label Period|Pregnancy|1|||
129003326|NCT01698320|464303643|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
129003327|NCT01698320|464303644|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
129003328|NCT01698320|464303645|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
129003329|NCT01698320|464303643|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
129003330|NCT01698320|464303644|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
128668861|NCT02152956|463085193|FG011|Overall Study|Death|143|||
128668862|NCT02152956|463085194|FG012|Overall Study|Death|12|||
128668863|NCT02152956|463085182|FG000|Overall Study|Lost to Follow-up|0|||
128668864|NCT02152956|463085183|FG001|Overall Study|Lost to Follow-up|1|||
128668865|NCT02152956|463085184|FG002|Overall Study|Lost to Follow-up|0|||
128668866|NCT02152956|463085185|FG003|Overall Study|Lost to Follow-up|0|||
129003331|NCT01698320|464303645|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
128668867|NCT02152956|463085186|FG004|Overall Study|Lost to Follow-up|0|||
128668868|NCT02152956|463085187|FG005|Overall Study|Lost to Follow-up|0|||
128668869|NCT02152956|463085188|FG006|Overall Study|Lost to Follow-up|0|||
128668870|NCT02152956|463085189|FG007|Overall Study|Lost to Follow-up|0|||
128668871|NCT02152956|463085190|FG008|Overall Study|Lost to Follow-up|0|||
128668872|NCT02152956|463085191|FG009|Overall Study|Lost to Follow-up|0|||
128668873|NCT02152956|463085192|FG010|Overall Study|Lost to Follow-up|0|||
128668874|NCT02152956|463085193|FG011|Overall Study|Lost to Follow-up|3|||
128668875|NCT02152956|463085194|FG012|Overall Study|Lost to Follow-up|0|||
128668876|NCT02152956|463085182|FG000|Overall Study|Withdrawal by Subject|1|||
128668877|NCT02152956|463085183|FG001|Overall Study|Withdrawal by Subject|0|||
128668878|NCT02152956|463085184|FG002|Overall Study|Withdrawal by Subject|1|||
128668879|NCT02152956|463085185|FG003|Overall Study|Withdrawal by Subject|0|||
128668880|NCT02152956|463085186|FG004|Overall Study|Withdrawal by Subject|2|||
128668881|NCT02152956|463085187|FG005|Overall Study|Withdrawal by Subject|2|||
129003332|NCT01952574|464303646|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
129003333|NCT01952574|464303647|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
129003334|NCT01952574|464303648|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
129003335|NCT01952574|464303649|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
129003336|NCT01952574|464303650|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129003337|NCT01952574|464303651|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129003338|NCT01952574|464303652|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129003339|NCT01952574|464303646|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
129003340|NCT01952574|464303647|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
129003341|NCT01952574|464303648|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
129003342|NCT01952574|464303649|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
129003343|NCT01952574|464303650|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
129003344|NCT01952574|464303651|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
129003345|NCT01952574|464303652|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
129003346|NCT01952574|464303646|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
129003347|NCT01952574|464303647|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
129003348|NCT01952574|464303648|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
129003349|NCT01952574|464303649|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
129003350|NCT01952574|464303650|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
129003351|NCT01952574|464303651|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
129003352|NCT01952574|464303652|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
129003353|NCT01952574|464303646|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
129003354|NCT01952574|464303647|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
129003355|NCT01952574|464303648|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
129003356|NCT01952574|464303649|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
129003357|NCT01952574|464303650|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
129003358|NCT01952574|464303651|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
129003359|NCT01952574|464303652|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
129003360|NCT01952574|464303646|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
129003361|NCT01952574|464303647|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
129003362|NCT01952574|464303648|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
129003363|NCT01952574|464303649|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
129003364|NCT01952574|464303650|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
129003365|NCT01952574|464303651|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
129003366|NCT01952574|464303652|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
129003367|NCT01952574|464303646|FG000|Open-label Treatment Phase|Missing|0|||
129003368|NCT01952574|464303647|FG001|Open-label Treatment Phase|Missing|0|||
129003369|NCT01952574|464303648|FG002|Open-label Treatment Phase|Missing|0|||
129003370|NCT01952574|464303649|FG003|Open-label Treatment Phase|Missing|0|||
129003371|NCT01952574|464303650|FG004|Open-label Treatment Phase|Missing|4|||
129003372|NCT01952574|464303651|FG005|Open-label Treatment Phase|Missing|0|||
129003373|NCT01952574|464303652|FG006|Open-label Treatment Phase|Missing|0|||
129003374|NCT01952574|464303646|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
129003375|NCT01952574|464303647|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
129003376|NCT01952574|464303648|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
129003377|NCT01952574|464303649|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
129003378|NCT01952574|464303650|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
129003379|NCT01952574|464303651|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
129003380|NCT01952574|464303652|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
129003381|NCT01952574|464303646|FG000|Open-label Treatment Phase|Death|0|||
129003382|NCT01952574|464303647|FG001|Open-label Treatment Phase|Death|0|||
129003383|NCT01952574|464303648|FG002|Open-label Treatment Phase|Death|0|||
129003384|NCT01952574|464303649|FG003|Open-label Treatment Phase|Death|0|||
129003385|NCT01952574|464303650|FG004|Open-label Treatment Phase|Death|1|||
129003386|NCT01952574|464303651|FG005|Open-label Treatment Phase|Death|0|||
129003387|NCT01952574|464303652|FG006|Open-label Treatment Phase|Death|0|||
129003388|NCT01952574|464303646|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129003389|NCT01952574|464303647|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129003390|NCT01952574|464303648|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129003391|NCT01952574|464303649|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129003392|NCT01952574|464303650|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129003393|NCT01952574|464303651|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
129003394|NCT01952574|464303652|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129003395|NCT01952574|464303646|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
129003396|NCT01952574|464303647|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
129003397|NCT01952574|464303648|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
129003398|NCT01952574|464303649|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
129003399|NCT01952574|464303650|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
129003400|NCT01952574|464303651|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
129003401|NCT01952574|464303652|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
129003402|NCT00770991|464303662|FG000|Overall Study|Physician Decision|2|||
129003403|NCT00770991|464303663|FG001|Overall Study|Physician Decision|0|||
129003404|NCT00770991|464303662|FG000|Overall Study|Withdrawal by Subject|1|||
129003405|NCT00770991|464303663|FG001|Overall Study|Withdrawal by Subject|0|||
129003406|NCT00770991|464303662|FG000|Overall Study|Adverse Event|1|||
129003407|NCT00770991|464303663|FG001|Overall Study|Adverse Event|5|||
129003408|NCT00770991|464303662|FG000|Overall Study|Pregnancy|1|||
128668882|NCT02152956|463085188|FG006|Overall Study|Withdrawal by Subject|0|||
128668883|NCT02152956|463085189|FG007|Overall Study|Withdrawal by Subject|0|||
128668884|NCT02152956|463085190|FG008|Overall Study|Withdrawal by Subject|1|||
128668885|NCT02152956|463085191|FG009|Overall Study|Withdrawal by Subject|0|||
128668886|NCT02152956|463085192|FG010|Overall Study|Withdrawal by Subject|0|||
128668887|NCT02152956|463085193|FG011|Overall Study|Withdrawal by Subject|4|||
128668888|NCT02152956|463085194|FG012|Overall Study|Withdrawal by Subject|0|||
128668889|NCT02152956|463085182|FG000|Overall Study|Physician Decision|0|||
128668890|NCT02152956|463085183|FG001|Overall Study|Physician Decision|0|||
128668891|NCT02152956|463085184|FG002|Overall Study|Physician Decision|0|||
128668892|NCT02152956|463085185|FG003|Overall Study|Physician Decision|0|||
128668893|NCT02152956|463085186|FG004|Overall Study|Physician Decision|0|||
128668894|NCT02152956|463085187|FG005|Overall Study|Physician Decision|0|||
128668895|NCT02152956|463085188|FG006|Overall Study|Physician Decision|0|||
128668896|NCT02152956|463085189|FG007|Overall Study|Physician Decision|0|||
128668897|NCT02152956|463085190|FG008|Overall Study|Physician Decision|0|||
128668898|NCT02152956|463085191|FG009|Overall Study|Physician Decision|0|||
128668899|NCT02152956|463085192|FG010|Overall Study|Physician Decision|0|||
128668900|NCT02152956|463085193|FG011|Overall Study|Physician Decision|1|||
128668901|NCT02152956|463085194|FG012|Overall Study|Physician Decision|0|||
128668902|NCT02152956|463085182|FG000|Overall Study|Study terminated by sponsor|0|||
128668903|NCT02152956|463085183|FG001|Overall Study|Study terminated by sponsor|0|||
128668904|NCT02152956|463085184|FG002|Overall Study|Study terminated by sponsor|0|||
128668905|NCT02152956|463085185|FG003|Overall Study|Study terminated by sponsor|0|||
128668906|NCT02152956|463085186|FG004|Overall Study|Study terminated by sponsor|0|||
128668907|NCT02152956|463085187|FG005|Overall Study|Study terminated by sponsor|0|||
128668908|NCT02152956|463085188|FG006|Overall Study|Study terminated by sponsor|0|||
128668909|NCT02152956|463085189|FG007|Overall Study|Study terminated by sponsor|0|||
128668910|NCT02152956|463085190|FG008|Overall Study|Study terminated by sponsor|0|||
128668911|NCT02152956|463085191|FG009|Overall Study|Study terminated by sponsor|0|||
128668912|NCT02152956|463085192|FG010|Overall Study|Study terminated by sponsor|0|||
128668913|NCT02152956|463085193|FG011|Overall Study|Study terminated by sponsor|29|||
128668914|NCT02152956|463085194|FG012|Overall Study|Study terminated by sponsor|0|||
128668915|NCT02152956|463085182|FG000|Overall Study|progressive disease|0|||
128668916|NCT02152956|463085183|FG001|Overall Study|progressive disease|0|||
128668917|NCT02152956|463085184|FG002|Overall Study|progressive disease|0|||
129003409|NCT00770991|464303663|FG001|Overall Study|Pregnancy|0|||
128668918|NCT02152956|463085185|FG003|Overall Study|progressive disease|0|||
128668919|NCT02152956|463085186|FG004|Overall Study|progressive disease|0|||
128668920|NCT02152956|463085187|FG005|Overall Study|progressive disease|0|||
128668921|NCT02152956|463085188|FG006|Overall Study|progressive disease|0|||
128668922|NCT02152956|463085189|FG007|Overall Study|progressive disease|0|||
128668923|NCT02152956|463085190|FG008|Overall Study|progressive disease|1|||
128668924|NCT02152956|463085191|FG009|Overall Study|progressive disease|0|||
128668925|NCT02152956|463085192|FG010|Overall Study|progressive disease|0|||
128668926|NCT02152956|463085193|FG011|Overall Study|progressive disease|1|||
128668927|NCT02152956|463085194|FG012|Overall Study|progressive disease|0|||
128668928|NCT02445794|463085195|FG000|Overall Study|Adverse Event|0|||
128668929|NCT02445794|463085196|FG001|Overall Study|Adverse Event|0|||
128668930|NCT02445794|463085197|FG002|Overall Study|Adverse Event|2|||
128668931|NCT02445794|463085198|FG003|Overall Study|Adverse Event|0|||
128668932|NCT01064947|463085200|FG000|Overall Study|negative culture|41|||
128668933|NCT00798759|463087209|FG000|Overall Study|Adverse Event|3|||
129003410|NCT02040766|464303665|FG000|Overall Study|Adverse Event|1|||
128668934|NCT00798759|463087210|FG001|Overall Study|Adverse Event|3|||
128668935|NCT00798759|463087209|FG000|Overall Study|Lost to Follow-up|1|||
128668936|NCT00798759|463087210|FG001|Overall Study|Lost to Follow-up|1|||
128668937|NCT00798759|463087209|FG000|Overall Study|Protocol Violation|4|||
128668938|NCT00798759|463087210|FG001|Overall Study|Protocol Violation|8|||
128668939|NCT00798759|463087209|FG000|Overall Study|Other|0|||
128668940|NCT00798759|463087210|FG001|Overall Study|Other|1|||
128668941|NCT00724711|463087211|FG000|Overall Study|Adverse Event|7|||
128668942|NCT00724711|463087212|FG001|Overall Study|Adverse Event|3|||
128668943|NCT00724711|463087211|FG000|Overall Study|Pregnancy|0|||
128668944|NCT00724711|463087212|FG001|Overall Study|Pregnancy|1|||
128668945|NCT00724711|463087211|FG000|Overall Study|Lack of Efficacy|0|||
128668946|NCT00724711|463087212|FG001|Overall Study|Lack of Efficacy|1|||
128668947|NCT00724711|463087211|FG000|Overall Study|Physician Decision|0|||
128668948|NCT00724711|463087212|FG001|Overall Study|Physician Decision|3|||
128668949|NCT00724711|463087211|FG000|Overall Study|Withdrawal by Subject|5|||
129003411|NCT02040766|464303666|FG001|Overall Study|Adverse Event|1|||
128668950|NCT00724711|463087212|FG001|Overall Study|Withdrawal by Subject|4|||
128668951|NCT00724711|463087211|FG000|Overall Study|Lost to Follow-up|4|||
129003412|NCT02040766|464303667|FG002|Overall Study|Adverse Event|1|||
128668952|NCT00724711|463087212|FG001|Overall Study|Lost to Follow-up|5|||
128668953|NCT00724711|463087211|FG000|Overall Study|Protocol Violation|1|||
128668954|NCT00724711|463087212|FG001|Overall Study|Protocol Violation|0|||
128668955|NCT00375609|463087213|FG000|Overall Study|Did not receive treatment|1|||
128668956|NCT00375609|463087214|FG001|Overall Study|Did not receive treatment|0|||
128668957|NCT00375609|463087215|FG002|Overall Study|Did not receive treatment|0|||
128668958|NCT00375609|463087213|FG000|Overall Study|Adverse Event|0|||
129003413|NCT02040766|464303668|FG003|Overall Study|Adverse Event|0|||
129003414|NCT02040766|464303669|FG004|Overall Study|Adverse Event|2|||
129003415|NCT02040766|464303665|FG000|Overall Study|Withdrawal by Subject|4|||
129003416|NCT02040766|464303666|FG001|Overall Study|Withdrawal by Subject|3|||
129003417|NCT02040766|464303667|FG002|Overall Study|Withdrawal by Subject|2|||
129003418|NCT02040766|464303668|FG003|Overall Study|Withdrawal by Subject|3|||
129003419|NCT02040766|464303669|FG004|Overall Study|Withdrawal by Subject|2|||
129003420|NCT02040766|464303665|FG000|Overall Study|Non-compliance|0|||
129003421|NCT02040766|464303666|FG001|Overall Study|Non-compliance|1|||
129003422|NCT02040766|464303667|FG002|Overall Study|Non-compliance|0|||
129003423|NCT02040766|464303668|FG003|Overall Study|Non-compliance|0|||
129003424|NCT02040766|464303669|FG004|Overall Study|Non-compliance|0|||
129003425|NCT02040766|464303665|FG000|Overall Study|Protocol Violation|2|||
129003426|NCT02040766|464303666|FG001|Overall Study|Protocol Violation|1|||
129003427|NCT02040766|464303667|FG002|Overall Study|Protocol Violation|2|||
129003428|NCT02040766|464303668|FG003|Overall Study|Protocol Violation|3|||
129003429|NCT02040766|464303669|FG004|Overall Study|Protocol Violation|0|||
129003430|NCT02040766|464303665|FG000|Overall Study|Lost to Follow-up|4|||
129003431|NCT02040766|464303666|FG001|Overall Study|Lost to Follow-up|1|||
129003432|NCT02040766|464303667|FG002|Overall Study|Lost to Follow-up|3|||
129003433|NCT02040766|464303668|FG003|Overall Study|Lost to Follow-up|1|||
129003434|NCT02040766|464303669|FG004|Overall Study|Lost to Follow-up|4|||
129003435|NCT02040766|464303665|FG000|Overall Study|Not reported|1|||
129003436|NCT02040766|464303666|FG001|Overall Study|Not reported|0|||
129003437|NCT02040766|464303667|FG002|Overall Study|Not reported|0|||
129003438|NCT02040766|464303668|FG003|Overall Study|Not reported|0|||
129003439|NCT02040766|464303669|FG004|Overall Study|Not reported|0|||
129003440|NCT02040766|464303665|FG000|Overall Study|Lack of Efficacy|6|||
129003441|NCT02040766|464303666|FG001|Overall Study|Lack of Efficacy|3|||
129003442|NCT02040766|464303667|FG002|Overall Study|Lack of Efficacy|4|||
129003443|NCT02040766|464303668|FG003|Overall Study|Lack of Efficacy|6|||
129003444|NCT02040766|464303669|FG004|Overall Study|Lack of Efficacy|5|||
129003445|NCT02974114|464303670|FG000|Overall Study|Other (Not specified)|0|||
129003446|NCT02974114|464303671|FG001|Overall Study|Other (Not specified)|1|||
129003447|NCT02974114|464303672|FG002|Overall Study|Other (Not specified)|2|||
129003448|NCT01580020|464303673|FG000|Overall Study|Lack of Efficacy|0|||
129003449|NCT01580020|464303674|FG001|Overall Study|Lack of Efficacy|5|||
129003450|NCT01580020|464303675|FG002|Overall Study|Lack of Efficacy|0|||
129003451|NCT01580020|464303676|FG003|Overall Study|Lack of Efficacy|1|||
129003452|NCT01580020|464303673|FG000|Overall Study|Withdrawal by Subject|0|||
129003453|NCT01580020|464303674|FG001|Overall Study|Withdrawal by Subject|1|||
129003454|NCT01580020|464303675|FG002|Overall Study|Withdrawal by Subject|1|||
129003455|NCT01580020|464303676|FG003|Overall Study|Withdrawal by Subject|0|||
129003456|NCT01580020|464303673|FG000|Overall Study|Adverse Event|1|||
129003457|NCT01580020|464303674|FG001|Overall Study|Adverse Event|1|||
129003458|NCT01580020|464303675|FG002|Overall Study|Adverse Event|1|||
129003459|NCT01580020|464303676|FG003|Overall Study|Adverse Event|1|||
129003460|NCT01580020|464303673|FG000|Overall Study|Administrative Problems|0|||
129003461|NCT01580020|464303674|FG001|Overall Study|Administrative Problems|0|||
129003462|NCT01580020|464303675|FG002|Overall Study|Administrative Problems|1|||
128668959|NCT00375609|463087214|FG001|Overall Study|Adverse Event|3|||
128763107|NCT03145766|463422737|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
129003463|NCT01580020|464303676|FG003|Overall Study|Administrative Problems|0|||
129003464|NCT01580020|464303673|FG000|Overall Study|Lost to Follow-up|0|||
129003465|NCT01580020|464303674|FG001|Overall Study|Lost to Follow-up|0|||
129003466|NCT01580020|464303675|FG002|Overall Study|Lost to Follow-up|1|||
129003467|NCT01580020|464303676|FG003|Overall Study|Lost to Follow-up|0|||
129003468|NCT01724359|464303677|FG000|Overall Study|Adverse Event|10|||
129003469|NCT01724359|464303677|FG000|Overall Study|Death|1|||
129003470|NCT01724359|464303677|FG000|Overall Study|Other|20|||
129003471|NCT01335464|464303684|FG000|Overall Study|Adverse Event|15|||
129003472|NCT01335464|464303685|FG001|Overall Study|Adverse Event|25|||
129003473|NCT01335464|464303684|FG000|Overall Study|Non compliant with protocol|2|||
129003474|NCT01335464|464303685|FG001|Overall Study|Non compliant with protocol|0|||
129003475|NCT01335464|464303684|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
129003476|NCT01335464|464303685|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
128668960|NCT00375609|463087215|FG002|Overall Study|Adverse Event|0|||
129003477|NCT01335464|464303684|FG000|Overall Study|Not treated|2|||
129003478|NCT01335464|464303685|FG001|Overall Study|Not treated|0|||
129003479|NCT01335464|464303684|FG000|Overall Study|Reason other than those stated above|1|||
129003480|NCT01335464|464303685|FG001|Overall Study|Reason other than those stated above|1|||
128668961|NCT00375609|463087213|FG000|Overall Study|Lost to Follow-up|1|||
129003481|NCT00446654|464303686|FG000|Overall Study|Withdrawal by Subject|1|||
129003482|NCT00446654|464303687|FG001|Overall Study|Withdrawal by Subject|0|||
129003483|NCT00446654|464303686|FG000|Overall Study|Adverse Event|1|||
129003484|NCT00446654|464303687|FG001|Overall Study|Adverse Event|0|||
129003485|NCT00593333|464303692|FG000|Overall Study|Lost to Follow-up|10|||
129003486|NCT00593333|464303693|FG001|Overall Study|Lost to Follow-up|11|||
129003487|NCT01752920|464303694|FG000|Overall Study|Adverse Event|1|||
129003488|NCT01752920|464303695|FG001|Overall Study|Adverse Event|0|||
129003489|NCT01752920|464303696|FG002|Overall Study|Adverse Event|5|||
129003490|NCT01752920|464303697|FG003|Overall Study|Adverse Event|10|||
129003491|NCT01752920|464303694|FG000|Overall Study|Clinical Disease Progression|6|||
129003492|NCT01752920|464303695|FG001|Overall Study|Clinical Disease Progression|4|||
129003493|NCT01752920|464303696|FG002|Overall Study|Clinical Disease Progression|1|||
129003494|NCT01752920|464303697|FG003|Overall Study|Clinical Disease Progression|13|||
129003495|NCT01752920|464303694|FG000|Overall Study|Physician Decision|1|||
129003496|NCT01752920|464303695|FG001|Overall Study|Physician Decision|0|||
129003497|NCT01752920|464303696|FG002|Overall Study|Physician Decision|0|||
129003498|NCT01752920|464303697|FG003|Overall Study|Physician Decision|3|||
129003499|NCT01752920|464303694|FG000|Overall Study|Radiographic Disease Progression|20|||
129003500|NCT01752920|464303695|FG001|Overall Study|Radiographic Disease Progression|7|||
129003501|NCT01752920|464303696|FG002|Overall Study|Radiographic Disease Progression|12|||
129003502|NCT01752920|464303697|FG003|Overall Study|Radiographic Disease Progression|29|||
129003503|NCT01752920|464303694|FG000|Overall Study|Study Terminated by Sponsor|0|||
129003504|NCT01752920|464303695|FG001|Overall Study|Study Terminated by Sponsor|0|||
129003505|NCT01752920|464303696|FG002|Overall Study|Study Terminated by Sponsor|0|||
129003506|NCT01752920|464303697|FG003|Overall Study|Study Terminated by Sponsor|1|||
129003507|NCT01752920|464303694|FG000|Overall Study|Withdrawal by Subject|0|||
129003508|NCT01752920|464303695|FG001|Overall Study|Withdrawal by Subject|1|||
129003509|NCT01752920|464303696|FG002|Overall Study|Withdrawal by Subject|0|||
129003510|NCT01752920|464303697|FG003|Overall Study|Withdrawal by Subject|1|||
129003511|NCT01752920|464303694|FG000|Overall Study|Lack of clinical benefit|1|||
129003512|NCT01752920|464303695|FG001|Overall Study|Lack of clinical benefit|1|||
129003513|NCT01752920|464303696|FG002|Overall Study|Lack of clinical benefit|1|||
129003514|NCT01752920|464303697|FG003|Overall Study|Lack of clinical benefit|1|||
129003515|NCT01186978|464303698|FG000|Overall Study|Withdrawal by Subject|1|||
129003516|NCT01227668|464303699|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
129003517|NCT01227668|464303700|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
129003518|NCT01227668|464303699|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
129003519|NCT01227668|464303700|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
129003520|NCT01227668|464303699|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
129003521|NCT01227668|464303700|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
129003522|NCT01227668|464303699|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
129003523|NCT01227668|464303700|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
129003524|NCT01227668|464303699|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
129003525|NCT01227668|464303700|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
129003526|NCT01227668|464303699|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
129003527|NCT01227668|464303700|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
129003528|NCT01227668|464303699|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
129003529|NCT01227668|464303700|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
129003530|NCT01227668|464303699|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
129003531|NCT01227668|464303700|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
129003532|NCT01227668|464303699|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
129003533|NCT01227668|464303700|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
129003534|NCT01227668|464303699|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
129003535|NCT01227668|464303700|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
129003536|NCT01227668|464303699|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
129003537|NCT01227668|464303700|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
129003538|NCT01227668|464303699|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
129003539|NCT01227668|464303700|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
129003540|NCT01709383|464303706|FG000|Overall Study|Lost to Follow-up|1|||
129003541|NCT01709383|464303707|FG001|Overall Study|Lost to Follow-up|0|||
129003542|NCT03264066|464303708|FG000|Overall Study|Adverse Event|1|||
129003543|NCT03264066|464303709|FG001|Overall Study|Adverse Event|1|||
129003544|NCT03264066|464303710|FG002|Overall Study|Adverse Event|0|||
129003545|NCT03264066|464303711|FG003|Overall Study|Adverse Event|0|||
129003546|NCT03264066|464303712|FG004|Overall Study|Adverse Event|0|||
129003547|NCT03264066|464303713|FG005|Overall Study|Adverse Event|0|||
129003548|NCT03264066|464303708|FG000|Overall Study|Death|12|||
129003549|NCT03264066|464303709|FG001|Overall Study|Death|12|||
129003550|NCT03264066|464303710|FG002|Overall Study|Death|8|||
129003551|NCT03264066|464303711|FG003|Overall Study|Death|10|||
129003552|NCT03264066|464303712|FG004|Overall Study|Death|6|||
129003553|NCT03264066|464303713|FG005|Overall Study|Death|1|||
129003554|NCT03264066|464303708|FG000|Overall Study|Lost to Follow-up|1|||
128668962|NCT00375609|463087214|FG001|Overall Study|Lost to Follow-up|0|||
128668963|NCT00375609|463087215|FG002|Overall Study|Lost to Follow-up|0|||
128668964|NCT00375609|463087213|FG000|Overall Study|Physician Decision|0|||
128668965|NCT00375609|463087214|FG001|Overall Study|Physician Decision|0|||
128668966|NCT00375609|463087215|FG002|Overall Study|Physician Decision|1|||
128668967|NCT00375609|463087213|FG000|Overall Study|Withdrawal by Subject|1|||
128668968|NCT00375609|463087214|FG001|Overall Study|Withdrawal by Subject|4|||
128668969|NCT00375609|463087215|FG002|Overall Study|Withdrawal by Subject|0|||
128668970|NCT00375609|463087213|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
128668971|NCT00375609|463087214|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
128668972|NCT00375609|463087215|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
128668973|NCT02338882|463087218|FG000|Overall Study|Death|1|||
128668974|NCT02338882|463087219|FG001|Overall Study|Death|0|||
128668975|NCT02338882|463087218|FG000|Overall Study|Lost to Follow-up|6|||
128668976|NCT02338882|463087219|FG001|Overall Study|Lost to Follow-up|3|||
128668977|NCT04838977|463087222|FG000|Overall Study|Lost to Follow-up|2|||
128668978|NCT04838977|463087223|FG001|Overall Study|Lost to Follow-up|3|||
128668979|NCT04838977|463087222|FG000|Overall Study|Withdrawal by Subject|1|||
128668980|NCT04838977|463087223|FG001|Overall Study|Withdrawal by Subject|1|||
128668981|NCT02891070|463087228|FG000|Overall Study|Adverse Event|1|||
128668982|NCT02891070|463087229|FG001|Overall Study|Adverse Event|0|||
128668983|NCT02891070|463087228|FG000|Overall Study|Physician Decision|0|||
128668984|NCT02891070|463087229|FG001|Overall Study|Physician Decision|1|||
128668985|NCT02891070|463087228|FG000|Overall Study|Lost to Follow-up|4|||
128668986|NCT02891070|463087229|FG001|Overall Study|Lost to Follow-up|4|||
128668987|NCT02891070|463087228|FG000|Overall Study|Other|1|||
128668988|NCT02891070|463087229|FG001|Overall Study|Other|0|||
128668989|NCT02891070|463087228|FG000|Overall Study|Protocol Violation|0|||
128668990|NCT02891070|463087229|FG001|Overall Study|Protocol Violation|1|||
128668991|NCT02891070|463087228|FG000|Overall Study|Withdrawal by Subject|1|||
128668992|NCT02891070|463087229|FG001|Overall Study|Withdrawal by Subject|2|||
128668993|NCT02891070|463087228|FG000|Overall Study|Death|3|||
128668994|NCT02891070|463087229|FG001|Overall Study|Death|0|||
128668995|NCT02934503|463087230|FG000|Overall Study|progression of disease|3|||
128668996|NCT02934503|463087230|FG000|Overall Study|Withdrawal by Subject|1|||
128668997|NCT00724867|463087231|FG000|Overall Study|Adverse Event|25|||
128668998|NCT00724867|463087231|FG000|Overall Study|Lack of Efficacy|14|||
128668999|NCT00724867|463087231|FG000|Overall Study|Lost to Follow-up|12|||
128669000|NCT00724867|463087231|FG000|Overall Study|Non-compliance with study drug|6|||
128669001|NCT00724867|463087231|FG000|Overall Study|Physician Decision|17|||
128669002|NCT00724867|463087231|FG000|Overall Study|Protocol Violation|1|||
128669003|NCT00724867|463087231|FG000|Overall Study|Withdrawal by Subject|31|||
128669004|NCT00724867|463087231|FG000|Overall Study|Sponsor decision to end study|14|||
128669005|NCT00724867|463087231|FG000|Overall Study|Subject incarcerated|1|||
128669006|NCT00724867|463087231|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
128669007|NCT00724867|463087231|FG000|Overall Study|Subject moved out of state|1|||
128669008|NCT00724867|463087231|FG000|Overall Study|Elected to exit due to site closure|2|||
128669009|NCT02881567|463087234|FG000|Overall Study|Adverse Event|1|||
128669010|NCT02881567|463087234|FG000|Overall Study|Lost to Follow-up|3|||
128669011|NCT02881567|463087234|FG000|Overall Study|Consent withdrawn|1|||
128669012|NCT02881567|463087234|FG000|Overall Study|Investigator decision|1|||
128669013|NCT02881567|463087234|FG000|Overall Study|Study terminated by sponsor|9|||
128669014|NCT02881567|463087234|FG000|Overall Study|Reason not Specified|3|||
128669015|NCT04335136|463087236|FG000|Overall Study|Death|8|||
128669016|NCT04335136|463087237|FG001|Overall Study|Death|4|||
128669017|NCT04335136|463087236|FG000|Overall Study|Lost to Follow-up|2|||
128669018|NCT04335136|463087237|FG001|Overall Study|Lost to Follow-up|0|||
128669019|NCT04335136|463087236|FG000|Overall Study|Protocol Violation|1|||
128669020|NCT04335136|463087237|FG001|Overall Study|Protocol Violation|0|||
128669021|NCT04335136|463087236|FG000|Overall Study|Withdrawal by Subject|1|||
128669022|NCT04335136|463087237|FG001|Overall Study|Withdrawal by Subject|1|||
128669023|NCT04335136|463087236|FG000|Overall Study|Health-threatening condition|0|||
128669024|NCT04335136|463087237|FG001|Overall Study|Health-threatening condition|1|||
128669025|NCT04335136|463087236|FG000|Overall Study|Adverse Event|0|||
128669026|NCT04335136|463087237|FG001|Overall Study|Adverse Event|1|||
128669027|NCT04335136|463087236|FG000|Overall Study|Erroneously randomized|2|||
128669028|NCT04335136|463087237|FG001|Overall Study|Erroneously randomized|0|||
128669029|NCT02423902|463087238|FG000|Overall Study|Disease progression|1|||
128669030|NCT02423902|463087239|FG001|Overall Study|Disease progression|4|||
128669031|NCT02350478|463087240|FG000|Overall Study|Lost to Follow-up|5|||
129215072|NCT02760498|465089437|FG001|Overall Study|Physician Decision|4|||
128669032|NCT02350478|463087241|FG001|Overall Study|Lost to Follow-up|1|||
128669033|NCT02722304|463087254|FG000|Overall Study|Study Terminated by Sponsor|1|||
128669034|NCT02722304|463087255|FG001|Overall Study|Study Terminated by Sponsor|0|||
128669035|NCT02722304|463087256|FG002|Overall Study|Study Terminated by Sponsor|2|||
128669036|NCT02722304|463087257|FG003|Overall Study|Study Terminated by Sponsor|1|||
128669037|NCT02722304|463087258|FG004|Overall Study|Study Terminated by Sponsor|1|||
128669038|NCT02722304|463087254|FG000|Overall Study|Other|0|||
129003555|NCT03264066|464303709|FG001|Overall Study|Lost to Follow-up|0|||
129003556|NCT03264066|464303710|FG002|Overall Study|Lost to Follow-up|0|||
129003557|NCT03264066|464303711|FG003|Overall Study|Lost to Follow-up|0|||
129003558|NCT03264066|464303712|FG004|Overall Study|Lost to Follow-up|0|||
129003559|NCT03264066|464303713|FG005|Overall Study|Lost to Follow-up|0|||
129003560|NCT03264066|464303708|FG000|Overall Study|Progressive Disease|0|||
129003561|NCT03264066|464303709|FG001|Overall Study|Progressive Disease|2|||
129003562|NCT03264066|464303710|FG002|Overall Study|Progressive Disease|1|||
129003563|NCT03264066|464303711|FG003|Overall Study|Progressive Disease|0|||
129003564|NCT03264066|464303712|FG004|Overall Study|Progressive Disease|0|||
129003565|NCT03264066|464303713|FG005|Overall Study|Progressive Disease|0|||
129003566|NCT03264066|464303708|FG000|Overall Study|Study Terminated by Sponsor|5|||
129003567|NCT03264066|464303709|FG001|Overall Study|Study Terminated by Sponsor|5|||
129003568|NCT03264066|464303710|FG002|Overall Study|Study Terminated by Sponsor|8|||
129003569|NCT03264066|464303711|FG003|Overall Study|Study Terminated by Sponsor|5|||
129003570|NCT03264066|464303712|FG004|Overall Study|Study Terminated by Sponsor|1|||
129003571|NCT03264066|464303713|FG005|Overall Study|Study Terminated by Sponsor|2|||
129003572|NCT03264066|464303708|FG000|Overall Study|Withdrawal by Subject|1|||
129003573|NCT03264066|464303709|FG001|Overall Study|Withdrawal by Subject|0|||
129003574|NCT03264066|464303710|FG002|Overall Study|Withdrawal by Subject|0|||
129003575|NCT03264066|464303711|FG003|Overall Study|Withdrawal by Subject|5|||
129003576|NCT03264066|464303712|FG004|Overall Study|Withdrawal by Subject|0|||
129003577|NCT03264066|464303713|FG005|Overall Study|Withdrawal by Subject|0|||
129003578|NCT01193517|464303719|FG000|Overall Study|Early Progression|1|||
129003579|NCT01193517|464303720|FG001|Overall Study|Early Progression|0|||
129003580|NCT01193517|464303721|FG002|Overall Study|Early Progression|0|||
129003581|NCT02115256|464303722|FG000|Overall Study|Withdrawal by Subject|0|||
129003582|NCT02115256|464303723|FG001|Overall Study|Withdrawal by Subject|1|||
129003583|NCT03775681|464303726|FG000|Overall Study|Physician Decision|3|||
129003584|NCT01512979|464303731|FG000|Overall Study|Adverse Event|2|||
129003585|NCT01512979|464303732|FG001|Overall Study|Adverse Event|2|||
129003586|NCT01512979|464303731|FG000|Overall Study|Protocol Violation|1|||
129003587|NCT01512979|464303732|FG001|Overall Study|Protocol Violation|4|||
129003588|NCT01512979|464303731|FG000|Overall Study|Lost to Follow-up|2|||
129003589|NCT01512979|464303732|FG001|Overall Study|Lost to Follow-up|5|||
129003590|NCT01512979|464303731|FG000|Overall Study|Withdrawal by Subject|1|||
129003591|NCT01512979|464303732|FG001|Overall Study|Withdrawal by Subject|2|||
129003592|NCT01512979|464303731|FG000|Overall Study|Reason other than stated above|13|||
129003593|NCT01512979|464303732|FG001|Overall Study|Reason other than stated above|9|||
129003594|NCT00526890|464303736|FG000|Overall Study|Adverse Event|2|||
129003595|NCT03529955|464303737|FG000|Overall Study|Adverse Event|1|||
129003596|NCT03529955|464303737|FG000|Overall Study|Lack of Efficacy|1|||
129003597|NCT00580983|464303738|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
129003598|NCT02468557|464305053|FG000|Overall Study|Adverse Event|1|||
129003599|NCT02468557|464305053|FG000|Overall Study|Death|1|||
129003600|NCT02468557|464305053|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
129003601|NCT02468557|464305053|FG000|Overall Study|All Enrolled but Never Dosed|4|||
129003602|NCT00982410|464305054|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
129003603|NCT00982410|464305055|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
129003604|NCT00982410|464305054|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
129003605|NCT00982410|464305055|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
129003606|NCT00982410|464305054|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
129003607|NCT00982410|464305055|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
129003608|NCT00982410|464305054|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
129003609|NCT00982410|464305055|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
129003610|NCT00982410|464305054|FG000|6-month Follow-up Assessment|participant no transportation|1|||
129003611|NCT00982410|464305055|FG001|6-month Follow-up Assessment|participant no transportation|0|||
129003612|NCT00982410|464305054|FG000|6-month Follow-up Assessment|incarceration|0|||
128669039|NCT02722304|463087255|FG001|Overall Study|Other|0|||
128669040|NCT02722304|463087256|FG002|Overall Study|Other|0|||
128878298|NCT01383499|463848426|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
128878299|NCT01383499|463848427|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129003613|NCT00982410|464305055|FG001|6-month Follow-up Assessment|incarceration|2|||
129003614|NCT00982410|464305054|FG000|6-month Follow-up Assessment|patent surgery|0|||
129003615|NCT00982410|464305055|FG001|6-month Follow-up Assessment|patent surgery|1|||
129003616|NCT00982410|464305054|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
129003617|NCT00982410|464305055|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
129003618|NCT00982410|464305054|FG000|12-month Follow-up Assessment|Death|0|||
129003619|NCT00982410|464305055|FG001|12-month Follow-up Assessment|Death|2|||
129003620|NCT00982410|464305054|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
129003621|NCT00982410|464305055|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
129003622|NCT00982410|464305054|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
128669041|NCT02722304|463087257|FG003|Overall Study|Other|1|||
129003623|NCT00982410|464305055|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
128669042|NCT02722304|463087258|FG004|Overall Study|Other|1|||
128669043|NCT02644109|463087259|FG000|Overall Study|Adverse Event|0|||
128669044|NCT02644109|463087260|FG001|Overall Study|Adverse Event|4|||
128669045|NCT01519869|463087261|FG000|Overall Study|Lost to Follow-up|1|||
128669046|NCT02511106|463087262|FG000|Overall Study|Lost to Follow-up|6|||
128669047|NCT02511106|463087263|FG001|Overall Study|Lost to Follow-up|4|||
128669048|NCT02511106|463087262|FG000|Overall Study|Withdrawal by Subject|24|||
128669049|NCT02511106|463087263|FG001|Overall Study|Withdrawal by Subject|21|||
128669050|NCT02511106|463087262|FG000|Overall Study|Death|42|||
128669051|NCT02511106|463087263|FG001|Overall Study|Death|82|||
128669052|NCT02511106|463087262|FG000|Overall Study|Ongoing study at data cut-off|3|||
128669053|NCT02511106|463087263|FG001|Overall Study|Ongoing study at data cut-off|2|||
128669054|NCT02511106|463087262|FG000|Overall Study|Without specified reason|3|||
128669055|NCT02511106|463087263|FG001|Overall Study|Without specified reason|0|||
128669056|NCT00344487|463087265|FG000|Overall Study|immunologic failure|1|||
128669057|NCT02695420|463087268|FG000|Overall Study|Death|0|||
128669058|NCT02695420|463087269|FG001|Overall Study|Death|1|||
128669059|NCT02695420|463087270|FG002|Overall Study|Death|0|||
128669060|NCT02695420|463087271|FG003|Overall Study|Death|0|||
128669061|NCT00916929|463087274|FG000|Overall Study|Lost to Follow-up|1|||
128669062|NCT00916929|463087275|FG001|Overall Study|Lost to Follow-up|3|||
128669063|NCT00916929|463087274|FG000|Overall Study|Death|5|||
128669064|NCT00916929|463087275|FG001|Overall Study|Death|10|||
128669065|NCT00916929|463087274|FG000|Overall Study|Withdrawal by Subject|1|||
128669066|NCT00916929|463087275|FG001|Overall Study|Withdrawal by Subject|5|||
128669067|NCT00916929|463087274|FG000|Overall Study|Left ventricular epicardial lead|1|||
128669068|NCT00916929|463087275|FG001|Overall Study|Left ventricular epicardial lead|2|||
128669069|NCT00916929|463087274|FG000|Overall Study|Transferred to hospice care|1|||
128669070|NCT00916929|463087275|FG001|Overall Study|Transferred to hospice care|1|||
128669071|NCT00916929|463087274|FG000|Overall Study|System explant|1|||
128669072|NCT00916929|463087275|FG001|Overall Study|System explant|0|||
128669073|NCT00916929|463087274|FG000|Overall Study|Moved to another state|0|||
128669074|NCT00916929|463087275|FG001|Overall Study|Moved to another state|1|||
128669075|NCT00916929|463087274|FG000|Overall Study|Device unable to process impedance data|0|||
128669076|NCT00916929|463087275|FG001|Overall Study|Device unable to process impedance data|7|||
128669077|NCT03037580|463087280|FG000|Overall Study|Withdrawal by Subject|3|||
128669078|NCT03037580|463087281|FG001|Overall Study|Withdrawal by Subject|0|||
128669079|NCT03037580|463087280|FG000|Overall Study|Adverse Event|1|||
128669080|NCT03037580|463087281|FG001|Overall Study|Adverse Event|0|||
128669081|NCT03037580|463087280|FG000|Overall Study|Study Terminated by Sponsor|12|||
128669082|NCT03037580|463087281|FG001|Overall Study|Study Terminated by Sponsor|15|||
128669083|NCT03037580|463087280|FG000|Overall Study|Death|0|||
128669084|NCT03037580|463087281|FG001|Overall Study|Death|1|||
128669085|NCT02442804|463087282|FG000|Overall Study|Withdrawal by Subject|0|||
128669086|NCT02442804|463087283|FG001|Overall Study|Withdrawal by Subject|1|||
128669087|NCT02442804|463087282|FG000|Overall Study|Adverse Event|1|||
128669088|NCT02442804|463087283|FG001|Overall Study|Adverse Event|0|||
128669089|NCT02036853|463087284|FG000|Overall Study|Adverse Event|0|||
128669090|NCT02036853|463087285|FG001|Overall Study|Adverse Event|2|||
128669091|NCT02036853|463087284|FG000|Overall Study|Lack of Efficacy|0|||
128669092|NCT02036853|463087285|FG001|Overall Study|Lack of Efficacy|2|||
128669093|NCT02036853|463087284|FG000|Overall Study|Physician Decision|0|||
128669094|NCT02036853|463087285|FG001|Overall Study|Physician Decision|1|||
128669095|NCT02036853|463087284|FG000|Overall Study|Withdrawal by Subject|0|||
128669096|NCT02036853|463087285|FG001|Overall Study|Withdrawal by Subject|1|||
128669097|NCT01742286|463087289|FG000|Escalation Phase|Administrative problems|1|||
128669098|NCT01742286|463087290|FG001|Escalation Phase|Administrative problems|1|||
128669099|NCT01742286|463087291|FG002|Escalation Phase|Administrative problems|0|||
128669100|NCT01742286|463087292|FG003|Escalation Phase|Administrative problems|0|||
128669101|NCT01742286|463087293|FG004|Escalation Phase|Administrative problems|0|||
128669102|NCT01742286|463087294|FG005|Escalation Phase|Administrative problems|0|||
128669103|NCT01742286|463087295|FG006|Escalation Phase|Administrative problems|2|||
128669104|NCT01742286|463087289|FG000|Escalation Phase|Adverse Event|0|||
128669105|NCT01742286|463087290|FG001|Escalation Phase|Adverse Event|1|||
128669106|NCT01742286|463087291|FG002|Escalation Phase|Adverse Event|2|||
128669107|NCT01742286|463087292|FG003|Escalation Phase|Adverse Event|0|||
128669108|NCT01742286|463087293|FG004|Escalation Phase|Adverse Event|0|||
128669109|NCT01742286|463087294|FG005|Escalation Phase|Adverse Event|1|||
128669110|NCT01742286|463087295|FG006|Escalation Phase|Adverse Event|0|||
128669111|NCT01742286|463087289|FG000|Escalation Phase|Disease progression|3|||
128669112|NCT01742286|463087290|FG001|Escalation Phase|Disease progression|7|||
129003624|NCT00982410|464305054|FG000|12-month Follow-up Assessment|incarceration|2|||
128669113|NCT01742286|463087291|FG002|Escalation Phase|Disease progression|4|||
128669114|NCT01742286|463087292|FG003|Escalation Phase|Disease progression|1|||
128669115|NCT01742286|463087293|FG004|Escalation Phase|Disease progression|4|||
128669116|NCT01742286|463087294|FG005|Escalation Phase|Disease progression|3|||
128669117|NCT01742286|463087295|FG006|Escalation Phase|Disease progression|2|||
128669118|NCT01742286|463087289|FG000|Escalation Phase|Death|0|||
128669119|NCT01742286|463087290|FG001|Escalation Phase|Death|0|||
128669120|NCT01742286|463087291|FG002|Escalation Phase|Death|0|||
128669121|NCT01742286|463087292|FG003|Escalation Phase|Death|0|||
128669122|NCT01742286|463087293|FG004|Escalation Phase|Death|0|||
128669123|NCT01742286|463087294|FG005|Escalation Phase|Death|1|||
128669124|NCT01742286|463087295|FG006|Escalation Phase|Death|0|||
128669125|NCT01742286|463087289|FG000|Escalation Phase|Physician Decision|0|||
128669126|NCT01742286|463087290|FG001|Escalation Phase|Physician Decision|3|||
128669127|NCT01742286|463087291|FG002|Escalation Phase|Physician Decision|0|||
128669128|NCT01742286|463087292|FG003|Escalation Phase|Physician Decision|1|||
128669129|NCT01742286|463087293|FG004|Escalation Phase|Physician Decision|0|||
128669130|NCT01742286|463087294|FG005|Escalation Phase|Physician Decision|0|||
128669131|NCT01742286|463087295|FG006|Escalation Phase|Physician Decision|2|||
128669132|NCT01742286|463087289|FG000|Escalation Phase|Subject/guardian decision|1|||
128878300|NCT04275089|463848430|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
128878301|NCT01079663|463848431|FG000|Overall Study|Adverse Event|0|||
128878302|NCT01079663|463848432|FG001|Overall Study|Adverse Event|2|||
128878303|NCT01079663|463848431|FG000|Overall Study|Protocol Violation|0|||
128878304|NCT01079663|463848432|FG001|Overall Study|Protocol Violation|2|||
128878305|NCT00297232|463848433|FG000|Overall Study|Lack of Efficacy|7|||
128878306|NCT00297232|463848433|FG000|Overall Study|Lost to Follow-up|10|||
128878307|NCT00297232|463848433|FG000|Overall Study|Adverse Event|63|||
128878308|NCT00297232|463848433|FG000|Overall Study|Voluntary Withdrawal|120|||
128878309|NCT00297232|463848433|FG000|Overall Study|Subject was Noncompliant|9|||
128878310|NCT00297232|463848433|FG000|Overall Study|Death|9|||
128878311|NCT00297232|463848433|FG000|Overall Study|Anti-natalizumab Positive|8|||
128878312|NCT00297232|463848433|FG000|Overall Study|Switched to Commercial Tysabri|22|||
128878313|NCT00297232|463848433|FG000|Overall Study|Disease Progression|8|||
128878314|NCT00297232|463848433|FG000|Overall Study|Fear of PML|10|||
128878315|NCT00297232|463848433|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
128878316|NCT00297232|463848433|FG000|Overall Study|Miscellaneous|5|||
128878317|NCT00297232|463848433|FG000|Overall Study|Sponsor Decision|34|||
128878318|NCT00297232|463848433|FG000|Overall Study|Subject Relocated|7|||
128878319|NCT00297232|463848433|FG000|Overall Study|Subject Withdrew Consent|37|||
128878320|NCT00297232|463848433|FG000|Overall Study|Persistently Positive Antibodies|11|||
128878321|NCT00297232|463848433|FG000|Overall Study|Investigator Withdrew From Program|19|||
128878322|NCT00297232|463848433|FG000|Overall Study|Did Not Enroll to Week 264|34|||
128878323|NCT00297232|463848433|FG000|Overall Study|Did Not Enroll to Week 480|17|||
128878324|NCT00297232|463848433|FG000|Overall Study|No data available after Week 264|161|||
128878325|NCT00297232|463848433|FG000|Overall Study|Other|1|||
128878326|NCT03038438|463848434|FG000|Overall Study|Death|3|||
128878327|NCT03038438|463848434|FG000|Overall Study|Lost to Follow-up|8|||
128878328|NCT03038438|463848434|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
128878329|NCT03038438|463848434|FG000|Overall Study|Withdrawal by Subject|5|||
128878330|NCT03038438|463848434|FG000|Overall Study|No 36-Month Follow-Up|18|||
128878331|NCT03625895|463848435|FG000|Overall Study|Protocol Violation|585|||
128878332|NCT02476279|463848436|FG000|Overall Study|Lost to Follow-up|1|||
128878333|NCT02476279|463848437|FG001|Overall Study|Lost to Follow-up|1|||
128878334|NCT00577473|463848438|FG000|Overall Study|Protocol Violation|1|||
128878335|NCT00577473|463848439|FG001|Overall Study|Protocol Violation|4|||
128878336|NCT00577473|463848438|FG000|Overall Study|Adverse Event|8|||
128878337|NCT00577473|463848439|FG001|Overall Study|Adverse Event|5|||
128878338|NCT00577473|463848438|FG000|Overall Study|Withdrawal by Subject|2|||
128878339|NCT00577473|463848439|FG001|Overall Study|Withdrawal by Subject|6|||
128878340|NCT00577473|463848438|FG000|Overall Study|Physician Decision|2|||
128878341|NCT00577473|463848439|FG001|Overall Study|Physician Decision|2|||
128878342|NCT00577473|463848438|FG000|Overall Study|Lack of Efficacy|8|||
128878343|NCT00577473|463848439|FG001|Overall Study|Lack of Efficacy|7|||
128878344|NCT01945060|463848448|FG000|Overall Study|Lost to follow up|1|||
128878345|NCT01945060|463848449|FG001|Overall Study|Lost to follow up|0|||
128878346|NCT01945060|463848448|FG000|Overall Study|Distress related to IV access|0|||
128878347|NCT01945060|463848449|FG001|Overall Study|Distress related to IV access|1|||
128878348|NCT00402597|463848450|FG000|Overall Study|Death|15|||
128878349|NCT00402597|463848451|FG001|Overall Study|Death|7|||
128878350|NCT00402597|463848452|FG002|Overall Study|Death|6|||
128878351|NCT00402597|463848453|FG003|Overall Study|Death|4|||
128878352|NCT00402597|463848454|FG004|Overall Study|Death|6|||
128878353|NCT00402597|463848450|FG000|Overall Study|Adverse Event|81|||
128878354|NCT00402597|463848451|FG001|Overall Study|Adverse Event|18|||
128878355|NCT00402597|463848452|FG002|Overall Study|Adverse Event|106|||
128878356|NCT00402597|463848453|FG003|Overall Study|Adverse Event|39|||
128878357|NCT00402597|463848454|FG004|Overall Study|Adverse Event|71|||
128878358|NCT00402597|463848450|FG000|Overall Study|Lost to Follow-up|8|||
128878359|NCT00402597|463848451|FG001|Overall Study|Lost to Follow-up|1|||
128878360|NCT00402597|463848452|FG002|Overall Study|Lost to Follow-up|8|||
128878361|NCT00402597|463848453|FG003|Overall Study|Lost to Follow-up|2|||
128878362|NCT00402597|463848454|FG004|Overall Study|Lost to Follow-up|3|||
128878363|NCT00402597|463848450|FG000|Overall Study|Withdrawal by Subject|57|||
128878364|NCT00402597|463848451|FG001|Overall Study|Withdrawal by Subject|16|||
128669133|NCT01742286|463087290|FG001|Escalation Phase|Subject/guardian decision|0|||
128669134|NCT01742286|463087291|FG002|Escalation Phase|Subject/guardian decision|0|||
128669135|NCT01742286|463087292|FG003|Escalation Phase|Subject/guardian decision|0|||
128669136|NCT01742286|463087293|FG004|Escalation Phase|Subject/guardian decision|0|||
128669137|NCT01742286|463087294|FG005|Escalation Phase|Subject/guardian decision|0|||
128669138|NCT01742286|463087295|FG006|Escalation Phase|Subject/guardian decision|0|||
128669139|NCT01742286|463087289|FG000|Expansion Phase|Administrative problems|0|||
128669140|NCT01742286|463087290|FG001|Expansion Phase|Administrative problems|0|||
128669141|NCT01742286|463087291|FG002|Expansion Phase|Administrative problems|0|||
128669142|NCT01742286|463087292|FG003|Expansion Phase|Administrative problems|0|||
128669143|NCT01742286|463087293|FG004|Expansion Phase|Administrative problems|0|||
128669144|NCT01742286|463087294|FG005|Expansion Phase|Administrative problems|0|||
128669145|NCT01742286|463087295|FG006|Expansion Phase|Administrative problems|5|||
128669146|NCT01742286|463087289|FG000|Expansion Phase|Physician Decision|0|||
128669147|NCT01742286|463087290|FG001|Expansion Phase|Physician Decision|0|||
129003625|NCT00982410|464305055|FG001|12-month Follow-up Assessment|incarceration|1|||
129003626|NCT00982410|464305054|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
129003627|NCT00982410|464305055|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
129003628|NCT02004847|464305062|FG000|Overall Study|Protocol Violation|1|||
129003629|NCT02004847|464305063|FG001|Overall Study|Protocol Violation|1|||
129003630|NCT02034799|464305064|FG000|Overall Study|Withdrawal by Subject|0|||
129003631|NCT02034799|464305065|FG001|Overall Study|Withdrawal by Subject|2|||
129003632|NCT02034799|464305064|FG000|Overall Study|Lost to Follow-up|0|||
129003633|NCT02034799|464305065|FG001|Overall Study|Lost to Follow-up|1|||
129003634|NCT02034799|464305064|FG000|Overall Study|Death|2|||
128669148|NCT01742286|463087291|FG002|Expansion Phase|Physician Decision|4|||
128669149|NCT01742286|463087292|FG003|Expansion Phase|Physician Decision|0|||
128669150|NCT01742286|463087293|FG004|Expansion Phase|Physician Decision|0|||
128669151|NCT01742286|463087294|FG005|Expansion Phase|Physician Decision|0|||
128669152|NCT01742286|463087295|FG006|Expansion Phase|Physician Decision|9|||
128669153|NCT01742286|463087289|FG000|Expansion Phase|Adverse Event|0|||
128669154|NCT01742286|463087290|FG001|Expansion Phase|Adverse Event|0|||
128669155|NCT01742286|463087291|FG002|Expansion Phase|Adverse Event|0|||
128669156|NCT01742286|463087292|FG003|Expansion Phase|Adverse Event|0|||
128669157|NCT01742286|463087293|FG004|Expansion Phase|Adverse Event|0|||
128669158|NCT01742286|463087294|FG005|Expansion Phase|Adverse Event|0|||
128669159|NCT01742286|463087295|FG006|Expansion Phase|Adverse Event|6|||
128669160|NCT01742286|463087289|FG000|Expansion Phase|Disease progression|0|||
128669161|NCT01742286|463087290|FG001|Expansion Phase|Disease progression|0|||
128669162|NCT01742286|463087291|FG002|Expansion Phase|Disease progression|3|||
128669163|NCT01742286|463087292|FG003|Expansion Phase|Disease progression|0|||
128669164|NCT01742286|463087293|FG004|Expansion Phase|Disease progression|0|||
128669165|NCT01742286|463087294|FG005|Expansion Phase|Disease progression|0|||
128669166|NCT01742286|463087295|FG006|Expansion Phase|Disease progression|15|||
128669167|NCT01742286|463087289|FG000|Expansion Phase|Withdrawal by Subject|0|||
128669168|NCT01742286|463087290|FG001|Expansion Phase|Withdrawal by Subject|0|||
128669169|NCT01742286|463087291|FG002|Expansion Phase|Withdrawal by Subject|0|||
128669170|NCT01742286|463087292|FG003|Expansion Phase|Withdrawal by Subject|0|||
128669171|NCT01742286|463087293|FG004|Expansion Phase|Withdrawal by Subject|0|||
128669172|NCT01742286|463087294|FG005|Expansion Phase|Withdrawal by Subject|0|||
128669173|NCT01742286|463087295|FG006|Expansion Phase|Withdrawal by Subject|1|||
128669174|NCT04530136|463087296|FG000|Overall Study|Lost to Follow-up|2|||
128669175|NCT04530136|463087297|FG001|Overall Study|Lost to Follow-up|3|||
128669176|NCT04530136|463087296|FG000|Overall Study|Withdrawal by Subject|1|||
128669177|NCT04530136|463087297|FG001|Overall Study|Withdrawal by Subject|0|||
128669178|NCT04530136|463087296|FG000|Overall Study|Death|0|||
128669179|NCT04530136|463087297|FG001|Overall Study|Death|1|||
128669180|NCT01309282|463087298|FG000|Overall Study|Lost to Follow-up|1|||
128669181|NCT02087423|463087299|FG000|Overall Study|Withdrawal by Subject|20|||
128669182|NCT02087423|463087300|FG001|Overall Study|Withdrawal by Subject|20|||
128669183|NCT02087423|463087301|FG002|Overall Study|Withdrawal by Subject|3|||
128669184|NCT02087423|463087299|FG000|Overall Study|Death|68|||
128669185|NCT02087423|463087300|FG001|Overall Study|Death|207|||
128669186|NCT02087423|463087301|FG002|Overall Study|Death|40|||
128669187|NCT02087423|463087299|FG000|Overall Study|Lost to Follow-up|0|||
128669188|NCT02087423|463087300|FG001|Overall Study|Lost to Follow-up|2|||
128669189|NCT02087423|463087301|FG002|Overall Study|Lost to Follow-up|0|||
128669190|NCT02087423|463087299|FG000|Overall Study|Terminated from study at final DCO|23|||
128669191|NCT02087423|463087300|FG001|Overall Study|Terminated from study at final DCO|36|||
128669192|NCT02087423|463087301|FG002|Overall Study|Terminated from study at final DCO|25|||
128669193|NCT01387542|463087302|FG000|Overall Study|Adverse Event|3|||
128669194|NCT01387542|463087302|FG000|Overall Study|Withdrawal by Subject|1|||
128669195|NCT01387542|463087302|FG000|Overall Study|Changed diagnosis|1|||
128669196|NCT01387542|463087302|FG000|Overall Study|Insufficient response|1|||
128669197|NCT01387542|463087302|FG000|Overall Study|Non-compliant|1|||
129003635|NCT02034799|464305065|FG001|Overall Study|Death|1|||
129003636|NCT00759148|464305074|FG000|Overall Study|Adverse Event|1|||
129003637|NCT00759148|464305075|FG001|Overall Study|Adverse Event|6|||
129003638|NCT00759148|464305074|FG000|Overall Study|Withdrawal by Subject|3|||
129003639|NCT00759148|464305075|FG001|Overall Study|Withdrawal by Subject|7|||
129003640|NCT00759148|464305074|FG000|Overall Study|Lost to Follow-up|3|||
128669198|NCT01387542|463087302|FG000|Overall Study|Lost to Follow-up|1|||
129003641|NCT00759148|464305075|FG001|Overall Study|Lost to Follow-up|9|||
129003642|NCT00759148|464305074|FG000|Overall Study|Treatment Failure|6|||
129003643|NCT00759148|464305075|FG001|Overall Study|Treatment Failure|10|||
129003644|NCT00759148|464305074|FG000|Overall Study|Reason not given|1|||
129003645|NCT00759148|464305075|FG001|Overall Study|Reason not given|0|||
129003646|NCT01133821|464305076|FG000|Overall Study|Lost to Follow-up|8|||
129003647|NCT01133821|464305077|FG001|Overall Study|Lost to Follow-up|11|||
129003648|NCT01133821|464305076|FG000|Overall Study|Withdrawal by Subject|8|||
129003649|NCT01133821|464305077|FG001|Overall Study|Withdrawal by Subject|3|||
129003650|NCT01133821|464305076|FG000|Overall Study|preferred other treatment|1|||
129003651|NCT01133821|464305077|FG001|Overall Study|preferred other treatment|1|||
129003652|NCT01133821|464305076|FG000|Overall Study|Protocol Violation|0|||
129003653|NCT01133821|464305077|FG001|Overall Study|Protocol Violation|1|||
129003654|NCT01133821|464305076|FG000|Overall Study|Refused participation|1|||
129003655|NCT01133821|464305077|FG001|Overall Study|Refused participation|3|||
129003656|NCT00434161|464305080|FG000|Overall Study|Adverse Event|5|||
129003657|NCT00434161|464305081|FG001|Overall Study|Adverse Event|1|||
129003658|NCT00434161|464305082|FG002|Overall Study|Adverse Event|4|||
129003659|NCT00434161|464305080|FG000|Overall Study|Lost to Follow-up|0|||
129003660|NCT00434161|464305081|FG001|Overall Study|Lost to Follow-up|1|||
129003661|NCT00434161|464305082|FG002|Overall Study|Lost to Follow-up|0|||
129003662|NCT00434161|464305080|FG000|Overall Study|Death|1|||
129003663|NCT00434161|464305081|FG001|Overall Study|Death|0|||
129003664|NCT00434161|464305082|FG002|Overall Study|Death|1|||
129003665|NCT00434161|464305080|FG000|Overall Study|Non-Compliance|1|||
129003666|NCT00434161|464305081|FG001|Overall Study|Non-Compliance|1|||
129003667|NCT00434161|464305082|FG002|Overall Study|Non-Compliance|0|||
129003668|NCT00434161|464305080|FG000|Overall Study|Withdrawal by Subject|2|||
129003669|NCT00434161|464305081|FG001|Overall Study|Withdrawal by Subject|0|||
129003670|NCT00434161|464305082|FG002|Overall Study|Withdrawal by Subject|3|||
129003671|NCT00434161|464305080|FG000|Overall Study|Logistical error study assessments|1|||
129003672|NCT00434161|464305081|FG001|Overall Study|Logistical error study assessments|0|||
129003673|NCT00434161|464305082|FG002|Overall Study|Logistical error study assessments|3|||
129003674|NCT03342898|464305083|FG000|Overall Study|Adverse Event|3|||
129003675|NCT03342898|464305084|FG001|Overall Study|Adverse Event|1|||
129003676|NCT03342898|464305085|FG002|Overall Study|Adverse Event|0|||
129003677|NCT03342898|464305083|FG000|Overall Study|Lost to Follow-up|44|||
129003678|NCT03342898|464305084|FG001|Overall Study|Lost to Follow-up|40|||
129003679|NCT03342898|464305085|FG002|Overall Study|Lost to Follow-up|42|||
129003680|NCT03342898|464305083|FG000|Overall Study|Withdrawal of Consent|5|||
129003681|NCT03342898|464305084|FG001|Overall Study|Withdrawal of Consent|9|||
129003682|NCT03342898|464305085|FG002|Overall Study|Withdrawal of Consent|11|||
129003683|NCT03342898|464305083|FG000|Overall Study|Death|0|||
129003684|NCT03342898|464305084|FG001|Overall Study|Death|1|||
129003685|NCT03342898|464305085|FG002|Overall Study|Death|1|||
129003686|NCT03342898|464305083|FG000|Overall Study|Reason not Specified|2|||
129003687|NCT03342898|464305084|FG001|Overall Study|Reason not Specified|2|||
129003688|NCT03342898|464305085|FG002|Overall Study|Reason not Specified|0|||
129003689|NCT01387282|464305086|FG000|Overall Study|Death|47|||
129003690|NCT01387282|464305087|FG001|Overall Study|Death|16|||
129003691|NCT01387282|464305086|FG000|Overall Study|Other|5|||
129003692|NCT01387282|464305087|FG001|Overall Study|Other|1|||
129003693|NCT01387282|464305086|FG000|Overall Study|Unrelated AE|6|||
129003694|NCT01387282|464305087|FG001|Overall Study|Unrelated AE|4|||
129003695|NCT01387282|464305086|FG000|Overall Study|Withdrawal by patient|33|||
128669199|NCT01010867|463087305|FG000|Overall Study|< 50% adherence to probiotic|1|||
128669200|NCT01233232|463087306|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
128669201|NCT01233232|463087307|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
129003696|NCT01387282|464305087|FG001|Overall Study|Withdrawal by patient|23|||
129003697|NCT01387282|464305086|FG000|Overall Study|Study drug-related AE|2|||
129003698|NCT01387282|464305087|FG001|Overall Study|Study drug-related AE|2|||
129003699|NCT01387282|464305086|FG000|Overall Study|Lost to Follow-up|4|||
129003700|NCT01387282|464305087|FG001|Overall Study|Lost to Follow-up|1|||
129003701|NCT01267266|464305088|FG000|Enrollment Phase|Withdrawal by Subject|2|||
129003702|NCT01267266|464305089|FG001|Enrollment Phase|Withdrawal by Subject|0|||
129003703|NCT01267266|464305088|FG000|Lead-in Phase|Lack of Efficacy|20|||
129003704|NCT01267266|464305089|FG001|Lead-in Phase|Lack of Efficacy|0|||
129003705|NCT01267266|464305088|FG000|Lead-in Phase|Adverse Event|2|||
128669202|NCT01233232|463087308|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
129003706|NCT01267266|464305089|FG001|Lead-in Phase|Adverse Event|0|||
129003707|NCT01267266|464305088|FG000|Lead-in Phase|Withdrawal by Subject|1|||
129003708|NCT01267266|464305089|FG001|Lead-in Phase|Withdrawal by Subject|0|||
129003709|NCT01466686|464305093|FG000|Overall Study|Withdrawal by Subject|1|||
129003710|NCT02049359|464305095|FG000|Overall Study|Lost to Follow-up|26|||
128669203|NCT02762370|463087309|FG000|Overall Study|Protocol Violation|1|||
128669204|NCT02762370|463087310|FG001|Overall Study|Protocol Violation|0|||
128669205|NCT02633020|463087312|FG000|Overall Study|Adverse Event|1|||
128669206|NCT02633020|463087313|FG001|Overall Study|Adverse Event|0|||
128669207|NCT00530816|463087314|FG000|Overall Study|Progressive Disease|16|||
128669208|NCT00530816|463087315|FG001|Overall Study|Progressive Disease|24|||
128669209|NCT00530816|463087316|FG002|Overall Study|Progressive Disease|24|||
128669210|NCT00530816|463087314|FG000|Overall Study|Adverse Event|6|||
128669211|NCT00530816|463087315|FG001|Overall Study|Adverse Event|13|||
128669212|NCT00530816|463087316|FG002|Overall Study|Adverse Event|7|||
128669213|NCT00530816|463087314|FG000|Overall Study|Other|3|||
128669214|NCT00530816|463087315|FG001|Overall Study|Other|3|||
128669215|NCT00530816|463087316|FG002|Overall Study|Other|4|||
128669216|NCT00530816|463087314|FG000|Overall Study|Withdrawal by Subject|1|||
128669217|NCT00530816|463087315|FG001|Overall Study|Withdrawal by Subject|2|||
128669218|NCT00530816|463087316|FG002|Overall Study|Withdrawal by Subject|6|||
128669219|NCT01136785|463087317|FG000|Overall Study|Protocol Violation|2|||
128669220|NCT01136785|463087318|FG001|Overall Study|Protocol Violation|1|||
129003711|NCT02049359|464305096|FG001|Overall Study|Lost to Follow-up|19|||
128669221|NCT01388985|463087321|FG000|Overall Study|Death|0|||
128669222|NCT01388985|463087322|FG001|Overall Study|Death|1|||
128669223|NCT01388985|463087321|FG000|Overall Study|Lost to Follow-up|30|||
128669224|NCT01388985|463087322|FG001|Overall Study|Lost to Follow-up|30|||
128669225|NCT01388985|463087321|FG000|Overall Study|Withdrawal by Subject|13|||
128669226|NCT01388985|463087322|FG001|Overall Study|Withdrawal by Subject|4|||
128669227|NCT01388985|463087321|FG000|Overall Study|Subject unavailable|1|||
128669228|NCT01388985|463087322|FG001|Overall Study|Subject unavailable|1|||
128669229|NCT01388985|463087321|FG000|Overall Study|Other (no reason)|0|||
128669230|NCT01388985|463087322|FG001|Overall Study|Other (no reason)|1|||
128669231|NCT01388985|463087321|FG000|Overall Study|Error of nurse|5|||
128669232|NCT01388985|463087322|FG001|Overall Study|Error of nurse|1|||
128669233|NCT01057589|463087323|FG000|Overall Study|Disease Progression|35|||
129003712|NCT01907087|464305097|FG000|Overall Study|Withdrawal by Subject|1|||
129003713|NCT03273387|464305098|FG000|Overall Study|Death|2|||
129003714|NCT03273387|464305099|FG001|Overall Study|Death|2|||
128669234|NCT01057589|463087323|FG000|Overall Study|Adverse Event|10|||
128669235|NCT01057589|463087323|FG000|Overall Study|Physician Decision|8|||
129003715|NCT03273387|464305098|FG000|Overall Study|Withdrawal by Subject|1|||
129003716|NCT03273387|464305099|FG001|Overall Study|Withdrawal by Subject|1|||
129003717|NCT05216978|464305100|FG000|Overall Study|Withdrawal by Subject|3|||
129003718|NCT05216978|464305100|FG000|Overall Study|Lost to Follow-up|5|||
129003719|NCT00658320|464305104|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
129003720|NCT00658320|464305105|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
129003721|NCT00658320|464305104|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
129003722|NCT00658320|464305105|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
129003723|NCT00658320|464305104|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
129003724|NCT00658320|464305105|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
129003725|NCT00658320|464305104|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
129003726|NCT00658320|464305105|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
129003727|NCT03907280|464305111|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
129003728|NCT03907280|464305112|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
129003729|NCT03907280|464305113|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
129003730|NCT01464827|464305116|FG000|Overall Study|Adverse Event|0|||
129003731|NCT01464827|464305117|FG001|Overall Study|Adverse Event|0|||
129003732|NCT01464827|464305118|FG002|Overall Study|Adverse Event|0|||
129003733|NCT01464827|464305119|FG003|Overall Study|Adverse Event|0|||
129003734|NCT01464827|464305120|FG004|Overall Study|Adverse Event|0|||
129003735|NCT01464827|464305121|FG005|Overall Study|Adverse Event|0|||
129003736|NCT01464827|464305122|FG006|Overall Study|Adverse Event|0|||
129003737|NCT01464827|464305123|FG007|Overall Study|Adverse Event|0|||
128669236|NCT01057589|463087323|FG000|Overall Study|Withdrawal by Subject|3|||
128669237|NCT01057589|463087323|FG000|Overall Study|Sponsor Decision|1|||
128669238|NCT01057589|463087323|FG000|Overall Study|Death|8|||
128669239|NCT01057589|463087323|FG000|Overall Study|Lost to Follow-up|1|||
128669240|NCT02954172|463087328|FG000|Overall Study|Protocol Violation|3|||
128669241|NCT02954172|463087329|FG001|Overall Study|Protocol Violation|0|||
128669242|NCT02954172|463087328|FG000|Overall Study|allergic reaction|2|||
128669243|NCT02954172|463087329|FG001|Overall Study|allergic reaction|1|||
128669244|NCT02954172|463087328|FG000|Overall Study|non-measurable lesions at baseline|1|||
129003738|NCT01464827|464305124|FG008|Overall Study|Adverse Event|0|||
128669245|NCT02954172|463087329|FG001|Overall Study|non-measurable lesions at baseline|2|||
128669246|NCT00853567|463087330|FG000|Overall Study|Study prematurely terminated|71|||
128669247|NCT01497366|463087334|FG000|Overall Study|Virologic failure|2|||
128669248|NCT01497366|463087335|FG001|Overall Study|Virologic failure|50|||
128669249|NCT01497366|463087334|FG000|Overall Study|Lost to Follow-up|11|||
129003739|NCT01464827|464305125|FG009|Overall Study|Adverse Event|0|||
129003740|NCT01464827|464305126|FG010|Overall Study|Adverse Event|0|||
129003741|NCT01464827|464305127|FG011|Overall Study|Adverse Event|0|||
129003742|NCT01464827|464305128|FG012|Overall Study|Adverse Event|1|||
129003743|NCT01464827|464305129|FG013|Overall Study|Adverse Event|0|||
129003744|NCT01464827|464305116|FG000|Overall Study|Withdrawal by Subject|1|||
129003745|NCT01464827|464305117|FG001|Overall Study|Withdrawal by Subject|0|||
129003746|NCT01464827|464305118|FG002|Overall Study|Withdrawal by Subject|0|||
129003747|NCT01464827|464305119|FG003|Overall Study|Withdrawal by Subject|0|||
129003748|NCT01464827|464305120|FG004|Overall Study|Withdrawal by Subject|1|||
129003749|NCT01464827|464305121|FG005|Overall Study|Withdrawal by Subject|0|||
129003750|NCT01464827|464305122|FG006|Overall Study|Withdrawal by Subject|0|||
129003751|NCT01464827|464305123|FG007|Overall Study|Withdrawal by Subject|1|||
129003752|NCT01464827|464305124|FG008|Overall Study|Withdrawal by Subject|0|||
129003753|NCT01464827|464305125|FG009|Overall Study|Withdrawal by Subject|0|||
129003754|NCT01464827|464305126|FG010|Overall Study|Withdrawal by Subject|0|||
129003755|NCT01464827|464305127|FG011|Overall Study|Withdrawal by Subject|0|||
129003756|NCT01464827|464305128|FG012|Overall Study|Withdrawal by Subject|0|||
129003757|NCT01464827|464305129|FG013|Overall Study|Withdrawal by Subject|0|||
129003758|NCT01464827|464305116|FG000|Overall Study|Lost to Follow-up|0|||
129003759|NCT01464827|464305117|FG001|Overall Study|Lost to Follow-up|2|||
129003760|NCT01464827|464305118|FG002|Overall Study|Lost to Follow-up|0|||
129003761|NCT01464827|464305119|FG003|Overall Study|Lost to Follow-up|2|||
129003762|NCT01464827|464305120|FG004|Overall Study|Lost to Follow-up|3|||
129003763|NCT01464827|464305121|FG005|Overall Study|Lost to Follow-up|1|||
129003764|NCT01464827|464305122|FG006|Overall Study|Lost to Follow-up|2|||
129003765|NCT01464827|464305123|FG007|Overall Study|Lost to Follow-up|2|||
129003766|NCT01464827|464305124|FG008|Overall Study|Lost to Follow-up|0|||
129003767|NCT01464827|464305125|FG009|Overall Study|Lost to Follow-up|0|||
129003768|NCT01464827|464305126|FG010|Overall Study|Lost to Follow-up|0|||
129003769|NCT01464827|464305127|FG011|Overall Study|Lost to Follow-up|1|||
129003770|NCT01464827|464305128|FG012|Overall Study|Lost to Follow-up|0|||
129003771|NCT01464827|464305129|FG013|Overall Study|Lost to Follow-up|1|||
129003772|NCT01464827|464305116|FG000|Overall Study|Other|2|||
129003773|NCT01464827|464305117|FG001|Overall Study|Other|3|||
129003774|NCT01464827|464305118|FG002|Overall Study|Other|0|||
129003775|NCT01464827|464305119|FG003|Overall Study|Other|2|||
129003776|NCT01464827|464305120|FG004|Overall Study|Other|3|||
129003777|NCT01464827|464305121|FG005|Overall Study|Other|0|||
129003778|NCT01464827|464305122|FG006|Overall Study|Other|1|||
129003779|NCT01464827|464305123|FG007|Overall Study|Other|0|||
129003780|NCT01464827|464305124|FG008|Overall Study|Other|3|||
129003781|NCT01464827|464305125|FG009|Overall Study|Other|1|||
129003782|NCT01464827|464305126|FG010|Overall Study|Other|2|||
129003783|NCT01464827|464305127|FG011|Overall Study|Other|0|||
129003784|NCT01464827|464305128|FG012|Overall Study|Other|1|||
129003785|NCT01464827|464305129|FG013|Overall Study|Other|0|||
129003786|NCT01464827|464305116|FG000|Overall Study|Not Treated|0|||
129003787|NCT01464827|464305117|FG001|Overall Study|Not Treated|2|||
129003788|NCT01464827|464305118|FG002|Overall Study|Not Treated|0|||
129003789|NCT01464827|464305119|FG003|Overall Study|Not Treated|0|||
129003790|NCT01464827|464305120|FG004|Overall Study|Not Treated|1|||
129003791|NCT01464827|464305121|FG005|Overall Study|Not Treated|0|||
129003792|NCT01464827|464305122|FG006|Overall Study|Not Treated|1|||
129003793|NCT01464827|464305123|FG007|Overall Study|Not Treated|0|||
129003794|NCT01464827|464305124|FG008|Overall Study|Not Treated|0|||
129003795|NCT01464827|464305125|FG009|Overall Study|Not Treated|2|||
129003796|NCT01464827|464305126|FG010|Overall Study|Not Treated|0|||
129003797|NCT01464827|464305127|FG011|Overall Study|Not Treated|1|||
129003798|NCT01464827|464305128|FG012|Overall Study|Not Treated|0|||
129003799|NCT01464827|464305129|FG013|Overall Study|Not Treated|2|||
129003800|NCT05487456|464305130|FG000|Overall Study|Withdrawal by Subject|0|||
129003801|NCT05487456|464305131|FG001|Overall Study|Withdrawal by Subject|0|||
129003802|NCT05487456|464305132|FG002|Overall Study|Withdrawal by Subject|1|||
129003803|NCT05487456|464305133|FG003|Overall Study|Withdrawal by Subject|0|||
129003804|NCT03882047|464305136|FG000|Overall Study|Adverse Event|0|||
129003805|NCT03882047|464305137|FG001|Overall Study|Adverse Event|2|||
129003806|NCT03882047|464305138|FG002|Overall Study|Adverse Event|2|||
129003807|NCT03882047|464305136|FG000|Overall Study|Treatment Failure|3|||
129003808|NCT03882047|464305137|FG001|Overall Study|Treatment Failure|3|||
129003809|NCT03882047|464305138|FG002|Overall Study|Treatment Failure|12|||
128878365|NCT00402597|463848452|FG002|Overall Study|Withdrawal by Subject|65|||
128878366|NCT00402597|463848453|FG003|Overall Study|Withdrawal by Subject|15|||
129003810|NCT03882047|464305136|FG000|Overall Study|Lost to Follow-up|0|||
129003811|NCT03882047|464305137|FG001|Overall Study|Lost to Follow-up|1|||
129003812|NCT03882047|464305138|FG002|Overall Study|Lost to Follow-up|0|||
129003813|NCT03882047|464305136|FG000|Overall Study|Did Not Wish to Continue|1|||
129003814|NCT03882047|464305137|FG001|Overall Study|Did Not Wish to Continue|4|||
129003815|NCT03882047|464305138|FG002|Overall Study|Did Not Wish to Continue|1|||
129003816|NCT03882047|464305136|FG000|Overall Study|Noncompliance With Protocol|2|||
129003817|NCT03882047|464305137|FG001|Overall Study|Noncompliance With Protocol|0|||
129003818|NCT03882047|464305138|FG002|Overall Study|Noncompliance With Protocol|0|||
128669250|NCT01497366|463087335|FG001|Overall Study|Lost to Follow-up|10|||
129003819|NCT03882047|464305136|FG000|Overall Study|Did Not Meet Eligibility|0|||
128669251|NCT01497366|463087334|FG000|Overall Study|Withdrawal by Subject|6|||
128669252|NCT01497366|463087335|FG001|Overall Study|Withdrawal by Subject|6|||
128669253|NCT01497366|463087334|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
128669254|NCT01497366|463087335|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
128669255|NCT01497366|463087334|FG000|Overall Study|Other|5|||
129003820|NCT03882047|464305137|FG001|Overall Study|Did Not Meet Eligibility|0|||
129003821|NCT03882047|464305138|FG002|Overall Study|Did Not Meet Eligibility|1|||
129003822|NCT00441584|464305139|FG000|Overall Study|Lack of Efficacy|79|||
128669256|NCT01497366|463087335|FG001|Overall Study|Other|0|||
128669257|NCT01497366|463087334|FG000|Overall Study|Death|1|||
128669258|NCT01497366|463087335|FG001|Overall Study|Death|1|||
128669259|NCT01497366|463087334|FG000|Overall Study|Randomized but not treated|7|||
129003823|NCT00441584|464305139|FG000|Overall Study|Withdrawal by Subject|8|||
129003824|NCT00441584|464305139|FG000|Overall Study|Adverse Event|6|||
129003825|NCT00441584|464305139|FG000|Overall Study|Protocol Violation|5|||
129003826|NCT00441584|464305139|FG000|Overall Study|Lost to Follow-up|4|||
129003827|NCT00441584|464305139|FG000|Overall Study|Failure to meet eligibility criteria|3|||
129003828|NCT03465891|464305142|FG000|Overall Study|Withdrawal by Subject|0|||
129003829|NCT03465891|464305143|FG001|Overall Study|Withdrawal by Subject|1|||
129003830|NCT03465891|464305142|FG000|Overall Study|Disease progression|1|||
129003831|NCT03465891|464305143|FG001|Overall Study|Disease progression|0|||
129003832|NCT01001169|464305144|FG000|Overall Study|Withdrawal by Subject|2|||
129003833|NCT01001169|464305145|FG001|Overall Study|Withdrawal by Subject|1|||
129003834|NCT02536378|464305150|FG000|Overall Study|Physician Decision|0|||
129003835|NCT02536378|464305151|FG001|Overall Study|Physician Decision|2|||
129003836|NCT02536378|464305150|FG000|Overall Study|Withdrawal by Subject|0|||
129003837|NCT02536378|464305151|FG001|Overall Study|Withdrawal by Subject|1|||
129003838|NCT02536378|464305150|FG000|Overall Study|Death|1|||
129003839|NCT02536378|464305151|FG001|Overall Study|Death|2|||
129003840|NCT02536378|464305150|FG000|Overall Study|Patient refused further follow up|6|||
129003841|NCT02536378|464305151|FG001|Overall Study|Patient refused further follow up|2|||
129003842|NCT00798889|464305152|FG000|Overall Study|Adverse Event|53|||
129003843|NCT00798889|464305152|FG000|Overall Study|Protocol Violation|2|||
129003844|NCT00798889|464305152|FG000|Overall Study|Withdrawal by Subject|31|||
129003845|NCT00798889|464305152|FG000|Overall Study|Lost to Follow-up|1|||
129003846|NCT00798889|464305152|FG000|Overall Study|Lack of Efficacy|213|||
129003847|NCT00798889|464305152|FG000|Overall Study|Decision of Sponsor|11|||
129003848|NCT00798889|464305152|FG000|Overall Study|Enrolled, Not treated|3|||
129003849|NCT00358826|464305153|FG000|Core Study|Adverse Event|1|||
129003850|NCT00358826|464305154|FG001|Core Study|Adverse Event|3|||
129003851|NCT00358826|464305155|FG002|Core Study|Adverse Event|1|||
129003852|NCT00358826|464305156|FG003|Core Study|Adverse Event|1|||
129003853|NCT00358826|464305157|FG004|Core Study|Adverse Event|0|||
129003854|NCT00358826|464305158|FG005|Core Study|Adverse Event|0|||
129003855|NCT00358826|464305159|FG006|Core Study|Adverse Event|0|||
129003856|NCT00358826|464305160|FG007|Core Study|Adverse Event|0|||
129003857|NCT00358826|464305153|FG000|Core Study|Withdrawal by Subject|2|||
129003858|NCT00358826|464305154|FG001|Core Study|Withdrawal by Subject|2|||
129003859|NCT00358826|464305155|FG002|Core Study|Withdrawal by Subject|0|||
129003860|NCT00358826|464305156|FG003|Core Study|Withdrawal by Subject|0|||
129003861|NCT00358826|464305157|FG004|Core Study|Withdrawal by Subject|0|||
129003862|NCT00358826|464305158|FG005|Core Study|Withdrawal by Subject|0|||
129003863|NCT00358826|464305159|FG006|Core Study|Withdrawal by Subject|0|||
129003864|NCT00358826|464305160|FG007|Core Study|Withdrawal by Subject|0|||
129003865|NCT00358826|464305153|FG000|Core Study|Lost to Follow-up|0|||
129003866|NCT00358826|464305154|FG001|Core Study|Lost to Follow-up|0|||
129003867|NCT00358826|464305155|FG002|Core Study|Lost to Follow-up|0|||
129003868|NCT00358826|464305156|FG003|Core Study|Lost to Follow-up|1|||
129003869|NCT00358826|464305157|FG004|Core Study|Lost to Follow-up|0|||
129003870|NCT00358826|464305158|FG005|Core Study|Lost to Follow-up|0|||
129003871|NCT00358826|464305159|FG006|Core Study|Lost to Follow-up|0|||
129003872|NCT00358826|464305160|FG007|Core Study|Lost to Follow-up|0|||
129003873|NCT00358826|464305153|FG000|Core Study|Physician Decision|0|||
128669260|NCT01497366|463087335|FG001|Overall Study|Randomized but not treated|21|||
128669261|NCT02745080|463087349|FG000|Overall Study|Adverse Event|13|||
128669262|NCT02745080|463087350|FG001|Overall Study|Adverse Event|21|||
129003874|NCT00358826|464305154|FG001|Core Study|Physician Decision|0|||
129003875|NCT00358826|464305155|FG002|Core Study|Physician Decision|1|||
129003876|NCT00358826|464305156|FG003|Core Study|Physician Decision|0|||
129003877|NCT00358826|464305157|FG004|Core Study|Physician Decision|0|||
129003878|NCT00358826|464305158|FG005|Core Study|Physician Decision|0|||
128669263|NCT02745080|463087349|FG000|Overall Study|Lack of Efficacy|11|||
128669264|NCT02745080|463087350|FG001|Overall Study|Lack of Efficacy|23|||
129003879|NCT00358826|464305159|FG006|Core Study|Physician Decision|0|||
129003880|NCT00358826|464305160|FG007|Core Study|Physician Decision|0|||
129003881|NCT00358826|464305153|FG000|MDCT Substudy|Adverse Event|0|||
129003882|NCT00358826|464305154|FG001|MDCT Substudy|Adverse Event|0|||
129003883|NCT00358826|464305155|FG002|MDCT Substudy|Adverse Event|0|||
129003884|NCT00358826|464305156|FG003|MDCT Substudy|Adverse Event|0|||
129003885|NCT00358826|464305157|FG004|MDCT Substudy|Adverse Event|1|||
129003886|NCT00358826|464305158|FG005|MDCT Substudy|Adverse Event|0|||
129003887|NCT00358826|464305159|FG006|MDCT Substudy|Adverse Event|0|||
129003888|NCT00358826|464305160|FG007|MDCT Substudy|Adverse Event|0|||
129003889|NCT00358826|464305153|FG000|MDCT Substudy|Lost to Follow-up|0|||
129003890|NCT00358826|464305154|FG001|MDCT Substudy|Lost to Follow-up|0|||
129003891|NCT00358826|464305155|FG002|MDCT Substudy|Lost to Follow-up|0|||
129003892|NCT00358826|464305156|FG003|MDCT Substudy|Lost to Follow-up|0|||
129003893|NCT00358826|464305157|FG004|MDCT Substudy|Lost to Follow-up|0|||
129003894|NCT00358826|464305158|FG005|MDCT Substudy|Lost to Follow-up|1|||
129003895|NCT00358826|464305159|FG006|MDCT Substudy|Lost to Follow-up|0|||
129003896|NCT00358826|464305160|FG007|MDCT Substudy|Lost to Follow-up|0|||
129003897|NCT00358826|464305153|FG000|MDCT Substudy|Withdrawal by Subject|0|||
129003898|NCT00358826|464305154|FG001|MDCT Substudy|Withdrawal by Subject|0|||
129003899|NCT00358826|464305155|FG002|MDCT Substudy|Withdrawal by Subject|0|||
129003900|NCT00358826|464305156|FG003|MDCT Substudy|Withdrawal by Subject|0|||
129003901|NCT00358826|464305157|FG004|MDCT Substudy|Withdrawal by Subject|0|||
129003902|NCT00358826|464305158|FG005|MDCT Substudy|Withdrawal by Subject|1|||
129003903|NCT00358826|464305159|FG006|MDCT Substudy|Withdrawal by Subject|0|||
129003904|NCT00358826|464305160|FG007|MDCT Substudy|Withdrawal by Subject|0|||
129003905|NCT00481247|464305165|FG000|Overall Study|Death|0|||
129003906|NCT00481247|464305166|FG001|Overall Study|Death|1|||
129003907|NCT00481247|464305165|FG000|Overall Study|Disease progression|18|||
129003908|NCT00481247|464305166|FG001|Overall Study|Disease progression|22|||
129003909|NCT00481247|464305165|FG000|Overall Study|Intolerance|42|||
129003910|NCT00481247|464305166|FG001|Overall Study|Intolerance|17|||
129003911|NCT00481247|464305165|FG000|Overall Study|Treatment failure|10|||
129003912|NCT00481247|464305166|FG001|Overall Study|Treatment failure|14|||
129003913|NCT00481247|464305165|FG000|Overall Study|AE unrelated to study drug|13|||
129003914|NCT00481247|464305166|FG001|Overall Study|AE unrelated to study drug|4|||
129003915|NCT00481247|464305165|FG000|Overall Study|Withdrawal by Subject|8|||
129003916|NCT00481247|464305166|FG001|Overall Study|Withdrawal by Subject|13|||
129003917|NCT00481247|464305165|FG000|Overall Study|Pregnancy|2|||
129003918|NCT00481247|464305166|FG001|Overall Study|Pregnancy|1|||
129003919|NCT00481247|464305165|FG000|Overall Study|Lost to Follow-up|1|||
129003920|NCT00481247|464305166|FG001|Overall Study|Lost to Follow-up|2|||
129003921|NCT00481247|464305165|FG000|Overall Study|Poor compliance/noncompliance|1|||
129003922|NCT00481247|464305166|FG001|Overall Study|Poor compliance/noncompliance|7|||
129003923|NCT00481247|464305165|FG000|Overall Study|Administrative reason by sponsor|157|||
129003924|NCT00481247|464305166|FG001|Overall Study|Administrative reason by sponsor|162|||
129003925|NCT00481247|464305165|FG000|Overall Study|Varied|6|||
129003926|NCT00481247|464305166|FG001|Overall Study|Varied|15|||
129003927|NCT00481247|464305165|FG000|Overall Study|Did not receive treatment|1|||
129003928|NCT00481247|464305166|FG001|Overall Study|Did not receive treatment|2|||
129003929|NCT01716754|464305167|FG000|Overall Study|Death|0|||
129003930|NCT01716754|464305168|FG001|Overall Study|Death|0|||
129003931|NCT01716754|464305169|FG002|Overall Study|Death|0|||
129003932|NCT01716754|464305170|FG003|Overall Study|Death|1|||
129003933|NCT01716754|464305167|FG000|Overall Study|Protocol deviation|0|||
129003934|NCT01716754|464305168|FG001|Overall Study|Protocol deviation|2|||
129003935|NCT01716754|464305169|FG002|Overall Study|Protocol deviation|7|||
129003936|NCT01716754|464305170|FG003|Overall Study|Protocol deviation|2|||
129003937|NCT01716754|464305167|FG000|Overall Study|Non-compliance with study treatment|0|||
129003938|NCT01716754|464305168|FG001|Overall Study|Non-compliance with study treatment|0|||
129003939|NCT01716754|464305169|FG002|Overall Study|Non-compliance with study treatment|1|||
129003940|NCT01716754|464305170|FG003|Overall Study|Non-compliance with study treatment|0|||
129003941|NCT01716754|464305167|FG000|Overall Study|Physician Decision|1|||
129003942|NCT01716754|464305168|FG001|Overall Study|Physician Decision|0|||
129003943|NCT01716754|464305169|FG002|Overall Study|Physician Decision|0|||
129003944|NCT01716754|464305170|FG003|Overall Study|Physician Decision|0|||
129003945|NCT01716754|464305167|FG000|Overall Study|Lost to Follow-up|1|||
129003946|NCT01716754|464305168|FG001|Overall Study|Lost to Follow-up|0|||
129003947|NCT01716754|464305169|FG002|Overall Study|Lost to Follow-up|0|||
129003948|NCT01716754|464305170|FG003|Overall Study|Lost to Follow-up|1|||
129003949|NCT01716754|464305167|FG000|Overall Study|Adverse Event|4|||
129003950|NCT01716754|464305168|FG001|Overall Study|Adverse Event|2|||
129003951|NCT01716754|464305169|FG002|Overall Study|Adverse Event|2|||
129003952|NCT01716754|464305170|FG003|Overall Study|Adverse Event|1|||
129003953|NCT01716754|464305167|FG000|Overall Study|Withdrawal by Subject|5|||
129003954|NCT01716754|464305168|FG001|Overall Study|Withdrawal by Subject|0|||
129003955|NCT01716754|464305169|FG002|Overall Study|Withdrawal by Subject|4|||
129003956|NCT01716754|464305170|FG003|Overall Study|Withdrawal by Subject|3|||
129003957|NCT02535000|464305172|FG000|Overall Study|Cancellation of surgery.|1|||
129003958|NCT02535000|464305173|FG001|Overall Study|Cancellation of surgery.|2|||
129003959|NCT04317781|464305174|FG000|Overall Study|Adverse Event|1|||
129003960|NCT04317781|464305174|FG000|Overall Study|Disease relapse|1|||
129003961|NCT04317781|464305174|FG000|Overall Study|Withdrawal by Subject|1|||
129003962|NCT01620489|464305175|FG000|Overall Study|Adverse Event|17|||
129003963|NCT01620489|464305176|FG001|Overall Study|Adverse Event|4|||
129003964|NCT01620489|464305175|FG000|Overall Study|Protocol Violation|0|||
129003965|NCT01620489|464305176|FG001|Overall Study|Protocol Violation|3|||
129003966|NCT01620489|464305175|FG000|Overall Study|Withdrawal Criteria|17|||
129003967|NCT01620489|464305176|FG001|Overall Study|Withdrawal Criteria|25|||
128669265|NCT02745080|463087349|FG000|Overall Study|Lost to Follow-up|3|||
128669266|NCT02745080|463087350|FG001|Overall Study|Lost to Follow-up|3|||
128669267|NCT02745080|463087349|FG000|Overall Study|Physician Decision|3|||
128669268|NCT02745080|463087350|FG001|Overall Study|Physician Decision|0|||
128669269|NCT02745080|463087349|FG000|Overall Study|Protocol Violation|3|||
128669270|NCT02745080|463087350|FG001|Overall Study|Protocol Violation|1|||
128669271|NCT02745080|463087349|FG000|Overall Study|Withdrawal by Subject|22|||
128669272|NCT02745080|463087350|FG001|Overall Study|Withdrawal by Subject|41|||
128669273|NCT01001325|463087353|FG000|Overall Study|Lost to Follow-up|16|||
128669274|NCT01001325|463087354|FG001|Overall Study|Lost to Follow-up|10|||
128669275|NCT01001325|463087353|FG000|Overall Study|Protocol Violation|2|||
128669276|NCT01001325|463087354|FG001|Overall Study|Protocol Violation|0|||
128669277|NCT00899431|463087357|FG000|Overall Study|Physician Decision|1|||
128669278|NCT00899431|463087358|FG001|Overall Study|Physician Decision|0|||
128669279|NCT00899431|463087359|FG002|Overall Study|Physician Decision|0|||
128669280|NCT00661427|463087360|FG000|Overall Study|Adverse Event|5|||
128669281|NCT00661427|463087361|FG001|Overall Study|Adverse Event|5|||
128669282|NCT00661427|463087360|FG000|Overall Study|Patient not treated|0|||
128669283|NCT00661427|463087361|FG001|Overall Study|Patient not treated|2|||
128669284|NCT01821560|463087362|FG000|Overall Study|Lost to Follow-up|5|||
128669285|NCT01821560|463087363|FG001|Overall Study|Lost to Follow-up|5|||
128669286|NCT01821560|463087362|FG000|Overall Study|Withdrawal by Subject|1|||
128669287|NCT01821560|463087363|FG001|Overall Study|Withdrawal by Subject|1|||
128669288|NCT01821560|463087362|FG000|Overall Study|Protocol Violation|0|||
128669289|NCT01821560|463087363|FG001|Overall Study|Protocol Violation|1|||
128669290|NCT00531427|463087364|FG000|Overall Study|Withdrawal by Subject|7|||
128669291|NCT00531427|463087365|FG001|Overall Study|Withdrawal by Subject|13|||
128669292|NCT00531427|463087364|FG000|Overall Study|Adverse Event|44|||
128669293|NCT00531427|463087365|FG001|Overall Study|Adverse Event|30|||
128669294|NCT00531427|463087364|FG000|Overall Study|Lost to Follow-up|4|||
128669295|NCT00531427|463087365|FG001|Overall Study|Lost to Follow-up|3|||
128669296|NCT00531427|463087364|FG000|Overall Study|Lack of Efficacy|14|||
128669297|NCT00531427|463087365|FG001|Overall Study|Lack of Efficacy|39|||
128669298|NCT00531427|463087364|FG000|Overall Study|Administrative|4|||
128669299|NCT00531427|463087365|FG001|Overall Study|Administrative|9|||
128669300|NCT01338298|463087366|FG000|Overall Study|Withdrawal by Subject|1|||
128669301|NCT01338298|463087367|FG001|Overall Study|Withdrawal by Subject|1|||
128669302|NCT01338298|463087366|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
128669303|NCT01338298|463087367|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
128669304|NCT01338298|463087366|FG000|Overall Study|Administrative error|0|||
128669305|NCT01338298|463087367|FG001|Overall Study|Administrative error|1|||
128669306|NCT01338298|463087366|FG000|Overall Study|Positive symptom worsening|1|||
128669307|NCT01338298|463087367|FG001|Overall Study|Positive symptom worsening|0|||
128669308|NCT01338298|463087366|FG000|Overall Study|Depressive symptoms and nausea|1|||
128669309|NCT01338298|463087367|FG001|Overall Study|Depressive symptoms and nausea|0|||
128669310|NCT01338298|463087366|FG000|Overall Study|Non-adherence|1|||
128669311|NCT01338298|463087367|FG001|Overall Study|Non-adherence|0|||
128669312|NCT01253577|463087370|FG000|Overall Study|Lost to Follow-up|3|||
128669313|NCT00334113|463087371|FG000|Overall Study|Lost to Follow-up|2|||
128669314|NCT00334113|463087372|FG001|Overall Study|Lost to Follow-up|2|||
128669315|NCT00334113|463087371|FG000|Overall Study|Withdrawal by Subject|0|||
128669316|NCT00334113|463087372|FG001|Overall Study|Withdrawal by Subject|1|||
128669317|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
128669318|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
128669319|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
128669320|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
128669321|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Other|2|||
128669322|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
128669323|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
129003968|NCT01620489|464305175|FG000|Overall Study|Unclassified|1|||
128669324|NCT02509026|463087373|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
128669325|NCT02509026|463087373|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
128878367|NCT00402597|463848454|FG004|Overall Study|Withdrawal by Subject|24|||
128669326|NCT02509026|463087373|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
128669327|NCT02509026|463087373|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
128669328|NCT02509026|463087373|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
128669329|NCT02509026|463087373|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
128669330|NCT05601544|463087374|FG000|Phase 2 Period 1|Adverse Event|0|||
128669331|NCT05601544|463087375|FG001|Phase 2 Period 1|Adverse Event|1|||
128669332|NCT05601544|463087376|FG002|Phase 2 Period 1|Adverse Event|0|||
129003969|NCT01620489|464305176|FG001|Overall Study|Unclassified|2|||
128669333|NCT05601544|463087377|FG003|Phase 2 Period 1|Adverse Event|0|||
128669334|NCT05601544|463087378|FG004|Phase 2 Period 1|Adverse Event|0|||
129003970|NCT01738581|464305177|FG000|Overall Study|Lost to Follow-up|1|||
129003971|NCT01738581|464305178|FG001|Overall Study|Lost to Follow-up|0|||
129003972|NCT00696709|464305179|FG000|Overall Study|Withdrawal by Subject|1|||
129003973|NCT00696709|464305180|FG001|Overall Study|Withdrawal by Subject|2|||
129003974|NCT00696709|464305181|FG002|Overall Study|Withdrawal by Subject|1|||
129003975|NCT00696709|464305182|FG003|Overall Study|Withdrawal by Subject|4|||
129003976|NCT00696709|464305183|FG004|Overall Study|Withdrawal by Subject|3|||
129003977|NCT00696709|464305179|FG000|Overall Study|Protocol Violation|1|||
129003978|NCT00696709|464305180|FG001|Overall Study|Protocol Violation|0|||
129003979|NCT00696709|464305181|FG002|Overall Study|Protocol Violation|0|||
129003980|NCT00696709|464305182|FG003|Overall Study|Protocol Violation|0|||
129003981|NCT00696709|464305183|FG004|Overall Study|Protocol Violation|0|||
129003982|NCT00696709|464305179|FG000|Overall Study|Lost to Follow-up|1|||
129003983|NCT00696709|464305180|FG001|Overall Study|Lost to Follow-up|1|||
129003984|NCT00696709|464305181|FG002|Overall Study|Lost to Follow-up|0|||
129003985|NCT00696709|464305182|FG003|Overall Study|Lost to Follow-up|0|||
129003986|NCT00696709|464305183|FG004|Overall Study|Lost to Follow-up|0|||
129003987|NCT00696709|464305179|FG000|Overall Study|Adverse Event|0|||
129003988|NCT00696709|464305180|FG001|Overall Study|Adverse Event|0|||
129003989|NCT00696709|464305181|FG002|Overall Study|Adverse Event|0|||
129003990|NCT00696709|464305182|FG003|Overall Study|Adverse Event|1|||
129003991|NCT00696709|464305183|FG004|Overall Study|Adverse Event|0|||
129003992|NCT00321711|464305184|FG000|Part A|Adverse Event|3|||
129003993|NCT00321711|464305185|FG001|Part A|Adverse Event|3|||
129003994|NCT00321711|464305186|FG002|Part A|Adverse Event|2|||
129003995|NCT00321711|464305187|FG003|Part A|Adverse Event|0|||
129003996|NCT00321711|464305188|FG004|Part A|Adverse Event|0|||
129003997|NCT00321711|464305184|FG000|Part A|Withdrawal by Subject|1|||
129003998|NCT00321711|464305185|FG001|Part A|Withdrawal by Subject|1|||
129003999|NCT00321711|464305186|FG002|Part A|Withdrawal by Subject|1|||
129004000|NCT00321711|464305187|FG003|Part A|Withdrawal by Subject|0|||
129004001|NCT00321711|464305188|FG004|Part A|Withdrawal by Subject|0|||
129004002|NCT00321711|464305184|FG000|Part A|Disease progression|0|||
129004003|NCT00321711|464305185|FG001|Part A|Disease progression|1|||
129004004|NCT00321711|464305186|FG002|Part A|Disease progression|0|||
129004005|NCT00321711|464305187|FG003|Part A|Disease progression|0|||
129004006|NCT00321711|464305188|FG004|Part A|Disease progression|0|||
129004007|NCT00321711|464305184|FG000|Part A|Requirement for alternative therapy|0|||
129004008|NCT00321711|464305185|FG001|Part A|Requirement for alternative therapy|2|||
129004009|NCT00321711|464305186|FG002|Part A|Requirement for alternative therapy|1|||
129004010|NCT00321711|464305187|FG003|Part A|Requirement for alternative therapy|0|||
129004011|NCT00321711|464305188|FG004|Part A|Requirement for alternative therapy|0|||
129004012|NCT00321711|464305184|FG000|Part A|Physician Decision|0|||
129004013|NCT00321711|464305185|FG001|Part A|Physician Decision|1|||
129004014|NCT00321711|464305186|FG002|Part A|Physician Decision|3|||
129004015|NCT00321711|464305187|FG003|Part A|Physician Decision|0|||
129004016|NCT00321711|464305188|FG004|Part A|Physician Decision|0|||
129004017|NCT00321711|464305184|FG000|Part A|Other|1|||
129004018|NCT00321711|464305185|FG001|Part A|Other|2|||
129004019|NCT00321711|464305186|FG002|Part A|Other|3|||
129004020|NCT00321711|464305187|FG003|Part A|Other|0|||
129004021|NCT00321711|464305188|FG004|Part A|Other|0|||
129004022|NCT00321711|464305184|FG000|Part A|Protocol deviation|0|||
129004023|NCT00321711|464305185|FG001|Part A|Protocol deviation|0|||
129004024|NCT00321711|464305186|FG002|Part A|Protocol deviation|1|||
129004025|NCT00321711|464305187|FG003|Part A|Protocol deviation|0|||
129004026|NCT00321711|464305188|FG004|Part A|Protocol deviation|0|||
129004027|NCT00321711|464305184|FG000|Part B|Noncompliance|0|||
129004028|NCT00321711|464305185|FG001|Part B|Noncompliance|0|||
129004029|NCT00321711|464305186|FG002|Part B|Noncompliance|0|||
128669335|NCT05601544|463087379|FG005|Phase 2 Period 1|Adverse Event|0|||
129004030|NCT00321711|464305187|FG003|Part B|Noncompliance|0|||
129004031|NCT00321711|464305188|FG004|Part B|Noncompliance|1|||
129004032|NCT00321711|464305184|FG000|Part B|Adverse Event|0|||
129004033|NCT00321711|464305185|FG001|Part B|Adverse Event|0|||
129004034|NCT00321711|464305186|FG002|Part B|Adverse Event|0|||
129004035|NCT00321711|464305187|FG003|Part B|Adverse Event|2|||
128669336|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
128669337|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
128669338|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
129004036|NCT00321711|464305188|FG004|Part B|Adverse Event|1|||
129004037|NCT00321711|464305184|FG000|Part B|Disease progression|0|||
129004038|NCT00321711|464305185|FG001|Part B|Disease progression|0|||
129004039|NCT00321711|464305186|FG002|Part B|Disease progression|0|||
129004040|NCT00321711|464305187|FG003|Part B|Disease progression|1|||
129004041|NCT00321711|464305188|FG004|Part B|Disease progression|0|||
129004042|NCT00321711|464305184|FG000|Part B|Physician Decision|0|||
129004043|NCT00321711|464305185|FG001|Part B|Physician Decision|0|||
129004044|NCT00321711|464305186|FG002|Part B|Physician Decision|0|||
129004045|NCT00321711|464305187|FG003|Part B|Physician Decision|1|||
129004046|NCT00321711|464305188|FG004|Part B|Physician Decision|2|||
128669339|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
128669340|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
128669341|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
128669342|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
129004047|NCT00321711|464305184|FG000|Part B|Death|0|||
129004048|NCT00321711|464305185|FG001|Part B|Death|0|||
129004049|NCT00321711|464305186|FG002|Part B|Death|0|||
129004050|NCT00321711|464305187|FG003|Part B|Death|2|||
129004051|NCT00321711|464305188|FG004|Part B|Death|1|||
129004052|NCT01484028|464305193|FG000|Period 1|Lost to Follow-up|0|||
129004053|NCT01484028|464305194|FG001|Period 1|Lost to Follow-up|1|||
129004054|NCT01484028|464305195|FG002|Period 1|Lost to Follow-up|0|||
129004055|NCT01484028|464305196|FG003|Period 1|Lost to Follow-up|0|||
129004056|NCT01484028|464305193|FG000|Period 1|Non-Compliance to Protocol|0|||
129004057|NCT01484028|464305194|FG001|Period 1|Non-Compliance to Protocol|1|||
129004058|NCT01484028|464305195|FG002|Period 1|Non-Compliance to Protocol|0|||
129004059|NCT01484028|464305196|FG003|Period 1|Non-Compliance to Protocol|1|||
129004060|NCT01484028|464305193|FG000|Period 1|Lens Discomfort|0|||
129004061|NCT01484028|464305194|FG001|Period 1|Lens Discomfort|1|||
129004062|NCT01484028|464305195|FG002|Period 1|Lens Discomfort|0|||
129004063|NCT01484028|464305196|FG003|Period 1|Lens Discomfort|0|||
129004064|NCT01855126|464305201|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
129004065|NCT01855126|464305202|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
129004066|NCT01855126|464305201|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
129004067|NCT01855126|464305202|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
129004068|NCT01748890|464305213|FG000|Overall Study|Insufficient recruitment for analysis|4|||
129004069|NCT03740100|464305214|FG000|Overall Study|Adverse Event|1|||
129004070|NCT03740100|464305214|FG000|Overall Study|Death|1|||
129004071|NCT03387059|464305216|FG000|Overall Study|Study termination|5|||
129004072|NCT03387059|464305217|FG001|Overall Study|Study termination|4|||
129004073|NCT01859702|464305218|FG000|Overall Study|Protocol deviation|3|||
129004074|NCT01859702|464305218|FG000|Overall Study|Adverse Event|2|||
129004075|NCT04014959|464306909|FG000|Baseline MRI and Assessments|Physician Decision|2|||
129004076|NCT04014959|464306909|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
129004077|NCT04014959|464306909|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
129004078|NCT03997448|464306914|FG000|Study Treatment|Disease Progression|1|||
129004079|NCT03997448|464306914|FG000|Study Treatment|Symptomatic Deterioration|1|||
129004080|NCT03997448|464306914|FG000|Follow up|Death|2|||
129004081|NCT03997448|464306914|FG000|Follow up|study terminated|1|||
129004082|NCT02482805|464306915|FG000|Overall Study|Lost to Follow-up|4|||
129004083|NCT02482805|464306916|FG001|Overall Study|Lost to Follow-up|4|||
129004084|NCT02482805|464306917|FG002|Overall Study|Lost to Follow-up|0|||
129004085|NCT00633152|464306929|FG000|Overall Study|Adverse Event|1|||
129004086|NCT00633152|464306930|FG001|Overall Study|Adverse Event|0|||
129004087|NCT00633152|464306929|FG000|Overall Study|Randomized, did not receive study drug|5|||
129004088|NCT00633152|464306930|FG001|Overall Study|Randomized, did not receive study drug|2|||
129004089|NCT00633152|464306929|FG000|Overall Study|Withdrawal by Subject|1|||
129004090|NCT00633152|464306930|FG001|Overall Study|Withdrawal by Subject|1|||
129004091|NCT00633152|464306929|FG000|Overall Study|Lost to Follow-up|4|||
129004092|NCT00633152|464306930|FG001|Overall Study|Lost to Follow-up|1|||
129004093|NCT00633152|464306929|FG000|Overall Study|Miscellaneous Other|3|||
129004094|NCT00633152|464306930|FG001|Overall Study|Miscellaneous Other|2|||
129004095|NCT02180061|464306931|FG000|Overall Study|Adverse Event|4|||
129004096|NCT02180061|464306932|FG001|Overall Study|Adverse Event|2|||
129004097|NCT02180061|464306931|FG000|Overall Study|Clinical Progression|5|||
129004098|NCT02180061|464306932|FG001|Overall Study|Clinical Progression|1|||
129004099|NCT02180061|464306931|FG000|Overall Study|Progressive Disease|15|||
129004100|NCT02180061|464306932|FG001|Overall Study|Progressive Disease|5|||
129004101|NCT02180061|464306931|FG000|Overall Study|Physician Decision|1|||
128669343|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
128669344|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
128669345|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
129004102|NCT02180061|464306932|FG001|Overall Study|Physician Decision|0|||
129004103|NCT01007916|464306949|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
129004104|NCT01007916|464306950|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
129004105|NCT01007916|464306949|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
128669346|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
128669347|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
129004106|NCT01007916|464306950|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
129004107|NCT01927757|464306967|FG000|Overall Study|Withdrawal by Subject|14|||
129004108|NCT01927757|464306967|FG000|Overall Study|Lost to Follow-up|2|||
129004109|NCT01927757|464306967|FG000|Overall Study|Decision by Sponsor|2|||
129004110|NCT01927757|464306967|FG000|Overall Study|Other|1|||
129004111|NCT01927757|464306967|FG000|Overall Study|Ethical Reasons|4|||
129004112|NCT00268346|464306968|FG000|Overall Study|Adverse Event|0|||
129004113|NCT00268346|464306969|FG001|Overall Study|Adverse Event|1|||
129004114|NCT00268346|464306968|FG000|Overall Study|Death|0|||
129004115|NCT00268346|464306969|FG001|Overall Study|Death|1|||
129004116|NCT00268346|464306968|FG000|Overall Study|Withdrawal by Subject|0|||
129004117|NCT00268346|464306969|FG001|Overall Study|Withdrawal by Subject|1|||
129004118|NCT00294723|464306970|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
129004119|NCT00294723|464306971|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
129004120|NCT00294723|464306972|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
129004121|NCT00294723|464306970|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
129004122|NCT00294723|464306971|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
129004123|NCT00294723|464306972|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
129004124|NCT00294723|464306970|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
129004125|NCT00294723|464306971|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
129004126|NCT00294723|464306972|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
129004127|NCT00294723|464306970|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
129004128|NCT00294723|464306971|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
129004129|NCT00294723|464306972|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
129004130|NCT00294723|464306970|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
129004131|NCT00294723|464306971|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
129004132|NCT00294723|464306972|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
129004133|NCT00294723|464306970|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
129004134|NCT00294723|464306971|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
128669348|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
129004135|NCT00294723|464306972|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
129004136|NCT00294723|464306970|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
129004137|NCT00294723|464306971|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
129004138|NCT00294723|464306972|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
129004139|NCT00294723|464306970|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
129004140|NCT00294723|464306971|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
129004141|NCT00294723|464306972|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
129004142|NCT00294723|464306970|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
129004143|NCT00294723|464306971|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
129004144|NCT00294723|464306972|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
129004145|NCT00294723|464306970|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
129004146|NCT00294723|464306971|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
129004147|NCT00294723|464306972|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
129004148|NCT00294723|464306970|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
129004149|NCT00294723|464306971|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
129004150|NCT00294723|464306972|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
129004151|NCT00294723|464306970|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
129004152|NCT00294723|464306971|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
129004153|NCT00294723|464306972|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
129004154|NCT01958281|464306973|FG000|Overall Study|Lack of Efficacy|5|||
129004155|NCT01958281|464306974|FG001|Overall Study|Lack of Efficacy|2|||
129004156|NCT01958281|464306975|FG002|Overall Study|Lack of Efficacy|0|||
129004157|NCT01958281|464306973|FG000|Overall Study|Adverse Event|0|||
129004158|NCT01958281|464306974|FG001|Overall Study|Adverse Event|2|||
129004159|NCT01958281|464306975|FG002|Overall Study|Adverse Event|0|||
129004160|NCT01958281|464306973|FG000|Overall Study|Withdrew Consent|1|||
129004161|NCT01958281|464306974|FG001|Overall Study|Withdrew Consent|0|||
129004162|NCT01958281|464306975|FG002|Overall Study|Withdrew Consent|0|||
129004163|NCT02784106|464306976|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
129004164|NCT02784106|464306977|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
129004165|NCT02784106|464306978|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129004166|NCT02784106|464306979|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129004167|NCT02784106|464306976|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
129004168|NCT02784106|464306977|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129004169|NCT02784106|464306978|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129004170|NCT02784106|464306979|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129004171|NCT02784106|464306976|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
128669349|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
128669350|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
128669351|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
128669352|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
128669353|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
128669354|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
129004172|NCT02784106|464306977|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
129004173|NCT02784106|464306978|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
129004174|NCT02784106|464306979|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
128878368|NCT00402597|463848450|FG000|Overall Study|reason not specified|30|||
128669355|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
128669356|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
128669357|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
128669358|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
128669359|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
128669360|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
128669361|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
128669362|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
128669363|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
129004175|NCT02784106|464306976|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
129004176|NCT02784106|464306977|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129004177|NCT02784106|464306978|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129004178|NCT02784106|464306979|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129004179|NCT02784106|464306976|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
129004180|NCT02784106|464306977|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
129004181|NCT02784106|464306978|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
129004182|NCT02784106|464306979|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
129004183|NCT02784106|464306976|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
129004184|NCT02784106|464306977|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
129004185|NCT02784106|464306978|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
129004186|NCT02784106|464306979|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
129004187|NCT03222141|464306982|FG000|Overall Study|Death|15|||
129004188|NCT03222141|464306982|FG000|Overall Study|Lost to Follow-up|3|||
129004189|NCT01992107|464306985|FG000|Overall Study|Administrative reasons|2|||
129004190|NCT01992107|464306986|FG001|Overall Study|Administrative reasons|0|||
129004191|NCT01992107|464306987|FG002|Overall Study|Administrative reasons|0|||
129004192|NCT01992107|464306985|FG000|Overall Study|Adverse Event|0|||
129004193|NCT01992107|464306986|FG001|Overall Study|Adverse Event|1|||
129004194|NCT01992107|464306987|FG002|Overall Study|Adverse Event|0|||
129004195|NCT01992107|464306985|FG000|Overall Study|Lost to Follow-up|46|||
129004196|NCT01992107|464306986|FG001|Overall Study|Lost to Follow-up|22|||
129004197|NCT01992107|464306987|FG002|Overall Study|Lost to Follow-up|26|||
129004198|NCT01992107|464306985|FG000|Overall Study|noncompliance and were unavailable|7|||
129004199|NCT01992107|464306986|FG001|Overall Study|noncompliance and were unavailable|3|||
129004200|NCT01992107|464306987|FG002|Overall Study|noncompliance and were unavailable|2|||
129004201|NCT01992107|464306985|FG000|Overall Study|Withdrawal by Subject|13|||
129004202|NCT01992107|464306986|FG001|Overall Study|Withdrawal by Subject|7|||
129004203|NCT01992107|464306987|FG002|Overall Study|Withdrawal by Subject|8|||
129004204|NCT02022007|464306988|FG000|Overall Study|Withdrawal by Subject|1|||
129004205|NCT02022007|464306989|FG001|Overall Study|Withdrawal by Subject|1|||
129004206|NCT02022007|464306990|FG002|Overall Study|Withdrawal by Subject|1|||
129004207|NCT02022007|464306988|FG000|Overall Study|Noncompliant|0|||
129004208|NCT02022007|464306989|FG001|Overall Study|Noncompliant|0|||
129004209|NCT02022007|464306990|FG002|Overall Study|Noncompliant|1|||
129004210|NCT01107535|464306991|FG000|Overall Study|Death|5|||
129004211|NCT01214603|464306992|FG000|Overall Study|Adverse Event|0|||
129004212|NCT01214603|464306993|FG001|Overall Study|Adverse Event|0|||
129004213|NCT01214603|464306994|FG002|Overall Study|Adverse Event|1|||
129004214|NCT01214603|464306992|FG000|Overall Study|Death|1|||
129004215|NCT01214603|464306993|FG001|Overall Study|Death|0|||
129004216|NCT01214603|464306994|FG002|Overall Study|Death|0|||
129004217|NCT01214603|464306992|FG000|Overall Study|Progressive Disease|4|||
129004218|NCT01214603|464306993|FG001|Overall Study|Progressive Disease|1|||
129004219|NCT01214603|464306994|FG002|Overall Study|Progressive Disease|3|||
129004220|NCT02444533|464306995|FG000|Overall Study|Not able to complete forms|0|||
129004221|NCT02444533|464306996|FG001|Overall Study|Not able to complete forms|2|||
129004222|NCT02444533|464306995|FG000|Overall Study|Only gave post-procedure complications|2|||
129004223|NCT02444533|464306996|FG001|Overall Study|Only gave post-procedure complications|2|||
129004224|NCT01388647|464306997|FG000|Overall Study|Adverse Event|1|||
129004225|NCT01388647|464306998|FG001|Overall Study|Adverse Event|2|||
129004226|NCT03567057|464306999|FG000|Overall Study|Adverse Event|56|||
129004227|NCT03567057|464307000|FG001|Overall Study|Adverse Event|53|||
129004228|NCT03567057|464307001|FG002|Overall Study|Adverse Event|28|||
129004229|NCT03567057|464306999|FG000|Overall Study|Withdrawal by Subject|22|||
129004230|NCT03567057|464307000|FG001|Overall Study|Withdrawal by Subject|24|||
129004231|NCT03567057|464307001|FG002|Overall Study|Withdrawal by Subject|13|||
129004232|NCT03567057|464306999|FG000|Overall Study|Lost to Follow-up|3|||
129004233|NCT03567057|464307000|FG001|Overall Study|Lost to Follow-up|5|||
129004234|NCT03567057|464307001|FG002|Overall Study|Lost to Follow-up|2|||
129004235|NCT03567057|464306999|FG000|Overall Study|COVID-19 pandemic|4|||
129004236|NCT03567057|464307000|FG001|Overall Study|COVID-19 pandemic|3|||
129004237|NCT03567057|464307001|FG002|Overall Study|COVID-19 pandemic|0|||
129004238|NCT03567057|464306999|FG000|Overall Study|Non-compliance with study drug|4|||
129004239|NCT03567057|464307000|FG001|Overall Study|Non-compliance with study drug|2|||
129004240|NCT03567057|464307001|FG002|Overall Study|Non-compliance with study drug|0|||
129004241|NCT03567057|464306999|FG000|Overall Study|Lack of Efficacy|3|||
129004242|NCT03567057|464307000|FG001|Overall Study|Lack of Efficacy|0|||
129004243|NCT03567057|464307001|FG002|Overall Study|Lack of Efficacy|1|||
129004244|NCT03567057|464306999|FG000|Overall Study|Death|1|||
129004245|NCT03567057|464307000|FG001|Overall Study|Death|0|||
129004246|NCT03567057|464307001|FG002|Overall Study|Death|0|||
129004247|NCT03567057|464306999|FG000|Overall Study|Physician Decision|1|||
129004248|NCT03567057|464307000|FG001|Overall Study|Physician Decision|0|||
129004249|NCT03567057|464307001|FG002|Overall Study|Physician Decision|0|||
129004250|NCT03567057|464306999|FG000|Overall Study|Unstable medical condition|1|||
129004251|NCT03567057|464307000|FG001|Overall Study|Unstable medical condition|0|||
129004252|NCT03567057|464307001|FG002|Overall Study|Unstable medical condition|0|||
129004253|NCT03567057|464306999|FG000|Overall Study|Medical history event|0|||
129004254|NCT03567057|464307000|FG001|Overall Study|Medical history event|0|||
129004255|NCT03567057|464307001|FG002|Overall Study|Medical history event|1|||
129004256|NCT03567057|464306999|FG000|Overall Study|Other|0|||
129004257|NCT03567057|464307000|FG001|Overall Study|Other|0|||
129004258|NCT03567057|464307001|FG002|Overall Study|Other|1|||
129004259|NCT00490061|464307002|FG000|Overall Study|Physician Decision|1|||
129004260|NCT01155583|464307003|FG000|Phase I|Screen failure - did not start treatment|0|||
129004261|NCT01155583|464307004|FG001|Phase I|Screen failure - did not start treatment|0|||
129004262|NCT01155583|464307005|FG002|Phase I|Screen failure - did not start treatment|0|||
129004263|NCT01155583|464307006|FG003|Phase I|Screen failure - did not start treatment|0|||
129004264|NCT01155583|464307007|FG004|Phase I|Screen failure - did not start treatment|1|||
129004265|NCT01155583|464307008|FG005|Phase I|Screen failure - did not start treatment|0|||
129004266|NCT01155583|464307009|FG006|Phase I|Screen failure - did not start treatment|0|||
129004267|NCT01155583|464307010|FG007|Phase I|Screen failure - did not start treatment|2|||
129004268|NCT01155583|464307011|FG008|Phase I|Screen failure - did not start treatment|0|||
129004269|NCT01155583|464307003|FG000|Phase I|Withdrawal by Subject|0|||
129004270|NCT01155583|464307004|FG001|Phase I|Withdrawal by Subject|0|||
129004271|NCT01155583|464307005|FG002|Phase I|Withdrawal by Subject|0|||
128669364|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
128669365|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
128669366|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
128669367|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
128669368|NCT03818035|463087389|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
128669369|NCT03818035|463087390|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
128669370|NCT03818035|463087391|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
128669371|NCT03818035|463087392|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
128669372|NCT03818035|463087389|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
128669373|NCT03818035|463087390|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
128669374|NCT03818035|463087391|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
128669375|NCT03818035|463087392|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
128669376|NCT03818035|463087389|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
128669377|NCT03818035|463087390|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
128669378|NCT03818035|463087391|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
128669379|NCT03818035|463087392|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
128669380|NCT03818035|463087389|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
128669381|NCT03818035|463087390|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
128669382|NCT03818035|463087391|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
128669383|NCT03818035|463087392|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
128669384|NCT03818035|463087389|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
128669385|NCT03818035|463087390|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
128669386|NCT03818035|463087391|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
128669387|NCT03818035|463087392|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
128669388|NCT03818035|463087389|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
128669389|NCT03818035|463087390|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
128669390|NCT03818035|463087391|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
128669391|NCT03818035|463087392|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
128669392|NCT03818035|463087389|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
128669393|NCT03818035|463087390|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
128669394|NCT03818035|463087391|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
128669395|NCT03818035|463087392|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
128669396|NCT03374202|463087393|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
128669397|NCT03374202|463087394|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
128669398|NCT03374202|463087395|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
128669399|NCT03374202|463087393|FG000|Five Year Long Term Follow Up|Death|0|||
128669400|NCT03374202|463087394|FG001|Five Year Long Term Follow Up|Death|1|||
129004272|NCT01155583|464307006|FG003|Phase I|Withdrawal by Subject|0|||
129004273|NCT01155583|464307007|FG004|Phase I|Withdrawal by Subject|0|||
129004274|NCT01155583|464307008|FG005|Phase I|Withdrawal by Subject|0|||
129004275|NCT01155583|464307009|FG006|Phase I|Withdrawal by Subject|0|||
129004276|NCT01155583|464307010|FG007|Phase I|Withdrawal by Subject|1|||
128669401|NCT03374202|463087395|FG002|Five Year Long Term Follow Up|Death|0|||
129004277|NCT01155583|464307011|FG008|Phase I|Withdrawal by Subject|0|||
129004278|NCT00952484|464307012|FG000|Overall Study|Withdrawal by Subject|0|||
129004279|NCT00952484|464307013|FG001|Overall Study|Withdrawal by Subject|1|||
129004280|NCT00952484|464307014|FG002|Overall Study|Withdrawal by Subject|0|||
129004281|NCT00886483|464307025|FG000|Overall Study|Lost to Follow-up|0|||
129004282|NCT00886483|464307026|FG001|Overall Study|Lost to Follow-up|1|||
129004283|NCT00886483|464307025|FG000|Overall Study|Pursue medications|1|||
129004284|NCT00886483|464307026|FG001|Overall Study|Pursue medications|2|||
129004285|NCT00886483|464307025|FG000|Overall Study|Distance to center, poor grades|1|||
129004286|NCT00886483|464307026|FG001|Overall Study|Distance to center, poor grades|0|||
129004287|NCT00192296|464307029|FG000|Overall Study|Withdrawal by Subject|0|||
129004288|NCT00192296|464307030|FG001|Overall Study|Withdrawal by Subject|1|||
129004289|NCT00192296|464307031|FG002|Overall Study|Withdrawal by Subject|0|||
129004290|NCT00192296|464307032|FG003|Overall Study|Withdrawal by Subject|0|||
129004291|NCT00617461|464307033|FG000|First Treatment Intervention Period|Adverse Event|2|||
129004292|NCT00617461|464307034|FG001|First Treatment Intervention Period|Adverse Event|0|||
129004293|NCT00617461|464307033|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
129004294|NCT00617461|464307034|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
129004295|NCT00617461|464307033|FG000|First Treatment Intervention Period|Protocol Violation|2|||
129004296|NCT00617461|464307034|FG001|First Treatment Intervention Period|Protocol Violation|1|||
129004297|NCT00617461|464307033|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
129004298|NCT00617461|464307034|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
129004299|NCT00617461|464307033|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
128669402|NCT00843284|463088896|FG000|Overall Study|Adverse Event|39|||
128669403|NCT00843284|463088896|FG000|Overall Study|Lack of Efficacy|5|||
128669404|NCT00843284|463088896|FG000|Overall Study|Lost to Follow-up|11|||
128669405|NCT00843284|463088896|FG000|Overall Study|Other|10|||
128669406|NCT00843284|463088896|FG000|Overall Study|Withdrawal by Subject|4|||
128669407|NCT00843284|463088896|FG000|Overall Study|Death|3|||
128669408|NCT00122980|463088901|FG000|Overall Study|Death|0|||
128669409|NCT00122980|463088902|FG001|Overall Study|Death|1|||
128669410|NCT00122980|463088901|FG000|Overall Study|Physician Decision|2|||
128669411|NCT00122980|463088902|FG001|Overall Study|Physician Decision|0|||
128669412|NCT00122980|463088901|FG000|Overall Study|Protocol Violation|5|||
128669413|NCT00122980|463088902|FG001|Overall Study|Protocol Violation|1|||
128669414|NCT00122980|463088901|FG000|Overall Study|Withdrawal by Subject|2|||
128669415|NCT00122980|463088902|FG001|Overall Study|Withdrawal by Subject|3|||
128669416|NCT00122980|463088901|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
128669417|NCT00122980|463088902|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
128669418|NCT00122980|463088901|FG000|Overall Study|Study termination|27|||
128669419|NCT00122980|463088902|FG001|Overall Study|Study termination|35|||
128669420|NCT01124864|463088903|FG000|Overall Study|Follow up phase competed as per protocol|18|||
128669421|NCT01124864|463088904|FG001|Overall Study|Follow up phase competed as per protocol|22|||
128669422|NCT01124864|463088905|FG002|Overall Study|Follow up phase competed as per protocol|24|||
128669423|NCT01124864|463088906|FG003|Overall Study|Follow up phase competed as per protocol|18|||
128669424|NCT01124864|463088907|FG004|Overall Study|Follow up phase competed as per protocol|26|||
128669425|NCT01124864|463088908|FG005|Overall Study|Follow up phase competed as per protocol|2|||
128669426|NCT01124864|463088903|FG000|Overall Study|Death|6|||
128669427|NCT01124864|463088904|FG001|Overall Study|Death|9|||
128669428|NCT01124864|463088905|FG002|Overall Study|Death|6|||
128669429|NCT01124864|463088906|FG003|Overall Study|Death|2|||
128669430|NCT01124864|463088907|FG004|Overall Study|Death|1|||
128669431|NCT01124864|463088908|FG005|Overall Study|Death|0|||
128669432|NCT01124864|463088903|FG000|Overall Study|Withdrawal by Subject|2|||
128669433|NCT01124864|463088904|FG001|Overall Study|Withdrawal by Subject|3|||
128669434|NCT01124864|463088905|FG002|Overall Study|Withdrawal by Subject|4|||
128669435|NCT01124864|463088906|FG003|Overall Study|Withdrawal by Subject|0|||
128669436|NCT01124864|463088907|FG004|Overall Study|Withdrawal by Subject|2|||
128669437|NCT01124864|463088908|FG005|Overall Study|Withdrawal by Subject|1|||
128669438|NCT01124864|463088903|FG000|Overall Study|Lost to Follow-up|1|||
128669439|NCT01124864|463088904|FG001|Overall Study|Lost to Follow-up|1|||
128669440|NCT01124864|463088905|FG002|Overall Study|Lost to Follow-up|0|||
128669441|NCT01124864|463088906|FG003|Overall Study|Lost to Follow-up|1|||
128669442|NCT01124864|463088907|FG004|Overall Study|Lost to Follow-up|0|||
128669443|NCT01124864|463088908|FG005|Overall Study|Lost to Follow-up|0|||
128669444|NCT01124864|463088903|FG000|Overall Study|Protocol Violation|1|||
128669445|NCT01124864|463088904|FG001|Overall Study|Protocol Violation|0|||
128669446|NCT01124864|463088905|FG002|Overall Study|Protocol Violation|0|||
128669447|NCT01124864|463088906|FG003|Overall Study|Protocol Violation|0|||
128669448|NCT01124864|463088907|FG004|Overall Study|Protocol Violation|1|||
128669449|NCT01124864|463088908|FG005|Overall Study|Protocol Violation|0|||
128669450|NCT01243242|463088909|FG000|Overall Study|Adverse Event|1|||
129004300|NCT00617461|464307034|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
129004301|NCT00617461|464307033|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
129004302|NCT00617461|464307034|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
129004303|NCT00617461|464307033|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
129004304|NCT00617461|464307034|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
129004305|NCT00617461|464307033|FG000|Second Treatment Intervention Period|Adverse Event|0|||
129004306|NCT00617461|464307034|FG001|Second Treatment Intervention Period|Adverse Event|1|||
129004307|NCT00617461|464307033|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
129004308|NCT00617461|464307034|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
129004309|NCT00617461|464307033|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
129004310|NCT00617461|464307034|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
129004311|NCT00617461|464307033|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
129004312|NCT00617461|464307034|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
129004313|NCT00903383|464307038|FG000|Overall Study|Adverse Event|1|||
129004314|NCT00903383|464307039|FG001|Overall Study|Adverse Event|2|||
129004315|NCT00903383|464307040|FG002|Overall Study|Adverse Event|3|||
129004316|NCT00903383|464307041|FG003|Overall Study|Adverse Event|1|||
129004317|NCT00903383|464307038|FG000|Overall Study|Physician Decision|1|||
129004318|NCT00903383|464307039|FG001|Overall Study|Physician Decision|2|||
129004319|NCT00903383|464307040|FG002|Overall Study|Physician Decision|0|||
129004320|NCT00903383|464307041|FG003|Overall Study|Physician Decision|0|||
129004321|NCT00903383|464307038|FG000|Overall Study|Lost to Follow-up|0|||
129004322|NCT00903383|464307039|FG001|Overall Study|Lost to Follow-up|0|||
129004323|NCT00903383|464307040|FG002|Overall Study|Lost to Follow-up|0|||
129004324|NCT00903383|464307041|FG003|Overall Study|Lost to Follow-up|1|||
129004325|NCT00903383|464307038|FG000|Overall Study|Decision of Sponsor|1|||
129004326|NCT00903383|464307039|FG001|Overall Study|Decision of Sponsor|0|||
129004327|NCT00903383|464307040|FG002|Overall Study|Decision of Sponsor|0|||
129004328|NCT00903383|464307041|FG003|Overall Study|Decision of Sponsor|0|||
129004329|NCT00903383|464307038|FG000|Overall Study|Withdrawal by Subject|4|||
129004330|NCT00903383|464307039|FG001|Overall Study|Withdrawal by Subject|1|||
129004331|NCT00903383|464307040|FG002|Overall Study|Withdrawal by Subject|0|||
129004332|NCT00903383|464307041|FG003|Overall Study|Withdrawal by Subject|2|||
129004333|NCT00903383|464307038|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
129004334|NCT00903383|464307039|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
129004335|NCT00903383|464307040|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
129004336|NCT00903383|464307041|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
129004337|NCT00903383|464307038|FG000|Overall Study|Patient Decision|0|||
129004338|NCT00903383|464307039|FG001|Overall Study|Patient Decision|0|||
129004339|NCT00903383|464307040|FG002|Overall Study|Patient Decision|0|||
129004340|NCT00903383|464307041|FG003|Overall Study|Patient Decision|1|||
129004341|NCT01821625|464307044|FG000|Overall Study|Withdrawal by Subject|2|||
129004342|NCT01821625|464307044|FG000|Overall Study|Lack of Efficacy|2|||
129004343|NCT01821625|464307044|FG000|Overall Study|Adverse Event|1|||
129004344|NCT01821625|464307044|FG000|Overall Study|Medical contraindication|1|||
129004345|NCT00320593|464307047|FG000|Overall Study|Lost to Follow-up|3|||
129004346|NCT00320593|464307048|FG001|Overall Study|Lost to Follow-up|0|||
129004347|NCT00320593|464307047|FG000|Overall Study|Moved to another state|1|||
129004348|NCT00320593|464307048|FG001|Overall Study|Moved to another state|0|||
129004349|NCT00320593|464307047|FG000|Overall Study|Withdrawal by Subject|2|||
129004350|NCT00320593|464307048|FG001|Overall Study|Withdrawal by Subject|1|||
129004351|NCT00320593|464307047|FG000|Overall Study|Withdrawal by clinical center|1|||
129004352|NCT00320593|464307048|FG001|Overall Study|Withdrawal by clinical center|0|||
129004353|NCT00457665|464307049|FG000|12 Months|Drug allergy|1|||
129004354|NCT00457665|464307050|FG001|12 Months|Drug allergy|1|||
129004355|NCT00457665|464307049|FG000|12 Months|High HIV viral load|5|||
129004356|NCT00457665|464307050|FG001|12 Months|High HIV viral load|1|||
129004357|NCT00457665|464307049|FG000|12 Months|Lipodystrophy|2|||
129004358|NCT00457665|464307050|FG001|12 Months|Lipodystrophy|0|||
129004359|NCT00457665|464307049|FG000|12 Months|Withdrawal by Subject|0|||
129004360|NCT00457665|464307050|FG001|12 Months|Withdrawal by Subject|2|||
129004361|NCT00457665|464307049|FG000|12 Months|Abnormal Liver function tests|0|||
129004362|NCT00457665|464307050|FG001|12 Months|Abnormal Liver function tests|5|||
129004363|NCT00457665|464307049|FG000|24 Months|Withdrawal by Subject|3|||
129004364|NCT00457665|464307050|FG001|24 Months|Withdrawal by Subject|2|||
129004365|NCT00457665|464307049|FG000|24 Months|Lipodystrophy|1|||
128669451|NCT01243242|463088910|FG001|Overall Study|Adverse Event|1|||
128669452|NCT01243242|463088909|FG000|Overall Study|Withdrawal by Subject|1|||
128669453|NCT01243242|463088910|FG001|Overall Study|Withdrawal by Subject|1|||
129004366|NCT00457665|464307050|FG001|24 Months|Lipodystrophy|1|||
129004367|NCT00457665|464307049|FG000|24 Months|Abnormal liver function tests|1|||
129004368|NCT00457665|464307050|FG001|24 Months|Abnormal liver function tests|5|||
129004369|NCT02649231|464307052|FG000|Overall Study|Adverse Event|0|||
129004370|NCT02649231|464307053|FG001|Overall Study|Adverse Event|0|||
129004371|NCT02649231|464307054|FG002|Overall Study|Adverse Event|0|||
129004372|NCT02649231|464307055|FG003|Overall Study|Adverse Event|1|||
129004373|NCT02649231|464307052|FG000|Overall Study|Lost to Follow-up|2|||
129004374|NCT02649231|464307053|FG001|Overall Study|Lost to Follow-up|1|||
129004375|NCT02649231|464307054|FG002|Overall Study|Lost to Follow-up|1|||
129004376|NCT02649231|464307055|FG003|Overall Study|Lost to Follow-up|0|||
129004377|NCT02649231|464307052|FG000|Overall Study|Withdrawal by Subject|0|||
129004378|NCT02649231|464307053|FG001|Overall Study|Withdrawal by Subject|1|||
129004379|NCT02649231|464307054|FG002|Overall Study|Withdrawal by Subject|0|||
129004380|NCT02649231|464307055|FG003|Overall Study|Withdrawal by Subject|1|||
129004381|NCT02649231|464307052|FG000|Overall Study|Protocol Violation|2|||
129004382|NCT02649231|464307053|FG001|Overall Study|Protocol Violation|1|||
129004383|NCT02649231|464307054|FG002|Overall Study|Protocol Violation|1|||
129004384|NCT02649231|464307055|FG003|Overall Study|Protocol Violation|0|||
129004385|NCT01851590|464307060|FG000|Overall Study|Withdrawal by Subject|0|||
129004386|NCT01851590|464307061|FG001|Overall Study|Withdrawal by Subject|0|||
129004387|NCT01851590|464307062|FG002|Overall Study|Withdrawal by Subject|1|||
129004388|NCT01851590|464307060|FG000|Overall Study|Adverse Event|0|||
129004389|NCT01851590|464307061|FG001|Overall Study|Adverse Event|0|||
129004390|NCT01851590|464307062|FG002|Overall Study|Adverse Event|2|||
129004391|NCT01851590|464307060|FG000|Overall Study|Lack of Efficacy|0|||
129004392|NCT01851590|464307061|FG001|Overall Study|Lack of Efficacy|1|||
129004393|NCT01851590|464307062|FG002|Overall Study|Lack of Efficacy|0|||
129004394|NCT00310856|464307065|FG000|Overall Study|Withdrawal by Subject|2|||
129004395|NCT00310856|464307066|FG001|Overall Study|Withdrawal by Subject|2|||
129004396|NCT00310856|464307067|FG002|Overall Study|Withdrawal by Subject|2|||
129004397|NCT00310856|464307065|FG000|Overall Study|Lost to Follow-up|1|||
129004398|NCT00310856|464307066|FG001|Overall Study|Lost to Follow-up|2|||
129004399|NCT00310856|464307067|FG002|Overall Study|Lost to Follow-up|6|||
129004400|NCT00310856|464307065|FG000|Overall Study|Inappropriate enrollment|1|||
129004401|NCT00310856|464307066|FG001|Overall Study|Inappropriate enrollment|1|||
129004402|NCT00310856|464307067|FG002|Overall Study|Inappropriate enrollment|0|||
129004403|NCT00310856|464307065|FG000|Overall Study|Unable to classify|1|||
129004404|NCT00310856|464307066|FG001|Overall Study|Unable to classify|0|||
129004405|NCT00310856|464307067|FG002|Overall Study|Unable to classify|0|||
129004406|NCT02611752|464307068|FG000|Overall Study|Adverse Event|0|||
129004407|NCT02611752|464307069|FG001|Overall Study|Adverse Event|1|||
129004408|NCT00947856|464307075|FG000|Treatment Period|Progressive Disease|33|||
129004409|NCT00947856|464307076|FG001|Treatment Period|Progressive Disease|12|||
129004410|NCT00947856|464307075|FG000|Treatment Period|Adverse Event|15|||
129004411|NCT00947856|464307076|FG001|Treatment Period|Adverse Event|9|||
129004412|NCT00947856|464307075|FG000|Treatment Period|Physician Decision|14|||
129004413|NCT00947856|464307076|FG001|Treatment Period|Physician Decision|6|||
129004414|NCT00947856|464307075|FG000|Treatment Period|Study Stopped by Sponsor|4|||
129004415|NCT00947856|464307076|FG001|Treatment Period|Study Stopped by Sponsor|4|||
129004416|NCT00947856|464307075|FG000|Treatment Period|Withdrawal by Subject|12|||
129004417|NCT00947856|464307076|FG001|Treatment Period|Withdrawal by Subject|1|||
129004418|NCT00947856|464307075|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
129004419|NCT00947856|464307076|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
129004420|NCT00947856|464307075|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
129004421|NCT00947856|464307076|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
129004422|NCT00947856|464307075|FG000|Follow-up Period|Lost to Follow-up|7|||
129004423|NCT00947856|464307076|FG001|Follow-up Period|Lost to Follow-up|0|||
129004424|NCT00947856|464307075|FG000|Follow-up Period|Patient unavailable for site visits|1|||
129004425|NCT00947856|464307076|FG001|Follow-up Period|Patient unavailable for site visits|0|||
129004426|NCT00947856|464307075|FG000|Follow-up Period|Withdrawal by Subject|1|||
129004427|NCT00947856|464307076|FG001|Follow-up Period|Withdrawal by Subject|0|||
129004428|NCT01211769|464307077|FG000|Overall Study|Lost to Follow-up|7|||
129004429|NCT01211769|464307078|FG001|Overall Study|Lost to Follow-up|9|||
129004430|NCT01211769|464307079|FG002|Overall Study|Lost to Follow-up|5|||
129004431|NCT01211769|464307080|FG003|Overall Study|Lost to Follow-up|9|||
129004432|NCT01211769|464307077|FG000|Overall Study|Physician Decision|2|||
128669454|NCT01243242|463088909|FG000|Overall Study|Physician Decision|0|||
128669455|NCT01243242|463088910|FG001|Overall Study|Physician Decision|1|||
128669456|NCT01243242|463088909|FG000|Overall Study|sponsor decision|0|||
129004433|NCT01211769|464307078|FG001|Overall Study|Physician Decision|0|||
129004434|NCT01211769|464307079|FG002|Overall Study|Physician Decision|2|||
129004435|NCT01211769|464307080|FG003|Overall Study|Physician Decision|1|||
129004436|NCT01211769|464307077|FG000|Overall Study|Adverse Event|0|||
129004437|NCT01211769|464307078|FG001|Overall Study|Adverse Event|1|||
129004438|NCT01211769|464307079|FG002|Overall Study|Adverse Event|1|||
129004439|NCT01211769|464307080|FG003|Overall Study|Adverse Event|1|||
129004440|NCT01348542|464307081|FG000|Overall Study|Withdrawal by Subject|3|||
129004441|NCT01348542|464307082|FG001|Overall Study|Withdrawal by Subject|0|||
129004442|NCT03402893|464307083|FG000|Overall Study|Withdrawal by Subject|1|||
128669457|NCT01243242|463088910|FG001|Overall Study|sponsor decision|1|||
128669458|NCT01243242|463088909|FG000|Overall Study|non compliance|1|||
129004443|NCT00926289|464307084|FG000|Overall Study|Adverse Event|9|||
129004444|NCT00926289|464307085|FG001|Overall Study|Adverse Event|11|||
129004445|NCT00926289|464307084|FG000|Overall Study|Protocol Violation|8|||
129004446|NCT00926289|464307085|FG001|Overall Study|Protocol Violation|12|||
129004447|NCT00926289|464307084|FG000|Overall Study|Lost to Follow-up|3|||
129004448|NCT00926289|464307085|FG001|Overall Study|Lost to Follow-up|6|||
129004449|NCT00926289|464307084|FG000|Overall Study|Withdrawal by Subject|4|||
129004450|NCT00926289|464307085|FG001|Overall Study|Withdrawal by Subject|4|||
129004451|NCT00926289|464307084|FG000|Overall Study|Other|1|||
129004452|NCT00926289|464307085|FG001|Overall Study|Other|3|||
129004453|NCT00146770|464307087|FG000|Overall Study|Adverse Event|2|||
129004454|NCT00146770|464307088|FG001|Overall Study|Adverse Event|0|||
129004455|NCT00146770|464307087|FG000|Overall Study|Pregnancy|1|||
129004456|NCT00146770|464307088|FG001|Overall Study|Pregnancy|0|||
129004457|NCT00146770|464307087|FG000|Overall Study|Withdrawal by Subject|2|||
129004458|NCT00146770|464307088|FG001|Overall Study|Withdrawal by Subject|0|||
129004459|NCT02995837|464307094|FG000|Overall Study|Lost to Follow-up|9|||
129004460|NCT02995837|464307095|FG001|Overall Study|Lost to Follow-up|8|||
129004461|NCT01077713|464307096|FG000|Overall Study|Withdrawal by Subject|1|||
129004462|NCT01077713|464307097|FG001|Overall Study|Withdrawal by Subject|2|||
129004463|NCT01077713|464307096|FG000|Overall Study|Progressive Disease (PD)|0|||
129004464|NCT01077713|464307097|FG001|Overall Study|Progressive Disease (PD)|1|||
128669459|NCT01243242|463088910|FG001|Overall Study|non compliance|0|||
128669460|NCT01256294|463088920|FG000|Overall Study|Adverse Event|1|||
128669461|NCT01256294|463088921|FG001|Overall Study|Adverse Event|0|||
128669462|NCT01256294|463088920|FG000|Overall Study|Withdrawal by Subject|1|||
128669463|NCT01256294|463088921|FG001|Overall Study|Withdrawal by Subject|1|||
128669464|NCT01256294|463088920|FG000|Overall Study|Protocol deviation|2|||
128669465|NCT01256294|463088921|FG001|Overall Study|Protocol deviation|1|||
128669466|NCT02160899|463088922|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
128669467|NCT02160899|463088923|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
128669468|NCT02160899|463088924|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
128669469|NCT02160899|463088925|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
128669470|NCT02160899|463088926|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
128669471|NCT02160899|463088927|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
128669472|NCT01945710|463088929|FG000|Overall Study|Progressive Disease|5|||
128669473|NCT01945710|463088930|FG001|Overall Study|Progressive Disease|4|||
128669474|NCT01945710|463088931|FG002|Overall Study|Progressive Disease|3|||
128669475|NCT01945710|463088932|FG003|Overall Study|Progressive Disease|2|||
129004465|NCT01077713|464307096|FG000|Overall Study|Death|28|||
128669476|NCT01945710|463088933|FG004|Overall Study|Progressive Disease|7|||
128669477|NCT01945710|463088934|FG005|Overall Study|Progressive Disease|3|||
128669478|NCT01945710|463088935|FG006|Overall Study|Progressive Disease|19|||
128669479|NCT01945710|463088929|FG000|Overall Study|Adverse Event|0|||
128669480|NCT01945710|463088930|FG001|Overall Study|Adverse Event|1|||
128669481|NCT01945710|463088931|FG002|Overall Study|Adverse Event|0|||
128669482|NCT01945710|463088932|FG003|Overall Study|Adverse Event|0|||
128669483|NCT01945710|463088933|FG004|Overall Study|Adverse Event|0|||
128669484|NCT01945710|463088934|FG005|Overall Study|Adverse Event|0|||
128669485|NCT01945710|463088935|FG006|Overall Study|Adverse Event|0|||
128669486|NCT01945710|463088929|FG000|Overall Study|Other|2|||
128669487|NCT01945710|463088930|FG001|Overall Study|Other|0|||
128669488|NCT01945710|463088931|FG002|Overall Study|Other|3|||
129004466|NCT01077713|464307097|FG001|Overall Study|Death|29|||
129004467|NCT01077713|464307096|FG000|Overall Study|Lost to Follow-up|1|||
129004468|NCT01077713|464307097|FG001|Overall Study|Lost to Follow-up|1|||
129004469|NCT01077713|464307096|FG000|Overall Study|Adverse Event|2|||
129004470|NCT01077713|464307097|FG001|Overall Study|Adverse Event|1|||
129004471|NCT01077713|464307096|FG000|Overall Study|Other|4|||
129004472|NCT01077713|464307097|FG001|Overall Study|Other|2|||
129004473|NCT00289458|464307098|FG000|Overall Study|Death|1|||
129004474|NCT00289458|464307099|FG001|Overall Study|Death|0|||
129004475|NCT00289458|464307100|FG002|Overall Study|Death|0|||
129004476|NCT00289458|464307098|FG000|Overall Study|Physician Decision|3|||
129004477|NCT00289458|464307099|FG001|Overall Study|Physician Decision|4|||
129004478|NCT00289458|464307100|FG002|Overall Study|Physician Decision|2|||
129004479|NCT00289458|464307098|FG000|Overall Study|Withdrawal by Subject|2|||
129004480|NCT00289458|464307099|FG001|Overall Study|Withdrawal by Subject|2|||
128669489|NCT01945710|463088932|FG003|Overall Study|Other|1|||
128669490|NCT01945710|463088933|FG004|Overall Study|Other|1|||
129004481|NCT00289458|464307100|FG002|Overall Study|Withdrawal by Subject|4|||
129004482|NCT00874757|464307101|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
128669491|NCT01945710|463088934|FG005|Overall Study|Other|0|||
129004483|NCT02806232|464309180|FG000|Overall Study|Lost to Follow-up|1|||
129004484|NCT02806232|464309181|FG001|Overall Study|Lost to Follow-up|2|||
129004485|NCT02806232|464309182|FG002|Overall Study|Lost to Follow-up|1|||
129004486|NCT02806232|464309183|FG003|Overall Study|Lost to Follow-up|0|||
129004487|NCT02806232|464309184|FG004|Overall Study|Lost to Follow-up|0|||
129004488|NCT02806232|464309185|FG005|Overall Study|Lost to Follow-up|1|||
128669492|NCT01945710|463088935|FG006|Overall Study|Other|4|||
128669493|NCT01945710|463088929|FG000|Overall Study|Withdrawal by Subject|0|||
128669494|NCT01945710|463088930|FG001|Overall Study|Withdrawal by Subject|1|||
128669495|NCT01945710|463088931|FG002|Overall Study|Withdrawal by Subject|1|||
129004489|NCT02806232|464309186|FG006|Overall Study|Lost to Follow-up|0|||
128669496|NCT01945710|463088932|FG003|Overall Study|Withdrawal by Subject|0|||
129004490|NCT02806232|464309187|FG007|Overall Study|Lost to Follow-up|0|||
128669497|NCT01945710|463088933|FG004|Overall Study|Withdrawal by Subject|1|||
128669498|NCT01945710|463088934|FG005|Overall Study|Withdrawal by Subject|0|||
128669499|NCT01945710|463088935|FG006|Overall Study|Withdrawal by Subject|0|||
128669500|NCT01368562|463088936|FG000|Overall Study|Adverse Event|1|||
128669501|NCT01368562|463088936|FG000|Overall Study|Disease progression|1|||
128669502|NCT01368562|463088936|FG000|Overall Study|Lost to Follow-up|1|||
128669503|NCT01368562|463088936|FG000|Overall Study|Death|6|||
128669504|NCT01368562|463088936|FG000|Overall Study|Unresponsive to treatment|5|||
128669505|NCT01368562|463088936|FG000|Overall Study|Other|3|||
128669506|NCT01368562|463088936|FG000|Overall Study|Other than specified|2|||
128669507|NCT01754727|463088939|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
128669508|NCT00095940|463088943|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
128669509|NCT00095940|463088944|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
128669510|NCT00095940|463088945|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
128669511|NCT00095940|463088946|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
128669512|NCT00095940|463088947|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
128669513|NCT00095940|463088948|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
128669514|NCT00095940|463088949|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
128669515|NCT00095940|463088950|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
128669516|NCT00095940|463088951|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
128669517|NCT00095940|463088943|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
128669518|NCT00095940|463088944|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
128669519|NCT00095940|463088945|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
128669520|NCT00095940|463088946|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
128669521|NCT00095940|463088947|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
128669522|NCT00095940|463088948|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
128669523|NCT00095940|463088949|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
128669524|NCT00095940|463088950|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
128669525|NCT00095940|463088951|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
128669526|NCT00095940|463088943|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669527|NCT00095940|463088944|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669528|NCT00095940|463088945|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669529|NCT00095940|463088946|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669530|NCT00095940|463088947|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669531|NCT00095940|463088948|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669532|NCT00095940|463088949|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669533|NCT00095940|463088950|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
128669534|NCT00095940|463088951|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
128669535|NCT02314637|463088952|FG000|Overall Study|Adverse Event|4|||
128669536|NCT02314637|463088953|FG001|Overall Study|Adverse Event|8|||
128669537|NCT02314637|463088952|FG000|Overall Study|Lack of Efficacy|1|||
128669538|NCT02314637|463088953|FG001|Overall Study|Lack of Efficacy|0|||
128669539|NCT02314637|463088952|FG000|Overall Study|Physician Decision|5|||
128669540|NCT02314637|463088953|FG001|Overall Study|Physician Decision|2|||
128669541|NCT02314637|463088952|FG000|Overall Study|Withdrawal by Subject|5|||
128669542|NCT02314637|463088953|FG001|Overall Study|Withdrawal by Subject|4|||
128669543|NCT02314637|463088952|FG000|Overall Study|Other Reason|1|||
128669544|NCT02314637|463088953|FG001|Overall Study|Other Reason|0|||
128669545|NCT01536067|463088957|FG000|Overall Study|Disease Progression|1|||
128669546|NCT03120351|463088958|FG000|Overall Study|Physician Decision|1|||
128669547|NCT03120351|463088959|FG001|Overall Study|Physician Decision|1|||
128669548|NCT01256190|463088960|FG000|Overall Study|Lost to Follow-up|2|||
128669549|NCT01256190|463088961|FG001|Overall Study|Lost to Follow-up|0|||
128669550|NCT04693234|463088962|FG000|Overall Study|Death|79|||
128669551|NCT04693234|463088963|FG001|Overall Study|Death|19|||
129004491|NCT02806232|464309188|FG008|Overall Study|Lost to Follow-up|0|||
129004492|NCT02806232|464309180|FG000|Overall Study|Withdrawal by Subject|0|||
129004493|NCT02806232|464309181|FG001|Overall Study|Withdrawal by Subject|2|||
129004494|NCT02806232|464309182|FG002|Overall Study|Withdrawal by Subject|0|||
129004495|NCT02806232|464309183|FG003|Overall Study|Withdrawal by Subject|0|||
129004496|NCT02806232|464309184|FG004|Overall Study|Withdrawal by Subject|2|||
129004497|NCT02806232|464309185|FG005|Overall Study|Withdrawal by Subject|1|||
129004498|NCT02806232|464309186|FG006|Overall Study|Withdrawal by Subject|0|||
129004499|NCT02806232|464309187|FG007|Overall Study|Withdrawal by Subject|0|||
129004500|NCT02806232|464309188|FG008|Overall Study|Withdrawal by Subject|0|||
128669552|NCT04693234|463088962|FG000|Overall Study|Sponsor Ended Study|47|||
129004501|NCT01806597|464309193|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
128669553|NCT04693234|463088963|FG001|Overall Study|Sponsor Ended Study|18|||
128669554|NCT04693234|463088962|FG000|Overall Study|Withdrawal by Subject|10|||
128669555|NCT04693234|463088963|FG001|Overall Study|Withdrawal by Subject|2|||
129004502|NCT01806597|464309194|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
129004503|NCT01806597|464309195|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
128669556|NCT04693234|463088962|FG000|Overall Study|Lost to Follow-up|2|||
128669557|NCT04693234|463088963|FG001|Overall Study|Lost to Follow-up|1|||
128669558|NCT04643158|463088964|FG000|Overall Study|Study terminated by sponsor|0|||
128669559|NCT04643158|463088965|FG001|Overall Study|Study terminated by sponsor|0|||
128669560|NCT04643158|463088966|FG002|Overall Study|Study terminated by sponsor|1|||
128669561|NCT04643158|463088967|FG003|Overall Study|Study terminated by sponsor|0|||
128669562|NCT04643158|463088968|FG004|Overall Study|Study terminated by sponsor|0|||
128669563|NCT04643158|463088969|FG005|Overall Study|Study terminated by sponsor|1|||
128669564|NCT04643158|463088970|FG006|Overall Study|Study terminated by sponsor|0|||
128669565|NCT04643158|463088964|FG000|Overall Study|Global/country situation|0|||
128669566|NCT04643158|463088965|FG001|Overall Study|Global/country situation|0|||
128669567|NCT04643158|463088966|FG002|Overall Study|Global/country situation|1|||
128669568|NCT04643158|463088967|FG003|Overall Study|Global/country situation|0|||
128669569|NCT04643158|463088968|FG004|Overall Study|Global/country situation|0|||
128669570|NCT04643158|463088969|FG005|Overall Study|Global/country situation|0|||
128669571|NCT04643158|463088970|FG006|Overall Study|Global/country situation|0|||
128669572|NCT04643158|463088964|FG000|Overall Study|Withdrawal by Subject|0|||
128669573|NCT04643158|463088965|FG001|Overall Study|Withdrawal by Subject|0|||
128669574|NCT04643158|463088966|FG002|Overall Study|Withdrawal by Subject|0|||
128669575|NCT04643158|463088967|FG003|Overall Study|Withdrawal by Subject|0|||
128669576|NCT04643158|463088968|FG004|Overall Study|Withdrawal by Subject|0|||
128669577|NCT04643158|463088969|FG005|Overall Study|Withdrawal by Subject|1|||
129004504|NCT01806597|464309196|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
129004505|NCT01806597|464309197|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
129004506|NCT01806597|464309198|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
129004507|NCT01806597|464309193|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
129004508|NCT01806597|464309194|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129004509|NCT01806597|464309195|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129004510|NCT01806597|464309196|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129004511|NCT01806597|464309197|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
129004512|NCT01806597|464309198|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129004513|NCT01806597|464309193|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129004514|NCT01806597|464309194|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
129004515|NCT01806597|464309195|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129004516|NCT01806597|464309196|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129004517|NCT01806597|464309197|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129004518|NCT01806597|464309198|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129004519|NCT01806597|464309193|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
129004520|NCT01806597|464309194|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
129004521|NCT01806597|464309195|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
129004522|NCT01806597|464309196|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
129004523|NCT01806597|464309197|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
129004524|NCT01806597|464309198|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
129004525|NCT01806597|464309193|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129004526|NCT01806597|464309194|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
129004527|NCT01806597|464309195|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129004528|NCT01806597|464309196|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129004529|NCT01806597|464309197|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129004530|NCT01806597|464309198|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129004531|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
129004532|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
129004533|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
129004534|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
129004535|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
129004536|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
129004537|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
129004538|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
129004539|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
129004540|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
129004541|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
129004542|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
129004543|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
129004544|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129004545|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129004546|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129004547|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129004548|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129004549|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
128669578|NCT04643158|463088970|FG006|Overall Study|Withdrawal by Subject|0|||
128669579|NCT04540198|463088971|FG000|Overall Study|Lost to Follow-up|25|||
128669580|NCT04540198|463088972|FG001|Overall Study|Lost to Follow-up|23|||
129004550|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
128669581|NCT04540198|463088971|FG000|Overall Study|Withdrawal by Subject|15|||
128669582|NCT04540198|463088972|FG001|Overall Study|Withdrawal by Subject|9|||
128669583|NCT04540198|463088971|FG000|Overall Study|Discontinued|1|||
128669584|NCT04540198|463088972|FG001|Overall Study|Discontinued|0|||
128669585|NCT02888119|463088973|FG000|Overall Study|Lost to Follow-up|5|||
128669586|NCT02888119|463088974|FG001|Overall Study|Lost to Follow-up|4|||
128669587|NCT02888119|463088975|FG002|Overall Study|Lost to Follow-up|0|||
128669588|NCT04195893|463088982|FG000|Second Intervention|Withdrawal by Subject|1|||
129004551|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129004552|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129004553|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129004554|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129004555|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
129004556|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129004557|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129004558|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129004559|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129004560|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129004561|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129004562|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
129004563|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129004564|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
129004565|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129004566|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129004567|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
129004568|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
129004569|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
129004570|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
129004571|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
129004572|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
129004573|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
129004574|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
129004575|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
129004576|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
129004577|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
129004578|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
129004579|NCT01806597|464309193|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
129004580|NCT01806597|464309194|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129004581|NCT01806597|464309195|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129004582|NCT01806597|464309196|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129004583|NCT01806597|464309197|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129004584|NCT01806597|464309198|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129004585|NCT01806597|464309193|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129004586|NCT01806597|464309194|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129004587|NCT01806597|464309195|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129004588|NCT01806597|464309196|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129004589|NCT01806597|464309197|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129004590|NCT01806597|464309198|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
129004591|NCT01806597|464309193|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129004592|NCT01806597|464309194|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129004593|NCT01806597|464309195|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129004594|NCT01806597|464309196|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129004595|NCT01806597|464309197|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129004596|NCT01806597|464309198|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
129004597|NCT01806597|464309193|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129004598|NCT01806597|464309194|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129004599|NCT01806597|464309195|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129004600|NCT01806597|464309196|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
128669589|NCT04195893|463088983|FG001|Second Intervention|Withdrawal by Subject|0|||
128669590|NCT03679754|463088984|FG000|Overall Study|Investigator request|1|||
128669591|NCT00964171|463088985|FG000|Overall Study|Death|5|||
128763108|NCT03145766|463422733|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
128763109|NCT03145766|463422734|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
129004601|NCT01806597|464309197|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129004602|NCT01806597|464309198|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
129004603|NCT01806597|464309193|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129004604|NCT01806597|464309194|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129004605|NCT01806597|464309195|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129004606|NCT01806597|464309196|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129004607|NCT01806597|464309197|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129004608|NCT01806597|464309198|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
128669592|NCT00910299|463088989|FG000|Overall Study|Withdrawal by Subject|16|||
128669593|NCT00910299|463088990|FG001|Overall Study|Withdrawal by Subject|13|||
128669594|NCT00910299|463088989|FG000|Overall Study|Sponsor Decision|58|||
128669595|NCT00910299|463088990|FG001|Overall Study|Sponsor Decision|60|||
128669596|NCT00910299|463088989|FG000|Overall Study|Didn't receive any study drug|2|||
128669597|NCT00910299|463088990|FG001|Overall Study|Didn't receive any study drug|1|||
128669598|NCT00711477|463088991|FG000|Overall Study|Adverse Event|3|||
128669599|NCT00711477|463088992|FG001|Overall Study|Adverse Event|1|||
128669600|NCT00711477|463088991|FG000|Overall Study|Lost to Follow-up|0|||
128669601|NCT00711477|463088992|FG001|Overall Study|Lost to Follow-up|1|||
128669602|NCT00711477|463088991|FG000|Overall Study|Noncompliance|0|||
128669603|NCT00711477|463088992|FG001|Overall Study|Noncompliance|1|||
128669604|NCT02929407|463088994|FG000|Overall Study|Adverse Event|1|||
128669605|NCT00884741|463088995|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
128669606|NCT00884741|463088996|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
128669607|NCT00884741|463088997|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
128669608|NCT00884741|463088998|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
128669609|NCT00884741|463088995|FG000|Step 1 Registration: Tissue Screening|Death|3|||
128669610|NCT00884741|463088996|FG001|Step 1 Registration: Tissue Screening|Death|0|||
128669611|NCT00884741|463088997|FG002|Step 1 Registration: Tissue Screening|Death|0|||
128669612|NCT00884741|463088998|FG003|Step 1 Registration: Tissue Screening|Death|0|||
128669613|NCT00884741|463088995|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
128669614|NCT00884741|463088996|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
128669615|NCT00884741|463088997|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
128669616|NCT00884741|463088998|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
128669617|NCT00884741|463088995|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
128669618|NCT00884741|463088996|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
128669619|NCT00884741|463088997|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
128669620|NCT00884741|463088998|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
128669621|NCT00884741|463088995|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
128669622|NCT00884741|463088996|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
128669623|NCT00884741|463088997|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
128669624|NCT00884741|463088998|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
128669625|NCT00884741|463088995|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
128669626|NCT00884741|463088996|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
128669627|NCT00884741|463088997|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
128669628|NCT00884741|463088998|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
128669629|NCT00884741|463088995|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
128669630|NCT00884741|463088996|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
128669631|NCT00884741|463088997|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
128669632|NCT00884741|463088998|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
128669633|NCT00884741|463088995|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
128669634|NCT00884741|463088996|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
128669635|NCT00884741|463088997|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
128669636|NCT00884741|463088998|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
128669637|NCT00884741|463088995|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
128669638|NCT00884741|463088996|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
129004609|NCT01806597|464309193|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129004610|NCT01806597|464309194|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129004611|NCT01806597|464309195|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129004612|NCT01806597|464309196|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129004613|NCT01806597|464309197|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129004614|NCT01806597|464309198|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
129004615|NCT01144663|464309199|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
129004616|NCT01144663|464309200|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
129004617|NCT01144663|464309201|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
129004618|NCT01144663|464309202|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
129004619|NCT01144663|464309199|FG000|Primary Vaccination Phase|Adverse Event|1|||
129004620|NCT01144663|464309200|FG001|Primary Vaccination Phase|Adverse Event|0|||
128669639|NCT00884741|463088997|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
128669640|NCT00884741|463088998|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
128669641|NCT00884741|463088995|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
128669642|NCT00884741|463088996|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
128669643|NCT00884741|463088997|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
128669644|NCT00884741|463088998|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
128669645|NCT00884741|463088995|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
128669646|NCT00884741|463088996|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
128669647|NCT00884741|463088997|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
128669648|NCT00884741|463088998|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
128669649|NCT00884741|463088995|FG000|Randomization|Protocol Violation|0|||
128669650|NCT00884741|463088996|FG001|Randomization|Protocol Violation|0|||
128669651|NCT00884741|463088997|FG002|Randomization|Protocol Violation|8|||
128669652|NCT00884741|463088998|FG003|Randomization|Protocol Violation|8|||
128669653|NCT00499590|463089001|FG000|Overall Study|Study Terminated|112|||
128669654|NCT00499590|463089002|FG001|Overall Study|Study Terminated|112|||
128669655|NCT00499590|463089003|FG002|Overall Study|Study Terminated|112|||
128669656|NCT00499590|463089001|FG000|Overall Study|Not treated|1|||
128669657|NCT00499590|463089002|FG001|Overall Study|Not treated|0|||
128669658|NCT00499590|463089003|FG002|Overall Study|Not treated|1|||
128669659|NCT05661851|463089005|FG000|Overall Study|Protocol Violation|1|||
128669660|NCT05661851|463089006|FG001|Overall Study|Protocol Violation|1|||
128669661|NCT05661851|463089005|FG000|Overall Study|Covid-19 Related|3|||
128669662|NCT05661851|463089006|FG001|Overall Study|Covid-19 Related|4|||
128669663|NCT05661851|463089005|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
128669664|NCT05661851|463089006|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
128669665|NCT05661851|463089005|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
128669666|NCT05661851|463089006|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
128669667|NCT00612807|463089007|FG000|Overall Study|Withdrawal by Subject|2|||
128669668|NCT00612807|463089008|FG001|Overall Study|Withdrawal by Subject|0|||
128669669|NCT00145977|463089009|FG000|Overall Study|Lack of Efficacy|0|||
128669670|NCT00145977|463089010|FG001|Overall Study|Lack of Efficacy|4|||
128669671|NCT00145977|463089009|FG000|Overall Study|Lost to Follow-up|1|||
128669672|NCT00145977|463089010|FG001|Overall Study|Lost to Follow-up|0|||
128669673|NCT00145977|463089009|FG000|Overall Study|Withdrawal by Subject|1|||
128669674|NCT00145977|463089010|FG001|Overall Study|Withdrawal by Subject|0|||
128669675|NCT02055118|463089017|FG000|Overall Study|Withdrawal by Subject|0|||
128669676|NCT02055118|463089018|FG001|Overall Study|Withdrawal by Subject|2|||
128669677|NCT02055118|463089019|FG002|Overall Study|Withdrawal by Subject|0|||
128669678|NCT02281383|463089020|FG000|Overall Study|Progressive Disease|1|||
128669679|NCT02281383|463089020|FG000|Overall Study|Withdrawal by Subject|6|||
128669680|NCT02281383|463089020|FG000|Overall Study|Protocol Violation|2|||
128669681|NCT02281383|463089020|FG000|Overall Study|Death|1|||
128669682|NCT02281383|463089020|FG000|Overall Study|Adverse Event|2|||
128669683|NCT02259088|463089021|FG000|Overall Study|Adverse Event|6|||
128669684|NCT02259088|463089022|FG001|Overall Study|Adverse Event|4|||
128669685|NCT02259088|463089021|FG000|Overall Study|Lost to Follow-up|2|||
128669686|NCT02259088|463089022|FG001|Overall Study|Lost to Follow-up|0|||
128669687|NCT02259088|463089021|FG000|Overall Study|Death|2|||
128669688|NCT02259088|463089022|FG001|Overall Study|Death|0|||
128669689|NCT02259088|463089021|FG000|Overall Study|Physician Decision|5|||
128669690|NCT02259088|463089022|FG001|Overall Study|Physician Decision|2|||
128669691|NCT02259088|463089021|FG000|Overall Study|Protocol deviation|5|||
128669692|NCT02259088|463089022|FG001|Overall Study|Protocol deviation|0|||
128669693|NCT02259088|463089021|FG000|Overall Study|Subject/guardian decision|8|||
128669694|NCT02259088|463089022|FG001|Overall Study|Subject/guardian decision|8|||
128669695|NCT02252939|463089023|FG000|Overall Study|Lost to Follow-up|3|||
128669696|NCT00870584|463089024|FG000|Overall Study|Adverse Event|3|||
128669697|NCT00870584|463089025|FG001|Overall Study|Adverse Event|3|||
128669698|NCT00870584|463089024|FG000|Overall Study|Withdrawal by Subject|6|||
128669699|NCT00870584|463089025|FG001|Overall Study|Withdrawal by Subject|7|||
128669700|NCT00870584|463089024|FG000|Overall Study|Lost to Follow-up|5|||
128669701|NCT00870584|463089025|FG001|Overall Study|Lost to Follow-up|1|||
128669702|NCT00870584|463089024|FG000|Overall Study|Protocol Deviation|2|||
128669703|NCT00870584|463089025|FG001|Overall Study|Protocol Deviation|2|||
128669704|NCT02560025|463089026|FG000|Overall Study|Ineligible after consent/ registration|3|||
128669705|NCT02703337|463089027|FG000|Period One (Part A)|Withdrawal by Subject|0|||
128669706|NCT02703337|463089028|FG001|Period One (Part A)|Withdrawal by Subject|0|||
128669707|NCT02703337|463089029|FG002|Period One (Part A)|Withdrawal by Subject|0|||
128669708|NCT02703337|463089030|FG003|Period One (Part A)|Withdrawal by Subject|0|||
128669709|NCT02703337|463089031|FG004|Period One (Part A)|Withdrawal by Subject|1|||
128669710|NCT02703337|463089032|FG005|Period One (Part A)|Withdrawal by Subject|0|||
128669711|NCT02703337|463089033|FG006|Period One (Part A)|Withdrawal by Subject|0|||
128669712|NCT02703337|463089034|FG007|Period One (Part A)|Withdrawal by Subject|0|||
129004621|NCT01144663|464309201|FG002|Primary Vaccination Phase|Adverse Event|0|||
128669713|NCT00282308|463089035|FG000|Treatment Period|Lost to Follow-up|1|||
129004622|NCT01144663|464309202|FG003|Primary Vaccination Phase|Adverse Event|1|||
129004623|NCT01144663|464309199|FG000|Primary Vaccination Phase|Protocol Violation|2|||
129004624|NCT01144663|464309200|FG001|Primary Vaccination Phase|Protocol Violation|0|||
129004625|NCT01144663|464309201|FG002|Primary Vaccination Phase|Protocol Violation|1|||
129004626|NCT01144663|464309202|FG003|Primary Vaccination Phase|Protocol Violation|0|||
129004627|NCT01144663|464309199|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
129004628|NCT01144663|464309200|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
129004629|NCT01144663|464309201|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
129004630|NCT01144663|464309202|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
129004631|NCT01144663|464309199|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
129004632|NCT01144663|464309200|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
129004633|NCT01144663|464309201|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
129004634|NCT01144663|464309202|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
129004635|NCT01144663|464309199|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
129004636|NCT01144663|464309200|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
129004637|NCT01144663|464309201|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
129004638|NCT01144663|464309202|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
129004639|NCT01144663|464309199|FG000|Primary Vaccination Phase|Other|0|||
129004640|NCT01144663|464309200|FG001|Primary Vaccination Phase|Other|1|||
129004641|NCT01144663|464309201|FG002|Primary Vaccination Phase|Other|0|||
129004642|NCT01144663|464309202|FG003|Primary Vaccination Phase|Other|2|||
129004643|NCT01144663|464309199|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
129004644|NCT01144663|464309200|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129004645|NCT01144663|464309201|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
129004646|NCT01144663|464309202|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
129004647|NCT01144663|464309199|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
129004648|NCT01144663|464309200|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
129004649|NCT01144663|464309201|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
129004650|NCT01144663|464309202|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
129004651|NCT01144663|464309199|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
129004652|NCT01144663|464309200|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
129004653|NCT01144663|464309201|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
129004654|NCT01144663|464309202|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
129004655|NCT01144663|464309199|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
129004656|NCT01144663|464309200|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
129004657|NCT01144663|464309201|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
129004658|NCT01144663|464309202|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
129004659|NCT01144663|464309199|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
129004660|NCT01144663|464309200|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
129004661|NCT01144663|464309201|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
129004662|NCT01144663|464309202|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
129004663|NCT01144663|464309199|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
129004664|NCT01144663|464309200|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
129004665|NCT01144663|464309201|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
129004666|NCT01144663|464309202|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
129004667|NCT01073020|464309205|FG000|Overall Study|Withdrawal by Subject|6|||
129004668|NCT01073020|464309206|FG001|Overall Study|Withdrawal by Subject|4|||
129004669|NCT01073020|464309207|FG002|Overall Study|Withdrawal by Subject|1|||
129004670|NCT01073020|464309208|FG003|Overall Study|Withdrawal by Subject|2|||
129004671|NCT01073020|464309205|FG000|Overall Study|Physician Decision|1|||
129004672|NCT01073020|464309206|FG001|Overall Study|Physician Decision|0|||
129004673|NCT01073020|464309207|FG002|Overall Study|Physician Decision|2|||
129004674|NCT01073020|464309208|FG003|Overall Study|Physician Decision|0|||
129004675|NCT01073020|464309205|FG000|Overall Study|Death|0|||
129004676|NCT01073020|464309206|FG001|Overall Study|Death|1|||
129004677|NCT01073020|464309207|FG002|Overall Study|Death|0|||
129004678|NCT01073020|464309208|FG003|Overall Study|Death|0|||
129004679|NCT01335477|464309209|FG000|Overall Study|Adverse Event|30|||
129004680|NCT01335477|464309210|FG001|Overall Study|Adverse Event|42|||
129004681|NCT01335477|464309209|FG000|Overall Study|Non compliant with protocol|0|||
129004682|NCT01335477|464309210|FG001|Overall Study|Non compliant with protocol|2|||
128669714|NCT00282308|463089036|FG001|Treatment Period|Lost to Follow-up|0|||
128669715|NCT00282308|463089037|FG002|Treatment Period|Lost to Follow-up|0|||
129004683|NCT01335477|464309209|FG000|Overall Study|Lost to Follow-up|1|||
129004684|NCT01335477|464309210|FG001|Overall Study|Lost to Follow-up|2|||
129004685|NCT01335477|464309209|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
129004686|NCT01335477|464309210|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
129004687|NCT01335477|464309209|FG000|Overall Study|Not treated|1|||
129004688|NCT01335477|464309210|FG001|Overall Study|Not treated|2|||
129004689|NCT01335477|464309209|FG000|Overall Study|Reason other than those stated above|2|||
129004690|NCT01335477|464309210|FG001|Overall Study|Reason other than those stated above|2|||
129004691|NCT02497391|464309214|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
129004692|NCT02497391|464309215|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
129004693|NCT02497391|464309216|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
129004694|NCT02497391|464309217|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
129004695|NCT02497391|464309218|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
129004696|NCT02497391|464309219|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
129004697|NCT02497391|464309214|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
129004698|NCT02497391|464309215|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
129004699|NCT02497391|464309216|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
129004700|NCT02497391|464309217|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
129004701|NCT02497391|464309218|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
129004702|NCT02497391|464309219|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
129004703|NCT02497391|464309214|FG000|Period 3 (14 Days)|Adverse Event|0|||
129004704|NCT02497391|464309215|FG001|Period 3 (14 Days)|Adverse Event|1|||
129004705|NCT02497391|464309216|FG002|Period 3 (14 Days)|Adverse Event|0|||
129004706|NCT02497391|464309217|FG003|Period 3 (14 Days)|Adverse Event|0|||
129004707|NCT02497391|464309218|FG004|Period 3 (14 Days)|Adverse Event|0|||
129004708|NCT02497391|464309219|FG005|Period 3 (14 Days)|Adverse Event|0|||
129004709|NCT02497391|464309214|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
129004710|NCT02497391|464309215|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
129004711|NCT02497391|464309216|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
129004712|NCT02497391|464309217|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
129004713|NCT02497391|464309218|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
129004714|NCT02497391|464309219|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
129004715|NCT02497391|464309214|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
129004716|NCT02497391|464309215|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
129004717|NCT02497391|464309216|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
129004718|NCT02497391|464309217|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
129004719|NCT02497391|464309218|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
129004720|NCT02497391|464309219|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
129004721|NCT03031899|464309220|FG000|Overall Study|Protocol Violation|1|||
129004722|NCT03031899|464309220|FG000|Overall Study|lesion disappeared after stopping habit|1|||
129004723|NCT03740698|464309222|FG000|Overall Study|Physician Decision|0|||
129004724|NCT03740698|464309223|FG001|Overall Study|Physician Decision|1|||
129004725|NCT03740698|464309224|FG002|Overall Study|Physician Decision|1|||
129004726|NCT01469364|464309225|FG000|Overall Study|Adverse Event|1|||
129004727|NCT01469364|464309225|FG000|Overall Study|Withdrawal by Subject|1|||
129004728|NCT03433001|464309228|FG000|Overall Study|Lack of Efficacy|109|||
129004729|NCT03433001|464309228|FG000|Overall Study|Adverse Event|69|||
129004730|NCT03433001|464309228|FG000|Overall Study|Withdrawal by Subject|10|||
129004731|NCT03433001|464309228|FG000|Overall Study|Death|12|||
129004732|NCT03433001|464309228|FG000|Overall Study|Lost to Follow-up|4|||
129004733|NCT03433001|464309228|FG000|Overall Study|Other|25|||
129004734|NCT02040428|464309229|FG000|Overall Study|Death|4|||
129004735|NCT02040428|464309230|FG001|Overall Study|Death|3|||
129004736|NCT02040428|464309229|FG000|Overall Study|Withdrawal by Subject|1|||
129004737|NCT02040428|464309230|FG001|Overall Study|Withdrawal by Subject|1|||
129004738|NCT01165996|464309231|FG000|Overall Study|Death|1|||
129004739|NCT01165996|464309231|FG000|Overall Study|Physician Decision|1|||
129004740|NCT01399723|464309232|FG000|Overall Study|Lost to Follow-up|0|||
129004741|NCT01399723|464309233|FG001|Overall Study|Lost to Follow-up|1|||
129004742|NCT00752791|464309237|FG000|Overall Study|Adverse Event|7|||
129004743|NCT00752791|464309237|FG000|Overall Study|Withdrawal by Subject|1|||
129004744|NCT00752791|464309237|FG000|Overall Study|Physician Decision|1|||
129004745|NCT00752791|464309237|FG000|Overall Study|Death|1|||
129004746|NCT00752791|464309237|FG000|Overall Study|Renal transplant|3|||
129004747|NCT00752791|464309237|FG000|Overall Study|Switched to hemodialysis|2|||
129004748|NCT00752791|464309237|FG000|Overall Study|Protocol deviation|1|||
129004749|NCT01333033|464309244|FG000|Overall Study|Ineligible|0|||
129004750|NCT01333033|464309245|FG001|Overall Study|Ineligible|0|||
129004751|NCT01333033|464309246|FG002|Overall Study|Ineligible|0|||
129004752|NCT01333033|464309247|FG003|Overall Study|Ineligible|0|||
129004753|NCT01333033|464309248|FG004|Overall Study|Ineligible|6|||
129004754|NCT01333033|464309249|FG005|Overall Study|Ineligible|8|||
128763110|NCT03145766|463422735|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
129004755|NCT01333033|464309244|FG000|Overall Study|Withdrawal by Subject|0|||
129004756|NCT01333033|464309245|FG001|Overall Study|Withdrawal by Subject|0|||
129004757|NCT01333033|464309246|FG002|Overall Study|Withdrawal by Subject|0|||
129004758|NCT01333033|464309247|FG003|Overall Study|Withdrawal by Subject|0|||
129004759|NCT01333033|464309248|FG004|Overall Study|Withdrawal by Subject|4|||
129004760|NCT01333033|464309249|FG005|Overall Study|Withdrawal by Subject|2|||
129004761|NCT01333033|464309244|FG000|Overall Study|PET inevaluable|0|||
129004762|NCT01333033|464309245|FG001|Overall Study|PET inevaluable|0|||
129004763|NCT01333033|464309246|FG002|Overall Study|PET inevaluable|0|||
129004764|NCT01333033|464309247|FG003|Overall Study|PET inevaluable|0|||
129004765|NCT01333033|464309248|FG004|Overall Study|PET inevaluable|2|||
129004766|NCT01333033|464309249|FG005|Overall Study|PET inevaluable|4|||
129004767|NCT01333033|464309244|FG000|Overall Study|Adverse Event|0|||
129004768|NCT01333033|464309245|FG001|Overall Study|Adverse Event|0|||
129004769|NCT01333033|464309246|FG002|Overall Study|Adverse Event|0|||
128669716|NCT00282308|463089035|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
128669717|NCT00282308|463089036|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
128669718|NCT00282308|463089037|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
128669719|NCT00282308|463089035|FG000|Treatment Period|Adverse Event|0|||
128669720|NCT00282308|463089036|FG001|Treatment Period|Adverse Event|2|||
128669721|NCT00282308|463089037|FG002|Treatment Period|Adverse Event|0|||
128669722|NCT00282308|463089035|FG000|Treatment Period|Not Treated with Study Drug|1|||
128669723|NCT00282308|463089036|FG001|Treatment Period|Not Treated with Study Drug|0|||
128669724|NCT00282308|463089037|FG002|Treatment Period|Not Treated with Study Drug|0|||
128669725|NCT00282308|463089035|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
128669726|NCT00282308|463089036|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
128669727|NCT00282308|463089037|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
128669728|NCT00282308|463089035|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
128669729|NCT00282308|463089036|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
128669730|NCT00282308|463089037|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
128669731|NCT00282308|463089035|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
129004770|NCT01333033|464309247|FG003|Overall Study|Adverse Event|0|||
129004771|NCT01333033|464309248|FG004|Overall Study|Adverse Event|2|||
129004772|NCT01333033|464309249|FG005|Overall Study|Adverse Event|1|||
129004773|NCT01333033|464309244|FG000|Overall Study|Progression|0|||
129004774|NCT01333033|464309245|FG001|Overall Study|Progression|0|||
129004775|NCT01333033|464309246|FG002|Overall Study|Progression|0|||
129004776|NCT01333033|464309247|FG003|Overall Study|Progression|0|||
128669732|NCT00282308|463089036|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
128669733|NCT00282308|463089037|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
128669734|NCT00282308|463089035|FG000|Safety Follow-up Period|Adverse Event|0|||
129004777|NCT01333033|464309248|FG004|Overall Study|Progression|0|||
129004778|NCT01333033|464309249|FG005|Overall Study|Progression|1|||
129004779|NCT01333033|464309244|FG000|Overall Study|MD Decision|0|||
129004780|NCT01333033|464309245|FG001|Overall Study|MD Decision|0|||
129004781|NCT01333033|464309246|FG002|Overall Study|MD Decision|0|||
129004782|NCT01333033|464309247|FG003|Overall Study|MD Decision|0|||
129004783|NCT01333033|464309248|FG004|Overall Study|MD Decision|0|||
129004784|NCT01333033|464309249|FG005|Overall Study|MD Decision|2|||
129004785|NCT03687125|464309250|FG000|Overall Study|Progressive Disease|2|||
129004786|NCT03687125|464309251|FG001|Overall Study|Progressive Disease|1|||
129004787|NCT03687125|464309250|FG000|Overall Study|Protocol Violation|1|||
129004788|NCT03687125|464309251|FG001|Overall Study|Protocol Violation|0|||
129004789|NCT02087046|464309252|FG000|Overall Study|Adverse Event|4|||
129004790|NCT02087046|464309252|FG000|Overall Study|Death|1|||
129004791|NCT02087046|464309252|FG000|Overall Study|Lost to Follow-up|3|||
129004792|NCT02087046|464309252|FG000|Overall Study|Withdrawal by Subject|2|||
129004793|NCT02087046|464309252|FG000|Overall Study|Physician Decision|1|||
129004794|NCT01507896|464309254|FG000|Overall Study|Withdrawal by Subject|1|||
129004795|NCT01507896|464309254|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
129004796|NCT00585351|464309256|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
129004797|NCT00585351|464309257|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
129004798|NCT00585351|464309258|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
129004799|NCT00585351|464309259|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
129004800|NCT00585351|464309260|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
129004801|NCT00585351|464309261|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
129004802|NCT00585351|464309262|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
129004803|NCT00585351|464309263|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
129004804|NCT00585351|464309256|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
129004805|NCT00585351|464309257|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
129004806|NCT00585351|464309258|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
129004807|NCT00585351|464309259|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
129004808|NCT00585351|464309260|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
129004809|NCT00585351|464309261|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
129004810|NCT00585351|464309262|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
129004811|NCT00585351|464309263|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
129004812|NCT00585351|464309256|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
129004813|NCT00585351|464309257|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
129004814|NCT00585351|464309258|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
129004815|NCT00585351|464309259|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
129004816|NCT00585351|464309260|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
128669735|NCT00282308|463089036|FG001|Safety Follow-up Period|Adverse Event|0|||
129004817|NCT00585351|464309261|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
129004818|NCT00585351|464309262|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
129004819|NCT00585351|464309263|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
129004820|NCT00585351|464309256|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
129004821|NCT00585351|464309257|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
129004822|NCT00585351|464309258|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129004823|NCT00585351|464309259|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129004824|NCT00585351|464309260|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129004825|NCT00585351|464309261|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129004826|NCT00585351|464309262|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129004827|NCT00585351|464309263|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129004828|NCT00585351|464309256|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129004829|NCT00585351|464309257|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129004830|NCT00585351|464309258|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129004831|NCT00585351|464309259|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129004832|NCT00585351|464309260|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129004833|NCT00585351|464309261|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129004834|NCT00585351|464309262|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
129004835|NCT00585351|464309263|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
129004836|NCT00585351|464309256|FG000|Enrollment Period (Intervention)|Death|0|||
129004837|NCT00585351|464309257|FG001|Enrollment Period (Intervention)|Death|0|||
129004838|NCT00585351|464309258|FG002|Enrollment Period (Intervention)|Death|0|||
129004839|NCT00585351|464309259|FG003|Enrollment Period (Intervention)|Death|0|||
128669736|NCT00282308|463089037|FG002|Safety Follow-up Period|Adverse Event|1|||
128669737|NCT00282308|463089035|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
128669738|NCT00282308|463089036|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
128669739|NCT00282308|463089037|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
128669740|NCT00282308|463089035|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
128669741|NCT00282308|463089036|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
128669742|NCT00282308|463089037|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
128669743|NCT00282308|463089035|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
128669744|NCT00282308|463089036|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
128669745|NCT00282308|463089037|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
128669746|NCT01584440|463089038|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
128669747|NCT01584440|463089039|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
128669748|NCT01584440|463089040|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
128669749|NCT01584440|463089041|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
128669750|NCT01584440|463089042|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
128669751|NCT01584440|463089038|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
128669752|NCT01584440|463089039|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
128669753|NCT01584440|463089040|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
128669754|NCT01584440|463089041|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
128669755|NCT01584440|463089042|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
128669756|NCT01584440|463089038|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
128669757|NCT01584440|463089039|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
128669758|NCT01584440|463089040|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
128669759|NCT01584440|463089041|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
128669760|NCT01584440|463089042|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
128669761|NCT01584440|463089038|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
128669762|NCT01584440|463089039|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
128669763|NCT01584440|463089040|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
128669764|NCT01584440|463089041|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
128669765|NCT01584440|463089042|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
128669766|NCT01584440|463089038|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
128669767|NCT01584440|463089039|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
128669768|NCT01584440|463089040|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
128669769|NCT01584440|463089041|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
128669770|NCT01584440|463089042|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
128669771|NCT01584440|463089038|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
128669772|NCT01584440|463089039|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
128669773|NCT01584440|463089040|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
128669774|NCT01584440|463089041|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
128669775|NCT01584440|463089042|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
128669776|NCT01584440|463089038|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
129004840|NCT00585351|464309260|FG004|Enrollment Period (Intervention)|Death|1|||
129004841|NCT00585351|464309261|FG005|Enrollment Period (Intervention)|Death|0|||
129004842|NCT00585351|464309262|FG006|Enrollment Period (Intervention)|Death|1|||
128669777|NCT01584440|463089039|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
128669778|NCT01584440|463089040|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
128669779|NCT01584440|463089041|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
128669780|NCT01584440|463089042|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
128669781|NCT01584440|463089038|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
129004843|NCT00585351|464309263|FG007|Enrollment Period (Intervention)|Death|0|||
129004844|NCT00585351|464309256|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129004845|NCT00585351|464309257|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129004846|NCT00585351|464309258|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129004847|NCT00585351|464309259|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129004848|NCT00585351|464309260|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
129004849|NCT00585351|464309261|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
129004850|NCT00585351|464309262|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129004851|NCT00585351|464309263|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129004852|NCT01842958|464309265|FG000|Overall Study|Lost to Follow-up|1|||
129004853|NCT01842958|464309266|FG001|Overall Study|Lost to Follow-up|1|||
129004854|NCT01829477|464309267|FG000|Overall Study|Study Terminated by Sponsor|15|||
129004855|NCT01829477|464309268|FG001|Overall Study|Study Terminated by Sponsor|15|||
129004856|NCT01829477|464309267|FG000|Overall Study|Withdrawal by Subject|1|||
129004857|NCT01829477|464309268|FG001|Overall Study|Withdrawal by Subject|0|||
129004858|NCT00818623|464309273|FG000|Overall Study|Adverse Event|1|||
129004859|NCT00818623|464309274|FG001|Overall Study|Adverse Event|0|||
129004860|NCT00818623|464309275|FG002|Overall Study|Adverse Event|1|||
129004861|NCT00818623|464309276|FG003|Overall Study|Adverse Event|0|||
129004862|NCT00818623|464309277|FG004|Overall Study|Adverse Event|0|||
129004863|NCT00818623|464309278|FG005|Overall Study|Adverse Event|1|||
129004864|NCT00818623|464309279|FG006|Overall Study|Adverse Event|0|||
129004865|NCT00818623|464309280|FG007|Overall Study|Adverse Event|0|||
129004866|NCT00818623|464309273|FG000|Overall Study|Bad prostate specific antigen response|0|||
129004867|NCT00818623|464309274|FG001|Overall Study|Bad prostate specific antigen response|3|||
129004868|NCT00818623|464309275|FG002|Overall Study|Bad prostate specific antigen response|2|||
129004869|NCT00818623|464309276|FG003|Overall Study|Bad prostate specific antigen response|5|||
129004870|NCT00818623|464309277|FG004|Overall Study|Bad prostate specific antigen response|0|||
129004871|NCT00818623|464309278|FG005|Overall Study|Bad prostate specific antigen response|1|||
129004872|NCT00818623|464309279|FG006|Overall Study|Bad prostate specific antigen response|0|||
129004873|NCT00818623|464309280|FG007|Overall Study|Bad prostate specific antigen response|0|||
129004874|NCT00818623|464309273|FG000|Overall Study|Withdrawal by Subject|0|||
129004875|NCT00818623|464309274|FG001|Overall Study|Withdrawal by Subject|1|||
129004876|NCT00818623|464309275|FG002|Overall Study|Withdrawal by Subject|1|||
129004877|NCT00818623|464309276|FG003|Overall Study|Withdrawal by Subject|0|||
129004878|NCT00818623|464309277|FG004|Overall Study|Withdrawal by Subject|0|||
129004879|NCT00818623|464309278|FG005|Overall Study|Withdrawal by Subject|1|||
129004880|NCT00818623|464309279|FG006|Overall Study|Withdrawal by Subject|1|||
129004881|NCT00818623|464309280|FG007|Overall Study|Withdrawal by Subject|1|||
129004882|NCT00818623|464309273|FG000|Overall Study|Protocol Violation|1|||
129004883|NCT00818623|464309274|FG001|Overall Study|Protocol Violation|0|||
129004884|NCT00818623|464309275|FG002|Overall Study|Protocol Violation|0|||
129004885|NCT00818623|464309276|FG003|Overall Study|Protocol Violation|0|||
129004886|NCT00818623|464309277|FG004|Overall Study|Protocol Violation|1|||
129004887|NCT00818623|464309278|FG005|Overall Study|Protocol Violation|0|||
129004888|NCT00818623|464309279|FG006|Overall Study|Protocol Violation|1|||
129004889|NCT00818623|464309280|FG007|Overall Study|Protocol Violation|0|||
129004890|NCT00818623|464309273|FG000|Overall Study|Need of additional treatment|0|||
128669782|NCT01584440|463089039|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
128669783|NCT01584440|463089040|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
128669784|NCT01584440|463089041|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
128669785|NCT01584440|463089042|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
128669786|NCT01584440|463089038|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
128669787|NCT01584440|463089039|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
128669788|NCT01584440|463089040|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
128669789|NCT01584440|463089041|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
128669790|NCT01584440|463089042|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
128669791|NCT02872285|463089043|FG000|Overall Study|Withdrawal by Subject|2|||
128669792|NCT02872285|463089044|FG001|Overall Study|Withdrawal by Subject|0|||
128669793|NCT02872285|463089043|FG000|Overall Study|Lost to Follow-up|2|||
128669794|NCT02872285|463089044|FG001|Overall Study|Lost to Follow-up|2|||
128669795|NCT02872285|463089043|FG000|Overall Study|Discontinued due to back surgery|1|||
128669796|NCT02872285|463089044|FG001|Overall Study|Discontinued due to back surgery|0|||
128669797|NCT00721968|463089045|FG000|Overall Study|Lost to Follow-up|2|||
128669798|NCT00721968|463089046|FG001|Overall Study|Lost to Follow-up|0|||
128669799|NCT02626624|463089050|FG000|Overall Study|Adverse Event|1|||
129004891|NCT00818623|464309274|FG001|Overall Study|Need of additional treatment|0|||
129004892|NCT00818623|464309275|FG002|Overall Study|Need of additional treatment|0|||
129004893|NCT00818623|464309276|FG003|Overall Study|Need of additional treatment|0|||
129004894|NCT00818623|464309277|FG004|Overall Study|Need of additional treatment|1|||
128669800|NCT02626624|463089050|FG000|Overall Study|Lost to Follow-up|3|||
129004895|NCT00818623|464309278|FG005|Overall Study|Need of additional treatment|0|||
128669801|NCT02626624|463089050|FG000|Overall Study|Protocol Violation|4|||
129004896|NCT00818623|464309279|FG006|Overall Study|Need of additional treatment|0|||
129004897|NCT00818623|464309280|FG007|Overall Study|Need of additional treatment|0|||
129004898|NCT00818623|464309273|FG000|Overall Study|Lack of trial drug at site|0|||
129004899|NCT00818623|464309274|FG001|Overall Study|Lack of trial drug at site|0|||
129004900|NCT00818623|464309275|FG002|Overall Study|Lack of trial drug at site|0|||
129004901|NCT00818623|464309276|FG003|Overall Study|Lack of trial drug at site|0|||
129004902|NCT00818623|464309277|FG004|Overall Study|Lack of trial drug at site|2|||
129004903|NCT00818623|464309278|FG005|Overall Study|Lack of trial drug at site|0|||
129004904|NCT00818623|464309279|FG006|Overall Study|Lack of trial drug at site|1|||
129004905|NCT00818623|464309280|FG007|Overall Study|Lack of trial drug at site|0|||
129004906|NCT00818623|464309273|FG000|Overall Study|Disease progression|0|||
129004907|NCT00818623|464309274|FG001|Overall Study|Disease progression|0|||
129004908|NCT00818623|464309275|FG002|Overall Study|Disease progression|0|||
129004909|NCT00818623|464309276|FG003|Overall Study|Disease progression|0|||
129004910|NCT00818623|464309277|FG004|Overall Study|Disease progression|0|||
129004911|NCT00818623|464309278|FG005|Overall Study|Disease progression|0|||
129004912|NCT00818623|464309279|FG006|Overall Study|Disease progression|1|||
129004913|NCT00818623|464309280|FG007|Overall Study|Disease progression|0|||
129004914|NCT00602030|464309281|FG000|Lead-in Phase|Disease Progression|2|||
129004915|NCT00602030|464309282|FG001|Lead-in Phase|Disease Progression|3|||
129004916|NCT00602030|464309283|FG002|Lead-in Phase|Disease Progression|0|||
128669802|NCT02626624|463089050|FG000|Overall Study|Death|2|||
128669803|NCT01395524|463090588|FG000|Overall Study|Non-compliance with study schedule|1|||
128669804|NCT01395524|463090589|FG001|Overall Study|Non-compliance with study schedule|0|||
128669805|NCT01395524|463090590|FG002|Overall Study|Non-compliance with study schedule|1|||
128669806|NCT01395524|463090588|FG000|Overall Study|Lost to Follow-up|3|||
128669807|NCT01395524|463090589|FG001|Overall Study|Lost to Follow-up|1|||
128669808|NCT01395524|463090590|FG002|Overall Study|Lost to Follow-up|1|||
128669809|NCT01395524|463090588|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
128669810|NCT01395524|463090589|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
128669811|NCT01395524|463090590|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
128669812|NCT01395524|463090588|FG000|Overall Study|Severe noncompliance with protocol|1|||
128669813|NCT01395524|463090589|FG001|Overall Study|Severe noncompliance with protocol|0|||
128669814|NCT01395524|463090590|FG002|Overall Study|Severe noncompliance with protocol|0|||
128669815|NCT01395524|463090588|FG000|Overall Study|Adverse Event|4|||
128669816|NCT01395524|463090589|FG001|Overall Study|Adverse Event|4|||
128669817|NCT01395524|463090590|FG002|Overall Study|Adverse Event|3|||
128669818|NCT01395524|463090588|FG000|Overall Study|Death|1|||
129004917|NCT00602030|464309284|FG003|Lead-in Phase|Disease Progression|0|||
129004918|NCT00602030|464309285|FG004|Lead-in Phase|Disease Progression|0|||
129004919|NCT00602030|464309281|FG000|Lead-in Phase|Adverse Event|0|||
129004920|NCT00602030|464309282|FG001|Lead-in Phase|Adverse Event|2|||
129004921|NCT00602030|464309283|FG002|Lead-in Phase|Adverse Event|0|||
129004922|NCT00602030|464309284|FG003|Lead-in Phase|Adverse Event|0|||
129004923|NCT00602030|464309285|FG004|Lead-in Phase|Adverse Event|0|||
129004924|NCT00602030|464309281|FG000|Double-blind Phase|Disease progression|0|||
129004925|NCT00602030|464309282|FG001|Double-blind Phase|Disease progression|0|||
129004926|NCT00602030|464309283|FG002|Double-blind Phase|Disease progression|33|||
129004927|NCT00602030|464309284|FG003|Double-blind Phase|Disease progression|30|||
129004928|NCT00602030|464309285|FG004|Double-blind Phase|Disease progression|0|||
129004929|NCT00602030|464309281|FG000|Double-blind Phase|Adverse Event|0|||
129004930|NCT00602030|464309282|FG001|Double-blind Phase|Adverse Event|0|||
129004931|NCT00602030|464309283|FG002|Double-blind Phase|Adverse Event|9|||
129004932|NCT00602030|464309284|FG003|Double-blind Phase|Adverse Event|18|||
129004933|NCT00602030|464309285|FG004|Double-blind Phase|Adverse Event|0|||
129004934|NCT00602030|464309281|FG000|Double-blind Phase|Consent withdrawal|0|||
129004935|NCT00602030|464309282|FG001|Double-blind Phase|Consent withdrawal|0|||
129004936|NCT00602030|464309283|FG002|Double-blind Phase|Consent withdrawal|4|||
129004937|NCT00602030|464309284|FG003|Double-blind Phase|Consent withdrawal|3|||
129004938|NCT00602030|464309285|FG004|Double-blind Phase|Consent withdrawal|0|||
129004939|NCT00602030|464309281|FG000|Double-blind Phase|Death|0|||
129004940|NCT00602030|464309282|FG001|Double-blind Phase|Death|0|||
129004941|NCT00602030|464309283|FG002|Double-blind Phase|Death|3|||
129004942|NCT00602030|464309284|FG003|Double-blind Phase|Death|3|||
129004943|NCT00602030|464309285|FG004|Double-blind Phase|Death|0|||
128669819|NCT01395524|463090589|FG001|Overall Study|Death|0|||
128669820|NCT01395524|463090590|FG002|Overall Study|Death|0|||
129004944|NCT00602030|464309281|FG000|Double-blind Phase|Administrative decision|0|||
129004945|NCT00602030|464309282|FG001|Double-blind Phase|Administrative decision|0|||
129004946|NCT00602030|464309283|FG002|Double-blind Phase|Administrative decision|0|||
129004947|NCT00602030|464309284|FG003|Double-blind Phase|Administrative decision|2|||
129004948|NCT00602030|464309285|FG004|Double-blind Phase|Administrative decision|0|||
129004949|NCT00602030|464309281|FG000|Double-blind Phase|Ineligibility|0|||
129004950|NCT00602030|464309282|FG001|Double-blind Phase|Ineligibility|0|||
129004951|NCT00602030|464309283|FG002|Double-blind Phase|Ineligibility|0|||
129004952|NCT00602030|464309284|FG003|Double-blind Phase|Ineligibility|1|||
129004953|NCT00602030|464309285|FG004|Double-blind Phase|Ineligibility|0|||
129004954|NCT00602030|464309281|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
129004955|NCT00602030|464309282|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
129004956|NCT00602030|464309283|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
129004957|NCT00602030|464309284|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
129004958|NCT00602030|464309285|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
129004959|NCT00602030|464309281|FG000|Double-blind Phase|Reason not specified|0|||
129004960|NCT00602030|464309282|FG001|Double-blind Phase|Reason not specified|0|||
129004961|NCT00602030|464309283|FG002|Double-blind Phase|Reason not specified|4|||
129004962|NCT00602030|464309284|FG003|Double-blind Phase|Reason not specified|2|||
129004963|NCT00602030|464309285|FG004|Double-blind Phase|Reason not specified|0|||
129004964|NCT00602030|464309281|FG000|Crossover Phase|Disease Progression|0|||
129004965|NCT00602030|464309282|FG001|Crossover Phase|Disease Progression|0|||
129004966|NCT00602030|464309283|FG002|Crossover Phase|Disease Progression|0|||
129004967|NCT00602030|464309284|FG003|Crossover Phase|Disease Progression|0|||
129004968|NCT00602030|464309285|FG004|Crossover Phase|Disease Progression|11|||
129004969|NCT00602030|464309281|FG000|Crossover Phase|Adverse Event|0|||
129004970|NCT00602030|464309282|FG001|Crossover Phase|Adverse Event|0|||
129004971|NCT00602030|464309283|FG002|Crossover Phase|Adverse Event|0|||
129004972|NCT00602030|464309284|FG003|Crossover Phase|Adverse Event|0|||
129004973|NCT00602030|464309285|FG004|Crossover Phase|Adverse Event|3|||
129004974|NCT00602030|464309281|FG000|Crossover Phase|Consent withdrawal|0|||
129004975|NCT00602030|464309282|FG001|Crossover Phase|Consent withdrawal|0|||
129004976|NCT00602030|464309283|FG002|Crossover Phase|Consent withdrawal|0|||
129004977|NCT00602030|464309284|FG003|Crossover Phase|Consent withdrawal|0|||
129004978|NCT00602030|464309285|FG004|Crossover Phase|Consent withdrawal|2|||
129004979|NCT00638157|464309308|FG000|Overall Study|Adverse Event|0|||
129004980|NCT00638157|464309309|FG001|Overall Study|Adverse Event|1|||
129004981|NCT00638157|464309308|FG000|Overall Study|Clinical (symptomatic) failure|1|||
129004982|NCT00638157|464309309|FG001|Overall Study|Clinical (symptomatic) failure|1|||
129004983|NCT00638157|464309308|FG000|Overall Study|Microbiological failure|1|||
129004984|NCT00638157|464309309|FG001|Overall Study|Microbiological failure|0|||
129004985|NCT00638157|464309308|FG000|Overall Study|Lost to Follow-up|1|||
129004986|NCT00638157|464309309|FG001|Overall Study|Lost to Follow-up|0|||
129004987|NCT00638157|464309308|FG000|Overall Study|Physician Decision|1|||
129004988|NCT00638157|464309309|FG001|Overall Study|Physician Decision|0|||
129004989|NCT00638157|464309308|FG000|Overall Study|Other|1|||
129004990|NCT00638157|464309309|FG001|Overall Study|Other|2|||
129004991|NCT00638157|464309308|FG000|Overall Study|Randomized, not treated|2|||
129004992|NCT00638157|464309309|FG001|Overall Study|Randomized, not treated|0|||
129004993|NCT00876733|464309310|FG000|Overall Study|Adverse Event|34|||
129004994|NCT00876733|464309311|FG001|Overall Study|Adverse Event|20|||
129004995|NCT00876733|464309312|FG002|Overall Study|Adverse Event|10|||
129004996|NCT00876733|464309313|FG003|Overall Study|Adverse Event|3|||
129004997|NCT00876733|464309310|FG000|Overall Study|Lack of Efficacy|17|||
128669821|NCT01395524|463090588|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
128669822|NCT01395524|463090589|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
128669823|NCT01395524|463090590|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
128669824|NCT01395524|463090588|FG000|Overall Study|Withdrawal by Subject|4|||
128669825|NCT01395524|463090589|FG001|Overall Study|Withdrawal by Subject|8|||
128669826|NCT01395524|463090590|FG002|Overall Study|Withdrawal by Subject|8|||
128669827|NCT01395524|463090588|FG000|Overall Study|Did not receive treatment|1|||
128669828|NCT01395524|463090589|FG001|Overall Study|Did not receive treatment|1|||
128669829|NCT01395524|463090590|FG002|Overall Study|Did not receive treatment|3|||
128669830|NCT01395524|463090588|FG000|Overall Study|Subject had spinal surgery|0|||
128669831|NCT01395524|463090589|FG001|Overall Study|Subject had spinal surgery|0|||
128669832|NCT01395524|463090590|FG002|Overall Study|Subject had spinal surgery|1|||
128669833|NCT01657461|463090591|FG000|Overall Study|Death|9|||
128669834|NCT01657461|463090592|FG001|Overall Study|Death|12|||
128669835|NCT01657461|463090591|FG000|Overall Study|Lost to Follow-up|0|||
128669836|NCT01657461|463090592|FG001|Overall Study|Lost to Follow-up|3|||
128669837|NCT01657461|463090591|FG000|Overall Study|Physician Decision|0|||
128669838|NCT01657461|463090592|FG001|Overall Study|Physician Decision|2|||
128669839|NCT01657461|463090591|FG000|Overall Study|Withdrawal by Subject|1|||
128669840|NCT01657461|463090592|FG001|Overall Study|Withdrawal by Subject|3|||
128669841|NCT01868542|463090593|FG000|Overall Study|Protocol Violation|0|||
128669842|NCT01868542|463090594|FG001|Overall Study|Protocol Violation|1|||
129004998|NCT00876733|464309311|FG001|Overall Study|Lack of Efficacy|9|||
129004999|NCT00876733|464309312|FG002|Overall Study|Lack of Efficacy|10|||
129005000|NCT00876733|464309313|FG003|Overall Study|Lack of Efficacy|1|||
129005001|NCT00876733|464309310|FG000|Overall Study|Lost to Follow-up|26|||
129005002|NCT00876733|464309311|FG001|Overall Study|Lost to Follow-up|10|||
129005003|NCT00876733|464309312|FG002|Overall Study|Lost to Follow-up|3|||
129005004|NCT00876733|464309313|FG003|Overall Study|Lost to Follow-up|2|||
129005005|NCT00876733|464309310|FG000|Overall Study|Data not available|14|||
129005006|NCT00876733|464309311|FG001|Overall Study|Data not available|3|||
128669843|NCT01868542|463090593|FG000|Overall Study|Unclassified|0|||
128669844|NCT01868542|463090594|FG001|Overall Study|Unclassified|1|||
129005007|NCT00876733|464309312|FG002|Overall Study|Data not available|7|||
129005008|NCT00876733|464309313|FG003|Overall Study|Data not available|1|||
129005009|NCT02843074|464309314|FG000|Overall Study|Withdrawal by Subject|5|||
128669845|NCT00669409|463090599|FG000|Part 2|Withdrawal by Subject|0|||
128669846|NCT00669409|463090600|FG001|Part 2|Withdrawal by Subject|0|||
128669847|NCT00669409|463090601|FG002|Part 2|Withdrawal by Subject|0|||
129005010|NCT02843074|464309314|FG000|Overall Study|Progressive disease|1|||
129005011|NCT02843074|464309314|FG000|Overall Study|Physician Decision|1|||
129005012|NCT02843074|464309314|FG000|Overall Study|Lost to Follow-up|1|||
129005013|NCT02843074|464309314|FG000|Overall Study|Death|9|||
129005014|NCT00543439|464309315|FG000|Period 1|Adverse Event|0|||
129005015|NCT00543439|464309316|FG001|Period 1|Adverse Event|2|||
129005016|NCT00543439|464309317|FG002|Period 1|Adverse Event|1|||
129005017|NCT00543439|464309315|FG000|Period 1|Withdrawal by Subject|1|||
129005018|NCT00543439|464309316|FG001|Period 1|Withdrawal by Subject|1|||
129005019|NCT00543439|464309317|FG002|Period 1|Withdrawal by Subject|0|||
129005020|NCT00543439|464309315|FG000|Period 1|Physician Decision|0|||
129005021|NCT00543439|464309316|FG001|Period 1|Physician Decision|0|||
129005022|NCT00543439|464309317|FG002|Period 1|Physician Decision|1|||
129005023|NCT00543439|464309315|FG000|Period 2|Protocol Violation|1|||
129005024|NCT00543439|464309316|FG001|Period 2|Protocol Violation|0|||
129005025|NCT00543439|464309317|FG002|Period 2|Protocol Violation|1|||
129005026|NCT00543439|464309315|FG000|Period 2|Adverse Event|0|||
129005027|NCT00543439|464309316|FG001|Period 2|Adverse Event|1|||
129005028|NCT00543439|464309317|FG002|Period 2|Adverse Event|1|||
129005029|NCT01214330|464309318|FG000|Overall Study|Withdrawal by Subject|2|||
129005030|NCT01214330|464309318|FG000|Overall Study|Withdrawal by Subject|2|||
128669848|NCT00669409|463090602|FG003|Part 2|Withdrawal by Subject|0|||
128669849|NCT00669409|463090603|FG004|Part 2|Withdrawal by Subject|0|||
128669850|NCT00669409|463090604|FG005|Part 2|Withdrawal by Subject|0|||
128669851|NCT00669409|463090605|FG006|Part 2|Withdrawal by Subject|0|||
128669852|NCT00669409|463090606|FG007|Part 2|Withdrawal by Subject|0|||
128669853|NCT00669409|463090607|FG008|Part 2|Withdrawal by Subject|0|||
128669854|NCT00669409|463090608|FG009|Part 2|Withdrawal by Subject|1|||
128669855|NCT00669409|463090609|FG010|Part 2|Withdrawal by Subject|0|||
128669856|NCT03583385|463090610|FG000|Treatment Period 1|Withdrawal by Subject|1|||
128669857|NCT03583385|463090611|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128669858|NCT03583385|463090610|FG000|Treatment Period 2|Adverse Event|1|||
128669859|NCT03583385|463090611|FG001|Treatment Period 2|Adverse Event|0|||
128669860|NCT03539549|463090617|FG000|Overall Study|Adverse Event|12|||
128669861|NCT03539549|463090617|FG000|Overall Study|Lost to Follow-up|1|||
128669862|NCT03539549|463090617|FG000|Overall Study|Death|2|||
128669863|NCT03539549|463090617|FG000|Overall Study|Progressive Disease|1|||
128669864|NCT03539549|463090617|FG000|Overall Study|Reason not Specified|1|||
128669865|NCT02864862|463090623|FG000|Overall Study|Lost to Follow-up|1|||
128669866|NCT02864862|463090624|FG001|Overall Study|Lost to Follow-up|0|||
128669867|NCT02864862|463090625|FG002|Overall Study|Lost to Follow-up|1|||
128669868|NCT02864862|463090623|FG000|Overall Study|Protocol Violation|0|||
128669869|NCT02864862|463090624|FG001|Overall Study|Protocol Violation|0|||
128669870|NCT02864862|463090625|FG002|Overall Study|Protocol Violation|1|||
128669871|NCT05573386|463090629|FG000|Overall Study|Withdrawal by Subject|3|||
128669872|NCT05573386|463090630|FG001|Overall Study|Withdrawal by Subject|2|||
128669873|NCT03646123|463090631|FG000|Overall Study|Withdrawal by Subject|2|||
128669874|NCT03646123|463090632|FG001|Overall Study|Withdrawal by Subject|2|||
128669875|NCT03646123|463090633|FG002|Overall Study|Withdrawal by Subject|3|||
128669876|NCT03646123|463090631|FG000|Overall Study|Study termination by sponsor|0|||
128669877|NCT03646123|463090632|FG001|Overall Study|Study termination by sponsor|45|||
128669878|NCT03646123|463090633|FG002|Overall Study|Study termination by sponsor|139|||
128669879|NCT03646123|463090631|FG000|Overall Study|Lost to Follow-up|4|||
128669880|NCT03646123|463090632|FG001|Overall Study|Lost to Follow-up|10|||
128669881|NCT03646123|463090633|FG002|Overall Study|Lost to Follow-up|10|||
128669882|NCT03646123|463090631|FG000|Overall Study|Death|2|||
128669883|NCT03646123|463090632|FG001|Overall Study|Death|1|||
128669884|NCT03646123|463090633|FG002|Overall Study|Death|1|||
128669885|NCT03646123|463090631|FG000|Overall Study|Other|2|||
128669886|NCT03646123|463090632|FG001|Overall Study|Other|0|||
128669887|NCT03646123|463090633|FG002|Overall Study|Other|2|||
128669888|NCT01802073|463090636|FG000|Overall Study|Lost to Follow-up|0|||
128669889|NCT01802073|463090637|FG001|Overall Study|Lost to Follow-up|1|||
129005031|NCT00686036|464309320|FG000|Overall Study|Adverse Event|3|||
129005032|NCT00686036|464309321|FG001|Overall Study|Adverse Event|0|||
129005033|NCT00686036|464309320|FG000|Overall Study|Withdrawal by Subject|3|||
129005034|NCT00686036|464309321|FG001|Overall Study|Withdrawal by Subject|1|||
129005035|NCT00686036|464309320|FG000|Overall Study|Study terminated by AstraZeneca|2|||
129005036|NCT00686036|464309321|FG001|Overall Study|Study terminated by AstraZeneca|1|||
129005037|NCT00686036|464309320|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
129005038|NCT00686036|464309321|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
128669890|NCT01802073|463090636|FG000|Overall Study|Non-compliant|4|||
128669891|NCT01802073|463090637|FG001|Overall Study|Non-compliant|2|||
128669892|NCT01802073|463090636|FG000|Overall Study|Withdrawal by Subject|1|||
128669893|NCT01802073|463090637|FG001|Overall Study|Withdrawal by Subject|1|||
128669894|NCT01802073|463090636|FG000|Overall Study|Physician Decision|0|||
128669895|NCT01802073|463090637|FG001|Overall Study|Physician Decision|7|||
128669896|NCT02123472|463090641|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
128669897|NCT02123472|463090642|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
128669898|NCT00918736|463090643|FG000|Overall Study|Withdrawal by Subject|4|||
128669899|NCT01474018|463090644|FG000|Overall Study|Lost to Follow-up|0|||
128669900|NCT01474018|463090645|FG001|Overall Study|Lost to Follow-up|1|||
128669901|NCT01474018|463090644|FG000|Overall Study|Withdrawal by Subject|0|||
128669902|NCT01474018|463090645|FG001|Overall Study|Withdrawal by Subject|2|||
128669903|NCT02433080|463090646|FG000|Overall Study|Lost to Follow-up|1|||
128669904|NCT02433080|463090647|FG001|Overall Study|Lost to Follow-up|2|||
128669905|NCT02433080|463090646|FG000|Overall Study|Withdrawal by Subject|0|||
128669906|NCT02433080|463090647|FG001|Overall Study|Withdrawal by Subject|2|||
128669907|NCT01137604|463090648|FG000|Overall Study|Adverse Event|3|||
128669908|NCT01137604|463090649|FG001|Overall Study|Adverse Event|6|||
128669909|NCT01137604|463090650|FG002|Overall Study|Adverse Event|9|||
128669910|NCT01137604|463090651|FG003|Overall Study|Adverse Event|9|||
128669911|NCT01137604|463090648|FG000|Overall Study|Participant Choice|0|||
128669912|NCT01137604|463090649|FG001|Overall Study|Participant Choice|2|||
128669913|NCT01137604|463090650|FG002|Overall Study|Participant Choice|2|||
128669914|NCT01137604|463090651|FG003|Overall Study|Participant Choice|0|||
129005039|NCT00686036|464309320|FG000|Overall Study|Other reasons not identified|0|||
129005040|NCT00686036|464309321|FG001|Overall Study|Other reasons not identified|4|||
129005041|NCT01199601|464309325|FG000|Overall Study|Lost to Follow-up|47|||
129005042|NCT01199601|464309326|FG001|Overall Study|Lost to Follow-up|66|||
129005043|NCT01199601|464309325|FG000|Overall Study|Withdrawal by Subject|15|||
129005044|NCT01199601|464309326|FG001|Overall Study|Withdrawal by Subject|3|||
129005045|NCT01199601|464309325|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
129005046|NCT01199601|464309326|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
129005047|NCT02669264|464309327|FG000|Overall Study|Death|5|||
129005048|NCT02669264|464309328|FG001|Overall Study|Death|5|||
129005049|NCT02669264|464309329|FG002|Overall Study|Death|3|||
129005050|NCT02669264|464309330|FG003|Overall Study|Death|3|||
129005051|NCT02669264|464309331|FG004|Overall Study|Death|3|||
129005052|NCT02669264|464309332|FG005|Overall Study|Death|6|||
129005053|NCT02669264|464309333|FG006|Overall Study|Death|3|||
129005054|NCT02669264|464309327|FG000|Overall Study|Withdrawal by Subject|0|||
129005055|NCT02669264|464309328|FG001|Overall Study|Withdrawal by Subject|1|||
129005056|NCT02669264|464309329|FG002|Overall Study|Withdrawal by Subject|0|||
129005057|NCT02669264|464309330|FG003|Overall Study|Withdrawal by Subject|0|||
129005058|NCT02669264|464309331|FG004|Overall Study|Withdrawal by Subject|1|||
129005059|NCT02669264|464309332|FG005|Overall Study|Withdrawal by Subject|0|||
129005060|NCT02669264|464309333|FG006|Overall Study|Withdrawal by Subject|0|||
129005061|NCT02669264|464309327|FG000|Overall Study|Lost to Follow-up|0|||
129005062|NCT02669264|464309328|FG001|Overall Study|Lost to Follow-up|0|||
129005063|NCT02669264|464309329|FG002|Overall Study|Lost to Follow-up|0|||
129005064|NCT02669264|464309330|FG003|Overall Study|Lost to Follow-up|0|||
129005065|NCT02669264|464309331|FG004|Overall Study|Lost to Follow-up|1|||
129005066|NCT02669264|464309332|FG005|Overall Study|Lost to Follow-up|0|||
129005067|NCT02669264|464309333|FG006|Overall Study|Lost to Follow-up|0|||
129005068|NCT02669264|464309327|FG000|Overall Study|Miscellaneous|0|||
129005069|NCT02669264|464309328|FG001|Overall Study|Miscellaneous|0|||
129005070|NCT02669264|464309329|FG002|Overall Study|Miscellaneous|0|||
129005071|NCT02669264|464309330|FG003|Overall Study|Miscellaneous|0|||
129005072|NCT02669264|464309331|FG004|Overall Study|Miscellaneous|0|||
129005073|NCT02669264|464309332|FG005|Overall Study|Miscellaneous|0|||
129005074|NCT02669264|464309333|FG006|Overall Study|Miscellaneous|2|||
129005075|NCT01688037|464309334|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
129005076|NCT01688037|464309335|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
129005077|NCT01688037|464309336|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
129005078|NCT01688037|464309334|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
129005079|NCT01688037|464309335|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
129005080|NCT01688037|464309336|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
129005081|NCT01688037|464309334|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
129005082|NCT01688037|464309335|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
129005083|NCT01688037|464309336|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
129005084|NCT01688037|464309334|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
129005085|NCT01688037|464309335|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
129005086|NCT01688037|464309336|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
129005087|NCT01688037|464309334|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
129005088|NCT01688037|464309335|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
128669915|NCT01137604|463090648|FG000|Overall Study|Withdrawal of consent|0|||
129005089|NCT01688037|464309336|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
128669916|NCT01137604|463090649|FG001|Overall Study|Withdrawal of consent|0|||
128669917|NCT01137604|463090650|FG002|Overall Study|Withdrawal of consent|0|||
129005090|NCT01688037|464309334|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
129005091|NCT01688037|464309335|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
129005092|NCT01688037|464309336|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
129005093|NCT01688037|464309334|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
129005094|NCT01688037|464309335|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
129005095|NCT01688037|464309336|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
129005096|NCT01688037|464309334|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
129005097|NCT01688037|464309335|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
129005098|NCT01688037|464309336|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
129005099|NCT01688037|464309334|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
129005100|NCT01688037|464309335|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
129005101|NCT01688037|464309336|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
129005102|NCT01688037|464309334|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
129005103|NCT01688037|464309335|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
129005104|NCT01688037|464309336|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
129005105|NCT03035227|464309337|FG000|Overall Study|study stopped due to PI leaving institut|1|||
129005106|NCT03035227|464309338|FG001|Overall Study|study stopped due to PI leaving institut|1|||
129005107|NCT02100956|464309339|FG000|At Least One Week Between Injections|Adverse Event|0|||
129005108|NCT02100956|464309340|FG001|At Least One Week Between Injections|Adverse Event|1|||
129005109|NCT00859469|464309342|FG000|Overall Study|Adverse Event|2|||
129005110|NCT00859469|464309342|FG000|Overall Study|Lack of Efficacy|9|||
129005111|NCT00859469|464309342|FG000|Overall Study|Withdrawal by Subject|1|||
129005112|NCT00859469|464309342|FG000|Overall Study|Death|16|||
129005113|NCT02220907|464309343|FG000|Overall Study|Adverse Event|7|||
129005114|NCT02220907|464309343|FG000|Overall Study|Physician Decision|1|||
129005115|NCT02220907|464309343|FG000|Overall Study|Withdrawal by Subject|2|||
129005116|NCT02220907|464309343|FG000|Overall Study|Conflict with the stopping criteria|1|||
129005117|NCT03111147|464309344|FG000|Overall Study|Lost to Follow-up|2|||
129005118|NCT03111147|464309345|FG001|Overall Study|Lost to Follow-up|5|||
128669918|NCT01137604|463090651|FG003|Overall Study|Withdrawal of consent|2|||
128669919|NCT01137604|463090648|FG000|Overall Study|Clinical progression/deterioration|1|||
128669920|NCT01137604|463090649|FG001|Overall Study|Clinical progression/deterioration|2|||
128669921|NCT01137604|463090650|FG002|Overall Study|Clinical progression/deterioration|2|||
128669922|NCT01137604|463090651|FG003|Overall Study|Clinical progression/deterioration|0|||
128669923|NCT03462511|463090655|FG000|Overall Study|Withdrawal by Subject|2|||
128669924|NCT03462511|463090656|FG001|Overall Study|Withdrawal by Subject|3|||
128669925|NCT02925416|463090657|FG000|Overall Study|Adverse Event|2|||
128669926|NCT02925416|463090658|FG001|Overall Study|Adverse Event|0|||
128669927|NCT00200356|463090659|FG000|Overall Study|Lack of Efficacy|3|||
128669928|NCT00200356|463090660|FG001|Overall Study|Lack of Efficacy|3|||
128669929|NCT00200356|463090659|FG000|Overall Study|Protocol Violation|4|||
128669930|NCT00200356|463090660|FG001|Overall Study|Protocol Violation|4|||
128669931|NCT00200356|463090659|FG000|Overall Study|Nontreatment|1|||
128669932|NCT00200356|463090660|FG001|Overall Study|Nontreatment|0|||
128669933|NCT01297491|463090661|FG000|Overall Study|Adverse Event|11|||
128669934|NCT01297491|463090662|FG001|Overall Study|Adverse Event|6|||
128669935|NCT01297491|463090661|FG000|Overall Study|Physician Decision|3|||
128669936|NCT01297491|463090662|FG001|Overall Study|Physician Decision|2|||
128669937|NCT01297491|463090661|FG000|Overall Study|Progressive disease|11|||
128669938|NCT01297491|463090662|FG001|Overall Study|Progressive disease|20|||
128669939|NCT01297491|463090661|FG000|Overall Study|Patient/Guardian decision|3|||
128669940|NCT01297491|463090662|FG001|Overall Study|Patient/Guardian decision|4|||
128669941|NCT01297491|463090661|FG000|Overall Study|Death|2|||
128669942|NCT01297491|463090662|FG001|Overall Study|Death|1|||
128669943|NCT01015638|463090665|FG000|Overall Study|Withdrawal by Subject|1|||
128669944|NCT01015638|463090666|FG001|Overall Study|Withdrawal by Subject|0|||
128669945|NCT00776919|463090672|FG000|Overall Study|Withdrawal by Subject|16|||
128669946|NCT00776919|463090673|FG001|Overall Study|Withdrawal by Subject|14|||
128669947|NCT00776919|463090674|FG002|Overall Study|Withdrawal by Subject|15|||
128669948|NCT00776919|463090675|FG003|Overall Study|Withdrawal by Subject|26|||
128669949|NCT00776919|463090672|FG000|Overall Study|Lost to Follow-up|8|||
128669950|NCT00776919|463090673|FG001|Overall Study|Lost to Follow-up|12|||
128669951|NCT00776919|463090674|FG002|Overall Study|Lost to Follow-up|11|||
128669952|NCT00776919|463090675|FG003|Overall Study|Lost to Follow-up|8|||
128669953|NCT00776919|463090672|FG000|Overall Study|Adverse Event|1|||
128669954|NCT00776919|463090673|FG001|Overall Study|Adverse Event|0|||
128669955|NCT00776919|463090674|FG002|Overall Study|Adverse Event|2|||
128669956|NCT00776919|463090675|FG003|Overall Study|Adverse Event|2|||
129005119|NCT03111147|464309344|FG000|Overall Study|Withdrawal by Subject|4|||
128669957|NCT00776919|463090672|FG000|Overall Study|Protocol Violation|1|||
128669958|NCT00776919|463090673|FG001|Overall Study|Protocol Violation|2|||
128669959|NCT00776919|463090674|FG002|Overall Study|Protocol Violation|0|||
128669960|NCT00776919|463090675|FG003|Overall Study|Protocol Violation|1|||
129005120|NCT03111147|464309345|FG001|Overall Study|Withdrawal by Subject|3|||
129005121|NCT03111147|464309344|FG000|Overall Study|Protocol Violation|2|||
128669961|NCT00776919|463090672|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
128669962|NCT00776919|463090673|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
128669963|NCT00776919|463090674|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
129005122|NCT03111147|464309345|FG001|Overall Study|Protocol Violation|1|||
129005123|NCT03111147|464309344|FG000|Overall Study|Death|1|||
129005124|NCT03111147|464309345|FG001|Overall Study|Death|1|||
129005125|NCT00095199|464309348|FG000|Overall Study|Adverse Event|40|||
129005126|NCT00095199|464309349|FG001|Overall Study|Adverse Event|22|||
129005127|NCT00095199|464309350|FG002|Overall Study|Adverse Event|26|||
129005128|NCT00095199|464309351|FG003|Overall Study|Adverse Event|11|||
129005129|NCT00095199|464309348|FG000|Overall Study|Progressive disease|213|||
129005130|NCT00095199|464309349|FG001|Overall Study|Progressive disease|179|||
129005131|NCT00095199|464309350|FG002|Overall Study|Progressive disease|105|||
129005132|NCT00095199|464309351|FG003|Overall Study|Progressive disease|98|||
129005133|NCT00095199|464309348|FG000|Overall Study|Death|10|||
129005134|NCT00095199|464309349|FG001|Overall Study|Death|6|||
129005135|NCT00095199|464309350|FG002|Overall Study|Death|11|||
129005136|NCT00095199|464309351|FG003|Overall Study|Death|9|||
129005137|NCT00095199|464309348|FG000|Overall Study|Withdrawal by Subject|21|||
129005138|NCT00095199|464309349|FG001|Overall Study|Withdrawal by Subject|16|||
129005139|NCT00095199|464309350|FG002|Overall Study|Withdrawal by Subject|13|||
129005140|NCT00095199|464309351|FG003|Overall Study|Withdrawal by Subject|22|||
129005141|NCT00095199|464309348|FG000|Overall Study|Protocol Violation|4|||
129005142|NCT00095199|464309349|FG001|Overall Study|Protocol Violation|4|||
129005143|NCT00095199|464309350|FG002|Overall Study|Protocol Violation|2|||
129005144|NCT00095199|464309351|FG003|Overall Study|Protocol Violation|0|||
129005145|NCT00095199|464309348|FG000|Overall Study|Liver function test results elevated|0|||
129005146|NCT00095199|464309349|FG001|Overall Study|Liver function test results elevated|0|||
129005147|NCT00095199|464309350|FG002|Overall Study|Liver function test results elevated|1|||
129005148|NCT00095199|464309351|FG003|Overall Study|Liver function test results elevated|1|||
129005149|NCT00095199|464309348|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
129005150|NCT00095199|464309349|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
129005151|NCT00095199|464309350|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
129005152|NCT00095199|464309351|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
129005153|NCT00095199|464309348|FG000|Overall Study|Physician Decision|5|||
129005154|NCT00095199|464309349|FG001|Overall Study|Physician Decision|6|||
129005155|NCT00095199|464309350|FG002|Overall Study|Physician Decision|1|||
129005156|NCT00095199|464309351|FG003|Overall Study|Physician Decision|1|||
129005157|NCT00095199|464309348|FG000|Overall Study|Not eligible|1|||
129005158|NCT00095199|464309349|FG001|Overall Study|Not eligible|7|||
129005159|NCT00095199|464309350|FG002|Overall Study|Not eligible|0|||
129005160|NCT00095199|464309351|FG003|Overall Study|Not eligible|1|||
129005161|NCT00095199|464309348|FG000|Overall Study|Started Palliative Radiotherapy|1|||
129005162|NCT00095199|464309349|FG001|Overall Study|Started Palliative Radiotherapy|0|||
129005163|NCT00095199|464309350|FG002|Overall Study|Started Palliative Radiotherapy|0|||
129005164|NCT00095199|464309351|FG003|Overall Study|Started Palliative Radiotherapy|0|||
129005165|NCT00095199|464309348|FG000|Overall Study|Started radiotherapy regimen|0|||
129005166|NCT00095199|464309349|FG001|Overall Study|Started radiotherapy regimen|1|||
129005167|NCT00095199|464309350|FG002|Overall Study|Started radiotherapy regimen|0|||
129005168|NCT00095199|464309351|FG003|Overall Study|Started radiotherapy regimen|0|||
129005169|NCT00095199|464309348|FG000|Overall Study|Primary tumor removed in other surgery|0|||
129005170|NCT00095199|464309349|FG001|Overall Study|Primary tumor removed in other surgery|1|||
129005171|NCT00095199|464309350|FG002|Overall Study|Primary tumor removed in other surgery|0|||
129005172|NCT00095199|464309351|FG003|Overall Study|Primary tumor removed in other surgery|0|||
129005173|NCT00095199|464309348|FG000|Overall Study|Data inadvertently lost by site|1|||
129005174|NCT00095199|464309349|FG001|Overall Study|Data inadvertently lost by site|0|||
129005175|NCT00095199|464309350|FG002|Overall Study|Data inadvertently lost by site|0|||
129005176|NCT00095199|464309351|FG003|Overall Study|Data inadvertently lost by site|0|||
129005177|NCT01896297|464309354|FG000|Overall Study|Died in post treatment phase|1|||
129005178|NCT01070394|464309355|FG000|Overall Study|Adverse Event|6|||
129005179|NCT01070394|464309355|FG000|Overall Study|Withdrawal by Subject|1|||
129005180|NCT01098240|464309356|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
129005181|NCT01098240|464309357|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
129005182|NCT01098240|464309358|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
129005183|NCT01098240|464309356|FG000|Open-Label Phase|Protocol Violation|4|||
129005184|NCT01098240|464309357|FG001|Open-Label Phase|Protocol Violation|0|||
129005185|NCT01098240|464309358|FG002|Open-Label Phase|Protocol Violation|0|||
129005186|NCT01098240|464309356|FG000|Open-Label Phase|Lost to Follow-up|13|||
129005187|NCT01098240|464309357|FG001|Open-Label Phase|Lost to Follow-up|0|||
129005188|NCT01098240|464309358|FG002|Open-Label Phase|Lost to Follow-up|0|||
129005189|NCT01098240|464309356|FG000|Open-Label Phase|Other|19|||
129005190|NCT01098240|464309357|FG001|Open-Label Phase|Other|0|||
129005191|NCT01098240|464309358|FG002|Open-Label Phase|Other|0|||
129005192|NCT01098240|464309356|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
129005193|NCT01098240|464309357|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129005194|NCT01098240|464309358|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129005195|NCT01098240|464309356|FG000|Open-Label Phase|Pregnancy|1|||
129005196|NCT01098240|464309357|FG001|Open-Label Phase|Pregnancy|0|||
129005197|NCT01098240|464309358|FG002|Open-Label Phase|Pregnancy|0|||
129005198|NCT01098240|464309356|FG000|Open-Label Phase|Withdrawal by Subject|9|||
129005199|NCT01098240|464309357|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129005200|NCT01098240|464309358|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129005201|NCT01098240|464309356|FG000|Open-Label Phase|Adverse Event|12|||
129005202|NCT01098240|464309357|FG001|Open-Label Phase|Adverse Event|0|||
129005203|NCT01098240|464309358|FG002|Open-Label Phase|Adverse Event|0|||
129005204|NCT01098240|464309356|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
129005205|NCT01098240|464309357|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
129005206|NCT01098240|464309358|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
129005207|NCT01098240|464309356|FG000|Double-Blind Phase|Protocol Violation|0|||
129005208|NCT01098240|464309357|FG001|Double-Blind Phase|Protocol Violation|2|||
129005209|NCT01098240|464309358|FG002|Double-Blind Phase|Protocol Violation|4|||
129005210|NCT01098240|464309356|FG000|Double-Blind Phase|Lost to Follow-up|0|||
128669964|NCT00776919|463090675|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
128669965|NCT02379637|463090676|FG000|Overall Study|Protocol Violation|0|||
129005211|NCT01098240|464309357|FG001|Double-Blind Phase|Lost to Follow-up|2|||
129005212|NCT01098240|464309358|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129005213|NCT01098240|464309356|FG000|Double-Blind Phase|Other|0|||
129005214|NCT01098240|464309357|FG001|Double-Blind Phase|Other|2|||
129005215|NCT01098240|464309358|FG002|Double-Blind Phase|Other|2|||
129005216|NCT01098240|464309356|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
129005217|NCT01098240|464309357|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
129005218|NCT01098240|464309358|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
129005219|NCT01098240|464309356|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
129005220|NCT01098240|464309357|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
129005221|NCT01098240|464309358|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
129005222|NCT01098240|464309356|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129005223|NCT01098240|464309357|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
129005224|NCT01098240|464309358|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
129005225|NCT01098240|464309356|FG000|Double-Blind Phase|Adverse Event|0|||
129005226|NCT01098240|464309357|FG001|Double-Blind Phase|Adverse Event|3|||
129005227|NCT01098240|464309358|FG002|Double-Blind Phase|Adverse Event|3|||
129005228|NCT03280537|464309359|FG000|Overall Study|Withdrawal by Subject|2|||
129005229|NCT03280537|464309360|FG001|Overall Study|Withdrawal by Subject|4|||
129005230|NCT01588106|464309361|FG000|Overall Study|Withdrawal by Subject|5|||
129005231|NCT01588106|464309362|FG001|Overall Study|Withdrawal by Subject|4|||
129005232|NCT03083132|464309363|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
129005233|NCT03083132|464309364|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
129005234|NCT03083132|464309363|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
128669966|NCT02379637|463090677|FG001|Overall Study|Protocol Violation|1|||
128669967|NCT02379637|463090676|FG000|Overall Study|Adverse Event|1|||
128669968|NCT02379637|463090677|FG001|Overall Study|Adverse Event|0|||
128669969|NCT02379637|463090676|FG000|Overall Study|Withdrawal by Subject|1|||
128669970|NCT02379637|463090677|FG001|Overall Study|Withdrawal by Subject|0|||
128669971|NCT03179605|463090678|FG000|Overall Study|Withdrawal by Subject|1|||
128669972|NCT00228553|463090682|FG000|Overall Study|Adverse Event|112|||
128669973|NCT00228553|463090682|FG000|Overall Study|Lack of Efficacy|34|||
128669974|NCT00228553|463090682|FG000|Overall Study|Lost to Follow-up|67|||
128669975|NCT00228553|463090682|FG000|Overall Study|Physician Decision|48|||
128669976|NCT00228553|463090682|FG000|Overall Study|Protocol Violation|6|||
128669977|NCT00228553|463090682|FG000|Overall Study|Withdrawal by Subject|115|||
128669978|NCT00228553|463090682|FG000|Overall Study|Pregnancy|2|||
128669979|NCT00228553|463090682|FG000|Overall Study|Miscellaneous|46|||
128669980|NCT02878798|463090683|FG000|Overall Study|Withdrawal by Subject|5|||
128669981|NCT02878798|463090684|FG001|Overall Study|Withdrawal by Subject|4|||
128669982|NCT02878798|463090683|FG000|Overall Study|Lost to Follow-up|2|||
128669983|NCT02878798|463090684|FG001|Overall Study|Lost to Follow-up|2|||
128669984|NCT02878798|463090683|FG000|Overall Study|Protocol Violation|0|||
128669985|NCT02878798|463090684|FG001|Overall Study|Protocol Violation|1|||
128669986|NCT00101452|463090687|FG000|Overall Study|Adverse Event|2|||
128669987|NCT00101452|463090688|FG001|Overall Study|Adverse Event|0|||
128669988|NCT00101452|463090689|FG002|Overall Study|Adverse Event|1|||
129005235|NCT03083132|464309364|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
129005236|NCT03083132|464309363|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
129005237|NCT03083132|464309364|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
129005238|NCT03118739|464309365|FG000|Overall Study|Physician Decision|0|||
129005239|NCT03118739|464309366|FG001|Overall Study|Physician Decision|1|||
129005240|NCT03118739|464309365|FG000|Overall Study|Withdrawal by Subject|5|||
129005241|NCT03118739|464309366|FG001|Overall Study|Withdrawal by Subject|3|||
129005242|NCT03118739|464309365|FG000|Overall Study|Lost to Follow-up|2|||
128669989|NCT00101452|463090687|FG000|Overall Study|Lost to Follow-up|13|||
128669990|NCT00101452|463090688|FG001|Overall Study|Lost to Follow-up|8|||
128669991|NCT00101452|463090689|FG002|Overall Study|Lost to Follow-up|14|||
128669992|NCT00101452|463090687|FG000|Overall Study|Withdrawal by Subject|10|||
128669993|NCT00101452|463090688|FG001|Overall Study|Withdrawal by Subject|14|||
129005243|NCT03118739|464309366|FG001|Overall Study|Lost to Follow-up|0|||
129005244|NCT00669955|464309367|FG000|Overall Study|Adverse Event|3|||
129005245|NCT00669955|464309368|FG001|Overall Study|Adverse Event|5|||
129005246|NCT00669955|464309367|FG000|Overall Study|Death|0|||
129005247|NCT00669955|464309368|FG001|Overall Study|Death|1|||
129005248|NCT00669955|464309367|FG000|Overall Study|Withdrawal by Subject|2|||
129005249|NCT00669955|464309368|FG001|Overall Study|Withdrawal by Subject|3|||
129005250|NCT00669955|464309367|FG000|Overall Study|Lost to Follow-up|5|||
129005251|NCT00669955|464309368|FG001|Overall Study|Lost to Follow-up|7|||
129005252|NCT00669955|464309367|FG000|Overall Study|Protocol Violation|2|||
129005253|NCT00669955|464309368|FG001|Overall Study|Protocol Violation|7|||
129005254|NCT00669955|464309367|FG000|Overall Study|Investigator Sponsor Judgement|0|||
129005255|NCT00669955|464309368|FG001|Overall Study|Investigator Sponsor Judgement|1|||
129005256|NCT00669955|464309367|FG000|Overall Study|not compliant with study drug/visit|2|||
129005257|NCT00669955|464309368|FG001|Overall Study|not compliant with study drug/visit|3|||
129005258|NCT04274192|464309372|FG000|Overall Study|Protocol Violation|1|||
129005259|NCT04274192|464309373|FG001|Overall Study|Protocol Violation|0|||
129005260|NCT03507439|464309374|FG000|Overall Study|Other|2|||
129005261|NCT03507439|464309375|FG001|Overall Study|Other|1|||
129005262|NCT03507439|464309374|FG000|Overall Study|Withdrawal by Subject|1|||
129005263|NCT03507439|464309375|FG001|Overall Study|Withdrawal by Subject|0|||
129005264|NCT03507439|464309374|FG000|Overall Study|Death|1|||
129005265|NCT03507439|464309375|FG001|Overall Study|Death|1|||
129005266|NCT01621490|464310789|FG000|Overall Study|Subject no longer meets study criteria|0|||
129005267|NCT01621490|464310790|FG001|Overall Study|Subject no longer meets study criteria|0|||
129005268|NCT01621490|464310791|FG002|Overall Study|Subject no longer meets study criteria|0|||
129005269|NCT01621490|464310792|FG003|Overall Study|Subject no longer meets study criteria|0|||
129005270|NCT01621490|464310793|FG004|Overall Study|Subject no longer meets study criteria|1|||
129005271|NCT01621490|464310794|FG005|Overall Study|Subject no longer meets study criteria|0|||
129005272|NCT01621490|464310795|FG006|Overall Study|Subject no longer meets study criteria|0|||
129005273|NCT01621490|464310796|FG007|Overall Study|Subject no longer meets study criteria|0|||
129005274|NCT01621490|464310797|FG008|Overall Study|Subject no longer meets study criteria|0|||
129005275|NCT01621490|464310798|FG009|Overall Study|Subject no longer meets study criteria|0|||
129005276|NCT01621490|464310799|FG010|Overall Study|Subject no longer meets study criteria|0|||
129005277|NCT01621490|464310789|FG000|Overall Study|Maximum clinical benefit|3|||
129005278|NCT01621490|464310790|FG001|Overall Study|Maximum clinical benefit|2|||
129005279|NCT01621490|464310791|FG002|Overall Study|Maximum clinical benefit|0|||
129005280|NCT01621490|464310792|FG003|Overall Study|Maximum clinical benefit|0|||
129005281|NCT01621490|464310793|FG004|Overall Study|Maximum clinical benefit|0|||
129005282|NCT01621490|464310794|FG005|Overall Study|Maximum clinical benefit|0|||
129005283|NCT01621490|464310795|FG006|Overall Study|Maximum clinical benefit|1|||
129005284|NCT01621490|464310796|FG007|Overall Study|Maximum clinical benefit|2|||
129005285|NCT01621490|464310797|FG008|Overall Study|Maximum clinical benefit|2|||
129005286|NCT01621490|464310798|FG009|Overall Study|Maximum clinical benefit|0|||
129005287|NCT01621490|464310799|FG010|Overall Study|Maximum clinical benefit|0|||
129005288|NCT01621490|464310789|FG000|Overall Study|Withdrawal by Subject|1|||
129005289|NCT01621490|464310790|FG001|Overall Study|Withdrawal by Subject|0|||
129005290|NCT01621490|464310791|FG002|Overall Study|Withdrawal by Subject|0|||
129005291|NCT01621490|464310792|FG003|Overall Study|Withdrawal by Subject|0|||
129005292|NCT01621490|464310793|FG004|Overall Study|Withdrawal by Subject|0|||
129005293|NCT01621490|464310794|FG005|Overall Study|Withdrawal by Subject|1|||
129005294|NCT01621490|464310795|FG006|Overall Study|Withdrawal by Subject|0|||
129005295|NCT01621490|464310796|FG007|Overall Study|Withdrawal by Subject|0|||
129005296|NCT01621490|464310797|FG008|Overall Study|Withdrawal by Subject|0|||
129005297|NCT01621490|464310798|FG009|Overall Study|Withdrawal by Subject|0|||
129005298|NCT01621490|464310799|FG010|Overall Study|Withdrawal by Subject|0|||
129005299|NCT01621490|464310789|FG000|Overall Study|Subject request to discontinue study|1|||
129005300|NCT01621490|464310790|FG001|Overall Study|Subject request to discontinue study|3|||
129005301|NCT01621490|464310791|FG002|Overall Study|Subject request to discontinue study|1|||
129005302|NCT01621490|464310792|FG003|Overall Study|Subject request to discontinue study|1|||
129005303|NCT01621490|464310793|FG004|Overall Study|Subject request to discontinue study|0|||
129005304|NCT01621490|464310794|FG005|Overall Study|Subject request to discontinue study|2|||
129005305|NCT01621490|464310795|FG006|Overall Study|Subject request to discontinue study|1|||
129005306|NCT01621490|464310796|FG007|Overall Study|Subject request to discontinue study|0|||
129005307|NCT01621490|464310797|FG008|Overall Study|Subject request to discontinue study|1|||
129005308|NCT01621490|464310798|FG009|Overall Study|Subject request to discontinue study|0|||
129005309|NCT01621490|464310799|FG010|Overall Study|Subject request to discontinue study|0|||
129005310|NCT01621490|464310789|FG000|Overall Study|Adverse event unrelated to study drug|1|||
129005311|NCT01621490|464310790|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129005312|NCT01621490|464310791|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129005313|NCT01621490|464310792|FG003|Overall Study|Adverse event unrelated to study drug|0|||
128878369|NCT00402597|463848451|FG001|Overall Study|reason not specified|4|||
129005314|NCT01621490|464310793|FG004|Overall Study|Adverse event unrelated to study drug|0|||
129005315|NCT01621490|464310794|FG005|Overall Study|Adverse event unrelated to study drug|0|||
129005316|NCT01621490|464310795|FG006|Overall Study|Adverse event unrelated to study drug|0|||
129005317|NCT01621490|464310796|FG007|Overall Study|Adverse event unrelated to study drug|2|||
129005318|NCT01621490|464310797|FG008|Overall Study|Adverse event unrelated to study drug|0|||
129005319|NCT01621490|464310798|FG009|Overall Study|Adverse event unrelated to study drug|0|||
129005320|NCT01621490|464310799|FG010|Overall Study|Adverse event unrelated to study drug|0|||
129005321|NCT01621490|464310789|FG000|Overall Study|Disease progression|27|||
129005322|NCT01621490|464310790|FG001|Overall Study|Disease progression|28|||
129005323|NCT01621490|464310791|FG002|Overall Study|Disease progression|1|||
129005324|NCT01621490|464310792|FG003|Overall Study|Disease progression|5|||
129005325|NCT01621490|464310793|FG004|Overall Study|Disease progression|3|||
129005326|NCT01621490|464310794|FG005|Overall Study|Disease progression|8|||
129005327|NCT01621490|464310795|FG006|Overall Study|Disease progression|7|||
129005328|NCT01621490|464310796|FG007|Overall Study|Disease progression|1|||
129005329|NCT01621490|464310797|FG008|Overall Study|Disease progression|4|||
129005330|NCT01621490|464310798|FG009|Overall Study|Disease progression|1|||
129005331|NCT01621490|464310799|FG010|Overall Study|Disease progression|1|||
129005332|NCT01621490|464310789|FG000|Overall Study|Study drug toxicity|1|||
129005333|NCT01621490|464310790|FG001|Overall Study|Study drug toxicity|4|||
128669994|NCT00101452|463090689|FG002|Overall Study|Withdrawal by Subject|9|||
128669995|NCT00101452|463090687|FG000|Overall Study|Baseline Fail|2|||
129005334|NCT01621490|464310791|FG002|Overall Study|Study drug toxicity|5|||
129005335|NCT01621490|464310792|FG003|Overall Study|Study drug toxicity|3|||
129005336|NCT01621490|464310793|FG004|Overall Study|Study drug toxicity|1|||
129005337|NCT01621490|464310794|FG005|Overall Study|Study drug toxicity|10|||
129005338|NCT01621490|464310795|FG006|Overall Study|Study drug toxicity|1|||
129005339|NCT01621490|464310796|FG007|Overall Study|Study drug toxicity|4|||
129005340|NCT01621490|464310797|FG008|Overall Study|Study drug toxicity|1|||
129005341|NCT01621490|464310798|FG009|Overall Study|Study drug toxicity|0|||
129005342|NCT01621490|464310799|FG010|Overall Study|Study drug toxicity|0|||
129005343|NCT01621490|464310789|FG000|Overall Study|Death|0|||
129005344|NCT01621490|464310790|FG001|Overall Study|Death|0|||
129005345|NCT01621490|464310791|FG002|Overall Study|Death|0|||
129005346|NCT01621490|464310792|FG003|Overall Study|Death|0|||
129005347|NCT01621490|464310793|FG004|Overall Study|Death|0|||
129005348|NCT01621490|464310794|FG005|Overall Study|Death|0|||
129005349|NCT01621490|464310795|FG006|Overall Study|Death|0|||
129005350|NCT01621490|464310796|FG007|Overall Study|Death|0|||
128669996|NCT00101452|463090688|FG001|Overall Study|Baseline Fail|1|||
128669997|NCT00101452|463090689|FG002|Overall Study|Baseline Fail|2|||
128669998|NCT00101452|463090687|FG000|Overall Study|Physician Decision|0|||
128669999|NCT00101452|463090688|FG001|Overall Study|Physician Decision|3|||
128670000|NCT00101452|463090689|FG002|Overall Study|Physician Decision|2|||
128670001|NCT00101452|463090687|FG000|Overall Study|Protocol Violation|2|||
128670002|NCT00101452|463090688|FG001|Overall Study|Protocol Violation|1|||
128670003|NCT00101452|463090689|FG002|Overall Study|Protocol Violation|3|||
128670004|NCT00101452|463090687|FG000|Overall Study|Other|15|||
128670005|NCT00101452|463090688|FG001|Overall Study|Other|16|||
128670006|NCT00101452|463090689|FG002|Overall Study|Other|12|||
128670007|NCT01014910|463090690|FG000|Overall Study|Withdrawal by Subject|0|||
128670008|NCT01014910|463090691|FG001|Overall Study|Withdrawal by Subject|2|||
128670009|NCT00782834|463090692|FG000|Treatment Phase|fibrous tumor not GIST|1|||
128670010|NCT01215097|463090693|FG000|Overall Study|Adverse Event|1|||
128670011|NCT01215097|463090694|FG001|Overall Study|Adverse Event|3|||
129005351|NCT01621490|464310797|FG008|Overall Study|Death|1|||
129005352|NCT01621490|464310798|FG009|Overall Study|Death|0|||
129005353|NCT01621490|464310799|FG010|Overall Study|Death|0|||
129005354|NCT01621490|464310789|FG000|Overall Study|Other reasons|7|||
129005355|NCT01621490|464310790|FG001|Overall Study|Other reasons|6|||
129005356|NCT01621490|464310791|FG002|Overall Study|Other reasons|4|||
129005357|NCT01621490|464310792|FG003|Overall Study|Other reasons|1|||
129005358|NCT01621490|464310793|FG004|Overall Study|Other reasons|1|||
129005359|NCT01621490|464310794|FG005|Overall Study|Other reasons|3|||
129005360|NCT01621490|464310795|FG006|Overall Study|Other reasons|1|||
129005361|NCT01621490|464310796|FG007|Overall Study|Other reasons|1|||
129005362|NCT01621490|464310797|FG008|Overall Study|Other reasons|1|||
129005363|NCT01621490|464310798|FG009|Overall Study|Other reasons|0|||
129005364|NCT01621490|464310799|FG010|Overall Study|Other reasons|0|||
128670012|NCT01215097|463090693|FG000|Overall Study|Protocol Violation|0|||
128670013|NCT01215097|463090694|FG001|Overall Study|Protocol Violation|2|||
128670014|NCT01215097|463090693|FG000|Overall Study|Lost to Follow-up|2|||
128670015|NCT01215097|463090694|FG001|Overall Study|Lost to Follow-up|0|||
129005365|NCT00506753|464310800|FG000|Overall Study|Lost to Follow-up|21|||
129005366|NCT00506753|464310801|FG001|Overall Study|Lost to Follow-up|15|||
129005367|NCT00125359|464310802|FG000|Overall Study|Death|4|||
128670016|NCT01215097|463090693|FG000|Overall Study|Withdrawal by Subject|6|||
128670017|NCT01215097|463090694|FG001|Overall Study|Withdrawal by Subject|3|||
128670018|NCT01215097|463090693|FG000|Overall Study|Lack of Efficacy|0|||
129005368|NCT00125359|464310802|FG000|Overall Study|Adverse Event|5|||
128670019|NCT01215097|463090694|FG001|Overall Study|Lack of Efficacy|3|||
128670020|NCT01215097|463090693|FG000|Overall Study|patient's refusal to come|2|||
128670021|NCT01215097|463090694|FG001|Overall Study|patient's refusal to come|2|||
128670022|NCT01215097|463090693|FG000|Overall Study|patient's private reason|1|||
128670023|NCT01215097|463090694|FG001|Overall Study|patient's private reason|1|||
128670024|NCT01165216|463090706|FG000|Overall Study|Adverse Event|6|||
128670025|NCT01165216|463090707|FG001|Overall Study|Adverse Event|3|||
128670026|NCT01165216|463090706|FG000|Overall Study|Withdrawal by Subject|1|||
128670027|NCT01165216|463090707|FG001|Overall Study|Withdrawal by Subject|1|||
128670028|NCT01165216|463090706|FG000|Overall Study|Disease progression|1|||
128670029|NCT01165216|463090707|FG001|Overall Study|Disease progression|3|||
128670030|NCT04303195|463090709|FG000|Overall Study|Adverse Event|1|||
128670031|NCT04303195|463090710|FG001|Overall Study|Adverse Event|3|||
128670032|NCT04303195|463090711|FG002|Overall Study|Adverse Event|7|||
128670033|NCT04303195|463090712|FG003|Overall Study|Adverse Event|0|||
128670034|NCT04303195|463090709|FG000|Overall Study|Lost to Follow-up|1|||
128670035|NCT04303195|463090710|FG001|Overall Study|Lost to Follow-up|0|||
128670036|NCT04303195|463090711|FG002|Overall Study|Lost to Follow-up|1|||
128670037|NCT04303195|463090712|FG003|Overall Study|Lost to Follow-up|4|||
128670038|NCT04303195|463090709|FG000|Overall Study|Withdrawal by Subject|3|||
128670039|NCT04303195|463090710|FG001|Overall Study|Withdrawal by Subject|1|||
128670040|NCT04303195|463090711|FG002|Overall Study|Withdrawal by Subject|1|||
128670041|NCT04303195|463090712|FG003|Overall Study|Withdrawal by Subject|1|||
128670042|NCT04303195|463090709|FG000|Overall Study|No study drug administered or protocol deviation|0|||
128670043|NCT04303195|463090710|FG001|Overall Study|No study drug administered or protocol deviation|2|||
128670044|NCT04303195|463090711|FG002|Overall Study|No study drug administered or protocol deviation|0|||
128670045|NCT04303195|463090712|FG003|Overall Study|No study drug administered or protocol deviation|2|||
128670046|NCT06457204|463090713|FG000|Washout|Adverse Event|0|||
128670047|NCT06457204|463090714|FG001|Washout|Adverse Event|2|||
128670048|NCT01065454|463090715|FG000|Treatment|Adverse Event|7|||
128670049|NCT01065454|463090716|FG001|Treatment|Adverse Event|4|||
128670050|NCT01065454|463090717|FG002|Treatment|Adverse Event|3|||
128670051|NCT01065454|463090718|FG003|Treatment|Adverse Event|6|||
128670052|NCT01065454|463090715|FG000|Treatment|Death|1|||
128670053|NCT01065454|463090716|FG001|Treatment|Death|0|||
128670054|NCT01065454|463090717|FG002|Treatment|Death|0|||
128670055|NCT01065454|463090718|FG003|Treatment|Death|0|||
129005369|NCT00125359|464310802|FG000|Overall Study|Physician Decision|14|||
129005370|NCT02451670|464310803|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
129005371|NCT02451670|464310804|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
129005372|NCT00461500|464310805|FG000|Overall Study|Adverse Event|1|||
129005373|NCT00461500|464310806|FG001|Overall Study|Adverse Event|0|||
129005374|NCT00461500|464310805|FG000|Overall Study|Lack of Efficacy|0|||
129005375|NCT00461500|464310806|FG001|Overall Study|Lack of Efficacy|1|||
129005376|NCT00461500|464310805|FG000|Overall Study|Expired Drug Treatment|1|||
129005377|NCT00461500|464310806|FG001|Overall Study|Expired Drug Treatment|1|||
129005378|NCT00461500|464310805|FG000|Overall Study|Study Stopped|1|||
129005379|NCT00461500|464310806|FG001|Overall Study|Study Stopped|2|||
129005380|NCT00461500|464310805|FG000|Overall Study|Drug Treatment Misuse|1|||
129005381|NCT00461500|464310806|FG001|Overall Study|Drug Treatment Misuse|0|||
129005382|NCT00461500|464310805|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
129005383|NCT00461500|464310806|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
129005384|NCT00461500|464310805|FG000|Overall Study|Lost to Follow-up|2|||
129005385|NCT00461500|464310806|FG001|Overall Study|Lost to Follow-up|2|||
129005386|NCT01513551|464310807|FG000|Overall Study|Death|0|||
129005387|NCT01513551|464310808|FG001|Overall Study|Death|1|||
129005388|NCT01513551|464310809|FG002|Overall Study|Death|0|||
129005389|NCT01513551|464310807|FG000|Overall Study|Lost to Follow-up|3|||
129005390|NCT01513551|464310808|FG001|Overall Study|Lost to Follow-up|5|||
129005391|NCT01513551|464310809|FG002|Overall Study|Lost to Follow-up|2|||
129005392|NCT01513551|464310807|FG000|Overall Study|Withdrawal by Subject|1|||
129005393|NCT01513551|464310808|FG001|Overall Study|Withdrawal by Subject|0|||
129005394|NCT01513551|464310809|FG002|Overall Study|Withdrawal by Subject|2|||
129005395|NCT01513551|464310807|FG000|Overall Study|Randomized but not vaccinated|0|||
129005396|NCT01513551|464310808|FG001|Overall Study|Randomized but not vaccinated|0|||
129005397|NCT01513551|464310809|FG002|Overall Study|Randomized but not vaccinated|1|||
129005398|NCT02247479|464310811|FG000|Overall Study|Adverse Event|8|||
129005399|NCT02247479|464310812|FG001|Overall Study|Adverse Event|9|||
129005400|NCT02247479|464310813|FG002|Overall Study|Adverse Event|8|||
129005401|NCT02247479|464310811|FG000|Overall Study|Death|5|||
128670056|NCT01065454|463090715|FG000|Treatment|Non-compliance|1|||
128670057|NCT01065454|463090716|FG001|Treatment|Non-compliance|0|||
128670058|NCT01065454|463090717|FG002|Treatment|Non-compliance|0|||
128670059|NCT01065454|463090718|FG003|Treatment|Non-compliance|1|||
128670060|NCT01065454|463090715|FG000|Treatment|Protocol Decision|0|||
128670061|NCT01065454|463090716|FG001|Treatment|Protocol Decision|0|||
128670062|NCT01065454|463090717|FG002|Treatment|Protocol Decision|3|||
128670063|NCT01065454|463090718|FG003|Treatment|Protocol Decision|2|||
128670064|NCT01065454|463090715|FG000|Treatment|Protocol Violation|1|||
129005402|NCT02247479|464310812|FG001|Overall Study|Death|4|||
129005403|NCT02247479|464310813|FG002|Overall Study|Death|6|||
129005404|NCT02247479|464310811|FG000|Overall Study|Lost to Follow-up|3|||
129005405|NCT02247479|464310812|FG001|Overall Study|Lost to Follow-up|3|||
129005406|NCT02247479|464310813|FG002|Overall Study|Lost to Follow-up|1|||
129005407|NCT02247479|464310811|FG000|Overall Study|Non-compliance|0|||
129005408|NCT02247479|464310812|FG001|Overall Study|Non-compliance|0|||
129005409|NCT02247479|464310813|FG002|Overall Study|Non-compliance|1|||
129005410|NCT02247479|464310811|FG000|Overall Study|Withdrawal by Subject|25|||
129005411|NCT02247479|464310812|FG001|Overall Study|Withdrawal by Subject|29|||
129005412|NCT02247479|464310813|FG002|Overall Study|Withdrawal by Subject|24|||
128670065|NCT01065454|463090716|FG001|Treatment|Protocol Violation|0|||
128670066|NCT01065454|463090717|FG002|Treatment|Protocol Violation|1|||
128670067|NCT01065454|463090718|FG003|Treatment|Protocol Violation|0|||
128670068|NCT01065454|463090715|FG000|Treatment|Withdrawal by Subject|3|||
128670069|NCT01065454|463090716|FG001|Treatment|Withdrawal by Subject|1|||
129005413|NCT02247479|464310811|FG000|Overall Study|Study Terminated by Sponsor|98|||
129005414|NCT02247479|464310812|FG001|Overall Study|Study Terminated by Sponsor|88|||
129005415|NCT02247479|464310813|FG002|Overall Study|Study Terminated by Sponsor|94|||
129005416|NCT02247479|464310811|FG000|Overall Study|Physician Decision|1|||
129005417|NCT02247479|464310812|FG001|Overall Study|Physician Decision|0|||
129005418|NCT02247479|464310813|FG002|Overall Study|Physician Decision|2|||
129005419|NCT02247479|464310811|FG000|Overall Study|Unspecified Reason|2|||
129005420|NCT02247479|464310812|FG001|Overall Study|Unspecified Reason|5|||
129005421|NCT02247479|464310813|FG002|Overall Study|Unspecified Reason|2|||
129005422|NCT00094302|464310817|FG000|Overall Study|Lost to Follow-up|43|||
129005423|NCT00094302|464310818|FG001|Overall Study|Lost to Follow-up|41|||
129005424|NCT00094302|464310817|FG000|Overall Study|Physician Decision|5|||
129005425|NCT00094302|464310818|FG001|Overall Study|Physician Decision|8|||
129005426|NCT00094302|464310817|FG000|Overall Study|Withdrawal by Subject|103|||
129005427|NCT00094302|464310818|FG001|Overall Study|Withdrawal by Subject|111|||
129005428|NCT00094302|464310817|FG000|Overall Study|Death|266|||
129005429|NCT00094302|464310818|FG001|Overall Study|Death|246|||
129005430|NCT01162499|464310824|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
128670070|NCT01065454|463090717|FG002|Treatment|Withdrawal by Subject|2|||
128670071|NCT01065454|463090718|FG003|Treatment|Withdrawal by Subject|3|||
128670072|NCT01065454|463090715|FG000|Follow up|Adverse Event|1|||
128670073|NCT01065454|463090716|FG001|Follow up|Adverse Event|0|||
128670074|NCT01065454|463090717|FG002|Follow up|Adverse Event|0|||
128670075|NCT01065454|463090718|FG003|Follow up|Adverse Event|1|||
128670076|NCT01065454|463090715|FG000|Follow up|Death|0|||
128670077|NCT01065454|463090716|FG001|Follow up|Death|1|||
128670078|NCT01065454|463090717|FG002|Follow up|Death|1|||
128670079|NCT01065454|463090718|FG003|Follow up|Death|0|||
128670080|NCT01065454|463090715|FG000|Follow up|Lost to Follow-up|0|||
128670081|NCT01065454|463090716|FG001|Follow up|Lost to Follow-up|0|||
128670082|NCT01065454|463090717|FG002|Follow up|Lost to Follow-up|0|||
128670083|NCT01065454|463090718|FG003|Follow up|Lost to Follow-up|1|||
128670084|NCT01065454|463090715|FG000|Follow up|Progressive disease|0|||
128670085|NCT01065454|463090716|FG001|Follow up|Progressive disease|0|||
128670086|NCT01065454|463090717|FG002|Follow up|Progressive disease|0|||
128670087|NCT01065454|463090718|FG003|Follow up|Progressive disease|1|||
128670088|NCT01065454|463090715|FG000|Follow up|Withdrawal by Subject|1|||
128670089|NCT01065454|463090716|FG001|Follow up|Withdrawal by Subject|1|||
128670090|NCT01065454|463090717|FG002|Follow up|Withdrawal by Subject|1|||
129005431|NCT01162499|464310825|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
129005432|NCT01590433|464310826|FG000|Overall Study|Lost to Follow-up|20|||
129005433|NCT01590433|464310827|FG001|Overall Study|Lost to Follow-up|8|||
129005434|NCT01590433|464310826|FG000|Overall Study|Withdrawal by Subject|21|||
129005435|NCT01590433|464310827|FG001|Overall Study|Withdrawal by Subject|11|||
129005436|NCT01590433|464310826|FG000|Overall Study|Adverse Event|11|||
129005437|NCT01590433|464310827|FG001|Overall Study|Adverse Event|3|||
129005438|NCT00555009|464310828|FG000|Overall Study|Withdrawal by Subject|0|||
128670091|NCT01065454|463090718|FG003|Follow up|Withdrawal by Subject|0|||
129005439|NCT00555009|464310829|FG001|Overall Study|Withdrawal by Subject|1|||
129005440|NCT00555009|464310828|FG000|Overall Study|Terminated by Sponsor|2|||
129005441|NCT00555009|464310829|FG001|Overall Study|Terminated by Sponsor|5|||
129005442|NCT02058628|464310830|FG000|Overall Study|Adverse Event|1|||
129005443|NCT02058628|464310831|FG001|Overall Study|Adverse Event|0|||
128670092|NCT01065454|463090715|FG000|Follow up|study ongoing|37|||
129005444|NCT02058628|464310830|FG000|Overall Study|Withdrawal by Subject|2|||
129005445|NCT02058628|464310831|FG001|Overall Study|Withdrawal by Subject|2|||
129005446|NCT02058628|464310830|FG000|Overall Study|Lost to Follow-up|2|||
129005447|NCT02058628|464310831|FG001|Overall Study|Lost to Follow-up|4|||
129005448|NCT02058628|464310830|FG000|Overall Study|Not in time schedule|0|||
128670093|NCT01065454|463090716|FG001|Follow up|study ongoing|22|||
128670094|NCT01065454|463090717|FG002|Follow up|study ongoing|15|||
128670095|NCT01065454|463090718|FG003|Follow up|study ongoing|41|||
128670096|NCT01601652|463090719|FG000|Overall Study|Death|1|||
128670097|NCT01097005|463090729|FG000|Overall Study|Case Report Form not collected|18|||
128670098|NCT01097005|463090729|FG000|Overall Study|Subjects cannot visit the hospital|1|||
129005449|NCT02058628|464310831|FG001|Overall Study|Not in time schedule|1|||
129005450|NCT02058628|464310830|FG000|Overall Study|The visit date was not in timeline|0|||
129005451|NCT02058628|464310831|FG001|Overall Study|The visit date was not in timeline|1|||
129005452|NCT02058628|464310830|FG000|Overall Study|A lot of time for study for participant|1|||
129005453|NCT02058628|464310831|FG001|Overall Study|A lot of time for study for participant|0|||
129005454|NCT02058628|464310830|FG000|Overall Study|Non compliance|1|||
129005455|NCT02058628|464310831|FG001|Overall Study|Non compliance|0|||
129005456|NCT03355742|464310832|FG000|Overall Study|Lost to Follow-up|4|||
129005457|NCT03355742|464310832|FG000|Overall Study|Withdrawal by Subject|29|||
129005458|NCT03355742|464310832|FG000|Overall Study|Physician Decision|6|||
129005459|NCT03355742|464310832|FG000|Overall Study|Death|55|||
129005460|NCT03355742|464310832|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
129005461|NCT04527471|464310835|FG000|Overall Study|Adverse Event|1|||
129005462|NCT04527471|464310836|FG001|Overall Study|Adverse Event|0|||
129005463|NCT04527471|464310835|FG000|Overall Study|Lost to Follow-up|1|||
129005464|NCT04527471|464310836|FG001|Overall Study|Lost to Follow-up|0|||
129005465|NCT00449072|464310855|FG000|Overall Study|Adverse Event|3|||
129005466|NCT00449072|464310856|FG001|Overall Study|Adverse Event|1|||
129005467|NCT00449072|464310855|FG000|Overall Study|Protocol Violation|14|||
129005468|NCT00449072|464310856|FG001|Overall Study|Protocol Violation|12|||
129005469|NCT00449072|464310855|FG000|Overall Study|Lost to Follow-up|5|||
129005470|NCT00449072|464310856|FG001|Overall Study|Lost to Follow-up|7|||
129005471|NCT00449072|464310855|FG000|Overall Study|Withdrawal by Subject|11|||
129005472|NCT00449072|464310856|FG001|Overall Study|Withdrawal by Subject|8|||
129005473|NCT00449072|464310855|FG000|Overall Study|Lack of Efficacy|1|||
129005474|NCT00449072|464310856|FG001|Overall Study|Lack of Efficacy|1|||
129005475|NCT00449072|464310855|FG000|Overall Study|Physician Decision|1|||
129005476|NCT00449072|464310856|FG001|Overall Study|Physician Decision|0|||
129005477|NCT00449072|464310855|FG000|Overall Study|Not treated|0|||
129005478|NCT00449072|464310856|FG001|Overall Study|Not treated|1|||
129005479|NCT00449072|464310855|FG000|Overall Study|Excluded medication|0|||
129005480|NCT00449072|464310856|FG001|Overall Study|Excluded medication|2|||
129005481|NCT00449072|464310855|FG000|Overall Study|Non-compliance|2|||
129005482|NCT00449072|464310856|FG001|Overall Study|Non-compliance|5|||
129005483|NCT00449072|464310855|FG000|Overall Study|Sponsor decision|1|||
129005484|NCT00449072|464310856|FG001|Overall Study|Sponsor decision|3|||
129005485|NCT00449072|464310855|FG000|Overall Study|Relocation|3|||
129005486|NCT00449072|464310856|FG001|Overall Study|Relocation|2|||
129005487|NCT01787825|464310857|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
129005488|NCT01787825|464310858|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
129005489|NCT01787825|464310857|FG000|Overall Study|Data Not Analyzable|5|||
129005490|NCT01787825|464310858|FG001|Overall Study|Data Not Analyzable|1|||
129005491|NCT00989261|464310863|FG000|Overall Study|Still in follow up|12|||
129005492|NCT00989261|464310864|FG001|Overall Study|Still in follow up|21|||
129005493|NCT00989261|464310863|FG000|Overall Study|Withdrawal by Subject|0|||
129005494|NCT00989261|464310864|FG001|Overall Study|Withdrawal by Subject|1|||
129005495|NCT00989261|464310863|FG000|Overall Study|Lost to Follow-up|3|||
129005496|NCT00989261|464310864|FG001|Overall Study|Lost to Follow-up|0|||
129005497|NCT00718159|464310865|FG000|Overall Study|Progressive Disease|3|||
129005498|NCT00718159|464310866|FG001|Overall Study|Progressive Disease|3|||
129005499|NCT00718159|464310867|FG002|Overall Study|Progressive Disease|2|||
129005500|NCT00718159|464310868|FG003|Overall Study|Progressive Disease|0|||
129005501|NCT00718159|464310869|FG004|Overall Study|Progressive Disease|6|||
129005502|NCT00718159|464310870|FG005|Overall Study|Progressive Disease|0|||
129005503|NCT00718159|464310871|FG006|Overall Study|Progressive Disease|0|||
129005504|NCT00718159|464310865|FG000|Overall Study|Death due to Adverse Event|0|||
128670099|NCT01097005|463090729|FG000|Overall Study|Poor medication compliance|1|||
128670100|NCT01097005|463090729|FG000|Overall Study|No examination data available|244|||
128670101|NCT01097005|463090729|FG000|Overall Study|Deviation from exclusion criteria|37|||
128670102|NCT01097005|463090729|FG000|Overall Study|Adverse Event|14|||
128670103|NCT01097005|463090729|FG000|Overall Study|Discontinuance by complication|50|||
128670104|NCT03425253|463090732|FG000|Overall Study|Adverse Event|2|||
128670105|NCT03425253|463090732|FG000|Overall Study|Lost to Follow-up|3|||
128670106|NCT03425253|463090732|FG000|Overall Study|Withdrew Consent|6|||
128670107|NCT03425253|463090732|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
128670108|NCT04129151|463092399|FG000|Overall Study|Adverse Event|1|||
128670109|NCT04129151|463092399|FG000|Overall Study|Disease Progression|7|||
128670110|NCT04129151|463092399|FG000|Overall Study|Study closure|1|||
128670111|NCT01311024|463092401|FG000|Overall Study|Protocol Violation|35|||
129005505|NCT00718159|464310866|FG001|Overall Study|Death due to Adverse Event|0|||
129005506|NCT00718159|464310867|FG002|Overall Study|Death due to Adverse Event|0|||
129005507|NCT00718159|464310868|FG003|Overall Study|Death due to Adverse Event|2|||
129005508|NCT00718159|464310869|FG004|Overall Study|Death due to Adverse Event|2|||
129005509|NCT00718159|464310870|FG005|Overall Study|Death due to Adverse Event|0|||
128670112|NCT01311024|463092402|FG001|Overall Study|Protocol Violation|22|||
128670113|NCT01523275|463092403|FG000|Overall Study|Lost to Follow-up|1|||
128670114|NCT01523275|463092404|FG001|Overall Study|Lost to Follow-up|2|||
129005510|NCT00718159|464310871|FG006|Overall Study|Death due to Adverse Event|0|||
128670115|NCT01523275|463092403|FG000|Overall Study|Withdrawal by Subject|1|||
128670116|NCT01523275|463092404|FG001|Overall Study|Withdrawal by Subject|0|||
128670117|NCT03595228|463092409|FG000|Overall Study|Death|2|||
128670118|NCT03595228|463092409|FG000|Overall Study|Lack of Efficacy|13|||
128670119|NCT03595228|463092409|FG000|Overall Study|Withdrawal by Subject|3|||
128670120|NCT03595228|463092409|FG000|Overall Study|Withdrawal by Sponsor|1|||
128670121|NCT00435045|463092411|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
128670122|NCT00435045|463092412|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
128670123|NCT00435045|463092411|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
128670124|NCT00435045|463092412|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
128670125|NCT00435045|463092411|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
128670126|NCT00435045|463092412|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
128670127|NCT00435045|463092411|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
128670128|NCT00435045|463092412|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
128670129|NCT00435045|463092411|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
128670130|NCT00435045|463092412|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
128670131|NCT00435045|463092411|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
128670132|NCT00435045|463092412|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
128670133|NCT00435045|463092411|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
128670134|NCT00435045|463092412|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
128670135|NCT00435045|463092411|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
129005511|NCT00718159|464310865|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
129005512|NCT00718159|464310866|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
129005513|NCT00718159|464310867|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
129005514|NCT00718159|464310868|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
129005515|NCT00718159|464310869|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
129005516|NCT00718159|464310870|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
129005517|NCT00718159|464310871|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
129005518|NCT00718159|464310865|FG000|Overall Study|Investigator Decision|0|||
129005519|NCT00718159|464310866|FG001|Overall Study|Investigator Decision|0|||
129005520|NCT00718159|464310867|FG002|Overall Study|Investigator Decision|0|||
129005521|NCT00718159|464310868|FG003|Overall Study|Investigator Decision|0|||
129005522|NCT00718159|464310869|FG004|Overall Study|Investigator Decision|0|||
129005523|NCT00718159|464310870|FG005|Overall Study|Investigator Decision|1|||
129005524|NCT00718159|464310871|FG006|Overall Study|Investigator Decision|1|||
129005525|NCT01798485|464310880|FG000|Overall Study|Adverse Event|32|||
129005526|NCT01798485|464310881|FG001|Overall Study|Adverse Event|40|||
129005527|NCT01798485|464310880|FG000|Overall Study|Withdrawal by Subject|27|||
129005528|NCT01798485|464310881|FG001|Overall Study|Withdrawal by Subject|31|||
129005529|NCT01798485|464310880|FG000|Overall Study|Lost to Follow-up|0|||
129005530|NCT01798485|464310881|FG001|Overall Study|Lost to Follow-up|3|||
129005531|NCT01798485|464310880|FG000|Overall Study|Physician Decision|14|||
129005532|NCT01798485|464310881|FG001|Overall Study|Physician Decision|10|||
129005533|NCT01798485|464310880|FG000|Overall Study|Objective Disease Progression|152|||
129005534|NCT01798485|464310881|FG001|Overall Study|Objective Disease Progression|106|||
129005535|NCT01798485|464310880|FG000|Overall Study|Death|25|||
129005536|NCT01798485|464310881|FG001|Overall Study|Death|22|||
129005537|NCT01798485|464310880|FG000|Overall Study|Sponsor Decision|61|||
129005538|NCT01798485|464310881|FG001|Overall Study|Sponsor Decision|54|||
129005539|NCT01798485|464310880|FG000|Overall Study|Clinical Progression|35|||
129005540|NCT01798485|464310881|FG001|Overall Study|Clinical Progression|24|||
129005541|NCT00681863|464310882|FG000|Overall Study|Adverse Event|1|||
129005542|NCT00681863|464310882|FG000|Overall Study|Lost to Follow-up|2|||
129005543|NCT00681863|464310882|FG000|Overall Study|Lack of Efficacy|2|||
129005544|NCT00681863|464310882|FG000|Overall Study|Other|18|||
129005545|NCT01076166|464310883|FG000|Overall Study|Adverse Event|3|||
129005546|NCT01076166|464310883|FG000|Overall Study|Symptoms improved/resolved|6|||
129005547|NCT05476679|464310888|FG000|Overall Study|Withdrawal by Subject|0|||
129005548|NCT05476679|464310889|FG001|Overall Study|Withdrawal by Subject|0|||
129005549|NCT05476679|464310890|FG002|Overall Study|Withdrawal by Subject|0|||
129005550|NCT05476679|464310891|FG003|Overall Study|Withdrawal by Subject|1|||
129005551|NCT05476679|464310892|FG004|Overall Study|Withdrawal by Subject|0|||
129005552|NCT05476679|464310888|FG000|Overall Study|Lost to Follow-up|0|||
128670136|NCT00435045|463092412|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
128670137|NCT00435045|463092411|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
129005553|NCT05476679|464310889|FG001|Overall Study|Lost to Follow-up|0|||
129005554|NCT05476679|464310890|FG002|Overall Study|Lost to Follow-up|0|||
129005555|NCT05476679|464310891|FG003|Overall Study|Lost to Follow-up|1|||
129005556|NCT05476679|464310892|FG004|Overall Study|Lost to Follow-up|0|||
129005557|NCT01498484|464310895|FG000|Overall Study|Death|6|||
128670138|NCT00435045|463092412|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
128670139|NCT00435045|463092411|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
129005558|NCT01498484|464310896|FG001|Overall Study|Death|3|||
129005559|NCT01498484|464310897|FG002|Overall Study|Death|1|||
129005560|NCT01498484|464310898|FG003|Overall Study|Death|1|||
129005561|NCT01498484|464310899|FG004|Overall Study|Death|0|||
129005562|NCT01498484|464310900|FG005|Overall Study|Death|0|||
129005563|NCT01498484|464310901|FG006|Overall Study|Death|10|||
129005564|NCT01498484|464310902|FG007|Overall Study|Death|1|||
129005565|NCT01498484|464310903|FG008|Overall Study|Death|0|||
129005566|NCT01498484|464310895|FG000|Overall Study|Physician Decision|3|||
129005567|NCT01498484|464310896|FG001|Overall Study|Physician Decision|2|||
129005568|NCT01498484|464310897|FG002|Overall Study|Physician Decision|1|||
129005569|NCT01498484|464310898|FG003|Overall Study|Physician Decision|1|||
129005570|NCT01498484|464310899|FG004|Overall Study|Physician Decision|0|||
129005571|NCT01498484|464310900|FG005|Overall Study|Physician Decision|0|||
129005572|NCT01498484|464310901|FG006|Overall Study|Physician Decision|8|||
129005573|NCT01498484|464310902|FG007|Overall Study|Physician Decision|13|||
129005574|NCT01498484|464310903|FG008|Overall Study|Physician Decision|1|||
129005575|NCT01498484|464310895|FG000|Overall Study|Adverse Event|0|||
129005576|NCT01498484|464310896|FG001|Overall Study|Adverse Event|0|||
129005577|NCT01498484|464310897|FG002|Overall Study|Adverse Event|0|||
129005578|NCT01498484|464310898|FG003|Overall Study|Adverse Event|0|||
129005579|NCT01498484|464310899|FG004|Overall Study|Adverse Event|0|||
129005580|NCT01498484|464310900|FG005|Overall Study|Adverse Event|1|||
129005581|NCT01498484|464310901|FG006|Overall Study|Adverse Event|0|||
129005582|NCT01498484|464310902|FG007|Overall Study|Adverse Event|0|||
129005583|NCT01498484|464310903|FG008|Overall Study|Adverse Event|0|||
129005584|NCT01498484|464310895|FG000|Overall Study|Withdrawal by Subject|0|||
129005585|NCT01498484|464310896|FG001|Overall Study|Withdrawal by Subject|0|||
129005586|NCT01498484|464310897|FG002|Overall Study|Withdrawal by Subject|0|||
129005587|NCT01498484|464310898|FG003|Overall Study|Withdrawal by Subject|1|||
129005588|NCT01498484|464310899|FG004|Overall Study|Withdrawal by Subject|0|||
129005589|NCT01498484|464310900|FG005|Overall Study|Withdrawal by Subject|0|||
129005590|NCT01498484|464310901|FG006|Overall Study|Withdrawal by Subject|1|||
129005591|NCT01498484|464310902|FG007|Overall Study|Withdrawal by Subject|0|||
129005592|NCT01498484|464310903|FG008|Overall Study|Withdrawal by Subject|0|||
129005593|NCT01498484|464310895|FG000|Overall Study|Other|5|||
129005594|NCT01498484|464310896|FG001|Overall Study|Other|2|||
129005595|NCT01498484|464310897|FG002|Overall Study|Other|0|||
129005596|NCT01498484|464310898|FG003|Overall Study|Other|0|||
129005597|NCT01498484|464310899|FG004|Overall Study|Other|1|||
129005598|NCT01498484|464310900|FG005|Overall Study|Other|0|||
129005599|NCT01498484|464310901|FG006|Overall Study|Other|3|||
129005600|NCT01498484|464310902|FG007|Overall Study|Other|0|||
129005601|NCT01498484|464310903|FG008|Overall Study|Other|1|||
129005602|NCT00319956|464310904|FG000|Overall Study|Death|20|||
129005603|NCT00319956|464310905|FG001|Overall Study|Death|24|||
129005604|NCT00753714|464310907|FG000|Overall Study|Lack of Efficacy|21|||
129005605|NCT00753714|464310908|FG001|Overall Study|Lack of Efficacy|34|||
129005606|NCT00753714|464310907|FG000|Overall Study|Adverse Event|26|||
129005607|NCT00753714|464310908|FG001|Overall Study|Adverse Event|18|||
129005608|NCT00753714|464310907|FG000|Overall Study|Protocol Violation|1|||
129005609|NCT00753714|464310908|FG001|Overall Study|Protocol Violation|0|||
129005610|NCT00753714|464310907|FG000|Overall Study|Lost to Follow-up|0|||
129005611|NCT00753714|464310908|FG001|Overall Study|Lost to Follow-up|1|||
129005612|NCT00753714|464310907|FG000|Overall Study|Withdrawal by Subject|2|||
129005613|NCT00753714|464310908|FG001|Overall Study|Withdrawal by Subject|1|||
129005614|NCT00753714|464310907|FG000|Overall Study|Death|3|||
129005615|NCT00753714|464310908|FG001|Overall Study|Death|3|||
129005616|NCT00753714|464310907|FG000|Overall Study|Other|7|||
129005617|NCT00753714|464310908|FG001|Overall Study|Other|5|||
129005618|NCT02607800|464310909|FG000|Overall Study|Lost to Follow-up|7|||
129005619|NCT02607800|464310910|FG001|Overall Study|Lost to Follow-up|10|||
129005620|NCT02607800|464310909|FG000|Overall Study|Withdrew Consent|2|||
129005621|NCT02607800|464310910|FG001|Overall Study|Withdrew Consent|0|||
129005622|NCT02607800|464310909|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
129005623|NCT02607800|464310910|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
129005624|NCT02486796|464310911|FG000|Overall Study|Withdrawal by Subject|1|||
129005625|NCT02486796|464310912|FG001|Overall Study|Withdrawal by Subject|1|||
129005626|NCT02486796|464310911|FG000|Overall Study|Physician Decision|1|||
129005627|NCT02486796|464310912|FG001|Overall Study|Physician Decision|0|||
129005628|NCT01185288|464310913|FG000|Overall Study|Adverse Event|7|||
129005629|NCT01185288|464310914|FG001|Overall Study|Adverse Event|6|||
129005630|NCT01185288|464310913|FG000|Overall Study|Withdrawal by Subject|6|||
129005631|NCT01185288|464310914|FG001|Overall Study|Withdrawal by Subject|4|||
129005632|NCT01185288|464310913|FG000|Overall Study|Lost to Follow-up|2|||
129005633|NCT01185288|464310914|FG001|Overall Study|Lost to Follow-up|5|||
129005634|NCT01185288|464310913|FG000|Overall Study|Lack of Efficacy|2|||
129005635|NCT01185288|464310914|FG001|Overall Study|Lack of Efficacy|0|||
129005636|NCT01185288|464310913|FG000|Overall Study|Investigator discretion|1|||
129005637|NCT01185288|464310914|FG001|Overall Study|Investigator discretion|0|||
129005638|NCT01185288|464310913|FG000|Overall Study|Did not meet inclusion criteria|1|||
129005639|NCT01185288|464310914|FG001|Overall Study|Did not meet inclusion criteria|0|||
129005640|NCT01185288|464310913|FG000|Overall Study|Noncompliance|0|||
128670140|NCT00435045|463092412|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
128670141|NCT00435045|463092411|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
128670142|NCT00435045|463092412|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
128670143|NCT02424578|463092415|FG000|Overall Study|Withdrawal by Subject|0|||
128670144|NCT02424578|463092416|FG001|Overall Study|Withdrawal by Subject|1|||
128670145|NCT01703754|463092419|FG000|Overall Study|Clinically significant disease progression|2|||
129005641|NCT01185288|464310914|FG001|Overall Study|Noncompliance|1|||
129005642|NCT00278512|464310915|FG000|Overall Study|Death|1|||
129005643|NCT00278512|464310916|FG001|Overall Study|Death|0|||
129005644|NCT01202747|464310917|FG000|Overall Study|Withdrawal by Subject|1|||
129005645|NCT01620177|464310918|FG000|Overall Study|Failure at Screening Visit|43|||
129005646|NCT01620177|464310918|FG000|Overall Study|Withdrawal by Subject|26|||
129005647|NCT01620177|464310918|FG000|Overall Study|Lost to Follow-up|7|||
129005648|NCT01620177|464310918|FG000|Overall Study|Physician Decision|2|||
129005649|NCT01620177|464310918|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
129005650|NCT01626885|464310924|FG000|Overall Study|Adverse Event|8|||
129005651|NCT01626885|464310924|FG000|Overall Study|Withdrawal by Subject|4|||
129005652|NCT01533428|464310927|FG000|Overall Study|Adverse Event|0|||
129005653|NCT01533428|464310928|FG001|Overall Study|Adverse Event|1|||
129005654|NCT01533428|464310927|FG000|Overall Study|Lost to Follow-up|2|||
129005655|NCT01533428|464310928|FG001|Overall Study|Lost to Follow-up|1|||
129005656|NCT01533428|464310927|FG000|Overall Study|Withdrawal by Subject|7|||
129005657|NCT01533428|464310928|FG001|Overall Study|Withdrawal by Subject|6|||
129005658|NCT01364870|464310929|FG000|Overall Study|Withdrawal by Subject|13|||
129005659|NCT01364870|464310930|FG001|Overall Study|Withdrawal by Subject|24|||
129005660|NCT01364870|464310931|FG002|Overall Study|Withdrawal by Subject|10|||
129005661|NCT01364870|464310929|FG000|Overall Study|Adverse Event|8|||
129005662|NCT01364870|464310930|FG001|Overall Study|Adverse Event|6|||
129005663|NCT01364870|464310931|FG002|Overall Study|Adverse Event|4|||
129005664|NCT01364870|464310929|FG000|Overall Study|Protocol Violation|1|||
129005665|NCT01364870|464310930|FG001|Overall Study|Protocol Violation|0|||
129005666|NCT01364870|464310931|FG002|Overall Study|Protocol Violation|0|||
129005667|NCT02666430|464310932|FG000|Period 1|Lost to Follow-up|1|||
129005668|NCT02666430|464310933|FG001|Period 1|Lost to Follow-up|0|||
129005669|NCT02666430|464310932|FG000|Period 1|Adverse Event|0|||
129005670|NCT02666430|464310933|FG001|Period 1|Adverse Event|1|||
129005671|NCT02666430|464310932|FG000|Period 2|Withdrawal by Subject|1|||
129005672|NCT02666430|464310933|FG001|Period 2|Withdrawal by Subject|4|||
129005673|NCT02666430|464310932|FG000|Period 3|Lost to Follow-up|1|||
129005674|NCT02666430|464310933|FG001|Period 3|Lost to Follow-up|0|||
129005675|NCT03828461|464310934|FG000|Overall Study|Lost to Follow-up|1|||
129005676|NCT03828461|464310934|FG000|Overall Study|Withdrawal by Subject|3|||
129005677|NCT00576199|464310935|FG000|Overall Study|Adverse Event|12|||
129005678|NCT00576199|464310935|FG000|Overall Study|Insufficient Therapeutic Response|14|||
129005679|NCT00576199|464310935|FG000|Overall Study|Refused Treatment|2|||
129005680|NCT00576199|464310935|FG000|Overall Study|Reason Unspecified|2|||
129005681|NCT04317053|464310937|FG000|Overall Study|Withdrawn (screen failure)|4|||
129005682|NCT04317053|464310938|FG001|Overall Study|Withdrawn (screen failure)|2|||
129005683|NCT00096265|464312610|FG000|Overall Study|Ineligible|1|||
129005684|NCT00096265|464312611|FG001|Overall Study|Ineligible|0|||
129005685|NCT00096265|464312612|FG002|Overall Study|Ineligible|0|||
129005686|NCT01506323|464312613|FG000|Overall Study|Lost to Follow-up|5|||
129005687|NCT01506323|464312614|FG001|Overall Study|Lost to Follow-up|4|||
129005688|NCT01506323|464312613|FG000|Overall Study|Withdrawal by Subject|4|||
129005689|NCT01506323|464312614|FG001|Overall Study|Withdrawal by Subject|4|||
129005690|NCT01506323|464312613|FG000|Overall Study|Lack of Efficacy|1|||
129005691|NCT01506323|464312614|FG001|Overall Study|Lack of Efficacy|3|||
129005692|NCT01506323|464312613|FG000|Overall Study|Moved out of area|5|||
129005693|NCT01506323|464312614|FG001|Overall Study|Moved out of area|2|||
129005694|NCT01506323|464312613|FG000|Overall Study|Schedule or Transportation conflict|8|||
129005695|NCT01506323|464312614|FG001|Overall Study|Schedule or Transportation conflict|0|||
129005696|NCT01506323|464312613|FG000|Overall Study|Started another treatment|1|||
129005697|NCT01506323|464312614|FG001|Overall Study|Started another treatment|0|||
129005698|NCT02891200|464312615|FG000|Overall Study|Lost to Follow-up|31|||
129005699|NCT02891200|464312616|FG001|Overall Study|Lost to Follow-up|36|||
129005700|NCT02891200|464312615|FG000|Overall Study|Death|10|||
129005701|NCT02891200|464312616|FG001|Overall Study|Death|9|||
129005702|NCT02891200|464312615|FG000|Overall Study|Withdrawal by Subject|1|||
129005703|NCT02891200|464312616|FG001|Overall Study|Withdrawal by Subject|4|||
129005704|NCT00444795|464312618|FG000|Overall Study|Not Treated|1|||
129005705|NCT00444795|464312618|FG000|Overall Study|Treated Prior to the Contract Date|2|||
129005706|NCT00988169|464312619|FG000|Overall Study|Withdrawal by Subject|1|||
128670146|NCT01703754|463092420|FG001|Overall Study|Clinically significant disease progression|2|||
129005707|NCT03083483|464312627|FG000|Overall Study|Adverse Event|1|||
129005708|NCT03083483|464312628|FG001|Overall Study|Adverse Event|1|||
129005709|NCT03083483|464312629|FG002|Overall Study|Adverse Event|1|||
129005710|NCT03083483|464312627|FG000|Overall Study|Lost to Follow-up|2|||
129005711|NCT03083483|464312628|FG001|Overall Study|Lost to Follow-up|1|||
129005712|NCT03083483|464312629|FG002|Overall Study|Lost to Follow-up|1|||
129005713|NCT03083483|464312627|FG000|Overall Study|technological issues|1|||
129005714|NCT03083483|464312628|FG001|Overall Study|technological issues|0|||
129005715|NCT03083483|464312629|FG002|Overall Study|technological issues|1|||
129005716|NCT02710071|464312633|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
129005717|NCT02710071|464312634|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
129005718|NCT02710071|464312633|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
129005719|NCT02710071|464312634|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
129005720|NCT02637557|464312641|FG000|Overall Study|Adverse Event|3|||
129005721|NCT02637557|464312642|FG001|Overall Study|Adverse Event|1|||
129005722|NCT02637557|464312643|FG002|Overall Study|Adverse Event|3|||
129005723|NCT02637557|464312644|FG003|Overall Study|Adverse Event|3|||
129005724|NCT02637557|464312641|FG000|Overall Study|Lost to Follow-up|1|||
129005725|NCT02637557|464312642|FG001|Overall Study|Lost to Follow-up|1|||
129005726|NCT02637557|464312643|FG002|Overall Study|Lost to Follow-up|0|||
129005727|NCT02637557|464312644|FG003|Overall Study|Lost to Follow-up|1|||
129005728|NCT02637557|464312641|FG000|Overall Study|Physician Decision|1|||
129005729|NCT02637557|464312642|FG001|Overall Study|Physician Decision|0|||
129005730|NCT02637557|464312643|FG002|Overall Study|Physician Decision|0|||
129005731|NCT02637557|464312644|FG003|Overall Study|Physician Decision|0|||
129005732|NCT02637557|464312641|FG000|Overall Study|Protocol Violation|2|||
129005733|NCT02637557|464312642|FG001|Overall Study|Protocol Violation|0|||
129005734|NCT02637557|464312643|FG002|Overall Study|Protocol Violation|2|||
129005735|NCT02637557|464312644|FG003|Overall Study|Protocol Violation|1|||
129005736|NCT02637557|464312641|FG000|Overall Study|Withdrawal by Subject|1|||
129005737|NCT02637557|464312642|FG001|Overall Study|Withdrawal by Subject|3|||
129005738|NCT02637557|464312643|FG002|Overall Study|Withdrawal by Subject|4|||
129005739|NCT02637557|464312644|FG003|Overall Study|Withdrawal by Subject|2|||
129005740|NCT00613574|464312645|FG000|Overall Study|Adverse Event|3|||
129005741|NCT00613574|464312645|FG000|Overall Study|Lost to Follow-up|2|||
129005742|NCT00613574|464312645|FG000|Overall Study|Other|1|||
129005743|NCT04604184|464312652|FG000|Overall Study|Adverse Event|5|||
129005744|NCT04604184|464312653|FG001|Overall Study|Adverse Event|5|||
129005745|NCT04604184|464312652|FG000|Overall Study|Death|2|||
129005746|NCT04604184|464312653|FG001|Overall Study|Death|1|||
129005747|NCT04604184|464312652|FG000|Overall Study|Withdrawal by Subject|1|||
129005748|NCT04604184|464312653|FG001|Overall Study|Withdrawal by Subject|3|||
129005749|NCT04604184|464312652|FG000|Overall Study|Not treated|2|||
129005750|NCT04604184|464312653|FG001|Overall Study|Not treated|2|||
129005751|NCT04604184|464312652|FG000|Overall Study|Due to sponsor decision|9|||
129005752|NCT04604184|464312653|FG001|Overall Study|Due to sponsor decision|7|||
129005753|NCT04604184|464312652|FG000|Overall Study|Physician Decision|0|||
129005754|NCT04604184|464312653|FG001|Overall Study|Physician Decision|1|||
129005755|NCT04604184|464312652|FG000|Overall Study|Transfer to healthcare|1|||
129005756|NCT04604184|464312653|FG001|Overall Study|Transfer to healthcare|0|||
129005757|NCT01751412|464312654|FG000|Overall Study|Disease Progression Before Treatment|1|||
129005758|NCT03734237|464312657|FG000|Overall Study|Lost to Follow-up|1|||
129005759|NCT03734237|464312658|FG001|Overall Study|Lost to Follow-up|3|||
129005760|NCT03734237|464312659|FG002|Overall Study|Lost to Follow-up|0|||
129005761|NCT03734237|464312657|FG000|Overall Study|Withdrawal by Subject|7|||
129005762|NCT03734237|464312658|FG001|Overall Study|Withdrawal by Subject|9|||
128670147|NCT01703754|463092421|FG002|Overall Study|Clinically significant disease progression|1|||
128670148|NCT01703754|463092419|FG000|Overall Study|Adverse Event|1|||
129005763|NCT03734237|464312659|FG002|Overall Study|Withdrawal by Subject|10|||
129005764|NCT02711956|464312660|FG000|Overall Study|Adverse Event|0|||
129005765|NCT02711956|464312661|FG001|Overall Study|Adverse Event|0|||
128670149|NCT01703754|463092420|FG001|Overall Study|Adverse Event|1|||
128670150|NCT01703754|463092421|FG002|Overall Study|Adverse Event|0|||
128670151|NCT01703754|463092419|FG000|Overall Study|Withdrawal by Subject|2|||
128670152|NCT01703754|463092420|FG001|Overall Study|Withdrawal by Subject|0|||
128670153|NCT01703754|463092421|FG002|Overall Study|Withdrawal by Subject|0|||
129005766|NCT02711956|464312662|FG002|Overall Study|Adverse Event|0|||
129005767|NCT02711956|464312663|FG003|Overall Study|Adverse Event|1|||
129005768|NCT02711956|464312664|FG004|Overall Study|Adverse Event|2|||
129005769|NCT02711956|464312665|FG005|Overall Study|Adverse Event|0|||
129005770|NCT02711956|464312666|FG006|Overall Study|Adverse Event|0|||
129005771|NCT02711956|464312667|FG007|Overall Study|Adverse Event|1|||
129005772|NCT02711956|464312668|FG008|Overall Study|Adverse Event|1|||
129005773|NCT02711956|464312669|FG009|Overall Study|Adverse Event|1|||
129005774|NCT02711956|464312670|FG010|Overall Study|Adverse Event|1|||
129005775|NCT02711956|464312671|FG011|Overall Study|Adverse Event|0|||
129005776|NCT02711956|464312672|FG012|Overall Study|Adverse Event|0|||
129005777|NCT02711956|464312673|FG013|Overall Study|Adverse Event|0|||
129005778|NCT02711956|464312674|FG014|Overall Study|Adverse Event|2|||
128670154|NCT04973436|463092424|FG000|Overall Study|Lost to Follow-up|3|||
129005779|NCT02711956|464312660|FG000|Overall Study|Physician Decision|0|||
129005780|NCT02711956|464312661|FG001|Overall Study|Physician Decision|0|||
129005781|NCT02711956|464312662|FG002|Overall Study|Physician Decision|0|||
129005782|NCT02711956|464312663|FG003|Overall Study|Physician Decision|2|||
129005783|NCT02711956|464312664|FG004|Overall Study|Physician Decision|0|||
129005784|NCT02711956|464312665|FG005|Overall Study|Physician Decision|0|||
129005785|NCT02711956|464312666|FG006|Overall Study|Physician Decision|0|||
129005786|NCT02711956|464312667|FG007|Overall Study|Physician Decision|0|||
129005787|NCT02711956|464312668|FG008|Overall Study|Physician Decision|0|||
129005788|NCT02711956|464312669|FG009|Overall Study|Physician Decision|0|||
129005789|NCT02711956|464312670|FG010|Overall Study|Physician Decision|0|||
129005790|NCT02711956|464312671|FG011|Overall Study|Physician Decision|0|||
129005791|NCT02711956|464312672|FG012|Overall Study|Physician Decision|0|||
129005792|NCT02711956|464312673|FG013|Overall Study|Physician Decision|0|||
129005793|NCT02711956|464312674|FG014|Overall Study|Physician Decision|0|||
129005794|NCT02711956|464312660|FG000|Overall Study|Withdrawal by Subject|0|||
129005795|NCT02711956|464312661|FG001|Overall Study|Withdrawal by Subject|0|||
129005796|NCT02711956|464312662|FG002|Overall Study|Withdrawal by Subject|0|||
129005797|NCT02711956|464312663|FG003|Overall Study|Withdrawal by Subject|0|||
129005798|NCT02711956|464312664|FG004|Overall Study|Withdrawal by Subject|0|||
129005799|NCT02711956|464312665|FG005|Overall Study|Withdrawal by Subject|0|||
129005800|NCT02711956|464312666|FG006|Overall Study|Withdrawal by Subject|1|||
129005801|NCT02711956|464312667|FG007|Overall Study|Withdrawal by Subject|0|||
129005802|NCT02711956|464312668|FG008|Overall Study|Withdrawal by Subject|0|||
129005803|NCT02711956|464312669|FG009|Overall Study|Withdrawal by Subject|0|||
129005804|NCT02711956|464312670|FG010|Overall Study|Withdrawal by Subject|0|||
129005805|NCT02711956|464312671|FG011|Overall Study|Withdrawal by Subject|1|||
129005806|NCT02711956|464312672|FG012|Overall Study|Withdrawal by Subject|6|||
129005807|NCT02711956|464312673|FG013|Overall Study|Withdrawal by Subject|0|||
129005808|NCT02711956|464312674|FG014|Overall Study|Withdrawal by Subject|1|||
129005809|NCT02711956|464312660|FG000|Overall Study|Clinical progression|1|||
129005810|NCT02711956|464312661|FG001|Overall Study|Clinical progression|0|||
129005811|NCT02711956|464312662|FG002|Overall Study|Clinical progression|0|||
129005812|NCT02711956|464312663|FG003|Overall Study|Clinical progression|0|||
129005813|NCT02711956|464312664|FG004|Overall Study|Clinical progression|0|||
129005814|NCT02711956|464312665|FG005|Overall Study|Clinical progression|0|||
129005815|NCT02711956|464312666|FG006|Overall Study|Clinical progression|1|||
129005816|NCT02711956|464312667|FG007|Overall Study|Clinical progression|0|||
129005817|NCT02711956|464312668|FG008|Overall Study|Clinical progression|1|||
129005818|NCT02711956|464312669|FG009|Overall Study|Clinical progression|0|||
129005819|NCT02711956|464312670|FG010|Overall Study|Clinical progression|0|||
129005820|NCT02711956|464312671|FG011|Overall Study|Clinical progression|2|||
129005821|NCT02711956|464312672|FG012|Overall Study|Clinical progression|4|||
129005822|NCT02711956|464312673|FG013|Overall Study|Clinical progression|1|||
129005823|NCT02711956|464312674|FG014|Overall Study|Clinical progression|1|||
129005824|NCT02711956|464312660|FG000|Overall Study|Radiographic progression|1|||
129005825|NCT02711956|464312661|FG001|Overall Study|Radiographic progression|1|||
129005826|NCT02711956|464312662|FG002|Overall Study|Radiographic progression|2|||
129005827|NCT02711956|464312663|FG003|Overall Study|Radiographic progression|0|||
129005828|NCT02711956|464312664|FG004|Overall Study|Radiographic progression|1|||
129005829|NCT02711956|464312665|FG005|Overall Study|Radiographic progression|0|||
129005830|NCT02711956|464312666|FG006|Overall Study|Radiographic progression|0|||
129005831|NCT02711956|464312667|FG007|Overall Study|Radiographic progression|0|||
129005832|NCT02711956|464312668|FG008|Overall Study|Radiographic progression|2|||
129005833|NCT02711956|464312669|FG009|Overall Study|Radiographic progression|1|||
129005834|NCT02711956|464312670|FG010|Overall Study|Radiographic progression|0|||
129005835|NCT02711956|464312671|FG011|Overall Study|Radiographic progression|5|||
129005836|NCT02711956|464312672|FG012|Overall Study|Radiographic progression|3|||
129005837|NCT02711956|464312673|FG013|Overall Study|Radiographic progression|0|||
129005838|NCT02711956|464312674|FG014|Overall Study|Radiographic progression|1|||
129005839|NCT02711956|464312660|FG000|Overall Study|PSA progression with clinical progression|0|||
129005840|NCT02711956|464312661|FG001|Overall Study|PSA progression with clinical progression|0|||
129005841|NCT02711956|464312662|FG002|Overall Study|PSA progression with clinical progression|0|||
129005842|NCT02711956|464312663|FG003|Overall Study|PSA progression with clinical progression|0|||
129005843|NCT02711956|464312664|FG004|Overall Study|PSA progression with clinical progression|1|||
129005844|NCT02711956|464312665|FG005|Overall Study|PSA progression with clinical progression|0|||
129005845|NCT02711956|464312666|FG006|Overall Study|PSA progression with clinical progression|0|||
129005846|NCT02711956|464312667|FG007|Overall Study|PSA progression with clinical progression|0|||
129005847|NCT02711956|464312668|FG008|Overall Study|PSA progression with clinical progression|0|||
129005848|NCT02711956|464312669|FG009|Overall Study|PSA progression with clinical progression|0|||
129005849|NCT02711956|464312670|FG010|Overall Study|PSA progression with clinical progression|0|||
129005850|NCT02711956|464312671|FG011|Overall Study|PSA progression with clinical progression|0|||
129005851|NCT02711956|464312672|FG012|Overall Study|PSA progression with clinical progression|1|||
129005852|NCT02711956|464312673|FG013|Overall Study|PSA progression with clinical progression|1|||
129005853|NCT02711956|464312674|FG014|Overall Study|PSA progression with clinical progression|0|||
129005854|NCT02711956|464312660|FG000|Overall Study|PSA progression with radiographic progression|0|||
129005855|NCT02711956|464312661|FG001|Overall Study|PSA progression with radiographic progression|1|||
128670155|NCT04973436|463092424|FG000|Overall Study|Withdrawal by Subject|1|||
128670156|NCT04973436|463092424|FG000|Overall Study|Death|2|||
128670157|NCT00566696|463092425|FG000|Overall Study|Met Exclusion Criteria|2|||
128670158|NCT00566696|463092425|FG000|Overall Study|Muromonab not available|1|||
128670159|NCT00566696|463092425|FG000|Overall Study|Health Status Change|1|||
128670160|NCT00566696|463092425|FG000|Overall Study|Physician Decision|1|||
128670161|NCT00566696|463092425|FG000|Overall Study|Non-Patient Donors|37|||
128670162|NCT01276054|463092428|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
128670163|NCT01276054|463092429|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
128670164|NCT02640508|463092430|FG000|Overall Study|Death|19|||
128670165|NCT02640508|463092430|FG000|Overall Study|Withdrawal by Subject|8|||
128670166|NCT02640508|463092430|FG000|Overall Study|Physician Decision|1|||
128670167|NCT02640508|463092430|FG000|Overall Study|Lost to Follow-up|1|||
128670168|NCT02792829|463092431|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
128670169|NCT02792829|463092432|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
128670170|NCT02792829|463092433|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
128670171|NCT02792829|463092434|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
128670172|NCT02792829|463092435|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129005856|NCT02711956|464312662|FG002|Overall Study|PSA progression with radiographic progression|0|||
129005857|NCT02711956|464312663|FG003|Overall Study|PSA progression with radiographic progression|0|||
129005858|NCT02711956|464312664|FG004|Overall Study|PSA progression with radiographic progression|0|||
129005859|NCT02711956|464312665|FG005|Overall Study|PSA progression with radiographic progression|2|||
129005860|NCT02711956|464312666|FG006|Overall Study|PSA progression with radiographic progression|2|||
129005861|NCT02711956|464312667|FG007|Overall Study|PSA progression with radiographic progression|1|||
129005862|NCT02711956|464312668|FG008|Overall Study|PSA progression with radiographic progression|0|||
129005863|NCT02711956|464312669|FG009|Overall Study|PSA progression with radiographic progression|1|||
129005864|NCT02711956|464312670|FG010|Overall Study|PSA progression with radiographic progression|0|||
129005865|NCT02711956|464312671|FG011|Overall Study|PSA progression with radiographic progression|1|||
129005866|NCT02711956|464312672|FG012|Overall Study|PSA progression with radiographic progression|2|||
129005867|NCT02711956|464312673|FG013|Overall Study|PSA progression with radiographic progression|3|||
129005868|NCT02711956|464312674|FG014|Overall Study|PSA progression with radiographic progression|3|||
129005869|NCT01844583|464312675|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
129005870|NCT01844583|464312676|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
129005871|NCT01625377|464312677|FG000|Overall Study|Death|1|||
129005872|NCT01625377|464312678|FG001|Overall Study|Death|1|||
129005873|NCT01625377|464312677|FG000|Overall Study|Administrative Problem|1|||
129005874|NCT01625377|464312678|FG001|Overall Study|Administrative Problem|1|||
129005875|NCT01625377|464312677|FG000|Overall Study|Protocol Violation|0|||
129005876|NCT01625377|464312678|FG001|Overall Study|Protocol Violation|3|||
129005877|NCT01625377|464312677|FG000|Overall Study|Adverse Event|3|||
129005878|NCT01625377|464312678|FG001|Overall Study|Adverse Event|16|||
129005879|NCT01625377|464312677|FG000|Overall Study|Graft loss|1|||
129005880|NCT01625377|464312678|FG001|Overall Study|Graft loss|0|||
129005881|NCT01625377|464312677|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129005882|NCT01625377|464312678|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129005883|NCT01625377|464312677|FG000|Overall Study|Abnormal laboratory values|1|||
129005884|NCT01625377|464312678|FG001|Overall Study|Abnormal laboratory values|0|||
129005885|NCT03294538|464312683|FG000|Overall Study|Adverse Event|0|||
129005886|NCT03294538|464312684|FG001|Overall Study|Adverse Event|1|||
129005887|NCT03294538|464312685|FG002|Overall Study|Adverse Event|1|||
129005888|NCT03294538|464312683|FG000|Overall Study|Lost to Follow-up|1|||
129005889|NCT03294538|464312684|FG001|Overall Study|Lost to Follow-up|0|||
129005890|NCT03294538|464312685|FG002|Overall Study|Lost to Follow-up|0|||
129005891|NCT03294538|464312683|FG000|Overall Study|Outside of Visit Window|4|||
129005892|NCT03294538|464312684|FG001|Overall Study|Outside of Visit Window|4|||
129005893|NCT03294538|464312685|FG002|Overall Study|Outside of Visit Window|1|||
129005894|NCT01769378|464312689|FG000|Overall Study|Adverse Event|10|||
129005895|NCT01769378|464312690|FG001|Overall Study|Adverse Event|0|||
129005896|NCT01769378|464312689|FG000|Overall Study|Entry criteria not met|1|||
129005897|NCT01769378|464312690|FG001|Overall Study|Entry criteria not met|0|||
129005898|NCT01769378|464312689|FG000|Overall Study|Protocol Violation|1|||
129005899|NCT01769378|464312690|FG001|Overall Study|Protocol Violation|1|||
129005900|NCT01769378|464312689|FG000|Overall Study|Withdrawal by Subject|10|||
129005901|NCT01769378|464312690|FG001|Overall Study|Withdrawal by Subject|3|||
129005902|NCT01769378|464312689|FG000|Overall Study|Sponsor Decision|1|||
129005903|NCT01769378|464312690|FG001|Overall Study|Sponsor Decision|0|||
129005904|NCT01769378|464312689|FG000|Overall Study|Lost to Follow-up|2|||
129005905|NCT01769378|464312690|FG001|Overall Study|Lost to Follow-up|0|||
129005906|NCT01238848|464312693|FG000|Overall Study|Physician Decision|13|||
129005907|NCT01238848|464312694|FG001|Overall Study|Physician Decision|5|||
129005908|NCT00576901|464312695|FG000|Overall Study|Withdrawal by Subject|1|||
129005909|NCT00576901|464312695|FG000|Overall Study|Disease course|1|||
128670173|NCT02792829|463092436|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129005910|NCT00576901|464312695|FG000|Overall Study|Protocol Violation|1|||
129005911|NCT01755858|464312698|FG000|Overall Study|Adverse Event|1|||
129005912|NCT01755858|464312699|FG001|Overall Study|Adverse Event|1|||
129005913|NCT01338636|464312700|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
129005914|NCT02385526|464312701|FG000|Overall Study|Withdrawal by Subject|0|||
129005915|NCT02385526|464312702|FG001|Overall Study|Withdrawal by Subject|2|||
129005916|NCT02385526|464312703|FG002|Overall Study|Withdrawal by Subject|0|||
129005917|NCT02385526|464312701|FG000|Overall Study|Lost to Follow-up|0|||
129005918|NCT02385526|464312702|FG001|Overall Study|Lost to Follow-up|1|||
129005919|NCT02385526|464312703|FG002|Overall Study|Lost to Follow-up|0|||
129005920|NCT02385526|464312701|FG000|Overall Study|Physician Decision|1|||
129005921|NCT02385526|464312702|FG001|Overall Study|Physician Decision|0|||
129005922|NCT02385526|464312703|FG002|Overall Study|Physician Decision|0|||
129005923|NCT02385526|464312701|FG000|Overall Study|Protocol Violation|1|||
129005924|NCT02385526|464312702|FG001|Overall Study|Protocol Violation|0|||
129005925|NCT02385526|464312703|FG002|Overall Study|Protocol Violation|0|||
129005926|NCT03532009|464312704|FG000|Overall Study|Other|1|||
129005927|NCT03532009|464312705|FG001|Overall Study|Other|1|||
129005928|NCT03532009|464312704|FG000|Overall Study|Death|1|||
129005929|NCT03532009|464312705|FG001|Overall Study|Death|1|||
129005930|NCT03532009|464312704|FG000|Overall Study|Withdrawal by Patient|0|||
129005931|NCT03532009|464312705|FG001|Overall Study|Withdrawal by Patient|2|||
129005932|NCT02035137|464312706|FG000|Overall Study|Physician Decision|0|||
129005933|NCT02035137|464312707|FG001|Overall Study|Physician Decision|0|||
129005934|NCT02035137|464312708|FG002|Overall Study|Physician Decision|1|||
129005935|NCT02035137|464312706|FG000|Overall Study|Withdrawal by Subject|0|||
129005936|NCT02035137|464312707|FG001|Overall Study|Withdrawal by Subject|1|||
129005937|NCT02035137|464312708|FG002|Overall Study|Withdrawal by Subject|2|||
129005938|NCT02035137|464312706|FG000|Overall Study|Ineligible|0|||
129005939|NCT02035137|464312707|FG001|Overall Study|Ineligible|1|||
129005940|NCT02035137|464312708|FG002|Overall Study|Ineligible|2|||
129005941|NCT02035137|464312706|FG000|Overall Study|Disease progression prior to treatment start|2|||
129005942|NCT02035137|464312707|FG001|Overall Study|Disease progression prior to treatment start|0|||
129005943|NCT02035137|464312708|FG002|Overall Study|Disease progression prior to treatment start|0|||
129005944|NCT01006707|464312715|FG000|Study Session 1|Lost to Follow-up|2|||
129005945|NCT01006707|464312716|FG001|Study Session 1|Lost to Follow-up|0|||
129005946|NCT01006707|464312717|FG002|Study Session 1|Lost to Follow-up|0|||
129005947|NCT01006707|464312715|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
129005948|NCT01006707|464312716|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
129005949|NCT01006707|464312717|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
129005950|NCT05034731|464312718|FG000|Overall Study|Screen fail|1|||
129005951|NCT05034731|464312719|FG001|Overall Study|Screen fail|1|||
129005952|NCT00283686|464312721|FG000|Overall Study|Death|1|||
128670174|NCT02792829|463092437|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
128670175|NCT02792829|463092438|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
128670176|NCT02792829|463092431|FG000|Treatment Period 2|Adverse Event|0|||
128670177|NCT02792829|463092432|FG001|Treatment Period 2|Adverse Event|0|||
128670178|NCT02792829|463092433|FG002|Treatment Period 2|Adverse Event|0|||
128670179|NCT02792829|463092434|FG003|Treatment Period 2|Adverse Event|0|||
128670180|NCT02792829|463092435|FG004|Treatment Period 2|Adverse Event|1|||
128670181|NCT02792829|463092436|FG005|Treatment Period 2|Adverse Event|0|||
128670182|NCT02792829|463092437|FG006|Treatment Period 2|Adverse Event|1|||
128670183|NCT02792829|463092438|FG007|Treatment Period 2|Adverse Event|1|||
128670184|NCT02792829|463092431|FG000|Treatment Period 2|Use of proscribed medications|0|||
128670185|NCT02792829|463092432|FG001|Treatment Period 2|Use of proscribed medications|0|||
128670186|NCT02792829|463092433|FG002|Treatment Period 2|Use of proscribed medications|0|||
128670187|NCT02792829|463092434|FG003|Treatment Period 2|Use of proscribed medications|0|||
128670188|NCT02792829|463092435|FG004|Treatment Period 2|Use of proscribed medications|0|||
128670189|NCT02792829|463092436|FG005|Treatment Period 2|Use of proscribed medications|0|||
128670190|NCT02792829|463092437|FG006|Treatment Period 2|Use of proscribed medications|0|||
128670191|NCT02792829|463092438|FG007|Treatment Period 2|Use of proscribed medications|1|||
128670192|NCT00452361|463092439|FG000|Overall Study|Adverse Event|8|||
128670193|NCT00452361|463092440|FG001|Overall Study|Adverse Event|0|||
129005953|NCT00283686|464312722|FG001|Overall Study|Death|1|||
129005954|NCT00283686|464312723|FG002|Overall Study|Death|1|||
129005955|NCT00283686|464312724|FG003|Overall Study|Death|0|||
129005956|NCT00283686|464312721|FG000|Overall Study|Lost to Follow-up|21|||
128670194|NCT00452361|463092439|FG000|Overall Study|Withdrawal by Subject|0|||
128670195|NCT00452361|463092440|FG001|Overall Study|Withdrawal by Subject|1|||
128670196|NCT00452361|463092439|FG000|Overall Study|Premature termination|13|||
129005957|NCT00283686|464312722|FG001|Overall Study|Lost to Follow-up|31|||
129005958|NCT00283686|464312723|FG002|Overall Study|Lost to Follow-up|26|||
129005959|NCT00283686|464312724|FG003|Overall Study|Lost to Follow-up|20|||
129005960|NCT00283686|464312721|FG000|Overall Study|Less than full participation|7|||
129005961|NCT00283686|464312722|FG001|Overall Study|Less than full participation|9|||
129005962|NCT00283686|464312723|FG002|Overall Study|Less than full participation|6|||
129005963|NCT00283686|464312724|FG003|Overall Study|Less than full participation|12|||
129005964|NCT02970669|464312725|FG000|Double-blind Period|Adverse Event|4|||
129005965|NCT02970669|464312726|FG001|Double-blind Period|Adverse Event|0|||
129005966|NCT02970669|464312725|FG000|Double-blind Period|Death|1|||
129005967|NCT02970669|464312726|FG001|Double-blind Period|Death|0|||
129005968|NCT02970669|464312725|FG000|Double-blind Period|Study terminated by sponsor|1|||
129005969|NCT02970669|464312726|FG001|Double-blind Period|Study terminated by sponsor|2|||
129005970|NCT02970669|464312725|FG000|Double-blind Period|Physician Decision|0|||
129005971|NCT02970669|464312726|FG001|Double-blind Period|Physician Decision|2|||
129005972|NCT02970669|464312725|FG000|Double-blind Period|Withdrawal by Subject|2|||
129005973|NCT02970669|464312726|FG001|Double-blind Period|Withdrawal by Subject|2|||
129005974|NCT02970669|464312725|FG000|Open-label Period|Withdrawal by Subject|2|||
129005975|NCT02970669|464312726|FG001|Open-label Period|Withdrawal by Subject|2|||
129005976|NCT02970669|464312725|FG000|Open-label Period|Adverse Event|1|||
129005977|NCT02970669|464312726|FG001|Open-label Period|Adverse Event|0|||
129005978|NCT02970669|464312725|FG000|Open-label Period|Physician Decision|1|||
129005979|NCT02970669|464312726|FG001|Open-label Period|Physician Decision|0|||
129005980|NCT03521999|464312727|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
129005981|NCT03521999|464312728|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
129005982|NCT03521999|464312727|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
129005983|NCT03521999|464312728|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
129005984|NCT03521999|464312727|FG000|Completed 3 Month Follow up|Death|0|||
129005985|NCT03521999|464312728|FG001|Completed 3 Month Follow up|Death|1|||
129005986|NCT03521999|464312727|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
129005987|NCT03521999|464312728|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
129005988|NCT00467584|464312733|FG000|Overall Study|Withdrawal by Subject|4|||
129005989|NCT00467584|464312734|FG001|Overall Study|Withdrawal by Subject|5|||
129005990|NCT00467584|464312735|FG002|Overall Study|Withdrawal by Subject|1|||
129005991|NCT02292238|464312739|FG000|Overall Study|Protocol Violation|1|||
129005992|NCT02292238|464312740|FG001|Overall Study|Protocol Violation|2|||
129005993|NCT02292238|464312739|FG000|Overall Study|Withdrawal by Subject|2|||
129005994|NCT02292238|464312740|FG001|Overall Study|Withdrawal by Subject|1|||
129005995|NCT02292238|464312739|FG000|Overall Study|Lost to Follow-up|1|||
129005996|NCT02292238|464312740|FG001|Overall Study|Lost to Follow-up|0|||
129005997|NCT02292238|464312739|FG000|Overall Study|Physician Decision|0|||
129005998|NCT02292238|464312740|FG001|Overall Study|Physician Decision|1|||
129005999|NCT01789320|464312741|FG000|Overall Study|Re-enrolled into study|1|||
129006000|NCT01789320|464312741|FG000|Overall Study|Lost to Follow-up|1|||
129006001|NCT02789111|464312746|FG000|Overall Study|Withdrawal by Subject|1|||
129006002|NCT02789111|464312747|FG001|Overall Study|Withdrawal by Subject|4|||
129006003|NCT00673790|464312750|FG000|Overall Study|Adverse Event|23|||
129006004|NCT00673790|464312751|FG001|Overall Study|Adverse Event|14|||
129006005|NCT00673790|464312752|FG002|Overall Study|Adverse Event|2|||
129006006|NCT00673790|464312750|FG000|Overall Study|Lack of Efficacy|2|||
129006007|NCT00673790|464312751|FG001|Overall Study|Lack of Efficacy|2|||
129006008|NCT00673790|464312752|FG002|Overall Study|Lack of Efficacy|2|||
129006009|NCT00673790|464312750|FG000|Overall Study|Protocol Violation|6|||
129006010|NCT00673790|464312751|FG001|Overall Study|Protocol Violation|9|||
129006011|NCT00673790|464312752|FG002|Overall Study|Protocol Violation|1|||
129006012|NCT00673790|464312750|FG000|Overall Study|Withdrawal by Subject|7|||
129006013|NCT00673790|464312751|FG001|Overall Study|Withdrawal by Subject|4|||
129006014|NCT00673790|464312752|FG002|Overall Study|Withdrawal by Subject|1|||
129006015|NCT00673790|464312750|FG000|Overall Study|Lost to Follow-up|6|||
129006016|NCT00673790|464312751|FG001|Overall Study|Lost to Follow-up|6|||
129006017|NCT00673790|464312752|FG002|Overall Study|Lost to Follow-up|5|||
129006018|NCT00673790|464312750|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
129006019|NCT00673790|464312751|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
129006020|NCT00673790|464312752|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
129006021|NCT00673790|464312750|FG000|Overall Study|Poor compliance|1|||
129006022|NCT00673790|464312751|FG001|Overall Study|Poor compliance|0|||
129006023|NCT00673790|464312752|FG002|Overall Study|Poor compliance|0|||
129006024|NCT00673790|464312750|FG000|Overall Study|Participated in two Nebivolol studies|0|||
129006025|NCT00673790|464312751|FG001|Overall Study|Participated in two Nebivolol studies|0|||
129006026|NCT00673790|464312752|FG002|Overall Study|Participated in two Nebivolol studies|1|||
129006027|NCT00673790|464312750|FG000|Overall Study|Unconfirmed pregnancy|0|||
129006028|NCT00673790|464312751|FG001|Overall Study|Unconfirmed pregnancy|1|||
129006029|NCT00673790|464312752|FG002|Overall Study|Unconfirmed pregnancy|0|||
129006030|NCT00673790|464312750|FG000|Overall Study|Randomization criteria not met|0|||
129006031|NCT00673790|464312751|FG001|Overall Study|Randomization criteria not met|1|||
129006032|NCT00673790|464312752|FG002|Overall Study|Randomization criteria not met|0|||
129006033|NCT00601484|464312756|FG000|Overall Study|Adverse Event|0|||
129006034|NCT00601484|464312757|FG001|Overall Study|Adverse Event|1|||
129006035|NCT00601484|464312756|FG000|Overall Study|Lost to Follow-up|4|||
129006036|NCT00601484|464312757|FG001|Overall Study|Lost to Follow-up|3|||
129006037|NCT00601484|464312756|FG000|Overall Study|Lack of Efficacy|0|||
129006038|NCT00601484|464312757|FG001|Overall Study|Lack of Efficacy|2|||
129006039|NCT00601484|464312756|FG000|Overall Study|Withdrawal by Subject|1|||
128670197|NCT00452361|463092440|FG001|Overall Study|Premature termination|9|||
128670198|NCT03116152|463092441|FG000|Overall Study|Disease Progression|49|||
128670199|NCT03116152|463092442|FG001|Overall Study|Disease Progression|47|||
128670200|NCT03116152|463092441|FG000|Overall Study|Death|5|||
128670201|NCT03116152|463092442|FG001|Overall Study|Death|2|||
128670202|NCT03116152|463092441|FG000|Overall Study|Adverse Event|21|||
128670203|NCT03116152|463092442|FG001|Overall Study|Adverse Event|7|||
128670204|NCT03116152|463092441|FG000|Overall Study|Protocol Violation|2|||
128670205|NCT03116152|463092442|FG001|Overall Study|Protocol Violation|2|||
128670206|NCT03116152|463092441|FG000|Overall Study|Withdrawal by Subject|0|||
128670207|NCT03116152|463092442|FG001|Overall Study|Withdrawal by Subject|1|||
128670208|NCT03116152|463092441|FG000|Overall Study|Physician Decision|3|||
128670209|NCT03116152|463092442|FG001|Overall Study|Physician Decision|2|||
128670210|NCT03116152|463092441|FG000|Overall Study|other|11|||
128670211|NCT03116152|463092442|FG001|Overall Study|other|34|||
128670212|NCT00862641|463092446|FG000|Overall Study|Randomized, but drug not received|1|||
128670213|NCT00862641|463092447|FG001|Overall Study|Randomized, but drug not received|4|||
128670214|NCT00862641|463092448|FG002|Overall Study|Randomized, but drug not received|1|||
128670215|NCT00862641|463092449|FG003|Overall Study|Randomized, but drug not received|4|||
128670216|NCT02365480|463092450|FG000|Overall Study|Withdrawal by Subject|2|||
128670217|NCT02365480|463092451|FG001|Overall Study|Withdrawal by Subject|0|||
128670218|NCT02791763|463092452|FG000|Overall Study|Protocol Violation|0|||
128670219|NCT02791763|463092453|FG001|Overall Study|Protocol Violation|0|||
129006040|NCT00601484|464312757|FG001|Overall Study|Withdrawal by Subject|1|||
129006041|NCT00601484|464312756|FG000|Overall Study|Randomized, but not treated|0|||
129006042|NCT00601484|464312757|FG001|Overall Study|Randomized, but not treated|1|||
129006043|NCT01200394|464312758|FG000|Overall Study|Adverse Event|0|||
129006044|NCT01200394|464312759|FG001|Overall Study|Adverse Event|14|||
129006045|NCT01200394|464312758|FG000|Overall Study|Death|1|||
129006046|NCT01200394|464312759|FG001|Overall Study|Death|0|||
129006047|NCT01200394|464312758|FG000|Overall Study|Lost to Follow-up|0|||
129006048|NCT01200394|464312759|FG001|Overall Study|Lost to Follow-up|1|||
129006049|NCT01200394|464312758|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129006050|NCT01200394|464312759|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
129006051|NCT01200394|464312758|FG000|Overall Study|Protocol Violation|0|||
129006052|NCT01200394|464312759|FG001|Overall Study|Protocol Violation|3|||
129006053|NCT01200394|464312758|FG000|Overall Study|Withdrawal by Subject|0|||
129006054|NCT01200394|464312759|FG001|Overall Study|Withdrawal by Subject|5|||
129006055|NCT01200394|464312758|FG000|Overall Study|Other|0|||
128670220|NCT02791763|463092454|FG002|Overall Study|Protocol Violation|1|||
128670221|NCT02791763|463092452|FG000|Overall Study|Withdrawal by Subject|5|||
128670222|NCT02791763|463092453|FG001|Overall Study|Withdrawal by Subject|1|||
128670223|NCT02791763|463092454|FG002|Overall Study|Withdrawal by Subject|0|||
128670224|NCT02791763|463092452|FG000|Overall Study|Physician Decision|0|||
128670225|NCT02791763|463092453|FG001|Overall Study|Physician Decision|1|||
128670226|NCT02791763|463092454|FG002|Overall Study|Physician Decision|0|||
128670227|NCT02791763|463092452|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
128670228|NCT02791763|463092453|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
128670229|NCT02791763|463092454|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
128670230|NCT02791763|463092452|FG000|Overall Study|Cancer event|1|||
128670231|NCT02791763|463092453|FG001|Overall Study|Cancer event|3|||
128670232|NCT02791763|463092454|FG002|Overall Study|Cancer event|0|||
128670233|NCT02791763|463092452|FG000|Overall Study|Participant had renal transplant|3|||
128670234|NCT02791763|463092453|FG001|Overall Study|Participant had renal transplant|0|||
128670235|NCT02791763|463092454|FG002|Overall Study|Participant had renal transplant|0|||
128670236|NCT02791763|463092452|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
128670237|NCT02791763|463092453|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
128670238|NCT02791763|463092454|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
128670239|NCT02791763|463092452|FG000|Overall Study|Adverse Event|12|||
128670240|NCT02791763|463092453|FG001|Overall Study|Adverse Event|13|||
129006056|NCT01200394|464312759|FG001|Overall Study|Other|1|||
129006057|NCT01463683|464312763|FG000|Overall Study|Adverse Event|2|||
128670241|NCT02791763|463092454|FG002|Overall Study|Adverse Event|7|||
128670242|NCT04534686|463092455|FG000|Baseline Measurement|Lost to Follow-up|4|||
128670243|NCT04534686|463092456|FG001|Baseline Measurement|Lost to Follow-up|6|||
128670244|NCT04534686|463092455|FG000|Baseline Measurement|Withdrawal by Subject|3|||
128670245|NCT04534686|463092456|FG001|Baseline Measurement|Withdrawal by Subject|1|||
128670246|NCT04534686|463092455|FG000|Intervention|Withdrawal by Subject|2|||
128670247|NCT04534686|463092456|FG001|Intervention|Withdrawal by Subject|2|||
129006058|NCT01463683|464312764|FG001|Overall Study|Adverse Event|0|||
129006059|NCT01463683|464312765|FG002|Overall Study|Adverse Event|0|||
129006060|NCT01463683|464312763|FG000|Overall Study|Lost to Follow-up|10|||
129006061|NCT01463683|464312764|FG001|Overall Study|Lost to Follow-up|9|||
128670248|NCT00635999|463092457|FG000|Overall Study|Withdrawal by Subject|4|||
128670249|NCT00635999|463092458|FG001|Overall Study|Withdrawal by Subject|2|||
128670250|NCT00635999|463092459|FG002|Overall Study|Withdrawal by Subject|1|||
129006062|NCT01463683|464312765|FG002|Overall Study|Lost to Follow-up|7|||
128670251|NCT01781299|463092460|FG000|Overall Study|Withdrawal by Subject|0|||
128670252|NCT01781299|463092461|FG001|Overall Study|Withdrawal by Subject|1|||
128670253|NCT02636361|463092462|FG000|Period 4|Physician Decision|0|||
128670254|NCT02636361|463092463|FG001|Period 4|Physician Decision|0|||
128670255|NCT02636361|463092464|FG002|Period 4|Physician Decision|0|||
128670256|NCT02636361|463092465|FG003|Period 4|Physician Decision|1|||
128670257|NCT02636361|463092466|FG004|Period 4|Physician Decision|0|||
128670258|NCT02032238|463092467|FG000|Overall Study|Lost to Follow-up|2|||
128670259|NCT02032238|463092468|FG001|Overall Study|Lost to Follow-up|0|||
128670260|NCT02410343|463092469|FG000|Core Period (24 Weeks)|Adverse Event|1|||
128670261|NCT02410343|463092470|FG001|Core Period (24 Weeks)|Adverse Event|0|||
128670262|NCT02410343|463092469|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
128670263|NCT02410343|463092470|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
128670264|NCT02410343|463092469|FG000|Extension Period (12 Months)|Adverse Event|1|||
128670265|NCT02410343|463092470|FG001|Extension Period (12 Months)|Adverse Event|0|||
128670266|NCT02410343|463092469|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
128670267|NCT02410343|463092470|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
128670268|NCT02720042|463092471|FG000|Overall Study|Death|3|||
128670269|NCT02720042|463092471|FG000|Overall Study|Lost to Follow-up|4|||
128670270|NCT02720042|463092471|FG000|Overall Study|Withdrawal by Subject|1|||
128670271|NCT02720042|463092471|FG000|Overall Study|Physician Decision|3|||
128670272|NCT02720042|463092471|FG000|Overall Study|Phasix Mesh explanted|1|||
128670273|NCT02720042|463092471|FG000|Overall Study|unable due to non-study-related illness|3|||
128670274|NCT01510769|463092474|FG000|Overall Study|Adverse Event|7|||
128670275|NCT01510769|463092475|FG001|Overall Study|Adverse Event|6|||
128670276|NCT01510769|463092476|FG002|Overall Study|Adverse Event|4|||
128670277|NCT01510769|463092474|FG000|Overall Study|Gout Flare|0|||
128670278|NCT01510769|463092475|FG001|Overall Study|Gout Flare|3|||
128670279|NCT01510769|463092476|FG002|Overall Study|Gout Flare|1|||
128670280|NCT01510769|463092474|FG000|Overall Study|Protocol Violation|11|||
128670281|NCT01510769|463092475|FG001|Overall Study|Protocol Violation|10|||
128670282|NCT01510769|463092476|FG002|Overall Study|Protocol Violation|9|||
128670283|NCT01510769|463092474|FG000|Overall Study|Lost to Follow-up|5|||
128670284|NCT01510769|463092475|FG001|Overall Study|Lost to Follow-up|1|||
128670285|NCT01510769|463092476|FG002|Overall Study|Lost to Follow-up|5|||
128670286|NCT01510769|463092474|FG000|Overall Study|Withdrawal by Subject|3|||
128670287|NCT01510769|463092475|FG001|Overall Study|Withdrawal by Subject|4|||
128670288|NCT01510769|463092476|FG002|Overall Study|Withdrawal by Subject|3|||
128670289|NCT01510769|463092474|FG000|Overall Study|Death|1|||
128670290|NCT01510769|463092475|FG001|Overall Study|Death|1|||
128670291|NCT01510769|463092476|FG002|Overall Study|Death|0|||
128670292|NCT01516034|463092481|FG000|Overall Study|Physician Decision|1|||
128670293|NCT01516034|463092481|FG000|Overall Study|Lack of Efficacy|7|||
128670294|NCT01818752|463092482|FG000|Overall Study|Adverse Event|64|||
128670295|NCT01818752|463092483|FG001|Overall Study|Adverse Event|74|||
128670296|NCT01818752|463092482|FG000|Overall Study|Death|14|||
128670297|NCT01818752|463092483|FG001|Overall Study|Death|18|||
128670298|NCT01818752|463092482|FG000|Overall Study|Non-compliance|16|||
128670299|NCT01818752|463092483|FG001|Overall Study|Non-compliance|20|||
128670300|NCT01818752|463092482|FG000|Overall Study|Withdrawal by Subject|15|||
128670301|NCT01818752|463092483|FG001|Overall Study|Withdrawal by Subject|14|||
128670302|NCT01818752|463092482|FG000|Overall Study|Physician Decision|9|||
128670303|NCT01818752|463092483|FG001|Overall Study|Physician Decision|8|||
128670304|NCT01818752|463092482|FG000|Overall Study|Disease Progression|54|||
128670305|NCT01818752|463092483|FG001|Overall Study|Disease Progression|48|||
128670306|NCT01818752|463092482|FG000|Overall Study|Other|7|||
128670307|NCT01818752|463092483|FG001|Overall Study|Other|8|||
128670308|NCT01818752|463092482|FG000|Overall Study|Continuing Treatment|1|||
128670309|NCT01818752|463092483|FG001|Overall Study|Continuing Treatment|4|||
128670310|NCT01818752|463092482|FG000|Overall Study|Randomized but not Dosed|7|||
128670311|NCT01818752|463092483|FG001|Overall Study|Randomized but not Dosed|4|||
128670312|NCT01033448|463092484|FG000|Overall Study|Withdrawal by Subject|4|||
128670313|NCT01033448|463092484|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
128670314|NCT01033448|463092484|FG000|Overall Study|Lost to Follow-up|3|||
128670315|NCT01033448|463092484|FG000|Overall Study|Withdrew due to other reasons|3|||
128670316|NCT01033448|463092484|FG000|Overall Study|Unknown disposition|1|||
128670317|NCT04270370|463092485|FG000|Overall Study|Lost to Follow-up|1|||
128670318|NCT04270370|463092486|FG001|Overall Study|Lost to Follow-up|0|||
128670319|NCT04270370|463092487|FG002|Overall Study|Lost to Follow-up|0|||
128670320|NCT04270370|463092488|FG003|Overall Study|Lost to Follow-up|0|||
128670321|NCT04270370|463092489|FG004|Overall Study|Lost to Follow-up|0|||
128670322|NCT04270370|463092490|FG005|Overall Study|Lost to Follow-up|0|||
128670323|NCT04270370|463092491|FG006|Overall Study|Lost to Follow-up|0|||
128670324|NCT04270370|463092492|FG007|Overall Study|Lost to Follow-up|0|||
128670325|NCT04270370|463092493|FG008|Overall Study|Lost to Follow-up|1|||
128670326|NCT04270370|463092494|FG009|Overall Study|Lost to Follow-up|0|||
128670327|NCT04270370|463092495|FG010|Overall Study|Lost to Follow-up|0|||
128670328|NCT04270370|463092496|FG011|Overall Study|Lost to Follow-up|0|||
129006063|NCT01463683|464312763|FG000|Overall Study|Physician Decision|0|||
128670329|NCT03060551|463092497|FG000|Overall Study|Withdrawal by Subject|1|||
128670330|NCT03060551|463092497|FG000|Overall Study|Adverse Event|1|||
128670331|NCT01324141|463092498|FG000|Overall Study|Declined to participate before treatment started|1|||
128670332|NCT01324141|463092498|FG000|Overall Study|Disease progression on study|1|||
128670333|NCT05477108|463092501|FG000|Overall Study|Participants randomized, not treated|1|||
128670334|NCT05477108|463092502|FG001|Overall Study|Participants randomized, not treated|1|||
128670335|NCT05477108|463092503|FG002|Overall Study|Participants randomized, not treated|1|||
128670336|NCT05477108|463092501|FG000|Overall Study|Physician Decision|0|||
128670337|NCT05477108|463092502|FG001|Overall Study|Physician Decision|0|||
128670338|NCT05477108|463092503|FG002|Overall Study|Physician Decision|1|||
128670339|NCT05477108|463092501|FG000|Overall Study|withdrawn from study|0|||
128670340|NCT05477108|463092502|FG001|Overall Study|withdrawn from study|0|||
128670341|NCT05477108|463092503|FG002|Overall Study|withdrawn from study|1|||
128670342|NCT02660983|463092504|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
128670343|NCT02660983|463092505|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
128670344|NCT02660983|463092504|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
128670345|NCT02660983|463092505|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
128670346|NCT02660983|463092504|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
128670347|NCT02660983|463092505|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
128670348|NCT02660983|463092504|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
128670349|NCT02660983|463092505|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
128670350|NCT02660983|463092504|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
128670351|NCT02660983|463092505|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
128670352|NCT02660983|463092504|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
128670353|NCT02660983|463092505|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
128670354|NCT02660983|463092504|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
128670355|NCT02660983|463092505|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
128670356|NCT05688670|463092506|FG000|Overall Study|Change in surgery plan|1|||
128670357|NCT05688670|463092507|FG001|Overall Study|Change in surgery plan|4|||
128670358|NCT05688670|463092506|FG000|Overall Study|Inability to extubate|1|||
128670359|NCT05688670|463092507|FG001|Overall Study|Inability to extubate|2|||
128670360|NCT05688670|463092506|FG000|Overall Study|Day of surgery cancellation|0|||
128670361|NCT05688670|463092507|FG001|Overall Study|Day of surgery cancellation|1|||
128670362|NCT05688670|463092506|FG000|Overall Study|Reintubated on PCICU arrival|0|||
128670363|NCT05688670|463092507|FG001|Overall Study|Reintubated on PCICU arrival|1|||
128670364|NCT04614324|463092512|FG000|Overall Study|Lost to Follow-up|3|||
128670365|NCT04614324|463092512|FG000|Overall Study|Physician Decision|1|||
128670366|NCT04614324|463092512|FG000|Overall Study|Withdrawal by Subject|2|||
128670367|NCT04614324|463092512|FG000|Overall Study|Remaining in Follow up|123|||
128670368|NCT05289037|463092513|FG000|Overall Study|Withdrawal by Subject|7|||
128670369|NCT05289037|463092514|FG001|Overall Study|Withdrawal by Subject|0|||
128670370|NCT05289037|463092515|FG002|Overall Study|Withdrawal by Subject|3|||
128670371|NCT05289037|463092516|FG003|Overall Study|Withdrawal by Subject|3|||
128670372|NCT05289037|463092517|FG004|Overall Study|Withdrawal by Subject|1|||
128670373|NCT05289037|463092518|FG005|Overall Study|Withdrawal by Subject|5|||
128670374|NCT05289037|463092519|FG006|Overall Study|Withdrawal by Subject|2|||
128670375|NCT05289037|463092520|FG007|Overall Study|Withdrawal by Subject|1|||
128670376|NCT05289037|463092521|FG008|Overall Study|Withdrawal by Subject|2|||
128670377|NCT05289037|463092522|FG009|Overall Study|Withdrawal by Subject|2|||
128670378|NCT05289037|463092523|FG010|Overall Study|Withdrawal by Subject|1|||
128670379|NCT05289037|463092524|FG011|Overall Study|Withdrawal by Subject|0|||
128670380|NCT05289037|463092525|FG012|Overall Study|Withdrawal by Subject|1|||
128670381|NCT05289037|463092526|FG013|Overall Study|Withdrawal by Subject|2|||
128670382|NCT05289037|463092527|FG014|Overall Study|Withdrawal by Subject|0|||
128670383|NCT05289037|463092528|FG015|Overall Study|Withdrawal by Subject|3|||
128670384|NCT05289037|463092529|FG016|Overall Study|Withdrawal by Subject|3|||
128670385|NCT05289037|463092513|FG000|Overall Study|Lost to Follow-up|1|||
128670386|NCT05289037|463092514|FG001|Overall Study|Lost to Follow-up|4|||
129006064|NCT01463683|464312764|FG001|Overall Study|Physician Decision|3|||
129006065|NCT01463683|464312765|FG002|Overall Study|Physician Decision|1|||
129006066|NCT01463683|464312763|FG000|Overall Study|Pregnancy|2|||
128670387|NCT05289037|463092515|FG002|Overall Study|Lost to Follow-up|3|||
128670388|NCT05289037|463092516|FG003|Overall Study|Lost to Follow-up|3|||
128670389|NCT05289037|463092517|FG004|Overall Study|Lost to Follow-up|3|||
128670390|NCT05289037|463092518|FG005|Overall Study|Lost to Follow-up|2|||
128670391|NCT05289037|463092519|FG006|Overall Study|Lost to Follow-up|3|||
128670392|NCT05289037|463092520|FG007|Overall Study|Lost to Follow-up|2|||
128670393|NCT05289037|463092521|FG008|Overall Study|Lost to Follow-up|2|||
128670394|NCT05289037|463092522|FG009|Overall Study|Lost to Follow-up|1|||
128670395|NCT05289037|463092523|FG010|Overall Study|Lost to Follow-up|3|||
128670396|NCT05289037|463092524|FG011|Overall Study|Lost to Follow-up|4|||
128670397|NCT05289037|463092525|FG012|Overall Study|Lost to Follow-up|2|||
128670398|NCT05289037|463092526|FG013|Overall Study|Lost to Follow-up|7|||
129006067|NCT01463683|464312764|FG001|Overall Study|Pregnancy|2|||
128670399|NCT05289037|463092527|FG014|Overall Study|Lost to Follow-up|4|||
128670400|NCT05289037|463092528|FG015|Overall Study|Lost to Follow-up|6|||
128670401|NCT05289037|463092529|FG016|Overall Study|Lost to Follow-up|4|||
128670402|NCT05289037|463092513|FG000|Overall Study|Death|0|||
128670403|NCT05289037|463092514|FG001|Overall Study|Death|0|||
128670404|NCT05289037|463092515|FG002|Overall Study|Death|0|||
128670405|NCT05289037|463092516|FG003|Overall Study|Death|0|||
129006068|NCT01463683|464312765|FG002|Overall Study|Pregnancy|1|||
129006069|NCT01463683|464312763|FG000|Overall Study|Withdrawal by Subject|5|||
129006070|NCT01463683|464312764|FG001|Overall Study|Withdrawal by Subject|17|||
129006071|NCT01463683|464312765|FG002|Overall Study|Withdrawal by Subject|2|||
129006072|NCT04345471|464312770|FG000|Overall Study|Adverse Event|8|||
129006073|NCT04345471|464312771|FG001|Overall Study|Adverse Event|5|||
129006074|NCT04345471|464312772|FG002|Overall Study|Adverse Event|6|||
128670406|NCT05289037|463092517|FG004|Overall Study|Death|0|||
128670407|NCT05289037|463092518|FG005|Overall Study|Death|1|||
128670408|NCT05289037|463092519|FG006|Overall Study|Death|0|||
128670409|NCT05289037|463092520|FG007|Overall Study|Death|0|||
128670410|NCT05289037|463092521|FG008|Overall Study|Death|0|||
128670411|NCT05289037|463092522|FG009|Overall Study|Death|0|||
128670412|NCT05289037|463092523|FG010|Overall Study|Death|0|||
128670413|NCT05289037|463092524|FG011|Overall Study|Death|0|||
128670414|NCT05289037|463092525|FG012|Overall Study|Death|0|||
128670415|NCT05289037|463092526|FG013|Overall Study|Death|0|||
128670416|NCT05289037|463092527|FG014|Overall Study|Death|1|||
128670417|NCT05289037|463092528|FG015|Overall Study|Death|0|||
128670418|NCT05289037|463092529|FG016|Overall Study|Death|0|||
128670419|NCT05289037|463092513|FG000|Overall Study|Did not receive vaccine|0|||
128670420|NCT05289037|463092514|FG001|Overall Study|Did not receive vaccine|3|||
128670421|NCT05289037|463092515|FG002|Overall Study|Did not receive vaccine|0|||
128670422|NCT05289037|463092516|FG003|Overall Study|Did not receive vaccine|0|||
128670423|NCT05289037|463092517|FG004|Overall Study|Did not receive vaccine|1|||
128670424|NCT05289037|463092518|FG005|Overall Study|Did not receive vaccine|1|||
128670425|NCT05289037|463092519|FG006|Overall Study|Did not receive vaccine|1|||
128670426|NCT05289037|463092520|FG007|Overall Study|Did not receive vaccine|0|||
128670427|NCT05289037|463092521|FG008|Overall Study|Did not receive vaccine|0|||
128670428|NCT05289037|463092522|FG009|Overall Study|Did not receive vaccine|0|||
128670429|NCT05289037|463092523|FG010|Overall Study|Did not receive vaccine|0|||
128670430|NCT05289037|463092524|FG011|Overall Study|Did not receive vaccine|0|||
128670431|NCT05289037|463092525|FG012|Overall Study|Did not receive vaccine|0|||
128670432|NCT05289037|463092526|FG013|Overall Study|Did not receive vaccine|0|||
128670433|NCT05289037|463092527|FG014|Overall Study|Did not receive vaccine|1|||
128670434|NCT05289037|463092528|FG015|Overall Study|Did not receive vaccine|0|||
128670435|NCT05289037|463092529|FG016|Overall Study|Did not receive vaccine|0|||
128670436|NCT05289037|463092513|FG000|Overall Study|Unable to make last visit|0|||
128670437|NCT05289037|463092514|FG001|Overall Study|Unable to make last visit|0|||
128670438|NCT05289037|463092515|FG002|Overall Study|Unable to make last visit|1|||
128670439|NCT05289037|463092516|FG003|Overall Study|Unable to make last visit|0|||
129006075|NCT04345471|464312770|FG000|Overall Study|Lack of Efficacy|1|||
129006076|NCT04345471|464312771|FG001|Overall Study|Lack of Efficacy|1|||
129006077|NCT04345471|464312772|FG002|Overall Study|Lack of Efficacy|0|||
129006078|NCT04345471|464312770|FG000|Overall Study|Protocol Violation|0|||
129006079|NCT04345471|464312771|FG001|Overall Study|Protocol Violation|1|||
129006080|NCT04345471|464312772|FG002|Overall Study|Protocol Violation|2|||
129006081|NCT04345471|464312770|FG000|Overall Study|Withdrawal by Subject|10|||
129006082|NCT04345471|464312771|FG001|Overall Study|Withdrawal by Subject|5|||
129006083|NCT04345471|464312772|FG002|Overall Study|Withdrawal by Subject|10|||
129006084|NCT03896490|464312807|FG000|Overall Study|Withdrawal by Subject|1|||
128670440|NCT05289037|463092517|FG004|Overall Study|Unable to make last visit|0|||
128670441|NCT05289037|463092518|FG005|Overall Study|Unable to make last visit|0|||
128670442|NCT05289037|463092519|FG006|Overall Study|Unable to make last visit|0|||
128670443|NCT05289037|463092520|FG007|Overall Study|Unable to make last visit|0|||
128670444|NCT05289037|463092521|FG008|Overall Study|Unable to make last visit|0|||
128670445|NCT05289037|463092522|FG009|Overall Study|Unable to make last visit|0|||
128670446|NCT05289037|463092523|FG010|Overall Study|Unable to make last visit|0|||
128670447|NCT05289037|463092524|FG011|Overall Study|Unable to make last visit|0|||
128670448|NCT05289037|463092525|FG012|Overall Study|Unable to make last visit|0|||
128670449|NCT05289037|463092526|FG013|Overall Study|Unable to make last visit|0|||
128670450|NCT05289037|463092527|FG014|Overall Study|Unable to make last visit|0|||
129006085|NCT03896490|464312808|FG001|Overall Study|Withdrawal by Subject|1|||
129006086|NCT00003782|464312809|FG000|Overall Study|No follow up data|30|||
129006087|NCT00003782|464312810|FG001|Overall Study|No follow up data|31|||
129006088|NCT00003782|464312811|FG002|Overall Study|No follow up data|26|||
128670451|NCT05289037|463092528|FG015|Overall Study|Unable to make last visit|0|||
128670452|NCT05289037|463092529|FG016|Overall Study|Unable to make last visit|0|||
129006089|NCT01890707|464312812|FG000|Overall Study|Lost to Follow-up|1|||
129006090|NCT01890707|464312813|FG001|Overall Study|Lost to Follow-up|1|||
129006091|NCT01326026|464312815|FG000|Overall Study|Adverse Event|4|||
128670453|NCT05289037|463092513|FG000|Overall Study|Protocol deviation|0|||
128670454|NCT05289037|463092514|FG001|Overall Study|Protocol deviation|0|||
128670455|NCT05289037|463092515|FG002|Overall Study|Protocol deviation|0|||
128670456|NCT05289037|463092516|FG003|Overall Study|Protocol deviation|0|||
128670457|NCT05289037|463092517|FG004|Overall Study|Protocol deviation|0|||
129006092|NCT01326026|464312816|FG001|Overall Study|Adverse Event|3|||
129006093|NCT01326026|464312815|FG000|Overall Study|Withdrawal Criteria|5|||
128670458|NCT05289037|463092518|FG005|Overall Study|Protocol deviation|0|||
128670459|NCT05289037|463092519|FG006|Overall Study|Protocol deviation|0|||
128670460|NCT05289037|463092520|FG007|Overall Study|Protocol deviation|0|||
128670461|NCT05289037|463092521|FG008|Overall Study|Protocol deviation|0|||
129006094|NCT01326026|464312816|FG001|Overall Study|Withdrawal Criteria|7|||
129006095|NCT01326026|464312815|FG000|Overall Study|Other|3|||
129006096|NCT01326026|464312816|FG001|Overall Study|Other|3|||
128670462|NCT05289037|463092522|FG009|Overall Study|Protocol deviation|0|||
128670463|NCT05289037|463092523|FG010|Overall Study|Protocol deviation|0|||
128670464|NCT05289037|463092524|FG011|Overall Study|Protocol deviation|0|||
128670465|NCT05289037|463092525|FG012|Overall Study|Protocol deviation|0|||
128670466|NCT05289037|463092526|FG013|Overall Study|Protocol deviation|0|||
128670467|NCT05289037|463092527|FG014|Overall Study|Protocol deviation|0|||
128670468|NCT05289037|463092528|FG015|Overall Study|Protocol deviation|1|||
128670469|NCT05289037|463092529|FG016|Overall Study|Protocol deviation|0|||
128670470|NCT05141448|463092530|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
128670471|NCT05141448|463092531|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
128670472|NCT05141448|463092532|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
128670473|NCT05141448|463092533|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
128670474|NCT05141448|463092534|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
128670475|NCT05141448|463092535|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
128670476|NCT05141448|463092530|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
128670477|NCT05141448|463092531|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
128670478|NCT05141448|463092532|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
128670479|NCT05141448|463092533|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
128670480|NCT05141448|463092534|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
128670481|NCT05141448|463092535|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
128670482|NCT05141448|463092530|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
128670483|NCT05141448|463092531|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
128670484|NCT05141448|463092532|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
128670485|NCT05141448|463092533|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
128670486|NCT05141448|463092534|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
128670487|NCT05141448|463092535|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
128670488|NCT05141448|463092530|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
128670489|NCT05141448|463092531|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
128670490|NCT05141448|463092532|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
128670491|NCT05141448|463092533|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
128670492|NCT05141448|463092534|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
128670493|NCT05141448|463092535|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
128670494|NCT05141448|463092530|FG000|Period 2|COVID-19 Related|0|||
128670495|NCT05141448|463092531|FG001|Period 2|COVID-19 Related|0|||
128670496|NCT05141448|463092532|FG002|Period 2|COVID-19 Related|0|||
128670497|NCT05141448|463092533|FG003|Period 2|COVID-19 Related|1|||
128670498|NCT05141448|463092534|FG004|Period 2|COVID-19 Related|0|||
128670499|NCT05141448|463092535|FG005|Period 2|COVID-19 Related|1|||
128670500|NCT05141448|463092530|FG000|3|Covid-19 related|2|||
128670501|NCT05141448|463092531|FG001|3|Covid-19 related|0|||
128670502|NCT05141448|463092532|FG002|3|Covid-19 related|0|||
128670503|NCT05141448|463092533|FG003|3|Covid-19 related|0|||
128670504|NCT05141448|463092534|FG004|3|Covid-19 related|0|||
128670505|NCT05141448|463092535|FG005|3|Covid-19 related|1|||
128670506|NCT05141448|463092530|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
128670507|NCT05141448|463092531|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
128670508|NCT05141448|463092532|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
128670509|NCT05141448|463092533|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
128670510|NCT05141448|463092534|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
128670511|NCT05141448|463092535|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
129006097|NCT05188521|464314597|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
129006098|NCT05188521|464314598|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
128670512|NCT04627285|463092536|FG000|Overall Study|Adverse Event|0|||
128670513|NCT04627285|463092537|FG001|Overall Study|Adverse Event|2|||
128670514|NCT04627285|463092536|FG000|Overall Study|Lost to Follow-up|1|||
128670515|NCT04627285|463092537|FG001|Overall Study|Lost to Follow-up|0|||
128670516|NCT04627285|463092536|FG000|Overall Study|Withdrawal by Subject|1|||
128670517|NCT04627285|463092537|FG001|Overall Study|Withdrawal by Subject|1|||
128670518|NCT04627285|463092536|FG000|Overall Study|Sponsor decision|5|||
129006099|NCT01341639|464314599|FG000|Infant Series|Protocol Violation|1|||
128670519|NCT04627285|463092537|FG001|Overall Study|Sponsor decision|0|||
128670520|NCT04627285|463092536|FG000|Overall Study|Participant left country; aunt informed the site|0|||
128670521|NCT04627285|463092537|FG001|Overall Study|Participant left country; aunt informed the site|1|||
128670522|NCT01217307|463094436|FG000|Overall Study|Withdrawal by Subject|0|||
128670523|NCT01217307|463094437|FG001|Overall Study|Withdrawal by Subject|1|||
128670524|NCT02730195|463094440|FG000|Overall Study|Withdrawal by Subject|1|||
128670525|NCT01904773|463094442|FG000|Screen|Screen failure|3|||
128670526|NCT01904773|463094443|FG001|Screen|Screen failure|0|||
128670527|NCT01904773|463094444|FG002|Screen|Screen failure|0|||
128670528|NCT01904773|463094445|FG003|Screen|Screen failure|0|||
128670529|NCT01904773|463094446|FG004|Screen|Screen failure|0|||
128670530|NCT01904773|463094447|FG005|Screen|Screen failure|0|||
128670531|NCT01904773|463094448|FG006|Screen|Screen failure|0|||
128670532|NCT01904773|463094449|FG007|Screen|Screen failure|0|||
128670533|NCT01904773|463094450|FG008|Screen|Screen failure|0|||
128670534|NCT01904773|463094442|FG000|Screen|Withdrawal by Subject|1|||
128670535|NCT01904773|463094443|FG001|Screen|Withdrawal by Subject|0|||
128670536|NCT01904773|463094444|FG002|Screen|Withdrawal by Subject|0|||
128670537|NCT01904773|463094445|FG003|Screen|Withdrawal by Subject|0|||
128670538|NCT01904773|463094446|FG004|Screen|Withdrawal by Subject|0|||
128670539|NCT01904773|463094447|FG005|Screen|Withdrawal by Subject|0|||
128670540|NCT01904773|463094448|FG006|Screen|Withdrawal by Subject|0|||
128670541|NCT01904773|463094449|FG007|Screen|Withdrawal by Subject|0|||
128670542|NCT01904773|463094450|FG008|Screen|Withdrawal by Subject|0|||
128670543|NCT01904773|463094442|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
128670544|NCT01904773|463094443|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670545|NCT01904773|463094444|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670546|NCT01904773|463094445|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670547|NCT01904773|463094446|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670548|NCT01904773|463094447|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670549|NCT01904773|463094448|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670550|NCT01904773|463094449|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670551|NCT01904773|463094450|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
128670552|NCT01904773|463094442|FG000|First Intervention|Adverse Event|0|||
128670553|NCT01904773|463094443|FG001|First Intervention|Adverse Event|0|||
128670554|NCT01904773|463094444|FG002|First Intervention|Adverse Event|0|||
128670555|NCT01904773|463094445|FG003|First Intervention|Adverse Event|0|||
128670556|NCT01904773|463094446|FG004|First Intervention|Adverse Event|0|||
128670557|NCT01904773|463094447|FG005|First Intervention|Adverse Event|0|||
128670558|NCT01904773|463094448|FG006|First Intervention|Adverse Event|1|||
128670559|NCT01904773|463094449|FG007|First Intervention|Adverse Event|0|||
128670560|NCT01904773|463094450|FG008|First Intervention|Adverse Event|0|||
128670561|NCT01904773|463094442|FG000|Placebo Washout First Intervention|Condition worsened|0|||
128670562|NCT01904773|463094443|FG001|Placebo Washout First Intervention|Condition worsened|1|||
128670563|NCT01904773|463094444|FG002|Placebo Washout First Intervention|Condition worsened|0|||
128670564|NCT01904773|463094445|FG003|Placebo Washout First Intervention|Condition worsened|0|||
128670565|NCT01904773|463094446|FG004|Placebo Washout First Intervention|Condition worsened|0|||
128670566|NCT01904773|463094447|FG005|Placebo Washout First Intervention|Condition worsened|0|||
128670567|NCT01904773|463094448|FG006|Placebo Washout First Intervention|Condition worsened|0|||
128670568|NCT01904773|463094449|FG007|Placebo Washout First Intervention|Condition worsened|0|||
128670569|NCT01904773|463094450|FG008|Placebo Washout First Intervention|Condition worsened|0|||
128670570|NCT01904773|463094442|FG000|Fifth Intervention|Adverse Event|0|||
128670571|NCT01904773|463094443|FG001|Fifth Intervention|Adverse Event|0|||
128670572|NCT01904773|463094444|FG002|Fifth Intervention|Adverse Event|0|||
128670573|NCT01904773|463094445|FG003|Fifth Intervention|Adverse Event|0|||
128670574|NCT01904773|463094446|FG004|Fifth Intervention|Adverse Event|0|||
128670575|NCT01904773|463094447|FG005|Fifth Intervention|Adverse Event|0|||
128670576|NCT01904773|463094448|FG006|Fifth Intervention|Adverse Event|0|||
128670577|NCT01904773|463094449|FG007|Fifth Intervention|Adverse Event|1|||
128670578|NCT01904773|463094450|FG008|Fifth Intervention|Adverse Event|0|||
128670579|NCT01904773|463094442|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
128670580|NCT01904773|463094443|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
128670581|NCT01904773|463094444|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
128670582|NCT01904773|463094445|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
128670583|NCT01904773|463094446|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129006100|NCT01341639|464314600|FG001|Infant Series|Protocol Violation|0|||
128670584|NCT01904773|463094447|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
128670585|NCT01904773|463094448|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
128670586|NCT01904773|463094449|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
128670587|NCT01904773|463094450|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
128670588|NCT00220779|463094454|FG000|Overall Study|Adverse Event|1|||
128670589|NCT00220779|463094455|FG001|Overall Study|Adverse Event|0|||
128670590|NCT00220779|463094456|FG002|Overall Study|Adverse Event|0|||
128670591|NCT00220779|463094454|FG000|Overall Study|Withdrawal by Subject|1|||
128670592|NCT00220779|463094455|FG001|Overall Study|Withdrawal by Subject|4|||
128670593|NCT00220779|463094456|FG002|Overall Study|Withdrawal by Subject|1|||
128670594|NCT00220779|463094454|FG000|Overall Study|Non-compliance|1|||
128670595|NCT00220779|463094455|FG001|Overall Study|Non-compliance|0|||
128670596|NCT00220779|463094456|FG002|Overall Study|Non-compliance|0|||
128670597|NCT00220779|463094454|FG000|Overall Study|Too time consuming|1|||
128670598|NCT00220779|463094455|FG001|Overall Study|Too time consuming|0|||
128670599|NCT00220779|463094456|FG002|Overall Study|Too time consuming|0|||
128670600|NCT00220779|463094454|FG000|Overall Study|Pregnancy|0|||
128670601|NCT00220779|463094455|FG001|Overall Study|Pregnancy|0|||
128670602|NCT00220779|463094456|FG002|Overall Study|Pregnancy|2|||
128670603|NCT00220779|463094454|FG000|Overall Study|Lack of Efficacy|3|||
128670604|NCT00220779|463094455|FG001|Overall Study|Lack of Efficacy|0|||
128670605|NCT00220779|463094456|FG002|Overall Study|Lack of Efficacy|1|||
128670606|NCT02248675|463094457|FG000|Overall Study|Lost to Follow-up|3|||
128670607|NCT02248675|463094458|FG001|Overall Study|Lost to Follow-up|1|||
128670608|NCT03390101|463094461|FG000|Weeks 0-12|Withdrawal by Subject|0|||
128670609|NCT03390101|463094462|FG001|Weeks 0-12|Withdrawal by Subject|1|||
128670610|NCT03390101|463094463|FG002|Weeks 0-12|Withdrawal by Subject|1|||
128670611|NCT03390101|463094461|FG000|Weeks 0-12|Lost to Follow-up|0|||
128670612|NCT03390101|463094462|FG001|Weeks 0-12|Lost to Follow-up|1|||
128670613|NCT03390101|463094463|FG002|Weeks 0-12|Lost to Follow-up|0|||
128670614|NCT03390101|463094461|FG000|Weeks 12-54|Withdrawal by Subject|0|||
128670615|NCT03390101|463094462|FG001|Weeks 12-54|Withdrawal by Subject|3|||
128670616|NCT03390101|463094463|FG002|Weeks 12-54|Withdrawal by Subject|1|||
128670617|NCT03390101|463094461|FG000|Weeks 12-54|Pregnancy|1|||
128670618|NCT03390101|463094462|FG001|Weeks 12-54|Pregnancy|0|||
128670619|NCT03390101|463094463|FG002|Weeks 12-54|Pregnancy|0|||
128670620|NCT03390101|463094461|FG000|Weeks 12-54|Adverse Event|2|||
128670621|NCT03390101|463094462|FG001|Weeks 12-54|Adverse Event|1|||
128670622|NCT03390101|463094463|FG002|Weeks 12-54|Adverse Event|1|||
128670623|NCT00281658|463094468|FG000|Randomized Phase|Adverse Event|0|||
128670624|NCT00281658|463094469|FG001|Randomized Phase|Adverse Event|2|||
128670625|NCT00281658|463094470|FG002|Randomized Phase|Adverse Event|0|||
128670626|NCT00281658|463094471|FG003|Randomized Phase|Adverse Event|0|||
128670627|NCT00281658|463094468|FG000|Randomized Phase|Lost to Follow-up|34|||
128670628|NCT00281658|463094469|FG001|Randomized Phase|Lost to Follow-up|27|||
128670629|NCT00281658|463094470|FG002|Randomized Phase|Lost to Follow-up|0|||
128670630|NCT00281658|463094471|FG003|Randomized Phase|Lost to Follow-up|0|||
129006101|NCT01341639|464314599|FG000|Infant Series|Not Vaccinated|0|||
129006102|NCT01341639|464314600|FG001|Infant Series|Not Vaccinated|1|||
129006103|NCT01341639|464314599|FG000|Infant Series|Adverse Event|0|||
129006104|NCT01341639|464314600|FG001|Infant Series|Adverse Event|5|||
129006105|NCT01341639|464314599|FG000|Infant Series|Withdrawal by Subject|11|||
129006106|NCT01341639|464314600|FG001|Infant Series|Withdrawal by Subject|8|||
129006107|NCT01341639|464314599|FG000|Infant Series|Lost to Follow-up|0|||
129006108|NCT01341639|464314600|FG001|Infant Series|Lost to Follow-up|2|||
129006109|NCT01341639|464314599|FG000|Infant Series|Site 0048 Participants|17|||
129006110|NCT01341639|464314600|FG001|Infant Series|Site 0048 Participants|16|||
129006111|NCT01341639|464314599|FG000|Interim Period|Withdrawal by Subject|6|||
129006112|NCT01341639|464314600|FG001|Interim Period|Withdrawal by Subject|7|||
129006113|NCT01341639|464314599|FG000|Interim Period|Lost to Follow-up|2|||
129006114|NCT01341639|464314600|FG001|Interim Period|Lost to Follow-up|0|||
129006115|NCT01341639|464314599|FG000|Interim Period|Physician Decision|0|||
129006116|NCT01341639|464314600|FG001|Interim Period|Physician Decision|1|||
129006117|NCT01341639|464314599|FG000|Interim Period|Protocol Violation|0|||
129006118|NCT01341639|464314600|FG001|Interim Period|Protocol Violation|1|||
129006119|NCT01341639|464314599|FG000|Post-Treatment|Withdrawal by Subject|0|||
129006120|NCT01341639|464314600|FG001|Post-Treatment|Withdrawal by Subject|1|||
129006121|NCT01341639|464314599|FG000|Post-Treatment|Adverse Event|0|||
129006122|NCT01341639|464314600|FG001|Post-Treatment|Adverse Event|2|||
128670631|NCT00281658|463094468|FG000|Randomized Phase|Withdrawal by Subject|8|||
128670632|NCT00281658|463094469|FG001|Randomized Phase|Withdrawal by Subject|7|||
128670633|NCT00281658|463094470|FG002|Randomized Phase|Withdrawal by Subject|0|||
128670634|NCT00281658|463094471|FG003|Randomized Phase|Withdrawal by Subject|0|||
128670635|NCT00281658|463094468|FG000|Randomized Phase|Study closed/terminated|1|||
128670636|NCT00281658|463094469|FG001|Randomized Phase|Study closed/terminated|1|||
128670637|NCT00281658|463094470|FG002|Randomized Phase|Study closed/terminated|0|||
128670638|NCT00281658|463094471|FG003|Randomized Phase|Study closed/terminated|0|||
128670639|NCT00281658|463094468|FG000|Randomized Phase|Disease progression|36|||
128670640|NCT00281658|463094469|FG001|Randomized Phase|Disease progression|27|||
128670641|NCT00281658|463094470|FG002|Randomized Phase|Disease progression|0|||
128670642|NCT00281658|463094471|FG003|Randomized Phase|Disease progression|0|||
129006123|NCT04582266|464314601|FG000|Overall Study|Lost to Follow-up|7|||
129006124|NCT04582266|464314602|FG001|Overall Study|Lost to Follow-up|5|||
129006125|NCT04582266|464314601|FG000|Overall Study|Withdrawal by Subject|1|||
128670643|NCT00281658|463094468|FG000|Randomized Phase|Physician Decision|1|||
128670644|NCT00281658|463094469|FG001|Randomized Phase|Physician Decision|1|||
128670645|NCT00281658|463094470|FG002|Randomized Phase|Physician Decision|0|||
128670646|NCT00281658|463094471|FG003|Randomized Phase|Physician Decision|0|||
128670647|NCT00281658|463094468|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
128670648|NCT00281658|463094469|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
128670649|NCT00281658|463094470|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
128670650|NCT00281658|463094471|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
128670651|NCT00281658|463094468|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
128670652|NCT00281658|463094469|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
128670653|NCT00281658|463094470|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
129006126|NCT04582266|464314602|FG001|Overall Study|Withdrawal by Subject|0|||
129006127|NCT04582266|464314601|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
128670654|NCT00281658|463094471|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
128670655|NCT00281658|463094468|FG000|Randomized Phase|Treatment ongoing|1|||
128670656|NCT00281658|463094469|FG001|Randomized Phase|Treatment ongoing|0|||
128670657|NCT00281658|463094470|FG002|Randomized Phase|Treatment ongoing|0|||
128670658|NCT00281658|463094471|FG003|Randomized Phase|Treatment ongoing|0|||
128670659|NCT00281658|463094468|FG000|Open Label Phase|Adverse Event|0|||
128670660|NCT00281658|463094469|FG001|Open Label Phase|Adverse Event|0|||
128670661|NCT00281658|463094470|FG002|Open Label Phase|Adverse Event|1|||
128670662|NCT00281658|463094471|FG003|Open Label Phase|Adverse Event|0|||
128670663|NCT00281658|463094468|FG000|Open Label Phase|Lost to Follow-up|0|||
128670664|NCT00281658|463094469|FG001|Open Label Phase|Lost to Follow-up|0|||
128670665|NCT00281658|463094470|FG002|Open Label Phase|Lost to Follow-up|16|||
128670666|NCT00281658|463094471|FG003|Open Label Phase|Lost to Follow-up|2|||
128670667|NCT00281658|463094468|FG000|Open Label Phase|Withdrawal by Subject|0|||
128670668|NCT00281658|463094469|FG001|Open Label Phase|Withdrawal by Subject|0|||
128670669|NCT00281658|463094470|FG002|Open Label Phase|Withdrawal by Subject|3|||
128670670|NCT00281658|463094471|FG003|Open Label Phase|Withdrawal by Subject|2|||
128670671|NCT00281658|463094468|FG000|Open Label Phase|Disease progression|0|||
128670672|NCT00281658|463094469|FG001|Open Label Phase|Disease progression|0|||
128670673|NCT00281658|463094470|FG002|Open Label Phase|Disease progression|18|||
129006128|NCT04582266|464314602|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
129006129|NCT01241461|464314603|FG000|Overall Study|Progressive Disease|3|||
129006130|NCT01241461|464314604|FG001|Overall Study|Progressive Disease|6|||
129006131|NCT01132118|464314605|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
129006132|NCT01132118|464314606|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
129006133|NCT01132118|464314605|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129006134|NCT01132118|464314606|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
129006135|NCT01132118|464314605|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
129006136|NCT01132118|464314606|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
129006137|NCT03705351|464314609|FG000|Overall Study|Study termination|3|||
129006138|NCT03705351|464314609|FG000|Overall Study|Death|1|||
129006139|NCT03705351|464314609|FG000|Overall Study|Lack of Efficacy|2|||
129006140|NCT03705351|464314609|FG000|Overall Study|Withdrawal by Subject|1|||
129006141|NCT01299038|464314617|FG000|Overall Study|Withdrawal by Subject|1|||
129006142|NCT01299038|464314618|FG001|Overall Study|Withdrawal by Subject|0|||
129006143|NCT00322556|464314619|FG000|Overall Study|Adverse Event|1|||
129006144|NCT00322556|464314619|FG000|Overall Study|Withdrawal by Subject|1|||
129006145|NCT00322556|464314619|FG000|Overall Study|Lost to Follow-up|3|||
129006146|NCT00322556|464314619|FG000|Overall Study|Other Reason|7|||
129006147|NCT00832078|464314620|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
129006148|NCT00832078|464314621|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
129006149|NCT00832078|464314620|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
129006150|NCT00832078|464314621|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
129006151|NCT01767597|464314622|FG000|Overall Study|Incomplete intervention|3|||
129006152|NCT01767597|464314623|FG001|Overall Study|Incomplete intervention|1|||
129006153|NCT01767597|464314622|FG000|Overall Study|Withdrawal by Subject|1|||
129006154|NCT01767597|464314623|FG001|Overall Study|Withdrawal by Subject|0|||
129006155|NCT02961920|464314624|FG000|Overall Study|did not achive stydy protocol schedule|1|||
129006156|NCT02961920|464314625|FG001|Overall Study|did not achive stydy protocol schedule|1|||
129006157|NCT02232074|464314626|FG000|Overall Study|Withdrawal by Subject|5|||
129006158|NCT02232074|464314627|FG001|Overall Study|Withdrawal by Subject|3|||
129006159|NCT02232074|464314626|FG000|Overall Study|No legal concerns at baseline|36|||
129006160|NCT02232074|464314627|FG001|Overall Study|No legal concerns at baseline|41|||
129006161|NCT02232074|464314626|FG000|Overall Study|deemed ineligible|0|||
129006162|NCT02232074|464314627|FG001|Overall Study|deemed ineligible|1|||
129006163|NCT04480463|464314630|FG000|Overall Study|Death|0|||
129006164|NCT04480463|464314631|FG001|Overall Study|Death|1|||
128670674|NCT00281658|463094471|FG003|Open Label Phase|Disease progression|0|||
128670675|NCT00281658|463094468|FG000|Open Label Phase|Physician Decision|0|||
128670676|NCT00281658|463094469|FG001|Open Label Phase|Physician Decision|0|||
128670677|NCT00281658|463094470|FG002|Open Label Phase|Physician Decision|1|||
128670678|NCT00281658|463094471|FG003|Open Label Phase|Physician Decision|0|||
128670679|NCT00281658|463094468|FG000|Open Label Phase|Relocation of patient|0|||
129006165|NCT04480463|464314630|FG000|Overall Study|Adverse Event|6|||
129006166|NCT04480463|464314631|FG001|Overall Study|Adverse Event|8|||
129006167|NCT04480463|464314630|FG000|Overall Study|Lost to Follow-up|3|||
129006168|NCT04480463|464314631|FG001|Overall Study|Lost to Follow-up|2|||
129006169|NCT04480463|464314630|FG000|Overall Study|Physician Decision|2|||
129006170|NCT04480463|464314631|FG001|Overall Study|Physician Decision|5|||
129006171|NCT04480463|464314630|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
129006172|NCT04480463|464314631|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
129006173|NCT04480463|464314630|FG000|Overall Study|Protocol Violation|2|||
129006174|NCT04480463|464314631|FG001|Overall Study|Protocol Violation|1|||
129006175|NCT04480463|464314630|FG000|Overall Study|Withdrawal by Subject|6|||
129006176|NCT04480463|464314631|FG001|Overall Study|Withdrawal by Subject|7|||
129006177|NCT04480463|464314630|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
129006178|NCT04480463|464314631|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
129006179|NCT04480463|464314630|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
129006180|NCT04480463|464314631|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
129006181|NCT04480463|464314630|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
129006182|NCT04480463|464314631|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
129006183|NCT04480463|464314630|FG000|Overall Study|Other|6|||
128670680|NCT00281658|463094469|FG001|Open Label Phase|Relocation of patient|0|||
129006184|NCT04480463|464314631|FG001|Overall Study|Other|4|||
129006185|NCT00704418|464314632|FG000|Overall Study|Withdrawal by Subject|2|||
129006186|NCT00704418|464314633|FG001|Overall Study|Withdrawal by Subject|0|||
129006187|NCT00704418|464314632|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
129006188|NCT00704418|464314633|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
129006189|NCT02322879|464314635|FG000|First Intervention|Physician Decision|1|||
129006190|NCT02322879|464314636|FG001|First Intervention|Physician Decision|0|||
129006191|NCT01579474|464314637|FG000|Overall Study|Adverse Event|1|||
129006192|NCT01579474|464314638|FG001|Overall Study|Adverse Event|13|||
129006193|NCT01579474|464314639|FG002|Overall Study|Adverse Event|2|||
129006194|NCT01579474|464314640|FG003|Overall Study|Adverse Event|0|||
129006195|NCT01579474|464314641|FG004|Overall Study|Adverse Event|0|||
129006196|NCT01579474|464314642|FG005|Overall Study|Adverse Event|1|||
129006197|NCT01579474|464314637|FG000|Overall Study|Lack of Efficacy|1|||
129006198|NCT01579474|464314638|FG001|Overall Study|Lack of Efficacy|0|||
129006199|NCT01579474|464314639|FG002|Overall Study|Lack of Efficacy|0|||
129006200|NCT01579474|464314640|FG003|Overall Study|Lack of Efficacy|0|||
129006201|NCT01579474|464314641|FG004|Overall Study|Lack of Efficacy|1|||
129006202|NCT01579474|464314642|FG005|Overall Study|Lack of Efficacy|0|||
129006203|NCT01579474|464314637|FG000|Overall Study|Withdrawal by Subject|1|||
129006204|NCT01579474|464314638|FG001|Overall Study|Withdrawal by Subject|0|||
129006205|NCT01579474|464314639|FG002|Overall Study|Withdrawal by Subject|0|||
129006206|NCT01579474|464314640|FG003|Overall Study|Withdrawal by Subject|0|||
129006207|NCT01579474|464314641|FG004|Overall Study|Withdrawal by Subject|0|||
129006208|NCT01579474|464314642|FG005|Overall Study|Withdrawal by Subject|0|||
129006209|NCT02637076|464314643|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
129006210|NCT02637076|464314644|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
129006211|NCT02637076|464314643|FG000|Overall Study|Withdrawal by Subject|0|||
129006212|NCT02637076|464314644|FG001|Overall Study|Withdrawal by Subject|4|||
129006213|NCT00130520|464314645|FG000|Overall Study|Adverse Event|11|||
129006214|NCT00130520|464314645|FG000|Overall Study|Death|1|||
129006215|NCT00130520|464314645|FG000|Overall Study|Physician Decision|1|||
129006216|NCT00130520|464314645|FG000|Overall Study|Withdrawal by Subject|1|||
128670681|NCT00281658|463094470|FG002|Open Label Phase|Relocation of patient|1|||
128670682|NCT00281658|463094471|FG003|Open Label Phase|Relocation of patient|0|||
128670683|NCT00281658|463094468|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
128670684|NCT00281658|463094469|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
128670685|NCT00281658|463094470|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
128670686|NCT00281658|463094471|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
128670687|NCT00813943|463094475|FG000|Overall Study|Ongoing at cut-off date|5|||
128670688|NCT00813943|463094476|FG001|Overall Study|Ongoing at cut-off date|5|||
128670689|NCT00813943|463094477|FG002|Overall Study|Ongoing at cut-off date|3|||
128670690|NCT01343693|463094478|FG000|Overall Study|Lost to Follow-up|9|||
129006217|NCT00130520|464314645|FG000|Overall Study|Disease Progression|23|||
129006218|NCT00130520|464314645|FG000|Overall Study|Protocol non-compliance|1|||
129006219|NCT00130520|464314645|FG000|Overall Study|Did not meet re-treatment criteria|1|||
129006220|NCT01673009|464314646|FG000|Overall Study|Physician Decision|5|||
129006221|NCT01673009|464314646|FG000|Overall Study|Withdrawal by Subject|8|||
129006222|NCT00782509|464314651|FG000|Overall Study|Adverse Event|20|||
129006223|NCT00782509|464314652|FG001|Overall Study|Adverse Event|10|||
128670691|NCT02551991|463094479|FG000|Overall Study|Death|5|||
128670692|NCT02551991|463094480|FG001|Overall Study|Death|7|||
128670693|NCT02551991|463094481|FG002|Overall Study|Death|8|||
128670694|NCT02551991|463094482|FG003|Overall Study|Death|7|||
128670695|NCT02551991|463094483|FG004|Overall Study|Death|17|||
128670696|NCT02551991|463094479|FG000|Overall Study|Withdrawal by Subject|1|||
129006224|NCT00782509|464314653|FG002|Overall Study|Adverse Event|20|||
129006225|NCT00782509|464314651|FG000|Overall Study|Lost to Follow-up|1|||
129006226|NCT00782509|464314652|FG001|Overall Study|Lost to Follow-up|2|||
129006227|NCT00782509|464314653|FG002|Overall Study|Lost to Follow-up|3|||
129006228|NCT00782509|464314651|FG000|Overall Study|Withdrawal by Subject|3|||
129006229|NCT00782509|464314652|FG001|Overall Study|Withdrawal by Subject|5|||
129006230|NCT00782509|464314653|FG002|Overall Study|Withdrawal by Subject|8|||
129006231|NCT00782509|464314651|FG000|Overall Study|Non compliance with protocol|2|||
129006232|NCT00782509|464314652|FG001|Overall Study|Non compliance with protocol|0|||
129006233|NCT00782509|464314653|FG002|Overall Study|Non compliance with protocol|0|||
129006234|NCT00782509|464314651|FG000|Overall Study|Other reasons not stated above|5|||
129006235|NCT00782509|464314652|FG001|Overall Study|Other reasons not stated above|2|||
129006236|NCT00782509|464314653|FG002|Overall Study|Other reasons not stated above|3|||
129006237|NCT00782509|464314651|FG000|Overall Study|Lack of Efficacy|10|||
129006238|NCT00782509|464314652|FG001|Overall Study|Lack of Efficacy|5|||
129006239|NCT00782509|464314653|FG002|Overall Study|Lack of Efficacy|2|||
129006240|NCT02398188|464314654|FG000|Overall Study|Adverse Event|2|||
129006241|NCT02398188|464314655|FG001|Overall Study|Adverse Event|3|||
129006242|NCT02398188|464314654|FG000|Overall Study|Lost to Follow-up|5|||
129006243|NCT02398188|464314655|FG001|Overall Study|Lost to Follow-up|0|||
129006244|NCT02398188|464314654|FG000|Overall Study|Non-compliance|4|||
129006245|NCT02398188|464314655|FG001|Overall Study|Non-compliance|4|||
129006246|NCT02398188|464314654|FG000|Overall Study|Protocol Violation|6|||
129006247|NCT02398188|464314655|FG001|Overall Study|Protocol Violation|10|||
129006248|NCT02398188|464314654|FG000|Overall Study|Sponsor Decision|2|||
129006249|NCT02398188|464314655|FG001|Overall Study|Sponsor Decision|1|||
129006250|NCT02398188|464314654|FG000|Overall Study|Pregnancy|1|||
129006251|NCT02398188|464314655|FG001|Overall Study|Pregnancy|0|||
129006252|NCT02398188|464314654|FG000|Overall Study|Withdrawal by Subject|7|||
129006253|NCT02398188|464314655|FG001|Overall Study|Withdrawal by Subject|16|||
129006254|NCT01259869|464314656|FG000|Overall Study|Duplicated registration|1|||
129006255|NCT00175019|464314657|FG000|Overall Study|Adverse Event|54|||
129006256|NCT00175019|464314658|FG001|Overall Study|Adverse Event|22|||
129006257|NCT00175019|464314659|FG002|Overall Study|Adverse Event|2|||
129006258|NCT00175019|464314657|FG000|Overall Study|Protocol Violation|6|||
129006259|NCT00175019|464314658|FG001|Overall Study|Protocol Violation|3|||
129006260|NCT00175019|464314659|FG002|Overall Study|Protocol Violation|3|||
129006261|NCT00175019|464314657|FG000|Overall Study|Lost to Follow-up|42|||
129006262|NCT00175019|464314658|FG001|Overall Study|Lost to Follow-up|39|||
129006263|NCT00175019|464314659|FG002|Overall Study|Lost to Follow-up|9|||
129006264|NCT00175019|464314657|FG000|Overall Study|Did not continue under Amendment 4|1|||
129006265|NCT00175019|464314658|FG001|Overall Study|Did not continue under Amendment 4|1|||
129006266|NCT00175019|464314659|FG002|Overall Study|Did not continue under Amendment 4|2|||
129006267|NCT00175019|464314657|FG000|Overall Study|Personal Reason(s)|39|||
129006268|NCT00175019|464314658|FG001|Overall Study|Personal Reason(s)|31|||
129006269|NCT00175019|464314659|FG002|Overall Study|Personal Reason(s)|8|||
129006270|NCT00175019|464314657|FG000|Overall Study|Therapeutic Failure|10|||
129006271|NCT00175019|464314658|FG001|Overall Study|Therapeutic Failure|38|||
129006272|NCT00175019|464314659|FG002|Overall Study|Therapeutic Failure|22|||
129006273|NCT00175019|464314657|FG000|Overall Study|Gout Flare|2|||
129006274|NCT00175019|464314658|FG001|Overall Study|Gout Flare|3|||
129006275|NCT00175019|464314659|FG002|Overall Study|Gout Flare|0|||
129006276|NCT00175019|464314657|FG000|Overall Study|Reason Not Specified|40|||
129006277|NCT00175019|464314658|FG001|Overall Study|Reason Not Specified|34|||
128670697|NCT02551991|463094480|FG001|Overall Study|Withdrawal by Subject|0|||
128670698|NCT02551991|463094481|FG002|Overall Study|Withdrawal by Subject|0|||
129006278|NCT00175019|464314659|FG002|Overall Study|Reason Not Specified|11|||
129006279|NCT03209570|464314660|FG000|Overall Study|Death|1|||
129006280|NCT03209570|464314661|FG001|Overall Study|Death|0|||
129006281|NCT03209570|464314660|FG000|Overall Study|Incomplete Data|8|||
129006282|NCT03209570|464314661|FG001|Overall Study|Incomplete Data|10|||
129006283|NCT03209570|464314660|FG000|Overall Study|Protocol Violation|1|||
129006284|NCT03209570|464314661|FG001|Overall Study|Protocol Violation|0|||
129006285|NCT03209570|464314660|FG000|Overall Study|Withdrawal by Subject|0|||
129006286|NCT03209570|464314661|FG001|Overall Study|Withdrawal by Subject|3|||
129006287|NCT00220701|464314672|FG000|Overall Study|Lost to Follow-up|5|||
129006288|NCT00220701|464314673|FG001|Overall Study|Lost to Follow-up|4|||
128670699|NCT02551991|463094482|FG003|Overall Study|Withdrawal by Subject|0|||
128670700|NCT02551991|463094483|FG004|Overall Study|Withdrawal by Subject|2|||
129006289|NCT00755326|464314675|FG000|Overall Study|Lost to Follow-up|2|||
129006290|NCT00755326|464314676|FG001|Overall Study|Lost to Follow-up|3|||
128670701|NCT02551991|463094479|FG000|Overall Study|Lost to Follow-up|0|||
129006291|NCT04041570|464314682|FG000|Overall Study|Moved from Area|0|||
128670702|NCT02551991|463094480|FG001|Overall Study|Lost to Follow-up|0|||
128670703|NCT02551991|463094481|FG002|Overall Study|Lost to Follow-up|1|||
128670704|NCT02551991|463094482|FG003|Overall Study|Lost to Follow-up|0|||
128670705|NCT02551991|463094483|FG004|Overall Study|Lost to Follow-up|0|||
128670706|NCT02551991|463094479|FG000|Overall Study|Sponsor Decision|1|||
128670707|NCT02551991|463094480|FG001|Overall Study|Sponsor Decision|0|||
128670708|NCT02551991|463094481|FG002|Overall Study|Sponsor Decision|1|||
128670709|NCT02551991|463094482|FG003|Overall Study|Sponsor Decision|0|||
128670710|NCT02551991|463094483|FG004|Overall Study|Sponsor Decision|5|||
128670711|NCT02551991|463094479|FG000|Overall Study|Other|0|||
128670712|NCT02551991|463094480|FG001|Overall Study|Other|0|||
128670713|NCT02551991|463094481|FG002|Overall Study|Other|0|||
128670714|NCT02551991|463094482|FG003|Overall Study|Other|0|||
128670715|NCT02551991|463094483|FG004|Overall Study|Other|1|||
128670716|NCT00265148|463094484|FG000|Overall Study|Adverse Event|2|||
128670717|NCT00265148|463094485|FG001|Overall Study|Adverse Event|2|||
128670718|NCT00265148|463094484|FG000|Overall Study|Lack of Efficacy|0|||
128670719|NCT00265148|463094485|FG001|Overall Study|Lack of Efficacy|2|||
128670720|NCT00265148|463094484|FG000|Overall Study|Protocol Violation|3|||
128670721|NCT00265148|463094485|FG001|Overall Study|Protocol Violation|2|||
128670722|NCT00265148|463094484|FG000|Overall Study|Lost to Follow-up|0|||
128670723|NCT00265148|463094485|FG001|Overall Study|Lost to Follow-up|1|||
128670724|NCT00265148|463094484|FG000|Overall Study|Withdrawal by Subject|2|||
128670725|NCT00265148|463094485|FG001|Overall Study|Withdrawal by Subject|1|||
128670726|NCT00265148|463094484|FG000|Overall Study|Physician Decision|1|||
128670727|NCT00265148|463094485|FG001|Overall Study|Physician Decision|0|||
128670728|NCT00265148|463094484|FG000|Overall Study|Increasing frailty|0|||
128670729|NCT00265148|463094485|FG001|Overall Study|Increasing frailty|1|||
129006292|NCT04041570|464314683|FG001|Overall Study|Moved from Area|2|||
129006293|NCT00384033|464314694|FG000|Overall Study|Adverse Event|10|||
129006294|NCT00384033|464314695|FG001|Overall Study|Adverse Event|8|||
129006295|NCT00384033|464314696|FG002|Overall Study|Adverse Event|11|||
129006296|NCT00384033|464314697|FG003|Overall Study|Adverse Event|20|||
129006297|NCT00384033|464314694|FG000|Overall Study|Failed to return|1|||
129006298|NCT00384033|464314695|FG001|Overall Study|Failed to return|3|||
129006299|NCT00384033|464314696|FG002|Overall Study|Failed to return|2|||
129006300|NCT00384033|464314697|FG003|Overall Study|Failed to return|2|||
129006301|NCT00384033|464314694|FG000|Overall Study|Physician Decision|1|||
129006302|NCT00384033|464314695|FG001|Overall Study|Physician Decision|0|||
129006303|NCT00384033|464314696|FG002|Overall Study|Physician Decision|0|||
129006304|NCT00384033|464314697|FG003|Overall Study|Physician Decision|0|||
129006305|NCT00384033|464314694|FG000|Overall Study|Lost to Follow-up|6|||
129006306|NCT00384033|464314695|FG001|Overall Study|Lost to Follow-up|12|||
129006307|NCT00384033|464314696|FG002|Overall Study|Lost to Follow-up|7|||
129006308|NCT00384033|464314697|FG003|Overall Study|Lost to Follow-up|7|||
129006309|NCT00384033|464314694|FG000|Overall Study|Other|2|||
129006310|NCT00384033|464314695|FG001|Overall Study|Other|0|||
129006311|NCT00384033|464314696|FG002|Overall Study|Other|0|||
129006312|NCT00384033|464314697|FG003|Overall Study|Other|0|||
129006313|NCT00384033|464314694|FG000|Overall Study|Protocol Violation|5|||
129006314|NCT00384033|464314695|FG001|Overall Study|Protocol Violation|0|||
129006315|NCT00384033|464314696|FG002|Overall Study|Protocol Violation|5|||
129006316|NCT00384033|464314697|FG003|Overall Study|Protocol Violation|6|||
129006317|NCT00384033|464314694|FG000|Overall Study|Withdrawal by Subject|6|||
129006318|NCT00384033|464314695|FG001|Overall Study|Withdrawal by Subject|2|||
129006319|NCT00384033|464314696|FG002|Overall Study|Withdrawal by Subject|5|||
129006320|NCT00384033|464314697|FG003|Overall Study|Withdrawal by Subject|2|||
129006321|NCT00384033|464314694|FG000|Overall Study|Lack of Efficacy|7|||
129006322|NCT00384033|464314695|FG001|Overall Study|Lack of Efficacy|3|||
129006323|NCT00384033|464314696|FG002|Overall Study|Lack of Efficacy|3|||
129006324|NCT00384033|464314697|FG003|Overall Study|Lack of Efficacy|1|||
129006325|NCT00384033|464314694|FG000|Overall Study|Randomized but not treated|3|||
128670730|NCT00265148|463094484|FG000|Overall Study|Subject chose to change of the dose|1|||
128670731|NCT00265148|463094485|FG001|Overall Study|Subject chose to change of the dose|0|||
128670732|NCT01463007|463094488|FG000|Overall Study|Physician Decision|1|||
128670733|NCT00942994|463094491|FG000|Overall Study|Adverse Event|7|||
128670734|NCT00942994|463094492|FG001|Overall Study|Adverse Event|4|||
128763111|NCT03145766|463422736|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
128763112|NCT03145766|463422737|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
128670735|NCT00942994|463094491|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128670736|NCT00942994|463094492|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128670737|NCT00942994|463094491|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129006326|NCT00384033|464314695|FG001|Overall Study|Randomized but not treated|7|||
129006327|NCT00384033|464314696|FG002|Overall Study|Randomized but not treated|10|||
129006328|NCT00384033|464314697|FG003|Overall Study|Randomized but not treated|2|||
129006329|NCT00290745|464314698|FG000|Overall Study|Withdrawal by Subject|4|||
129006330|NCT00290745|464314698|FG000|Overall Study|Physician Decision|2|||
129006331|NCT00290745|464314698|FG000|Overall Study|Surgery after 3 months for progression|3|||
129006332|NCT00290745|464314698|FG000|Overall Study|Baseline MRI not available|3|||
129006333|NCT02750306|464314699|FG000|Overall Study|Withdrawal by Subject|5|||
129006334|NCT02750306|464314700|FG001|Overall Study|Withdrawal by Subject|2|||
129006335|NCT02750306|464314699|FG000|Overall Study|Protocol Violation|1|||
129006336|NCT02750306|464314700|FG001|Overall Study|Protocol Violation|0|||
129006337|NCT02737306|464314701|FG000|Overall Study|Adverse Event|3|||
129006338|NCT02737306|464314702|FG001|Overall Study|Adverse Event|0|||
129006339|NCT02737306|464314701|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
129006340|NCT02737306|464314702|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
129006341|NCT03361423|464314703|FG000|Overall Study|Withdrawal by Subject|4|||
128670738|NCT00942994|463094492|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128670739|NCT00942994|463094491|FG000|Overall Study|Patient withdrew consent|5|||
128670740|NCT00942994|463094492|FG001|Overall Study|Patient withdrew consent|8|||
128670741|NCT00942994|463094491|FG000|Overall Study|Lost to Follow-up|1|||
128670742|NCT00942994|463094492|FG001|Overall Study|Lost to Follow-up|4|||
128670743|NCT00942994|463094491|FG000|Overall Study|Protocol deviation|1|||
128670744|NCT00942994|463094492|FG001|Overall Study|Protocol deviation|2|||
128670745|NCT01874340|463094495|FG000|Overall Study|Study terminated by Sponsor|6|||
128670746|NCT01874340|463094496|FG001|Overall Study|Study terminated by Sponsor|8|||
128670747|NCT01874340|463094497|FG002|Overall Study|Study terminated by Sponsor|8|||
128670748|NCT01874340|463094498|FG003|Overall Study|Study terminated by Sponsor|4|||
128670749|NCT01874340|463094495|FG000|Overall Study|Withdrawal by Subject|0|||
128670750|NCT01874340|463094496|FG001|Overall Study|Withdrawal by Subject|0|||
128670751|NCT01874340|463094497|FG002|Overall Study|Withdrawal by Subject|0|||
128670752|NCT01874340|463094498|FG003|Overall Study|Withdrawal by Subject|1|||
128670753|NCT00689117|463094507|FG000|Overall Study|Adverse Event|6|||
128670754|NCT00689117|463094508|FG001|Overall Study|Adverse Event|0|||
128670755|NCT00689117|463094509|FG002|Overall Study|Adverse Event|5|||
128878370|NCT00402597|463848452|FG002|Overall Study|reason not specified|27|||
128878371|NCT00402597|463848453|FG003|Overall Study|reason not specified|14|||
128878372|NCT00402597|463848454|FG004|Overall Study|reason not specified|20|||
128878373|NCT02319525|463848455|FG000|Overall Study|Withdrawal by Subject|2|||
128878374|NCT02319525|463848456|FG001|Overall Study|Withdrawal by Subject|1|||
128878375|NCT00577577|463848458|FG000|Overall Study|Adverse Event|3|||
128878376|NCT00577577|463848459|FG001|Overall Study|Adverse Event|2|||
128878377|NCT00577577|463848458|FG000|Overall Study|Lost to Follow-up|1|||
128878378|NCT00577577|463848459|FG001|Overall Study|Lost to Follow-up|0|||
128878379|NCT00577577|463848458|FG000|Overall Study|Protocol Violation|0|||
128878380|NCT00577577|463848459|FG001|Overall Study|Protocol Violation|3|||
128878381|NCT00577577|463848458|FG000|Overall Study|Transportation|1|||
128878382|NCT00577577|463848459|FG001|Overall Study|Transportation|0|||
128878383|NCT00232544|463848464|FG000|Overall Study|Lost to Follow-up|20|||
128878384|NCT00232544|463848465|FG001|Overall Study|Lost to Follow-up|15|||
128878385|NCT00986973|463848466|FG000|Overall Study|Withdrawn by study team|1|||
128878386|NCT01465347|463848467|FG000|Overall Study|Withdrawal by Subject|1|||
128670756|NCT00689117|463094510|FG003|Overall Study|Adverse Event|0|||
128670757|NCT00689117|463094507|FG000|Overall Study|Lost to Follow-up|26|||
128670758|NCT00689117|463094508|FG001|Overall Study|Lost to Follow-up|19|||
128670759|NCT00689117|463094509|FG002|Overall Study|Lost to Follow-up|17|||
128670760|NCT00689117|463094510|FG003|Overall Study|Lost to Follow-up|11|||
128670761|NCT00689117|463094507|FG000|Overall Study|Lack of Efficacy|1|||
128670762|NCT00689117|463094508|FG001|Overall Study|Lack of Efficacy|2|||
128670763|NCT00689117|463094509|FG002|Overall Study|Lack of Efficacy|2|||
128670764|NCT00689117|463094510|FG003|Overall Study|Lack of Efficacy|2|||
128670765|NCT00689117|463094507|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
128670766|NCT00689117|463094508|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
128670767|NCT00689117|463094509|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
128670768|NCT00689117|463094510|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
128670769|NCT00689117|463094507|FG000|Overall Study|Withdrawal by Subject|19|||
128670770|NCT00689117|463094508|FG001|Overall Study|Withdrawal by Subject|18|||
128670771|NCT00689117|463094509|FG002|Overall Study|Withdrawal by Subject|26|||
128670772|NCT00689117|463094510|FG003|Overall Study|Withdrawal by Subject|13|||
128670773|NCT00689117|463094507|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
128670774|NCT00689117|463094508|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
128670775|NCT00689117|463094509|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
128670776|NCT00689117|463094510|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
128670777|NCT00689117|463094507|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
128670778|NCT00689117|463094508|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
128670779|NCT00689117|463094509|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128670780|NCT00689117|463094510|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128878387|NCT01465347|463848468|FG001|Overall Study|Withdrawal by Subject|1|||
128878388|NCT01465347|463848467|FG000|Overall Study|Physician Decision|0|||
128878389|NCT01465347|463848468|FG001|Overall Study|Physician Decision|1|||
128878390|NCT01465347|463848467|FG000|Overall Study|Admitted to hospice|0|||
128878391|NCT01465347|463848468|FG001|Overall Study|Admitted to hospice|1|||
129006342|NCT03361423|464314704|FG001|Overall Study|Withdrawal by Subject|3|||
129006343|NCT03361423|464314703|FG000|Overall Study|Did not treat|19|||
129006344|NCT03361423|464314704|FG001|Overall Study|Did not treat|18|||
129006345|NCT03361423|464314703|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
129006346|NCT03361423|464314704|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
129006347|NCT03361423|464314703|FG000|Overall Study|Missing data|4|||
129006348|NCT03361423|464314704|FG001|Overall Study|Missing data|1|||
129006349|NCT01336894|464314705|FG000|Follow-up|Study terminated prematurely|2|||
129006350|NCT01336894|464314706|FG001|Follow-up|Study terminated prematurely|7|||
129006351|NCT00622908|464314707|FG000|Overall Study|Protocol Violation|1|||
129006352|NCT00622908|464314708|FG001|Overall Study|Protocol Violation|0|||
129006353|NCT00622908|464314707|FG000|Overall Study|Adverse Event|0|||
129006354|NCT00622908|464314708|FG001|Overall Study|Adverse Event|1|||
129006355|NCT00622908|464314707|FG000|Overall Study|Lack of Efficacy|1|||
129006356|NCT00622908|464314708|FG001|Overall Study|Lack of Efficacy|7|||
129006357|NCT00622908|464314707|FG000|Overall Study|Lost to Follow-up|1|||
129006358|NCT00622908|464314708|FG001|Overall Study|Lost to Follow-up|0|||
129006359|NCT00622908|464314707|FG000|Overall Study|Refusal|0|||
129006360|NCT00622908|464314708|FG001|Overall Study|Refusal|1|||
129006361|NCT00622908|464314707|FG000|Overall Study|Termination by study sponser|0|||
129006362|NCT00622908|464314708|FG001|Overall Study|Termination by study sponser|1|||
129006363|NCT03937466|464314709|FG000|Overall Study|not eligbile after the 2-week diary|9|||
129006364|NCT03937466|464314709|FG000|Overall Study|never returned their diary|6|||
129006365|NCT03937466|464314709|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
129006366|NCT03937466|464314709|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
129006367|NCT00113490|464314710|FG000|Overall Study|Withdrawal by Subject|1|||
129006368|NCT00113490|464314711|FG001|Overall Study|Withdrawal by Subject|3|||
129006369|NCT00113490|464314710|FG000|Overall Study|Lost to Follow-up|1|||
129006370|NCT00113490|464314711|FG001|Overall Study|Lost to Follow-up|0|||
129006371|NCT02162758|464314712|FG000|Overall Study|Study termination|0|||
129006372|NCT02162758|464314713|FG001|Overall Study|Study termination|1|||
129006373|NCT04471935|464314714|FG000|Overall Study|Withdrawal by Subject|1|||
129006374|NCT04471935|464314714|FG000|Overall Study|Deemed ineligible to participate|1|||
129006375|NCT03213210|464314717|FG000|Overall Study|Lost to Follow-up|2|||
128670781|NCT00689117|463094507|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
128670782|NCT00689117|463094508|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
128670783|NCT00689117|463094509|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
129006376|NCT03213210|464314717|FG000|Overall Study|Study termination|3|||
129006377|NCT01325207|464314725|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
128670784|NCT00689117|463094510|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
128670785|NCT00689117|463094507|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
128670786|NCT00689117|463094508|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
128670787|NCT00689117|463094509|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
128670788|NCT00689117|463094510|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
128670789|NCT00689117|463094507|FG000|Overall Study|Use of Prohibitive Medication|2|||
128670790|NCT00689117|463094508|FG001|Overall Study|Use of Prohibitive Medication|1|||
128670791|NCT00689117|463094509|FG002|Overall Study|Use of Prohibitive Medication|3|||
128670792|NCT00689117|463094510|FG003|Overall Study|Use of Prohibitive Medication|0|||
128670793|NCT00689117|463094507|FG000|Overall Study|Pregnancy|0|||
128670794|NCT00689117|463094508|FG001|Overall Study|Pregnancy|2|||
128670795|NCT00689117|463094509|FG002|Overall Study|Pregnancy|0|||
128670796|NCT00689117|463094510|FG003|Overall Study|Pregnancy|2|||
128670797|NCT00689117|463094507|FG000|Overall Study|Incarceration|2|||
128670798|NCT00689117|463094508|FG001|Overall Study|Incarceration|0|||
128670799|NCT00689117|463094509|FG002|Overall Study|Incarceration|0|||
128670800|NCT00689117|463094510|FG003|Overall Study|Incarceration|0|||
128670801|NCT00689117|463094507|FG000|Overall Study|Fear of Birth Defects|0|||
128670802|NCT00689117|463094508|FG001|Overall Study|Fear of Birth Defects|0|||
128670803|NCT00689117|463094509|FG002|Overall Study|Fear of Birth Defects|1|||
128670804|NCT00689117|463094510|FG003|Overall Study|Fear of Birth Defects|0|||
128670805|NCT00689117|463094507|FG000|Overall Study|Transportation|1|||
128670806|NCT00689117|463094508|FG001|Overall Study|Transportation|0|||
128670807|NCT00689117|463094509|FG002|Overall Study|Transportation|0|||
128670808|NCT00689117|463094510|FG003|Overall Study|Transportation|0|||
128670809|NCT00689117|463094507|FG000|Overall Study|Patient Withdrew from Study|0|||
128670810|NCT00689117|463094508|FG001|Overall Study|Patient Withdrew from Study|0|||
128670811|NCT00689117|463094509|FG002|Overall Study|Patient Withdrew from Study|0|||
128670812|NCT00689117|463094510|FG003|Overall Study|Patient Withdrew from Study|1|||
128878392|NCT01590082|463848469|FG000|Overall Study|Withdrawal by Subject|1|||
129006378|NCT01325207|464314726|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129006379|NCT01325207|464314727|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129006380|NCT01325207|464314728|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129006381|NCT01325207|464314729|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
129006382|NCT01325207|464314730|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129006383|NCT01325207|464314725|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
129006384|NCT01325207|464314726|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
128670813|NCT00689117|463094507|FG000|Overall Study|Personal Reason|0|||
128670814|NCT00689117|463094508|FG001|Overall Study|Personal Reason|1|||
128670815|NCT00689117|463094509|FG002|Overall Study|Personal Reason|0|||
128670816|NCT00689117|463094510|FG003|Overall Study|Personal Reason|0|||
128670817|NCT00689117|463094507|FG000|Overall Study|Dispensing Error|0|||
128670818|NCT00689117|463094508|FG001|Overall Study|Dispensing Error|1|||
129006385|NCT01325207|464314727|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
129006386|NCT01325207|464314728|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
129006387|NCT01325207|464314729|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
129006388|NCT01325207|464314730|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
129006389|NCT01325207|464314725|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129006390|NCT01325207|464314726|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129006391|NCT01325207|464314727|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129006392|NCT01325207|464314728|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129006393|NCT01325207|464314729|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
129006394|NCT01325207|464314730|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
129006395|NCT01325207|464314725|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129006396|NCT01325207|464314726|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
129006397|NCT01325207|464314727|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129006398|NCT01325207|464314728|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129006399|NCT01325207|464314729|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129006400|NCT01325207|464314730|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129006401|NCT01325207|464314725|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129006402|NCT01325207|464314726|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129006403|NCT01325207|464314727|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129006404|NCT01325207|464314728|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129006405|NCT01325207|464314729|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129006406|NCT01325207|464314730|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
129006407|NCT01325207|464314725|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129006408|NCT01325207|464314726|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129006409|NCT01325207|464314727|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129006410|NCT01325207|464314728|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129006411|NCT01325207|464314729|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129006412|NCT01325207|464314730|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
129006413|NCT01325207|464314725|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129006414|NCT01325207|464314726|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129006415|NCT01325207|464314727|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129006416|NCT01325207|464314728|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129006417|NCT01325207|464314729|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
129006418|NCT01325207|464314730|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129006419|NCT00708422|464314731|FG000|Overall Study|Adverse Event|3|||
129006420|NCT00708422|464314732|FG001|Overall Study|Adverse Event|1|||
129006421|NCT00708422|464314731|FG000|Overall Study|Withdrawal by Subject|1|||
129006422|NCT00708422|464314732|FG001|Overall Study|Withdrawal by Subject|0|||
129006423|NCT01254409|464314733|FG000|Overall Study|Adverse Event|0|||
129006424|NCT01254409|464314734|FG001|Overall Study|Adverse Event|1|||
129006425|NCT01254409|464314735|FG002|Overall Study|Adverse Event|0|||
129006426|NCT01254409|464314736|FG003|Overall Study|Adverse Event|0|||
129006427|NCT01564758|464314744|FG000|Overall Study|Death|8|||
129006428|NCT01564758|464314744|FG000|Overall Study|Adverse Event|3|||
129006429|NCT01564758|464314744|FG000|Overall Study|Other|3|||
129006430|NCT00249821|464314745|FG000|Overall Study|Technical problem|0|||
129006431|NCT00249821|464314746|FG001|Overall Study|Technical problem|1|||
129006432|NCT02482571|464314747|FG000|Overall Study|Adverse Event|1|||
129006433|NCT02482571|464314747|FG000|Overall Study|Scanner or Respiract failure|3|||
129006434|NCT02482571|464314747|FG000|Overall Study|Withdrawal by Subject|4|||
129006435|NCT01446913|464314748|FG000|Overall Study|Significant illness|1|||
129006436|NCT01446913|464314749|FG001|Overall Study|Significant illness|1|||
129006437|NCT01446913|464314750|FG002|Overall Study|Significant illness|1|||
129006438|NCT01446913|464314748|FG000|Overall Study|Withdrawal by Subject|5|||
129006439|NCT01446913|464314749|FG001|Overall Study|Withdrawal by Subject|3|||
129006440|NCT01446913|464314750|FG002|Overall Study|Withdrawal by Subject|5|||
129006441|NCT01446913|464314748|FG000|Overall Study|Physician Decision|0|||
129006442|NCT01446913|464314749|FG001|Overall Study|Physician Decision|0|||
129006443|NCT01446913|464314750|FG002|Overall Study|Physician Decision|2|||
128670819|NCT00689117|463094509|FG002|Overall Study|Dispensing Error|0|||
128670820|NCT00689117|463094510|FG003|Overall Study|Dispensing Error|0|||
129006444|NCT01446913|464314748|FG000|Overall Study|Lost to Follow-up|3|||
129006445|NCT01446913|464314749|FG001|Overall Study|Lost to Follow-up|5|||
128670821|NCT01206322|463094511|FG000|Overall Study|Adverse Event|0|||
128670822|NCT01206322|463094512|FG001|Overall Study|Adverse Event|0|||
128670823|NCT01206322|463094513|FG002|Overall Study|Adverse Event|0|||
128670824|NCT01206322|463094514|FG003|Overall Study|Adverse Event|1|||
129006446|NCT01446913|464314750|FG002|Overall Study|Lost to Follow-up|3|||
128670825|NCT00444678|463094515|FG000|Overall Study|Toxicity|11|||
128670826|NCT00444678|463094515|FG000|Overall Study|Disease Progression|12|||
128670827|NCT00444678|463094515|FG000|Overall Study|Death|3|||
128670828|NCT00444678|463094515|FG000|Overall Study|Physician Decision|3|||
128670829|NCT00444678|463094515|FG000|Overall Study|Withdrawal by Subject|2|||
128670830|NCT00606905|463094518|FG000|Overall Study|No Pregnancy|9|||
128670831|NCT00606905|463094519|FG001|Overall Study|No Pregnancy|6|||
128670832|NCT00606905|463094518|FG000|Overall Study|Non-Index Pregnancy|1|||
128670833|NCT00606905|463094519|FG001|Overall Study|Non-Index Pregnancy|4|||
128670834|NCT00606905|463094518|FG000|Overall Study|Withdrew|5|||
128670835|NCT00606905|463094519|FG001|Overall Study|Withdrew|5|||
128670836|NCT00859638|463094520|FG000|Overall Study|Lost to Follow-up|6|||
128670837|NCT00859638|463094521|FG001|Overall Study|Lost to Follow-up|1|||
128670838|NCT00859638|463094520|FG000|Overall Study|Withdrawal by Subject|3|||
128670839|NCT00859638|463094521|FG001|Overall Study|Withdrawal by Subject|2|||
128670840|NCT00859638|463094520|FG000|Overall Study|Ill health|1|||
128670841|NCT00859638|463094521|FG001|Overall Study|Ill health|1|||
128670842|NCT02969408|463094523|FG000|Overall Study|Adverse Event|2|||
128670843|NCT02969408|463094523|FG000|Overall Study|Withdrawal by Subject|8|||
128670844|NCT02969408|463094523|FG000|Overall Study|Lost to Follow-up|4|||
128670845|NCT02969408|463094523|FG000|Overall Study|Protocol Violation|1|||
128670846|NCT02969408|463094523|FG000|Overall Study|Other than specified|1|||
128670847|NCT02779556|463094527|FG000|Baseline|Partial baseline interview completed|1|||
128670848|NCT02779556|463094528|FG001|Baseline|Partial baseline interview completed|0|||
128670849|NCT02779556|463094527|FG000|3 Months|Lost to Follow-up|40|||
128670850|NCT02779556|463094528|FG001|3 Months|Lost to Follow-up|29|||
128670851|NCT02779556|463094527|FG000|3 Months|Missed 3 month clinic visit|27|||
128670852|NCT02779556|463094528|FG001|3 Months|Missed 3 month clinic visit|19|||
128670853|NCT02779556|463094527|FG000|6 Month|Lost to Follow-up|33|||
128670854|NCT02779556|463094528|FG001|6 Month|Lost to Follow-up|39|||
128670855|NCT02779556|463094527|FG000|6 Month HbA1c|No value collected during window|69|||
128670856|NCT02779556|463094528|FG001|6 Month HbA1c|No value collected during window|50|||
128670857|NCT02779556|463094527|FG000|12 Month HbA1c|No value collected during window|138|||
128670858|NCT02779556|463094528|FG001|12 Month HbA1c|No value collected during window|102|||
128670859|NCT03110770|463094532|FG000|Overall Study|Death|1|||
128670860|NCT03110770|463094533|FG001|Overall Study|Death|0|||
128670861|NCT03110770|463094534|FG002|Overall Study|Death|0|||
128670862|NCT03110770|463094535|FG003|Overall Study|Death|1|||
128670863|NCT03110770|463094536|FG004|Overall Study|Death|0|||
128670864|NCT03110770|463094532|FG000|Overall Study|Enrolled but did not receive product|0|||
128670865|NCT03110770|463094533|FG001|Overall Study|Enrolled but did not receive product|0|||
128670866|NCT03110770|463094534|FG002|Overall Study|Enrolled but did not receive product|0|||
128670867|NCT03110770|463094535|FG003|Overall Study|Enrolled but did not receive product|8|||
128670868|NCT03110770|463094536|FG004|Overall Study|Enrolled but did not receive product|7|||
128670869|NCT03110770|463094532|FG000|Overall Study|Lost to Follow-up|0|||
128670870|NCT03110770|463094533|FG001|Overall Study|Lost to Follow-up|0|||
128670871|NCT03110770|463094534|FG002|Overall Study|Lost to Follow-up|0|||
128670872|NCT03110770|463094535|FG003|Overall Study|Lost to Follow-up|53|||
128670873|NCT03110770|463094536|FG004|Overall Study|Lost to Follow-up|45|||
128670874|NCT03110770|463094532|FG000|Overall Study|Investigator Decision|0|||
128670875|NCT03110770|463094533|FG001|Overall Study|Investigator Decision|0|||
129006447|NCT00814320|464314751|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
129006448|NCT00814320|464314752|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
129006449|NCT00814320|464314751|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
129006450|NCT00814320|464314752|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
129006451|NCT00814320|464314751|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
129006452|NCT00814320|464314752|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
128670876|NCT03110770|463094534|FG002|Overall Study|Investigator Decision|0|||
128670877|NCT03110770|463094535|FG003|Overall Study|Investigator Decision|5|||
128670878|NCT03110770|463094536|FG004|Overall Study|Investigator Decision|3|||
128670879|NCT03110770|463094532|FG000|Overall Study|Withdrawal by Subject|0|||
128670880|NCT03110770|463094533|FG001|Overall Study|Withdrawal by Subject|0|||
128670881|NCT03110770|463094534|FG002|Overall Study|Withdrawal by Subject|0|||
128670882|NCT03110770|463094535|FG003|Overall Study|Withdrawal by Subject|24|||
128670883|NCT03110770|463094536|FG004|Overall Study|Withdrawal by Subject|24|||
128670884|NCT03110770|463094532|FG000|Overall Study|Moved from area|5|||
128670885|NCT03110770|463094533|FG001|Overall Study|Moved from area|0|||
128670886|NCT03110770|463094534|FG002|Overall Study|Moved from area|2|||
128670887|NCT03110770|463094535|FG003|Overall Study|Moved from area|42|||
128670888|NCT03110770|463094536|FG004|Overall Study|Moved from area|43|||
128670889|NCT03110770|463094532|FG000|Overall Study|Illness/Injury unrelated to product|0|||
128670890|NCT03110770|463094533|FG001|Overall Study|Illness/Injury unrelated to product|0|||
128670891|NCT03110770|463094534|FG002|Overall Study|Illness/Injury unrelated to product|0|||
129006453|NCT00814320|464314751|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
128670892|NCT03110770|463094535|FG003|Overall Study|Illness/Injury unrelated to product|0|||
128670893|NCT03110770|463094536|FG004|Overall Study|Illness/Injury unrelated to product|1|||
128670894|NCT01086358|463094539|FG000|First Intervention|Lost to Follow-up|9|||
128670895|NCT01086358|463094540|FG001|First Intervention|Lost to Follow-up|4|||
128670896|NCT01086358|463094539|FG000|First Intervention|Withdrawal by Subject|0|||
128670897|NCT01086358|463094540|FG001|First Intervention|Withdrawal by Subject|1|||
128670898|NCT01086358|463094539|FG000|Second Intervention|Lost to Follow-up|4|||
128670899|NCT01086358|463094540|FG001|Second Intervention|Lost to Follow-up|4|||
128670900|NCT01767142|463094541|FG000|Overall Study|Lost to Follow-up|3|||
128670901|NCT03206788|463094547|FG000|Overall Study|Withdrawal by Subject|0|||
128670902|NCT03206788|463094548|FG001|Overall Study|Withdrawal by Subject|1|||
128670903|NCT03206788|463094547|FG000|Overall Study|Adverse Event|0|||
128670904|NCT03206788|463094548|FG001|Overall Study|Adverse Event|1|||
128670905|NCT03206788|463094547|FG000|Overall Study|Physician Decision|0|||
128670906|NCT03206788|463094548|FG001|Overall Study|Physician Decision|1|||
128670907|NCT02471612|463094549|FG000|Overall Study|Lost to Follow-up|2|||
128670908|NCT02082340|463094550|FG000|Overall Study|Lost to Follow-up|1|||
128670909|NCT02082340|463094551|FG001|Overall Study|Lost to Follow-up|1|||
128670910|NCT01625260|463094552|FG000|Overall Study|Adverse Event|3|||
128670911|NCT01625260|463094553|FG001|Overall Study|Adverse Event|0|||
128670912|NCT01625260|463094552|FG000|Overall Study|Study Terminated by Investigator|2|||
128670913|NCT01625260|463094553|FG001|Overall Study|Study Terminated by Investigator|0|||
128670914|NCT01625260|463094552|FG000|Overall Study|Disease Progression|2|||
128670915|NCT01625260|463094553|FG001|Overall Study|Disease Progression|0|||
128670916|NCT01625260|463094552|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
128670917|NCT01625260|463094553|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
128670918|NCT03899805|463094554|FG000|Overall Study|Physician Decision|3|||
128670919|NCT03899805|463094555|FG001|Overall Study|Physician Decision|0|||
129006454|NCT00814320|464314752|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
129006455|NCT00814320|464314751|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
128670920|NCT03899805|463094556|FG002|Overall Study|Physician Decision|2|||
128670921|NCT03899805|463094554|FG000|Overall Study|Withdrawal by Subject|1|||
128670922|NCT03899805|463094555|FG001|Overall Study|Withdrawal by Subject|0|||
128670923|NCT03899805|463094556|FG002|Overall Study|Withdrawal by Subject|2|||
128670924|NCT03899805|463094554|FG000|Overall Study|Progressive Disease|10|||
128670925|NCT03899805|463094555|FG001|Overall Study|Progressive Disease|18|||
128670926|NCT03899805|463094556|FG002|Overall Study|Progressive Disease|12|||
128670927|NCT03899805|463094554|FG000|Overall Study|Adverse Event|3|||
128670928|NCT03899805|463094555|FG001|Overall Study|Adverse Event|1|||
128670929|NCT03899805|463094556|FG002|Overall Study|Adverse Event|0|||
128670930|NCT03899805|463094554|FG000|Overall Study|Death|2|||
128670931|NCT03899805|463094555|FG001|Overall Study|Death|0|||
128670932|NCT03899805|463094556|FG002|Overall Study|Death|0|||
128670933|NCT03899805|463094554|FG000|Overall Study|Came off for surgery|0|||
128670934|NCT03899805|463094555|FG001|Overall Study|Came off for surgery|0|||
128670935|NCT03899805|463094556|FG002|Overall Study|Came off for surgery|1|||
128670936|NCT03317405|463094557|FG000|Overall Study|Withdrawal by Subject|1|||
128670937|NCT03317405|463094558|FG001|Overall Study|Withdrawal by Subject|0|||
128670938|NCT03317405|463094559|FG002|Overall Study|Withdrawal by Subject|0|||
128670939|NCT03317405|463094557|FG000|Overall Study|Physician Decision|0|||
128670940|NCT03317405|463094558|FG001|Overall Study|Physician Decision|0|||
128670941|NCT03317405|463094559|FG002|Overall Study|Physician Decision|1|||
128670942|NCT03317405|463094557|FG000|Overall Study|Surgery Rescheduled|0|||
128670943|NCT03317405|463094558|FG001|Overall Study|Surgery Rescheduled|1|||
128670944|NCT03317405|463094559|FG002|Overall Study|Surgery Rescheduled|0|||
128670945|NCT00984620|463094562|FG000|Overall Study|Adverse Event|5|||
128670946|NCT00984620|463094563|FG001|Overall Study|Adverse Event|5|||
128670947|NCT00984620|463094562|FG000|Overall Study|Lost to Follow-up|1|||
128670948|NCT00984620|463094563|FG001|Overall Study|Lost to Follow-up|1|||
128670949|NCT00984620|463094562|FG000|Overall Study|Withdrawal by Subject|0|||
128670950|NCT00984620|463094563|FG001|Overall Study|Withdrawal by Subject|2|||
129006456|NCT00814320|464314752|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
129006457|NCT00814320|464314751|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
129006458|NCT00814320|464314752|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
128670951|NCT00984620|463094562|FG000|Overall Study|reason other than listed above|0|||
128670952|NCT00984620|463094563|FG001|Overall Study|reason other than listed above|4|||
128670953|NCT01018810|463094564|FG000|Overall Study|Withdrawal by Subject|0|||
128670954|NCT01018810|463094565|FG001|Overall Study|Withdrawal by Subject|1|||
128670955|NCT01018810|463094566|FG002|Overall Study|Withdrawal by Subject|0|||
128670956|NCT01018810|463094567|FG003|Overall Study|Withdrawal by Subject|0|||
129006459|NCT00814320|464314751|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
128670957|NCT01018810|463094568|FG004|Overall Study|Withdrawal by Subject|0|||
128670958|NCT01018810|463094564|FG000|Overall Study|Sponsor Decision|2|||
128670959|NCT01018810|463094565|FG001|Overall Study|Sponsor Decision|0|||
128670960|NCT01018810|463094566|FG002|Overall Study|Sponsor Decision|1|||
128670961|NCT01018810|463094567|FG003|Overall Study|Sponsor Decision|1|||
129006460|NCT00814320|464314752|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
129006461|NCT00814320|464314751|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
129006462|NCT00814320|464314752|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
129006463|NCT00814320|464314751|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
129006464|NCT00814320|464314752|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
129006465|NCT00814320|464314751|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
129006466|NCT00814320|464314752|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
129006467|NCT00491504|464314753|FG000|Overall Study|Adverse Event|0|||
129006468|NCT00491504|464314754|FG001|Overall Study|Adverse Event|1|||
129006469|NCT00491504|464314755|FG002|Overall Study|Adverse Event|0|||
129006470|NCT00491504|464314756|FG003|Overall Study|Adverse Event|0|||
129006471|NCT00491504|464314753|FG000|Overall Study|Withdrawal by Subject|0|||
129006472|NCT00491504|464314754|FG001|Overall Study|Withdrawal by Subject|0|||
129006473|NCT00491504|464314755|FG002|Overall Study|Withdrawal by Subject|1|||
129006474|NCT00491504|464314756|FG003|Overall Study|Withdrawal by Subject|2|||
129006475|NCT00491504|464314753|FG000|Overall Study|Protocol Violation|0|||
129006476|NCT00491504|464314754|FG001|Overall Study|Protocol Violation|0|||
129006477|NCT00491504|464314755|FG002|Overall Study|Protocol Violation|3|||
128670962|NCT01018810|463094568|FG004|Overall Study|Sponsor Decision|1|||
128670963|NCT01640314|463094569|FG000|Overall Study|Protocol Violation|0|||
128670964|NCT01640314|463094570|FG001|Overall Study|Protocol Violation|1|||
128670965|NCT04450381|463094571|FG000|Overall Study|Protocol Violation|4|||
129006478|NCT00491504|464314756|FG003|Overall Study|Protocol Violation|2|||
129006479|NCT00745251|464314757|FG000|Overall Study|Adverse Event|1|||
129006480|NCT00745251|464314758|FG001|Overall Study|Adverse Event|2|||
129006481|NCT00745251|464314757|FG000|Overall Study|Withdrawal by Subject|1|||
129006482|NCT00745251|464314758|FG001|Overall Study|Withdrawal by Subject|1|||
129006483|NCT01618305|464314760|FG000|Overall Study|Death|0|||
129006484|NCT01618305|464314761|FG001|Overall Study|Death|1|||
129006485|NCT01618305|464314760|FG000|Overall Study|Lost to Follow-up|11|||
129006486|NCT01618305|464314761|FG001|Overall Study|Lost to Follow-up|7|||
129006487|NCT01618305|464314760|FG000|Overall Study|Protocol Violation|1|||
129006488|NCT01618305|464314761|FG001|Overall Study|Protocol Violation|0|||
129006489|NCT01618305|464314760|FG000|Overall Study|Withdrawal by Subject|3|||
129006490|NCT01618305|464314761|FG001|Overall Study|Withdrawal by Subject|2|||
129006491|NCT02708277|464314762|FG000|Overall Study|Lost to Follow-up|7|||
129006492|NCT02708277|464314763|FG001|Overall Study|Lost to Follow-up|4|||
129006493|NCT01960816|464314764|FG000|Overall Study|Lost to Follow-up|1|||
129006494|NCT01118728|464314765|FG000|Overall Study|Adverse Event|17|||
129006495|NCT01118728|464314765|FG000|Overall Study|Lack of Efficacy|27|||
129006496|NCT01118728|464314765|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
129006497|NCT01118728|464314765|FG000|Overall Study|Withdrawal by Subject|3|||
129006498|NCT01118728|464314765|FG000|Overall Study|Lost to Follow-up|4|||
129006499|NCT00385541|464314766|FG000|Overall Study|severe pain, clinician requested unblind|0|||
129006500|NCT00385541|464314767|FG001|Overall Study|severe pain, clinician requested unblind|1|||
129006501|NCT00929708|464314768|FG000|Overall Study|Protocol Violation|2|||
129006502|NCT00929708|464314769|FG001|Overall Study|Protocol Violation|1|||
129006503|NCT00929708|464314770|FG002|Overall Study|Protocol Violation|1|||
128670966|NCT04450381|463094571|FG000|Overall Study|Wrong device setting|2|||
128670967|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
128670968|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
128670969|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Adverse Event|7|||
128670970|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Adverse Event|6|||
128670971|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
128670972|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
128670973|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Physician Decision|4|||
128670974|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Physician Decision|4|||
128670975|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
128670976|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
128670977|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
128670978|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
128670979|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
128670980|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
128670981|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Non-compliance|1|||
128670982|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Non-compliance|0|||
128670983|NCT00470834|463094574|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
128670984|NCT00470834|463094575|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
129006504|NCT00929708|464314771|FG003|Overall Study|Protocol Violation|1|||
129006505|NCT00929708|464314772|FG004|Overall Study|Protocol Violation|1|||
129006506|NCT00929708|464314768|FG000|Overall Study|Withdrawal by Subject|2|||
129006507|NCT00929708|464314769|FG001|Overall Study|Withdrawal by Subject|0|||
129006508|NCT00929708|464314770|FG002|Overall Study|Withdrawal by Subject|0|||
129006509|NCT00929708|464314771|FG003|Overall Study|Withdrawal by Subject|2|||
129006510|NCT00929708|464314772|FG004|Overall Study|Withdrawal by Subject|1|||
129006511|NCT00929708|464314768|FG000|Overall Study|Adverse Event|0|||
128670985|NCT00470834|463094574|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
128670986|NCT00470834|463094575|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
128670987|NCT00470834|463094574|FG000|Extension Period (24 Months)|Adverse Event|3|||
128670988|NCT00470834|463094575|FG001|Extension Period (24 Months)|Adverse Event|4|||
128670989|NCT00470834|463094574|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
128670990|NCT00470834|463094575|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
128670991|NCT00470834|463094574|FG000|Extension Period (24 Months)|Physician Decision|4|||
128670992|NCT00470834|463094575|FG001|Extension Period (24 Months)|Physician Decision|3|||
128670993|NCT00470834|463094574|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
128670994|NCT00470834|463094575|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
128670995|NCT00470834|463094574|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
128670996|NCT00470834|463094575|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
128670997|NCT00470834|463094574|FG000|Extension Period (24 Months)|Non-compliance|0|||
128670998|NCT00470834|463094575|FG001|Extension Period (24 Months)|Non-compliance|1|||
128670999|NCT00470834|463094574|FG000|Extension Period (24 Months)|Disease Progression|0|||
128671000|NCT00470834|463094575|FG001|Extension Period (24 Months)|Disease Progression|1|||
128671001|NCT01989208|463094578|FG000|200 mg (7 Days)|Protocol Violation|0|||
128671002|NCT01989208|463094579|FG001|200 mg (7 Days)|Protocol Violation|1|||
128671003|NCT02872935|463094583|FG000|Overall Study|Other|0|||
128671004|NCT02872935|463094584|FG001|Overall Study|Other|1|||
128671005|NCT05405257|463094586|FG000|Overall Study|Withdrawal by Subject|1|||
128671006|NCT00246740|463094593|FG000|Initial Enrollment|Death|1|||
128671007|NCT00246740|463094594|FG001|Initial Enrollment|Death|0|||
129006512|NCT00929708|464314769|FG001|Overall Study|Adverse Event|0|||
129006513|NCT00929708|464314770|FG002|Overall Study|Adverse Event|0|||
129006514|NCT00929708|464314771|FG003|Overall Study|Adverse Event|0|||
129006515|NCT00929708|464314772|FG004|Overall Study|Adverse Event|3|||
129006516|NCT00929708|464314768|FG000|Overall Study|Physician Decision|0|||
129006517|NCT00929708|464314769|FG001|Overall Study|Physician Decision|2|||
129006518|NCT00929708|464314770|FG002|Overall Study|Physician Decision|2|||
129006519|NCT00929708|464314771|FG003|Overall Study|Physician Decision|2|||
129006520|NCT00929708|464314772|FG004|Overall Study|Physician Decision|1|||
129006521|NCT00929708|464314768|FG000|Overall Study|Lost to Follow-up|0|||
129006522|NCT00929708|464314769|FG001|Overall Study|Lost to Follow-up|0|||
129006523|NCT00929708|464314770|FG002|Overall Study|Lost to Follow-up|0|||
129006524|NCT00929708|464314771|FG003|Overall Study|Lost to Follow-up|1|||
129006525|NCT00929708|464314772|FG004|Overall Study|Lost to Follow-up|0|||
129006526|NCT01893138|464314773|FG000|Double-Blind Period|Withdrawal by Subject|1|||
129006527|NCT01893138|464314774|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129006528|NCT01893138|464314773|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
129006529|NCT01893138|464314774|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
129006530|NCT01893138|464314773|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
129006531|NCT01893138|464314774|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
129006532|NCT01893138|464314773|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
129006533|NCT01893138|464314774|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
129006534|NCT01893138|464314773|FG000|Open Label - Unblinded Period|Adverse Event|1|||
129006535|NCT01893138|464314774|FG001|Open Label - Unblinded Period|Adverse Event|0|||
129006536|NCT01628120|464316579|FG000|Overall Study|Withdrawal by Subject|7|||
129006537|NCT01628120|464316579|FG000|Overall Study|Adverse Event|12|||
129006538|NCT01628120|464316579|FG000|Overall Study|Lost to Follow-up|1|||
129006539|NCT01628120|464316579|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
129006540|NCT01628120|464316579|FG000|Overall Study|Non-compliant with Study Procedures|1|||
129006541|NCT01628120|464316579|FG000|Overall Study|Not Treated|3|||
129006542|NCT01628120|464316579|FG000|Overall Study|Sponsor Decision|5|||
129006543|NCT01628120|464316579|FG000|Overall Study|Switched Dialysis Method|2|||
129006544|NCT01628120|464316579|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
129006545|NCT01628120|464316579|FG000|Overall Study|Moved or Relocated|5|||
129006546|NCT01628120|464316579|FG000|Overall Study|Kidney Transplant|2|||
129006547|NCT01628120|464316579|FG000|Overall Study|Use of Standard of Care|1|||
128671008|NCT00246740|463094593|FG000|Initial Enrollment|Additional surgery scheduled|0|||
128671009|NCT00246740|463094594|FG001|Initial Enrollment|Additional surgery scheduled|2|||
128671010|NCT00246740|463094593|FG000|Initial Enrollment|Surgery schedule change|4|||
128671011|NCT00246740|463094594|FG001|Initial Enrollment|Surgery schedule change|4|||
129006548|NCT02295774|464316582|FG000|Overall Study|Physician Decision|1|||
129006549|NCT02295774|464316582|FG000|Overall Study|Withdrawal by Subject|2|||
129006550|NCT00586521|464316583|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
129006551|NCT02207621|464316588|FG000|Overall Study|Adverse Event|71|||
129006552|NCT02207621|464316589|FG001|Overall Study|Adverse Event|15|||
129006553|NCT02207621|464316590|FG002|Overall Study|Adverse Event|132|||
129006554|NCT02207621|464316588|FG000|Overall Study|Withdrawal by Subject|9|||
129006555|NCT02207621|464316589|FG001|Overall Study|Withdrawal by Subject|9|||
129006556|NCT02207621|464316590|FG002|Overall Study|Withdrawal by Subject|13|||
129006557|NCT02207621|464316588|FG000|Overall Study|Non-Compliant|3|||
128774788|NCT02555371|463468338|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
128671012|NCT00246740|463094593|FG000|Initial Enrollment|Other|1|||
128671013|NCT00246740|463094594|FG001|Initial Enrollment|Other|2|||
128671014|NCT02873429|463094596|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
128671015|NCT02873429|463094597|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
128671016|NCT02873429|463094596|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
128671017|NCT02873429|463094597|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
128671018|NCT02873429|463094596|FG000|16 Weeks|Lost to Follow-up|3|||
128671019|NCT02873429|463094597|FG001|16 Weeks|Lost to Follow-up|0|||
128671020|NCT00744042|463094598|FG000|Overall Study|Withdrawal by Subject|1|||
128671021|NCT03158285|463094602|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
128671022|NCT03158285|463094603|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
128671023|NCT03158285|463094604|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
128671024|NCT03158285|463094602|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
128671025|NCT03158285|463094603|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
128671026|NCT03158285|463094604|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
128671027|NCT03158285|463094602|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
128671028|NCT03158285|463094603|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
128671029|NCT03158285|463094604|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
128671030|NCT03158285|463094602|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
128671031|NCT03158285|463094603|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
128671032|NCT03158285|463094604|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
128671033|NCT03158285|463094602|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
128671034|NCT03158285|463094603|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
128671035|NCT03158285|463094604|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
128671036|NCT03158285|463094602|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
128671037|NCT03158285|463094603|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
128671038|NCT03158285|463094604|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
128671039|NCT03158285|463094602|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
128671040|NCT03158285|463094603|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
128671041|NCT03158285|463094604|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
128671042|NCT03158285|463094602|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
128671043|NCT03158285|463094603|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
128671044|NCT03158285|463094604|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
128671045|NCT03158285|463094602|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
128671046|NCT03158285|463094603|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
128671047|NCT03158285|463094604|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
128671048|NCT03158285|463094602|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
128671049|NCT03158285|463094603|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
128671050|NCT03158285|463094604|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
128671051|NCT03158285|463094602|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
128671052|NCT03158285|463094603|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
128671053|NCT03158285|463094604|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
128671054|NCT03158285|463094602|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
128671055|NCT03158285|463094603|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
128671056|NCT03158285|463094604|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
128671057|NCT03158285|463094602|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
128671058|NCT03158285|463094603|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
128671059|NCT03158285|463094604|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
128671060|NCT03158285|463094602|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
128671061|NCT03158285|463094603|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
128671062|NCT03158285|463094604|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
128671063|NCT03158285|463094602|FG000|Active Treatment Period: Week 52-100|Death|1|||
128671064|NCT03158285|463094603|FG001|Active Treatment Period: Week 52-100|Death|0|||
128671065|NCT03158285|463094604|FG002|Active Treatment Period: Week 52-100|Death|0|||
128671066|NCT03158285|463094602|FG000|Active Treatment Period: Week 52-100|Other|4|||
128671067|NCT03158285|463094603|FG001|Active Treatment Period: Week 52-100|Other|1|||
128671068|NCT03158285|463094604|FG002|Active Treatment Period: Week 52-100|Other|0|||
128671069|NCT02228980|463094605|FG000|Overall Study|Adverse Event|14|||
128671070|NCT02228980|463094606|FG001|Overall Study|Adverse Event|0|||
128671071|NCT02228980|463094607|FG002|Overall Study|Adverse Event|0|||
128671072|NCT02228980|463094608|FG003|Overall Study|Adverse Event|0|||
128671073|NCT02228980|463094605|FG000|Overall Study|Protocol Violation|7|||
128671074|NCT02228980|463094606|FG001|Overall Study|Protocol Violation|0|||
128671075|NCT02228980|463094607|FG002|Overall Study|Protocol Violation|0|||
128671076|NCT02228980|463094608|FG003|Overall Study|Protocol Violation|0|||
128671077|NCT02228980|463094605|FG000|Overall Study|Withdrawal by Subject|3|||
128671078|NCT02228980|463094606|FG001|Overall Study|Withdrawal by Subject|3|||
128671079|NCT02228980|463094607|FG002|Overall Study|Withdrawal by Subject|2|||
128671080|NCT02228980|463094608|FG003|Overall Study|Withdrawal by Subject|3|||
128671081|NCT04629066|463094609|FG000|Overall Study|Lost to Follow-up|3|||
128671082|NCT04629066|463094610|FG001|Overall Study|Lost to Follow-up|2|||
128671083|NCT00530504|463094613|FG000|Overall Study|Death|54|||
128671084|NCT00530504|463094613|FG000|Overall Study|Lost to Follow-up|26|||
128671085|NCT00530504|463094613|FG000|Overall Study|Withdrawal by Subject|39|||
128671086|NCT00530504|463094613|FG000|Overall Study|Exited study due to other reasons|33|||
128671087|NCT03952039|463094616|FG000|Overall Study|Adverse Event|22|||
128671088|NCT03952039|463094617|FG001|Overall Study|Adverse Event|8|||
128671089|NCT03952039|463094616|FG000|Overall Study|Withdrawal by Participant|17|||
128671090|NCT03952039|463094617|FG001|Overall Study|Withdrawal by Participant|12|||
128671091|NCT03952039|463094616|FG000|Overall Study|Death|13|||
128671092|NCT03952039|463094617|FG001|Overall Study|Death|6|||
128671093|NCT03952039|463094616|FG000|Overall Study|Lack of Efficacy|12|||
128671094|NCT03952039|463094617|FG001|Overall Study|Lack of Efficacy|2|||
128671095|NCT03952039|463094616|FG000|Overall Study|Physician Decision|9|||
128671096|NCT03952039|463094617|FG001|Overall Study|Physician Decision|3|||
128671097|NCT03952039|463094616|FG000|Overall Study|Progressive Disease|6|||
128671098|NCT03952039|463094617|FG001|Overall Study|Progressive Disease|4|||
128671099|NCT03952039|463094616|FG000|Overall Study|Other Reasons|12|||
128671100|NCT03952039|463094617|FG001|Overall Study|Other Reasons|4|||
128671101|NCT05009979|463094618|FG000|Overall Study|Withdrawal by Subject|1|||
128671102|NCT03844945|463096299|FG000|Overall Study|Adverse Event|1|||
128671103|NCT03844945|463096300|FG001|Overall Study|Adverse Event|1|||
128671104|NCT03844945|463096301|FG002|Overall Study|Adverse Event|4|||
128671105|NCT03844945|463096302|FG003|Overall Study|Adverse Event|0|||
128671106|NCT03844945|463096299|FG000|Overall Study|Withdrawal by Subject|0|||
128671107|NCT03844945|463096300|FG001|Overall Study|Withdrawal by Subject|0|||
128671108|NCT03844945|463096301|FG002|Overall Study|Withdrawal by Subject|1|||
128671109|NCT03844945|463096302|FG003|Overall Study|Withdrawal by Subject|0|||
128671110|NCT03844945|463096299|FG000|Overall Study|Lack of Efficacy|0|||
128671111|NCT03844945|463096300|FG001|Overall Study|Lack of Efficacy|0|||
128671112|NCT03844945|463096301|FG002|Overall Study|Lack of Efficacy|0|||
128671113|NCT03844945|463096302|FG003|Overall Study|Lack of Efficacy|1|||
128671114|NCT04473235|463096305|FG000|Overall Study|Lost to Follow-up|6|||
128671115|NCT04473235|463096306|FG001|Overall Study|Lost to Follow-up|5|||
128671116|NCT04473235|463096305|FG000|Overall Study|Declined continuation|2|||
128671117|NCT04473235|463096306|FG001|Overall Study|Declined continuation|0|||
128671118|NCT04473235|463096305|FG000|Overall Study|Physician Decision|1|||
128671119|NCT04473235|463096306|FG001|Overall Study|Physician Decision|1|||
128671120|NCT04473235|463096305|FG000|Overall Study|Protocol Violation|10|||
128671121|NCT04473235|463096306|FG001|Overall Study|Protocol Violation|6|||
128671122|NCT01754402|463096307|FG000|Overall Study|Death|0|||
128671123|NCT01754402|463096308|FG001|Overall Study|Death|0|||
128671124|NCT01754402|463096309|FG002|Overall Study|Death|1|||
128671125|NCT01754402|463096307|FG000|Overall Study|Adverse Event|2|||
128671126|NCT01754402|463096308|FG001|Overall Study|Adverse Event|2|||
128671127|NCT01754402|463096309|FG002|Overall Study|Adverse Event|1|||
128671128|NCT01754402|463096307|FG000|Overall Study|Withdrawal by Subject|0|||
128671129|NCT01754402|463096308|FG001|Overall Study|Withdrawal by Subject|0|||
128671130|NCT01754402|463096309|FG002|Overall Study|Withdrawal by Subject|1|||
128671131|NCT01754402|463096307|FG000|Overall Study|Lack of Efficacy|0|||
128671132|NCT01754402|463096308|FG001|Overall Study|Lack of Efficacy|0|||
128671133|NCT01754402|463096309|FG002|Overall Study|Lack of Efficacy|1|||
128671134|NCT01282463|463096310|FG000|Overall Study|Lost to Follow-up|1|||
128671135|NCT01282463|463096311|FG001|Overall Study|Lost to Follow-up|0|||
128671136|NCT01282463|463096312|FG002|Overall Study|Lost to Follow-up|0|||
128671137|NCT01282463|463096310|FG000|Overall Study|Withdrawal by Subject|6|||
128671138|NCT01282463|463096311|FG001|Overall Study|Withdrawal by Subject|2|||
128671139|NCT01282463|463096312|FG002|Overall Study|Withdrawal by Subject|3|||
128671140|NCT01282463|463096310|FG000|Overall Study|"Never Treated Death"|0|||
128671141|NCT01282463|463096311|FG001|Overall Study|"Never Treated Death"|1|||
128671142|NCT01282463|463096312|FG002|Overall Study|"Never Treated Death"|0|||
128671143|NCT01282463|463096310|FG000|Overall Study|"Never Treated PD"|0|||
129006558|NCT02207621|464316589|FG001|Overall Study|Non-Compliant|3|||
129006559|NCT02207621|464316590|FG002|Overall Study|Non-Compliant|1|||
128671144|NCT01282463|463096311|FG001|Overall Study|"Never Treated PD"|1|||
128671145|NCT01282463|463096312|FG002|Overall Study|"Never Treated PD"|0|||
128671146|NCT01282463|463096310|FG000|Overall Study|Protocol Violation|0|||
128671147|NCT01282463|463096311|FG001|Overall Study|Protocol Violation|0|||
128671148|NCT01282463|463096312|FG002|Overall Study|Protocol Violation|1|||
128671149|NCT01282463|463096310|FG000|Overall Study|Physician Decision|1|||
128671150|NCT01282463|463096311|FG001|Overall Study|Physician Decision|0|||
128671151|NCT01282463|463096312|FG002|Overall Study|Physician Decision|0|||
128671152|NCT02051933|463096315|FG000|Overall Study|Physician Decision|0|||
128671153|NCT02051933|463096316|FG001|Overall Study|Physician Decision|1|||
128671154|NCT01221285|463096317|FG000|Overall Study|Withdrawal by Subject|1|||
128671155|NCT00588861|463096321|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
128671156|NCT00588861|463096322|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
128671157|NCT00588861|463096321|FG000|6 Months|Patients did not return for follow-up|98|||
128671158|NCT00588861|463096322|FG001|6 Months|Patients did not return for follow-up|73|||
128671159|NCT00588861|463096321|FG000|1 Year|Patients did not return for follow-up|89|||
128671160|NCT00588861|463096322|FG001|1 Year|Patients did not return for follow-up|82|||
128671161|NCT00588861|463096321|FG000|2 Years|Patients did not return for follow-up|92|||
128671162|NCT00588861|463096322|FG001|2 Years|Patients did not return for follow-up|87|||
128671163|NCT00588861|463096321|FG000|4 Years|Patients did not return for follow-up|91|||
128671164|NCT00588861|463096322|FG001|4 Years|Patients did not return for follow-up|103|||
128671165|NCT00588861|463096321|FG000|6 Years|Patients did not return for follow-up|104|||
128671166|NCT00588861|463096322|FG001|6 Years|Patients did not return for follow-up|109|||
128671167|NCT00588861|463096321|FG000|8 Years|Patients did not return for follow-up|105|||
128671168|NCT00588861|463096322|FG001|8 Years|Patients did not return for follow-up|114|||
128671169|NCT00588861|463096321|FG000|10 Years|Incomplete due to study termination|107|||
128671170|NCT00588861|463096322|FG001|10 Years|Incomplete due to study termination|114|||
128671171|NCT01239992|463096323|FG000|Overall Study|Withdrawal by Subject|2|||
128671172|NCT02848729|463096326|FG000|Overall Study|Withdrawal by Subject|1|||
128671173|NCT02848729|463096327|FG001|Overall Study|Withdrawal by Subject|0|||
128671174|NCT02848729|463096326|FG000|Overall Study|Emesis|15|||
128671175|NCT02848729|463096327|FG001|Overall Study|Emesis|11|||
128671176|NCT00791076|463096328|FG000|Overall Study|Study was terminated,PI left institution|8|||
128671177|NCT03319745|463096332|FG000|Overall Study|Death|1|||
128671178|NCT03319745|463096332|FG000|Overall Study|Toxicity Precluding Surgery|1|||
128671179|NCT01317550|463096333|FG000|Overall Study|Withdrawal by Subject|1|||
128671180|NCT01317550|463096334|FG001|Overall Study|Withdrawal by Subject|0|||
128671181|NCT01317550|463096335|FG002|Overall Study|Withdrawal by Subject|0|||
128671182|NCT01317550|463096336|FG003|Overall Study|Withdrawal by Subject|0|||
128671183|NCT01317550|463096333|FG000|Overall Study|Lack of compliance study med|1|||
128671184|NCT01317550|463096334|FG001|Overall Study|Lack of compliance study med|0|||
128671185|NCT01317550|463096335|FG002|Overall Study|Lack of compliance study med|0|||
128671186|NCT01317550|463096336|FG003|Overall Study|Lack of compliance study med|0|||
128671187|NCT03179202|463096337|FG000|Overall Study|Screen Failure|67|||
128671188|NCT03179202|463096337|FG000|Overall Study|Subject Lost to Follow Up|12|||
128671189|NCT03179202|463096337|FG000|Overall Study|Withdrawal by Subject|7|||
128671190|NCT03179202|463096337|FG000|Overall Study|Adverse Event|3|||
128671191|NCT03179202|463096337|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
128671192|NCT03179202|463096337|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
128671193|NCT03255629|463096338|FG000|Overall Study|Adverse Event|1|||
128671194|NCT03255629|463096339|FG001|Overall Study|Adverse Event|0|||
128671195|NCT03255629|463096338|FG000|Overall Study|did not experience hypoglycemia|2|||
128671196|NCT03255629|463096339|FG001|Overall Study|did not experience hypoglycemia|1|||
128671197|NCT01024309|463096340|FG000|Overall Study|Physician Decision|4|||
128671198|NCT01024309|463096341|FG001|Overall Study|Physician Decision|0|||
128671199|NCT01024309|463096340|FG000|Overall Study|Withdrawal by Subject|4|||
128671200|NCT01024309|463096341|FG001|Overall Study|Withdrawal by Subject|4|||
128671201|NCT05194579|463096344|FG000|Overall Study|Lost to Follow-up|2|||
129006560|NCT02207621|464316588|FG000|Overall Study|Lost to Follow-up|1|||
129006561|NCT02207621|464316589|FG001|Overall Study|Lost to Follow-up|0|||
129006562|NCT02207621|464316590|FG002|Overall Study|Lost to Follow-up|3|||
129006563|NCT02207621|464316588|FG000|Overall Study|Lack of Efficacy|10|||
129006564|NCT02207621|464316589|FG001|Overall Study|Lack of Efficacy|2|||
129006565|NCT02207621|464316590|FG002|Overall Study|Lack of Efficacy|4|||
129006566|NCT02207621|464316588|FG000|Overall Study|Disallowed Concurrent Medication|2|||
129006567|NCT02207621|464316589|FG001|Overall Study|Disallowed Concurrent Medication|5|||
129006568|NCT02207621|464316590|FG002|Overall Study|Disallowed Concurrent Medication|2|||
129006569|NCT02207621|464316588|FG000|Overall Study|Physician Decision|1|||
129006570|NCT02207621|464316589|FG001|Overall Study|Physician Decision|2|||
129006571|NCT02207621|464316590|FG002|Overall Study|Physician Decision|2|||
129006572|NCT02207621|464316588|FG000|Overall Study|Protocol Violation|4|||
129006573|NCT02207621|464316589|FG001|Overall Study|Protocol Violation|10|||
129006574|NCT02207621|464316590|FG002|Overall Study|Protocol Violation|6|||
129006575|NCT02207621|464316588|FG000|Overall Study|Death|2|||
129006576|NCT02207621|464316589|FG001|Overall Study|Death|0|||
129006577|NCT02207621|464316590|FG002|Overall Study|Death|0|||
129006578|NCT02207621|464316588|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
129006579|NCT02207621|464316589|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
129006580|NCT02207621|464316590|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
128671202|NCT05194579|463096345|FG001|Overall Study|Lost to Follow-up|3|||
128671203|NCT05194579|463096344|FG000|Overall Study|Withdrawal by Subject|3|||
128671204|NCT05194579|463096345|FG001|Overall Study|Withdrawal by Subject|4|||
129006581|NCT02173704|464316591|FG000|Overall Study|Adverse Event|1|||
129006582|NCT02173704|464316592|FG001|Overall Study|Adverse Event|0|||
129006583|NCT02173704|464316591|FG000|Overall Study|Lost to Follow-up|1|||
129006584|NCT02173704|464316592|FG001|Overall Study|Lost to Follow-up|0|||
129006585|NCT02173704|464316591|FG000|Overall Study|Other|1|||
129006586|NCT02173704|464316592|FG001|Overall Study|Other|0|||
129006587|NCT02173704|464316591|FG000|Overall Study|Protocol Violation|1|||
129006588|NCT02173704|464316592|FG001|Overall Study|Protocol Violation|0|||
129006589|NCT02173704|464316591|FG000|Overall Study|Withdrawal by Subject|9|||
128671205|NCT05194579|463096344|FG000|Overall Study|Refused further study procedures|0|||
128671206|NCT05194579|463096345|FG001|Overall Study|Refused further study procedures|1|||
128671207|NCT05194579|463096344|FG000|Overall Study|Protocol deviation|1|||
128671208|NCT05194579|463096345|FG001|Overall Study|Protocol deviation|0|||
128671209|NCT01639729|463096346|FG000|Overall Study|Withdrawal by Subject|1|||
128671210|NCT01639729|463096347|FG001|Overall Study|Withdrawal by Subject|0|||
128671211|NCT01639729|463096348|FG002|Overall Study|Withdrawal by Subject|1|||
128671212|NCT01639729|463096349|FG003|Overall Study|Withdrawal by Subject|1|||
128671213|NCT01639729|463096350|FG004|Overall Study|Withdrawal by Subject|0|||
128671214|NCT01639729|463096351|FG005|Overall Study|Withdrawal by Subject|0|||
128671215|NCT00567255|463096355|FG000|Overall Study|Adverse Event|241|||
128671216|NCT00567255|463096356|FG001|Overall Study|Adverse Event|68|||
128671217|NCT00567255|463096355|FG000|Overall Study|Lost to Follow-up|77|||
128671218|NCT00567255|463096356|FG001|Overall Study|Lost to Follow-up|48|||
128671219|NCT00567255|463096355|FG000|Overall Study|Withdrawal by Subject|75|||
128671220|NCT00567255|463096356|FG001|Overall Study|Withdrawal by Subject|56|||
128671221|NCT00567255|463096355|FG000|Overall Study|Lack of Efficacy|19|||
128671222|NCT00567255|463096356|FG001|Overall Study|Lack of Efficacy|33|||
128671223|NCT00567255|463096355|FG000|Overall Study|Protocol Violation|20|||
128671224|NCT00567255|463096356|FG001|Overall Study|Protocol Violation|8|||
128671225|NCT00567255|463096355|FG000|Overall Study|Pregnancy|6|||
128671226|NCT00567255|463096356|FG001|Overall Study|Pregnancy|0|||
128671227|NCT00567255|463096355|FG000|Overall Study|Drug noncompliance,moved,other|25|||
128671228|NCT00567255|463096356|FG001|Overall Study|Drug noncompliance,moved,other|15|||
128671229|NCT03083990|463096361|FG000|Overall Study|Adverse Event|1|||
128671230|NCT03083990|463096362|FG001|Overall Study|Adverse Event|0|||
128671231|NCT04975438|463096363|FG000|Overall Study|Lost to Follow-up|1|||
128671232|NCT04975438|463096364|FG001|Overall Study|Lost to Follow-up|0|||
128671233|NCT04975438|463096365|FG002|Overall Study|Lost to Follow-up|1|||
128671234|NCT04975438|463096366|FG003|Overall Study|Lost to Follow-up|0|||
128671235|NCT04975438|463096363|FG000|Overall Study|Withdrawal by Subject|1|||
128671236|NCT04975438|463096364|FG001|Overall Study|Withdrawal by Subject|0|||
128671237|NCT04975438|463096365|FG002|Overall Study|Withdrawal by Subject|0|||
128671238|NCT04975438|463096366|FG003|Overall Study|Withdrawal by Subject|0|||
128671239|NCT01950013|463096372|FG000|Overall Study|Withdrawal by Subject|0|||
128671240|NCT01950013|463096373|FG001|Overall Study|Withdrawal by Subject|2|||
128671241|NCT01950013|463096374|FG002|Overall Study|Withdrawal by Subject|0|||
128671242|NCT03091348|463096377|FG000|Overall Study|Lost to Follow-up|2|||
128671243|NCT03091348|463096378|FG001|Overall Study|Lost to Follow-up|1|||
128671244|NCT00706342|463096379|FG000|Overall Study|Adverse Event|3|||
128671245|NCT00706342|463096379|FG000|Overall Study|Not responding to treatment|2|||
128671246|NCT00706342|463096379|FG000|Overall Study|Withdrawn due to failure to respond|1|||
128671247|NCT00706342|463096379|FG000|Overall Study|Death|1|||
128671248|NCT00706342|463096379|FG000|Overall Study|Withdrew from the study on his own.|1|||
128671249|NCT00706342|463096379|FG000|Overall Study|Investigator discretion|2|||
128671250|NCT00706342|463096379|FG000|Overall Study|Non-responder Week 12|1|||
128671251|NCT00706342|463096379|FG000|Overall Study|Ongoing|6|||
128671252|NCT00706342|463096379|FG000|Overall Study|WIthdrawal of consent|1|||
128671253|NCT01419197|463096384|FG000|Overall Study|Death|247|||
129006590|NCT02173704|464316592|FG001|Overall Study|Withdrawal by Subject|4|||
129006591|NCT00419926|464316593|FG000|Overall Study|Withdrawal by Subject|7|||
129006592|NCT00419926|464316594|FG001|Overall Study|Withdrawal by Subject|3|||
129006593|NCT00419926|464316593|FG000|Overall Study|Administrative Problem|4|||
129006594|NCT00419926|464316594|FG001|Overall Study|Administrative Problem|4|||
129006595|NCT00419926|464316593|FG000|Overall Study|Lost to Follow-up|1|||
129006596|NCT00419926|464316594|FG001|Overall Study|Lost to Follow-up|2|||
129006597|NCT00419926|464316593|FG000|Overall Study|Death|2|||
129006598|NCT00419926|464316594|FG001|Overall Study|Death|1|||
129006599|NCT02374918|464316599|FG000|Overall Study|Protocol Violation|2|||
129006600|NCT02374918|464316600|FG001|Overall Study|Protocol Violation|0|||
129006601|NCT02374918|464316601|FG002|Overall Study|Protocol Violation|2|||
129006602|NCT02374918|464316602|FG003|Overall Study|Protocol Violation|1|||
129006603|NCT02374918|464316599|FG000|Overall Study|Withdrawal by Subject|1|||
129006604|NCT02374918|464316600|FG001|Overall Study|Withdrawal by Subject|1|||
129006605|NCT02374918|464316601|FG002|Overall Study|Withdrawal by Subject|1|||
129006606|NCT02374918|464316602|FG003|Overall Study|Withdrawal by Subject|0|||
128671254|NCT01419197|463096385|FG001|Overall Study|Death|122|||
129006607|NCT02374918|464316599|FG000|Overall Study|Lack of Efficacy|0|||
129006608|NCT02374918|464316600|FG001|Overall Study|Lack of Efficacy|0|||
129006609|NCT02374918|464316601|FG002|Overall Study|Lack of Efficacy|1|||
128671255|NCT01419197|463096384|FG000|Overall Study|Physician Decision|4|||
129006610|NCT02374918|464316602|FG003|Overall Study|Lack of Efficacy|1|||
129006611|NCT01180244|464316603|FG000|Overall Study|Lack of Efficacy|0|||
129006612|NCT01180244|464316604|FG001|Overall Study|Lack of Efficacy|7|||
128671256|NCT01419197|463096385|FG001|Overall Study|Physician Decision|4|||
128671257|NCT01419197|463096384|FG000|Overall Study|Non-compliance|3|||
128671258|NCT01419197|463096385|FG001|Overall Study|Non-compliance|1|||
129006613|NCT01180244|464316603|FG000|Overall Study|Physician Decision|3|||
129006614|NCT01180244|464316604|FG001|Overall Study|Physician Decision|0|||
129006615|NCT01180244|464316603|FG000|Overall Study|Adverse Event|1|||
129006616|NCT01180244|464316604|FG001|Overall Study|Adverse Event|0|||
129006617|NCT01180244|464316603|FG000|Overall Study|Withdrawal by Subject|0|||
129006618|NCT01180244|464316604|FG001|Overall Study|Withdrawal by Subject|1|||
129006619|NCT01180244|464316603|FG000|Overall Study|Protocol Violation|1|||
129006620|NCT01180244|464316604|FG001|Overall Study|Protocol Violation|0|||
129006621|NCT01180244|464316603|FG000|Overall Study|Lost to Follow-up|1|||
129006622|NCT01180244|464316604|FG001|Overall Study|Lost to Follow-up|0|||
129006623|NCT00729859|464316605|FG000|Overall Study|Adverse Event|0|||
129006624|NCT00729859|464316606|FG001|Overall Study|Adverse Event|1|||
129006625|NCT00729859|464316607|FG002|Overall Study|Adverse Event|0|||
129006626|NCT00729859|464316605|FG000|Overall Study|Withdrawal by Subject|0|||
129006627|NCT00729859|464316606|FG001|Overall Study|Withdrawal by Subject|1|||
129006628|NCT00729859|464316607|FG002|Overall Study|Withdrawal by Subject|0|||
129006629|NCT02623829|464316610|FG000|Overall Study|Lost to Follow-up|1|||
129006630|NCT02623829|464316611|FG001|Overall Study|Lost to Follow-up|1|||
129006631|NCT03349333|464316612|FG000|Overall Study|Progression of Disease|36|||
129006632|NCT03349333|464316612|FG000|Overall Study|Adverse Event|11|||
129006633|NCT03349333|464316612|FG000|Overall Study|Other|6|||
129006634|NCT03349333|464316612|FG000|Overall Study|Withdrawal by Subject|5|||
129006635|NCT03349333|464316612|FG000|Overall Study|Conditions interfere with participation|2|||
129006636|NCT03349333|464316612|FG000|Overall Study|Physician Decision|2|||
129006637|NCT03349333|464316612|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
129006638|NCT03349333|464316612|FG000|Overall Study|Patients in treatment less than 24 month|8|||
129006639|NCT00783796|464316613|FG000|Overall Study|Did not receive any stent|4|||
129006640|NCT00783796|464316613|FG000|Overall Study|Received non-XIENCE V stent|1|||
129006641|NCT00783796|464316613|FG000|Overall Study|Received commercial XIENCE V stent|1|||
129006642|NCT03267264|464316615|FG000|Overall Study|Withdrawal by Subject|1|||
129006643|NCT03267264|464316616|FG001|Overall Study|Withdrawal by Subject|0|||
129006644|NCT03267264|464316617|FG002|Overall Study|Withdrawal by Subject|2|||
128671259|NCT01419197|463096384|FG000|Overall Study|Withdrawal by Subject|33|||
128671260|NCT01419197|463096385|FG001|Overall Study|Withdrawal by Subject|32|||
128671261|NCT01419197|463096384|FG000|Overall Study|Study Completed by Sponsor|103|||
128671262|NCT01419197|463096385|FG001|Overall Study|Study Completed by Sponsor|34|||
128671263|NCT01419197|463096384|FG000|Overall Study|Reason Not Specified|0|||
128671264|NCT01419197|463096385|FG001|Overall Study|Reason Not Specified|1|||
128671265|NCT01419197|463096384|FG000|Overall Study|Lost to Follow-up|14|||
128671266|NCT01419197|463096385|FG001|Overall Study|Lost to Follow-up|4|||
128671267|NCT00146848|463096389|FG000|Pre-randomization|Death|19|||
128671268|NCT00146848|463096390|FG001|Pre-randomization|Death|0|||
128671269|NCT00146848|463096391|FG002|Pre-randomization|Death|0|||
128671270|NCT00146848|463096389|FG000|Pre-randomization|Lost to Follow-up|70|||
128671271|NCT00146848|463096390|FG001|Pre-randomization|Lost to Follow-up|0|||
128671272|NCT00146848|463096391|FG002|Pre-randomization|Lost to Follow-up|0|||
128671273|NCT00146848|463096389|FG000|Pre-randomization|Physician Decision|8|||
128671274|NCT00146848|463096390|FG001|Pre-randomization|Physician Decision|0|||
129006645|NCT03267264|464316618|FG003|Overall Study|Withdrawal by Subject|4|||
129006646|NCT01766921|464316619|FG000|Overall Study|Administrative Reason|5|||
129006647|NCT01766921|464316620|FG001|Overall Study|Administrative Reason|5|||
129006648|NCT01766921|464316619|FG000|Overall Study|Death|1|||
129006649|NCT01766921|464316620|FG001|Overall Study|Death|1|||
129006650|NCT01766921|464316619|FG000|Overall Study|Lost to Follow-up|1|||
129006651|NCT01766921|464316620|FG001|Overall Study|Lost to Follow-up|3|||
129006652|NCT01766921|464316619|FG000|Overall Study|Unclassified|2|||
129006653|NCT01766921|464316620|FG001|Overall Study|Unclassified|2|||
129006654|NCT01766921|464316619|FG000|Overall Study|Protocol Violation|1|||
129006655|NCT01766921|464316620|FG001|Overall Study|Protocol Violation|1|||
129006656|NCT01766921|464316619|FG000|Overall Study|Withdrawal by Subject|14|||
129006657|NCT01766921|464316620|FG001|Overall Study|Withdrawal by Subject|5|||
129006658|NCT01659567|464316623|FG000|Overall Study|Lack of Efficacy|22|||
129006659|NCT01659567|464316623|FG000|Overall Study|Switched to Pegferon|6|||
129006660|NCT01659567|464316623|FG000|Overall Study|Adverse Event|12|||
128671275|NCT00146848|463096391|FG002|Pre-randomization|Physician Decision|0|||
128878393|NCT01590082|463848470|FG001|Overall Study|Withdrawal by Subject|0|||
129006661|NCT01659567|464316623|FG000|Overall Study|Good result at early stage of treatment|5|||
129006662|NCT01659567|464316623|FG000|Overall Study|Withdrawal by Subject|64|||
129006663|NCT01659567|464316623|FG000|Overall Study|Progression of the main disease|1|||
128671276|NCT00146848|463096389|FG000|Pre-randomization|Protocol Violation|172|||
128671277|NCT00146848|463096390|FG001|Pre-randomization|Protocol Violation|0|||
129006664|NCT01659567|464316623|FG000|Overall Study|Other|13|||
129006665|NCT03019965|464316624|FG000|Overall Study|Withdrawal by Subject|1|||
129006666|NCT03019965|464316625|FG001|Overall Study|Withdrawal by Subject|0|||
129006667|NCT03019965|464316624|FG000|Overall Study|Protocol Violation|1|||
129006668|NCT03019965|464316625|FG001|Overall Study|Protocol Violation|3|||
129006669|NCT03019965|464316624|FG000|Overall Study|viral or fungal infection|3|||
129006670|NCT03019965|464316625|FG001|Overall Study|viral or fungal infection|4|||
128878394|NCT01590082|463848469|FG000|Overall Study|Ineligible|1|||
129215073|NCT02760498|465089438|FG002|Overall Study|Physician Decision|1|||
128671278|NCT00146848|463096391|FG002|Pre-randomization|Protocol Violation|0|||
128671279|NCT00146848|463096389|FG000|Pre-randomization|Withdrawal by Subject|40|||
128671280|NCT00146848|463096390|FG001|Pre-randomization|Withdrawal by Subject|0|||
128671281|NCT00146848|463096391|FG002|Pre-randomization|Withdrawal by Subject|0|||
128671282|NCT00146848|463096389|FG000|Post-randomization|Lost to Follow-up|12|||
128671283|NCT00146848|463096390|FG001|Post-randomization|Lost to Follow-up|15|||
128671284|NCT00146848|463096391|FG002|Post-randomization|Lost to Follow-up|12|||
128671285|NCT00146848|463096389|FG000|Post-randomization|Withdrawn|26|||
128671286|NCT00146848|463096390|FG001|Post-randomization|Withdrawn|32|||
128671287|NCT00146848|463096391|FG002|Post-randomization|Withdrawn|27|||
128671288|NCT01798849|463096392|FG000|Overall Study|Physician Decision|0|||
128671289|NCT01798849|463096393|FG001|Overall Study|Physician Decision|0|||
128671290|NCT01798849|463096394|FG002|Overall Study|Physician Decision|1|||
128671291|NCT04556383|463096395|FG000|PCP|Lack of Efficacy|28|||
128671292|NCT04556383|463096396|FG001|PCP|Lack of Efficacy|23|||
128671293|NCT04556383|463096397|FG002|PCP|Lack of Efficacy|23|||
128878395|NCT01590082|463848470|FG001|Overall Study|Ineligible|0|||
129006671|NCT03019965|464316624|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
129006672|NCT03019965|464316625|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
129006673|NCT03019965|464316624|FG000|Overall Study|Physician Decision|1|||
129006674|NCT03019965|464316625|FG001|Overall Study|Physician Decision|1|||
129006675|NCT01915732|464316626|FG000|Overall Study|Withdrawal by Subject|18|||
129006676|NCT01915732|464316627|FG001|Overall Study|Withdrawal by Subject|18|||
129006677|NCT01915732|464316626|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
129006678|NCT01915732|464316627|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129006679|NCT01915732|464316626|FG000|Overall Study|Adverse Event|12|||
129006680|NCT01915732|464316627|FG001|Overall Study|Adverse Event|4|||
129006681|NCT01915732|464316626|FG000|Overall Study|Protocol Violation|5|||
129006682|NCT01915732|464316627|FG001|Overall Study|Protocol Violation|5|||
129006683|NCT01915732|464316626|FG000|Overall Study|Lack of Efficacy|6|||
129006684|NCT01915732|464316627|FG001|Overall Study|Lack of Efficacy|11|||
129006685|NCT01915732|464316626|FG000|Overall Study|Lost to Follow-up|22|||
129006686|NCT01915732|464316627|FG001|Overall Study|Lost to Follow-up|26|||
129006687|NCT01915732|464316626|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
129006688|NCT01915732|464316627|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
129006689|NCT01915732|464316626|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
129006690|NCT01915732|464316627|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
129006691|NCT01915732|464316626|FG000|Overall Study|Drug Release Error|1|||
129006692|NCT01915732|464316627|FG001|Overall Study|Drug Release Error|0|||
129006693|NCT01915732|464316626|FG000|Overall Study|Recovered|1|||
129006694|NCT01915732|464316627|FG001|Overall Study|Recovered|0|||
129006695|NCT01915732|464316626|FG000|Overall Study|Pregnancy|1|||
129006696|NCT01915732|464316627|FG001|Overall Study|Pregnancy|0|||
129006697|NCT01915732|464316626|FG000|Overall Study|Poor Perceived Efficacy|1|||
129006698|NCT01915732|464316627|FG001|Overall Study|Poor Perceived Efficacy|0|||
129006699|NCT01915732|464316626|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
129006700|NCT01915732|464316627|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
129006701|NCT01915732|464316626|FG000|Overall Study|Got Well|0|||
129006702|NCT01915732|464316627|FG001|Overall Study|Got Well|1|||
129006703|NCT01915732|464316626|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
129006704|NCT01915732|464316627|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
129006705|NCT01915732|464316626|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
129006706|NCT01915732|464316627|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
129006707|NCT01915732|464316626|FG000|Overall Study|Job Transfer|0|||
129006708|NCT01915732|464316627|FG001|Overall Study|Job Transfer|1|||
129006709|NCT01915732|464316626|FG000|Overall Study|Improper Facial Procedure|0|||
129006710|NCT01915732|464316627|FG001|Overall Study|Improper Facial Procedure|1|||
129006711|NCT01915732|464316626|FG000|Overall Study|Poor Conscious Effect|0|||
129006712|NCT01915732|464316627|FG001|Overall Study|Poor Conscious Effect|1|||
129006713|NCT00299156|464316630|FG000|Period 2 (Randomized)|Screen Failure|0|||
129006714|NCT00299156|464316631|FG001|Period 2 (Randomized)|Screen Failure|1|||
129006715|NCT00299156|464316632|FG002|Period 2 (Randomized)|Screen Failure|0|||
129006716|NCT01166568|464316644|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
129006717|NCT01166568|464316645|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
129006718|NCT01166568|464316646|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
129006719|NCT01166568|464316644|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
129006720|NCT01166568|464316645|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
129006721|NCT01166568|464316646|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
129006722|NCT01166568|464316644|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
129006723|NCT01166568|464316645|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
129006724|NCT01166568|464316646|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
128671294|NCT04556383|463096398|FG003|PCP|Lack of Efficacy|0|||
128671295|NCT04556383|463096395|FG000|PCP|Study terminated by sponsor|15|||
128671296|NCT04556383|463096396|FG001|PCP|Study terminated by sponsor|13|||
128671297|NCT04556383|463096397|FG002|PCP|Study terminated by sponsor|16|||
128671298|NCT04556383|463096398|FG003|PCP|Study terminated by sponsor|0|||
128671299|NCT04556383|463096395|FG000|PCP|Withdrawal by Subject|8|||
128671300|NCT04556383|463096396|FG001|PCP|Withdrawal by Subject|6|||
128671301|NCT04556383|463096397|FG002|PCP|Withdrawal by Subject|6|||
128671302|NCT04556383|463096398|FG003|PCP|Withdrawal by Subject|0|||
128671303|NCT04556383|463096395|FG000|PCP|Adverse Event|1|||
128671304|NCT04556383|463096396|FG001|PCP|Adverse Event|7|||
129006725|NCT01654380|464316647|FG000|Part B, Period 1|Physician Decision|0|||
129006726|NCT01654380|464316648|FG001|Part B, Period 1|Physician Decision|0|||
129006727|NCT01654380|464316649|FG002|Part B, Period 1|Physician Decision|1|||
128671305|NCT04556383|463096397|FG002|PCP|Adverse Event|7|||
128671306|NCT04556383|463096398|FG003|PCP|Adverse Event|0|||
128671307|NCT04556383|463096395|FG000|PCP|Other, Not Specified|1|||
128671308|NCT04556383|463096396|FG001|PCP|Other, Not Specified|2|||
128671309|NCT04556383|463096397|FG002|PCP|Other, Not Specified|1|||
128671310|NCT04556383|463096398|FG003|PCP|Other, Not Specified|0|||
128671311|NCT04556383|463096395|FG000|PCP|Protocol Violation|1|||
128671312|NCT04556383|463096396|FG001|PCP|Protocol Violation|0|||
128671313|NCT04556383|463096397|FG002|PCP|Protocol Violation|1|||
128671314|NCT04556383|463096398|FG003|PCP|Protocol Violation|0|||
128671315|NCT04556383|463096395|FG000|PCP|Lost to Follow-up|1|||
128671316|NCT04556383|463096396|FG001|PCP|Lost to Follow-up|0|||
128671317|NCT04556383|463096397|FG002|PCP|Lost to Follow-up|0|||
128671318|NCT04556383|463096398|FG003|PCP|Lost to Follow-up|0|||
128671319|NCT04556383|463096395|FG000|PCP|Physician Decision|0|||
128671320|NCT04556383|463096396|FG001|PCP|Physician Decision|1|||
128671321|NCT04556383|463096397|FG002|PCP|Physician Decision|0|||
128671322|NCT04556383|463096398|FG003|PCP|Physician Decision|0|||
128671323|NCT04556383|463096395|FG000|PCP|Site terminated by sponsor|0|||
128671324|NCT04556383|463096396|FG001|PCP|Site terminated by sponsor|1|||
128671325|NCT04556383|463096397|FG002|PCP|Site terminated by sponsor|0|||
128671326|NCT04556383|463096398|FG003|PCP|Site terminated by sponsor|0|||
128671327|NCT04556383|463096395|FG000|OLE|Study terminated by sponsor|0|||
128671328|NCT04556383|463096396|FG001|OLE|Study terminated by sponsor|0|||
128671329|NCT04556383|463096397|FG002|OLE|Study terminated by sponsor|0|||
128671330|NCT04556383|463096398|FG003|OLE|Study terminated by sponsor|68|||
128671331|NCT04556383|463096395|FG000|OLE|Withdrawal by Subject|0|||
128671332|NCT04556383|463096396|FG001|OLE|Withdrawal by Subject|0|||
128671333|NCT04556383|463096397|FG002|OLE|Withdrawal by Subject|0|||
128671334|NCT04556383|463096398|FG003|OLE|Withdrawal by Subject|10|||
128671335|NCT04556383|463096395|FG000|OLE|Lack of Efficacy|0|||
128671336|NCT04556383|463096396|FG001|OLE|Lack of Efficacy|0|||
128671337|NCT04556383|463096397|FG002|OLE|Lack of Efficacy|0|||
128671338|NCT04556383|463096398|FG003|OLE|Lack of Efficacy|7|||
128671339|NCT04556383|463096395|FG000|OLE|Adverse Event|0|||
128671340|NCT04556383|463096396|FG001|OLE|Adverse Event|0|||
128671341|NCT04556383|463096397|FG002|OLE|Adverse Event|0|||
128671342|NCT04556383|463096398|FG003|OLE|Adverse Event|2|||
128671343|NCT04556383|463096395|FG000|OLE|Other, Not Specified|0|||
128671344|NCT04556383|463096396|FG001|OLE|Other, Not Specified|0|||
128671345|NCT04556383|463096397|FG002|OLE|Other, Not Specified|0|||
128671346|NCT04556383|463096398|FG003|OLE|Other, Not Specified|2|||
128671347|NCT04556383|463096395|FG000|OLE|Death|0|||
128671348|NCT04556383|463096396|FG001|OLE|Death|0|||
128671349|NCT04556383|463096397|FG002|OLE|Death|0|||
128671350|NCT04556383|463096398|FG003|OLE|Death|1|||
128671351|NCT04556383|463096395|FG000|OLE|Lost to Follow-up|0|||
128671352|NCT04556383|463096396|FG001|OLE|Lost to Follow-up|0|||
128671353|NCT04556383|463096397|FG002|OLE|Lost to Follow-up|0|||
129006728|NCT01654380|464316650|FG003|Part B, Period 1|Physician Decision|0|||
129006729|NCT00684671|464316651|FG000|Overall Study|Adverse Event|1|||
129006730|NCT00684671|464316652|FG001|Overall Study|Adverse Event|0|||
129006731|NCT00684671|464316653|FG002|Overall Study|Adverse Event|0|||
128671354|NCT04556383|463096398|FG003|OLE|Lost to Follow-up|1|||
128671355|NCT00119678|463096404|FG000|Double-blind Treatment Period|Death|1|||
128671356|NCT00119678|463096405|FG001|Double-blind Treatment Period|Death|0|||
128671357|NCT00119678|463096404|FG000|Double-blind Treatment Period|Adverse Event|7|||
128671358|NCT00119678|463096405|FG001|Double-blind Treatment Period|Adverse Event|1|||
128671359|NCT00119678|463096404|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
128671360|NCT00119678|463096405|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
128671361|NCT00119678|463096404|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
128671362|NCT00119678|463096405|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
128671363|NCT00119678|463096404|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
128671364|NCT00119678|463096405|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
128671365|NCT00119678|463096404|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
129006732|NCT00684671|464316651|FG000|Overall Study|Lost to Follow-up|1|||
128671366|NCT00119678|463096405|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
128671367|NCT00119678|463096404|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
128671368|NCT00119678|463096405|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
128671369|NCT00119678|463096404|FG000|Double-blind Treatment Period|Pregnancy|0|||
128671370|NCT00119678|463096405|FG001|Double-blind Treatment Period|Pregnancy|2|||
128671371|NCT00119678|463096404|FG000|Double-blind Treatment Period|Not treated|1|||
129006733|NCT00684671|464316652|FG001|Overall Study|Lost to Follow-up|0|||
128671372|NCT00119678|463096405|FG001|Double-blind Treatment Period|Not treated|2|||
128671373|NCT00119678|463096404|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
128671374|NCT00119678|463096405|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
128671375|NCT00119678|463096404|FG000|Open-label Treatment Period|Death|1|||
128671376|NCT00119678|463096405|FG001|Open-label Treatment Period|Death|0|||
128671377|NCT00119678|463096404|FG000|Open-label Treatment Period|Adverse Event|3|||
128671378|NCT00119678|463096405|FG001|Open-label Treatment Period|Adverse Event|0|||
128671379|NCT00119678|463096404|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
128671380|NCT00119678|463096405|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
128671381|NCT00119678|463096404|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
128671382|NCT00119678|463096405|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
128671383|NCT00119678|463096404|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
128671384|NCT00119678|463096405|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
128671385|NCT00119678|463096404|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
128671386|NCT00119678|463096405|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
128671387|NCT00119678|463096404|FG000|Open-label Treatment Period|Pregnancy|1|||
128671388|NCT00119678|463096405|FG001|Open-label Treatment Period|Pregnancy|0|||
128671389|NCT00119678|463096404|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
128671390|NCT00119678|463096405|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
128671391|NCT01761240|463096406|FG000|Overall Study|Progressive disease:radiology assessment|3|||
128671392|NCT01761240|463096407|FG001|Overall Study|Progressive disease:radiology assessment|3|||
128671393|NCT01761240|463096408|FG002|Overall Study|Progressive disease:radiology assessment|0|||
128671394|NCT01761240|463096409|FG003|Overall Study|Progressive disease:radiology assessment|0|||
128671395|NCT01761240|463096410|FG004|Overall Study|Progressive disease:radiology assessment|0|||
128671396|NCT01761240|463096406|FG000|Overall Study|Progressive disease:clinical assessment|0|||
128671397|NCT01761240|463096407|FG001|Overall Study|Progressive disease:clinical assessment|0|||
128671398|NCT01761240|463096408|FG002|Overall Study|Progressive disease:clinical assessment|3|||
128671399|NCT01761240|463096409|FG003|Overall Study|Progressive disease:clinical assessment|1|||
128671400|NCT01761240|463096410|FG004|Overall Study|Progressive disease:clinical assessment|0|||
128671401|NCT01761240|463096406|FG000|Overall Study|Withdrawal by Subject|0|||
128671402|NCT01761240|463096407|FG001|Overall Study|Withdrawal by Subject|0|||
128671403|NCT01761240|463096408|FG002|Overall Study|Withdrawal by Subject|0|||
128671404|NCT01761240|463096409|FG003|Overall Study|Withdrawal by Subject|3|||
128671405|NCT01761240|463096410|FG004|Overall Study|Withdrawal by Subject|1|||
128671406|NCT01761240|463096406|FG000|Overall Study|Adverse Event|0|||
128671407|NCT01761240|463096407|FG001|Overall Study|Adverse Event|0|||
128671408|NCT01761240|463096408|FG002|Overall Study|Adverse Event|0|||
128671409|NCT01761240|463096409|FG003|Overall Study|Adverse Event|1|||
128671410|NCT01761240|463096410|FG004|Overall Study|Adverse Event|6|||
128671411|NCT01761240|463096406|FG000|Overall Study|Death|0|||
128671412|NCT01761240|463096407|FG001|Overall Study|Death|1|||
128671413|NCT01761240|463096408|FG002|Overall Study|Death|1|||
128671414|NCT01761240|463096409|FG003|Overall Study|Death|2|||
128671415|NCT01761240|463096410|FG004|Overall Study|Death|1|||
128671416|NCT01761240|463096406|FG000|Overall Study|Non-compliance|0|||
128671417|NCT01761240|463096407|FG001|Overall Study|Non-compliance|0|||
128671418|NCT01761240|463096408|FG002|Overall Study|Non-compliance|1|||
128671419|NCT01761240|463096409|FG003|Overall Study|Non-compliance|0|||
128671420|NCT01761240|463096410|FG004|Overall Study|Non-compliance|0|||
128671421|NCT00509145|463096413|FG000|Overall Study|Death|0|||
128671422|NCT00509145|463096414|FG001|Overall Study|Death|2|||
128671423|NCT00509145|463096413|FG000|Overall Study|Adverse Event|42|||
128671424|NCT00509145|463096414|FG001|Overall Study|Adverse Event|28|||
128671425|NCT00509145|463096413|FG000|Overall Study|Withdrawal by Subject|32|||
128671426|NCT00509145|463096414|FG001|Overall Study|Withdrawal by Subject|38|||
128671427|NCT00509145|463096413|FG000|Overall Study|Physician Decision|11|||
128671428|NCT00509145|463096414|FG001|Overall Study|Physician Decision|14|||
128671429|NCT00509145|463096413|FG000|Overall Study|Protocol Violation|1|||
128671430|NCT00509145|463096414|FG001|Overall Study|Protocol Violation|6|||
128671431|NCT00509145|463096413|FG000|Overall Study|Pregnancy|3|||
128671432|NCT00509145|463096414|FG001|Overall Study|Pregnancy|8|||
129006734|NCT00684671|464316653|FG002|Overall Study|Lost to Follow-up|0|||
129006735|NCT00684671|464316651|FG000|Overall Study|Alcoholic dependance|1|||
129006736|NCT00684671|464316652|FG001|Overall Study|Alcoholic dependance|0|||
129006737|NCT00684671|464316653|FG002|Overall Study|Alcoholic dependance|0|||
129006738|NCT03335371|464316654|FG000|Overall Study|Lost to Follow-up|0|||
128671433|NCT00509145|463096413|FG000|Overall Study|Lost to Follow-up|6|||
128671434|NCT00509145|463096414|FG001|Overall Study|Lost to Follow-up|5|||
128671435|NCT00509145|463096413|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
128671436|NCT00509145|463096414|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
128671437|NCT00509145|463096413|FG000|Overall Study|Other|6|||
128671438|NCT00509145|463096414|FG001|Overall Study|Other|6|||
128671439|NCT01994889|463096415|FG000|Overall Study|Adverse Event|5|||
129006739|NCT03335371|464316655|FG001|Overall Study|Lost to Follow-up|0|||
129006740|NCT03335371|464316656|FG002|Overall Study|Lost to Follow-up|0|||
128671440|NCT01994889|463096416|FG001|Overall Study|Adverse Event|12|||
128671441|NCT01994889|463096417|FG002|Overall Study|Adverse Event|11|||
128671442|NCT01994889|463096415|FG000|Overall Study|Cardiac Device Implantation|0|||
128671443|NCT01994889|463096416|FG001|Overall Study|Cardiac Device Implantation|2|||
128671444|NCT01994889|463096417|FG002|Overall Study|Cardiac Device Implantation|0|||
128671445|NCT01994889|463096415|FG000|Overall Study|Organ Transplantation|1|||
128671446|NCT01994889|463096416|FG001|Overall Study|Organ Transplantation|5|||
128671447|NCT01994889|463096417|FG002|Overall Study|Organ Transplantation|5|||
128671448|NCT01994889|463096415|FG000|Overall Study|No longer willing to participate|8|||
128671449|NCT01994889|463096416|FG001|Overall Study|No longer willing to participate|17|||
128671450|NCT01994889|463096417|FG002|Overall Study|No longer willing to participate|37|||
128671451|NCT01994889|463096415|FG000|Overall Study|Lost to Follow-up|0|||
128671452|NCT01994889|463096416|FG001|Overall Study|Lost to Follow-up|1|||
128671453|NCT01994889|463096417|FG002|Overall Study|Lost to Follow-up|0|||
129006741|NCT03335371|464316657|FG003|Overall Study|Lost to Follow-up|0|||
128671454|NCT01994889|463096415|FG000|Overall Study|Protocol Violation|0|||
128671455|NCT01994889|463096416|FG001|Overall Study|Protocol Violation|1|||
128671456|NCT01994889|463096417|FG002|Overall Study|Protocol Violation|1|||
128671457|NCT01994889|463096415|FG000|Overall Study|Death|14|||
128671458|NCT01994889|463096416|FG001|Overall Study|Death|25|||
128671459|NCT01994889|463096417|FG002|Overall Study|Death|38|||
128671460|NCT02969655|463096419|FG000|Overall Study|Withdrawal by Subject|3|||
128671461|NCT02969655|463096420|FG001|Overall Study|Withdrawal by Subject|2|||
128671462|NCT02969655|463096419|FG000|Overall Study|Physician Decision|4|||
128671463|NCT02969655|463096420|FG001|Overall Study|Physician Decision|3|||
128671464|NCT02969655|463096419|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
128671465|NCT02969655|463096420|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
128671466|NCT02969655|463096419|FG000|Overall Study|Adverse Event|10|||
128671467|NCT02969655|463096420|FG001|Overall Study|Adverse Event|8|||
128671468|NCT00335764|463096421|FG000|Overall Study|wrong histology|1|||
128671469|NCT00335764|463096422|FG001|Overall Study|wrong histology|0|||
128671470|NCT00335764|463096423|FG002|Overall Study|wrong histology|0|||
128671471|NCT00335764|463096424|FG003|Overall Study|wrong histology|0|||
128671472|NCT00335764|463096425|FG004|Overall Study|wrong histology|1|||
128671473|NCT02466659|463096428|FG000|Overall Study|Lost to Follow-up|5|||
128671474|NCT02466659|463096429|FG001|Overall Study|Lost to Follow-up|2|||
128671475|NCT00929643|463096430|FG000|Overall Study|Protocol Violation|2|||
128671476|NCT01536392|463096433|FG000|Overall Study|Adverse Event|2|||
128671477|NCT01536392|463096434|FG001|Overall Study|Adverse Event|2|||
128671478|NCT01536392|463096433|FG000|Overall Study|Physician Decision|2|||
128671479|NCT01536392|463096434|FG001|Overall Study|Physician Decision|3|||
128671480|NCT01536392|463096433|FG000|Overall Study|Withdrawal by Subject|3|||
128671481|NCT01536392|463096434|FG001|Overall Study|Withdrawal by Subject|6|||
128671482|NCT01536392|463096433|FG000|Overall Study|Non Compliance|3|||
128671483|NCT01536392|463096434|FG001|Overall Study|Non Compliance|4|||
128671484|NCT01536392|463096433|FG000|Overall Study|Completed therapy early|3|||
128671485|NCT01536392|463096434|FG001|Overall Study|Completed therapy early|0|||
128671486|NCT00934440|463096435|FG000|Overall Study|Lost to Follow-up|1|||
128671487|NCT00750152|463096437|FG000|Overall Study|Adverse Event|2|||
128671488|NCT00750152|463096438|FG001|Overall Study|Adverse Event|1|||
128671489|NCT00750152|463096437|FG000|Overall Study|Lost to Follow-up|8|||
129006742|NCT03335371|464316658|FG004|Overall Study|Lost to Follow-up|1|||
128671490|NCT00750152|463096438|FG001|Overall Study|Lost to Follow-up|13|||
128671491|NCT00750152|463096437|FG000|Overall Study|Withdrawal by Subject|3|||
128671492|NCT00750152|463096438|FG001|Overall Study|Withdrawal by Subject|3|||
128671493|NCT00750152|463096437|FG000|Overall Study|Physician Decision|1|||
128671494|NCT00750152|463096438|FG001|Overall Study|Physician Decision|1|||
128671495|NCT00750152|463096437|FG000|Overall Study|Non-compliance|0|||
128671496|NCT00750152|463096438|FG001|Overall Study|Non-compliance|1|||
128671497|NCT00750152|463096437|FG000|Overall Study|Termination by sponsor|1|||
128671498|NCT00750152|463096438|FG001|Overall Study|Termination by sponsor|0|||
128671499|NCT00750152|463096437|FG000|Overall Study|Other|7|||
129006743|NCT03335371|464316654|FG000|Overall Study|Withdrawal by Subject|0|||
129006744|NCT03335371|464316655|FG001|Overall Study|Withdrawal by Subject|0|||
128671500|NCT00750152|463096438|FG001|Overall Study|Other|8|||
128671501|NCT01642615|463096439|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
128671502|NCT01642615|463096440|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
128671503|NCT01642615|463096441|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
128671504|NCT01642615|463096439|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
129006745|NCT03335371|464316656|FG002|Overall Study|Withdrawal by Subject|0|||
129006746|NCT03335371|464316657|FG003|Overall Study|Withdrawal by Subject|0|||
128671505|NCT01642615|463096440|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
128671506|NCT01642615|463096441|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
128671507|NCT01642615|463096439|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
128671508|NCT01642615|463096440|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
128671509|NCT01642615|463096441|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
128671510|NCT01642615|463096439|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
128671511|NCT01642615|463096440|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
128671512|NCT01642615|463096441|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
128671513|NCT01642615|463096439|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
128671514|NCT01642615|463096440|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
128671515|NCT01642615|463096441|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
128671516|NCT01642615|463096439|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
128671517|NCT01642615|463096440|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
128671518|NCT01642615|463096441|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
128671519|NCT01642615|463096439|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
128671520|NCT01642615|463096440|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
128671521|NCT01642615|463096441|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
128671522|NCT01642615|463096439|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
128671523|NCT01642615|463096440|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
128671524|NCT01642615|463096441|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
128671525|NCT01642615|463096439|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
128671526|NCT01642615|463096440|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
128671527|NCT01642615|463096441|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
128671528|NCT01028300|463096444|FG000|Overall Study|Study Terminated|4|||
128671529|NCT01214395|463096447|FG000|Overall Study|All patients had infection|5|||
128671530|NCT00715910|463096448|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
128671531|NCT00715910|463096449|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
128671532|NCT00715910|463096450|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
128671533|NCT00715910|463096451|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
128671534|NCT00715910|463096452|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
128671535|NCT00715910|463096453|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
128671536|NCT00715910|463096448|FG000|Booster and ESFU Phase|Other|0|||
128671537|NCT00715910|463096449|FG001|Booster and ESFU Phase|Other|0|||
128671538|NCT00715910|463096450|FG002|Booster and ESFU Phase|Other|0|||
128671539|NCT00715910|463096451|FG003|Booster and ESFU Phase|Other|5|||
128671540|NCT00715910|463096452|FG004|Booster and ESFU Phase|Other|1|||
128671541|NCT00715910|463096453|FG005|Booster and ESFU Phase|Other|0|||
128671542|NCT02034409|463096457|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
128671543|NCT02034409|463096458|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
128671544|NCT02034409|463096457|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
128671545|NCT02034409|463096458|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
128671546|NCT02034409|463096457|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
128671547|NCT02034409|463096458|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
128671548|NCT02034409|463096457|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
128671549|NCT02034409|463096458|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
128671550|NCT02034409|463096457|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
128671551|NCT02034409|463096458|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
128671552|NCT02034409|463096457|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
128671553|NCT02034409|463096458|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
128671554|NCT01699867|463096459|FG000|Overall Study|Screening Failure|3|||
128671555|NCT01808092|463096462|FG000|Overall Study|Death|39|||
128671556|NCT01808092|463096463|FG001|Overall Study|Death|29|||
128671557|NCT01808092|463096462|FG000|Overall Study|Lost to Follow-up|3|||
128671558|NCT01808092|463096463|FG001|Overall Study|Lost to Follow-up|7|||
128671559|NCT01808092|463096462|FG000|Overall Study|Withdrawal by Subject|9|||
128671560|NCT01808092|463096463|FG001|Overall Study|Withdrawal by Subject|4|||
128671561|NCT01808092|463096462|FG000|Overall Study|Other Eligibility criteria|3|||
128671562|NCT01808092|463096463|FG001|Overall Study|Other Eligibility criteria|5|||
128671563|NCT03703297|463096464|FG000|Overall Study|Death|115|||
128671564|NCT03703297|463096465|FG001|Overall Study|Death|0|||
128671565|NCT03703297|463096466|FG002|Overall Study|Death|144|||
128671566|NCT03703297|463096464|FG000|Overall Study|Withdrawal by Subject|9|||
128671567|NCT03703297|463096465|FG001|Overall Study|Withdrawal by Subject|0|||
128671568|NCT03703297|463096466|FG002|Overall Study|Withdrawal by Subject|11|||
128671569|NCT03703297|463096464|FG000|Overall Study|Ongoing at the time of DCO|140|||
128671570|NCT03703297|463096465|FG001|Overall Study|Ongoing at the time of DCO|200|||
128671571|NCT03703297|463096466|FG002|Overall Study|Ongoing at the time of DCO|111|||
129006747|NCT03335371|464316658|FG004|Overall Study|Withdrawal by Subject|1|||
128671572|NCT01888432|463098726|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
128671573|NCT01888432|463098727|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
128671574|NCT01888432|463098726|FG000|12-month Analysis (FAS)|Physician Decision|1|||
128671575|NCT01888432|463098727|FG001|12-month Analysis (FAS)|Physician Decision|1|||
128671576|NCT01888432|463098726|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
128671577|NCT01888432|463098727|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
128671578|NCT01888432|463098726|FG000|12-month Analysis (FAS)|Death|4|||
128671579|NCT01888432|463098727|FG001|12-month Analysis (FAS)|Death|3|||
128671580|NCT01888432|463098726|FG000|24-month Analysis (FAS)|Graft loss|0|||
128671581|NCT01888432|463098727|FG001|24-month Analysis (FAS)|Graft loss|1|||
129006748|NCT03335371|464316654|FG000|Overall Study|Randomization Error|0|||
129006749|NCT03335371|464316655|FG001|Overall Study|Randomization Error|0|||
129006750|NCT03335371|464316656|FG002|Overall Study|Randomization Error|1|||
129006751|NCT03335371|464316657|FG003|Overall Study|Randomization Error|0|||
129006752|NCT03335371|464316658|FG004|Overall Study|Randomization Error|0|||
129006753|NCT01725451|464316660|FG000|Period 1|Withdrawal by Subject|1|||
129006754|NCT01725451|464316661|FG001|Period 1|Withdrawal by Subject|0|||
129006755|NCT01725451|464316662|FG002|Period 1|Withdrawal by Subject|0|||
129006756|NCT01725451|464316663|FG003|Period 1|Withdrawal by Subject|0|||
129006757|NCT01725451|464316660|FG000|Washout From Period 3|Protocol Violation|0|||
129006758|NCT01725451|464316661|FG001|Washout From Period 3|Protocol Violation|0|||
128671582|NCT01888432|463098726|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
128671583|NCT01888432|463098727|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
128671584|NCT01888432|463098726|FG000|24-month Analysis (FAS)|Physician Decision|2|||
128671585|NCT01888432|463098727|FG001|24-month Analysis (FAS)|Physician Decision|4|||
128671586|NCT01888432|463098726|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
128671587|NCT01888432|463098727|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
128671588|NCT01888432|463098726|FG000|24-month Analysis (FAS)|Death|8|||
128671589|NCT01888432|463098727|FG001|24-month Analysis (FAS)|Death|4|||
128671590|NCT01888432|463098726|FG000|36-month Analysis (Extension)|Death|1|||
128671591|NCT01888432|463098727|FG001|36-month Analysis (Extension)|Death|0|||
128671592|NCT00130247|463098730|FG000|Overall Study|Pregnancy|1|||
128671593|NCT00130247|463098731|FG001|Overall Study|Pregnancy|0|||
128671594|NCT00130247|463098730|FG000|Overall Study|Post-randomization exclusion|1|||
128671595|NCT00130247|463098731|FG001|Overall Study|Post-randomization exclusion|2|||
128671596|NCT00130247|463098730|FG000|Overall Study|Not compliant with DOT|0|||
128671597|NCT00130247|463098731|FG001|Overall Study|Not compliant with DOT|2|||
128671598|NCT02123251|463098732|FG000|Overall Study|Death|1|||
128671599|NCT02123251|463098733|FG001|Overall Study|Death|1|||
128671600|NCT02123251|463098732|FG000|Overall Study|Withdrawal by Subject|0|||
128671601|NCT02123251|463098733|FG001|Overall Study|Withdrawal by Subject|3|||
128671602|NCT02123251|463098732|FG000|Overall Study|Lost Medicaid eligibility|29|||
128671603|NCT02123251|463098733|FG001|Overall Study|Lost Medicaid eligibility|22|||
128671604|NCT02123251|463098732|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
128671605|NCT02123251|463098733|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
128671606|NCT02704143|463098734|FG000|Overall Study|disease progression|10|||
128671607|NCT01235598|463098735|FG000|Overall Study|Adverse Event|0|||
128671608|NCT01235598|463098736|FG001|Overall Study|Adverse Event|3|||
128671609|NCT01235598|463098735|FG000|Overall Study|Lack of Efficacy|0|||
129006759|NCT01725451|464316662|FG002|Washout From Period 3|Protocol Violation|1|||
129006760|NCT01725451|464316663|FG003|Washout From Period 3|Protocol Violation|0|||
129006761|NCT01725451|464316660|FG000|Washout From Period 3|Adverse Event|0|||
128671610|NCT01235598|463098736|FG001|Overall Study|Lack of Efficacy|1|||
128671611|NCT01235598|463098735|FG000|Overall Study|Withdrawal by Subject|1|||
128671612|NCT01235598|463098736|FG001|Overall Study|Withdrawal by Subject|0|||
128671613|NCT02151773|463098737|FG000|Overall Study|Protocol Deviation|64|||
128671614|NCT00395343|463098738|FG000|Overall Study|Adverse Event|13|||
128671615|NCT00395343|463098739|FG001|Overall Study|Adverse Event|5|||
128671616|NCT00395343|463098738|FG000|Overall Study|Lack of Efficacy|0|||
128671617|NCT00395343|463098739|FG001|Overall Study|Lack of Efficacy|1|||
128671618|NCT00395343|463098738|FG000|Overall Study|Lost to Follow-up|4|||
128671619|NCT00395343|463098739|FG001|Overall Study|Lost to Follow-up|4|||
128671620|NCT00395343|463098738|FG000|Overall Study|Physician Decision|2|||
128671621|NCT00395343|463098739|FG001|Overall Study|Physician Decision|4|||
129006762|NCT01725451|464316661|FG001|Washout From Period 3|Adverse Event|1|||
129006763|NCT01725451|464316662|FG002|Washout From Period 3|Adverse Event|0|||
129006764|NCT01725451|464316663|FG003|Washout From Period 3|Adverse Event|0|||
128671622|NCT00395343|463098738|FG000|Overall Study|Protocol Violation|6|||
128671623|NCT00395343|463098739|FG001|Overall Study|Protocol Violation|8|||
128671624|NCT00395343|463098738|FG000|Overall Study|Withdrawal by Subject|11|||
128671625|NCT00395343|463098739|FG001|Overall Study|Withdrawal by Subject|12|||
128671626|NCT00395343|463098738|FG000|Overall Study|Other|5|||
129006765|NCT01725451|464316660|FG000|Period 4|Adverse Event|0|||
128671627|NCT00395343|463098739|FG001|Overall Study|Other|2|||
128671628|NCT00387790|463098742|FG000|Overall Study|Adverse Event|5|||
128671629|NCT00387790|463098742|FG000|Overall Study|Lack of Efficacy|2|||
129006766|NCT01725451|464316661|FG001|Period 4|Adverse Event|0|||
128671630|NCT00387790|463098742|FG000|Overall Study|Physician Decision|2|||
128671631|NCT00387790|463098742|FG000|Overall Study|Withdrawal by Subject|3|||
129006767|NCT01725451|464316662|FG002|Period 4|Adverse Event|1|||
129006768|NCT01725451|464316663|FG003|Period 4|Adverse Event|0|||
129006769|NCT02015793|464316666|FG000|Overall Study|Adverse Event|3|||
129006770|NCT02015793|464316667|FG001|Overall Study|Adverse Event|3|||
129006771|NCT02015793|464316666|FG000|Overall Study|Withdrawal by Subject|1|||
129006772|NCT02015793|464316667|FG001|Overall Study|Withdrawal by Subject|1|||
128671632|NCT00387790|463098742|FG000|Overall Study|Ineligible for study|2|||
128671633|NCT00966875|463098743|FG000|Part A|Adverse Event|2|||
128671634|NCT00966875|463098744|FG001|Part A|Adverse Event|1|||
128671635|NCT00966875|463098745|FG002|Part A|Adverse Event|0|||
128671636|NCT00966875|463098746|FG003|Part A|Adverse Event|1|||
128671637|NCT00966875|463098747|FG004|Part A|Adverse Event|0|||
128671638|NCT00966875|463098748|FG005|Part A|Adverse Event|1|||
128671639|NCT00966875|463098749|FG006|Part A|Adverse Event|0|||
128671640|NCT00966875|463098750|FG007|Part A|Adverse Event|3|||
128671641|NCT00966875|463098751|FG008|Part A|Adverse Event|3|||
128671642|NCT00966875|463098743|FG000|Part A|Entry Criteria|0|||
128671643|NCT00966875|463098744|FG001|Part A|Entry Criteria|0|||
128671644|NCT00966875|463098745|FG002|Part A|Entry Criteria|0|||
128671645|NCT00966875|463098746|FG003|Part A|Entry Criteria|0|||
128671646|NCT00966875|463098747|FG004|Part A|Entry Criteria|0|||
128671647|NCT00966875|463098748|FG005|Part A|Entry Criteria|2|||
128671648|NCT00966875|463098749|FG006|Part A|Entry Criteria|0|||
128671649|NCT00966875|463098750|FG007|Part A|Entry Criteria|0|||
128671650|NCT00966875|463098751|FG008|Part A|Entry Criteria|0|||
128671651|NCT00966875|463098743|FG000|Part A|Lack of Efficacy|0|||
128671652|NCT00966875|463098744|FG001|Part A|Lack of Efficacy|1|||
128671653|NCT00966875|463098745|FG002|Part A|Lack of Efficacy|0|||
128671654|NCT00966875|463098746|FG003|Part A|Lack of Efficacy|0|||
128671655|NCT00966875|463098747|FG004|Part A|Lack of Efficacy|0|||
128671656|NCT00966875|463098748|FG005|Part A|Lack of Efficacy|0|||
128671657|NCT00966875|463098749|FG006|Part A|Lack of Efficacy|4|||
128671658|NCT00966875|463098750|FG007|Part A|Lack of Efficacy|0|||
128671659|NCT00966875|463098751|FG008|Part A|Lack of Efficacy|0|||
128671660|NCT00966875|463098743|FG000|Part A|Lost to Follow-up|2|||
128671661|NCT00966875|463098744|FG001|Part A|Lost to Follow-up|0|||
128671662|NCT00966875|463098745|FG002|Part A|Lost to Follow-up|0|||
128671663|NCT00966875|463098746|FG003|Part A|Lost to Follow-up|0|||
128671664|NCT00966875|463098747|FG004|Part A|Lost to Follow-up|0|||
128671665|NCT00966875|463098748|FG005|Part A|Lost to Follow-up|1|||
128671666|NCT00966875|463098749|FG006|Part A|Lost to Follow-up|0|||
128671667|NCT00966875|463098750|FG007|Part A|Lost to Follow-up|0|||
128671668|NCT00966875|463098751|FG008|Part A|Lost to Follow-up|0|||
128671669|NCT00966875|463098743|FG000|Part A|Parent/Caregiver Decision|0|||
128671670|NCT00966875|463098744|FG001|Part A|Parent/Caregiver Decision|0|||
128671671|NCT00966875|463098745|FG002|Part A|Parent/Caregiver Decision|0|||
128671672|NCT00966875|463098746|FG003|Part A|Parent/Caregiver Decision|1|||
128671673|NCT00966875|463098747|FG004|Part A|Parent/Caregiver Decision|0|||
128671674|NCT00966875|463098748|FG005|Part A|Parent/Caregiver Decision|0|||
128671675|NCT00966875|463098749|FG006|Part A|Parent/Caregiver Decision|0|||
128671676|NCT00966875|463098750|FG007|Part A|Parent/Caregiver Decision|0|||
128671677|NCT00966875|463098751|FG008|Part A|Parent/Caregiver Decision|0|||
128671678|NCT00966875|463098743|FG000|Part A|Physician Decision|0|||
128671679|NCT00966875|463098744|FG001|Part A|Physician Decision|0|||
128671680|NCT00966875|463098745|FG002|Part A|Physician Decision|0|||
128671681|NCT00966875|463098746|FG003|Part A|Physician Decision|0|||
128671682|NCT00966875|463098747|FG004|Part A|Physician Decision|1|||
128671683|NCT00966875|463098748|FG005|Part A|Physician Decision|0|||
128671684|NCT00966875|463098749|FG006|Part A|Physician Decision|1|||
128671685|NCT00966875|463098750|FG007|Part A|Physician Decision|0|||
128671686|NCT00966875|463098751|FG008|Part A|Physician Decision|2|||
128671687|NCT00966875|463098743|FG000|Part A|Sponsor Decision|0|||
128671688|NCT00966875|463098744|FG001|Part A|Sponsor Decision|0|||
128671689|NCT00966875|463098745|FG002|Part A|Sponsor Decision|1|||
128671690|NCT00966875|463098746|FG003|Part A|Sponsor Decision|0|||
128671691|NCT00966875|463098747|FG004|Part A|Sponsor Decision|1|||
128671692|NCT00966875|463098748|FG005|Part A|Sponsor Decision|0|||
128671693|NCT00966875|463098749|FG006|Part A|Sponsor Decision|0|||
128671694|NCT00966875|463098750|FG007|Part A|Sponsor Decision|2|||
128671695|NCT00966875|463098751|FG008|Part A|Sponsor Decision|1|||
128671696|NCT00966875|463098743|FG000|Part A|Withdrawal by Subject|2|||
128671697|NCT00966875|463098744|FG001|Part A|Withdrawal by Subject|2|||
128671698|NCT00966875|463098745|FG002|Part A|Withdrawal by Subject|1|||
128671699|NCT00966875|463098746|FG003|Part A|Withdrawal by Subject|1|||
128671700|NCT00966875|463098747|FG004|Part A|Withdrawal by Subject|3|||
128671701|NCT00966875|463098748|FG005|Part A|Withdrawal by Subject|0|||
128671702|NCT00966875|463098749|FG006|Part A|Withdrawal by Subject|5|||
129006773|NCT00437281|464316668|FG000|Overall Study|Adverse Event|0|||
128671703|NCT00966875|463098750|FG007|Part A|Withdrawal by Subject|1|||
128671704|NCT00966875|463098751|FG008|Part A|Withdrawal by Subject|1|||
128671705|NCT00966875|463098743|FG000|Part A|Protocol Violation|0|||
128671706|NCT00966875|463098744|FG001|Part A|Protocol Violation|0|||
128671707|NCT00966875|463098745|FG002|Part A|Protocol Violation|0|||
128671708|NCT00966875|463098746|FG003|Part A|Protocol Violation|0|||
128671709|NCT00966875|463098747|FG004|Part A|Protocol Violation|0|||
128671710|NCT00966875|463098748|FG005|Part A|Protocol Violation|0|||
128671711|NCT00966875|463098749|FG006|Part A|Protocol Violation|2|||
128671712|NCT00966875|463098750|FG007|Part A|Protocol Violation|1|||
128671713|NCT00966875|463098751|FG008|Part A|Protocol Violation|1|||
128671714|NCT00966875|463098743|FG000|Part B|Adverse Event|0|||
128671715|NCT00966875|463098744|FG001|Part B|Adverse Event|1|||
128671716|NCT00966875|463098745|FG002|Part B|Adverse Event|1|||
128671717|NCT00966875|463098746|FG003|Part B|Adverse Event|0|||
128671718|NCT00966875|463098747|FG004|Part B|Adverse Event|1|||
128671719|NCT00966875|463098748|FG005|Part B|Adverse Event|0|||
128671720|NCT00966875|463098749|FG006|Part B|Adverse Event|5|||
128671721|NCT00966875|463098750|FG007|Part B|Adverse Event|2|||
128671722|NCT00966875|463098751|FG008|Part B|Adverse Event|2|||
128671723|NCT00966875|463098743|FG000|Part B|Death|0|||
128671724|NCT00966875|463098744|FG001|Part B|Death|0|||
128671725|NCT00966875|463098745|FG002|Part B|Death|1|||
128671726|NCT00966875|463098746|FG003|Part B|Death|0|||
128671727|NCT00966875|463098747|FG004|Part B|Death|0|||
128671728|NCT00966875|463098748|FG005|Part B|Death|0|||
128671729|NCT00966875|463098749|FG006|Part B|Death|0|||
128671730|NCT00966875|463098750|FG007|Part B|Death|1|||
128671731|NCT00966875|463098751|FG008|Part B|Death|0|||
128671732|NCT00966875|463098743|FG000|Part B|Lack of Efficacy|2|||
128671733|NCT00966875|463098744|FG001|Part B|Lack of Efficacy|1|||
128671734|NCT00966875|463098745|FG002|Part B|Lack of Efficacy|1|||
128671735|NCT00966875|463098746|FG003|Part B|Lack of Efficacy|1|||
128671736|NCT00966875|463098747|FG004|Part B|Lack of Efficacy|2|||
128671737|NCT00966875|463098748|FG005|Part B|Lack of Efficacy|3|||
128671738|NCT00966875|463098749|FG006|Part B|Lack of Efficacy|12|||
128671739|NCT00966875|463098750|FG007|Part B|Lack of Efficacy|9|||
128671740|NCT00966875|463098751|FG008|Part B|Lack of Efficacy|6|||
128671741|NCT00966875|463098743|FG000|Part B|Lost to Follow-up|0|||
128671742|NCT00966875|463098744|FG001|Part B|Lost to Follow-up|0|||
128671743|NCT00966875|463098745|FG002|Part B|Lost to Follow-up|0|||
128671744|NCT00966875|463098746|FG003|Part B|Lost to Follow-up|1|||
128671745|NCT00966875|463098747|FG004|Part B|Lost to Follow-up|0|||
128671746|NCT00966875|463098748|FG005|Part B|Lost to Follow-up|0|||
128671747|NCT00966875|463098749|FG006|Part B|Lost to Follow-up|0|||
128671748|NCT00966875|463098750|FG007|Part B|Lost to Follow-up|0|||
128671749|NCT00966875|463098751|FG008|Part B|Lost to Follow-up|1|||
128671750|NCT00966875|463098743|FG000|Part B|Physician Decision|0|||
128671751|NCT00966875|463098744|FG001|Part B|Physician Decision|0|||
128671752|NCT00966875|463098745|FG002|Part B|Physician Decision|1|||
128671753|NCT00966875|463098746|FG003|Part B|Physician Decision|0|||
128671754|NCT00966875|463098747|FG004|Part B|Physician Decision|2|||
128671755|NCT00966875|463098748|FG005|Part B|Physician Decision|1|||
128671756|NCT00966875|463098749|FG006|Part B|Physician Decision|0|||
128671757|NCT00966875|463098750|FG007|Part B|Physician Decision|0|||
128671758|NCT00966875|463098751|FG008|Part B|Physician Decision|2|||
129006774|NCT00437281|464316669|FG001|Overall Study|Adverse Event|0|||
129006775|NCT00437281|464316670|FG002|Overall Study|Adverse Event|0|||
129006776|NCT00437281|464316671|FG003|Overall Study|Adverse Event|1|||
129006777|NCT00437281|464316672|FG004|Overall Study|Adverse Event|0|||
129006778|NCT00437281|464316673|FG005|Overall Study|Adverse Event|1|||
129006779|NCT00437281|464316674|FG006|Overall Study|Adverse Event|0|||
129006780|NCT00437281|464316675|FG007|Overall Study|Adverse Event|0|||
129006781|NCT00437281|464316676|FG008|Overall Study|Adverse Event|0|||
129006782|NCT00437281|464316677|FG009|Overall Study|Adverse Event|1|||
129006783|NCT00437281|464316678|FG010|Overall Study|Adverse Event|0|||
129006784|NCT00437281|464316679|FG011|Overall Study|Adverse Event|0|||
129006785|NCT00437281|464316680|FG012|Overall Study|Adverse Event|0|||
129006786|NCT00437281|464316681|FG013|Overall Study|Adverse Event|1|||
129006787|NCT00437281|464316682|FG014|Overall Study|Adverse Event|1|||
129006788|NCT00437281|464316683|FG015|Overall Study|Adverse Event|0|||
129006789|NCT00437281|464316684|FG016|Overall Study|Adverse Event|0|||
129006790|NCT00437281|464316685|FG017|Overall Study|Adverse Event|0|||
129006791|NCT00437281|464316686|FG018|Overall Study|Adverse Event|1|||
129006792|NCT00437281|464316687|FG019|Overall Study|Adverse Event|0|||
129006793|NCT00437281|464316668|FG000|Overall Study|Lost to Follow-up|0|||
129006794|NCT00437281|464316669|FG001|Overall Study|Lost to Follow-up|0|||
129006795|NCT00437281|464316670|FG002|Overall Study|Lost to Follow-up|0|||
129006796|NCT00437281|464316671|FG003|Overall Study|Lost to Follow-up|0|||
129006797|NCT00437281|464316672|FG004|Overall Study|Lost to Follow-up|0|||
129006798|NCT00437281|464316673|FG005|Overall Study|Lost to Follow-up|0|||
129006799|NCT00437281|464316674|FG006|Overall Study|Lost to Follow-up|0|||
129006800|NCT00437281|464316675|FG007|Overall Study|Lost to Follow-up|0|||
128671759|NCT00966875|463098743|FG000|Part B|Sponsor Decision|1|||
128671760|NCT00966875|463098744|FG001|Part B|Sponsor Decision|0|||
128671761|NCT00966875|463098745|FG002|Part B|Sponsor Decision|0|||
128671762|NCT00966875|463098746|FG003|Part B|Sponsor Decision|0|||
128671763|NCT00966875|463098747|FG004|Part B|Sponsor Decision|0|||
128671764|NCT00966875|463098748|FG005|Part B|Sponsor Decision|1|||
128671765|NCT00966875|463098749|FG006|Part B|Sponsor Decision|0|||
128671766|NCT00966875|463098750|FG007|Part B|Sponsor Decision|2|||
128671767|NCT00966875|463098751|FG008|Part B|Sponsor Decision|1|||
128671768|NCT00966875|463098743|FG000|Part B|Withdrawal by Subject|2|||
128671769|NCT00966875|463098744|FG001|Part B|Withdrawal by Subject|1|||
128671770|NCT00966875|463098745|FG002|Part B|Withdrawal by Subject|2|||
128671771|NCT00966875|463098746|FG003|Part B|Withdrawal by Subject|1|||
128671772|NCT00966875|463098747|FG004|Part B|Withdrawal by Subject|2|||
128671773|NCT00966875|463098748|FG005|Part B|Withdrawal by Subject|1|||
128671774|NCT00966875|463098749|FG006|Part B|Withdrawal by Subject|4|||
128671775|NCT00966875|463098750|FG007|Part B|Withdrawal by Subject|5|||
128671776|NCT00966875|463098751|FG008|Part B|Withdrawal by Subject|5|||
128671777|NCT00966875|463098743|FG000|Part B|Entry Criteria|0|||
128671778|NCT00966875|463098744|FG001|Part B|Entry Criteria|0|||
128671779|NCT00966875|463098745|FG002|Part B|Entry Criteria|0|||
129006801|NCT00437281|464316676|FG008|Overall Study|Lost to Follow-up|0|||
129006802|NCT00437281|464316677|FG009|Overall Study|Lost to Follow-up|0|||
129006803|NCT00437281|464316678|FG010|Overall Study|Lost to Follow-up|0|||
129006804|NCT00437281|464316679|FG011|Overall Study|Lost to Follow-up|0|||
129006805|NCT00437281|464316680|FG012|Overall Study|Lost to Follow-up|0|||
129006806|NCT00437281|464316681|FG013|Overall Study|Lost to Follow-up|0|||
129006807|NCT00437281|464316682|FG014|Overall Study|Lost to Follow-up|0|||
129006808|NCT00437281|464316683|FG015|Overall Study|Lost to Follow-up|0|||
129006809|NCT00437281|464316684|FG016|Overall Study|Lost to Follow-up|0|||
129006810|NCT00437281|464316685|FG017|Overall Study|Lost to Follow-up|0|||
129006811|NCT00437281|464316686|FG018|Overall Study|Lost to Follow-up|0|||
129006812|NCT00437281|464316687|FG019|Overall Study|Lost to Follow-up|1|||
129006813|NCT00601354|464316688|FG000|Overall Study|Lost to Follow-up|4|||
129006814|NCT00601354|464316689|FG001|Overall Study|Lost to Follow-up|5|||
129006815|NCT01862328|464316690|FG000|Overall Study|Progressive Disease|3|||
129006816|NCT01862328|464316691|FG001|Overall Study|Progressive Disease|11|||
129006817|NCT01862328|464316692|FG002|Overall Study|Progressive Disease|5|||
129006818|NCT01862328|464316693|FG003|Overall Study|Progressive Disease|6|||
129006819|NCT01862328|464316694|FG004|Overall Study|Progressive Disease|7|||
128671780|NCT00966875|463098746|FG003|Part B|Entry Criteria|0|||
128671781|NCT00966875|463098747|FG004|Part B|Entry Criteria|0|||
128671782|NCT00966875|463098748|FG005|Part B|Entry Criteria|0|||
128671783|NCT00966875|463098749|FG006|Part B|Entry Criteria|1|||
128671784|NCT00966875|463098750|FG007|Part B|Entry Criteria|0|||
128671785|NCT00966875|463098751|FG008|Part B|Entry Criteria|1|||
128671786|NCT02386189|463098752|FG000|Overall Study|Lost to Follow-up|2|||
128671787|NCT02386189|463098753|FG001|Overall Study|Lost to Follow-up|3|||
128671788|NCT02386189|463098752|FG000|Overall Study|Withdrawal by Subject|1|||
128671789|NCT02386189|463098753|FG001|Overall Study|Withdrawal by Subject|0|||
128671790|NCT02386189|463098752|FG000|Overall Study|Death|1|||
128671791|NCT02386189|463098753|FG001|Overall Study|Death|0|||
128671792|NCT04657666|463098754|FG000|Period 1|Withdrawal of participant consent|2|||
128671793|NCT04657666|463098755|FG001|Period 1|Withdrawal of participant consent|1|||
128671794|NCT04657666|463098754|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
128671795|NCT04657666|463098755|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
128671796|NCT04657666|463098754|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
128671797|NCT04657666|463098755|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
128671798|NCT04657666|463098754|FG000|Period 2|Other|2|||
128671799|NCT04657666|463098755|FG001|Period 2|Other|0|||
128671800|NCT04657666|463098754|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
128671801|NCT04657666|463098755|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
128671802|NCT03700684|463098764|FG000|Overall Study|COVID-19|0|||
128671803|NCT03700684|463098765|FG001|Overall Study|COVID-19|0|||
128671804|NCT03700684|463098766|FG002|Overall Study|COVID-19|2|||
128671805|NCT00870103|463098767|FG000|Overall Study|Physician Decision|2|||
128671806|NCT00870103|463098767|FG000|Overall Study|Lost to Follow-up|2|||
128671807|NCT01120782|463098768|FG000|Overall Study|Test article shipping error|11|||
128671808|NCT00640224|463098769|FG000|Overall Study|Lost to Follow-up|5|||
128671809|NCT00640224|463098770|FG001|Overall Study|Lost to Follow-up|2|||
128671810|NCT00640224|463098771|FG002|Overall Study|Lost to Follow-up|0|||
128671811|NCT00640224|463098772|FG003|Overall Study|Lost to Follow-up|0|||
128671812|NCT00640224|463098769|FG000|Overall Study|Withdrawal by Subject|1|||
128671813|NCT00640224|463098770|FG001|Overall Study|Withdrawal by Subject|0|||
128671814|NCT00640224|463098771|FG002|Overall Study|Withdrawal by Subject|0|||
128671815|NCT00640224|463098772|FG003|Overall Study|Withdrawal by Subject|0|||
128671816|NCT00640224|463098769|FG000|Overall Study|Headaches|0|||
128671817|NCT00640224|463098770|FG001|Overall Study|Headaches|1|||
128671818|NCT00640224|463098771|FG002|Overall Study|Headaches|0|||
129006820|NCT01862328|464316695|FG005|Overall Study|Progressive Disease|4|||
129006821|NCT01862328|464316696|FG006|Overall Study|Progressive Disease|3|||
129006822|NCT01862328|464316690|FG000|Overall Study|Adverse Event|0|||
129006823|NCT01862328|464316691|FG001|Overall Study|Adverse Event|4|||
129006824|NCT01862328|464316692|FG002|Overall Study|Adverse Event|0|||
128671819|NCT00640224|463098772|FG003|Overall Study|Headaches|0|||
128671820|NCT02937584|463098777|FG000|Period 1|Adverse Event|1|||
128671821|NCT02937584|463098778|FG001|Period 1|Adverse Event|2|||
128671822|NCT02937584|463098777|FG000|Washout|Adverse Event|0|||
128671823|NCT02937584|463098778|FG001|Washout|Adverse Event|1|||
128671824|NCT04075734|463098787|FG000|Overall Study|Lost to Follow-up|1|||
128671825|NCT04075734|463098788|FG001|Overall Study|Lost to Follow-up|1|||
128671826|NCT04075734|463098789|FG002|Overall Study|Lost to Follow-up|0|||
128671827|NCT04075734|463098787|FG000|Overall Study|Withdrawal by Subject|3|||
128671828|NCT04075734|463098788|FG001|Overall Study|Withdrawal by Subject|0|||
128671829|NCT04075734|463098789|FG002|Overall Study|Withdrawal by Subject|0|||
128671830|NCT03615040|463098790|FG000|Overall Study|Withdrawal by Subject|2|||
128671831|NCT03615040|463098791|FG001|Overall Study|Withdrawal by Subject|1|||
128671832|NCT03615040|463098790|FG000|Overall Study|Physician Decision|2|||
128671833|NCT03615040|463098791|FG001|Overall Study|Physician Decision|2|||
128671834|NCT03615040|463098790|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
129006825|NCT01862328|464316693|FG003|Overall Study|Adverse Event|1|||
128671835|NCT03615040|463098791|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
128671836|NCT03615040|463098790|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
128671837|NCT03615040|463098791|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
128671838|NCT03615040|463098790|FG000|Overall Study|Death|0|||
128671839|NCT03615040|463098791|FG001|Overall Study|Death|2|||
128671840|NCT01776307|463098792|FG000|Overall Study|Not dosed|0|||
128671841|NCT01776307|463098793|FG001|Overall Study|Not dosed|0|||
128671842|NCT01776307|463098794|FG002|Overall Study|Not dosed|1|||
128671843|NCT04074161|463098797|FG000|Overall Study|Withdrawal by Subject|2|||
128671844|NCT04074161|463098798|FG001|Overall Study|Withdrawal by Subject|4|||
128671845|NCT04074161|463098799|FG002|Overall Study|Withdrawal by Subject|1|||
128671846|NCT04074161|463098797|FG000|Overall Study|Lost to Follow-up|4|||
128671847|NCT04074161|463098798|FG001|Overall Study|Lost to Follow-up|5|||
128671848|NCT04074161|463098799|FG002|Overall Study|Lost to Follow-up|3|||
128671849|NCT03890666|463098811|FG000|Overall Study|Withdrawal by Subject|0|||
128671850|NCT03890666|463098812|FG001|Overall Study|Withdrawal by Subject|1|||
128671851|NCT03890666|463098811|FG000|Overall Study|Protocol deviation|1|||
128671852|NCT03890666|463098812|FG001|Overall Study|Protocol deviation|4|||
128671853|NCT03890666|463098811|FG000|Overall Study|Lost to Follow-up|2|||
128671854|NCT03890666|463098812|FG001|Overall Study|Lost to Follow-up|5|||
128671855|NCT03890666|463098811|FG000|Overall Study|Other than specified|1|||
128671856|NCT03890666|463098812|FG001|Overall Study|Other than specified|8|||
128671857|NCT03232333|463098813|FG000|Overall Study|Infection or Osteomyelitis|9|||
128671858|NCT03232333|463098813|FG000|Overall Study|Lost to Follow-up|4|||
128671859|NCT03232333|463098813|FG000|Overall Study|Withdrawal by Subject|2|||
128671860|NCT03052426|463098814|FG000|Overall Study|Withdrawal by Subject|0|||
128671861|NCT03052426|463098815|FG001|Overall Study|Withdrawal by Subject|1|||
128671862|NCT03052426|463098816|FG002|Overall Study|Withdrawal by Subject|0|||
128671863|NCT03052426|463098814|FG000|Overall Study|Lost to Follow-up|2|||
128671864|NCT03052426|463098815|FG001|Overall Study|Lost to Follow-up|0|||
128671865|NCT03052426|463098816|FG002|Overall Study|Lost to Follow-up|1|||
128671866|NCT04145219|463098817|FG000|Overall Study|Adverse Event|18|||
128671867|NCT04145219|463098818|FG001|Overall Study|Adverse Event|6|||
128671868|NCT04145219|463098817|FG000|Overall Study|Lost to Follow-up|2|||
128671869|NCT04145219|463098818|FG001|Overall Study|Lost to Follow-up|3|||
128671870|NCT04145219|463098817|FG000|Overall Study|Physician Decision|0|||
128671871|NCT04145219|463098818|FG001|Overall Study|Physician Decision|2|||
128671872|NCT04145219|463098817|FG000|Overall Study|Withdrawal by Subject|12|||
128671873|NCT04145219|463098818|FG001|Overall Study|Withdrawal by Subject|8|||
128671874|NCT04145219|463098817|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
128671875|NCT04145219|463098818|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
128671876|NCT03672097|463098819|FG000|Period 1|Withdrawal by Subject|2|||
128671877|NCT03672097|463098819|FG000|Period 1|Adverse Event|1|||
128671878|NCT03672097|463098819|FG000|Period 1|Did not receive treatment|1|||
128671879|NCT03672097|463098819|FG000|Period 2|Withdrawal by Subject|3|||
128671880|NCT03672097|463098819|FG000|Period 2|Other|1|||
128671881|NCT01290796|463098820|FG000|Overall Study|Lost to Follow-up|21|||
128671882|NCT01290796|463098820|FG000|Overall Study|Withdrawal by Subject|4|||
128671883|NCT01290796|463098820|FG000|Overall Study|Physician Decision|2|||
128671884|NCT01290796|463098820|FG000|Overall Study|Secondary Surgical Intervention|2|||
128671885|NCT01290796|463098820|FG000|Overall Study|Withdrawal by Sponsor|1|||
128671886|NCT03087617|463098821|FG000|Overall Study|Lost to Follow-up|32|||
128671887|NCT03087617|463098822|FG001|Overall Study|Lost to Follow-up|30|||
128671888|NCT03087617|463098823|FG002|Overall Study|Lost to Follow-up|30|||
128671889|NCT03087617|463098824|FG003|Overall Study|Lost to Follow-up|39|||
128671890|NCT00275340|463098827|FG000|Overall Study|Lost to Follow-up|2|||
128671891|NCT00275340|463098828|FG001|Overall Study|Lost to Follow-up|4|||
128671892|NCT02674204|463098830|FG000|Overall Study|Adverse Event|1|||
128671893|NCT02674204|463098831|FG001|Overall Study|Adverse Event|0|||
128671894|NCT00486811|463098832|FG000|Overall Study|Adverse Event|28|||
129006826|NCT01862328|464316694|FG004|Overall Study|Adverse Event|0|||
129006827|NCT01862328|464316695|FG005|Overall Study|Adverse Event|2|||
129006828|NCT01862328|464316696|FG006|Overall Study|Adverse Event|4|||
129006829|NCT01862328|464316690|FG000|Overall Study|Other|0|||
129006830|NCT01862328|464316691|FG001|Overall Study|Other|2|||
129006831|NCT01862328|464316692|FG002|Overall Study|Other|1|||
128671895|NCT00486811|463098833|FG001|Overall Study|Adverse Event|60|||
128671896|NCT00486811|463098834|FG002|Overall Study|Adverse Event|135|||
128671897|NCT00486811|463098832|FG000|Overall Study|Lack of Efficacy|34|||
128671898|NCT00486811|463098833|FG001|Overall Study|Lack of Efficacy|14|||
129006832|NCT01862328|464316693|FG003|Overall Study|Other|0|||
128671899|NCT00486811|463098834|FG002|Overall Study|Lack of Efficacy|7|||
128671900|NCT00486811|463098832|FG000|Overall Study|Lost to Follow-up|4|||
128671901|NCT00486811|463098833|FG001|Overall Study|Lost to Follow-up|6|||
128671902|NCT00486811|463098834|FG002|Overall Study|Lost to Follow-up|4|||
128671903|NCT00486811|463098832|FG000|Overall Study|Withdrawal by Subject|33|||
128671904|NCT00486811|463098833|FG001|Overall Study|Withdrawal by Subject|44|||
128671905|NCT00486811|463098834|FG002|Overall Study|Withdrawal by Subject|58|||
129006833|NCT01862328|464316694|FG004|Overall Study|Other|4|||
128671906|NCT00486811|463098832|FG000|Overall Study|Study drug non-compliant|5|||
128671907|NCT00486811|463098833|FG001|Overall Study|Study drug non-compliant|6|||
128671908|NCT00486811|463098834|FG002|Overall Study|Study drug non-compliant|3|||
128671909|NCT00486811|463098832|FG000|Overall Study|All other|18|||
128671910|NCT00486811|463098833|FG001|Overall Study|All other|11|||
128671911|NCT00486811|463098834|FG002|Overall Study|All other|7|||
128671912|NCT01711216|463098835|FG000|Overall Study|Adverse Event|4|||
128671913|NCT01711216|463098835|FG000|Overall Study|Pregnancy|56|||
128671914|NCT01711216|463098835|FG000|Overall Study|Withdrawal by Subject|6|||
128671915|NCT01711216|463098835|FG000|Overall Study|Lost to Follow-up|46|||
128671916|NCT01711216|463098835|FG000|Overall Study|variety of other minor reasons|83|||
128671917|NCT01711216|463098835|FG000|Overall Study|no reason specified|22|||
128671918|NCT02929498|463098836|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
128671919|NCT02929498|463098837|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
128671920|NCT02929498|463098838|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
128671921|NCT02929498|463098836|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
128671922|NCT02929498|463098837|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
128671923|NCT02929498|463098838|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
128671924|NCT01030666|463098839|FG000|Overall Study|Lost to Follow-up|3|||
128671925|NCT01030666|463098840|FG001|Overall Study|Lost to Follow-up|2|||
128671926|NCT04002908|463098843|FG000|Overall Study|Death|41|||
128671927|NCT04002908|463098844|FG001|Overall Study|Death|0|||
128671928|NCT04002908|463098845|FG002|Overall Study|Death|0|||
128671929|NCT04002908|463098846|FG003|Overall Study|Death|0|||
128671930|NCT04002908|463098843|FG000|Overall Study|Withdrawal by Subject|112|||
128671931|NCT04002908|463098844|FG001|Overall Study|Withdrawal by Subject|0|||
128671932|NCT04002908|463098845|FG002|Overall Study|Withdrawal by Subject|0|||
128671933|NCT04002908|463098846|FG003|Overall Study|Withdrawal by Subject|0|||
128671934|NCT04002908|463098843|FG000|Overall Study|Lost to Follow-up|72|||
128671935|NCT04002908|463098844|FG001|Overall Study|Lost to Follow-up|0|||
128671936|NCT04002908|463098845|FG002|Overall Study|Lost to Follow-up|0|||
128671937|NCT04002908|463098846|FG003|Overall Study|Lost to Follow-up|0|||
128671938|NCT04002908|463098843|FG000|Overall Study|Infant died, so mother withdrawn|34|||
128671939|NCT04002908|463098844|FG001|Overall Study|Infant died, so mother withdrawn|0|||
128671940|NCT04002908|463098845|FG002|Overall Study|Infant died, so mother withdrawn|0|||
128671941|NCT04002908|463098846|FG003|Overall Study|Infant died, so mother withdrawn|0|||
128671942|NCT00006289|463098851|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
128671943|NCT00006289|463098852|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
128671944|NCT00006289|463098851|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
128671945|NCT00006289|463098852|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
128671946|NCT00557856|463098863|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
128671947|NCT00557856|463098864|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
128671948|NCT00557856|463098865|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
128671949|NCT00557856|463098866|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
128671950|NCT00557856|463098867|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
128671951|NCT00557856|463098868|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
128671952|NCT00557856|463098869|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
128671953|NCT00557856|463098870|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
128671954|NCT00557856|463098871|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
128671955|NCT00557856|463098863|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
128671956|NCT00557856|463098864|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
128671957|NCT00557856|463098865|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
128671958|NCT00557856|463098866|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
128671959|NCT00557856|463098867|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
128671960|NCT00557856|463098868|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
128671961|NCT00557856|463098869|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
128671962|NCT00557856|463098870|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
128671963|NCT00557856|463098871|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
128671964|NCT00557856|463098863|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
128671965|NCT00557856|463098864|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
128671966|NCT00557856|463098865|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
128671967|NCT00557856|463098866|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
128671968|NCT00557856|463098867|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
128671969|NCT00557856|463098868|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
128671970|NCT00557856|463098869|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
128671971|NCT00557856|463098870|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
128671972|NCT00557856|463098871|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
128671973|NCT00557856|463098863|FG000|Part 1: Dose Escalation Phase|Other|0|||
128671974|NCT00557856|463098864|FG001|Part 1: Dose Escalation Phase|Other|0|||
128671975|NCT00557856|463098865|FG002|Part 1: Dose Escalation Phase|Other|1|||
128671976|NCT00557856|463098866|FG003|Part 1: Dose Escalation Phase|Other|1|||
128671977|NCT00557856|463098867|FG004|Part 1: Dose Escalation Phase|Other|0|||
128671978|NCT00557856|463098868|FG005|Part 1: Dose Escalation Phase|Other|0|||
128671979|NCT00557856|463098869|FG006|Part 1: Dose Escalation Phase|Other|0|||
128671980|NCT00557856|463098870|FG007|Part 1: Dose Escalation Phase|Other|1|||
128671981|NCT00557856|463098871|FG008|Part 1: Dose Escalation Phase|Other|0|||
128671982|NCT00557856|463098863|FG000|Part 1: Dose Escalation Phase|Death|0|||
128671983|NCT00557856|463098864|FG001|Part 1: Dose Escalation Phase|Death|0|||
128671984|NCT00557856|463098865|FG002|Part 1: Dose Escalation Phase|Death|0|||
128671985|NCT00557856|463098866|FG003|Part 1: Dose Escalation Phase|Death|0|||
128671986|NCT00557856|463098867|FG004|Part 1: Dose Escalation Phase|Death|0|||
128671987|NCT00557856|463098868|FG005|Part 1: Dose Escalation Phase|Death|1|||
129006834|NCT01862328|464316695|FG005|Overall Study|Other|0|||
129006835|NCT01862328|464316696|FG006|Overall Study|Other|1|||
129006836|NCT01862328|464316690|FG000|Overall Study|Withdrawal by Subject|1|||
129006837|NCT01862328|464316691|FG001|Overall Study|Withdrawal by Subject|1|||
129006838|NCT01862328|464316692|FG002|Overall Study|Withdrawal by Subject|0|||
129006839|NCT01862328|464316693|FG003|Overall Study|Withdrawal by Subject|0|||
128671988|NCT00557856|463098869|FG006|Part 1: Dose Escalation Phase|Death|0|||
128671989|NCT00557856|463098870|FG007|Part 1: Dose Escalation Phase|Death|0|||
128671990|NCT00557856|463098871|FG008|Part 1: Dose Escalation Phase|Death|0|||
128671991|NCT00557856|463098863|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
128671992|NCT00557856|463098864|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
128671993|NCT00557856|463098865|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
128671994|NCT00557856|463098866|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
128671995|NCT00557856|463098867|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
128671996|NCT00557856|463098868|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
128671997|NCT00557856|463098869|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
128671998|NCT00557856|463098870|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
128671999|NCT00557856|463098871|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
128672000|NCT00557856|463098863|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
128672001|NCT00557856|463098864|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672002|NCT00557856|463098865|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672003|NCT00557856|463098866|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672004|NCT00557856|463098867|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672005|NCT00557856|463098868|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672006|NCT00557856|463098869|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672007|NCT00557856|463098870|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672008|NCT00557856|463098871|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
128672009|NCT00557856|463098863|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
128672010|NCT00557856|463098864|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
128672011|NCT00557856|463098865|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
129006840|NCT01862328|464316694|FG004|Overall Study|Withdrawal by Subject|1|||
129006841|NCT01862328|464316695|FG005|Overall Study|Withdrawal by Subject|1|||
129006842|NCT01862328|464316696|FG006|Overall Study|Withdrawal by Subject|1|||
129006843|NCT01862328|464316690|FG000|Overall Study|Symptomatic Deterioration|0|||
129006844|NCT01862328|464316691|FG001|Overall Study|Symptomatic Deterioration|0|||
129006845|NCT01862328|464316692|FG002|Overall Study|Symptomatic Deterioration|0|||
129006846|NCT01862328|464316693|FG003|Overall Study|Symptomatic Deterioration|0|||
129006847|NCT01862328|464316694|FG004|Overall Study|Symptomatic Deterioration|0|||
129006848|NCT01862328|464316695|FG005|Overall Study|Symptomatic Deterioration|0|||
129006849|NCT01862328|464316696|FG006|Overall Study|Symptomatic Deterioration|1|||
129006850|NCT01656889|464316698|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
129006851|NCT01656889|464316699|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
129006852|NCT01656889|464316698|FG000|Treatment Period, 12 Weeks|Death|0|||
129006853|NCT01656889|464316699|FG001|Treatment Period, 12 Weeks|Death|1|||
129006854|NCT01656889|464316698|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
129006855|NCT01656889|464316699|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
129006856|NCT01656889|464316698|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
129006857|NCT01656889|464316699|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
129006858|NCT01656889|464316698|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
129006859|NCT01656889|464316699|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
129006860|NCT01656889|464316698|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
129006861|NCT01656889|464316699|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
129006862|NCT01656889|464316698|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
129006863|NCT01656889|464316699|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
129006864|NCT01656889|464316698|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
129006865|NCT01656889|464316699|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
129006866|NCT01656889|464316698|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
129006867|NCT01656889|464316699|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
129006868|NCT01656889|464316698|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
128672012|NCT00557856|463098866|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
128672013|NCT00557856|463098867|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
128672014|NCT00557856|463098868|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
128672015|NCT00557856|463098869|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
128672016|NCT00557856|463098870|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
128672017|NCT00557856|463098871|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
128672018|NCT00557856|463098863|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672019|NCT00557856|463098864|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672020|NCT00557856|463098865|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672021|NCT00557856|463098866|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672022|NCT00557856|463098867|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672023|NCT00557856|463098868|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672024|NCT00557856|463098869|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672025|NCT00557856|463098870|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
128672026|NCT00557856|463098871|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
128672027|NCT00557856|463098863|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
128672028|NCT00557856|463098864|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
128672029|NCT00557856|463098865|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
128672030|NCT00557856|463098866|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
128672031|NCT00557856|463098867|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
128672032|NCT00557856|463098868|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
128672033|NCT00557856|463098869|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
128672034|NCT00557856|463098870|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
128672035|NCT00557856|463098871|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
128672036|NCT00557856|463098863|FG000|Part 2: Exploratory Phase|Other|0|||
128672037|NCT00557856|463098864|FG001|Part 2: Exploratory Phase|Other|0|||
128672038|NCT00557856|463098865|FG002|Part 2: Exploratory Phase|Other|0|||
128672039|NCT00557856|463098866|FG003|Part 2: Exploratory Phase|Other|0|||
128672040|NCT00557856|463098867|FG004|Part 2: Exploratory Phase|Other|0|||
128672041|NCT00557856|463098868|FG005|Part 2: Exploratory Phase|Other|0|||
128672042|NCT00557856|463098869|FG006|Part 2: Exploratory Phase|Other|0|||
128672043|NCT00557856|463098870|FG007|Part 2: Exploratory Phase|Other|0|||
128672044|NCT00557856|463098871|FG008|Part 2: Exploratory Phase|Other|1|||
128672045|NCT00557856|463098863|FG000|Part 2: Exploratory Phase|Death|0|||
128672046|NCT00557856|463098864|FG001|Part 2: Exploratory Phase|Death|0|||
128672047|NCT00557856|463098865|FG002|Part 2: Exploratory Phase|Death|0|||
128672048|NCT00557856|463098866|FG003|Part 2: Exploratory Phase|Death|0|||
128672049|NCT00557856|463098867|FG004|Part 2: Exploratory Phase|Death|0|||
128672050|NCT00557856|463098868|FG005|Part 2: Exploratory Phase|Death|0|||
128672051|NCT00557856|463098869|FG006|Part 2: Exploratory Phase|Death|0|||
128672052|NCT00557856|463098870|FG007|Part 2: Exploratory Phase|Death|0|||
128672053|NCT00557856|463098871|FG008|Part 2: Exploratory Phase|Death|2|||
128672054|NCT00557856|463098863|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672055|NCT00557856|463098864|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672056|NCT00557856|463098865|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672057|NCT00557856|463098866|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672058|NCT00557856|463098867|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672059|NCT00557856|463098868|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672060|NCT00557856|463098869|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672061|NCT00557856|463098870|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
128672062|NCT00557856|463098871|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
129006869|NCT01656889|464316699|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
129006870|NCT02521948|464316700|FG000|Overall Study|Adverse Event|2|||
129006871|NCT02521948|464316700|FG000|Overall Study|Death|4|||
129006872|NCT02521948|464316700|FG000|Overall Study|Lost to Follow-up|1|||
129006873|NCT02521948|464316700|FG000|Overall Study|Did not attend one or both follow-ups|6|||
129006874|NCT02427607|464316701|FG000|Overall Study|Withdrawal by Subject|1|||
129006875|NCT00423800|464316702|FG000|Overall Study|Protocol Violation|0|||
129006876|NCT00423800|464316703|FG001|Overall Study|Protocol Violation|1|||
129006877|NCT04000009|464316704|FG000|Overall Study|Adverse Event|13|||
129006878|NCT04000009|464316704|FG000|Overall Study|Lack of Efficacy|7|||
129006879|NCT04000009|464316704|FG000|Overall Study|Lost to Follow-up|8|||
129006880|NCT04000009|464316704|FG000|Overall Study|Noncompliance with study drug|4|||
128672063|NCT05092360|463098872|FG000|Overall Study|Withdrawal by Subject|21|||
128672064|NCT05092360|463098873|FG001|Overall Study|Withdrawal by Subject|4|||
128672065|NCT05092360|463098874|FG002|Overall Study|Withdrawal by Subject|9|||
128672066|NCT05092360|463098875|FG003|Overall Study|Withdrawal by Subject|26|||
128672067|NCT05092360|463098872|FG000|Overall Study|Death|97|||
128672068|NCT05092360|463098873|FG001|Overall Study|Death|14|||
128672069|NCT05092360|463098874|FG002|Overall Study|Death|31|||
128672070|NCT05092360|463098875|FG003|Overall Study|Death|101|||
129006881|NCT04000009|464316704|FG000|Overall Study|Physician Decision|1|||
129215074|NCT02760498|465089439|FG003|Overall Study|Physician Decision|4|||
128672071|NCT05092360|463098872|FG000|Overall Study|Lost to Follow-up|1|||
128672072|NCT05092360|463098873|FG001|Overall Study|Lost to Follow-up|2|||
128672073|NCT05092360|463098874|FG002|Overall Study|Lost to Follow-up|2|||
128672074|NCT05092360|463098875|FG003|Overall Study|Lost to Follow-up|2|||
128672075|NCT05092360|463098872|FG000|Overall Study|Study terminated by sponsor|65|||
128672076|NCT05092360|463098873|FG001|Overall Study|Study terminated by sponsor|7|||
128672077|NCT05092360|463098874|FG002|Overall Study|Study terminated by sponsor|13|||
128672078|NCT05092360|463098875|FG003|Overall Study|Study terminated by sponsor|61|||
128672079|NCT01525225|463098876|FG000|Enrollment|No longer met study criteria|1|||
128672080|NCT01525225|463098876|FG000|Enrollment|Other|1|||
128672081|NCT00243841|463098877|FG000|Overall Study|Physician Decision|0|||
128672082|NCT00243841|463098878|FG001|Overall Study|Physician Decision|0|||
128672083|NCT00243841|463098879|FG002|Overall Study|Physician Decision|1|||
129006882|NCT04000009|464316704|FG000|Overall Study|Use of prohibited medication|3|||
129006883|NCT04000009|464316704|FG000|Overall Study|Pregnancy|1|||
129006884|NCT04000009|464316704|FG000|Overall Study|Withdrawal by Subject|22|||
129006885|NCT04000009|464316704|FG000|Overall Study|Study terminated by sponsor|98|||
129006886|NCT04000009|464316704|FG000|Overall Study|Not further specified|8|||
129006887|NCT00679783|464316706|FG000|Overall Study|Adverse Event|0|||
129006888|NCT00679783|464316707|FG001|Overall Study|Adverse Event|0|||
129006889|NCT00679783|464316708|FG002|Overall Study|Adverse Event|0|||
129006890|NCT00679783|464316709|FG003|Overall Study|Adverse Event|3|||
129006891|NCT00679783|464316710|FG004|Overall Study|Adverse Event|0|||
129006892|NCT00679783|464316711|FG005|Overall Study|Adverse Event|0|||
129006893|NCT00679783|464316712|FG006|Overall Study|Adverse Event|1|||
129006894|NCT00679783|464316706|FG000|Overall Study|Lack of Efficacy|0|||
128672084|NCT00243841|463098880|FG003|Overall Study|Physician Decision|0|||
128672085|NCT00243841|463098881|FG004|Overall Study|Physician Decision|0|||
128672086|NCT00243841|463098882|FG005|Overall Study|Physician Decision|2|||
128672087|NCT00363545|463098883|FG000|Overall Study|Serious Adverse Event|0|||
128672088|NCT00363545|463098884|FG001|Overall Study|Serious Adverse Event|1|||
128672089|NCT00363545|463098883|FG000|Overall Study|Withdrawal by Subject|12|||
128672090|NCT00363545|463098884|FG001|Overall Study|Withdrawal by Subject|15|||
128672091|NCT00363545|463098883|FG000|Overall Study|Migrated/moved from study area|3|||
128672092|NCT00363545|463098884|FG001|Overall Study|Migrated/moved from study area|6|||
128672093|NCT00363545|463098883|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
128672094|NCT00363545|463098884|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
128672095|NCT00363545|463098883|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
128672096|NCT00363545|463098884|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
128672097|NCT00363545|463098883|FG000|Overall Study|Others|1|||
128672098|NCT00363545|463098884|FG001|Overall Study|Others|0|||
128672099|NCT01379508|463098885|FG000|Treatment to Week 104|Adverse Event|2|||
128672100|NCT01379508|463098886|FG001|Treatment to Week 104|Adverse Event|0|||
128672101|NCT01379508|463098887|FG002|Treatment to Week 104|Adverse Event|5|||
128672102|NCT01379508|463098888|FG003|Treatment to Week 104|Adverse Event|0|||
128672103|NCT01379508|463098885|FG000|Treatment to Week 104|Abnormal lab value|1|||
128672104|NCT01379508|463098886|FG001|Treatment to Week 104|Abnormal lab value|0|||
128672105|NCT01379508|463098887|FG002|Treatment to Week 104|Abnormal lab value|0|||
128672106|NCT01379508|463098888|FG003|Treatment to Week 104|Abnormal lab value|0|||
128672107|NCT01379508|463098885|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
128672108|NCT01379508|463098886|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
128672109|NCT01379508|463098887|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
128672110|NCT01379508|463098888|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
128672111|NCT01379508|463098885|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
128672112|NCT01379508|463098886|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
128672113|NCT01379508|463098887|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
128672114|NCT01379508|463098888|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
128672115|NCT01379508|463098885|FG000|Treatment to Week 104|Lost to Follow-up|5|||
128672116|NCT01379508|463098886|FG001|Treatment to Week 104|Lost to Follow-up|0|||
128672117|NCT01379508|463098887|FG002|Treatment to Week 104|Lost to Follow-up|3|||
128672118|NCT01379508|463098888|FG003|Treatment to Week 104|Lost to Follow-up|0|||
129006895|NCT00679783|464316707|FG001|Overall Study|Lack of Efficacy|1|||
129006896|NCT00679783|464316708|FG002|Overall Study|Lack of Efficacy|0|||
129006897|NCT00679783|464316709|FG003|Overall Study|Lack of Efficacy|2|||
128672119|NCT01379508|463098885|FG000|Treatment to Week 104|Administrative problems|3|||
128672120|NCT01379508|463098886|FG001|Treatment to Week 104|Administrative problems|1|||
128672121|NCT01379508|463098887|FG002|Treatment to Week 104|Administrative problems|0|||
128672122|NCT01379508|463098888|FG003|Treatment to Week 104|Administrative problems|0|||
128672123|NCT01379508|463098885|FG000|Treatment to Week 104|Protocol Violation|1|||
129006898|NCT00679783|464316710|FG004|Overall Study|Lack of Efficacy|0|||
129006899|NCT00679783|464316711|FG005|Overall Study|Lack of Efficacy|0|||
129006900|NCT00679783|464316712|FG006|Overall Study|Lack of Efficacy|0|||
128672124|NCT01379508|463098886|FG001|Treatment to Week 104|Protocol Violation|1|||
128672125|NCT01379508|463098887|FG002|Treatment to Week 104|Protocol Violation|1|||
128672126|NCT01379508|463098888|FG003|Treatment to Week 104|Protocol Violation|0|||
128672127|NCT01379508|463098885|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
129006901|NCT00679783|464316706|FG000|Overall Study|Withdrawal by Subject|0|||
129006902|NCT00679783|464316707|FG001|Overall Study|Withdrawal by Subject|0|||
129006903|NCT00679783|464316708|FG002|Overall Study|Withdrawal by Subject|1|||
128672128|NCT01379508|463098886|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
128672129|NCT01379508|463098887|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
128672130|NCT01379508|463098888|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
128672131|NCT01379508|463098885|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
128672132|NCT01379508|463098886|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
128672133|NCT01379508|463098887|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
128672134|NCT01379508|463098888|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
128672135|NCT01379508|463098885|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
128672136|NCT01379508|463098886|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
128672137|NCT01379508|463098887|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
128672138|NCT01379508|463098888|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
128672139|NCT01379508|463098885|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
128672140|NCT01379508|463098886|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
128672141|NCT01379508|463098887|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
128672142|NCT01379508|463098888|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
128672143|NCT02537015|463098891|FG000|Overall Study|Adverse Event|3|||
128672144|NCT02537015|463098891|FG000|Overall Study|Withdrawal by Subject|2|||
128672145|NCT02537015|463098891|FG000|Overall Study|Other Miscellaneous Reasons|1|||
128672146|NCT01696929|463100472|FG000|Overall Study|Physician Decision|1|||
128672147|NCT02156271|463100473|FG000|Overall Study|Physician Decision|4|||
128672148|NCT02156271|463100474|FG001|Overall Study|Physician Decision|3|||
128672149|NCT00109590|463100475|FG000|Overall Study|Lost to Follow-up|1|||
128672150|NCT00109590|463100476|FG001|Overall Study|Lost to Follow-up|0|||
128672151|NCT00109590|463100477|FG002|Overall Study|Lost to Follow-up|1|||
128672152|NCT00109590|463100475|FG000|Overall Study|Never Started Treatment|1|||
128672153|NCT00109590|463100476|FG001|Overall Study|Never Started Treatment|2|||
128672154|NCT00109590|463100477|FG002|Overall Study|Never Started Treatment|3|||
128672155|NCT00745849|463100478|FG000|First Intervention|Withdrawal by Subject|0|||
128672156|NCT00745849|463100479|FG001|First Intervention|Withdrawal by Subject|1|||
128672157|NCT00745849|463100478|FG000|First Intervention|Lost to Follow-up|1|||
128672158|NCT00745849|463100479|FG001|First Intervention|Lost to Follow-up|1|||
128672159|NCT00745849|463100478|FG000|Second Intervention|Lost to Follow-up|2|||
128672160|NCT00745849|463100479|FG001|Second Intervention|Lost to Follow-up|1|||
128672161|NCT04590248|463100481|FG000|Overall Study|Lost to Follow-up|1|||
128672162|NCT04590248|463100481|FG000|Overall Study|Withdrawal by Subject|16|||
128672163|NCT04590248|463100481|FG000|Overall Study|Other|2|||
128672164|NCT02052414|463100484|FG000|Overall Study|Adverse Event|12|||
128672165|NCT02052414|463100484|FG000|Overall Study|Lack of Efficacy|2|||
128672166|NCT02052414|463100484|FG000|Overall Study|Withdrawal by Subject|3|||
128672167|NCT04605991|463100487|FG000|Overall Study|Adverse Event|5|||
128672168|NCT04605991|463100487|FG000|Overall Study|Lack of Efficacy|1|||
128672169|NCT04605991|463100487|FG000|Overall Study|Lost to Follow-up|8|||
128672170|NCT04605991|463100487|FG000|Overall Study|Physician Decision|4|||
128672171|NCT04605991|463100487|FG000|Overall Study|Withdrawal by Subject|14|||
128672172|NCT04605991|463100487|FG000|Overall Study|Non-compliance with study|1|||
128672173|NCT03263702|463100488|FG000|Overall Study|Lost to Follow-up|2|||
128672174|NCT03263702|463100489|FG001|Overall Study|Lost to Follow-up|2|||
128672175|NCT03263702|463100488|FG000|Overall Study|Withdrawal by Subject|1|||
128672176|NCT03263702|463100489|FG001|Overall Study|Withdrawal by Subject|2|||
128672177|NCT01589653|463100491|FG000|Overall Study|Protocol Violation|3|||
128672178|NCT01589653|463100492|FG001|Overall Study|Protocol Violation|1|||
128672179|NCT01589653|463100491|FG000|Overall Study|Withdrawal criteria|4|||
128672180|NCT01589653|463100492|FG001|Overall Study|Withdrawal criteria|7|||
128672181|NCT01589653|463100491|FG000|Overall Study|Unclassified|0|||
128672182|NCT01589653|463100492|FG001|Overall Study|Unclassified|3|||
128672183|NCT03330002|463100493|FG000|Overall Study|Lost to Follow-up|15|||
128672184|NCT03330002|463100493|FG000|Overall Study|Death|7|||
128672185|NCT00635219|463100494|FG000|Overall Study|Adverse Event|12|||
128672186|NCT00635219|463100495|FG001|Overall Study|Adverse Event|10|||
128672187|NCT00635219|463100496|FG002|Overall Study|Adverse Event|18|||
128672188|NCT00635219|463100497|FG003|Overall Study|Adverse Event|15|||
128672189|NCT00635219|463100498|FG004|Overall Study|Adverse Event|19|||
128672190|NCT00635219|463100494|FG000|Overall Study|Lack of Efficacy|5|||
128672191|NCT00635219|463100495|FG001|Overall Study|Lack of Efficacy|6|||
128672192|NCT00635219|463100496|FG002|Overall Study|Lack of Efficacy|3|||
128672193|NCT00635219|463100497|FG003|Overall Study|Lack of Efficacy|4|||
129006904|NCT00679783|464316709|FG003|Overall Study|Withdrawal by Subject|1|||
128672194|NCT00635219|463100498|FG004|Overall Study|Lack of Efficacy|6|||
128672195|NCT00635219|463100494|FG000|Overall Study|Non-compliance With Study Product|0|||
128672196|NCT00635219|463100495|FG001|Overall Study|Non-compliance With Study Product|0|||
129006905|NCT00679783|464316710|FG004|Overall Study|Withdrawal by Subject|0|||
129006906|NCT00679783|464316711|FG005|Overall Study|Withdrawal by Subject|0|||
128672197|NCT00635219|463100496|FG002|Overall Study|Non-compliance With Study Product|0|||
128672198|NCT00635219|463100497|FG003|Overall Study|Non-compliance With Study Product|2|||
128672199|NCT00635219|463100498|FG004|Overall Study|Non-compliance With Study Product|1|||
128672200|NCT00635219|463100494|FG000|Overall Study|Protocol Violation|0|||
128672201|NCT00635219|463100495|FG001|Overall Study|Protocol Violation|2|||
128672202|NCT00635219|463100496|FG002|Overall Study|Protocol Violation|3|||
128672203|NCT00635219|463100497|FG003|Overall Study|Protocol Violation|2|||
128672204|NCT00635219|463100498|FG004|Overall Study|Protocol Violation|4|||
128672205|NCT00635219|463100494|FG000|Overall Study|Withdrawal of Consent|8|||
128672206|NCT00635219|463100495|FG001|Overall Study|Withdrawal of Consent|6|||
128672207|NCT00635219|463100496|FG002|Overall Study|Withdrawal of Consent|8|||
128672208|NCT00635219|463100497|FG003|Overall Study|Withdrawal of Consent|11|||
128672209|NCT00635219|463100498|FG004|Overall Study|Withdrawal of Consent|8|||
128672210|NCT00635219|463100494|FG000|Overall Study|Lost to Follow-up|0|||
128672211|NCT00635219|463100495|FG001|Overall Study|Lost to Follow-up|0|||
128672212|NCT00635219|463100496|FG002|Overall Study|Lost to Follow-up|2|||
128672213|NCT00635219|463100497|FG003|Overall Study|Lost to Follow-up|0|||
128672214|NCT00635219|463100498|FG004|Overall Study|Lost to Follow-up|3|||
128672215|NCT00635219|463100494|FG000|Overall Study|Administrative or Other Reasons|0|||
128672216|NCT00635219|463100495|FG001|Overall Study|Administrative or Other Reasons|1|||
128672217|NCT00635219|463100496|FG002|Overall Study|Administrative or Other Reasons|1|||
128672218|NCT00635219|463100497|FG003|Overall Study|Administrative or Other Reasons|0|||
128672219|NCT00635219|463100498|FG004|Overall Study|Administrative or Other Reasons|1|||
128672220|NCT01598129|463100499|FG000|Overall Study|Disease progression|6|||
128672221|NCT01598129|463100499|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
128672222|NCT01598129|463100499|FG000|Overall Study|Withdrawal by Subject|1|||
128672223|NCT00505076|463100500|FG000|Overall Study|Adverse Event|1|||
128672224|NCT00505076|463100501|FG001|Overall Study|Adverse Event|0|||
128672225|NCT00505076|463100502|FG002|Overall Study|Adverse Event|1|||
128672226|NCT00505076|463100500|FG000|Overall Study|Protocol Violation|2|||
128672227|NCT00505076|463100501|FG001|Overall Study|Protocol Violation|1|||
128672228|NCT00505076|463100502|FG002|Overall Study|Protocol Violation|2|||
128672229|NCT00505076|463100500|FG000|Overall Study|Withdrawal by Subject|0|||
128672230|NCT00505076|463100501|FG001|Overall Study|Withdrawal by Subject|1|||
128672231|NCT00505076|463100502|FG002|Overall Study|Withdrawal by Subject|2|||
128672232|NCT00591318|463100505|FG000|Overall Study|Lack of Efficacy|2|||
128672233|NCT00591318|463100506|FG001|Overall Study|Lack of Efficacy|0|||
128672234|NCT00591318|463100505|FG000|Overall Study|Adverse Event|2|||
128672235|NCT00591318|463100506|FG001|Overall Study|Adverse Event|0|||
128672236|NCT04224688|463100512|FG000|Overall Study|Withdrawal by Subject|1|||
128672237|NCT04224688|463100513|FG001|Overall Study|Withdrawal by Subject|3|||
128672238|NCT04224688|463100512|FG000|Overall Study|Lack of Efficacy|1|||
128672239|NCT04224688|463100513|FG001|Overall Study|Lack of Efficacy|1|||
128672240|NCT04224688|463100512|FG000|Overall Study|Adverse event, not fatal|0|||
128672241|NCT04224688|463100513|FG001|Overall Study|Adverse event, not fatal|2|||
128672242|NCT04224688|463100512|FG000|Overall Study|COVID-19|0|||
128672243|NCT04224688|463100513|FG001|Overall Study|COVID-19|1|||
128672244|NCT02745145|463100516|FG000|Overall Study|Adverse Event|1|||
128672245|NCT02745145|463100517|FG001|Overall Study|Adverse Event|0|||
128672246|NCT02745145|463100518|FG002|Overall Study|Adverse Event|0|||
128672247|NCT02745145|463100516|FG000|Overall Study|Death|0|||
128672248|NCT02745145|463100517|FG001|Overall Study|Death|1|||
128672249|NCT02745145|463100518|FG002|Overall Study|Death|0|||
128672250|NCT02745145|463100516|FG000|Overall Study|Progressive disease|0|||
128672251|NCT02745145|463100517|FG001|Overall Study|Progressive disease|0|||
128672252|NCT02745145|463100518|FG002|Overall Study|Progressive disease|1|||
128672253|NCT02745145|463100516|FG000|Overall Study|Withdrew consent|1|||
128672254|NCT02745145|463100517|FG001|Overall Study|Withdrew consent|1|||
128672255|NCT02745145|463100518|FG002|Overall Study|Withdrew consent|1|||
128672256|NCT02745145|463100516|FG000|Overall Study|Study Termination|8|||
128672257|NCT02745145|463100517|FG001|Overall Study|Study Termination|3|||
128672258|NCT02745145|463100518|FG002|Overall Study|Study Termination|7|||
128672259|NCT00388583|463100519|FG000|Overall Study|Protocol Violation|1|||
128672260|NCT00388583|463100520|FG001|Overall Study|Protocol Violation|0|||
128672261|NCT00388583|463100519|FG000|Overall Study|Withdrawal by Subject|3|||
129006907|NCT00679783|464316712|FG006|Overall Study|Withdrawal by Subject|0|||
129006908|NCT00679783|464316706|FG000|Overall Study|Not Captured|0|||
129006909|NCT00679783|464316707|FG001|Overall Study|Not Captured|0|||
128672262|NCT00388583|463100520|FG001|Overall Study|Withdrawal by Subject|3|||
129006910|NCT00679783|464316708|FG002|Overall Study|Not Captured|0|||
128672263|NCT00388583|463100519|FG000|Overall Study|Serious Adverse Event|2|||
129006911|NCT00679783|464316709|FG003|Overall Study|Not Captured|5|||
128672264|NCT00388583|463100520|FG001|Overall Study|Serious Adverse Event|0|||
128672265|NCT00388583|463100519|FG000|Overall Study|Did not receive vaccine|0|||
128672266|NCT00388583|463100520|FG001|Overall Study|Did not receive vaccine|1|||
128672267|NCT00322621|463100521|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
128672268|NCT00322621|463100522|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
128672269|NCT00322621|463100523|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
128672270|NCT00322621|463100521|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
128672271|NCT00322621|463100522|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
128672272|NCT00322621|463100523|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
128672273|NCT00322621|463100521|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
128672274|NCT00322621|463100522|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
128672275|NCT00322621|463100523|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
128672276|NCT00322621|463100521|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
128672277|NCT00322621|463100522|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
128672278|NCT00322621|463100523|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
128672279|NCT00322621|463100521|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
128672280|NCT00322621|463100522|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
128672281|NCT00322621|463100523|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
128672282|NCT00322621|463100521|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
128672283|NCT00322621|463100522|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
128672284|NCT00322621|463100523|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
128672285|NCT00322621|463100521|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
128672286|NCT00322621|463100522|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
128672287|NCT00322621|463100523|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
128672288|NCT00322621|463100521|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
128672289|NCT00322621|463100522|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
128672290|NCT00322621|463100523|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
128672291|NCT00322621|463100521|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
128672292|NCT00322621|463100522|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
128672293|NCT00322621|463100523|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
128672294|NCT00322621|463100521|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
128672295|NCT00322621|463100522|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
128672296|NCT00322621|463100523|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
128672297|NCT00322621|463100521|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
128672298|NCT00322621|463100522|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
128672299|NCT00322621|463100523|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
128672300|NCT01565343|463100526|FG000|Overall Study|Administrative decision/technical issues|1|||
128672301|NCT01565343|463100527|FG001|Overall Study|Administrative decision/technical issues|0|||
128672302|NCT01565343|463100528|FG002|Overall Study|Administrative decision/technical issues|0|||
128672303|NCT01853839|463100534|FG000|Overall Study|Violated inclusion criteria|2|||
128672304|NCT01853839|463100534|FG000|Overall Study|Not meet ITT population definition|58|||
128672305|NCT01853839|463100534|FG000|Overall Study|End of treatment visit too early|33|||
128672306|NCT01853839|463100534|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
128672307|NCT02709538|463100535|FG000|Overall Study|Adverse Event|13|||
128672308|NCT02709538|463100536|FG001|Overall Study|Adverse Event|2|||
128672309|NCT02709538|463100537|FG002|Overall Study|Adverse Event|3|||
128672310|NCT02709538|463100535|FG000|Overall Study|Lack of Efficacy|1|||
128672311|NCT02709538|463100536|FG001|Overall Study|Lack of Efficacy|0|||
128672312|NCT02709538|463100537|FG002|Overall Study|Lack of Efficacy|0|||
128672313|NCT02709538|463100535|FG000|Overall Study|Lost to Follow-up|24|||
128672314|NCT02709538|463100536|FG001|Overall Study|Lost to Follow-up|8|||
128672315|NCT02709538|463100537|FG002|Overall Study|Lost to Follow-up|4|||
128672316|NCT02709538|463100535|FG000|Overall Study|Physician Decision|1|||
128672317|NCT02709538|463100536|FG001|Overall Study|Physician Decision|0|||
128672318|NCT02709538|463100537|FG002|Overall Study|Physician Decision|0|||
128672319|NCT02709538|463100535|FG000|Overall Study|Withdrawal by Subject|40|||
128672320|NCT02709538|463100536|FG001|Overall Study|Withdrawal by Subject|7|||
128672321|NCT02709538|463100537|FG002|Overall Study|Withdrawal by Subject|4|||
128672322|NCT02709538|463100535|FG000|Overall Study|Non-compliance with study procedures|5|||
128672323|NCT02709538|463100536|FG001|Overall Study|Non-compliance with study procedures|0|||
128672324|NCT02709538|463100537|FG002|Overall Study|Non-compliance with study procedures|0|||
128672325|NCT02709538|463100535|FG000|Overall Study|Non-compliance with study drug|2|||
128672326|NCT02709538|463100536|FG001|Overall Study|Non-compliance with study drug|0|||
128672327|NCT02709538|463100537|FG002|Overall Study|Non-compliance with study drug|0|||
128672328|NCT02709538|463100535|FG000|Overall Study|Protocol deviation|10|||
128672329|NCT02709538|463100536|FG001|Overall Study|Protocol deviation|4|||
128672330|NCT02709538|463100537|FG002|Overall Study|Protocol deviation|4|||
129006912|NCT00679783|464316710|FG004|Overall Study|Not Captured|0|||
128672331|NCT02709538|463100535|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
128672332|NCT02709538|463100536|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
128672333|NCT02709538|463100537|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
128672334|NCT02709538|463100535|FG000|Overall Study|Other|16|||
128672335|NCT02709538|463100536|FG001|Overall Study|Other|7|||
128672336|NCT02709538|463100537|FG002|Overall Study|Other|5|||
128672337|NCT02059291|463100538|FG000|Epoch 2|Lack of Efficacy|0|||
128672338|NCT02059291|463100539|FG001|Epoch 2|Lack of Efficacy|0|||
128672339|NCT02059291|463100540|FG002|Epoch 2|Lack of Efficacy|0|||
128672340|NCT02059291|463100541|FG003|Epoch 2|Lack of Efficacy|1|||
128672341|NCT02059291|463100542|FG004|Epoch 2|Lack of Efficacy|0|||
128672342|NCT02059291|463100543|FG005|Epoch 2|Lack of Efficacy|1|||
128672343|NCT02059291|463100544|FG006|Epoch 2|Lack of Efficacy|0|||
128672344|NCT02059291|463100545|FG007|Epoch 2|Lack of Efficacy|0|||
128672345|NCT02059291|463100546|FG008|Epoch 2|Lack of Efficacy|0|||
128672346|NCT02059291|463100547|FG009|Epoch 2|Lack of Efficacy|0|||
128672347|NCT02059291|463100548|FG010|Epoch 2|Lack of Efficacy|0|||
128672348|NCT02059291|463100549|FG011|Epoch 2|Lack of Efficacy|0|||
128672349|NCT02059291|463100550|FG012|Epoch 2|Lack of Efficacy|0|||
128672350|NCT02059291|463100551|FG013|Epoch 2|Lack of Efficacy|0|||
128672351|NCT02059291|463100552|FG014|Epoch 2|Lack of Efficacy|0|||
128672352|NCT02059291|463100553|FG015|Epoch 2|Lack of Efficacy|0|||
128672353|NCT02059291|463100554|FG016|Epoch 2|Lack of Efficacy|0|||
128672354|NCT02059291|463100555|FG017|Epoch 2|Lack of Efficacy|0|||
128672355|NCT02059291|463100556|FG018|Epoch 2|Lack of Efficacy|0|||
128672356|NCT02059291|463100557|FG019|Epoch 2|Lack of Efficacy|0|||
128672357|NCT02059291|463100558|FG020|Epoch 2|Lack of Efficacy|0|||
128672358|NCT02059291|463100559|FG021|Epoch 2|Lack of Efficacy|0|||
128672359|NCT02059291|463100560|FG022|Epoch 2|Lack of Efficacy|0|||
128672360|NCT02059291|463100561|FG023|Epoch 2|Lack of Efficacy|0|||
128672361|NCT02059291|463100562|FG024|Epoch 2|Lack of Efficacy|0|||
128672362|NCT02059291|463100538|FG000|Epoch 2|Adverse Event|0|||
128672363|NCT02059291|463100539|FG001|Epoch 2|Adverse Event|0|||
128672364|NCT02059291|463100540|FG002|Epoch 2|Adverse Event|1|||
128672365|NCT02059291|463100541|FG003|Epoch 2|Adverse Event|1|||
128672366|NCT02059291|463100542|FG004|Epoch 2|Adverse Event|0|||
128672367|NCT02059291|463100543|FG005|Epoch 2|Adverse Event|0|||
128672368|NCT02059291|463100544|FG006|Epoch 2|Adverse Event|0|||
128672369|NCT02059291|463100545|FG007|Epoch 2|Adverse Event|1|||
128672370|NCT02059291|463100546|FG008|Epoch 2|Adverse Event|1|||
128672371|NCT02059291|463100547|FG009|Epoch 2|Adverse Event|0|||
128672372|NCT02059291|463100548|FG010|Epoch 2|Adverse Event|0|||
128672373|NCT02059291|463100549|FG011|Epoch 2|Adverse Event|0|||
128672374|NCT02059291|463100550|FG012|Epoch 2|Adverse Event|0|||
128672375|NCT02059291|463100551|FG013|Epoch 2|Adverse Event|0|||
128672376|NCT02059291|463100552|FG014|Epoch 2|Adverse Event|0|||
128672377|NCT02059291|463100553|FG015|Epoch 2|Adverse Event|0|||
128672378|NCT02059291|463100554|FG016|Epoch 2|Adverse Event|0|||
128672379|NCT02059291|463100555|FG017|Epoch 2|Adverse Event|0|||
128672380|NCT02059291|463100556|FG018|Epoch 2|Adverse Event|0|||
128672381|NCT02059291|463100557|FG019|Epoch 2|Adverse Event|0|||
128672382|NCT02059291|463100558|FG020|Epoch 2|Adverse Event|0|||
128672383|NCT02059291|463100559|FG021|Epoch 2|Adverse Event|0|||
128672384|NCT02059291|463100560|FG022|Epoch 2|Adverse Event|0|||
128672385|NCT02059291|463100561|FG023|Epoch 2|Adverse Event|0|||
128672386|NCT02059291|463100562|FG024|Epoch 2|Adverse Event|0|||
128672387|NCT02059291|463100538|FG000|Epoch 2|Withdrawal by Subject|0|||
128672388|NCT02059291|463100539|FG001|Epoch 2|Withdrawal by Subject|1|||
128672389|NCT02059291|463100540|FG002|Epoch 2|Withdrawal by Subject|0|||
128672390|NCT02059291|463100541|FG003|Epoch 2|Withdrawal by Subject|0|||
128672391|NCT02059291|463100542|FG004|Epoch 2|Withdrawal by Subject|0|||
128672392|NCT02059291|463100543|FG005|Epoch 2|Withdrawal by Subject|1|||
128672393|NCT02059291|463100544|FG006|Epoch 2|Withdrawal by Subject|0|||
128672394|NCT02059291|463100545|FG007|Epoch 2|Withdrawal by Subject|0|||
128672395|NCT02059291|463100546|FG008|Epoch 2|Withdrawal by Subject|1|||
128672396|NCT02059291|463100547|FG009|Epoch 2|Withdrawal by Subject|0|||
128672397|NCT02059291|463100548|FG010|Epoch 2|Withdrawal by Subject|0|||
128672398|NCT02059291|463100549|FG011|Epoch 2|Withdrawal by Subject|0|||
128672399|NCT02059291|463100550|FG012|Epoch 2|Withdrawal by Subject|0|||
128672400|NCT02059291|463100551|FG013|Epoch 2|Withdrawal by Subject|0|||
128672401|NCT02059291|463100552|FG014|Epoch 2|Withdrawal by Subject|0|||
128672402|NCT02059291|463100553|FG015|Epoch 2|Withdrawal by Subject|0|||
128672403|NCT02059291|463100554|FG016|Epoch 2|Withdrawal by Subject|0|||
128672404|NCT02059291|463100555|FG017|Epoch 2|Withdrawal by Subject|0|||
128672405|NCT02059291|463100556|FG018|Epoch 2|Withdrawal by Subject|0|||
128672406|NCT02059291|463100557|FG019|Epoch 2|Withdrawal by Subject|0|||
129006913|NCT00679783|464316711|FG005|Overall Study|Not Captured|0|||
129006914|NCT00679783|464316712|FG006|Overall Study|Not Captured|0|||
129006915|NCT00679783|464316706|FG000|Overall Study|Ongoing at data cut-off|2|||
128672407|NCT02059291|463100558|FG020|Epoch 2|Withdrawal by Subject|0|||
128672408|NCT02059291|463100559|FG021|Epoch 2|Withdrawal by Subject|0|||
128672409|NCT02059291|463100560|FG022|Epoch 2|Withdrawal by Subject|0|||
128672410|NCT02059291|463100561|FG023|Epoch 2|Withdrawal by Subject|0|||
128672411|NCT02059291|463100562|FG024|Epoch 2|Withdrawal by Subject|0|||
128672412|NCT02059291|463100538|FG000|Epoch 3|Physician Decision|0|||
128672413|NCT02059291|463100539|FG001|Epoch 3|Physician Decision|0|||
128672414|NCT02059291|463100540|FG002|Epoch 3|Physician Decision|0|||
128672415|NCT02059291|463100541|FG003|Epoch 3|Physician Decision|0|||
128672416|NCT02059291|463100542|FG004|Epoch 3|Physician Decision|0|||
128672417|NCT02059291|463100543|FG005|Epoch 3|Physician Decision|0|||
128672418|NCT02059291|463100544|FG006|Epoch 3|Physician Decision|0|||
128672419|NCT02059291|463100545|FG007|Epoch 3|Physician Decision|0|||
128672420|NCT02059291|463100546|FG008|Epoch 3|Physician Decision|0|||
128672421|NCT02059291|463100547|FG009|Epoch 3|Physician Decision|0|||
129006916|NCT00679783|464316707|FG001|Overall Study|Ongoing at data cut-off|2|||
128672422|NCT02059291|463100548|FG010|Epoch 3|Physician Decision|0|||
128672423|NCT02059291|463100549|FG011|Epoch 3|Physician Decision|0|||
128672424|NCT02059291|463100550|FG012|Epoch 3|Physician Decision|0|||
128672425|NCT02059291|463100551|FG013|Epoch 3|Physician Decision|1|||
128672426|NCT02059291|463100552|FG014|Epoch 3|Physician Decision|0|||
128672427|NCT02059291|463100553|FG015|Epoch 3|Physician Decision|1|||
128672428|NCT02059291|463100554|FG016|Epoch 3|Physician Decision|0|||
128672429|NCT02059291|463100555|FG017|Epoch 3|Physician Decision|0|||
128672430|NCT02059291|463100556|FG018|Epoch 3|Physician Decision|0|||
128672431|NCT02059291|463100557|FG019|Epoch 3|Physician Decision|0|||
128672432|NCT02059291|463100558|FG020|Epoch 3|Physician Decision|0|||
128672433|NCT02059291|463100559|FG021|Epoch 3|Physician Decision|0|||
128672434|NCT02059291|463100560|FG022|Epoch 3|Physician Decision|0|||
128672435|NCT02059291|463100561|FG023|Epoch 3|Physician Decision|0|||
128672436|NCT02059291|463100562|FG024|Epoch 3|Physician Decision|0|||
129006917|NCT00679783|464316708|FG002|Overall Study|Ongoing at data cut-off|0|||
129006918|NCT00679783|464316709|FG003|Overall Study|Ongoing at data cut-off|9|||
129006919|NCT00679783|464316710|FG004|Overall Study|Ongoing at data cut-off|1|||
129006920|NCT00679783|464316711|FG005|Overall Study|Ongoing at data cut-off|0|||
128672437|NCT02059291|463100538|FG000|Epoch 3|Adverse Event|0|||
128672438|NCT02059291|463100539|FG001|Epoch 3|Adverse Event|0|||
128672439|NCT02059291|463100540|FG002|Epoch 3|Adverse Event|0|||
128672440|NCT02059291|463100541|FG003|Epoch 3|Adverse Event|0|||
128672441|NCT02059291|463100542|FG004|Epoch 3|Adverse Event|0|||
128672442|NCT02059291|463100543|FG005|Epoch 3|Adverse Event|0|||
128672443|NCT02059291|463100544|FG006|Epoch 3|Adverse Event|0|||
128672444|NCT02059291|463100545|FG007|Epoch 3|Adverse Event|0|||
128672445|NCT02059291|463100546|FG008|Epoch 3|Adverse Event|0|||
128672446|NCT02059291|463100547|FG009|Epoch 3|Adverse Event|0|||
128672447|NCT02059291|463100548|FG010|Epoch 3|Adverse Event|0|||
128672448|NCT02059291|463100549|FG011|Epoch 3|Adverse Event|0|||
128672449|NCT02059291|463100550|FG012|Epoch 3|Adverse Event|0|||
128672450|NCT02059291|463100551|FG013|Epoch 3|Adverse Event|0|||
128672451|NCT02059291|463100552|FG014|Epoch 3|Adverse Event|0|||
128672452|NCT02059291|463100553|FG015|Epoch 3|Adverse Event|1|||
128672453|NCT02059291|463100554|FG016|Epoch 3|Adverse Event|0|||
128672454|NCT02059291|463100555|FG017|Epoch 3|Adverse Event|0|||
128672455|NCT02059291|463100556|FG018|Epoch 3|Adverse Event|0|||
128672456|NCT02059291|463100557|FG019|Epoch 3|Adverse Event|0|||
128672457|NCT02059291|463100558|FG020|Epoch 3|Adverse Event|0|||
128672458|NCT02059291|463100559|FG021|Epoch 3|Adverse Event|0|||
128672459|NCT02059291|463100560|FG022|Epoch 3|Adverse Event|0|||
128672460|NCT02059291|463100561|FG023|Epoch 3|Adverse Event|0|||
128672461|NCT02059291|463100562|FG024|Epoch 3|Adverse Event|0|||
128672462|NCT02059291|463100538|FG000|Epoch 3|Lack of Efficacy|0|||
128672463|NCT02059291|463100539|FG001|Epoch 3|Lack of Efficacy|0|||
128672464|NCT02059291|463100540|FG002|Epoch 3|Lack of Efficacy|0|||
128672465|NCT02059291|463100541|FG003|Epoch 3|Lack of Efficacy|0|||
128672466|NCT02059291|463100542|FG004|Epoch 3|Lack of Efficacy|0|||
128672467|NCT02059291|463100543|FG005|Epoch 3|Lack of Efficacy|0|||
128672468|NCT02059291|463100544|FG006|Epoch 3|Lack of Efficacy|0|||
128672469|NCT02059291|463100545|FG007|Epoch 3|Lack of Efficacy|0|||
128672470|NCT02059291|463100546|FG008|Epoch 3|Lack of Efficacy|0|||
128672471|NCT02059291|463100547|FG009|Epoch 3|Lack of Efficacy|0|||
128672472|NCT02059291|463100548|FG010|Epoch 3|Lack of Efficacy|0|||
128672473|NCT02059291|463100549|FG011|Epoch 3|Lack of Efficacy|0|||
128672474|NCT02059291|463100550|FG012|Epoch 3|Lack of Efficacy|0|||
129006921|NCT00679783|464316712|FG006|Overall Study|Ongoing at data cut-off|0|||
129006922|NCT01754259|464316715|FG000|Overall Study|Withdrawal by Subject|2|||
129006923|NCT01754259|464316716|FG001|Overall Study|Withdrawal by Subject|4|||
129006924|NCT01754259|464316715|FG000|Overall Study|Adverse Event|3|||
129006925|NCT01754259|464316716|FG001|Overall Study|Adverse Event|1|||
129006926|NCT01754259|464316715|FG000|Overall Study|Lost to Follow-up|0|||
129006927|NCT01754259|464316716|FG001|Overall Study|Lost to Follow-up|1|||
129006928|NCT00619385|464316719|FG000|Overall Study|Adverse Event|0|||
128672475|NCT02059291|463100551|FG013|Epoch 3|Lack of Efficacy|0|||
128672476|NCT02059291|463100552|FG014|Epoch 3|Lack of Efficacy|0|||
128672477|NCT02059291|463100553|FG015|Epoch 3|Lack of Efficacy|3|||
128672478|NCT02059291|463100554|FG016|Epoch 3|Lack of Efficacy|0|||
128672479|NCT02059291|463100555|FG017|Epoch 3|Lack of Efficacy|0|||
128672480|NCT02059291|463100556|FG018|Epoch 3|Lack of Efficacy|0|||
128672481|NCT02059291|463100557|FG019|Epoch 3|Lack of Efficacy|0|||
128672482|NCT02059291|463100558|FG020|Epoch 3|Lack of Efficacy|0|||
128672483|NCT02059291|463100559|FG021|Epoch 3|Lack of Efficacy|0|||
128672484|NCT02059291|463100560|FG022|Epoch 3|Lack of Efficacy|0|||
128672485|NCT02059291|463100561|FG023|Epoch 3|Lack of Efficacy|0|||
128672486|NCT02059291|463100562|FG024|Epoch 3|Lack of Efficacy|0|||
128672487|NCT02059291|463100538|FG000|Epoch 3|Withdrawal by Subject|0|||
128672488|NCT02059291|463100539|FG001|Epoch 3|Withdrawal by Subject|0|||
128672489|NCT02059291|463100540|FG002|Epoch 3|Withdrawal by Subject|0|||
128672490|NCT02059291|463100541|FG003|Epoch 3|Withdrawal by Subject|0|||
128672491|NCT02059291|463100542|FG004|Epoch 3|Withdrawal by Subject|0|||
128672492|NCT02059291|463100543|FG005|Epoch 3|Withdrawal by Subject|0|||
129006929|NCT00619385|464316720|FG001|Overall Study|Adverse Event|0|||
129006930|NCT00619385|464316721|FG002|Overall Study|Adverse Event|3|||
128672493|NCT02059291|463100544|FG006|Epoch 3|Withdrawal by Subject|0|||
128672494|NCT02059291|463100545|FG007|Epoch 3|Withdrawal by Subject|0|||
128672495|NCT02059291|463100546|FG008|Epoch 3|Withdrawal by Subject|0|||
128672496|NCT02059291|463100547|FG009|Epoch 3|Withdrawal by Subject|0|||
128672497|NCT02059291|463100548|FG010|Epoch 3|Withdrawal by Subject|0|||
128672498|NCT02059291|463100549|FG011|Epoch 3|Withdrawal by Subject|0|||
128672499|NCT02059291|463100550|FG012|Epoch 3|Withdrawal by Subject|0|||
128672500|NCT02059291|463100551|FG013|Epoch 3|Withdrawal by Subject|0|||
128672501|NCT02059291|463100552|FG014|Epoch 3|Withdrawal by Subject|0|||
128672502|NCT02059291|463100553|FG015|Epoch 3|Withdrawal by Subject|1|||
128672503|NCT02059291|463100554|FG016|Epoch 3|Withdrawal by Subject|0|||
128672504|NCT02059291|463100555|FG017|Epoch 3|Withdrawal by Subject|0|||
128672505|NCT02059291|463100556|FG018|Epoch 3|Withdrawal by Subject|0|||
128672506|NCT02059291|463100557|FG019|Epoch 3|Withdrawal by Subject|0|||
128672507|NCT02059291|463100558|FG020|Epoch 3|Withdrawal by Subject|0|||
128672508|NCT02059291|463100559|FG021|Epoch 3|Withdrawal by Subject|0|||
128672509|NCT02059291|463100560|FG022|Epoch 3|Withdrawal by Subject|0|||
128672510|NCT02059291|463100561|FG023|Epoch 3|Withdrawal by Subject|0|||
128672511|NCT02059291|463100562|FG024|Epoch 3|Withdrawal by Subject|0|||
128672512|NCT02059291|463100538|FG000|Epoch 4|Adverse Event|0|||
128672513|NCT02059291|463100539|FG001|Epoch 4|Adverse Event|0|||
128672514|NCT02059291|463100540|FG002|Epoch 4|Adverse Event|0|||
128672515|NCT02059291|463100541|FG003|Epoch 4|Adverse Event|0|||
128672516|NCT02059291|463100542|FG004|Epoch 4|Adverse Event|0|||
128672517|NCT02059291|463100543|FG005|Epoch 4|Adverse Event|0|||
128672518|NCT02059291|463100544|FG006|Epoch 4|Adverse Event|0|||
128672519|NCT02059291|463100545|FG007|Epoch 4|Adverse Event|0|||
128672520|NCT02059291|463100546|FG008|Epoch 4|Adverse Event|0|||
128672521|NCT02059291|463100547|FG009|Epoch 4|Adverse Event|0|||
128672522|NCT02059291|463100548|FG010|Epoch 4|Adverse Event|0|||
128672523|NCT02059291|463100549|FG011|Epoch 4|Adverse Event|0|||
128672524|NCT02059291|463100550|FG012|Epoch 4|Adverse Event|0|||
128672525|NCT02059291|463100551|FG013|Epoch 4|Adverse Event|0|||
128672526|NCT02059291|463100552|FG014|Epoch 4|Adverse Event|0|||
128672527|NCT02059291|463100553|FG015|Epoch 4|Adverse Event|0|||
128672528|NCT02059291|463100554|FG016|Epoch 4|Adverse Event|1|||
128672529|NCT02059291|463100555|FG017|Epoch 4|Adverse Event|0|||
128672530|NCT02059291|463100556|FG018|Epoch 4|Adverse Event|0|||
128672531|NCT02059291|463100557|FG019|Epoch 4|Adverse Event|0|||
128672532|NCT02059291|463100558|FG020|Epoch 4|Adverse Event|0|||
128672533|NCT02059291|463100559|FG021|Epoch 4|Adverse Event|0|||
128672534|NCT02059291|463100560|FG022|Epoch 4|Adverse Event|1|||
128672535|NCT02059291|463100561|FG023|Epoch 4|Adverse Event|0|||
128672536|NCT02059291|463100562|FG024|Epoch 4|Adverse Event|0|||
128672537|NCT02059291|463100538|FG000|Epoch 4|Pregnancy|0|||
128672538|NCT02059291|463100539|FG001|Epoch 4|Pregnancy|0|||
128672539|NCT02059291|463100540|FG002|Epoch 4|Pregnancy|0|||
128672540|NCT02059291|463100541|FG003|Epoch 4|Pregnancy|0|||
128672541|NCT02059291|463100542|FG004|Epoch 4|Pregnancy|0|||
128672542|NCT02059291|463100543|FG005|Epoch 4|Pregnancy|0|||
128672543|NCT02059291|463100544|FG006|Epoch 4|Pregnancy|0|||
128672544|NCT02059291|463100545|FG007|Epoch 4|Pregnancy|0|||
128672545|NCT02059291|463100546|FG008|Epoch 4|Pregnancy|0|||
128672546|NCT02059291|463100547|FG009|Epoch 4|Pregnancy|0|||
128672547|NCT02059291|463100548|FG010|Epoch 4|Pregnancy|0|||
128672548|NCT02059291|463100549|FG011|Epoch 4|Pregnancy|0|||
128672549|NCT02059291|463100550|FG012|Epoch 4|Pregnancy|0|||
128672550|NCT02059291|463100551|FG013|Epoch 4|Pregnancy|0|||
128672551|NCT02059291|463100552|FG014|Epoch 4|Pregnancy|0|||
128672552|NCT02059291|463100553|FG015|Epoch 4|Pregnancy|0|||
128672553|NCT02059291|463100554|FG016|Epoch 4|Pregnancy|1|||
128672554|NCT02059291|463100555|FG017|Epoch 4|Pregnancy|0|||
128672555|NCT02059291|463100556|FG018|Epoch 4|Pregnancy|0|||
129006931|NCT00619385|464316719|FG000|Overall Study|Other|1|||
129006932|NCT00619385|464316720|FG001|Overall Study|Other|2|||
129006933|NCT00619385|464316721|FG002|Overall Study|Other|1|||
128672556|NCT02059291|463100557|FG019|Epoch 4|Pregnancy|0|||
128672557|NCT02059291|463100558|FG020|Epoch 4|Pregnancy|0|||
128672558|NCT02059291|463100559|FG021|Epoch 4|Pregnancy|0|||
128672559|NCT02059291|463100560|FG022|Epoch 4|Pregnancy|0|||
128672560|NCT02059291|463100561|FG023|Epoch 4|Pregnancy|0|||
128672561|NCT02059291|463100562|FG024|Epoch 4|Pregnancy|0|||
128672562|NCT02059291|463100538|FG000|Epoch 4|Withdrawal by Subject|0|||
128672563|NCT02059291|463100539|FG001|Epoch 4|Withdrawal by Subject|0|||
128672564|NCT02059291|463100540|FG002|Epoch 4|Withdrawal by Subject|0|||
129006934|NCT02041702|464316724|FG000|Overall Study|Lost to Follow-up|1|||
128672565|NCT02059291|463100541|FG003|Epoch 4|Withdrawal by Subject|0|||
128672566|NCT02059291|463100542|FG004|Epoch 4|Withdrawal by Subject|0|||
129006935|NCT02041702|464316725|FG001|Overall Study|Lost to Follow-up|6|||
128672567|NCT02059291|463100543|FG005|Epoch 4|Withdrawal by Subject|0|||
128672568|NCT02059291|463100544|FG006|Epoch 4|Withdrawal by Subject|0|||
128672569|NCT02059291|463100545|FG007|Epoch 4|Withdrawal by Subject|0|||
128672570|NCT02059291|463100546|FG008|Epoch 4|Withdrawal by Subject|0|||
128672571|NCT02059291|463100547|FG009|Epoch 4|Withdrawal by Subject|0|||
128672572|NCT02059291|463100548|FG010|Epoch 4|Withdrawal by Subject|0|||
128672573|NCT02059291|463100549|FG011|Epoch 4|Withdrawal by Subject|0|||
128672574|NCT02059291|463100550|FG012|Epoch 4|Withdrawal by Subject|0|||
129006936|NCT02041702|464316724|FG000|Overall Study|Death|4|||
128672575|NCT02059291|463100551|FG013|Epoch 4|Withdrawal by Subject|0|||
128672576|NCT02059291|463100552|FG014|Epoch 4|Withdrawal by Subject|0|||
128672577|NCT02059291|463100553|FG015|Epoch 4|Withdrawal by Subject|0|||
128672578|NCT02059291|463100554|FG016|Epoch 4|Withdrawal by Subject|0|||
128672579|NCT02059291|463100555|FG017|Epoch 4|Withdrawal by Subject|0|||
128672580|NCT02059291|463100556|FG018|Epoch 4|Withdrawal by Subject|0|||
128672581|NCT02059291|463100557|FG019|Epoch 4|Withdrawal by Subject|0|||
128672582|NCT02059291|463100558|FG020|Epoch 4|Withdrawal by Subject|1|||
128672583|NCT02059291|463100559|FG021|Epoch 4|Withdrawal by Subject|0|||
128672584|NCT02059291|463100560|FG022|Epoch 4|Withdrawal by Subject|0|||
128672585|NCT02059291|463100561|FG023|Epoch 4|Withdrawal by Subject|0|||
128672586|NCT02059291|463100562|FG024|Epoch 4|Withdrawal by Subject|0|||
128672587|NCT02059291|463100538|FG000|Epoch 4|Lack of Efficacy|0|||
128672588|NCT02059291|463100539|FG001|Epoch 4|Lack of Efficacy|0|||
128672589|NCT02059291|463100540|FG002|Epoch 4|Lack of Efficacy|0|||
128672590|NCT02059291|463100541|FG003|Epoch 4|Lack of Efficacy|0|||
128672591|NCT02059291|463100542|FG004|Epoch 4|Lack of Efficacy|0|||
128672592|NCT02059291|463100543|FG005|Epoch 4|Lack of Efficacy|0|||
128672593|NCT02059291|463100544|FG006|Epoch 4|Lack of Efficacy|0|||
128672594|NCT02059291|463100545|FG007|Epoch 4|Lack of Efficacy|0|||
128672595|NCT02059291|463100546|FG008|Epoch 4|Lack of Efficacy|0|||
128672596|NCT02059291|463100547|FG009|Epoch 4|Lack of Efficacy|0|||
128672597|NCT02059291|463100548|FG010|Epoch 4|Lack of Efficacy|0|||
128672598|NCT02059291|463100549|FG011|Epoch 4|Lack of Efficacy|0|||
128672599|NCT02059291|463100550|FG012|Epoch 4|Lack of Efficacy|0|||
128672600|NCT02059291|463100551|FG013|Epoch 4|Lack of Efficacy|0|||
128672601|NCT02059291|463100552|FG014|Epoch 4|Lack of Efficacy|0|||
128672602|NCT02059291|463100553|FG015|Epoch 4|Lack of Efficacy|0|||
128672603|NCT02059291|463100554|FG016|Epoch 4|Lack of Efficacy|0|||
128672604|NCT02059291|463100555|FG017|Epoch 4|Lack of Efficacy|0|||
128672605|NCT02059291|463100556|FG018|Epoch 4|Lack of Efficacy|0|||
128672606|NCT02059291|463100557|FG019|Epoch 4|Lack of Efficacy|0|||
128672607|NCT02059291|463100558|FG020|Epoch 4|Lack of Efficacy|0|||
128672608|NCT02059291|463100559|FG021|Epoch 4|Lack of Efficacy|0|||
128672609|NCT02059291|463100560|FG022|Epoch 4|Lack of Efficacy|0|||
128672610|NCT02059291|463100561|FG023|Epoch 4|Lack of Efficacy|1|||
128672611|NCT02059291|463100562|FG024|Epoch 4|Lack of Efficacy|0|||
128672612|NCT01433289|463100563|FG000|Overall Study|Pregnancy|0|||
128672613|NCT01433289|463100564|FG001|Overall Study|Pregnancy|1|||
128672614|NCT01433289|463100565|FG002|Overall Study|Pregnancy|0|||
128672615|NCT01433289|463100566|FG003|Overall Study|Pregnancy|0|||
128672616|NCT04343235|463100572|FG000|Overall Study|Lost to Follow-up|3|||
128672617|NCT04343235|463100573|FG001|Overall Study|Lost to Follow-up|2|||
128672618|NCT00787267|463100574|FG000|Overall Study|Screen failure/Ineligible|10|||
128672619|NCT00787267|463100574|FG000|Overall Study|No Reason Provided|1|||
128672620|NCT00787267|463100574|FG000|Overall Study|Withdrawal by Subject|1|||
128672621|NCT01763996|463100575|FG000|Treatment Period 2|Adverse Event|0|||
128672622|NCT01763996|463100576|FG001|Treatment Period 2|Adverse Event|1|||
128672623|NCT00865280|463100577|FG000|Overall Study|Withdrawal by Subject|4|||
128672624|NCT00865280|463100578|FG001|Overall Study|Withdrawal by Subject|1|||
128672625|NCT00865280|463100577|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
128672626|NCT00865280|463100578|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
128672627|NCT00865280|463100577|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
128672628|NCT00865280|463100578|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
128672629|NCT00865280|463100577|FG000|Overall Study|Exclusion Condition|1|||
128672630|NCT00865280|463100578|FG001|Overall Study|Exclusion Condition|0|||
128672631|NCT00865280|463100577|FG000|Overall Study|Adverse Event|0|||
128672632|NCT00865280|463100578|FG001|Overall Study|Adverse Event|1|||
128672633|NCT01788215|463100579|FG000|Overall Study|Withdrawal by Subject|0|||
128672634|NCT01788215|463100580|FG001|Overall Study|Withdrawal by Subject|1|||
128672635|NCT01788215|463100579|FG000|Overall Study|Lost to Follow-up|2|||
128672636|NCT01788215|463100580|FG001|Overall Study|Lost to Follow-up|0|||
128672637|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
128672638|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
129006937|NCT02041702|464316725|FG001|Overall Study|Death|0|||
129006938|NCT02041702|464316724|FG000|Overall Study|Withdrawal by Subject|4|||
129006939|NCT02041702|464316725|FG001|Overall Study|Withdrawal by Subject|3|||
128672639|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
129006940|NCT02041702|464316724|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
129006941|NCT02041702|464316725|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
128672640|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
128672641|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
128672642|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
128672643|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
128672644|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
128672645|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
128672646|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
129006942|NCT02041702|464316724|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
128672647|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
128672648|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
128672649|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
128672650|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
128672651|NCT00612105|463100586|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
128672652|NCT00612105|463100587|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
128672653|NCT00612105|463100586|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
128672654|NCT00612105|463100587|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
128672655|NCT00612105|463100586|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
128672656|NCT00612105|463100587|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
128672657|NCT00612105|463100586|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
128672658|NCT00612105|463100587|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
128672659|NCT00612105|463100586|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
128672660|NCT00612105|463100587|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
128672661|NCT01105767|463100588|FG000|Overall Study|Lost to Follow-up|1160|||
128672662|NCT01105767|463100589|FG001|Overall Study|Lost to Follow-up|1614|||
128672663|NCT01105767|463100590|FG002|Overall Study|Lost to Follow-up|1184|||
128672664|NCT00743106|463100591|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
128672665|NCT00743106|463100592|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
128672666|NCT00271505|463100597|FG000|Overall Study|Screen Failure|3|||
128672667|NCT00271505|463100597|FG000|Overall Study|Adverse Event|1|||
128672668|NCT00271505|463100597|FG000|Overall Study|Death|1|||
128672669|NCT02874144|463100600|FG000|Overall Study|Lost to Follow-up|3|||
128672670|NCT02874144|463100601|FG001|Overall Study|Lost to Follow-up|5|||
128672671|NCT03753789|463100605|FG000|Overall Study|Withdrawal by Subject|2|||
128672672|NCT01578850|463100610|FG000|Period 1|Insufficient Clinical Response|1|||
128672673|NCT01578850|463100611|FG001|Period 1|Insufficient Clinical Response|0|||
128672674|NCT01578850|463100612|FG002|Period 1|Insufficient Clinical Response|0|||
128672675|NCT01578850|463100610|FG000|Period 1|Adverse Event|11|||
128672676|NCT01578850|463100611|FG001|Period 1|Adverse Event|0|||
128672677|NCT01578850|463100612|FG002|Period 1|Adverse Event|0|||
128672678|NCT01578850|463100610|FG000|Period 1|Death|1|||
128672679|NCT01578850|463100611|FG001|Period 1|Death|0|||
128672680|NCT01578850|463100612|FG002|Period 1|Death|0|||
128672681|NCT01578850|463100610|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
129006943|NCT02041702|464316725|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
128672682|NCT01578850|463100611|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
128672683|NCT01578850|463100612|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
128672684|NCT01578850|463100610|FG000|Period 1|Withdrawal by Subject|9|||
128672685|NCT01578850|463100611|FG001|Period 1|Withdrawal by Subject|0|||
128672686|NCT01578850|463100612|FG002|Period 1|Withdrawal by Subject|0|||
128672687|NCT01578850|463100610|FG000|Period 1|Study Terminated by Sponsor|3|||
128672688|NCT01578850|463100611|FG001|Period 1|Study Terminated by Sponsor|0|||
128672689|NCT01578850|463100612|FG002|Period 1|Study Terminated by Sponsor|0|||
128672690|NCT01578850|463100610|FG000|Period 2|Insufficient Clinical Response|0|||
128672691|NCT01578850|463100611|FG001|Period 2|Insufficient Clinical Response|1|||
128672692|NCT01578850|463100612|FG002|Period 2|Insufficient Clinical Response|0|||
128672693|NCT01578850|463100610|FG000|Period 2|Adverse Event|0|||
128672694|NCT01578850|463100611|FG001|Period 2|Adverse Event|3|||
129006944|NCT00717756|464316727|FG000|Overall Study|Withdrawal by Subject|1|||
129006945|NCT00306384|464316728|FG000|Overall Study|Adverse Event|103|||
129006946|NCT00306384|464316729|FG001|Overall Study|Adverse Event|87|||
129006947|NCT00306384|464316730|FG002|Overall Study|Adverse Event|40|||
129006948|NCT00306384|464316728|FG000|Overall Study|Major protocol deviation|43|||
129006949|NCT00306384|464316729|FG001|Overall Study|Major protocol deviation|51|||
129006950|NCT00306384|464316730|FG002|Overall Study|Major protocol deviation|18|||
129006951|NCT00306384|464316728|FG000|Overall Study|Lost to Follow-up|57|||
129006952|NCT00306384|464316729|FG001|Overall Study|Lost to Follow-up|41|||
129006953|NCT00306384|464316730|FG002|Overall Study|Lost to Follow-up|35|||
129006954|NCT00306384|464316728|FG000|Overall Study|Voluntary withdrawal|199|||
129006955|NCT00306384|464316729|FG001|Overall Study|Voluntary withdrawal|187|||
129006956|NCT00306384|464316730|FG002|Overall Study|Voluntary withdrawal|91|||
129006957|NCT00306384|464316728|FG000|Overall Study|Study termination|1|||
129006958|NCT00306384|464316729|FG001|Overall Study|Study termination|0|||
129006959|NCT00306384|464316730|FG002|Overall Study|Study termination|1|||
129006960|NCT00306384|464316728|FG000|Overall Study|Pregnancy|3|||
128672695|NCT01578850|463100612|FG002|Period 2|Adverse Event|6|||
128672696|NCT01578850|463100610|FG000|Period 2|Lost to Follow-up|0|||
128672697|NCT01578850|463100611|FG001|Period 2|Lost to Follow-up|1|||
128672698|NCT01578850|463100612|FG002|Period 2|Lost to Follow-up|2|||
128672699|NCT01578850|463100610|FG000|Period 2|Withdrawal by Subject|0|||
128672700|NCT01578850|463100611|FG001|Period 2|Withdrawal by Subject|2|||
128672701|NCT01578850|463100612|FG002|Period 2|Withdrawal by Subject|2|||
128672702|NCT01578850|463100610|FG000|Period 2|Study Terminated by Sponsor|0|||
129006961|NCT00306384|464316729|FG001|Overall Study|Pregnancy|1|||
129006962|NCT00306384|464316730|FG002|Overall Study|Pregnancy|1|||
129006963|NCT00306384|464316728|FG000|Overall Study|Lack of Efficacy|26|||
129006964|NCT00306384|464316729|FG001|Overall Study|Lack of Efficacy|40|||
128672703|NCT01578850|463100611|FG001|Period 2|Study Terminated by Sponsor|5|||
128672704|NCT01578850|463100612|FG002|Period 2|Study Terminated by Sponsor|4|||
128672705|NCT01578850|463100610|FG000|Period 2|Unspecified Reasons|0|||
128672706|NCT01578850|463100611|FG001|Period 2|Unspecified Reasons|1|||
128672707|NCT01578850|463100612|FG002|Period 2|Unspecified Reasons|0|||
128672708|NCT02744040|463100615|FG000|Overall Study|Withdrawal by Subject|3|||
128672709|NCT02744040|463100616|FG001|Overall Study|Withdrawal by Subject|2|||
128672710|NCT02744040|463100617|FG002|Overall Study|Withdrawal by Subject|2|||
128672711|NCT02744040|463100615|FG000|Overall Study|Physician Decision|0|||
128672712|NCT02744040|463100616|FG001|Overall Study|Physician Decision|8|||
128672713|NCT02744040|463100617|FG002|Overall Study|Physician Decision|13|||
128672714|NCT02744040|463100615|FG000|Overall Study|Lost to Follow-up|3|||
128672715|NCT02744040|463100616|FG001|Overall Study|Lost to Follow-up|1|||
129006965|NCT00306384|464316730|FG002|Overall Study|Lack of Efficacy|38|||
129006966|NCT00306384|464316728|FG000|Overall Study|Investigator discretion|28|||
129006967|NCT00306384|464316729|FG001|Overall Study|Investigator discretion|31|||
129006968|NCT00306384|464316730|FG002|Overall Study|Investigator discretion|21|||
129006969|NCT00306384|464316728|FG000|Overall Study|Other|80|||
129006970|NCT00306384|464316729|FG001|Overall Study|Other|70|||
129006971|NCT00306384|464316730|FG002|Overall Study|Other|32|||
129006972|NCT00306384|464316728|FG000|Overall Study|Site closure|2|||
129006973|NCT00306384|464316729|FG001|Overall Study|Site closure|0|||
129006974|NCT00306384|464316730|FG002|Overall Study|Site closure|0|||
129006975|NCT02928848|464316731|FG000|Arm 2|Withdrawal by Subject|1|||
129006976|NCT02928848|464316732|FG001|Arm 2|Withdrawal by Subject|0|||
129006977|NCT03850509|464316733|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
129006978|NCT03850509|464316734|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
129006979|NCT00969332|464316735|FG000|Overall Study|Physician Decision|8|||
129006980|NCT00969332|464316735|FG000|Overall Study|Withdrawal by Subject|3|||
129006981|NCT02729896|464316738|FG000|Overall Study|Death|0|||
129006982|NCT02729896|464316739|FG001|Overall Study|Death|2|||
129006983|NCT02729896|464316740|FG002|Overall Study|Death|13|||
129006984|NCT02729896|464316738|FG000|Overall Study|Lost to Follow-up|0|||
129006985|NCT02729896|464316739|FG001|Overall Study|Lost to Follow-up|2|||
129006986|NCT02729896|464316740|FG002|Overall Study|Lost to Follow-up|3|||
129006987|NCT02729896|464316738|FG000|Overall Study|Other|0|||
129006988|NCT02729896|464316739|FG001|Overall Study|Other|2|||
129006989|NCT02729896|464316740|FG002|Overall Study|Other|0|||
129006990|NCT02729896|464316738|FG000|Overall Study|Physician Decision|1|||
129006991|NCT02729896|464316739|FG001|Overall Study|Physician Decision|2|||
129006992|NCT02729896|464316740|FG002|Overall Study|Physician Decision|3|||
129006993|NCT02729896|464316738|FG000|Overall Study|Progressive Disease|0|||
129006994|NCT02729896|464316739|FG001|Overall Study|Progressive Disease|1|||
129006995|NCT02729896|464316740|FG002|Overall Study|Progressive Disease|0|||
129006996|NCT02729896|464316738|FG000|Overall Study|Withdrawal by Subject|1|||
129006997|NCT02729896|464316739|FG001|Overall Study|Withdrawal by Subject|0|||
129006998|NCT02729896|464316740|FG002|Overall Study|Withdrawal by Subject|3|||
129006999|NCT00582309|464316741|FG000|Overall Study|Protocol Violation|0|||
129007000|NCT00582309|464316742|FG001|Overall Study|Protocol Violation|0|||
129007001|NCT00582309|464316743|FG002|Overall Study|Protocol Violation|2|||
129007002|NCT01565083|464316744|FG000|Overall Study|Withdrawal by Subject|6|||
129007003|NCT01565083|464316745|FG001|Overall Study|Withdrawal by Subject|4|||
129007004|NCT01565083|464316744|FG000|Overall Study|Lost to Follow-up|2|||
129007005|NCT01565083|464316745|FG001|Overall Study|Lost to Follow-up|7|||
129007006|NCT01565083|464316744|FG000|Overall Study|Death|22|||
129007007|NCT01565083|464316745|FG001|Overall Study|Death|23|||
129007008|NCT01565083|464316744|FG000|Overall Study|Other|3|||
129007009|NCT01565083|464316745|FG001|Overall Study|Other|5|||
129007010|NCT01058421|464316746|FG000|1 Month Outcomes|Death|10|||
129007011|NCT01058421|464316747|FG001|1 Month Outcomes|Death|6|||
129007012|NCT01058421|464316746|FG000|1 Month Outcomes|Lost to Follow-up|8|||
129007013|NCT01058421|464316747|FG001|1 Month Outcomes|Lost to Follow-up|7|||
129007014|NCT01058421|464316746|FG000|1 Month Outcomes|Remained in Hospital|5|||
129007015|NCT01058421|464316747|FG001|1 Month Outcomes|Remained in Hospital|12|||
129007016|NCT01058421|464316746|FG000|1 Month Outcomes|Remained in Other Facility|16|||
129007017|NCT01058421|464316747|FG001|1 Month Outcomes|Remained in Other Facility|17|||
129007018|NCT01058421|464316746|FG000|3 Month Outcomes|Death|3|||
129007019|NCT01058421|464316747|FG001|3 Month Outcomes|Death|5|||
129007020|NCT01058421|464316746|FG000|3 Month Outcomes|Lost to Follow-up|12|||
128672716|NCT02744040|463100617|FG002|Overall Study|Lost to Follow-up|7|||
128672717|NCT00096356|463100618|FG000|Overall Study|Adverse Event|11|||
129007021|NCT01058421|464316747|FG001|3 Month Outcomes|Lost to Follow-up|11|||
129007022|NCT01058421|464316746|FG000|3 Month Outcomes|Remained in Hospital|0|||
129007023|NCT01058421|464316747|FG001|3 Month Outcomes|Remained in Hospital|2|||
129007024|NCT01058421|464316746|FG000|3 Month Outcomes|Remained in Other Facility|5|||
129007025|NCT01058421|464316747|FG001|3 Month Outcomes|Remained in Other Facility|8|||
129007026|NCT01058421|464316746|FG000|6 Month Outcomes|Death|2|||
129007027|NCT01058421|464316747|FG001|6 Month Outcomes|Death|2|||
129007028|NCT01058421|464316746|FG000|6 Month Outcomes|Lost to Follow-up|16|||
128672718|NCT00096356|463100619|FG001|Overall Study|Adverse Event|9|||
128672719|NCT00096356|463100618|FG000|Overall Study|Physician Decision|5|||
128672720|NCT00096356|463100619|FG001|Overall Study|Physician Decision|3|||
128672721|NCT00096356|463100618|FG000|Overall Study|Withdrawal by Subject|17|||
128672722|NCT00096356|463100619|FG001|Overall Study|Withdrawal by Subject|23|||
128672723|NCT00096356|463100618|FG000|Overall Study|Lack of Efficacy|1|||
128672724|NCT00096356|463100619|FG001|Overall Study|Lack of Efficacy|0|||
128672725|NCT00096356|463100618|FG000|Overall Study|multiple reasons|10|||
128672726|NCT00096356|463100619|FG001|Overall Study|multiple reasons|18|||
128672727|NCT03288142|463100623|FG000|Overall Study|Lost to Follow-up|22|||
128672728|NCT03288142|463100624|FG001|Overall Study|Lost to Follow-up|15|||
128672729|NCT00946153|463100625|FG000|Phase 2|Adverse Event|0|||
128672730|NCT00946153|463100626|FG001|Phase 2|Adverse Event|0|||
128672731|NCT00946153|463100627|FG002|Phase 2|Adverse Event|0|||
128672732|NCT00946153|463100628|FG003|Phase 2|Adverse Event|0|||
128672733|NCT00946153|463100629|FG004|Phase 2|Adverse Event|6|||
128672734|NCT00946153|463100625|FG000|Phase 2|Need more reduction of dose|0|||
128672735|NCT00946153|463100626|FG001|Phase 2|Need more reduction of dose|0|||
128672736|NCT00946153|463100627|FG002|Phase 2|Need more reduction of dose|0|||
128672737|NCT00946153|463100628|FG003|Phase 2|Need more reduction of dose|0|||
129007029|NCT01058421|464316747|FG001|6 Month Outcomes|Lost to Follow-up|21|||
129007030|NCT01058421|464316746|FG000|6 Month Outcomes|Remained in Other Facility|1|||
129007031|NCT01058421|464316747|FG001|6 Month Outcomes|Remained in Other Facility|3|||
129007032|NCT01379781|464317985|FG000|Overall Study|Lost to Follow-up|11|||
129007033|NCT01379781|464317986|FG001|Overall Study|Lost to Follow-up|8|||
128672738|NCT00946153|463100629|FG004|Phase 2|Need more reduction of dose|2|||
128672739|NCT00946153|463100625|FG000|Phase 2|Physician Decision|0|||
128672740|NCT00946153|463100626|FG001|Phase 2|Physician Decision|0|||
128672741|NCT00946153|463100627|FG002|Phase 2|Physician Decision|0|||
128672742|NCT00946153|463100628|FG003|Phase 2|Physician Decision|0|||
128672743|NCT00946153|463100629|FG004|Phase 2|Physician Decision|1|||
128672744|NCT00946153|463100625|FG000|Phase 2|14 days washout for recovery due to AE|0|||
128672745|NCT00946153|463100626|FG001|Phase 2|14 days washout for recovery due to AE|0|||
128672746|NCT00946153|463100627|FG002|Phase 2|14 days washout for recovery due to AE|0|||
128672747|NCT00946153|463100628|FG003|Phase 2|14 days washout for recovery due to AE|0|||
128672748|NCT00946153|463100629|FG004|Phase 2|14 days washout for recovery due to AE|4|||
128672749|NCT04359901|463100630|FG000|Overall Study|Withdrawal by Subject|0|||
128672750|NCT04359901|463100631|FG001|Overall Study|Withdrawal by Subject|1|||
128672751|NCT04359901|463100630|FG000|Overall Study|Death|6|||
128672752|NCT04359901|463100631|FG001|Overall Study|Death|2|||
128672753|NCT04236141|463102850|FG000|Overall Study|Death|18|||
128672754|NCT04236141|463102851|FG001|Overall Study|Death|10|||
128672755|NCT04236141|463102850|FG000|Overall Study|Withdrawal by Participant|1|||
128672756|NCT04236141|463102851|FG001|Overall Study|Withdrawal by Participant|0|||
128672757|NCT04236141|463102850|FG000|Overall Study|Reason not Specified|1|||
129007034|NCT03329027|464317989|FG000|Overall Study|Lost to Follow-up|1|||
129007035|NCT03329027|464317990|FG001|Overall Study|Lost to Follow-up|0|||
129007036|NCT03329027|464317991|FG002|Overall Study|Lost to Follow-up|1|||
128672758|NCT04236141|463102851|FG001|Overall Study|Reason not Specified|0|||
128672759|NCT04236141|463102850|FG000|Overall Study|Study terminated by Sponsor|8|||
129007037|NCT03329027|464317989|FG000|Overall Study|Protocol Violation|9|||
129007038|NCT03329027|464317990|FG001|Overall Study|Protocol Violation|5|||
129007039|NCT03329027|464317991|FG002|Overall Study|Protocol Violation|7|||
129007040|NCT02742090|464318003|FG000|Overall Study|Adverse Event|10|||
129007041|NCT02742090|464318003|FG000|Overall Study|Death|3|||
129007042|NCT02742090|464318003|FG000|Overall Study|Disease Progression|25|||
129007043|NCT02742090|464318003|FG000|Overall Study|Investigator's Decision|1|||
129007044|NCT02742090|464318003|FG000|Overall Study|Lost to Follow-up|1|||
129007045|NCT02742090|464318003|FG000|Overall Study|Non-compliance with Study|1|||
129007046|NCT02742090|464318003|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
129007047|NCT02742090|464318003|FG000|Overall Study|Withdrawal by Subject|4|||
129007048|NCT02742090|464318003|FG000|Overall Study|Reason Not Specified|1|||
129007049|NCT00836927|464318006|FG000|Overall Study|Progressive disease|2|||
129007050|NCT00836927|464318007|FG001|Overall Study|Progressive disease|0|||
129007051|NCT00836927|464318008|FG002|Overall Study|Progressive disease|0|||
129007052|NCT00836927|464318009|FG003|Overall Study|Progressive disease|1|||
128672760|NCT04236141|463102851|FG001|Overall Study|Study terminated by Sponsor|4|||
128672761|NCT01925131|463102852|FG000|Overall Study|Death|0|||
128672762|NCT01925131|463102853|FG001|Overall Study|Death|0|||
128672763|NCT01925131|463102854|FG002|Overall Study|Death|1|||
128672764|NCT01925131|463102855|FG003|Overall Study|Death|0|||
128672765|NCT01925131|463102856|FG004|Overall Study|Death|0|||
128672766|NCT01925131|463102857|FG005|Overall Study|Death|0|||
128672767|NCT01925131|463102852|FG000|Overall Study|Progression/Relapse|1|||
129007053|NCT00836927|464318010|FG004|Overall Study|Progressive disease|1|||
129007054|NCT00836927|464318006|FG000|Overall Study|Withdrawal by Subject|1|||
128672768|NCT01925131|463102853|FG001|Overall Study|Progression/Relapse|1|||
128672769|NCT01925131|463102854|FG002|Overall Study|Progression/Relapse|4|||
129007055|NCT00836927|464318007|FG001|Overall Study|Withdrawal by Subject|0|||
128672770|NCT01925131|463102855|FG003|Overall Study|Progression/Relapse|0|||
128672771|NCT01925131|463102856|FG004|Overall Study|Progression/Relapse|0|||
128672772|NCT01925131|463102857|FG005|Overall Study|Progression/Relapse|1|||
128672773|NCT01925131|463102852|FG000|Overall Study|Patient Refusal|1|||
128672774|NCT01925131|463102853|FG001|Overall Study|Patient Refusal|0|||
128672775|NCT01925131|463102854|FG002|Overall Study|Patient Refusal|0|||
128672776|NCT01925131|463102855|FG003|Overall Study|Patient Refusal|0|||
128672777|NCT01925131|463102856|FG004|Overall Study|Patient Refusal|0|||
128672778|NCT01925131|463102857|FG005|Overall Study|Patient Refusal|0|||
128672779|NCT01925131|463102852|FG000|Overall Study|Adverse Event|0|||
128672780|NCT01925131|463102853|FG001|Overall Study|Adverse Event|0|||
128672781|NCT01925131|463102854|FG002|Overall Study|Adverse Event|2|||
128672782|NCT01925131|463102855|FG003|Overall Study|Adverse Event|0|||
128672783|NCT01925131|463102856|FG004|Overall Study|Adverse Event|1|||
128672784|NCT01925131|463102857|FG005|Overall Study|Adverse Event|3|||
128672785|NCT01925131|463102852|FG000|Overall Study|Other - Not Protocol Specified|3|||
128672786|NCT01925131|463102853|FG001|Overall Study|Other - Not Protocol Specified|1|||
128672787|NCT01925131|463102854|FG002|Overall Study|Other - Not Protocol Specified|2|||
128672788|NCT01925131|463102855|FG003|Overall Study|Other - Not Protocol Specified|5|||
128672789|NCT01925131|463102856|FG004|Overall Study|Other - Not Protocol Specified|10|||
128672790|NCT01925131|463102857|FG005|Overall Study|Other - Not Protocol Specified|6|||
128672791|NCT01948193|463102858|FG000|Overall Study|Serious event|2|||
128672792|NCT01948193|463102858|FG000|Overall Study|Lost to Follow-up|7|||
128672793|NCT01794338|463102859|FG000|Overall Study|Death|2|||
128672794|NCT01794338|463102860|FG001|Overall Study|Death|0|||
128672795|NCT01794338|463102859|FG000|Overall Study|Lost to Follow-up|6|||
128672796|NCT01794338|463102860|FG001|Overall Study|Lost to Follow-up|9|||
128672797|NCT02522624|463102861|FG000|Overall Study|Technical failure|1|||
128672798|NCT02522624|463102862|FG001|Overall Study|Technical failure|0|||
128672799|NCT01954927|463102863|FG000|Overall Study|Withdrawal by Subject|3|||
128672800|NCT01954927|463102864|FG001|Overall Study|Withdrawal by Subject|1|||
128672801|NCT03320824|463102865|FG000|Overall Study|Withdrawal by Subject|8|||
128672802|NCT03320824|463102866|FG001|Overall Study|Withdrawal by Subject|1|||
128672803|NCT03320824|463102865|FG000|Overall Study|Lost to Follow-up|10|||
128672804|NCT03320824|463102866|FG001|Overall Study|Lost to Follow-up|1|||
128672805|NCT03320824|463102865|FG000|Overall Study|moved out of state|0|||
128672806|NCT03320824|463102866|FG001|Overall Study|moved out of state|1|||
128672807|NCT03320824|463102865|FG000|Overall Study|could not complete final visit|0|||
128672808|NCT03320824|463102866|FG001|Overall Study|could not complete final visit|1|||
128672809|NCT00955305|463102867|FG000|Overall Study|Disease progression|39|||
128672810|NCT00955305|463102868|FG001|Overall Study|Disease progression|41|||
128672811|NCT00955305|463102867|FG000|Overall Study|Adverse Event|22|||
128672812|NCT00955305|463102868|FG001|Overall Study|Adverse Event|22|||
128672813|NCT00955305|463102867|FG000|Overall Study|Death|2|||
128672814|NCT00955305|463102868|FG001|Overall Study|Death|1|||
128672815|NCT00955305|463102867|FG000|Overall Study|Withdrawal by Subject|5|||
128672816|NCT00955305|463102868|FG001|Overall Study|Withdrawal by Subject|4|||
128672817|NCT00955305|463102867|FG000|Overall Study|Alternative therapy|4|||
128672818|NCT00955305|463102868|FG001|Overall Study|Alternative therapy|0|||
128672819|NCT00955305|463102867|FG000|Overall Study|Other complicating disease|2|||
128672820|NCT00955305|463102868|FG001|Overall Study|Other complicating disease|4|||
128672821|NCT00955305|463102867|FG000|Overall Study|Physician Decision|1|||
128672822|NCT00955305|463102868|FG001|Overall Study|Physician Decision|0|||
128672823|NCT00955305|463102867|FG000|Overall Study|Continued presence of residual disease|0|||
128672824|NCT00955305|463102868|FG001|Overall Study|Continued presence of residual disease|1|||
128672825|NCT00955305|463102867|FG000|Overall Study|Functional decline|2|||
128672826|NCT00955305|463102868|FG001|Overall Study|Functional decline|0|||
128672827|NCT00955305|463102867|FG000|Overall Study|Maximum response achieved|0|||
128672828|NCT00955305|463102868|FG001|Overall Study|Maximum response achieved|1|||
128672829|NCT00955305|463102867|FG000|Overall Study|Lost to Follow-up|0|||
128672830|NCT00955305|463102868|FG001|Overall Study|Lost to Follow-up|1|||
128672831|NCT00955305|463102867|FG000|Overall Study|No off-treatment reason submitted|1|||
128672832|NCT00955305|463102868|FG001|Overall Study|No off-treatment reason submitted|0|||
128672833|NCT00955305|463102867|FG000|Overall Study|Never started protocol treatment|5|||
128672834|NCT00955305|463102868|FG001|Overall Study|Never started protocol treatment|5|||
128672835|NCT00955305|463102867|FG000|Overall Study|Ineligible|5|||
128672836|NCT00955305|463102868|FG001|Overall Study|Ineligible|7|||
128672837|NCT03387111|463102869|FG000|Overall Study|Progressive Disease|3|||
128672838|NCT03387111|463102869|FG000|Overall Study|Other|1|||
128672839|NCT03254108|463102873|FG000|Overall Study|Adverse Event|0|||
128672840|NCT03254108|463102874|FG001|Overall Study|Adverse Event|2|||
128672841|NCT03254108|463102875|FG002|Overall Study|Adverse Event|0|||
128672842|NCT03254108|463102876|FG003|Overall Study|Adverse Event|1|||
128672843|NCT03254108|463102877|FG004|Overall Study|Adverse Event|1|||
128672844|NCT03254108|463102873|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
128672845|NCT03254108|463102874|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
128672846|NCT03254108|463102875|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
128672847|NCT03254108|463102876|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
128672848|NCT03254108|463102877|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
128672849|NCT00490529|463102885|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
128672850|NCT00490529|463102885|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
128672851|NCT00490529|463102885|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
128672852|NCT00490529|463102885|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
128672853|NCT00490529|463102885|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
128672854|NCT00490529|463102885|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
128672855|NCT03254459|463102886|FG000|Overall Study|Adverse Event|7|||
128672856|NCT03254459|463102887|FG001|Overall Study|Adverse Event|20|||
128672857|NCT03254459|463102886|FG000|Overall Study|Withdrawal by Subject Consent|3|||
128672858|NCT03254459|463102887|FG001|Overall Study|Withdrawal by Subject Consent|1|||
128672859|NCT03254459|463102886|FG000|Overall Study|Lost to Follow-up|0|||
128672860|NCT03254459|463102887|FG001|Overall Study|Lost to Follow-up|1|||
128672861|NCT03254459|463102886|FG000|Overall Study|Miscellaneous|0|||
128672862|NCT03254459|463102887|FG001|Overall Study|Miscellaneous|1|||
128672863|NCT00727441|463102888|FG000|Overall Study|Disease Progression|11|||
128672864|NCT00727441|463102889|FG001|Overall Study|Disease Progression|14|||
129007056|NCT00836927|464318008|FG002|Overall Study|Withdrawal by Subject|0|||
129007057|NCT00836927|464318009|FG003|Overall Study|Withdrawal by Subject|0|||
129007058|NCT00836927|464318010|FG004|Overall Study|Withdrawal by Subject|0|||
128672865|NCT00727441|463102890|FG002|Overall Study|Disease Progression|17|||
128672866|NCT00727441|463102888|FG000|Overall Study|Eligibility|7|||
128672867|NCT00727441|463102889|FG001|Overall Study|Eligibility|5|||
128672868|NCT00727441|463102890|FG002|Overall Study|Eligibility|7|||
128672869|NCT00727441|463102888|FG000|Overall Study|Death|0|||
128672870|NCT00727441|463102889|FG001|Overall Study|Death|1|||
128672871|NCT00727441|463102890|FG002|Overall Study|Death|1|||
128672872|NCT00727441|463102888|FG000|Overall Study|Physician Decision|0|||
128672873|NCT00727441|463102889|FG001|Overall Study|Physician Decision|1|||
128672874|NCT00727441|463102890|FG002|Overall Study|Physician Decision|0|||
128672875|NCT00727441|463102888|FG000|Overall Study|Withdrawal by Subject|0|||
128672876|NCT00727441|463102889|FG001|Overall Study|Withdrawal by Subject|1|||
128672877|NCT00727441|463102890|FG002|Overall Study|Withdrawal by Subject|0|||
128672878|NCT00535288|463102891|FG000|Overall Study|Adverse Event|20|||
128672879|NCT00535288|463102892|FG001|Overall Study|Adverse Event|19|||
128672880|NCT00535288|463102893|FG002|Overall Study|Adverse Event|25|||
128672881|NCT00535288|463102894|FG003|Overall Study|Adverse Event|20|||
128672882|NCT00535288|463102895|FG004|Overall Study|Adverse Event|30|||
128672883|NCT00535288|463102891|FG000|Overall Study|Lost to Follow-up|0|||
128672884|NCT00535288|463102892|FG001|Overall Study|Lost to Follow-up|3|||
128672885|NCT00535288|463102893|FG002|Overall Study|Lost to Follow-up|0|||
128672886|NCT00535288|463102894|FG003|Overall Study|Lost to Follow-up|0|||
128672887|NCT00535288|463102895|FG004|Overall Study|Lost to Follow-up|0|||
128672888|NCT00535288|463102891|FG000|Overall Study|Lack of Efficacy|26|||
128672889|NCT00535288|463102892|FG001|Overall Study|Lack of Efficacy|3|||
128672890|NCT00535288|463102893|FG002|Overall Study|Lack of Efficacy|4|||
128672891|NCT00535288|463102894|FG003|Overall Study|Lack of Efficacy|4|||
128672892|NCT00535288|463102895|FG004|Overall Study|Lack of Efficacy|7|||
128672893|NCT00535288|463102891|FG000|Overall Study|Unwilling to cooperate|6|||
128672894|NCT00535288|463102892|FG001|Overall Study|Unwilling to cooperate|6|||
128672895|NCT00535288|463102893|FG002|Overall Study|Unwilling to cooperate|3|||
128672896|NCT00535288|463102894|FG003|Overall Study|Unwilling to cooperate|3|||
128672897|NCT00535288|463102895|FG004|Overall Study|Unwilling to cooperate|4|||
128672898|NCT00535288|463102891|FG000|Overall Study|Other|2|||
128672899|NCT00535288|463102892|FG001|Overall Study|Other|1|||
128672900|NCT00535288|463102893|FG002|Overall Study|Other|1|||
128672901|NCT00535288|463102894|FG003|Overall Study|Other|2|||
128672902|NCT00535288|463102895|FG004|Overall Study|Other|1|||
128672903|NCT01129583|463102901|FG000|Overall Study|Death|1|||
129007059|NCT02192905|464318016|FG000|Overall Study|Lost to Follow-up|1|||
129007060|NCT04820842|464318018|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129007061|NCT04820842|464318019|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
128672904|NCT01129583|463102902|FG001|Overall Study|Death|0|||
128672905|NCT01129583|463102901|FG000|Overall Study|Lost to Follow-up|1|||
128672906|NCT01129583|463102902|FG001|Overall Study|Lost to Follow-up|1|||
128672907|NCT01129583|463102901|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
128672908|NCT01129583|463102902|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
128672909|NCT02600871|463102903|FG000|Overall Study|Lost to Follow-up|13|||
128672910|NCT02600871|463102904|FG001|Overall Study|Lost to Follow-up|10|||
128672911|NCT02617485|463102917|FG000|Treatment and Observation Period|Adverse Event|9|||
128672912|NCT02617485|463102918|FG001|Treatment and Observation Period|Adverse Event|1|||
128672913|NCT02617485|463102917|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
128672914|NCT02617485|463102918|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
128672915|NCT02617485|463102917|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
129007062|NCT04820842|464318020|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
129007063|NCT04820842|464318021|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129007064|NCT04820842|464318022|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129007065|NCT04820842|464318023|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129007066|NCT04820842|464318024|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129007067|NCT04820842|464318018|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
129007068|NCT04820842|464318019|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
129007069|NCT04820842|464318020|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
129007070|NCT04820842|464318021|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007071|NCT04820842|464318022|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007072|NCT04820842|464318023|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007073|NCT04820842|464318024|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007074|NCT04820842|464318018|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129007075|NCT04820842|464318019|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
129007076|NCT04820842|464318020|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129007077|NCT04820842|464318021|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129215075|NCT02760498|465089440|FG004|Overall Study|Physician Decision|0|||
128672916|NCT02617485|463102918|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
128672917|NCT02617485|463102917|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
128672918|NCT02617485|463102918|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
128672919|NCT02617485|463102917|FG000|Treatment and Observation Period|Physician Decision|0|||
128672920|NCT02617485|463102918|FG001|Treatment and Observation Period|Physician Decision|1|||
128672921|NCT02617485|463102917|FG000|Follow-up Period|Adverse Event|1|||
128672922|NCT02617485|463102918|FG001|Follow-up Period|Adverse Event|0|||
128672923|NCT02617485|463102917|FG000|Follow-up Period|Withdrawal by Subject|1|||
128672924|NCT02617485|463102918|FG001|Follow-up Period|Withdrawal by Subject|0|||
128672925|NCT02617485|463102917|FG000|Follow-up Period|Disease progression|2|||
128672926|NCT02617485|463102918|FG001|Follow-up Period|Disease progression|1|||
128672927|NCT02617485|463102917|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
128672928|NCT02617485|463102918|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
128672929|NCT02617485|463102917|FG000|Follow-up Period|Patient needed radiotherapy|9|||
128672930|NCT02617485|463102918|FG001|Follow-up Period|Patient needed radiotherapy|5|||
128672931|NCT02617485|463102917|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
128672932|NCT02617485|463102918|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
128672933|NCT00409331|463102922|FG000|Overall Study|Physician Decision|1|||
128672934|NCT01511055|463102933|FG000|Overall Study|Withdrawal by Subject|6|||
128672935|NCT00830869|463102934|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
128672936|NCT00830869|463102935|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
128672937|NCT00830869|463102936|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
128672938|NCT00830869|463102937|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
128672939|NCT00830869|463102938|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
128672940|NCT00830869|463102939|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
128672941|NCT00830869|463102940|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
128672942|NCT00830869|463102941|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
128672943|NCT00830869|463102942|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
128672944|NCT00830869|463102943|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
128672945|NCT00830869|463102944|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
128672946|NCT00830869|463102945|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
128672947|NCT00830869|463102934|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
128672948|NCT00830869|463102935|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
128672949|NCT00830869|463102936|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
128672950|NCT00830869|463102937|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
128672951|NCT00830869|463102938|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
128672952|NCT00830869|463102939|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
128672953|NCT00830869|463102940|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
128672954|NCT00830869|463102941|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
128672955|NCT00830869|463102942|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
128672956|NCT00830869|463102943|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
128672957|NCT00830869|463102944|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
128672958|NCT00830869|463102945|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
128672959|NCT00830869|463102934|FG000|Period 1: Part 1|Adverse Event|0|||
128672960|NCT00830869|463102935|FG001|Period 1: Part 1|Adverse Event|0|||
128672961|NCT00830869|463102936|FG002|Period 1: Part 1|Adverse Event|0|||
128672962|NCT00830869|463102937|FG003|Period 1: Part 1|Adverse Event|0|||
128672963|NCT00830869|463102938|FG004|Period 1: Part 1|Adverse Event|0|||
128672964|NCT00830869|463102939|FG005|Period 1: Part 1|Adverse Event|1|||
128672965|NCT00830869|463102940|FG006|Period 1: Part 1|Adverse Event|1|||
128672966|NCT00830869|463102941|FG007|Period 1: Part 1|Adverse Event|0|||
128672967|NCT00830869|463102942|FG008|Period 1: Part 1|Adverse Event|0|||
128672968|NCT00830869|463102943|FG009|Period 1: Part 1|Adverse Event|0|||
128672969|NCT00830869|463102944|FG010|Period 1: Part 1|Adverse Event|0|||
128672970|NCT00830869|463102945|FG011|Period 1: Part 1|Adverse Event|0|||
128672971|NCT00830869|463102934|FG000|Period 1: Part 1|Progressive disease|1|||
128672972|NCT00830869|463102935|FG001|Period 1: Part 1|Progressive disease|0|||
128672973|NCT00830869|463102936|FG002|Period 1: Part 1|Progressive disease|1|||
128672974|NCT00830869|463102937|FG003|Period 1: Part 1|Progressive disease|6|||
128672975|NCT00830869|463102938|FG004|Period 1: Part 1|Progressive disease|4|||
128672976|NCT00830869|463102939|FG005|Period 1: Part 1|Progressive disease|4|||
128672977|NCT00830869|463102940|FG006|Period 1: Part 1|Progressive disease|1|||
128672978|NCT00830869|463102941|FG007|Period 1: Part 1|Progressive disease|0|||
128672979|NCT00830869|463102942|FG008|Period 1: Part 1|Progressive disease|0|||
128672980|NCT00830869|463102943|FG009|Period 1: Part 1|Progressive disease|0|||
128672981|NCT00830869|463102944|FG010|Period 1: Part 1|Progressive disease|0|||
128672982|NCT00830869|463102945|FG011|Period 1: Part 1|Progressive disease|0|||
128672983|NCT00830869|463102934|FG000|Period 2: Part 2|Protocol Violation|0|||
128672984|NCT00830869|463102935|FG001|Period 2: Part 2|Protocol Violation|0|||
128672985|NCT00830869|463102936|FG002|Period 2: Part 2|Protocol Violation|0|||
128672986|NCT00830869|463102937|FG003|Period 2: Part 2|Protocol Violation|0|||
128672987|NCT00830869|463102938|FG004|Period 2: Part 2|Protocol Violation|0|||
128672988|NCT00830869|463102939|FG005|Period 2: Part 2|Protocol Violation|0|||
128672989|NCT00830869|463102940|FG006|Period 2: Part 2|Protocol Violation|0|||
128672990|NCT00830869|463102941|FG007|Period 2: Part 2|Protocol Violation|1|||
128672991|NCT00830869|463102942|FG008|Period 2: Part 2|Protocol Violation|0|||
128672992|NCT00830869|463102943|FG009|Period 2: Part 2|Protocol Violation|1|||
128672993|NCT00830869|463102944|FG010|Period 2: Part 2|Protocol Violation|0|||
128672994|NCT00830869|463102945|FG011|Period 2: Part 2|Protocol Violation|0|||
128672995|NCT00830869|463102934|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
128672996|NCT00830869|463102935|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
128672997|NCT00830869|463102936|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
128672998|NCT00830869|463102937|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
128672999|NCT00830869|463102938|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
128673000|NCT00830869|463102939|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
128673001|NCT00830869|463102940|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
128673002|NCT00830869|463102941|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
128673003|NCT00830869|463102942|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
128673004|NCT00830869|463102943|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
128673005|NCT00830869|463102944|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
128673006|NCT00830869|463102945|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
128673007|NCT00830869|463102934|FG000|Period 2: Part 2|Adverse Event|0|||
128673008|NCT00830869|463102935|FG001|Period 2: Part 2|Adverse Event|0|||
128673009|NCT00830869|463102936|FG002|Period 2: Part 2|Adverse Event|0|||
128673010|NCT00830869|463102937|FG003|Period 2: Part 2|Adverse Event|0|||
128673011|NCT00830869|463102938|FG004|Period 2: Part 2|Adverse Event|0|||
128673012|NCT00830869|463102939|FG005|Period 2: Part 2|Adverse Event|0|||
128673013|NCT00830869|463102940|FG006|Period 2: Part 2|Adverse Event|0|||
128673014|NCT00830869|463102941|FG007|Period 2: Part 2|Adverse Event|4|||
128673015|NCT00830869|463102942|FG008|Period 2: Part 2|Adverse Event|3|||
128673016|NCT00830869|463102943|FG009|Period 2: Part 2|Adverse Event|2|||
128673017|NCT00830869|463102944|FG010|Period 2: Part 2|Adverse Event|2|||
128673018|NCT00830869|463102945|FG011|Period 2: Part 2|Adverse Event|0|||
128673019|NCT00830869|463102934|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
128673020|NCT00830869|463102935|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
128673021|NCT00830869|463102936|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
128673022|NCT00830869|463102937|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
128673023|NCT00830869|463102938|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
128673024|NCT00830869|463102939|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
128673025|NCT00830869|463102940|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
128673026|NCT00830869|463102941|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
128673027|NCT00830869|463102942|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
128673028|NCT00830869|463102943|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
128673029|NCT00830869|463102944|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
128673030|NCT00830869|463102945|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
128673031|NCT00830869|463102934|FG000|Period 2: Part 2|Progressive disease|0|||
128673032|NCT00830869|463102935|FG001|Period 2: Part 2|Progressive disease|0|||
128673033|NCT00830869|463102936|FG002|Period 2: Part 2|Progressive disease|0|||
128673034|NCT00830869|463102937|FG003|Period 2: Part 2|Progressive disease|0|||
128673035|NCT00830869|463102938|FG004|Period 2: Part 2|Progressive disease|0|||
128673036|NCT00830869|463102939|FG005|Period 2: Part 2|Progressive disease|0|||
128673037|NCT00830869|463102940|FG006|Period 2: Part 2|Progressive disease|0|||
128673038|NCT00830869|463102941|FG007|Period 2: Part 2|Progressive disease|14|||
128673039|NCT00830869|463102942|FG008|Period 2: Part 2|Progressive disease|11|||
128673040|NCT00830869|463102943|FG009|Period 2: Part 2|Progressive disease|12|||
128673041|NCT00830869|463102944|FG010|Period 2: Part 2|Progressive disease|8|||
129215076|NCT02760498|465089441|FG005|Overall Study|Physician Decision|2|||
128673042|NCT00830869|463102945|FG011|Period 2: Part 2|Progressive disease|15|||
128673043|NCT00830869|463102934|FG000|Period 2: Part 2|Other|0|||
128673044|NCT00830869|463102935|FG001|Period 2: Part 2|Other|0|||
128673045|NCT00830869|463102936|FG002|Period 2: Part 2|Other|0|||
128673046|NCT00830869|463102937|FG003|Period 2: Part 2|Other|0|||
128673047|NCT00830869|463102938|FG004|Period 2: Part 2|Other|0|||
128673048|NCT00830869|463102939|FG005|Period 2: Part 2|Other|0|||
128673049|NCT00830869|463102940|FG006|Period 2: Part 2|Other|0|||
128673050|NCT00830869|463102941|FG007|Period 2: Part 2|Other|0|||
128673051|NCT00830869|463102942|FG008|Period 2: Part 2|Other|0|||
128673052|NCT00830869|463102943|FG009|Period 2: Part 2|Other|1|||
128673053|NCT00830869|463102944|FG010|Period 2: Part 2|Other|0|||
128673054|NCT00830869|463102945|FG011|Period 2: Part 2|Other|0|||
128673055|NCT00617669|463102946|FG000|Overall Study|Withdrawal by Subject|71|||
128673056|NCT00617669|463102947|FG001|Overall Study|Withdrawal by Subject|77|||
128673057|NCT00617669|463102946|FG000|Overall Study|Lost to Follow-up|3|||
128673058|NCT00617669|463102947|FG001|Overall Study|Lost to Follow-up|2|||
128673059|NCT00617669|463102946|FG000|Overall Study|Adverse Event|87|||
128673060|NCT00617669|463102947|FG001|Overall Study|Adverse Event|76|||
128673061|NCT00617669|463102946|FG000|Overall Study|Protocol Violation|2|||
128673062|NCT00617669|463102947|FG001|Overall Study|Protocol Violation|3|||
128673063|NCT00617669|463102946|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
128673064|NCT00617669|463102947|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
128673065|NCT00617669|463102946|FG000|Overall Study|Patients randomized but not treated|2|||
128673066|NCT00617669|463102947|FG001|Overall Study|Patients randomized but not treated|3|||
128673067|NCT03745820|463102948|FG000|Overall Study|Adverse Event|0|||
128673068|NCT03745820|463102949|FG001|Overall Study|Adverse Event|3|||
128673069|NCT03745820|463102950|FG002|Overall Study|Adverse Event|2|||
128673070|NCT03745820|463102948|FG000|Overall Study|Non-Compliance with Study Drug|4|||
128673071|NCT03745820|463102949|FG001|Overall Study|Non-Compliance with Study Drug|3|||
128673072|NCT03745820|463102950|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128673073|NCT03745820|463102948|FG000|Overall Study|Withdrawal by Subject|4|||
128673074|NCT03745820|463102949|FG001|Overall Study|Withdrawal by Subject|4|||
128673075|NCT03745820|463102950|FG002|Overall Study|Withdrawal by Subject|4|||
128673076|NCT03745820|463102948|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
128673077|NCT03745820|463102949|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
128673078|NCT03745820|463102950|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
128673079|NCT03745820|463102948|FG000|Overall Study|Lost to Follow-up|2|||
128673080|NCT03745820|463102949|FG001|Overall Study|Lost to Follow-up|0|||
128673081|NCT03745820|463102950|FG002|Overall Study|Lost to Follow-up|3|||
128673082|NCT03745820|463102948|FG000|Overall Study|Reason not Specified|2|||
128673083|NCT03745820|463102949|FG001|Overall Study|Reason not Specified|4|||
128673084|NCT03745820|463102950|FG002|Overall Study|Reason not Specified|1|||
128673085|NCT00507728|463102951|FG000|Randomization to Month 3|Lost to Follow-up|15|||
128673086|NCT00507728|463102952|FG001|Randomization to Month 3|Lost to Follow-up|14|||
128673087|NCT00507728|463102953|FG002|Randomization to Month 3|Lost to Follow-up|20|||
128673088|NCT00507728|463102951|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
128673089|NCT00507728|463102952|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
128673090|NCT00507728|463102953|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
128673091|NCT03680742|463102954|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
128673092|NCT01410357|463102955|FG000|Overall Study|Death|2|||
128673093|NCT01410357|463102956|FG001|Overall Study|Death|1|||
128673094|NCT01410357|463102955|FG000|Overall Study|Withdrawal by Subject|1|||
128673095|NCT01410357|463102956|FG001|Overall Study|Withdrawal by Subject|2|||
128673096|NCT01410357|463102955|FG000|Overall Study|Lost to Follow-up|23|||
128673097|NCT01410357|463102956|FG001|Overall Study|Lost to Follow-up|21|||
128673098|NCT00615901|463102957|FG000|Overall Study|Withdrawal by Subject|2|||
128673099|NCT00615901|463102957|FG000|Overall Study|Adverse Event|7|||
128673100|NCT03598114|463102958|FG000|Overall Study|Staff turnover/left the program|3|||
128673101|NCT03598114|463102959|FG001|Overall Study|Staff turnover/left the program|39|||
128673102|NCT02527200|463102960|FG000|Overall Study|Withdrawal by Subject|3|||
128673103|NCT02527200|463102961|FG001|Overall Study|Withdrawal by Subject|2|||
128673104|NCT02527200|463102962|FG002|Overall Study|Withdrawal by Subject|1|||
128673105|NCT02527200|463102963|FG003|Overall Study|Withdrawal by Subject|0|||
128673106|NCT02527200|463102960|FG000|Overall Study|Unclassified|0|||
128673107|NCT02527200|463102961|FG001|Overall Study|Unclassified|1|||
128673108|NCT02527200|463102962|FG002|Overall Study|Unclassified|0|||
128673109|NCT02527200|463102963|FG003|Overall Study|Unclassified|0|||
128673110|NCT02527200|463102960|FG000|Overall Study|Lost to Follow-up|0|||
128673111|NCT02527200|463102961|FG001|Overall Study|Lost to Follow-up|0|||
128673112|NCT02527200|463102962|FG002|Overall Study|Lost to Follow-up|1|||
128673113|NCT02527200|463102963|FG003|Overall Study|Lost to Follow-up|0|||
128673114|NCT00668733|463102967|FG000|Overall Study|Lost to Follow-up|2|||
128673115|NCT00668733|463102968|FG001|Overall Study|Lost to Follow-up|3|||
128673116|NCT00668733|463102967|FG000|Overall Study|Withdrawal by Subject|0|||
128673117|NCT00668733|463102968|FG001|Overall Study|Withdrawal by Subject|4|||
128673118|NCT01909791|463102969|FG000|Overall Study|Death|9|||
128673119|NCT01909791|463102970|FG001|Overall Study|Death|8|||
128673120|NCT01909791|463102971|FG002|Overall Study|Death|4|||
128673121|NCT01909791|463102969|FG000|Overall Study|Withdrawal by Subject|5|||
128673122|NCT01909791|463102970|FG001|Overall Study|Withdrawal by Subject|9|||
128673123|NCT01909791|463102971|FG002|Overall Study|Withdrawal by Subject|13|||
128673124|NCT01909791|463102969|FG000|Overall Study|Lost to Follow-up|5|||
128673125|NCT01909791|463102970|FG001|Overall Study|Lost to Follow-up|11|||
128673126|NCT01909791|463102971|FG002|Overall Study|Lost to Follow-up|10|||
128673127|NCT01909791|463102969|FG000|Overall Study|Missed Visit|2|||
128673128|NCT01909791|463102970|FG001|Overall Study|Missed Visit|0|||
128673129|NCT01909791|463102971|FG002|Overall Study|Missed Visit|1|||
128673130|NCT01659554|463102972|FG000|Overall Study|Study Termination|4|||
128673131|NCT00945906|463102975|FG000|Overall Study|Withdrawal by Subject|1|||
128673132|NCT00945906|463102975|FG000|Overall Study|Did not want to return for last visit|2|||
128673133|NCT00945906|463102975|FG000|Overall Study|Unable to return for last visit|2|||
128673134|NCT00945906|463102975|FG000|Overall Study|Moved to another country|2|||
128673135|NCT04250077|463102977|FG000|Overall Study|Withdrawal by Subject|0|||
128673136|NCT04250077|463102978|FG001|Overall Study|Withdrawal by Subject|1|||
128673137|NCT04250077|463102979|FG002|Overall Study|Withdrawal by Subject|0|||
128673138|NCT04250077|463102977|FG000|Overall Study|Lost to Follow-up|2|||
128673139|NCT04250077|463102978|FG001|Overall Study|Lost to Follow-up|3|||
128673140|NCT04250077|463102979|FG002|Overall Study|Lost to Follow-up|0|||
128673141|NCT01022398|463102980|FG000|Overall Study|Study terminated|2|||
128673142|NCT01022398|463102981|FG001|Overall Study|Study terminated|2|||
128673143|NCT00361634|463102983|FG000|Overall Study|Lost to Follow-up|1|||
128673144|NCT00361634|463102983|FG000|Overall Study|Withdrawal by Subject|1|||
128673145|NCT00233454|463102984|FG000|Overall Study|Death|6|||
128673146|NCT02366091|463102985|FG000|Overall Study|Withdrawal by Subject|3|||
128673147|NCT02366091|463102986|FG001|Overall Study|Withdrawal by Subject|7|||
128673148|NCT02366091|463102987|FG002|Overall Study|Withdrawal by Subject|3|||
128673149|NCT02366091|463102988|FG003|Overall Study|Withdrawal by Subject|1|||
128673150|NCT01155011|463102990|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
128673151|NCT01155011|463102991|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
128673152|NCT01155011|463102990|FG000|Baseline to 6 Months|investigator decision, moved|4|||
128673153|NCT01155011|463102991|FG001|Baseline to 6 Months|investigator decision, moved|5|||
128673154|NCT01155011|463102990|FG000|Baseline to 6 Months|Death|0|||
128673155|NCT01155011|463102991|FG001|Baseline to 6 Months|Death|1|||
128673156|NCT01155011|463102990|FG000|6 to 12 Months|Withdrawal by Subject|8|||
128673157|NCT01155011|463102991|FG001|6 to 12 Months|Withdrawal by Subject|5|||
128673158|NCT01155011|463102990|FG000|6 to 12 Months|Death|1|||
128673159|NCT01155011|463102991|FG001|6 to 12 Months|Death|5|||
128673160|NCT01743001|463102992|FG000|Overall Study|Physician Decision|1|||
128673161|NCT01743001|463102993|FG001|Overall Study|Physician Decision|0|||
128673162|NCT01743001|463102992|FG000|Overall Study|Pregnancy|1|||
128673163|NCT01743001|463102993|FG001|Overall Study|Pregnancy|0|||
128673164|NCT01743001|463102992|FG000|Overall Study|Death|1|||
128673165|NCT01743001|463102993|FG001|Overall Study|Death|0|||
128673166|NCT02160041|463102994|FG000|Overall Study|Adverse Event|11|||
128673167|NCT02160041|463102994|FG000|Overall Study|Death|2|||
128673168|NCT02160041|463102994|FG000|Overall Study|disease progression|57|||
128673169|NCT02160041|463102994|FG000|Overall Study|Protocol Violation|1|||
128673170|NCT02160041|463102994|FG000|Overall Study|non-compliance with study|1|||
128673171|NCT02160041|463102994|FG000|Overall Study|Physician Decision|3|||
128673172|NCT02160041|463102994|FG000|Overall Study|Withdrawal by Subject|8|||
128673173|NCT02160041|463102994|FG000|Overall Study|study terminated by by sponsor|1|||
128673174|NCT01403948|463102995|FG000|Overall Study|Progressive disease|0|||
128673175|NCT01403948|463102996|FG001|Overall Study|Progressive disease|2|||
128673176|NCT01403948|463102997|FG002|Overall Study|Progressive disease|2|||
128673177|NCT01403948|463102998|FG003|Overall Study|Progressive disease|4|||
128673178|NCT01403948|463102999|FG004|Overall Study|Progressive disease|2|||
128673179|NCT01403948|463103000|FG005|Overall Study|Progressive disease|6|||
128673180|NCT01403948|463103001|FG006|Overall Study|Progressive disease|2|||
128673181|NCT01403948|463103002|FG007|Overall Study|Progressive disease|4|||
128673182|NCT01403948|463103003|FG008|Overall Study|Progressive disease|5|||
128673183|NCT01403948|463103004|FG009|Overall Study|Progressive disease|5|||
128673184|NCT01403948|463102995|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
128673185|NCT01403948|463102996|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
128673186|NCT01403948|463102997|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
128673187|NCT01403948|463102998|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
128673188|NCT01403948|463102999|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
128673189|NCT01403948|463103000|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
128673190|NCT01403948|463103001|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
128673191|NCT01403948|463103002|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
128673192|NCT01403948|463103003|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
128673193|NCT01403948|463103004|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
128673194|NCT01403948|463102995|FG000|Overall Study|Lost to Follow-up|0|||
128673195|NCT01403948|463102996|FG001|Overall Study|Lost to Follow-up|0|||
128673196|NCT01403948|463102997|FG002|Overall Study|Lost to Follow-up|0|||
128673197|NCT01403948|463102998|FG003|Overall Study|Lost to Follow-up|0|||
128673198|NCT01403948|463102999|FG004|Overall Study|Lost to Follow-up|0|||
128673199|NCT01403948|463103000|FG005|Overall Study|Lost to Follow-up|0|||
128673200|NCT01403948|463103001|FG006|Overall Study|Lost to Follow-up|0|||
128673201|NCT01403948|463103002|FG007|Overall Study|Lost to Follow-up|0|||
128673202|NCT01403948|463103003|FG008|Overall Study|Lost to Follow-up|0|||
128673203|NCT01403948|463103004|FG009|Overall Study|Lost to Follow-up|1|||
128673204|NCT01403948|463102995|FG000|Overall Study|Refused cont. medication|0|||
128673205|NCT01403948|463102996|FG001|Overall Study|Refused cont. medication|0|||
128673206|NCT01403948|463102997|FG002|Overall Study|Refused cont. medication|0|||
128673207|NCT01403948|463102998|FG003|Overall Study|Refused cont. medication|0|||
128673208|NCT01403948|463102999|FG004|Overall Study|Refused cont. medication|1|||
128673209|NCT01403948|463103000|FG005|Overall Study|Refused cont. medication|0|||
128673210|NCT01403948|463103001|FG006|Overall Study|Refused cont. medication|0|||
128673211|NCT01403948|463103002|FG007|Overall Study|Refused cont. medication|0|||
128673212|NCT01403948|463103003|FG008|Overall Study|Refused cont. medication|0|||
128673213|NCT01403948|463103004|FG009|Overall Study|Refused cont. medication|1|||
128673214|NCT01403948|463102995|FG000|Overall Study|other than above|1|||
128673215|NCT01403948|463102996|FG001|Overall Study|other than above|2|||
128673216|NCT01403948|463102997|FG002|Overall Study|other than above|1|||
128673217|NCT01403948|463102998|FG003|Overall Study|other than above|0|||
128673218|NCT01403948|463102999|FG004|Overall Study|other than above|1|||
128673219|NCT01403948|463103000|FG005|Overall Study|other than above|1|||
128673220|NCT01403948|463103001|FG006|Overall Study|other than above|2|||
128673221|NCT01403948|463103002|FG007|Overall Study|other than above|0|||
128673222|NCT01403948|463103003|FG008|Overall Study|other than above|0|||
128673223|NCT01403948|463103004|FG009|Overall Study|other than above|0|||
128673224|NCT00763698|463103005|FG000|Overall Study|Unsuccessful Implant|5|||
128673225|NCT00763698|463103005|FG000|Overall Study|Death|4|||
128673226|NCT00763698|463103005|FG000|Overall Study|Withdrawal by Subject|1|||
128673227|NCT00080899|463103006|FG000|Overall Study|Adverse Event|1|||
128673228|NCT03698591|463103007|FG000|Overall Study|Withdrawal by Subject|2|||
128673229|NCT03698591|463103008|FG001|Overall Study|Withdrawal by Subject|2|||
128673230|NCT03698591|463103007|FG000|Overall Study|Failed drug screen|1|||
128673231|NCT03698591|463103008|FG001|Overall Study|Failed drug screen|1|||
128673232|NCT03698591|463103007|FG000|Overall Study|Failed health screen|0|||
128673233|NCT03698591|463103008|FG001|Overall Study|Failed health screen|1|||
128673234|NCT03698591|463103007|FG000|Overall Study|Ineligible for financial compensation|1|||
128673235|NCT03698591|463103008|FG001|Overall Study|Ineligible for financial compensation|0|||
128673236|NCT03698591|463103007|FG000|Overall Study|Equipment Error|1|||
128673237|NCT03698591|463103008|FG001|Overall Study|Equipment Error|0|||
128673238|NCT03698591|463103007|FG000|Overall Study|Could not establish TMS dosage|0|||
128673239|NCT03698591|463103008|FG001|Overall Study|Could not establish TMS dosage|1|||
128673240|NCT01675167|463103010|FG000|Open-label Titration Phase|Adverse Event|81|||
128673241|NCT01675167|463103011|FG001|Open-label Titration Phase|Adverse Event|0|||
128673242|NCT01675167|463103012|FG002|Open-label Titration Phase|Adverse Event|0|||
128673243|NCT01675167|463103010|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
128673244|NCT01675167|463103011|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
128673245|NCT01675167|463103012|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
128673246|NCT01675167|463103010|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
128673247|NCT01675167|463103011|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
128673248|NCT01675167|463103012|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
128673249|NCT01675167|463103010|FG000|Open-label Titration Phase|Protocol Violation|43|||
128673250|NCT01675167|463103011|FG001|Open-label Titration Phase|Protocol Violation|0|||
128673251|NCT01675167|463103012|FG002|Open-label Titration Phase|Protocol Violation|0|||
128673252|NCT01675167|463103010|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
128673253|NCT01675167|463103011|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
128673254|NCT01675167|463103012|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
128673255|NCT01675167|463103010|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
128673256|NCT01675167|463103011|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
128673257|NCT01675167|463103012|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
128673258|NCT01675167|463103010|FG000|Open-label Titration Phase|Other|55|||
128673259|NCT01675167|463103011|FG001|Open-label Titration Phase|Other|0|||
128673260|NCT01675167|463103012|FG002|Open-label Titration Phase|Other|0|||
128673261|NCT01675167|463103010|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
128673262|NCT01675167|463103011|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
128673263|NCT01675167|463103012|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
128673264|NCT01675167|463103010|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
128673265|NCT01675167|463103011|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
128673266|NCT01675167|463103012|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
128673267|NCT01675167|463103010|FG000|Double-blind Treatment Phase|Adverse Event|0|||
128673268|NCT01675167|463103011|FG001|Double-blind Treatment Phase|Adverse Event|5|||
128673269|NCT01675167|463103012|FG002|Double-blind Treatment Phase|Adverse Event|13|||
128673270|NCT01675167|463103010|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
128673271|NCT01675167|463103011|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
128673272|NCT01675167|463103012|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
128673273|NCT01675167|463103010|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
128673274|NCT01675167|463103011|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
128673275|NCT01675167|463103012|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
128673276|NCT01675167|463103010|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
128673277|NCT01675167|463103011|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
128673278|NCT01675167|463103012|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
128673279|NCT01675167|463103010|FG000|Double-blind Treatment Phase|Other|0|||
128673280|NCT01675167|463103011|FG001|Double-blind Treatment Phase|Other|7|||
128673281|NCT01675167|463103012|FG002|Double-blind Treatment Phase|Other|5|||
128673282|NCT00881868|463103013|FG000|Overall Study|Adverse Event|0|||
128673283|NCT00881868|463103014|FG001|Overall Study|Adverse Event|1|||
128673284|NCT00881868|463103013|FG000|Overall Study|Lost to Follow-up|2|||
128673285|NCT00881868|463103014|FG001|Overall Study|Lost to Follow-up|1|||
128673286|NCT00881868|463103013|FG000|Overall Study|Physician Decision|4|||
128673287|NCT00881868|463103014|FG001|Overall Study|Physician Decision|0|||
128673288|NCT00881868|463103013|FG000|Overall Study|Protocol Violation|2|||
128673289|NCT00881868|463103014|FG001|Overall Study|Protocol Violation|0|||
128673290|NCT03255083|463103015|FG000|Overall Study|Clinical progression|1|||
128673291|NCT03255083|463103016|FG001|Overall Study|Clinical progression|0|||
128673292|NCT03255083|463103017|FG002|Overall Study|Clinical progression|0|||
128673293|NCT03255083|463103018|FG003|Overall Study|Clinical progression|0|||
128673294|NCT03255083|463103015|FG000|Overall Study|Adverse Event|0|||
128673295|NCT03255083|463103016|FG001|Overall Study|Adverse Event|1|||
128673296|NCT03255083|463103017|FG002|Overall Study|Adverse Event|0|||
128673297|NCT03255083|463103018|FG003|Overall Study|Adverse Event|0|||
128673298|NCT03255083|463103015|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
128673299|NCT03255083|463103016|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
128673300|NCT03255083|463103017|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
128673301|NCT03255083|463103018|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
128673302|NCT03255083|463103015|FG000|Overall Study|Withdrawal by Subject|1|||
128673303|NCT03255083|463103016|FG001|Overall Study|Withdrawal by Subject|1|||
128673304|NCT03255083|463103017|FG002|Overall Study|Withdrawal by Subject|1|||
128673305|NCT03255083|463103018|FG003|Overall Study|Withdrawal by Subject|0|||
128673306|NCT01182844|463103019|FG000|Overall Study|Withdrawal by Subject|0|||
128673307|NCT01182844|463103020|FG001|Overall Study|Withdrawal by Subject|2|||
128673308|NCT01457352|463103021|FG000|Period 1|Adverse Event|2|||
128673309|NCT01457352|463103022|FG001|Period 1|Adverse Event|0|||
128673310|NCT01457352|463103021|FG000|Period 1|Withdrawal by Subject|2|||
128673311|NCT01457352|463103022|FG001|Period 1|Withdrawal by Subject|0|||
128673312|NCT01457352|463103021|FG000|Period 1|Physician Decision|2|||
128673313|NCT01457352|463103022|FG001|Period 1|Physician Decision|0|||
128673314|NCT01457352|463103021|FG000|Period 1|MS related disease progression|1|||
128673315|NCT01457352|463103022|FG001|Period 1|MS related disease progression|0|||
128673316|NCT01457352|463103021|FG000|Period 1|Withdrawn|1|||
128673317|NCT01457352|463103022|FG001|Period 1|Withdrawn|0|||
128673318|NCT01457352|463103021|FG000|Period 1|withdrew per sponsor|1|||
128673319|NCT01457352|463103022|FG001|Period 1|withdrew per sponsor|0|||
128673320|NCT01457352|463103021|FG000|Period 1|Protocol Violation|4|||
128673321|NCT01457352|463103022|FG001|Period 1|Protocol Violation|0|||
128673322|NCT01457352|463103021|FG000|Period 1|Did not meet eligibility criteria|3|||
128673323|NCT01457352|463103022|FG001|Period 1|Did not meet eligibility criteria|0|||
128673324|NCT01457352|463103021|FG000|Period 2|Withdrawal by Subject|23|||
128673325|NCT01457352|463103022|FG001|Period 2|Withdrawal by Subject|0|||
128673326|NCT01457352|463103021|FG000|Period 2|Adverse Event|22|||
128673327|NCT01457352|463103022|FG001|Period 2|Adverse Event|0|||
128673328|NCT01457352|463103021|FG000|Period 2|no analysis|10|||
128673329|NCT01457352|463103022|FG001|Period 2|no analysis|0|||
128673330|NCT01457352|463103021|FG000|Period 2|Lack of Efficacy|8|||
128673331|NCT01457352|463103022|FG001|Period 2|Lack of Efficacy|0|||
128673332|NCT01457352|463103021|FG000|Period 2|Protocol Violation|4|||
128673333|NCT01457352|463103022|FG001|Period 2|Protocol Violation|0|||
128673334|NCT01457352|463103021|FG000|Period 2|Sponsor's withdrawal|7|||
128673335|NCT01457352|463103022|FG001|Period 2|Sponsor's withdrawal|0|||
128673336|NCT01457352|463103021|FG000|Period 2|Lost to Follow-up|1|||
128673337|NCT01457352|463103022|FG001|Period 2|Lost to Follow-up|0|||
128673338|NCT01457352|463103021|FG000|Period 2|dose change|1|||
128673339|NCT01457352|463103022|FG001|Period 2|dose change|0|||
128673340|NCT01457352|463103021|FG000|Period 2|Physician Decision|1|||
128673341|NCT01457352|463103022|FG001|Period 2|Physician Decision|0|||
128673342|NCT01457352|463103021|FG000|Period 2|Did not meet eligibility criteria|3|||
128673343|NCT01457352|463103022|FG001|Period 2|Did not meet eligibility criteria|0|||
128673344|NCT01457352|463103021|FG000|Period 3|Adverse Event|1|||
128673345|NCT01457352|463103022|FG001|Period 3|Adverse Event|1|||
128673346|NCT01457352|463103021|FG000|Period 3|Withdrawal by Subject|0|||
128673347|NCT01457352|463103022|FG001|Period 3|Withdrawal by Subject|2|||
128673348|NCT01457352|463103021|FG000|Period 3|incorrect treatment|0|||
128673349|NCT01457352|463103022|FG001|Period 3|incorrect treatment|1|||
128673350|NCT01457352|463103021|FG000|Period 3|Sponsor's withdrawal|0|||
128673351|NCT01457352|463103022|FG001|Period 3|Sponsor's withdrawal|1|||
128673352|NCT04174365|463103023|FG000|Overall Study|Lost to Follow-up|1|||
128673353|NCT04174365|463103024|FG001|Overall Study|Lost to Follow-up|2|||
128673354|NCT04174365|463103023|FG000|Overall Study|Adverse Event|2|||
128673355|NCT04174365|463103024|FG001|Overall Study|Adverse Event|1|||
128673356|NCT04174365|463103023|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
128673357|NCT04174365|463103024|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
128673358|NCT04174365|463103023|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
128673359|NCT04174365|463103024|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
128673360|NCT04174365|463103023|FG000|Overall Study|Protocol Deviation|1|||
128673361|NCT04174365|463103024|FG001|Overall Study|Protocol Deviation|0|||
128673362|NCT04174365|463103023|FG000|Overall Study|Lack of Efficacy|0|||
128673363|NCT04174365|463103024|FG001|Overall Study|Lack of Efficacy|2|||
128673364|NCT04174365|463103023|FG000|Overall Study|Disease Relapse|1|||
128673365|NCT04174365|463103024|FG001|Overall Study|Disease Relapse|0|||
128673366|NCT04174365|463103023|FG000|Overall Study|Reason Not Specified|0|||
128673367|NCT04174365|463103024|FG001|Overall Study|Reason Not Specified|1|||
128673368|NCT03135119|463104720|FG000|Overall Study|Lost to Follow-up|2|||
128673369|NCT03135119|463104721|FG001|Overall Study|Lost to Follow-up|0|||
128673370|NCT03135119|463104720|FG000|Overall Study|Physician Decision|1|||
128673371|NCT03135119|463104721|FG001|Overall Study|Physician Decision|1|||
128673372|NCT03135119|463104720|FG000|Overall Study|COVID-19 Shutdown|2|||
128673373|NCT03135119|463104721|FG001|Overall Study|COVID-19 Shutdown|2|||
128673374|NCT00833417|463104726|FG000|Overall Study|Adverse Event|5|||
128673375|NCT00833417|463104727|FG001|Overall Study|Adverse Event|16|||
128673376|NCT00833417|463104726|FG000|Overall Study|Death|1|||
128673377|NCT00833417|463104727|FG001|Overall Study|Death|3|||
128673378|NCT00833417|463104726|FG000|Overall Study|Lost to Follow-up|1|||
128673379|NCT00833417|463104727|FG001|Overall Study|Lost to Follow-up|2|||
128673380|NCT00833417|463104726|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
128673381|NCT00833417|463104727|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
128673382|NCT00833417|463104726|FG000|Overall Study|Patient Decision to Withdraw|4|||
128673383|NCT00833417|463104727|FG001|Overall Study|Patient Decision to Withdraw|23|||
128673384|NCT00833417|463104726|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
128673385|NCT00833417|463104727|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
128673386|NCT00833417|463104726|FG000|Overall Study|Disease Progression|18|||
128673387|NCT00833417|463104727|FG001|Overall Study|Disease Progression|17|||
128673388|NCT00833417|463104726|FG000|Overall Study|Reason Not Specified|0|||
128673389|NCT00833417|463104727|FG001|Overall Study|Reason Not Specified|1|||
128673390|NCT05315908|463104728|FG000|Overall Study|Lost to Follow-up|4477|||
128673391|NCT05315908|463104729|FG001|Overall Study|Lost to Follow-up|4606|||
128673392|NCT01561898|463104730|FG000|Overall Study|Withdrawal by Subject|0|||
128673393|NCT01561898|463104731|FG001|Overall Study|Withdrawal by Subject|8|||
128673394|NCT01561898|463104732|FG002|Overall Study|Withdrawal by Subject|12|||
128673395|NCT01561898|463104733|FG003|Overall Study|Withdrawal by Subject|5|||
128673396|NCT01561898|463104730|FG000|Overall Study|Lack of Efficacy|0|||
128673397|NCT01561898|463104731|FG001|Overall Study|Lack of Efficacy|8|||
128673398|NCT01561898|463104732|FG002|Overall Study|Lack of Efficacy|10|||
128673399|NCT01561898|463104733|FG003|Overall Study|Lack of Efficacy|5|||
128673400|NCT01561898|463104730|FG000|Overall Study|Worsening of complications|0|||
128673401|NCT01561898|463104731|FG001|Overall Study|Worsening of complications|1|||
128673402|NCT01561898|463104732|FG002|Overall Study|Worsening of complications|0|||
128673403|NCT01561898|463104733|FG003|Overall Study|Worsening of complications|0|||
128673404|NCT01561898|463104730|FG000|Overall Study|Lost to Follow-up|0|||
128673405|NCT01561898|463104731|FG001|Overall Study|Lost to Follow-up|0|||
128673406|NCT01561898|463104732|FG002|Overall Study|Lost to Follow-up|1|||
128673407|NCT01561898|463104733|FG003|Overall Study|Lost to Follow-up|0|||
128673408|NCT01561898|463104730|FG000|Overall Study|Adverse Event|1|||
129007078|NCT04820842|464318022|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129007079|NCT04820842|464318023|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
128673409|NCT01561898|463104731|FG001|Overall Study|Adverse Event|19|||
129007080|NCT04820842|464318024|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
128673410|NCT01561898|463104732|FG002|Overall Study|Adverse Event|14|||
128673411|NCT01561898|463104733|FG003|Overall Study|Adverse Event|9|||
128673412|NCT01561898|463104730|FG000|Overall Study|Physician Decision|1|||
128673413|NCT01561898|463104731|FG001|Overall Study|Physician Decision|5|||
128673414|NCT01561898|463104732|FG002|Overall Study|Physician Decision|7|||
128673415|NCT01561898|463104733|FG003|Overall Study|Physician Decision|1|||
128673416|NCT00294762|463104734|FG000|Overall Study|Did not receive study treatment|3|||
128673417|NCT00294762|463104735|FG001|Overall Study|Did not receive study treatment|3|||
128673418|NCT02238080|463104736|FG000|Overall Study|Death|13|||
129215077|NCT02760498|465089436|FG000|Overall Study|Disease progression|21|||
128673419|NCT02238080|463104736|FG000|Overall Study|Treatment interrupted|6|||
128673420|NCT02238080|463104736|FG000|Overall Study|Withdrawal by Subject|2|||
128673421|NCT02238080|463104736|FG000|Overall Study|Other|4|||
128673422|NCT01738646|463104737|FG000|Overall Study|Still Receiving Treatment|2|||
128673423|NCT00647270|463104738|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
128673424|NCT00647270|463104739|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
128673425|NCT00647270|463104740|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
128673426|NCT00647270|463104738|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
128673427|NCT00647270|463104739|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
128673428|NCT00647270|463104740|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
128673429|NCT00647270|463104738|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
128673430|NCT00647270|463104739|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
128673431|NCT00647270|463104740|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
128673432|NCT00647270|463104738|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
128673433|NCT00647270|463104739|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
128673434|NCT00647270|463104740|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
128673435|NCT00647270|463104738|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
128673436|NCT00647270|463104739|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
128673437|NCT00647270|463104740|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
128673438|NCT00647270|463104738|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
128673439|NCT00647270|463104739|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
128673440|NCT00647270|463104740|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
128673441|NCT00647270|463104738|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
128673442|NCT00647270|463104739|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
128673443|NCT00647270|463104740|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
128673444|NCT00422084|463104741|FG000|Overall Study|Adverse Event|21|||
128673445|NCT00422084|463104742|FG001|Overall Study|Adverse Event|7|||
128673446|NCT00422084|463104741|FG000|Overall Study|Withdrawal by Subject|12|||
128673447|NCT00422084|463104742|FG001|Overall Study|Withdrawal by Subject|9|||
128673448|NCT00422084|463104741|FG000|Overall Study|Lost to Follow-up|14|||
128673449|NCT00422084|463104742|FG001|Overall Study|Lost to Follow-up|9|||
128673450|NCT00422084|463104741|FG000|Overall Study|Protocol Violation|4|||
128673451|NCT00422084|463104742|FG001|Overall Study|Protocol Violation|1|||
128673452|NCT00422084|463104741|FG000|Overall Study|Lack of Efficacy|40|||
128673453|NCT00422084|463104742|FG001|Overall Study|Lack of Efficacy|42|||
128673454|NCT00422084|463104741|FG000|Overall Study|P. vivax infection|3|||
128673455|NCT00422084|463104742|FG001|Overall Study|P. vivax infection|6|||
128673456|NCT00422084|463104741|FG000|Overall Study|Cyesis|1|||
128673457|NCT00422084|463104742|FG001|Overall Study|Cyesis|0|||
128673458|NCT00422084|463104741|FG000|Overall Study|Withdrawn from study accidentally|1|||
128673459|NCT00422084|463104742|FG001|Overall Study|Withdrawn from study accidentally|0|||
128673460|NCT00422084|463104741|FG000|Overall Study|Non-compliance|1|||
128673461|NCT00422084|463104742|FG001|Overall Study|Non-compliance|0|||
128673462|NCT00422084|463104741|FG000|Overall Study|Re-location|0|||
128673463|NCT00422084|463104742|FG001|Overall Study|Re-location|1|||
128673464|NCT00422084|463104741|FG000|Overall Study|Not defined|1|||
129007081|NCT04820842|464318018|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007082|NCT04820842|464318019|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007083|NCT04820842|464318020|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007084|NCT04820842|464318021|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
129007085|NCT04820842|464318022|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007086|NCT04820842|464318023|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129007087|NCT04820842|464318024|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
129007088|NCT02688400|464318029|FG000|Overall Study|Protocol Violation|2|||
129007089|NCT02688400|464318030|FG001|Overall Study|Protocol Violation|5|||
129007090|NCT02688400|464318029|FG000|Overall Study|Lack of Efficacy|7|||
129007091|NCT02688400|464318030|FG001|Overall Study|Lack of Efficacy|7|||
129007092|NCT02688400|464318029|FG000|Overall Study|Adverse Event|21|||
129007093|NCT02688400|464318030|FG001|Overall Study|Adverse Event|12|||
128673465|NCT00422084|463104742|FG001|Overall Study|Not defined|1|||
128673466|NCT00759564|463104745|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
128673467|NCT00759564|463104746|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
128673468|NCT00759564|463104747|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
128673469|NCT00759564|463104748|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
128673470|NCT00759564|463104749|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
128673471|NCT00329849|463104750|FG000|Overall Study|Withdrawal by Subject|6|||
128673472|NCT00329849|463104751|FG001|Overall Study|Withdrawal by Subject|4|||
128673473|NCT00653432|463104752|FG000|Overall Study|Adverse Event|4|||
128673474|NCT00653432|463104753|FG001|Overall Study|Adverse Event|1|||
128673475|NCT00653432|463104752|FG000|Overall Study|Withdrawal by Subject|4|||
128673476|NCT00653432|463104753|FG001|Overall Study|Withdrawal by Subject|5|||
128673477|NCT00653432|463104752|FG000|Overall Study|Lost to Follow-up|7|||
128673478|NCT00653432|463104753|FG001|Overall Study|Lost to Follow-up|6|||
128673479|NCT00653432|463104752|FG000|Overall Study|Use/Need of Con Therapy|2|||
128673480|NCT00653432|463104753|FG001|Overall Study|Use/Need of Con Therapy|1|||
128673481|NCT00653432|463104752|FG000|Overall Study|Other - Reason Not Provided|5|||
128673482|NCT00653432|463104753|FG001|Overall Study|Other - Reason Not Provided|3|||
128673483|NCT00835211|463104755|FG000|First Intervention|Withdrawal by Subject|0|||
128673484|NCT00835211|463104756|FG001|First Intervention|Withdrawal by Subject|1|||
128673485|NCT00835211|463104755|FG000|Washout: 7 Days|Adverse Event|2|||
128673486|NCT00835211|463104756|FG001|Washout: 7 Days|Adverse Event|1|||
128673487|NCT00835211|463104755|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
128673488|NCT00835211|463104756|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
128673489|NCT02343549|463104757|FG000|Overall Study|Death|11|||
128673490|NCT02343549|463104757|FG000|Overall Study|Withdrawal by Subject|2|||
128673491|NCT01090323|463104758|FG000|Overall Study|Adverse Event|12|||
128673492|NCT01090323|463104759|FG001|Overall Study|Adverse Event|2|||
128673493|NCT01090323|463104758|FG000|Overall Study|Abnormal Lab Values|3|||
128673494|NCT01090323|463104759|FG001|Overall Study|Abnormal Lab Values|1|||
128673495|NCT01090323|463104758|FG000|Overall Study|Abnormal Test Procedure Results|2|||
128673496|NCT01090323|463104759|FG001|Overall Study|Abnormal Test Procedure Results|0|||
128673497|NCT01090323|463104758|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
128673498|NCT01090323|463104759|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128673499|NCT01090323|463104758|FG000|Overall Study|Condition no longer requires drug|5|||
128673500|NCT01090323|463104759|FG001|Overall Study|Condition no longer requires drug|4|||
128673501|NCT01090323|463104758|FG000|Overall Study|Protocol Violation|2|||
128673502|NCT01090323|463104759|FG001|Overall Study|Protocol Violation|1|||
128673503|NCT01090323|463104758|FG000|Overall Study|Withdrew consent|33|||
128673504|NCT01090323|463104759|FG001|Overall Study|Withdrew consent|11|||
128673505|NCT01090323|463104758|FG000|Overall Study|Lost to Follow-up|11|||
128673506|NCT01090323|463104759|FG001|Overall Study|Lost to Follow-up|6|||
128673507|NCT01090323|463104758|FG000|Overall Study|Administrative problems|6|||
128673508|NCT01090323|463104759|FG001|Overall Study|Administrative problems|4|||
128673509|NCT01090323|463104758|FG000|Overall Study|Death|1|||
128673510|NCT01090323|463104759|FG001|Overall Study|Death|2|||
128673511|NCT01090323|463104758|FG000|Overall Study|Stopped end of core|7|||
128673512|NCT01090323|463104759|FG001|Overall Study|Stopped end of core|0|||
128673513|NCT01090323|463104758|FG000|Overall Study|Stopped end of extension 1#|3|||
128673514|NCT01090323|463104759|FG001|Overall Study|Stopped end of extension 1#|1|||
128673515|NCT05498701|463104760|FG000|Period 3|Adverse Event|1|||
128673516|NCT05498701|463104761|FG001|Period 3|Adverse Event|0|||
128673517|NCT01864005|463104762|FG000|Overall Study|Protocol Violation|0|||
128673518|NCT01864005|463104763|FG001|Overall Study|Protocol Violation|1|||
128673519|NCT01864005|463104762|FG000|Overall Study|Withdrawal by Subject|0|||
128673520|NCT01864005|463104763|FG001|Overall Study|Withdrawal by Subject|1|||
128673521|NCT01864005|463104762|FG000|Overall Study|Incorrect enrolment|1|||
128673522|NCT01864005|463104763|FG001|Overall Study|Incorrect enrolment|0|||
128673523|NCT01864005|463104762|FG000|Overall Study|Disease need|1|||
128673524|NCT01864005|463104763|FG001|Overall Study|Disease need|1|||
128673525|NCT01864005|463104762|FG000|Overall Study|Need GP IIb/IIIa|1|||
128673526|NCT01864005|463104763|FG001|Overall Study|Need GP IIb/IIIa|3|||
128673527|NCT02350764|463104767|FG000|Overall Study|Adverse Event|4|||
128673528|NCT02350764|463104767|FG000|Overall Study|Death|3|||
128673529|NCT02350764|463104767|FG000|Overall Study|Physician Decision|2|||
128673530|NCT02350764|463104767|FG000|Overall Study|Withdrawal by Subject|2|||
128673531|NCT00600119|463104768|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
128673532|NCT00600119|463104769|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
128673533|NCT00600119|463104770|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
128673534|NCT00600119|463104771|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
128673535|NCT00600119|463104772|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
128673536|NCT00600119|463104773|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
128673537|NCT00600119|463104768|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
128673538|NCT00600119|463104769|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
128673539|NCT00600119|463104770|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
128673540|NCT00600119|463104771|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
128673541|NCT00600119|463104772|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
128673542|NCT00600119|463104773|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
128673543|NCT00600119|463104768|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
128673544|NCT00600119|463104769|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
128673545|NCT00600119|463104770|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
128673546|NCT00600119|463104771|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
128673547|NCT00600119|463104772|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
128673548|NCT00600119|463104773|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
128673549|NCT00600119|463104768|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
128673550|NCT00600119|463104769|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
128673551|NCT00600119|463104770|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
128673552|NCT00600119|463104771|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
128673553|NCT00600119|463104772|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
128673554|NCT00600119|463104773|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
128673555|NCT00600119|463104768|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
128673556|NCT00600119|463104769|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
128673557|NCT00600119|463104770|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
128673558|NCT00600119|463104771|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
128673559|NCT00600119|463104772|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
128673560|NCT00600119|463104773|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
128673561|NCT00600119|463104768|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
128673562|NCT00600119|463104769|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
128673563|NCT00600119|463104770|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
128673564|NCT00600119|463104771|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
128673565|NCT00600119|463104772|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
128673566|NCT00600119|463104773|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
128673567|NCT00600119|463104768|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
128673568|NCT00600119|463104769|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
128673569|NCT00600119|463104770|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
128673570|NCT00600119|463104771|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
128673571|NCT00600119|463104772|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
128673572|NCT00600119|463104773|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
128673573|NCT00600119|463104768|FG000|Double-blind Treatment Period|Other|0|||
128673574|NCT00600119|463104769|FG001|Double-blind Treatment Period|Other|0|||
128673575|NCT00600119|463104770|FG002|Double-blind Treatment Period|Other|0|||
128673576|NCT00600119|463104771|FG003|Double-blind Treatment Period|Other|0|||
128673577|NCT00600119|463104772|FG004|Double-blind Treatment Period|Other|2|||
128673578|NCT00600119|463104773|FG005|Double-blind Treatment Period|Other|1|||
128673579|NCT00600119|463104768|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
128673580|NCT00600119|463104769|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
128673581|NCT00600119|463104770|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
128673582|NCT00600119|463104771|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
128673583|NCT00600119|463104772|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
128673584|NCT00600119|463104773|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
129007094|NCT02688400|464318029|FG000|Overall Study|Withdrawal by Subject|15|||
129007095|NCT02688400|464318030|FG001|Overall Study|Withdrawal by Subject|13|||
129007096|NCT02688400|464318029|FG000|Overall Study|No study medication intake|1|||
129007097|NCT02688400|464318030|FG001|Overall Study|No study medication intake|4|||
129007098|NCT02688400|464318029|FG000|Overall Study|Lost to Follow-up|0|||
129007099|NCT02688400|464318030|FG001|Overall Study|Lost to Follow-up|3|||
129007100|NCT01075763|464318032|FG000|Overall Study|Lost to Follow-up|2|||
129007101|NCT01075763|464318033|FG001|Overall Study|Lost to Follow-up|1|||
128673585|NCT00600119|463104768|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
128673586|NCT00600119|463104769|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
128673587|NCT00600119|463104770|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
128673588|NCT00600119|463104771|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
128673589|NCT00600119|463104772|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
128673590|NCT00600119|463104773|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
128673591|NCT00600119|463104768|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
128673592|NCT00600119|463104769|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
128673593|NCT00600119|463104770|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
128673594|NCT00600119|463104771|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
128673595|NCT00600119|463104772|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
128673596|NCT00600119|463104773|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
128673597|NCT00600119|463104768|FG000|Double-blind Treatment Period|Physician Decision|2|||
128673598|NCT00600119|463104769|FG001|Double-blind Treatment Period|Physician Decision|0|||
128673599|NCT00600119|463104770|FG002|Double-blind Treatment Period|Physician Decision|0|||
128673600|NCT00600119|463104771|FG003|Double-blind Treatment Period|Physician Decision|0|||
128673601|NCT00600119|463104772|FG004|Double-blind Treatment Period|Physician Decision|0|||
128673602|NCT00600119|463104773|FG005|Double-blind Treatment Period|Physician Decision|0|||
128673603|NCT00600119|463104768|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
128673604|NCT00600119|463104769|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
128673605|NCT00600119|463104770|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
128673606|NCT00600119|463104771|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129007102|NCT01075763|464318032|FG000|Overall Study|Lack of Efficacy|0|||
129007103|NCT01075763|464318033|FG001|Overall Study|Lack of Efficacy|1|||
129007104|NCT01075763|464318032|FG000|Overall Study|Withdrawal by Subject|2|||
128673607|NCT00600119|463104772|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
128673608|NCT00600119|463104773|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
128673609|NCT00600119|463104768|FG000|Double-blind Treatment Period|Adverse Event|1|||
128673610|NCT00600119|463104769|FG001|Double-blind Treatment Period|Adverse Event|1|||
128673611|NCT00600119|463104770|FG002|Double-blind Treatment Period|Adverse Event|0|||
128673612|NCT00600119|463104771|FG003|Double-blind Treatment Period|Adverse Event|1|||
128673613|NCT00600119|463104772|FG004|Double-blind Treatment Period|Adverse Event|2|||
128673614|NCT00600119|463104773|FG005|Double-blind Treatment Period|Adverse Event|10|||
128673615|NCT00600119|463104768|FG000|Follow-up Period|Adverse Event|0|||
128673616|NCT00600119|463104769|FG001|Follow-up Period|Adverse Event|0|||
128673617|NCT00600119|463104770|FG002|Follow-up Period|Adverse Event|0|||
128673618|NCT00600119|463104771|FG003|Follow-up Period|Adverse Event|0|||
128673619|NCT00600119|463104772|FG004|Follow-up Period|Adverse Event|0|||
128673620|NCT00600119|463104773|FG005|Follow-up Period|Adverse Event|1|||
128673621|NCT00600119|463104768|FG000|Follow-up Period|Other|1|||
128673622|NCT00600119|463104769|FG001|Follow-up Period|Other|0|||
128673623|NCT00600119|463104770|FG002|Follow-up Period|Other|0|||
128673624|NCT00600119|463104771|FG003|Follow-up Period|Other|0|||
128673625|NCT00600119|463104772|FG004|Follow-up Period|Other|0|||
128673626|NCT00600119|463104773|FG005|Follow-up Period|Other|0|||
128673627|NCT03241368|463104774|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
128673628|NCT03241368|463104774|FG000|Overall Study|Lost to Follow-up|1|||
128673629|NCT03241368|463104774|FG000|Overall Study|Physician Decision|6|||
128673630|NCT03241368|463104774|FG000|Overall Study|Withdrawal by Subject|6|||
128673631|NCT03241368|463104774|FG000|Overall Study|Protocol Violation|1|||
128673632|NCT00729469|463104775|FG000|Overall Study|Adverse Event|14|||
128673633|NCT00729469|463104776|FG001|Overall Study|Adverse Event|25|||
128673634|NCT00729469|463104775|FG000|Overall Study|Lost to Follow-up|9|||
128673635|NCT00729469|463104776|FG001|Overall Study|Lost to Follow-up|9|||
128673636|NCT00729469|463104775|FG000|Overall Study|Protocol Violation|2|||
128673637|NCT00729469|463104776|FG001|Overall Study|Protocol Violation|1|||
128673638|NCT00729469|463104775|FG000|Overall Study|Withdrawal by Subject|19|||
128673639|NCT00729469|463104776|FG001|Overall Study|Withdrawal by Subject|8|||
128673640|NCT00729469|463104775|FG000|Overall Study|Other-Not mentioned|9|||
128673641|NCT00729469|463104776|FG001|Overall Study|Other-Not mentioned|4|||
128673642|NCT01270802|463104779|FG000|Overall Study|Withdrawal by Subject|1|||
128673643|NCT01270802|463104780|FG001|Overall Study|Withdrawal by Subject|0|||
128673644|NCT01270802|463104779|FG000|Overall Study|Adverse Event|1|||
128673645|NCT01270802|463104780|FG001|Overall Study|Adverse Event|0|||
128673646|NCT01270802|463104779|FG000|Overall Study|Lost to Follow-up|0|||
128673647|NCT01270802|463104780|FG001|Overall Study|Lost to Follow-up|1|||
128673648|NCT01566214|463104781|FG000|Overall Study|Lost to Follow-up|3|||
128673649|NCT01566214|463104782|FG001|Overall Study|Lost to Follow-up|0|||
128673650|NCT00561977|463104783|FG000|Overall Study|Withdrawal by Subject|0|||
128673651|NCT00561977|463104784|FG001|Overall Study|Withdrawal by Subject|2|||
128673652|NCT00561977|463104785|FG002|Overall Study|Withdrawal by Subject|1|||
128673653|NCT00561977|463104783|FG000|Overall Study|Pregnancy|0|||
128673654|NCT00561977|463104784|FG001|Overall Study|Pregnancy|1|||
128673655|NCT00561977|463104785|FG002|Overall Study|Pregnancy|1|||
128673656|NCT04620798|463104788|FG000|Overall Study|Lost to Follow-up|126|||
128673657|NCT04620798|463104789|FG001|Overall Study|Lost to Follow-up|138|||
128673658|NCT01960907|463104795|FG000|Overall Study|Death|4|||
128673659|NCT01960907|463104796|FG001|Overall Study|Death|3|||
128673660|NCT01960907|463104795|FG000|Overall Study|Withdrawal by Subject|32|||
128673661|NCT01960907|463104796|FG001|Overall Study|Withdrawal by Subject|42|||
128673662|NCT01616693|463104797|FG000|Evaluated for Safety|Physician Decision|1|||
128673663|NCT01616693|463104798|FG001|Evaluated for Safety|Physician Decision|0|||
128673664|NCT01616693|463104799|FG002|Evaluated for Safety|Physician Decision|1|||
128673665|NCT01616693|463104800|FG003|Evaluated for Safety|Physician Decision|0|||
128673666|NCT01616693|463104797|FG000|Received Both Vaccines|Adverse Event|2|||
128673667|NCT01616693|463104798|FG001|Received Both Vaccines|Adverse Event|0|||
128673668|NCT01616693|463104799|FG002|Received Both Vaccines|Adverse Event|0|||
128673669|NCT01616693|463104800|FG003|Received Both Vaccines|Adverse Event|0|||
128673670|NCT01616693|463104797|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
128673671|NCT01616693|463104798|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
128673672|NCT01616693|463104799|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
128673673|NCT01616693|463104800|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
128673674|NCT01616693|463104797|FG000|Received Both Vaccines|Lost to Follow-up|4|||
128673675|NCT01616693|463104798|FG001|Received Both Vaccines|Lost to Follow-up|3|||
128673676|NCT01616693|463104799|FG002|Received Both Vaccines|Lost to Follow-up|4|||
128673677|NCT01616693|463104800|FG003|Received Both Vaccines|Lost to Follow-up|4|||
128673678|NCT01616693|463104797|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
128673679|NCT01616693|463104798|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
128673680|NCT01616693|463104799|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
128673681|NCT01616693|463104800|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
128673682|NCT00832624|463104804|FG000|Overall Study|Study Terminated|10|||
128673683|NCT02395172|463104805|FG000|Overall Study|Participants randomized but not treated|3|||
128673684|NCT02395172|463104806|FG001|Overall Study|Participants randomized but not treated|31|||
128673685|NCT00653939|463104807|FG000|Overall Study|Adverse Event|1|||
129007105|NCT01075763|464318033|FG001|Overall Study|Withdrawal by Subject|2|||
129007106|NCT03731182|464318038|FG000|Overall Study|Lost to Follow-up|2|||
128673686|NCT00653939|463104808|FG001|Overall Study|Adverse Event|3|||
128673687|NCT00653939|463104807|FG000|Overall Study|Withdrawal by Subject|3|||
128673688|NCT00653939|463104808|FG001|Overall Study|Withdrawal by Subject|3|||
128673689|NCT00653939|463104807|FG000|Overall Study|Physician Decision|4|||
128673690|NCT00653939|463104808|FG001|Overall Study|Physician Decision|0|||
128673691|NCT00653939|463104807|FG000|Overall Study|Disease Progression|2|||
128673692|NCT00653939|463104808|FG001|Overall Study|Disease Progression|3|||
128673693|NCT00653939|463104807|FG000|Overall Study|Other|2|||
128673694|NCT00653939|463104808|FG001|Overall Study|Other|6|||
128673695|NCT00717236|463104809|FG000|Double-Blind Period|Adverse Event|33|||
128673696|NCT00717236|463104810|FG001|Double-Blind Period|Adverse Event|6|||
128673697|NCT00717236|463104809|FG000|Double-Blind Period|Lack of Efficacy|6|||
128673698|NCT00717236|463104810|FG001|Double-Blind Period|Lack of Efficacy|6|||
128673699|NCT00717236|463104809|FG000|Double-Blind Period|Lost to Follow-up|3|||
128673700|NCT00717236|463104810|FG001|Double-Blind Period|Lost to Follow-up|5|||
128673701|NCT00717236|463104809|FG000|Double-Blind Period|Withdrawal by Subject|10|||
128673702|NCT00717236|463104810|FG001|Double-Blind Period|Withdrawal by Subject|2|||
128673703|NCT00717236|463104809|FG000|Double-Blind Period|Loss of efficacy|3|||
128673704|NCT00717236|463104810|FG001|Double-Blind Period|Loss of efficacy|0|||
128673705|NCT00717236|463104809|FG000|Double-Blind Period|Other: Death|1|||
128673706|NCT00717236|463104810|FG001|Double-Blind Period|Other: Death|0|||
128673707|NCT00717236|463104809|FG000|Double-Blind Period|Other: Pregnancy|1|||
128673708|NCT00717236|463104810|FG001|Double-Blind Period|Other: Pregnancy|0|||
128673709|NCT00717236|463104809|FG000|Double-Blind Period|Other: Protocol Violation|2|||
128673710|NCT00717236|463104810|FG001|Double-Blind Period|Other: Protocol Violation|0|||
128673711|NCT00717236|463104809|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
128673712|NCT00717236|463104810|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
128673713|NCT00717236|463104809|FG000|Double-Blind Period|Other: Site withdrew|2|||
128673714|NCT00717236|463104810|FG001|Double-Blind Period|Other: Site withdrew|0|||
128673715|NCT00717236|463104809|FG000|Double-Blind Period|Other: Screening failure|1|||
128673716|NCT00717236|463104810|FG001|Double-Blind Period|Other: Screening failure|0|||
128673717|NCT00717236|463104809|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
128673718|NCT00717236|463104810|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
128673719|NCT00717236|463104809|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
128673720|NCT00717236|463104810|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
128673721|NCT00717236|463104809|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
128673722|NCT00717236|463104810|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
128673723|NCT00717236|463104809|FG000|Double-Blind Period|Other: History of cancer|1|||
128673724|NCT00717236|463104810|FG001|Double-Blind Period|Other: History of cancer|0|||
128673725|NCT00717236|463104809|FG000|Double-Blind Period|Other: Sponsor request|1|||
128673726|NCT00717236|463104810|FG001|Double-Blind Period|Other: Sponsor request|0|||
128673727|NCT00717236|463104809|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
128673728|NCT00717236|463104810|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
128673729|NCT00717236|463104809|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
128673730|NCT00717236|463104810|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
128673731|NCT00717236|463104809|FG000|Double-Blind Period|Other: Subject moved|1|||
128673732|NCT00717236|463104810|FG001|Double-Blind Period|Other: Subject moved|1|||
128673733|NCT00717236|463104809|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
128673734|NCT00717236|463104810|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
128673735|NCT00717236|463104809|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
128673736|NCT00717236|463104810|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
128673737|NCT00717236|463104809|FG000|Double-Blind Period|Other: Transportation problems|0|||
128673738|NCT00717236|463104810|FG001|Double-Blind Period|Other: Transportation problems|1|||
128673739|NCT00717236|463104809|FG000|Double-Blind Period|Other: Investigator Decision|0|||
128673740|NCT00717236|463104810|FG001|Double-Blind Period|Other: Investigator Decision|1|||
128673741|NCT00717236|463104809|FG000|Open-Label Period|Adverse Event|29|||
128673742|NCT00717236|463104810|FG001|Open-Label Period|Adverse Event|4|||
129007107|NCT03731182|464318039|FG001|Overall Study|Lost to Follow-up|0|||
128673743|NCT00717236|463104809|FG000|Open-Label Period|Lack of Efficacy|30|||
129007108|NCT03731182|464318038|FG000|Overall Study|Physician Decision|1|||
129007109|NCT03731182|464318039|FG001|Overall Study|Physician Decision|0|||
128673744|NCT00717236|463104810|FG001|Open-Label Period|Lack of Efficacy|8|||
128673745|NCT00717236|463104809|FG000|Open-Label Period|Lost to Follow-up|28|||
128673746|NCT00717236|463104810|FG001|Open-Label Period|Lost to Follow-up|4|||
128673747|NCT00717236|463104809|FG000|Open-Label Period|Withdrawal by Subject|20|||
128673748|NCT00717236|463104810|FG001|Open-Label Period|Withdrawal by Subject|2|||
128673749|NCT00717236|463104809|FG000|Open-Label Period|Loss of Efficacy|6|||
128673750|NCT00717236|463104810|FG001|Open-Label Period|Loss of Efficacy|1|||
128673751|NCT00717236|463104809|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
128673752|NCT00717236|463104810|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
129007110|NCT03731182|464318038|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
129007111|NCT03731182|464318039|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
128673753|NCT00717236|463104809|FG000|Open-Label Period|Other: Lack of Compliance|1|||
128673754|NCT00717236|463104810|FG001|Open-Label Period|Other: Lack of Compliance|1|||
129007112|NCT02006706|464318040|FG000|Overall Study|Lost to Follow-up|1|||
129007113|NCT00582036|464318041|FG000|Overall Study|Withdrawal by Subject|0|||
129007114|NCT00582036|464318042|FG001|Overall Study|Withdrawal by Subject|1|||
129007115|NCT04161144|464318043|FG000|Overall Study|Withdrawal by Subject|0|||
129007116|NCT04161144|464318044|FG001|Overall Study|Withdrawal by Subject|1|||
129007117|NCT04161144|464318043|FG000|Overall Study|Protocol Violation|1|||
129007118|NCT04161144|464318044|FG001|Overall Study|Protocol Violation|0|||
129007119|NCT00958256|464318047|FG000|Overall Study|Adverse Event|3|||
129007120|NCT03036579|464318050|FG000|2 Years|Lost to Follow-up|1|||
129007121|NCT03036579|464318051|FG001|2 Years|Lost to Follow-up|0|||
129007122|NCT03036579|464318050|FG000|3 Years|Lost to Follow-up|0|||
129007123|NCT03036579|464318051|FG001|3 Years|Lost to Follow-up|1|||
129007124|NCT02848599|464318052|FG000|Overall Study|Protocol Violation|7|||
129007125|NCT02848599|464318053|FG001|Overall Study|Protocol Violation|9|||
129007126|NCT01090765|464318054|FG000|Overall Study|Patient withdrew consent|0|||
129007127|NCT01090765|464318055|FG001|Overall Study|Patient withdrew consent|0|||
129007128|NCT01090765|464318056|FG002|Overall Study|Patient withdrew consent|0|||
128673755|NCT00717236|463104809|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
128673756|NCT00717236|463104810|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
128673757|NCT00717236|463104809|FG000|Open-Label Period|Other: Moved|1|||
128673758|NCT00717236|463104810|FG001|Open-Label Period|Other: Moved|0|||
128673759|NCT00717236|463104809|FG000|Open-Label Period|Other: Investigator Decision|1|||
128673760|NCT00717236|463104810|FG001|Open-Label Period|Other: Investigator Decision|0|||
128673761|NCT00717236|463104809|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
128673762|NCT00717236|463104810|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
128673763|NCT00717236|463104809|FG000|Open-Label Period|Other: Sponsor Request|3|||
128673764|NCT00717236|463104810|FG001|Open-Label Period|Other: Sponsor Request|0|||
128673765|NCT00717236|463104809|FG000|Open-Label Period|Other: Cataract Surgery|1|||
128673766|NCT00717236|463104810|FG001|Open-Label Period|Other: Cataract Surgery|0|||
128673767|NCT00717236|463104809|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
128673768|NCT00717236|463104810|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
128673769|NCT00717236|463104809|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
128673770|NCT00717236|463104810|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
128673771|NCT00717236|463104809|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
128673772|NCT00717236|463104810|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
128673773|NCT00475982|463104811|FG000|Overall Study|surgery rescheduled|7|||
128673774|NCT00475982|463104812|FG001|Overall Study|surgery rescheduled|3|||
128673775|NCT00783198|463104817|FG000|Overall Study|Adverse Event|15|||
128673776|NCT00783198|463104818|FG001|Overall Study|Adverse Event|19|||
128673777|NCT00783198|463104819|FG002|Overall Study|Adverse Event|3|||
128673778|NCT00783198|463104817|FG000|Overall Study|Lost to Follow-up|11|||
128673779|NCT00783198|463104818|FG001|Overall Study|Lost to Follow-up|1|||
128673780|NCT00783198|463104819|FG002|Overall Study|Lost to Follow-up|7|||
128673781|NCT00783198|463104817|FG000|Overall Study|Withdrawal by Subject|22|||
128673782|NCT00783198|463104818|FG001|Overall Study|Withdrawal by Subject|14|||
128673783|NCT00783198|463104819|FG002|Overall Study|Withdrawal by Subject|20|||
128673784|NCT00783198|463104817|FG000|Overall Study|Noncompliance with protocol|7|||
128673785|NCT00783198|463104818|FG001|Overall Study|Noncompliance with protocol|7|||
128673786|NCT00783198|463104819|FG002|Overall Study|Noncompliance with protocol|10|||
128673787|NCT00783198|463104817|FG000|Overall Study|Did not meet protocol eligibility|0|||
128673788|NCT00783198|463104818|FG001|Overall Study|Did not meet protocol eligibility|1|||
128673789|NCT00783198|463104819|FG002|Overall Study|Did not meet protocol eligibility|0|||
128673790|NCT00783198|463104817|FG000|Overall Study|Administrative|2|||
128673791|NCT00783198|463104818|FG001|Overall Study|Administrative|1|||
128673792|NCT00783198|463104819|FG002|Overall Study|Administrative|2|||
128673793|NCT03704636|463104820|FG000|Overall Study|Inadequate Venous Flow|3|||
128673794|NCT00539188|463104823|FG000|Overall Study|Withdrawal by Subject|1|||
128673795|NCT00539188|463104824|FG001|Overall Study|Withdrawal by Subject|0|||
129007129|NCT01090765|464318057|FG003|Overall Study|Patient withdrew consent|0|||
129007130|NCT01090765|464318058|FG004|Overall Study|Patient withdrew consent|1|||
128673796|NCT00539188|463104823|FG000|Overall Study|Lost to Follow-up|2|||
128673797|NCT00539188|463104824|FG001|Overall Study|Lost to Follow-up|1|||
129007131|NCT01090765|464318059|FG005|Overall Study|Patient withdrew consent|1|||
129007132|NCT01090765|464318054|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
129007133|NCT01090765|464318055|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
128673798|NCT04784442|463104825|FG000|Overall Study|Adverse Event|1|||
128673799|NCT04784442|463104826|FG001|Overall Study|Adverse Event|0|||
128673800|NCT04784442|463104827|FG002|Overall Study|Adverse Event|2|||
128673801|NCT04784442|463104828|FG003|Overall Study|Adverse Event|1|||
128673802|NCT04784442|463104825|FG000|Overall Study|Protocol Violation|1|||
129007134|NCT01090765|464318056|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
129007135|NCT01090765|464318057|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
129007136|NCT01090765|464318058|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
129007137|NCT01090765|464318059|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
129007138|NCT01090765|464318054|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
129007139|NCT01090765|464318055|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
129007140|NCT01090765|464318056|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
129007141|NCT01090765|464318057|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
129007142|NCT01090765|464318058|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
129007143|NCT01090765|464318059|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
129007144|NCT02623959|464318063|FG000|Overall Study|Progression|0|||
129007145|NCT02623959|464318064|FG001|Overall Study|Progression|1|||
129007146|NCT00421174|464318067|FG000|Overall Study|Withdrawal by Subject|0|||
129007147|NCT00421174|464318068|FG001|Overall Study|Withdrawal by Subject|1|||
129007148|NCT00421174|464318067|FG000|Overall Study|Ineligible due to infection|2|||
129007149|NCT00421174|464318068|FG001|Overall Study|Ineligible due to infection|0|||
129007150|NCT00992407|464318069|FG000|Overall Study|Protocol Violation|2|||
129007151|NCT00992407|464318070|FG001|Overall Study|Protocol Violation|1|||
129007152|NCT00992407|464318069|FG000|Overall Study|Lost to Follow-up|3|||
129007153|NCT00992407|464318070|FG001|Overall Study|Lost to Follow-up|3|||
129007154|NCT00992407|464318069|FG000|Overall Study|Adverse Event|3|||
129007155|NCT00992407|464318070|FG001|Overall Study|Adverse Event|2|||
129007156|NCT00992407|464318069|FG000|Overall Study|protocol Violation & Adverse events|2|||
129007157|NCT00992407|464318070|FG001|Overall Study|protocol Violation & Adverse events|4|||
129007158|NCT00992407|464318069|FG000|Overall Study|Other|2|||
129007159|NCT00992407|464318070|FG001|Overall Study|Other|0|||
129007160|NCT00992407|464318069|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
129007161|NCT00992407|464318070|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
129007162|NCT00992407|464318069|FG000|Overall Study|Study medication not administered|17|||
129007163|NCT00992407|464318070|FG001|Overall Study|Study medication not administered|13|||
128673803|NCT04784442|463104826|FG001|Overall Study|Protocol Violation|0|||
128673804|NCT04784442|463104827|FG002|Overall Study|Protocol Violation|0|||
128673805|NCT04784442|463104828|FG003|Overall Study|Protocol Violation|0|||
128673806|NCT04784442|463104825|FG000|Overall Study|Non-compliance with study drug|1|||
128673807|NCT04784442|463104826|FG001|Overall Study|Non-compliance with study drug|0|||
128673808|NCT04784442|463104827|FG002|Overall Study|Non-compliance with study drug|0|||
128673809|NCT04784442|463104828|FG003|Overall Study|Non-compliance with study drug|0|||
128673810|NCT00852371|463104829|FG000|Overall Study|Lost to Follow-up|2|||
128673811|NCT00852371|463104830|FG001|Overall Study|Lost to Follow-up|3|||
128673812|NCT00852371|463104831|FG002|Overall Study|Lost to Follow-up|4|||
128673813|NCT00852371|463104832|FG003|Overall Study|Lost to Follow-up|2|||
128673814|NCT01590758|463104833|FG000|Overall Study|Withdrawal by Subject|0|||
128673815|NCT01590758|463104834|FG001|Overall Study|Withdrawal by Subject|3|||
128673816|NCT01590758|463104833|FG000|Overall Study|Physician Decision|1|||
128673817|NCT01590758|463104834|FG001|Overall Study|Physician Decision|2|||
128673818|NCT01590758|463104833|FG000|Overall Study|Lost to Follow-up|4|||
128673819|NCT01590758|463104834|FG001|Overall Study|Lost to Follow-up|2|||
128673820|NCT04525885|463104835|FG000|Overall Study|Screen Failure|1|||
128673821|NCT04525885|463104836|FG001|Overall Study|Screen Failure|0|||
128673822|NCT04525885|463104837|FG002|Overall Study|Screen Failure|0|||
128673823|NCT04525885|463104835|FG000|Overall Study|Withdrawal by Subject|14|||
128673824|NCT04525885|463104836|FG001|Overall Study|Withdrawal by Subject|6|||
128673825|NCT04525885|463104837|FG002|Overall Study|Withdrawal by Subject|20|||
128673826|NCT04525885|463104835|FG000|Overall Study|Physician Decision|1|||
128673827|NCT04525885|463104836|FG001|Overall Study|Physician Decision|0|||
128673828|NCT04525885|463104837|FG002|Overall Study|Physician Decision|1|||
128673829|NCT02756806|463104838|FG000|Overall Study|Study terminated early|5|||
128673830|NCT02717832|463104839|FG000|Overall Study|Inability to place IV|3|||
128673831|NCT01008423|463104840|FG000|Overall Study|Adverse Event|13|||
128673832|NCT01008423|463104841|FG001|Overall Study|Adverse Event|6|||
128673833|NCT01008423|463104840|FG000|Overall Study|Withdrawal by Subject|4|||
128673834|NCT01008423|463104841|FG001|Overall Study|Withdrawal by Subject|7|||
128673835|NCT01008423|463104840|FG000|Overall Study|Lost to Follow-up|0|||
128673836|NCT01008423|463104841|FG001|Overall Study|Lost to Follow-up|2|||
128673837|NCT01008423|463104840|FG000|Overall Study|Low Cortisol|0|||
128673838|NCT01008423|463104841|FG001|Overall Study|Low Cortisol|1|||
129007164|NCT00812253|464318072|FG000|Overall Study|Withdrawal by Subject|3|||
129007165|NCT00812253|464318073|FG001|Overall Study|Withdrawal by Subject|2|||
128673839|NCT01008423|463104840|FG000|Overall Study|Lack of Efficacy|0|||
128673840|NCT01008423|463104841|FG001|Overall Study|Lack of Efficacy|5|||
128673841|NCT01008423|463104840|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
128673842|NCT01008423|463104841|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
128673843|NCT01008423|463104840|FG000|Overall Study|Personal Conflict|1|||
129007166|NCT00812253|464318072|FG000|Overall Study|Protocol Violation|1|||
129007167|NCT00812253|464318073|FG001|Overall Study|Protocol Violation|1|||
129007168|NCT00812253|464318072|FG000|Overall Study|Lost to Follow-up|2|||
129007169|NCT00812253|464318073|FG001|Overall Study|Lost to Follow-up|0|||
129007170|NCT02918162|464318074|FG000|Overall Study|Withdrawal by Subject|1|||
129007171|NCT02918162|464318074|FG000|Overall Study|Omental Disease|1|||
129007172|NCT00395226|464318075|FG000|Overall Study|Adverse Event|4|||
129007173|NCT00395226|464318076|FG001|Overall Study|Adverse Event|3|||
129007174|NCT00395226|464318075|FG000|Overall Study|Withdrawal by Subject|0|||
129007175|NCT00395226|464318076|FG001|Overall Study|Withdrawal by Subject|1|||
129007176|NCT00395226|464318075|FG000|Overall Study|Lost to Follow-up|0|||
129007177|NCT00395226|464318076|FG001|Overall Study|Lost to Follow-up|1|||
129007178|NCT01000337|464318080|FG000|Overall Study|Lost to Follow-up|4|||
129007179|NCT01000337|464318081|FG001|Overall Study|Lost to Follow-up|3|||
129007180|NCT01612000|464318082|FG000|Overall Study|Lost to Follow-up|6|||
129007181|NCT01612000|464318083|FG001|Overall Study|Lost to Follow-up|4|||
129007182|NCT01612000|464318084|FG002|Overall Study|Lost to Follow-up|4|||
129007183|NCT01612000|464318085|FG003|Overall Study|Lost to Follow-up|8|||
129007184|NCT01612000|464318082|FG000|Overall Study|Physician Decision|0|||
129007185|NCT01612000|464318083|FG001|Overall Study|Physician Decision|0|||
129007186|NCT01612000|464318084|FG002|Overall Study|Physician Decision|1|||
129007187|NCT01612000|464318085|FG003|Overall Study|Physician Decision|0|||
129007188|NCT01612000|464318082|FG000|Overall Study|Withdrawal by Subject|3|||
129007189|NCT01612000|464318083|FG001|Overall Study|Withdrawal by Subject|1|||
129007190|NCT01612000|464318084|FG002|Overall Study|Withdrawal by Subject|2|||
129007191|NCT01612000|464318085|FG003|Overall Study|Withdrawal by Subject|2|||
129007192|NCT04652453|464318089|FG000|Overall Study|Death|8|||
129007193|NCT04652453|464318090|FG001|Overall Study|Death|2|||
129007194|NCT04652453|464318091|FG002|Overall Study|Death|0|||
129007195|NCT04652453|464318089|FG000|Overall Study|Hospice|5|||
129007196|NCT04652453|464318090|FG001|Overall Study|Hospice|5|||
129007197|NCT04652453|464318091|FG002|Overall Study|Hospice|0|||
129007198|NCT04652453|464318089|FG000|Overall Study|Withdrawal by Subject|2|||
129007199|NCT04652453|464318090|FG001|Overall Study|Withdrawal by Subject|0|||
129007200|NCT04652453|464318091|FG002|Overall Study|Withdrawal by Subject|0|||
129007201|NCT02978326|464318092|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
129007202|NCT02978326|464318093|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
129007203|NCT02978326|464318094|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
129007204|NCT02978326|464318092|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
129007205|NCT02978326|464318093|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
129007206|NCT02978326|464318094|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
129007207|NCT02978326|464318092|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
129007208|NCT02978326|464318093|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
129007209|NCT02978326|464318094|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
129007210|NCT02978326|464318092|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
129007211|NCT02978326|464318093|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
129007212|NCT02978326|464318094|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
129007213|NCT00947427|464318095|FG000|Overall Study|Withdrawal by Subject|1|||
129007214|NCT00947427|464318096|FG001|Overall Study|Withdrawal by Subject|3|||
128673844|NCT01008423|463104841|FG001|Overall Study|Personal Conflict|0|||
128673845|NCT01008423|463104840|FG000|Overall Study|Other|0|||
128673846|NCT01008423|463104841|FG001|Overall Study|Other|1|||
128673847|NCT00934843|463104843|FG000|Overall Study|Protocol Violation|0|||
128673848|NCT00934843|463104844|FG001|Overall Study|Protocol Violation|1|||
128673849|NCT01144299|463104845|FG000|Overall Study|Lost to Follow-up|1|||
128673850|NCT01144299|463104846|FG001|Overall Study|Lost to Follow-up|0|||
128673851|NCT01144299|463104845|FG000|Overall Study|Withdrawal by Subject|1|||
128673852|NCT01144299|463104846|FG001|Overall Study|Withdrawal by Subject|0|||
128673853|NCT01375075|463104855|FG000|Overall Study|Adverse Event|0|||
128673854|NCT01375075|463104856|FG001|Overall Study|Adverse Event|0|||
128673855|NCT01375075|463104857|FG002|Overall Study|Adverse Event|3|||
128673856|NCT01375075|463104858|FG003|Overall Study|Adverse Event|1|||
128673857|NCT01375075|463104859|FG004|Overall Study|Adverse Event|0|||
128673858|NCT01375075|463104860|FG005|Overall Study|Adverse Event|1|||
128673859|NCT01375075|463104855|FG000|Overall Study|Entry Criterion Not Met|1|||
128673860|NCT01375075|463104856|FG001|Overall Study|Entry Criterion Not Met|0|||
128673861|NCT01375075|463104857|FG002|Overall Study|Entry Criterion Not Met|0|||
128673862|NCT01375075|463104858|FG003|Overall Study|Entry Criterion Not Met|0|||
128673863|NCT01375075|463104859|FG004|Overall Study|Entry Criterion Not Met|0|||
128673864|NCT01375075|463104860|FG005|Overall Study|Entry Criterion Not Met|1|||
128673865|NCT01375075|463104855|FG000|Overall Study|Withdrawal by Subject|0|||
128673866|NCT01375075|463104856|FG001|Overall Study|Withdrawal by Subject|1|||
128673867|NCT01375075|463104857|FG002|Overall Study|Withdrawal by Subject|0|||
129007215|NCT00947427|464318095|FG000|Overall Study|Protocol Violation|0|||
129007216|NCT00947427|464318096|FG001|Overall Study|Protocol Violation|1|||
129007217|NCT01937364|464318099|FG000|Overall Study|Adverse Event|2|||
129007218|NCT01937364|464318100|FG001|Overall Study|Adverse Event|1|||
129007219|NCT00936975|464318101|FG000|Overall Study|Withdrawal by Subject|1|||
129007220|NCT00936975|464318101|FG000|Overall Study|Disease progression|3|||
129007221|NCT00936975|464318101|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
129007222|NCT04104646|464318102|FG000|Overall Study|Withdrawal by Subject|1|||
128673868|NCT01375075|463104858|FG003|Overall Study|Withdrawal by Subject|0|||
128673869|NCT01375075|463104859|FG004|Overall Study|Withdrawal by Subject|0|||
128673870|NCT01375075|463104860|FG005|Overall Study|Withdrawal by Subject|1|||
129007223|NCT04104646|464318103|FG001|Overall Study|Withdrawal by Subject|1|||
129007224|NCT04104646|464318102|FG000|Overall Study|Lost to Follow-up|1|||
129007225|NCT04104646|464318103|FG001|Overall Study|Lost to Follow-up|0|||
129007226|NCT04104646|464318102|FG000|Overall Study|Physician Decision|2|||
129007227|NCT04104646|464318103|FG001|Overall Study|Physician Decision|0|||
129007228|NCT03271528|464318106|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
129007229|NCT03271528|464318107|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
129007230|NCT03271528|464318106|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
129007231|NCT03271528|464318107|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
129007232|NCT03271528|464318106|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
129007233|NCT03271528|464318107|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
129007234|NCT03271528|464318106|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
129007235|NCT03271528|464318107|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
129007236|NCT03271528|464318106|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
129007237|NCT03271528|464318107|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
129007238|NCT03271528|464318106|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
129007239|NCT03271528|464318107|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
128673871|NCT01011309|463104862|FG000|Overall Study|Adverse Event|2|||
128673872|NCT01011309|463104863|FG001|Overall Study|Adverse Event|1|||
128673873|NCT01011309|463104864|FG002|Overall Study|Adverse Event|2|||
128673874|NCT01011309|463104862|FG000|Overall Study|Lack of Efficacy|0|||
128673875|NCT01011309|463104863|FG001|Overall Study|Lack of Efficacy|1|||
128673876|NCT01011309|463104864|FG002|Overall Study|Lack of Efficacy|0|||
128673877|NCT01011309|463104862|FG000|Overall Study|Protocol Violation|0|||
128673878|NCT01011309|463104863|FG001|Overall Study|Protocol Violation|1|||
128673879|NCT01011309|463104864|FG002|Overall Study|Protocol Violation|3|||
128673880|NCT00831493|463104865|FG000|Overall Study|Intractable nausea and vomiting|1|||
128673881|NCT03976648|463104874|FG000|Overall Study|Adverse Event|0|||
129007240|NCT03271528|464318106|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
129007241|NCT03271528|464318107|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
129007242|NCT01873859|464318108|FG000|Overall Study|Withdrawal by Subject|0|||
129007243|NCT01873859|464318109|FG001|Overall Study|Withdrawal by Subject|4|||
129007244|NCT03977584|464318110|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
129007245|NCT03977584|464318111|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
129007246|NCT03977584|464318112|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
129007247|NCT03504852|464318116|FG000|Overall Study|Withdrawal of informed consent|2|||
129007248|NCT03504852|464318117|FG001|Overall Study|Withdrawal of informed consent|1|||
129007249|NCT03504852|464318118|FG002|Overall Study|Withdrawal of informed consent|0|||
129007250|NCT03504852|464318116|FG000|Overall Study|Withdrawal by Subject|5|||
129007251|NCT03504852|464318117|FG001|Overall Study|Withdrawal by Subject|5|||
129007252|NCT03504852|464318118|FG002|Overall Study|Withdrawal by Subject|1|||
129007253|NCT03504852|464318116|FG000|Overall Study|Lost to Follow-up|4|||
129007254|NCT03504852|464318117|FG001|Overall Study|Lost to Follow-up|1|||
129007255|NCT03504852|464318118|FG002|Overall Study|Lost to Follow-up|0|||
129007256|NCT03504852|464318116|FG000|Overall Study|New therapy for study indication|1|||
129007257|NCT03504852|464318117|FG001|Overall Study|New therapy for study indication|0|||
129007258|NCT03504852|464318118|FG002|Overall Study|New therapy for study indication|0|||
129007259|NCT03504852|464318116|FG000|Overall Study|Lack of Efficacy|1|||
129007260|NCT03504852|464318117|FG001|Overall Study|Lack of Efficacy|2|||
129007261|NCT03504852|464318118|FG002|Overall Study|Lack of Efficacy|0|||
129007262|NCT03504852|464318116|FG000|Overall Study|Death|0|||
129007263|NCT03504852|464318117|FG001|Overall Study|Death|1|||
129007264|NCT03504852|464318118|FG002|Overall Study|Death|0|||
129007265|NCT03504852|464318116|FG000|Overall Study|Adverse Event|4|||
129007266|NCT03504852|464318117|FG001|Overall Study|Adverse Event|8|||
129007267|NCT03504852|464318118|FG002|Overall Study|Adverse Event|2|||
129007268|NCT01066052|464318119|FG000|Overall Study|Enrolled But Not Treated|3|||
129007269|NCT01066052|464318120|FG001|Overall Study|Enrolled But Not Treated|0|||
129007270|NCT01835145|464318121|FG000|Overall Study|Ineligible prior to treatment|1|||
129007271|NCT01835145|464318122|FG001|Overall Study|Ineligible prior to treatment|0|||
129007272|NCT01309919|464318143|FG000|Overall Study|Did not receive a postpartum IUD|17|||
129007273|NCT01309919|464318144|FG001|Overall Study|Did not receive a postpartum IUD|48|||
128673882|NCT03976648|463104875|FG001|Overall Study|Adverse Event|2|||
128673883|NCT03976648|463104874|FG000|Overall Study|Study terminated by sponsor|21|||
128673884|NCT03976648|463104875|FG001|Overall Study|Study terminated by sponsor|8|||
129007274|NCT00319449|464318145|FG000|Overall Study|Subject did not wish to continue|1|||
129007275|NCT00319449|464318146|FG001|Overall Study|Subject did not wish to continue|0|||
129007276|NCT00319449|464318145|FG000|Overall Study|Noncompliance with the protocol|1|||
129007277|NCT00319449|464318146|FG001|Overall Study|Noncompliance with the protocol|0|||
128673885|NCT01981551|463104876|FG000|Overall Study|Refused further treatment|8|||
128673886|NCT01981551|463104876|FG000|Overall Study|Adverse Event|1|||
128673887|NCT00960570|463104877|FG000|21 Day Washout Period|Adverse Event|1|||
128673888|NCT00960570|463104877|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
128673889|NCT00960570|463104877|FG000|1 Day Period Between Dosing|Adverse Event|2|||
128673890|NCT00960570|463104877|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
128673891|NCT01451437|463104878|FG000|Overall Study|Adverse Event|0|||
128673892|NCT01451437|463104879|FG001|Overall Study|Adverse Event|0|||
128673893|NCT01451437|463104880|FG002|Overall Study|Adverse Event|0|||
128673894|NCT01451437|463104881|FG003|Overall Study|Adverse Event|0|||
128673895|NCT01451437|463104882|FG004|Overall Study|Adverse Event|0|||
128673896|NCT01451437|463104883|FG005|Overall Study|Adverse Event|1|||
128673897|NCT01451437|463104884|FG006|Overall Study|Adverse Event|1|||
128673898|NCT01451437|463104885|FG007|Overall Study|Adverse Event|2|||
128673899|NCT01451437|463104886|FG008|Overall Study|Adverse Event|1|||
128673900|NCT01451437|463104878|FG000|Overall Study|Physician Decision|1|||
128673901|NCT01451437|463104879|FG001|Overall Study|Physician Decision|1|||
128673902|NCT01451437|463104880|FG002|Overall Study|Physician Decision|2|||
128673903|NCT01451437|463104881|FG003|Overall Study|Physician Decision|0|||
128673904|NCT01451437|463104882|FG004|Overall Study|Physician Decision|0|||
128673905|NCT01451437|463104883|FG005|Overall Study|Physician Decision|0|||
128673906|NCT01451437|463104884|FG006|Overall Study|Physician Decision|0|||
128673907|NCT01451437|463104885|FG007|Overall Study|Physician Decision|0|||
128673908|NCT01451437|463104886|FG008|Overall Study|Physician Decision|0|||
128673909|NCT01451437|463104878|FG000|Overall Study|Disease Progression|0|||
128673910|NCT01451437|463104879|FG001|Overall Study|Disease Progression|0|||
128673911|NCT01451437|463104880|FG002|Overall Study|Disease Progression|1|||
128673912|NCT01451437|463104881|FG003|Overall Study|Disease Progression|1|||
128673913|NCT01451437|463104882|FG004|Overall Study|Disease Progression|3|||
128673914|NCT01451437|463104883|FG005|Overall Study|Disease Progression|2|||
128673915|NCT01451437|463104884|FG006|Overall Study|Disease Progression|3|||
128673916|NCT01451437|463104885|FG007|Overall Study|Disease Progression|1|||
128673917|NCT01451437|463104886|FG008|Overall Study|Disease Progression|3|||
128673918|NCT01451437|463104878|FG000|Overall Study|Protocol Violation|0|||
128673919|NCT01451437|463104879|FG001|Overall Study|Protocol Violation|0|||
128673920|NCT01451437|463104880|FG002|Overall Study|Protocol Violation|0|||
128673921|NCT01451437|463104881|FG003|Overall Study|Protocol Violation|0|||
128673922|NCT01451437|463104882|FG004|Overall Study|Protocol Violation|0|||
128673923|NCT01451437|463104883|FG005|Overall Study|Protocol Violation|0|||
128673924|NCT01451437|463104884|FG006|Overall Study|Protocol Violation|1|||
128673925|NCT01451437|463104885|FG007|Overall Study|Protocol Violation|0|||
128673926|NCT01451437|463104886|FG008|Overall Study|Protocol Violation|0|||
128673927|NCT01451437|463104878|FG000|Overall Study|Withdrawal by Subject|0|||
128673928|NCT01451437|463104879|FG001|Overall Study|Withdrawal by Subject|0|||
128673929|NCT01451437|463104880|FG002|Overall Study|Withdrawal by Subject|0|||
128673930|NCT01451437|463104881|FG003|Overall Study|Withdrawal by Subject|0|||
128673931|NCT01451437|463104882|FG004|Overall Study|Withdrawal by Subject|1|||
128673932|NCT01451437|463104883|FG005|Overall Study|Withdrawal by Subject|0|||
128673933|NCT01451437|463104884|FG006|Overall Study|Withdrawal by Subject|1|||
128673934|NCT01451437|463104885|FG007|Overall Study|Withdrawal by Subject|0|||
128673935|NCT01451437|463104886|FG008|Overall Study|Withdrawal by Subject|0|||
128673936|NCT03472547|463104892|FG000|Overall Study|Withdrawal by Subject|30|||
128673937|NCT01325337|463106464|FG000|Overall Study|Adverse Event|0|||
128673938|NCT01325337|463106465|FG001|Overall Study|Adverse Event|2|||
129007278|NCT02102490|464318147|FG000|Overall Study|Death|6|||
129007279|NCT02102490|464318147|FG000|Overall Study|Lost to Follow-up|1|||
129007280|NCT01346410|464318148|FG000|Overall Study|Death|1|||
129007281|NCT00458302|464320220|FG000|Overall Study|Adverse Event|4|||
129007282|NCT00458302|464320221|FG001|Overall Study|Adverse Event|14|||
129007283|NCT00458302|464320220|FG000|Overall Study|Pregnancy|2|||
129007284|NCT00458302|464320221|FG001|Overall Study|Pregnancy|1|||
129007285|NCT00458302|464320220|FG000|Overall Study|Protocol Violation|0|||
129007286|NCT00458302|464320221|FG001|Overall Study|Protocol Violation|2|||
129007287|NCT00458302|464320220|FG000|Overall Study|Withdrawal by Subject|6|||
128673939|NCT01325337|463106466|FG002|Overall Study|Adverse Event|2|||
128673940|NCT01325337|463106467|FG003|Overall Study|Adverse Event|1|||
128673941|NCT01325337|463106468|FG004|Overall Study|Adverse Event|2|||
128673942|NCT01325337|463106464|FG000|Overall Study|Lost to Follow-up|2|||
128673943|NCT01325337|463106465|FG001|Overall Study|Lost to Follow-up|2|||
128673944|NCT01325337|463106466|FG002|Overall Study|Lost to Follow-up|2|||
128673945|NCT01325337|463106467|FG003|Overall Study|Lost to Follow-up|1|||
128673946|NCT01325337|463106468|FG004|Overall Study|Lost to Follow-up|2|||
128673947|NCT01325337|463106464|FG000|Overall Study|Personal Reasons|2|||
128673948|NCT01325337|463106465|FG001|Overall Study|Personal Reasons|5|||
128673949|NCT01325337|463106466|FG002|Overall Study|Personal Reasons|4|||
128673950|NCT01325337|463106467|FG003|Overall Study|Personal Reasons|8|||
128673951|NCT01325337|463106468|FG004|Overall Study|Personal Reasons|3|||
129007288|NCT00458302|464320221|FG001|Overall Study|Withdrawal by Subject|4|||
129007289|NCT00458302|464320220|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
129007290|NCT00458302|464320221|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
128673952|NCT01325337|463106464|FG000|Overall Study|Withdrawal by Subject|1|||
128673953|NCT01325337|463106465|FG001|Overall Study|Withdrawal by Subject|0|||
128673954|NCT01325337|463106466|FG002|Overall Study|Withdrawal by Subject|1|||
128673955|NCT01325337|463106467|FG003|Overall Study|Withdrawal by Subject|0|||
128673956|NCT01325337|463106468|FG004|Overall Study|Withdrawal by Subject|1|||
128673957|NCT01964755|463106478|FG000|Overall Study|Death|2|||
128673958|NCT02894502|463106479|FG000|Baseline|Withdrawal by Subject|24|||
128673959|NCT02894502|463106480|FG001|Baseline|Withdrawal by Subject|31|||
128673960|NCT02894502|463106481|FG002|Baseline|Withdrawal by Subject|36|||
128673961|NCT02894502|463106479|FG000|Baseline|Death|3|||
128673962|NCT02894502|463106480|FG001|Baseline|Death|1|||
128673963|NCT02894502|463106481|FG002|Baseline|Death|9|||
128673964|NCT02894502|463106479|FG000|First Follow up|Withdrawal by Subject|32|||
128673965|NCT02894502|463106480|FG001|First Follow up|Withdrawal by Subject|29|||
128673966|NCT02894502|463106481|FG002|First Follow up|Withdrawal by Subject|37|||
128673967|NCT02894502|463106479|FG000|First Follow up|Death|2|||
128673968|NCT02894502|463106480|FG001|First Follow up|Death|2|||
128673969|NCT02894502|463106481|FG002|First Follow up|Death|3|||
128673970|NCT02894502|463106479|FG000|Second Follow up|Withdrawal by Subject|13|||
128673971|NCT02894502|463106480|FG001|Second Follow up|Withdrawal by Subject|15|||
128673972|NCT02894502|463106481|FG002|Second Follow up|Withdrawal by Subject|13|||
128673973|NCT02894502|463106479|FG000|Second Follow up|Death|2|||
128673974|NCT02894502|463106480|FG001|Second Follow up|Death|3|||
128673975|NCT02894502|463106481|FG002|Second Follow up|Death|1|||
128673976|NCT02894502|463106479|FG000|Third Follow up|Withdrawal by Subject|5|||
128673977|NCT02894502|463106480|FG001|Third Follow up|Withdrawal by Subject|6|||
128673978|NCT02894502|463106481|FG002|Third Follow up|Withdrawal by Subject|3|||
128673979|NCT02894502|463106479|FG000|Third Follow up|Death|1|||
128673980|NCT02894502|463106480|FG001|Third Follow up|Death|1|||
128673981|NCT02894502|463106481|FG002|Third Follow up|Death|0|||
128673982|NCT01332799|463106485|FG000|Overall Study|Insufficient funding|10|||
128673983|NCT01332799|463106486|FG001|Overall Study|Insufficient funding|10|||
128673984|NCT02168387|463106489|FG000|Overall Study|Planned exubation|6|||
128673985|NCT02168387|463106490|FG001|Overall Study|Planned exubation|3|||
128673986|NCT02168387|463106489|FG000|Overall Study|Death|1|||
128673987|NCT02168387|463106490|FG001|Overall Study|Death|0|||
128673988|NCT03467152|463106491|FG000|Overall Study|Adverse Event|4|||
128673989|NCT03467152|463106492|FG001|Overall Study|Adverse Event|5|||
128673990|NCT03467152|463106493|FG002|Overall Study|Adverse Event|0|||
128673991|NCT03467152|463106491|FG000|Overall Study|Subject Choice|1|||
128673992|NCT03467152|463106492|FG001|Overall Study|Subject Choice|3|||
128673993|NCT03467152|463106493|FG002|Overall Study|Subject Choice|0|||
128673994|NCT03467152|463106491|FG000|Overall Study|Lost to Follow-up|1|||
128673995|NCT03467152|463106492|FG001|Overall Study|Lost to Follow-up|0|||
128673996|NCT03467152|463106493|FG002|Overall Study|Lost to Follow-up|0|||
128673997|NCT03467152|463106491|FG000|Overall Study|Withdrawal by Subject|4|||
128673998|NCT03467152|463106492|FG001|Overall Study|Withdrawal by Subject|2|||
128673999|NCT03467152|463106493|FG002|Overall Study|Withdrawal by Subject|0|||
128674000|NCT03467152|463106491|FG000|Overall Study|Others|3|||
128674001|NCT03467152|463106492|FG001|Overall Study|Others|0|||
128674002|NCT03467152|463106493|FG002|Overall Study|Others|0|||
128674003|NCT03467152|463106491|FG000|Overall Study|Not treated|3|||
128674004|NCT03467152|463106492|FG001|Overall Study|Not treated|1|||
128674005|NCT03467152|463106493|FG002|Overall Study|Not treated|6|||
129007291|NCT00458302|464320220|FG000|Overall Study|Study Termination By Sponsor|1|||
128674006|NCT01236547|463106494|FG000|Overall Study|Protocol Violation|0|||
128674007|NCT01236547|463106495|FG001|Overall Study|Protocol Violation|1|||
128674008|NCT01236547|463106496|FG002|Overall Study|Protocol Violation|1|||
128674009|NCT01236547|463106497|FG003|Overall Study|Protocol Violation|6|||
129007292|NCT00458302|464320221|FG001|Overall Study|Study Termination By Sponsor|0|||
129007293|NCT00458302|464320220|FG000|Overall Study|Lost to Follow-up|2|||
129007294|NCT00458302|464320221|FG001|Overall Study|Lost to Follow-up|0|||
128674010|NCT01236547|463106498|FG004|Overall Study|Protocol Violation|12|||
128674011|NCT00910624|463106499|FG000|Treatment Phase|Adverse Event|2|||
128674012|NCT00910624|463106500|FG001|Treatment Phase|Adverse Event|6|||
128674013|NCT00910624|463106501|FG002|Treatment Phase|Adverse Event|6|||
128674014|NCT00910624|463106502|FG003|Treatment Phase|Adverse Event|0|||
128674015|NCT00910624|463106499|FG000|Treatment Phase|Treatment Failure|23|||
128674016|NCT00910624|463106500|FG001|Treatment Phase|Treatment Failure|10|||
128674017|NCT00910624|463106501|FG002|Treatment Phase|Treatment Failure|0|||
128674018|NCT00910624|463106502|FG003|Treatment Phase|Treatment Failure|0|||
128674019|NCT00910624|463106499|FG000|Treatment Phase|Lost to Follow-up|0|||
128674020|NCT00910624|463106500|FG001|Treatment Phase|Lost to Follow-up|0|||
128674021|NCT00910624|463106501|FG002|Treatment Phase|Lost to Follow-up|1|||
128674022|NCT00910624|463106502|FG003|Treatment Phase|Lost to Follow-up|0|||
128674023|NCT00910624|463106499|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
128674024|NCT00910624|463106500|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
128674025|NCT00910624|463106501|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
128674026|NCT00910624|463106502|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
128674027|NCT00910624|463106499|FG000|Treatment Phase|Withdrawal by Subject|2|||
129007295|NCT00458302|464320220|FG000|Overall Study|Other|4|||
129007296|NCT00458302|464320221|FG001|Overall Study|Other|2|||
129007297|NCT02146430|464320222|FG000|Overall Study|Protocol Violation|5|||
129007298|NCT02146430|464320223|FG001|Overall Study|Protocol Violation|4|||
129007299|NCT02146430|464320224|FG002|Overall Study|Protocol Violation|8|||
129007300|NCT02146430|464320225|FG003|Overall Study|Protocol Violation|6|||
129007301|NCT02146430|464320222|FG000|Overall Study|Lack of Efficacy|13|||
129007302|NCT02146430|464320223|FG001|Overall Study|Lack of Efficacy|11|||
129007303|NCT02146430|464320224|FG002|Overall Study|Lack of Efficacy|8|||
129007304|NCT02146430|464320225|FG003|Overall Study|Lack of Efficacy|5|||
129007305|NCT02146430|464320222|FG000|Overall Study|Adverse Event|20|||
129007306|NCT02146430|464320223|FG001|Overall Study|Adverse Event|40|||
128674028|NCT00910624|463106500|FG001|Treatment Phase|Withdrawal by Subject|1|||
128674029|NCT00910624|463106501|FG002|Treatment Phase|Withdrawal by Subject|0|||
128674030|NCT00910624|463106502|FG003|Treatment Phase|Withdrawal by Subject|0|||
128674031|NCT00910624|463106499|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
128674032|NCT00910624|463106500|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
128674033|NCT00910624|463106501|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
128674034|NCT00910624|463106502|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
128674035|NCT00910624|463106499|FG000|Follow-Up Phase|Adverse Event|0|||
128674036|NCT00910624|463106500|FG001|Follow-Up Phase|Adverse Event|0|||
128674037|NCT00910624|463106501|FG002|Follow-Up Phase|Adverse Event|1|||
128674038|NCT00910624|463106502|FG003|Follow-Up Phase|Adverse Event|0|||
128674039|NCT00910624|463106499|FG000|Follow-Up Phase|Lost to Follow-up|3|||
128674040|NCT00910624|463106500|FG001|Follow-Up Phase|Lost to Follow-up|1|||
128674041|NCT00910624|463106501|FG002|Follow-Up Phase|Lost to Follow-up|2|||
128674042|NCT00910624|463106502|FG003|Follow-Up Phase|Lost to Follow-up|0|||
128674043|NCT00910624|463106499|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
128674044|NCT00910624|463106500|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
128674045|NCT00910624|463106501|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
128674046|NCT00910624|463106502|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
128674047|NCT00910624|463106499|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
128674048|NCT00910624|463106500|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
128674049|NCT00910624|463106501|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
128674050|NCT00910624|463106502|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
128674051|NCT00910624|463106499|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
128674052|NCT00910624|463106500|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
128674053|NCT00910624|463106501|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
128674054|NCT00910624|463106502|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
128674055|NCT00910624|463106499|FG000|Follow-Up Phase|Administrative|0|||
128674056|NCT00910624|463106500|FG001|Follow-Up Phase|Administrative|1|||
128674057|NCT00910624|463106501|FG002|Follow-Up Phase|Administrative|1|||
128674058|NCT00910624|463106502|FG003|Follow-Up Phase|Administrative|0|||
128674059|NCT01713933|463106503|FG000|Overall Study|Lost to Follow-up|2|||
128674060|NCT01713933|463106503|FG000|Overall Study|Withdrawal by Subject|3|||
128674061|NCT01713933|463106503|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
128674062|NCT00412373|463106504|FG000|Overall Study|Adverse Event|8|||
128674063|NCT00412373|463106505|FG001|Overall Study|Adverse Event|13|||
128674064|NCT00412373|463106504|FG000|Overall Study|Lack of Efficacy|16|||
128674065|NCT00412373|463106505|FG001|Overall Study|Lack of Efficacy|22|||
128674066|NCT00412373|463106504|FG000|Overall Study|Lost to Follow-up|7|||
128674067|NCT00412373|463106505|FG001|Overall Study|Lost to Follow-up|13|||
128674068|NCT00412373|463106504|FG000|Overall Study|Withdrawal by Subject|8|||
128674069|NCT00412373|463106505|FG001|Overall Study|Withdrawal by Subject|27|||
128674070|NCT00412373|463106504|FG000|Overall Study|Other|2|||
128674071|NCT00412373|463106505|FG001|Overall Study|Other|2|||
128674072|NCT04022733|463106506|FG000|Overall Study|conversion to open surgery|3|||
128674073|NCT04022733|463106507|FG001|Overall Study|conversion to open surgery|2|||
128674074|NCT04022733|463106506|FG000|Overall Study|bradycardia|0|||
128674075|NCT04022733|463106507|FG001|Overall Study|bradycardia|1|||
129007307|NCT02146430|464320224|FG002|Overall Study|Adverse Event|32|||
128674076|NCT01104376|463106508|FG000|Overall Study|Withdrawal by Subject|15|||
128674077|NCT01104376|463106508|FG000|Overall Study|Consented but excluded after labs|13|||
128674078|NCT00797966|463106511|FG000|Phase A|Lost to Follow-up|0|||
128674079|NCT00797966|463106512|FG001|Phase A|Lost to Follow-up|0|||
128674080|NCT00797966|463106513|FG002|Phase A|Lost to Follow-up|0|||
128674081|NCT00797966|463106514|FG003|Phase A|Lost to Follow-up|0|||
128674082|NCT00797966|463106515|FG004|Phase A|Lost to Follow-up|33|||
128674083|NCT00797966|463106516|FG005|Phase A|Lost to Follow-up|0|||
128674084|NCT00797966|463106511|FG000|Phase A|Adverse Event|0|||
128674085|NCT00797966|463106512|FG001|Phase A|Adverse Event|0|||
128674086|NCT00797966|463106513|FG002|Phase A|Adverse Event|0|||
128674087|NCT00797966|463106514|FG003|Phase A|Adverse Event|0|||
128674088|NCT00797966|463106515|FG004|Phase A|Adverse Event|46|||
128674089|NCT00797966|463106516|FG005|Phase A|Adverse Event|0|||
129007308|NCT02146430|464320225|FG003|Overall Study|Adverse Event|49|||
129007309|NCT02146430|464320222|FG000|Overall Study|Reason missing or not reported|2|||
129007310|NCT02146430|464320223|FG001|Overall Study|Reason missing or not reported|3|||
128674090|NCT00797966|463106511|FG000|Phase A|Met withdrawal criteria|0|||
128674091|NCT00797966|463106512|FG001|Phase A|Met withdrawal criteria|0|||
128674092|NCT00797966|463106513|FG002|Phase A|Met withdrawal criteria|0|||
128674093|NCT00797966|463106514|FG003|Phase A|Met withdrawal criteria|0|||
128674094|NCT00797966|463106515|FG004|Phase A|Met withdrawal criteria|4|||
128674095|NCT00797966|463106516|FG005|Phase A|Met withdrawal criteria|0|||
128674096|NCT00797966|463106511|FG000|Phase A|Physician Decision|0|||
128674097|NCT00797966|463106512|FG001|Phase A|Physician Decision|0|||
128674098|NCT00797966|463106513|FG002|Phase A|Physician Decision|0|||
128674099|NCT00797966|463106514|FG003|Phase A|Physician Decision|0|||
128674100|NCT00797966|463106515|FG004|Phase A|Physician Decision|13|||
128674101|NCT00797966|463106516|FG005|Phase A|Physician Decision|0|||
128674102|NCT00797966|463106511|FG000|Phase A|Withdrawal by Subject|0|||
128674103|NCT00797966|463106512|FG001|Phase A|Withdrawal by Subject|0|||
128674104|NCT00797966|463106513|FG002|Phase A|Withdrawal by Subject|0|||
128674105|NCT00797966|463106514|FG003|Phase A|Withdrawal by Subject|0|||
128674106|NCT00797966|463106515|FG004|Phase A|Withdrawal by Subject|33|||
128674107|NCT00797966|463106516|FG005|Phase A|Withdrawal by Subject|0|||
128674108|NCT00797966|463106511|FG000|Phase A|Protocol deviation|0|||
128674109|NCT00797966|463106512|FG001|Phase A|Protocol deviation|0|||
128674110|NCT00797966|463106513|FG002|Phase A|Protocol deviation|0|||
128674111|NCT00797966|463106514|FG003|Phase A|Protocol deviation|0|||
128674112|NCT00797966|463106515|FG004|Phase A|Protocol deviation|56|||
128674113|NCT00797966|463106516|FG005|Phase A|Protocol deviation|0|||
128674114|NCT00797966|463106511|FG000|Phase B|Lost to Follow-up|0|||
129007311|NCT02146430|464320224|FG002|Overall Study|Reason missing or not reported|4|||
129007312|NCT02146430|464320225|FG003|Overall Study|Reason missing or not reported|5|||
129007313|NCT02146430|464320222|FG000|Overall Study|Withdrawal by Subject|27|||
129007314|NCT02146430|464320223|FG001|Overall Study|Withdrawal by Subject|29|||
129007315|NCT02146430|464320224|FG002|Overall Study|Withdrawal by Subject|30|||
129007316|NCT02146430|464320225|FG003|Overall Study|Withdrawal by Subject|34|||
129007317|NCT01893905|464320226|FG000|Overall Study|Withdrawal by Subject|1|||
129007318|NCT01893905|464320227|FG001|Overall Study|Withdrawal by Subject|0|||
129007319|NCT01893905|464320226|FG000|Overall Study|Adverse Event|9|||
129007320|NCT01893905|464320227|FG001|Overall Study|Adverse Event|3|||
129007321|NCT01893905|464320226|FG000|Overall Study|Lack of Efficacy|5|||
129007322|NCT01893905|464320227|FG001|Overall Study|Lack of Efficacy|7|||
129007323|NCT01893905|464320226|FG000|Overall Study|Lost to Follow-up|1|||
129007324|NCT01893905|464320227|FG001|Overall Study|Lost to Follow-up|0|||
129007325|NCT01893905|464320226|FG000|Overall Study|Protocol Violation|6|||
129007326|NCT01893905|464320227|FG001|Overall Study|Protocol Violation|1|||
129007327|NCT01893905|464320226|FG000|Overall Study|Lack of adherence to treatment|2|||
129007328|NCT01893905|464320227|FG001|Overall Study|Lack of adherence to treatment|0|||
129007329|NCT01893905|464320226|FG000|Overall Study|Other reason|1|||
129007330|NCT01893905|464320227|FG001|Overall Study|Other reason|3|||
129007331|NCT01768858|464320228|FG000|Overall Study|Lost to Follow-up|9|||
129007332|NCT01768858|464320228|FG000|Overall Study|Lack of Efficacy|8|||
129007333|NCT01768858|464320228|FG000|Overall Study|Serious Adverse Event|1|||
129007334|NCT01768858|464320228|FG000|Overall Study|Participant moved to Germany|1|||
129007335|NCT01768858|464320228|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
129007336|NCT01768858|464320228|FG000|Overall Study|Exanthema|1|||
129007337|NCT01768858|464320228|FG000|Overall Study|Withdrawal by Subject|1|||
129007338|NCT00614055|464320232|FG000|Overall Study|Adverse Event|1|||
129007339|NCT00614055|464320233|FG001|Overall Study|Adverse Event|0|||
129007340|NCT00614055|464320234|FG002|Overall Study|Adverse Event|0|||
129007341|NCT00614055|464320232|FG000|Overall Study|Protocol Violation|2|||
129007342|NCT00614055|464320233|FG001|Overall Study|Protocol Violation|2|||
129007343|NCT00614055|464320234|FG002|Overall Study|Protocol Violation|1|||
129007344|NCT00614055|464320232|FG000|Overall Study|Lack of Efficacy|0|||
129007345|NCT00614055|464320233|FG001|Overall Study|Lack of Efficacy|0|||
129007346|NCT00614055|464320234|FG002|Overall Study|Lack of Efficacy|2|||
129007347|NCT00614055|464320232|FG000|Overall Study|Unclassified|1|||
128674115|NCT00797966|463106512|FG001|Phase B|Lost to Follow-up|1|||
128674116|NCT00797966|463106513|FG002|Phase B|Lost to Follow-up|3|||
129007348|NCT00614055|464320233|FG001|Overall Study|Unclassified|4|||
128674117|NCT00797966|463106514|FG003|Phase B|Lost to Follow-up|0|||
128674118|NCT00797966|463106515|FG004|Phase B|Lost to Follow-up|0|||
128674119|NCT00797966|463106516|FG005|Phase B|Lost to Follow-up|0|||
128674120|NCT00797966|463106511|FG000|Phase B|Adverse Event|2|||
128674121|NCT00797966|463106512|FG001|Phase B|Adverse Event|1|||
128674122|NCT00797966|463106513|FG002|Phase B|Adverse Event|3|||
128674123|NCT00797966|463106514|FG003|Phase B|Adverse Event|1|||
128674124|NCT00797966|463106515|FG004|Phase B|Adverse Event|0|||
129007349|NCT00614055|464320234|FG002|Overall Study|Unclassified|2|||
129007350|NCT01691859|464320236|FG000|Overall Study|Adverse Event|19|||
129007351|NCT01691859|464320236|FG000|Overall Study|Lack of Efficacy|11|||
129007352|NCT01691859|464320236|FG000|Overall Study|Protocol Violation|4|||
129007353|NCT01691859|464320236|FG000|Overall Study|Product commercially available|221|||
129007354|NCT01691859|464320236|FG000|Overall Study|Study closed/terminated|50|||
129007355|NCT01691859|464320236|FG000|Overall Study|Lost to Follow-up|5|||
128674125|NCT00797966|463106516|FG005|Phase B|Adverse Event|0|||
128674126|NCT00797966|463106511|FG000|Phase B|Met Withdrawal Criteria|3|||
128674127|NCT00797966|463106512|FG001|Phase B|Met Withdrawal Criteria|3|||
128674128|NCT00797966|463106513|FG002|Phase B|Met Withdrawal Criteria|6|||
128674129|NCT00797966|463106514|FG003|Phase B|Met Withdrawal Criteria|1|||
128674130|NCT00797966|463106515|FG004|Phase B|Met Withdrawal Criteria|0|||
128674131|NCT00797966|463106516|FG005|Phase B|Met Withdrawal Criteria|0|||
128674132|NCT00797966|463106511|FG000|Phase B|Physician Decision|1|||
128674133|NCT00797966|463106512|FG001|Phase B|Physician Decision|0|||
128674134|NCT00797966|463106513|FG002|Phase B|Physician Decision|3|||
128674135|NCT00797966|463106514|FG003|Phase B|Physician Decision|1|||
128674136|NCT00797966|463106515|FG004|Phase B|Physician Decision|0|||
128674137|NCT00797966|463106516|FG005|Phase B|Physician Decision|0|||
128674138|NCT00797966|463106511|FG000|Phase B|Withdrawal by Subject|1|||
128674139|NCT00797966|463106512|FG001|Phase B|Withdrawal by Subject|4|||
128674140|NCT00797966|463106513|FG002|Phase B|Withdrawal by Subject|3|||
128674141|NCT00797966|463106514|FG003|Phase B|Withdrawal by Subject|3|||
128674142|NCT00797966|463106515|FG004|Phase B|Withdrawal by Subject|0|||
128674143|NCT00797966|463106516|FG005|Phase B|Withdrawal by Subject|0|||
128674144|NCT00797966|463106511|FG000|Phase B|Protocol Deviation|4|||
128674145|NCT00797966|463106512|FG001|Phase B|Protocol Deviation|8|||
128674146|NCT00797966|463106513|FG002|Phase B|Protocol Deviation|2|||
128674147|NCT00797966|463106514|FG003|Phase B|Protocol Deviation|6|||
128674148|NCT00797966|463106515|FG004|Phase B|Protocol Deviation|0|||
128674149|NCT00797966|463106516|FG005|Phase B|Protocol Deviation|0|||
128674150|NCT00797966|463106511|FG000|Phase B|Lack of Efficacy|0|||
128674151|NCT00797966|463106512|FG001|Phase B|Lack of Efficacy|1|||
128674152|NCT00797966|463106513|FG002|Phase B|Lack of Efficacy|1|||
128674153|NCT00797966|463106514|FG003|Phase B|Lack of Efficacy|4|||
128674154|NCT00797966|463106515|FG004|Phase B|Lack of Efficacy|0|||
128674155|NCT00797966|463106516|FG005|Phase B|Lack of Efficacy|0|||
128674156|NCT00797966|463106511|FG000|Phase A+|Lost to Follow-up|0|||
128674157|NCT00797966|463106512|FG001|Phase A+|Lost to Follow-up|0|||
128674158|NCT00797966|463106513|FG002|Phase A+|Lost to Follow-up|0|||
128674159|NCT00797966|463106514|FG003|Phase A+|Lost to Follow-up|0|||
128674160|NCT00797966|463106515|FG004|Phase A+|Lost to Follow-up|0|||
128674161|NCT00797966|463106516|FG005|Phase A+|Lost to Follow-up|9|||
128674162|NCT00797966|463106511|FG000|Phase A+|Met withdrawal criteria|0|||
129007356|NCT01691859|464320236|FG000|Overall Study|Physician Decision|6|||
129007357|NCT01691859|464320236|FG000|Overall Study|Withdrawal by Subject|31|||
129007358|NCT01296932|464320237|FG000|Overall Study|Dose limiting toxicity|0|||
129007359|NCT01296932|464320238|FG001|Overall Study|Dose limiting toxicity|0|||
129007360|NCT01296932|464320239|FG002|Overall Study|Dose limiting toxicity|0|||
129007361|NCT01296932|464320240|FG003|Overall Study|Dose limiting toxicity|0|||
128674163|NCT00797966|463106512|FG001|Phase A+|Met withdrawal criteria|0|||
128674164|NCT00797966|463106513|FG002|Phase A+|Met withdrawal criteria|0|||
128674165|NCT00797966|463106514|FG003|Phase A+|Met withdrawal criteria|0|||
128674166|NCT00797966|463106515|FG004|Phase A+|Met withdrawal criteria|0|||
128674167|NCT00797966|463106516|FG005|Phase A+|Met withdrawal criteria|5|||
128674168|NCT00797966|463106511|FG000|Phase A+|Withdrawal by Subject|0|||
128674169|NCT00797966|463106512|FG001|Phase A+|Withdrawal by Subject|0|||
128674170|NCT00797966|463106513|FG002|Phase A+|Withdrawal by Subject|0|||
128674171|NCT00797966|463106514|FG003|Phase A+|Withdrawal by Subject|0|||
128674172|NCT00797966|463106515|FG004|Phase A+|Withdrawal by Subject|0|||
128674173|NCT00797966|463106516|FG005|Phase A+|Withdrawal by Subject|6|||
128674174|NCT00797966|463106511|FG000|Phase A+|Adverse Event|0|||
128674175|NCT00797966|463106512|FG001|Phase A+|Adverse Event|0|||
128674176|NCT00797966|463106513|FG002|Phase A+|Adverse Event|0|||
128674177|NCT00797966|463106514|FG003|Phase A+|Adverse Event|0|||
128674178|NCT00797966|463106515|FG004|Phase A+|Adverse Event|0|||
128674179|NCT00797966|463106516|FG005|Phase A+|Adverse Event|4|||
128674180|NCT00797966|463106511|FG000|Phase A+|Protocol deviation|0|||
128674181|NCT00797966|463106512|FG001|Phase A+|Protocol deviation|0|||
128674182|NCT00797966|463106513|FG002|Phase A+|Protocol deviation|0|||
128674183|NCT00797966|463106514|FG003|Phase A+|Protocol deviation|0|||
128674184|NCT00797966|463106515|FG004|Phase A+|Protocol deviation|0|||
128674185|NCT00797966|463106516|FG005|Phase A+|Protocol deviation|4|||
128674186|NCT02855541|463106528|FG000|Overall Study|Change in health status|2|||
128674187|NCT02855541|463106528|FG000|Overall Study|Withdrawal by Subject|2|||
128674188|NCT00422513|463106529|FG000|Overall Study|Lack of Efficacy|4|||
128674189|NCT00422513|463106530|FG001|Overall Study|Lack of Efficacy|5|||
128674190|NCT00422513|463106529|FG000|Overall Study|Protocol Violation|23|||
128674191|NCT00422513|463106530|FG001|Overall Study|Protocol Violation|7|||
128674192|NCT00422513|463106529|FG000|Overall Study|Refused Treatment|4|||
128674193|NCT00422513|463106530|FG001|Overall Study|Refused Treatment|2|||
128674194|NCT00422513|463106529|FG000|Overall Study|Withdrawal by Subject|2|||
128674195|NCT00422513|463106530|FG001|Overall Study|Withdrawal by Subject|1|||
128674196|NCT00422513|463106529|FG000|Overall Study|early termination of the study|67|||
128674197|NCT00422513|463106530|FG001|Overall Study|early termination of the study|80|||
128674198|NCT00422513|463106529|FG000|Overall Study|Adverse Event|4|||
129007362|NCT01296932|464320241|FG004|Overall Study|Dose limiting toxicity|0|||
129007363|NCT01296932|464320242|FG005|Overall Study|Dose limiting toxicity|0|||
129007364|NCT01296932|464320243|FG006|Overall Study|Dose limiting toxicity|1|||
128674199|NCT00422513|463106530|FG001|Overall Study|Adverse Event|4|||
128674200|NCT00422513|463106529|FG000|Overall Study|Death|3|||
128674201|NCT00422513|463106530|FG001|Overall Study|Death|7|||
128674202|NCT03032380|463106531|FG000|Overall Study|Adverse Event|0|||
128674203|NCT03032380|463106532|FG001|Overall Study|Adverse Event|1|||
128674204|NCT03032380|463106531|FG000|Overall Study|Lack of Efficacy|1|||
128674205|NCT03032380|463106532|FG001|Overall Study|Lack of Efficacy|0|||
128674206|NCT03032380|463106531|FG000|Overall Study|Withdrawal by Subject|2|||
128674207|NCT03032380|463106532|FG001|Overall Study|Withdrawal by Subject|3|||
128674208|NCT03032380|463106531|FG000|Overall Study|Recovery|0|||
128674209|NCT03032380|463106532|FG001|Overall Study|Recovery|1|||
128674210|NCT03032380|463106531|FG000|Overall Study|Death|39|||
128674211|NCT03032380|463106532|FG001|Overall Study|Death|34|||
128674212|NCT03032380|463106531|FG000|Overall Study|Other - Miscellaneous|0|||
128674213|NCT03032380|463106532|FG001|Overall Study|Other - Miscellaneous|1|||
128674214|NCT01883453|463106533|FG000|Overall Study|No episode of common cold|25|||
128674215|NCT01883453|463106534|FG001|Overall Study|No episode of common cold|23|||
128674216|NCT04093024|463106537|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
128674217|NCT04093024|463106538|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
128674218|NCT04093024|463106537|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
128674219|NCT04093024|463106538|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
128674220|NCT04093024|463106537|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
128674221|NCT04093024|463106538|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
128674222|NCT04093024|463106537|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
128674223|NCT04093024|463106538|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
128674224|NCT04493892|463106549|FG000|Overall Study|Withdrawal by Subject|15|||
128674225|NCT02267317|463106554|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
128674226|NCT02267317|463106555|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
128674227|NCT02267317|463106556|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
128674228|NCT02267317|463106557|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
128674229|NCT02267317|463106558|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
128674230|NCT02267317|463106559|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
128674231|NCT02267317|463106554|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
128674232|NCT02267317|463106555|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
128674233|NCT02267317|463106556|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
128674234|NCT02267317|463106557|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
128674235|NCT02267317|463106558|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
128674236|NCT02267317|463106559|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
128674237|NCT01128621|463106560|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
128674238|NCT01128621|463106561|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
128674239|NCT00796445|463106564|FG000|Overall Study|Protocol Violation|5|||
128674240|NCT00796445|463106565|FG001|Overall Study|Protocol Violation|3|||
128674241|NCT00796445|463106564|FG000|Overall Study|Adverse event, serious fatal|10|||
128674242|NCT00796445|463106565|FG001|Overall Study|Adverse event, serious fatal|5|||
128674243|NCT00796445|463106564|FG000|Overall Study|Adverse event, non-fatal|4|||
128674244|NCT00796445|463106565|FG001|Overall Study|Adverse event, non-fatal|0|||
128674245|NCT00796445|463106564|FG000|Overall Study|Disease progression/recurrence|537|||
128674246|NCT00796445|463106565|FG001|Overall Study|Disease progression/recurrence|268|||
128674247|NCT00796445|463106564|FG000|Overall Study|Other|10|||
128674248|NCT00796445|463106565|FG001|Overall Study|Other|7|||
128674249|NCT00796445|463106564|FG000|Overall Study|Withdrawal by Subject|18|||
128674250|NCT00796445|463106565|FG001|Overall Study|Withdrawal by Subject|9|||
128674251|NCT00796445|463106564|FG000|Overall Study|Invalid Informed Consent Form|1|||
128674252|NCT00796445|463106565|FG001|Overall Study|Invalid Informed Consent Form|0|||
128674253|NCT02208063|463106566|FG000|Overall Study|Death|3|||
128674254|NCT02208063|463106567|FG001|Overall Study|Death|5|||
128674255|NCT02208063|463106566|FG000|Overall Study|Not Specified in report|3|||
128674256|NCT02208063|463106567|FG001|Overall Study|Not Specified in report|4|||
128674257|NCT02208063|463106566|FG000|Overall Study|Withdrawal by Subject|5|||
128674258|NCT02208063|463106567|FG001|Overall Study|Withdrawal by Subject|2|||
128674259|NCT02208063|463106566|FG000|Overall Study|Lost to Follow-up|1|||
128674260|NCT02208063|463106567|FG001|Overall Study|Lost to Follow-up|0|||
128674261|NCT00913458|463106568|FG000|Phase 1|Non-Responder|54|||
128674262|NCT00913458|463106569|FG001|Phase 1|Non-Responder|0|||
128674263|NCT00913458|463106570|FG002|Phase 1|Non-Responder|0|||
128674264|NCT00913458|463106571|FG003|Phase 1|Non-Responder|0|||
128674265|NCT00913458|463106572|FG004|Phase 1|Non-Responder|0|||
128674266|NCT00913458|463106573|FG005|Phase 1|Non-Responder|0|||
128674267|NCT00913458|463106574|FG006|Phase 1|Non-Responder|0|||
129007365|NCT01296932|464320244|FG007|Overall Study|Dose limiting toxicity|0|||
128674268|NCT00913458|463106568|FG000|Phase 1|Subject Request|17|||
128674269|NCT00913458|463106569|FG001|Phase 1|Subject Request|0|||
128674270|NCT00913458|463106570|FG002|Phase 1|Subject Request|0|||
128674271|NCT00913458|463106571|FG003|Phase 1|Subject Request|0|||
128674272|NCT00913458|463106572|FG004|Phase 1|Subject Request|0|||
128674273|NCT00913458|463106573|FG005|Phase 1|Subject Request|0|||
128674274|NCT00913458|463106574|FG006|Phase 1|Subject Request|0|||
128674275|NCT00913458|463106568|FG000|Phase 1|Adverse Event|20|||
128674276|NCT00913458|463106569|FG001|Phase 1|Adverse Event|0|||
128674277|NCT00913458|463106570|FG002|Phase 1|Adverse Event|0|||
128674278|NCT00913458|463106571|FG003|Phase 1|Adverse Event|0|||
128674279|NCT00913458|463106572|FG004|Phase 1|Adverse Event|0|||
128674280|NCT00913458|463106573|FG005|Phase 1|Adverse Event|0|||
128674281|NCT00913458|463106574|FG006|Phase 1|Adverse Event|0|||
128674282|NCT00913458|463106568|FG000|Phase 1|Lost to Follow-up|2|||
128674283|NCT00913458|463106569|FG001|Phase 1|Lost to Follow-up|0|||
128674284|NCT00913458|463106570|FG002|Phase 1|Lost to Follow-up|0|||
128674285|NCT00913458|463106571|FG003|Phase 1|Lost to Follow-up|0|||
128674286|NCT00913458|463106572|FG004|Phase 1|Lost to Follow-up|0|||
128674287|NCT00913458|463106573|FG005|Phase 1|Lost to Follow-up|0|||
128674288|NCT00913458|463106574|FG006|Phase 1|Lost to Follow-up|0|||
128674289|NCT00913458|463106568|FG000|Phase 1|Protocol Violation|10|||
128674290|NCT00913458|463106569|FG001|Phase 1|Protocol Violation|0|||
128674291|NCT00913458|463106570|FG002|Phase 1|Protocol Violation|0|||
128674292|NCT00913458|463106571|FG003|Phase 1|Protocol Violation|0|||
128674293|NCT00913458|463106572|FG004|Phase 1|Protocol Violation|0|||
128674294|NCT00913458|463106573|FG005|Phase 1|Protocol Violation|0|||
128674295|NCT00913458|463106574|FG006|Phase 1|Protocol Violation|0|||
128674296|NCT00913458|463106568|FG000|Phase 1|Sponsor|2|||
128674297|NCT00913458|463106569|FG001|Phase 1|Sponsor|0|||
128674298|NCT00913458|463106570|FG002|Phase 1|Sponsor|0|||
128674299|NCT00913458|463106571|FG003|Phase 1|Sponsor|0|||
128674300|NCT00913458|463106572|FG004|Phase 1|Sponsor|0|||
128674301|NCT00913458|463106573|FG005|Phase 1|Sponsor|0|||
128674302|NCT00913458|463106574|FG006|Phase 1|Sponsor|0|||
128674303|NCT00913458|463106568|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
128674304|NCT00913458|463106569|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
128674305|NCT00913458|463106570|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
128674306|NCT00913458|463106571|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
128674307|NCT00913458|463106572|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
128674308|NCT00913458|463106573|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
128674309|NCT00913458|463106574|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
128674310|NCT00913458|463106568|FG000|Phase 2|Non-Responder|0|||
128674311|NCT00913458|463106569|FG001|Phase 2|Non-Responder|5|||
128674312|NCT00913458|463106570|FG002|Phase 2|Non-Responder|7|||
128674313|NCT00913458|463106571|FG003|Phase 2|Non-Responder|12|||
128674314|NCT00913458|463106572|FG004|Phase 2|Non-Responder|0|||
128674315|NCT00913458|463106573|FG005|Phase 2|Non-Responder|0|||
128674316|NCT00913458|463106574|FG006|Phase 2|Non-Responder|0|||
128674317|NCT00913458|463106568|FG000|Phase 2|Subject Request|0|||
128674318|NCT00913458|463106569|FG001|Phase 2|Subject Request|0|||
128674319|NCT00913458|463106570|FG002|Phase 2|Subject Request|1|||
128674320|NCT00913458|463106571|FG003|Phase 2|Subject Request|2|||
128674321|NCT00913458|463106572|FG004|Phase 2|Subject Request|0|||
128674322|NCT00913458|463106573|FG005|Phase 2|Subject Request|0|||
128674323|NCT00913458|463106574|FG006|Phase 2|Subject Request|0|||
128674324|NCT00913458|463106568|FG000|Phase 2|Adverse Event|0|||
128674325|NCT00913458|463106569|FG001|Phase 2|Adverse Event|3|||
128674326|NCT00913458|463106570|FG002|Phase 2|Adverse Event|0|||
128674327|NCT00913458|463106571|FG003|Phase 2|Adverse Event|1|||
128674328|NCT00913458|463106572|FG004|Phase 2|Adverse Event|0|||
128674329|NCT00913458|463106573|FG005|Phase 2|Adverse Event|0|||
128674330|NCT00913458|463106574|FG006|Phase 2|Adverse Event|0|||
128674331|NCT00913458|463106568|FG000|Phase 2|Lost to Follow-up|0|||
128674332|NCT00913458|463106569|FG001|Phase 2|Lost to Follow-up|0|||
128674333|NCT00913458|463106570|FG002|Phase 2|Lost to Follow-up|0|||
128674334|NCT00913458|463106571|FG003|Phase 2|Lost to Follow-up|1|||
128674335|NCT00913458|463106572|FG004|Phase 2|Lost to Follow-up|0|||
128674336|NCT00913458|463106573|FG005|Phase 2|Lost to Follow-up|0|||
128674337|NCT00913458|463106574|FG006|Phase 2|Lost to Follow-up|0|||
128674338|NCT00913458|463106568|FG000|Phase 2|Protocol Violation|0|||
128674339|NCT00913458|463106569|FG001|Phase 2|Protocol Violation|2|||
128674340|NCT00913458|463106570|FG002|Phase 2|Protocol Violation|0|||
128674341|NCT00913458|463106571|FG003|Phase 2|Protocol Violation|0|||
128674342|NCT00913458|463106572|FG004|Phase 2|Protocol Violation|0|||
128674343|NCT00913458|463106573|FG005|Phase 2|Protocol Violation|0|||
128674344|NCT00913458|463106574|FG006|Phase 2|Protocol Violation|0|||
128674345|NCT00913458|463106568|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
128674346|NCT00913458|463106569|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
128674347|NCT00913458|463106570|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
128674348|NCT00913458|463106571|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
128674349|NCT00913458|463106572|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
128674350|NCT00913458|463106573|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
128674351|NCT00913458|463106574|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
128674352|NCT00913458|463106568|FG000|Phase 3|Adverse Event|0|||
128674353|NCT00913458|463106569|FG001|Phase 3|Adverse Event|0|||
128674354|NCT00913458|463106570|FG002|Phase 3|Adverse Event|0|||
128674355|NCT00913458|463106571|FG003|Phase 3|Adverse Event|0|||
128674356|NCT00913458|463106572|FG004|Phase 3|Adverse Event|5|||
128674357|NCT00913458|463106573|FG005|Phase 3|Adverse Event|4|||
128674358|NCT00913458|463106574|FG006|Phase 3|Adverse Event|1|||
128674359|NCT00913458|463106568|FG000|Phase 3|Lost to Follow-up|0|||
128674360|NCT00913458|463106569|FG001|Phase 3|Lost to Follow-up|0|||
128674361|NCT00913458|463106570|FG002|Phase 3|Lost to Follow-up|0|||
128674362|NCT00913458|463106571|FG003|Phase 3|Lost to Follow-up|0|||
128674363|NCT00913458|463106572|FG004|Phase 3|Lost to Follow-up|2|||
128674364|NCT00913458|463106573|FG005|Phase 3|Lost to Follow-up|0|||
128674365|NCT00913458|463106574|FG006|Phase 3|Lost to Follow-up|0|||
128674366|NCT00913458|463106568|FG000|Phase 3|Non-Responder|0|||
128674367|NCT00913458|463106569|FG001|Phase 3|Non-Responder|0|||
128674368|NCT00913458|463106570|FG002|Phase 3|Non-Responder|0|||
128674369|NCT00913458|463106571|FG003|Phase 3|Non-Responder|0|||
128674370|NCT00913458|463106572|FG004|Phase 3|Non-Responder|0|||
128674371|NCT00913458|463106573|FG005|Phase 3|Non-Responder|1|||
128674372|NCT00913458|463106574|FG006|Phase 3|Non-Responder|3|||
128674373|NCT00913458|463106568|FG000|Phase 3|Withdrawal by Subject|0|||
128674374|NCT00913458|463106569|FG001|Phase 3|Withdrawal by Subject|0|||
128674375|NCT00913458|463106570|FG002|Phase 3|Withdrawal by Subject|0|||
128674376|NCT00913458|463106571|FG003|Phase 3|Withdrawal by Subject|0|||
128674377|NCT00913458|463106572|FG004|Phase 3|Withdrawal by Subject|1|||
128674378|NCT00913458|463106573|FG005|Phase 3|Withdrawal by Subject|2|||
128674379|NCT00913458|463106574|FG006|Phase 3|Withdrawal by Subject|0|||
128674380|NCT00913458|463106568|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
128674381|NCT00913458|463106569|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
128674382|NCT00913458|463106570|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
128674383|NCT00913458|463106571|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
128674384|NCT00913458|463106572|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
128674385|NCT00913458|463106573|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
128674386|NCT00913458|463106574|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
128674387|NCT00917644|463106575|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
128674388|NCT00917644|463106576|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
128674389|NCT00917644|463106575|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
128674390|NCT00917644|463106576|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
128674391|NCT00917644|463106575|FG000|Period 2: Second Intervention|family emergency|1|||
128674392|NCT00917644|463106576|FG001|Period 2: Second Intervention|family emergency|0|||
128674393|NCT01253811|463106581|FG000|Overall Study|Withdrawal criteria|1|||
128674394|NCT03774823|463106582|FG000|Overall Study|Withdrawal by Subject|1|||
128674395|NCT03774823|463106583|FG001|Overall Study|Withdrawal by Subject|1|||
128674396|NCT01087736|463106584|FG000|Overall Study|Lost to Follow-up|1|||
128674397|NCT01087736|463106585|FG001|Overall Study|Lost to Follow-up|0|||
128674398|NCT01087736|463106584|FG000|Overall Study|Death|0|||
128674399|NCT01087736|463106585|FG001|Overall Study|Death|1|||
128674400|NCT01087736|463106584|FG000|Overall Study|Withdrawal by Subject|0|||
128674401|NCT01087736|463106585|FG001|Overall Study|Withdrawal by Subject|1|||
128674402|NCT00958438|463106589|FG000|Overall Study|Protocol Violation|3|||
128674403|NCT00958438|463106590|FG001|Overall Study|Protocol Violation|2|||
129007366|NCT01296932|464320245|FG008|Overall Study|Dose limiting toxicity|1|||
128674404|NCT00958438|463106591|FG002|Overall Study|Protocol Violation|2|||
128674405|NCT00958438|463106589|FG000|Overall Study|Withdrawal by Subject|4|||
128674406|NCT00958438|463106590|FG001|Overall Study|Withdrawal by Subject|2|||
128674407|NCT00958438|463106591|FG002|Overall Study|Withdrawal by Subject|1|||
128674408|NCT00958438|463106589|FG000|Overall Study|Adverse Event|0|||
128674409|NCT00958438|463106590|FG001|Overall Study|Adverse Event|3|||
128674410|NCT00958438|463106591|FG002|Overall Study|Adverse Event|0|||
128674411|NCT00958438|463106589|FG000|Overall Study|Physician Decision|1|||
128674412|NCT00958438|463106590|FG001|Overall Study|Physician Decision|0|||
128674413|NCT00958438|463106591|FG002|Overall Study|Physician Decision|1|||
129007367|NCT01296932|464320237|FG000|Overall Study|Progressive disease|2|||
129007368|NCT01296932|464320238|FG001|Overall Study|Progressive disease|0|||
128674414|NCT00958438|463106589|FG000|Overall Study|Other than specified above|2|||
128674415|NCT00958438|463106590|FG001|Overall Study|Other than specified above|3|||
128674416|NCT00958438|463106591|FG002|Overall Study|Other than specified above|2|||
128674417|NCT02788279|463106592|FG000|Overall Study|Death|62|||
128674418|NCT02788279|463106593|FG001|Overall Study|Death|136|||
128674419|NCT02788279|463106594|FG002|Overall Study|Death|72|||
128674420|NCT02788279|463106592|FG000|Overall Study|Withdrawal by Subject|10|||
128674421|NCT02788279|463106593|FG001|Overall Study|Withdrawal by Subject|15|||
128674422|NCT02788279|463106594|FG002|Overall Study|Withdrawal by Subject|5|||
128674423|NCT02788279|463106592|FG000|Overall Study|Lost to Follow-up|0|||
128674424|NCT02788279|463106593|FG001|Overall Study|Lost to Follow-up|3|||
128674425|NCT02788279|463106594|FG002|Overall Study|Lost to Follow-up|2|||
128674426|NCT02788279|463106592|FG000|Overall Study|Sponsor decision|18|||
129007369|NCT01296932|464320239|FG002|Overall Study|Progressive disease|1|||
129007370|NCT01296932|464320240|FG003|Overall Study|Progressive disease|1|||
128674427|NCT02788279|463106593|FG001|Overall Study|Sponsor decision|29|||
128674428|NCT02788279|463106594|FG002|Overall Study|Sponsor decision|11|||
128674429|NCT01782469|463106595|FG000|Overall Study|Lost to Follow-up|1|||
128674430|NCT00638183|463106598|FG000|Overall Study|Adverse Event|23|||
128674431|NCT00638183|463106598|FG000|Overall Study|Lack of Efficacy|14|||
128674432|NCT00638183|463106598|FG000|Overall Study|Physician Decision|9|||
128674433|NCT00638183|463106598|FG000|Overall Study|Lost to Follow-up|46|||
128674434|NCT00638183|463106598|FG000|Overall Study|Other reason not defined above|27|||
128674435|NCT00006409|463106599|FG000|Baseline|Protocol Violation|48|||
128674436|NCT00006409|463106600|FG001|Baseline|Protocol Violation|70|||
128674437|NCT00006409|463106601|FG002|Baseline|Protocol Violation|0|||
128674438|NCT00006409|463106602|FG003|Baseline|Protocol Violation|0|||
128674439|NCT00006409|463106603|FG004|Baseline|Protocol Violation|0|||
128674440|NCT00006409|463106604|FG005|Baseline|Protocol Violation|0|||
128674441|NCT00006409|463106599|FG000|Post-2 Year Intervention|Protocol Violation|0|||
128674442|NCT00006409|463106600|FG001|Post-2 Year Intervention|Protocol Violation|0|||
128674443|NCT00006409|463106601|FG002|Post-2 Year Intervention|Protocol Violation|251|||
128674444|NCT00006409|463106602|FG003|Post-2 Year Intervention|Protocol Violation|168|||
128674445|NCT00006409|463106603|FG004|Post-2 Year Intervention|Protocol Violation|0|||
128674446|NCT00006409|463106604|FG005|Post-2 Year Intervention|Protocol Violation|0|||
128674447|NCT00006409|463106599|FG000|Post-3 Year Intervention|Protocol Violation|0|||
128674448|NCT00006409|463106600|FG001|Post-3 Year Intervention|Protocol Violation|0|||
128674449|NCT00006409|463106601|FG002|Post-3 Year Intervention|Protocol Violation|0|||
128674450|NCT00006409|463106602|FG003|Post-3 Year Intervention|Protocol Violation|0|||
128674451|NCT00006409|463106603|FG004|Post-3 Year Intervention|Protocol Violation|62|||
128674452|NCT00006409|463106604|FG005|Post-3 Year Intervention|Protocol Violation|62|||
128674453|NCT01328444|463106605|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
128674454|NCT01328444|463106606|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
128674455|NCT01328444|463106607|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
128674456|NCT01328444|463106608|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
128674457|NCT01328444|463106609|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
128674458|NCT01328444|463106610|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
128674459|NCT01328444|463106605|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
128674460|NCT01328444|463106606|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
128674461|NCT01328444|463106607|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
128674462|NCT01328444|463106608|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
128674463|NCT01328444|463106609|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
128674464|NCT01328444|463106610|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
128674465|NCT01328444|463106605|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
128674466|NCT01328444|463106606|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
128674467|NCT01328444|463106607|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
128674468|NCT01328444|463106608|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
128674469|NCT01328444|463106609|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
128674470|NCT01328444|463106610|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
128674471|NCT01328444|463106605|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
128674472|NCT01328444|463106606|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
128674473|NCT01328444|463106607|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
128674474|NCT01328444|463106608|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
128674475|NCT01328444|463106609|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
128674476|NCT01328444|463106610|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
128674477|NCT01328444|463106605|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
128674478|NCT01328444|463106606|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129007371|NCT01296932|464320241|FG004|Overall Study|Progressive disease|2|||
129007372|NCT01296932|464320242|FG005|Overall Study|Progressive disease|3|||
129007373|NCT01296932|464320243|FG006|Overall Study|Progressive disease|1|||
128674479|NCT01328444|463106607|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128674480|NCT01328444|463106608|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129007374|NCT01296932|464320244|FG007|Overall Study|Progressive disease|0|||
129007375|NCT01296932|464320245|FG008|Overall Study|Progressive disease|0|||
128674481|NCT01328444|463106609|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128674482|NCT01328444|463106610|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
128674483|NCT01328444|463106605|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
128674484|NCT01328444|463106606|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
128674485|NCT01328444|463106607|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129007376|NCT01296932|464320237|FG000|Overall Study|Withdrawal by Subject|0|||
129007377|NCT01296932|464320238|FG001|Overall Study|Withdrawal by Subject|0|||
129007378|NCT01296932|464320239|FG002|Overall Study|Withdrawal by Subject|1|||
128674486|NCT01328444|463106608|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
128674487|NCT01328444|463106609|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129007379|NCT01296932|464320240|FG003|Overall Study|Withdrawal by Subject|1|||
129007380|NCT01296932|464320241|FG004|Overall Study|Withdrawal by Subject|0|||
128674488|NCT01328444|463106610|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
128674489|NCT01328444|463106605|FG000|Washout Period (14 Days)|Adverse Event|1|||
128674490|NCT01328444|463106606|FG001|Washout Period (14 Days)|Adverse Event|1|||
128674491|NCT01328444|463106607|FG002|Washout Period (14 Days)|Adverse Event|0|||
128674492|NCT01328444|463106608|FG003|Washout Period (14 Days)|Adverse Event|1|||
128674493|NCT01328444|463106609|FG004|Washout Period (14 Days)|Adverse Event|1|||
128674494|NCT01328444|463106610|FG005|Washout Period (14 Days)|Adverse Event|2|||
128674495|NCT01328444|463106605|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
128674496|NCT01328444|463106606|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
128674497|NCT01328444|463106607|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
128674498|NCT01328444|463106608|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
128674499|NCT01328444|463106609|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
128674500|NCT01328444|463106610|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
128674501|NCT01328444|463106605|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
128674502|NCT01328444|463106606|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
128674503|NCT01328444|463106607|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
128674504|NCT01328444|463106608|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
128674505|NCT01328444|463106609|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
128674506|NCT01328444|463106610|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
128674507|NCT01328444|463106605|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
128674508|NCT01328444|463106606|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
128674509|NCT01328444|463106607|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
128674510|NCT01328444|463106608|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
128674511|NCT01328444|463106609|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
128674512|NCT01328444|463106610|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
128674513|NCT01328444|463106605|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
128674514|NCT01328444|463106606|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
128674515|NCT01328444|463106607|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
128674516|NCT01328444|463106608|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
128674517|NCT01328444|463106609|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
128674518|NCT01328444|463106610|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
128674519|NCT01328444|463106605|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
128674520|NCT01328444|463106606|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
128674521|NCT01328444|463106607|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
128674522|NCT01328444|463106608|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
128674523|NCT01328444|463106609|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
128674524|NCT01328444|463106610|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
128674525|NCT01328444|463106605|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
128674526|NCT01328444|463106606|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
128674527|NCT01328444|463106607|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
128674528|NCT01328444|463106608|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
128674529|NCT01328444|463106609|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
128674530|NCT01328444|463106610|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
128674531|NCT01328444|463106605|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
128674532|NCT01328444|463106606|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
128674533|NCT01328444|463106607|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
128674534|NCT01328444|463106608|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
128674535|NCT01328444|463106609|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
128674536|NCT01328444|463106610|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
128674537|NCT01328444|463106605|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128674538|NCT01328444|463106606|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128674539|NCT01328444|463106607|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128674540|NCT01328444|463106608|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128674541|NCT01328444|463106609|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128674542|NCT01328444|463106610|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128674543|NCT03531632|463106611|FG000|Overall Study|Adverse Event|0|||
129007381|NCT01296932|464320242|FG005|Overall Study|Withdrawal by Subject|0|||
129007382|NCT01296932|464320243|FG006|Overall Study|Withdrawal by Subject|3|||
128674544|NCT03531632|463106612|FG001|Overall Study|Adverse Event|0|||
128674545|NCT03531632|463106613|FG002|Overall Study|Adverse Event|1|||
128674546|NCT03531632|463106611|FG000|Overall Study|Death|4|||
129007383|NCT01296932|464320244|FG007|Overall Study|Withdrawal by Subject|0|||
129007384|NCT01296932|464320245|FG008|Overall Study|Withdrawal by Subject|0|||
129007385|NCT01296932|464320237|FG000|Overall Study|Adverse Event|1|||
128674547|NCT03531632|463106612|FG001|Overall Study|Death|0|||
128674548|NCT03531632|463106613|FG002|Overall Study|Death|14|||
128674549|NCT03531632|463106611|FG000|Overall Study|Study Terminated|1|||
128674550|NCT03531632|463106612|FG001|Overall Study|Study Terminated|3|||
128674551|NCT03531632|463106613|FG002|Overall Study|Study Terminated|11|||
128674552|NCT02743611|463106614|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
129007386|NCT01296932|464320238|FG001|Overall Study|Adverse Event|1|||
128674553|NCT02743611|463106615|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
128674554|NCT02743611|463106616|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
128674555|NCT02743611|463106617|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
128674556|NCT01546623|463106618|FG000|Overall Study|Adverse Event|2|||
128674557|NCT01546623|463106619|FG001|Overall Study|Adverse Event|3|||
128674558|NCT01546623|463106618|FG000|Overall Study|Major Protocol Deviation|1|||
128674559|NCT01546623|463106619|FG001|Overall Study|Major Protocol Deviation|1|||
128674560|NCT01546623|463106618|FG000|Overall Study|High Prostate specific antigen|2|||
128674561|NCT01546623|463106619|FG001|Overall Study|High Prostate specific antigen|1|||
128674562|NCT01546623|463106618|FG000|Overall Study|Did Not Receive Study Drug|1|||
128674563|NCT01546623|463106619|FG001|Overall Study|Did Not Receive Study Drug|1|||
128674564|NCT01134705|463106620|FG000|Overall Study|Adverse Event|1|||
128674565|NCT01134705|463106621|FG001|Overall Study|Adverse Event|7|||
128674566|NCT01134705|463106620|FG000|Overall Study|Withdrawal by Subject|6|||
128674567|NCT01134705|463106621|FG001|Overall Study|Withdrawal by Subject|6|||
128674568|NCT01134705|463106620|FG000|Overall Study|Pregnancy|1|||
128674569|NCT01134705|463106621|FG001|Overall Study|Pregnancy|0|||
128674570|NCT01134705|463106620|FG000|Overall Study|Lost to Follow-up|5|||
128674571|NCT01134705|463106621|FG001|Overall Study|Lost to Follow-up|2|||
128674572|NCT01134705|463106620|FG000|Overall Study|Protocol Violation|1|||
128674573|NCT01134705|463106621|FG001|Overall Study|Protocol Violation|1|||
128674574|NCT01134705|463106620|FG000|Overall Study|Other|1|||
128674575|NCT01134705|463106621|FG001|Overall Study|Other|6|||
128674576|NCT00402740|463106633|FG000|Overall Study|Withdrawal by Subject|18|||
128674577|NCT00402740|463106633|FG000|Overall Study|Death|50|||
128674578|NCT00402740|463106633|FG000|Overall Study|Lost to Follow-up|6|||
128674579|NCT00402740|463106633|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
128674580|NCT00402740|463106633|FG000|Overall Study|Subject disposition unknown.|1|||
128674581|NCT01031836|463108510|FG000|Stage I|Adverse Event|1|||
128674582|NCT01031836|463108511|FG001|Stage I|Adverse Event|1|||
128674583|NCT01031836|463108512|FG002|Stage I|Adverse Event|0|||
128674584|NCT01031836|463108513|FG003|Stage I|Adverse Event|0|||
128674585|NCT01031836|463108514|FG004|Stage I|Adverse Event|0|||
128674586|NCT01031836|463108515|FG005|Stage I|Adverse Event|0|||
128674587|NCT01031836|463108510|FG000|Stage I|Other|0|||
128674588|NCT01031836|463108511|FG001|Stage I|Other|1|||
128674589|NCT01031836|463108512|FG002|Stage I|Other|0|||
128674590|NCT01031836|463108513|FG003|Stage I|Other|0|||
128674591|NCT01031836|463108514|FG004|Stage I|Other|0|||
128674592|NCT01031836|463108515|FG005|Stage I|Other|1|||
128674593|NCT01031836|463108510|FG000|Stage II|Adverse Event|0|||
128674594|NCT01031836|463108511|FG001|Stage II|Adverse Event|0|||
128674595|NCT01031836|463108512|FG002|Stage II|Adverse Event|2|||
128674596|NCT01031836|463108513|FG003|Stage II|Adverse Event|2|||
128674597|NCT01031836|463108514|FG004|Stage II|Adverse Event|1|||
128674598|NCT01031836|463108515|FG005|Stage II|Adverse Event|1|||
128674599|NCT01031836|463108510|FG000|Stage II|Other|2|||
128674600|NCT01031836|463108511|FG001|Stage II|Other|0|||
128674601|NCT01031836|463108512|FG002|Stage II|Other|0|||
128674602|NCT01031836|463108513|FG003|Stage II|Other|1|||
128674603|NCT01031836|463108514|FG004|Stage II|Other|1|||
128674604|NCT01031836|463108515|FG005|Stage II|Other|0|||
128674605|NCT02043899|463108516|FG000|Overall Study|Adverse Event|3|||
128674606|NCT02043899|463108516|FG000|Overall Study|Physician Decision|1|||
128674607|NCT02043899|463108516|FG000|Overall Study|Withdrawal by Subject|2|||
128674608|NCT02043899|463108516|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
128674609|NCT02043899|463108516|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
128674610|NCT02043899|463108516|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
128674611|NCT02043899|463108516|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
128674612|NCT02043899|463108516|FG000|Overall Study|Treatment delayed|1|||
128674613|NCT00843778|463108520|FG000|Overall Study|Adverse Event|15|||
128674614|NCT00843778|463108520|FG000|Overall Study|Lack of Efficacy|14|||
128674615|NCT00843778|463108520|FG000|Overall Study|Loss of efficacy|2|||
128674616|NCT00843778|463108520|FG000|Overall Study|Withdrawal by Subject|4|||
128674617|NCT02184455|463108521|FG000|Overall Study|Lost to Follow-up|1|||
128674618|NCT01347580|463108522|FG000|Overall Study|Withdrawal by Subject|13|||
128674619|NCT01347580|463108523|FG001|Overall Study|Withdrawal by Subject|23|||
128674620|NCT01347580|463108522|FG000|Overall Study|Death|30|||
128674621|NCT01347580|463108523|FG001|Overall Study|Death|19|||
128674622|NCT01347580|463108522|FG000|Overall Study|Protocol Violation|10|||
128674623|NCT01347580|463108523|FG001|Overall Study|Protocol Violation|7|||
128674624|NCT01347580|463108522|FG000|Overall Study|Lost to Follow-up|3|||
128674625|NCT01347580|463108523|FG001|Overall Study|Lost to Follow-up|1|||
128674626|NCT01347580|463108522|FG000|Overall Study|Had other reason|9|||
128674627|NCT01347580|463108523|FG001|Overall Study|Had other reason|6|||
128674628|NCT03005873|463108525|FG000|Overall Study|Prohibited medication use post radnomization|1|||
128674629|NCT03005873|463108526|FG001|Overall Study|Prohibited medication use post radnomization|1|||
128674630|NCT03005873|463108527|FG002|Overall Study|Prohibited medication use post radnomization|1|||
128674631|NCT03005873|463108525|FG000|Overall Study|Withdrew consent|0|||
128674632|NCT03005873|463108526|FG001|Overall Study|Withdrew consent|1|||
128674633|NCT03005873|463108527|FG002|Overall Study|Withdrew consent|2|||
128674634|NCT03005873|463108525|FG000|Overall Study|Lost to Follow-up|0|||
128674635|NCT03005873|463108526|FG001|Overall Study|Lost to Follow-up|1|||
128674636|NCT03005873|463108527|FG002|Overall Study|Lost to Follow-up|0|||
128674637|NCT03005873|463108525|FG000|Overall Study|Ineligible post randomization|0|||
128674638|NCT03005873|463108526|FG001|Overall Study|Ineligible post randomization|0|||
128674639|NCT03005873|463108527|FG002|Overall Study|Ineligible post randomization|1|||
128674640|NCT04140227|463108528|FG000|Overall Study|Withdrawal by Subject|26|||
128674641|NCT04140227|463108528|FG000|Overall Study|Lost to Follow-up|8|||
128674642|NCT04140227|463108528|FG000|Overall Study|Adverse Event|8|||
128674643|NCT04140227|463108528|FG000|Overall Study|Death|1|||
128674644|NCT04140227|463108528|FG000|Overall Study|Other|3|||
128674645|NCT04140227|463108528|FG000|Overall Study|Protocol Violation|2|||
128674646|NCT00538785|463108534|FG000|Overall Study|Death|9|||
128674647|NCT00538785|463108535|FG001|Overall Study|Death|10|||
128674648|NCT00538785|463108534|FG000|Overall Study|Withdrawal of consent|9|||
128674649|NCT00538785|463108535|FG001|Overall Study|Withdrawal of consent|7|||
128674650|NCT00538785|463108534|FG000|Overall Study|Lost to Follow-up|1|||
128674651|NCT00538785|463108535|FG001|Overall Study|Lost to Follow-up|0|||
128674652|NCT01009840|463108536|FG000|Overall Study|Lost to Follow-up|1|||
128674653|NCT01009840|463108536|FG000|Overall Study|Adverse Event|4|||
128674654|NCT01009840|463108536|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
128674655|NCT01009840|463108536|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
128674656|NCT01009840|463108536|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
128674657|NCT03859973|463108537|FG000|Overall Study|Other reason than listed|3|||
128674658|NCT03859973|463108538|FG001|Overall Study|Other reason than listed|2|||
128674659|NCT03859973|463108537|FG000|Overall Study|COVID-19 related, not due to AE|3|||
128674660|NCT03859973|463108538|FG001|Overall Study|COVID-19 related, not due to AE|4|||
128674661|NCT03859973|463108537|FG000|Overall Study|Withdrawal by Subject|8|||
128674662|NCT03859973|463108538|FG001|Overall Study|Withdrawal by Subject|9|||
128674663|NCT03859973|463108537|FG000|Overall Study|Lost to Follow-up|2|||
128674664|NCT03859973|463108538|FG001|Overall Study|Lost to Follow-up|3|||
128674665|NCT03859973|463108537|FG000|Overall Study|Protocol Violation|1|||
128674666|NCT03859973|463108538|FG001|Overall Study|Protocol Violation|3|||
128674667|NCT03859973|463108537|FG000|Overall Study|Adverse Event|3|||
128674668|NCT03859973|463108538|FG001|Overall Study|Adverse Event|5|||
128674669|NCT01478048|463108539|FG000|Overall Study|Disease Progression|52|||
128674670|NCT01478048|463108540|FG001|Overall Study|Disease Progression|35|||
128674671|NCT01478048|463108539|FG000|Overall Study|study drug toxicity|11|||
128674672|NCT01478048|463108540|FG001|Overall Study|study drug toxicity|14|||
128674673|NCT01478048|463108539|FG000|Overall Study|Adverse Event|2|||
128674674|NCT01478048|463108540|FG001|Overall Study|Adverse Event|11|||
128674675|NCT01478048|463108539|FG000|Overall Study|subject request to discontinue treatment|3|||
128674676|NCT01478048|463108540|FG001|Overall Study|subject request to discontinue treatment|5|||
128674677|NCT01478048|463108539|FG000|Overall Study|Withdrawal by Subject|2|||
128674678|NCT01478048|463108540|FG001|Overall Study|Withdrawal by Subject|5|||
128674679|NCT01478048|463108539|FG000|Overall Study|non-specified|6|||
128674680|NCT01478048|463108540|FG001|Overall Study|non-specified|4|||
128674681|NCT01478048|463108539|FG000|Overall Study|poor/non-compliance|0|||
128674682|NCT01478048|463108540|FG001|Overall Study|poor/non-compliance|1|||
128674683|NCT01478048|463108539|FG000|Overall Study|no longer meets study criteria|1|||
128674684|NCT01478048|463108540|FG001|Overall Study|no longer meets study criteria|0|||
128674685|NCT03337490|463108545|FG000|Overall Study|Withdrawal by Subject|1|||
128674686|NCT03337490|463108546|FG001|Overall Study|Withdrawal by Subject|0|||
128674687|NCT03337490|463108547|FG002|Overall Study|Withdrawal by Subject|0|||
128674688|NCT03337490|463108545|FG000|Overall Study|Lack of Efficacy|10|||
128674689|NCT03337490|463108546|FG001|Overall Study|Lack of Efficacy|12|||
128674690|NCT03337490|463108547|FG002|Overall Study|Lack of Efficacy|35|||
128674691|NCT03337490|463108545|FG000|Overall Study|Physician Decision|0|||
128674692|NCT03337490|463108546|FG001|Overall Study|Physician Decision|1|||
128674693|NCT03337490|463108547|FG002|Overall Study|Physician Decision|0|||
128674694|NCT03337490|463108545|FG000|Overall Study|Lost to Follow-up|0|||
128674695|NCT03337490|463108546|FG001|Overall Study|Lost to Follow-up|1|||
128674696|NCT03337490|463108547|FG002|Overall Study|Lost to Follow-up|0|||
128674697|NCT01541397|463108548|FG000|Overall Study|Study ended prior to data collection|4|||
128674698|NCT01541397|463108549|FG001|Overall Study|Study ended prior to data collection|2|||
128674699|NCT01689532|463108550|FG000|Overall Study|Adverse Event|9|||
128674700|NCT01689532|463108551|FG001|Overall Study|Adverse Event|5|||
128674701|NCT01689532|463108550|FG000|Overall Study|Lack of Efficacy|2|||
128674702|NCT01689532|463108551|FG001|Overall Study|Lack of Efficacy|2|||
128674703|NCT01689532|463108550|FG000|Overall Study|Withdrawal by Subject|1|||
128674704|NCT01689532|463108551|FG001|Overall Study|Withdrawal by Subject|2|||
129007387|NCT01296932|464320239|FG002|Overall Study|Adverse Event|1|||
128674705|NCT01689532|463108550|FG000|Overall Study|Physician Decision|2|||
128674706|NCT01689532|463108551|FG001|Overall Study|Physician Decision|0|||
128674707|NCT01363349|463108552|FG000|Overall Study|Adverse Event|6|||
128674708|NCT01363349|463108553|FG001|Overall Study|Adverse Event|7|||
128674709|NCT01363349|463108552|FG000|Overall Study|Lack of Efficacy|3|||
128674710|NCT01363349|463108553|FG001|Overall Study|Lack of Efficacy|10|||
128674711|NCT01363349|463108552|FG000|Overall Study|Non compliance/Protocol deviations|2|||
128674712|NCT01363349|463108553|FG001|Overall Study|Non compliance/Protocol deviations|2|||
128674713|NCT01363349|463108552|FG000|Overall Study|Withdrawal by Subject|14|||
128674714|NCT01363349|463108553|FG001|Overall Study|Withdrawal by Subject|6|||
129007388|NCT01296932|464320240|FG003|Overall Study|Adverse Event|2|||
129007389|NCT01296932|464320241|FG004|Overall Study|Adverse Event|1|||
129007390|NCT01296932|464320242|FG005|Overall Study|Adverse Event|0|||
129007391|NCT01296932|464320243|FG006|Overall Study|Adverse Event|0|||
129007392|NCT01296932|464320244|FG007|Overall Study|Adverse Event|0|||
129007393|NCT01296932|464320245|FG008|Overall Study|Adverse Event|1|||
128674715|NCT01363349|463108552|FG000|Overall Study|Lost to Follow-up|5|||
128674716|NCT01363349|463108553|FG001|Overall Study|Lost to Follow-up|6|||
128674717|NCT01363349|463108552|FG000|Overall Study|Not reported|36|||
128674718|NCT01363349|463108553|FG001|Overall Study|Not reported|37|||
128674719|NCT01363349|463108552|FG000|Overall Study|missing|1|||
128674720|NCT01363349|463108553|FG001|Overall Study|missing|2|||
128674721|NCT01958489|463108554|FG000|Period 2|Adverse Event|0|||
128674722|NCT01958489|463108555|FG001|Period 2|Adverse Event|1|||
128674723|NCT03595618|463108556|FG000|Overall Study|Adverse Event|16|||
128674724|NCT03595618|463108557|FG001|Overall Study|Adverse Event|17|||
128674725|NCT03595618|463108558|FG002|Overall Study|Adverse Event|20|||
128674726|NCT03595618|463108559|FG003|Overall Study|Adverse Event|8|||
128674727|NCT03595618|463108556|FG000|Overall Study|Withdrawal by Subject|12|||
128674728|NCT03595618|463108557|FG001|Overall Study|Withdrawal by Subject|14|||
128674729|NCT03595618|463108558|FG002|Overall Study|Withdrawal by Subject|14|||
128674730|NCT03595618|463108559|FG003|Overall Study|Withdrawal by Subject|10|||
128674731|NCT03595618|463108556|FG000|Overall Study|Lost to Follow-up|6|||
128674732|NCT03595618|463108557|FG001|Overall Study|Lost to Follow-up|4|||
128674733|NCT03595618|463108558|FG002|Overall Study|Lost to Follow-up|5|||
128674734|NCT03595618|463108559|FG003|Overall Study|Lost to Follow-up|6|||
128674735|NCT03595618|463108556|FG000|Overall Study|Protocol Violation|2|||
128674736|NCT03595618|463108557|FG001|Overall Study|Protocol Violation|0|||
128674737|NCT03595618|463108558|FG002|Overall Study|Protocol Violation|6|||
128674738|NCT03595618|463108559|FG003|Overall Study|Protocol Violation|2|||
128674739|NCT03595618|463108556|FG000|Overall Study|Physician Decision|0|||
128674740|NCT03595618|463108557|FG001|Overall Study|Physician Decision|0|||
128674741|NCT03595618|463108558|FG002|Overall Study|Physician Decision|1|||
128674742|NCT03595618|463108559|FG003|Overall Study|Physician Decision|2|||
128674743|NCT03595618|463108556|FG000|Overall Study|Miscellaneous|7|||
128674744|NCT03595618|463108557|FG001|Overall Study|Miscellaneous|5|||
128674745|NCT03595618|463108558|FG002|Overall Study|Miscellaneous|10|||
128674746|NCT03595618|463108559|FG003|Overall Study|Miscellaneous|6|||
128674747|NCT02338232|463108560|FG000|Overall Study|Screen Failure|3|||
128674748|NCT02338232|463108560|FG000|Overall Study|Withdrawal by Subject|6|||
128674749|NCT02338232|463108560|FG000|Overall Study|Adverse Event|2|||
128674750|NCT02279407|463108561|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
128674751|NCT02279407|463108562|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
128674752|NCT02279407|463108563|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
128674753|NCT02279407|463108564|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
128674754|NCT02279407|463108561|FG000|Overall Study|Withdrawal by Subject|1|||
128674755|NCT02279407|463108562|FG001|Overall Study|Withdrawal by Subject|0|||
128674756|NCT02279407|463108563|FG002|Overall Study|Withdrawal by Subject|1|||
128674757|NCT02279407|463108564|FG003|Overall Study|Withdrawal by Subject|1|||
128674758|NCT02279407|463108561|FG000|Overall Study|Adverse Event|1|||
128674759|NCT02279407|463108562|FG001|Overall Study|Adverse Event|1|||
128674760|NCT02279407|463108563|FG002|Overall Study|Adverse Event|2|||
128674761|NCT02279407|463108564|FG003|Overall Study|Adverse Event|0|||
128674762|NCT02500056|463108565|FG000|Overall Study|Lost to Follow-up|3|||
128674763|NCT02500056|463108566|FG001|Overall Study|Lost to Follow-up|7|||
128674764|NCT02500056|463108565|FG000|Overall Study|Recurrence|1|||
128674765|NCT02500056|463108566|FG001|Overall Study|Recurrence|0|||
128674766|NCT02500056|463108565|FG000|Overall Study|Death|3|||
128674767|NCT02500056|463108566|FG001|Overall Study|Death|1|||
128674768|NCT00864916|463108567|FG000|Overall Study|Lost to Follow-up|4|||
128674769|NCT00864916|463108568|FG001|Overall Study|Lost to Follow-up|4|||
128674770|NCT00864916|463108567|FG000|Overall Study|Protocol Violation|1|||
128674771|NCT00864916|463108568|FG001|Overall Study|Protocol Violation|0|||
128674772|NCT00864916|463108567|FG000|Overall Study|Withdrawal by Subject|1|||
128674773|NCT00864916|463108568|FG001|Overall Study|Withdrawal by Subject|0|||
128674774|NCT03996369|463108572|FG000|Overall Study|Protocol deviation|1|||
129007394|NCT01296932|464320237|FG000|Overall Study|Investigator decision|0|||
128674775|NCT03996369|463108573|FG001|Overall Study|Protocol deviation|1|||
128674776|NCT03996369|463108572|FG000|Overall Study|Physician Decision|4|||
128674777|NCT03996369|463108573|FG001|Overall Study|Physician Decision|2|||
128674778|NCT03996369|463108572|FG000|Overall Study|Participant decision|0|||
128674779|NCT03996369|463108573|FG001|Overall Study|Participant decision|1|||
129007395|NCT01296932|464320238|FG001|Overall Study|Investigator decision|1|||
129215078|NCT02760498|465089437|FG001|Overall Study|Disease progression|19|||
128674780|NCT03996369|463108572|FG000|Overall Study|Lack of Efficacy|4|||
128674781|NCT03996369|463108573|FG001|Overall Study|Lack of Efficacy|0|||
128674782|NCT03996369|463108572|FG000|Overall Study|Adverse Event|9|||
128674783|NCT03996369|463108573|FG001|Overall Study|Adverse Event|0|||
128674784|NCT03996369|463108572|FG000|Overall Study|Withdrawal by Subject|6|||
128674785|NCT03996369|463108573|FG001|Overall Study|Withdrawal by Subject|8|||
128674786|NCT03996369|463108572|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
128674787|NCT03996369|463108573|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
128674788|NCT03996369|463108572|FG000|Overall Study|Lost to Follow-up|0|||
128674789|NCT03996369|463108573|FG001|Overall Study|Lost to Follow-up|1|||
128674790|NCT02238067|463108577|FG000|Overall Study|Not completed survey at Month 6|45|||
128674791|NCT00869778|463108578|FG000|Overall Study|Adverse Event|2|||
128674792|NCT00869778|463108579|FG001|Overall Study|Adverse Event|0|||
128674793|NCT00869778|463108580|FG002|Overall Study|Adverse Event|0|||
128674794|NCT00869778|463108578|FG000|Overall Study|Withdrawal by Subject|3|||
128674795|NCT00869778|463108579|FG001|Overall Study|Withdrawal by Subject|4|||
128674796|NCT00869778|463108580|FG002|Overall Study|Withdrawal by Subject|5|||
128674797|NCT00869778|463108578|FG000|Overall Study|Pregnancy|1|||
128674798|NCT00869778|463108579|FG001|Overall Study|Pregnancy|0|||
128674799|NCT00869778|463108580|FG002|Overall Study|Pregnancy|0|||
128674800|NCT00869778|463108578|FG000|Overall Study|Protocol Violation|5|||
128674801|NCT00869778|463108579|FG001|Overall Study|Protocol Violation|3|||
128674802|NCT00869778|463108580|FG002|Overall Study|Protocol Violation|5|||
128674803|NCT00869778|463108578|FG000|Overall Study|Unblinding|1|||
128674804|NCT00869778|463108579|FG001|Overall Study|Unblinding|0|||
128674805|NCT00869778|463108580|FG002|Overall Study|Unblinding|0|||
128674806|NCT02184572|463108586|FG000|Overall Study|Lost to Follow-up|29|||
128674807|NCT02184572|463108587|FG001|Overall Study|Lost to Follow-up|21|||
128674808|NCT02184572|463108586|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
128674809|NCT02184572|463108587|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
128674810|NCT02184572|463108586|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
128674811|NCT02184572|463108587|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
128674812|NCT02184572|463108586|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
128674813|NCT02184572|463108587|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
128674814|NCT02184572|463108586|FG000|Overall Study|Traveling Outside The Country|1|||
128674815|NCT02184572|463108587|FG001|Overall Study|Traveling Outside The Country|0|||
128674816|NCT02184572|463108586|FG000|Overall Study|Withdrawal by Subject|14|||
128674817|NCT02184572|463108587|FG001|Overall Study|Withdrawal by Subject|9|||
128674818|NCT03726996|463108588|FG000|Overall Study|Parent's decision|2|||
129007396|NCT01296932|464320239|FG002|Overall Study|Investigator decision|0|||
129007397|NCT01296932|464320240|FG003|Overall Study|Investigator decision|1|||
129007398|NCT01296932|464320241|FG004|Overall Study|Investigator decision|0|||
129007399|NCT01296932|464320242|FG005|Overall Study|Investigator decision|0|||
129007400|NCT01296932|464320243|FG006|Overall Study|Investigator decision|1|||
129007401|NCT01296932|464320244|FG007|Overall Study|Investigator decision|0|||
129007402|NCT01296932|464320245|FG008|Overall Study|Investigator decision|1|||
129007403|NCT01296932|464320237|FG000|Overall Study|No clinical benefit anymore|0|||
129007404|NCT01296932|464320238|FG001|Overall Study|No clinical benefit anymore|1|||
129007405|NCT01296932|464320239|FG002|Overall Study|No clinical benefit anymore|0|||
129007406|NCT01296932|464320240|FG003|Overall Study|No clinical benefit anymore|0|||
129007407|NCT01296932|464320241|FG004|Overall Study|No clinical benefit anymore|0|||
129007408|NCT01296932|464320242|FG005|Overall Study|No clinical benefit anymore|0|||
129007409|NCT01296932|464320243|FG006|Overall Study|No clinical benefit anymore|0|||
129007410|NCT01296932|464320244|FG007|Overall Study|No clinical benefit anymore|0|||
129007411|NCT01296932|464320245|FG008|Overall Study|No clinical benefit anymore|0|||
129007412|NCT01296932|464320237|FG000|Overall Study|Physician Decision|0|||
129007413|NCT01296932|464320238|FG001|Overall Study|Physician Decision|0|||
129007414|NCT01296932|464320239|FG002|Overall Study|Physician Decision|1|||
129007415|NCT01296932|464320240|FG003|Overall Study|Physician Decision|0|||
129007416|NCT01296932|464320241|FG004|Overall Study|Physician Decision|0|||
129007417|NCT01296932|464320242|FG005|Overall Study|Physician Decision|0|||
129007418|NCT01296932|464320243|FG006|Overall Study|Physician Decision|0|||
129007419|NCT01296932|464320244|FG007|Overall Study|Physician Decision|0|||
129007420|NCT01296932|464320245|FG008|Overall Study|Physician Decision|0|||
129007421|NCT01296932|464320237|FG000|Overall Study|IV problems, administration not possible|0|||
129007422|NCT01296932|464320238|FG001|Overall Study|IV problems, administration not possible|0|||
129007423|NCT01296932|464320239|FG002|Overall Study|IV problems, administration not possible|1|||
128674819|NCT03726996|463108588|FG000|Overall Study|Study early termination|2|||
128674820|NCT03148691|463108589|FG000|Overall Study|Protocol Violation|1|||
128674821|NCT03148691|463108590|FG001|Overall Study|Protocol Violation|2|||
128674822|NCT03148691|463108591|FG002|Overall Study|Protocol Violation|7|||
129007424|NCT01296932|464320240|FG003|Overall Study|IV problems, administration not possible|0|||
129007425|NCT01296932|464320241|FG004|Overall Study|IV problems, administration not possible|0|||
129007426|NCT01296932|464320242|FG005|Overall Study|IV problems, administration not possible|0|||
129007427|NCT01296932|464320243|FG006|Overall Study|IV problems, administration not possible|0|||
129007428|NCT01296932|464320244|FG007|Overall Study|IV problems, administration not possible|0|||
129007429|NCT01296932|464320245|FG008|Overall Study|IV problems, administration not possible|0|||
129007430|NCT01296932|464320237|FG000|Overall Study|per protocol|0|||
129007431|NCT01296932|464320238|FG001|Overall Study|per protocol|0|||
129007432|NCT01296932|464320239|FG002|Overall Study|per protocol|1|||
129007433|NCT01296932|464320240|FG003|Overall Study|per protocol|1|||
129007434|NCT01296932|464320241|FG004|Overall Study|per protocol|0|||
129007435|NCT01296932|464320242|FG005|Overall Study|per protocol|0|||
129007436|NCT01296932|464320243|FG006|Overall Study|per protocol|0|||
129007437|NCT01296932|464320244|FG007|Overall Study|per protocol|0|||
129007438|NCT01296932|464320245|FG008|Overall Study|per protocol|0|||
129007439|NCT01296932|464320237|FG000|Overall Study|Low benefit and too many side effects|0|||
129007440|NCT01296932|464320238|FG001|Overall Study|Low benefit and too many side effects|0|||
129007441|NCT01296932|464320239|FG002|Overall Study|Low benefit and too many side effects|0|||
129007442|NCT01296932|464320240|FG003|Overall Study|Low benefit and too many side effects|0|||
129007443|NCT01296932|464320241|FG004|Overall Study|Low benefit and too many side effects|0|||
129007444|NCT01296932|464320242|FG005|Overall Study|Low benefit and too many side effects|0|||
129007445|NCT01296932|464320243|FG006|Overall Study|Low benefit and too many side effects|0|||
129007446|NCT01296932|464320244|FG007|Overall Study|Low benefit and too many side effects|1|||
129007447|NCT01296932|464320245|FG008|Overall Study|Low benefit and too many side effects|0|||
129007448|NCT01296932|464320237|FG000|Overall Study|No adequate treatment response|0|||
129007449|NCT01296932|464320238|FG001|Overall Study|No adequate treatment response|0|||
129007450|NCT01296932|464320239|FG002|Overall Study|No adequate treatment response|0|||
129007451|NCT01296932|464320240|FG003|Overall Study|No adequate treatment response|0|||
129007452|NCT01296932|464320241|FG004|Overall Study|No adequate treatment response|0|||
129007453|NCT01296932|464320242|FG005|Overall Study|No adequate treatment response|0|||
129007454|NCT01296932|464320243|FG006|Overall Study|No adequate treatment response|0|||
129007455|NCT01296932|464320244|FG007|Overall Study|No adequate treatment response|1|||
129007456|NCT01296932|464320245|FG008|Overall Study|No adequate treatment response|0|||
129007457|NCT01296932|464320237|FG000|Overall Study|Dosage already reduced, AE still present|0|||
129007458|NCT01296932|464320238|FG001|Overall Study|Dosage already reduced, AE still present|0|||
129007459|NCT01296932|464320239|FG002|Overall Study|Dosage already reduced, AE still present|0|||
129007460|NCT01296932|464320240|FG003|Overall Study|Dosage already reduced, AE still present|0|||
129007461|NCT01296932|464320241|FG004|Overall Study|Dosage already reduced, AE still present|0|||
129007462|NCT01296932|464320242|FG005|Overall Study|Dosage already reduced, AE still present|0|||
129007463|NCT01296932|464320243|FG006|Overall Study|Dosage already reduced, AE still present|0|||
129007464|NCT01296932|464320244|FG007|Overall Study|Dosage already reduced, AE still present|0|||
129007465|NCT01296932|464320245|FG008|Overall Study|Dosage already reduced, AE still present|1|||
129007466|NCT02352337|464320246|FG000|Overall Study|Patients never treated|4|||
129007467|NCT02352337|464320247|FG001|Overall Study|Patients never treated|1|||
129007468|NCT02352337|464320248|FG002|Overall Study|Patients never treated|2|||
129007469|NCT01829464|464320249|FG000|Overall Study|Adverse Event|1|||
129007470|NCT01829464|464320250|FG001|Overall Study|Adverse Event|0|||
129007471|NCT01829464|464320251|FG002|Overall Study|Adverse Event|0|||
129007472|NCT01829464|464320249|FG000|Overall Study|Lost to Follow-up|0|||
129007473|NCT01829464|464320250|FG001|Overall Study|Lost to Follow-up|0|||
129007474|NCT01829464|464320251|FG002|Overall Study|Lost to Follow-up|1|||
129007475|NCT01829464|464320249|FG000|Overall Study|Withdrawal by Subject|2|||
129007476|NCT01829464|464320250|FG001|Overall Study|Withdrawal by Subject|0|||
129007477|NCT01829464|464320251|FG002|Overall Study|Withdrawal by Subject|0|||
129007478|NCT01829464|464320249|FG000|Overall Study|Study terminated by sponsor|25|||
129007479|NCT01829464|464320250|FG001|Overall Study|Study terminated by sponsor|28|||
129007480|NCT01829464|464320251|FG002|Overall Study|Study terminated by sponsor|25|||
129007481|NCT01829464|464320249|FG000|Overall Study|Lack of Efficacy|0|||
129007482|NCT01829464|464320250|FG001|Overall Study|Lack of Efficacy|1|||
129007483|NCT01829464|464320251|FG002|Overall Study|Lack of Efficacy|0|||
129007484|NCT02336737|464320258|FG000|Overall Study|Withdrawal by Subject|5|||
129007485|NCT02336737|464320258|FG000|Overall Study|Physician Decision|8|||
129007486|NCT02396381|464320259|FG000|Overall Study|Adverse Event|3|||
129007487|NCT02396381|464320260|FG001|Overall Study|Adverse Event|2|||
129007488|NCT02396381|464320259|FG000|Overall Study|Withdrawal by Subject|33|||
129007489|NCT02396381|464320260|FG001|Overall Study|Withdrawal by Subject|24|||
129007490|NCT02396381|464320259|FG000|Overall Study|Lost to Follow-up|49|||
129007491|NCT02396381|464320260|FG001|Overall Study|Lost to Follow-up|31|||
129007492|NCT02396381|464320259|FG000|Overall Study|Protocol Violation|1|||
129007493|NCT02396381|464320260|FG001|Overall Study|Protocol Violation|0|||
129007494|NCT02396381|464320259|FG000|Overall Study|Site terminated by sponsor|7|||
129007495|NCT02396381|464320260|FG001|Overall Study|Site terminated by sponsor|8|||
129007496|NCT02396381|464320259|FG000|Overall Study|Physician Decision|5|||
129007497|NCT02396381|464320260|FG001|Overall Study|Physician Decision|5|||
129007498|NCT02396381|464320259|FG000|Overall Study|Pregnancy|2|||
129007499|NCT02396381|464320260|FG001|Overall Study|Pregnancy|0|||
129007500|NCT02396381|464320259|FG000|Overall Study|Non-compliance with study procedures|1|||
129007501|NCT02396381|464320260|FG001|Overall Study|Non-compliance with study procedures|0|||
129007502|NCT02396381|464320259|FG000|Overall Study|Moved out of town/state|1|||
129007503|NCT02396381|464320260|FG001|Overall Study|Moved out of town/state|3|||
129007504|NCT02396381|464320259|FG000|Overall Study|Could not complete visit|1|||
129007505|NCT02396381|464320260|FG001|Overall Study|Could not complete visit|0|||
129007506|NCT02396381|464320259|FG000|Overall Study|Possible conflict of interest|1|||
129007507|NCT02396381|464320260|FG001|Overall Study|Possible conflict of interest|0|||
129007508|NCT02396381|464320259|FG000|Overall Study|Randomization/Screening Error|3|||
129007509|NCT02396381|464320260|FG001|Overall Study|Randomization/Screening Error|1|||
129007510|NCT00356200|464320261|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
129007511|NCT00356200|464320262|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
129007512|NCT00356200|464320261|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
129007513|NCT00356200|464320262|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
129007514|NCT00635778|464320263|FG000|Overall Study|Adverse Event|1|||
129007515|NCT00635778|464320264|FG001|Overall Study|Adverse Event|0|||
129007516|NCT00635778|464320265|FG002|Overall Study|Adverse Event|0|||
129007517|NCT00635778|464320266|FG003|Overall Study|Adverse Event|3|||
129007518|NCT00635778|464320267|FG004|Overall Study|Adverse Event|3|||
129007519|NCT00635778|464320268|FG005|Overall Study|Adverse Event|6|||
129007520|NCT00635778|464320269|FG006|Overall Study|Adverse Event|1|||
129007521|NCT00635778|464320263|FG000|Overall Study|Withdrawal by Subject|0|||
129007522|NCT00635778|464320264|FG001|Overall Study|Withdrawal by Subject|0|||
129007523|NCT00635778|464320265|FG002|Overall Study|Withdrawal by Subject|0|||
129007524|NCT00635778|464320266|FG003|Overall Study|Withdrawal by Subject|1|||
129007525|NCT00635778|464320267|FG004|Overall Study|Withdrawal by Subject|0|||
129007526|NCT00635778|464320268|FG005|Overall Study|Withdrawal by Subject|1|||
129007527|NCT00635778|464320269|FG006|Overall Study|Withdrawal by Subject|1|||
129007528|NCT00635778|464320263|FG000|Overall Study|Progressive disease|0|||
129007529|NCT00635778|464320264|FG001|Overall Study|Progressive disease|3|||
129007530|NCT00635778|464320265|FG002|Overall Study|Progressive disease|3|||
129007531|NCT00635778|464320266|FG003|Overall Study|Progressive disease|4|||
129007532|NCT00635778|464320267|FG004|Overall Study|Progressive disease|5|||
129007533|NCT00635778|464320268|FG005|Overall Study|Progressive disease|14|||
129007534|NCT00635778|464320269|FG006|Overall Study|Progressive disease|4|||
129007535|NCT01884025|464320270|FG000|Overall Study|Lost to Follow-up|3|||
129007536|NCT01884025|464320271|FG001|Overall Study|Lost to Follow-up|4|||
129007537|NCT02324465|464320272|FG000|Overall Study|device failure|0|||
129007538|NCT02324465|464320273|FG001|Overall Study|device failure|1|||
129007539|NCT02655237|464320276|FG000|Overall Study|Adverse Event|10|||
129007540|NCT02655237|464320277|FG001|Overall Study|Adverse Event|7|||
129007541|NCT02655237|464320276|FG000|Overall Study|Protocol Deviation|2|||
129007542|NCT02655237|464320277|FG001|Overall Study|Protocol Deviation|0|||
129007543|NCT02655237|464320276|FG000|Overall Study|Withdrawal by Participant|1|||
129007544|NCT02655237|464320277|FG001|Overall Study|Withdrawal by Participant|2|||
129007545|NCT02655237|464320276|FG000|Overall Study|Lack of Efficacy|0|||
129007546|NCT02655237|464320277|FG001|Overall Study|Lack of Efficacy|1|||
129007547|NCT02655237|464320276|FG000|Overall Study|Recovery Leading to Surgery|2|||
129007548|NCT02655237|464320277|FG001|Overall Study|Recovery Leading to Surgery|1|||
129007549|NCT02655237|464320276|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
129007550|NCT02655237|464320277|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
129007551|NCT02655237|464320276|FG000|Overall Study|Randomized but Not Treated|1|||
129007552|NCT02655237|464320277|FG001|Overall Study|Randomized but Not Treated|0|||
129007553|NCT02132247|464320278|FG000|Overall Study|Protocol Violation|1|||
129007554|NCT02132247|464320279|FG001|Overall Study|Protocol Violation|0|||
129007555|NCT03679741|464320282|FG000|Period 1|No longer meet eligibility criteria|1|||
129007556|NCT03679741|464320283|FG001|Period 1|No longer meet eligibility criteria|0|||
129007557|NCT03679741|464320282|FG000|Period 1|Lost to Follow-up|0|||
129007558|NCT03679741|464320283|FG001|Period 1|Lost to Follow-up|1|||
129007559|NCT03679741|464320282|FG000|Period 1|Adverse Event|1|||
129007560|NCT03679741|464320283|FG001|Period 1|Adverse Event|1|||
129007561|NCT03679741|464320282|FG000|Period 1|Withdrawal by Subject|0|||
129007562|NCT03679741|464320283|FG001|Period 1|Withdrawal by Subject|1|||
129007563|NCT03679741|464320282|FG000|Period 2|Adverse Event|2|||
129007564|NCT03679741|464320283|FG001|Period 2|Adverse Event|1|||
129007565|NCT03679741|464320282|FG000|Period 2|Withdrawal by Subject|1|||
129007566|NCT03679741|464320283|FG001|Period 2|Withdrawal by Subject|1|||
129007567|NCT01860976|464320285|FG000|Blinded Treatment|Adverse Event|1|||
129007568|NCT01860976|464320286|FG001|Blinded Treatment|Adverse Event|3|||
129007569|NCT01860976|464320285|FG000|Blinded Treatment|Lack of Efficacy|5|||
129007570|NCT01860976|464320286|FG001|Blinded Treatment|Lack of Efficacy|12|||
129007571|NCT01860976|464320285|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
129007572|NCT01860976|464320286|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
129007573|NCT01860976|464320285|FG000|Blinded Treatment|Withdrawal by Subject|3|||
129007574|NCT01860976|464320286|FG001|Blinded Treatment|Withdrawal by Subject|5|||
129007575|NCT01860976|464320285|FG000|Blinded Treatment|Subject no longer met criteria|1|||
128674823|NCT03148691|463108589|FG000|Overall Study|Lost to Follow-up|0|||
129007576|NCT01860976|464320286|FG001|Blinded Treatment|Subject no longer met criteria|0|||
129007577|NCT01860976|464320285|FG000|Blinded Treatment|Entered Open-Label in error|0|||
129007578|NCT01860976|464320286|FG001|Blinded Treatment|Entered Open-Label in error|1|||
129007579|NCT01860976|464320285|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
129007580|NCT01860976|464320286|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
129007581|NCT01860976|464320285|FG000|Open-Label|Adverse Event|2|||
129007582|NCT01860976|464320286|FG001|Open-Label|Adverse Event|4|||
129007583|NCT01860976|464320285|FG000|Open-Label|Lack of Efficacy|16|||
129007584|NCT01860976|464320286|FG001|Open-Label|Lack of Efficacy|8|||
129007585|NCT01860976|464320285|FG000|Open-Label|Lost to Follow-up|1|||
129007586|NCT01860976|464320286|FG001|Open-Label|Lost to Follow-up|2|||
129007587|NCT01860976|464320285|FG000|Open-Label|Subject request discontinue treatment|4|||
129007588|NCT01860976|464320286|FG001|Open-Label|Subject request discontinue treatment|3|||
129007589|NCT01860976|464320285|FG000|Open-Label|Withdrawal by Subject|4|||
129007590|NCT01860976|464320286|FG001|Open-Label|Withdrawal by Subject|1|||
129007591|NCT01860976|464320285|FG000|Open-Label|Other Reasons|1|||
129007592|NCT01860976|464320286|FG001|Open-Label|Other Reasons|1|||
129007593|NCT01860976|464320285|FG000|Long Term Extension|Adverse Event|4|||
129007594|NCT01860976|464320286|FG001|Long Term Extension|Adverse Event|0|||
129007595|NCT01860976|464320285|FG000|Long Term Extension|Lack of Efficacy|2|||
129007596|NCT01860976|464320286|FG001|Long Term Extension|Lack of Efficacy|0|||
129007597|NCT01860976|464320285|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
129007598|NCT01860976|464320286|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
129007599|NCT01860976|464320285|FG000|Long Term Extension|Lost to Follow-up|2|||
129007600|NCT01860976|464320286|FG001|Long Term Extension|Lost to Follow-up|0|||
129007601|NCT01860976|464320285|FG000|Long Term Extension|subject withdrew consent|7|||
129007602|NCT01860976|464320286|FG001|Long Term Extension|subject withdrew consent|0|||
129007603|NCT02227862|464320287|FG000|Overall Study|Protocol Violation|7|||
129007604|NCT02227862|464320288|FG001|Overall Study|Protocol Violation|9|||
129007605|NCT02227862|464320287|FG000|Overall Study|Other|0|||
129007606|NCT02227862|464320288|FG001|Overall Study|Other|2|||
129007607|NCT02227862|464320287|FG000|Overall Study|Adverse Event|4|||
129007608|NCT02227862|464320288|FG001|Overall Study|Adverse Event|3|||
129007609|NCT02227862|464320287|FG000|Overall Study|Withdrawal by Subject|7|||
129007610|NCT02227862|464320288|FG001|Overall Study|Withdrawal by Subject|6|||
129007611|NCT02227862|464320287|FG000|Overall Study|Lost to Follow-up|1|||
129007612|NCT02227862|464320288|FG001|Overall Study|Lost to Follow-up|2|||
129007613|NCT02354586|464320294|FG000|Overall Study|Death|230|||
129007614|NCT02354586|464320294|FG000|Overall Study|Withdrawal by Subject|59|||
129007615|NCT02354586|464320294|FG000|Overall Study|Lost to Follow-up|11|||
129007616|NCT02354586|464320294|FG000|Overall Study|Sponsor decision|51|||
129007617|NCT02354586|464320294|FG000|Overall Study|Site closure|2|||
129007618|NCT02354586|464320294|FG000|Overall Study|Intercurrent illness|1|||
129007619|NCT02354586|464320294|FG000|Overall Study|Protocol Violation|3|||
129007620|NCT02354586|464320294|FG000|Overall Study|Physician Decision|13|||
129007621|NCT02354586|464320294|FG000|Overall Study|Lack of Efficacy|86|||
129007622|NCT02354586|464320294|FG000|Overall Study|Adverse Event|7|||
129007623|NCT00634907|464320296|FG000|Overall Study|Withdrawal by Subject|3|||
129007624|NCT00634907|464320297|FG001|Overall Study|Withdrawal by Subject|0|||
129007625|NCT00634907|464320296|FG000|Overall Study|Physician Decision|3|||
129007626|NCT00634907|464320297|FG001|Overall Study|Physician Decision|9|||
129007627|NCT00634907|464320296|FG000|Overall Study|Withdrawal by Subject|11|||
129007628|NCT00634907|464320297|FG001|Overall Study|Withdrawal by Subject|8|||
129007629|NCT02419313|464320304|FG000|First Intervention|Lost to Follow-up|2|||
129007630|NCT02419313|464320305|FG001|First Intervention|Lost to Follow-up|0|||
129007631|NCT02419313|464320304|FG000|Second Intervention|Lost to Follow-up|1|||
129007632|NCT02419313|464320305|FG001|Second Intervention|Lost to Follow-up|0|||
129007633|NCT02204371|464320306|FG000|Overall Study|Adverse Event|1|||
129007634|NCT00620763|464320309|FG000|Period: First Intervention|Withdrawal by Subject|0|||
129007635|NCT00620763|464320310|FG001|Period: First Intervention|Withdrawal by Subject|2|||
129007636|NCT00620763|464320309|FG000|Period: First Intervention|Protocol Violation|0|||
129007637|NCT00620763|464320310|FG001|Period: First Intervention|Protocol Violation|3|||
129007638|NCT00620763|464320309|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
129007639|NCT00620763|464320310|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
129007640|NCT00368966|464320314|FG000|Infant Series|Withdrawal by Subject|11|||
129007641|NCT00368966|464320315|FG001|Infant Series|Withdrawal by Subject|6|||
129007642|NCT00368966|464320314|FG000|Infant Series|Protocol Violation|2|||
129007643|NCT00368966|464320315|FG001|Infant Series|Protocol Violation|1|||
129007644|NCT00368966|464320314|FG000|Infant Series|Lost to Follow-up|2|||
129007645|NCT00368966|464320315|FG001|Infant Series|Lost to Follow-up|0|||
129007646|NCT00368966|464320314|FG000|Infant Series|Randomization error|0|||
129007647|NCT00368966|464320315|FG001|Infant Series|Randomization error|1|||
129007648|NCT00368966|464320314|FG000|Infant Series|Failed to meet eligibility criteria|0|||
129007649|NCT00368966|464320315|FG001|Infant Series|Failed to meet eligibility criteria|1|||
129007650|NCT00368966|464320314|FG000|Infant Series|Adverse Event|0|||
129007651|NCT00368966|464320315|FG001|Infant Series|Adverse Event|1|||
129007652|NCT00368966|464320314|FG000|Infant Series|Failed to return|1|||
129007653|NCT00368966|464320315|FG001|Infant Series|Failed to return|0|||
129007654|NCT00368966|464320314|FG000|After Infant|Failed to return|3|||
129007655|NCT00368966|464320315|FG001|After Infant|Failed to return|1|||
129007656|NCT00368966|464320314|FG000|After Infant|Adverse Event|1|||
129007657|NCT00368966|464320315|FG001|After Infant|Adverse Event|2|||
129007658|NCT00368966|464320314|FG000|After Infant|Withdrawal by Subject|1|||
129007659|NCT00368966|464320315|FG001|After Infant|Withdrawal by Subject|1|||
129007660|NCT00368966|464320314|FG000|After Infant|Death|1|||
129007661|NCT00368966|464320315|FG001|After Infant|Death|0|||
129007662|NCT00368966|464320314|FG000|After Infant|Lost to Follow-up|0|||
129007663|NCT00368966|464320315|FG001|After Infant|Lost to Follow-up|1|||
129007664|NCT00368966|464320314|FG000|Toddler Dose|Withdrawal by Subject|1|||
129007665|NCT00368966|464320315|FG001|Toddler Dose|Withdrawal by Subject|1|||
129007666|NCT00368966|464320314|FG000|Toddler Dose|Lost to Follow-up|0|||
129007667|NCT00368966|464320315|FG001|Toddler Dose|Lost to Follow-up|2|||
129007668|NCT02866175|464320316|FG000|Overall Study|Adverse Event|56|||
129007669|NCT02866175|464320317|FG001|Overall Study|Adverse Event|54|||
129007670|NCT02866175|464320316|FG000|Overall Study|Withdrawal by Subject|31|||
129007671|NCT02866175|464320317|FG001|Overall Study|Withdrawal by Subject|52|||
129007672|NCT02866175|464320316|FG000|Overall Study|Death|30|||
129007673|NCT02866175|464320317|FG001|Overall Study|Death|23|||
129007674|NCT02866175|464320316|FG000|Overall Study|Other|7|||
129007675|NCT02866175|464320317|FG001|Overall Study|Other|14|||
129007676|NCT02866175|464320316|FG000|Overall Study|Progressive disease|1|||
129007677|NCT02866175|464320317|FG001|Overall Study|Progressive disease|1|||
129007678|NCT02866175|464320316|FG000|Overall Study|Lost to Follow-up|2|||
129007679|NCT02866175|464320317|FG001|Overall Study|Lost to Follow-up|0|||
129007680|NCT02866175|464320316|FG000|Overall Study|Lack of Efficacy|0|||
129007681|NCT02866175|464320317|FG001|Overall Study|Lack of Efficacy|1|||
129007682|NCT02866175|464320316|FG000|Overall Study|Physician Decision|3|||
129007683|NCT02866175|464320317|FG001|Overall Study|Physician Decision|15|||
129007684|NCT02866175|464320316|FG000|Overall Study|Did not receive treatment|5|||
129007685|NCT02866175|464320317|FG001|Overall Study|Did not receive treatment|15|||
129007686|NCT01694485|464320318|FG000|Overall Study|Withdrawal by Subject|20|||
129007687|NCT01694485|464320319|FG001|Overall Study|Withdrawal by Subject|6|||
129007688|NCT01694485|464320320|FG002|Overall Study|Withdrawal by Subject|7|||
129007689|NCT01694485|464320321|FG003|Overall Study|Withdrawal by Subject|25|||
129007690|NCT01694485|464320322|FG004|Overall Study|Withdrawal by Subject|18|||
129007691|NCT01694485|464320318|FG000|Overall Study|Sponsor Decision|3|||
129007692|NCT01694485|464320319|FG001|Overall Study|Sponsor Decision|0|||
129007693|NCT01694485|464320320|FG002|Overall Study|Sponsor Decision|0|||
129007694|NCT01694485|464320321|FG003|Overall Study|Sponsor Decision|2|||
129007695|NCT01694485|464320322|FG004|Overall Study|Sponsor Decision|0|||
129007696|NCT01694485|464320318|FG000|Overall Study|Lost to Follow-up|9|||
129007697|NCT01694485|464320319|FG001|Overall Study|Lost to Follow-up|1|||
129007698|NCT01694485|464320320|FG002|Overall Study|Lost to Follow-up|6|||
129007699|NCT01694485|464320321|FG003|Overall Study|Lost to Follow-up|10|||
129007700|NCT01694485|464320322|FG004|Overall Study|Lost to Follow-up|7|||
129007701|NCT01694485|464320318|FG000|Overall Study|Death|1|||
129007702|NCT01694485|464320319|FG001|Overall Study|Death|0|||
129007703|NCT01694485|464320320|FG002|Overall Study|Death|0|||
129007704|NCT01694485|464320321|FG003|Overall Study|Death|1|||
129007705|NCT01694485|464320322|FG004|Overall Study|Death|0|||
129007706|NCT01595009|464320323|FG000|Core|Patients completed per protocol|85|||
129007707|NCT01595009|464320324|FG001|Core|Patients completed per protocol|44|||
129007708|NCT01595009|464320325|FG002|Core|Patients completed per protocol|0|||
129007709|NCT01595009|464320326|FG003|Core|Patients completed per protocol|0|||
129007710|NCT01595009|464320323|FG000|Core|Adverse Event|19|||
129007711|NCT01595009|464320324|FG001|Core|Adverse Event|23|||
129007712|NCT01595009|464320325|FG002|Core|Adverse Event|0|||
129007713|NCT01595009|464320326|FG003|Core|Adverse Event|0|||
129007714|NCT01595009|464320323|FG000|Core|Disease progression|14|||
129007715|NCT01595009|464320324|FG001|Core|Disease progression|26|||
129007716|NCT01595009|464320325|FG002|Core|Disease progression|0|||
129007717|NCT01595009|464320326|FG003|Core|Disease progression|0|||
129007718|NCT01595009|464320323|FG000|Core|Withdrawal by Subject|4|||
129007719|NCT01595009|464320324|FG001|Core|Withdrawal by Subject|17|||
129007720|NCT01595009|464320325|FG002|Core|Withdrawal by Subject|0|||
129007721|NCT01595009|464320326|FG003|Core|Withdrawal by Subject|0|||
129007722|NCT01595009|464320323|FG000|Core|Death|3|||
129007723|NCT01595009|464320324|FG001|Core|Death|6|||
129007724|NCT01595009|464320325|FG002|Core|Death|0|||
129007725|NCT01595009|464320326|FG003|Core|Death|0|||
129007726|NCT01595009|464320323|FG000|Core|Lost to Follow-up|1|||
129007727|NCT01595009|464320324|FG001|Core|Lost to Follow-up|2|||
128674824|NCT03148691|463108590|FG001|Overall Study|Lost to Follow-up|0|||
129007728|NCT01595009|464320325|FG002|Core|Lost to Follow-up|0|||
129007729|NCT01595009|464320326|FG003|Core|Lost to Follow-up|0|||
129007730|NCT01595009|464320323|FG000|Core|Protocol deviation|0|||
129007731|NCT01595009|464320324|FG001|Core|Protocol deviation|1|||
129007732|NCT01595009|464320325|FG002|Core|Protocol deviation|0|||
129007733|NCT01595009|464320326|FG003|Core|Protocol deviation|0|||
129007734|NCT01595009|464320323|FG000|Core|Administrative problems|0|||
129007735|NCT01595009|464320324|FG001|Core|Administrative problems|1|||
129007736|NCT01595009|464320325|FG002|Core|Administrative problems|0|||
129007737|NCT01595009|464320326|FG003|Core|Administrative problems|0|||
129007738|NCT01595009|464320323|FG000|Extension|Administrative problems|0|||
129007739|NCT01595009|464320324|FG001|Extension|Administrative problems|0|||
129007740|NCT01595009|464320325|FG002|Extension|Administrative problems|0|||
129007741|NCT01595009|464320326|FG003|Extension|Administrative problems|1|||
129007742|NCT01595009|464320323|FG000|Extension|Patients completed per protocol|0|||
129007743|NCT01595009|464320324|FG001|Extension|Patients completed per protocol|0|||
129007744|NCT01595009|464320325|FG002|Extension|Patients completed per protocol|0|||
129007745|NCT01595009|464320326|FG003|Extension|Patients completed per protocol|2|||
129007746|NCT01595009|464320323|FG000|Extension|Disease progression|0|||
129007747|NCT01595009|464320324|FG001|Extension|Disease progression|0|||
129007748|NCT01595009|464320325|FG002|Extension|Disease progression|4|||
129007749|NCT01595009|464320326|FG003|Extension|Disease progression|7|||
129007750|NCT01595009|464320323|FG000|Extension|Adverse Event|0|||
129007751|NCT01595009|464320324|FG001|Extension|Adverse Event|0|||
129007752|NCT01595009|464320325|FG002|Extension|Adverse Event|0|||
129007753|NCT01595009|464320326|FG003|Extension|Adverse Event|1|||
129007754|NCT02907203|464320327|FG000|Overall Study|Death|1|||
129007755|NCT02907203|464320327|FG000|Overall Study|Lost to Follow-up|3|||
129007756|NCT02907203|464320327|FG000|Overall Study|Withdrawal by Subject|3|||
129007757|NCT02907203|464320327|FG000|Overall Study|Surgical bypass|1|||
129007758|NCT04956666|464320329|FG000|Overall Study|Adverse Event|18|||
129007759|NCT04956666|464320329|FG000|Overall Study|Physician Decision|5|||
129007760|NCT00662025|464320333|FG000|Overall Study|Objective progression or relapse|51|||
129007761|NCT00662025|464320333|FG000|Overall Study|Adverse Event|7|||
129007762|NCT00662025|464320333|FG000|Overall Study|Withdrawal by Subject|1|||
129007763|NCT00662025|464320333|FG000|Overall Study|Results of other clinical study|2|||
129007764|NCT00662025|464320333|FG000|Overall Study|Target lesion cannot be evaluated|1|||
129007765|NCT00662025|464320333|FG000|Overall Study|Domestic circumstances|1|||
129007766|NCT00760383|464320334|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
129007767|NCT00760383|464320335|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
129007768|NCT00626925|464320336|FG000|Overall Study|Lost to Follow-up|1|||
129007769|NCT00626925|464320337|FG001|Overall Study|Lost to Follow-up|2|||
129007770|NCT00626925|464320336|FG000|Overall Study|relapse|1|||
129007771|NCT00626925|464320337|FG001|Overall Study|relapse|0|||
129007772|NCT00626925|464320336|FG000|Overall Study|Adverse effect|6|||
129007773|NCT00626925|464320337|FG001|Overall Study|Adverse effect|2|||
129007774|NCT00626925|464320336|FG000|Overall Study|Lack of Efficacy|1|||
129007775|NCT00626925|464320337|FG001|Overall Study|Lack of Efficacy|4|||
129007776|NCT00626925|464320336|FG000|Overall Study|Time constraints|3|||
129007777|NCT00626925|464320337|FG001|Overall Study|Time constraints|1|||
129007778|NCT01215942|464320342|FG000|Treatment Period|Adverse Event|15|||
129007779|NCT01215942|464320343|FG001|Treatment Period|Adverse Event|26|||
129007780|NCT01215942|464320342|FG000|Treatment Period|Death|2|||
129007781|NCT01215942|464320343|FG001|Treatment Period|Death|4|||
129007782|NCT01215942|464320342|FG000|Treatment Period|Lack of Efficacy|23|||
129007783|NCT01215942|464320343|FG001|Treatment Period|Lack of Efficacy|62|||
129007784|NCT01215942|464320342|FG000|Treatment Period|Lost to Follow-up|3|||
129007785|NCT01215942|464320343|FG001|Treatment Period|Lost to Follow-up|4|||
129007786|NCT01215942|464320342|FG000|Treatment Period|Withdrawal by Subject|17|||
129007787|NCT01215942|464320343|FG001|Treatment Period|Withdrawal by Subject|40|||
129007788|NCT01215942|464320342|FG000|Treatment Period|Physician Decision|5|||
129007789|NCT01215942|464320343|FG001|Treatment Period|Physician Decision|5|||
129007790|NCT01215942|464320342|FG000|Treatment Period|Protocol Violation|0|||
129007791|NCT01215942|464320343|FG001|Treatment Period|Protocol Violation|1|||
129007792|NCT01215942|464320342|FG000|Treatment Period|Sponsor Decision|349|||
129007793|NCT01215942|464320343|FG001|Treatment Period|Sponsor Decision|530|||
129007794|NCT01215942|464320342|FG000|Post-Treatment Follow-Up Period|Death|0|||
129007795|NCT01215942|464320343|FG001|Post-Treatment Follow-Up Period|Death|1|||
129007796|NCT01215942|464320342|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
129007797|NCT01215942|464320343|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
129007798|NCT01215942|464320342|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
129007799|NCT01215942|464320343|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
129007800|NCT01215942|464320342|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
129007801|NCT01215942|464320343|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
129007802|NCT01215942|464320342|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
129007803|NCT01215942|464320343|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
129007804|NCT03305055|464320344|FG000|Overall Study|Withdrawal by Subject|0|||
129007805|NCT03305055|464320345|FG001|Overall Study|Withdrawal by Subject|1|||
129007806|NCT03305055|464320344|FG000|Overall Study|Adverse Event|1|||
129007807|NCT03305055|464320345|FG001|Overall Study|Adverse Event|1|||
129007808|NCT01047345|464320350|FG000|Base Study|Adverse Event|3|||
129007809|NCT01047345|464320351|FG001|Base Study|Adverse Event|0|||
129007810|NCT01047345|464320352|FG002|Base Study|Adverse Event|0|||
129007811|NCT01047345|464320350|FG000|Base Study|Lost to Follow-up|4|||
129007812|NCT01047345|464320351|FG001|Base Study|Lost to Follow-up|1|||
129007813|NCT01047345|464320352|FG002|Base Study|Lost to Follow-up|0|||
129007814|NCT01047345|464320350|FG000|Base Study|Protocol Violation|3|||
129007815|NCT01047345|464320351|FG001|Base Study|Protocol Violation|1|||
129007816|NCT01047345|464320352|FG002|Base Study|Protocol Violation|0|||
129007817|NCT01047345|464320350|FG000|Base Study|Withdrawal by Subject|12|||
129007818|NCT01047345|464320351|FG001|Base Study|Withdrawal by Subject|4|||
129007819|NCT01047345|464320352|FG002|Base Study|Withdrawal by Subject|0|||
129007820|NCT01047345|464320350|FG000|Extension|Withdrawal by Subject|0|||
129007821|NCT01047345|464320351|FG001|Extension|Withdrawal by Subject|0|||
129007822|NCT01047345|464320352|FG002|Extension|Withdrawal by Subject|1|||
129007823|NCT01047345|464320350|FG000|Extension|Lost to Follow-up|0|||
129007824|NCT01047345|464320351|FG001|Extension|Lost to Follow-up|0|||
129007825|NCT01047345|464320352|FG002|Extension|Lost to Follow-up|5|||
129007826|NCT01816477|464320353|FG000|Overall Study|Withdrawal by Subject|13|||
129007827|NCT01816477|464320354|FG001|Overall Study|Withdrawal by Subject|1|||
129007828|NCT01816477|464320353|FG000|Overall Study|Unable to tolerate catheter placement|3|||
129007829|NCT01816477|464320354|FG001|Overall Study|Unable to tolerate catheter placement|0|||
129007830|NCT00819247|464320357|FG000|Overall Study|Adverse Event|0|||
129007831|NCT00819247|464320358|FG001|Overall Study|Adverse Event|5|||
129007832|NCT00819247|464320359|FG002|Overall Study|Adverse Event|3|||
129007833|NCT00819247|464320357|FG000|Overall Study|Insufficient testosterone response|5|||
129007834|NCT00819247|464320358|FG001|Overall Study|Insufficient testosterone response|8|||
129007835|NCT00819247|464320359|FG002|Overall Study|Insufficient testosterone response|10|||
129007836|NCT00819247|464320357|FG000|Overall Study|Withdrawal by Subject|1|||
129007837|NCT00819247|464320358|FG001|Overall Study|Withdrawal by Subject|0|||
129007838|NCT00819247|464320359|FG002|Overall Study|Withdrawal by Subject|0|||
129007839|NCT00819247|464320357|FG000|Overall Study|Protocol Violation|1|||
129007840|NCT00819247|464320358|FG001|Overall Study|Protocol Violation|0|||
129007841|NCT00819247|464320359|FG002|Overall Study|Protocol Violation|1|||
129007842|NCT00819247|464320357|FG000|Overall Study|Mistakenly withdrawn|0|||
129007843|NCT00819247|464320358|FG001|Overall Study|Mistakenly withdrawn|1|||
129007844|NCT00819247|464320359|FG002|Overall Study|Mistakenly withdrawn|0|||
129007845|NCT00819247|464320357|FG000|Overall Study|Bad prostate-specific antigen response|3|||
129007846|NCT00819247|464320358|FG001|Overall Study|Bad prostate-specific antigen response|2|||
129007847|NCT00819247|464320359|FG002|Overall Study|Bad prostate-specific antigen response|0|||
129007848|NCT00819247|464320357|FG000|Overall Study|Other|1|||
129007849|NCT00819247|464320358|FG001|Overall Study|Other|0|||
129007850|NCT00819247|464320359|FG002|Overall Study|Other|0|||
129007851|NCT00282256|464320360|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
129007852|NCT00282256|464320360|FG000|Extension Treatment Period|Adverse Event|2|||
129007853|NCT02540356|464320361|FG000|Overall Study|Terminated due to disease progression|1|||
129007854|NCT02540356|464320362|FG001|Overall Study|Terminated due to disease progression|0|||
129007855|NCT01513148|464320363|FG000|Overall Study|Protocol Violation|2|||
129007856|NCT01513148|464320364|FG001|Overall Study|Protocol Violation|2|||
129007857|NCT01411995|464320374|FG000|Overall Study|Failed IUD insertion|0|||
129007858|NCT01411995|464320375|FG001|Overall Study|Failed IUD insertion|1|||
129007859|NCT02974153|464320376|FG000|Overall Study|Adverse Event|6|||
129007860|NCT02974153|464320377|FG001|Overall Study|Adverse Event|0|||
129007861|NCT02974153|464320378|FG002|Overall Study|Adverse Event|1|||
129007862|NCT02974153|464320376|FG000|Overall Study|Lack of Efficacy|6|||
129007863|NCT02974153|464320377|FG001|Overall Study|Lack of Efficacy|5|||
129007864|NCT02974153|464320378|FG002|Overall Study|Lack of Efficacy|10|||
129007865|NCT02974153|464320376|FG000|Overall Study|Lost to Follow-up|9|||
129007866|NCT02974153|464320377|FG001|Overall Study|Lost to Follow-up|10|||
129007867|NCT02974153|464320378|FG002|Overall Study|Lost to Follow-up|17|||
129007868|NCT02974153|464320376|FG000|Overall Study|Physician Decision|0|||
129007869|NCT02974153|464320377|FG001|Overall Study|Physician Decision|2|||
129007870|NCT02974153|464320378|FG002|Overall Study|Physician Decision|1|||
129007871|NCT02974153|464320376|FG000|Overall Study|Withdrawal by Subject|9|||
129007872|NCT02974153|464320377|FG001|Overall Study|Withdrawal by Subject|16|||
129007873|NCT02974153|464320378|FG002|Overall Study|Withdrawal by Subject|11|||
129007874|NCT02974153|464320376|FG000|Overall Study|Study Burden|8|||
129007875|NCT02974153|464320377|FG001|Overall Study|Study Burden|7|||
129007876|NCT02974153|464320378|FG002|Overall Study|Study Burden|3|||
129007877|NCT02974153|464320376|FG000|Overall Study|Other|14|||
129007878|NCT02974153|464320377|FG001|Overall Study|Other|8|||
129007879|NCT02974153|464320378|FG002|Overall Study|Other|7|||
129007880|NCT02277769|464320379|FG000|Overall Study|Protocol Violation|3|||
129007881|NCT02277769|464320380|FG001|Overall Study|Protocol Violation|3|||
129007882|NCT02277769|464320381|FG002|Overall Study|Protocol Violation|5|||
129007883|NCT02277769|464320379|FG000|Overall Study|Lack of Efficacy|17|||
129007884|NCT02277769|464320380|FG001|Overall Study|Lack of Efficacy|0|||
129007885|NCT02277769|464320381|FG002|Overall Study|Lack of Efficacy|4|||
129007886|NCT02277769|464320379|FG000|Overall Study|Adverse Event|14|||
129007887|NCT02277769|464320380|FG001|Overall Study|Adverse Event|2|||
129007888|NCT02277769|464320381|FG002|Overall Study|Adverse Event|4|||
129007889|NCT02277769|464320379|FG000|Overall Study|Other than specified above|12|||
129007890|NCT02277769|464320380|FG001|Overall Study|Other than specified above|8|||
129007891|NCT02277769|464320381|FG002|Overall Study|Other than specified above|5|||
129007892|NCT00203307|464320384|FG000|First Intervention|Adverse Event|2|||
129007893|NCT00203307|464320385|FG001|First Intervention|Adverse Event|0|||
129007894|NCT03730103|464320386|FG000|Overall Study|Did not meet inclusion criteria|0|||
129007895|NCT03730103|464320387|FG001|Overall Study|Did not meet inclusion criteria|5|||
129007896|NCT01488578|464320388|FG000|Overall Study|Protocol Violation|1836|||
129007897|NCT02308111|464320389|FG000|Overall Study|Adverse Event|31|||
129007898|NCT02308111|464320390|FG001|Overall Study|Adverse Event|19|||
129007899|NCT02308111|464320389|FG000|Overall Study|Death|9|||
129007900|NCT02308111|464320390|FG001|Overall Study|Death|6|||
129007901|NCT02308111|464320389|FG000|Overall Study|Lost to Follow-up|2|||
129007902|NCT02308111|464320390|FG001|Overall Study|Lost to Follow-up|7|||
129007903|NCT02308111|464320389|FG000|Overall Study|Physician Decision|6|||
129007904|NCT02308111|464320390|FG001|Overall Study|Physician Decision|17|||
129007905|NCT02308111|464320389|FG000|Overall Study|Protocol Violation|0|||
129007906|NCT02308111|464320390|FG001|Overall Study|Protocol Violation|1|||
129007907|NCT02308111|464320389|FG000|Overall Study|Withdrawal by Subject|28|||
129007908|NCT02308111|464320390|FG001|Overall Study|Withdrawal by Subject|38|||
129007909|NCT02308111|464320389|FG000|Overall Study|Study Terminated by Sponsor|72|||
129007910|NCT02308111|464320390|FG001|Overall Study|Study Terminated by Sponsor|61|||
129007911|NCT02308111|464320389|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
129007912|NCT02308111|464320390|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
129007913|NCT02308111|464320389|FG000|Overall Study|Site Closure|3|||
129007914|NCT02308111|464320390|FG001|Overall Study|Site Closure|3|||
129007915|NCT02308111|464320389|FG000|Overall Study|Non-compliance with Study Drug|3|||
129007916|NCT02308111|464320390|FG001|Overall Study|Non-compliance with Study Drug|1|||
129007917|NCT02308111|464320389|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
129007918|NCT02308111|464320390|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
129007919|NCT02308111|464320389|FG000|Overall Study|Liver Transplant|3|||
129007920|NCT02308111|464320390|FG001|Overall Study|Liver Transplant|3|||
129007921|NCT02308111|464320389|FG000|Overall Study|Liver Transplant Waitlist|2|||
129007922|NCT02308111|464320390|FG001|Overall Study|Liver Transplant Waitlist|2|||
129007923|NCT02308111|464320389|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
129007924|NCT02308111|464320390|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
129007925|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
129007926|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
129007927|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
129007928|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
129007929|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
129007930|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
129007931|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
129007932|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
129007933|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
129007934|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
129007935|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
129007936|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
129007937|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
129007938|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
129007939|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
129007940|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
129007941|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
129007942|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
129007943|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
129007944|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
129007945|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
129007946|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
129007947|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
129007948|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
129007949|NCT00455533|464320393|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
129007950|NCT00455533|464320394|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
129007951|NCT00455533|464320395|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
129007952|NCT00455533|464320393|FG000|Period Two: Randomized Period|Death|0|||
129007953|NCT00455533|464320394|FG001|Period Two: Randomized Period|Death|0|||
129007954|NCT00455533|464320395|FG002|Period Two: Randomized Period|Death|3|||
129007955|NCT00455533|464320393|FG000|Period Two: Randomized Period|Disease Progression|0|||
129007956|NCT00455533|464320394|FG001|Period Two: Randomized Period|Disease Progression|1|||
129007957|NCT00455533|464320395|FG002|Period Two: Randomized Period|Disease Progression|1|||
129007958|NCT00455533|464320393|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
129007959|NCT00455533|464320394|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
129007960|NCT00455533|464320395|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
129007961|NCT00455533|464320393|FG000|Period Two: Randomized Period|Other - need reasons|0|||
129007962|NCT00455533|464320394|FG001|Period Two: Randomized Period|Other - need reasons|1|||
129007963|NCT00455533|464320395|FG002|Period Two: Randomized Period|Other - need reasons|0|||
129007964|NCT00455533|464320393|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
129007965|NCT00455533|464320394|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
129007966|NCT00455533|464320395|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
129007967|NCT00455533|464320393|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
129007968|NCT00455533|464320394|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
129007969|NCT00455533|464320395|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
129007970|NCT00979628|464320400|FG000|Overall Study|received regimen < 24 hours|7|||
129007971|NCT00979628|464320401|FG001|Overall Study|received regimen < 24 hours|6|||
129007972|NCT00979628|464320402|FG002|Overall Study|received regimen < 24 hours|5|||
129007973|NCT00979628|464320400|FG000|Overall Study|received steroids|1|||
129007974|NCT00979628|464320401|FG001|Overall Study|received steroids|1|||
129007975|NCT00979628|464320402|FG002|Overall Study|received steroids|0|||
129007976|NCT00979628|464320400|FG000|Overall Study|transferred to ICU|1|||
129007977|NCT00979628|464320401|FG001|Overall Study|transferred to ICU|2|||
129007978|NCT00979628|464320402|FG002|Overall Study|transferred to ICU|1|||
129007979|NCT01736553|464320407|FG000|Overall Study|Death|12|||
129007980|NCT01736553|464320408|FG001|Overall Study|Death|0|||
129007981|NCT01736553|464320407|FG000|Overall Study|Withdrawal by Subject|5|||
129007982|NCT01736553|464320408|FG001|Overall Study|Withdrawal by Subject|2|||
129007983|NCT01736553|464320407|FG000|Overall Study|Lost to Follow-up|2|||
129007984|NCT01736553|464320408|FG001|Overall Study|Lost to Follow-up|2|||
129007985|NCT02154529|464320409|FG000|Overall Study|Death|1|||
129007986|NCT02154529|464320410|FG001|Overall Study|Death|1|||
129007987|NCT02154529|464320411|FG002|Overall Study|Death|5|||
129007988|NCT02154529|464320412|FG003|Overall Study|Death|1|||
129007989|NCT02154529|464320409|FG000|Overall Study|Termination of study by sponsor|2|||
129007990|NCT02154529|464320410|FG001|Overall Study|Termination of study by sponsor|2|||
129007991|NCT02154529|464320411|FG002|Overall Study|Termination of study by sponsor|3|||
129007992|NCT02154529|464320412|FG003|Overall Study|Termination of study by sponsor|1|||
129007993|NCT02154529|464320409|FG000|Overall Study|Lost to Follow-up|1|||
129007994|NCT02154529|464320410|FG001|Overall Study|Lost to Follow-up|0|||
129007995|NCT02154529|464320411|FG002|Overall Study|Lost to Follow-up|0|||
129007996|NCT02154529|464320412|FG003|Overall Study|Lost to Follow-up|0|||
129007997|NCT02178709|464322439|FG000|Overall Study|Adverse Event|5|||
129007998|NCT02178709|464322439|FG000|Overall Study|Death|2|||
129007999|NCT02178709|464322439|FG000|Overall Study|Withdrawal by Subject|2|||
129008000|NCT02178709|464322439|FG000|Overall Study|Physician Decision|2|||
129008001|NCT02178709|464322439|FG000|Overall Study|Disease Progression|5|||
129008002|NCT02224456|464322440|FG000|Overall Study|Lack of Efficacy|1|||
129008003|NCT02224456|464322440|FG000|Overall Study|Lost to Follow-up|15|||
129008004|NCT02224456|464322440|FG000|Overall Study|Withdrawal by Subject|9|||
129008005|NCT02224456|464322440|FG000|Overall Study|Physician Decision|3|||
129008006|NCT02224456|464322440|FG000|Overall Study|Death|2|||
129008007|NCT02224456|464322440|FG000|Overall Study|Pregnancy|4|||
129008008|NCT02224456|464322440|FG000|Overall Study|Protocol Violation|1|||
129008009|NCT02224456|464322440|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
129008010|NCT02946385|464322441|FG000|Overall Study|Lost to Follow-up|0|||
129008011|NCT02946385|464322442|FG001|Overall Study|Lost to Follow-up|0|||
129008012|NCT02946385|464322443|FG002|Overall Study|Lost to Follow-up|3|||
129008013|NCT02946385|464322444|FG003|Overall Study|Lost to Follow-up|0|||
129008014|NCT02946385|464322445|FG004|Overall Study|Lost to Follow-up|2|||
129008015|NCT02946385|464322446|FG005|Overall Study|Lost to Follow-up|1|||
129008016|NCT01644890|464322447|FG000|Overall Study|Adverse Event|7|||
129008017|NCT01644890|464322448|FG001|Overall Study|Adverse Event|20|||
129008018|NCT01644890|464322447|FG000|Overall Study|Death|1|||
129008019|NCT01644890|464322448|FG001|Overall Study|Death|3|||
129008020|NCT01644890|464322447|FG000|Overall Study|Physician Decision|3|||
129008021|NCT01644890|464322448|FG001|Overall Study|Physician Decision|9|||
129008022|NCT01644890|464322447|FG000|Overall Study|Protocol Violation|6|||
129008023|NCT01644890|464322448|FG001|Overall Study|Protocol Violation|7|||
129008024|NCT01644890|464322447|FG000|Overall Study|Withdrawal by Subject|19|||
129008025|NCT01644890|464322448|FG001|Overall Study|Withdrawal by Subject|27|||
129008026|NCT01644890|464322447|FG000|Overall Study|Progression Disease|160|||
129008027|NCT01644890|464322448|FG001|Overall Study|Progression Disease|131|||
129008028|NCT01644890|464322447|FG000|Overall Study|Clinical Progression|6|||
129008029|NCT01644890|464322448|FG001|Overall Study|Clinical Progression|6|||
129008030|NCT01644890|464322447|FG000|Overall Study|> 28 days since last dose of study drug|6|||
129008031|NCT01644890|464322448|FG001|Overall Study|> 28 days since last dose of study drug|3|||
129008032|NCT01644890|464322447|FG000|Overall Study|Other|8|||
129008033|NCT01644890|464322448|FG001|Overall Study|Other|9|||
129008034|NCT01060670|464322449|FG000|Run In|screen failure|0|||
129008035|NCT01060670|464322450|FG001|Run In|screen failure|238|||
129008036|NCT04849988|464322453|FG000|Overall Study|Lack of Efficacy|3|||
129008037|NCT04849988|464322454|FG001|Overall Study|Lack of Efficacy|4|||
129008038|NCT04849988|464322455|FG002|Overall Study|Lack of Efficacy|1|||
129008039|NCT04849988|464322456|FG003|Overall Study|Lack of Efficacy|4|||
129008040|NCT04849988|464322453|FG000|Overall Study|Other reasons|1|||
129008041|NCT04849988|464322454|FG001|Overall Study|Other reasons|2|||
129008042|NCT04849988|464322455|FG002|Overall Study|Other reasons|2|||
129008043|NCT04849988|464322456|FG003|Overall Study|Other reasons|1|||
129008044|NCT02761980|464322461|FG000|Overall Study|Adverse Event|4|||
129008045|NCT02761980|464322462|FG001|Overall Study|Adverse Event|6|||
129008046|NCT02761980|464322463|FG002|Overall Study|Adverse Event|5|||
129008047|NCT02761980|464322464|FG003|Overall Study|Adverse Event|6|||
129008048|NCT02761980|464322461|FG000|Overall Study|Withdrawal by Subject|0|||
129008049|NCT02761980|464322462|FG001|Overall Study|Withdrawal by Subject|1|||
129008050|NCT02761980|464322463|FG002|Overall Study|Withdrawal by Subject|0|||
129008051|NCT02761980|464322464|FG003|Overall Study|Withdrawal by Subject|0|||
129008052|NCT02761980|464322461|FG000|Overall Study|Other|0|||
129008053|NCT02761980|464322462|FG001|Overall Study|Other|0|||
129008054|NCT02761980|464322463|FG002|Overall Study|Other|1|||
129008055|NCT02761980|464322464|FG003|Overall Study|Other|0|||
129008056|NCT01052116|464322465|FG000|Overall Study|Lost to Follow-up|11|||
129008057|NCT01052116|464322466|FG001|Overall Study|Lost to Follow-up|17|||
129008058|NCT01052116|464322465|FG000|Overall Study|Withdrawal by Subject|3|||
129008059|NCT01052116|464322466|FG001|Overall Study|Withdrawal by Subject|6|||
129008060|NCT01052116|464322465|FG000|Overall Study|Spirometry not performed|0|||
129008061|NCT01052116|464322466|FG001|Overall Study|Spirometry not performed|4|||
129008062|NCT00101582|464322467|FG000|Overall Study|Ineligibility determined|0|||
129008063|NCT00101582|464322468|FG001|Overall Study|Ineligibility determined|1|||
129008064|NCT00101582|464322467|FG000|Overall Study|Adverse Event|1|||
129008065|NCT00101582|464322468|FG001|Overall Study|Adverse Event|4|||
129008066|NCT00101582|464322467|FG000|Overall Study|Withdrawal by Subject|6|||
129008067|NCT00101582|464322468|FG001|Overall Study|Withdrawal by Subject|4|||
129008068|NCT00101582|464322467|FG000|Overall Study|Physician Decision|1|||
129008069|NCT00101582|464322468|FG001|Overall Study|Physician Decision|0|||
129008070|NCT00101582|464322467|FG000|Overall Study|Death|3|||
129008071|NCT00101582|464322468|FG001|Overall Study|Death|5|||
129008072|NCT00101582|464322467|FG000|Overall Study|Other|0|||
129008073|NCT00101582|464322468|FG001|Overall Study|Other|1|||
129008074|NCT00056160|464322469|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
129008075|NCT00056160|464322470|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
129008076|NCT00056160|464322469|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
129008077|NCT00056160|464322470|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
129008078|NCT00056160|464322469|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
129008079|NCT00056160|464322470|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
129008080|NCT00056160|464322469|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
129008081|NCT00056160|464322470|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
129008082|NCT00056160|464322469|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
129008083|NCT00056160|464322470|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
129008084|NCT00056160|464322469|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
129008085|NCT00056160|464322470|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
129008086|NCT00056160|464322469|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
129008087|NCT00056160|464322470|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
129008088|NCT00056160|464322469|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
129008089|NCT00056160|464322470|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
129008090|NCT00056160|464322469|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
129008091|NCT00056160|464322470|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
129008092|NCT00056160|464322469|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
129008093|NCT00056160|464322470|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
129008094|NCT00056160|464322469|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
129008095|NCT00056160|464322470|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
129008096|NCT00056160|464322469|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
129008097|NCT00056160|464322470|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
129008098|NCT00056160|464322469|FG000|Final Follow-up|Transferred into expanded access study.|3|||
129008099|NCT00056160|464322470|FG001|Final Follow-up|Transferred into expanded access study.|0|||
129008100|NCT00056160|464322469|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
129008101|NCT00056160|464322470|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
129008102|NCT00056160|464322469|FG000|Final Follow-up|Adverse Event|1|||
129008103|NCT00056160|464322470|FG001|Final Follow-up|Adverse Event|0|||
129008104|NCT03312530|464322472|FG000|Overall Study|Death|5|||
129008105|NCT03312530|464322473|FG001|Overall Study|Death|5|||
129008106|NCT03312530|464322474|FG002|Overall Study|Death|4|||
129008107|NCT03312530|464322475|FG003|Overall Study|Death|10|||
129008108|NCT03312530|464322476|FG004|Overall Study|Death|8|||
129008109|NCT03312530|464322472|FG000|Overall Study|Lost to Follow-up|0|||
129008110|NCT03312530|464322473|FG001|Overall Study|Lost to Follow-up|0|||
129008111|NCT03312530|464322474|FG002|Overall Study|Lost to Follow-up|0|||
129008112|NCT03312530|464322475|FG003|Overall Study|Lost to Follow-up|1|||
129008113|NCT03312530|464322476|FG004|Overall Study|Lost to Follow-up|0|||
129008114|NCT03312530|464322472|FG000|Overall Study|Participant in another sponsor study.|0|||
129008115|NCT03312530|464322473|FG001|Overall Study|Participant in another sponsor study.|0|||
129008116|NCT03312530|464322474|FG002|Overall Study|Participant in another sponsor study.|0|||
129008117|NCT03312530|464322475|FG003|Overall Study|Participant in another sponsor study.|1|||
129008118|NCT03312530|464322476|FG004|Overall Study|Participant in another sponsor study.|0|||
129008119|NCT03312530|464322472|FG000|Overall Study|Study terminated by sponsor|1|||
129008120|NCT03312530|464322473|FG001|Overall Study|Study terminated by sponsor|0|||
129008121|NCT03312530|464322474|FG002|Overall Study|Study terminated by sponsor|2|||
129008122|NCT03312530|464322475|FG003|Overall Study|Study terminated by sponsor|3|||
129008123|NCT03312530|464322476|FG004|Overall Study|Study terminated by sponsor|7|||
129008124|NCT03312530|464322472|FG000|Overall Study|Withdrawal by Subject|0|||
129008125|NCT03312530|464322473|FG001|Overall Study|Withdrawal by Subject|1|||
129008126|NCT03312530|464322474|FG002|Overall Study|Withdrawal by Subject|0|||
129008127|NCT03312530|464322475|FG003|Overall Study|Withdrawal by Subject|0|||
129008128|NCT03312530|464322476|FG004|Overall Study|Withdrawal by Subject|0|||
129008129|NCT03312530|464322472|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129008130|NCT03312530|464322473|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129008131|NCT03312530|464322474|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129008132|NCT03312530|464322475|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
129008133|NCT03312530|464322476|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129008134|NCT03093324|464322477|FG000|Overall Study|Adverse Event|4|||
129008135|NCT03093324|464322478|FG001|Overall Study|Adverse Event|15|||
129008136|NCT03093324|464322477|FG000|Overall Study|Lost to Follow-up|1|||
129008137|NCT03093324|464322478|FG001|Overall Study|Lost to Follow-up|0|||
129008138|NCT03093324|464322477|FG000|Overall Study|Protocol Deviation|2|||
129008139|NCT03093324|464322478|FG001|Overall Study|Protocol Deviation|2|||
129098632|NCT04015518|464652412|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
129098633|NCT04015518|464652413|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
129098634|NCT04015518|464652409|FG000|Overall Study|Pregnancy|0|||
129098635|NCT04015518|464652410|FG001|Overall Study|Pregnancy|0|||
129098636|NCT04015518|464652411|FG002|Overall Study|Pregnancy|0|||
129098637|NCT04015518|464652412|FG003|Overall Study|Pregnancy|0|||
129098638|NCT04015518|464652413|FG004|Overall Study|Pregnancy|1|||
129098639|NCT04015518|464652409|FG000|Overall Study|Personal reasons|1|||
129098640|NCT04015518|464652410|FG001|Overall Study|Personal reasons|0|||
129098641|NCT04015518|464652411|FG002|Overall Study|Personal reasons|0|||
129098642|NCT04015518|464652412|FG003|Overall Study|Personal reasons|0|||
129098643|NCT04015518|464652413|FG004|Overall Study|Personal reasons|1|||
129098644|NCT04015518|464652409|FG000|Overall Study|Withdrew consent|1|||
129098645|NCT04015518|464652410|FG001|Overall Study|Withdrew consent|0|||
129098646|NCT04015518|464652411|FG002|Overall Study|Withdrew consent|0|||
129098647|NCT04015518|464652412|FG003|Overall Study|Withdrew consent|0|||
129098648|NCT04015518|464652413|FG004|Overall Study|Withdrew consent|0|||
129098649|NCT04015518|464652409|FG000|Overall Study|Prostate carcinoma|1|||
129098650|NCT04015518|464652410|FG001|Overall Study|Prostate carcinoma|0|||
129098651|NCT04015518|464652411|FG002|Overall Study|Prostate carcinoma|0|||
129098652|NCT04015518|464652412|FG003|Overall Study|Prostate carcinoma|0|||
129098653|NCT04015518|464652413|FG004|Overall Study|Prostate carcinoma|0|||
129098654|NCT04015518|464652409|FG000|Overall Study|Could not keep appointments due to work|1|||
129098655|NCT04015518|464652410|FG001|Overall Study|Could not keep appointments due to work|0|||
129098656|NCT04015518|464652411|FG002|Overall Study|Could not keep appointments due to work|0|||
129098657|NCT04015518|464652412|FG003|Overall Study|Could not keep appointments due to work|0|||
129008140|NCT03093324|464322477|FG000|Overall Study|Withdrawal by Subject|2|||
129008141|NCT03093324|464322478|FG001|Overall Study|Withdrawal by Subject|2|||
129008142|NCT04583579|464322479|FG000|Overall Study|Lost to Follow-up|4|||
129008143|NCT00278200|464322480|FG000|Overall Study|Death|1|||
129008144|NCT00278200|464322481|FG001|Overall Study|Death|3|||
129008145|NCT00278200|464322480|FG000|Overall Study|Physician Decision|0|||
129008146|NCT00278200|464322481|FG001|Overall Study|Physician Decision|1|||
129008147|NCT03519256|464322486|FG000|Overall Study|Disease recurrence|4|||
129008148|NCT03519256|464322487|FG001|Overall Study|Disease recurrence|4|||
129008149|NCT03519256|464322488|FG002|Overall Study|Disease recurrence|5|||
129008150|NCT03519256|464322489|FG003|Overall Study|Disease recurrence|2|||
129008151|NCT03519256|464322486|FG000|Overall Study|Study drug toxicity|0|||
129098658|NCT04015518|464652413|FG004|Overall Study|Could not keep appointments due to work|0|||
129008152|NCT03519256|464322487|FG001|Overall Study|Study drug toxicity|2|||
129008153|NCT03519256|464322488|FG002|Overall Study|Study drug toxicity|5|||
129008154|NCT03519256|464322489|FG003|Overall Study|Study drug toxicity|2|||
129008155|NCT03519256|464322486|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129008156|NCT03519256|464322487|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129008157|NCT03519256|464322488|FG002|Overall Study|Adverse event unrelated to study drug|1|||
129008158|NCT03519256|464322489|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129008159|NCT03519256|464322486|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129098659|NCT02195427|464652414|FG000|Overall Study|Did not consent to study extension|13|||
129098660|NCT02195427|464652415|FG001|Overall Study|Did not consent to study extension|9|||
129008160|NCT03519256|464322487|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129008161|NCT03519256|464322488|FG002|Overall Study|Participant request to discontinue study treatment|0|||
129008162|NCT03519256|464322489|FG003|Overall Study|Participant request to discontinue study treatment|2|||
129008163|NCT03519256|464322486|FG000|Overall Study|Other reasons|0|||
129008164|NCT03519256|464322487|FG001|Overall Study|Other reasons|0|||
129008165|NCT03519256|464322488|FG002|Overall Study|Other reasons|2|||
129008166|NCT03519256|464322489|FG003|Overall Study|Other reasons|0|||
129008167|NCT03519256|464322486|FG000|Overall Study|Disease progression|6|||
129008168|NCT03519256|464322487|FG001|Overall Study|Disease progression|3|||
129008169|NCT03519256|464322488|FG002|Overall Study|Disease progression|2|||
129008170|NCT03519256|464322489|FG003|Overall Study|Disease progression|1|||
129008171|NCT03519256|464322486|FG000|Overall Study|Lost to Follow-up|0|||
129008172|NCT03519256|464322487|FG001|Overall Study|Lost to Follow-up|1|||
129008173|NCT03519256|464322488|FG002|Overall Study|Lost to Follow-up|0|||
129008174|NCT03519256|464322489|FG003|Overall Study|Lost to Follow-up|0|||
129008175|NCT05431153|464322490|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129008176|NCT05431153|464322491|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129008177|NCT05431153|464322492|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129008178|NCT05431153|464322493|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129008179|NCT05431153|464322494|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
129008180|NCT05431153|464322495|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129008181|NCT04828161|464322496|FG000|Overall Study|Withdrawal by Subject|0|||
129008182|NCT04828161|464322497|FG001|Overall Study|Withdrawal by Subject|3|||
129008183|NCT04828161|464322498|FG002|Overall Study|Withdrawal by Subject|3|||
129008184|NCT04828161|464322499|FG003|Overall Study|Withdrawal by Subject|4|||
129008185|NCT04828161|464322496|FG000|Overall Study|Lost to Follow-up|1|||
129008186|NCT04828161|464322497|FG001|Overall Study|Lost to Follow-up|4|||
129008187|NCT04828161|464322498|FG002|Overall Study|Lost to Follow-up|2|||
129008188|NCT04828161|464322499|FG003|Overall Study|Lost to Follow-up|2|||
129008189|NCT04828161|464322496|FG000|Overall Study|Other|2|||
129008190|NCT04828161|464322497|FG001|Overall Study|Other|0|||
129008191|NCT04828161|464322498|FG002|Overall Study|Other|2|||
129008192|NCT04828161|464322499|FG003|Overall Study|Other|0|||
129008193|NCT04828161|464322496|FG000|Overall Study|Death|0|||
129008194|NCT04828161|464322497|FG001|Overall Study|Death|0|||
129008195|NCT04828161|464322498|FG002|Overall Study|Death|0|||
129008196|NCT04828161|464322499|FG003|Overall Study|Death|2|||
129008197|NCT02458638|464322502|FG000|Overall Study|Death|309|||
129008198|NCT02458638|464322502|FG000|Overall Study|End of Cohort/End of Study|67|||
129008199|NCT02458638|464322502|FG000|Overall Study|Lost to Follow-up|31|||
129008200|NCT02458638|464322502|FG000|Overall Study|Other Reasons|4|||
129008201|NCT02458638|464322502|FG000|Overall Study|Physician Decision|1|||
129008202|NCT02458638|464322502|FG000|Overall Study|Withdrawal by Subject|47|||
129008203|NCT00135707|464322511|FG000|Overall Study|Lost to Follow-up|94|||
129008204|NCT00135707|464322512|FG001|Overall Study|Lost to Follow-up|89|||
129008205|NCT00135707|464322511|FG000|Overall Study|Withdrawal by Subject|0|||
129008206|NCT00135707|464322512|FG001|Overall Study|Withdrawal by Subject|1|||
129008207|NCT00135707|464322511|FG000|Overall Study|Institutional review board request|1|||
129008208|NCT00135707|464322512|FG001|Overall Study|Institutional review board request|0|||
129008209|NCT03093454|464322513|FG000|Overall Study|Withdrawal by Subject|1|||
129008210|NCT03093454|464322514|FG001|Overall Study|Withdrawal by Subject|1|||
129008211|NCT03093454|464322513|FG000|Overall Study|Scheduling conflict|3|||
129008212|NCT03093454|464322514|FG001|Overall Study|Scheduling conflict|1|||
129008213|NCT03093454|464322513|FG000|Overall Study|Physician Decision|2|||
129008214|NCT03093454|464322514|FG001|Overall Study|Physician Decision|1|||
129008215|NCT04540497|464322518|FG000|Overall Study|Adverse Event|0|||
129008216|NCT04540497|464322519|FG001|Overall Study|Adverse Event|2|||
129008217|NCT04540497|464322518|FG000|Overall Study|Lost to Follow-up|1|||
129008218|NCT04540497|464322519|FG001|Overall Study|Lost to Follow-up|0|||
129008219|NCT04540497|464322518|FG000|Overall Study|Withdrawal by Subject|1|||
129008220|NCT04540497|464322519|FG001|Overall Study|Withdrawal by Subject|1|||
129098661|NCT02195427|464652414|FG000|Overall Study|Withdrawal by Subject|4|||
129098662|NCT02195427|464652415|FG001|Overall Study|Withdrawal by Subject|2|||
129098663|NCT02195427|464652414|FG000|Overall Study|Lost to Follow-up|0|||
129098664|NCT02195427|464652415|FG001|Overall Study|Lost to Follow-up|1|||
129098665|NCT02195427|464652414|FG000|Overall Study|Protocol Violation|7|||
129098666|NCT02195427|464652415|FG001|Overall Study|Protocol Violation|14|||
129098667|NCT02195427|464652414|FG000|Overall Study|Conditional re-treatment at W52|2|||
129098668|NCT02195427|464652415|FG001|Overall Study|Conditional re-treatment at W52|1|||
129098669|NCT00505661|464652416|FG000|Overall Study|Not Eligible|4|||
129098670|NCT00463840|464652417|FG000|Overall Study|Disease progression|7|||
129008221|NCT04540497|464322518|FG000|Overall Study|Miscellaneous|2|||
129098671|NCT00463840|464652417|FG000|Overall Study|Withdrawal by Subject|2|||
129008222|NCT04540497|464322519|FG001|Overall Study|Miscellaneous|1|||
129008223|NCT02524379|464322524|FG000|Overall Study|Death|1|||
129008224|NCT01290263|464322527|FG000|Overall Study|Adverse Event|0|||
129008225|NCT01290263|464322528|FG001|Overall Study|Adverse Event|0|||
129008226|NCT01290263|464322529|FG002|Overall Study|Adverse Event|0|||
129098672|NCT00463840|464652417|FG000|Overall Study|Adverse Event|3|||
129098673|NCT01653327|464652418|FG000|Overall Study|Withdrawal by Subject|1|||
129098674|NCT01738191|464652419|FG000|Overall Study|Withdrawal by Subject|4|||
129098675|NCT01738191|464652420|FG001|Overall Study|Withdrawal by Subject|1|||
129098676|NCT04607980|464652421|FG000|Overall Study|Adverse Event|3|||
129098677|NCT04607980|464652422|FG001|Overall Study|Adverse Event|4|||
129098678|NCT04607980|464652421|FG000|Overall Study|Death|0|||
129098679|NCT04607980|464652422|FG001|Overall Study|Death|1|||
129098680|NCT04607980|464652421|FG000|Overall Study|Withdrawal by Subject|2|||
129098681|NCT04607980|464652422|FG001|Overall Study|Withdrawal by Subject|5|||
129098682|NCT04607980|464652421|FG000|Overall Study|Lost to Follow-up|4|||
129098683|NCT04607980|464652422|FG001|Overall Study|Lost to Follow-up|8|||
129098684|NCT04607980|464652421|FG000|Overall Study|Protocol Violation|0|||
129098685|NCT04607980|464652422|FG001|Overall Study|Protocol Violation|3|||
129098686|NCT04607980|464652421|FG000|Overall Study|Other|3|||
129098687|NCT04607980|464652422|FG001|Overall Study|Other|0|||
129098688|NCT02109445|464652425|FG000|Overall Study|Symptomatic deterioration|2|||
129098689|NCT02109445|464652425|FG000|Overall Study|Adverse Event|1|||
129098690|NCT02578940|464654104|FG000|Overall Study|Screening failure|5|||
129098691|NCT02578940|464654104|FG000|Overall Study|Lost to Follow-up|1|||
129098692|NCT04591015|464654107|FG000|Overall Study|Death|6|||
129008227|NCT01290263|464322530|FG003|Overall Study|Adverse Event|1|||
129008228|NCT01290263|464322531|FG004|Overall Study|Adverse Event|1|||
129008229|NCT01290263|464322527|FG000|Overall Study|Lack of Efficacy|8|||
129008230|NCT01290263|464322528|FG001|Overall Study|Lack of Efficacy|2|||
129008231|NCT01290263|464322529|FG002|Overall Study|Lack of Efficacy|7|||
129008232|NCT01290263|464322530|FG003|Overall Study|Lack of Efficacy|24|||
129008233|NCT01290263|464322531|FG004|Overall Study|Lack of Efficacy|33|||
129008234|NCT01290263|464322527|FG000|Overall Study|Withdrawal by Subject|3|||
129008235|NCT01290263|464322528|FG001|Overall Study|Withdrawal by Subject|1|||
129008236|NCT01290263|464322529|FG002|Overall Study|Withdrawal by Subject|0|||
129008237|NCT01290263|464322530|FG003|Overall Study|Withdrawal by Subject|1|||
129008238|NCT01290263|464322531|FG004|Overall Study|Withdrawal by Subject|2|||
129008239|NCT01290263|464322527|FG000|Overall Study|Participant Non-Compliance|0|||
129008240|NCT01290263|464322528|FG001|Overall Study|Participant Non-Compliance|0|||
129008241|NCT01290263|464322529|FG002|Overall Study|Participant Non-Compliance|0|||
129008242|NCT01290263|464322530|FG003|Overall Study|Participant Non-Compliance|1|||
129008243|NCT01290263|464322531|FG004|Overall Study|Participant Non-Compliance|1|||
129008244|NCT03738332|464322532|FG000|Overall Study|Withdrawal by Subject|1|||
129008245|NCT04700449|464322533|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
129008246|NCT04700449|464322534|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
129008247|NCT04700449|464322535|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
129008248|NCT04700449|464322536|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
129008249|NCT04700449|464322533|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
129008250|NCT04700449|464322534|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
129008251|NCT04700449|464322535|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
129008252|NCT04700449|464322536|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
129008253|NCT04700449|464322533|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
129008254|NCT04700449|464322534|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
129008255|NCT04700449|464322535|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
129008256|NCT04700449|464322536|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
129008257|NCT04700449|464322533|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
129008258|NCT04700449|464322534|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
129008259|NCT04700449|464322535|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
129008260|NCT04700449|464322536|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
129008261|NCT04700449|464322533|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
129008262|NCT04700449|464322534|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
129008263|NCT04700449|464322535|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
129008264|NCT04700449|464322536|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
129008265|NCT04700449|464322533|FG000|Stage 1: Double-Blind Period|Other|0|||
129008266|NCT04700449|464322534|FG001|Stage 1: Double-Blind Period|Other|0|||
129008267|NCT04700449|464322535|FG002|Stage 1: Double-Blind Period|Other|1|||
129008268|NCT04700449|464322536|FG003|Stage 1: Double-Blind Period|Other|0|||
129008269|NCT04700449|464322533|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
129008270|NCT04700449|464322534|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
129008271|NCT04700449|464322535|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
129008272|NCT04700449|464322536|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
129008273|NCT04700449|464322533|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
129008274|NCT04700449|464322534|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
129008275|NCT04700449|464322535|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
129008276|NCT04700449|464322536|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
129098693|NCT04591015|464654108|FG001|Overall Study|Death|4|||
129008277|NCT04700449|464322533|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
129008278|NCT04700449|464322534|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
129008279|NCT04700449|464322535|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
129008280|NCT04700449|464322536|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
129008281|NCT04700449|464322533|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
129008282|NCT04700449|464322534|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
129008283|NCT04700449|464322535|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
129008284|NCT04700449|464322536|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
129008285|NCT04700449|464322533|FG000|Stage 2 Sub-study 1|Other|1|||
129008286|NCT04700449|464322534|FG001|Stage 2 Sub-study 1|Other|2|||
129008287|NCT04700449|464322535|FG002|Stage 2 Sub-study 1|Other|0|||
129008288|NCT04700449|464322536|FG003|Stage 2 Sub-study 1|Other|0|||
129008289|NCT04700449|464322533|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
129008290|NCT04700449|464322534|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
129008291|NCT04700449|464322535|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
129008292|NCT04700449|464322536|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
129008293|NCT04700449|464322533|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
129008294|NCT04700449|464322534|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
129008295|NCT04700449|464322535|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
129008296|NCT04700449|464322536|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
129008297|NCT04700449|464322533|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
129008298|NCT04700449|464322534|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
129008299|NCT04700449|464322535|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
129008300|NCT04700449|464322536|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
129008301|NCT04700449|464322533|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
129008302|NCT04700449|464322534|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
129008303|NCT04700449|464322535|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
129008304|NCT04700449|464322536|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
129008305|NCT04700449|464322533|FG000|Stage 2 Sub-study 2|Other|0|||
129008306|NCT04700449|464322534|FG001|Stage 2 Sub-study 2|Other|0|||
129008307|NCT04700449|464322535|FG002|Stage 2 Sub-study 2|Other|0|||
129008308|NCT04700449|464322536|FG003|Stage 2 Sub-study 2|Other|5|||
129008309|NCT01521559|464322537|FG000|Overall Study|Adverse Event|0|||
129008310|NCT01521559|464322538|FG001|Overall Study|Adverse Event|4|||
129008311|NCT01521559|464322537|FG000|Overall Study|Death|1|||
129008312|NCT01521559|464322538|FG001|Overall Study|Death|0|||
129008313|NCT01521559|464322537|FG000|Overall Study|Withdrawal by Subject|9|||
129008314|NCT01521559|464322538|FG001|Overall Study|Withdrawal by Subject|11|||
129008315|NCT01521559|464322537|FG000|Overall Study|Lost to Follow-up|3|||
129008316|NCT01521559|464322538|FG001|Overall Study|Lost to Follow-up|1|||
129008317|NCT01521559|464322537|FG000|Overall Study|Protocol Violation|1|||
129008318|NCT01521559|464322538|FG001|Overall Study|Protocol Violation|0|||
129008319|NCT01521559|464322537|FG000|Overall Study|Other|1|||
129008320|NCT01521559|464322538|FG001|Overall Study|Other|2|||
129008321|NCT02228382|464322539|FG000|Overall Study|Death|5|||
129008322|NCT02228382|464322540|FG001|Overall Study|Death|7|||
129008323|NCT02228382|464322541|FG002|Overall Study|Death|5|||
129008324|NCT02228382|464322542|FG003|Overall Study|Death|0|||
129008325|NCT02228382|464322543|FG004|Overall Study|Death|2|||
129008326|NCT02228382|464322539|FG000|Overall Study|Participant refused further follow-up|0|||
129008327|NCT02228382|464322540|FG001|Overall Study|Participant refused further follow-up|0|||
129008328|NCT02228382|464322541|FG002|Overall Study|Participant refused further follow-up|1|||
129008329|NCT02228382|464322542|FG003|Overall Study|Participant refused further follow-up|0|||
129008330|NCT02228382|464322543|FG004|Overall Study|Participant refused further follow-up|0|||
129008331|NCT02228382|464322539|FG000|Overall Study|Study terminated by sponsor|3|||
129008332|NCT02228382|464322540|FG001|Overall Study|Study terminated by sponsor|5|||
129008333|NCT02228382|464322541|FG002|Overall Study|Study terminated by sponsor|7|||
129008334|NCT02228382|464322542|FG003|Overall Study|Study terminated by sponsor|0|||
129008335|NCT02228382|464322543|FG004|Overall Study|Study terminated by sponsor|0|||
129008336|NCT02228382|464322539|FG000|Overall Study|Lost to Follow-up|0|||
129008337|NCT02228382|464322540|FG001|Overall Study|Lost to Follow-up|0|||
129008338|NCT02228382|464322541|FG002|Overall Study|Lost to Follow-up|3|||
129008339|NCT02228382|464322542|FG003|Overall Study|Lost to Follow-up|1|||
129008340|NCT02228382|464322543|FG004|Overall Study|Lost to Follow-up|0|||
129008341|NCT02228382|464322539|FG000|Overall Study|Withdrawal by Subject|0|||
129008342|NCT02228382|464322540|FG001|Overall Study|Withdrawal by Subject|3|||
129008343|NCT02228382|464322541|FG002|Overall Study|Withdrawal by Subject|2|||
129008344|NCT02228382|464322542|FG003|Overall Study|Withdrawal by Subject|1|||
129008345|NCT02228382|464322543|FG004|Overall Study|Withdrawal by Subject|0|||
129008346|NCT02228382|464322539|FG000|Overall Study|Other|2|||
129008347|NCT02228382|464322540|FG001|Overall Study|Other|3|||
129008348|NCT02228382|464322541|FG002|Overall Study|Other|3|||
129008349|NCT02228382|464322542|FG003|Overall Study|Other|0|||
129008350|NCT02228382|464322543|FG004|Overall Study|Other|0|||
129008351|NCT00520741|464322545|FG000|Overall Study|Adverse Event|16|||
129008352|NCT00520741|464322546|FG001|Overall Study|Adverse Event|56|||
129008353|NCT00520741|464322545|FG000|Overall Study|Lack of Efficacy|11|||
129008354|NCT00520741|464322546|FG001|Overall Study|Lack of Efficacy|30|||
129098694|NCT04591015|464654107|FG000|Overall Study|Withdrawal by Subject|6|||
129008355|NCT00520741|464322545|FG000|Overall Study|Withdrawal by Subject|0|||
129008356|NCT00520741|464322546|FG001|Overall Study|Withdrawal by Subject|11|||
129008357|NCT00520741|464322545|FG000|Overall Study|Protocol Violation|2|||
129008358|NCT00520741|464322546|FG001|Overall Study|Protocol Violation|15|||
129008359|NCT00520741|464322545|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
129008360|NCT00520741|464322546|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
129008361|NCT00520741|464322545|FG000|Overall Study|Lost to Follow-up|4|||
129008362|NCT00520741|464322546|FG001|Overall Study|Lost to Follow-up|4|||
129008363|NCT00520741|464322545|FG000|Overall Study|Other reasons for premature termination|0|||
129008364|NCT00520741|464322546|FG001|Overall Study|Other reasons for premature termination|6|||
129008365|NCT02750761|464322547|FG000|Overall Study|Lost to Follow-up|0|||
129098695|NCT04591015|464654108|FG001|Overall Study|Withdrawal by Subject|3|||
129098696|NCT04591015|464654107|FG000|Overall Study|Lost to Follow-up|16|||
129098697|NCT04591015|464654108|FG001|Overall Study|Lost to Follow-up|11|||
129098698|NCT02686814|464654109|FG000|Overall Study|Physician Decision|14|||
129008366|NCT02750761|464322548|FG001|Overall Study|Lost to Follow-up|0|||
129008367|NCT02750761|464322549|FG002|Overall Study|Lost to Follow-up|1|||
129008368|NCT02750761|464322550|FG003|Overall Study|Lost to Follow-up|0|||
129008369|NCT02750761|464322551|FG004|Overall Study|Lost to Follow-up|0|||
129008370|NCT02750761|464322552|FG005|Overall Study|Lost to Follow-up|0|||
129008371|NCT03522948|464322566|FG000|Overall Study|Lost to Follow-up|1|||
129008372|NCT01802879|464322567|FG000|Overall Study|Administrative problems|2|||
129008373|NCT01802879|464322567|FG000|Overall Study|Disease progression|6|||
129008374|NCT00698685|464322568|FG000|Overall Study|Sister withdrew as donor|1|||
129008375|NCT00698685|464322568|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
129008376|NCT02799602|464322569|FG000|Overall Study|Protocol Violation|1|||
129008377|NCT02799602|464322570|FG001|Overall Study|Protocol Violation|0|||
129008378|NCT02799602|464322569|FG000|Overall Study|Physician Decision|5|||
129008379|NCT02799602|464322570|FG001|Overall Study|Physician Decision|6|||
129008380|NCT02799602|464322569|FG000|Overall Study|Lost to Follow-up|4|||
129008381|NCT02799602|464322570|FG001|Overall Study|Lost to Follow-up|2|||
129008382|NCT02799602|464322569|FG000|Overall Study|Additional primary malignancy|11|||
129008383|NCT02799602|464322570|FG001|Overall Study|Additional primary malignancy|6|||
129008384|NCT02799602|464322569|FG000|Overall Study|Non-compliance with study drug|14|||
129008385|NCT02799602|464322570|FG001|Overall Study|Non-compliance with study drug|12|||
129008386|NCT02799602|464322569|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
129008387|NCT02799602|464322570|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
129008388|NCT02799602|464322569|FG000|Overall Study|Withdrawal by Subject|26|||
129008389|NCT02799602|464322570|FG001|Overall Study|Withdrawal by Subject|40|||
129008390|NCT02799602|464322569|FG000|Overall Study|Progressive disease - clinical progression|131|||
129008391|NCT02799602|464322570|FG001|Overall Study|Progressive disease - clinical progression|276|||
129008392|NCT02799602|464322569|FG000|Overall Study|Progressive disease - radiological progression|90|||
129008393|NCT02799602|464322570|FG001|Overall Study|Progressive disease - radiological progression|133|||
129008394|NCT02799602|464322569|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
129008395|NCT02799602|464322570|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
129008396|NCT02799602|464322569|FG000|Overall Study|Death|9|||
129008397|NCT02799602|464322570|FG001|Overall Study|Death|5|||
129008398|NCT02799602|464322569|FG000|Overall Study|Other|287|||
129008399|NCT02799602|464322570|FG001|Overall Study|Other|118|||
129008400|NCT02799602|464322569|FG000|Overall Study|Study drug never administered|0|||
129008401|NCT02799602|464322570|FG001|Overall Study|Study drug never administered|3|||
129008402|NCT02626949|464322571|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
129008403|NCT02626949|464322572|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
129008404|NCT02626949|464322571|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
129008405|NCT02626949|464322572|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
129008406|NCT02626949|464322571|FG000|Enrolled|Lost to Follow-up|7|||
129008407|NCT02626949|464322572|FG001|Enrolled|Lost to Follow-up|6|||
129098699|NCT02686814|464654109|FG000|Overall Study|Withdrawal by Subject|4|||
129098700|NCT02686814|464654109|FG000|Overall Study|Death|1|||
129098701|NCT00290693|464654110|FG000|Overall Study|Withdrawal by Subject|2|||
129098702|NCT02907619|464654111|FG000|Overall Study|Study terminated by sponsor|18|||
129098703|NCT02907619|464654112|FG001|Overall Study|Study terminated by sponsor|18|||
129098704|NCT02907619|464654113|FG002|Overall Study|Study terminated by sponsor|19|||
129098705|NCT02907619|464654111|FG000|Overall Study|Death|0|||
129098706|NCT02907619|464654112|FG001|Overall Study|Death|0|||
129098707|NCT02907619|464654113|FG002|Overall Study|Death|1|||
129098708|NCT02907619|464654111|FG000|Overall Study|Withdrawal by Subject|1|||
129098709|NCT02907619|464654112|FG001|Overall Study|Withdrawal by Subject|1|||
129098710|NCT02907619|464654113|FG002|Overall Study|Withdrawal by Subject|0|||
129098711|NCT02907619|464654111|FG000|Overall Study|Other|0|||
129008408|NCT02626949|464322571|FG000|Enrolled|Withdrawal by Subject|3|||
129008409|NCT02626949|464322572|FG001|Enrolled|Withdrawal by Subject|2|||
129008410|NCT00329602|464322576|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
129008411|NCT00329602|464322577|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
129008412|NCT00329602|464322578|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
129008413|NCT00329602|464322576|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
129098712|NCT02907619|464654112|FG001|Overall Study|Other|1|||
129008414|NCT00329602|464322577|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
129008415|NCT00329602|464322578|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
129008416|NCT00329602|464322576|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
129008417|NCT00329602|464322577|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
129008418|NCT00329602|464322578|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
129008419|NCT00329602|464322576|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
129008420|NCT00329602|464322577|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
129008421|NCT00329602|464322578|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
129008422|NCT00329602|464322576|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
129008423|NCT00329602|464322577|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
129008424|NCT00329602|464322578|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
129008425|NCT00329602|464322576|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
129008426|NCT00329602|464322577|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
129008427|NCT00329602|464322578|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
129008428|NCT02576990|464322579|FG000|Overall Study|Death|29|||
129008429|NCT02576990|464322580|FG001|Overall Study|Death|18|||
129008430|NCT02576990|464322579|FG000|Overall Study|Physician Decision|1|||
129008431|NCT02576990|464322580|FG001|Overall Study|Physician Decision|0|||
129008432|NCT02576990|464322579|FG000|Overall Study|Screen failure|2|||
129008433|NCT02576990|464322580|FG001|Overall Study|Screen failure|0|||
129008434|NCT02576990|464322579|FG000|Overall Study|Sponsor's decision|24|||
128878396|NCT02414932|463848471|FG000|Overall Study|Withdrawal by Subject|2|||
128878397|NCT02414932|463848472|FG001|Overall Study|Withdrawal by Subject|3|||
129008435|NCT02576990|464322580|FG001|Overall Study|Sponsor's decision|4|||
129008436|NCT02576990|464322579|FG000|Overall Study|Withdrawal by Subject|0|||
129008437|NCT02576990|464322580|FG001|Overall Study|Withdrawal by Subject|2|||
129008438|NCT02415959|464322581|FG000|Overall Study|Adverse Event|0|||
129008439|NCT02415959|464322582|FG001|Overall Study|Adverse Event|1|||
129008440|NCT02415959|464322583|FG002|Overall Study|Adverse Event|0|||
129008441|NCT02415959|464322584|FG003|Overall Study|Adverse Event|0|||
129008442|NCT02415959|464322585|FG004|Overall Study|Adverse Event|0|||
129008443|NCT02415959|464322581|FG000|Overall Study|Protocol Violation|0|||
129008444|NCT02415959|464322582|FG001|Overall Study|Protocol Violation|0|||
129008445|NCT02415959|464322583|FG002|Overall Study|Protocol Violation|0|||
129008446|NCT02415959|464322584|FG003|Overall Study|Protocol Violation|1|||
129008447|NCT02415959|464322585|FG004|Overall Study|Protocol Violation|0|||
129008448|NCT00911859|464322586|FG000|Treatment Period|Adverse Event|3|||
129008449|NCT00911859|464322587|FG001|Treatment Period|Adverse Event|3|||
129008450|NCT00911859|464322588|FG002|Treatment Period|Adverse Event|7|||
129008451|NCT00911859|464322586|FG000|Treatment Period|Death|1|||
129008452|NCT00911859|464322587|FG001|Treatment Period|Death|3|||
129008453|NCT00911859|464322588|FG002|Treatment Period|Death|5|||
129008454|NCT00911859|464322586|FG000|Treatment Period|Lack of Efficacy|1|||
129008455|NCT00911859|464322587|FG001|Treatment Period|Lack of Efficacy|7|||
129008456|NCT00911859|464322588|FG002|Treatment Period|Lack of Efficacy|5|||
129008457|NCT00911859|464322586|FG000|Treatment Period|Physician Decision|3|||
129008458|NCT00911859|464322587|FG001|Treatment Period|Physician Decision|3|||
129008459|NCT00911859|464322588|FG002|Treatment Period|Physician Decision|3|||
129008460|NCT00911859|464322586|FG000|Treatment Period|Withdrawal by Subject|0|||
129008461|NCT00911859|464322587|FG001|Treatment Period|Withdrawal by Subject|4|||
129008462|NCT00911859|464322588|FG002|Treatment Period|Withdrawal by Subject|5|||
129008463|NCT00911859|464322586|FG000|Treatment Period|Did not receive study treatment|0|||
129008464|NCT00911859|464322587|FG001|Treatment Period|Did not receive study treatment|1|||
129008465|NCT00911859|464322588|FG002|Treatment Period|Did not receive study treatment|0|||
129008466|NCT00911859|464322586|FG000|Maintainance Period|Lack of Efficacy|0|||
129008467|NCT00911859|464322587|FG001|Maintainance Period|Lack of Efficacy|0|||
129008468|NCT00911859|464322588|FG002|Maintainance Period|Lack of Efficacy|9|||
129008469|NCT00911859|464322586|FG000|Maintainance Period|Physician Decision|0|||
129008470|NCT00911859|464322587|FG001|Maintainance Period|Physician Decision|0|||
129008471|NCT00911859|464322588|FG002|Maintainance Period|Physician Decision|9|||
129008472|NCT00911859|464322586|FG000|Maintainance Period|Withdrawal by Subject|0|||
129008473|NCT00911859|464322587|FG001|Maintainance Period|Withdrawal by Subject|0|||
129008474|NCT00911859|464322588|FG002|Maintainance Period|Withdrawal by Subject|3|||
129008475|NCT00911859|464322586|FG000|Follow-up Period|Death|5|||
129008476|NCT00911859|464322587|FG001|Follow-up Period|Death|8|||
129008477|NCT00911859|464322588|FG002|Follow-up Period|Death|10|||
129008478|NCT00911859|464322586|FG000|Follow-up Period|Lost to Follow-up|1|||
129008479|NCT00911859|464322587|FG001|Follow-up Period|Lost to Follow-up|1|||
129008480|NCT00911859|464322588|FG002|Follow-up Period|Lost to Follow-up|0|||
129008481|NCT00911859|464322586|FG000|Follow-up Period|Withdrawal by Subject|0|||
129008482|NCT00911859|464322587|FG001|Follow-up Period|Withdrawal by Subject|4|||
129008483|NCT00911859|464322588|FG002|Follow-up Period|Withdrawal by Subject|4|||
129008484|NCT00911859|464322586|FG000|Follow-up Period|Study terminated by sponsor|5|||
129008485|NCT00911859|464322587|FG001|Follow-up Period|Study terminated by sponsor|33|||
129008486|NCT00911859|464322588|FG002|Follow-up Period|Study terminated by sponsor|27|||
129008487|NCT01048333|464322589|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129008488|NCT01048333|464322590|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
129008489|NCT01048333|464322591|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129008490|NCT01048333|464322592|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129008491|NCT01048333|464322593|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129008492|NCT01048333|464322594|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129008493|NCT00634179|464322602|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
129008494|NCT00767325|464322605|FG000|Overall Study|Lack of Efficacy|2|||
129008495|NCT00767325|464322605|FG000|Overall Study|Adverse Event|7|||
129008496|NCT00767325|464322605|FG000|Overall Study|Lost to Follow-up|3|||
129008497|NCT00767325|464322605|FG000|Overall Study|No longer met study criteria|2|||
129008498|NCT00767325|464322605|FG000|Overall Study|Missed visit due to family reasons|1|||
129008499|NCT03538756|464322606|FG000|Long-Term Follow-up|Adverse Event|0|||
129008500|NCT03538756|464322607|FG001|Long-Term Follow-up|Adverse Event|0|||
129008501|NCT03538756|464322608|FG002|Long-Term Follow-up|Adverse Event|6|||
129008502|NCT03538756|464322606|FG000|Long-Term Follow-up|Death|0|||
129008503|NCT03538756|464322607|FG001|Long-Term Follow-up|Death|0|||
129008504|NCT03538756|464322608|FG002|Long-Term Follow-up|Death|1|||
129008505|NCT03538756|464322606|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
129008506|NCT03538756|464322607|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
129008507|NCT03538756|464322608|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
129008508|NCT03538756|464322606|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
129008509|NCT03538756|464322607|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
129008510|NCT03538756|464322608|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
129008511|NCT03538756|464322606|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
129008512|NCT03538756|464322607|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
129008513|NCT03538756|464322608|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
129008514|NCT00752856|464322609|FG000|Overall Study|randomized but did not do viral kinetics|0|||
129008515|NCT00752856|464322610|FG001|Overall Study|randomized but did not do viral kinetics|1|||
129008516|NCT03131999|464322611|FG000|Overall Study|Withdrawal by Subject|0|||
129008517|NCT03131999|464322612|FG001|Overall Study|Withdrawal by Subject|1|||
129008518|NCT00996736|464322618|FG000|Overall Study|Death|1|||
129008519|NCT00996736|464322619|FG001|Overall Study|Death|1|||
129008520|NCT00996736|464322618|FG000|Overall Study|Lost to Follow-up|15|||
129008521|NCT00996736|464322619|FG001|Overall Study|Lost to Follow-up|14|||
129008522|NCT00996736|464322618|FG000|Overall Study|Visit not within 3-month window|5|||
129008523|NCT00996736|464322619|FG001|Overall Study|Visit not within 3-month window|3|||
129008524|NCT02688608|464322620|FG000|Overall Study|Lost to Follow-up|1|||
129008525|NCT02456909|464322621|FG000|Overall Study|Did not receive allocated intervention|24|||
129008526|NCT02456909|464322622|FG001|Overall Study|Did not receive allocated intervention|26|||
129008527|NCT02456909|464322621|FG000|Overall Study|Did not complete the primary outcome|0|||
129008528|NCT02456909|464322622|FG001|Overall Study|Did not complete the primary outcome|1|||
129008529|NCT01497938|464322625|FG000|Overall Study|Adverse Event|0|||
129008530|NCT01497938|464322626|FG001|Overall Study|Adverse Event|1|||
129008531|NCT01497938|464322625|FG000|Overall Study|Physician Decision|0|||
129008532|NCT01497938|464322626|FG001|Overall Study|Physician Decision|1|||
129008533|NCT01497938|464322625|FG000|Overall Study|Withdrawal by Subject|4|||
129098713|NCT02907619|464654113|FG002|Overall Study|Other|0|||
129098714|NCT01908582|464654114|FG000|Period 2|Physician Decision|1|||
129098715|NCT01908582|464654114|FG000|Period 2|Withdrawal by Subject|1|||
129098716|NCT03484403|464654118|FG000|Overall Study|Withdrawal by Subject|6|||
129098717|NCT03484403|464654119|FG001|Overall Study|Withdrawal by Subject|4|||
129098718|NCT04767529|464654126|FG000|Overall Study|Adverse Event|0|||
129098719|NCT04767529|464654127|FG001|Overall Study|Adverse Event|4|||
129098720|NCT04767529|464654128|FG002|Overall Study|Adverse Event|3|||
129098721|NCT04767529|464654126|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
129098722|NCT04767529|464654127|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
129098723|NCT04767529|464654128|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
129098724|NCT04767529|464654126|FG000|Overall Study|Required use of a prohibited medication|0|||
129098725|NCT04767529|464654127|FG001|Overall Study|Required use of a prohibited medication|1|||
129098726|NCT04767529|464654128|FG002|Overall Study|Required use of a prohibited medication|0|||
129098727|NCT04767529|464654126|FG000|Overall Study|Withdrawal by Subject|7|||
129098728|NCT04767529|464654127|FG001|Overall Study|Withdrawal by Subject|5|||
129098729|NCT04767529|464654128|FG002|Overall Study|Withdrawal by Subject|4|||
129098730|NCT04767529|464654126|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
129098731|NCT04767529|464654127|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
129215079|NCT02760498|465089438|FG002|Overall Study|Disease progression|20|||
129008534|NCT01497938|464322626|FG001|Overall Study|Withdrawal by Subject|0|||
129008535|NCT01497938|464322625|FG000|Overall Study|Device Violation|1|||
129008536|NCT01497938|464322626|FG001|Overall Study|Device Violation|0|||
129008537|NCT00365352|464322627|FG000|Overall Study|Adverse Event|6|||
129008538|NCT00365352|464322628|FG001|Overall Study|Adverse Event|7|||
129008539|NCT00365352|464322629|FG002|Overall Study|Adverse Event|8|||
129008540|NCT00365352|464322627|FG000|Overall Study|Participant Withdrew Consent|8|||
129008541|NCT00365352|464322628|FG001|Overall Study|Participant Withdrew Consent|3|||
129098732|NCT04767529|464654128|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
129098733|NCT04767529|464654126|FG000|Overall Study|Lost to Follow-up|0|||
129098734|NCT04767529|464654127|FG001|Overall Study|Lost to Follow-up|2|||
129098735|NCT04767529|464654128|FG002|Overall Study|Lost to Follow-up|3|||
129098736|NCT01937884|464654137|FG000|Overall Study|Withdrawal by Subject|1|||
129098737|NCT01937884|464654138|FG001|Overall Study|Withdrawal by Subject|0|||
129098738|NCT00004088|464654139|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
129098739|NCT00004088|464654139|FG000|Overall Study|Withdrawal by Subject|1|||
129098740|NCT00004088|464654139|FG000|Overall Study|Protocol Violation|3|||
129098741|NCT00004088|464654139|FG000|Overall Study|Physician Decision|1|||
129098742|NCT02722746|464654140|FG000|Overall Study|Withdrawal by Subject|0|||
129098743|NCT02722746|464654141|FG001|Overall Study|Withdrawal by Subject|1|||
129098744|NCT02722746|464654142|FG002|Overall Study|Withdrawal by Subject|0|||
129098745|NCT02722746|464654140|FG000|Overall Study|Protocol Violation|8|||
129098746|NCT02722746|464654141|FG001|Overall Study|Protocol Violation|4|||
129098747|NCT02722746|464654142|FG002|Overall Study|Protocol Violation|6|||
129098748|NCT00981058|464654143|FG000|Overall Study|Progressive Disease|38|||
129098749|NCT00981058|464654144|FG001|Overall Study|Progressive Disease|31|||
129098750|NCT00981058|464654143|FG000|Overall Study|Lost to Follow-up|3|||
129098751|NCT00981058|464654144|FG001|Overall Study|Lost to Follow-up|2|||
129098752|NCT00981058|464654143|FG000|Overall Study|Physician Decision|4|||
129098753|NCT00981058|464654144|FG001|Overall Study|Physician Decision|5|||
129098754|NCT00981058|464654143|FG000|Overall Study|Randomization Error|0|||
129098755|NCT00981058|464654144|FG001|Overall Study|Randomization Error|1|||
129098756|NCT00981058|464654143|FG000|Overall Study|Withdrawal by Subject|24|||
129098757|NCT00981058|464654144|FG001|Overall Study|Withdrawal by Subject|22|||
129098758|NCT02667587|464654145|FG000|Pre-Treatment|Not reported|1|||
129098759|NCT02667587|464654146|FG001|Pre-Treatment|Not reported|0|||
129098760|NCT02667587|464654145|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129098761|NCT02667587|464654146|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
129098762|NCT02667587|464654145|FG000|Pre-Treatment|Participant withdrew consent|0|||
129098763|NCT02667587|464654146|FG001|Pre-Treatment|Participant withdrew consent|1|||
129098764|NCT02667587|464654145|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
129098765|NCT02667587|464654146|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
129098766|NCT02667587|464654145|FG000|End of Treatment|Disease Progression|193|||
129098767|NCT02667587|464654146|FG001|End of Treatment|Disease Progression|226|||
129098768|NCT02667587|464654145|FG000|End of Treatment|Study Drug Toxicity|75|||
129098769|NCT02667587|464654146|FG001|End of Treatment|Study Drug Toxicity|19|||
129098770|NCT02667587|464654145|FG000|End of Treatment|Death|2|||
129098771|NCT02667587|464654146|FG001|End of Treatment|Death|1|||
129098772|NCT02667587|464654145|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
129098773|NCT02667587|464654146|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
129098774|NCT02667587|464654145|FG000|End of Treatment|participant request to discontinue treatment|33|||
129098775|NCT02667587|464654146|FG001|End of Treatment|participant request to discontinue treatment|35|||
129098776|NCT02667587|464654145|FG000|End of Treatment|participant withdrew consent|5|||
129098777|NCT02667587|464654146|FG001|End of Treatment|participant withdrew consent|6|||
129098778|NCT02667587|464654145|FG000|End of Treatment|Lost to Follow-up|1|||
129098779|NCT02667587|464654146|FG001|End of Treatment|Lost to Follow-up|2|||
129098780|NCT02667587|464654145|FG000|End of Treatment|maximum clinical benefit|4|||
129098781|NCT02667587|464654146|FG001|End of Treatment|maximum clinical benefit|4|||
129098782|NCT02667587|464654145|FG000|End of Treatment|poor or non compliant|0|||
129098783|NCT02667587|464654146|FG001|End of Treatment|poor or non compliant|1|||
129098784|NCT02667587|464654145|FG000|End of Treatment|participant no longer meets study criteria|1|||
129098785|NCT02667587|464654146|FG001|End of Treatment|participant no longer meets study criteria|1|||
129098786|NCT02667587|464654145|FG000|End of Treatment|administrative reason by sponsor|1|||
129098787|NCT02667587|464654146|FG001|End of Treatment|administrative reason by sponsor|29|||
129098788|NCT02667587|464654145|FG000|End of Treatment|other reasonse|21|||
129098789|NCT02667587|464654146|FG001|End of Treatment|other reasonse|10|||
129098790|NCT01134263|464654147|FG000|Overall Study|Serious adverse event|2|||
129098791|NCT01134263|464654148|FG001|Overall Study|Serious adverse event|1|||
129098792|NCT01134263|464654149|FG002|Overall Study|Serious adverse event|1|||
129098793|NCT01134263|464654150|FG003|Overall Study|Serious adverse event|1|||
129098794|NCT01134263|464654151|FG004|Overall Study|Serious adverse event|1|||
129098795|NCT01134263|464654147|FG000|Overall Study|Other adverse event|1|||
129098796|NCT01134263|464654148|FG001|Overall Study|Other adverse event|2|||
129098797|NCT01134263|464654149|FG002|Overall Study|Other adverse event|5|||
129098798|NCT01134263|464654150|FG003|Overall Study|Other adverse event|3|||
129098799|NCT01134263|464654151|FG004|Overall Study|Other adverse event|0|||
129098800|NCT01134263|464654147|FG000|Overall Study|Protocol Violation|8|||
129098801|NCT01134263|464654148|FG001|Overall Study|Protocol Violation|7|||
129098802|NCT01134263|464654149|FG002|Overall Study|Protocol Violation|2|||
129098803|NCT01134263|464654150|FG003|Overall Study|Protocol Violation|4|||
129098804|NCT01134263|464654151|FG004|Overall Study|Protocol Violation|2|||
129098805|NCT01134263|464654147|FG000|Overall Study|Lost to Follow-up|4|||
129098806|NCT01134263|464654148|FG001|Overall Study|Lost to Follow-up|3|||
129008542|NCT00365352|464322629|FG002|Overall Study|Participant Withdrew Consent|4|||
129098807|NCT01134263|464654149|FG002|Overall Study|Lost to Follow-up|5|||
129098808|NCT01134263|464654150|FG003|Overall Study|Lost to Follow-up|3|||
129098809|NCT01134263|464654151|FG004|Overall Study|Lost to Follow-up|1|||
129098810|NCT01134263|464654147|FG000|Overall Study|Withdrawal by Subject|8|||
129098811|NCT01134263|464654148|FG001|Overall Study|Withdrawal by Subject|6|||
129098812|NCT01134263|464654149|FG002|Overall Study|Withdrawal by Subject|16|||
129098813|NCT01134263|464654150|FG003|Overall Study|Withdrawal by Subject|7|||
129098814|NCT01134263|464654151|FG004|Overall Study|Withdrawal by Subject|5|||
129098815|NCT01134263|464654147|FG000|Overall Study|Enrolled, but not treated|1|||
129098816|NCT01134263|464654148|FG001|Overall Study|Enrolled, but not treated|1|||
129098817|NCT01134263|464654149|FG002|Overall Study|Enrolled, but not treated|0|||
129098818|NCT01134263|464654150|FG003|Overall Study|Enrolled, but not treated|1|||
129098819|NCT01134263|464654151|FG004|Overall Study|Enrolled, but not treated|0|||
129098820|NCT05182606|464654155|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
129098821|NCT01955109|464654158|FG000|Overall Study|Adverse Event|2|||
129098822|NCT01955109|464654159|FG001|Overall Study|Adverse Event|0|||
129098823|NCT01955109|464654158|FG000|Overall Study|Participant unwilling to continue|35|||
129098824|NCT01955109|464654159|FG001|Overall Study|Participant unwilling to continue|7|||
129098825|NCT01955109|464654158|FG000|Overall Study|Physician Decision|2|||
129098826|NCT01955109|464654159|FG001|Overall Study|Physician Decision|0|||
129098827|NCT01955109|464654158|FG000|Overall Study|Lost to Follow-up|3|||
129098828|NCT01955109|464654159|FG001|Overall Study|Lost to Follow-up|1|||
129098829|NCT01955109|464654158|FG000|Overall Study|Non-compliance|3|||
129098830|NCT01955109|464654159|FG001|Overall Study|Non-compliance|1|||
129098831|NCT00438256|464654163|FG000|Overall Study|Ineligible for Resection|2|||
129098832|NCT00438256|464654164|FG001|Overall Study|Ineligible for Resection|1|||
129098833|NCT00438256|464654165|FG002|Overall Study|Ineligible for Resection|1|||
129098834|NCT00438256|464654166|FG003|Overall Study|Ineligible for Resection|7|||
129098835|NCT00438256|464654163|FG000|Overall Study|Excluded final Diagnosis|0|||
129098836|NCT00438256|464654164|FG001|Overall Study|Excluded final Diagnosis|0|||
129098837|NCT00438256|464654165|FG002|Overall Study|Excluded final Diagnosis|0|||
129098838|NCT00438256|464654166|FG003|Overall Study|Excluded final Diagnosis|2|||
129098839|NCT01133288|464654167|FG000|Eligibility Assessment|met exclusion criteria|5|||
129098840|NCT01133288|464654167|FG000|Intervention Allocation|study terminated|2|||
129098841|NCT00750919|464654175|FG000|Overall Study|Adverse Event|9|||
129098842|NCT00750919|464654175|FG000|Overall Study|Withdrawal by Subject|1|||
129098843|NCT00750919|464654175|FG000|Overall Study|Lack of Efficacy|8|||
129098844|NCT00750919|464654175|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
129098845|NCT00750919|464654175|FG000|Overall Study|Other|36|||
129098846|NCT00574795|464654181|FG000|Infant Series|Withdrawal by Subject|2|||
129098847|NCT00574795|464654181|FG000|Infant Series|Protocol Violation|2|||
129098848|NCT00574795|464654181|FG000|Infant Series|Adverse Event|1|||
129098849|NCT00574795|464654181|FG000|After Infant Series|Withdrawal by Subject|1|||
129098850|NCT00574795|464654181|FG000|After Infant Series|Adverse Event|2|||
129098851|NCT00574795|464654181|FG000|Toddler Dose|Withdrawal by Subject|1|||
129098852|NCT01094782|464654182|FG000|Overall Study|Withdrawal by Subject|5|||
129098853|NCT01094782|464654183|FG001|Overall Study|Withdrawal by Subject|5|||
129098854|NCT01094782|464654184|FG002|Overall Study|Withdrawal by Subject|1|||
129098855|NCT01094782|464654185|FG003|Overall Study|Withdrawal by Subject|5|||
129098856|NCT01094782|464654186|FG004|Overall Study|Withdrawal by Subject|5|||
129098857|NCT01094782|464654187|FG005|Overall Study|Withdrawal by Subject|0|||
129098858|NCT01094782|464654182|FG000|Overall Study|Lost to Follow-up|1|||
129098859|NCT01094782|464654183|FG001|Overall Study|Lost to Follow-up|0|||
129098860|NCT01094782|464654184|FG002|Overall Study|Lost to Follow-up|0|||
129098861|NCT01094782|464654185|FG003|Overall Study|Lost to Follow-up|2|||
129098862|NCT01094782|464654186|FG004|Overall Study|Lost to Follow-up|1|||
129098863|NCT01094782|464654187|FG005|Overall Study|Lost to Follow-up|4|||
129098864|NCT01094782|464654182|FG000|Overall Study|Positive Drug Screen|2|||
129098865|NCT01094782|464654183|FG001|Overall Study|Positive Drug Screen|2|||
129098866|NCT01094782|464654184|FG002|Overall Study|Positive Drug Screen|1|||
129098867|NCT01094782|464654185|FG003|Overall Study|Positive Drug Screen|1|||
129008543|NCT00365352|464322627|FG000|Overall Study|Lack of Efficacy|3|||
129008544|NCT00365352|464322628|FG001|Overall Study|Lack of Efficacy|0|||
129008545|NCT00365352|464322629|FG002|Overall Study|Lack of Efficacy|0|||
129008546|NCT00365352|464322627|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
129008547|NCT00365352|464322628|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
129008548|NCT00365352|464322629|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
129008549|NCT00365352|464322627|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
129098868|NCT01094782|464654186|FG004|Overall Study|Positive Drug Screen|3|||
129098869|NCT01094782|464654187|FG005|Overall Study|Positive Drug Screen|2|||
129098870|NCT01094782|464654182|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
129098871|NCT01094782|464654183|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
129098872|NCT01094782|464654184|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
129098873|NCT01094782|464654185|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
129008550|NCT00365352|464322628|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
129008551|NCT00365352|464322629|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
129008552|NCT00365352|464322627|FG000|Overall Study|Lost to Follow-up|1|||
129008553|NCT00365352|464322628|FG001|Overall Study|Lost to Follow-up|1|||
129008554|NCT00365352|464322629|FG002|Overall Study|Lost to Follow-up|0|||
129008555|NCT00365352|464322627|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
129008556|NCT00365352|464322628|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
129008557|NCT00365352|464322629|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
129008558|NCT00409578|464322634|FG000|Overall Study|Adverse Event|27|||
129008559|NCT00409578|464322635|FG001|Overall Study|Adverse Event|37|||
129008560|NCT00409578|464322636|FG002|Overall Study|Adverse Event|25|||
129008561|NCT00409578|464322637|FG003|Overall Study|Adverse Event|33|||
129008562|NCT00409578|464322634|FG000|Overall Study|Abnormal laboratory value(s)|2|||
129008563|NCT00409578|464322635|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129008564|NCT00409578|464322636|FG002|Overall Study|Abnormal laboratory value(s)|2|||
129008565|NCT00409578|464322637|FG003|Overall Study|Abnormal laboratory value(s)|4|||
129008566|NCT00409578|464322634|FG000|Overall Study|Lack of Efficacy|0|||
129008567|NCT00409578|464322635|FG001|Overall Study|Lack of Efficacy|0|||
129008568|NCT00409578|464322636|FG002|Overall Study|Lack of Efficacy|0|||
129008569|NCT00409578|464322637|FG003|Overall Study|Lack of Efficacy|2|||
129008570|NCT00409578|464322634|FG000|Overall Study|Subject no longer requires study drug|0|||
129008571|NCT00409578|464322635|FG001|Overall Study|Subject no longer requires study drug|0|||
129008572|NCT00409578|464322636|FG002|Overall Study|Subject no longer requires study drug|0|||
129098874|NCT01094782|464654186|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
129098875|NCT01094782|464654187|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
129098876|NCT01094782|464654182|FG000|Overall Study|Unable to Complete Questionnaires|0|||
129098877|NCT01094782|464654183|FG001|Overall Study|Unable to Complete Questionnaires|1|||
128674825|NCT03148691|463108591|FG002|Overall Study|Lost to Follow-up|1|||
128674826|NCT03148691|463108589|FG000|Overall Study|Other|1|||
128674827|NCT03148691|463108590|FG001|Overall Study|Other|0|||
128674828|NCT03148691|463108591|FG002|Overall Study|Other|0|||
128674829|NCT03148691|463108589|FG000|Overall Study|Withdrawal by Subject|1|||
128674830|NCT03148691|463108590|FG001|Overall Study|Withdrawal by Subject|0|||
128674831|NCT03148691|463108591|FG002|Overall Study|Withdrawal by Subject|0|||
128674832|NCT00171834|463108592|FG000|Overall Study|Adverse Event|2|||
128674833|NCT00171834|463108593|FG001|Overall Study|Adverse Event|1|||
128674834|NCT00171834|463108594|FG002|Overall Study|Adverse Event|3|||
128674835|NCT00171834|463108595|FG003|Overall Study|Adverse Event|2|||
128674836|NCT00171834|463108596|FG004|Overall Study|Adverse Event|2|||
128674837|NCT00171834|463108597|FG005|Overall Study|Adverse Event|15|||
128674838|NCT00171834|463108598|FG006|Overall Study|Adverse Event|1|||
128674839|NCT00171834|463108592|FG000|Overall Study|Withdrawal by Subject|0|||
128674840|NCT00171834|463108593|FG001|Overall Study|Withdrawal by Subject|2|||
128674841|NCT00171834|463108594|FG002|Overall Study|Withdrawal by Subject|0|||
128674842|NCT00171834|463108595|FG003|Overall Study|Withdrawal by Subject|1|||
128674843|NCT00171834|463108596|FG004|Overall Study|Withdrawal by Subject|1|||
128674844|NCT00171834|463108597|FG005|Overall Study|Withdrawal by Subject|1|||
128674845|NCT00171834|463108598|FG006|Overall Study|Withdrawal by Subject|0|||
128674846|NCT00171834|463108592|FG000|Overall Study|Death from study indication|0|||
128674847|NCT00171834|463108593|FG001|Overall Study|Death from study indication|1|||
128674848|NCT00171834|463108594|FG002|Overall Study|Death from study indication|0|||
128674849|NCT00171834|463108595|FG003|Overall Study|Death from study indication|0|||
128674850|NCT00171834|463108596|FG004|Overall Study|Death from study indication|1|||
128674851|NCT00171834|463108597|FG005|Overall Study|Death from study indication|0|||
128674852|NCT00171834|463108598|FG006|Overall Study|Death from study indication|0|||
128674853|NCT00171834|463108592|FG000|Overall Study|Disease Progression|4|||
128674854|NCT00171834|463108593|FG001|Overall Study|Disease Progression|8|||
128674855|NCT00171834|463108594|FG002|Overall Study|Disease Progression|8|||
128674856|NCT00171834|463108595|FG003|Overall Study|Disease Progression|9|||
128674857|NCT00171834|463108596|FG004|Overall Study|Disease Progression|2|||
128674858|NCT00171834|463108597|FG005|Overall Study|Disease Progression|18|||
128674859|NCT00171834|463108598|FG006|Overall Study|Disease Progression|3|||
128674860|NCT00171834|463108592|FG000|Overall Study|Treatment Duration Completed|0|||
128674861|NCT00171834|463108593|FG001|Overall Study|Treatment Duration Completed|0|||
128674862|NCT00171834|463108594|FG002|Overall Study|Treatment Duration Completed|1|||
128674863|NCT00171834|463108595|FG003|Overall Study|Treatment Duration Completed|0|||
128674864|NCT00171834|463108596|FG004|Overall Study|Treatment Duration Completed|2|||
128674865|NCT00171834|463108597|FG005|Overall Study|Treatment Duration Completed|1|||
128674866|NCT00171834|463108598|FG006|Overall Study|Treatment Duration Completed|0|||
128674867|NCT00439738|463108602|FG000|Overall Study|Withdrawal by Subject|16|||
128878398|NCT02414932|463848471|FG000|Overall Study|Adverse Event|1|||
129008573|NCT00409578|464322637|FG003|Overall Study|Subject no longer requires study drug|1|||
129008574|NCT00409578|464322634|FG000|Overall Study|Withdrawal by Subject|8|||
129098878|NCT01094782|464654184|FG002|Overall Study|Unable to Complete Questionnaires|0|||
129098879|NCT01094782|464654185|FG003|Overall Study|Unable to Complete Questionnaires|0|||
128674868|NCT00439738|463108603|FG001|Overall Study|Withdrawal by Subject|13|||
128674869|NCT00439738|463108602|FG000|Overall Study|Adverse Event|6|||
128674870|NCT00439738|463108603|FG001|Overall Study|Adverse Event|4|||
128674871|NCT00439738|463108602|FG000|Overall Study|Lost to Follow-up|5|||
128674872|NCT00439738|463108603|FG001|Overall Study|Lost to Follow-up|6|||
128674873|NCT00439738|463108602|FG000|Overall Study|Protocol Violation|6|||
128674874|NCT00439738|463108603|FG001|Overall Study|Protocol Violation|3|||
128674875|NCT00439738|463108602|FG000|Overall Study|Lack of Efficacy|2|||
128674876|NCT00439738|463108603|FG001|Overall Study|Lack of Efficacy|2|||
128674877|NCT00439738|463108602|FG000|Overall Study|Abnormal Lab Values|1|||
128674878|NCT00439738|463108603|FG001|Overall Study|Abnormal Lab Values|0|||
128674879|NCT00978757|463108604|FG000|Overall Study|Physician Decision|1|||
128674880|NCT00978757|463108605|FG001|Overall Study|Physician Decision|3|||
128674881|NCT01700387|463108606|FG000|Overall Study|Withdrawal by Subject|1|||
128674882|NCT01700387|463108607|FG001|Overall Study|Withdrawal by Subject|2|||
128674883|NCT01700387|463108606|FG000|Overall Study|Adverse Event|1|||
128674884|NCT01700387|463108607|FG001|Overall Study|Adverse Event|1|||
128674885|NCT01700387|463108606|FG000|Overall Study|Lost to Follow-up|2|||
128674886|NCT01700387|463108607|FG001|Overall Study|Lost to Follow-up|1|||
128674887|NCT01185353|463108609|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
128674888|NCT01185353|463108610|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
128674889|NCT01185353|463108611|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
128674890|NCT01185353|463108612|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
128674891|NCT01185353|463108613|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
128674892|NCT01185353|463108614|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
128674893|NCT01185353|463108615|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
128674894|NCT01185353|463108616|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
128674895|NCT01185353|463108617|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
128674896|NCT01185353|463108618|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
128674897|NCT01185353|463108609|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674898|NCT01185353|463108610|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674899|NCT01185353|463108611|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674900|NCT01185353|463108612|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674901|NCT01185353|463108613|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
128674902|NCT01185353|463108614|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674903|NCT01185353|463108615|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674904|NCT01185353|463108616|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674905|NCT01185353|463108617|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674906|NCT01185353|463108618|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
128674907|NCT01185353|463108609|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
128674908|NCT01185353|463108610|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674909|NCT01185353|463108611|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674910|NCT01185353|463108612|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674911|NCT01185353|463108613|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
128674912|NCT01185353|463108614|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674913|NCT01185353|463108615|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674914|NCT01185353|463108616|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674915|NCT01185353|463108617|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674916|NCT01185353|463108618|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
128674917|NCT01185353|463108609|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674918|NCT01185353|463108610|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674919|NCT01185353|463108611|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
128674920|NCT01185353|463108612|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674921|NCT01185353|463108613|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
128674922|NCT01185353|463108614|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674923|NCT01185353|463108615|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674924|NCT01185353|463108616|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674925|NCT01185353|463108617|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674926|NCT01185353|463108618|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
128674927|NCT01185353|463108609|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674928|NCT01185353|463108610|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674929|NCT01185353|463108611|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674930|NCT01185353|463108612|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674931|NCT01185353|463108613|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
128674932|NCT01185353|463108614|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674933|NCT01185353|463108615|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674934|NCT01185353|463108616|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674935|NCT01185353|463108617|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674936|NCT01185353|463108618|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
128674937|NCT01185353|463108609|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
128674938|NCT01185353|463108610|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674939|NCT01185353|463108611|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674940|NCT01185353|463108612|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674941|NCT01185353|463108613|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
128674942|NCT01185353|463108614|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674943|NCT01185353|463108615|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674944|NCT01185353|463108616|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674945|NCT01185353|463108617|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674946|NCT01185353|463108618|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
128674947|NCT01185353|463108609|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674948|NCT01185353|463108610|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674949|NCT01185353|463108611|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
128674950|NCT01185353|463108612|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674951|NCT01185353|463108613|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674952|NCT01185353|463108614|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
128674953|NCT01185353|463108615|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674954|NCT01185353|463108616|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674955|NCT01185353|463108617|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674956|NCT01185353|463108618|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
128674957|NCT01185353|463108609|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674958|NCT01185353|463108610|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
128674959|NCT01185353|463108611|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674960|NCT01185353|463108612|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
128674961|NCT01185353|463108613|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674962|NCT01185353|463108614|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674963|NCT01185353|463108615|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674964|NCT01185353|463108616|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674965|NCT01185353|463108617|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674966|NCT01185353|463108618|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
128674967|NCT01185353|463108609|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674968|NCT01185353|463108610|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674969|NCT01185353|463108611|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674970|NCT01185353|463108612|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
128674971|NCT01185353|463108613|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674972|NCT01185353|463108614|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674973|NCT01185353|463108615|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
128674974|NCT01185353|463108616|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674975|NCT01185353|463108617|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674976|NCT01185353|463108618|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
128674977|NCT01185353|463108609|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
128674978|NCT01185353|463108610|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
128674979|NCT01185353|463108611|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
128674980|NCT01185353|463108612|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
128674981|NCT01185353|463108613|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
128674982|NCT01185353|463108614|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
128674983|NCT01185353|463108615|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
128674984|NCT01185353|463108616|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
128674985|NCT01185353|463108617|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
128674986|NCT01185353|463108618|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
128674987|NCT01185353|463108609|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129008575|NCT00409578|464322635|FG001|Overall Study|Withdrawal by Subject|15|||
129008576|NCT00409578|464322636|FG002|Overall Study|Withdrawal by Subject|16|||
129008577|NCT00409578|464322637|FG003|Overall Study|Withdrawal by Subject|17|||
129008578|NCT00409578|464322634|FG000|Overall Study|Lost to Follow-up|2|||
129008579|NCT00409578|464322635|FG001|Overall Study|Lost to Follow-up|0|||
129008580|NCT00409578|464322636|FG002|Overall Study|Lost to Follow-up|2|||
129008581|NCT00409578|464322637|FG003|Overall Study|Lost to Follow-up|2|||
129008582|NCT00409578|464322634|FG000|Overall Study|Administrative problems|8|||
129008583|NCT00409578|464322635|FG001|Overall Study|Administrative problems|9|||
129008584|NCT00409578|464322636|FG002|Overall Study|Administrative problems|2|||
129008585|NCT00409578|464322637|FG003|Overall Study|Administrative problems|4|||
129008586|NCT00409578|464322634|FG000|Overall Study|Death|2|||
129008587|NCT00409578|464322635|FG001|Overall Study|Death|4|||
129008588|NCT00409578|464322636|FG002|Overall Study|Death|4|||
128674988|NCT01185353|463108610|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674989|NCT01185353|463108611|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674990|NCT01185353|463108612|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674991|NCT01185353|463108613|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674992|NCT01185353|463108614|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674993|NCT01185353|463108615|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
128674994|NCT01185353|463108616|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674995|NCT01185353|463108617|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674996|NCT01185353|463108618|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
128674997|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
128674998|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
128674999|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
128675000|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
128675001|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
128675002|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
128675003|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
128675004|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
128675005|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
128675006|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
128675007|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
128675008|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
128675009|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
128675010|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
128675011|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
128675012|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
128675013|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
128675014|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
129008589|NCT00409578|464322637|FG003|Overall Study|Death|2|||
129008590|NCT00409578|464322634|FG000|Overall Study|Protocol Violation|3|||
128675015|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
128675016|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
128675017|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
128675018|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
128675019|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
128675020|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
128675021|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
128675022|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
128675023|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
128675024|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
128675025|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
128675026|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
128675027|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675028|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675029|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675030|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675031|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675032|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675033|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675034|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675035|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
128675036|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
128675037|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Death|0|||
128675038|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Death|0|||
128675039|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Death|0|||
128675040|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Death|0|||
128675041|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Death|0|||
128675042|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Death|0|||
128675043|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Death|0|||
128675044|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Death|0|||
128675045|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Death|0|||
128675046|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Death|1|||
129008591|NCT00409578|464322635|FG001|Overall Study|Protocol Violation|2|||
129008592|NCT00409578|464322636|FG002|Overall Study|Protocol Violation|3|||
129008593|NCT00409578|464322637|FG003|Overall Study|Protocol Violation|1|||
129008594|NCT00409578|464322634|FG000|Overall Study|Missing|0|||
129008595|NCT00409578|464322635|FG001|Overall Study|Missing|1|||
129008596|NCT00409578|464322636|FG002|Overall Study|Missing|0|||
129008597|NCT00409578|464322637|FG003|Overall Study|Missing|1|||
129008598|NCT02109133|464322638|FG000|Overall Study|Lost to Follow-up|1|||
129008599|NCT02109133|464322639|FG001|Overall Study|Lost to Follow-up|0|||
129008600|NCT05200858|464322642|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
129008601|NCT05200858|464322643|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
128675047|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
128675048|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
128675049|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129008602|NCT05200858|464322644|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
129008603|NCT05200858|464322645|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
128675050|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129008604|NCT00313703|464324679|FG000|Overall Study|Lost to Follow-up|11|||
129008605|NCT00313703|464324680|FG001|Overall Study|Lost to Follow-up|2|||
129098880|NCT01094782|464654186|FG004|Overall Study|Unable to Complete Questionnaires|0|||
129098881|NCT01094782|464654187|FG005|Overall Study|Unable to Complete Questionnaires|0|||
129098882|NCT01094782|464654182|FG000|Overall Study|Healthy Subject Had Pain|0|||
129098883|NCT01094782|464654183|FG001|Overall Study|Healthy Subject Had Pain|1|||
129098884|NCT01094782|464654184|FG002|Overall Study|Healthy Subject Had Pain|0|||
129098885|NCT01094782|464654185|FG003|Overall Study|Healthy Subject Had Pain|0|||
129098886|NCT01094782|464654186|FG004|Overall Study|Healthy Subject Had Pain|0|||
129098887|NCT01094782|464654187|FG005|Overall Study|Healthy Subject Had Pain|0|||
129098888|NCT01094782|464654182|FG000|Overall Study|Hypertension|0|||
129098889|NCT01094782|464654183|FG001|Overall Study|Hypertension|0|||
129098890|NCT01094782|464654184|FG002|Overall Study|Hypertension|1|||
129098891|NCT01094782|464654185|FG003|Overall Study|Hypertension|0|||
129098892|NCT01094782|464654186|FG004|Overall Study|Hypertension|0|||
129098893|NCT01094782|464654187|FG005|Overall Study|Hypertension|0|||
129098894|NCT01094782|464654182|FG000|Overall Study|Wrong Pain Condition|0|||
129098895|NCT01094782|464654183|FG001|Overall Study|Wrong Pain Condition|0|||
129098896|NCT01094782|464654184|FG002|Overall Study|Wrong Pain Condition|0|||
128675051|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
128675052|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
128675053|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
128675054|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
128675055|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
128675056|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
128675057|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675058|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675059|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675060|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675061|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675062|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675063|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675064|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675065|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
128675066|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
128675067|NCT01185353|463108609|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675068|NCT01185353|463108610|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675069|NCT01185353|463108611|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675070|NCT01185353|463108612|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675071|NCT01185353|463108613|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675072|NCT01185353|463108614|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675073|NCT01185353|463108615|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675074|NCT01185353|463108616|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675075|NCT01185353|463108617|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
128675076|NCT01185353|463108618|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
128675077|NCT01185353|463108609|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675078|NCT01185353|463108610|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675079|NCT01185353|463108611|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675080|NCT01185353|463108612|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675081|NCT01185353|463108613|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675082|NCT01185353|463108614|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675083|NCT01185353|463108615|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675084|NCT01185353|463108616|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
128675085|NCT01185353|463108617|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
128675086|NCT01185353|463108618|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
128675087|NCT01185353|463108609|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
128675088|NCT01185353|463108610|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
128675089|NCT01185353|463108611|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
128675090|NCT01185353|463108612|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
128675091|NCT01185353|463108613|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
128675092|NCT01185353|463108614|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
128675093|NCT01185353|463108615|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
128675094|NCT01185353|463108616|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
128675095|NCT01185353|463108617|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
128675096|NCT01185353|463108618|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
128675097|NCT01185353|463108609|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
128675098|NCT01185353|463108610|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
128675099|NCT01185353|463108611|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
128675100|NCT01185353|463108612|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129098897|NCT01094782|464654185|FG003|Overall Study|Wrong Pain Condition|2|||
129098898|NCT01094782|464654186|FG004|Overall Study|Wrong Pain Condition|1|||
129098899|NCT01094782|464654187|FG005|Overall Study|Wrong Pain Condition|1|||
129215080|NCT02760498|465089439|FG003|Overall Study|Disease progression|18|||
129215081|NCT02760498|465089440|FG004|Overall Study|Disease progression|4|||
128675101|NCT01185353|463108613|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
128675102|NCT01185353|463108614|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
128675103|NCT01185353|463108615|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
128675104|NCT01185353|463108616|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
128675105|NCT01185353|463108617|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
128675106|NCT01185353|463108618|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
128675107|NCT02270944|463108619|FG000|Overall Study|Lost to Follow-up|9|||
128675108|NCT02270944|463108620|FG001|Overall Study|Lost to Follow-up|4|||
129008606|NCT00313703|464324681|FG002|Overall Study|Lost to Follow-up|5|||
129008607|NCT00313703|464324682|FG003|Overall Study|Lost to Follow-up|12|||
129008608|NCT00275002|464324688|FG000|Overall Study|Death|1|||
129008609|NCT00275002|464324689|FG001|Overall Study|Death|0|||
129008610|NCT00275002|464324688|FG000|Overall Study|Disease progression|21|||
129008611|NCT00275002|464324689|FG001|Overall Study|Disease progression|15|||
129008612|NCT00275002|464324688|FG000|Overall Study|Adverse Event|0|||
129008613|NCT00275002|464324689|FG001|Overall Study|Adverse Event|1|||
129008614|NCT00576381|464324699|FG000|Overall Study|Reoperation|3|||
129008615|NCT00576381|464324699|FG000|Overall Study|Adverse Event|4|||
129008616|NCT01031537|464324700|FG000|Overall Study|medical reasons not related to study|3|||
129008617|NCT01031537|464324700|FG000|Overall Study|Lack of Efficacy|1|||
129008618|NCT01031537|464324700|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
129008619|NCT01031537|464324700|FG000|Overall Study|moved, met exclusion criteria|10|||
129008620|NCT01031537|464324700|FG000|Overall Study|Withdrawal by Subject|5|||
129008621|NCT01031537|464324700|FG000|Overall Study|PI removal, no longer met eligibility|12|||
129008622|NCT00623103|464324701|FG000|Overall Study|Adverse Event|70|||
129008623|NCT00623103|464324702|FG001|Overall Study|Adverse Event|60|||
129008624|NCT00623103|464324701|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129008625|NCT00623103|464324702|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
129008626|NCT00623103|464324701|FG000|Overall Study|Withdrawal by Subject|18|||
129008627|NCT00623103|464324702|FG001|Overall Study|Withdrawal by Subject|24|||
129008628|NCT00623103|464324701|FG000|Overall Study|Lost to Follow-up|4|||
129008629|NCT00623103|464324702|FG001|Overall Study|Lost to Follow-up|1|||
129008630|NCT00623103|464324701|FG000|Overall Study|Administrative problems|2|||
129008631|NCT00623103|464324702|FG001|Overall Study|Administrative problems|4|||
129008632|NCT00623103|464324701|FG000|Overall Study|Death|11|||
129008633|NCT00623103|464324702|FG001|Overall Study|Death|11|||
129008634|NCT00623103|464324701|FG000|Overall Study|Protocol deviation|2|||
129008635|NCT00623103|464324702|FG001|Overall Study|Protocol deviation|1|||
129008636|NCT01506947|464324706|FG000|Overall Study|Lost to Follow-up|7|||
129008637|NCT01506947|464324706|FG000|Overall Study|Adverse Event|5|||
129008638|NCT01506947|464324706|FG000|Overall Study|Death|1|||
129008639|NCT01506947|464324706|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
129008640|NCT01700621|464324707|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
129008641|NCT01700621|464324708|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
129008642|NCT01700621|464324707|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
129008643|NCT01700621|464324708|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
129008644|NCT01700621|464324707|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
129008645|NCT01700621|464324708|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
129008646|NCT02166697|464324709|FG000|Overall Study|Protocol Violation|347|||
129008647|NCT02720510|464324713|FG000|Overall Study|Study Terminated by the sponsor|2|||
129008648|NCT02720510|464324714|FG001|Overall Study|Study Terminated by the sponsor|0|||
129008649|NCT02720510|464324713|FG000|Overall Study|Adverse Event|0|||
129008650|NCT02720510|464324714|FG001|Overall Study|Adverse Event|1|||
129008651|NCT02720510|464324713|FG000|Overall Study|Physician Decision|1|||
129008652|NCT02720510|464324714|FG001|Overall Study|Physician Decision|2|||
129008653|NCT01618266|464324720|FG000|Overall Study|Lost to Follow-up|9|||
129008654|NCT01618266|464324720|FG000|Overall Study|Treatment satisfaction|10|||
129008655|NCT01618266|464324720|FG000|Overall Study|Other reasons|11|||
129008656|NCT01618266|464324720|FG000|Overall Study|Lack of Efficacy|23|||
129008657|NCT01618266|464324720|FG000|Overall Study|Protocol Violation|43|||
129008658|NCT02985151|464324721|FG000|Original Randomization|Withdrawal by Subject|0|||
129008659|NCT02985151|464324722|FG001|Original Randomization|Withdrawal by Subject|1|||
129008660|NCT00625807|464324725|FG000|Overall Study|schedule conflict|2|||
129008661|NCT00625807|464324726|FG001|Overall Study|schedule conflict|8|||
129008662|NCT01966042|464324727|FG000|Overall Study|Death|2|||
129008663|NCT02224391|464324728|FG000|Overall Study|Lost to Follow-up|26|||
129008664|NCT02224391|464324729|FG001|Overall Study|Lost to Follow-up|19|||
129008665|NCT02224391|464324728|FG000|Overall Study|Withdrawal by Subject|6|||
129008666|NCT02224391|464324729|FG001|Overall Study|Withdrawal by Subject|5|||
128675109|NCT02270944|463108619|FG000|Overall Study|Withdrawal by Subject|2|||
129008667|NCT00084084|464324731|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
129008668|NCT00084084|464324731|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
129008669|NCT00108732|464324732|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
129008670|NCT00108732|464324732|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
129008671|NCT00108732|464324732|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
129098900|NCT01094782|464654182|FG000|Overall Study|Recent Interventional Injection|0|||
129098901|NCT01094782|464654183|FG001|Overall Study|Recent Interventional Injection|0|||
129098902|NCT01094782|464654184|FG002|Overall Study|Recent Interventional Injection|0|||
129098903|NCT01094782|464654185|FG003|Overall Study|Recent Interventional Injection|0|||
129098904|NCT01094782|464654186|FG004|Overall Study|Recent Interventional Injection|0|||
129098905|NCT01094782|464654187|FG005|Overall Study|Recent Interventional Injection|1|||
129098906|NCT01094782|464654182|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129098907|NCT01094782|464654183|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
128675110|NCT02270944|463108620|FG001|Overall Study|Withdrawal by Subject|1|||
128675111|NCT01978938|463108621|FG000|Overall Study|Lost to Follow-up|12|||
128675112|NCT01978938|463108622|FG001|Overall Study|Lost to Follow-up|6|||
128675113|NCT01978938|463108621|FG000|Overall Study|Withdrawal by Subject|8|||
128675114|NCT01978938|463108622|FG001|Overall Study|Withdrawal by Subject|4|||
128675115|NCT01978938|463108621|FG000|Overall Study|Adverse Event, non-fatal|2|||
128675116|NCT01978938|463108622|FG001|Overall Study|Adverse Event, non-fatal|1|||
128675117|NCT01978938|463108621|FG000|Overall Study|Participant noncompliance|1|||
128675118|NCT01978938|463108622|FG001|Overall Study|Participant noncompliance|1|||
128675119|NCT01978938|463108621|FG000|Overall Study|Did not meet inclusion criteria|0|||
128675120|NCT01978938|463108622|FG001|Overall Study|Did not meet inclusion criteria|1|||
128675121|NCT01978938|463108621|FG000|Overall Study|Previously scheduled procedure|0|||
128675122|NCT01978938|463108622|FG001|Overall Study|Previously scheduled procedure|1|||
128675123|NCT00095147|463108623|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
128675124|NCT00095147|463108624|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
128675125|NCT00095147|463108625|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
128675126|NCT00095147|463108626|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
128675127|NCT00095147|463108627|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
128675128|NCT00095147|463108623|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
128675129|NCT00095147|463108624|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
128675130|NCT00095147|463108625|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
128675131|NCT00095147|463108626|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
128675132|NCT00095147|463108627|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
128675133|NCT00095147|463108623|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
128675134|NCT00095147|463108624|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
128675135|NCT00095147|463108625|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
128675136|NCT00095147|463108626|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
128675137|NCT00095147|463108627|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
128675138|NCT00095147|463108623|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
128675139|NCT00095147|463108624|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
128675140|NCT00095147|463108625|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
128675141|NCT00095147|463108626|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
128675142|NCT00095147|463108627|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
128675143|NCT00095147|463108623|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
128675144|NCT00095147|463108624|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
128675145|NCT00095147|463108625|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
128675146|NCT00095147|463108626|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
128675147|NCT00095147|463108627|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
128675148|NCT00095147|463108623|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
128675149|NCT00095147|463108624|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
128675150|NCT00095147|463108625|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
128675151|NCT00095147|463108626|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
128675152|NCT00095147|463108627|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
128675153|NCT00095147|463108623|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
128675154|NCT00095147|463108624|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
128675155|NCT00095147|463108625|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
128675156|NCT00095147|463108626|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
128675157|NCT00095147|463108627|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
128675158|NCT00095147|463108623|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
128675159|NCT00095147|463108624|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
128675160|NCT00095147|463108625|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
128675161|NCT00095147|463108626|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
128675162|NCT00095147|463108627|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
128675163|NCT00095147|463108623|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
128675164|NCT00095147|463108624|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
128675165|NCT00095147|463108625|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
128675166|NCT00095147|463108626|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
128675167|NCT00095147|463108627|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
128675168|NCT00095147|463108623|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
128675169|NCT00095147|463108624|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
128878399|NCT02414932|463848472|FG001|Overall Study|Adverse Event|0|||
128675170|NCT00095147|463108625|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
128675171|NCT00095147|463108626|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
128675172|NCT00095147|463108627|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
128675173|NCT00095147|463108623|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
128675174|NCT00095147|463108624|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
128675175|NCT00095147|463108625|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
128675176|NCT00095147|463108626|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
128675177|NCT00095147|463108627|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
128675178|NCT00095147|463108623|FG000|Long-term Extension Period|Death|0|||
128675179|NCT00095147|463108624|FG001|Long-term Extension Period|Death|0|||
128675180|NCT00095147|463108625|FG002|Long-term Extension Period|Death|0|||
128675181|NCT00095147|463108626|FG003|Long-term Extension Period|Death|0|||
128675182|NCT00095147|463108627|FG004|Long-term Extension Period|Death|3|||
128675183|NCT00095147|463108623|FG000|Long-term Extension Period|Adverse Event|0|||
128675184|NCT00095147|463108624|FG001|Long-term Extension Period|Adverse Event|0|||
128675185|NCT00095147|463108625|FG002|Long-term Extension Period|Adverse Event|0|||
128675186|NCT00095147|463108626|FG003|Long-term Extension Period|Adverse Event|0|||
128675187|NCT00095147|463108627|FG004|Long-term Extension Period|Adverse Event|11|||
128675188|NCT00095147|463108623|FG000|Long-term Extension Period|Lack of Efficacy|0|||
128675189|NCT00095147|463108624|FG001|Long-term Extension Period|Lack of Efficacy|0|||
128675190|NCT00095147|463108625|FG002|Long-term Extension Period|Lack of Efficacy|0|||
128675191|NCT00095147|463108626|FG003|Long-term Extension Period|Lack of Efficacy|0|||
128675192|NCT00095147|463108627|FG004|Long-term Extension Period|Lack of Efficacy|9|||
128675193|NCT00095147|463108623|FG000|Long-term Extension Period|Lost to Follow-up|0|||
128675194|NCT00095147|463108624|FG001|Long-term Extension Period|Lost to Follow-up|0|||
128675195|NCT00095147|463108625|FG002|Long-term Extension Period|Lost to Follow-up|0|||
128675196|NCT00095147|463108626|FG003|Long-term Extension Period|Lost to Follow-up|0|||
128675197|NCT00095147|463108627|FG004|Long-term Extension Period|Lost to Follow-up|6|||
128675198|NCT00095147|463108623|FG000|Long-term Extension Period|Withdrawal of consent|0|||
128675199|NCT00095147|463108624|FG001|Long-term Extension Period|Withdrawal of consent|0|||
128675200|NCT00095147|463108625|FG002|Long-term Extension Period|Withdrawal of consent|0|||
128675201|NCT00095147|463108626|FG003|Long-term Extension Period|Withdrawal of consent|0|||
128675202|NCT00095147|463108627|FG004|Long-term Extension Period|Withdrawal of consent|12|||
128675203|NCT00095147|463108623|FG000|Long-term Extension Period|Pregnancy|0|||
128675204|NCT00095147|463108624|FG001|Long-term Extension Period|Pregnancy|0|||
128675205|NCT00095147|463108625|FG002|Long-term Extension Period|Pregnancy|0|||
128675206|NCT00095147|463108626|FG003|Long-term Extension Period|Pregnancy|0|||
128675207|NCT00095147|463108627|FG004|Long-term Extension Period|Pregnancy|1|||
128675208|NCT00095147|463108623|FG000|Long-term Extension Period|No longer meets study criteria|0|||
128675209|NCT00095147|463108624|FG001|Long-term Extension Period|No longer meets study criteria|0|||
128675210|NCT00095147|463108625|FG002|Long-term Extension Period|No longer meets study criteria|0|||
128675211|NCT00095147|463108626|FG003|Long-term Extension Period|No longer meets study criteria|0|||
128675212|NCT00095147|463108627|FG004|Long-term Extension Period|No longer meets study criteria|1|||
128675213|NCT00095147|463108623|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
128675214|NCT00095147|463108624|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
128675215|NCT00095147|463108625|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
128675216|NCT00095147|463108626|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
128675217|NCT00095147|463108627|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
128675218|NCT00095147|463108623|FG000|Long-term Extension Period|Leaving country|0|||
128675219|NCT00095147|463108624|FG001|Long-term Extension Period|Leaving country|0|||
128675220|NCT00095147|463108625|FG002|Long-term Extension Period|Leaving country|0|||
128675221|NCT00095147|463108626|FG003|Long-term Extension Period|Leaving country|0|||
128675222|NCT00095147|463108627|FG004|Long-term Extension Period|Leaving country|1|||
128675223|NCT02342418|463108628|FG000|Overall Study|Adverse Event|0|||
128675224|NCT02342418|463108629|FG001|Overall Study|Adverse Event|1|||
128675225|NCT04255394|463108630|FG000|Overall Study|Death|35|||
128675226|NCT04255394|463108631|FG001|Overall Study|Death|25|||
128675227|NCT04255394|463108630|FG000|Overall Study|Device removed|2|||
128675228|NCT04255394|463108631|FG001|Overall Study|Device removed|10|||
128675229|NCT04255394|463108630|FG000|Overall Study|Withdrawal by Subject|9|||
128675230|NCT04255394|463108631|FG001|Overall Study|Withdrawal by Subject|8|||
128675231|NCT04255394|463108630|FG000|Overall Study|Screen Failure/Not treated|12|||
128675232|NCT04255394|463108631|FG001|Overall Study|Screen Failure/Not treated|8|||
129008672|NCT00108732|464324732|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
129008673|NCT00108732|464324732|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
129008674|NCT00108732|464324732|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
129008675|NCT00108732|464324732|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
129008676|NCT02187042|464324733|FG000|Overall Study|Death|1|||
128675233|NCT04255394|463108630|FG000|Overall Study|Lost to Follow-up|123|||
129008677|NCT02187042|464324734|FG001|Overall Study|Death|1|||
129008678|NCT02187042|464324733|FG000|Overall Study|Toxicity|6|||
128675234|NCT04255394|463108631|FG001|Overall Study|Lost to Follow-up|265|||
128675235|NCT04255394|463108630|FG000|Overall Study|Adverse Event|1|||
128675236|NCT04255394|463108631|FG001|Overall Study|Adverse Event|3|||
128675237|NCT03678870|463108637|FG000|Overall Study|prescribed non- protocol medications|10|||
128675238|NCT03678870|463108638|FG001|Overall Study|prescribed non- protocol medications|6|||
128675239|NCT03678870|463108637|FG000|Overall Study|Lost to Follow-up|3|||
128675240|NCT03678870|463108638|FG001|Overall Study|Lost to Follow-up|2|||
128675241|NCT03104816|463108640|FG000|Overall Study|Lack of Efficacy|0|||
128675242|NCT03104816|463108641|FG001|Overall Study|Lack of Efficacy|2|||
128675243|NCT03104816|463108642|FG002|Overall Study|Lack of Efficacy|0|||
128675244|NCT03104816|463108640|FG000|Overall Study|Protocol Violation|2|||
128675245|NCT03104816|463108641|FG001|Overall Study|Protocol Violation|0|||
128675246|NCT03104816|463108642|FG002|Overall Study|Protocol Violation|2|||
128675247|NCT01159431|463108644|FG000|Overall Study|Adverse Event|1|||
128675248|NCT01159431|463108645|FG001|Overall Study|Adverse Event|2|||
128675249|NCT01159431|463108644|FG000|Overall Study|non-compliance|1|||
128675250|NCT01159431|463108645|FG001|Overall Study|non-compliance|1|||
128675251|NCT01159431|463108644|FG000|Overall Study|Lack of Efficacy|0|||
128675252|NCT01159431|463108645|FG001|Overall Study|Lack of Efficacy|3|||
128675253|NCT01227629|463108646|FG000|Overall Study|Adverse Event|2|||
128675254|NCT01227629|463108647|FG001|Overall Study|Adverse Event|2|||
128675255|NCT01227629|463108648|FG002|Overall Study|Adverse Event|1|||
128675256|NCT01227629|463108649|FG003|Overall Study|Adverse Event|6|||
128675257|NCT01227629|463108650|FG004|Overall Study|Adverse Event|1|||
128675258|NCT01227629|463108651|FG005|Overall Study|Adverse Event|1|||
128675259|NCT01227629|463108652|FG006|Overall Study|Adverse Event|6|||
129008679|NCT02187042|464324734|FG001|Overall Study|Toxicity|5|||
129008680|NCT02187042|464324733|FG000|Overall Study|Participant choice|1|||
129008681|NCT02187042|464324734|FG001|Overall Study|Participant choice|0|||
129008682|NCT02187042|464324733|FG000|Overall Study|Doctor choice|1|||
129008683|NCT02187042|464324734|FG001|Overall Study|Doctor choice|0|||
129008684|NCT02187042|464324733|FG000|Overall Study|Progressive disease|4|||
129008685|NCT02187042|464324734|FG001|Overall Study|Progressive disease|8|||
129008686|NCT02116803|464324736|FG000|Overall Study|Adverse Event|2|||
129008687|NCT02116803|464324737|FG001|Overall Study|Adverse Event|1|||
129008688|NCT02116803|464324736|FG000|Overall Study|Physician Decision|1|||
129008689|NCT02116803|464324737|FG001|Overall Study|Physician Decision|0|||
129008690|NCT02116803|464324736|FG000|Overall Study|Progressive disease|4|||
129008691|NCT02116803|464324737|FG001|Overall Study|Progressive disease|0|||
129008692|NCT02116803|464324736|FG000|Overall Study|Study terminated by sponsor|2|||
129008693|NCT02116803|464324737|FG001|Overall Study|Study terminated by sponsor|1|||
129008694|NCT02116803|464324736|FG000|Overall Study|Death|1|||
129008695|NCT02116803|464324737|FG001|Overall Study|Death|0|||
129008696|NCT01974895|464324740|FG000|Overall Study|Protocol Violation|1|||
129008697|NCT01974895|464324741|FG001|Overall Study|Protocol Violation|0|||
129008698|NCT01974895|464324740|FG000|Overall Study|Lost to Follow-up|4|||
129008699|NCT01974895|464324741|FG001|Overall Study|Lost to Follow-up|6|||
129008700|NCT01974895|464324740|FG000|Overall Study|Withdrawal by Subject|0|||
129008701|NCT01974895|464324741|FG001|Overall Study|Withdrawal by Subject|1|||
129008702|NCT01974895|464324740|FG000|Overall Study|Other (Missed Visit)|1|||
129008703|NCT01974895|464324741|FG001|Overall Study|Other (Missed Visit)|0|||
129008704|NCT01974895|464324740|FG000|Overall Study|Other (Reason unknown)|9|||
129008705|NCT01974895|464324741|FG001|Overall Study|Other (Reason unknown)|8|||
129008706|NCT01984242|464324742|FG000|Overall Study|Death|52|||
129008707|NCT01984242|464324743|FG001|Overall Study|Death|50|||
129008708|NCT01984242|464324744|FG002|Overall Study|Death|52|||
129008709|NCT01984242|464324742|FG000|Overall Study|Withdrawal by Subject|5|||
129008710|NCT01984242|464324743|FG001|Overall Study|Withdrawal by Subject|3|||
129008711|NCT01984242|464324744|FG002|Overall Study|Withdrawal by Subject|10|||
129008712|NCT01984242|464324742|FG000|Overall Study|Physician Decision|0|||
129008713|NCT01984242|464324743|FG001|Overall Study|Physician Decision|0|||
129008714|NCT01984242|464324744|FG002|Overall Study|Physician Decision|1|||
129008715|NCT01984242|464324742|FG000|Overall Study|Lost to Follow-up|4|||
129008716|NCT01984242|464324743|FG001|Overall Study|Lost to Follow-up|0|||
129008717|NCT01984242|464324744|FG002|Overall Study|Lost to Follow-up|3|||
129008718|NCT01984242|464324742|FG000|Overall Study|Sponsor Decision|1|||
129008719|NCT01984242|464324743|FG001|Overall Study|Sponsor Decision|0|||
128675260|NCT01227629|463108653|FG007|Overall Study|Adverse Event|6|||
129008720|NCT01984242|464324744|FG002|Overall Study|Sponsor Decision|0|||
129008721|NCT01984242|464324742|FG000|Overall Study|Non-Compliance|1|||
128675261|NCT01227629|463108654|FG008|Overall Study|Adverse Event|4|||
128675262|NCT01227629|463108655|FG009|Overall Study|Adverse Event|0|||
128675263|NCT01227629|463108646|FG000|Overall Study|Protocol Violation|0|||
129008722|NCT01984242|464324743|FG001|Overall Study|Non-Compliance|0|||
129008723|NCT01984242|464324744|FG002|Overall Study|Non-Compliance|0|||
129008724|NCT01984242|464324742|FG000|Overall Study|Study terminated by Sponsor|38|||
129008725|NCT01984242|464324743|FG001|Overall Study|Study terminated by Sponsor|50|||
128675264|NCT01227629|463108647|FG001|Overall Study|Protocol Violation|0|||
128675265|NCT01227629|463108648|FG002|Overall Study|Protocol Violation|0|||
129008726|NCT01984242|464324744|FG002|Overall Study|Study terminated by Sponsor|34|||
128675266|NCT01227629|463108649|FG003|Overall Study|Protocol Violation|1|||
128675267|NCT01227629|463108650|FG004|Overall Study|Protocol Violation|0|||
128675268|NCT01227629|463108651|FG005|Overall Study|Protocol Violation|0|||
128675269|NCT01227629|463108652|FG006|Overall Study|Protocol Violation|0|||
128675270|NCT01227629|463108653|FG007|Overall Study|Protocol Violation|0|||
128675271|NCT01227629|463108654|FG008|Overall Study|Protocol Violation|0|||
128675272|NCT01227629|463108655|FG009|Overall Study|Protocol Violation|0|||
128675273|NCT01227629|463108646|FG000|Overall Study|Lost to Follow-up|0|||
128675274|NCT01227629|463108647|FG001|Overall Study|Lost to Follow-up|0|||
128675275|NCT01227629|463108648|FG002|Overall Study|Lost to Follow-up|0|||
128675276|NCT01227629|463108649|FG003|Overall Study|Lost to Follow-up|0|||
128675277|NCT01227629|463108650|FG004|Overall Study|Lost to Follow-up|1|||
128675278|NCT01227629|463108651|FG005|Overall Study|Lost to Follow-up|0|||
128675279|NCT01227629|463108652|FG006|Overall Study|Lost to Follow-up|0|||
128675280|NCT01227629|463108653|FG007|Overall Study|Lost to Follow-up|0|||
128675281|NCT01227629|463108654|FG008|Overall Study|Lost to Follow-up|0|||
128675282|NCT01227629|463108655|FG009|Overall Study|Lost to Follow-up|0|||
128675283|NCT01227629|463108646|FG000|Overall Study|Withdrawal by Subject|0|||
128675284|NCT01227629|463108647|FG001|Overall Study|Withdrawal by Subject|0|||
128675285|NCT01227629|463108648|FG002|Overall Study|Withdrawal by Subject|0|||
128675286|NCT01227629|463108649|FG003|Overall Study|Withdrawal by Subject|0|||
128675287|NCT01227629|463108650|FG004|Overall Study|Withdrawal by Subject|0|||
128675288|NCT01227629|463108651|FG005|Overall Study|Withdrawal by Subject|0|||
128675289|NCT01227629|463108652|FG006|Overall Study|Withdrawal by Subject|2|||
128675290|NCT01227629|463108653|FG007|Overall Study|Withdrawal by Subject|0|||
128675291|NCT01227629|463108654|FG008|Overall Study|Withdrawal by Subject|0|||
128675292|NCT01227629|463108655|FG009|Overall Study|Withdrawal by Subject|1|||
128675293|NCT01227629|463108646|FG000|Overall Study|Other|0|||
128675294|NCT01227629|463108647|FG001|Overall Study|Other|0|||
128675295|NCT01227629|463108648|FG002|Overall Study|Other|0|||
128675296|NCT01227629|463108649|FG003|Overall Study|Other|1|||
128675297|NCT01227629|463108650|FG004|Overall Study|Other|0|||
128675298|NCT01227629|463108651|FG005|Overall Study|Other|0|||
128675299|NCT01227629|463108652|FG006|Overall Study|Other|0|||
128675300|NCT01227629|463108653|FG007|Overall Study|Other|0|||
128675301|NCT01227629|463108654|FG008|Overall Study|Other|2|||
128675302|NCT01227629|463108655|FG009|Overall Study|Other|1|||
128675303|NCT00534599|463108661|FG000|Overall Study|Adverse Event|25|||
128675304|NCT00534599|463108662|FG001|Overall Study|Adverse Event|4|||
128675305|NCT00534599|463108661|FG000|Overall Study|Incorrect enrollment|2|||
128675306|NCT00534599|463108662|FG001|Overall Study|Incorrect enrollment|1|||
128675307|NCT00534599|463108661|FG000|Overall Study|Mis-randomization|2|||
128675308|NCT00534599|463108662|FG001|Overall Study|Mis-randomization|2|||
128675309|NCT00534599|463108661|FG000|Overall Study|Developed study-specific d/c criteria|5|||
128675310|NCT00534599|463108662|FG001|Overall Study|Developed study-specific d/c criteria|0|||
128675311|NCT00534599|463108661|FG000|Overall Study|Lack of Efficacy|0|||
128675312|NCT00534599|463108662|FG001|Overall Study|Lack of Efficacy|1|||
128675313|NCT00534599|463108661|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
128675314|NCT00534599|463108662|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
128675315|NCT00534599|463108661|FG000|Overall Study|Protocol Violation|1|||
128675316|NCT00534599|463108662|FG001|Overall Study|Protocol Violation|3|||
128675317|NCT00534599|463108661|FG000|Overall Study|Lost to Follow-up|11|||
128675318|NCT00534599|463108662|FG001|Overall Study|Lost to Follow-up|14|||
128675319|NCT00534599|463108661|FG000|Overall Study|Withdrawal by Subject|4|||
128675320|NCT00534599|463108662|FG001|Overall Study|Withdrawal by Subject|6|||
128675321|NCT00534599|463108661|FG000|Overall Study|Other|7|||
129008727|NCT01984242|464324742|FG000|Overall Study|Disease Progression|0|||
128675322|NCT00534599|463108662|FG001|Overall Study|Other|0|||
128675323|NCT03645434|463108664|FG000|Period 1|Adverse Event|0|||
128675324|NCT03645434|463108665|FG001|Period 1|Adverse Event|0|||
129008728|NCT01984242|464324743|FG001|Overall Study|Disease Progression|0|||
129008729|NCT01984242|464324744|FG002|Overall Study|Disease Progression|1|||
129008730|NCT04543136|464324747|FG000|Overall Study|Withdrawal by Subject|0|||
129008731|NCT04543136|464324748|FG001|Overall Study|Withdrawal by Subject|1|||
129008732|NCT04543136|464324749|FG002|Overall Study|Withdrawal by Subject|0|||
129008733|NCT04543136|464324750|FG003|Overall Study|Withdrawal by Subject|1|||
128675325|NCT03645434|463108666|FG002|Period 1|Adverse Event|0|||
128675326|NCT03645434|463108667|FG003|Period 1|Adverse Event|1|||
129008734|NCT04543136|464324751|FG004|Overall Study|Withdrawal by Subject|0|||
128675327|NCT03645434|463108668|FG004|Period 1|Adverse Event|0|||
128675328|NCT03645434|463108669|FG005|Period 1|Adverse Event|0|||
128675329|NCT03645434|463108664|FG000|Period 1|COPD exacerbation|0|||
129008735|NCT04543136|464324752|FG005|Overall Study|Withdrawal by Subject|0|||
128675330|NCT03645434|463108665|FG001|Period 1|COPD exacerbation|0|||
128675331|NCT03645434|463108666|FG002|Period 1|COPD exacerbation|0|||
128675332|NCT03645434|463108667|FG003|Period 1|COPD exacerbation|0|||
128675333|NCT03645434|463108668|FG004|Period 1|COPD exacerbation|1|||
129008736|NCT01626079|464324755|FG000|Overall Study|Death|167|||
128675334|NCT03645434|463108669|FG005|Period 1|COPD exacerbation|0|||
128675335|NCT03137069|463110672|FG000|Overall Study|Withdrawal by Subject|1|||
129098908|NCT01094782|464654184|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129098909|NCT01094782|464654185|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129098910|NCT01094782|464654186|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
129098911|NCT01094782|464654187|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129098912|NCT01094782|464654182|FG000|Overall Study|Noncompliance With Study Schedule|0|||
129098913|NCT01094782|464654183|FG001|Overall Study|Noncompliance With Study Schedule|0|||
129098914|NCT01094782|464654184|FG002|Overall Study|Noncompliance With Study Schedule|0|||
129098915|NCT01094782|464654185|FG003|Overall Study|Noncompliance With Study Schedule|1|||
129098916|NCT01094782|464654186|FG004|Overall Study|Noncompliance With Study Schedule|0|||
129098917|NCT01094782|464654187|FG005|Overall Study|Noncompliance With Study Schedule|0|||
129098918|NCT02912455|464654188|FG000|Overall Study|Withdrawal by Subject|0|||
128675336|NCT03137069|463110673|FG001|Overall Study|Withdrawal by Subject|2|||
128675337|NCT03137069|463110674|FG002|Overall Study|Withdrawal by Subject|2|||
128675338|NCT03137069|463110675|FG003|Overall Study|Withdrawal by Subject|2|||
128675339|NCT03137069|463110676|FG004|Overall Study|Withdrawal by Subject|0|||
128675340|NCT03137069|463110677|FG005|Overall Study|Withdrawal by Subject|0|||
128675341|NCT03137069|463110672|FG000|Overall Study|Adverse Event|0|||
128675342|NCT03137069|463110673|FG001|Overall Study|Adverse Event|3|||
128675343|NCT03137069|463110674|FG002|Overall Study|Adverse Event|1|||
128675344|NCT03137069|463110675|FG003|Overall Study|Adverse Event|1|||
128675345|NCT03137069|463110676|FG004|Overall Study|Adverse Event|0|||
128675346|NCT03137069|463110677|FG005|Overall Study|Adverse Event|1|||
128675347|NCT03137069|463110672|FG000|Overall Study|Protocol Violation|0|||
128675348|NCT03137069|463110673|FG001|Overall Study|Protocol Violation|1|||
128675349|NCT03137069|463110674|FG002|Overall Study|Protocol Violation|0|||
128675350|NCT03137069|463110675|FG003|Overall Study|Protocol Violation|1|||
128675351|NCT03137069|463110676|FG004|Overall Study|Protocol Violation|1|||
128675352|NCT03137069|463110677|FG005|Overall Study|Protocol Violation|1|||
128675353|NCT03137069|463110672|FG000|Overall Study|Physician Decision|0|||
128675354|NCT03137069|463110673|FG001|Overall Study|Physician Decision|0|||
128675355|NCT03137069|463110674|FG002|Overall Study|Physician Decision|0|||
128675356|NCT03137069|463110675|FG003|Overall Study|Physician Decision|1|||
128675357|NCT03137069|463110676|FG004|Overall Study|Physician Decision|0|||
128675358|NCT03137069|463110677|FG005|Overall Study|Physician Decision|0|||
128675359|NCT03137069|463110672|FG000|Overall Study|Study Terminated by Sponsor|0|||
128675360|NCT03137069|463110673|FG001|Overall Study|Study Terminated by Sponsor|0|||
128675361|NCT03137069|463110674|FG002|Overall Study|Study Terminated by Sponsor|0|||
128675362|NCT03137069|463110675|FG003|Overall Study|Study Terminated by Sponsor|0|||
128675363|NCT03137069|463110676|FG004|Overall Study|Study Terminated by Sponsor|1|||
128675364|NCT03137069|463110677|FG005|Overall Study|Study Terminated by Sponsor|0|||
128675365|NCT03137069|463110672|FG000|Overall Study|Data Entry Error|0|||
128675366|NCT03137069|463110673|FG001|Overall Study|Data Entry Error|0|||
128675367|NCT03137069|463110674|FG002|Overall Study|Data Entry Error|0|||
128675368|NCT03137069|463110675|FG003|Overall Study|Data Entry Error|1|||
128675369|NCT03137069|463110676|FG004|Overall Study|Data Entry Error|0|||
128675370|NCT03137069|463110677|FG005|Overall Study|Data Entry Error|0|||
128675371|NCT00336856|463110678|FG000|Overall Study|Withdrawal by Subject|3|||
128675372|NCT00336856|463110678|FG000|Overall Study|Found ineligible at time of analysis|1|||
128675373|NCT00362180|463110679|FG000|Treated Period|Withdrawal by Subject|1|||
128675374|NCT00362180|463110680|FG001|Treated Period|Withdrawal by Subject|0|||
128675375|NCT00362180|463110681|FG002|Treated Period|Withdrawal by Subject|0|||
128675376|NCT00362180|463110682|FG003|Treated Period|Withdrawal by Subject|0|||
128675377|NCT00362180|463110683|FG004|Treated Period|Withdrawal by Subject|0|||
128675378|NCT00362180|463110684|FG005|Treated Period|Withdrawal by Subject|0|||
128675379|NCT00362180|463110685|FG006|Treated Period|Withdrawal by Subject|0|||
128675380|NCT00362180|463110686|FG007|Treated Period|Withdrawal by Subject|0|||
128675381|NCT00362180|463110687|FG008|Treated Period|Withdrawal by Subject|0|||
128675382|NCT00362180|463110679|FG000|Treated Period|Adverse Event|0|||
128675383|NCT00362180|463110680|FG001|Treated Period|Adverse Event|0|||
128675384|NCT00362180|463110681|FG002|Treated Period|Adverse Event|0|||
128675385|NCT00362180|463110682|FG003|Treated Period|Adverse Event|0|||
128675386|NCT00362180|463110683|FG004|Treated Period|Adverse Event|0|||
128675387|NCT00362180|463110684|FG005|Treated Period|Adverse Event|1|||
128675388|NCT00362180|463110685|FG006|Treated Period|Adverse Event|0|||
128675389|NCT00362180|463110686|FG007|Treated Period|Adverse Event|1|||
128675390|NCT00362180|463110687|FG008|Treated Period|Adverse Event|0|||
128675391|NCT02434471|463110688|FG000|Overall Study|Physician Decision|9|||
128675392|NCT00369629|463110689|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
128675393|NCT00369629|463110690|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
128675394|NCT00369629|463110691|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
128675395|NCT00369629|463110692|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
128675396|NCT00369629|463110689|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
128675397|NCT00369629|463110690|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
128675398|NCT00369629|463110691|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
128675399|NCT00369629|463110692|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
129098919|NCT02912455|464654189|FG001|Overall Study|Withdrawal by Subject|1|||
129098920|NCT02912455|464654188|FG000|Overall Study|Lack of Efficacy|0|||
129098921|NCT02912455|464654189|FG001|Overall Study|Lack of Efficacy|1|||
128675400|NCT00369629|463110689|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
128675401|NCT00369629|463110690|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
128675402|NCT00369629|463110691|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
128675403|NCT00369629|463110692|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
128675404|NCT00369629|463110689|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
128675405|NCT00369629|463110690|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
128675406|NCT00369629|463110691|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
128675407|NCT00369629|463110692|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
128675408|NCT00369629|463110689|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
128675409|NCT00369629|463110690|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
128675410|NCT00369629|463110691|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
128675411|NCT00369629|463110692|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
128675412|NCT00369629|463110689|FG000|Completed 4 More Cycles|Progressive disease|2|||
128675413|NCT00369629|463110690|FG001|Completed 4 More Cycles|Progressive disease|1|||
128675414|NCT00369629|463110691|FG002|Completed 4 More Cycles|Progressive disease|2|||
128675415|NCT00369629|463110692|FG003|Completed 4 More Cycles|Progressive disease|0|||
128675416|NCT00369629|463110689|FG000|Follow up for 1 Year|Death|2|||
128675417|NCT00369629|463110690|FG001|Follow up for 1 Year|Death|1|||
128675418|NCT00369629|463110691|FG002|Follow up for 1 Year|Death|1|||
128675419|NCT00369629|463110692|FG003|Follow up for 1 Year|Death|0|||
128675420|NCT00369629|463110689|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
128675421|NCT00369629|463110690|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
128675422|NCT00369629|463110691|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
128675423|NCT00369629|463110692|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
128675424|NCT00369629|463110689|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
128675425|NCT00369629|463110690|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
128675426|NCT00369629|463110691|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
128675427|NCT00369629|463110692|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
128675428|NCT03338959|463110693|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
128675429|NCT03338959|463110693|FG000|Overall Study|Physician Decision|1|||
128675430|NCT01604278|463110694|FG000|Overall Study|Lack of Efficacy|0|||
128675431|NCT01604278|463110695|FG001|Overall Study|Lack of Efficacy|1|||
128675432|NCT01604278|463110694|FG000|Overall Study|Lost to Follow-up|1|||
128675433|NCT01604278|463110695|FG001|Overall Study|Lost to Follow-up|0|||
128675434|NCT01604278|463110694|FG000|Overall Study|Administrative problems|2|||
128675435|NCT01604278|463110695|FG001|Overall Study|Administrative problems|1|||
128675436|NCT01604278|463110694|FG000|Overall Study|Withdrawal by Subject|3|||
128675437|NCT01604278|463110695|FG001|Overall Study|Withdrawal by Subject|3|||
128675438|NCT01604278|463110694|FG000|Overall Study|Adverse Event|3|||
128675439|NCT01604278|463110695|FG001|Overall Study|Adverse Event|5|||
128675440|NCT01604278|463110694|FG000|Overall Study|Protocol Deviation|5|||
128675441|NCT01604278|463110695|FG001|Overall Study|Protocol Deviation|3|||
128675442|NCT02870933|463110699|FG000|Overall Study|Death|2|||
128675443|NCT02870933|463110700|FG001|Overall Study|Death|1|||
128675444|NCT02870933|463110699|FG000|Overall Study|Withdrawal by Subject|0|||
128675445|NCT02870933|463110700|FG001|Overall Study|Withdrawal by Subject|1|||
128675446|NCT01250496|463110701|FG000|Overall Study|Study terminated|124|||
128675447|NCT01250496|463110702|FG001|Overall Study|Study terminated|124|||
128675448|NCT01425463|463110703|FG000|Overall Study|Adverse Event|5|||
128675449|NCT01425463|463110704|FG001|Overall Study|Adverse Event|7|||
128675450|NCT01425463|463110703|FG000|Overall Study|Lack of Efficacy|1|||
128675451|NCT01425463|463110704|FG001|Overall Study|Lack of Efficacy|1|||
128675452|NCT01425463|463110703|FG000|Overall Study|Protocol Violation|2|||
128675453|NCT01425463|463110704|FG001|Overall Study|Protocol Violation|2|||
128675454|NCT01425463|463110703|FG000|Overall Study|Lost to Follow-up|5|||
128675455|NCT01425463|463110704|FG001|Overall Study|Lost to Follow-up|2|||
128675456|NCT01425463|463110703|FG000|Overall Study|Withdrawal by Subject|7|||
129098922|NCT02912455|464654188|FG000|Overall Study|Lost to Follow-up|2|||
128675457|NCT01425463|463110704|FG001|Overall Study|Withdrawal by Subject|5|||
128675458|NCT01425463|463110703|FG000|Overall Study|Unknown Reason|4|||
128675459|NCT01425463|463110704|FG001|Overall Study|Unknown Reason|7|||
129098923|NCT02912455|464654189|FG001|Overall Study|Lost to Follow-up|1|||
129098924|NCT01810783|464654196|FG000|Overall Study|Adverse Event|32|||
129098925|NCT01810783|464654196|FG000|Overall Study|Withdrawal by Subject|22|||
129098926|NCT01810783|464654196|FG000|Overall Study|Lack of Efficacy|12|||
128675460|NCT01122264|463110707|FG000|Overall Study|Adverse Event|6|||
128675461|NCT01122264|463110708|FG001|Overall Study|Adverse Event|5|||
128675462|NCT01122264|463110709|FG002|Overall Study|Adverse Event|7|||
128675463|NCT01122264|463110707|FG000|Overall Study|Death|1|||
128675464|NCT01122264|463110708|FG001|Overall Study|Death|0|||
128675465|NCT01122264|463110709|FG002|Overall Study|Death|0|||
128675466|NCT01122264|463110707|FG000|Overall Study|Lost to Follow-up|5|||
129098927|NCT01810783|464654196|FG000|Overall Study|Lost to Follow-up|10|||
128675467|NCT01122264|463110708|FG001|Overall Study|Lost to Follow-up|9|||
128675468|NCT01122264|463110709|FG002|Overall Study|Lost to Follow-up|13|||
128675469|NCT01122264|463110707|FG000|Overall Study|Entry Criteria Not Met|1|||
128675470|NCT01122264|463110708|FG001|Overall Study|Entry Criteria Not Met|0|||
128675471|NCT01122264|463110709|FG002|Overall Study|Entry Criteria Not Met|0|||
128675472|NCT01122264|463110707|FG000|Overall Study|Protocol Violation|7|||
128675473|NCT01122264|463110708|FG001|Overall Study|Protocol Violation|7|||
128675474|NCT01122264|463110709|FG002|Overall Study|Protocol Violation|9|||
128675475|NCT01122264|463110707|FG000|Overall Study|Withdrawal by Subject|6|||
128675476|NCT01122264|463110708|FG001|Overall Study|Withdrawal by Subject|6|||
128675477|NCT01122264|463110709|FG002|Overall Study|Withdrawal by Subject|16|||
128675478|NCT01122264|463110707|FG000|Overall Study|Physician Decision|3|||
128675479|NCT01122264|463110708|FG001|Overall Study|Physician Decision|1|||
128675480|NCT01122264|463110709|FG002|Overall Study|Physician Decision|1|||
128675481|NCT01122264|463110707|FG000|Overall Study|Lack of Efficacy|3|||
128675482|NCT01122264|463110708|FG001|Overall Study|Lack of Efficacy|1|||
128675483|NCT01122264|463110709|FG002|Overall Study|Lack of Efficacy|1|||
128675484|NCT04585009|463110710|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
128675485|NCT04585009|463110711|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675486|NCT04585009|463110712|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675487|NCT04585009|463110713|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675488|NCT04585009|463110714|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675489|NCT04585009|463110715|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675490|NCT04585009|463110716|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675491|NCT04585009|463110717|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675492|NCT04585009|463110718|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675493|NCT04585009|463110719|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675494|NCT04585009|463110720|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675495|NCT04585009|463110721|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
128675496|NCT04585009|463110710|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
128675497|NCT04585009|463110711|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675498|NCT04585009|463110712|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675499|NCT04585009|463110713|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129008737|NCT01626079|464324756|FG001|Overall Study|Death|192|||
128675500|NCT04585009|463110714|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675501|NCT04585009|463110715|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675502|NCT04585009|463110716|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675503|NCT04585009|463110717|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675504|NCT04585009|463110718|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675505|NCT04585009|463110719|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675506|NCT04585009|463110720|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675507|NCT04585009|463110721|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
128675508|NCT04585009|463110710|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675509|NCT04585009|463110711|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675510|NCT04585009|463110712|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675511|NCT04585009|463110713|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675512|NCT04585009|463110714|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675513|NCT04585009|463110715|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675514|NCT04585009|463110716|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675515|NCT04585009|463110717|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
128675516|NCT04585009|463110718|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675517|NCT04585009|463110719|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675518|NCT04585009|463110720|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675519|NCT04585009|463110721|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
128675520|NCT04585009|463110710|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675521|NCT04585009|463110711|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675522|NCT04585009|463110712|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675523|NCT04585009|463110713|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675524|NCT04585009|463110714|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
128675525|NCT04585009|463110715|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675526|NCT04585009|463110716|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675527|NCT04585009|463110717|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675528|NCT04585009|463110718|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129008738|NCT01626079|464324757|FG002|Overall Study|Death|39|||
129008739|NCT01626079|464324755|FG000|Overall Study|Withdrawal by Subject|23|||
129008740|NCT01626079|464324756|FG001|Overall Study|Withdrawal by Subject|37|||
129008741|NCT01626079|464324757|FG002|Overall Study|Withdrawal by Subject|5|||
128675529|NCT04585009|463110719|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675530|NCT04585009|463110720|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675531|NCT04585009|463110721|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
128675532|NCT04585009|463110710|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675533|NCT04585009|463110711|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675534|NCT04585009|463110712|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675535|NCT04585009|463110713|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675536|NCT04585009|463110714|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675537|NCT04585009|463110715|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675538|NCT04585009|463110716|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675539|NCT04585009|463110717|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675540|NCT04585009|463110718|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675541|NCT04585009|463110719|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
128675542|NCT04585009|463110720|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675543|NCT04585009|463110721|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
128675544|NCT04585009|463110710|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675545|NCT04585009|463110711|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675546|NCT04585009|463110712|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675547|NCT04585009|463110713|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675548|NCT04585009|463110714|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675549|NCT04585009|463110715|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675550|NCT04585009|463110716|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675551|NCT04585009|463110717|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675552|NCT04585009|463110718|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675553|NCT04585009|463110719|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675554|NCT04585009|463110720|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
128675555|NCT04585009|463110721|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
128675556|NCT00097981|463110730|FG000|Overall Study|Adverse Event|31|||
128675557|NCT00097981|463110731|FG001|Overall Study|Adverse Event|44|||
128675558|NCT00097981|463110730|FG000|Overall Study|Withdrawal by Subject|10|||
128675559|NCT00097981|463110731|FG001|Overall Study|Withdrawal by Subject|8|||
128675560|NCT00097981|463110730|FG000|Overall Study|Protocol Violation|1|||
128675561|NCT00097981|463110731|FG001|Overall Study|Protocol Violation|1|||
128675562|NCT00097981|463110730|FG000|Overall Study|Death|2|||
128675563|NCT00097981|463110731|FG001|Overall Study|Death|4|||
128675564|NCT00097981|463110730|FG000|Overall Study|Physician Decision|7|||
128675565|NCT00097981|463110731|FG001|Overall Study|Physician Decision|1|||
128675566|NCT00097981|463110730|FG000|Overall Study|Disease Progression|8|||
128675567|NCT00097981|463110731|FG001|Overall Study|Disease Progression|2|||
128675568|NCT00097981|463110730|FG000|Overall Study|Transplant planned|28|||
128675569|NCT00097981|463110731|FG001|Overall Study|Transplant planned|27|||
128675570|NCT00097981|463110730|FG000|Overall Study|Other|19|||
128675571|NCT00097981|463110731|FG001|Overall Study|Other|13|||
128675572|NCT01002820|463110734|FG000|Overall Study|Adverse Event|1|||
128675573|NCT01002820|463110734|FG000|Overall Study|Withdrawal by Subject|2|||
128675574|NCT01002820|463110734|FG000|Overall Study|Lack of Efficacy|1|||
128675575|NCT00895011|463110739|FG000|Overall Study|Withdrawal by Subject|14|||
128675576|NCT00895011|463110740|FG001|Overall Study|Withdrawal by Subject|7|||
128675577|NCT00895011|463110741|FG002|Overall Study|Withdrawal by Subject|2|||
128675578|NCT00895011|463110739|FG000|Overall Study|Lost to Follow-up|5|||
128675579|NCT00895011|463110740|FG001|Overall Study|Lost to Follow-up|4|||
128675580|NCT00895011|463110741|FG002|Overall Study|Lost to Follow-up|1|||
128675581|NCT00895011|463110739|FG000|Overall Study|Protocol Violation|3|||
128675582|NCT00895011|463110740|FG001|Overall Study|Protocol Violation|1|||
128675583|NCT00895011|463110741|FG002|Overall Study|Protocol Violation|3|||
128675584|NCT00895011|463110739|FG000|Overall Study|Adverse Event|1|||
128675585|NCT00895011|463110740|FG001|Overall Study|Adverse Event|2|||
128675586|NCT00895011|463110741|FG002|Overall Study|Adverse Event|2|||
128675587|NCT00895011|463110739|FG000|Overall Study|schedule conflict|1|||
128675588|NCT00895011|463110740|FG001|Overall Study|schedule conflict|0|||
128675589|NCT00895011|463110741|FG002|Overall Study|schedule conflict|0|||
128675590|NCT03642132|463110744|FG000|Chemotherapy Period|Adverse Event|1|||
128675591|NCT03642132|463110745|FG001|Chemotherapy Period|Adverse Event|1|||
128675592|NCT03642132|463110746|FG002|Chemotherapy Period|Adverse Event|0|||
128675593|NCT03642132|463110744|FG000|Chemotherapy Period|Physician's decision|4|||
128675594|NCT03642132|463110745|FG001|Chemotherapy Period|Physician's decision|1|||
128675595|NCT03642132|463110746|FG002|Chemotherapy Period|Physician's decision|0|||
129008742|NCT01626079|464324755|FG000|Overall Study|Lost to Follow-up|7|||
128675596|NCT03642132|463110744|FG000|Chemotherapy Period|Progressive disease|0|||
128675597|NCT03642132|463110745|FG001|Chemotherapy Period|Progressive disease|0|||
128675598|NCT03642132|463110746|FG002|Chemotherapy Period|Progressive disease|1|||
128675599|NCT03642132|463110744|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
128675600|NCT03642132|463110745|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
128675601|NCT03642132|463110746|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
129098928|NCT01810783|464654196|FG000|Overall Study|Protocol Violation|5|||
129098929|NCT01810783|464654196|FG000|Overall Study|Non-compliance with IMP|4|||
129098930|NCT01810783|464654196|FG000|Overall Study|Adminstrative or other reason(s)|23|||
129098931|NCT01810783|464654196|FG000|Overall Study|Enrolled, not treated|1|||
129098932|NCT02134353|464654197|FG000|Overall Study|Adverse Event|10|||
129098933|NCT02134353|464654198|FG001|Overall Study|Adverse Event|6|||
129098934|NCT02134353|464654197|FG000|Overall Study|Lost to Follow-up|1|||
129098935|NCT02134353|464654198|FG001|Overall Study|Lost to Follow-up|1|||
129098936|NCT02134353|464654197|FG000|Overall Study|Lack of Efficacy|2|||
129098937|NCT02134353|464654198|FG001|Overall Study|Lack of Efficacy|1|||
128675602|NCT03642132|463110744|FG000|Chemotherapy Period|Other|1|||
128675603|NCT03642132|463110745|FG001|Chemotherapy Period|Other|0|||
128675604|NCT03642132|463110746|FG002|Chemotherapy Period|Other|2|||
128675605|NCT03642132|463110744|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
128675606|NCT03642132|463110745|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
128675607|NCT03642132|463110746|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
128675608|NCT03642132|463110744|FG000|Maintenance Period|Adverse Event|1|||
128675609|NCT03642132|463110745|FG001|Maintenance Period|Adverse Event|2|||
128675610|NCT03642132|463110746|FG002|Maintenance Period|Adverse Event|0|||
128675611|NCT03642132|463110744|FG000|Maintenance Period|Non-compliance with study drug|0|||
128675612|NCT03642132|463110745|FG001|Maintenance Period|Non-compliance with study drug|0|||
128675613|NCT03642132|463110746|FG002|Maintenance Period|Non-compliance with study drug|1|||
128675614|NCT03642132|463110744|FG000|Maintenance Period|Physician's decision|2|||
128675615|NCT03642132|463110745|FG001|Maintenance Period|Physician's decision|2|||
128675616|NCT03642132|463110746|FG002|Maintenance Period|Physician's decision|2|||
128675617|NCT03642132|463110744|FG000|Maintenance Period|Progressive disease|9|||
128675618|NCT03642132|463110745|FG001|Maintenance Period|Progressive disease|3|||
128675619|NCT03642132|463110746|FG002|Maintenance Period|Progressive disease|6|||
128675620|NCT03642132|463110744|FG000|Maintenance Period|Other|0|||
128675621|NCT03642132|463110745|FG001|Maintenance Period|Other|0|||
128675622|NCT03642132|463110746|FG002|Maintenance Period|Other|3|||
128675623|NCT03642132|463110744|FG000|Maintenance Period|Withdrawal by Subject|1|||
128675624|NCT03642132|463110745|FG001|Maintenance Period|Withdrawal by Subject|1|||
128675625|NCT03642132|463110746|FG002|Maintenance Period|Withdrawal by Subject|2|||
128675626|NCT03642132|463110744|FG000|Follow-up Period|Other|0|||
128675627|NCT03642132|463110745|FG001|Follow-up Period|Other|0|||
128675628|NCT03642132|463110746|FG002|Follow-up Period|Other|1|||
128675629|NCT03642132|463110744|FG000|Follow-up Period|Withdrawal by Subject|1|||
128675630|NCT03642132|463110745|FG001|Follow-up Period|Withdrawal by Subject|2|||
128675631|NCT03642132|463110746|FG002|Follow-up Period|Withdrawal by Subject|0|||
128675632|NCT03642132|463110744|FG000|Follow-up Period|Study terminated by sponsor|1|||
128675633|NCT03642132|463110745|FG001|Follow-up Period|Study terminated by sponsor|0|||
128675634|NCT03642132|463110746|FG002|Follow-up Period|Study terminated by sponsor|1|||
128675635|NCT03642132|463110744|FG000|Follow-up Period|Lack of Efficacy|1|||
128675636|NCT03642132|463110745|FG001|Follow-up Period|Lack of Efficacy|0|||
128675637|NCT03642132|463110746|FG002|Follow-up Period|Lack of Efficacy|0|||
128675638|NCT03642132|463110744|FG000|Follow-up Period|Death|1|||
128675639|NCT03642132|463110745|FG001|Follow-up Period|Death|0|||
128675640|NCT03642132|463110746|FG002|Follow-up Period|Death|2|||
128675641|NCT03642132|463110744|FG000|Follow-up Period|Adverse Event|1|||
128675642|NCT03642132|463110745|FG001|Follow-up Period|Adverse Event|0|||
128675643|NCT03642132|463110746|FG002|Follow-up Period|Adverse Event|0|||
128675644|NCT02577887|463110747|FG000|Overall Study|Death|93|||
128675645|NCT02577887|463110747|FG000|Overall Study|Protocol Violation|125|||
128675646|NCT02577887|463110747|FG000|Overall Study|Withdrawal by Subject|80|||
128675647|NCT03560518|463110748|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
128675648|NCT03560518|463110749|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
128675649|NCT03560518|463110750|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
128675650|NCT03560518|463110748|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
128675651|NCT03560518|463110749|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
128675652|NCT03560518|463110750|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
128675653|NCT03560518|463110748|FG000|Double Blind Treatment Period|Protocol Violation|1|||
128675654|NCT03560518|463110749|FG001|Double Blind Treatment Period|Protocol Violation|2|||
128675655|NCT03560518|463110750|FG002|Double Blind Treatment Period|Protocol Violation|0|||
128675656|NCT03560518|463110748|FG000|Double Blind Treatment Period|Pregnancy|0|||
128675657|NCT03560518|463110749|FG001|Double Blind Treatment Period|Pregnancy|2|||
128675658|NCT03560518|463110750|FG002|Double Blind Treatment Period|Pregnancy|0|||
129098938|NCT02134353|464654197|FG000|Overall Study|Withdrawal by Subject|12|||
129098939|NCT02134353|464654198|FG001|Overall Study|Withdrawal by Subject|13|||
128675659|NCT03560518|463110748|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
128675660|NCT03560518|463110749|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
128675661|NCT03560518|463110750|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
128675662|NCT03560518|463110748|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
128675663|NCT03560518|463110749|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
128675664|NCT03560518|463110750|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
129098940|NCT02134353|464654197|FG000|Overall Study|Death|0|||
128675665|NCT03560518|463110748|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
128675666|NCT03560518|463110749|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
128675667|NCT03560518|463110750|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
128675668|NCT03560518|463110748|FG000|Double Blind Treatment Period|Adverse Event|0|||
128675669|NCT03560518|463110749|FG001|Double Blind Treatment Period|Adverse Event|3|||
128675670|NCT03560518|463110750|FG002|Double Blind Treatment Period|Adverse Event|1|||
128675671|NCT01101308|463110751|FG000|Period 1|Adverse Event|2|||
128675672|NCT01101308|463110752|FG001|Period 1|Adverse Event|1|||
128675673|NCT01101308|463110751|FG000|Period 1|Positive for cotinine|1|||
128675674|NCT01101308|463110752|FG001|Period 1|Positive for cotinine|0|||
128675675|NCT01185301|463110754|FG000|Overall Study|Adverse Event|3|||
129008743|NCT01626079|464324756|FG001|Overall Study|Lost to Follow-up|4|||
129008744|NCT01626079|464324757|FG002|Overall Study|Lost to Follow-up|2|||
129008745|NCT01626079|464324755|FG000|Overall Study|Missed Visits|1|||
129008746|NCT01626079|464324756|FG001|Overall Study|Missed Visits|4|||
129008747|NCT01626079|464324757|FG002|Overall Study|Missed Visits|6|||
129008748|NCT01457053|464324759|FG000|Overall Study|Unable to undergo selected treatment|1|||
129008749|NCT01457053|464324760|FG001|Overall Study|Unable to undergo selected treatment|1|||
129008750|NCT03982433|464324761|FG000|Overall Study|Lost to Follow-up|1|||
129008751|NCT00865709|464324762|FG000|Treatment|Adverse Event|9|||
129008752|NCT00865709|464324763|FG001|Treatment|Adverse Event|6|||
129008753|NCT00865709|464324762|FG000|Treatment|Withdrawal by Subject|10|||
129008754|NCT00865709|464324763|FG001|Treatment|Withdrawal by Subject|7|||
129008755|NCT00865709|464324762|FG000|Treatment|Physician Decision|3|||
129008756|NCT00865709|464324763|FG001|Treatment|Physician Decision|2|||
129008757|NCT00865709|464324762|FG000|Treatment|Surgery|8|||
129008758|NCT00865709|464324763|FG001|Treatment|Surgery|3|||
129008759|NCT00429923|464324764|FG000|Overall Study|Adverse Event|0|||
129008760|NCT00429923|464324765|FG001|Overall Study|Adverse Event|2|||
129008761|NCT00429923|464324766|FG002|Overall Study|Adverse Event|3|||
129008762|NCT00429923|464324764|FG000|Overall Study|Lack of Efficacy|4|||
129008763|NCT00429923|464324765|FG001|Overall Study|Lack of Efficacy|1|||
129008764|NCT00429923|464324766|FG002|Overall Study|Lack of Efficacy|33|||
129008765|NCT00429923|464324764|FG000|Overall Study|Lost to Follow-up|0|||
129008766|NCT00429923|464324765|FG001|Overall Study|Lost to Follow-up|0|||
129008767|NCT00429923|464324766|FG002|Overall Study|Lost to Follow-up|2|||
129008768|NCT00429923|464324764|FG000|Overall Study|Withdrew Consent|1|||
129008769|NCT00429923|464324765|FG001|Overall Study|Withdrew Consent|0|||
129008770|NCT00429923|464324766|FG002|Overall Study|Withdrew Consent|1|||
129008771|NCT00429923|464324764|FG000|Overall Study|Early Termination|0|||
129008772|NCT00429923|464324765|FG001|Overall Study|Early Termination|1|||
129008773|NCT00429923|464324766|FG002|Overall Study|Early Termination|0|||
129008774|NCT03922477|464324773|FG000|Overall Study|Death|9|||
129008775|NCT03922477|464324773|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
129008776|NCT03922477|464324773|FG000|Overall Study|Physician Decision|1|||
129008777|NCT03922477|464324773|FG000|Overall Study|Withdrawal by Subject|2|||
129008778|NCT03387098|464324779|FG000|Overall Study|progressive disease|1|||
129008779|NCT03387098|464324779|FG000|Overall Study|Withdrawal by Subject|2|||
129008780|NCT03387098|464324779|FG000|Overall Study|study terminated by sponsor|1|||
129008781|NCT00662129|464324780|FG000|Overall Study|Protocol Violation|1|||
129008782|NCT00662129|464324780|FG000|Overall Study|Cancel prior to beginning treatment|1|||
129008783|NCT00662129|464324780|FG000|Overall Study|Ineligible|1|||
129008784|NCT02153736|464324781|FG000|Overall Study|Lost to Follow-up|1|||
129008785|NCT02153736|464324782|FG001|Overall Study|Lost to Follow-up|0|||
129008786|NCT02153736|464324781|FG000|Overall Study|Medical status change made ineligible|1|||
129008787|NCT02153736|464324782|FG001|Overall Study|Medical status change made ineligible|0|||
129008788|NCT02153736|464324781|FG000|Overall Study|Death|0|||
129008789|NCT02153736|464324782|FG001|Overall Study|Death|1|||
129008790|NCT02153736|464324781|FG000|Overall Study|Withdrawal by Subject|0|||
129008791|NCT02153736|464324782|FG001|Overall Study|Withdrawal by Subject|1|||
128675676|NCT01185301|463110755|FG001|Overall Study|Adverse Event|0|||
128675677|NCT01185301|463110756|FG002|Overall Study|Adverse Event|2|||
128675678|NCT01185301|463110757|FG003|Overall Study|Adverse Event|3|||
128675679|NCT01185301|463110754|FG000|Overall Study|Withdrawal by Subject|7|||
129008792|NCT00720122|464324793|FG000|Overall Study|Lost to Follow-up|1|||
129008793|NCT00720122|464324793|FG000|Overall Study|Physician Decision|1|||
129008794|NCT00720122|464324793|FG000|Overall Study|Withdrawal by Subject|7|||
129008795|NCT03072459|464324794|FG000|Overall Study|Device revised/removed|1|||
129008796|NCT03072459|464324794|FG000|Overall Study|Subject not able to return|1|||
129008797|NCT02579096|464324795|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
129008798|NCT02579096|464324796|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
129008799|NCT02579096|464324795|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
129008800|NCT02579096|464324796|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
129008801|NCT02579096|464324795|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
129008802|NCT02579096|464324796|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
129008803|NCT02579096|464324795|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
129008804|NCT02579096|464324796|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
129008805|NCT02579096|464324795|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
128675680|NCT01185301|463110755|FG001|Overall Study|Withdrawal by Subject|5|||
128675681|NCT01185301|463110756|FG002|Overall Study|Withdrawal by Subject|2|||
128675682|NCT01185301|463110757|FG003|Overall Study|Withdrawal by Subject|3|||
128675683|NCT01185301|463110754|FG000|Overall Study|Lost to Follow-up|2|||
129008806|NCT02579096|464324796|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
129008807|NCT02579096|464324795|FG000|Phase 2, Weeks 25 - 48|Death|2|||
129008808|NCT02579096|464324796|FG001|Phase 2, Weeks 25 - 48|Death|4|||
129008809|NCT02579096|464324795|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
129008810|NCT02579096|464324796|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
129008811|NCT02579096|464324795|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
129008812|NCT02579096|464324796|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
129008813|NCT02579096|464324795|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
129008814|NCT02579096|464324796|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
129008815|NCT02579096|464324795|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
129008816|NCT02579096|464324796|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
129008817|NCT02579096|464324795|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
129008818|NCT02579096|464324796|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
129008819|NCT02579096|464324795|FG000|Phase 3, Weeks 49 - 72|Death|3|||
129008820|NCT02579096|464324796|FG001|Phase 3, Weeks 49 - 72|Death|2|||
129008821|NCT02579096|464324795|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
129008822|NCT02579096|464324796|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
129008823|NCT02579096|464324795|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
129008824|NCT02579096|464324796|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
129008825|NCT02579096|464324795|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
129008826|NCT02579096|464324796|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
129008827|NCT02579096|464324795|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
129008828|NCT02579096|464324796|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
129008829|NCT02579096|464324795|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
129008830|NCT02579096|464324796|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
129008831|NCT02579096|464324795|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
129008832|NCT02579096|464324796|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
129008833|NCT02275364|464324797|FG000|Period 1|Withdrawal by Subject|1|||
129008834|NCT02275364|464324798|FG001|Period 1|Withdrawal by Subject|0|||
129008835|NCT02275364|464324797|FG000|Period 1|Other reason|1|||
129008836|NCT02275364|464324798|FG001|Period 1|Other reason|0|||
129008837|NCT02097121|464324799|FG000|Overall Study|Other, not specified|4|||
129008838|NCT02097121|464324800|FG001|Overall Study|Other, not specified|2|||
129008839|NCT02097121|464324801|FG002|Overall Study|Other, not specified|3|||
129008840|NCT02097121|464324799|FG000|Overall Study|Lack of Efficacy|2|||
129008841|NCT02097121|464324800|FG001|Overall Study|Lack of Efficacy|1|||
129008842|NCT02097121|464324801|FG002|Overall Study|Lack of Efficacy|3|||
129008843|NCT02097121|464324799|FG000|Overall Study|Withdrawal by Subject|0|||
129008844|NCT02097121|464324800|FG001|Overall Study|Withdrawal by Subject|1|||
129008845|NCT02097121|464324801|FG002|Overall Study|Withdrawal by Subject|2|||
129008846|NCT02097121|464324799|FG000|Overall Study|Adverse Event|0|||
129008847|NCT02097121|464324800|FG001|Overall Study|Adverse Event|1|||
129008848|NCT02097121|464324801|FG002|Overall Study|Adverse Event|0|||
129008849|NCT02097121|464324799|FG000|Overall Study|Lost to Follow-up|1|||
129008850|NCT02097121|464324800|FG001|Overall Study|Lost to Follow-up|1|||
129008851|NCT02097121|464324801|FG002|Overall Study|Lost to Follow-up|2|||
129008852|NCT03066999|464324802|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
129008853|NCT03066999|464324803|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
129008854|NCT03595657|464324804|FG000|Overall Study|Adverse Event|14|||
129008855|NCT03595657|464324804|FG000|Overall Study|Death|1|||
129008856|NCT03595657|464324804|FG000|Overall Study|Lack of Efficacy|40|||
129008857|NCT03595657|464324804|FG000|Overall Study|Withdrawal by Subject|10|||
129008858|NCT03595657|464324804|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
129008859|NCT03595657|464324804|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
129008860|NCT01361126|464324805|FG000|Overall Study|Sponsor decision|0|||
129008861|NCT01361126|464324806|FG001|Overall Study|Sponsor decision|2|||
129008862|NCT00663871|464324808|FG000|Overall Study|Lost to Follow-up|5|||
129008863|NCT00663871|464324809|FG001|Overall Study|Lost to Follow-up|5|||
129008864|NCT00663871|464324808|FG000|Overall Study|Withdrawal by Subject|5|||
129008865|NCT00663871|464324809|FG001|Overall Study|Withdrawal by Subject|2|||
129008866|NCT04094870|464324810|FG000|Overall Study|Lost to Follow-up|1|||
129008867|NCT04094870|464324811|FG001|Overall Study|Lost to Follow-up|1|||
129008868|NCT03384745|464324812|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129008869|NCT03384745|464324813|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129008870|NCT03384745|464324814|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
129008871|NCT03384745|464324815|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
129008872|NCT03384745|464324816|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129008873|NCT03384745|464324817|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129008874|NCT03384745|464324812|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129098941|NCT02134353|464654198|FG001|Overall Study|Death|1|||
128675684|NCT01185301|463110755|FG001|Overall Study|Lost to Follow-up|0|||
128675685|NCT01185301|463110756|FG002|Overall Study|Lost to Follow-up|0|||
129098942|NCT02134353|464654197|FG000|Overall Study|Pregnancy|0|||
129098943|NCT02134353|464654198|FG001|Overall Study|Pregnancy|1|||
129098944|NCT02134353|464654197|FG000|Overall Study|Relocation|1|||
129098945|NCT02134353|464654198|FG001|Overall Study|Relocation|0|||
129098946|NCT02134353|464654197|FG000|Overall Study|Other - Patient's Choice|0|||
129098947|NCT02134353|464654198|FG001|Overall Study|Other - Patient's Choice|1|||
129098948|NCT00477607|464654199|FG000|Overall Study|Lost to Follow-up|7|||
129098949|NCT00477607|464654200|FG001|Overall Study|Lost to Follow-up|7|||
129098950|NCT00358956|464654201|FG000|Overall Study|Adverse Event|3|||
129098951|NCT00358956|464654201|FG000|Overall Study|condition under investigation worsened|4|||
129098952|NCT00358956|464654201|FG000|Overall Study|Withdrawal by Subject|1|||
129098953|NCT04776018|464654202|FG000|Overall Study|Death|0|||
129098954|NCT04776018|464654203|FG001|Overall Study|Death|1|||
129098955|NCT04776018|464654204|FG002|Overall Study|Death|4|||
129098956|NCT04776018|464654205|FG003|Overall Study|Death|1|||
129098957|NCT04776018|464654206|FG004|Overall Study|Death|4|||
129098958|NCT04776018|464654207|FG005|Overall Study|Death|0|||
129098959|NCT04776018|464654208|FG006|Overall Study|Death|0|||
129098960|NCT04776018|464654202|FG000|Overall Study|Study terminated by sponsor|2|||
129098961|NCT04776018|464654203|FG001|Overall Study|Study terminated by sponsor|1|||
129098962|NCT04776018|464654204|FG002|Overall Study|Study terminated by sponsor|4|||
129098963|NCT04776018|464654205|FG003|Overall Study|Study terminated by sponsor|0|||
129098964|NCT04776018|464654206|FG004|Overall Study|Study terminated by sponsor|3|||
129098965|NCT04776018|464654207|FG005|Overall Study|Study terminated by sponsor|0|||
129098966|NCT04776018|464654208|FG006|Overall Study|Study terminated by sponsor|0|||
129098967|NCT04776018|464654202|FG000|Overall Study|Withdrawal by Subject|1|||
129098968|NCT04776018|464654203|FG001|Overall Study|Withdrawal by Subject|0|||
129098969|NCT04776018|464654204|FG002|Overall Study|Withdrawal by Subject|0|||
129098970|NCT04776018|464654205|FG003|Overall Study|Withdrawal by Subject|2|||
129098971|NCT04776018|464654206|FG004|Overall Study|Withdrawal by Subject|1|||
129098972|NCT04776018|464654207|FG005|Overall Study|Withdrawal by Subject|0|||
129098973|NCT04776018|464654208|FG006|Overall Study|Withdrawal by Subject|0|||
129098974|NCT04776018|464654202|FG000|Overall Study|Other|0|||
129098975|NCT04776018|464654203|FG001|Overall Study|Other|1|||
129098976|NCT04776018|464654204|FG002|Overall Study|Other|1|||
129098977|NCT04776018|464654205|FG003|Overall Study|Other|0|||
129098978|NCT04776018|464654206|FG004|Overall Study|Other|0|||
129098979|NCT04776018|464654207|FG005|Overall Study|Other|0|||
129098980|NCT04776018|464654208|FG006|Overall Study|Other|0|||
129098981|NCT04776018|464654202|FG000|Overall Study|Lost to Follow-up|0|||
129098982|NCT04776018|464654203|FG001|Overall Study|Lost to Follow-up|0|||
129098983|NCT04776018|464654204|FG002|Overall Study|Lost to Follow-up|1|||
129098984|NCT04776018|464654205|FG003|Overall Study|Lost to Follow-up|0|||
129098985|NCT04776018|464654206|FG004|Overall Study|Lost to Follow-up|0|||
129098986|NCT04776018|464654207|FG005|Overall Study|Lost to Follow-up|0|||
129098987|NCT04776018|464654208|FG006|Overall Study|Lost to Follow-up|0|||
129098988|NCT02908074|464654209|FG000|Overall Study|sponsor/ICON decision|0|||
129098989|NCT02908074|464654210|FG001|Overall Study|sponsor/ICON decision|0|||
129098990|NCT02908074|464654211|FG002|Overall Study|sponsor/ICON decision|1|||
129098991|NCT02908074|464654212|FG003|Overall Study|sponsor/ICON decision|0|||
128675686|NCT01185301|463110757|FG003|Overall Study|Lost to Follow-up|1|||
128675687|NCT01185301|463110754|FG000|Overall Study|Other Reason|3|||
128675688|NCT01185301|463110755|FG001|Overall Study|Other Reason|2|||
128675689|NCT01185301|463110756|FG002|Overall Study|Other Reason|2|||
128675690|NCT01185301|463110757|FG003|Overall Study|Other Reason|2|||
128675691|NCT02683746|463110758|FG000|Overall Study|Adverse Event|3|||
128675692|NCT02683746|463110759|FG001|Overall Study|Adverse Event|2|||
128675693|NCT02683746|463110758|FG000|Overall Study|Lost to Follow-up|5|||
128675694|NCT02683746|463110759|FG001|Overall Study|Lost to Follow-up|6|||
128675695|NCT02683746|463110758|FG000|Overall Study|Withdrawal by Subject|6|||
128675696|NCT02683746|463110759|FG001|Overall Study|Withdrawal by Subject|5|||
128675697|NCT02683746|463110758|FG000|Overall Study|Physician Decision|2|||
128675698|NCT02683746|463110759|FG001|Overall Study|Physician Decision|1|||
128675699|NCT04987944|463110760|FG000|Overall Study|Adverse Event|0|||
128675700|NCT04987944|463110761|FG001|Overall Study|Adverse Event|1|||
128675701|NCT04987944|463110760|FG000|Overall Study|Withdrawal by Subject|0|||
129098992|NCT02908074|464654213|FG004|Overall Study|sponsor/ICON decision|0|||
129098993|NCT02908074|464654214|FG005|Overall Study|sponsor/ICON decision|0|||
129098994|NCT02908074|464654209|FG000|Overall Study|Protocol Violation|0|||
129098995|NCT02908074|464654210|FG001|Overall Study|Protocol Violation|1|||
129098996|NCT02908074|464654211|FG002|Overall Study|Protocol Violation|0|||
129098997|NCT02908074|464654212|FG003|Overall Study|Protocol Violation|0|||
128675702|NCT04987944|463110761|FG001|Overall Study|Withdrawal by Subject|1|||
128675703|NCT00357760|463110768|FG000|Overall Study|Disease progression|44|||
128675704|NCT00357760|463110769|FG001|Overall Study|Disease progression|17|||
129098998|NCT02908074|464654213|FG004|Overall Study|Protocol Violation|0|||
129098999|NCT02908074|464654214|FG005|Overall Study|Protocol Violation|0|||
129099000|NCT02908074|464654209|FG000|Overall Study|Adverse Event|5|||
128675705|NCT00357760|463110768|FG000|Overall Study|Adverse Event|10|||
128675706|NCT00357760|463110769|FG001|Overall Study|Adverse Event|7|||
128675707|NCT00357760|463110768|FG000|Overall Study|Death|0|||
128675708|NCT00357760|463110769|FG001|Overall Study|Death|3|||
128675709|NCT00357760|463110768|FG000|Overall Study|Alternative therapy|1|||
129008875|NCT03384745|464324813|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129008876|NCT03384745|464324814|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129008877|NCT03384745|464324815|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129008878|NCT03384745|464324816|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
129008879|NCT03384745|464324817|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
129008880|NCT03384745|464324812|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
129008881|NCT03384745|464324813|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
129008882|NCT03384745|464324814|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
129008883|NCT03384745|464324815|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
129008884|NCT03384745|464324816|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
129008885|NCT03384745|464324817|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
129008886|NCT03384745|464324812|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129008887|NCT03384745|464324813|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129008888|NCT03384745|464324814|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
129008889|NCT03384745|464324815|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129008890|NCT03384745|464324816|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129008891|NCT03384745|464324817|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129008892|NCT03384745|464324812|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129008893|NCT03384745|464324813|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129008894|NCT03384745|464324814|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129008895|NCT03384745|464324815|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
129008896|NCT03384745|464324816|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
129008897|NCT03384745|464324817|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129008898|NCT03384745|464324812|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129008899|NCT03384745|464324813|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129008900|NCT03384745|464324814|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129008901|NCT03384745|464324815|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129008902|NCT03384745|464324816|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
129008903|NCT03384745|464324817|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129008904|NCT03384745|464324812|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129008905|NCT03384745|464324813|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129008906|NCT03384745|464324814|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
129008907|NCT03384745|464324815|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
129008908|NCT03384745|464324816|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129008909|NCT03384745|464324817|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129008910|NCT03384745|464324812|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
129008911|NCT03384745|464324813|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
129008912|NCT03384745|464324814|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
129008913|NCT03384745|464324815|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
129008914|NCT03384745|464324816|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
129008915|NCT03384745|464324817|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
129008916|NCT03384745|464324812|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
129008917|NCT03384745|464324813|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
129008918|NCT03384745|464324814|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
129008919|NCT03384745|464324815|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
129008920|NCT03384745|464324816|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
129008921|NCT03384745|464324817|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
129008922|NCT03384745|464324812|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129008923|NCT03384745|464324813|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129008924|NCT03384745|464324814|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129008925|NCT03384745|464324815|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
129008926|NCT03384745|464324816|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129008927|NCT03384745|464324817|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129008928|NCT03384745|464324812|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
129008929|NCT03384745|464324813|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
129008930|NCT03384745|464324814|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
129008931|NCT03384745|464324815|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
129008932|NCT03384745|464324816|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
129008933|NCT03384745|464324817|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
129008934|NCT02742181|464324820|FG000|Overall Study|Physician Decision|1|||
129008935|NCT02742181|464324821|FG001|Overall Study|Physician Decision|0|||
129008936|NCT02260492|464324822|FG000|Overall Study|Adverse Event|6|||
128675710|NCT00357760|463110769|FG001|Overall Study|Alternative therapy|0|||
128675711|NCT00357760|463110768|FG000|Overall Study|Withdrawal by Subject|0|||
128675712|NCT00357760|463110769|FG001|Overall Study|Withdrawal by Subject|2|||
128675713|NCT00357760|463110768|FG000|Overall Study|Never started treatment|2|||
128675714|NCT00357760|463110769|FG001|Overall Study|Never started treatment|1|||
128675715|NCT00357760|463110768|FG000|Overall Study|Ineligible|0|||
128675716|NCT00357760|463110769|FG001|Overall Study|Ineligible|2|||
128675717|NCT00357760|463110768|FG000|Overall Study|Physician Decision|2|||
128675718|NCT00357760|463110769|FG001|Overall Study|Physician Decision|1|||
128675719|NCT00357760|463110768|FG000|Overall Study|Protocol Violation|0|||
128675720|NCT00357760|463110769|FG001|Overall Study|Protocol Violation|1|||
128675721|NCT00357760|463110768|FG000|Overall Study|To receive hospice care|0|||
128675722|NCT00357760|463110769|FG001|Overall Study|To receive hospice care|1|||
128675723|NCT04136444|463110770|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
128675724|NCT04136444|463110771|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
128675725|NCT04905498|463110772|FG000|Overall Study|Lost to Follow-up|0|||
128675726|NCT04905498|463110773|FG001|Overall Study|Lost to Follow-up|2|||
128675727|NCT04905498|463110772|FG000|Overall Study|COVID lockdown|1|||
128675728|NCT04905498|463110773|FG001|Overall Study|COVID lockdown|0|||
128675729|NCT03180619|463110776|FG000|Overall Study|Withdrew Consent|5|||
128675730|NCT03180619|463110777|FG001|Overall Study|Withdrew Consent|0|||
128675731|NCT03180619|463110778|FG002|Overall Study|Withdrew Consent|2|||
128675732|NCT03180619|463110776|FG000|Overall Study|Death|2|||
128675733|NCT03180619|463110777|FG001|Overall Study|Death|1|||
128675734|NCT03180619|463110778|FG002|Overall Study|Death|2|||
129008937|NCT02260492|464324823|FG001|Overall Study|Adverse Event|1|||
129008938|NCT02260492|464324824|FG002|Overall Study|Adverse Event|2|||
129008939|NCT02260492|464324822|FG000|Overall Study|Death|0|||
129008940|NCT02260492|464324823|FG001|Overall Study|Death|1|||
129008941|NCT02260492|464324824|FG002|Overall Study|Death|0|||
129008942|NCT02260492|464324822|FG000|Overall Study|Lost to Follow-up|12|||
129008943|NCT02260492|464324823|FG001|Overall Study|Lost to Follow-up|9|||
129008944|NCT02260492|464324824|FG002|Overall Study|Lost to Follow-up|0|||
129008945|NCT02260492|464324822|FG000|Overall Study|Physician Decision|2|||
129008946|NCT02260492|464324823|FG001|Overall Study|Physician Decision|0|||
129008947|NCT02260492|464324824|FG002|Overall Study|Physician Decision|1|||
129008948|NCT02260492|464324822|FG000|Overall Study|Withdrawal by Subject|3|||
129008949|NCT02260492|464324823|FG001|Overall Study|Withdrawal by Subject|2|||
129008950|NCT02260492|464324824|FG002|Overall Study|Withdrawal by Subject|2|||
129008951|NCT01691508|464326570|FG000|Overall Study|Adverse Event|3|||
129008952|NCT01691508|464326571|FG001|Overall Study|Adverse Event|3|||
129008953|NCT01691508|464326570|FG000|Overall Study|Withdrawal by Subject|1|||
129008954|NCT01691508|464326571|FG001|Overall Study|Withdrawal by Subject|0|||
129008955|NCT02309099|464326577|FG000|Overall Study|Adverse Event|2|||
129008956|NCT02309099|464326578|FG001|Overall Study|Adverse Event|0|||
129008957|NCT06165744|464326579|FG000|Overall Study|Non device-related adverse event|1|||
129008958|NCT02518113|464326580|FG000|Overall Study|Adverse Event|1|||
129008959|NCT02518113|464326581|FG001|Overall Study|Adverse Event|0|||
129008960|NCT02518113|464326582|FG002|Overall Study|Adverse Event|1|||
129008961|NCT02518113|464326583|FG003|Overall Study|Adverse Event|0|||
129008962|NCT02518113|464326580|FG000|Overall Study|Death|1|||
129008963|NCT02518113|464326581|FG001|Overall Study|Death|2|||
129008964|NCT02518113|464326582|FG002|Overall Study|Death|0|||
129008965|NCT02518113|464326583|FG003|Overall Study|Death|0|||
129008966|NCT02518113|464326580|FG000|Overall Study|Physician Decision|0|||
129008967|NCT02518113|464326581|FG001|Overall Study|Physician Decision|1|||
129008968|NCT02518113|464326582|FG002|Overall Study|Physician Decision|0|||
129008969|NCT02518113|464326583|FG003|Overall Study|Physician Decision|0|||
129008970|NCT02518113|464326580|FG000|Overall Study|Progressive Disease|1|||
129008971|NCT02518113|464326581|FG001|Overall Study|Progressive Disease|2|||
129008972|NCT02518113|464326582|FG002|Overall Study|Progressive Disease|3|||
129008973|NCT02518113|464326583|FG003|Overall Study|Progressive Disease|0|||
129008974|NCT00527423|464326612|FG000|Overall Study|Protocol Violation|1|||
129008975|NCT00527423|464326612|FG000|Overall Study|Adverse Event|5|||
129008976|NCT00527423|464326612|FG000|Overall Study|Physician Decision|4|||
129008977|NCT00527423|464326612|FG000|Overall Study|Withdrawal by Subject|10|||
129008978|NCT00527423|464326612|FG000|Overall Study|Lost to Follow-up|4|||
129008979|NCT00527423|464326612|FG000|Overall Study|OTHER|4|||
129008980|NCT00527423|464326612|FG000|Overall Study|Death|9|||
129008981|NCT03702621|464326613|FG000|Overall Study|Physician Decision|6|||
129008982|NCT03702621|464326614|FG001|Overall Study|Physician Decision|6|||
128675735|NCT03180619|463110776|FG000|Overall Study|Adverse Event|2|||
128675736|NCT03180619|463110777|FG001|Overall Study|Adverse Event|0|||
128675737|NCT03180619|463110778|FG002|Overall Study|Adverse Event|1|||
129008983|NCT03194464|464326616|FG000|Overall Study|data not usable|2|||
129008984|NCT03103100|464326617|FG000|Overall Study|Adverse Event|1|||
129008985|NCT03103100|464326618|FG001|Overall Study|Adverse Event|0|||
129008986|NCT03103100|464326619|FG002|Overall Study|Adverse Event|0|||
129008987|NCT03103100|464326617|FG000|Overall Study|Physician Decision|1|||
129008988|NCT03103100|464326618|FG001|Overall Study|Physician Decision|0|||
129008989|NCT03103100|464326619|FG002|Overall Study|Physician Decision|2|||
129008990|NCT00436007|464326622|FG000|Overall Study|Withdrawal by Subject|5|||
128675738|NCT03180619|463110776|FG000|Overall Study|Investigator's discretion|2|||
128675739|NCT03180619|463110777|FG001|Overall Study|Investigator's discretion|0|||
128675740|NCT03180619|463110778|FG002|Overall Study|Investigator's discretion|1|||
128675741|NCT03077087|463110781|FG000|Overall Study|Physician Decision|2|||
128675742|NCT01989468|463110782|FG000|Overall Study|Adverse Event|10|||
128675743|NCT01989468|463110783|FG001|Overall Study|Adverse Event|15|||
128675744|NCT01989468|463110784|FG002|Overall Study|Adverse Event|4|||
128675745|NCT01989468|463110785|FG003|Overall Study|Adverse Event|5|||
128675746|NCT01989468|463110786|FG004|Overall Study|Adverse Event|4|||
128675747|NCT01989468|463110782|FG000|Overall Study|Lack of Efficacy|11|||
128675748|NCT01989468|463110783|FG001|Overall Study|Lack of Efficacy|11|||
128675749|NCT01989468|463110784|FG002|Overall Study|Lack of Efficacy|7|||
128675750|NCT01989468|463110785|FG003|Overall Study|Lack of Efficacy|4|||
128675751|NCT01989468|463110786|FG004|Overall Study|Lack of Efficacy|2|||
128675752|NCT01989468|463110782|FG000|Overall Study|Lost to Follow-up|5|||
128675753|NCT01989468|463110783|FG001|Overall Study|Lost to Follow-up|2|||
128675754|NCT01989468|463110784|FG002|Overall Study|Lost to Follow-up|0|||
128675755|NCT01989468|463110785|FG003|Overall Study|Lost to Follow-up|1|||
128675756|NCT01989468|463110786|FG004|Overall Study|Lost to Follow-up|1|||
128675757|NCT01989468|463110782|FG000|Overall Study|Physician Decision|4|||
128675758|NCT01989468|463110783|FG001|Overall Study|Physician Decision|1|||
128675759|NCT01989468|463110784|FG002|Overall Study|Physician Decision|0|||
128675760|NCT01989468|463110785|FG003|Overall Study|Physician Decision|1|||
128675761|NCT01989468|463110786|FG004|Overall Study|Physician Decision|0|||
128675762|NCT01989468|463110782|FG000|Overall Study|Pregnancy|0|||
128675763|NCT01989468|463110783|FG001|Overall Study|Pregnancy|1|||
128675764|NCT01989468|463110784|FG002|Overall Study|Pregnancy|0|||
128675765|NCT01989468|463110785|FG003|Overall Study|Pregnancy|0|||
128675766|NCT01989468|463110786|FG004|Overall Study|Pregnancy|0|||
128675767|NCT01989468|463110782|FG000|Overall Study|Technical Problems|3|||
128675768|NCT01989468|463110783|FG001|Overall Study|Technical Problems|1|||
128675769|NCT01989468|463110784|FG002|Overall Study|Technical Problems|3|||
128675770|NCT01989468|463110785|FG003|Overall Study|Technical Problems|1|||
128675771|NCT01989468|463110786|FG004|Overall Study|Technical Problems|0|||
128675772|NCT01989468|463110782|FG000|Overall Study|Subject Guardian Decision|11|||
128675773|NCT01989468|463110783|FG001|Overall Study|Subject Guardian Decision|6|||
128675774|NCT01989468|463110784|FG002|Overall Study|Subject Guardian Decision|4|||
128675775|NCT01989468|463110785|FG003|Overall Study|Subject Guardian Decision|4|||
128675776|NCT01989468|463110786|FG004|Overall Study|Subject Guardian Decision|1|||
128675777|NCT01989468|463110782|FG000|Overall Study|Death|3|||
128675778|NCT01989468|463110783|FG001|Overall Study|Death|0|||
128675779|NCT01989468|463110784|FG002|Overall Study|Death|1|||
128675780|NCT01989468|463110785|FG003|Overall Study|Death|0|||
128675781|NCT01989468|463110786|FG004|Overall Study|Death|0|||
128675782|NCT03222492|463110789|FG000|Overall Study|Withdrawal by Subject|0|||
128675783|NCT03222492|463110790|FG001|Overall Study|Withdrawal by Subject|0|||
128675784|NCT03222492|463110791|FG002|Overall Study|Withdrawal by Subject|1|||
129008991|NCT00436007|464326623|FG001|Overall Study|Withdrawal by Subject|3|||
129008992|NCT00436007|464326624|FG002|Overall Study|Withdrawal by Subject|4|||
129008993|NCT00436007|464326622|FG000|Overall Study|Lost to Follow-up|14|||
129008994|NCT00436007|464326623|FG001|Overall Study|Lost to Follow-up|10|||
129008995|NCT00436007|464326624|FG002|Overall Study|Lost to Follow-up|13|||
129008996|NCT00436007|464326622|FG000|Overall Study|Physician Decision|0|||
129008997|NCT00436007|464326623|FG001|Overall Study|Physician Decision|0|||
129008998|NCT00436007|464326624|FG002|Overall Study|Physician Decision|2|||
129008999|NCT00436007|464326622|FG000|Overall Study|Death|0|||
129009000|NCT00436007|464326623|FG001|Overall Study|Death|1|||
129009001|NCT00436007|464326624|FG002|Overall Study|Death|3|||
129009002|NCT00436007|464326622|FG000|Overall Study|Other|0|||
129009003|NCT00436007|464326623|FG001|Overall Study|Other|0|||
129009004|NCT00436007|464326624|FG002|Overall Study|Other|1|||
129009005|NCT01957488|464326625|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
129009006|NCT01957488|464326626|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
129009007|NCT01957488|464326627|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
128675785|NCT03222492|463110792|FG003|Overall Study|Withdrawal by Subject|0|||
128675786|NCT03222492|463110789|FG000|Overall Study|COVID-19 related|0|||
128675787|NCT03222492|463110790|FG001|Overall Study|COVID-19 related|0|||
128675788|NCT03222492|463110791|FG002|Overall Study|COVID-19 related|1|||
128675789|NCT03222492|463110792|FG003|Overall Study|COVID-19 related|0|||
129009008|NCT01957488|464326628|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
128675790|NCT01224782|463110800|FG000|Overall Study|Lost to Follow-up|177|||
128675791|NCT01224782|463110800|FG000|Overall Study|Withdrawal by Subject|16|||
128675792|NCT01224782|463110800|FG000|Overall Study|Death|14|||
128675793|NCT01224782|463110800|FG000|Overall Study|Improvement|13|||
128675794|NCT01224782|463110800|FG000|Overall Study|Adverse Event|12|||
128675795|NCT01224782|463110800|FG000|Overall Study|Adverse Reaction|11|||
128675796|NCT01224782|463110800|FG000|Overall Study|Noncompliance|10|||
128675797|NCT01224782|463110800|FG000|Overall Study|Other|4|||
128675798|NCT01224782|463110800|FG000|Overall Study|Start of Dialysis|3|||
129009009|NCT01957488|464326629|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
129009010|NCT01957488|464326630|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
128675799|NCT01224782|463110800|FG000|Overall Study|Change of Treatment|1|||
128675800|NCT01224782|463110800|FG000|Overall Study|Financial Reasons|1|||
128675801|NCT01224782|463110800|FG000|Overall Study|Deterioration|1|||
128675802|NCT01224782|463110800|FG000|Overall Study|Transplantation|1|||
128675803|NCT02112045|463110803|FG000|Overall Study|Withdrawal by Subject|1|||
128675804|NCT02112045|463110804|FG001|Overall Study|Withdrawal by Subject|0|||
128675805|NCT00065429|463110805|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
128675806|NCT00065429|463110806|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
128675807|NCT00065429|463110807|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
128675808|NCT00065429|463110808|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
128675809|NCT00065429|463110809|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
128675810|NCT00065429|463110810|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
128675811|NCT00065429|463110811|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
128675812|NCT00065429|463110805|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
128675813|NCT00065429|463110806|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
128675814|NCT00065429|463110807|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
128675815|NCT00065429|463110808|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
128675816|NCT00065429|463110809|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
128675817|NCT00065429|463110810|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
128675818|NCT00065429|463110811|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
128675819|NCT00065429|463110805|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
128675820|NCT00065429|463110806|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
128675821|NCT00065429|463110807|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
128675822|NCT00065429|463110808|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
128675823|NCT00065429|463110809|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
128675824|NCT00065429|463110810|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
128675825|NCT00065429|463110811|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
128675826|NCT00065429|463110805|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
128675827|NCT00065429|463110806|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
128675828|NCT00065429|463110807|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
128675829|NCT00065429|463110808|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
128675830|NCT00065429|463110809|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
128675831|NCT00065429|463110810|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
128675832|NCT00065429|463110811|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
128675833|NCT00065429|463110805|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
128675834|NCT00065429|463110806|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
128675835|NCT00065429|463110807|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
128675836|NCT00065429|463110808|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
128675837|NCT00065429|463110809|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
128675838|NCT00065429|463110810|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
129009011|NCT01957488|464326625|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
129009012|NCT01957488|464326626|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
129009013|NCT01957488|464326627|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
129009014|NCT01957488|464326628|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
129009015|NCT01957488|464326629|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
129009016|NCT01957488|464326630|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
129009017|NCT01957488|464326625|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
129009018|NCT01957488|464326626|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
129009019|NCT01957488|464326627|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
129009020|NCT01957488|464326628|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
129009021|NCT01957488|464326629|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
129009022|NCT01957488|464326630|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
129009023|NCT01957488|464326625|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129009024|NCT01957488|464326626|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129009025|NCT01957488|464326627|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129009026|NCT01957488|464326628|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
129009027|NCT01957488|464326629|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
129009028|NCT01957488|464326630|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
128675839|NCT00065429|463110811|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
128675840|NCT00065429|463110805|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
128675841|NCT00065429|463110806|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
128675842|NCT00065429|463110807|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
128675843|NCT00065429|463110808|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
128675844|NCT00065429|463110809|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
128675845|NCT00065429|463110810|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
128675846|NCT00065429|463110811|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
128675847|NCT00065429|463110805|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
128675848|NCT00065429|463110806|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
128675849|NCT00065429|463110807|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
128675850|NCT00065429|463110808|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
129009029|NCT01957488|464326625|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
128675851|NCT00065429|463110809|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
128675852|NCT00065429|463110810|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
128675853|NCT00065429|463110811|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
128675854|NCT00977080|463110813|FG000|Overall Study|Adverse Event|2|||
128675855|NCT00977080|463110814|FG001|Overall Study|Adverse Event|7|||
128675856|NCT00977080|463110815|FG002|Overall Study|Adverse Event|7|||
128675857|NCT00977080|463110816|FG003|Overall Study|Adverse Event|7|||
128675858|NCT00977080|463110813|FG000|Overall Study|Withdrawal by Subject|1|||
128675859|NCT00977080|463110814|FG001|Overall Study|Withdrawal by Subject|5|||
128675860|NCT00977080|463110815|FG002|Overall Study|Withdrawal by Subject|1|||
128675861|NCT00977080|463110816|FG003|Overall Study|Withdrawal by Subject|5|||
128675862|NCT00977080|463110813|FG000|Overall Study|Protocol Violation|7|||
128675863|NCT00977080|463110814|FG001|Overall Study|Protocol Violation|3|||
128675864|NCT00977080|463110815|FG002|Overall Study|Protocol Violation|4|||
128675865|NCT00977080|463110816|FG003|Overall Study|Protocol Violation|3|||
128675866|NCT00977080|463110813|FG000|Overall Study|Noncompliance|0|||
128675867|NCT00977080|463110814|FG001|Overall Study|Noncompliance|2|||
128675868|NCT00977080|463110815|FG002|Overall Study|Noncompliance|1|||
128675869|NCT00977080|463110816|FG003|Overall Study|Noncompliance|0|||
128675870|NCT00977080|463110813|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
128675871|NCT00977080|463110814|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
128675872|NCT00977080|463110815|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
128675873|NCT00977080|463110816|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
128675874|NCT00977080|463110813|FG000|Overall Study|Required kidney transplantation|1|||
128675875|NCT00977080|463110814|FG001|Overall Study|Required kidney transplantation|3|||
128675876|NCT00977080|463110815|FG002|Overall Study|Required kidney transplantation|3|||
128675877|NCT00977080|463110816|FG003|Overall Study|Required kidney transplantation|1|||
128675878|NCT00977080|463110813|FG000|Overall Study|Travel for family reasons|1|||
128675879|NCT00977080|463110814|FG001|Overall Study|Travel for family reasons|0|||
128675880|NCT00977080|463110815|FG002|Overall Study|Travel for family reasons|0|||
128675881|NCT00977080|463110816|FG003|Overall Study|Travel for family reasons|0|||
128675882|NCT00441116|463110819|FG000|Overall Study|Adverse Event|1|||
128675883|NCT00441116|463110820|FG001|Overall Study|Adverse Event|1|||
128675884|NCT00441116|463110819|FG000|Overall Study|Withdrawal by Subject|1|||
128675885|NCT00441116|463110820|FG001|Overall Study|Withdrawal by Subject|0|||
128675886|NCT00441116|463110819|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
128878400|NCT01210664|463848474|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129009030|NCT01957488|464326626|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129009031|NCT01957488|464326627|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129009032|NCT01957488|464326628|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129009033|NCT01957488|464326629|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
129009034|NCT01957488|464326630|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129009035|NCT01957488|464326625|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
129009036|NCT01957488|464326626|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
129009037|NCT01957488|464326627|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
129009038|NCT01957488|464326628|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
129009039|NCT01957488|464326629|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
129009040|NCT01957488|464326630|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
129009041|NCT01957488|464326625|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
129009042|NCT01957488|464326626|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
129009043|NCT01957488|464326627|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
129009044|NCT01957488|464326628|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
129009045|NCT01957488|464326629|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
129009046|NCT01957488|464326630|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
129009047|NCT01957488|464326625|FG000|Test Period 2 (2 Weeks)|Other|1|||
129009048|NCT01957488|464326626|FG001|Test Period 2 (2 Weeks)|Other|0|||
129009049|NCT01957488|464326627|FG002|Test Period 2 (2 Weeks)|Other|0|||
129009050|NCT01957488|464326628|FG003|Test Period 2 (2 Weeks)|Other|0|||
129009051|NCT01957488|464326629|FG004|Test Period 2 (2 Weeks)|Other|0|||
129009052|NCT01957488|464326630|FG005|Test Period 2 (2 Weeks)|Other|0|||
129009053|NCT01957488|464326625|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129009054|NCT01957488|464326626|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
128675887|NCT00441116|463110820|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
128675888|NCT02509117|463110824|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675889|NCT02509117|463110825|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
128675890|NCT02509117|463110826|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675891|NCT02509117|463110827|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128878401|NCT01210664|463848475|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129009055|NCT01957488|464326627|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129009056|NCT01957488|464326628|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129009057|NCT01957488|464326629|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129009058|NCT01957488|464326630|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129099001|NCT02908074|464654210|FG001|Overall Study|Adverse Event|2|||
128675892|NCT02509117|463110828|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675893|NCT02509117|463110829|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675894|NCT02509117|463110830|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675895|NCT02509117|463110831|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675896|NCT02509117|463110832|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675897|NCT02509117|463110833|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
128675898|NCT02509117|463110824|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128675899|NCT02509117|463110825|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128675900|NCT02509117|463110826|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128675901|NCT02509117|463110827|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128675902|NCT02509117|463110828|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128717768|NCT03447990|463264022|FG003|Overall Study|Withdrawal by Subject|0|||
129009059|NCT01957488|464326625|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
129099002|NCT02908074|464654211|FG002|Overall Study|Adverse Event|0|||
129099003|NCT02908074|464654212|FG003|Overall Study|Adverse Event|0|||
129099004|NCT02908074|464654213|FG004|Overall Study|Adverse Event|1|||
129099005|NCT02908074|464654214|FG005|Overall Study|Adverse Event|0|||
129099006|NCT02908074|464654209|FG000|Overall Study|AESI|1|||
129099007|NCT02908074|464654210|FG001|Overall Study|AESI|0|||
129099008|NCT02908074|464654211|FG002|Overall Study|AESI|1|||
129099009|NCT02908074|464654212|FG003|Overall Study|AESI|0|||
129099010|NCT02908074|464654213|FG004|Overall Study|AESI|1|||
129099011|NCT02908074|464654214|FG005|Overall Study|AESI|0|||
129099012|NCT02908074|464654209|FG000|Overall Study|Discontinuation criteria per protocol|0|||
129099013|NCT02908074|464654210|FG001|Overall Study|Discontinuation criteria per protocol|0|||
129099014|NCT02908074|464654211|FG002|Overall Study|Discontinuation criteria per protocol|1|||
129099015|NCT02908074|464654212|FG003|Overall Study|Discontinuation criteria per protocol|0|||
129099016|NCT02908074|464654213|FG004|Overall Study|Discontinuation criteria per protocol|0|||
129099017|NCT02908074|464654214|FG005|Overall Study|Discontinuation criteria per protocol|1|||
129099018|NCT02908074|464654209|FG000|Overall Study|Withdrawal by Subject|3|||
129099019|NCT02908074|464654210|FG001|Overall Study|Withdrawal by Subject|2|||
129099020|NCT02908074|464654211|FG002|Overall Study|Withdrawal by Subject|2|||
129099021|NCT02908074|464654212|FG003|Overall Study|Withdrawal by Subject|2|||
129099022|NCT02908074|464654213|FG004|Overall Study|Withdrawal by Subject|2|||
129099023|NCT02908074|464654214|FG005|Overall Study|Withdrawal by Subject|2|||
129099024|NCT02908074|464654209|FG000|Overall Study|Lost to Follow-up|0|||
129099025|NCT02908074|464654210|FG001|Overall Study|Lost to Follow-up|1|||
129099026|NCT02908074|464654211|FG002|Overall Study|Lost to Follow-up|1|||
129099027|NCT02908074|464654212|FG003|Overall Study|Lost to Follow-up|1|||
129099028|NCT02908074|464654213|FG004|Overall Study|Lost to Follow-up|0|||
129099029|NCT02908074|464654214|FG005|Overall Study|Lost to Follow-up|1|||
129099030|NCT01900431|464654217|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
129099031|NCT01900431|464654218|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
129009060|NCT01957488|464326626|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
129009061|NCT01957488|464326627|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
129009062|NCT01957488|464326628|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
129009063|NCT01957488|464326629|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
129009064|NCT01957488|464326630|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
129009065|NCT01957488|464326625|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129009066|NCT01957488|464326626|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129009067|NCT01957488|464326627|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129009068|NCT01957488|464326628|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129009069|NCT01957488|464326629|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129009070|NCT01957488|464326630|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
129009071|NCT01957488|464326625|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
129009072|NCT01957488|464326626|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129009073|NCT01957488|464326627|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129009074|NCT01957488|464326628|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129009075|NCT01957488|464326629|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129009076|NCT01957488|464326630|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129009077|NCT01957488|464326625|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129099032|NCT01900431|464654219|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
129099033|NCT01900431|464654217|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
129099034|NCT01900431|464654218|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
129099035|NCT01900431|464654219|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
129099036|NCT01900431|464654217|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
129099037|NCT01900431|464654218|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
129009078|NCT01957488|464326626|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
129009079|NCT01957488|464326627|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129009080|NCT01957488|464326628|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129009081|NCT01957488|464326629|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129009082|NCT01957488|464326630|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129009083|NCT01439165|464326632|FG000|Overall Study|Protocol Violation|3|||
129009084|NCT01439165|464326633|FG001|Overall Study|Protocol Violation|0|||
129009085|NCT01439165|464326632|FG000|Overall Study|Lost to Follow-up|11|||
129009086|NCT01439165|464326633|FG001|Overall Study|Lost to Follow-up|1|||
129009087|NCT01439165|464326632|FG000|Overall Study|Withdrawal by Subject|7|||
129009088|NCT01439165|464326633|FG001|Overall Study|Withdrawal by Subject|1|||
129009089|NCT00810368|464326634|FG000|Overall Study|Lost to Follow-up|4|||
129009090|NCT00810368|464326635|FG001|Overall Study|Lost to Follow-up|2|||
129009091|NCT00810368|464326634|FG000|Overall Study|Lack of Efficacy|2|||
129009092|NCT00810368|464326635|FG001|Overall Study|Lack of Efficacy|0|||
129009093|NCT02433678|464326638|FG000|Overall Study|Lost to Follow-up|1|||
129009094|NCT02433678|464326639|FG001|Overall Study|Lost to Follow-up|2|||
129009095|NCT03365375|464326642|FG000|Overall Study|Withdrawal by Subject|0|||
129009096|NCT03365375|464326643|FG001|Overall Study|Withdrawal by Subject|1|||
129009097|NCT03365375|464326642|FG000|Overall Study|Lost to Follow-up|0|||
129009098|NCT03365375|464326643|FG001|Overall Study|Lost to Follow-up|4|||
129009099|NCT00266409|464326647|FG000|Overall Study|Lack of Efficacy|2|||
129009100|NCT00266409|464326648|FG001|Overall Study|Lack of Efficacy|6|||
129009101|NCT00266409|464326649|FG002|Overall Study|Lack of Efficacy|1|||
129009102|NCT00266409|464326650|FG003|Overall Study|Lack of Efficacy|2|||
129009103|NCT00266409|464326647|FG000|Overall Study|Adverse Event|7|||
129009104|NCT00266409|464326648|FG001|Overall Study|Adverse Event|2|||
129009105|NCT00266409|464326649|FG002|Overall Study|Adverse Event|1|||
129009106|NCT00266409|464326650|FG003|Overall Study|Adverse Event|1|||
129009107|NCT00266409|464326647|FG000|Overall Study|Lost to Follow-up|18|||
129009108|NCT00266409|464326648|FG001|Overall Study|Lost to Follow-up|21|||
129009109|NCT00266409|464326649|FG002|Overall Study|Lost to Follow-up|6|||
129009110|NCT00266409|464326650|FG003|Overall Study|Lost to Follow-up|8|||
129009111|NCT00266409|464326647|FG000|Overall Study|Withdrawal by Subject|6|||
129009112|NCT00266409|464326648|FG001|Overall Study|Withdrawal by Subject|10|||
129009113|NCT00266409|464326649|FG002|Overall Study|Withdrawal by Subject|3|||
129009114|NCT00266409|464326650|FG003|Overall Study|Withdrawal by Subject|9|||
129009115|NCT00266409|464326647|FG000|Overall Study|Protocol Violation|5|||
129009116|NCT00266409|464326648|FG001|Overall Study|Protocol Violation|3|||
129009117|NCT00266409|464326649|FG002|Overall Study|Protocol Violation|4|||
129009118|NCT00266409|464326650|FG003|Overall Study|Protocol Violation|2|||
129009119|NCT00266409|464326647|FG000|Overall Study|Other|7|||
129009120|NCT00266409|464326648|FG001|Overall Study|Other|4|||
129009121|NCT00266409|464326649|FG002|Overall Study|Other|2|||
129009122|NCT00266409|464326650|FG003|Overall Study|Other|0|||
129009123|NCT00635154|464326654|FG000|Overall Study|Alternative Treatment|8|||
129009124|NCT00635154|464326654|FG000|Overall Study|Other|4|||
129009125|NCT00635154|464326654|FG000|Overall Study|Still on treatment|21|||
129009126|NCT01399736|464326655|FG000|Overall Study|Withdrawal by Subject|4|||
129009127|NCT01399736|464326656|FG001|Overall Study|Withdrawal by Subject|2|||
129009128|NCT01399736|464326655|FG000|Overall Study|Lost to Follow-up|0|||
129009129|NCT01399736|464326656|FG001|Overall Study|Lost to Follow-up|2|||
129009130|NCT03500484|464326657|FG000|Overall Study|Adverse Event|2|||
129009131|NCT03500484|464326658|FG001|Overall Study|Adverse Event|0|||
129009132|NCT03500484|464326657|FG000|Overall Study|Physician Decision|1|||
129009133|NCT03500484|464326658|FG001|Overall Study|Physician Decision|0|||
129009134|NCT03500484|464326657|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
129009135|NCT03500484|464326658|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
129009136|NCT00536575|464326659|FG000|Overall Study|Withdrawal by Subject|1|||
129009137|NCT00536575|464326659|FG000|Overall Study|Death|1|||
129009138|NCT00788957|464326668|FG000|Part 1|Death|8|||
129009139|NCT00788957|464326669|FG001|Part 1|Death|0|||
129009140|NCT00788957|464326670|FG002|Part 1|Death|0|||
129009141|NCT00788957|464326671|FG003|Part 1|Death|0|||
129099038|NCT01900431|464654219|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
129009142|NCT00788957|464326672|FG004|Part 1|Death|0|||
129009143|NCT00788957|464326673|FG005|Part 1|Death|0|||
129009144|NCT00788957|464326668|FG000|Part 1|Lost to Follow-up|1|||
129009145|NCT00788957|464326669|FG001|Part 1|Lost to Follow-up|0|||
129009146|NCT00788957|464326670|FG002|Part 1|Lost to Follow-up|0|||
129009147|NCT00788957|464326671|FG003|Part 1|Lost to Follow-up|0|||
129009148|NCT00788957|464326672|FG004|Part 1|Lost to Follow-up|0|||
129009149|NCT00788957|464326673|FG005|Part 1|Lost to Follow-up|0|||
129009150|NCT00788957|464326668|FG000|Part 2|Withdrawal by Subject|0|||
129009151|NCT00788957|464326669|FG001|Part 2|Withdrawal by Subject|9|||
129009152|NCT00788957|464326670|FG002|Part 2|Withdrawal by Subject|5|||
129009153|NCT00788957|464326671|FG003|Part 2|Withdrawal by Subject|3|||
129009154|NCT00788957|464326672|FG004|Part 2|Withdrawal by Subject|0|||
129009155|NCT00788957|464326673|FG005|Part 2|Withdrawal by Subject|0|||
129009156|NCT00788957|464326668|FG000|Part 2|Death|0|||
129009157|NCT00788957|464326669|FG001|Part 2|Death|32|||
129009158|NCT00788957|464326670|FG002|Part 2|Death|35|||
129009159|NCT00788957|464326671|FG003|Part 2|Death|37|||
129009160|NCT00788957|464326672|FG004|Part 2|Death|0|||
129009161|NCT00788957|464326673|FG005|Part 2|Death|0|||
129009162|NCT00788957|464326668|FG000|Part 2|Lost to Follow-up|0|||
129009163|NCT00788957|464326669|FG001|Part 2|Lost to Follow-up|0|||
129009164|NCT00788957|464326670|FG002|Part 2|Lost to Follow-up|3|||
129009165|NCT00788957|464326671|FG003|Part 2|Lost to Follow-up|0|||
129009166|NCT00788957|464326672|FG004|Part 2|Lost to Follow-up|0|||
129009167|NCT00788957|464326673|FG005|Part 2|Lost to Follow-up|0|||
129009168|NCT00788957|464326668|FG000|Part 2|On-study at time of data cut-off|0|||
129009169|NCT00788957|464326669|FG001|Part 2|On-study at time of data cut-off|1|||
129009170|NCT00788957|464326670|FG002|Part 2|On-study at time of data cut-off|1|||
129009171|NCT00788957|464326671|FG003|Part 2|On-study at time of data cut-off|1|||
129009172|NCT00788957|464326672|FG004|Part 2|On-study at time of data cut-off|0|||
129009173|NCT00788957|464326673|FG005|Part 2|On-study at time of data cut-off|0|||
129009174|NCT00788957|464326668|FG000|Part 3|Withdrawal by Subject|0|||
129009175|NCT00788957|464326669|FG001|Part 3|Withdrawal by Subject|0|||
129009176|NCT00788957|464326670|FG002|Part 3|Withdrawal by Subject|0|||
129009177|NCT00788957|464326671|FG003|Part 3|Withdrawal by Subject|0|||
129009178|NCT00788957|464326672|FG004|Part 3|Withdrawal by Subject|0|||
129009179|NCT00788957|464326673|FG005|Part 3|Withdrawal by Subject|2|||
129009180|NCT00788957|464326668|FG000|Part 3|Death|0|||
129009181|NCT00788957|464326669|FG001|Part 3|Death|0|||
129009182|NCT00788957|464326670|FG002|Part 3|Death|0|||
129009183|NCT00788957|464326671|FG003|Part 3|Death|0|||
129009184|NCT00788957|464326672|FG004|Part 3|Death|8|||
129009185|NCT00788957|464326673|FG005|Part 3|Death|8|||
129009186|NCT00788957|464326668|FG000|Part 3|On-study at time of data cut-off|0|||
129009187|NCT00788957|464326669|FG001|Part 3|On-study at time of data cut-off|0|||
129009188|NCT00788957|464326670|FG002|Part 3|On-study at time of data cut-off|0|||
129009189|NCT00788957|464326671|FG003|Part 3|On-study at time of data cut-off|0|||
129009190|NCT00788957|464326672|FG004|Part 3|On-study at time of data cut-off|1|||
129009191|NCT00788957|464326673|FG005|Part 3|On-study at time of data cut-off|0|||
129009192|NCT03276975|464326674|FG000|Overall Study|Withdrawal by Subject|1|||
129009193|NCT03276975|464326675|FG001|Overall Study|Withdrawal by Subject|0|||
129009194|NCT00918567|464326678|FG000|Overall Study|Lack of Efficacy|3|||
129009195|NCT00918567|464326679|FG001|Overall Study|Lack of Efficacy|1|||
129009196|NCT00918567|464326678|FG000|Overall Study|Withdrawal by Subject|1|||
129009197|NCT00918567|464326679|FG001|Overall Study|Withdrawal by Subject|1|||
129009198|NCT00918567|464326678|FG000|Overall Study|Adverse Event|1|||
129009199|NCT00918567|464326679|FG001|Overall Study|Adverse Event|0|||
129009200|NCT02568384|464326680|FG000|Overall Study|Mobile devices incompatible with App|2|||
129009201|NCT01485536|464326681|FG000|Overall Study|Withdrawal by Subject|3|||
129009202|NCT01485536|464326681|FG000|Overall Study|Adverse Event|1|||
129009203|NCT00796510|464326682|FG000|Overall Study|Death|1|||
129009204|NCT00796510|464326683|FG001|Overall Study|Death|0|||
129009205|NCT00796510|464326682|FG000|Overall Study|Study Terminated|2|||
129009206|NCT00796510|464326683|FG001|Overall Study|Study Terminated|0|||
129009207|NCT00661999|464326688|FG000|Overall Study|Adverse Event|11|||
129009208|NCT00661999|464326689|FG001|Overall Study|Adverse Event|5|||
129009209|NCT00661999|464326690|FG002|Overall Study|Adverse Event|8|||
129009210|NCT00661999|464326688|FG000|Overall Study|Death|8|||
129009211|NCT00661999|464326689|FG001|Overall Study|Death|6|||
129009212|NCT00661999|464326690|FG002|Overall Study|Death|3|||
129009213|NCT00661999|464326688|FG000|Overall Study|Other Reasons|5|||
129009214|NCT00661999|464326689|FG001|Overall Study|Other Reasons|12|||
129009215|NCT00661999|464326690|FG002|Overall Study|Other Reasons|23|||
129099039|NCT01900431|464654217|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
129099040|NCT01900431|464654218|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
129099041|NCT01900431|464654219|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
129099042|NCT01900431|464654217|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
129099043|NCT01900431|464654218|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
129099044|NCT01900431|464654219|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
129099045|NCT01900431|464654217|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
129099046|NCT01900431|464654218|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
129099047|NCT01900431|464654219|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
129099048|NCT01900431|464654217|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
129099049|NCT01900431|464654218|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
129099050|NCT01900431|464654219|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
129099051|NCT01900431|464654217|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
129099052|NCT01900431|464654218|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
129009216|NCT00661999|464326688|FG000|Overall Study|Withdrawal by Subject|30|||
129009217|NCT00661999|464326689|FG001|Overall Study|Withdrawal by Subject|23|||
129009218|NCT00661999|464326690|FG002|Overall Study|Withdrawal by Subject|14|||
129009219|NCT00661999|464326688|FG000|Overall Study|Alternative Treatment|1|||
129009220|NCT00661999|464326689|FG001|Overall Study|Alternative Treatment|0|||
129009221|NCT00661999|464326690|FG002|Overall Study|Alternative Treatment|0|||
129009222|NCT00661999|464326688|FG000|Overall Study|Other Medical Problems|4|||
129009223|NCT00661999|464326689|FG001|Overall Study|Other Medical Problems|4|||
129009224|NCT00661999|464326690|FG002|Overall Study|Other Medical Problems|9|||
129099053|NCT01900431|464654219|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
129099054|NCT01900431|464654217|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
129099055|NCT01900431|464654218|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
129099056|NCT01900431|464654219|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
129099057|NCT03172364|464654220|FG000|Overall Study|Adverse Event|1|||
129099058|NCT03172364|464654221|FG001|Overall Study|Adverse Event|1|||
129099059|NCT03172364|464654220|FG000|Overall Study|Protocol Violation|1|||
129099060|NCT03172364|464654221|FG001|Overall Study|Protocol Violation|0|||
129099061|NCT03755518|464654222|FG000|Overall Study|Lack of Efficacy|10|||
129099062|NCT03755518|464654222|FG000|Overall Study|Adverse Event|7|||
129099063|NCT03755518|464654222|FG000|Overall Study|Study Terminated by Sponsor|5|||
129099064|NCT03755518|464654222|FG000|Overall Study|Death|1|||
129099065|NCT03755518|464654222|FG000|Overall Study|Withdrawal by Subject|3|||
129099066|NCT03755518|464654222|FG000|Overall Study|Progressive Disease|4|||
129099067|NCT03755518|464654222|FG000|Overall Study|Bone Marrow Transplant|4|||
129099068|NCT03755518|464654222|FG000|Overall Study|Physicians Decision|1|||
129099069|NCT03755518|464654222|FG000|Overall Study|Relapse|1|||
129099070|NCT03755518|464654222|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
129099071|NCT03755518|464654222|FG000|Overall Study|Withdrawal by PI|1|||
129099072|NCT02732327|464654223|FG000|Overall Study|Protocol Violation|0|||
129099073|NCT02732327|464654224|FG001|Overall Study|Protocol Violation|1|||
129099074|NCT04503668|464654225|FG000|Overall Study|Incomplete data|4|||
129099075|NCT04503668|464654226|FG001|Overall Study|Incomplete data|3|||
129099076|NCT04503668|464654225|FG000|Overall Study|Withdrawal by Subject|1|||
129099077|NCT04503668|464654226|FG001|Overall Study|Withdrawal by Subject|1|||
129099078|NCT04503668|464654225|FG000|Overall Study|Adverse Event|2|||
129099079|NCT04503668|464654226|FG001|Overall Study|Adverse Event|0|||
129099080|NCT00603382|464654227|FG000|Overall Study|Adverse Event|0|||
129099081|NCT00603382|464654228|FG001|Overall Study|Adverse Event|1|||
129099082|NCT00603382|464654229|FG002|Overall Study|Adverse Event|1|||
129099083|NCT00603382|464654230|FG003|Overall Study|Adverse Event|2|||
129099084|NCT00603382|464654231|FG004|Overall Study|Adverse Event|1|||
129099085|NCT00603382|464654232|FG005|Overall Study|Adverse Event|2|||
129099086|NCT00603382|464654227|FG000|Overall Study|Lack of Efficacy|14|||
129099087|NCT00603382|464654228|FG001|Overall Study|Lack of Efficacy|9|||
129099088|NCT00603382|464654229|FG002|Overall Study|Lack of Efficacy|3|||
129099089|NCT00603382|464654230|FG003|Overall Study|Lack of Efficacy|6|||
129099090|NCT00603382|464654231|FG004|Overall Study|Lack of Efficacy|6|||
129099091|NCT00603382|464654232|FG005|Overall Study|Lack of Efficacy|11|||
129099092|NCT00603382|464654227|FG000|Overall Study|Protocol Violation|1|||
129099093|NCT00603382|464654228|FG001|Overall Study|Protocol Violation|0|||
129099094|NCT00603382|464654229|FG002|Overall Study|Protocol Violation|1|||
129099095|NCT00603382|464654230|FG003|Overall Study|Protocol Violation|2|||
129099096|NCT00603382|464654231|FG004|Overall Study|Protocol Violation|1|||
129099097|NCT00603382|464654232|FG005|Overall Study|Protocol Violation|0|||
128675903|NCT02509117|463110829|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128675904|NCT02509117|463110830|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128675905|NCT02509117|463110831|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
128675906|NCT02509117|463110832|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129099098|NCT00603382|464654227|FG000|Overall Study|Lost to Follow-up|0|||
128675907|NCT02509117|463110833|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
128675908|NCT02509117|463110824|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675909|NCT02509117|463110825|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675910|NCT02509117|463110826|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675911|NCT02509117|463110827|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675912|NCT02509117|463110828|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675913|NCT02509117|463110829|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675914|NCT02509117|463110830|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675915|NCT02509117|463110831|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675916|NCT02509117|463110832|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
128675917|NCT02509117|463110833|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
128675918|NCT00548184|463110836|FG000|Overall Study|Adverse Event|3|||
128675919|NCT00548184|463110836|FG000|Overall Study|took other drug|1|||
129099099|NCT00603382|464654228|FG001|Overall Study|Lost to Follow-up|1|||
129099100|NCT00603382|464654229|FG002|Overall Study|Lost to Follow-up|1|||
129099101|NCT00603382|464654230|FG003|Overall Study|Lost to Follow-up|1|||
129099102|NCT00603382|464654231|FG004|Overall Study|Lost to Follow-up|0|||
129099103|NCT00603382|464654232|FG005|Overall Study|Lost to Follow-up|1|||
129099104|NCT00603382|464654227|FG000|Overall Study|Physician Decision|0|||
129099105|NCT00603382|464654228|FG001|Overall Study|Physician Decision|0|||
129099106|NCT00603382|464654229|FG002|Overall Study|Physician Decision|2|||
129099107|NCT00603382|464654230|FG003|Overall Study|Physician Decision|0|||
129099108|NCT00603382|464654231|FG004|Overall Study|Physician Decision|1|||
129099109|NCT00603382|464654232|FG005|Overall Study|Physician Decision|3|||
128675920|NCT00548184|463110836|FG000|Overall Study|Found Her2 negative|1|||
128675921|NCT01765218|463110845|FG000|Overall Study|Protocol Violation|1|||
128675922|NCT01765218|463110846|FG001|Overall Study|Protocol Violation|2|||
128675923|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
128675924|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
128675925|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
128675926|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
128675927|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
128675928|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
128675929|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
128675930|NCT00946985|463110847|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
128675931|NCT00946985|463110847|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
128675932|NCT04345367|463110848|FG000|Overall Study|Other|3|||
128675933|NCT04345367|463110849|FG001|Overall Study|Other|4|||
128675934|NCT04345367|463110848|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
128675935|NCT04345367|463110849|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
128675936|NCT04345367|463110848|FG000|Overall Study|Withdrawal by Subject|11|||
128675937|NCT04345367|463110849|FG001|Overall Study|Withdrawal by Subject|11|||
128675938|NCT04345367|463110848|FG000|Overall Study|Protocol Violation|4|||
129009225|NCT00510510|464326691|FG000|Overall Study|Adverse Event|4|||
129099110|NCT00603382|464654227|FG000|Overall Study|Withdrawal by Subject|3|||
129009226|NCT00510510|464326692|FG001|Overall Study|Adverse Event|3|||
129009227|NCT00510510|464326693|FG002|Overall Study|Adverse Event|6|||
129009228|NCT00510510|464326691|FG000|Overall Study|Lack of Efficacy|0|||
129009229|NCT00510510|464326692|FG001|Overall Study|Lack of Efficacy|1|||
129009230|NCT00510510|464326693|FG002|Overall Study|Lack of Efficacy|1|||
129009231|NCT00510510|464326691|FG000|Overall Study|Subjects no longer requires study drug|0|||
129009232|NCT00510510|464326692|FG001|Overall Study|Subjects no longer requires study drug|0|||
129009233|NCT00510510|464326693|FG002|Overall Study|Subjects no longer requires study drug|2|||
129009234|NCT00510510|464326691|FG000|Overall Study|Withdrawal by Subject|1|||
129009235|NCT00510510|464326692|FG001|Overall Study|Withdrawal by Subject|2|||
129009236|NCT00510510|464326693|FG002|Overall Study|Withdrawal by Subject|3|||
129009237|NCT00510510|464326691|FG000|Overall Study|Lost to Follow-up|0|||
129009238|NCT00510510|464326692|FG001|Overall Study|Lost to Follow-up|0|||
129009239|NCT00510510|464326693|FG002|Overall Study|Lost to Follow-up|1|||
129009240|NCT00510510|464326691|FG000|Overall Study|Protocol Violation|0|||
129009241|NCT00510510|464326692|FG001|Overall Study|Protocol Violation|3|||
129009242|NCT00510510|464326693|FG002|Overall Study|Protocol Violation|4|||
129009243|NCT02984683|464326696|FG000|Overall Study|Adverse Event|3|||
129009244|NCT02984683|464326697|FG001|Overall Study|Adverse Event|3|||
129009245|NCT02984683|464326696|FG000|Overall Study|Withdrawal by Subject|1|||
129009246|NCT02984683|464326697|FG001|Overall Study|Withdrawal by Subject|0|||
129009247|NCT02984683|464326696|FG000|Overall Study|Disease progression|7|||
129009248|NCT02984683|464326697|FG001|Overall Study|Disease progression|9|||
129009249|NCT02739984|464326698|FG000|Overall Study|Sponsor Decision|1|||
129009250|NCT02739984|464326699|FG001|Overall Study|Sponsor Decision|0|||
129009251|NCT02739984|464326698|FG000|Overall Study|Withdrawal by Subject|1|||
129009252|NCT02739984|464326699|FG001|Overall Study|Withdrawal by Subject|1|||
129009253|NCT02739984|464326698|FG000|Overall Study|Death|0|||
129009254|NCT02739984|464326699|FG001|Overall Study|Death|1|||
129009255|NCT02739984|464326698|FG000|Overall Study|Lost to Follow-up|3|||
129009256|NCT02739984|464326699|FG001|Overall Study|Lost to Follow-up|0|||
129009257|NCT03008460|464326700|FG000|Overall Study|Protocol deviation|0|||
129009258|NCT03008460|464326701|FG001|Overall Study|Protocol deviation|2|||
129009259|NCT03008460|464326700|FG000|Overall Study|Study drug not dispensed|0|||
129009260|NCT03008460|464326701|FG001|Overall Study|Study drug not dispensed|1|||
129009261|NCT03008460|464326700|FG000|Overall Study|Adverse Event|0|||
129009262|NCT03008460|464326701|FG001|Overall Study|Adverse Event|1|||
129009263|NCT03008460|464326700|FG000|Overall Study|Withdrawal by Subject|5|||
129009264|NCT03008460|464326701|FG001|Overall Study|Withdrawal by Subject|6|||
129009265|NCT03008460|464326700|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
129009266|NCT03008460|464326701|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
129009267|NCT03008460|464326700|FG000|Overall Study|End of study visit outside permitted time window|0|||
129009268|NCT03008460|464326701|FG001|Overall Study|End of study visit outside permitted time window|1|||
129009269|NCT03008460|464326700|FG000|Overall Study|Lost to Follow-up|1|||
129009270|NCT03008460|464326701|FG001|Overall Study|Lost to Follow-up|3|||
129009271|NCT04947579|464326704|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129009272|NCT04947579|464326705|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129099111|NCT00603382|464654228|FG001|Overall Study|Withdrawal by Subject|3|||
128675939|NCT04345367|463110849|FG001|Overall Study|Protocol Violation|3|||
128675940|NCT04345367|463110848|FG000|Overall Study|Lost to Follow-up|2|||
129009273|NCT04947579|464326706|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129009274|NCT04947579|464326707|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
129009275|NCT04947579|464326708|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129215082|NCT02760498|465089441|FG005|Overall Study|Disease progression|55|||
128675941|NCT04345367|463110849|FG001|Overall Study|Lost to Follow-up|4|||
128675942|NCT04345367|463110848|FG000|Overall Study|Lack of Efficacy|2|||
128675943|NCT04345367|463110849|FG001|Overall Study|Lack of Efficacy|0|||
128675944|NCT04345367|463110848|FG000|Overall Study|Death|2|||
128675945|NCT04345367|463110849|FG001|Overall Study|Death|0|||
129009276|NCT04947579|464326709|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129009277|NCT04947579|464326704|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129009278|NCT04947579|464326705|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129009279|NCT04947579|464326706|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
129009280|NCT04947579|464326707|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129009281|NCT04947579|464326708|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129009282|NCT04947579|464326709|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129009283|NCT04947579|464326704|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
129009284|NCT04947579|464326705|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
129009285|NCT04947579|464326706|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
129009286|NCT04947579|464326707|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
129009287|NCT04947579|464326708|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
129009288|NCT04947579|464326709|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
129009289|NCT04947579|464326704|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
129009290|NCT04947579|464326705|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
129009291|NCT04947579|464326706|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
129009292|NCT04947579|464326707|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
129009293|NCT04947579|464326708|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
129009294|NCT04947579|464326709|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
129009295|NCT04947579|464326704|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
129009296|NCT04947579|464326705|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129009297|NCT04947579|464326706|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129009298|NCT04947579|464326707|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129009299|NCT04947579|464326708|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129009300|NCT04947579|464326709|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129009301|NCT04947579|464326704|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129009302|NCT04947579|464326705|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129009303|NCT04947579|464326706|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
129009304|NCT04947579|464326707|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129009305|NCT04947579|464326708|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129009306|NCT04947579|464326709|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129009307|NCT04947579|464326704|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129009308|NCT04947579|464326705|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
129009309|NCT04947579|464326706|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129009310|NCT04947579|464326707|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129009311|NCT04947579|464326708|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129009312|NCT04947579|464326709|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
129009313|NCT04947579|464326704|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129009314|NCT04947579|464326705|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129009315|NCT04947579|464326706|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
129009316|NCT04947579|464326707|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129009317|NCT04947579|464326708|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129009318|NCT04947579|464326709|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129009319|NCT04947579|464326704|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
129009320|NCT04947579|464326705|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
129009321|NCT04947579|464326706|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
129009322|NCT04947579|464326707|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
129009323|NCT04947579|464326708|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
129009324|NCT04947579|464326709|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
129009325|NCT04947579|464326704|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
129009326|NCT04947579|464326705|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
129009327|NCT04947579|464326706|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
129009328|NCT04947579|464326707|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
129009329|NCT04947579|464326708|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
129009330|NCT04947579|464326709|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
129009331|NCT04947579|464326704|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
129009332|NCT04947579|464326705|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
129009333|NCT04947579|464326706|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
129009334|NCT04947579|464326707|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
128675946|NCT04345367|463110848|FG000|Overall Study|Adverse Event|10|||
129099112|NCT00603382|464654229|FG002|Overall Study|Withdrawal by Subject|1|||
129099113|NCT00603382|464654230|FG003|Overall Study|Withdrawal by Subject|1|||
129099114|NCT00603382|464654231|FG004|Overall Study|Withdrawal by Subject|0|||
129099115|NCT00603382|464654232|FG005|Overall Study|Withdrawal by Subject|1|||
129099116|NCT03403621|464654233|FG000|Overall Study|Withdrawal by Subject|2|||
129099117|NCT03403621|464654234|FG001|Overall Study|Withdrawal by Subject|2|||
129099118|NCT00583102|464654235|FG000|Overall Study|Adverse Event|3|||
129099119|NCT03611582|464654238|FG000|Overall Study|Adverse Event|26|||
129099120|NCT03611582|464654239|FG001|Overall Study|Adverse Event|6|||
129099121|NCT03611582|464654238|FG000|Overall Study|Protocol Violation|0|||
129099122|NCT03611582|464654239|FG001|Overall Study|Protocol Violation|1|||
129099123|NCT03611582|464654238|FG000|Overall Study|Pregnancy|1|||
129099124|NCT03611582|464654239|FG001|Overall Study|Pregnancy|2|||
129099125|NCT03611582|464654238|FG000|Overall Study|Lack of Efficacy|0|||
129099126|NCT03611582|464654239|FG001|Overall Study|Lack of Efficacy|1|||
129099127|NCT03611582|464654238|FG000|Overall Study|At the discretion of the investigator|1|||
129099128|NCT03611582|464654239|FG001|Overall Study|At the discretion of the investigator|0|||
129099129|NCT03611582|464654238|FG000|Overall Study|Safety concern as judged by the investigator|1|||
128675947|NCT04345367|463110849|FG001|Overall Study|Adverse Event|9|||
128675948|NCT00781885|463110850|FG000|Overall Study|Physician Decision|1|||
128675949|NCT03041129|463110857|FG000|Overall Study|Withdrawal by Subject|2|||
129009335|NCT04947579|464326708|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
129009336|NCT04947579|464326709|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
129009337|NCT01575054|464326710|FG000|Overall Study|Other Reasons|5|||
129009338|NCT01575054|464326711|FG001|Overall Study|Other Reasons|3|||
129009339|NCT01575054|464326710|FG000|Overall Study|Protocol Violation|2|||
129009340|NCT01575054|464326711|FG001|Overall Study|Protocol Violation|1|||
129009341|NCT01575054|464326710|FG000|Overall Study|Personal Reasons|10|||
129009342|NCT01575054|464326711|FG001|Overall Study|Personal Reasons|11|||
129009343|NCT01575054|464326710|FG000|Overall Study|Lost to Follow-up|3|||
129009344|NCT01575054|464326711|FG001|Overall Study|Lost to Follow-up|3|||
129009345|NCT01575054|464326710|FG000|Overall Study|Adverse Event|9|||
129009346|NCT01575054|464326711|FG001|Overall Study|Adverse Event|8|||
129009347|NCT00462982|464326716|FG000|Overall Study|Adverse Event|1|||
129009348|NCT00462982|464326716|FG000|Overall Study|Patient Not Treated|2|||
129009349|NCT02683187|464326717|FG000|Overall Study|Failed IV access|3|||
129009350|NCT02683187|464326717|FG000|Overall Study|Withdrawal by Subject|5|||
129009351|NCT00770315|464326718|FG000|Overall Study|Adverse Event|11|||
129009352|NCT00770315|464326719|FG001|Overall Study|Adverse Event|17|||
129009353|NCT00770315|464326720|FG002|Overall Study|Adverse Event|16|||
129009354|NCT00770315|464326721|FG003|Overall Study|Adverse Event|6|||
129009355|NCT00770315|464326718|FG000|Overall Study|Lost to Follow-up|9|||
129009356|NCT00770315|464326719|FG001|Overall Study|Lost to Follow-up|5|||
129009357|NCT00770315|464326720|FG002|Overall Study|Lost to Follow-up|10|||
129009358|NCT00770315|464326721|FG003|Overall Study|Lost to Follow-up|3|||
129009359|NCT00770315|464326718|FG000|Overall Study|Withdrawal by Subject|13|||
129009360|NCT00770315|464326719|FG001|Overall Study|Withdrawal by Subject|17|||
129009361|NCT00770315|464326720|FG002|Overall Study|Withdrawal by Subject|24|||
129009362|NCT00770315|464326721|FG003|Overall Study|Withdrawal by Subject|20|||
129009363|NCT00770315|464326718|FG000|Overall Study|Noncompliance with Protocol|7|||
129009364|NCT00770315|464326719|FG001|Overall Study|Noncompliance with Protocol|4|||
129009365|NCT00770315|464326720|FG002|Overall Study|Noncompliance with Protocol|7|||
129009366|NCT00770315|464326721|FG003|Overall Study|Noncompliance with Protocol|9|||
129009367|NCT02585258|464326722|FG000|Overall Study|Adverse Event|28|||
129009368|NCT02585258|464326723|FG001|Overall Study|Adverse Event|29|||
129009369|NCT02585258|464326722|FG000|Overall Study|Death|3|||
129009370|NCT02585258|464326723|FG001|Overall Study|Death|2|||
129009371|NCT02585258|464326722|FG000|Overall Study|Lack of Efficacy|7|||
129009372|NCT02585258|464326723|FG001|Overall Study|Lack of Efficacy|9|||
129009373|NCT02585258|464326722|FG000|Overall Study|includes covid-related access problems|42|||
129009374|NCT02585258|464326723|FG001|Overall Study|includes covid-related access problems|46|||
129009375|NCT02585258|464326722|FG000|Overall Study|Lost to Follow-up|5|||
129009376|NCT02585258|464326723|FG001|Overall Study|Lost to Follow-up|2|||
129009377|NCT01919190|464328832|FG000|Overall Study|Intra-op findings, etc.|3|||
129099130|NCT03611582|464654239|FG001|Overall Study|Safety concern as judged by the investigator|2|||
129099131|NCT03611582|464654238|FG000|Overall Study|Withdrawal by Subject|4|||
128675950|NCT03041129|463110858|FG001|Overall Study|Withdrawal by Subject|0|||
128675951|NCT03041129|463110859|FG002|Overall Study|Withdrawal by Subject|0|||
129009378|NCT01919190|464328833|FG001|Overall Study|Intra-op findings, etc.|0|||
129009379|NCT02322047|464328834|FG000|Overall Study|Physician Decision|1|||
129009380|NCT02322047|464328835|FG001|Overall Study|Physician Decision|0|||
129009381|NCT02322047|464328836|FG002|Overall Study|Physician Decision|0|||
129009382|NCT02322047|464328837|FG003|Overall Study|Physician Decision|0|||
129009383|NCT02322047|464328834|FG000|Overall Study|Withdrawal by Subject|1|||
129009384|NCT02322047|464328835|FG001|Overall Study|Withdrawal by Subject|0|||
129009385|NCT02322047|464328836|FG002|Overall Study|Withdrawal by Subject|0|||
129099132|NCT03611582|464654239|FG001|Overall Study|Withdrawal by Subject|3|||
129099133|NCT03611582|464654238|FG000|Overall Study|Lost to Follow-up|18|||
129099134|NCT03611582|464654239|FG001|Overall Study|Lost to Follow-up|7|||
129099135|NCT03611582|464654238|FG000|Overall Study|other|17|||
129099136|NCT03611582|464654239|FG001|Overall Study|other|16|||
129099137|NCT04459598|464654240|FG000|Overall Study|Adverse Event|1|||
129099138|NCT04459598|464654241|FG001|Overall Study|Adverse Event|1|||
129099139|NCT01078298|464654242|FG000|Overall Study|Lost to Follow-up|12|||
129099140|NCT01078298|464654243|FG001|Overall Study|Lost to Follow-up|13|||
129099141|NCT01078298|464654242|FG000|Overall Study|Withdrawal by Subject|31|||
129099142|NCT01078298|464654243|FG001|Overall Study|Withdrawal by Subject|33|||
129099143|NCT01078298|464654242|FG000|Overall Study|Protocol Violation|6|||
129099144|NCT01078298|464654243|FG001|Overall Study|Protocol Violation|6|||
129099145|NCT01078298|464654242|FG000|Overall Study|Adverse Event|6|||
129099146|NCT01078298|464654243|FG001|Overall Study|Adverse Event|5|||
129099147|NCT01078298|464654242|FG000|Overall Study|Death|2|||
129099148|NCT01078298|464654243|FG001|Overall Study|Death|0|||
129099149|NCT01078298|464654242|FG000|Overall Study|Did not meet entrance criteria|0|||
129099150|NCT01078298|464654243|FG001|Overall Study|Did not meet entrance criteria|1|||
129099151|NCT01078298|464654242|FG000|Overall Study|Other|24|||
129099152|NCT01078298|464654243|FG001|Overall Study|Other|32|||
129099153|NCT00866333|464654244|FG000|Overall Study|Withdrawal of consent|0|||
129099154|NCT00866333|464654245|FG001|Overall Study|Withdrawal of consent|1|||
129099155|NCT00866333|464654246|FG002|Overall Study|Withdrawal of consent|2|||
129099156|NCT00866333|464654244|FG000|Overall Study|Reason not Specified|3|||
129099157|NCT00866333|464654245|FG001|Overall Study|Reason not Specified|1|||
129099158|NCT00866333|464654246|FG002|Overall Study|Reason not Specified|1|||
129099159|NCT00866333|464654244|FG000|Overall Study|Study Terminated by Sponsor|2|||
129099160|NCT00866333|464654245|FG001|Overall Study|Study Terminated by Sponsor|5|||
129099161|NCT00866333|464654246|FG002|Overall Study|Study Terminated by Sponsor|9|||
129099162|NCT03089853|464655255|FG000|Overall Study|Lost to Follow-up|2|||
129099163|NCT03089853|464655256|FG001|Overall Study|Lost to Follow-up|1|||
129099164|NCT00441363|464655257|FG000|Overall Study|Adverse Event|4|||
129099165|NCT00441363|464655258|FG001|Overall Study|Adverse Event|2|||
129099166|NCT00441363|464655257|FG000|Overall Study|Withdrawal by Subject|3|||
129099167|NCT00441363|464655258|FG001|Overall Study|Withdrawal by Subject|4|||
129099168|NCT00441363|464655257|FG000|Overall Study|Physician Decision|6|||
129099169|NCT00441363|464655258|FG001|Overall Study|Physician Decision|7|||
129099170|NCT00441363|464655257|FG000|Overall Study|Lost to Follow-up|2|||
129099171|NCT00441363|464655258|FG001|Overall Study|Lost to Follow-up|2|||
129099172|NCT00441363|464655257|FG000|Overall Study|Other|2|||
129099173|NCT00441363|464655258|FG001|Overall Study|Other|0|||
129099174|NCT04114656|464655261|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
129099175|NCT04114656|464655262|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
129099176|NCT04114656|464655261|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
129099177|NCT04114656|464655262|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
129099178|NCT04114656|464655261|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
129099179|NCT04114656|464655262|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
129099180|NCT04114656|464655261|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
129099181|NCT04114656|464655262|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
129099182|NCT04114656|464655261|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
129099183|NCT04114656|464655262|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
129099184|NCT03326518|464655268|FG000|Overall Study|Protocol Violation|1|||
129099185|NCT03326518|464655269|FG001|Overall Study|Protocol Violation|0|||
129099186|NCT03326518|464655270|FG002|Overall Study|Protocol Violation|0|||
129099187|NCT03326518|464655268|FG000|Overall Study|Withdrawal by Subject|1|||
129099188|NCT03326518|464655269|FG001|Overall Study|Withdrawal by Subject|0|||
129099189|NCT03326518|464655270|FG002|Overall Study|Withdrawal by Subject|0|||
129099190|NCT03326518|464655268|FG000|Overall Study|Lost to Follow-up|1|||
129099191|NCT03326518|464655269|FG001|Overall Study|Lost to Follow-up|0|||
129099192|NCT03326518|464655270|FG002|Overall Study|Lost to Follow-up|1|||
129099193|NCT01375374|464655273|FG000|Overall Study|Adverse Event|1|||
129099194|NCT02065518|464655274|FG000|Overall Study|Lost to Follow-up|3|||
129099195|NCT02065518|464655275|FG001|Overall Study|Lost to Follow-up|4|||
129099196|NCT02065518|464655276|FG002|Overall Study|Lost to Follow-up|0|||
128675952|NCT03041129|463110860|FG003|Overall Study|Withdrawal by Subject|0|||
129099197|NCT02065518|464655277|FG003|Overall Study|Lost to Follow-up|3|||
129099198|NCT02065518|464655274|FG000|Overall Study|Withdrawal by Subject|3|||
129099199|NCT02065518|464655275|FG001|Overall Study|Withdrawal by Subject|4|||
129099200|NCT02065518|464655276|FG002|Overall Study|Withdrawal by Subject|9|||
129099201|NCT02065518|464655277|FG003|Overall Study|Withdrawal by Subject|2|||
129099202|NCT04849416|464655278|FG000|Overall Study|Ongoing Treatment|12|||
128675953|NCT01947855|463110861|FG000|Overall Study|Withdrawal by Subject|1|||
129099203|NCT04849416|464655279|FG001|Overall Study|Ongoing Treatment|5|||
129099204|NCT04849416|464655280|FG002|Overall Study|Ongoing Treatment|3|||
129099205|NCT04849416|464655278|FG000|Overall Study|On Post-Treatment Follow-up|8|||
128675954|NCT01947855|463110862|FG001|Overall Study|Withdrawal by Subject|0|||
128675955|NCT01947855|463110863|FG002|Overall Study|Withdrawal by Subject|0|||
129009386|NCT02322047|464328837|FG003|Overall Study|Withdrawal by Subject|1|||
129009387|NCT02322047|464328834|FG000|Overall Study|Adverse Event|0|||
129009388|NCT02322047|464328835|FG001|Overall Study|Adverse Event|1|||
129009389|NCT02322047|464328836|FG002|Overall Study|Adverse Event|0|||
129009390|NCT02322047|464328837|FG003|Overall Study|Adverse Event|0|||
129009391|NCT02322047|464328834|FG000|Overall Study|Lost to Follow-up|0|||
129009392|NCT02322047|464328835|FG001|Overall Study|Lost to Follow-up|0|||
129009393|NCT02322047|464328836|FG002|Overall Study|Lost to Follow-up|1|||
129009394|NCT02322047|464328837|FG003|Overall Study|Lost to Follow-up|1|||
129009395|NCT02207231|464328838|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
129009396|NCT02207231|464328839|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
129009397|NCT02207231|464328840|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
129009398|NCT02207231|464328841|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
129009399|NCT02207231|464328838|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
129009400|NCT02207231|464328839|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
129009401|NCT02207231|464328840|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
129009402|NCT02207231|464328841|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
129009403|NCT02207231|464328838|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
129009404|NCT02207231|464328839|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
129009405|NCT02207231|464328840|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
129009406|NCT02207231|464328841|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
129009407|NCT02207231|464328838|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
129009408|NCT02207231|464328839|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
129009409|NCT02207231|464328840|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
129009410|NCT02207231|464328841|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
129009411|NCT02207231|464328838|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
129009412|NCT02207231|464328839|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
129009413|NCT02207231|464328840|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
129009414|NCT02207231|464328841|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
129009415|NCT02207231|464328838|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
129009416|NCT02207231|464328839|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
129009417|NCT02207231|464328840|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
129009418|NCT02207231|464328841|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
129009419|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
129009420|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
129009421|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
129009422|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
129009423|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
129009424|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
129009425|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
129009426|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
129009427|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
129009428|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
129009429|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
129009430|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
129009431|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
129009432|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
129009433|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
129009434|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
129009435|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
129009436|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
129009437|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
129009438|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
129009439|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
129009440|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
129009441|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
129009442|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
129009443|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
129009444|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
129009445|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
129009446|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
129009447|NCT02207231|464328838|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
129009448|NCT02207231|464328839|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
129009449|NCT02207231|464328840|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
129009450|NCT02207231|464328841|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
129099206|NCT04849416|464655279|FG001|Overall Study|On Post-Treatment Follow-up|9|||
129099207|NCT04849416|464655280|FG002|Overall Study|On Post-Treatment Follow-up|10|||
129099208|NCT04849416|464655278|FG000|Overall Study|Withdrawal by Subject|0|||
129099209|NCT04849416|464655279|FG001|Overall Study|Withdrawal by Subject|0|||
128675956|NCT03865316|463112734|FG000|Overall Study|Procedure Cancelled|4|||
128675957|NCT03865316|463112734|FG000|Overall Study|Equipment failure|4|||
128675958|NCT00877773|463112739|FG000|Overall Study|Disease Progression|44|||
128675959|NCT03328182|463112740|FG000|Overall Study|Withdrawal by Subject|1|||
128675960|NCT03328182|463112740|FG000|Overall Study|Protocol Violation|2|||
128675961|NCT03328182|463112740|FG000|Overall Study|No Product Evaluated|1|||
128675962|NCT00874939|463112741|FG000|Overall Study|Study terminated|4|||
128675963|NCT00003590|463112744|FG000|Overall Study|Ineligible Patient|1|||
128675964|NCT00003590|463112744|FG000|Overall Study|Adverse Event|7|||
128675965|NCT00003590|463112744|FG000|Overall Study|Withdrawal by Subject|1|||
129009451|NCT02207231|464328838|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
129009452|NCT02207231|464328839|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
129009453|NCT02207231|464328840|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
129009454|NCT02207231|464328841|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
129009455|NCT02207231|464328838|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
129009456|NCT02207231|464328839|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
129009457|NCT02207231|464328840|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
129009458|NCT02207231|464328841|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
129009459|NCT02207231|464328838|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
129009460|NCT02207231|464328839|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
129009461|NCT02207231|464328840|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
129009462|NCT02207231|464328841|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
129009463|NCT02207231|464328838|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
129009464|NCT02207231|464328839|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
129009465|NCT02207231|464328840|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
129009466|NCT02207231|464328841|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
129009467|NCT02207231|464328838|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
129009468|NCT02207231|464328839|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
129009469|NCT02207231|464328840|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
129009470|NCT02207231|464328841|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
129009471|NCT02207231|464328838|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
129009472|NCT02207231|464328839|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
129009473|NCT02207231|464328840|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
129009474|NCT02207231|464328841|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
129009475|NCT02207231|464328838|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
129009476|NCT02207231|464328839|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
129009477|NCT02207231|464328840|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
129009478|NCT02207231|464328841|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
129009479|NCT02016300|464328849|FG000|Overall Study|Lost to Follow-up|0|||
129009480|NCT02016300|464328850|FG001|Overall Study|Lost to Follow-up|3|||
129009481|NCT05456529|464328851|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
129009482|NCT05456529|464328851|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
129009483|NCT05456529|464328851|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
129009484|NCT05456529|464328851|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
129009485|NCT05456529|464328851|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
129009486|NCT05456529|464328851|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
129009487|NCT05456529|464328851|FG000|44-week Long-term Safety Period|Physician Decision|2|||
129009488|NCT05456529|464328851|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
129009489|NCT05456529|464328851|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
129009490|NCT05456529|464328851|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
129009491|NCT05456529|464328851|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
129009492|NCT00797108|464328852|FG000|Overall Study|Adverse Event|1|||
129009493|NCT00797108|464328853|FG001|Overall Study|Adverse Event|0|||
129009494|NCT00797108|464328854|FG002|Overall Study|Adverse Event|3|||
129009495|NCT00797108|464328852|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
129009496|NCT00797108|464328853|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
129009497|NCT00797108|464328854|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
129009498|NCT00797108|464328852|FG000|Overall Study|Global Deterioration of Health Status|0|||
129009499|NCT00797108|464328853|FG001|Overall Study|Global Deterioration of Health Status|1|||
129009500|NCT00797108|464328854|FG002|Overall Study|Global Deterioration of Health Status|0|||
129099210|NCT04849416|464655280|FG002|Overall Study|Withdrawal by Subject|1|||
128675966|NCT00003590|463112744|FG000|Overall Study|Lack of Efficacy|11|||
129099211|NCT04849416|464655278|FG000|Overall Study|Lost to Follow-up|1|||
128675967|NCT00003590|463112744|FG000|Overall Study|Death|1|||
128675968|NCT00003590|463112744|FG000|Overall Study|Physician Decision|1|||
128675969|NCT00883688|463112750|FG000|Overall Study|Ineligible|2|||
128675970|NCT01328366|463112753|FG000|Overall Study|Death|1|||
128878402|NCT01210664|463848476|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
128878403|NCT01210664|463848477|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
128878404|NCT01210664|463848474|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129009501|NCT00797108|464328852|FG000|Overall Study|Lack of Efficacy|1|||
129009502|NCT00797108|464328853|FG001|Overall Study|Lack of Efficacy|0|||
129009503|NCT00797108|464328854|FG002|Overall Study|Lack of Efficacy|1|||
129009504|NCT00797108|464328852|FG000|Overall Study|Other|0|||
129009505|NCT00797108|464328853|FG001|Overall Study|Other|0|||
129009506|NCT00797108|464328854|FG002|Overall Study|Other|2|||
129009507|NCT00797108|464328852|FG000|Overall Study|Randomized but not Treated|2|||
129009508|NCT00797108|464328853|FG001|Overall Study|Randomized but not Treated|0|||
129009509|NCT00797108|464328854|FG002|Overall Study|Randomized but not Treated|0|||
129009510|NCT02270736|464328855|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129009511|NCT02270736|464328856|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
129009512|NCT02270736|464328857|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129009513|NCT02270736|464328858|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129009514|NCT02270736|464328859|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129009515|NCT02270736|464328855|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
129009516|NCT02270736|464328856|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
129009517|NCT02270736|464328857|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
129009518|NCT02270736|464328858|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
129009519|NCT02270736|464328859|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
129009520|NCT02270736|464328855|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129009521|NCT02270736|464328856|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
129009522|NCT02270736|464328857|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129009523|NCT02270736|464328858|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129009524|NCT02270736|464328859|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129009525|NCT02270736|464328855|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129009526|NCT02270736|464328856|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129009527|NCT02270736|464328857|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
129009528|NCT02270736|464328858|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129009529|NCT02270736|464328859|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129009530|NCT02270736|464328855|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129009531|NCT02270736|464328856|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129009532|NCT02270736|464328857|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129009533|NCT02270736|464328858|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
129009534|NCT02270736|464328859|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129009535|NCT02270736|464328855|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129009536|NCT02270736|464328856|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129009537|NCT02270736|464328857|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129009538|NCT02270736|464328858|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
129009539|NCT02270736|464328859|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129009540|NCT02270736|464328855|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129009541|NCT02270736|464328856|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129009542|NCT02270736|464328857|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129009543|NCT02270736|464328858|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
129009544|NCT02270736|464328859|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129009545|NCT02270736|464328855|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129009546|NCT02270736|464328856|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129009547|NCT02270736|464328857|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129009548|NCT02270736|464328858|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
129009549|NCT02270736|464328859|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129009550|NCT02270736|464328855|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129009551|NCT02270736|464328856|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129009552|NCT02270736|464328857|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129009553|NCT02270736|464328858|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
129009554|NCT02270736|464328859|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129009555|NCT01631864|464328860|FG000|Overall Study|Withdrawal by Subject|0|||
129009556|NCT01631864|464328861|FG001|Overall Study|Withdrawal by Subject|1|||
129009557|NCT01631864|464328860|FG000|Overall Study|Adverse Event|2|||
129009558|NCT01631864|464328861|FG001|Overall Study|Adverse Event|3|||
129009559|NCT02153398|464328864|FG000|Overall Study|Withdrawal by Subject|1|||
129009560|NCT02153398|464328865|FG001|Overall Study|Withdrawal by Subject|0|||
129009561|NCT02153398|464328866|FG002|Overall Study|Withdrawal by Subject|0|||
129009562|NCT02153398|464328867|FG003|Overall Study|Withdrawal by Subject|0|||
129009563|NCT02153398|464328868|FG004|Overall Study|Withdrawal by Subject|0|||
129009564|NCT02153398|464328864|FG000|Overall Study|Adverse Event|0|||
128878405|NCT01210664|463848475|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
128878406|NCT01210664|463848476|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
128878407|NCT01210664|463848477|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129009565|NCT02153398|464328865|FG001|Overall Study|Adverse Event|0|||
129099212|NCT04849416|464655279|FG001|Overall Study|Lost to Follow-up|0|||
129099213|NCT04849416|464655280|FG002|Overall Study|Lost to Follow-up|0|||
129099214|NCT01038752|464655290|FG000|Overall Study|Tumor Progression|2|||
129099215|NCT01038752|464655291|FG001|Overall Study|Tumor Progression|2|||
129099216|NCT01038752|464655290|FG000|Overall Study|Lost to Follow-up|3|||
129099217|NCT01038752|464655291|FG001|Overall Study|Lost to Follow-up|3|||
129099218|NCT04165135|464655292|FG000|Overall Study|Protocol Violation|10|||
129099219|NCT04165135|464655292|FG000|Overall Study|Participants withdrawal of consent|5|||
129099220|NCT01618916|464655293|FG000|Overall Study|Adverse Event|1|||
129099221|NCT01618916|464655294|FG001|Overall Study|Adverse Event|0|||
129099222|NCT01618916|464655295|FG002|Overall Study|Adverse Event|0|||
129099223|NCT01618916|464655296|FG003|Overall Study|Adverse Event|0|||
129099224|NCT01618916|464655297|FG004|Overall Study|Adverse Event|0|||
129099225|NCT01618916|464655298|FG005|Overall Study|Adverse Event|0|||
129099226|NCT01618916|464655293|FG000|Overall Study|Withdrawal by Subject|0|||
129099227|NCT01618916|464655294|FG001|Overall Study|Withdrawal by Subject|1|||
129099228|NCT01618916|464655295|FG002|Overall Study|Withdrawal by Subject|1|||
129099229|NCT01618916|464655296|FG003|Overall Study|Withdrawal by Subject|0|||
129099230|NCT01618916|464655297|FG004|Overall Study|Withdrawal by Subject|1|||
129099231|NCT01618916|464655298|FG005|Overall Study|Withdrawal by Subject|0|||
129099232|NCT01618916|464655293|FG000|Overall Study|Lost to Follow-up|1|||
129099233|NCT01618916|464655294|FG001|Overall Study|Lost to Follow-up|0|||
129099234|NCT01618916|464655295|FG002|Overall Study|Lost to Follow-up|0|||
129099235|NCT01618916|464655296|FG003|Overall Study|Lost to Follow-up|2|||
129099236|NCT01618916|464655297|FG004|Overall Study|Lost to Follow-up|0|||
129099237|NCT01618916|464655298|FG005|Overall Study|Lost to Follow-up|0|||
129099238|NCT04521114|464655299|FG000|Overall Study|Lost to Follow-up|1|||
129099239|NCT04521114|464655300|FG001|Overall Study|Lost to Follow-up|2|||
129099240|NCT04521114|464655301|FG002|Overall Study|Lost to Follow-up|0|||
129099241|NCT04521114|464655299|FG000|Overall Study|Withdrawal by Subject|1|||
129099242|NCT04521114|464655300|FG001|Overall Study|Withdrawal by Subject|2|||
129099243|NCT04521114|464655301|FG002|Overall Study|Withdrawal by Subject|2|||
129099244|NCT04521114|464655299|FG000|Overall Study|Adverse Event|1|||
129099245|NCT04521114|464655300|FG001|Overall Study|Adverse Event|0|||
129099246|NCT04521114|464655301|FG002|Overall Study|Adverse Event|0|||
129099247|NCT04521114|464655299|FG000|Overall Study|Sponsor Wish|1|||
129099248|NCT04521114|464655300|FG001|Overall Study|Sponsor Wish|0|||
129099249|NCT04521114|464655301|FG002|Overall Study|Sponsor Wish|0|||
129099250|NCT04521114|464655299|FG000|Overall Study|Withdrawal of Consent|2|||
129099251|NCT04521114|464655300|FG001|Overall Study|Withdrawal of Consent|2|||
129099252|NCT04521114|464655301|FG002|Overall Study|Withdrawal of Consent|0|||
129099253|NCT01084538|464655309|FG000|Overall Study|Drug not available|30|||
129099254|NCT01084538|464655309|FG000|Overall Study|Adverse Event|9|||
129099255|NCT01084538|464655309|FG000|Overall Study|Kidney transplant|6|||
129099256|NCT01084538|464655309|FG000|Overall Study|Serious Adverse Event|3|||
129099257|NCT01084538|464655309|FG000|Overall Study|Lack of effectiveness|2|||
129099258|NCT01084538|464655309|FG000|Overall Study|Patient noncompliance|2|||
129099259|NCT01084538|464655309|FG000|Overall Study|Hyperphosphatemia|2|||
129099260|NCT01084538|464655309|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
129099261|NCT01084538|464655309|FG000|Overall Study|Change of residence|2|||
129099262|NCT01084538|464655309|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
129009566|NCT02153398|464328866|FG002|Overall Study|Adverse Event|1|||
129009567|NCT02153398|464328867|FG003|Overall Study|Adverse Event|1|||
129009568|NCT02153398|464328868|FG004|Overall Study|Adverse Event|0|||
129009569|NCT02402166|464328869|FG000|Overall Study|Adverse Event|2|||
129009570|NCT02402166|464328869|FG000|Overall Study|Withdrawal by Subject|2|||
129009571|NCT02402166|464328869|FG000|Overall Study|Lost to Follow-up|1|||
129009572|NCT03331042|464328870|FG000|Overall Study|Protocol Violation|1|||
129009573|NCT03331042|464328871|FG001|Overall Study|Protocol Violation|0|||
129009574|NCT03331042|464328872|FG002|Overall Study|Protocol Violation|0|||
129099263|NCT01084538|464655309|FG000|Overall Study|Reason unknown|8|||
129009575|NCT03331042|464328873|FG003|Overall Study|Protocol Violation|0|||
129009576|NCT03331042|464328870|FG000|Overall Study|Physician Decision|0|||
129099264|NCT01625689|464655314|FG000|Overall Study|Migration|2|||
129099265|NCT01625689|464655315|FG001|Overall Study|Migration|1|||
129099266|NCT00106639|464655316|FG000|Overall Study|Adverse Event|3|||
129099267|NCT00106639|464655317|FG001|Overall Study|Adverse Event|4|||
129099268|NCT00106639|464655318|FG002|Overall Study|Adverse Event|1|||
129099269|NCT00106639|464655316|FG000|Overall Study|Protocol Violation|0|||
129099270|NCT00106639|464655317|FG001|Overall Study|Protocol Violation|1|||
129099271|NCT00106639|464655318|FG002|Overall Study|Protocol Violation|0|||
129099272|NCT00106639|464655316|FG000|Overall Study|Withdrawal by Subject|0|||
129099273|NCT00106639|464655317|FG001|Overall Study|Withdrawal by Subject|1|||
129099274|NCT00106639|464655318|FG002|Overall Study|Withdrawal by Subject|0|||
129099275|NCT00106639|464655316|FG000|Overall Study|Participant defaulted|0|||
129099276|NCT00106639|464655317|FG001|Overall Study|Participant defaulted|1|||
129099277|NCT00106639|464655318|FG002|Overall Study|Participant defaulted|1|||
129099278|NCT01210144|464655320|FG000|Overall Study|Lack of ovarian response|1|||
129099279|NCT01210144|464655321|FG001|Overall Study|Lack of ovarian response|0|||
129099280|NCT01210144|464655320|FG000|Overall Study|No fertilization|1|||
129099281|NCT01210144|464655321|FG001|Overall Study|No fertilization|0|||
129099282|NCT01210144|464655320|FG000|Overall Study|No transfer|1|||
129099283|NCT01210144|464655321|FG001|Overall Study|No transfer|0|||
129099284|NCT00494221|464655326|FG000|Overall Study|Death|15|||
129099285|NCT00494221|464655327|FG001|Overall Study|Death|9|||
129099286|NCT00494221|464655328|FG002|Overall Study|Death|14|||
129099287|NCT00494221|464655326|FG000|Overall Study|Withdrawal by Subject|1|||
129099288|NCT00494221|464655327|FG001|Overall Study|Withdrawal by Subject|2|||
129099289|NCT00494221|464655328|FG002|Overall Study|Withdrawal by Subject|0|||
129099290|NCT03782974|464655329|FG000|Overall Study|Withdrawal by Subject|7|||
129099291|NCT03782974|464655330|FG001|Overall Study|Withdrawal by Subject|7|||
129099292|NCT03782974|464655329|FG000|Overall Study|Pregnancy|1|||
129099293|NCT03782974|464655330|FG001|Overall Study|Pregnancy|0|||
129099294|NCT00395642|464655331|FG000|Overall Study|Death|4|||
129099295|NCT00395642|464655331|FG000|Overall Study|Lost to Follow-up|1|||
129099296|NCT00395642|464655331|FG000|Overall Study|Physician Decision|7|||
129099297|NCT00395642|464655331|FG000|Overall Study|Withdrawal by Subject|1|||
129099298|NCT01783821|464655334|FG000|Overall Study|Screen Failure|1|||
129099299|NCT01783821|464655335|FG001|Overall Study|Screen Failure|1|||
129099300|NCT02333383|464655336|FG000|Overall Study|Adalimumab discontinuation|21|||
129099301|NCT02333383|464655336|FG000|Overall Study|Lost to Follow-up|15|||
128675971|NCT01328366|463112753|FG000|Overall Study|Withdrawal by Subject|2|||
128675972|NCT01328366|463112753|FG000|Overall Study|Lost to Follow-up|7|||
129099302|NCT02333383|464655336|FG000|Overall Study|Withdrawal by Subject|3|||
129099303|NCT02333383|464655336|FG000|Overall Study|Transfer to another hospital|2|||
129099304|NCT01907217|464655339|FG000|Overall Study|Withdrawal by Subject|0|||
129099305|NCT01907217|464655340|FG001|Overall Study|Withdrawal by Subject|2|||
129099306|NCT00659776|464655349|FG000|Overall Study|Withdrawal by Subject|12|||
129099307|NCT00659776|464655350|FG001|Overall Study|Withdrawal by Subject|2|||
129099308|NCT00659776|464655351|FG002|Overall Study|Withdrawal by Subject|0|||
129099309|NCT01180049|464655352|FG000|Overall Study|Other|9|||
129099310|NCT01180049|464655353|FG001|Overall Study|Other|7|||
129099311|NCT01180049|464655352|FG000|Overall Study|Lost to Follow-up|8|||
129099312|NCT01180049|464655353|FG001|Overall Study|Lost to Follow-up|6|||
129099313|NCT01180049|464655352|FG000|Overall Study|Death|36|||
129099314|NCT01180049|464655353|FG001|Overall Study|Death|35|||
129099315|NCT00350779|464655357|FG000|Overall Study|Adverse Event|4|||
129099316|NCT00350779|464655358|FG001|Overall Study|Adverse Event|2|||
129099317|NCT00350779|464655357|FG000|Overall Study|Lack of Efficacy|0|||
129099318|NCT00350779|464655358|FG001|Overall Study|Lack of Efficacy|4|||
129099319|NCT00350779|464655357|FG000|Overall Study|Lost to Follow-up|2|||
129099320|NCT00350779|464655358|FG001|Overall Study|Lost to Follow-up|0|||
129099321|NCT00350779|464655357|FG000|Overall Study|Physician Decision|2|||
129099322|NCT00350779|464655358|FG001|Overall Study|Physician Decision|4|||
129099323|NCT00350779|464655357|FG000|Overall Study|Protocol Violation|3|||
129099324|NCT00350779|464655358|FG001|Overall Study|Protocol Violation|1|||
129099325|NCT00350779|464655357|FG000|Overall Study|Withdrawal by Subject|9|||
129099326|NCT00350779|464655358|FG001|Overall Study|Withdrawal by Subject|8|||
129099327|NCT00350779|464655357|FG000|Overall Study|Patient Moved|2|||
129099328|NCT00350779|464655358|FG001|Overall Study|Patient Moved|1|||
129099329|NCT00350779|464655357|FG000|Overall Study|Non-compliance with study procedures|0|||
129099330|NCT00350779|464655358|FG001|Overall Study|Non-compliance with study procedures|1|||
129099331|NCT02012959|464655359|FG000|Treatment Phase A|Adverse Event|2|||
129099332|NCT02012959|464655360|FG001|Treatment Phase A|Adverse Event|0|||
129099333|NCT02012959|464655361|FG002|Treatment Phase A|Adverse Event|0|||
128675973|NCT01673347|463112757|FG000|Overall Study|failure of allograft|7|||
128675974|NCT02661178|463112759|FG000|Part 1|Protocol Violation|1|||
128675975|NCT02661178|463112760|FG001|Part 1|Protocol Violation|0|||
128675976|NCT02661178|463112761|FG002|Part 1|Protocol Violation|0|||
128675977|NCT02661178|463112762|FG003|Part 1|Protocol Violation|0|||
129099334|NCT02012959|464655362|FG003|Treatment Phase A|Adverse Event|0|||
129099335|NCT02012959|464655363|FG004|Treatment Phase A|Adverse Event|0|||
129099336|NCT00642954|464656990|FG000|Overall Study|Progressive Disease|3|||
129099337|NCT00642954|464656991|FG001|Overall Study|Progressive Disease|3|||
129099338|NCT00642954|464656992|FG002|Overall Study|Progressive Disease|3|||
129099339|NCT00642954|464656993|FG003|Overall Study|Progressive Disease|3|||
129099340|NCT00642954|464656994|FG004|Overall Study|Progressive Disease|9|||
129099341|NCT00642954|464656990|FG000|Overall Study|Withdrawal by Subject|0|||
128675978|NCT02661178|463112763|FG004|Part 1|Protocol Violation|0|||
128675979|NCT02661178|463112764|FG005|Part 1|Protocol Violation|0|||
128675980|NCT02661178|463112765|FG006|Part 1|Protocol Violation|0|||
129099342|NCT00642954|464656991|FG001|Overall Study|Withdrawal by Subject|0|||
129099343|NCT00642954|464656992|FG002|Overall Study|Withdrawal by Subject|0|||
129099344|NCT00642954|464656993|FG003|Overall Study|Withdrawal by Subject|0|||
129099345|NCT00642954|464656994|FG004|Overall Study|Withdrawal by Subject|1|||
129099346|NCT00642954|464656990|FG000|Overall Study|Adverse Event|1|||
129099347|NCT00642954|464656991|FG001|Overall Study|Adverse Event|1|||
129099348|NCT00642954|464656992|FG002|Overall Study|Adverse Event|0|||
129099349|NCT00642954|464656993|FG003|Overall Study|Adverse Event|0|||
129099350|NCT00642954|464656994|FG004|Overall Study|Adverse Event|6|||
129099351|NCT01663857|464656995|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
129099352|NCT01663857|464656996|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
129099353|NCT01663857|464656997|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
129099354|NCT01663857|464656998|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
129099355|NCT01663857|464656995|FG000|Overall Study|Lost to Follow-up|0|||
129099356|NCT01663857|464656996|FG001|Overall Study|Lost to Follow-up|0|||
129099357|NCT01663857|464656997|FG002|Overall Study|Lost to Follow-up|3|||
129099358|NCT01663857|464656998|FG003|Overall Study|Lost to Follow-up|1|||
129099359|NCT03052920|464656999|FG000|Overall Study|Withdrawal by Subject|1|||
129099360|NCT03015194|464657000|FG000|Overall Study|Death|10|||
129099361|NCT03015194|464657000|FG000|Overall Study|Withdrawal by Subject|2|||
129099362|NCT00433017|464657002|FG000|Overall Study|Adverse Event|5|||
129099363|NCT00433017|464657003|FG001|Overall Study|Adverse Event|3|||
129099364|NCT00433017|464657002|FG000|Overall Study|Withdrawal by Subject|4|||
129099365|NCT00433017|464657003|FG001|Overall Study|Withdrawal by Subject|5|||
129099366|NCT00433017|464657002|FG000|Overall Study|Lost to Follow-up|3|||
129099367|NCT00433017|464657003|FG001|Overall Study|Lost to Follow-up|4|||
129099368|NCT00433017|464657002|FG000|Overall Study|Administrative problems|80|||
129099369|NCT00433017|464657003|FG001|Overall Study|Administrative problems|86|||
129099370|NCT00433017|464657002|FG000|Overall Study|Protocol Violation|1|||
129099371|NCT00433017|464657003|FG001|Overall Study|Protocol Violation|0|||
129099372|NCT00433017|464657002|FG000|Overall Study|Death|2|||
129099373|NCT00433017|464657003|FG001|Overall Study|Death|2|||
129099374|NCT00433017|464657002|FG000|Overall Study|Subject no longer requires study drug|1|||
129099375|NCT00433017|464657003|FG001|Overall Study|Subject no longer requires study drug|1|||
129099376|NCT01108237|464657006|FG000|Overall Study|No alignment data|2|||
129099377|NCT01108237|464657007|FG001|Overall Study|No alignment data|15|||
129099378|NCT01108237|464657006|FG000|Overall Study|Did not meet criteria for analysis|7|||
129099379|NCT01108237|464657007|FG001|Overall Study|Did not meet criteria for analysis|0|||
129099380|NCT00564278|464657009|FG000|Overall Study|Lost to Follow-up|35|||
129099381|NCT00564278|464657010|FG001|Overall Study|Lost to Follow-up|33|||
129099382|NCT00564278|464657009|FG000|Overall Study|Physician Decision|1|||
129099383|NCT00564278|464657010|FG001|Overall Study|Physician Decision|2|||
129099384|NCT00564278|464657009|FG000|Overall Study|Withdrawal by Subject|11|||
129099385|NCT00564278|464657010|FG001|Overall Study|Withdrawal by Subject|7|||
129099386|NCT06439095|464657011|FG000|Overall Study|Lost to Follow-up|2|||
129099387|NCT03341936|464657012|FG000|Overall Study|Ineligible|1|||
129099388|NCT03341936|464657012|FG000|Overall Study|Disease Progression|2|||
129099389|NCT03341936|464657012|FG000|Overall Study|Withdrew Consent|4|||
129099390|NCT03341936|464657012|FG000|Overall Study|Non-Compliance|1|||
129099391|NCT03341936|464657012|FG000|Overall Study|Physician Decision|1|||
129099392|NCT03341936|464657012|FG000|Overall Study|Withdrawal by Subject|1|||
129099393|NCT03341936|464657012|FG000|Overall Study|Other|1|||
129099394|NCT02368886|464657013|FG000|Overall Study|Cancel|1|||
129099395|NCT02368886|464657014|FG001|Overall Study|Cancel|1|||
129099396|NCT02368886|464657015|FG002|Overall Study|Cancel|1|||
129099397|NCT02368886|464657016|FG003|Overall Study|Cancel|3|||
129099398|NCT02368886|464657013|FG000|Overall Study|Ineligible|0|||
129099399|NCT02368886|464657014|FG001|Overall Study|Ineligible|0|||
129099400|NCT02368886|464657015|FG002|Overall Study|Ineligible|0|||
129099401|NCT02368886|464657016|FG003|Overall Study|Ineligible|1|||
129099402|NCT02131636|464657021|FG000|Overall Study|Personal Reasons|4|||
129099403|NCT02131636|464657022|FG001|Overall Study|Personal Reasons|4|||
128675981|NCT02661178|463112766|FG007|Part 1|Protocol Violation|0|||
128675982|NCT02661178|463112767|FG008|Part 1|Protocol Violation|0|||
128675983|NCT02661178|463112768|FG009|Part 1|Protocol Violation|0|||
128675984|NCT02661178|463112769|FG010|Part 1|Protocol Violation|0|||
128675985|NCT02661178|463112770|FG011|Part 1|Protocol Violation|0|||
128675986|NCT02661178|463112771|FG012|Part 1|Protocol Violation|0|||
129099404|NCT02131636|464657021|FG000|Overall Study|Lost to Follow-up|4|||
129099405|NCT02131636|464657022|FG001|Overall Study|Lost to Follow-up|0|||
129099406|NCT02131636|464657021|FG000|Overall Study|Adverse Event|4|||
129099407|NCT02131636|464657022|FG001|Overall Study|Adverse Event|1|||
129099408|NCT02173379|464657023|FG000|Overall Study|Lost to Follow-up|89|||
128675987|NCT02661178|463112772|FG013|Part 1|Protocol Violation|0|||
128675988|NCT02661178|463112773|FG014|Part 1|Protocol Violation|0|||
129099409|NCT02173379|464657024|FG001|Overall Study|Lost to Follow-up|81|||
129099410|NCT02173379|464657023|FG000|Overall Study|Withdrawal by Subject|24|||
129099411|NCT02173379|464657024|FG001|Overall Study|Withdrawal by Subject|29|||
129099412|NCT02173379|464657023|FG000|Overall Study|Physician Decision|8|||
129099413|NCT02173379|464657024|FG001|Overall Study|Physician Decision|8|||
129099414|NCT02173379|464657023|FG000|Overall Study|Death|75|||
129099415|NCT02173379|464657024|FG001|Overall Study|Death|72|||
129099416|NCT02173379|464657023|FG000|Overall Study|Other Reason|1|||
128675989|NCT03085914|463112775|FG000|Overall Study|Death|6|||
129009577|NCT03331042|464328871|FG001|Overall Study|Physician Decision|0|||
129009578|NCT03331042|464328872|FG002|Overall Study|Physician Decision|1|||
129009579|NCT03331042|464328873|FG003|Overall Study|Physician Decision|0|||
129009580|NCT03331042|464328870|FG000|Overall Study|Lost to Follow-up|0|||
129009581|NCT03331042|464328871|FG001|Overall Study|Lost to Follow-up|0|||
129009582|NCT03331042|464328872|FG002|Overall Study|Lost to Follow-up|0|||
129009583|NCT03331042|464328873|FG003|Overall Study|Lost to Follow-up|1|||
129009584|NCT00001849|464328877|FG000|Overall Study|Death|4|||
129009585|NCT00001849|464328877|FG000|Overall Study|Lost to Follow-up|2|||
129009586|NCT00001849|464328877|FG000|Overall Study|Withdrawal by Subject|2|||
129009587|NCT00001849|464328877|FG000|Overall Study|tumor remained occult|6|||
129009588|NCT02428699|464328879|FG000|Washout Period 1|Screen Failure|1|||
129009589|NCT02428699|464328880|FG001|Washout Period 1|Screen Failure|2|||
129009590|NCT01781286|464328883|FG000|Overall Study|Lost to Follow-up|0|||
129009591|NCT01781286|464328884|FG001|Overall Study|Lost to Follow-up|0|||
129009592|NCT01781286|464328885|FG002|Overall Study|Lost to Follow-up|0|||
129009593|NCT01781286|464328886|FG003|Overall Study|Lost to Follow-up|0|||
129009594|NCT01781286|464328887|FG004|Overall Study|Lost to Follow-up|0|||
129009595|NCT01781286|464328888|FG005|Overall Study|Lost to Follow-up|1|||
129009596|NCT01781286|464328883|FG000|Overall Study|Time Constraints|2|||
129009597|NCT01781286|464328884|FG001|Overall Study|Time Constraints|0|||
129009598|NCT01781286|464328885|FG002|Overall Study|Time Constraints|2|||
129009599|NCT01781286|464328886|FG003|Overall Study|Time Constraints|0|||
129009600|NCT01781286|464328887|FG004|Overall Study|Time Constraints|0|||
129009601|NCT01781286|464328888|FG005|Overall Study|Time Constraints|0|||
129009602|NCT01781286|464328883|FG000|Overall Study|Noncompliance|0|||
129009603|NCT01781286|464328884|FG001|Overall Study|Noncompliance|0|||
129009604|NCT01781286|464328885|FG002|Overall Study|Noncompliance|0|||
129009605|NCT01781286|464328886|FG003|Overall Study|Noncompliance|1|||
129009606|NCT01781286|464328887|FG004|Overall Study|Noncompliance|0|||
129009607|NCT01781286|464328888|FG005|Overall Study|Noncompliance|0|||
129009608|NCT03594123|464328889|FG000|Overall Study|Lost to Follow-up|0|||
129009609|NCT03594123|464328890|FG001|Overall Study|Lost to Follow-up|1|||
129009610|NCT03594123|464328889|FG000|Overall Study|Adverse Event|8|||
129009611|NCT03594123|464328890|FG001|Overall Study|Adverse Event|5|||
129009612|NCT03594123|464328889|FG000|Overall Study|Site Terminated by Sponsor|4|||
129009613|NCT03594123|464328890|FG001|Overall Study|Site Terminated by Sponsor|1|||
129009614|NCT03594123|464328889|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
129009615|NCT03594123|464328890|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
129009616|NCT03594123|464328889|FG000|Overall Study|Lack of Efficacy|1|||
129009617|NCT03594123|464328890|FG001|Overall Study|Lack of Efficacy|0|||
129009618|NCT03594123|464328889|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
129009619|NCT03594123|464328890|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
129009620|NCT02483975|464328891|FG000|Overall Study|Adverse Event|0|||
129009621|NCT02483975|464328892|FG001|Overall Study|Adverse Event|1|||
129009622|NCT02483975|464328891|FG000|Overall Study|Lost to Follow-up|0|||
129009623|NCT02483975|464328892|FG001|Overall Study|Lost to Follow-up|1|||
129009624|NCT02483975|464328891|FG000|Overall Study|Physician Decision|2|||
129009625|NCT02483975|464328892|FG001|Overall Study|Physician Decision|0|||
129009626|NCT01505530|464328895|FG000|Overall Study|Progressive Disease|19|||
129009627|NCT01505530|464328896|FG001|Overall Study|Progressive Disease|17|||
129009628|NCT01505530|464328897|FG002|Overall Study|Progressive Disease|18|||
129009629|NCT01505530|464328895|FG000|Overall Study|Adverse Event|1|||
129009630|NCT01505530|464328896|FG001|Overall Study|Adverse Event|1|||
129009631|NCT01505530|464328897|FG002|Overall Study|Adverse Event|0|||
129009632|NCT01505530|464328895|FG000|Overall Study|Withdrawal by Subject|7|||
129009633|NCT01505530|464328896|FG001|Overall Study|Withdrawal by Subject|8|||
129009634|NCT01505530|464328897|FG002|Overall Study|Withdrawal by Subject|6|||
129009635|NCT01505530|464328895|FG000|Overall Study|Physician Decision|6|||
129009636|NCT01505530|464328896|FG001|Overall Study|Physician Decision|2|||
129009637|NCT01505530|464328897|FG002|Overall Study|Physician Decision|5|||
129009638|NCT01505530|464328895|FG000|Overall Study|Sponsor Decision|1|||
129009639|NCT01505530|464328896|FG001|Overall Study|Sponsor Decision|8|||
129009640|NCT01505530|464328897|FG002|Overall Study|Sponsor Decision|7|||
129009641|NCT01505530|464328895|FG000|Overall Study|Death|7|||
129099417|NCT02173379|464657024|FG001|Overall Study|Other Reason|0|||
129099418|NCT00715520|464657029|FG000|Overall Study|Screen failure|8|||
129099419|NCT00715520|464657030|FG001|Overall Study|Screen failure|1|||
129009642|NCT01505530|464328896|FG001|Overall Study|Death|6|||
129009643|NCT01505530|464328897|FG002|Overall Study|Death|5|||
129009644|NCT01505530|464328895|FG000|Overall Study|entry criteria not met|0|||
129009645|NCT01505530|464328896|FG001|Overall Study|entry criteria not met|1|||
129009646|NCT01505530|464328897|FG002|Overall Study|entry criteria not met|0|||
129009647|NCT02492958|464328898|FG000|Overall Study|Withdrawal by Subject|0|||
129009648|NCT02492958|464328899|FG001|Overall Study|Withdrawal by Subject|0|||
129009649|NCT02492958|464328900|FG002|Overall Study|Withdrawal by Subject|1|||
129009650|NCT02492958|464328901|FG003|Overall Study|Withdrawal by Subject|0|||
129009651|NCT02492958|464328898|FG000|Overall Study|Adverse Event|1|||
129099420|NCT00715520|464657031|FG002|Overall Study|Screen failure|1|||
129009652|NCT02492958|464328899|FG001|Overall Study|Adverse Event|0|||
129009653|NCT02492958|464328900|FG002|Overall Study|Adverse Event|1|||
129009654|NCT02492958|464328901|FG003|Overall Study|Adverse Event|0|||
129009655|NCT02795104|464328902|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
129009656|NCT02795104|464328903|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
129009657|NCT02795104|464328904|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
129009658|NCT02795104|464328902|FG000|Overall Study|Withdrawal by Subject|0|||
129009659|NCT02795104|464328903|FG001|Overall Study|Withdrawal by Subject|2|||
129009660|NCT02795104|464328904|FG002|Overall Study|Withdrawal by Subject|0|||
129009661|NCT02795104|464328902|FG000|Overall Study|Lost to Follow-up|0|||
129009662|NCT02795104|464328903|FG001|Overall Study|Lost to Follow-up|0|||
129009663|NCT02795104|464328904|FG002|Overall Study|Lost to Follow-up|1|||
129009664|NCT00948675|464328905|FG000|Overall Study|Lost to Follow-up|1|||
129009665|NCT00948675|464328906|FG001|Overall Study|Lost to Follow-up|0|||
129009666|NCT00770510|464328910|FG000|Overall Study|Lost to Follow-up|2|||
129009667|NCT00770510|464328910|FG000|Overall Study|Pregnancy|1|||
129009668|NCT00770510|464328910|FG000|Overall Study|Withdrawal by Subject|2|||
129009669|NCT01089647|464328917|FG000|Overall Study|Lost to Follow-up|2|||
129009670|NCT01089647|464328918|FG001|Overall Study|Lost to Follow-up|2|||
129009671|NCT01089647|464328917|FG000|Overall Study|Withdrawal by Subject|2|||
129009672|NCT01089647|464328918|FG001|Overall Study|Withdrawal by Subject|1|||
129009673|NCT01089647|464328917|FG000|Overall Study|Adverse Event|0|||
129009674|NCT01089647|464328918|FG001|Overall Study|Adverse Event|1|||
129009675|NCT00995553|464328919|FG000|Overall Study|Withdrawal by Subject|2|||
129009676|NCT00995553|464328920|FG001|Overall Study|Withdrawal by Subject|6|||
129009677|NCT00927810|464328921|FG000|Overall Study|Withdrawal by Subject|0|||
129009678|NCT00927810|464328922|FG001|Overall Study|Withdrawal by Subject|3|||
129009679|NCT00927810|464328923|FG002|Overall Study|Withdrawal by Subject|0|||
129009680|NCT00927810|464328924|FG003|Overall Study|Withdrawal by Subject|1|||
129009681|NCT00927810|464328921|FG000|Overall Study|Lost to Follow-up|0|||
129009682|NCT00927810|464328922|FG001|Overall Study|Lost to Follow-up|2|||
129009683|NCT00927810|464328923|FG002|Overall Study|Lost to Follow-up|1|||
129009684|NCT00927810|464328924|FG003|Overall Study|Lost to Follow-up|1|||
129009685|NCT00927810|464328921|FG000|Overall Study|Death|0|||
129009686|NCT00927810|464328922|FG001|Overall Study|Death|2|||
129009687|NCT00927810|464328923|FG002|Overall Study|Death|0|||
129009688|NCT00927810|464328924|FG003|Overall Study|Death|0|||
129009689|NCT00927810|464328921|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129009690|NCT00927810|464328922|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129009691|NCT00927810|464328923|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129009692|NCT00927810|464328924|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129009693|NCT00198029|464328927|FG000|Overall Study|Withdrawal by Subject|4|||
129009694|NCT00814463|464328930|FG000|Overall Study|Lost to Follow-up|1|||
129009695|NCT02430870|464328932|FG000|Part 2|Voluntary Withdrawal|0|||
129009696|NCT02430870|464328933|FG001|Part 2|Voluntary Withdrawal|0|||
129009697|NCT02430870|464328934|FG002|Part 2|Voluntary Withdrawal|0|||
129009698|NCT02430870|464328935|FG003|Part 2|Voluntary Withdrawal|0|||
129009699|NCT02430870|464328936|FG004|Part 2|Voluntary Withdrawal|0|||
129009700|NCT02430870|464328937|FG005|Part 2|Voluntary Withdrawal|0|||
129009701|NCT02430870|464328938|FG006|Part 2|Voluntary Withdrawal|1|||
129009702|NCT02430870|464328939|FG007|Part 2|Voluntary Withdrawal|0|||
129009703|NCT02430870|464328932|FG000|Part 2|Other Reason Not Specified|0|||
129009704|NCT02430870|464328933|FG001|Part 2|Other Reason Not Specified|0|||
129009705|NCT02430870|464328934|FG002|Part 2|Other Reason Not Specified|0|||
129009706|NCT02430870|464328935|FG003|Part 2|Other Reason Not Specified|0|||
129009707|NCT02430870|464328936|FG004|Part 2|Other Reason Not Specified|0|||
129009708|NCT02430870|464328937|FG005|Part 2|Other Reason Not Specified|0|||
129009709|NCT02430870|464328938|FG006|Part 2|Other Reason Not Specified|0|||
129009710|NCT02430870|464328939|FG007|Part 2|Other Reason Not Specified|1|||
129009711|NCT01265784|464328940|FG000|Overall Study|Lost to Follow-up|5|||
129009712|NCT01265784|464328941|FG001|Overall Study|Lost to Follow-up|3|||
129009713|NCT01265784|464328942|FG002|Overall Study|Lost to Follow-up|2|||
129009714|NCT01265784|464328940|FG000|Overall Study|Withdrawal by Subject|0|||
129009715|NCT01265784|464328941|FG001|Overall Study|Withdrawal by Subject|5|||
129009716|NCT01265784|464328942|FG002|Overall Study|Withdrawal by Subject|0|||
129009717|NCT01265784|464328940|FG000|Overall Study|Physician Decision|1|||
129009718|NCT01265784|464328941|FG001|Overall Study|Physician Decision|0|||
129009719|NCT01265784|464328942|FG002|Overall Study|Physician Decision|1|||
129009720|NCT01265784|464328940|FG000|Overall Study|Adverse Event|1|||
129009721|NCT01265784|464328941|FG001|Overall Study|Adverse Event|0|||
129009722|NCT01265784|464328942|FG002|Overall Study|Adverse Event|0|||
129009723|NCT01265784|464328940|FG000|Overall Study|Death|3|||
129009724|NCT01265784|464328941|FG001|Overall Study|Death|0|||
129009725|NCT01265784|464328942|FG002|Overall Study|Death|0|||
129009726|NCT01265784|464328940|FG000|Overall Study|Protocol Violation|2|||
129009727|NCT01265784|464328941|FG001|Overall Study|Protocol Violation|0|||
129009728|NCT01265784|464328942|FG002|Overall Study|Protocol Violation|0|||
129009729|NCT01265784|464328940|FG000|Overall Study|Incorrectly Randomized|0|||
129009730|NCT01265784|464328941|FG001|Overall Study|Incorrectly Randomized|0|||
128675990|NCT03085914|463112776|FG001|Overall Study|Death|6|||
128675991|NCT03085914|463112777|FG002|Overall Study|Death|4|||
128675992|NCT03085914|463112778|FG003|Overall Study|Death|1|||
128675993|NCT03085914|463112779|FG004|Overall Study|Death|5|||
128675994|NCT03085914|463112780|FG005|Overall Study|Death|2|||
128675995|NCT03085914|463112781|FG006|Overall Study|Death|2|||
128675996|NCT03085914|463112775|FG000|Overall Study|Withdrawal by Subject|1|||
128675997|NCT03085914|463112776|FG001|Overall Study|Withdrawal by Subject|1|||
128675998|NCT03085914|463112777|FG002|Overall Study|Withdrawal by Subject|2|||
128675999|NCT03085914|463112778|FG003|Overall Study|Withdrawal by Subject|2|||
128676000|NCT03085914|463112779|FG004|Overall Study|Withdrawal by Subject|2|||
128676001|NCT03085914|463112780|FG005|Overall Study|Withdrawal by Subject|0|||
128676002|NCT03085914|463112781|FG006|Overall Study|Withdrawal by Subject|1|||
129009731|NCT01265784|464328942|FG002|Overall Study|Incorrectly Randomized|1|||
129009732|NCT00368277|464328945|FG000|Overall Study|Adverse Event|33|||
129009733|NCT00368277|464328946|FG001|Overall Study|Adverse Event|49|||
129009734|NCT00368277|464328945|FG000|Overall Study|Death|2|||
129009735|NCT00368277|464328946|FG001|Overall Study|Death|1|||
129009736|NCT00368277|464328945|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
129009737|NCT00368277|464328946|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
129009738|NCT00368277|464328945|FG000|Overall Study|Protocol deviation|7|||
129009739|NCT00368277|464328946|FG001|Overall Study|Protocol deviation|0|||
129009740|NCT00368277|464328945|FG000|Overall Study|Patient withdrew consent|32|||
129009741|NCT00368277|464328946|FG001|Overall Study|Patient withdrew consent|28|||
129009742|NCT00368277|464328945|FG000|Overall Study|Lost to Follow-up|8|||
129009743|NCT00368277|464328946|FG001|Overall Study|Lost to Follow-up|6|||
129009744|NCT00984295|464328947|FG000|Overall Study|Lost to Follow-up|31|||
129009745|NCT00984295|464328948|FG001|Overall Study|Lost to Follow-up|12|||
129009746|NCT00984295|464328949|FG002|Overall Study|Lost to Follow-up|13|||
129009747|NCT00984295|464328947|FG000|Overall Study|Protocol Violation|2|||
129009748|NCT00984295|464328948|FG001|Overall Study|Protocol Violation|1|||
129009749|NCT00984295|464328949|FG002|Overall Study|Protocol Violation|4|||
129009750|NCT00984295|464328947|FG000|Overall Study|Withdrawal by Subject|18|||
129009751|NCT00984295|464328948|FG001|Overall Study|Withdrawal by Subject|9|||
129009752|NCT00984295|464328949|FG002|Overall Study|Withdrawal by Subject|12|||
129009753|NCT00984295|464328947|FG000|Overall Study|CAE - discontinued test vaccine|0|||
129009754|NCT00984295|464328948|FG001|Overall Study|CAE - discontinued test vaccine|1|||
129009755|NCT00984295|464328949|FG002|Overall Study|CAE - discontinued test vaccine|3|||
129009756|NCT00984295|464328947|FG000|Overall Study|Missed one or more blood samplings|3|||
129009757|NCT00984295|464328948|FG001|Overall Study|Missed one or more blood samplings|7|||
129009758|NCT00984295|464328949|FG002|Overall Study|Missed one or more blood samplings|2|||
129009759|NCT00984295|464328947|FG000|Overall Study|Incomplete safety follow-up|11|||
129009760|NCT00984295|464328948|FG001|Overall Study|Incomplete safety follow-up|2|||
129009761|NCT00984295|464328949|FG002|Overall Study|Incomplete safety follow-up|3|||
129009762|NCT04799158|464328950|FG000|Run-In Period|Adverse Event|6|||
129009763|NCT04799158|464328951|FG001|Run-In Period|Adverse Event|0|||
129009764|NCT04799158|464328952|FG002|Run-In Period|Adverse Event|0|||
129009765|NCT04799158|464328953|FG003|Run-In Period|Adverse Event|0|||
129009766|NCT04799158|464328954|FG004|Run-In Period|Adverse Event|0|||
129009767|NCT04799158|464328950|FG000|Run-In Period|Lost to Follow-up|4|||
129009768|NCT04799158|464328951|FG001|Run-In Period|Lost to Follow-up|0|||
129009769|NCT04799158|464328952|FG002|Run-In Period|Lost to Follow-up|0|||
129009770|NCT04799158|464328953|FG003|Run-In Period|Lost to Follow-up|0|||
129009771|NCT04799158|464328954|FG004|Run-In Period|Lost to Follow-up|0|||
129009772|NCT04799158|464328950|FG000|Run-In Period|Significant Protocol Deviation|1|||
129009773|NCT04799158|464328951|FG001|Run-In Period|Significant Protocol Deviation|0|||
129009774|NCT04799158|464328952|FG002|Run-In Period|Significant Protocol Deviation|0|||
129009775|NCT04799158|464328953|FG003|Run-In Period|Significant Protocol Deviation|0|||
129009776|NCT04799158|464328954|FG004|Run-In Period|Significant Protocol Deviation|0|||
129009777|NCT04799158|464328950|FG000|Run-In Period|Withdrawal by Subject|11|||
129009778|NCT04799158|464328951|FG001|Run-In Period|Withdrawal by Subject|0|||
129009779|NCT04799158|464328952|FG002|Run-In Period|Withdrawal by Subject|0|||
129009780|NCT04799158|464328953|FG003|Run-In Period|Withdrawal by Subject|0|||
129009781|NCT04799158|464328954|FG004|Run-In Period|Withdrawal by Subject|0|||
129099421|NCT00715520|464657029|FG000|Overall Study|Withdrawal by Subject|2|||
129099422|NCT00715520|464657030|FG001|Overall Study|Withdrawal by Subject|0|||
129009782|NCT04799158|464328950|FG000|Run-In Period|Miscellaneous|3|||
129009783|NCT04799158|464328951|FG001|Run-In Period|Miscellaneous|0|||
129009784|NCT04799158|464328952|FG002|Run-In Period|Miscellaneous|0|||
129009785|NCT04799158|464328953|FG003|Run-In Period|Miscellaneous|0|||
129009786|NCT04799158|464328954|FG004|Run-In Period|Miscellaneous|0|||
129009787|NCT04799158|464328950|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
129009788|NCT04799158|464328951|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129009789|NCT04799158|464328952|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
128676003|NCT03085914|463112775|FG000|Overall Study|Lost to Follow-up|0|||
128676004|NCT03085914|463112776|FG001|Overall Study|Lost to Follow-up|0|||
128676005|NCT03085914|463112777|FG002|Overall Study|Lost to Follow-up|1|||
129099423|NCT00715520|464657031|FG002|Overall Study|Withdrawal by Subject|1|||
129099424|NCT02290925|464657033|FG000|First Period of Three Months|Lost to Follow-up|2|||
129099425|NCT02290925|464657034|FG001|First Period of Three Months|Lost to Follow-up|1|||
129099426|NCT02290925|464657033|FG000|First Period of Three Months|Death|1|||
129099427|NCT02290925|464657034|FG001|First Period of Three Months|Death|0|||
129099428|NCT02290925|464657033|FG000|First Period of Three Months|Insulin Started|1|||
129099429|NCT02290925|464657034|FG001|First Period of Three Months|Insulin Started|1|||
129099430|NCT02290925|464657033|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
129099431|NCT02290925|464657034|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
129099432|NCT02290925|464657033|FG000|Second Period of 3 Months|insulin started|0|||
129099433|NCT02290925|464657034|FG001|Second Period of 3 Months|insulin started|1|||
129099434|NCT04942210|464657035|FG000|Overall Study|Adverse Event|0|||
129099435|NCT04942210|464657036|FG001|Overall Study|Adverse Event|1|||
129099436|NCT04942210|464657035|FG000|Overall Study|Protocol Deviation|4|||
129099437|NCT04942210|464657036|FG001|Overall Study|Protocol Deviation|1|||
129099438|NCT04942210|464657035|FG000|Overall Study|Withdrawal by Subject|5|||
129099439|NCT04942210|464657036|FG001|Overall Study|Withdrawal by Subject|2|||
129099440|NCT04942210|464657035|FG000|Overall Study|Lost to Follow-up|16|||
129099441|NCT04942210|464657036|FG001|Overall Study|Lost to Follow-up|7|||
129099442|NCT04942210|464657035|FG000|Overall Study|Ongoing at the time of DBL date|60|||
129099443|NCT04942210|464657036|FG001|Overall Study|Ongoing at the time of DBL date|25|||
129099444|NCT04942210|464657035|FG000|Overall Study|Randomized but did not receive vaccination|3|||
129099445|NCT04942210|464657036|FG001|Overall Study|Randomized but did not receive vaccination|0|||
129099446|NCT05697627|464657037|FG000|Overall Study|Adverse Event|1|||
129099447|NCT02570750|464657038|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
129099448|NCT02570750|464657039|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
129099449|NCT02570750|464657038|FG000|Overall Study|Protocol deviation|4|||
129099450|NCT02570750|464657039|FG001|Overall Study|Protocol deviation|2|||
129099451|NCT02570750|464657038|FG000|Overall Study|Withdrawal by Subject|5|||
129099452|NCT02570750|464657039|FG001|Overall Study|Withdrawal by Subject|0|||
129099453|NCT02570750|464657038|FG000|Overall Study|Lost to Follow-up|2|||
129099454|NCT02570750|464657039|FG001|Overall Study|Lost to Follow-up|2|||
129099455|NCT02570750|464657038|FG000|Overall Study|Adverse Event|2|||
129099456|NCT02570750|464657039|FG001|Overall Study|Adverse Event|1|||
129099457|NCT04122625|464657040|FG000|Part A (up to 2.92 Years)|Death|2|||
129099458|NCT04122625|464657041|FG001|Part A (up to 2.92 Years)|Death|4|||
129099459|NCT04122625|464657042|FG002|Part A (up to 2.92 Years)|Death|0|||
129099460|NCT04122625|464657043|FG003|Part A (up to 2.92 Years)|Death|0|||
129099461|NCT04122625|464657044|FG004|Part A (up to 2.92 Years)|Death|0|||
129099462|NCT04122625|464657045|FG005|Part A (up to 2.92 Years)|Death|0|||
129099463|NCT04122625|464657040|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
129099464|NCT04122625|464657041|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
129099465|NCT04122625|464657042|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
129099466|NCT04122625|464657043|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
129099467|NCT04122625|464657044|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
129099468|NCT04122625|464657045|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
129099469|NCT04122625|464657040|FG000|Part B (up to 2.33 Years)|Death|0|||
129099470|NCT04122625|464657041|FG001|Part B (up to 2.33 Years)|Death|0|||
129099471|NCT04122625|464657042|FG002|Part B (up to 2.33 Years)|Death|5|||
129099472|NCT04122625|464657043|FG003|Part B (up to 2.33 Years)|Death|7|||
129099473|NCT04122625|464657044|FG004|Part B (up to 2.33 Years)|Death|6|||
129099474|NCT04122625|464657045|FG005|Part B (up to 2.33 Years)|Death|7|||
129099475|NCT01410240|464657046|FG000|Overall Study|Physician Decision|0|||
129099476|NCT01410240|464657047|FG001|Overall Study|Physician Decision|0|||
129099477|NCT01410240|464657048|FG002|Overall Study|Physician Decision|1|||
129099478|NCT01410240|464657046|FG000|Overall Study|Missed week 6 assessments|1|||
129099479|NCT01410240|464657047|FG001|Overall Study|Missed week 6 assessments|1|||
129099480|NCT01410240|464657048|FG002|Overall Study|Missed week 6 assessments|1|||
129099481|NCT02776670|464657049|FG000|Overall Study|Adverse Event|0|||
129099482|NCT02776670|464657050|FG001|Overall Study|Adverse Event|2|||
129099483|NCT02776670|464657049|FG000|Overall Study|Protocol Violation|0|||
129099484|NCT02776670|464657050|FG001|Overall Study|Protocol Violation|2|||
129099485|NCT02776670|464657049|FG000|Overall Study|Withdrawal by Subject|0|||
129099486|NCT02776670|464657050|FG001|Overall Study|Withdrawal by Subject|1|||
129099487|NCT02776670|464657049|FG000|Overall Study|Other - Reason not given|0|||
128676006|NCT03085914|463112778|FG003|Overall Study|Lost to Follow-up|0|||
129099488|NCT02776670|464657050|FG001|Overall Study|Other - Reason not given|1|||
129099489|NCT02697591|464657053|FG000|Overall Study|Lost to Follow-up|0|||
129099490|NCT02697591|464657054|FG001|Overall Study|Lost to Follow-up|0|||
129099491|NCT02697591|464657055|FG002|Overall Study|Lost to Follow-up|0|||
129099492|NCT02697591|464657056|FG003|Overall Study|Lost to Follow-up|0|||
129099493|NCT02697591|464657057|FG004|Overall Study|Lost to Follow-up|0|||
129099494|NCT02697591|464657058|FG005|Overall Study|Lost to Follow-up|1|||
129099495|NCT02697591|464657059|FG006|Overall Study|Lost to Follow-up|1|||
129099496|NCT02697591|464657060|FG007|Overall Study|Lost to Follow-up|0|||
129099497|NCT02697591|464657061|FG008|Overall Study|Lost to Follow-up|0|||
128676007|NCT03085914|463112779|FG004|Overall Study|Lost to Follow-up|0|||
128676008|NCT03085914|463112780|FG005|Overall Study|Lost to Follow-up|1|||
128676009|NCT03085914|463112781|FG006|Overall Study|Lost to Follow-up|1|||
128676010|NCT03085914|463112775|FG000|Overall Study|Reason was not specified,|2|||
128676011|NCT03085914|463112776|FG001|Overall Study|Reason was not specified,|2|||
128676012|NCT03085914|463112777|FG002|Overall Study|Reason was not specified,|2|||
128676013|NCT03085914|463112778|FG003|Overall Study|Reason was not specified,|3|||
128676014|NCT03085914|463112779|FG004|Overall Study|Reason was not specified,|3|||
128676015|NCT03085914|463112780|FG005|Overall Study|Reason was not specified,|3|||
128676016|NCT03085914|463112781|FG006|Overall Study|Reason was not specified,|6|||
128676017|NCT03085914|463112775|FG000|Overall Study|Progressive Disease|0|||
128676018|NCT03085914|463112776|FG001|Overall Study|Progressive Disease|0|||
128676019|NCT03085914|463112777|FG002|Overall Study|Progressive Disease|2|||
129009790|NCT04799158|464328953|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129009791|NCT04799158|464328954|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129009792|NCT04799158|464328950|FG000|On-Demand Treatment Period|Adverse Event|0|||
129009793|NCT04799158|464328951|FG001|On-Demand Treatment Period|Adverse Event|1|||
129009794|NCT04799158|464328952|FG002|On-Demand Treatment Period|Adverse Event|0|||
129009795|NCT04799158|464328953|FG003|On-Demand Treatment Period|Adverse Event|0|||
129009796|NCT04799158|464328954|FG004|On-Demand Treatment Period|Adverse Event|1|||
129009797|NCT04799158|464328950|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
129009798|NCT04799158|464328951|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
129009799|NCT04799158|464328952|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
129009800|NCT04799158|464328953|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
129009801|NCT04799158|464328954|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
129009802|NCT04799158|464328950|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129009803|NCT04799158|464328951|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129009804|NCT04799158|464328952|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129009805|NCT04799158|464328953|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
129009806|NCT04799158|464328954|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129009807|NCT04799158|464328950|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
129009808|NCT04799158|464328951|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
129009809|NCT04799158|464328952|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
129009810|NCT04799158|464328953|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
129009811|NCT04799158|464328954|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
129009812|NCT04799158|464328950|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
129009813|NCT04799158|464328951|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
129009814|NCT04799158|464328952|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
129009815|NCT04799158|464328953|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
129009816|NCT04799158|464328954|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
129009817|NCT04799158|464328950|FG000|On-Demand Treatment Period|Miscellaneous|0|||
129009818|NCT04799158|464328951|FG001|On-Demand Treatment Period|Miscellaneous|0|||
129009819|NCT04799158|464328952|FG002|On-Demand Treatment Period|Miscellaneous|0|||
129009820|NCT04799158|464328953|FG003|On-Demand Treatment Period|Miscellaneous|0|||
129009821|NCT04799158|464328954|FG004|On-Demand Treatment Period|Miscellaneous|1|||
129009822|NCT03283709|464328970|FG000|Overall Study|trial terminated|0|||
129009823|NCT03283709|464328971|FG001|Overall Study|trial terminated|1|||
129009824|NCT01734772|464328972|FG000|Overall Study|Adverse Event|1|||
129009825|NCT01734772|464328973|FG001|Overall Study|Adverse Event|2|||
129009826|NCT01734772|464328972|FG000|Overall Study|Withdrawal by Subject|0|||
129009827|NCT01734772|464328973|FG001|Overall Study|Withdrawal by Subject|1|||
129009828|NCT01867242|464328974|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
129009829|NCT01867242|464328975|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
129009830|NCT01867242|464328976|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
129009831|NCT01790568|464328982|FG000|Overall Study|Progression prior to transplant|0|||
129009832|NCT01790568|464328983|FG001|Overall Study|Progression prior to transplant|1|||
129009833|NCT00264810|464328984|FG000|Baseline|Withdrawal by Subject|10|||
129009834|NCT00264810|464328985|FG001|Baseline|Withdrawal by Subject|10|||
129009835|NCT00264810|464328984|FG000|Baseline|Physician Decision|7|||
129009836|NCT00264810|464328985|FG001|Baseline|Physician Decision|8|||
129009837|NCT00264810|464328984|FG000|Baseline|Subject Compliance Failure|3|||
128676020|NCT03085914|463112778|FG003|Overall Study|Progressive Disease|2|||
128676021|NCT03085914|463112779|FG004|Overall Study|Progressive Disease|1|||
128878408|NCT01210664|463848474|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
129009838|NCT00264810|464328985|FG001|Baseline|Subject Compliance Failure|3|||
129009839|NCT00264810|464328984|FG000|Baseline|Insufficient Seizure Frequency|2|||
129009840|NCT00264810|464328985|FG001|Baseline|Insufficient Seizure Frequency|2|||
129009841|NCT00264810|464328984|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
129009842|NCT00264810|464328985|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
129009843|NCT00264810|464328984|FG000|Baseline|Other|0|||
128676022|NCT03085914|463112780|FG005|Overall Study|Progressive Disease|1|||
128676023|NCT03085914|463112781|FG006|Overall Study|Progressive Disease|1|||
128676024|NCT03085914|463112775|FG000|Overall Study|Study Terminated by the Sponsor|0|||
128676025|NCT03085914|463112776|FG001|Overall Study|Study Terminated by the Sponsor|0|||
128676026|NCT03085914|463112777|FG002|Overall Study|Study Terminated by the Sponsor|0|||
128676027|NCT03085914|463112778|FG003|Overall Study|Study Terminated by the Sponsor|1|||
128676028|NCT03085914|463112779|FG004|Overall Study|Study Terminated by the Sponsor|2|||
128676029|NCT03085914|463112780|FG005|Overall Study|Study Terminated by the Sponsor|1|||
128676030|NCT03085914|463112781|FG006|Overall Study|Study Terminated by the Sponsor|0|||
128676031|NCT01242813|463112782|FG000|Overall Study|Lost to Follow-up|2|||
128676032|NCT01369329|463112785|FG000|Overall Study|Withdrawal by Subject|8|||
128676033|NCT01369329|463112786|FG001|Overall Study|Withdrawal by Subject|6|||
128676034|NCT01369329|463112787|FG002|Overall Study|Withdrawal by Subject|10|||
128676035|NCT01369329|463112785|FG000|Overall Study|Lost to Follow-up|2|||
128676036|NCT01369329|463112786|FG001|Overall Study|Lost to Follow-up|2|||
128676037|NCT01369329|463112787|FG002|Overall Study|Lost to Follow-up|2|||
128676038|NCT01369329|463112785|FG000|Overall Study|Other|2|||
128676039|NCT01369329|463112786|FG001|Overall Study|Other|3|||
128676040|NCT01369329|463112787|FG002|Overall Study|Other|2|||
128676041|NCT01252667|463112788|FG000|Overall Study|Transplant aborted post-conditioning|0|||
128676042|NCT01252667|463112789|FG001|Overall Study|Transplant aborted post-conditioning|0|||
128676043|NCT01252667|463112790|FG002|Overall Study|Transplant aborted post-conditioning|0|||
128676044|NCT01252667|463112791|FG003|Overall Study|Transplant aborted post-conditioning|0|||
128676045|NCT01252667|463112792|FG004|Overall Study|Transplant aborted post-conditioning|0|||
128676046|NCT01252667|463112793|FG005|Overall Study|Transplant aborted post-conditioning|1|||
129099498|NCT02697591|464657062|FG009|Overall Study|Lost to Follow-up|1|||
129099499|NCT02697591|464657053|FG000|Overall Study|Withdrawal by Subject|1|||
129099500|NCT02697591|464657054|FG001|Overall Study|Withdrawal by Subject|1|||
129099501|NCT02697591|464657055|FG002|Overall Study|Withdrawal by Subject|2|||
129099502|NCT02697591|464657056|FG003|Overall Study|Withdrawal by Subject|1|||
129099503|NCT02697591|464657057|FG004|Overall Study|Withdrawal by Subject|7|||
129099504|NCT02697591|464657058|FG005|Overall Study|Withdrawal by Subject|6|||
129099505|NCT02697591|464657059|FG006|Overall Study|Withdrawal by Subject|9|||
129099506|NCT02697591|464657060|FG007|Overall Study|Withdrawal by Subject|1|||
128676047|NCT04644315|463112794|FG000|Overall Study|Subject withdrawal of consent|1|||
128676048|NCT01836276|463112795|FG000|Overall Study|Lost to Follow-up|28|||
128676049|NCT01836276|463112796|FG001|Overall Study|Lost to Follow-up|51|||
128676050|NCT00331552|463112799|FG000|Period 3: Phase II|Neurological Symptoms|1|||
128676051|NCT00331552|463112800|FG001|Period 3: Phase II|Neurological Symptoms|0|||
128676052|NCT00331552|463112799|FG000|Period 3: Phase II|Severe Nausea|1|||
129099507|NCT02697591|464657061|FG008|Overall Study|Withdrawal by Subject|6|||
129099508|NCT02697591|464657062|FG009|Overall Study|Withdrawal by Subject|10|||
129099509|NCT02697591|464657053|FG000|Overall Study|Physician Decision|1|||
129099510|NCT02697591|464657054|FG001|Overall Study|Physician Decision|0|||
129099511|NCT02697591|464657055|FG002|Overall Study|Physician Decision|0|||
129099512|NCT02697591|464657056|FG003|Overall Study|Physician Decision|0|||
129099513|NCT02697591|464657057|FG004|Overall Study|Physician Decision|1|||
129099514|NCT02697591|464657058|FG005|Overall Study|Physician Decision|2|||
129099515|NCT02697591|464657059|FG006|Overall Study|Physician Decision|0|||
129099516|NCT02697591|464657060|FG007|Overall Study|Physician Decision|0|||
129099517|NCT02697591|464657061|FG008|Overall Study|Physician Decision|1|||
129099518|NCT02697591|464657062|FG009|Overall Study|Physician Decision|1|||
129099519|NCT02697591|464657053|FG000|Overall Study|Death|2|||
129099520|NCT02697591|464657054|FG001|Overall Study|Death|3|||
129099521|NCT02697591|464657055|FG002|Overall Study|Death|1|||
129099522|NCT02697591|464657056|FG003|Overall Study|Death|1|||
129099523|NCT02697591|464657057|FG004|Overall Study|Death|4|||
129099524|NCT02697591|464657058|FG005|Overall Study|Death|5|||
129099525|NCT02697591|464657059|FG006|Overall Study|Death|3|||
129099526|NCT02697591|464657060|FG007|Overall Study|Death|1|||
129099527|NCT02697591|464657061|FG008|Overall Study|Death|1|||
129099528|NCT02697591|464657062|FG009|Overall Study|Death|5|||
129099529|NCT02697591|464657053|FG000|Overall Study|Reason not Specified|0|||
129099530|NCT02697591|464657054|FG001|Overall Study|Reason not Specified|0|||
129099531|NCT02697591|464657055|FG002|Overall Study|Reason not Specified|0|||
129099532|NCT02697591|464657056|FG003|Overall Study|Reason not Specified|1|||
128676053|NCT00331552|463112800|FG001|Period 3: Phase II|Severe Nausea|0|||
128676054|NCT01445548|463112801|FG000|Overall Study|Adverse Event|1|||
128676055|NCT02122783|463112808|FG000|Overall Study|Adverse Event|0|||
128676056|NCT02122783|463112809|FG001|Overall Study|Adverse Event|1|||
128676057|NCT01579812|463112811|FG000|Overall Study|Ineligible after treatment start|40|||
128676058|NCT01579812|463112811|FG000|Overall Study|Patient choice|3|||
128676059|NCT01579812|463112811|FG000|Overall Study|Noncompliance|3|||
129099533|NCT02697591|464657057|FG004|Overall Study|Reason not Specified|1|||
129099534|NCT02697591|464657058|FG005|Overall Study|Reason not Specified|2|||
129099535|NCT02697591|464657059|FG006|Overall Study|Reason not Specified|3|||
129099536|NCT02697591|464657060|FG007|Overall Study|Reason not Specified|1|||
129099537|NCT02697591|464657061|FG008|Overall Study|Reason not Specified|1|||
129099538|NCT02697591|464657062|FG009|Overall Study|Reason not Specified|3|||
129099539|NCT04379700|464657067|FG000|Overall Study|Withdrawal by Subject|10|||
129099540|NCT04379700|464657067|FG000|Overall Study|Screen Fail|4|||
129099541|NCT04379700|464657067|FG000|Overall Study|Lost to Follow-up|3|||
128676060|NCT01579812|463112811|FG000|Overall Study|Withdrawal by Subject|6|||
128676061|NCT01133990|463112813|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
128676062|NCT01133990|463112814|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128676063|NCT01133990|463112815|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128676064|NCT01133990|463112816|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128676065|NCT01133990|463112817|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128676066|NCT01133990|463112818|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128676067|NCT01133990|463112813|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
128676068|NCT01133990|463112814|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
128676069|NCT01133990|463112815|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
128676070|NCT01133990|463112816|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
128676071|NCT01133990|463112817|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
129009844|NCT00264810|464328985|FG001|Baseline|Other|1|||
129009845|NCT00264810|464328984|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
129009846|NCT00264810|464328985|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
129009847|NCT00264810|464328984|FG000|Stimulation Optimization Period|Death|0|||
129009848|NCT00264810|464328985|FG001|Stimulation Optimization Period|Death|1|||
129009849|NCT00264810|464328984|FG000|Blinded Evaluation Period|Explant due to infection|1|||
129009850|NCT00264810|464328985|FG001|Blinded Evaluation Period|Explant due to infection|1|||
129009851|NCT00264810|464328984|FG000|Open Label Evaluation Period|Explant due to infection|1|||
129009852|NCT00264810|464328985|FG001|Open Label Evaluation Period|Explant due to infection|1|||
129009853|NCT00264810|464328984|FG000|Open Label Evaluation Period|Death|3|||
129009854|NCT00264810|464328985|FG001|Open Label Evaluation Period|Death|2|||
129009855|NCT00264810|464328984|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
129009856|NCT00264810|464328985|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
129009857|NCT02994056|464328986|FG000|Overall Study|Death|8|||
129009858|NCT02994056|464328986|FG000|Overall Study|Withdrew Consent|1|||
129009859|NCT02199509|464328989|FG000|Overall Study|Suicidal Ideation|0|||
129009860|NCT02199509|464328990|FG001|Overall Study|Suicidal Ideation|1|||
129009861|NCT02199509|464328989|FG000|Overall Study|Misunderstood titration schedule|1|||
129009862|NCT02199509|464328990|FG001|Overall Study|Misunderstood titration schedule|0|||
129009863|NCT02093689|464328991|FG000|Overall Study|Physician Decision|4|||
129009864|NCT02093689|464328992|FG001|Overall Study|Physician Decision|0|||
129009865|NCT02093689|464328993|FG002|Overall Study|Physician Decision|0|||
129009866|NCT03481309|464328997|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
129009867|NCT03481309|464328998|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129009868|NCT03481309|464328999|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129009869|NCT03481309|464329000|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129009870|NCT03481309|464329001|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129009871|NCT03481309|464329002|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129009872|NCT03309956|464329003|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
129009873|NCT03495869|464329004|FG000|Overall Study|Lost to Follow-up|4|||
129009874|NCT03495869|464329005|FG001|Overall Study|Lost to Follow-up|17|||
129009875|NCT03495869|464329006|FG002|Overall Study|Lost to Follow-up|8|||
129009876|NCT03495869|464329007|FG003|Overall Study|Lost to Follow-up|14|||
129009877|NCT03495869|464329004|FG000|Overall Study|Withdrawal by Subject|0|||
129009878|NCT03495869|464329005|FG001|Overall Study|Withdrawal by Subject|3|||
129009879|NCT03495869|464329006|FG002|Overall Study|Withdrawal by Subject|0|||
129009880|NCT03495869|464329007|FG003|Overall Study|Withdrawal by Subject|3|||
129009881|NCT03495869|464329004|FG000|Overall Study|Dropped from study|0|||
129009882|NCT03495869|464329005|FG001|Overall Study|Dropped from study|7|||
129009883|NCT03495869|464329006|FG002|Overall Study|Dropped from study|2|||
129009884|NCT03495869|464329007|FG003|Overall Study|Dropped from study|4|||
129009885|NCT02768298|464329008|FG000|Overall Study|Adverse Event|1|||
129009886|NCT02768298|464329009|FG001|Overall Study|Adverse Event|4|||
129009887|NCT02768298|464329008|FG000|Overall Study|Death|2|||
129009888|NCT02768298|464329009|FG001|Overall Study|Death|1|||
129009889|NCT02768298|464329008|FG000|Overall Study|Non-compliance with study treatment|0|||
129009890|NCT02768298|464329009|FG001|Overall Study|Non-compliance with study treatment|1|||
129009891|NCT02768298|464329008|FG000|Overall Study|Subject/guardian decision|1|||
129009892|NCT02768298|464329009|FG001|Overall Study|Subject/guardian decision|0|||
129009893|NCT02768298|464329008|FG000|Overall Study|Withdrawal of informed consent|0|||
129009894|NCT02768298|464329009|FG001|Overall Study|Withdrawal of informed consent|1|||
129009895|NCT04634409|464329010|FG000|Overall Study|Death|0|||
129009896|NCT04634409|464329011|FG001|Overall Study|Death|0|||
129009897|NCT04634409|464329012|FG002|Overall Study|Death|0|||
129009898|NCT04634409|464329013|FG003|Overall Study|Death|0|||
129009899|NCT04634409|464329014|FG004|Overall Study|Death|0|||
129009900|NCT04634409|464329015|FG005|Overall Study|Death|0|||
129009901|NCT04634409|464329016|FG006|Overall Study|Death|0|||
129009902|NCT04634409|464329017|FG007|Overall Study|Death|0|||
129009903|NCT04634409|464329018|FG008|Overall Study|Death|0|||
129009904|NCT04634409|464329019|FG009|Overall Study|Death|0|||
129009905|NCT04634409|464329020|FG010|Overall Study|Death|1|||
128676072|NCT01133990|463112818|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
128676073|NCT01133990|463112813|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
128676074|NCT01133990|463112814|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128676075|NCT01133990|463112815|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128676076|NCT01133990|463112816|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128676077|NCT01133990|463112817|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128676078|NCT01133990|463112818|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128676079|NCT01133990|463112813|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
128676080|NCT01133990|463112814|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
128676081|NCT01133990|463112815|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
128676082|NCT01133990|463112816|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
128676083|NCT01133990|463112817|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
128676084|NCT01133990|463112818|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
128676085|NCT05277337|463112819|FG000|Overall Study|Lost to Follow-up|2|||
128676086|NCT05277337|463112820|FG001|Overall Study|Lost to Follow-up|0|||
128676087|NCT05277337|463112819|FG000|Overall Study|Withdrawal by Subject|1|||
128676088|NCT05277337|463112820|FG001|Overall Study|Withdrawal by Subject|0|||
128676089|NCT02282345|463112822|FG000|Overall Study|Progression|0|||
128676090|NCT02282345|463112823|FG001|Overall Study|Progression|1|||
128676091|NCT04740905|463112838|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
128676092|NCT04740905|463112839|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
128676093|NCT04740905|463112838|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
128676094|NCT04740905|463112839|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
128676095|NCT04740905|463112838|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
128676096|NCT04740905|463112839|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
128676097|NCT04740905|463112838|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
128676098|NCT04740905|463112839|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
128676099|NCT04740905|463112838|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
128676100|NCT04740905|463112839|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
128676101|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
129099542|NCT00592592|464657068|FG000|Overall Study|Patient found ineligible upon chart review|1|||
129099543|NCT00530790|464657069|FG000|Overall Study|Adverse Event|2|||
129099544|NCT00530790|464657069|FG000|Overall Study|Withdrawal by Subject|2|||
129099545|NCT00530790|464657069|FG000|Overall Study|Physician Decision|1|||
129099546|NCT05053035|464657070|FG000|Overall Study|Withdrawal by Subject|1|||
129099547|NCT05053035|464657071|FG001|Overall Study|Withdrawal by Subject|0|||
129099548|NCT00938587|464657074|FG000|Overall Study|Adverse Event|2|||
129099549|NCT00938587|464657075|FG001|Overall Study|Adverse Event|0|||
129099550|NCT00938587|464657076|FG002|Overall Study|Adverse Event|0|||
129099551|NCT00938587|464657077|FG003|Overall Study|Adverse Event|2|||
129099552|NCT00938587|464657074|FG000|Overall Study|Did not meet entrance criteria|0|||
129099553|NCT00938587|464657075|FG001|Overall Study|Did not meet entrance criteria|0|||
129099554|NCT00938587|464657076|FG002|Overall Study|Did not meet entrance criteria|1|||
129099555|NCT00938587|464657077|FG003|Overall Study|Did not meet entrance criteria|0|||
129099556|NCT00938587|464657074|FG000|Overall Study|Withdrawal by Subject|1|||
129099557|NCT00938587|464657075|FG001|Overall Study|Withdrawal by Subject|1|||
129099558|NCT00938587|464657076|FG002|Overall Study|Withdrawal by Subject|0|||
129099559|NCT00938587|464657077|FG003|Overall Study|Withdrawal by Subject|0|||
129099560|NCT00048997|464657082|FG000|Overall Study|Protocol Violation|7|||
129099561|NCT00048997|464657083|FG001|Overall Study|Protocol Violation|2|||
129099562|NCT00048997|464657082|FG000|Overall Study|Withdrawal by Subject|6|||
129099563|NCT00048997|464657083|FG001|Overall Study|Withdrawal by Subject|1|||
129099564|NCT02819440|464657084|FG000|Overall Study|Adverse Event|3|||
129099565|NCT02819440|464657085|FG001|Overall Study|Adverse Event|1|||
129099566|NCT02819440|464657084|FG000|Overall Study|Lost to Follow-up|1|||
129099567|NCT02819440|464657085|FG001|Overall Study|Lost to Follow-up|3|||
129099568|NCT02819440|464657084|FG000|Overall Study|Withdrawal by Subject|9|||
129099569|NCT02819440|464657085|FG001|Overall Study|Withdrawal by Subject|8|||
129099570|NCT00575510|464657088|FG000|Overall Study|Lost to Follow-up|4|||
129099571|NCT00575510|464657089|FG001|Overall Study|Lost to Follow-up|6|||
128878409|NCT01210664|463848475|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
129099572|NCT00575510|464657090|FG002|Overall Study|Lost to Follow-up|9|||
129099573|NCT00575510|464657088|FG000|Overall Study|Withdrawal by Subject|1|||
129099574|NCT00575510|464657089|FG001|Overall Study|Withdrawal by Subject|0|||
129099575|NCT00575510|464657090|FG002|Overall Study|Withdrawal by Subject|0|||
128676102|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
128676103|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
129099576|NCT00575510|464657088|FG000|Overall Study|Clinic Called Patient|7|||
129099577|NCT00575510|464657089|FG001|Overall Study|Clinic Called Patient|7|||
129099578|NCT00575510|464657090|FG002|Overall Study|Clinic Called Patient|7|||
129099579|NCT00575510|464657088|FG000|Overall Study|Pregnancy|0|||
128676104|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
128676105|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
128676106|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
129099580|NCT00575510|464657089|FG001|Overall Study|Pregnancy|0|||
129099581|NCT00575510|464657090|FG002|Overall Study|Pregnancy|1|||
129099582|NCT01693185|464657093|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
129099583|NCT01693185|464657094|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
129099584|NCT02279745|464657095|FG000|Overall Study|Adverse Event|7|||
129099585|NCT02279745|464657095|FG000|Overall Study|Death|6|||
129099586|NCT02279745|464657095|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
129099587|NCT02279745|464657095|FG000|Overall Study|Withdrawal by Subject|2|||
129099588|NCT02279745|464657095|FG000|Overall Study|Pregnancy|1|||
129099589|NCT02279745|464657095|FG000|Overall Study|Study Non-compliance|1|||
129099590|NCT02279745|464657095|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
129099591|NCT00380718|464657096|FG000|Overall Study|Adverse Event|1|||
129099592|NCT00380718|464657096|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
129099593|NCT01606748|464657097|FG000|Overall Study|Adverse Event|1|||
129099594|NCT01606748|464657098|FG001|Overall Study|Adverse Event|0|||
129099595|NCT01606748|464657097|FG000|Overall Study|Progressive Disease|1|||
129099596|NCT01606748|464657098|FG001|Overall Study|Progressive Disease|0|||
129099597|NCT01606748|464657097|FG000|Overall Study|Withdrawal by Subject|1|||
129099598|NCT01606748|464657098|FG001|Overall Study|Withdrawal by Subject|0|||
129099599|NCT03742258|464657102|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
129099600|NCT03742258|464657103|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
129099601|NCT03742258|464657104|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
129099602|NCT03742258|464657102|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
129099603|NCT03742258|464657103|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
129099604|NCT03742258|464657104|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
129099605|NCT03742258|464657102|FG000|Survival Follow-Up|Still in Follow-up|0|||
129099606|NCT03742258|464657103|FG001|Survival Follow-Up|Still in Follow-up|0|||
129099607|NCT03742258|464657104|FG002|Survival Follow-Up|Still in Follow-up|2|||
129099608|NCT01952080|464657105|FG000|Overall Study|Withdrawal by Subject|0|||
129099609|NCT01952080|464657106|FG001|Overall Study|Withdrawal by Subject|0|||
129099610|NCT01952080|464657107|FG002|Overall Study|Withdrawal by Subject|0|||
129099611|NCT01952080|464657108|FG003|Overall Study|Withdrawal by Subject|1|||
129099612|NCT01952080|464657105|FG000|Overall Study|Protocol Non-compliance|0|||
128676107|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
128676108|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
128676109|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
128676110|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
128676111|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
128676112|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
128676113|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
128676114|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
128676115|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
129009906|NCT04634409|464329021|FG011|Overall Study|Death|0|||
129009907|NCT04634409|464329022|FG012|Overall Study|Death|1|||
129009908|NCT04634409|464329023|FG013|Overall Study|Death|0|||
129009909|NCT04634409|464329024|FG014|Overall Study|Death|0|||
129009910|NCT04634409|464329025|FG015|Overall Study|Death|0|||
129009911|NCT04634409|464329026|FG016|Overall Study|Death|0|||
129009912|NCT04634409|464329027|FG017|Overall Study|Death|0|||
129009913|NCT04634409|464329028|FG018|Overall Study|Death|0|||
129009914|NCT04634409|464329029|FG019|Overall Study|Death|0|||
129009915|NCT04634409|464329030|FG020|Overall Study|Death|0|||
129009916|NCT04634409|464329031|FG021|Overall Study|Death|0|||
129009917|NCT04634409|464329032|FG022|Overall Study|Death|0|||
129009918|NCT04634409|464329033|FG023|Overall Study|Death|0|||
129009919|NCT04634409|464329034|FG024|Overall Study|Death|0|||
129009920|NCT04634409|464329035|FG025|Overall Study|Death|0|||
129009921|NCT04634409|464329036|FG026|Overall Study|Death|0|||
129009922|NCT04634409|464329010|FG000|Overall Study|Adverse Event|0|||
129009923|NCT04634409|464329011|FG001|Overall Study|Adverse Event|0|||
129009924|NCT04634409|464329012|FG002|Overall Study|Adverse Event|1|||
129009925|NCT04634409|464329013|FG003|Overall Study|Adverse Event|0|||
129009926|NCT04634409|464329014|FG004|Overall Study|Adverse Event|0|||
129009927|NCT04634409|464329015|FG005|Overall Study|Adverse Event|1|||
129009928|NCT04634409|464329016|FG006|Overall Study|Adverse Event|0|||
129009929|NCT04634409|464329017|FG007|Overall Study|Adverse Event|0|||
129009930|NCT04634409|464329018|FG008|Overall Study|Adverse Event|0|||
129009931|NCT04634409|464329019|FG009|Overall Study|Adverse Event|0|||
129009932|NCT04634409|464329020|FG010|Overall Study|Adverse Event|0|||
129009933|NCT04634409|464329021|FG011|Overall Study|Adverse Event|0|||
129099613|NCT01952080|464657106|FG001|Overall Study|Protocol Non-compliance|1|||
129009934|NCT04634409|464329022|FG012|Overall Study|Adverse Event|0|||
129009935|NCT04634409|464329023|FG013|Overall Study|Adverse Event|0|||
129009936|NCT04634409|464329024|FG014|Overall Study|Adverse Event|0|||
129009937|NCT04634409|464329025|FG015|Overall Study|Adverse Event|0|||
128676116|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
128676117|NCT04740905|463112838|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
128676118|NCT04740905|463112839|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
128676119|NCT03051620|463112840|FG000|Overall Study|Lost to Follow-up|6|||
128676120|NCT03051620|463112840|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
128676121|NCT00393510|463112841|FG000|Overall Study|Physician Decision|3|||
128676122|NCT00393510|463112842|FG001|Overall Study|Physician Decision|9|||
128676123|NCT02412488|463112843|FG000|Overall Study|Lost to Follow-up|10|||
128676124|NCT02412488|463112843|FG000|Overall Study|Withdrawal by Subject|5|||
128676125|NCT02412488|463112843|FG000|Overall Study|Physician Decision|1|||
128676126|NCT02412488|463112843|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
128676127|NCT02412488|463112843|FG000|Overall Study|Reveal LINQ explant|1|||
128676128|NCT00313781|463112844|FG000|Before Crossover|Death|22|||
128676129|NCT00313781|463112845|FG001|Before Crossover|Death|8|||
128676130|NCT00313781|463112846|FG002|Before Crossover|Death|0|||
128676131|NCT00313781|463112844|FG000|Before Crossover|Lost to Follow-up|0|||
129099614|NCT01952080|464657107|FG002|Overall Study|Protocol Non-compliance|0|||
129099615|NCT01952080|464657108|FG003|Overall Study|Protocol Non-compliance|0|||
129099616|NCT00564395|464657109|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
128676132|NCT00313781|463112845|FG001|Before Crossover|Lost to Follow-up|3|||
128676133|NCT00313781|463112846|FG002|Before Crossover|Lost to Follow-up|0|||
128676134|NCT00313781|463112844|FG000|Before Crossover|Withdrawal by Subject|3|||
128676135|NCT00313781|463112845|FG001|Before Crossover|Withdrawal by Subject|1|||
129009938|NCT04634409|464329026|FG016|Overall Study|Adverse Event|0|||
129009939|NCT04634409|464329027|FG017|Overall Study|Adverse Event|0|||
129009940|NCT04634409|464329028|FG018|Overall Study|Adverse Event|0|||
129009941|NCT04634409|464329029|FG019|Overall Study|Adverse Event|0|||
129009942|NCT04634409|464329030|FG020|Overall Study|Adverse Event|0|||
129009943|NCT04634409|464329031|FG021|Overall Study|Adverse Event|0|||
129009944|NCT04634409|464329032|FG022|Overall Study|Adverse Event|0|||
129009945|NCT04634409|464329033|FG023|Overall Study|Adverse Event|0|||
129009946|NCT04634409|464329034|FG024|Overall Study|Adverse Event|0|||
129009947|NCT04634409|464329035|FG025|Overall Study|Adverse Event|0|||
129009948|NCT04634409|464329036|FG026|Overall Study|Adverse Event|0|||
129009949|NCT04634409|464329010|FG000|Overall Study|Lost to Follow-up|3|||
129009950|NCT04634409|464329011|FG001|Overall Study|Lost to Follow-up|1|||
129009951|NCT04634409|464329012|FG002|Overall Study|Lost to Follow-up|1|||
129009952|NCT04634409|464329013|FG003|Overall Study|Lost to Follow-up|3|||
129009953|NCT04634409|464329014|FG004|Overall Study|Lost to Follow-up|1|||
129009954|NCT04634409|464329015|FG005|Overall Study|Lost to Follow-up|1|||
129009955|NCT04634409|464329016|FG006|Overall Study|Lost to Follow-up|1|||
129009956|NCT04634409|464329017|FG007|Overall Study|Lost to Follow-up|3|||
129009957|NCT04634409|464329018|FG008|Overall Study|Lost to Follow-up|3|||
129009958|NCT04634409|464329019|FG009|Overall Study|Lost to Follow-up|11|||
129009959|NCT04634409|464329020|FG010|Overall Study|Lost to Follow-up|8|||
129009960|NCT04634409|464329021|FG011|Overall Study|Lost to Follow-up|15|||
129009961|NCT04634409|464329022|FG012|Overall Study|Lost to Follow-up|3|||
129009962|NCT04634409|464329023|FG013|Overall Study|Lost to Follow-up|2|||
129009963|NCT04634409|464329024|FG014|Overall Study|Lost to Follow-up|7|||
129009964|NCT04634409|464329025|FG015|Overall Study|Lost to Follow-up|0|||
129009965|NCT04634409|464329026|FG016|Overall Study|Lost to Follow-up|0|||
129009966|NCT04634409|464329027|FG017|Overall Study|Lost to Follow-up|0|||
129009967|NCT04634409|464329028|FG018|Overall Study|Lost to Follow-up|0|||
129009968|NCT04634409|464329029|FG019|Overall Study|Lost to Follow-up|0|||
129009969|NCT04634409|464329030|FG020|Overall Study|Lost to Follow-up|0|||
129009970|NCT04634409|464329031|FG021|Overall Study|Lost to Follow-up|0|||
129009971|NCT04634409|464329032|FG022|Overall Study|Lost to Follow-up|0|||
129009972|NCT04634409|464329033|FG023|Overall Study|Lost to Follow-up|0|||
129009973|NCT04634409|464329034|FG024|Overall Study|Lost to Follow-up|0|||
129009974|NCT04634409|464329035|FG025|Overall Study|Lost to Follow-up|0|||
129009975|NCT04634409|464329036|FG026|Overall Study|Lost to Follow-up|0|||
129009976|NCT04634409|464329010|FG000|Overall Study|Withdrawal by Subject|3|||
129009977|NCT04634409|464329011|FG001|Overall Study|Withdrawal by Subject|1|||
129009978|NCT04634409|464329012|FG002|Overall Study|Withdrawal by Subject|6|||
129009979|NCT04634409|464329013|FG003|Overall Study|Withdrawal by Subject|4|||
129009980|NCT04634409|464329014|FG004|Overall Study|Withdrawal by Subject|2|||
129009981|NCT04634409|464329015|FG005|Overall Study|Withdrawal by Subject|0|||
129009982|NCT04634409|464329016|FG006|Overall Study|Withdrawal by Subject|0|||
129009983|NCT04634409|464329017|FG007|Overall Study|Withdrawal by Subject|2|||
129009984|NCT04634409|464329018|FG008|Overall Study|Withdrawal by Subject|3|||
129009985|NCT04634409|464329019|FG009|Overall Study|Withdrawal by Subject|2|||
129009986|NCT04634409|464329020|FG010|Overall Study|Withdrawal by Subject|3|||
129009987|NCT04634409|464329021|FG011|Overall Study|Withdrawal by Subject|2|||
129009988|NCT04634409|464329022|FG012|Overall Study|Withdrawal by Subject|2|||
128676136|NCT00313781|463112846|FG002|Before Crossover|Withdrawal by Subject|0|||
128676137|NCT00313781|463112844|FG000|Before Crossover|Other|45|||
129009989|NCT04634409|464329023|FG013|Overall Study|Withdrawal by Subject|1|||
129009990|NCT04634409|464329024|FG014|Overall Study|Withdrawal by Subject|5|||
128676138|NCT00313781|463112845|FG001|Before Crossover|Other|30|||
128676139|NCT00313781|463112846|FG002|Before Crossover|Other|0|||
128676140|NCT00313781|463112844|FG000|Before Crossover|Crossover|0|||
128676141|NCT00313781|463112845|FG001|Before Crossover|Crossover|37|||
128676142|NCT00313781|463112846|FG002|Before Crossover|Crossover|0|||
128676143|NCT00313781|463112844|FG000|Before Crossover|Randomized, not treated|5|||
128676144|NCT00313781|463112845|FG001|Before Crossover|Randomized, not treated|0|||
128676145|NCT00313781|463112846|FG002|Before Crossover|Randomized, not treated|0|||
128676146|NCT00313781|463112844|FG000|After Crossover|Death|0|||
128676147|NCT00313781|463112845|FG001|After Crossover|Death|0|||
128676148|NCT00313781|463112846|FG002|After Crossover|Death|6|||
128676149|NCT00313781|463112844|FG000|After Crossover|Withdrawal by Subject|0|||
128676150|NCT00313781|463112845|FG001|After Crossover|Withdrawal by Subject|0|||
128676151|NCT00313781|463112846|FG002|After Crossover|Withdrawal by Subject|3|||
128676152|NCT00313781|463112844|FG000|After Crossover|Other|0|||
128676153|NCT00313781|463112845|FG001|After Crossover|Other|0|||
128676154|NCT00313781|463112846|FG002|After Crossover|Other|18|||
128676155|NCT03567343|463112847|FG000|Overall Study|Lost to Follow-up|2|||
128676156|NCT03567343|463112848|FG001|Overall Study|Lost to Follow-up|1|||
129099617|NCT00564395|464657110|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
129099618|NCT00564395|464657109|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
129099619|NCT00564395|464657110|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
129099620|NCT00594386|464657111|FG000|Overall Study|Major protocol violation|2|||
129099621|NCT00594386|464657111|FG000|Overall Study|Lack of Efficacy|12|||
129099622|NCT00594386|464657111|FG000|Overall Study|Adverse Event|68|||
129099623|NCT00594386|464657111|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
129099624|NCT00594386|464657111|FG000|Overall Study|Subject withdrew consent|35|||
129099625|NCT00594386|464657111|FG000|Overall Study|Study ended per sponsor|115|||
129099626|NCT00594386|464657111|FG000|Overall Study|Lost to Follow-up|6|||
129099627|NCT00594386|464657111|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
129099628|NCT00594386|464657111|FG000|Overall Study|Other: Subject moved to Seattle|1|||
129099629|NCT00594386|464657111|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
129099630|NCT00594386|464657111|FG000|Overall Study|Other: Study terminated per investigator|2|||
129099631|NCT00594386|464657111|FG000|Overall Study|Other: Sponsor closure of study|1|||
129099632|NCT00594386|464657111|FG000|Overall Study|Other: Site terminated participation|1|||
129099633|NCT00594386|464657111|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
129099634|NCT00594386|464657111|FG000|Overall Study|Other: Loss of drivers license|1|||
129099635|NCT00094536|464657114|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
129099636|NCT00094536|464657114|FG000|Treatment and Follow-up|Adverse Event|4|||
129099637|NCT00094536|464657114|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
129099638|NCT00094536|464657114|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
129099639|NCT00094536|464657114|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
129099640|NCT00094536|464657114|FG000|Treatment and Follow-up|Subject non-compliance|9|||
129099641|NCT00094536|464657114|FG000|Treatment and Follow-up|Unable to attend visits|1|||
129099642|NCT01714609|464657119|FG000|Overall Study|Protocol Violation|1|||
129099643|NCT01714609|464657120|FG001|Overall Study|Protocol Violation|0|||
129099644|NCT00630747|464657121|FG000|Overall Study|Death|1|||
129099645|NCT00630747|464657121|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
129099646|NCT00630747|464657121|FG000|Overall Study|Returned to country of origin|1|||
129099647|NCT02306694|464657124|FG000|Overall Study|Withdrawal by Subject|3|||
128676157|NCT03567343|463112847|FG000|Overall Study|No longer eligible|2|||
128676158|NCT03567343|463112848|FG001|Overall Study|No longer eligible|1|||
128676159|NCT03567343|463112847|FG000|Overall Study|Adverse Event|1|||
128676160|NCT03567343|463112848|FG001|Overall Study|Adverse Event|0|||
128676161|NCT03567343|463112847|FG000|Overall Study|Protocol Violation|1|||
128676162|NCT03567343|463112848|FG001|Overall Study|Protocol Violation|1|||
128676163|NCT00834080|463112849|FG000|Overall Study|Adverse Event|7|||
128676164|NCT00834080|463112849|FG000|Overall Study|Lost to Follow-up|7|||
128676165|NCT00834080|463112849|FG000|Overall Study|Withdrawal by Subject|5|||
128676166|NCT00834080|463112849|FG000|Overall Study|Other - Pregnancy|1|||
128676167|NCT00834080|463112849|FG000|Overall Study|Other - False positive tests of the UDS|1|||
128676168|NCT00834080|463112849|FG000|Overall Study|Physician Decision|1|||
128878410|NCT01210664|463848476|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
128878411|NCT01210664|463848477|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
129099648|NCT02306694|464657124|FG000|Overall Study|Lost to Follow-up|1|||
129099649|NCT01905592|464657125|FG000|Overall Study|Disease Progression|51|||
128676169|NCT00834080|463112849|FG000|Overall Study|Subject Relocated|1|||
128676170|NCT00796523|463112850|FG000|Overall Study|Lost to Follow-up|9|||
128676171|NCT00796523|463112851|FG001|Overall Study|Lost to Follow-up|7|||
128676172|NCT02431260|463112853|FG000|Overall Study|Subject Decision|0|||
128676173|NCT02431260|463112854|FG001|Overall Study|Subject Decision|1|||
128676174|NCT02431260|463112855|FG002|Overall Study|Subject Decision|1|||
128676175|NCT02431260|463112856|FG003|Overall Study|Subject Decision|0|||
129099650|NCT01905592|464657126|FG001|Overall Study|Disease Progression|110|||
129099651|NCT01905592|464657125|FG000|Overall Study|Toxicity|1|||
129099652|NCT01905592|464657126|FG001|Overall Study|Toxicity|16|||
128676176|NCT02431260|463112857|FG004|Overall Study|Subject Decision|0|||
128676177|NCT02431260|463112858|FG005|Overall Study|Subject Decision|0|||
128676178|NCT02431260|463112859|FG006|Overall Study|Subject Decision|0|||
128676179|NCT02431260|463112860|FG007|Overall Study|Subject Decision|0|||
128676180|NCT02431260|463112861|FG008|Overall Study|Subject Decision|1|||
128676181|NCT02431260|463112862|FG009|Overall Study|Subject Decision|1|||
128676182|NCT02431260|463112863|FG010|Overall Study|Subject Decision|0|||
128676183|NCT02431260|463112864|FG011|Overall Study|Subject Decision|1|||
128676184|NCT02431260|463112865|FG012|Overall Study|Subject Decision|0|||
128676185|NCT02431260|463112866|FG013|Overall Study|Subject Decision|0|||
128676186|NCT02431260|463112853|FG000|Overall Study|Death|4|||
128676187|NCT02431260|463112854|FG001|Overall Study|Death|4|||
128676188|NCT02431260|463112855|FG002|Overall Study|Death|3|||
128676189|NCT02431260|463112856|FG003|Overall Study|Death|4|||
128676190|NCT02431260|463112857|FG004|Overall Study|Death|2|||
128676191|NCT02431260|463112858|FG005|Overall Study|Death|2|||
128676192|NCT02431260|463112859|FG006|Overall Study|Death|3|||
128676193|NCT02431260|463112860|FG007|Overall Study|Death|1|||
128676194|NCT02431260|463112861|FG008|Overall Study|Death|6|||
128676195|NCT02431260|463112862|FG009|Overall Study|Death|6|||
128676196|NCT02431260|463112863|FG010|Overall Study|Death|3|||
128676197|NCT02431260|463112864|FG011|Overall Study|Death|2|||
128676198|NCT02431260|463112865|FG012|Overall Study|Death|5|||
128676199|NCT02431260|463112866|FG013|Overall Study|Death|1|||
128676200|NCT02431260|463112853|FG000|Overall Study|Lost to Follow-up|0|||
128676201|NCT02431260|463112854|FG001|Overall Study|Lost to Follow-up|0|||
128676202|NCT02431260|463112855|FG002|Overall Study|Lost to Follow-up|0|||
128676203|NCT02431260|463112856|FG003|Overall Study|Lost to Follow-up|0|||
128676204|NCT02431260|463112857|FG004|Overall Study|Lost to Follow-up|0|||
128676205|NCT02431260|463112858|FG005|Overall Study|Lost to Follow-up|1|||
128676206|NCT02431260|463112859|FG006|Overall Study|Lost to Follow-up|0|||
128676207|NCT02431260|463112860|FG007|Overall Study|Lost to Follow-up|0|||
128676208|NCT02431260|463112861|FG008|Overall Study|Lost to Follow-up|0|||
128676209|NCT02431260|463112862|FG009|Overall Study|Lost to Follow-up|0|||
128676210|NCT02431260|463112863|FG010|Overall Study|Lost to Follow-up|0|||
128676211|NCT02431260|463112864|FG011|Overall Study|Lost to Follow-up|0|||
128676212|NCT02431260|463112865|FG012|Overall Study|Lost to Follow-up|0|||
128676213|NCT02431260|463112866|FG013|Overall Study|Lost to Follow-up|0|||
128676214|NCT02431260|463112853|FG000|Overall Study|Study Terminated by the Sponsor|0|||
128676215|NCT02431260|463112854|FG001|Overall Study|Study Terminated by the Sponsor|0|||
128676216|NCT02431260|463112855|FG002|Overall Study|Study Terminated by the Sponsor|2|||
128676217|NCT02431260|463112856|FG003|Overall Study|Study Terminated by the Sponsor|1|||
128676218|NCT02431260|463112857|FG004|Overall Study|Study Terminated by the Sponsor|1|||
128676219|NCT02431260|463112858|FG005|Overall Study|Study Terminated by the Sponsor|0|||
128676220|NCT02431260|463112859|FG006|Overall Study|Study Terminated by the Sponsor|1|||
128676221|NCT02431260|463112860|FG007|Overall Study|Study Terminated by the Sponsor|2|||
128676222|NCT02431260|463112861|FG008|Overall Study|Study Terminated by the Sponsor|1|||
128676223|NCT02431260|463112862|FG009|Overall Study|Study Terminated by the Sponsor|1|||
128676224|NCT02431260|463112863|FG010|Overall Study|Study Terminated by the Sponsor|1|||
128676225|NCT02431260|463112864|FG011|Overall Study|Study Terminated by the Sponsor|0|||
128676226|NCT02431260|463112865|FG012|Overall Study|Study Terminated by the Sponsor|4|||
128676227|NCT02431260|463112866|FG013|Overall Study|Study Terminated by the Sponsor|0|||
128676228|NCT02431260|463112853|FG000|Overall Study|Physician Decision|0|||
128676229|NCT02431260|463112854|FG001|Overall Study|Physician Decision|0|||
128676230|NCT02431260|463112855|FG002|Overall Study|Physician Decision|0|||
128676231|NCT02431260|463112856|FG003|Overall Study|Physician Decision|0|||
128676232|NCT02431260|463112857|FG004|Overall Study|Physician Decision|0|||
128676233|NCT02431260|463112858|FG005|Overall Study|Physician Decision|1|||
128676234|NCT02431260|463112859|FG006|Overall Study|Physician Decision|0|||
128676235|NCT02431260|463112860|FG007|Overall Study|Physician Decision|0|||
128676236|NCT02431260|463112861|FG008|Overall Study|Physician Decision|0|||
128676237|NCT02431260|463112862|FG009|Overall Study|Physician Decision|0|||
128676238|NCT02431260|463112863|FG010|Overall Study|Physician Decision|0|||
128676239|NCT02431260|463112864|FG011|Overall Study|Physician Decision|0|||
129009991|NCT04634409|464329025|FG015|Overall Study|Withdrawal by Subject|0|||
128676240|NCT02431260|463112865|FG012|Overall Study|Physician Decision|0|||
128676241|NCT02431260|463112866|FG013|Overall Study|Physician Decision|0|||
128676242|NCT02431260|463112853|FG000|Overall Study|Other Unspecified|0|||
128676243|NCT02431260|463112854|FG001|Overall Study|Other Unspecified|0|||
128676244|NCT02431260|463112855|FG002|Overall Study|Other Unspecified|0|||
128676245|NCT02431260|463112856|FG003|Overall Study|Other Unspecified|0|||
128676246|NCT02431260|463112857|FG004|Overall Study|Other Unspecified|0|||
128676247|NCT02431260|463112858|FG005|Overall Study|Other Unspecified|0|||
128676248|NCT02431260|463112859|FG006|Overall Study|Other Unspecified|0|||
128676249|NCT02431260|463112860|FG007|Overall Study|Other Unspecified|0|||
128676250|NCT02431260|463112861|FG008|Overall Study|Other Unspecified|0|||
128676251|NCT02431260|463112862|FG009|Overall Study|Other Unspecified|0|||
128676252|NCT02431260|463112863|FG010|Overall Study|Other Unspecified|0|||
128676253|NCT02431260|463112864|FG011|Overall Study|Other Unspecified|1|||
128676254|NCT02431260|463112865|FG012|Overall Study|Other Unspecified|1|||
128676255|NCT02431260|463112866|FG013|Overall Study|Other Unspecified|0|||
128676256|NCT01755026|463112867|FG000|Overall Study|Adverse Event|1|||
129009992|NCT04634409|464329026|FG016|Overall Study|Withdrawal by Subject|0|||
129009993|NCT04634409|464329027|FG017|Overall Study|Withdrawal by Subject|1|||
129009994|NCT04634409|464329028|FG018|Overall Study|Withdrawal by Subject|0|||
129009995|NCT04634409|464329029|FG019|Overall Study|Withdrawal by Subject|0|||
129009996|NCT04634409|464329030|FG020|Overall Study|Withdrawal by Subject|0|||
129009997|NCT04634409|464329031|FG021|Overall Study|Withdrawal by Subject|0|||
129009998|NCT04634409|464329032|FG022|Overall Study|Withdrawal by Subject|0|||
129009999|NCT04634409|464329033|FG023|Overall Study|Withdrawal by Subject|1|||
129010000|NCT04634409|464329034|FG024|Overall Study|Withdrawal by Subject|0|||
129010001|NCT04634409|464329035|FG025|Overall Study|Withdrawal by Subject|0|||
129010002|NCT04634409|464329036|FG026|Overall Study|Withdrawal by Subject|0|||
129010003|NCT04634409|464329010|FG000|Overall Study|Other - As reported by Investigator|1|||
129010004|NCT04634409|464329011|FG001|Overall Study|Other - As reported by Investigator|0|||
129010005|NCT04634409|464329012|FG002|Overall Study|Other - As reported by Investigator|0|||
129010006|NCT04634409|464329013|FG003|Overall Study|Other - As reported by Investigator|0|||
129010007|NCT04634409|464329014|FG004|Overall Study|Other - As reported by Investigator|0|||
129010008|NCT04634409|464329015|FG005|Overall Study|Other - As reported by Investigator|0|||
129010009|NCT04634409|464329016|FG006|Overall Study|Other - As reported by Investigator|0|||
129010010|NCT04634409|464329017|FG007|Overall Study|Other - As reported by Investigator|6|||
129010011|NCT04634409|464329018|FG008|Overall Study|Other - As reported by Investigator|4|||
129010012|NCT04634409|464329019|FG009|Overall Study|Other - As reported by Investigator|0|||
129010013|NCT04634409|464329020|FG010|Overall Study|Other - As reported by Investigator|1|||
129010014|NCT04634409|464329021|FG011|Overall Study|Other - As reported by Investigator|2|||
129010015|NCT04634409|464329022|FG012|Overall Study|Other - As reported by Investigator|2|||
129010016|NCT04634409|464329023|FG013|Overall Study|Other - As reported by Investigator|1|||
129010017|NCT04634409|464329024|FG014|Overall Study|Other - As reported by Investigator|0|||
129010018|NCT04634409|464329025|FG015|Overall Study|Other - As reported by Investigator|0|||
129010019|NCT04634409|464329026|FG016|Overall Study|Other - As reported by Investigator|0|||
129010020|NCT04634409|464329027|FG017|Overall Study|Other - As reported by Investigator|0|||
129010021|NCT04634409|464329028|FG018|Overall Study|Other - As reported by Investigator|0|||
129010022|NCT04634409|464329029|FG019|Overall Study|Other - As reported by Investigator|0|||
129010023|NCT04634409|464329030|FG020|Overall Study|Other - As reported by Investigator|0|||
129010024|NCT04634409|464329031|FG021|Overall Study|Other - As reported by Investigator|0|||
129010025|NCT04634409|464329032|FG022|Overall Study|Other - As reported by Investigator|0|||
129010026|NCT04634409|464329033|FG023|Overall Study|Other - As reported by Investigator|0|||
129010027|NCT04634409|464329034|FG024|Overall Study|Other - As reported by Investigator|0|||
129010028|NCT04634409|464329035|FG025|Overall Study|Other - As reported by Investigator|0|||
129010029|NCT04634409|464329036|FG026|Overall Study|Other - As reported by Investigator|0|||
129010030|NCT02346201|464329038|FG000|Overall Study|Adverse Event|3|||
129010031|NCT02346201|464329039|FG001|Overall Study|Adverse Event|2|||
129010032|NCT02346201|464329038|FG000|Overall Study|Lost to Follow-up|1|||
129010033|NCT02346201|464329039|FG001|Overall Study|Lost to Follow-up|0|||
129010034|NCT02346201|464329038|FG000|Overall Study|Withdrawal by Subject|6|||
129010035|NCT02346201|464329039|FG001|Overall Study|Withdrawal by Subject|3|||
129010036|NCT02346201|464329038|FG000|Overall Study|Unavailable for future follow-up|0|||
129010037|NCT02346201|464329039|FG001|Overall Study|Unavailable for future follow-up|1|||
129010038|NCT02346201|464329038|FG000|Overall Study|Physician Decision|0|||
129010039|NCT02346201|464329039|FG001|Overall Study|Physician Decision|1|||
129010040|NCT02346201|464329038|FG000|Overall Study|Missed final visit|0|||
129010041|NCT02346201|464329039|FG001|Overall Study|Missed final visit|2|||
129010042|NCT03708211|464329040|FG000|Overall Study|Progressive Disease|10|||
129010043|NCT03708211|464329041|FG001|Overall Study|Progressive Disease|7|||
129010044|NCT03708211|464329040|FG000|Overall Study|Withdrawal by Subject|0|||
129010045|NCT03708211|464329041|FG001|Overall Study|Withdrawal by Subject|1|||
129010046|NCT03708211|464329040|FG000|Overall Study|Other|2|||
129010047|NCT03708211|464329041|FG001|Overall Study|Other|0|||
129010048|NCT01508936|464329042|FG000|Overall Study|Adverse Event|11|||
129010049|NCT01508936|464329043|FG001|Overall Study|Adverse Event|32|||
129010050|NCT01508936|464329042|FG000|Overall Study|Lack of Efficacy|0|||
129010051|NCT01508936|464329043|FG001|Overall Study|Lack of Efficacy|1|||
129010052|NCT01508936|464329042|FG000|Overall Study|Withdrawal by Subject|4|||
129010053|NCT01508936|464329043|FG001|Overall Study|Withdrawal by Subject|18|||
129010054|NCT01508936|464329042|FG000|Overall Study|Protocol Violation|2|||
129010055|NCT01508936|464329043|FG001|Overall Study|Protocol Violation|3|||
129010056|NCT01508936|464329042|FG000|Overall Study|Lost to Follow-up|2|||
129010057|NCT01508936|464329043|FG001|Overall Study|Lost to Follow-up|9|||
129099653|NCT01905592|464657125|FG000|Overall Study|Physician Decision|0|||
129010058|NCT01508936|464329042|FG000|Overall Study|Other|0|||
129010059|NCT01508936|464329043|FG001|Overall Study|Other|5|||
129010060|NCT01508936|464329042|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
129010061|NCT01508936|464329043|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
129010062|NCT00679367|464329044|FG000|Overall Study|Adverse Event|7|||
128676257|NCT01755026|463112868|FG001|Overall Study|Adverse Event|0|||
129099654|NCT01905592|464657126|FG001|Overall Study|Physician Decision|2|||
129099655|NCT01905592|464657125|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
129099656|NCT01905592|464657126|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
129099657|NCT01905592|464657125|FG000|Overall Study|Protocol Violation|0|||
129099658|NCT01905592|464657126|FG001|Overall Study|Protocol Violation|1|||
129099659|NCT01905592|464657125|FG000|Overall Study|Sponsor's decision|1|||
129099660|NCT01905592|464657126|FG001|Overall Study|Sponsor's decision|1|||
129099661|NCT01905592|464657125|FG000|Overall Study|Not treated|7|||
129099662|NCT01905592|464657126|FG001|Overall Study|Not treated|3|||
129099663|NCT01905592|464657125|FG000|Overall Study|Withdrawal by Subject|10|||
129099664|NCT01905592|464657126|FG001|Overall Study|Withdrawal by Subject|2|||
129099665|NCT01687283|464659012|FG000|Overall Study|Adverse Event|11|||
129099666|NCT01687283|464659013|FG001|Overall Study|Adverse Event|4|||
129099667|NCT01687283|464659012|FG000|Overall Study|Lack of Efficacy|3|||
129099668|NCT01687283|464659013|FG001|Overall Study|Lack of Efficacy|1|||
129099669|NCT01687283|464659012|FG000|Overall Study|Protocol Violation|1|||
129099670|NCT01687283|464659013|FG001|Overall Study|Protocol Violation|3|||
129099671|NCT01687283|464659012|FG000|Overall Study|protocol defined stopping criteria|8|||
129099672|NCT01687283|464659013|FG001|Overall Study|protocol defined stopping criteria|10|||
129099673|NCT01687283|464659012|FG000|Overall Study|Lost to Follow-up|1|||
129099674|NCT01687283|464659013|FG001|Overall Study|Lost to Follow-up|1|||
129099675|NCT01687283|464659012|FG000|Overall Study|Investigator discretion|2|||
129099676|NCT01687283|464659013|FG001|Overall Study|Investigator discretion|0|||
129099677|NCT01687283|464659012|FG000|Overall Study|Withdrawal by Subject|9|||
129099678|NCT01687283|464659013|FG001|Overall Study|Withdrawal by Subject|8|||
129099679|NCT03041467|464659014|FG000|Overall Study|Death|46|||
128676258|NCT01755026|463112867|FG000|Overall Study|Withdrawal by Subject|1|||
128676259|NCT01755026|463112868|FG001|Overall Study|Withdrawal by Subject|1|||
129099680|NCT03041467|464659015|FG001|Overall Study|Death|39|||
129099681|NCT03041467|464659014|FG000|Overall Study|Withdrawal by Subject|36|||
129099682|NCT03041467|464659015|FG001|Overall Study|Withdrawal by Subject|37|||
129099683|NCT03041467|464659014|FG000|Overall Study|Lost to Follow-up|6|||
129099684|NCT03041467|464659015|FG001|Overall Study|Lost to Follow-up|8|||
129099685|NCT03041467|464659014|FG000|Overall Study|Declined consent for study extension|21|||
129099686|NCT03041467|464659015|FG001|Overall Study|Declined consent for study extension|33|||
129099687|NCT03041467|464659014|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
129099688|NCT03041467|464659015|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
129099689|NCT02732015|464659016|FG000|Overall Study|Lost to Follow-up|0|||
129099690|NCT02732015|464659017|FG001|Overall Study|Lost to Follow-up|1|||
129099691|NCT01980628|464659018|FG000|Overall Study|Adverse Event|12|||
129099692|NCT01980628|464659018|FG000|Overall Study|Physician Decision|5|||
129099693|NCT01980628|464659018|FG000|Overall Study|Withdrawal by Subject|4|||
129099694|NCT01980628|464659018|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
129099695|NCT02469168|464659020|FG000|Overall Study|Trial closed|1|||
129099696|NCT02469168|464659021|FG001|Overall Study|Trial closed|0|||
129099697|NCT01760447|464659024|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
129099698|NCT01760447|464659025|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
129099699|NCT01760447|464659026|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
129099700|NCT01760447|464659027|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
129099701|NCT01760447|464659024|FG000|Weeks 0-20|Withdrawal by Subject|2|||
129099702|NCT01760447|464659025|FG001|Weeks 0-20|Withdrawal by Subject|0|||
128676260|NCT00392379|463112871|FG000|Overall Study|Withdrawal by Subject|17|||
128676261|NCT00392379|463112872|FG001|Overall Study|Withdrawal by Subject|28|||
128676262|NCT00392379|463112871|FG000|Overall Study|Lost to Follow-up|4|||
128676263|NCT00392379|463112872|FG001|Overall Study|Lost to Follow-up|9|||
128676264|NCT00392379|463112871|FG000|Overall Study|Adverse Event|1|||
128676265|NCT00392379|463112872|FG001|Overall Study|Adverse Event|1|||
128676266|NCT02365233|463112873|FG000|Overall Study|IRB withheld the data|1|||
129099703|NCT01760447|464659026|FG002|Weeks 0-20|Withdrawal by Subject|1|||
129099704|NCT01760447|464659027|FG003|Weeks 0-20|Withdrawal by Subject|0|||
129099705|NCT01760447|464659024|FG000|Weeks 0-20|Lost to Follow-up|1|||
129099706|NCT01760447|464659025|FG001|Weeks 0-20|Lost to Follow-up|0|||
129099707|NCT01760447|464659026|FG002|Weeks 0-20|Lost to Follow-up|1|||
129099708|NCT01760447|464659027|FG003|Weeks 0-20|Lost to Follow-up|1|||
128676267|NCT02365233|463112874|FG001|Overall Study|IRB withheld the data|2|||
128676268|NCT02365233|463112875|FG002|Overall Study|IRB withheld the data|2|||
129099709|NCT01760447|464659024|FG000|Weeks 0-20|Randomized but not treated|0|||
129099710|NCT01760447|464659025|FG001|Weeks 0-20|Randomized but not treated|0|||
128676269|NCT01806662|463112879|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
128676270|NCT01806662|463112880|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
129099711|NCT01760447|464659026|FG002|Weeks 0-20|Randomized but not treated|2|||
129099712|NCT01760447|464659027|FG003|Weeks 0-20|Randomized but not treated|0|||
129099713|NCT01760447|464659024|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
129099714|NCT01760447|464659025|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
129099715|NCT01760447|464659026|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
129099716|NCT01760447|464659027|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
128676271|NCT01806662|463112879|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
128676272|NCT01806662|463112880|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
128676273|NCT01806662|463112879|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
128676274|NCT01806662|463112880|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
129010063|NCT00679367|464329044|FG000|Overall Study|inability to swallow oral drugs|1|||
129010064|NCT00679367|464329044|FG000|Overall Study|Lack of Efficacy|3|||
129010065|NCT00679367|464329044|FG000|Overall Study|Withdrawal by Subject|1|||
129010066|NCT04603937|464329047|FG000|Overall Study|Adverse Event|9|||
129010067|NCT04603937|464329048|FG001|Overall Study|Adverse Event|10|||
129010068|NCT04603937|464329047|FG000|Overall Study|Withdrawal by Subject|7|||
129010069|NCT04603937|464329048|FG001|Overall Study|Withdrawal by Subject|6|||
129010070|NCT04603937|464329047|FG000|Overall Study|Lost to Follow-up|5|||
129010071|NCT04603937|464329048|FG001|Overall Study|Lost to Follow-up|6|||
129010072|NCT04603937|464329047|FG000|Overall Study|Physician Decision|0|||
129010073|NCT04603937|464329048|FG001|Overall Study|Physician Decision|1|||
129010074|NCT04603937|464329047|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
129010075|NCT04603937|464329048|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
129010076|NCT02518685|464329049|FG000|Overall Study|Adverse Event|29|||
129010077|NCT02518685|464329050|FG001|Overall Study|Adverse Event|1|||
129010078|NCT02518685|464329049|FG000|Overall Study|Withdrawal by Subject|10|||
129010079|NCT02518685|464329050|FG001|Overall Study|Withdrawal by Subject|3|||
129010080|NCT02518685|464329049|FG000|Overall Study|relocation, study fatigue|7|||
129010081|NCT02518685|464329050|FG001|Overall Study|relocation, study fatigue|2|||
129010082|NCT02518685|464329049|FG000|Overall Study|Pregnancy|1|||
129010083|NCT02518685|464329050|FG001|Overall Study|Pregnancy|0|||
129010084|NCT02518685|464329049|FG000|Overall Study|Physician Decision|1|||
129010085|NCT02518685|464329050|FG001|Overall Study|Physician Decision|0|||
129010086|NCT02518685|464329049|FG000|Overall Study|Lost to Follow-up|1|||
129010087|NCT02518685|464329050|FG001|Overall Study|Lost to Follow-up|4|||
129010088|NCT01611090|464329051|FG000|Randomized Period|Lost to Follow-up|8|||
129010089|NCT01611090|464329052|FG001|Randomized Period|Lost to Follow-up|3|||
129010090|NCT01611090|464329053|FG002|Randomized Period|Lost to Follow-up|0|||
129010091|NCT01611090|464329051|FG000|Randomized Period|Withdrawal by Subject|22|||
129010092|NCT01611090|464329052|FG001|Randomized Period|Withdrawal by Subject|26|||
129010093|NCT01611090|464329053|FG002|Randomized Period|Withdrawal by Subject|0|||
129010094|NCT01611090|464329051|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
129010095|NCT01611090|464329052|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
129010096|NCT01611090|464329053|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
129010097|NCT01611090|464329051|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
129010098|NCT01611090|464329052|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
129010099|NCT01611090|464329053|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
129010100|NCT00922779|464329054|FG000|Overall Study|Adverse Event|67|||
129010101|NCT00922779|464329054|FG000|Overall Study|Pregnancy|7|||
129010102|NCT00922779|464329054|FG000|Overall Study|Withdrawal by Subject|308|||
129010103|NCT00922779|464329054|FG000|Overall Study|Lost to Follow-up|44|||
129010104|NCT00922779|464329054|FG000|Overall Study|Other|27|||
129010105|NCT00922779|464329054|FG000|Overall Study|Missing|1874|||
129010106|NCT01922349|464329055|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
129010107|NCT01922349|464329056|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
129010108|NCT01922349|464329057|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
129010109|NCT01922349|464329058|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
129010110|NCT02448771|464329059|FG000|Overall Study|Disease Progression|30|||
129010111|NCT02448771|464329059|FG000|Overall Study|Unacceptable Toxicity|1|||
129010112|NCT02448771|464329059|FG000|Overall Study|Physician Decision|3|||
129010113|NCT02448771|464329059|FG000|Overall Study|Started new therapy|2|||
129010114|NCT01210001|464330932|FG000|Overall Study|Not treated|1|||
129010115|NCT01210001|464330933|FG001|Overall Study|Not treated|0|||
129010116|NCT01210001|464330934|FG002|Overall Study|Not treated|0|||
129010117|NCT01210001|464330932|FG000|Overall Study|Adverse Event|4|||
129010118|NCT01210001|464330933|FG001|Overall Study|Adverse Event|2|||
129010119|NCT01210001|464330934|FG002|Overall Study|Adverse Event|5|||
129010120|NCT01210001|464330932|FG000|Overall Study|Non compliant with protocol|2|||
129010121|NCT01210001|464330933|FG001|Overall Study|Non compliant with protocol|2|||
128676275|NCT01806662|463112879|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
128676276|NCT01806662|463112880|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
129010122|NCT01210001|464330934|FG002|Overall Study|Non compliant with protocol|3|||
129010123|NCT01210001|464330932|FG000|Overall Study|Lost to Follow-up|4|||
129010124|NCT01210001|464330933|FG001|Overall Study|Lost to Follow-up|3|||
129010125|NCT01210001|464330934|FG002|Overall Study|Lost to Follow-up|2|||
129010126|NCT01210001|464330932|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
129010127|NCT01210001|464330933|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
129010128|NCT01210001|464330934|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
129010129|NCT01210001|464330932|FG000|Overall Study|Other reason not defined above|2|||
129010130|NCT01210001|464330933|FG001|Overall Study|Other reason not defined above|2|||
129010131|NCT01210001|464330934|FG002|Overall Study|Other reason not defined above|1|||
129099717|NCT01760447|464659024|FG000|Weeks 20-54|Withdrawal by Subject|2|||
129099718|NCT01760447|464659025|FG001|Weeks 20-54|Withdrawal by Subject|1|||
129099719|NCT01760447|464659026|FG002|Weeks 20-54|Withdrawal by Subject|1|||
129099720|NCT01760447|464659027|FG003|Weeks 20-54|Withdrawal by Subject|2|||
129099721|NCT01760447|464659024|FG000|Weeks 20-54|Lost to Follow-up|0|||
129099722|NCT01760447|464659025|FG001|Weeks 20-54|Lost to Follow-up|0|||
129099723|NCT01760447|464659026|FG002|Weeks 20-54|Lost to Follow-up|1|||
129099724|NCT01760447|464659027|FG003|Weeks 20-54|Lost to Follow-up|2|||
129099725|NCT00255840|464659030|FG000|Overall Study|Lost to Follow-up|10|||
129099726|NCT00255840|464659031|FG001|Overall Study|Lost to Follow-up|14|||
129099727|NCT00255840|464659030|FG000|Overall Study|Discontinued intervention|53|||
129099728|NCT00255840|464659031|FG001|Overall Study|Discontinued intervention|56|||
129099729|NCT04278924|464659033|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
129099730|NCT04278924|464659034|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
129099731|NCT04278924|464659035|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129099732|NCT04278924|464659036|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
129099733|NCT04278924|464659037|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129099734|NCT04278924|464659038|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129099735|NCT04278924|464659039|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129099736|NCT04278924|464659033|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
129099737|NCT04278924|464659034|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
129099738|NCT04278924|464659035|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
129099739|NCT04278924|464659036|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
129099740|NCT04278924|464659037|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
129099741|NCT04278924|464659038|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
129099742|NCT04278924|464659039|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
129099743|NCT06226649|464659040|FG000|Overall Study|Withdrawal by Subject|4|||
129099744|NCT06226649|464659041|FG001|Overall Study|Withdrawal by Subject|1|||
129099745|NCT04847232|464659042|FG000|Overall Study|Death|123|||
129099746|NCT04847232|464659043|FG001|Overall Study|Death|115|||
129099747|NCT04847232|464659042|FG000|Overall Study|Lost to Follow-up|3|||
129099748|NCT04847232|464659043|FG001|Overall Study|Lost to Follow-up|10|||
129099749|NCT04847232|464659042|FG000|Overall Study|Withdrawal by Subject|73|||
129099750|NCT04847232|464659043|FG001|Overall Study|Withdrawal by Subject|101|||
129099751|NCT04847232|464659042|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
129099752|NCT04847232|464659043|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
129099753|NCT00631163|464659044|FG000|Number of Participants in Year 1|Adverse Event|12|||
129099754|NCT00631163|464659044|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
129099755|NCT00631163|464659044|FG000|Number of Participants in Year 1|Death|6|||
129099756|NCT00631163|464659044|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
129099757|NCT00631163|464659044|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
129099758|NCT00631163|464659044|FG000|Number of Participants in Year 1|Administrative problems|6|||
129099759|NCT00631163|464659044|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
129099760|NCT00631163|464659044|FG000|Number of Participants in Year 2|Adverse Event|1|||
129099761|NCT00631163|464659044|FG000|Number of Participants in Year 2|Protocol Violation|1|||
129099762|NCT00631163|464659044|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
129099763|NCT04348500|464659047|FG000|Overall Study|Death|2|||
129099764|NCT04348500|464659048|FG001|Overall Study|Death|2|||
129099765|NCT04348500|464659047|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
129099766|NCT04348500|464659048|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
129099767|NCT03699540|464659049|FG000|Overall Study|Lost to Follow-up|1|||
129099768|NCT00624832|464659052|FG000|Overall Study|Adverse Event|0|||
129099769|NCT00624832|464659053|FG001|Overall Study|Adverse Event|1|||
129099770|NCT00624832|464659054|FG002|Overall Study|Adverse Event|0|||
129099771|NCT00624832|464659055|FG003|Overall Study|Adverse Event|1|||
129099772|NCT00624832|464659052|FG000|Overall Study|Abnormal Laboratory Value|2|||
129099773|NCT00624832|464659053|FG001|Overall Study|Abnormal Laboratory Value|0|||
129099774|NCT00624832|464659054|FG002|Overall Study|Abnormal Laboratory Value|0|||
129099775|NCT00624832|464659055|FG003|Overall Study|Abnormal Laboratory Value|0|||
129099776|NCT02700698|464659056|FG000|Overall Study|Withdrawal by Subject|1|||
129099777|NCT02700698|464659057|FG001|Overall Study|Withdrawal by Subject|0|||
128676277|NCT01917656|463112888|FG000|Overall Study|Adverse Event|11|||
128676278|NCT01917656|463112889|FG001|Overall Study|Adverse Event|0|||
128676279|NCT01917656|463112888|FG000|Overall Study|Withdrawal criteria|8|||
128676280|NCT01917656|463112889|FG001|Overall Study|Withdrawal criteria|14|||
129099778|NCT03517449|464659064|FG000|Overall Study|Death|184|||
129099779|NCT03517449|464659065|FG001|Overall Study|Death|236|||
129099780|NCT03517449|464659064|FG000|Overall Study|Lost to Follow-up|0|||
129099781|NCT03517449|464659065|FG001|Overall Study|Lost to Follow-up|2|||
129099782|NCT03517449|464659064|FG000|Overall Study|Withdrawal by Subject|7|||
129099783|NCT03517449|464659065|FG001|Overall Study|Withdrawal by Subject|26|||
129099784|NCT03517449|464659064|FG000|Overall Study|Participants Ongoing|220|||
129099785|NCT03517449|464659065|FG001|Overall Study|Participants Ongoing|152|||
129099786|NCT02005627|464659070|FG000|Overall Study|Lost to Follow-up|1|||
128676281|NCT01917656|463112888|FG000|Overall Study|Unclassified|0|||
128676282|NCT01917656|463112889|FG001|Overall Study|Unclassified|3|||
128676283|NCT01917656|463112888|FG000|Overall Study|Withdrawal by Subject|4|||
128676284|NCT01917656|463112889|FG001|Overall Study|Withdrawal by Subject|3|||
129010132|NCT01739790|464330935|FG000|Overall Study|Early Trial Termination|2|||
129010133|NCT01739790|464330936|FG001|Overall Study|Early Trial Termination|4|||
129010134|NCT00262600|464330937|FG000|Overall Study|Lost to Follow-up|17|||
129010135|NCT00262600|464330938|FG001|Overall Study|Lost to Follow-up|31|||
129010136|NCT00262600|464330939|FG002|Overall Study|Lost to Follow-up|41|||
129010137|NCT00262600|464330937|FG000|Overall Study|Withdrawal by Subject|128|||
129010138|NCT00262600|464330938|FG001|Overall Study|Withdrawal by Subject|145|||
129010139|NCT00262600|464330939|FG002|Overall Study|Withdrawal by Subject|139|||
129010140|NCT00262600|464330937|FG000|Overall Study|Not Treated|32|||
129010141|NCT00262600|464330938|FG001|Overall Study|Not Treated|17|||
129010142|NCT00262600|464330939|FG002|Overall Study|Not Treated|24|||
129010143|NCT00262600|464330937|FG000|Overall Study|Other|58|||
129010144|NCT00262600|464330938|FG001|Overall Study|Other|59|||
129010145|NCT00262600|464330939|FG002|Overall Study|Other|62|||
129010146|NCT00376220|464330940|FG000|Overall Study|Lost to Follow-up|7|||
129010147|NCT00376220|464330941|FG001|Overall Study|Lost to Follow-up|10|||
129010148|NCT00376220|464330940|FG000|Overall Study|Withdrawal by Subject|3|||
129010149|NCT00376220|464330941|FG001|Overall Study|Withdrawal by Subject|2|||
129010150|NCT00531206|464330946|FG000|Overall Study|Adverse Event related|5|||
129010151|NCT00531206|464330946|FG000|Overall Study|Lack of Efficacy|2|||
129010152|NCT00531206|464330946|FG000|Overall Study|Lost to Follow-up|5|||
129010153|NCT00531206|464330946|FG000|Overall Study|including non-related adverse events|8|||
129010154|NCT00721409|464330947|FG000|Overall Study|Global deterioration of health status|2|||
129010155|NCT00721409|464330948|FG001|Overall Study|Global deterioration of health status|6|||
129010156|NCT00721409|464330949|FG002|Overall Study|Global deterioration of health status|3|||
129010157|NCT00721409|464330947|FG000|Overall Study|Death|0|||
129010158|NCT00721409|464330948|FG001|Overall Study|Death|1|||
129010159|NCT00721409|464330949|FG002|Overall Study|Death|0|||
129010160|NCT00721409|464330947|FG000|Overall Study|Randomized not Treated|0|||
129010161|NCT00721409|464330948|FG001|Overall Study|Randomized not Treated|1|||
129010162|NCT00721409|464330949|FG002|Overall Study|Randomized not Treated|4|||
129010163|NCT00721409|464330947|FG000|Overall Study|Reason not specified|1|||
129010164|NCT00721409|464330948|FG001|Overall Study|Reason not specified|0|||
129010165|NCT00721409|464330949|FG002|Overall Study|Reason not specified|2|||
129010166|NCT00721409|464330947|FG000|Overall Study|Adverse Event|0|||
129010167|NCT00721409|464330948|FG001|Overall Study|Adverse Event|13|||
129010168|NCT00721409|464330949|FG002|Overall Study|Adverse Event|2|||
129010169|NCT00721409|464330947|FG000|Overall Study|Lost to Follow-up|0|||
129010170|NCT00721409|464330948|FG001|Overall Study|Lost to Follow-up|0|||
129010171|NCT00721409|464330949|FG002|Overall Study|Lost to Follow-up|1|||
129010172|NCT00721409|464330947|FG000|Overall Study|Withdrawal by Subject|1|||
129010173|NCT00721409|464330948|FG001|Overall Study|Withdrawal by Subject|6|||
129010174|NCT00721409|464330949|FG002|Overall Study|Withdrawal by Subject|5|||
129010175|NCT00721409|464330947|FG000|Overall Study|Objective progression or relapse|8|||
129010176|NCT00721409|464330948|FG001|Overall Study|Objective progression or relapse|55|||
129010177|NCT00721409|464330949|FG002|Overall Study|Objective progression or relapse|62|||
129010178|NCT00322491|464330953|FG000|Overall Study|Adverse Event|1|||
129010179|NCT00322491|464330954|FG001|Overall Study|Adverse Event|0|||
129010180|NCT00322491|464330953|FG000|Overall Study|Death|1|||
129010181|NCT00322491|464330954|FG001|Overall Study|Death|2|||
129010182|NCT00688064|464330956|FG000|Overall Study|Protocol Violation|0|||
129010183|NCT00688064|464330957|FG001|Overall Study|Protocol Violation|1|||
129010184|NCT00688064|464330956|FG000|Overall Study|Adverse Event|2|||
129010185|NCT00688064|464330957|FG001|Overall Study|Adverse Event|4|||
129010186|NCT00688064|464330956|FG000|Overall Study|Withdrawal by Subject|7|||
129010187|NCT00688064|464330957|FG001|Overall Study|Withdrawal by Subject|7|||
129010188|NCT00688064|464330956|FG000|Overall Study|Lost to Follow-up|10|||
129010189|NCT00688064|464330957|FG001|Overall Study|Lost to Follow-up|10|||
129010190|NCT00688064|464330956|FG000|Overall Study|Lack of Efficacy|0|||
129010191|NCT00688064|464330957|FG001|Overall Study|Lack of Efficacy|1|||
129010192|NCT00688064|464330956|FG000|Overall Study|Pregnancy|1|||
128676285|NCT01917656|463112888|FG000|Overall Study|Lost to Follow-up|3|||
129010193|NCT00688064|464330957|FG001|Overall Study|Pregnancy|0|||
129010194|NCT00688064|464330956|FG000|Overall Study|Any other reasons|1|||
129010195|NCT00688064|464330957|FG001|Overall Study|Any other reasons|3|||
129010196|NCT00720096|464330958|FG000|Overall Study|Withdrawal by Subject|0|||
129010197|NCT00720096|464330959|FG001|Overall Study|Withdrawal by Subject|2|||
129010198|NCT00442936|464330960|FG000|Overall Study|Protocol Violation|1|||
129010199|NCT00442936|464330961|FG001|Overall Study|Protocol Violation|0|||
129010200|NCT00442936|464330962|FG002|Overall Study|Protocol Violation|1|||
129010201|NCT00442936|464330963|FG003|Overall Study|Protocol Violation|1|||
129010202|NCT00524459|464330964|FG000|Overall Study|Withdrawal by Subject|1|||
129010203|NCT00524459|464330964|FG000|Overall Study|Other|1|||
129010204|NCT01574248|464330965|FG000|Overall Study|Withdrawal by Subject|2|||
129010205|NCT01574248|464330966|FG001|Overall Study|Withdrawal by Subject|0|||
129099787|NCT02005627|464659071|FG001|Overall Study|Lost to Follow-up|2|||
129099788|NCT02005627|464659070|FG000|Overall Study|Withdrawal by Subject|1|||
129099789|NCT02005627|464659071|FG001|Overall Study|Withdrawal by Subject|2|||
129099790|NCT00548249|464659072|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
129099791|NCT00548249|464659073|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
129099792|NCT00548249|464659074|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
129099793|NCT00548249|464659075|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
129099794|NCT00548249|464659076|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
129099795|NCT00548249|464659072|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
129099796|NCT00548249|464659073|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
129099797|NCT00548249|464659074|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
129099798|NCT00548249|464659075|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
129099799|NCT00548249|464659076|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
129099800|NCT00548249|464659072|FG000|Overall Study|Protocol Violation|1|||
129099801|NCT00548249|464659073|FG001|Overall Study|Protocol Violation|1|||
129099802|NCT00548249|464659074|FG002|Overall Study|Protocol Violation|4|||
129099803|NCT00548249|464659075|FG003|Overall Study|Protocol Violation|0|||
129099804|NCT00548249|464659076|FG004|Overall Study|Protocol Violation|3|||
129099805|NCT00548249|464659072|FG000|Overall Study|Miscellaneous|2|||
129099806|NCT00548249|464659073|FG001|Overall Study|Miscellaneous|3|||
129099807|NCT00548249|464659074|FG002|Overall Study|Miscellaneous|2|||
129099808|NCT00548249|464659075|FG003|Overall Study|Miscellaneous|0|||
129099809|NCT00548249|464659076|FG004|Overall Study|Miscellaneous|2|||
129099810|NCT00548249|464659072|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
129099811|NCT00548249|464659073|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
128676286|NCT01917656|463112889|FG001|Overall Study|Lost to Follow-up|4|||
128676287|NCT02285062|463112890|FG000|Pre-Treatment Period|Protocol Violation|0|||
128676288|NCT02285062|463112891|FG001|Pre-Treatment Period|Protocol Violation|2|||
128676289|NCT02285062|463112890|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
128676290|NCT02285062|463112891|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129010206|NCT01574248|464330965|FG000|Overall Study|Missing primary endpoint data|1|||
129010207|NCT01574248|464330966|FG001|Overall Study|Missing primary endpoint data|0|||
129010208|NCT01424722|464330967|FG000|Overall Study|Sponsor terminated investigation|2258|||
129010209|NCT00995410|464330968|FG000|Overall Study|Adverse Event|51|||
129010210|NCT00995410|464330968|FG000|Overall Study|Withdrawal by Subject|7|||
129010211|NCT00995410|464330968|FG000|Overall Study|Lost to Follow-up|2|||
129010212|NCT00995410|464330968|FG000|Overall Study|Misc|28|||
129010213|NCT00818883|464330969|FG000|Overall Study|Adverse Event|28|||
129010214|NCT00818883|464330970|FG001|Overall Study|Adverse Event|19|||
129010215|NCT00818883|464330969|FG000|Overall Study|Protocol Violation|2|||
129010216|NCT00818883|464330970|FG001|Overall Study|Protocol Violation|2|||
129010217|NCT00818883|464330969|FG000|Overall Study|Lost to Follow-up|3|||
129010218|NCT00818883|464330970|FG001|Overall Study|Lost to Follow-up|2|||
129010219|NCT00818883|464330969|FG000|Overall Study|Withdrawal by Subject|16|||
129010220|NCT00818883|464330970|FG001|Overall Study|Withdrawal by Subject|14|||
129010221|NCT00818883|464330969|FG000|Overall Study|Lack of Efficacy|0|||
129010222|NCT00818883|464330970|FG001|Overall Study|Lack of Efficacy|2|||
129010223|NCT00818883|464330969|FG000|Overall Study|Other|2|||
129010224|NCT00818883|464330970|FG001|Overall Study|Other|7|||
129010225|NCT03992196|464330971|FG000|Enrollment|lost to follow-up prior dosing|1|||
129010226|NCT03992196|464330972|FG001|Enrollment|lost to follow-up prior dosing|0|||
129010227|NCT03992196|464330973|FG002|Enrollment|lost to follow-up prior dosing|0|||
129010228|NCT03992196|464330971|FG000|Treatment|Protocol Violation|0|||
129010229|NCT03992196|464330972|FG001|Treatment|Protocol Violation|0|||
129010230|NCT03992196|464330973|FG002|Treatment|Protocol Violation|1|||
129010231|NCT03992196|464330971|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
129010232|NCT03992196|464330972|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
129010233|NCT03992196|464330973|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
129010234|NCT03992196|464330971|FG000|Treatment|Withdrawal due to non-compliance|0|||
129010235|NCT03992196|464330972|FG001|Treatment|Withdrawal due to non-compliance|0|||
129010236|NCT03992196|464330973|FG002|Treatment|Withdrawal due to non-compliance|1|||
129010237|NCT03992196|464330971|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
129010238|NCT03992196|464330972|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
129010239|NCT03992196|464330973|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
129010240|NCT03992196|464330971|FG000|Treatment|Withdrawal by parent/guardian|0|||
129010241|NCT03992196|464330972|FG001|Treatment|Withdrawal by parent/guardian|0|||
129099812|NCT00548249|464659074|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
129099813|NCT00548249|464659075|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
129010242|NCT03992196|464330973|FG002|Treatment|Withdrawal by parent/guardian|2|||
129010243|NCT00048048|464330974|FG000|Core Treatment|Withdrawal by Subject|0|||
129010244|NCT00048048|464330975|FG001|Core Treatment|Withdrawal by Subject|0|||
129099814|NCT00548249|464659076|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
129099815|NCT00548249|464659072|FG000|Overall Study|Adverse Event|2|||
128676291|NCT00821509|463112892|FG000|Overall Study|Withdrawal by Subject|12|||
129099816|NCT00548249|464659073|FG001|Overall Study|Adverse Event|2|||
129099817|NCT00548249|464659074|FG002|Overall Study|Adverse Event|0|||
129099818|NCT00548249|464659075|FG003|Overall Study|Adverse Event|1|||
129099819|NCT00548249|464659076|FG004|Overall Study|Adverse Event|1|||
129099820|NCT00548249|464659072|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
129099821|NCT00548249|464659073|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
129099822|NCT00548249|464659074|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
129099823|NCT00548249|464659075|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
129099824|NCT00548249|464659076|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
129099825|NCT00548249|464659072|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
129099826|NCT00548249|464659073|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
129099827|NCT00548249|464659074|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
129099828|NCT00548249|464659075|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
129099829|NCT00548249|464659076|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
129099830|NCT00548249|464659072|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
128676292|NCT00821509|463112893|FG001|Overall Study|Withdrawal by Subject|11|||
128676293|NCT00821509|463112894|FG002|Overall Study|Withdrawal by Subject|34|||
129010245|NCT00048048|464330976|FG002|Core Treatment|Withdrawal by Subject|1|||
129010246|NCT00048048|464330977|FG003|Core Treatment|Withdrawal by Subject|0|||
129010247|NCT00048048|464330978|FG004|Core Treatment|Withdrawal by Subject|0|||
129010248|NCT00048048|464330979|FG005|Core Treatment|Withdrawal by Subject|0|||
129010249|NCT00048048|464330980|FG006|Core Treatment|Withdrawal by Subject|0|||
129010250|NCT00048048|464330981|FG007|Core Treatment|Withdrawal by Subject|0|||
129010251|NCT00048048|464330982|FG008|Core Treatment|Withdrawal by Subject|0|||
129010252|NCT00048048|464330983|FG009|Core Treatment|Withdrawal by Subject|0|||
129010253|NCT00048048|464330984|FG010|Core Treatment|Withdrawal by Subject|0|||
129010254|NCT00048048|464330985|FG011|Core Treatment|Withdrawal by Subject|0|||
129010255|NCT00048048|464330974|FG000|Core Treatment|Adverse Event|0|||
129010256|NCT00048048|464330975|FG001|Core Treatment|Adverse Event|0|||
129010257|NCT00048048|464330976|FG002|Core Treatment|Adverse Event|0|||
129010258|NCT00048048|464330977|FG003|Core Treatment|Adverse Event|0|||
129010259|NCT00048048|464330978|FG004|Core Treatment|Adverse Event|0|||
129010260|NCT00048048|464330979|FG005|Core Treatment|Adverse Event|0|||
129010261|NCT00048048|464330980|FG006|Core Treatment|Adverse Event|0|||
129010262|NCT00048048|464330981|FG007|Core Treatment|Adverse Event|1|||
129010263|NCT00048048|464330982|FG008|Core Treatment|Adverse Event|0|||
129010264|NCT00048048|464330983|FG009|Core Treatment|Adverse Event|0|||
129010265|NCT00048048|464330984|FG010|Core Treatment|Adverse Event|0|||
129010266|NCT00048048|464330985|FG011|Core Treatment|Adverse Event|0|||
129010267|NCT00048048|464330974|FG000|Extension Year 1|Early withdrawals|0|||
129010268|NCT00048048|464330975|FG001|Extension Year 1|Early withdrawals|0|||
129010269|NCT00048048|464330976|FG002|Extension Year 1|Early withdrawals|0|||
129010270|NCT00048048|464330977|FG003|Extension Year 1|Early withdrawals|0|||
129010271|NCT00048048|464330978|FG004|Extension Year 1|Early withdrawals|0|||
129010272|NCT00048048|464330979|FG005|Extension Year 1|Early withdrawals|0|||
129010273|NCT00048048|464330980|FG006|Extension Year 1|Early withdrawals|0|||
129010274|NCT00048048|464330981|FG007|Extension Year 1|Early withdrawals|0|||
129010275|NCT00048048|464330982|FG008|Extension Year 1|Early withdrawals|0|||
129010276|NCT00048048|464330983|FG009|Extension Year 1|Early withdrawals|2|||
129010277|NCT00048048|464330984|FG010|Extension Year 1|Early withdrawals|2|||
129010278|NCT00048048|464330985|FG011|Extension Year 1|Early withdrawals|4|||
129010279|NCT00048048|464330974|FG000|Extension Year 2|Early withdrawals|0|||
129010280|NCT00048048|464330975|FG001|Extension Year 2|Early withdrawals|0|||
129010281|NCT00048048|464330976|FG002|Extension Year 2|Early withdrawals|0|||
129010282|NCT00048048|464330977|FG003|Extension Year 2|Early withdrawals|0|||
129010283|NCT00048048|464330978|FG004|Extension Year 2|Early withdrawals|0|||
129010284|NCT00048048|464330979|FG005|Extension Year 2|Early withdrawals|0|||
129010285|NCT00048048|464330980|FG006|Extension Year 2|Early withdrawals|0|||
128676294|NCT03612856|463112895|FG000|Pre-dose Period|Physician Decision|0|||
128676295|NCT03612856|463112896|FG001|Pre-dose Period|Physician Decision|1|||
128676296|NCT03612856|463112897|FG002|Pre-dose Period|Physician Decision|1|||
128676297|NCT03612856|463112895|FG000|Pre-dose Period|Withdrawal by Subject|0|||
128676298|NCT03612856|463112896|FG001|Pre-dose Period|Withdrawal by Subject|1|||
128676299|NCT03612856|463112897|FG002|Pre-dose Period|Withdrawal by Subject|0|||
129010286|NCT00048048|464330981|FG007|Extension Year 2|Early withdrawals|0|||
129010287|NCT00048048|464330982|FG008|Extension Year 2|Early withdrawals|0|||
129010288|NCT00048048|464330983|FG009|Extension Year 2|Early withdrawals|0|||
129099831|NCT00548249|464659073|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
128676300|NCT03720652|463112898|FG000|Overall Study|Withdrawal by Subject|2|||
129010289|NCT00048048|464330984|FG010|Extension Year 2|Early withdrawals|4|||
129010290|NCT00048048|464330985|FG011|Extension Year 2|Early withdrawals|2|||
129010291|NCT02684578|464330986|FG000|Overall Study|Withdrawal by Subject|10|||
129010292|NCT02684578|464330987|FG001|Overall Study|Withdrawal by Subject|7|||
129010293|NCT02684578|464330986|FG000|Overall Study|Lost to Follow-up|0|||
129010294|NCT02684578|464330987|FG001|Overall Study|Lost to Follow-up|3|||
129099832|NCT00548249|464659074|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
129099833|NCT00548249|464659075|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
129099834|NCT00548249|464659076|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
129099835|NCT00548249|464659072|FG000|Overall Study|Prolonged hospitalization|0|||
129099836|NCT00548249|464659073|FG001|Overall Study|Prolonged hospitalization|0|||
129099837|NCT00548249|464659074|FG002|Overall Study|Prolonged hospitalization|2|||
129099838|NCT00548249|464659075|FG003|Overall Study|Prolonged hospitalization|1|||
129099839|NCT00548249|464659076|FG004|Overall Study|Prolonged hospitalization|0|||
129099840|NCT00548249|464659072|FG000|Overall Study|Withdrawal by Subject|2|||
129099841|NCT00548249|464659073|FG001|Overall Study|Withdrawal by Subject|0|||
129099842|NCT00548249|464659074|FG002|Overall Study|Withdrawal by Subject|0|||
129099843|NCT00548249|464659075|FG003|Overall Study|Withdrawal by Subject|0|||
129099844|NCT00548249|464659076|FG004|Overall Study|Withdrawal by Subject|0|||
129099845|NCT00548249|464659072|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
129099846|NCT00548249|464659073|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
129099847|NCT00548249|464659074|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
129099848|NCT00548249|464659075|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
128676301|NCT03720652|463112899|FG001|Overall Study|Withdrawal by Subject|7|||
128676302|NCT03720652|463112898|FG000|Overall Study|Lost to Follow-up|0|||
128676303|NCT03720652|463112899|FG001|Overall Study|Lost to Follow-up|4|||
128676304|NCT01454778|463112904|FG000|Overall Study|Lost to Follow-up|2|||
128676305|NCT01454778|463112904|FG000|Overall Study|Death|1|||
128676306|NCT00348881|463112905|FG000|Overall Study|Lost to Follow-up|12|||
128676307|NCT00348881|463112906|FG001|Overall Study|Lost to Follow-up|6|||
128676308|NCT00348881|463112905|FG000|Overall Study|Withdrawal by Subject|3|||
128676309|NCT00348881|463112906|FG001|Overall Study|Withdrawal by Subject|4|||
128676310|NCT00348881|463112905|FG000|Overall Study|Adverse Event|2|||
128676311|NCT00348881|463112906|FG001|Overall Study|Adverse Event|0|||
128676312|NCT00348881|463112905|FG000|Overall Study|Serious Adverse Event|0|||
128676313|NCT00348881|463112906|FG001|Overall Study|Serious Adverse Event|2|||
128676314|NCT03658876|463114428|FG000|Overall Study|Protocol Violation|3|||
128676315|NCT03658876|463114429|FG001|Overall Study|Protocol Violation|2|||
128676316|NCT03658876|463114428|FG000|Overall Study|Withdrawal by Subject|2|||
128676317|NCT03658876|463114429|FG001|Overall Study|Withdrawal by Subject|0|||
128676318|NCT03658876|463114428|FG000|Overall Study|Death|0|||
128676319|NCT03658876|463114429|FG001|Overall Study|Death|1|||
128676320|NCT03658876|463114428|FG000|Overall Study|Intercurrent illness|6|||
128676321|NCT03658876|463114429|FG001|Overall Study|Intercurrent illness|4|||
128676322|NCT03658876|463114428|FG000|Overall Study|Transplantation/other operation|1|||
128676323|NCT03658876|463114429|FG001|Overall Study|Transplantation/other operation|5|||
128676324|NCT01330017|463114430|FG000|Overall Study|Adverse Event|0|||
128676325|NCT01330017|463114431|FG001|Overall Study|Adverse Event|1|||
128676326|NCT01330017|463114432|FG002|Overall Study|Adverse Event|1|||
128676327|NCT01330017|463114433|FG003|Overall Study|Adverse Event|4|||
128676328|NCT01330017|463114434|FG004|Overall Study|Adverse Event|0|||
128676329|NCT01330017|463114430|FG000|Overall Study|Withdrawal by Subject|0|||
128676330|NCT01330017|463114431|FG001|Overall Study|Withdrawal by Subject|0|||
128676331|NCT01330017|463114432|FG002|Overall Study|Withdrawal by Subject|1|||
128676332|NCT01330017|463114433|FG003|Overall Study|Withdrawal by Subject|0|||
128676333|NCT01330017|463114434|FG004|Overall Study|Withdrawal by Subject|1|||
128676334|NCT01330017|463114430|FG000|Overall Study|Lost to Follow-up|0|||
128676335|NCT01330017|463114431|FG001|Overall Study|Lost to Follow-up|0|||
128676336|NCT01330017|463114432|FG002|Overall Study|Lost to Follow-up|1|||
128676337|NCT01330017|463114433|FG003|Overall Study|Lost to Follow-up|0|||
128676338|NCT01330017|463114434|FG004|Overall Study|Lost to Follow-up|0|||
128676339|NCT01330017|463114430|FG000|Overall Study|Protocol Violation|0|||
128676340|NCT01330017|463114431|FG001|Overall Study|Protocol Violation|0|||
128676341|NCT01330017|463114432|FG002|Overall Study|Protocol Violation|0|||
128676342|NCT01330017|463114433|FG003|Overall Study|Protocol Violation|1|||
128676343|NCT01330017|463114434|FG004|Overall Study|Protocol Violation|0|||
128676344|NCT01330017|463114430|FG000|Overall Study|Unknown Reason|5|||
128676345|NCT01330017|463114431|FG001|Overall Study|Unknown Reason|3|||
128676346|NCT01330017|463114432|FG002|Overall Study|Unknown Reason|5|||
128676347|NCT01330017|463114433|FG003|Overall Study|Unknown Reason|7|||
129099849|NCT00548249|464659076|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
129099850|NCT00548249|464659072|FG000|Overall Study|Sponsor's request|0|||
129099851|NCT00548249|464659073|FG001|Overall Study|Sponsor's request|0|||
129099852|NCT00548249|464659074|FG002|Overall Study|Sponsor's request|0|||
129099853|NCT00548249|464659075|FG003|Overall Study|Sponsor's request|1|||
129099854|NCT00548249|464659076|FG004|Overall Study|Sponsor's request|0|||
128676348|NCT01330017|463114434|FG004|Overall Study|Unknown Reason|2|||
128676349|NCT02616146|463114435|FG000|Overall Study|Adverse Event|64|||
128676350|NCT02616146|463114436|FG001|Overall Study|Adverse Event|24|||
128676351|NCT02616146|463114435|FG000|Overall Study|Lost to Follow-up|23|||
128676352|NCT02616146|463114436|FG001|Overall Study|Lost to Follow-up|13|||
128676353|NCT02616146|463114435|FG000|Overall Study|Non-compliance with study protocol|2|||
128676354|NCT02616146|463114436|FG001|Overall Study|Non-compliance with study protocol|0|||
129099855|NCT03003000|464659077|FG000|Overall Study|Adverse Event|1|||
129099856|NCT03003000|464659078|FG001|Overall Study|Adverse Event|2|||
129099857|NCT03003000|464659079|FG002|Overall Study|Adverse Event|3|||
129099858|NCT03003000|464659077|FG000|Overall Study|Lack of Efficacy|1|||
128676355|NCT02616146|463114435|FG000|Overall Study|Non-compliance with study drug|4|||
128676356|NCT02616146|463114436|FG001|Overall Study|Non-compliance with study drug|2|||
128676357|NCT02616146|463114435|FG000|Overall Study|Pregnancy|2|||
128676358|NCT02616146|463114436|FG001|Overall Study|Pregnancy|2|||
128676359|NCT02616146|463114435|FG000|Overall Study|Pregnancy wish|3|||
128676360|NCT02616146|463114436|FG001|Overall Study|Pregnancy wish|0|||
128676361|NCT02616146|463114435|FG000|Overall Study|Protocol Violation|6|||
128676362|NCT02616146|463114436|FG001|Overall Study|Protocol Violation|3|||
128676363|NCT02616146|463114435|FG000|Overall Study|Study terminated by sponsor|1372|||
128676364|NCT02616146|463114436|FG001|Overall Study|Study terminated by sponsor|432|||
128676365|NCT02616146|463114435|FG000|Overall Study|Participant moved|4|||
128676366|NCT02616146|463114436|FG001|Overall Study|Participant moved|3|||
128676367|NCT02616146|463114435|FG000|Overall Study|Withdrawal by Subject|30|||
128676368|NCT02616146|463114436|FG001|Overall Study|Withdrawal by Subject|24|||
128676369|NCT02616146|463114435|FG000|Overall Study|Physician Decision|2|||
128676370|NCT02616146|463114436|FG001|Overall Study|Physician Decision|1|||
128676371|NCT01221272|463114437|FG000|Period 1|Adverse Event|2|||
128676372|NCT01221272|463114438|FG001|Period 1|Adverse Event|0|||
128676373|NCT01221272|463114437|FG000|Period 1|Consent Withdrawal|0|||
128676374|NCT01221272|463114438|FG001|Period 1|Consent Withdrawal|1|||
129099859|NCT03003000|464659078|FG001|Overall Study|Lack of Efficacy|0|||
129099860|NCT03003000|464659079|FG002|Overall Study|Lack of Efficacy|0|||
129099861|NCT03003000|464659077|FG000|Overall Study|Non-compliant with protocol|0|||
129099862|NCT03003000|464659078|FG001|Overall Study|Non-compliant with protocol|1|||
129099863|NCT03003000|464659079|FG002|Overall Study|Non-compliant with protocol|1|||
129099864|NCT03003000|464659077|FG000|Overall Study|Refused to continue medication|2|||
129099865|NCT03003000|464659078|FG001|Overall Study|Refused to continue medication|0|||
129099866|NCT03003000|464659079|FG002|Overall Study|Refused to continue medication|0|||
129099867|NCT03003000|464659077|FG000|Overall Study|Other than listed|1|||
129099868|NCT03003000|464659078|FG001|Overall Study|Other than listed|1|||
129099869|NCT03003000|464659079|FG002|Overall Study|Other than listed|1|||
129099870|NCT04933617|464659081|FG000|Dose Escalation|Early closure of study|0|||
129099871|NCT04933617|464659082|FG001|Dose Escalation|Early closure of study|3|||
129099872|NCT04933617|464659083|FG002|Dose Escalation|Early closure of study|0|||
129099873|NCT04933617|464659084|FG003|Dose Escalation|Early closure of study|0|||
129099874|NCT04933617|464659085|FG004|Dose Escalation|Early closure of study|0|||
129099875|NCT02191046|464659087|FG000|Overall Study|low compliance|5|||
129099876|NCT02191046|464659088|FG001|Overall Study|low compliance|1|||
129099877|NCT03760458|464659089|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
129099878|NCT03760458|464659090|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
129099879|NCT03760458|464659091|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
129099880|NCT03760458|464659092|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
129099881|NCT03760458|464659093|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
129099882|NCT02007278|464659107|FG000|Overall Study|Failure to comply with an eligibility|0|||
129099883|NCT02007278|464659108|FG001|Overall Study|Failure to comply with an eligibility|1|||
129099884|NCT02007278|464659107|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
129099885|NCT02007278|464659108|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
129099886|NCT02007278|464659107|FG000|Overall Study|Incorrect medication administration|1|||
129099887|NCT02007278|464659108|FG001|Overall Study|Incorrect medication administration|0|||
129099888|NCT02007278|464659107|FG000|Overall Study|Mis-randomization|1|||
129099889|NCT02007278|464659108|FG001|Overall Study|Mis-randomization|1|||
129099890|NCT00002525|464659109|FG000|Overall Study|Adverse Event|36|||
129099891|NCT00002525|464659110|FG001|Overall Study|Adverse Event|0|||
129099892|NCT00002525|464659109|FG000|Overall Study|Death|5|||
129099893|NCT00002525|464659110|FG001|Overall Study|Death|0|||
128676375|NCT01221272|463114437|FG000|Period 1|Significant Dosing Noncompliance|0|||
128676376|NCT01221272|463114438|FG001|Period 1|Significant Dosing Noncompliance|1|||
128676377|NCT01221272|463114437|FG000|Period 2|Adverse Event|0|||
128676378|NCT01221272|463114438|FG001|Period 2|Adverse Event|2|||
128676379|NCT01106092|463114441|FG000|Overall Study|Withdrawal by Subject|0|||
128676380|NCT01106092|463114442|FG001|Overall Study|Withdrawal by Subject|0|||
129099894|NCT00002525|464659109|FG000|Overall Study|Withdrawal by Subject|11|||
128676381|NCT01106092|463114443|FG002|Overall Study|Withdrawal by Subject|0|||
128676382|NCT01106092|463114444|FG003|Overall Study|Withdrawal by Subject|1|||
129099895|NCT00002525|464659110|FG001|Overall Study|Withdrawal by Subject|0|||
129099896|NCT00002525|464659109|FG000|Overall Study|Start non-protocol therapy|1|||
129099897|NCT00002525|464659110|FG001|Overall Study|Start non-protocol therapy|0|||
129099898|NCT00002525|464659109|FG000|Overall Study|Other complicating disease|1|||
129099899|NCT00002525|464659110|FG001|Overall Study|Other complicating disease|0|||
129099900|NCT00002525|464659109|FG000|Overall Study|Duke's A, B1, D disease|92|||
129099901|NCT00002525|464659110|FG001|Overall Study|Duke's A, B1, D disease|0|||
128676383|NCT04839562|463114451|FG000|Overall Study|Withdrawal by Subject|0|||
128676384|NCT04839562|463114452|FG001|Overall Study|Withdrawal by Subject|1|||
128676385|NCT04839562|463114451|FG000|Overall Study|Physician Decision|0|||
128676386|NCT04839562|463114452|FG001|Overall Study|Physician Decision|1|||
128676387|NCT01246466|463114455|FG000|Overall Study|Death|1|||
128676388|NCT01246466|463114455|FG000|Overall Study|Withdrawal by Subject|1|||
128676389|NCT01012219|463114458|FG000|Period 1|Withdrawal by Subject|1|||
128676390|NCT01012219|463114458|FG000|Period 2|Withdrawal by Subject|1|||
128676391|NCT01350544|463114462|FG000|Overall Study|Administrative Withdrawal|0|||
128676392|NCT01350544|463114463|FG001|Overall Study|Administrative Withdrawal|1|||
128676393|NCT01350544|463114462|FG000|Overall Study|Death|1|||
128676394|NCT01350544|463114463|FG001|Overall Study|Death|2|||
128676395|NCT01350544|463114462|FG000|Overall Study|Moved out of LA County|2|||
128676396|NCT01350544|463114463|FG001|Overall Study|Moved out of LA County|2|||
129099902|NCT00002525|464659109|FG000|Overall Study|Error|6|||
129099903|NCT00002525|464659110|FG001|Overall Study|Error|0|||
129099904|NCT00002525|464659109|FG000|Overall Study|Other|26|||
129099905|NCT00002525|464659110|FG001|Overall Study|Other|0|||
129099906|NCT00002525|464659109|FG000|Overall Study|Never start protocol therapy|8|||
129099907|NCT00002525|464659110|FG001|Overall Study|Never start protocol therapy|0|||
129099908|NCT02886884|464659111|FG000|Follow-up|Withdrawal by Subject|0|||
129099909|NCT02886884|464659112|FG001|Follow-up|Withdrawal by Subject|0|||
129099910|NCT02886884|464659113|FG002|Follow-up|Withdrawal by Subject|0|||
129099911|NCT02886884|464659114|FG003|Follow-up|Withdrawal by Subject|1|||
129099912|NCT03230838|464659116|FG000|Overall Study|Withdrawal by Subject|3|||
129099913|NCT03230838|464659117|FG001|Overall Study|Withdrawal by Subject|0|||
129099914|NCT03230838|464659116|FG000|Overall Study|Temperature excursion|1|||
129099915|NCT03230838|464659117|FG001|Overall Study|Temperature excursion|0|||
129099916|NCT00435188|464659120|FG000|Overall Study|Death|1|||
129099917|NCT00435188|464659121|FG001|Overall Study|Death|6|||
129099918|NCT00435188|464659120|FG000|Overall Study|Withdrawal by Subject|16|||
129099919|NCT00435188|464659121|FG001|Overall Study|Withdrawal by Subject|11|||
129099920|NCT00435188|464659120|FG000|Overall Study|Lost to Follow-up|5|||
129099921|NCT00435188|464659121|FG001|Overall Study|Lost to Follow-up|6|||
129099922|NCT01915771|464659124|FG000|Day 1|Withdrawal by Subject|1|||
129099923|NCT01915771|464659124|FG000|Day 15|Withdrawal by Subject|1|||
129099924|NCT03420222|464659127|FG000|Overall Study|Withdrawal by Subject|5|||
129099925|NCT03420222|464659128|FG001|Overall Study|Withdrawal by Subject|0|||
129099926|NCT03420222|464659127|FG000|Overall Study|Physician Decision|0|||
129099927|NCT03420222|464659128|FG001|Overall Study|Physician Decision|1|||
129099928|NCT02697734|464659129|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
129099929|NCT02697734|464659130|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
129099930|NCT02697734|464659129|FG000|Core Phase - up to Week 48|Adverse Event|1|||
129099931|NCT02697734|464659130|FG001|Core Phase - up to Week 48|Adverse Event|2|||
129099932|NCT02697734|464659129|FG000|Core Phase - up to Week 48|Physician Decision|1|||
129099933|NCT02697734|464659130|FG001|Core Phase - up to Week 48|Physician Decision|0|||
129099934|NCT02697734|464659129|FG000|Optional Extension Phase|Adverse Event|5|||
129099935|NCT02697734|464659130|FG001|Optional Extension Phase|Adverse Event|1|||
129099936|NCT02697734|464659129|FG000|Optional Extension Phase|Physician Decision|0|||
129099937|NCT02697734|464659130|FG001|Optional Extension Phase|Physician Decision|1|||
129099938|NCT02334384|464659133|FG000|Overall Study|Lost to Follow-up|1|||
129099939|NCT02334384|464659134|FG001|Overall Study|Lost to Follow-up|1|||
129099940|NCT02651688|464659135|FG000|Overall Study|Non-compliance|0|||
129099941|NCT02651688|464659136|FG001|Overall Study|Non-compliance|0|||
129099942|NCT02651688|464659137|FG002|Overall Study|Non-compliance|1|||
129099943|NCT02651688|464659135|FG000|Overall Study|Principal Investigator (PI) decision|0|||
129099944|NCT02651688|464659136|FG001|Overall Study|Principal Investigator (PI) decision|2|||
129099945|NCT02651688|464659137|FG002|Overall Study|Principal Investigator (PI) decision|0|||
129099946|NCT02651688|464659135|FG000|Overall Study|Lost to Follow-up|1|||
129099947|NCT02651688|464659136|FG001|Overall Study|Lost to Follow-up|3|||
129099948|NCT02651688|464659137|FG002|Overall Study|Lost to Follow-up|0|||
129099949|NCT02651688|464659135|FG000|Overall Study|Withdrawal by Subject|1|||
128676397|NCT01350544|463114462|FG000|Overall Study|Medical Issues|1|||
128676398|NCT01350544|463114463|FG001|Overall Study|Medical Issues|1|||
129099950|NCT02651688|464659136|FG001|Overall Study|Withdrawal by Subject|0|||
129099951|NCT02651688|464659137|FG002|Overall Study|Withdrawal by Subject|2|||
129099952|NCT00055497|464659138|FG000|Overall Study|Adverse Event|1|||
129099953|NCT00055497|464659139|FG001|Overall Study|Adverse Event|1|||
129099954|NCT00055497|464659140|FG002|Overall Study|Adverse Event|1|||
129099955|NCT00055497|464659141|FG003|Overall Study|Adverse Event|28|||
129099956|NCT00055497|464659138|FG000|Overall Study|Withdrawal by Subject|3|||
129099957|NCT00055497|464659139|FG001|Overall Study|Withdrawal by Subject|1|||
129099958|NCT00055497|464659140|FG002|Overall Study|Withdrawal by Subject|1|||
129099959|NCT00055497|464659141|FG003|Overall Study|Withdrawal by Subject|15|||
129099960|NCT00055497|464659138|FG000|Overall Study|Lost to Follow-up|0|||
128676399|NCT01350544|463114462|FG000|Overall Study|Withdrawal by Subject|0|||
128676400|NCT01350544|463114463|FG001|Overall Study|Withdrawal by Subject|1|||
128676401|NCT01350544|463114462|FG000|Overall Study|Incarceration|1|||
129099961|NCT00055497|464659139|FG001|Overall Study|Lost to Follow-up|1|||
129099962|NCT00055497|464659140|FG002|Overall Study|Lost to Follow-up|0|||
129099963|NCT00055497|464659141|FG003|Overall Study|Lost to Follow-up|5|||
129099964|NCT00055497|464659138|FG000|Overall Study|Protocol Violation|0|||
129099965|NCT00055497|464659139|FG001|Overall Study|Protocol Violation|0|||
129099966|NCT00055497|464659140|FG002|Overall Study|Protocol Violation|0|||
129099967|NCT00055497|464659141|FG003|Overall Study|Protocol Violation|3|||
129099968|NCT00055497|464659138|FG000|Overall Study|Lack of Efficacy|1|||
129099969|NCT00055497|464659139|FG001|Overall Study|Lack of Efficacy|0|||
129099970|NCT00055497|464659140|FG002|Overall Study|Lack of Efficacy|0|||
129099971|NCT00055497|464659141|FG003|Overall Study|Lack of Efficacy|27|||
129099972|NCT00055497|464659138|FG000|Overall Study|Administrative Reasons|0|||
129099973|NCT00055497|464659139|FG001|Overall Study|Administrative Reasons|0|||
129099974|NCT00055497|464659140|FG002|Overall Study|Administrative Reasons|0|||
129099975|NCT00055497|464659141|FG003|Overall Study|Administrative Reasons|1|||
129099976|NCT00055497|464659138|FG000|Overall Study|Other|0|||
129099977|NCT00055497|464659139|FG001|Overall Study|Other|0|||
129099978|NCT00055497|464659140|FG002|Overall Study|Other|0|||
129099979|NCT00055497|464659141|FG003|Overall Study|Other|11|||
129099980|NCT00048165|464659142|FG000|Completed 6 Months Study|Administration/Other|8|||
129099981|NCT00048165|464659143|FG001|Completed 6 Months Study|Administration/Other|8|||
129099982|NCT00048165|464659142|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
129099983|NCT00048165|464659143|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
129099984|NCT00048165|464659142|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
129099985|NCT00048165|464659143|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
129099986|NCT00048165|464659142|FG000|Completed 6 Months Study|Death|12|||
129099987|NCT00048165|464659143|FG001|Completed 6 Months Study|Death|6|||
129099988|NCT00048165|464659142|FG000|Completed 6 Months Study|Insufficient therapy|1|||
129099989|NCT00048165|464659143|FG001|Completed 6 Months Study|Insufficient therapy|4|||
129099990|NCT00048165|464659142|FG000|Completed 6 Months Study|Other violation|4|||
129099991|NCT00048165|464659143|FG001|Completed 6 Months Study|Other violation|6|||
129099992|NCT00048165|464659142|FG000|Completed 6 Months Study|Refused treatment|5|||
129099993|NCT00048165|464659143|FG001|Completed 6 Months Study|Refused treatment|5|||
129099994|NCT00048165|464659142|FG000|Completed 6 Months Study|Violation criteria|0|||
129099995|NCT00048165|464659143|FG001|Completed 6 Months Study|Violation criteria|2|||
129099996|NCT00048165|464659142|FG000|Completed 6 Months Study|Did not receive study drug|6|||
129099997|NCT00048165|464659143|FG001|Completed 6 Months Study|Did not receive study drug|6|||
129099998|NCT00048165|464659142|FG000|Completed 12 Months Study|Administration/Other|0|||
129099999|NCT00048165|464659143|FG001|Completed 12 Months Study|Administration/Other|2|||
129100000|NCT00048165|464659142|FG000|Completed 12 Months Study|Death|2|||
129100001|NCT00048165|464659143|FG001|Completed 12 Months Study|Death|1|||
129100002|NCT00048165|464659142|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
129100003|NCT00048165|464659143|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
129100004|NCT00731731|464659144|FG000|Overall Study|Protocol Violation|0|||
129100005|NCT00731731|464659145|FG001|Overall Study|Protocol Violation|0|||
129100006|NCT00731731|464659146|FG002|Overall Study|Protocol Violation|1|||
129100007|NCT00731731|464659144|FG000|Overall Study|Cancel prior to treatment|0|||
129100008|NCT00731731|464659145|FG001|Overall Study|Cancel prior to treatment|0|||
129100009|NCT00731731|464659146|FG002|Overall Study|Cancel prior to treatment|2|||
129100010|NCT03970200|464659147|FG000|Overall Study|Death|2|||
129100011|NCT03970200|464659148|FG001|Overall Study|Death|2|||
129100012|NCT03970200|464659149|FG002|Overall Study|Death|1|||
129100013|NCT03970200|464659147|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
129100014|NCT03970200|464659148|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
129100015|NCT03970200|464659149|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
129100016|NCT02112877|464659150|FG000|Overall Study|Withdrawal by Subject|1|||
128676402|NCT01350544|463114463|FG001|Overall Study|Incarceration|0|||
128676403|NCT01350544|463114462|FG000|Overall Study|Lost to Follow-up|18|||
128676404|NCT01350544|463114463|FG001|Overall Study|Lost to Follow-up|15|||
128676405|NCT01444092|463114464|FG000|Overall Study|Adverse Event|8|||
128676406|NCT01444092|463114464|FG000|Overall Study|Protocol Violation|1|||
128676407|NCT01444092|463114464|FG000|Overall Study|Withdrawal by Subject|1|||
128676408|NCT01444092|463114464|FG000|Overall Study|Other Eligibility criteria|7|||
128676409|NCT01038869|463114469|FG000|Overall Study|Withdrawal by Subject|1|||
128676410|NCT01038869|463114469|FG000|Overall Study|Lost to Follow-up|6|||
128676411|NCT02353143|463114470|FG000|Overall Study|Withdrawal by Subject|1|||
128676412|NCT02353143|463114471|FG001|Overall Study|Withdrawal by Subject|0|||
128676413|NCT02353143|463114472|FG002|Overall Study|Withdrawal by Subject|0|||
129100017|NCT02112877|464659151|FG001|Overall Study|Withdrawal by Subject|7|||
129100018|NCT02112877|464659150|FG000|Overall Study|Visit Missed|1|||
129100019|NCT02112877|464659151|FG001|Overall Study|Visit Missed|6|||
129100020|NCT01429441|464659152|FG000|Overall Study|Adverse Event|5|||
129100021|NCT01429441|464659153|FG001|Overall Study|Adverse Event|1|||
129100022|NCT01429441|464659152|FG000|Overall Study|Death|0|||
129100023|NCT01429441|464659153|FG001|Overall Study|Death|2|||
128676414|NCT02353143|463114473|FG003|Overall Study|Withdrawal by Subject|0|||
128676415|NCT02353143|463114474|FG004|Overall Study|Withdrawal by Subject|1|||
128676416|NCT02353143|463114475|FG005|Overall Study|Withdrawal by Subject|0|||
128676417|NCT02353143|463114476|FG006|Overall Study|Withdrawal by Subject|0|||
128676418|NCT02353143|463114477|FG007|Overall Study|Withdrawal by Subject|1|||
128676419|NCT02353143|463114478|FG008|Overall Study|Withdrawal by Subject|1|||
128676420|NCT02353143|463114470|FG000|Overall Study|Lack of Efficacy|2|||
128676421|NCT02353143|463114471|FG001|Overall Study|Lack of Efficacy|1|||
128676422|NCT02353143|463114472|FG002|Overall Study|Lack of Efficacy|2|||
128676423|NCT02353143|463114473|FG003|Overall Study|Lack of Efficacy|4|||
128676424|NCT02353143|463114474|FG004|Overall Study|Lack of Efficacy|13|||
128676425|NCT02353143|463114475|FG005|Overall Study|Lack of Efficacy|2|||
129010295|NCT02684578|464330986|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
129010296|NCT02684578|464330987|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
129010297|NCT02684578|464330986|FG000|Overall Study|Missing follow-up data|0|||
129010298|NCT02684578|464330987|FG001|Overall Study|Missing follow-up data|1|||
129010299|NCT00973700|464330988|FG000|Overall Study|Withdrawal by Subject|2|||
129010300|NCT00973700|464330989|FG001|Overall Study|Withdrawal by Subject|2|||
129010301|NCT00973700|464330990|FG002|Overall Study|Withdrawal by Subject|8|||
129010302|NCT00973700|464330991|FG003|Overall Study|Withdrawal by Subject|4|||
129010303|NCT00973700|464330992|FG004|Overall Study|Withdrawal by Subject|4|||
129010304|NCT00973700|464330988|FG000|Overall Study|Lost to Follow-up|5|||
129010305|NCT00973700|464330989|FG001|Overall Study|Lost to Follow-up|0|||
129010306|NCT00973700|464330990|FG002|Overall Study|Lost to Follow-up|1|||
129010307|NCT00973700|464330991|FG003|Overall Study|Lost to Follow-up|8|||
129010308|NCT00973700|464330992|FG004|Overall Study|Lost to Follow-up|5|||
129010309|NCT00973700|464330988|FG000|Overall Study|Inappropriate enrolment|0|||
129010310|NCT00973700|464330989|FG001|Overall Study|Inappropriate enrolment|0|||
129010311|NCT00973700|464330990|FG002|Overall Study|Inappropriate enrolment|0|||
129010312|NCT00973700|464330991|FG003|Overall Study|Inappropriate enrolment|4|||
129010313|NCT00973700|464330992|FG004|Overall Study|Inappropriate enrolment|0|||
129010314|NCT00973700|464330988|FG000|Overall Study|Unable to Classify|0|||
129010315|NCT00973700|464330989|FG001|Overall Study|Unable to Classify|0|||
129010316|NCT00973700|464330990|FG002|Overall Study|Unable to Classify|1|||
129010317|NCT00973700|464330991|FG003|Overall Study|Unable to Classify|2|||
129010318|NCT00973700|464330992|FG004|Overall Study|Unable to Classify|1|||
129010319|NCT05518487|464330993|FG000|Overall Study|Withdrawal by Subject|3|||
129010320|NCT02752776|464330995|FG000|Overall Study|Adverse Event|15|||
129010321|NCT02752776|464330996|FG001|Overall Study|Adverse Event|23|||
129010322|NCT02752776|464330997|FG002|Overall Study|Adverse Event|11|||
129010323|NCT02752776|464330995|FG000|Overall Study|Lack of Efficacy|2|||
129010324|NCT02752776|464330996|FG001|Overall Study|Lack of Efficacy|6|||
129010325|NCT02752776|464330997|FG002|Overall Study|Lack of Efficacy|14|||
129010326|NCT02752776|464330995|FG000|Overall Study|Lost to Follow-up|11|||
129010327|NCT02752776|464330996|FG001|Overall Study|Lost to Follow-up|12|||
129010328|NCT02752776|464330997|FG002|Overall Study|Lost to Follow-up|4|||
129010329|NCT02752776|464330995|FG000|Overall Study|Non-compliance with study treatment|0|||
129010330|NCT02752776|464330996|FG001|Overall Study|Non-compliance with study treatment|0|||
129010331|NCT02752776|464330997|FG002|Overall Study|Non-compliance with study treatment|1|||
129010332|NCT02752776|464330995|FG000|Overall Study|Physician Decision|2|||
129010333|NCT02752776|464330996|FG001|Overall Study|Physician Decision|6|||
129010334|NCT02752776|464330997|FG002|Overall Study|Physician Decision|2|||
129010335|NCT02752776|464330995|FG000|Overall Study|Pregnancy|1|||
129010336|NCT02752776|464330996|FG001|Overall Study|Pregnancy|6|||
129010337|NCT02752776|464330997|FG002|Overall Study|Pregnancy|3|||
129010338|NCT02752776|464330995|FG000|Overall Study|Protocol Violation|10|||
129010339|NCT02752776|464330996|FG001|Overall Study|Protocol Violation|13|||
129010340|NCT02752776|464330997|FG002|Overall Study|Protocol Violation|6|||
129010341|NCT02752776|464330995|FG000|Overall Study|Subject/guardian decision|8|||
129010342|NCT02752776|464330996|FG001|Overall Study|Subject/guardian decision|6|||
129010343|NCT02752776|464330997|FG002|Overall Study|Subject/guardian decision|4|||
129010344|NCT02752776|464330995|FG000|Overall Study|Death|0|||
129010345|NCT02752776|464330996|FG001|Overall Study|Death|0|||
129010346|NCT02752776|464330997|FG002|Overall Study|Death|1|||
129010347|NCT02752776|464330995|FG000|Overall Study|Withdrawal by Subject|3|||
128676426|NCT02353143|463114476|FG006|Overall Study|Lack of Efficacy|2|||
129010348|NCT02752776|464330996|FG001|Overall Study|Withdrawal by Subject|4|||
129010349|NCT02752776|464330997|FG002|Overall Study|Withdrawal by Subject|2|||
129010350|NCT01193608|464330998|FG000|Overall Study|Other|0|||
129010351|NCT01193608|464330999|FG001|Overall Study|Other|1|||
129010352|NCT01193608|464331000|FG002|Overall Study|Other|0|||
129010353|NCT01193608|464331001|FG003|Overall Study|Other|0|||
129010354|NCT01193608|464331002|FG004|Overall Study|Other|0|||
129010355|NCT01193608|464331003|FG005|Overall Study|Other|0|||
128676427|NCT02353143|463114477|FG007|Overall Study|Lack of Efficacy|2|||
128676428|NCT02353143|463114478|FG008|Overall Study|Lack of Efficacy|1|||
129010356|NCT01193608|464330998|FG000|Overall Study|Withdrawal by Subject|0|||
129010357|NCT01193608|464330999|FG001|Overall Study|Withdrawal by Subject|1|||
129010358|NCT01193608|464331000|FG002|Overall Study|Withdrawal by Subject|2|||
129010359|NCT01193608|464331001|FG003|Overall Study|Withdrawal by Subject|3|||
129010360|NCT01193608|464331002|FG004|Overall Study|Withdrawal by Subject|3|||
128676429|NCT02353143|463114470|FG000|Overall Study|reason not specified|1|||
128676430|NCT02353143|463114471|FG001|Overall Study|reason not specified|2|||
128676431|NCT02353143|463114472|FG002|Overall Study|reason not specified|0|||
128676432|NCT02353143|463114473|FG003|Overall Study|reason not specified|0|||
128676433|NCT02353143|463114474|FG004|Overall Study|reason not specified|6|||
128676434|NCT02353143|463114475|FG005|Overall Study|reason not specified|1|||
128676435|NCT02353143|463114476|FG006|Overall Study|reason not specified|0|||
128676436|NCT02353143|463114477|FG007|Overall Study|reason not specified|3|||
128676437|NCT02353143|463114478|FG008|Overall Study|reason not specified|1|||
128676438|NCT02353143|463114470|FG000|Overall Study|Physician Decision|0|||
128676439|NCT02353143|463114471|FG001|Overall Study|Physician Decision|4|||
128676440|NCT02353143|463114472|FG002|Overall Study|Physician Decision|2|||
128676441|NCT02353143|463114473|FG003|Overall Study|Physician Decision|3|||
128676442|NCT02353143|463114474|FG004|Overall Study|Physician Decision|4|||
128676443|NCT02353143|463114475|FG005|Overall Study|Physician Decision|0|||
128676444|NCT02353143|463114476|FG006|Overall Study|Physician Decision|1|||
128676445|NCT02353143|463114477|FG007|Overall Study|Physician Decision|2|||
129010361|NCT01193608|464331003|FG005|Overall Study|Withdrawal by Subject|0|||
129010362|NCT01193608|464330998|FG000|Overall Study|Lost to Follow-up|0|||
129010363|NCT01193608|464330999|FG001|Overall Study|Lost to Follow-up|0|||
129010364|NCT01193608|464331000|FG002|Overall Study|Lost to Follow-up|0|||
129010365|NCT01193608|464331001|FG003|Overall Study|Lost to Follow-up|0|||
129010366|NCT01193608|464331002|FG004|Overall Study|Lost to Follow-up|1|||
129010367|NCT01193608|464331003|FG005|Overall Study|Lost to Follow-up|2|||
129010368|NCT01193608|464330998|FG000|Overall Study|Adverse Event|0|||
129010369|NCT01193608|464330999|FG001|Overall Study|Adverse Event|0|||
129010370|NCT01193608|464331000|FG002|Overall Study|Adverse Event|0|||
129010371|NCT01193608|464331001|FG003|Overall Study|Adverse Event|0|||
129010372|NCT01193608|464331002|FG004|Overall Study|Adverse Event|1|||
129010373|NCT01193608|464331003|FG005|Overall Study|Adverse Event|0|||
129010374|NCT00712010|464331004|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
129010375|NCT01946165|464331005|FG000|Overall Study|Physician Decision|2|||
129010376|NCT01946165|464331006|FG001|Overall Study|Physician Decision|0|||
129010377|NCT01946165|464331005|FG000|Overall Study|Withdrawal by Subject|0|||
129010378|NCT01946165|464331006|FG001|Overall Study|Withdrawal by Subject|2|||
129010379|NCT01901055|464331007|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
129010380|NCT01901055|464331008|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
129010381|NCT01901055|464331007|FG000|Randomization But Not Titrated|Physician Decision|0|||
129010382|NCT01901055|464331008|FG001|Randomization But Not Titrated|Physician Decision|1|||
129010383|NCT01901055|464331007|FG000|Started Protocol to Week 6|Physician Decision|2|||
129010384|NCT01901055|464331008|FG001|Started Protocol to Week 6|Physician Decision|1|||
129010385|NCT01901055|464331007|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
129010386|NCT01901055|464331008|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
129010387|NCT01901055|464331007|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
129010388|NCT01901055|464331008|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
129010389|NCT01901055|464331007|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
129010390|NCT01901055|464331008|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
129010391|NCT01901055|464331007|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
129010392|NCT01901055|464331008|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
129010393|NCT01901055|464331007|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
129010394|NCT01901055|464331008|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
129010395|NCT01901055|464331007|FG000|Week 24|Withdrawal by Subject|13|||
129010396|NCT01901055|464331008|FG001|Week 24|Withdrawal by Subject|19|||
129010397|NCT01901055|464331007|FG000|Week 24|Physician Decision|1|||
129010398|NCT01901055|464331008|FG001|Week 24|Physician Decision|0|||
129010399|NCT01901055|464331007|FG000|Week 36|Withdrawal by Subject|0|||
129010400|NCT01901055|464331008|FG001|Week 36|Withdrawal by Subject|5|||
129010401|NCT00525590|464331017|FG000|Overall Study|Adverse Event|3|||
129010402|NCT00525590|464331017|FG000|Overall Study|Physician Decision|3|||
129010403|NCT00525590|464331017|FG000|Overall Study|Withdrawal by Subject|16|||
129010404|NCT00525590|464331017|FG000|Overall Study|Lost to Follow-up|1|||
129010405|NCT00525590|464331017|FG000|Overall Study|Death|9|||
129010406|NCT00525590|464331017|FG000|Overall Study|Other|13|||
129010407|NCT02674334|464331023|FG000|Overall Study|Lost to Follow-up|5|||
129010408|NCT02674334|464331024|FG001|Overall Study|Lost to Follow-up|3|||
129010409|NCT02674334|464331023|FG000|Overall Study|participant difficulty breathing|1|||
129010410|NCT02674334|464331024|FG001|Overall Study|participant difficulty breathing|0|||
129010411|NCT02674334|464331023|FG000|Overall Study|NIRS not recording|1|||
129010412|NCT02674334|464331024|FG001|Overall Study|NIRS not recording|0|||
129010413|NCT00449150|464331025|FG000|Overall Study|Adverse Event|11|||
129010414|NCT00449150|464331026|FG001|Overall Study|Adverse Event|18|||
129010415|NCT00449150|464331027|FG002|Overall Study|Adverse Event|9|||
128676446|NCT02353143|463114478|FG008|Overall Study|Physician Decision|0|||
129010416|NCT00449150|464331025|FG000|Overall Study|Lack of Efficacy|1|||
128676447|NCT02353143|463114470|FG000|Overall Study|Adverse Event|0|||
129100024|NCT01429441|464659152|FG000|Overall Study|Lost to Follow-up|5|||
129100025|NCT01429441|464659153|FG001|Overall Study|Lost to Follow-up|2|||
129100026|NCT01429441|464659152|FG000|Overall Study|Physician Decision|1|||
129100027|NCT01429441|464659153|FG001|Overall Study|Physician Decision|0|||
129100028|NCT01429441|464659152|FG000|Overall Study|Withdrawal by Subject|27|||
129100029|NCT01429441|464659153|FG001|Overall Study|Withdrawal by Subject|18|||
129100030|NCT02083653|464659164|FG000|Overall Study|Randomized but not Treated|0|||
129100031|NCT02083653|464659165|FG001|Overall Study|Randomized but not Treated|2|||
129100032|NCT02083653|464659166|FG002|Overall Study|Randomized but not Treated|7|||
129100033|NCT02083653|464659164|FG000|Overall Study|Adverse Event|12|||
129100034|NCT02083653|464659165|FG001|Overall Study|Adverse Event|5|||
129100035|NCT02083653|464659166|FG002|Overall Study|Adverse Event|4|||
129100036|NCT02083653|464659164|FG000|Overall Study|Lost to Follow-up|1|||
129100037|NCT02083653|464659165|FG001|Overall Study|Lost to Follow-up|0|||
129100038|NCT02083653|464659166|FG002|Overall Study|Lost to Follow-up|0|||
129100039|NCT02083653|464659164|FG000|Overall Study|Death|2|||
129100040|NCT02083653|464659165|FG001|Overall Study|Death|2|||
129100041|NCT02083653|464659166|FG002|Overall Study|Death|2|||
129100042|NCT02083653|464659164|FG000|Overall Study|Progressive Disease|65|||
129100043|NCT02083653|464659165|FG001|Overall Study|Progressive Disease|73|||
129100044|NCT02083653|464659166|FG002|Overall Study|Progressive Disease|63|||
129100045|NCT02083653|464659164|FG000|Overall Study|Withdrawal by Subject|2|||
129100046|NCT02083653|464659165|FG001|Overall Study|Withdrawal by Subject|1|||
129100047|NCT02083653|464659166|FG002|Overall Study|Withdrawal by Subject|2|||
129100048|NCT02083653|464659164|FG000|Overall Study|Other Events|0|||
129100049|NCT02083653|464659165|FG001|Overall Study|Other Events|2|||
129100050|NCT02083653|464659166|FG002|Overall Study|Other Events|2|||
129100051|NCT02083653|464659164|FG000|Overall Study|Reason Missing|0|||
129100052|NCT02083653|464659165|FG001|Overall Study|Reason Missing|0|||
129100053|NCT02083653|464659166|FG002|Overall Study|Reason Missing|4|||
129100054|NCT00621517|464659167|FG000|Overall Study|Lost to Follow-up|3|||
129100055|NCT00621517|464659168|FG001|Overall Study|Lost to Follow-up|3|||
129100056|NCT00621517|464659167|FG000|Overall Study|Withdrawal by Subject|3|||
129100057|NCT00621517|464659168|FG001|Overall Study|Withdrawal by Subject|4|||
129100058|NCT00621517|464659167|FG000|Overall Study|Adverse Event|1|||
129100059|NCT00621517|464659168|FG001|Overall Study|Adverse Event|0|||
129100060|NCT03084315|464659169|FG000|Overall Study|Lost to Follow-up|8|||
129100061|NCT03084315|464659170|FG001|Overall Study|Lost to Follow-up|7|||
129100062|NCT03084315|464659169|FG000|Overall Study|Withdrawal by Subject|2|||
129100063|NCT03084315|464659170|FG001|Overall Study|Withdrawal by Subject|2|||
129100064|NCT00073008|464659171|FG000|Overall Study|Missing|6|||
129100065|NCT00073008|464659172|FG001|Overall Study|Missing|6|||
129100066|NCT00073008|464659171|FG000|Overall Study|Withdrawal by Subject|2|||
129100067|NCT00073008|464659172|FG001|Overall Study|Withdrawal by Subject|2|||
129100068|NCT00073008|464659171|FG000|Overall Study|Lost to Follow-up|1|||
129100069|NCT00073008|464659172|FG001|Overall Study|Lost to Follow-up|3|||
128676448|NCT02353143|463114471|FG001|Overall Study|Adverse Event|0|||
128676449|NCT02353143|463114472|FG002|Overall Study|Adverse Event|1|||
128676450|NCT02353143|463114473|FG003|Overall Study|Adverse Event|0|||
128676451|NCT02353143|463114474|FG004|Overall Study|Adverse Event|1|||
128676452|NCT02353143|463114475|FG005|Overall Study|Adverse Event|1|||
128676453|NCT02353143|463114476|FG006|Overall Study|Adverse Event|0|||
128676454|NCT02353143|463114477|FG007|Overall Study|Adverse Event|0|||
128676455|NCT02353143|463114478|FG008|Overall Study|Adverse Event|0|||
128676456|NCT02353143|463114470|FG000|Overall Study|patient receiving other treatment for AML|0|||
129010417|NCT00449150|464331026|FG001|Overall Study|Lack of Efficacy|2|||
129010418|NCT00449150|464331027|FG002|Overall Study|Lack of Efficacy|2|||
129010419|NCT00449150|464331025|FG000|Overall Study|Other|16|||
129010420|NCT00449150|464331026|FG001|Overall Study|Other|13|||
129010421|NCT00449150|464331027|FG002|Overall Study|Other|14|||
129010422|NCT00449150|464331025|FG000|Overall Study|Withdrawal by Subject|17|||
129010423|NCT00449150|464331026|FG001|Overall Study|Withdrawal by Subject|18|||
129010424|NCT00449150|464331027|FG002|Overall Study|Withdrawal by Subject|21|||
129010425|NCT00449150|464331025|FG000|Overall Study|Protocol Violation|1|||
129010426|NCT00449150|464331026|FG001|Overall Study|Protocol Violation|2|||
129010427|NCT00449150|464331027|FG002|Overall Study|Protocol Violation|1|||
129010428|NCT02660242|464331030|FG000|Glucose Tabs|Lost to Follow-up|1|||
129010429|NCT02660242|464331030|FG000|Glucagon Injection|Lost to Follow-up|1|||
129010430|NCT01345019|464331036|FG000|Blinded Treatment Phase|Death|147|||
129010431|NCT01345019|464331037|FG001|Blinded Treatment Phase|Death|137|||
129010432|NCT01345019|464331036|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
129010433|NCT01345019|464331037|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
129010434|NCT01345019|464331036|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
129010435|NCT01345019|464331037|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
129010436|NCT01345019|464331036|FG000|Blinded Treatment Phase|Disease Progression|12|||
129010437|NCT01345019|464331037|FG001|Blinded Treatment Phase|Disease Progression|10|||
129010438|NCT01345019|464331036|FG000|Blinded Treatment Phase|Adverse Event|6|||
129010439|NCT01345019|464331037|FG001|Blinded Treatment Phase|Adverse Event|13|||
129100070|NCT00073008|464659171|FG000|Overall Study|Death|46|||
129100071|NCT00073008|464659172|FG001|Overall Study|Death|47|||
129100072|NCT00073008|464659171|FG000|Overall Study|"Other selected on Case Report Form"|7|||
129100073|NCT00073008|464659172|FG001|Overall Study|"Other selected on Case Report Form"|5|||
129100074|NCT02669667|464659174|FG000|Overall Study|Lost to Follow-up|0|||
129100075|NCT02669667|464659175|FG001|Overall Study|Lost to Follow-up|0|||
129100076|NCT02669667|464659176|FG002|Overall Study|Lost to Follow-up|0|||
129100077|NCT02669667|464659177|FG003|Overall Study|Lost to Follow-up|0|||
129100078|NCT02669667|464659178|FG004|Overall Study|Lost to Follow-up|0|||
129100079|NCT02669667|464659179|FG005|Overall Study|Lost to Follow-up|1|||
129100080|NCT02669667|464659180|FG006|Overall Study|Lost to Follow-up|0|||
129100081|NCT02227368|464660907|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
129100082|NCT02227368|464660908|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
129100083|NCT02227368|464660907|FG000|Overall Study|Lost to Follow-up|1|||
129100084|NCT02227368|464660908|FG001|Overall Study|Lost to Follow-up|0|||
129100085|NCT02227368|464660907|FG000|Overall Study|Adverse Event|1|||
129100086|NCT02227368|464660908|FG001|Overall Study|Adverse Event|0|||
129100087|NCT02510820|464660912|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129100088|NCT02510820|464660913|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129100089|NCT02510820|464660912|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129100090|NCT02510820|464660913|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129100091|NCT03046056|464660914|FG000|Overall Study|Non-responder at Week 10|6|||
129100092|NCT03046056|464660915|FG001|Overall Study|Non-responder at Week 10|6|||
129100093|NCT03046056|464660916|FG002|Overall Study|Non-responder at Week 10|4|||
129100094|NCT03046056|464660914|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
129100095|NCT03046056|464660915|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
129100096|NCT03046056|464660916|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
129100097|NCT03046056|464660914|FG000|Overall Study|Adverse Event|1|||
129100098|NCT03046056|464660915|FG001|Overall Study|Adverse Event|5|||
129100099|NCT03046056|464660916|FG002|Overall Study|Adverse Event|0|||
129100100|NCT03046056|464660914|FG000|Overall Study|Non-compliance With Study Drug|0|||
129100101|NCT03046056|464660915|FG001|Overall Study|Non-compliance With Study Drug|0|||
129100102|NCT03046056|464660916|FG002|Overall Study|Non-compliance With Study Drug|2|||
129100103|NCT03046056|464660914|FG000|Overall Study|Protocol Violation|1|||
129100104|NCT03046056|464660915|FG001|Overall Study|Protocol Violation|1|||
129100105|NCT03046056|464660916|FG002|Overall Study|Protocol Violation|0|||
129100106|NCT03046056|464660914|FG000|Overall Study|Investigator's Discretion|0|||
129100107|NCT03046056|464660915|FG001|Overall Study|Investigator's Discretion|1|||
129100108|NCT03046056|464660916|FG002|Overall Study|Investigator's Discretion|0|||
129100109|NCT03046056|464660914|FG000|Overall Study|Withdrew Consent|1|||
129100110|NCT03046056|464660915|FG001|Overall Study|Withdrew Consent|0|||
129100111|NCT03046056|464660916|FG002|Overall Study|Withdrew Consent|0|||
129100112|NCT02913105|464660917|FG000|Overall Study|Adverse Event|11|||
129100113|NCT02913105|464660918|FG001|Overall Study|Adverse Event|0|||
129100114|NCT02913105|464660919|FG002|Overall Study|Adverse Event|4|||
129100115|NCT02913105|464660917|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129100116|NCT02913105|464660918|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129100117|NCT02913105|464660919|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129100118|NCT02913105|464660917|FG000|Overall Study|Reason Not Specified|3|||
129100119|NCT02913105|464660918|FG001|Overall Study|Reason Not Specified|1|||
129100120|NCT02913105|464660919|FG002|Overall Study|Reason Not Specified|1|||
129100121|NCT02913105|464660917|FG000|Overall Study|Physician Decision|1|||
129100122|NCT02913105|464660918|FG001|Overall Study|Physician Decision|1|||
129100123|NCT02913105|464660919|FG002|Overall Study|Physician Decision|0|||
129100124|NCT02913105|464660917|FG000|Overall Study|Withdrawal by Subject|0|||
129100125|NCT02913105|464660918|FG001|Overall Study|Withdrawal by Subject|3|||
129100126|NCT02913105|464660919|FG002|Overall Study|Withdrawal by Subject|1|||
129100127|NCT01317004|464660920|FG000|Overall Study|Withdrawal by Subject|1|||
129100128|NCT01317004|464660921|FG001|Overall Study|Withdrawal by Subject|4|||
129100129|NCT01317004|464660920|FG000|Overall Study|Protocol Violation|0|||
129100130|NCT01317004|464660921|FG001|Overall Study|Protocol Violation|2|||
129100131|NCT01317004|464660920|FG000|Overall Study|Adverse Event|3|||
129100132|NCT01317004|464660921|FG001|Overall Study|Adverse Event|3|||
129100133|NCT01344759|464660925|FG000|Overall Study|Patients failed to reach sedation level|0|||
129100134|NCT01344759|464660926|FG001|Overall Study|Patients failed to reach sedation level|2|||
129100135|NCT01153009|464660927|FG000|Overall Study|Adverse Event|4|||
129100136|NCT01153009|464660928|FG001|Overall Study|Adverse Event|14|||
129100137|NCT01153009|464660929|FG002|Overall Study|Adverse Event|14|||
129100138|NCT01153009|464660930|FG003|Overall Study|Adverse Event|10|||
129100139|NCT01153009|464660927|FG000|Overall Study|Lack of Efficacy|9|||
129100140|NCT01153009|464660928|FG001|Overall Study|Lack of Efficacy|0|||
129100141|NCT01153009|464660929|FG002|Overall Study|Lack of Efficacy|2|||
129100142|NCT01153009|464660930|FG003|Overall Study|Lack of Efficacy|1|||
129100143|NCT01153009|464660927|FG000|Overall Study|Noncompliance with Study Medication|1|||
129100144|NCT01153009|464660928|FG001|Overall Study|Noncompliance with Study Medication|3|||
129100145|NCT01153009|464660929|FG002|Overall Study|Noncompliance with Study Medication|4|||
128676457|NCT02353143|463114471|FG001|Overall Study|patient receiving other treatment for AML|0|||
128676458|NCT02353143|463114472|FG002|Overall Study|patient receiving other treatment for AML|1|||
128676459|NCT02353143|463114473|FG003|Overall Study|patient receiving other treatment for AML|0|||
128676460|NCT02353143|463114474|FG004|Overall Study|patient receiving other treatment for AML|0|||
128676461|NCT02353143|463114475|FG005|Overall Study|patient receiving other treatment for AML|0|||
128676462|NCT02353143|463114476|FG006|Overall Study|patient receiving other treatment for AML|0|||
128676463|NCT02353143|463114477|FG007|Overall Study|patient receiving other treatment for AML|0|||
128676464|NCT02353143|463114478|FG008|Overall Study|patient receiving other treatment for AML|0|||
128676465|NCT02353143|463114470|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
128676466|NCT02353143|463114471|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
128676467|NCT02353143|463114472|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
128676468|NCT02353143|463114473|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
128878412|NCT01853644|463848478|FG000|Registration and Treatment Start|Did not start treatment|1|||
129010440|NCT01345019|464331036|FG000|Blinded Treatment Phase|Administrative Decision|10|||
129010441|NCT01345019|464331037|FG001|Blinded Treatment Phase|Administrative Decision|8|||
129010442|NCT01345019|464331036|FG000|Blinded Treatment Phase|Noncompliance|5|||
129010443|NCT01345019|464331037|FG001|Blinded Treatment Phase|Noncompliance|3|||
129010444|NCT01345019|464331036|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
129010445|NCT01345019|464331037|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
129010446|NCT01345019|464331036|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
129010447|NCT01345019|464331037|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
129010448|NCT01345019|464331036|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
129010449|NCT01345019|464331037|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
129010450|NCT01345019|464331036|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
129010451|NCT01345019|464331037|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
129010452|NCT01345019|464331036|FG000|Open Label Treatment Phase|Death|49|||
129010453|NCT01345019|464331037|FG001|Open Label Treatment Phase|Death|48|||
129010454|NCT01345019|464331036|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
129010455|NCT01345019|464331037|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
129010456|NCT01345019|464331036|FG000|Open Label Treatment Phase|Adverse Event|30|||
129010457|NCT01345019|464331037|FG001|Open Label Treatment Phase|Adverse Event|51|||
129010458|NCT01345019|464331036|FG000|Open Label Treatment Phase|Administrative Decision|30|||
129010459|NCT01345019|464331037|FG001|Open Label Treatment Phase|Administrative Decision|15|||
129010460|NCT01345019|464331036|FG000|Open Label Treatment Phase|Disease Progression|17|||
129010461|NCT01345019|464331037|FG001|Open Label Treatment Phase|Disease Progression|18|||
129010462|NCT01345019|464331036|FG000|Open Label Treatment Phase|Noncompliance|5|||
129010463|NCT01345019|464331037|FG001|Open Label Treatment Phase|Noncompliance|4|||
129010464|NCT01345019|464331036|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
129010465|NCT01345019|464331037|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
129010466|NCT01345019|464331036|FG000|Open Label Treatment Phase|Pregnancy|1|||
129010467|NCT01345019|464331037|FG001|Open Label Treatment Phase|Pregnancy|0|||
129010468|NCT01345019|464331036|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
129010469|NCT01345019|464331037|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
129010470|NCT01345019|464331036|FG000|Open Label Treatment Phase|Protocol Violation|0|||
129010471|NCT01345019|464331037|FG001|Open Label Treatment Phase|Protocol Violation|1|||
129010472|NCT03830164|464331040|FG000|Overall Study|Adverse Event|0|||
129010473|NCT03830164|464331041|FG001|Overall Study|Adverse Event|2|||
129010474|NCT03830164|464331042|FG002|Overall Study|Adverse Event|0|||
129010475|NCT03830164|464331040|FG000|Overall Study|Lack of Efficacy|1|||
129010476|NCT03830164|464331041|FG001|Overall Study|Lack of Efficacy|5|||
129010477|NCT03830164|464331042|FG002|Overall Study|Lack of Efficacy|0|||
129010478|NCT03830164|464331040|FG000|Overall Study|Lost to Follow-up|0|||
129010479|NCT03830164|464331041|FG001|Overall Study|Lost to Follow-up|1|||
129010480|NCT03830164|464331042|FG002|Overall Study|Lost to Follow-up|0|||
129010481|NCT03830164|464331040|FG000|Overall Study|Withdrawal by Subject|1|||
129010482|NCT03830164|464331041|FG001|Overall Study|Withdrawal by Subject|0|||
129010483|NCT03830164|464331042|FG002|Overall Study|Withdrawal by Subject|0|||
129010484|NCT02192099|464331043|FG000|Overall Study|Adverse Event|1|||
129010485|NCT02192099|464331043|FG000|Overall Study|Lost to Follow-up|2|||
129010486|NCT02192099|464331043|FG000|Overall Study|Physician Decision|1|||
129010487|NCT02192099|464331043|FG000|Overall Study|Pregnancy|1|||
129010488|NCT02192099|464331043|FG000|Overall Study|Protocol Violation|8|||
129010489|NCT02192099|464331043|FG000|Overall Study|Study Terminated by Sponsor|32|||
129010490|NCT02192099|464331043|FG000|Overall Study|Withdrawal by Subject|11|||
129010491|NCT02192099|464331043|FG000|Overall Study|Miscellaneous Reasons|5|||
129010492|NCT02796664|464331046|FG000|Overall Study|Withdrawal by Subject|0|||
129010493|NCT02796664|464331047|FG001|Overall Study|Withdrawal by Subject|3|||
129010494|NCT02796664|464331046|FG000|Overall Study|Noncompliance|1|||
129010495|NCT02796664|464331047|FG001|Overall Study|Noncompliance|1|||
129010496|NCT02796664|464331046|FG000|Overall Study|Death|0|||
129010497|NCT02796664|464331047|FG001|Overall Study|Death|1|||
129010498|NCT02246478|464331048|FG000|Multiple-dose Phase|Protocol Violation|1|||
129010499|NCT02246478|464331049|FG001|Multiple-dose Phase|Protocol Violation|0|||
129010500|NCT02246478|464331050|FG002|Multiple-dose Phase|Protocol Violation|0|||
128676469|NCT02353143|463114474|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
128676470|NCT02353143|463114475|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
128676471|NCT02353143|463114476|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
128676472|NCT02353143|463114477|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
128676473|NCT02353143|463114478|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
128676474|NCT02946931|463114481|FG000|Overall Study|Did not require collection of CRFs|588|||
128676475|NCT02946931|463114481|FG000|Overall Study|Other than listed|37|||
128676476|NCT02946931|463114481|FG000|Overall Study|Discharge from hospital|118|||
128676477|NCT02946931|463114481|FG000|Overall Study|Adverse Event|81|||
128676478|NCT02946931|463114481|FG000|Overall Study|CRFs not valid|1|||
129010501|NCT02246478|464331051|FG003|Multiple-dose Phase|Protocol Violation|1|||
129010502|NCT01531205|464331053|FG000|Overall Study|Did not proceed to surgery|1|||
129010503|NCT02001558|464331054|FG000|Overall Study|Lost to Follow-up|8|||
129010504|NCT02001558|464331055|FG001|Overall Study|Lost to Follow-up|14|||
129010505|NCT04128007|464331056|FG000|Overall Study|Withdrawal by Subject|9|||
129010506|NCT04128007|464331057|FG001|Overall Study|Withdrawal by Subject|6|||
129010507|NCT04128007|464331056|FG000|Overall Study|Protocol Violation|1|||
129010508|NCT04128007|464331057|FG001|Overall Study|Protocol Violation|0|||
129010509|NCT04128007|464331056|FG000|Overall Study|Lost to Follow-up|8|||
129010510|NCT04128007|464331057|FG001|Overall Study|Lost to Follow-up|7|||
129010511|NCT04128007|464331056|FG000|Overall Study|Adverse Event|5|||
129010512|NCT04128007|464331057|FG001|Overall Study|Adverse Event|2|||
129010513|NCT04128007|464331056|FG000|Overall Study|Not reported|0|||
129010514|NCT04128007|464331057|FG001|Overall Study|Not reported|2|||
129010515|NCT04117607|464331058|FG000|Overall Study|Early Termination|0|||
129010516|NCT04117607|464331059|FG001|Overall Study|Early Termination|1|||
129010517|NCT04117607|464331060|FG002|Overall Study|Early Termination|0|||
129010518|NCT04117607|464331061|FG003|Overall Study|Early Termination|0|||
129010519|NCT04117607|464331062|FG004|Overall Study|Early Termination|0|||
129010520|NCT04117607|464331063|FG005|Overall Study|Early Termination|0|||
129010521|NCT04117607|464331064|FG006|Overall Study|Early Termination|1|||
129010522|NCT04117607|464331065|FG007|Overall Study|Early Termination|0|||
129010523|NCT04117607|464331066|FG008|Overall Study|Early Termination|0|||
129010524|NCT04117607|464331067|FG009|Overall Study|Early Termination|0|||
129010525|NCT04117607|464331068|FG010|Overall Study|Early Termination|0|||
129010526|NCT04117607|464331069|FG011|Overall Study|Early Termination|0|||
129010527|NCT04117607|464331070|FG012|Overall Study|Early Termination|0|||
129010528|NCT04117607|464331071|FG013|Overall Study|Early Termination|0|||
129010529|NCT00950807|464331075|FG000|Treatment Period 1|Lack of Efficacy|1|||
129010530|NCT00950807|464331076|FG001|Treatment Period 1|Lack of Efficacy|0|||
129010531|NCT00950807|464331077|FG002|Treatment Period 1|Lack of Efficacy|0|||
129010532|NCT00950807|464331078|FG003|Treatment Period 1|Lack of Efficacy|0|||
129010533|NCT00950807|464331079|FG004|Treatment Period 1|Lack of Efficacy|0|||
129010534|NCT00950807|464331080|FG005|Treatment Period 1|Lack of Efficacy|1|||
129010535|NCT00950807|464331081|FG006|Treatment Period 1|Lack of Efficacy|0|||
129010536|NCT00950807|464331082|FG007|Treatment Period 1|Lack of Efficacy|0|||
129010537|NCT00950807|464331083|FG008|Treatment Period 1|Lack of Efficacy|0|||
129010538|NCT00950807|464331084|FG009|Treatment Period 1|Lack of Efficacy|0|||
129010539|NCT00950807|464331075|FG000|Treatment Period 1|Protocol Violation|1|||
129010540|NCT00950807|464331076|FG001|Treatment Period 1|Protocol Violation|0|||
129010541|NCT00950807|464331077|FG002|Treatment Period 1|Protocol Violation|0|||
129010542|NCT00950807|464331078|FG003|Treatment Period 1|Protocol Violation|0|||
129010543|NCT00950807|464331079|FG004|Treatment Period 1|Protocol Violation|0|||
129010544|NCT00950807|464331080|FG005|Treatment Period 1|Protocol Violation|0|||
129010545|NCT00950807|464331081|FG006|Treatment Period 1|Protocol Violation|0|||
129010546|NCT00950807|464331082|FG007|Treatment Period 1|Protocol Violation|0|||
129010547|NCT00950807|464331083|FG008|Treatment Period 1|Protocol Violation|0|||
129010548|NCT00950807|464331084|FG009|Treatment Period 1|Protocol Violation|0|||
129010549|NCT00950807|464331075|FG000|Treatment Period 1|Lost to Follow-up|0|||
129010550|NCT00950807|464331076|FG001|Treatment Period 1|Lost to Follow-up|0|||
129010551|NCT00950807|464331077|FG002|Treatment Period 1|Lost to Follow-up|1|||
129010552|NCT00950807|464331078|FG003|Treatment Period 1|Lost to Follow-up|0|||
129010553|NCT00950807|464331079|FG004|Treatment Period 1|Lost to Follow-up|0|||
129010554|NCT00950807|464331080|FG005|Treatment Period 1|Lost to Follow-up|0|||
129010555|NCT00950807|464331081|FG006|Treatment Period 1|Lost to Follow-up|0|||
129010556|NCT00950807|464331082|FG007|Treatment Period 1|Lost to Follow-up|0|||
129010557|NCT00950807|464331083|FG008|Treatment Period 1|Lost to Follow-up|0|||
129010558|NCT00950807|464331084|FG009|Treatment Period 1|Lost to Follow-up|0|||
129010559|NCT00950807|464331075|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129010560|NCT00950807|464331076|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129010561|NCT00950807|464331077|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129010562|NCT00950807|464331078|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129010563|NCT00950807|464331079|FG004|Treatment Period 1|Withdrawal by Subject|1|||
129010564|NCT00950807|464331080|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129010565|NCT00950807|464331081|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129010566|NCT00950807|464331082|FG007|Treatment Period 1|Withdrawal by Subject|0|||
129010567|NCT00950807|464331083|FG008|Treatment Period 1|Withdrawal by Subject|1|||
129100146|NCT01153009|464660930|FG003|Overall Study|Noncompliance with Study Medication|1|||
129100147|NCT01153009|464660927|FG000|Overall Study|Protocol Deviations|4|||
129100148|NCT01153009|464660928|FG001|Overall Study|Protocol Deviations|3|||
129100149|NCT01153009|464660929|FG002|Overall Study|Protocol Deviations|3|||
129100150|NCT01153009|464660930|FG003|Overall Study|Protocol Deviations|2|||
129100151|NCT01153009|464660927|FG000|Overall Study|Withdrawal of Consent|5|||
129100152|NCT01153009|464660928|FG001|Overall Study|Withdrawal of Consent|5|||
129100153|NCT01153009|464660929|FG002|Overall Study|Withdrawal of Consent|4|||
129100154|NCT01153009|464660930|FG003|Overall Study|Withdrawal of Consent|6|||
129100155|NCT01153009|464660927|FG000|Overall Study|Lost to Follow-up|8|||
129100156|NCT01153009|464660928|FG001|Overall Study|Lost to Follow-up|8|||
129100157|NCT01153009|464660929|FG002|Overall Study|Lost to Follow-up|11|||
129100158|NCT01153009|464660930|FG003|Overall Study|Lost to Follow-up|15|||
129100159|NCT01153009|464660927|FG000|Overall Study|Other|1|||
129100160|NCT01153009|464660928|FG001|Overall Study|Other|1|||
129100161|NCT01153009|464660929|FG002|Overall Study|Other|3|||
129100162|NCT01153009|464660930|FG003|Overall Study|Other|2|||
129100163|NCT04494425|464660931|FG000|Overall Study|Death|160|||
128676479|NCT02946931|463114481|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
128676480|NCT03339297|463114482|FG000|Overall Study|Relapse of Hematologic Disease|1|||
128676481|NCT03339297|463114483|FG001|Overall Study|Relapse of Hematologic Disease|0|||
128676482|NCT03339297|463114482|FG000|Overall Study|Death|10|||
128676483|NCT03339297|463114483|FG001|Overall Study|Death|7|||
128676484|NCT03339297|463114482|FG000|Overall Study|Hepatic Candidosis|1|||
128676485|NCT03339297|463114483|FG001|Overall Study|Hepatic Candidosis|0|||
128676486|NCT03339297|463114482|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
128676487|NCT03339297|463114483|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
128676488|NCT03339297|463114482|FG000|Overall Study|Consent Withdrawn by Participant|3|||
128676489|NCT03339297|463114483|FG001|Overall Study|Consent Withdrawn by Participant|3|||
128676490|NCT03339297|463114482|FG000|Overall Study|Disease Relapse|2|||
128676491|NCT03339297|463114483|FG001|Overall Study|Disease Relapse|0|||
128676492|NCT03339297|463114482|FG000|Overall Study|Physician Decision|1|||
128676493|NCT03339297|463114483|FG001|Overall Study|Physician Decision|1|||
129100164|NCT04494425|464660932|FG001|Overall Study|Death|166|||
129100165|NCT04494425|464660931|FG000|Overall Study|Withdrawal by Subject|10|||
129100166|NCT04494425|464660932|FG001|Overall Study|Withdrawal by Subject|40|||
129100167|NCT04494425|464660931|FG000|Overall Study|Other|1|||
129100168|NCT04494425|464660932|FG001|Overall Study|Other|1|||
129100169|NCT04494425|464660931|FG000|Overall Study|Ongoing at the time of PCD|265|||
129100170|NCT04494425|464660932|FG001|Overall Study|Ongoing at the time of PCD|223|||
129100171|NCT04003623|464660937|FG000|Overall Study|Withdrawal by Subject|1|||
129100172|NCT04003623|464660938|FG001|Overall Study|Withdrawal by Subject|0|||
129100173|NCT00703326|464660940|FG000|Overall Study|Lost to Follow-up|47|||
129100174|NCT00703326|464660941|FG001|Overall Study|Lost to Follow-up|18|||
129100175|NCT00703326|464660940|FG000|Overall Study|Withdrawal by Subject|54|||
129100176|NCT00703326|464660941|FG001|Overall Study|Withdrawal by Subject|20|||
129100177|NCT00703326|464660940|FG000|Overall Study|Adverse Event|1|||
129100178|NCT00703326|464660941|FG001|Overall Study|Adverse Event|0|||
129100179|NCT01744483|464660945|FG000|Overall Study|Death|9|||
128676494|NCT03339297|463114482|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
128676495|NCT03339297|463114483|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
128676496|NCT03339297|463114482|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
128676497|NCT03339297|463114483|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
128676498|NCT03339297|463114482|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
128676499|NCT03339297|463114483|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
128676500|NCT03339297|463114482|FG000|Overall Study|Adverse Event, Non-fatal|1|||
128676501|NCT03339297|463114483|FG001|Overall Study|Adverse Event, Non-fatal|0|||
129100180|NCT01744483|464660946|FG001|Overall Study|Death|4|||
129100181|NCT01744483|464660947|FG002|Overall Study|Death|11|||
128676502|NCT03339297|463114482|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
128676503|NCT03339297|463114483|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
128676504|NCT03339297|463114482|FG000|Overall Study|Patient Was Not Eligible|1|||
128676505|NCT03339297|463114483|FG001|Overall Study|Patient Was Not Eligible|0|||
128676506|NCT02213133|463114487|FG000|Overall Study|Participant discontinued study therapy|2|||
129100182|NCT01744483|464660945|FG000|Overall Study|Lost to Follow-up|8|||
129100183|NCT01744483|464660946|FG001|Overall Study|Lost to Follow-up|9|||
128676507|NCT02213133|463114488|FG001|Overall Study|Participant discontinued study therapy|0|||
128676508|NCT02213133|463114489|FG002|Overall Study|Participant discontinued study therapy|0|||
129100184|NCT01744483|464660947|FG002|Overall Study|Lost to Follow-up|11|||
129100185|NCT01744483|464660945|FG000|Overall Study|Protocol Violation|1|||
129100186|NCT01744483|464660946|FG001|Overall Study|Protocol Violation|2|||
129100187|NCT01744483|464660947|FG002|Overall Study|Protocol Violation|1|||
129100188|NCT01744483|464660945|FG000|Overall Study|Withdrawal by Subject|4|||
129100189|NCT01744483|464660946|FG001|Overall Study|Withdrawal by Subject|6|||
129100190|NCT01744483|464660947|FG002|Overall Study|Withdrawal by Subject|2|||
129100191|NCT01744483|464660945|FG000|Overall Study|No ICU Admit|5|||
128676509|NCT02213133|463114487|FG000|Overall Study|Participant withdrew informed consent|2|||
128676510|NCT02213133|463114488|FG001|Overall Study|Participant withdrew informed consent|1|||
128676511|NCT02213133|463114489|FG002|Overall Study|Participant withdrew informed consent|2|||
128676512|NCT02213133|463114487|FG000|Overall Study|Disease progression|11|||
128676513|NCT02213133|463114488|FG001|Overall Study|Disease progression|2|||
128676514|NCT02213133|463114489|FG002|Overall Study|Disease progression|0|||
128676515|NCT02213133|463114487|FG000|Overall Study|Adverse Event (AE)|1|||
128676516|NCT02213133|463114488|FG001|Overall Study|Adverse Event (AE)|0|||
128676517|NCT02213133|463114489|FG002|Overall Study|Adverse Event (AE)|0|||
128676518|NCT02213133|463114487|FG000|Overall Study|Death|16|||
128676519|NCT02213133|463114488|FG001|Overall Study|Death|2|||
128676520|NCT02213133|463114489|FG002|Overall Study|Death|1|||
128676521|NCT02213133|463114487|FG000|Overall Study|Other|5|||
128676522|NCT02213133|463114488|FG001|Overall Study|Other|0|||
128676523|NCT02213133|463114489|FG002|Overall Study|Other|0|||
128676524|NCT01119937|463114494|FG000|Overall Study|Adverse Event|11|||
128676525|NCT01119937|463114495|FG001|Overall Study|Adverse Event|5|||
128676526|NCT01119937|463114494|FG000|Overall Study|Protocol deviation|3|||
128676527|NCT01119937|463114495|FG001|Overall Study|Protocol deviation|1|||
128676528|NCT01119937|463114494|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
128676529|NCT01119937|463114495|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128676530|NCT01119937|463114494|FG000|Overall Study|Withdrawal by Subject|2|||
128676531|NCT01119937|463114495|FG001|Overall Study|Withdrawal by Subject|1|||
128676532|NCT03316911|463114496|FG000|Overall Study|Lost to Follow-up|33|||
129100192|NCT01744483|464660946|FG001|Overall Study|No ICU Admit|1|||
129100193|NCT01744483|464660947|FG002|Overall Study|No ICU Admit|2|||
129100194|NCT01744483|464660945|FG000|Overall Study|Routed to OSH|2|||
129100195|NCT01744483|464660946|FG001|Overall Study|Routed to OSH|0|||
129100196|NCT01744483|464660947|FG002|Overall Study|Routed to OSH|1|||
128676533|NCT03316911|463114497|FG001|Overall Study|Lost to Follow-up|29|||
128676534|NCT02536404|463114502|FG000|Overall Study|Adverse Event|5|||
128676535|NCT02536404|463114503|FG001|Overall Study|Adverse Event|0|||
129100197|NCT01190189|464660948|FG000|Overall Study|Lost to Follow-up|4|||
129100198|NCT01190189|464660948|FG000|Overall Study|Withdrawal by Subject|1|||
129100199|NCT01190189|464660948|FG000|Overall Study|Migrated/moved from study area|1|||
129100200|NCT03214679|464660950|FG000|Overall Study|Lost to Follow-up|12|||
129100201|NCT03214679|464660951|FG001|Overall Study|Lost to Follow-up|14|||
129100202|NCT03214679|464660950|FG000|Overall Study|not eligible|2|||
129100203|NCT03214679|464660951|FG001|Overall Study|not eligible|0|||
129100204|NCT01754766|464660957|FG000|Overall Study|Personal reasons|1|||
129100205|NCT01754766|464660958|FG001|Overall Study|Personal reasons|1|||
129100206|NCT01754766|464660959|FG002|Overall Study|Personal reasons|0|||
129100207|NCT01709409|464660962|FG000|Overall Study|Protocol Violation|1|||
129100208|NCT01709409|464660963|FG001|Overall Study|Protocol Violation|0|||
129100209|NCT02412878|464660964|FG000|Overall Study|Withdrawal by Subject|19|||
129100210|NCT02412878|464660965|FG001|Overall Study|Withdrawal by Subject|10|||
129100211|NCT02412878|464660964|FG000|Overall Study|Lost to Follow-up|2|||
129100212|NCT02412878|464660965|FG001|Overall Study|Lost to Follow-up|3|||
129100213|NCT04571385|464660966|FG000|Overall Study|Participant non-compliance|1|||
129100214|NCT04571385|464660967|FG001|Overall Study|Participant non-compliance|0|||
129100215|NCT04571385|464660968|FG002|Overall Study|Participant non-compliance|0|||
129100216|NCT04571385|464660966|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
129100217|NCT04571385|464660967|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
129100218|NCT04571385|464660968|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
129100219|NCT04571385|464660966|FG000|Overall Study|Screen failure|0|||
129100220|NCT04571385|464660967|FG001|Overall Study|Screen failure|0|||
129100221|NCT04571385|464660968|FG002|Overall Study|Screen failure|1|||
129100222|NCT02263729|464660969|FG000|Overall Study|Lost to Follow-up|1|||
129100223|NCT02263729|464660970|FG001|Overall Study|Lost to Follow-up|1|||
128676536|NCT02536404|463114502|FG000|Overall Study|Withdrawal by Subject|4|||
128676537|NCT02536404|463114503|FG001|Overall Study|Withdrawal by Subject|1|||
128676538|NCT02536404|463114502|FG000|Overall Study|Physician Decision|10|||
128676539|NCT02536404|463114503|FG001|Overall Study|Physician Decision|0|||
128676540|NCT02536404|463114502|FG000|Overall Study|Sponsor decision|1|||
128676541|NCT02536404|463114503|FG001|Overall Study|Sponsor decision|0|||
129100224|NCT01212159|464660971|FG000|Overall Study|Withdrawal by Subject|12|||
129100225|NCT01212159|464660972|FG001|Overall Study|Withdrawal by Subject|12|||
129100226|NCT01306214|464660973|FG000|Overall Study|Death|0|||
129100227|NCT01306214|464660974|FG001|Overall Study|Death|0|||
129100228|NCT01306214|464660975|FG002|Overall Study|Death|1|||
128676542|NCT00770146|463114504|FG000|Treatment Period|Withdrawal by Subject|6|||
128676543|NCT00770146|463114505|FG001|Treatment Period|Withdrawal by Subject|13|||
128676544|NCT00770146|463114504|FG000|Treatment Period|Adverse Event|2|||
128676545|NCT00770146|463114505|FG001|Treatment Period|Adverse Event|26|||
128676546|NCT00770146|463114504|FG000|Treatment Period|Other|1|||
129100229|NCT01306214|464660973|FG000|Overall Study|Lost to Follow-up|3|||
129100230|NCT01306214|464660974|FG001|Overall Study|Lost to Follow-up|5|||
129100231|NCT01306214|464660975|FG002|Overall Study|Lost to Follow-up|4|||
129100232|NCT01306214|464660973|FG000|Overall Study|Withdrawal by Subject|24|||
128676547|NCT00770146|463114505|FG001|Treatment Period|Other|5|||
128676548|NCT00770146|463114504|FG000|Treatment Period|Protocol non-compliance|0|||
128676549|NCT00770146|463114505|FG001|Treatment Period|Protocol non-compliance|1|||
128676550|NCT00770146|463114504|FG000|Follow-up Period|Withdrawal by Subject|7|||
128676551|NCT00770146|463114505|FG001|Follow-up Period|Withdrawal by Subject|13|||
128676552|NCT00770146|463114504|FG000|Follow-up Period|Adverse Event|0|||
128676553|NCT00770146|463114505|FG001|Follow-up Period|Adverse Event|2|||
128676554|NCT00770146|463114504|FG000|Follow-up Period|Other|4|||
129100233|NCT01306214|464660974|FG001|Overall Study|Withdrawal by Subject|22|||
129100234|NCT01306214|464660975|FG002|Overall Study|Withdrawal by Subject|16|||
129100235|NCT01306214|464660973|FG000|Overall Study|Not treated|1|||
129100236|NCT01306214|464660974|FG001|Overall Study|Not treated|1|||
129100237|NCT01306214|464660975|FG002|Overall Study|Not treated|1|||
129100238|NCT03959488|464660976|FG000|Season 1|Other|6|||
129100239|NCT03959488|464660977|FG001|Season 1|Other|7|||
129100240|NCT03959488|464660978|FG002|Season 1|Other|0|||
129100241|NCT03959488|464660979|FG003|Season 1|Other|0|||
129100242|NCT03959488|464660980|FG004|Season 1|Other|0|||
129100243|NCT03959488|464660976|FG000|Season 1|Withdrawal by parent/guardian|43|||
129100244|NCT03959488|464660977|FG001|Season 1|Withdrawal by parent/guardian|28|||
129100245|NCT03959488|464660978|FG002|Season 1|Withdrawal by parent/guardian|0|||
129100246|NCT03959488|464660979|FG003|Season 1|Withdrawal by parent/guardian|0|||
129100247|NCT03959488|464660980|FG004|Season 1|Withdrawal by parent/guardian|0|||
129100248|NCT03959488|464660976|FG000|Season 1|Due to COVID-19 pandemic|2|||
129100249|NCT03959488|464660977|FG001|Season 1|Due to COVID-19 pandemic|3|||
129100250|NCT03959488|464660978|FG002|Season 1|Due to COVID-19 pandemic|0|||
129100251|NCT03959488|464660979|FG003|Season 1|Due to COVID-19 pandemic|0|||
129100252|NCT03959488|464660980|FG004|Season 1|Due to COVID-19 pandemic|0|||
129100253|NCT03959488|464660976|FG000|Season 1|Lost to Follow-up|17|||
129100254|NCT03959488|464660977|FG001|Season 1|Lost to Follow-up|7|||
129100255|NCT03959488|464660978|FG002|Season 1|Lost to Follow-up|0|||
129100256|NCT03959488|464660979|FG003|Season 1|Lost to Follow-up|0|||
129100257|NCT03959488|464660980|FG004|Season 1|Lost to Follow-up|0|||
129100258|NCT03959488|464660976|FG000|Season 1|Death|5|||
129100259|NCT03959488|464660977|FG001|Season 1|Death|1|||
129100260|NCT03959488|464660978|FG002|Season 1|Death|0|||
129100261|NCT03959488|464660979|FG003|Season 1|Death|0|||
129100262|NCT03959488|464660980|FG004|Season 1|Death|0|||
129100263|NCT03959488|464660976|FG000|Season 2|Other|0|||
129100264|NCT03959488|464660977|FG001|Season 2|Other|0|||
129100265|NCT03959488|464660978|FG002|Season 2|Other|2|||
129100266|NCT03959488|464660979|FG003|Season 2|Other|0|||
129100267|NCT03959488|464660980|FG004|Season 2|Other|0|||
129100268|NCT03959488|464660976|FG000|Season 2|Withdrawal by parent/guardian|0|||
129100269|NCT03959488|464660977|FG001|Season 2|Withdrawal by parent/guardian|0|||
129100270|NCT03959488|464660978|FG002|Season 2|Withdrawal by parent/guardian|3|||
129100271|NCT03959488|464660979|FG003|Season 2|Withdrawal by parent/guardian|1|||
129100272|NCT03959488|464660980|FG004|Season 2|Withdrawal by parent/guardian|1|||
129100273|NCT03959488|464660976|FG000|Season 2|Lost to Follow-up|0|||
129100274|NCT03959488|464660977|FG001|Season 2|Lost to Follow-up|0|||
129100275|NCT03959488|464660978|FG002|Season 2|Lost to Follow-up|1|||
129100276|NCT03959488|464660979|FG003|Season 2|Lost to Follow-up|0|||
129100277|NCT03959488|464660980|FG004|Season 2|Lost to Follow-up|1|||
129100278|NCT01026818|464660981|FG000|Screening Period|Entry Criteria Not Met|105|||
129100279|NCT01026818|464660982|FG001|Screening Period|Entry Criteria Not Met|0|||
129100280|NCT01026818|464660983|FG002|Screening Period|Entry Criteria Not Met|0|||
129100281|NCT01026818|464660984|FG003|Screening Period|Entry Criteria Not Met|0|||
129100282|NCT01026818|464660981|FG000|Screening Period|Withdrawal by Subject|49|||
129100283|NCT01026818|464660982|FG001|Screening Period|Withdrawal by Subject|0|||
129100284|NCT01026818|464660983|FG002|Screening Period|Withdrawal by Subject|0|||
129100285|NCT01026818|464660984|FG003|Screening Period|Withdrawal by Subject|0|||
129100286|NCT01026818|464660981|FG000|Screening Period|Protocol Deviation|3|||
129100287|NCT01026818|464660982|FG001|Screening Period|Protocol Deviation|0|||
128676555|NCT00770146|463114505|FG001|Follow-up Period|Other|5|||
128676556|NCT00816023|463114509|FG000|Overall Study|Lost to Follow-up|1|||
128676557|NCT00816023|463114510|FG001|Overall Study|Lost to Follow-up|1|||
128676558|NCT00816023|463114511|FG002|Overall Study|Lost to Follow-up|0|||
129100288|NCT01026818|464660983|FG002|Screening Period|Protocol Deviation|0|||
129100289|NCT01026818|464660984|FG003|Screening Period|Protocol Deviation|0|||
129100290|NCT01026818|464660981|FG000|Screening Period|Adverse Event|2|||
129100291|NCT01026818|464660982|FG001|Screening Period|Adverse Event|0|||
129100292|NCT01026818|464660983|FG002|Screening Period|Adverse Event|0|||
129100293|NCT01026818|464660984|FG003|Screening Period|Adverse Event|0|||
129100294|NCT01026818|464660981|FG000|Screening Period|Physician Decision|1|||
129100295|NCT01026818|464660982|FG001|Screening Period|Physician Decision|0|||
129100296|NCT01026818|464660983|FG002|Screening Period|Physician Decision|0|||
128676559|NCT00816023|463114512|FG003|Overall Study|Lost to Follow-up|0|||
128676560|NCT00816023|463114509|FG000|Overall Study|Withdrawal by Subject|1|||
128676561|NCT00816023|463114510|FG001|Overall Study|Withdrawal by Subject|0|||
129100297|NCT01026818|464660984|FG003|Screening Period|Physician Decision|0|||
129100298|NCT01026818|464660981|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
129100299|NCT01026818|464660982|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
129100300|NCT01026818|464660983|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
128676562|NCT00816023|463114511|FG002|Overall Study|Withdrawal by Subject|0|||
128676563|NCT00816023|463114512|FG003|Overall Study|Withdrawal by Subject|0|||
128676564|NCT00816023|463114509|FG000|Overall Study|Physician Decision|0|||
128676565|NCT00816023|463114510|FG001|Overall Study|Physician Decision|0|||
129100301|NCT01026818|464660984|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
129100302|NCT01026818|464660981|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
129100303|NCT01026818|464660982|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
128676566|NCT00816023|463114511|FG002|Overall Study|Physician Decision|1|||
128676567|NCT00816023|463114512|FG003|Overall Study|Physician Decision|0|||
128676568|NCT00816023|463114509|FG000|Overall Study|assessments complete prior to window|1|||
128676569|NCT00816023|463114510|FG001|Overall Study|assessments complete prior to window|1|||
128676570|NCT00816023|463114511|FG002|Overall Study|assessments complete prior to window|2|||
128676571|NCT00816023|463114512|FG003|Overall Study|assessments complete prior to window|1|||
128676572|NCT00816023|463114509|FG000|Overall Study|Randomized Not Treated|6|||
128676573|NCT00816023|463114510|FG001|Overall Study|Randomized Not Treated|4|||
128676574|NCT00816023|463114511|FG002|Overall Study|Randomized Not Treated|6|||
128676575|NCT00816023|463114512|FG003|Overall Study|Randomized Not Treated|11|||
128676576|NCT00636363|463114513|FG000|Overall Study|Conjunctivitis|0|||
128676577|NCT00636363|463114514|FG001|Overall Study|Conjunctivitis|0|||
128676578|NCT00636363|463114515|FG002|Overall Study|Conjunctivitis|1|||
129100304|NCT01026818|464660983|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
129100305|NCT01026818|464660984|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
129100306|NCT01026818|464660981|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
129100307|NCT01026818|464660982|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
129100308|NCT01026818|464660983|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
129100309|NCT01026818|464660984|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
129100310|NCT01026818|464660981|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
129100311|NCT01026818|464660982|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
129100312|NCT01026818|464660983|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
129100313|NCT01026818|464660984|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
129100314|NCT01026818|464660981|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
129100315|NCT01026818|464660982|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
129100316|NCT01026818|464660983|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
129100317|NCT01026818|464660984|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
129100318|NCT01026818|464660981|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
129100319|NCT01026818|464660982|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
129100320|NCT01026818|464660983|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
129100321|NCT01026818|464660984|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
129100322|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
129100323|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
129100324|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
129100325|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
129100326|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
129100327|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
129100328|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
129100329|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
129100330|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
129100331|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
129100332|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
129100333|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
129100334|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
129100335|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
129100336|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
129100337|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
129100338|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
129100339|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
129100340|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
129100341|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
129100342|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
129100343|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
129100344|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
128676579|NCT00636363|463114513|FG000|Overall Study|Adverse Event|0|||
128676580|NCT00636363|463114514|FG001|Overall Study|Adverse Event|0|||
128676581|NCT00636363|463114515|FG002|Overall Study|Adverse Event|1|||
128676582|NCT00636363|463114513|FG000|Overall Study|Positive slit lamp finding|0|||
128676583|NCT00636363|463114514|FG001|Overall Study|Positive slit lamp finding|2|||
128676584|NCT00636363|463114515|FG002|Overall Study|Positive slit lamp finding|1|||
128676585|NCT00636363|463114513|FG000|Overall Study|Study related symptoms/complaints|8|||
128676586|NCT00636363|463114514|FG001|Overall Study|Study related symptoms/complaints|7|||
128676587|NCT00636363|463114515|FG002|Overall Study|Study related symptoms/complaints|4|||
128676588|NCT00636363|463114513|FG000|Overall Study|Met ineligibility criteria|0|||
128676589|NCT00636363|463114514|FG001|Overall Study|Met ineligibility criteria|0|||
128676590|NCT00636363|463114515|FG002|Overall Study|Met ineligibility criteria|3|||
128676591|NCT00636363|463114513|FG000|Overall Study|Missed > 1 visit|0|||
128676592|NCT00636363|463114514|FG001|Overall Study|Missed > 1 visit|1|||
128676593|NCT00636363|463114515|FG002|Overall Study|Missed > 1 visit|3|||
128676594|NCT00636363|463114513|FG000|Overall Study|Lack of motivation|1|||
128676595|NCT00636363|463114514|FG001|Overall Study|Lack of motivation|0|||
128676596|NCT00636363|463114515|FG002|Overall Study|Lack of motivation|1|||
128676597|NCT00636363|463114513|FG000|Overall Study|Protocol Violation|0|||
128676598|NCT00636363|463114514|FG001|Overall Study|Protocol Violation|3|||
128676599|NCT00636363|463114515|FG002|Overall Study|Protocol Violation|0|||
128676600|NCT00636363|463114513|FG000|Overall Study|Lost to Follow-up|3|||
128676601|NCT00636363|463114514|FG001|Overall Study|Lost to Follow-up|4|||
128676602|NCT00636363|463114515|FG002|Overall Study|Lost to Follow-up|2|||
128676603|NCT00636363|463114513|FG000|Overall Study|Withdrawal by Subject|1|||
128676604|NCT00636363|463114514|FG001|Overall Study|Withdrawal by Subject|3|||
128676605|NCT00636363|463114515|FG002|Overall Study|Withdrawal by Subject|2|||
128676606|NCT00796991|463114516|FG000|Overall Study|Adverse Event|0|||
128676607|NCT00796991|463114517|FG001|Overall Study|Adverse Event|0|||
128676608|NCT00796991|463114518|FG002|Overall Study|Adverse Event|1|||
128676609|NCT00796991|463114516|FG000|Overall Study|Death|2|||
128676610|NCT00796991|463114517|FG001|Overall Study|Death|0|||
128676611|NCT00796991|463114518|FG002|Overall Study|Death|0|||
128676612|NCT00796991|463114516|FG000|Overall Study|Disease Progression|10|||
128676613|NCT00796991|463114517|FG001|Overall Study|Disease Progression|9|||
128676614|NCT00796991|463114518|FG002|Overall Study|Disease Progression|7|||
128676615|NCT00796991|463114516|FG000|Overall Study|Study Drug Toxicity|3|||
128676616|NCT00796991|463114517|FG001|Overall Study|Study Drug Toxicity|3|||
128676617|NCT00796991|463114518|FG002|Overall Study|Study Drug Toxicity|5|||
128676618|NCT00796991|463114516|FG000|Overall Study|Withdrawal by Subject|0|||
128676619|NCT00796991|463114517|FG001|Overall Study|Withdrawal by Subject|0|||
128676620|NCT00796991|463114518|FG002|Overall Study|Withdrawal by Subject|1|||
128676621|NCT03007888|463114521|FG000|First Intervention (14 Days)|Adverse Event|1|||
128676622|NCT03007888|463114522|FG001|First Intervention (14 Days)|Adverse Event|0|||
128676623|NCT00043550|463114525|FG000|Overall Study|Withdrawal by Subject|22|||
128676624|NCT00043550|463114526|FG001|Overall Study|Withdrawal by Subject|12|||
128676625|NCT00043550|463114527|FG002|Overall Study|Withdrawal by Subject|20|||
128676626|NCT00827931|463114528|FG000|Overall Study|Death|3|||
128676627|NCT00827931|463114529|FG001|Overall Study|Death|5|||
128676628|NCT00827931|463114528|FG000|Overall Study|Adverse Event|1|||
128676629|NCT00827931|463114529|FG001|Overall Study|Adverse Event|0|||
128676630|NCT00827931|463114528|FG000|Overall Study|Lost to Follow-up|1|||
128676631|NCT00827931|463114529|FG001|Overall Study|Lost to Follow-up|0|||
128676632|NCT00827931|463114528|FG000|Overall Study|Withdrawal by Subject|0|||
128676633|NCT00827931|463114529|FG001|Overall Study|Withdrawal by Subject|1|||
128676634|NCT00827931|463114528|FG000|Overall Study|Other|1|||
128676635|NCT00827931|463114529|FG001|Overall Study|Other|0|||
128676636|NCT02081859|463114530|FG000|Overall Study|No fertilization|2|||
128676637|NCT02081859|463114531|FG001|Overall Study|No fertilization|2|||
128676638|NCT02081859|463114530|FG000|Overall Study|No sperm|1|||
128676639|NCT02081859|463114531|FG001|Overall Study|No sperm|0|||
128676640|NCT02081859|463114530|FG000|Overall Study|Unanticipated freeze all cycle|2|||
128676641|NCT02081859|463114531|FG001|Overall Study|Unanticipated freeze all cycle|6|||
128676642|NCT02081859|463114530|FG000|Overall Study|< 4 embryos|27|||
129010568|NCT00950807|464331084|FG009|Treatment Period 1|Withdrawal by Subject|0|||
129010569|NCT00950807|464331075|FG000|Treatment Period 1|Adverse Event|0|||
129010570|NCT00950807|464331076|FG001|Treatment Period 1|Adverse Event|0|||
129010571|NCT00950807|464331077|FG002|Treatment Period 1|Adverse Event|0|||
128676643|NCT02081859|463114531|FG001|Overall Study|< 4 embryos|23|||
128676644|NCT02081859|463114530|FG000|Overall Study|Other reasons|2|||
128676645|NCT02081859|463114531|FG001|Overall Study|Other reasons|0|||
128676646|NCT02015221|463114532|FG000|Overall Study|Withdrawal by Subject|8|||
128676647|NCT02015221|463114533|FG001|Overall Study|Withdrawal by Subject|6|||
128676648|NCT02015221|463114532|FG000|Overall Study|Lost to Follow-up|1|||
129010572|NCT00950807|464331078|FG003|Treatment Period 1|Adverse Event|0|||
128676649|NCT02015221|463114533|FG001|Overall Study|Lost to Follow-up|0|||
128676650|NCT00995566|463114534|FG000|Overall Study|Adverse Event|2|||
128676651|NCT00995566|463114534|FG000|Overall Study|Early study termination|52|||
128676652|NCT01870076|463114535|FG000|Overall Study|Withdrawal by Subject|1|||
128676653|NCT01870076|463114536|FG001|Overall Study|Withdrawal by Subject|0|||
128676654|NCT01870076|463114537|FG002|Overall Study|Withdrawal by Subject|1|||
128676655|NCT01870076|463114538|FG003|Overall Study|Withdrawal by Subject|0|||
129010573|NCT00950807|464331079|FG004|Treatment Period 1|Adverse Event|0|||
128676656|NCT00492063|463114545|FG000|Overall Study|Death|0|||
129100345|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
129100346|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
129100347|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
129100348|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
129100349|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
129100350|NCT01026818|464660981|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
129100351|NCT01026818|464660982|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
129100352|NCT01026818|464660983|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
129100353|NCT01026818|464660984|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
129100354|NCT01026818|464660981|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
129100355|NCT01026818|464660982|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
129100356|NCT01026818|464660983|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
129100357|NCT01026818|464660984|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
129100358|NCT01026818|464660981|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
129100359|NCT01026818|464660982|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
129100360|NCT01026818|464660983|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
129100361|NCT01026818|464660984|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
129100362|NCT01026818|464660981|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
129100363|NCT01026818|464660982|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
129100364|NCT01026818|464660983|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
129100365|NCT01026818|464660984|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
129100366|NCT01026818|464660981|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
129100367|NCT01026818|464660982|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
129100368|NCT01026818|464660983|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
129100369|NCT01026818|464660984|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
129100370|NCT01026818|464660981|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
129100371|NCT01026818|464660982|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
129100372|NCT01026818|464660983|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
129100373|NCT01026818|464660984|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
129100374|NCT01031004|464660985|FG000|Overall Study|Protocol Violation|0|||
129100375|NCT01031004|464660986|FG001|Overall Study|Protocol Violation|1|||
129100376|NCT01031004|464660985|FG000|Overall Study|Lost to Follow-up|1|||
129100377|NCT01031004|464660986|FG001|Overall Study|Lost to Follow-up|0|||
129100378|NCT01641471|464660987|FG000|Overall Study|Withdrawal by Subject|19|||
129100379|NCT01641471|464660988|FG001|Overall Study|Withdrawal by Subject|19|||
129100380|NCT01641471|464660987|FG000|Overall Study|Lost to Follow-up|2|||
129100381|NCT01641471|464660988|FG001|Overall Study|Lost to Follow-up|4|||
129100382|NCT01641471|464660987|FG000|Overall Study|Protocol Violation|2|||
129100383|NCT01641471|464660988|FG001|Overall Study|Protocol Violation|4|||
129100384|NCT04575584|464660992|FG000|Overall Study|Death|6|||
129100385|NCT04575584|464660993|FG001|Overall Study|Death|4|||
129100386|NCT04575584|464660994|FG002|Overall Study|Death|6|||
129100387|NCT04575584|464660995|FG003|Overall Study|Death|2|||
129100388|NCT04575584|464660996|FG004|Overall Study|Death|0|||
129100389|NCT04575584|464660997|FG005|Overall Study|Death|0|||
129100390|NCT04575584|464660992|FG000|Overall Study|Lost to Follow-up|1|||
129100391|NCT04575584|464660993|FG001|Overall Study|Lost to Follow-up|1|||
129100392|NCT04575584|464660994|FG002|Overall Study|Lost to Follow-up|1|||
129100393|NCT04575584|464660995|FG003|Overall Study|Lost to Follow-up|1|||
129100394|NCT04575584|464660996|FG004|Overall Study|Lost to Follow-up|0|||
129100395|NCT04575584|464660997|FG005|Overall Study|Lost to Follow-up|0|||
129100396|NCT04575584|464660992|FG000|Overall Study|Physician Decision|0|||
129100397|NCT04575584|464660993|FG001|Overall Study|Physician Decision|1|||
129100398|NCT04575584|464660994|FG002|Overall Study|Physician Decision|1|||
129100399|NCT04575584|464660995|FG003|Overall Study|Physician Decision|1|||
129100400|NCT04575584|464660996|FG004|Overall Study|Physician Decision|0|||
129100401|NCT04575584|464660997|FG005|Overall Study|Physician Decision|0|||
129100402|NCT04575584|464660992|FG000|Overall Study|Withdrawal by Subject|7|||
129100403|NCT04575584|464660993|FG001|Overall Study|Withdrawal by Subject|9|||
129100404|NCT04575584|464660994|FG002|Overall Study|Withdrawal by Subject|5|||
129100405|NCT04575584|464660995|FG003|Overall Study|Withdrawal by Subject|3|||
129100406|NCT04575584|464660996|FG004|Overall Study|Withdrawal by Subject|0|||
129100407|NCT04575584|464660997|FG005|Overall Study|Withdrawal by Subject|0|||
129100408|NCT04575584|464660992|FG000|Overall Study|Not recorded|0|||
129100409|NCT04575584|464660993|FG001|Overall Study|Not recorded|0|||
129100410|NCT04575584|464660994|FG002|Overall Study|Not recorded|0|||
129100411|NCT04575584|464660995|FG003|Overall Study|Not recorded|1|||
129100412|NCT04575584|464660996|FG004|Overall Study|Not recorded|0|||
129100413|NCT04575584|464660997|FG005|Overall Study|Not recorded|0|||
129100414|NCT03488563|464660998|FG000|Overall Study|Lost to Follow-up|7|||
129100415|NCT03488563|464660999|FG001|Overall Study|Lost to Follow-up|6|||
129100416|NCT03488563|464661000|FG002|Overall Study|Lost to Follow-up|7|||
129100417|NCT03488563|464660998|FG000|Overall Study|Withdrawal by Subject|8|||
129100418|NCT03488563|464660999|FG001|Overall Study|Withdrawal by Subject|7|||
128676657|NCT00492063|463114546|FG001|Overall Study|Death|0|||
129100419|NCT03488563|464661000|FG002|Overall Study|Withdrawal by Subject|7|||
129100420|NCT03488563|464660998|FG000|Overall Study|Physician Decision|0|||
129100421|NCT03488563|464660999|FG001|Overall Study|Physician Decision|0|||
129100422|NCT03488563|464661000|FG002|Overall Study|Physician Decision|1|||
129100423|NCT03488563|464660998|FG000|Overall Study|Protocol Violation|3|||
129100424|NCT03488563|464660999|FG001|Overall Study|Protocol Violation|2|||
129100425|NCT03488563|464661000|FG002|Overall Study|Protocol Violation|6|||
129100426|NCT03488563|464660998|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
129100427|NCT03488563|464660999|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
129100428|NCT03488563|464661000|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
129100429|NCT03488563|464660998|FG000|Overall Study|Use of prohibited medication|2|||
129100430|NCT03488563|464660999|FG001|Overall Study|Use of prohibited medication|0|||
129100431|NCT03488563|464661000|FG002|Overall Study|Use of prohibited medication|0|||
129100432|NCT03488563|464660998|FG000|Overall Study|Adverse Event|1|||
129100433|NCT03488563|464660999|FG001|Overall Study|Adverse Event|0|||
129100434|NCT03488563|464661000|FG002|Overall Study|Adverse Event|1|||
129100435|NCT03488563|464660998|FG000|Overall Study|Subject returned for ET visit|0|||
128878413|NCT01853644|463848478|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
129010574|NCT00950807|464331080|FG005|Treatment Period 1|Adverse Event|1|||
129010575|NCT00950807|464331081|FG006|Treatment Period 1|Adverse Event|0|||
129010576|NCT00950807|464331082|FG007|Treatment Period 1|Adverse Event|0|||
129010577|NCT00950807|464331083|FG008|Treatment Period 1|Adverse Event|0|||
129010578|NCT00950807|464331084|FG009|Treatment Period 1|Adverse Event|0|||
129010579|NCT00950807|464331075|FG000|Washout Period 1|Lack of Efficacy|0|||
129010580|NCT00950807|464331076|FG001|Washout Period 1|Lack of Efficacy|0|||
129010581|NCT00950807|464331077|FG002|Washout Period 1|Lack of Efficacy|0|||
129010582|NCT00950807|464331078|FG003|Washout Period 1|Lack of Efficacy|0|||
129010583|NCT00950807|464331079|FG004|Washout Period 1|Lack of Efficacy|0|||
129010584|NCT00950807|464331080|FG005|Washout Period 1|Lack of Efficacy|0|||
129010585|NCT00950807|464331081|FG006|Washout Period 1|Lack of Efficacy|1|||
129010586|NCT00950807|464331082|FG007|Washout Period 1|Lack of Efficacy|0|||
129010587|NCT00950807|464331083|FG008|Washout Period 1|Lack of Efficacy|0|||
129010588|NCT00950807|464331084|FG009|Washout Period 1|Lack of Efficacy|0|||
129010589|NCT00950807|464331075|FG000|Washout Period 1|Withdrawal by Subject|0|||
129010590|NCT00950807|464331076|FG001|Washout Period 1|Withdrawal by Subject|0|||
129010591|NCT00950807|464331077|FG002|Washout Period 1|Withdrawal by Subject|0|||
129010592|NCT00950807|464331078|FG003|Washout Period 1|Withdrawal by Subject|0|||
129010593|NCT00950807|464331079|FG004|Washout Period 1|Withdrawal by Subject|0|||
129010594|NCT00950807|464331080|FG005|Washout Period 1|Withdrawal by Subject|0|||
129010595|NCT00950807|464331081|FG006|Washout Period 1|Withdrawal by Subject|0|||
129010596|NCT00950807|464331082|FG007|Washout Period 1|Withdrawal by Subject|0|||
129010597|NCT00950807|464331083|FG008|Washout Period 1|Withdrawal by Subject|1|||
129010598|NCT00950807|464331084|FG009|Washout Period 1|Withdrawal by Subject|0|||
129010599|NCT00950807|464331075|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
129010600|NCT00950807|464331076|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129010601|NCT00950807|464331077|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129010602|NCT00950807|464331078|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129010603|NCT00950807|464331079|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129010604|NCT00950807|464331080|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129010605|NCT00950807|464331081|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
129010606|NCT00950807|464331082|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
129010607|NCT00950807|464331083|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129010608|NCT00950807|464331084|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129010609|NCT00950807|464331075|FG000|Washout Period 1|Adverse Event|2|||
129010610|NCT00950807|464331076|FG001|Washout Period 1|Adverse Event|0|||
129010611|NCT00950807|464331077|FG002|Washout Period 1|Adverse Event|0|||
129010612|NCT00950807|464331078|FG003|Washout Period 1|Adverse Event|1|||
129010613|NCT00950807|464331079|FG004|Washout Period 1|Adverse Event|1|||
129010614|NCT00950807|464331080|FG005|Washout Period 1|Adverse Event|0|||
129010615|NCT00950807|464331081|FG006|Washout Period 1|Adverse Event|0|||
129010616|NCT00950807|464331082|FG007|Washout Period 1|Adverse Event|0|||
129010617|NCT00950807|464331083|FG008|Washout Period 1|Adverse Event|0|||
129010618|NCT00950807|464331084|FG009|Washout Period 1|Adverse Event|0|||
129010619|NCT00950807|464331075|FG000|Treatment Period 2|Lack of Efficacy|1|||
129010620|NCT00950807|464331076|FG001|Treatment Period 2|Lack of Efficacy|0|||
129010621|NCT00950807|464331077|FG002|Treatment Period 2|Lack of Efficacy|0|||
129010622|NCT00950807|464331078|FG003|Treatment Period 2|Lack of Efficacy|0|||
129010623|NCT00950807|464331079|FG004|Treatment Period 2|Lack of Efficacy|0|||
129010624|NCT00950807|464331080|FG005|Treatment Period 2|Lack of Efficacy|0|||
129010625|NCT00950807|464331081|FG006|Treatment Period 2|Lack of Efficacy|0|||
129010626|NCT00950807|464331082|FG007|Treatment Period 2|Lack of Efficacy|0|||
129010627|NCT00950807|464331083|FG008|Treatment Period 2|Lack of Efficacy|0|||
129010628|NCT00950807|464331084|FG009|Treatment Period 2|Lack of Efficacy|0|||
129010629|NCT00950807|464331075|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129010630|NCT00950807|464331076|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129010631|NCT00950807|464331077|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129010632|NCT00950807|464331078|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129010633|NCT00950807|464331079|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129010634|NCT00950807|464331080|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129010635|NCT00950807|464331081|FG006|Treatment Period 2|Withdrawal by Subject|1|||
129010636|NCT00950807|464331082|FG007|Treatment Period 2|Withdrawal by Subject|2|||
129010637|NCT00950807|464331083|FG008|Treatment Period 2|Withdrawal by Subject|0|||
129010638|NCT00950807|464331084|FG009|Treatment Period 2|Withdrawal by Subject|0|||
129010639|NCT00950807|464331075|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
129010640|NCT00950807|464331076|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010641|NCT00950807|464331077|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010642|NCT00950807|464331078|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010643|NCT00950807|464331079|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010644|NCT00950807|464331080|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010645|NCT00950807|464331081|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010646|NCT00950807|464331082|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010647|NCT00950807|464331083|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010648|NCT00950807|464331084|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129010649|NCT00950807|464331075|FG000|Treatment Period 2|Adverse Event|0|||
129010650|NCT00950807|464331076|FG001|Treatment Period 2|Adverse Event|1|||
129010651|NCT00950807|464331077|FG002|Treatment Period 2|Adverse Event|0|||
129010652|NCT00950807|464331078|FG003|Treatment Period 2|Adverse Event|1|||
129010653|NCT00950807|464331079|FG004|Treatment Period 2|Adverse Event|0|||
129010654|NCT00950807|464331080|FG005|Treatment Period 2|Adverse Event|1|||
129010655|NCT00950807|464331081|FG006|Treatment Period 2|Adverse Event|0|||
129010656|NCT00950807|464331082|FG007|Treatment Period 2|Adverse Event|1|||
129010657|NCT00950807|464331083|FG008|Treatment Period 2|Adverse Event|0|||
129010658|NCT00950807|464331084|FG009|Treatment Period 2|Adverse Event|0|||
129010659|NCT00950807|464331075|FG000|Washout Period 2|Lack of Efficacy|1|||
129010660|NCT00950807|464331076|FG001|Washout Period 2|Lack of Efficacy|0|||
129010661|NCT00950807|464331077|FG002|Washout Period 2|Lack of Efficacy|0|||
129010662|NCT00950807|464331078|FG003|Washout Period 2|Lack of Efficacy|0|||
129010663|NCT00950807|464331079|FG004|Washout Period 2|Lack of Efficacy|0|||
129010664|NCT00950807|464331080|FG005|Washout Period 2|Lack of Efficacy|0|||
129010665|NCT00950807|464331081|FG006|Washout Period 2|Lack of Efficacy|0|||
129010666|NCT00950807|464331082|FG007|Washout Period 2|Lack of Efficacy|0|||
129010667|NCT00950807|464331083|FG008|Washout Period 2|Lack of Efficacy|0|||
129010668|NCT00950807|464331084|FG009|Washout Period 2|Lack of Efficacy|0|||
129010669|NCT00950807|464331075|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129010670|NCT00950807|464331076|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129010671|NCT00950807|464331077|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129010672|NCT00950807|464331078|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129010673|NCT00950807|464331079|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129010674|NCT00950807|464331080|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129010675|NCT00950807|464331081|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129010676|NCT00950807|464331082|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129010677|NCT00950807|464331083|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129010678|NCT00950807|464331084|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129010679|NCT00950807|464331075|FG000|Washout Period 2|Adverse Event|3|||
129010680|NCT00950807|464331076|FG001|Washout Period 2|Adverse Event|0|||
129010681|NCT00950807|464331077|FG002|Washout Period 2|Adverse Event|0|||
129010682|NCT00950807|464331078|FG003|Washout Period 2|Adverse Event|1|||
129010683|NCT00950807|464331079|FG004|Washout Period 2|Adverse Event|0|||
129010684|NCT00950807|464331080|FG005|Washout Period 2|Adverse Event|0|||
129010685|NCT00950807|464331081|FG006|Washout Period 2|Adverse Event|0|||
129010686|NCT00950807|464331082|FG007|Washout Period 2|Adverse Event|0|||
129010687|NCT00950807|464331083|FG008|Washout Period 2|Adverse Event|0|||
129010688|NCT00950807|464331084|FG009|Washout Period 2|Adverse Event|0|||
129010689|NCT00950807|464331075|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129010690|NCT00950807|464331076|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129010691|NCT00950807|464331077|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129010692|NCT00950807|464331078|FG003|Treatment Period 3|Withdrawal by Subject|0|||
129010693|NCT00950807|464331079|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129010694|NCT00950807|464331080|FG005|Treatment Period 3|Withdrawal by Subject|0|||
129010695|NCT00950807|464331081|FG006|Treatment Period 3|Withdrawal by Subject|0|||
129010696|NCT00950807|464331082|FG007|Treatment Period 3|Withdrawal by Subject|0|||
129100436|NCT03488563|464660999|FG001|Overall Study|Subject returned for ET visit|1|||
129010697|NCT00950807|464331083|FG008|Treatment Period 3|Withdrawal by Subject|0|||
129010698|NCT00950807|464331084|FG009|Treatment Period 3|Withdrawal by Subject|1|||
129010699|NCT00950807|464331075|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
129010700|NCT00950807|464331076|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129010701|NCT00950807|464331077|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129100437|NCT03488563|464661000|FG002|Overall Study|Subject returned for ET visit|0|||
129100438|NCT03488563|464660998|FG000|Overall Study|Sponsor's decision|0|||
129100439|NCT03488563|464660999|FG001|Overall Study|Sponsor's decision|0|||
129100440|NCT03488563|464661000|FG002|Overall Study|Sponsor's decision|1|||
129100441|NCT02769312|464661013|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
129100442|NCT02769312|464661014|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
129100443|NCT02769312|464661013|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
129100444|NCT02769312|464661014|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
129100445|NCT02769312|464661013|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
129100446|NCT02769312|464661014|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
129100447|NCT02769312|464661013|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
129100448|NCT02769312|464661014|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
129100449|NCT02769312|464661013|FG000|Follow-up|Lost to Follow-up|1|||
129100450|NCT02769312|464661014|FG001|Follow-up|Lost to Follow-up|1|||
129100451|NCT02815267|464661015|FG000|Double-Blind Phase|Adverse Event|0|||
129100452|NCT02815267|464661016|FG001|Double-Blind Phase|Adverse Event|3|||
129100453|NCT02815267|464661015|FG000|Double-Blind Phase|Lost to Follow-up|17|||
129100454|NCT02815267|464661016|FG001|Double-Blind Phase|Lost to Follow-up|9|||
129100455|NCT02815267|464661015|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
129100456|NCT02815267|464661016|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
129100457|NCT02815267|464661015|FG000|Double-Blind Phase|Protocol Violation|3|||
129100458|NCT02815267|464661016|FG001|Double-Blind Phase|Protocol Violation|2|||
129100459|NCT02815267|464661015|FG000|Double-Blind Phase|Site withdrawal|1|||
129100460|NCT02815267|464661016|FG001|Double-Blind Phase|Site withdrawal|6|||
129100461|NCT02815267|464661015|FG000|Double-Blind Phase|Received a disallowed medication|1|||
129100462|NCT02815267|464661016|FG001|Double-Blind Phase|Received a disallowed medication|1|||
129100463|NCT02815267|464661015|FG000|Open-Label Phase|Adverse Event|1|||
129100464|NCT02815267|464661016|FG001|Open-Label Phase|Adverse Event|1|||
129100465|NCT02815267|464661015|FG000|Open-Label Phase|Lost to Follow-up|23|||
129100466|NCT02815267|464661016|FG001|Open-Label Phase|Lost to Follow-up|9|||
129100467|NCT02815267|464661015|FG000|Open-Label Phase|Withdrawal by Subject|24|||
129100468|NCT02815267|464661016|FG001|Open-Label Phase|Withdrawal by Subject|13|||
129100469|NCT02815267|464661015|FG000|Open-Label Phase|Protocol Violation|0|||
129100470|NCT02815267|464661016|FG001|Open-Label Phase|Protocol Violation|1|||
129100471|NCT02815267|464661015|FG000|Open-Label Phase|Administrative|21|||
129100472|NCT02815267|464661016|FG001|Open-Label Phase|Administrative|12|||
129100473|NCT02815267|464661015|FG000|Open-Label Phase|Other|2|||
129100474|NCT02815267|464661016|FG001|Open-Label Phase|Other|5|||
129100475|NCT03594955|464661017|FG000|Overall Study|Adverse Event|1|||
129100476|NCT03594955|464661017|FG000|Overall Study|Progressive disease|5|||
129100477|NCT03594955|464661017|FG000|Overall Study|Sponsor's decision|1|||
129100478|NCT05600036|464661020|FG000|Overall Study|Adverse Event|0|||
129100479|NCT05600036|464661021|FG001|Overall Study|Adverse Event|2|||
129100480|NCT05600036|464661022|FG002|Overall Study|Adverse Event|1|||
129100481|NCT05600036|464661023|FG003|Overall Study|Adverse Event|0|||
129100482|NCT05600036|464661024|FG004|Overall Study|Adverse Event|1|||
129100483|NCT05600036|464661025|FG005|Overall Study|Adverse Event|0|||
129100484|NCT05600036|464661020|FG000|Overall Study|Lost to Follow-up|0|||
129100485|NCT05600036|464661021|FG001|Overall Study|Lost to Follow-up|2|||
129100486|NCT05600036|464661022|FG002|Overall Study|Lost to Follow-up|1|||
129100487|NCT05600036|464661023|FG003|Overall Study|Lost to Follow-up|1|||
129100488|NCT05600036|464661024|FG004|Overall Study|Lost to Follow-up|0|||
129100489|NCT05600036|464661025|FG005|Overall Study|Lost to Follow-up|0|||
129100490|NCT05600036|464661020|FG000|Overall Study|Protocol Violation|0|||
129100491|NCT05600036|464661021|FG001|Overall Study|Protocol Violation|0|||
129100492|NCT05600036|464661022|FG002|Overall Study|Protocol Violation|2|||
129100493|NCT05600036|464661023|FG003|Overall Study|Protocol Violation|0|||
129100494|NCT05600036|464661024|FG004|Overall Study|Protocol Violation|0|||
129100495|NCT05600036|464661025|FG005|Overall Study|Protocol Violation|0|||
129100496|NCT05600036|464661020|FG000|Overall Study|Withdrawal by Subject|0|||
129100497|NCT05600036|464661021|FG001|Overall Study|Withdrawal by Subject|1|||
129100498|NCT05600036|464661022|FG002|Overall Study|Withdrawal by Subject|2|||
129100499|NCT05600036|464661023|FG003|Overall Study|Withdrawal by Subject|0|||
129100500|NCT05600036|464661024|FG004|Overall Study|Withdrawal by Subject|3|||
129100501|NCT05600036|464661025|FG005|Overall Study|Withdrawal by Subject|5|||
129100502|NCT05600036|464661020|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129100503|NCT05600036|464661021|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129100504|NCT05600036|464661022|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129100505|NCT05600036|464661023|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
129100506|NCT05600036|464661024|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129100507|NCT05600036|464661025|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129100508|NCT05600036|464661020|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129100509|NCT05600036|464661021|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
129100510|NCT05600036|464661022|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129100511|NCT05600036|464661023|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129100512|NCT05600036|464661024|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129100513|NCT05600036|464661025|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129100514|NCT05600036|464661020|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129100515|NCT05600036|464661021|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129100516|NCT05600036|464661022|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129100517|NCT05600036|464661023|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
129100518|NCT05600036|464661024|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129100519|NCT05600036|464661025|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129100520|NCT02714036|464661026|FG000|Overall Study|Adverse Event|9|||
129100521|NCT02714036|464661027|FG001|Overall Study|Adverse Event|2|||
129100522|NCT02714036|464661026|FG000|Overall Study|Withdrawal by Subject|3|||
129100523|NCT02714036|464661027|FG001|Overall Study|Withdrawal by Subject|2|||
129100524|NCT01006590|464661028|FG000|Overall Study|Adverse Event|2|||
129100525|NCT01006590|464661029|FG001|Overall Study|Adverse Event|3|||
129100526|NCT01006590|464661028|FG000|Overall Study|Death|1|||
129100527|NCT01006590|464661029|FG001|Overall Study|Death|1|||
129100528|NCT01006590|464661028|FG000|Overall Study|Lost to Follow-up|1|||
129100529|NCT01006590|464661029|FG001|Overall Study|Lost to Follow-up|1|||
129100530|NCT01006590|464661028|FG000|Overall Study|Protocol Violation|1|||
129100531|NCT01006590|464661029|FG001|Overall Study|Protocol Violation|0|||
129100532|NCT01006590|464661028|FG000|Overall Study|Withdrawal by Subject|4|||
129100533|NCT01006590|464661029|FG001|Overall Study|Withdrawal by Subject|2|||
129100534|NCT01006590|464661028|FG000|Overall Study|Study specific discontinuation criteria|16|||
129100535|NCT01006590|464661029|FG001|Overall Study|Study specific discontinuation criteria|23|||
129100536|NCT01006590|464661028|FG000|Overall Study|Other|3|||
129100537|NCT01006590|464661029|FG001|Overall Study|Other|2|||
129100538|NCT03332095|464661030|FG000|Overall Study|Lost to Follow-up|1|||
129100539|NCT03332095|464661031|FG001|Overall Study|Lost to Follow-up|0|||
129100540|NCT03332095|464661030|FG000|Overall Study|Pregnancy|0|||
129100541|NCT03332095|464661031|FG001|Overall Study|Pregnancy|1|||
129100542|NCT00703118|464661032|FG000|Overall Study|Adverse Event|1|||
129100543|NCT00703118|464661033|FG001|Overall Study|Adverse Event|2|||
129100544|NCT00703118|464661034|FG002|Overall Study|Adverse Event|2|||
129100545|NCT00703118|464661032|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
129100546|NCT00703118|464661033|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
129100547|NCT00703118|464661034|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
129100548|NCT00703118|464661032|FG000|Overall Study|Lost to Follow-up|6|||
129100549|NCT00703118|464661033|FG001|Overall Study|Lost to Follow-up|4|||
129100550|NCT00703118|464661034|FG002|Overall Study|Lost to Follow-up|4|||
129100551|NCT00703118|464661032|FG000|Overall Study|Withdrawal by Subject|8|||
129100552|NCT00703118|464661033|FG001|Overall Study|Withdrawal by Subject|7|||
129100553|NCT00703118|464661034|FG002|Overall Study|Withdrawal by Subject|13|||
129100554|NCT00703118|464661032|FG000|Overall Study|Other|0|||
129100555|NCT00703118|464661033|FG001|Overall Study|Other|0|||
129100556|NCT00703118|464661034|FG002|Overall Study|Other|1|||
129100557|NCT00431067|464661035|FG000|Overall Study|Other Adverse Event|9|||
129100558|NCT00431067|464661035|FG000|Overall Study|Progressive disease|30|||
129100559|NCT00431067|464661035|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
129100560|NCT00830518|464661045|FG000|Overall Study|Progressive Disease|18|||
129100561|NCT00830518|464661046|FG001|Overall Study|Progressive Disease|8|||
129100562|NCT00830518|464661045|FG000|Overall Study|Symptomatic Deterioration|4|||
129100563|NCT00830518|464661046|FG001|Overall Study|Symptomatic Deterioration|1|||
129100564|NCT00830518|464661045|FG000|Overall Study|Adverse Event|14|||
129100565|NCT00830518|464661046|FG001|Overall Study|Adverse Event|1|||
129100566|NCT00830518|464661045|FG000|Overall Study|Withdrawal by Patient|2|||
129100567|NCT00830518|464661046|FG001|Overall Study|Withdrawal by Patient|0|||
129100568|NCT00830518|464661045|FG000|Overall Study|Reason not Specified|8|||
129100569|NCT00830518|464661046|FG001|Overall Study|Reason not Specified|1|||
129100570|NCT02155322|464661051|FG000|Overall Study|Adverse Event|1|||
129100571|NCT02155322|464661051|FG000|Overall Study|Physician Decision|1|||
128676658|NCT00492063|463114547|FG002|Overall Study|Death|1|||
128676659|NCT00492063|463114548|FG003|Overall Study|Death|2|||
128676660|NCT00492063|463114545|FG000|Overall Study|Withdrawal by Subject|4|||
128676661|NCT00492063|463114546|FG001|Overall Study|Withdrawal by Subject|3|||
129100572|NCT02155322|464661051|FG000|Overall Study|Relapse/Recurrence|8|||
129100573|NCT02155322|464661051|FG000|Overall Study|Withdrawal by Subject|4|||
128676662|NCT00492063|463114547|FG002|Overall Study|Withdrawal by Subject|5|||
129100574|NCT03337048|464661055|FG000|Overall Study|Withdrawal by Subject|2|||
129100575|NCT03337048|464661056|FG001|Overall Study|Withdrawal by Subject|0|||
129100576|NCT03337048|464661057|FG002|Overall Study|Withdrawal by Subject|0|||
128676663|NCT00492063|463114548|FG003|Overall Study|Withdrawal by Subject|4|||
128676664|NCT00492063|463114545|FG000|Overall Study|Lost to Follow-up|6|||
129100577|NCT02791438|464661058|FG000|Treatment Period|Adverse Event|1|||
129100578|NCT02791438|464661059|FG001|Treatment Period|Adverse Event|0|||
129100579|NCT02791438|464661058|FG000|Treatment Period|Withdrawal by Subject|0|||
129100580|NCT02791438|464661059|FG001|Treatment Period|Withdrawal by Subject|1|||
129100581|NCT02791438|464661058|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
129100582|NCT02791438|464661059|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
129100583|NCT02839876|464661060|FG000|Overall Study|Protocol Violation|10|||
129100584|NCT02839876|464661061|FG001|Overall Study|Protocol Violation|11|||
129100585|NCT01156051|464661065|FG000|Overall Study|Lost to Follow-up|1|||
129100586|NCT01156051|464661066|FG001|Overall Study|Lost to Follow-up|0|||
129100587|NCT01156051|464661065|FG000|Overall Study|patient not compliant with protocol|0|||
129100588|NCT01156051|464661066|FG001|Overall Study|patient not compliant with protocol|1|||
129100589|NCT02071082|464661073|FG000|Overall Study|Enrolled and Never Treated|1|||
129100590|NCT02071082|464661074|FG001|Overall Study|Enrolled and Never Treated|1|||
129100591|NCT02071082|464661073|FG000|Overall Study|Adverse Event|0|||
129100592|NCT02071082|464661074|FG001|Overall Study|Adverse Event|1|||
129100593|NCT02071082|464661073|FG000|Overall Study|Withdrew Consent|0|||
129100594|NCT02071082|464661074|FG001|Overall Study|Withdrew Consent|4|||
129100595|NCT02071082|464661073|FG000|Overall Study|Lost to Follow-up|1|||
129100596|NCT02071082|464661074|FG001|Overall Study|Lost to Follow-up|1|||
129100597|NCT02494401|464661078|FG000|Overall Study|Lost to Follow-up|22|||
129100598|NCT02494401|464661079|FG001|Overall Study|Lost to Follow-up|25|||
129100599|NCT02494401|464661078|FG000|Overall Study|Withdrawal by Subject|3|||
129100600|NCT02494401|464661079|FG001|Overall Study|Withdrawal by Subject|2|||
129100601|NCT00958412|464661080|FG000|Overall Study|Study prematurely terminated|18|||
129100602|NCT01859949|464662701|FG000|Overall Study|Family Matters|0|||
129100603|NCT01859949|464662702|FG001|Overall Study|Family Matters|1|||
129100604|NCT01859949|464662701|FG000|Overall Study|Physician Decision|2|||
129100605|NCT01859949|464662702|FG001|Overall Study|Physician Decision|4|||
129100606|NCT01859949|464662701|FG000|Overall Study|Withdrawal by Subject|11|||
129100607|NCT01859949|464662702|FG001|Overall Study|Withdrawal by Subject|10|||
129100608|NCT01859949|464662701|FG000|Overall Study|Protocol Violation|1|||
129100609|NCT01859949|464662702|FG001|Overall Study|Protocol Violation|1|||
129100610|NCT01859949|464662701|FG000|Overall Study|Adverse Event|0|||
129100611|NCT01859949|464662702|FG001|Overall Study|Adverse Event|1|||
129100612|NCT01890759|464662703|FG000|Overall Study|Protocol Violation|0|||
129100613|NCT01890759|464662704|FG001|Overall Study|Protocol Violation|2|||
129100614|NCT01890759|464662703|FG000|Overall Study|Lost to Follow-up|0|||
129100615|NCT01890759|464662704|FG001|Overall Study|Lost to Follow-up|2|||
129100616|NCT01890759|464662703|FG000|Overall Study|Withdrawal by Subject|2|||
129100617|NCT01890759|464662704|FG001|Overall Study|Withdrawal by Subject|8|||
129100618|NCT01270321|464662709|FG000|Overall Study|Death|3|||
129100619|NCT01270321|464662710|FG001|Overall Study|Death|1|||
129100620|NCT01270321|464662711|FG002|Overall Study|Death|4|||
129100621|NCT01270321|464662709|FG000|Overall Study|Adverse Event|7|||
129100622|NCT01270321|464662710|FG001|Overall Study|Adverse Event|9|||
129100623|NCT01270321|464662711|FG002|Overall Study|Adverse Event|5|||
129100624|NCT01393106|464662713|FG000|Overall Study|Adverse Event|3|||
129100625|NCT01393106|464662713|FG000|Overall Study|Withdrawal by Subject|1|||
129100626|NCT01393106|464662713|FG000|Overall Study|Lack of Efficacy|1|||
129100627|NCT05437640|464662716|FG000|Washout (1 Week)|Adverse Event|1|||
129100628|NCT05437640|464662717|FG001|Washout (1 Week)|Adverse Event|0|||
129100629|NCT00904917|464662718|FG000|Overall Study|Lost to Follow-up|2|||
129100630|NCT00904917|464662719|FG001|Overall Study|Lost to Follow-up|2|||
129100631|NCT00904917|464662720|FG002|Overall Study|Lost to Follow-up|2|||
129100632|NCT00904917|464662721|FG003|Overall Study|Lost to Follow-up|2|||
129100633|NCT04228965|464662724|FG000|Overall Study|Lost to Follow-up|26|||
129100634|NCT04228965|464662725|FG001|Overall Study|Lost to Follow-up|11|||
129100635|NCT04228965|464662724|FG000|Overall Study|Withdrawal by Subject|18|||
129100636|NCT04228965|464662725|FG001|Overall Study|Withdrawal by Subject|5|||
129100637|NCT00734656|464662728|FG000|Lab Session 1|Withdrawal by Subject|2|||
129100638|NCT00734656|464662729|FG001|Lab Session 1|Withdrawal by Subject|0|||
129100639|NCT00734656|464662730|FG002|Lab Session 1|Withdrawal by Subject|0|||
129100640|NCT00734656|464662731|FG003|Lab Session 1|Withdrawal by Subject|0|||
129100641|NCT00734656|464662728|FG000|Washout 1|Withdrawal by Subject|1|||
129100642|NCT00734656|464662729|FG001|Washout 1|Withdrawal by Subject|5|||
129100643|NCT00734656|464662730|FG002|Washout 1|Withdrawal by Subject|2|||
129100644|NCT00734656|464662731|FG003|Washout 1|Withdrawal by Subject|3|||
129100645|NCT00734656|464662728|FG000|Lab Session 2|Withdrawal by Subject|1|||
129100646|NCT00734656|464662729|FG001|Lab Session 2|Withdrawal by Subject|0|||
129100647|NCT00734656|464662730|FG002|Lab Session 2|Withdrawal by Subject|0|||
129100648|NCT00734656|464662731|FG003|Lab Session 2|Withdrawal by Subject|1|||
129100649|NCT00734656|464662728|FG000|Washout 2|Withdrawal by Subject|1|||
129100650|NCT00734656|464662729|FG001|Washout 2|Withdrawal by Subject|1|||
129100651|NCT00734656|464662730|FG002|Washout 2|Withdrawal by Subject|1|||
129100652|NCT00734656|464662731|FG003|Washout 2|Withdrawal by Subject|0|||
129100653|NCT00734656|464662728|FG000|Washout 3|Withdrawal by Subject|1|||
129100654|NCT00734656|464662729|FG001|Washout 3|Withdrawal by Subject|0|||
129100655|NCT00734656|464662730|FG002|Washout 3|Withdrawal by Subject|0|||
129100656|NCT00734656|464662731|FG003|Washout 3|Withdrawal by Subject|1|||
129100657|NCT00734656|464662728|FG000|Lab Session 4|Withdrawal by Subject|0|||
128676665|NCT00492063|463114546|FG001|Overall Study|Lost to Follow-up|11|||
128676666|NCT00492063|463114547|FG002|Overall Study|Lost to Follow-up|5|||
128676667|NCT00492063|463114548|FG003|Overall Study|Lost to Follow-up|3|||
128676668|NCT00492063|463114545|FG000|Overall Study|Protocol Violation|0|||
128676669|NCT00492063|463114546|FG001|Overall Study|Protocol Violation|0|||
128676670|NCT00492063|463114547|FG002|Overall Study|Protocol Violation|0|||
128676671|NCT00492063|463114548|FG003|Overall Study|Protocol Violation|1|||
128676672|NCT00510653|463114551|FG000|Overall Study|Withdrawal by Subject|8|||
128676673|NCT00510653|463114551|FG000|Overall Study|Monetary|3|||
128676674|NCT00436501|463114552|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
128676675|NCT00436501|463114553|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
129010702|NCT00950807|464331078|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129010703|NCT00950807|464331079|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129010704|NCT00950807|464331080|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129010705|NCT00950807|464331081|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129010706|NCT00950807|464331082|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
129010707|NCT00950807|464331083|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129010708|NCT00950807|464331084|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129010709|NCT00950807|464331075|FG000|Treatment Period 3|Adverse Event|0|||
129010710|NCT00950807|464331076|FG001|Treatment Period 3|Adverse Event|0|||
129010711|NCT00950807|464331077|FG002|Treatment Period 3|Adverse Event|0|||
129010712|NCT00950807|464331078|FG003|Treatment Period 3|Adverse Event|0|||
129010713|NCT00950807|464331079|FG004|Treatment Period 3|Adverse Event|0|||
129010714|NCT00950807|464331080|FG005|Treatment Period 3|Adverse Event|0|||
129010715|NCT00950807|464331081|FG006|Treatment Period 3|Adverse Event|1|||
129010716|NCT00950807|464331082|FG007|Treatment Period 3|Adverse Event|0|||
129010717|NCT00950807|464331083|FG008|Treatment Period 3|Adverse Event|0|||
129010718|NCT00950807|464331084|FG009|Treatment Period 3|Adverse Event|0|||
129010719|NCT00337077|464331085|FG000|Overall Study|Progressive disease|25|||
129010720|NCT00337077|464331086|FG001|Overall Study|Progressive disease|37|||
129010721|NCT00337077|464331087|FG002|Overall Study|Progressive disease|19|||
129010722|NCT00337077|464331085|FG000|Overall Study|Adverse Event|7|||
129010723|NCT00337077|464331086|FG001|Overall Study|Adverse Event|7|||
129010724|NCT00337077|464331087|FG002|Overall Study|Adverse Event|1|||
129010725|NCT00337077|464331085|FG000|Overall Study|Death|0|||
129010726|NCT00337077|464331086|FG001|Overall Study|Death|1|||
129010727|NCT00337077|464331087|FG002|Overall Study|Death|0|||
129010728|NCT00337077|464331085|FG000|Overall Study|Withdrawal by Subject|7|||
129010729|NCT00337077|464331086|FG001|Overall Study|Withdrawal by Subject|2|||
129010730|NCT00337077|464331087|FG002|Overall Study|Withdrawal by Subject|2|||
129010731|NCT00337077|464331085|FG000|Overall Study|Alternative therapy|1|||
129010732|NCT00337077|464331086|FG001|Overall Study|Alternative therapy|0|||
129010733|NCT00337077|464331087|FG002|Overall Study|Alternative therapy|0|||
129010734|NCT00337077|464331085|FG000|Overall Study|Physician Decision|1|||
129010735|NCT00337077|464331086|FG001|Overall Study|Physician Decision|4|||
129010736|NCT00337077|464331087|FG002|Overall Study|Physician Decision|2|||
129010737|NCT00337077|464331085|FG000|Overall Study|Never started treatment|1|||
129010738|NCT00337077|464331086|FG001|Overall Study|Never started treatment|1|||
129010739|NCT00337077|464331087|FG002|Overall Study|Never started treatment|0|||
129010740|NCT00337077|464331085|FG000|Overall Study|Ineligible|1|||
129010741|NCT00337077|464331086|FG001|Overall Study|Ineligible|1|||
129010742|NCT00337077|464331087|FG002|Overall Study|Ineligible|1|||
129010743|NCT02780687|464331098|FG000|Overall Study|Adverse Event|1|||
129010744|NCT02780687|464331099|FG001|Overall Study|Adverse Event|1|||
129010745|NCT02780687|464331098|FG000|Overall Study|Withdrawal by Subject|2|||
129010746|NCT02780687|464331099|FG001|Overall Study|Withdrawal by Subject|1|||
129010747|NCT02780687|464331098|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
129010748|NCT02780687|464331099|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
129010749|NCT02780687|464331098|FG000|Overall Study|progressive disease|29|||
129010750|NCT02780687|464331099|FG001|Overall Study|progressive disease|6|||
129040310|NCT03123783|464438831|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129040311|NCT02953678|464438835|FG000|Overall Study|Adverse Event|20|||
129040312|NCT02953678|464438835|FG000|Overall Study|Death|7|||
129040313|NCT02953678|464438835|FG000|Overall Study|Physician Decision|23|||
129040314|NCT02953678|464438835|FG000|Overall Study|Progressive Disease of GVHD|7|||
129040315|NCT02953678|464438835|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
128676676|NCT00436501|463114552|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
128676677|NCT00436501|463114553|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
128676678|NCT02312687|463114555|FG000|Overall Study|Other, Not Specified|1|||
129040316|NCT02953678|464438835|FG000|Overall Study|Withdrawal by participant|3|||
129040317|NCT02953678|464438835|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
129040318|NCT02953678|464438835|FG000|Overall Study|Participants were transferred to commercial product.|3|||
129040319|NCT00544817|464440116|FG000|Combined Modality|Lack of Efficacy|2|||
129040320|NCT00544817|464440116|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
129040321|NCT00544817|464440116|FG000|Combined Modality|Adverse Event|2|||
129100658|NCT00734656|464662729|FG001|Lab Session 4|Withdrawal by Subject|0|||
129100659|NCT00734656|464662730|FG002|Lab Session 4|Withdrawal by Subject|0|||
129100660|NCT00734656|464662731|FG003|Lab Session 4|Withdrawal by Subject|1|||
129100661|NCT03915626|464662732|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
129100662|NCT02190721|464662740|FG000|Overall Study|Patient was out of the city|0|||
129100663|NCT02190721|464662741|FG001|Overall Study|Patient was out of the city|1|||
129100664|NCT02190721|464662742|FG002|Overall Study|Patient was out of the city|0|||
129100665|NCT05025332|464662744|FG000|Screening|Screen failure|12|||
129100666|NCT05025332|464662744|FG000|Treatment & Follow Up|Protocol Violation|1|||
129100667|NCT05025332|464662744|FG000|Treatment & Follow Up|Adverse Event|4|||
129100668|NCT01928199|464662745|FG000|Overall Study|Lost to Follow-up|2|||
129100669|NCT01928199|464662746|FG001|Overall Study|Lost to Follow-up|1|||
129100670|NCT01928199|464662745|FG000|Overall Study|Withdrawal by Subject|3|||
129100671|NCT01928199|464662746|FG001|Overall Study|Withdrawal by Subject|5|||
129010751|NCT01298570|464332821|FG000|Overall Study|Disease progression, relapse during acti|64|||
129010752|NCT01298570|464332822|FG001|Overall Study|Disease progression, relapse during acti|40|||
129010753|NCT01298570|464332821|FG000|Overall Study|Adverse Event|20|||
129010754|NCT01298570|464332822|FG001|Overall Study|Adverse Event|2|||
129010755|NCT01298570|464332821|FG000|Overall Study|Withdrawal by Subject|21|||
129010756|NCT01298570|464332822|FG001|Overall Study|Withdrawal by Subject|6|||
129010757|NCT01298570|464332821|FG000|Overall Study|Treatment delay > 4 weeks|4|||
129010758|NCT01298570|464332822|FG001|Overall Study|Treatment delay > 4 weeks|5|||
129010759|NCT01298570|464332821|FG000|Overall Study|Physician Decision|4|||
129010760|NCT01298570|464332822|FG001|Overall Study|Physician Decision|2|||
129010761|NCT01298570|464332821|FG000|Overall Study|Other complicating disease|2|||
129010762|NCT01298570|464332822|FG001|Overall Study|Other complicating disease|1|||
129010763|NCT01298570|464332821|FG000|Overall Study|Surgery|2|||
129010764|NCT01298570|464332822|FG001|Overall Study|Surgery|1|||
129010765|NCT01298570|464332821|FG000|Overall Study|Symptomatic progression/deterioration|3|||
129010766|NCT01298570|464332822|FG001|Overall Study|Symptomatic progression/deterioration|2|||
129010767|NCT01298570|464332821|FG000|Overall Study|Death|0|||
129010768|NCT01298570|464332822|FG001|Overall Study|Death|1|||
129010769|NCT01298570|464332821|FG000|Overall Study|Ineligibility|0|||
129010770|NCT01298570|464332822|FG001|Overall Study|Ineligibility|1|||
129010771|NCT01451762|464332826|FG000|Overall Study|Lost to Follow-up|3|||
129010772|NCT01451762|464332827|FG001|Overall Study|Lost to Follow-up|6|||
129010773|NCT01451762|464332828|FG002|Overall Study|Lost to Follow-up|6|||
129010774|NCT00502775|464332834|FG000|Overall Study|Adverse Event|1|||
129010775|NCT00502775|464332835|FG001|Overall Study|Adverse Event|2|||
129010776|NCT00502775|464332836|FG002|Overall Study|Adverse Event|1|||
129010777|NCT00502775|464332834|FG000|Overall Study|Protocol Violation|1|||
129010778|NCT00502775|464332835|FG001|Overall Study|Protocol Violation|5|||
129010779|NCT00502775|464332836|FG002|Overall Study|Protocol Violation|2|||
129010780|NCT00502775|464332834|FG000|Overall Study|Withdrawal by Subject|1|||
129010781|NCT00502775|464332835|FG001|Overall Study|Withdrawal by Subject|1|||
129010782|NCT00502775|464332836|FG002|Overall Study|Withdrawal by Subject|2|||
129010783|NCT00502775|464332834|FG000|Overall Study|Sponsor Terminated Study|1|||
129010784|NCT00502775|464332835|FG001|Overall Study|Sponsor Terminated Study|0|||
129010785|NCT00502775|464332836|FG002|Overall Study|Sponsor Terminated Study|1|||
129010786|NCT00502775|464332834|FG000|Overall Study|Non-compliance with eDiary|4|||
129010787|NCT00502775|464332835|FG001|Overall Study|Non-compliance with eDiary|1|||
129010788|NCT00502775|464332836|FG002|Overall Study|Non-compliance with eDiary|1|||
129010789|NCT00502775|464332834|FG000|Overall Study|Subject unable to swallow capsule|1|||
129010790|NCT00502775|464332835|FG001|Overall Study|Subject unable to swallow capsule|0|||
129010791|NCT00502775|464332836|FG002|Overall Study|Subject unable to swallow capsule|1|||
129010792|NCT00502775|464332834|FG000|Overall Study|Logpad compliance <80%|1|||
129010793|NCT00502775|464332835|FG001|Overall Study|Logpad compliance <80%|0|||
129010794|NCT00502775|464332836|FG002|Overall Study|Logpad compliance <80%|0|||
129010795|NCT00502775|464332834|FG000|Overall Study|Randomized in error|0|||
129010796|NCT00502775|464332835|FG001|Overall Study|Randomized in error|1|||
129010797|NCT00502775|464332836|FG002|Overall Study|Randomized in error|1|||
129010798|NCT00502775|464332834|FG000|Overall Study|Non-compliance|0|||
129010799|NCT00502775|464332835|FG001|Overall Study|Non-compliance|2|||
129010800|NCT00502775|464332836|FG002|Overall Study|Non-compliance|2|||
129010801|NCT00502775|464332834|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
129010802|NCT00502775|464332835|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
129010803|NCT00502775|464332836|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
129010804|NCT00502775|464332834|FG000|Overall Study|Declining pollen counts|0|||
129010805|NCT00502775|464332835|FG001|Overall Study|Declining pollen counts|1|||
129010806|NCT00502775|464332836|FG002|Overall Study|Declining pollen counts|1|||
129010807|NCT00502775|464332834|FG000|Overall Study|Subject in jail|0|||
129100672|NCT01502956|464662747|FG000|Overall Study|Death|0|||
129100673|NCT01502956|464662748|FG001|Overall Study|Death|2|||
129100674|NCT01502956|464662747|FG000|Overall Study|Lost to Follow-up|14|||
129010808|NCT00502775|464332835|FG001|Overall Study|Subject in jail|1|||
129010809|NCT00502775|464332836|FG002|Overall Study|Subject in jail|0|||
129100675|NCT01502956|464662748|FG001|Overall Study|Lost to Follow-up|11|||
129100676|NCT01502956|464662747|FG000|Overall Study|Physician Decision|2|||
129100677|NCT01502956|464662748|FG001|Overall Study|Physician Decision|3|||
129100678|NCT01502956|464662747|FG000|Overall Study|Withdrawal by Subject|8|||
129100679|NCT01502956|464662748|FG001|Overall Study|Withdrawal by Subject|10|||
129100680|NCT02626000|464662751|FG000|Overall Study|Decision by Sponsor|1|||
129100681|NCT02626000|464662751|FG000|Overall Study|Death|29|||
129100682|NCT03539484|464662752|FG000|Overall Study|Death|1|||
129100683|NCT03539484|464662753|FG001|Overall Study|Death|0|||
129100684|NCT03539484|464662754|FG002|Overall Study|Death|0|||
129100685|NCT03539484|464662755|FG003|Overall Study|Death|2|||
129100686|NCT03539484|464662756|FG004|Overall Study|Death|8|||
129100687|NCT03539484|464662757|FG005|Overall Study|Death|3|||
129100688|NCT03539484|464662758|FG006|Overall Study|Death|0|||
129100689|NCT03539484|464662752|FG000|Overall Study|Lost to Follow-up|0|||
129100690|NCT03539484|464662753|FG001|Overall Study|Lost to Follow-up|1|||
129100691|NCT03539484|464662754|FG002|Overall Study|Lost to Follow-up|0|||
129100692|NCT03539484|464662755|FG003|Overall Study|Lost to Follow-up|0|||
129100693|NCT03539484|464662756|FG004|Overall Study|Lost to Follow-up|1|||
129100694|NCT03539484|464662757|FG005|Overall Study|Lost to Follow-up|0|||
129100695|NCT03539484|464662758|FG006|Overall Study|Lost to Follow-up|0|||
129100696|NCT03539484|464662752|FG000|Overall Study|Withdrawal by Subject|0|||
129100697|NCT03539484|464662753|FG001|Overall Study|Withdrawal by Subject|0|||
129100698|NCT03539484|464662754|FG002|Overall Study|Withdrawal by Subject|0|||
129100699|NCT03539484|464662755|FG003|Overall Study|Withdrawal by Subject|0|||
129100700|NCT03539484|464662756|FG004|Overall Study|Withdrawal by Subject|2|||
129100701|NCT03539484|464662757|FG005|Overall Study|Withdrawal by Subject|0|||
129100702|NCT03539484|464662758|FG006|Overall Study|Withdrawal by Subject|1|||
129100703|NCT03539484|464662752|FG000|Overall Study|Study Terminated by Sponsor|0|||
129100704|NCT03539484|464662753|FG001|Overall Study|Study Terminated by Sponsor|0|||
129100705|NCT03539484|464662754|FG002|Overall Study|Study Terminated by Sponsor|1|||
129100706|NCT03539484|464662755|FG003|Overall Study|Study Terminated by Sponsor|1|||
129100707|NCT03539484|464662756|FG004|Overall Study|Study Terminated by Sponsor|2|||
129100708|NCT03539484|464662757|FG005|Overall Study|Study Terminated by Sponsor|2|||
129100709|NCT03539484|464662758|FG006|Overall Study|Study Terminated by Sponsor|1|||
129100710|NCT02476916|464662759|FG000|Core Period|Adverse Event|2|||
129100711|NCT02476916|464662760|FG001|Core Period|Adverse Event|2|||
129100712|NCT02476916|464662759|FG000|Core Period|Investigator decision|1|||
129100713|NCT02476916|464662760|FG001|Core Period|Investigator decision|1|||
129100714|NCT02476916|464662759|FG000|Core Period|Withdrawal by Subject|3|||
129100715|NCT02476916|464662760|FG001|Core Period|Withdrawal by Subject|0|||
129100716|NCT02476916|464662759|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
129100717|NCT02476916|464662760|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
129100718|NCT02476916|464662759|FG000|Extension Period|On Treatment|12|||
129100719|NCT02476916|464662760|FG001|Extension Period|On Treatment|17|||
129100720|NCT06010732|464662761|FG000|Crossover Period 1|Protocol Violation|0|||
129100721|NCT06010732|464662762|FG001|Crossover Period 1|Protocol Violation|0|||
129100722|NCT06010732|464662763|FG002|Crossover Period 1|Protocol Violation|1|||
129100723|NCT06010732|464662764|FG003|Crossover Period 1|Protocol Violation|0|||
129100724|NCT06010732|464662765|FG004|Crossover Period 1|Protocol Violation|1|||
129100725|NCT06010732|464662766|FG005|Crossover Period 1|Protocol Violation|0|||
129100726|NCT06010732|464662761|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129100727|NCT06010732|464662762|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
129100728|NCT06010732|464662763|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129100729|NCT06010732|464662764|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129100730|NCT06010732|464662765|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129100731|NCT06010732|464662766|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129100732|NCT06010732|464662761|FG000|Crossover Period 2|Adverse Event|0|||
129100733|NCT06010732|464662762|FG001|Crossover Period 2|Adverse Event|1|||
129100734|NCT06010732|464662763|FG002|Crossover Period 2|Adverse Event|0|||
129100735|NCT06010732|464662764|FG003|Crossover Period 2|Adverse Event|0|||
128676679|NCT00384111|463114556|FG000|Overall Study|Disease Progression|3|||
128676680|NCT00384111|463114556|FG000|Overall Study|Adverse Event|1|||
129100736|NCT06010732|464662765|FG004|Crossover Period 2|Adverse Event|0|||
129100737|NCT06010732|464662766|FG005|Crossover Period 2|Adverse Event|0|||
129100738|NCT06010732|464662761|FG000|Crossover Period 2|broken denture|0|||
129100739|NCT06010732|464662762|FG001|Crossover Period 2|broken denture|0|||
129100740|NCT06010732|464662763|FG002|Crossover Period 2|broken denture|1|||
129100741|NCT06010732|464662764|FG003|Crossover Period 2|broken denture|0|||
129100742|NCT06010732|464662765|FG004|Crossover Period 2|broken denture|0|||
129100743|NCT06010732|464662766|FG005|Crossover Period 2|broken denture|0|||
128676681|NCT00384111|463114556|FG000|Overall Study|Investigator Decision|3|||
128676682|NCT00384111|463114556|FG000|Overall Study|Study Terminated by the Sponsor|19|||
128676683|NCT00217464|463114559|FG000|Overall Study|Progression|15|||
129100744|NCT04401202|464662767|FG000|Overall Study|Lost to Follow-up|2|||
128676684|NCT00217464|463114559|FG000|Overall Study|Other|2|||
129100745|NCT04401202|464662768|FG001|Overall Study|Lost to Follow-up|2|||
129100746|NCT04401202|464662767|FG000|Overall Study|Adverse Event|0|||
128676685|NCT01576159|463114560|FG000|Overall Study|Withdrawal by Subject|0|||
128676686|NCT01576159|463114561|FG001|Overall Study|Withdrawal by Subject|1|||
128676687|NCT01576159|463114562|FG002|Overall Study|Withdrawal by Subject|0|||
128676688|NCT01576159|463114563|FG003|Overall Study|Withdrawal by Subject|0|||
128676689|NCT01576159|463114560|FG000|Overall Study|Physician Decision|0|||
129010810|NCT00502775|464332834|FG000|Overall Study|Subject took disallowed drug|0|||
129010811|NCT00502775|464332835|FG001|Overall Study|Subject took disallowed drug|0|||
129010812|NCT00502775|464332836|FG002|Overall Study|Subject took disallowed drug|1|||
129010813|NCT00287118|464332838|FG000|Overall Study|Adverse Event|30|||
129010814|NCT00287118|464332838|FG000|Overall Study|Death|1|||
129010815|NCT00287118|464332838|FG000|Overall Study|Lack of Efficacy|11|||
129010816|NCT00287118|464332838|FG000|Overall Study|Lost to Follow-up|1|||
129010817|NCT00287118|464332838|FG000|Overall Study|Protocol Violation|2|||
129010818|NCT00287118|464332838|FG000|Overall Study|Other|7|||
129010819|NCT04471207|464332839|FG000|Overall Study|Lost to Follow-up|4|||
129010820|NCT04471207|464332840|FG001|Overall Study|Lost to Follow-up|1|||
129010821|NCT04471207|464332839|FG000|Overall Study|Medication Contraindication|0|||
129010822|NCT04471207|464332840|FG001|Overall Study|Medication Contraindication|1|||
129010823|NCT04471207|464332839|FG000|Overall Study|Loss of Interest|2|||
129010824|NCT04471207|464332840|FG001|Overall Study|Loss of Interest|1|||
129010825|NCT04471207|464332839|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
129010826|NCT04471207|464332840|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
129010827|NCT04471207|464332839|FG000|Overall Study|Scheduling Conflicts|3|||
129010828|NCT04471207|464332840|FG001|Overall Study|Scheduling Conflicts|1|||
129010829|NCT04471207|464332839|FG000|Overall Study|Physician Decision|1|||
129010830|NCT04471207|464332840|FG001|Overall Study|Physician Decision|0|||
129010831|NCT04471207|464332839|FG000|Overall Study|Unwilling to Use System|0|||
129010832|NCT04471207|464332840|FG001|Overall Study|Unwilling to Use System|1|||
129010833|NCT00561730|464332841|FG000|Overall Study|Adverse Event|2|||
129010834|NCT00561730|464332841|FG000|Overall Study|Handling of the drug|1|||
129010835|NCT00561730|464332841|FG000|Overall Study|Lost to Follow-up|5|||
129010836|NCT00561730|464332841|FG000|Overall Study|Not specified reasons|1|||
129010837|NCT02906709|464332848|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
129010838|NCT02906709|464332849|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
129010839|NCT02906709|464332848|FG000|Phase A (Week 0 to Week 16)|Death|0|||
129010840|NCT02906709|464332849|FG001|Phase A (Week 0 to Week 16)|Death|1|||
129010841|NCT02906709|464332848|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
129010842|NCT02906709|464332849|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
129010843|NCT02906709|464332848|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
129010844|NCT02906709|464332849|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
129010845|NCT00920140|464332851|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
129010846|NCT00920140|464332852|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
129010847|NCT00920140|464332853|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
129010848|NCT00920140|464332854|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
129010849|NCT00920140|464332855|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
129010850|NCT00920140|464332851|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
129010851|NCT00920140|464332852|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
129010852|NCT00920140|464332853|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
129010853|NCT00920140|464332854|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
129010854|NCT00920140|464332855|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
129010855|NCT00920140|464332851|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129010856|NCT00920140|464332852|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
129010857|NCT00920140|464332853|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129010858|NCT00920140|464332854|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129010859|NCT00920140|464332855|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129010860|NCT00920140|464332851|FG000|Phase 2|Adverse Event|0|||
129010861|NCT00920140|464332852|FG001|Phase 2|Adverse Event|0|||
129010862|NCT00920140|464332853|FG002|Phase 2|Adverse Event|14|||
129010863|NCT00920140|464332854|FG003|Phase 2|Adverse Event|2|||
129010864|NCT00920140|464332855|FG004|Phase 2|Adverse Event|3|||
129010865|NCT00920140|464332851|FG000|Phase 2|Lack of Efficacy|0|||
129010866|NCT00920140|464332852|FG001|Phase 2|Lack of Efficacy|0|||
129010867|NCT00920140|464332853|FG002|Phase 2|Lack of Efficacy|29|||
129010868|NCT00920140|464332854|FG003|Phase 2|Lack of Efficacy|14|||
129010869|NCT00920140|464332855|FG004|Phase 2|Lack of Efficacy|5|||
129010870|NCT00920140|464332851|FG000|Phase 2|Lost to Follow-up|0|||
129010871|NCT00920140|464332852|FG001|Phase 2|Lost to Follow-up|0|||
129010872|NCT00920140|464332853|FG002|Phase 2|Lost to Follow-up|0|||
129010873|NCT00920140|464332854|FG003|Phase 2|Lost to Follow-up|1|||
129010874|NCT00920140|464332855|FG004|Phase 2|Lost to Follow-up|0|||
129010875|NCT00920140|464332851|FG000|Phase 2|Physician Decision|0|||
129010876|NCT00920140|464332852|FG001|Phase 2|Physician Decision|0|||
129010877|NCT00920140|464332853|FG002|Phase 2|Physician Decision|3|||
129010878|NCT00920140|464332854|FG003|Phase 2|Physician Decision|3|||
129010879|NCT00920140|464332855|FG004|Phase 2|Physician Decision|2|||
129010880|NCT00920140|464332851|FG000|Phase 2|Withdrawal by Subject|0|||
129010881|NCT00920140|464332852|FG001|Phase 2|Withdrawal by Subject|0|||
129010882|NCT00920140|464332853|FG002|Phase 2|Withdrawal by Subject|4|||
128676690|NCT01576159|463114561|FG001|Overall Study|Physician Decision|0|||
128676691|NCT01576159|463114562|FG002|Overall Study|Physician Decision|1|||
128676692|NCT01576159|463114563|FG003|Overall Study|Physician Decision|0|||
128676693|NCT01576159|463114560|FG000|Overall Study|Lost to Follow-up|0|||
128676694|NCT01576159|463114561|FG001|Overall Study|Lost to Follow-up|0|||
128676695|NCT01576159|463114562|FG002|Overall Study|Lost to Follow-up|0|||
128676696|NCT01576159|463114563|FG003|Overall Study|Lost to Follow-up|1|||
128676697|NCT01576159|463114560|FG000|Overall Study|Protocol Violation|1|||
128676698|NCT01576159|463114561|FG001|Overall Study|Protocol Violation|0|||
128676699|NCT01576159|463114562|FG002|Overall Study|Protocol Violation|0|||
128676700|NCT01576159|463114563|FG003|Overall Study|Protocol Violation|0|||
128676701|NCT00169442|463114564|FG000|Overall Study|Withdrawal by Subject|0|||
128676702|NCT00169442|463114565|FG001|Overall Study|Withdrawal by Subject|0|||
128676703|NCT00169442|463114566|FG002|Overall Study|Withdrawal by Subject|1|||
128676704|NCT00169442|463114567|FG003|Overall Study|Withdrawal by Subject|0|||
128676705|NCT00169442|463114568|FG004|Overall Study|Withdrawal by Subject|0|||
128676706|NCT00169442|463114569|FG005|Overall Study|Withdrawal by Subject|0|||
128676707|NCT00169442|463114564|FG000|Overall Study|Migrated/moved from study area|0|||
128676708|NCT00169442|463114565|FG001|Overall Study|Migrated/moved from study area|0|||
128676709|NCT00169442|463114566|FG002|Overall Study|Migrated/moved from study area|0|||
128676710|NCT00169442|463114567|FG003|Overall Study|Migrated/moved from study area|0|||
128676711|NCT00169442|463114568|FG004|Overall Study|Migrated/moved from study area|0|||
128676712|NCT00169442|463114569|FG005|Overall Study|Migrated/moved from study area|2|||
128676713|NCT00169442|463114564|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
128676714|NCT00169442|463114565|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
128676715|NCT00169442|463114566|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
128676716|NCT00169442|463114567|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
128676717|NCT00169442|463114568|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
128676718|NCT00169442|463114569|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
128676719|NCT00169442|463114564|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
128676720|NCT00169442|463114565|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
128676721|NCT00169442|463114566|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
128676722|NCT00169442|463114567|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
128676723|NCT00169442|463114568|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
128676724|NCT00169442|463114569|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
128676725|NCT01426789|463114570|FG000|Part 1|Protocol deviation|0|||
128676726|NCT01426789|463114571|FG001|Part 1|Protocol deviation|1|||
129010883|NCT00920140|464332854|FG003|Phase 2|Withdrawal by Subject|2|||
129010884|NCT00920140|464332855|FG004|Phase 2|Withdrawal by Subject|1|||
129010885|NCT01124149|464332856|FG000|Acute Phase|Withdrawal by Subject|22|||
129010886|NCT01124149|464332856|FG000|Acute Phase|Adverse Event|21|||
129010887|NCT01124149|464332856|FG000|Acute Phase|Lack of Efficacy|17|||
129010888|NCT01124149|464332856|FG000|Acute Phase|Protocol Violation|14|||
129010889|NCT01124149|464332856|FG000|Acute Phase|Lost to Follow-up|2|||
129010890|NCT01124149|464332856|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
129010891|NCT01124149|464332856|FG000|Acute Phase|Sponsor request|1|||
129010892|NCT01124149|464332856|FG000|Acute Phase|UC symptoms not ameliorated|1|||
129010893|NCT01124149|464332856|FG000|Acute Phase|Non-compliance|1|||
129010894|NCT01124149|464332856|FG000|Acute Phase|Low hemoglobin|1|||
129010895|NCT01124149|464332856|FG000|Acute Phase|Travelling to another country|1|||
129010896|NCT01124149|464332856|FG000|Acute Phase|Sponsor decision|1|||
129010897|NCT01124149|464332856|FG000|Maintenance Phase|Lack of Efficacy|40|||
129010898|NCT01124149|464332856|FG000|Maintenance Phase|Adverse Event|24|||
129010899|NCT01124149|464332856|FG000|Maintenance Phase|Lost to Follow-up|15|||
129010900|NCT01124149|464332856|FG000|Maintenance Phase|Withdrawal by Subject|10|||
129010901|NCT01124149|464332856|FG000|Maintenance Phase|Protocol Violation|5|||
129010902|NCT01124149|464332856|FG000|Maintenance Phase|Coordinator error|1|||
129010903|NCT01124149|464332856|FG000|Maintenance Phase|Non-compliance|1|||
129010904|NCT00977106|464332857|FG000|Overall Study|Adverse Event|5|||
129010905|NCT00977106|464332858|FG001|Overall Study|Adverse Event|6|||
129010906|NCT00977106|464332857|FG000|Overall Study|Withdrawal by Subject|2|||
129010907|NCT00977106|464332858|FG001|Overall Study|Withdrawal by Subject|2|||
129010908|NCT00977106|464332857|FG000|Overall Study|Lack of Efficacy|2|||
129010909|NCT00977106|464332858|FG001|Overall Study|Lack of Efficacy|2|||
129010910|NCT00977106|464332857|FG000|Overall Study|Protocol Violation|0|||
129010911|NCT00977106|464332858|FG001|Overall Study|Protocol Violation|1|||
129010912|NCT00977106|464332857|FG000|Overall Study|Other|1|||
129010913|NCT00977106|464332858|FG001|Overall Study|Other|0|||
129010914|NCT01644500|464332859|FG000|Overall Study|Adverse Event|6|||
129010915|NCT01644500|464332860|FG001|Overall Study|Adverse Event|1|||
129010916|NCT01644500|464332861|FG002|Overall Study|Adverse Event|2|||
129010917|NCT01644500|464332859|FG000|Overall Study|Death|0|||
129010918|NCT01644500|464332860|FG001|Overall Study|Death|1|||
129100747|NCT04401202|464662768|FG001|Overall Study|Adverse Event|1|||
129100748|NCT04401202|464662767|FG000|Overall Study|Hospitalized|4|||
128676727|NCT01426789|463114572|FG002|Part 1|Protocol deviation|0|||
129010919|NCT01644500|464332861|FG002|Overall Study|Death|0|||
128676728|NCT01426789|463114573|FG003|Part 1|Protocol deviation|0|||
128676729|NCT01426789|463114574|FG004|Part 1|Protocol deviation|0|||
129100749|NCT04401202|464662768|FG001|Overall Study|Hospitalized|1|||
128676730|NCT01426789|463114575|FG005|Part 1|Protocol deviation|0|||
128676731|NCT01426789|463114570|FG000|Part 1|Lost to Follow-up|1|||
128676732|NCT01426789|463114571|FG001|Part 1|Lost to Follow-up|2|||
128676733|NCT01426789|463114572|FG002|Part 1|Lost to Follow-up|0|||
128676734|NCT01426789|463114573|FG003|Part 1|Lost to Follow-up|0|||
128676735|NCT01426789|463114574|FG004|Part 1|Lost to Follow-up|0|||
128676736|NCT01426789|463114575|FG005|Part 1|Lost to Follow-up|0|||
128676737|NCT01426789|463114570|FG000|Part 1|Lack of Efficacy|2|||
128676738|NCT01426789|463114571|FG001|Part 1|Lack of Efficacy|1|||
128676739|NCT01426789|463114572|FG002|Part 1|Lack of Efficacy|0|||
128676740|NCT01426789|463114573|FG003|Part 1|Lack of Efficacy|0|||
128676741|NCT01426789|463114574|FG004|Part 1|Lack of Efficacy|0|||
128676742|NCT01426789|463114575|FG005|Part 1|Lack of Efficacy|0|||
128676743|NCT01426789|463114570|FG000|Part 1|Adverse Event|3|||
128676744|NCT01426789|463114571|FG001|Part 1|Adverse Event|0|||
128676745|NCT01426789|463114572|FG002|Part 1|Adverse Event|0|||
128676746|NCT01426789|463114573|FG003|Part 1|Adverse Event|0|||
128676747|NCT01426789|463114574|FG004|Part 1|Adverse Event|0|||
128676748|NCT01426789|463114575|FG005|Part 1|Adverse Event|0|||
128676749|NCT01426789|463114570|FG000|Part 2|Protocol deviation|0|||
128676750|NCT01426789|463114571|FG001|Part 2|Protocol deviation|0|||
128676751|NCT01426789|463114572|FG002|Part 2|Protocol deviation|1|||
128676752|NCT01426789|463114573|FG003|Part 2|Protocol deviation|0|||
128676753|NCT01426789|463114574|FG004|Part 2|Protocol deviation|0|||
128676754|NCT01426789|463114575|FG005|Part 2|Protocol deviation|0|||
128676755|NCT01426789|463114570|FG000|Part 2|Death|0|||
128676756|NCT01426789|463114571|FG001|Part 2|Death|0|||
128676757|NCT01426789|463114572|FG002|Part 2|Death|1|||
128676758|NCT01426789|463114573|FG003|Part 2|Death|0|||
128676759|NCT01426789|463114574|FG004|Part 2|Death|1|||
128676760|NCT01426789|463114575|FG005|Part 2|Death|0|||
128676761|NCT01426789|463114570|FG000|Part 2|Administrative problems|0|||
129100750|NCT00329745|464662771|FG000|Overall Study|Protocol Violation|1|||
129100751|NCT00329745|464662772|FG001|Overall Study|Protocol Violation|0|||
129100752|NCT00329745|464662771|FG000|Overall Study|Withdrawal by Subject|0|||
129100753|NCT00329745|464662772|FG001|Overall Study|Withdrawal by Subject|1|||
128676762|NCT01426789|463114571|FG001|Part 2|Administrative problems|0|||
128676763|NCT01426789|463114572|FG002|Part 2|Administrative problems|2|||
129100754|NCT00329745|464662771|FG000|Overall Study|Lost to Follow-up|86|||
129100755|NCT00329745|464662772|FG001|Overall Study|Lost to Follow-up|101|||
129100756|NCT01597492|464662773|FG000|Overall Study|Withdrawal by Subject|1|||
129100757|NCT01597492|464662774|FG001|Overall Study|Withdrawal by Subject|2|||
129100758|NCT01597492|464662773|FG000|Overall Study|Adverse Event|3|||
129100759|NCT01597492|464662774|FG001|Overall Study|Adverse Event|0|||
129100760|NCT01597492|464662773|FG000|Overall Study|Lost to Follow-up|0|||
129100761|NCT01597492|464662774|FG001|Overall Study|Lost to Follow-up|2|||
129100762|NCT01597492|464662773|FG000|Overall Study|Other Reason|2|||
129100763|NCT01597492|464662774|FG001|Overall Study|Other Reason|0|||
129100764|NCT01939223|464662778|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
129100765|NCT01939223|464662779|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
129100766|NCT01939223|464662778|FG000|Overall Study|Disease recurrence (radiological)|1|||
129100767|NCT01939223|464662779|FG001|Overall Study|Disease recurrence (radiological)|3|||
129100768|NCT01939223|464662778|FG000|Overall Study|Study stopped by Sponsor|5|||
129100769|NCT01939223|464662779|FG001|Overall Study|Study stopped by Sponsor|7|||
129100770|NCT01939223|464662778|FG000|Overall Study|Withdrawal by Subject|6|||
129100771|NCT01939223|464662779|FG001|Overall Study|Withdrawal by Subject|0|||
129100772|NCT03624569|464662780|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129100773|NCT03624569|464662781|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
129100774|NCT03624569|464662780|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
129100775|NCT03624569|464662781|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
129100776|NCT01557517|464662782|FG000|Overall Study|Death|1|||
128676764|NCT01426789|463114573|FG003|Part 2|Administrative problems|0|||
128676765|NCT01426789|463114574|FG004|Part 2|Administrative problems|1|||
128676766|NCT01426789|463114575|FG005|Part 2|Administrative problems|0|||
128676767|NCT01426789|463114570|FG000|Part 2|Lost to Follow-up|0|||
128676768|NCT01426789|463114571|FG001|Part 2|Lost to Follow-up|0|||
128676769|NCT01426789|463114572|FG002|Part 2|Lost to Follow-up|4|||
128676770|NCT01426789|463114573|FG003|Part 2|Lost to Follow-up|0|||
129100777|NCT01557517|464662783|FG001|Overall Study|Death|0|||
129100778|NCT01557517|464662782|FG000|Overall Study|Refused further treatment|0|||
129100779|NCT01557517|464662783|FG001|Overall Study|Refused further treatment|2|||
129100780|NCT01557517|464662782|FG000|Overall Study|Adverse Event|0|||
129100781|NCT01557517|464662783|FG001|Overall Study|Adverse Event|2|||
128676771|NCT01426789|463114574|FG004|Part 2|Lost to Follow-up|1|||
128676772|NCT01426789|463114575|FG005|Part 2|Lost to Follow-up|0|||
128676773|NCT01426789|463114570|FG000|Part 2|Withdrawal by Subject|0|||
128676774|NCT01426789|463114571|FG001|Part 2|Withdrawal by Subject|0|||
128676775|NCT01426789|463114572|FG002|Part 2|Withdrawal by Subject|0|||
128676776|NCT01426789|463114573|FG003|Part 2|Withdrawal by Subject|1|||
128676777|NCT01426789|463114574|FG004|Part 2|Withdrawal by Subject|2|||
128676778|NCT01426789|463114575|FG005|Part 2|Withdrawal by Subject|0|||
128676779|NCT01426789|463114570|FG000|Part 2|Lack of Efficacy|0|||
128676780|NCT01426789|463114571|FG001|Part 2|Lack of Efficacy|0|||
128676781|NCT01426789|463114572|FG002|Part 2|Lack of Efficacy|5|||
128676782|NCT01426789|463114573|FG003|Part 2|Lack of Efficacy|0|||
128676783|NCT01426789|463114574|FG004|Part 2|Lack of Efficacy|2|||
128676784|NCT01426789|463114575|FG005|Part 2|Lack of Efficacy|0|||
128676785|NCT01426789|463114570|FG000|Part 2|Adverse Event|0|||
128676786|NCT01426789|463114571|FG001|Part 2|Adverse Event|0|||
128676787|NCT01426789|463114572|FG002|Part 2|Adverse Event|2|||
128676788|NCT01426789|463114573|FG003|Part 2|Adverse Event|0|||
128676789|NCT01426789|463114574|FG004|Part 2|Adverse Event|1|||
128676790|NCT01426789|463114575|FG005|Part 2|Adverse Event|0|||
128676791|NCT00311584|463114578|FG000|Overall Study|Death|1|||
128676792|NCT00311584|463114579|FG001|Overall Study|Death|0|||
128676793|NCT00311584|463114578|FG000|Overall Study|Lack of Efficacy|12|||
128676794|NCT00311584|463114579|FG001|Overall Study|Lack of Efficacy|15|||
128676795|NCT00311584|463114578|FG000|Overall Study|Physician Decision|4|||
128676796|NCT00311584|463114579|FG001|Overall Study|Physician Decision|5|||
128676797|NCT00311584|463114578|FG000|Overall Study|Withdrawal by Subject|1|||
128676798|NCT00311584|463114579|FG001|Overall Study|Withdrawal by Subject|1|||
128676799|NCT00311584|463114578|FG000|Overall Study|ineligible|2|||
128676800|NCT00311584|463114579|FG001|Overall Study|ineligible|2|||
128676801|NCT00835731|463114580|FG000|Overall Study|Withdrawal by Subject|1|||
128676802|NCT00835731|463114581|FG001|Overall Study|Withdrawal by Subject|0|||
128676803|NCT00835731|463114580|FG000|Overall Study|Physician Decision|1|||
128676804|NCT00835731|463114581|FG001|Overall Study|Physician Decision|1|||
128676805|NCT01155167|463114582|FG000|Overall Study|Insufficient ultrasound data|2|||
128676806|NCT01155167|463114583|FG001|Overall Study|Insufficient ultrasound data|0|||
128676807|NCT01155167|463114582|FG000|Overall Study|Access site changed to femoral artery|1|||
128676808|NCT01155167|463114583|FG001|Overall Study|Access site changed to femoral artery|0|||
128676809|NCT00167778|463114584|FG000|Overall Study|Withdrawal by Subject|1|||
128676810|NCT02654717|463114585|FG000|Overall Study|Adverse Event|2|||
128676811|NCT02654717|463114586|FG001|Overall Study|Adverse Event|2|||
128676812|NCT02654717|463114585|FG000|Overall Study|Protocol Violation|1|||
128676813|NCT02654717|463114586|FG001|Overall Study|Protocol Violation|2|||
128676814|NCT02654717|463114585|FG000|Overall Study|Withdrawal by Subject|0|||
128676815|NCT02654717|463114586|FG001|Overall Study|Withdrawal by Subject|1|||
128676816|NCT02654717|463114585|FG000|Overall Study|Non-permitted medication|3|||
128676817|NCT02654717|463114586|FG001|Overall Study|Non-permitted medication|0|||
128676818|NCT00576420|463116806|FG000|Overall Study|Death|0|||
128676819|NCT00576420|463116807|FG001|Overall Study|Death|0|||
128676820|NCT00576420|463116808|FG002|Overall Study|Death|1|||
128676821|NCT01340872|463116810|FG000|Double-blind Phase|Adverse Event|6|||
128676822|NCT01340872|463116811|FG001|Double-blind Phase|Adverse Event|4|||
128676823|NCT01340872|463116812|FG002|Double-blind Phase|Adverse Event|0|||
128676824|NCT01340872|463116813|FG003|Double-blind Phase|Adverse Event|0|||
128676825|NCT01340872|463116810|FG000|Double-blind Phase|Withdrawal by Subject|3|||
128676826|NCT01340872|463116811|FG001|Double-blind Phase|Withdrawal by Subject|5|||
128676827|NCT01340872|463116812|FG002|Double-blind Phase|Withdrawal by Subject|0|||
129100782|NCT01557517|464662782|FG000|Overall Study|Pt declined before treatment started|1|||
129100783|NCT01557517|464662783|FG001|Overall Study|Pt declined before treatment started|0|||
129100784|NCT01204918|464662794|FG000|Overall Study|Withdrawal by Subject|4|||
129100785|NCT01204918|464662795|FG001|Overall Study|Withdrawal by Subject|10|||
129100786|NCT01204918|464662796|FG002|Overall Study|Withdrawal by Subject|5|||
129100787|NCT00849290|464662801|FG000|Overall Study|Adverse Event|3|||
128676828|NCT01340872|463116813|FG003|Double-blind Phase|Withdrawal by Subject|0|||
128676829|NCT01340872|463116810|FG000|Double-blind Phase|Lost to Follow-up|0|||
128676830|NCT01340872|463116811|FG001|Double-blind Phase|Lost to Follow-up|1|||
128676831|NCT01340872|463116812|FG002|Double-blind Phase|Lost to Follow-up|0|||
128676832|NCT01340872|463116813|FG003|Double-blind Phase|Lost to Follow-up|0|||
128676833|NCT01340872|463116810|FG000|Double-blind Phase|Protocol Violation|0|||
128676834|NCT01340872|463116811|FG001|Double-blind Phase|Protocol Violation|1|||
128676835|NCT01340872|463116812|FG002|Double-blind Phase|Protocol Violation|0|||
128676836|NCT01340872|463116813|FG003|Double-blind Phase|Protocol Violation|0|||
128676837|NCT01340872|463116810|FG000|Open-label Phase|Physician Decision|0|||
128676838|NCT01340872|463116811|FG001|Open-label Phase|Physician Decision|0|||
128676839|NCT01340872|463116812|FG002|Open-label Phase|Physician Decision|2|||
128676840|NCT01340872|463116813|FG003|Open-label Phase|Physician Decision|1|||
128676841|NCT01340872|463116810|FG000|Open-label Phase|Pregnancy|0|||
128676842|NCT01340872|463116811|FG001|Open-label Phase|Pregnancy|0|||
128676843|NCT01340872|463116812|FG002|Open-label Phase|Pregnancy|1|||
128676844|NCT01340872|463116813|FG003|Open-label Phase|Pregnancy|0|||
128676845|NCT01340872|463116810|FG000|Open-label Phase|Adverse Event|0|||
128676846|NCT01340872|463116811|FG001|Open-label Phase|Adverse Event|0|||
128676847|NCT01340872|463116812|FG002|Open-label Phase|Adverse Event|8|||
128676848|NCT01340872|463116813|FG003|Open-label Phase|Adverse Event|4|||
128676849|NCT01340872|463116810|FG000|Open-label Phase|Withdrawal by Subject|0|||
128676850|NCT01340872|463116811|FG001|Open-label Phase|Withdrawal by Subject|0|||
128676851|NCT01340872|463116812|FG002|Open-label Phase|Withdrawal by Subject|1|||
128676852|NCT01340872|463116813|FG003|Open-label Phase|Withdrawal by Subject|6|||
128676853|NCT01340872|463116810|FG000|Open-label Phase|Worsening of IBD|0|||
128676854|NCT01340872|463116811|FG001|Open-label Phase|Worsening of IBD|0|||
129010920|NCT01644500|464332859|FG000|Overall Study|Lost to Follow-up|3|||
129010921|NCT01644500|464332860|FG001|Overall Study|Lost to Follow-up|8|||
129010922|NCT01644500|464332861|FG002|Overall Study|Lost to Follow-up|0|||
129010923|NCT01644500|464332859|FG000|Overall Study|Protocol Violation|1|||
129010924|NCT01644500|464332860|FG001|Overall Study|Protocol Violation|1|||
129010925|NCT01644500|464332861|FG002|Overall Study|Protocol Violation|0|||
129010926|NCT01644500|464332859|FG000|Overall Study|Withdrawal by Subject|11|||
129215083|NCT02760498|465089436|FG000|Overall Study|Withdrawal by Subject|4|||
129215084|NCT02760498|465089437|FG001|Overall Study|Withdrawal by Subject|7|||
129010927|NCT01644500|464332860|FG001|Overall Study|Withdrawal by Subject|12|||
129010928|NCT01644500|464332861|FG002|Overall Study|Withdrawal by Subject|12|||
129010929|NCT01644500|464332859|FG000|Overall Study|Physician Decision|1|||
129010930|NCT01644500|464332860|FG001|Overall Study|Physician Decision|1|||
129010931|NCT01644500|464332861|FG002|Overall Study|Physician Decision|1|||
129010932|NCT01400425|464332869|FG000|Overall Study|Withdrawal by Subject|10|||
129010933|NCT02388763|464332872|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
129010934|NCT02388763|464332873|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
129010935|NCT02388763|464332872|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
129010936|NCT02388763|464332873|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
129010937|NCT01458405|464332884|FG000|Phase 1 (up to 12 Months)|Other|0|||
129010938|NCT01458405|464332885|FG001|Phase 1 (up to 12 Months)|Other|1|||
129010939|NCT01458405|464332886|FG002|Phase 1 (up to 12 Months)|Other|0|||
129010940|NCT01458405|464332887|FG003|Phase 1 (up to 12 Months)|Other|0|||
129010941|NCT01458405|464332884|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
129010942|NCT01458405|464332885|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
129010943|NCT01458405|464332886|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
129010944|NCT01458405|464332887|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
129010945|NCT01458405|464332884|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
129010946|NCT01458405|464332885|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
129010947|NCT01458405|464332886|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
129010948|NCT01458405|464332887|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
129010949|NCT01458405|464332884|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
129010950|NCT01458405|464332885|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
129010951|NCT01458405|464332886|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
129010952|NCT01458405|464332887|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
129010953|NCT02194998|464332888|FG000|On-HCV Treatment|Did not pick up study medication|0|||
129010954|NCT02194998|464332889|FG001|On-HCV Treatment|Did not pick up study medication|1|||
129010955|NCT02194998|464332890|FG002|On-HCV Treatment|Did not pick up study medication|0|||
129010956|NCT02194998|464332891|FG003|On-HCV Treatment|Did not pick up study medication|0|||
129010957|NCT02194998|464332888|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
129010958|NCT02194998|464332889|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
129010959|NCT02194998|464332890|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
129010960|NCT02194998|464332891|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
129010961|NCT02497781|464332892|FG000|Overall Study|Withdrawal by Subject|2|||
129010962|NCT02497781|464332893|FG001|Overall Study|Withdrawal by Subject|0|||
129010963|NCT02497781|464332892|FG000|Overall Study|Lack of Efficacy|0|||
129010964|NCT02497781|464332893|FG001|Overall Study|Lack of Efficacy|1|||
129010965|NCT02497781|464332892|FG000|Overall Study|Randomised but not treated|1|||
129010966|NCT02497781|464332893|FG001|Overall Study|Randomised but not treated|1|||
129010967|NCT02497781|464332892|FG000|Overall Study|Lost to Follow-up|1|||
129010968|NCT02497781|464332893|FG001|Overall Study|Lost to Follow-up|1|||
129010969|NCT02236130|464332894|FG000|Overall Study|Lost to Follow-up|7|||
129010970|NCT02236130|464332895|FG001|Overall Study|Lost to Follow-up|12|||
129010971|NCT00454636|464332896|FG000|Overall Study|Adverse Event|10|||
129010972|NCT00454636|464332897|FG001|Overall Study|Adverse Event|6|||
129010973|NCT00454636|464332898|FG002|Overall Study|Adverse Event|9|||
129010974|NCT00454636|464332899|FG003|Overall Study|Adverse Event|15|||
129010975|NCT00454636|464332896|FG000|Overall Study|Disease Progression|11|||
129010976|NCT00454636|464332897|FG001|Overall Study|Disease Progression|12|||
129010977|NCT00454636|464332898|FG002|Overall Study|Disease Progression|4|||
129010978|NCT00454636|464332899|FG003|Overall Study|Disease Progression|11|||
129010979|NCT00454636|464332896|FG000|Overall Study|Protocol Violation|3|||
129010980|NCT00454636|464332897|FG001|Overall Study|Protocol Violation|2|||
129010981|NCT00454636|464332898|FG002|Overall Study|Protocol Violation|3|||
129010982|NCT00454636|464332899|FG003|Overall Study|Protocol Violation|3|||
129010983|NCT00454636|464332896|FG000|Overall Study|Death|6|||
129010984|NCT00454636|464332897|FG001|Overall Study|Death|1|||
129010985|NCT00454636|464332898|FG002|Overall Study|Death|1|||
129010986|NCT00454636|464332899|FG003|Overall Study|Death|1|||
128676855|NCT01340872|463116812|FG002|Open-label Phase|Worsening of IBD|1|||
129010987|NCT00454636|464332896|FG000|Overall Study|Patient refusal|1|||
129100788|NCT00849290|464662801|FG000|Overall Study|Death|14|||
129100789|NCT00849290|464662801|FG000|Overall Study|Withdrawal by Subject|11|||
129100790|NCT00849290|464662801|FG000|Overall Study|Lost to Follow-up|2|||
129100791|NCT00849290|464662801|FG000|Overall Study|Protocol Violation|5|||
129100792|NCT00849290|464662801|FG000|Overall Study|Disease Progression|20|||
129100793|NCT01119846|464662806|FG000|Overall Study|Adverse Event|1|||
129100794|NCT01119846|464662807|FG001|Overall Study|Adverse Event|0|||
129100795|NCT01119846|464662808|FG002|Overall Study|Adverse Event|6|||
129100796|NCT01119846|464662806|FG000|Overall Study|Physician Decision|1|||
129100797|NCT01119846|464662807|FG001|Overall Study|Physician Decision|0|||
129100798|NCT01119846|464662808|FG002|Overall Study|Physician Decision|0|||
129100799|NCT01119846|464662806|FG000|Overall Study|Protocol Violation|0|||
129100800|NCT01119846|464662807|FG001|Overall Study|Protocol Violation|0|||
129100801|NCT01119846|464662808|FG002|Overall Study|Protocol Violation|1|||
129100802|NCT01119846|464662806|FG000|Overall Study|Withdrawal by Subject|0|||
129100803|NCT01119846|464662807|FG001|Overall Study|Withdrawal by Subject|0|||
129100804|NCT01119846|464662808|FG002|Overall Study|Withdrawal by Subject|4|||
129100805|NCT03304184|464662810|FG000|Overall Study|Withdrawal by Subject|1|||
129100806|NCT03304184|464662811|FG001|Overall Study|Withdrawal by Subject|2|||
129100807|NCT01605825|464662816|FG000|Overall Study|Adverse Event|4|||
129100808|NCT01605825|464662817|FG001|Overall Study|Adverse Event|2|||
129100809|NCT01605825|464662816|FG000|Overall Study|Withdrawal by Subject|0|||
129100810|NCT01605825|464662817|FG001|Overall Study|Withdrawal by Subject|1|||
129100811|NCT01605825|464662816|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
129100812|NCT01605825|464662817|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
129100813|NCT01605825|464662816|FG000|Overall Study|Non-Compliance with Protocol|3|||
129100814|NCT01605825|464662817|FG001|Overall Study|Non-Compliance with Protocol|0|||
129100815|NCT03244618|464662822|FG000|Overall Study|Lost to Follow-up|3|||
129100816|NCT03244618|464662823|FG001|Overall Study|Lost to Follow-up|4|||
129100817|NCT03244618|464662822|FG000|Overall Study|Protocol Violation|4|||
129100818|NCT03244618|464662823|FG001|Overall Study|Protocol Violation|3|||
129100819|NCT03244618|464662822|FG000|Overall Study|Withdrawal by Subject|0|||
129100820|NCT03244618|464662823|FG001|Overall Study|Withdrawal by Subject|2|||
129100821|NCT00913770|464662825|FG000|Overall Study|Unable to contact|24|||
129100822|NCT00913770|464662826|FG001|Overall Study|Unable to contact|19|||
129100823|NCT00913770|464662827|FG002|Overall Study|Unable to contact|13|||
129100824|NCT00913770|464662825|FG000|Overall Study|Refused|11|||
129100825|NCT00913770|464662826|FG001|Overall Study|Refused|10|||
129100826|NCT00913770|464662827|FG002|Overall Study|Refused|8|||
129100827|NCT00394771|464662830|FG000|Overall Study|Did not meet protocol requirements|1|||
129100828|NCT00394771|464662831|FG001|Overall Study|Did not meet protocol requirements|0|||
129100829|NCT00394771|464662832|FG002|Overall Study|Did not meet protocol requirements|2|||
129100830|NCT00394771|464662833|FG003|Overall Study|Did not meet protocol requirements|0|||
129100831|NCT00394771|464662830|FG000|Overall Study|Protocol Violation|2|||
129100832|NCT00394771|464662831|FG001|Overall Study|Protocol Violation|4|||
129100833|NCT00394771|464662832|FG002|Overall Study|Protocol Violation|9|||
129100834|NCT00394771|464662833|FG003|Overall Study|Protocol Violation|7|||
129100835|NCT00394771|464662830|FG000|Overall Study|Withdrawal by Subject|10|||
129100836|NCT00394771|464662831|FG001|Overall Study|Withdrawal by Subject|6|||
129100837|NCT00394771|464662832|FG002|Overall Study|Withdrawal by Subject|8|||
129100838|NCT00394771|464662833|FG003|Overall Study|Withdrawal by Subject|12|||
129100839|NCT00394771|464662830|FG000|Overall Study|Adverse Event|10|||
129100840|NCT00394771|464662831|FG001|Overall Study|Adverse Event|5|||
129100841|NCT00394771|464662832|FG002|Overall Study|Adverse Event|12|||
129100842|NCT00394771|464662833|FG003|Overall Study|Adverse Event|8|||
128676856|NCT01340872|463116813|FG003|Open-label Phase|Worsening of IBD|0|||
129100843|NCT00394771|464662830|FG000|Overall Study|Participant pregnant|0|||
129100844|NCT00394771|464662831|FG001|Overall Study|Participant pregnant|1|||
129100845|NCT00394771|464662832|FG002|Overall Study|Participant pregnant|2|||
129100846|NCT00394771|464662833|FG003|Overall Study|Participant pregnant|2|||
129100847|NCT00394771|464662830|FG000|Overall Study|Lost to Follow-up|15|||
128676857|NCT01771809|463116816|FG000|Overall Study|Adverse Event|4|||
128676858|NCT01771809|463116817|FG001|Overall Study|Adverse Event|12|||
129100848|NCT00394771|464662831|FG001|Overall Study|Lost to Follow-up|15|||
129100849|NCT00394771|464662832|FG002|Overall Study|Lost to Follow-up|13|||
129100850|NCT00394771|464662833|FG003|Overall Study|Lost to Follow-up|10|||
129100851|NCT00394771|464662830|FG000|Overall Study|Other|3|||
129100852|NCT00394771|464662831|FG001|Overall Study|Other|3|||
128676859|NCT01771809|463116816|FG000|Overall Study|Protocol Violation|0|||
129100853|NCT00394771|464662832|FG002|Overall Study|Other|1|||
128676860|NCT01771809|463116817|FG001|Overall Study|Protocol Violation|1|||
128676861|NCT01771809|463116816|FG000|Overall Study|Withdrawal by Subject|34|||
129100854|NCT00394771|464662833|FG003|Overall Study|Other|0|||
129100855|NCT00586898|464662838|FG000|Overall Study|Adverse Event|1|||
129100856|NCT00586898|464662838|FG000|Overall Study|Patiemt Non-compliance|1|||
129100857|NCT00586898|464662838|FG000|Overall Study|Evaluable for Toxicity Only|5|||
129100858|NCT03816007|464662839|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
129100859|NCT03816007|464662840|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
129100860|NCT03816007|464662839|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
128676862|NCT01771809|463116817|FG001|Overall Study|Withdrawal by Subject|42|||
129100861|NCT03816007|464662840|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
129100862|NCT03816007|464662839|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
129100863|NCT03816007|464662840|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
129100864|NCT01926197|464662841|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
129100865|NCT01926197|464662842|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
129100866|NCT01926197|464662841|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
129100867|NCT01926197|464662842|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
129100868|NCT01428115|464662844|FG000|Overall Study|Lack of Efficacy|3|||
129100869|NCT01428115|464662844|FG000|Overall Study|Lost to Follow-up|10|||
129100870|NCT01428115|464662844|FG000|Overall Study|Pregnancy|1|||
129100871|NCT01428115|464662844|FG000|Overall Study|Protocol Violation|3|||
129100872|NCT01428115|464662844|FG000|Overall Study|Withdrawal by Subject|4|||
129100873|NCT02620384|464662845|FG000|Overall Study|Adverse Event|2|||
129100874|NCT02620384|464662846|FG001|Overall Study|Adverse Event|1|||
129100875|NCT02620384|464662845|FG000|Overall Study|Discharged prior to 2nd dose|2|||
129100876|NCT02620384|464662846|FG001|Overall Study|Discharged prior to 2nd dose|5|||
129100877|NCT02620384|464662845|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
129100878|NCT02620384|464662846|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
129100879|NCT02101359|464662847|FG000|Overall Study|Not included|23|||
129100880|NCT02101359|464662848|FG001|Overall Study|Not included|13|||
129100881|NCT02101359|464662847|FG000|Overall Study|Withdrawal by Subject|5|||
129100882|NCT02101359|464662848|FG001|Overall Study|Withdrawal by Subject|4|||
129100883|NCT02101359|464662847|FG000|Overall Study|Lost to Follow-up|1|||
129100884|NCT02101359|464662848|FG001|Overall Study|Lost to Follow-up|0|||
129100885|NCT02101359|464662847|FG000|Overall Study|Protocol Violation|0|||
129100886|NCT02101359|464662848|FG001|Overall Study|Protocol Violation|2|||
129100887|NCT01483599|464662850|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
129100888|NCT01483599|464662851|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100889|NCT01483599|464662852|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100890|NCT01483599|464662853|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
129100891|NCT01483599|464662854|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
129100892|NCT01483599|464662855|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
129100893|NCT01483599|464662856|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
129100894|NCT01483599|464662857|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100895|NCT01483599|464662858|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100896|NCT01483599|464662859|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100897|NCT01483599|464662860|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100898|NCT01483599|464662861|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100899|NCT01483599|464662862|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100900|NCT01483599|464662863|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129100901|NCT01483599|464662850|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100902|NCT01483599|464662851|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
129100903|NCT01483599|464662852|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100904|NCT01483599|464662853|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
129100905|NCT01483599|464662854|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100906|NCT01483599|464662855|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100907|NCT01483599|464662856|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
129100908|NCT01483599|464662857|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100909|NCT01483599|464662858|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100910|NCT01483599|464662859|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100911|NCT01483599|464662860|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100912|NCT01483599|464662861|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100913|NCT01483599|464662862|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100914|NCT01483599|464662863|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129100915|NCT01483599|464662850|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
129100916|NCT01483599|464662851|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100917|NCT01483599|464662852|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100918|NCT01483599|464662853|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100919|NCT01483599|464662854|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100920|NCT01483599|464662855|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100921|NCT01483599|464662856|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
128676863|NCT01771809|463116816|FG000|Overall Study|Lost to Follow-up|1|||
128676864|NCT01771809|463116817|FG001|Overall Study|Lost to Follow-up|3|||
128676865|NCT01771809|463116816|FG000|Overall Study|Other (Insufficient clinical response)|22|||
129100922|NCT01483599|464662857|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
128676866|NCT01771809|463116817|FG001|Overall Study|Other (Insufficient clinical response)|20|||
128676867|NCT01771809|463116816|FG000|Overall Study|Death|1|||
129010988|NCT00454636|464332897|FG001|Overall Study|Patient refusal|1|||
129010989|NCT00454636|464332898|FG002|Overall Study|Patient refusal|3|||
129010990|NCT00454636|464332899|FG003|Overall Study|Patient refusal|2|||
129010991|NCT00454636|464332896|FG000|Overall Study|Lost to Follow-up|0|||
129010992|NCT00454636|464332897|FG001|Overall Study|Lost to Follow-up|1|||
129010993|NCT00454636|464332898|FG002|Overall Study|Lost to Follow-up|0|||
129010994|NCT00454636|464332899|FG003|Overall Study|Lost to Follow-up|0|||
129010995|NCT01400113|464332900|FG000|Overall Study|Withdrawal by Subject|1|||
129010996|NCT01400113|464332901|FG001|Overall Study|Withdrawal by Subject|1|||
129010997|NCT01179919|464332902|FG000|Overall Study|Protocol Violation|1|||
129010998|NCT01179919|464332902|FG000|Overall Study|Adverse Event|1|||
129010999|NCT00806156|464332903|FG000|Overall Study|Death|35|||
129011000|NCT00806156|464332904|FG001|Overall Study|Death|95|||
129011001|NCT00806156|464332903|FG000|Overall Study|Did not meet eligibility criteria|1|||
129011002|NCT00806156|464332904|FG001|Overall Study|Did not meet eligibility criteria|0|||
129011003|NCT00806156|464332903|FG000|Overall Study|Study terminated by Sponsor|2|||
129011004|NCT00806156|464332904|FG001|Overall Study|Study terminated by Sponsor|40|||
129011005|NCT00806156|464332903|FG000|Overall Study|Consent withdrawn by subject|1|||
129011006|NCT00806156|464332904|FG001|Overall Study|Consent withdrawn by subject|3|||
129011007|NCT00806156|464332903|FG000|Overall Study|Lost to Follow-up|0|||
129011008|NCT00806156|464332904|FG001|Overall Study|Lost to Follow-up|1|||
129011009|NCT01025037|464332909|FG000|Overall Study|Adverse Event|3|||
129011010|NCT01025037|464332909|FG000|Overall Study|Lost to Follow-up|7|||
129011011|NCT01025037|464332909|FG000|Overall Study|Withdrawal by Subject|1|||
129011012|NCT00337571|464332911|FG000|Overall Study|Lack of Efficacy|3|||
129011013|NCT00337571|464332912|FG001|Overall Study|Lack of Efficacy|0|||
129011014|NCT00337571|464332913|FG002|Overall Study|Lack of Efficacy|0|||
129011015|NCT00337571|464332914|FG003|Overall Study|Lack of Efficacy|0|||
129011016|NCT00337571|464332911|FG000|Overall Study|Adverse Event|4|||
129011017|NCT00337571|464332912|FG001|Overall Study|Adverse Event|5|||
129011018|NCT00337571|464332913|FG002|Overall Study|Adverse Event|8|||
129011019|NCT00337571|464332914|FG003|Overall Study|Adverse Event|4|||
129011020|NCT00337571|464332911|FG000|Overall Study|Withdrawal by Subject|2|||
129011021|NCT00337571|464332912|FG001|Overall Study|Withdrawal by Subject|2|||
129011022|NCT00337571|464332913|FG002|Overall Study|Withdrawal by Subject|1|||
129011023|NCT00337571|464332914|FG003|Overall Study|Withdrawal by Subject|0|||
129011024|NCT00337571|464332911|FG000|Overall Study|Lost to Follow-up|3|||
129011025|NCT00337571|464332912|FG001|Overall Study|Lost to Follow-up|1|||
129011026|NCT00337571|464332913|FG002|Overall Study|Lost to Follow-up|0|||
129100923|NCT01483599|464662858|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100924|NCT01483599|464662859|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100925|NCT01483599|464662860|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100926|NCT01483599|464662861|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100927|NCT01483599|464662862|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100928|NCT01483599|464662863|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129100929|NCT01483599|464662850|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
129100930|NCT01483599|464662851|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
129100931|NCT01483599|464662852|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
129100932|NCT01483599|464662853|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
128676868|NCT01771809|463116817|FG001|Overall Study|Death|0|||
128676869|NCT01771809|463116816|FG000|Overall Study|Other (other)|9|||
129011027|NCT00337571|464332914|FG003|Overall Study|Lost to Follow-up|1|||
129011028|NCT00337571|464332911|FG000|Overall Study|Poor/noncompliance|1|||
129011029|NCT00337571|464332912|FG001|Overall Study|Poor/noncompliance|1|||
129011030|NCT00337571|464332913|FG002|Overall Study|Poor/noncompliance|1|||
129011031|NCT00337571|464332914|FG003|Overall Study|Poor/noncompliance|1|||
129011032|NCT00337571|464332911|FG000|Overall Study|No longer met study criteria|1|||
129011033|NCT00337571|464332912|FG001|Overall Study|No longer met study criteria|0|||
129011034|NCT00337571|464332913|FG002|Overall Study|No longer met study criteria|0|||
129011035|NCT00337571|464332914|FG003|Overall Study|No longer met study criteria|0|||
129011036|NCT00337571|464332911|FG000|Overall Study|High Potassium level|0|||
129011037|NCT00337571|464332912|FG001|Overall Study|High Potassium level|0|||
129011038|NCT00337571|464332913|FG002|Overall Study|High Potassium level|0|||
129011039|NCT00337571|464332914|FG003|Overall Study|High Potassium level|1|||
129011040|NCT01890915|464332915|FG000|Overall Study|Adverse Event|1|||
129011041|NCT01890915|464332916|FG001|Overall Study|Adverse Event|0|||
129011042|NCT01890915|464332915|FG000|Overall Study|Protocol Violation|2|||
129011043|NCT01890915|464332916|FG001|Overall Study|Protocol Violation|0|||
129011044|NCT01890915|464332915|FG000|Overall Study|Equipment Malfunction|0|||
129011045|NCT01890915|464332916|FG001|Overall Study|Equipment Malfunction|1|||
129011046|NCT02114697|464332917|FG000|Overall Study|Study terminated|5|||
129011047|NCT02114697|464332918|FG001|Overall Study|Study terminated|4|||
129011048|NCT00424489|464332919|FG000|Overall Study|Death|3|||
129011049|NCT03552757|464332922|FG000|Overall Study|Withdrawal by Subject|10|||
129011050|NCT03552757|464332923|FG001|Overall Study|Withdrawal by Subject|5|||
129100933|NCT01483599|464662854|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
129100934|NCT01483599|464662855|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
129100935|NCT01483599|464662856|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
129100936|NCT01483599|464662857|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
129100937|NCT01483599|464662858|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
129100938|NCT01483599|464662859|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
129100939|NCT01483599|464662860|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
129100940|NCT01483599|464662861|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
129100941|NCT01483599|464662862|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
129100942|NCT01483599|464662863|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
129100943|NCT01483599|464662850|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
129100944|NCT01483599|464662851|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
129100945|NCT01483599|464662852|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
129100946|NCT01483599|464662853|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
129100947|NCT01483599|464662854|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
129100948|NCT01483599|464662855|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
129100949|NCT01483599|464662856|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
129100950|NCT01483599|464662857|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
129100951|NCT01483599|464662858|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
129100952|NCT01483599|464662859|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
129100953|NCT01483599|464662860|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
129100954|NCT01483599|464662861|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
129100955|NCT01483599|464662862|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
129100956|NCT01483599|464662863|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
129100957|NCT01483599|464662850|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100958|NCT01483599|464662851|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100959|NCT01483599|464662852|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100960|NCT01483599|464662853|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100961|NCT01483599|464662854|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100962|NCT01483599|464662855|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100963|NCT01483599|464662856|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100964|NCT01483599|464662857|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129100965|NCT01483599|464662858|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129100966|NCT01483599|464662859|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100967|NCT01483599|464662860|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100968|NCT01483599|464662861|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129100969|NCT01483599|464662862|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129100970|NCT01483599|464662863|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129100971|NCT01483599|464662850|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100972|NCT01483599|464662851|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100973|NCT01483599|464662852|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100974|NCT01483599|464662853|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100975|NCT01483599|464662854|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100976|NCT01483599|464662855|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100977|NCT01483599|464662856|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100978|NCT01483599|464662857|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100979|NCT01483599|464662858|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
129100980|NCT01483599|464662859|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100981|NCT01483599|464662860|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100982|NCT01483599|464662861|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
129100983|NCT01483599|464662862|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129100984|NCT01483599|464662863|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
129100985|NCT01483599|464662850|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100986|NCT01483599|464662851|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100987|NCT01483599|464662852|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100988|NCT01483599|464662853|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100989|NCT01483599|464662854|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100990|NCT01483599|464662855|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100991|NCT01483599|464662856|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100992|NCT01483599|464662857|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100993|NCT01483599|464662858|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
129100994|NCT01483599|464662859|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100995|NCT01483599|464662860|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
129100996|NCT01483599|464662861|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100997|NCT01483599|464662862|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129100998|NCT01483599|464662863|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
128676870|NCT01771809|463116817|FG001|Overall Study|Other (other)|5|||
128676871|NCT01142089|463116823|FG000|Overall Study|Physician Decision|1|||
128676872|NCT01142089|463116824|FG001|Overall Study|Physician Decision|0|||
128676873|NCT01142089|463116823|FG000|Overall Study|Withdrawal by Subject|1|||
129011051|NCT03552757|464332924|FG002|Overall Study|Withdrawal by Subject|12|||
129011052|NCT03552757|464332922|FG000|Overall Study|Lost to Follow-up|2|||
129011053|NCT03552757|464332923|FG001|Overall Study|Lost to Follow-up|7|||
129011054|NCT03552757|464332924|FG002|Overall Study|Lost to Follow-up|7|||
129011055|NCT03552757|464332922|FG000|Overall Study|Death|1|||
129011056|NCT03552757|464332923|FG001|Overall Study|Death|1|||
129011057|NCT03552757|464332924|FG002|Overall Study|Death|1|||
129011058|NCT00386009|464332928|FG000|Overall Study|Adverse Event|0|||
129011059|NCT00386009|464332929|FG001|Overall Study|Adverse Event|2|||
129011060|NCT00386009|464332928|FG000|Overall Study|Death|1|||
129011061|NCT00386009|464332929|FG001|Overall Study|Death|0|||
129011062|NCT00386009|464332928|FG000|Overall Study|Entry Criteria Not Met|0|||
129011063|NCT00386009|464332929|FG001|Overall Study|Entry Criteria Not Met|2|||
129011064|NCT00386009|464332928|FG000|Overall Study|Lost to Follow-up|1|||
129011065|NCT00386009|464332929|FG001|Overall Study|Lost to Follow-up|1|||
129011066|NCT00386009|464332928|FG000|Overall Study|Protocol Violation|1|||
129011067|NCT00386009|464332929|FG001|Overall Study|Protocol Violation|0|||
129011068|NCT00386009|464332928|FG000|Overall Study|Sponsor Decision|1|||
129011069|NCT00386009|464332929|FG001|Overall Study|Sponsor Decision|1|||
129011070|NCT00386009|464332928|FG000|Overall Study|Withdrawal by Subject|5|||
129011071|NCT00386009|464332929|FG001|Overall Study|Withdrawal by Subject|4|||
129011072|NCT04646109|464332934|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
129011073|NCT04646109|464332935|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
129011074|NCT00117949|464332936|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
129011075|NCT00117949|464332937|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
129011076|NCT00117949|464332938|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
129011077|NCT00117949|464332939|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
129011078|NCT00117949|464332936|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
129011079|NCT00117949|464332937|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
129011080|NCT00117949|464332938|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
129011081|NCT00117949|464332939|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
129011082|NCT00117949|464332936|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
129011083|NCT00117949|464332937|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
129011084|NCT00117949|464332938|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
129011085|NCT00117949|464332939|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
129011086|NCT00117949|464332936|FG000|Overall Study|PSA increase >=10ng/mL|0|||
129011087|NCT00117949|464332937|FG001|Overall Study|PSA increase >=10ng/mL|1|||
129011088|NCT00117949|464332938|FG002|Overall Study|PSA increase >=10ng/mL|1|||
129011089|NCT00117949|464332939|FG003|Overall Study|PSA increase >=10ng/mL|0|||
129011090|NCT00117949|464332936|FG000|Overall Study|PSA reduction <=50%|0|||
129011091|NCT00117949|464332937|FG001|Overall Study|PSA reduction <=50%|2|||
129011092|NCT00117949|464332938|FG002|Overall Study|PSA reduction <=50%|2|||
129011093|NCT00117949|464332939|FG003|Overall Study|PSA reduction <=50%|4|||
129011094|NCT00117949|464332936|FG000|Overall Study|Hepatic abnormalities|0|||
129011095|NCT00117949|464332937|FG001|Overall Study|Hepatic abnormalities|1|||
129011096|NCT00117949|464332938|FG002|Overall Study|Hepatic abnormalities|0|||
129011097|NCT00117949|464332939|FG003|Overall Study|Hepatic abnormalities|1|||
129011098|NCT03184441|464332947|FG000|Overall Study|Withdrawal by Subject|1|||
129011099|NCT01868009|464332948|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
129011100|NCT01868009|464332949|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
129011101|NCT01868009|464332948|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
129011102|NCT01868009|464332949|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
129011103|NCT01868009|464332948|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
129011104|NCT01868009|464332949|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
129011105|NCT04803357|464332952|FG000|Overall Study|Withdrawal by Subject|31|||
129011106|NCT04803357|464332953|FG001|Overall Study|Withdrawal by Subject|5|||
128676874|NCT01142089|463116824|FG001|Overall Study|Withdrawal by Subject|2|||
129011107|NCT00182091|464332954|FG000|Overall Study|Withdrawal by Subject|1|||
129011108|NCT00182091|464332955|FG001|Overall Study|Withdrawal by Subject|0|||
129011109|NCT00182091|464332956|FG002|Overall Study|Withdrawal by Subject|0|||
129011110|NCT00182091|464332957|FG003|Overall Study|Withdrawal by Subject|0|||
129011111|NCT01046253|464332958|FG000|Second Intervention|Adverse Event|0|||
129011112|NCT01046253|464332959|FG001|Second Intervention|Adverse Event|1|||
129011113|NCT01046253|464332958|FG000|Second Intervention|Protocol Violation|0|||
129011114|NCT01046253|464332959|FG001|Second Intervention|Protocol Violation|1|||
129011115|NCT02339909|464332962|FG000|Overall Study|Became ineligible after randomisation|89|||
129011116|NCT02339909|464332963|FG001|Overall Study|Became ineligible after randomisation|63|||
129011117|NCT02339909|464332964|FG002|Overall Study|Became ineligible after randomisation|71|||
129011118|NCT00860028|464332972|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
129011119|NCT00860028|464332973|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
128676875|NCT01142089|463116823|FG000|Overall Study|Use of prohibited medications|0|||
128676876|NCT01142089|463116824|FG001|Overall Study|Use of prohibited medications|1|||
128676877|NCT01142089|463116823|FG000|Overall Study|Noncompliance with study procedures|2|||
128676878|NCT01142089|463116824|FG001|Overall Study|Noncompliance with study procedures|1|||
128676879|NCT01142089|463116823|FG000|Overall Study|Patient required rescue medication|8|||
128676880|NCT01142089|463116824|FG001|Overall Study|Patient required rescue medication|17|||
128676881|NCT02907892|463116829|FG000|Overall Study|Lost to Follow-up|27|||
128676882|NCT02907892|463116830|FG001|Overall Study|Lost to Follow-up|40|||
128676883|NCT01974765|463116831|FG000|Overall Study|Withdrawal by Subject|1|||
129011120|NCT00993616|464332975|FG000|Overall Study|No tumor at entry|1|||
129011121|NCT00993616|464332975|FG000|Overall Study|Never treated|1|||
129011122|NCT03815942|464334395|FG000|Overall Study|Withdrawal by Subject|0|||
129011123|NCT03815942|464334396|FG001|Overall Study|Withdrawal by Subject|17|||
129011124|NCT02785913|464334397|FG000|Overall Study|Adverse Event|5|||
129011125|NCT02785913|464334397|FG000|Overall Study|Death|2|||
129011126|NCT02785913|464334397|FG000|Overall Study|Progression|18|||
129011127|NCT02785913|464334397|FG000|Overall Study|Not protocol specified|1|||
129011128|NCT03717064|464334398|FG000|Period 2|Adverse Event|1|||
129011129|NCT02841709|464334399|FG000|5th Intervention|Adverse Event|2|||
129011130|NCT02841709|464334400|FG001|5th Intervention|Adverse Event|0|||
129011131|NCT02841709|464334401|FG002|5th Intervention|Adverse Event|0|||
129011132|NCT02841709|464334402|FG003|5th Intervention|Adverse Event|0|||
129011133|NCT02841709|464334403|FG004|5th Intervention|Adverse Event|2|||
129011134|NCT01929109|464334404|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
129011135|NCT01929109|464334405|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
129011136|NCT01929109|464334406|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
129011137|NCT01929109|464334407|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
129011138|NCT01929109|464334408|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
129011139|NCT00076102|464334409|FG000|Overall Study|Clinical progression|1|||
129011140|NCT00076102|464334409|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
129011141|NCT00076102|464334409|FG000|Overall Study|plexiform neurofibroma surgery|1|||
129011142|NCT00076102|464334409|FG000|Overall Study|refusal of further therapy|2|||
129011143|NCT01402908|464334412|FG000|Overall Study|Withdrawal by Subject|30|||
129011144|NCT01402908|464334413|FG001|Overall Study|Withdrawal by Subject|17|||
129011145|NCT01402908|464334412|FG000|Overall Study|Lost to Follow-up|3|||
129011146|NCT01402908|464334413|FG001|Overall Study|Lost to Follow-up|1|||
129011147|NCT01402908|464334412|FG000|Overall Study|Physician Decision|1|||
129011148|NCT01402908|464334413|FG001|Overall Study|Physician Decision|0|||
129011149|NCT02581345|464334414|FG000|Part 1: up to Week 16|Adverse Event|3|||
129011150|NCT02581345|464334415|FG001|Part 1: up to Week 16|Adverse Event|8|||
129011151|NCT02581345|464334416|FG002|Part 1: up to Week 16|Adverse Event|0|||
129011152|NCT02581345|464334417|FG003|Part 1: up to Week 16|Adverse Event|0|||
129011153|NCT02581345|464334414|FG000|Part 1: up to Week 16|Physician Decision|2|||
129011154|NCT02581345|464334415|FG001|Part 1: up to Week 16|Physician Decision|4|||
129011155|NCT02581345|464334416|FG002|Part 1: up to Week 16|Physician Decision|0|||
129011156|NCT02581345|464334417|FG003|Part 1: up to Week 16|Physician Decision|0|||
129011157|NCT02581345|464334414|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
129011158|NCT02581345|464334415|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
129011159|NCT02581345|464334416|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
129011160|NCT02581345|464334417|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
129011161|NCT02581345|464334414|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
129011162|NCT02581345|464334415|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
129011163|NCT02581345|464334416|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
129011164|NCT02581345|464334417|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
129011165|NCT02581345|464334414|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
129011166|NCT02581345|464334415|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
129011167|NCT02581345|464334416|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
129011168|NCT02581345|464334417|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
129011169|NCT02581345|464334414|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
129011170|NCT02581345|464334415|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
129011171|NCT02581345|464334416|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
129011172|NCT02581345|464334417|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
129011173|NCT02581345|464334414|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
129011174|NCT02581345|464334415|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
129011175|NCT02581345|464334416|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
129011176|NCT02581345|464334417|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
129011177|NCT02581345|464334414|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
129011178|NCT02581345|464334415|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
129011179|NCT02581345|464334416|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
129011180|NCT02581345|464334417|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
129011181|NCT02581345|464334414|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
129011182|NCT02581345|464334415|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
129011183|NCT02581345|464334416|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
129011184|NCT02581345|464334417|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
128676884|NCT01974765|463116831|FG000|Overall Study|Death|1|||
128676885|NCT01974765|463116831|FG000|Overall Study|Adverse Event|2|||
128676886|NCT00730028|463116835|FG000|Overall Study|Adverse Event|23|||
128676887|NCT00730028|463116836|FG001|Overall Study|Adverse Event|26|||
128676888|NCT00730028|463116837|FG002|Overall Study|Adverse Event|16|||
128676889|NCT00730028|463116838|FG003|Overall Study|Adverse Event|20|||
128676890|NCT00730028|463116839|FG004|Overall Study|Adverse Event|43|||
128676891|NCT00730028|463116835|FG000|Overall Study|Lost to Follow-up|13|||
128676892|NCT00730028|463116836|FG001|Overall Study|Lost to Follow-up|26|||
128676893|NCT00730028|463116837|FG002|Overall Study|Lost to Follow-up|22|||
128676894|NCT00730028|463116838|FG003|Overall Study|Lost to Follow-up|26|||
128676895|NCT00730028|463116839|FG004|Overall Study|Lost to Follow-up|25|||
128676896|NCT00730028|463116835|FG000|Overall Study|Protocol Violation|6|||
128676897|NCT00730028|463116836|FG001|Overall Study|Protocol Violation|1|||
128676898|NCT00730028|463116837|FG002|Overall Study|Protocol Violation|1|||
128676899|NCT00730028|463116838|FG003|Overall Study|Protocol Violation|2|||
128676900|NCT00730028|463116839|FG004|Overall Study|Protocol Violation|0|||
128676901|NCT00730028|463116835|FG000|Overall Study|Withdrawal by Subject|9|||
128676902|NCT00730028|463116836|FG001|Overall Study|Withdrawal by Subject|5|||
128676903|NCT00730028|463116837|FG002|Overall Study|Withdrawal by Subject|4|||
128676904|NCT00730028|463116838|FG003|Overall Study|Withdrawal by Subject|5|||
128676905|NCT00730028|463116839|FG004|Overall Study|Withdrawal by Subject|9|||
128676906|NCT00730028|463116835|FG000|Overall Study|Physician Decision|3|||
128676907|NCT00730028|463116836|FG001|Overall Study|Physician Decision|3|||
128676908|NCT00730028|463116837|FG002|Overall Study|Physician Decision|2|||
128676909|NCT00730028|463116838|FG003|Overall Study|Physician Decision|3|||
128676910|NCT00730028|463116839|FG004|Overall Study|Physician Decision|2|||
128676911|NCT00730028|463116835|FG000|Overall Study|Treatment Failure|5|||
128676912|NCT00730028|463116836|FG001|Overall Study|Treatment Failure|5|||
128676913|NCT00730028|463116837|FG002|Overall Study|Treatment Failure|0|||
128676914|NCT00730028|463116838|FG003|Overall Study|Treatment Failure|0|||
128676915|NCT00730028|463116839|FG004|Overall Study|Treatment Failure|1|||
128676916|NCT00730028|463116835|FG000|Overall Study|Randomization Error|1|||
128676917|NCT00730028|463116836|FG001|Overall Study|Randomization Error|0|||
128676918|NCT00730028|463116837|FG002|Overall Study|Randomization Error|0|||
128676919|NCT00730028|463116838|FG003|Overall Study|Randomization Error|0|||
128676920|NCT00730028|463116839|FG004|Overall Study|Randomization Error|2|||
128676921|NCT00003472|463116840|FG000|Overall Study|Not evaluable|3|||
128676922|NCT00528970|463116841|FG000|Overall Study|Adverse Event|6|||
128676923|NCT00528970|463116842|FG001|Overall Study|Adverse Event|8|||
128676924|NCT00528970|463116843|FG002|Overall Study|Adverse Event|5|||
128676925|NCT00528970|463116841|FG000|Overall Study|Lost to Follow-up|0|||
128676926|NCT00528970|463116842|FG001|Overall Study|Lost to Follow-up|0|||
129011185|NCT02581345|464334414|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
129011186|NCT02581345|464334415|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
129011187|NCT02581345|464334416|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
129011188|NCT02581345|464334417|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
128676927|NCT00528970|463116843|FG002|Overall Study|Lost to Follow-up|1|||
128676928|NCT00528970|463116841|FG000|Overall Study|Other than specified|2|||
128676929|NCT00528970|463116842|FG001|Overall Study|Other than specified|3|||
128676930|NCT00528970|463116843|FG002|Overall Study|Other than specified|3|||
128676931|NCT00528970|463116841|FG000|Overall Study|Protocol Violation|2|||
128676932|NCT00528970|463116842|FG001|Overall Study|Protocol Violation|1|||
129011189|NCT02581345|464334414|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
129011190|NCT02581345|464334415|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
129011191|NCT02581345|464334416|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
129011192|NCT02581345|464334417|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
129011193|NCT02581345|464334414|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
129011194|NCT02581345|464334415|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
129011195|NCT02581345|464334416|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
129011196|NCT02581345|464334417|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
129011197|NCT01244126|464334420|FG000|Overall Study|Protocol Violation|3|||
129011198|NCT01244126|464334421|FG001|Overall Study|Protocol Violation|3|||
129011199|NCT01244126|464334422|FG002|Overall Study|Protocol Violation|9|||
128676933|NCT00528970|463116843|FG002|Overall Study|Protocol Violation|4|||
128676934|NCT00528970|463116841|FG000|Overall Study|Lack of Efficacy|0|||
129011200|NCT00863746|464334427|FG000|Treatment|Not treated|4|||
129011201|NCT00863746|464334428|FG001|Treatment|Not treated|2|||
129011202|NCT00863746|464334427|FG000|Treatment|Adverse Event|41|||
128676935|NCT00528970|463116842|FG001|Overall Study|Lack of Efficacy|0|||
128676936|NCT00528970|463116843|FG002|Overall Study|Lack of Efficacy|1|||
128676937|NCT00528970|463116841|FG000|Overall Study|Withdrawal by Subject|4|||
128676938|NCT00528970|463116842|FG001|Overall Study|Withdrawal by Subject|3|||
128676939|NCT00528970|463116843|FG002|Overall Study|Withdrawal by Subject|5|||
128676940|NCT00528970|463116841|FG000|Overall Study|Randomized but not treated|0|||
128676941|NCT00528970|463116842|FG001|Overall Study|Randomized but not treated|0|||
128676942|NCT00528970|463116843|FG002|Overall Study|Randomized but not treated|1|||
128676943|NCT03860935|463116844|FG000|Overall Study|Withdrawal of Consent|15|||
128676944|NCT03860935|463116845|FG001|Overall Study|Withdrawal of Consent|6|||
128676945|NCT03860935|463116844|FG000|Overall Study|Death|75|||
128676946|NCT03860935|463116845|FG001|Overall Study|Death|51|||
128676947|NCT03086967|463116846|FG000|Overall Study|Screen Failure|2|||
128676948|NCT03086967|463116847|FG001|Overall Study|Screen Failure|2|||
129011203|NCT00863746|464334428|FG001|Treatment|Adverse Event|16|||
129011204|NCT00863746|464334427|FG000|Treatment|non-compliant with study medication|4|||
129011205|NCT00863746|464334428|FG001|Treatment|non-compliant with study medication|0|||
129011206|NCT00863746|464334427|FG000|Treatment|Consent withdrawn|15|||
129011207|NCT00863746|464334428|FG001|Treatment|Consent withdrawn|14|||
129011208|NCT00863746|464334427|FG000|Treatment|Lost to Follow-up|1|||
129011209|NCT00863746|464334428|FG001|Treatment|Lost to Follow-up|0|||
129011210|NCT00863746|464334427|FG000|Treatment|Protocol Violation|5|||
129011211|NCT00863746|464334428|FG001|Treatment|Protocol Violation|3|||
129011212|NCT00863746|464334427|FG000|Treatment|Other|1|||
129011213|NCT00863746|464334428|FG001|Treatment|Other|0|||
129011214|NCT00863746|464334427|FG000|Survival Follow up|Death|244|||
129011215|NCT00863746|464334428|FG001|Survival Follow up|Death|271|||
129011216|NCT00863746|464334427|FG000|Survival Follow up|Lost to Follow-up|2|||
129011217|NCT00863746|464334428|FG001|Survival Follow up|Lost to Follow-up|1|||
129011218|NCT00863746|464334427|FG000|Survival Follow up|Consent Withdrawn|7|||
129011219|NCT00863746|464334428|FG001|Survival Follow up|Consent Withdrawn|8|||
129011220|NCT00453362|464334429|FG000|Overall Study|Adverse Event|5|||
129011221|NCT00453362|464334429|FG000|Overall Study|Death|7|||
129011222|NCT00453362|464334429|FG000|Overall Study|Physician Decision|2|||
129011223|NCT00453362|464334429|FG000|Overall Study|Withdrawal by Subject|3|||
129011224|NCT00453362|464334429|FG000|Overall Study|Progression of disease|56|||
129011225|NCT00453362|464334429|FG000|Overall Study|Screening Failure|14|||
129011226|NCT04885296|464334430|FG000|Period 1|Covid-19 Related|1|||
129011227|NCT04885296|464334431|FG001|Period 1|Covid-19 Related|0|||
129011228|NCT04885296|464334430|FG000|Period 1|Adverse Event|0|||
129011229|NCT04885296|464334431|FG001|Period 1|Adverse Event|1|||
129011230|NCT04885296|464334430|FG000|Period 1|Withdrawal by Subject|1|||
129011231|NCT04885296|464334431|FG001|Period 1|Withdrawal by Subject|1|||
129011232|NCT04885296|464334430|FG000|Period 1|Test Article No Longer Available|1|||
129011233|NCT04885296|464334431|FG001|Period 1|Test Article No Longer Available|0|||
129011234|NCT04885296|464334430|FG000|Period 1|Dispensed Study lens in Error|1|||
129011235|NCT04885296|464334431|FG001|Period 1|Dispensed Study lens in Error|0|||
129011236|NCT04885296|464334430|FG000|Period 1|Lost to Follow-up|1|||
129011237|NCT04885296|464334431|FG001|Period 1|Lost to Follow-up|0|||
129011238|NCT04885296|464334430|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
129011239|NCT04885296|464334431|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
129011240|NCT00862979|464334432|FG000|Overall Study|Adverse Event|6|||
129011241|NCT00862979|464334433|FG001|Overall Study|Adverse Event|3|||
129011242|NCT00862979|464334432|FG000|Overall Study|Protocol Violation|0|||
129011243|NCT00862979|464334433|FG001|Overall Study|Protocol Violation|1|||
129011244|NCT00862979|464334432|FG000|Overall Study|Patient withdrew consent|2|||
129011245|NCT00862979|464334433|FG001|Overall Study|Patient withdrew consent|1|||
129011246|NCT00862979|464334432|FG000|Overall Study|Administrative problems|0|||
129011247|NCT00862979|464334433|FG001|Overall Study|Administrative problems|1|||
129011248|NCT00862979|464334432|FG000|Overall Study|Death|0|||
129011249|NCT00862979|464334433|FG001|Overall Study|Death|1|||
129011250|NCT01367275|464334437|FG000|Overall Study|Ineligible|1|||
129011251|NCT01367275|464334437|FG000|Overall Study|Disease Progression|2|||
129011252|NCT05346055|464334438|FG000|Overall Study|Withdrawal by Subject|1|||
129011253|NCT05346055|464334438|FG000|Overall Study|Protocol Violation|1|||
129011254|NCT05346055|464334438|FG000|Overall Study|Therapist decision|1|||
129011255|NCT01545076|464334441|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
129011256|NCT01545076|464334442|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
129011257|NCT01545076|464334443|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
129011258|NCT01545076|464334444|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
129011259|NCT01545076|464334445|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
129011260|NCT01545076|464334441|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
129011261|NCT01545076|464334442|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
129011262|NCT01545076|464334443|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
129011263|NCT01545076|464334444|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
129011264|NCT01545076|464334445|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
129011265|NCT01545076|464334441|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
128676949|NCT02230527|463116848|FG000|Overall Study|Withdrawal by Subject|1|||
129011266|NCT01545076|464334442|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
129011267|NCT01545076|464334443|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
129011268|NCT01545076|464334444|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
129011269|NCT01545076|464334445|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
129011270|NCT01545076|464334441|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
129011271|NCT01545076|464334442|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129011272|NCT01545076|464334443|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129011273|NCT01545076|464334444|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
128676950|NCT02230527|463116849|FG001|Overall Study|Withdrawal by Subject|1|||
128676951|NCT02230527|463116848|FG000|Overall Study|Death|1|||
128676952|NCT02230527|463116849|FG001|Overall Study|Death|0|||
128676953|NCT02230527|463116848|FG000|Overall Study|Lost to Follow-up|2|||
128676954|NCT02230527|463116849|FG001|Overall Study|Lost to Follow-up|1|||
128676955|NCT02230527|463116848|FG000|Overall Study|Other|1|||
128676956|NCT02230527|463116849|FG001|Overall Study|Other|0|||
128676957|NCT04461600|463116850|FG000|Overall Study|Death|6|||
128676958|NCT04461600|463116851|FG001|Overall Study|Death|5|||
128676959|NCT04461600|463116850|FG000|Overall Study|Withdrawal by Subject|0|||
128676960|NCT04461600|463116851|FG001|Overall Study|Withdrawal by Subject|1|||
128676961|NCT00704522|463116854|FG000|Overall Study|Lack of Efficacy|65|||
128676962|NCT00704522|463116855|FG001|Overall Study|Lack of Efficacy|17|||
129011274|NCT01545076|464334445|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129011275|NCT01545076|464334441|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
129100999|NCT01483599|464662850|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101000|NCT01483599|464662851|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101001|NCT01483599|464662852|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129011276|NCT01545076|464334442|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129011277|NCT01545076|464334443|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129011278|NCT01545076|464334444|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129011279|NCT01545076|464334445|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129011280|NCT01545076|464334441|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129011281|NCT01545076|464334442|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129011282|NCT01545076|464334443|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129011283|NCT01545076|464334444|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
129011284|NCT01545076|464334445|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129011285|NCT01545076|464334441|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
129011286|NCT01545076|464334442|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
129011287|NCT01545076|464334443|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
129011288|NCT01545076|464334444|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
129011289|NCT01545076|464334445|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
129011290|NCT01545076|464334441|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
129011291|NCT01545076|464334442|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
129011292|NCT01545076|464334443|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
129011293|NCT01545076|464334444|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
129011294|NCT01545076|464334445|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
129011295|NCT01545076|464334441|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
129011296|NCT01545076|464334442|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
129011297|NCT01545076|464334443|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
129011298|NCT01545076|464334444|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
129011299|NCT01545076|464334445|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
129011300|NCT00264797|464334453|FG000|Overall Study|Withdrawal by Subject|11|||
129011301|NCT00264797|464334454|FG001|Overall Study|Withdrawal by Subject|11|||
129011302|NCT00264797|464334453|FG000|Overall Study|Lost to Follow-up|9|||
129011303|NCT00264797|464334454|FG001|Overall Study|Lost to Follow-up|17|||
129011304|NCT00264797|464334453|FG000|Overall Study|Moved from area|3|||
129011305|NCT00264797|464334454|FG001|Overall Study|Moved from area|1|||
129011306|NCT00264797|464334453|FG000|Overall Study|Practical Problems|2|||
129011307|NCT00264797|464334454|FG001|Overall Study|Practical Problems|3|||
129011308|NCT00264797|464334453|FG000|Overall Study|Incarceration|4|||
129011309|NCT00264797|464334454|FG001|Overall Study|Incarceration|5|||
129011310|NCT00264797|464334453|FG000|Overall Study|Pressure/advice from Outsiders|1|||
129011311|NCT00264797|464334454|FG001|Overall Study|Pressure/advice from Outsiders|1|||
129011312|NCT00264797|464334453|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
129011313|NCT00264797|464334454|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
129011314|NCT00264797|464334453|FG000|Overall Study|Other|3|||
129011315|NCT00264797|464334454|FG001|Overall Study|Other|4|||
129011316|NCT01153984|464334455|FG000|Overall Study|Withdrawal by Subject|1|||
129011317|NCT01153984|464334455|FG000|Overall Study|Adverse Event|1|||
129011318|NCT02460159|464334456|FG000|Overall Study|Adverse Event|4|||
129011319|NCT02460159|464334457|FG001|Overall Study|Adverse Event|1|||
129011320|NCT02460159|464334456|FG000|Overall Study|Withdrawal by Subject|2|||
128676963|NCT00704522|463116854|FG000|Overall Study|Failure to appear again at hospital|56|||
128676964|NCT00704522|463116855|FG001|Overall Study|Failure to appear again at hospital|10|||
128676965|NCT00704522|463116854|FG000|Overall Study|Withdrawal by Subject|17|||
129011321|NCT02460159|464334457|FG001|Overall Study|Withdrawal by Subject|0|||
128676966|NCT00704522|463116855|FG001|Overall Study|Withdrawal by Subject|8|||
128676967|NCT00704522|463116854|FG000|Overall Study|Adverse Event|9|||
128676968|NCT00704522|463116855|FG001|Overall Study|Adverse Event|1|||
128676969|NCT00704522|463116854|FG000|Overall Study|Undefined causes|9|||
128676970|NCT00704522|463116855|FG001|Overall Study|Undefined causes|7|||
128676971|NCT00704522|463116854|FG000|Overall Study|No information on therapy end|27|||
128676972|NCT00704522|463116855|FG001|Overall Study|No information on therapy end|2|||
128676973|NCT00701662|463116856|FG000|Overall Study|Lack of Efficacy|1|||
128676974|NCT00635024|463116857|FG000|Overall Study|Adverse Event|1|||
128676975|NCT01105065|463116858|FG000|Overall Study|Adverse Event|5|||
128676976|NCT01105065|463116858|FG000|Overall Study|Technical Problems|1|||
128676977|NCT02984943|463116859|FG000|Overall Study|Withdrawal by Subject|3|||
128676978|NCT02984943|463116859|FG000|Overall Study|Physician Decision|1|||
128676979|NCT04575597|463116862|FG000|Overall Study|Death|0|||
128676980|NCT04575597|463116863|FG001|Overall Study|Death|0|||
128676981|NCT04575597|463116864|FG002|Overall Study|Death|0|||
128676982|NCT04575597|463116865|FG003|Overall Study|Death|1|||
128676983|NCT04575597|463116866|FG004|Overall Study|Death|3|||
129101002|NCT01483599|464662853|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101003|NCT01483599|464662854|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101004|NCT01483599|464662855|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101005|NCT01483599|464662856|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101006|NCT01483599|464662857|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101007|NCT01483599|464662858|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
129101008|NCT01483599|464662859|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101009|NCT01483599|464662860|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101010|NCT01483599|464662861|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129101011|NCT01483599|464662862|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
129101012|NCT01483599|464662863|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
129101013|NCT01483599|464662850|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
129101014|NCT01483599|464662851|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
129101015|NCT01483599|464662852|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
129101016|NCT01483599|464662853|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
129101017|NCT01483599|464662854|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
129101018|NCT01483599|464662855|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
129101019|NCT01483599|464662856|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
129101020|NCT01483599|464662857|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
129101021|NCT01483599|464662858|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
129101022|NCT01483599|464662859|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
129101023|NCT01483599|464662860|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
129101024|NCT01483599|464662861|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
129101025|NCT01483599|464662862|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
129101026|NCT01483599|464662863|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
129101027|NCT00966355|464662864|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
129101028|NCT00966355|464662865|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
129101029|NCT00966355|464662866|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
129101030|NCT00966355|464662864|FG000|Overall Study|newly diagnosed advanced HCC|11|||
129101031|NCT00966355|464662865|FG001|Overall Study|newly diagnosed advanced HCC|12|||
128676984|NCT04575597|463116867|FG005|Overall Study|Death|14|||
128676985|NCT04575597|463116862|FG000|Overall Study|Lost to Follow-up|2|||
128676986|NCT04575597|463116863|FG001|Overall Study|Lost to Follow-up|1|||
128676987|NCT04575597|463116864|FG002|Overall Study|Lost to Follow-up|1|||
128676988|NCT04575597|463116865|FG003|Overall Study|Lost to Follow-up|2|||
128676989|NCT04575597|463116866|FG004|Overall Study|Lost to Follow-up|10|||
128676990|NCT04575597|463116867|FG005|Overall Study|Lost to Follow-up|8|||
128676991|NCT04575597|463116862|FG000|Overall Study|Withdrawal by Subject|2|||
128676992|NCT04575597|463116863|FG001|Overall Study|Withdrawal by Subject|2|||
128676993|NCT04575597|463116864|FG002|Overall Study|Withdrawal by Subject|4|||
128676994|NCT04575597|463116865|FG003|Overall Study|Withdrawal by Subject|2|||
128676995|NCT04575597|463116866|FG004|Overall Study|Withdrawal by Subject|25|||
129011322|NCT02636907|464334460|FG000|Autoinjector Assessment Period|Adverse Event|2|||
129011323|NCT02636907|464334460|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
129011324|NCT02636907|464334460|FG000|Extension Phase|Adverse Event|2|||
129011325|NCT02636907|464334460|FG000|Extension Phase|Withdrawal by Subject|4|||
129011326|NCT02636907|464334460|FG000|Extension Phase|Physician Decision|1|||
129011327|NCT02636907|464334460|FG000|Extension Phase|Lost to Follow-up|2|||
129011328|NCT02636907|464334460|FG000|Extension Phase|Lack of Efficacy|1|||
129011329|NCT00860405|464334467|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
129011330|NCT00860405|464334468|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
129011331|NCT02465567|464334469|FG000|Overall Study|Adverse Event|118|||
128676996|NCT04575597|463116867|FG005|Overall Study|Withdrawal by Subject|28|||
128676997|NCT04575597|463116862|FG000|Overall Study|Not Recorded|0|||
128676998|NCT04575597|463116863|FG001|Overall Study|Not Recorded|0|||
128676999|NCT04575597|463116864|FG002|Overall Study|Not Recorded|0|||
128677000|NCT04575597|463116865|FG003|Overall Study|Not Recorded|0|||
128677001|NCT04575597|463116866|FG004|Overall Study|Not Recorded|0|||
128677002|NCT04575597|463116867|FG005|Overall Study|Not Recorded|2|||
128677003|NCT04575597|463116862|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129011332|NCT02465567|464334470|FG001|Overall Study|Adverse Event|113|||
129011333|NCT02465567|464334471|FG002|Overall Study|Adverse Event|147|||
129011334|NCT02465567|464334472|FG003|Overall Study|Adverse Event|138|||
129011335|NCT02465567|464334469|FG000|Overall Study|Lack of Efficacy|103|||
129011336|NCT02465567|464334470|FG001|Overall Study|Lack of Efficacy|102|||
129011337|NCT02465567|464334471|FG002|Overall Study|Lack of Efficacy|171|||
129011338|NCT02465567|464334472|FG003|Overall Study|Lack of Efficacy|135|||
129011339|NCT02465567|464334469|FG000|Overall Study|Withdrawal by Subject|104|||
129011340|NCT02465567|464334470|FG001|Overall Study|Withdrawal by Subject|94|||
129011341|NCT02465567|464334471|FG002|Overall Study|Withdrawal by Subject|123|||
129011342|NCT02465567|464334472|FG003|Overall Study|Withdrawal by Subject|130|||
129011343|NCT02465567|464334469|FG000|Overall Study|Physician Decision|23|||
129011344|NCT02465567|464334470|FG001|Overall Study|Physician Decision|33|||
129011345|NCT02465567|464334471|FG002|Overall Study|Physician Decision|38|||
129011346|NCT02465567|464334472|FG003|Overall Study|Physician Decision|28|||
129011347|NCT02465567|464334469|FG000|Overall Study|Major Protocol Deviation|24|||
129011348|NCT02465567|464334470|FG001|Overall Study|Major Protocol Deviation|26|||
129011349|NCT02465567|464334471|FG002|Overall Study|Major Protocol Deviation|22|||
129011350|NCT02465567|464334472|FG003|Overall Study|Major Protocol Deviation|25|||
129011351|NCT02465567|464334469|FG000|Overall Study|Lost to Follow-up|25|||
129011352|NCT02465567|464334470|FG001|Overall Study|Lost to Follow-up|21|||
129011353|NCT02465567|464334471|FG002|Overall Study|Lost to Follow-up|19|||
129011354|NCT02465567|464334472|FG003|Overall Study|Lost to Follow-up|15|||
129011355|NCT02465567|464334469|FG000|Overall Study|Protocol Specified Criteria|20|||
129011356|NCT02465567|464334470|FG001|Overall Study|Protocol Specified Criteria|10|||
129011357|NCT02465567|464334471|FG002|Overall Study|Protocol Specified Criteria|9|||
129011358|NCT02465567|464334472|FG003|Overall Study|Protocol Specified Criteria|12|||
129011359|NCT02465567|464334469|FG000|Overall Study|Administrative Reasons|12|||
129011360|NCT02465567|464334470|FG001|Overall Study|Administrative Reasons|9|||
129011361|NCT02465567|464334471|FG002|Overall Study|Administrative Reasons|11|||
129011362|NCT02465567|464334472|FG003|Overall Study|Administrative Reasons|5|||
129011363|NCT02465567|464334469|FG000|Overall Study|Randomized but not treated|1|||
129011364|NCT02465567|464334470|FG001|Overall Study|Randomized but not treated|5|||
129011365|NCT02465567|464334471|FG002|Overall Study|Randomized but not treated|4|||
129011366|NCT02465567|464334472|FG003|Overall Study|Randomized but not treated|5|||
129011367|NCT02465567|464334469|FG000|Overall Study|enrolled in >1 studies|18|||
129011368|NCT02465567|464334470|FG001|Overall Study|enrolled in >1 studies|11|||
129011369|NCT02465567|464334471|FG002|Overall Study|enrolled in >1 studies|19|||
129011370|NCT02465567|464334472|FG003|Overall Study|enrolled in >1 studies|15|||
129011371|NCT02465567|464334469|FG000|Overall Study|missing PI Signature|1|||
129011372|NCT02465567|464334470|FG001|Overall Study|missing PI Signature|0|||
129011373|NCT02465567|464334471|FG002|Overall Study|missing PI Signature|0|||
129011374|NCT02465567|464334472|FG003|Overall Study|missing PI Signature|0|||
129011375|NCT00497796|464334475|FG000|Overall Study|Adverse event (not related)|9|||
129011376|NCT00497796|464334476|FG001|Overall Study|Adverse event (not related)|9|||
129011377|NCT00497796|464334475|FG000|Overall Study|Adverse event (related)|5|||
129011378|NCT00497796|464334476|FG001|Overall Study|Adverse event (related)|4|||
129011379|NCT00497796|464334475|FG000|Overall Study|CMV infection or disease treatment|30|||
129011380|NCT00497796|464334476|FG001|Overall Study|CMV infection or disease treatment|4|||
129011381|NCT00497796|464334475|FG000|Overall Study|Consent withdrawn|10|||
129011382|NCT00497796|464334476|FG001|Overall Study|Consent withdrawn|3|||
129011383|NCT00497796|464334475|FG000|Overall Study|Investigator/sponsor discretion|31|||
129011384|NCT00497796|464334476|FG001|Overall Study|Investigator/sponsor discretion|34|||
129011385|NCT00497796|464334475|FG000|Overall Study|Lost to Follow-up|0|||
129011386|NCT00497796|464334476|FG001|Overall Study|Lost to Follow-up|1|||
129011387|NCT00497796|464334475|FG000|Overall Study|Not applicable (randomized not treated)|0|||
129011388|NCT00497796|464334476|FG001|Overall Study|Not applicable (randomized not treated)|4|||
129011389|NCT01492400|464334479|FG000|Overall Study|Miscellaneous Reasons|2|||
129011390|NCT01492400|464334480|FG001|Overall Study|Miscellaneous Reasons|3|||
129011391|NCT01492400|464334479|FG000|Overall Study|Personal Reasons|0|||
129011392|NCT01492400|464334480|FG001|Overall Study|Personal Reasons|5|||
129011393|NCT01492400|464334479|FG000|Overall Study|Lost to Follow-up|3|||
129011394|NCT01492400|464334480|FG001|Overall Study|Lost to Follow-up|1|||
129011395|NCT01492400|464334479|FG000|Overall Study|Pregnancy|0|||
129011396|NCT01492400|464334480|FG001|Overall Study|Pregnancy|1|||
129011397|NCT01492400|464334479|FG000|Overall Study|Lack of Efficacy|1|||
129011398|NCT01492400|464334480|FG001|Overall Study|Lack of Efficacy|1|||
129011399|NCT01492400|464334479|FG000|Overall Study|Adverse Event|10|||
129011400|NCT01492400|464334480|FG001|Overall Study|Adverse Event|5|||
129011401|NCT00604500|464334481|FG000|Overall Study|Adverse Event|2|||
129011402|NCT00604500|464334481|FG000|Overall Study|Protocol Violation|2|||
129011403|NCT00604500|464334481|FG000|Overall Study|Treatment Failure|1|||
129011404|NCT00604500|464334481|FG000|Overall Study|Withdrawal by Subject|4|||
129011405|NCT00604500|464334481|FG000|Overall Study|Administrative|1|||
129011406|NCT00604500|464334481|FG000|Overall Study|Did not meet protocol eligibility|1|||
129011407|NCT00320112|464334482|FG000|Overall Study|Lost to Follow-up|3|||
129011408|NCT00320112|464334483|FG001|Overall Study|Lost to Follow-up|4|||
129101032|NCT00966355|464662866|FG002|Overall Study|newly diagnosed advanced HCC|10|||
129101033|NCT00966355|464662864|FG000|Overall Study|Lost to Follow-up|5|||
129101034|NCT00966355|464662865|FG001|Overall Study|Lost to Follow-up|4|||
129101035|NCT00966355|464662866|FG002|Overall Study|Lost to Follow-up|3|||
129101036|NCT00385827|464664362|FG000|Part 1|Adverse Event|1|||
129101037|NCT00385827|464664363|FG001|Part 1|Adverse Event|0|||
129101038|NCT00385827|464664364|FG002|Part 1|Adverse Event|0|||
129101039|NCT00385827|464664362|FG000|Part 1|Death|2|||
129101040|NCT00385827|464664363|FG001|Part 1|Death|0|||
129101041|NCT00385827|464664364|FG002|Part 1|Death|0|||
129101042|NCT00385827|464664362|FG000|Part 1|Lack of Efficacy|5|||
129101043|NCT00385827|464664363|FG001|Part 1|Lack of Efficacy|0|||
129101044|NCT00385827|464664364|FG002|Part 1|Lack of Efficacy|0|||
129101045|NCT00385827|464664362|FG000|Part 1|Other|1|||
129101046|NCT00385827|464664363|FG001|Part 1|Other|0|||
129101047|NCT00385827|464664364|FG002|Part 1|Other|0|||
129101048|NCT00385827|464664362|FG000|Part 2|Adverse Event|0|||
129101049|NCT00385827|464664363|FG001|Part 2|Adverse Event|6|||
129101050|NCT00385827|464664364|FG002|Part 2|Adverse Event|10|||
129101051|NCT00385827|464664362|FG000|Part 2|Death|0|||
129101052|NCT00385827|464664363|FG001|Part 2|Death|0|||
129101053|NCT00385827|464664364|FG002|Part 2|Death|2|||
129101054|NCT00385827|464664362|FG000|Part 2|Lack of Efficacy|0|||
129101055|NCT00385827|464664363|FG001|Part 2|Lack of Efficacy|14|||
129101056|NCT00385827|464664364|FG002|Part 2|Lack of Efficacy|13|||
129101057|NCT00385827|464664362|FG000|Part 2|Randomized but not treated|0|||
129101058|NCT00385827|464664363|FG001|Part 2|Randomized but not treated|2|||
129101059|NCT00385827|464664364|FG002|Part 2|Randomized but not treated|2|||
129101060|NCT00385827|464664362|FG000|Part 2|Other|0|||
129101061|NCT00385827|464664363|FG001|Part 2|Other|11|||
129101062|NCT00385827|464664364|FG002|Part 2|Other|21|||
129101063|NCT00410072|464664365|FG000|Day 1 to Week 48|Adverse Event|1|||
129101064|NCT00410072|464664366|FG001|Day 1 to Week 48|Adverse Event|2|||
129101065|NCT00410072|464664365|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
129101066|NCT00410072|464664366|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
129101067|NCT00410072|464664365|FG000|Day 1 to Week 48|Other|0|||
129101068|NCT00410072|464664366|FG001|Day 1 to Week 48|Other|1|||
129101069|NCT00410072|464664365|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
129101070|NCT00410072|464664366|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
129101071|NCT00410072|464664365|FG000|Day 1 to Week 48|Pregnancy|0|||
129101072|NCT00410072|464664366|FG001|Day 1 to Week 48|Pregnancy|2|||
129101073|NCT00410072|464664365|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
129101074|NCT00410072|464664366|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
129101075|NCT00410072|464664365|FG000|After Week 48 to Week 96|Adverse Event|1|||
129101076|NCT00410072|464664366|FG001|After Week 48 to Week 96|Adverse Event|2|||
129101077|NCT00410072|464664365|FG000|After Week 48 to Week 96|Death|0|||
129101078|NCT00410072|464664366|FG001|After Week 48 to Week 96|Death|1|||
129101079|NCT00410072|464664365|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
129101080|NCT00410072|464664366|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
129101081|NCT00410072|464664365|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
129101082|NCT00410072|464664366|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
129101083|NCT00410072|464664365|FG000|After Week 48 to Week 96|Other|2|||
129101084|NCT00410072|464664366|FG001|After Week 48 to Week 96|Other|0|||
129101085|NCT00410072|464664365|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
129101086|NCT00410072|464664366|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
129101087|NCT00410072|464664365|FG000|After Week 48 to Week 96|Pregnancy|0|||
129101088|NCT00410072|464664366|FG001|After Week 48 to Week 96|Pregnancy|2|||
129101089|NCT00410072|464664365|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
129101090|NCT00410072|464664366|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
129101091|NCT01421147|464664367|FG000|Treatment Period|Adverse Event|2|||
129101092|NCT01421147|464664368|FG001|Treatment Period|Adverse Event|3|||
129101093|NCT01421147|464664367|FG000|Treatment Period|Lost to Follow-up|2|||
129101094|NCT01421147|464664368|FG001|Treatment Period|Lost to Follow-up|1|||
129101095|NCT01421147|464664367|FG000|Treatment Period|Physician Decision|2|||
128677004|NCT04575597|463116863|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129101096|NCT01421147|464664368|FG001|Treatment Period|Physician Decision|2|||
129101097|NCT01421147|464664367|FG000|Treatment Period|Withdrawal by Subject|10|||
129101098|NCT01421147|464664368|FG001|Treatment Period|Withdrawal by Subject|5|||
129101099|NCT01421147|464664367|FG000|Extension Period|Adverse Event|0|||
129101100|NCT01421147|464664368|FG001|Extension Period|Adverse Event|2|||
129101101|NCT01421147|464664367|FG000|Extension Period|Death|0|||
129101102|NCT01421147|464664368|FG001|Extension Period|Death|1|||
129101103|NCT01421147|464664367|FG000|Extension Period|Lost to Follow-up|2|||
129101104|NCT01421147|464664368|FG001|Extension Period|Lost to Follow-up|5|||
129101105|NCT01421147|464664367|FG000|Extension Period|Physician Decision|1|||
129101106|NCT01421147|464664368|FG001|Extension Period|Physician Decision|0|||
129101107|NCT01421147|464664367|FG000|Extension Period|Withdrawal by Subject|5|||
129101108|NCT01421147|464664368|FG001|Extension Period|Withdrawal by Subject|3|||
129101109|NCT03307837|464664370|FG000|Overall Study|Withdrawal by Subject|0|||
129101110|NCT03307837|464664371|FG001|Overall Study|Withdrawal by Subject|0|||
129101111|NCT03307837|464664372|FG002|Overall Study|Withdrawal by Subject|1|||
129101112|NCT03307837|464664373|FG003|Overall Study|Withdrawal by Subject|0|||
129101113|NCT03307837|464664374|FG004|Overall Study|Withdrawal by Subject|0|||
129101114|NCT03307837|464664375|FG005|Overall Study|Withdrawal by Subject|1|||
129101115|NCT03307837|464664370|FG000|Overall Study|Lost to Follow-up|1|||
129101116|NCT03307837|464664371|FG001|Overall Study|Lost to Follow-up|1|||
129101117|NCT03307837|464664372|FG002|Overall Study|Lost to Follow-up|0|||
129101118|NCT03307837|464664373|FG003|Overall Study|Lost to Follow-up|0|||
129101119|NCT03307837|464664374|FG004|Overall Study|Lost to Follow-up|0|||
129101120|NCT03307837|464664375|FG005|Overall Study|Lost to Follow-up|1|||
129101121|NCT02155309|464664378|FG000|Overall Study|Protocol Violation|0|||
129101122|NCT02155309|464664379|FG001|Overall Study|Protocol Violation|0|||
129101123|NCT02155309|464664380|FG002|Overall Study|Protocol Violation|1|||
129101124|NCT04676152|464664381|FG000|Overall Study|screen fail|9|||
129101125|NCT02634801|464664389|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
129101126|NCT02634801|464664390|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
129101127|NCT02634801|464664391|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
129101128|NCT02634801|464664389|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
129101129|NCT02634801|464664390|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
129101130|NCT02634801|464664391|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
129101131|NCT02634801|464664389|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
129101132|NCT02634801|464664390|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
129101133|NCT02634801|464664391|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
129101134|NCT02634801|464664389|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
129101135|NCT02634801|464664390|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
129101136|NCT02634801|464664391|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
129101137|NCT02634801|464664389|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
129101138|NCT02634801|464664390|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
129101139|NCT02634801|464664391|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
129101140|NCT02634801|464664389|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
129101141|NCT02634801|464664390|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
129101142|NCT02634801|464664391|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
129101143|NCT02634801|464664389|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
129101144|NCT02634801|464664390|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
129101145|NCT02634801|464664391|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
129101146|NCT02634801|464664389|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
129101147|NCT02634801|464664390|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
129101148|NCT02634801|464664391|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
129101149|NCT02634801|464664389|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
129101150|NCT02634801|464664390|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
129101151|NCT02634801|464664391|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
129101152|NCT02634801|464664389|FG000|Follow-up Period|Lost to Follow-up|3|||
129101153|NCT02634801|464664390|FG001|Follow-up Period|Lost to Follow-up|1|||
129101154|NCT02634801|464664391|FG002|Follow-up Period|Lost to Follow-up|2|||
129101155|NCT02634801|464664389|FG000|Follow-up Period|Physician Decision|0|||
129101156|NCT02634801|464664390|FG001|Follow-up Period|Physician Decision|0|||
129101157|NCT02634801|464664391|FG002|Follow-up Period|Physician Decision|1|||
129101158|NCT02634801|464664389|FG000|Follow-up Period|Withdrawal by Subject|1|||
128677005|NCT04575597|463116864|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128677006|NCT04575597|463116865|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128677007|NCT04575597|463116866|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
129101159|NCT02634801|464664390|FG001|Follow-up Period|Withdrawal by Subject|2|||
129101160|NCT02634801|464664391|FG002|Follow-up Period|Withdrawal by Subject|5|||
129101161|NCT02634801|464664389|FG000|Follow-up Period|Adverse Event|1|||
129101162|NCT02634801|464664390|FG001|Follow-up Period|Adverse Event|5|||
129101163|NCT02634801|464664391|FG002|Follow-up Period|Adverse Event|0|||
129101164|NCT00662311|464664396|FG000|Overall Study|Respiratory Infection|1|||
129101165|NCT00662311|464664397|FG001|Overall Study|Respiratory Infection|0|||
129101166|NCT00662311|464664398|FG002|Overall Study|Respiratory Infection|0|||
129101167|NCT01467271|464664399|FG000|Overall Study|Death|84|||
129101168|NCT01467271|464664399|FG000|Overall Study|Lost to Follow-up|83|||
129101169|NCT01467271|464664399|FG000|Overall Study|Retraction of patient's consent|21|||
128677008|NCT04575597|463116867|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
129101170|NCT01467271|464664399|FG000|Overall Study|Other reason|14|||
129101171|NCT02335346|464664418|FG000|Overall Study|Adverse Event|11|||
128677009|NCT01525901|463116874|FG000|Period 2: 12 Weeks|Adverse Event|0|||
129101172|NCT02335346|464664418|FG000|Overall Study|Withdrawal by Subject|1|||
129101173|NCT03300050|464664419|FG000|Overall Study|Lost to Follow-up|2|||
128677010|NCT01525901|463116875|FG001|Period 2: 12 Weeks|Adverse Event|1|||
129101174|NCT03300050|464664420|FG001|Overall Study|Lost to Follow-up|1|||
128677011|NCT01525901|463116876|FG002|Period 2: 12 Weeks|Adverse Event|0|||
129101175|NCT03300050|464664421|FG002|Overall Study|Lost to Follow-up|0|||
128677012|NCT01525901|463116877|FG003|Period 2: 12 Weeks|Adverse Event|0|||
129101176|NCT03300050|464664422|FG003|Overall Study|Lost to Follow-up|0|||
128677013|NCT05027971|463116882|FG000|Overall Study|Physician Decision|7|||
129011409|NCT00320112|464334482|FG000|Overall Study|Withdrawal by Subject|3|||
129011410|NCT00320112|464334483|FG001|Overall Study|Withdrawal by Subject|0|||
129011411|NCT00320112|464334482|FG000|Overall Study|Death|2|||
129011412|NCT00320112|464334483|FG001|Overall Study|Death|1|||
129011413|NCT02899338|464334484|FG000|Overall Study|Adverse Event|1|||
129011414|NCT02899338|464334485|FG001|Overall Study|Adverse Event|2|||
129011415|NCT02899338|464334484|FG000|Overall Study|Withdrawal by Subject|2|||
129011416|NCT02899338|464334485|FG001|Overall Study|Withdrawal by Subject|0|||
129011417|NCT02353169|464334488|FG000|Overall Study|QTc > 450 msec|1|||
129011418|NCT02353169|464334489|FG001|Overall Study|QTc > 450 msec|1|||
129011419|NCT02353169|464334490|FG002|Overall Study|QTc > 450 msec|1|||
129011420|NCT02353169|464334491|FG003|Overall Study|QTc > 450 msec|1|||
129011421|NCT02353169|464334488|FG000|Overall Study|OR team declined|2|||
129011422|NCT02353169|464334489|FG001|Overall Study|OR team declined|0|||
129011423|NCT02353169|464334490|FG002|Overall Study|OR team declined|0|||
129011424|NCT02353169|464334491|FG003|Overall Study|OR team declined|0|||
129011425|NCT02353169|464334488|FG000|Overall Study|Inhalational induction|0|||
129011426|NCT02353169|464334489|FG001|Overall Study|Inhalational induction|2|||
129011427|NCT02353169|464334490|FG002|Overall Study|Inhalational induction|0|||
129011428|NCT02353169|464334491|FG003|Overall Study|Inhalational induction|0|||
129011429|NCT02353169|464334488|FG000|Overall Study|ECG data error|0|||
129011430|NCT02353169|464334489|FG001|Overall Study|ECG data error|3|||
129011431|NCT02353169|464334490|FG002|Overall Study|ECG data error|2|||
129011432|NCT02353169|464334491|FG003|Overall Study|ECG data error|2|||
129011433|NCT02353169|464334488|FG000|Overall Study|Pre-op medication|0|||
129011434|NCT02353169|464334489|FG001|Overall Study|Pre-op medication|0|||
129011435|NCT02353169|464334490|FG002|Overall Study|Pre-op medication|1|||
129011436|NCT02353169|464334491|FG003|Overall Study|Pre-op medication|0|||
129011437|NCT00796822|464334492|FG000|Overall Study|Lost to Follow-up|2|||
129011438|NCT00796822|464334493|FG001|Overall Study|Lost to Follow-up|0|||
129011439|NCT00796822|464334492|FG000|Overall Study|Adverse Event|1|||
129011440|NCT00796822|464334493|FG001|Overall Study|Adverse Event|0|||
129011441|NCT00906347|464334494|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
129011442|NCT00906347|464334495|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
129011443|NCT00906347|464334494|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
129011444|NCT00906347|464334495|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
129011445|NCT00906347|464334494|FG000|Received Study Drug|Refused study drug|1|||
129011446|NCT00906347|464334495|FG001|Received Study Drug|Refused study drug|0|||
129011447|NCT00906347|464334494|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
129011448|NCT00906347|464334495|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
129011449|NCT00680121|464334499|FG000|Overall Study|Lost to Follow-up|27|||
129011450|NCT00680121|464334500|FG001|Overall Study|Lost to Follow-up|23|||
129011451|NCT02603952|464334501|FG000|Overall Study|Withdrawal by Subject|1|||
129011452|NCT02603952|464334502|FG001|Overall Study|Withdrawal by Subject|0|||
129011453|NCT02603952|464334503|FG002|Overall Study|Withdrawal by Subject|0|||
129011454|NCT02603952|464334504|FG003|Overall Study|Withdrawal by Subject|0|||
129011455|NCT02603952|464334501|FG000|Overall Study|Received oseltamivir by error|0|||
129011456|NCT02603952|464334502|FG001|Overall Study|Received oseltamivir by error|0|||
129011457|NCT02603952|464334503|FG002|Overall Study|Received oseltamivir by error|0|||
129011458|NCT02603952|464334504|FG003|Overall Study|Received oseltamivir by error|1|||
129011459|NCT00577460|464334507|FG000|Overall Study|Adverse Event|11|||
129011460|NCT00577460|464334508|FG001|Overall Study|Adverse Event|7|||
129011461|NCT00577460|464334509|FG002|Overall Study|Adverse Event|14|||
129011462|NCT00577460|464334507|FG000|Overall Study|Protocol Violation|0|||
129011463|NCT00577460|464334508|FG001|Overall Study|Protocol Violation|1|||
129011464|NCT00577460|464334509|FG002|Overall Study|Protocol Violation|1|||
129101177|NCT03300050|464664423|FG004|Overall Study|Lost to Follow-up|1|||
129101178|NCT03300050|464664419|FG000|Overall Study|Withdrawal by Subject|1|||
129011465|NCT00577460|464334507|FG000|Overall Study|Lost to Follow-up|0|||
129011466|NCT00577460|464334508|FG001|Overall Study|Lost to Follow-up|3|||
129011467|NCT00577460|464334509|FG002|Overall Study|Lost to Follow-up|4|||
129011468|NCT00577460|464334507|FG000|Overall Study|Withdrawal by Subject|5|||
129011469|NCT00577460|464334508|FG001|Overall Study|Withdrawal by Subject|5|||
129011470|NCT00577460|464334509|FG002|Overall Study|Withdrawal by Subject|6|||
129011471|NCT00577460|464334507|FG000|Overall Study|Other|0|||
129011472|NCT00577460|464334508|FG001|Overall Study|Other|3|||
129011473|NCT00577460|464334509|FG002|Overall Study|Other|2|||
129011474|NCT04591626|464334510|FG000|Overall Study|Adverse Event|4|||
129011475|NCT04591626|464334511|FG001|Overall Study|Adverse Event|0|||
129011476|NCT04591626|464334510|FG000|Overall Study|Withdrawal by Subject|5|||
129011477|NCT04591626|464334511|FG001|Overall Study|Withdrawal by Subject|3|||
129011478|NCT04591626|464334510|FG000|Overall Study|Physician Decision|0|||
129101179|NCT03300050|464664420|FG001|Overall Study|Withdrawal by Subject|1|||
129011479|NCT04591626|464334511|FG001|Overall Study|Physician Decision|1|||
129011480|NCT04591626|464334510|FG000|Overall Study|Death|0|||
129011481|NCT04591626|464334511|FG001|Overall Study|Death|1|||
129101180|NCT03300050|464664421|FG002|Overall Study|Withdrawal by Subject|1|||
129101181|NCT03300050|464664422|FG003|Overall Study|Withdrawal by Subject|0|||
129101182|NCT03300050|464664423|FG004|Overall Study|Withdrawal by Subject|0|||
129101183|NCT03300050|464664419|FG000|Overall Study|Death|0|||
129101184|NCT03300050|464664420|FG001|Overall Study|Death|0|||
129101185|NCT03300050|464664421|FG002|Overall Study|Death|1|||
129101186|NCT03300050|464664422|FG003|Overall Study|Death|0|||
129101187|NCT03300050|464664423|FG004|Overall Study|Death|0|||
129101188|NCT03300050|464664419|FG000|Overall Study|Not Eligible at Randomization|0|||
129101189|NCT03300050|464664420|FG001|Overall Study|Not Eligible at Randomization|0|||
129101190|NCT03300050|464664421|FG002|Overall Study|Not Eligible at Randomization|1|||
129101191|NCT03300050|464664422|FG003|Overall Study|Not Eligible at Randomization|1|||
129101192|NCT03300050|464664423|FG004|Overall Study|Not Eligible at Randomization|0|||
129101193|NCT02178358|464664437|FG000|Overall Study|Withdrawal by Subject|0|||
129101194|NCT02178358|464664438|FG001|Overall Study|Withdrawal by Subject|2|||
129101195|NCT02178358|464664439|FG002|Overall Study|Withdrawal by Subject|2|||
129101196|NCT02178358|464664437|FG000|Overall Study|Lost to Follow-up|1|||
129101197|NCT02178358|464664438|FG001|Overall Study|Lost to Follow-up|0|||
129101198|NCT02178358|464664439|FG002|Overall Study|Lost to Follow-up|0|||
129101199|NCT01066663|464664440|FG000|Overall Study|Adverse Event|0|||
129101200|NCT01066663|464664441|FG001|Overall Study|Adverse Event|0|||
129101201|NCT01066663|464664442|FG002|Overall Study|Adverse Event|1|||
129101202|NCT01090050|464664443|FG000|Overall Study|Lost to Follow-up|0|||
129101203|NCT01090050|464664444|FG001|Overall Study|Lost to Follow-up|1|||
129101204|NCT01090050|464664443|FG000|Overall Study|Lack of Efficacy|1|||
129101205|NCT01090050|464664444|FG001|Overall Study|Lack of Efficacy|5|||
129101206|NCT01090050|464664443|FG000|Overall Study|Physician Decision|0|||
129101207|NCT01090050|464664444|FG001|Overall Study|Physician Decision|1|||
128677014|NCT05027971|463116883|FG001|Overall Study|Physician Decision|3|||
129101208|NCT02232061|464664445|FG000|Overall Study|Administrative problems|1|||
129101209|NCT02232061|464664445|FG000|Overall Study|Withdrawal by Subject|1|||
129101210|NCT00560703|464664447|FG000|Overall Study|Adverse Event|0|||
129101211|NCT00560703|464664448|FG001|Overall Study|Adverse Event|2|||
129101212|NCT00560703|464664447|FG000|Overall Study|Protocol Violation|0|||
129101213|NCT00560703|464664448|FG001|Overall Study|Protocol Violation|2|||
129101214|NCT00560703|464664447|FG000|Overall Study|Withdrawal by Subject|0|||
129101215|NCT00560703|464664448|FG001|Overall Study|Withdrawal by Subject|1|||
129101216|NCT00560703|464664447|FG000|Overall Study|non-compliance|0|||
129101217|NCT00560703|464664448|FG001|Overall Study|non-compliance|1|||
128677015|NCT05027971|463116882|FG000|Overall Study|Lost to Follow-up|1|||
128677016|NCT05027971|463116883|FG001|Overall Study|Lost to Follow-up|1|||
128677017|NCT05027971|463116882|FG000|Overall Study|Withdrawal by Subject|0|||
128677018|NCT05027971|463116883|FG001|Overall Study|Withdrawal by Subject|2|||
128677019|NCT05027971|463116882|FG000|Overall Study|Non-study fiber used.|0|||
128677020|NCT05027971|463116883|FG001|Overall Study|Non-study fiber used.|1|||
128677021|NCT05027971|463116882|FG000|Overall Study|Protocol Violation|0|||
129101218|NCT00339833|464664452|FG000|Overall Study|Withdrawal by Subject|1|||
129101219|NCT00339833|464664453|FG001|Overall Study|Withdrawal by Subject|2|||
128677022|NCT05027971|463116883|FG001|Overall Study|Protocol Violation|2|||
128677023|NCT02486627|463116885|FG000|Overall Study|Death|1|||
128677024|NCT02486627|463116886|FG001|Overall Study|Death|0|||
128677025|NCT02486627|463116885|FG000|Overall Study|Other Unspecified|0|||
128677026|NCT02486627|463116886|FG001|Overall Study|Other Unspecified|2|||
129101220|NCT00339833|464664452|FG000|Overall Study|toothache|0|||
129101221|NCT00339833|464664453|FG001|Overall Study|toothache|1|||
129101222|NCT00339833|464664452|FG000|Overall Study|indigestion|0|||
129101223|NCT00339833|464664453|FG001|Overall Study|indigestion|1|||
129101224|NCT00339833|464664452|FG000|Overall Study|Chest pain|0|||
129101225|NCT00339833|464664453|FG001|Overall Study|Chest pain|1|||
129101226|NCT00339833|464664452|FG000|Overall Study|minor infection|0|||
128677027|NCT02486627|463116885|FG000|Overall Study|Consent Withdrawn by Participant|4|||
128677028|NCT02486627|463116886|FG001|Overall Study|Consent Withdrawn by Participant|3|||
128677029|NCT02486627|463116885|FG000|Overall Study|Significant Participant Noncompliance|1|||
128677030|NCT02486627|463116886|FG001|Overall Study|Significant Participant Noncompliance|1|||
129101227|NCT00339833|464664453|FG001|Overall Study|minor infection|1|||
129101228|NCT00339833|464664452|FG000|Overall Study|Poor venous access|2|||
128677031|NCT02486627|463116885|FG000|Overall Study|Lost to Follow-up|1|||
129101229|NCT00339833|464664453|FG001|Overall Study|Poor venous access|2|||
129101230|NCT00339833|464664452|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
129101231|NCT00339833|464664453|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
129101232|NCT00339833|464664452|FG000|Overall Study|Error in data records|1|||
128677032|NCT02486627|463116886|FG001|Overall Study|Lost to Follow-up|3|||
129101233|NCT00339833|464664453|FG001|Overall Study|Error in data records|0|||
129101234|NCT03585712|464664456|FG000|Treatment Period 1|Protocol Violation|1|||
129101235|NCT03585712|464664457|FG001|Treatment Period 1|Protocol Violation|0|||
129101236|NCT03585712|464664458|FG002|Treatment Period 1|Protocol Violation|0|||
129101237|NCT03585712|464664456|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
129101238|NCT03585712|464664457|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
129011482|NCT04591626|464334510|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129011483|NCT04591626|464334511|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129011484|NCT02672553|464334513|FG000|Overall Study|Death|3|||
129011485|NCT02672553|464334514|FG001|Overall Study|Death|5|||
129011486|NCT02672553|464334513|FG000|Overall Study|Valve Explant|1|||
129011487|NCT02672553|464334514|FG001|Overall Study|Valve Explant|0|||
129011488|NCT02672553|464334513|FG000|Overall Study|Conversion to Commercial Valve|3|||
129011489|NCT02672553|464334514|FG001|Overall Study|Conversion to Commercial Valve|0|||
129011490|NCT02672553|464334513|FG000|Overall Study|Withdrawal by Subject|3|||
129011491|NCT02672553|464334514|FG001|Overall Study|Withdrawal by Subject|3|||
129011492|NCT02672553|464334513|FG000|Overall Study|Intraoperative screen failure|2|||
129011493|NCT02672553|464334514|FG001|Overall Study|Intraoperative screen failure|0|||
129011494|NCT00841100|464334517|FG000|Phase 1 (28 Days)|Adverse Event|1|||
129011495|NCT00841100|464334517|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
129011496|NCT01355081|464334518|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
129011497|NCT01355081|464334519|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
129011498|NCT01355081|464334520|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
129011499|NCT01355081|464334518|FG000|Overall Study|Major Protocol Deviation|0|||
129011500|NCT01355081|464334519|FG001|Overall Study|Major Protocol Deviation|1|||
129011501|NCT01355081|464334520|FG002|Overall Study|Major Protocol Deviation|0|||
129011502|NCT01355081|464334518|FG000|Overall Study|Lost to Follow-up|0|||
129011503|NCT01355081|464334519|FG001|Overall Study|Lost to Follow-up|0|||
129011504|NCT01355081|464334520|FG002|Overall Study|Lost to Follow-up|1|||
129011505|NCT01355081|464334518|FG000|Overall Study|Withdrawal of Consent|2|||
129011506|NCT01355081|464334519|FG001|Overall Study|Withdrawal of Consent|3|||
129011507|NCT01355081|464334520|FG002|Overall Study|Withdrawal of Consent|3|||
129011508|NCT01355081|464334518|FG000|Overall Study|Lack of Efficacy|2|||
129011509|NCT01355081|464334519|FG001|Overall Study|Lack of Efficacy|1|||
129011510|NCT01355081|464334520|FG002|Overall Study|Lack of Efficacy|1|||
129011511|NCT01355081|464334518|FG000|Overall Study|Non Compliance with Study Medication|0|||
129011512|NCT01355081|464334519|FG001|Overall Study|Non Compliance with Study Medication|1|||
129011513|NCT01355081|464334520|FG002|Overall Study|Non Compliance with Study Medication|0|||
129011514|NCT01475474|464334521|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
129011515|NCT01475474|464334521|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
129011516|NCT01658943|464334524|FG000|Overall Study|Adverse Event|6|||
129011517|NCT01658943|464334525|FG001|Overall Study|Adverse Event|13|||
129011518|NCT01658943|464334524|FG000|Overall Study|Withdrawal by Subject|9|||
129011519|NCT01658943|464334525|FG001|Overall Study|Withdrawal by Subject|2|||
129011520|NCT01658943|464334524|FG000|Overall Study|Progression/Relapse|39|||
129011521|NCT01658943|464334525|FG001|Overall Study|Progression/Relapse|40|||
129011522|NCT01658943|464334524|FG000|Overall Study|Death|4|||
129011523|NCT01658943|464334525|FG001|Overall Study|Death|2|||
129011524|NCT01658943|464334524|FG000|Overall Study|not protocol specified|4|||
129011525|NCT01658943|464334525|FG001|Overall Study|not protocol specified|1|||
129011526|NCT01658943|464334524|FG000|Overall Study|Not eligible|7|||
129011527|NCT01658943|464334525|FG001|Overall Study|Not eligible|9|||
129011528|NCT01658943|464334524|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
129011529|NCT01658943|464334525|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
129011530|NCT00475020|464334527|FG000|Overall Study|Physician Decision|3|||
129011531|NCT00475020|464334527|FG000|Overall Study|Insurance Denial|1|||
129011532|NCT00475020|464334527|FG000|Overall Study|Donor not able to donate the last minute|1|||
129011533|NCT02514174|464334531|FG000|Overall Study|Patient refused to continue medication|1|||
129011534|NCT02514174|464334531|FG000|Overall Study|Adverse Event|2|||
129011535|NCT02514174|464334531|FG000|Overall Study|Study closed by sponsor|9|||
129011536|NCT02514174|464334531|FG000|Overall Study|Progressive disease|11|||
129011537|NCT02514174|464334531|FG000|Overall Study|Treatment change|1|||
129011538|NCT02514174|464334531|FG000|Overall Study|Treated off study with Afatinib.|1|||
129011539|NCT02130466|464334532|FG000|Overall Study|Death|4|||
129011540|NCT02130466|464334533|FG001|Overall Study|Death|1|||
129011541|NCT02130466|464334534|FG002|Overall Study|Death|1|||
129011542|NCT02130466|464334535|FG003|Overall Study|Death|3|||
129011543|NCT02130466|464334536|FG004|Overall Study|Death|2|||
129011544|NCT02130466|464334537|FG005|Overall Study|Death|30|||
129011545|NCT02130466|464334538|FG006|Overall Study|Death|45|||
129011546|NCT02130466|464334539|FG007|Overall Study|Death|2|||
129011547|NCT02130466|464334540|FG008|Overall Study|Death|3|||
129011548|NCT02130466|464334541|FG009|Overall Study|Death|4|||
129011549|NCT02130466|464334542|FG010|Overall Study|Death|5|||
129011550|NCT02130466|464334543|FG011|Overall Study|Death|3|||
129011551|NCT02130466|464334544|FG012|Overall Study|Death|11|||
129011552|NCT02130466|464334545|FG013|Overall Study|Death|7|||
129011553|NCT02130466|464334532|FG000|Overall Study|Lost to Follow-up|1|||
129011554|NCT02130466|464334533|FG001|Overall Study|Lost to Follow-up|0|||
129011555|NCT02130466|464334534|FG002|Overall Study|Lost to Follow-up|0|||
129011556|NCT02130466|464334535|FG003|Overall Study|Lost to Follow-up|0|||
129011557|NCT02130466|464334536|FG004|Overall Study|Lost to Follow-up|0|||
129011558|NCT02130466|464334537|FG005|Overall Study|Lost to Follow-up|1|||
129011559|NCT02130466|464334538|FG006|Overall Study|Lost to Follow-up|0|||
128677033|NCT01073462|463116887|FG000|Overall Study|Death|14|||
128677034|NCT01073462|463116887|FG000|Overall Study|Kidney transplant|10|||
128677035|NCT01073462|463116887|FG000|Overall Study|Low parathyroid hormone levels|8|||
128677036|NCT01073462|463116887|FG000|Overall Study|Serious adverse event|2|||
128677037|NCT01073462|463116887|FG000|Overall Study|Lost to Follow-up|7|||
128677038|NCT01238588|463116888|FG000|Overall Study|Withdrawal by Subject|1|||
128677039|NCT01238588|463116888|FG000|Overall Study|Physician Decision|2|||
128677040|NCT05395091|463116891|FG000|Baseline to Month 12|Adverse Event|7|||
128677041|NCT05395091|463116892|FG001|Baseline to Month 12|Adverse Event|2|||
128677042|NCT05395091|463116893|FG002|Baseline to Month 12|Adverse Event|0|||
128677043|NCT05395091|463116891|FG000|Baseline to Month 12|Death|3|||
128677044|NCT05395091|463116892|FG001|Baseline to Month 12|Death|1|||
128677045|NCT05395091|463116893|FG002|Baseline to Month 12|Death|0|||
128677046|NCT05395091|463116891|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
128677047|NCT05395091|463116892|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
128677048|NCT05395091|463116893|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
128677049|NCT05395091|463116891|FG000|Baseline to Month 12|Protocol Violation|2|||
128677050|NCT05395091|463116892|FG001|Baseline to Month 12|Protocol Violation|3|||
128677051|NCT05395091|463116893|FG002|Baseline to Month 12|Protocol Violation|0|||
128677052|NCT05395091|463116891|FG000|Baseline to Month 12|Physician Decision|1|||
128677053|NCT05395091|463116892|FG001|Baseline to Month 12|Physician Decision|0|||
128677054|NCT05395091|463116893|FG002|Baseline to Month 12|Physician Decision|0|||
128677055|NCT05395091|463116891|FG000|Month 12 to Month 18|Death|1|||
128677056|NCT05395091|463116892|FG001|Month 12 to Month 18|Death|0|||
128677057|NCT05395091|463116893|FG002|Month 12 to Month 18|Death|0|||
128677058|NCT05395091|463116891|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
128677059|NCT05395091|463116892|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
128677060|NCT05395091|463116893|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
128677061|NCT05395091|463116891|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
128677062|NCT05395091|463116892|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
128677063|NCT05395091|463116893|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
128677064|NCT05395091|463116891|FG000|Month 12 to Month 18|Other reasons|0|||
128677065|NCT05395091|463116892|FG001|Month 12 to Month 18|Other reasons|0|||
128677066|NCT05395091|463116893|FG002|Month 12 to Month 18|Other reasons|1|||
128677067|NCT03554486|463116894|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
128677068|NCT03554486|463116895|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
128677069|NCT03554486|463116896|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
128677070|NCT03554486|463116894|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
128677071|NCT03554486|463116895|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
128677072|NCT03554486|463116896|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
128677073|NCT03554486|463116894|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
128677074|NCT03554486|463116895|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
128677075|NCT03554486|463116896|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
128677076|NCT01509053|463116897|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
128677077|NCT01509053|463116897|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
128677078|NCT01509053|463116897|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
128677079|NCT01509053|463116897|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
128677080|NCT01509053|463116897|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
128677081|NCT01509053|463116897|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
128677082|NCT01915303|463116898|FG000|Core Phase|Adverse Event|7|||
128677083|NCT01915303|463116898|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
128677084|NCT01915303|463116898|FG000|Core Phase|Death|2|||
128677085|NCT01915303|463116898|FG000|Core Phase|Protocol Violation|2|||
128677086|NCT01915303|463116898|FG000|Core Phase|Abnormal lab value|1|||
128677087|NCT01915303|463116898|FG000|Core Phase|Withdrawal by Subject|1|||
128677088|NCT01915303|463116898|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
128677089|NCT01915303|463116898|FG000|Extension Phase|Withdrawal by Subject|4|||
128677090|NCT01915303|463116898|FG000|Extension Phase|Adverse Event|3|||
128677091|NCT01915303|463116898|FG000|Extension Phase|Death|1|||
128677092|NCT01915303|463116898|FG000|Extension Phase|Protocol Violation|1|||
128677093|NCT02925338|463116899|FG000|Overall Study|Death|0|||
129011560|NCT02130466|464334539|FG007|Overall Study|Lost to Follow-up|0|||
129011561|NCT02130466|464334540|FG008|Overall Study|Lost to Follow-up|0|||
129011562|NCT02130466|464334541|FG009|Overall Study|Lost to Follow-up|0|||
128677094|NCT02925338|463116900|FG001|Overall Study|Death|2|||
128677095|NCT02925338|463116901|FG002|Overall Study|Death|1|||
128677096|NCT02925338|463116902|FG003|Overall Study|Death|0|||
128677097|NCT02925338|463116903|FG004|Overall Study|Death|0|||
128677098|NCT02925338|463116899|FG000|Overall Study|Lost to Follow-up|30|||
128677099|NCT02925338|463116900|FG001|Overall Study|Lost to Follow-up|10|||
128677100|NCT02925338|463116901|FG002|Overall Study|Lost to Follow-up|1|||
128677101|NCT02925338|463116902|FG003|Overall Study|Lost to Follow-up|16|||
128677102|NCT02925338|463116903|FG004|Overall Study|Lost to Follow-up|3|||
128677103|NCT02925338|463116899|FG000|Overall Study|Withdrawal by Subject|3|||
128677104|NCT02925338|463116900|FG001|Overall Study|Withdrawal by Subject|0|||
129101239|NCT03585712|464664458|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
129101240|NCT03585712|464664456|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
128677105|NCT02925338|463116901|FG002|Overall Study|Withdrawal by Subject|3|||
128677106|NCT02925338|463116902|FG003|Overall Study|Withdrawal by Subject|2|||
128677107|NCT02925338|463116903|FG004|Overall Study|Withdrawal by Subject|2|||
128677108|NCT02925338|463116899|FG000|Overall Study|Missing|38|||
128677109|NCT02925338|463116900|FG001|Overall Study|Missing|27|||
128677110|NCT02925338|463116901|FG002|Overall Study|Missing|0|||
128677111|NCT02925338|463116902|FG003|Overall Study|Missing|3|||
128677112|NCT02925338|463116903|FG004|Overall Study|Missing|2|||
128677113|NCT02925338|463116899|FG000|Overall Study|Participant's Decision|11|||
128677114|NCT02925338|463116900|FG001|Overall Study|Participant's Decision|7|||
128677115|NCT02925338|463116901|FG002|Overall Study|Participant's Decision|3|||
128677116|NCT02925338|463116902|FG003|Overall Study|Participant's Decision|8|||
128677117|NCT02925338|463116903|FG004|Overall Study|Participant's Decision|1|||
128677118|NCT02925338|463116899|FG000|Overall Study|Treatment Discontinuation|144|||
128677119|NCT02925338|463116900|FG001|Overall Study|Treatment Discontinuation|65|||
128677120|NCT02925338|463116901|FG002|Overall Study|Treatment Discontinuation|56|||
128677121|NCT02925338|463116902|FG003|Overall Study|Treatment Discontinuation|131|||
128677122|NCT02925338|463116903|FG004|Overall Study|Treatment Discontinuation|22|||
128677123|NCT00280748|463116907|FG000|Overall Study|Decline in performance|3|||
128677124|NCT00280748|463116907|FG000|Overall Study|Extra-cranial disease progression|1|||
128677125|NCT00029146|463116908|FG000|Overall Study|Lost to Follow-up|2|||
128677126|NCT00029146|463116909|FG001|Overall Study|Lost to Follow-up|1|||
128677127|NCT01433250|463116910|FG000|Overall Study|Protocol Violation|0|||
128677128|NCT01433250|463116911|FG001|Overall Study|Protocol Violation|1|||
128677129|NCT01433250|463116910|FG000|Overall Study|Withdrawal by Subject|3|||
128677130|NCT01433250|463116911|FG001|Overall Study|Withdrawal by Subject|2|||
128677131|NCT02576145|463116914|FG000|Overall Study|Adverse Event|1|||
129101241|NCT03585712|464664457|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
129101242|NCT03585712|464664458|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
129101243|NCT03585712|464664456|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
129101244|NCT03585712|464664457|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
129101245|NCT03585712|464664458|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
129101246|NCT01853696|464664467|FG000|Overall Study|Withdrawal by Subject|1|||
129101247|NCT01853696|464664468|FG001|Overall Study|Withdrawal by Subject|1|||
129101248|NCT01853696|464664467|FG000|Overall Study|Lost to Follow-up|5|||
129101249|NCT01853696|464664468|FG001|Overall Study|Lost to Follow-up|4|||
129101250|NCT03004924|464664469|FG000|Overall Study|Adverse Event|6|||
128677132|NCT02576145|463116915|FG001|Overall Study|Adverse Event|0|||
128677133|NCT02576145|463116914|FG000|Overall Study|Withdrawal by Subject|1|||
128677134|NCT02576145|463116915|FG001|Overall Study|Withdrawal by Subject|0|||
128677135|NCT02576145|463116914|FG000|Overall Study|Acute rejection|1|||
128677136|NCT02576145|463116915|FG001|Overall Study|Acute rejection|0|||
128677137|NCT02576145|463116914|FG000|Overall Study|Tetanus Titers Decreased|0|||
128677138|NCT02576145|463116915|FG001|Overall Study|Tetanus Titers Decreased|1|||
128677139|NCT02660138|463116917|FG000|Overall Study|Adverse Event|0|||
128677140|NCT02660138|463116918|FG001|Overall Study|Adverse Event|3|||
128677141|NCT02660138|463116919|FG002|Overall Study|Adverse Event|2|||
128677142|NCT02660138|463116917|FG000|Overall Study|Lack of Efficacy|1|||
128677143|NCT02660138|463116918|FG001|Overall Study|Lack of Efficacy|2|||
128677144|NCT02660138|463116919|FG002|Overall Study|Lack of Efficacy|1|||
128677145|NCT02660138|463116917|FG000|Overall Study|Withdrawal by Subject|7|||
128677146|NCT02660138|463116918|FG001|Overall Study|Withdrawal by Subject|6|||
128677147|NCT02660138|463116919|FG002|Overall Study|Withdrawal by Subject|6|||
128677148|NCT02660138|463116917|FG000|Overall Study|Lost to Follow-up|4|||
128677149|NCT02660138|463116918|FG001|Overall Study|Lost to Follow-up|4|||
128677150|NCT02660138|463116919|FG002|Overall Study|Lost to Follow-up|1|||
128677151|NCT02660138|463116917|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
128677152|NCT02660138|463116918|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
128677153|NCT02660138|463116919|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
128677154|NCT02660138|463116917|FG000|Overall Study|Other|1|||
128677155|NCT02660138|463116918|FG001|Overall Study|Other|1|||
128677156|NCT02660138|463116919|FG002|Overall Study|Other|0|||
128677157|NCT02660138|463116917|FG000|Overall Study|Not treated|0|||
128677158|NCT02660138|463116918|FG001|Overall Study|Not treated|1|||
128677159|NCT02660138|463116919|FG002|Overall Study|Not treated|0|||
128677160|NCT00308581|463116920|FG000|Induction Phase|Adverse Event|0|||
128677161|NCT00308581|463116921|FG001|Induction Phase|Adverse Event|0|||
128677162|NCT00308581|463116922|FG002|Induction Phase|Adverse Event|37|||
128677163|NCT00308581|463116920|FG000|Induction Phase|Lack of Efficacy|0|||
128677164|NCT00308581|463116921|FG001|Induction Phase|Lack of Efficacy|0|||
128677165|NCT00308581|463116922|FG002|Induction Phase|Lack of Efficacy|121|||
128677166|NCT00308581|463116920|FG000|Induction Phase|Withdrawal by Subject|0|||
128677167|NCT00308581|463116921|FG001|Induction Phase|Withdrawal by Subject|0|||
128677168|NCT00308581|463116922|FG002|Induction Phase|Withdrawal by Subject|5|||
129101251|NCT03004924|464664470|FG001|Overall Study|Adverse Event|5|||
129101252|NCT03004924|464664471|FG002|Overall Study|Adverse Event|10|||
128677169|NCT00308581|463116920|FG000|Induction Phase|Unknown reason|0|||
128677170|NCT00308581|463116921|FG001|Induction Phase|Unknown reason|0|||
128677171|NCT00308581|463116922|FG002|Induction Phase|Unknown reason|3|||
128677172|NCT00308581|463116920|FG000|Randomized Maintenance Phase|Adverse Event|10|||
128677173|NCT00308581|463116921|FG001|Randomized Maintenance Phase|Adverse Event|17|||
128677174|NCT00308581|463116922|FG002|Randomized Maintenance Phase|Adverse Event|0|||
128677175|NCT00308581|463116920|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
128677176|NCT00308581|463116921|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
128677177|NCT00308581|463116922|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
128677178|NCT00308581|463116920|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
128677179|NCT00308581|463116921|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
128677180|NCT00308581|463116922|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
128677181|NCT00308581|463116920|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
128677182|NCT00308581|463116921|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
128677183|NCT00308581|463116922|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
128677184|NCT00308581|463116920|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
128677185|NCT00308581|463116921|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
128677186|NCT00308581|463116922|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
128677187|NCT00308581|463116920|FG000|Randomized Maintenance Phase|Unknown reason|3|||
128677188|NCT00308581|463116921|FG001|Randomized Maintenance Phase|Unknown reason|0|||
128677189|NCT00308581|463116922|FG002|Randomized Maintenance Phase|Unknown reason|0|||
128677190|NCT00899353|463116923|FG000|Overall Study|Adverse Event|2|||
128677191|NCT00899353|463116923|FG000|Overall Study|Lost to Follow-up|1|||
128677192|NCT00899353|463116923|FG000|Overall Study|Withdrawal by Subject|2|||
128677193|NCT02730793|463116925|FG000|Overall Study|Physician Decision|0|||
128677194|NCT02730793|463116926|FG001|Overall Study|Physician Decision|1|||
128677195|NCT02730793|463116925|FG000|Overall Study|Withdrawal by Subject|0|||
128677196|NCT02730793|463116926|FG001|Overall Study|Withdrawal by Subject|1|||
128677197|NCT00534313|463116927|FG000|Short-term Period|Adverse Event|1|||
128677198|NCT00534313|463116928|FG001|Short-term Period|Adverse Event|2|||
128677199|NCT00534313|463116929|FG002|Short-term Period|Adverse Event|1|||
128677200|NCT00534313|463116930|FG003|Short-term Period|Adverse Event|3|||
128677201|NCT00534313|463116927|FG000|Short-term Period|Lack of Efficacy|3|||
128677202|NCT00534313|463116928|FG001|Short-term Period|Lack of Efficacy|4|||
128677203|NCT00534313|463116929|FG002|Short-term Period|Lack of Efficacy|0|||
128677204|NCT00534313|463116930|FG003|Short-term Period|Lack of Efficacy|3|||
128677205|NCT00534313|463116927|FG000|Short-term Period|Participant not meeting study criteria|0|||
128677206|NCT00534313|463116928|FG001|Short-term Period|Participant not meeting study criteria|0|||
128677207|NCT00534313|463116929|FG002|Short-term Period|Participant not meeting study criteria|0|||
128677208|NCT00534313|463116930|FG003|Short-term Period|Participant not meeting study criteria|1|||
128677209|NCT00534313|463116927|FG000|Short-term Period|Participant withdrew consent|2|||
128677210|NCT00534313|463116928|FG001|Short-term Period|Participant withdrew consent|0|||
128677211|NCT00534313|463116929|FG002|Short-term Period|Participant withdrew consent|0|||
128677212|NCT00534313|463116930|FG003|Short-term Period|Participant withdrew consent|2|||
128677213|NCT00534313|463116927|FG000|Short-term Period|Pregnancy|0|||
128677214|NCT00534313|463116928|FG001|Short-term Period|Pregnancy|0|||
128677215|NCT00534313|463116929|FG002|Short-term Period|Pregnancy|1|||
128677216|NCT00534313|463116930|FG003|Short-term Period|Pregnancy|0|||
128677217|NCT00534313|463116927|FG000|Long-term Period|Adverse Event|2|||
128677218|NCT00534313|463116928|FG001|Long-term Period|Adverse Event|1|||
128677219|NCT00534313|463116929|FG002|Long-term Period|Adverse Event|0|||
128677220|NCT00534313|463116930|FG003|Long-term Period|Adverse Event|1|||
128677221|NCT00534313|463116927|FG000|Long-term Period|Lack of Efficacy|14|||
128677222|NCT00534313|463116928|FG001|Long-term Period|Lack of Efficacy|10|||
128677223|NCT00534313|463116929|FG002|Long-term Period|Lack of Efficacy|14|||
128677224|NCT00534313|463116930|FG003|Long-term Period|Lack of Efficacy|12|||
128677225|NCT00534313|463116927|FG000|Long-term Period|Lost to Follow-up|1|||
128677226|NCT00534313|463116928|FG001|Long-term Period|Lost to Follow-up|2|||
128677227|NCT00534313|463116929|FG002|Long-term Period|Lost to Follow-up|0|||
128677228|NCT00534313|463116930|FG003|Long-term Period|Lost to Follow-up|0|||
128677229|NCT00534313|463116927|FG000|Long-term Period|Withdrawal by Subject|2|||
128677230|NCT00534313|463116928|FG001|Long-term Period|Withdrawal by Subject|2|||
128677231|NCT00534313|463116929|FG002|Long-term Period|Withdrawal by Subject|0|||
128677232|NCT00534313|463116930|FG003|Long-term Period|Withdrawal by Subject|0|||
128677233|NCT00534313|463116927|FG000|Long-term Period|No longer meets study criteria|0|||
128677234|NCT00534313|463116928|FG001|Long-term Period|No longer meets study criteria|1|||
128677235|NCT00534313|463116929|FG002|Long-term Period|No longer meets study criteria|0|||
128677236|NCT00534313|463116930|FG003|Long-term Period|No longer meets study criteria|0|||
128677237|NCT00534313|463116927|FG000|Long-term Period|Poor compliance/noncompliance|0|||
128677238|NCT00534313|463116928|FG001|Long-term Period|Poor compliance/noncompliance|1|||
128677239|NCT00534313|463116929|FG002|Long-term Period|Poor compliance/noncompliance|1|||
128677240|NCT00534313|463116930|FG003|Long-term Period|Poor compliance/noncompliance|0|||
128677241|NCT00534313|463116927|FG000|Long-term Period|Administrative reason by sponsor|17|||
128677242|NCT00534313|463116928|FG001|Long-term Period|Administrative reason by sponsor|15|||
128677243|NCT00534313|463116929|FG002|Long-term Period|Administrative reason by sponsor|26|||
128677244|NCT00534313|463116930|FG003|Long-term Period|Administrative reason by sponsor|18|||
128677245|NCT00534313|463116927|FG000|Long-term Period|Other|1|||
128677246|NCT00534313|463116928|FG001|Long-term Period|Other|2|||
128677247|NCT00534313|463116929|FG002|Long-term Period|Other|2|||
128677248|NCT00534313|463116930|FG003|Long-term Period|Other|2|||
128677249|NCT00927940|463116931|FG000|Overall Study|Death|1|||
128677250|NCT00608569|463116935|FG000|Overall Study|Death|4|||
128677251|NCT00608569|463116936|FG001|Overall Study|Death|3|||
128677252|NCT00608569|463116935|FG000|Overall Study|Lost to Follow-up|4|||
128677253|NCT00608569|463116936|FG001|Overall Study|Lost to Follow-up|5|||
128677254|NCT00608569|463116935|FG000|Overall Study|Withdrawal by Subject|1|||
128677255|NCT00608569|463116936|FG001|Overall Study|Withdrawal by Subject|0|||
128677256|NCT00608569|463116935|FG000|Overall Study|Adverse Event|1|||
128677257|NCT00608569|463116936|FG001|Overall Study|Adverse Event|0|||
128677258|NCT00608569|463116935|FG000|Overall Study|Unable to adhere with study requirements|0|||
128677259|NCT00608569|463116936|FG001|Overall Study|Unable to adhere with study requirements|1|||
128677260|NCT02282293|463116937|FG000|Overall Study|Lost to Follow-up|2|||
128677261|NCT02282293|463116938|FG001|Overall Study|Lost to Follow-up|2|||
128677262|NCT02282293|463116937|FG000|Overall Study|Unable to comply with study procedures|1|||
128677263|NCT02282293|463116938|FG001|Overall Study|Unable to comply with study procedures|0|||
129011563|NCT02130466|464334542|FG010|Overall Study|Lost to Follow-up|0|||
129011564|NCT02130466|464334543|FG011|Overall Study|Lost to Follow-up|0|||
129011565|NCT02130466|464334544|FG012|Overall Study|Lost to Follow-up|1|||
129011566|NCT02130466|464334545|FG013|Overall Study|Lost to Follow-up|0|||
129011567|NCT02130466|464334532|FG000|Overall Study|Physician Decision|0|||
129011568|NCT02130466|464334533|FG001|Overall Study|Physician Decision|0|||
129011569|NCT02130466|464334534|FG002|Overall Study|Physician Decision|0|||
129011570|NCT02130466|464334535|FG003|Overall Study|Physician Decision|0|||
129011571|NCT02130466|464334536|FG004|Overall Study|Physician Decision|0|||
129011572|NCT02130466|464334537|FG005|Overall Study|Physician Decision|1|||
129011573|NCT02130466|464334538|FG006|Overall Study|Physician Decision|1|||
129011574|NCT02130466|464334539|FG007|Overall Study|Physician Decision|0|||
129011575|NCT02130466|464334540|FG008|Overall Study|Physician Decision|0|||
129011576|NCT02130466|464334541|FG009|Overall Study|Physician Decision|0|||
129011577|NCT02130466|464334542|FG010|Overall Study|Physician Decision|0|||
129011578|NCT02130466|464334543|FG011|Overall Study|Physician Decision|0|||
129011579|NCT02130466|464334544|FG012|Overall Study|Physician Decision|0|||
129011580|NCT02130466|464334545|FG013|Overall Study|Physician Decision|0|||
129011581|NCT02130466|464334532|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129011582|NCT02130466|464334533|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
129011583|NCT02130466|464334534|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129011584|NCT02130466|464334535|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
129011585|NCT02130466|464334536|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129011586|NCT02130466|464334537|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
129011587|NCT02130466|464334538|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
129011588|NCT02130466|464334539|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129011589|NCT02130466|464334540|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129011590|NCT02130466|464334541|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129011591|NCT02130466|464334542|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129011592|NCT02130466|464334543|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129011593|NCT02130466|464334544|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129011594|NCT02130466|464334545|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
129011595|NCT02130466|464334532|FG000|Overall Study|Withdrawal by Subject|1|||
129011596|NCT02130466|464334533|FG001|Overall Study|Withdrawal by Subject|0|||
129011597|NCT02130466|464334534|FG002|Overall Study|Withdrawal by Subject|0|||
129011598|NCT02130466|464334535|FG003|Overall Study|Withdrawal by Subject|0|||
129011599|NCT02130466|464334536|FG004|Overall Study|Withdrawal by Subject|0|||
129011600|NCT02130466|464334537|FG005|Overall Study|Withdrawal by Subject|1|||
129011601|NCT02130466|464334538|FG006|Overall Study|Withdrawal by Subject|0|||
129011602|NCT02130466|464334539|FG007|Overall Study|Withdrawal by Subject|0|||
129011603|NCT02130466|464334540|FG008|Overall Study|Withdrawal by Subject|1|||
129011604|NCT02130466|464334541|FG009|Overall Study|Withdrawal by Subject|0|||
129011605|NCT02130466|464334542|FG010|Overall Study|Withdrawal by Subject|0|||
129011606|NCT02130466|464334543|FG011|Overall Study|Withdrawal by Subject|0|||
129011607|NCT02130466|464334544|FG012|Overall Study|Withdrawal by Subject|0|||
129011608|NCT02130466|464334545|FG013|Overall Study|Withdrawal by Subject|0|||
129011609|NCT04529109|464334546|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
129011610|NCT04529109|464334547|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
129011611|NCT03100903|464335933|FG000|Overall Study|Withdrawal by Subject|0|||
128677264|NCT02282293|463116937|FG000|Overall Study|Moved out of study area|0|||
129011612|NCT03100903|464335934|FG001|Overall Study|Withdrawal by Subject|0|||
129011613|NCT03100903|464335935|FG002|Overall Study|Withdrawal by Subject|1|||
129011614|NCT00433147|464335936|FG000|Overall Study|Adverse Event|0|||
129011615|NCT00433147|464335937|FG001|Overall Study|Adverse Event|1|||
129011616|NCT00433147|464335938|FG002|Overall Study|Adverse Event|0|||
129011617|NCT00433147|464335939|FG003|Overall Study|Adverse Event|0|||
129011618|NCT01027143|464335942|FG000|Overall Study|Lost to Follow-up|9|||
129011619|NCT01027143|464335943|FG001|Overall Study|Lost to Follow-up|4|||
129011620|NCT02564263|464335944|FG000|Overall Study|Adverse Event|31|||
129011621|NCT02564263|464335945|FG001|Overall Study|Adverse Event|29|||
129011622|NCT02564263|464335944|FG000|Overall Study|Death|270|||
129011623|NCT02564263|464335945|FG001|Overall Study|Death|262|||
129011624|NCT02564263|464335944|FG000|Overall Study|Withdrawal by Subject|4|||
129011625|NCT02564263|464335945|FG001|Overall Study|Withdrawal by Subject|19|||
129011626|NCT02564263|464335944|FG000|Overall Study|Sponsor's decision|9|||
129011627|NCT02564263|464335945|FG001|Overall Study|Sponsor's decision|4|||
129011628|NCT03444038|464335946|FG000|Overall Study|Adverse Event|12|||
129011629|NCT03444038|464335946|FG000|Overall Study|Withdrawal by Subject|7|||
129011630|NCT03444038|464335946|FG000|Overall Study|Lost to Follow-up|1|||
129011631|NCT03444038|464335946|FG000|Overall Study|Physician Decision|2|||
129011632|NCT03444038|464335946|FG000|Overall Study|Lack of Efficacy|7|||
129011633|NCT00728949|464335947|FG000|Overall Study|Adverse Event|8|||
129011634|NCT00728949|464335948|FG001|Overall Study|Adverse Event|0|||
129011635|NCT00728949|464335947|FG000|Overall Study|Withdrawal by Subject|2|||
129011636|NCT00728949|464335948|FG001|Overall Study|Withdrawal by Subject|2|||
129011637|NCT00728949|464335947|FG000|Overall Study|Abnormal Lab Results|0|||
129011638|NCT00728949|464335948|FG001|Overall Study|Abnormal Lab Results|2|||
129011639|NCT00728949|464335947|FG000|Overall Study|On treatment at cutoff date|1|||
129011640|NCT00728949|464335948|FG001|Overall Study|On treatment at cutoff date|0|||
129011641|NCT02319148|464335949|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
129011642|NCT02319148|464335950|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
129011643|NCT02319148|464335951|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
129011644|NCT02319148|464335952|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
129011645|NCT02319148|464335949|FG000|Second Intervention Period|No longer willing to participate|0|||
129011646|NCT02319148|464335950|FG001|Second Intervention Period|No longer willing to participate|1|||
129011647|NCT02319148|464335951|FG002|Second Intervention Period|No longer willing to participate|0|||
129011648|NCT02319148|464335952|FG003|Second Intervention Period|No longer willing to participate|0|||
129011649|NCT02319148|464335949|FG000|Second Intervention Period|Other|0|||
129011650|NCT02319148|464335950|FG001|Second Intervention Period|Other|0|||
129011651|NCT02319148|464335951|FG002|Second Intervention Period|Other|0|||
129011652|NCT02319148|464335952|FG003|Second Intervention Period|Other|1|||
129011653|NCT01087970|464335954|FG000|Overall Study|Protocol Violation|2|||
129011654|NCT00543309|464335955|FG000|Overall Study|Physician Decision|0|||
129011655|NCT00543309|464335956|FG001|Overall Study|Physician Decision|1|||
129011656|NCT00543309|464335957|FG002|Overall Study|Physician Decision|0|||
129011657|NCT01249664|464335958|FG000|Overall Study|Withdrawal by Subject|5|||
129011658|NCT01249664|464335959|FG001|Overall Study|Withdrawal by Subject|0|||
129011659|NCT01249664|464335958|FG000|Overall Study|Adverse Event|1|||
129011660|NCT01249664|464335959|FG001|Overall Study|Adverse Event|0|||
129011661|NCT00762086|464335960|FG000|Overall Study|Adverse Event|2|||
129011662|NCT00762086|464335961|FG001|Overall Study|Adverse Event|0|||
129011663|NCT00762086|464335960|FG000|Overall Study|Lost to Follow-up|0|||
129011664|NCT00762086|464335961|FG001|Overall Study|Lost to Follow-up|2|||
129011665|NCT00762086|464335960|FG000|Overall Study|Non compliance|1|||
129011666|NCT00762086|464335961|FG001|Overall Study|Non compliance|0|||
129011667|NCT00762086|464335960|FG000|Overall Study|Withdrawal by Subject|2|||
129011668|NCT00762086|464335961|FG001|Overall Study|Withdrawal by Subject|2|||
129011669|NCT00762086|464335960|FG000|Overall Study|Ineligible to participate in the study|1|||
129011670|NCT00762086|464335961|FG001|Overall Study|Ineligible to participate in the study|0|||
129011671|NCT01074554|464335966|FG000|Overall Study|Adverse Event|3|||
129011672|NCT01074554|464335967|FG001|Overall Study|Adverse Event|3|||
129011673|NCT01074554|464335966|FG000|Overall Study|Lost to Follow-up|0|||
129011674|NCT01074554|464335967|FG001|Overall Study|Lost to Follow-up|1|||
129011675|NCT04276883|464335968|FG000|Overall Study|Withdrawal by Subject|2|||
129011676|NCT04276883|464335969|FG001|Overall Study|Withdrawal by Subject|3|||
129011677|NCT04276883|464335970|FG002|Overall Study|Withdrawal by Subject|6|||
129011678|NCT04276883|464335968|FG000|Overall Study|Lost to Follow-up|1|||
129011679|NCT04276883|464335969|FG001|Overall Study|Lost to Follow-up|3|||
129011680|NCT04276883|464335970|FG002|Overall Study|Lost to Follow-up|0|||
129011681|NCT04276883|464335968|FG000|Overall Study|Adverse Event|0|||
129011682|NCT04276883|464335969|FG001|Overall Study|Adverse Event|1|||
129011683|NCT04276883|464335970|FG002|Overall Study|Adverse Event|0|||
129011684|NCT04276883|464335968|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
129011685|NCT04276883|464335969|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
129011686|NCT04276883|464335970|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
129011687|NCT01876706|464335971|FG000|Overall Study|BPH Intervention|9|||
129011688|NCT01876706|464335971|FG000|Overall Study|Lost to Follow-up|7|||
129011689|NCT01876706|464335971|FG000|Overall Study|Withdrawals|6|||
128677265|NCT02282293|463116938|FG001|Overall Study|Moved out of study area|1|||
128677266|NCT03011892|463116939|FG000|Double Blind (DB) Period|Adverse Event|0|||
128677267|NCT03011892|463116940|FG001|Double Blind (DB) Period|Adverse Event|1|||
128677268|NCT03011892|463116941|FG002|Double Blind (DB) Period|Adverse Event|1|||
128677269|NCT03011892|463116942|FG003|Double Blind (DB) Period|Adverse Event|0|||
128677270|NCT03011892|463116943|FG004|Double Blind (DB) Period|Adverse Event|0|||
128677271|NCT03011892|463116944|FG005|Double Blind (DB) Period|Adverse Event|0|||
128677272|NCT03011892|463116945|FG006|Double Blind (DB) Period|Adverse Event|0|||
128677273|NCT03011892|463116946|FG007|Double Blind (DB) Period|Adverse Event|0|||
128677274|NCT03011892|463116947|FG008|Double Blind (DB) Period|Adverse Event|0|||
128677275|NCT03011892|463116948|FG009|Double Blind (DB) Period|Adverse Event|0|||
128677276|NCT03011892|463116949|FG010|Double Blind (DB) Period|Adverse Event|0|||
128677277|NCT03011892|463116950|FG011|Double Blind (DB) Period|Adverse Event|0|||
128677278|NCT03011892|463116939|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
128677279|NCT03011892|463116940|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
129011690|NCT01876706|464335971|FG000|Overall Study|Death|3|||
129011691|NCT01370408|464335976|FG000|Overall Study|treatment failure|9|||
129011692|NCT02073643|464335978|FG000|Overall Study|Lost to Follow-up|24|||
129011693|NCT01062256|464335979|FG000|Overall Study|Adverse Event|1|||
129011694|NCT01062256|464335980|FG001|Overall Study|Adverse Event|0|||
129011695|NCT01062256|464335981|FG002|Overall Study|Adverse Event|0|||
129011696|NCT01062256|464335979|FG000|Overall Study|Withdrawal by Subject|1|||
129011697|NCT01062256|464335980|FG001|Overall Study|Withdrawal by Subject|1|||
129011698|NCT01062256|464335981|FG002|Overall Study|Withdrawal by Subject|1|||
129011699|NCT01062256|464335979|FG000|Overall Study|Ineligible|1|||
129011700|NCT01062256|464335980|FG001|Overall Study|Ineligible|4|||
129011701|NCT01062256|464335981|FG002|Overall Study|Ineligible|3|||
129011702|NCT01062256|464335979|FG000|Overall Study|Administrative|0|||
129011703|NCT01062256|464335980|FG001|Overall Study|Administrative|2|||
129011704|NCT01062256|464335981|FG002|Overall Study|Administrative|0|||
129011705|NCT03049488|464335984|FG000|Overall Study|Lost to Follow-up|1|||
129011706|NCT03049488|464335985|FG001|Overall Study|Lost to Follow-up|1|||
129011707|NCT03049488|464335986|FG002|Overall Study|Lost to Follow-up|0|||
129011708|NCT03049488|464335987|FG003|Overall Study|Lost to Follow-up|0|||
129011709|NCT03049488|464335988|FG004|Overall Study|Lost to Follow-up|0|||
129011710|NCT03049488|464335989|FG005|Overall Study|Lost to Follow-up|0|||
129011711|NCT03049488|464335984|FG000|Overall Study|Moved from Area|1|||
129011712|NCT03049488|464335985|FG001|Overall Study|Moved from Area|0|||
129011713|NCT03049488|464335986|FG002|Overall Study|Moved from Area|0|||
129011714|NCT03049488|464335987|FG003|Overall Study|Moved from Area|1|||
129011715|NCT03049488|464335988|FG004|Overall Study|Moved from Area|1|||
129011716|NCT03049488|464335989|FG005|Overall Study|Moved from Area|0|||
129011717|NCT03049488|464335984|FG000|Overall Study|Physician Decision|0|||
129011718|NCT03049488|464335985|FG001|Overall Study|Physician Decision|1|||
129011719|NCT03049488|464335986|FG002|Overall Study|Physician Decision|0|||
129011720|NCT03049488|464335987|FG003|Overall Study|Physician Decision|0|||
129011721|NCT03049488|464335988|FG004|Overall Study|Physician Decision|0|||
129011722|NCT03049488|464335989|FG005|Overall Study|Physician Decision|0|||
129011723|NCT03049488|464335984|FG000|Overall Study|Withdrawal by Subject|0|||
129011724|NCT03049488|464335985|FG001|Overall Study|Withdrawal by Subject|0|||
129011725|NCT03049488|464335986|FG002|Overall Study|Withdrawal by Subject|0|||
129011726|NCT03049488|464335987|FG003|Overall Study|Withdrawal by Subject|1|||
129011727|NCT03049488|464335988|FG004|Overall Study|Withdrawal by Subject|1|||
129011728|NCT03049488|464335989|FG005|Overall Study|Withdrawal by Subject|0|||
129011729|NCT00891293|464335991|FG000|Overall Study|Adverse Event|2|||
129011730|NCT00891293|464335991|FG000|Overall Study|Protocol Violation|2|||
129011731|NCT00891293|464335991|FG000|Overall Study|Laboratory abnormality|4|||
129011732|NCT00891293|464335991|FG000|Overall Study|Lost to Follow-up|7|||
129011733|NCT00891293|464335991|FG000|Overall Study|Subject withdrew consent|7|||
129011734|NCT00891293|464335991|FG000|Overall Study|Sponsor termination|62|||
129011735|NCT01448057|464335992|FG000|Overall Study|Protocol Violation|3|||
129011736|NCT01448057|464335993|FG001|Overall Study|Protocol Violation|2|||
128677280|NCT03011892|463116941|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
128677281|NCT03011892|463116942|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
128677282|NCT03011892|463116943|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
128677283|NCT03011892|463116944|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
129011737|NCT01448057|464335992|FG000|Overall Study|Lost to Follow-up|3|||
129011738|NCT01448057|464335993|FG001|Overall Study|Lost to Follow-up|0|||
129011739|NCT01448057|464335992|FG000|Overall Study|Adverse Event|0|||
129011740|NCT01448057|464335993|FG001|Overall Study|Adverse Event|2|||
129011741|NCT01448057|464335992|FG000|Overall Study|Withdrawal by Subject|2|||
129011742|NCT01448057|464335993|FG001|Overall Study|Withdrawal by Subject|0|||
129011743|NCT03883906|464335998|FG000|Overall Study|Withdrawal by Subject|2|||
129011744|NCT03883906|464335998|FG000|Overall Study|Physician Decision|5|||
129011745|NCT01226797|464336019|FG000|Overall Study|Adverse Event|1|||
129011746|NCT01226797|464336020|FG001|Overall Study|Adverse Event|0|||
129011747|NCT01226797|464336019|FG000|Overall Study|No longer willing to participate|1|||
129011748|NCT01226797|464336020|FG001|Overall Study|No longer willing to participate|0|||
129011749|NCT01226797|464336019|FG000|Overall Study|Protocol Violation|0|||
128677284|NCT03011892|463116945|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
128677285|NCT03011892|463116946|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
128677286|NCT03011892|463116947|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
128677287|NCT03011892|463116948|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
128677288|NCT03011892|463116949|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
128677289|NCT03011892|463116950|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
128677290|NCT03011892|463116939|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
128677291|NCT03011892|463116940|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
128677292|NCT03011892|463116941|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
128677293|NCT03011892|463116942|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
128677294|NCT03011892|463116943|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
128677295|NCT03011892|463116944|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
128677296|NCT03011892|463116945|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
128677297|NCT03011892|463116946|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
128677298|NCT03011892|463116947|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
128677299|NCT03011892|463116948|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
128677300|NCT03011892|463116949|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
128677301|NCT03011892|463116950|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
128677302|NCT03011892|463116939|FG000|Double Blind (DB) Period|Other|1|||
128677303|NCT03011892|463116940|FG001|Double Blind (DB) Period|Other|1|||
128677304|NCT03011892|463116941|FG002|Double Blind (DB) Period|Other|1|||
128677305|NCT03011892|463116942|FG003|Double Blind (DB) Period|Other|0|||
128677306|NCT03011892|463116943|FG004|Double Blind (DB) Period|Other|1|||
128677307|NCT03011892|463116944|FG005|Double Blind (DB) Period|Other|0|||
128677308|NCT03011892|463116945|FG006|Double Blind (DB) Period|Other|0|||
128677309|NCT03011892|463116946|FG007|Double Blind (DB) Period|Other|0|||
128677310|NCT03011892|463116947|FG008|Double Blind (DB) Period|Other|0|||
128677311|NCT03011892|463116948|FG009|Double Blind (DB) Period|Other|0|||
128677312|NCT03011892|463116949|FG010|Double Blind (DB) Period|Other|0|||
128677313|NCT03011892|463116950|FG011|Double Blind (DB) Period|Other|0|||
128677314|NCT03011892|463116939|FG000|Double Blind (DB) Period|Physician Decision|1|||
128677315|NCT03011892|463116940|FG001|Double Blind (DB) Period|Physician Decision|0|||
128677316|NCT03011892|463116941|FG002|Double Blind (DB) Period|Physician Decision|1|||
128677317|NCT03011892|463116942|FG003|Double Blind (DB) Period|Physician Decision|0|||
128677318|NCT03011892|463116943|FG004|Double Blind (DB) Period|Physician Decision|0|||
128677319|NCT03011892|463116944|FG005|Double Blind (DB) Period|Physician Decision|0|||
128677320|NCT03011892|463116945|FG006|Double Blind (DB) Period|Physician Decision|0|||
128677321|NCT03011892|463116946|FG007|Double Blind (DB) Period|Physician Decision|0|||
128677322|NCT03011892|463116947|FG008|Double Blind (DB) Period|Physician Decision|0|||
128677323|NCT03011892|463116948|FG009|Double Blind (DB) Period|Physician Decision|0|||
128677324|NCT03011892|463116949|FG010|Double Blind (DB) Period|Physician Decision|0|||
128677325|NCT03011892|463116950|FG011|Double Blind (DB) Period|Physician Decision|0|||
128677326|NCT03011892|463116939|FG000|Double Blind (DB) Period|Pregnancy|0|||
128677327|NCT03011892|463116940|FG001|Double Blind (DB) Period|Pregnancy|0|||
128677328|NCT03011892|463116941|FG002|Double Blind (DB) Period|Pregnancy|0|||
128677329|NCT03011892|463116942|FG003|Double Blind (DB) Period|Pregnancy|0|||
128677330|NCT03011892|463116943|FG004|Double Blind (DB) Period|Pregnancy|1|||
128677331|NCT03011892|463116944|FG005|Double Blind (DB) Period|Pregnancy|0|||
128677332|NCT03011892|463116945|FG006|Double Blind (DB) Period|Pregnancy|0|||
128677333|NCT03011892|463116946|FG007|Double Blind (DB) Period|Pregnancy|0|||
128677334|NCT03011892|463116947|FG008|Double Blind (DB) Period|Pregnancy|0|||
128677335|NCT03011892|463116948|FG009|Double Blind (DB) Period|Pregnancy|0|||
128677336|NCT03011892|463116949|FG010|Double Blind (DB) Period|Pregnancy|0|||
128677337|NCT03011892|463116950|FG011|Double Blind (DB) Period|Pregnancy|0|||
128677338|NCT03011892|463116939|FG000|Double Blind (DB) Period|Protocol Violation|1|||
128677339|NCT03011892|463116940|FG001|Double Blind (DB) Period|Protocol Violation|0|||
128677340|NCT03011892|463116941|FG002|Double Blind (DB) Period|Protocol Violation|0|||
129011750|NCT01226797|464336020|FG001|Overall Study|Protocol Violation|1|||
129011751|NCT01318499|464336021|FG000|Overall Study|Adverse Event|16|||
129011752|NCT01318499|464336022|FG001|Overall Study|Adverse Event|11|||
129011753|NCT01318499|464336023|FG002|Overall Study|Adverse Event|6|||
129011754|NCT01318499|464336021|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
129011755|NCT01318499|464336022|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
128677341|NCT03011892|463116942|FG003|Double Blind (DB) Period|Protocol Violation|0|||
128677342|NCT03011892|463116943|FG004|Double Blind (DB) Period|Protocol Violation|0|||
128677343|NCT03011892|463116944|FG005|Double Blind (DB) Period|Protocol Violation|0|||
128677344|NCT03011892|463116945|FG006|Double Blind (DB) Period|Protocol Violation|0|||
128677345|NCT03011892|463116946|FG007|Double Blind (DB) Period|Protocol Violation|0|||
128677346|NCT03011892|463116947|FG008|Double Blind (DB) Period|Protocol Violation|0|||
128677347|NCT03011892|463116948|FG009|Double Blind (DB) Period|Protocol Violation|0|||
128677348|NCT03011892|463116949|FG010|Double Blind (DB) Period|Protocol Violation|0|||
128677349|NCT03011892|463116950|FG011|Double Blind (DB) Period|Protocol Violation|0|||
128677350|NCT03011892|463116939|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
129101253|NCT03004924|464664469|FG000|Overall Study|Protocol Violation|4|||
129101254|NCT03004924|464664470|FG001|Overall Study|Protocol Violation|0|||
129101255|NCT03004924|464664471|FG002|Overall Study|Protocol Violation|1|||
129101256|NCT03004924|464664469|FG000|Overall Study|Withdrawal by Subject|5|||
129101257|NCT03004924|464664470|FG001|Overall Study|Withdrawal by Subject|3|||
129101258|NCT03004924|464664471|FG002|Overall Study|Withdrawal by Subject|5|||
128677351|NCT03011892|463116940|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
128677352|NCT03011892|463116941|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
128677353|NCT03011892|463116942|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
128677354|NCT03011892|463116943|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
128677355|NCT03011892|463116944|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
128677356|NCT03011892|463116945|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
128677357|NCT03011892|463116946|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
128677358|NCT03011892|463116947|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
128677359|NCT03011892|463116948|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
128677360|NCT03011892|463116949|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
128677361|NCT03011892|463116950|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
128677362|NCT03011892|463116939|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
128677363|NCT03011892|463116940|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
128677364|NCT03011892|463116941|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
128677365|NCT03011892|463116942|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
128677366|NCT03011892|463116943|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
128677367|NCT03011892|463116944|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
128677368|NCT03011892|463116945|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
128677369|NCT03011892|463116946|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
128677370|NCT03011892|463116947|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
128677371|NCT03011892|463116948|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
128677372|NCT03011892|463116949|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
128677373|NCT03011892|463116950|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
128677374|NCT03011892|463116939|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
128677375|NCT03011892|463116940|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
128677376|NCT03011892|463116941|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
128677377|NCT03011892|463116942|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
128677378|NCT03011892|463116943|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
128677379|NCT03011892|463116944|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
128677380|NCT03011892|463116945|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
128677381|NCT03011892|463116946|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
128677382|NCT03011892|463116947|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
128677383|NCT03011892|463116948|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
129011756|NCT01318499|464336023|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
129011757|NCT01318499|464336021|FG000|Overall Study|Noncompliance|2|||
129011758|NCT01318499|464336022|FG001|Overall Study|Noncompliance|3|||
129011759|NCT01318499|464336023|FG002|Overall Study|Noncompliance|0|||
129011760|NCT01318499|464336021|FG000|Overall Study|Treatment Failure|19|||
129011761|NCT01318499|464336022|FG001|Overall Study|Treatment Failure|19|||
129011762|NCT01318499|464336023|FG002|Overall Study|Treatment Failure|101|||
129011763|NCT01318499|464336021|FG000|Overall Study|Protocol Violation|2|||
129011764|NCT01318499|464336022|FG001|Overall Study|Protocol Violation|4|||
129011765|NCT01318499|464336023|FG002|Overall Study|Protocol Violation|2|||
129011766|NCT01318499|464336021|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
129011767|NCT01318499|464336022|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
129011768|NCT01318499|464336023|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
129011769|NCT01318499|464336021|FG000|Overall Study|Other|7|||
129011770|NCT01318499|464336022|FG001|Overall Study|Other|10|||
129011771|NCT01318499|464336023|FG002|Overall Study|Other|22|||
129011772|NCT04977336|464336027|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
129011773|NCT04977336|464336028|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129011774|NCT04977336|464336029|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129011775|NCT04977336|464336030|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
129011776|NCT04977336|464336031|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
129011777|NCT04977336|464336027|FG000|Overall Study|Lost to Follow-up|0|||
129011778|NCT04977336|464336028|FG001|Overall Study|Lost to Follow-up|0|||
129011779|NCT04977336|464336029|FG002|Overall Study|Lost to Follow-up|1|||
129011780|NCT04977336|464336030|FG003|Overall Study|Lost to Follow-up|0|||
128677384|NCT03011892|463116949|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
129011781|NCT04977336|464336031|FG004|Overall Study|Lost to Follow-up|0|||
129011782|NCT01347710|464336032|FG000|Overall Study|Withdrawal by Subject|2|||
129011783|NCT01347710|464336032|FG000|Overall Study|Adverse Event|4|||
129011784|NCT01347710|464336032|FG000|Overall Study|Angio or SPECT not completed|18|||
129011785|NCT01347710|464336032|FG000|Overall Study|issue with vitals prior to dosing|1|||
129011786|NCT01347710|464336032|FG000|Overall Study|Lost to Follow-up|1|||
129011787|NCT01347710|464336032|FG000|Overall Study|Physician Decision|2|||
129101259|NCT03004924|464664469|FG000|Overall Study|Lost to Follow-up|6|||
128677385|NCT03011892|463116950|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
128677386|NCT03011892|463116939|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
128677387|NCT03011892|463116940|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
128677388|NCT03011892|463116941|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
128677389|NCT03011892|463116942|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
128677390|NCT03011892|463116943|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
128677391|NCT03011892|463116944|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
129101260|NCT03004924|464664470|FG001|Overall Study|Lost to Follow-up|1|||
129101261|NCT03004924|464664471|FG002|Overall Study|Lost to Follow-up|4|||
129101262|NCT03004924|464664469|FG000|Overall Study|Lack of Efficacy|2|||
129101263|NCT03004924|464664470|FG001|Overall Study|Lack of Efficacy|4|||
129101264|NCT03004924|464664471|FG002|Overall Study|Lack of Efficacy|2|||
129101265|NCT03004924|464664469|FG000|Overall Study|Physician Decision|1|||
129101266|NCT03004924|464664470|FG001|Overall Study|Physician Decision|0|||
129101267|NCT03004924|464664471|FG002|Overall Study|Physician Decision|1|||
129101268|NCT03004924|464664469|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129101269|NCT03004924|464664470|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129101270|NCT03004924|464664471|FG002|Overall Study|Withdrawal by parent/guardian|2|||
129101271|NCT03004924|464664469|FG000|Overall Study|Screen Failure|1|||
129101272|NCT03004924|464664470|FG001|Overall Study|Screen Failure|0|||
129101273|NCT03004924|464664471|FG002|Overall Study|Screen Failure|0|||
129101274|NCT03004924|464664469|FG000|Overall Study|Pregnancy|0|||
129101275|NCT03004924|464664470|FG001|Overall Study|Pregnancy|1|||
129101276|NCT03004924|464664471|FG002|Overall Study|Pregnancy|0|||
129101277|NCT03004924|464664469|FG000|Overall Study|Terminated by Sponsor|0|||
129101278|NCT03004924|464664470|FG001|Overall Study|Terminated by Sponsor|0|||
129101279|NCT03004924|464664471|FG002|Overall Study|Terminated by Sponsor|1|||
129101280|NCT03004924|464664469|FG000|Overall Study|Missed Study Visit|0|||
129101281|NCT03004924|464664470|FG001|Overall Study|Missed Study Visit|0|||
129101282|NCT03004924|464664471|FG002|Overall Study|Missed Study Visit|2|||
129101283|NCT03004924|464664469|FG000|Overall Study|HSV1 Positive|1|||
129101284|NCT03004924|464664470|FG001|Overall Study|HSV1 Positive|0|||
129101285|NCT03004924|464664471|FG002|Overall Study|HSV1 Positive|0|||
129101286|NCT01280682|464664472|FG000|Overall Study|Lost to Follow-up|0|||
129101287|NCT01280682|464664473|FG001|Overall Study|Lost to Follow-up|6|||
129101288|NCT01280682|464664472|FG000|Overall Study|Withdrawal by Subject|0|||
129101289|NCT01280682|464664473|FG001|Overall Study|Withdrawal by Subject|7|||
129101290|NCT00269477|464664476|FG000|Overall Study|Protocol Violation|5|||
129101291|NCT00269477|464664477|FG001|Overall Study|Protocol Violation|5|||
129101292|NCT00269477|464664478|FG002|Overall Study|Protocol Violation|1|||
128677392|NCT03011892|463116945|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
128677393|NCT03011892|463116946|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
128677394|NCT03011892|463116947|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
128677395|NCT03011892|463116948|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
128677396|NCT03011892|463116949|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
128677397|NCT03011892|463116950|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
128677398|NCT03011892|463116939|FG000|Open Label (OL) Period|Reason not specified|0|||
128677399|NCT03011892|463116940|FG001|Open Label (OL) Period|Reason not specified|0|||
128677400|NCT03011892|463116941|FG002|Open Label (OL) Period|Reason not specified|0|||
128677401|NCT03011892|463116942|FG003|Open Label (OL) Period|Reason not specified|0|||
129101293|NCT00269477|464664479|FG003|Overall Study|Protocol Violation|0|||
129101294|NCT00269477|464664476|FG000|Overall Study|Missed post-vaccination blood draw|0|||
129101295|NCT00269477|464664477|FG001|Overall Study|Missed post-vaccination blood draw|1|||
129101296|NCT00269477|464664478|FG002|Overall Study|Missed post-vaccination blood draw|0|||
129101297|NCT00269477|464664479|FG003|Overall Study|Missed post-vaccination blood draw|0|||
129101298|NCT01964716|464664482|FG000|Overall Study|Withdrawal by Subject|2|||
129101299|NCT01964716|464664483|FG001|Overall Study|Withdrawal by Subject|3|||
129101300|NCT01964716|464664482|FG000|Overall Study|Lost to Follow-up|1|||
128677402|NCT03011892|463116943|FG004|Open Label (OL) Period|Reason not specified|0|||
128677403|NCT03011892|463116944|FG005|Open Label (OL) Period|Reason not specified|0|||
128677404|NCT03011892|463116945|FG006|Open Label (OL) Period|Reason not specified|0|||
128677405|NCT03011892|463116946|FG007|Open Label (OL) Period|Reason not specified|1|||
128677406|NCT03011892|463116947|FG008|Open Label (OL) Period|Reason not specified|0|||
128677407|NCT03011892|463116948|FG009|Open Label (OL) Period|Reason not specified|0|||
128677408|NCT03011892|463116949|FG010|Open Label (OL) Period|Reason not specified|0|||
128677409|NCT03011892|463116950|FG011|Open Label (OL) Period|Reason not specified|0|||
129101301|NCT01964716|464664483|FG001|Overall Study|Lost to Follow-up|2|||
129101302|NCT01964716|464664482|FG000|Overall Study|No longer met eligibility criteria|1|||
129101303|NCT01964716|464664483|FG001|Overall Study|No longer met eligibility criteria|1|||
129101304|NCT01964716|464664482|FG000|Overall Study|Death|1|||
129101305|NCT01964716|464664483|FG001|Overall Study|Death|0|||
129101306|NCT01464619|464664484|FG000|Overall Study|Lost to Follow-up|3|||
129101307|NCT01464619|464664485|FG001|Overall Study|Lost to Follow-up|4|||
129101308|NCT00080483|464664490|FG000|Overall Study|Lost to Follow-up|1|||
129101309|NCT00080483|464664491|FG001|Overall Study|Lost to Follow-up|1|||
129101310|NCT00080483|464664490|FG000|Overall Study|Physician Decision|1|||
128677410|NCT01089361|463116952|FG000|Overall Study|Death|1|||
128677411|NCT01089361|463116953|FG001|Overall Study|Death|0|||
128677412|NCT04463069|463116954|FG000|Overall Study|Withdrawal by Subject|2|||
128677413|NCT04463069|463116955|FG001|Overall Study|Withdrawal by Subject|10|||
128677414|NCT04463069|463116954|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
128677415|NCT04463069|463116955|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
128677416|NCT01181986|463116956|FG000|Phase 1|Lost to Follow-up|0|||
128677417|NCT01181986|463116957|FG001|Phase 1|Lost to Follow-up|1|||
128677418|NCT01181986|463116958|FG002|Phase 1|Lost to Follow-up|1|||
128677419|NCT01181986|463116956|FG000|Phase 1|Adverse Event|0|||
128677420|NCT01181986|463116957|FG001|Phase 1|Adverse Event|0|||
128677421|NCT01181986|463116958|FG002|Phase 1|Adverse Event|1|||
128677422|NCT01181986|463116956|FG000|Phase 1|Protocol Violation|1|||
128677423|NCT01181986|463116957|FG001|Phase 1|Protocol Violation|0|||
128677424|NCT01181986|463116958|FG002|Phase 1|Protocol Violation|0|||
128677425|NCT01181986|463116956|FG000|Phase 2|Adverse Event|0|||
128677426|NCT01181986|463116957|FG001|Phase 2|Adverse Event|3|||
128677427|NCT01181986|463116958|FG002|Phase 2|Adverse Event|0|||
128677428|NCT01181986|463116956|FG000|Phase 2|Medical condition|0|||
128677429|NCT01181986|463116957|FG001|Phase 2|Medical condition|1|||
128677430|NCT01181986|463116958|FG002|Phase 2|Medical condition|0|||
129011788|NCT01347710|464336032|FG000|Overall Study|Other|3|||
129011789|NCT01606306|464336034|FG000|Overall Study|Lack of Efficacy|2|||
129011790|NCT01606306|464336035|FG001|Overall Study|Lack of Efficacy|1|||
129011791|NCT01606306|464336036|FG002|Overall Study|Lack of Efficacy|4|||
129011792|NCT01606306|464336037|FG003|Overall Study|Lack of Efficacy|4|||
129011793|NCT01606306|464336038|FG004|Overall Study|Lack of Efficacy|1|||
129011794|NCT01606306|464336039|FG005|Overall Study|Lack of Efficacy|2|||
129011795|NCT01606306|464336034|FG000|Overall Study|Adverse Event|1|||
129011796|NCT01606306|464336035|FG001|Overall Study|Adverse Event|0|||
129011797|NCT01606306|464336036|FG002|Overall Study|Adverse Event|1|||
129011798|NCT01606306|464336037|FG003|Overall Study|Adverse Event|1|||
129011799|NCT01606306|464336038|FG004|Overall Study|Adverse Event|2|||
129011800|NCT01606306|464336039|FG005|Overall Study|Adverse Event|0|||
129011801|NCT01606306|464336034|FG000|Overall Study|Lost to Follow-up|7|||
129011802|NCT01606306|464336035|FG001|Overall Study|Lost to Follow-up|4|||
129011803|NCT01606306|464336036|FG002|Overall Study|Lost to Follow-up|5|||
129011804|NCT01606306|464336037|FG003|Overall Study|Lost to Follow-up|4|||
129011805|NCT01606306|464336038|FG004|Overall Study|Lost to Follow-up|3|||
129011806|NCT01606306|464336039|FG005|Overall Study|Lost to Follow-up|5|||
129011807|NCT01606306|464336034|FG000|Overall Study|Withdrawal by Subject|4|||
129011808|NCT01606306|464336035|FG001|Overall Study|Withdrawal by Subject|3|||
129011809|NCT01606306|464336036|FG002|Overall Study|Withdrawal by Subject|4|||
129011810|NCT01606306|464336037|FG003|Overall Study|Withdrawal by Subject|4|||
129011811|NCT01606306|464336038|FG004|Overall Study|Withdrawal by Subject|5|||
129011812|NCT01606306|464336039|FG005|Overall Study|Withdrawal by Subject|4|||
129011813|NCT01606306|464336034|FG000|Overall Study|Physician Decision|1|||
129011814|NCT01606306|464336035|FG001|Overall Study|Physician Decision|2|||
129011815|NCT01606306|464336036|FG002|Overall Study|Physician Decision|0|||
129011816|NCT01606306|464336037|FG003|Overall Study|Physician Decision|0|||
129011817|NCT01606306|464336038|FG004|Overall Study|Physician Decision|0|||
129011818|NCT01606306|464336039|FG005|Overall Study|Physician Decision|0|||
129011819|NCT00408902|464336042|FG000|Overall Study|Lack of Efficacy|7|||
129011820|NCT00408902|464336042|FG000|Overall Study|Adverse Event|3|||
129011821|NCT00970281|464336043|FG000|Overall Study|Lack of Efficacy|1|||
129011822|NCT00970281|464336044|FG001|Overall Study|Lack of Efficacy|14|||
129011823|NCT00970281|464336043|FG000|Overall Study|Withdrawal by Subject|0|||
129011824|NCT00970281|464336044|FG001|Overall Study|Withdrawal by Subject|1|||
129011825|NCT00970281|464336043|FG000|Overall Study|Physician Decision|1|||
129011826|NCT00970281|464336044|FG001|Overall Study|Physician Decision|1|||
129011827|NCT00878995|464336045|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
129011828|NCT00878995|464336046|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
129011829|NCT03338972|464336047|FG000|Overall Study|Death|1|||
129011830|NCT03338972|464336048|FG001|Overall Study|Death|1|||
129011831|NCT03338972|464336049|FG002|Overall Study|Death|0|||
129011832|NCT03338972|464336050|FG003|Overall Study|Death|0|||
128677431|NCT03073733|463116961|FG000|Overall Study|Lost to Follow-up|1|||
129011833|NCT03338972|464336047|FG000|Overall Study|Withdrawal by Subject|1|||
129011834|NCT03338972|464336048|FG001|Overall Study|Withdrawal by Subject|0|||
129011835|NCT03338972|464336049|FG002|Overall Study|Withdrawal by Subject|0|||
128677432|NCT03073733|463116962|FG001|Overall Study|Lost to Follow-up|0|||
128677433|NCT03073733|463116963|FG002|Overall Study|Lost to Follow-up|0|||
129011836|NCT03338972|464336050|FG003|Overall Study|Withdrawal by Subject|0|||
128677434|NCT03073733|463116961|FG000|Overall Study|Physician Decision|0|||
128677435|NCT03073733|463116962|FG001|Overall Study|Physician Decision|1|||
129011837|NCT02480764|464336051|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129011838|NCT02480764|464336052|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
129011839|NCT02480764|464336053|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
128677436|NCT03073733|463116963|FG002|Overall Study|Physician Decision|0|||
128677437|NCT03073733|463116961|FG000|Overall Study|Withdrawal by Subject|0|||
128677438|NCT03073733|463116962|FG001|Overall Study|Withdrawal by Subject|0|||
128677439|NCT03073733|463116963|FG002|Overall Study|Withdrawal by Subject|1|||
128677440|NCT02880956|463116965|FG000|Overall Study|Adverse Event|3|||
128677441|NCT02880956|463116966|FG001|Overall Study|Adverse Event|6|||
128677442|NCT02880956|463116967|FG002|Overall Study|Adverse Event|5|||
128677443|NCT02880956|463116968|FG003|Overall Study|Adverse Event|4|||
128677444|NCT02880956|463116965|FG000|Overall Study|Withdrawal by Subject|9|||
128677445|NCT02880956|463116966|FG001|Overall Study|Withdrawal by Subject|4|||
128677446|NCT02880956|463116967|FG002|Overall Study|Withdrawal by Subject|6|||
128677447|NCT02880956|463116968|FG003|Overall Study|Withdrawal by Subject|11|||
128677448|NCT02880956|463116965|FG000|Overall Study|Lost to Follow-up|0|||
128677449|NCT02880956|463116966|FG001|Overall Study|Lost to Follow-up|1|||
128677450|NCT02880956|463116967|FG002|Overall Study|Lost to Follow-up|0|||
128677451|NCT02880956|463116968|FG003|Overall Study|Lost to Follow-up|0|||
128677452|NCT02880956|463116965|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
128677453|NCT02880956|463116966|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
128677454|NCT02880956|463116967|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
128677455|NCT02880956|463116968|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
128677456|NCT02880956|463116965|FG000|Overall Study|Other, Not Specified|4|||
128677457|NCT02880956|463116966|FG001|Overall Study|Other, Not Specified|2|||
128677458|NCT02880956|463116967|FG002|Overall Study|Other, Not Specified|0|||
128677459|NCT02880956|463116968|FG003|Overall Study|Other, Not Specified|3|||
128717769|NCT03447990|463264023|FG004|Overall Study|Withdrawal by Subject|0|||
128717770|NCT03447990|463264024|FG005|Overall Study|Withdrawal by Subject|0|||
128717771|NCT03447990|463264025|FG006|Overall Study|Withdrawal by Subject|1|||
128717772|NCT00238121|463264026|FG000|Overall Study|Withdrawal by Subject|1|||
128717773|NCT00238121|463264027|FG001|Overall Study|Withdrawal by Subject|1|||
128717774|NCT00238121|463264026|FG000|Overall Study|Adverse Event|2|||
128717775|NCT00238121|463264027|FG001|Overall Study|Adverse Event|1|||
128717776|NCT03255382|463264028|FG000|Overall Study|Adverse Event|3|||
128717777|NCT03255382|463264029|FG001|Overall Study|Adverse Event|0|||
128717778|NCT03255382|463264028|FG000|Overall Study|Lost to Follow-up|2|||
128717779|NCT03255382|463264029|FG001|Overall Study|Lost to Follow-up|0|||
128717780|NCT03255382|463264028|FG000|Overall Study|Withdrawal by Subject|2|||
128717781|NCT03255382|463264029|FG001|Overall Study|Withdrawal by Subject|0|||
128717782|NCT03255382|463264028|FG000|Overall Study|Other|6|||
128717783|NCT03255382|463264029|FG001|Overall Study|Other|0|||
128717784|NCT02221284|463264030|FG000|Overall Study|Case Report Forms Uncollected|56|||
128717785|NCT02221284|463264030|FG000|Overall Study|Protocol Deviation|5|||
128717786|NCT01675128|463264033|FG000|Overall Study|Disease progression on study|1|||
128717787|NCT01675128|463264034|FG001|Overall Study|Disease progression on study|1|||
128717788|NCT01675128|463264035|FG002|Overall Study|Disease progression on study|1|||
128717789|NCT01675128|463264033|FG000|Overall Study|Refused further treatment|1|||
128717790|NCT01675128|463264034|FG001|Overall Study|Refused further treatment|0|||
128717791|NCT01675128|463264035|FG002|Overall Study|Refused further treatment|0|||
128717792|NCT01675128|463264033|FG000|Overall Study|Pulmonary complication; off study|0|||
128717793|NCT01675128|463264034|FG001|Overall Study|Pulmonary complication; off study|1|||
128717794|NCT01675128|463264035|FG002|Overall Study|Pulmonary complication; off study|0|||
128717795|NCT00832585|463264044|FG000|Overall Study|Withdrawal by Subject|1|||
128717796|NCT00832585|463264044|FG000|Overall Study|Lost to Follow-up|1|||
128717797|NCT01374087|463264048|FG000|Overall Study|Adverse Event|1|||
128717798|NCT01374087|463264049|FG001|Overall Study|Adverse Event|0|||
128717799|NCT01374087|463264048|FG000|Overall Study|Disease progression|2|||
128717800|NCT01374087|463264049|FG001|Overall Study|Disease progression|2|||
128717801|NCT01374087|463264048|FG000|Overall Study|Study discontinued|13|||
128717802|NCT01374087|463264049|FG001|Overall Study|Study discontinued|13|||
128717803|NCT03526458|463264050|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
128717804|NCT03526458|463264051|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
128717805|NCT03526458|463264050|FG000|Overall Study|Stone passed, surgery cancelled|2|||
128717806|NCT03526458|463264051|FG001|Overall Study|Stone passed, surgery cancelled|1|||
128717807|NCT03526458|463264050|FG000|Overall Study|Withdrawal by Subject|1|||
128717808|NCT03526458|463264051|FG001|Overall Study|Withdrawal by Subject|0|||
128717809|NCT03526458|463264050|FG000|Overall Study|Physician Decision|2|||
128717810|NCT03526458|463264051|FG001|Overall Study|Physician Decision|1|||
128717811|NCT03526458|463264050|FG000|Overall Study|Lack of equipment|1|||
128717812|NCT03526458|463264051|FG001|Overall Study|Lack of equipment|1|||
128717813|NCT04170348|463264052|FG000|Overall Study|Lost to Follow-up|2|||
128717814|NCT04170348|463264053|FG001|Overall Study|Lost to Follow-up|2|||
128717815|NCT04170348|463264052|FG000|Overall Study|Withdrawal by Subject|1|||
128717816|NCT04170348|463264053|FG001|Overall Study|Withdrawal by Subject|5|||
128717817|NCT04170348|463264052|FG000|Overall Study|Non-adherence|1|||
128717818|NCT04170348|463264053|FG001|Overall Study|Non-adherence|1|||
128717819|NCT04170348|463264052|FG000|Overall Study|Adverse Event|1|||
128717820|NCT04170348|463264053|FG001|Overall Study|Adverse Event|0|||
128717821|NCT00529542|463264054|FG000|Overall Study|Withdrawal by Subject|1|||
129101311|NCT00080483|464664491|FG001|Overall Study|Physician Decision|1|||
129101312|NCT04527978|464664495|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
129101313|NCT04527978|464664496|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
129101314|NCT01370616|464664497|FG000|Overall Study|Adverse Event|11|||
129101315|NCT01370616|464664498|FG001|Overall Study|Adverse Event|16|||
129101316|NCT01370616|464664497|FG000|Overall Study|Death|1|||
129101317|NCT01370616|464664498|FG001|Overall Study|Death|0|||
129101318|NCT01370616|464664497|FG000|Overall Study|Lack of Efficacy|6|||
129101319|NCT01370616|464664498|FG001|Overall Study|Lack of Efficacy|2|||
129101320|NCT01370616|464664497|FG000|Overall Study|Lost to Follow-up|0|||
129101321|NCT01370616|464664498|FG001|Overall Study|Lost to Follow-up|3|||
129101322|NCT01370616|464664497|FG000|Overall Study|Physician Decision|6|||
129101323|NCT01370616|464664498|FG001|Overall Study|Physician Decision|6|||
129101324|NCT01370616|464664497|FG000|Overall Study|Progressive Disease|0|||
129101325|NCT01370616|464664498|FG001|Overall Study|Progressive Disease|1|||
129101326|NCT01370616|464664497|FG000|Overall Study|Recovery|1|||
129101327|NCT01370616|464664498|FG001|Overall Study|Recovery|0|||
129101328|NCT01370616|464664497|FG000|Overall Study|Technical Problems|3|||
129101329|NCT01370616|464664498|FG001|Overall Study|Technical Problems|5|||
128677460|NCT03603509|463118730|FG000|Overall Study|Lost to Follow-up|3|||
129011840|NCT02480764|464336051|FG000|Overall Study|Major Protocol Deviation|1|||
129011841|NCT02480764|464336052|FG001|Overall Study|Major Protocol Deviation|4|||
129011842|NCT02480764|464336053|FG002|Overall Study|Major Protocol Deviation|3|||
129011843|NCT02480764|464336051|FG000|Overall Study|Lost to Follow-up|0|||
129011844|NCT02480764|464336052|FG001|Overall Study|Lost to Follow-up|1|||
129011845|NCT02480764|464336053|FG002|Overall Study|Lost to Follow-up|2|||
129011846|NCT02480764|464336051|FG000|Overall Study|Voluntary Withdrawal|6|||
129011847|NCT02480764|464336052|FG001|Overall Study|Voluntary Withdrawal|5|||
129011848|NCT02480764|464336053|FG002|Overall Study|Voluntary Withdrawal|10|||
129011849|NCT02480764|464336051|FG000|Overall Study|Lack of Efficacy|0|||
129011850|NCT02480764|464336052|FG001|Overall Study|Lack of Efficacy|3|||
129011851|NCT02480764|464336053|FG002|Overall Study|Lack of Efficacy|3|||
129011852|NCT02480764|464336051|FG000|Overall Study|Reason not Specified|0|||
129011853|NCT02480764|464336052|FG001|Overall Study|Reason not Specified|1|||
129011854|NCT02480764|464336053|FG002|Overall Study|Reason not Specified|0|||
129011855|NCT01030965|464336054|FG000|Overall Study|Lack of Efficacy|3|||
129011856|NCT01030965|464336055|FG001|Overall Study|Lack of Efficacy|2|||
129011857|NCT01030965|464336056|FG002|Overall Study|Lack of Efficacy|0|||
129011858|NCT01030965|464336057|FG003|Overall Study|Lack of Efficacy|3|||
129011859|NCT01030965|464336054|FG000|Overall Study|Protocol Violation|1|||
129011860|NCT01030965|464336055|FG001|Overall Study|Protocol Violation|1|||
129011861|NCT01030965|464336056|FG002|Overall Study|Protocol Violation|1|||
129011862|NCT01030965|464336057|FG003|Overall Study|Protocol Violation|1|||
129011863|NCT01030965|464336054|FG000|Overall Study|Adverse Event|0|||
129011864|NCT01030965|464336055|FG001|Overall Study|Adverse Event|1|||
129011865|NCT01030965|464336056|FG002|Overall Study|Adverse Event|2|||
129011866|NCT01030965|464336057|FG003|Overall Study|Adverse Event|1|||
129011867|NCT01030965|464336054|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
129011868|NCT01030965|464336055|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
129011869|NCT01030965|464336056|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
129011870|NCT01030965|464336057|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
129011871|NCT01030965|464336054|FG000|Overall Study|Withdrawal by Subject|0|||
129011872|NCT01030965|464336055|FG001|Overall Study|Withdrawal by Subject|1|||
129011873|NCT01030965|464336056|FG002|Overall Study|Withdrawal by Subject|0|||
129011874|NCT01030965|464336057|FG003|Overall Study|Withdrawal by Subject|2|||
129011875|NCT03144687|464336060|FG000|Overall Study|Death|0|||
129011876|NCT03144687|464336061|FG001|Overall Study|Death|2|||
129011877|NCT03144687|464336060|FG000|Overall Study|Lost to Follow-up|0|||
129011878|NCT03144687|464336061|FG001|Overall Study|Lost to Follow-up|1|||
129011879|NCT03144687|464336060|FG000|Overall Study|Physician Decision|0|||
129011880|NCT03144687|464336061|FG001|Overall Study|Physician Decision|1|||
129011881|NCT03144687|464336060|FG000|Overall Study|Withdrawal by Subject|1|||
129101330|NCT01370616|464664497|FG000|Overall Study|Withdrawal by Subject|34|||
129101331|NCT01370616|464664498|FG001|Overall Study|Withdrawal by Subject|34|||
129101332|NCT02324699|464664499|FG000|Overall Study|study terminated|1|||
129101333|NCT01578499|464664502|FG000|Overall Study|Reason not Specified|0|||
128677461|NCT03603509|463118731|FG001|Overall Study|Lost to Follow-up|4|||
129011882|NCT03144687|464336061|FG001|Overall Study|Withdrawal by Subject|3|||
129011883|NCT03144687|464336060|FG000|Overall Study|Not Reported|2|||
129011884|NCT03144687|464336061|FG001|Overall Study|Not Reported|0|||
129011885|NCT01054599|464336062|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
129011886|NCT01054599|464336063|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
129011887|NCT01054599|464336062|FG000|Overall Study|Protocol Violation|1|||
129011888|NCT01054599|464336063|FG001|Overall Study|Protocol Violation|0|||
129011889|NCT01054599|464336062|FG000|Overall Study|Spells/seizure-like episodes|1|||
129101334|NCT01578499|464664503|FG001|Overall Study|Reason not Specified|1|||
129101335|NCT01578499|464664502|FG000|Overall Study|Lost to Follow-up|2|||
128677462|NCT02656680|463118734|FG000|Overall Study|Lost to Follow-up|0|||
129101336|NCT01578499|464664503|FG001|Overall Study|Lost to Follow-up|1|||
128677463|NCT02656680|463118735|FG001|Overall Study|Lost to Follow-up|1|||
128677464|NCT02656680|463118736|FG002|Overall Study|Lost to Follow-up|7|||
128677465|NCT04966910|463118737|FG000|Baseline|Participant did not complete measure|0|||
128677466|NCT04966910|463118738|FG001|Baseline|Participant did not complete measure|0|||
128677467|NCT04966910|463118739|FG002|Baseline|Participant did not complete measure|1|||
128677468|NCT04966910|463118740|FG003|Baseline|Participant did not complete measure|0|||
128677469|NCT04966910|463118737|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
128677470|NCT04966910|463118738|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
128677471|NCT04966910|463118739|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
128677472|NCT04966910|463118740|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
128677473|NCT04966910|463118737|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
128677474|NCT04966910|463118738|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
128677475|NCT04966910|463118739|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
128677476|NCT04966910|463118740|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
128677477|NCT04966910|463118737|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
128677478|NCT04966910|463118738|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
128677479|NCT04966910|463118739|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
128677480|NCT04966910|463118740|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
128677481|NCT01430754|463118744|FG000|Run-In Phase|Circadian Period Ineligible|24|||
128677482|NCT01430754|463118745|FG001|Run-In Phase|Circadian Period Ineligible|0|||
128677483|NCT01430754|463118744|FG000|Run-In Phase|Protocol Violation|6|||
128677484|NCT01430754|463118745|FG001|Run-In Phase|Protocol Violation|0|||
128677485|NCT01430754|463118744|FG000|Run-In Phase|Adverse Event|2|||
128677486|NCT01430754|463118745|FG001|Run-In Phase|Adverse Event|0|||
128677487|NCT01430754|463118744|FG000|Run-In Phase|Other|2|||
128677488|NCT01430754|463118745|FG001|Run-In Phase|Other|0|||
128677489|NCT01430754|463118744|FG000|Run-In Phase|Withdrawal by Subject|2|||
128677490|NCT01430754|463118745|FG001|Run-In Phase|Withdrawal by Subject|0|||
128677491|NCT01430754|463118744|FG000|Run-In Phase|Lost to Follow-up|1|||
128677492|NCT01430754|463118745|FG001|Run-In Phase|Lost to Follow-up|0|||
128677493|NCT00775203|463118750|FG000|Overall Study|Adverse Event|25|||
128677494|NCT00775203|463118751|FG001|Overall Study|Adverse Event|6|||
128677495|NCT00775203|463118750|FG000|Overall Study|Lack of Efficacy|8|||
128677496|NCT00775203|463118751|FG001|Overall Study|Lack of Efficacy|9|||
128677497|NCT00775203|463118750|FG000|Overall Study|Withdrawal by Subject|11|||
128677498|NCT00775203|463118751|FG001|Overall Study|Withdrawal by Subject|9|||
128677499|NCT00775203|463118750|FG000|Overall Study|Lost to Follow-up|11|||
128677500|NCT00775203|463118751|FG001|Overall Study|Lost to Follow-up|15|||
128677501|NCT00775203|463118750|FG000|Overall Study|Administrative reason|2|||
128677502|NCT00775203|463118751|FG001|Overall Study|Administrative reason|0|||
128677503|NCT00775203|463118750|FG000|Overall Study|Noncompliance|4|||
128677504|NCT00775203|463118751|FG001|Overall Study|Noncompliance|2|||
128677505|NCT00775203|463118750|FG000|Overall Study|Protocol Violation|0|||
128677506|NCT00775203|463118751|FG001|Overall Study|Protocol Violation|1|||
128677507|NCT00775203|463118750|FG000|Overall Study|Entered other study|1|||
128677508|NCT00775203|463118751|FG001|Overall Study|Entered other study|0|||
128677509|NCT00775203|463118750|FG000|Overall Study|Physician Decision|0|||
128677510|NCT00775203|463118751|FG001|Overall Study|Physician Decision|1|||
128677511|NCT01587898|463118754|FG000|Overall Study|Adverse Event|1|||
128677512|NCT01587898|463118755|FG001|Overall Study|Adverse Event|1|||
128677513|NCT01587898|463118756|FG002|Overall Study|Adverse Event|0|||
128677514|NCT01587898|463118757|FG003|Overall Study|Adverse Event|0|||
128677515|NCT01587898|463118754|FG000|Overall Study|Protocol Violation|0|||
128677516|NCT01587898|463118755|FG001|Overall Study|Protocol Violation|2|||
128677517|NCT01587898|463118756|FG002|Overall Study|Protocol Violation|1|||
128677518|NCT01587898|463118757|FG003|Overall Study|Protocol Violation|1|||
128677519|NCT01587898|463118754|FG000|Overall Study|Lost to Follow-up|0|||
128677520|NCT01587898|463118755|FG001|Overall Study|Lost to Follow-up|0|||
128677521|NCT01587898|463118756|FG002|Overall Study|Lost to Follow-up|0|||
128677522|NCT01587898|463118757|FG003|Overall Study|Lost to Follow-up|1|||
128677523|NCT01587898|463118754|FG000|Overall Study|Withdrawal by Subject|2|||
128677524|NCT01587898|463118755|FG001|Overall Study|Withdrawal by Subject|1|||
128677525|NCT01587898|463118756|FG002|Overall Study|Withdrawal by Subject|0|||
128677526|NCT01587898|463118757|FG003|Overall Study|Withdrawal by Subject|0|||
128677527|NCT01587898|463118754|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
128677528|NCT01587898|463118755|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
128677529|NCT01587898|463118756|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
128677530|NCT01587898|463118757|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
128677531|NCT01738477|463118758|FG000|Overall Study|Lost to Follow-up|1|||
128677532|NCT01738477|463118759|FG001|Overall Study|Lost to Follow-up|4|||
128677533|NCT02437110|463118760|FG000|Screening|Lost to Follow-up|3|||
128677534|NCT02437110|463118760|FG000|Screening|Physician Decision|1|||
128677535|NCT02437110|463118760|FG000|ART|Adverse Event|3|||
128677536|NCT02437110|463118760|FG000|ART|Protocol Violation|3|||
128677537|NCT02437110|463118760|FG000|ART|Withdrawal by Subject|4|||
128677538|NCT02437110|463118760|FG000|ART|Lost to follow-up prior to start of intervention|1|||
128677539|NCT02437110|463118760|FG000|ART|Physician decision prior to start of intervention|2|||
128677540|NCT02437110|463118760|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
128677541|NCT02437110|463118760|FG000|Post-ART|Lost to Follow-up|3|||
128677542|NCT02437110|463118760|FG000|Post-ART|Protocol Violation|4|||
128677543|NCT02437110|463118760|FG000|Post-ART|Withdrawal by Subject|3|||
128677544|NCT00321646|463118764|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
128677545|NCT00321646|463118764|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
128677546|NCT00321646|463118764|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
128677547|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
128677548|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
128677549|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
128677550|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
128677551|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
128677552|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
128677553|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
128677554|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
128677555|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
128677556|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
128677557|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
128677558|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
128677559|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
129101337|NCT01578499|464664502|FG000|Overall Study|Withdrawal by Subject|10|||
129101338|NCT01578499|464664503|FG001|Overall Study|Withdrawal by Subject|16|||
129101339|NCT01578499|464664502|FG000|Overall Study|Death|20|||
129101340|NCT01578499|464664503|FG001|Overall Study|Death|25|||
129101341|NCT01578499|464664502|FG000|Overall Study|Died and End of Study Page not Completed|2|||
128677560|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
128677561|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
129101342|NCT01578499|464664503|FG001|Overall Study|Died and End of Study Page not Completed|0|||
129101343|NCT02670382|464664504|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
129101344|NCT02670382|464664505|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
129101345|NCT03469999|464664508|FG000|Overall Study|Lost to Follow-up|2|||
128677562|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
129101346|NCT01863732|464664509|FG000|Overall Study|Adverse Event|2|||
129101347|NCT01863732|464664510|FG001|Overall Study|Adverse Event|0|||
129101348|NCT01863732|464664511|FG002|Overall Study|Adverse Event|3|||
129101349|NCT01863732|464664512|FG003|Overall Study|Adverse Event|3|||
129101350|NCT01863732|464664509|FG000|Overall Study|Lack of Efficacy|1|||
129101351|NCT01863732|464664510|FG001|Overall Study|Lack of Efficacy|0|||
129101352|NCT01863732|464664511|FG002|Overall Study|Lack of Efficacy|2|||
129101353|NCT01863732|464664512|FG003|Overall Study|Lack of Efficacy|1|||
129101354|NCT01863732|464664509|FG000|Overall Study|Lost to Follow-up|2|||
129101355|NCT01863732|464664510|FG001|Overall Study|Lost to Follow-up|2|||
129101356|NCT01863732|464664511|FG002|Overall Study|Lost to Follow-up|1|||
129101357|NCT01863732|464664512|FG003|Overall Study|Lost to Follow-up|1|||
129101358|NCT01863732|464664509|FG000|Overall Study|Physician Decision|1|||
128677563|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
128677564|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
128677565|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
128677566|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
128677567|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
129101359|NCT01863732|464664510|FG001|Overall Study|Physician Decision|0|||
129101360|NCT01863732|464664511|FG002|Overall Study|Physician Decision|1|||
129101361|NCT01863732|464664512|FG003|Overall Study|Physician Decision|0|||
129101362|NCT01863732|464664509|FG000|Overall Study|Pregnancy|0|||
129101363|NCT01863732|464664510|FG001|Overall Study|Pregnancy|0|||
128677568|NCT01227824|463118766|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
128677569|NCT01227824|463118767|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
128677570|NCT01227824|463118768|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
128677571|NCT01227824|463118766|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
128677572|NCT01227824|463118767|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
128677573|NCT01227824|463118768|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
128677574|NCT01227824|463118766|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
129101364|NCT01863732|464664511|FG002|Overall Study|Pregnancy|0|||
129101365|NCT01863732|464664512|FG003|Overall Study|Pregnancy|1|||
129101366|NCT01863732|464664509|FG000|Overall Study|Technical problems|0|||
129101367|NCT01863732|464664510|FG001|Overall Study|Technical problems|1|||
129101368|NCT01863732|464664511|FG002|Overall Study|Technical problems|1|||
129101369|NCT01863732|464664512|FG003|Overall Study|Technical problems|0|||
129101370|NCT01863732|464664509|FG000|Overall Study|Subject/guardian decision|6|||
129101371|NCT01863732|464664510|FG001|Overall Study|Subject/guardian decision|9|||
129101372|NCT01863732|464664511|FG002|Overall Study|Subject/guardian decision|3|||
128677575|NCT01227824|463118767|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
128677576|NCT01227824|463118768|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
128677577|NCT01227824|463118766|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
128677578|NCT01227824|463118767|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
128677579|NCT01227824|463118768|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
128677580|NCT01227824|463118766|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
128677581|NCT01227824|463118767|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
128677582|NCT01227824|463118768|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
128677583|NCT01227824|463118766|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
128677584|NCT01227824|463118767|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
128677585|NCT01227824|463118768|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
128677586|NCT01227824|463118766|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
128677587|NCT01227824|463118767|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
128677588|NCT01227824|463118768|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
128677589|NCT01227824|463118766|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
128677590|NCT01227824|463118767|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
128677591|NCT01227824|463118768|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
128677592|NCT01284491|463118774|FG000|Overall Study|Study termination|13|||
128677593|NCT02694757|463118777|FG000|Overall Study|Lack of Efficacy|3|||
128677594|NCT02395302|463118780|FG000|Overall Study|Screen Failure|3|||
128677595|NCT02395302|463118780|FG000|Overall Study|Run In Failure|7|||
128677596|NCT02395302|463118780|FG000|Overall Study|Withdrawal by Subject|2|||
128677597|NCT02395302|463118780|FG000|Overall Study|Physician Decision|2|||
128677598|NCT02650921|463118781|FG000|Overall Study|Withdrawal by Subject|4|||
128677599|NCT02650921|463118781|FG000|Overall Study|Lost to Follow-up|2|||
128677600|NCT02650921|463118781|FG000|Overall Study|Adverse Event|1|||
128677601|NCT02650921|463118781|FG000|Overall Study|Due to Medical Condition|1|||
129101373|NCT01863732|464664512|FG003|Overall Study|Subject/guardian decision|1|||
129101374|NCT01863732|464664509|FG000|Overall Study|Death|1|||
129101375|NCT01863732|464664510|FG001|Overall Study|Death|0|||
129101376|NCT01863732|464664511|FG002|Overall Study|Death|0|||
129101377|NCT01863732|464664512|FG003|Overall Study|Death|1|||
129101378|NCT00460746|464664513|FG000|Overall Study|Adverse Event|1|||
129101379|NCT00460746|464664513|FG000|Overall Study|Lost to Follow-up|1|||
129101380|NCT00171158|464666116|FG000|Core Study|Death|27|||
129101381|NCT00171158|464666116|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
129101382|NCT00171158|464666116|FG000|Core Study|Protocol Violation|4|||
129101383|NCT00171158|464666116|FG000|Core Study|Administrative problems|1|||
129101384|NCT00171158|464666116|FG000|Core Study|Adverse event, non-fatal|21|||
129101385|NCT00171158|464666116|FG000|Core Study|Consent withdrawn by subject|6|||
129101386|NCT00171158|464666116|FG000|Core Study|No longer required drug (BMT)|14|||
129101387|NCT00171158|464666116|FG000|Core Study|Abnormal Laboratory Values|2|||
129101388|NCT00171158|464666116|FG000|Core Study|Lost to Follow-up|1|||
129101389|NCT00171158|464666116|FG000|E2 Extension|Other|7|||
129101390|NCT03536663|464666119|FG000|Endexo|Protocol Violation|1|||
129101391|NCT00762034|464666120|FG000|Induction Period|Protocol Violation|1|||
129101392|NCT00762034|464666121|FG001|Induction Period|Protocol Violation|2|||
129101393|NCT00762034|464666120|FG000|Induction Period|Entry Criterion Not Met|12|||
129101394|NCT00762034|464666121|FG001|Induction Period|Entry Criterion Not Met|11|||
129101395|NCT00762034|464666120|FG000|Induction Period|Adverse Event|27|||
129101396|NCT00762034|464666121|FG001|Induction Period|Adverse Event|38|||
129101397|NCT00762034|464666120|FG000|Induction Period|Lost to Follow-up|1|||
129101398|NCT00762034|464666121|FG001|Induction Period|Lost to Follow-up|1|||
129101399|NCT00762034|464666120|FG000|Induction Period|Progressive Disease|73|||
129101400|NCT00762034|464666121|FG001|Induction Period|Progressive Disease|55|||
129101401|NCT00762034|464666120|FG000|Induction Period|Physician Decision|21|||
129101402|NCT00762034|464666121|FG001|Induction Period|Physician Decision|20|||
129101403|NCT00762034|464666120|FG000|Induction Period|Withdrawal by Subject|15|||
129101404|NCT00762034|464666121|FG001|Induction Period|Withdrawal by Subject|19|||
129101405|NCT00762034|464666120|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
129101406|NCT00762034|464666121|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
129101407|NCT00762034|464666120|FG000|Induction Period|Deaths Due to Study Disease|9|||
129101408|NCT00762034|464666121|FG001|Induction Period|Deaths Due to Study Disease|9|||
129101409|NCT00762034|464666120|FG000|Maintenance Period|Protocol Violation|1|||
128677602|NCT01087788|463118782|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
128677603|NCT01087788|463118783|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
128677604|NCT01087788|463118784|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
128677605|NCT01087788|463118782|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
128677606|NCT01087788|463118783|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
129101410|NCT00762034|464666121|FG001|Maintenance Period|Protocol Violation|3|||
129101411|NCT00762034|464666120|FG000|Maintenance Period|Entry Criterion Not Met|0|||
128677607|NCT01087788|463118784|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
129101412|NCT00762034|464666121|FG001|Maintenance Period|Entry Criterion Not Met|2|||
129011890|NCT01054599|464336063|FG001|Overall Study|Spells/seizure-like episodes|1|||
129011891|NCT01054599|464336062|FG000|Overall Study|Timing/scheduling difficulties|1|||
129011892|NCT01054599|464336063|FG001|Overall Study|Timing/scheduling difficulties|1|||
129011893|NCT01054599|464336062|FG000|Overall Study|Visual impairment, WTAR <80|0|||
129011894|NCT01054599|464336063|FG001|Overall Study|Visual impairment, WTAR <80|1|||
129011895|NCT01054599|464336062|FG000|Overall Study|Lost to Follow-up|0|||
129011896|NCT01054599|464336063|FG001|Overall Study|Lost to Follow-up|2|||
129011897|NCT01054599|464336062|FG000|Overall Study|Adverse Event|0|||
129011898|NCT01054599|464336063|FG001|Overall Study|Adverse Event|1|||
129011899|NCT01054599|464336062|FG000|Overall Study|Withdrawal by Subject|0|||
129011900|NCT01054599|464336063|FG001|Overall Study|Withdrawal by Subject|1|||
129011901|NCT00743197|464336064|FG000|Overall Study|Study terminated due to departure of PI.|1|||
129011902|NCT00743197|464336065|FG001|Overall Study|Study terminated due to departure of PI.|2|||
129011903|NCT04025879|464336068|FG000|Randomization|Participant withdrew consent|0|||
129011904|NCT04025879|464336069|FG001|Randomization|Participant withdrew consent|1|||
129011905|NCT04025879|464336068|FG000|Randomization|Participant no longer met study criteria|1|||
129011906|NCT04025879|464336069|FG001|Randomization|Participant no longer met study criteria|1|||
129011907|NCT04025879|464336068|FG000|Treatment|Ongoing treatment|10|||
129011908|NCT04025879|464336069|FG001|Treatment|Ongoing treatment|8|||
129011909|NCT04025879|464336068|FG000|Treatment|Disease progression/recurrence|36|||
129011910|NCT04025879|464336069|FG001|Treatment|Disease progression/recurrence|72|||
129011911|NCT04025879|464336068|FG000|Treatment|Study drug toxicity|36|||
129011912|NCT04025879|464336069|FG001|Treatment|Study drug toxicity|13|||
129011913|NCT04025879|464336068|FG000|Treatment|Death|2|||
129011914|NCT04025879|464336069|FG001|Treatment|Death|0|||
129011915|NCT04025879|464336068|FG000|Treatment|Adverse event unrelated to study drug|21|||
129011916|NCT04025879|464336069|FG001|Treatment|Adverse event unrelated to study drug|14|||
129011917|NCT04025879|464336068|FG000|Treatment|Participant request to discontinue study treatment|16|||
129011918|NCT04025879|464336069|FG001|Treatment|Participant request to discontinue study treatment|8|||
129011919|NCT04025879|464336068|FG000|Treatment|Participant withdrew consent|1|||
129011920|NCT04025879|464336069|FG001|Treatment|Participant withdrew consent|3|||
129011921|NCT04025879|464336068|FG000|Treatment|Participant no longer meets study criteria|3|||
129011922|NCT04025879|464336069|FG001|Treatment|Participant no longer meets study criteria|2|||
129011923|NCT04025879|464336068|FG000|Treatment|Lost to Follow-up|1|||
129011924|NCT04025879|464336069|FG001|Treatment|Lost to Follow-up|0|||
129011925|NCT04025879|464336068|FG000|Treatment|Other reasons|15|||
129011926|NCT04025879|464336069|FG001|Treatment|Other reasons|17|||
129011927|NCT04025879|464336068|FG000|Treatment|Administrative reason by sponsor|0|||
129011928|NCT04025879|464336069|FG001|Treatment|Administrative reason by sponsor|1|||
129011929|NCT04025879|464336068|FG000|Treatment|Not reported|2|||
129011930|NCT04025879|464336069|FG001|Treatment|Not reported|0|||
129011931|NCT02170688|464336070|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
129011932|NCT02170688|464336071|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
129011933|NCT02170688|464336072|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
129011934|NCT02170688|464336073|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
129011935|NCT02170688|464336074|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
129011936|NCT02170688|464336070|FG000|Overall Study|Full dose not received|0|||
129011937|NCT02170688|464336071|FG001|Overall Study|Full dose not received|1|||
129011938|NCT02170688|464336072|FG002|Overall Study|Full dose not received|0|||
129011939|NCT02170688|464336073|FG003|Overall Study|Full dose not received|0|||
128677608|NCT01087788|463118782|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
128677609|NCT01087788|463118783|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
128677610|NCT01087788|463118784|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
128677611|NCT01087788|463118782|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
128677612|NCT01087788|463118783|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
128677613|NCT01087788|463118784|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
128677614|NCT01087788|463118782|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
128677615|NCT01087788|463118783|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
128677616|NCT01087788|463118784|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
128677617|NCT01087788|463118782|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
128677618|NCT01087788|463118783|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
128677619|NCT01087788|463118784|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
128677620|NCT01087788|463118782|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
129011940|NCT02170688|464336074|FG004|Overall Study|Full dose not received|0|||
129011941|NCT02170688|464336070|FG000|Overall Study|Physician Decision|0|||
129011942|NCT02170688|464336071|FG001|Overall Study|Physician Decision|0|||
129011943|NCT02170688|464336072|FG002|Overall Study|Physician Decision|1|||
129011944|NCT02170688|464336073|FG003|Overall Study|Physician Decision|0|||
129011945|NCT02170688|464336074|FG004|Overall Study|Physician Decision|0|||
129011946|NCT01471522|464336077|FG000|Overall Study|Withdrawal by Subject|28|||
129011947|NCT01471522|464336078|FG001|Overall Study|Withdrawal by Subject|22|||
128677621|NCT01087788|463118783|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
129011948|NCT01471522|464336077|FG000|Overall Study|Lost to Follow-up|36|||
128677622|NCT01087788|463118784|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
128677623|NCT01087788|463118782|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
128677624|NCT01087788|463118783|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
128677625|NCT01087788|463118784|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
128677626|NCT01087788|463118782|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
128677627|NCT01087788|463118783|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
128677628|NCT01087788|463118784|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
128677629|NCT01087788|463118782|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
128677630|NCT01087788|463118783|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
128677631|NCT01087788|463118784|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
128677632|NCT01087788|463118782|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
128677633|NCT01087788|463118783|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
128677634|NCT01087788|463118784|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
128677635|NCT01087788|463118782|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
128677636|NCT01087788|463118783|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
128677637|NCT01087788|463118784|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
128677638|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
128677639|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
128677640|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
128677641|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
128677642|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
128677643|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
128677644|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
128677645|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
128677646|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
128677647|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
128677648|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
128677649|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
128677650|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
128677651|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
128677652|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
128677653|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
128677654|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
128677655|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
128677656|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
128677657|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
129011949|NCT01471522|464336078|FG001|Overall Study|Lost to Follow-up|26|||
129011950|NCT02507375|464336080|FG000|Overall Study|Progressive Disease|4|||
129011951|NCT02507375|464336081|FG001|Overall Study|Progressive Disease|5|||
129011952|NCT02507375|464336080|FG000|Overall Study|Death|0|||
129011953|NCT02507375|464336081|FG001|Overall Study|Death|1|||
129011954|NCT02507375|464336080|FG000|Overall Study|Refused treatment|0|||
129011955|NCT02507375|464336081|FG001|Overall Study|Refused treatment|1|||
129011956|NCT02507375|464336080|FG000|Overall Study|Adverse Event|0|||
129011957|NCT02507375|464336081|FG001|Overall Study|Adverse Event|1|||
129011958|NCT00522457|464336082|FG000|Overall Study|Due to disease progression|16|||
129011959|NCT00522457|464336082|FG000|Overall Study|Adverse Event|2|||
129011960|NCT01691248|464336083|FG000|Overall Study|Protocol Violation|43|||
129011961|NCT01691248|464336084|FG001|Overall Study|Protocol Violation|27|||
129011962|NCT01691248|464336083|FG000|Overall Study|Adverse Event|24|||
129011963|NCT01691248|464336084|FG001|Overall Study|Adverse Event|22|||
129011964|NCT01691248|464336083|FG000|Overall Study|Withdrawal by Subject|20|||
129011965|NCT01691248|464336084|FG001|Overall Study|Withdrawal by Subject|18|||
129011966|NCT01691248|464336083|FG000|Overall Study|Confirmed CDAD|14|||
129011967|NCT01691248|464336084|FG001|Overall Study|Confirmed CDAD|31|||
129011968|NCT01691248|464336083|FG000|Overall Study|Lost to Follow-up|2|||
129011969|NCT01691248|464336084|FG001|Overall Study|Lost to Follow-up|5|||
129011970|NCT01691248|464336083|FG000|Overall Study|Reason not provided|4|||
129011971|NCT01691248|464336084|FG001|Overall Study|Reason not provided|4|||
129011972|NCT01691248|464336083|FG000|Overall Study|Not Treated|4|||
129011973|NCT01691248|464336084|FG001|Overall Study|Not Treated|7|||
129011974|NCT02863575|464336085|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
129011975|NCT02863575|464336086|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
129011976|NCT02863575|464336087|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
129011977|NCT02863575|464336085|FG000|Overall Study|Withdrawal by Subject|0|||
128677658|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
128677659|NCT01087788|463118782|FG000|24-weeks Dose-blind Period|Patient moved|0|||
129011978|NCT02863575|464336086|FG001|Overall Study|Withdrawal by Subject|1|||
129011979|NCT02863575|464336087|FG002|Overall Study|Withdrawal by Subject|1|||
129011980|NCT02863575|464336085|FG000|Overall Study|Adverse Event|0|||
129011981|NCT02863575|464336086|FG001|Overall Study|Adverse Event|1|||
128677660|NCT01087788|463118783|FG001|24-weeks Dose-blind Period|Patient moved|0|||
128677661|NCT01087788|463118784|FG002|24-weeks Dose-blind Period|Patient moved|1|||
128677662|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
128677663|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
128677664|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
128677665|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
128677666|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
128677667|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
128677668|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
128677669|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
128677670|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
128677671|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
128677672|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
128677673|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
128677674|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
128677675|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
128677676|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
128677677|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
128677678|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
128677679|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
128677680|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
128677681|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
128677682|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
128677683|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
128677684|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
128677685|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
128677686|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
128677687|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
128677688|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
128677689|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
128677690|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
128677691|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
128677692|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
128677693|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
128677694|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
128677695|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
128677696|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
128677697|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
128677698|NCT01087788|463118782|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
128677699|NCT01087788|463118783|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
128677700|NCT01087788|463118784|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
128677701|NCT00783302|463118785|FG000|Overall Study|Lost to Follow-up|17|||
128677702|NCT00783302|463118785|FG000|Overall Study|Technical Problems|11|||
128677703|NCT00783302|463118785|FG000|Overall Study|Protocol Violation|3|||
128677704|NCT00783302|463118785|FG000|Overall Study|Physician Decision|1|||
128677705|NCT00783302|463118785|FG000|Overall Study|Withdrawal by Subject|3|||
128677706|NCT04604132|463118786|FG000|Overall Study|Adverse Event|2|||
128677707|NCT04604132|463118787|FG001|Overall Study|Adverse Event|0|||
128677708|NCT04604132|463118788|FG002|Overall Study|Adverse Event|0|||
128677709|NCT04604132|463118789|FG003|Overall Study|Adverse Event|1|||
128677710|NCT04604132|463118790|FG004|Overall Study|Adverse Event|2|||
128677711|NCT04604132|463118786|FG000|Overall Study|Study terminated by sponsor|0|||
128677712|NCT04604132|463118787|FG001|Overall Study|Study terminated by sponsor|0|||
128677713|NCT04604132|463118788|FG002|Overall Study|Study terminated by sponsor|0|||
128677714|NCT04604132|463118789|FG003|Overall Study|Study terminated by sponsor|0|||
128677715|NCT04604132|463118790|FG004|Overall Study|Study terminated by sponsor|1|||
128677716|NCT04604132|463118786|FG000|Overall Study|Progressive disease: Clinical progression|0|||
128677717|NCT04604132|463118787|FG001|Overall Study|Progressive disease: Clinical progression|0|||
128677718|NCT04604132|463118788|FG002|Overall Study|Progressive disease: Clinical progression|1|||
128677719|NCT04604132|463118789|FG003|Overall Study|Progressive disease: Clinical progression|0|||
128677720|NCT04604132|463118790|FG004|Overall Study|Progressive disease: Clinical progression|0|||
128677721|NCT04604132|463118786|FG000|Overall Study|Progressive disease: Radiological progression|8|||
128677722|NCT04604132|463118787|FG001|Overall Study|Progressive disease: Radiological progression|7|||
128677723|NCT04604132|463118788|FG002|Overall Study|Progressive disease: Radiological progression|10|||
128677724|NCT04604132|463118789|FG003|Overall Study|Progressive disease: Radiological progression|4|||
128677725|NCT04604132|463118790|FG004|Overall Study|Progressive disease: Radiological progression|3|||
128677726|NCT04604132|463118786|FG000|Overall Study|Death|3|||
128677727|NCT04604132|463118787|FG001|Overall Study|Death|1|||
128677728|NCT04604132|463118788|FG002|Overall Study|Death|2|||
128677729|NCT04604132|463118789|FG003|Overall Study|Death|1|||
128677730|NCT04604132|463118790|FG004|Overall Study|Death|0|||
128677731|NCT00952380|463118791|FG000|Overall Study|Other|0|||
128677732|NCT00952380|463118792|FG001|Overall Study|Other|0|||
128677733|NCT00952380|463118793|FG002|Overall Study|Other|0|||
128677734|NCT00952380|463118794|FG003|Overall Study|Other|0|||
128677735|NCT00952380|463118795|FG004|Overall Study|Other|1|||
128677736|NCT00952380|463118791|FG000|Overall Study|Withdrawal by Subject|0|||
128677737|NCT00952380|463118792|FG001|Overall Study|Withdrawal by Subject|0|||
128677738|NCT00952380|463118793|FG002|Overall Study|Withdrawal by Subject|1|||
128677739|NCT00952380|463118794|FG003|Overall Study|Withdrawal by Subject|0|||
128677740|NCT00952380|463118795|FG004|Overall Study|Withdrawal by Subject|2|||
128677741|NCT00952380|463118791|FG000|Overall Study|Adverse Event|0|||
128677742|NCT00952380|463118792|FG001|Overall Study|Adverse Event|1|||
128677743|NCT00952380|463118793|FG002|Overall Study|Adverse Event|0|||
128677744|NCT00952380|463118794|FG003|Overall Study|Adverse Event|0|||
128677745|NCT00952380|463118795|FG004|Overall Study|Adverse Event|3|||
128677746|NCT00952380|463118791|FG000|Overall Study|Physician Decision|0|||
128677747|NCT00952380|463118792|FG001|Overall Study|Physician Decision|0|||
128677748|NCT00952380|463118793|FG002|Overall Study|Physician Decision|1|||
128677749|NCT00952380|463118794|FG003|Overall Study|Physician Decision|2|||
128677750|NCT00952380|463118795|FG004|Overall Study|Physician Decision|0|||
128677751|NCT00952380|463118791|FG000|Overall Study|Non-compliant to protocol|0|||
128677752|NCT00952380|463118792|FG001|Overall Study|Non-compliant to protocol|0|||
128677753|NCT00952380|463118793|FG002|Overall Study|Non-compliant to protocol|0|||
128677754|NCT00952380|463118794|FG003|Overall Study|Non-compliant to protocol|1|||
128677755|NCT00952380|463118795|FG004|Overall Study|Non-compliant to protocol|0|||
128677756|NCT03400956|463118796|FG000|Treatment Period 1|Adverse Event|0|||
128677757|NCT03400956|463118797|FG001|Treatment Period 1|Adverse Event|1|||
128677758|NCT03400956|463118798|FG002|Treatment Period 1|Adverse Event|0|||
128677759|NCT03400956|463118796|FG000|Treatment Period 1|Lost to Follow-up|0|||
128677760|NCT03400956|463118797|FG001|Treatment Period 1|Lost to Follow-up|0|||
128677761|NCT03400956|463118798|FG002|Treatment Period 1|Lost to Follow-up|1|||
128677762|NCT03400956|463118796|FG000|Treatment Period 1|Protocol Violation|0|||
128677763|NCT03400956|463118797|FG001|Treatment Period 1|Protocol Violation|2|||
128677764|NCT03400956|463118798|FG002|Treatment Period 1|Protocol Violation|0|||
128677765|NCT03400956|463118796|FG000|Treatment Period 1|Study terminated by sponsor|3|||
128677766|NCT03400956|463118797|FG001|Treatment Period 1|Study terminated by sponsor|1|||
128677767|NCT03400956|463118798|FG002|Treatment Period 1|Study terminated by sponsor|1|||
128677768|NCT03400956|463118796|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128677769|NCT03400956|463118797|FG001|Treatment Period 1|Withdrawal by Subject|2|||
128677770|NCT03400956|463118798|FG002|Treatment Period 1|Withdrawal by Subject|4|||
128677771|NCT03400956|463118796|FG000|Treatment Period 1|Other|1|||
128677772|NCT03400956|463118797|FG001|Treatment Period 1|Other|2|||
128677773|NCT03400956|463118798|FG002|Treatment Period 1|Other|3|||
128677774|NCT03400956|463118796|FG000|Post-treatment Period 1|Adverse Event|0|||
128677775|NCT03400956|463118797|FG001|Post-treatment Period 1|Adverse Event|0|||
128677776|NCT03400956|463118798|FG002|Post-treatment Period 1|Adverse Event|1|||
128677777|NCT03400956|463118796|FG000|Post-treatment Period 1|Physician Decision|2|||
128677778|NCT03400956|463118797|FG001|Post-treatment Period 1|Physician Decision|3|||
128677779|NCT03400956|463118798|FG002|Post-treatment Period 1|Physician Decision|0|||
128677780|NCT03400956|463118796|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
128677781|NCT03400956|463118797|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
128677782|NCT03400956|463118798|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
128677783|NCT03400956|463118796|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
128677784|NCT03400956|463118797|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
128677785|NCT03400956|463118798|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
128677786|NCT03400956|463118796|FG000|Post-treatment Period 1|Other|4|||
128677787|NCT03400956|463118797|FG001|Post-treatment Period 1|Other|3|||
128677788|NCT03400956|463118798|FG002|Post-treatment Period 1|Other|4|||
128677789|NCT03400956|463118796|FG000|Treatment Period 2|Adverse Event|2|||
128677790|NCT03400956|463118797|FG001|Treatment Period 2|Adverse Event|1|||
128677791|NCT03400956|463118798|FG002|Treatment Period 2|Adverse Event|1|||
128677792|NCT03400956|463118796|FG000|Treatment Period 2|Lost to Follow-up|1|||
128677793|NCT03400956|463118797|FG001|Treatment Period 2|Lost to Follow-up|1|||
128677794|NCT03400956|463118798|FG002|Treatment Period 2|Lost to Follow-up|0|||
128677795|NCT03400956|463118796|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129011982|NCT02863575|464336087|FG002|Overall Study|Adverse Event|0|||
129011983|NCT00788125|464337981|FG000|Overall Study|Death|6|||
129011984|NCT00444145|464337989|FG000|Overall Study|Withdrawal by Subject|2|||
129011985|NCT00444145|464337989|FG000|Overall Study|Lost to Follow-up|1|||
129011986|NCT00444145|464337989|FG000|Overall Study|non-compliant|11|||
129011987|NCT00444145|464337989|FG000|Overall Study|Screen Failures|5|||
129011988|NCT01374919|464337990|FG000|Overall Study|Withdrawal by Subject|2|||
129011989|NCT00630305|464337991|FG000|Overall Study|Withdrawal by Subject|1|||
129011990|NCT00630305|464337991|FG000|Overall Study|Inability to insert contact lens|1|||
129011991|NCT01494506|464337992|FG000|Overall Study|Lack of Efficacy|77|||
129011992|NCT01494506|464337993|FG001|Overall Study|Lack of Efficacy|83|||
129011993|NCT01494506|464337994|FG002|Overall Study|Lack of Efficacy|57|||
128677796|NCT03400956|463118797|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128677797|NCT03400956|463118798|FG002|Treatment Period 2|Withdrawal by Subject|3|||
128677798|NCT03400956|463118796|FG000|Treatment Period 2|Other|1|||
128677799|NCT03400956|463118797|FG001|Treatment Period 2|Other|1|||
128677800|NCT03400956|463118798|FG002|Treatment Period 2|Other|0|||
129101413|NCT00762034|464666120|FG000|Maintenance Period|Adverse Event|42|||
129101414|NCT00762034|464666121|FG001|Maintenance Period|Adverse Event|26|||
129101415|NCT00762034|464666120|FG000|Maintenance Period|Progressive Disease|186|||
129101416|NCT00762034|464666121|FG001|Maintenance Period|Progressive Disease|224|||
129101417|NCT00762034|464666120|FG000|Maintenance Period|Physician Decision|25|||
129101418|NCT00762034|464666121|FG001|Maintenance Period|Physician Decision|20|||
129101419|NCT00762034|464666120|FG000|Maintenance Period|Withdrawal by Subject|34|||
129101420|NCT00762034|464666121|FG001|Maintenance Period|Withdrawal by Subject|14|||
129101421|NCT00762034|464666120|FG000|Maintenance Period|Death not due to study disease|2|||
129101422|NCT00762034|464666121|FG001|Maintenance Period|Death not due to study disease|5|||
129101423|NCT00762034|464666120|FG000|Maintenance Period|Death due to study disease|3|||
129101424|NCT00762034|464666121|FG001|Maintenance Period|Death due to study disease|3|||
129101425|NCT00762034|464666120|FG000|Maintenance Period|Other|1|||
129101426|NCT00762034|464666121|FG001|Maintenance Period|Other|1|||
129101427|NCT02442206|464666122|FG000|Period 1|Adverse Event|1|||
129101428|NCT02442206|464666123|FG001|Period 1|Adverse Event|1|||
129101429|NCT02442206|464666122|FG000|Period 1|withdrew consent|0|||
129101430|NCT02442206|464666123|FG001|Period 1|withdrew consent|1|||
129101431|NCT02442206|464666122|FG000|Period 1|COPD exacerbation|0|||
129101432|NCT02442206|464666123|FG001|Period 1|COPD exacerbation|1|||
129101433|NCT02442206|464666122|FG000|Period 2|Adverse Event|1|||
129101434|NCT02442206|464666123|FG001|Period 2|Adverse Event|0|||
129101435|NCT00497146|464666124|FG000|Treatment Period|Adverse Event|6|||
129101436|NCT00497146|464666125|FG001|Treatment Period|Adverse Event|2|||
129101437|NCT00497146|464666124|FG000|Treatment Period|Withdrawal by Subject|5|||
129101438|NCT00497146|464666125|FG001|Treatment Period|Withdrawal by Subject|9|||
128677801|NCT03400956|463118796|FG000|Follow-up Period|Withdrawal by Subject|0|||
128677802|NCT03400956|463118797|FG001|Follow-up Period|Withdrawal by Subject|0|||
128677803|NCT03400956|463118798|FG002|Follow-up Period|Withdrawal by Subject|1|||
128677804|NCT03400956|463118796|FG000|Follow-up Period|Other|0|||
128677805|NCT03400956|463118797|FG001|Follow-up Period|Other|0|||
128677806|NCT03400956|463118798|FG002|Follow-up Period|Other|1|||
128677807|NCT00160667|463118799|FG000|Overall Study|Adverse Event|3|||
129011994|NCT01494506|464337992|FG000|Overall Study|Adverse Event|17|||
129011995|NCT01494506|464337993|FG001|Overall Study|Adverse Event|10|||
129011996|NCT01494506|464337994|FG002|Overall Study|Adverse Event|11|||
129011997|NCT01494506|464337992|FG000|Overall Study|Death|9|||
129011998|NCT01494506|464337993|FG001|Overall Study|Death|5|||
129011999|NCT01494506|464337994|FG002|Overall Study|Death|2|||
129012000|NCT01494506|464337992|FG000|Overall Study|Physician Decision|7|||
129012001|NCT01494506|464337993|FG001|Overall Study|Physician Decision|5|||
129012002|NCT01494506|464337994|FG002|Overall Study|Physician Decision|4|||
129012003|NCT01494506|464337992|FG000|Overall Study|Withdrawal by Subject|17|||
129012004|NCT01494506|464337993|FG001|Overall Study|Withdrawal by Subject|20|||
129012005|NCT01494506|464337994|FG002|Overall Study|Withdrawal by Subject|14|||
129012006|NCT01494506|464337992|FG000|Overall Study|Clinical Deterioration|21|||
129012007|NCT01494506|464337993|FG001|Overall Study|Clinical Deterioration|17|||
129012008|NCT01494506|464337994|FG002|Overall Study|Clinical Deterioration|13|||
129012009|NCT01494506|464337992|FG000|Overall Study|Sponsor Decision|0|||
129012010|NCT01494506|464337993|FG001|Overall Study|Sponsor Decision|0|||
129012011|NCT01494506|464337994|FG002|Overall Study|Sponsor Decision|1|||
129012012|NCT01494506|464337992|FG000|Overall Study|Other|0|||
129012013|NCT01494506|464337993|FG001|Overall Study|Other|3|||
129012014|NCT01494506|464337994|FG002|Overall Study|Other|1|||
129012015|NCT02777528|464338006|FG000|Overall Study|Still in study|24|||
129012016|NCT02777528|464338007|FG001|Overall Study|Still in study|10|||
129012017|NCT02777528|464338008|FG002|Overall Study|Still in study|1|||
129012018|NCT02777528|464338006|FG000|Overall Study|Study Device Explanted|1|||
129012019|NCT02777528|464338007|FG001|Overall Study|Study Device Explanted|0|||
129012020|NCT02777528|464338008|FG002|Overall Study|Study Device Explanted|0|||
129012021|NCT02777528|464338006|FG000|Overall Study|Death|14|||
129012022|NCT02777528|464338007|FG001|Overall Study|Death|7|||
129012023|NCT02777528|464338008|FG002|Overall Study|Death|1|||
129012024|NCT02777528|464338006|FG000|Overall Study|Withdrawal by Subject|2|||
129012025|NCT02777528|464338007|FG001|Overall Study|Withdrawal by Subject|2|||
129012026|NCT02777528|464338008|FG002|Overall Study|Withdrawal by Subject|1|||
129012027|NCT02777528|464338006|FG000|Overall Study|Physician Decision|2|||
129012028|NCT02777528|464338007|FG001|Overall Study|Physician Decision|1|||
129101439|NCT00497146|464666124|FG000|Treatment Period|Lost to Follow-up|1|||
129101440|NCT00497146|464666125|FG001|Treatment Period|Lost to Follow-up|3|||
129101441|NCT00497146|464666124|FG000|Treatment Period|Required dialysis|4|||
129101442|NCT00497146|464666125|FG001|Treatment Period|Required dialysis|1|||
129101443|NCT00497146|464666124|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
129101444|NCT00497146|464666125|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
129101445|NCT00497146|464666124|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
128677808|NCT00160667|463118800|FG001|Overall Study|Adverse Event|1|||
128677809|NCT00160667|463118801|FG002|Overall Study|Adverse Event|4|||
128677810|NCT00160667|463118799|FG000|Overall Study|Withdrawal by Subject|2|||
128677811|NCT00160667|463118800|FG001|Overall Study|Withdrawal by Subject|0|||
128677812|NCT00160667|463118801|FG002|Overall Study|Withdrawal by Subject|1|||
128677813|NCT00160667|463118799|FG000|Overall Study|Lack of Efficacy|0|||
128677814|NCT00160667|463118800|FG001|Overall Study|Lack of Efficacy|1|||
128677815|NCT00160667|463118801|FG002|Overall Study|Lack of Efficacy|0|||
128677816|NCT00160667|463118799|FG000|Overall Study|Protocol Violation|0|||
128677817|NCT00160667|463118800|FG001|Overall Study|Protocol Violation|1|||
128677818|NCT00160667|463118801|FG002|Overall Study|Protocol Violation|0|||
128677819|NCT00160667|463118799|FG000|Overall Study|Patient decision|0|||
128677820|NCT00160667|463118800|FG001|Overall Study|Patient decision|0|||
128677821|NCT00160667|463118801|FG002|Overall Study|Patient decision|1|||
128677822|NCT01306929|463118807|FG000|Overall Study|Withdrawal by Subject|23|||
128677823|NCT01306929|463118807|FG000|Overall Study|Adverse Event|21|||
128677824|NCT01306929|463118807|FG000|Overall Study|Physician Decision|13|||
128677825|NCT01306929|463118807|FG000|Overall Study|Death|8|||
128677826|NCT01306929|463118807|FG000|Overall Study|Withdrawal by parent/guardian|5|||
128677827|NCT01306929|463118807|FG000|Overall Study|Protocol Violation|3|||
128677828|NCT01306929|463118807|FG000|Overall Study|Non-compliance with study drug|2|||
128677829|NCT01306929|463118807|FG000|Overall Study|Lost to Follow-up|2|||
128677830|NCT01306929|463118807|FG000|Overall Study|Various|17|||
128677831|NCT03709576|463118815|FG000|Overall Study|progression prior to enrollment|1|||
128677832|NCT03044574|463118819|FG000|Overall Study|Lost to Follow-up|37|||
128677833|NCT03044574|463118820|FG001|Overall Study|Lost to Follow-up|45|||
128677834|NCT00890045|463118823|FG000|Overall Study|Death|0|||
128677835|NCT00890045|463118824|FG001|Overall Study|Death|1|||
128677836|NCT00890045|463118823|FG000|Overall Study|Did not receive HeRO Graft|0|||
128677837|NCT00890045|463118824|FG001|Overall Study|Did not receive HeRO Graft|2|||
128677838|NCT00890045|463118823|FG000|Overall Study|Lost to Follow-up|5|||
128677839|NCT00890045|463118824|FG001|Overall Study|Lost to Follow-up|7|||
128677840|NCT00483756|463118829|FG000|Overall Study|Death|2|||
128677841|NCT00483756|463118830|FG001|Overall Study|Death|0|||
128677842|NCT00483756|463118831|FG002|Overall Study|Death|1|||
128677843|NCT00483756|463118829|FG000|Overall Study|Adverse Event|19|||
128677844|NCT00483756|463118830|FG001|Overall Study|Adverse Event|38|||
128677845|NCT00483756|463118831|FG002|Overall Study|Adverse Event|40|||
128677846|NCT00483756|463118829|FG000|Overall Study|Lack of Efficacy|1|||
128677847|NCT00483756|463118830|FG001|Overall Study|Lack of Efficacy|0|||
128677848|NCT00483756|463118831|FG002|Overall Study|Lack of Efficacy|0|||
128677849|NCT00483756|463118829|FG000|Overall Study|Lost to Follow-up|3|||
128677850|NCT00483756|463118830|FG001|Overall Study|Lost to Follow-up|1|||
128677851|NCT00483756|463118831|FG002|Overall Study|Lost to Follow-up|0|||
128677852|NCT00483756|463118829|FG000|Overall Study|Withdrawal by Subject|5|||
128677853|NCT00483756|463118830|FG001|Overall Study|Withdrawal by Subject|3|||
128677854|NCT00483756|463118831|FG002|Overall Study|Withdrawal by Subject|4|||
128677855|NCT00483756|463118829|FG000|Overall Study|Other|2|||
128677856|NCT00483756|463118830|FG001|Overall Study|Other|4|||
128677857|NCT00483756|463118831|FG002|Overall Study|Other|3|||
128677858|NCT00483756|463118829|FG000|Overall Study|Randomized, Not Treated|1|||
128677859|NCT00483756|463118830|FG001|Overall Study|Randomized, Not Treated|4|||
128677860|NCT00483756|463118831|FG002|Overall Study|Randomized, Not Treated|4|||
128677861|NCT00710762|463118832|FG000|Overall Study|Progressive disease|27|||
128677862|NCT00710762|463118833|FG001|Overall Study|Progressive disease|30|||
128677863|NCT00710762|463118832|FG000|Overall Study|Adverse Event other disease worsening|2|||
128677864|NCT00710762|463118833|FG001|Overall Study|Adverse Event other disease worsening|1|||
128677865|NCT00710762|463118832|FG000|Overall Study|Other Adverse Event|7|||
128677866|NCT00710762|463118833|FG001|Overall Study|Other Adverse Event|7|||
128677867|NCT00710762|463118832|FG000|Overall Study|Lost to Follow-up|1|||
128677868|NCT00710762|463118833|FG001|Overall Study|Lost to Follow-up|0|||
128677869|NCT00710762|463118832|FG000|Overall Study|Reason other than listed above|2|||
128677870|NCT00710762|463118833|FG001|Overall Study|Reason other than listed above|2|||
128677871|NCT00495040|463118835|FG000|Overall Study|Withdrawal by Subject|3|||
128677872|NCT01700439|463118839|FG000|Overall Study|Lost to Follow-up|47|||
128677873|NCT01700439|463118839|FG000|Overall Study|Withdrawal by Subject|183|||
128677874|NCT01700439|463118839|FG000|Overall Study|Death|186|||
128677875|NCT00592774|463118840|FG000|Overall Study|Adverse Event|5|||
128677876|NCT00592774|463118841|FG001|Overall Study|Adverse Event|19|||
128677877|NCT00592774|463118842|FG002|Overall Study|Adverse Event|2|||
128677878|NCT00592774|463118843|FG003|Overall Study|Adverse Event|14|||
128677879|NCT00592774|463118844|FG004|Overall Study|Adverse Event|8|||
128677880|NCT00592774|463118840|FG000|Overall Study|Protocol Violation|0|||
128677881|NCT00592774|463118841|FG001|Overall Study|Protocol Violation|1|||
128677882|NCT00592774|463118842|FG002|Overall Study|Protocol Violation|0|||
128677883|NCT00592774|463118843|FG003|Overall Study|Protocol Violation|0|||
128677884|NCT00592774|463118844|FG004|Overall Study|Protocol Violation|1|||
128677885|NCT00592774|463118840|FG000|Overall Study|Withdrawal by Subject|3|||
128677886|NCT00592774|463118841|FG001|Overall Study|Withdrawal by Subject|7|||
129012029|NCT02777528|464338008|FG002|Overall Study|Physician Decision|0|||
129101446|NCT00497146|464666125|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
129101447|NCT00497146|464666124|FG000|Treatment Period|Other Reason|2|||
129101448|NCT00497146|464666125|FG001|Treatment Period|Other Reason|3|||
129101449|NCT00497146|464666124|FG000|Long-term Follow-up Period|Adverse Event|2|||
129101450|NCT00497146|464666125|FG001|Long-term Follow-up Period|Adverse Event|2|||
129101451|NCT00497146|464666124|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
129101452|NCT00497146|464666125|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
129101453|NCT00497146|464666124|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
129101454|NCT00497146|464666125|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
129101455|NCT00497146|464666124|FG000|Long-term Follow-up Period|Other|0|||
129101456|NCT00497146|464666125|FG001|Long-term Follow-up Period|Other|1|||
129101457|NCT01471444|464666126|FG000|Overall Study|Physician Decision|3|||
129012030|NCT02777528|464338006|FG000|Overall Study|Lost to Follow-up|2|||
129012031|NCT02777528|464338007|FG001|Overall Study|Lost to Follow-up|0|||
129012032|NCT02777528|464338008|FG002|Overall Study|Lost to Follow-up|0|||
129012033|NCT02777528|464338006|FG000|Overall Study|Discontinued due to Other|1|||
129012034|NCT02777528|464338007|FG001|Overall Study|Discontinued due to Other|0|||
129012035|NCT02777528|464338008|FG002|Overall Study|Discontinued due to Other|0|||
129012036|NCT01882647|464338011|FG000|Overall Study|Lost to Follow-up|2|||
129012037|NCT01882647|464338012|FG001|Overall Study|Lost to Follow-up|2|||
129012038|NCT01882647|464338011|FG000|Overall Study|Withdrawal by Subject|0|||
129012039|NCT01882647|464338012|FG001|Overall Study|Withdrawal by Subject|4|||
129101458|NCT01471444|464666127|FG001|Overall Study|Physician Decision|2|||
129101459|NCT01471444|464666126|FG000|Overall Study|Withdrawal by Subject|0|||
129101460|NCT01471444|464666127|FG001|Overall Study|Withdrawal by Subject|1|||
129101461|NCT01299896|464666130|FG000|Overall Study|Withdrawal by Subject|1|||
129101462|NCT01299896|464666131|FG001|Overall Study|Withdrawal by Subject|7|||
129101463|NCT01299896|464666130|FG000|Overall Study|Lost to Follow-up|0|||
129101464|NCT01299896|464666131|FG001|Overall Study|Lost to Follow-up|11|||
129101465|NCT02107313|464666132|FG000|Overall Study|One participant did not do the FED cohor|0|||
129101466|NCT02107313|464666133|FG001|Overall Study|One participant did not do the FED cohor|1|||
129101467|NCT00582426|464666144|FG000|Overall Study|Lost to Follow-up|0|||
129101468|NCT00582426|464666145|FG001|Overall Study|Lost to Follow-up|2|||
129101469|NCT00582426|464666144|FG000|Overall Study|Adverse Event|4|||
129101470|NCT00582426|464666145|FG001|Overall Study|Adverse Event|2|||
129101471|NCT00582426|464666144|FG000|Overall Study|Protocol Violation|6|||
129101472|NCT00582426|464666145|FG001|Overall Study|Protocol Violation|2|||
129101473|NCT00582426|464666144|FG000|Overall Study|Death|4|||
129101474|NCT00582426|464666145|FG001|Overall Study|Death|3|||
129101475|NCT00582426|464666144|FG000|Overall Study|Withdrawal by Subject|3|||
128677887|NCT00592774|463118842|FG002|Overall Study|Withdrawal by Subject|0|||
129012040|NCT03292653|464338014|FG000|Overall Study|Adverse Event|0|||
129012041|NCT03292653|464338015|FG001|Overall Study|Adverse Event|0|||
129012042|NCT03292653|464338016|FG002|Overall Study|Adverse Event|1|||
129012043|NCT03292653|464338014|FG000|Overall Study|Did not Receive Treatment|1|||
129012044|NCT03292653|464338015|FG001|Overall Study|Did not Receive Treatment|0|||
129012045|NCT03292653|464338016|FG002|Overall Study|Did not Receive Treatment|0|||
129012046|NCT04720664|464338017|FG000|Overall Study|Adverse Event|2|||
129012047|NCT04720664|464338017|FG000|Overall Study|Lack of Efficacy|9|||
129012048|NCT03311646|464338018|FG000|Overall Study|Physician Decision|1|||
129012049|NCT03311646|464338018|FG000|Overall Study|Withdrawal by Subject|5|||
129012050|NCT03311646|464338018|FG000|Overall Study|Lost to Follow-up|5|||
129012051|NCT03311646|464338018|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
129012052|NCT01492361|464338019|FG000|Overall Study|Withdrawal by Subject|281|||
129012053|NCT01492361|464338020|FG001|Overall Study|Withdrawal by Subject|297|||
129012054|NCT01492361|464338019|FG000|Overall Study|Physician Decision|12|||
129012055|NCT01492361|464338020|FG001|Overall Study|Physician Decision|12|||
129012056|NCT01492361|464338019|FG000|Overall Study|Lost to Follow-up|6|||
129012057|NCT01492361|464338020|FG001|Overall Study|Lost to Follow-up|13|||
129101476|NCT00582426|464666145|FG001|Overall Study|Withdrawal by Subject|2|||
128677888|NCT00592774|463118843|FG003|Overall Study|Withdrawal by Subject|0|||
128677889|NCT00592774|463118844|FG004|Overall Study|Withdrawal by Subject|0|||
128677890|NCT00592774|463118840|FG000|Overall Study|Lack of Efficacy|3|||
128677891|NCT00592774|463118841|FG001|Overall Study|Lack of Efficacy|3|||
128677892|NCT00592774|463118842|FG002|Overall Study|Lack of Efficacy|0|||
128677893|NCT00592774|463118843|FG003|Overall Study|Lack of Efficacy|0|||
129012058|NCT01492361|464338019|FG000|Overall Study|Other than specified above|106|||
129012059|NCT01492361|464338020|FG001|Overall Study|Other than specified above|138|||
129012060|NCT03127137|464338027|FG000|Overall Study|Requested sedation after consent|1|||
129012061|NCT03127137|464338028|FG001|Overall Study|Requested sedation after consent|0|||
129101477|NCT00582426|464666144|FG000|Overall Study|Disease Progression|2|||
128677894|NCT00592774|463118844|FG004|Overall Study|Lack of Efficacy|2|||
128677895|NCT00592774|463118840|FG000|Overall Study|Physician Decision|0|||
129101478|NCT00582426|464666145|FG001|Overall Study|Disease Progression|2|||
129101479|NCT00582426|464666144|FG000|Overall Study|Use of illicit drugs|1|||
129101480|NCT00582426|464666145|FG001|Overall Study|Use of illicit drugs|0|||
129101481|NCT01548768|464666146|FG000|Overall Study|Withdrawal by Subject|0|||
129012062|NCT03127137|464338027|FG000|Overall Study|Malfunction in electronic data collection|1|||
129012063|NCT03127137|464338028|FG001|Overall Study|Malfunction in electronic data collection|0|||
129012064|NCT03127137|464338027|FG000|Overall Study|Post procedure testing could not be obtained|0|||
129012065|NCT03127137|464338028|FG001|Overall Study|Post procedure testing could not be obtained|1|||
129012066|NCT03247556|464338031|FG000|Overall Study|Adverse Event|1|||
129012067|NCT03247556|464338032|FG001|Overall Study|Adverse Event|4|||
129012068|NCT03247556|464338033|FG002|Overall Study|Adverse Event|5|||
129012069|NCT03247556|464338031|FG000|Overall Study|Lost to Follow-up|5|||
129012070|NCT03247556|464338032|FG001|Overall Study|Lost to Follow-up|5|||
129012071|NCT03247556|464338033|FG002|Overall Study|Lost to Follow-up|4|||
129012072|NCT03247556|464338031|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
129012073|NCT03247556|464338032|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
129012074|NCT03247556|464338033|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
129012075|NCT03247556|464338031|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
129012076|NCT03247556|464338032|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
129012077|NCT03247556|464338033|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
129012078|NCT03247556|464338031|FG000|Overall Study|Protocol Violation|2|||
129012079|NCT03247556|464338032|FG001|Overall Study|Protocol Violation|0|||
129012080|NCT03247556|464338033|FG002|Overall Study|Protocol Violation|1|||
129012081|NCT03247556|464338031|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
129012082|NCT03247556|464338032|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
128677896|NCT00592774|463118841|FG001|Overall Study|Physician Decision|1|||
128677897|NCT00592774|463118842|FG002|Overall Study|Physician Decision|1|||
128677898|NCT00592774|463118843|FG003|Overall Study|Physician Decision|0|||
128677899|NCT00592774|463118844|FG004|Overall Study|Physician Decision|1|||
128677900|NCT00592774|463118840|FG000|Overall Study|Other|0|||
128677901|NCT00592774|463118841|FG001|Overall Study|Other|1|||
128677902|NCT00592774|463118842|FG002|Overall Study|Other|1|||
128677903|NCT00592774|463118843|FG003|Overall Study|Other|0|||
128677904|NCT00592774|463118844|FG004|Overall Study|Other|2|||
128677905|NCT01892384|463118845|FG000|Overall Study|Withdrawal by Subject|1|||
128677906|NCT01892384|463118846|FG001|Overall Study|Withdrawal by Subject|1|||
128677907|NCT01892384|463118847|FG002|Overall Study|Withdrawal by Subject|0|||
128677908|NCT01892384|463118848|FG003|Overall Study|Withdrawal by Subject|0|||
128677909|NCT00621621|463118855|FG000|Overall Study|Subjects were exited at EP study|30|||
128677910|NCT00621621|463118856|FG001|Overall Study|Subjects were exited at EP study|0|||
128677911|NCT01829243|463118859|FG000|First Intervention|Screen Failure|4|||
128677912|NCT01829243|463118860|FG001|First Intervention|Screen Failure|2|||
128677913|NCT00807573|463118880|FG000|Overall Study|Withdrawal by Subject|1|||
128677914|NCT00807573|463118880|FG000|Overall Study|Adverse Event|1|||
128677915|NCT04054947|463118881|FG000|Overall Study|Withdrawal by Subject|1|||
128677916|NCT04054947|463118882|FG001|Overall Study|Withdrawal by Subject|0|||
128677917|NCT04054947|463118881|FG000|Overall Study|Lost to Follow-up|2|||
128677918|NCT04054947|463118882|FG001|Overall Study|Lost to Follow-up|5|||
128677919|NCT00853970|463118887|FG000|Overall Study|Withdrawal by Subject|2|||
128677920|NCT00853970|463118888|FG001|Overall Study|Withdrawal by Subject|1|||
128677921|NCT00853970|463118887|FG000|Overall Study|Cancelled surgery|4|||
128677922|NCT00853970|463118888|FG001|Overall Study|Cancelled surgery|2|||
128677923|NCT02055365|463120258|FG000|Overall Study|Prematurely Withdrawn|1|||
128677924|NCT01258998|463120259|FG000|Overall Study|Ineligible|1|||
128677925|NCT01143389|463120260|FG000|Overall Study|Lost to Follow-up|26|||
128677926|NCT01143389|463120261|FG001|Overall Study|Lost to Follow-up|25|||
128677927|NCT02276027|463120264|FG000|Overall Study|Death|1|||
128677928|NCT02276027|463120265|FG001|Overall Study|Death|0|||
128677929|NCT02276027|463120266|FG002|Overall Study|Death|0|||
128677930|NCT02276027|463120267|FG003|Overall Study|Death|2|||
128677931|NCT02276027|463120264|FG000|Overall Study|Physician Decision|0|||
128677932|NCT02276027|463120265|FG001|Overall Study|Physician Decision|0|||
128677933|NCT02276027|463120266|FG002|Overall Study|Physician Decision|0|||
128677934|NCT02276027|463120267|FG003|Overall Study|Physician Decision|1|||
128677935|NCT02276027|463120264|FG000|Overall Study|Progressive disease|1|||
128677936|NCT02276027|463120265|FG001|Overall Study|Progressive disease|13|||
128677937|NCT02276027|463120266|FG002|Overall Study|Progressive disease|12|||
129012083|NCT03247556|464338033|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
129012084|NCT01682083|464338034|FG000|Overall Study|Lost to Follow-up|11|||
128677938|NCT02276027|463120267|FG003|Overall Study|Progressive disease|14|||
128677939|NCT02276027|463120264|FG000|Overall Study|Subject/guardian decision|0|||
128677940|NCT02276027|463120265|FG001|Overall Study|Subject/guardian decision|1|||
128677941|NCT02276027|463120266|FG002|Overall Study|Subject/guardian decision|0|||
128677942|NCT02276027|463120267|FG003|Overall Study|Subject/guardian decision|3|||
129012085|NCT01682083|464338035|FG001|Overall Study|Lost to Follow-up|18|||
128677943|NCT02276027|463120264|FG000|Overall Study|Adverse Event|0|||
128677944|NCT02276027|463120265|FG001|Overall Study|Adverse Event|2|||
128677945|NCT02276027|463120266|FG002|Overall Study|Adverse Event|8|||
128677946|NCT02276027|463120267|FG003|Overall Study|Adverse Event|2|||
128677947|NCT03224598|463120268|FG000|Overall Study|Lost to Follow-up|0|||
128677948|NCT03224598|463120269|FG001|Overall Study|Lost to Follow-up|2|||
129012086|NCT01682083|464338034|FG000|Overall Study|Withdrawal by Subject|31|||
129101482|NCT01548768|464666147|FG001|Overall Study|Withdrawal by Subject|2|||
129101483|NCT01548768|464666148|FG002|Overall Study|Withdrawal by Subject|1|||
129101484|NCT01548768|464666149|FG003|Overall Study|Withdrawal by Subject|0|||
129101485|NCT01548768|464666146|FG000|Overall Study|Physician Decision|1|||
129101486|NCT01548768|464666147|FG001|Overall Study|Physician Decision|0|||
129101487|NCT01548768|464666148|FG002|Overall Study|Physician Decision|0|||
129101488|NCT01548768|464666149|FG003|Overall Study|Physician Decision|0|||
129101489|NCT01548768|464666146|FG000|Overall Study|Adverse Event|0|||
129101490|NCT01548768|464666147|FG001|Overall Study|Adverse Event|0|||
129101491|NCT01548768|464666148|FG002|Overall Study|Adverse Event|0|||
129101492|NCT01548768|464666149|FG003|Overall Study|Adverse Event|1|||
129101493|NCT01548768|464666146|FG000|Overall Study|Non-Compliance|0|||
129101494|NCT01548768|464666147|FG001|Overall Study|Non-Compliance|0|||
129101495|NCT01548768|464666148|FG002|Overall Study|Non-Compliance|0|||
129101496|NCT01548768|464666149|FG003|Overall Study|Non-Compliance|3|||
129101497|NCT04126317|464666153|FG000|Overall Study|Adverse Event|0|||
129101498|NCT04126317|464666154|FG001|Overall Study|Adverse Event|1|||
129101499|NCT04126317|464666153|FG000|Overall Study|Withdrawal by Subject|4|||
129101500|NCT04126317|464666154|FG001|Overall Study|Withdrawal by Subject|1|||
129101501|NCT02985021|464666156|FG000|Overall Study|Inability to comply with study procedures|1|||
129101502|NCT00790556|464666157|FG000|Treatment Period 1|Physician Decision|1|||
129101503|NCT00790556|464666158|FG001|Treatment Period 1|Physician Decision|0|||
129101504|NCT00790556|464666157|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129101505|NCT00790556|464666158|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129101506|NCT00482170|464666160|FG000|Overall Study|Adverse Event|5|||
129101507|NCT00482170|464666161|FG001|Overall Study|Adverse Event|14|||
129101508|NCT00482170|464666160|FG000|Overall Study|Withdrawal by Subject|6|||
129101509|NCT00482170|464666161|FG001|Overall Study|Withdrawal by Subject|1|||
129101510|NCT00482170|464666160|FG000|Overall Study|Protocol Violation|2|||
129101511|NCT00482170|464666161|FG001|Overall Study|Protocol Violation|3|||
129101512|NCT00482170|464666160|FG000|Overall Study|Lost to Follow-up|2|||
129101513|NCT00482170|464666161|FG001|Overall Study|Lost to Follow-up|0|||
129101514|NCT00482170|464666160|FG000|Overall Study|Unspecified reason|0|||
129101515|NCT00482170|464666161|FG001|Overall Study|Unspecified reason|2|||
129101516|NCT00162097|464666162|FG000|Overall Study|Participant no longer met study criteria|0|||
129101517|NCT00162097|464666163|FG001|Overall Study|Participant no longer met study criteria|0|||
129101518|NCT00162097|464666164|FG002|Overall Study|Participant no longer met study criteria|0|||
129101519|NCT00162097|464666165|FG003|Overall Study|Participant no longer met study criteria|1|||
129101520|NCT01658904|464666170|FG000|Overall Study|Principal Investigator discretion|2|||
129101521|NCT01658904|464666171|FG001|Overall Study|Principal Investigator discretion|0|||
129101522|NCT01658904|464666172|FG002|Overall Study|Principal Investigator discretion|0|||
129101523|NCT01603394|464666183|FG000|Overall Study|Adverse Event|1|||
129101524|NCT00840034|464666185|FG000|Acute Treatment Phase|Adverse Event|6|||
128677949|NCT03224598|463120270|FG002|Overall Study|Lost to Follow-up|0|||
128677950|NCT03224598|463120268|FG000|Overall Study|Other|0|||
128677951|NCT03224598|463120269|FG001|Overall Study|Other|1|||
128677952|NCT03224598|463120270|FG002|Overall Study|Other|0|||
128677953|NCT01527357|463120280|FG000|Overall Study|Death|8|||
128677954|NCT01527357|463120281|FG001|Overall Study|Death|2|||
128677955|NCT01527357|463120280|FG000|Overall Study|Lost to Follow-up|6|||
128677956|NCT01527357|463120281|FG001|Overall Study|Lost to Follow-up|4|||
128677957|NCT01527357|463120280|FG000|Overall Study|Withdrew Consent|1|||
128677958|NCT01527357|463120281|FG001|Overall Study|Withdrew Consent|1|||
128677959|NCT01527357|463120280|FG000|Overall Study|Non-compliance|0|||
128677960|NCT01527357|463120281|FG001|Overall Study|Non-compliance|1|||
128677961|NCT01527357|463120280|FG000|Overall Study|No Day 29 Visit|0|||
128677962|NCT01527357|463120281|FG001|Overall Study|No Day 29 Visit|1|||
128677963|NCT01527357|463120280|FG000|Overall Study|Did Not Receive Treatment|2|||
128677964|NCT01527357|463120281|FG001|Overall Study|Did Not Receive Treatment|0|||
128677965|NCT02446171|463120282|FG000|Overall Study|Withdrawal by Subject|0|||
128677966|NCT02446171|463120283|FG001|Overall Study|Withdrawal by Subject|0|||
129101525|NCT00840034|464666186|FG001|Acute Treatment Phase|Adverse Event|8|||
129101526|NCT00840034|464666185|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
129101527|NCT00840034|464666186|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
128677967|NCT02446171|463120284|FG002|Overall Study|Withdrawal by Subject|2|||
128878414|NCT01853644|463848478|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
128878415|NCT01853644|463848478|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
129101528|NCT00840034|464666185|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
129101529|NCT00840034|464666186|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
129101530|NCT00840034|464666185|FG000|Acute Treatment Phase|Physician Decision|0|||
129101531|NCT00840034|464666186|FG001|Acute Treatment Phase|Physician Decision|1|||
129101532|NCT00840034|464666185|FG000|Acute Treatment Phase|Protocol Violation|2|||
128677968|NCT02446171|463120285|FG003|Overall Study|Withdrawal by Subject|0|||
129101533|NCT00840034|464666186|FG001|Acute Treatment Phase|Protocol Violation|4|||
129101534|NCT00840034|464666185|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
129101535|NCT00840034|464666186|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
129101536|NCT00840034|464666185|FG000|Taper Phase|Adverse Event|1|||
129012087|NCT01682083|464338035|FG001|Overall Study|Withdrawal by Subject|40|||
129012088|NCT01682083|464338034|FG000|Overall Study|Death|60|||
129012089|NCT01682083|464338035|FG001|Overall Study|Death|93|||
129012090|NCT01682083|464338034|FG000|Overall Study|Physician Decision|5|||
129012091|NCT01682083|464338035|FG001|Overall Study|Physician Decision|4|||
129012092|NCT03952143|464338036|FG000|Lead-In Period|Adverse Event|2|||
129012093|NCT03952143|464338037|FG001|Lead-In Period|Adverse Event|0|||
129012094|NCT03952143|464338038|FG002|Lead-In Period|Adverse Event|0|||
129012095|NCT03952143|464338036|FG000|Lead-In Period|Lack of Efficacy|2|||
129012096|NCT03952143|464338037|FG001|Lead-In Period|Lack of Efficacy|0|||
129012097|NCT03952143|464338038|FG002|Lead-In Period|Lack of Efficacy|0|||
128677969|NCT04531462|463120286|FG000|Overall Study|Withdrawal by Subject|3|||
128677970|NCT04531462|463120287|FG001|Overall Study|Withdrawal by Subject|1|||
128677971|NCT04531462|463120286|FG000|Overall Study|Adverse Event|3|||
128677972|NCT04531462|463120287|FG001|Overall Study|Adverse Event|3|||
129012098|NCT03952143|464338036|FG000|Lead-In Period|Physician Decision|5|||
129012099|NCT03952143|464338037|FG001|Lead-In Period|Physician Decision|0|||
129012100|NCT03952143|464338038|FG002|Lead-In Period|Physician Decision|0|||
129012101|NCT03952143|464338036|FG000|Lead-In Period|Protocol Violation|5|||
129012102|NCT03952143|464338037|FG001|Lead-In Period|Protocol Violation|0|||
129012103|NCT03952143|464338038|FG002|Lead-In Period|Protocol Violation|0|||
129012104|NCT03952143|464338036|FG000|Lead-In Period|Withdrawal by Subject|19|||
129012105|NCT03952143|464338037|FG001|Lead-In Period|Withdrawal by Subject|0|||
129012106|NCT03952143|464338038|FG002|Lead-In Period|Withdrawal by Subject|0|||
129012107|NCT03952143|464338036|FG000|Treatment Period|Adverse Event|0|||
129012108|NCT03952143|464338037|FG001|Treatment Period|Adverse Event|0|||
129012109|NCT03952143|464338038|FG002|Treatment Period|Adverse Event|1|||
129012110|NCT03952143|464338036|FG000|Treatment Period|Lost to Follow-up|0|||
129012111|NCT03952143|464338037|FG001|Treatment Period|Lost to Follow-up|2|||
129012112|NCT03952143|464338038|FG002|Treatment Period|Lost to Follow-up|0|||
129012113|NCT03952143|464338036|FG000|Treatment Period|Physician Decision|0|||
129012114|NCT03952143|464338037|FG001|Treatment Period|Physician Decision|0|||
129012115|NCT03952143|464338038|FG002|Treatment Period|Physician Decision|2|||
129012116|NCT03952143|464338036|FG000|Treatment Period|Protocol Violation|0|||
129012117|NCT03952143|464338037|FG001|Treatment Period|Protocol Violation|0|||
129012118|NCT03952143|464338038|FG002|Treatment Period|Protocol Violation|1|||
129012119|NCT03952143|464338036|FG000|Treatment Period|Withdrawal by Subject|0|||
129012120|NCT03952143|464338037|FG001|Treatment Period|Withdrawal by Subject|5|||
129012121|NCT03952143|464338038|FG002|Treatment Period|Withdrawal by Subject|26|||
129012122|NCT03952143|464338036|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
129012123|NCT03952143|464338037|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
129012124|NCT03952143|464338038|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
129012125|NCT03952143|464338036|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
129012126|NCT03952143|464338037|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
129012127|NCT03952143|464338038|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
129012128|NCT01866319|464338039|FG000|Overall Study|Adverse Event|12|||
129012129|NCT01866319|464338040|FG001|Overall Study|Adverse Event|5|||
129012130|NCT01866319|464338041|FG002|Overall Study|Adverse Event|9|||
129012131|NCT01866319|464338039|FG000|Overall Study|Clinical progression|3|||
129012132|NCT01866319|464338040|FG001|Overall Study|Clinical progression|2|||
128677973|NCT00504582|463120288|FG000|Overall Study|Lost to Follow-up|1|||
128677974|NCT00504582|463120289|FG001|Overall Study|Lost to Follow-up|0|||
128677975|NCT00504582|463120290|FG002|Overall Study|Lost to Follow-up|0|||
128677976|NCT00348933|463120293|FG000|Overall Study|Withdrawal by Subject|10|||
128677977|NCT00348933|463120293|FG000|Overall Study|Lost to Follow-up|6|||
128677978|NCT00348933|463120293|FG000|Overall Study|Protocol Violation|2|||
128677979|NCT00348933|463120293|FG000|Overall Study|Adverse Event|7|||
128677980|NCT01489111|463120294|FG000|Overall Study|Withdrawal criterion|1|||
129012133|NCT01866319|464338041|FG002|Overall Study|Clinical progression|2|||
129012134|NCT01866319|464338039|FG000|Overall Study|Death|153|||
129012135|NCT01866319|464338040|FG001|Overall Study|Death|154|||
129012136|NCT01866319|464338041|FG002|Overall Study|Death|147|||
129012137|NCT01866319|464338039|FG000|Overall Study|Lost to Follow-up|6|||
129012138|NCT01866319|464338040|FG001|Overall Study|Lost to Follow-up|3|||
129012139|NCT01866319|464338041|FG002|Overall Study|Lost to Follow-up|8|||
129012140|NCT01866319|464338039|FG000|Overall Study|Physician Decision|1|||
129012141|NCT01866319|464338040|FG001|Overall Study|Physician Decision|0|||
128677981|NCT03811093|463120296|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
128677982|NCT03811093|463120297|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
128677983|NCT03811093|463120296|FG000|Overall Study|Unable to measure body fat percentage|2|||
129012142|NCT01866319|464338041|FG002|Overall Study|Physician Decision|1|||
129012143|NCT01866319|464338039|FG000|Overall Study|Protocol Violation|0|||
129012144|NCT01866319|464338040|FG001|Overall Study|Protocol Violation|0|||
129012145|NCT01866319|464338041|FG002|Overall Study|Protocol Violation|1|||
129012146|NCT01866319|464338039|FG000|Overall Study|Withdrawal by Subject|32|||
129012147|NCT01866319|464338040|FG001|Overall Study|Withdrawal by Subject|14|||
129012148|NCT01866319|464338041|FG002|Overall Study|Withdrawal by Subject|12|||
128677984|NCT03811093|463120297|FG001|Overall Study|Unable to measure body fat percentage|0|||
128677985|NCT00464490|463120298|FG000|Overall Study|Physician Decision|11|||
128677986|NCT00464490|463120299|FG001|Overall Study|Physician Decision|11|||
128878416|NCT01853644|463848478|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
128878417|NCT01853644|463848478|FG000|Continued Treatment After First Response|Adverse Event|2|||
129012149|NCT03980483|464338046|FG000|Overall Study|Adverse Event|13|||
129012150|NCT03980483|464338047|FG001|Overall Study|Adverse Event|29|||
129012151|NCT03980483|464338048|FG002|Overall Study|Adverse Event|11|||
129012152|NCT03980483|464338049|FG003|Overall Study|Adverse Event|2|||
129012153|NCT03980483|464338050|FG004|Overall Study|Adverse Event|2|||
129012154|NCT03980483|464338051|FG005|Overall Study|Adverse Event|2|||
129012155|NCT03980483|464338046|FG000|Overall Study|Lack of Efficacy|7|||
129012156|NCT03980483|464338047|FG001|Overall Study|Lack of Efficacy|6|||
129012157|NCT03980483|464338048|FG002|Overall Study|Lack of Efficacy|0|||
129012158|NCT03980483|464338049|FG003|Overall Study|Lack of Efficacy|3|||
129012159|NCT03980483|464338050|FG004|Overall Study|Lack of Efficacy|1|||
129012160|NCT03980483|464338051|FG005|Overall Study|Lack of Efficacy|1|||
129012161|NCT03980483|464338046|FG000|Overall Study|Lost to Follow-up|2|||
129012162|NCT03980483|464338047|FG001|Overall Study|Lost to Follow-up|4|||
129012163|NCT03980483|464338048|FG002|Overall Study|Lost to Follow-up|2|||
129012164|NCT03980483|464338049|FG003|Overall Study|Lost to Follow-up|1|||
129012165|NCT03980483|464338050|FG004|Overall Study|Lost to Follow-up|2|||
129012166|NCT03980483|464338051|FG005|Overall Study|Lost to Follow-up|0|||
129012167|NCT03980483|464338046|FG000|Overall Study|Protocol Violation|4|||
129012168|NCT03980483|464338047|FG001|Overall Study|Protocol Violation|2|||
129012169|NCT03980483|464338048|FG002|Overall Study|Protocol Violation|1|||
129012170|NCT03980483|464338049|FG003|Overall Study|Protocol Violation|1|||
129012171|NCT03980483|464338050|FG004|Overall Study|Protocol Violation|0|||
129012172|NCT03980483|464338051|FG005|Overall Study|Protocol Violation|0|||
129012173|NCT03980483|464338046|FG000|Overall Study|Physician Decision|14|||
129012174|NCT03980483|464338047|FG001|Overall Study|Physician Decision|10|||
129012175|NCT03980483|464338048|FG002|Overall Study|Physician Decision|7|||
129012176|NCT03980483|464338049|FG003|Overall Study|Physician Decision|4|||
129012177|NCT03980483|464338050|FG004|Overall Study|Physician Decision|4|||
129012178|NCT03980483|464338051|FG005|Overall Study|Physician Decision|2|||
129012179|NCT03980483|464338046|FG000|Overall Study|Withdrawal by Subject|38|||
129012180|NCT03980483|464338047|FG001|Overall Study|Withdrawal by Subject|21|||
129012181|NCT03980483|464338048|FG002|Overall Study|Withdrawal by Subject|15|||
129012182|NCT03980483|464338049|FG003|Overall Study|Withdrawal by Subject|5|||
129012183|NCT03980483|464338050|FG004|Overall Study|Withdrawal by Subject|3|||
129012184|NCT03980483|464338051|FG005|Overall Study|Withdrawal by Subject|4|||
129012185|NCT03980483|464338046|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
129012186|NCT03980483|464338047|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129012187|NCT03980483|464338048|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129012188|NCT03980483|464338049|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129012189|NCT03980483|464338050|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129012190|NCT03980483|464338051|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129012191|NCT03980483|464338046|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129012192|NCT03980483|464338047|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
129012193|NCT03980483|464338048|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129012194|NCT03980483|464338049|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129012195|NCT03980483|464338050|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129012196|NCT03980483|464338051|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129012197|NCT03980483|464338046|FG000|Overall Study|Other|0|||
129012198|NCT03980483|464338047|FG001|Overall Study|Other|1|||
129012199|NCT03980483|464338048|FG002|Overall Study|Other|0|||
129012200|NCT03980483|464338049|FG003|Overall Study|Other|0|||
129012201|NCT03980483|464338050|FG004|Overall Study|Other|0|||
129012202|NCT03980483|464338051|FG005|Overall Study|Other|0|||
129012203|NCT00760266|464338054|FG000|Overall Study|Adverse Event|13|||
129012204|NCT00760266|464338055|FG001|Overall Study|Adverse Event|7|||
129012205|NCT00760266|464338054|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129012206|NCT00760266|464338055|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129012207|NCT00760266|464338054|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129012208|NCT00760266|464338055|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129012209|NCT00760266|464338054|FG000|Overall Study|Lack of Efficacy|2|||
129012210|NCT00760266|464338055|FG001|Overall Study|Lack of Efficacy|2|||
129012211|NCT00760266|464338054|FG000|Overall Study|Protocol deviation|2|||
129012212|NCT00760266|464338055|FG001|Overall Study|Protocol deviation|4|||
129012213|NCT00760266|464338054|FG000|Overall Study|Patient withdrew consent|3|||
129012214|NCT00760266|464338055|FG001|Overall Study|Patient withdrew consent|3|||
129012215|NCT00760266|464338054|FG000|Overall Study|Lost to Follow-up|2|||
129012216|NCT00760266|464338055|FG001|Overall Study|Lost to Follow-up|1|||
129012217|NCT00760266|464338054|FG000|Overall Study|Administrative Problems|0|||
129012218|NCT00760266|464338055|FG001|Overall Study|Administrative Problems|1|||
129012219|NCT00220337|464338058|FG000|Overall Study|Adverse Event|70|||
129012220|NCT00220337|464338058|FG000|Overall Study|Lack of Efficacy|17|||
129101537|NCT00840034|464666186|FG001|Taper Phase|Adverse Event|0|||
128878418|NCT01853644|463848478|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
128878419|NCT02891408|463848479|FG000|Overall Study|Lost to Follow-up|0|||
128878420|NCT02891408|463848480|FG001|Overall Study|Lost to Follow-up|0|||
128878421|NCT02891408|463848481|FG002|Overall Study|Lost to Follow-up|1|||
128878422|NCT02891408|463848482|FG003|Overall Study|Lost to Follow-up|0|||
128878423|NCT02891408|463848483|FG004|Overall Study|Lost to Follow-up|0|||
128878424|NCT02891408|463848484|FG005|Overall Study|Lost to Follow-up|0|||
128878425|NCT02891408|463848485|FG006|Overall Study|Lost to Follow-up|0|||
128878426|NCT01442779|463848486|FG000|Overall Study|Withdrawal by Subject|3|||
128878427|NCT01442779|463848486|FG000|Overall Study|Death|3|||
128878428|NCT01442779|463848486|FG000|Overall Study|Non-compliance|1|||
128878429|NCT02372136|463848487|FG000|Overall Study|Death|3|||
128878430|NCT02372136|463848488|FG001|Overall Study|Death|1|||
128878431|NCT00985946|463848489|FG000|Overall Study|Lost to Follow-up|6|||
128878432|NCT00985946|463848489|FG000|Overall Study|Withdrawal by Subject|1|||
128878433|NCT02471833|463848490|FG000|Overall Study|Lost to Follow-up|1|||
128878434|NCT02471833|463848491|FG001|Overall Study|Lost to Follow-up|0|||
128878435|NCT02471833|463848492|FG002|Overall Study|Lost to Follow-up|0|||
128878436|NCT02471833|463848490|FG000|Overall Study|Withdrawal by Subject|2|||
128878437|NCT02471833|463848491|FG001|Overall Study|Withdrawal by Subject|1|||
128878438|NCT02471833|463848492|FG002|Overall Study|Withdrawal by Subject|5|||
128878439|NCT02673515|463848496|FG000|Overall Study|Lack of motivation|2|||
128878440|NCT02673515|463848497|FG001|Overall Study|Lack of motivation|1|||
128878441|NCT03965351|463848499|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
128878442|NCT03965351|463848500|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
128677987|NCT03188042|463120300|FG000|Overall Study|Withdrawal by Subject|1|||
128677988|NCT03188042|463120301|FG001|Overall Study|Withdrawal by Subject|1|||
128677989|NCT01475071|463120305|FG000|Overall Study|Physician Decision|1|||
128677990|NCT01475071|463120305|FG000|Overall Study|Withdrawal by Subject|6|||
128677991|NCT01475071|463120305|FG000|Overall Study|Lost to Follow-up|1|||
128677992|NCT01343823|463120306|FG000|Overall Study|Study Terminated|1|||
128677993|NCT01343823|463120307|FG001|Overall Study|Study Terminated|0|||
128677994|NCT01343823|463120308|FG002|Overall Study|Study Terminated|0|||
128677995|NCT01343823|463120309|FG003|Overall Study|Study Terminated|1|||
128677996|NCT01343823|463120306|FG000|Overall Study|Withdrawal by Subject|1|||
128677997|NCT01343823|463120307|FG001|Overall Study|Withdrawal by Subject|0|||
128677998|NCT01343823|463120308|FG002|Overall Study|Withdrawal by Subject|0|||
128677999|NCT01343823|463120309|FG003|Overall Study|Withdrawal by Subject|0|||
128678000|NCT00923364|463120310|FG000|Overall Study|Death|3|||
128678001|NCT00923364|463120311|FG001|Overall Study|Death|0|||
128678002|NCT00923364|463120310|FG000|Overall Study|Did not go to transplant|1|||
128678003|NCT00923364|463120311|FG001|Overall Study|Did not go to transplant|0|||
128678004|NCT00779259|463120312|FG000|Quinine Alone|Adverse Event|2|||
128678005|NCT01534182|463120315|FG000|Overall Study|Administrative problems|1|||
128678006|NCT01534182|463120316|FG001|Overall Study|Administrative problems|0|||
128678007|NCT01534182|463120315|FG000|Overall Study|Withdrawal by Subject|4|||
128678008|NCT01534182|463120316|FG001|Overall Study|Withdrawal by Subject|7|||
128678009|NCT01534182|463120315|FG000|Overall Study|Adverse Event|7|||
128678010|NCT01534182|463120316|FG001|Overall Study|Adverse Event|3|||
128678011|NCT00674154|463120317|FG000|Overall Study|Withdrawal by Subject|3|||
128678012|NCT00674154|463120318|FG001|Overall Study|Withdrawal by Subject|1|||
128678013|NCT00674154|463120317|FG000|Overall Study|Did not want parathyroidectomy|0|||
128678014|NCT00674154|463120318|FG001|Overall Study|Did not want parathyroidectomy|2|||
128678015|NCT00924170|463120322|FG000|Overall Study|Refused further treatment|0|||
128678016|NCT00924170|463120323|FG001|Overall Study|Refused further treatment|1|||
128678017|NCT00924170|463120322|FG000|Overall Study|Physician Decision|0|||
128678018|NCT00924170|463120323|FG001|Overall Study|Physician Decision|1|||
128678019|NCT00924170|463120322|FG000|Overall Study|Progressive disease|3|||
128678020|NCT00924170|463120323|FG001|Overall Study|Progressive disease|6|||
128678021|NCT00924170|463120322|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
128678022|NCT00924170|463120323|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
128678023|NCT00924170|463120322|FG000|Overall Study|Death|1|||
128878443|NCT03965351|463848499|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
128878444|NCT03965351|463848500|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
128878445|NCT00490724|463848501|FG000|Period I|Physician Decision|0|||
129101538|NCT00840034|464666185|FG000|Taper Phase|Lost to Follow-up|1|||
129101539|NCT00840034|464666186|FG001|Taper Phase|Lost to Follow-up|1|||
129101540|NCT00840034|464666185|FG000|Taper Phase|Withdrawal by Subject|1|||
129101541|NCT00840034|464666186|FG001|Taper Phase|Withdrawal by Subject|1|||
129101542|NCT04399538|464666187|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
128678024|NCT00924170|463120323|FG001|Overall Study|Death|0|||
128678025|NCT02025556|463120327|FG000|Overall Study|Adverse Event|0|||
128678026|NCT02025556|463120328|FG001|Overall Study|Adverse Event|4|||
128678027|NCT02025556|463120329|FG002|Overall Study|Adverse Event|2|||
128678028|NCT02025556|463120327|FG000|Overall Study|Lack of Efficacy|2|||
128678029|NCT02025556|463120328|FG001|Overall Study|Lack of Efficacy|1|||
128878446|NCT00490724|463848502|FG001|Period I|Physician Decision|0|||
129101543|NCT04399538|464666188|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
129101544|NCT04399538|464666189|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
129101545|NCT04399538|464666190|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
129101546|NCT04399538|464666191|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
129101547|NCT04399538|464666187|FG000|Double-Blind Treatment|Adverse Event|0|||
129101548|NCT04399538|464666188|FG001|Double-Blind Treatment|Adverse Event|0|||
129101549|NCT04399538|464666189|FG002|Double-Blind Treatment|Adverse Event|0|||
129101550|NCT04399538|464666190|FG003|Double-Blind Treatment|Adverse Event|0|||
129101551|NCT04399538|464666191|FG004|Double-Blind Treatment|Adverse Event|1|||
129101552|NCT04399538|464666187|FG000|Follow-Up|Adverse Event|0|||
129101553|NCT04399538|464666188|FG001|Follow-Up|Adverse Event|0|||
129101554|NCT04399538|464666189|FG002|Follow-Up|Adverse Event|0|||
129101555|NCT04399538|464666190|FG003|Follow-Up|Adverse Event|0|||
129101556|NCT04399538|464666191|FG004|Follow-Up|Adverse Event|1|||
129101557|NCT04399538|464666187|FG000|Follow-Up|Withdrawal by Subject|0|||
129101558|NCT04399538|464666188|FG001|Follow-Up|Withdrawal by Subject|0|||
129101559|NCT04399538|464666189|FG002|Follow-Up|Withdrawal by Subject|0|||
129101560|NCT04399538|464666190|FG003|Follow-Up|Withdrawal by Subject|2|||
129101561|NCT04399538|464666191|FG004|Follow-Up|Withdrawal by Subject|0|||
129101562|NCT01215435|464666192|FG000|Overall Study|Adverse Event|1|||
129101563|NCT01215435|464666193|FG001|Overall Study|Adverse Event|0|||
129101564|NCT01215435|464666192|FG000|Overall Study|Protocol Violation|2|||
129101565|NCT01215435|464666193|FG001|Overall Study|Protocol Violation|0|||
129101566|NCT01215435|464666192|FG000|Overall Study|Withdrawal Criteria|8|||
129101567|NCT01215435|464666193|FG001|Overall Study|Withdrawal Criteria|11|||
129101568|NCT01215435|464666192|FG000|Overall Study|Lost to Follow-up|3|||
129101569|NCT01215435|464666193|FG001|Overall Study|Lost to Follow-up|0|||
129101570|NCT01215435|464666192|FG000|Overall Study|Unclassified|5|||
129101571|NCT01215435|464666193|FG001|Overall Study|Unclassified|5|||
129101572|NCT00636961|464666206|FG000|Period 1|Administrative problems|1|||
129101573|NCT00636961|464666207|FG001|Period 1|Administrative problems|1|||
129101574|NCT00636961|464666206|FG000|Period 2|Adverse Event|1|||
129101575|NCT00636961|464666207|FG001|Period 2|Adverse Event|0|||
129101576|NCT02179749|464666209|FG000|Overall Study|Adverse Event|0|||
129101577|NCT02179749|464666210|FG001|Overall Study|Adverse Event|0|||
129101578|NCT02179749|464666211|FG002|Overall Study|Adverse Event|1|||
129101579|NCT02179749|464666209|FG000|Overall Study|Withdrawal by Subject|0|||
129101580|NCT02179749|464666210|FG001|Overall Study|Withdrawal by Subject|0|||
129101581|NCT02179749|464666211|FG002|Overall Study|Withdrawal by Subject|1|||
129101582|NCT02756364|464666213|FG000|Overall Study|Site Terminated by Sponsor|24|||
129101583|NCT02756364|464666214|FG001|Overall Study|Site Terminated by Sponsor|30|||
129101584|NCT02756364|464666215|FG002|Overall Study|Site Terminated by Sponsor|21|||
129101585|NCT02756364|464666213|FG000|Overall Study|Death|20|||
129101586|NCT02756364|464666214|FG001|Overall Study|Death|15|||
129101587|NCT02756364|464666215|FG002|Overall Study|Death|18|||
129101588|NCT02756364|464666213|FG000|Overall Study|Withdrawal by Patient|2|||
129101589|NCT02756364|464666214|FG001|Overall Study|Withdrawal by Patient|1|||
129101590|NCT02756364|464666215|FG002|Overall Study|Withdrawal by Patient|8|||
129101591|NCT02756364|464666213|FG000|Overall Study|Lost to Follow-up|0|||
129101592|NCT02756364|464666214|FG001|Overall Study|Lost to Follow-up|1|||
128678030|NCT02025556|463120329|FG002|Overall Study|Lack of Efficacy|0|||
129101593|NCT02756364|464666215|FG002|Overall Study|Lost to Follow-up|1|||
129101594|NCT02223364|464666216|FG000|Overall Study|Protocol Violation|3|||
129101595|NCT02223364|464666217|FG001|Overall Study|Protocol Violation|0|||
129101596|NCT02223364|464666218|FG002|Overall Study|Protocol Violation|3|||
129101597|NCT02223364|464666216|FG000|Overall Study|subject expired before surgery|1|||
129101598|NCT02223364|464666217|FG001|Overall Study|subject expired before surgery|0|||
128678031|NCT02025556|463120327|FG000|Overall Study|Protocol Violation|2|||
128678032|NCT02025556|463120328|FG001|Overall Study|Protocol Violation|1|||
128678033|NCT02025556|463120329|FG002|Overall Study|Protocol Violation|0|||
129101599|NCT02223364|464666218|FG002|Overall Study|subject expired before surgery|0|||
129101600|NCT02223364|464666216|FG000|Overall Study|Physician Decision|1|||
129101601|NCT02223364|464666217|FG001|Overall Study|Physician Decision|0|||
128878447|NCT00490724|463848503|FG002|Period I|Physician Decision|1|||
128678034|NCT02025556|463120327|FG000|Overall Study|Withdrawal by Subject|0|||
129101602|NCT02223364|464666218|FG002|Overall Study|Physician Decision|0|||
129101603|NCT00793546|464666219|FG000|Overall Study|Death|3|||
129101604|NCT00793546|464666220|FG001|Overall Study|Death|0|||
129101605|NCT00793546|464666219|FG000|Overall Study|Lost to Follow-up|1|||
129101606|NCT00793546|464666220|FG001|Overall Study|Lost to Follow-up|0|||
129101607|NCT00793546|464666219|FG000|Overall Study|Withdrawal by Subject|1|||
129101608|NCT00793546|464666220|FG001|Overall Study|Withdrawal by Subject|1|||
129101609|NCT00793546|464666219|FG000|Overall Study|Study Terminated by Sponsor|8|||
128678035|NCT02025556|463120328|FG001|Overall Study|Withdrawal by Subject|3|||
129101610|NCT00793546|464666220|FG001|Overall Study|Study Terminated by Sponsor|27|||
129101611|NCT00793546|464666219|FG000|Overall Study|Other|1|||
129101612|NCT00793546|464666220|FG001|Overall Study|Other|0|||
129101613|NCT01841567|464666221|FG000|Overall Study|Adverse Event|3|||
129101614|NCT01416155|464666222|FG000|Overall Study|Adverse Event|8|||
129101615|NCT01416155|464666222|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
128678036|NCT02025556|463120329|FG002|Overall Study|Withdrawal by Subject|6|||
128678037|NCT02025556|463120327|FG000|Overall Study|Lost to Follow-up|2|||
128678038|NCT02025556|463120328|FG001|Overall Study|Lost to Follow-up|4|||
128678039|NCT02025556|463120329|FG002|Overall Study|Lost to Follow-up|0|||
128678040|NCT02025556|463120327|FG000|Overall Study|Reason not reported|0|||
128678041|NCT02025556|463120328|FG001|Overall Study|Reason not reported|0|||
128678042|NCT02025556|463120329|FG002|Overall Study|Reason not reported|1|||
128678043|NCT01203852|463120334|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
128678044|NCT01203852|463120334|FG000|Washout 2 Weeks|Physician Decision|46|||
128678045|NCT01903252|463120337|FG000|Double-Blind Induction|Adverse Event|20|||
128678046|NCT01903252|463120338|FG001|Double-Blind Induction|Adverse Event|18|||
128678047|NCT01903252|463120339|FG002|Double-Blind Induction|Adverse Event|0|||
128678048|NCT01903252|463120340|FG003|Double-Blind Induction|Adverse Event|0|||
128678049|NCT01903252|463120341|FG004|Double-Blind Induction|Adverse Event|0|||
128678050|NCT01903252|463120342|FG005|Double-Blind Induction|Adverse Event|0|||
128678051|NCT01903252|463120337|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
129012221|NCT00220337|464338058|FG000|Overall Study|Withdrawal by Subject|68|||
129012222|NCT00220337|464338058|FG000|Overall Study|Protocol Violation|2|||
129012223|NCT00220337|464338058|FG000|Overall Study|Lost to Follow-up|5|||
129012224|NCT00220337|464338058|FG000|Overall Study|Other|12|||
129012225|NCT00220337|464338058|FG000|Overall Study|Unsatisfactory compliance|5|||
129012226|NCT00659607|464338061|FG000|Overall Study|No blood pressure recorded|147|||
129012227|NCT00659607|464338061|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
129012228|NCT00659607|464338061|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
129012229|NCT00659607|464338061|FG000|Overall Study|No recorded efficacy data|15|||
129012230|NCT00659607|464338061|FG000|Overall Study|Inconsistent BP measuring date|2|||
129012231|NCT02191891|464338062|FG000|Overall Study|Withdrawal by Subject|0|||
129012232|NCT02191891|464338063|FG001|Overall Study|Withdrawal by Subject|1|||
129012233|NCT02191891|464338064|FG002|Overall Study|Withdrawal by Subject|0|||
129012234|NCT02191891|464338065|FG003|Overall Study|Withdrawal by Subject|0|||
129012235|NCT02191891|464338066|FG004|Overall Study|Withdrawal by Subject|1|||
129012236|NCT02191891|464338062|FG000|Overall Study|Adverse Event|0|||
129012237|NCT02191891|464338063|FG001|Overall Study|Adverse Event|1|||
129012238|NCT02191891|464338064|FG002|Overall Study|Adverse Event|0|||
129012239|NCT02191891|464338065|FG003|Overall Study|Adverse Event|0|||
129012240|NCT02191891|464338066|FG004|Overall Study|Adverse Event|2|||
129012241|NCT02191891|464338062|FG000|Overall Study|Disease Progression|4|||
129012242|NCT02191891|464338063|FG001|Overall Study|Disease Progression|10|||
129012243|NCT02191891|464338064|FG002|Overall Study|Disease Progression|4|||
129012244|NCT02191891|464338065|FG003|Overall Study|Disease Progression|2|||
129012245|NCT02191891|464338066|FG004|Overall Study|Disease Progression|7|||
129012246|NCT00486837|464338067|FG000|Overall Study|Withdrawal by Subject|1|||
129012247|NCT00486837|464338068|FG001|Overall Study|Withdrawal by Subject|0|||
129012248|NCT00486837|464338067|FG000|Overall Study|Adverse Event|1|||
129012249|NCT00486837|464338068|FG001|Overall Study|Adverse Event|1|||
129012250|NCT00486837|464338067|FG000|Overall Study|Protocol Violation|4|||
129012251|NCT00486837|464338068|FG001|Overall Study|Protocol Violation|2|||
129012252|NCT00486837|464338067|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
129012253|NCT00486837|464338068|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
129012254|NCT02468778|464338071|FG000|Overall Study|Death|2|||
129012255|NCT02468778|464338072|FG001|Overall Study|Death|1|||
129012256|NCT02468778|464338073|FG002|Overall Study|Death|0|||
129012257|NCT02468778|464338071|FG000|Overall Study|Lost to Follow-up|1|||
129012258|NCT02468778|464338072|FG001|Overall Study|Lost to Follow-up|2|||
129012259|NCT02468778|464338073|FG002|Overall Study|Lost to Follow-up|2|||
129012260|NCT02468778|464338071|FG000|Overall Study|Withdrawal by Subject|0|||
129012261|NCT02468778|464338072|FG001|Overall Study|Withdrawal by Subject|1|||
129012262|NCT02468778|464338073|FG002|Overall Study|Withdrawal by Subject|1|||
129012263|NCT03130699|464338081|FG000|Overall Study|Lost to Follow-up|34|||
129012264|NCT03130699|464338082|FG001|Overall Study|Lost to Follow-up|37|||
129012265|NCT03130699|464338083|FG002|Overall Study|Lost to Follow-up|26|||
129012266|NCT03130699|464338081|FG000|Overall Study|Withdrawal by Subject|5|||
129012267|NCT03130699|464338082|FG001|Overall Study|Withdrawal by Subject|1|||
129012268|NCT03130699|464338083|FG002|Overall Study|Withdrawal by Subject|0|||
129012269|NCT03130699|464338081|FG000|Overall Study|Withdrawal by PI|1|||
129012270|NCT03130699|464338082|FG001|Overall Study|Withdrawal by PI|2|||
129012271|NCT03130699|464338083|FG002|Overall Study|Withdrawal by PI|5|||
129012272|NCT03130699|464338081|FG000|Overall Study|Death|0|||
129012273|NCT03130699|464338082|FG001|Overall Study|Death|0|||
128678052|NCT01903252|463120338|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
129012274|NCT03130699|464338083|FG002|Overall Study|Death|1|||
129012275|NCT01199861|464338084|FG000|Overall Study|Administrative problems|1|||
129012276|NCT01199861|464338085|FG001|Overall Study|Administrative problems|0|||
128678053|NCT01903252|463120339|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
128678054|NCT01903252|463120340|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
129012277|NCT01199861|464338084|FG000|Overall Study|Adverse Event|1|||
129012278|NCT01199861|464338085|FG001|Overall Study|Adverse Event|0|||
129012279|NCT00669864|464338086|FG000|Overall Study|Lost to Follow-up|2|||
129101616|NCT01416155|464666222|FG000|Overall Study|Withdrawal by Subject|33|||
129101617|NCT01416155|464666222|FG000|Overall Study|Investigator decision|8|||
129101618|NCT01416155|464666222|FG000|Overall Study|Other|7|||
129101619|NCT02984267|464666227|FG000|Overall Study|Protocol Violation|1|||
129101620|NCT02984267|464666228|FG001|Overall Study|Protocol Violation|0|||
129101621|NCT02984267|464666227|FG000|Overall Study|Withdrawal by Subject|0|||
129101622|NCT02984267|464666228|FG001|Overall Study|Withdrawal by Subject|1|||
129101623|NCT00742027|464666229|FG000|Overall Study|Disease Progression|76|||
129101624|NCT00742027|464666229|FG000|Overall Study|New Cancer Therapy|19|||
128678055|NCT01903252|463120341|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
128678056|NCT01903252|463120342|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
128678057|NCT01903252|463120337|FG000|Double-Blind Induction|Physician Decision|2|||
128678058|NCT01903252|463120338|FG001|Double-Blind Induction|Physician Decision|3|||
128678059|NCT01903252|463120339|FG002|Double-Blind Induction|Physician Decision|0|||
128678060|NCT01903252|463120340|FG003|Double-Blind Induction|Physician Decision|0|||
128678061|NCT01903252|463120341|FG004|Double-Blind Induction|Physician Decision|0|||
128678062|NCT01903252|463120342|FG005|Double-Blind Induction|Physician Decision|0|||
128678063|NCT01903252|463120337|FG000|Double-Blind Induction|non-compliance,|7|||
129101625|NCT00742027|464666229|FG000|Overall Study|Withdrawal by Subject|18|||
129101626|NCT00742027|464666229|FG000|Overall Study|Death|7|||
129101627|NCT00742027|464666229|FG000|Overall Study|Lost to Follow-up|4|||
129101628|NCT00742027|464666229|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
129101629|NCT00742027|464666229|FG000|Overall Study|Missing|2|||
129101630|NCT00742027|464666229|FG000|Overall Study|Administrative Problems|1|||
129101631|NCT03597139|464666230|FG000|Overall Study|Adverse Event|3|||
129101632|NCT03597139|464666231|FG001|Overall Study|Adverse Event|0|||
128678064|NCT01903252|463120338|FG001|Double-Blind Induction|non-compliance,|7|||
128678065|NCT01903252|463120339|FG002|Double-Blind Induction|non-compliance,|0|||
128678066|NCT01903252|463120340|FG003|Double-Blind Induction|non-compliance,|0|||
128678067|NCT01903252|463120341|FG004|Double-Blind Induction|non-compliance,|0|||
128678068|NCT01903252|463120342|FG005|Double-Blind Induction|non-compliance,|0|||
128678069|NCT01903252|463120337|FG000|Extended Induction, Open-Label|Adverse Event|0|||
128678070|NCT01903252|463120338|FG001|Extended Induction, Open-Label|Adverse Event|0|||
128678071|NCT01903252|463120339|FG002|Extended Induction, Open-Label|Adverse Event|17|||
128678072|NCT01903252|463120340|FG003|Extended Induction, Open-Label|Adverse Event|0|||
128678073|NCT01903252|463120341|FG004|Extended Induction, Open-Label|Adverse Event|0|||
128678074|NCT01903252|463120342|FG005|Extended Induction, Open-Label|Adverse Event|0|||
128678075|NCT01903252|463120337|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
128678076|NCT01903252|463120338|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
128678077|NCT01903252|463120339|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
128678078|NCT01903252|463120340|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
128678079|NCT01903252|463120341|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
128678080|NCT01903252|463120342|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
128678081|NCT01903252|463120337|FG000|Extended Induction, Open-Label|Physician Decision|0|||
128678082|NCT01903252|463120338|FG001|Extended Induction, Open-Label|Physician Decision|0|||
128678083|NCT01903252|463120339|FG002|Extended Induction, Open-Label|Physician Decision|1|||
128678084|NCT01903252|463120340|FG003|Extended Induction, Open-Label|Physician Decision|0|||
128678085|NCT01903252|463120341|FG004|Extended Induction, Open-Label|Physician Decision|0|||
128678086|NCT01903252|463120342|FG005|Extended Induction, Open-Label|Physician Decision|0|||
128678087|NCT01903252|463120337|FG000|Maintenance, Open-Label|Adverse Event|0|||
128678088|NCT01903252|463120338|FG001|Maintenance, Open-Label|Adverse Event|0|||
128678089|NCT01903252|463120339|FG002|Maintenance, Open-Label|Adverse Event|0|||
128678090|NCT01903252|463120340|FG003|Maintenance, Open-Label|Adverse Event|3|||
128678091|NCT01903252|463120341|FG004|Maintenance, Open-Label|Adverse Event|9|||
128678092|NCT01903252|463120342|FG005|Maintenance, Open-Label|Adverse Event|14|||
128678093|NCT01903252|463120337|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
128678094|NCT01903252|463120338|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
128678095|NCT01903252|463120339|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
128678096|NCT01903252|463120340|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
128678097|NCT01903252|463120341|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
128678098|NCT01903252|463120342|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
128678099|NCT01903252|463120337|FG000|Maintenance, Open-Label|Other|0|||
128678100|NCT01903252|463120338|FG001|Maintenance, Open-Label|Other|0|||
128678101|NCT01903252|463120339|FG002|Maintenance, Open-Label|Other|0|||
128678102|NCT01903252|463120340|FG003|Maintenance, Open-Label|Other|2|||
128678103|NCT01903252|463120341|FG004|Maintenance, Open-Label|Other|6|||
128678104|NCT01903252|463120342|FG005|Maintenance, Open-Label|Other|2|||
128678105|NCT01381562|463120343|FG000|Overall Study|Adverse Event|0|||
129101633|NCT03597139|464666230|FG000|Overall Study|Protocol Non-compliance|1|||
129101634|NCT03597139|464666231|FG001|Overall Study|Protocol Non-compliance|0|||
129101635|NCT00520767|464666232|FG000|Overall Study|Death|2|||
129101636|NCT00382109|464666235|FG000|Overall Study|Adverse Event|3|||
129101637|NCT00382109|464666236|FG001|Overall Study|Adverse Event|0|||
129101638|NCT00382109|464666235|FG000|Overall Study|Physician Decision|6|||
129101639|NCT00382109|464666236|FG001|Overall Study|Physician Decision|1|||
128678106|NCT01381562|463120344|FG001|Overall Study|Adverse Event|1|||
128678107|NCT01381562|463120345|FG002|Overall Study|Adverse Event|0|||
128678108|NCT01642732|463120346|FG000|Overall Study|Withdrawal by Subject|1|||
128678109|NCT00053898|463120354|FG000|Overall Study|No follow-up data from any source|9|||
128678110|NCT00053898|463120355|FG001|Overall Study|No follow-up data from any source|12|||
128678111|NCT00053898|463120354|FG000|Overall Study|Follow-up from telephone contact only|5|||
128678112|NCT00053898|463120355|FG001|Overall Study|Follow-up from telephone contact only|1|||
128678113|NCT01077375|463120362|FG000|Overall Study|Adverse Event|2|||
128678114|NCT01077375|463120363|FG001|Overall Study|Adverse Event|15|||
128678115|NCT01077375|463120362|FG000|Overall Study|Lack of Efficacy|6|||
128678116|NCT01077375|463120363|FG001|Overall Study|Lack of Efficacy|8|||
128678117|NCT01077375|463120362|FG000|Overall Study|Withdrawal by Subject|0|||
128678118|NCT01077375|463120363|FG001|Overall Study|Withdrawal by Subject|6|||
128678119|NCT01077375|463120362|FG000|Overall Study|Lost to Follow-up|2|||
128678120|NCT01077375|463120363|FG001|Overall Study|Lost to Follow-up|5|||
128678121|NCT01077375|463120362|FG000|Overall Study|Other Reason|0|||
128678122|NCT01077375|463120363|FG001|Overall Study|Other Reason|1|||
128678123|NCT01924429|463120364|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
128678124|NCT01924429|463120365|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
128678125|NCT00906971|463120366|FG000|Overall Study|Withdrawal by Subject|8|||
128678126|NCT00906971|463120367|FG001|Overall Study|Withdrawal by Subject|2|||
128678127|NCT00906971|463120366|FG000|Overall Study|Lost to Follow-up|0|||
128678128|NCT00906971|463120367|FG001|Overall Study|Lost to Follow-up|1|||
128678129|NCT00545129|463120368|FG000|Overall Study|Lack of Efficacy|2|||
128678130|NCT00545129|463120369|FG001|Overall Study|Lack of Efficacy|5|||
128678131|NCT00545129|463120368|FG000|Overall Study|Death|2|||
128678132|NCT00545129|463120369|FG001|Overall Study|Death|1|||
128678133|NCT00545129|463120368|FG000|Overall Study|Adverse Event|1|||
128678134|NCT00545129|463120369|FG001|Overall Study|Adverse Event|1|||
128678135|NCT00545129|463120368|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
128678136|NCT00545129|463120369|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
128678137|NCT00545129|463120368|FG000|Overall Study|Other|3|||
128678138|NCT00545129|463120369|FG001|Overall Study|Other|3|||
128678139|NCT01894568|463120370|FG000|Overall Study|Adverse Event|2|||
128678140|NCT01894568|463120371|FG001|Overall Study|Adverse Event|3|||
128678141|NCT01894568|463120370|FG000|Overall Study|Protocol required discontinuation|2|||
128678142|NCT01894568|463120371|FG001|Overall Study|Protocol required discontinuation|1|||
128678143|NCT01894568|463120370|FG000|Overall Study|Withdrawal by Subject|5|||
128678144|NCT01894568|463120371|FG001|Overall Study|Withdrawal by Subject|5|||
128678145|NCT01894568|463120370|FG000|Overall Study|Physician Decision|1|||
128678146|NCT01894568|463120371|FG001|Overall Study|Physician Decision|0|||
128678147|NCT01894568|463120370|FG000|Overall Study|Lost to Follow-up|0|||
128678148|NCT01894568|463120371|FG001|Overall Study|Lost to Follow-up|1|||
128678149|NCT01514370|463120374|FG000|Overall Study|Protocol Violation|2|||
128678150|NCT01514370|463120375|FG001|Overall Study|Protocol Violation|3|||
128678151|NCT01514370|463120374|FG000|Overall Study|Lost to Follow-up|0|||
128678152|NCT01514370|463120375|FG001|Overall Study|Lost to Follow-up|2|||
128678153|NCT01514370|463120374|FG000|Overall Study|Withdrawal by Subject|2|||
128678154|NCT01514370|463120375|FG001|Overall Study|Withdrawal by Subject|1|||
128678155|NCT01514370|463120374|FG000|Overall Study|Adverse Event|1|||
128678156|NCT01514370|463120375|FG001|Overall Study|Adverse Event|3|||
128678157|NCT01514370|463120374|FG000|Overall Study|Other|6|||
128678158|NCT01514370|463120375|FG001|Overall Study|Other|7|||
128678159|NCT01551420|463120376|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
128678160|NCT01551420|463120377|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
128678161|NCT01551420|463120376|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
128678162|NCT01551420|463120377|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
128678163|NCT01551420|463120376|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
128678164|NCT01551420|463120377|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
128678165|NCT01551420|463120376|FG000|Screened for Part B Eligibility|Declined participation|8|||
128678166|NCT01551420|463120377|FG001|Screened for Part B Eligibility|Declined participation|1|||
128678167|NCT01551420|463120376|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
128678168|NCT01551420|463120377|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
128678169|NCT01551420|463120376|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
128678170|NCT01551420|463120377|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
128678171|NCT01551420|463120376|FG000|Home Use (Part B)|Withdrawal by staff|0|||
129012280|NCT00669864|464338086|FG000|Overall Study|Protocol Violation|2|||
129012281|NCT00669864|464338086|FG000|Overall Study|Withdrawal by Subject|3|||
129012282|NCT00669864|464338086|FG000|Overall Study|Other|2|||
128678172|NCT01551420|463120377|FG001|Home Use (Part B)|Withdrawal by staff|1|||
128678173|NCT01606878|463120378|FG000|Overall Study|Adverse Event|1|||
129012283|NCT02545998|464338091|FG000|Overall Study|Lost to Follow-up|12|||
128678174|NCT01606878|463120379|FG001|Overall Study|Adverse Event|1|||
128678175|NCT01606878|463120380|FG002|Overall Study|Adverse Event|0|||
128678176|NCT01606878|463120381|FG003|Overall Study|Adverse Event|0|||
128678177|NCT01606878|463120382|FG004|Overall Study|Adverse Event|0|||
129012284|NCT02545998|464338092|FG001|Overall Study|Lost to Follow-up|3|||
128678178|NCT01606878|463120383|FG005|Overall Study|Adverse Event|0|||
128678179|NCT01606878|463120384|FG006|Overall Study|Adverse Event|1|||
128678180|NCT01606878|463120385|FG007|Overall Study|Adverse Event|0|||
128678181|NCT01606878|463120386|FG008|Overall Study|Adverse Event|1|||
128678182|NCT01606878|463120387|FG009|Overall Study|Adverse Event|3|||
128678183|NCT01606878|463120388|FG010|Overall Study|Adverse Event|0|||
128678184|NCT01606878|463120378|FG000|Overall Study|Lack of Efficacy|1|||
128678185|NCT01606878|463120379|FG001|Overall Study|Lack of Efficacy|1|||
128678186|NCT01606878|463120380|FG002|Overall Study|Lack of Efficacy|1|||
128678187|NCT01606878|463120381|FG003|Overall Study|Lack of Efficacy|2|||
128678188|NCT01606878|463120382|FG004|Overall Study|Lack of Efficacy|1|||
128678189|NCT01606878|463120383|FG005|Overall Study|Lack of Efficacy|2|||
128678190|NCT01606878|463120384|FG006|Overall Study|Lack of Efficacy|1|||
128678191|NCT01606878|463120385|FG007|Overall Study|Lack of Efficacy|2|||
128678192|NCT01606878|463120386|FG008|Overall Study|Lack of Efficacy|2|||
128678193|NCT01606878|463120387|FG009|Overall Study|Lack of Efficacy|0|||
128678194|NCT01606878|463120388|FG010|Overall Study|Lack of Efficacy|1|||
128678195|NCT01606878|463120378|FG000|Overall Study|Physician Decision|1|||
128678196|NCT01606878|463120379|FG001|Overall Study|Physician Decision|0|||
128678197|NCT01606878|463120380|FG002|Overall Study|Physician Decision|2|||
128678198|NCT01606878|463120381|FG003|Overall Study|Physician Decision|1|||
128678199|NCT01606878|463120382|FG004|Overall Study|Physician Decision|1|||
128678200|NCT01606878|463120383|FG005|Overall Study|Physician Decision|1|||
128678201|NCT01606878|463120384|FG006|Overall Study|Physician Decision|2|||
128678202|NCT01606878|463120385|FG007|Overall Study|Physician Decision|0|||
128678203|NCT01606878|463120386|FG008|Overall Study|Physician Decision|1|||
128678204|NCT01606878|463120387|FG009|Overall Study|Physician Decision|0|||
128678205|NCT01606878|463120388|FG010|Overall Study|Physician Decision|0|||
128678206|NCT01606878|463120378|FG000|Overall Study|Withdrawal by Subject|3|||
128678207|NCT01606878|463120379|FG001|Overall Study|Withdrawal by Subject|2|||
128678208|NCT01606878|463120380|FG002|Overall Study|Withdrawal by Subject|2|||
128678209|NCT01606878|463120381|FG003|Overall Study|Withdrawal by Subject|0|||
128678210|NCT01606878|463120382|FG004|Overall Study|Withdrawal by Subject|1|||
128678211|NCT01606878|463120383|FG005|Overall Study|Withdrawal by Subject|1|||
128678212|NCT01606878|463120384|FG006|Overall Study|Withdrawal by Subject|2|||
128678213|NCT01606878|463120385|FG007|Overall Study|Withdrawal by Subject|1|||
128678214|NCT01606878|463120386|FG008|Overall Study|Withdrawal by Subject|2|||
128678215|NCT01606878|463120387|FG009|Overall Study|Withdrawal by Subject|0|||
128678216|NCT01606878|463120388|FG010|Overall Study|Withdrawal by Subject|2|||
128678217|NCT00002931|463122098|FG000|Overall Study|rapidly progressing disease during|2|||
128678218|NCT01879579|463122099|FG000|Overall Study|Phone incompatible with texting platform|3|||
128678219|NCT01879579|463122100|FG001|Overall Study|Phone incompatible with texting platform|0|||
128678220|NCT01879579|463122099|FG000|Overall Study|Did not enroll in texting platform|1|||
128678221|NCT01879579|463122100|FG001|Overall Study|Did not enroll in texting platform|0|||
128678222|NCT01879579|463122099|FG000|Overall Study|Did not initiate insulin treatment|1|||
128678223|NCT01879579|463122100|FG001|Overall Study|Did not initiate insulin treatment|0|||
128678224|NCT01879579|463122099|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
128678225|NCT01879579|463122100|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
128678226|NCT01879579|463122099|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
128678227|NCT01879579|463122100|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
128678228|NCT02292784|463122101|FG000|Overall Study|Lost to Follow-up|1|||
128678229|NCT02292784|463122102|FG001|Overall Study|Lost to Follow-up|17|||
128678230|NCT02292784|463122103|FG002|Overall Study|Lost to Follow-up|18|||
128678231|NCT02292784|463122101|FG000|Overall Study|Withdrawal by Subject|0|||
128678232|NCT02292784|463122102|FG001|Overall Study|Withdrawal by Subject|3|||
128678233|NCT02292784|463122103|FG002|Overall Study|Withdrawal by Subject|3|||
128678234|NCT01264081|463122104|FG000|Participants Screened|Screening failures|30|||
128678235|NCT01264081|463122104|FG000|Started Treatment|Withdrawal by Subject|1|||
128678236|NCT01264081|463122104|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
128678237|NCT00134784|463122105|FG000|Overall Study|Withdrawal by Subject|2|||
128678238|NCT00134784|463122106|FG001|Overall Study|Withdrawal by Subject|2|||
128678239|NCT00134784|463122107|FG002|Overall Study|Withdrawal by Subject|2|||
128678240|NCT00134784|463122108|FG003|Overall Study|Withdrawal by Subject|1|||
128678241|NCT02716896|463122109|FG000|Overall Study|Physician Decision|0|||
128678242|NCT02716896|463122110|FG001|Overall Study|Physician Decision|1|||
128678243|NCT00603590|463122114|FG000|Overall Study|Did not attend study clinic|39|||
128678244|NCT00603590|463122115|FG001|Overall Study|Did not attend study clinic|30|||
128678245|NCT00603590|463122114|FG000|Overall Study|Refused blood test|5|||
128678246|NCT00603590|463122115|FG001|Overall Study|Refused blood test|1|||
128678247|NCT00603590|463122114|FG000|Overall Study|Patient discontinued study drug|22|||
128678248|NCT00603590|463122115|FG001|Overall Study|Patient discontinued study drug|15|||
128678249|NCT00603590|463122114|FG000|Overall Study|Adverse Event|2|||
128678250|NCT00603590|463122115|FG001|Overall Study|Adverse Event|0|||
128678251|NCT00603590|463122114|FG000|Overall Study|Lost to Follow-up|8|||
128678252|NCT00603590|463122115|FG001|Overall Study|Lost to Follow-up|4|||
128678253|NCT00603590|463122114|FG000|Overall Study|Cardiovascular event|0|||
128678254|NCT00603590|463122115|FG001|Overall Study|Cardiovascular event|1|||
129101640|NCT00382109|464666235|FG000|Overall Study|Withdrawal by Subject|1|||
129101641|NCT00382109|464666236|FG001|Overall Study|Withdrawal by Subject|0|||
129101642|NCT00382109|464666235|FG000|Overall Study|ineligible|2|||
129101643|NCT00382109|464666236|FG001|Overall Study|ineligible|0|||
129101644|NCT00382109|464666235|FG000|Overall Study|Other|0|||
129101645|NCT00382109|464666236|FG001|Overall Study|Other|2|||
129101646|NCT00382109|464666235|FG000|Overall Study|consent withdrawal|0|||
129101647|NCT00382109|464666236|FG001|Overall Study|consent withdrawal|1|||
129101648|NCT01249833|464666237|FG000|Overall Study|Lost to Follow-up|0|||
129101649|NCT01249833|464666238|FG001|Overall Study|Lost to Follow-up|1|||
129101650|NCT03796676|464666239|FG000|Overall Study|Adverse Event|2|||
129101651|NCT03796676|464666240|FG001|Overall Study|Adverse Event|1|||
129101652|NCT03796676|464666241|FG002|Overall Study|Adverse Event|2|||
129101653|NCT03796676|464666239|FG000|Overall Study|Lost to Follow-up|2|||
129101654|NCT03796676|464666240|FG001|Overall Study|Lost to Follow-up|1|||
128678255|NCT03565367|463122116|FG000|Overall Study|No scan due to technical issues|4|||
128678256|NCT03565367|463122117|FG001|Overall Study|No scan due to technical issues|0|||
128678257|NCT00137839|463122123|FG000|Overall Study|Adverse Event|7|||
128878448|NCT00490724|463848501|FG000|Period II|Treatment Discontinuation|3|||
128878449|NCT00490724|463848502|FG001|Period II|Treatment Discontinuation|1|||
128678258|NCT00137839|463122123|FG000|Overall Study|Physician Decision|7|||
128678259|NCT00137839|463122123|FG000|Overall Study|Death|8|||
128678260|NCT00137839|463122123|FG000|Overall Study|Disease Progression|60|||
128678261|NCT00137839|463122123|FG000|Overall Study|Not Start Treatment|1|||
128678262|NCT00137839|463122123|FG000|Overall Study|Prolonged Treatment Delay|1|||
128878450|NCT00490724|463848503|FG002|Period II|Treatment Discontinuation|3|||
128878451|NCT00994682|463848504|FG000|Double Bilnd|Withdrawal by Subject|5|||
128878452|NCT00994682|463848505|FG001|Double Bilnd|Withdrawal by Subject|6|||
128878453|NCT00994682|463848504|FG000|Double Bilnd|Lost to Follow-up|3|||
128678263|NCT02882152|463122128|FG000|Overall Study|Lost to Follow-up|1|||
128678264|NCT02882152|463122129|FG001|Overall Study|Lost to Follow-up|0|||
128678265|NCT01011478|463122135|FG000|Overall Study|No follow up data|12|||
128678266|NCT01011478|463122136|FG001|Overall Study|No follow up data|7|||
128678267|NCT04352127|463122138|FG000|Overall Study|Unable to obtain readings|4|||
128678268|NCT04352127|463122139|FG001|Overall Study|Unable to obtain readings|1|||
128678269|NCT01437995|463122140|FG000|Overall Study|Lost to Follow-up|11|||
128678270|NCT01437995|463122141|FG001|Overall Study|Lost to Follow-up|18|||
128678271|NCT01437995|463122142|FG002|Overall Study|Lost to Follow-up|20|||
128678272|NCT05338671|463122143|FG000|Overall Study|Lost to Follow-up|2|||
128678273|NCT05338671|463122144|FG001|Overall Study|Lost to Follow-up|2|||
128678274|NCT05338671|463122143|FG000|Overall Study|Root canal completed in a single visit|1|||
128678275|NCT05338671|463122144|FG001|Overall Study|Root canal completed in a single visit|0|||
128678276|NCT04456673|463122145|FG000|Overall Study|Adverse Event|7|||
128678277|NCT04456673|463122146|FG001|Overall Study|Adverse Event|14|||
128678278|NCT04456673|463122145|FG000|Overall Study|Poor compliance to protocol|1|||
128678279|NCT04456673|463122146|FG001|Overall Study|Poor compliance to protocol|0|||
128678280|NCT04456673|463122145|FG000|Overall Study|Withdrawal by Subject|31|||
128678281|NCT04456673|463122146|FG001|Overall Study|Withdrawal by Subject|23|||
128678282|NCT04456673|463122145|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
128678283|NCT04456673|463122146|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
128678284|NCT04391049|463122147|FG000|Overall Study|Protocol Violation|1|||
128678285|NCT03874429|463122148|FG000|Overall Study|Adverse Event|2|||
128678286|NCT03874429|463122149|FG001|Overall Study|Adverse Event|2|||
128678287|NCT03874429|463122148|FG000|Overall Study|Lack of Efficacy|0|||
128678288|NCT03874429|463122149|FG001|Overall Study|Lack of Efficacy|1|||
128678289|NCT03874429|463122148|FG000|Overall Study|Covid-19 pandemic|4|||
128678290|NCT03874429|463122149|FG001|Overall Study|Covid-19 pandemic|2|||
128678291|NCT01215916|463122153|FG000|Overall Study|Progressive Disease|0|||
128678292|NCT01215916|463122154|FG001|Overall Study|Progressive Disease|2|||
128678293|NCT01215916|463122155|FG002|Overall Study|Progressive Disease|1|||
128678294|NCT01215916|463122156|FG003|Overall Study|Progressive Disease|2|||
128678295|NCT01215916|463122157|FG004|Overall Study|Progressive Disease|5|||
128878454|NCT00994682|463848505|FG001|Double Bilnd|Lost to Follow-up|3|||
128878455|NCT00994682|463848504|FG000|Double Bilnd|Adverse Event|1|||
128878456|NCT00994682|463848505|FG001|Double Bilnd|Adverse Event|0|||
128678296|NCT01215916|463122158|FG005|Overall Study|Progressive Disease|4|||
128678297|NCT01215916|463122159|FG006|Overall Study|Progressive Disease|5|||
128678298|NCT01215916|463122160|FG007|Overall Study|Progressive Disease|3|||
128678299|NCT01215916|463122161|FG008|Overall Study|Progressive Disease|1|||
128678300|NCT01215916|463122153|FG000|Overall Study|Adverse Event|1|||
128678301|NCT01215916|463122154|FG001|Overall Study|Adverse Event|1|||
128878457|NCT00994682|463848504|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
128878458|NCT00994682|463848505|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
129101655|NCT03796676|464666241|FG002|Overall Study|Lost to Follow-up|0|||
129101656|NCT03796676|464666239|FG000|Overall Study|Protocol Violation|0|||
129101657|NCT03796676|464666240|FG001|Overall Study|Protocol Violation|0|||
129101658|NCT03796676|464666241|FG002|Overall Study|Protocol Violation|1|||
128678302|NCT01215916|463122155|FG002|Overall Study|Adverse Event|0|||
129101659|NCT03796676|464666239|FG000|Overall Study|Withdrawal by Subject|1|||
128878459|NCT00994682|463848504|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
128878460|NCT00994682|463848505|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
128878461|NCT00994682|463848504|FG000|Pioglitazone Open Label|Physician Decision|6|||
128878462|NCT00994682|463848505|FG001|Pioglitazone Open Label|Physician Decision|1|||
128878463|NCT00153062|463850398|FG000|Overall Study|Death|360|||
128878464|NCT00153062|463850399|FG001|Overall Study|Death|352|||
128878465|NCT00153062|463850400|FG002|Overall Study|Death|369|||
128878466|NCT00153062|463850401|FG003|Overall Study|Death|365|||
128878467|NCT00153062|463850398|FG000|Overall Study|Withdrawal by Subject|14|||
128878468|NCT00153062|463850399|FG001|Overall Study|Withdrawal by Subject|30|||
128878469|NCT00153062|463850400|FG002|Overall Study|Withdrawal by Subject|27|||
128878470|NCT00153062|463850401|FG003|Overall Study|Withdrawal by Subject|28|||
128878471|NCT00153062|463850398|FG000|Overall Study|Lost to Follow-up|12|||
128878472|NCT00153062|463850399|FG001|Overall Study|Lost to Follow-up|20|||
128878473|NCT00153062|463850400|FG002|Overall Study|Lost to Follow-up|15|||
128878474|NCT00153062|463850401|FG003|Overall Study|Lost to Follow-up|16|||
128878475|NCT00153062|463850398|FG000|Overall Study|Adverse Event|0|||
128878476|NCT00153062|463850399|FG001|Overall Study|Adverse Event|1|||
128878477|NCT00153062|463850400|FG002|Overall Study|Adverse Event|1|||
128878478|NCT00153062|463850401|FG003|Overall Study|Adverse Event|0|||
128878479|NCT00153062|463850398|FG000|Overall Study|Protocol Violation|0|||
128878480|NCT00153062|463850399|FG001|Overall Study|Protocol Violation|2|||
128878481|NCT00153062|463850400|FG002|Overall Study|Protocol Violation|1|||
128878482|NCT00153062|463850401|FG003|Overall Study|Protocol Violation|1|||
128878483|NCT00153062|463850398|FG000|Overall Study|No disposition data available|1|||
128878484|NCT00153062|463850399|FG001|Overall Study|No disposition data available|1|||
128878485|NCT00153062|463850400|FG002|Overall Study|No disposition data available|1|||
128878486|NCT00153062|463850401|FG003|Overall Study|No disposition data available|1|||
128878487|NCT00153062|463850398|FG000|Overall Study|Other|0|||
128878488|NCT00153062|463850399|FG001|Overall Study|Other|0|||
128878489|NCT00153062|463850400|FG002|Overall Study|Other|1|||
128878490|NCT00153062|463850401|FG003|Overall Study|Other|0|||
128878491|NCT00275262|463850408|FG000|Overall Study|Adverse Event|2|||
128878492|NCT00275262|463850409|FG001|Overall Study|Adverse Event|0|||
128878493|NCT00275262|463850408|FG000|Overall Study|Disease progression|2|||
128878494|NCT00275262|463850409|FG001|Overall Study|Disease progression|5|||
128678303|NCT01215916|463122156|FG003|Overall Study|Adverse Event|1|||
128678304|NCT01215916|463122157|FG004|Overall Study|Adverse Event|0|||
128678305|NCT01215916|463122158|FG005|Overall Study|Adverse Event|0|||
128678306|NCT01215916|463122159|FG006|Overall Study|Adverse Event|3|||
128678307|NCT01215916|463122160|FG007|Overall Study|Adverse Event|0|||
128678308|NCT01215916|463122161|FG008|Overall Study|Adverse Event|0|||
128678309|NCT01215916|463122153|FG000|Overall Study|Withdrawal by Subject|0|||
128678310|NCT01215916|463122154|FG001|Overall Study|Withdrawal by Subject|1|||
128878495|NCT00275262|463850408|FG000|Overall Study|Lost to Follow-up|0|||
128878496|NCT00275262|463850409|FG001|Overall Study|Lost to Follow-up|2|||
128878497|NCT00275262|463850408|FG000|Overall Study|Protocol Violation|0|||
128878498|NCT00275262|463850409|FG001|Overall Study|Protocol Violation|2|||
128878499|NCT00275262|463850408|FG000|Overall Study|Death|1|||
128878500|NCT00275262|463850409|FG001|Overall Study|Death|0|||
128878501|NCT00275262|463850408|FG000|Overall Study|Started Chemotherapy|1|||
128878502|NCT00275262|463850409|FG001|Overall Study|Started Chemotherapy|0|||
128878503|NCT01589237|463850422|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
128878504|NCT01589237|463850423|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
128878505|NCT01589237|463850424|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
128678311|NCT01215916|463122155|FG002|Overall Study|Withdrawal by Subject|1|||
128678312|NCT01215916|463122156|FG003|Overall Study|Withdrawal by Subject|2|||
128678313|NCT01215916|463122157|FG004|Overall Study|Withdrawal by Subject|0|||
128678314|NCT01215916|463122158|FG005|Overall Study|Withdrawal by Subject|0|||
128678315|NCT01215916|463122159|FG006|Overall Study|Withdrawal by Subject|1|||
128678316|NCT01215916|463122160|FG007|Overall Study|Withdrawal by Subject|0|||
128678317|NCT01215916|463122161|FG008|Overall Study|Withdrawal by Subject|0|||
128678318|NCT01215916|463122153|FG000|Overall Study|Death|0|||
128878506|NCT01589237|463850425|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
128678319|NCT01215916|463122154|FG001|Overall Study|Death|1|||
128678320|NCT01215916|463122155|FG002|Overall Study|Death|0|||
128878507|NCT01589237|463850422|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
128878508|NCT01589237|463850423|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
128878509|NCT01589237|463850424|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
129012285|NCT02545998|464338091|FG000|Overall Study|Withdrawal by Subject|3|||
128878510|NCT01589237|463850425|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
128878511|NCT01589237|463850422|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
128878512|NCT01589237|463850423|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
128678321|NCT01215916|463122156|FG003|Overall Study|Death|0|||
128678322|NCT01215916|463122157|FG004|Overall Study|Death|1|||
128878513|NCT01589237|463850424|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
129012286|NCT02545998|464338092|FG001|Overall Study|Withdrawal by Subject|2|||
128878514|NCT01589237|463850425|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
128878515|NCT01589237|463850422|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
128878516|NCT01589237|463850423|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
128878517|NCT01589237|463850424|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
128878518|NCT01589237|463850425|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
128878519|NCT02594163|463850426|FG000|Treatment Period|Progressive disease|2|||
128878520|NCT02594163|463850427|FG001|Treatment Period|Progressive disease|3|||
128878521|NCT02594163|463850426|FG000|Treatment Period|Adverse Event|1|||
128878522|NCT02594163|463850427|FG001|Treatment Period|Adverse Event|5|||
128878523|NCT02594163|463850426|FG000|Treatment Period|Physician Decision|1|||
128878524|NCT02594163|463850427|FG001|Treatment Period|Physician Decision|3|||
128878525|NCT02594163|463850426|FG000|Treatment Period|Study termination by sponsor|2|||
128878526|NCT02594163|463850427|FG001|Treatment Period|Study termination by sponsor|1|||
128878527|NCT02594163|463850426|FG000|Treatment Period|Other, Non-AE|1|||
128878528|NCT02594163|463850427|FG001|Treatment Period|Other, Non-AE|0|||
128878529|NCT02594163|463850426|FG000|Follow-up Period|Withdrawal by Subject|0|||
128878530|NCT02594163|463850427|FG001|Follow-up Period|Withdrawal by Subject|1|||
128878531|NCT02594163|463850426|FG000|Follow-up Period|Study Termination by Sponsor|6|||
128878532|NCT02594163|463850427|FG001|Follow-up Period|Study Termination by Sponsor|4|||
128878533|NCT02594163|463850426|FG000|Follow-up Period|Lost to Follow-up|1|||
128878534|NCT02594163|463850427|FG001|Follow-up Period|Lost to Follow-up|0|||
128878535|NCT02594163|463850426|FG000|Follow-up Period|Death|2|||
128878536|NCT02594163|463850427|FG001|Follow-up Period|Death|5|||
128878537|NCT02594163|463850426|FG000|Follow-up Period|Adverse Event|0|||
128878538|NCT02594163|463850427|FG001|Follow-up Period|Adverse Event|1|||
128878539|NCT02594163|463850426|FG000|Follow-up Period|Progressive Disease|2|||
128878540|NCT02594163|463850427|FG001|Follow-up Period|Progressive Disease|0|||
128878541|NCT02594163|463850426|FG000|Follow-up Period|Physician Decision|0|||
128878542|NCT02594163|463850427|FG001|Follow-up Period|Physician Decision|1|||
128878543|NCT01290029|463850430|FG000|Overall Study|Other|2|||
128878544|NCT00189488|463850431|FG000|Overall Study|Ineligibility determined|1|||
128878545|NCT00189488|463850432|FG001|Overall Study|Ineligibility determined|0|||
128878546|NCT00189488|463850431|FG000|Overall Study|Protocol deviation|2|||
128878547|NCT00189488|463850432|FG001|Overall Study|Protocol deviation|1|||
128878548|NCT00189488|463850431|FG000|Overall Study|Adverse Event|2|||
128878549|NCT00189488|463850432|FG001|Overall Study|Adverse Event|1|||
128878550|NCT00189488|463850431|FG000|Overall Study|Withdrawal by Subject|2|||
128878551|NCT00189488|463850432|FG001|Overall Study|Withdrawal by Subject|6|||
128878552|NCT00189488|463850431|FG000|Overall Study|Disease progression|2|||
128878553|NCT00189488|463850432|FG001|Overall Study|Disease progression|4|||
128878554|NCT00189488|463850431|FG000|Overall Study|Administrative Decision|0|||
128878555|NCT00189488|463850432|FG001|Overall Study|Administrative Decision|2|||
128878556|NCT00189488|463850431|FG000|Overall Study|Death|5|||
128878557|NCT00189488|463850432|FG001|Overall Study|Death|8|||
128878558|NCT00189488|463850431|FG000|Overall Study|Other|1|||
128878559|NCT00189488|463850432|FG001|Overall Study|Other|0|||
128878560|NCT01877837|463850433|FG000|Overall Study|Lost to Follow-up|1|||
128878561|NCT01877837|463850433|FG000|Overall Study|Ineligible|4|||
128878562|NCT00645801|463850435|FG000|Overall Study|unclear if patient took all the medication.|1|||
128878563|NCT00645801|463850436|FG001|Overall Study|unclear if patient took all the medication.|0|||
128878564|NCT00645801|463850435|FG000|Overall Study|Lost to Follow-up|19|||
128878565|NCT00645801|463850436|FG001|Overall Study|Lost to Follow-up|15|||
128878566|NCT00705679|463850437|FG000|Overall Study|Adverse Event|1|||
128878567|NCT00705679|463850438|FG001|Overall Study|Adverse Event|1|||
128878568|NCT00705679|463850439|FG002|Overall Study|Adverse Event|0|||
128878569|NCT00705679|463850440|FG003|Overall Study|Adverse Event|0|||
128678323|NCT01215916|463122158|FG005|Overall Study|Death|0|||
128678324|NCT01215916|463122159|FG006|Overall Study|Death|0|||
128678325|NCT01215916|463122160|FG007|Overall Study|Death|0|||
128678326|NCT01215916|463122161|FG008|Overall Study|Death|1|||
128678327|NCT01215916|463122153|FG000|Overall Study|Physician Decision|0|||
128678328|NCT01215916|463122154|FG001|Overall Study|Physician Decision|0|||
128678329|NCT01215916|463122155|FG002|Overall Study|Physician Decision|1|||
128678330|NCT01215916|463122156|FG003|Overall Study|Physician Decision|1|||
128678331|NCT01215916|463122157|FG004|Overall Study|Physician Decision|0|||
128678332|NCT01215916|463122158|FG005|Overall Study|Physician Decision|0|||
128678333|NCT01215916|463122159|FG006|Overall Study|Physician Decision|0|||
128878570|NCT00705679|463850441|FG004|Overall Study|Adverse Event|0|||
128878571|NCT00705679|463850437|FG000|Overall Study|Death|0|||
128878572|NCT00705679|463850438|FG001|Overall Study|Death|0|||
128878573|NCT00705679|463850439|FG002|Overall Study|Death|3|||
128878574|NCT00705679|463850440|FG003|Overall Study|Death|2|||
128878575|NCT00705679|463850441|FG004|Overall Study|Death|1|||
128878576|NCT00705679|463850437|FG000|Overall Study|Lost to Follow-up|32|||
128878577|NCT00705679|463850438|FG001|Overall Study|Lost to Follow-up|60|||
128878578|NCT00705679|463850439|FG002|Overall Study|Lost to Follow-up|44|||
128878579|NCT00705679|463850440|FG003|Overall Study|Lost to Follow-up|30|||
128878580|NCT00705679|463850441|FG004|Overall Study|Lost to Follow-up|35|||
128678334|NCT01215916|463122160|FG007|Overall Study|Physician Decision|0|||
128678335|NCT01215916|463122161|FG008|Overall Study|Physician Decision|0|||
128678336|NCT00045942|463122162|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
128678337|NCT00045942|463122163|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678338|NCT00045942|463122164|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678339|NCT00045942|463122165|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678340|NCT00045942|463122166|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678341|NCT00045942|463122167|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678342|NCT00045942|463122168|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678343|NCT00045942|463122169|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678344|NCT00045942|463122170|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
128678345|NCT00045942|463122162|FG000|PKC412A2104 (Core)|Adverse Event|5|||
128678346|NCT00045942|463122163|FG001|PKC412A2104 (Core)|Adverse Event|0|||
128678347|NCT00045942|463122164|FG002|PKC412A2104 (Core)|Adverse Event|0|||
128678348|NCT00045942|463122165|FG003|PKC412A2104 (Core)|Adverse Event|0|||
128678349|NCT00045942|463122166|FG004|PKC412A2104 (Core)|Adverse Event|0|||
128678350|NCT00045942|463122167|FG005|PKC412A2104 (Core)|Adverse Event|0|||
128678351|NCT00045942|463122168|FG006|PKC412A2104 (Core)|Adverse Event|0|||
128678352|NCT00045942|463122169|FG007|PKC412A2104 (Core)|Adverse Event|0|||
128678353|NCT00045942|463122170|FG008|PKC412A2104 (Core)|Adverse Event|0|||
128678354|NCT00045942|463122162|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
128678355|NCT00045942|463122163|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678356|NCT00045942|463122164|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678357|NCT00045942|463122165|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678358|NCT00045942|463122166|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678359|NCT00045942|463122167|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678360|NCT00045942|463122168|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678361|NCT00045942|463122169|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678362|NCT00045942|463122170|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
128678363|NCT00045942|463122162|FG000|PKC412A2104 (Core)|Death|1|||
128678364|NCT00045942|463122163|FG001|PKC412A2104 (Core)|Death|0|||
128678365|NCT00045942|463122164|FG002|PKC412A2104 (Core)|Death|0|||
128678366|NCT00045942|463122165|FG003|PKC412A2104 (Core)|Death|0|||
128678367|NCT00045942|463122166|FG004|PKC412A2104 (Core)|Death|0|||
128678368|NCT00045942|463122167|FG005|PKC412A2104 (Core)|Death|0|||
128678369|NCT00045942|463122168|FG006|PKC412A2104 (Core)|Death|0|||
128678370|NCT00045942|463122169|FG007|PKC412A2104 (Core)|Death|0|||
128678371|NCT00045942|463122170|FG008|PKC412A2104 (Core)|Death|0|||
128678372|NCT00045942|463122162|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
128678373|NCT00045942|463122163|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
128678374|NCT00045942|463122164|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
128678375|NCT00045942|463122165|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
128678376|NCT00045942|463122166|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
128678377|NCT00045942|463122167|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
128678378|NCT00045942|463122168|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
128678379|NCT00045942|463122169|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
128678380|NCT00045942|463122170|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
128678381|NCT00045942|463122162|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
128678382|NCT00045942|463122163|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
128678383|NCT00045942|463122164|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
128678384|NCT00045942|463122165|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
128678385|NCT00045942|463122166|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
128678386|NCT00045942|463122167|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
128678387|NCT00045942|463122168|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
128678388|NCT00045942|463122169|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
128678389|NCT00045942|463122170|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
128678390|NCT00045942|463122162|FG000|PKC412A2104E1|Lack of Efficacy|0|||
129012287|NCT01004172|464338101|FG000|Overall Study|Progressive Disease in CNS Only|16|||
129012288|NCT01004172|464338101|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
129012289|NCT01004172|464338101|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
129012290|NCT01004172|464338101|FG000|Overall Study|Adverse Event|1|||
129012291|NCT01004172|464338101|FG000|Overall Study|Physician Decision|1|||
129012292|NCT01004172|464338101|FG000|Overall Study|Symptomatic Deterioration|2|||
129012293|NCT02003183|464338102|FG000|Overall Study|Lost to Follow-up|0|||
129012294|NCT02003183|464338103|FG001|Overall Study|Lost to Follow-up|2|||
128678391|NCT00045942|463122163|FG001|PKC412A2104E1|Lack of Efficacy|11|||
128678392|NCT00045942|463122164|FG002|PKC412A2104E1|Lack of Efficacy|11|||
128678393|NCT00045942|463122165|FG003|PKC412A2104E1|Lack of Efficacy|23|||
128678394|NCT00045942|463122166|FG004|PKC412A2104E1|Lack of Efficacy|17|||
128678395|NCT00045942|463122167|FG005|PKC412A2104E1|Lack of Efficacy|0|||
129012295|NCT01759290|464338104|FG000|Overall Study|Subjects withdrawn consent|5|||
129012296|NCT01759290|464338104|FG000|Overall Study|Physician Decision|2|||
128678396|NCT00045942|463122168|FG006|PKC412A2104E1|Lack of Efficacy|0|||
128678397|NCT00045942|463122169|FG007|PKC412A2104E1|Lack of Efficacy|0|||
128678398|NCT00045942|463122170|FG008|PKC412A2104E1|Lack of Efficacy|0|||
128678399|NCT00045942|463122162|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
129012297|NCT01759290|464338104|FG000|Overall Study|Death|17|||
128878581|NCT00705679|463850437|FG000|Overall Study|Physician Decision|0|||
128878582|NCT00705679|463850438|FG001|Overall Study|Physician Decision|1|||
128878583|NCT00705679|463850439|FG002|Overall Study|Physician Decision|0|||
128878584|NCT00705679|463850440|FG003|Overall Study|Physician Decision|1|||
128878585|NCT00705679|463850441|FG004|Overall Study|Physician Decision|0|||
128878586|NCT00705679|463850437|FG000|Overall Study|Withdrawal by Subject|32|||
128878587|NCT00705679|463850438|FG001|Overall Study|Withdrawal by Subject|77|||
128878588|NCT00705679|463850439|FG002|Overall Study|Withdrawal by Subject|68|||
128878589|NCT00705679|463850440|FG003|Overall Study|Withdrawal by Subject|47|||
129012298|NCT01759290|464338104|FG000|Overall Study|Lost to Follow-up|53|||
129012299|NCT01759290|464338104|FG000|Overall Study|Unknown reason|4|||
128678400|NCT00045942|463122163|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
128678401|NCT00045942|463122164|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
128678402|NCT00045942|463122165|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
128678403|NCT00045942|463122166|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
129012300|NCT03629249|464338105|FG000|Overall Study|Study terminated by sponsor|197|||
129012301|NCT03629249|464338106|FG001|Overall Study|Study terminated by sponsor|197|||
129012302|NCT03629249|464338107|FG002|Overall Study|Study terminated by sponsor|194|||
129012303|NCT03629249|464338105|FG000|Overall Study|Protocol deviation|0|||
129012304|NCT03629249|464338106|FG001|Overall Study|Protocol deviation|2|||
129012305|NCT03629249|464338107|FG002|Overall Study|Protocol deviation|5|||
129012306|NCT03629249|464338105|FG000|Overall Study|Subject decision|1|||
129012307|NCT03629249|464338106|FG001|Overall Study|Subject decision|1|||
129012308|NCT03629249|464338107|FG002|Overall Study|Subject decision|3|||
129012309|NCT03629249|464338105|FG000|Overall Study|Adverse Event|1|||
129012310|NCT03629249|464338106|FG001|Overall Study|Adverse Event|1|||
129012311|NCT03629249|464338107|FG002|Overall Study|Adverse Event|0|||
129012312|NCT03629249|464338105|FG000|Overall Study|Death|1|||
129012313|NCT03629249|464338106|FG001|Overall Study|Death|0|||
129012314|NCT03629249|464338107|FG002|Overall Study|Death|0|||
129012315|NCT03629249|464338105|FG000|Overall Study|Physician Decision|1|||
129012316|NCT03629249|464338106|FG001|Overall Study|Physician Decision|0|||
129012317|NCT03629249|464338107|FG002|Overall Study|Physician Decision|0|||
129012318|NCT00352690|464338108|FG000|Overall Study|Determined to be ineligible|2|||
129012319|NCT00352690|464338109|FG001|Overall Study|Determined to be ineligible|0|||
129012320|NCT02719522|464338112|FG000|Overall Study|Implant Failure|4|||
129012321|NCT02719522|464338112|FG000|Overall Study|Death|2|||
129012322|NCT02719522|464338112|FG000|Overall Study|Lost to Follow-up|5|||
129012323|NCT02097290|464338115|FG000|Overall Study|Death|6|||
129012324|NCT02097290|464338115|FG000|Overall Study|Total Withdrawals|3|||
129012325|NCT02097290|464338115|FG000|Overall Study|Attempt|8|||
129012326|NCT06096168|464338116|FG000|Overall Study|Death|30|||
129012327|NCT06096168|464338116|FG000|Overall Study|Revision|2|||
129012328|NCT01478620|464338117|FG000|Overall Study|Lost to Follow-up|6|||
129012329|NCT02888171|464338118|FG000|Overall Study|Lost to Follow-up|2|||
129012330|NCT02888171|464338119|FG001|Overall Study|Lost to Follow-up|1|||
129012331|NCT02888171|464338118|FG000|Overall Study|Withdrawal by Subject|3|||
129012332|NCT02888171|464338119|FG001|Overall Study|Withdrawal by Subject|2|||
129012333|NCT02888171|464338118|FG000|Overall Study|Adverse Event|0|||
129012334|NCT02888171|464338119|FG001|Overall Study|Adverse Event|1|||
129012335|NCT01411332|464338122|FG000|Enrollment|Protocol Violation|0|||
128678404|NCT00045942|463122167|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
128878590|NCT00705679|463850441|FG004|Overall Study|Withdrawal by Subject|33|||
128878591|NCT00932113|463850442|FG000|Overall Study|Lost to Follow-up|1|||
129012336|NCT01411332|464338123|FG001|Enrollment|Protocol Violation|1|||
129012337|NCT01411332|464338122|FG000|Enrollment|Withdrawal by Subject|0|||
129012338|NCT01411332|464338123|FG001|Enrollment|Withdrawal by Subject|1|||
129012339|NCT01411332|464338122|FG000|Treatment|Lost to Follow-up|1|||
129012340|NCT01411332|464338123|FG001|Treatment|Lost to Follow-up|0|||
129012341|NCT02848326|464339503|FG000|Treatment Period|Adverse Event|5|||
129012342|NCT02848326|464339504|FG001|Treatment Period|Adverse Event|4|||
129012343|NCT02848326|464339505|FG002|Treatment Period|Adverse Event|11|||
129012344|NCT02848326|464339506|FG003|Treatment Period|Adverse Event|6|||
129012345|NCT02848326|464339507|FG004|Treatment Period|Adverse Event|5|||
129012346|NCT02848326|464339508|FG005|Treatment Period|Adverse Event|7|||
129012347|NCT02848326|464339503|FG000|Treatment Period|Withdrawal of Consent|20|||
129012348|NCT02848326|464339504|FG001|Treatment Period|Withdrawal of Consent|6|||
129012349|NCT02848326|464339505|FG002|Treatment Period|Withdrawal of Consent|9|||
129012350|NCT02848326|464339506|FG003|Treatment Period|Withdrawal of Consent|6|||
129012351|NCT02848326|464339507|FG004|Treatment Period|Withdrawal of Consent|9|||
129012352|NCT02848326|464339508|FG005|Treatment Period|Withdrawal of Consent|6|||
129012353|NCT02848326|464339503|FG000|Treatment Period|Lost to Follow-up|5|||
129012354|NCT02848326|464339504|FG001|Treatment Period|Lost to Follow-up|1|||
129012355|NCT02848326|464339505|FG002|Treatment Period|Lost to Follow-up|11|||
129012356|NCT02848326|464339506|FG003|Treatment Period|Lost to Follow-up|7|||
129012357|NCT02848326|464339507|FG004|Treatment Period|Lost to Follow-up|2|||
129012358|NCT02848326|464339508|FG005|Treatment Period|Lost to Follow-up|3|||
129012359|NCT02848326|464339503|FG000|Treatment Period|Pregnancy|0|||
129012360|NCT02848326|464339504|FG001|Treatment Period|Pregnancy|0|||
128678405|NCT00045942|463122168|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
128678406|NCT00045942|463122169|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
128678407|NCT00045942|463122170|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
128678408|NCT00045942|463122162|FG000|PKC412A2104E1|Adverse Event|0|||
129012361|NCT02848326|464339505|FG002|Treatment Period|Pregnancy|1|||
129012362|NCT02848326|464339506|FG003|Treatment Period|Pregnancy|1|||
129012363|NCT02848326|464339507|FG004|Treatment Period|Pregnancy|0|||
129012364|NCT02848326|464339508|FG005|Treatment Period|Pregnancy|1|||
129012365|NCT02848326|464339503|FG000|Treatment Period|Protocol Violation|4|||
129012366|NCT02848326|464339504|FG001|Treatment Period|Protocol Violation|3|||
129012367|NCT02848326|464339505|FG002|Treatment Period|Protocol Violation|4|||
129012368|NCT02848326|464339506|FG003|Treatment Period|Protocol Violation|2|||
129012369|NCT02848326|464339507|FG004|Treatment Period|Protocol Violation|3|||
129012370|NCT02848326|464339508|FG005|Treatment Period|Protocol Violation|3|||
129012371|NCT02848326|464339503|FG000|Treatment Period|Non-compliance with Study Drug|4|||
129012372|NCT02848326|464339504|FG001|Treatment Period|Non-compliance with Study Drug|0|||
129012373|NCT02848326|464339505|FG002|Treatment Period|Non-compliance with Study Drug|0|||
129012374|NCT02848326|464339506|FG003|Treatment Period|Non-compliance with Study Drug|1|||
129012375|NCT02848326|464339507|FG004|Treatment Period|Non-compliance with Study Drug|0|||
129012376|NCT02848326|464339508|FG005|Treatment Period|Non-compliance with Study Drug|0|||
129012377|NCT02848326|464339503|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
129012378|NCT02848326|464339504|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
129012379|NCT02848326|464339505|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
129012380|NCT02848326|464339506|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
129012381|NCT02848326|464339507|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
129012382|NCT02848326|464339508|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
129012383|NCT02848326|464339503|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
129012384|NCT02848326|464339504|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
129012385|NCT02848326|464339505|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
129012386|NCT02848326|464339506|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
129012387|NCT02848326|464339507|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
129012388|NCT02848326|464339508|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
129012389|NCT02637232|464339510|FG000|Overall Study|Lost to Follow-up|42|||
129012390|NCT02637232|464339510|FG000|Overall Study|Adverse Event|11|||
129012391|NCT02637232|464339510|FG000|Overall Study|patient 's decision|2|||
129012392|NCT02999178|464339511|FG000|Overall Study|Adverse Event|85|||
129012393|NCT02999178|464339512|FG001|Overall Study|Adverse Event|62|||
129012394|NCT02999178|464339511|FG000|Overall Study|Protocol Violation|1|||
129012395|NCT02999178|464339512|FG001|Overall Study|Protocol Violation|2|||
129012396|NCT02999178|464339511|FG000|Overall Study|Lost to Follow-up|0|||
129012397|NCT02999178|464339512|FG001|Overall Study|Lost to Follow-up|2|||
129012398|NCT02999178|464339511|FG000|Overall Study|Withdrawal by Subject|21|||
129012399|NCT02999178|464339512|FG001|Overall Study|Withdrawal by Subject|21|||
129012400|NCT02999178|464339511|FG000|Overall Study|Other reason not defined above|7|||
129012401|NCT02999178|464339512|FG001|Overall Study|Other reason not defined above|13|||
129012402|NCT00090857|464339513|FG000|Overall Study|Lost to Follow-up|0|||
129012403|NCT00090857|464339514|FG001|Overall Study|Lost to Follow-up|1|||
129012404|NCT00090857|464339513|FG000|Overall Study|Withdrawal by Subject|2|||
129012405|NCT00090857|464339514|FG001|Overall Study|Withdrawal by Subject|0|||
129012406|NCT00090857|464339513|FG000|Overall Study|Adverse Event|2|||
129012407|NCT00090857|464339514|FG001|Overall Study|Adverse Event|2|||
129012408|NCT05097326|464339515|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
129012409|NCT05097326|464339516|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
129012410|NCT02684344|464339517|FG000|Overall Study|Withdrawal by Subject|0|||
129012411|NCT02684344|464339518|FG001|Overall Study|Withdrawal by Subject|1|||
129012412|NCT03480425|464339519|FG000|Overall Study|Force transducer technical failure|1|||
129012413|NCT02424188|464339521|FG000|Overall Study|Death|2|||
129012414|NCT02424188|464339522|FG001|Overall Study|Death|2|||
129012415|NCT02424188|464339521|FG000|Overall Study|Lost to Follow-up|1|||
129012416|NCT02424188|464339522|FG001|Overall Study|Lost to Follow-up|3|||
129012417|NCT02424188|464339521|FG000|Overall Study|Incarceration|1|||
129012418|NCT02424188|464339522|FG001|Overall Study|Incarceration|0|||
129012419|NCT03471078|464339527|FG000|Overall Study|Withdrawal by Subject|9|||
129012420|NCT03471078|464339528|FG001|Overall Study|Withdrawal by Subject|1|||
129012421|NCT03471078|464339527|FG000|Overall Study|Adverse Event|4|||
129012422|NCT03471078|464339528|FG001|Overall Study|Adverse Event|1|||
129012423|NCT03471078|464339527|FG000|Overall Study|Physician Decision|3|||
129012424|NCT03471078|464339528|FG001|Overall Study|Physician Decision|2|||
129012425|NCT03471078|464339527|FG000|Overall Study|Death|2|||
129012426|NCT03471078|464339528|FG001|Overall Study|Death|0|||
129012427|NCT03471078|464339527|FG000|Overall Study|Other|3|||
129012428|NCT03471078|464339528|FG001|Overall Study|Other|2|||
129012429|NCT02473640|464339532|FG000|Treatment Period 1|Adverse Event|1|||
129012430|NCT02395822|464339533|FG000|Overall Study|Withdrawal by Subject|1|||
129012431|NCT02395822|464339533|FG000|Overall Study|Death|1|||
129012432|NCT02937701|464339534|FG000|Day 1 to Week 22|Adverse Event|11|||
129012433|NCT02937701|464339535|FG001|Day 1 to Week 22|Adverse Event|14|||
128678409|NCT00045942|463122163|FG001|PKC412A2104E1|Adverse Event|1|||
128678410|NCT00045942|463122164|FG002|PKC412A2104E1|Adverse Event|1|||
128678411|NCT00045942|463122165|FG003|PKC412A2104E1|Adverse Event|3|||
128678412|NCT00045942|463122166|FG004|PKC412A2104E1|Adverse Event|6|||
128678413|NCT00045942|463122167|FG005|PKC412A2104E1|Adverse Event|0|||
128678414|NCT00045942|463122168|FG006|PKC412A2104E1|Adverse Event|0|||
128678415|NCT00045942|463122169|FG007|PKC412A2104E1|Adverse Event|0|||
128678416|NCT00045942|463122170|FG008|PKC412A2104E1|Adverse Event|0|||
128678417|NCT00045942|463122162|FG000|PKC412A2104E1|Death|0|||
128678418|NCT00045942|463122163|FG001|PKC412A2104E1|Death|4|||
128678419|NCT00045942|463122164|FG002|PKC412A2104E1|Death|1|||
128678420|NCT00045942|463122165|FG003|PKC412A2104E1|Death|1|||
128678421|NCT00045942|463122166|FG004|PKC412A2104E1|Death|1|||
128678422|NCT00045942|463122167|FG005|PKC412A2104E1|Death|0|||
128678423|NCT00045942|463122168|FG006|PKC412A2104E1|Death|0|||
128678424|NCT00045942|463122169|FG007|PKC412A2104E1|Death|0|||
128678425|NCT00045942|463122170|FG008|PKC412A2104E1|Death|0|||
128678426|NCT00045942|463122162|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
128678427|NCT00045942|463122163|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
128678428|NCT00045942|463122164|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
128678429|NCT00045942|463122165|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
128678430|NCT00045942|463122166|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
128678431|NCT00045942|463122167|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
128678432|NCT00045942|463122168|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
128678433|NCT00045942|463122169|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
128678434|NCT00045942|463122170|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
128678435|NCT00045942|463122162|FG000|PKC412A2104E2|Lost to Follow-up|0|||
128678436|NCT00045942|463122163|FG001|PKC412A2104E2|Lost to Follow-up|0|||
128678437|NCT00045942|463122164|FG002|PKC412A2104E2|Lost to Follow-up|0|||
128678438|NCT00045942|463122165|FG003|PKC412A2104E2|Lost to Follow-up|0|||
129012434|NCT02937701|464339536|FG002|Day 1 to Week 22|Adverse Event|0|||
129012435|NCT02937701|464339537|FG003|Day 1 to Week 22|Adverse Event|0|||
129012436|NCT02937701|464339538|FG004|Day 1 to Week 22|Adverse Event|0|||
129012437|NCT02937701|464339534|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
129012438|NCT02937701|464339535|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
129012439|NCT02937701|464339536|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
129012440|NCT02937701|464339537|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
129012441|NCT02937701|464339538|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
129012442|NCT02937701|464339534|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
129012443|NCT02937701|464339535|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
129012444|NCT02937701|464339536|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
129012445|NCT02937701|464339537|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
129012446|NCT02937701|464339538|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
129012447|NCT02937701|464339534|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
129012448|NCT02937701|464339535|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
129012449|NCT02937701|464339536|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
129012450|NCT02937701|464339537|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
129012451|NCT02937701|464339538|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
129012452|NCT02937701|464339534|FG000|Day 1 to Week 22|Death|1|||
129012453|NCT02937701|464339535|FG001|Day 1 to Week 22|Death|1|||
129012454|NCT02937701|464339536|FG002|Day 1 to Week 22|Death|0|||
129012455|NCT02937701|464339537|FG003|Day 1 to Week 22|Death|0|||
129012456|NCT02937701|464339538|FG004|Day 1 to Week 22|Death|0|||
129012457|NCT02937701|464339534|FG000|Day 1 to Week 22|Protocol Violation|1|||
129012458|NCT02937701|464339535|FG001|Day 1 to Week 22|Protocol Violation|1|||
129012459|NCT02937701|464339536|FG002|Day 1 to Week 22|Protocol Violation|0|||
129012460|NCT02937701|464339537|FG003|Day 1 to Week 22|Protocol Violation|0|||
129012461|NCT02937701|464339538|FG004|Day 1 to Week 22|Protocol Violation|0|||
129012462|NCT02937701|464339534|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
129012463|NCT02937701|464339535|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
129012464|NCT02937701|464339536|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
129012465|NCT02937701|464339537|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
129012466|NCT02937701|464339538|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
129012467|NCT02937701|464339534|FG000|Day 1 to Week 22|Physician Decision|2|||
129012468|NCT02937701|464339535|FG001|Day 1 to Week 22|Physician Decision|0|||
129012469|NCT02937701|464339536|FG002|Day 1 to Week 22|Physician Decision|0|||
129012470|NCT02937701|464339537|FG003|Day 1 to Week 22|Physician Decision|0|||
129101660|NCT03796676|464666240|FG001|Overall Study|Withdrawal by Subject|1|||
128678439|NCT00045942|463122166|FG004|PKC412A2104E2|Lost to Follow-up|0|||
128678440|NCT00045942|463122167|FG005|PKC412A2104E2|Lost to Follow-up|0|||
128678441|NCT00045942|463122168|FG006|PKC412A2104E2|Lost to Follow-up|0|||
128678442|NCT00045942|463122169|FG007|PKC412A2104E2|Lost to Follow-up|3|||
128678443|NCT00045942|463122170|FG008|PKC412A2104E2|Lost to Follow-up|0|||
128678444|NCT00045942|463122162|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
128678445|NCT00045942|463122163|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
129012471|NCT02937701|464339538|FG004|Day 1 to Week 22|Physician Decision|0|||
129012472|NCT02937701|464339534|FG000|Day 1 to Week 22|Other|1|||
129012473|NCT02937701|464339535|FG001|Day 1 to Week 22|Other|0|||
129101661|NCT03796676|464666241|FG002|Overall Study|Withdrawal by Subject|0|||
129101662|NCT03796676|464666239|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
129101663|NCT03796676|464666240|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
129101664|NCT03796676|464666241|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
128878592|NCT00932113|463850443|FG001|Overall Study|Lost to Follow-up|0|||
128878593|NCT01403610|463850444|FG000|Overall Study|Withdrawal by Subject|2|||
128878594|NCT01403610|463850445|FG001|Overall Study|Withdrawal by Subject|0|||
128878595|NCT01403610|463850446|FG002|Overall Study|Withdrawal by Subject|0|||
128878596|NCT01403610|463850447|FG003|Overall Study|Withdrawal by Subject|0|||
128878597|NCT01403610|463850444|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
128878598|NCT01403610|463850445|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
128878599|NCT01403610|463850446|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
128878600|NCT01403610|463850447|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
128878601|NCT00896051|463850451|FG000|Overall Study|Adverse Event|2|||
128878602|NCT00896051|463850452|FG001|Overall Study|Adverse Event|1|||
128878603|NCT00896051|463850451|FG000|Overall Study|Lost to Follow-up|3|||
128878604|NCT00896051|463850452|FG001|Overall Study|Lost to Follow-up|2|||
128878605|NCT00896051|463850451|FG000|Overall Study|Withdrawal by Subject|3|||
129101665|NCT01900899|464666245|FG000|Overall Study|Withdrawal by Subject|7|||
128878606|NCT00896051|463850452|FG001|Overall Study|Withdrawal by Subject|2|||
128878607|NCT00896051|463850451|FG000|Overall Study|Subject noncompliant|1|||
128878608|NCT00896051|463850452|FG001|Overall Study|Subject noncompliant|3|||
128878609|NCT00896051|463850451|FG000|Overall Study|Other|1|||
128878610|NCT00896051|463850452|FG001|Overall Study|Other|1|||
128878611|NCT02935452|463850453|FG000|Overall Study|work and life commintment|3|||
128878612|NCT02935452|463850454|FG001|Overall Study|work and life commintment|1|||
128878613|NCT00876928|463850455|FG000|Overall Study|Lost to Follow-up|2|||
128878614|NCT00876928|463850456|FG001|Overall Study|Lost to Follow-up|5|||
128878615|NCT00876928|463850455|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
128878616|NCT00876928|463850456|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
128878617|NCT02090959|463850462|FG000|Overall Study|Withdrawal by Subject|10|||
128878618|NCT02090959|463850462|FG000|Overall Study|Adverse Event|1|||
128678446|NCT00045942|463122164|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
128678447|NCT00045942|463122165|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
128678448|NCT00045942|463122166|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
128678449|NCT00045942|463122167|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
128678450|NCT00045942|463122168|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
128678451|NCT00045942|463122169|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
128678452|NCT00045942|463122170|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
128678453|NCT00045942|463122162|FG000|PKC412A2104E2|Lack of Efficacy|0|||
128678454|NCT00045942|463122163|FG001|PKC412A2104E2|Lack of Efficacy|0|||
128678455|NCT00045942|463122164|FG002|PKC412A2104E2|Lack of Efficacy|0|||
128678456|NCT00045942|463122165|FG003|PKC412A2104E2|Lack of Efficacy|0|||
128678457|NCT00045942|463122166|FG004|PKC412A2104E2|Lack of Efficacy|0|||
128678458|NCT00045942|463122167|FG005|PKC412A2104E2|Lack of Efficacy|3|||
128678459|NCT00045942|463122168|FG006|PKC412A2104E2|Lack of Efficacy|2|||
128678460|NCT00045942|463122169|FG007|PKC412A2104E2|Lack of Efficacy|2|||
128678461|NCT00045942|463122170|FG008|PKC412A2104E2|Lack of Efficacy|6|||
128678462|NCT00045942|463122162|FG000|PKC412A2104E2|Adverse Event|0|||
128678463|NCT00045942|463122163|FG001|PKC412A2104E2|Adverse Event|0|||
128678464|NCT00045942|463122164|FG002|PKC412A2104E2|Adverse Event|0|||
128678465|NCT00045942|463122165|FG003|PKC412A2104E2|Adverse Event|0|||
128678466|NCT00045942|463122166|FG004|PKC412A2104E2|Adverse Event|0|||
128678467|NCT00045942|463122167|FG005|PKC412A2104E2|Adverse Event|4|||
128678468|NCT00045942|463122168|FG006|PKC412A2104E2|Adverse Event|3|||
128678469|NCT00045942|463122169|FG007|PKC412A2104E2|Adverse Event|1|||
128678470|NCT00045942|463122170|FG008|PKC412A2104E2|Adverse Event|0|||
128678471|NCT00045942|463122162|FG000|PKC412A2104E2|Death|0|||
128678472|NCT00045942|463122163|FG001|PKC412A2104E2|Death|0|||
128678473|NCT00045942|463122164|FG002|PKC412A2104E2|Death|0|||
128678474|NCT00045942|463122165|FG003|PKC412A2104E2|Death|0|||
128678475|NCT00045942|463122166|FG004|PKC412A2104E2|Death|0|||
128678476|NCT00045942|463122167|FG005|PKC412A2104E2|Death|1|||
128678477|NCT00045942|463122168|FG006|PKC412A2104E2|Death|2|||
128678478|NCT00045942|463122169|FG007|PKC412A2104E2|Death|0|||
128678479|NCT00045942|463122170|FG008|PKC412A2104E2|Death|0|||
128678480|NCT05028361|463122171|FG000|Overall Study|Withdrawal by Subject|1|||
128878619|NCT02090959|463850462|FG000|Overall Study|Investigator decision|2|||
128878620|NCT02090959|463850462|FG000|Overall Study|Study termination|6|||
128878621|NCT02090959|463850462|FG000|Overall Study|Enrolled but not treated|1|||
128678481|NCT05028361|463122172|FG001|Overall Study|Withdrawal by Subject|0|||
128678482|NCT02047318|463122178|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
128878622|NCT02090959|463850462|FG000|Overall Study|Transfer for compassionate use medicine|4|||
128878623|NCT02090959|463850462|FG000|Overall Study|Move to medical need program|3|||
129101666|NCT01900899|464666246|FG001|Overall Study|Withdrawal by Subject|1|||
128678483|NCT02047318|463122178|FG000|Core Study Period|Adverse Event|1|||
128678484|NCT02047318|463122178|FG000|Core Study Period|Withdrawal by caregiver|3|||
128678485|NCT02047318|463122178|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
128678486|NCT02296138|463122179|FG000|Overall Study|Adverse Event|348|||
128678487|NCT02296138|463122180|FG001|Overall Study|Adverse Event|259|||
128678488|NCT02296138|463122179|FG000|Overall Study|Lack of Efficacy|59|||
128678489|NCT02296138|463122180|FG001|Overall Study|Lack of Efficacy|37|||
128678490|NCT02296138|463122179|FG000|Overall Study|Protocol Violation|35|||
128678491|NCT02296138|463122180|FG001|Overall Study|Protocol Violation|36|||
128678492|NCT02296138|463122179|FG000|Overall Study|Lost to Follow-up|9|||
128678493|NCT02296138|463122180|FG001|Overall Study|Lost to Follow-up|12|||
128678494|NCT02296138|463122179|FG000|Overall Study|Withdrawal by Subject|184|||
128678495|NCT02296138|463122180|FG001|Overall Study|Withdrawal by Subject|131|||
128678496|NCT02296138|463122179|FG000|Overall Study|Not Treated|1|||
128678497|NCT02296138|463122180|FG001|Overall Study|Not Treated|1|||
128678498|NCT02296138|463122179|FG000|Overall Study|Patients with data irregularities|10|||
128878624|NCT02090959|463850462|FG000|Overall Study|Entered in to other study|34|||
128878625|NCT02090959|463850462|FG000|Overall Study|Switched to commercial supply|88|||
128878626|NCT02090959|463850462|FG000|Overall Study|Other than specified|2|||
128678499|NCT02296138|463122180|FG001|Overall Study|Patients with data irregularities|11|||
128678500|NCT02296138|463122179|FG000|Overall Study|Other than specified|15|||
128678501|NCT02296138|463122180|FG001|Overall Study|Other than specified|13|||
128678502|NCT00711516|463122181|FG000|Overall Study|Adverse Event|1|||
128678503|NCT00711516|463122182|FG001|Overall Study|Adverse Event|1|||
128678504|NCT00711516|463122181|FG000|Overall Study|Withdrawal by Subject|0|||
128678505|NCT00711516|463122182|FG001|Overall Study|Withdrawal by Subject|1|||
128678506|NCT00711516|463122181|FG000|Overall Study|Protocol Violation|0|||
128678507|NCT00711516|463122182|FG001|Overall Study|Protocol Violation|1|||
128678508|NCT02095132|463122186|FG000|Overall Study|Adverse Event|0|||
128678509|NCT02095132|463122187|FG001|Overall Study|Adverse Event|0|||
128678510|NCT02095132|463122188|FG002|Overall Study|Adverse Event|0|||
128678511|NCT02095132|463122189|FG003|Overall Study|Adverse Event|0|||
128678512|NCT02095132|463122190|FG004|Overall Study|Adverse Event|1|||
128678513|NCT02095132|463122191|FG005|Overall Study|Adverse Event|0|||
128678514|NCT02095132|463122192|FG006|Overall Study|Adverse Event|1|||
128678515|NCT02095132|463122193|FG007|Overall Study|Adverse Event|0|||
128678516|NCT02095132|463122194|FG008|Overall Study|Adverse Event|0|||
128678517|NCT02095132|463122186|FG000|Overall Study|Death|0|||
128678518|NCT02095132|463122187|FG001|Overall Study|Death|0|||
128678519|NCT02095132|463122188|FG002|Overall Study|Death|0|||
128678520|NCT02095132|463122189|FG003|Overall Study|Death|0|||
128678521|NCT02095132|463122190|FG004|Overall Study|Death|0|||
128678522|NCT02095132|463122191|FG005|Overall Study|Death|0|||
128678523|NCT02095132|463122192|FG006|Overall Study|Death|1|||
128678524|NCT02095132|463122193|FG007|Overall Study|Death|0|||
128678525|NCT02095132|463122194|FG008|Overall Study|Death|0|||
128678526|NCT02095132|463122186|FG000|Overall Study|Lack of Efficacy|3|||
128678527|NCT02095132|463122187|FG001|Overall Study|Lack of Efficacy|5|||
128678528|NCT02095132|463122188|FG002|Overall Study|Lack of Efficacy|2|||
128678529|NCT02095132|463122189|FG003|Overall Study|Lack of Efficacy|8|||
128878627|NCT01052103|463850464|FG000|Overall Study|Adverse Event|10|||
128878628|NCT01052103|463850465|FG001|Overall Study|Adverse Event|6|||
128878629|NCT01052103|463850464|FG000|Overall Study|Entry Criteria Not Met|3|||
128878630|NCT01052103|463850465|FG001|Overall Study|Entry Criteria Not Met|1|||
128878631|NCT01052103|463850464|FG000|Overall Study|Lost to Follow-up|3|||
128878632|NCT01052103|463850465|FG001|Overall Study|Lost to Follow-up|5|||
128878633|NCT01052103|463850464|FG000|Overall Study|Protocol Violation|10|||
128878634|NCT01052103|463850465|FG001|Overall Study|Protocol Violation|4|||
128878635|NCT01052103|463850464|FG000|Overall Study|Scheduling conflict|2|||
128878636|NCT01052103|463850465|FG001|Overall Study|Scheduling conflict|1|||
128678530|NCT02095132|463122190|FG004|Overall Study|Lack of Efficacy|3|||
128678531|NCT02095132|463122191|FG005|Overall Study|Lack of Efficacy|6|||
128678532|NCT02095132|463122192|FG006|Overall Study|Lack of Efficacy|10|||
128878637|NCT01052103|463850464|FG000|Overall Study|Sponsor Decision|2|||
128878638|NCT01052103|463850465|FG001|Overall Study|Sponsor Decision|0|||
128678533|NCT02095132|463122193|FG007|Overall Study|Lack of Efficacy|9|||
128678534|NCT02095132|463122194|FG008|Overall Study|Lack of Efficacy|8|||
128678535|NCT02095132|463122186|FG000|Overall Study|Physician Decision|1|||
128678536|NCT02095132|463122187|FG001|Overall Study|Physician Decision|0|||
128878639|NCT01052103|463850464|FG000|Overall Study|Withdrawal by Subject|3|||
128678537|NCT02095132|463122188|FG002|Overall Study|Physician Decision|0|||
128678538|NCT02095132|463122189|FG003|Overall Study|Physician Decision|0|||
128678539|NCT02095132|463122190|FG004|Overall Study|Physician Decision|0|||
128678540|NCT02095132|463122191|FG005|Overall Study|Physician Decision|0|||
128878640|NCT01052103|463850465|FG001|Overall Study|Withdrawal by Subject|6|||
128878641|NCT01052103|463850464|FG000|Overall Study|Perceived Lack of Efficacy|1|||
128878642|NCT01052103|463850465|FG001|Overall Study|Perceived Lack of Efficacy|0|||
128678541|NCT02095132|463122192|FG006|Overall Study|Physician Decision|1|||
128678542|NCT02095132|463122193|FG007|Overall Study|Physician Decision|0|||
128678543|NCT02095132|463122194|FG008|Overall Study|Physician Decision|2|||
128678544|NCT02095132|463122186|FG000|Overall Study|Withdrawal by Subject|0|||
128678545|NCT02095132|463122187|FG001|Overall Study|Withdrawal by Subject|0|||
128878643|NCT05398237|463850469|FG000|Overall Study|Withdrawal by Subject|1|||
128878644|NCT01248065|463850472|FG000|Overall Study|Lost to Follow-up|3|||
128878645|NCT01248065|463850473|FG001|Overall Study|Lost to Follow-up|5|||
128878646|NCT01248065|463850472|FG000|Overall Study|Withdrawal by Subject|14|||
128878647|NCT01248065|463850473|FG001|Overall Study|Withdrawal by Subject|11|||
128878648|NCT01248065|463850472|FG000|Overall Study|Adverse Event|3|||
128878649|NCT01248065|463850473|FG001|Overall Study|Adverse Event|0|||
128878650|NCT01248065|463850472|FG000|Overall Study|Third treatment failure event|3|||
128878651|NCT01248065|463850473|FG001|Overall Study|Third treatment failure event|1|||
128878652|NCT01248065|463850472|FG000|Overall Study|Other|3|||
128878653|NCT01248065|463850473|FG001|Overall Study|Other|5|||
128878654|NCT00321373|463850479|FG000|Overall Study|Adverse Event|0|||
128878655|NCT00321373|463850480|FG001|Overall Study|Adverse Event|0|||
128878656|NCT00321373|463850481|FG002|Overall Study|Adverse Event|1|||
128878657|NCT00321373|463850479|FG000|Overall Study|Lost to Follow-up|1|||
128878658|NCT00321373|463850480|FG001|Overall Study|Lost to Follow-up|0|||
128878659|NCT00321373|463850481|FG002|Overall Study|Lost to Follow-up|1|||
128878660|NCT00321373|463850479|FG000|Overall Study|Withdrawal by Subject|1|||
128878661|NCT00321373|463850480|FG001|Overall Study|Withdrawal by Subject|0|||
128878662|NCT00321373|463850481|FG002|Overall Study|Withdrawal by Subject|0|||
128878663|NCT00321373|463850479|FG000|Overall Study|Other|0|||
128878664|NCT00321373|463850480|FG001|Overall Study|Other|0|||
128878665|NCT00321373|463850481|FG002|Overall Study|Other|1|||
128878666|NCT00946101|463850482|FG000|Overall Study|Lost to Follow-up|2|||
128878667|NCT00946101|463850483|FG001|Overall Study|Lost to Follow-up|1|||
128878668|NCT00946101|463850482|FG000|Overall Study|Withdrawal of consent|2|||
128878669|NCT00946101|463850483|FG001|Overall Study|Withdrawal of consent|0|||
128878670|NCT00946101|463850482|FG000|Overall Study|Physician Decision|0|||
128878671|NCT00946101|463850483|FG001|Overall Study|Physician Decision|1|||
128878672|NCT00552240|463850489|FG000|Overall Study|Adverse Event|9|||
128878673|NCT00552240|463850490|FG001|Overall Study|Adverse Event|9|||
128878674|NCT00552240|463850489|FG000|Overall Study|Protocol Violation|1|||
128878675|NCT00552240|463850490|FG001|Overall Study|Protocol Violation|1|||
128878676|NCT00552240|463850489|FG000|Overall Study|Lost to Follow-up|5|||
128878677|NCT00552240|463850490|FG001|Overall Study|Lost to Follow-up|6|||
128878678|NCT00552240|463850489|FG000|Overall Study|Withdrawal by Subject|2|||
128878679|NCT00552240|463850490|FG001|Overall Study|Withdrawal by Subject|2|||
128878680|NCT00552240|463850489|FG000|Overall Study|Lack of Efficacy|6|||
128878681|NCT00552240|463850490|FG001|Overall Study|Lack of Efficacy|0|||
128878682|NCT00552240|463850489|FG000|Overall Study|Other|1|||
128878683|NCT00552240|463850490|FG001|Overall Study|Other|0|||
128878684|NCT02783768|463850492|FG000|Overall Study|Lost to Follow-up|1|||
128878685|NCT02783768|463850493|FG001|Overall Study|Lost to Follow-up|0|||
128878686|NCT01323647|463850494|FG000|Overall Study|Migrated/moved from study area|2|||
128878687|NCT01323647|463850495|FG001|Overall Study|Migrated/moved from study area|0|||
128878688|NCT01323647|463850494|FG000|Overall Study|Withdrawal by Subject|5|||
128678546|NCT02095132|463122188|FG002|Overall Study|Withdrawal by Subject|2|||
128678547|NCT02095132|463122189|FG003|Overall Study|Withdrawal by Subject|2|||
128878689|NCT01323647|463850495|FG001|Overall Study|Withdrawal by Subject|0|||
128878690|NCT01323647|463850494|FG000|Overall Study|Lost to Follow-up|2|||
128878691|NCT01323647|463850495|FG001|Overall Study|Lost to Follow-up|0|||
128878692|NCT01236339|463850500|FG000|Overall Study|Termination of study by sponsor|11|||
128878693|NCT01236339|463850501|FG001|Overall Study|Termination of study by sponsor|13|||
128878694|NCT02054741|463850502|FG000|Overall Study|Protocol Violation|13|||
128678548|NCT02095132|463122190|FG004|Overall Study|Withdrawal by Subject|3|||
128678549|NCT02095132|463122191|FG005|Overall Study|Withdrawal by Subject|0|||
128878695|NCT02054741|463850503|FG001|Overall Study|Protocol Violation|2|||
128878696|NCT02054741|463850502|FG000|Overall Study|Withdrawal by Subject|10|||
128878697|NCT02054741|463850503|FG001|Overall Study|Withdrawal by Subject|5|||
128678550|NCT02095132|463122192|FG006|Overall Study|Withdrawal by Subject|5|||
128878698|NCT02054741|463850502|FG000|Overall Study|Death|94|||
128878699|NCT02054741|463850503|FG001|Overall Study|Death|90|||
128878700|NCT02054741|463850502|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
128878701|NCT02054741|463850503|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
128878702|NCT00938860|463850505|FG000|Overall Study|Adverse Event|2|||
128878703|NCT00938860|463850506|FG001|Overall Study|Adverse Event|1|||
128878704|NCT00938860|463850505|FG000|Overall Study|Abnormal laboratory values|2|||
128878705|NCT00938860|463850506|FG001|Overall Study|Abnormal laboratory values|2|||
128878706|NCT00938860|463850505|FG000|Overall Study|Withdrawal by Subject|11|||
128878707|NCT00938860|463850506|FG001|Overall Study|Withdrawal by Subject|8|||
128878708|NCT00938860|463850505|FG000|Overall Study|Lost to Follow-up|4|||
128878709|NCT00938860|463850506|FG001|Overall Study|Lost to Follow-up|4|||
129012474|NCT02937701|464339536|FG002|Day 1 to Week 22|Other|0|||
129012475|NCT02937701|464339537|FG003|Day 1 to Week 22|Other|0|||
129012476|NCT02937701|464339538|FG004|Day 1 to Week 22|Other|0|||
129012477|NCT02937701|464339534|FG000|Week 22 to Week 50|Adverse Event|0|||
129012478|NCT02937701|464339535|FG001|Week 22 to Week 50|Adverse Event|0|||
129012479|NCT02937701|464339536|FG002|Week 22 to Week 50|Adverse Event|10|||
128878710|NCT00938860|463850505|FG000|Overall Study|Administration problems|2|||
128878711|NCT00938860|463850506|FG001|Overall Study|Administration problems|0|||
128878712|NCT00938860|463850505|FG000|Overall Study|Death|1|||
128878713|NCT00938860|463850506|FG001|Overall Study|Death|1|||
128878714|NCT00938860|463850505|FG000|Overall Study|Protocol Violation|3|||
128878715|NCT00938860|463850506|FG001|Overall Study|Protocol Violation|1|||
128878716|NCT01054170|463850510|FG000|Overall Study|Protocol Violation|1|||
128878717|NCT01054170|463850511|FG001|Overall Study|Protocol Violation|0|||
128878718|NCT01054170|463850510|FG000|Overall Study|Withdrawal by Subject|3|||
128878719|NCT01054170|463850511|FG001|Overall Study|Withdrawal by Subject|2|||
128878720|NCT01054170|463850510|FG000|Overall Study|Adverse Event|0|||
128878721|NCT01054170|463850511|FG001|Overall Study|Adverse Event|4|||
128878722|NCT05249829|463850512|FG000|Overall Study|Participant Relocation|0|||
128878723|NCT05249829|463850513|FG001|Overall Study|Participant Relocation|1|||
128878724|NCT05249829|463850514|FG002|Overall Study|Participant Relocation|2|||
128878725|NCT05249829|463850515|FG003|Overall Study|Participant Relocation|2|||
128878726|NCT05249829|463850512|FG000|Overall Study|Withdrawal by Subject|9|||
128878727|NCT05249829|463850513|FG001|Overall Study|Withdrawal by Subject|17|||
128878728|NCT05249829|463850514|FG002|Overall Study|Withdrawal by Subject|40|||
128878729|NCT05249829|463850515|FG003|Overall Study|Withdrawal by Subject|35|||
128878730|NCT05249829|463850512|FG000|Overall Study|Physician Decision|1|||
128878731|NCT05249829|463850513|FG001|Overall Study|Physician Decision|0|||
128878732|NCT05249829|463850514|FG002|Overall Study|Physician Decision|0|||
128878733|NCT05249829|463850515|FG003|Overall Study|Physician Decision|0|||
128878734|NCT05249829|463850512|FG000|Overall Study|Lost to Follow-up|16|||
128878735|NCT05249829|463850513|FG001|Overall Study|Lost to Follow-up|16|||
128878736|NCT05249829|463850514|FG002|Overall Study|Lost to Follow-up|57|||
128878737|NCT05249829|463850515|FG003|Overall Study|Lost to Follow-up|60|||
128878738|NCT05249829|463850512|FG000|Overall Study|Adverse Event|2|||
128878739|NCT05249829|463850513|FG001|Overall Study|Adverse Event|2|||
128878740|NCT05249829|463850514|FG002|Overall Study|Adverse Event|2|||
128878741|NCT05249829|463850515|FG003|Overall Study|Adverse Event|2|||
128878742|NCT05249829|463850512|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
128878743|NCT05249829|463850513|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
128878744|NCT05249829|463850514|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
128878745|NCT05249829|463850515|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
128878746|NCT05249829|463850512|FG000|Overall Study|Protocol Violation|2|||
128878747|NCT05249829|463850513|FG001|Overall Study|Protocol Violation|0|||
128878748|NCT05249829|463850514|FG002|Overall Study|Protocol Violation|5|||
128878749|NCT05249829|463850515|FG003|Overall Study|Protocol Violation|3|||
128878750|NCT05249829|463850512|FG000|Overall Study|Death|0|||
128878751|NCT05249829|463850513|FG001|Overall Study|Death|1|||
128878752|NCT05249829|463850514|FG002|Overall Study|Death|2|||
128878753|NCT05249829|463850515|FG003|Overall Study|Death|4|||
128878754|NCT00513604|463850516|FG000|Overall Study|Not treated|2|||
128878755|NCT00513604|463850517|FG001|Overall Study|Not treated|0|||
128878756|NCT00513604|463850518|FG002|Overall Study|Not treated|1|||
128878757|NCT00513604|463850519|FG003|Overall Study|Not treated|0|||
128878758|NCT00513604|463850520|FG004|Overall Study|Not treated|0|||
128878759|NCT00513604|463850516|FG000|Overall Study|Death during treatment|0|||
128878760|NCT00513604|463850517|FG001|Overall Study|Death during treatment|3|||
128878761|NCT00513604|463850518|FG002|Overall Study|Death during treatment|2|||
128878762|NCT00513604|463850519|FG003|Overall Study|Death during treatment|0|||
128878763|NCT00513604|463850520|FG004|Overall Study|Death during treatment|0|||
128878764|NCT01535560|463850525|FG000|Overall Study|Adverse Event|12|||
128878765|NCT01535560|463850526|FG001|Overall Study|Adverse Event|7|||
128878766|NCT01535560|463850525|FG000|Overall Study|Lost to Follow-up|1|||
128878767|NCT01535560|463850526|FG001|Overall Study|Lost to Follow-up|3|||
128878768|NCT01535560|463850525|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
128878769|NCT01535560|463850526|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
128878770|NCT01535560|463850525|FG000|Overall Study|Treatment Failure|21|||
128878771|NCT01535560|463850526|FG001|Overall Study|Treatment Failure|83|||
128878772|NCT01535560|463850525|FG000|Overall Study|Other|0|||
128878773|NCT01535560|463850526|FG001|Overall Study|Other|1|||
128878774|NCT01535560|463850525|FG000|Overall Study|Randomized in Error|0|||
128678551|NCT02095132|463122193|FG007|Overall Study|Withdrawal by Subject|0|||
128678552|NCT02095132|463122194|FG008|Overall Study|Withdrawal by Subject|0|||
128878775|NCT01535560|463850526|FG001|Overall Study|Randomized in Error|1|||
128878776|NCT02009761|463850527|FG000|Overall Study|Adverse Event|4|||
128878777|NCT02842827|463850528|FG000|Overall Study|Adverse Event|0|||
128878778|NCT02842827|463850529|FG001|Overall Study|Adverse Event|1|||
128878779|NCT02842827|463850530|FG002|Overall Study|Adverse Event|0|||
128878780|NCT02842827|463850531|FG003|Overall Study|Adverse Event|1|||
128878781|NCT02842827|463850532|FG004|Overall Study|Adverse Event|0|||
128678553|NCT01029405|463122195|FG000|Overall Study|Withdrawal by Subject|0|||
128878782|NCT02842827|463850533|FG005|Overall Study|Adverse Event|1|||
128878783|NCT02842827|463850534|FG006|Overall Study|Adverse Event|0|||
128878784|NCT02842827|463850535|FG007|Overall Study|Adverse Event|0|||
128878785|NCT02842827|463850528|FG000|Overall Study|Death|1|||
128878786|NCT02842827|463850529|FG001|Overall Study|Death|0|||
129012480|NCT02937701|464339537|FG003|Week 22 to Week 50|Adverse Event|3|||
129012481|NCT02937701|464339538|FG004|Week 22 to Week 50|Adverse Event|3|||
129012482|NCT02937701|464339534|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
129012483|NCT02937701|464339535|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
129012484|NCT02937701|464339536|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
129012485|NCT02937701|464339537|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
129012486|NCT02937701|464339538|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
129012487|NCT02937701|464339534|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
129012488|NCT02937701|464339535|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
129012489|NCT02937701|464339536|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
129012490|NCT02937701|464339537|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
129012491|NCT02937701|464339538|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
129012492|NCT02937701|464339534|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
129012493|NCT02937701|464339535|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
129012494|NCT02937701|464339536|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
129012495|NCT02937701|464339537|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
129012496|NCT02937701|464339538|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
129012497|NCT02937701|464339534|FG000|Week 22 to Week 50|Physician Decision|0|||
129012498|NCT02937701|464339535|FG001|Week 22 to Week 50|Physician Decision|0|||
129012499|NCT02937701|464339536|FG002|Week 22 to Week 50|Physician Decision|2|||
129012500|NCT02937701|464339537|FG003|Week 22 to Week 50|Physician Decision|0|||
129012501|NCT02937701|464339538|FG004|Week 22 to Week 50|Physician Decision|1|||
129012502|NCT02937701|464339534|FG000|Week 22 to Week 50|Other|0|||
129012503|NCT02937701|464339535|FG001|Week 22 to Week 50|Other|0|||
129012504|NCT02937701|464339536|FG002|Week 22 to Week 50|Other|0|||
129012505|NCT02937701|464339537|FG003|Week 22 to Week 50|Other|0|||
129012506|NCT02937701|464339538|FG004|Week 22 to Week 50|Other|1|||
129012507|NCT01996033|464339544|FG000|Overall Study|Death|1|||
129012508|NCT01996033|464339544|FG000|Overall Study|Physician Decision|1|||
129012509|NCT01996033|464339544|FG000|Overall Study|Withdrawal by Subject|4|||
129012510|NCT01996033|464339544|FG000|Overall Study|Lost to Follow-up|3|||
129012511|NCT02143102|464339547|FG000|Overall Study|Lost to Follow-up|11|||
129012512|NCT02143102|464339548|FG001|Overall Study|Lost to Follow-up|0|||
129012513|NCT01203878|464339549|FG000|Overall Study|Withdrawal by Subject|0|||
129012514|NCT01203878|464339550|FG001|Overall Study|Withdrawal by Subject|0|||
129012515|NCT01203878|464339551|FG002|Overall Study|Withdrawal by Subject|1|||
129012516|NCT01203878|464339549|FG000|Overall Study|Adverse Event|0|||
129012517|NCT01203878|464339550|FG001|Overall Study|Adverse Event|0|||
129012518|NCT01203878|464339551|FG002|Overall Study|Adverse Event|2|||
129012519|NCT01225146|464339552|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
129012520|NCT01225146|464339553|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
129012521|NCT01239121|464339554|FG000|Overall Study|Withdrawal by Subject|2|||
129012522|NCT01239121|464339555|FG001|Overall Study|Withdrawal by Subject|4|||
129012523|NCT01239121|464339556|FG002|Overall Study|Withdrawal by Subject|0|||
129012524|NCT00623779|464339560|FG000|Overall Study|Adverse Event|1|||
129012525|NCT00623779|464339561|FG001|Overall Study|Adverse Event|3|||
129012526|NCT00623779|464339562|FG002|Overall Study|Adverse Event|0|||
129012527|NCT00623779|464339560|FG000|Overall Study|Criteria from CSR|2|||
129012528|NCT00623779|464339561|FG001|Overall Study|Criteria from CSR|0|||
129012529|NCT00623779|464339562|FG002|Overall Study|Criteria from CSR|1|||
129012530|NCT01273181|464339563|FG000|Phase I, Dose 1|Study termination|1|||
129012531|NCT01273181|464339564|FG001|Phase I, Dose 1|Study termination|0|||
129012532|NCT01273181|464339565|FG002|Phase I, Dose 1|Study termination|0|||
129012533|NCT01273181|464339566|FG003|Phase I, Dose 1|Study termination|0|||
129012534|NCT01273181|464339563|FG000|Phase I, Dose 2|Death during treatment|0|||
129012535|NCT01273181|464339564|FG001|Phase I, Dose 2|Death during treatment|1|||
129012536|NCT01273181|464339565|FG002|Phase I, Dose 2|Death during treatment|0|||
129012537|NCT01273181|464339566|FG003|Phase I, Dose 2|Death during treatment|0|||
129012538|NCT01273181|464339563|FG000|Phase 2, Dose 1|Study termination|0|||
129012539|NCT01273181|464339564|FG001|Phase 2, Dose 1|Study termination|0|||
129012540|NCT01273181|464339565|FG002|Phase 2, Dose 1|Study termination|1|||
129012541|NCT01273181|464339566|FG003|Phase 2, Dose 1|Study termination|0|||
128878787|NCT02842827|463850530|FG002|Overall Study|Death|2|||
129012542|NCT01273181|464339563|FG000|Phase 2, Dose 2|Death during treatment|0|||
129012543|NCT01273181|464339564|FG001|Phase 2, Dose 2|Death during treatment|0|||
129012544|NCT01273181|464339565|FG002|Phase 2, Dose 2|Death during treatment|0|||
129012545|NCT01273181|464339566|FG003|Phase 2, Dose 2|Death during treatment|1|||
129012546|NCT00944697|464339567|FG000|Overall Study|Withdrawal by Subject|1|||
129012547|NCT00944697|464339568|FG001|Overall Study|Withdrawal by Subject|1|||
129012548|NCT00944697|464339567|FG000|Overall Study|Adverse Event|0|||
129012549|NCT00944697|464339568|FG001|Overall Study|Adverse Event|3|||
129012550|NCT00944697|464339567|FG000|Overall Study|Administrative|1|||
129012551|NCT00944697|464339568|FG001|Overall Study|Administrative|1|||
129012552|NCT03657160|464339569|FG000|Overall Study|Adverse Event|5|||
129012553|NCT03657160|464339570|FG001|Overall Study|Adverse Event|6|||
129012554|NCT03657160|464339569|FG000|Overall Study|Protocol Deviation|3|||
129012555|NCT03657160|464339570|FG001|Overall Study|Protocol Deviation|0|||
128878788|NCT02842827|463850531|FG003|Overall Study|Death|3|||
128878789|NCT02842827|463850532|FG004|Overall Study|Death|2|||
128878790|NCT02842827|463850533|FG005|Overall Study|Death|1|||
128878791|NCT02842827|463850534|FG006|Overall Study|Death|0|||
128878792|NCT02842827|463850535|FG007|Overall Study|Death|4|||
128878793|NCT02842827|463850528|FG000|Overall Study|Physician Decision|1|||
128878794|NCT02842827|463850529|FG001|Overall Study|Physician Decision|3|||
128878795|NCT02842827|463850530|FG002|Overall Study|Physician Decision|0|||
128878796|NCT02842827|463850531|FG003|Overall Study|Physician Decision|0|||
128878797|NCT02842827|463850532|FG004|Overall Study|Physician Decision|1|||
128878798|NCT02842827|463850533|FG005|Overall Study|Physician Decision|4|||
128678554|NCT01029405|463122196|FG001|Overall Study|Withdrawal by Subject|1|||
128678555|NCT01029405|463122197|FG002|Overall Study|Withdrawal by Subject|2|||
128678556|NCT01029405|463122198|FG003|Overall Study|Withdrawal by Subject|0|||
128678557|NCT01029405|463122195|FG000|Overall Study|Protocol Violation|0|||
128678558|NCT01029405|463122196|FG001|Overall Study|Protocol Violation|0|||
128678559|NCT01029405|463122197|FG002|Overall Study|Protocol Violation|0|||
128678560|NCT01029405|463122198|FG003|Overall Study|Protocol Violation|1|||
128678561|NCT01029405|463122195|FG000|Overall Study|Adverse Event|0|||
128678562|NCT01029405|463122196|FG001|Overall Study|Adverse Event|0|||
128678563|NCT01029405|463122197|FG002|Overall Study|Adverse Event|1|||
128678564|NCT01029405|463122198|FG003|Overall Study|Adverse Event|1|||
128678565|NCT01029405|463122195|FG000|Overall Study|Lost to Follow-up|2|||
128678566|NCT01029405|463122196|FG001|Overall Study|Lost to Follow-up|1|||
128678567|NCT01029405|463122197|FG002|Overall Study|Lost to Follow-up|1|||
128678568|NCT01029405|463122198|FG003|Overall Study|Lost to Follow-up|2|||
128678569|NCT01029405|463122195|FG000|Overall Study|Other|0|||
128678570|NCT01029405|463122196|FG001|Overall Study|Other|1|||
128678571|NCT01029405|463122197|FG002|Overall Study|Other|0|||
128678572|NCT01029405|463122198|FG003|Overall Study|Other|1|||
128678573|NCT00409175|463122199|FG000|Overall Study|Adverse Event|4|||
128678574|NCT00409175|463122200|FG001|Overall Study|Adverse Event|3|||
128678575|NCT00409175|463122199|FG000|Overall Study|Withdrawal by Subject|1|||
128678576|NCT00409175|463122200|FG001|Overall Study|Withdrawal by Subject|2|||
128678577|NCT00409175|463122199|FG000|Overall Study|Negative genotype|0|||
128678578|NCT00409175|463122200|FG001|Overall Study|Negative genotype|1|||
128678579|NCT00409175|463122199|FG000|Overall Study|Liver transplantation|13|||
128678580|NCT00409175|463122200|FG001|Overall Study|Liver transplantation|13|||
128678581|NCT02108262|463122203|FG000|Overall Study|Non-compliance|0|||
128678582|NCT02108262|463122204|FG001|Overall Study|Non-compliance|2|||
128678583|NCT02108262|463122205|FG002|Overall Study|Non-compliance|1|||
128678584|NCT02108262|463122206|FG003|Overall Study|Non-compliance|1|||
128678585|NCT02108262|463122203|FG000|Overall Study|Randomized by error/screen failure|0|||
128678586|NCT02108262|463122204|FG001|Overall Study|Randomized by error/screen failure|0|||
128678587|NCT02108262|463122205|FG002|Overall Study|Randomized by error/screen failure|1|||
129012556|NCT03657160|464339569|FG000|Overall Study|Withdrawal by Subject|18|||
129012557|NCT03657160|464339570|FG001|Overall Study|Withdrawal by Subject|16|||
129012558|NCT03657160|464339569|FG000|Overall Study|Site Termination|1|||
129012559|NCT03657160|464339570|FG001|Overall Study|Site Termination|0|||
128763113|NCT03145766|463422733|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
128763114|NCT03145766|463422734|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
128763115|NCT03145766|463422735|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
129012560|NCT03657160|464339569|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
129012561|NCT03657160|464339570|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
129012562|NCT03657160|464339569|FG000|Overall Study|Death|33|||
129012563|NCT03657160|464339570|FG001|Overall Study|Death|26|||
129012564|NCT03657160|464339569|FG000|Overall Study|Death (COVID-19-Related)|1|||
129012565|NCT03657160|464339570|FG001|Overall Study|Death (COVID-19-Related)|0|||
129012566|NCT03657160|464339569|FG000|Overall Study|Reason Not Specified|5|||
129012567|NCT03657160|464339570|FG001|Overall Study|Reason Not Specified|5|||
129012568|NCT03657160|464339569|FG000|Overall Study|Other (COVID-19-Related)|0|||
128678588|NCT02108262|463122206|FG003|Overall Study|Randomized by error/screen failure|0|||
129012569|NCT03657160|464339570|FG001|Overall Study|Other (COVID-19-Related)|1|||
129012570|NCT02732210|464339571|FG000|Overall Study|Site Closed|0|||
128678589|NCT02108262|463122203|FG000|Overall Study|Distance to center|0|||
128678590|NCT02108262|463122204|FG001|Overall Study|Distance to center|1|||
128678591|NCT02108262|463122205|FG002|Overall Study|Distance to center|1|||
128678592|NCT02108262|463122206|FG003|Overall Study|Distance to center|0|||
128678593|NCT02108262|463122203|FG000|Overall Study|Adverse Event|0|||
128678594|NCT02108262|463122204|FG001|Overall Study|Adverse Event|11|||
128678595|NCT02108262|463122205|FG002|Overall Study|Adverse Event|6|||
128678596|NCT02108262|463122206|FG003|Overall Study|Adverse Event|12|||
128678597|NCT02108262|463122203|FG000|Overall Study|Death|0|||
128678598|NCT02108262|463122204|FG001|Overall Study|Death|2|||
128878799|NCT02842827|463850534|FG006|Overall Study|Physician Decision|2|||
128878800|NCT02842827|463850535|FG007|Overall Study|Physician Decision|1|||
129012571|NCT02732210|464339572|FG001|Overall Study|Site Closed|11|||
129012572|NCT02732210|464339571|FG000|Overall Study|Study Ended|13|||
129012573|NCT02732210|464339572|FG001|Overall Study|Study Ended|13|||
128678599|NCT02108262|463122205|FG002|Overall Study|Death|2|||
128678600|NCT02108262|463122206|FG003|Overall Study|Death|1|||
128678601|NCT02108262|463122203|FG000|Overall Study|Lost to Follow-up|0|||
128678602|NCT02108262|463122204|FG001|Overall Study|Lost to Follow-up|0|||
128678603|NCT02108262|463122205|FG002|Overall Study|Lost to Follow-up|1|||
128678604|NCT02108262|463122206|FG003|Overall Study|Lost to Follow-up|0|||
128678605|NCT02108262|463122203|FG000|Overall Study|Physician Decision|0|||
128678606|NCT02108262|463122204|FG001|Overall Study|Physician Decision|0|||
128678607|NCT02108262|463122205|FG002|Overall Study|Physician Decision|2|||
128678608|NCT02108262|463122206|FG003|Overall Study|Physician Decision|0|||
128678609|NCT02108262|463122203|FG000|Overall Study|Withdrawal by Subject|0|||
128678610|NCT02108262|463122204|FG001|Overall Study|Withdrawal by Subject|7|||
128678611|NCT02108262|463122205|FG002|Overall Study|Withdrawal by Subject|3|||
129012574|NCT02732210|464339571|FG000|Overall Study|Withdrawal by Subject|28|||
129012575|NCT02732210|464339572|FG001|Overall Study|Withdrawal by Subject|87|||
129012576|NCT02732210|464339571|FG000|Overall Study|Lost to Follow-up|5|||
129012577|NCT02732210|464339572|FG001|Overall Study|Lost to Follow-up|57|||
129012578|NCT02732210|464339571|FG000|Overall Study|Death|4|||
129012579|NCT02732210|464339572|FG001|Overall Study|Death|15|||
129012580|NCT02732210|464339571|FG000|Overall Study|Other|35|||
129012581|NCT02732210|464339572|FG001|Overall Study|Other|103|||
129012582|NCT02732210|464339571|FG000|Overall Study|Missing|0|||
129012583|NCT02732210|464339572|FG001|Overall Study|Missing|8|||
129012584|NCT04638153|464339573|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129012585|NCT04638153|464339574|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129012586|NCT04638153|464339575|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129012587|NCT04638153|464339573|FG000|Overall Study|Study terminated by sponsor|4|||
129012588|NCT04638153|464339574|FG001|Overall Study|Study terminated by sponsor|2|||
129012589|NCT04638153|464339575|FG002|Overall Study|Study terminated by sponsor|14|||
129012590|NCT04006171|464339578|FG000|Overall Study|Withdrawal by Subject|8|||
129012591|NCT04006171|464339579|FG001|Overall Study|Withdrawal by Subject|7|||
129012592|NCT04006171|464339578|FG000|Overall Study|missing serum samples|2|||
129012593|NCT04006171|464339579|FG001|Overall Study|missing serum samples|2|||
129012594|NCT04006171|464339578|FG000|Overall Study|insufficient sample volume|2|||
129012595|NCT04006171|464339579|FG001|Overall Study|insufficient sample volume|3|||
129012596|NCT00440557|464339581|FG000|Overall Study|Withdrawal by Subject|10|||
129012597|NCT00440557|464339582|FG001|Overall Study|Withdrawal by Subject|5|||
129012598|NCT00440557|464339583|FG002|Overall Study|Withdrawal by Subject|11|||
129012599|NCT00440557|464339581|FG000|Overall Study|Lost to Follow-up|1|||
129012600|NCT00440557|464339582|FG001|Overall Study|Lost to Follow-up|2|||
129012601|NCT00440557|464339583|FG002|Overall Study|Lost to Follow-up|6|||
129012602|NCT00440557|464339581|FG000|Overall Study|Adverse Event|3|||
129012603|NCT00440557|464339582|FG001|Overall Study|Adverse Event|3|||
129012604|NCT00440557|464339583|FG002|Overall Study|Adverse Event|5|||
129012605|NCT00440557|464339581|FG000|Overall Study|Death|2|||
129012606|NCT00440557|464339582|FG001|Overall Study|Death|6|||
129012607|NCT00440557|464339583|FG002|Overall Study|Death|3|||
129012608|NCT00440557|464339581|FG000|Overall Study|Began Dialysis|4|||
129012609|NCT00440557|464339582|FG001|Overall Study|Began Dialysis|1|||
129012610|NCT00440557|464339583|FG002|Overall Study|Began Dialysis|4|||
129012611|NCT00440557|464339581|FG000|Overall Study|Principal Investigator decision|0|||
129012612|NCT00440557|464339582|FG001|Overall Study|Principal Investigator decision|3|||
129012613|NCT00440557|464339583|FG002|Overall Study|Principal Investigator decision|1|||
129012614|NCT00440557|464339581|FG000|Overall Study|Patient moved|1|||
129012615|NCT00440557|464339582|FG001|Overall Study|Patient moved|2|||
129012616|NCT00440557|464339583|FG002|Overall Study|Patient moved|1|||
128678612|NCT02108262|463122206|FG003|Overall Study|Withdrawal by Subject|4|||
128678613|NCT02108262|463122203|FG000|Overall Study|Due to key hepatic values|0|||
128678614|NCT02108262|463122204|FG001|Overall Study|Due to key hepatic values|1|||
128678615|NCT02108262|463122205|FG002|Overall Study|Due to key hepatic values|0|||
128678616|NCT02108262|463122206|FG003|Overall Study|Due to key hepatic values|0|||
129012617|NCT00440557|464339581|FG000|Overall Study|Principal Investigator's office closed|3|||
129012618|NCT00440557|464339582|FG001|Overall Study|Principal Investigator's office closed|6|||
129012619|NCT00440557|464339583|FG002|Overall Study|Principal Investigator's office closed|4|||
129012620|NCT00440557|464339581|FG000|Overall Study|Patient transferred to nursing home|0|||
129012621|NCT00440557|464339582|FG001|Overall Study|Patient transferred to nursing home|1|||
129012622|NCT00440557|464339583|FG002|Overall Study|Patient transferred to nursing home|0|||
129012623|NCT00440557|464339581|FG000|Overall Study|Patient had surgery|1|||
129012624|NCT00440557|464339582|FG001|Overall Study|Patient had surgery|0|||
129012625|NCT00440557|464339583|FG002|Overall Study|Patient had surgery|0|||
129012626|NCT00874237|464339589|FG000|Overall Study|Physician Decision|0|||
129012627|NCT00874237|464339590|FG001|Overall Study|Physician Decision|1|||
129012628|NCT00874237|464339591|FG002|Overall Study|Physician Decision|0|||
128678617|NCT02108262|463122203|FG000|Overall Study|Unable to contact patient|0|||
128678618|NCT02108262|463122204|FG001|Overall Study|Unable to contact patient|3|||
129012629|NCT00874237|464339592|FG003|Overall Study|Physician Decision|0|||
129012630|NCT00874237|464339593|FG004|Overall Study|Physician Decision|0|||
129012631|NCT00874237|464339594|FG005|Overall Study|Physician Decision|0|||
128678619|NCT02108262|463122205|FG002|Overall Study|Unable to contact patient|1|||
128678620|NCT02108262|463122206|FG003|Overall Study|Unable to contact patient|2|||
128678621|NCT02108262|463122203|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
128678622|NCT02108262|463122204|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
128678623|NCT02108262|463122205|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
128678624|NCT02108262|463122206|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
128678625|NCT02108262|463122203|FG000|Overall Study|Patient did not want another infusion|0|||
128678626|NCT02108262|463122204|FG001|Overall Study|Patient did not want another infusion|3|||
128678627|NCT02108262|463122205|FG002|Overall Study|Patient did not want another infusion|3|||
128678628|NCT02108262|463122206|FG003|Overall Study|Patient did not want another infusion|2|||
128678629|NCT02108262|463122203|FG000|Overall Study|Vacation|0|||
128678630|NCT02108262|463122204|FG001|Overall Study|Vacation|1|||
128678631|NCT02108262|463122205|FG002|Overall Study|Vacation|0|||
128678632|NCT02108262|463122206|FG003|Overall Study|Vacation|0|||
128678633|NCT02108262|463122203|FG000|Overall Study|Patient decision|0|||
128678634|NCT02108262|463122204|FG001|Overall Study|Patient decision|7|||
128678635|NCT02108262|463122205|FG002|Overall Study|Patient decision|9|||
128678636|NCT02108262|463122206|FG003|Overall Study|Patient decision|14|||
128678637|NCT02108262|463122203|FG000|Overall Study|Missed IV due to pharmacy error|0|||
128678638|NCT02108262|463122204|FG001|Overall Study|Missed IV due to pharmacy error|0|||
128678639|NCT02108262|463122205|FG002|Overall Study|Missed IV due to pharmacy error|1|||
128678640|NCT02108262|463122206|FG003|Overall Study|Missed IV due to pharmacy error|0|||
128678641|NCT01895361|463122207|FG000|Overall Study|Adverse Event|1|||
128678642|NCT01895361|463122208|FG001|Overall Study|Adverse Event|1|||
128678643|NCT01895361|463122209|FG002|Overall Study|Adverse Event|3|||
128678644|NCT01895361|463122207|FG000|Overall Study|Death|2|||
128678645|NCT01895361|463122208|FG001|Overall Study|Death|1|||
128678646|NCT01895361|463122209|FG002|Overall Study|Death|2|||
128678647|NCT01895361|463122207|FG000|Overall Study|Lost to Follow-up|4|||
128678648|NCT01895361|463122208|FG001|Overall Study|Lost to Follow-up|4|||
128678649|NCT01895361|463122209|FG002|Overall Study|Lost to Follow-up|6|||
128678650|NCT01895361|463122207|FG000|Overall Study|Non-compliance with study|1|||
128678651|NCT01895361|463122208|FG001|Overall Study|Non-compliance with study|3|||
128678652|NCT01895361|463122209|FG002|Overall Study|Non-compliance with study|1|||
128678653|NCT01895361|463122207|FG000|Overall Study|Physician Decision|2|||
128678654|NCT01895361|463122208|FG001|Overall Study|Physician Decision|2|||
128678655|NCT01895361|463122209|FG002|Overall Study|Physician Decision|2|||
128678656|NCT01895361|463122207|FG000|Overall Study|Withdrawal by Subject|7|||
128678657|NCT01895361|463122208|FG001|Overall Study|Withdrawal by Subject|6|||
128678658|NCT01895361|463122209|FG002|Overall Study|Withdrawal by Subject|6|||
128678659|NCT01895361|463122207|FG000|Overall Study|Lack of Efficacy|0|||
128678660|NCT01895361|463122208|FG001|Overall Study|Lack of Efficacy|1|||
128678661|NCT01895361|463122209|FG002|Overall Study|Lack of Efficacy|0|||
128678662|NCT01895361|463122207|FG000|Overall Study|Reasons different from categories above|7|||
128678663|NCT01895361|463122208|FG001|Overall Study|Reasons different from categories above|3|||
128678664|NCT01895361|463122209|FG002|Overall Study|Reasons different from categories above|4|||
128678665|NCT01268579|463122213|FG000|Overall Study|Adverse Event|1|||
128678666|NCT01268579|463122213|FG000|Overall Study|Withdrawal by Subject|2|||
128678667|NCT01209832|463122214|FG000|Period 1|Sponsor Decision and was not dosed|1|||
128678668|NCT01209832|463122214|FG000|Period 2|Sponsor Decision|1|||
128678669|NCT00868517|463122217|FG000|Overall Study|Withdrawal by Subject|3|||
128678670|NCT00868517|463122218|FG001|Overall Study|Withdrawal by Subject|3|||
128678671|NCT00868517|463122219|FG002|Overall Study|Withdrawal by Subject|2|||
128678672|NCT00868517|463122217|FG000|Overall Study|Protocol Violation|1|||
128678673|NCT00868517|463122218|FG001|Overall Study|Protocol Violation|1|||
128678674|NCT00868517|463122219|FG002|Overall Study|Protocol Violation|0|||
128678675|NCT00420641|463122222|FG000|Overall Study|Adverse Event|3|||
128678676|NCT00420641|463122223|FG001|Overall Study|Adverse Event|25|||
128678677|NCT00420641|463122224|FG002|Overall Study|Adverse Event|10|||
128678678|NCT00420641|463122222|FG000|Overall Study|Lost to Follow-up|2|||
128678679|NCT00420641|463122223|FG001|Overall Study|Lost to Follow-up|4|||
128678680|NCT00420641|463122224|FG002|Overall Study|Lost to Follow-up|2|||
128678681|NCT00420641|463122222|FG000|Overall Study|Protocol Violation|8|||
128878801|NCT02842827|463850528|FG000|Overall Study|Protocol Defined Disease Progression|0|||
128678682|NCT00420641|463122223|FG001|Overall Study|Protocol Violation|8|||
128678683|NCT00420641|463122224|FG002|Overall Study|Protocol Violation|7|||
128678684|NCT00420641|463122222|FG000|Overall Study|Withdrawal by Subject|15|||
128678685|NCT00420641|463122223|FG001|Overall Study|Withdrawal by Subject|21|||
128678686|NCT00420641|463122224|FG002|Overall Study|Withdrawal by Subject|14|||
128678687|NCT00420641|463122222|FG000|Overall Study|Lack of Efficacy|6|||
128678688|NCT00420641|463122223|FG001|Overall Study|Lack of Efficacy|5|||
128678689|NCT00420641|463122224|FG002|Overall Study|Lack of Efficacy|4|||
128678690|NCT00420641|463122222|FG000|Overall Study|Non-compliance|7|||
128678691|NCT00420641|463122223|FG001|Overall Study|Non-compliance|5|||
128678692|NCT00420641|463122224|FG002|Overall Study|Non-compliance|4|||
128678693|NCT00420641|463122222|FG000|Overall Study|Other|4|||
128678694|NCT00420641|463122223|FG001|Overall Study|Other|4|||
128878802|NCT02842827|463850529|FG001|Overall Study|Protocol Defined Disease Progression|0|||
128878803|NCT02842827|463850530|FG002|Overall Study|Protocol Defined Disease Progression|0|||
128878804|NCT02842827|463850531|FG003|Overall Study|Protocol Defined Disease Progression|0|||
128878805|NCT02842827|463850532|FG004|Overall Study|Protocol Defined Disease Progression|0|||
128878806|NCT02842827|463850533|FG005|Overall Study|Protocol Defined Disease Progression|1|||
129101667|NCT01900899|464666245|FG000|Overall Study|Migrated from study area|2|||
129101668|NCT01900899|464666246|FG001|Overall Study|Migrated from study area|0|||
129101669|NCT00248833|464666247|FG000|Overall Study|Adverse Event|2|||
129101670|NCT00248833|464666248|FG001|Overall Study|Adverse Event|0|||
128678695|NCT00420641|463122224|FG002|Overall Study|Other|3|||
128878807|NCT02842827|463850534|FG006|Overall Study|Protocol Defined Disease Progression|0|||
128878808|NCT02842827|463850535|FG007|Overall Study|Protocol Defined Disease Progression|0|||
128878809|NCT02842827|463850528|FG000|Overall Study|Participant Withdrawal of Consent|1|||
128878810|NCT02842827|463850529|FG001|Overall Study|Participant Withdrawal of Consent|2|||
128878811|NCT02842827|463850530|FG002|Overall Study|Participant Withdrawal of Consent|2|||
128878812|NCT02842827|463850531|FG003|Overall Study|Participant Withdrawal of Consent|2|||
128878813|NCT02842827|463850532|FG004|Overall Study|Participant Withdrawal of Consent|2|||
128878814|NCT02842827|463850533|FG005|Overall Study|Participant Withdrawal of Consent|1|||
128878815|NCT02842827|463850534|FG006|Overall Study|Participant Withdrawal of Consent|2|||
128878816|NCT02842827|463850535|FG007|Overall Study|Participant Withdrawal of Consent|1|||
128878817|NCT00943111|463850543|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
128878818|NCT00943111|463850544|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
128878819|NCT00943111|463850545|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
128878820|NCT00943111|463850543|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
128878821|NCT00943111|463850544|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
128878822|NCT00943111|463850545|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
128878823|NCT00943111|463850543|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
128878824|NCT00943111|463850544|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
128878825|NCT00943111|463850545|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
128878826|NCT00943111|463850543|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
128878827|NCT00943111|463850544|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
128878828|NCT00943111|463850545|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
128878829|NCT00943111|463850543|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
128878830|NCT00943111|463850544|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
128878831|NCT00943111|463850545|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
128878832|NCT00943111|463850543|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
128878833|NCT00943111|463850544|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
128878834|NCT00943111|463850545|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
128878835|NCT00943111|463850543|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
128878836|NCT00943111|463850544|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
128878837|NCT00943111|463850545|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
128878838|NCT00943111|463850543|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
128878839|NCT00943111|463850544|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
128878840|NCT00943111|463850545|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
128878841|NCT01796548|463850546|FG000|Overall Study|Lost to Follow-up|1|||
128878842|NCT01796548|463850546|FG000|Overall Study|Other|2|||
128878843|NCT02859324|463850547|FG000|Overall Study|Death|4|||
128878844|NCT02859324|463850548|FG001|Overall Study|Death|6|||
128878845|NCT02859324|463850549|FG002|Overall Study|Death|5|||
128878846|NCT02859324|463850547|FG000|Overall Study|Other reasons|3|||
128878847|NCT02859324|463850548|FG001|Overall Study|Other reasons|3|||
128878848|NCT02859324|463850549|FG002|Overall Study|Other reasons|0|||
128878849|NCT04227704|463850555|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
128878850|NCT04227704|463850556|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
128878851|NCT04227704|463850557|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
128878852|NCT04227704|463850555|FG000|Overall Study|due to C/S being cancelled|1|||
128878853|NCT04227704|463850556|FG001|Overall Study|due to C/S being cancelled|0|||
128878854|NCT04227704|463850557|FG002|Overall Study|due to C/S being cancelled|0|||
128878855|NCT00112047|463850558|FG000|Randomized Phase|Lost to Follow-up|26|||
128878856|NCT00112047|463850559|FG001|Randomized Phase|Lost to Follow-up|33|||
128878857|NCT00112047|463850558|FG000|Randomized Phase|Adverse Event|10|||
128878858|NCT00112047|463850559|FG001|Randomized Phase|Adverse Event|10|||
128678696|NCT03459690|463122225|FG000|Overall Study|Lost to Follow-up|0|||
128678697|NCT03459690|463122226|FG001|Overall Study|Lost to Follow-up|1|||
128678698|NCT03459690|463122225|FG000|Overall Study|Withdrawal by Subject|1|||
128678699|NCT03459690|463122226|FG001|Overall Study|Withdrawal by Subject|1|||
128678700|NCT02586506|463122227|FG000|Overall Study|Protocol Violation|6|||
128678701|NCT02586506|463122227|FG000|Overall Study|Lost to Follow-up|1|||
128678702|NCT02586506|463122227|FG000|Overall Study|Other Reason|2|||
129101671|NCT00248833|464666249|FG002|Overall Study|Adverse Event|0|||
129101672|NCT00248833|464666247|FG000|Overall Study|Withdrawal by Subject|0|||
128878859|NCT00112047|463850558|FG000|Randomized Phase|Withrawal of consent|10|||
128878860|NCT00112047|463850559|FG001|Randomized Phase|Withrawal of consent|18|||
128878861|NCT00112047|463850558|FG000|Randomized Phase|Sub-optimal virological response|3|||
128878862|NCT00112047|463850559|FG001|Randomized Phase|Sub-optimal virological response|13|||
128878863|NCT00112047|463850558|FG000|Randomized Phase|Noncompliance|8|||
128878864|NCT00112047|463850559|FG001|Randomized Phase|Noncompliance|4|||
128878865|NCT00112047|463850558|FG000|Randomized Phase|Protocol Violation|2|||
128878866|NCT00112047|463850559|FG001|Randomized Phase|Protocol Violation|0|||
128878867|NCT00112047|463850558|FG000|Randomized Phase|Pregnancy|3|||
128878868|NCT00112047|463850559|FG001|Randomized Phase|Pregnancy|1|||
128878869|NCT00112047|463850558|FG000|Randomized Phase|Death|1|||
128878870|NCT00112047|463850559|FG001|Randomized Phase|Death|3|||
128878871|NCT00112047|463850558|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
128878872|NCT00112047|463850559|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
128878873|NCT00112047|463850558|FG000|Randomized Phase|Inability to swallow pills|0|||
128878874|NCT00112047|463850559|FG001|Randomized Phase|Inability to swallow pills|1|||
128878875|NCT00112047|463850558|FG000|Randomized Phase|Incarceration|3|||
128878876|NCT00112047|463850559|FG001|Randomized Phase|Incarceration|2|||
128878877|NCT00112047|463850558|FG000|Randomized Phase|Moved out of State|0|||
128878878|NCT00112047|463850559|FG001|Randomized Phase|Moved out of State|1|||
128878879|NCT00112047|463850558|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
128878880|NCT00112047|463850559|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
128878881|NCT00112047|463850558|FG000|Randomized Phase|High Hepatitis B DNA|0|||
129101673|NCT00248833|464666248|FG001|Overall Study|Withdrawal by Subject|1|||
129101674|NCT00248833|464666249|FG002|Overall Study|Withdrawal by Subject|1|||
129101675|NCT00248833|464666247|FG000|Overall Study|Lost to Follow-up|1|||
129101676|NCT00248833|464666248|FG001|Overall Study|Lost to Follow-up|1|||
129101677|NCT00248833|464666249|FG002|Overall Study|Lost to Follow-up|1|||
128678703|NCT02815280|463122228|FG000|Double-Blind Phase|Adverse Event|1|||
128678704|NCT02815280|463122229|FG001|Double-Blind Phase|Adverse Event|1|||
128678705|NCT02815280|463122228|FG000|Double-Blind Phase|Lost to Follow-up|10|||
129101678|NCT00248833|464666247|FG000|Overall Study|Other|0|||
129101679|NCT00248833|464666248|FG001|Overall Study|Other|1|||
129101680|NCT00248833|464666249|FG002|Overall Study|Other|0|||
129101681|NCT00723697|464666252|FG000|Overall Study|Physician questionnaires not received|2|||
129101682|NCT00723697|464666252|FG000|Overall Study|Missing Informed Consent Form|10|||
129101683|NCT00723697|464666252|FG000|Overall Study|Other exclusion criteria applied|6|||
129101684|NCT02164318|464667672|FG000|Overall Study|Withdrawal by Subject|0|||
129101685|NCT02164318|464667673|FG001|Overall Study|Withdrawal by Subject|1|||
128678706|NCT02815280|463122229|FG001|Double-Blind Phase|Lost to Follow-up|9|||
128678707|NCT02815280|463122228|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
128678708|NCT02815280|463122229|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
128678709|NCT02815280|463122228|FG000|Double-Blind Phase|Protocol Violation|2|||
128678710|NCT02815280|463122229|FG001|Double-Blind Phase|Protocol Violation|2|||
128878882|NCT00112047|463850559|FG001|Randomized Phase|High Hepatitis B DNA|1|||
128878883|NCT00112047|463850558|FG000|Atripla Phase|Adverse Event|2|||
128878884|NCT00112047|463850559|FG001|Atripla Phase|Adverse Event|1|||
128878885|NCT00112047|463850558|FG000|Atripla Phase|Lost to Follow-up|5|||
128878886|NCT00112047|463850559|FG001|Atripla Phase|Lost to Follow-up|7|||
128878887|NCT00112047|463850558|FG000|Atripla Phase|Pregnancy|0|||
128878888|NCT00112047|463850559|FG001|Atripla Phase|Pregnancy|1|||
128878889|NCT00112047|463850558|FG000|Atripla Phase|Death|0|||
128878890|NCT00112047|463850559|FG001|Atripla Phase|Death|2|||
128878891|NCT00112047|463850558|FG000|Atripla Phase|Withdrew consent|7|||
128878892|NCT00112047|463850559|FG001|Atripla Phase|Withdrew consent|7|||
128878893|NCT00112047|463850558|FG000|Atripla Phase|Sub-optimal virological response|0|||
128878894|NCT00112047|463850559|FG001|Atripla Phase|Sub-optimal virological response|1|||
128878895|NCT00112047|463850558|FG000|Atripla Phase|Non-compliance|1|||
128678711|NCT02815280|463122228|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
128678712|NCT02815280|463122229|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
128678713|NCT02815280|463122228|FG000|Open-Label Phase|Adverse Event|2|||
128878896|NCT00112047|463850559|FG001|Atripla Phase|Non-compliance|0|||
128878897|NCT00112047|463850558|FG000|Atripla Phase|Other|3|||
128878898|NCT00112047|463850559|FG001|Atripla Phase|Other|1|||
128878899|NCT01307579|463850560|FG000|Overall Study|Death|3|||
128878900|NCT01307579|463850561|FG001|Overall Study|Death|6|||
128878901|NCT01307579|463850560|FG000|Overall Study|Physician Decision|26|||
128878902|NCT01307579|463850561|FG001|Overall Study|Physician Decision|29|||
128878903|NCT01307579|463850560|FG000|Overall Study|Withdrawal by Subject|7|||
128878904|NCT01307579|463850561|FG001|Overall Study|Withdrawal by Subject|3|||
128878905|NCT01307579|463850560|FG000|Overall Study|Institutional diagnosis of IFD|21|||
128878906|NCT01307579|463850561|FG001|Overall Study|Institutional diagnosis of IFD|36|||
129101686|NCT02164318|464667674|FG002|Overall Study|Withdrawal by Subject|0|||
129101687|NCT02164318|464667675|FG003|Overall Study|Withdrawal by Subject|1|||
128878907|NCT01307579|463850560|FG000|Overall Study|Begin conditioning for HSCT|42|||
129101688|NCT03084302|464667680|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
128678714|NCT02815280|463122229|FG001|Open-Label Phase|Adverse Event|3|||
128678715|NCT02815280|463122228|FG000|Open-Label Phase|Lost to Follow-up|18|||
128678716|NCT02815280|463122229|FG001|Open-Label Phase|Lost to Follow-up|9|||
128678717|NCT02815280|463122228|FG000|Open-Label Phase|Withdrawal by Subject|33|||
128678718|NCT02815280|463122229|FG001|Open-Label Phase|Withdrawal by Subject|18|||
128678719|NCT02815280|463122228|FG000|Open-Label Phase|Protocol Violation|3|||
128678720|NCT02815280|463122229|FG001|Open-Label Phase|Protocol Violation|0|||
128678721|NCT02815280|463122228|FG000|Open-Label Phase|Administrative|26|||
128678722|NCT02815280|463122229|FG001|Open-Label Phase|Administrative|12|||
128678723|NCT02815280|463122228|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
128678724|NCT02815280|463122229|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
128678725|NCT02514473|463122244|FG000|Overall Study|Adverse Event|0|||
128678726|NCT02514473|463122245|FG001|Overall Study|Adverse Event|2|||
128678727|NCT02514473|463122244|FG000|Overall Study|Withdrawal by Subject|2|||
128678728|NCT02514473|463122245|FG001|Overall Study|Withdrawal by Subject|1|||
128678729|NCT02514473|463122244|FG000|Overall Study|Lost to Follow-up|0|||
128678730|NCT02514473|463122245|FG001|Overall Study|Lost to Follow-up|1|||
128678731|NCT02514473|463122244|FG000|Overall Study|Other|1|||
128678732|NCT02514473|463122245|FG001|Overall Study|Other|1|||
128678733|NCT02158364|463122246|FG000|Overall Study|Case report forms uncollected|10|||
128678734|NCT02158364|463122246|FG000|Overall Study|Protocol Deviation|50|||
128678735|NCT01944839|463122249|FG000|Overall Study|Physician Decision|2|||
128678736|NCT01944839|463122250|FG001|Overall Study|Physician Decision|2|||
128678737|NCT01944839|463122249|FG000|Overall Study|Protocol Violation|0|||
128678738|NCT01944839|463122250|FG001|Overall Study|Protocol Violation|1|||
128678739|NCT01944839|463122249|FG000|Overall Study|Adverse Event|10|||
128678740|NCT01944839|463122250|FG001|Overall Study|Adverse Event|5|||
128678741|NCT01944839|463122249|FG000|Overall Study|Withdrawal by Subject|9|||
128678742|NCT01944839|463122250|FG001|Overall Study|Withdrawal by Subject|17|||
128678743|NCT01944839|463122249|FG000|Overall Study|Lost to Follow-up|1|||
128678744|NCT01944839|463122250|FG001|Overall Study|Lost to Follow-up|0|||
128678745|NCT01944839|463122249|FG000|Overall Study|Subject non-compliance|0|||
128678746|NCT01944839|463122250|FG001|Overall Study|Subject non-compliance|3|||
128878908|NCT01307579|463850561|FG001|Overall Study|Begin conditioning for HSCT|44|||
128878909|NCT01307579|463850560|FG000|Overall Study|Refractory or relapsed AML|38|||
128878910|NCT01307579|463850561|FG001|Overall Study|Refractory or relapsed AML|23|||
128878911|NCT01307579|463850560|FG000|Overall Study|Ineligible|3|||
128878912|NCT01307579|463850561|FG001|Overall Study|Ineligible|4|||
128878913|NCT02336178|463852794|FG000|Overall Study|Lost to Follow-up|1|||
128878914|NCT02336178|463852794|FG000|Overall Study|Protocol Violation|1|||
128878915|NCT02336178|463852794|FG000|Overall Study|Withdrawal by Subject|1|||
128878916|NCT02336178|463852794|FG000|Overall Study|Other|1|||
128878917|NCT00618982|463852795|FG000|Overall Study|Adverse Event|23|||
128878918|NCT00618982|463852795|FG000|Overall Study|Withdrawal by Subject|1|||
128878919|NCT00618982|463852795|FG000|Overall Study|Protocol Violation|1|||
128878920|NCT00618982|463852795|FG000|Overall Study|ongoing, still treated with study med.|25|||
128878921|NCT01776541|463852798|FG000|Overall Study|Administrative Reason|6|||
128878922|NCT01776541|463852799|FG001|Overall Study|Administrative Reason|2|||
128878923|NCT01776541|463852798|FG000|Overall Study|Death|4|||
128878924|NCT01776541|463852799|FG001|Overall Study|Death|0|||
128878925|NCT01776541|463852798|FG000|Overall Study|Lost to Follow-up|27|||
128878926|NCT01776541|463852799|FG001|Overall Study|Lost to Follow-up|48|||
128878927|NCT01776541|463852798|FG000|Overall Study|Unclassified|5|||
128878928|NCT01776541|463852799|FG001|Overall Study|Unclassified|4|||
128878929|NCT01776541|463852798|FG000|Overall Study|Protocol Violation|2|||
128878930|NCT01776541|463852799|FG001|Overall Study|Protocol Violation|1|||
128878931|NCT01776541|463852798|FG000|Overall Study|Withdrawal by Subject|12|||
128878932|NCT01776541|463852799|FG001|Overall Study|Withdrawal by Subject|20|||
128878933|NCT00156819|463852800|FG000|Overall Study|Lost to Follow-up|1|||
128878934|NCT00156819|463852801|FG001|Overall Study|Lost to Follow-up|1|||
128878935|NCT00156819|463852802|FG002|Overall Study|Lost to Follow-up|3|||
128878936|NCT00522873|463852805|FG000|Overall Study|Adverse Event|41|||
128878937|NCT00522873|463852806|FG001|Overall Study|Adverse Event|26|||
128878938|NCT00522873|463852805|FG000|Overall Study|Withdrawal by Subject|20|||
128878939|NCT00522873|463852806|FG001|Overall Study|Withdrawal by Subject|9|||
128878940|NCT00522873|463852805|FG000|Overall Study|Protocol Violation|14|||
128678747|NCT05093790|463122251|FG000|Overall Study|Failure to meet continuation criteria|0|||
128678748|NCT05093790|463122252|FG001|Overall Study|Failure to meet continuation criteria|0|||
128678749|NCT05093790|463122253|FG002|Overall Study|Failure to meet continuation criteria|1|||
128678750|NCT05093790|463122254|FG003|Overall Study|Failure to meet continuation criteria|0|||
128678751|NCT05093790|463122251|FG000|Overall Study|Adverse Event|1|||
128678752|NCT05093790|463122252|FG001|Overall Study|Adverse Event|0|||
128678753|NCT05093790|463122253|FG002|Overall Study|Adverse Event|0|||
128878941|NCT00522873|463852806|FG001|Overall Study|Protocol Violation|4|||
128878942|NCT00522873|463852805|FG000|Overall Study|Lost to Follow-up|11|||
128878943|NCT00522873|463852806|FG001|Overall Study|Lost to Follow-up|3|||
128878944|NCT00522873|463852805|FG000|Overall Study|Personal Reasons|8|||
128878945|NCT00522873|463852806|FG001|Overall Study|Personal Reasons|1|||
128878946|NCT00522873|463852805|FG000|Overall Study|Medication Errors|1|||
128878947|NCT00522873|463852806|FG001|Overall Study|Medication Errors|1|||
128878948|NCT00522873|463852805|FG000|Overall Study|Never Received Medication|1|||
128878949|NCT00522873|463852806|FG001|Overall Study|Never Received Medication|0|||
128878950|NCT00799513|463852807|FG000|Overall Study|Physician Decision|1|||
128878951|NCT00799513|463852807|FG000|Overall Study|Adverse Event|1|||
128878952|NCT00666679|463852810|FG000|First Intervention|Lost to Follow-up|1|||
128878953|NCT00666679|463852811|FG001|First Intervention|Lost to Follow-up|0|||
128878954|NCT00666679|463852810|FG000|First Intervention|Protocol Violation|1|||
128878955|NCT00666679|463852811|FG001|First Intervention|Protocol Violation|0|||
128878956|NCT00666679|463852810|FG000|First Intervention|Withdrawal by Subject|1|||
128878957|NCT00666679|463852811|FG001|First Intervention|Withdrawal by Subject|0|||
128878958|NCT00666679|463852810|FG000|First Intervention|Randomized did not start treatment|1|||
128878959|NCT00666679|463852811|FG001|First Intervention|Randomized did not start treatment|1|||
128878960|NCT00666679|463852810|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
128878961|NCT00666679|463852811|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
128878962|NCT00666679|463852810|FG000|Washout Period of 1 Week|Protocol Violation|0|||
128878963|NCT00666679|463852811|FG001|Washout Period of 1 Week|Protocol Violation|1|||
128678754|NCT05093790|463122254|FG003|Overall Study|Adverse Event|0|||
128878964|NCT00666679|463852810|FG000|Second Intervention|Adverse Event|1|||
128878965|NCT00666679|463852811|FG001|Second Intervention|Adverse Event|0|||
128678755|NCT04449029|463122255|FG000|Overall Study|Adverse Event|0|||
128678756|NCT04449029|463122256|FG001|Overall Study|Adverse Event|1|||
128678757|NCT04449029|463122257|FG002|Overall Study|Adverse Event|1|||
128678758|NCT04449029|463122258|FG003|Overall Study|Adverse Event|0|||
128678759|NCT04449029|463122259|FG004|Overall Study|Adverse Event|1|||
128678760|NCT04449029|463122260|FG005|Overall Study|Adverse Event|0|||
128678761|NCT04449029|463122261|FG006|Overall Study|Adverse Event|1|||
128678762|NCT04449029|463122262|FG007|Overall Study|Adverse Event|0|||
128678763|NCT04449029|463122255|FG000|Overall Study|Lost to Follow-up|0|||
128678764|NCT04449029|463122256|FG001|Overall Study|Lost to Follow-up|1|||
128678765|NCT04449029|463122257|FG002|Overall Study|Lost to Follow-up|0|||
128678766|NCT04449029|463122258|FG003|Overall Study|Lost to Follow-up|0|||
128678767|NCT04449029|463122259|FG004|Overall Study|Lost to Follow-up|0|||
128678768|NCT04449029|463122260|FG005|Overall Study|Lost to Follow-up|0|||
128678769|NCT04449029|463122261|FG006|Overall Study|Lost to Follow-up|0|||
128678770|NCT04449029|463122262|FG007|Overall Study|Lost to Follow-up|0|||
128678771|NCT04449029|463122255|FG000|Overall Study|Protocol Violation|0|||
128678772|NCT04449029|463122256|FG001|Overall Study|Protocol Violation|1|||
128678773|NCT04449029|463122257|FG002|Overall Study|Protocol Violation|0|||
128678774|NCT04449029|463122258|FG003|Overall Study|Protocol Violation|0|||
128678775|NCT04449029|463122259|FG004|Overall Study|Protocol Violation|0|||
128678776|NCT04449029|463122260|FG005|Overall Study|Protocol Violation|0|||
128678777|NCT04449029|463122261|FG006|Overall Study|Protocol Violation|0|||
128678778|NCT04449029|463122262|FG007|Overall Study|Protocol Violation|0|||
128678779|NCT04449029|463122255|FG000|Overall Study|Physician Decision|0|||
128678780|NCT04449029|463122256|FG001|Overall Study|Physician Decision|0|||
128678781|NCT04449029|463122257|FG002|Overall Study|Physician Decision|0|||
128678782|NCT04449029|463122258|FG003|Overall Study|Physician Decision|0|||
128678783|NCT04449029|463122259|FG004|Overall Study|Physician Decision|0|||
128678784|NCT04449029|463122260|FG005|Overall Study|Physician Decision|1|||
128678785|NCT04449029|463122261|FG006|Overall Study|Physician Decision|0|||
128678786|NCT04449029|463122262|FG007|Overall Study|Physician Decision|0|||
128678787|NCT04449029|463122255|FG000|Overall Study|Withdrawal by Subject|3|||
128678788|NCT04449029|463122256|FG001|Overall Study|Withdrawal by Subject|0|||
128678789|NCT04449029|463122257|FG002|Overall Study|Withdrawal by Subject|1|||
128678790|NCT04449029|463122258|FG003|Overall Study|Withdrawal by Subject|1|||
128678791|NCT04449029|463122259|FG004|Overall Study|Withdrawal by Subject|5|||
128678792|NCT04449029|463122260|FG005|Overall Study|Withdrawal by Subject|1|||
128678793|NCT04449029|463122261|FG006|Overall Study|Withdrawal by Subject|4|||
128878966|NCT00666679|463852810|FG000|Second Intervention|Death|0|||
128878967|NCT00666679|463852811|FG001|Second Intervention|Death|1|||
128878968|NCT05062759|463852815|FG000|Overall Study|Death|0|||
128878969|NCT05062759|463852816|FG001|Overall Study|Death|1|||
128678794|NCT04449029|463122262|FG007|Overall Study|Withdrawal by Subject|0|||
128678795|NCT00627445|463122263|FG000|Overall Study|Adverse Event|3|||
128678796|NCT00627445|463122264|FG001|Overall Study|Adverse Event|3|||
128678797|NCT00627445|463122263|FG000|Overall Study|Lack of Efficacy|0|||
128678798|NCT00627445|463122264|FG001|Overall Study|Lack of Efficacy|1|||
128678799|NCT00627445|463122263|FG000|Overall Study|Other|6|||
128678800|NCT00627445|463122264|FG001|Overall Study|Other|8|||
128878970|NCT05062759|463852815|FG000|Overall Study|Lost to Follow-up|1|||
128878971|NCT05062759|463852816|FG001|Overall Study|Lost to Follow-up|0|||
128678801|NCT04098224|463122265|FG000|Overall Study|Adverse Event|1|||
128678802|NCT04098224|463122266|FG001|Overall Study|Adverse Event|0|||
128678803|NCT04098224|463122265|FG000|Overall Study|Physician Decision|1|||
128878972|NCT02781844|463852817|FG000|Treatment Period 1|Adverse Event|0|||
128678804|NCT04098224|463122266|FG001|Overall Study|Physician Decision|0|||
128878973|NCT02781844|463852818|FG001|Treatment Period 1|Adverse Event|0|||
128878974|NCT02781844|463852819|FG002|Treatment Period 1|Adverse Event|0|||
128878975|NCT02781844|463852820|FG003|Treatment Period 1|Adverse Event|0|||
128878976|NCT02781844|463852821|FG004|Treatment Period 1|Adverse Event|0|||
128678805|NCT04098224|463122265|FG000|Overall Study|Patient not required enteral feeding|1|||
128678806|NCT04098224|463122266|FG001|Overall Study|Patient not required enteral feeding|0|||
128678807|NCT04098224|463122265|FG000|Overall Study|Patient failure nasogastric tube|1|||
128678808|NCT04098224|463122266|FG001|Overall Study|Patient failure nasogastric tube|0|||
128678809|NCT04098224|463122265|FG000|Overall Study|Patient early extubation|1|||
128678810|NCT04098224|463122266|FG001|Overall Study|Patient early extubation|3|||
128678811|NCT02217527|463122267|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
128678812|NCT02217527|463122268|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
128878977|NCT02781844|463852822|FG005|Treatment Period 1|Adverse Event|1|||
128878978|NCT02781844|463852823|FG006|Treatment Period 1|Adverse Event|0|||
128878979|NCT02781844|463852824|FG007|Treatment Period 1|Adverse Event|0|||
128878980|NCT02518490|463852827|FG000|Overall Study|Withdrawal by Subject|1|||
128878981|NCT02518490|463852828|FG001|Overall Study|Withdrawal by Subject|1|||
128878982|NCT03010176|463852829|FG000|Overall Study|Death|21|||
128878983|NCT03010176|463852830|FG001|Overall Study|Death|35|||
128878984|NCT03010176|463852831|FG002|Overall Study|Death|19|||
128878985|NCT03010176|463852832|FG003|Overall Study|Death|19|||
128878986|NCT03010176|463852833|FG004|Overall Study|Death|14|||
128878987|NCT03010176|463852834|FG005|Overall Study|Death|0|||
128678813|NCT02217527|463122267|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
128678814|NCT02217527|463122268|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
128678815|NCT00247611|463122274|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
128678816|NCT00247611|463122275|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
128678817|NCT00247611|463122274|FG000|Baselined|Completed baseline only|9|||
128678818|NCT00247611|463122275|FG001|Baselined|Completed baseline only|8|||
128678819|NCT00502203|463122276|FG000|Overall Study|Inevaluable|1|||
128678820|NCT03836001|463122277|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
128678821|NCT03836001|463122278|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
128678822|NCT03836001|463122279|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
128678823|NCT03836001|463122277|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
128678824|NCT03836001|463122278|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
128678825|NCT03836001|463122279|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
128878988|NCT03010176|463852829|FG000|Overall Study|Lost to Follow-up|0|||
128878989|NCT03010176|463852830|FG001|Overall Study|Lost to Follow-up|0|||
128878990|NCT03010176|463852831|FG002|Overall Study|Lost to Follow-up|0|||
128878991|NCT03010176|463852832|FG003|Overall Study|Lost to Follow-up|0|||
128878992|NCT03010176|463852833|FG004|Overall Study|Lost to Follow-up|1|||
128878993|NCT03010176|463852834|FG005|Overall Study|Lost to Follow-up|0|||
128878994|NCT03010176|463852829|FG000|Overall Study|Physician Decision|0|||
128878995|NCT03010176|463852830|FG001|Overall Study|Physician Decision|4|||
128878996|NCT03010176|463852831|FG002|Overall Study|Physician Decision|0|||
128878997|NCT03010176|463852832|FG003|Overall Study|Physician Decision|1|||
128878998|NCT03010176|463852833|FG004|Overall Study|Physician Decision|0|||
128878999|NCT03010176|463852834|FG005|Overall Study|Physician Decision|0|||
128879000|NCT03010176|463852829|FG000|Overall Study|Sponsor Decision|0|||
128879001|NCT03010176|463852830|FG001|Overall Study|Sponsor Decision|4|||
128879002|NCT03010176|463852831|FG002|Overall Study|Sponsor Decision|4|||
128879003|NCT03010176|463852832|FG003|Overall Study|Sponsor Decision|1|||
128879004|NCT03010176|463852833|FG004|Overall Study|Sponsor Decision|6|||
128879005|NCT03010176|463852834|FG005|Overall Study|Sponsor Decision|0|||
128879006|NCT03010176|463852829|FG000|Overall Study|Withdrawal by Subject|11|||
128879007|NCT03010176|463852830|FG001|Overall Study|Withdrawal by Subject|9|||
128879008|NCT03010176|463852831|FG002|Overall Study|Withdrawal by Subject|3|||
128879009|NCT03010176|463852832|FG003|Overall Study|Withdrawal by Subject|0|||
128879010|NCT03010176|463852833|FG004|Overall Study|Withdrawal by Subject|4|||
128879011|NCT03010176|463852834|FG005|Overall Study|Withdrawal by Subject|0|||
128879012|NCT04256629|463852835|FG000|Overall Study|Adverse Event|0|||
128879013|NCT04256629|463852836|FG001|Overall Study|Adverse Event|0|||
128879014|NCT04256629|463852837|FG002|Overall Study|Adverse Event|0|||
128879015|NCT04256629|463852838|FG003|Overall Study|Adverse Event|0|||
128879016|NCT04256629|463852839|FG004|Overall Study|Adverse Event|0|||
128879017|NCT04256629|463852840|FG005|Overall Study|Adverse Event|1|||
128879018|NCT04256629|463852835|FG000|Overall Study|Protocol Violation|0|||
128678826|NCT03836001|463122277|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
128879019|NCT04256629|463852836|FG001|Overall Study|Protocol Violation|1|||
128879020|NCT04256629|463852837|FG002|Overall Study|Protocol Violation|0|||
128879021|NCT04256629|463852838|FG003|Overall Study|Protocol Violation|0|||
128879022|NCT04256629|463852839|FG004|Overall Study|Protocol Violation|0|||
128879023|NCT04256629|463852840|FG005|Overall Study|Protocol Violation|0|||
128879024|NCT01774487|463852841|FG000|Overall Study|Did not tolerate taste|4|||
128879025|NCT01774487|463852842|FG001|Overall Study|Did not tolerate taste|4|||
128879026|NCT00346632|463852843|FG000|Overall Study|Progressive Disease|2|||
128879027|NCT00346632|463852844|FG001|Overall Study|Progressive Disease|2|||
128879028|NCT00346632|463852845|FG002|Overall Study|Progressive Disease|4|||
128879029|NCT00346632|463852846|FG003|Overall Study|Progressive Disease|3|||
128879030|NCT00346632|463852847|FG004|Overall Study|Progressive Disease|3|||
128879031|NCT00346632|463852848|FG005|Overall Study|Progressive Disease|1|||
128879032|NCT00346632|463852849|FG006|Overall Study|Progressive Disease|2|||
128879033|NCT00346632|463852850|FG007|Overall Study|Progressive Disease|2|||
128879034|NCT00346632|463852851|FG008|Overall Study|Progressive Disease|2|||
128879035|NCT00346632|463852852|FG009|Overall Study|Progressive Disease|2|||
128879036|NCT00346632|463852843|FG000|Overall Study|Adverse Event|0|||
128879037|NCT00346632|463852844|FG001|Overall Study|Adverse Event|0|||
128879038|NCT00346632|463852845|FG002|Overall Study|Adverse Event|0|||
128879039|NCT00346632|463852846|FG003|Overall Study|Adverse Event|0|||
128879040|NCT00346632|463852847|FG004|Overall Study|Adverse Event|1|||
128879041|NCT00346632|463852848|FG005|Overall Study|Adverse Event|1|||
128879042|NCT00346632|463852849|FG006|Overall Study|Adverse Event|1|||
128879043|NCT00346632|463852850|FG007|Overall Study|Adverse Event|0|||
128879044|NCT00346632|463852851|FG008|Overall Study|Adverse Event|0|||
128879045|NCT00346632|463852852|FG009|Overall Study|Adverse Event|0|||
128879046|NCT00346632|463852843|FG000|Overall Study|Death|0|||
128879047|NCT00346632|463852844|FG001|Overall Study|Death|0|||
128879048|NCT00346632|463852845|FG002|Overall Study|Death|1|||
128879049|NCT00346632|463852846|FG003|Overall Study|Death|0|||
128879050|NCT00346632|463852847|FG004|Overall Study|Death|0|||
128879051|NCT00346632|463852848|FG005|Overall Study|Death|0|||
128879052|NCT00346632|463852849|FG006|Overall Study|Death|0|||
128879053|NCT00346632|463852850|FG007|Overall Study|Death|0|||
128879054|NCT00346632|463852851|FG008|Overall Study|Death|0|||
128879055|NCT00346632|463852852|FG009|Overall Study|Death|0|||
128879056|NCT00346632|463852843|FG000|Overall Study|Protocol Violation|0|||
128879057|NCT00346632|463852844|FG001|Overall Study|Protocol Violation|0|||
128879058|NCT00346632|463852845|FG002|Overall Study|Protocol Violation|0|||
128879059|NCT00346632|463852846|FG003|Overall Study|Protocol Violation|0|||
128879060|NCT00346632|463852847|FG004|Overall Study|Protocol Violation|0|||
128879061|NCT00346632|463852848|FG005|Overall Study|Protocol Violation|0|||
128879062|NCT00346632|463852849|FG006|Overall Study|Protocol Violation|1|||
128879063|NCT00346632|463852850|FG007|Overall Study|Protocol Violation|0|||
128879064|NCT00346632|463852851|FG008|Overall Study|Protocol Violation|0|||
128879065|NCT00346632|463852852|FG009|Overall Study|Protocol Violation|0|||
128879066|NCT00346632|463852843|FG000|Overall Study|Withdrawal by Subject|0|||
128879067|NCT00346632|463852844|FG001|Overall Study|Withdrawal by Subject|0|||
128879068|NCT00346632|463852845|FG002|Overall Study|Withdrawal by Subject|0|||
128879069|NCT00346632|463852846|FG003|Overall Study|Withdrawal by Subject|0|||
128879070|NCT00346632|463852847|FG004|Overall Study|Withdrawal by Subject|0|||
128879071|NCT00346632|463852848|FG005|Overall Study|Withdrawal by Subject|0|||
128879072|NCT00346632|463852849|FG006|Overall Study|Withdrawal by Subject|1|||
128879073|NCT00346632|463852850|FG007|Overall Study|Withdrawal by Subject|0|||
128879074|NCT00346632|463852851|FG008|Overall Study|Withdrawal by Subject|0|||
128678827|NCT03836001|463122278|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
128879075|NCT00346632|463852852|FG009|Overall Study|Withdrawal by Subject|0|||
128879076|NCT00346632|463852843|FG000|Overall Study|Switched to alternative treatment|0|||
128879077|NCT00346632|463852844|FG001|Overall Study|Switched to alternative treatment|0|||
128879078|NCT00346632|463852845|FG002|Overall Study|Switched to alternative treatment|1|||
128879079|NCT00346632|463852846|FG003|Overall Study|Switched to alternative treatment|0|||
128879080|NCT00346632|463852847|FG004|Overall Study|Switched to alternative treatment|0|||
128678828|NCT03836001|463122279|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
128678829|NCT03836001|463122277|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
128678830|NCT03836001|463122278|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
128678831|NCT03836001|463122279|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
128678832|NCT03039621|463123797|FG000|Overall Study|Violation of inclusion criteria|3|||
128678833|NCT03039621|463123798|FG001|Overall Study|Violation of inclusion criteria|2|||
128678834|NCT03039621|463123797|FG000|Overall Study|Non-compliance with protocol requirement|4|||
128678835|NCT03039621|463123798|FG001|Overall Study|Non-compliance with protocol requirement|5|||
128678836|NCT03039621|463123797|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
128879081|NCT00346632|463852848|FG005|Overall Study|Switched to alternative treatment|0|||
128879082|NCT00346632|463852849|FG006|Overall Study|Switched to alternative treatment|0|||
128879083|NCT00346632|463852850|FG007|Overall Study|Switched to alternative treatment|0|||
128879084|NCT00346632|463852851|FG008|Overall Study|Switched to alternative treatment|0|||
128879085|NCT00346632|463852852|FG009|Overall Study|Switched to alternative treatment|0|||
128879086|NCT00346632|463852843|FG000|Overall Study|Not Stated|1|||
128879087|NCT00346632|463852844|FG001|Overall Study|Not Stated|1|||
128879088|NCT00346632|463852845|FG002|Overall Study|Not Stated|0|||
128879089|NCT00346632|463852846|FG003|Overall Study|Not Stated|0|||
128879090|NCT00346632|463852847|FG004|Overall Study|Not Stated|0|||
128879091|NCT00346632|463852848|FG005|Overall Study|Not Stated|0|||
128879092|NCT00346632|463852849|FG006|Overall Study|Not Stated|0|||
128879093|NCT00346632|463852850|FG007|Overall Study|Not Stated|2|||
128879094|NCT00346632|463852851|FG008|Overall Study|Not Stated|2|||
128879095|NCT00346632|463852852|FG009|Overall Study|Not Stated|1|||
128678837|NCT03039621|463123798|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
128678838|NCT03039621|463123797|FG000|Overall Study|Violation of non-inclusion criteria|1|||
128678839|NCT03039621|463123798|FG001|Overall Study|Violation of non-inclusion criteria|2|||
128678840|NCT02519855|463123803|FG000|Overall Study|Adverse Event|0|||
128678841|NCT02519855|463123804|FG001|Overall Study|Adverse Event|1|||
128678842|NCT02519855|463123803|FG000|Overall Study|Lost to Follow-up|3|||
128678843|NCT02519855|463123804|FG001|Overall Study|Lost to Follow-up|3|||
128678844|NCT00003830|463123818|FG000|Overall Study|No follow up data|3|||
128678845|NCT00003830|463123819|FG001|Overall Study|No follow up data|0|||
128678846|NCT00003830|463123818|FG000|Overall Study|Sentinel node positive patients|829|||
128678847|NCT00003830|463123819|FG001|Overall Study|Sentinel node positive patients|793|||
128678848|NCT03699475|463123823|FG000|Overall Study|Death|1|||
128678849|NCT03739242|463123824|FG000|Overall Study|Withdrawal by Subject|1|||
128678850|NCT03739242|463123825|FG001|Overall Study|Withdrawal by Subject|1|||
128678851|NCT03739242|463123824|FG000|Overall Study|Protocol Violation|0|||
128678852|NCT03739242|463123825|FG001|Overall Study|Protocol Violation|1|||
128678853|NCT01752036|463123826|FG000|Overall Study|Death|2|||
128678854|NCT00159822|463123829|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
128678855|NCT00159822|463123829|FG000|Voriconazole Treatment Period|Adverse Event|9|||
128678856|NCT00159822|463123829|FG000|Voriconazole Treatment Period|Death|4|||
128678857|NCT00159822|463123829|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
128678858|NCT00159822|463123829|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
128678859|NCT00159822|463123829|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
128678860|NCT00159822|463123829|FG000|Post-treatment Follow-up Period|Death|1|||
128678861|NCT00159822|463123829|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
128678862|NCT00159822|463123829|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
128678863|NCT00275821|463123831|FG000|Overall Study|Adverse Event|4|||
128678864|NCT00275821|463123832|FG001|Overall Study|Adverse Event|12|||
128678865|NCT00275821|463123833|FG002|Overall Study|Adverse Event|5|||
128678866|NCT00275821|463123831|FG000|Overall Study|Administrative problems|3|||
128678867|NCT00275821|463123832|FG001|Overall Study|Administrative problems|4|||
128678868|NCT00275821|463123833|FG002|Overall Study|Administrative problems|4|||
128678869|NCT00275821|463123831|FG000|Overall Study|Withdrawal by Subject|0|||
128678870|NCT00275821|463123832|FG001|Overall Study|Withdrawal by Subject|2|||
128678871|NCT00275821|463123833|FG002|Overall Study|Withdrawal by Subject|1|||
128678872|NCT00275821|463123831|FG000|Overall Study|Lost to Follow-up|0|||
128678873|NCT00275821|463123832|FG001|Overall Study|Lost to Follow-up|1|||
128678874|NCT00275821|463123833|FG002|Overall Study|Lost to Follow-up|1|||
128678875|NCT00275821|463123831|FG000|Overall Study|Death|0|||
128678876|NCT00275821|463123832|FG001|Overall Study|Death|2|||
128678877|NCT00275821|463123833|FG002|Overall Study|Death|1|||
128678878|NCT00275821|463123831|FG000|Overall Study|Lack of Efficacy|2|||
128678879|NCT00275821|463123832|FG001|Overall Study|Lack of Efficacy|1|||
128678880|NCT00275821|463123833|FG002|Overall Study|Lack of Efficacy|0|||
128678881|NCT00275821|463123831|FG000|Overall Study|Protocol Violation|5|||
128678882|NCT00275821|463123832|FG001|Overall Study|Protocol Violation|1|||
128678883|NCT00275821|463123833|FG002|Overall Study|Protocol Violation|0|||
128678884|NCT00329901|463123834|FG000|Overall Study|Withdrawal by Subject|4|||
128678885|NCT00329901|463123835|FG001|Overall Study|Withdrawal by Subject|3|||
128678886|NCT00329901|463123836|FG002|Overall Study|Withdrawal by Subject|2|||
128678887|NCT00329901|463123834|FG000|Overall Study|Lost to Follow-up|2|||
128678888|NCT00329901|463123835|FG001|Overall Study|Lost to Follow-up|0|||
128678889|NCT00329901|463123836|FG002|Overall Study|Lost to Follow-up|1|||
128678890|NCT00329901|463123834|FG000|Overall Study|Protocol Violation|1|||
128678891|NCT00329901|463123835|FG001|Overall Study|Protocol Violation|0|||
128678892|NCT00329901|463123836|FG002|Overall Study|Protocol Violation|1|||
128678893|NCT00329901|463123834|FG000|Overall Study|Unable to classify|2|||
128678894|NCT00329901|463123835|FG001|Overall Study|Unable to classify|2|||
128678895|NCT00329901|463123836|FG002|Overall Study|Unable to classify|0|||
128678896|NCT00992589|463123837|FG000|Open-Label Phase|Adverse Event|4|||
128678897|NCT00992589|463123838|FG001|Open-Label Phase|Adverse Event|0|||
128678898|NCT00992589|463123839|FG002|Open-Label Phase|Adverse Event|0|||
128678899|NCT00992589|463123840|FG003|Open-Label Phase|Adverse Event|0|||
128678900|NCT00992589|463123837|FG000|Open-Label Phase|Withdrawal by Subject|20|||
128678901|NCT00992589|463123838|FG001|Open-Label Phase|Withdrawal by Subject|0|||
128678902|NCT00992589|463123839|FG002|Open-Label Phase|Withdrawal by Subject|0|||
128678903|NCT00992589|463123840|FG003|Open-Label Phase|Withdrawal by Subject|0|||
128678904|NCT00992589|463123837|FG000|Open-Label Phase|Lost to Follow-up|1|||
128678905|NCT00992589|463123838|FG001|Open-Label Phase|Lost to Follow-up|0|||
128678906|NCT00992589|463123839|FG002|Open-Label Phase|Lost to Follow-up|0|||
128678907|NCT00992589|463123840|FG003|Open-Label Phase|Lost to Follow-up|0|||
128678908|NCT00992589|463123837|FG000|Open-Label Phase|Protocol Violation|3|||
128678909|NCT00992589|463123838|FG001|Open-Label Phase|Protocol Violation|0|||
128678910|NCT00992589|463123839|FG002|Open-Label Phase|Protocol Violation|0|||
128678911|NCT00992589|463123840|FG003|Open-Label Phase|Protocol Violation|0|||
128678912|NCT00992589|463123837|FG000|Open-Label Phase|Physician Decision|4|||
128678913|NCT00992589|463123838|FG001|Open-Label Phase|Physician Decision|0|||
128879096|NCT00918580|463852853|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
128879097|NCT00918580|463852853|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
128879098|NCT00918580|463852853|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
128879099|NCT00918580|463852853|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
128879100|NCT00918580|463852853|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
128879101|NCT00918580|463852853|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
128879102|NCT00918580|463852853|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
128879103|NCT00477334|463852854|FG000|Overall Study|Discontinued prior to taking study drug|106|||
128879104|NCT00477334|463852855|FG001|Overall Study|Discontinued prior to taking study drug|53|||
128879105|NCT00477334|463852854|FG000|Overall Study|Adverse Event|1|||
128879106|NCT00477334|463852855|FG001|Overall Study|Adverse Event|2|||
128879107|NCT00477334|463852854|FG000|Overall Study|Withdrawal by Subject|2|||
128879108|NCT00477334|463852855|FG001|Overall Study|Withdrawal by Subject|1|||
128879109|NCT00477334|463852854|FG000|Overall Study|Lost to Follow-up|15|||
128879110|NCT00477334|463852855|FG001|Overall Study|Lost to Follow-up|4|||
128879111|NCT00477334|463852854|FG000|Overall Study|Administrative Problems|39|||
128879112|NCT00477334|463852855|FG001|Overall Study|Administrative Problems|15|||
128879113|NCT00477334|463852854|FG000|Overall Study|Protocol Violation|7|||
128879114|NCT00477334|463852855|FG001|Overall Study|Protocol Violation|1|||
128879115|NCT03587974|463852856|FG000|Overall Study|caregiver demented, care recipient died|3|||
128879116|NCT03587974|463852857|FG001|Overall Study|caregiver demented, care recipient died|3|||
128879117|NCT03587974|463852856|FG000|Overall Study|Withdrawal by Subject|2|||
128879118|NCT03587974|463852857|FG001|Overall Study|Withdrawal by Subject|1|||
128879119|NCT04447846|463852858|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
128879120|NCT00461032|463852861|FG000|Overall Study|Adverse Event|5|||
128879121|NCT00461032|463852862|FG001|Overall Study|Adverse Event|6|||
129101689|NCT03084302|464667680|FG000|Overall Study|No valid objective monitor data|6|||
129101690|NCT00929994|464667681|FG000|Overall Study|Withdrawal by Subject|1|||
129101691|NCT00929994|464667681|FG000|Overall Study|medical issue unrelated to intervention|4|||
129101692|NCT00929994|464667681|FG000|Overall Study|employment|1|||
128678914|NCT00992589|463123839|FG002|Open-Label Phase|Physician Decision|0|||
128678915|NCT00992589|463123840|FG003|Open-Label Phase|Physician Decision|0|||
128879122|NCT00461032|463852861|FG000|Overall Study|Lack of Efficacy|5|||
128678916|NCT00992589|463123837|FG000|Open-Label Phase|Other|45|||
128678917|NCT00992589|463123838|FG001|Open-Label Phase|Other|0|||
128678918|NCT00992589|463123839|FG002|Open-Label Phase|Other|0|||
128678919|NCT00992589|463123840|FG003|Open-Label Phase|Other|0|||
128678920|NCT00992589|463123837|FG000|Double-Blind Phase|Adverse Event|0|||
128678921|NCT00992589|463123838|FG001|Double-Blind Phase|Adverse Event|6|||
128678922|NCT00992589|463123839|FG002|Double-Blind Phase|Adverse Event|2|||
128678923|NCT00992589|463123840|FG003|Double-Blind Phase|Adverse Event|3|||
128678924|NCT00992589|463123837|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
128678925|NCT00992589|463123838|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
128678926|NCT00992589|463123839|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
128678927|NCT00992589|463123840|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
128678928|NCT00992589|463123837|FG000|Double-Blind Phase|Lost to Follow-up|0|||
128678929|NCT00992589|463123838|FG001|Double-Blind Phase|Lost to Follow-up|0|||
128678930|NCT00992589|463123839|FG002|Double-Blind Phase|Lost to Follow-up|0|||
128678931|NCT00992589|463123840|FG003|Double-Blind Phase|Lost to Follow-up|2|||
128678932|NCT00992589|463123837|FG000|Double-Blind Phase|Other|0|||
128678933|NCT00992589|463123838|FG001|Double-Blind Phase|Other|1|||
128678934|NCT00992589|463123839|FG002|Double-Blind Phase|Other|6|||
128678935|NCT00992589|463123840|FG003|Double-Blind Phase|Other|3|||
128678936|NCT02142387|463123841|FG000|Overall Study|<19 years old|49|||
128678937|NCT02142387|463123842|FG001|Overall Study|<19 years old|326|||
128678938|NCT02142387|463123841|FG000|Overall Study|non-cardiac etiology|504|||
128678939|NCT02142387|463123842|FG001|Overall Study|non-cardiac etiology|3431|||
128678940|NCT02142387|463123841|FG000|Overall Study|CPR not performed|74|||
128678941|NCT02142387|463123842|FG001|Overall Study|CPR not performed|473|||
128678942|NCT02142387|463123841|FG000|Overall Study|witnessed by paramedic|139|||
128678943|NCT02142387|463123842|FG001|Overall Study|witnessed by paramedic|917|||
128678944|NCT02142387|463123841|FG000|Overall Study|incomplete data|1|||
128678945|NCT02142387|463123842|FG001|Overall Study|incomplete data|9|||
128678946|NCT02142387|463123841|FG000|Overall Study|occurred not at home|298|||
128678947|NCT02142387|463123842|FG001|Overall Study|occurred not at home|2474|||
128879123|NCT00461032|463852862|FG001|Overall Study|Lack of Efficacy|1|||
128879124|NCT00461032|463852861|FG000|Overall Study|Lost to Follow-up|7|||
128678948|NCT00761150|463123848|FG000|Open-label Period|Adverse Event|36|||
128678949|NCT00761150|463123849|FG001|Open-label Period|Adverse Event|0|||
128879125|NCT00461032|463852862|FG001|Overall Study|Lost to Follow-up|12|||
128879126|NCT00461032|463852861|FG000|Overall Study|Protocol Violation|4|||
128879127|NCT00461032|463852862|FG001|Overall Study|Protocol Violation|4|||
128879128|NCT00461032|463852861|FG000|Overall Study|Withdrawal by Subject|7|||
128678950|NCT00761150|463123850|FG002|Open-label Period|Adverse Event|0|||
128678951|NCT00761150|463123848|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
128678952|NCT00761150|463123849|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
128879129|NCT00461032|463852862|FG001|Overall Study|Withdrawal by Subject|15|||
128879130|NCT00461032|463852861|FG000|Overall Study|Patient Moved or Relocated|2|||
128879131|NCT00461032|463852862|FG001|Overall Study|Patient Moved or Relocated|1|||
128879132|NCT00461032|463852861|FG000|Overall Study|Other|7|||
128879133|NCT00461032|463852862|FG001|Overall Study|Other|5|||
128879134|NCT03486457|463852863|FG000|Up to Month 3|Adverse Event|2|||
128879135|NCT03486457|463852864|FG001|Up to Month 3|Adverse Event|5|||
128879136|NCT03486457|463852863|FG000|Up to Month 3|Lack of Efficacy|1|||
128879137|NCT03486457|463852864|FG001|Up to Month 3|Lack of Efficacy|0|||
128879138|NCT03486457|463852863|FG000|Up to Month 3|Withdrawal by Subject|1|||
128879139|NCT03486457|463852864|FG001|Up to Month 3|Withdrawal by Subject|0|||
128879140|NCT03486457|463852863|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
128879141|NCT03486457|463852864|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
128879142|NCT03486457|463852863|FG000|Up to Month 3|Other|1|||
128879143|NCT03486457|463852864|FG001|Up to Month 3|Other|0|||
128879144|NCT03486457|463852863|FG000|Month 3 to Month 6|Adverse Event|2|||
128879145|NCT03486457|463852864|FG001|Month 3 to Month 6|Adverse Event|0|||
128879146|NCT03486457|463852863|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
128879147|NCT03486457|463852864|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
128879148|NCT03486457|463852863|FG000|Month 3 to Month 6|Pregnancy|0|||
128879149|NCT03486457|463852864|FG001|Month 3 to Month 6|Pregnancy|1|||
128879150|NCT03486457|463852863|FG000|Month 3 to Month 6|Other|1|||
128879151|NCT03486457|463852864|FG001|Month 3 to Month 6|Other|0|||
128879152|NCT01878214|463852865|FG000|Overall Study|Withdrawal by Subject|18|||
128879153|NCT01878214|463852866|FG001|Overall Study|Withdrawal by Subject|7|||
128879154|NCT01878214|463852865|FG000|Overall Study|Death|0|||
128879155|NCT01878214|463852866|FG001|Overall Study|Death|1|||
128879156|NCT01878214|463852865|FG000|Overall Study|Lost to Follow-up|35|||
128879157|NCT01878214|463852866|FG001|Overall Study|Lost to Follow-up|36|||
128879158|NCT00093808|463852869|FG000|Overall Study|Cancel participation before receiving tx|1|||
128879159|NCT00093808|463852869|FG000|Overall Study|Protocol Violation|1|||
128879160|NCT02647866|463852870|FG000|Overall Study|Adverse Event|0|||
128879161|NCT02647866|463852871|FG001|Overall Study|Adverse Event|0|||
128879162|NCT02647866|463852872|FG002|Overall Study|Adverse Event|2|||
128879163|NCT02647866|463852873|FG003|Overall Study|Adverse Event|2|||
128879164|NCT02647866|463852874|FG004|Overall Study|Adverse Event|1|||
128879165|NCT02647866|463852870|FG000|Overall Study|Disease Worsening|3|||
128879166|NCT02647866|463852871|FG001|Overall Study|Disease Worsening|1|||
128879167|NCT02647866|463852872|FG002|Overall Study|Disease Worsening|0|||
128879168|NCT02647866|463852873|FG003|Overall Study|Disease Worsening|0|||
128879169|NCT02647866|463852874|FG004|Overall Study|Disease Worsening|1|||
128879170|NCT02647866|463852870|FG000|Overall Study|Withdrawal by Subject|1|||
128879171|NCT02647866|463852871|FG001|Overall Study|Withdrawal by Subject|1|||
128879172|NCT02647866|463852872|FG002|Overall Study|Withdrawal by Subject|2|||
128879173|NCT02647866|463852873|FG003|Overall Study|Withdrawal by Subject|4|||
128879174|NCT02647866|463852874|FG004|Overall Study|Withdrawal by Subject|4|||
128879175|NCT02647866|463852870|FG000|Overall Study|Physician Decision|0|||
128879176|NCT02647866|463852871|FG001|Overall Study|Physician Decision|1|||
128879177|NCT02647866|463852872|FG002|Overall Study|Physician Decision|1|||
128879178|NCT02647866|463852873|FG003|Overall Study|Physician Decision|0|||
128879179|NCT02647866|463852874|FG004|Overall Study|Physician Decision|2|||
128879180|NCT02647866|463852870|FG000|Overall Study|Death|0|||
128879181|NCT02647866|463852871|FG001|Overall Study|Death|1|||
128879182|NCT02647866|463852872|FG002|Overall Study|Death|0|||
128879183|NCT02647866|463852873|FG003|Overall Study|Death|0|||
128879184|NCT02647866|463852874|FG004|Overall Study|Death|0|||
128879185|NCT02647866|463852870|FG000|Overall Study|Subject moved to different country|1|||
128879186|NCT02647866|463852871|FG001|Overall Study|Subject moved to different country|0|||
128879187|NCT02647866|463852872|FG002|Overall Study|Subject moved to different country|0|||
128879188|NCT02647866|463852873|FG003|Overall Study|Subject moved to different country|0|||
128879189|NCT02647866|463852874|FG004|Overall Study|Subject moved to different country|0|||
128879190|NCT00069108|463852878|FG000|Overall Study|Withdrawal by Subject|5|||
128678953|NCT00761150|463123850|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
128678954|NCT00761150|463123848|FG000|Open-label Period|Lost to Follow-up|7|||
128879191|NCT00069108|463852879|FG001|Overall Study|Withdrawal by Subject|9|||
128879192|NCT00069108|463852878|FG000|Overall Study|Adverse Event|64|||
128879193|NCT00069108|463852879|FG001|Overall Study|Adverse Event|42|||
128879194|NCT00069108|463852878|FG000|Overall Study|Death|6|||
128879195|NCT00069108|463852879|FG001|Overall Study|Death|6|||
128879196|NCT00069108|463852878|FG000|Overall Study|Administration|15|||
128678955|NCT00761150|463123849|FG001|Open-label Period|Lost to Follow-up|0|||
128879197|NCT00069108|463852879|FG001|Overall Study|Administration|4|||
128879198|NCT00069108|463852878|FG000|Overall Study|Insufficient therapy|117|||
128678956|NCT00761150|463123850|FG002|Open-label Period|Lost to Follow-up|0|||
128879199|NCT00069108|463852879|FG001|Overall Study|Insufficient therapy|144|||
128879200|NCT00069108|463852878|FG000|Overall Study|Violation criteria|1|||
128879201|NCT00069108|463852879|FG001|Overall Study|Violation criteria|4|||
128879202|NCT00069108|463852878|FG000|Overall Study|Refused treatment|5|||
128879203|NCT00069108|463852879|FG001|Overall Study|Refused treatment|10|||
128678957|NCT00761150|463123848|FG000|Open-label Period|Lack of Efficacy|4|||
128678958|NCT00761150|463123849|FG001|Open-label Period|Lack of Efficacy|0|||
128678959|NCT00761150|463123850|FG002|Open-label Period|Lack of Efficacy|0|||
128678960|NCT00761150|463123848|FG000|Open-label Period|Withdrawal by Subject|5|||
128678961|NCT00761150|463123849|FG001|Open-label Period|Withdrawal by Subject|0|||
128678962|NCT00761150|463123850|FG002|Open-label Period|Withdrawal by Subject|0|||
128678963|NCT00761150|463123848|FG000|Open-label Period|Noncompliance|2|||
128678964|NCT00761150|463123849|FG001|Open-label Period|Noncompliance|0|||
128678965|NCT00761150|463123850|FG002|Open-label Period|Noncompliance|0|||
128678966|NCT00761150|463123848|FG000|Open-label Period|Other|5|||
128678967|NCT00761150|463123849|FG001|Open-label Period|Other|0|||
128678968|NCT00761150|463123850|FG002|Open-label Period|Other|0|||
128678969|NCT00761150|463123848|FG000|Double-blind Period|Lack of Efficacy|0|||
128678970|NCT00761150|463123849|FG001|Double-blind Period|Lack of Efficacy|2|||
128678971|NCT00761150|463123850|FG002|Double-blind Period|Lack of Efficacy|19|||
128678972|NCT00761150|463123848|FG000|Double-blind Period|Adverse Event|0|||
128678973|NCT00761150|463123849|FG001|Double-blind Period|Adverse Event|3|||
128678974|NCT00761150|463123850|FG002|Double-blind Period|Adverse Event|3|||
128678975|NCT00761150|463123848|FG000|Double-blind Period|Withdrawal by Subject|0|||
128678976|NCT00761150|463123849|FG001|Double-blind Period|Withdrawal by Subject|3|||
128678977|NCT00761150|463123850|FG002|Double-blind Period|Withdrawal by Subject|2|||
128678978|NCT00761150|463123848|FG000|Double-blind Period|Lost to Follow-up|0|||
128678979|NCT00761150|463123849|FG001|Double-blind Period|Lost to Follow-up|2|||
128678980|NCT00761150|463123850|FG002|Double-blind Period|Lost to Follow-up|1|||
128678981|NCT00761150|463123848|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
128678982|NCT00761150|463123849|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
128678983|NCT00761150|463123850|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
128678984|NCT00761150|463123848|FG000|Double-blind Period|Noncompliance|0|||
128678985|NCT00761150|463123849|FG001|Double-blind Period|Noncompliance|1|||
128678986|NCT00761150|463123850|FG002|Double-blind Period|Noncompliance|0|||
128678987|NCT00761150|463123848|FG000|Double-blind Period|Other|0|||
128678988|NCT00761150|463123849|FG001|Double-blind Period|Other|3|||
128678989|NCT00761150|463123850|FG002|Double-blind Period|Other|3|||
128678990|NCT02692651|463123851|FG000|Study Treatment|Death|7|||
128678991|NCT02692651|463123852|FG001|Study Treatment|Death|3|||
128678992|NCT02692651|463123851|FG000|Study Treatment|comfort care|1|||
128678993|NCT02692651|463123852|FG001|Study Treatment|comfort care|1|||
128678994|NCT02692651|463123851|FG000|Study Treatment|Protocol violation per treating team preference|8|||
128678995|NCT02692651|463123852|FG001|Study Treatment|Protocol violation per treating team preference|6|||
128678996|NCT02692651|463123851|FG000|Post Study Treatment Follow-up|Death|4|||
128678997|NCT02692651|463123852|FG001|Post Study Treatment Follow-up|Death|4|||
128678998|NCT02480712|463123853|FG000|Overall Study|Enrolled but Never Treated|1|||
128678999|NCT02480712|463123853|FG000|Overall Study|Lost to Follow-up|5|||
128679000|NCT02480712|463123853|FG000|Overall Study|Withdrew Consent|3|||
128679001|NCT02480712|463123853|FG000|Overall Study|Death|1|||
128679002|NCT02480712|463123853|FG000|Overall Study|Lack of Efficacy|1|||
128679003|NCT05463198|463123854|FG000|Overall Study|Withdrawal by Subject|19|||
128679004|NCT05463198|463123854|FG000|Overall Study|Procedure Notes Missing|18|||
128879204|NCT01415531|463852880|FG000|Overall Study|Adverse Event|7|||
128879205|NCT01415531|463852881|FG001|Overall Study|Adverse Event|10|||
128879206|NCT01415531|463852880|FG000|Overall Study|Lack of Efficacy|3|||
128879207|NCT01415531|463852881|FG001|Overall Study|Lack of Efficacy|2|||
128679005|NCT01860846|463123855|FG000|Overall Study|Lost to Follow-up|33|||
128679006|NCT02239120|463123856|FG000|Overall Study|Death|56|||
128679007|NCT02239120|463123857|FG001|Overall Study|Death|58|||
128679008|NCT02239120|463123856|FG000|Overall Study|Lost to Follow-up|19|||
128679009|NCT02239120|463123857|FG001|Overall Study|Lost to Follow-up|14|||
128679010|NCT01925989|463123858|FG000|Period 1|Sponsor Decision|1|||
128679011|NCT01925989|463123859|FG001|Period 1|Sponsor Decision|1|||
128679012|NCT01925989|463123860|FG002|Period 1|Sponsor Decision|0|||
128679013|NCT01925989|463123858|FG000|Period 1|Withdrawal by Subject|0|||
128679014|NCT01925989|463123859|FG001|Period 1|Withdrawal by Subject|1|||
128679015|NCT01925989|463123860|FG002|Period 1|Withdrawal by Subject|0|||
128679016|NCT01107379|463123870|FG000|Overall Study|Withdrawal by Subject|18|||
128679017|NCT01107379|463123870|FG000|Overall Study|Lost to Follow-up|3|||
128679018|NCT04559529|463123871|FG000|First Intervention (1 Day)|Adverse Event|0|||
128679019|NCT04559529|463123872|FG001|First Intervention (1 Day)|Adverse Event|0|||
128679020|NCT04559529|463123873|FG002|First Intervention (1 Day)|Adverse Event|0|||
128879208|NCT01415531|463852880|FG000|Overall Study|Protocol Violation|0|||
128679021|NCT04559529|463123874|FG003|First Intervention (1 Day)|Adverse Event|1|||
128879209|NCT01415531|463852881|FG001|Overall Study|Protocol Violation|1|||
128679022|NCT04559529|463123871|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
128679023|NCT04559529|463123872|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
128679024|NCT04559529|463123873|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
128679025|NCT04559529|463123874|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
128679026|NCT04559529|463123871|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
128879210|NCT01415531|463852880|FG000|Overall Study|Withdrawal by Subject|5|||
129012632|NCT00874237|464339589|FG000|Overall Study|Withdrawal by Subject|0|||
129012633|NCT00874237|464339590|FG001|Overall Study|Withdrawal by Subject|0|||
129012634|NCT00874237|464339591|FG002|Overall Study|Withdrawal by Subject|1|||
129012635|NCT00874237|464339592|FG003|Overall Study|Withdrawal by Subject|0|||
129012636|NCT00874237|464339593|FG004|Overall Study|Withdrawal by Subject|0|||
129012637|NCT00874237|464339594|FG005|Overall Study|Withdrawal by Subject|0|||
129012638|NCT03912337|464339595|FG000|Overall Study|Withdrawal of Consent From Study|1|||
129012639|NCT03912337|464339596|FG001|Overall Study|Withdrawal of Consent From Study|0|||
129012640|NCT03912337|464339595|FG000|Overall Study|Lost to Follow-up|1|||
129012641|NCT03912337|464339596|FG001|Overall Study|Lost to Follow-up|1|||
129012642|NCT03752528|464339597|FG000|Part A|Lost to Follow-up|1|||
129012643|NCT03752528|464339597|FG000|Part A|Protocol Violation|1|||
129012644|NCT03752528|464339597|FG000|Part B|Protocol Violation|1|||
129012645|NCT03752528|464339597|FG000|Part B|Study terminated by sponsor|3|||
129012646|NCT00537030|464339598|FG000|Overall Study|Physician Decision|2|||
129012647|NCT00537030|464339598|FG000|Overall Study|Withdrawal by Subject|2|||
129012648|NCT00537030|464339598|FG000|Overall Study|≥ Grade 2 allergy|7|||
129012649|NCT00537030|464339598|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
129012650|NCT00537030|464339598|FG000|Overall Study|Ineligible|2|||
129012651|NCT00537030|464339598|FG000|Overall Study|Inevaluable|2|||
129012652|NCT00414765|464339599|FG000|Overall Study|Adverse Event|5|||
129012653|NCT00414765|464339600|FG001|Overall Study|Adverse Event|9|||
129012654|NCT00414765|464339599|FG000|Overall Study|Withdrawal by Subject|1|||
129012655|NCT00414765|464339600|FG001|Overall Study|Withdrawal by Subject|1|||
129012656|NCT00414765|464339599|FG000|Overall Study|Disease Progression|0|||
129012657|NCT00414765|464339600|FG001|Overall Study|Disease Progression|1|||
129012658|NCT02458469|464339601|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129012659|NCT02458469|464339602|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129012660|NCT02458469|464339603|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
129012661|NCT02458469|464339604|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129012662|NCT02458469|464339605|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129012663|NCT02458469|464339606|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129012664|NCT02458469|464339601|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
129012665|NCT02458469|464339602|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
129012666|NCT02458469|464339603|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
129012667|NCT02458469|464339604|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
129012668|NCT02458469|464339605|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
129012669|NCT02458469|464339606|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
129012670|NCT02458469|464339601|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129012671|NCT02458469|464339602|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129012672|NCT02458469|464339603|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129012673|NCT02458469|464339604|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129012674|NCT02458469|464339605|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129012675|NCT02458469|464339606|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
129012676|NCT04534283|464339607|FG000|Overall Study|Physician Decision|2|||
129012677|NCT04534283|464339607|FG000|Overall Study|Withdrawal by Subject|1|||
129012678|NCT04534283|464339607|FG000|Overall Study|Disease Progression|12|||
129012679|NCT04534283|464339607|FG000|Overall Study|Adverse Event|1|||
129012680|NCT00661505|464339608|FG000|Overall Study|Adverse Event|3|||
129012681|NCT00661505|464339608|FG000|Overall Study|Protocol Violation|14|||
129012682|NCT00661505|464339608|FG000|Overall Study|Withdrawal by Subject|8|||
129012683|NCT00661505|464339608|FG000|Overall Study|Lost to Follow-up|3|||
129012684|NCT00661505|464339608|FG000|Overall Study|Other|2|||
129012685|NCT03561883|464339609|FG000|Overall Study|Adverse Event|10|||
129012686|NCT03561883|464339610|FG001|Overall Study|Adverse Event|13|||
129012687|NCT03561883|464339609|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129012688|NCT03561883|464339610|FG001|Overall Study|Non-Compliance With Study Drug|2|||
129012689|NCT03561883|464339609|FG000|Overall Study|Protocol Violation|2|||
129012690|NCT03561883|464339610|FG001|Overall Study|Protocol Violation|3|||
129012691|NCT03561883|464339609|FG000|Overall Study|Withdrawal by Subject|14|||
129012692|NCT03561883|464339610|FG001|Overall Study|Withdrawal by Subject|6|||
129012693|NCT03561883|464339609|FG000|Overall Study|Lost to Follow-up|2|||
129012694|NCT03561883|464339610|FG001|Overall Study|Lost to Follow-up|6|||
129012695|NCT03561883|464339609|FG000|Overall Study|Study Terminated by Sponsor|12|||
129012696|NCT03561883|464339610|FG001|Overall Study|Study Terminated by Sponsor|11|||
129012697|NCT03561883|464339609|FG000|Overall Study|Physician Decision|1|||
129012698|NCT03561883|464339610|FG001|Overall Study|Physician Decision|0|||
129012699|NCT03561883|464339609|FG000|Overall Study|Randomized by Mistake|1|||
129012700|NCT03561883|464339610|FG001|Overall Study|Randomized by Mistake|0|||
129012701|NCT03561883|464339609|FG000|Overall Study|Other, Not Specified|3|||
129012702|NCT03561883|464339610|FG001|Overall Study|Other, Not Specified|2|||
129012703|NCT06354270|464339611|FG000|Overall Study|Withdrawal by Subject|1|||
129012704|NCT06354270|464339612|FG001|Overall Study|Withdrawal by Subject|0|||
129012705|NCT01939197|464339613|FG000|Overall Study|Withdrawal by Subject|1|||
129012706|NCT01939197|464339614|FG001|Overall Study|Withdrawal by Subject|0|||
129101693|NCT01214668|464667682|FG000|Overall Study|Adverse Event|0|||
128879211|NCT01415531|463852881|FG001|Overall Study|Withdrawal by Subject|4|||
128879212|NCT01415531|463852880|FG000|Overall Study|Lost to Follow-up|6|||
128879213|NCT01415531|463852881|FG001|Overall Study|Lost to Follow-up|14|||
128879214|NCT01415531|463852880|FG000|Overall Study|Lack of Compliance|1|||
128879215|NCT01415531|463852881|FG001|Overall Study|Lack of Compliance|4|||
128879216|NCT01415531|463852880|FG000|Overall Study|Other Reasons|3|||
128879217|NCT01415531|463852881|FG001|Overall Study|Other Reasons|2|||
128879218|NCT00394082|463852884|FG000|Overall Study|Unacceptable toxicity|15|||
128879219|NCT00394082|463852884|FG000|Overall Study|Adverse Event|4|||
128879220|NCT00394082|463852884|FG000|Overall Study|Physician Decision|4|||
128679027|NCT04559529|463123872|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
128679028|NCT04559529|463123873|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
128679029|NCT04559529|463123874|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
128679030|NCT00609362|463123875|FG000|Overall Study|Withdrawal by Subject|2|||
128679031|NCT00609362|463123876|FG001|Overall Study|Withdrawal by Subject|1|||
128879221|NCT00394082|463852884|FG000|Overall Study|Withdrawal by Subject|2|||
128879222|NCT00394082|463852884|FG000|Overall Study|Other|1|||
128879223|NCT02344004|463852886|FG000|Overall Study|Adverse Event|11|||
128879224|NCT02344004|463852887|FG001|Overall Study|Adverse Event|1|||
128879225|NCT02344004|463852886|FG000|Overall Study|Death|9|||
128879226|NCT02344004|463852887|FG001|Overall Study|Death|7|||
128879227|NCT02344004|463852886|FG000|Overall Study|Physician Decision|4|||
128879228|NCT02344004|463852887|FG001|Overall Study|Physician Decision|1|||
128879229|NCT02344004|463852886|FG000|Overall Study|Withdrawal by Subject|22|||
128879230|NCT02344004|463852887|FG001|Overall Study|Withdrawal by Subject|5|||
128879231|NCT02344004|463852886|FG000|Overall Study|Rescue Medication|2|||
128879232|NCT02344004|463852887|FG001|Overall Study|Rescue Medication|0|||
128879233|NCT02344004|463852886|FG000|Overall Study|Other Not Specified|12|||
128879234|NCT02344004|463852887|FG001|Overall Study|Other Not Specified|0|||
128879235|NCT02344004|463852886|FG000|Overall Study|Protocol Violation|1|||
128879236|NCT02344004|463852887|FG001|Overall Study|Protocol Violation|0|||
128879237|NCT03881553|463852895|FG000|Overall Study|Discharged prior to participation|1|||
128879238|NCT03881553|463852896|FG001|Overall Study|Discharged prior to participation|1|||
128879239|NCT03881553|463852897|FG002|Overall Study|Discharged prior to participation|0|||
128879240|NCT03881553|463852895|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
128879241|NCT03881553|463852896|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
128879242|NCT03881553|463852897|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
128879243|NCT00336895|463852901|FG000|Overall Study|diarrhea|1|||
128879244|NCT00336895|463852901|FG000|Overall Study|nausea and upset stomach|1|||
128879245|NCT00336895|463852901|FG000|Overall Study|Physician Decision|1|||
128879246|NCT00336895|463852901|FG000|Overall Study|screen failed|1|||
128679032|NCT00609362|463123875|FG000|Overall Study|Adverse Event|1|||
128879247|NCT00598273|463852902|FG000|Overall Study|Adverse Event|4|||
128879248|NCT00598273|463852903|FG001|Overall Study|Adverse Event|5|||
128879249|NCT00598273|463852904|FG002|Overall Study|Adverse Event|2|||
129215085|NCT02760498|465089438|FG002|Overall Study|Withdrawal by Subject|5|||
129215086|NCT02760498|465089439|FG003|Overall Study|Withdrawal by Subject|1|||
129215087|NCT02760498|465089440|FG004|Overall Study|Withdrawal by Subject|0|||
129215088|NCT02760498|465089441|FG005|Overall Study|Withdrawal by Subject|6|||
128679033|NCT00609362|463123876|FG001|Overall Study|Adverse Event|0|||
128679034|NCT01009281|463123877|FG000|Overall Study|Administrative problems|7|||
128679035|NCT00548405|463123878|FG000|Overall Study|Adverse Event|6|||
128679036|NCT00548405|463123879|FG001|Overall Study|Adverse Event|2|||
129012707|NCT01939197|464339615|FG002|Overall Study|Withdrawal by Subject|0|||
129012708|NCT01939197|464339616|FG003|Overall Study|Withdrawal by Subject|0|||
129012709|NCT01939197|464339617|FG004|Overall Study|Withdrawal by Subject|1|||
129012710|NCT01939197|464339618|FG005|Overall Study|Withdrawal by Subject|0|||
129012711|NCT01939197|464339619|FG006|Overall Study|Withdrawal by Subject|0|||
129215089|NCT02760498|465089436|FG000|Overall Study|Other than specified|1|||
128679037|NCT00548405|463123880|FG002|Overall Study|Adverse Event|0|||
128679038|NCT00548405|463123878|FG000|Overall Study|Lack of Efficacy|6|||
128879250|NCT00598273|463852902|FG000|Overall Study|Death|6|||
128879251|NCT00598273|463852903|FG001|Overall Study|Death|12|||
128879252|NCT00598273|463852904|FG002|Overall Study|Death|8|||
128879253|NCT00598273|463852902|FG000|Overall Study|Lost to Follow-up|8|||
129012712|NCT01939197|464339613|FG000|Overall Study|Lost to Follow-up|0|||
129012713|NCT01939197|464339614|FG001|Overall Study|Lost to Follow-up|1|||
129012714|NCT01939197|464339615|FG002|Overall Study|Lost to Follow-up|0|||
129012715|NCT01939197|464339616|FG003|Overall Study|Lost to Follow-up|1|||
128879254|NCT00598273|463852903|FG001|Overall Study|Lost to Follow-up|3|||
128879255|NCT00598273|463852904|FG002|Overall Study|Lost to Follow-up|5|||
128879256|NCT00598273|463852902|FG000|Overall Study|Physician Decision|0|||
128879257|NCT00598273|463852903|FG001|Overall Study|Physician Decision|0|||
128879258|NCT00598273|463852904|FG002|Overall Study|Physician Decision|1|||
128879259|NCT00598273|463852902|FG000|Overall Study|Withdrawal by Subject|12|||
128879260|NCT00598273|463852903|FG001|Overall Study|Withdrawal by Subject|10|||
129215090|NCT02760498|465089437|FG001|Overall Study|Other than specified|6|||
128679039|NCT00548405|463123879|FG001|Overall Study|Lack of Efficacy|0|||
128679040|NCT00548405|463123880|FG002|Overall Study|Lack of Efficacy|0|||
128679041|NCT00548405|463123878|FG000|Overall Study|Physician Decision|3|||
128679042|NCT00548405|463123879|FG001|Overall Study|Physician Decision|4|||
128679043|NCT00548405|463123880|FG002|Overall Study|Physician Decision|1|||
128679044|NCT00548405|463123878|FG000|Overall Study|Pregnancy|1|||
128679045|NCT00548405|463123879|FG001|Overall Study|Pregnancy|0|||
128679046|NCT00548405|463123880|FG002|Overall Study|Pregnancy|0|||
128679047|NCT00548405|463123878|FG000|Overall Study|Protocol Violation|1|||
128679048|NCT00548405|463123879|FG001|Overall Study|Protocol Violation|0|||
128679049|NCT00548405|463123880|FG002|Overall Study|Protocol Violation|0|||
128679050|NCT00548405|463123878|FG000|Overall Study|Withdrawal by Subject|36|||
128679051|NCT00548405|463123879|FG001|Overall Study|Withdrawal by Subject|12|||
128679052|NCT00548405|463123880|FG002|Overall Study|Withdrawal by Subject|5|||
128679053|NCT00548405|463123878|FG000|Overall Study|Lost to Follow-up|1|||
128679054|NCT00548405|463123879|FG001|Overall Study|Lost to Follow-up|1|||
128679055|NCT00548405|463123880|FG002|Overall Study|Lost to Follow-up|2|||
128679056|NCT00548405|463123878|FG000|Overall Study|Death|0|||
128679057|NCT00548405|463123879|FG001|Overall Study|Death|1|||
128679058|NCT00548405|463123880|FG002|Overall Study|Death|1|||
128679059|NCT00548405|463123878|FG000|Overall Study|Sponsor decision|1|||
128679060|NCT00548405|463123879|FG001|Overall Study|Sponsor decision|0|||
128679061|NCT00548405|463123880|FG002|Overall Study|Sponsor decision|0|||
128679062|NCT00548405|463123878|FG000|Overall Study|Randomized but not treated|1|||
128679063|NCT00548405|463123879|FG001|Overall Study|Randomized but not treated|0|||
128679064|NCT00548405|463123880|FG002|Overall Study|Randomized but not treated|0|||
128679065|NCT02582684|463123881|FG000|Overall Study|Unable to contact subject/parent|4|||
128679066|NCT02582684|463123881|FG000|Overall Study|Subject not able to get to clinic|10|||
128679067|NCT02582684|463123881|FG000|Overall Study|Subject withdrew consent|1|||
128679068|NCT02582684|463123881|FG000|Overall Study|Found to be ineligible after enrollment|2|||
128679069|NCT01878149|463123882|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
128679070|NCT01878149|463123883|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
128679071|NCT02241889|463123893|FG000|Overall Study|device issues|0|||
128679072|NCT02241889|463123894|FG001|Overall Study|device issues|0|||
128679073|NCT02241889|463123895|FG002|Overall Study|device issues|1|||
128679074|NCT02241889|463123896|FG003|Overall Study|device issues|0|||
128679075|NCT02241889|463123897|FG004|Overall Study|device issues|0|||
128679076|NCT02241889|463123898|FG005|Overall Study|device issues|0|||
128679077|NCT02241889|463123893|FG000|Overall Study|Withdrawal by Subject|0|||
128679078|NCT02241889|463123894|FG001|Overall Study|Withdrawal by Subject|0|||
128679079|NCT02241889|463123895|FG002|Overall Study|Withdrawal by Subject|0|||
128679080|NCT02241889|463123896|FG003|Overall Study|Withdrawal by Subject|0|||
128679081|NCT02241889|463123897|FG004|Overall Study|Withdrawal by Subject|0|||
128679082|NCT02241889|463123898|FG005|Overall Study|Withdrawal by Subject|1|||
128679083|NCT04658940|463123902|FG000|Overall Study|Withdrawal by Subject|1|||
128679084|NCT01120067|463123903|FG000|Overall Study|Lost to Follow-up|3|||
128679085|NCT01120067|463123904|FG001|Overall Study|Lost to Follow-up|1|||
128879261|NCT00598273|463852904|FG002|Overall Study|Withdrawal by Subject|10|||
128879262|NCT00598273|463852902|FG000|Overall Study|Noncompliance|3|||
128879263|NCT00598273|463852903|FG001|Overall Study|Noncompliance|2|||
128879264|NCT00598273|463852904|FG002|Overall Study|Noncompliance|3|||
128879265|NCT00598273|463852902|FG000|Overall Study|Relocation|0|||
128879266|NCT00598273|463852903|FG001|Overall Study|Relocation|2|||
128879267|NCT00598273|463852904|FG002|Overall Study|Relocation|4|||
128879268|NCT00598273|463852902|FG000|Overall Study|Renal transplant|1|||
128879269|NCT00598273|463852903|FG001|Overall Study|Renal transplant|0|||
128879270|NCT00598273|463852904|FG002|Overall Study|Renal transplant|1|||
128879271|NCT00598273|463852902|FG000|Overall Study|Site elected to close|1|||
128879272|NCT00598273|463852903|FG001|Overall Study|Site elected to close|0|||
128879273|NCT00598273|463852904|FG002|Overall Study|Site elected to close|0|||
128879274|NCT00598273|463852902|FG000|Overall Study|Started dialysis|6|||
128679086|NCT01120067|463123903|FG000|Overall Study|fail to engage >3 sessions|2|||
128679087|NCT01120067|463123904|FG001|Overall Study|fail to engage >3 sessions|0|||
128679088|NCT00266877|463123905|FG000|Overall Study|Death|1|||
128679089|NCT00266877|463123906|FG001|Overall Study|Death|1|||
128679090|NCT00266877|463123907|FG002|Overall Study|Death|1|||
128679091|NCT00266877|463123905|FG000|Overall Study|Adverse Event|6|||
128679092|NCT00266877|463123906|FG001|Overall Study|Adverse Event|4|||
128679093|NCT00266877|463123907|FG002|Overall Study|Adverse Event|1|||
128679094|NCT00266877|463123905|FG000|Overall Study|Physician Decision|2|||
128679095|NCT00266877|463123906|FG001|Overall Study|Physician Decision|1|||
128679096|NCT00266877|463123907|FG002|Overall Study|Physician Decision|1|||
128679097|NCT00266877|463123905|FG000|Overall Study|Withdrawal by Subject|3|||
128679098|NCT00266877|463123906|FG001|Overall Study|Withdrawal by Subject|1|||
128879275|NCT00598273|463852903|FG001|Overall Study|Started dialysis|4|||
128879276|NCT00598273|463852904|FG002|Overall Study|Started dialysis|5|||
128879277|NCT00906945|463852905|FG000|Overall Study|Found to be not eligible|0|||
128679099|NCT00266877|463123907|FG002|Overall Study|Withdrawal by Subject|1|||
128679100|NCT00266877|463123905|FG000|Overall Study|Disease Progression|72|||
128879278|NCT00906945|463852906|FG001|Overall Study|Found to be not eligible|0|||
128879279|NCT00906945|463852907|FG002|Overall Study|Found to be not eligible|0|||
128879280|NCT00906945|463852908|FG003|Overall Study|Found to be not eligible|1|||
128879281|NCT00906945|463852909|FG004|Overall Study|Found to be not eligible|1|||
128879282|NCT00906945|463852910|FG005|Overall Study|Found to be not eligible|1|||
128879283|NCT00906945|463852905|FG000|Overall Study|Physician Decision|0|||
128879284|NCT00906945|463852906|FG001|Overall Study|Physician Decision|0|||
128879285|NCT00906945|463852907|FG002|Overall Study|Physician Decision|0|||
128879286|NCT00906945|463852908|FG003|Overall Study|Physician Decision|0|||
128879287|NCT00906945|463852909|FG004|Overall Study|Physician Decision|0|||
128879288|NCT00906945|463852910|FG005|Overall Study|Physician Decision|1|||
128879289|NCT02481947|463852911|FG000|Overall Study|Withdrawal by Subject|24|||
128879290|NCT02481947|463852912|FG001|Overall Study|Withdrawal by Subject|10|||
128879291|NCT02481947|463852911|FG000|Overall Study|Lost to Follow-up|11|||
128879292|NCT02481947|463852912|FG001|Overall Study|Lost to Follow-up|5|||
128879293|NCT02481947|463852911|FG000|Overall Study|Adverse Event|6|||
128879294|NCT02481947|463852912|FG001|Overall Study|Adverse Event|11|||
128879295|NCT02481947|463852911|FG000|Overall Study|Physician Decision|4|||
128879296|NCT02481947|463852912|FG001|Overall Study|Physician Decision|5|||
128879297|NCT02481947|463852911|FG000|Overall Study|Protocol Violation|1|||
128879298|NCT02481947|463852912|FG001|Overall Study|Protocol Violation|5|||
128879299|NCT03426605|463852913|FG000|Overall Study|AML relapse or progression|2|||
128679101|NCT00266877|463123906|FG001|Overall Study|Disease Progression|37|||
128679102|NCT00266877|463123907|FG002|Overall Study|Disease Progression|23|||
128679103|NCT00266877|463123905|FG000|Overall Study|Symptomatic Deterioration|6|||
128679104|NCT00266877|463123906|FG001|Overall Study|Symptomatic Deterioration|3|||
128679105|NCT00266877|463123907|FG002|Overall Study|Symptomatic Deterioration|1|||
128679106|NCT00266877|463123905|FG000|Overall Study|Hospitalization|1|||
128679107|NCT00266877|463123906|FG001|Overall Study|Hospitalization|0|||
128679108|NCT00266877|463123907|FG002|Overall Study|Hospitalization|0|||
128679109|NCT00266877|463123905|FG000|Overall Study|Concomitant Radiotherapy|0|||
128679110|NCT00266877|463123906|FG001|Overall Study|Concomitant Radiotherapy|1|||
128679111|NCT00266877|463123907|FG002|Overall Study|Concomitant Radiotherapy|0|||
128679112|NCT03985878|463123914|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
128679113|NCT03985878|463123914|FG000|Overall Study|Study Terminated by Sponsor|12|||
128679114|NCT03985878|463123914|FG000|Overall Study|Withdrawal by Subject|1|||
128879300|NCT03426605|463852914|FG001|Overall Study|AML relapse or progression|1|||
128879301|NCT03426605|463852915|FG002|Overall Study|AML relapse or progression|2|||
128879302|NCT03426605|463852916|FG003|Overall Study|AML relapse or progression|2|||
128879303|NCT03426605|463852913|FG000|Overall Study|Treatment failure|3|||
128879304|NCT03426605|463852914|FG001|Overall Study|Treatment failure|2|||
128879305|NCT03426605|463852915|FG002|Overall Study|Treatment failure|0|||
128879306|NCT03426605|463852916|FG003|Overall Study|Treatment failure|0|||
128879307|NCT03426605|463852913|FG000|Overall Study|Adverse Event|1|||
128879308|NCT03426605|463852914|FG001|Overall Study|Adverse Event|0|||
128879309|NCT03426605|463852915|FG002|Overall Study|Adverse Event|1|||
128879310|NCT03426605|463852916|FG003|Overall Study|Adverse Event|1|||
128879311|NCT03426605|463852913|FG000|Overall Study|Withdrawal by Subject|0|||
128879312|NCT03426605|463852914|FG001|Overall Study|Withdrawal by Subject|0|||
128879313|NCT03426605|463852915|FG002|Overall Study|Withdrawal by Subject|1|||
128879314|NCT03426605|463852916|FG003|Overall Study|Withdrawal by Subject|1|||
128879315|NCT01815138|463852917|FG000|Overall Study|Withdrawal by Subject|0|||
128879316|NCT01815138|463852918|FG001|Overall Study|Withdrawal by Subject|1|||
128879317|NCT01815138|463852917|FG000|Overall Study|Physician Decision|8|||
128879318|NCT01815138|463852918|FG001|Overall Study|Physician Decision|5|||
128879319|NCT03426267|463852921|FG000|Overall Study|Physician Decision|1|||
128879320|NCT03426267|463852922|FG001|Overall Study|Physician Decision|4|||
128879321|NCT03426267|463852921|FG000|Overall Study|Lost to Follow-up|1|||
128879322|NCT03426267|463852922|FG001|Overall Study|Lost to Follow-up|0|||
128679115|NCT00278915|463123917|FG000|Overall Study|Disease progression|1|||
128679116|NCT02520089|463123918|FG000|Overall Study|Lost to Follow-up|3|||
128679117|NCT02520089|463123919|FG001|Overall Study|Lost to Follow-up|4|||
128679118|NCT03353740|463123925|FG000|Overall Study|Images for these participants not viable|52|||
128679119|NCT03473548|463123926|FG000|Overall Study|Did not attempt HST testing|3|||
128879323|NCT03426267|463852921|FG000|Overall Study|Withdrawal by Subject|4|||
128879324|NCT03426267|463852922|FG001|Overall Study|Withdrawal by Subject|10|||
128879325|NCT03426267|463852921|FG000|Overall Study|Protocol Violation|1|||
128879326|NCT03426267|463852922|FG001|Overall Study|Protocol Violation|3|||
128679120|NCT03473548|463123927|FG001|Overall Study|Did not attempt HST testing|0|||
128879327|NCT03426267|463852921|FG000|Overall Study|Adverse Event|9|||
128879328|NCT03426267|463852922|FG001|Overall Study|Adverse Event|27|||
128879329|NCT03426267|463852921|FG000|Overall Study|Prohibited Treatment Intake|2|||
128879330|NCT03426267|463852922|FG001|Overall Study|Prohibited Treatment Intake|3|||
128879331|NCT03426267|463852921|FG000|Overall Study|Lack of Efficacy|0|||
128879332|NCT03426267|463852922|FG001|Overall Study|Lack of Efficacy|25|||
128879333|NCT03426267|463852921|FG000|Overall Study|other|3|||
128879334|NCT03426267|463852922|FG001|Overall Study|other|0|||
128679121|NCT00129311|463123929|FG000|Overall Study|Withdrawal by Subject|12|||
128879335|NCT00609765|463852923|FG000|Overall Study|Study ended prior to 12 months|1|||
128879336|NCT02649946|463852925|FG000|Overall Study|Withdrawal by Subject|1|||
128879337|NCT02649946|463852926|FG001|Overall Study|Withdrawal by Subject|1|||
129101694|NCT01214668|464667683|FG001|Overall Study|Adverse Event|1|||
129101695|NCT01214668|464667684|FG002|Overall Study|Adverse Event|0|||
129101696|NCT01214668|464667685|FG003|Overall Study|Adverse Event|2|||
129101697|NCT01214668|464667686|FG004|Overall Study|Adverse Event|1|||
129101698|NCT01214668|464667687|FG005|Overall Study|Adverse Event|1|||
129101699|NCT01214668|464667682|FG000|Overall Study|Death|0|||
129101700|NCT01214668|464667683|FG001|Overall Study|Death|0|||
129101701|NCT01214668|464667684|FG002|Overall Study|Death|1|||
129101702|NCT01214668|464667685|FG003|Overall Study|Death|0|||
129101703|NCT01214668|464667686|FG004|Overall Study|Death|0|||
129101704|NCT01214668|464667687|FG005|Overall Study|Death|0|||
129101705|NCT01214668|464667682|FG000|Overall Study|Progressive Disease|4|||
129101706|NCT01214668|464667683|FG001|Overall Study|Progressive Disease|2|||
129101707|NCT01214668|464667684|FG002|Overall Study|Progressive Disease|5|||
129101708|NCT01214668|464667685|FG003|Overall Study|Progressive Disease|4|||
129101709|NCT01214668|464667686|FG004|Overall Study|Progressive Disease|4|||
128879338|NCT02649946|463852925|FG000|Overall Study|Death|7|||
128879339|NCT02649946|463852926|FG001|Overall Study|Death|9|||
128879340|NCT02649946|463852925|FG000|Overall Study|Physician Decision|1|||
128879341|NCT02649946|463852926|FG001|Overall Study|Physician Decision|0|||
128879342|NCT02649946|463852925|FG000|Overall Study|Lost to Follow-up|2|||
128879343|NCT02649946|463852926|FG001|Overall Study|Lost to Follow-up|1|||
128879344|NCT02649946|463852925|FG000|Overall Study|Erroneously enrolled|1|||
128879345|NCT02649946|463852926|FG001|Overall Study|Erroneously enrolled|0|||
128879346|NCT02649946|463852925|FG000|Overall Study|Missed 6-month follow-up visit|0|||
128879347|NCT02649946|463852926|FG001|Overall Study|Missed 6-month follow-up visit|4|||
128879348|NCT00950950|463852927|FG000|Overall Study|Adverse Event|1|||
128879349|NCT00950950|463852928|FG001|Overall Study|Adverse Event|0|||
128879350|NCT00950950|463852927|FG000|Overall Study|Withdrawal by Subject|0|||
128879351|NCT00950950|463852928|FG001|Overall Study|Withdrawal by Subject|1|||
128879352|NCT01047293|463852934|FG000|Overall Study|DLT criteria not fulfilled|1|||
128879353|NCT01047293|463852935|FG001|Overall Study|DLT criteria not fulfilled|1|||
128879354|NCT01047293|463852936|FG002|Overall Study|DLT criteria not fulfilled|0|||
128879355|NCT01047293|463852937|FG003|Overall Study|DLT criteria not fulfilled|0|||
128879356|NCT02054520|463852938|FG000|Overall Study|Adverse Event|1|||
128879357|NCT02054520|463852939|FG001|Overall Study|Adverse Event|4|||
128879358|NCT02054520|463852940|FG002|Overall Study|Adverse Event|2|||
128879359|NCT02054520|463852941|FG003|Overall Study|Adverse Event|1|||
128879360|NCT02054520|463852942|FG004|Overall Study|Adverse Event|1|||
128879361|NCT02054520|463852943|FG005|Overall Study|Adverse Event|0|||
128879362|NCT02054520|463852938|FG000|Overall Study|Lack of Efficacy|7|||
128879363|NCT02054520|463852939|FG001|Overall Study|Lack of Efficacy|0|||
128879364|NCT02054520|463852940|FG002|Overall Study|Lack of Efficacy|2|||
128879365|NCT02054520|463852941|FG003|Overall Study|Lack of Efficacy|1|||
128879366|NCT02054520|463852942|FG004|Overall Study|Lack of Efficacy|3|||
128879367|NCT02054520|463852943|FG005|Overall Study|Lack of Efficacy|2|||
128879368|NCT02054520|463852938|FG000|Overall Study|Withdrawal by Subject|1|||
128879369|NCT02054520|463852939|FG001|Overall Study|Withdrawal by Subject|0|||
128879370|NCT02054520|463852940|FG002|Overall Study|Withdrawal by Subject|0|||
128879371|NCT02054520|463852941|FG003|Overall Study|Withdrawal by Subject|2|||
128879372|NCT02054520|463852942|FG004|Overall Study|Withdrawal by Subject|1|||
128879373|NCT02054520|463852943|FG005|Overall Study|Withdrawal by Subject|0|||
128879374|NCT02054520|463852938|FG000|Overall Study|Physician Decision|0|||
128879375|NCT02054520|463852939|FG001|Overall Study|Physician Decision|1|||
128679122|NCT00129311|463123930|FG001|Overall Study|Withdrawal by Subject|19|||
128879376|NCT02054520|463852940|FG002|Overall Study|Physician Decision|0|||
128879377|NCT02054520|463852941|FG003|Overall Study|Physician Decision|1|||
128879378|NCT02054520|463852942|FG004|Overall Study|Physician Decision|0|||
128879379|NCT02054520|463852943|FG005|Overall Study|Physician Decision|1|||
128879380|NCT02054520|463852938|FG000|Overall Study|Study terminated by Sponsor|0|||
128879381|NCT02054520|463852939|FG001|Overall Study|Study terminated by Sponsor|0|||
128879382|NCT02054520|463852940|FG002|Overall Study|Study terminated by Sponsor|2|||
128879383|NCT02054520|463852941|FG003|Overall Study|Study terminated by Sponsor|1|||
128879384|NCT02054520|463852942|FG004|Overall Study|Study terminated by Sponsor|0|||
128879385|NCT02054520|463852943|FG005|Overall Study|Study terminated by Sponsor|0|||
129101710|NCT01214668|464667687|FG005|Overall Study|Progressive Disease|5|||
129101711|NCT01214668|464667682|FG000|Overall Study|Withdrawal by Subject|0|||
129101712|NCT01214668|464667683|FG001|Overall Study|Withdrawal by Subject|0|||
128879386|NCT01272804|463852944|FG000|Overall Study|Adverse Event|1|||
128879387|NCT01272804|463852945|FG001|Overall Study|Adverse Event|0|||
129101713|NCT01214668|464667684|FG002|Overall Study|Withdrawal by Subject|0|||
129101714|NCT01214668|464667685|FG003|Overall Study|Withdrawal by Subject|0|||
128879388|NCT01272804|463852946|FG002|Overall Study|Adverse Event|0|||
128879389|NCT01272804|463852947|FG003|Overall Study|Adverse Event|0|||
128879390|NCT01272804|463852948|FG004|Overall Study|Adverse Event|2|||
129101715|NCT01214668|464667686|FG004|Overall Study|Withdrawal by Subject|1|||
128679123|NCT02232880|463123931|FG000|Overall Study|study stopped prior to randomization|1|||
128679124|NCT02545543|463123932|FG000|Overall Study|Lost to Follow-up|67|||
128679125|NCT02545543|463123933|FG001|Overall Study|Lost to Follow-up|25|||
128679126|NCT02545543|463123932|FG000|Overall Study|Physician Decision|3|||
128679127|NCT02545543|463123933|FG001|Overall Study|Physician Decision|0|||
128679128|NCT02545543|463123932|FG000|Overall Study|Withdrawal by Subject|9|||
128679129|NCT02545543|463123933|FG001|Overall Study|Withdrawal by Subject|8|||
128679130|NCT02545543|463123932|FG000|Overall Study|Noncomplaince|1|||
128679131|NCT02545543|463123933|FG001|Overall Study|Noncomplaince|0|||
128679132|NCT02545543|463123932|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
128679133|NCT02545543|463123933|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
128679134|NCT02829944|463123937|FG000|Overall Study|Physician Decision|0|||
128679135|NCT02829944|463123938|FG001|Overall Study|Physician Decision|1|||
128679136|NCT02829944|463123937|FG000|Overall Study|Screen Failure|2|||
128679137|NCT02829944|463123938|FG001|Overall Study|Screen Failure|2|||
128679138|NCT02829944|463123937|FG000|Overall Study|Inadequate Neuraxial Block|1|||
128679139|NCT02829944|463123938|FG001|Overall Study|Inadequate Neuraxial Block|1|||
128679140|NCT02829944|463123937|FG000|Overall Study|Withdrawal by Subject|2|||
128679141|NCT02829944|463123938|FG001|Overall Study|Withdrawal by Subject|1|||
128679142|NCT02829944|463123937|FG000|Overall Study|Catheter Displacement|1|||
128679143|NCT02829944|463123938|FG001|Overall Study|Catheter Displacement|0|||
128679144|NCT02829944|463123937|FG000|Overall Study|Catheter broke|0|||
128679145|NCT02829944|463123938|FG001|Overall Study|Catheter broke|1|||
128679146|NCT02829944|463123937|FG000|Overall Study|Staff unavailable|0|||
128679147|NCT02829944|463123938|FG001|Overall Study|Staff unavailable|1|||
128679148|NCT01395784|463123939|FG000|Overall Study|Lost to Follow-up|7|||
128679149|NCT01395784|463123939|FG000|Overall Study|Withdrawal by Subject|3|||
128679150|NCT01395784|463123939|FG000|Overall Study|Physician Decision|5|||
128679151|NCT04268823|463123940|FG000|Overall Study|Adverse Event|1|||
128679152|NCT04268823|463123941|FG001|Overall Study|Adverse Event|0|||
128679153|NCT04268823|463123940|FG000|Overall Study|Participant Decision|1|||
128679154|NCT04268823|463123941|FG001|Overall Study|Participant Decision|0|||
128679155|NCT00336583|463125199|FG000|Overall Study|Lost to Follow-up|1|||
128679156|NCT00336583|463125199|FG000|Overall Study|Death|1|||
128679157|NCT01095094|463125201|FG000|Overall Study|Withdrawal by Subject|1|||
128679158|NCT01095094|463125201|FG000|Overall Study|Death|1|||
128679159|NCT01095094|463125201|FG000|Overall Study|Physician Decision|1|||
128679160|NCT03718299|463125202|FG000|Overall Study|Adverse Event|1|||
128679161|NCT03718299|463125202|FG000|Overall Study|Withdrawal by Subject|6|||
128679162|NCT03718299|463125202|FG000|Overall Study|Physician Decision|2|||
128679163|NCT03718299|463125202|FG000|Overall Study|Lost to Follow-up|1|||
128679164|NCT01205581|463125206|FG000|Overall Study|Withdrawal by Subject|1|||
128679165|NCT01205581|463125207|FG001|Overall Study|Withdrawal by Subject|0|||
128679166|NCT01205581|463125208|FG002|Overall Study|Withdrawal by Subject|0|||
128679167|NCT01205581|463125209|FG003|Overall Study|Withdrawal by Subject|0|||
128679168|NCT01205581|463125210|FG004|Overall Study|Withdrawal by Subject|0|||
128679169|NCT01205581|463125211|FG005|Overall Study|Withdrawal by Subject|0|||
128679170|NCT02278471|463125212|FG000|Overall Study|Lost to Follow-up|6|||
128679171|NCT02278471|463125213|FG001|Overall Study|Lost to Follow-up|15|||
128679172|NCT02278471|463125212|FG000|Overall Study|Death|2|||
128679173|NCT02278471|463125213|FG001|Overall Study|Death|2|||
128679174|NCT02278471|463125212|FG000|Overall Study|Withdrawal by Subject|0|||
128679175|NCT02278471|463125213|FG001|Overall Study|Withdrawal by Subject|3|||
128679176|NCT00640835|463125214|FG000|Overall Study|Adverse Event|5|||
128679177|NCT00640835|463125215|FG001|Overall Study|Adverse Event|3|||
128679178|NCT00640835|463125214|FG000|Overall Study|Withdrawal by Subject|12|||
128679179|NCT00640835|463125215|FG001|Overall Study|Withdrawal by Subject|14|||
128679180|NCT00640835|463125214|FG000|Overall Study|Physician Decision|10|||
128679181|NCT00640835|463125215|FG001|Overall Study|Physician Decision|14|||
128679182|NCT00640835|463125214|FG000|Overall Study|Sponsor's Decision|11|||
128679183|NCT00640835|463125215|FG001|Overall Study|Sponsor's Decision|7|||
128679184|NCT00640835|463125214|FG000|Overall Study|Protocol Violation|2|||
128679185|NCT00640835|463125215|FG001|Overall Study|Protocol Violation|2|||
128679186|NCT00640835|463125214|FG000|Overall Study|Lost to Follow-up|17|||
128679187|NCT00640835|463125215|FG001|Overall Study|Lost to Follow-up|13|||
128679188|NCT00640835|463125214|FG000|Overall Study|Other Reason|19|||
128679189|NCT00640835|463125215|FG001|Overall Study|Other Reason|4|||
128679190|NCT03468543|463125216|FG000|Overall Study|Protocol stopping rules met|3|||
128679191|NCT04535167|463125220|FG000|Treatment|Adverse Event|0|||
128679192|NCT04535167|463125221|FG001|Treatment|Adverse Event|0|||
128679193|NCT04535167|463125222|FG002|Treatment|Adverse Event|0|||
128679194|NCT04535167|463125223|FG003|Treatment|Adverse Event|0|||
128679195|NCT04535167|463125224|FG004|Treatment|Adverse Event|0|||
128679196|NCT04535167|463125225|FG005|Treatment|Adverse Event|0|||
128679197|NCT04535167|463125226|FG006|Treatment|Adverse Event|1|||
128679198|NCT04535167|463125220|FG000|Follow-Up|Death|0|||
128679199|NCT04535167|463125221|FG001|Follow-Up|Death|0|||
128679200|NCT04535167|463125222|FG002|Follow-Up|Death|0|||
128679201|NCT04535167|463125223|FG003|Follow-Up|Death|0|||
128679202|NCT04535167|463125224|FG004|Follow-Up|Death|0|||
128879391|NCT01272804|463852949|FG005|Overall Study|Adverse Event|1|||
128879392|NCT02318797|463852950|FG000|Overall Study|Death|3|||
128879393|NCT02318797|463852951|FG001|Overall Study|Death|6|||
128879394|NCT02318797|463852950|FG000|Overall Study|Lost to Follow-up|85|||
128879395|NCT02318797|463852951|FG001|Overall Study|Lost to Follow-up|96|||
128879396|NCT02308020|463852954|FG000|Overall Study|Lost to Follow-up|1|||
128879397|NCT02308020|463852955|FG001|Overall Study|Lost to Follow-up|7|||
128879398|NCT02308020|463852956|FG002|Overall Study|Lost to Follow-up|0|||
128879399|NCT02308020|463852957|FG003|Overall Study|Lost to Follow-up|0|||
128879400|NCT02308020|463852958|FG004|Overall Study|Lost to Follow-up|1|||
128879401|NCT02308020|463852959|FG005|Overall Study|Lost to Follow-up|2|||
128879402|NCT02308020|463852954|FG000|Overall Study|Sponsor Decision|0|||
128879403|NCT02308020|463852955|FG001|Overall Study|Sponsor Decision|8|||
128879404|NCT02308020|463852956|FG002|Overall Study|Sponsor Decision|0|||
128879405|NCT02308020|463852957|FG003|Overall Study|Sponsor Decision|2|||
128879406|NCT02308020|463852958|FG004|Overall Study|Sponsor Decision|2|||
128879407|NCT02308020|463852959|FG005|Overall Study|Sponsor Decision|1|||
128879408|NCT02308020|463852954|FG000|Overall Study|Withdrawal by Subject|3|||
128879409|NCT02308020|463852955|FG001|Overall Study|Withdrawal by Subject|5|||
128879410|NCT02308020|463852956|FG002|Overall Study|Withdrawal by Subject|3|||
128879411|NCT02308020|463852957|FG003|Overall Study|Withdrawal by Subject|2|||
128879412|NCT02308020|463852958|FG004|Overall Study|Withdrawal by Subject|1|||
128879413|NCT02308020|463852959|FG005|Overall Study|Withdrawal by Subject|2|||
128879414|NCT03333837|463852960|FG000|Overall Study|Adverse Event|2|||
129101716|NCT01214668|464667687|FG005|Overall Study|Withdrawal by Subject|0|||
128679203|NCT04535167|463125225|FG005|Follow-Up|Death|0|||
128679204|NCT04535167|463125226|FG006|Follow-Up|Death|1|||
128679205|NCT04535167|463125220|FG000|Follow-Up|Lost to Follow-up|0|||
128679206|NCT04535167|463125221|FG001|Follow-Up|Lost to Follow-up|0|||
129101717|NCT01964989|464667688|FG000|Overall Study|Protocol Violation|3|||
129101718|NCT01964989|464667689|FG001|Overall Study|Protocol Violation|4|||
129101719|NCT01964989|464667688|FG000|Overall Study|Administrative Reason|103|||
128679207|NCT04535167|463125222|FG002|Follow-Up|Lost to Follow-up|0|||
128679208|NCT04535167|463125223|FG003|Follow-Up|Lost to Follow-up|1|||
128679209|NCT04535167|463125224|FG004|Follow-Up|Lost to Follow-up|0|||
128679210|NCT04535167|463125225|FG005|Follow-Up|Lost to Follow-up|0|||
128679211|NCT04535167|463125226|FG006|Follow-Up|Lost to Follow-up|0|||
128679212|NCT00978432|463125227|FG000|Overall Study|Withdrawal by Subject|0|||
128679213|NCT00978432|463125228|FG001|Overall Study|Withdrawal by Subject|0|||
128679214|NCT00978432|463125229|FG002|Overall Study|Withdrawal by Subject|1|||
128679215|NCT00978432|463125227|FG000|Overall Study|Lack of Efficacy|1|||
128679216|NCT00978432|463125228|FG001|Overall Study|Lack of Efficacy|1|||
128679217|NCT00978432|463125229|FG002|Overall Study|Lack of Efficacy|3|||
128679218|NCT00978432|463125227|FG000|Overall Study|Adverse Event|2|||
128679219|NCT00978432|463125228|FG001|Overall Study|Adverse Event|0|||
128679220|NCT00978432|463125229|FG002|Overall Study|Adverse Event|1|||
128679221|NCT04618770|463125230|FG000|Overall Study|Censored from Analysis|12|||
128679222|NCT04618770|463125230|FG000|Overall Study|Early Termination|25|||
128679223|NCT00246571|463125233|FG000|Overall Study|Adverse Event|7|||
128679224|NCT00246571|463125234|FG001|Overall Study|Adverse Event|0|||
128679225|NCT00246571|463125233|FG000|Overall Study|Protocol Violation|0|||
128679226|NCT00246571|463125234|FG001|Overall Study|Protocol Violation|1|||
129101720|NCT01964989|464667689|FG001|Overall Study|Administrative Reason|95|||
129101721|NCT01964989|464667688|FG000|Overall Study|Adverse Event|0|||
129101722|NCT01964989|464667689|FG001|Overall Study|Adverse Event|1|||
129101723|NCT01964989|464667688|FG000|Overall Study|Death|1|||
129101724|NCT01964989|464667689|FG001|Overall Study|Death|3|||
129101725|NCT01964989|464667688|FG000|Overall Study|Withdrawal by Subject|156|||
129101726|NCT01964989|464667689|FG001|Overall Study|Withdrawal by Subject|160|||
129101727|NCT01964989|464667688|FG000|Overall Study|Lost to Follow-up|254|||
129101728|NCT01964989|464667689|FG001|Overall Study|Lost to Follow-up|232|||
128679227|NCT00246571|463125233|FG000|Overall Study|Withdrawal by Subject|2|||
129012716|NCT01939197|464339617|FG004|Overall Study|Lost to Follow-up|3|||
129012717|NCT01939197|464339618|FG005|Overall Study|Lost to Follow-up|1|||
129012718|NCT01939197|464339619|FG006|Overall Study|Lost to Follow-up|2|||
129012719|NCT00745095|464339620|FG000|Overall Study|Declined to participate|1|||
129012720|NCT00745095|464339621|FG001|Overall Study|Declined to participate|0|||
129012721|NCT00745095|464339622|FG002|Overall Study|Declined to participate|0|||
129012722|NCT00745095|464339623|FG003|Overall Study|Declined to participate|0|||
129101729|NCT01964989|464667688|FG000|Overall Study|Other|267|||
128879415|NCT03333837|463852961|FG001|Overall Study|Adverse Event|1|||
128679228|NCT00246571|463125234|FG001|Overall Study|Withdrawal by Subject|3|||
128679229|NCT00246571|463125233|FG000|Overall Study|Lack of Efficacy|84|||
129012723|NCT00745095|464339624|FG004|Overall Study|Declined to participate|92|||
129012724|NCT00745095|464339625|FG005|Overall Study|Declined to participate|95|||
129101730|NCT01964989|464667689|FG001|Overall Study|Other|252|||
128679230|NCT00246571|463125234|FG001|Overall Study|Lack of Efficacy|21|||
128679231|NCT00246571|463125233|FG000|Overall Study|Death|17|||
128879416|NCT03333837|463852962|FG002|Overall Study|Adverse Event|1|||
129101731|NCT00424593|464667690|FG000|Acute Double-Blind Period|Adverse Event|16|||
128679232|NCT00246571|463125234|FG001|Overall Study|Death|3|||
128679233|NCT00246571|463125233|FG000|Overall Study|Sponsor|0|||
128679234|NCT00246571|463125234|FG001|Overall Study|Sponsor|1|||
128679235|NCT00246571|463125233|FG000|Overall Study|Did not meet entrance criteria|2|||
128679236|NCT00246571|463125234|FG001|Overall Study|Did not meet entrance criteria|1|||
128679237|NCT00246571|463125233|FG000|Overall Study|Laboratory abnormalities|1|||
128679238|NCT00246571|463125234|FG001|Overall Study|Laboratory abnormalities|0|||
128679239|NCT00246571|463125233|FG000|Overall Study|Crossover participants|0|||
128679240|NCT00246571|463125234|FG001|Overall Study|Crossover participants|74|||
128679241|NCT02160002|463125235|FG000|Overall Study|Withdrawal by Subject|2|||
128679242|NCT02160002|463125236|FG001|Overall Study|Withdrawal by Subject|1|||
128679243|NCT04896229|463125237|FG000|Overall Study|Lost to Follow-up|113|||
128679244|NCT04896229|463125238|FG001|Overall Study|Lost to Follow-up|113|||
128679245|NCT04418661|463125239|FG000|Overall Study|Adverse Event|0|||
128679246|NCT04418661|463125240|FG001|Overall Study|Adverse Event|1|||
128679247|NCT04418661|463125241|FG002|Overall Study|Adverse Event|5|||
128679248|NCT04418661|463125242|FG003|Overall Study|Adverse Event|3|||
128679249|NCT04418661|463125243|FG004|Overall Study|Adverse Event|0|||
128679250|NCT04418661|463125244|FG005|Overall Study|Adverse Event|2|||
128679251|NCT04418661|463125239|FG000|Overall Study|Progressive disease|4|||
128679252|NCT04418661|463125240|FG001|Overall Study|Progressive disease|11|||
128679253|NCT04418661|463125241|FG002|Overall Study|Progressive disease|6|||
128679254|NCT04418661|463125242|FG003|Overall Study|Progressive disease|11|||
128679255|NCT04418661|463125243|FG004|Overall Study|Progressive disease|1|||
128679256|NCT04418661|463125244|FG005|Overall Study|Progressive disease|12|||
128679257|NCT04418661|463125239|FG000|Overall Study|Withdrawal by Subject|0|||
128679258|NCT04418661|463125240|FG001|Overall Study|Withdrawal by Subject|1|||
128679259|NCT04418661|463125241|FG002|Overall Study|Withdrawal by Subject|0|||
128679260|NCT04418661|463125242|FG003|Overall Study|Withdrawal by Subject|1|||
128679261|NCT04418661|463125243|FG004|Overall Study|Withdrawal by Subject|0|||
128679262|NCT04418661|463125244|FG005|Overall Study|Withdrawal by Subject|0|||
128679263|NCT04418661|463125239|FG000|Overall Study|Other|0|||
128679264|NCT04418661|463125240|FG001|Overall Study|Other|0|||
128679265|NCT04418661|463125241|FG002|Overall Study|Other|1|||
128679266|NCT04418661|463125242|FG003|Overall Study|Other|3|||
128679267|NCT04418661|463125243|FG004|Overall Study|Other|0|||
128679268|NCT04418661|463125244|FG005|Overall Study|Other|1|||
128679269|NCT00713310|463125248|FG000|Overall Study|Adverse Event|5|||
128679270|NCT00713310|463125249|FG001|Overall Study|Adverse Event|2|||
128679271|NCT00713310|463125248|FG000|Overall Study|Lack of Efficacy|0|||
128679272|NCT00713310|463125249|FG001|Overall Study|Lack of Efficacy|2|||
128679273|NCT00713310|463125248|FG000|Overall Study|Withdrawal by Subject|0|||
128679274|NCT00713310|463125249|FG001|Overall Study|Withdrawal by Subject|2|||
128679275|NCT00761748|463125250|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
128679276|NCT00761748|463125251|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
128679277|NCT00761748|463125250|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
128679278|NCT00761748|463125251|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
128679279|NCT03312751|463125252|FG000|Overall Study|Death|7|||
128679280|NCT03312751|463125253|FG001|Overall Study|Death|9|||
128679281|NCT03312751|463125252|FG000|Overall Study|Study discontinuation due to other reason|0|||
128879417|NCT03333837|463852963|FG003|Overall Study|Adverse Event|1|||
128879418|NCT03333837|463852964|FG004|Overall Study|Adverse Event|0|||
128879419|NCT03333837|463852960|FG000|Overall Study|Caregiver withdrew|0|||
128879420|NCT03333837|463852961|FG001|Overall Study|Caregiver withdrew|2|||
128879421|NCT03333837|463852962|FG002|Overall Study|Caregiver withdrew|1|||
128879422|NCT03333837|463852963|FG003|Overall Study|Caregiver withdrew|0|||
128879423|NCT03333837|463852964|FG004|Overall Study|Caregiver withdrew|0|||
128879424|NCT03333837|463852960|FG000|Overall Study|Withdrawal by Subject|0|||
128679282|NCT03312751|463125253|FG001|Overall Study|Study discontinuation due to other reason|1|||
128679283|NCT03490981|463125254|FG000|Overall Study|Lost to Follow-up|1|||
128679284|NCT03490981|463125255|FG001|Overall Study|Lost to Follow-up|2|||
128679285|NCT00282464|463125262|FG000|Overall Study|Adverse Event|26|||
128679286|NCT00282464|463125263|FG001|Overall Study|Adverse Event|20|||
128679287|NCT00282464|463125262|FG000|Overall Study|Lack of Efficacy|8|||
128679288|NCT00282464|463125263|FG001|Overall Study|Lack of Efficacy|8|||
128679289|NCT00282464|463125262|FG000|Overall Study|Lost to Follow-up|10|||
128679290|NCT00282464|463125263|FG001|Overall Study|Lost to Follow-up|10|||
128679291|NCT00282464|463125262|FG000|Overall Study|Withdrawal by Subject|24|||
128679292|NCT00282464|463125263|FG001|Overall Study|Withdrawal by Subject|10|||
128679293|NCT00282464|463125262|FG000|Overall Study|laboratory abnormality|1|||
128679294|NCT00282464|463125263|FG001|Overall Study|laboratory abnormality|2|||
128679295|NCT00282464|463125262|FG000|Overall Study|Protocol Violation|0|||
128679296|NCT00282464|463125263|FG001|Overall Study|Protocol Violation|7|||
128679297|NCT00282464|463125262|FG000|Overall Study|Patient moved|1|||
128679298|NCT00282464|463125263|FG001|Overall Study|Patient moved|0|||
128679299|NCT00282464|463125262|FG000|Overall Study|patient non-compliant|3|||
128879425|NCT03333837|463852961|FG001|Overall Study|Withdrawal by Subject|0|||
128879426|NCT03333837|463852962|FG002|Overall Study|Withdrawal by Subject|1|||
128879427|NCT03333837|463852963|FG003|Overall Study|Withdrawal by Subject|1|||
128879428|NCT03333837|463852964|FG004|Overall Study|Withdrawal by Subject|3|||
128879429|NCT03333837|463852960|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
128879430|NCT03333837|463852961|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
128879431|NCT03333837|463852962|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
128879432|NCT03333837|463852963|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
128879433|NCT03333837|463852964|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
128879434|NCT04217590|463852965|FG000|Overall Study|Other|1|||
128879435|NCT04217590|463852966|FG001|Overall Study|Other|1|||
128879436|NCT04217590|463852965|FG000|Overall Study|Withdrawal by Subject|3|||
128879437|NCT04217590|463852966|FG001|Overall Study|Withdrawal by Subject|1|||
128879438|NCT04217590|463852965|FG000|Overall Study|Death|0|||
128879439|NCT04217590|463852966|FG001|Overall Study|Death|1|||
128879440|NCT02232243|463852967|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
128879441|NCT02232243|463852968|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
128879442|NCT02232243|463852969|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
128879443|NCT00704405|463852970|FG000|Overall Study (NC Population)|Adverse Event|1|||
128879444|NCT00704405|463852971|FG001|Overall Study (NC Population)|Adverse Event|0|||
128879445|NCT00704405|463852972|FG002|Overall Study (NC Population)|Adverse Event|0|||
128879446|NCT00704405|463852973|FG003|Overall Study (NC Population)|Adverse Event|0|||
128879447|NCT00704405|463852974|FG004|Overall Study (NC Population)|Adverse Event|0|||
128879448|NCT00704405|463852970|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
128879449|NCT00704405|463852971|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
128879450|NCT00704405|463852972|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
128879451|NCT00704405|463852973|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
128879452|NCT00704405|463852974|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
128879453|NCT00704405|463852970|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
128879454|NCT00704405|463852971|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
128879455|NCT00704405|463852972|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
128879456|NCT00704405|463852973|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
129101732|NCT00424593|464667691|FG001|Acute Double-Blind Period|Adverse Event|7|||
129101733|NCT00424593|464667690|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
129101734|NCT00424593|464667691|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
129101735|NCT00424593|464667690|FG000|Acute Double-Blind Period|Protocol Violation|2|||
128879457|NCT00704405|463852974|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
128879458|NCT00704405|463852970|FG000|Overall Study (NC Population)|Other|0|||
128879459|NCT00704405|463852971|FG001|Overall Study (NC Population)|Other|0|||
128879460|NCT00704405|463852972|FG002|Overall Study (NC Population)|Other|0|||
128879461|NCT00704405|463852973|FG003|Overall Study (NC Population)|Other|0|||
128879462|NCT00704405|463852974|FG004|Overall Study (NC Population)|Other|1|||
128879463|NCT00704405|463852970|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
128879464|NCT00704405|463852971|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
128879465|NCT00704405|463852972|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
129101736|NCT00424593|464667691|FG001|Acute Double-Blind Period|Protocol Violation|2|||
129101737|NCT00424593|464667690|FG000|Acute Double-Blind Period|Physician Decision|1|||
129101738|NCT00424593|464667691|FG001|Acute Double-Blind Period|Physician Decision|2|||
129101739|NCT00424593|464667690|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
129101740|NCT00424593|464667691|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
128679300|NCT00282464|463125263|FG001|Overall Study|patient non-compliant|0|||
128679301|NCT00282464|463125262|FG000|Overall Study|patient no show|0|||
128679302|NCT00282464|463125263|FG001|Overall Study|patient no show|1|||
128679303|NCT00282464|463125262|FG000|Overall Study|patient incarcerated|0|||
128679304|NCT00282464|463125263|FG001|Overall Study|patient incarcerated|1|||
128679305|NCT00282464|463125262|FG000|Overall Study|family crisis|0|||
128679306|NCT00282464|463125263|FG001|Overall Study|family crisis|1|||
128679307|NCT00282464|463125262|FG000|Overall Study|dispensed wrong kit|0|||
128679308|NCT00282464|463125263|FG001|Overall Study|dispensed wrong kit|1|||
128679309|NCT00282464|463125262|FG000|Overall Study|dropped due to missed visits|0|||
128679310|NCT00282464|463125263|FG001|Overall Study|dropped due to missed visits|1|||
128679311|NCT00475423|463125264|FG000|Overall Study|Protocol Violation|5|||
128679312|NCT00475423|463125264|FG000|Overall Study|Adverse Event|4|||
128679313|NCT00475423|463125264|FG000|Overall Study|Withdrawal by Subject|6|||
128679314|NCT00475423|463125264|FG000|Overall Study|Lack of Efficacy|8|||
128679315|NCT00475423|463125264|FG000|Overall Study|Death|1|||
128679316|NCT00475423|463125264|FG000|Overall Study|Reason not specified|1|||
128679317|NCT00475423|463125264|FG000|Overall Study|Lost to Follow-up|7|||
128679318|NCT00466687|463125267|FG000|Overall Study|Adverse Event|1|||
128679319|NCT00466687|463125267|FG000|Overall Study|Other complicating illness|3|||
128679320|NCT00466687|463125267|FG000|Overall Study|Withdrawal by Subject|1|||
128679321|NCT00466687|463125267|FG000|Overall Study|Disease progression|29|||
128679322|NCT00046891|463125268|FG000|Overall Study|Cancels|5|||
128679323|NCT00046891|463125269|FG001|Overall Study|Cancels|9|||
128679324|NCT00046891|463125268|FG000|Overall Study|Ineligible|1|||
128679325|NCT00046891|463125269|FG001|Overall Study|Ineligible|1|||
128679326|NCT00046891|463125268|FG000|Overall Study|Withdrawal by Subject|18|||
128679327|NCT00046891|463125269|FG001|Overall Study|Withdrawal by Subject|15|||
128679328|NCT00046891|463125268|FG000|Overall Study|Adverse Event|5|||
128679329|NCT00046891|463125269|FG001|Overall Study|Adverse Event|5|||
128679330|NCT02496676|463125270|FG000|Phase 1 - Period 1|Adverse Event|0|||
128679331|NCT02496676|463125271|FG001|Phase 1 - Period 1|Adverse Event|1|||
128679332|NCT02496676|463125270|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
128679333|NCT02496676|463125271|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
128679334|NCT04381988|463125277|FG000|Overall Study|The study was terminated|4|||
128679335|NCT04381988|463125278|FG001|Overall Study|The study was terminated|0|||
128679336|NCT01624870|463125280|FG000|Overall Study|Death|19|||
128679337|NCT01624870|463125280|FG000|Overall Study|Withdrawal by Subject|1|||
128679338|NCT01624870|463125280|FG000|Overall Study|CoreValve not implanted|6|||
128679339|NCT01624870|463125280|FG000|Overall Study|Lost to follow up|1|||
128679340|NCT04672252|463125284|FG000|Overall Study|Protocol Violation|1|||
128679341|NCT04672252|463125285|FG001|Overall Study|Protocol Violation|0|||
128679342|NCT04391569|463125286|FG000|Overall Study|Death|15|||
128679343|NCT04391569|463125287|FG001|Overall Study|Death|10|||
128679344|NCT04391569|463125286|FG000|Overall Study|Withdrawal by Subject|1|||
128679345|NCT04391569|463125287|FG001|Overall Study|Withdrawal by Subject|0|||
128679346|NCT04391569|463125286|FG000|Overall Study|Lost to Follow-up|3|||
128679347|NCT04391569|463125287|FG001|Overall Study|Lost to Follow-up|2|||
128679348|NCT04391569|463125286|FG000|Overall Study|Lack of Efficacy|0|||
128679349|NCT04391569|463125287|FG001|Overall Study|Lack of Efficacy|1|||
128679350|NCT04391569|463125286|FG000|Overall Study|Participant discharged to hospice facility|0|||
128679351|NCT04391569|463125287|FG001|Overall Study|Participant discharged to hospice facility|1|||
128679352|NCT04391569|463125286|FG000|Overall Study|Participant family decision|1|||
128679353|NCT04391569|463125287|FG001|Overall Study|Participant family decision|0|||
128679354|NCT04391569|463125286|FG000|Overall Study|Participant discharged prematurely|1|||
128679355|NCT04391569|463125287|FG001|Overall Study|Participant discharged prematurely|0|||
128679356|NCT03025035|463125288|FG000|Overall Study|Death|2|||
128679357|NCT03025035|463125288|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
128679358|NCT00899392|463125289|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
128679359|NCT00899392|463125290|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
128679360|NCT01431638|463125297|FG000|Overall Study|Adverse Event|1|||
128679361|NCT01431638|463125298|FG001|Overall Study|Adverse Event|3|||
128679362|NCT01431638|463125299|FG002|Overall Study|Adverse Event|1|||
128679363|NCT01431638|463125297|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128679364|NCT01431638|463125298|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128679365|NCT01431638|463125299|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
128679366|NCT01431638|463125297|FG000|Overall Study|Participants condition no longer requires study drug|0|||
128679367|NCT01431638|463125298|FG001|Overall Study|Participants condition no longer requires study drug|1|||
128679368|NCT01431638|463125299|FG002|Overall Study|Participants condition no longer requires study drug|0|||
128679369|NCT01431638|463125297|FG000|Overall Study|Participant withdrew consent|14|||
128679370|NCT01431638|463125298|FG001|Overall Study|Participant withdrew consent|5|||
128679371|NCT01431638|463125299|FG002|Overall Study|Participant withdrew consent|8|||
128679372|NCT01431638|463125297|FG000|Overall Study|Lost to Follow-up|7|||
128679373|NCT01431638|463125298|FG001|Overall Study|Lost to Follow-up|9|||
128679374|NCT01431638|463125299|FG002|Overall Study|Lost to Follow-up|7|||
128679375|NCT01431638|463125297|FG000|Overall Study|Administrative problems|1|||
128679376|NCT01431638|463125298|FG001|Overall Study|Administrative problems|4|||
128679377|NCT01431638|463125299|FG002|Overall Study|Administrative problems|6|||
128679378|NCT01431638|463125297|FG000|Overall Study|Death|1|||
128679379|NCT01431638|463125298|FG001|Overall Study|Death|0|||
128679380|NCT01431638|463125299|FG002|Overall Study|Death|0|||
128679381|NCT01431638|463125297|FG000|Overall Study|Protocol deviation|1|||
128679382|NCT01431638|463125298|FG001|Overall Study|Protocol deviation|1|||
128679383|NCT01431638|463125299|FG002|Overall Study|Protocol deviation|4|||
128679384|NCT01431638|463125297|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
128679385|NCT01431638|463125298|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
128679386|NCT01431638|463125299|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
128679387|NCT01239732|463125300|FG000|Overall Study|Termination of study per protocol|667|||
128679388|NCT01239732|463125300|FG000|Overall Study|Death|226|||
128679389|NCT01239732|463125300|FG000|Overall Study|Withdrawal by Subject|87|||
128679390|NCT01239732|463125300|FG000|Overall Study|Adverse Event|6|||
128679391|NCT01239732|463125300|FG000|Overall Study|Protocol Violation|3|||
128679392|NCT01239732|463125300|FG000|Overall Study|Participant non compliance|5|||
128679393|NCT01239732|463125300|FG000|Overall Study|Study termination by sponsor|2|||
128679394|NCT01239732|463125300|FG000|Overall Study|Investigator's decision|4|||
128679395|NCT01239732|463125300|FG000|Overall Study|Treatment failure|2|||
128679396|NCT01239732|463125300|FG000|Overall Study|Other|19|||
128679397|NCT02048241|463125301|FG000|Overall Study|Withdrawal by Subject|0|||
128679398|NCT02048241|463125302|FG001|Overall Study|Withdrawal by Subject|1|||
129101741|NCT00424593|464667690|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
129101742|NCT00424593|464667691|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
129101743|NCT00424593|464667690|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
129101744|NCT00424593|464667691|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
129101745|NCT00424593|464667690|FG000|Dose-Blind Extension Period|Adverse Event|18|||
129101746|NCT00424593|464667691|FG001|Dose-Blind Extension Period|Adverse Event|0|||
129101747|NCT00424593|464667690|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
129101748|NCT00424593|464667691|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
129101749|NCT00424593|464667690|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
129101750|NCT00424593|464667691|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
129101751|NCT00424593|464667690|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
129101752|NCT00424593|464667691|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
129101753|NCT00424593|464667690|FG000|Dose-Blind Extension Period|Physician Decision|3|||
129101754|NCT00424593|464667691|FG001|Dose-Blind Extension Period|Physician Decision|0|||
129101755|NCT01796301|464667692|FG000|Overall Study|Withdrawal by Subject|15|||
129101756|NCT01796301|464667693|FG001|Overall Study|Withdrawal by Subject|15|||
129101757|NCT01796301|464667692|FG000|Overall Study|Lost to Follow-up|3|||
128879466|NCT00704405|463852973|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
128879467|NCT00704405|463852974|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
128879468|NCT00704405|463852970|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
128879469|NCT00704405|463852971|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
128879470|NCT00704405|463852972|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
128879471|NCT00704405|463852973|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
128879472|NCT00704405|463852974|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
128879473|NCT01395888|463852975|FG000|2-week Run-in Period|Adverse Event|2|||
128879474|NCT01395888|463852976|FG001|2-week Run-in Period|Adverse Event|0|||
128879475|NCT01395888|463852977|FG002|2-week Run-in Period|Adverse Event|0|||
128879476|NCT01395888|463852975|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
128879477|NCT01395888|463852976|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
128879478|NCT01395888|463852977|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
128879479|NCT01395888|463852975|FG000|2-week Run-in Period|Lost to Follow-up|1|||
128879480|NCT01395888|463852976|FG001|2-week Run-in Period|Lost to Follow-up|0|||
128879481|NCT01395888|463852977|FG002|2-week Run-in Period|Lost to Follow-up|0|||
128879482|NCT01395888|463852975|FG000|2-week Run-in Period|Protocol Violation|2|||
128879483|NCT01395888|463852976|FG001|2-week Run-in Period|Protocol Violation|0|||
128879484|NCT01395888|463852977|FG002|2-week Run-in Period|Protocol Violation|0|||
128879485|NCT01395888|463852975|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
128879486|NCT01395888|463852976|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
128879487|NCT01395888|463852977|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
128879488|NCT01395888|463852975|FG000|Treatment Period (TP)|Adverse Event|0|||
128879489|NCT01395888|463852976|FG001|Treatment Period (TP)|Adverse Event|7|||
128879490|NCT01395888|463852977|FG002|Treatment Period (TP)|Adverse Event|6|||
128879491|NCT01395888|463852975|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
128879492|NCT01395888|463852976|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
128879493|NCT01395888|463852977|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
128879494|NCT01395888|463852975|FG000|Treatment Period (TP)|Protocol Violation|0|||
128879495|NCT01395888|463852976|FG001|Treatment Period (TP)|Protocol Violation|1|||
128879496|NCT01395888|463852977|FG002|Treatment Period (TP)|Protocol Violation|5|||
128879497|NCT01395888|463852975|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
128879498|NCT01395888|463852976|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
128879499|NCT01395888|463852977|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
128879500|NCT01395888|463852975|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
128879501|NCT01395888|463852976|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
128879502|NCT01395888|463852977|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
128879503|NCT03218397|463852978|FG000|Overall Study|Prior positive blood culture|8|||
129101758|NCT01796301|464667693|FG001|Overall Study|Lost to Follow-up|3|||
129101759|NCT01796301|464667692|FG000|Overall Study|Death|0|||
129101760|NCT01796301|464667693|FG001|Overall Study|Death|1|||
129101761|NCT01796301|464667692|FG000|Overall Study|Decision by Sponsor|0|||
129101762|NCT01796301|464667693|FG001|Overall Study|Decision by Sponsor|1|||
129101763|NCT00667563|464667694|FG000|Overall Study|Protocol Violation|24|||
129101764|NCT02187029|464667695|FG000|Overall Study|Adverse Event|0|||
129101765|NCT02187029|464667696|FG001|Overall Study|Adverse Event|1|||
129101766|NCT02187029|464667697|FG002|Overall Study|Adverse Event|1|||
128879504|NCT03218397|463852979|FG001|Overall Study|Prior positive blood culture|13|||
128879505|NCT03218397|463852978|FG000|Overall Study|Comfort care|8|||
128879506|NCT03218397|463852979|FG001|Overall Study|Comfort care|5|||
128879507|NCT03218397|463852978|FG000|Overall Study|Comfort care and positive blood culture|1|||
128879508|NCT03218397|463852979|FG001|Overall Study|Comfort care and positive blood culture|0|||
128879509|NCT03218397|463852978|FG000|Overall Study|Comfort care and mixed culture|0|||
128879510|NCT03218397|463852979|FG001|Overall Study|Comfort care and mixed culture|1|||
129101767|NCT02187029|464667698|FG003|Overall Study|Adverse Event|0|||
129101768|NCT02187029|464667695|FG000|Overall Study|Study Terminated by Sponsor|0|||
128679399|NCT00402233|463125303|FG000|Overall Study|Adverse Event|1|||
128679400|NCT00402233|463125304|FG001|Overall Study|Adverse Event|7|||
128679401|NCT00402233|463125305|FG002|Overall Study|Adverse Event|9|||
128679402|NCT00402233|463125306|FG003|Overall Study|Adverse Event|9|||
128679403|NCT00402233|463125303|FG000|Overall Study|Protocol Violation|0|||
128679404|NCT00402233|463125304|FG001|Overall Study|Protocol Violation|1|||
128679405|NCT00402233|463125305|FG002|Overall Study|Protocol Violation|0|||
128679406|NCT00402233|463125306|FG003|Overall Study|Protocol Violation|0|||
128679407|NCT00402233|463125303|FG000|Overall Study|Withdrawal by Subject|2|||
128679408|NCT00402233|463125304|FG001|Overall Study|Withdrawal by Subject|1|||
128679409|NCT00402233|463125305|FG002|Overall Study|Withdrawal by Subject|2|||
128679410|NCT00402233|463125306|FG003|Overall Study|Withdrawal by Subject|2|||
128679411|NCT00402233|463125303|FG000|Overall Study|Worsening of disease under study|2|||
128679412|NCT00402233|463125304|FG001|Overall Study|Worsening of disease under study|0|||
128679413|NCT00402233|463125305|FG002|Overall Study|Worsening of disease under study|0|||
128679414|NCT00402233|463125306|FG003|Overall Study|Worsening of disease under study|0|||
128679415|NCT00402233|463125303|FG000|Overall Study|Worsening of other pre-existing disease|0|||
128679416|NCT00402233|463125304|FG001|Overall Study|Worsening of other pre-existing disease|1|||
128679417|NCT00402233|463125305|FG002|Overall Study|Worsening of other pre-existing disease|0|||
128679418|NCT00402233|463125306|FG003|Overall Study|Worsening of other pre-existing disease|0|||
128679419|NCT03579602|463125307|FG000|Overall Study|Subject unable to receive study drug|0|||
128679420|NCT03579602|463125308|FG001|Overall Study|Subject unable to receive study drug|2|||
128679421|NCT03579602|463125307|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
128679422|NCT03579602|463125308|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
128679423|NCT02518464|463125309|FG000|Overall Study|Adverse Event|2|||
128679424|NCT00604214|463125335|FG000|Baseline to Day 28|Death|223|||
128679425|NCT00604214|463125336|FG001|Baseline to Day 28|Death|202|||
128679426|NCT00604214|463125335|FG000|Baseline to Day 28|Lost to Follow-up|2|||
128679427|NCT00604214|463125336|FG001|Baseline to Day 28|Lost to Follow-up|4|||
128679428|NCT00604214|463125335|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
128679429|NCT00604214|463125336|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
128679430|NCT00604214|463125335|FG000|Day 29 to Day 90|Death|64|||
128679431|NCT00604214|463125336|FG001|Day 29 to Day 90|Death|67|||
128679432|NCT00604214|463125335|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
128679433|NCT00604214|463125336|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
128679434|NCT00604214|463125335|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
128679435|NCT00604214|463125336|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
128879511|NCT03218397|463852978|FG000|Overall Study|Mixed culture|2|||
129101769|NCT02187029|464667696|FG001|Overall Study|Study Terminated by Sponsor|0|||
129101770|NCT02187029|464667697|FG002|Overall Study|Study Terminated by Sponsor|10|||
129101771|NCT02187029|464667698|FG003|Overall Study|Study Terminated by Sponsor|3|||
129101772|NCT02187029|464667695|FG000|Overall Study|Withdrawal by Subject|1|||
129101773|NCT02187029|464667696|FG001|Overall Study|Withdrawal by Subject|0|||
129101774|NCT02187029|464667697|FG002|Overall Study|Withdrawal by Subject|0|||
129101775|NCT02187029|464667698|FG003|Overall Study|Withdrawal by Subject|0|||
129101776|NCT03042910|464667700|FG000|Overall Study|Adverse Event|1|||
129101777|NCT03042910|464667700|FG000|Overall Study|Disease Progression|2|||
129101778|NCT03042910|464667700|FG000|Overall Study|Withdrawal by Subject|3|||
129101779|NCT03042910|464667700|FG000|Overall Study|Enrolled but not treated|1|||
129101780|NCT02756819|464667704|FG000|Overall Study|Lost for observation|23|||
129101781|NCT02756819|464667704|FG000|Overall Study|Patient's unwillingness|16|||
129101782|NCT02756819|464667704|FG000|Overall Study|Insufficient efficacy|2|||
129101783|NCT02756819|464667704|FG000|Overall Study|Adverse Event|2|||
129101784|NCT02756819|464667704|FG000|Overall Study|Reason not Specified|9|||
129101785|NCT01491841|464667706|FG000|Overall Study|Screen Failure|10|||
129101786|NCT01491841|464667706|FG000|Overall Study|Withdrawal by Subject|1|||
128679436|NCT00604214|463125335|FG000|Day 91 to Day 180|Death|19|||
128679437|NCT00604214|463125336|FG001|Day 91 to Day 180|Death|23|||
128679438|NCT00604214|463125335|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
128679439|NCT00604214|463125336|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
128679440|NCT00604214|463125335|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
128679441|NCT00604214|463125336|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
128679442|NCT00130442|463126683|FG000|Overall Study|Withdrawal by Subject|0|||
128679443|NCT00130442|463126684|FG001|Overall Study|Withdrawal by Subject|1|||
128679444|NCT00130442|463126683|FG000|Overall Study|did not meet criteria|1|||
128679445|NCT00130442|463126684|FG001|Overall Study|did not meet criteria|1|||
128679446|NCT00814333|463126686|FG000|Enrollment|Lost to Follow-up|1|||
128679447|NCT00814333|463126687|FG001|Enrollment|Lost to Follow-up|0|||
128679448|NCT02233946|463126688|FG000|Baseline|Withdrawal by Subject|2|||
129101787|NCT02933528|464667707|FG000|Overall Study|Lost to Follow-up|2|||
129101788|NCT01301079|464667708|FG000|Overall Study|Lost to Follow-up|2|||
129101789|NCT01301079|464667709|FG001|Overall Study|Lost to Follow-up|2|||
128679449|NCT02233946|463126689|FG001|Baseline|Withdrawal by Subject|0|||
128679450|NCT02233946|463126688|FG000|3-months Follow-up|Lost to Follow-up|53|||
128679451|NCT02233946|463126689|FG001|3-months Follow-up|Lost to Follow-up|29|||
128679452|NCT02233946|463126688|FG000|6-months Follow-up|Lost to Follow-up|21|||
128879512|NCT03218397|463852979|FG001|Overall Study|Mixed culture|2|||
128879513|NCT03218397|463852978|FG000|Overall Study|Inaccessible hospital records|2|||
128879514|NCT03218397|463852979|FG001|Overall Study|Inaccessible hospital records|5|||
128879515|NCT03218397|463852978|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
128879516|NCT03218397|463852979|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
128879517|NCT03218397|463852978|FG000|Overall Study|Randomized during laboratory off hours|2|||
128879518|NCT03218397|463852979|FG001|Overall Study|Randomized during laboratory off hours|1|||
128879519|NCT01946438|463852980|FG000|Overall Study|Adverse Event|0|||
128879520|NCT01946438|463852981|FG001|Overall Study|Adverse Event|0|||
128879521|NCT01946438|463852982|FG002|Overall Study|Adverse Event|0|||
128879522|NCT01946438|463852983|FG003|Overall Study|Adverse Event|1|||
128879523|NCT01946438|463852980|FG000|Overall Study|Serious Adverse event|1|||
128879524|NCT01946438|463852981|FG001|Overall Study|Serious Adverse event|0|||
129101790|NCT00264290|464667711|FG000|Intervention (8 Weeks)|Adverse Event|1|||
129101791|NCT00264290|464667712|FG001|Intervention (8 Weeks)|Adverse Event|0|||
129101792|NCT02496039|464667713|FG000|Overall Study|Adverse Event|3|||
129101793|NCT02496039|464667713|FG000|Overall Study|Protocol Violation|1|||
129101794|NCT04472494|464667714|FG000|Pre-treatment|Other reasons|2|||
129101795|NCT04472494|464667715|FG001|Pre-treatment|Other reasons|0|||
129101796|NCT04472494|464667714|FG000|Treatment|Death|5|||
129101797|NCT04472494|464667715|FG001|Treatment|Death|2|||
129101798|NCT04472494|464667714|FG000|Treatment|Hospital discharge|1|||
129101799|NCT04472494|464667715|FG001|Treatment|Hospital discharge|1|||
129101800|NCT00571103|464667716|FG000|Overall Study|Withdrawal by Subject|1|||
129101801|NCT00571103|464667716|FG000|Overall Study|Lost to Follow-up|1|||
129101802|NCT01308463|464667717|FG000|Overall Study|Study Discontinued|23|||
129101803|NCT01308463|464667717|FG000|Overall Study|Death|4|||
129101804|NCT01308463|464667717|FG000|Overall Study|Revision|2|||
129101805|NCT03297021|464667718|FG000|Overall Study|Incomplete/illegible data sheet|4|||
129101806|NCT03297021|464667719|FG001|Overall Study|Incomplete/illegible data sheet|2|||
129101807|NCT03297021|464667720|FG002|Overall Study|Incomplete/illegible data sheet|3|||
129101808|NCT03297021|464667718|FG000|Overall Study|Missing Post-Op Data|1|||
129101809|NCT03297021|464667719|FG001|Overall Study|Missing Post-Op Data|2|||
129101810|NCT03297021|464667720|FG002|Overall Study|Missing Post-Op Data|1|||
129101811|NCT00948922|464667722|FG000|Overall Study|Did not start study treatment|2|||
129101812|NCT00948922|464667723|FG001|Overall Study|Did not start study treatment|5|||
129101813|NCT00948922|464667724|FG002|Overall Study|Did not start study treatment|0|||
129101814|NCT00948922|464667722|FG000|Overall Study|Withdrawal by Subject|0|||
129101815|NCT00948922|464667723|FG001|Overall Study|Withdrawal by Subject|2|||
128879525|NCT01946438|463852982|FG002|Overall Study|Serious Adverse event|0|||
128879526|NCT01946438|463852983|FG003|Overall Study|Serious Adverse event|0|||
128879527|NCT01946438|463852980|FG000|Overall Study|Protocol Violation|0|||
128879528|NCT01946438|463852981|FG001|Overall Study|Protocol Violation|0|||
128879529|NCT01946438|463852982|FG002|Overall Study|Protocol Violation|1|||
128879530|NCT01946438|463852983|FG003|Overall Study|Protocol Violation|0|||
128879531|NCT01946438|463852980|FG000|Overall Study|Withdrawal by Subject|1|||
128879532|NCT01946438|463852981|FG001|Overall Study|Withdrawal by Subject|0|||
128879533|NCT01946438|463852982|FG002|Overall Study|Withdrawal by Subject|0|||
128879534|NCT01946438|463852983|FG003|Overall Study|Withdrawal by Subject|0|||
128879535|NCT03432260|463852992|FG000|Overall Study|Lost to Follow-up|1|||
128879536|NCT03432260|463852993|FG001|Overall Study|Lost to Follow-up|1|||
128879537|NCT03432260|463852994|FG002|Overall Study|Lost to Follow-up|0|||
128879538|NCT03432260|463852995|FG003|Overall Study|Lost to Follow-up|0|||
128879539|NCT03432260|463852996|FG004|Overall Study|Lost to Follow-up|1|||
128879540|NCT00031551|463854866|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
128879541|NCT00031551|463854867|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
128879542|NCT00409773|463854868|FG000|Overall Study|Adverse Event|3|||
128879543|NCT00409773|463854869|FG001|Overall Study|Adverse Event|4|||
128879544|NCT00409773|463854870|FG002|Overall Study|Adverse Event|4|||
128879545|NCT00409773|463854871|FG003|Overall Study|Adverse Event|2|||
128879546|NCT00409773|463854872|FG004|Overall Study|Adverse Event|6|||
128879547|NCT00409773|463854868|FG000|Overall Study|Lost to Follow-up|6|||
128879548|NCT00409773|463854869|FG001|Overall Study|Lost to Follow-up|1|||
128879549|NCT00409773|463854870|FG002|Overall Study|Lost to Follow-up|2|||
128879550|NCT00409773|463854871|FG003|Overall Study|Lost to Follow-up|3|||
128879551|NCT00409773|463854872|FG004|Overall Study|Lost to Follow-up|1|||
128879552|NCT00409773|463854868|FG000|Overall Study|Physician Decision|0|||
128879553|NCT00409773|463854869|FG001|Overall Study|Physician Decision|0|||
128879554|NCT00409773|463854870|FG002|Overall Study|Physician Decision|0|||
128879555|NCT00409773|463854871|FG003|Overall Study|Physician Decision|2|||
128879556|NCT00409773|463854872|FG004|Overall Study|Physician Decision|0|||
128879557|NCT00409773|463854868|FG000|Overall Study|Protocol Violation|0|||
128879558|NCT00409773|463854869|FG001|Overall Study|Protocol Violation|2|||
128879559|NCT00409773|463854870|FG002|Overall Study|Protocol Violation|3|||
128879560|NCT00409773|463854871|FG003|Overall Study|Protocol Violation|3|||
128879561|NCT00409773|463854872|FG004|Overall Study|Protocol Violation|1|||
128879562|NCT00409773|463854868|FG000|Overall Study|Withdrawal by Subject|0|||
128879563|NCT00409773|463854869|FG001|Overall Study|Withdrawal by Subject|0|||
128679453|NCT02233946|463126689|FG001|6-months Follow-up|Lost to Follow-up|2|||
128679454|NCT02233946|463126688|FG000|9-month Follow-up|Lost to Follow-up|20|||
128679455|NCT02233946|463126689|FG001|9-month Follow-up|Lost to Follow-up|11|||
128679456|NCT02233946|463126688|FG000|12-month Follow-up|Lost to Follow-up|28|||
128679457|NCT02233946|463126689|FG001|12-month Follow-up|Lost to Follow-up|11|||
128679458|NCT00910247|463126690|FG000|Overall Study|Adverse Event|15|||
128679459|NCT00910247|463126690|FG000|Overall Study|Death|2|||
128679460|NCT00910247|463126690|FG000|Overall Study|Lost to Follow-up|10|||
128679461|NCT00910247|463126690|FG000|Overall Study|Physician Decision|3|||
128679462|NCT00910247|463126690|FG000|Overall Study|Protocol Violation|10|||
128679463|NCT00910247|463126690|FG000|Overall Study|Withdrawal by Subject|25|||
128679464|NCT00910247|463126690|FG000|Overall Study|Not collected|4|||
128679465|NCT02927067|463126691|FG000|Overall Study|Withdrawn Consent|20|||
128679466|NCT02927067|463126692|FG001|Overall Study|Withdrawn Consent|12|||
128679467|NCT02927067|463126691|FG000|Overall Study|Death|18|||
128679468|NCT02927067|463126692|FG001|Overall Study|Death|31|||
128679469|NCT02927067|463126691|FG000|Overall Study|Adverse Event|13|||
128679470|NCT02927067|463126692|FG001|Overall Study|Adverse Event|10|||
128679471|NCT02927067|463126691|FG000|Overall Study|Noncompliance|5|||
128679472|NCT02927067|463126692|FG001|Overall Study|Noncompliance|2|||
128679473|NCT02927067|463126691|FG000|Overall Study|Reason not Specified|4|||
128679474|NCT02927067|463126692|FG001|Overall Study|Reason not Specified|6|||
128679475|NCT01727700|463126695|FG000|Overall Study|Adverse Event|0|||
128679476|NCT01727700|463126696|FG001|Overall Study|Adverse Event|7|||
128679477|NCT01727700|463126697|FG002|Overall Study|Adverse Event|1|||
128679478|NCT01727700|463126695|FG000|Overall Study|Particpant withdrew consent|0|||
128679479|NCT01727700|463126696|FG001|Overall Study|Particpant withdrew consent|3|||
128679480|NCT01727700|463126697|FG002|Overall Study|Particpant withdrew consent|1|||
128679481|NCT01727700|463126695|FG000|Overall Study|Protocol Violation|2|||
128679482|NCT01727700|463126696|FG001|Overall Study|Protocol Violation|0|||
128679483|NCT01727700|463126697|FG002|Overall Study|Protocol Violation|0|||
128679484|NCT01757691|463126701|FG000|Overall Study|Administrative problems|2|||
129012725|NCT00745095|464339620|FG000|Overall Study|Ineligible due to GFR criteria|0|||
129012726|NCT00745095|464339621|FG001|Overall Study|Ineligible due to GFR criteria|2|||
129012727|NCT00745095|464339622|FG002|Overall Study|Ineligible due to GFR criteria|3|||
129012728|NCT00745095|464339623|FG003|Overall Study|Ineligible due to GFR criteria|3|||
129012729|NCT00745095|464339624|FG004|Overall Study|Ineligible due to GFR criteria|30|||
129012730|NCT00745095|464339625|FG005|Overall Study|Ineligible due to GFR criteria|28|||
129012731|NCT00958243|464339626|FG000|Overall Study|Withdrawal by Subject|0|||
129012732|NCT00958243|464339627|FG001|Overall Study|Withdrawal by Subject|1|||
129012733|NCT00958243|464339628|FG002|Overall Study|Withdrawal by Subject|3|||
129012734|NCT00958243|464339629|FG003|Overall Study|Withdrawal by Subject|1|||
129012735|NCT00958243|464339630|FG004|Overall Study|Withdrawal by Subject|1|||
129012736|NCT00958243|464339631|FG005|Overall Study|Withdrawal by Subject|5|||
129012737|NCT00958243|464339626|FG000|Overall Study|Lost to Follow-up|2|||
129012738|NCT00958243|464339627|FG001|Overall Study|Lost to Follow-up|5|||
129012739|NCT00958243|464339628|FG002|Overall Study|Lost to Follow-up|11|||
129012740|NCT00958243|464339629|FG003|Overall Study|Lost to Follow-up|2|||
129012741|NCT00958243|464339630|FG004|Overall Study|Lost to Follow-up|8|||
129012742|NCT00958243|464339631|FG005|Overall Study|Lost to Follow-up|5|||
129012743|NCT01974141|464339636|FG000|Overall Study|Other Reasons|28|||
129012744|NCT01974141|464339637|FG001|Overall Study|Other Reasons|18|||
129012745|NCT01974141|464339636|FG000|Overall Study|Protocol Violation|2|||
129012746|NCT01974141|464339637|FG001|Overall Study|Protocol Violation|6|||
129012747|NCT01974141|464339636|FG000|Overall Study|Personal Reasons|21|||
129012748|NCT01974141|464339637|FG001|Overall Study|Personal Reasons|20|||
129012749|NCT01974141|464339636|FG000|Overall Study|Lost to Follow-up|38|||
129012750|NCT01974141|464339637|FG001|Overall Study|Lost to Follow-up|29|||
129012751|NCT01974141|464339636|FG000|Overall Study|Pregnancy|3|||
129012752|NCT01974141|464339637|FG001|Overall Study|Pregnancy|3|||
129012753|NCT01974141|464339636|FG000|Overall Study|Lack of Efficacy|0|||
129012754|NCT01974141|464339637|FG001|Overall Study|Lack of Efficacy|1|||
129012755|NCT01974141|464339636|FG000|Overall Study|Adverse Event|4|||
129012756|NCT01974141|464339637|FG001|Overall Study|Adverse Event|5|||
129012757|NCT00950872|464339641|FG000|Overall Study|Withdrawal by Subject|1|||
129012758|NCT00950872|464339641|FG000|Overall Study|Did not have surgery|2|||
129012759|NCT01139164|464339643|FG000|Overall Study|Withdrawn prior to study start|0|||
129012760|NCT01139164|464339644|FG001|Overall Study|Withdrawn prior to study start|2|||
129012761|NCT01139164|464339645|FG002|Overall Study|Withdrawn prior to study start|0|||
129012762|NCT00406848|464339650|FG000|Overall Study|Withdrawal by Subject|27|||
128679485|NCT01757691|463126702|FG001|Overall Study|Administrative problems|0|||
128679486|NCT02054481|463126705|FG000|Overall Study|Adverse Event|1|||
128679487|NCT02054481|463126706|FG001|Overall Study|Adverse Event|1|||
128679488|NCT02054481|463126707|FG002|Overall Study|Adverse Event|0|||
128679489|NCT02054481|463126708|FG003|Overall Study|Adverse Event|1|||
128679490|NCT02054481|463126705|FG000|Overall Study|Lost to Follow-up|1|||
128679491|NCT02054481|463126706|FG001|Overall Study|Lost to Follow-up|0|||
129012763|NCT00406848|464339651|FG001|Overall Study|Withdrawal by Subject|22|||
128679492|NCT02054481|463126707|FG002|Overall Study|Lost to Follow-up|0|||
128679493|NCT02054481|463126708|FG003|Overall Study|Lost to Follow-up|0|||
128679494|NCT02054481|463126705|FG000|Overall Study|Other reason|2|||
128679495|NCT02054481|463126706|FG001|Overall Study|Other reason|1|||
128679496|NCT02054481|463126707|FG002|Overall Study|Other reason|2|||
128679497|NCT02054481|463126708|FG003|Overall Study|Other reason|0|||
128679498|NCT02320903|463126709|FG000|Overall Study|Withdrawal by Subject|0|||
128879564|NCT00409773|463854870|FG002|Overall Study|Withdrawal by Subject|0|||
129101816|NCT00948922|464667724|FG002|Overall Study|Withdrawal by Subject|1|||
128679499|NCT02320903|463126710|FG001|Overall Study|Withdrawal by Subject|9|||
128679500|NCT02320903|463126711|FG002|Overall Study|Withdrawal by Subject|9|||
128679501|NCT02320903|463126709|FG000|Overall Study|Exited therapy; no longer eligible|8|||
128679502|NCT02320903|463126710|FG001|Overall Study|Exited therapy; no longer eligible|2|||
128679503|NCT02320903|463126711|FG002|Overall Study|Exited therapy; no longer eligible|2|||
128679504|NCT02320903|463126709|FG000|Overall Study|Lost to Follow-up|0|||
128679505|NCT02320903|463126710|FG001|Overall Study|Lost to Follow-up|5|||
128679506|NCT02320903|463126711|FG002|Overall Study|Lost to Follow-up|5|||
128679507|NCT02919969|463126714|FG000|Overall Study|Lack of Efficacy|22|||
128679508|NCT02919969|463126714|FG000|Overall Study|Death|4|||
128679509|NCT02919969|463126714|FG000|Overall Study|Physician Decision|3|||
128679510|NCT02919969|463126714|FG000|Overall Study|Withdrawal by Subject|2|||
128679511|NCT01842633|463126715|FG000|Overall Study|Screen Failure|1|||
128679512|NCT01842633|463126716|FG001|Overall Study|Screen Failure|0|||
128679513|NCT01842633|463126717|FG002|Overall Study|Screen Failure|0|||
128679514|NCT01842633|463126715|FG000|Overall Study|Adverse Event|1|||
128679515|NCT01842633|463126716|FG001|Overall Study|Adverse Event|1|||
128679516|NCT01842633|463126717|FG002|Overall Study|Adverse Event|0|||
128679517|NCT01842633|463126715|FG000|Overall Study|Withdrawal by Subject|0|||
128679518|NCT01842633|463126716|FG001|Overall Study|Withdrawal by Subject|1|||
128679519|NCT01842633|463126717|FG002|Overall Study|Withdrawal by Subject|0|||
128679520|NCT01842633|463126715|FG000|Overall Study|Technical issues|1|||
128679521|NCT01842633|463126716|FG001|Overall Study|Technical issues|0|||
128679522|NCT01842633|463126717|FG002|Overall Study|Technical issues|0|||
128679523|NCT05347147|463126718|FG000|Overall Study|Lost to Follow-up|0|||
128679524|NCT05347147|463126719|FG001|Overall Study|Lost to Follow-up|1|||
128679525|NCT05347147|463126718|FG000|Overall Study|Sponsor request|3|||
128679526|NCT05347147|463126719|FG001|Overall Study|Sponsor request|3|||
128679527|NCT05347147|463126718|FG000|Overall Study|Study termination|2|||
128679528|NCT05347147|463126719|FG001|Overall Study|Study termination|1|||
128679529|NCT02093351|463126720|FG000|Part A|Adverse Event|0|||
128679530|NCT02093351|463126721|FG001|Part A|Adverse Event|1|||
128679531|NCT02093351|463126722|FG002|Part A|Adverse Event|1|||
128679532|NCT02093351|463126723|FG003|Part A|Adverse Event|0|||
128679533|NCT02093351|463126720|FG000|Part A|Condition under investigation worsened|2|||
128679534|NCT02093351|463126721|FG001|Part A|Condition under investigation worsened|0|||
128679535|NCT02093351|463126722|FG002|Part A|Condition under investigation worsened|2|||
128679536|NCT02093351|463126723|FG003|Part A|Condition under investigation worsened|0|||
128679537|NCT02093351|463126720|FG000|Part A|Death|0|||
128679538|NCT02093351|463126721|FG001|Part A|Death|1|||
128679539|NCT02093351|463126722|FG002|Part A|Death|0|||
128679540|NCT02093351|463126723|FG003|Part A|Death|0|||
128679541|NCT02093351|463126720|FG000|Part B|Patient decision|0|||
128679542|NCT02093351|463126721|FG001|Part B|Patient decision|0|||
128679543|NCT02093351|463126722|FG002|Part B|Patient decision|0|||
128679544|NCT02093351|463126723|FG003|Part B|Patient decision|3|||
128679545|NCT02093351|463126720|FG000|Part B|Disease progression|0|||
128679546|NCT02093351|463126721|FG001|Part B|Disease progression|0|||
128679547|NCT02093351|463126722|FG002|Part B|Disease progression|0|||
128679548|NCT02093351|463126723|FG003|Part B|Disease progression|4|||
128679549|NCT02093351|463126720|FG000|Part B|Complete response|0|||
128679550|NCT02093351|463126721|FG001|Part B|Complete response|0|||
128679551|NCT02093351|463126722|FG002|Part B|Complete response|0|||
128679552|NCT02093351|463126723|FG003|Part B|Complete response|1|||
128679553|NCT02093351|463126720|FG000|Part B|Adverse event + disease progression|0|||
128679554|NCT02093351|463126721|FG001|Part B|Adverse event + disease progression|0|||
128679555|NCT02093351|463126722|FG002|Part B|Adverse event + disease progression|0|||
128679556|NCT02093351|463126723|FG003|Part B|Adverse event + disease progression|1|||
128679557|NCT02093351|463126720|FG000|Part B|Lack of therapeutic response|0|||
128679558|NCT02093351|463126721|FG001|Part B|Lack of therapeutic response|0|||
128679559|NCT02093351|463126722|FG002|Part B|Lack of therapeutic response|0|||
128679560|NCT02093351|463126723|FG003|Part B|Lack of therapeutic response|12|||
128679561|NCT02093351|463126720|FG000|Part B|Condition under investigation worsened|0|||
128679562|NCT02093351|463126721|FG001|Part B|Condition under investigation worsened|0|||
128679563|NCT02093351|463126722|FG002|Part B|Condition under investigation worsened|0|||
128679564|NCT02093351|463126723|FG003|Part B|Condition under investigation worsened|39|||
128679565|NCT02093351|463126720|FG000|Part B|Adverse Event|0|||
128679566|NCT02093351|463126721|FG001|Part B|Adverse Event|0|||
128679567|NCT02093351|463126722|FG002|Part B|Adverse Event|0|||
128679568|NCT02093351|463126723|FG003|Part B|Adverse Event|2|||
128679569|NCT02093351|463126720|FG000|Part B|Death|0|||
128679570|NCT02093351|463126721|FG001|Part B|Death|0|||
128679571|NCT02093351|463126722|FG002|Part B|Death|0|||
128679572|NCT02093351|463126723|FG003|Part B|Death|1|||
128679573|NCT01099709|463126724|FG000|Period 1|Withdrawal by Subject|0|||
128679574|NCT01099709|463126725|FG001|Period 1|Withdrawal by Subject|1|||
128679575|NCT01099709|463126724|FG000|Period 1|Positive cotinine test|0|||
128679576|NCT01099709|463126725|FG001|Period 1|Positive cotinine test|1|||
128679577|NCT01099709|463126724|FG000|Period 1|Adverse Event|1|||
128679578|NCT01099709|463126725|FG001|Period 1|Adverse Event|0|||
128679579|NCT01122394|463126733|FG000|Overall Study|Withdrawal by Subject|1|||
128679580|NCT01122394|463126734|FG001|Overall Study|Withdrawal by Subject|1|||
128679581|NCT01122394|463126733|FG000|Overall Study|Lost to Follow-up|2|||
128679582|NCT01122394|463126734|FG001|Overall Study|Lost to Follow-up|2|||
128679583|NCT01122394|463126733|FG000|Overall Study|Adverse Event|0|||
128679584|NCT01122394|463126734|FG001|Overall Study|Adverse Event|1|||
128679585|NCT02446743|463126735|FG000|Overall Study|Withdrawal by Subject|1|||
128679586|NCT02446743|463126736|FG001|Overall Study|Withdrawal by Subject|1|||
128679587|NCT02446743|463126735|FG000|Overall Study|Lost to Follow-up|1|||
128679588|NCT02446743|463126736|FG001|Overall Study|Lost to Follow-up|0|||
128679589|NCT02446743|463126735|FG000|Overall Study|Adverse Event|1|||
128679590|NCT02446743|463126736|FG001|Overall Study|Adverse Event|1|||
128679591|NCT02446743|463126735|FG000|Overall Study|Other|2|||
128679592|NCT02446743|463126736|FG001|Overall Study|Other|3|||
128679593|NCT01931670|463126738|FG000|Treatment Period|Exclusionary Medication Received|1|||
128679594|NCT01931670|463126739|FG001|Treatment Period|Exclusionary Medication Received|1|||
128679595|NCT01931670|463126740|FG002|Treatment Period|Exclusionary Medication Received|1|||
128679596|NCT01931670|463126738|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
128679597|NCT01931670|463126739|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
128679598|NCT01931670|463126740|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
128679599|NCT01931670|463126738|FG000|Treatment Period|Subject Noncompliant|4|||
128679600|NCT01931670|463126739|FG001|Treatment Period|Subject Noncompliant|9|||
128679601|NCT01931670|463126740|FG002|Treatment Period|Subject Noncompliant|5|||
128679602|NCT01931670|463126738|FG000|Treatment Period|Adverse Event|19|||
128679603|NCT01931670|463126739|FG001|Treatment Period|Adverse Event|8|||
128679604|NCT01931670|463126740|FG002|Treatment Period|Adverse Event|21|||
128679605|NCT01931670|463126738|FG000|Treatment Period|Lack of Efficacy|11|||
128679606|NCT01931670|463126739|FG001|Treatment Period|Lack of Efficacy|2|||
128679607|NCT01931670|463126740|FG002|Treatment Period|Lack of Efficacy|2|||
129012764|NCT00406848|464339650|FG000|Overall Study|Adverse Event|38|||
129012765|NCT00406848|464339651|FG001|Overall Study|Adverse Event|7|||
129012766|NCT00406848|464339650|FG000|Overall Study|Lack of Efficacy|9|||
129012767|NCT00406848|464339651|FG001|Overall Study|Lack of Efficacy|14|||
129012768|NCT00406848|464339650|FG000|Overall Study|Protocol Violation|10|||
129012769|NCT00406848|464339651|FG001|Overall Study|Protocol Violation|6|||
129012770|NCT00406848|464339650|FG000|Overall Study|Lost to Follow-up|6|||
129012771|NCT00406848|464339651|FG001|Overall Study|Lost to Follow-up|2|||
129012772|NCT00406848|464339650|FG000|Overall Study|Physician Decision|2|||
129012773|NCT00406848|464339651|FG001|Overall Study|Physician Decision|2|||
129012774|NCT00406848|464339650|FG000|Overall Study|Sponsor Decision|1|||
129012775|NCT00406848|464339651|FG001|Overall Study|Sponsor Decision|1|||
129012776|NCT05277389|464339655|FG000|Overall Study|Lost to Follow-up|1|||
129012777|NCT05277389|464339656|FG001|Overall Study|Lost to Follow-up|4|||
129012778|NCT03544138|464339659|FG000|Overall Study|Lost to Follow-up|29|||
129012779|NCT01766778|464339660|FG000|Overall Study|Adverse Event|4|||
129012780|NCT01766778|464339661|FG001|Overall Study|Adverse Event|4|||
129012781|NCT01766778|464339660|FG000|Overall Study|Withdrawal by Subject|1|||
129012782|NCT01766778|464339661|FG001|Overall Study|Withdrawal by Subject|0|||
129012783|NCT00419770|464340903|FG000|Overall Study|Withdrawal by Subject|5|||
129012784|NCT00419770|464340904|FG001|Overall Study|Withdrawal by Subject|1|||
129012785|NCT00414466|464340910|FG000|Overall Study|Adverse Event|0|||
129012786|NCT00414466|464340911|FG001|Overall Study|Adverse Event|0|||
129012787|NCT00414466|464340912|FG002|Overall Study|Adverse Event|1|||
129012788|NCT00414466|464340913|FG003|Overall Study|Adverse Event|1|||
129012789|NCT00414466|464340910|FG000|Overall Study|Lack of Efficacy|1|||
129012790|NCT00414466|464340911|FG001|Overall Study|Lack of Efficacy|0|||
129012791|NCT00414466|464340912|FG002|Overall Study|Lack of Efficacy|0|||
129012792|NCT00414466|464340913|FG003|Overall Study|Lack of Efficacy|0|||
129012793|NCT00414466|464340910|FG000|Overall Study|Withdrawn by Sponsor|1|||
129012794|NCT00414466|464340911|FG001|Overall Study|Withdrawn by Sponsor|0|||
128679608|NCT01931670|463126738|FG000|Treatment Period|Pregnancy|7|||
128679609|NCT01931670|463126739|FG001|Treatment Period|Pregnancy|2|||
128679610|NCT01931670|463126740|FG002|Treatment Period|Pregnancy|0|||
128679611|NCT01931670|463126738|FG000|Treatment Period|Other|8|||
129012795|NCT00414466|464340912|FG002|Overall Study|Withdrawn by Sponsor|0|||
129012796|NCT00414466|464340913|FG003|Overall Study|Withdrawn by Sponsor|0|||
129012797|NCT04526210|464340914|FG000|Overall Study|Sponsor decision|7|||
129012798|NCT04526210|464340915|FG001|Overall Study|Sponsor decision|5|||
129012799|NCT04526210|464340914|FG000|Overall Study|Withdrawal by Subject|3|||
129012800|NCT04526210|464340915|FG001|Overall Study|Withdrawal by Subject|2|||
129012801|NCT01781637|464340916|FG000|Overall Study|Adverse Event|1|||
128879565|NCT00409773|463854871|FG003|Overall Study|Withdrawal by Subject|2|||
128879566|NCT00409773|463854872|FG004|Overall Study|Withdrawal by Subject|1|||
128879567|NCT00409773|463854868|FG000|Overall Study|Lack of Eligibility|0|||
128879568|NCT00409773|463854869|FG001|Overall Study|Lack of Eligibility|0|||
128879569|NCT00409773|463854870|FG002|Overall Study|Lack of Eligibility|0|||
128879570|NCT00409773|463854871|FG003|Overall Study|Lack of Eligibility|0|||
128879571|NCT00409773|463854872|FG004|Overall Study|Lack of Eligibility|1|||
128879572|NCT02359877|463854873|FG000|Overall Study|Withdrawal by Subject|1|||
128879573|NCT02359877|463854874|FG001|Overall Study|Withdrawal by Subject|0|||
128879574|NCT02359877|463854875|FG002|Overall Study|Withdrawal by Subject|0|||
128879575|NCT02359877|463854876|FG003|Overall Study|Withdrawal by Subject|2|||
128879576|NCT02359877|463854873|FG000|Overall Study|Adverse Event|0|||
128879577|NCT02359877|463854874|FG001|Overall Study|Adverse Event|0|||
128879578|NCT02359877|463854875|FG002|Overall Study|Adverse Event|0|||
128879579|NCT02359877|463854876|FG003|Overall Study|Adverse Event|1|||
128879580|NCT01919814|463854877|FG000|Overall Study|Adverse Event|1|||
128879581|NCT01919814|463854878|FG001|Overall Study|Adverse Event|0|||
128879582|NCT01919814|463854877|FG000|Overall Study|Protocol Violation|1|||
128879583|NCT01919814|463854878|FG001|Overall Study|Protocol Violation|0|||
128879584|NCT01919814|463854877|FG000|Overall Study|Withdrawal by Subject|1|||
128879585|NCT01919814|463854878|FG001|Overall Study|Withdrawal by Subject|0|||
128879586|NCT02164383|463854879|FG000|Overall Study|Lost to Follow-up|1|||
128879587|NCT02164383|463854880|FG001|Overall Study|Lost to Follow-up|0|||
128679612|NCT01931670|463126739|FG001|Treatment Period|Other|7|||
128679613|NCT01931670|463126740|FG002|Treatment Period|Other|2|||
128679614|NCT01931670|463126738|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
128679615|NCT01931670|463126739|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
128679616|NCT01931670|463126740|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
128679617|NCT01931670|463126738|FG000|Treatment Period|Lost to Follow-up|19|||
128679618|NCT01931670|463126739|FG001|Treatment Period|Lost to Follow-up|5|||
128679619|NCT01931670|463126740|FG002|Treatment Period|Lost to Follow-up|7|||
128679620|NCT01931670|463126738|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
128679621|NCT01931670|463126739|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
128679622|NCT01931670|463126740|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
128679623|NCT01931670|463126738|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
128679624|NCT01931670|463126739|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
128679625|NCT01931670|463126740|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
128679626|NCT01931670|463126738|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
128679627|NCT01931670|463126739|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
128679628|NCT01931670|463126740|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
128679629|NCT01931670|463126738|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
128679630|NCT01931670|463126739|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
128679631|NCT01931670|463126740|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
128679632|NCT01931670|463126738|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
128679633|NCT01931670|463126739|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
128679634|NCT01931670|463126740|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
128679635|NCT01931670|463126738|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
128679636|NCT01931670|463126739|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
128679637|NCT01931670|463126740|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
128679638|NCT00976508|463126741|FG000|Overall Study|Death|7|||
128679639|NCT00976508|463126742|FG001|Overall Study|Death|1|||
128679640|NCT00976508|463126741|FG000|Overall Study|Lost to Follow-up|1|||
128679641|NCT00976508|463126742|FG001|Overall Study|Lost to Follow-up|0|||
128679642|NCT00976508|463126741|FG000|Overall Study|Withdrawal by Subject|1|||
128679643|NCT00976508|463126742|FG001|Overall Study|Withdrawal by Subject|0|||
128679644|NCT00976508|463126741|FG000|Overall Study|Disease Progression|4|||
128679645|NCT00976508|463126742|FG001|Overall Study|Disease Progression|4|||
128679646|NCT00976508|463126741|FG000|Overall Study|Subject Enrolled in Hospice|1|||
128679647|NCT00976508|463126742|FG001|Overall Study|Subject Enrolled in Hospice|0|||
128679648|NCT00976508|463126741|FG000|Overall Study|Terminated by the Sponsor|0|||
128679649|NCT00976508|463126742|FG001|Overall Study|Terminated by the Sponsor|1|||
128679650|NCT01992159|463126743|FG000|Overall Study|Withdrawal by Subject|4|||
128679651|NCT01992159|463126744|FG001|Overall Study|Withdrawal by Subject|7|||
128679652|NCT01992159|463126745|FG002|Overall Study|Withdrawal by Subject|0|||
128679653|NCT01992159|463126746|FG003|Overall Study|Withdrawal by Subject|3|||
128679654|NCT01992159|463126743|FG000|Overall Study|Adverse Event|0|||
128679655|NCT01992159|463126744|FG001|Overall Study|Adverse Event|1|||
128679656|NCT01992159|463126745|FG002|Overall Study|Adverse Event|0|||
128679657|NCT01992159|463126746|FG003|Overall Study|Adverse Event|1|||
128679658|NCT01992159|463126743|FG000|Overall Study|Death|0|||
128879588|NCT02831387|463854882|FG000|Overall Study|Withdrawal by Subject|1|||
128879589|NCT02831387|463854883|FG001|Overall Study|Withdrawal by Subject|1|||
128879590|NCT02831387|463854882|FG000|Overall Study|Discontinued due to stock recovery|0|||
129012802|NCT01781637|464340917|FG001|Overall Study|Adverse Event|0|||
128679659|NCT01992159|463126744|FG001|Overall Study|Death|0|||
128679660|NCT01992159|463126745|FG002|Overall Study|Death|1|||
128679661|NCT01992159|463126746|FG003|Overall Study|Death|0|||
128679662|NCT03023046|463126747|FG000|Overall Study|Withdrawal by Subject|1|||
128679663|NCT04972630|463126749|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
128679664|NCT04972630|463126750|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
128679665|NCT04972630|463126751|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
128679666|NCT00075270|463126752|FG000|Overall Study|Withdrawal by Subject|28|||
128679667|NCT00075270|463126753|FG001|Overall Study|Withdrawal by Subject|21|||
128679668|NCT00075270|463126752|FG000|Overall Study|Lost to Follow-up|25|||
128679669|NCT00075270|463126753|FG001|Overall Study|Lost to Follow-up|28|||
128679670|NCT00075270|463126752|FG000|Overall Study|Protocol Violation|0|||
128679671|NCT00075270|463126753|FG001|Overall Study|Protocol Violation|2|||
128679672|NCT00075270|463126752|FG000|Overall Study|Death|198|||
128679673|NCT00075270|463126753|FG001|Overall Study|Death|215|||
128679674|NCT00075270|463126752|FG000|Overall Study|Other/Unknown|9|||
128679675|NCT00075270|463126753|FG001|Overall Study|Other/Unknown|5|||
128679676|NCT00075270|463126752|FG000|Overall Study|Missing|26|||
128679677|NCT00075270|463126753|FG001|Overall Study|Missing|13|||
128679678|NCT01129024|463126757|FG000|Overall Study|Physician Decision|5|||
128679679|NCT01129024|463126757|FG000|Overall Study|Study Terminated by Sponsor|8|||
128879591|NCT02831387|463854883|FG001|Overall Study|Discontinued due to stock recovery|1|||
128879592|NCT00192647|463854884|FG000|Overall Study|Death|1|||
128879593|NCT00192647|463854885|FG001|Overall Study|Death|1|||
128879594|NCT00192647|463854884|FG000|Overall Study|Adverse Event|35|||
128879595|NCT00192647|463854885|FG001|Overall Study|Adverse Event|29|||
128879596|NCT00192647|463854884|FG000|Overall Study|Laboratory Test Abnormality|4|||
128879597|NCT00192647|463854885|FG001|Overall Study|Laboratory Test Abnormality|2|||
128679680|NCT01129024|463126757|FG000|Overall Study|Withdrawal by Subject|2|||
128679681|NCT01129024|463126757|FG000|Overall Study|Lack of Efficacy|3|||
128679682|NCT01129024|463126757|FG000|Overall Study|Needed a Platelet Transfusion|1|||
128879598|NCT00192647|463854884|FG000|Overall Study|Insufficient Therapeutic Response|53|||
128679683|NCT00686634|463126763|FG000|Overall Study|Protocol Violation|6|||
128679684|NCT02361580|463126766|FG000|Overall Study|Lost to Follow-up|6|||
128879599|NCT00192647|463854885|FG001|Overall Study|Insufficient Therapeutic Response|83|||
128879600|NCT00192647|463854884|FG000|Overall Study|Entry Criteria Violation|6|||
128879601|NCT00192647|463854885|FG001|Overall Study|Entry Criteria Violation|6|||
128879602|NCT00192647|463854884|FG000|Overall Study|Protocol Violation|3|||
128879603|NCT00192647|463854885|FG001|Overall Study|Protocol Violation|1|||
128679685|NCT02361580|463126767|FG001|Overall Study|Lost to Follow-up|3|||
128679686|NCT00924781|463126768|FG000|Overall Study|Study terminated by sponsor|12|||
128679687|NCT00924781|463126769|FG001|Overall Study|Study terminated by sponsor|10|||
128879604|NCT00192647|463854884|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
128879605|NCT00192647|463854885|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
128879606|NCT00192647|463854884|FG000|Overall Study|Failure to Return|11|||
128879607|NCT00192647|463854885|FG001|Overall Study|Failure to Return|13|||
128879608|NCT00192647|463854884|FG000|Overall Study|Other/Administrative|5|||
128879609|NCT00192647|463854885|FG001|Overall Study|Other/Administrative|3|||
128879610|NCT01828073|463854886|FG000|Overall Study|Lost to Follow-up|1|||
128879611|NCT01828073|463854887|FG001|Overall Study|Lost to Follow-up|2|||
128879612|NCT00690443|463854888|FG000|Overall Study|Adverse Event|1|||
128879613|NCT00690443|463854889|FG001|Overall Study|Adverse Event|2|||
128879614|NCT01350336|463854890|FG000|Overall Study|Lost to Follow-up|31|||
128879615|NCT01350336|463854890|FG000|Overall Study|Withdrawal by Subject|14|||
128879616|NCT01350336|463854890|FG000|Overall Study|Physician Decision|8|||
128879617|NCT01350336|463854890|FG000|Overall Study|Death|4|||
128879618|NCT02079610|463854891|FG000|Overall Study|Withdrawal by Subject|1|||
128879619|NCT02079610|463854892|FG001|Overall Study|Withdrawal by Subject|1|||
128879620|NCT01111474|463854893|FG000|Overall Study|Lost to Follow-up|12|||
129012803|NCT01781637|464340916|FG000|Overall Study|Lack of Efficacy|2|||
129012804|NCT01781637|464340917|FG001|Overall Study|Lack of Efficacy|6|||
129012805|NCT01781637|464340916|FG000|Overall Study|Withdrawal by Subject|1|||
129012806|NCT01781637|464340917|FG001|Overall Study|Withdrawal by Subject|0|||
129012807|NCT01085045|464340920|FG000|Part A|Withdrawal by Subject|4|||
129012808|NCT01085045|464340920|FG000|Part A|Adverse Event|6|||
129012809|NCT01085045|464340920|FG000|Part A|Protocol Violation|1|||
129012810|NCT01085045|464340920|FG000|Part A|Protocol Specified Criteria|7|||
129012811|NCT01085045|464340920|FG000|Part B|Withdrawal by Subject|2|||
129012812|NCT01085045|464340920|FG000|Part B|Protocol Specified Criteria|6|||
129012813|NCT01085045|464340920|FG000|Part B|Lost to Follow-up|1|||
129012814|NCT01085045|464340920|FG000|Part B|Adverse Event|6|||
129012815|NCT02127281|464340925|FG000|Overall Study|Lost to Follow-up|1|||
129012816|NCT02127281|464340926|FG001|Overall Study|Lost to Follow-up|0|||
129012817|NCT03227445|464340931|FG000|Period 1 (28 Days)|Adverse Event|1|||
129012818|NCT03227445|464340932|FG001|Period 1 (28 Days)|Adverse Event|2|||
129012819|NCT03227445|464340933|FG002|Period 1 (28 Days)|Adverse Event|0|||
129012820|NCT03227445|464340934|FG003|Period 1 (28 Days)|Adverse Event|1|||
129012821|NCT03227445|464340931|FG000|Period 1 (28 Days)|Protocol Violation|1|||
129101817|NCT00948922|464667722|FG000|Overall Study|Death|3|||
129101818|NCT00948922|464667723|FG001|Overall Study|Death|0|||
129101819|NCT00948922|464667724|FG002|Overall Study|Death|0|||
129101820|NCT00948922|464667722|FG000|Overall Study|Disease progression|0|||
129101821|NCT00948922|464667723|FG001|Overall Study|Disease progression|1|||
129101822|NCT00948922|464667724|FG002|Overall Study|Disease progression|0|||
129101823|NCT00948922|464667722|FG000|Overall Study|Insurance issues|1|||
129101824|NCT00948922|464667723|FG001|Overall Study|Insurance issues|0|||
129101825|NCT00948922|464667724|FG002|Overall Study|Insurance issues|0|||
129101826|NCT00948922|464667722|FG000|Overall Study|Transplant eligibility issues|2|||
129101827|NCT00948922|464667723|FG001|Overall Study|Transplant eligibility issues|3|||
129101828|NCT00948922|464667724|FG002|Overall Study|Transplant eligibility issues|0|||
129101829|NCT00948922|464667722|FG000|Overall Study|Not evaluable at time of analysis|0|||
129101830|NCT00948922|464667723|FG001|Overall Study|Not evaluable at time of analysis|3|||
129101831|NCT00948922|464667724|FG002|Overall Study|Not evaluable at time of analysis|0|||
129101832|NCT02784288|464667725|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
129101833|NCT02095197|464667726|FG000|Overall Study|Lost to Follow-up|0|||
129101834|NCT02095197|464667727|FG001|Overall Study|Lost to Follow-up|3|||
129101835|NCT00217581|464667736|FG000|Overall Study|Withdrawal by Subject|1|||
129101836|NCT04399889|464667737|FG000|Overall Study|Death|5|||
129101837|NCT04399889|464667738|FG001|Overall Study|Death|1|||
129101838|NCT04399889|464667739|FG002|Overall Study|Death|1|||
129101839|NCT02829047|464667743|FG000|Overall Study|Withdrawal by Subject|1|||
128679688|NCT00708201|463126770|FG000|Overall Study|Adverse Event|4|||
128679689|NCT00708201|463126771|FG001|Overall Study|Adverse Event|4|||
128679690|NCT00708201|463126770|FG000|Overall Study|Withdrawal by Subject|1|||
129101840|NCT03077607|464667744|FG000|Period 1 (15 Days)|Adverse Event|1|||
129101841|NCT03077607|464667745|FG001|Period 1 (15 Days)|Adverse Event|0|||
129101842|NCT03077607|464667744|FG000|Period 1 (15 Days)|Death|1|||
129101843|NCT03077607|464667745|FG001|Period 1 (15 Days)|Death|0|||
129101844|NCT03077607|464667744|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
129101845|NCT03077607|464667745|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
129101846|NCT03077607|464667744|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
129101847|NCT03077607|464667745|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
129101848|NCT01005901|464667747|FG000|Overall Study|Withdrawal by Subject|38|||
129101849|NCT01005901|464667748|FG001|Overall Study|Withdrawal by Subject|14|||
129101850|NCT01005901|464667747|FG000|Overall Study|Adverse Event|30|||
129101851|NCT01005901|464667748|FG001|Overall Study|Adverse Event|16|||
129101852|NCT01005901|464667747|FG000|Overall Study|Administrative problems|21|||
129101853|NCT01005901|464667748|FG001|Overall Study|Administrative problems|13|||
129101854|NCT01005901|464667747|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129101855|NCT01005901|464667748|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
129101856|NCT01005901|464667747|FG000|Overall Study|Protocol Violation|4|||
129101857|NCT01005901|464667748|FG001|Overall Study|Protocol Violation|3|||
129101858|NCT01005901|464667747|FG000|Overall Study|Death|2|||
129101859|NCT01005901|464667748|FG001|Overall Study|Death|3|||
129101860|NCT01005901|464667747|FG000|Overall Study|Lost to Follow-up|1|||
129101861|NCT01005901|464667748|FG001|Overall Study|Lost to Follow-up|2|||
129101862|NCT01005901|464667747|FG000|Overall Study|Patient's inability to use the device|1|||
129101863|NCT01005901|464667748|FG001|Overall Study|Patient's inability to use the device|1|||
129101864|NCT01005901|464667747|FG000|Overall Study|No longer requires study drug|0|||
129101865|NCT01005901|464667748|FG001|Overall Study|No longer requires study drug|1|||
129101866|NCT00760487|464667749|FG000|Overall Study|Unilateral implantation|3|||
129101867|NCT06360588|464667750|FG000|Overall Study|Adverse Event|3|||
129101868|NCT06360588|464667750|FG000|Overall Study|Death|2|||
128679691|NCT00708201|463126771|FG001|Overall Study|Withdrawal by Subject|1|||
128679692|NCT00708201|463126770|FG000|Overall Study|Lost to Follow-up|2|||
128679693|NCT00708201|463126771|FG001|Overall Study|Lost to Follow-up|0|||
128679694|NCT00708201|463126770|FG000|Overall Study|Protocol Violation|0|||
128679695|NCT00708201|463126771|FG001|Overall Study|Protocol Violation|1|||
129101869|NCT06360588|464667750|FG000|Overall Study|Disease Progression|14|||
129101870|NCT06360588|464667750|FG000|Overall Study|Withdrawal by Subject|1|||
129101871|NCT06360588|464667750|FG000|Overall Study|Lack of Efficacy|1|||
129101872|NCT06360588|464667750|FG000|Overall Study|Ineligible|1|||
129101873|NCT02087943|464667752|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
129101874|NCT02087943|464667753|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
128679696|NCT01653132|463126772|FG000|First Intervention|Protocol Violation|1|||
128679697|NCT01653132|463126773|FG001|First Intervention|Protocol Violation|0|||
128679698|NCT02677324|463126774|FG000|Overall Study|Disease Progression|6|||
128679699|NCT02677324|463126774|FG000|Overall Study|Inability to Swallow pills|1|||
129101875|NCT02087943|464667754|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
129101876|NCT02087943|464667755|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
129101877|NCT02087943|464667756|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
128679700|NCT02677324|463126774|FG000|Overall Study|Non-compliance|1|||
128679701|NCT02677324|463126774|FG000|Overall Study|Lack of Efficacy|1|||
128679702|NCT02677324|463126774|FG000|Overall Study|Medical insurance coverage|1|||
128679703|NCT02677324|463126774|FG000|Overall Study|Adverse Event|1|||
128679704|NCT02677324|463126774|FG000|Overall Study|IgM Myeloma diagnosis|1|||
128679705|NCT01261780|463126775|FG000|Overall Study|Withdrawal by Subject|1|||
128679706|NCT01261780|463126776|FG001|Overall Study|Withdrawal by Subject|0|||
128679707|NCT01261780|463126775|FG000|Overall Study|Event not related to subject|1|||
128679708|NCT01261780|463126776|FG001|Overall Study|Event not related to subject|2|||
128679709|NCT00732940|463126777|FG000|Overall Study|Withdrawal by Subject|1|||
128679710|NCT00732940|463126778|FG001|Overall Study|Withdrawal by Subject|2|||
128679711|NCT00732940|463126777|FG000|Overall Study|Adverse Event|0|||
128679712|NCT00732940|463126778|FG001|Overall Study|Adverse Event|1|||
128679713|NCT00732940|463126777|FG000|Overall Study|Lost to Follow-up|1|||
128679714|NCT00732940|463126778|FG001|Overall Study|Lost to Follow-up|0|||
128679715|NCT01589770|463126779|FG000|Overall Study|EGFR <60ml/min|6|||
128679716|NCT01589770|463126780|FG001|Overall Study|EGFR <60ml/min|4|||
128679717|NCT01589770|463126779|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
128679718|NCT01589770|463126780|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
128679719|NCT00938886|463126785|FG000|Overall Study|Death|0|||
128679720|NCT00938886|463126786|FG001|Overall Study|Death|1|||
128679721|NCT00938886|463126785|FG000|Overall Study|Withdrawal by Subject|4|||
128679722|NCT00938886|463126786|FG001|Overall Study|Withdrawal by Subject|7|||
128679723|NCT00938886|463126785|FG000|Overall Study|Lost to Follow-up|3|||
128679724|NCT00938886|463126786|FG001|Overall Study|Lost to Follow-up|2|||
128679725|NCT00913692|463126787|FG000|Screening (4 Months)|Physician Decision|3|||
128679726|NCT00913692|463126787|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
128679727|NCT00913692|463126787|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
128679728|NCT02889562|463126788|FG000|Overall Study|Physician Decision|0|||
128679729|NCT02889562|463126789|FG001|Overall Study|Physician Decision|1|||
128679730|NCT02889562|463126788|FG000|Overall Study|Withdrawal by Subject|0|||
128679731|NCT02889562|463126789|FG001|Overall Study|Withdrawal by Subject|1|||
128679732|NCT01470989|463126792|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
128679733|NCT01470989|463126793|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
128679734|NCT01470989|463126792|FG000|Overall Study|Adverse Event|2|||
128679735|NCT01470989|463126793|FG001|Overall Study|Adverse Event|5|||
128679736|NCT01470989|463126792|FG000|Overall Study|Abnormal laboratory value|1|||
128679737|NCT01470989|463126793|FG001|Overall Study|Abnormal laboratory value|1|||
128679738|NCT01470989|463126792|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128679739|NCT01470989|463126793|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
128679740|NCT01470989|463126792|FG000|Overall Study|Withdrawal by Subject|19|||
128679741|NCT01470989|463126793|FG001|Overall Study|Withdrawal by Subject|17|||
128679742|NCT01470989|463126792|FG000|Overall Study|Lost to Follow-up|18|||
128679743|NCT01470989|463126793|FG001|Overall Study|Lost to Follow-up|13|||
128679744|NCT01470989|463126792|FG000|Overall Study|Administrative problems|2|||
128679745|NCT01470989|463126793|FG001|Overall Study|Administrative problems|4|||
128679746|NCT01470989|463126792|FG000|Overall Study|Death|2|||
128679747|NCT01470989|463126793|FG001|Overall Study|Death|2|||
128679748|NCT01470989|463126792|FG000|Overall Study|Protocol deviation|1|||
128679749|NCT01470989|463126793|FG001|Overall Study|Protocol deviation|2|||
128679750|NCT00969280|463126794|FG000|Overall Study|Protocol Violation|2|||
128679751|NCT00969280|463126795|FG001|Overall Study|Protocol Violation|1|||
128679752|NCT00969280|463126794|FG000|Overall Study|Withdrawal by Subject|0|||
128679753|NCT00969280|463126795|FG001|Overall Study|Withdrawal by Subject|1|||
128679754|NCT00969280|463126794|FG000|Overall Study|infection of influenza A(H1N1)|0|||
128679755|NCT00969280|463126795|FG001|Overall Study|infection of influenza A(H1N1)|1|||
128679756|NCT00773383|463128202|FG000|Overall Study|Adverse Event|4|||
128679757|NCT00773383|463128202|FG000|Overall Study|Death|1|||
128679758|NCT00773383|463128202|FG000|Overall Study|Progression of Disease|23|||
128679759|NCT00773383|463128202|FG000|Overall Study|Other|2|||
128679760|NCT00773383|463128202|FG000|Overall Study|No study dose received|1|||
128679761|NCT03384693|463128203|FG000|Overall Study|Adverse Event|3|||
128679762|NCT03621475|463128206|FG000|Overall Study|No longer required restraints at initiation|0|||
128679763|NCT03621475|463128207|FG001|Overall Study|No longer required restraints at initiation|1|||
128679764|NCT00039871|463128208|FG000|Overall Study|Adverse Event|165|||
128679765|NCT00039871|463128208|FG000|Overall Study|Lost to Follow-up|18|||
128679766|NCT00039871|463128208|FG000|Overall Study|Protocol Violation|24|||
128679767|NCT00039871|463128208|FG000|Overall Study|Withdrawal by Subject|97|||
128679768|NCT00039871|463128208|FG000|Overall Study|Did not meet eligibility criteria|11|||
128679769|NCT00039871|463128208|FG000|Overall Study|Administrative|1|||
128679770|NCT00039871|463128208|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
128679771|NCT00039871|463128208|FG000|Overall Study|Never entered follow-up|7|||
128679772|NCT03560739|463128209|FG000|Overall Study|Adverse Event|0|||
128679773|NCT03560739|463128210|FG001|Overall Study|Adverse Event|1|||
128679774|NCT03560739|463128211|FG002|Overall Study|Adverse Event|0|||
128679775|NCT03560739|463128212|FG003|Overall Study|Adverse Event|0|||
128679776|NCT03361176|463128213|FG000|Overall Study|Lost to Follow-up|1|||
128679777|NCT03361176|463128214|FG001|Overall Study|Lost to Follow-up|2|||
128679778|NCT03361176|463128213|FG000|Overall Study|Adverse Event|0|||
128679779|NCT03361176|463128214|FG001|Overall Study|Adverse Event|2|||
128679780|NCT03361176|463128213|FG000|Overall Study|Withdrawal by Subject|0|||
128679781|NCT03361176|463128214|FG001|Overall Study|Withdrawal by Subject|1|||
128679782|NCT04389970|463128215|FG000|Overall Study|Lost to Follow-up|1|||
128679783|NCT03123185|463128216|FG000|Overall Study|Withdrawal by Subject|0|||
128679784|NCT03123185|463128217|FG001|Overall Study|Withdrawal by Subject|0|||
128679785|NCT03123185|463128218|FG002|Overall Study|Withdrawal by Subject|0|||
128679786|NCT03123185|463128219|FG003|Overall Study|Withdrawal by Subject|0|||
128679787|NCT03123185|463128220|FG004|Overall Study|Withdrawal by Subject|0|||
128679788|NCT03123185|463128221|FG005|Overall Study|Withdrawal by Subject|0|||
128679789|NCT03123185|463128222|FG006|Overall Study|Withdrawal by Subject|0|||
128679790|NCT03123185|463128223|FG007|Overall Study|Withdrawal by Subject|0|||
128679791|NCT03123185|463128224|FG008|Overall Study|Withdrawal by Subject|0|||
128679792|NCT03123185|463128225|FG009|Overall Study|Withdrawal by Subject|0|||
128679793|NCT03123185|463128226|FG010|Overall Study|Withdrawal by Subject|0|||
128679794|NCT03123185|463128227|FG011|Overall Study|Withdrawal by Subject|0|||
128679795|NCT03123185|463128228|FG012|Overall Study|Withdrawal by Subject|1|||
128679796|NCT03123185|463128229|FG013|Overall Study|Withdrawal by Subject|0|||
128679797|NCT00718081|463128232|FG000|Overall Study|Adverse Event|0|||
128679798|NCT00718081|463128233|FG001|Overall Study|Adverse Event|1|||
128679799|NCT00718081|463128234|FG002|Overall Study|Adverse Event|0|||
128679800|NCT00718081|463128232|FG000|Overall Study|Lack of Efficacy|7|||
128679801|NCT00718081|463128233|FG001|Overall Study|Lack of Efficacy|3|||
128679802|NCT00718081|463128234|FG002|Overall Study|Lack of Efficacy|21|||
128679803|NCT01397825|463128237|FG000|Overall Study|Progressive Disease|10|||
128679804|NCT01397825|463128238|FG001|Overall Study|Progressive Disease|3|||
128679805|NCT01397825|463128239|FG002|Overall Study|Progressive Disease|11|||
128679806|NCT01397825|463128240|FG003|Overall Study|Progressive Disease|1|||
128679807|NCT01397825|463128241|FG004|Overall Study|Progressive Disease|0|||
128679808|NCT01397825|463128237|FG000|Overall Study|Symptomatic Deterioration|2|||
128679809|NCT01397825|463128238|FG001|Overall Study|Symptomatic Deterioration|0|||
128679810|NCT01397825|463128239|FG002|Overall Study|Symptomatic Deterioration|4|||
128679811|NCT01397825|463128240|FG003|Overall Study|Symptomatic Deterioration|0|||
128679812|NCT01397825|463128241|FG004|Overall Study|Symptomatic Deterioration|0|||
128679813|NCT01397825|463128237|FG000|Overall Study|Adverse Event|0|||
128679814|NCT01397825|463128238|FG001|Overall Study|Adverse Event|1|||
128679815|NCT01397825|463128239|FG002|Overall Study|Adverse Event|5|||
128679816|NCT01397825|463128240|FG003|Overall Study|Adverse Event|1|||
128679817|NCT01397825|463128241|FG004|Overall Study|Adverse Event|0|||
128679818|NCT01397825|463128237|FG000|Overall Study|Withdrawal by Subject|1|||
128679819|NCT01397825|463128238|FG001|Overall Study|Withdrawal by Subject|0|||
128679820|NCT01397825|463128239|FG002|Overall Study|Withdrawal by Subject|5|||
128679821|NCT01397825|463128240|FG003|Overall Study|Withdrawal by Subject|1|||
128679822|NCT01397825|463128241|FG004|Overall Study|Withdrawal by Subject|0|||
128679823|NCT00815516|463128242|FG000|Overall Study|Death|3|||
129012822|NCT03227445|464340932|FG001|Period 1 (28 Days)|Protocol Violation|0|||
129012823|NCT03227445|464340933|FG002|Period 1 (28 Days)|Protocol Violation|0|||
129012824|NCT03227445|464340934|FG003|Period 1 (28 Days)|Protocol Violation|0|||
129012825|NCT03227445|464340931|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
129012826|NCT03227445|464340932|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
129012827|NCT03227445|464340933|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
129012828|NCT03227445|464340934|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
129012829|NCT03227445|464340931|FG000|Period 2 (28 Days)|Adverse Event|1|||
129012830|NCT03227445|464340932|FG001|Period 2 (28 Days)|Adverse Event|0|||
129012831|NCT03227445|464340933|FG002|Period 2 (28 Days)|Adverse Event|2|||
129012832|NCT03227445|464340934|FG003|Period 2 (28 Days)|Adverse Event|1|||
129012833|NCT03227445|464340931|FG000|Period 2 (28 Days)|Protocol Violation|0|||
129012834|NCT03227445|464340932|FG001|Period 2 (28 Days)|Protocol Violation|0|||
129012835|NCT03227445|464340933|FG002|Period 2 (28 Days)|Protocol Violation|0|||
129012836|NCT03227445|464340934|FG003|Period 2 (28 Days)|Protocol Violation|1|||
129012837|NCT03227445|464340931|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
129012838|NCT03227445|464340932|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
129012839|NCT03227445|464340933|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
129012840|NCT03227445|464340934|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
129012841|NCT00755196|464340936|FG000|Overall Study|Lost to Follow-up|1|||
129012842|NCT00755196|464340936|FG000|Overall Study|Lack of Efficiency|1|||
129012843|NCT01703832|464340937|FG000|Overall Study|Withdrawal by Subject|1|||
129012844|NCT01703832|464340938|FG001|Overall Study|Withdrawal by Subject|0|||
129012845|NCT01991470|464340939|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
129012846|NCT01991470|464340939|FG000|Enlite 1 Period|Adverse Event|1|||
129012847|NCT01991470|464340939|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
129012848|NCT01991470|464340939|FG000|Enlite 3 Period|Lost to Follow-up|1|||
129012849|NCT01991470|464340939|FG000|Enlite 3 Period|Physician Decision|2|||
129012850|NCT01991470|464340939|FG000|Enlite 3 Period|Physician Decision|8|||
128679824|NCT00815516|463128243|FG001|Overall Study|Death|1|||
128679825|NCT00815516|463128242|FG000|Overall Study|Physician Decision|1|||
129012851|NCT01991470|464340939|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
128679826|NCT00815516|463128243|FG001|Overall Study|Physician Decision|0|||
128679827|NCT01741012|463128250|FG000|Overall Study|Lost to Follow-up|1|||
128679828|NCT01741012|463128250|FG000|Overall Study|Withdrawal by Subject|2|||
128679829|NCT00470158|463128251|FG000|Overall Study|Death|0|||
128679830|NCT00470158|463128252|FG001|Overall Study|Death|0|||
128679831|NCT00470158|463128253|FG002|Overall Study|Death|0|||
128679832|NCT00470158|463128254|FG003|Overall Study|Death|0|||
128679833|NCT00470158|463128255|FG004|Overall Study|Death|2|||
128679834|NCT00470158|463128251|FG000|Overall Study|Lost to Follow-up|7|||
128679835|NCT00470158|463128252|FG001|Overall Study|Lost to Follow-up|8|||
128679836|NCT00470158|463128253|FG002|Overall Study|Lost to Follow-up|8|||
128679837|NCT00470158|463128254|FG003|Overall Study|Lost to Follow-up|5|||
128679838|NCT00470158|463128255|FG004|Overall Study|Lost to Follow-up|4|||
128679839|NCT00470158|463128251|FG000|Overall Study|Protocol Violation|1|||
128679840|NCT00470158|463128252|FG001|Overall Study|Protocol Violation|0|||
128679841|NCT00470158|463128253|FG002|Overall Study|Protocol Violation|0|||
128679842|NCT00470158|463128254|FG003|Overall Study|Protocol Violation|0|||
128679843|NCT00470158|463128255|FG004|Overall Study|Protocol Violation|0|||
128679844|NCT00880685|463128256|FG000|Memantine 10mg|Lost to Follow-up|2|||
128679845|NCT00880685|463128256|FG000|Memantine 20mg|Withdrawal by Subject|1|||
128679846|NCT01249118|463128257|FG000|First Washout Period|Physician Decision|0|||
128679847|NCT01249118|463128258|FG001|First Washout Period|Physician Decision|1|||
129101878|NCT02087943|464667752|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
129101879|NCT02087943|464667753|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
129101880|NCT02087943|464667754|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
129101881|NCT02087943|464667755|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
129101882|NCT02087943|464667756|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
129101883|NCT02087943|464667752|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
128679848|NCT01249118|463128259|FG002|First Washout Period|Physician Decision|0|||
128679849|NCT04179890|463128260|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
128679850|NCT04179890|463128261|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
128679851|NCT04179890|463128260|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
128679852|NCT04179890|463128261|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
128679853|NCT04179890|463128260|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
128679854|NCT04179890|463128261|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
128679855|NCT04179890|463128260|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
128679856|NCT04179890|463128261|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
128679857|NCT04179890|463128260|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
128679858|NCT04179890|463128261|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
128679859|NCT04179890|463128260|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
128679860|NCT04179890|463128261|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
128679861|NCT04179890|463128260|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
128679862|NCT04179890|463128261|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
128679863|NCT04179890|463128260|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
128679864|NCT04179890|463128261|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
128679865|NCT04179890|463128260|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
128679866|NCT04179890|463128261|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
128679867|NCT01236118|463128262|FG000|Overall Study|Adverse Event|2|||
128679868|NCT01236118|463128263|FG001|Overall Study|Adverse Event|0|||
128679869|NCT01236118|463128264|FG002|Overall Study|Adverse Event|2|||
128679870|NCT01236118|463128262|FG000|Overall Study|Physician Decision|0|||
128679871|NCT01236118|463128263|FG001|Overall Study|Physician Decision|1|||
128679872|NCT01236118|463128264|FG002|Overall Study|Physician Decision|0|||
128679873|NCT01236118|463128262|FG000|Overall Study|Withdrawal by Subject|0|||
128679874|NCT01236118|463128263|FG001|Overall Study|Withdrawal by Subject|0|||
128679875|NCT01236118|463128264|FG002|Overall Study|Withdrawal by Subject|1|||
128679876|NCT00095238|463128265|FG000|Overall Study|Lack of Efficacy|9|||
128679877|NCT00095238|463128266|FG001|Overall Study|Lack of Efficacy|9|||
128679878|NCT00095238|463128265|FG000|Overall Study|Adverse Event|331|||
128679879|NCT00095238|463128266|FG001|Overall Study|Adverse Event|287|||
128679880|NCT00095238|463128265|FG000|Overall Study|Subject Withdrew Consent|208|||
128679881|NCT00095238|463128266|FG001|Overall Study|Subject Withdrew Consent|223|||
128679882|NCT00095238|463128265|FG000|Overall Study|Death|154|||
128679883|NCT00095238|463128266|FG001|Overall Study|Death|170|||
128679884|NCT00095238|463128265|FG000|Overall Study|Lost to Follow-up|19|||
128679885|NCT00095238|463128266|FG001|Overall Study|Lost to Follow-up|24|||
128679886|NCT00095238|463128265|FG000|Overall Study|Noncompliance|44|||
129101884|NCT02087943|464667753|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
128679887|NCT00095238|463128266|FG001|Overall Study|Noncompliance|45|||
128679888|NCT00095238|463128265|FG000|Overall Study|No longer met study criteria|4|||
128679889|NCT00095238|463128266|FG001|Overall Study|No longer met study criteria|5|||
128679890|NCT00095238|463128265|FG000|Overall Study|Study terminated by sponsor|0|||
128679891|NCT00095238|463128266|FG001|Overall Study|Study terminated by sponsor|1|||
128679892|NCT00095238|463128265|FG000|Overall Study|Missing|1|||
128679893|NCT00095238|463128266|FG001|Overall Study|Missing|0|||
128679894|NCT00095238|463128265|FG000|Overall Study|Other Reasons|87|||
128679895|NCT00095238|463128266|FG001|Overall Study|Other Reasons|88|||
128679896|NCT04393298|463128267|FG000|Overall Study|Adverse Event|0|||
128679897|NCT04393298|463128268|FG001|Overall Study|Adverse Event|0|||
128679898|NCT04393298|463128269|FG002|Overall Study|Adverse Event|0|||
128679899|NCT04393298|463128270|FG003|Overall Study|Adverse Event|0|||
128679900|NCT04393298|463128271|FG004|Overall Study|Adverse Event|1|||
128679901|NCT04393298|463128272|FG005|Overall Study|Adverse Event|0|||
128679902|NCT04393298|463128273|FG006|Overall Study|Adverse Event|0|||
128679903|NCT04393298|463128274|FG007|Overall Study|Adverse Event|0|||
128679904|NCT04393298|463128275|FG008|Overall Study|Adverse Event|2|||
128679905|NCT04393298|463128276|FG009|Overall Study|Adverse Event|0|||
128679906|NCT04393298|463128277|FG010|Overall Study|Adverse Event|0|||
128679907|NCT04393298|463128278|FG011|Overall Study|Adverse Event|0|||
128679908|NCT04393298|463128279|FG012|Overall Study|Adverse Event|1|||
128679909|NCT04393298|463128280|FG013|Overall Study|Adverse Event|1|||
128679910|NCT04393298|463128281|FG014|Overall Study|Adverse Event|0|||
128679911|NCT04393298|463128267|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679912|NCT04393298|463128268|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679913|NCT04393298|463128269|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
128679914|NCT04393298|463128270|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679915|NCT04393298|463128271|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679916|NCT04393298|463128272|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679917|NCT04393298|463128273|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679918|NCT04393298|463128274|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679919|NCT04393298|463128275|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679920|NCT04393298|463128276|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679921|NCT04393298|463128277|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129012852|NCT00243932|464340940|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
129012853|NCT00243932|464340941|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
129012854|NCT00243932|464340942|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
129012855|NCT00880568|464340943|FG000|Overall Study|Disease progression|3|||
129012856|NCT00880568|464340944|FG001|Overall Study|Disease progression|3|||
129012857|NCT00880568|464340945|FG002|Overall Study|Disease progression|3|||
129012858|NCT00880568|464340946|FG003|Overall Study|Disease progression|1|||
129012859|NCT00880568|464340947|FG004|Overall Study|Disease progression|3|||
129012860|NCT00880568|464340948|FG005|Overall Study|Disease progression|3|||
129012861|NCT00880568|464340949|FG006|Overall Study|Disease progression|5|||
129012862|NCT00880568|464340950|FG007|Overall Study|Disease progression|0|||
129012863|NCT00880568|464340951|FG008|Overall Study|Disease progression|3|||
129012864|NCT00880568|464340943|FG000|Overall Study|Adverse Event|0|||
129012865|NCT00880568|464340944|FG001|Overall Study|Adverse Event|0|||
129012866|NCT00880568|464340945|FG002|Overall Study|Adverse Event|0|||
129012867|NCT00880568|464340946|FG003|Overall Study|Adverse Event|0|||
129012868|NCT00880568|464340947|FG004|Overall Study|Adverse Event|0|||
129012869|NCT00880568|464340948|FG005|Overall Study|Adverse Event|0|||
129012870|NCT00880568|464340949|FG006|Overall Study|Adverse Event|1|||
129012871|NCT00880568|464340950|FG007|Overall Study|Adverse Event|1|||
129012872|NCT00880568|464340951|FG008|Overall Study|Adverse Event|0|||
129012873|NCT00880568|464340943|FG000|Overall Study|Withdrawal by Subject|0|||
129012874|NCT00880568|464340944|FG001|Overall Study|Withdrawal by Subject|0|||
129012875|NCT00880568|464340945|FG002|Overall Study|Withdrawal by Subject|0|||
129012876|NCT00880568|464340946|FG003|Overall Study|Withdrawal by Subject|0|||
129012877|NCT00880568|464340947|FG004|Overall Study|Withdrawal by Subject|0|||
129012878|NCT00880568|464340948|FG005|Overall Study|Withdrawal by Subject|0|||
129012879|NCT00880568|464340949|FG006|Overall Study|Withdrawal by Subject|0|||
129012880|NCT00880568|464340950|FG007|Overall Study|Withdrawal by Subject|1|||
129012881|NCT00880568|464340951|FG008|Overall Study|Withdrawal by Subject|0|||
129012882|NCT00849901|464340952|FG000|Acute Treatment Phase|Adverse Event|9|||
129012883|NCT00849901|464340953|FG001|Acute Treatment Phase|Adverse Event|1|||
129012884|NCT00849901|464340954|FG002|Acute Treatment Phase|Adverse Event|3|||
129012885|NCT00849901|464340952|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
129012886|NCT00849901|464340953|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
129012887|NCT00849901|464340954|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
129012888|NCT00849901|464340952|FG000|Acute Treatment Phase|Protocol Violation|0|||
129012889|NCT00849901|464340953|FG001|Acute Treatment Phase|Protocol Violation|2|||
129012890|NCT00849901|464340954|FG002|Acute Treatment Phase|Protocol Violation|1|||
129012891|NCT00849901|464340952|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
129101885|NCT02087943|464667754|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
129101886|NCT02087943|464667755|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
129101887|NCT02087943|464667756|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
129101888|NCT02087943|464667752|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
129101889|NCT02087943|464667753|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
129101890|NCT02087943|464667754|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
129101891|NCT02087943|464667755|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
129101892|NCT02087943|464667756|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
129101893|NCT02087943|464667752|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129101894|NCT02087943|464667753|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
129101895|NCT02087943|464667754|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129101896|NCT02087943|464667755|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129101897|NCT02087943|464667756|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129101898|NCT02087943|464667752|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
129101899|NCT02087943|464667753|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
129101900|NCT02087943|464667754|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
129101901|NCT02087943|464667755|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
129101902|NCT02087943|464667756|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
129101903|NCT02087943|464667752|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
129101904|NCT02087943|464667753|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
129101905|NCT02087943|464667754|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
129101906|NCT02087943|464667755|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
129101907|NCT02087943|464667756|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
129101908|NCT02087943|464667752|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129101909|NCT02087943|464667753|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129101910|NCT02087943|464667754|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
129101911|NCT02087943|464667755|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129101912|NCT02087943|464667756|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129101913|NCT02087943|464667752|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129101914|NCT02087943|464667753|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129101915|NCT02087943|464667754|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129101916|NCT02087943|464667755|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129101917|NCT02087943|464667756|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
129101918|NCT02087943|464667752|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
129101919|NCT02087943|464667753|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
129101920|NCT02087943|464667754|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
129101921|NCT02087943|464667755|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
129101922|NCT02087943|464667756|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
129101923|NCT01690299|464667757|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
129101924|NCT01690299|464667758|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
129101925|NCT01690299|464667759|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
129101926|NCT01690299|464667760|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
129101927|NCT01690299|464667761|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
129101928|NCT01690299|464667762|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
129101929|NCT01690299|464667757|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
129101930|NCT01690299|464667758|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129101931|NCT01690299|464667759|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129101932|NCT01690299|464667760|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129101933|NCT01690299|464667761|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129101934|NCT01690299|464667762|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129101935|NCT01690299|464667757|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
129101936|NCT01690299|464667758|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
129101937|NCT01690299|464667759|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129101938|NCT01690299|464667760|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129101939|NCT01690299|464667761|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
128679922|NCT04393298|463128278|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679923|NCT04393298|463128279|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
128679924|NCT04393298|463128280|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129012892|NCT00849901|464340953|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
129012893|NCT00849901|464340954|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
129012894|NCT00849901|464340952|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
129012895|NCT00849901|464340953|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
129012896|NCT00849901|464340954|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
129012897|NCT00849901|464340952|FG000|Acute Treatment Phase|Physician Decision|1|||
129012898|NCT00849901|464340953|FG001|Acute Treatment Phase|Physician Decision|1|||
129012899|NCT00849901|464340954|FG002|Acute Treatment Phase|Physician Decision|1|||
129101940|NCT01690299|464667762|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129101941|NCT01690299|464667757|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
129101942|NCT01690299|464667758|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
129101943|NCT01690299|464667759|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
129101944|NCT01690299|464667760|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
129101945|NCT01690299|464667761|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
129101946|NCT01690299|464667762|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
129101947|NCT01690299|464667757|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
129101948|NCT01690299|464667758|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
129101949|NCT01690299|464667759|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
129101950|NCT01690299|464667760|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
129101951|NCT01690299|464667761|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
129101952|NCT01690299|464667762|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
129101953|NCT01690299|464667757|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
129101954|NCT01690299|464667758|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
129101955|NCT01690299|464667759|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
129101956|NCT01690299|464667760|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
129101957|NCT01690299|464667761|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
129101958|NCT01690299|464667762|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
129101959|NCT01690299|464667757|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129101960|NCT01690299|464667758|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129101961|NCT01690299|464667759|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129101962|NCT01690299|464667760|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129101963|NCT01690299|464667761|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
129101964|NCT01690299|464667762|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
129101965|NCT01690299|464667757|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
129101966|NCT01690299|464667758|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
129101967|NCT01690299|464667759|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
129101968|NCT01690299|464667760|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
129101969|NCT01690299|464667761|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
129101970|NCT01690299|464667762|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
129101971|NCT01690299|464667757|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
129101972|NCT01690299|464667758|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
129101973|NCT01690299|464667759|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
129101974|NCT01690299|464667760|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
129101975|NCT01690299|464667761|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
129101976|NCT01690299|464667762|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
129101977|NCT01690299|464667757|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129101978|NCT01690299|464667758|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129101979|NCT01690299|464667759|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129101980|NCT01690299|464667760|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129101981|NCT01690299|464667761|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129101982|NCT01690299|464667762|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
129101983|NCT03836209|464667763|FG000|Overall Study|Adverse Event|5|||
129101984|NCT03836209|464667764|FG001|Overall Study|Adverse Event|2|||
129101985|NCT03836209|464667763|FG000|Overall Study|Death|4|||
129101986|NCT03836209|464667764|FG001|Overall Study|Death|1|||
129101987|NCT03836209|464667763|FG000|Overall Study|Lack of Efficacy|7|||
129101988|NCT03836209|464667764|FG001|Overall Study|Lack of Efficacy|10|||
129101989|NCT03836209|464667763|FG000|Overall Study|Physician Decision|7|||
129101990|NCT03836209|464667764|FG001|Overall Study|Physician Decision|11|||
129101991|NCT03836209|464667763|FG000|Overall Study|Protocol Violation|0|||
129101992|NCT03836209|464667764|FG001|Overall Study|Protocol Violation|3|||
129101993|NCT03836209|464667763|FG000|Overall Study|Withdrawal by Subject|2|||
129101994|NCT03836209|464667764|FG001|Overall Study|Withdrawal by Subject|10|||
129101995|NCT03836209|464667763|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
129101996|NCT03836209|464667764|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
129101997|NCT03739710|464667765|FG000|Overall Study|Screen Failed|81|||
129101998|NCT01753115|464667766|FG000|Overall Study|Lost to Follow-up|3|||
129101999|NCT01753115|464667767|FG001|Overall Study|Lost to Follow-up|6|||
129102000|NCT01753115|464667768|FG002|Overall Study|Lost to Follow-up|8|||
129102001|NCT01753115|464667766|FG000|Overall Study|Withdrawal by Subject|6|||
129102002|NCT01753115|464667767|FG001|Overall Study|Withdrawal by Subject|5|||
129102003|NCT01753115|464667768|FG002|Overall Study|Withdrawal by Subject|6|||
129102004|NCT01753115|464667766|FG000|Overall Study|Subject non-compliant|3|||
129102005|NCT01753115|464667767|FG001|Overall Study|Subject non-compliant|3|||
129102006|NCT01753115|464667768|FG002|Overall Study|Subject non-compliant|0|||
128679925|NCT04393298|463128281|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
128679926|NCT04393298|463128267|FG000|Overall Study|Lack of Efficacy|0|||
129012900|NCT00849901|464340952|FG000|Acute Treatment Phase|Sponsor Decision|1|||
129012901|NCT00849901|464340953|FG001|Acute Treatment Phase|Sponsor Decision|0|||
129012902|NCT00849901|464340954|FG002|Acute Treatment Phase|Sponsor Decision|0|||
129012903|NCT00849901|464340952|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
129012904|NCT00849901|464340953|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
129012905|NCT00849901|464340954|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
129012906|NCT00849901|464340952|FG000|Extension Phase|Adverse Event|2|||
129012907|NCT00849901|464340953|FG001|Extension Phase|Adverse Event|8|||
129012908|NCT00849901|464340954|FG002|Extension Phase|Adverse Event|4|||
129012909|NCT00849901|464340952|FG000|Extension Phase|Lost to Follow-up|3|||
129012910|NCT00849901|464340953|FG001|Extension Phase|Lost to Follow-up|0|||
129012911|NCT00849901|464340954|FG002|Extension Phase|Lost to Follow-up|1|||
129012912|NCT00849901|464340952|FG000|Extension Phase|Protocol Violation|2|||
129012913|NCT00849901|464340953|FG001|Extension Phase|Protocol Violation|2|||
129012914|NCT00849901|464340954|FG002|Extension Phase|Protocol Violation|4|||
129012915|NCT00849901|464340952|FG000|Extension Phase|Withdrawal by Subject|7|||
129012916|NCT00849901|464340953|FG001|Extension Phase|Withdrawal by Subject|6|||
129012917|NCT00849901|464340954|FG002|Extension Phase|Withdrawal by Subject|3|||
129012918|NCT00849901|464340952|FG000|Extension Phase|Parent or Caregiver Decision|10|||
129012919|NCT00849901|464340953|FG001|Extension Phase|Parent or Caregiver Decision|4|||
129012920|NCT00849901|464340954|FG002|Extension Phase|Parent or Caregiver Decision|4|||
129012921|NCT00849901|464340952|FG000|Extension Phase|Physician Decision|1|||
129012922|NCT00849901|464340953|FG001|Extension Phase|Physician Decision|2|||
129012923|NCT00849901|464340954|FG002|Extension Phase|Physician Decision|0|||
129012924|NCT00849901|464340952|FG000|Extension Phase|Lack of Efficacy|2|||
129012925|NCT00849901|464340953|FG001|Extension Phase|Lack of Efficacy|4|||
129012926|NCT00849901|464340954|FG002|Extension Phase|Lack of Efficacy|1|||
129012927|NCT00437658|464340955|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
129012928|NCT00437658|464340956|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
129012929|NCT00437658|464340957|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
129012930|NCT00437658|464340955|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
129012931|NCT00437658|464340956|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
129012932|NCT00437658|464340957|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
129012933|NCT00437658|464340955|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
129012934|NCT00437658|464340956|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
129012935|NCT00437658|464340957|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
129012936|NCT00437658|464340955|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
129012937|NCT00437658|464340956|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
129012938|NCT00437658|464340957|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
129012939|NCT00437658|464340955|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
129012940|NCT00437658|464340956|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
129012941|NCT00437658|464340957|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
129012942|NCT00437658|464340955|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
129012943|NCT00437658|464340956|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
129012944|NCT00437658|464340957|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
129012945|NCT00437658|464340955|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
129012946|NCT00437658|464340956|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
129012947|NCT00437658|464340957|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
129012948|NCT00437658|464340955|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
129012949|NCT00437658|464340956|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
129012950|NCT00437658|464340957|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
129012951|NCT00437658|464340955|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
129012952|NCT00437658|464340956|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
129012953|NCT00437658|464340957|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
129012954|NCT00437658|464340955|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
129012955|NCT00437658|464340956|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
129012956|NCT00437658|464340957|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
129012957|NCT00437658|464340955|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
129012958|NCT00437658|464340956|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
129012959|NCT00437658|464340957|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
129012960|NCT00437658|464340955|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
128679927|NCT04393298|463128268|FG001|Overall Study|Lack of Efficacy|0|||
129012961|NCT00437658|464340956|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
129012962|NCT00437658|464340957|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
129012963|NCT04407806|464340958|FG000|Overall Study|Withdrawal by Subject|1|||
129102007|NCT01753115|464667766|FG000|Overall Study|Used excluded drug|0|||
128679928|NCT04393298|463128269|FG002|Overall Study|Lack of Efficacy|0|||
129012964|NCT04407806|464340959|FG001|Overall Study|Withdrawal by Subject|2|||
129012965|NCT02731157|464340960|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
129012966|NCT01856309|464340961|FG000|Overall Study|Death|4|||
129102008|NCT01753115|464667767|FG001|Overall Study|Used excluded drug|1|||
129102009|NCT01753115|464667768|FG002|Overall Study|Used excluded drug|0|||
129102010|NCT01424241|464667771|FG000|Overall Study|Withdrawal by Subject|1|||
129102011|NCT01424241|464667771|FG000|Overall Study|Time constraints|2|||
129102012|NCT00496587|464667772|FG000|Overall Study|Adverse Event|2|||
129102013|NCT00496587|464667772|FG000|Overall Study|Progressive Disease|24|||
129102014|NCT00496587|464667772|FG000|Overall Study|Withdrawal by Subject|2|||
129102015|NCT00496587|464667772|FG000|Overall Study|Death|1|||
129102016|NCT00496587|464667772|FG000|Overall Study|Complications unrelated|2|||
129102017|NCT05259917|464667778|FG000|Overall Study|Protocol Violation|0|||
129102018|NCT05259917|464667779|FG001|Overall Study|Protocol Violation|0|||
129102019|NCT05259917|464667780|FG002|Overall Study|Protocol Violation|1|||
129102020|NCT05259917|464667781|FG003|Overall Study|Protocol Violation|0|||
129102021|NCT05259917|464667782|FG004|Overall Study|Protocol Violation|0|||
129102022|NCT05259917|464667783|FG005|Overall Study|Protocol Violation|0|||
129102023|NCT05259917|464667778|FG000|Overall Study|Lost to Follow-up|0|||
129102024|NCT05259917|464667779|FG001|Overall Study|Lost to Follow-up|0|||
129102025|NCT05259917|464667780|FG002|Overall Study|Lost to Follow-up|1|||
129102026|NCT05259917|464667781|FG003|Overall Study|Lost to Follow-up|0|||
129102027|NCT05259917|464667782|FG004|Overall Study|Lost to Follow-up|0|||
129102028|NCT05259917|464667783|FG005|Overall Study|Lost to Follow-up|1|||
129102029|NCT05259917|464667778|FG000|Overall Study|Physician Decision|0|||
129102030|NCT05259917|464667779|FG001|Overall Study|Physician Decision|1|||
129102031|NCT05259917|464667780|FG002|Overall Study|Physician Decision|0|||
129102032|NCT05259917|464667781|FG003|Overall Study|Physician Decision|0|||
129102033|NCT05259917|464667782|FG004|Overall Study|Physician Decision|0|||
129102034|NCT05259917|464667783|FG005|Overall Study|Physician Decision|0|||
129102035|NCT05259917|464667778|FG000|Overall Study|Withdrawal by Subject|0|||
129102036|NCT05259917|464667779|FG001|Overall Study|Withdrawal by Subject|1|||
129102037|NCT05259917|464667780|FG002|Overall Study|Withdrawal by Subject|0|||
129102038|NCT05259917|464667781|FG003|Overall Study|Withdrawal by Subject|0|||
129102039|NCT05259917|464667782|FG004|Overall Study|Withdrawal by Subject|1|||
129102040|NCT05259917|464667783|FG005|Overall Study|Withdrawal by Subject|1|||
129102041|NCT05259917|464667778|FG000|Overall Study|Trial Termination by Sponsor|7|||
129102042|NCT05259917|464667779|FG001|Overall Study|Trial Termination by Sponsor|2|||
129102043|NCT05259917|464667780|FG002|Overall Study|Trial Termination by Sponsor|3|||
129102044|NCT05259917|464667781|FG003|Overall Study|Trial Termination by Sponsor|5|||
129102045|NCT05259917|464667782|FG004|Overall Study|Trial Termination by Sponsor|11|||
129102046|NCT05259917|464667783|FG005|Overall Study|Trial Termination by Sponsor|4|||
129102047|NCT05259917|464667778|FG000|Overall Study|Other|1|||
129102048|NCT05259917|464667779|FG001|Overall Study|Other|0|||
129102049|NCT05259917|464667780|FG002|Overall Study|Other|2|||
129102050|NCT05259917|464667781|FG003|Overall Study|Other|0|||
129102051|NCT05259917|464667782|FG004|Overall Study|Other|0|||
129102052|NCT05259917|464667783|FG005|Overall Study|Other|0|||
129102053|NCT02383355|464667786|FG000|Overall Study|Adverse Event|2|||
129102054|NCT02383355|464667787|FG001|Overall Study|Adverse Event|0|||
129102055|NCT01146561|464667789|FG000|Overall Study|Withdrawal by Subject|1|||
129102056|NCT01146561|464667789|FG000|Overall Study|Lost to Follow-up|1|||
129102057|NCT02717442|464667792|FG000|Overall Study|Study Terminated by Sponsor|31|||
129102058|NCT02717442|464667793|FG001|Overall Study|Study Terminated by Sponsor|29|||
129102059|NCT02717442|464667792|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
129102060|NCT02717442|464667793|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
129102061|NCT02717442|464667792|FG000|Overall Study|Other - Not Specified|2|||
129102062|NCT02717442|464667793|FG001|Overall Study|Other - Not Specified|0|||
129102063|NCT02772809|464667797|FG000|Overall Study|not completed some tasks|6|||
129102064|NCT02774005|464667800|FG000|Overall Study|Adverse Event|8|||
129102065|NCT02774005|464667800|FG000|Overall Study|Withdrawal by Subject|23|||
129102066|NCT02774005|464667800|FG000|Overall Study|Lost to Follow-up|7|||
129102067|NCT02774005|464667800|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
129102068|NCT02774005|464667800|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
129102069|NCT02774005|464667800|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
129102070|NCT02774005|464667800|FG000|Overall Study|Death|1|||
129102071|NCT02774005|464667800|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
129102072|NCT02774005|464667800|FG000|Overall Study|Lack of compliance with study medication|4|||
129102073|NCT02774005|464667800|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
129102074|NCT02774005|464667800|FG000|Overall Study|another study|1|||
129102075|NCT02774005|464667800|FG000|Overall Study|cardiologist imposed travel restriction|1|||
129102076|NCT00534105|464667801|FG000|Overall Study|Lost to Follow-up|23|||
129102077|NCT00534105|464667802|FG001|Overall Study|Lost to Follow-up|39|||
129102078|NCT00978341|464667804|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
129102079|NCT00978341|464667805|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
129102080|NCT00448812|464667806|FG000|Year 2|Missed visit but remained in study|4|||
129102081|NCT00448812|464667807|FG001|Year 2|Missed visit but remained in study|1|||
129102082|NCT00448812|464667806|FG000|Year 3|Withdrawal by Subject|1|||
129102083|NCT00448812|464667807|FG001|Year 3|Withdrawal by Subject|3|||
129102084|NCT00448812|464667806|FG000|Year 3|Lost to Follow-up|1|||
129102085|NCT00448812|464667807|FG001|Year 3|Lost to Follow-up|0|||
129102086|NCT00448812|464667806|FG000|Year 3|Missed visit but remained in study|2|||
129102087|NCT00448812|464667807|FG001|Year 3|Missed visit but remained in study|0|||
129102088|NCT00448812|464667806|FG000|Year 5|Missed visit but remained in study|1|||
129102089|NCT00448812|464667807|FG001|Year 5|Missed visit but remained in study|0|||
129102090|NCT03035916|464667808|FG000|Overall Study|Puncture failed|0|||
129102091|NCT03035916|464667809|FG001|Overall Study|Puncture failed|2|||
129102092|NCT03035916|464667810|FG002|Overall Study|Puncture failed|0|||
129102093|NCT03885999|464667811|FG000|Overall Study|Adverse Event|1|||
128679929|NCT04393298|463128270|FG003|Overall Study|Lack of Efficacy|0|||
128679930|NCT04393298|463128271|FG004|Overall Study|Lack of Efficacy|0|||
128679931|NCT04393298|463128272|FG005|Overall Study|Lack of Efficacy|0|||
128679932|NCT04393298|463128273|FG006|Overall Study|Lack of Efficacy|0|||
128679933|NCT04393298|463128274|FG007|Overall Study|Lack of Efficacy|0|||
128679934|NCT04393298|463128275|FG008|Overall Study|Lack of Efficacy|0|||
128679935|NCT04393298|463128276|FG009|Overall Study|Lack of Efficacy|0|||
128679936|NCT04393298|463128277|FG010|Overall Study|Lack of Efficacy|0|||
128679937|NCT04393298|463128278|FG011|Overall Study|Lack of Efficacy|0|||
128679938|NCT04393298|463128279|FG012|Overall Study|Lack of Efficacy|0|||
128679939|NCT04393298|463128280|FG013|Overall Study|Lack of Efficacy|0|||
128679940|NCT04393298|463128281|FG014|Overall Study|Lack of Efficacy|1|||
128679941|NCT04393298|463128267|FG000|Overall Study|Progression|1|||
128679942|NCT04393298|463128268|FG001|Overall Study|Progression|0|||
128679943|NCT04393298|463128269|FG002|Overall Study|Progression|0|||
128679944|NCT04393298|463128270|FG003|Overall Study|Progression|0|||
128679945|NCT04393298|463128271|FG004|Overall Study|Progression|0|||
128679946|NCT04393298|463128272|FG005|Overall Study|Progression|0|||
128679947|NCT04393298|463128273|FG006|Overall Study|Progression|0|||
128679948|NCT04393298|463128274|FG007|Overall Study|Progression|0|||
128679949|NCT04393298|463128275|FG008|Overall Study|Progression|0|||
128679950|NCT04393298|463128276|FG009|Overall Study|Progression|0|||
128679951|NCT04393298|463128277|FG010|Overall Study|Progression|1|||
128679952|NCT04393298|463128278|FG011|Overall Study|Progression|1|||
129102094|NCT02452554|464667812|FG000|Overall Study|Death|2|||
129102095|NCT02452554|464667813|FG001|Overall Study|Death|1|||
129102096|NCT02452554|464667814|FG002|Overall Study|Death|0|||
129102097|NCT02452554|464667815|FG003|Overall Study|Death|0|||
129102098|NCT02452554|464667816|FG004|Overall Study|Death|0|||
129102099|NCT02452554|464667817|FG005|Overall Study|Death|0|||
129102100|NCT02452554|464667812|FG000|Overall Study|Lack of Efficacy|13|||
129102101|NCT02452554|464667813|FG001|Overall Study|Lack of Efficacy|14|||
129102102|NCT02452554|464667814|FG002|Overall Study|Lack of Efficacy|9|||
129102103|NCT02452554|464667815|FG003|Overall Study|Lack of Efficacy|1|||
129102104|NCT02452554|464667816|FG004|Overall Study|Lack of Efficacy|5|||
129102105|NCT02452554|464667817|FG005|Overall Study|Lack of Efficacy|8|||
129102106|NCT02452554|464667812|FG000|Overall Study|Physician Decision|0|||
129102107|NCT02452554|464667813|FG001|Overall Study|Physician Decision|1|||
129102108|NCT02452554|464667814|FG002|Overall Study|Physician Decision|0|||
129102109|NCT02452554|464667815|FG003|Overall Study|Physician Decision|0|||
129102110|NCT02452554|464667816|FG004|Overall Study|Physician Decision|0|||
129102111|NCT02452554|464667817|FG005|Overall Study|Physician Decision|0|||
129102112|NCT02452554|464667812|FG000|Overall Study|Withdrawal by Subject|1|||
129102113|NCT02452554|464667813|FG001|Overall Study|Withdrawal by Subject|0|||
129102114|NCT02452554|464667814|FG002|Overall Study|Withdrawal by Subject|2|||
129102115|NCT02452554|464667815|FG003|Overall Study|Withdrawal by Subject|0|||
129102116|NCT02452554|464667816|FG004|Overall Study|Withdrawal by Subject|0|||
129102117|NCT02452554|464667817|FG005|Overall Study|Withdrawal by Subject|1|||
129102118|NCT02452554|464667812|FG000|Overall Study|Ineligible|0|||
129102119|NCT02452554|464667813|FG001|Overall Study|Ineligible|1|||
129102120|NCT02452554|464667814|FG002|Overall Study|Ineligible|0|||
129102121|NCT02452554|464667815|FG003|Overall Study|Ineligible|0|||
129102122|NCT02452554|464667816|FG004|Overall Study|Ineligible|0|||
129102123|NCT02452554|464667817|FG005|Overall Study|Ineligible|0|||
128679953|NCT04393298|463128279|FG012|Overall Study|Progression|0|||
128679954|NCT04393298|463128280|FG013|Overall Study|Progression|0|||
128679955|NCT04393298|463128281|FG014|Overall Study|Progression|0|||
128679956|NCT04393298|463128267|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
128679957|NCT04393298|463128268|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679958|NCT04393298|463128269|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679959|NCT04393298|463128270|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
129102124|NCT02452554|464667812|FG000|Overall Study|Never Received Treatment|1|||
129102125|NCT02452554|464667813|FG001|Overall Study|Never Received Treatment|0|||
129102126|NCT02452554|464667814|FG002|Overall Study|Never Received Treatment|0|||
128679960|NCT04393298|463128271|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679961|NCT04393298|463128272|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679962|NCT04393298|463128273|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
129102127|NCT02452554|464667815|FG003|Overall Study|Never Received Treatment|0|||
129102128|NCT02452554|464667816|FG004|Overall Study|Never Received Treatment|0|||
129102129|NCT02452554|464667817|FG005|Overall Study|Never Received Treatment|0|||
129012967|NCT01856309|464340962|FG001|Overall Study|Death|6|||
129012968|NCT01856309|464340963|FG002|Overall Study|Death|11|||
129012969|NCT01856309|464340964|FG003|Overall Study|Death|6|||
129012970|NCT01856309|464340961|FG000|Overall Study|Lost to Follow-up|6|||
129012971|NCT01856309|464340962|FG001|Overall Study|Lost to Follow-up|2|||
129012972|NCT01856309|464340963|FG002|Overall Study|Lost to Follow-up|4|||
129012973|NCT01856309|464340964|FG003|Overall Study|Lost to Follow-up|8|||
129012974|NCT01856309|464340961|FG000|Overall Study|Withdrawal by Subject|11|||
129012975|NCT01856309|464340962|FG001|Overall Study|Withdrawal by Subject|13|||
129012976|NCT01856309|464340963|FG002|Overall Study|Withdrawal by Subject|28|||
129012977|NCT01856309|464340964|FG003|Overall Study|Withdrawal by Subject|26|||
129012978|NCT01856309|464340961|FG000|Overall Study|Other|227|||
129012979|NCT01856309|464340962|FG001|Overall Study|Other|225|||
129012980|NCT01856309|464340963|FG002|Overall Study|Other|447|||
129012981|NCT01856309|464340964|FG003|Overall Study|Other|469|||
129012982|NCT01856309|464340961|FG000|Overall Study|Lack of Efficacy|14|||
129012983|NCT01856309|464340962|FG001|Overall Study|Lack of Efficacy|9|||
129012984|NCT01856309|464340963|FG002|Overall Study|Lack of Efficacy|40|||
129012985|NCT01856309|464340964|FG003|Overall Study|Lack of Efficacy|25|||
129012986|NCT01856309|464340961|FG000|Overall Study|Adverse Event|31|||
129012987|NCT01856309|464340962|FG001|Overall Study|Adverse Event|31|||
129012988|NCT01856309|464340963|FG002|Overall Study|Adverse Event|55|||
129012989|NCT01856309|464340964|FG003|Overall Study|Adverse Event|65|||
129012990|NCT01856309|464340961|FG000|Overall Study|Pregnancy|0|||
129012991|NCT01856309|464340962|FG001|Overall Study|Pregnancy|0|||
129012992|NCT01856309|464340963|FG002|Overall Study|Pregnancy|0|||
129012993|NCT01856309|464340964|FG003|Overall Study|Pregnancy|1|||
129012994|NCT01856309|464340961|FG000|Overall Study|Physician Decision|6|||
129012995|NCT01856309|464340962|FG001|Overall Study|Physician Decision|1|||
129012996|NCT01856309|464340963|FG002|Overall Study|Physician Decision|6|||
129012997|NCT01856309|464340964|FG003|Overall Study|Physician Decision|8|||
129012998|NCT01856309|464340961|FG000|Overall Study|Noncompliance With Study Drug|0|||
129012999|NCT01856309|464340962|FG001|Overall Study|Noncompliance With Study Drug|1|||
129013000|NCT01856309|464340963|FG002|Overall Study|Noncompliance With Study Drug|4|||
129013001|NCT01856309|464340964|FG003|Overall Study|Noncompliance With Study Drug|1|||
129013002|NCT01434693|464340965|FG000|Overall Study|Adverse Event|1|||
129013003|NCT01434693|464340966|FG001|Overall Study|Adverse Event|0|||
129013004|NCT01434693|464340967|FG002|Overall Study|Adverse Event|0|||
129013005|NCT01434693|464340968|FG003|Overall Study|Adverse Event|0|||
129013006|NCT01434693|464340965|FG000|Overall Study|Withdrawal by Subject|1|||
129013007|NCT01434693|464340966|FG001|Overall Study|Withdrawal by Subject|0|||
129013008|NCT01434693|464340967|FG002|Overall Study|Withdrawal by Subject|1|||
129013009|NCT01434693|464340968|FG003|Overall Study|Withdrawal by Subject|1|||
129013010|NCT01434693|464340965|FG000|Overall Study|Lost to Follow-up|1|||
129013011|NCT01434693|464340966|FG001|Overall Study|Lost to Follow-up|0|||
129013012|NCT01434693|464340967|FG002|Overall Study|Lost to Follow-up|0|||
129013013|NCT01434693|464340968|FG003|Overall Study|Lost to Follow-up|0|||
129013014|NCT01440283|464340969|FG000|Overall Study|Death|3|||
129013015|NCT01440283|464340969|FG000|Overall Study|Withdrawal by Subject|4|||
129013016|NCT01440283|464340969|FG000|Overall Study|Physician Decision|3|||
129013017|NCT02327130|464340972|FG000|Overall Study|Discharged in less than 5 days|5|||
129013018|NCT02327130|464340972|FG000|Overall Study|Physician Decision|2|||
129013019|NCT02327130|464340972|FG000|Overall Study|Unable to provide breath sample|1|||
129013020|NCT02327130|464340972|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
129013021|NCT02327130|464340972|FG000|Overall Study|Met exclusion criteria|3|||
129013022|NCT01378975|464340976|FG000|Overall Study|Death|77|||
129013023|NCT01378975|464340977|FG001|Overall Study|Death|46|||
129013024|NCT01378975|464340976|FG000|Overall Study|Investigator Request|1|||
129013025|NCT01378975|464340977|FG001|Overall Study|Investigator Request|0|||
129013026|NCT01378975|464340976|FG000|Overall Study|Lost to Follow-up|4|||
129013027|NCT01378975|464340977|FG001|Overall Study|Lost to Follow-up|1|||
129013028|NCT01378975|464340976|FG000|Overall Study|Withdrew Consent|4|||
129013029|NCT01378975|464340977|FG001|Overall Study|Withdrew Consent|3|||
129013030|NCT02343120|464340981|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
129013031|NCT02343120|464340982|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
129013032|NCT02343120|464340983|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
129013033|NCT02343120|464340984|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
129013034|NCT02343120|464340985|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
129013035|NCT02343120|464340981|FG000|Part 1: Dose Escalation|Death|1|||
129013036|NCT02343120|464340982|FG001|Part 1: Dose Escalation|Death|2|||
129013037|NCT02343120|464340983|FG002|Part 1: Dose Escalation|Death|2|||
129013038|NCT02343120|464340984|FG003|Part 1: Dose Escalation|Death|2|||
129013039|NCT02343120|464340985|FG004|Part 1: Dose Escalation|Death|1|||
129013040|NCT02343120|464340981|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
129013041|NCT02343120|464340982|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
129013042|NCT02343120|464340983|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
129013043|NCT02343120|464340984|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
129013044|NCT02343120|464340985|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
129013045|NCT02343120|464340981|FG000|Part 2: Expansion|Sponsor decision|0|||
129102130|NCT00467558|464667820|FG000|Overall Study|Lost to Follow-up|2|||
129102131|NCT00467558|464667821|FG001|Overall Study|Lost to Follow-up|0|||
129102132|NCT02636439|464667822|FG000|Overall Study|Adverse Event|2|||
129102133|NCT02636439|464667823|FG001|Overall Study|Adverse Event|2|||
129102134|NCT02636439|464667822|FG000|Overall Study|Lost to Follow-up|1|||
129102135|NCT02636439|464667823|FG001|Overall Study|Lost to Follow-up|0|||
129102136|NCT02636439|464667822|FG000|Overall Study|Non-compliance|1|||
129102137|NCT02636439|464667823|FG001|Overall Study|Non-compliance|1|||
129102138|NCT02636439|464667822|FG000|Overall Study|Personal reasons|2|||
129102139|NCT02636439|464667823|FG001|Overall Study|Personal reasons|0|||
129102140|NCT05188729|464667825|FG000|Overall Study|Withdrawal by Subject|0|||
129102141|NCT05188729|464667826|FG001|Overall Study|Withdrawal by Subject|0|||
129102142|NCT05188729|464667827|FG002|Overall Study|Withdrawal by Subject|0|||
129102143|NCT05188729|464667828|FG003|Overall Study|Withdrawal by Subject|0|||
129102144|NCT05188729|464667829|FG004|Overall Study|Withdrawal by Subject|0|||
129102145|NCT05188729|464667830|FG005|Overall Study|Withdrawal by Subject|0|||
129102146|NCT05188729|464667831|FG006|Overall Study|Withdrawal by Subject|0|||
129102147|NCT05188729|464667832|FG007|Overall Study|Withdrawal by Subject|0|||
129102148|NCT05188729|464667833|FG008|Overall Study|Withdrawal by Subject|0|||
129102149|NCT05188729|464667834|FG009|Overall Study|Withdrawal by Subject|1|||
129102150|NCT05188729|464667835|FG010|Overall Study|Withdrawal by Subject|0|||
129102151|NCT05188729|464667836|FG011|Overall Study|Withdrawal by Subject|0|||
129102152|NCT05188729|464667837|FG012|Overall Study|Withdrawal by Subject|0|||
129102153|NCT05188729|464667825|FG000|Overall Study|Lost to Follow-up|0|||
129102154|NCT05188729|464667826|FG001|Overall Study|Lost to Follow-up|0|||
129102155|NCT05188729|464667827|FG002|Overall Study|Lost to Follow-up|0|||
129102156|NCT05188729|464667828|FG003|Overall Study|Lost to Follow-up|0|||
129102157|NCT05188729|464667829|FG004|Overall Study|Lost to Follow-up|0|||
129102158|NCT05188729|464667830|FG005|Overall Study|Lost to Follow-up|0|||
129102159|NCT05188729|464667831|FG006|Overall Study|Lost to Follow-up|0|||
129102160|NCT05188729|464667832|FG007|Overall Study|Lost to Follow-up|0|||
129102161|NCT05188729|464667833|FG008|Overall Study|Lost to Follow-up|0|||
129102162|NCT05188729|464667834|FG009|Overall Study|Lost to Follow-up|0|||
129102163|NCT05188729|464667835|FG010|Overall Study|Lost to Follow-up|1|||
129102164|NCT05188729|464667836|FG011|Overall Study|Lost to Follow-up|1|||
129102165|NCT05188729|464667837|FG012|Overall Study|Lost to Follow-up|0|||
129102166|NCT02734862|464670442|FG000|Part A|Death|3|||
129102167|NCT02734862|464670443|FG001|Part A|Death|4|||
129102168|NCT02734862|464670444|FG002|Part A|Death|6|||
129102169|NCT02734862|464670442|FG000|Part A|Lost to Follow-up|2|||
129102170|NCT02734862|464670443|FG001|Part A|Lost to Follow-up|1|||
129102171|NCT02734862|464670444|FG002|Part A|Lost to Follow-up|1|||
129102172|NCT02734862|464670442|FG000|Part A|Withdrawal by Subject|1|||
129102173|NCT02734862|464670443|FG001|Part A|Withdrawal by Subject|1|||
129102174|NCT02734862|464670444|FG002|Part A|Withdrawal by Subject|2|||
129102175|NCT02734862|464670442|FG000|Part A|Physician Decision|2|||
129102176|NCT02734862|464670443|FG001|Part A|Physician Decision|0|||
129102177|NCT02734862|464670444|FG002|Part A|Physician Decision|1|||
129102178|NCT02734862|464670442|FG000|Part A|Adverse Event|2|||
129102179|NCT02734862|464670443|FG001|Part A|Adverse Event|0|||
129102180|NCT02734862|464670444|FG002|Part A|Adverse Event|1|||
129102181|NCT02734862|464670442|FG000|Part A|Noncompliance|1|||
129102182|NCT02734862|464670443|FG001|Part A|Noncompliance|1|||
129102183|NCT02734862|464670444|FG002|Part A|Noncompliance|0|||
129102184|NCT02734862|464670442|FG000|Part A|Other|1|||
129102185|NCT02734862|464670443|FG001|Part A|Other|1|||
129102186|NCT02734862|464670444|FG002|Part A|Other|3|||
129102187|NCT02734862|464670442|FG000|Part B|Death|8|||
129102188|NCT02734862|464670443|FG001|Part B|Death|3|||
129102189|NCT02734862|464670444|FG002|Part B|Death|5|||
129102190|NCT02734862|464670442|FG000|Part B|Lost to Follow-up|2|||
128679963|NCT04393298|463128274|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679964|NCT04393298|463128275|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679965|NCT04393298|463128276|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679966|NCT04393298|463128277|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679967|NCT04393298|463128278|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679968|NCT04393298|463128279|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679969|NCT04393298|463128280|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
128679970|NCT04393298|463128281|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
129102191|NCT02734862|464670443|FG001|Part B|Lost to Follow-up|2|||
129102192|NCT02734862|464670444|FG002|Part B|Lost to Follow-up|0|||
129102193|NCT02734862|464670442|FG000|Part B|Withdrawal by Subject|3|||
129102194|NCT02734862|464670443|FG001|Part B|Withdrawal by Subject|1|||
129102195|NCT02734862|464670444|FG002|Part B|Withdrawal by Subject|0|||
129102196|NCT02734862|464670442|FG000|Part B|Other|0|||
129102197|NCT02734862|464670443|FG001|Part B|Other|1|||
129102198|NCT02734862|464670444|FG002|Part B|Other|0|||
129102199|NCT02757625|464670445|FG000|Overall Study|Investigator's discretion|0|||
129102200|NCT02757625|464670446|FG001|Overall Study|Investigator's discretion|0|||
129102201|NCT02757625|464670447|FG002|Overall Study|Investigator's discretion|1|||
129102202|NCT02757625|464670448|FG003|Overall Study|Investigator's discretion|0|||
129102203|NCT02757625|464670445|FG000|Overall Study|Adverse Event|0|||
128679971|NCT04393298|463128267|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679972|NCT04393298|463128268|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
128679973|NCT04393298|463128269|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679974|NCT04393298|463128270|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679975|NCT04393298|463128271|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679976|NCT04393298|463128272|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679977|NCT04393298|463128273|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679978|NCT04393298|463128274|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679979|NCT04393298|463128275|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679980|NCT04393298|463128276|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679981|NCT04393298|463128277|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129013046|NCT02343120|464340982|FG001|Part 2: Expansion|Sponsor decision|0|||
129013047|NCT02343120|464340983|FG002|Part 2: Expansion|Sponsor decision|0|||
129013048|NCT02343120|464340984|FG003|Part 2: Expansion|Sponsor decision|165|||
129013049|NCT02343120|464340985|FG004|Part 2: Expansion|Sponsor decision|67|||
129013050|NCT02343120|464340981|FG000|Part 2: Expansion|Death|0|||
129013051|NCT02343120|464340982|FG001|Part 2: Expansion|Death|0|||
129013052|NCT02343120|464340983|FG002|Part 2: Expansion|Death|0|||
129013053|NCT02343120|464340984|FG003|Part 2: Expansion|Death|74|||
129013054|NCT02343120|464340985|FG004|Part 2: Expansion|Death|17|||
129013055|NCT02343120|464340981|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
129013056|NCT02343120|464340982|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
129013057|NCT02343120|464340983|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
129013058|NCT02343120|464340984|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
129013059|NCT02343120|464340985|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
129013060|NCT02343120|464340981|FG000|Part 2: Expansion|Lost to Follow-up|0|||
129013061|NCT02343120|464340982|FG001|Part 2: Expansion|Lost to Follow-up|0|||
129013062|NCT02343120|464340983|FG002|Part 2: Expansion|Lost to Follow-up|0|||
129013063|NCT02343120|464340984|FG003|Part 2: Expansion|Lost to Follow-up|5|||
129013064|NCT02343120|464340985|FG004|Part 2: Expansion|Lost to Follow-up|2|||
129013065|NCT02343120|464340981|FG000|Part 2: Expansion|Other|0|||
129013066|NCT02343120|464340982|FG001|Part 2: Expansion|Other|0|||
129013067|NCT02343120|464340983|FG002|Part 2: Expansion|Other|0|||
129013068|NCT02343120|464340984|FG003|Part 2: Expansion|Other|1|||
129013069|NCT02343120|464340985|FG004|Part 2: Expansion|Other|5|||
129013070|NCT02343120|464340981|FG000|Part 2: Expansion|Adverse Event|0|||
129013071|NCT02343120|464340982|FG001|Part 2: Expansion|Adverse Event|0|||
129013072|NCT02343120|464340983|FG002|Part 2: Expansion|Adverse Event|0|||
129013073|NCT02343120|464340984|FG003|Part 2: Expansion|Adverse Event|1|||
129013074|NCT02343120|464340985|FG004|Part 2: Expansion|Adverse Event|1|||
129013075|NCT03991494|464340988|FG000|Overall Study|Progressive Disease|4|||
129013076|NCT01104662|464340989|FG000|Overall Study|Adverse Event|2|||
129013077|NCT01104662|464340990|FG001|Overall Study|Adverse Event|2|||
129013078|NCT01104662|464340991|FG002|Overall Study|Adverse Event|0|||
129013079|NCT01104662|464340992|FG003|Overall Study|Adverse Event|1|||
129013080|NCT01104662|464340993|FG004|Overall Study|Adverse Event|1|||
129013081|NCT01104662|464340994|FG005|Overall Study|Adverse Event|1|||
129013082|NCT01104662|464340995|FG006|Overall Study|Adverse Event|0|||
129013083|NCT01104662|464340996|FG007|Overall Study|Adverse Event|0|||
129013084|NCT01104662|464340989|FG000|Overall Study|Clinical Failure|1|||
129013085|NCT01104662|464340990|FG001|Overall Study|Clinical Failure|0|||
129013086|NCT01104662|464340991|FG002|Overall Study|Clinical Failure|0|||
129013087|NCT01104662|464340992|FG003|Overall Study|Clinical Failure|0|||
129013088|NCT01104662|464340993|FG004|Overall Study|Clinical Failure|0|||
129013089|NCT01104662|464340994|FG005|Overall Study|Clinical Failure|1|||
129013090|NCT01104662|464340995|FG006|Overall Study|Clinical Failure|0|||
129013091|NCT01104662|464340996|FG007|Overall Study|Clinical Failure|0|||
129013092|NCT01104662|464340989|FG000|Overall Study|Participant left investigator's care|1|||
129013093|NCT01104662|464340990|FG001|Overall Study|Participant left investigator's care|1|||
129013094|NCT01104662|464340991|FG002|Overall Study|Participant left investigator's care|0|||
129013095|NCT01104662|464340992|FG003|Overall Study|Participant left investigator's care|0|||
129013096|NCT01104662|464340993|FG004|Overall Study|Participant left investigator's care|0|||
128879621|NCT01016977|463854894|FG000|Overall Study|Lost to Follow-up|1|||
129013097|NCT01104662|464340994|FG005|Overall Study|Participant left investigator's care|0|||
129013098|NCT01104662|464340995|FG006|Overall Study|Participant left investigator's care|0|||
129013099|NCT01104662|464340996|FG007|Overall Study|Participant left investigator's care|0|||
129013100|NCT01104662|464340989|FG000|Overall Study|Reason not specified|3|||
129013101|NCT01104662|464340990|FG001|Overall Study|Reason not specified|3|||
129013102|NCT01104662|464340991|FG002|Overall Study|Reason not specified|0|||
129013103|NCT01104662|464340992|FG003|Overall Study|Reason not specified|0|||
129013104|NCT01104662|464340993|FG004|Overall Study|Reason not specified|0|||
129013105|NCT01104662|464340994|FG005|Overall Study|Reason not specified|1|||
129013106|NCT01104662|464340995|FG006|Overall Study|Reason not specified|0|||
129013107|NCT01104662|464340996|FG007|Overall Study|Reason not specified|0|||
129013108|NCT01104662|464340989|FG000|Overall Study|Randomized but not treated|3|||
129102204|NCT02757625|464670446|FG001|Overall Study|Adverse Event|0|||
129102205|NCT02757625|464670447|FG002|Overall Study|Adverse Event|1|||
129102206|NCT02757625|464670448|FG003|Overall Study|Adverse Event|0|||
129102207|NCT04854057|464670449|FG000|Overall Study|Adverse Event|0|||
129102208|NCT04854057|464670450|FG001|Overall Study|Adverse Event|1|||
129102209|NCT02131233|464670451|FG000|Overall Study|Not Treated|2|||
129102210|NCT02131233|464670452|FG001|Overall Study|Not Treated|3|||
129102211|NCT02131233|464670451|FG000|Overall Study|Adverse Event|7|||
129102212|NCT02131233|464670452|FG001|Overall Study|Adverse Event|6|||
129102213|NCT02131233|464670451|FG000|Overall Study|Death|0|||
129102214|NCT02131233|464670452|FG001|Overall Study|Death|1|||
129102215|NCT02131233|464670451|FG000|Overall Study|Lack of Efficacy|6|||
129102216|NCT02131233|464670452|FG001|Overall Study|Lack of Efficacy|3|||
129102217|NCT02131233|464670451|FG000|Overall Study|Lost to Follow-up|14|||
129102218|NCT02131233|464670452|FG001|Overall Study|Lost to Follow-up|13|||
129102219|NCT02131233|464670451|FG000|Overall Study|Non-Compliance With Study Drug|8|||
129102220|NCT02131233|464670452|FG001|Overall Study|Non-Compliance With Study Drug|5|||
129102221|NCT02131233|464670451|FG000|Overall Study|Physician Decision|7|||
129102222|NCT02131233|464670452|FG001|Overall Study|Physician Decision|0|||
129102223|NCT02131233|464670451|FG000|Overall Study|Pregnancy|4|||
129102224|NCT02131233|464670452|FG001|Overall Study|Pregnancy|0|||
129102225|NCT02131233|464670451|FG000|Overall Study|Withdrawal by Subject|18|||
129102226|NCT02131233|464670452|FG001|Overall Study|Withdrawal by Subject|11|||
129102227|NCT03519919|464670453|FG000|Overall Study|Withdrawal by Subject|1|||
129102228|NCT03519919|464670453|FG000|Overall Study|Lack of Efficacy|1|||
129102229|NCT03519919|464670453|FG000|Overall Study|Screen Failure|1|||
129102230|NCT05114564|464670454|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
129102231|NCT05114564|464670455|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
129102232|NCT05114564|464670454|FG000|First Intervention|Adverse Event|0|||
129102233|NCT05114564|464670455|FG001|First Intervention|Adverse Event|1|||
129102234|NCT00493311|464670456|FG000|Overall Study|Need for rescue medication|2|||
129102235|NCT00493311|464670457|FG001|Overall Study|Need for rescue medication|2|||
129102236|NCT02779075|464670458|FG000|Overall Study|Withdrawal by Subject|1|||
129102237|NCT02779075|464670459|FG001|Overall Study|Withdrawal by Subject|3|||
129102238|NCT02779075|464670458|FG000|Overall Study|IV lost during 2nd study|1|||
128679982|NCT04393298|463128278|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679983|NCT04393298|463128279|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679984|NCT04393298|463128280|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679985|NCT04393298|463128281|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
128679986|NCT04393298|463128267|FG000|Overall Study|Clinical Progression|0|||
128679987|NCT04393298|463128268|FG001|Overall Study|Clinical Progression|2|||
128679988|NCT04393298|463128269|FG002|Overall Study|Clinical Progression|0|||
128679989|NCT04393298|463128270|FG003|Overall Study|Clinical Progression|0|||
128679990|NCT04393298|463128271|FG004|Overall Study|Clinical Progression|0|||
128679991|NCT04393298|463128272|FG005|Overall Study|Clinical Progression|0|||
128679992|NCT04393298|463128273|FG006|Overall Study|Clinical Progression|0|||
128679993|NCT04393298|463128274|FG007|Overall Study|Clinical Progression|0|||
128679994|NCT04393298|463128275|FG008|Overall Study|Clinical Progression|0|||
128679995|NCT04393298|463128276|FG009|Overall Study|Clinical Progression|0|||
128679996|NCT04393298|463128277|FG010|Overall Study|Clinical Progression|0|||
128679997|NCT04393298|463128278|FG011|Overall Study|Clinical Progression|0|||
128679998|NCT04393298|463128279|FG012|Overall Study|Clinical Progression|0|||
128679999|NCT04393298|463128280|FG013|Overall Study|Clinical Progression|0|||
128680000|NCT04393298|463128281|FG014|Overall Study|Clinical Progression|0|||
128680001|NCT04393298|463128267|FG000|Overall Study|Disease Progression|0|||
128680002|NCT04393298|463128268|FG001|Overall Study|Disease Progression|1|||
128680003|NCT04393298|463128269|FG002|Overall Study|Disease Progression|0|||
128680004|NCT04393298|463128270|FG003|Overall Study|Disease Progression|0|||
128680005|NCT04393298|463128271|FG004|Overall Study|Disease Progression|0|||
128680006|NCT04393298|463128272|FG005|Overall Study|Disease Progression|3|||
128680007|NCT04393298|463128273|FG006|Overall Study|Disease Progression|2|||
128680008|NCT04393298|463128274|FG007|Overall Study|Disease Progression|1|||
128680009|NCT04393298|463128275|FG008|Overall Study|Disease Progression|2|||
128680010|NCT04393298|463128276|FG009|Overall Study|Disease Progression|1|||
128680011|NCT04393298|463128277|FG010|Overall Study|Disease Progression|0|||
128680012|NCT04393298|463128278|FG011|Overall Study|Disease Progression|3|||
129102239|NCT02779075|464670459|FG001|Overall Study|IV lost during 2nd study|0|||
129102240|NCT01951573|464670460|FG000|Washout Period|Adverse Event|0|||
129102241|NCT01951573|464670461|FG001|Washout Period|Adverse Event|1|||
128680013|NCT04393298|463128279|FG012|Overall Study|Disease Progression|0|||
128680014|NCT04393298|463128280|FG013|Overall Study|Disease Progression|0|||
128680015|NCT04393298|463128281|FG014|Overall Study|Disease Progression|1|||
128680016|NCT04393298|463128267|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680017|NCT04393298|463128268|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129102242|NCT00707980|464670462|FG000|Overall Study|Adverse Event|49|||
129102243|NCT00707980|464670462|FG000|Overall Study|Lack of Efficacy|35|||
128680018|NCT04393298|463128269|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
128680019|NCT04393298|463128270|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680020|NCT04393298|463128271|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680021|NCT04393298|463128272|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680022|NCT04393298|463128273|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129013109|NCT01104662|464340990|FG001|Overall Study|Randomized but not treated|4|||
129013110|NCT01104662|464340991|FG002|Overall Study|Randomized but not treated|1|||
129013111|NCT01104662|464340992|FG003|Overall Study|Randomized but not treated|0|||
129013112|NCT01104662|464340993|FG004|Overall Study|Randomized but not treated|0|||
129013113|NCT01104662|464340994|FG005|Overall Study|Randomized but not treated|1|||
129013114|NCT01104662|464340995|FG006|Overall Study|Randomized but not treated|0|||
129013115|NCT01104662|464340996|FG007|Overall Study|Randomized but not treated|0|||
129013116|NCT02079532|464340997|FG000|Overall Study|Adverse Event|7|||
129013117|NCT02079532|464340997|FG000|Overall Study|Additional or changed therapy|2|||
129013118|NCT02079532|464340997|FG000|Overall Study|Lack of Efficacy|9|||
129013119|NCT02079532|464340997|FG000|Overall Study|Protocol Violation|3|||
129013120|NCT02079532|464340997|FG000|Overall Study|Withdrawal by Subject|1|||
129013121|NCT02079532|464340997|FG000|Overall Study|Administrative problems|1|||
129013122|NCT02079532|464340997|FG000|Overall Study|Inclusion into ReFIRST|3|||
129013123|NCT02079532|464340997|FG000|Overall Study|Other|3|||
129013124|NCT02158936|464341000|FG000|Overall Study|Study closed/ terminated|57|||
129013125|NCT02158936|464341001|FG001|Overall Study|Study closed/ terminated|77|||
129013126|NCT02158936|464341000|FG000|Overall Study|Azacitidine tx discontinued|53|||
129013127|NCT02158936|464341001|FG001|Overall Study|Azacitidine tx discontinued|46|||
129013128|NCT02158936|464341000|FG000|Overall Study|Adverse Event|39|||
129013129|NCT02158936|464341001|FG001|Overall Study|Adverse Event|24|||
129013130|NCT02158936|464341000|FG000|Overall Study|Withdrawal by Subject|15|||
129013131|NCT02158936|464341001|FG001|Overall Study|Withdrawal by Subject|16|||
129013132|NCT02158936|464341000|FG000|Overall Study|Physician Decision|15|||
129013133|NCT02158936|464341001|FG001|Overall Study|Physician Decision|13|||
129013134|NCT02158936|464341000|FG000|Overall Study|Lost to Follow-up|0|||
129013135|NCT02158936|464341001|FG001|Overall Study|Lost to Follow-up|1|||
129013136|NCT01432171|464341002|FG000|Overall Study|Death|1|||
129013137|NCT01432171|464341003|FG001|Overall Study|Death|2|||
129013138|NCT01432171|464341002|FG000|Overall Study|Lost to Follow-up|6|||
129013139|NCT01432171|464341003|FG001|Overall Study|Lost to Follow-up|5|||
129013140|NCT01432171|464341002|FG000|Overall Study|Withdrawal by Subject|3|||
129013141|NCT01432171|464341003|FG001|Overall Study|Withdrawal by Subject|1|||
129013142|NCT01432171|464341002|FG000|Overall Study|Noncompliance|2|||
129013143|NCT01432171|464341003|FG001|Overall Study|Noncompliance|3|||
129013144|NCT01432171|464341002|FG000|Overall Study|Insurance denial trial coverage|1|||
129013145|NCT01432171|464341003|FG001|Overall Study|Insurance denial trial coverage|0|||
129013146|NCT01432171|464341002|FG000|Overall Study|Patient moved to palliative care|1|||
129013147|NCT01432171|464341003|FG001|Overall Study|Patient moved to palliative care|0|||
129013148|NCT01706926|464341004|FG000|Overall Study|Lost to Follow-up|0|||
129013149|NCT01706926|464341005|FG001|Overall Study|Lost to Follow-up|0|||
129013150|NCT01706926|464341006|FG002|Overall Study|Lost to Follow-up|1|||
129013151|NCT01706926|464341007|FG003|Overall Study|Lost to Follow-up|0|||
129013152|NCT01706926|464341004|FG000|Overall Study|Withdrawal by Subject|2|||
129013153|NCT01706926|464341005|FG001|Overall Study|Withdrawal by Subject|0|||
129013154|NCT01706926|464341006|FG002|Overall Study|Withdrawal by Subject|1|||
129013155|NCT01706926|464341007|FG003|Overall Study|Withdrawal by Subject|2|||
129013156|NCT01706926|464341004|FG000|Overall Study|Other|4|||
129013157|NCT01706926|464341005|FG001|Overall Study|Other|4|||
129013158|NCT01706926|464341006|FG002|Overall Study|Other|4|||
129013159|NCT01706926|464341007|FG003|Overall Study|Other|3|||
129013160|NCT03805438|464342623|FG000|Overall Study|Lack of Efficacy|1|||
129013161|NCT03805438|464342623|FG000|Overall Study|Protocol Violation|1|||
129013162|NCT00366899|464342624|FG000|Infant Series|Withdrawal by Subject|4|||
129013163|NCT00366899|464342625|FG001|Infant Series|Withdrawal by Subject|7|||
129013164|NCT00366899|464342624|FG000|Infant Series|Protocol Violation|2|||
129013165|NCT00366899|464342625|FG001|Infant Series|Protocol Violation|1|||
129013166|NCT00366899|464342624|FG000|Infant Series|Failed to return|1|||
129013167|NCT00366899|464342625|FG001|Infant Series|Failed to return|1|||
129013168|NCT00366899|464342624|FG000|Infant Series|Lost to Follow-up|0|||
129013169|NCT00366899|464342625|FG001|Infant Series|Lost to Follow-up|2|||
129013170|NCT00366899|464342624|FG000|Infant Series|Adverse Event|0|||
129013171|NCT00366899|464342625|FG001|Infant Series|Adverse Event|1|||
129013172|NCT00366899|464342624|FG000|Infant Series|Physician Decision|1|||
129013173|NCT00366899|464342625|FG001|Infant Series|Physician Decision|0|||
129013174|NCT00366899|464342624|FG000|Infant Series|Randomized but not consented|1|||
129013175|NCT00366899|464342625|FG001|Infant Series|Randomized but not consented|0|||
129013176|NCT00366899|464342624|FG000|After Infant Series|Lost to Follow-up|4|||
129013177|NCT00366899|464342625|FG001|After Infant Series|Lost to Follow-up|3|||
129013178|NCT00366899|464342624|FG000|After Infant Series|Withdrawal by Subject|1|||
129013179|NCT00366899|464342625|FG001|After Infant Series|Withdrawal by Subject|4|||
129013180|NCT00366899|464342624|FG000|After Infant Series|Adverse Event|1|||
129102244|NCT00707980|464670462|FG000|Overall Study|Non-Compliance with Study Drug|28|||
129102245|NCT00707980|464670462|FG000|Overall Study|Protocol Deviations|19|||
129102246|NCT00707980|464670462|FG000|Overall Study|Withdrawal of Consent|81|||
129102247|NCT00707980|464670462|FG000|Overall Study|Lost to Follow-up|59|||
129102248|NCT00707980|464670462|FG000|Overall Study|Other|39|||
129102249|NCT01909973|464670463|FG000|Overall Study|Lost to Follow-up|1|||
129102250|NCT01909973|464670464|FG001|Overall Study|Lost to Follow-up|0|||
129102251|NCT00460239|464670465|FG000|Overall Study|Physician Decision|0|||
129102252|NCT00460239|464670466|FG001|Overall Study|Physician Decision|1|||
129102253|NCT00460239|464670467|FG002|Overall Study|Physician Decision|0|||
129102254|NCT00460239|464670468|FG003|Overall Study|Physician Decision|0|||
129102255|NCT00460239|464670469|FG004|Overall Study|Physician Decision|0|||
129102256|NCT00460239|464670470|FG005|Overall Study|Physician Decision|2|||
129102257|NCT00460239|464670471|FG006|Overall Study|Physician Decision|0|||
129102258|NCT00460239|464670472|FG007|Overall Study|Physician Decision|0|||
129102259|NCT00460239|464670473|FG008|Overall Study|Physician Decision|0|||
129102260|NCT00460239|464670465|FG000|Overall Study|Withdrawal by Subject|0|||
129102261|NCT00460239|464670466|FG001|Overall Study|Withdrawal by Subject|0|||
129102262|NCT00460239|464670467|FG002|Overall Study|Withdrawal by Subject|0|||
129102263|NCT00460239|464670468|FG003|Overall Study|Withdrawal by Subject|0|||
129102264|NCT00460239|464670469|FG004|Overall Study|Withdrawal by Subject|0|||
129102265|NCT00460239|464670470|FG005|Overall Study|Withdrawal by Subject|1|||
129102266|NCT00460239|464670471|FG006|Overall Study|Withdrawal by Subject|0|||
129102267|NCT00460239|464670472|FG007|Overall Study|Withdrawal by Subject|0|||
129102268|NCT00460239|464670473|FG008|Overall Study|Withdrawal by Subject|0|||
129102269|NCT04217317|464670501|FG000|Overall Study|Lack of Efficacy|4|||
129102270|NCT04217317|464670501|FG000|Overall Study|Physician Decision|1|||
129102271|NCT04313400|464670505|FG000|Overall Study|Withdrawal by Subject|0|||
129102272|NCT04313400|464670506|FG001|Overall Study|Withdrawal by Subject|0|||
129102273|NCT04313400|464670507|FG002|Overall Study|Withdrawal by Subject|0|||
129102274|NCT04313400|464670508|FG003|Overall Study|Withdrawal by Subject|0|||
129102275|NCT04313400|464670509|FG004|Overall Study|Withdrawal by Subject|0|||
129102276|NCT04313400|464670510|FG005|Overall Study|Withdrawal by Subject|4|||
129102277|NCT04313400|464670511|FG006|Overall Study|Withdrawal by Subject|1|||
129102278|NCT04313400|464670505|FG000|Overall Study|Adverse Event|0|||
129102279|NCT04313400|464670506|FG001|Overall Study|Adverse Event|0|||
129102280|NCT04313400|464670507|FG002|Overall Study|Adverse Event|0|||
129102281|NCT04313400|464670508|FG003|Overall Study|Adverse Event|0|||
129102282|NCT04313400|464670509|FG004|Overall Study|Adverse Event|0|||
129102283|NCT04313400|464670510|FG005|Overall Study|Adverse Event|1|||
129102284|NCT04313400|464670511|FG006|Overall Study|Adverse Event|0|||
129102285|NCT04313400|464670505|FG000|Overall Study|Lost to Follow-up|0|||
129102286|NCT04313400|464670506|FG001|Overall Study|Lost to Follow-up|0|||
129102287|NCT04313400|464670507|FG002|Overall Study|Lost to Follow-up|0|||
129102288|NCT04313400|464670508|FG003|Overall Study|Lost to Follow-up|0|||
129102289|NCT04313400|464670509|FG004|Overall Study|Lost to Follow-up|0|||
128680023|NCT04393298|463128274|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680024|NCT04393298|463128275|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680025|NCT04393298|463128276|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680026|NCT04393298|463128277|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680027|NCT04393298|463128278|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680028|NCT04393298|463128279|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680029|NCT04393298|463128280|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680030|NCT04393298|463128281|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
128680031|NCT04393298|463128267|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680032|NCT04393298|463128268|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680033|NCT04393298|463128269|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
128680034|NCT04393298|463128270|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680035|NCT04393298|463128271|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680036|NCT04393298|463128272|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680037|NCT04393298|463128273|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680038|NCT04393298|463128274|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680039|NCT04393298|463128275|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680040|NCT04393298|463128276|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
129102290|NCT04313400|464670510|FG005|Overall Study|Lost to Follow-up|1|||
129102291|NCT04313400|464670511|FG006|Overall Study|Lost to Follow-up|0|||
129102292|NCT00359294|464670514|FG000|Overall Study|Progressive disease|1|||
129102293|NCT00359294|464670515|FG001|Overall Study|Progressive disease|1|||
129102294|NCT00359294|464670516|FG002|Overall Study|Progressive disease|2|||
129102295|NCT00359294|464670517|FG003|Overall Study|Progressive disease|3|||
129102296|NCT00359294|464670518|FG004|Overall Study|Progressive disease|2|||
129102297|NCT00359294|464670514|FG000|Overall Study|Withdrawal by Subject|0|||
129102298|NCT00359294|464670515|FG001|Overall Study|Withdrawal by Subject|0|||
129102299|NCT00359294|464670516|FG002|Overall Study|Withdrawal by Subject|0|||
128680041|NCT04393298|463128277|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680042|NCT04393298|463128278|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680043|NCT04393298|463128279|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680044|NCT04393298|463128280|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680045|NCT04393298|463128281|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
128680046|NCT04393298|463128267|FG000|Overall Study|Progressive Disease (PD)|0|||
128680047|NCT04393298|463128268|FG001|Overall Study|Progressive Disease (PD)|0|||
128680048|NCT04393298|463128269|FG002|Overall Study|Progressive Disease (PD)|0|||
128680049|NCT04393298|463128270|FG003|Overall Study|Progressive Disease (PD)|3|||
128680050|NCT04393298|463128271|FG004|Overall Study|Progressive Disease (PD)|0|||
128680051|NCT04393298|463128272|FG005|Overall Study|Progressive Disease (PD)|0|||
128680052|NCT04393298|463128273|FG006|Overall Study|Progressive Disease (PD)|0|||
128680053|NCT04393298|463128274|FG007|Overall Study|Progressive Disease (PD)|0|||
128680054|NCT04393298|463128275|FG008|Overall Study|Progressive Disease (PD)|0|||
129102300|NCT00359294|464670517|FG003|Overall Study|Withdrawal by Subject|0|||
129102301|NCT00359294|464670518|FG004|Overall Study|Withdrawal by Subject|1|||
129102302|NCT00359294|464670514|FG000|Overall Study|Not treated|0|||
128680055|NCT04393298|463128276|FG009|Overall Study|Progressive Disease (PD)|0|||
129013181|NCT00366899|464342625|FG001|After Infant Series|Adverse Event|2|||
129013182|NCT00366899|464342624|FG000|After Infant Series|Protocol Violation|1|||
129013183|NCT00366899|464342625|FG001|After Infant Series|Protocol Violation|0|||
129013184|NCT00366899|464342624|FG000|Toddler Dose|Withdrawal by Subject|1|||
129013185|NCT00366899|464342625|FG001|Toddler Dose|Withdrawal by Subject|1|||
129013186|NCT00366899|464342624|FG000|Toddler Dose|Protocol Violation|1|||
129013187|NCT00366899|464342625|FG001|Toddler Dose|Protocol Violation|0|||
129013188|NCT01619800|464342626|FG000|Overall Study|study terminated|2|||
129013189|NCT01619800|464342627|FG001|Overall Study|study terminated|0|||
129013190|NCT00416520|464342629|FG000|Open-label Period|Adverse Event|28|||
129013191|NCT00416520|464342630|FG001|Open-label Period|Adverse Event|10|||
129013192|NCT00416520|464342631|FG002|Open-label Period|Adverse Event|0|||
129013193|NCT00416520|464342632|FG003|Open-label Period|Adverse Event|0|||
129013194|NCT00416520|464342629|FG000|Open-label Period|Death|2|||
129013195|NCT00416520|464342630|FG001|Open-label Period|Death|1|||
129013196|NCT00416520|464342631|FG002|Open-label Period|Death|0|||
129013197|NCT00416520|464342632|FG003|Open-label Period|Death|0|||
129013198|NCT00416520|464342629|FG000|Open-label Period|Lack of Efficacy|8|||
129013199|NCT00416520|464342630|FG001|Open-label Period|Lack of Efficacy|1|||
129013200|NCT00416520|464342631|FG002|Open-label Period|Lack of Efficacy|0|||
129013201|NCT00416520|464342632|FG003|Open-label Period|Lack of Efficacy|0|||
129013202|NCT00416520|464342629|FG000|Open-label Period|Protocol Violation|3|||
129013203|NCT00416520|464342630|FG001|Open-label Period|Protocol Violation|3|||
129013204|NCT00416520|464342631|FG002|Open-label Period|Protocol Violation|0|||
129013205|NCT00416520|464342632|FG003|Open-label Period|Protocol Violation|0|||
129013206|NCT00416520|464342629|FG000|Open-label Period|Withdrawal by Subject|16|||
129013207|NCT00416520|464342630|FG001|Open-label Period|Withdrawal by Subject|5|||
129013208|NCT00416520|464342631|FG002|Open-label Period|Withdrawal by Subject|0|||
129013209|NCT00416520|464342632|FG003|Open-label Period|Withdrawal by Subject|0|||
129013210|NCT00416520|464342629|FG000|Open-label Period|Other Reasons|3|||
129013211|NCT00416520|464342630|FG001|Open-label Period|Other Reasons|12|||
129013212|NCT00416520|464342631|FG002|Open-label Period|Other Reasons|0|||
129013213|NCT00416520|464342632|FG003|Open-label Period|Other Reasons|0|||
129013214|NCT00416520|464342629|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
129013215|NCT00416520|464342630|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
129013216|NCT00416520|464342631|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
129013217|NCT00416520|464342632|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
129013218|NCT00416520|464342629|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
129013219|NCT00416520|464342630|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
129013220|NCT00416520|464342631|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
129013221|NCT00416520|464342632|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
129013222|NCT00416520|464342629|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
129013223|NCT00416520|464342630|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
129013224|NCT00416520|464342631|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
129013225|NCT00416520|464342632|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
129013226|NCT05628675|464342636|FG000|Overall Study|Lost to Follow-up|2|||
129013227|NCT05628675|464342636|FG000|Overall Study|Withdrawal by Subject|1|||
129013228|NCT01648166|464342640|FG000|Overall Study|inadequate toenail samples|53|||
129102303|NCT00359294|464670515|FG001|Overall Study|Not treated|0|||
128680056|NCT04393298|463128277|FG010|Overall Study|Progressive Disease (PD)|0|||
128680057|NCT04393298|463128278|FG011|Overall Study|Progressive Disease (PD)|0|||
129013229|NCT01648166|464342641|FG001|Overall Study|inadequate toenail samples|100|||
129013230|NCT00883090|464342642|FG000|Overall Study|Sponsor's decision|1|||
129013231|NCT00883090|464342642|FG000|Overall Study|Withdrawal by Subject|1|||
129013232|NCT02532764|464342643|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129013233|NCT02532764|464342644|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
128680058|NCT04393298|463128279|FG012|Overall Study|Progressive Disease (PD)|0|||
128680059|NCT04393298|463128280|FG013|Overall Study|Progressive Disease (PD)|0|||
128680060|NCT04393298|463128281|FG014|Overall Study|Progressive Disease (PD)|0|||
128680061|NCT04393298|463128267|FG000|Overall Study|Started a New Cancer Treatment|0|||
128680062|NCT04393298|463128268|FG001|Overall Study|Started a New Cancer Treatment|0|||
128680063|NCT04393298|463128269|FG002|Overall Study|Started a New Cancer Treatment|0|||
128680064|NCT04393298|463128270|FG003|Overall Study|Started a New Cancer Treatment|0|||
128680065|NCT04393298|463128271|FG004|Overall Study|Started a New Cancer Treatment|1|||
128680066|NCT04393298|463128272|FG005|Overall Study|Started a New Cancer Treatment|0|||
128680067|NCT04393298|463128273|FG006|Overall Study|Started a New Cancer Treatment|0|||
128680068|NCT04393298|463128274|FG007|Overall Study|Started a New Cancer Treatment|0|||
128680069|NCT04393298|463128275|FG008|Overall Study|Started a New Cancer Treatment|0|||
128680070|NCT04393298|463128276|FG009|Overall Study|Started a New Cancer Treatment|0|||
128680071|NCT04393298|463128277|FG010|Overall Study|Started a New Cancer Treatment|0|||
128680072|NCT04393298|463128278|FG011|Overall Study|Started a New Cancer Treatment|0|||
128680073|NCT04393298|463128279|FG012|Overall Study|Started a New Cancer Treatment|0|||
128680074|NCT04393298|463128280|FG013|Overall Study|Started a New Cancer Treatment|0|||
128680075|NCT04393298|463128281|FG014|Overall Study|Started a New Cancer Treatment|0|||
128680076|NCT04393298|463128267|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680077|NCT04393298|463128268|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680078|NCT04393298|463128269|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680079|NCT04393298|463128270|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680080|NCT04393298|463128271|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
128680081|NCT04393298|463128272|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680082|NCT04393298|463128273|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680083|NCT04393298|463128274|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680084|NCT04393298|463128275|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680085|NCT04393298|463128276|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680086|NCT04393298|463128277|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680087|NCT04393298|463128278|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680088|NCT04393298|463128279|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680089|NCT04393298|463128280|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680090|NCT04393298|463128281|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
128680091|NCT04393298|463128267|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680092|NCT04393298|463128268|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680093|NCT04393298|463128269|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680094|NCT04393298|463128270|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680095|NCT04393298|463128271|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129102304|NCT00359294|464670516|FG002|Overall Study|Not treated|0|||
129102305|NCT00359294|464670517|FG003|Overall Study|Not treated|1|||
129102306|NCT00359294|464670518|FG004|Overall Study|Not treated|0|||
129102307|NCT00359294|464670514|FG000|Overall Study|Physician Decision|0|||
129102308|NCT00359294|464670515|FG001|Overall Study|Physician Decision|0|||
129102309|NCT00359294|464670516|FG002|Overall Study|Physician Decision|1|||
129102310|NCT00359294|464670517|FG003|Overall Study|Physician Decision|0|||
129102311|NCT00359294|464670518|FG004|Overall Study|Physician Decision|0|||
129102312|NCT01808222|464670519|FG000|Overall Study|mpMR scan was not performed|1|||
129102313|NCT00524680|464670520|FG000|Overall Study|progression|0|||
129102314|NCT00524680|464670521|FG001|Overall Study|progression|0|||
129102315|NCT00524680|464670522|FG002|Overall Study|progression|0|||
129102316|NCT00524680|464670523|FG003|Overall Study|progression|1|||
129102317|NCT00524680|464670520|FG000|Overall Study|Adverse Event|2|||
129102318|NCT00524680|464670521|FG001|Overall Study|Adverse Event|0|||
129102319|NCT00524680|464670522|FG002|Overall Study|Adverse Event|0|||
129102320|NCT00524680|464670523|FG003|Overall Study|Adverse Event|1|||
129102321|NCT00524680|464670520|FG000|Overall Study|Other|0|||
129102322|NCT00524680|464670521|FG001|Overall Study|Other|1|||
129102323|NCT00524680|464670522|FG002|Overall Study|Other|2|||
129102324|NCT00524680|464670523|FG003|Overall Study|Other|3|||
129102325|NCT00524680|464670520|FG000|Overall Study|Withdrawal by Subject|1|||
129102326|NCT00524680|464670521|FG001|Overall Study|Withdrawal by Subject|0|||
129102327|NCT00524680|464670522|FG002|Overall Study|Withdrawal by Subject|1|||
129102328|NCT00524680|464670523|FG003|Overall Study|Withdrawal by Subject|1|||
128680096|NCT04393298|463128272|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
128680097|NCT04393298|463128273|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129102329|NCT03124537|464670524|FG000|Overall Study|Lost to Follow-up|3|||
129102330|NCT03124537|464670525|FG001|Overall Study|Lost to Follow-up|5|||
129102331|NCT03124537|464670524|FG000|Overall Study|App Crash, Incomplete Data|7|||
129102332|NCT03124537|464670525|FG001|Overall Study|App Crash, Incomplete Data|8|||
129102333|NCT03681184|464670526|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
129102334|NCT03681184|464670527|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
129102335|NCT01607346|464670530|FG000|Overall Study|Adverse Event|3|||
129102336|NCT01098162|464670531|FG000|Overall Study|Adverse Event|37|||
128680098|NCT04393298|463128274|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680099|NCT04393298|463128275|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680100|NCT04393298|463128276|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680101|NCT04393298|463128277|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680102|NCT04393298|463128278|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680103|NCT04393298|463128279|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680104|NCT04393298|463128280|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680105|NCT04393298|463128281|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
128680106|NCT04393298|463128267|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680107|NCT04393298|463128268|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680108|NCT04393298|463128269|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680109|NCT04393298|463128270|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680110|NCT04393298|463128271|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680111|NCT04393298|463128272|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
128680112|NCT04393298|463128273|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680113|NCT04393298|463128274|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680114|NCT04393298|463128275|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129013234|NCT02532764|464342645|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129013235|NCT02532764|464342646|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129013236|NCT02532764|464342647|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129013237|NCT02532764|464342648|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129013238|NCT02532764|464342649|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129013239|NCT02532764|464342650|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
129013240|NCT02532764|464342651|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
129013241|NCT02532764|464342652|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
129013242|NCT03527745|464342653|FG000|Overall Study|Lost to Follow-up|3|||
129013243|NCT03527745|464342654|FG001|Overall Study|Lost to Follow-up|6|||
129013244|NCT03527745|464342655|FG002|Overall Study|Lost to Follow-up|7|||
129013245|NCT03527745|464342656|FG003|Overall Study|Lost to Follow-up|9|||
129013246|NCT03527745|464342657|FG004|Overall Study|Lost to Follow-up|0|||
129013247|NCT03527745|464342658|FG005|Overall Study|Lost to Follow-up|2|||
129013248|NCT03527745|464342659|FG006|Overall Study|Lost to Follow-up|3|||
129013249|NCT03527745|464342660|FG007|Overall Study|Lost to Follow-up|2|||
129013250|NCT03527745|464342661|FG008|Overall Study|Lost to Follow-up|3|||
129013251|NCT03527745|464342662|FG009|Overall Study|Lost to Follow-up|2|||
129013252|NCT03527745|464342663|FG010|Overall Study|Lost to Follow-up|1|||
129013253|NCT03527745|464342664|FG011|Overall Study|Lost to Follow-up|1|||
129013254|NCT03527745|464342665|FG012|Overall Study|Lost to Follow-up|0|||
129013255|NCT03527745|464342666|FG013|Overall Study|Lost to Follow-up|0|||
129013256|NCT03527745|464342667|FG014|Overall Study|Lost to Follow-up|0|||
129013257|NCT03527745|464342668|FG015|Overall Study|Lost to Follow-up|0|||
129013258|NCT03527745|464342669|FG016|Overall Study|Lost to Follow-up|1|||
129013259|NCT03527745|464342670|FG017|Overall Study|Lost to Follow-up|0|||
129013260|NCT03527745|464342671|FG018|Overall Study|Lost to Follow-up|0|||
129013261|NCT03527745|464342672|FG019|Overall Study|Lost to Follow-up|1|||
129013262|NCT03527745|464342673|FG020|Overall Study|Lost to Follow-up|1|||
129013263|NCT03527745|464342674|FG021|Overall Study|Lost to Follow-up|5|||
129013264|NCT03527745|464342675|FG022|Overall Study|Lost to Follow-up|6|||
129013265|NCT03527745|464342676|FG023|Overall Study|Lost to Follow-up|8|||
129013266|NCT03527745|464342677|FG024|Overall Study|Lost to Follow-up|1|||
129013267|NCT03527745|464342678|FG025|Overall Study|Lost to Follow-up|3|||
129013268|NCT01475838|464342681|FG000|Randomized Phase|Randomized but Not Treated|0|||
129013269|NCT01475838|464342682|FG001|Randomized Phase|Randomized but Not Treated|5|||
129013270|NCT01475838|464342681|FG000|Randomized Phase|Adverse Event|6|||
129013271|NCT01475838|464342682|FG001|Randomized Phase|Adverse Event|1|||
129013272|NCT01475838|464342681|FG000|Randomized Phase|Pregnancy|0|||
129013273|NCT01475838|464342682|FG001|Randomized Phase|Pregnancy|1|||
129013274|NCT01475838|464342681|FG000|Randomized Phase|Investigators Discretion|1|||
129013275|NCT01475838|464342682|FG001|Randomized Phase|Investigators Discretion|2|||
129013276|NCT01475838|464342681|FG000|Randomized Phase|Withdrew Consent|10|||
129013277|NCT01475838|464342682|FG001|Randomized Phase|Withdrew Consent|14|||
129013278|NCT01475838|464342681|FG000|Randomized Phase|Lost to Follow-up|3|||
129013279|NCT01475838|464342682|FG001|Randomized Phase|Lost to Follow-up|4|||
129013280|NCT01475838|464342681|FG000|Randomized Phase|Participant Noncompliance|1|||
129013281|NCT01475838|464342682|FG001|Randomized Phase|Participant Noncompliance|5|||
129013282|NCT01475838|464342681|FG000|Randomized Phase|Protocol Violation|9|||
129013283|NCT01475838|464342682|FG001|Randomized Phase|Protocol Violation|4|||
129013284|NCT01475838|464342681|FG000|Extension Phase|Participant Noncompliance|1|||
129013285|NCT01475838|464342682|FG001|Extension Phase|Participant Noncompliance|0|||
129013286|NCT00048568|464342683|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
129013287|NCT00048568|464342684|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
129013288|NCT00048568|464342685|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
129102337|NCT01098162|464670531|FG000|Overall Study|Lack of Efficacy|4|||
129102338|NCT01098162|464670531|FG000|Overall Study|Wish of Patient|7|||
129102339|NCT01098162|464670531|FG000|Overall Study|Lost to Follow-up|9|||
129102340|NCT01098162|464670531|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
129102341|NCT01098162|464670531|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
129102342|NCT01098162|464670531|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
129102343|NCT01098162|464670531|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
129102344|NCT01098162|464670531|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
129102345|NCT01098162|464670531|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
129102346|NCT01098162|464670531|FG000|Overall Study|Other Reason|1|||
129102347|NCT01098162|464670531|FG000|Overall Study|Reason Unknown|26|||
129102348|NCT00625183|464670532|FG000|Overall Study|Disease Progression|1|||
129102349|NCT04318132|464670533|FG000|Overall Study|Protocol Violation|0|||
129102350|NCT04318132|464670534|FG001|Overall Study|Protocol Violation|0|||
129102351|NCT04318132|464670535|FG002|Overall Study|Protocol Violation|3|||
129102352|NCT04318132|464670536|FG003|Overall Study|Protocol Violation|0|||
129102353|NCT04424914|464670537|FG000|Overall Study|Other|0|||
129102354|NCT04424914|464670538|FG001|Overall Study|Other|0|||
129102355|NCT04424914|464670539|FG002|Overall Study|Other|28|||
129102356|NCT04424914|464670537|FG000|Overall Study|Withdrawal by Subject|3|||
129102357|NCT04424914|464670538|FG001|Overall Study|Withdrawal by Subject|0|||
129102358|NCT04424914|464670539|FG002|Overall Study|Withdrawal by Subject|0|||
129102359|NCT04424914|464670537|FG000|Overall Study|Study terminated by sponsor|23|||
129102360|NCT04424914|464670538|FG001|Overall Study|Study terminated by sponsor|7|||
129102361|NCT04424914|464670539|FG002|Overall Study|Study terminated by sponsor|0|||
129102362|NCT04424914|464670537|FG000|Overall Study|Lost to Follow-up|0|||
129102363|NCT04424914|464670538|FG001|Overall Study|Lost to Follow-up|0|||
129102364|NCT04424914|464670539|FG002|Overall Study|Lost to Follow-up|1|||
129102365|NCT04424914|464670537|FG000|Overall Study|Death|3|||
129102366|NCT04424914|464670538|FG001|Overall Study|Death|1|||
129102367|NCT04424914|464670539|FG002|Overall Study|Death|0|||
129102368|NCT01778751|464670544|FG000|Overall Study|Lost to Follow-up|1|||
129102369|NCT01778751|464670545|FG001|Overall Study|Lost to Follow-up|0|||
129102370|NCT01778751|464670544|FG000|Overall Study|Withdrawal by Subject|0|||
129102371|NCT01778751|464670545|FG001|Overall Study|Withdrawal by Subject|2|||
129102372|NCT01778751|464670544|FG000|Overall Study|Transfered care|1|||
129102373|NCT01778751|464670545|FG001|Overall Study|Transfered care|0|||
129102374|NCT03628716|464670549|FG000|Overall Study|Adverse Event|1|||
129102375|NCT03628716|464670550|FG001|Overall Study|Adverse Event|1|||
129102376|NCT03628716|464670549|FG000|Overall Study|Death|1|||
129102377|NCT03628716|464670550|FG001|Overall Study|Death|0|||
129102378|NCT03628716|464670549|FG000|Overall Study|Lack of Efficacy|15|||
129102379|NCT03628716|464670550|FG001|Overall Study|Lack of Efficacy|20|||
129102380|NCT03628716|464670549|FG000|Overall Study|Withdrawal by Subject|1|||
129102381|NCT03628716|464670550|FG001|Overall Study|Withdrawal by Subject|2|||
129102382|NCT03628716|464670549|FG000|Overall Study|Study Terminated by Sponsor|1|||
129102383|NCT03628716|464670550|FG001|Overall Study|Study Terminated by Sponsor|0|||
129102384|NCT00856843|464670551|FG000|Overall Study|Withdrawal by Subject|1|||
129102385|NCT00856843|464670552|FG001|Overall Study|Withdrawal by Subject|5|||
128680115|NCT04393298|463128276|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129102386|NCT00856843|464670551|FG000|Overall Study|Lack of Efficacy|1|||
129102387|NCT00856843|464670552|FG001|Overall Study|Lack of Efficacy|0|||
129102388|NCT01573754|464670553|FG000|Overall Study|Noncompliance or remission not achieved|3|||
129102389|NCT01573754|464670554|FG001|Overall Study|Noncompliance or remission not achieved|15|||
128680116|NCT04393298|463128277|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680117|NCT04393298|463128278|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680118|NCT04393298|463128279|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129102390|NCT00829829|464670558|FG000|Overall Study|Protocol Violation|0|||
129102391|NCT00829829|464670559|FG001|Overall Study|Protocol Violation|3|||
129102392|NCT00829829|464670560|FG002|Overall Study|Protocol Violation|0|||
129102393|NCT00829829|464670558|FG000|Overall Study|Adverse Event|4|||
129102394|NCT00829829|464670559|FG001|Overall Study|Adverse Event|4|||
128680119|NCT04393298|463128280|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
128680120|NCT04393298|463128281|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
128680121|NCT04393298|463128267|FG000|Overall Study|Death|0|||
129102395|NCT00829829|464670560|FG002|Overall Study|Adverse Event|3|||
129102396|NCT00829829|464670558|FG000|Overall Study|Withdrawal by Subject|8|||
129102397|NCT00829829|464670559|FG001|Overall Study|Withdrawal by Subject|4|||
129102398|NCT00829829|464670560|FG002|Overall Study|Withdrawal by Subject|2|||
129102399|NCT00829829|464670558|FG000|Overall Study|Decision by the Sponsor|1|||
129102400|NCT00829829|464670559|FG001|Overall Study|Decision by the Sponsor|0|||
128680122|NCT04393298|463128268|FG001|Overall Study|Death|0|||
128680123|NCT04393298|463128269|FG002|Overall Study|Death|0|||
129102401|NCT00829829|464670560|FG002|Overall Study|Decision by the Sponsor|2|||
129102402|NCT00829829|464670558|FG000|Overall Study|Lost to Follow-up|7|||
129102403|NCT00829829|464670559|FG001|Overall Study|Lost to Follow-up|3|||
129102404|NCT00829829|464670560|FG002|Overall Study|Lost to Follow-up|3|||
129013289|NCT00048568|464342683|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
129013290|NCT00048568|464342684|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
129013291|NCT00048568|464342685|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
129013292|NCT00048568|464342683|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
129013293|NCT00048568|464342684|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
129013294|NCT00048568|464342685|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
129013295|NCT00048568|464342683|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
129013296|NCT00048568|464342684|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
129013297|NCT00048568|464342685|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
129013298|NCT00048568|464342683|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
129013299|NCT00048568|464342684|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
129013300|NCT00048568|464342685|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
129013301|NCT00048568|464342683|FG000|Double-Blind Period Days 170 to 365|Death|1|||
129013302|NCT00048568|464342684|FG001|Double-Blind Period Days 170 to 365|Death|1|||
129013303|NCT00048568|464342685|FG002|Double-Blind Period Days 170 to 365|Death|0|||
129013304|NCT00048568|464342683|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
129013305|NCT00048568|464342684|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
129013306|NCT00048568|464342685|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
129013307|NCT00048568|464342683|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
129013308|NCT00048568|464342684|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
129013309|NCT00048568|464342685|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
129013310|NCT00048568|464342683|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
129013311|NCT00048568|464342684|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
129013312|NCT00048568|464342685|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
129013313|NCT00048568|464342683|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
129013314|NCT00048568|464342684|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
129013315|NCT00048568|464342685|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
129013316|NCT00048568|464342683|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
129013317|NCT00048568|464342684|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
129013318|NCT00048568|464342685|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
129013319|NCT00048568|464342683|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
129013320|NCT00048568|464342684|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
129013321|NCT00048568|464342685|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
129013322|NCT00048568|464342683|FG000|Open-Label Period|Death|0|||
129013323|NCT00048568|464342684|FG001|Open-Label Period|Death|0|||
129013324|NCT00048568|464342685|FG002|Open-Label Period|Death|13|||
129013325|NCT00048568|464342683|FG000|Open-Label Period|Adverse Event|0|||
129013326|NCT00048568|464342684|FG001|Open-Label Period|Adverse Event|0|||
129013327|NCT00048568|464342685|FG002|Open-Label Period|Adverse Event|49|||
129013328|NCT00048568|464342683|FG000|Open-Label Period|Lack of Efficacy|0|||
129013329|NCT00048568|464342684|FG001|Open-Label Period|Lack of Efficacy|0|||
129013330|NCT00048568|464342685|FG002|Open-Label Period|Lack of Efficacy|32|||
129013331|NCT00048568|464342683|FG000|Open-Label Period|Withdrawal by Subject|0|||
129013332|NCT00048568|464342684|FG001|Open-Label Period|Withdrawal by Subject|0|||
129013333|NCT00048568|464342685|FG002|Open-Label Period|Withdrawal by Subject|26|||
129013334|NCT00048568|464342683|FG000|Open-Label Period|Pregnancy|0|||
129013335|NCT00048568|464342684|FG001|Open-Label Period|Pregnancy|0|||
129013336|NCT00048568|464342685|FG002|Open-Label Period|Pregnancy|5|||
129013337|NCT00048568|464342683|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
129013338|NCT00048568|464342684|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
129013339|NCT00048568|464342685|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
129013340|NCT00048568|464342683|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
129013341|NCT00048568|464342684|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
129013342|NCT00048568|464342685|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
129013343|NCT00048568|464342683|FG000|Open-Label Period|Unknown Reasons|0|||
129013344|NCT00048568|464342684|FG001|Open-Label Period|Unknown Reasons|0|||
129013345|NCT00048568|464342685|FG002|Open-Label Period|Unknown Reasons|25|||
129013346|NCT00048568|464342683|FG000|Open-Label Period|Lost to Follow-up|0|||
129013347|NCT00048568|464342684|FG001|Open-Label Period|Lost to Follow-up|0|||
129013348|NCT00048568|464342685|FG002|Open-Label Period|Lost to Follow-up|7|||
129013349|NCT01717976|464342686|FG000|Overall Study|Protocol Violation|0|||
129013350|NCT01717976|464342687|FG001|Overall Study|Protocol Violation|1|||
128680124|NCT04393298|463128270|FG003|Overall Study|Death|0|||
128680125|NCT04393298|463128271|FG004|Overall Study|Death|0|||
128680126|NCT04393298|463128272|FG005|Overall Study|Death|1|||
128680127|NCT04393298|463128273|FG006|Overall Study|Death|1|||
128680128|NCT04393298|463128274|FG007|Overall Study|Death|0|||
129013351|NCT03831048|464342688|FG000|Overall Study|Protocol Violation|9|||
129013352|NCT03831048|464342689|FG001|Overall Study|Protocol Violation|3|||
129013353|NCT03831048|464342688|FG000|Overall Study|Death|4|||
129013354|NCT03831048|464342689|FG001|Overall Study|Death|9|||
129013355|NCT03831048|464342688|FG000|Overall Study|Re-transplant|0|||
128680129|NCT04393298|463128275|FG008|Overall Study|Death|1|||
129102405|NCT00829829|464670558|FG000|Overall Study|Other than specified above|2|||
129102406|NCT00829829|464670559|FG001|Overall Study|Other than specified above|2|||
129102407|NCT00829829|464670560|FG002|Overall Study|Other than specified above|1|||
129102408|NCT02685072|464670561|FG000|Treatment Period|Lost to Follow-up|12|||
129102409|NCT02685072|464670562|FG001|Treatment Period|Lost to Follow-up|6|||
129102410|NCT02685072|464670561|FG000|Treatment Period|Withdrawal by Subject|1|||
129102411|NCT02685072|464670562|FG001|Treatment Period|Withdrawal by Subject|3|||
129102412|NCT02685072|464670561|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
129102413|NCT02685072|464670562|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
129102414|NCT01994902|464670563|FG000|Test Period 1|Withdrawal by Subject|3|||
129102415|NCT01994902|464670564|FG001|Test Period 1|Withdrawal by Subject|0|||
129102416|NCT01994902|464670563|FG000|Test Period 1|device deficiency with adverse event|0|||
129102417|NCT01994902|464670564|FG001|Test Period 1|device deficiency with adverse event|1|||
129102418|NCT01994902|464670563|FG000|Test Period 1|Adverse Event|2|||
129102419|NCT01994902|464670564|FG001|Test Period 1|Adverse Event|1|||
129102420|NCT01994902|464670563|FG000|Test Period 1|Lack of Efficacy|0|||
129102421|NCT01994902|464670564|FG001|Test Period 1|Lack of Efficacy|1|||
129102422|NCT01994902|464670563|FG000|Test Period 1|bag too small|1|||
129102423|NCT01994902|464670564|FG001|Test Period 1|bag too small|0|||
129102424|NCT01994902|464670563|FG000|Test Period 2|Withdrawal by Subject|0|||
129102425|NCT01994902|464670564|FG001|Test Period 2|Withdrawal by Subject|2|||
129102426|NCT01994902|464670563|FG000|Test Period 2|Lack of Efficacy|0|||
129102427|NCT01994902|464670564|FG001|Test Period 2|Lack of Efficacy|1|||
129102428|NCT01994902|464670563|FG000|Test Period 2|Other|0|||
129102429|NCT01994902|464670564|FG001|Test Period 2|Other|3|||
129102430|NCT02634710|464670565|FG000|Overall Study|Death|4|||
129102431|NCT00528372|464670566|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
129102432|NCT00528372|464670567|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102433|NCT00528372|464670568|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102434|NCT00528372|464670569|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102435|NCT00528372|464670570|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102436|NCT00528372|464670571|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102437|NCT00528372|464670572|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102438|NCT00528372|464670573|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102439|NCT00528372|464670574|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129102440|NCT00528372|464670566|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129102441|NCT00528372|464670567|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
129102442|NCT00528372|464670568|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
129102443|NCT00528372|464670569|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
129102444|NCT00528372|464670570|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129102445|NCT00528372|464670571|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
129102446|NCT00528372|464670572|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
129102447|NCT00528372|464670573|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129102448|NCT00528372|464670574|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129102449|NCT00528372|464670566|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
129102450|NCT00528372|464670567|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
129102451|NCT00528372|464670568|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
129102452|NCT00528372|464670569|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
129102453|NCT00528372|464670570|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
129102454|NCT00528372|464670571|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
129102455|NCT00528372|464670572|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
129102456|NCT00528372|464670573|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
129102457|NCT00528372|464670574|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
129102458|NCT00528372|464670566|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
129102459|NCT00528372|464670567|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
129102460|NCT00528372|464670568|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
129102461|NCT00528372|464670569|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
129102462|NCT00528372|464670570|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
129102463|NCT00528372|464670571|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
129102464|NCT00528372|464670572|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
129102465|NCT00528372|464670573|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
129102466|NCT00528372|464670574|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
129102467|NCT00528372|464670566|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129102468|NCT00528372|464670567|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129102469|NCT00528372|464670568|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129102470|NCT00528372|464670569|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
129102471|NCT00528372|464670570|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129102472|NCT00528372|464670571|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
128680130|NCT04393298|463128276|FG009|Overall Study|Death|1|||
129102473|NCT00528372|464670572|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129102474|NCT00528372|464670573|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129102475|NCT00528372|464670574|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129102476|NCT00528372|464670566|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
129102477|NCT00528372|464670567|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129102478|NCT00528372|464670568|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
129102479|NCT00528372|464670569|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129102480|NCT00528372|464670570|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129102481|NCT00528372|464670571|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
129102482|NCT00528372|464670572|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129102483|NCT00528372|464670573|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129102484|NCT00528372|464670574|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129102485|NCT00528372|464670566|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
129102486|NCT00528372|464670567|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129102487|NCT00528372|464670568|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129102488|NCT00528372|464670569|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
129102489|NCT00528372|464670570|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
128680131|NCT04393298|463128277|FG010|Overall Study|Death|0|||
128680132|NCT04393298|463128278|FG011|Overall Study|Death|1|||
128680133|NCT04393298|463128279|FG012|Overall Study|Death|1|||
129102490|NCT00528372|464670571|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129102491|NCT00528372|464670572|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129102492|NCT00528372|464670573|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
129102493|NCT00528372|464670574|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129102494|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
129102495|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
129102496|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
129102497|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
129102498|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
129102499|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
129102500|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
129102501|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
129102502|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
129102503|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
129102504|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
129102505|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
129102506|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
129102507|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
129102508|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
129102509|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
129102510|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
129102511|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
129102512|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
129102513|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
129102514|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
129102515|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
129102516|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
129102517|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
129102518|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
129102519|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
129102520|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
129102521|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
129102522|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
129102523|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
129102524|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
129102525|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
129102526|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
129102527|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
129102528|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
129102529|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
128680134|NCT04393298|463128280|FG013|Overall Study|Death|0|||
128680135|NCT04393298|463128281|FG014|Overall Study|Death|1|||
128680136|NCT04393298|463128267|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129102530|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
128680137|NCT04393298|463128268|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680138|NCT04393298|463128269|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680139|NCT04393298|463128270|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680140|NCT04393298|463128271|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680141|NCT04393298|463128272|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
128680142|NCT04393298|463128273|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680143|NCT04393298|463128274|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680144|NCT04393298|463128275|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680145|NCT04393298|463128276|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680146|NCT04393298|463128277|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680147|NCT04393298|463128278|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680148|NCT04393298|463128279|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129013356|NCT03831048|464342689|FG001|Overall Study|Re-transplant|2|||
129013357|NCT03831048|464342688|FG000|Overall Study|Protocol violation and death|1|||
129013358|NCT03831048|464342689|FG001|Overall Study|Protocol violation and death|1|||
129013359|NCT00560235|464342693|FG000|Phase 1|Discontinued|8|||
129013360|NCT00560235|464342694|FG001|Phase 1|Discontinued|0|||
129013361|NCT00560235|464342695|FG002|Phase 1|Discontinued|0|||
129013362|NCT00560235|464342693|FG000|Phase 1B|Discontinued|0|||
129013363|NCT00560235|464342694|FG001|Phase 1B|Discontinued|19|||
129013364|NCT00560235|464342695|FG002|Phase 1B|Discontinued|0|||
129013365|NCT00560235|464342693|FG000|Phase 2|Discontinued|0|||
129013366|NCT00560235|464342694|FG001|Phase 2|Discontinued|0|||
129013367|NCT00560235|464342695|FG002|Phase 2|Discontinued|96|||
129013368|NCT00560235|464342693|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
129013369|NCT00560235|464342694|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
129013370|NCT00560235|464342695|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
129013371|NCT01315249|464342698|FG000|Overall Study|Adverse Event|22|||
129013372|NCT01315249|464342699|FG001|Overall Study|Adverse Event|26|||
129013373|NCT01315249|464342698|FG000|Overall Study|Withdrawal by Subject|11|||
129013374|NCT01315249|464342699|FG001|Overall Study|Withdrawal by Subject|10|||
129013375|NCT01315249|464342698|FG000|Overall Study|Protocol Violation|8|||
129013376|NCT01315249|464342699|FG001|Overall Study|Protocol Violation|5|||
129013377|NCT01315249|464342698|FG000|Overall Study|Abnormal test results|1|||
129013378|NCT01315249|464342699|FG001|Overall Study|Abnormal test results|2|||
129013379|NCT01315249|464342698|FG000|Overall Study|Administrative problems|1|||
129013380|NCT01315249|464342699|FG001|Overall Study|Administrative problems|0|||
129013381|NCT01315249|464342698|FG000|Overall Study|inability to use device|1|||
129013382|NCT01315249|464342699|FG001|Overall Study|inability to use device|0|||
129013383|NCT01315249|464342698|FG000|Overall Study|Lack of Efficacy|0|||
129013384|NCT01315249|464342699|FG001|Overall Study|Lack of Efficacy|1|||
129013385|NCT01315249|464342698|FG000|Overall Study|Lost to Follow-up|0|||
129013386|NCT01315249|464342699|FG001|Overall Study|Lost to Follow-up|2|||
129013387|NCT01315249|464342698|FG000|Overall Study|Death|0|||
129013388|NCT01315249|464342699|FG001|Overall Study|Death|1|||
129013389|NCT00864097|464342720|FG000|Overall Study|Death|0|||
129013390|NCT00864097|464342721|FG001|Overall Study|Death|1|||
129013391|NCT00864097|464342722|FG002|Overall Study|Death|0|||
129013392|NCT00864097|464342723|FG003|Overall Study|Death|0|||
129013393|NCT00864097|464342720|FG000|Overall Study|Adverse Event|6|||
129013394|NCT00864097|464342721|FG001|Overall Study|Adverse Event|8|||
129013395|NCT00864097|464342722|FG002|Overall Study|Adverse Event|11|||
129013396|NCT00864097|464342723|FG003|Overall Study|Adverse Event|9|||
129013397|NCT00864097|464342720|FG000|Overall Study|Lack of Efficacy|9|||
129013398|NCT00864097|464342721|FG001|Overall Study|Lack of Efficacy|3|||
129013399|NCT00864097|464342722|FG002|Overall Study|Lack of Efficacy|7|||
129013400|NCT00864097|464342723|FG003|Overall Study|Lack of Efficacy|2|||
129013401|NCT00864097|464342720|FG000|Overall Study|Lost to Follow-up|0|||
129013402|NCT00864097|464342721|FG001|Overall Study|Lost to Follow-up|1|||
129013403|NCT00864097|464342722|FG002|Overall Study|Lost to Follow-up|0|||
129013404|NCT00864097|464342723|FG003|Overall Study|Lost to Follow-up|1|||
129013405|NCT00864097|464342720|FG000|Overall Study|Withdrawal by Subject|15|||
129013406|NCT00864097|464342721|FG001|Overall Study|Withdrawal by Subject|11|||
128879622|NCT01016977|463854895|FG001|Overall Study|Lost to Follow-up|0|||
129013407|NCT00864097|464342722|FG002|Overall Study|Withdrawal by Subject|11|||
129013408|NCT00864097|464342723|FG003|Overall Study|Withdrawal by Subject|12|||
129013409|NCT00864097|464342720|FG000|Overall Study|Protocol Violation|2|||
129013410|NCT00864097|464342721|FG001|Overall Study|Protocol Violation|1|||
129013411|NCT00864097|464342722|FG002|Overall Study|Protocol Violation|0|||
129013412|NCT00864097|464342723|FG003|Overall Study|Protocol Violation|1|||
129013413|NCT00864097|464342720|FG000|Overall Study|Terminated by sponsor|105|||
129013414|NCT00864097|464342721|FG001|Overall Study|Terminated by sponsor|112|||
129013415|NCT00864097|464342722|FG002|Overall Study|Terminated by sponsor|102|||
129013416|NCT00864097|464342723|FG003|Overall Study|Terminated by sponsor|99|||
129013417|NCT00864097|464342720|FG000|Overall Study|Randomized but not treated|2|||
129013418|NCT00864097|464342721|FG001|Overall Study|Randomized but not treated|0|||
129013419|NCT00864097|464342722|FG002|Overall Study|Randomized but not treated|1|||
129102531|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129102532|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129102533|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129102534|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129102535|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129102536|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129102537|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129102538|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129102539|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129102540|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129102541|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129102542|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129102543|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
129102544|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
129102545|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129102546|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129102547|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129102548|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129102549|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
129102550|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129102551|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129102552|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129102553|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129102554|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
129102555|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129102556|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
129102557|NCT00528372|464670566|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
129102558|NCT00528372|464670567|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
129102559|NCT00528372|464670568|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
129102560|NCT00528372|464670569|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
129102561|NCT00528372|464670570|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
129102562|NCT00528372|464670571|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
129102563|NCT00528372|464670572|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
129102564|NCT00528372|464670573|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
129102565|NCT00528372|464670574|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
129102566|NCT03275389|464670580|FG000|Overall Study|Lost to Follow-up|10|||
129102567|NCT03275389|464670581|FG001|Overall Study|Lost to Follow-up|10|||
129102568|NCT03275389|464670582|FG002|Overall Study|Lost to Follow-up|19|||
129102569|NCT03275389|464670583|FG003|Overall Study|Lost to Follow-up|12|||
129102570|NCT03275389|464670584|FG004|Overall Study|Lost to Follow-up|11|||
129102571|NCT03275389|464670585|FG005|Overall Study|Lost to Follow-up|12|||
129102572|NCT03275389|464670586|FG006|Overall Study|Lost to Follow-up|21|||
129102573|NCT03275389|464670587|FG007|Overall Study|Lost to Follow-up|15|||
129102574|NCT03275389|464670588|FG008|Overall Study|Lost to Follow-up|12|||
129102575|NCT03275389|464670589|FG009|Overall Study|Lost to Follow-up|14|||
129102576|NCT03275389|464670580|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129102577|NCT03275389|464670581|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129102578|NCT03275389|464670582|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129102579|NCT03275389|464670583|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129102580|NCT03275389|464670584|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129102581|NCT03275389|464670585|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
129102582|NCT03275389|464670586|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129102583|NCT03275389|464670587|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129102584|NCT03275389|464670588|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
128680149|NCT04393298|463128280|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680150|NCT04393298|463128281|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
128680151|NCT04393298|463128267|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
128680152|NCT04393298|463128268|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
128680153|NCT04393298|463128269|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
128680154|NCT04393298|463128270|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
128680155|NCT04393298|463128271|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
128680156|NCT04393298|463128272|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
128680157|NCT04393298|463128273|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
128680158|NCT04393298|463128274|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
128680159|NCT04393298|463128275|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
128680160|NCT04393298|463128276|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
128680161|NCT04393298|463128277|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
128680162|NCT04393298|463128278|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
128680163|NCT04393298|463128279|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
128680164|NCT04393298|463128280|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
128680165|NCT04393298|463128281|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
128680166|NCT04393298|463128267|FG000|Overall Study|Patient Passed Away|0|||
128680167|NCT04393298|463128268|FG001|Overall Study|Patient Passed Away|0|||
128680168|NCT04393298|463128269|FG002|Overall Study|Patient Passed Away|0|||
128680169|NCT04393298|463128270|FG003|Overall Study|Patient Passed Away|0|||
128680170|NCT04393298|463128271|FG004|Overall Study|Patient Passed Away|0|||
128680171|NCT04393298|463128272|FG005|Overall Study|Patient Passed Away|0|||
128680172|NCT04393298|463128273|FG006|Overall Study|Patient Passed Away|0|||
128680173|NCT04393298|463128274|FG007|Overall Study|Patient Passed Away|1|||
128680174|NCT04393298|463128275|FG008|Overall Study|Patient Passed Away|0|||
128680175|NCT04393298|463128276|FG009|Overall Study|Patient Passed Away|0|||
128680176|NCT04393298|463128277|FG010|Overall Study|Patient Passed Away|0|||
128680177|NCT04393298|463128278|FG011|Overall Study|Patient Passed Away|0|||
128680178|NCT04393298|463128279|FG012|Overall Study|Patient Passed Away|0|||
128680179|NCT04393298|463128280|FG013|Overall Study|Patient Passed Away|0|||
128680180|NCT04393298|463128281|FG014|Overall Study|Patient Passed Away|0|||
128680181|NCT04393298|463128267|FG000|Overall Study|Patient Deceased|0|||
128680182|NCT04393298|463128268|FG001|Overall Study|Patient Deceased|0|||
128680183|NCT04393298|463128269|FG002|Overall Study|Patient Deceased|0|||
128680184|NCT04393298|463128270|FG003|Overall Study|Patient Deceased|0|||
128680185|NCT04393298|463128271|FG004|Overall Study|Patient Deceased|0|||
128680186|NCT04393298|463128272|FG005|Overall Study|Patient Deceased|0|||
128680187|NCT04393298|463128273|FG006|Overall Study|Patient Deceased|0|||
128680188|NCT04393298|463128274|FG007|Overall Study|Patient Deceased|1|||
128680189|NCT04393298|463128275|FG008|Overall Study|Patient Deceased|0|||
128680190|NCT04393298|463128276|FG009|Overall Study|Patient Deceased|0|||
128680191|NCT04393298|463128277|FG010|Overall Study|Patient Deceased|0|||
128680192|NCT04393298|463128278|FG011|Overall Study|Patient Deceased|0|||
128680193|NCT04393298|463128279|FG012|Overall Study|Patient Deceased|0|||
128680194|NCT04393298|463128280|FG013|Overall Study|Patient Deceased|0|||
128680195|NCT04393298|463128281|FG014|Overall Study|Patient Deceased|0|||
128680196|NCT04393298|463128267|FG000|Overall Study|Patient Discharged to Hospice|0|||
128680197|NCT04393298|463128268|FG001|Overall Study|Patient Discharged to Hospice|0|||
128680198|NCT04393298|463128269|FG002|Overall Study|Patient Discharged to Hospice|0|||
128680199|NCT04393298|463128270|FG003|Overall Study|Patient Discharged to Hospice|0|||
128680200|NCT04393298|463128271|FG004|Overall Study|Patient Discharged to Hospice|0|||
128680201|NCT04393298|463128272|FG005|Overall Study|Patient Discharged to Hospice|0|||
129013420|NCT00864097|464342723|FG003|Overall Study|Randomized but not treated|0|||
129013421|NCT00864097|464342720|FG000|Overall Study|Other|0|||
129013422|NCT00864097|464342721|FG001|Overall Study|Other|0|||
129013423|NCT00864097|464342722|FG002|Overall Study|Other|0|||
129013424|NCT00864097|464342723|FG003|Overall Study|Other|1|||
129013425|NCT00262223|464342724|FG000|Treatment Phase|Withdrawal by Subject|3|||
129013426|NCT00262223|464342725|FG001|Treatment Phase|Withdrawal by Subject|6|||
129013427|NCT00262223|464342724|FG000|Treatment Phase|Adverse Event|1|||
129013428|NCT00262223|464342725|FG001|Treatment Phase|Adverse Event|2|||
129013429|NCT00262223|464342724|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
129013430|NCT00262223|464342725|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
129013431|NCT00262223|464342724|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
129013432|NCT00262223|464342725|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
129013433|NCT00262223|464342724|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
129013434|NCT00262223|464342725|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
129013435|NCT01804270|464342728|FG000|Overall Study|Withdrawal by Subject|1|||
129013436|NCT01804270|464342729|FG001|Overall Study|Withdrawal by Subject|1|||
129013437|NCT01328093|464342734|FG000|Double-Blind Phase|Adverse Event|78|||
129013438|NCT01328093|464342735|FG001|Double-Blind Phase|Adverse Event|15|||
129013439|NCT01328093|464342734|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
129013440|NCT01328093|464342735|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
129013441|NCT01328093|464342734|FG000|Double-Blind Phase|Lost to Follow-up|39|||
129013442|NCT01328093|464342735|FG001|Double-Blind Phase|Lost to Follow-up|14|||
129013443|NCT01328093|464342734|FG000|Double-Blind Phase|Protocol Violation|30|||
128680202|NCT04393298|463128273|FG006|Overall Study|Patient Discharged to Hospice|0|||
128680203|NCT04393298|463128274|FG007|Overall Study|Patient Discharged to Hospice|0|||
128680204|NCT04393298|463128275|FG008|Overall Study|Patient Discharged to Hospice|1|||
128680205|NCT04393298|463128276|FG009|Overall Study|Patient Discharged to Hospice|0|||
129013444|NCT01328093|464342735|FG001|Double-Blind Phase|Protocol Violation|10|||
129013445|NCT01328093|464342734|FG000|Double-Blind Phase|Lack of Efficacy|55|||
128680206|NCT04393298|463128277|FG010|Overall Study|Patient Discharged to Hospice|0|||
128680207|NCT04393298|463128278|FG011|Overall Study|Patient Discharged to Hospice|0|||
128680208|NCT04393298|463128279|FG012|Overall Study|Patient Discharged to Hospice|0|||
128680209|NCT04393298|463128280|FG013|Overall Study|Patient Discharged to Hospice|0|||
129013446|NCT01328093|464342735|FG001|Double-Blind Phase|Lack of Efficacy|13|||
129102585|NCT03275389|464670589|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
128680210|NCT04393298|463128281|FG014|Overall Study|Patient Discharged to Hospice|0|||
128680211|NCT04393298|463128267|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680212|NCT04393298|463128268|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129102586|NCT03275389|464670580|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
129102587|NCT03275389|464670581|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129102588|NCT03275389|464670582|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129102589|NCT03275389|464670583|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
129102590|NCT03275389|464670584|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129102591|NCT03275389|464670585|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129102592|NCT03275389|464670586|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129102593|NCT03275389|464670587|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129102594|NCT03275389|464670588|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129102595|NCT03275389|464670589|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129102596|NCT03275389|464670580|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129102597|NCT03275389|464670581|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129102598|NCT03275389|464670582|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129102599|NCT03275389|464670583|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
129102600|NCT03275389|464670584|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129102601|NCT03275389|464670585|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129102602|NCT03275389|464670586|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129102603|NCT03275389|464670587|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129102604|NCT03275389|464670588|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129102605|NCT03275389|464670589|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129102606|NCT03275389|464670580|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102607|NCT03275389|464670581|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102608|NCT03275389|464670582|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
129102609|NCT03275389|464670583|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102610|NCT03275389|464670584|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102611|NCT03275389|464670585|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102612|NCT03275389|464670586|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102613|NCT03275389|464670587|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102614|NCT03275389|464670588|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129102615|NCT03275389|464670589|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
129102616|NCT03275389|464670580|FG000|Overall Study|Other|0|||
129102617|NCT03275389|464670581|FG001|Overall Study|Other|4|||
129102618|NCT03275389|464670582|FG002|Overall Study|Other|3|||
129102619|NCT03275389|464670583|FG003|Overall Study|Other|2|||
129102620|NCT03275389|464670584|FG004|Overall Study|Other|2|||
129102621|NCT03275389|464670585|FG005|Overall Study|Other|2|||
129102622|NCT03275389|464670586|FG006|Overall Study|Other|0|||
129102623|NCT03275389|464670587|FG007|Overall Study|Other|0|||
129102624|NCT03275389|464670588|FG008|Overall Study|Other|1|||
129102625|NCT03275389|464670589|FG009|Overall Study|Other|0|||
129102626|NCT02432144|464670590|FG000|Overall Study|Participant Non-Compliance|1|||
129102627|NCT01451554|464670591|FG000|Overall Study|Withdrawal by Subject|14|||
129102628|NCT01451554|464670592|FG001|Overall Study|Withdrawal by Subject|9|||
129102629|NCT01402986|464670593|FG000|Overall Study|Withdrawal by Subject|7|||
129102630|NCT01402986|464670594|FG001|Overall Study|Withdrawal by Subject|10|||
129102631|NCT01402986|464670595|FG002|Overall Study|Withdrawal by Subject|7|||
129102632|NCT01402986|464670596|FG003|Overall Study|Withdrawal by Subject|13|||
128680213|NCT04393298|463128269|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680214|NCT04393298|463128270|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680215|NCT04393298|463128271|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680216|NCT04393298|463128272|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680217|NCT04393298|463128273|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680218|NCT04393298|463128274|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680219|NCT04393298|463128275|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129102633|NCT01402986|464670593|FG000|Overall Study|Death|0|||
128680220|NCT04393298|463128276|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
128680221|NCT04393298|463128277|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680222|NCT04393298|463128278|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129102634|NCT01402986|464670594|FG001|Overall Study|Death|0|||
129102635|NCT01402986|464670595|FG002|Overall Study|Death|0|||
129102636|NCT01402986|464670596|FG003|Overall Study|Death|2|||
129102637|NCT01402986|464670593|FG000|Overall Study|Lost to Follow-up|0|||
129102638|NCT01402986|464670594|FG001|Overall Study|Lost to Follow-up|0|||
129102639|NCT01402986|464670595|FG002|Overall Study|Lost to Follow-up|0|||
128680223|NCT04393298|463128279|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680224|NCT04393298|463128280|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129102640|NCT01402986|464670596|FG003|Overall Study|Lost to Follow-up|1|||
128680225|NCT04393298|463128281|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
128680226|NCT04393298|463128267|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
128680227|NCT04393298|463128268|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
128680228|NCT04393298|463128269|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
128680229|NCT04393298|463128270|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
128680230|NCT04393298|463128271|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
128680231|NCT04393298|463128272|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
128680232|NCT04393298|463128273|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
128680233|NCT04393298|463128274|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
128680234|NCT04393298|463128275|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
128680235|NCT04393298|463128276|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
128680236|NCT04393298|463128277|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
128680237|NCT04393298|463128278|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
128680238|NCT04393298|463128279|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
128680239|NCT04393298|463128280|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
128680240|NCT04393298|463128281|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
128680241|NCT02311582|463128282|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
128680242|NCT02311582|463128283|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
129013447|NCT01328093|464342734|FG000|Double-Blind Phase|Sponsor Decision|17|||
129013448|NCT01328093|464342735|FG001|Double-Blind Phase|Sponsor Decision|3|||
129013449|NCT01328093|464342734|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
129013450|NCT01328093|464342735|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
129013451|NCT01328093|464342734|FG000|Double-Blind Phase|Scheduling conflict|8|||
129013452|NCT01328093|464342735|FG001|Double-Blind Phase|Scheduling conflict|3|||
129013453|NCT01328093|464342734|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
129013454|NCT01328093|464342735|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
129013455|NCT01328093|464342734|FG000|Double-Blind Phase|Death|1|||
129013456|NCT01328093|464342735|FG001|Double-Blind Phase|Death|0|||
129013457|NCT01328093|464342734|FG000|Open-Label Phase|Sponsor Decision|98|||
129013458|NCT01328093|464342735|FG001|Open-Label Phase|Sponsor Decision|34|||
129013459|NCT01328093|464342734|FG000|Open-Label Phase|Protocol Violation|8|||
129013460|NCT01328093|464342735|FG001|Open-Label Phase|Protocol Violation|3|||
129013461|NCT01328093|464342734|FG000|Open-Label Phase|Lost to Follow-up|10|||
129013462|NCT01328093|464342735|FG001|Open-Label Phase|Lost to Follow-up|1|||
129013463|NCT01328093|464342734|FG000|Open-Label Phase|Adverse Event|10|||
129013464|NCT01328093|464342735|FG001|Open-Label Phase|Adverse Event|4|||
129013465|NCT01328093|464342734|FG000|Open-Label Phase|Lack of Efficacy|5|||
129013466|NCT01328093|464342735|FG001|Open-Label Phase|Lack of Efficacy|6|||
129013467|NCT01328093|464342734|FG000|Open-Label Phase|Withdrawal by Subject|4|||
129013468|NCT01328093|464342735|FG001|Open-Label Phase|Withdrawal by Subject|1|||
129013469|NCT01328093|464342734|FG000|Open-Label Phase|Scheduling conflict|2|||
129013470|NCT01328093|464342735|FG001|Open-Label Phase|Scheduling conflict|1|||
129013471|NCT01328093|464342734|FG000|Open-Label Phase|Subject is moving or has moved|2|||
129013472|NCT01328093|464342735|FG001|Open-Label Phase|Subject is moving or has moved|0|||
129013473|NCT01328093|464342734|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
129013474|NCT01328093|464342735|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
129013475|NCT05150964|464342738|FG000|Overall Study|Lost to Follow-up|2|||
129013476|NCT00832377|464342739|FG000|Overall Study|Protocol Violation|1|||
129013477|NCT03661528|464342740|FG000|Overall Study|Death|1|||
129013478|NCT03661528|464342741|FG001|Overall Study|Death|0|||
129013479|NCT03661528|464342740|FG000|Overall Study|Physician Decision|3|||
129013480|NCT03661528|464342741|FG001|Overall Study|Physician Decision|1|||
129013481|NCT03661528|464342740|FG000|Overall Study|Other than Specified|5|||
129013482|NCT03661528|464342741|FG001|Overall Study|Other than Specified|2|||
129013483|NCT03661528|464342740|FG000|Overall Study|Withdrawal by Subject|5|||
129013484|NCT03661528|464342741|FG001|Overall Study|Withdrawal by Subject|3|||
129013485|NCT03661528|464342740|FG000|Overall Study|Disease Progression|8|||
129013486|NCT03661528|464342741|FG001|Overall Study|Disease Progression|13|||
129013487|NCT03661528|464342740|FG000|Overall Study|Adverse Event|61|||
129013488|NCT03661528|464342741|FG001|Overall Study|Adverse Event|55|||
129013489|NCT01449630|464342743|FG000|Period 1|Physician Decision|1|||
129013490|NCT01449630|464342744|FG001|Period 1|Physician Decision|0|||
129013491|NCT01449630|464342745|FG002|Period 1|Physician Decision|0|||
129013492|NCT01449630|464342746|FG003|Period 1|Physician Decision|1|||
129013493|NCT01449630|464342747|FG004|Period 1|Physician Decision|0|||
129013494|NCT01449630|464342748|FG005|Period 1|Physician Decision|0|||
128680243|NCT02311582|463128284|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
128680244|NCT02311582|463128285|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
129013495|NCT01449630|464342749|FG006|Period 1|Physician Decision|0|||
129013496|NCT01449630|464342750|FG007|Period 1|Physician Decision|0|||
129013497|NCT01449630|464342751|FG008|Period 1|Physician Decision|0|||
129013498|NCT01449630|464342743|FG000|Period 1|Sponsor Decision|0|||
129013499|NCT01449630|464342744|FG001|Period 1|Sponsor Decision|0|||
129013500|NCT01449630|464342745|FG002|Period 1|Sponsor Decision|0|||
129013501|NCT01449630|464342746|FG003|Period 1|Sponsor Decision|0|||
129013502|NCT01449630|464342747|FG004|Period 1|Sponsor Decision|0|||
129013503|NCT01449630|464342748|FG005|Period 1|Sponsor Decision|1|||
129013504|NCT01449630|464342749|FG006|Period 1|Sponsor Decision|0|||
129013505|NCT01449630|464342750|FG007|Period 1|Sponsor Decision|0|||
129013506|NCT01449630|464342751|FG008|Period 1|Sponsor Decision|0|||
129013507|NCT01449630|464342743|FG000|Period 2|Sponsor Decision|0|||
129013508|NCT01449630|464342744|FG001|Period 2|Sponsor Decision|0|||
129013509|NCT01449630|464342745|FG002|Period 2|Sponsor Decision|0|||
129013510|NCT01449630|464342746|FG003|Period 2|Sponsor Decision|0|||
129013511|NCT01449630|464342747|FG004|Period 2|Sponsor Decision|0|||
129013512|NCT01449630|464342748|FG005|Period 2|Sponsor Decision|0|||
129013513|NCT01449630|464342749|FG006|Period 2|Sponsor Decision|1|||
129013514|NCT01449630|464342750|FG007|Period 2|Sponsor Decision|0|||
129013515|NCT01449630|464342751|FG008|Period 2|Sponsor Decision|0|||
129013516|NCT01735630|464342756|FG000|Overall Study|Adverse Event|8|||
129013517|NCT01735630|464342757|FG001|Overall Study|Adverse Event|7|||
129013518|NCT01735630|464342756|FG000|Overall Study|Lost to Follow-up|1|||
129013519|NCT01735630|464342757|FG001|Overall Study|Lost to Follow-up|0|||
129013520|NCT01735630|464342756|FG000|Overall Study|Physician Decision|0|||
129013521|NCT01735630|464342757|FG001|Overall Study|Physician Decision|1|||
129013522|NCT01735630|464342756|FG000|Overall Study|Sponsor Decision|2|||
129013523|NCT01735630|464342757|FG001|Overall Study|Sponsor Decision|1|||
129013524|NCT01735630|464342756|FG000|Overall Study|Withdrawal by Subject|7|||
129013525|NCT01735630|464342757|FG001|Overall Study|Withdrawal by Subject|9|||
129013526|NCT03099538|464342758|FG000|Overall Study|Lack of Efficacy|3|||
129013527|NCT01941030|464342772|FG000|Overall Study|Death|3|||
129013528|NCT01941030|464342773|FG001|Overall Study|Death|2|||
128680245|NCT02311582|463128286|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
128680246|NCT04656275|463128289|FG000|Overall Study|Study terminated by sponsor|2|||
128680247|NCT04656275|463128290|FG001|Overall Study|Study terminated by sponsor|4|||
128680248|NCT00934648|463128296|FG000|Overall Study|Failure to return|8|||
128680249|NCT00934648|463128296|FG000|Overall Study|Withdrawal by Subject|1|||
128680250|NCT01993836|463128297|FG000|Overall Study|Surgery Cancelled|3|||
128680251|NCT01993836|463128298|FG001|Overall Study|Surgery Cancelled|0|||
128680252|NCT01993836|463128299|FG002|Overall Study|Surgery Cancelled|0|||
128680253|NCT01993836|463128297|FG000|Overall Study|Physician Decision|2|||
128680254|NCT01993836|463128298|FG001|Overall Study|Physician Decision|1|||
128680255|NCT01993836|463128299|FG002|Overall Study|Physician Decision|0|||
128680256|NCT01993836|463128297|FG000|Overall Study|Death|0|||
128680257|NCT01993836|463128298|FG001|Overall Study|Death|2|||
128680258|NCT01993836|463128299|FG002|Overall Study|Death|0|||
128680259|NCT01993836|463128297|FG000|Overall Study|Withdrawal by Subject|12|||
128680260|NCT01993836|463128298|FG001|Overall Study|Withdrawal by Subject|10|||
128680261|NCT01993836|463128299|FG002|Overall Study|Withdrawal by Subject|5|||
128680262|NCT02195687|463128301|FG000|Overall Study|Personal Reasons|1|||
128680263|NCT02195687|463128302|FG001|Overall Study|Personal Reasons|1|||
128680264|NCT02195687|463128301|FG000|Overall Study|Lost to Follow-up|4|||
128680265|NCT02195687|463128302|FG001|Overall Study|Lost to Follow-up|1|||
128680266|NCT04369924|463128305|FG000|Overall Study|Lost to Follow-up|302|||
128680267|NCT04369924|463128306|FG001|Overall Study|Lost to Follow-up|339|||
128680268|NCT03828370|463128307|FG000|3 Month Follow-up|Lost to Follow-up|4|||
128680269|NCT03828370|463128308|FG001|3 Month Follow-up|Lost to Follow-up|12|||
128680270|NCT03828370|463128307|FG000|9 Month Follow up|Lost to Follow-up|12|||
128680271|NCT03828370|463128308|FG001|9 Month Follow up|Lost to Follow-up|20|||
128680272|NCT02554279|463128311|FG000|Overall Study|Adverse Event|2|||
128680273|NCT02554279|463128312|FG001|Overall Study|Adverse Event|5|||
128680274|NCT02554279|463128311|FG000|Overall Study|Lost to Follow-up|3|||
128680275|NCT02554279|463128312|FG001|Overall Study|Lost to Follow-up|2|||
128680276|NCT02554279|463128311|FG000|Overall Study|Withdrawal by Subject|6|||
128680277|NCT02554279|463128312|FG001|Overall Study|Withdrawal by Subject|4|||
128680278|NCT02554279|463128311|FG000|Overall Study|Protocol Violation|2|||
128680279|NCT02554279|463128312|FG001|Overall Study|Protocol Violation|1|||
128680280|NCT02554279|463128311|FG000|Overall Study|Other reason|19|||
128680281|NCT02554279|463128312|FG001|Overall Study|Other reason|6|||
128680282|NCT00812487|463128313|FG000|Overall Study|Lost to Follow-up|2|||
129013529|NCT01941030|464342772|FG000|Overall Study|Lost to Follow-up|6|||
129013530|NCT01941030|464342773|FG001|Overall Study|Lost to Follow-up|5|||
129013531|NCT01941030|464342772|FG000|Overall Study|Withdrawal by Subject|4|||
129013532|NCT01941030|464342773|FG001|Overall Study|Withdrawal by Subject|6|||
128680283|NCT00812487|463128314|FG001|Overall Study|Lost to Follow-up|0|||
128680284|NCT00812487|463128313|FG000|Overall Study|Withdrawal by Subject|3|||
128680285|NCT00812487|463128314|FG001|Overall Study|Withdrawal by Subject|2|||
128680286|NCT00812487|463128313|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
129013533|NCT00162123|464342774|FG000|Overall Study|Disease progression|27|||
129013534|NCT00162123|464342775|FG001|Overall Study|Disease progression|19|||
128680287|NCT00812487|463128314|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
128680288|NCT00812487|463128313|FG000|Overall Study|Protocol Violation|0|||
128680289|NCT00812487|463128314|FG001|Overall Study|Protocol Violation|1|||
128680290|NCT02360605|463128315|FG000|Overall Study|Withdrawal by Subject|4|||
128680291|NCT02360605|463128316|FG001|Overall Study|Withdrawal by Subject|9|||
128680292|NCT02360605|463128315|FG000|Overall Study|Lost to Follow-up|7|||
128680293|NCT02360605|463128316|FG001|Overall Study|Lost to Follow-up|8|||
128680294|NCT02360605|463128315|FG000|Overall Study|Death|0|||
129102641|NCT01402986|464670593|FG000|Overall Study|Other|2|||
129102642|NCT01402986|464670594|FG001|Overall Study|Other|5|||
129102643|NCT01402986|464670595|FG002|Overall Study|Other|1|||
129102644|NCT01402986|464670596|FG003|Overall Study|Other|6|||
129102645|NCT02427802|464670597|FG000|Overall Study|Adverse Event|11|||
129102646|NCT02427802|464670598|FG001|Overall Study|Adverse Event|3|||
129102647|NCT02427802|464670599|FG002|Overall Study|Adverse Event|7|||
129102648|NCT02427802|464670597|FG000|Overall Study|Death|0|||
129102649|NCT02427802|464670598|FG001|Overall Study|Death|4|||
129102650|NCT02427802|464670599|FG002|Overall Study|Death|1|||
129102651|NCT02427802|464670597|FG000|Overall Study|Lost to Follow-up|13|||
128680295|NCT02360605|463128316|FG001|Overall Study|Death|1|||
128680296|NCT00723203|463128319|FG000|Overall Study|Withdrawal by Subject|3|||
129013535|NCT00162123|464342776|FG002|Overall Study|Disease progression|10|||
129013536|NCT00162123|464342777|FG003|Overall Study|Disease progression|4|||
129013537|NCT00162123|464342778|FG004|Overall Study|Disease progression|8|||
129013538|NCT00162123|464342779|FG005|Overall Study|Disease progression|3|||
129013539|NCT00162123|464342780|FG006|Overall Study|Disease progression|1|||
129013540|NCT00162123|464342781|FG007|Overall Study|Disease progression|0|||
129013541|NCT00162123|464342774|FG000|Overall Study|Study drug toxicity|6|||
129013542|NCT00162123|464342775|FG001|Overall Study|Study drug toxicity|1|||
129013543|NCT00162123|464342776|FG002|Overall Study|Study drug toxicity|5|||
129013544|NCT00162123|464342777|FG003|Overall Study|Study drug toxicity|0|||
129013545|NCT00162123|464342778|FG004|Overall Study|Study drug toxicity|4|||
129013546|NCT00162123|464342779|FG005|Overall Study|Study drug toxicity|1|||
129013547|NCT00162123|464342780|FG006|Overall Study|Study drug toxicity|1|||
129013548|NCT00162123|464342781|FG007|Overall Study|Study drug toxicity|0|||
129013549|NCT00162123|464342774|FG000|Overall Study|Death|3|||
129013550|NCT00162123|464342775|FG001|Overall Study|Death|3|||
129013551|NCT00162123|464342776|FG002|Overall Study|Death|1|||
129013552|NCT00162123|464342777|FG003|Overall Study|Death|1|||
129013553|NCT00162123|464342778|FG004|Overall Study|Death|1|||
129013554|NCT00162123|464342779|FG005|Overall Study|Death|1|||
129013555|NCT00162123|464342780|FG006|Overall Study|Death|0|||
129013556|NCT00162123|464342781|FG007|Overall Study|Death|0|||
129013557|NCT00162123|464342774|FG000|Overall Study|Withdrawal by Subject|2|||
129013558|NCT00162123|464342775|FG001|Overall Study|Withdrawal by Subject|0|||
129013559|NCT00162123|464342776|FG002|Overall Study|Withdrawal by Subject|2|||
129013560|NCT00162123|464342777|FG003|Overall Study|Withdrawal by Subject|1|||
129013561|NCT00162123|464342778|FG004|Overall Study|Withdrawal by Subject|1|||
129013562|NCT00162123|464342779|FG005|Overall Study|Withdrawal by Subject|2|||
129013563|NCT00162123|464342780|FG006|Overall Study|Withdrawal by Subject|1|||
129013564|NCT00162123|464342781|FG007|Overall Study|Withdrawal by Subject|0|||
129013565|NCT00162123|464342774|FG000|Overall Study|Deterioration without progression|2|||
129013566|NCT00162123|464342775|FG001|Overall Study|Deterioration without progression|2|||
129013567|NCT00162123|464342776|FG002|Overall Study|Deterioration without progression|3|||
129013568|NCT00162123|464342777|FG003|Overall Study|Deterioration without progression|0|||
129013569|NCT00162123|464342778|FG004|Overall Study|Deterioration without progression|1|||
129013570|NCT00162123|464342779|FG005|Overall Study|Deterioration without progression|0|||
129013571|NCT00162123|464342780|FG006|Overall Study|Deterioration without progression|0|||
129013572|NCT00162123|464342781|FG007|Overall Study|Deterioration without progression|0|||
129013573|NCT00162123|464342774|FG000|Overall Study|Adverse Event|1|||
129013574|NCT00162123|464342775|FG001|Overall Study|Adverse Event|2|||
129013575|NCT00162123|464342776|FG002|Overall Study|Adverse Event|0|||
129013576|NCT00162123|464342777|FG003|Overall Study|Adverse Event|2|||
129013577|NCT00162123|464342778|FG004|Overall Study|Adverse Event|1|||
129013578|NCT00162123|464342779|FG005|Overall Study|Adverse Event|0|||
129013579|NCT00162123|464342780|FG006|Overall Study|Adverse Event|0|||
129013580|NCT00162123|464342781|FG007|Overall Study|Adverse Event|0|||
128680297|NCT02106923|463128324|FG000|Overall Study|Protocol Violation|0|||
128680298|NCT02106923|463128325|FG001|Overall Study|Protocol Violation|0|||
129013581|NCT00162123|464342774|FG000|Overall Study|Not specified (before treatment)|2|||
129013582|NCT00162123|464342775|FG001|Overall Study|Not specified (before treatment)|0|||
129013583|NCT00162123|464342776|FG002|Overall Study|Not specified (before treatment)|0|||
129013584|NCT00162123|464342777|FG003|Overall Study|Not specified (before treatment)|0|||
129013585|NCT00162123|464342778|FG004|Overall Study|Not specified (before treatment)|12|||
129102652|NCT02427802|464670598|FG001|Overall Study|Lost to Follow-up|8|||
129102653|NCT02427802|464670599|FG002|Overall Study|Lost to Follow-up|8|||
129013586|NCT00162123|464342779|FG005|Overall Study|Not specified (before treatment)|1|||
129102654|NCT02427802|464670597|FG000|Overall Study|Physician Decision|4|||
129102655|NCT02427802|464670598|FG001|Overall Study|Physician Decision|2|||
129102656|NCT02427802|464670599|FG002|Overall Study|Physician Decision|4|||
128680299|NCT02106923|463128326|FG002|Overall Study|Protocol Violation|0|||
128680300|NCT02106923|463128327|FG003|Overall Study|Protocol Violation|0|||
128680301|NCT02106923|463128328|FG004|Overall Study|Protocol Violation|0|||
129102657|NCT02427802|464670597|FG000|Overall Study|Withdrawal by Subject|10|||
129102658|NCT02427802|464670598|FG001|Overall Study|Withdrawal by Subject|5|||
129102659|NCT02427802|464670599|FG002|Overall Study|Withdrawal by Subject|11|||
129102660|NCT02427802|464670597|FG000|Overall Study|Protocol Violation|3|||
129102661|NCT02427802|464670598|FG001|Overall Study|Protocol Violation|1|||
129102662|NCT02427802|464670599|FG002|Overall Study|Protocol Violation|1|||
129102663|NCT02427802|464670597|FG000|Overall Study|protocol specific treatment unrelated|18|||
129102664|NCT02427802|464670598|FG001|Overall Study|protocol specific treatment unrelated|11|||
129102665|NCT02427802|464670599|FG002|Overall Study|protocol specific treatment unrelated|11|||
129102666|NCT01085084|464670600|FG000|Overall Study|Withdrawal by Subject|1|||
129102667|NCT01085084|464670601|FG001|Overall Study|Withdrawal by Subject|0|||
129102668|NCT01085084|464670602|FG002|Overall Study|Withdrawal by Subject|0|||
129102669|NCT01085084|464670600|FG000|Overall Study|Lost to Follow-up|2|||
129102670|NCT01085084|464670601|FG001|Overall Study|Lost to Follow-up|1|||
129102671|NCT01085084|464670602|FG002|Overall Study|Lost to Follow-up|1|||
129102672|NCT01085084|464670600|FG000|Overall Study|Adverse Event|4|||
129102673|NCT01085084|464670601|FG001|Overall Study|Adverse Event|3|||
129102674|NCT01085084|464670602|FG002|Overall Study|Adverse Event|6|||
129102675|NCT01085084|464670600|FG000|Overall Study|Treatment Failure|0|||
129102676|NCT01085084|464670601|FG001|Overall Study|Treatment Failure|1|||
129102677|NCT01085084|464670602|FG002|Overall Study|Treatment Failure|2|||
129102678|NCT02749799|464670603|FG000|Overall Study|Adverse Event|2|||
129102679|NCT02749799|464670603|FG000|Overall Study|Lost to Follow-up|4|||
129102680|NCT02749799|464670603|FG000|Overall Study|Protocol Violation|1|||
129102681|NCT02749799|464670603|FG000|Overall Study|Withdrawal by Subject|1|||
129102682|NCT02634983|464670604|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
129102683|NCT02634983|464670605|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
129102684|NCT03749109|464670606|FG000|Overall Study|Adverse Event|2|||
129102685|NCT03749109|464670607|FG001|Overall Study|Adverse Event|0|||
129102686|NCT02070978|464670608|FG000|Overall Study|Adverse Event|6|||
129102687|NCT02070978|464670609|FG001|Overall Study|Adverse Event|2|||
129102688|NCT02070978|464670610|FG002|Overall Study|Adverse Event|0|||
129102689|NCT02070978|464670608|FG000|Overall Study|Lost to Follow-up|1|||
129102690|NCT02070978|464670609|FG001|Overall Study|Lost to Follow-up|3|||
129102691|NCT02070978|464670610|FG002|Overall Study|Lost to Follow-up|4|||
129102692|NCT02070978|464670608|FG000|Overall Study|Withdrawal by Subject|3|||
129102693|NCT02070978|464670609|FG001|Overall Study|Withdrawal by Subject|5|||
129102694|NCT02070978|464670610|FG002|Overall Study|Withdrawal by Subject|3|||
129102695|NCT02070978|464670608|FG000|Overall Study|Protocol Violation|1|||
129102696|NCT02070978|464670609|FG001|Overall Study|Protocol Violation|0|||
129102697|NCT02070978|464670610|FG002|Overall Study|Protocol Violation|3|||
129102698|NCT02070978|464670608|FG000|Overall Study|Lack of Efficacy|0|||
129102699|NCT02070978|464670609|FG001|Overall Study|Lack of Efficacy|1|||
129102700|NCT02070978|464670610|FG002|Overall Study|Lack of Efficacy|0|||
129102701|NCT02070978|464670608|FG000|Overall Study|Death|0|||
129102702|NCT02070978|464670609|FG001|Overall Study|Death|0|||
129102703|NCT02070978|464670610|FG002|Overall Study|Death|2|||
129102704|NCT02070978|464670608|FG000|Overall Study|Un-specified|3|||
129102705|NCT02070978|464670609|FG001|Overall Study|Un-specified|2|||
129102706|NCT02070978|464670610|FG002|Overall Study|Un-specified|2|||
129102707|NCT02070978|464670608|FG000|Overall Study|Terminated by Sponsor|33|||
129102708|NCT02070978|464670609|FG001|Overall Study|Terminated by Sponsor|40|||
129102709|NCT02070978|464670610|FG002|Overall Study|Terminated by Sponsor|39|||
129102710|NCT03951753|464670611|FG000|Overall Study|Adverse Event|1|||
129102711|NCT03951753|464670612|FG001|Overall Study|Adverse Event|0|||
129102712|NCT03951753|464670613|FG002|Overall Study|Adverse Event|3|||
129102713|NCT03951753|464670611|FG000|Overall Study|Withdrawal by Subject|3|||
129102714|NCT03951753|464670612|FG001|Overall Study|Withdrawal by Subject|1|||
129102715|NCT03951753|464670613|FG002|Overall Study|Withdrawal by Subject|0|||
129102716|NCT03951753|464670611|FG000|Overall Study|Lost to Follow-up|0|||
129102717|NCT03951753|464670612|FG001|Overall Study|Lost to Follow-up|0|||
128680302|NCT02106923|463128329|FG005|Overall Study|Protocol Violation|1|||
128680303|NCT03485495|463128330|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
128680304|NCT03485495|463128331|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
128680305|NCT01056380|463128334|FG000|Overall Study|Lost to Follow-up|2|||
128680306|NCT01056380|463128335|FG001|Overall Study|Lost to Follow-up|3|||
129102718|NCT03951753|464670613|FG002|Overall Study|Lost to Follow-up|1|||
128680307|NCT03901456|463128336|FG000|Overall Study|Withdrawal by Subject|0|||
129102719|NCT03178851|464670614|FG000|Overall Study|Death|48|||
129102720|NCT03178851|464670615|FG001|Overall Study|Death|2|||
129102721|NCT03178851|464670616|FG002|Overall Study|Death|25|||
129102722|NCT03178851|464670614|FG000|Overall Study|Withdrawal by Subject|8|||
129102723|NCT03178851|464670615|FG001|Overall Study|Withdrawal by Subject|0|||
129102724|NCT03178851|464670616|FG002|Overall Study|Withdrawal by Subject|0|||
129102725|NCT03178851|464670614|FG000|Overall Study|Lost to Follow-up|5|||
128680308|NCT03901456|463128337|FG001|Overall Study|Withdrawal by Subject|0|||
129102726|NCT03178851|464670615|FG001|Overall Study|Lost to Follow-up|2|||
129102727|NCT03178851|464670616|FG002|Overall Study|Lost to Follow-up|0|||
129013587|NCT00162123|464342780|FG006|Overall Study|Not specified (before treatment)|0|||
129013588|NCT00162123|464342781|FG007|Overall Study|Not specified (before treatment)|0|||
129013589|NCT00162123|464342774|FG000|Overall Study|Not specified (after start of treatment)|0|||
129013590|NCT00162123|464342775|FG001|Overall Study|Not specified (after start of treatment)|0|||
129013591|NCT00162123|464342776|FG002|Overall Study|Not specified (after start of treatment)|0|||
129013592|NCT00162123|464342777|FG003|Overall Study|Not specified (after start of treatment)|0|||
129013593|NCT00162123|464342778|FG004|Overall Study|Not specified (after start of treatment)|3|||
129013594|NCT00162123|464342779|FG005|Overall Study|Not specified (after start of treatment)|0|||
129013595|NCT00162123|464342780|FG006|Overall Study|Not specified (after start of treatment)|0|||
129013596|NCT00162123|464342781|FG007|Overall Study|Not specified (after start of treatment)|0|||
129013597|NCT00162123|464342774|FG000|Overall Study|Physician Decision|1|||
129013598|NCT00162123|464342775|FG001|Overall Study|Physician Decision|2|||
129013599|NCT00162123|464342776|FG002|Overall Study|Physician Decision|0|||
129013600|NCT00162123|464342777|FG003|Overall Study|Physician Decision|0|||
129013601|NCT00162123|464342778|FG004|Overall Study|Physician Decision|0|||
129013602|NCT00162123|464342779|FG005|Overall Study|Physician Decision|1|||
129013603|NCT00162123|464342780|FG006|Overall Study|Physician Decision|1|||
129013604|NCT00162123|464342781|FG007|Overall Study|Physician Decision|0|||
129013605|NCT00162123|464342774|FG000|Overall Study|Tumor assessment only (not treated)|0|||
129013606|NCT00162123|464342775|FG001|Overall Study|Tumor assessment only (not treated)|0|||
129013607|NCT00162123|464342776|FG002|Overall Study|Tumor assessment only (not treated)|0|||
129013608|NCT00162123|464342777|FG003|Overall Study|Tumor assessment only (not treated)|0|||
129013609|NCT00162123|464342778|FG004|Overall Study|Tumor assessment only (not treated)|0|||
129013610|NCT00162123|464342779|FG005|Overall Study|Tumor assessment only (not treated)|0|||
129013611|NCT00162123|464342780|FG006|Overall Study|Tumor assessment only (not treated)|0|||
129013612|NCT00162123|464342781|FG007|Overall Study|Tumor assessment only (not treated)|1|||
129013613|NCT00162123|464342774|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
129013614|NCT00162123|464342775|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
129013615|NCT00162123|464342776|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
129013616|NCT00162123|464342777|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
129013617|NCT00162123|464342778|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
129013618|NCT00162123|464342779|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
129013619|NCT00162123|464342780|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
129013620|NCT00162123|464342781|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
129013621|NCT01936948|464342783|FG000|Overall Study|no 30-day follow-up data|0|||
129013622|NCT01936948|464342784|FG001|Overall Study|no 30-day follow-up data|3|||
129013623|NCT01936948|464342785|FG002|Overall Study|no 30-day follow-up data|3|||
129013624|NCT01936948|464342786|FG003|Overall Study|no 30-day follow-up data|3|||
129013625|NCT02930005|464342787|FG000|Overall Study|Lost to Follow-up|1|||
129013626|NCT02930005|464342788|FG001|Overall Study|Lost to Follow-up|5|||
129013627|NCT02781727|464342789|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
129013628|NCT02781727|464342790|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
129013629|NCT02781727|464342789|FG000|Treatment Period|Withdrawal by Subject|1|||
129013630|NCT02781727|464342790|FG001|Treatment Period|Withdrawal by Subject|0|||
129013631|NCT02781727|464342789|FG000|Treatment Period|Lost to Follow-up|0|||
129013632|NCT02781727|464342790|FG001|Treatment Period|Lost to Follow-up|1|||
129013633|NCT00822926|464342795|FG000|Second Injection Visit|Lost to Follow-up|1|||
129013634|NCT00822926|464342796|FG001|Second Injection Visit|Lost to Follow-up|0|||
129013635|NCT00822926|464342795|FG000|Second Injection Visit|Withdrawal by Subject|0|||
129013636|NCT00822926|464342796|FG001|Second Injection Visit|Withdrawal by Subject|1|||
129013637|NCT02534493|464342808|FG000|Overall Study|Lost to Follow-up|1|||
129013638|NCT02534493|464342808|FG000|Overall Study|Withdrawal by Subject|1|||
129013639|NCT02924038|464344561|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
129013640|NCT02924038|464344562|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
129013641|NCT01101022|464344571|FG000|Overall Study|Adverse Event|6|||
129013642|NCT01101022|464344572|FG001|Overall Study|Adverse Event|2|||
129013643|NCT01101022|464344571|FG000|Overall Study|Protocol Violation|4|||
129013644|NCT01101022|464344572|FG001|Overall Study|Protocol Violation|3|||
129013645|NCT01101022|464344571|FG000|Overall Study|Withdrawal by Subject|3|||
129013646|NCT01101022|464344572|FG001|Overall Study|Withdrawal by Subject|8|||
129013647|NCT01101022|464344571|FG000|Overall Study|Lost to Follow-up|1|||
129013648|NCT01101022|464344572|FG001|Overall Study|Lost to Follow-up|4|||
129013649|NCT01101022|464344571|FG000|Overall Study|Lack of Efficacy|0|||
129013650|NCT01101022|464344572|FG001|Overall Study|Lack of Efficacy|7|||
129013651|NCT01101022|464344571|FG000|Overall Study|Sponsor decision|1|||
129013652|NCT01101022|464344572|FG001|Overall Study|Sponsor decision|1|||
129013653|NCT01101022|464344571|FG000|Overall Study|Non-compliance|1|||
129013654|NCT01101022|464344572|FG001|Overall Study|Non-compliance|0|||
129013655|NCT01101022|464344571|FG000|Overall Study|Work schedule|1|||
129013656|NCT01101022|464344572|FG001|Overall Study|Work schedule|1|||
129013657|NCT01101022|464344571|FG000|Overall Study|Vacation|0|||
129013658|NCT01101022|464344572|FG001|Overall Study|Vacation|1|||
129013659|NCT01519661|464344573|FG000|Overall Study|Protocol deviation|6|||
129102728|NCT03178851|464670614|FG000|Overall Study|Adverse Event|0|||
129102729|NCT03178851|464670615|FG001|Overall Study|Adverse Event|0|||
129102730|NCT03178851|464670616|FG002|Overall Study|Adverse Event|1|||
129102731|NCT03178851|464670614|FG000|Overall Study|Study Termination by Sponsor|31|||
129102732|NCT03178851|464670615|FG001|Overall Study|Study Termination by Sponsor|7|||
129102733|NCT03178851|464670616|FG002|Overall Study|Study Termination by Sponsor|26|||
129102734|NCT02669043|464670621|FG000|Overall Study|Didn't meet I/E criteria|4|||
129102735|NCT02552888|464670624|FG000|Overall Study|Lost to Follow-up|1|||
129102736|NCT02552888|464670625|FG001|Overall Study|Lost to Follow-up|1|||
129102737|NCT00401193|464673094|FG000|Overall Study|Adverse Event|1|||
129102738|NCT00401193|464673095|FG001|Overall Study|Adverse Event|3|||
129102739|NCT00401193|464673096|FG002|Overall Study|Adverse Event|1|||
129102740|NCT00401193|464673094|FG000|Overall Study|Protocol Violation|3|||
129102741|NCT00401193|464673095|FG001|Overall Study|Protocol Violation|1|||
129102742|NCT00401193|464673096|FG002|Overall Study|Protocol Violation|1|||
129102743|NCT00401193|464673094|FG000|Overall Study|Lost to Follow-up|6|||
129102744|NCT00401193|464673095|FG001|Overall Study|Lost to Follow-up|5|||
129102745|NCT00401193|464673096|FG002|Overall Study|Lost to Follow-up|1|||
129102746|NCT00401193|464673094|FG000|Overall Study|Withdrawal by Subject|2|||
129102747|NCT00401193|464673095|FG001|Overall Study|Withdrawal by Subject|0|||
129102748|NCT00401193|464673096|FG002|Overall Study|Withdrawal by Subject|1|||
129102749|NCT00401193|464673094|FG000|Overall Study|Other Event|3|||
129102750|NCT00401193|464673095|FG001|Overall Study|Other Event|2|||
129102751|NCT00401193|464673096|FG002|Overall Study|Other Event|2|||
129102752|NCT00398216|464673097|FG000|Overall Study|Adverse Event|4|||
129102753|NCT00398216|464673098|FG001|Overall Study|Adverse Event|2|||
129102754|NCT00398216|464673099|FG002|Overall Study|Adverse Event|5|||
129102755|NCT00398216|464673100|FG003|Overall Study|Adverse Event|7|||
129102756|NCT00398216|464673101|FG004|Overall Study|Adverse Event|2|||
129102757|NCT00398216|464673097|FG000|Overall Study|Protocol Violation|2|||
129102758|NCT00398216|464673098|FG001|Overall Study|Protocol Violation|4|||
129102759|NCT00398216|464673099|FG002|Overall Study|Protocol Violation|5|||
129102760|NCT00398216|464673100|FG003|Overall Study|Protocol Violation|7|||
129102761|NCT00398216|464673101|FG004|Overall Study|Protocol Violation|5|||
129102762|NCT00398216|464673097|FG000|Overall Study|Lost to Follow-up|1|||
129102763|NCT00398216|464673098|FG001|Overall Study|Lost to Follow-up|6|||
129102764|NCT00398216|464673099|FG002|Overall Study|Lost to Follow-up|4|||
129102765|NCT00398216|464673100|FG003|Overall Study|Lost to Follow-up|4|||
129102766|NCT00398216|464673101|FG004|Overall Study|Lost to Follow-up|1|||
129102767|NCT00398216|464673097|FG000|Overall Study|Death|0|||
129102768|NCT00398216|464673098|FG001|Overall Study|Death|3|||
129102769|NCT00398216|464673099|FG002|Overall Study|Death|0|||
129102770|NCT00398216|464673100|FG003|Overall Study|Death|0|||
129102771|NCT00398216|464673101|FG004|Overall Study|Death|0|||
129102772|NCT00398216|464673097|FG000|Overall Study|Withdrawal by Subject|1|||
129102773|NCT00398216|464673098|FG001|Overall Study|Withdrawal by Subject|0|||
129102774|NCT00398216|464673099|FG002|Overall Study|Withdrawal by Subject|3|||
129102775|NCT00398216|464673100|FG003|Overall Study|Withdrawal by Subject|1|||
129102776|NCT00398216|464673101|FG004|Overall Study|Withdrawal by Subject|2|||
129102777|NCT00398216|464673097|FG000|Overall Study|administrative reasons|3|||
129102778|NCT00398216|464673098|FG001|Overall Study|administrative reasons|4|||
129102779|NCT00398216|464673099|FG002|Overall Study|administrative reasons|4|||
129102780|NCT00398216|464673100|FG003|Overall Study|administrative reasons|3|||
129102781|NCT00398216|464673101|FG004|Overall Study|administrative reasons|3|||
129102782|NCT00398216|464673097|FG000|Overall Study|entrance criteria|0|||
129102783|NCT00398216|464673098|FG001|Overall Study|entrance criteria|0|||
129102784|NCT00398216|464673099|FG002|Overall Study|entrance criteria|0|||
129102785|NCT00398216|464673100|FG003|Overall Study|entrance criteria|0|||
129102786|NCT00398216|464673101|FG004|Overall Study|entrance criteria|2|||
129102787|NCT00376532|464673102|FG000|Overall Study|Lack sufficient blood sample|6|||
129102788|NCT00376532|464673103|FG001|Overall Study|Lack sufficient blood sample|6|||
129102789|NCT04227405|464673104|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
128680309|NCT03901456|463128338|FG002|Overall Study|Withdrawal by Subject|1|||
129102790|NCT04227405|464673105|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
129102791|NCT04227405|464673104|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
129102792|NCT04227405|464673105|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
129102793|NCT04227405|464673104|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
129102794|NCT04227405|464673105|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
129102795|NCT02207400|464673106|FG000|Overall Study|Adverse Event|1|||
129102796|NCT02207400|464673107|FG001|Overall Study|Adverse Event|1|||
129102797|NCT02207400|464673106|FG000|Overall Study|Lost to Follow-up|6|||
129102798|NCT02207400|464673107|FG001|Overall Study|Lost to Follow-up|7|||
129102799|NCT02207400|464673106|FG000|Overall Study|Protocol Violation|1|||
129102800|NCT02207400|464673107|FG001|Overall Study|Protocol Violation|1|||
129102801|NCT02207400|464673106|FG000|Overall Study|Withdrawal by Subject|8|||
129102802|NCT02207400|464673107|FG001|Overall Study|Withdrawal by Subject|4|||
129102803|NCT02207400|464673106|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
128680310|NCT03901456|463128336|FG000|Overall Study|Lost to Follow-up|0|||
128680311|NCT03901456|463128337|FG001|Overall Study|Lost to Follow-up|1|||
129102804|NCT02207400|464673107|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
129102805|NCT02757352|464673110|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
129102806|NCT02757352|464673111|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102807|NCT02757352|464673112|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
129102808|NCT02757352|464673113|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102809|NCT02757352|464673114|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102810|NCT02757352|464673115|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102811|NCT02757352|464673116|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102812|NCT02757352|464673117|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102813|NCT02757352|464673118|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102814|NCT02757352|464673119|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129102815|NCT02757352|464673110|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102816|NCT02757352|464673111|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102817|NCT02757352|464673112|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
129102818|NCT02757352|464673113|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102819|NCT02757352|464673114|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102820|NCT02757352|464673115|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102821|NCT02757352|464673116|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102822|NCT02757352|464673117|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102823|NCT02757352|464673118|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102824|NCT02757352|464673119|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129102825|NCT02757352|464673110|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
129102826|NCT02757352|464673111|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
129102827|NCT02757352|464673112|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
129102828|NCT02757352|464673113|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129102829|NCT02757352|464673114|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129102830|NCT02757352|464673115|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
128680312|NCT03901456|463128338|FG002|Overall Study|Lost to Follow-up|0|||
129102831|NCT02757352|464673116|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129102832|NCT02757352|464673117|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129102833|NCT02757352|464673118|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129102834|NCT02757352|464673119|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129102835|NCT02757352|464673110|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102836|NCT02757352|464673111|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
129102837|NCT02757352|464673112|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102838|NCT02757352|464673113|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102839|NCT02757352|464673114|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102840|NCT02757352|464673115|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102841|NCT02757352|464673116|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102842|NCT02757352|464673117|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102843|NCT02757352|464673118|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102844|NCT02757352|464673119|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129102845|NCT02757352|464673110|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102846|NCT02757352|464673111|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129102847|NCT02757352|464673112|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102848|NCT02757352|464673113|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102849|NCT02757352|464673114|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102850|NCT02757352|464673115|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102851|NCT02757352|464673116|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102852|NCT02757352|464673117|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102853|NCT02757352|464673118|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102854|NCT02757352|464673119|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102855|NCT02757352|464673110|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129102856|NCT02757352|464673111|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129102857|NCT02757352|464673112|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
129102858|NCT02757352|464673113|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102859|NCT02757352|464673114|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102860|NCT02757352|464673115|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
128680313|NCT00773838|463128340|FG000|Overall Study|Adverse Event|29|||
128680314|NCT00773838|463128340|FG000|Overall Study|Lost to Follow-up|1|||
128680315|NCT00773838|463128340|FG000|Overall Study|Physician Decision|8|||
128680316|NCT00773838|463128340|FG000|Overall Study|Progressive Disease|82|||
128680317|NCT00773838|463128340|FG000|Overall Study|Protocol Violation|2|||
128680318|NCT00773838|463128340|FG000|Overall Study|Withdrawal by Subject|21|||
128680319|NCT01658813|463128345|FG000|Overall Study|Disease progression|3|||
128680320|NCT02674854|463128346|FG000|Overall Study|Adverse Event|17|||
128680321|NCT02674854|463128347|FG001|Overall Study|Adverse Event|15|||
128680322|NCT02674854|463128348|FG002|Overall Study|Adverse Event|5|||
128680323|NCT02674854|463128346|FG000|Overall Study|Withdrawal by Subject|1|||
128680324|NCT02674854|463128347|FG001|Overall Study|Withdrawal by Subject|5|||
128680325|NCT02674854|463128348|FG002|Overall Study|Withdrawal by Subject|4|||
128680326|NCT02674854|463128346|FG000|Overall Study|No-compliant subject|1|||
128680327|NCT02674854|463128347|FG001|Overall Study|No-compliant subject|0|||
129013660|NCT01519661|464344573|FG000|Overall Study|Lost to Follow-up|3|||
129013661|NCT01519661|464344573|FG000|Overall Study|Withdrawal by Subject|17|||
129013662|NCT01519661|464344573|FG000|Overall Study|Lack of Efficacy|6|||
129013663|NCT01519661|464344573|FG000|Overall Study|Adverse Event|29|||
129013664|NCT01139047|464344574|FG000|Overall Study|Withdrawal by Subject|1|||
129013665|NCT01941095|464344575|FG000|Overall Study|Insufficient therapeutic response|13|||
129013666|NCT01941095|464344575|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
129013667|NCT01941095|464344575|FG000|Overall Study|Adverse Event|11|||
129013668|NCT01941095|464344575|FG000|Overall Study|Physician Decision|3|||
129013669|NCT01941095|464344575|FG000|Overall Study|Withdrawal by Subject|17|||
129013670|NCT01941095|464344575|FG000|Overall Study|Lost to Follow-up|10|||
129013671|NCT02918877|464344578|FG000|Overall Study|Withdrawal by Subject|2|||
129013672|NCT02918877|464344579|FG001|Overall Study|Withdrawal by Subject|2|||
129013673|NCT02918877|464344578|FG000|Overall Study|Surgery cancelled|1|||
129013674|NCT02918877|464344579|FG001|Overall Study|Surgery cancelled|0|||
129013675|NCT02918877|464344578|FG000|Overall Study|Physician Decision|1|||
129013676|NCT02918877|464344579|FG001|Overall Study|Physician Decision|0|||
129013677|NCT02918877|464344578|FG000|Overall Study|Received intraoperative steroids|1|||
129013678|NCT02918877|464344579|FG001|Overall Study|Received intraoperative steroids|0|||
129013679|NCT02918877|464344578|FG000|Overall Study|Unable to obtain lab samples|1|||
129013680|NCT02918877|464344579|FG001|Overall Study|Unable to obtain lab samples|0|||
129013681|NCT02918877|464344578|FG000|Overall Study|Unsafe to perform BAL|0|||
129013682|NCT02918877|464344579|FG001|Overall Study|Unsafe to perform BAL|1|||
129013683|NCT05818137|464344580|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
129013684|NCT05818137|464344580|FG000|Extension Treatment Period|Ongoing participants|44|||
129013685|NCT01604850|464344585|FG000|Overall Study|Enrolled but never treated|0|||
129013686|NCT01604850|464344586|FG001|Overall Study|Enrolled but never treated|1|||
129013687|NCT01604850|464344585|FG000|Overall Study|Efficacy Failure|50|||
129013688|NCT01604850|464344586|FG001|Overall Study|Efficacy Failure|29|||
129013689|NCT01604850|464344585|FG000|Overall Study|Lost to Follow-up|1|||
129013690|NCT01604850|464344586|FG001|Overall Study|Lost to Follow-up|0|||
129013691|NCT01604850|464344585|FG000|Overall Study|Subject withdrew consent|1|||
129013692|NCT01604850|464344586|FG001|Overall Study|Subject withdrew consent|0|||
129013693|NCT00727571|464344587|FG000|Overall Study|Ineligibility determined|1|||
129013694|NCT00727571|464344588|FG001|Overall Study|Ineligibility determined|1|||
129013695|NCT00727571|464344589|FG002|Overall Study|Ineligibility determined|1|||
129013696|NCT00727571|464344590|FG003|Overall Study|Ineligibility determined|0|||
129013697|NCT00727571|464344587|FG000|Overall Study|Death|0|||
129013698|NCT00727571|464344588|FG001|Overall Study|Death|19|||
129013699|NCT00727571|464344589|FG002|Overall Study|Death|5|||
129013700|NCT00727571|464344590|FG003|Overall Study|Death|1|||
129013701|NCT00727571|464344587|FG000|Overall Study|Physician Decision|0|||
129013702|NCT00727571|464344588|FG001|Overall Study|Physician Decision|5|||
129013703|NCT00727571|464344589|FG002|Overall Study|Physician Decision|0|||
129013704|NCT00727571|464344590|FG003|Overall Study|Physician Decision|0|||
129013705|NCT00727571|464344587|FG000|Overall Study|Withdrawal by Subject|0|||
129013706|NCT00727571|464344588|FG001|Overall Study|Withdrawal by Subject|10|||
129013707|NCT00727571|464344589|FG002|Overall Study|Withdrawal by Subject|11|||
129013708|NCT00727571|464344590|FG003|Overall Study|Withdrawal by Subject|0|||
129013709|NCT00727571|464344587|FG000|Overall Study|Subject Non Compliance|0|||
129013710|NCT00727571|464344588|FG001|Overall Study|Subject Non Compliance|6|||
129013711|NCT00727571|464344589|FG002|Overall Study|Subject Non Compliance|0|||
129013712|NCT00727571|464344590|FG003|Overall Study|Subject Non Compliance|4|||
129013713|NCT00727571|464344587|FG000|Overall Study|Dismissed from nursing home|0|||
129013714|NCT00727571|464344588|FG001|Overall Study|Dismissed from nursing home|9|||
129013715|NCT00727571|464344589|FG002|Overall Study|Dismissed from nursing home|5|||
129013716|NCT00727571|464344590|FG003|Overall Study|Dismissed from nursing home|0|||
129013717|NCT00727571|464344587|FG000|Overall Study|Hospitalization|0|||
128680328|NCT02674854|463128348|FG002|Overall Study|No-compliant subject|1|||
128680329|NCT02674854|463128346|FG000|Overall Study|Lost to Follow-up|1|||
128680330|NCT02674854|463128347|FG001|Overall Study|Lost to Follow-up|0|||
129013718|NCT00727571|464344588|FG001|Overall Study|Hospitalization|1|||
129013719|NCT00727571|464344589|FG002|Overall Study|Hospitalization|0|||
129013720|NCT00727571|464344590|FG003|Overall Study|Hospitalization|1|||
129013721|NCT00727571|464344587|FG000|Overall Study|AE not leading to hospitalization|0|||
129013722|NCT00727571|464344588|FG001|Overall Study|AE not leading to hospitalization|0|||
129013723|NCT00727571|464344589|FG002|Overall Study|AE not leading to hospitalization|2|||
129013724|NCT00727571|464344590|FG003|Overall Study|AE not leading to hospitalization|0|||
129102861|NCT02757352|464673116|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102862|NCT02757352|464673117|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102863|NCT02757352|464673118|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102864|NCT02757352|464673119|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102865|NCT02757352|464673110|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
129102866|NCT02757352|464673111|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
129102867|NCT02757352|464673112|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
129102868|NCT02757352|464673113|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129102869|NCT02757352|464673114|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129102870|NCT02757352|464673115|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129102871|NCT02757352|464673116|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129102872|NCT02757352|464673117|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129102873|NCT02757352|464673118|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129102874|NCT02757352|464673119|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129102875|NCT02757352|464673110|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102876|NCT02757352|464673111|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102877|NCT02757352|464673112|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102878|NCT02757352|464673113|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
129102879|NCT02757352|464673114|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102880|NCT02757352|464673115|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
129102881|NCT02757352|464673116|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102882|NCT02757352|464673117|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102883|NCT02757352|464673118|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102884|NCT02757352|464673119|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129102885|NCT02757352|464673110|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102886|NCT02757352|464673111|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102887|NCT02757352|464673112|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102888|NCT02757352|464673113|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
129102889|NCT02757352|464673114|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129102890|NCT02757352|464673115|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
129102891|NCT02757352|464673116|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102892|NCT02757352|464673117|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102893|NCT02757352|464673118|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102894|NCT02757352|464673119|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129102895|NCT02757352|464673110|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102896|NCT02757352|464673111|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102897|NCT02757352|464673112|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102898|NCT02757352|464673113|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102899|NCT02757352|464673114|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
129102900|NCT02757352|464673115|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102901|NCT02757352|464673116|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102902|NCT02757352|464673117|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102903|NCT02757352|464673118|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102904|NCT02757352|464673119|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129102905|NCT02757352|464673110|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102906|NCT02757352|464673111|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102907|NCT02757352|464673112|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102908|NCT02757352|464673113|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102909|NCT02757352|464673114|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102910|NCT02757352|464673115|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
129102911|NCT02757352|464673116|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102912|NCT02757352|464673117|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102913|NCT02757352|464673118|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102914|NCT02757352|464673119|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129102915|NCT02757352|464673110|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102916|NCT02757352|464673111|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102917|NCT02757352|464673112|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102918|NCT02757352|464673113|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
129102919|NCT02757352|464673114|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129102920|NCT02757352|464673115|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129102921|NCT02757352|464673116|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
128680331|NCT02674854|463128348|FG002|Overall Study|Lost to Follow-up|2|||
128680332|NCT02674854|463128346|FG000|Overall Study|Lack of Efficacy|0|||
128680333|NCT02674854|463128347|FG001|Overall Study|Lack of Efficacy|3|||
128680334|NCT02674854|463128348|FG002|Overall Study|Lack of Efficacy|0|||
128680335|NCT02674854|463128346|FG000|Overall Study|Disallowed Concurrent Medication|2|||
128680336|NCT02674854|463128347|FG001|Overall Study|Disallowed Concurrent Medication|2|||
128680337|NCT02674854|463128348|FG002|Overall Study|Disallowed Concurrent Medication|0|||
128680338|NCT02674854|463128346|FG000|Overall Study|Protocol Violation|1|||
128680339|NCT02674854|463128347|FG001|Overall Study|Protocol Violation|1|||
128680340|NCT02674854|463128348|FG002|Overall Study|Protocol Violation|2|||
128680341|NCT02674854|463128346|FG000|Overall Study|Death|0|||
128680342|NCT02674854|463128347|FG001|Overall Study|Death|1|||
128680343|NCT02674854|463128348|FG002|Overall Study|Death|0|||
128680344|NCT02674854|463128346|FG000|Overall Study|Subject missed V6.2|1|||
128680345|NCT02674854|463128347|FG001|Overall Study|Subject missed V6.2|0|||
128680346|NCT02674854|463128348|FG002|Overall Study|Subject missed V6.2|0|||
128680347|NCT04231981|463128349|FG000|Overall Study|Adverse Event|1|||
128680348|NCT04231981|463128349|FG000|Overall Study|Death|16|||
128680349|NCT04231981|463128349|FG000|Overall Study|Lost to Follow-up|1|||
128680350|NCT02119676|463128350|FG000|Overall Study|Adverse Event|9|||
128680351|NCT02119676|463128351|FG001|Overall Study|Adverse Event|17|||
128680352|NCT02119676|463128352|FG002|Overall Study|Adverse Event|10|||
128680353|NCT02119676|463128353|FG003|Overall Study|Adverse Event|10|||
128680354|NCT02119676|463128350|FG000|Overall Study|Disease progression|53|||
128680355|NCT02119676|463128351|FG001|Overall Study|Disease progression|55|||
128680356|NCT02119676|463128352|FG002|Overall Study|Disease progression|68|||
128680357|NCT02119676|463128353|FG003|Overall Study|Disease progression|73|||
128680358|NCT02119676|463128350|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
128680359|NCT02119676|463128351|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
128680360|NCT02119676|463128352|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
128680361|NCT02119676|463128353|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
128680362|NCT02119676|463128350|FG000|Overall Study|Physician Decision|4|||
128680363|NCT02119676|463128351|FG001|Overall Study|Physician Decision|2|||
128680364|NCT02119676|463128352|FG002|Overall Study|Physician Decision|3|||
128680365|NCT02119676|463128353|FG003|Overall Study|Physician Decision|2|||
128680366|NCT02119676|463128350|FG000|Overall Study|Death|9|||
128680367|NCT02119676|463128351|FG001|Overall Study|Death|3|||
128680368|NCT02119676|463128352|FG002|Overall Study|Death|2|||
128680369|NCT02119676|463128353|FG003|Overall Study|Death|1|||
128680370|NCT02119676|463128350|FG000|Overall Study|Noncompliance|0|||
128680371|NCT02119676|463128351|FG001|Overall Study|Noncompliance|1|||
128680372|NCT02119676|463128352|FG002|Overall Study|Noncompliance|0|||
128680373|NCT02119676|463128353|FG003|Overall Study|Noncompliance|0|||
128680374|NCT02119676|463128350|FG000|Overall Study|Lost to Follow-up|0|||
128680375|NCT02119676|463128351|FG001|Overall Study|Lost to Follow-up|0|||
128680376|NCT02119676|463128352|FG002|Overall Study|Lost to Follow-up|1|||
128680377|NCT02119676|463128353|FG003|Overall Study|Lost to Follow-up|0|||
128680378|NCT02119676|463128350|FG000|Overall Study|Protocol deviation|0|||
129013725|NCT00727571|464344587|FG000|Overall Study|Other|0|||
129013726|NCT00727571|464344588|FG001|Overall Study|Other|4|||
129013727|NCT00727571|464344589|FG002|Overall Study|Other|6|||
129013728|NCT00727571|464344590|FG003|Overall Study|Other|0|||
129013729|NCT03164772|464344592|FG000|Overall Study|Death|4|||
129013730|NCT03164772|464344593|FG001|Overall Study|Death|2|||
129013731|NCT03164772|464344592|FG000|Overall Study|Adverse Event|1|||
128680379|NCT02119676|463128351|FG001|Overall Study|Protocol deviation|0|||
128680380|NCT02119676|463128352|FG002|Overall Study|Protocol deviation|1|||
128680381|NCT02119676|463128353|FG003|Overall Study|Protocol deviation|0|||
128680382|NCT02119676|463128350|FG000|Overall Study|Other, unspecified|2|||
128680383|NCT02119676|463128351|FG001|Overall Study|Other, unspecified|1|||
128680384|NCT02119676|463128352|FG002|Overall Study|Other, unspecified|3|||
128680385|NCT02119676|463128353|FG003|Overall Study|Other, unspecified|4|||
128680386|NCT02119676|463128350|FG000|Overall Study|Did not receive study med|2|||
128680387|NCT02119676|463128351|FG001|Overall Study|Did not receive study med|2|||
128680388|NCT02119676|463128352|FG002|Overall Study|Did not receive study med|4|||
128680389|NCT02119676|463128353|FG003|Overall Study|Did not receive study med|5|||
128680390|NCT02216812|463128354|FG000|Overall Study|Lost to Follow-up|10|||
128680391|NCT02216812|463128355|FG001|Overall Study|Lost to Follow-up|5|||
128680392|NCT01585584|463128356|FG000|Overall Study|Lack of Efficacy|1|||
128680393|NCT01585584|463128356|FG000|Overall Study|Withdrawal by Subject|1|||
128680394|NCT01585584|463128356|FG000|Overall Study|Physician Decision|2|||
128680395|NCT00527488|463128357|FG000|Overall Study|Withdrawn prior to dosing|0|||
128680396|NCT00527488|463128358|FG001|Overall Study|Withdrawn prior to dosing|1|||
128680397|NCT00527488|463128359|FG002|Overall Study|Withdrawn prior to dosing|1|||
128680398|NCT00527488|463128360|FG003|Overall Study|Withdrawn prior to dosing|0|||
128680399|NCT01958827|463128361|FG000|Overall Study|Adverse Event|3|||
128680400|NCT01958827|463128361|FG000|Overall Study|Lack of Efficacy|6|||
128680401|NCT01958827|463128361|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
128680402|NCT00266864|463128362|FG000|Overall Study|Lost to Follow-up|4|||
128680403|NCT00266864|463128363|FG001|Overall Study|Lost to Follow-up|1|||
129013732|NCT03164772|464344593|FG001|Overall Study|Adverse Event|4|||
128680404|NCT00266864|463128362|FG000|Overall Study|Withdrawal by Subject|1|||
128680405|NCT00266864|463128363|FG001|Overall Study|Withdrawal by Subject|1|||
128680406|NCT03036800|463128364|FG000|Overall Study|Protocol Violation|1|||
128680407|NCT03036800|463128365|FG001|Overall Study|Protocol Violation|0|||
129013733|NCT03164772|464344592|FG000|Overall Study|Progressive Disease|11|||
129013734|NCT03164772|464344593|FG001|Overall Study|Progressive Disease|21|||
129013735|NCT03164772|464344592|FG000|Overall Study|Physician Decision|2|||
129013736|NCT03164772|464344593|FG001|Overall Study|Physician Decision|0|||
129013737|NCT03164772|464344592|FG000|Overall Study|Withdrawal by Subject|0|||
129013738|NCT03164772|464344593|FG001|Overall Study|Withdrawal by Subject|4|||
129013739|NCT04099888|464344596|FG000|Overall Study|Study terminated by sponsor|9|||
129013740|NCT04099888|464344597|FG001|Overall Study|Study terminated by sponsor|11|||
129013741|NCT04099888|464344596|FG000|Overall Study|Lost to Follow-up|1|||
129013742|NCT04099888|464344597|FG001|Overall Study|Lost to Follow-up|1|||
129013743|NCT04099888|464344596|FG000|Overall Study|Withdrawal by Subject|5|||
129013744|NCT04099888|464344597|FG001|Overall Study|Withdrawal by Subject|6|||
129013745|NCT04099888|464344596|FG000|Overall Study|Death|5|||
129013746|NCT04099888|464344597|FG001|Overall Study|Death|2|||
129013747|NCT04099888|464344596|FG000|Overall Study|Other|1|||
129013748|NCT04099888|464344597|FG001|Overall Study|Other|0|||
129013749|NCT04538170|464344598|FG000|Overall Study|Withdrawal by Subject|104|||
129013750|NCT04538170|464344599|FG001|Overall Study|Withdrawal by Subject|210|||
129013751|NCT00051025|464344603|FG000|Overall Study|Progressive Disease|1|||
129013752|NCT00051025|464344604|FG001|Overall Study|Progressive Disease|1|||
129013753|NCT00051025|464344603|FG000|Overall Study|Adverse Event|1|||
129013754|NCT00051025|464344604|FG001|Overall Study|Adverse Event|1|||
129013755|NCT00051025|464344603|FG000|Overall Study|Withdrawal by Subject|0|||
129013756|NCT00051025|464344604|FG001|Overall Study|Withdrawal by Subject|1|||
129013757|NCT00051025|464344603|FG000|Overall Study|Death|0|||
129013758|NCT00051025|464344604|FG001|Overall Study|Death|1|||
129013759|NCT00274937|464344605|FG000|Overall Study|Physician Decision|10|||
129013760|NCT00274937|464344605|FG000|Overall Study|Withdrawal by Subject|6|||
129013761|NCT00274937|464344605|FG000|Overall Study|Progressive Disease|4|||
129013762|NCT02189941|464344606|FG000|Overall Study|Non-compliance|0|||
129013763|NCT02189941|464344607|FG001|Overall Study|Non-compliance|0|||
129013764|NCT02189941|464344608|FG002|Overall Study|Non-compliance|1|||
129013765|NCT00445003|464344610|FG000|Overall Study|Death|1|||
129013766|NCT00445003|464344611|FG001|Overall Study|Death|2|||
129013767|NCT00445003|464344612|FG002|Overall Study|Death|1|||
129013768|NCT00445003|464344610|FG000|Overall Study|Missed Visit|3|||
129013769|NCT00445003|464344611|FG001|Overall Study|Missed Visit|5|||
129013770|NCT00445003|464344612|FG002|Overall Study|Missed Visit|1|||
129013771|NCT00445003|464344610|FG000|Overall Study|Dropped|1|||
129013772|NCT00445003|464344611|FG001|Overall Study|Dropped|3|||
129013773|NCT00445003|464344612|FG002|Overall Study|Dropped|2|||
129013774|NCT01471093|464344613|FG000|Overall Study|Adverse Event|1|||
129013775|NCT01471093|464344614|FG001|Overall Study|Adverse Event|0|||
129013776|NCT01471093|464344615|FG002|Overall Study|Adverse Event|0|||
129013777|NCT01471093|464344616|FG003|Overall Study|Adverse Event|0|||
129013778|NCT02475954|464344617|FG000|Overall Study|Withdrawal by Subject|2|||
129013779|NCT02475954|464344618|FG001|Overall Study|Withdrawal by Subject|2|||
129013780|NCT02475954|464344617|FG000|Overall Study|Lost to Follow-up|11|||
129013781|NCT02475954|464344618|FG001|Overall Study|Lost to Follow-up|9|||
129013782|NCT02475954|464344617|FG000|Overall Study|Death|1|||
129013783|NCT02475954|464344618|FG001|Overall Study|Death|1|||
129013784|NCT02932878|464344619|FG000|Overall Study|Due to Lab Results|2|||
129013785|NCT02932878|464344620|FG001|Overall Study|Due to Lab Results|1|||
129013786|NCT01918397|464344621|FG000|Overall Study|Never started treatment|2|||
129013787|NCT01918397|464344622|FG001|Overall Study|Never started treatment|1|||
129013788|NCT01918397|464344623|FG002|Overall Study|Never started treatment|0|||
129013789|NCT01918397|464344624|FG003|Overall Study|Never started treatment|0|||
129013790|NCT01918397|464344621|FG000|Overall Study|Adverse Event|1|||
129013791|NCT01918397|464344622|FG001|Overall Study|Adverse Event|1|||
129013792|NCT01918397|464344623|FG002|Overall Study|Adverse Event|1|||
129013793|NCT01918397|464344624|FG003|Overall Study|Adverse Event|0|||
129013794|NCT01918397|464344621|FG000|Overall Study|Lack of compliance|2|||
129013795|NCT01918397|464344622|FG001|Overall Study|Lack of compliance|2|||
129013796|NCT01918397|464344623|FG002|Overall Study|Lack of compliance|3|||
128680408|NCT03036800|463128364|FG000|Overall Study|Non-compliance|1|||
128680409|NCT03036800|463128365|FG001|Overall Study|Non-compliance|0|||
128680410|NCT03036800|463128364|FG000|Overall Study|Lost to Follow-up|1|||
129013797|NCT01918397|464344624|FG003|Overall Study|Lack of compliance|0|||
129013798|NCT01918397|464344621|FG000|Overall Study|Pregnancy|0|||
129013799|NCT01918397|464344622|FG001|Overall Study|Pregnancy|1|||
129013800|NCT01918397|464344623|FG002|Overall Study|Pregnancy|0|||
129013801|NCT01918397|464344624|FG003|Overall Study|Pregnancy|0|||
129013802|NCT01918397|464344621|FG000|Overall Study|Rifampin susceptible|0|||
129013803|NCT01918397|464344622|FG001|Overall Study|Rifampin susceptible|0|||
129013804|NCT01918397|464344623|FG002|Overall Study|Rifampin susceptible|0|||
129013805|NCT01918397|464344624|FG003|Overall Study|Rifampin susceptible|2|||
129013806|NCT01918397|464344621|FG000|Overall Study|Treatment failure|0|||
129102922|NCT02757352|464673117|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102923|NCT02757352|464673118|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102924|NCT02757352|464673119|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129102925|NCT02757352|464673110|FG000|Follow-Up Period|Adverse Event|0|||
129102926|NCT02757352|464673111|FG001|Follow-Up Period|Adverse Event|0|||
129102927|NCT02757352|464673112|FG002|Follow-Up Period|Adverse Event|0|||
129102928|NCT02757352|464673113|FG003|Follow-Up Period|Adverse Event|0|||
129102929|NCT02757352|464673114|FG004|Follow-Up Period|Adverse Event|0|||
129102930|NCT02757352|464673115|FG005|Follow-Up Period|Adverse Event|0|||
129102931|NCT02757352|464673116|FG006|Follow-Up Period|Adverse Event|1|||
129102932|NCT02757352|464673117|FG007|Follow-Up Period|Adverse Event|0|||
128680411|NCT03036800|463128365|FG001|Overall Study|Lost to Follow-up|0|||
128680412|NCT03036800|463128364|FG000|Overall Study|Death|1|||
128680413|NCT03036800|463128365|FG001|Overall Study|Death|0|||
128680414|NCT03036800|463128364|FG000|Overall Study|Tolerance|5|||
128680415|NCT03036800|463128365|FG001|Overall Study|Tolerance|0|||
128680416|NCT03036800|463128364|FG000|Overall Study|Unknown/no reason given|50|||
129013807|NCT01918397|464344622|FG001|Overall Study|Treatment failure|0|||
129013808|NCT01918397|464344623|FG002|Overall Study|Treatment failure|0|||
129013809|NCT01918397|464344624|FG003|Overall Study|Treatment failure|1|||
129013810|NCT01918397|464344621|FG000|Overall Study|Withdrawal by Subject|3|||
129013811|NCT01918397|464344622|FG001|Overall Study|Withdrawal by Subject|2|||
129013812|NCT01918397|464344623|FG002|Overall Study|Withdrawal by Subject|1|||
129013813|NCT01918397|464344624|FG003|Overall Study|Withdrawal by Subject|1|||
129013814|NCT01918397|464344621|FG000|Overall Study|XDR at baseline|0|||
129013815|NCT01918397|464344622|FG001|Overall Study|XDR at baseline|0|||
129013816|NCT01918397|464344623|FG002|Overall Study|XDR at baseline|1|||
129013817|NCT01918397|464344624|FG003|Overall Study|XDR at baseline|0|||
129013818|NCT01918397|464344621|FG000|Overall Study|Lost to Follow-up|2|||
129013819|NCT01918397|464344622|FG001|Overall Study|Lost to Follow-up|1|||
129013820|NCT01918397|464344623|FG002|Overall Study|Lost to Follow-up|1|||
129013821|NCT01918397|464344624|FG003|Overall Study|Lost to Follow-up|1|||
129013822|NCT01918397|464344621|FG000|Overall Study|Increased QTc|1|||
129013823|NCT01918397|464344622|FG001|Overall Study|Increased QTc|0|||
129013824|NCT01918397|464344623|FG002|Overall Study|Increased QTc|0|||
129013825|NCT01918397|464344624|FG003|Overall Study|Increased QTc|1|||
129013826|NCT01918397|464344621|FG000|Overall Study|Death|0|||
129013827|NCT01918397|464344622|FG001|Overall Study|Death|0|||
129013828|NCT01918397|464344623|FG002|Overall Study|Death|1|||
129013829|NCT01918397|464344624|FG003|Overall Study|Death|0|||
129013830|NCT01918397|464344621|FG000|Overall Study|Involved in another investigative trial|0|||
129013831|NCT01918397|464344622|FG001|Overall Study|Involved in another investigative trial|0|||
129013832|NCT01918397|464344623|FG002|Overall Study|Involved in another investigative trial|0|||
129013833|NCT01918397|464344624|FG003|Overall Study|Involved in another investigative trial|1|||
129013834|NCT00620022|464344628|FG000|Treatment Period 1|Adverse Event|4|||
129013835|NCT00620022|464344629|FG001|Treatment Period 1|Adverse Event|6|||
129013836|NCT00620022|464344628|FG000|Treatment Period 1|Subject withdrew consent|1|||
129013837|NCT00620022|464344629|FG001|Treatment Period 1|Subject withdrew consent|0|||
129013838|NCT00620022|464344628|FG000|Treatment Period 2|Adverse Event|2|||
129013839|NCT00620022|464344629|FG001|Treatment Period 2|Adverse Event|2|||
129013840|NCT02152566|464344630|FG000|Overall Study|Lost to Follow-up|1|||
129013841|NCT02152566|464344630|FG000|Overall Study|Withdrawal by Subject|2|||
129013842|NCT02334722|464344631|FG000|Overall Study|Lost to Follow-up|4|||
129013843|NCT02334722|464344632|FG001|Overall Study|Lost to Follow-up|0|||
129013844|NCT02334722|464344631|FG000|Overall Study|6 week questionnaire not completed|2|||
129013845|NCT02334722|464344632|FG001|Overall Study|6 week questionnaire not completed|0|||
129013846|NCT02334722|464344631|FG000|Overall Study|Unable to obtain medication|1|||
129013847|NCT02334722|464344632|FG001|Overall Study|Unable to obtain medication|1|||
129013848|NCT02334722|464344631|FG000|Overall Study|Withdrawal by Subject|0|||
129013849|NCT02334722|464344632|FG001|Overall Study|Withdrawal by Subject|3|||
129013850|NCT02334722|464344631|FG000|Overall Study|Adverse Event|0|||
129013851|NCT02334722|464344632|FG001|Overall Study|Adverse Event|2|||
129013852|NCT02334722|464344631|FG000|Overall Study|Physician Decision|0|||
129013853|NCT02334722|464344632|FG001|Overall Study|Physician Decision|1|||
129102933|NCT02757352|464673118|FG008|Follow-Up Period|Adverse Event|2|||
129102934|NCT02757352|464673119|FG009|Follow-Up Period|Adverse Event|0|||
128680417|NCT03036800|463128365|FG001|Overall Study|Unknown/no reason given|39|||
128680418|NCT01077154|463128366|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
129013854|NCT00856388|464344633|FG000|Overall Study|Other|1|||
129013855|NCT01617668|464344636|FG000|Overall Study|Adverse Event|7|||
129013856|NCT01617668|464344637|FG001|Overall Study|Adverse Event|0|||
129013857|NCT01617668|464344638|FG002|Overall Study|Adverse Event|12|||
129013858|NCT01617668|464344639|FG003|Overall Study|Adverse Event|5|||
129013859|NCT01617668|464344636|FG000|Overall Study|Physician Decision|1|||
129013860|NCT01617668|464344637|FG001|Overall Study|Physician Decision|2|||
129013861|NCT01617668|464344638|FG002|Overall Study|Physician Decision|3|||
129013862|NCT01617668|464344639|FG003|Overall Study|Physician Decision|0|||
129102935|NCT02757352|464673110|FG000|Follow-Up Period|Lost to Follow-up|0|||
128680419|NCT01077154|463128367|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
128680420|NCT01077154|463128366|FG000|Overall Study|Withdrawal by Subject|369|||
128680421|NCT01077154|463128367|FG001|Overall Study|Withdrawal by Subject|385|||
128680422|NCT01077154|463128366|FG000|Overall Study|Death|215|||
128680423|NCT01077154|463128367|FG001|Overall Study|Death|214|||
128680424|NCT01077154|463128366|FG000|Overall Study|Lost to Follow-up|43|||
128680425|NCT01077154|463128367|FG001|Overall Study|Lost to Follow-up|35|||
128680426|NCT01077154|463128366|FG000|Overall Study|Noncompliance|22|||
128680427|NCT01077154|463128367|FG001|Overall Study|Noncompliance|20|||
128680428|NCT01077154|463128366|FG000|Overall Study|Disease Progression|18|||
128680429|NCT01077154|463128367|FG001|Overall Study|Disease Progression|20|||
128680430|NCT01077154|463128366|FG000|Overall Study|Ineligibility Determined|10|||
128680431|NCT01077154|463128367|FG001|Overall Study|Ineligibility Determined|14|||
128680432|NCT01077154|463128366|FG000|Overall Study|Other|14|||
128680433|NCT01077154|463128367|FG001|Overall Study|Other|11|||
128680434|NCT01077154|463128366|FG000|Overall Study|Adverse Event|9|||
128680435|NCT01077154|463128367|FG001|Overall Study|Adverse Event|9|||
128680436|NCT01077154|463128366|FG000|Overall Study|Administrative Decision|1|||
128680437|NCT01077154|463128367|FG001|Overall Study|Administrative Decision|6|||
128680438|NCT01077154|463128366|FG000|Overall Study|Protocol Deviation|1|||
128680439|NCT01077154|463128367|FG001|Overall Study|Protocol Deviation|0|||
128680440|NCT00686998|463128368|FG000|Overall Study|Adverse Event|3|||
128680441|NCT00686998|463128369|FG001|Overall Study|Adverse Event|2|||
128680442|NCT00686998|463128370|FG002|Overall Study|Adverse Event|1|||
128680443|NCT00686998|463128368|FG000|Overall Study|Withdrawal by Subject|2|||
128680444|NCT00686998|463128369|FG001|Overall Study|Withdrawal by Subject|1|||
128680445|NCT00686998|463128370|FG002|Overall Study|Withdrawal by Subject|2|||
128680446|NCT00686998|463128368|FG000|Overall Study|Lack of Efficacy|7|||
128680447|NCT00686998|463128369|FG001|Overall Study|Lack of Efficacy|5|||
128680448|NCT00686998|463128370|FG002|Overall Study|Lack of Efficacy|0|||
128680449|NCT00686998|463128368|FG000|Overall Study|Other|0|||
128680450|NCT00686998|463128369|FG001|Overall Study|Other|0|||
128680451|NCT00686998|463128370|FG002|Overall Study|Other|1|||
128680452|NCT00686998|463128368|FG000|Overall Study|Safety Reasons|1|||
128680453|NCT00686998|463128369|FG001|Overall Study|Safety Reasons|0|||
128680454|NCT00686998|463128370|FG002|Overall Study|Safety Reasons|0|||
129013863|NCT01617668|464344636|FG000|Overall Study|Progressive Disease|4|||
129013864|NCT01617668|464344637|FG001|Overall Study|Progressive Disease|4|||
129013865|NCT01617668|464344638|FG002|Overall Study|Progressive Disease|6|||
129013866|NCT01617668|464344639|FG003|Overall Study|Progressive Disease|9|||
129013867|NCT01617668|464344636|FG000|Overall Study|Subject/guardian decision|1|||
129013868|NCT01617668|464344637|FG001|Overall Study|Subject/guardian decision|3|||
129013869|NCT01617668|464344638|FG002|Overall Study|Subject/guardian decision|2|||
129013870|NCT01617668|464344639|FG003|Overall Study|Subject/guardian decision|1|||
129013871|NCT00925769|464344640|FG000|Overall Study|Major toxicity|1|||
129013872|NCT00925769|464344641|FG001|Overall Study|Major toxicity|0|||
129013873|NCT00925769|464344642|FG002|Overall Study|Major toxicity|1|||
129013874|NCT00925769|464344643|FG003|Overall Study|Major toxicity|1|||
129013875|NCT00925769|464344644|FG004|Overall Study|Major toxicity|0|||
129013876|NCT00925769|464344645|FG005|Overall Study|Major toxicity|0|||
129013877|NCT00925769|464344640|FG000|Overall Study|Disease progression|4|||
129013878|NCT00925769|464344641|FG001|Overall Study|Disease progression|5|||
129013879|NCT00925769|464344642|FG002|Overall Study|Disease progression|3|||
129013880|NCT00925769|464344643|FG003|Overall Study|Disease progression|4|||
129013881|NCT00925769|464344644|FG004|Overall Study|Disease progression|2|||
129013882|NCT00925769|464344645|FG005|Overall Study|Disease progression|3|||
129013883|NCT00925769|464344640|FG000|Overall Study|Death|0|||
129013884|NCT00925769|464344641|FG001|Overall Study|Death|0|||
129013885|NCT00925769|464344642|FG002|Overall Study|Death|1|||
129013886|NCT00925769|464344643|FG003|Overall Study|Death|0|||
129013887|NCT00925769|464344644|FG004|Overall Study|Death|0|||
129013888|NCT00925769|464344645|FG005|Overall Study|Death|0|||
128680455|NCT05985980|463128371|FG000|Overall Study|Withdrawal by Subject|1|||
128680456|NCT05985980|463128371|FG000|Overall Study|Withdrawal by Subject|1|||
128680457|NCT05985980|463128371|FG000|Overall Study|Withdrawal by Subject|1|||
128680458|NCT05985980|463128371|FG000|Overall Study|Withdrawal by Subject|1|||
128680459|NCT04085367|463130155|FG000|Overall Study|Adverse Event|1|||
128680460|NCT04085367|463130156|FG001|Overall Study|Adverse Event|1|||
128680461|NCT04085367|463130155|FG000|Overall Study|Withdrawal by Subject|13|||
128680462|NCT04085367|463130156|FG001|Overall Study|Withdrawal by Subject|4|||
128680463|NCT04085367|463130155|FG000|Overall Study|Lost to Follow-up|3|||
128680464|NCT04085367|463130156|FG001|Overall Study|Lost to Follow-up|1|||
128680465|NCT04085367|463130155|FG000|Overall Study|Other unspecified|2|||
128680466|NCT04085367|463130156|FG001|Overall Study|Other unspecified|1|||
128680467|NCT04085367|463130155|FG000|Overall Study|Status Unknown|1|||
128680468|NCT04085367|463130156|FG001|Overall Study|Status Unknown|1|||
129013889|NCT00925769|464344640|FG000|Overall Study|Physician Decision|1|||
129013890|NCT00925769|464344641|FG001|Overall Study|Physician Decision|0|||
129013891|NCT00925769|464344642|FG002|Overall Study|Physician Decision|0|||
129013892|NCT00925769|464344643|FG003|Overall Study|Physician Decision|0|||
128680469|NCT00706849|463130167|FG000|Treatment Period|Adverse Event|0|||
128680470|NCT00706849|463130168|FG001|Treatment Period|Adverse Event|9|||
128680471|NCT00706849|463130167|FG000|Treatment Period|Other|0|||
128680472|NCT00706849|463130168|FG001|Treatment Period|Other|1|||
128680473|NCT00706849|463130167|FG000|Follow-up Period|Withdrawal by Subject|0|||
128680474|NCT00706849|463130168|FG001|Follow-up Period|Withdrawal by Subject|2|||
128680475|NCT00706849|463130167|FG000|Follow-up Period|Protocol non-compliance|0|||
128680476|NCT00706849|463130168|FG001|Follow-up Period|Protocol non-compliance|1|||
128680477|NCT01611454|463130169|FG000|Overall Study|Lack of Efficacy|18|||
128680478|NCT01611454|463130170|FG001|Overall Study|Lack of Efficacy|10|||
129013893|NCT00925769|464344644|FG004|Overall Study|Physician Decision|0|||
129013894|NCT00925769|464344645|FG005|Overall Study|Physician Decision|0|||
129013895|NCT00925769|464344640|FG000|Overall Study|Missing documentation|0|||
129013896|NCT00925769|464344641|FG001|Overall Study|Missing documentation|1|||
129013897|NCT00925769|464344642|FG002|Overall Study|Missing documentation|0|||
129013898|NCT00925769|464344643|FG003|Overall Study|Missing documentation|0|||
129013899|NCT00925769|464344644|FG004|Overall Study|Missing documentation|0|||
129013900|NCT00925769|464344645|FG005|Overall Study|Missing documentation|0|||
129013901|NCT00925769|464344640|FG000|Overall Study|End of study visit not done|0|||
129013902|NCT00925769|464344641|FG001|Overall Study|End of study visit not done|0|||
129013903|NCT00925769|464344642|FG002|Overall Study|End of study visit not done|1|||
129013904|NCT00925769|464344643|FG003|Overall Study|End of study visit not done|0|||
129013905|NCT00925769|464344644|FG004|Overall Study|End of study visit not done|0|||
129013906|NCT00925769|464344645|FG005|Overall Study|End of study visit not done|0|||
129013907|NCT00925769|464344640|FG000|Overall Study|Participant is unable to swallow drug|0|||
129013908|NCT00925769|464344641|FG001|Overall Study|Participant is unable to swallow drug|0|||
129013909|NCT00925769|464344642|FG002|Overall Study|Participant is unable to swallow drug|0|||
129013910|NCT00925769|464344643|FG003|Overall Study|Participant is unable to swallow drug|1|||
129013911|NCT00925769|464344644|FG004|Overall Study|Participant is unable to swallow drug|0|||
129013912|NCT00925769|464344645|FG005|Overall Study|Participant is unable to swallow drug|0|||
129013913|NCT00925769|464344640|FG000|Overall Study|Adverse Event|0|||
129013914|NCT00925769|464344641|FG001|Overall Study|Adverse Event|0|||
129013915|NCT00925769|464344642|FG002|Overall Study|Adverse Event|0|||
129013916|NCT00925769|464344643|FG003|Overall Study|Adverse Event|0|||
129013917|NCT00925769|464344644|FG004|Overall Study|Adverse Event|1|||
129013918|NCT00925769|464344645|FG005|Overall Study|Adverse Event|0|||
129013919|NCT02017964|464344646|FG000|Overall Study|Patient deemed ineligible|1|||
129013920|NCT00686959|464344648|FG000|Overall Study|Participants censored (no death events)|124|||
129013921|NCT00686959|464344649|FG001|Overall Study|Participants censored (no death events)|117|||
129013922|NCT00150462|464344650|FG000|Overall Study|Disease Progression or Relapse|3|||
129013923|NCT00150462|464344651|FG001|Overall Study|Disease Progression or Relapse|1|||
129013924|NCT00150462|464344652|FG002|Overall Study|Disease Progression or Relapse|2|||
129013925|NCT00150462|464344653|FG003|Overall Study|Disease Progression or Relapse|1|||
129013926|NCT00150462|464344654|FG004|Overall Study|Disease Progression or Relapse|2|||
129013927|NCT00150462|464344655|FG005|Overall Study|Disease Progression or Relapse|2|||
129013928|NCT00150462|464344656|FG006|Overall Study|Disease Progression or Relapse|3|||
129013929|NCT00150462|464344657|FG007|Overall Study|Disease Progression or Relapse|5|||
129013930|NCT00150462|464344658|FG008|Overall Study|Disease Progression or Relapse|5|||
129013931|NCT00150462|464344659|FG009|Overall Study|Disease Progression or Relapse|3|||
129013932|NCT00150462|464344660|FG010|Overall Study|Disease Progression or Relapse|2|||
129013933|NCT00150462|464344650|FG000|Overall Study|Withdrawal by Subject|0|||
129013934|NCT00150462|464344651|FG001|Overall Study|Withdrawal by Subject|1|||
129013935|NCT00150462|464344652|FG002|Overall Study|Withdrawal by Subject|1|||
129013936|NCT00150462|464344653|FG003|Overall Study|Withdrawal by Subject|0|||
129013937|NCT00150462|464344654|FG004|Overall Study|Withdrawal by Subject|1|||
129013938|NCT00150462|464344655|FG005|Overall Study|Withdrawal by Subject|2|||
129013939|NCT00150462|464344656|FG006|Overall Study|Withdrawal by Subject|0|||
129013940|NCT00150462|464344657|FG007|Overall Study|Withdrawal by Subject|1|||
129013941|NCT00150462|464344658|FG008|Overall Study|Withdrawal by Subject|0|||
129013942|NCT00150462|464344659|FG009|Overall Study|Withdrawal by Subject|1|||
129013943|NCT00150462|464344660|FG010|Overall Study|Withdrawal by Subject|0|||
129013944|NCT00150462|464344650|FG000|Overall Study|Death|0|||
129013945|NCT00150462|464344651|FG001|Overall Study|Death|1|||
129013946|NCT00150462|464344652|FG002|Overall Study|Death|0|||
129013947|NCT00150462|464344653|FG003|Overall Study|Death|0|||
129013948|NCT00150462|464344654|FG004|Overall Study|Death|0|||
129013949|NCT00150462|464344655|FG005|Overall Study|Death|0|||
129013950|NCT00150462|464344656|FG006|Overall Study|Death|0|||
129013951|NCT00150462|464344657|FG007|Overall Study|Death|0|||
129013952|NCT00150462|464344658|FG008|Overall Study|Death|1|||
129013953|NCT00150462|464344659|FG009|Overall Study|Death|0|||
129013954|NCT00150462|464344660|FG010|Overall Study|Death|0|||
129013955|NCT00150462|464344650|FG000|Overall Study|Adverse Event|0|||
128680479|NCT03269552|463130172|FG000|Overall Study|Adverse Event|2|||
128680480|NCT00920907|463130173|FG000|Induction Period|Adverse Event|0|||
128680481|NCT00920907|463130174|FG001|Induction Period|Adverse Event|2|||
128680482|NCT00920907|463130173|FG000|Induction Period|Death|1|||
128680483|NCT00920907|463130174|FG001|Induction Period|Death|1|||
128680484|NCT00920907|463130173|FG000|Induction Period|Disease Progression|12|||
128680485|NCT00920907|463130174|FG001|Induction Period|Disease Progression|11|||
128680486|NCT00920907|463130173|FG000|Induction Period|Study Drug Toxicity|8|||
128680487|NCT00920907|463130174|FG001|Induction Period|Study Drug Toxicity|6|||
128680488|NCT00920907|463130173|FG000|Induction Period|No longer meets study criteria|0|||
128680489|NCT00920907|463130174|FG001|Induction Period|No longer meets study criteria|1|||
128680490|NCT00920907|463130173|FG000|Induction Period|Withdrawal by Subject|1|||
128680491|NCT00920907|463130174|FG001|Induction Period|Withdrawal by Subject|1|||
128680492|NCT00920907|463130173|FG000|Maintenance Period|Disease Progression|3|||
128680493|NCT00920907|463130174|FG001|Maintenance Period|Disease Progression|7|||
128680494|NCT00920907|463130173|FG000|Maintenance Period|Administrative (study closure)|7|||
128680495|NCT00920907|463130174|FG001|Maintenance Period|Administrative (study closure)|2|||
128680496|NCT00920907|463130173|FG000|Maintenance Period|Study Drug Toxicity|0|||
128680497|NCT00920907|463130174|FG001|Maintenance Period|Study Drug Toxicity|2|||
128680498|NCT00920907|463130173|FG000|Maintenance Period|Death|1|||
128680499|NCT00920907|463130174|FG001|Maintenance Period|Death|1|||
128680500|NCT00920907|463130173|FG000|Maintenance Period|Withdrawal by Subject|1|||
128680501|NCT00920907|463130174|FG001|Maintenance Period|Withdrawal by Subject|0|||
129013956|NCT00150462|464344651|FG001|Overall Study|Adverse Event|0|||
129013957|NCT00150462|464344652|FG002|Overall Study|Adverse Event|0|||
129013958|NCT00150462|464344653|FG003|Overall Study|Adverse Event|1|||
129013959|NCT00150462|464344654|FG004|Overall Study|Adverse Event|0|||
129013960|NCT00150462|464344655|FG005|Overall Study|Adverse Event|0|||
129013961|NCT00150462|464344656|FG006|Overall Study|Adverse Event|0|||
129013962|NCT00150462|464344657|FG007|Overall Study|Adverse Event|2|||
129013963|NCT00150462|464344658|FG008|Overall Study|Adverse Event|0|||
129013964|NCT00150462|464344659|FG009|Overall Study|Adverse Event|1|||
129013965|NCT00150462|464344660|FG010|Overall Study|Adverse Event|0|||
129013966|NCT00150462|464344650|FG000|Overall Study|Physician Decision|0|||
129013967|NCT00150462|464344651|FG001|Overall Study|Physician Decision|0|||
129013968|NCT00150462|464344652|FG002|Overall Study|Physician Decision|1|||
129013969|NCT00150462|464344653|FG003|Overall Study|Physician Decision|1|||
129013970|NCT00150462|464344654|FG004|Overall Study|Physician Decision|0|||
129013971|NCT00150462|464344655|FG005|Overall Study|Physician Decision|0|||
129013972|NCT00150462|464344656|FG006|Overall Study|Physician Decision|0|||
129013973|NCT00150462|464344657|FG007|Overall Study|Physician Decision|0|||
129013974|NCT00150462|464344658|FG008|Overall Study|Physician Decision|0|||
129013975|NCT00150462|464344659|FG009|Overall Study|Physician Decision|0|||
129013976|NCT00150462|464344660|FG010|Overall Study|Physician Decision|0|||
129013977|NCT00150462|464344650|FG000|Overall Study|Other|0|||
129013978|NCT00150462|464344651|FG001|Overall Study|Other|0|||
129013979|NCT00150462|464344652|FG002|Overall Study|Other|0|||
129013980|NCT00150462|464344653|FG003|Overall Study|Other|0|||
129013981|NCT00150462|464344654|FG004|Overall Study|Other|0|||
129013982|NCT00150462|464344655|FG005|Overall Study|Other|0|||
129013983|NCT00150462|464344656|FG006|Overall Study|Other|0|||
129013984|NCT00150462|464344657|FG007|Overall Study|Other|0|||
129013985|NCT00150462|464344658|FG008|Overall Study|Other|0|||
129013986|NCT00150462|464344659|FG009|Overall Study|Other|1|||
129013987|NCT00150462|464344660|FG010|Overall Study|Other|1|||
129013988|NCT01196052|464344663|FG000|Overall Study|Adverse Event|9|||
129013989|NCT01196052|464344663|FG000|Overall Study|Lost to Follow-up|1|||
129013990|NCT01196052|464344663|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
129013991|NCT01196052|464344663|FG000|Overall Study|Reason not Specified|5|||
129013992|NCT01196052|464344663|FG000|Overall Study|Withdrawal by Subject|6|||
129013993|NCT02178722|464344664|FG000|Overall Study|Withdrawal by Subject|0|||
129013994|NCT02178722|464344665|FG001|Overall Study|Withdrawal by Subject|0|||
129013995|NCT02178722|464344666|FG002|Overall Study|Withdrawal by Subject|0|||
129013996|NCT02178722|464344667|FG003|Overall Study|Withdrawal by Subject|2|||
129013997|NCT02178722|464344668|FG004|Overall Study|Withdrawal by Subject|33|||
129013998|NCT02178722|464344664|FG000|Overall Study|Death|2|||
129013999|NCT02178722|464344665|FG001|Overall Study|Death|13|||
129014000|NCT02178722|464344666|FG002|Overall Study|Death|12|||
129014001|NCT02178722|464344667|FG003|Overall Study|Death|12|||
129014002|NCT02178722|464344668|FG004|Overall Study|Death|205|||
129014003|NCT02178722|464344664|FG000|Overall Study|Lost to Follow-up|0|||
129014004|NCT02178722|464344665|FG001|Overall Study|Lost to Follow-up|0|||
128680502|NCT00920907|463130173|FG000|Maintenance Period|Adverse Event|0|||
128680503|NCT00920907|463130174|FG001|Maintenance Period|Adverse Event|1|||
128680504|NCT02616601|463130175|FG000|Overall Study|Withdrawal by Subject|4|||
128680505|NCT02616601|463130176|FG001|Overall Study|Withdrawal by Subject|4|||
128680506|NCT02616601|463130177|FG002|Overall Study|Withdrawal by Subject|3|||
128680507|NCT02616601|463130175|FG000|Overall Study|Adverse Event|2|||
128680508|NCT02616601|463130176|FG001|Overall Study|Adverse Event|0|||
128680509|NCT02616601|463130177|FG002|Overall Study|Adverse Event|2|||
129014005|NCT02178722|464344666|FG002|Overall Study|Lost to Follow-up|0|||
129014006|NCT02178722|464344667|FG003|Overall Study|Lost to Follow-up|2|||
129014007|NCT02178722|464344668|FG004|Overall Study|Lost to Follow-up|11|||
129102936|NCT02757352|464673111|FG001|Follow-Up Period|Lost to Follow-up|0|||
129102937|NCT02757352|464673112|FG002|Follow-Up Period|Lost to Follow-up|0|||
129102938|NCT02757352|464673113|FG003|Follow-Up Period|Lost to Follow-up|0|||
129102939|NCT02757352|464673114|FG004|Follow-Up Period|Lost to Follow-up|0|||
129102940|NCT02757352|464673115|FG005|Follow-Up Period|Lost to Follow-up|0|||
129102941|NCT02757352|464673116|FG006|Follow-Up Period|Lost to Follow-up|0|||
129102942|NCT02757352|464673117|FG007|Follow-Up Period|Lost to Follow-up|0|||
129102943|NCT02757352|464673118|FG008|Follow-Up Period|Lost to Follow-up|1|||
129102944|NCT02757352|464673119|FG009|Follow-Up Period|Lost to Follow-up|0|||
129102945|NCT02757352|464673110|FG000|Follow-Up Period|Lack of Efficacy|0|||
129102946|NCT02757352|464673111|FG001|Follow-Up Period|Lack of Efficacy|0|||
129014008|NCT02178722|464344664|FG000|Overall Study|Study terminated by Sponsor|2|||
129014009|NCT02178722|464344665|FG001|Overall Study|Study terminated by Sponsor|7|||
129014010|NCT02178722|464344666|FG002|Overall Study|Study terminated by Sponsor|6|||
129014011|NCT02178722|464344667|FG003|Overall Study|Study terminated by Sponsor|4|||
129014012|NCT02178722|464344668|FG004|Overall Study|Study terminated by Sponsor|128|||
129102947|NCT02757352|464673112|FG002|Follow-Up Period|Lack of Efficacy|0|||
129102948|NCT02757352|464673113|FG003|Follow-Up Period|Lack of Efficacy|0|||
129102949|NCT02757352|464673114|FG004|Follow-Up Period|Lack of Efficacy|0|||
129102950|NCT02757352|464673115|FG005|Follow-Up Period|Lack of Efficacy|0|||
129102951|NCT02757352|464673116|FG006|Follow-Up Period|Lack of Efficacy|0|||
129102952|NCT02757352|464673117|FG007|Follow-Up Period|Lack of Efficacy|0|||
129102953|NCT02757352|464673118|FG008|Follow-Up Period|Lack of Efficacy|1|||
129102954|NCT02757352|464673119|FG009|Follow-Up Period|Lack of Efficacy|1|||
129102955|NCT02757352|464673110|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129102956|NCT02757352|464673111|FG001|Follow-Up Period|Withdrawal by Subject|0|||
129102957|NCT02757352|464673112|FG002|Follow-Up Period|Withdrawal by Subject|0|||
129102958|NCT02757352|464673113|FG003|Follow-Up Period|Withdrawal by Subject|0|||
129102959|NCT02757352|464673114|FG004|Follow-Up Period|Withdrawal by Subject|0|||
129102960|NCT02757352|464673115|FG005|Follow-Up Period|Withdrawal by Subject|0|||
129102961|NCT02757352|464673116|FG006|Follow-Up Period|Withdrawal by Subject|0|||
129102962|NCT02757352|464673117|FG007|Follow-Up Period|Withdrawal by Subject|1|||
129102963|NCT02757352|464673118|FG008|Follow-Up Period|Withdrawal by Subject|6|||
129102964|NCT02757352|464673119|FG009|Follow-Up Period|Withdrawal by Subject|2|||
129102965|NCT02362425|464673120|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
129102966|NCT02362425|464673121|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
129102967|NCT02362425|464673122|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
129102968|NCT02362425|464673123|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
129102969|NCT02362425|464673120|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
129102970|NCT02362425|464673121|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
129102971|NCT02362425|464673122|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
129102972|NCT02362425|464673123|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
129102973|NCT02362425|464673120|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
129102974|NCT02362425|464673121|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
129102975|NCT02362425|464673122|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
129102976|NCT02362425|464673123|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
129014013|NCT02178722|464344664|FG000|Overall Study|Physician Decision|0|||
129014014|NCT02178722|464344665|FG001|Overall Study|Physician Decision|0|||
129014015|NCT02178722|464344666|FG002|Overall Study|Physician Decision|0|||
129014016|NCT02178722|464344667|FG003|Overall Study|Physician Decision|0|||
129014017|NCT02178722|464344668|FG004|Overall Study|Physician Decision|3|||
129014018|NCT02178722|464344664|FG000|Overall Study|Other|0|||
129014019|NCT02178722|464344665|FG001|Overall Study|Other|0|||
129014020|NCT02178722|464344666|FG002|Overall Study|Other|0|||
129014021|NCT02178722|464344667|FG003|Overall Study|Other|0|||
129014022|NCT02178722|464344668|FG004|Overall Study|Other|2|||
129014023|NCT03340727|464344669|FG000|Overall Study|Death|1|||
129014024|NCT03340727|464344670|FG001|Overall Study|Death|0|||
129014025|NCT03340727|464344669|FG000|Overall Study|Lost to Follow-up|31|||
129014026|NCT03340727|464344670|FG001|Overall Study|Lost to Follow-up|35|||
129014027|NCT03340727|464344669|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
129014028|NCT03340727|464344670|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
129014029|NCT03340727|464344669|FG000|Overall Study|Transferred to another facility|10|||
129014030|NCT03340727|464344670|FG001|Overall Study|Transferred to another facility|7|||
129102977|NCT02362425|464673120|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
129102978|NCT02362425|464673121|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
129102979|NCT02362425|464673122|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
129102980|NCT02362425|464673123|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
129102981|NCT02362425|464673120|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
128680510|NCT02616601|463130175|FG000|Overall Study|Death|1|||
129014031|NCT03340727|464344669|FG000|Overall Study|Withdrawal by Subject|28|||
129014032|NCT03340727|464344670|FG001|Overall Study|Withdrawal by Subject|17|||
129014033|NCT01720264|464344671|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
129014034|NCT01720264|464344671|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
128680511|NCT02616601|463130176|FG001|Overall Study|Death|0|||
128680512|NCT02616601|463130177|FG002|Overall Study|Death|0|||
128680513|NCT02616601|463130175|FG000|Overall Study|Lost to Follow-up|1|||
128680514|NCT02616601|463130176|FG001|Overall Study|Lost to Follow-up|0|||
128680515|NCT02616601|463130177|FG002|Overall Study|Lost to Follow-up|1|||
128680516|NCT02616601|463130175|FG000|Overall Study|Non-Compliance with Test Article|1|||
128680517|NCT02616601|463130176|FG001|Overall Study|Non-Compliance with Test Article|0|||
128680518|NCT02616601|463130177|FG002|Overall Study|Non-Compliance with Test Article|1|||
128680519|NCT02186301|463130178|FG000|Overall Study|Progressive Disease|7|||
128680520|NCT02186301|463130179|FG001|Overall Study|Progressive Disease|22|||
128680521|NCT02186301|463130180|FG002|Overall Study|Progressive Disease|27|||
128680522|NCT02186301|463130178|FG000|Overall Study|Adverse Event|5|||
128680523|NCT02186301|463130179|FG001|Overall Study|Adverse Event|5|||
128680524|NCT02186301|463130180|FG002|Overall Study|Adverse Event|5|||
128680525|NCT02186301|463130178|FG000|Overall Study|Death|1|||
128680526|NCT02186301|463130179|FG001|Overall Study|Death|0|||
128680527|NCT02186301|463130180|FG002|Overall Study|Death|0|||
128680528|NCT02186301|463130178|FG000|Overall Study|Withdrawal by Subject|5|||
128680529|NCT02186301|463130179|FG001|Overall Study|Withdrawal by Subject|1|||
128680530|NCT02186301|463130180|FG002|Overall Study|Withdrawal by Subject|3|||
128680531|NCT02186301|463130178|FG000|Overall Study|Physician Decision|1|||
128680532|NCT02186301|463130179|FG001|Overall Study|Physician Decision|0|||
128680533|NCT02186301|463130180|FG002|Overall Study|Physician Decision|1|||
128680534|NCT02186301|463130178|FG000|Overall Study|Study Terminated by Sponsor|1|||
128680535|NCT02186301|463130179|FG001|Overall Study|Study Terminated by Sponsor|0|||
128680536|NCT02186301|463130180|FG002|Overall Study|Study Terminated by Sponsor|11|||
128680537|NCT02186301|463130178|FG000|Overall Study|Protocol Deviation|0|||
129014035|NCT01720264|464344671|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
129014036|NCT00877032|464344672|FG000|Overall Study|Did not meet entrance criteria|0|||
129014037|NCT00877032|464344673|FG001|Overall Study|Did not meet entrance criteria|0|||
129014038|NCT00877032|464344674|FG002|Overall Study|Did not meet entrance criteria|0|||
129014039|NCT00877032|464344675|FG003|Overall Study|Did not meet entrance criteria|1|||
129014040|NCT00877032|464344676|FG004|Overall Study|Did not meet entrance criteria|0|||
129014041|NCT00877032|464344677|FG005|Overall Study|Did not meet entrance criteria|0|||
129014042|NCT00877032|464344678|FG006|Overall Study|Did not meet entrance criteria|2|||
129014043|NCT00615069|464344688|FG000|Overall Study|Death|10|||
129014044|NCT00615069|464344688|FG000|Overall Study|Physician Decision|2|||
129014045|NCT00615069|464344688|FG000|Overall Study|Withdrawal by Subject|4|||
129014046|NCT00669942|464344689|FG000|Parts 2 and 3|Adverse Event|0|||
129014047|NCT00669942|464344690|FG001|Parts 2 and 3|Adverse Event|0|||
129014048|NCT00669942|464344691|FG002|Parts 2 and 3|Adverse Event|0|||
129014049|NCT00669942|464344692|FG003|Parts 2 and 3|Adverse Event|0|||
129014050|NCT00669942|464344693|FG004|Parts 2 and 3|Adverse Event|0|||
129014051|NCT00669942|464344694|FG005|Parts 2 and 3|Adverse Event|0|||
129014052|NCT00669942|464344695|FG006|Parts 2 and 3|Adverse Event|0|||
129014053|NCT00669942|464344696|FG007|Parts 2 and 3|Adverse Event|2|||
129014054|NCT00669942|464344697|FG008|Parts 2 and 3|Adverse Event|1|||
129014055|NCT00669942|464344698|FG009|Parts 2 and 3|Adverse Event|0|||
129014056|NCT00669942|464344699|FG010|Parts 2 and 3|Adverse Event|0|||
129014057|NCT00669942|464344700|FG011|Parts 2 and 3|Adverse Event|0|||
129014058|NCT00669942|464344689|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
129014059|NCT00669942|464344690|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
129014060|NCT00669942|464344691|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
129014061|NCT00669942|464344692|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
129014062|NCT00669942|464344693|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
129014063|NCT00669942|464344694|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
129014064|NCT00669942|464344695|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
129014065|NCT00669942|464344696|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
129014066|NCT00669942|464344697|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
129014067|NCT00669942|464344698|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
129014068|NCT00669942|464344699|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
129014069|NCT00669942|464344700|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
129014070|NCT00669942|464344689|FG000|Parts 2 and 3|Protocol Violation|0|||
129014071|NCT00669942|464344690|FG001|Parts 2 and 3|Protocol Violation|0|||
129014072|NCT00669942|464344691|FG002|Parts 2 and 3|Protocol Violation|0|||
129014073|NCT00669942|464344692|FG003|Parts 2 and 3|Protocol Violation|0|||
128680538|NCT02186301|463130179|FG001|Overall Study|Protocol Deviation|2|||
129014074|NCT00669942|464344693|FG004|Parts 2 and 3|Protocol Violation|0|||
129014075|NCT00669942|464344694|FG005|Parts 2 and 3|Protocol Violation|1|||
129014076|NCT00669942|464344695|FG006|Parts 2 and 3|Protocol Violation|0|||
129014077|NCT00669942|464344696|FG007|Parts 2 and 3|Protocol Violation|0|||
129014078|NCT00669942|464344697|FG008|Parts 2 and 3|Protocol Violation|0|||
129014079|NCT00669942|464344698|FG009|Parts 2 and 3|Protocol Violation|0|||
128680539|NCT02186301|463130180|FG002|Overall Study|Protocol Deviation|0|||
128680540|NCT02186301|463130178|FG000|Overall Study|Missing|0|||
128680541|NCT02186301|463130179|FG001|Overall Study|Missing|0|||
128680542|NCT02186301|463130180|FG002|Overall Study|Missing|2|||
128680543|NCT02186301|463130178|FG000|Overall Study|Other|0|||
128680544|NCT02186301|463130179|FG001|Overall Study|Other|0|||
128680545|NCT02186301|463130180|FG002|Overall Study|Other|1|||
128680546|NCT00371761|463130181|FG000|Overall Study|Adverse Event|1|||
128680547|NCT00371761|463130182|FG001|Overall Study|Adverse Event|1|||
128680548|NCT00371761|463130181|FG000|Overall Study|Withdrawal by Subject|1|||
128680549|NCT00371761|463130182|FG001|Overall Study|Withdrawal by Subject|3|||
128680550|NCT00371761|463130181|FG000|Overall Study|Investigator Judgment|2|||
128680551|NCT00371761|463130182|FG001|Overall Study|Investigator Judgment|3|||
128680552|NCT00371761|463130181|FG000|Overall Study|Study termination|4|||
128680553|NCT00371761|463130182|FG001|Overall Study|Study termination|3|||
129014080|NCT00669942|464344699|FG010|Parts 2 and 3|Protocol Violation|0|||
129014081|NCT00669942|464344700|FG011|Parts 2 and 3|Protocol Violation|0|||
129014082|NCT00259012|464344703|FG000|Overall Study|Adverse Event|0|||
129014083|NCT00259012|464344704|FG001|Overall Study|Adverse Event|1|||
129014084|NCT00259012|464344703|FG000|Overall Study|Withdrawal by Subject|1|||
129014085|NCT00259012|464344704|FG001|Overall Study|Withdrawal by Subject|0|||
129014086|NCT00259012|464344703|FG000|Overall Study|Physician Decision|0|||
129014087|NCT00259012|464344704|FG001|Overall Study|Physician Decision|1|||
129014088|NCT00259012|464344703|FG000|Overall Study|Lost to Follow-up|0|||
129014089|NCT00259012|464344704|FG001|Overall Study|Lost to Follow-up|1|||
129014090|NCT00259012|464344703|FG000|Overall Study|Protocol Violation|1|||
129014091|NCT00259012|464344704|FG001|Overall Study|Protocol Violation|1|||
129014092|NCT02016170|464344717|FG000|Overall Study|Adverse Event|1|||
129014093|NCT02016170|464344718|FG001|Overall Study|Adverse Event|1|||
129014094|NCT02016170|464344719|FG002|Overall Study|Adverse Event|0|||
129014095|NCT02016170|464344717|FG000|Overall Study|Protocol Violation|1|||
129014096|NCT02016170|464344718|FG001|Overall Study|Protocol Violation|0|||
129014097|NCT02016170|464344719|FG002|Overall Study|Protocol Violation|0|||
129014098|NCT01479439|464344720|FG000|Overall Study|Adverse Event|1|||
129014099|NCT01479439|464344721|FG001|Overall Study|Adverse Event|0|||
129014100|NCT01479439|464344722|FG002|Overall Study|Adverse Event|0|||
129014101|NCT01479439|464344720|FG000|Overall Study|Lost to Follow-up|0|||
129014102|NCT01479439|464344721|FG001|Overall Study|Lost to Follow-up|1|||
129014103|NCT01479439|464344722|FG002|Overall Study|Lost to Follow-up|0|||
129014104|NCT01479439|464344720|FG000|Overall Study|Protocol Violation|0|||
129014105|NCT01479439|464344721|FG001|Overall Study|Protocol Violation|0|||
129014106|NCT01479439|464344722|FG002|Overall Study|Protocol Violation|2|||
129014107|NCT02365207|464344723|FG000|Overall Study|Withdrawal by Subject|1|||
129014108|NCT02365207|464344723|FG000|Overall Study|Physician Decision|1|||
129014109|NCT05067647|464344724|FG000|Overall Study|Lost to Follow-up|1|||
129014110|NCT00870870|464344727|FG000|Overall Study|Withdrawal by Subject|0|||
129014111|NCT00870870|464344728|FG001|Overall Study|Withdrawal by Subject|1|||
129014112|NCT00870870|464344729|FG002|Overall Study|Withdrawal by Subject|1|||
129014113|NCT00870870|464344730|FG003|Overall Study|Withdrawal by Subject|3|||
129014114|NCT00870870|464344727|FG000|Overall Study|Adverse Event|0|||
129014115|NCT00870870|464344728|FG001|Overall Study|Adverse Event|0|||
129014116|NCT00870870|464344729|FG002|Overall Study|Adverse Event|2|||
129014117|NCT00870870|464344730|FG003|Overall Study|Adverse Event|2|||
129014118|NCT03125200|464344736|FG000|Overall Study|Study Termination|0|||
129014119|NCT03125200|464344737|FG001|Overall Study|Study Termination|0|||
129014120|NCT03125200|464344738|FG002|Overall Study|Study Termination|0|||
129014121|NCT03125200|464344739|FG003|Overall Study|Study Termination|1|||
129014122|NCT03125200|464344740|FG004|Overall Study|Study Termination|1|||
129014123|NCT03125200|464344741|FG005|Overall Study|Study Termination|2|||
129014124|NCT03125200|464344742|FG006|Overall Study|Study Termination|1|||
129014125|NCT03125200|464344736|FG000|Overall Study|Clinical Progression|0|||
129014126|NCT03125200|464344737|FG001|Overall Study|Clinical Progression|0|||
129014127|NCT03125200|464344738|FG002|Overall Study|Clinical Progression|0|||
129014128|NCT03125200|464344739|FG003|Overall Study|Clinical Progression|1|||
129014129|NCT03125200|464344740|FG004|Overall Study|Clinical Progression|0|||
129014130|NCT03125200|464344741|FG005|Overall Study|Clinical Progression|1|||
129014131|NCT03125200|464344742|FG006|Overall Study|Clinical Progression|0|||
129014132|NCT03125200|464344736|FG000|Overall Study|Progressive Disease|2|||
129014133|NCT03125200|464344737|FG001|Overall Study|Progressive Disease|1|||
129014134|NCT03125200|464344738|FG002|Overall Study|Progressive Disease|2|||
129014135|NCT03125200|464344739|FG003|Overall Study|Progressive Disease|1|||
129014136|NCT03125200|464344740|FG004|Overall Study|Progressive Disease|2|||
129014137|NCT03125200|464344741|FG005|Overall Study|Progressive Disease|0|||
129014138|NCT03125200|464344742|FG006|Overall Study|Progressive Disease|1|||
128680554|NCT01275339|463130184|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
128680555|NCT01275339|463130185|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
128680556|NCT01275339|463130186|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
129014139|NCT03125200|464344736|FG000|Overall Study|Lack of Efficacy|0|||
129014140|NCT03125200|464344737|FG001|Overall Study|Lack of Efficacy|0|||
129014141|NCT03125200|464344738|FG002|Overall Study|Lack of Efficacy|0|||
129014142|NCT03125200|464344739|FG003|Overall Study|Lack of Efficacy|1|||
129014143|NCT03125200|464344740|FG004|Overall Study|Lack of Efficacy|0|||
129014144|NCT03125200|464344741|FG005|Overall Study|Lack of Efficacy|0|||
129014145|NCT03125200|464344742|FG006|Overall Study|Lack of Efficacy|0|||
129014146|NCT03125200|464344736|FG000|Overall Study|Toxicity|0|||
128680557|NCT01275339|463130187|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
128680558|NCT01275339|463130184|FG000|Overall Study|Withdrawal by Subject|0|||
128680559|NCT01275339|463130185|FG001|Overall Study|Withdrawal by Subject|0|||
128680560|NCT01275339|463130186|FG002|Overall Study|Withdrawal by Subject|1|||
128680561|NCT01275339|463130187|FG003|Overall Study|Withdrawal by Subject|0|||
128680562|NCT02478398|463130188|FG000|Overall Study|Adverse Event|20|||
128680563|NCT02478398|463130189|FG001|Overall Study|Adverse Event|5|||
128680564|NCT02478398|463130188|FG000|Overall Study|Lost to Follow-up|5|||
128680565|NCT02478398|463130189|FG001|Overall Study|Lost to Follow-up|4|||
128680566|NCT02478398|463130188|FG000|Overall Study|Non-Compliance With Study Drug|5|||
128680567|NCT02478398|463130189|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128680568|NCT02478398|463130188|FG000|Overall Study|Protocol Violation|3|||
128680569|NCT02478398|463130189|FG001|Overall Study|Protocol Violation|1|||
128680570|NCT02478398|463130188|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
129014147|NCT03125200|464344737|FG001|Overall Study|Toxicity|0|||
129014148|NCT03125200|464344738|FG002|Overall Study|Toxicity|0|||
129014149|NCT03125200|464344739|FG003|Overall Study|Toxicity|1|||
129014150|NCT03125200|464344740|FG004|Overall Study|Toxicity|0|||
129014151|NCT03125200|464344741|FG005|Overall Study|Toxicity|0|||
129014152|NCT03125200|464344742|FG006|Overall Study|Toxicity|0|||
129014153|NCT03125200|464344736|FG000|Overall Study|Consent Withdrawn by Subject|0|||
129014154|NCT03125200|464344737|FG001|Overall Study|Consent Withdrawn by Subject|1|||
129014155|NCT03125200|464344738|FG002|Overall Study|Consent Withdrawn by Subject|0|||
129014156|NCT03125200|464344739|FG003|Overall Study|Consent Withdrawn by Subject|0|||
129014157|NCT03125200|464344740|FG004|Overall Study|Consent Withdrawn by Subject|1|||
129014158|NCT03125200|464344741|FG005|Overall Study|Consent Withdrawn by Subject|0|||
129014159|NCT03125200|464344742|FG006|Overall Study|Consent Withdrawn by Subject|1|||
129014160|NCT00119379|464344743|FG000|Overall Study|Adverse Event|4|||
129014161|NCT00119379|464344744|FG001|Overall Study|Adverse Event|1|||
129014162|NCT01937390|464344750|FG000|Overall Study|Death|2|||
129014163|NCT01937390|464344750|FG000|Overall Study|Lost to Follow-up|7|||
129014164|NCT01937390|464344750|FG000|Overall Study|Withdrawal by Subject|5|||
129014165|NCT01937390|464344750|FG000|Overall Study|Fail to return|21|||
129014166|NCT01706536|464344756|FG000|Overall Study|Withdrawal by Subject|1|||
129014167|NCT01706536|464344757|FG001|Overall Study|Withdrawal by Subject|0|||
129014168|NCT01706536|464344758|FG002|Overall Study|Withdrawal by Subject|1|||
129014169|NCT01706536|464344759|FG003|Overall Study|Withdrawal by Subject|0|||
129014170|NCT01706536|464344760|FG004|Overall Study|Withdrawal by Subject|0|||
129014171|NCT01706536|464344756|FG000|Overall Study|Adverse Event|2|||
129014172|NCT01706536|464344757|FG001|Overall Study|Adverse Event|3|||
129014173|NCT01706536|464344758|FG002|Overall Study|Adverse Event|4|||
129014174|NCT01706536|464344759|FG003|Overall Study|Adverse Event|3|||
129014175|NCT01706536|464344760|FG004|Overall Study|Adverse Event|2|||
129014176|NCT01706536|464344756|FG000|Overall Study|Lack of Efficacy|1|||
129014177|NCT01706536|464344757|FG001|Overall Study|Lack of Efficacy|0|||
129014178|NCT01706536|464344758|FG002|Overall Study|Lack of Efficacy|0|||
129014179|NCT01706536|464344759|FG003|Overall Study|Lack of Efficacy|1|||
129014180|NCT01706536|464344760|FG004|Overall Study|Lack of Efficacy|0|||
129014181|NCT01706536|464344756|FG000|Overall Study|non compliance|0|||
129014182|NCT01706536|464344757|FG001|Overall Study|non compliance|1|||
129014183|NCT01706536|464344758|FG002|Overall Study|non compliance|0|||
129014184|NCT01706536|464344759|FG003|Overall Study|non compliance|0|||
129014185|NCT01706536|464344760|FG004|Overall Study|non compliance|0|||
129014186|NCT00683293|464344769|FG000|Overall Study|Withdrawal by Subject|2|||
129014187|NCT00683293|464344770|FG001|Overall Study|Withdrawal by Subject|3|||
129014188|NCT03262012|464344771|FG000|Overall Study|Withdrawal by Subject|15|||
129014189|NCT03262012|464344772|FG001|Overall Study|Withdrawal by Subject|13|||
129014190|NCT03262012|464344773|FG002|Overall Study|Withdrawal by Subject|8|||
129014191|NCT03262012|464344774|FG003|Overall Study|Withdrawal by Subject|7|||
129014192|NCT03262012|464344771|FG000|Overall Study|Adverse Event|10|||
129014193|NCT03262012|464344772|FG001|Overall Study|Adverse Event|12|||
129014194|NCT03262012|464344773|FG002|Overall Study|Adverse Event|4|||
129014195|NCT03262012|464344774|FG003|Overall Study|Adverse Event|6|||
128680571|NCT02478398|463130189|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
129014196|NCT03262012|464344771|FG000|Overall Study|Physician Decision|2|||
129014197|NCT03262012|464344772|FG001|Overall Study|Physician Decision|5|||
129014198|NCT03262012|464344773|FG002|Overall Study|Physician Decision|1|||
129014199|NCT03262012|464344774|FG003|Overall Study|Physician Decision|0|||
129014200|NCT03262012|464344771|FG000|Overall Study|Lack of Efficacy|0|||
129014201|NCT03262012|464344772|FG001|Overall Study|Lack of Efficacy|5|||
129014202|NCT03262012|464344773|FG002|Overall Study|Lack of Efficacy|1|||
129014203|NCT03262012|464344774|FG003|Overall Study|Lack of Efficacy|2|||
129014204|NCT03262012|464344771|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
128680572|NCT02478398|463130188|FG000|Overall Study|Withdrawal By Participant|10|||
128680573|NCT02478398|463130189|FG001|Overall Study|Withdrawal By Participant|4|||
128680574|NCT01736657|463130196|FG000|Overall Study|insufficient vascular access|1|||
128680575|NCT00997438|463130207|FG000|Overall Study|Blood draw difficulty|2|||
129014205|NCT03262012|464344772|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
129102982|NCT02362425|464673121|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
128680576|NCT00997438|463130208|FG001|Overall Study|Blood draw difficulty|0|||
128680577|NCT00997438|463130209|FG002|Overall Study|Blood draw difficulty|1|||
128680578|NCT00997438|463130207|FG000|Overall Study|Withdrawal by Subject|1|||
128680579|NCT00997438|463130208|FG001|Overall Study|Withdrawal by Subject|1|||
128680580|NCT00997438|463130209|FG002|Overall Study|Withdrawal by Subject|0|||
128680581|NCT00997438|463130207|FG000|Overall Study|Exclusion criteria at visit 1|2|||
128680582|NCT00997438|463130208|FG001|Overall Study|Exclusion criteria at visit 1|2|||
128680583|NCT00997438|463130209|FG002|Overall Study|Exclusion criteria at visit 1|3|||
128680584|NCT03505671|463130210|FG000|Overall Study|Withdrawal by Subject|2|||
128680585|NCT03505671|463130211|FG001|Overall Study|Withdrawal by Subject|1|||
128680586|NCT03505671|463130210|FG000|Overall Study|Lost to Follow-up|1|||
128680587|NCT03505671|463130211|FG001|Overall Study|Lost to Follow-up|0|||
128879623|NCT01016977|463854894|FG000|Overall Study|Withdrawal by Subject|2|||
129014206|NCT03262012|464344773|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
129014207|NCT03262012|464344774|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
129014208|NCT01469546|464344775|FG000|Received 5 mg Dose|Adverse Event|13|||
129014209|NCT01469546|464344775|FG000|Received 5 mg Dose|Death|2|||
129014210|NCT01469546|464344775|FG000|Received 5 mg Dose|Protocol Violation|2|||
129014211|NCT01469546|464344775|FG000|Received 5 mg Dose|Progressive Disease|3|||
129014212|NCT01469546|464344775|FG000|Received 5 mg Dose|Physician Decision|3|||
129102983|NCT02362425|464673122|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
129102984|NCT02362425|464673123|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
129102985|NCT02362425|464673120|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
129102986|NCT02362425|464673121|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
129102987|NCT02362425|464673122|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
129102988|NCT02362425|464673123|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
129014213|NCT03601637|464345816|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
129014214|NCT03601637|464345817|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
129014215|NCT03601637|464345816|FG000|Overall Study|Adverse Event|1|||
129014216|NCT03601637|464345817|FG001|Overall Study|Adverse Event|1|||
129014217|NCT03601637|464345816|FG000|Overall Study|Other|0|||
129014218|NCT03601637|464345817|FG001|Overall Study|Other|1|||
129014219|NCT01248247|464345818|FG000|Overall Study|Adverse Event|2|||
129014220|NCT01248247|464345819|FG001|Overall Study|Adverse Event|4|||
129014221|NCT01248247|464345820|FG002|Overall Study|Adverse Event|4|||
129014222|NCT01248247|464345821|FG003|Overall Study|Adverse Event|2|||
129014223|NCT01248247|464345818|FG000|Overall Study|Death|0|||
129014224|NCT01248247|464345819|FG001|Overall Study|Death|1|||
129014225|NCT01248247|464345820|FG002|Overall Study|Death|4|||
129014226|NCT01248247|464345821|FG003|Overall Study|Death|7|||
129014227|NCT01248247|464345818|FG000|Overall Study|Lost to Follow-up|0|||
129014228|NCT01248247|464345819|FG001|Overall Study|Lost to Follow-up|1|||
129014229|NCT01248247|464345820|FG002|Overall Study|Lost to Follow-up|1|||
129014230|NCT01248247|464345821|FG003|Overall Study|Lost to Follow-up|0|||
129014231|NCT01248247|464345818|FG000|Overall Study|Alternative treatment|0|||
129014232|NCT01248247|464345819|FG001|Overall Study|Alternative treatment|1|||
129014233|NCT01248247|464345820|FG002|Overall Study|Alternative treatment|0|||
129014234|NCT01248247|464345821|FG003|Overall Study|Alternative treatment|0|||
129014235|NCT01248247|464345818|FG000|Overall Study|Other|2|||
129014236|NCT01248247|464345819|FG001|Overall Study|Other|8|||
129014237|NCT01248247|464345820|FG002|Overall Study|Other|8|||
129014238|NCT01248247|464345821|FG003|Overall Study|Other|5|||
129014239|NCT01248247|464345818|FG000|Overall Study|Progression|18|||
129014240|NCT01248247|464345819|FG001|Overall Study|Progression|27|||
129014241|NCT01248247|464345820|FG002|Overall Study|Progression|56|||
129014242|NCT01248247|464345821|FG003|Overall Study|Progression|44|||
129014243|NCT01248247|464345818|FG000|Overall Study|Refuse further treatment|0|||
129014244|NCT01248247|464345819|FG001|Overall Study|Refuse further treatment|0|||
129014245|NCT01248247|464345820|FG002|Overall Study|Refuse further treatment|1|||
129014246|NCT01248247|464345821|FG003|Overall Study|Refuse further treatment|2|||
129014247|NCT01248247|464345818|FG000|Overall Study|Complicating disease|0|||
129102989|NCT02362425|464673120|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
128879624|NCT01016977|463854895|FG001|Overall Study|Withdrawal by Subject|2|||
129014248|NCT01248247|464345819|FG001|Overall Study|Complicating disease|0|||
129014249|NCT01248247|464345820|FG002|Overall Study|Complicating disease|1|||
129014250|NCT01248247|464345821|FG003|Overall Study|Complicating disease|1|||
129014251|NCT01108094|464345826|FG000|Overall Study|Adverse Event|2|||
129014252|NCT01108094|464345827|FG001|Overall Study|Adverse Event|0|||
129014253|NCT01108094|464345828|FG002|Overall Study|Adverse Event|0|||
129014254|NCT01108094|464345829|FG003|Overall Study|Adverse Event|0|||
129014255|NCT01108094|464345826|FG000|Overall Study|Withdrawal by Subject|1|||
129014256|NCT01108094|464345827|FG001|Overall Study|Withdrawal by Subject|0|||
128680588|NCT02038829|463130214|FG000|Washout Period 1|Death|0|||
128680589|NCT02038829|463130215|FG001|Washout Period 1|Death|0|||
128680590|NCT02038829|463130216|FG002|Washout Period 1|Death|0|||
129014257|NCT01108094|464345828|FG002|Overall Study|Withdrawal by Subject|0|||
129102990|NCT02362425|464673121|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
129102991|NCT02362425|464673122|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
129102992|NCT02362425|464673123|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
129102993|NCT02362425|464673120|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
129102994|NCT02362425|464673121|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
129102995|NCT02362425|464673122|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
129102996|NCT02362425|464673123|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
129102997|NCT00802672|464673124|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
129102998|NCT00802672|464673125|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
129102999|NCT00802672|464673126|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
129103000|NCT00802672|464673124|FG000|Overall Study|Adverse Event|1|||
129103001|NCT00802672|464673125|FG001|Overall Study|Adverse Event|1|||
129103002|NCT00802672|464673126|FG002|Overall Study|Adverse Event|1|||
129103003|NCT00802672|464673124|FG000|Overall Study|Protocol Violation|2|||
129103004|NCT00802672|464673125|FG001|Overall Study|Protocol Violation|1|||
129103005|NCT00802672|464673126|FG002|Overall Study|Protocol Violation|1|||
129103006|NCT00802672|464673124|FG000|Overall Study|Lost to Follow-up|5|||
129103007|NCT00802672|464673125|FG001|Overall Study|Lost to Follow-up|5|||
129103008|NCT00802672|464673126|FG002|Overall Study|Lost to Follow-up|3|||
129103009|NCT00802672|464673124|FG000|Overall Study|Withdrawal by Subject|1|||
129103010|NCT00802672|464673125|FG001|Overall Study|Withdrawal by Subject|1|||
129103011|NCT00802672|464673126|FG002|Overall Study|Withdrawal by Subject|2|||
128680591|NCT02038829|463130217|FG003|Washout Period 1|Death|0|||
129014258|NCT01108094|464345829|FG003|Overall Study|Withdrawal by Subject|0|||
129014259|NCT00420303|464345832|FG000|Overall Study|Serious Adverse Event|1|||
129014260|NCT00420303|464345833|FG001|Overall Study|Serious Adverse Event|0|||
129014261|NCT00420303|464345832|FG000|Overall Study|Lack of Efficacy|0|||
129014262|NCT00420303|464345833|FG001|Overall Study|Lack of Efficacy|3|||
129014263|NCT00420303|464345832|FG000|Overall Study|Physician Decision|0|||
129014264|NCT00420303|464345833|FG001|Overall Study|Physician Decision|1|||
129014265|NCT04455633|464345837|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
129014266|NCT04455633|464345838|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
129014267|NCT04455633|464345839|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
129014268|NCT04455633|464345837|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
129014269|NCT04455633|464345838|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
129014270|NCT04455633|464345839|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
129014271|NCT04455633|464345837|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
129014272|NCT04455633|464345838|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
129014273|NCT04455633|464345839|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
129014274|NCT04455633|464345837|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
129014275|NCT04455633|464345838|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
129014276|NCT04455633|464345839|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
129014277|NCT04015232|464345841|FG000|Overall Study|Withdrawal by Subject|7|||
129014278|NCT04015232|464345842|FG001|Overall Study|Withdrawal by Subject|4|||
129014279|NCT04015232|464345841|FG000|Overall Study|Protocol Violation|1|||
129014280|NCT04015232|464345842|FG001|Overall Study|Protocol Violation|0|||
129014281|NCT04015232|464345841|FG000|Overall Study|Medical Grounds|3|||
129014282|NCT04015232|464345842|FG001|Overall Study|Medical Grounds|3|||
129014283|NCT01029353|464345843|FG000|Overall Study|Lost to Follow-up|4|||
129014284|NCT01029353|464345844|FG001|Overall Study|Lost to Follow-up|5|||
129014285|NCT01029353|464345845|FG002|Overall Study|Lost to Follow-up|5|||
129014286|NCT01029353|464345846|FG003|Overall Study|Lost to Follow-up|4|||
129014287|NCT01029353|464345843|FG000|Overall Study|Consent Withdrawn|2|||
129014288|NCT01029353|464345844|FG001|Overall Study|Consent Withdrawn|0|||
129014289|NCT01029353|464345845|FG002|Overall Study|Consent Withdrawn|0|||
129014290|NCT01029353|464345846|FG003|Overall Study|Consent Withdrawn|0|||
129014291|NCT01029353|464345843|FG000|Overall Study|Primary Outcome Indeterminate|1|||
129014292|NCT01029353|464345844|FG001|Overall Study|Primary Outcome Indeterminate|3|||
129014293|NCT01029353|464345845|FG002|Overall Study|Primary Outcome Indeterminate|2|||
129014294|NCT01029353|464345846|FG003|Overall Study|Primary Outcome Indeterminate|0|||
129014295|NCT01900730|464345847|FG000|Overall Study|Withdrawal by Subject|1|||
129014296|NCT01900730|464345848|FG001|Overall Study|Withdrawal by Subject|0|||
129014297|NCT01900730|464345847|FG000|Overall Study|Screen Failure|1|||
129014298|NCT01900730|464345848|FG001|Overall Study|Screen Failure|0|||
129014299|NCT02942264|464345849|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129103012|NCT00802672|464673124|FG000|Overall Study|other|3|||
128680592|NCT02038829|463130218|FG004|Washout Period 1|Death|1|||
129014300|NCT02942264|464345850|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
129014301|NCT02942264|464345851|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129014302|NCT02942264|464345852|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129014303|NCT02942264|464345853|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129014304|NCT02942264|464345854|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129103013|NCT00802672|464673125|FG001|Overall Study|other|1|||
129103014|NCT00802672|464673126|FG002|Overall Study|other|2|||
129103015|NCT03026283|464673128|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
129103016|NCT03026283|464673129|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
129103017|NCT03026283|464673130|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
129103018|NCT03026283|464673131|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
129103019|NCT03026283|464673132|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
129103020|NCT03026283|464673133|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
129103021|NCT03026283|464673134|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
129103022|NCT03026283|464673135|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
129103023|NCT03026283|464673128|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
129103024|NCT03026283|464673129|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
129103025|NCT03026283|464673130|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
129103026|NCT03026283|464673131|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
129103027|NCT03026283|464673132|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
129103028|NCT03026283|464673133|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
129103029|NCT03026283|464673134|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
129103030|NCT03026283|464673135|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
129103031|NCT03026283|464673128|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129103032|NCT03026283|464673129|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
129103033|NCT03026283|464673130|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129103034|NCT03026283|464673131|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129103035|NCT03026283|464673132|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129103036|NCT03026283|464673133|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129103037|NCT03026283|464673134|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129103038|NCT03026283|464673135|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129103039|NCT03026283|464673128|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129103040|NCT03026283|464673129|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129103041|NCT03026283|464673130|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
129103042|NCT03026283|464673131|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
128680593|NCT02038829|463130219|FG005|Washout Period 1|Death|0|||
128680594|NCT02038829|463130220|FG006|Washout Period 1|Death|0|||
128680595|NCT02038829|463130221|FG007|Washout Period 1|Death|0|||
128680596|NCT02038829|463130222|FG008|Washout Period 1|Death|0|||
128680597|NCT02038829|463130223|FG009|Washout Period 1|Death|0|||
128680598|NCT02038829|463130224|FG010|Washout Period 1|Death|0|||
128680599|NCT02038829|463130225|FG011|Washout Period 1|Death|0|||
128680600|NCT02038829|463130214|FG000|Treatment Period 2|Adverse Event|0|||
128680601|NCT02038829|463130215|FG001|Treatment Period 2|Adverse Event|0|||
128680602|NCT02038829|463130216|FG002|Treatment Period 2|Adverse Event|0|||
128680603|NCT02038829|463130217|FG003|Treatment Period 2|Adverse Event|0|||
128680604|NCT02038829|463130218|FG004|Treatment Period 2|Adverse Event|0|||
128680605|NCT02038829|463130219|FG005|Treatment Period 2|Adverse Event|0|||
128680606|NCT02038829|463130220|FG006|Treatment Period 2|Adverse Event|0|||
128680607|NCT02038829|463130221|FG007|Treatment Period 2|Adverse Event|0|||
128680608|NCT02038829|463130222|FG008|Treatment Period 2|Adverse Event|0|||
128680609|NCT02038829|463130223|FG009|Treatment Period 2|Adverse Event|0|||
128680610|NCT02038829|463130224|FG010|Treatment Period 2|Adverse Event|1|||
128680611|NCT02038829|463130225|FG011|Treatment Period 2|Adverse Event|0|||
128680612|NCT02038829|463130214|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128680613|NCT02038829|463130215|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128680614|NCT02038829|463130216|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128680615|NCT02038829|463130217|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128680616|NCT02038829|463130218|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128680617|NCT02038829|463130219|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129014305|NCT02942264|464345855|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
129014306|NCT02942264|464345856|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129014307|NCT02942264|464345857|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129014308|NCT02942264|464345849|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129014309|NCT02942264|464345850|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129014310|NCT02942264|464345851|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129014311|NCT02942264|464345852|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129014312|NCT02942264|464345853|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129014313|NCT02942264|464345854|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129103043|NCT03026283|464673132|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
128680618|NCT02038829|463130220|FG006|Treatment Period 2|Withdrawal by Subject|0|||
128680619|NCT02038829|463130221|FG007|Treatment Period 2|Withdrawal by Subject|0|||
129014314|NCT02942264|464345855|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129014315|NCT02942264|464345856|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
128680620|NCT02038829|463130222|FG008|Treatment Period 2|Withdrawal by Subject|0|||
128680621|NCT02038829|463130223|FG009|Treatment Period 2|Withdrawal by Subject|0|||
128680622|NCT02038829|463130224|FG010|Treatment Period 2|Withdrawal by Subject|0|||
129103044|NCT03026283|464673133|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129103045|NCT03026283|464673134|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129103046|NCT03026283|464673135|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129103047|NCT03026283|464673128|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129103048|NCT03026283|464673129|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129103049|NCT03026283|464673130|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129103050|NCT03026283|464673131|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
129103051|NCT03026283|464673132|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
129103052|NCT03026283|464673133|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129103053|NCT03026283|464673134|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129103054|NCT03026283|464673135|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129103055|NCT03026283|464673128|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129103056|NCT03026283|464673129|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129103057|NCT03026283|464673130|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129103058|NCT03026283|464673131|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
129103059|NCT03026283|464673132|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
129103060|NCT03026283|464673133|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
129103061|NCT03026283|464673134|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129103062|NCT03026283|464673135|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129103063|NCT03026283|464673128|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129103064|NCT03026283|464673129|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129103065|NCT03026283|464673130|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129103066|NCT03026283|464673131|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
129103067|NCT03026283|464673132|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129103068|NCT03026283|464673133|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
129103069|NCT03026283|464673134|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129103070|NCT03026283|464673135|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129103071|NCT03026283|464673128|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129103072|NCT03026283|464673129|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129103073|NCT03026283|464673130|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129103074|NCT03026283|464673131|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
129103075|NCT03026283|464673132|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
128680623|NCT02038829|463130225|FG011|Treatment Period 2|Withdrawal by Subject|0|||
128680624|NCT02038829|463130214|FG000|Washout Period 2|Adverse Event|0|||
128680625|NCT02038829|463130215|FG001|Washout Period 2|Adverse Event|0|||
128680626|NCT02038829|463130216|FG002|Washout Period 2|Adverse Event|0|||
128680627|NCT02038829|463130217|FG003|Washout Period 2|Adverse Event|0|||
128680628|NCT02038829|463130218|FG004|Washout Period 2|Adverse Event|0|||
128680629|NCT02038829|463130219|FG005|Washout Period 2|Adverse Event|0|||
128680630|NCT02038829|463130220|FG006|Washout Period 2|Adverse Event|0|||
128680631|NCT02038829|463130221|FG007|Washout Period 2|Adverse Event|0|||
128680632|NCT02038829|463130222|FG008|Washout Period 2|Adverse Event|1|||
128680633|NCT02038829|463130223|FG009|Washout Period 2|Adverse Event|0|||
128680634|NCT02038829|463130224|FG010|Washout Period 2|Adverse Event|0|||
128680635|NCT02038829|463130225|FG011|Washout Period 2|Adverse Event|0|||
128680636|NCT02038829|463130214|FG000|Washout Period 2|Withdrawal by Subject|0|||
128680637|NCT02038829|463130215|FG001|Washout Period 2|Withdrawal by Subject|0|||
128680638|NCT02038829|463130216|FG002|Washout Period 2|Withdrawal by Subject|0|||
128680639|NCT02038829|463130217|FG003|Washout Period 2|Withdrawal by Subject|0|||
129014316|NCT02942264|464345857|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
129014317|NCT01572948|464345860|FG000|Overall Study|Lost to Follow-up|1|||
129014318|NCT01572948|464345861|FG001|Overall Study|Lost to Follow-up|0|||
129014319|NCT01572948|464345860|FG000|Overall Study|unable to contact|0|||
129014320|NCT01572948|464345861|FG001|Overall Study|unable to contact|1|||
129014321|NCT03553823|464345862|FG000|Overall Study|Physician Decision|0|||
129014322|NCT03553823|464345863|FG001|Overall Study|Physician Decision|1|||
129014323|NCT03603314|464345864|FG000|Overall Study|Lost to Follow-up|0|||
129014324|NCT03603314|464345865|FG001|Overall Study|Lost to Follow-up|3|||
129014325|NCT03603314|464345866|FG002|Overall Study|Lost to Follow-up|0|||
129014326|NCT03603314|464345864|FG000|Overall Study|Protocol Violation|0|||
129014327|NCT03603314|464345865|FG001|Overall Study|Protocol Violation|1|||
129014328|NCT03603314|464345866|FG002|Overall Study|Protocol Violation|0|||
129014329|NCT03603314|464345864|FG000|Overall Study|Adverse Event|2|||
129014330|NCT03603314|464345865|FG001|Overall Study|Adverse Event|0|||
129014331|NCT03603314|464345866|FG002|Overall Study|Adverse Event|0|||
129014332|NCT03603314|464345864|FG000|Overall Study|Physician Decision|1|||
129014333|NCT03603314|464345865|FG001|Overall Study|Physician Decision|1|||
128680640|NCT02038829|463130218|FG004|Washout Period 2|Withdrawal by Subject|0|||
128680641|NCT02038829|463130219|FG005|Washout Period 2|Withdrawal by Subject|1|||
128680642|NCT02038829|463130220|FG006|Washout Period 2|Withdrawal by Subject|0|||
129014334|NCT03603314|464345866|FG002|Overall Study|Physician Decision|0|||
128680643|NCT02038829|463130221|FG007|Washout Period 2|Withdrawal by Subject|0|||
128680644|NCT02038829|463130222|FG008|Washout Period 2|Withdrawal by Subject|0|||
128680645|NCT02038829|463130223|FG009|Washout Period 2|Withdrawal by Subject|0|||
128680646|NCT02038829|463130224|FG010|Washout Period 2|Withdrawal by Subject|0|||
128680647|NCT02038829|463130225|FG011|Washout Period 2|Withdrawal by Subject|0|||
128680648|NCT02038829|463130214|FG000|Treatment Period 4|Adverse Event|0|||
128680649|NCT02038829|463130215|FG001|Treatment Period 4|Adverse Event|1|||
128680650|NCT02038829|463130216|FG002|Treatment Period 4|Adverse Event|0|||
128680651|NCT02038829|463130217|FG003|Treatment Period 4|Adverse Event|0|||
128680652|NCT02038829|463130218|FG004|Treatment Period 4|Adverse Event|0|||
128680653|NCT02038829|463130219|FG005|Treatment Period 4|Adverse Event|0|||
128680654|NCT02038829|463130220|FG006|Treatment Period 4|Adverse Event|0|||
128680655|NCT02038829|463130221|FG007|Treatment Period 4|Adverse Event|0|||
128680656|NCT02038829|463130222|FG008|Treatment Period 4|Adverse Event|0|||
128680657|NCT02038829|463130223|FG009|Treatment Period 4|Adverse Event|0|||
128680658|NCT02038829|463130224|FG010|Treatment Period 4|Adverse Event|0|||
128680659|NCT02038829|463130225|FG011|Treatment Period 4|Adverse Event|0|||
128680660|NCT02038829|463130214|FG000|Washout Period 4|Adverse Event|0|||
128680661|NCT02038829|463130215|FG001|Washout Period 4|Adverse Event|0|||
128680662|NCT02038829|463130216|FG002|Washout Period 4|Adverse Event|0|||
128680663|NCT02038829|463130217|FG003|Washout Period 4|Adverse Event|0|||
128680664|NCT02038829|463130218|FG004|Washout Period 4|Adverse Event|0|||
128680665|NCT02038829|463130219|FG005|Washout Period 4|Adverse Event|0|||
128680666|NCT02038829|463130220|FG006|Washout Period 4|Adverse Event|1|||
128680667|NCT02038829|463130221|FG007|Washout Period 4|Adverse Event|0|||
128680668|NCT02038829|463130222|FG008|Washout Period 4|Adverse Event|0|||
128680669|NCT02038829|463130223|FG009|Washout Period 4|Adverse Event|0|||
128680670|NCT02038829|463130224|FG010|Washout Period 4|Adverse Event|0|||
128680671|NCT02038829|463130225|FG011|Washout Period 4|Adverse Event|0|||
128680672|NCT02038829|463130214|FG000|Treatment Period 6|Adverse Event|0|||
128680673|NCT02038829|463130215|FG001|Treatment Period 6|Adverse Event|0|||
128680674|NCT02038829|463130216|FG002|Treatment Period 6|Adverse Event|1|||
128680675|NCT02038829|463130217|FG003|Treatment Period 6|Adverse Event|0|||
128680676|NCT02038829|463130218|FG004|Treatment Period 6|Adverse Event|0|||
128680677|NCT02038829|463130219|FG005|Treatment Period 6|Adverse Event|0|||
128680678|NCT02038829|463130220|FG006|Treatment Period 6|Adverse Event|0|||
128680679|NCT02038829|463130221|FG007|Treatment Period 6|Adverse Event|0|||
128680680|NCT02038829|463130222|FG008|Treatment Period 6|Adverse Event|0|||
128680681|NCT02038829|463130223|FG009|Treatment Period 6|Adverse Event|0|||
128680682|NCT02038829|463130224|FG010|Treatment Period 6|Adverse Event|0|||
128680683|NCT02038829|463130225|FG011|Treatment Period 6|Adverse Event|0|||
128680684|NCT02579928|463130226|FG000|Overall Study|Withdrawal by Subject|1|||
128680685|NCT02579928|463130227|FG001|Overall Study|Withdrawal by Subject|0|||
128680686|NCT03754972|463130230|FG000|Overall Study|Protocol Violation|25|||
128680687|NCT03422627|463130231|FG000|Overall Study|Protocol-specified Criteria|1|||
128680688|NCT03422627|463130232|FG001|Overall Study|Protocol-specified Criteria|1|||
128680689|NCT03422627|463130233|FG002|Overall Study|Protocol-specified Criteria|0|||
128680690|NCT03422627|463130234|FG003|Overall Study|Protocol-specified Criteria|0|||
128680691|NCT03422627|463130235|FG004|Overall Study|Protocol-specified Criteria|2|||
128680692|NCT03422627|463130231|FG000|Overall Study|Requirement for Alternative Therapy|1|||
128680693|NCT03422627|463130232|FG001|Overall Study|Requirement for Alternative Therapy|1|||
128680694|NCT03422627|463130233|FG002|Overall Study|Requirement for Alternative Therapy|2|||
128680695|NCT03422627|463130234|FG003|Overall Study|Requirement for Alternative Therapy|0|||
128680696|NCT03422627|463130235|FG004|Overall Study|Requirement for Alternative Therapy|0|||
129103076|NCT03026283|464673133|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129103077|NCT03026283|464673134|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129103078|NCT03026283|464673135|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129103079|NCT03026283|464673128|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129103080|NCT03026283|464673129|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129103081|NCT03026283|464673130|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129103082|NCT03026283|464673131|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
128680697|NCT03422627|463130231|FG000|Overall Study|Disease Progression|1|||
128680698|NCT03422627|463130232|FG001|Overall Study|Disease Progression|0|||
128680699|NCT03422627|463130233|FG002|Overall Study|Disease Progression|1|||
128680700|NCT03422627|463130234|FG003|Overall Study|Disease Progression|2|||
128680701|NCT03422627|463130235|FG004|Overall Study|Disease Progression|0|||
128680702|NCT03422627|463130231|FG000|Overall Study|Adverse Event|2|||
128680703|NCT03422627|463130232|FG001|Overall Study|Adverse Event|1|||
128680704|NCT03422627|463130233|FG002|Overall Study|Adverse Event|0|||
128680705|NCT03422627|463130234|FG003|Overall Study|Adverse Event|0|||
128680706|NCT03422627|463130235|FG004|Overall Study|Adverse Event|2|||
128680707|NCT03422627|463130231|FG000|Overall Study|Ineligibility Determined|0|||
128680708|NCT03422627|463130232|FG001|Overall Study|Ineligibility Determined|1|||
128680709|NCT03422627|463130233|FG002|Overall Study|Ineligibility Determined|0|||
128680710|NCT03422627|463130234|FG003|Overall Study|Ineligibility Determined|0|||
128680711|NCT03422627|463130235|FG004|Overall Study|Ineligibility Determined|0|||
128680712|NCT03422627|463130231|FG000|Overall Study|Death|0|||
128680713|NCT03422627|463130232|FG001|Overall Study|Death|1|||
128680714|NCT03422627|463130233|FG002|Overall Study|Death|1|||
128680715|NCT03422627|463130234|FG003|Overall Study|Death|0|||
128680716|NCT03422627|463130235|FG004|Overall Study|Death|0|||
128680717|NCT03422627|463130231|FG000|Overall Study|Withdrawal by Subject|0|||
128680718|NCT03422627|463130232|FG001|Overall Study|Withdrawal by Subject|0|||
128680719|NCT03422627|463130233|FG002|Overall Study|Withdrawal by Subject|0|||
128680720|NCT03422627|463130234|FG003|Overall Study|Withdrawal by Subject|1|||
128680721|NCT03422627|463130235|FG004|Overall Study|Withdrawal by Subject|0|||
128680722|NCT00290407|463130236|FG000|Overall Study|Physician Decision|2|||
128680723|NCT01933789|463130237|FG000|Overall Study|Death|0|||
128680724|NCT01933789|463130238|FG001|Overall Study|Death|0|||
128680725|NCT01933789|463130239|FG002|Overall Study|Death|0|||
128680726|NCT01933789|463130240|FG003|Overall Study|Death|0|||
128680727|NCT01933789|463130241|FG004|Overall Study|Death|21|||
128680728|NCT01933789|463130242|FG005|Overall Study|Death|32|||
128680729|NCT01933789|463130243|FG006|Overall Study|Death|0|||
128680730|NCT01933789|463130244|FG007|Overall Study|Death|0|||
128680731|NCT01933789|463130245|FG008|Overall Study|Death|0|||
128680732|NCT01933789|463130237|FG000|Overall Study|Lost to Follow-up|0|||
128680733|NCT01933789|463130238|FG001|Overall Study|Lost to Follow-up|0|||
128680734|NCT01933789|463130239|FG002|Overall Study|Lost to Follow-up|0|||
128680735|NCT01933789|463130240|FG003|Overall Study|Lost to Follow-up|1|||
128680736|NCT01933789|463130241|FG004|Overall Study|Lost to Follow-up|8|||
128680737|NCT01933789|463130242|FG005|Overall Study|Lost to Follow-up|9|||
128680738|NCT01933789|463130243|FG006|Overall Study|Lost to Follow-up|1|||
128680739|NCT01933789|463130244|FG007|Overall Study|Lost to Follow-up|4|||
128680740|NCT01933789|463130245|FG008|Overall Study|Lost to Follow-up|0|||
128680741|NCT01933789|463130237|FG000|Overall Study|Withdrawal by Subject|2|||
128680742|NCT01933789|463130238|FG001|Overall Study|Withdrawal by Subject|1|||
128680743|NCT01933789|463130239|FG002|Overall Study|Withdrawal by Subject|0|||
128680744|NCT01933789|463130240|FG003|Overall Study|Withdrawal by Subject|0|||
128680745|NCT01933789|463130241|FG004|Overall Study|Withdrawal by Subject|17|||
128680746|NCT01933789|463130242|FG005|Overall Study|Withdrawal by Subject|16|||
128680747|NCT01933789|463130243|FG006|Overall Study|Withdrawal by Subject|1|||
128680748|NCT01933789|463130244|FG007|Overall Study|Withdrawal by Subject|4|||
128680749|NCT01933789|463130245|FG008|Overall Study|Withdrawal by Subject|0|||
128680750|NCT01933789|463130237|FG000|Overall Study|Became Ineligible|4|||
128680751|NCT01933789|463130238|FG001|Overall Study|Became Ineligible|0|||
128680752|NCT01933789|463130239|FG002|Overall Study|Became Ineligible|0|||
128680753|NCT01933789|463130240|FG003|Overall Study|Became Ineligible|0|||
128680754|NCT01933789|463130241|FG004|Overall Study|Became Ineligible|13|||
128680755|NCT01933789|463130242|FG005|Overall Study|Became Ineligible|10|||
128680756|NCT01933789|463130243|FG006|Overall Study|Became Ineligible|13|||
128680757|NCT01933789|463130244|FG007|Overall Study|Became Ineligible|6|||
128680758|NCT01933789|463130245|FG008|Overall Study|Became Ineligible|0|||
128680759|NCT01117792|463130246|FG000|Overall Study|Death|1|||
129014335|NCT03603314|464345864|FG000|Overall Study|Withdrawal by Subject|4|||
129014336|NCT03603314|464345865|FG001|Overall Study|Withdrawal by Subject|5|||
129014337|NCT03603314|464345866|FG002|Overall Study|Withdrawal by Subject|3|||
129014338|NCT03603314|464345864|FG000|Overall Study|Other|0|||
129014339|NCT03603314|464345865|FG001|Overall Study|Other|1|||
129014340|NCT03603314|464345866|FG002|Overall Study|Other|0|||
128680760|NCT01117792|463130246|FG000|Overall Study|Adverse Event|3|||
129014341|NCT03450070|464345867|FG000|Overall Study|Withdrawal by Subject|8|||
129014342|NCT01496183|464345873|FG000|Overall Study|Physician Decision|3|||
129014343|NCT01496183|464345874|FG001|Overall Study|Physician Decision|1|||
129014344|NCT01496183|464345873|FG000|Overall Study|Withdrawal by Subject|0|||
129014345|NCT01496183|464345874|FG001|Overall Study|Withdrawal by Subject|1|||
129014346|NCT03002077|464345875|FG000|Overall Study|Non-compliance with Study Drug|4|||
129014347|NCT03002077|464345875|FG000|Overall Study|Non-compliance w/Background ADT|1|||
128680761|NCT01721577|463130247|FG000|Overall Study|Lack of Efficacy|1|||
128680762|NCT01721577|463130248|FG001|Overall Study|Lack of Efficacy|0|||
128680763|NCT01721577|463130247|FG000|Overall Study|Death|1|||
128680764|NCT01721577|463130248|FG001|Overall Study|Death|0|||
129014348|NCT03002077|464345875|FG000|Overall Study|Study Terminated by Sponsor|257|||
128680765|NCT01721577|463130247|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
128680766|NCT01721577|463130248|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
128680767|NCT01721577|463130247|FG000|Overall Study|Adverse Event|0|||
129014349|NCT03002077|464345875|FG000|Overall Study|Site Terminated by Sponsor|5|||
128680768|NCT01721577|463130248|FG001|Overall Study|Adverse Event|2|||
128680769|NCT00274924|463130251|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
128680770|NCT00274924|463130252|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
128680771|NCT00274924|463130253|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
128680772|NCT00274924|463130251|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
128680773|NCT00274924|463130252|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
128680774|NCT00274924|463130253|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
129014350|NCT03002077|464345875|FG000|Overall Study|Miscellaneous Reasons|10|||
129014351|NCT03002077|464345875|FG000|Overall Study|Adverse Event|23|||
129103083|NCT03026283|464673132|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
129103084|NCT03026283|464673133|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
129103085|NCT03026283|464673134|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129103086|NCT03026283|464673135|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129103087|NCT02090283|464673145|FG000|Overall Study|Withdrawal by Subject|6|||
129103088|NCT02090283|464673146|FG001|Overall Study|Withdrawal by Subject|6|||
129103089|NCT02090283|464673147|FG002|Overall Study|Withdrawal by Subject|6|||
129103090|NCT02090283|464673145|FG000|Overall Study|Sponsor Terminated Study|6|||
129103091|NCT02090283|464673146|FG001|Overall Study|Sponsor Terminated Study|6|||
129103092|NCT02090283|464673147|FG002|Overall Study|Sponsor Terminated Study|1|||
129103093|NCT02090283|464673145|FG000|Overall Study|Lost to Follow-up|2|||
129103094|NCT02090283|464673146|FG001|Overall Study|Lost to Follow-up|2|||
129103095|NCT02090283|464673147|FG002|Overall Study|Lost to Follow-up|3|||
129103096|NCT02090283|464673145|FG000|Overall Study|Adverse Event|1|||
129103097|NCT02090283|464673146|FG001|Overall Study|Adverse Event|1|||
129103098|NCT02090283|464673147|FG002|Overall Study|Adverse Event|0|||
129103099|NCT02090283|464673145|FG000|Overall Study|Protocol Violation|2|||
129103100|NCT02090283|464673146|FG001|Overall Study|Protocol Violation|0|||
129103101|NCT02090283|464673147|FG002|Overall Study|Protocol Violation|0|||
129103102|NCT01411319|464673155|FG000|Overall Study|Lost to Follow-up|1|||
129103103|NCT02499263|464673156|FG000|Overall Study|Lost to Follow-up|9|||
129103104|NCT02499263|464673156|FG000|Overall Study|Participant's withdrawal of consent|4|||
129103105|NCT02499263|464673156|FG000|Overall Study|Lack of Efficacy|22|||
129103106|NCT02499263|464673156|FG000|Overall Study|investigator's judgment|12|||
129103107|NCT02499263|464673156|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
129103108|NCT02499263|464673156|FG000|Overall Study|Participant's decision|3|||
129103109|NCT02499263|464673156|FG000|Overall Study|Pregnancy|1|||
129103110|NCT02075008|464673163|FG000|Overall Study|Technical problems|1|||
129103111|NCT02075008|464673163|FG000|Overall Study|Pregnancy|1|||
129103112|NCT02075008|464673163|FG000|Overall Study|Physician Decision|1|||
129103113|NCT02075008|464673163|FG000|Overall Study|Lost to Follow-up|1|||
129103114|NCT02075008|464673163|FG000|Overall Study|Lack of Efficacy|1|||
129103115|NCT02075008|464673163|FG000|Overall Study|Death|1|||
129103116|NCT02075008|464673163|FG000|Overall Study|Adverse Event|5|||
129103117|NCT02075008|464673163|FG000|Overall Study|Withdrawal by Subject|6|||
129103118|NCT02075008|464673163|FG000|Overall Study|Study terminated by Sponsor|159|||
129103119|NCT00660595|464673164|FG000|Overall Study|Lost to Follow-up|0|||
129103120|NCT00660595|464673165|FG001|Overall Study|Lost to Follow-up|1|||
129103121|NCT00660595|464673164|FG000|Overall Study|Did not consent to participate in study|12|||
129103122|NCT00660595|464673165|FG001|Overall Study|Did not consent to participate in study|8|||
129103123|NCT00660595|464673164|FG000|Overall Study|Participant left hospital|1|||
128680775|NCT00274924|463130251|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
128680776|NCT00274924|463130252|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
128680777|NCT00274924|463130253|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
128680778|NCT00274924|463130251|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
128680779|NCT00274924|463130252|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
128680780|NCT00274924|463130253|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
128680781|NCT00274924|463130251|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
128680782|NCT00274924|463130252|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
128680783|NCT00274924|463130253|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
128680784|NCT00274924|463130251|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
128680785|NCT00274924|463130252|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
128680786|NCT00274924|463130253|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
128680787|NCT00274924|463130251|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
128680788|NCT00274924|463130252|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
128680789|NCT00274924|463130253|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
128680790|NCT00274924|463130251|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
128680791|NCT00274924|463130252|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
128680792|NCT00274924|463130253|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
128680793|NCT00274924|463130251|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
128680794|NCT00274924|463130252|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
128680795|NCT00274924|463130253|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
128680796|NCT00274924|463130251|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
128680797|NCT00274924|463130252|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
129103124|NCT00660595|464673165|FG001|Overall Study|Participant left hospital|0|||
129103125|NCT00660595|464673164|FG000|Overall Study|Non Specified reasons|5|||
129103126|NCT00660595|464673165|FG001|Overall Study|Non Specified reasons|0|||
129103127|NCT05205005|464673180|FG000|Overall Study|Withdrawal by Subject|1|||
129103128|NCT05205005|464673181|FG001|Overall Study|Withdrawal by Subject|0|||
129103129|NCT05205005|464673180|FG000|Overall Study|Adverse Event|1|||
128680798|NCT00274924|463130253|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
128680799|NCT00274924|463130251|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
128680800|NCT00274924|463130252|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
128680801|NCT00274924|463130253|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
128680802|NCT00274924|463130251|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
128680803|NCT00274924|463130252|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
128680804|NCT00274924|463130253|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
128680805|NCT00274924|463130251|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
128680806|NCT00274924|463130252|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
128680807|NCT00274924|463130253|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
128680808|NCT00740051|463130254|FG000|Overall Study|Lack of Efficacy|2|||
128680809|NCT00740051|463130255|FG001|Overall Study|Lack of Efficacy|5|||
128680810|NCT00740051|463130254|FG000|Overall Study|Adverse Event|1|||
128680811|NCT00740051|463130255|FG001|Overall Study|Adverse Event|4|||
128680812|NCT00740051|463130254|FG000|Overall Study|Protocol Violation|2|||
128680813|NCT00740051|463130255|FG001|Overall Study|Protocol Violation|6|||
128680814|NCT00740051|463130254|FG000|Overall Study|Lost to Follow-up|3|||
128680815|NCT00740051|463130255|FG001|Overall Study|Lost to Follow-up|8|||
128680816|NCT00740051|463130254|FG000|Overall Study|Withdrawal by Subject|6|||
128680817|NCT00740051|463130255|FG001|Overall Study|Withdrawal by Subject|8|||
128680818|NCT00740051|463130254|FG000|Overall Study|Other reason (not specified)|4|||
128680819|NCT00740051|463130255|FG001|Overall Study|Other reason (not specified)|1|||
128680820|NCT01966432|463130257|FG000|Overall Study|Lost to Follow-up|3|||
128680821|NCT01966432|463130258|FG001|Overall Study|Lost to Follow-up|2|||
128680822|NCT01966432|463130259|FG002|Overall Study|Lost to Follow-up|5|||
128680823|NCT01966432|463130257|FG000|Overall Study|Withdrawal by Subject|1|||
128680824|NCT01966432|463130258|FG001|Overall Study|Withdrawal by Subject|3|||
128680825|NCT01966432|463130259|FG002|Overall Study|Withdrawal by Subject|0|||
128680826|NCT01966432|463130257|FG000|Overall Study|Subject Incarcerated|0|||
128680827|NCT01966432|463130258|FG001|Overall Study|Subject Incarcerated|0|||
128680828|NCT01966432|463130259|FG002|Overall Study|Subject Incarcerated|1|||
128680829|NCT01966432|463130257|FG000|Overall Study|SBIRT program ended|1|||
128680830|NCT01966432|463130258|FG001|Overall Study|SBIRT program ended|8|||
128680831|NCT01966432|463130259|FG002|Overall Study|SBIRT program ended|20|||
128680832|NCT01055496|463130260|FG000|Overall Study|Withdrawal by Subject|2|||
128680833|NCT01055496|463130261|FG001|Overall Study|Withdrawal by Subject|4|||
128680834|NCT01055496|463130260|FG000|Overall Study|Death|13|||
128680835|NCT01055496|463130261|FG001|Overall Study|Death|23|||
128680836|NCT01055496|463130260|FG000|Overall Study|Lost to Follow-up|0|||
128680837|NCT01055496|463130261|FG001|Overall Study|Lost to Follow-up|2|||
128680838|NCT01055496|463130260|FG000|Overall Study|Other - Unspecified|0|||
128680839|NCT01055496|463130261|FG001|Overall Study|Other - Unspecified|1|||
128680840|NCT01903525|463130264|FG000|Overall Study|Lost to Follow-up|5|||
128680841|NCT01903525|463130265|FG001|Overall Study|Lost to Follow-up|9|||
128680842|NCT01903525|463130264|FG000|Overall Study|Adverse Event|0|||
128680843|NCT01903525|463130265|FG001|Overall Study|Adverse Event|1|||
128680844|NCT01673282|463130267|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
128680845|NCT01673282|463130268|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
128680846|NCT01673282|463130267|FG000|Overall Study|Lack of Efficacy|9|||
128680847|NCT01673282|463130268|FG001|Overall Study|Lack of Efficacy|2|||
128680848|NCT01673282|463130267|FG000|Overall Study|Lost to Follow-up|11|||
128680849|NCT01673282|463130268|FG001|Overall Study|Lost to Follow-up|10|||
128680850|NCT01673282|463130267|FG000|Overall Study|Withdrawal by Subject|3|||
128680851|NCT01673282|463130268|FG001|Overall Study|Withdrawal by Subject|3|||
128680852|NCT01673282|463130267|FG000|Overall Study|Other|1|||
128680853|NCT01673282|463130268|FG001|Overall Study|Other|6|||
128680854|NCT01323920|463130274|FG000|Overall Study|Death|5|||
128680855|NCT01323920|463130274|FG000|Overall Study|Withdrawal by Subject|1|||
128680856|NCT02915874|463130275|FG000|Overall Study|Lost to Follow-up|5|||
128680857|NCT02915874|463130276|FG001|Overall Study|Lost to Follow-up|4|||
128680858|NCT02915874|463130275|FG000|Overall Study|Withdrawal by Subject|1|||
128680859|NCT02915874|463130276|FG001|Overall Study|Withdrawal by Subject|1|||
128680860|NCT02915874|463130275|FG000|Overall Study|Started New Anxiety Medication|0|||
128680861|NCT02915874|463130276|FG001|Overall Study|Started New Anxiety Medication|1|||
128680862|NCT03562767|463130278|FG000|Overall Study|Physician Decision|2|||
128680863|NCT03562767|463130279|FG001|Overall Study|Physician Decision|0|||
128680864|NCT03562767|463130280|FG002|Overall Study|Physician Decision|0|||
128680865|NCT03562767|463130278|FG000|Overall Study|Logistic Reason|1|||
128680866|NCT03562767|463130279|FG001|Overall Study|Logistic Reason|3|||
128680867|NCT03562767|463130280|FG002|Overall Study|Logistic Reason|0|||
128680868|NCT00509262|463130281|FG000|Overall Study|Adverse Event|16|||
128680869|NCT00509262|463130282|FG001|Overall Study|Adverse Event|18|||
128680870|NCT00509262|463130281|FG000|Overall Study|Other|2|||
128680871|NCT00509262|463130282|FG001|Overall Study|Other|2|||
128680872|NCT00509262|463130281|FG000|Overall Study|Lack of Efficacy|1|||
128680873|NCT00509262|463130282|FG001|Overall Study|Lack of Efficacy|0|||
128680874|NCT00509262|463130281|FG000|Overall Study|Lost to Follow-up|1|||
128680875|NCT00509262|463130282|FG001|Overall Study|Lost to Follow-up|6|||
129014352|NCT03002077|464345875|FG000|Overall Study|Lack of Efficacy|20|||
128680876|NCT00509262|463130281|FG000|Overall Study|Physician Decision|1|||
128680877|NCT00509262|463130282|FG001|Overall Study|Physician Decision|3|||
128680878|NCT00509262|463130281|FG000|Overall Study|Protocol Violation|2|||
128680879|NCT00509262|463130282|FG001|Overall Study|Protocol Violation|2|||
128680880|NCT00509262|463130281|FG000|Overall Study|Withdrawal by Subject|24|||
128680881|NCT00509262|463130282|FG001|Overall Study|Withdrawal by Subject|11|||
128680882|NCT04738318|463130287|FG000|Overall Study|Protocol Violation|1|||
128680883|NCT04738318|463130288|FG001|Overall Study|Protocol Violation|0|||
128680884|NCT02290431|463130289|FG000|Overall Study|Adverse Event|20|||
128680885|NCT02290431|463130289|FG000|Overall Study|Progressive disease|4|||
128680886|NCT02290431|463130289|FG000|Overall Study|Study terminated by Sponsor|1|||
128680887|NCT02290431|463130289|FG000|Overall Study|Physician Decision|2|||
128680888|NCT00821327|463130290|FG000|Overall Study|Adverse Event|13|||
128680889|NCT00821327|463130290|FG000|Overall Study|Patient Request|1|||
128680890|NCT00821327|463130290|FG000|Overall Study|Investigator Request|2|||
128680891|NCT00821327|463130290|FG000|Overall Study|Sponsor Request|1|||
128680892|NCT00821327|463130290|FG000|Overall Study|Disease Progression|13|||
128680893|NCT00821327|463130290|FG000|Overall Study|Other/Unknown|5|||
128680894|NCT00459979|463130291|FG000|Overall Study|Withdrawal by Subject|1|||
128680895|NCT00459979|463130291|FG000|Overall Study|Protocol Violation|1|||
128680896|NCT00219544|463130292|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
128680897|NCT00219544|463130293|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
128680898|NCT00219544|463130292|FG000|Single Blind Treatment Period|Adverse Event|9|||
128680899|NCT00219544|463130293|FG001|Single Blind Treatment Period|Adverse Event|0|||
128680900|NCT00219544|463130292|FG000|Single Blind Treatment Period|Protocol Violation|4|||
128680901|NCT00219544|463130293|FG001|Single Blind Treatment Period|Protocol Violation|0|||
128680902|NCT00219544|463130292|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
128680903|NCT00219544|463130293|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
128680904|NCT00219544|463130292|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
128680905|NCT00219544|463130293|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
128680906|NCT00219544|463130292|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
128680907|NCT00219544|463130293|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
128680908|NCT00570232|463130294|FG000|Overall Study|Adverse Event|10|||
128680909|NCT00570232|463130294|FG000|Overall Study|discontinued due to medical condition|3|||
128680910|NCT00570232|463130294|FG000|Overall Study|discontinued due to recurrence|8|||
128680911|NCT00570232|463130294|FG000|Overall Study|discontinued due to noncompliance|2|||
128680912|NCT01007253|463130297|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
128680913|NCT01007253|463130298|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
128680914|NCT01007253|463130299|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
128680915|NCT01007253|463130300|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
128680916|NCT00814801|463130301|FG000|Overall Study|Adverse Event|15|||
128680917|NCT00814801|463130302|FG001|Overall Study|Adverse Event|16|||
128680918|NCT00814801|463130303|FG002|Overall Study|Adverse Event|19|||
128680919|NCT00814801|463130301|FG000|Overall Study|Withdrawal by Subject|9|||
128680920|NCT00814801|463130302|FG001|Overall Study|Withdrawal by Subject|11|||
128680921|NCT00814801|463130303|FG002|Overall Study|Withdrawal by Subject|14|||
128680922|NCT00814801|463130301|FG000|Overall Study|Inappropriate as a subject|1|||
128680923|NCT00814801|463130302|FG001|Overall Study|Inappropriate as a subject|1|||
128680924|NCT00814801|463130303|FG002|Overall Study|Inappropriate as a subject|1|||
129103130|NCT05205005|464673181|FG001|Overall Study|Adverse Event|0|||
129103131|NCT01148459|464673184|FG000|Overall Study|Serious Adverse Event|5|||
129103132|NCT01148459|464673185|FG001|Overall Study|Serious Adverse Event|4|||
129103133|NCT01148459|464673184|FG000|Overall Study|Withdrawal by Subject|1|||
129103134|NCT01148459|464673185|FG001|Overall Study|Withdrawal by Subject|0|||
129103135|NCT01148459|464673184|FG000|Overall Study|Migrated/moved from study area|3|||
129103136|NCT01148459|464673185|FG001|Overall Study|Migrated/moved from study area|6|||
129103137|NCT01148459|464673184|FG000|Overall Study|Lost to Follow-up|2|||
128680925|NCT00814801|463130301|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
128680926|NCT00814801|463130302|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
128680927|NCT00814801|463130303|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
128680928|NCT00814801|463130301|FG000|Overall Study|Missing or change of caregiver|6|||
128680929|NCT00814801|463130302|FG001|Overall Study|Missing or change of caregiver|2|||
128680930|NCT00814801|463130303|FG002|Overall Study|Missing or change of caregiver|4|||
128680931|NCT00814801|463130301|FG000|Overall Study|Non-compliance|0|||
128680932|NCT00814801|463130302|FG001|Overall Study|Non-compliance|1|||
128680933|NCT00814801|463130303|FG002|Overall Study|Non-compliance|1|||
128680934|NCT00814801|463130301|FG000|Overall Study|Other|2|||
128680935|NCT00814801|463130302|FG001|Overall Study|Other|6|||
128680936|NCT00814801|463130303|FG002|Overall Study|Other|4|||
128680937|NCT00586664|463130304|FG000|Overall Study|Withdrawal by Subject|3|||
128680938|NCT00586664|463130305|FG001|Overall Study|Withdrawal by Subject|7|||
128680939|NCT00586664|463130306|FG002|Overall Study|Withdrawal by Subject|1|||
128680940|NCT00586664|463130304|FG000|Overall Study|Exclusion criteria met|2|||
128680941|NCT00586664|463130305|FG001|Overall Study|Exclusion criteria met|0|||
128680942|NCT00586664|463130306|FG002|Overall Study|Exclusion criteria met|0|||
129103138|NCT01148459|464673185|FG001|Overall Study|Lost to Follow-up|0|||
129103139|NCT01148459|464673184|FG000|Overall Study|Refusal|1|||
129103140|NCT01148459|464673185|FG001|Overall Study|Refusal|0|||
128680943|NCT02751931|463130307|FG000|Overall Study|Adverse Event|3|||
128680944|NCT02751931|463130308|FG001|Overall Study|Adverse Event|0|||
128680945|NCT02751931|463130307|FG000|Overall Study|Other: Miscelleneous|10|||
128680946|NCT02751931|463130308|FG001|Overall Study|Other: Miscelleneous|8|||
128680947|NCT01037088|463130309|FG000|Overall Study|Withdrawal by Subject|3|||
128680948|NCT01163318|463130324|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
129103141|NCT01148459|464673184|FG000|Overall Study|Failure to comply with study procedures|0|||
129103142|NCT01148459|464673185|FG001|Overall Study|Failure to comply with study procedures|1|||
128680949|NCT01163318|463130324|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
128680950|NCT01163318|463130324|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
128680951|NCT01163318|463130324|FG000|Overall Study|Participants Without Case Report Form|7|||
128680952|NCT01163318|463130324|FG000|Overall Study|Multiple Reasons Per Participant|224|||
128680953|NCT01006603|463130325|FG000|Overall Study|Withdrawal by Subject|17|||
129103143|NCT00694356|464673186|FG000|Overall Study|Adverse Event|1|||
129103144|NCT00694356|464673187|FG001|Overall Study|Adverse Event|0|||
129103145|NCT00694356|464673188|FG002|Overall Study|Adverse Event|0|||
128680954|NCT01006603|463130326|FG001|Overall Study|Withdrawal by Subject|19|||
128680955|NCT01006603|463130325|FG000|Overall Study|Lost to Follow-up|0|||
128680956|NCT01006603|463130326|FG001|Overall Study|Lost to Follow-up|1|||
128680957|NCT01006603|463130325|FG000|Overall Study|Safety reason|1|||
128680958|NCT01006603|463130326|FG001|Overall Study|Safety reason|1|||
128680959|NCT01006603|463130325|FG000|Overall Study|Protocol Violation|1|||
128680960|NCT01006603|463130326|FG001|Overall Study|Protocol Violation|3|||
128680961|NCT01006603|463130325|FG000|Overall Study|Incorrect enrolment|0|||
128680962|NCT01006603|463130326|FG001|Overall Study|Incorrect enrolment|2|||
128680963|NCT01006603|463130325|FG000|Overall Study|Adverse Event|15|||
128680964|NCT01006603|463130326|FG001|Overall Study|Adverse Event|7|||
128680965|NCT01006603|463130325|FG000|Overall Study|Death|1|||
128680966|NCT01006603|463130326|FG001|Overall Study|Death|1|||
128680967|NCT01006603|463130325|FG000|Overall Study|Study specific discontinuation criteria|33|||
128680968|NCT01006603|463130326|FG001|Overall Study|Study specific discontinuation criteria|34|||
128680969|NCT01006603|463130325|FG000|Overall Study|Other|3|||
128680970|NCT01006603|463130326|FG001|Overall Study|Other|7|||
128680971|NCT02497976|463131898|FG000|Overall Study|Withdrawal by Subject|2|||
128680972|NCT02497976|463131899|FG001|Overall Study|Withdrawal by Subject|0|||
128680973|NCT02497976|463131898|FG000|Overall Study|Moved out of area|0|||
128680974|NCT02497976|463131899|FG001|Overall Study|Moved out of area|1|||
128680975|NCT00584740|463131900|FG000|Overall Study|Adverse Event|1|||
128680976|NCT00584740|463131901|FG001|Overall Study|Adverse Event|1|||
128680977|NCT00584740|463131900|FG000|Overall Study|Lack of Efficacy|8|||
128680978|NCT00584740|463131901|FG001|Overall Study|Lack of Efficacy|2|||
128680979|NCT00584740|463131900|FG000|Overall Study|Withdrawal by Subject|3|||
128680980|NCT00584740|463131901|FG001|Overall Study|Withdrawal by Subject|2|||
128680981|NCT00584740|463131900|FG000|Overall Study|Lost to Follow-up|0|||
128680982|NCT00584740|463131901|FG001|Overall Study|Lost to Follow-up|1|||
128680983|NCT00930982|463131902|FG000|Overall Study|Adverse Event|19|||
128680984|NCT00930982|463131903|FG001|Overall Study|Adverse Event|23|||
128680985|NCT00930982|463131902|FG000|Overall Study|Protocol Violation|1|||
128680986|NCT00930982|463131903|FG001|Overall Study|Protocol Violation|5|||
128680987|NCT00930982|463131902|FG000|Overall Study|Withdrawal by Subject|1|||
128680988|NCT00930982|463131903|FG001|Overall Study|Withdrawal by Subject|1|||
128774789|NCT02555371|463468339|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129014353|NCT03002077|464345875|FG000|Overall Study|Withdrawal by Subject|72|||
129014354|NCT03002077|464345875|FG000|Overall Study|Lost to Follow-up|21|||
129014355|NCT03002077|464345875|FG000|Overall Study|Pregnancy|4|||
129014356|NCT03002077|464345875|FG000|Overall Study|Protocol Violation|21|||
129014357|NCT04625114|464345876|FG000|Overall Study|Adverse Event|3|||
129014358|NCT04625114|464345877|FG001|Overall Study|Adverse Event|1|||
129014359|NCT04625114|464345876|FG000|Overall Study|Withdrawal by Subject|2|||
129014360|NCT04625114|464345877|FG001|Overall Study|Withdrawal by Subject|0|||
129014361|NCT00472290|464345878|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
128680989|NCT03915860|463131904|FG000|Overall Study|Adverse Event|3|||
128680990|NCT03915860|463131904|FG000|Overall Study|Withdrawal by Subject|6|||
128680991|NCT03915860|463131904|FG000|Overall Study|Lost to Follow-up|2|||
128680992|NCT03915860|463131904|FG000|Overall Study|Other than specified|3|||
128680993|NCT02195011|463131905|FG000|Overall Study|Adverse Event|4|||
128680994|NCT02195011|463131906|FG001|Overall Study|Adverse Event|0|||
128680995|NCT02195011|463131905|FG000|Overall Study|Progressive Disease|18|||
128680996|NCT02195011|463131906|FG001|Overall Study|Progressive Disease|1|||
128680997|NCT02195011|463131905|FG000|Overall Study|Withdrawal by Subject|3|||
128680998|NCT02195011|463131906|FG001|Overall Study|Withdrawal by Subject|0|||
129014362|NCT00472290|464345878|FG000|Overall Study|Protocol Specified Criteria|7|||
129014363|NCT00472290|464345878|FG000|Overall Study|Administrative Decision|37|||
129014364|NCT00472290|464345878|FG000|Overall Study|Death|3|||
128680999|NCT01609478|463131907|FG000|Overall Study|Adverse Event|3|||
129103146|NCT00694356|464673186|FG000|Overall Study|Progressive Disease|2|||
129103147|NCT00694356|464673187|FG001|Overall Study|Progressive Disease|6|||
129103148|NCT00694356|464673188|FG002|Overall Study|Progressive Disease|6|||
129103149|NCT01763203|464673195|FG000|Overall Study|Death|4|||
129103150|NCT01763203|464673196|FG001|Overall Study|Death|7|||
129103151|NCT01763203|464673195|FG000|Overall Study|Lost to Follow-up|12|||
129103152|NCT01763203|464673196|FG001|Overall Study|Lost to Follow-up|12|||
129103153|NCT01763203|464673195|FG000|Overall Study|Withdrawal by Subject|8|||
129103154|NCT01763203|464673196|FG001|Overall Study|Withdrawal by Subject|12|||
129103155|NCT01763203|464673195|FG000|Overall Study|Moved out of study region|7|||
129103156|NCT01763203|464673196|FG001|Overall Study|Moved out of study region|10|||
129103157|NCT01763203|464673195|FG000|Overall Study|Physician Decision|2|||
129103158|NCT01763203|464673196|FG001|Overall Study|Physician Decision|1|||
129103159|NCT02187861|464673197|FG000|Overall Study|Adverse Event|2|||
129103160|NCT02187861|464673198|FG001|Overall Study|Adverse Event|1|||
129103161|NCT02187861|464673199|FG002|Overall Study|Adverse Event|2|||
129103162|NCT02187861|464673200|FG003|Overall Study|Adverse Event|1|||
129103163|NCT02187861|464673197|FG000|Overall Study|Death|0|||
129103164|NCT02187861|464673198|FG001|Overall Study|Death|3|||
129103165|NCT02187861|464673199|FG002|Overall Study|Death|1|||
129103166|NCT02187861|464673200|FG003|Overall Study|Death|2|||
129103167|NCT02187861|464673197|FG000|Overall Study|Physician Decision|0|||
129103168|NCT02187861|464673198|FG001|Overall Study|Physician Decision|1|||
129103169|NCT02187861|464673199|FG002|Overall Study|Physician Decision|0|||
129103170|NCT02187861|464673200|FG003|Overall Study|Physician Decision|3|||
129103171|NCT02187861|464673197|FG000|Overall Study|Progressive Disease|4|||
129103172|NCT02187861|464673198|FG001|Overall Study|Progressive Disease|42|||
129103173|NCT02187861|464673199|FG002|Overall Study|Progressive Disease|19|||
129103174|NCT02187861|464673200|FG003|Overall Study|Progressive Disease|22|||
129103175|NCT02187861|464673197|FG000|Overall Study|Withdrawal by Subject|0|||
129103176|NCT02187861|464673198|FG001|Overall Study|Withdrawal by Subject|0|||
129103177|NCT02187861|464673199|FG002|Overall Study|Withdrawal by Subject|3|||
129103178|NCT02187861|464673200|FG003|Overall Study|Withdrawal by Subject|3|||
129103179|NCT02187861|464673197|FG000|Overall Study|Other|0|||
129103180|NCT02187861|464673198|FG001|Overall Study|Other|1|||
129103181|NCT02187861|464673199|FG002|Overall Study|Other|7|||
129103182|NCT02187861|464673200|FG003|Overall Study|Other|1|||
129103183|NCT00645671|464673201|FG000|Overall Study|Protocol Violation|1|||
129103184|NCT00645671|464673202|FG001|Overall Study|Protocol Violation|0|||
129103185|NCT00645671|464673201|FG000|Overall Study|Withdrawal by Subject|0|||
129103186|NCT00645671|464673202|FG001|Overall Study|Withdrawal by Subject|4|||
129103187|NCT00645671|464673201|FG000|Overall Study|Adverse Event|0|||
129103188|NCT00645671|464673202|FG001|Overall Study|Adverse Event|1|||
129103189|NCT00645671|464673201|FG000|Overall Study|Physician Decision|0|||
129103190|NCT00645671|464673202|FG001|Overall Study|Physician Decision|1|||
129103191|NCT01152996|464673203|FG000|Overall Study|Withdrawal by Subject|142|||
129103192|NCT01152996|464673203|FG000|Overall Study|Adverse Event|115|||
129103193|NCT01152996|464673203|FG000|Overall Study|Lost to Follow-up|112|||
129103194|NCT01152996|464673203|FG000|Overall Study|Lack of Efficacy|68|||
129103195|NCT01152996|464673203|FG000|Overall Study|Noncompliance|41|||
129103196|NCT01152996|464673203|FG000|Overall Study|Other|36|||
129103197|NCT01152996|464673203|FG000|Overall Study|Protocol Violation|22|||
129103198|NCT01152996|464673203|FG000|Overall Study|Elevated liver enzymes|1|||
129103199|NCT02072941|464673204|FG000|Overall Study|Withdrawal by Subject|29|||
129103200|NCT02072941|464673205|FG001|Overall Study|Withdrawal by Subject|21|||
129014365|NCT00472290|464345878|FG000|Overall Study|Lost to Follow-up|1|||
129014366|NCT00472290|464345878|FG000|Overall Study|Lack of Efficacy|1|||
129014367|NCT00472290|464345878|FG000|Overall Study|Disease Progression|4|||
129014368|NCT00472290|464345878|FG000|Overall Study|Withdrawal by Subject|5|||
129014369|NCT00472290|464345878|FG000|Overall Study|Adverse Event|6|||
129014370|NCT00472290|464345878|FG000|Overall Study|Requirement for alternative therapy|7|||
129014371|NCT00777829|464345879|FG000|Overall Study|Withdrawal by Subject|0|||
129014372|NCT00777829|464345880|FG001|Overall Study|Withdrawal by Subject|2|||
129014373|NCT00336479|464345885|FG000|Overall Study|Adverse Event|8|||
129014374|NCT00336479|464345886|FG001|Overall Study|Adverse Event|11|||
129014375|NCT00336479|464345887|FG002|Overall Study|Adverse Event|18|||
129014376|NCT00336479|464345888|FG003|Overall Study|Adverse Event|4|||
129014377|NCT00336479|464345885|FG000|Overall Study|Noncompliant|1|||
129014378|NCT00336479|464345886|FG001|Overall Study|Noncompliant|7|||
129014379|NCT00336479|464345887|FG002|Overall Study|Noncompliant|3|||
129103201|NCT02072941|464673204|FG000|Overall Study|Lost to Follow-up|4|||
129103202|NCT02072941|464673205|FG001|Overall Study|Lost to Follow-up|4|||
129014380|NCT00336479|464345888|FG003|Overall Study|Noncompliant|0|||
129014381|NCT00336479|464345885|FG000|Overall Study|Physician Decision|2|||
129014382|NCT00336479|464345886|FG001|Overall Study|Physician Decision|3|||
129014383|NCT00336479|464345887|FG002|Overall Study|Physician Decision|1|||
129103203|NCT02072941|464673204|FG000|Overall Study|Death|3|||
129103204|NCT02072941|464673205|FG001|Overall Study|Death|2|||
129103205|NCT02072941|464673204|FG000|Overall Study|Removed by Study Staff|2|||
129103206|NCT02072941|464673205|FG001|Overall Study|Removed by Study Staff|2|||
129103207|NCT03224624|464673214|FG000|Overall Study|Lost to Follow-up|9|||
129103208|NCT03224624|464673215|FG001|Overall Study|Lost to Follow-up|4|||
129103209|NCT03224624|464673214|FG000|Overall Study|Death|1|||
129103210|NCT03224624|464673215|FG001|Overall Study|Death|0|||
129103211|NCT01884545|464673216|FG000|Overall Study|Lost to Follow-up|6|||
129103212|NCT01884545|464673217|FG001|Overall Study|Lost to Follow-up|4|||
129103213|NCT01884545|464673218|FG002|Overall Study|Lost to Follow-up|9|||
129103214|NCT01884545|464673219|FG003|Overall Study|Lost to Follow-up|4|||
129103215|NCT01884545|464673216|FG000|Overall Study|Patient withdrawn|7|||
129103216|NCT01884545|464673217|FG001|Overall Study|Patient withdrawn|12|||
129103217|NCT01884545|464673218|FG002|Overall Study|Patient withdrawn|5|||
129103218|NCT01884545|464673219|FG003|Overall Study|Patient withdrawn|5|||
129103219|NCT01884545|464673216|FG000|Overall Study|Non-adherence|0|||
129103220|NCT01884545|464673217|FG001|Overall Study|Non-adherence|2|||
129103221|NCT01884545|464673218|FG002|Overall Study|Non-adherence|0|||
129103222|NCT01884545|464673219|FG003|Overall Study|Non-adherence|0|||
129103223|NCT02782377|464673220|FG000|Overall Study|Physician Decision|5|||
129103224|NCT00770913|464673221|FG000|Overall Study|Adverse Event|1|||
129103225|NCT00770913|464673222|FG001|Overall Study|Adverse Event|3|||
129103226|NCT00770913|464673223|FG002|Overall Study|Adverse Event|6|||
129103227|NCT00770913|464673221|FG000|Overall Study|Refusal to continue participation|6|||
129103228|NCT00770913|464673222|FG001|Overall Study|Refusal to continue participation|4|||
129103229|NCT00770913|464673223|FG002|Overall Study|Refusal to continue participation|5|||
129103230|NCT00770913|464673221|FG000|Overall Study|Physician Decision|0|||
129103231|NCT00770913|464673222|FG001|Overall Study|Physician Decision|1|||
129103232|NCT00770913|464673223|FG002|Overall Study|Physician Decision|1|||
129103233|NCT00770913|464673221|FG000|Overall Study|Protocol Violation|3|||
129103234|NCT00770913|464673222|FG001|Overall Study|Protocol Violation|0|||
129103235|NCT00770913|464673223|FG002|Overall Study|Protocol Violation|1|||
129103236|NCT00770913|464673221|FG000|Overall Study|Incorrect drug was allocated|1|||
129103237|NCT00770913|464673222|FG001|Overall Study|Incorrect drug was allocated|0|||
129103238|NCT00770913|464673223|FG002|Overall Study|Incorrect drug was allocated|0|||
129103239|NCT03383692|464673229|FG000|Overall Study|Progressive disease as per RECIST|3|||
129103240|NCT03383692|464673230|FG001|Overall Study|Progressive disease as per RECIST|3|||
129103241|NCT03383692|464673229|FG000|Overall Study|Clinical progression|0|||
129103242|NCT03383692|464673230|FG001|Overall Study|Clinical progression|1|||
129103243|NCT03383692|464673229|FG000|Overall Study|Adverse Event|3|||
129103244|NCT03383692|464673230|FG001|Overall Study|Adverse Event|0|||
129103245|NCT00893971|464673235|FG000|Overall Study|Physician Decision|3|||
129103246|NCT02453256|464673236|FG000|Double Blind Period|Death|1|||
129103247|NCT02453256|464673237|FG001|Double Blind Period|Death|1|||
129103248|NCT02453256|464673236|FG000|Double Blind Period|Adverse Event|3|||
129103249|NCT02453256|464673237|FG001|Double Blind Period|Adverse Event|2|||
129103250|NCT02453256|464673236|FG000|Double Blind Period|Withdrawal by Subject|9|||
129103251|NCT02453256|464673237|FG001|Double Blind Period|Withdrawal by Subject|5|||
129103252|NCT02453256|464673236|FG000|Double Blind Period|Other|0|||
129103253|NCT02453256|464673237|FG001|Double Blind Period|Other|1|||
129103254|NCT02453256|464673236|FG000|Open Label Period|Adverse Event|1|||
129103255|NCT02453256|464673237|FG001|Open Label Period|Adverse Event|3|||
129103256|NCT02453256|464673236|FG000|Open Label Period|Death|0|||
129103257|NCT02453256|464673237|FG001|Open Label Period|Death|1|||
129103258|NCT02453256|464673236|FG000|Open Label Period|Lost to Follow-up|1|||
129103259|NCT02453256|464673237|FG001|Open Label Period|Lost to Follow-up|0|||
129103260|NCT02453256|464673236|FG000|Open Label Period|Other|0|||
129103261|NCT02453256|464673237|FG001|Open Label Period|Other|2|||
129103262|NCT02453256|464673236|FG000|Open Label Period|Withdrawal by Subject|5|||
129103263|NCT02453256|464673237|FG001|Open Label Period|Withdrawal by Subject|1|||
129103264|NCT01366638|464673238|FG000|Overall Study|Withdrawal by Subject|0|||
129103265|NCT01366638|464673239|FG001|Overall Study|Withdrawal by Subject|0|||
129103266|NCT01366638|464673240|FG002|Overall Study|Withdrawal by Subject|6|||
129103267|NCT01366638|464673238|FG000|Overall Study|Other|1|||
129103268|NCT01366638|464673239|FG001|Overall Study|Other|0|||
129103269|NCT01366638|464673240|FG002|Overall Study|Other|0|||
129103270|NCT01237327|464673241|FG000|Overall Study|Protocol Violation: Core Study|1|||
128681000|NCT01609478|463131908|FG001|Overall Study|Adverse Event|1|||
128681001|NCT01609478|463131909|FG002|Overall Study|Adverse Event|5|||
129103271|NCT01237327|464673242|FG001|Overall Study|Protocol Violation: Core Study|0|||
129103272|NCT01237327|464673241|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
129103273|NCT01237327|464673242|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
129103274|NCT01237327|464673241|FG000|Overall Study|Progression of Disease: Core Study|18|||
129103275|NCT01237327|464673242|FG001|Overall Study|Progression of Disease: Core Study|22|||
129103276|NCT01237327|464673241|FG000|Overall Study|Progression of Disease: Extension Study|15|||
129103277|NCT01237327|464673242|FG001|Overall Study|Progression of Disease: Extension Study|13|||
129103278|NCT01237327|464673241|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
129103279|NCT01237327|464673242|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
129103280|NCT01237327|464673241|FG000|Overall Study|Withdrawal by Subject|1|||
129103281|NCT01237327|464673242|FG001|Overall Study|Withdrawal by Subject|3|||
129103282|NCT01237327|464673241|FG000|Overall Study|Lost to Follow-up|3|||
129103283|NCT01237327|464673242|FG001|Overall Study|Lost to Follow-up|0|||
129103284|NCT02483572|464673245|FG000|Overall Study|Withdrawal by Subject|1|||
128681002|NCT01609478|463131907|FG000|Overall Study|Protocol Deviation|0|||
128681003|NCT01609478|463131908|FG001|Overall Study|Protocol Deviation|1|||
128681004|NCT01609478|463131909|FG002|Overall Study|Protocol Deviation|1|||
128681005|NCT01609478|463131907|FG000|Overall Study|Non-Compliance with study treatment|1|||
128681006|NCT01609478|463131908|FG001|Overall Study|Non-Compliance with study treatment|0|||
128681007|NCT01609478|463131909|FG002|Overall Study|Non-Compliance with study treatment|0|||
128681008|NCT01609478|463131907|FG000|Overall Study|Physician Decision|1|||
128681009|NCT01609478|463131908|FG001|Overall Study|Physician Decision|0|||
128681010|NCT01609478|463131909|FG002|Overall Study|Physician Decision|1|||
128681011|NCT01609478|463131907|FG000|Overall Study|Withdrawal by Subject|2|||
128681012|NCT01609478|463131908|FG001|Overall Study|Withdrawal by Subject|0|||
128681013|NCT01609478|463131909|FG002|Overall Study|Withdrawal by Subject|2|||
128681014|NCT04966741|463131910|FG000|Overall Study|Lost to Follow-up|1|||
129014384|NCT00336479|464345888|FG003|Overall Study|Physician Decision|0|||
129014385|NCT00336479|464345885|FG000|Overall Study|Lost to Follow-up|3|||
129014386|NCT00336479|464345886|FG001|Overall Study|Lost to Follow-up|2|||
129014387|NCT00336479|464345887|FG002|Overall Study|Lost to Follow-up|0|||
129014388|NCT00336479|464345888|FG003|Overall Study|Lost to Follow-up|0|||
129014389|NCT00336479|464345885|FG000|Overall Study|Withdrawal by Subject|3|||
129014390|NCT00336479|464345886|FG001|Overall Study|Withdrawal by Subject|2|||
129014391|NCT00336479|464345887|FG002|Overall Study|Withdrawal by Subject|3|||
129014392|NCT00336479|464345888|FG003|Overall Study|Withdrawal by Subject|0|||
129014393|NCT00336479|464345885|FG000|Overall Study|Other|0|||
129014394|NCT00336479|464345886|FG001|Overall Study|Other|0|||
129014395|NCT00336479|464345887|FG002|Overall Study|Other|1|||
129014396|NCT00336479|464345888|FG003|Overall Study|Other|0|||
129014397|NCT00336479|464345885|FG000|Overall Study|Virologic Stopping Rule|20|||
129014398|NCT00336479|464345886|FG001|Overall Study|Virologic Stopping Rule|0|||
129014399|NCT00336479|464345887|FG002|Overall Study|Virologic Stopping Rule|0|||
129014400|NCT00336479|464345888|FG003|Overall Study|Virologic Stopping Rule|0|||
129014401|NCT01722877|464345889|FG000|Overall Study|Death|1|||
129014402|NCT01722877|464345889|FG000|Overall Study|Lost to Follow-up|1|||
129014403|NCT01395030|464345892|FG000|Overall Study|Did not complete FCH PET/CT|7|||
129014404|NCT02079766|464345893|FG000|Overall Study|Physician Decision|1|||
129014405|NCT02079766|464345894|FG001|Overall Study|Physician Decision|0|||
129014406|NCT02079766|464345893|FG000|Overall Study|Withdrawal by Subject|1|||
129014407|NCT02079766|464345894|FG001|Overall Study|Withdrawal by Subject|0|||
129014408|NCT00857623|464345899|FG000|Overall Study|Adverse Event|5|||
129014409|NCT00857623|464345900|FG001|Overall Study|Adverse Event|2|||
129014410|NCT00857623|464345899|FG000|Overall Study|Study-specific discontinuation criteria|5|||
129014411|NCT00857623|464345900|FG001|Overall Study|Study-specific discontinuation criteria|3|||
129014412|NCT00857623|464345899|FG000|Overall Study|Withdrawal by Subject|2|||
129014413|NCT00857623|464345900|FG001|Overall Study|Withdrawal by Subject|1|||
129014414|NCT00857623|464345899|FG000|Overall Study|Lack of Efficacy|1|||
129014415|NCT00857623|464345900|FG001|Overall Study|Lack of Efficacy|1|||
129014416|NCT00857623|464345899|FG000|Overall Study|Severe non-compliance to protocol|1|||
129014417|NCT00857623|464345900|FG001|Overall Study|Severe non-compliance to protocol|1|||
129014418|NCT00857623|464345899|FG000|Overall Study|Intake of prohibited medication|0|||
129014419|NCT00857623|464345900|FG001|Overall Study|Intake of prohibited medication|1|||
129014420|NCT00857623|464345899|FG000|Overall Study|Positive for HEP C|0|||
129014421|NCT00857623|464345900|FG001|Overall Study|Positive for HEP C|1|||
129014422|NCT00694551|464345901|FG000|Overall Study|Disease Progression|1|||
129014423|NCT00694551|464345902|FG001|Overall Study|Disease Progression|0|||
129014424|NCT00694551|464345903|FG002|Overall Study|Disease Progression|1|||
129014425|NCT02920996|464345908|FG000|Overall Study|Adverse Event|8|||
129014426|NCT02920996|464345909|FG001|Overall Study|Adverse Event|0|||
129014427|NCT02920996|464345908|FG000|Overall Study|Physician Decision|1|||
129014428|NCT02920996|464345909|FG001|Overall Study|Physician Decision|0|||
129014429|NCT02920996|464345908|FG000|Overall Study|Death|1|||
129014430|NCT02920996|464345909|FG001|Overall Study|Death|0|||
129014431|NCT02920996|464345908|FG000|Overall Study|Missing|1|||
129014432|NCT02920996|464345909|FG001|Overall Study|Missing|0|||
129014433|NCT02920996|464345908|FG000|Overall Study|Subject Non-Compliance|1|||
129014434|NCT02920996|464345909|FG001|Overall Study|Subject Non-Compliance|0|||
129014435|NCT01402947|464345912|FG000|First Intervention|Adverse Event|0|||
128681015|NCT04966741|463131911|FG001|Overall Study|Lost to Follow-up|0|||
129014436|NCT01402947|464345913|FG001|First Intervention|Adverse Event|1|||
129014437|NCT00385684|464345914|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
129014438|NCT00385684|464345915|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
129014439|NCT00385684|464345914|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
129014440|NCT00385684|464345915|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
129014441|NCT00385684|464345914|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
129014442|NCT00385684|464345915|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
129014443|NCT00591630|464345916|FG000|Overall Study|Death|0|||
129014444|NCT00591630|464345917|FG001|Overall Study|Death|0|||
129014445|NCT00591630|464345918|FG002|Overall Study|Death|1|||
129014446|NCT00591630|464345919|FG003|Overall Study|Death|0|||
129014447|NCT00154102|464345920|FG000|Overall Study|investigational study phase ongoing|7|||
129103285|NCT02483572|464673246|FG001|Overall Study|Withdrawal by Subject|0|||
129103286|NCT02483572|464673245|FG000|Overall Study|Lost to Follow-up|1|||
129103287|NCT02483572|464673246|FG001|Overall Study|Lost to Follow-up|0|||
129103288|NCT02483572|464673245|FG000|Overall Study|Physician Decision|0|||
129103289|NCT02483572|464673246|FG001|Overall Study|Physician Decision|1|||
129103290|NCT05052697|464673247|FG000|Substudy A|Lost to Follow-up|0|||
129103291|NCT05052697|464673248|FG001|Substudy A|Lost to Follow-up|0|||
129103292|NCT05052697|464673249|FG002|Substudy A|Lost to Follow-up|0|||
129103293|NCT05052697|464673250|FG003|Substudy A|Lost to Follow-up|0|||
129103294|NCT05052697|464673251|FG004|Substudy A|Lost to Follow-up|0|||
129103295|NCT05052697|464673252|FG005|Substudy A|Lost to Follow-up|1|||
129103296|NCT05052697|464673253|FG006|Substudy A|Lost to Follow-up|0|||
129103297|NCT05052697|464673254|FG007|Substudy A|Lost to Follow-up|0|||
129103298|NCT05052697|464673255|FG008|Substudy A|Lost to Follow-up|0|||
129103299|NCT05052697|464673256|FG009|Substudy A|Lost to Follow-up|0|||
129103300|NCT05052697|464673257|FG010|Substudy A|Lost to Follow-up|0|||
129103301|NCT05052697|464673258|FG011|Substudy A|Lost to Follow-up|0|||
129103302|NCT05052697|464673259|FG012|Substudy A|Lost to Follow-up|0|||
129103303|NCT05052697|464673260|FG013|Substudy A|Lost to Follow-up|0|||
129103304|NCT05052697|464673261|FG014|Substudy A|Lost to Follow-up|0|||
129103305|NCT05052697|464673262|FG015|Substudy A|Lost to Follow-up|2|||
129103306|NCT05052697|464673263|FG016|Substudy A|Lost to Follow-up|0|||
129103307|NCT05052697|464673264|FG017|Substudy A|Lost to Follow-up|0|||
129103308|NCT05052697|464673265|FG018|Substudy A|Lost to Follow-up|0|||
129103309|NCT05052697|464673266|FG019|Substudy A|Lost to Follow-up|0|||
129103310|NCT05052697|464673267|FG020|Substudy A|Lost to Follow-up|0|||
129103311|NCT05052697|464673268|FG021|Substudy A|Lost to Follow-up|0|||
129103312|NCT05052697|464673269|FG022|Substudy A|Lost to Follow-up|0|||
129103313|NCT05052697|464673270|FG023|Substudy A|Lost to Follow-up|0|||
129103314|NCT05052697|464673271|FG024|Substudy A|Lost to Follow-up|0|||
129103315|NCT05052697|464673272|FG025|Substudy A|Lost to Follow-up|0|||
129103316|NCT05052697|464673273|FG026|Substudy A|Lost to Follow-up|0|||
129103317|NCT05052697|464673274|FG027|Substudy A|Lost to Follow-up|0|||
129103318|NCT05052697|464673275|FG028|Substudy A|Lost to Follow-up|0|||
129103319|NCT05052697|464673276|FG029|Substudy A|Lost to Follow-up|0|||
129103320|NCT05052697|464673277|FG030|Substudy A|Lost to Follow-up|0|||
129103321|NCT05052697|464673278|FG031|Substudy A|Lost to Follow-up|0|||
129103322|NCT05052697|464673279|FG032|Substudy A|Lost to Follow-up|0|||
129103323|NCT05052697|464673280|FG033|Substudy A|Lost to Follow-up|0|||
129103324|NCT05052697|464673247|FG000|Substudy A|No longer met eligibility criteria|0|||
129103325|NCT05052697|464673248|FG001|Substudy A|No longer met eligibility criteria|0|||
129103326|NCT05052697|464673249|FG002|Substudy A|No longer met eligibility criteria|0|||
129103327|NCT05052697|464673250|FG003|Substudy A|No longer met eligibility criteria|0|||
129103328|NCT05052697|464673251|FG004|Substudy A|No longer met eligibility criteria|0|||
129103329|NCT05052697|464673252|FG005|Substudy A|No longer met eligibility criteria|0|||
129103330|NCT05052697|464673253|FG006|Substudy A|No longer met eligibility criteria|0|||
129103331|NCT05052697|464673254|FG007|Substudy A|No longer met eligibility criteria|0|||
129103332|NCT05052697|464673255|FG008|Substudy A|No longer met eligibility criteria|0|||
129103333|NCT05052697|464673256|FG009|Substudy A|No longer met eligibility criteria|0|||
129103334|NCT05052697|464673257|FG010|Substudy A|No longer met eligibility criteria|0|||
129103335|NCT05052697|464673258|FG011|Substudy A|No longer met eligibility criteria|0|||
129103336|NCT05052697|464673259|FG012|Substudy A|No longer met eligibility criteria|0|||
129103337|NCT05052697|464673260|FG013|Substudy A|No longer met eligibility criteria|1|||
129103338|NCT05052697|464673261|FG014|Substudy A|No longer met eligibility criteria|0|||
129103339|NCT05052697|464673262|FG015|Substudy A|No longer met eligibility criteria|0|||
129103340|NCT05052697|464673263|FG016|Substudy A|No longer met eligibility criteria|0|||
129103341|NCT05052697|464673264|FG017|Substudy A|No longer met eligibility criteria|0|||
129103342|NCT05052697|464673265|FG018|Substudy A|No longer met eligibility criteria|0|||
129103343|NCT05052697|464673266|FG019|Substudy A|No longer met eligibility criteria|0|||
129103344|NCT05052697|464673267|FG020|Substudy A|No longer met eligibility criteria|0|||
129103345|NCT05052697|464673268|FG021|Substudy A|No longer met eligibility criteria|0|||
129103346|NCT05052697|464673269|FG022|Substudy A|No longer met eligibility criteria|0|||
129103347|NCT05052697|464673270|FG023|Substudy A|No longer met eligibility criteria|0|||
129103348|NCT05052697|464673271|FG024|Substudy A|No longer met eligibility criteria|0|||
129103349|NCT05052697|464673272|FG025|Substudy A|No longer met eligibility criteria|0|||
129103350|NCT05052697|464673273|FG026|Substudy A|No longer met eligibility criteria|0|||
129103351|NCT05052697|464673274|FG027|Substudy A|No longer met eligibility criteria|0|||
129103352|NCT05052697|464673275|FG028|Substudy A|No longer met eligibility criteria|0|||
129103353|NCT05052697|464673276|FG029|Substudy A|No longer met eligibility criteria|0|||
129103354|NCT05052697|464673277|FG030|Substudy A|No longer met eligibility criteria|0|||
129103355|NCT05052697|464673278|FG031|Substudy A|No longer met eligibility criteria|0|||
129103356|NCT05052697|464673279|FG032|Substudy A|No longer met eligibility criteria|0|||
129103357|NCT05052697|464673280|FG033|Substudy A|No longer met eligibility criteria|0|||
129103358|NCT05052697|464673247|FG000|Substudy A|Not vaccinated|0|||
129103359|NCT05052697|464673248|FG001|Substudy A|Not vaccinated|0|||
129103360|NCT05052697|464673249|FG002|Substudy A|Not vaccinated|0|||
128681016|NCT02522871|463131919|FG000|Overall Study|Protocol Violation|1|||
128681017|NCT02522871|463131920|FG001|Overall Study|Protocol Violation|4|||
128681018|NCT02522871|463131919|FG000|Overall Study|Treated without randomization|1|||
128681019|NCT02522871|463131920|FG001|Overall Study|Treated without randomization|0|||
128681020|NCT02522871|463131919|FG000|Overall Study|Death|9|||
128681021|NCT02522871|463131920|FG001|Overall Study|Death|9|||
128681022|NCT02522871|463131919|FG000|Overall Study|Died in operating room prior to transplant|0|||
128681023|NCT02522871|463131920|FG001|Overall Study|Died in operating room prior to transplant|1|||
128681024|NCT00725842|463131921|FG000|Overall Study|Lost to Follow-up|19|||
128681025|NCT00725842|463131921|FG000|Overall Study|Death|1|||
128681026|NCT00725842|463131921|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
128681027|NCT00725842|463131921|FG000|Overall Study|Consent date prior to study start date|5|||
128681028|NCT00725842|463131921|FG000|Overall Study|Inclusion criterion not met|1|||
128681029|NCT00725842|463131921|FG000|Overall Study|No Visit 1 data|1|||
128681030|NCT01853618|463131922|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
128681031|NCT01853618|463131923|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
128681032|NCT01853618|463131924|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
128681033|NCT01853618|463131925|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
128681034|NCT01853618|463131926|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
128681035|NCT01853618|463131922|FG000|Overall Study|Progressive disease|1|||
128681036|NCT01853618|463131923|FG001|Overall Study|Progressive disease|1|||
128681037|NCT01853618|463131924|FG002|Overall Study|Progressive disease|1|||
128681038|NCT01853618|463131925|FG003|Overall Study|Progressive disease|1|||
128681039|NCT01853618|463131926|FG004|Overall Study|Progressive disease|2|||
128681040|NCT01853618|463131922|FG000|Overall Study|Physician Decision|0|||
128681041|NCT01853618|463131923|FG001|Overall Study|Physician Decision|1|||
128681042|NCT01853618|463131924|FG002|Overall Study|Physician Decision|1|||
128681043|NCT01853618|463131925|FG003|Overall Study|Physician Decision|0|||
128681044|NCT01853618|463131926|FG004|Overall Study|Physician Decision|0|||
128681045|NCT01853618|463131922|FG000|Overall Study|Refused further treatment|0|||
128681046|NCT01853618|463131923|FG001|Overall Study|Refused further treatment|0|||
128681047|NCT01853618|463131924|FG002|Overall Study|Refused further treatment|0|||
128681048|NCT01853618|463131925|FG003|Overall Study|Refused further treatment|0|||
128681049|NCT01853618|463131926|FG004|Overall Study|Refused further treatment|1|||
128681050|NCT01715129|463131929|FG000|Overall Study|Adverse Event, fatal|1|||
128681051|NCT01715129|463131929|FG000|Overall Study|Lack of Efficacy|3|||
128681052|NCT01715129|463131929|FG000|Overall Study|Protocol Violation|1|||
128681053|NCT01715129|463131929|FG000|Overall Study|Consent Withdrawn|2|||
128681054|NCT01715129|463131929|FG000|Overall Study|Lost to Follow-up|1|||
128681055|NCT01715129|463131929|FG000|Overall Study|Other|1|||
128681056|NCT02793622|463131930|FG000|Overall Study|Lost to Follow-up|31|||
128681057|NCT02793622|463131931|FG001|Overall Study|Lost to Follow-up|19|||
128681058|NCT02793622|463131930|FG000|Overall Study|Withdrawal by Subject|21|||
128681059|NCT02793622|463131931|FG001|Overall Study|Withdrawal by Subject|17|||
128681060|NCT02793622|463131930|FG000|Overall Study|Adverse Event|0|||
128681061|NCT02793622|463131931|FG001|Overall Study|Adverse Event|1|||
128681062|NCT02793622|463131930|FG000|Overall Study|Protocol Violation|1|||
128681063|NCT02793622|463131931|FG001|Overall Study|Protocol Violation|5|||
128681064|NCT01146860|463131932|FG000|Overall Study|Withdrawal by Subject|0|||
128681065|NCT01146860|463131933|FG001|Overall Study|Withdrawal by Subject|1|||
129014448|NCT00154102|464345921|FG001|Overall Study|investigational study phase ongoing|2|||
129014449|NCT00463606|464345922|FG000|Overall Study|Adverse Event|21|||
129014450|NCT00463606|464345923|FG001|Overall Study|Adverse Event|18|||
129014451|NCT00463606|464345924|FG002|Overall Study|Adverse Event|11|||
129014452|NCT00463606|464345922|FG000|Overall Study|Withdrawal by Subject|11|||
129014453|NCT00463606|464345923|FG001|Overall Study|Withdrawal by Subject|11|||
129014454|NCT00463606|464345924|FG002|Overall Study|Withdrawal by Subject|5|||
129014455|NCT00463606|464345922|FG000|Overall Study|Lost to Follow-up|2|||
129014456|NCT00463606|464345923|FG001|Overall Study|Lost to Follow-up|2|||
129014457|NCT00463606|464345924|FG002|Overall Study|Lost to Follow-up|3|||
129014458|NCT00463606|464345922|FG000|Overall Study|Subject noncompliance|1|||
129014459|NCT00463606|464345923|FG001|Overall Study|Subject noncompliance|1|||
129014460|NCT00463606|464345924|FG002|Overall Study|Subject noncompliance|0|||
129014461|NCT00463606|464345922|FG000|Overall Study|Subject moved out of town|1|||
129014462|NCT00463606|464345923|FG001|Overall Study|Subject moved out of town|0|||
129014463|NCT00463606|464345924|FG002|Overall Study|Subject moved out of town|0|||
129014464|NCT00463606|464345922|FG000|Overall Study|Physician Decision|0|||
128681066|NCT00722371|463131934|FG000|Overall Study|Adverse Event|6|||
128681067|NCT00722371|463131935|FG001|Overall Study|Adverse Event|13|||
128681068|NCT00722371|463131936|FG002|Overall Study|Adverse Event|9|||
128681069|NCT00722371|463131937|FG003|Overall Study|Adverse Event|10|||
128681070|NCT00722371|463131938|FG004|Overall Study|Adverse Event|6|||
128681071|NCT00722371|463131939|FG005|Overall Study|Adverse Event|8|||
129014465|NCT00463606|464345923|FG001|Overall Study|Physician Decision|1|||
129014466|NCT00463606|464345924|FG002|Overall Study|Physician Decision|0|||
128681072|NCT00722371|463131940|FG006|Overall Study|Adverse Event|4|||
128681073|NCT00722371|463131934|FG000|Overall Study|Contraindication|0|||
128681074|NCT00722371|463131935|FG001|Overall Study|Contraindication|0|||
128681075|NCT00722371|463131936|FG002|Overall Study|Contraindication|1|||
128681076|NCT00722371|463131937|FG003|Overall Study|Contraindication|0|||
128681077|NCT00722371|463131938|FG004|Overall Study|Contraindication|0|||
128681078|NCT00722371|463131939|FG005|Overall Study|Contraindication|0|||
128681079|NCT00722371|463131940|FG006|Overall Study|Contraindication|0|||
129014467|NCT00463606|464345922|FG000|Overall Study|Sponsor request|0|||
129103361|NCT05052697|464673250|FG003|Substudy A|Not vaccinated|1|||
129103362|NCT05052697|464673251|FG004|Substudy A|Not vaccinated|0|||
129014468|NCT00463606|464345923|FG001|Overall Study|Sponsor request|1|||
129014469|NCT00463606|464345924|FG002|Overall Study|Sponsor request|0|||
129014470|NCT00463606|464345922|FG000|Overall Study|Exclusion criteria violation|2|||
129014471|NCT00463606|464345923|FG001|Overall Study|Exclusion criteria violation|0|||
129014472|NCT00463606|464345924|FG002|Overall Study|Exclusion criteria violation|0|||
129014473|NCT00463606|464345922|FG000|Overall Study|Coordinator error|1|||
129014474|NCT00463606|464345923|FG001|Overall Study|Coordinator error|0|||
129014475|NCT00463606|464345924|FG002|Overall Study|Coordinator error|0|||
129014476|NCT00463606|464345922|FG000|Overall Study|Patient randomized in error|1|||
129014477|NCT00463606|464345923|FG001|Overall Study|Patient randomized in error|0|||
129014478|NCT00463606|464345924|FG002|Overall Study|Patient randomized in error|0|||
129014479|NCT00463606|464345922|FG000|Overall Study|Participation in another ABT-335 trial|1|||
129014480|NCT00463606|464345923|FG001|Overall Study|Participation in another ABT-335 trial|0|||
129014481|NCT00463606|464345924|FG002|Overall Study|Participation in another ABT-335 trial|0|||
129014482|NCT00463606|464345922|FG000|Overall Study|Protocol Violation|0|||
129014483|NCT00463606|464345923|FG001|Overall Study|Protocol Violation|0|||
129014484|NCT00463606|464345924|FG002|Overall Study|Protocol Violation|1|||
129014485|NCT02682602|464345926|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
129014486|NCT02682602|464345927|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
129014487|NCT02682602|464345926|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
129014488|NCT02682602|464345927|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
129014489|NCT04349917|464347573|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
129014490|NCT04349917|464347574|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
129014491|NCT04349917|464347573|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
129014492|NCT04349917|464347574|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
129014493|NCT00441467|464347575|FG000|Overall Study|Adverse Event|6|||
129014494|NCT00441467|464347575|FG000|Overall Study|Withdrawal by Subject|3|||
129014495|NCT00441467|464347575|FG000|Overall Study|Progressive disease|9|||
129014496|NCT01507051|464347577|FG000|Overall Study|Withdrawal by Subject|1|||
129014497|NCT01507051|464347578|FG001|Overall Study|Withdrawal by Subject|3|||
129014498|NCT01507051|464347579|FG002|Overall Study|Withdrawal by Subject|1|||
129014499|NCT01507051|464347580|FG003|Overall Study|Withdrawal by Subject|6|||
129014500|NCT01507051|464347577|FG000|Overall Study|Physician Decision|0|||
129014501|NCT01507051|464347578|FG001|Overall Study|Physician Decision|0|||
129014502|NCT01507051|464347579|FG002|Overall Study|Physician Decision|0|||
129014503|NCT01507051|464347580|FG003|Overall Study|Physician Decision|1|||
129014504|NCT01507051|464347577|FG000|Overall Study|Adverse Event|1|||
129014505|NCT01507051|464347578|FG001|Overall Study|Adverse Event|0|||
129014506|NCT01507051|464347579|FG002|Overall Study|Adverse Event|0|||
129014507|NCT01507051|464347580|FG003|Overall Study|Adverse Event|0|||
129014508|NCT00745420|464347582|FG000|Overall Study|Ineligible|1|||
129014509|NCT00485472|464347583|FG000|Overall Study|Adverse Event|8|||
129014510|NCT00485472|464347584|FG001|Overall Study|Adverse Event|5|||
129014511|NCT00485472|464347583|FG000|Overall Study|Lack of Efficacy|5|||
129014512|NCT00485472|464347584|FG001|Overall Study|Lack of Efficacy|4|||
129014513|NCT00485472|464347583|FG000|Overall Study|Withdrawal by Subject|1|||
129014514|NCT00485472|464347584|FG001|Overall Study|Withdrawal by Subject|0|||
129014515|NCT00485472|464347583|FG000|Overall Study|Protocol Violation|0|||
129014516|NCT00485472|464347584|FG001|Overall Study|Protocol Violation|1|||
129014517|NCT00485472|464347583|FG000|Overall Study|Other|2|||
129014518|NCT00485472|464347584|FG001|Overall Study|Other|1|||
129103363|NCT05052697|464673252|FG005|Substudy A|Not vaccinated|0|||
128681080|NCT00722371|463131934|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
128681081|NCT00722371|463131935|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
129014519|NCT00485472|464347583|FG000|Overall Study|Lost to Follow-up|0|||
129014520|NCT00485472|464347584|FG001|Overall Study|Lost to Follow-up|1|||
129103364|NCT05052697|464673253|FG006|Substudy A|Not vaccinated|0|||
129014521|NCT00088829|464347586|FG000|Overall Study|PI left institution and study was close|22|||
129014522|NCT01287013|464347589|FG000|Overall Study|Non-evaluable|3|||
129014523|NCT01287013|464347590|FG001|Overall Study|Non-evaluable|5|||
129014524|NCT01287013|464347591|FG002|Overall Study|Non-evaluable|21|||
129014525|NCT02109042|464347592|FG000|Overall Study|Sponsor Decision|15|||
129014526|NCT03203447|464347593|FG000|Overall Study|Withdrawal by Subject|2|||
129014527|NCT03203447|464347594|FG001|Overall Study|Withdrawal by Subject|1|||
129014528|NCT03203447|464347593|FG000|Overall Study|Lost to Follow-up|1|||
129103365|NCT05052697|464673254|FG007|Substudy A|Not vaccinated|0|||
128681082|NCT00722371|463131936|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
128681083|NCT00722371|463131937|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
129103366|NCT05052697|464673255|FG008|Substudy A|Not vaccinated|1|||
129103367|NCT05052697|464673256|FG009|Substudy A|Not vaccinated|0|||
129103368|NCT05052697|464673257|FG010|Substudy A|Not vaccinated|0|||
129103369|NCT05052697|464673258|FG011|Substudy A|Not vaccinated|0|||
129103370|NCT05052697|464673259|FG012|Substudy A|Not vaccinated|0|||
129103371|NCT05052697|464673260|FG013|Substudy A|Not vaccinated|0|||
129103372|NCT05052697|464673261|FG014|Substudy A|Not vaccinated|0|||
129103373|NCT05052697|464673262|FG015|Substudy A|Not vaccinated|0|||
129103374|NCT05052697|464673263|FG016|Substudy A|Not vaccinated|0|||
129103375|NCT05052697|464673264|FG017|Substudy A|Not vaccinated|0|||
129103376|NCT05052697|464673265|FG018|Substudy A|Not vaccinated|0|||
129103377|NCT05052697|464673266|FG019|Substudy A|Not vaccinated|0|||
129103378|NCT05052697|464673267|FG020|Substudy A|Not vaccinated|0|||
129103379|NCT05052697|464673268|FG021|Substudy A|Not vaccinated|0|||
129103380|NCT05052697|464673269|FG022|Substudy A|Not vaccinated|0|||
129103381|NCT05052697|464673270|FG023|Substudy A|Not vaccinated|0|||
129103382|NCT05052697|464673271|FG024|Substudy A|Not vaccinated|0|||
128681084|NCT00722371|463131938|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
128681085|NCT00722371|463131939|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
128681086|NCT00722371|463131940|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
128681087|NCT00722371|463131934|FG000|Overall Study|Excluded medication|0|||
128681088|NCT00722371|463131935|FG001|Overall Study|Excluded medication|1|||
128681089|NCT00722371|463131936|FG002|Overall Study|Excluded medication|1|||
128681090|NCT00722371|463131937|FG003|Overall Study|Excluded medication|0|||
128681091|NCT00722371|463131938|FG004|Overall Study|Excluded medication|0|||
128681092|NCT00722371|463131939|FG005|Overall Study|Excluded medication|0|||
128681093|NCT00722371|463131940|FG006|Overall Study|Excluded medication|1|||
128681094|NCT00722371|463131934|FG000|Overall Study|Hyperglycemia|2|||
128681095|NCT00722371|463131935|FG001|Overall Study|Hyperglycemia|6|||
128681096|NCT00722371|463131936|FG002|Overall Study|Hyperglycemia|4|||
128681097|NCT00722371|463131937|FG003|Overall Study|Hyperglycemia|2|||
128681098|NCT00722371|463131938|FG004|Overall Study|Hyperglycemia|5|||
128681099|NCT00722371|463131939|FG005|Overall Study|Hyperglycemia|1|||
128681100|NCT00722371|463131940|FG006|Overall Study|Hyperglycemia|1|||
128681101|NCT00722371|463131934|FG000|Overall Study|Hypoglycemia|1|||
128681102|NCT00722371|463131935|FG001|Overall Study|Hypoglycemia|0|||
128681103|NCT00722371|463131936|FG002|Overall Study|Hypoglycemia|0|||
128681104|NCT00722371|463131937|FG003|Overall Study|Hypoglycemia|0|||
128681105|NCT00722371|463131938|FG004|Overall Study|Hypoglycemia|0|||
128681106|NCT00722371|463131939|FG005|Overall Study|Hypoglycemia|0|||
128681107|NCT00722371|463131940|FG006|Overall Study|Hypoglycemia|0|||
128681108|NCT00722371|463131934|FG000|Overall Study|Lack of Efficacy|4|||
128681109|NCT00722371|463131935|FG001|Overall Study|Lack of Efficacy|6|||
128681110|NCT00722371|463131936|FG002|Overall Study|Lack of Efficacy|6|||
128681111|NCT00722371|463131937|FG003|Overall Study|Lack of Efficacy|6|||
128681112|NCT00722371|463131938|FG004|Overall Study|Lack of Efficacy|2|||
128681113|NCT00722371|463131939|FG005|Overall Study|Lack of Efficacy|3|||
129014529|NCT03203447|464347594|FG001|Overall Study|Lost to Follow-up|10|||
129014530|NCT03203447|464347593|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
129014531|NCT03203447|464347594|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
129014532|NCT00528606|464347595|FG000|Overall Study|Withdrew consent|4|||
129014533|NCT00528606|464347596|FG001|Overall Study|Withdrew consent|3|||
129014534|NCT00528606|464347595|FG000|Overall Study|Lost to Follow-up|4|||
129014535|NCT00528606|464347596|FG001|Overall Study|Lost to Follow-up|1|||
129014536|NCT00528606|464347595|FG000|Overall Study|Adverse Event|3|||
129014537|NCT00528606|464347596|FG001|Overall Study|Adverse Event|0|||
129014538|NCT00528606|464347595|FG000|Overall Study|Other|2|||
129014539|NCT00528606|464347596|FG001|Overall Study|Other|0|||
129014540|NCT03478397|464347601|FG000|Overall Study|Refused to participate|31|||
129014541|NCT03478397|464347602|FG001|Overall Study|Refused to participate|7|||
129014542|NCT02188303|464347603|FG000|Overall Study|Adverse Event|0|||
129014543|NCT02188303|464347604|FG001|Overall Study|Adverse Event|0|||
129014544|NCT02188303|464347605|FG002|Overall Study|Adverse Event|0|||
129014545|NCT02188303|464347606|FG003|Overall Study|Adverse Event|0|||
129014546|NCT02188303|464347607|FG004|Overall Study|Adverse Event|0|||
129014547|NCT02188303|464347608|FG005|Overall Study|Adverse Event|2|||
129014548|NCT02188303|464347609|FG006|Overall Study|Adverse Event|0|||
129014549|NCT02188303|464347610|FG007|Overall Study|Adverse Event|2|||
129014550|NCT02188303|464347603|FG000|Overall Study|Dose Termination Criteria Met|0|||
129103383|NCT05052697|464673272|FG025|Substudy A|Not vaccinated|0|||
129103384|NCT05052697|464673273|FG026|Substudy A|Not vaccinated|0|||
129103385|NCT05052697|464673274|FG027|Substudy A|Not vaccinated|0|||
129103386|NCT05052697|464673275|FG028|Substudy A|Not vaccinated|0|||
128681114|NCT00722371|463131940|FG006|Overall Study|Lack of Efficacy|0|||
128681115|NCT00722371|463131934|FG000|Overall Study|Lost to Follow-up|11|||
128681116|NCT00722371|463131935|FG001|Overall Study|Lost to Follow-up|14|||
128681117|NCT00722371|463131936|FG002|Overall Study|Lost to Follow-up|21|||
129014551|NCT02188303|464347604|FG001|Overall Study|Dose Termination Criteria Met|0|||
129014552|NCT02188303|464347605|FG002|Overall Study|Dose Termination Criteria Met|0|||
129103387|NCT05052697|464673276|FG029|Substudy A|Not vaccinated|0|||
129103388|NCT05052697|464673277|FG030|Substudy A|Not vaccinated|0|||
128681118|NCT00722371|463131937|FG003|Overall Study|Lost to Follow-up|13|||
129103389|NCT05052697|464673278|FG031|Substudy A|Not vaccinated|0|||
129103390|NCT05052697|464673279|FG032|Substudy A|Not vaccinated|0|||
129103391|NCT05052697|464673280|FG033|Substudy A|Not vaccinated|0|||
129103392|NCT05052697|464673247|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103393|NCT05052697|464673248|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103394|NCT05052697|464673249|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103395|NCT05052697|464673250|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103396|NCT05052697|464673251|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103397|NCT05052697|464673252|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103398|NCT05052697|464673253|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103399|NCT05052697|464673254|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103400|NCT05052697|464673255|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103401|NCT05052697|464673256|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103402|NCT05052697|464673257|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103403|NCT05052697|464673258|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103404|NCT05052697|464673259|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103405|NCT05052697|464673260|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103406|NCT05052697|464673261|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
128681119|NCT00722371|463131938|FG004|Overall Study|Lost to Follow-up|8|||
128681120|NCT00722371|463131939|FG005|Overall Study|Lost to Follow-up|16|||
129103407|NCT05052697|464673262|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103408|NCT05052697|464673263|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103409|NCT05052697|464673264|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103410|NCT05052697|464673265|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
129103411|NCT05052697|464673266|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
129103412|NCT05052697|464673267|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103413|NCT05052697|464673268|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
129103414|NCT05052697|464673269|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
129103415|NCT05052697|464673270|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103416|NCT05052697|464673271|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103417|NCT05052697|464673272|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
128681121|NCT00722371|463131940|FG006|Overall Study|Lost to Follow-up|13|||
128681122|NCT00722371|463131934|FG000|Overall Study|Physician Decision|5|||
128681123|NCT00722371|463131935|FG001|Overall Study|Physician Decision|2|||
128681124|NCT00722371|463131936|FG002|Overall Study|Physician Decision|2|||
128681125|NCT00722371|463131937|FG003|Overall Study|Physician Decision|5|||
128681126|NCT00722371|463131938|FG004|Overall Study|Physician Decision|2|||
128681127|NCT00722371|463131939|FG005|Overall Study|Physician Decision|3|||
128681128|NCT00722371|463131940|FG006|Overall Study|Physician Decision|4|||
128681129|NCT00722371|463131934|FG000|Overall Study|Pregnancy|1|||
128681130|NCT00722371|463131935|FG001|Overall Study|Pregnancy|1|||
128681131|NCT00722371|463131936|FG002|Overall Study|Pregnancy|0|||
128681132|NCT00722371|463131937|FG003|Overall Study|Pregnancy|0|||
128681133|NCT00722371|463131938|FG004|Overall Study|Pregnancy|0|||
128681134|NCT00722371|463131939|FG005|Overall Study|Pregnancy|1|||
128681135|NCT00722371|463131940|FG006|Overall Study|Pregnancy|0|||
128681136|NCT00722371|463131934|FG000|Overall Study|Protocol Violation|6|||
128681137|NCT00722371|463131935|FG001|Overall Study|Protocol Violation|1|||
128681138|NCT00722371|463131936|FG002|Overall Study|Protocol Violation|0|||
128681139|NCT00722371|463131937|FG003|Overall Study|Protocol Violation|1|||
128681140|NCT00722371|463131938|FG004|Overall Study|Protocol Violation|4|||
128681141|NCT00722371|463131939|FG005|Overall Study|Protocol Violation|2|||
128681142|NCT00722371|463131940|FG006|Overall Study|Protocol Violation|1|||
128681143|NCT00722371|463131934|FG000|Overall Study|Withdrawal by Subject|18|||
128681144|NCT00722371|463131935|FG001|Overall Study|Withdrawal by Subject|27|||
128681145|NCT00722371|463131936|FG002|Overall Study|Withdrawal by Subject|19|||
128681146|NCT00722371|463131937|FG003|Overall Study|Withdrawal by Subject|23|||
128681147|NCT00722371|463131938|FG004|Overall Study|Withdrawal by Subject|19|||
128681148|NCT00722371|463131939|FG005|Overall Study|Withdrawal by Subject|18|||
128681149|NCT00722371|463131940|FG006|Overall Study|Withdrawal by Subject|26|||
128681150|NCT01092832|463131941|FG000|Overall Study|Other|1|||
128681151|NCT01092832|463131942|FG001|Overall Study|Other|0|||
128681152|NCT01075191|463131943|FG000|Overall Study|Death|1|||
128681153|NCT01075191|463131943|FG000|Overall Study|Intensification|3|||
128681154|NCT01075191|463131943|FG000|Overall Study|Co-morbidities|1|||
129103418|NCT05052697|464673273|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103419|NCT05052697|464673274|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
128681155|NCT01075191|463131943|FG000|Overall Study|Adverse Event|4|||
128681156|NCT01075191|463131943|FG000|Overall Study|Noncompliance|3|||
128681157|NCT01075191|463131943|FG000|Overall Study|Therapy Break|3|||
128681158|NCT01075191|463131943|FG000|Overall Study|Patient's Wish|2|||
128681159|NCT01075191|463131943|FG000|Overall Study|Unknown Reasons|1|||
128681160|NCT02068768|463131948|FG000|Overall Study|Lost to Follow-up|5|||
128681161|NCT02068768|463131948|FG000|Overall Study|Early Termination by Sponsor|2|||
129103420|NCT05052697|464673275|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103421|NCT05052697|464673276|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103422|NCT05052697|464673277|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103423|NCT05052697|464673278|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103424|NCT05052697|464673279|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129103425|NCT05052697|464673280|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
128681162|NCT00555425|463131949|FG000|Overall Study|Missed Medication > 1 wk|34|||
128681163|NCT00555425|463131950|FG001|Overall Study|Missed Medication > 1 wk|15|||
128681164|NCT00555425|463131949|FG000|Overall Study|Missed 3 physician management visits|1|||
128681165|NCT00555425|463131950|FG001|Overall Study|Missed 3 physician management visits|0|||
128681166|NCT00555425|463131949|FG000|Overall Study|Met criteria for protective transfer|16|||
128681167|NCT00555425|463131950|FG001|Overall Study|Met criteria for protective transfer|3|||
129014553|NCT02188303|464347606|FG003|Overall Study|Dose Termination Criteria Met|0|||
129103426|NCT05052697|464673247|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103427|NCT05052697|464673248|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103428|NCT05052697|464673249|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103429|NCT05052697|464673250|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103430|NCT05052697|464673251|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103431|NCT05052697|464673252|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103432|NCT05052697|464673253|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103433|NCT05052697|464673254|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
129014554|NCT02188303|464347607|FG004|Overall Study|Dose Termination Criteria Met|0|||
129014555|NCT02188303|464347608|FG005|Overall Study|Dose Termination Criteria Met|0|||
129014556|NCT02188303|464347609|FG006|Overall Study|Dose Termination Criteria Met|2|||
129014557|NCT02188303|464347610|FG007|Overall Study|Dose Termination Criteria Met|4|||
129014558|NCT04206332|464347611|FG000|Part A|Lost to Follow-up|0|||
129014559|NCT04206332|464347612|FG001|Part A|Lost to Follow-up|1|||
129014560|NCT04206332|464347613|FG002|Part A|Lost to Follow-up|0|||
129014561|NCT04206332|464347614|FG003|Part A|Lost to Follow-up|0|||
129014562|NCT04206332|464347615|FG004|Part A|Lost to Follow-up|0|||
129014563|NCT04206332|464347616|FG005|Part A|Lost to Follow-up|0|||
129014564|NCT04206332|464347617|FG006|Part A|Lost to Follow-up|0|||
129014565|NCT04206332|464347618|FG007|Part A|Lost to Follow-up|0|||
129014566|NCT04206332|464347619|FG008|Part A|Lost to Follow-up|0|||
129014567|NCT04206332|464347620|FG009|Part A|Lost to Follow-up|0|||
129014568|NCT04206332|464347621|FG010|Part A|Lost to Follow-up|0|||
129014569|NCT04206332|464347622|FG011|Part A|Lost to Follow-up|0|||
129014570|NCT04206332|464347623|FG012|Part A|Lost to Follow-up|0|||
129014571|NCT04206332|464347624|FG013|Part A|Lost to Follow-up|0|||
129014572|NCT04206332|464347625|FG014|Part A|Lost to Follow-up|0|||
129014573|NCT04206332|464347626|FG015|Part A|Lost to Follow-up|0|||
129014574|NCT04206332|464347627|FG016|Part A|Lost to Follow-up|0|||
129014575|NCT04206332|464347611|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014576|NCT04206332|464347612|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014577|NCT04206332|464347613|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014578|NCT04206332|464347614|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014579|NCT04206332|464347615|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014580|NCT04206332|464347616|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
129014581|NCT04206332|464347617|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014582|NCT04206332|464347618|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014583|NCT04206332|464347619|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014584|NCT04206332|464347620|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014585|NCT04206332|464347621|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014586|NCT04206332|464347622|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014587|NCT04206332|464347623|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014588|NCT04206332|464347624|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014589|NCT04206332|464347625|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014590|NCT04206332|464347626|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014591|NCT04206332|464347627|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129014592|NCT04206332|464347611|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014593|NCT04206332|464347612|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014594|NCT04206332|464347613|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
128681168|NCT00555425|463131949|FG000|Overall Study|Became pregnant and transferred care|0|||
128681169|NCT00555425|463131950|FG001|Overall Study|Became pregnant and transferred care|1|||
128681170|NCT02635646|463131952|FG000|Overall Study|Lost to Follow-up|24|||
129014595|NCT04206332|464347614|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014596|NCT04206332|464347615|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014597|NCT04206332|464347616|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014598|NCT04206332|464347617|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014599|NCT04206332|464347618|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
129014600|NCT04206332|464347619|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014601|NCT04206332|464347620|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014602|NCT04206332|464347621|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
129014603|NCT04206332|464347622|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014604|NCT04206332|464347623|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014605|NCT04206332|464347624|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014606|NCT04206332|464347625|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014607|NCT04206332|464347626|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014608|NCT04206332|464347627|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014609|NCT04206332|464347611|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014610|NCT04206332|464347612|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014611|NCT04206332|464347613|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014612|NCT04206332|464347614|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014613|NCT04206332|464347615|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014614|NCT04206332|464347616|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014615|NCT04206332|464347617|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014616|NCT04206332|464347618|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014617|NCT04206332|464347619|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014618|NCT04206332|464347620|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014619|NCT04206332|464347621|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014620|NCT04206332|464347622|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014621|NCT04206332|464347623|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014622|NCT04206332|464347624|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014623|NCT04206332|464347625|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014624|NCT04206332|464347626|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129014625|NCT04206332|464347627|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
129014626|NCT04206332|464347611|FG000|Part C|Withdrawal by Subject|0|||
129014627|NCT04206332|464347612|FG001|Part C|Withdrawal by Subject|0|||
129014628|NCT04206332|464347613|FG002|Part C|Withdrawal by Subject|0|||
129014629|NCT04206332|464347614|FG003|Part C|Withdrawal by Subject|0|||
129014630|NCT04206332|464347615|FG004|Part C|Withdrawal by Subject|0|||
129014631|NCT04206332|464347616|FG005|Part C|Withdrawal by Subject|0|||
129014632|NCT04206332|464347617|FG006|Part C|Withdrawal by Subject|0|||
129014633|NCT04206332|464347618|FG007|Part C|Withdrawal by Subject|0|||
129014634|NCT04206332|464347619|FG008|Part C|Withdrawal by Subject|0|||
129014635|NCT04206332|464347620|FG009|Part C|Withdrawal by Subject|0|||
129014636|NCT04206332|464347621|FG010|Part C|Withdrawal by Subject|0|||
129014637|NCT04206332|464347622|FG011|Part C|Withdrawal by Subject|0|||
129014638|NCT04206332|464347623|FG012|Part C|Withdrawal by Subject|0|||
129014639|NCT04206332|464347624|FG013|Part C|Withdrawal by Subject|0|||
129014640|NCT04206332|464347625|FG014|Part C|Withdrawal by Subject|2|||
129014641|NCT04206332|464347626|FG015|Part C|Withdrawal by Subject|0|||
129014642|NCT04206332|464347627|FG016|Part C|Withdrawal by Subject|0|||
129014643|NCT00569374|464347630|FG000|Overall Study|Withdrawal by Subject|4|||
129014644|NCT00912288|464347631|FG000|Overall Study|Death|0|||
129014645|NCT00912288|464347632|FG001|Overall Study|Death|1|||
129014646|NCT00912288|464347631|FG000|Overall Study|Adverse Event|1|||
129014647|NCT00912288|464347632|FG001|Overall Study|Adverse Event|1|||
129014648|NCT00912288|464347631|FG000|Overall Study|Lost to Follow-up|1|||
129014649|NCT00912288|464347632|FG001|Overall Study|Lost to Follow-up|0|||
129014650|NCT00912288|464347631|FG000|Overall Study|Protocol Violation|1|||
129014651|NCT00912288|464347632|FG001|Overall Study|Protocol Violation|0|||
129103434|NCT05052697|464673255|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
128681171|NCT02635646|463131953|FG001|Overall Study|Lost to Follow-up|25|||
128681172|NCT02635646|463131952|FG000|Overall Study|Pregnancy|1|||
129014652|NCT00912288|464347631|FG000|Overall Study|Withdrawal by Subject|3|||
129014653|NCT00912288|464347632|FG001|Overall Study|Withdrawal by Subject|3|||
129014654|NCT00912288|464347631|FG000|Overall Study|Study terminated by sponsor|34|||
129014655|NCT00912288|464347632|FG001|Overall Study|Study terminated by sponsor|35|||
129014656|NCT00912288|464347631|FG000|Overall Study|Other|1|||
129014657|NCT00912288|464347632|FG001|Overall Study|Other|0|||
129014658|NCT00050778|464347635|FG000|Overall Study|Adverse Event|13|||
129014659|NCT00050778|464347636|FG001|Overall Study|Adverse Event|3|||
129014660|NCT00050778|464347637|FG002|Overall Study|Adverse Event|2|||
129014661|NCT00050778|464347635|FG000|Overall Study|Death|0|||
129014662|NCT00050778|464347636|FG001|Overall Study|Death|1|||
129014663|NCT00050778|464347637|FG002|Overall Study|Death|1|||
129014664|NCT00050778|464347635|FG000|Overall Study|Lack of Efficacy|16|||
129014665|NCT00050778|464347636|FG001|Overall Study|Lack of Efficacy|2|||
129014666|NCT00050778|464347637|FG002|Overall Study|Lack of Efficacy|2|||
129014667|NCT00050778|464347635|FG000|Overall Study|Lost to Follow-up|0|||
129014668|NCT00050778|464347636|FG001|Overall Study|Lost to Follow-up|2|||
129014669|NCT00050778|464347637|FG002|Overall Study|Lost to Follow-up|4|||
129014670|NCT00050778|464347635|FG000|Overall Study|Physician Decision|3|||
129014671|NCT00050778|464347636|FG001|Overall Study|Physician Decision|0|||
129014672|NCT00050778|464347637|FG002|Overall Study|Physician Decision|2|||
129014673|NCT00050778|464347635|FG000|Overall Study|Protocol Violation|2|||
129014674|NCT00050778|464347636|FG001|Overall Study|Protocol Violation|0|||
129014675|NCT00050778|464347637|FG002|Overall Study|Protocol Violation|1|||
129014676|NCT00050778|464347635|FG000|Overall Study|Withdrawal by Subject|6|||
129014677|NCT00050778|464347636|FG001|Overall Study|Withdrawal by Subject|8|||
129014678|NCT00050778|464347637|FG002|Overall Study|Withdrawal by Subject|4|||
129014679|NCT00050778|464347635|FG000|Overall Study|Randomized but not treated|4|||
129014680|NCT00050778|464347636|FG001|Overall Study|Randomized but not treated|5|||
129014681|NCT00050778|464347637|FG002|Overall Study|Randomized but not treated|2|||
129014682|NCT00050778|464347635|FG000|Overall Study|Familial and personal reasons|1|||
129014683|NCT00050778|464347636|FG001|Overall Study|Familial and personal reasons|0|||
129014684|NCT00050778|464347637|FG002|Overall Study|Familial and personal reasons|0|||
129014685|NCT01126736|464347640|FG000|Overall Study|Death|2|||
129014686|NCT01126736|464347641|FG001|Overall Study|Death|2|||
129014687|NCT01126736|464347642|FG002|Overall Study|Death|1|||
129014688|NCT01126736|464347643|FG003|Overall Study|Death|19|||
129014689|NCT01126736|464347644|FG004|Overall Study|Death|19|||
129014690|NCT01126736|464347640|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
129014691|NCT01126736|464347641|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
129014692|NCT01126736|464347642|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
129014693|NCT01126736|464347643|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
129014694|NCT01126736|464347644|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
129014695|NCT01126736|464347640|FG000|Overall Study|Lost to Follow-up|0|||
129014696|NCT01126736|464347641|FG001|Overall Study|Lost to Follow-up|0|||
129014697|NCT01126736|464347642|FG002|Overall Study|Lost to Follow-up|0|||
129014698|NCT01126736|464347643|FG003|Overall Study|Lost to Follow-up|1|||
129014699|NCT01126736|464347644|FG004|Overall Study|Lost to Follow-up|1|||
129014700|NCT01126736|464347640|FG000|Overall Study|Administrative reasons|0|||
129014701|NCT01126736|464347641|FG001|Overall Study|Administrative reasons|0|||
129014702|NCT01126736|464347642|FG002|Overall Study|Administrative reasons|0|||
129014703|NCT01126736|464347643|FG003|Overall Study|Administrative reasons|0|||
129014704|NCT01126736|464347644|FG004|Overall Study|Administrative reasons|1|||
129014705|NCT01126736|464347640|FG000|Overall Study|Progressive disease|0|||
129014706|NCT01126736|464347641|FG001|Overall Study|Progressive disease|0|||
129014707|NCT01126736|464347642|FG002|Overall Study|Progressive disease|0|||
129014708|NCT01126736|464347643|FG003|Overall Study|Progressive disease|2|||
129014709|NCT01126736|464347644|FG004|Overall Study|Progressive disease|1|||
129014710|NCT01126736|464347640|FG000|Overall Study|Withdrawal by Subject|0|||
129014711|NCT01126736|464347641|FG001|Overall Study|Withdrawal by Subject|0|||
129014712|NCT01126736|464347642|FG002|Overall Study|Withdrawal by Subject|0|||
129014713|NCT01126736|464347643|FG003|Overall Study|Withdrawal by Subject|1|||
129014714|NCT01126736|464347644|FG004|Overall Study|Withdrawal by Subject|1|||
129014715|NCT01126736|464347640|FG000|Overall Study|Other|2|||
129014716|NCT01126736|464347641|FG001|Overall Study|Other|4|||
129014717|NCT01126736|464347642|FG002|Overall Study|Other|4|||
129014718|NCT01126736|464347643|FG003|Overall Study|Other|16|||
129014719|NCT01126736|464347644|FG004|Overall Study|Other|15|||
129014720|NCT00064753|464347645|FG000|Overall Study|Death|251|||
129014721|NCT00064753|464347646|FG001|Overall Study|Death|242|||
129014722|NCT00064753|464347645|FG000|Overall Study|Withdrawal by Subject|198|||
129014723|NCT00064753|464347646|FG001|Overall Study|Withdrawal by Subject|171|||
129014724|NCT00064753|464347645|FG000|Overall Study|Lost to Follow-up|225|||
129014725|NCT00064753|464347646|FG001|Overall Study|Lost to Follow-up|235|||
129014726|NCT04869787|464347653|FG000|Screening|Physician Decision|1|||
129014727|NCT04869787|464347653|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
129014728|NCT00813293|464347655|FG000|Overall Study|Intercurrent illness|1|||
129014729|NCT00813293|464347656|FG001|Overall Study|Intercurrent illness|0|||
129014730|NCT00813293|464347655|FG000|Overall Study|Adverse Event|0|||
128681173|NCT02635646|463131953|FG001|Overall Study|Pregnancy|1|||
128681174|NCT00400153|463131961|FG000|Overall Study|AE due to study disease worsening|14|||
128681175|NCT00400153|463131962|FG001|Overall Study|AE due to study disease worsening|19|||
128681176|NCT00400153|463131963|FG002|Overall Study|AE due to study disease worsening|20|||
128681177|NCT00400153|463131961|FG000|Overall Study|AE due to other disease worsening|2|||
128681178|NCT00400153|463131962|FG001|Overall Study|AE due to other disease worsening|1|||
128681179|NCT00400153|463131963|FG002|Overall Study|AE due to other disease worsening|0|||
129014731|NCT00813293|464347656|FG001|Overall Study|Adverse Event|1|||
129014732|NCT02107092|464347657|FG000|Overall Study|Miscellaneous|3|||
129014733|NCT02107092|464347657|FG000|Overall Study|Subject compliance|3|||
129014734|NCT02107092|464347657|FG000|Overall Study|Hypo-or hyperkalemia|2|||
129014735|NCT02107092|464347657|FG000|Overall Study|Met ECG withdrawal criteria|3|||
129014736|NCT02107092|464347657|FG000|Overall Study|Physician Decision|3|||
129014737|NCT02107092|464347657|FG000|Overall Study|Lost to Follow-up|2|||
129014738|NCT02107092|464347657|FG000|Overall Study|Withdrawal by Subject|9|||
129014739|NCT02107092|464347657|FG000|Overall Study|Adverse Event|7|||
129014740|NCT02107092|464347657|FG000|Overall Study|Expected progression of CKD|12|||
129014741|NCT00707161|464347659|FG000|Overall Study|Physician Decision|6|||
129014742|NCT02661295|464347662|FG000|Overall Study|Death|1|||
129014743|NCT02661295|464347662|FG000|Overall Study|Transferred Out|1|||
129014744|NCT02661295|464347662|FG000|Overall Study|Kidney Transplant|1|||
129014745|NCT02661295|464347662|FG000|Overall Study|Withdrawn due to side effects|8|||
129014746|NCT02661295|464347662|FG000|Overall Study|Withdrawn due to access type|1|||
129014747|NCT02661295|464347662|FG000|Overall Study|Withdrawn due to allergies|1|||
129014748|NCT02661295|464347662|FG000|Overall Study|Withdrawn due to non-compliance|1|||
129014749|NCT02661295|464347662|FG000|Overall Study|Withdrawal by Subject|3|||
129014750|NCT02661295|464347662|FG000|Overall Study|Failed screening|2|||
129014751|NCT03627091|464347663|FG000|Overall Study|Adverse Event|0|||
129014752|NCT03627091|464347664|FG001|Overall Study|Adverse Event|0|||
129014753|NCT03627091|464347665|FG002|Overall Study|Adverse Event|2|||
129014754|NCT03627091|464347663|FG000|Overall Study|Withdrawal by Subject|2|||
129014755|NCT03627091|464347664|FG001|Overall Study|Withdrawal by Subject|0|||
129014756|NCT03627091|464347665|FG002|Overall Study|Withdrawal by Subject|2|||
129014757|NCT03627091|464347663|FG000|Overall Study|Physician Decision|2|||
129014758|NCT03627091|464347664|FG001|Overall Study|Physician Decision|0|||
129014759|NCT03627091|464347665|FG002|Overall Study|Physician Decision|0|||
129014760|NCT03627091|464347663|FG000|Overall Study|Site terminated by sponsor|0|||
129014761|NCT03627091|464347664|FG001|Overall Study|Site terminated by sponsor|1|||
129014762|NCT03627091|464347665|FG002|Overall Study|Site terminated by sponsor|0|||
129014763|NCT03627091|464347663|FG000|Overall Study|Disease relapse|7|||
129014764|NCT03627091|464347664|FG001|Overall Study|Disease relapse|5|||
129014765|NCT03627091|464347665|FG002|Overall Study|Disease relapse|1|||
129014766|NCT03627091|464347663|FG000|Overall Study|Other|1|||
129014767|NCT03627091|464347664|FG001|Overall Study|Other|0|||
129014768|NCT03627091|464347665|FG002|Overall Study|Other|0|||
129014769|NCT01376167|464347670|FG000|Overall Study|Lost to Follow-up|2|||
129014770|NCT01376167|464347671|FG001|Overall Study|Lost to Follow-up|4|||
129014771|NCT01376167|464347672|FG002|Overall Study|Lost to Follow-up|2|||
129014772|NCT01376167|464347670|FG000|Overall Study|Physician Decision|1|||
129014773|NCT01376167|464347671|FG001|Overall Study|Physician Decision|1|||
129014774|NCT01376167|464347672|FG002|Overall Study|Physician Decision|0|||
129014775|NCT01376167|464347670|FG000|Overall Study|Withdrawal by Subject|1|||
129014776|NCT01376167|464347671|FG001|Overall Study|Withdrawal by Subject|5|||
129014777|NCT01376167|464347672|FG002|Overall Study|Withdrawal by Subject|4|||
129014778|NCT01173692|464347678|FG000|Overall Study|Adverse Event|1|||
129014779|NCT01173692|464347679|FG001|Overall Study|Adverse Event|2|||
129014780|NCT01173692|464347678|FG000|Overall Study|Withdrawal by Subject|1|||
129014781|NCT01173692|464347679|FG001|Overall Study|Withdrawal by Subject|3|||
129014782|NCT00678639|464347680|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
129014783|NCT00678639|464347681|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
129014784|NCT00986245|464347684|FG000|First Intervention|Poor compliance|8|||
129014785|NCT00986245|464347685|FG001|First Intervention|Poor compliance|4|||
129014786|NCT00986245|464347684|FG000|First Intervention|Lack of Efficacy|1|||
129014787|NCT00986245|464347685|FG001|First Intervention|Lack of Efficacy|2|||
129014788|NCT00986245|464347684|FG000|First Intervention|Withdrawal by Subject|0|||
129014789|NCT00986245|464347685|FG001|First Intervention|Withdrawal by Subject|1|||
129014790|NCT00986245|464347684|FG000|First Intervention|Protocol Violation|0|||
129014791|NCT00986245|464347685|FG001|First Intervention|Protocol Violation|1|||
129014792|NCT00986245|464347684|FG000|First Intervention|Out of indication|1|||
129014793|NCT00986245|464347685|FG001|First Intervention|Out of indication|0|||
129014794|NCT00986245|464347684|FG000|Second Intervention|Poor compliance|1|||
128681180|NCT00400153|463131961|FG000|Overall Study|AE due to other condition|3|||
129014795|NCT00986245|464347685|FG001|Second Intervention|Poor compliance|0|||
129014796|NCT00986245|464347684|FG000|Second Intervention|Lost to Follow-up|1|||
129014797|NCT00986245|464347685|FG001|Second Intervention|Lost to Follow-up|0|||
129014798|NCT00986245|464347684|FG000|Second Intervention|Protocol Violation|0|||
129014799|NCT00986245|464347685|FG001|Second Intervention|Protocol Violation|1|||
128681181|NCT00400153|463131962|FG001|Overall Study|AE due to other condition|14|||
128681182|NCT00400153|463131963|FG002|Overall Study|AE due to other condition|15|||
128681183|NCT00400153|463131961|FG000|Overall Study|Protocol Violation|7|||
128681184|NCT00400153|463131962|FG001|Overall Study|Protocol Violation|4|||
128681185|NCT00400153|463131963|FG002|Overall Study|Protocol Violation|9|||
128681186|NCT00400153|463131961|FG000|Overall Study|Lost to Follow-up|2|||
128681187|NCT00400153|463131962|FG001|Overall Study|Lost to Follow-up|1|||
128681188|NCT00400153|463131963|FG002|Overall Study|Lost to Follow-up|4|||
128681189|NCT00400153|463131961|FG000|Overall Study|Withdrawal by Subject|12|||
128681190|NCT00400153|463131962|FG001|Overall Study|Withdrawal by Subject|11|||
128681191|NCT00400153|463131963|FG002|Overall Study|Withdrawal by Subject|10|||
128681192|NCT00400153|463131961|FG000|Overall Study|Other reasons - not mentioned above|8|||
128681193|NCT00400153|463131962|FG001|Overall Study|Other reasons - not mentioned above|5|||
128681194|NCT00400153|463131963|FG002|Overall Study|Other reasons - not mentioned above|3|||
128681195|NCT00393042|463131964|FG000|First Intervention|Withdrawal by Subject|1|||
128681196|NCT00393042|463131965|FG001|First Intervention|Withdrawal by Subject|2|||
128681197|NCT00393042|463131964|FG000|First Intervention|Lost to Follow-up|3|||
128681198|NCT00393042|463131965|FG001|First Intervention|Lost to Follow-up|3|||
128681199|NCT00393042|463131964|FG000|First Intervention|Protocol Violation|1|||
128681200|NCT00393042|463131965|FG001|First Intervention|Protocol Violation|0|||
128681201|NCT00393042|463131964|FG000|First Intervention|Adverse Event|0|||
128681202|NCT00393042|463131965|FG001|First Intervention|Adverse Event|1|||
128681203|NCT00393042|463131964|FG000|Second Intervetion|Adverse Event|0|||
128681204|NCT00393042|463131965|FG001|Second Intervetion|Adverse Event|3|||
128681205|NCT00393042|463131964|FG000|Second Intervetion|Withdrawal by Subject|0|||
128681206|NCT00393042|463131965|FG001|Second Intervetion|Withdrawal by Subject|2|||
128681207|NCT00393042|463131964|FG000|Second Intervetion|Lack of Efficacy|1|||
128681208|NCT00393042|463131965|FG001|Second Intervetion|Lack of Efficacy|0|||
128681209|NCT00393042|463131964|FG000|Second Intervetion|Lost to Follow-up|0|||
128681210|NCT00393042|463131965|FG001|Second Intervetion|Lost to Follow-up|2|||
128681211|NCT00393042|463131964|FG000|Second Intervetion|Protocol Violation|1|||
128681212|NCT00393042|463131965|FG001|Second Intervetion|Protocol Violation|1|||
128681213|NCT01150474|463131966|FG000|Overall Study|Withdrawal by Subject|5|||
128681214|NCT01150474|463131967|FG001|Overall Study|Withdrawal by Subject|2|||
128681215|NCT01150474|463131966|FG000|Overall Study|Cancer found|1|||
128681216|NCT01150474|463131967|FG001|Overall Study|Cancer found|0|||
128681217|NCT01150474|463131966|FG000|Overall Study|Multiple Studies|0|||
128681218|NCT01150474|463131967|FG001|Overall Study|Multiple Studies|1|||
128681219|NCT01150474|463131966|FG000|Overall Study|Rectotomy|1|||
128681220|NCT01150474|463131967|FG001|Overall Study|Rectotomy|0|||
128681221|NCT01150474|463131966|FG000|Overall Study|Drug did not arrive in time|1|||
128681222|NCT01150474|463131967|FG001|Overall Study|Drug did not arrive in time|0|||
128681223|NCT01150474|463131966|FG000|Overall Study|Drug not administered|1|||
128681224|NCT01150474|463131967|FG001|Overall Study|Drug not administered|0|||
129014800|NCT02849652|464347691|FG000|Overall Study|Lost to Follow-up|104|||
129014801|NCT02849652|464347692|FG001|Overall Study|Lost to Follow-up|35|||
129014802|NCT02849652|464347693|FG002|Overall Study|Lost to Follow-up|116|||
129014803|NCT02849652|464347694|FG003|Overall Study|Lost to Follow-up|22|||
129014804|NCT02849652|464347691|FG000|Overall Study|Withdrawal by Subject|10|||
129014805|NCT02849652|464347692|FG001|Overall Study|Withdrawal by Subject|2|||
129014806|NCT02849652|464347693|FG002|Overall Study|Withdrawal by Subject|8|||
129014807|NCT02849652|464347694|FG003|Overall Study|Withdrawal by Subject|4|||
129014808|NCT00565448|464347695|FG000|Overall Study|Adverse Event|1|||
129014809|NCT00565448|464347696|FG001|Overall Study|Adverse Event|2|||
129014810|NCT00565448|464347695|FG000|Overall Study|Disease progression|1|||
129014811|NCT00565448|464347696|FG001|Overall Study|Disease progression|0|||
129014812|NCT00565448|464347695|FG000|Overall Study|Withdrawal by Subject|1|||
129014813|NCT00565448|464347696|FG001|Overall Study|Withdrawal by Subject|0|||
129014814|NCT01863745|464347697|FG000|Overall Study|Disease Progression|9|||
129014815|NCT01863745|464347697|FG000|Overall Study|Adverse Event|2|||
129014816|NCT01863745|464347697|FG000|Overall Study|Death|1|||
129014817|NCT01863745|464347697|FG000|Overall Study|Withdrawal by Subject|1|||
129014818|NCT00302952|464347698|FG000|Overall Study|Physician Decision|1|||
129014819|NCT00302952|464347699|FG001|Overall Study|Physician Decision|1|||
128681225|NCT01150474|463131966|FG000|Overall Study|Surgery Changed|1|||
128681226|NCT01150474|463131967|FG001|Overall Study|Surgery Changed|0|||
128681227|NCT01423604|463131968|FG000|Safety Run-In|Adverse Event|3|||
129014820|NCT00302952|464347698|FG000|Overall Study|Withdrawal by Subject|2|||
129014821|NCT00302952|464347699|FG001|Overall Study|Withdrawal by Subject|3|||
129014822|NCT00302952|464347698|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
129014823|NCT00302952|464347699|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
129014824|NCT02373098|464347700|FG000|Overall Study|Lost to Follow-up|1|||
129103435|NCT05052697|464673256|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
128681228|NCT01423604|463131969|FG001|Safety Run-In|Adverse Event|0|||
128681229|NCT01423604|463131968|FG000|Safety Run-In|Death|1|||
128681230|NCT01423604|463131969|FG001|Safety Run-In|Death|0|||
128879625|NCT02354508|463854897|FG000|Period 1: Core Phase|Adverse Event|1|||
129014825|NCT02373098|464347701|FG001|Overall Study|Lost to Follow-up|0|||
129103436|NCT05052697|464673257|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103437|NCT05052697|464673258|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103438|NCT05052697|464673259|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103439|NCT05052697|464673260|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103440|NCT05052697|464673261|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103441|NCT05052697|464673262|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103442|NCT05052697|464673263|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103443|NCT05052697|464673264|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
128681231|NCT01423604|463131968|FG000|Safety Run-In|Physician Decision|1|||
128681232|NCT01423604|463131969|FG001|Safety Run-In|Physician Decision|0|||
129103444|NCT05052697|464673265|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103445|NCT05052697|464673266|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103446|NCT05052697|464673267|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103447|NCT05052697|464673268|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103448|NCT05052697|464673269|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
128681233|NCT01423604|463131968|FG000|Safety Run-In|Disease progression|3|||
128681234|NCT01423604|463131969|FG001|Safety Run-In|Disease progression|0|||
128681235|NCT01423604|463131968|FG000|Safety Run-In|Patient decision|1|||
128681236|NCT01423604|463131969|FG001|Safety Run-In|Patient decision|0|||
128681237|NCT01423604|463131968|FG000|Randomized|Adverse Event|4|||
129103449|NCT05052697|464673270|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103450|NCT05052697|464673271|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103451|NCT05052697|464673272|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103452|NCT05052697|464673273|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103453|NCT05052697|464673274|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103454|NCT05052697|464673275|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103455|NCT05052697|464673276|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103456|NCT05052697|464673277|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103457|NCT05052697|464673278|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103458|NCT05052697|464673279|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103459|NCT05052697|464673280|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
129103460|NCT05052697|464673247|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103461|NCT05052697|464673248|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103462|NCT05052697|464673249|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103463|NCT05052697|464673250|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103464|NCT05052697|464673251|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103465|NCT05052697|464673252|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103466|NCT05052697|464673253|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103467|NCT05052697|464673254|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103468|NCT05052697|464673255|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103469|NCT05052697|464673256|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
128681238|NCT01423604|463131969|FG001|Randomized|Adverse Event|10|||
128681239|NCT01423604|463131968|FG000|Randomized|Death|1|||
128681240|NCT01423604|463131969|FG001|Randomized|Death|0|||
128681241|NCT01423604|463131968|FG000|Randomized|Physician Decision|16|||
128681242|NCT01423604|463131969|FG001|Randomized|Physician Decision|13|||
128681243|NCT01423604|463131968|FG000|Randomized|Other - unspecified|37|||
128681244|NCT01423604|463131969|FG001|Randomized|Other - unspecified|31|||
128681245|NCT01423604|463131968|FG000|Randomized|Patient decision|5|||
128681246|NCT01423604|463131969|FG001|Randomized|Patient decision|9|||
128681247|NCT00424255|463131970|FG000|Overall Study|Death|115|||
128681248|NCT00424255|463131971|FG001|Overall Study|Death|111|||
128681249|NCT00424255|463131970|FG000|Overall Study|Lost to Follow-up|26|||
128681250|NCT00424255|463131971|FG001|Overall Study|Lost to Follow-up|20|||
128681251|NCT00424255|463131970|FG000|Overall Study|Protocol Violation|0|||
128681252|NCT00424255|463131971|FG001|Overall Study|Protocol Violation|1|||
128681253|NCT00424255|463131970|FG000|Overall Study|Withdrawal by Subject|34|||
128681254|NCT00424255|463131971|FG001|Overall Study|Withdrawal by Subject|38|||
128681255|NCT00424255|463131970|FG000|Overall Study|Physician Decision|3|||
128681256|NCT00424255|463131971|FG001|Overall Study|Physician Decision|7|||
128681257|NCT00424255|463131970|FG000|Overall Study|Cognitive Disturbance|1|||
128681258|NCT00424255|463131971|FG001|Overall Study|Cognitive Disturbance|0|||
128681259|NCT00424255|463131970|FG000|Overall Study|Non-compliance by Participants|1|||
128681260|NCT00424255|463131971|FG001|Overall Study|Non-compliance by Participants|0|||
128681261|NCT00424255|463131970|FG000|Overall Study|Fatigue|1|||
128681262|NCT00424255|463131971|FG001|Overall Study|Fatigue|0|||
128681263|NCT00424255|463131970|FG000|Overall Study|Disease Progression|0|||
128681264|NCT00424255|463131971|FG001|Overall Study|Disease Progression|2|||
128681265|NCT00424255|463131970|FG000|Overall Study|Sponsor Terminated Study|161|||
128681266|NCT00424255|463131971|FG001|Overall Study|Sponsor Terminated Study|167|||
128681267|NCT01226121|463131972|FG000|Overall Study|Lost to Follow-up|2|||
128681268|NCT01226121|463131973|FG001|Overall Study|Lost to Follow-up|0|||
128681269|NCT01226121|463131974|FG002|Overall Study|Lost to Follow-up|1|||
128681270|NCT01163032|463131979|FG000|Randomization Phase|Withdrawal by Subject|2|||
128681271|NCT01163032|463131980|FG001|Randomization Phase|Withdrawal by Subject|3|||
128681272|NCT01163032|463131981|FG002|Randomization Phase|Withdrawal by Subject|0|||
129014826|NCT02373098|464347700|FG000|Overall Study|Protocol Violation|3|||
129014827|NCT02373098|464347701|FG001|Overall Study|Protocol Violation|0|||
129014828|NCT02373098|464347700|FG000|Overall Study|Withdrawal by Subject|5|||
128681273|NCT01163032|463131979|FG000|Randomization Phase|Adverse Event|3|||
128681274|NCT01163032|463131980|FG001|Randomization Phase|Adverse Event|3|||
128681275|NCT01163032|463131981|FG002|Randomization Phase|Adverse Event|0|||
128681276|NCT01163032|463131979|FG000|Randomization Phase|Protocol Violation|0|||
128681277|NCT01163032|463131980|FG001|Randomization Phase|Protocol Violation|1|||
128681278|NCT01163032|463131981|FG002|Randomization Phase|Protocol Violation|0|||
128681279|NCT01163032|463131979|FG000|Randomization Phase|Various*|5|||
128681280|NCT01163032|463131980|FG001|Randomization Phase|Various*|4|||
128681281|NCT01163032|463131981|FG002|Randomization Phase|Various*|0|||
128681282|NCT01163032|463131979|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
128681283|NCT01163032|463131980|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
128681284|NCT01163032|463131981|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
128681285|NCT01163032|463131979|FG000|Open Label Extension Phase|Adverse Event|0|||
128681286|NCT01163032|463131980|FG001|Open Label Extension Phase|Adverse Event|0|||
128681287|NCT01163032|463131981|FG002|Open Label Extension Phase|Adverse Event|3|||
128681288|NCT01163032|463131979|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
128681289|NCT01163032|463131980|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
128681290|NCT01163032|463131981|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
129014829|NCT02373098|464347701|FG001|Overall Study|Withdrawal by Subject|0|||
129014830|NCT02373098|464347700|FG000|Overall Study|Adverse Event|3|||
129014831|NCT02373098|464347701|FG001|Overall Study|Adverse Event|0|||
129014832|NCT00420238|464347702|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
129014833|NCT00420238|464347703|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
129014834|NCT00420238|464347702|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
129014835|NCT00420238|464347703|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
129014836|NCT00420238|464347702|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
129014837|NCT00420238|464347703|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
129014838|NCT00420238|464347702|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
129014839|NCT00420238|464347703|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
129014840|NCT00420238|464347702|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
129014841|NCT00420238|464347703|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
129014842|NCT00420238|464347702|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
129014843|NCT00420238|464347703|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
129014844|NCT05214560|464347704|FG000|Overall Study|Screening Failure|1|||
129014845|NCT05214560|464347704|FG000|Overall Study|Physician Decision|4|||
129014846|NCT05214560|464347704|FG000|Overall Study|Withdrawal by Subject|1|||
129014847|NCT05214560|464347704|FG000|Overall Study|Lost to Follow-up|2|||
129014848|NCT05214560|464347704|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
129014849|NCT05214560|464347704|FG000|Overall Study|Study physician not available for the anesthesia|3|||
129014850|NCT05214560|464347704|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
129014851|NCT05214560|464347704|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
129014852|NCT05214560|464347704|FG000|Overall Study|Surgery not performed|3|||
129014853|NCT03639311|464347705|FG000|Maintenance Phase|Lost to Follow-up|1|||
129014854|NCT03639311|464347706|FG001|Maintenance Phase|Lost to Follow-up|0|||
129014855|NCT03639311|464347707|FG002|Maintenance Phase|Lost to Follow-up|0|||
129014856|NCT03639311|464347705|FG000|Maintenance Phase|Adverse Event|1|||
129014857|NCT03639311|464347706|FG001|Maintenance Phase|Adverse Event|0|||
129014858|NCT03639311|464347707|FG002|Maintenance Phase|Adverse Event|0|||
129014859|NCT03639311|464347705|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
129014860|NCT03639311|464347706|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
129014861|NCT03639311|464347707|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
129014862|NCT03639311|464347705|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
129014863|NCT03639311|464347706|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
129014864|NCT03639311|464347707|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
129014865|NCT03639311|464347705|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
129014866|NCT03639311|464347706|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
129014867|NCT03639311|464347707|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
129014868|NCT03639311|464347705|FG000|Maintenance Phase|Lack of Efficacy|1|||
129014869|NCT03639311|464347706|FG001|Maintenance Phase|Lack of Efficacy|0|||
129014870|NCT03639311|464347707|FG002|Maintenance Phase|Lack of Efficacy|0|||
129014871|NCT03018249|464347708|FG000|Overall Study|Withdrawal by Subject|2|||
129014872|NCT03018249|464347709|FG001|Overall Study|Withdrawal by Subject|2|||
128681291|NCT01163032|463131979|FG000|Open Label Extension Phase|Protocol Violation|0|||
128681292|NCT01163032|463131980|FG001|Open Label Extension Phase|Protocol Violation|0|||
129103470|NCT05052697|464673257|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
128681293|NCT01163032|463131981|FG002|Open Label Extension Phase|Protocol Violation|1|||
129103471|NCT05052697|464673258|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129014873|NCT00304083|464347717|FG000|Overall Study|Withdrawal by Subject|4|||
129014874|NCT00304083|464347718|FG001|Overall Study|Withdrawal by Subject|2|||
129014875|NCT00304083|464347717|FG000|Overall Study|Physician Decision|8|||
129014876|NCT00304083|464347718|FG001|Overall Study|Physician Decision|3|||
129014877|NCT00304083|464347717|FG000|Overall Study|Disease Progression|5|||
129014878|NCT00304083|464347718|FG001|Overall Study|Disease Progression|1|||
129014879|NCT00304083|464347717|FG000|Overall Study|Other|5|||
129014880|NCT00304083|464347718|FG001|Overall Study|Other|2|||
129014881|NCT03966365|464347721|FG000|Overall Study|Protocol Violation|1|||
129014882|NCT03966365|464347722|FG001|Overall Study|Protocol Violation|0|||
129014883|NCT01044732|464347723|FG000|Overall Study|Lost to Follow-up|2|||
129014884|NCT01044732|464347724|FG001|Overall Study|Lost to Follow-up|1|||
129014885|NCT01044732|464347723|FG000|Overall Study|Physician Decision|5|||
129014886|NCT01044732|464347724|FG001|Overall Study|Physician Decision|3|||
129014887|NCT01044732|464347723|FG000|Overall Study|Protocol Violation|11|||
129014888|NCT01044732|464347724|FG001|Overall Study|Protocol Violation|12|||
129014889|NCT01044732|464347723|FG000|Overall Study|Withdrawal by Subject|0|||
129014890|NCT01044732|464347724|FG001|Overall Study|Withdrawal by Subject|1|||
129014891|NCT01044732|464347723|FG000|Overall Study|Inadequate bowel preparation|11|||
129014892|NCT01044732|464347724|FG001|Overall Study|Inadequate bowel preparation|17|||
129014893|NCT01044732|464347723|FG000|Overall Study|Inability to reach cecum|5|||
129014894|NCT01044732|464347724|FG001|Overall Study|Inability to reach cecum|2|||
129014895|NCT01044732|464347723|FG000|Overall Study|Technical error or malfunction|15|||
129014896|NCT01044732|464347724|FG001|Overall Study|Technical error or malfunction|14|||
129014897|NCT01569152|464347725|FG000|Phase IIa, Period 1|Early Escape|5|||
129014898|NCT01569152|464347726|FG001|Phase IIa, Period 1|Early Escape|22|||
129014899|NCT01569152|464347727|FG002|Phase IIa, Period 1|Early Escape|0|||
129014900|NCT01569152|464347725|FG000|Phase IIa, Period 1|Adverse Event|4|||
129014901|NCT01569152|464347726|FG001|Phase IIa, Period 1|Adverse Event|0|||
129014902|NCT01569152|464347727|FG002|Phase IIa, Period 1|Adverse Event|0|||
129014903|NCT01569152|464347725|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
128681294|NCT01163032|463131979|FG000|Open Label Extension Phase|Study Termination|0|||
128681295|NCT01163032|463131980|FG001|Open Label Extension Phase|Study Termination|0|||
128681296|NCT01163032|463131981|FG002|Open Label Extension Phase|Study Termination|7|||
128681297|NCT01163032|463131979|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
128681298|NCT01163032|463131980|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
128681299|NCT01163032|463131981|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
128681300|NCT01307020|463131984|FG000|Overall Study|Lost to Follow-up|0|||
128681301|NCT01307020|463131985|FG001|Overall Study|Lost to Follow-up|0|||
128681302|NCT01307020|463131986|FG002|Overall Study|Lost to Follow-up|1|||
128681303|NCT01307020|463131987|FG003|Overall Study|Lost to Follow-up|1|||
128681304|NCT01307020|463131988|FG004|Overall Study|Lost to Follow-up|0|||
128681305|NCT01307020|463131989|FG005|Overall Study|Lost to Follow-up|0|||
128681306|NCT01307020|463131990|FG006|Overall Study|Lost to Follow-up|1|||
128681307|NCT01307020|463131991|FG007|Overall Study|Lost to Follow-up|0|||
128681308|NCT01307020|463131992|FG008|Overall Study|Lost to Follow-up|0|||
128681309|NCT01307020|463131993|FG009|Overall Study|Lost to Follow-up|0|||
128681310|NCT01307020|463131984|FG000|Overall Study|Electronic data capture failure|0|||
128681311|NCT01307020|463131985|FG001|Overall Study|Electronic data capture failure|1|||
128681312|NCT01307020|463131986|FG002|Overall Study|Electronic data capture failure|0|||
128681313|NCT01307020|463131987|FG003|Overall Study|Electronic data capture failure|0|||
128681314|NCT01307020|463131988|FG004|Overall Study|Electronic data capture failure|0|||
128681315|NCT01307020|463131989|FG005|Overall Study|Electronic data capture failure|0|||
128681316|NCT01307020|463131990|FG006|Overall Study|Electronic data capture failure|0|||
128681317|NCT01307020|463131991|FG007|Overall Study|Electronic data capture failure|0|||
128681318|NCT01307020|463131992|FG008|Overall Study|Electronic data capture failure|0|||
128681319|NCT01307020|463131993|FG009|Overall Study|Electronic data capture failure|0|||
128681320|NCT02380690|463131994|FG000|Overall Study|Lost to Follow-up|14|||
128681321|NCT02380690|463131995|FG001|Overall Study|Lost to Follow-up|4|||
128681322|NCT02380690|463131994|FG000|Overall Study|Withdrawal by Subject|20|||
128681323|NCT02380690|463131995|FG001|Overall Study|Withdrawal by Subject|8|||
128681324|NCT00829933|463131996|FG000|Overall Study|Adverse Event|2|||
128681325|NCT00829933|463131997|FG001|Overall Study|Adverse Event|3|||
128681326|NCT00829933|463131998|FG002|Overall Study|Adverse Event|2|||
128681327|NCT00829933|463131999|FG003|Overall Study|Adverse Event|1|||
128681328|NCT00829933|463131996|FG000|Overall Study|Death|0|||
128681329|NCT00829933|463131997|FG001|Overall Study|Death|0|||
129014904|NCT01569152|464347726|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
129014905|NCT01569152|464347727|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
129014906|NCT01569152|464347725|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
129014907|NCT01569152|464347726|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
129014908|NCT01569152|464347727|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
129014909|NCT01569152|464347725|FG000|Phase IIa, Period 1|Protocol Violation|0|||
129014910|NCT01569152|464347726|FG001|Phase IIa, Period 1|Protocol Violation|1|||
129014911|NCT01569152|464347727|FG002|Phase IIa, Period 1|Protocol Violation|0|||
129014912|NCT01569152|464347725|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
128681330|NCT00829933|463131998|FG002|Overall Study|Death|1|||
128681331|NCT00829933|463131999|FG003|Overall Study|Death|1|||
128681332|NCT00829933|463131996|FG000|Overall Study|Lack of Efficacy|0|||
128681333|NCT00829933|463131997|FG001|Overall Study|Lack of Efficacy|1|||
128681334|NCT00829933|463131998|FG002|Overall Study|Lack of Efficacy|0|||
128681335|NCT00829933|463131999|FG003|Overall Study|Lack of Efficacy|0|||
128681336|NCT00829933|463131996|FG000|Overall Study|Physician Decision|5|||
128681337|NCT00829933|463131997|FG001|Overall Study|Physician Decision|7|||
128681338|NCT00829933|463131998|FG002|Overall Study|Physician Decision|8|||
128681339|NCT00829933|463131999|FG003|Overall Study|Physician Decision|1|||
128681340|NCT00829933|463131996|FG000|Overall Study|Pregnancy|0|||
128681341|NCT00829933|463131997|FG001|Overall Study|Pregnancy|0|||
129014913|NCT01569152|464347726|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
129014914|NCT01569152|464347727|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
129014915|NCT01569152|464347725|FG000|Safety Extension, Period 3|Adverse Event|0|||
128681342|NCT00829933|463131998|FG002|Overall Study|Pregnancy|0|||
128681343|NCT00829933|463131999|FG003|Overall Study|Pregnancy|2|||
128681344|NCT00829933|463131996|FG000|Overall Study|Protocol Violation|2|||
128681345|NCT00829933|463131997|FG001|Overall Study|Protocol Violation|1|||
128681346|NCT00829933|463131998|FG002|Overall Study|Protocol Violation|0|||
128681347|NCT00829933|463131999|FG003|Overall Study|Protocol Violation|0|||
128681348|NCT00829933|463131996|FG000|Overall Study|withdrew before treatment started|5|||
128681349|NCT00829933|463131997|FG001|Overall Study|withdrew before treatment started|1|||
128681350|NCT00829933|463131998|FG002|Overall Study|withdrew before treatment started|2|||
128681351|NCT00829933|463131999|FG003|Overall Study|withdrew before treatment started|9|||
128681352|NCT03119701|463132000|FG000|6-day Dosing|Death|4|||
128681353|NCT03119701|463132001|FG001|6-day Dosing|Death|1|||
128681354|NCT03119701|463132000|FG000|6-day Dosing|Adverse Event|3|||
129014916|NCT01569152|464347726|FG001|Safety Extension, Period 3|Adverse Event|0|||
128681355|NCT03119701|463132001|FG001|6-day Dosing|Adverse Event|0|||
128681356|NCT03119701|463132000|FG000|6-day Dosing|Physician Decision|0|||
128681357|NCT03119701|463132001|FG001|6-day Dosing|Physician Decision|1|||
128681358|NCT03119701|463132000|FG000|6-day Dosing|Withdrawal by Subject|0|||
128681359|NCT03119701|463132001|FG001|6-day Dosing|Withdrawal by Subject|1|||
128681360|NCT03119701|463132000|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
128681361|NCT03119701|463132001|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
128681362|NCT02207946|463132010|FG000|Overall Study|Lost to Follow-up|1|||
128681363|NCT02207946|463132011|FG001|Overall Study|Lost to Follow-up|0|||
128681364|NCT02207946|463132010|FG000|Overall Study|Adverse Event|0|||
128681365|NCT02207946|463132011|FG001|Overall Study|Adverse Event|1|||
128681366|NCT02361346|463132012|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
128681367|NCT02361346|463132013|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
129014917|NCT01569152|464347727|FG002|Safety Extension, Period 3|Adverse Event|4|||
129014918|NCT01569152|464347725|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
129014919|NCT01569152|464347726|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
129014920|NCT01569152|464347727|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
129014921|NCT01569152|464347725|FG000|Safety Extension, Period 3|Physician Decision|0|||
129014922|NCT01569152|464347726|FG001|Safety Extension, Period 3|Physician Decision|0|||
129014923|NCT01569152|464347727|FG002|Safety Extension, Period 3|Physician Decision|2|||
129014924|NCT01569152|464347725|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
129014925|NCT01569152|464347726|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
129014926|NCT01569152|464347727|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
129014927|NCT00824265|464347732|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
129014928|NCT00824265|464347733|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
129014929|NCT00824265|464347732|FG000|Treatment Phase|Protocol Violation|1|||
129014930|NCT00824265|464347733|FG001|Treatment Phase|Protocol Violation|0|||
129014931|NCT00824265|464347732|FG000|Treatment Phase|Lost to Follow-up|1|||
129014932|NCT00824265|464347733|FG001|Treatment Phase|Lost to Follow-up|1|||
128681368|NCT02361346|463132014|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
128681369|NCT02361346|463132015|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
128681370|NCT02361346|463132016|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
129014933|NCT00824265|464347732|FG000|Treatment Phase|Physician Decision|6|||
129014934|NCT00824265|464347733|FG001|Treatment Phase|Physician Decision|12|||
129014935|NCT00824265|464347732|FG000|Treatment Phase|Withdrawal by Subject|6|||
128681371|NCT02361346|463132017|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
128681372|NCT02361346|463132018|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
128681373|NCT02361346|463132019|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
129014936|NCT00824265|464347733|FG001|Treatment Phase|Withdrawal by Subject|15|||
128681374|NCT02361346|463132020|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
128681375|NCT02361346|463132012|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
128681376|NCT02361346|463132013|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
128681377|NCT02361346|463132014|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
128681378|NCT02361346|463132015|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
128681379|NCT02361346|463132016|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
128681380|NCT02361346|463132017|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129014937|NCT00824265|464347732|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
129014938|NCT00824265|464347733|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
129014939|NCT00824265|464347732|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
129014940|NCT00824265|464347733|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
129014941|NCT02801877|464347734|FG000|Overall Study|Lost to Follow-up|1|||
129014942|NCT02801877|464347735|FG001|Overall Study|Lost to Follow-up|1|||
129014943|NCT02801877|464347736|FG002|Overall Study|Lost to Follow-up|2|||
129014944|NCT02801877|464347737|FG003|Overall Study|Lost to Follow-up|0|||
129014945|NCT02801877|464347734|FG000|Overall Study|Never Started Treatment|2|||
129014946|NCT02801877|464347735|FG001|Overall Study|Never Started Treatment|0|||
129014947|NCT02801877|464347736|FG002|Overall Study|Never Started Treatment|4|||
129014948|NCT02801877|464347737|FG003|Overall Study|Never Started Treatment|0|||
129014949|NCT00705536|464349669|FG000|Start Period 1|Withdrawal by Subject|0|||
129014950|NCT00705536|464349670|FG001|Start Period 1|Withdrawal by Subject|0|||
129014951|NCT00705536|464349671|FG002|Start Period 1|Withdrawal by Subject|0|||
129014952|NCT00705536|464349672|FG003|Start Period 1|Withdrawal by Subject|1|||
129014953|NCT04188106|464349673|FG000|Overall Study|Lost to Follow-up|5|||
129014954|NCT04188106|464349673|FG000|Overall Study|Non-Compliance|1|||
129014955|NCT02289963|464349674|FG000|Overall Study|Adverse Event|1|||
129014956|NCT02289963|464349675|FG001|Overall Study|Adverse Event|2|||
129014957|NCT02289963|464349674|FG000|Overall Study|Poor compliance to protocol|1|||
129014958|NCT02289963|464349675|FG001|Overall Study|Poor compliance to protocol|0|||
129014959|NCT02289963|464349674|FG000|Overall Study|Withdrawal by Subject|1|||
129014960|NCT02289963|464349675|FG001|Overall Study|Withdrawal by Subject|0|||
129014961|NCT02289963|464349674|FG000|Overall Study|Last injection missed|2|||
129014962|NCT02289963|464349675|FG001|Overall Study|Last injection missed|2|||
129014963|NCT02289963|464349674|FG000|Overall Study|End treatment visit outside visit window|0|||
129014964|NCT02289963|464349675|FG001|Overall Study|End treatment visit outside visit window|4|||
129014965|NCT02289963|464349674|FG000|Overall Study|Other than specified above|0|||
129014966|NCT02289963|464349675|FG001|Overall Study|Other than specified above|2|||
129014967|NCT01042522|464349676|FG000|Overall Study|Adverse Event|1|||
129014968|NCT01042522|464349677|FG001|Overall Study|Adverse Event|2|||
129014969|NCT01042522|464349676|FG000|Overall Study|Disease Progression|5|||
129014970|NCT01042522|464349677|FG001|Overall Study|Disease Progression|0|||
129014971|NCT01042522|464349676|FG000|Overall Study|Death|1|||
129014972|NCT01042522|464349677|FG001|Overall Study|Death|0|||
129014973|NCT01042522|464349676|FG000|Overall Study|Patient Refused|0|||
129014974|NCT01042522|464349677|FG001|Overall Study|Patient Refused|3|||
129014975|NCT01042522|464349676|FG000|Overall Study|Withdrawal by Subject|1|||
129014976|NCT01042522|464349677|FG001|Overall Study|Withdrawal by Subject|1|||
129014977|NCT00549718|464349680|FG000|Overall Study|Insufficient clinical response|20|||
129014978|NCT00549718|464349681|FG001|Overall Study|Insufficient clinical response|7|||
129014979|NCT00549718|464349682|FG002|Overall Study|Insufficient clinical response|18|||
129014980|NCT00549718|464349683|FG003|Overall Study|Insufficient clinical response|32|||
129014981|NCT00549718|464349680|FG000|Overall Study|Adverse Event|6|||
129014982|NCT00549718|464349681|FG001|Overall Study|Adverse Event|8|||
129014983|NCT00549718|464349682|FG002|Overall Study|Adverse Event|7|||
129014984|NCT00549718|464349683|FG003|Overall Study|Adverse Event|3|||
129014985|NCT00549718|464349680|FG000|Overall Study|Lost to Follow-up|4|||
129014986|NCT00549718|464349681|FG001|Overall Study|Lost to Follow-up|2|||
129014987|NCT00549718|464349682|FG002|Overall Study|Lost to Follow-up|0|||
129014988|NCT00549718|464349683|FG003|Overall Study|Lost to Follow-up|6|||
129014989|NCT00549718|464349680|FG000|Overall Study|Withdrawal by Subject|9|||
129014990|NCT00549718|464349681|FG001|Overall Study|Withdrawal by Subject|18|||
129014991|NCT00549718|464349682|FG002|Overall Study|Withdrawal by Subject|12|||
129014992|NCT00549718|464349683|FG003|Overall Study|Withdrawal by Subject|13|||
129014993|NCT00549718|464349680|FG000|Overall Study|Administrative|2|||
129014994|NCT00549718|464349681|FG001|Overall Study|Administrative|2|||
129014995|NCT00549718|464349682|FG002|Overall Study|Administrative|2|||
129014996|NCT00549718|464349683|FG003|Overall Study|Administrative|1|||
129014997|NCT02311361|464349684|FG000|Overall Study|Did not receive treatment|0|||
129014998|NCT02311361|464349685|FG001|Overall Study|Did not receive treatment|1|||
129014999|NCT02311361|464349686|FG002|Overall Study|Did not receive treatment|0|||
129015000|NCT02311361|464349687|FG003|Overall Study|Did not receive treatment|1|||
129015001|NCT02653664|464349688|FG000|Post-Treatment|Withdrawal by Subject|6|||
129015002|NCT02653664|464349689|FG001|Post-Treatment|Withdrawal by Subject|5|||
129015003|NCT02653664|464349690|FG002|Post-Treatment|Withdrawal by Subject|7|||
129015004|NCT02653664|464349688|FG000|Post-Treatment|Lost to Follow-up|8|||
129015005|NCT02653664|464349689|FG001|Post-Treatment|Lost to Follow-up|1|||
129015006|NCT02653664|464349690|FG002|Post-Treatment|Lost to Follow-up|7|||
129015007|NCT02653664|464349688|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
129015008|NCT02653664|464349689|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
129015009|NCT02653664|464349690|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
129015010|NCT02653664|464349688|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
129015011|NCT02653664|464349689|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
129015012|NCT02653664|464349690|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
129015013|NCT02653664|464349688|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
128681381|NCT02361346|463132018|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
128681382|NCT02361346|463132019|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
128681383|NCT02361346|463132020|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
128681384|NCT02361346|463132012|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
128681385|NCT02361346|463132013|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
128681386|NCT02361346|463132014|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
128681387|NCT02361346|463132015|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
128681388|NCT02361346|463132016|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
128681389|NCT02361346|463132017|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
128681390|NCT02361346|463132018|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
128681391|NCT02361346|463132019|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
128681392|NCT02361346|463132020|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
128681393|NCT02361346|463132012|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681394|NCT02361346|463132013|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681395|NCT02361346|463132014|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681396|NCT02361346|463132015|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681397|NCT02361346|463132016|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681398|NCT02361346|463132017|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681399|NCT02361346|463132018|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681400|NCT02361346|463132019|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
128681401|NCT02361346|463132020|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
128681402|NCT02361346|463132012|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681403|NCT02361346|463132013|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681404|NCT02361346|463132014|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681405|NCT02361346|463132015|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681406|NCT02361346|463132016|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681407|NCT02361346|463132017|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681408|NCT02361346|463132018|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681409|NCT02361346|463132019|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
128681410|NCT02361346|463132020|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
128681411|NCT02361346|463132012|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681412|NCT02361346|463132013|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681413|NCT02361346|463132014|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681414|NCT02361346|463132015|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681415|NCT02361346|463132016|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681416|NCT02361346|463132017|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681417|NCT02361346|463132018|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681418|NCT02361346|463132019|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
128681419|NCT02361346|463132020|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
128681420|NCT05772702|463132028|FG000|Overall Study|Adverse Event|1|||
128681421|NCT00884377|463133576|FG000|Overall Study|Withdrawal by Subject|1|||
128681422|NCT00884377|463133577|FG001|Overall Study|Withdrawal by Subject|0|||
128681423|NCT00884377|463133576|FG000|Overall Study|Could not confirm diagnosis|1|||
128681424|NCT00884377|463133577|FG001|Overall Study|Could not confirm diagnosis|0|||
128681425|NCT00884377|463133576|FG000|Overall Study|Physician Decision|0|||
128681426|NCT00884377|463133577|FG001|Overall Study|Physician Decision|1|||
128681427|NCT02003365|463133578|FG000|Overall Study|Lost to Follow-up|0|||
128681428|NCT02003365|463133579|FG001|Overall Study|Lost to Follow-up|0|||
128681429|NCT02003365|463133580|FG002|Overall Study|Lost to Follow-up|1|||
128681430|NCT00622739|463133581|FG000|Overall Study|Physician Decision|1|||
128681431|NCT00622739|463133582|FG001|Overall Study|Physician Decision|0|||
128681432|NCT00622739|463133581|FG000|Overall Study|Adverse Event|1|||
128681433|NCT00622739|463133582|FG001|Overall Study|Adverse Event|2|||
128681434|NCT00622739|463133581|FG000|Overall Study|Lack of Efficacy|0|||
128681435|NCT00622739|463133582|FG001|Overall Study|Lack of Efficacy|2|||
128681436|NCT00622739|463133581|FG000|Overall Study|Withdrawal by Subject|0|||
128681437|NCT00622739|463133582|FG001|Overall Study|Withdrawal by Subject|1|||
128681438|NCT00622739|463133581|FG000|Overall Study|Lost to Follow-up|0|||
128681439|NCT00622739|463133582|FG001|Overall Study|Lost to Follow-up|1|||
128681440|NCT03150485|463133583|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
128681441|NCT03150485|463133584|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
128681442|NCT03150485|463133585|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
128681443|NCT03150485|463133586|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
128681444|NCT03150485|463133587|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
128681445|NCT03150485|463133588|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
128681446|NCT03387150|463133590|FG000|Overall Study|Withdrawal by Subject|3|||
128681447|NCT03387150|463133591|FG001|Overall Study|Withdrawal by Subject|0|||
128681448|NCT03387150|463133592|FG002|Overall Study|Withdrawal by Subject|3|||
128681449|NCT03387150|463133593|FG003|Overall Study|Withdrawal by Subject|4|||
128681450|NCT03387150|463133594|FG004|Overall Study|Withdrawal by Subject|1|||
128681451|NCT03387150|463133595|FG005|Overall Study|Withdrawal by Subject|2|||
129103472|NCT05052697|464673259|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103473|NCT05052697|464673260|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
128681452|NCT03387150|463133596|FG006|Overall Study|Withdrawal by Subject|0|||
128681453|NCT03387150|463133590|FG000|Overall Study|Lost to Follow-up|3|||
128681454|NCT03387150|463133591|FG001|Overall Study|Lost to Follow-up|2|||
128681455|NCT03387150|463133592|FG002|Overall Study|Lost to Follow-up|2|||
128681456|NCT03387150|463133593|FG003|Overall Study|Lost to Follow-up|3|||
128681457|NCT03387150|463133594|FG004|Overall Study|Lost to Follow-up|3|||
128681458|NCT03387150|463133595|FG005|Overall Study|Lost to Follow-up|3|||
128681459|NCT03387150|463133596|FG006|Overall Study|Lost to Follow-up|0|||
128681460|NCT03387150|463133590|FG000|Overall Study|Participant unable to adhere to visit|0|||
128681461|NCT03387150|463133591|FG001|Overall Study|Participant unable to adhere to visit|1|||
128681462|NCT03387150|463133592|FG002|Overall Study|Participant unable to adhere to visit|0|||
128681463|NCT03387150|463133593|FG003|Overall Study|Participant unable to adhere to visit|0|||
128681464|NCT03387150|463133594|FG004|Overall Study|Participant unable to adhere to visit|2|||
128681465|NCT03387150|463133595|FG005|Overall Study|Participant unable to adhere to visit|2|||
128681466|NCT03387150|463133596|FG006|Overall Study|Participant unable to adhere to visit|0|||
128681467|NCT01362595|463133604|FG000|Overall Study|Screen failure|10|||
128681468|NCT01362595|463133604|FG000|Overall Study|Withdrawal by Subject|2|||
128681469|NCT02469038|463133605|FG000|Overall Study|Physician Decision|4|||
128681470|NCT02469038|463133606|FG001|Overall Study|Physician Decision|5|||
128681471|NCT02448680|463133607|FG000|Overall Study|Physician Decision|1|||
128681472|NCT02448680|463133608|FG001|Overall Study|Physician Decision|1|||
128681473|NCT02448680|463133607|FG000|Overall Study|Withdrawal by Subject|0|||
128681474|NCT02448680|463133608|FG001|Overall Study|Withdrawal by Subject|2|||
128681475|NCT00636987|463133609|FG000|Overall Study|Death|44|||
128681476|NCT00636987|463133609|FG000|Overall Study|Explanted|13|||
128681477|NCT00636987|463133609|FG000|Overall Study|Lost to Follow-up|63|||
128681478|NCT00636987|463133609|FG000|Overall Study|5 year visit window not complete|69|||
128681479|NCT01251146|463133610|FG000|Overall Study|Lost to Follow-up|3|||
128681480|NCT01251146|463133611|FG001|Overall Study|Lost to Follow-up|10|||
128681481|NCT01739400|463133612|FG000|Overall Study|Physician Decision|3|||
128681482|NCT01739400|463133613|FG001|Overall Study|Physician Decision|0|||
128681483|NCT01739400|463133612|FG000|Overall Study|Lost to Follow-up|2|||
128681484|NCT01739400|463133613|FG001|Overall Study|Lost to Follow-up|0|||
128681485|NCT01739400|463133612|FG000|Overall Study|Death|5|||
128681486|NCT01739400|463133613|FG001|Overall Study|Death|2|||
128681487|NCT01739400|463133612|FG000|Overall Study|Withdrawal by Subject|7|||
128681488|NCT01739400|463133613|FG001|Overall Study|Withdrawal by Subject|7|||
128681489|NCT01083173|463133620|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
128681490|NCT01083173|463133621|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
128681491|NCT01083173|463133620|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
128681492|NCT01083173|463133621|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
128681493|NCT01083173|463133620|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
128681494|NCT01083173|463133621|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
128681495|NCT01083173|463133620|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
128681496|NCT01083173|463133621|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
128681497|NCT01083173|463133620|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
128681498|NCT01083173|463133621|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
128681499|NCT01083173|463133620|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
128681500|NCT01083173|463133621|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
128681501|NCT01083173|463133620|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
128681502|NCT01083173|463133621|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
128681503|NCT01083173|463133620|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
128681504|NCT01083173|463133621|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
128681505|NCT01083173|463133620|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
128681506|NCT01083173|463133621|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
128681507|NCT01083173|463133620|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
128681508|NCT01083173|463133621|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
128681509|NCT01083173|463133620|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
128681510|NCT01083173|463133621|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
128681511|NCT03410823|463133622|FG000|Overall Study|Death|1|||
128681512|NCT03410823|463133622|FG000|Overall Study|Withdrawal by Subject|2|||
129103474|NCT05052697|464673261|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103475|NCT05052697|464673262|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
128681513|NCT03410823|463133622|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
128681514|NCT03569293|463133623|FG000|Overall Study|Adverse Event|4|||
128681515|NCT03569293|463133624|FG001|Overall Study|Adverse Event|1|||
128681516|NCT03569293|463133625|FG002|Overall Study|Adverse Event|5|||
129103476|NCT05052697|464673263|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129015014|NCT02653664|464349689|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
129015015|NCT02653664|464349690|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
129015016|NCT02653664|464349688|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
129015017|NCT02653664|464349689|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
129015018|NCT02653664|464349690|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
129015019|NCT02653664|464349688|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
129015020|NCT02653664|464349689|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
129015021|NCT02653664|464349690|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
129015022|NCT02653664|464349688|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
129015023|NCT02653664|464349689|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
129015024|NCT02653664|464349690|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
129015025|NCT02653664|464349688|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
129015026|NCT02653664|464349689|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
129015027|NCT02653664|464349690|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
129015028|NCT02653664|464349688|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
129015029|NCT02653664|464349689|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
129015030|NCT02653664|464349690|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
129015031|NCT00633594|464349691|FG000|Overall Study|Adverse Event|0|||
129015032|NCT00633594|464349692|FG001|Overall Study|Adverse Event|4|||
129015033|NCT00633594|464349693|FG002|Overall Study|Adverse Event|7|||
129015034|NCT00633594|464349691|FG000|Overall Study|Death|0|||
129015035|NCT00633594|464349692|FG001|Overall Study|Death|1|||
129015036|NCT00633594|464349693|FG002|Overall Study|Death|2|||
129015037|NCT00633594|464349691|FG000|Overall Study|Disease Progression|0|||
129015038|NCT00633594|464349692|FG001|Overall Study|Disease Progression|0|||
129015039|NCT00633594|464349693|FG002|Overall Study|Disease Progression|1|||
129015040|NCT00365300|464349697|FG000|Open-label Phase|Adverse Event|4|||
129015041|NCT00365300|464349698|FG001|Open-label Phase|Adverse Event|0|||
129015042|NCT00365300|464349697|FG000|Open-label Phase|Failed to Return|1|||
129015043|NCT00365300|464349698|FG001|Open-label Phase|Failed to Return|0|||
129015044|NCT00365300|464349697|FG000|Open-label Phase|Physician Decision|1|||
129015045|NCT00365300|464349698|FG001|Open-label Phase|Physician Decision|0|||
129015046|NCT00365300|464349697|FG000|Open-label Phase|Noncompliance|9|||
129015047|NCT00365300|464349698|FG001|Open-label Phase|Noncompliance|0|||
129015048|NCT00365300|464349697|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
129103477|NCT05052697|464673264|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103478|NCT05052697|464673265|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103479|NCT05052697|464673266|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
128681517|NCT03569293|463133626|FG003|Overall Study|Adverse Event|1|||
128681518|NCT03569293|463133627|FG004|Overall Study|Adverse Event|0|||
128681519|NCT03569293|463133628|FG005|Overall Study|Adverse Event|0|||
128681520|NCT03569293|463133623|FG000|Overall Study|Withdrawal by Subject|16|||
128681521|NCT03569293|463133624|FG001|Overall Study|Withdrawal by Subject|2|||
128681522|NCT03569293|463133625|FG002|Overall Study|Withdrawal by Subject|4|||
128681523|NCT03569293|463133626|FG003|Overall Study|Withdrawal by Subject|1|||
128681524|NCT03569293|463133627|FG004|Overall Study|Withdrawal by Subject|0|||
128681525|NCT03569293|463133628|FG005|Overall Study|Withdrawal by Subject|0|||
128681526|NCT03569293|463133623|FG000|Overall Study|Lost to Follow-up|1|||
128681527|NCT03569293|463133624|FG001|Overall Study|Lost to Follow-up|3|||
128681528|NCT03569293|463133625|FG002|Overall Study|Lost to Follow-up|1|||
128681529|NCT03569293|463133626|FG003|Overall Study|Lost to Follow-up|1|||
129103480|NCT05052697|464673267|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103481|NCT05052697|464673268|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103482|NCT05052697|464673269|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103483|NCT05052697|464673270|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103484|NCT05052697|464673271|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103485|NCT05052697|464673272|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103486|NCT05052697|464673273|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103487|NCT05052697|464673274|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103488|NCT05052697|464673275|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103489|NCT05052697|464673276|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103490|NCT05052697|464673277|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103491|NCT05052697|464673278|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103492|NCT05052697|464673279|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103493|NCT05052697|464673280|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129103494|NCT05052697|464673247|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103495|NCT05052697|464673248|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103496|NCT05052697|464673249|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103497|NCT05052697|464673250|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103498|NCT05052697|464673251|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103499|NCT05052697|464673252|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129015049|NCT00365300|464349698|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
128681530|NCT03569293|463133627|FG004|Overall Study|Lost to Follow-up|0|||
128681531|NCT03569293|463133628|FG005|Overall Study|Lost to Follow-up|0|||
128681532|NCT03569293|463133623|FG000|Overall Study|Other|8|||
128681533|NCT03569293|463133624|FG001|Overall Study|Other|2|||
128681534|NCT03569293|463133625|FG002|Overall Study|Other|1|||
128681535|NCT03569293|463133626|FG003|Overall Study|Other|1|||
128681536|NCT03569293|463133627|FG004|Overall Study|Other|0|||
128681537|NCT03569293|463133628|FG005|Overall Study|Other|0|||
128681538|NCT03569293|463133623|FG000|Overall Study|Ongoing at Time of Analysis|8|||
128681539|NCT03569293|463133624|FG001|Overall Study|Ongoing at Time of Analysis|1|||
128681540|NCT03569293|463133625|FG002|Overall Study|Ongoing at Time of Analysis|3|||
128681541|NCT03569293|463133626|FG003|Overall Study|Ongoing at Time of Analysis|0|||
128681542|NCT03569293|463133627|FG004|Overall Study|Ongoing at Time of Analysis|0|||
128681543|NCT03569293|463133628|FG005|Overall Study|Ongoing at Time of Analysis|0|||
128681544|NCT05128929|463133630|FG000|Overall Study|Adverse Event|0|||
128681545|NCT05128929|463133631|FG001|Overall Study|Adverse Event|1|||
128681546|NCT02742246|463133632|FG000|Overall Study|Never initiated treatment|5|||
128681547|NCT02742246|463133633|FG001|Overall Study|Never initiated treatment|3|||
128681548|NCT02742246|463133634|FG002|Overall Study|Never initiated treatment|1|||
128681549|NCT02742246|463133632|FG000|Overall Study|dropped out during treatment|7|||
128681550|NCT02742246|463133633|FG001|Overall Study|dropped out during treatment|13|||
128681551|NCT02742246|463133634|FG002|Overall Study|dropped out during treatment|10|||
128681552|NCT02742246|463133632|FG000|Overall Study|Death|1|||
128681553|NCT02742246|463133633|FG001|Overall Study|Death|0|||
128681554|NCT02742246|463133634|FG002|Overall Study|Death|0|||
128681555|NCT03553836|463133636|FG000|Overall Study|Ongoing in Study|460|||
128681556|NCT03553836|463133637|FG001|Overall Study|Ongoing in Study|459|||
128681557|NCT03553836|463133636|FG000|Overall Study|Withdrawal by Subject|9|||
128681558|NCT03553836|463133637|FG001|Overall Study|Withdrawal by Subject|10|||
128681559|NCT03553836|463133636|FG000|Overall Study|Lost to Follow-up|1|||
129103500|NCT05052697|464673253|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103501|NCT05052697|464673254|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103502|NCT05052697|464673255|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103503|NCT05052697|464673256|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103504|NCT05052697|464673257|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103505|NCT05052697|464673258|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103506|NCT05052697|464673259|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103507|NCT05052697|464673260|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103508|NCT05052697|464673261|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103509|NCT05052697|464673262|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103510|NCT05052697|464673263|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103511|NCT05052697|464673264|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
129103512|NCT05052697|464673265|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103513|NCT05052697|464673266|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103514|NCT05052697|464673267|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103515|NCT05052697|464673268|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103516|NCT05052697|464673269|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103517|NCT05052697|464673270|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103518|NCT05052697|464673271|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103519|NCT05052697|464673272|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
129103520|NCT05052697|464673273|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103521|NCT05052697|464673274|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
129103522|NCT05052697|464673275|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103523|NCT05052697|464673276|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103524|NCT05052697|464673277|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103525|NCT05052697|464673278|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103526|NCT05052697|464673279|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103527|NCT05052697|464673280|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129103528|NCT05052697|464673247|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103529|NCT05052697|464673248|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103530|NCT05052697|464673249|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103531|NCT05052697|464673250|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103532|NCT05052697|464673251|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103533|NCT05052697|464673252|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
128681560|NCT03553836|463133637|FG001|Overall Study|Lost to Follow-up|3|||
128681561|NCT03553836|463133636|FG000|Overall Study|Death|17|||
128681562|NCT03553836|463133637|FG001|Overall Study|Death|17|||
128681563|NCT03220438|463133638|FG000|Overall Study|Lost to Follow-up|0|||
128681564|NCT03220438|463133639|FG001|Overall Study|Lost to Follow-up|0|||
128681565|NCT03220438|463133640|FG002|Overall Study|Lost to Follow-up|1|||
128681566|NCT03220438|463133641|FG003|Overall Study|Lost to Follow-up|0|||
128681567|NCT04062123|463133642|FG000|Overall Study|Withdrawal by Subject|0|||
128681568|NCT04062123|463133643|FG001|Overall Study|Withdrawal by Subject|1|||
128681569|NCT04062123|463133644|FG002|Overall Study|Withdrawal by Subject|0|||
128681570|NCT01850602|463133648|FG000|Overall Study|Adverse Event|7|||
128681571|NCT01850602|463133649|FG001|Overall Study|Adverse Event|10|||
128681572|NCT01850602|463133648|FG000|Overall Study|Physician Decision|2|||
128681573|NCT01850602|463133649|FG001|Overall Study|Physician Decision|1|||
128681574|NCT01850602|463133648|FG000|Overall Study|Withdrawal by Subject|2|||
128681575|NCT01850602|463133649|FG001|Overall Study|Withdrawal by Subject|4|||
128681576|NCT01850602|463133648|FG000|Overall Study|Decrease in serum calcium|2|||
128681577|NCT01850602|463133649|FG001|Overall Study|Decrease in serum calcium|3|||
128681578|NCT01850602|463133648|FG000|Overall Study|Increase in serum ferritin|1|||
128681579|NCT01850602|463133649|FG001|Overall Study|Increase in serum ferritin|0|||
128681580|NCT01857310|463133650|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
128681581|NCT01857310|463133651|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
128681582|NCT00768469|463133653|FG000|Overall Study|Adverse Event|0|||
128681583|NCT00768469|463133654|FG001|Overall Study|Adverse Event|2|||
128681584|NCT00768469|463133653|FG000|Overall Study|Disease Progression|3|||
128681585|NCT00768469|463133654|FG001|Overall Study|Disease Progression|4|||
128681586|NCT00768469|463133653|FG000|Overall Study|Withdrawal by Subject|0|||
129103534|NCT05052697|464673253|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103535|NCT05052697|464673254|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103536|NCT05052697|464673255|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103537|NCT05052697|464673256|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103538|NCT05052697|464673257|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103539|NCT05052697|464673258|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103540|NCT05052697|464673259|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103541|NCT05052697|464673260|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103542|NCT05052697|464673261|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103543|NCT05052697|464673262|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103544|NCT05052697|464673263|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103545|NCT05052697|464673264|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103546|NCT05052697|464673265|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103547|NCT05052697|464673266|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103548|NCT05052697|464673267|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103549|NCT05052697|464673268|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103550|NCT05052697|464673269|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103551|NCT05052697|464673270|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103552|NCT05052697|464673271|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103553|NCT05052697|464673272|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103554|NCT05052697|464673273|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103555|NCT05052697|464673274|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103556|NCT05052697|464673275|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
129103557|NCT05052697|464673276|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103558|NCT05052697|464673277|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
129103559|NCT05052697|464673278|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
129103560|NCT05052697|464673279|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
129103561|NCT05052697|464673280|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129103562|NCT05052697|464673247|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103563|NCT05052697|464673248|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103564|NCT05052697|464673249|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103565|NCT05052697|464673250|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103566|NCT05052697|464673251|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103567|NCT05052697|464673252|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103568|NCT05052697|464673253|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103569|NCT05052697|464673254|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103570|NCT05052697|464673255|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103571|NCT05052697|464673256|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103572|NCT05052697|464673257|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103573|NCT05052697|464673258|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103574|NCT05052697|464673259|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103575|NCT05052697|464673260|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103576|NCT05052697|464673261|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
128681587|NCT00768469|463133654|FG001|Overall Study|Withdrawal by Subject|1|||
129103577|NCT05052697|464673262|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103578|NCT05052697|464673263|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103579|NCT05052697|464673264|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103580|NCT05052697|464673265|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103581|NCT05052697|464673266|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103582|NCT05052697|464673267|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103583|NCT05052697|464673268|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
128681588|NCT02953509|463133657|FG000|Overall Study|Death|1|||
128681589|NCT02953509|463133658|FG001|Overall Study|Death|3|||
129015050|NCT00365300|464349697|FG000|Open-label Phase|Protocol Violation|1|||
129015051|NCT00365300|464349698|FG001|Open-label Phase|Protocol Violation|0|||
129015052|NCT00365300|464349697|FG000|Open-label Phase|Lack of Efficacy|1|||
129015053|NCT00365300|464349698|FG001|Open-label Phase|Lack of Efficacy|0|||
129015054|NCT00365300|464349697|FG000|Open-label Phase|Patient skipped open label phase|1|||
129015055|NCT00365300|464349698|FG001|Open-label Phase|Patient skipped open label phase|0|||
129015056|NCT00365300|464349697|FG000|Double-blind Phase|Failed to return|1|||
129015057|NCT00365300|464349698|FG001|Double-blind Phase|Failed to return|0|||
129015058|NCT00365300|464349697|FG000|Double-blind Phase|Noncompliance|1|||
129015059|NCT00365300|464349698|FG001|Double-blind Phase|Noncompliance|1|||
129015060|NCT00365300|464349697|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129015061|NCT00365300|464349698|FG001|Double-blind Phase|Withdrawal by Subject|1|||
129015062|NCT00365300|464349697|FG000|Double-blind Phase|Protocol Violation|3|||
129015063|NCT00365300|464349698|FG001|Double-blind Phase|Protocol Violation|1|||
129015064|NCT00365300|464349697|FG000|Double-blind Phase|Lack of Efficacy|6|||
129015065|NCT00365300|464349698|FG001|Double-blind Phase|Lack of Efficacy|6|||
129015066|NCT01179048|464349699|FG000|Overall Study|Withdrawn - does not allow contact|4|||
129015067|NCT01179048|464349700|FG001|Overall Study|Withdrawn - does not allow contact|8|||
129015068|NCT01179048|464349699|FG000|Overall Study|Lost to Follow-up|8|||
129015069|NCT01179048|464349700|FG001|Overall Study|Lost to Follow-up|9|||
129015070|NCT01179048|464349699|FG000|Overall Study|Alive|127|||
129015071|NCT01179048|464349700|FG001|Overall Study|Alive|142|||
129015072|NCT01520909|464349708|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
129015073|NCT01520909|464349709|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
129015074|NCT01520909|464349710|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
129015075|NCT01520909|464349708|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
129103584|NCT05052697|464673269|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103585|NCT05052697|464673270|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103586|NCT05052697|464673271|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103587|NCT05052697|464673272|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103588|NCT05052697|464673273|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103589|NCT05052697|464673274|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103590|NCT05052697|464673275|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
129103591|NCT05052697|464673276|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
129103592|NCT05052697|464673277|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
129103593|NCT05052697|464673278|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
129103594|NCT05052697|464673279|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
129103595|NCT05052697|464673280|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129103596|NCT05052697|464673247|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103597|NCT05052697|464673248|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103598|NCT05052697|464673249|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103599|NCT05052697|464673250|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103600|NCT05052697|464673251|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103601|NCT05052697|464673252|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103602|NCT05052697|464673253|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
128681590|NCT02953509|463133659|FG002|Overall Study|Death|3|||
128681591|NCT02953509|463133660|FG003|Overall Study|Death|4|||
128681592|NCT02953509|463133661|FG004|Overall Study|Death|12|||
129103603|NCT05052697|464673254|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103604|NCT05052697|464673255|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103605|NCT05052697|464673256|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103606|NCT05052697|464673257|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103607|NCT05052697|464673258|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103608|NCT05052697|464673259|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103609|NCT05052697|464673260|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103610|NCT05052697|464673261|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103611|NCT05052697|464673262|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103612|NCT05052697|464673263|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103613|NCT05052697|464673264|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103614|NCT05052697|464673265|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103615|NCT05052697|464673266|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103616|NCT05052697|464673267|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103617|NCT05052697|464673268|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103618|NCT05052697|464673269|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103619|NCT05052697|464673270|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103620|NCT05052697|464673271|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103621|NCT05052697|464673272|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103622|NCT05052697|464673273|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103623|NCT05052697|464673274|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129015076|NCT01520909|464349709|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
128681593|NCT02953509|463133662|FG005|Overall Study|Death|3|||
129015077|NCT01520909|464349710|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
129015078|NCT01520909|464349708|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
129015079|NCT01520909|464349709|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
129015080|NCT01520909|464349710|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
129015081|NCT01520909|464349708|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
129015082|NCT01520909|464349709|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
129015083|NCT01520909|464349710|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
129015084|NCT01038856|464349716|FG000|Overall Study|Adverse Event|2|||
129015085|NCT03136380|464349720|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129015086|NCT03136380|464349721|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
129015087|NCT03136380|464349722|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129015088|NCT03136380|464349723|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129103624|NCT05052697|464673275|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129015089|NCT03136380|464349724|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129015090|NCT00553280|464349730|FG000|Overall Study|Adverse Event|19|||
129015091|NCT00553280|464349730|FG000|Overall Study|Lack of Efficacy|3|||
129015092|NCT00553280|464349730|FG000|Overall Study|Withdrawal by Subject|3|||
129015093|NCT00553280|464349730|FG000|Overall Study|Physician Decision|1|||
129015094|NCT01544127|464349731|FG000|Overall Study|Lost to Follow-up|4|||
129015095|NCT01544127|464349732|FG001|Overall Study|Lost to Follow-up|2|||
129015096|NCT01544127|464349733|FG002|Overall Study|Lost to Follow-up|9|||
129015097|NCT01544127|464349731|FG000|Overall Study|Withdrawal by Subject|2|||
129015098|NCT01544127|464349732|FG001|Overall Study|Withdrawal by Subject|2|||
129015099|NCT01544127|464349733|FG002|Overall Study|Withdrawal by Subject|1|||
129015100|NCT01544127|464349731|FG000|Overall Study|Discharged out of catchment area|1|||
129015101|NCT01544127|464349732|FG001|Overall Study|Discharged out of catchment area|1|||
129015102|NCT01544127|464349733|FG002|Overall Study|Discharged out of catchment area|1|||
129015103|NCT01544127|464349731|FG000|Overall Study|Death|1|||
129015104|NCT01544127|464349732|FG001|Overall Study|Death|0|||
129015105|NCT01544127|464349733|FG002|Overall Study|Death|0|||
129015106|NCT01544127|464349731|FG000|Overall Study|Jail or Prison|1|||
129015107|NCT01544127|464349732|FG001|Overall Study|Jail or Prison|1|||
129015108|NCT01544127|464349733|FG002|Overall Study|Jail or Prison|2|||
129015109|NCT01544127|464349731|FG000|Overall Study|Became Psychotic|1|||
129015110|NCT01544127|464349732|FG001|Overall Study|Became Psychotic|0|||
129015111|NCT01544127|464349733|FG002|Overall Study|Became Psychotic|0|||
129015112|NCT01544127|464349731|FG000|Overall Study|Researcher withdrew|1|||
129015113|NCT01544127|464349732|FG001|Overall Study|Researcher withdrew|0|||
129015114|NCT01544127|464349733|FG002|Overall Study|Researcher withdrew|0|||
129015115|NCT01544127|464349731|FG000|Overall Study|Went active duty|0|||
129015116|NCT01544127|464349732|FG001|Overall Study|Went active duty|0|||
129015117|NCT01544127|464349733|FG002|Overall Study|Went active duty|1|||
129015118|NCT00533273|464349734|FG000|Double-blind|Withdrew consent|0|||
129015119|NCT00533273|464349735|FG001|Double-blind|Withdrew consent|2|||
129015120|NCT00533273|464349734|FG000|Open-label|Withdrawal by Subject|6|||
129015121|NCT00533273|464349735|FG001|Open-label|Withdrawal by Subject|0|||
129015122|NCT02794974|464349736|FG000|Overall Study|Physician Decision|0|||
129015123|NCT02794974|464349737|FG001|Overall Study|Physician Decision|1|||
129015124|NCT01873586|464349741|FG000|Overall Study|Lost to Follow-up|3|||
129015125|NCT02202850|464349742|FG000|Overall Study|Other|2|||
129015126|NCT02202850|464349743|FG001|Overall Study|Other|2|||
129015127|NCT02202850|464349742|FG000|Overall Study|Enbrel treatment discontinued|15|||
129015128|NCT02202850|464349743|FG001|Overall Study|Enbrel treatment discontinued|3|||
129015129|NCT02202850|464349742|FG000|Overall Study|Lost to Follow-up|7|||
129015130|NCT02202850|464349743|FG001|Overall Study|Lost to Follow-up|1|||
129015131|NCT02914600|464349744|FG000|Overall Study|Adverse Event|298|||
129015132|NCT02914600|464349745|FG001|Overall Study|Adverse Event|35|||
129015133|NCT02914600|464349746|FG002|Overall Study|Adverse Event|25|||
129015134|NCT02914600|464349744|FG000|Overall Study|Sponsors decision|287|||
129015135|NCT02914600|464349745|FG001|Overall Study|Sponsors decision|41|||
129015136|NCT02914600|464349746|FG002|Overall Study|Sponsors decision|12|||
129015137|NCT02914600|464349744|FG000|Overall Study|Withdrawal by Subject|158|||
129015138|NCT02914600|464349745|FG001|Overall Study|Withdrawal by Subject|20|||
129015139|NCT02914600|464349746|FG002|Overall Study|Withdrawal by Subject|18|||
129015140|NCT02914600|464349744|FG000|Overall Study|Investigators discretion|169|||
129015141|NCT02914600|464349745|FG001|Overall Study|Investigators discretion|14|||
129015142|NCT02914600|464349746|FG002|Overall Study|Investigators discretion|13|||
129015143|NCT02914600|464349744|FG000|Overall Study|Lost to Follow-up|10|||
129015144|NCT02914600|464349745|FG001|Overall Study|Lost to Follow-up|4|||
129015145|NCT02914600|464349746|FG002|Overall Study|Lost to Follow-up|0|||
129015146|NCT02914600|464349744|FG000|Overall Study|Pregnancy|8|||
129015147|NCT02914600|464349745|FG001|Overall Study|Pregnancy|0|||
129015148|NCT02914600|464349746|FG002|Overall Study|Pregnancy|0|||
129015149|NCT02914600|464349744|FG000|Overall Study|Protocol Violation|5|||
129015150|NCT02914600|464349745|FG001|Overall Study|Protocol Violation|3|||
129015151|NCT02914600|464349746|FG002|Overall Study|Protocol Violation|0|||
129103625|NCT05052697|464673276|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103626|NCT05052697|464673277|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103627|NCT05052697|464673278|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103628|NCT05052697|464673279|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
129103629|NCT05052697|464673280|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129103630|NCT05052697|464673247|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103631|NCT05052697|464673248|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103632|NCT05052697|464673249|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103633|NCT05052697|464673250|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103634|NCT05052697|464673251|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103635|NCT05052697|464673252|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103636|NCT05052697|464673253|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103637|NCT05052697|464673254|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103638|NCT05052697|464673255|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103639|NCT05052697|464673256|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103640|NCT05052697|464673257|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103641|NCT05052697|464673258|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103642|NCT05052697|464673259|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103643|NCT05052697|464673260|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103644|NCT05052697|464673261|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103645|NCT05052697|464673262|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103646|NCT05052697|464673263|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103647|NCT05052697|464673264|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103648|NCT05052697|464673265|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103649|NCT05052697|464673266|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103650|NCT05052697|464673267|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103651|NCT05052697|464673268|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103652|NCT05052697|464673269|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103653|NCT05052697|464673270|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103654|NCT05052697|464673271|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103655|NCT05052697|464673272|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103656|NCT05052697|464673273|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103657|NCT05052697|464673274|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103658|NCT05052697|464673275|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
129103659|NCT05052697|464673276|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
129103660|NCT05052697|464673277|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
129103661|NCT05052697|464673278|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103662|NCT05052697|464673279|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103663|NCT05052697|464673280|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129103664|NCT01289574|464673281|FG000|Overall Study|Lack of Efficacy|4|||
129103665|NCT01289574|464673282|FG001|Overall Study|Lack of Efficacy|0|||
129103666|NCT01289574|464673283|FG002|Overall Study|Lack of Efficacy|1|||
129103667|NCT01289574|464673281|FG000|Overall Study|Lost to Follow-up|2|||
129103668|NCT01289574|464673282|FG001|Overall Study|Lost to Follow-up|0|||
129103669|NCT01289574|464673283|FG002|Overall Study|Lost to Follow-up|1|||
129103670|NCT01289574|464673281|FG000|Overall Study|Withdrawal by Subject|1|||
129103671|NCT01289574|464673282|FG001|Overall Study|Withdrawal by Subject|1|||
129103672|NCT01289574|464673283|FG002|Overall Study|Withdrawal by Subject|1|||
129103673|NCT01289574|464673281|FG000|Overall Study|Adverse Event|0|||
129103674|NCT01289574|464673282|FG001|Overall Study|Adverse Event|1|||
129103675|NCT01289574|464673283|FG002|Overall Study|Adverse Event|0|||
129103676|NCT01289574|464673281|FG000|Overall Study|Subject wanted alternate treatment|0|||
129103677|NCT01289574|464673282|FG001|Overall Study|Subject wanted alternate treatment|1|||
129103678|NCT01289574|464673283|FG002|Overall Study|Subject wanted alternate treatment|0|||
129103679|NCT00262002|464673284|FG000|Overall Study|Adverse Event|2|||
129103680|NCT00262002|464673285|FG001|Overall Study|Adverse Event|1|||
129103681|NCT00262002|464673286|FG002|Overall Study|Adverse Event|0|||
129103682|NCT00262002|464673287|FG003|Overall Study|Adverse Event|0|||
129103683|NCT00262002|464673288|FG004|Overall Study|Adverse Event|0|||
129103684|NCT00262002|464673289|FG005|Overall Study|Adverse Event|1|||
129103685|NCT00262002|464673290|FG006|Overall Study|Adverse Event|0|||
129103686|NCT00262002|464673284|FG000|Overall Study|Withdrawal by Subject|4|||
129103687|NCT00262002|464673285|FG001|Overall Study|Withdrawal by Subject|2|||
129103688|NCT00262002|464673286|FG002|Overall Study|Withdrawal by Subject|0|||
129103689|NCT00262002|464673287|FG003|Overall Study|Withdrawal by Subject|1|||
129103690|NCT00262002|464673288|FG004|Overall Study|Withdrawal by Subject|2|||
129103691|NCT00262002|464673289|FG005|Overall Study|Withdrawal by Subject|2|||
128681594|NCT02953509|463133663|FG006|Overall Study|Death|25|||
128681595|NCT02953509|463133664|FG007|Overall Study|Death|10|||
129103692|NCT00262002|464673290|FG006|Overall Study|Withdrawal by Subject|2|||
129103693|NCT00262002|464673284|FG000|Overall Study|Lost to Follow-up|2|||
128681596|NCT02953509|463133665|FG008|Overall Study|Death|21|||
128681597|NCT02953509|463133666|FG009|Overall Study|Death|20|||
129015152|NCT02914600|464349744|FG000|Overall Study|Non-compliance with study drug|6|||
129015153|NCT02914600|464349745|FG001|Overall Study|Non-compliance with study drug|1|||
129015154|NCT02914600|464349746|FG002|Overall Study|Non-compliance with study drug|0|||
129015155|NCT02914600|464349744|FG000|Overall Study|Death|3|||
129015156|NCT02914600|464349745|FG001|Overall Study|Death|1|||
129015157|NCT02914600|464349746|FG002|Overall Study|Death|1|||
129015158|NCT02914600|464349744|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
129015159|NCT02914600|464349745|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
129015160|NCT02914600|464349746|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
129015161|NCT02914600|464349744|FG000|Overall Study|Enrolled but not treated|1|||
129015162|NCT02914600|464349745|FG001|Overall Study|Enrolled but not treated|0|||
129015163|NCT02914600|464349746|FG002|Overall Study|Enrolled but not treated|0|||
129015164|NCT00454909|464349747|FG000|Overall Study|Withdrawal by Subject|1|||
129015165|NCT00454909|464349748|FG001|Overall Study|Withdrawal by Subject|0|||
129015166|NCT00454909|464349749|FG002|Overall Study|Withdrawal by Subject|0|||
129015167|NCT00454909|464349747|FG000|Overall Study|Migrated/moved from study area|0|||
129015168|NCT00454909|464349748|FG001|Overall Study|Migrated/moved from study area|0|||
129015169|NCT00454909|464349749|FG002|Overall Study|Migrated/moved from study area|1|||
129015170|NCT00454909|464349747|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
129015171|NCT00454909|464349748|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
129015172|NCT00454909|464349749|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
129015173|NCT00454909|464349747|FG000|Overall Study|Others|1|||
129015174|NCT00454909|464349748|FG001|Overall Study|Others|0|||
129015175|NCT00454909|464349749|FG002|Overall Study|Others|0|||
129015176|NCT02996682|464349750|FG000|Overall Study|Death|0|||
129015177|NCT02996682|464349751|FG001|Overall Study|Death|3|||
129015178|NCT02457520|464349752|FG000|Active Treatment Phase|Adverse Event|10|||
129015179|NCT02457520|464349752|FG000|Active Treatment Phase|Lost to Follow-up|8|||
129015180|NCT02457520|464349752|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
129015181|NCT02457520|464349752|FG000|Active Treatment Phase|other|4|||
129015182|NCT02457520|464349752|FG000|Active Treatment Phase|Physician Decision|1|||
129015183|NCT02457520|464349752|FG000|Active Treatment Phase|Protocol Violation|1|||
129015184|NCT02457520|464349752|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
129015185|NCT02457520|464349752|FG000|Post-treatment Period|Other: Retreatment Required|7|||
129015186|NCT02457520|464349752|FG000|Post-treatment Period|Lost to Follow-up|23|||
129015187|NCT02457520|464349752|FG000|Post-treatment Period|Other|3|||
129015188|NCT02457520|464349752|FG000|Post-treatment Period|Physician Decision|1|||
129015189|NCT02457520|464349752|FG000|Post-treatment Period|Withdrawal by Subject|14|||
129015190|NCT00282048|464349753|FG000|Overall Study|Lack of Efficacy|30|||
129015191|NCT00282048|464349753|FG000|Overall Study|Adverse Event|22|||
129015192|NCT00282048|464349753|FG000|Overall Study|Withdrawal by Subject|1|||
129015193|NCT00282048|464349753|FG000|Overall Study|Other|8|||
129015194|NCT00282048|464349753|FG000|Overall Study|Ongoing|1|||
129015195|NCT03522675|464349754|FG000|Overall Study|Screen fail|1|||
129015196|NCT03522675|464349754|FG000|Overall Study|Non-reactive to histamine|1|||
129015197|NCT00696020|464349757|FG000|Overall Study|Adverse Event|3|||
129015198|NCT00696020|464349758|FG001|Overall Study|Adverse Event|1|||
129015199|NCT00696020|464349759|FG002|Overall Study|Adverse Event|2|||
129015200|NCT00696020|464349760|FG003|Overall Study|Adverse Event|1|||
129015201|NCT00696020|464349757|FG000|Overall Study|Lack of Efficacy|1|||
129015202|NCT00696020|464349758|FG001|Overall Study|Lack of Efficacy|0|||
129015203|NCT00696020|464349759|FG002|Overall Study|Lack of Efficacy|0|||
129015204|NCT00696020|464349760|FG003|Overall Study|Lack of Efficacy|0|||
129015205|NCT00696020|464349757|FG000|Overall Study|Protocol Violation|0|||
129015206|NCT00696020|464349758|FG001|Overall Study|Protocol Violation|0|||
129015207|NCT00696020|464349759|FG002|Overall Study|Protocol Violation|0|||
129015208|NCT00696020|464349760|FG003|Overall Study|Protocol Violation|1|||
129015209|NCT00696020|464349757|FG000|Overall Study|Withdrawal by Subject|0|||
129015210|NCT00696020|464349758|FG001|Overall Study|Withdrawal by Subject|1|||
129015211|NCT00696020|464349759|FG002|Overall Study|Withdrawal by Subject|0|||
129015212|NCT00696020|464349760|FG003|Overall Study|Withdrawal by Subject|1|||
129015213|NCT00696020|464349757|FG000|Overall Study|Other not stated above|0|||
129015214|NCT00696020|464349758|FG001|Overall Study|Other not stated above|0|||
129015215|NCT00696020|464349759|FG002|Overall Study|Other not stated above|1|||
129015216|NCT00696020|464349760|FG003|Overall Study|Other not stated above|1|||
129015217|NCT01387022|464349761|FG000|Overall Study|Death|1|||
129015218|NCT01387022|464349762|FG001|Overall Study|Death|1|||
129015219|NCT01387022|464349761|FG000|Overall Study|Lost to Follow-up|0|||
129015220|NCT01387022|464349762|FG001|Overall Study|Lost to Follow-up|3|||
129103694|NCT00262002|464673285|FG001|Overall Study|Lost to Follow-up|0|||
129015221|NCT02076022|464349763|FG000|Overall Study|Withdrawal by Subject|2|||
129015222|NCT02076022|464349764|FG001|Overall Study|Withdrawal by Subject|0|||
129015223|NCT00312663|464349767|FG000|Immunization Phase|Adverse Event|0|||
129015224|NCT00312663|464349768|FG001|Immunization Phase|Adverse Event|1|||
129015225|NCT00312663|464349769|FG002|Immunization Phase|Adverse Event|0|||
129015226|NCT00301366|464349772|FG000|Overall Study|Adverse Event|1|||
129103695|NCT00262002|464673286|FG002|Overall Study|Lost to Follow-up|0|||
129103696|NCT00262002|464673287|FG003|Overall Study|Lost to Follow-up|2|||
129103697|NCT00262002|464673288|FG004|Overall Study|Lost to Follow-up|0|||
129103698|NCT00262002|464673289|FG005|Overall Study|Lost to Follow-up|1|||
129103699|NCT00262002|464673290|FG006|Overall Study|Lost to Follow-up|0|||
129103700|NCT00262002|464673284|FG000|Overall Study|Inapropriate enrollment|0|||
129103701|NCT00262002|464673285|FG001|Overall Study|Inapropriate enrollment|1|||
128681598|NCT02953509|463133657|FG000|Overall Study|Reason Not Specified|0|||
128681599|NCT02953509|463133658|FG001|Overall Study|Reason Not Specified|2|||
128681600|NCT02953509|463133659|FG002|Overall Study|Reason Not Specified|8|||
128681601|NCT02953509|463133660|FG003|Overall Study|Reason Not Specified|2|||
129103702|NCT00262002|464673286|FG002|Overall Study|Inapropriate enrollment|0|||
129103703|NCT00262002|464673287|FG003|Overall Study|Inapropriate enrollment|0|||
129103704|NCT00262002|464673288|FG004|Overall Study|Inapropriate enrollment|0|||
129103705|NCT00262002|464673289|FG005|Overall Study|Inapropriate enrollment|0|||
129103706|NCT00262002|464673290|FG006|Overall Study|Inapropriate enrollment|0|||
129103707|NCT00262002|464673284|FG000|Overall Study|Protocol Violation|3|||
129103708|NCT00262002|464673285|FG001|Overall Study|Protocol Violation|2|||
129103709|NCT00262002|464673286|FG002|Overall Study|Protocol Violation|0|||
129103710|NCT00262002|464673287|FG003|Overall Study|Protocol Violation|2|||
129103711|NCT00262002|464673288|FG004|Overall Study|Protocol Violation|5|||
129103712|NCT00262002|464673289|FG005|Overall Study|Protocol Violation|3|||
129103713|NCT00262002|464673290|FG006|Overall Study|Protocol Violation|2|||
129103714|NCT00262002|464673284|FG000|Overall Study|Unable to classify|0|||
129103715|NCT00262002|464673285|FG001|Overall Study|Unable to classify|0|||
129103716|NCT00262002|464673286|FG002|Overall Study|Unable to classify|0|||
129103717|NCT00262002|464673287|FG003|Overall Study|Unable to classify|0|||
129103718|NCT00262002|464673288|FG004|Overall Study|Unable to classify|0|||
129103719|NCT00262002|464673289|FG005|Overall Study|Unable to classify|0|||
129103720|NCT00262002|464673290|FG006|Overall Study|Unable to classify|2|||
129103721|NCT01790516|464673291|FG000|Overall Study|Physician Decision|1|||
129103722|NCT01790516|464673292|FG001|Overall Study|Physician Decision|0|||
129103723|NCT01554163|464673293|FG000|Overall Study|Adverse Event|3|||
129103724|NCT01554163|464673294|FG001|Overall Study|Adverse Event|0|||
129103725|NCT01554163|464673293|FG000|Overall Study|Lack of Efficacy|1|||
129103726|NCT01554163|464673294|FG001|Overall Study|Lack of Efficacy|0|||
129103727|NCT01554163|464673293|FG000|Overall Study|Lost to Follow-up|1|||
129103728|NCT01554163|464673294|FG001|Overall Study|Lost to Follow-up|0|||
129103729|NCT01554163|464673293|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129103730|NCT01554163|464673294|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129103731|NCT01554163|464673293|FG000|Overall Study|Protocol Violation|0|||
129103732|NCT01554163|464673294|FG001|Overall Study|Protocol Violation|4|||
129103733|NCT01554163|464673293|FG000|Overall Study|Withdrawal by Subject|1|||
129103734|NCT01554163|464673294|FG001|Overall Study|Withdrawal by Subject|5|||
129103735|NCT01554163|464673293|FG000|Overall Study|Not Treated|1|||
129103736|NCT01554163|464673294|FG001|Overall Study|Not Treated|0|||
129103737|NCT02226120|464673295|FG000|Overall Study|Adverse Event|60|||
129103738|NCT02226120|464673295|FG000|Overall Study|Death|172|||
129103739|NCT02226120|464673295|FG000|Overall Study|Study terminated by sponsor|1|||
129103740|NCT02226120|464673295|FG000|Overall Study|Technical problems|4|||
129103741|NCT02226120|464673295|FG000|Overall Study|Lost to Follow-up|13|||
129103742|NCT02226120|464673295|FG000|Overall Study|Physician Decision|21|||
129103743|NCT02226120|464673295|FG000|Overall Study|Withdrawal by parent/guardian|36|||
129103744|NCT02226120|464673295|FG000|Overall Study|Non-compliance with study drug|10|||
129103745|NCT02226120|464673295|FG000|Overall Study|Protocol deviation|1|||
129103746|NCT02226120|464673295|FG000|Overall Study|missing treatment disposition pages|2|||
129103747|NCT02526160|464674981|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
129103748|NCT02526160|464674982|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
129103749|NCT02526160|464674981|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
129103750|NCT02526160|464674982|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
129103751|NCT02526160|464674981|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
129103752|NCT02526160|464674982|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
129103753|NCT02526160|464674981|FG000|Open-Label Treatment Extension Period I|Death|0|||
129103754|NCT02526160|464674982|FG001|Open-Label Treatment Extension Period I|Death|1|||
129103755|NCT02526160|464674981|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
129103756|NCT02526160|464674982|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
129103757|NCT02526160|464674981|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
129103758|NCT02526160|464674982|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
129103759|NCT02526160|464674981|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
129103760|NCT02526160|464674982|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
129103761|NCT02526160|464674981|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
129103762|NCT02526160|464674982|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
129103763|NCT01048944|464674985|FG000|Overall Study|Protocol Violation|8|||
129103764|NCT01048944|464674986|FG001|Overall Study|Protocol Violation|10|||
129103765|NCT01048944|464674987|FG002|Overall Study|Protocol Violation|10|||
128681602|NCT02953509|463133661|FG004|Overall Study|Reason Not Specified|11|||
128681603|NCT02953509|463133662|FG005|Overall Study|Reason Not Specified|4|||
128681604|NCT02953509|463133663|FG006|Overall Study|Reason Not Specified|12|||
128681605|NCT02953509|463133664|FG007|Overall Study|Reason Not Specified|2|||
128681606|NCT02953509|463133665|FG008|Overall Study|Reason Not Specified|7|||
128681607|NCT02953509|463133666|FG009|Overall Study|Reason Not Specified|2|||
129103766|NCT01048944|464674988|FG003|Overall Study|Protocol Violation|2|||
129103767|NCT01844817|464674989|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
129103768|NCT01844817|464674990|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
129103769|NCT01844817|464674989|FG000|Treatment|Progressive Disease|27|||
128681608|NCT02953509|463133657|FG000|Overall Study|Consent Withdrawn|1|||
128681609|NCT02953509|463133658|FG001|Overall Study|Consent Withdrawn|1|||
128681610|NCT02953509|463133659|FG002|Overall Study|Consent Withdrawn|2|||
128681611|NCT02953509|463133660|FG003|Overall Study|Consent Withdrawn|1|||
128681612|NCT02953509|463133661|FG004|Overall Study|Consent Withdrawn|3|||
129103770|NCT01844817|464674990|FG001|Treatment|Progressive Disease|36|||
128681613|NCT02953509|463133662|FG005|Overall Study|Consent Withdrawn|0|||
128681614|NCT02953509|463133663|FG006|Overall Study|Consent Withdrawn|4|||
128681615|NCT02953509|463133664|FG007|Overall Study|Consent Withdrawn|1|||
128681616|NCT02953509|463133665|FG008|Overall Study|Consent Withdrawn|1|||
128681617|NCT02953509|463133666|FG009|Overall Study|Consent Withdrawn|4|||
128681618|NCT02953509|463133657|FG000|Overall Study|Lost to Follow-up|0|||
128681619|NCT02953509|463133658|FG001|Overall Study|Lost to Follow-up|0|||
128681620|NCT02953509|463133659|FG002|Overall Study|Lost to Follow-up|0|||
128681621|NCT02953509|463133660|FG003|Overall Study|Lost to Follow-up|0|||
128681622|NCT02953509|463133661|FG004|Overall Study|Lost to Follow-up|0|||
128681623|NCT02953509|463133662|FG005|Overall Study|Lost to Follow-up|0|||
128681624|NCT02953509|463133663|FG006|Overall Study|Lost to Follow-up|1|||
128681625|NCT02953509|463133664|FG007|Overall Study|Lost to Follow-up|1|||
128681626|NCT02953509|463133665|FG008|Overall Study|Lost to Follow-up|1|||
128681627|NCT02953509|463133666|FG009|Overall Study|Lost to Follow-up|1|||
128681628|NCT02953509|463133657|FG000|Overall Study|Study terminated by sponsor|1|||
128681629|NCT02953509|463133658|FG001|Overall Study|Study terminated by sponsor|0|||
128681630|NCT02953509|463133659|FG002|Overall Study|Study terminated by sponsor|0|||
128681631|NCT02953509|463133660|FG003|Overall Study|Study terminated by sponsor|0|||
128681632|NCT02953509|463133661|FG004|Overall Study|Study terminated by sponsor|0|||
129103771|NCT01844817|464674989|FG000|Treatment|Adverse Event|17|||
129103772|NCT01844817|464674990|FG001|Treatment|Adverse Event|9|||
129103773|NCT01844817|464674989|FG000|Treatment|Withdrawal by Subject|10|||
129103774|NCT01844817|464674990|FG001|Treatment|Withdrawal by Subject|6|||
129103775|NCT01844817|464674989|FG000|Treatment|Death|10|||
129103776|NCT01844817|464674990|FG001|Treatment|Death|8|||
129103777|NCT01844817|464674989|FG000|Treatment|Lost to Follow-up|0|||
129103778|NCT01844817|464674990|FG001|Treatment|Lost to Follow-up|1|||
129103779|NCT01844817|464674989|FG000|Treatment|Other|0|||
129103780|NCT01844817|464674990|FG001|Treatment|Other|3|||
129103781|NCT01133704|464674991|FG000|Overall Study|Death|44|||
129103782|NCT01133704|464674992|FG001|Overall Study|Death|26|||
128681633|NCT02953509|463133662|FG005|Overall Study|Study terminated by sponsor|0|||
128681634|NCT02953509|463133663|FG006|Overall Study|Study terminated by sponsor|1|||
128681635|NCT02953509|463133664|FG007|Overall Study|Study terminated by sponsor|0|||
128681636|NCT02953509|463133665|FG008|Overall Study|Study terminated by sponsor|1|||
128681637|NCT02953509|463133666|FG009|Overall Study|Study terminated by sponsor|1|||
128681638|NCT00484185|463133667|FG000|Overall Study|Lost to Follow-up|44|||
128681639|NCT00484185|463133667|FG000|Overall Study|Other|20|||
129103783|NCT01133704|464674991|FG000|Overall Study|Patient refused to continue|4|||
129103784|NCT01133704|464674992|FG001|Overall Study|Patient refused to continue|0|||
129103785|NCT01133704|464674991|FG000|Overall Study|Study Closure|1|||
129103786|NCT01133704|464674992|FG001|Overall Study|Study Closure|0|||
129103787|NCT03396822|464674995|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
129103788|NCT03396822|464674995|FG000|Overall Study|Physician Decision|1|||
128681640|NCT00484185|463133667|FG000|Overall Study|Randomized but not treated|5|||
128681641|NCT00484185|463133667|FG000|Overall Study|Death|2|||
128681642|NCT00459056|463133668|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
128681643|NCT00459056|463133669|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
128681644|NCT00645788|463133670|FG000|Overall Study|Did not receive study drug|1|||
128681645|NCT00645788|463133671|FG001|Overall Study|Did not receive study drug|1|||
128681646|NCT00645788|463133672|FG002|Overall Study|Did not receive study drug|0|||
128681647|NCT00645788|463133673|FG003|Overall Study|Did not receive study drug|0|||
128681648|NCT00645788|463133670|FG000|Overall Study|Adverse Event|4|||
128681649|NCT00645788|463133671|FG001|Overall Study|Adverse Event|9|||
128681650|NCT00645788|463133672|FG002|Overall Study|Adverse Event|5|||
128681651|NCT00645788|463133673|FG003|Overall Study|Adverse Event|3|||
128681652|NCT00645788|463133670|FG000|Overall Study|Lost to Follow-up|1|||
128681653|NCT00645788|463133671|FG001|Overall Study|Lost to Follow-up|0|||
129103789|NCT04985942|464674996|FG000|Overall Study|Adverse Event|14|||
129103790|NCT04985942|464674997|FG001|Overall Study|Adverse Event|2|||
129103791|NCT04985942|464674996|FG000|Overall Study|Lack of Efficacy|0|||
129103792|NCT04985942|464674997|FG001|Overall Study|Lack of Efficacy|3|||
129015227|NCT04213326|464349773|FG000|Overall Study|Consent withdrawn|51|||
129015228|NCT04213326|464349774|FG001|Overall Study|Consent withdrawn|241|||
129015229|NCT04213326|464349773|FG000|Overall Study|Lost to Follow-up|50|||
129015230|NCT04213326|464349774|FG001|Overall Study|Lost to Follow-up|902|||
129015231|NCT04213326|464349773|FG000|Overall Study|Protocol Violation|3|||
129015232|NCT04213326|464349774|FG001|Overall Study|Protocol Violation|25|||
129015233|NCT04213326|464349773|FG000|Overall Study|Participant eligibility changed|106|||
129015234|NCT04213326|464349774|FG001|Overall Study|Participant eligibility changed|19|||
129015235|NCT04213326|464349773|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
129015236|NCT04213326|464349774|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
129015237|NCT04213326|464349773|FG000|Overall Study|Incomplete study visit|0|||
129015238|NCT04213326|464349774|FG001|Overall Study|Incomplete study visit|367|||
129015239|NCT02549092|464349777|FG000|Treatment Period|Adverse Event|2|||
129015240|NCT02549092|464349778|FG001|Treatment Period|Adverse Event|2|||
129015241|NCT02549092|464349777|FG000|Treatment Period|Withdrawal by Subject|1|||
129015242|NCT02549092|464349778|FG001|Treatment Period|Withdrawal by Subject|3|||
129015243|NCT02549092|464349777|FG000|Treatment Period|Lack of Efficacy|0|||
129015244|NCT02549092|464349778|FG001|Treatment Period|Lack of Efficacy|2|||
129015245|NCT02549092|464349777|FG000|Extension/Transition Period|Adverse Event|1|||
129015246|NCT02549092|464349778|FG001|Extension/Transition Period|Adverse Event|1|||
129015247|NCT02549092|464349777|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
129015248|NCT02549092|464349778|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
129015249|NCT02549092|464349777|FG000|Extension/Transition Period|Other, Not Specified|4|||
129015250|NCT02549092|464349778|FG001|Extension/Transition Period|Other, Not Specified|2|||
129015251|NCT02511782|464349779|FG000|Overall Study|Withdrawal by Subject|1|||
129015252|NCT02511782|464349780|FG001|Overall Study|Withdrawal by Subject|0|||
129015253|NCT02511782|464349781|FG002|Overall Study|Withdrawal by Subject|0|||
129015254|NCT01214850|464349784|FG000|Overall Study|Withdrawal by Subject|38|||
129015255|NCT01214850|464349785|FG001|Overall Study|Withdrawal by Subject|31|||
129015256|NCT01214850|464349786|FG002|Overall Study|Withdrawal by Subject|28|||
129015257|NCT01214850|464349784|FG000|Overall Study|Lost to Follow-up|124|||
129015258|NCT01214850|464349785|FG001|Overall Study|Lost to Follow-up|98|||
129015259|NCT01214850|464349786|FG002|Overall Study|Lost to Follow-up|123|||
129015260|NCT01214850|464349784|FG000|Overall Study|Protocol Violation|5|||
129015261|NCT01214850|464349785|FG001|Overall Study|Protocol Violation|5|||
129015262|NCT01214850|464349786|FG002|Overall Study|Protocol Violation|6|||
129015263|NCT01214850|464349784|FG000|Overall Study|Adverse event or death|11|||
129015264|NCT01214850|464349785|FG001|Overall Study|Adverse event or death|8|||
129015265|NCT01214850|464349786|FG002|Overall Study|Adverse event or death|3|||
129015266|NCT01214850|464349784|FG000|Overall Study|Inappropriate enrollment|2|||
129015267|NCT01214850|464349785|FG001|Overall Study|Inappropriate enrollment|1|||
129015268|NCT01214850|464349786|FG002|Overall Study|Inappropriate enrollment|0|||
129015269|NCT01214850|464349784|FG000|Overall Study|Administrative reason|1|||
129015270|NCT01214850|464349785|FG001|Overall Study|Administrative reason|0|||
129015271|NCT01214850|464349786|FG002|Overall Study|Administrative reason|0|||
129015272|NCT01214850|464349784|FG000|Overall Study|Unable to classify|2|||
129015273|NCT01214850|464349785|FG001|Overall Study|Unable to classify|1|||
129015274|NCT01214850|464349786|FG002|Overall Study|Unable to classify|1|||
129015275|NCT00193609|464349787|FG000|Overall Study|Lack of Efficacy|2|||
129015276|NCT00193609|464349787|FG000|Overall Study|Adverse Event|2|||
129015277|NCT00854308|464349790|FG000|Overall Study|Disease progression|42|||
129015278|NCT00854308|464349791|FG001|Overall Study|Disease progression|50|||
129015279|NCT00854308|464349790|FG000|Overall Study|Adverse Event|8|||
129015280|NCT00854308|464349791|FG001|Overall Study|Adverse Event|3|||
129015281|NCT00854308|464349790|FG000|Overall Study|Death|2|||
129015282|NCT00854308|464349791|FG001|Overall Study|Death|5|||
129015283|NCT00854308|464349790|FG000|Overall Study|Physician Decision|6|||
129015284|NCT00854308|464349791|FG001|Overall Study|Physician Decision|6|||
129015285|NCT00854308|464349790|FG000|Overall Study|Withdrawal by Subject|4|||
129015286|NCT00854308|464349791|FG001|Overall Study|Withdrawal by Subject|2|||
129015287|NCT00854308|464349790|FG000|Overall Study|Sponsor's decision to terminate study|0|||
129015288|NCT00854308|464349791|FG001|Overall Study|Sponsor's decision to terminate study|1|||
129015289|NCT03048500|464349792|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
129015290|NCT03048500|464349792|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
129015291|NCT03048500|464349792|FG000|Reached 1st Response/Continued Treatment|Death|1|||
129015292|NCT03048500|464349792|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
129015293|NCT03048500|464349792|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
129015294|NCT03048500|464349792|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
129015295|NCT03048500|464349792|FG000|Follow up for 3 Years|Death|12|||
129015296|NCT00610363|464349793|FG000|Overall Study|Non-compliance with protocol|0|||
129015297|NCT00610363|464349794|FG001|Overall Study|Non-compliance with protocol|1|||
129015298|NCT00610363|464349793|FG000|Overall Study|Adverse Event|3|||
129015299|NCT00610363|464349794|FG001|Overall Study|Adverse Event|1|||
129015300|NCT00610363|464349793|FG000|Overall Study|Lack of Efficacy|2|||
129015301|NCT00610363|464349794|FG001|Overall Study|Lack of Efficacy|0|||
129015302|NCT00610363|464349793|FG000|Overall Study|Lost to Follow-up|4|||
129103793|NCT04985942|464674996|FG000|Overall Study|Lost to Follow-up|1|||
129103794|NCT04985942|464674997|FG001|Overall Study|Lost to Follow-up|1|||
129103795|NCT04985942|464674996|FG000|Overall Study|Protocol Violation|1|||
129103796|NCT04985942|464674997|FG001|Overall Study|Protocol Violation|1|||
129103797|NCT04985942|464674996|FG000|Overall Study|Withdrawal by Subject|5|||
129103798|NCT04985942|464674997|FG001|Overall Study|Withdrawal by Subject|4|||
129103799|NCT03630705|464674998|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
129103800|NCT03630705|464674999|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
129103801|NCT03630705|464675000|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129103802|NCT03630705|464675001|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129103803|NCT03630705|464674998|FG000|Overall Study|Lost to Follow-up|1|||
129103804|NCT03630705|464674999|FG001|Overall Study|Lost to Follow-up|2|||
129103805|NCT03630705|464675000|FG002|Overall Study|Lost to Follow-up|0|||
129103806|NCT03630705|464675001|FG003|Overall Study|Lost to Follow-up|0|||
129103807|NCT02849704|464675003|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
129103808|NCT02849704|464675004|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
129103809|NCT02849704|464675003|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
129103810|NCT02849704|464675004|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
129103811|NCT02849704|464675003|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
129103812|NCT02849704|464675004|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
129103813|NCT03638466|464675007|FG000|Overall Study|Early Termination|0|||
129103814|NCT03638466|464675008|FG001|Overall Study|Early Termination|1|||
129103815|NCT03251482|464675009|FG000|Overall Study|Withdrawal by Subject|0|||
129103816|NCT03251482|464675010|FG001|Overall Study|Withdrawal by Subject|1|||
129103817|NCT03251482|464675011|FG002|Overall Study|Withdrawal by Subject|0|||
129103818|NCT03251482|464675012|FG003|Overall Study|Withdrawal by Subject|0|||
129103819|NCT03251482|464675013|FG004|Overall Study|Withdrawal by Subject|0|||
129103820|NCT02447328|464675014|FG000|Overall Study|Withdrawal by Subject|1|||
129103821|NCT00314808|464675020|FG000|Overall Study|Disease Progression without AE|4|||
129103822|NCT00314808|464675020|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
129103823|NCT04304508|464675021|FG000|Overall Study|Subject Decision|29|||
129103824|NCT04304508|464675022|FG001|Overall Study|Subject Decision|39|||
129103825|NCT04304508|464675023|FG002|Overall Study|Subject Decision|37|||
129103826|NCT04304508|464675024|FG003|Overall Study|Subject Decision|48|||
129103827|NCT04304508|464675021|FG000|Overall Study|Death|6|||
129103828|NCT04304508|464675022|FG001|Overall Study|Death|1|||
129103829|NCT04304508|464675023|FG002|Overall Study|Death|8|||
129103830|NCT04304508|464675024|FG003|Overall Study|Death|5|||
129103831|NCT04304508|464675021|FG000|Overall Study|Non-compliance With Study Drug|3|||
129103832|NCT04304508|464675022|FG001|Overall Study|Non-compliance With Study Drug|1|||
129103833|NCT04304508|464675023|FG002|Overall Study|Non-compliance With Study Drug|2|||
129103834|NCT04304508|464675024|FG003|Overall Study|Non-compliance With Study Drug|0|||
129103835|NCT04304508|464675021|FG000|Overall Study|Switching To Other Therapy|1|||
129103836|NCT04304508|464675022|FG001|Overall Study|Switching To Other Therapy|1|||
129103837|NCT04304508|464675023|FG002|Overall Study|Switching To Other Therapy|1|||
129103838|NCT04304508|464675024|FG003|Overall Study|Switching To Other Therapy|2|||
129103839|NCT04304508|464675021|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
129103840|NCT04304508|464675022|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
129103841|NCT04304508|464675023|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
129103842|NCT04304508|464675024|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
129103843|NCT04304508|464675021|FG000|Overall Study|Withdrawal by Subject|7|||
129103844|NCT04304508|464675022|FG001|Overall Study|Withdrawal by Subject|5|||
129103845|NCT04304508|464675023|FG002|Overall Study|Withdrawal by Subject|11|||
129103846|NCT04304508|464675024|FG003|Overall Study|Withdrawal by Subject|6|||
129103847|NCT04304508|464675021|FG000|Overall Study|Logistical Difficulties|2|||
129103848|NCT04304508|464675022|FG001|Overall Study|Logistical Difficulties|2|||
129103849|NCT04304508|464675023|FG002|Overall Study|Logistical Difficulties|3|||
129103850|NCT04304508|464675024|FG003|Overall Study|Logistical Difficulties|2|||
129103851|NCT04304508|464675021|FG000|Overall Study|Missing Information|1|||
129103852|NCT04304508|464675022|FG001|Overall Study|Missing Information|2|||
129103853|NCT04304508|464675023|FG002|Overall Study|Missing Information|1|||
129103854|NCT04304508|464675024|FG003|Overall Study|Missing Information|3|||
129103855|NCT04304508|464675021|FG000|Overall Study|Other|7|||
129103856|NCT04304508|464675022|FG001|Overall Study|Other|6|||
129103857|NCT04304508|464675023|FG002|Overall Study|Other|5|||
128681654|NCT00645788|463133672|FG002|Overall Study|Lost to Follow-up|0|||
128681655|NCT00645788|463133673|FG003|Overall Study|Lost to Follow-up|0|||
129103858|NCT04304508|464675024|FG003|Overall Study|Other|4|||
129103859|NCT04304508|464675021|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
129103860|NCT04304508|464675022|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
129103861|NCT04304508|464675023|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
128681656|NCT00645788|463133670|FG000|Overall Study|Protocol Violation|1|||
129103862|NCT04304508|464675024|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
129103863|NCT04304508|464675021|FG000|Overall Study|Physician Decision|3|||
129103864|NCT04304508|464675022|FG001|Overall Study|Physician Decision|4|||
129103865|NCT04304508|464675023|FG002|Overall Study|Physician Decision|9|||
129103866|NCT04304508|464675024|FG003|Overall Study|Physician Decision|7|||
129103867|NCT04304508|464675021|FG000|Overall Study|Study drug never administered|10|||
128681657|NCT00645788|463133671|FG001|Overall Study|Protocol Violation|0|||
128681658|NCT00645788|463133672|FG002|Overall Study|Protocol Violation|2|||
128681659|NCT00645788|463133673|FG003|Overall Study|Protocol Violation|0|||
128681660|NCT00645788|463133670|FG000|Overall Study|Withdrawal by Subject|0|||
128681661|NCT00645788|463133671|FG001|Overall Study|Withdrawal by Subject|1|||
128681662|NCT00645788|463133672|FG002|Overall Study|Withdrawal by Subject|0|||
128681663|NCT00645788|463133673|FG003|Overall Study|Withdrawal by Subject|2|||
129103868|NCT04304508|464675022|FG001|Overall Study|Study drug never administered|4|||
129103869|NCT04304508|464675023|FG002|Overall Study|Study drug never administered|4|||
129103870|NCT04304508|464675024|FG003|Overall Study|Study drug never administered|4|||
129103871|NCT04304508|464675021|FG000|Overall Study|Adverse Event|49|||
129103872|NCT04304508|464675022|FG001|Overall Study|Adverse Event|50|||
129103873|NCT04304508|464675023|FG002|Overall Study|Adverse Event|51|||
129103874|NCT04304508|464675024|FG003|Overall Study|Adverse Event|56|||
129103875|NCT04304508|464675021|FG000|Overall Study|Lost to Follow-up|1|||
129103876|NCT04304508|464675022|FG001|Overall Study|Lost to Follow-up|5|||
129103877|NCT04304508|464675023|FG002|Overall Study|Lost to Follow-up|2|||
129103878|NCT04304508|464675024|FG003|Overall Study|Lost to Follow-up|3|||
129103879|NCT02688764|464675031|FG000|Overall Study|Adverse Event|3|||
129103880|NCT02688764|464675032|FG001|Overall Study|Adverse Event|3|||
129103881|NCT02688764|464675031|FG000|Overall Study|AE/Kidney transplant|1|||
129103882|NCT02688764|464675032|FG001|Overall Study|AE/Kidney transplant|0|||
129103883|NCT02688764|464675031|FG000|Overall Study|AE/Lack of efficacy|1|||
129103884|NCT02688764|464675032|FG001|Overall Study|AE/Lack of efficacy|0|||
129103885|NCT02688764|464675031|FG000|Overall Study|AE/Non-compl.|1|||
129103886|NCT02688764|464675032|FG001|Overall Study|AE/Non-compl.|0|||
129103887|NCT02688764|464675031|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
129103888|NCT02688764|464675032|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
129103889|NCT02688764|464675031|FG000|Overall Study|AE/Other|0|||
128681664|NCT00645788|463133670|FG000|Overall Study|Pulmonary exacerbation|13|||
128681665|NCT00645788|463133671|FG001|Overall Study|Pulmonary exacerbation|16|||
129015303|NCT00610363|464349794|FG001|Overall Study|Lost to Follow-up|0|||
129015304|NCT00610363|464349793|FG000|Overall Study|Withdrawal by Subject|1|||
129015305|NCT00610363|464349794|FG001|Overall Study|Withdrawal by Subject|0|||
129015306|NCT00610363|464349793|FG000|Overall Study|Other than specified above|1|||
129015307|NCT00610363|464349794|FG001|Overall Study|Other than specified above|1|||
129015308|NCT02008565|464349808|FG000|Overall Study|Protocol Violation|1|||
129015309|NCT02008565|464349809|FG001|Overall Study|Protocol Violation|1|||
129015310|NCT02008565|464349810|FG002|Overall Study|Protocol Violation|2|||
129015311|NCT02008565|464349811|FG003|Overall Study|Protocol Violation|0|||
129015312|NCT02193178|464349812|FG000|Overall Study|Lost to Follow-up|1|||
129015313|NCT02193178|464349812|FG000|Overall Study|Dry eyes|1|||
129015314|NCT03435081|464349813|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
129015315|NCT03435081|464349814|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
129015316|NCT03435081|464349815|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
129015317|NCT03435081|464349813|FG000|Week 0 to Week 16|Adverse Event|2|||
129015318|NCT03435081|464349814|FG001|Week 0 to Week 16|Adverse Event|2|||
129015319|NCT03435081|464349815|FG002|Week 0 to Week 16|Adverse Event|2|||
129015320|NCT03435081|464349813|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
129015321|NCT03435081|464349814|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
129015322|NCT03435081|464349815|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
129015323|NCT03435081|464349813|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
129015324|NCT03435081|464349814|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
129015325|NCT03435081|464349815|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
129015326|NCT03435081|464349813|FG000|Week 0 to Week 16|Pregnancy|1|||
129015327|NCT03435081|464349814|FG001|Week 0 to Week 16|Pregnancy|0|||
129015328|NCT03435081|464349815|FG002|Week 0 to Week 16|Pregnancy|0|||
128681666|NCT00645788|463133672|FG002|Overall Study|Pulmonary exacerbation|11|||
128681667|NCT00645788|463133673|FG003|Overall Study|Pulmonary exacerbation|9|||
128681668|NCT03149848|463133674|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
128681669|NCT03149848|463133674|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
128681670|NCT01244490|463133675|FG000|Overall Study|Lack of Efficacy|14|||
129015329|NCT03435081|464349813|FG000|Week 0 to Week 16|Non-compliance|1|||
129015330|NCT03435081|464349814|FG001|Week 0 to Week 16|Non-compliance|0|||
129015331|NCT03435081|464349815|FG002|Week 0 to Week 16|Non-compliance|2|||
129103890|NCT02688764|464675032|FG001|Overall Study|AE/Other|1|||
129103891|NCT02688764|464675031|FG000|Overall Study|AE/Physician decision|1|||
129015332|NCT03435081|464349813|FG000|Week 0 to Week 16|Inadequate Response|0|||
129015333|NCT03435081|464349814|FG001|Week 0 to Week 16|Inadequate Response|1|||
129015334|NCT03435081|464349815|FG002|Week 0 to Week 16|Inadequate Response|0|||
129103892|NCT02688764|464675032|FG001|Overall Study|AE/Physician decision|0|||
129103893|NCT02688764|464675031|FG000|Overall Study|AE/Withd. parent|3|||
129103894|NCT02688764|464675032|FG001|Overall Study|AE/Withd. parent|0|||
129103895|NCT02688764|464675031|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
129103896|NCT02688764|464675032|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
129103897|NCT02688764|464675031|FG000|Overall Study|AE/Withd. subject|1|||
129103898|NCT02688764|464675032|FG001|Overall Study|AE/Withd. subject|0|||
129103899|NCT02688764|464675031|FG000|Overall Study|Kidney transplant|10|||
129103900|NCT02688764|464675032|FG001|Overall Study|Kidney transplant|4|||
129103901|NCT02688764|464675031|FG000|Overall Study|Lack of Efficacy|3|||
129103902|NCT02688764|464675032|FG001|Overall Study|Lack of Efficacy|2|||
129103903|NCT02688764|464675031|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
129103904|NCT02688764|464675032|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
129103905|NCT02688764|464675031|FG000|Overall Study|Non-compliance with study drug|4|||
129103906|NCT02688764|464675032|FG001|Overall Study|Non-compliance with study drug|0|||
129103907|NCT02688764|464675031|FG000|Overall Study|Non-compl./Physician decision|2|||
129103908|NCT02688764|464675032|FG001|Overall Study|Non-compl./Physician decision|0|||
129103909|NCT02688764|464675031|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
128681671|NCT01244490|463133676|FG001|Overall Study|Lack of Efficacy|5|||
128681672|NCT01244490|463133677|FG002|Overall Study|Lack of Efficacy|5|||
128681673|NCT01244490|463133675|FG000|Overall Study|Withdrawal by Subject|4|||
128681674|NCT01244490|463133676|FG001|Overall Study|Withdrawal by Subject|4|||
128681675|NCT01244490|463133677|FG002|Overall Study|Withdrawal by Subject|9|||
128681676|NCT01244490|463133675|FG000|Overall Study|Adverse Event|1|||
128681677|NCT01244490|463133676|FG001|Overall Study|Adverse Event|9|||
128681678|NCT01244490|463133677|FG002|Overall Study|Adverse Event|5|||
128681679|NCT01244490|463133675|FG000|Overall Study|Lost to Follow-up|0|||
128681680|NCT01244490|463133676|FG001|Overall Study|Lost to Follow-up|6|||
128681681|NCT01244490|463133677|FG002|Overall Study|Lost to Follow-up|3|||
128681682|NCT01244490|463133675|FG000|Overall Study|Other|0|||
128681683|NCT01244490|463133676|FG001|Overall Study|Other|0|||
128681684|NCT01244490|463133677|FG002|Overall Study|Other|1|||
129015335|NCT03435081|464349813|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
129015336|NCT03435081|464349814|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
129103910|NCT02688764|464675032|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
129103911|NCT02688764|464675031|FG000|Overall Study|Non-compl./Withd. subject|0|||
129103912|NCT02688764|464675032|FG001|Overall Study|Non-compl./Withd. subject|2|||
129103913|NCT02688764|464675031|FG000|Overall Study|Phosphorus level outside safe range|0|||
129103914|NCT02688764|464675032|FG001|Overall Study|Phosphorus level outside safe range|1|||
129103915|NCT02688764|464675031|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
129103916|NCT02688764|464675032|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
129103917|NCT02688764|464675031|FG000|Overall Study|Study drug taste/Withd. parent|1|||
129103918|NCT02688764|464675032|FG001|Overall Study|Study drug taste/Withd. parent|0|||
129103919|NCT02688764|464675031|FG000|Overall Study|Subject moving out|2|||
129103920|NCT02688764|464675032|FG001|Overall Study|Subject moving out|0|||
129103921|NCT02688764|464675031|FG000|Overall Study|Subject taken off dialysis|1|||
129103922|NCT02688764|464675032|FG001|Overall Study|Subject taken off dialysis|0|||
129103923|NCT02688764|464675031|FG000|Overall Study|Withdrawal by parent|3|||
129103924|NCT02688764|464675032|FG001|Overall Study|Withdrawal by parent|0|||
129103925|NCT02113007|464675033|FG000|Overall Study|Progressive disease|2|||
129103926|NCT00885378|464675034|FG000|Overall Study|Lack of Efficacy|2|||
129103927|NCT00885378|464675035|FG001|Overall Study|Lack of Efficacy|2|||
129103928|NCT00885378|464675034|FG000|Overall Study|Withdrawal by Subject|1|||
129103929|NCT00885378|464675035|FG001|Overall Study|Withdrawal by Subject|2|||
129103930|NCT00885378|464675034|FG000|Overall Study|Lost to Follow-up|1|||
129103931|NCT00885378|464675035|FG001|Overall Study|Lost to Follow-up|2|||
129103932|NCT00885378|464675034|FG000|Overall Study|Poor/Noncompliance|2|||
129103933|NCT00885378|464675035|FG001|Overall Study|Poor/Noncompliance|2|||
129103934|NCT00885378|464675034|FG000|Overall Study|Protocol Violation|2|||
129103935|NCT00885378|464675035|FG001|Overall Study|Protocol Violation|0|||
129103936|NCT04750278|464675036|FG000|Overall Study|Death|9|||
129103937|NCT04750278|464675037|FG001|Overall Study|Death|10|||
129103938|NCT04750278|464675038|FG002|Overall Study|Death|10|||
129103939|NCT04750278|464675036|FG000|Overall Study|Withdrawal by Subject|4|||
129103940|NCT04750278|464675037|FG001|Overall Study|Withdrawal by Subject|1|||
129103941|NCT04750278|464675038|FG002|Overall Study|Withdrawal by Subject|2|||
129015337|NCT03435081|464349815|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
129015338|NCT03435081|464349813|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
129015339|NCT03435081|464349814|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
129015340|NCT03435081|464349815|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
129015341|NCT03435081|464349813|FG000|Week 16 to Week 104|Adverse Event|1|||
129015342|NCT03435081|464349814|FG001|Week 16 to Week 104|Adverse Event|0|||
129015343|NCT03435081|464349815|FG002|Week 16 to Week 104|Adverse Event|2|||
129103942|NCT04750278|464675036|FG000|Overall Study|Lost to Follow-up|1|||
129103943|NCT04750278|464675037|FG001|Overall Study|Lost to Follow-up|1|||
129103944|NCT04750278|464675038|FG002|Overall Study|Lost to Follow-up|1|||
129103945|NCT04750278|464675036|FG000|Overall Study|Pregnancy|1|||
128681685|NCT00327470|463133687|FG000|Overall Study|Randomized, but not treated|0|||
129015344|NCT03435081|464349813|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
129103946|NCT04750278|464675037|FG001|Overall Study|Pregnancy|0|||
129103947|NCT04750278|464675038|FG002|Overall Study|Pregnancy|0|||
128681686|NCT00327470|463133688|FG001|Overall Study|Randomized, but not treated|2|||
128681687|NCT00327470|463133687|FG000|Overall Study|Adverse Event|9|||
128681688|NCT00327470|463133688|FG001|Overall Study|Adverse Event|14|||
129015345|NCT03435081|464349814|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
129015346|NCT03435081|464349815|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
129015347|NCT03435081|464349813|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
128681689|NCT00327470|463133687|FG000|Overall Study|Lack of Efficacy|7|||
129015348|NCT03435081|464349814|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
129015349|NCT03435081|464349815|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
129015350|NCT03435081|464349813|FG000|Week 16 to Week 104|Non--Compliance|0|||
129015351|NCT03435081|464349814|FG001|Week 16 to Week 104|Non--Compliance|0|||
129015352|NCT03435081|464349815|FG002|Week 16 to Week 104|Non--Compliance|1|||
129015353|NCT04320849|464349818|FG000|Overall Study|Withdrawal by Subject|4|||
129015354|NCT04320849|464349818|FG000|Overall Study|Imaging data unavailable|2|||
129015355|NCT04320849|464349818|FG000|Overall Study|Incomplete imaging|2|||
129015356|NCT00214422|464349819|FG000|Overall Study|Physician Decision|2|||
129015357|NCT00214422|464349820|FG001|Overall Study|Physician Decision|0|||
129015358|NCT00214422|464349821|FG002|Overall Study|Physician Decision|0|||
129015359|NCT00214422|464349819|FG000|Overall Study|Developed esophageal ca|1|||
129015360|NCT00214422|464349820|FG001|Overall Study|Developed esophageal ca|0|||
129015361|NCT00214422|464349821|FG002|Overall Study|Developed esophageal ca|0|||
129015362|NCT00214422|464349819|FG000|Overall Study|Pt taken off study|1|||
129015363|NCT00214422|464349820|FG001|Overall Study|Pt taken off study|1|||
129015364|NCT00214422|464349821|FG002|Overall Study|Pt taken off study|0|||
129015365|NCT00214422|464349819|FG000|Overall Study|Disease progression on study|1|||
129015366|NCT00214422|464349820|FG001|Overall Study|Disease progression on study|0|||
129015367|NCT00214422|464349821|FG002|Overall Study|Disease progression on study|0|||
129015368|NCT00214422|464349819|FG000|Overall Study|Unable to make a radiation treatment|0|||
129015369|NCT00214422|464349820|FG001|Overall Study|Unable to make a radiation treatment|0|||
129015370|NCT00214422|464349821|FG002|Overall Study|Unable to make a radiation treatment|1|||
129015371|NCT03929393|464349822|FG000|Overall Study|Death|1|||
129015372|NCT03929393|464349823|FG001|Overall Study|Death|0|||
129015373|NCT03929393|464349822|FG000|Overall Study|Time Commitment|2|||
129015374|NCT03929393|464349823|FG001|Overall Study|Time Commitment|5|||
129015375|NCT03929393|464349822|FG000|Overall Study|Motor Vehicle Accident|0|||
129015376|NCT03929393|464349823|FG001|Overall Study|Motor Vehicle Accident|1|||
129015377|NCT03929393|464349822|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
129015378|NCT03929393|464349823|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
129015379|NCT03929393|464349822|FG000|Overall Study|Other|1|||
129015380|NCT03929393|464349823|FG001|Overall Study|Other|3|||
129015381|NCT02424097|464351392|FG000|Overall Study|Lost to Follow-up|1|||
128681690|NCT00327470|463133688|FG001|Overall Study|Lack of Efficacy|19|||
128681691|NCT00327470|463133687|FG000|Overall Study|Other|5|||
128681692|NCT00327470|463133688|FG001|Overall Study|Other|9|||
128681693|NCT00327470|463133687|FG000|Overall Study|Lost to Follow-up|1|||
128681694|NCT00327470|463133688|FG001|Overall Study|Lost to Follow-up|3|||
128681695|NCT00327470|463133687|FG000|Overall Study|Withdrawal by Subject|6|||
128681696|NCT00327470|463133688|FG001|Overall Study|Withdrawal by Subject|12|||
128681697|NCT00327470|463133687|FG000|Overall Study|Death|1|||
129015382|NCT02424097|464351393|FG001|Overall Study|Lost to Follow-up|2|||
129015383|NCT01675622|464351394|FG000|Overall Study|Withdrawal by Subject|2|||
129015384|NCT01675622|464351395|FG001|Overall Study|Withdrawal by Subject|2|||
129015385|NCT01675622|464351394|FG000|Overall Study|Adverse Event|12|||
129015386|NCT01675622|464351395|FG001|Overall Study|Adverse Event|10|||
129015387|NCT01675622|464351394|FG000|Overall Study|Protocol Violation|4|||
129015388|NCT01675622|464351395|FG001|Overall Study|Protocol Violation|1|||
129015389|NCT01675622|464351394|FG000|Overall Study|Lack of Efficacy|2|||
129015390|NCT01675622|464351395|FG001|Overall Study|Lack of Efficacy|4|||
129015391|NCT01675622|464351394|FG000|Overall Study|Lost to Follow-up|1|||
129015392|NCT01675622|464351395|FG001|Overall Study|Lost to Follow-up|3|||
129015393|NCT01675622|464351394|FG000|Overall Study|Other|5|||
129015394|NCT01675622|464351395|FG001|Overall Study|Other|4|||
129015395|NCT04032977|464351396|FG000|Overall Study|Withdrawal by Subject|6|||
129015396|NCT04032977|464351397|FG001|Overall Study|Withdrawal by Subject|1|||
129015397|NCT04032977|464351396|FG000|Overall Study|Lost to Follow-up|2|||
129015398|NCT04032977|464351397|FG001|Overall Study|Lost to Follow-up|7|||
129015399|NCT04032977|464351396|FG000|Overall Study|Pregnancy|1|||
129015400|NCT04032977|464351397|FG001|Overall Study|Pregnancy|0|||
129015401|NCT02880761|464351399|FG000|Overall Study|Death|6|||
129015402|NCT02880761|464351400|FG001|Overall Study|Death|8|||
129015403|NCT02880761|464351399|FG000|Overall Study|Withdrawal by Subject|3|||
129015404|NCT02880761|464351400|FG001|Overall Study|Withdrawal by Subject|6|||
129015405|NCT02880761|464351399|FG000|Overall Study|Protocol Violation|4|||
129015406|NCT02880761|464351400|FG001|Overall Study|Protocol Violation|3|||
129015407|NCT02880761|464351399|FG000|Overall Study|Lost to Follow-up|3|||
129015408|NCT02880761|464351400|FG001|Overall Study|Lost to Follow-up|4|||
129015409|NCT03075761|464351401|FG000|Overall Study|Lost to Follow-up|1|||
129103948|NCT04750278|464675036|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
129103949|NCT04750278|464675037|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
129103950|NCT04750278|464675038|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
129015410|NCT03075761|464351402|FG001|Overall Study|Lost to Follow-up|6|||
129015411|NCT03597256|464351403|FG000|Overall Study|Lost to Follow-up|3|||
129015412|NCT03597256|464351404|FG001|Overall Study|Lost to Follow-up|1|||
129015413|NCT03597256|464351403|FG000|Overall Study|Withdrawal by Subject|0|||
129015414|NCT03597256|464351404|FG001|Overall Study|Withdrawal by Subject|1|||
129015415|NCT03597256|464351403|FG000|Overall Study|Could not return for treatment|0|||
129015416|NCT03597256|464351404|FG001|Overall Study|Could not return for treatment|1|||
129015417|NCT03597256|464351403|FG000|Overall Study|Moved from location|0|||
129015418|NCT03597256|464351404|FG001|Overall Study|Moved from location|1|||
129015419|NCT03597256|464351403|FG000|Overall Study|Not accepted the treatment|0|||
129015420|NCT03597256|464351404|FG001|Overall Study|Not accepted the treatment|1|||
129015421|NCT02106156|464351405|FG000|Overall Study|Patient Died|19|||
129015422|NCT02106156|464351406|FG001|Overall Study|Patient Died|0|||
129015423|NCT02106156|464351407|FG002|Overall Study|Patient Died|0|||
129015424|NCT02106156|464351405|FG000|Overall Study|Lack of Tolerability|305|||
129015425|NCT02106156|464351406|FG001|Overall Study|Lack of Tolerability|3|||
129015426|NCT02106156|464351407|FG002|Overall Study|Lack of Tolerability|0|||
129015427|NCT02106156|464351405|FG000|Overall Study|Lack of Virological Response|1044|||
129015428|NCT02106156|464351406|FG001|Overall Study|Lack of Virological Response|8|||
129015429|NCT02106156|464351407|FG002|Overall Study|Lack of Virological Response|0|||
129015430|NCT02106156|464351405|FG000|Overall Study|Concomitant Disease|74|||
129015431|NCT02106156|464351406|FG001|Overall Study|Concomitant Disease|2|||
129015432|NCT02106156|464351407|FG002|Overall Study|Concomitant Disease|0|||
129015433|NCT02106156|464351405|FG000|Overall Study|Lack of Compliance|211|||
129015434|NCT02106156|464351406|FG001|Overall Study|Lack of Compliance|7|||
129015435|NCT02106156|464351407|FG002|Overall Study|Lack of Compliance|0|||
129015436|NCT02106156|464351405|FG000|Overall Study|Patients Request|307|||
129015437|NCT02106156|464351406|FG001|Overall Study|Patients Request|9|||
129015438|NCT02106156|464351407|FG002|Overall Study|Patients Request|0|||
129015439|NCT02106156|464351405|FG000|Overall Study|Lost to Follow-up|451|||
129015440|NCT02106156|464351406|FG001|Overall Study|Lost to Follow-up|8|||
129015441|NCT02106156|464351407|FG002|Overall Study|Lost to Follow-up|0|||
129015442|NCT02106156|464351405|FG000|Overall Study|Unplanned Event|82|||
129015443|NCT02106156|464351406|FG001|Overall Study|Unplanned Event|2|||
129015444|NCT02106156|464351407|FG002|Overall Study|Unplanned Event|0|||
129015445|NCT02106156|464351405|FG000|Overall Study|Change of Laboratory Parameter|10|||
129015446|NCT02106156|464351406|FG001|Overall Study|Change of Laboratory Parameter|0|||
129015447|NCT02106156|464351407|FG002|Overall Study|Change of Laboratory Parameter|0|||
129015448|NCT02106156|464351405|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
129015449|NCT02106156|464351406|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
129015450|NCT02106156|464351407|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
129015451|NCT02106156|464351405|FG000|Overall Study|Relocation/Change of Physician|40|||
129015452|NCT02106156|464351406|FG001|Overall Study|Relocation/Change of Physician|1|||
129015453|NCT02106156|464351407|FG002|Overall Study|Relocation/Change of Physician|0|||
129015454|NCT05017480|464351417|FG000|Stage 1 Study|Withdrawal by Subject|8|||
129015455|NCT05017480|464351418|FG001|Stage 1 Study|Withdrawal by Subject|6|||
129015456|NCT05017480|464351419|FG002|Stage 1 Study|Withdrawal by Subject|0|||
129015457|NCT05017480|464351420|FG003|Stage 1 Study|Withdrawal by Subject|0|||
129015458|NCT05017480|464351421|FG004|Stage 1 Study|Withdrawal by Subject|0|||
129015459|NCT05017480|464351417|FG000|Stage 1 Study|Adverse Event|1|||
129015460|NCT05017480|464351418|FG001|Stage 1 Study|Adverse Event|1|||
129015461|NCT05017480|464351419|FG002|Stage 1 Study|Adverse Event|0|||
129015462|NCT05017480|464351420|FG003|Stage 1 Study|Adverse Event|0|||
129015463|NCT05017480|464351421|FG004|Stage 1 Study|Adverse Event|0|||
129015464|NCT05017480|464351417|FG000|Stage 1 Study|Poor Compliance|1|||
129015465|NCT05017480|464351418|FG001|Stage 1 Study|Poor Compliance|1|||
129015466|NCT05017480|464351419|FG002|Stage 1 Study|Poor Compliance|0|||
129015467|NCT05017480|464351420|FG003|Stage 1 Study|Poor Compliance|0|||
129015468|NCT05017480|464351421|FG004|Stage 1 Study|Poor Compliance|0|||
129015469|NCT05017480|464351417|FG000|Stage 1 Study|Physician Decision|0|||
129103951|NCT04750278|464675036|FG000|Overall Study|Non-compliance|0|||
129103952|NCT04750278|464675037|FG001|Overall Study|Non-compliance|0|||
129103953|NCT04750278|464675038|FG002|Overall Study|Non-compliance|1|||
129103954|NCT04750278|464675036|FG000|Overall Study|Transfer to Outside Facility|0|||
129015470|NCT05017480|464351418|FG001|Stage 1 Study|Physician Decision|1|||
129015471|NCT05017480|464351419|FG002|Stage 1 Study|Physician Decision|0|||
129015472|NCT05017480|464351420|FG003|Stage 1 Study|Physician Decision|0|||
129015473|NCT05017480|464351421|FG004|Stage 1 Study|Physician Decision|0|||
129015474|NCT05017480|464351417|FG000|Stage 2 Study|Withdrawal by Subject|0|||
129015475|NCT05017480|464351418|FG001|Stage 2 Study|Withdrawal by Subject|0|||
129015476|NCT05017480|464351419|FG002|Stage 2 Study|Withdrawal by Subject|6|||
129015477|NCT05017480|464351420|FG003|Stage 2 Study|Withdrawal by Subject|9|||
129103955|NCT04750278|464675037|FG001|Overall Study|Transfer to Outside Facility|2|||
129103956|NCT04750278|464675038|FG002|Overall Study|Transfer to Outside Facility|1|||
129103957|NCT04750278|464675036|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
129103958|NCT04750278|464675037|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
129103959|NCT04750278|464675038|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
129103960|NCT04750278|464675036|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
129103961|NCT04750278|464675037|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
129103962|NCT04750278|464675038|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
129103963|NCT02579382|464675041|FG000|Main Study Phase|Lost to Follow-up|0|||
129103964|NCT02579382|464675042|FG001|Main Study Phase|Lost to Follow-up|0|||
129103965|NCT02579382|464675043|FG002|Main Study Phase|Lost to Follow-up|2|||
129103966|NCT02579382|464675044|FG003|Main Study Phase|Lost to Follow-up|0|||
129103967|NCT02579382|464675041|FG000|Main Study Phase|Withdrew Consent|0|||
129103968|NCT02579382|464675042|FG001|Main Study Phase|Withdrew Consent|0|||
129103969|NCT02579382|464675043|FG002|Main Study Phase|Withdrew Consent|0|||
129103970|NCT02579382|464675044|FG003|Main Study Phase|Withdrew Consent|2|||
128681698|NCT00327470|463133688|FG001|Overall Study|Death|4|||
129103971|NCT02579382|464675041|FG000|Main Study Phase|Lack of Efficacy|0|||
129103972|NCT02579382|464675042|FG001|Main Study Phase|Lack of Efficacy|0|||
129103973|NCT02579382|464675043|FG002|Main Study Phase|Lack of Efficacy|0|||
129103974|NCT02579382|464675044|FG003|Main Study Phase|Lack of Efficacy|1|||
129103975|NCT02579382|464675041|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
129103976|NCT02579382|464675042|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
129103977|NCT02579382|464675043|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
129103978|NCT02579382|464675044|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
129103979|NCT02579382|464675041|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
129103980|NCT02579382|464675042|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
129103981|NCT02579382|464675043|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
129103982|NCT02579382|464675044|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
129103983|NCT02579382|464675041|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
129103984|NCT02579382|464675042|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
129103985|NCT02579382|464675043|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
129103986|NCT02579382|464675044|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
129103987|NCT02579382|464675041|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
129103988|NCT02579382|464675042|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
129103989|NCT02579382|464675043|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
129103990|NCT02579382|464675044|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
129103991|NCT02579382|464675041|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
129103992|NCT02579382|464675042|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
129103993|NCT02579382|464675043|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
129103994|NCT02579382|464675044|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
129103995|NCT02579382|464675041|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
129103996|NCT02579382|464675042|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
129103997|NCT02579382|464675043|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
129103998|NCT02579382|464675044|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
129103999|NCT01775787|464675045|FG000|First 7-10 Days|Adverse Event|0|||
129104000|NCT01775787|464675046|FG001|First 7-10 Days|Adverse Event|1|||
129104001|NCT01775787|464675045|FG000|First 7-10 Days|family emergency|0|||
129104002|NCT01775787|464675046|FG001|First 7-10 Days|family emergency|1|||
129104003|NCT01775787|464675045|FG000|First 7-10 Days|time commitment|0|||
129104004|NCT01775787|464675046|FG001|First 7-10 Days|time commitment|2|||
129104005|NCT01775787|464675045|FG000|First 7-10 Days|concerns with using IV|1|||
129104006|NCT01775787|464675046|FG001|First 7-10 Days|concerns with using IV|2|||
129015478|NCT05017480|464351421|FG004|Stage 2 Study|Withdrawal by Subject|11|||
129015479|NCT05017480|464351417|FG000|Stage 2 Study|Lost to Follow-up|0|||
129015480|NCT05017480|464351418|FG001|Stage 2 Study|Lost to Follow-up|0|||
129015481|NCT05017480|464351419|FG002|Stage 2 Study|Lost to Follow-up|0|||
129015482|NCT05017480|464351420|FG003|Stage 2 Study|Lost to Follow-up|2|||
129015483|NCT05017480|464351421|FG004|Stage 2 Study|Lost to Follow-up|1|||
129015484|NCT05017480|464351417|FG000|Stage 2 Study|Adverse Event|0|||
129015485|NCT05017480|464351418|FG001|Stage 2 Study|Adverse Event|0|||
129015486|NCT05017480|464351419|FG002|Stage 2 Study|Adverse Event|0|||
129015487|NCT05017480|464351420|FG003|Stage 2 Study|Adverse Event|1|||
129015488|NCT05017480|464351421|FG004|Stage 2 Study|Adverse Event|0|||
129015489|NCT05017480|464351417|FG000|Stage 2 Study|COVID-19|0|||
129104007|NCT01775787|464675045|FG000|Second 7-10 Days|time commitment|0|||
129104008|NCT01775787|464675046|FG001|Second 7-10 Days|time commitment|1|||
128681699|NCT02581943|463133689|FG000|Overall Study|Death|5|||
129015490|NCT05017480|464351418|FG001|Stage 2 Study|COVID-19|0|||
128681700|NCT02581943|463133690|FG001|Overall Study|Death|2|||
129015491|NCT05017480|464351419|FG002|Stage 2 Study|COVID-19|0|||
129015492|NCT05017480|464351420|FG003|Stage 2 Study|COVID-19|1|||
129015493|NCT05017480|464351421|FG004|Stage 2 Study|COVID-19|0|||
128681701|NCT02581943|463133689|FG000|Overall Study|Disease Progression|12|||
128681702|NCT02581943|463133690|FG001|Overall Study|Disease Progression|15|||
128681703|NCT02581943|463133689|FG000|Overall Study|Withdrawal by Subject|1|||
128681704|NCT02581943|463133690|FG001|Overall Study|Withdrawal by Subject|2|||
128681705|NCT03021564|463133691|FG000|Overall Study|Death|84|||
128681706|NCT03021564|463133692|FG001|Overall Study|Death|466|||
128681707|NCT03021564|463133691|FG000|Overall Study|Lost to Follow-up|0|||
128681708|NCT03021564|463133692|FG001|Overall Study|Lost to Follow-up|2|||
128681709|NCT00745615|463133699|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
128681710|NCT00745615|463133700|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
128681711|NCT00745615|463133701|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
128681712|NCT00745615|463133702|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
128681713|NCT00745615|463133703|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
128681714|NCT00745615|463133704|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
128681715|NCT00745615|463133699|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
128681716|NCT00745615|463133700|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
128681717|NCT00745615|463133701|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
128681718|NCT00745615|463133702|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
128681719|NCT00745615|463133703|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
128681720|NCT00745615|463133704|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
128681721|NCT00745615|463133699|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
128681722|NCT00745615|463133700|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
128681723|NCT00745615|463133701|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
128681724|NCT00745615|463133702|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
128681725|NCT00745615|463133703|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
128681726|NCT00745615|463133704|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
128681727|NCT00745615|463133699|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
128681728|NCT00745615|463133700|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
128681729|NCT00745615|463133701|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
128681730|NCT00745615|463133702|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
128681731|NCT00745615|463133703|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129015494|NCT05017480|464351417|FG000|Stage 2 Study|Pregnancy|0|||
129015495|NCT05017480|464351418|FG001|Stage 2 Study|Pregnancy|0|||
129015496|NCT05017480|464351419|FG002|Stage 2 Study|Pregnancy|0|||
129015497|NCT05017480|464351420|FG003|Stage 2 Study|Pregnancy|0|||
129015498|NCT05017480|464351421|FG004|Stage 2 Study|Pregnancy|1|||
129015499|NCT01136382|464351426|FG000|Overall Study|Other|8|||
129015500|NCT01136382|464351427|FG001|Overall Study|Other|3|||
129015501|NCT01136382|464351426|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
129015502|NCT01136382|464351427|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
129015503|NCT01136382|464351426|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
129015504|NCT01136382|464351427|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
129015505|NCT01136382|464351426|FG000|Overall Study|Withdrawal by Subject|4|||
129015506|NCT01136382|464351427|FG001|Overall Study|Withdrawal by Subject|1|||
129015507|NCT00746798|464351428|FG000|Overall Study|Protocol Violation|0|||
129015508|NCT00746798|464351429|FG001|Overall Study|Protocol Violation|1|||
129015509|NCT00746798|464351430|FG002|Overall Study|Protocol Violation|0|||
129015510|NCT00746798|464351431|FG003|Overall Study|Protocol Violation|0|||
129015511|NCT00746798|464351428|FG000|Overall Study|Withdrawal by Subject|0|||
129015512|NCT00746798|464351429|FG001|Overall Study|Withdrawal by Subject|1|||
129015513|NCT00746798|464351430|FG002|Overall Study|Withdrawal by Subject|1|||
129015514|NCT00746798|464351431|FG003|Overall Study|Withdrawal by Subject|0|||
129015515|NCT00746798|464351428|FG000|Overall Study|Death|0|||
129015516|NCT00746798|464351429|FG001|Overall Study|Death|0|||
129015517|NCT00746798|464351430|FG002|Overall Study|Death|2|||
129015518|NCT00746798|464351431|FG003|Overall Study|Death|0|||
129015519|NCT00746798|464351428|FG000|Overall Study|Participant unable to return for visit|1|||
129015520|NCT00746798|464351429|FG001|Overall Study|Participant unable to return for visit|0|||
129015521|NCT00746798|464351430|FG002|Overall Study|Participant unable to return for visit|0|||
129015522|NCT00746798|464351431|FG003|Overall Study|Participant unable to return for visit|0|||
129015523|NCT02896361|464351432|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
129015524|NCT02896361|464351433|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
129015525|NCT02896361|464351434|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
129015526|NCT02896361|464351432|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
129015527|NCT02896361|464351433|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
129015528|NCT02896361|464351434|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
128681732|NCT00745615|463133704|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129015529|NCT01045096|464351436|FG000|Overall Study|Withdrawal by Subject|2|||
129015530|NCT01045096|464351437|FG001|Overall Study|Withdrawal by Subject|0|||
129015531|NCT01045096|464351438|FG002|Overall Study|Withdrawal by Subject|0|||
129015532|NCT01045096|464351436|FG000|Overall Study|Other|1|||
129015533|NCT01045096|464351437|FG001|Overall Study|Other|0|||
128681733|NCT00745615|463133699|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
128681734|NCT00745615|463133700|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
128681735|NCT00745615|463133701|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
128681736|NCT00745615|463133702|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
128681737|NCT00745615|463133703|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
128681738|NCT00745615|463133704|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
128681739|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
128681740|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
128681741|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
128681742|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
128681743|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
128681744|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
128681745|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
128681746|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
128681747|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
128681748|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
128681749|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
128681750|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
128681751|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
128681752|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
128681753|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
128681754|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
128681755|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
128681756|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
128681757|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
128681758|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
128681759|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
128681760|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
128681761|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
128681762|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
128681763|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
128681764|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
128681765|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
128681766|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
128681767|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
128681768|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
128681769|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
128681770|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
128681771|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
128681772|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
128681773|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
128681774|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
128681775|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
128681776|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
128681777|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
128681778|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
128681779|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
128681780|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
128681781|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
128681782|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
128681783|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
128681784|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
128681785|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
128681786|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
128681787|NCT00745615|463133699|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
128681788|NCT00745615|463133700|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
128681789|NCT00745615|463133701|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
128681790|NCT00745615|463133702|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129104009|NCT01775787|464675045|FG000|Second 7-10 Days|concerns with using IV|0|||
129104010|NCT01775787|464675046|FG001|Second 7-10 Days|concerns with using IV|1|||
129104011|NCT01616758|464675052|FG000|Overall Study|Adverse Event|1|||
129104012|NCT01616758|464675052|FG000|Overall Study|Withdrawal by Subject|2|||
129104013|NCT01616758|464675052|FG000|Overall Study|Disease progression|18|||
129104014|NCT01616758|464675052|FG000|Overall Study|Study termination by Sponsor|1|||
129104015|NCT04076319|464675057|FG000|Overall Study|Withdrawal by Subject|2|||
128681791|NCT00745615|463133703|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
128681792|NCT00745615|463133704|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
128681793|NCT00727532|463133708|FG000|Overall Study|Adverse Event|1|||
128681794|NCT00727532|463133708|FG000|Overall Study|Withdrawal by Subject|1|||
128681795|NCT01986933|463133713|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
128681796|NCT01986933|463133714|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
128681797|NCT01986933|463133715|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
128681798|NCT01986933|463133716|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
128681799|NCT01986933|463133717|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
128681800|NCT01986933|463133713|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
128681801|NCT01986933|463133714|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
128681802|NCT01986933|463133715|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
128681803|NCT01986933|463133716|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
128681804|NCT01986933|463133717|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
128681805|NCT01986933|463133713|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
128681806|NCT01986933|463133714|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
128681807|NCT01986933|463133715|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
128681808|NCT01986933|463133716|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
128681809|NCT01986933|463133717|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
128763116|NCT03145766|463422736|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
128763117|NCT03145766|463422737|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
128763118|NCT02799472|463422741|FG000|Overall Study|Withdrawal by Subject|2|||
128763119|NCT02799472|463422742|FG001|Overall Study|Withdrawal by Subject|4|||
128763120|NCT02799472|463422741|FG000|Overall Study|Lack of Efficacy|2|||
128763121|NCT02799472|463422742|FG001|Overall Study|Lack of Efficacy|0|||
128763122|NCT02799472|463422741|FG000|Overall Study|Lost to Follow-up|0|||
128681810|NCT01986933|463133713|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
128681811|NCT01986933|463133714|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
128681812|NCT01986933|463133715|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
128681813|NCT01986933|463133716|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
128681814|NCT01986933|463133717|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
128681815|NCT01986933|463133713|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
128681816|NCT01986933|463133714|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
128681817|NCT01986933|463133715|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
128763123|NCT02799472|463422742|FG001|Overall Study|Lost to Follow-up|1|||
128763124|NCT00674570|463422743|FG000|Overall Study|Withdrawal by Subject|0|||
128763125|NCT00674570|463422744|FG001|Overall Study|Withdrawal by Subject|2|||
128763126|NCT00674570|463422745|FG002|Overall Study|Withdrawal by Subject|0|||
128763127|NCT01966003|463422746|FG000|Overall Study|Death|43|||
128763128|NCT01966003|463422747|FG001|Overall Study|Death|36|||
128763129|NCT01966003|463422746|FG000|Overall Study|Protocol Violation|6|||
128763130|NCT01966003|463422747|FG001|Overall Study|Protocol Violation|4|||
128763131|NCT01966003|463422746|FG000|Overall Study|Lost to Follow-up|4|||
128763132|NCT01966003|463422747|FG001|Overall Study|Lost to Follow-up|3|||
128763133|NCT01966003|463422746|FG000|Overall Study|Physician Decision|12|||
128763134|NCT01966003|463422747|FG001|Overall Study|Physician Decision|13|||
128763135|NCT01966003|463422746|FG000|Overall Study|Withdrawal by Subject|29|||
128763136|NCT01966003|463422747|FG001|Overall Study|Withdrawal by Subject|19|||
128763137|NCT01966003|463422746|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
128763138|NCT01966003|463422747|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
129015534|NCT01045096|464351438|FG002|Overall Study|Other|0|||
129015535|NCT01511939|464351440|FG000|Overall Study|Withdrawal by Subject|2|||
129015536|NCT01511939|464351441|FG001|Overall Study|Withdrawal by Subject|1|||
129015537|NCT01511939|464351442|FG002|Overall Study|Withdrawal by Subject|0|||
129015538|NCT00324168|464351447|FG000|Overall Study|Lost to Follow-up|19|||
129015539|NCT00324168|464351448|FG001|Overall Study|Lost to Follow-up|18|||
129015540|NCT00324168|464351447|FG000|Overall Study|Death|3|||
129015541|NCT00324168|464351448|FG001|Overall Study|Death|3|||
129015542|NCT00324168|464351447|FG000|Overall Study|Patient did not visit in f/u window|6|||
129015543|NCT00324168|464351448|FG001|Overall Study|Patient did not visit in f/u window|9|||
129015544|NCT03497897|464351451|FG000|Overall Study|Adverse Event|1|||
129015545|NCT03497897|464351452|FG001|Overall Study|Adverse Event|1|||
129015546|NCT03497897|464351453|FG002|Overall Study|Adverse Event|1|||
129015547|NCT03497897|464351451|FG000|Overall Study|Lost to Follow-up|2|||
129015548|NCT03497897|464351452|FG001|Overall Study|Lost to Follow-up|0|||
129015549|NCT03497897|464351453|FG002|Overall Study|Lost to Follow-up|2|||
129015550|NCT03497897|464351451|FG000|Overall Study|Physician Decision|1|||
129015551|NCT03497897|464351452|FG001|Overall Study|Physician Decision|0|||
129015552|NCT03497897|464351453|FG002|Overall Study|Physician Decision|0|||
129015553|NCT03497897|464351451|FG000|Overall Study|Subject/Guardian Decision|2|||
129015554|NCT03497897|464351452|FG001|Overall Study|Subject/Guardian Decision|1|||
129015555|NCT03497897|464351453|FG002|Overall Study|Subject/Guardian Decision|3|||
129015556|NCT00358449|464351461|FG000|Overall Study|Adverse Event|1|||
129015557|NCT00358449|464351462|FG001|Overall Study|Adverse Event|0|||
129015558|NCT00358449|464351463|FG002|Overall Study|Adverse Event|1|||
129015559|NCT00358449|464351461|FG000|Overall Study|Lost to Follow-up|1|||
129015560|NCT00358449|464351462|FG001|Overall Study|Lost to Follow-up|0|||
129015561|NCT00358449|464351463|FG002|Overall Study|Lost to Follow-up|0|||
129015562|NCT00358449|464351461|FG000|Overall Study|Withdrawal by Subject|2|||
129015563|NCT00358449|464351462|FG001|Overall Study|Withdrawal by Subject|0|||
129015564|NCT00358449|464351463|FG002|Overall Study|Withdrawal by Subject|0|||
129015565|NCT00358449|464351461|FG000|Overall Study|Lack of Efficacy|0|||
128681818|NCT01986933|463133716|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
128681819|NCT01986933|463133717|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
128681820|NCT01986933|463133713|FG000|Active-to-active (Part B)|Adverse Event|0|||
128681821|NCT01986933|463133714|FG001|Active-to-active (Part B)|Adverse Event|2|||
128681822|NCT01986933|463133715|FG002|Active-to-active (Part B)|Adverse Event|0|||
128681823|NCT01986933|463133716|FG003|Active-to-active (Part B)|Adverse Event|1|||
128681824|NCT01986933|463133717|FG004|Active-to-active (Part B)|Adverse Event|3|||
128681825|NCT01986933|463133713|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
128681826|NCT01986933|463133714|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
128681827|NCT01986933|463133715|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
128681828|NCT01986933|463133716|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
128681829|NCT01986933|463133717|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
128681830|NCT01986933|463133713|FG000|Active-to-active (Part B)|Pregnancy|0|||
128681831|NCT01986933|463133714|FG001|Active-to-active (Part B)|Pregnancy|0|||
128681832|NCT01986933|463133715|FG002|Active-to-active (Part B)|Pregnancy|0|||
128681833|NCT01986933|463133716|FG003|Active-to-active (Part B)|Pregnancy|0|||
128681834|NCT01986933|463133717|FG004|Active-to-active (Part B)|Pregnancy|1|||
128681835|NCT01986933|463133713|FG000|Active-to-active (Part B)|Physician Decision|0|||
128681836|NCT01986933|463133714|FG001|Active-to-active (Part B)|Physician Decision|0|||
128681837|NCT01986933|463133715|FG002|Active-to-active (Part B)|Physician Decision|1|||
128681838|NCT01986933|463133716|FG003|Active-to-active (Part B)|Physician Decision|1|||
128681839|NCT01986933|463133717|FG004|Active-to-active (Part B)|Physician Decision|0|||
128681840|NCT01986933|463133713|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
128681841|NCT01986933|463133714|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
128681842|NCT01986933|463133715|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
128681843|NCT01986933|463133716|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
128681844|NCT01986933|463133717|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
128681845|NCT01986933|463133713|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
128681846|NCT01986933|463133714|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
128681847|NCT01986933|463133715|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
128681848|NCT01986933|463133716|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
128681849|NCT01986933|463133717|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
128681850|NCT01986933|463133713|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
128681851|NCT01986933|463133714|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
128681852|NCT01986933|463133715|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
128681853|NCT01986933|463133716|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
128681854|NCT01986933|463133717|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
129015566|NCT00358449|464351462|FG001|Overall Study|Lack of Efficacy|1|||
129015567|NCT00358449|464351463|FG002|Overall Study|Lack of Efficacy|0|||
128681855|NCT01986933|463133713|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
128681856|NCT01986933|463133714|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
128681857|NCT01986933|463133715|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
129015568|NCT00358449|464351461|FG000|Overall Study|Steriod Inhaler was Increased|0|||
129015569|NCT00358449|464351462|FG001|Overall Study|Steriod Inhaler was Increased|0|||
129015570|NCT00358449|464351463|FG002|Overall Study|Steriod Inhaler was Increased|1|||
129015571|NCT01367457|464351464|FG000|Overall Study|Death|2|||
129015572|NCT01367457|464351465|FG001|Overall Study|Death|0|||
129015573|NCT01367457|464351466|FG002|Overall Study|Death|0|||
129015574|NCT01367457|464351464|FG000|Overall Study|Investigator's decision|2|||
129015575|NCT01367457|464351465|FG001|Overall Study|Investigator's decision|0|||
129015576|NCT01367457|464351466|FG002|Overall Study|Investigator's decision|0|||
129015577|NCT01367457|464351464|FG000|Overall Study|Clinical decline (CD)|2|||
129015578|NCT01367457|464351465|FG001|Overall Study|Clinical decline (CD)|0|||
129015579|NCT01367457|464351466|FG002|Overall Study|Clinical decline (CD)|0|||
129015580|NCT01367457|464351464|FG000|Overall Study|Progression and death|8|||
129015581|NCT01367457|464351465|FG001|Overall Study|Progression and death|0|||
129015582|NCT01367457|464351466|FG002|Overall Study|Progression and death|0|||
129015583|NCT01367457|464351464|FG000|Overall Study|Toxicity|16|||
129015584|NCT01367457|464351465|FG001|Overall Study|Toxicity|0|||
129015585|NCT01367457|464351466|FG002|Overall Study|Toxicity|0|||
129015586|NCT01367457|464351464|FG000|Overall Study|Progression|137|||
129015587|NCT01367457|464351465|FG001|Overall Study|Progression|0|||
129015588|NCT01367457|464351466|FG002|Overall Study|Progression|0|||
129015589|NCT01367457|464351464|FG000|Overall Study|Patient asks for rest + slow progression|1|||
129015590|NCT01367457|464351465|FG001|Overall Study|Patient asks for rest + slow progression|0|||
129015591|NCT01367457|464351466|FG002|Overall Study|Patient asks for rest + slow progression|0|||
129015592|NCT01367457|464351464|FG000|Overall Study|Investigator's opinion, stable disease|1|||
129104016|NCT04076319|464675058|FG001|Overall Study|Withdrawal by Subject|0|||
129104017|NCT04076319|464675057|FG000|Overall Study|Death|1|||
129104018|NCT04076319|464675058|FG001|Overall Study|Death|0|||
129104019|NCT01054222|464675059|FG000|Overall Study|Lack of Efficacy|1|||
129104020|NCT01054222|464675059|FG000|Overall Study|Lost to Follow-up|4|||
129104021|NCT01054222|464675059|FG000|Overall Study|Withdrawal by Subject|6|||
129104022|NCT00824655|464675060|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
129104023|NCT00824655|464675061|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
129015593|NCT01367457|464351465|FG001|Overall Study|Investigator's opinion, stable disease|0|||
129015594|NCT01367457|464351466|FG002|Overall Study|Investigator's opinion, stable disease|0|||
129015595|NCT01367457|464351464|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
129015596|NCT01367457|464351465|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
129015597|NCT01367457|464351466|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
129015598|NCT01367457|464351464|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
129104024|NCT00824655|464675060|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
129104025|NCT00824655|464675061|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
129104026|NCT03782571|464675062|FG000|Period 1|Withdrawal by Subject|1|||
129104027|NCT03782571|464675063|FG001|Period 1|Withdrawal by Subject|0|||
129104028|NCT03782571|464675064|FG002|Period 1|Withdrawal by Subject|0|||
129104029|NCT03782571|464675065|FG003|Period 1|Withdrawal by Subject|0|||
129104030|NCT03782571|464675062|FG000|Period 3|Subject Unable to Attend V5|1|||
129104031|NCT03782571|464675063|FG001|Period 3|Subject Unable to Attend V5|0|||
129104032|NCT03782571|464675064|FG002|Period 3|Subject Unable to Attend V5|0|||
129104033|NCT03782571|464675065|FG003|Period 3|Subject Unable to Attend V5|0|||
129104034|NCT03782571|464675062|FG000|Period 3|Adverse Event|1|||
129104035|NCT03782571|464675063|FG001|Period 3|Adverse Event|0|||
129104036|NCT03782571|464675064|FG002|Period 3|Adverse Event|0|||
129104037|NCT03782571|464675065|FG003|Period 3|Adverse Event|0|||
129104038|NCT03252145|464675066|FG000|Overall Study|Withdrawal by Subject|1|||
129104039|NCT03252145|464675067|FG001|Overall Study|Withdrawal by Subject|0|||
129104040|NCT03252145|464675066|FG000|Overall Study|Complicating Disease|1|||
129104041|NCT03252145|464675067|FG001|Overall Study|Complicating Disease|2|||
129104042|NCT03504189|464675068|FG000|Overall Study|Withdrawal by Subject|1|||
129104043|NCT03504189|464675068|FG000|Overall Study|Screening Failure|1|||
129104044|NCT03504189|464675068|FG000|Overall Study|Device Failure|2|||
129104045|NCT03091738|464675069|FG000|Overall Study|Adverse Event|1|||
129104046|NCT03091738|464675069|FG000|Overall Study|Lost to Follow-up|1|||
129104047|NCT04336475|464675070|FG000|Overall Study|pain|1|||
129104048|NCT04336475|464675071|FG001|Overall Study|pain|0|||
129104049|NCT04336475|464675070|FG000|Overall Study|upper respiratory infection|1|||
129104050|NCT04336475|464675071|FG001|Overall Study|upper respiratory infection|0|||
129104051|NCT04336475|464675070|FG000|Overall Study|Lost to Follow-up|0|||
129104052|NCT04336475|464675071|FG001|Overall Study|Lost to Follow-up|2|||
128681858|NCT01986933|463133716|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
128681859|NCT01986933|463133717|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
128681860|NCT01986933|463133713|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
128681861|NCT01986933|463133714|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
128681862|NCT01986933|463133715|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
128681863|NCT01986933|463133716|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
129015599|NCT01367457|464351465|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
129015600|NCT01367457|464351466|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
129015601|NCT01367457|464351464|FG000|Overall Study|low grade toxicities + stable disease|1|||
129015602|NCT01367457|464351465|FG001|Overall Study|low grade toxicities + stable disease|0|||
129104053|NCT02213380|464675087|FG000|Underwent Randomization|Withdrawal by Subject|2|||
129104054|NCT02213380|464675088|FG001|Underwent Randomization|Withdrawal by Subject|0|||
129104055|NCT02213380|464675087|FG000|Underwent Randomization|Not treated|3|||
129104056|NCT02213380|464675088|FG001|Underwent Randomization|Not treated|3|||
129104057|NCT02213380|464675087|FG000|Per-protocol Analysis|Protocol Violation|32|||
129104058|NCT02213380|464675088|FG001|Per-protocol Analysis|Protocol Violation|36|||
128681864|NCT01986933|463133717|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
128681865|NCT01986933|463133713|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
129015603|NCT01367457|464351466|FG002|Overall Study|low grade toxicities + stable disease|0|||
129104059|NCT03498313|464675089|FG000|Experimental Period 1|Adverse Event|1|||
129104060|NCT03498313|464675090|FG001|Experimental Period 1|Adverse Event|0|||
129104061|NCT03498313|464675091|FG002|Experimental Period 1|Adverse Event|0|||
129104062|NCT03498313|464675092|FG003|Experimental Period 1|Adverse Event|1|||
129104063|NCT03498313|464675093|FG004|Experimental Period 1|Adverse Event|0|||
129104064|NCT03498313|464675094|FG005|Experimental Period 1|Adverse Event|0|||
129104065|NCT03498313|464675089|FG000|Experimental Period 1|Withdrawal by Subject|0|||
129104066|NCT03498313|464675090|FG001|Experimental Period 1|Withdrawal by Subject|1|||
129104067|NCT03498313|464675091|FG002|Experimental Period 1|Withdrawal by Subject|0|||
129104068|NCT03498313|464675092|FG003|Experimental Period 1|Withdrawal by Subject|0|||
129104069|NCT03498313|464675093|FG004|Experimental Period 1|Withdrawal by Subject|0|||
129104070|NCT03498313|464675094|FG005|Experimental Period 1|Withdrawal by Subject|0|||
129104071|NCT03498313|464675089|FG000|Washout Period 1|Anovulation|1|||
129104072|NCT03498313|464675090|FG001|Washout Period 1|Anovulation|0|||
128681866|NCT01986933|463133714|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
128681867|NCT01986933|463133715|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
128681868|NCT01986933|463133716|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
128681869|NCT01986933|463133717|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
128681870|NCT01986933|463133713|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
129104073|NCT03498313|464675091|FG002|Washout Period 1|Anovulation|0|||
129104074|NCT03498313|464675092|FG003|Washout Period 1|Anovulation|0|||
129104075|NCT03498313|464675093|FG004|Washout Period 1|Anovulation|0|||
129104076|NCT03498313|464675094|FG005|Washout Period 1|Anovulation|0|||
129104077|NCT03498313|464675089|FG000|Washout Period 1|Withdrawal by Subject|0|||
129104078|NCT03498313|464675090|FG001|Washout Period 1|Withdrawal by Subject|3|||
129104079|NCT03498313|464675091|FG002|Washout Period 1|Withdrawal by Subject|0|||
129104080|NCT03498313|464675092|FG003|Washout Period 1|Withdrawal by Subject|1|||
129104081|NCT03498313|464675093|FG004|Washout Period 1|Withdrawal by Subject|0|||
129104082|NCT03498313|464675094|FG005|Washout Period 1|Withdrawal by Subject|1|||
129104083|NCT03498313|464675089|FG000|Experimental Period 2|Adverse Event|0|||
129104084|NCT03498313|464675090|FG001|Experimental Period 2|Adverse Event|0|||
129104085|NCT03498313|464675091|FG002|Experimental Period 2|Adverse Event|0|||
129104086|NCT03498313|464675092|FG003|Experimental Period 2|Adverse Event|0|||
129104087|NCT03498313|464675093|FG004|Experimental Period 2|Adverse Event|1|||
129104088|NCT03498313|464675094|FG005|Experimental Period 2|Adverse Event|2|||
129104089|NCT03498313|464675089|FG000|Washout Period 2|Physician Decision|1|||
129104090|NCT03498313|464675090|FG001|Washout Period 2|Physician Decision|0|||
129104091|NCT03498313|464675091|FG002|Washout Period 2|Physician Decision|0|||
129104092|NCT03498313|464675092|FG003|Washout Period 2|Physician Decision|1|||
129104093|NCT03498313|464675093|FG004|Washout Period 2|Physician Decision|0|||
129104094|NCT03498313|464675094|FG005|Washout Period 2|Physician Decision|1|||
129104095|NCT03498313|464675089|FG000|Washout Period 2|Withdrawal by Subject|3|||
129104096|NCT03498313|464675090|FG001|Washout Period 2|Withdrawal by Subject|2|||
129104097|NCT03498313|464675091|FG002|Washout Period 2|Withdrawal by Subject|0|||
129104098|NCT03498313|464675092|FG003|Washout Period 2|Withdrawal by Subject|0|||
129104099|NCT03498313|464675093|FG004|Washout Period 2|Withdrawal by Subject|2|||
128681871|NCT01986933|463133714|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
128681872|NCT01986933|463133715|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
128681873|NCT01986933|463133716|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
128681874|NCT01986933|463133717|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
128681875|NCT01986933|463133713|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
128681876|NCT01986933|463133714|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
128681877|NCT01986933|463133715|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
128681878|NCT01986933|463133716|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
128681879|NCT01986933|463133717|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
128681880|NCT00817479|463133718|FG000|Overall Study|Physician Decision|1|||
128681881|NCT00817479|463133719|FG001|Overall Study|Physician Decision|1|||
128681882|NCT04030026|463133721|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
129104100|NCT03498313|464675094|FG005|Washout Period 2|Withdrawal by Subject|0|||
129104101|NCT03498313|464675089|FG000|Washout Period 2|Anovulation|0|||
129104102|NCT03498313|464675090|FG001|Washout Period 2|Anovulation|0|||
129104103|NCT03498313|464675091|FG002|Washout Period 2|Anovulation|0|||
129104104|NCT03498313|464675092|FG003|Washout Period 2|Anovulation|0|||
129104105|NCT03498313|464675093|FG004|Washout Period 2|Anovulation|0|||
129104106|NCT03498313|464675094|FG005|Washout Period 2|Anovulation|1|||
129104107|NCT00184002|464675095|FG000|Overall Study|Adverse Event|9|||
129104108|NCT00184002|464675095|FG000|Overall Study|Death|3|||
129104109|NCT00184002|464675095|FG000|Overall Study|Physician Decision|1|||
128681883|NCT04030026|463133722|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
128681884|NCT04030026|463133721|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
128681885|NCT04030026|463133722|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
128681886|NCT04030026|463133721|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
128681887|NCT04030026|463133722|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
128681888|NCT04030026|463133721|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
128763139|NCT01966003|463422746|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
129104110|NCT00184002|464675095|FG000|Overall Study|Withdrawal by Subject|4|||
129104111|NCT02171429|464675096|FG000|Overall Study|Other|0|||
129104112|NCT02171429|464675097|FG001|Overall Study|Other|1|||
129104113|NCT02171429|464675098|FG002|Overall Study|Other|1|||
129104114|NCT02171429|464675096|FG000|Overall Study|Non-Compliance|0|||
129104115|NCT02171429|464675097|FG001|Overall Study|Non-Compliance|0|||
129104116|NCT02171429|464675098|FG002|Overall Study|Non-Compliance|1|||
129104117|NCT02171429|464675096|FG000|Overall Study|Physician Decision|0|||
129104118|NCT02171429|464675097|FG001|Overall Study|Physician Decision|0|||
129104119|NCT02171429|464675098|FG002|Overall Study|Physician Decision|1|||
129104120|NCT02171429|464675096|FG000|Overall Study|Withdrawal by Subject|1|||
129104121|NCT02171429|464675097|FG001|Overall Study|Withdrawal by Subject|1|||
129104122|NCT02171429|464675098|FG002|Overall Study|Withdrawal by Subject|1|||
129104123|NCT02171429|464675096|FG000|Overall Study|Lost to Follow-up|0|||
129104124|NCT02171429|464675097|FG001|Overall Study|Lost to Follow-up|1|||
129104125|NCT02171429|464675098|FG002|Overall Study|Lost to Follow-up|0|||
129104126|NCT02171429|464675096|FG000|Overall Study|Death|0|||
129104127|NCT02171429|464675097|FG001|Overall Study|Death|0|||
129104128|NCT02171429|464675098|FG002|Overall Study|Death|1|||
129104129|NCT02020889|464675100|FG000|Overall Study|Adverse Event|0|||
129104130|NCT02020889|464675101|FG001|Overall Study|Adverse Event|1|||
129104131|NCT02020889|464675100|FG000|Overall Study|Lack of Efficacy|1|||
129104132|NCT02020889|464675101|FG001|Overall Study|Lack of Efficacy|0|||
129104133|NCT02020889|464675100|FG000|Overall Study|Lost to Follow-up|1|||
129104134|NCT02020889|464675101|FG001|Overall Study|Lost to Follow-up|0|||
129104135|NCT02020889|464675100|FG000|Overall Study|Physician Decision|2|||
129104136|NCT02020889|464675101|FG001|Overall Study|Physician Decision|0|||
129104137|NCT02020889|464675100|FG000|Overall Study|Withdrawal by Subject|3|||
129104138|NCT02020889|464675101|FG001|Overall Study|Withdrawal by Subject|2|||
129104139|NCT02768792|464675103|FG000|Overall Study|Adverse Event|1|||
129104140|NCT05980013|464675104|FG000|Overall Study|Withdrawal by Subject|0|||
129104141|NCT05980013|464675105|FG001|Overall Study|Withdrawal by Subject|1|||
128681889|NCT04030026|463133722|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
128681890|NCT04030026|463133721|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
128681891|NCT04030026|463133722|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
129104142|NCT05980013|464675104|FG000|Overall Study|Device Error|0|||
129104143|NCT05980013|464675105|FG001|Overall Study|Device Error|1|||
129104144|NCT01768559|464675106|FG000|Overall Study|Randomized but not treated|0|||
129104145|NCT01768559|464675107|FG001|Overall Study|Randomized but not treated|0|||
129104146|NCT01768559|464675108|FG002|Overall Study|Randomized but not treated|1|||
129104147|NCT01768559|464675106|FG000|Overall Study|Adverse Event|15|||
129104148|NCT01768559|464675107|FG001|Overall Study|Adverse Event|2|||
129104149|NCT01768559|464675108|FG002|Overall Study|Adverse Event|5|||
129104150|NCT01768559|464675106|FG000|Overall Study|Lack of Efficacy|6|||
129104151|NCT01768559|464675107|FG001|Overall Study|Lack of Efficacy|4|||
129104152|NCT01768559|464675108|FG002|Overall Study|Lack of Efficacy|0|||
129104153|NCT01768559|464675106|FG000|Overall Study|Poor compliance to protocol|0|||
129104154|NCT01768559|464675107|FG001|Overall Study|Poor compliance to protocol|3|||
129104155|NCT01768559|464675108|FG002|Overall Study|Poor compliance to protocol|2|||
129104156|NCT01768559|464675106|FG000|Overall Study|Other than specified|9|||
129104157|NCT01768559|464675107|FG001|Overall Study|Other than specified|8|||
129104158|NCT01768559|464675108|FG002|Overall Study|Other than specified|5|||
129104159|NCT00398047|464675113|FG000|Overall Study|all patient progressed before completion|3|||
129104160|NCT02521792|464675114|FG000|Overall Study|Study Terminated|6|||
129104161|NCT01188668|464675115|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
129104162|NCT01188668|464675115|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
129104163|NCT01188668|464675115|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
129104164|NCT00902746|464675116|FG000|Overall Study|Protocol Violation|7|||
129104165|NCT00902746|464675116|FG000|Overall Study|Withdrawal by Subject|16|||
129104166|NCT00902746|464675116|FG000|Overall Study|Adverse Event|8|||
129104167|NCT00902746|464675116|FG000|Overall Study|Lost to Follow-up|3|||
129104168|NCT00902746|464675116|FG000|Overall Study|Physician Decision|2|||
129104169|NCT00303472|464675117|FG000|Treatment Period|Adverse Event|0|||
129104170|NCT00303472|464675118|FG001|Treatment Period|Adverse Event|0|||
129104171|NCT00303472|464675119|FG002|Treatment Period|Adverse Event|0|||
129104172|NCT00303472|464675120|FG003|Treatment Period|Adverse Event|0|||
129104173|NCT00303472|464675121|FG004|Treatment Period|Adverse Event|1|||
129104174|NCT00303472|464675122|FG005|Treatment Period|Adverse Event|0|||
129104175|NCT00303472|464675123|FG006|Treatment Period|Adverse Event|0|||
129104176|NCT00303472|464675117|FG000|Treatment Period|Death|0|||
129104177|NCT00303472|464675118|FG001|Treatment Period|Death|0|||
129104178|NCT00303472|464675119|FG002|Treatment Period|Death|0|||
129104179|NCT00303472|464675120|FG003|Treatment Period|Death|1|||
129104180|NCT00303472|464675121|FG004|Treatment Period|Death|0|||
129104181|NCT00303472|464675122|FG005|Treatment Period|Death|0|||
129104182|NCT00303472|464675123|FG006|Treatment Period|Death|1|||
129104183|NCT00303472|464675117|FG000|Treatment Period|Withdrawal by Subject|0|||
129104184|NCT00303472|464675118|FG001|Treatment Period|Withdrawal by Subject|0|||
129104185|NCT00303472|464675119|FG002|Treatment Period|Withdrawal by Subject|0|||
129104186|NCT00303472|464675120|FG003|Treatment Period|Withdrawal by Subject|1|||
129104187|NCT00303472|464675121|FG004|Treatment Period|Withdrawal by Subject|0|||
129104188|NCT00303472|464675122|FG005|Treatment Period|Withdrawal by Subject|1|||
129104189|NCT00303472|464675123|FG006|Treatment Period|Withdrawal by Subject|0|||
129104190|NCT00303472|464675117|FG000|Treatment Period|Other|0|||
129104191|NCT00303472|464675118|FG001|Treatment Period|Other|0|||
129104192|NCT00303472|464675119|FG002|Treatment Period|Other|0|||
129104193|NCT00303472|464675120|FG003|Treatment Period|Other|0|||
129104194|NCT00303472|464675121|FG004|Treatment Period|Other|1|||
129104195|NCT00303472|464675122|FG005|Treatment Period|Other|0|||
129104196|NCT00303472|464675123|FG006|Treatment Period|Other|1|||
129104197|NCT00303472|464675117|FG000|Treatment Period|Disease Progression (to AML)|0|||
129104198|NCT00303472|464675118|FG001|Treatment Period|Disease Progression (to AML)|0|||
129104199|NCT00303472|464675119|FG002|Treatment Period|Disease Progression (to AML)|0|||
129104200|NCT00303472|464675120|FG003|Treatment Period|Disease Progression (to AML)|0|||
129104201|NCT00303472|464675121|FG004|Treatment Period|Disease Progression (to AML)|1|||
129104202|NCT00303472|464675122|FG005|Treatment Period|Disease Progression (to AML)|0|||
129104203|NCT00303472|464675123|FG006|Treatment Period|Disease Progression (to AML)|0|||
129104204|NCT00303472|464675117|FG000|Treatment Extension (Optional)|Adverse Event|1|||
129104205|NCT00303472|464675118|FG001|Treatment Extension (Optional)|Adverse Event|0|||
129104206|NCT00303472|464675119|FG002|Treatment Extension (Optional)|Adverse Event|1|||
129104207|NCT00303472|464675120|FG003|Treatment Extension (Optional)|Adverse Event|0|||
128681892|NCT04030026|463133721|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
128681893|NCT04030026|463133722|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
128681894|NCT04030026|463133721|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
128681895|NCT04030026|463133722|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
128681896|NCT00523367|463133723|FG000|Overall Study|19 screen failures|19|||
128681897|NCT00523367|463133723|FG000|Overall Study|4 Withdrawn by PI|4|||
129104208|NCT00303472|464675121|FG004|Treatment Extension (Optional)|Adverse Event|0|||
129104209|NCT00303472|464675122|FG005|Treatment Extension (Optional)|Adverse Event|0|||
129104210|NCT00303472|464675123|FG006|Treatment Extension (Optional)|Adverse Event|0|||
129104211|NCT00303472|464675117|FG000|Treatment Extension (Optional)|Death|2|||
129104212|NCT00303472|464675118|FG001|Treatment Extension (Optional)|Death|0|||
129104213|NCT00303472|464675119|FG002|Treatment Extension (Optional)|Death|1|||
128681898|NCT00811642|463133724|FG000|Overall Study|Adverse Event|3|||
128681899|NCT00811642|463133724|FG000|Overall Study|Protocol Violation|1|||
128681900|NCT00811642|463133724|FG000|Overall Study|Death|2|||
128681901|NCT00811642|463133724|FG000|Overall Study|Withdrawal by Subject|7|||
128681902|NCT00811642|463133724|FG000|Overall Study|Cumulative use of antifungal agent|2|||
128681903|NCT00782795|463133725|FG000|Overall Study|Withdrawal by Subject|1|||
129015604|NCT01367457|464351464|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
129015605|NCT01367457|464351465|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
129015606|NCT01367457|464351466|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
129015607|NCT01367457|464351464|FG000|Overall Study|Withdrawal by Subject|1|||
129015608|NCT01367457|464351465|FG001|Overall Study|Withdrawal by Subject|0|||
129015609|NCT01367457|464351466|FG002|Overall Study|Withdrawal by Subject|0|||
129015610|NCT01367457|464351464|FG000|Overall Study|CD, associated leukaemia|1|||
129015611|NCT01367457|464351465|FG001|Overall Study|CD, associated leukaemia|0|||
129015612|NCT01367457|464351466|FG002|Overall Study|CD, associated leukaemia|0|||
129015613|NCT01367457|464351464|FG000|Overall Study|Uncontrolled pain|1|||
129015614|NCT01367457|464351465|FG001|Overall Study|Uncontrolled pain|0|||
129015615|NCT01367457|464351466|FG002|Overall Study|Uncontrolled pain|0|||
129015616|NCT01367457|464351464|FG000|Overall Study|Overall status worsens to grade 4|1|||
129015617|NCT01367457|464351465|FG001|Overall Study|Overall status worsens to grade 4|0|||
129015618|NCT01367457|464351466|FG002|Overall Study|Overall status worsens to grade 4|0|||
129015619|NCT01367457|464351464|FG000|Overall Study|Stabilisation + frequent infections|1|||
129015620|NCT01367457|464351465|FG001|Overall Study|Stabilisation + frequent infections|0|||
129015621|NCT01367457|464351466|FG002|Overall Study|Stabilisation + frequent infections|0|||
129015622|NCT01367457|464351464|FG000|Overall Study|No clinical benefit|1|||
129015623|NCT01367457|464351465|FG001|Overall Study|No clinical benefit|0|||
129015624|NCT01367457|464351466|FG002|Overall Study|No clinical benefit|0|||
129015625|NCT01367457|464351464|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
129015626|NCT01367457|464351465|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
129015627|NCT01367457|464351466|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
129015628|NCT01367457|464351464|FG000|Overall Study|Overall decline|1|||
129015629|NCT01367457|464351465|FG001|Overall Study|Overall decline|0|||
129015630|NCT01367457|464351466|FG002|Overall Study|Overall decline|0|||
129015631|NCT01367457|464351464|FG000|Overall Study|Rejection of treatment|1|||
129015632|NCT01367457|464351465|FG001|Overall Study|Rejection of treatment|0|||
129015633|NCT01367457|464351466|FG002|Overall Study|Rejection of treatment|0|||
129015634|NCT01367457|464351464|FG000|Overall Study|Lost to Follow-up|1|||
129015635|NCT01367457|464351465|FG001|Overall Study|Lost to Follow-up|0|||
129015636|NCT01367457|464351466|FG002|Overall Study|Lost to Follow-up|0|||
129015637|NCT01367457|464351464|FG000|Overall Study|Death from septic shock|1|||
129015638|NCT01367457|464351465|FG001|Overall Study|Death from septic shock|0|||
129015639|NCT01367457|464351466|FG002|Overall Study|Death from septic shock|0|||
129015640|NCT01367457|464351464|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
129015641|NCT01367457|464351465|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
129015642|NCT01367457|464351466|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
129015643|NCT01367457|464351464|FG000|Overall Study|Patient's Wish|1|||
129015644|NCT01367457|464351465|FG001|Overall Study|Patient's Wish|0|||
129015645|NCT01367457|464351466|FG002|Overall Study|Patient's Wish|0|||
129015646|NCT01367457|464351464|FG000|Overall Study|Palliative. Overall decline|1|||
128681904|NCT00782795|463133726|FG001|Overall Study|Withdrawal by Subject|2|||
128681905|NCT04480424|463133727|FG000|Overall Study|Withdrawal by Subject|0|||
128681906|NCT04480424|463133728|FG001|Overall Study|Withdrawal by Subject|2|||
128681907|NCT04480424|463133727|FG000|Overall Study|Lost to Follow-up|3|||
128681908|NCT04480424|463133728|FG001|Overall Study|Lost to Follow-up|3|||
128681909|NCT04480424|463133727|FG000|Overall Study|Death|14|||
128681910|NCT04480424|463133728|FG001|Overall Study|Death|16|||
128681911|NCT04480424|463133727|FG000|Overall Study|Reason not Specified|5|||
129015647|NCT01367457|464351465|FG001|Overall Study|Palliative. Overall decline|0|||
129015648|NCT01367457|464351466|FG002|Overall Study|Palliative. Overall decline|0|||
129015649|NCT01367457|464351464|FG000|Overall Study|Suspected DP/suspected active infection|1|||
129015650|NCT01367457|464351465|FG001|Overall Study|Suspected DP/suspected active infection|0|||
129015651|NCT01367457|464351466|FG002|Overall Study|Suspected DP/suspected active infection|0|||
129015652|NCT01391793|464351471|FG000|Overall Study|Ineligible|3|||
129015653|NCT01391793|464351472|FG001|Overall Study|Ineligible|0|||
129015654|NCT01391793|464351471|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
129015655|NCT01391793|464351472|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
129015656|NCT01391793|464351471|FG000|Overall Study|No DMSA|73|||
129015657|NCT01391793|464351472|FG001|Overall Study|No DMSA|57|||
129015658|NCT01666730|464351474|FG000|Overall Study|Adverse Event|16|||
129015659|NCT01666730|464351474|FG000|Overall Study|Death|2|||
129015660|NCT01666730|464351474|FG000|Overall Study|Physician Decision|5|||
129015661|NCT01666730|464351474|FG000|Overall Study|Withdrawal by Subject|9|||
129015662|NCT01666730|464351474|FG000|Overall Study|Disease progression/relapse|18|||
129015663|NCT02087904|464351477|FG000|Overall Study|Did Not Receive Study Drug|0|||
129015664|NCT02087904|464351478|FG001|Overall Study|Did Not Receive Study Drug|0|||
129015665|NCT02087904|464351479|FG002|Overall Study|Did Not Receive Study Drug|2|||
129015666|NCT02087904|464351480|FG003|Overall Study|Did Not Receive Study Drug|1|||
129015667|NCT02087904|464351477|FG000|Overall Study|Adverse Event|8|||
129015668|NCT02087904|464351478|FG001|Overall Study|Adverse Event|4|||
129015669|NCT02087904|464351479|FG002|Overall Study|Adverse Event|4|||
129015670|NCT02087904|464351480|FG003|Overall Study|Adverse Event|12|||
129015671|NCT02087904|464351477|FG000|Overall Study|Lack of Efficacy|3|||
129015672|NCT02087904|464351478|FG001|Overall Study|Lack of Efficacy|6|||
129015673|NCT02087904|464351479|FG002|Overall Study|Lack of Efficacy|3|||
129015674|NCT02087904|464351480|FG003|Overall Study|Lack of Efficacy|2|||
129015675|NCT02087904|464351477|FG000|Overall Study|Other|6|||
129015676|NCT02087904|464351478|FG001|Overall Study|Other|2|||
129015677|NCT02087904|464351479|FG002|Overall Study|Other|4|||
129015678|NCT02087904|464351480|FG003|Overall Study|Other|4|||
129015679|NCT02087904|464351477|FG000|Overall Study|Withdrawal by Subject|8|||
129015680|NCT02087904|464351478|FG001|Overall Study|Withdrawal by Subject|3|||
129015681|NCT02087904|464351479|FG002|Overall Study|Withdrawal by Subject|7|||
129015682|NCT02087904|464351480|FG003|Overall Study|Withdrawal by Subject|4|||
129015683|NCT02087904|464351477|FG000|Overall Study|Lost to Follow-up|0|||
129015684|NCT02087904|464351478|FG001|Overall Study|Lost to Follow-up|4|||
129015685|NCT02087904|464351479|FG002|Overall Study|Lost to Follow-up|2|||
129015686|NCT02087904|464351480|FG003|Overall Study|Lost to Follow-up|2|||
129015687|NCT03025880|464351482|FG000|Overall Study|Adverse Event|1|||
129015688|NCT03025880|464351483|FG001|Overall Study|Adverse Event|0|||
129015689|NCT03025880|464351482|FG000|Overall Study|Death|1|||
129015690|NCT03025880|464351483|FG001|Overall Study|Death|1|||
129015691|NCT03025880|464351482|FG000|Overall Study|Withdrawal by Subject|0|||
129015692|NCT03025880|464351483|FG001|Overall Study|Withdrawal by Subject|1|||
129015693|NCT03025880|464351482|FG000|Overall Study|Physician Decision|0|||
129015694|NCT03025880|464351483|FG001|Overall Study|Physician Decision|1|||
129015695|NCT03025880|464351482|FG000|Overall Study|Progressive Disease|12|||
129015696|NCT03025880|464351483|FG001|Overall Study|Progressive Disease|19|||
129015697|NCT00893464|464351484|FG000|Overall Study|Did not complete therapy/experience PD|0|||
129015698|NCT00893464|464351485|FG001|Overall Study|Did not complete therapy/experience PD|0|||
129015699|NCT00893464|464351486|FG002|Overall Study|Did not complete therapy/experience PD|0|||
129015700|NCT00893464|464351487|FG003|Overall Study|Did not complete therapy/experience PD|0|||
129015701|NCT00893464|464351488|FG004|Overall Study|Did not complete therapy/experience PD|0|||
129015702|NCT00893464|464351489|FG005|Overall Study|Did not complete therapy/experience PD|0|||
129015703|NCT00893464|464351490|FG006|Overall Study|Did not complete therapy/experience PD|2|||
129015704|NCT00893464|464351491|FG007|Overall Study|Did not complete therapy/experience PD|2|||
128681912|NCT04480424|463133728|FG001|Overall Study|Reason not Specified|5|||
128681913|NCT02782923|463133729|FG000|Overall Study|Lost to Follow-up|15|||
129015705|NCT01389102|464351492|FG000|Overall Study|Adverse Event|1|||
129015706|NCT01389102|464351493|FG001|Overall Study|Adverse Event|3|||
129015707|NCT01389102|464351494|FG002|Overall Study|Adverse Event|2|||
129015708|NCT01389102|464351495|FG003|Overall Study|Adverse Event|2|||
129015709|NCT01389102|464351496|FG004|Overall Study|Adverse Event|2|||
129015710|NCT01389102|464351497|FG005|Overall Study|Adverse Event|2|||
129015711|NCT01389102|464351492|FG000|Overall Study|Hurricane Katrina|4|||
129015712|NCT01389102|464351493|FG001|Overall Study|Hurricane Katrina|2|||
129015713|NCT01389102|464351494|FG002|Overall Study|Hurricane Katrina|3|||
129015714|NCT01389102|464351495|FG003|Overall Study|Hurricane Katrina|0|||
128681914|NCT00562627|463135373|FG000|Overall Study|Protocol Violation|1|||
128681915|NCT00562627|463135374|FG001|Overall Study|Protocol Violation|1|||
128681916|NCT00562627|463135375|FG002|Overall Study|Protocol Violation|1|||
128681917|NCT00625742|463135376|FG000|Overall Study|Disease Progression|2|||
128681918|NCT00625742|463135376|FG000|Overall Study|Withdrawal by Subject|1|||
128681919|NCT00625742|463135376|FG000|Overall Study|Adverse Event|4|||
128681920|NCT00625742|463135376|FG000|Overall Study|Lost to Follow-up|4|||
128681921|NCT00625742|463135376|FG000|Overall Study|Ineligible|1|||
128681922|NCT01709578|463135377|FG000|Overall Study|Rescued and entered in long term safety|63|||
128681923|NCT01709578|463135378|FG001|Overall Study|Rescued and entered in long term safety|25|||
128681924|NCT01709578|463135379|FG002|Overall Study|Rescued and entered in long term safety|26|||
128681925|NCT01709578|463135377|FG000|Overall Study|Adverse Event|9|||
128681926|NCT01709578|463135378|FG001|Overall Study|Adverse Event|18|||
128681927|NCT01709578|463135379|FG002|Overall Study|Adverse Event|17|||
128681928|NCT01709578|463135377|FG000|Overall Study|Lack of Efficacy|5|||
128681929|NCT01709578|463135378|FG001|Overall Study|Lack of Efficacy|4|||
128681930|NCT01709578|463135379|FG002|Overall Study|Lack of Efficacy|2|||
128681931|NCT01709578|463135377|FG000|Overall Study|Poor compliance to protocol|1|||
128681932|NCT01709578|463135378|FG001|Overall Study|Poor compliance to protocol|2|||
128681933|NCT01709578|463135379|FG002|Overall Study|Poor compliance to protocol|1|||
128681934|NCT01709578|463135377|FG000|Overall Study|Other, not related to safety or efficacy|2|||
128681935|NCT01709578|463135378|FG001|Overall Study|Other, not related to safety or efficacy|7|||
128681936|NCT01709578|463135379|FG002|Overall Study|Other, not related to safety or efficacy|5|||
128681937|NCT04050371|463135380|FG000|Overall Study|Withdrawal by Subject|1|||
128681938|NCT04050371|463135381|FG001|Overall Study|Withdrawal by Subject|0|||
128681939|NCT01107418|463135382|FG000|Overall Study|Disease Progression|45|||
128681940|NCT01107418|463135382|FG000|Overall Study|Adverse Event|3|||
128681941|NCT01107418|463135382|FG000|Overall Study|Withdrawal by Subject|1|||
128681942|NCT01107418|463135382|FG000|Overall Study|Study Closing|1|||
128681943|NCT01107418|463135382|FG000|Overall Study|Started Other Therapy|1|||
128681944|NCT01107418|463135382|FG000|Overall Study|Entered Extension Study|1|||
128681945|NCT00597701|463135383|FG000|Overall Study|Withdrawal by Subject|5|||
128681946|NCT00597701|463135384|FG001|Overall Study|Withdrawal by Subject|5|||
128681947|NCT00597701|463135383|FG000|Overall Study|Death|0|||
128681948|NCT00597701|463135384|FG001|Overall Study|Death|1|||
128681949|NCT00597701|463135383|FG000|Overall Study|Physician Decision|2|||
128681950|NCT00597701|463135384|FG001|Overall Study|Physician Decision|0|||
128681951|NCT00597701|463135383|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
128681952|NCT00597701|463135384|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
128681953|NCT00301821|463135391|FG000|Overall Study|Ineligible|25|||
128681954|NCT00301821|463135391|FG000|Overall Study|Cancel|1|||
128681955|NCT01394718|463135395|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
129015715|NCT01389102|464351496|FG004|Overall Study|Hurricane Katrina|3|||
129015716|NCT01389102|464351497|FG005|Overall Study|Hurricane Katrina|1|||
129015717|NCT01389102|464351492|FG000|Overall Study|Lost to Follow-up|4|||
129015718|NCT01389102|464351493|FG001|Overall Study|Lost to Follow-up|1|||
128681956|NCT01394718|463135396|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
128681957|NCT04078178|463135397|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
128681958|NCT04078178|463135398|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
128681959|NCT04078178|463135397|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
128681960|NCT04078178|463135398|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
128681961|NCT04078178|463135397|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
128681962|NCT04078178|463135398|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
128681963|NCT04078178|463135397|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
128681964|NCT04078178|463135398|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
129015719|NCT01389102|464351494|FG002|Overall Study|Lost to Follow-up|1|||
129015720|NCT01389102|464351495|FG003|Overall Study|Lost to Follow-up|2|||
129015721|NCT01389102|464351496|FG004|Overall Study|Lost to Follow-up|4|||
129015722|NCT01389102|464351497|FG005|Overall Study|Lost to Follow-up|1|||
129015723|NCT01389102|464351492|FG000|Overall Study|Protocol Violation|0|||
129015724|NCT01389102|464351493|FG001|Overall Study|Protocol Violation|0|||
129015725|NCT01389102|464351494|FG002|Overall Study|Protocol Violation|3|||
128681965|NCT04078178|463135397|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
128681966|NCT04078178|463135398|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
128681967|NCT04617795|463135399|FG000|Main Study|Lost to Follow-up|1|||
128681968|NCT04617795|463135400|FG001|Main Study|Lost to Follow-up|0|||
128681969|NCT00472459|463135401|FG000|Overall Study|Adverse Event|13|||
128763140|NCT01966003|463422747|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
128763141|NCT01966003|463422746|FG000|Overall Study|Other|1|||
129015726|NCT01389102|464351495|FG003|Overall Study|Protocol Violation|0|||
129015727|NCT01389102|464351496|FG004|Overall Study|Protocol Violation|1|||
129015728|NCT01389102|464351497|FG005|Overall Study|Protocol Violation|1|||
128681970|NCT00472459|463135402|FG001|Overall Study|Adverse Event|13|||
128681971|NCT00472459|463135401|FG000|Overall Study|Withdrawal by Subject|5|||
128681972|NCT00472459|463135402|FG001|Overall Study|Withdrawal by Subject|5|||
128681973|NCT00472459|463135401|FG000|Overall Study|Protocol Violation|3|||
129015729|NCT01389102|464351492|FG000|Overall Study|Withdrawal by Subject|7|||
129015730|NCT01389102|464351493|FG001|Overall Study|Withdrawal by Subject|4|||
128681974|NCT00472459|463135402|FG001|Overall Study|Protocol Violation|3|||
128681975|NCT00472459|463135401|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
128681976|NCT00472459|463135402|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
129015731|NCT01389102|464351494|FG002|Overall Study|Withdrawal by Subject|9|||
129015732|NCT01389102|464351495|FG003|Overall Study|Withdrawal by Subject|2|||
129015733|NCT01389102|464351496|FG004|Overall Study|Withdrawal by Subject|3|||
129015734|NCT01389102|464351497|FG005|Overall Study|Withdrawal by Subject|3|||
129015735|NCT01389102|464351492|FG000|Overall Study|Subject Traveling Out of Country|0|||
129015736|NCT01389102|464351493|FG001|Overall Study|Subject Traveling Out of Country|0|||
129015737|NCT01389102|464351494|FG002|Overall Study|Subject Traveling Out of Country|0|||
129015738|NCT01389102|464351495|FG003|Overall Study|Subject Traveling Out of Country|1|||
129015739|NCT01389102|464351496|FG004|Overall Study|Subject Traveling Out of Country|0|||
129015740|NCT01389102|464351497|FG005|Overall Study|Subject Traveling Out of Country|0|||
129015741|NCT01389102|464351492|FG000|Overall Study|Subject Moved|2|||
129015742|NCT01389102|464351493|FG001|Overall Study|Subject Moved|0|||
129015743|NCT01389102|464351494|FG002|Overall Study|Subject Moved|1|||
129015744|NCT01389102|464351495|FG003|Overall Study|Subject Moved|0|||
129015745|NCT01389102|464351496|FG004|Overall Study|Subject Moved|0|||
129015746|NCT01389102|464351497|FG005|Overall Study|Subject Moved|0|||
129015747|NCT01389102|464351492|FG000|Overall Study|Unavailable due to husband's illness|0|||
129015748|NCT01389102|464351493|FG001|Overall Study|Unavailable due to husband's illness|1|||
129015749|NCT01389102|464351494|FG002|Overall Study|Unavailable due to husband's illness|0|||
129015750|NCT01389102|464351495|FG003|Overall Study|Unavailable due to husband's illness|0|||
129015751|NCT01389102|464351496|FG004|Overall Study|Unavailable due to husband's illness|0|||
129015752|NCT01389102|464351497|FG005|Overall Study|Unavailable due to husband's illness|0|||
129015753|NCT01389102|464351492|FG000|Overall Study|Investigator Judgement|0|||
129015754|NCT01389102|464351493|FG001|Overall Study|Investigator Judgement|1|||
129015755|NCT01389102|464351494|FG002|Overall Study|Investigator Judgement|0|||
129015756|NCT01389102|464351495|FG003|Overall Study|Investigator Judgement|0|||
129015757|NCT01389102|464351496|FG004|Overall Study|Investigator Judgement|0|||
129015758|NCT01389102|464351497|FG005|Overall Study|Investigator Judgement|0|||
129015759|NCT02910037|464351498|FG000|Overall Study|Withdrawal by Subject|4|||
129015760|NCT02910037|464351498|FG000|Overall Study|Lost to Follow-up|6|||
129015761|NCT00436553|464351499|FG000|Overall Study|Adverse Event|4|||
129015762|NCT00436553|464351500|FG001|Overall Study|Adverse Event|3|||
129015763|NCT00436553|464351501|FG002|Overall Study|Adverse Event|4|||
129015764|NCT00436553|464351499|FG000|Overall Study|Death|3|||
129015765|NCT00436553|464351500|FG001|Overall Study|Death|1|||
129015766|NCT00436553|464351501|FG002|Overall Study|Death|3|||
129015767|NCT00436553|464351499|FG000|Overall Study|Lost to Follow-up|0|||
129015768|NCT00436553|464351500|FG001|Overall Study|Lost to Follow-up|2|||
129015769|NCT00436553|464351501|FG002|Overall Study|Lost to Follow-up|0|||
129015770|NCT00436553|464351499|FG000|Overall Study|Protocol Violation|1|||
129015771|NCT00436553|464351500|FG001|Overall Study|Protocol Violation|0|||
129015772|NCT00436553|464351501|FG002|Overall Study|Protocol Violation|0|||
129015773|NCT00436553|464351499|FG000|Overall Study|Withdrawal by Subject|5|||
129015774|NCT00436553|464351500|FG001|Overall Study|Withdrawal by Subject|6|||
129015775|NCT00436553|464351501|FG002|Overall Study|Withdrawal by Subject|3|||
129015776|NCT01035060|464351506|FG000|Overall Study|Lost to Follow-up|0|||
129015777|NCT01035060|464351507|FG001|Overall Study|Lost to Follow-up|7|||
129015778|NCT01035060|464351506|FG000|Overall Study|Did not quality after 2nd screening|14|||
129015779|NCT01035060|464351507|FG001|Overall Study|Did not quality after 2nd screening|1|||
129015780|NCT01035060|464351506|FG000|Overall Study|Withdrawal by Subject|8|||
129015781|NCT01035060|464351507|FG001|Overall Study|Withdrawal by Subject|6|||
129015782|NCT01035060|464351506|FG000|Overall Study|Physician Decision|2|||
129015783|NCT01035060|464351507|FG001|Overall Study|Physician Decision|0|||
129015784|NCT02015390|464351512|FG000|Overall Study|Lost to Follow-up|1|||
129015785|NCT02015390|464351513|FG001|Overall Study|Lost to Follow-up|0|||
129015786|NCT02015390|464351512|FG000|Overall Study|Adverse Event|0|||
129015787|NCT02015390|464351513|FG001|Overall Study|Adverse Event|3|||
129015788|NCT02015390|464351512|FG000|Overall Study|Physician Decision|0|||
129015789|NCT02015390|464351513|FG001|Overall Study|Physician Decision|1|||
129015790|NCT02193880|464351514|FG000|Overall Study|patients did not collect enough HPC|3|||
129015791|NCT01661686|464351515|FG000|Overall Study|Lost to Follow-up|2|||
129015792|NCT01661686|464351516|FG001|Overall Study|Lost to Follow-up|1|||
128681977|NCT00472459|463135401|FG000|Overall Study|Lost to Follow-up|1|||
129015793|NCT01661686|464351515|FG000|Overall Study|did not receive allocated intervention|0|||
129015794|NCT01661686|464351516|FG001|Overall Study|did not receive allocated intervention|1|||
129015795|NCT02419937|464351519|FG000|Overall Study|Lost to Follow-up|1|||
129015796|NCT02419937|464351520|FG001|Overall Study|Lost to Follow-up|0|||
129015797|NCT02674477|464351522|FG000|Overall Study|Protocol Violation|8|||
129015798|NCT02674477|464351523|FG001|Overall Study|Protocol Violation|2|||
129015799|NCT00624065|464351524|FG000|Overall Study|Adverse Event|5|||
129015800|NCT00624065|464351525|FG001|Overall Study|Adverse Event|6|||
128681978|NCT00472459|463135402|FG001|Overall Study|Lost to Follow-up|1|||
128681979|NCT03442764|463135403|FG000|Overall Study|Adverse Event|1|||
128681980|NCT03442764|463135404|FG001|Overall Study|Adverse Event|0|||
128681981|NCT03442764|463135405|FG002|Overall Study|Adverse Event|0|||
128681982|NCT02395016|463135406|FG000|Overall Study|Adverse Event|4|||
128681983|NCT02395016|463135407|FG001|Overall Study|Adverse Event|3|||
128681984|NCT02395016|463135406|FG000|Overall Study|Withdrawal by Subject|9|||
128681985|NCT02395016|463135407|FG001|Overall Study|Withdrawal by Subject|6|||
128681986|NCT02395016|463135406|FG000|Overall Study|Protocol Violation|2|||
128681987|NCT02395016|463135407|FG001|Overall Study|Protocol Violation|3|||
128681988|NCT01547780|463135408|FG000|Baseline PET Scan|Physician Decision|1|||
128681989|NCT01547780|463135409|FG001|Baseline PET Scan|Physician Decision|0|||
128681990|NCT01547780|463135410|FG002|Baseline PET Scan|Physician Decision|1|||
128681991|NCT01547780|463135411|FG003|Baseline PET Scan|Physician Decision|0|||
128681992|NCT01547780|463135408|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
128681993|NCT01547780|463135409|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
128681994|NCT01547780|463135410|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
128681995|NCT01547780|463135411|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
128681996|NCT00814879|463135413|FG000|By Week 24|Cancer Diagnosis|1|||
128681997|NCT00814879|463135414|FG001|By Week 24|Cancer Diagnosis|0|||
128681998|NCT00814879|463135413|FG000|By Week 24|Incarceration|0|||
128681999|NCT00814879|463135414|FG001|By Week 24|Incarceration|1|||
128682000|NCT00814879|463135413|FG000|By Week 48|Lost to Follow-up|2|||
129104214|NCT00303472|464675120|FG003|Treatment Extension (Optional)|Death|0|||
129104215|NCT00303472|464675121|FG004|Treatment Extension (Optional)|Death|0|||
129104216|NCT00303472|464675122|FG005|Treatment Extension (Optional)|Death|0|||
129104217|NCT00303472|464675123|FG006|Treatment Extension (Optional)|Death|0|||
129104218|NCT00303472|464675117|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
129104219|NCT00303472|464675118|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
129104220|NCT00303472|464675119|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
129104221|NCT00303472|464675120|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
129104222|NCT00303472|464675121|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
129104223|NCT00303472|464675122|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
129104224|NCT00303472|464675123|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
129104225|NCT00303472|464675117|FG000|Treatment Extension (Optional)|Physician Decision|0|||
129104226|NCT00303472|464675118|FG001|Treatment Extension (Optional)|Physician Decision|4|||
129104227|NCT00303472|464675119|FG002|Treatment Extension (Optional)|Physician Decision|2|||
129104228|NCT00303472|464675120|FG003|Treatment Extension (Optional)|Physician Decision|3|||
129104229|NCT00303472|464675121|FG004|Treatment Extension (Optional)|Physician Decision|2|||
129104230|NCT00303472|464675122|FG005|Treatment Extension (Optional)|Physician Decision|0|||
129104231|NCT00303472|464675123|FG006|Treatment Extension (Optional)|Physician Decision|0|||
129104232|NCT00303472|464675117|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
129104233|NCT00303472|464675118|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
129104234|NCT00303472|464675119|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
129104235|NCT00303472|464675120|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
129104236|NCT00303472|464675121|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
129104237|NCT00303472|464675122|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
129104238|NCT00303472|464675123|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
129104239|NCT00303472|464675117|FG000|Treatment Extension (Optional)|Other|0|||
129104240|NCT00303472|464675118|FG001|Treatment Extension (Optional)|Other|2|||
129104241|NCT00303472|464675119|FG002|Treatment Extension (Optional)|Other|4|||
129104242|NCT00303472|464675120|FG003|Treatment Extension (Optional)|Other|2|||
129104243|NCT00303472|464675121|FG004|Treatment Extension (Optional)|Other|1|||
129104244|NCT00303472|464675122|FG005|Treatment Extension (Optional)|Other|0|||
129104245|NCT00303472|464675123|FG006|Treatment Extension (Optional)|Other|0|||
129104246|NCT00303472|464675117|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
129104247|NCT00303472|464675118|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129104248|NCT00303472|464675119|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
128682001|NCT00814879|463135414|FG001|By Week 48|Lost to Follow-up|2|||
128682002|NCT00814879|463135413|FG000|By Week 48|Death|0|||
128682003|NCT00814879|463135414|FG001|By Week 48|Death|1|||
128682004|NCT00588952|463135415|FG000|Overall Study|Adverse Event|0|||
128682005|NCT00588952|463135416|FG001|Overall Study|Adverse Event|2|||
129104249|NCT00303472|464675120|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129104250|NCT00303472|464675121|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129104251|NCT00303472|464675122|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
128682006|NCT00588952|463135415|FG000|Overall Study|Withdrawal by Subject|3|||
128682007|NCT00588952|463135416|FG001|Overall Study|Withdrawal by Subject|5|||
128682008|NCT01277042|463135417|FG000|Overall Study|Adverse Event|4|||
128682009|NCT01277042|463135418|FG001|Overall Study|Adverse Event|3|||
128682010|NCT01277042|463135417|FG000|Overall Study|Lost to Follow-up|2|||
128682011|NCT01277042|463135418|FG001|Overall Study|Lost to Follow-up|2|||
128682012|NCT01277042|463135417|FG000|Overall Study|Withdrawal by Subject|2|||
128682013|NCT01277042|463135418|FG001|Overall Study|Withdrawal by Subject|0|||
129015801|NCT00624065|464351524|FG000|Overall Study|Lost to Follow-up|4|||
129015802|NCT00624065|464351525|FG001|Overall Study|Lost to Follow-up|1|||
129015803|NCT00624065|464351524|FG000|Overall Study|Consent withdrawn|6|||
129015804|NCT00624065|464351525|FG001|Overall Study|Consent withdrawn|5|||
129015805|NCT00624065|464351524|FG000|Overall Study|Lack of Efficacy|0|||
129015806|NCT00624065|464351525|FG001|Overall Study|Lack of Efficacy|3|||
129015807|NCT00624065|464351524|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
129015808|NCT00624065|464351525|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
129015809|NCT00450190|464351528|FG000|Overall Study|Withdrawal by Subject|2|||
129015810|NCT01536574|464351529|FG000|Overall Study|Adverse Event|4|||
129015811|NCT01536574|464351530|FG001|Overall Study|Adverse Event|5|||
129015812|NCT01536574|464351529|FG000|Overall Study|Withdrawal by Subject|1|||
129015813|NCT01536574|464351530|FG001|Overall Study|Withdrawal by Subject|2|||
129015814|NCT01536574|464351529|FG000|Overall Study|Lack of Efficacy|1|||
129015815|NCT01536574|464351530|FG001|Overall Study|Lack of Efficacy|0|||
129015816|NCT02193165|464351533|FG000|4 Week Product Use|Lost to Follow-up|1|||
129015817|NCT02193165|464351534|FG001|4 Week Product Use|Lost to Follow-up|1|||
129015818|NCT02193165|464351535|FG002|4 Week Product Use|Lost to Follow-up|1|||
129015819|NCT02193165|464351533|FG000|6 Week Product Use|Lost to Follow-up|0|||
129015820|NCT02193165|464351534|FG001|6 Week Product Use|Lost to Follow-up|1|||
129015821|NCT02193165|464351535|FG002|6 Week Product Use|Lost to Follow-up|0|||
129015822|NCT01498120|464351536|FG000|Overall Study|Lost to Follow-up|1|||
129015823|NCT01498120|464351536|FG000|Overall Study|Withdrawal by Subject|5|||
129015824|NCT01498120|464351536|FG000|Overall Study|AE, non-serious non-fatal|3|||
129015825|NCT01498120|464351536|FG000|Overall Study|Other|4|||
129015826|NCT01171963|464351539|FG000|Overall Study|Adverse Event|10|||
129015827|NCT01171963|464351540|FG001|Overall Study|Adverse Event|15|||
129015828|NCT01171963|464351539|FG000|Overall Study|Lost to Follow-up|23|||
129015829|NCT01171963|464351540|FG001|Overall Study|Lost to Follow-up|24|||
129015830|NCT01171963|464351539|FG000|Overall Study|Other - diarrhoea|1|||
129015831|NCT01171963|464351540|FG001|Overall Study|Other - diarrhoea|0|||
129015832|NCT01171963|464351539|FG000|Overall Study|Withdrawal by Subject|114|||
129015833|NCT01171963|464351540|FG001|Overall Study|Withdrawal by Subject|129|||
129015834|NCT05093205|464351541|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
129015835|NCT05093205|464351542|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
129015836|NCT05093205|464351543|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
129104252|NCT00303472|464675123|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129104253|NCT02937636|464675125|FG000|Overall Study|Other (Not specified)|3|||
129104254|NCT02937636|464675126|FG001|Overall Study|Other (Not specified)|2|||
129104255|NCT02347072|464675132|FG000|Overall Study|Adverse Event|2|||
128682014|NCT01461057|463135419|FG000|Overall Study|Death|10|||
128682015|NCT01461057|463135420|FG001|Overall Study|Death|9|||
128682016|NCT01461057|463135419|FG000|Overall Study|Withdrawal by Subject|2|||
128682017|NCT01461057|463135420|FG001|Overall Study|Withdrawal by Subject|3|||
128682018|NCT01461057|463135419|FG000|Overall Study|Physician Decision|0|||
128682019|NCT01461057|463135420|FG001|Overall Study|Physician Decision|2|||
128682020|NCT01461057|463135419|FG000|Overall Study|Adverse Event|0|||
128682021|NCT01461057|463135420|FG001|Overall Study|Adverse Event|1|||
128682022|NCT01461057|463135419|FG000|Overall Study|Progression of Disease|1|||
128682023|NCT01461057|463135420|FG001|Overall Study|Progression of Disease|0|||
128682024|NCT01461057|463135419|FG000|Overall Study|Study Terminated by Sponsor|2|||
128682025|NCT01461057|463135420|FG001|Overall Study|Study Terminated by Sponsor|0|||
128682026|NCT01288976|463135421|FG000|Overall Study|Withdrawal by Subject|58|||
128682027|NCT01288976|463135422|FG001|Overall Study|Withdrawal by Subject|12|||
128682028|NCT01288976|463135423|FG002|Overall Study|Withdrawal by Subject|9|||
128682029|NCT01288976|463135421|FG000|Overall Study|Death|98|||
128682030|NCT01288976|463135422|FG001|Overall Study|Death|6|||
128682031|NCT01288976|463135423|FG002|Overall Study|Death|4|||
128682032|NCT01288976|463135421|FG000|Overall Study|Data unavailable|22|||
128682033|NCT01288976|463135422|FG001|Overall Study|Data unavailable|9|||
128682034|NCT01288976|463135423|FG002|Overall Study|Data unavailable|7|||
128682035|NCT00959374|463135426|FG000|Overall Study|Withdrawal by Subject|2|||
128682036|NCT00959374|463135426|FG000|Overall Study|Lost to Follow-up|14|||
128682037|NCT00959374|463135426|FG000|Overall Study|Death|1|||
128682038|NCT00959374|463135426|FG000|Overall Study|Protocol Violation|1|||
128682039|NCT00959374|463135426|FG000|Overall Study|Implant Removed/Not Replaced|4|||
129015837|NCT05093205|464351544|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
129015838|NCT05093205|464351545|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
129015839|NCT05093205|464351546|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
129104256|NCT02347072|464675132|FG000|Overall Study|Withdrawal by Subject|6|||
128682040|NCT00959374|463135426|FG000|Overall Study|Physician Decision|1|||
129015840|NCT05093205|464351547|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
128682041|NCT02284178|463135427|FG000|Overall Study|Met exclusion criteria|49|||
128682042|NCT02284178|463135428|FG001|Overall Study|Met exclusion criteria|54|||
128682043|NCT01483690|463135429|FG000|Overall Study|Adverse Event|1|||
128682044|NCT01483690|463135430|FG001|Overall Study|Adverse Event|2|||
128682045|NCT01483690|463135429|FG000|Overall Study|clinical deterioration|1|||
129015841|NCT05093205|464351548|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
129015842|NCT05093205|464351549|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
129015843|NCT05093205|464351550|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
129015844|NCT05093205|464351551|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
129015845|NCT05093205|464351552|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
129015846|NCT05093205|464351553|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
129015847|NCT05093205|464351541|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015848|NCT05093205|464351542|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015849|NCT05093205|464351543|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
129015850|NCT05093205|464351544|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015851|NCT05093205|464351545|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015852|NCT05093205|464351546|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015853|NCT05093205|464351547|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015854|NCT05093205|464351548|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015855|NCT05093205|464351549|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015856|NCT05093205|464351550|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015857|NCT05093205|464351551|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015858|NCT05093205|464351552|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015859|NCT05093205|464351553|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129015860|NCT05093205|464351541|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
129015861|NCT05093205|464351542|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
129015862|NCT05093205|464351543|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
129015863|NCT05093205|464351544|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
129015864|NCT05093205|464351545|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
129015865|NCT05093205|464351546|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
129015866|NCT05093205|464351547|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
129015867|NCT05093205|464351548|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
129015868|NCT05093205|464351549|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
129015869|NCT05093205|464351550|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
129015870|NCT05093205|464351551|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
129015871|NCT05093205|464351552|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
129015872|NCT05093205|464351553|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
129015873|NCT05093205|464351541|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
129015874|NCT05093205|464351542|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
129015875|NCT05093205|464351543|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
129015876|NCT05093205|464351544|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
129015877|NCT05093205|464351545|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
129015878|NCT05093205|464351546|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
129015879|NCT05093205|464351547|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
129015880|NCT05093205|464351548|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
129015881|NCT05093205|464351549|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
129015882|NCT05093205|464351550|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
129015883|NCT05093205|464351551|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
129015884|NCT05093205|464351552|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
129015885|NCT05093205|464351553|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
129015886|NCT05093205|464351541|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
129015887|NCT05093205|464351542|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
129015888|NCT05093205|464351543|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
129015889|NCT05093205|464351544|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
129015890|NCT05093205|464351545|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
129015891|NCT05093205|464351546|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
129015892|NCT05093205|464351547|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
129015893|NCT05093205|464351548|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
129015894|NCT05093205|464351549|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
129015895|NCT05093205|464351550|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
129015896|NCT05093205|464351551|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
129015897|NCT05093205|464351552|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
129015898|NCT05093205|464351553|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
129015899|NCT05093205|464351541|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
129015900|NCT05093205|464351542|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
128682046|NCT01483690|463135430|FG001|Overall Study|clinical deterioration|0|||
129015901|NCT05093205|464351543|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
129015902|NCT05093205|464351544|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
129015903|NCT05093205|464351545|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
129015904|NCT05093205|464351546|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
129015905|NCT05093205|464351547|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
129015906|NCT05093205|464351548|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
129015907|NCT05093205|464351549|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
129015908|NCT05093205|464351550|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
129015909|NCT05093205|464351551|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
129015910|NCT05093205|464351552|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
129015911|NCT05093205|464351553|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
129015912|NCT05093205|464351541|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
129104257|NCT02347072|464675132|FG000|Overall Study|Physician Decision|1|||
129104258|NCT02347072|464675132|FG000|Overall Study|Lost to Follow-up|2|||
129104259|NCT02347072|464675132|FG000|Overall Study|Protocol Violation|1|||
129104260|NCT02347072|464675132|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
128682047|NCT01483690|463135429|FG000|Overall Study|Physician Decision|0|||
128682048|NCT01483690|463135430|FG001|Overall Study|Physician Decision|2|||
128682049|NCT01483690|463135429|FG000|Overall Study|exclusionary procedure|0|||
128682050|NCT01483690|463135430|FG001|Overall Study|exclusionary procedure|1|||
128682051|NCT00478881|463135436|FG000|Overall Study|Adverse Event|31|||
128682052|NCT00478881|463135437|FG001|Overall Study|Adverse Event|12|||
128682053|NCT00478881|463135436|FG000|Overall Study|Lack of Efficacy|0|||
128682054|NCT00478881|463135437|FG001|Overall Study|Lack of Efficacy|3|||
128682055|NCT00478881|463135436|FG000|Overall Study|Lost to Follow-up|0|||
128682056|NCT00478881|463135437|FG001|Overall Study|Lost to Follow-up|1|||
128682057|NCT00478881|463135436|FG000|Overall Study|Protocol Violation|2|||
128682058|NCT00478881|463135437|FG001|Overall Study|Protocol Violation|2|||
128682059|NCT00478881|463135436|FG000|Overall Study|Withdrawal by Subject|6|||
128682060|NCT00478881|463135437|FG001|Overall Study|Withdrawal by Subject|2|||
128682061|NCT00478881|463135436|FG000|Overall Study|Non-Compliance with Study Medication|0|||
128682062|NCT00478881|463135437|FG001|Overall Study|Non-Compliance with Study Medication|2|||
128682063|NCT00737464|463135438|FG000|Overall Study|Adverse Event|1|||
128682064|NCT00737464|463135438|FG000|Overall Study|Death|6|||
128682065|NCT00737464|463135438|FG000|Overall Study|Other - Failure to Return|1|||
128682066|NCT00737464|463135438|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
128682067|NCT00737464|463135438|FG000|Overall Study|Other reasons|4|||
128879626|NCT02354508|463854898|FG001|Period 1: Core Phase|Adverse Event|1|||
128879627|NCT02354508|463854899|FG002|Period 1: Core Phase|Adverse Event|2|||
128879628|NCT02354508|463854897|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
128879629|NCT02354508|463854898|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
128682072|NCT01041495|463135446|FG000|Overall Study|Withdrawal by Subject|2|||
128682073|NCT01041495|463135447|FG001|Overall Study|Withdrawal by Subject|5|||
128682074|NCT01041495|463135446|FG000|Overall Study|Adverse Event|2|||
128682075|NCT01041495|463135447|FG001|Overall Study|Adverse Event|1|||
128682076|NCT01041495|463135446|FG000|Overall Study|Lost to Follow-up|0|||
128682077|NCT01041495|463135447|FG001|Overall Study|Lost to Follow-up|1|||
128682078|NCT03584373|463135448|FG000|Overall Study|Lost to Follow-up|7|||
128682079|NCT03584373|463135449|FG001|Overall Study|Lost to Follow-up|8|||
128682080|NCT01487577|463135450|FG000|Overall Study|Became ineligible after signing consent|1|||
128682081|NCT01479985|463135454|FG000|Overall Study|Tablet malfunction, no data saved|1|||
128682082|NCT01479985|463135455|FG001|Overall Study|Tablet malfunction, no data saved|1|||
128682083|NCT01479985|463135454|FG000|Overall Study|No decisional conflict scale responses|0|||
128682084|NCT01479985|463135455|FG001|Overall Study|No decisional conflict scale responses|2|||
128682085|NCT01479985|463135454|FG000|Overall Study|No post-visit survey|5|||
128682086|NCT01479985|463135455|FG001|Overall Study|No post-visit survey|3|||
128682087|NCT00662532|463135458|FG000|Overall Study|Adverse Event|0|||
128682088|NCT00662532|463135459|FG001|Overall Study|Adverse Event|1|||
128682089|NCT00662532|463135458|FG000|Overall Study|Lost to Follow-up|0|||
128682090|NCT00662532|463135459|FG001|Overall Study|Lost to Follow-up|1|||
128682091|NCT00367770|463135460|FG000|Overall Study|Adverse Event|1|||
128682092|NCT00367770|463135460|FG000|Overall Study|Withdrawal by Subject|1|||
128682093|NCT01155479|463135461|FG000|Part I|Adverse Event|13|||
128682094|NCT01155479|463135462|FG001|Part I|Adverse Event|8|||
128682095|NCT01155479|463135463|FG002|Part I|Adverse Event|18|||
128682096|NCT01155479|463135464|FG003|Part I|Adverse Event|7|||
128682097|NCT01155479|463135465|FG004|Part I|Adverse Event|6|||
128682098|NCT01155479|463135461|FG000|Part I|Administrative|2|||
128682099|NCT01155479|463135462|FG001|Part I|Administrative|2|||
128682100|NCT01155479|463135463|FG002|Part I|Administrative|2|||
128682101|NCT01155479|463135464|FG003|Part I|Administrative|0|||
128682102|NCT01155479|463135465|FG004|Part I|Administrative|0|||
128682103|NCT01155479|463135461|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
128682104|NCT01155479|463135462|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
128682105|NCT01155479|463135463|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
128682106|NCT01155479|463135464|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
128682107|NCT01155479|463135465|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
128682108|NCT01155479|463135461|FG000|Part I|Withdrawal by Subject|11|||
128682109|NCT01155479|463135462|FG001|Part I|Withdrawal by Subject|13|||
128682110|NCT01155479|463135463|FG002|Part I|Withdrawal by Subject|8|||
128682111|NCT01155479|463135464|FG003|Part I|Withdrawal by Subject|8|||
128682112|NCT01155479|463135465|FG004|Part I|Withdrawal by Subject|9|||
128682113|NCT01155479|463135461|FG000|Part I|Lost to Follow-up|0|||
128682114|NCT01155479|463135462|FG001|Part I|Lost to Follow-up|0|||
128763142|NCT01966003|463422747|FG001|Overall Study|Other|1|||
128682115|NCT01155479|463135463|FG002|Part I|Lost to Follow-up|1|||
128682116|NCT01155479|463135464|FG003|Part I|Lost to Follow-up|1|||
128682117|NCT01155479|463135465|FG004|Part I|Lost to Follow-up|0|||
128682118|NCT01155479|463135461|FG000|Part I|Treatment Failure|3|||
128682119|NCT01155479|463135462|FG001|Part I|Treatment Failure|0|||
128682120|NCT01155479|463135463|FG002|Part I|Treatment Failure|3|||
129104261|NCT04811664|464675136|FG000|Overall Study|Lost to Follow-up|78|||
129104262|NCT04811664|464675137|FG001|Overall Study|Lost to Follow-up|125|||
129104263|NCT04811664|464675138|FG002|Overall Study|Lost to Follow-up|46|||
129104264|NCT04811664|464675136|FG000|Overall Study|Withdrawal by Subject|39|||
129104265|NCT04811664|464675137|FG001|Overall Study|Withdrawal by Subject|76|||
129104266|NCT04811664|464675138|FG002|Overall Study|Withdrawal by Subject|12|||
129104267|NCT04811664|464675136|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
129104268|NCT04811664|464675137|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
129104269|NCT04811664|464675138|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
129104270|NCT04811664|464675136|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
129104271|NCT04811664|464675137|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
129104272|NCT04811664|464675138|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
129104273|NCT04811664|464675136|FG000|Overall Study|Protocol Violation|0|||
129104274|NCT04811664|464675137|FG001|Overall Study|Protocol Violation|5|||
129104275|NCT04811664|464675138|FG002|Overall Study|Protocol Violation|11|||
129104276|NCT04811664|464675136|FG000|Overall Study|Study Terminated by Sponsor|4|||
129104277|NCT04811664|464675137|FG001|Overall Study|Study Terminated by Sponsor|3|||
129104278|NCT04811664|464675138|FG002|Overall Study|Study Terminated by Sponsor|34|||
129104279|NCT04811664|464675136|FG000|Overall Study|Early Study Closure|3|||
129104280|NCT04811664|464675137|FG001|Overall Study|Early Study Closure|7|||
129104281|NCT04811664|464675138|FG002|Overall Study|Early Study Closure|79|||
129104282|NCT04811664|464675136|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
129104283|NCT04811664|464675137|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
129104284|NCT04811664|464675138|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
129104285|NCT03034135|464675139|FG000|Overall Study|Withdrawal by Subject|2|||
129104286|NCT01972464|464675143|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
129104287|NCT01972464|464675144|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
129104288|NCT01972464|464675143|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
129104289|NCT01972464|464675144|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
129104290|NCT01972464|464675143|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
129104291|NCT01972464|464675144|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
129104292|NCT01972464|464675143|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
129104293|NCT01972464|464675144|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
129104294|NCT02576977|464677099|FG000|Overall Study|Adverse Event|13|||
129104295|NCT02576977|464677100|FG001|Overall Study|Adverse Event|2|||
129104296|NCT02576977|464677099|FG000|Overall Study|Death|73|||
129104297|NCT02576977|464677100|FG001|Overall Study|Death|60|||
129104298|NCT02576977|464677099|FG000|Overall Study|Screen failure|1|||
129104299|NCT02576977|464677100|FG001|Overall Study|Screen failure|0|||
129104300|NCT02576977|464677099|FG000|Overall Study|Study Terminated at Selected Sites|27|||
129104301|NCT02576977|464677100|FG001|Overall Study|Study Terminated at Selected Sites|50|||
129104302|NCT02576977|464677099|FG000|Overall Study|Withdrawal by Subject|11|||
129104303|NCT02576977|464677100|FG001|Overall Study|Withdrawal by Subject|11|||
129104304|NCT02576977|464677099|FG000|Overall Study|Final Disposition Unknown|0|||
129104305|NCT02576977|464677100|FG001|Overall Study|Final Disposition Unknown|1|||
129104306|NCT02576977|464677099|FG000|Overall Study|Lost to Follow-up|1|||
129104307|NCT02576977|464677100|FG001|Overall Study|Lost to Follow-up|0|||
129104308|NCT02576977|464677099|FG000|Overall Study|Progressive Disease|0|||
129104309|NCT02576977|464677100|FG001|Overall Study|Progressive Disease|1|||
129104310|NCT01128400|464677103|FG000|Overall Study|Lost to Follow-up|1|||
129104311|NCT01128400|464677104|FG001|Overall Study|Lost to Follow-up|0|||
129104312|NCT01128400|464677105|FG002|Overall Study|Lost to Follow-up|1|||
129104313|NCT01128400|464677103|FG000|Overall Study|Screening failure|1|||
129104314|NCT01128400|464677104|FG001|Overall Study|Screening failure|0|||
129104315|NCT01128400|464677105|FG002|Overall Study|Screening failure|0|||
129104316|NCT01128400|464677103|FG000|Overall Study|were not invited to participate on taste|0|||
129104317|NCT01128400|464677104|FG001|Overall Study|were not invited to participate on taste|0|||
129104318|NCT01128400|464677105|FG002|Overall Study|were not invited to participate on taste|15|||
129104319|NCT01128400|464677103|FG000|Overall Study|Excluded due to sinus problems|0|||
129104320|NCT01128400|464677104|FG001|Overall Study|Excluded due to sinus problems|1|||
129104321|NCT01128400|464677105|FG002|Overall Study|Excluded due to sinus problems|0|||
129104322|NCT00199849|464677107|FG000|Overall Study|Unrelated illness or complication|0|||
129104323|NCT00199849|464677108|FG001|Overall Study|Unrelated illness or complication|1|||
129104324|NCT00199849|464677109|FG002|Overall Study|Unrelated illness or complication|0|||
129104325|NCT00199849|464677107|FG000|Overall Study|Progressive disease requiring intervention|0|||
129104326|NCT00199849|464677108|FG001|Overall Study|Progressive disease requiring intervention|0|||
129104327|NCT00199849|464677109|FG002|Overall Study|Progressive disease requiring intervention|1|||
128682121|NCT01155479|463135464|FG003|Part I|Treatment Failure|1|||
129104328|NCT00199849|464677107|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
129104329|NCT00199849|464677108|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
128682122|NCT01155479|463135465|FG004|Part I|Treatment Failure|2|||
128682123|NCT01155479|463135461|FG000|Part I|Did Not Receive Treatment|4|||
128682124|NCT01155479|463135462|FG001|Part I|Did Not Receive Treatment|2|||
128682125|NCT01155479|463135463|FG002|Part I|Did Not Receive Treatment|2|||
128682126|NCT01155479|463135464|FG003|Part I|Did Not Receive Treatment|6|||
128682127|NCT01155479|463135465|FG004|Part I|Did Not Receive Treatment|1|||
128682128|NCT01155479|463135461|FG000|Part I|Non-Compliance with Protocol|2|||
128682129|NCT01155479|463135462|FG001|Part I|Non-Compliance with Protocol|1|||
128682130|NCT01155479|463135463|FG002|Part I|Non-Compliance with Protocol|3|||
128682131|NCT01155479|463135464|FG003|Part I|Non-Compliance with Protocol|3|||
128682132|NCT01155479|463135465|FG004|Part I|Non-Compliance with Protocol|2|||
128682133|NCT01155479|463135461|FG000|Part II|Adverse Event|7|||
128682134|NCT01155479|463135462|FG001|Part II|Adverse Event|6|||
128682135|NCT01155479|463135463|FG002|Part II|Adverse Event|8|||
128682136|NCT01155479|463135464|FG003|Part II|Adverse Event|3|||
128682137|NCT01155479|463135465|FG004|Part II|Adverse Event|4|||
128682138|NCT01155479|463135461|FG000|Part II|Administrative|43|||
128682139|NCT01155479|463135462|FG001|Part II|Administrative|49|||
128682140|NCT01155479|463135463|FG002|Part II|Administrative|36|||
128682141|NCT01155479|463135464|FG003|Part II|Administrative|38|||
128682142|NCT01155479|463135465|FG004|Part II|Administrative|46|||
128682143|NCT01155479|463135461|FG000|Part II|Withdrawal by Subject|8|||
128682144|NCT01155479|463135462|FG001|Part II|Withdrawal by Subject|4|||
128682145|NCT01155479|463135463|FG002|Part II|Withdrawal by Subject|12|||
128682146|NCT01155479|463135464|FG003|Part II|Withdrawal by Subject|7|||
128682147|NCT01155479|463135465|FG004|Part II|Withdrawal by Subject|3|||
128682148|NCT01155479|463135461|FG000|Part II|Lost to Follow-up|1|||
128682149|NCT01155479|463135462|FG001|Part II|Lost to Follow-up|0|||
129104330|NCT00199849|464677109|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
129104331|NCT04727528|464677110|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
129104332|NCT04727528|464677111|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
129104333|NCT04727528|464677110|FG000|Open-label Period|Randomized who did not receive treatment|1|||
129104334|NCT04727528|464677111|FG001|Open-label Period|Randomized who did not receive treatment|0|||
129104335|NCT04727528|464677110|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129104336|NCT04727528|464677111|FG001|Double-blind Treatment Phase|Adverse Event|1|||
128682150|NCT01155479|463135463|FG002|Part II|Lost to Follow-up|0|||
129104337|NCT04727528|464677110|FG000|Double-blind Treatment Phase|Death|0|||
129104338|NCT04727528|464677111|FG001|Double-blind Treatment Phase|Death|1|||
129104339|NCT04727528|464677110|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
129104340|NCT04727528|464677111|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
129104341|NCT04727528|464677110|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
129104342|NCT04727528|464677111|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
129104343|NCT04727528|464677110|FG000|Double-blind Treatment Phase|Physician Decision|0|||
129104344|NCT04727528|464677111|FG001|Double-blind Treatment Phase|Physician Decision|1|||
129104345|NCT04727528|464677110|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
129104346|NCT04727528|464677111|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129104347|NCT01763827|464677114|FG000|Overall Study|Withdrawal by Subject|1|||
129104348|NCT01763827|464677115|FG001|Overall Study|Withdrawal by Subject|0|||
129104349|NCT01763827|464677116|FG002|Overall Study|Withdrawal by Subject|0|||
129104350|NCT01763827|464677117|FG003|Overall Study|Withdrawal by Subject|0|||
129104351|NCT01763827|464677118|FG004|Overall Study|Withdrawal by Subject|2|||
129104352|NCT01763827|464677119|FG005|Overall Study|Withdrawal by Subject|0|||
129104353|NCT01763827|464677114|FG000|Overall Study|Decision by sponsor|2|||
129104354|NCT01763827|464677115|FG001|Overall Study|Decision by sponsor|0|||
129104355|NCT01763827|464677116|FG002|Overall Study|Decision by sponsor|3|||
129104356|NCT01763827|464677117|FG003|Overall Study|Decision by sponsor|0|||
129104357|NCT01763827|464677118|FG004|Overall Study|Decision by sponsor|2|||
129104358|NCT01763827|464677119|FG005|Overall Study|Decision by sponsor|1|||
129104359|NCT01763827|464677114|FG000|Overall Study|Lost to Follow-up|0|||
129104360|NCT01763827|464677115|FG001|Overall Study|Lost to Follow-up|1|||
129104361|NCT01763827|464677116|FG002|Overall Study|Lost to Follow-up|1|||
129104362|NCT01763827|464677117|FG003|Overall Study|Lost to Follow-up|1|||
129104363|NCT01763827|464677118|FG004|Overall Study|Lost to Follow-up|2|||
129104364|NCT01763827|464677119|FG005|Overall Study|Lost to Follow-up|1|||
129104365|NCT01826981|464677122|FG000|Overall Study|Lack of Efficacy|0|||
129104366|NCT01826981|464677123|FG001|Overall Study|Lack of Efficacy|1|||
129104367|NCT01826981|464677124|FG002|Overall Study|Lack of Efficacy|0|||
129104368|NCT01826981|464677125|FG003|Overall Study|Lack of Efficacy|0|||
129104369|NCT01826981|464677126|FG004|Overall Study|Lack of Efficacy|5|||
129104370|NCT01826981|464677127|FG005|Overall Study|Lack of Efficacy|0|||
128682151|NCT01155479|463135464|FG003|Part II|Lost to Follow-up|0|||
128682152|NCT01155479|463135465|FG004|Part II|Lost to Follow-up|1|||
128682153|NCT01155479|463135461|FG000|Part II|Treatment Failure|0|||
128682154|NCT01155479|463135462|FG001|Part II|Treatment Failure|1|||
128682155|NCT01155479|463135463|FG002|Part II|Treatment Failure|2|||
128682156|NCT01155479|463135464|FG003|Part II|Treatment Failure|0|||
128682157|NCT01155479|463135465|FG004|Part II|Treatment Failure|1|||
128682158|NCT01155479|463135461|FG000|Part II|Non-Compliance with Protocol|0|||
129104371|NCT01826981|464677128|FG006|Overall Study|Lack of Efficacy|0|||
129104372|NCT01826981|464677129|FG007|Overall Study|Lack of Efficacy|8|||
129104373|NCT01826981|464677130|FG008|Overall Study|Lack of Efficacy|7|||
129104374|NCT01826981|464677131|FG009|Overall Study|Lack of Efficacy|0|||
129104375|NCT01826981|464677132|FG010|Overall Study|Lack of Efficacy|1|||
129104376|NCT01826981|464677133|FG011|Overall Study|Lack of Efficacy|0|||
128682159|NCT01155479|463135462|FG001|Part II|Non-Compliance with Protocol|1|||
128682160|NCT01155479|463135463|FG002|Part II|Non-Compliance with Protocol|0|||
128682161|NCT01155479|463135464|FG003|Part II|Non-Compliance with Protocol|2|||
128682162|NCT01155479|463135465|FG004|Part II|Non-Compliance with Protocol|0|||
128682163|NCT00998764|463135466|FG000|Overall Study|Lack of Efficacy|3|||
128682164|NCT00998764|463135467|FG001|Overall Study|Lack of Efficacy|6|||
128682165|NCT00998764|463135466|FG000|Overall Study|Adverse Event|17|||
128682166|NCT00998764|463135467|FG001|Overall Study|Adverse Event|12|||
128682167|NCT00998764|463135466|FG000|Overall Study|Withdrawal by Subject|19|||
128682168|NCT00998764|463135467|FG001|Overall Study|Withdrawal by Subject|25|||
128682169|NCT00998764|463135466|FG000|Overall Study|Physician Decision|3|||
128682170|NCT00998764|463135467|FG001|Overall Study|Physician Decision|3|||
128682171|NCT00998764|463135466|FG000|Overall Study|Death|3|||
128682172|NCT00998764|463135467|FG001|Overall Study|Death|1|||
128682173|NCT00998764|463135466|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
128682174|NCT00998764|463135467|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
128682175|NCT00998764|463135466|FG000|Overall Study|Protocol Violation|0|||
129015913|NCT05093205|464351542|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
129015914|NCT05093205|464351543|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
129015915|NCT05093205|464351544|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
129015916|NCT05093205|464351545|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
129015917|NCT05093205|464351546|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
129015918|NCT05093205|464351547|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
129015919|NCT05093205|464351548|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
129015920|NCT05093205|464351549|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
129015921|NCT05093205|464351550|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
129015922|NCT05093205|464351551|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
129015923|NCT05093205|464351552|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
129015924|NCT05093205|464351553|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
129015925|NCT05093205|464351541|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
129015926|NCT05093205|464351542|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
129015927|NCT05093205|464351543|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
129015928|NCT05093205|464351544|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
129015929|NCT05093205|464351545|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
129015930|NCT05093205|464351546|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
129015931|NCT05093205|464351547|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
129015932|NCT05093205|464351548|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
129015933|NCT05093205|464351549|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
129015934|NCT05093205|464351550|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
129015935|NCT05093205|464351551|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
129015936|NCT05093205|464351552|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
129015937|NCT05093205|464351553|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
129015938|NCT05093205|464351541|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015939|NCT05093205|464351542|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015940|NCT05093205|464351543|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015941|NCT05093205|464351544|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015942|NCT05093205|464351545|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015943|NCT05093205|464351546|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015944|NCT05093205|464351547|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015945|NCT05093205|464351548|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015946|NCT05093205|464351549|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015947|NCT05093205|464351550|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
129015948|NCT05093205|464351551|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015949|NCT05093205|464351552|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015950|NCT05093205|464351553|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129015951|NCT05093205|464351541|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
129015952|NCT05093205|464351542|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
129015953|NCT05093205|464351543|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
129015954|NCT05093205|464351544|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
129015955|NCT05093205|464351545|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
129015956|NCT05093205|464351546|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
129015957|NCT05093205|464351547|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
129015958|NCT05093205|464351548|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
129015959|NCT05093205|464351549|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
129015960|NCT05093205|464351550|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
129015961|NCT05093205|464351551|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
129104377|NCT01826981|464677134|FG012|Overall Study|Lack of Efficacy|0|||
128682176|NCT00998764|463135467|FG001|Overall Study|Protocol Violation|1|||
128682177|NCT00998764|463135466|FG000|Overall Study|Failed to Return|1|||
128682178|NCT00998764|463135467|FG001|Overall Study|Failed to Return|1|||
128682179|NCT00998764|463135466|FG000|Overall Study|Lost to Follow-up|1|||
128682180|NCT00998764|463135467|FG001|Overall Study|Lost to Follow-up|1|||
128682181|NCT00998764|463135466|FG000|Overall Study|Loss of Caregiver|0|||
128682182|NCT00998764|463135467|FG001|Overall Study|Loss of Caregiver|3|||
128682183|NCT00998764|463135466|FG000|Overall Study|Other|4|||
128682184|NCT00998764|463135467|FG001|Overall Study|Other|4|||
128682185|NCT00998764|463135466|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
128682186|NCT00998764|463135467|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
128682187|NCT04761627|463135468|FG000|Run-in Period|Death|1|||
128682188|NCT04761627|463135469|FG001|Run-in Period|Death|0|||
128682189|NCT04761627|463135470|FG002|Run-in Period|Death|0|||
128682190|NCT04761627|463135468|FG000|Run-in Period|Required alternative therapy|2|||
128682191|NCT04761627|463135469|FG001|Run-in Period|Required alternative therapy|0|||
128682192|NCT04761627|463135470|FG002|Run-in Period|Required alternative therapy|0|||
128682193|NCT04761627|463135468|FG000|Run-in Period|Lost to Follow-up|2|||
128682194|NCT04761627|463135469|FG001|Run-in Period|Lost to Follow-up|0|||
128682195|NCT04761627|463135470|FG002|Run-in Period|Lost to Follow-up|0|||
128682196|NCT04761627|463135468|FG000|Run-in Period|Protocol Violation|3|||
129015962|NCT05093205|464351552|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
129015963|NCT05093205|464351553|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
128682197|NCT04761627|463135469|FG001|Run-in Period|Protocol Violation|0|||
128682198|NCT04761627|463135470|FG002|Run-in Period|Protocol Violation|0|||
128682199|NCT04761627|463135468|FG000|Run-in Period|Abnormal liver function|1|||
129015964|NCT05093205|464351541|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015965|NCT05093205|464351542|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015966|NCT05093205|464351543|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015967|NCT05093205|464351544|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015968|NCT05093205|464351545|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015969|NCT05093205|464351546|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015970|NCT05093205|464351547|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015971|NCT05093205|464351548|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015972|NCT05093205|464351549|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015973|NCT05093205|464351550|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015974|NCT05093205|464351551|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
129015975|NCT05093205|464351552|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015976|NCT05093205|464351553|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129015977|NCT05093205|464351541|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015978|NCT05093205|464351542|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015979|NCT05093205|464351543|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015980|NCT05093205|464351544|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015981|NCT05093205|464351545|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015982|NCT05093205|464351546|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015983|NCT05093205|464351547|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015984|NCT05093205|464351548|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
128682200|NCT04761627|463135469|FG001|Run-in Period|Abnormal liver function|0|||
128682201|NCT04761627|463135470|FG002|Run-in Period|Abnormal liver function|0|||
128682202|NCT04761627|463135468|FG000|Run-in Period|Adverse Event|6|||
128682203|NCT04761627|463135469|FG001|Run-in Period|Adverse Event|0|||
128682204|NCT04761627|463135470|FG002|Run-in Period|Adverse Event|0|||
128682205|NCT04761627|463135468|FG000|Run-in Period|Withdrawal by Subject|7|||
128682206|NCT04761627|463135469|FG001|Run-in Period|Withdrawal by Subject|0|||
128682207|NCT04761627|463135470|FG002|Run-in Period|Withdrawal by Subject|0|||
128682208|NCT04761627|463135468|FG000|Run-in Period|Did not meet PASI 50|15|||
128682209|NCT04761627|463135469|FG001|Run-in Period|Did not meet PASI 50|0|||
128682210|NCT04761627|463135470|FG002|Run-in Period|Did not meet PASI 50|0|||
128682211|NCT04761627|463135468|FG000|Run-in Period|Study site closure|2|||
128682212|NCT04761627|463135469|FG001|Run-in Period|Study site closure|0|||
129015985|NCT05093205|464351549|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015986|NCT05093205|464351550|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015987|NCT05093205|464351551|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015988|NCT05093205|464351552|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
129015989|NCT05093205|464351553|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129015990|NCT05093205|464351541|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
128682213|NCT04761627|463135470|FG002|Run-in Period|Study site closure|0|||
128682214|NCT04761627|463135468|FG000|Run-in Period|Pregnancy|2|||
128682215|NCT04761627|463135469|FG001|Run-in Period|Pregnancy|0|||
128682216|NCT04761627|463135470|FG002|Run-in Period|Pregnancy|0|||
128682217|NCT04761627|463135468|FG000|Post-randomization Period|Military service|0|||
128682218|NCT04761627|463135469|FG001|Post-randomization Period|Military service|1|||
128682219|NCT04761627|463135470|FG002|Post-randomization Period|Military service|0|||
129015991|NCT05093205|464351542|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
129015992|NCT05093205|464351543|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
129015993|NCT05093205|464351544|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
128682220|NCT04761627|463135468|FG000|Post-randomization Period|Adverse Event|0|||
128682221|NCT04761627|463135469|FG001|Post-randomization Period|Adverse Event|4|||
129015994|NCT05093205|464351545|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
129015995|NCT05093205|464351546|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
129015996|NCT05093205|464351547|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
129015997|NCT05093205|464351548|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
129015998|NCT05093205|464351549|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
129015999|NCT05093205|464351550|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
129016000|NCT05093205|464351551|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
129016001|NCT05093205|464351552|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
129016002|NCT05093205|464351553|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
129016003|NCT05093205|464351541|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016004|NCT05093205|464351542|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016005|NCT05093205|464351543|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016006|NCT05093205|464351544|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016007|NCT05093205|464351545|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016008|NCT05093205|464351546|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016009|NCT05093205|464351547|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016010|NCT05093205|464351548|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016011|NCT05093205|464351549|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016012|NCT05093205|464351550|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016013|NCT05093205|464351551|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016014|NCT05093205|464351552|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
129016015|NCT05093205|464351553|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129016016|NCT03361228|464351554|FG000|Overall Study|Other|1|||
129016017|NCT03361228|464351555|FG001|Overall Study|Other|1|||
129016018|NCT03361228|464351554|FG000|Overall Study|Death|3|||
129016019|NCT03361228|464351555|FG001|Overall Study|Death|0|||
129016020|NCT04149964|464351558|FG000|Overall Study|Lost to Follow-up|19|||
129016021|NCT04149964|464351559|FG001|Overall Study|Lost to Follow-up|18|||
129016022|NCT04753437|464351560|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129016023|NCT04753437|464351561|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129016024|NCT04753437|464351560|FG000|Overall Study|Liver Function Test Abnormalities|2|||
129016025|NCT04753437|464351561|FG001|Overall Study|Liver Function Test Abnormalities|4|||
129016026|NCT01223365|464351562|FG000|Open-label Titration Period|Enrolled but not treated|1|||
129016027|NCT01223365|464351562|FG000|Open-label Titration Period|Adverse Event|23|||
129016028|NCT01223365|464351562|FG000|Open-label Titration Period|Lack of Efficacy|3|||
129016029|NCT01223365|464351562|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
129016030|NCT01223365|464351562|FG000|Open-label Titration Period|Protocol Violation|1|||
129016031|NCT01223365|464351562|FG000|Open-label Titration Period|Lost to Follow-up|2|||
129016032|NCT01223365|464351562|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
129016033|NCT01223365|464351562|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
129016034|NCT01223365|464351562|FG000|Open-label Titration Period|Starting physical therapy|1|||
129016035|NCT01223365|464351562|FG000|Open-label Treatment Period|Adverse Event|39|||
129016036|NCT01223365|464351562|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
129016037|NCT01223365|464351562|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
129016038|NCT01223365|464351562|FG000|Open-label Treatment Period|Protocol Violation|15|||
129016039|NCT01223365|464351562|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
129016040|NCT01223365|464351562|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
129016041|NCT01223365|464351562|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
129016042|NCT01223365|464351562|FG000|Open-label Treatment Period|Moved out of area|2|||
129016043|NCT01223365|464351562|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
129016044|NCT01223365|464351562|FG000|Open-label Treatment Period|"Out of window"|1|||
129016045|NCT01223365|464351562|FG000|Open-label Treatment Period|Starting physical therapy|1|||
129016046|NCT01223365|464351562|FG000|Open-label Treatment Period|Physician Decision|2|||
129016047|NCT03567174|464351563|FG000|Overall Study|Death|24|||
129016048|NCT03567174|464351564|FG001|Overall Study|Death|31|||
129016049|NCT03567174|464351563|FG000|Overall Study|Lost to Follow-up|165|||
129016050|NCT03567174|464351564|FG001|Overall Study|Lost to Follow-up|174|||
129016051|NCT03243630|464351565|FG000|Overall Study|Protocol Violation|1|||
129016052|NCT03243630|464351565|FG000|Overall Study|Physician Decision|1|||
129016053|NCT02140060|464351566|FG000|Overall Study|Adverse Event|0|||
129016054|NCT02140060|464351567|FG001|Overall Study|Adverse Event|0|||
129016055|NCT02140060|464351568|FG002|Overall Study|Adverse Event|0|||
129016056|NCT02140060|464351569|FG003|Overall Study|Adverse Event|1|||
129016057|NCT02140060|464351570|FG004|Overall Study|Adverse Event|1|||
129016058|NCT02140060|464351571|FG005|Overall Study|Adverse Event|1|||
129016059|NCT02140060|464351566|FG000|Overall Study|Lack of Efficacy|0|||
129016060|NCT02140060|464351567|FG001|Overall Study|Lack of Efficacy|0|||
129016061|NCT02140060|464351568|FG002|Overall Study|Lack of Efficacy|0|||
129016062|NCT02140060|464351569|FG003|Overall Study|Lack of Efficacy|1|||
129016063|NCT02140060|464351570|FG004|Overall Study|Lack of Efficacy|0|||
129016064|NCT02140060|464351571|FG005|Overall Study|Lack of Efficacy|0|||
129016065|NCT02817841|464353349|FG000|Overall Study|Lost to Follow-up|287|||
129104378|NCT01826981|464677135|FG013|Overall Study|Lack of Efficacy|3|||
129104379|NCT01826981|464677136|FG014|Overall Study|Lack of Efficacy|0|||
129104380|NCT01826981|464677122|FG000|Overall Study|Lost to Follow-up|0|||
129104381|NCT01826981|464677123|FG001|Overall Study|Lost to Follow-up|0|||
129104382|NCT01826981|464677124|FG002|Overall Study|Lost to Follow-up|0|||
129104383|NCT01826981|464677125|FG003|Overall Study|Lost to Follow-up|0|||
129104384|NCT01826981|464677126|FG004|Overall Study|Lost to Follow-up|1|||
129104385|NCT01826981|464677127|FG005|Overall Study|Lost to Follow-up|1|||
129104386|NCT01826981|464677128|FG006|Overall Study|Lost to Follow-up|0|||
129104387|NCT01826981|464677129|FG007|Overall Study|Lost to Follow-up|1|||
129104388|NCT01826981|464677130|FG008|Overall Study|Lost to Follow-up|0|||
129104389|NCT01826981|464677131|FG009|Overall Study|Lost to Follow-up|1|||
129104390|NCT01826981|464677132|FG010|Overall Study|Lost to Follow-up|1|||
129104391|NCT01826981|464677133|FG011|Overall Study|Lost to Follow-up|1|||
129104392|NCT01826981|464677134|FG012|Overall Study|Lost to Follow-up|1|||
129104393|NCT01826981|464677135|FG013|Overall Study|Lost to Follow-up|0|||
129104394|NCT01826981|464677136|FG014|Overall Study|Lost to Follow-up|0|||
128682222|NCT04761627|463135470|FG002|Post-randomization Period|Adverse Event|2|||
128682223|NCT04761627|463135468|FG000|Post-randomization Period|Lost to Follow-up|0|||
128682224|NCT04761627|463135469|FG001|Post-randomization Period|Lost to Follow-up|6|||
128682225|NCT04761627|463135470|FG002|Post-randomization Period|Lost to Follow-up|6|||
128682226|NCT04761627|463135468|FG000|Post-randomization Period|Withdrawal by Subject|0|||
128682227|NCT04761627|463135469|FG001|Post-randomization Period|Withdrawal by Subject|7|||
128682228|NCT04761627|463135470|FG002|Post-randomization Period|Withdrawal by Subject|6|||
128682229|NCT04761627|463135468|FG000|Post-randomization Period|Pregnancy|0|||
128682230|NCT04761627|463135469|FG001|Post-randomization Period|Pregnancy|0|||
128682231|NCT04761627|463135470|FG002|Post-randomization Period|Pregnancy|1|||
128682232|NCT04761627|463135468|FG000|Post-randomization Period|Study site closure|0|||
128682233|NCT04761627|463135469|FG001|Post-randomization Period|Study site closure|0|||
128682234|NCT04761627|463135470|FG002|Post-randomization Period|Study site closure|1|||
128682235|NCT04761627|463135468|FG000|Post-randomization Period|Family planning|0|||
128682236|NCT04761627|463135469|FG001|Post-randomization Period|Family planning|1|||
128682237|NCT04761627|463135470|FG002|Post-randomization Period|Family planning|0|||
128682238|NCT01214174|463135471|FG000|Overall Study|Withdrawal by Subject|0|||
128682239|NCT01214174|463135472|FG001|Overall Study|Withdrawal by Subject|0|||
128682240|NCT01214174|463135473|FG002|Overall Study|Withdrawal by Subject|1|||
128682241|NCT01634178|463135476|FG000|Treatment Period 1|Adverse Event|0|||
128682242|NCT01634178|463135477|FG001|Treatment Period 1|Adverse Event|1|||
129104395|NCT01826981|464677122|FG000|Overall Study|Withdrew Consent|0|||
129104396|NCT01826981|464677123|FG001|Overall Study|Withdrew Consent|0|||
129104397|NCT01826981|464677124|FG002|Overall Study|Withdrew Consent|0|||
129104398|NCT01826981|464677125|FG003|Overall Study|Withdrew Consent|0|||
129104399|NCT01826981|464677126|FG004|Overall Study|Withdrew Consent|0|||
129104400|NCT01826981|464677127|FG005|Overall Study|Withdrew Consent|0|||
129104401|NCT01826981|464677128|FG006|Overall Study|Withdrew Consent|1|||
129104402|NCT01826981|464677129|FG007|Overall Study|Withdrew Consent|1|||
129104403|NCT01826981|464677130|FG008|Overall Study|Withdrew Consent|0|||
129104404|NCT01826981|464677131|FG009|Overall Study|Withdrew Consent|0|||
129104405|NCT01826981|464677132|FG010|Overall Study|Withdrew Consent|0|||
129104406|NCT01826981|464677133|FG011|Overall Study|Withdrew Consent|1|||
129104407|NCT01826981|464677134|FG012|Overall Study|Withdrew Consent|0|||
129104408|NCT01826981|464677135|FG013|Overall Study|Withdrew Consent|1|||
128682243|NCT01634178|463135476|FG000|Treatment Period 2|Adverse Event|1|||
128682244|NCT01634178|463135477|FG001|Treatment Period 2|Adverse Event|0|||
128682245|NCT05867342|463135478|FG000|Overall Study|Investigator Decision|3|||
128682246|NCT05867342|463135479|FG001|Overall Study|Investigator Decision|3|||
128682247|NCT00470184|463135480|FG000|Overall Study|Not Treated(became ineligible)|4|||
128682248|NCT00470184|463135480|FG000|Overall Study|Not treated (other)|1|||
128682249|NCT00470184|463135480|FG000|Overall Study|disease Progression|4|||
128682250|NCT00470184|463135480|FG000|Overall Study|Adverse Event|3|||
128682251|NCT00470184|463135480|FG000|Overall Study|Withdrawal by Subject|4|||
128682252|NCT00470184|463135480|FG000|Overall Study|other|5|||
128682253|NCT00470184|463135480|FG000|Overall Study|recurrence|1|||
128682254|NCT00991952|463135482|FG000|Overall Study|Adverse Event|0|||
129104409|NCT01826981|464677136|FG014|Overall Study|Withdrew Consent|0|||
129104410|NCT01826981|464677122|FG000|Overall Study|Adverse Event|0|||
129104411|NCT01826981|464677123|FG001|Overall Study|Adverse Event|0|||
129104412|NCT01826981|464677124|FG002|Overall Study|Adverse Event|0|||
129104413|NCT01826981|464677125|FG003|Overall Study|Adverse Event|0|||
129104414|NCT01826981|464677126|FG004|Overall Study|Adverse Event|1|||
129104415|NCT01826981|464677127|FG005|Overall Study|Adverse Event|0|||
129104416|NCT01826981|464677128|FG006|Overall Study|Adverse Event|0|||
128682255|NCT00991952|463135483|FG001|Overall Study|Adverse Event|1|||
128682256|NCT02483533|463135485|FG000|Overall Study|Lack of Efficacy|50|||
128682257|NCT02483533|463135486|FG001|Overall Study|Lack of Efficacy|50|||
128682258|NCT00582816|463135487|FG000|Overall Study|Engraftment Failure|3|||
129104417|NCT01826981|464677129|FG007|Overall Study|Adverse Event|0|||
128682259|NCT02283177|463135490|FG000|Overall Study|Withdrawal by Subject|1|||
129104418|NCT01826981|464677130|FG008|Overall Study|Adverse Event|0|||
129104419|NCT01826981|464677131|FG009|Overall Study|Adverse Event|0|||
129104420|NCT01826981|464677132|FG010|Overall Study|Adverse Event|0|||
129104421|NCT01826981|464677133|FG011|Overall Study|Adverse Event|0|||
129104422|NCT01826981|464677134|FG012|Overall Study|Adverse Event|0|||
129104423|NCT01826981|464677135|FG013|Overall Study|Adverse Event|0|||
129104424|NCT01826981|464677136|FG014|Overall Study|Adverse Event|0|||
129104425|NCT01826981|464677122|FG000|Overall Study|Upper G-I Haemorrhage|0|||
129104426|NCT01826981|464677123|FG001|Overall Study|Upper G-I Haemorrhage|0|||
129104427|NCT01826981|464677124|FG002|Overall Study|Upper G-I Haemorrhage|0|||
129104428|NCT01826981|464677125|FG003|Overall Study|Upper G-I Haemorrhage|0|||
129104429|NCT01826981|464677126|FG004|Overall Study|Upper G-I Haemorrhage|0|||
129104430|NCT01826981|464677127|FG005|Overall Study|Upper G-I Haemorrhage|0|||
129104431|NCT01826981|464677128|FG006|Overall Study|Upper G-I Haemorrhage|0|||
129104432|NCT01826981|464677129|FG007|Overall Study|Upper G-I Haemorrhage|0|||
129104433|NCT01826981|464677130|FG008|Overall Study|Upper G-I Haemorrhage|0|||
129104434|NCT01826981|464677131|FG009|Overall Study|Upper G-I Haemorrhage|0|||
129104435|NCT01826981|464677132|FG010|Overall Study|Upper G-I Haemorrhage|0|||
129104436|NCT01826981|464677133|FG011|Overall Study|Upper G-I Haemorrhage|0|||
129104437|NCT01826981|464677134|FG012|Overall Study|Upper G-I Haemorrhage|0|||
129104438|NCT01826981|464677135|FG013|Overall Study|Upper G-I Haemorrhage|1|||
129104439|NCT01826981|464677136|FG014|Overall Study|Upper G-I Haemorrhage|0|||
129104440|NCT01826981|464677122|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104441|NCT01826981|464677123|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104442|NCT01826981|464677124|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104443|NCT01826981|464677125|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104444|NCT01826981|464677126|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104445|NCT01826981|464677127|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104446|NCT01826981|464677128|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104447|NCT01826981|464677129|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
129104448|NCT01826981|464677130|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104449|NCT01826981|464677131|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104450|NCT01826981|464677132|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104451|NCT01826981|464677133|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104452|NCT01826981|464677134|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104453|NCT01826981|464677135|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104454|NCT01826981|464677136|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
129104455|NCT02906579|464677139|FG000|Overall Study|Adverse Event|1|||
129104456|NCT02906579|464677139|FG000|Overall Study|Physician Decision|1|||
129104457|NCT02030119|464677140|FG000|Overall Study|Withdrawal by Subject|3|||
129104458|NCT02030119|464677141|FG001|Overall Study|Withdrawal by Subject|1|||
129104459|NCT02030119|464677142|FG002|Overall Study|Withdrawal by Subject|5|||
129104460|NCT02030119|464677143|FG003|Overall Study|Withdrawal by Subject|3|||
129104461|NCT02030119|464677140|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
129104462|NCT02030119|464677141|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
129104463|NCT02030119|464677142|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
129104464|NCT02030119|464677143|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
129104465|NCT00759655|464677144|FG000|Overall Study|Termination of the study by sponsor|1|||
129104466|NCT02793947|464677145|FG000|Overall Study|Death|1|||
129104467|NCT02793947|464677146|FG001|Overall Study|Death|0|||
129104468|NCT02793947|464677145|FG000|Overall Study|Physician Decision|1|||
129104469|NCT02793947|464677146|FG001|Overall Study|Physician Decision|5|||
129104470|NCT01704755|464677151|FG000|Overall Study|Adverse Event|4|||
129104471|NCT01704755|464677152|FG001|Overall Study|Adverse Event|1|||
129104472|NCT01704755|464677151|FG000|Overall Study|Lost to Follow-up|3|||
129104473|NCT01704755|464677152|FG001|Overall Study|Lost to Follow-up|4|||
129104474|NCT01704755|464677151|FG000|Overall Study|Withdrew consent|1|||
129104475|NCT01704755|464677152|FG001|Overall Study|Withdrew consent|1|||
129104476|NCT01704755|464677151|FG000|Overall Study|Other (not specified)|3|||
129104477|NCT01704755|464677152|FG001|Overall Study|Other (not specified)|1|||
129104478|NCT01704755|464677151|FG000|Overall Study|Withdrew consent and personal issues|1|||
129104479|NCT01704755|464677152|FG001|Overall Study|Withdrew consent and personal issues|0|||
129104480|NCT04105842|464677153|FG000|Overall Study|Withdrawal by Subject|2|||
129104481|NCT01639703|464677154|FG000|Overall Study|Withdrawal by Subject|5|||
129104482|NCT01639703|464677154|FG000|Overall Study|Other reason|7|||
129104483|NCT02087670|464677155|FG000|Overall Study|Withdrawal by Subject|3|||
129104484|NCT02087670|464677156|FG001|Overall Study|Withdrawal by Subject|2|||
129104485|NCT01042392|464677157|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
129104486|NCT01042392|464677158|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
129104487|NCT01042392|464677159|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
129104488|NCT01042392|464677160|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
129104489|NCT01042392|464677157|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
128682260|NCT02283177|463135491|FG001|Overall Study|Withdrawal by Subject|1|||
129104490|NCT01042392|464677158|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
128682261|NCT01101191|463135492|FG000|Period 1|Withdrawal by Subject|1|||
128682262|NCT01101191|463135493|FG001|Period 1|Withdrawal by Subject|0|||
128682263|NCT01101191|463135492|FG000|Period 1|Adverse Event|1|||
128682264|NCT01101191|463135493|FG001|Period 1|Adverse Event|2|||
128682265|NCT02009384|463135494|FG000|Overall Study|Death|2|||
128682266|NCT00718237|463135496|FG000|Overall Study|Adverse Event|1|||
128682267|NCT00718237|463135497|FG001|Overall Study|Adverse Event|3|||
128682268|NCT00718237|463135496|FG000|Overall Study|Lost to Follow-up|2|||
128682269|NCT00718237|463135497|FG001|Overall Study|Lost to Follow-up|2|||
128682270|NCT00718237|463135496|FG000|Overall Study|Physician Decision|1|||
128682271|NCT00718237|463135497|FG001|Overall Study|Physician Decision|0|||
128682272|NCT00718237|463135496|FG000|Overall Study|Withdrawal by Subject|9|||
129016066|NCT02817841|464353349|FG000|Overall Study|Withdrawal by Subject|183|||
129016067|NCT02817841|464353349|FG000|Overall Study|Adverse event not related to bleeding|131|||
129016068|NCT02817841|464353349|FG000|Overall Study|Adverse event related to bleeding|51|||
129016069|NCT02817841|464353349|FG000|Overall Study|Pregnancy|32|||
129016070|NCT02817841|464353349|FG000|Overall Study|Pregnancy wish|17|||
129016071|NCT02817841|464353349|FG000|Overall Study|Other reasons|53|||
129016072|NCT02817841|464353349|FG000|Overall Study|Protocol Violation|94|||
129016073|NCT01746017|464353358|FG000|Period 1|Withdrawal by Subject|0|||
129016074|NCT01746017|464353359|FG001|Period 1|Withdrawal by Subject|0|||
129016075|NCT01746017|464353360|FG002|Period 1|Withdrawal by Subject|0|||
129016076|NCT01746017|464353361|FG003|Period 1|Withdrawal by Subject|0|||
129016077|NCT01746017|464353362|FG004|Period 1|Withdrawal by Subject|0|||
129016078|NCT01746017|464353363|FG005|Period 1|Withdrawal by Subject|0|||
129016079|NCT01746017|464353364|FG006|Period 1|Withdrawal by Subject|1|||
129016080|NCT01746017|464353365|FG007|Period 1|Withdrawal by Subject|0|||
129016081|NCT01746017|464353366|FG008|Period 1|Withdrawal by Subject|0|||
129016082|NCT01746017|464353367|FG009|Period 1|Withdrawal by Subject|0|||
129016083|NCT01746017|464353368|FG010|Period 1|Withdrawal by Subject|0|||
129016084|NCT01746017|464353358|FG000|Period 3|Withdrawal by Subject|0|||
129016085|NCT01746017|464353359|FG001|Period 3|Withdrawal by Subject|0|||
129016086|NCT01746017|464353360|FG002|Period 3|Withdrawal by Subject|0|||
129016087|NCT01746017|464353361|FG003|Period 3|Withdrawal by Subject|0|||
129016088|NCT01746017|464353362|FG004|Period 3|Withdrawal by Subject|0|||
129016089|NCT01746017|464353363|FG005|Period 3|Withdrawal by Subject|1|||
129016090|NCT01746017|464353364|FG006|Period 3|Withdrawal by Subject|0|||
129016091|NCT01746017|464353365|FG007|Period 3|Withdrawal by Subject|0|||
129016092|NCT01746017|464353366|FG008|Period 3|Withdrawal by Subject|0|||
129016093|NCT01746017|464353367|FG009|Period 3|Withdrawal by Subject|0|||
129016094|NCT01746017|464353368|FG010|Period 3|Withdrawal by Subject|0|||
129016095|NCT00397488|464353369|FG000|Overall Study|Withdrawal by Subject|3|||
129016096|NCT00397488|464353369|FG000|Overall Study|Adverse Event|3|||
129016097|NCT00397488|464353369|FG000|Overall Study|Death|1|||
129016098|NCT02943447|464353370|FG000|Blinded Study Phase|Withdrew Consent|1|||
129016099|NCT02943447|464353371|FG001|Blinded Study Phase|Withdrew Consent|2|||
129016100|NCT02943447|464353372|FG002|Blinded Study Phase|Withdrew Consent|1|||
129016101|NCT02943447|464353370|FG000|Blinded Study Phase|Adverse Event|3|||
129016102|NCT02943447|464353371|FG001|Blinded Study Phase|Adverse Event|0|||
129016103|NCT02943447|464353372|FG002|Blinded Study Phase|Adverse Event|0|||
129016104|NCT02943447|464353370|FG000|Blinded Study Phase|Investigator's discretion|1|||
129016105|NCT02943447|464353371|FG001|Blinded Study Phase|Investigator's discretion|0|||
129016106|NCT02943447|464353372|FG002|Blinded Study Phase|Investigator's discretion|0|||
129016107|NCT02943447|464353370|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
129016108|NCT02943447|464353371|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
129016109|NCT02943447|464353372|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
129016110|NCT02943447|464353370|FG000|Open-Label Extension Phase|Adverse Event|4|||
129016111|NCT02943447|464353371|FG001|Open-Label Extension Phase|Adverse Event|7|||
129016112|NCT02943447|464353372|FG002|Open-Label Extension Phase|Adverse Event|3|||
129016113|NCT02943447|464353370|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
129016114|NCT02943447|464353371|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
129016115|NCT02943447|464353372|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
129016116|NCT02943447|464353370|FG000|Open-Label Extension Phase|Withdrew consent|1|||
128682273|NCT00718237|463135497|FG001|Overall Study|Withdrawal by Subject|10|||
128682274|NCT03189381|463135498|FG000|Overall Study|Death|1|||
128682275|NCT03189381|463135499|FG001|Overall Study|Death|0|||
128682276|NCT03761797|463135500|FG000|Overall Study|Changing hospital|11|||
128682277|NCT03761797|463135500|FG000|Overall Study|Improvement/remission|6|||
128682278|NCT03761797|463135500|FG000|Overall Study|Withdrawal by Subject|19|||
128682279|NCT03761797|463135500|FG000|Overall Study|Lost to Follow-up|33|||
128682280|NCT03761797|463135500|FG000|Overall Study|Adverse Event|37|||
129016117|NCT02943447|464353371|FG001|Open-Label Extension Phase|Withdrew consent|1|||
129016118|NCT02943447|464353372|FG002|Open-Label Extension Phase|Withdrew consent|1|||
129016119|NCT02943447|464353370|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129016120|NCT02943447|464353371|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
128682281|NCT03761797|463135500|FG000|Overall Study|Case report form (CRF) not collected|5|||
128682282|NCT03761797|463135500|FG000|Overall Study|No patient visit after entry|13|||
128682283|NCT03761797|463135500|FG000|Overall Study|Switch to other diabetes medication|10|||
128682284|NCT03761797|463135500|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
128682285|NCT03761797|463135500|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
128682286|NCT03761797|463135500|FG000|Overall Study|Insufficient effectives|2|||
128682287|NCT03761797|463135500|FG000|Overall Study|Excessive alcohol intake|1|||
128682288|NCT00251004|463135501|FG000|Overall Study|Withdrawal by Subject|23|||
128682289|NCT00251004|463135502|FG001|Overall Study|Withdrawal by Subject|16|||
128682290|NCT00251004|463135503|FG002|Overall Study|Withdrawal by Subject|14|||
128682291|NCT00251004|463135501|FG000|Overall Study|Death|9|||
128682292|NCT00251004|463135502|FG001|Overall Study|Death|10|||
128682293|NCT00251004|463135503|FG002|Overall Study|Death|8|||
128682294|NCT00251004|463135501|FG000|Overall Study|Lost to Follow-up|1|||
128682295|NCT00251004|463135502|FG001|Overall Study|Lost to Follow-up|2|||
128682296|NCT00251004|463135503|FG002|Overall Study|Lost to Follow-up|1|||
128682297|NCT00251004|463135501|FG000|Overall Study|Graft Loss|12|||
128682298|NCT00251004|463135502|FG001|Overall Study|Graft Loss|13|||
128682299|NCT00251004|463135503|FG002|Overall Study|Graft Loss|8|||
128682300|NCT00879879|463135504|FG000|Overall Study|Death|1|||
128682301|NCT00879879|463135504|FG000|Overall Study|Withdrawal by Subject|1|||
128682302|NCT00879879|463135504|FG000|Overall Study|Physician Decision|1|||
128682303|NCT02021656|463135506|FG000|Overall Study|Adverse Event|1|||
128682304|NCT02021656|463135506|FG000|Overall Study|Lack of Efficacy|2|||
128682305|NCT02021656|463135506|FG000|Overall Study|Lost to Follow-up|1|||
128682306|NCT02021656|463135506|FG000|Overall Study|Withdrew Consent|2|||
128682307|NCT00596362|463135507|FG000|Overall Study|Progressive Disease|1|||
128682308|NCT00356122|463135510|FG000|TREATMENT|Lack of Efficacy|26|||
128682309|NCT00356122|463135510|FG000|TREATMENT|Adverse Event|10|||
128682310|NCT00356122|463135510|FG000|TREATMENT|Subject's request|4|||
128682311|NCT00356122|463135510|FG000|TREATMENT|Other|4|||
128682312|NCT00356122|463135510|FG000|TREATMENT|Did not receive study medication|1|||
128682313|NCT00356122|463135510|FG000|FOLLOW-UP|Death|37|||
128682314|NCT00356122|463135510|FG000|FOLLOW-UP|Lost to Follow-up|2|||
128682315|NCT00356122|463135510|FG000|FOLLOW-UP|Other|2|||
128682316|NCT02418156|463135511|FG000|Overall Study|Lost to Follow-up|12|||
128682317|NCT02418156|463135511|FG000|Overall Study|Death|2|||
128682318|NCT02418156|463135511|FG000|Overall Study|Physician Decision|1|||
128682319|NCT02418156|463135511|FG000|Overall Study|Withdrawal by Subject|1|||
128682320|NCT02418156|463135511|FG000|Overall Study|Subject refused to return|1|||
128682321|NCT00993044|463135514|FG000|Irinotecan 50 mg|Physician Decision|1|||
128682322|NCT00734747|463135515|FG000|SRS Procedure|No staples placed|3|||
128682323|NCT00734747|463135515|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
128682324|NCT01909453|463135517|FG000|Overall Study|Ongoing|118|||
128682325|NCT01909453|463135518|FG001|Overall Study|Ongoing|103|||
128682326|NCT01909453|463135519|FG002|Overall Study|Ongoing|83|||
128682327|NCT01909453|463135520|FG003|Overall Study|Ongoing|164|||
128682328|NCT01909453|463135521|FG004|Overall Study|Ongoing|50|||
128682329|NCT01909453|463135517|FG000|Overall Study|Death|69|||
128682330|NCT01909453|463135518|FG001|Overall Study|Death|74|||
128682331|NCT01909453|463135519|FG002|Overall Study|Death|88|||
128682332|NCT01909453|463135520|FG003|Overall Study|Death|86|||
129016121|NCT02943447|464353372|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129016122|NCT01294787|464353373|FG000|Period 1|Adverse Event|0|||
129016123|NCT01294787|464353374|FG001|Period 1|Adverse Event|0|||
129016124|NCT01294787|464353375|FG002|Period 1|Adverse Event|0|||
129016125|NCT01294787|464353376|FG003|Period 1|Adverse Event|0|||
129016126|NCT01294787|464353377|FG004|Period 1|Adverse Event|1|||
129016127|NCT01294787|464353378|FG005|Period 1|Adverse Event|0|||
129016128|NCT01294787|464353373|FG000|Period 1|Withdrawal by Subject|0|||
129016129|NCT01294787|464353374|FG001|Period 1|Withdrawal by Subject|0|||
129016130|NCT01294787|464353375|FG002|Period 1|Withdrawal by Subject|0|||
129016131|NCT01294787|464353376|FG003|Period 1|Withdrawal by Subject|1|||
129016132|NCT01294787|464353377|FG004|Period 1|Withdrawal by Subject|1|||
128682333|NCT01909453|463135521|FG004|Overall Study|Death|29|||
128682334|NCT01909453|463135517|FG000|Overall Study|Lost to Follow-up|3|||
128682335|NCT01909453|463135518|FG001|Overall Study|Lost to Follow-up|4|||
128682336|NCT01909453|463135519|FG002|Overall Study|Lost to Follow-up|4|||
128682337|NCT01909453|463135520|FG003|Overall Study|Lost to Follow-up|3|||
128682338|NCT01909453|463135521|FG004|Overall Study|Lost to Follow-up|3|||
129016133|NCT01294787|464353378|FG005|Period 1|Withdrawal by Subject|1|||
128682339|NCT01909453|463135517|FG000|Overall Study|Withdrawal by Subject|2|||
128682340|NCT01909453|463135518|FG001|Overall Study|Withdrawal by Subject|13|||
128682341|NCT01909453|463135519|FG002|Overall Study|Withdrawal by Subject|16|||
128682342|NCT01909453|463135520|FG003|Overall Study|Withdrawal by Subject|5|||
129016134|NCT01294787|464353373|FG000|Period 1|Administrative problem|0|||
128682343|NCT01909453|463135521|FG004|Overall Study|Withdrawal by Subject|4|||
128682344|NCT04854642|463137329|FG000|Overall Study|Adverse Event|1|||
128682345|NCT04854642|463137330|FG001|Overall Study|Adverse Event|2|||
128682346|NCT04854642|463137329|FG000|Overall Study|Withdrawal by Subject|0|||
129016135|NCT01294787|464353374|FG001|Period 1|Administrative problem|0|||
129016136|NCT01294787|464353375|FG002|Period 1|Administrative problem|1|||
129016137|NCT01294787|464353376|FG003|Period 1|Administrative problem|0|||
129104491|NCT01042392|464677159|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
129104492|NCT01042392|464677160|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
129104493|NCT01042392|464677157|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
129104494|NCT01042392|464677158|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
129104495|NCT01042392|464677159|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
129104496|NCT01042392|464677160|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
129104497|NCT01042392|464677157|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
129104498|NCT01042392|464677158|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
129104499|NCT01042392|464677159|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
129104500|NCT01042392|464677160|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
129104501|NCT01042392|464677157|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
129104502|NCT01042392|464677158|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
129104503|NCT01042392|464677159|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
129104504|NCT01042392|464677160|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
129104505|NCT01042392|464677157|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
129104506|NCT01042392|464677158|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
129104507|NCT01042392|464677159|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
128682347|NCT04854642|463137330|FG001|Overall Study|Withdrawal by Subject|1|||
128682348|NCT01314911|463137331|FG000|Overall Study|Lost to Follow-up|3|||
128682349|NCT01314911|463137332|FG001|Overall Study|Lost to Follow-up|2|||
128682350|NCT01314911|463137331|FG000|Overall Study|Withdrawal by Subject|1|||
128682351|NCT01314911|463137332|FG001|Overall Study|Withdrawal by Subject|3|||
128682352|NCT01314911|463137331|FG000|Overall Study|Received Non-randomized Study Drug|0|||
128682353|NCT01314911|463137332|FG001|Overall Study|Received Non-randomized Study Drug|1|||
128682354|NCT01314911|463137331|FG000|Overall Study|Never Started Treatment|1|||
128682355|NCT01314911|463137332|FG001|Overall Study|Never Started Treatment|0|||
128682356|NCT04006119|463137340|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
128682357|NCT04006119|463137340|FG000|End of Treatment Veledimex|Adverse Event|2|||
128682358|NCT04006119|463137340|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
128682359|NCT04006119|463137340|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
128682360|NCT04006119|463137340|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
128682361|NCT04006119|463137340|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
128682362|NCT04850313|463137341|FG000|Overall Study|Withdrawal by Subject|0|||
128682363|NCT04850313|463137342|FG001|Overall Study|Withdrawal by Subject|1|||
128682364|NCT03350984|463137343|FG000|Overall Study|Death|1|||
128682365|NCT03350984|463137344|FG001|Overall Study|Death|0|||
129104508|NCT01042392|464677160|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
129104509|NCT01042392|464677157|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
128682366|NCT03350984|463137343|FG000|Overall Study|Lost to Follow-up|5|||
128682367|NCT03350984|463137344|FG001|Overall Study|Lost to Follow-up|6|||
128682368|NCT03350984|463137343|FG000|Overall Study|Protocol Violation|1|||
128682369|NCT03350984|463137344|FG001|Overall Study|Protocol Violation|2|||
128682370|NCT03350984|463137343|FG000|Overall Study|Physician Decision|1|||
128682371|NCT03350984|463137344|FG001|Overall Study|Physician Decision|0|||
128682372|NCT00642473|463137345|FG000|Overall Study|Withdrawal by Subject|0|||
128682373|NCT00642473|463137346|FG001|Overall Study|Withdrawal by Subject|5|||
128682374|NCT00642473|463137345|FG000|Overall Study|Progression or death|2|||
128682375|NCT00642473|463137346|FG001|Overall Study|Progression or death|4|||
128682376|NCT00642473|463137345|FG000|Overall Study|Other|2|||
129104510|NCT01042392|464677158|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
129104511|NCT01042392|464677159|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
129104512|NCT01042392|464677160|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
129104513|NCT01042392|464677157|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
129104514|NCT01042392|464677158|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
129104515|NCT01042392|464677159|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
129104516|NCT01042392|464677160|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
129104517|NCT01042392|464677157|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
129104518|NCT01042392|464677158|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
129104519|NCT01042392|464677159|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
128682377|NCT00642473|463137346|FG001|Overall Study|Other|2|||
128682378|NCT03780400|463137354|FG000|Overall Study|Lost to Follow-up|5|||
128682379|NCT03780400|463137354|FG000|Overall Study|Withdrawal by Subject|2|||
128682380|NCT03823378|463137355|FG000|Overall Study|Adverse Event|2|||
128682381|NCT03823378|463137356|FG001|Overall Study|Adverse Event|2|||
128682382|NCT03823378|463137357|FG002|Overall Study|Adverse Event|0|||
128682383|NCT03823378|463137358|FG003|Overall Study|Adverse Event|0|||
128682384|NCT03823378|463137359|FG004|Overall Study|Adverse Event|0|||
128682385|NCT03823378|463137360|FG005|Overall Study|Adverse Event|0|||
128682386|NCT03823378|463137355|FG000|Overall Study|Lost to Follow-up|0|||
128682387|NCT03823378|463137356|FG001|Overall Study|Lost to Follow-up|1|||
128682388|NCT03823378|463137357|FG002|Overall Study|Lost to Follow-up|0|||
128682389|NCT03823378|463137358|FG003|Overall Study|Lost to Follow-up|0|||
128682390|NCT03823378|463137359|FG004|Overall Study|Lost to Follow-up|1|||
128682391|NCT03823378|463137360|FG005|Overall Study|Lost to Follow-up|0|||
128682392|NCT03823378|463137355|FG000|Overall Study|Withdrawal by Subject|0|||
128682393|NCT03823378|463137356|FG001|Overall Study|Withdrawal by Subject|1|||
128682394|NCT03823378|463137357|FG002|Overall Study|Withdrawal by Subject|4|||
128682395|NCT03823378|463137358|FG003|Overall Study|Withdrawal by Subject|2|||
128682396|NCT03823378|463137359|FG004|Overall Study|Withdrawal by Subject|0|||
128682397|NCT03823378|463137360|FG005|Overall Study|Withdrawal by Subject|1|||
128682398|NCT03823378|463137355|FG000|Overall Study|Other, not specified|19|||
128682399|NCT03823378|463137356|FG001|Overall Study|Other, not specified|12|||
128682400|NCT03823378|463137357|FG002|Overall Study|Other, not specified|6|||
128682401|NCT03823378|463137358|FG003|Overall Study|Other, not specified|8|||
128682402|NCT03823378|463137359|FG004|Overall Study|Other, not specified|17|||
128682403|NCT03823378|463137360|FG005|Overall Study|Other, not specified|7|||
128682404|NCT01282203|463137361|FG000|Overall Study|Adverse Event|1|||
128682405|NCT00058539|463137364|FG000|Overall Study|Disease progression|24|||
129016138|NCT01294787|464353377|FG004|Period 1|Administrative problem|0|||
129016139|NCT01294787|464353378|FG005|Period 1|Administrative problem|1|||
129016140|NCT01294787|464353373|FG000|Period 2|Adverse Event|0|||
129016141|NCT01294787|464353374|FG001|Period 2|Adverse Event|3|||
129016142|NCT01294787|464353375|FG002|Period 2|Adverse Event|0|||
129016143|NCT01294787|464353376|FG003|Period 2|Adverse Event|1|||
129016144|NCT01294787|464353377|FG004|Period 2|Adverse Event|0|||
129016145|NCT01294787|464353378|FG005|Period 2|Adverse Event|0|||
129016146|NCT01294787|464353373|FG000|Period 2|No longer needs study drug|0|||
129016147|NCT01294787|464353374|FG001|Period 2|No longer needs study drug|0|||
129016148|NCT01294787|464353375|FG002|Period 2|No longer needs study drug|0|||
129016149|NCT01294787|464353376|FG003|Period 2|No longer needs study drug|1|||
129016150|NCT01294787|464353377|FG004|Period 2|No longer needs study drug|0|||
129016151|NCT01294787|464353378|FG005|Period 2|No longer needs study drug|0|||
129016152|NCT01294787|464353373|FG000|Period 3|Adverse Event|0|||
129016153|NCT01294787|464353374|FG001|Period 3|Adverse Event|0|||
129016154|NCT01294787|464353375|FG002|Period 3|Adverse Event|0|||
129016155|NCT01294787|464353376|FG003|Period 3|Adverse Event|0|||
129016156|NCT01294787|464353377|FG004|Period 3|Adverse Event|1|||
129016157|NCT01294787|464353378|FG005|Period 3|Adverse Event|0|||
129016158|NCT04657770|464353381|FG000|Overall Study|Withdrawal by Subject|3|||
129016159|NCT04657770|464353381|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
129016160|NCT03655106|464353382|FG000|Overall Study|Withdrawal by Subject|3|||
129016161|NCT03655106|464353383|FG001|Overall Study|Withdrawal by Subject|2|||
129016162|NCT03655106|464353382|FG000|Overall Study|Lost to Follow-up|2|||
129016163|NCT03655106|464353383|FG001|Overall Study|Lost to Follow-up|1|||
129016164|NCT03655106|464353382|FG000|Overall Study|Duplicate Enrollment|1|||
129016165|NCT03655106|464353383|FG001|Overall Study|Duplicate Enrollment|1|||
129016166|NCT03655106|464353382|FG000|Overall Study|Protocol Violation|3|||
129016167|NCT03655106|464353383|FG001|Overall Study|Protocol Violation|0|||
129016168|NCT03785548|464353384|FG000|Overall Study|age > 80|1|||
129016169|NCT03785548|464353385|FG001|Overall Study|age > 80|0|||
129016170|NCT03785548|464353384|FG000|Overall Study|no Postop queries|1|||
129016171|NCT03785548|464353385|FG001|Overall Study|no Postop queries|0|||
129016172|NCT05327491|464353388|FG000|Periods 1 & 2|Miscellaneous|0|||
129016173|NCT05327491|464353389|FG001|Periods 1 & 2|Miscellaneous|1|||
129016174|NCT05327491|464353390|FG002|Periods 1 & 2|Miscellaneous|0|||
129016175|NCT05327491|464353391|FG003|Periods 1 & 2|Miscellaneous|0|||
129016176|NCT05327491|464353388|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
129016177|NCT05327491|464353389|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
129016178|NCT05327491|464353390|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
128682406|NCT00058539|463137364|FG000|Overall Study|Adverse Event|3|||
128682407|NCT00058539|463137364|FG000|Overall Study|Withdrawal by Subject|5|||
128682408|NCT00058539|463137364|FG000|Overall Study|Physician Decision|9|||
128682409|NCT00058539|463137364|FG000|Overall Study|Death|1|||
128682410|NCT02963831|463137365|FG000|Overall Study|Progressive Disease|3|||
128763143|NCT00615264|463422750|FG000|Overall Study|Withdrawal by Subject|17|||
128763144|NCT00615264|463422751|FG001|Overall Study|Withdrawal by Subject|19|||
129016179|NCT05327491|464353391|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
129016180|NCT05038293|464353392|FG000|Overall Study|device was not operating properly for one subject.|1|||
129016181|NCT05038293|464353393|FG001|Overall Study|device was not operating properly for one subject.|0|||
129016182|NCT05038293|464353392|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
129016183|NCT05038293|464353393|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
129016184|NCT01171989|464353394|FG000|Overall Study|Lost to Follow-up|0|||
129016185|NCT01171989|464353395|FG001|Overall Study|Lost to Follow-up|0|||
129016186|NCT01171989|464353396|FG002|Overall Study|Lost to Follow-up|1|||
129016187|NCT01247701|464353399|FG000|Overall Study|Death|2|||
129016188|NCT01247701|464353399|FG000|Overall Study|Relapsed|8|||
129016189|NCT04166630|464353400|FG000|Overall Study|Withdrawal by Subject|0|||
129016190|NCT04166630|464353401|FG001|Overall Study|Withdrawal by Subject|1|||
128682411|NCT02963831|463137366|FG001|Overall Study|Progressive Disease|3|||
128682412|NCT02963831|463137367|FG002|Overall Study|Progressive Disease|16|||
128682413|NCT02963831|463137368|FG003|Overall Study|Progressive Disease|27|||
128682414|NCT02963831|463137365|FG000|Overall Study|Withdrawal by Subject|1|||
128682415|NCT02963831|463137366|FG001|Overall Study|Withdrawal by Subject|0|||
128682416|NCT02963831|463137367|FG002|Overall Study|Withdrawal by Subject|2|||
128682417|NCT02963831|463137368|FG003|Overall Study|Withdrawal by Subject|4|||
128682418|NCT02963831|463137365|FG000|Overall Study|Adverse Event|0|||
128682419|NCT02963831|463137366|FG001|Overall Study|Adverse Event|1|||
128682420|NCT02963831|463137367|FG002|Overall Study|Adverse Event|1|||
128682421|NCT02963831|463137368|FG003|Overall Study|Adverse Event|2|||
128682422|NCT02963831|463137365|FG000|Overall Study|Death|0|||
128682423|NCT02963831|463137366|FG001|Overall Study|Death|0|||
128682424|NCT02963831|463137367|FG002|Overall Study|Death|0|||
128682425|NCT02963831|463137368|FG003|Overall Study|Death|2|||
128682426|NCT01606254|463137369|FG000|Overall Study|Withdrawal by Subject|1|||
128682427|NCT01606254|463137370|FG001|Overall Study|Withdrawal by Subject|3|||
128682428|NCT01606254|463137371|FG002|Overall Study|Withdrawal by Subject|0|||
128682429|NCT01606254|463137372|FG003|Overall Study|Withdrawal by Subject|2|||
128682430|NCT01606254|463137369|FG000|Overall Study|Adverse Event|1|||
128682431|NCT01606254|463137370|FG001|Overall Study|Adverse Event|1|||
128682432|NCT01606254|463137371|FG002|Overall Study|Adverse Event|0|||
128682433|NCT01606254|463137372|FG003|Overall Study|Adverse Event|1|||
128682434|NCT04543409|463137373|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128682435|NCT04543409|463137374|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128682436|NCT04543409|463137373|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
128682437|NCT04543409|463137374|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
128682438|NCT04543409|463137373|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
128682439|NCT04543409|463137374|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
128682440|NCT04543409|463137373|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
128682441|NCT04543409|463137374|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
128682442|NCT04543409|463137373|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
128682443|NCT04543409|463137374|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
128682444|NCT04543409|463137373|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
128682445|NCT04543409|463137374|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
129016191|NCT00096447|464353402|FG000|Overall Study|Never treated|1|||
129016192|NCT04088760|464353403|FG000|Overall Study|Physician Decision|1|||
129016193|NCT02300103|464353404|FG000|Overall Study|Lack of Efficacy|3|||
129016194|NCT02300103|464353404|FG000|Overall Study|Protocol Violation|1|||
128682446|NCT04543409|463137373|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
128682447|NCT04543409|463137374|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
128682448|NCT04543409|463137373|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
129016195|NCT02300103|464353404|FG000|Overall Study|Withdrew Consent|2|||
129016196|NCT04091971|464353405|FG000|Overall Study|Withdrawal by Subject|1|||
129016197|NCT04091971|464353405|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
129016198|NCT04091971|464353405|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
129016199|NCT04466111|464353407|FG000|Prior to Trial Phase|Physician Decision|1|||
129016200|NCT00105196|464353408|FG000|Overall Study|Lack of Efficacy|2|||
129016201|NCT00105196|464353409|FG001|Overall Study|Lack of Efficacy|3|||
129016202|NCT00105196|464353408|FG000|Overall Study|Adverse Event|11|||
129016203|NCT00105196|464353409|FG001|Overall Study|Adverse Event|3|||
129016204|NCT00105196|464353408|FG000|Overall Study|Withdrawal by Subject|6|||
129016205|NCT00105196|464353409|FG001|Overall Study|Withdrawal by Subject|6|||
129016206|NCT00105196|464353408|FG000|Overall Study|Lost to Follow-up|3|||
129016207|NCT00105196|464353409|FG001|Overall Study|Lost to Follow-up|2|||
129016208|NCT00105196|464353408|FG000|Overall Study|Poor/noncompliance|3|||
129016209|NCT00105196|464353409|FG001|Overall Study|Poor/noncompliance|4|||
129016210|NCT00105196|464353408|FG000|Overall Study|Protocol Violation|5|||
129016211|NCT00105196|464353409|FG001|Overall Study|Protocol Violation|2|||
129016212|NCT00105196|464353408|FG000|Overall Study|pending surgery|0|||
129016213|NCT00105196|464353409|FG001|Overall Study|pending surgery|1|||
128682449|NCT04543409|463137374|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
128682450|NCT04543409|463137373|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
129016214|NCT00105196|464353408|FG000|Overall Study|marijuana use|0|||
128682451|NCT04543409|463137374|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
128682452|NCT04543409|463137373|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
128682453|NCT04543409|463137374|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
128682454|NCT04543409|463137373|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
128682455|NCT04543409|463137374|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
128682456|NCT03977454|463137375|FG000|Overall Study|immediate postoperative revision|2|||
128682457|NCT03977454|463137376|FG001|Overall Study|immediate postoperative revision|2|||
128682458|NCT02093026|463137377|FG000|Overall Study|Adverse Event|26|||
129016215|NCT00105196|464353409|FG001|Overall Study|marijuana use|1|||
128682459|NCT02093026|463137377|FG000|Overall Study|Death|10|||
128682460|NCT02093026|463137377|FG000|Overall Study|Other|157|||
128682461|NCT04365257|463137378|FG000|Overall Study|Physician Decision|1|||
128682462|NCT04365257|463137379|FG001|Overall Study|Physician Decision|0|||
128682463|NCT04365257|463137378|FG000|Overall Study|Patient Noncompliance|1|||
128682464|NCT04365257|463137379|FG001|Overall Study|Patient Noncompliance|0|||
128682465|NCT04365257|463137378|FG000|Overall Study|Withdrawal by Subject|0|||
128682466|NCT04365257|463137379|FG001|Overall Study|Withdrawal by Subject|1|||
128682467|NCT00518973|463137380|FG000|Overall Study|Withdrawal by Subject|3|||
128682468|NCT00518973|463137381|FG001|Overall Study|Withdrawal by Subject|2|||
128682469|NCT03452527|463137382|FG000|Overall Study|Withdrawal by Subject|1|||
128682470|NCT03452527|463137383|FG001|Overall Study|Withdrawal by Subject|1|||
128682471|NCT03452527|463137382|FG000|Overall Study|Study Terminated|2|||
128682472|NCT03452527|463137383|FG001|Overall Study|Study Terminated|3|||
128682473|NCT02129777|463137384|FG000|Double-Blind Period|Adverse Event|0|||
128682474|NCT02129777|463137385|FG001|Double-Blind Period|Adverse Event|0|||
128682475|NCT02129777|463137386|FG002|Double-Blind Period|Adverse Event|0|||
128682476|NCT02129777|463137387|FG003|Double-Blind Period|Adverse Event|0|||
128682477|NCT02129777|463137388|FG004|Double-Blind Period|Adverse Event|1|||
128682478|NCT02129777|463137389|FG005|Double-Blind Period|Adverse Event|0|||
128682479|NCT02129777|463137390|FG006|Double-Blind Period|Adverse Event|0|||
128682480|NCT02129777|463137384|FG000|Double-Blind Period|Lost to Follow-up|1|||
128682481|NCT02129777|463137385|FG001|Double-Blind Period|Lost to Follow-up|1|||
128682482|NCT02129777|463137386|FG002|Double-Blind Period|Lost to Follow-up|1|||
128682483|NCT02129777|463137387|FG003|Double-Blind Period|Lost to Follow-up|2|||
128682484|NCT02129777|463137388|FG004|Double-Blind Period|Lost to Follow-up|0|||
128682485|NCT02129777|463137389|FG005|Double-Blind Period|Lost to Follow-up|0|||
128682486|NCT02129777|463137390|FG006|Double-Blind Period|Lost to Follow-up|0|||
128682487|NCT02129777|463137384|FG000|Double-Blind Period|Withdrawal by Subject|2|||
128682488|NCT02129777|463137385|FG001|Double-Blind Period|Withdrawal by Subject|4|||
128682489|NCT02129777|463137386|FG002|Double-Blind Period|Withdrawal by Subject|3|||
128682490|NCT02129777|463137387|FG003|Double-Blind Period|Withdrawal by Subject|2|||
128682491|NCT02129777|463137388|FG004|Double-Blind Period|Withdrawal by Subject|3|||
128682492|NCT02129777|463137389|FG005|Double-Blind Period|Withdrawal by Subject|0|||
128682493|NCT02129777|463137390|FG006|Double-Blind Period|Withdrawal by Subject|0|||
128682494|NCT02129777|463137384|FG000|Double-Blind Period|Pregnancy|0|||
128682495|NCT02129777|463137385|FG001|Double-Blind Period|Pregnancy|0|||
128682496|NCT02129777|463137386|FG002|Double-Blind Period|Pregnancy|0|||
128682497|NCT02129777|463137387|FG003|Double-Blind Period|Pregnancy|0|||
128682498|NCT02129777|463137388|FG004|Double-Blind Period|Pregnancy|1|||
128682499|NCT02129777|463137389|FG005|Double-Blind Period|Pregnancy|0|||
128682500|NCT02129777|463137390|FG006|Double-Blind Period|Pregnancy|0|||
128682501|NCT02129777|463137384|FG000|Double-Blind Period|Lack of Efficacy|3|||
128682502|NCT02129777|463137385|FG001|Double-Blind Period|Lack of Efficacy|1|||
128682503|NCT02129777|463137386|FG002|Double-Blind Period|Lack of Efficacy|0|||
128682504|NCT02129777|463137387|FG003|Double-Blind Period|Lack of Efficacy|3|||
128682505|NCT02129777|463137388|FG004|Double-Blind Period|Lack of Efficacy|2|||
128682506|NCT02129777|463137389|FG005|Double-Blind Period|Lack of Efficacy|0|||
128682507|NCT02129777|463137390|FG006|Double-Blind Period|Lack of Efficacy|0|||
128682508|NCT02129777|463137384|FG000|Double-Blind Period|Other|1|||
128682509|NCT02129777|463137385|FG001|Double-Blind Period|Other|2|||
128682510|NCT02129777|463137386|FG002|Double-Blind Period|Other|0|||
128682511|NCT02129777|463137387|FG003|Double-Blind Period|Other|0|||
128682512|NCT02129777|463137388|FG004|Double-Blind Period|Other|0|||
128682513|NCT02129777|463137389|FG005|Double-Blind Period|Other|0|||
129016216|NCT00105196|464353408|FG000|Overall Study|Subject became unblinded|0|||
129016217|NCT00105196|464353409|FG001|Overall Study|Subject became unblinded|1|||
129016218|NCT01981720|464353412|FG000|Overall Study|Adverse Event|1|||
129016219|NCT01981720|464353412|FG000|Overall Study|Withdrawal by Subject|3|||
129016220|NCT01981720|464353412|FG000|Overall Study|Pregnancy|1|||
129016221|NCT00184600|464353413|FG000|Overall Study|Adverse Event|9|||
129016222|NCT00184600|464353414|FG001|Overall Study|Adverse Event|0|||
128682514|NCT02129777|463137390|FG006|Double-Blind Period|Other|0|||
128682515|NCT02129777|463137384|FG000|Open-Label Period|Lack of Efficacy|0|||
128682516|NCT02129777|463137385|FG001|Open-Label Period|Lack of Efficacy|0|||
128682517|NCT02129777|463137386|FG002|Open-Label Period|Lack of Efficacy|0|||
128682518|NCT02129777|463137387|FG003|Open-Label Period|Lack of Efficacy|0|||
128682519|NCT02129777|463137388|FG004|Open-Label Period|Lack of Efficacy|0|||
128682520|NCT02129777|463137389|FG005|Open-Label Period|Lack of Efficacy|0|||
129016223|NCT00184600|464353415|FG002|Overall Study|Adverse Event|5|||
128682521|NCT02129777|463137390|FG006|Open-Label Period|Lack of Efficacy|5|||
128682522|NCT02129777|463137384|FG000|Open-Label Period|Lost to Follow-up|0|||
128682523|NCT02129777|463137385|FG001|Open-Label Period|Lost to Follow-up|0|||
128682524|NCT02129777|463137386|FG002|Open-Label Period|Lost to Follow-up|0|||
128682525|NCT02129777|463137387|FG003|Open-Label Period|Lost to Follow-up|0|||
128682526|NCT02129777|463137388|FG004|Open-Label Period|Lost to Follow-up|0|||
128682527|NCT02129777|463137389|FG005|Open-Label Period|Lost to Follow-up|1|||
129016224|NCT00184600|464353413|FG000|Overall Study|Death|3|||
129016225|NCT00184600|464353414|FG001|Overall Study|Death|9|||
128682528|NCT02129777|463137390|FG006|Open-Label Period|Lost to Follow-up|1|||
128682529|NCT02129777|463137384|FG000|Open-Label Period|Withdrawal by Subject|0|||
128682530|NCT02129777|463137385|FG001|Open-Label Period|Withdrawal by Subject|0|||
128682531|NCT02129777|463137386|FG002|Open-Label Period|Withdrawal by Subject|0|||
128682532|NCT02129777|463137387|FG003|Open-Label Period|Withdrawal by Subject|0|||
128682533|NCT02129777|463137388|FG004|Open-Label Period|Withdrawal by Subject|0|||
128682534|NCT02129777|463137389|FG005|Open-Label Period|Withdrawal by Subject|1|||
128682535|NCT02129777|463137390|FG006|Open-Label Period|Withdrawal by Subject|3|||
128682536|NCT02129777|463137384|FG000|Open-Label Period|Study Termination|0|||
128682537|NCT02129777|463137385|FG001|Open-Label Period|Study Termination|0|||
128682538|NCT02129777|463137386|FG002|Open-Label Period|Study Termination|0|||
128682539|NCT02129777|463137387|FG003|Open-Label Period|Study Termination|0|||
128682540|NCT02129777|463137388|FG004|Open-Label Period|Study Termination|0|||
128682541|NCT02129777|463137389|FG005|Open-Label Period|Study Termination|10|||
128682542|NCT02129777|463137390|FG006|Open-Label Period|Study Termination|39|||
128682543|NCT01001299|463137391|FG000|Overall Study|Insufficient Therapeutic Response|20|||
128682544|NCT01001299|463137391|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
128682545|NCT01001299|463137391|FG000|Overall Study|Death|1|||
128682546|NCT01001299|463137391|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
128682547|NCT01001299|463137391|FG000|Overall Study|Withdrew Consent|1|||
128682548|NCT01565499|463137401|FG000|Overall Study|Physician Decision|1|||
128682549|NCT01565499|463137401|FG000|Overall Study|Adverse Event|5|||
128682550|NCT01565499|463137401|FG000|Overall Study|Withdrawal by Subject|2|||
128682551|NCT00174291|463137409|FG000|Overall Study|Lost to Follow-up|1|||
128682552|NCT00174291|463137410|FG001|Overall Study|Lost to Follow-up|1|||
128682553|NCT00174291|463137409|FG000|Overall Study|Protocol Violation|0|||
128682554|NCT00174291|463137410|FG001|Overall Study|Protocol Violation|2|||
128682555|NCT00174291|463137409|FG000|Overall Study|Study terminated by sponsor|1|||
128682556|NCT00174291|463137410|FG001|Overall Study|Study terminated by sponsor|0|||
128682557|NCT00174291|463137409|FG000|Overall Study|Withdrawal by Subject|3|||
128682558|NCT00174291|463137410|FG001|Overall Study|Withdrawal by Subject|3|||
128682559|NCT01923168|463137413|FG000|Overall Study|Protocol Violation|1|||
128682560|NCT01923168|463137414|FG001|Overall Study|Protocol Violation|1|||
128682561|NCT01923168|463137415|FG002|Overall Study|Protocol Violation|0|||
128682562|NCT01923168|463137413|FG000|Overall Study|Subject/guardian decision|14|||
128682563|NCT01923168|463137414|FG001|Overall Study|Subject/guardian decision|14|||
128682564|NCT01923168|463137415|FG002|Overall Study|Subject/guardian decision|4|||
128682565|NCT01923168|463137413|FG000|Overall Study|Adverse Event|12|||
128682566|NCT01923168|463137414|FG001|Overall Study|Adverse Event|12|||
128682567|NCT01923168|463137415|FG002|Overall Study|Adverse Event|0|||
128682568|NCT01923168|463137413|FG000|Overall Study|Physician Decision|6|||
128682569|NCT01923168|463137414|FG001|Overall Study|Physician Decision|9|||
128682570|NCT01923168|463137415|FG002|Overall Study|Physician Decision|5|||
128682571|NCT01923168|463137413|FG000|Overall Study|Progressive disease|4|||
128682572|NCT01923168|463137414|FG001|Overall Study|Progressive disease|3|||
128682573|NCT01923168|463137415|FG002|Overall Study|Progressive disease|7|||
129016226|NCT00184600|464353415|FG002|Overall Study|Death|7|||
129016227|NCT00184600|464353413|FG000|Overall Study|Lack of Efficacy|3|||
129016228|NCT00184600|464353414|FG001|Overall Study|Lack of Efficacy|1|||
129016229|NCT00184600|464353415|FG002|Overall Study|Lack of Efficacy|3|||
128682574|NCT01923168|463137413|FG000|Overall Study|Death|0|||
128682575|NCT01923168|463137414|FG001|Overall Study|Death|0|||
128682576|NCT01923168|463137415|FG002|Overall Study|Death|1|||
128682577|NCT03418571|463137418|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
128682578|NCT03418571|463137419|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
128682579|NCT02376829|463137420|FG000|Overall Study|Withdrawal by Subject|27|||
128682580|NCT02376829|463137421|FG001|Overall Study|Withdrawal by Subject|44|||
128682581|NCT03116347|463137422|FG000|Overall Study|Withdrawal by Subject|1|||
128682582|NCT03116347|463137423|FG001|Overall Study|Withdrawal by Subject|2|||
128682583|NCT01255787|463137424|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
128682584|NCT01255787|463137425|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
128682585|NCT01255787|463137426|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
128682586|NCT01255787|463137427|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
128682587|NCT01255787|463137424|FG000|Overall Study|Major Protocol Deviation|1|||
128682588|NCT01255787|463137425|FG001|Overall Study|Major Protocol Deviation|1|||
128682589|NCT01255787|463137426|FG002|Overall Study|Major Protocol Deviation|0|||
128682590|NCT01255787|463137427|FG003|Overall Study|Major Protocol Deviation|4|||
128682591|NCT01255787|463137424|FG000|Overall Study|Lost to Follow-up|1|||
128682592|NCT01255787|463137425|FG001|Overall Study|Lost to Follow-up|2|||
128682593|NCT01255787|463137426|FG002|Overall Study|Lost to Follow-up|4|||
128682594|NCT01255787|463137427|FG003|Overall Study|Lost to Follow-up|2|||
128682595|NCT01255787|463137424|FG000|Overall Study|Withdrawal of Consent|3|||
128682596|NCT01255787|463137425|FG001|Overall Study|Withdrawal of Consent|9|||
128682597|NCT01255787|463137426|FG002|Overall Study|Withdrawal of Consent|3|||
128682598|NCT01255787|463137427|FG003|Overall Study|Withdrawal of Consent|4|||
128763145|NCT00615264|463422750|FG000|Overall Study|Lost to Follow-up|6|||
129016230|NCT00184600|464353413|FG000|Overall Study|Lost to Follow-up|4|||
128682599|NCT01255787|463137424|FG000|Overall Study|Pregnancy|0|||
128682600|NCT01255787|463137425|FG001|Overall Study|Pregnancy|0|||
128682601|NCT01255787|463137426|FG002|Overall Study|Pregnancy|0|||
128682602|NCT01255787|463137427|FG003|Overall Study|Pregnancy|1|||
128682603|NCT01255787|463137424|FG000|Overall Study|Lack of Efficacy|2|||
128682604|NCT01255787|463137425|FG001|Overall Study|Lack of Efficacy|2|||
128682605|NCT01255787|463137426|FG002|Overall Study|Lack of Efficacy|2|||
128682606|NCT01255787|463137427|FG003|Overall Study|Lack of Efficacy|2|||
128682607|NCT01255787|463137424|FG000|Overall Study|Noncompliance with Study Drug|3|||
129104520|NCT01042392|464677160|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
129104521|NCT00587795|464677161|FG000|Overall Study|Withdrawal by Subject|1|||
129104522|NCT00587795|464677162|FG001|Overall Study|Withdrawal by Subject|0|||
128682608|NCT01255787|463137425|FG001|Overall Study|Noncompliance with Study Drug|1|||
128682609|NCT01255787|463137426|FG002|Overall Study|Noncompliance with Study Drug|0|||
128682610|NCT01255787|463137427|FG003|Overall Study|Noncompliance with Study Drug|0|||
128682611|NCT00476047|463137428|FG000|Overall Study|Lost to Follow-up|1|||
128682612|NCT03170232|463137429|FG000|Overall Study|Adverse Event|0|||
128682613|NCT03170232|463137430|FG001|Overall Study|Adverse Event|1|||
128682614|NCT03170232|463137429|FG000|Overall Study|Protocol Violation|0|||
128682615|NCT03170232|463137430|FG001|Overall Study|Protocol Violation|1|||
128682616|NCT03170232|463137429|FG000|Overall Study|Lack of Efficacy|0|||
128682617|NCT03170232|463137430|FG001|Overall Study|Lack of Efficacy|1|||
128682618|NCT03170232|463137429|FG000|Overall Study|Study closed/terminated|26|||
128682619|NCT03170232|463137430|FG001|Overall Study|Study closed/terminated|23|||
128682620|NCT03170232|463137429|FG000|Overall Study|Lost to Follow-up|1|||
128682621|NCT03170232|463137430|FG001|Overall Study|Lost to Follow-up|0|||
128682622|NCT03170232|463137429|FG000|Overall Study|Withdrawal by Subject|0|||
128682623|NCT03170232|463137430|FG001|Overall Study|Withdrawal by Subject|1|||
128682624|NCT00586326|463137431|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
128682625|NCT00586326|463137431|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
128682626|NCT00586326|463137431|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
128682627|NCT00586326|463137431|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
128682628|NCT00586326|463137431|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
128682629|NCT00586326|463137431|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
128682630|NCT00586326|463137431|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
128682631|NCT00586326|463137431|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
128682632|NCT00586326|463137431|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
128682633|NCT00586326|463137431|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
128682634|NCT00586326|463137431|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
128682635|NCT00586326|463137431|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
128682636|NCT00586326|463137431|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
128682637|NCT00586326|463137431|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
128682638|NCT00586326|463137431|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
128682639|NCT00586326|463137431|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
128682640|NCT00586326|463137431|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
128682641|NCT03882008|463137432|FG000|Overall Study|Withdrawal by Subject|1|||
128682642|NCT03882008|463137432|FG000|Overall Study|Lost to Follow-up|1|||
128682643|NCT04068896|463137433|FG000|Overall Study|Adverse Event|2|||
128682644|NCT04068896|463137434|FG001|Overall Study|Adverse Event|0|||
128682645|NCT04068896|463137435|FG002|Overall Study|Adverse Event|1|||
128682646|NCT04068896|463137436|FG003|Overall Study|Adverse Event|0|||
128682647|NCT04068896|463137437|FG004|Overall Study|Adverse Event|0|||
128682648|NCT04068896|463137438|FG005|Overall Study|Adverse Event|0|||
128682649|NCT04068896|463137433|FG000|Overall Study|Death|3|||
128682650|NCT04068896|463137434|FG001|Overall Study|Death|1|||
128682651|NCT04068896|463137435|FG002|Overall Study|Death|3|||
128682652|NCT04068896|463137436|FG003|Overall Study|Death|19|||
128682653|NCT04068896|463137437|FG004|Overall Study|Death|17|||
128682654|NCT04068896|463137438|FG005|Overall Study|Death|0|||
128682655|NCT04068896|463137433|FG000|Overall Study|Physician Decision|0|||
128682656|NCT04068896|463137434|FG001|Overall Study|Physician Decision|0|||
128682657|NCT04068896|463137435|FG002|Overall Study|Physician Decision|0|||
128682658|NCT04068896|463137436|FG003|Overall Study|Physician Decision|1|||
128682659|NCT04068896|463137437|FG004|Overall Study|Physician Decision|0|||
128682660|NCT04068896|463137438|FG005|Overall Study|Physician Decision|0|||
128682661|NCT04068896|463137433|FG000|Overall Study|progressive disease|3|||
128682662|NCT04068896|463137434|FG001|Overall Study|progressive disease|5|||
128682663|NCT04068896|463137435|FG002|Overall Study|progressive disease|3|||
128682664|NCT04068896|463137436|FG003|Overall Study|progressive disease|2|||
128682665|NCT04068896|463137437|FG004|Overall Study|progressive disease|1|||
128682666|NCT04068896|463137438|FG005|Overall Study|progressive disease|2|||
128682667|NCT04068896|463137433|FG000|Overall Study|Study terminated by sponsor|0|||
128682668|NCT04068896|463137434|FG001|Overall Study|Study terminated by sponsor|0|||
128682669|NCT04068896|463137435|FG002|Overall Study|Study terminated by sponsor|1|||
128682670|NCT04068896|463137436|FG003|Overall Study|Study terminated by sponsor|2|||
128682671|NCT04068896|463137437|FG004|Overall Study|Study terminated by sponsor|1|||
129016231|NCT00184600|464353414|FG001|Overall Study|Lost to Follow-up|6|||
129016232|NCT00184600|464353415|FG002|Overall Study|Lost to Follow-up|1|||
128682672|NCT04068896|463137438|FG005|Overall Study|Study terminated by sponsor|4|||
128682673|NCT04068896|463137433|FG000|Overall Study|Protocol Violation|0|||
128682674|NCT04068896|463137434|FG001|Overall Study|Protocol Violation|0|||
128682675|NCT04068896|463137435|FG002|Overall Study|Protocol Violation|0|||
128682676|NCT04068896|463137436|FG003|Overall Study|Protocol Violation|1|||
128682677|NCT04068896|463137437|FG004|Overall Study|Protocol Violation|0|||
128682678|NCT04068896|463137438|FG005|Overall Study|Protocol Violation|0|||
128682679|NCT04068896|463137433|FG000|Overall Study|Withdrawal by Subject|0|||
128682680|NCT04068896|463137434|FG001|Overall Study|Withdrawal by Subject|3|||
128682681|NCT04068896|463137435|FG002|Overall Study|Withdrawal by Subject|0|||
128682682|NCT04068896|463137436|FG003|Overall Study|Withdrawal by Subject|2|||
128682683|NCT04068896|463137437|FG004|Overall Study|Withdrawal by Subject|1|||
128682684|NCT04068896|463137438|FG005|Overall Study|Withdrawal by Subject|0|||
128682685|NCT04068896|463137433|FG000|Overall Study|Symptomatic deterioration|2|||
128682686|NCT04068896|463137434|FG001|Overall Study|Symptomatic deterioration|0|||
128682687|NCT04068896|463137435|FG002|Overall Study|Symptomatic deterioration|0|||
128682688|NCT04068896|463137436|FG003|Overall Study|Symptomatic deterioration|0|||
128682689|NCT04068896|463137437|FG004|Overall Study|Symptomatic deterioration|0|||
128682690|NCT04068896|463137438|FG005|Overall Study|Symptomatic deterioration|0|||
128682691|NCT02694718|463137439|FG000|Overall Study|Death|1|||
128682692|NCT02694718|463137439|FG000|Overall Study|Withdrawal by Subject|1|||
128682693|NCT02925793|463137440|FG000|Overall Study|Adverse Event|3|||
128682694|NCT02925793|463137441|FG001|Overall Study|Adverse Event|3|||
128682695|NCT02925793|463137442|FG002|Overall Study|Adverse Event|6|||
128682696|NCT02925793|463137440|FG000|Overall Study|Withdrawal by Subject|16|||
128682697|NCT02925793|463137441|FG001|Overall Study|Withdrawal by Subject|15|||
128682698|NCT02925793|463137442|FG002|Overall Study|Withdrawal by Subject|13|||
128682699|NCT02925793|463137440|FG000|Overall Study|Investigator Discretion|0|||
128682700|NCT02925793|463137441|FG001|Overall Study|Investigator Discretion|1|||
128682701|NCT02925793|463137442|FG002|Overall Study|Investigator Discretion|1|||
128682702|NCT02925793|463137440|FG000|Overall Study|Lost to Follow-up|2|||
128682703|NCT02925793|463137441|FG001|Overall Study|Lost to Follow-up|3|||
128682704|NCT02925793|463137442|FG002|Overall Study|Lost to Follow-up|1|||
128682705|NCT02925793|463137440|FG000|Overall Study|Lack of Efficacy|2|||
128682706|NCT02925793|463137441|FG001|Overall Study|Lack of Efficacy|6|||
128682707|NCT02925793|463137442|FG002|Overall Study|Lack of Efficacy|4|||
128682708|NCT02925793|463137440|FG000|Overall Study|Other:|2|||
128682709|NCT02925793|463137441|FG001|Overall Study|Other:|1|||
128682710|NCT02925793|463137442|FG002|Overall Study|Other:|3|||
128682711|NCT00256282|463137444|FG000|Overall Study|Disease progression, relapse during acti|12|||
128682712|NCT00256282|463137444|FG000|Overall Study|Adverse Event|3|||
128682713|NCT00256282|463137444|FG000|Overall Study|Physician Decision|1|||
128682714|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
128682715|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
128682716|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Other|2|||
128682717|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Other|2|||
128682718|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Personal reasons|2|||
128682719|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Personal reasons|2|||
128682720|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
128682721|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
128682722|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
128682723|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
128682724|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
128682725|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
128682726|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
128682727|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
128682728|NCT00667446|463137445|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
128682729|NCT00667446|463137446|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
128682730|NCT00667446|463137445|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
128682731|NCT00667446|463137446|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
128682732|NCT01343901|463137447|FG000|Overall Study|Death|85|||
128682733|NCT01343901|463137447|FG000|Overall Study|Physician Decision|4|||
128682734|NCT01343901|463137447|FG000|Overall Study|Lost to Follow-up|12|||
128682735|NCT01343901|463137447|FG000|Overall Study|Management by another medical team|11|||
128682736|NCT01343901|463137447|FG000|Overall Study|Participant decision|1|||
128682737|NCT03324581|463137453|FG000|Overall Study|Adverse Event|18|||
129016233|NCT00184600|464353413|FG000|Overall Study|Protocol Violation|2|||
129016234|NCT00184600|464353414|FG001|Overall Study|Protocol Violation|2|||
128682738|NCT03324581|463137454|FG001|Overall Study|Adverse Event|11|||
128682739|NCT03324581|463137455|FG002|Overall Study|Adverse Event|7|||
128682740|NCT03324581|463137453|FG000|Overall Study|Lack of Efficacy|0|||
128682741|NCT03324581|463137454|FG001|Overall Study|Lack of Efficacy|1|||
128682742|NCT03324581|463137455|FG002|Overall Study|Lack of Efficacy|0|||
128682743|NCT03324581|463137453|FG000|Overall Study|Lost to Follow-up|5|||
128879630|NCT02354508|463854899|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
128879631|NCT02354508|463854897|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
128879632|NCT02354508|463854898|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
128879633|NCT02354508|463854899|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
128879634|NCT02354508|463854897|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
128879635|NCT02354508|463854898|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
128879636|NCT02354508|463854899|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
128879637|NCT02354508|463854897|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
128879638|NCT02354508|463854898|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
128879639|NCT02354508|463854899|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
128879640|NCT02354508|463854897|FG000|Period 2: Extension Phase|Physician Decision|5|||
128879641|NCT02354508|463854898|FG001|Period 2: Extension Phase|Physician Decision|0|||
128879642|NCT02354508|463854899|FG002|Period 2: Extension Phase|Physician Decision|1|||
128879643|NCT02354508|463854897|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
128879644|NCT02354508|463854898|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
128879645|NCT02354508|463854899|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
128879646|NCT02354508|463854897|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
128879647|NCT02354508|463854898|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
128879648|NCT02354508|463854899|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
129104523|NCT02869893|464677167|FG000|Overall Study|participant aversion to IV|5|||
129104524|NCT02869893|464677167|FG000|Overall Study|participant fear of MRI scanner|2|||
129104525|NCT03146741|464677168|FG000|Overall Study|Txp with non-HCV+ heart|4|||
129104526|NCT03146741|464677168|FG000|Overall Study|Listeted for MOT|2|||
129104527|NCT03146741|464677168|FG000|Overall Study|Physician Decision|2|||
129104528|NCT03146741|464677168|FG000|Overall Study|Awaiting txp|2|||
129104529|NCT00837967|464677169|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
129104530|NCT00837967|464677170|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
129104531|NCT00551525|464677171|FG000|Overall Study|Protocol Violation|5|||
129104532|NCT04676724|464677172|FG000|Overall Study|Adverse Event|2|||
129104533|NCT04676724|464677173|FG001|Overall Study|Adverse Event|0|||
129104534|NCT04676724|464677172|FG000|Overall Study|Lost to Follow-up|1|||
129104535|NCT04676724|464677173|FG001|Overall Study|Lost to Follow-up|0|||
129104536|NCT04676724|464677172|FG000|Overall Study|Physician Decision|0|||
129104537|NCT04676724|464677173|FG001|Overall Study|Physician Decision|1|||
129104538|NCT04676724|464677172|FG000|Overall Study|Withdrawal by Subject|3|||
129104539|NCT04676724|464677173|FG001|Overall Study|Withdrawal by Subject|2|||
129104540|NCT02081001|464677179|FG000|Overall Study|Adverse Event|0|||
129104541|NCT02081001|464677180|FG001|Overall Study|Adverse Event|0|||
129104542|NCT02081001|464677181|FG002|Overall Study|Adverse Event|0|||
129104543|NCT02081001|464677182|FG003|Overall Study|Adverse Event|0|||
129104544|NCT02081001|464677183|FG004|Overall Study|Adverse Event|1|||
129104545|NCT02081001|464677184|FG005|Overall Study|Adverse Event|0|||
129104546|NCT02081001|464677185|FG006|Overall Study|Adverse Event|0|||
129104547|NCT02081001|464677186|FG007|Overall Study|Adverse Event|0|||
129104548|NCT02081001|464677187|FG008|Overall Study|Adverse Event|0|||
129104549|NCT02081001|464677188|FG009|Overall Study|Adverse Event|0|||
129104550|NCT02081001|464677189|FG010|Overall Study|Adverse Event|0|||
129104551|NCT02081001|464677190|FG011|Overall Study|Adverse Event|0|||
129104552|NCT02588092|464677211|FG000|Overall Study|Death|4|||
129104553|NCT02588092|464677212|FG001|Overall Study|Death|3|||
129104554|NCT02588092|464677213|FG002|Overall Study|Death|3|||
129104555|NCT02588092|464677214|FG003|Overall Study|Death|3|||
129104556|NCT02588092|464677215|FG004|Overall Study|Death|2|||
129104557|NCT02588092|464677216|FG005|Overall Study|Death|2|||
129104558|NCT02588092|464677217|FG006|Overall Study|Death|2|||
129104559|NCT02588092|464677218|FG007|Overall Study|Death|1|||
129104560|NCT02588092|464677219|FG008|Overall Study|Death|5|||
129104561|NCT02588092|464677220|FG009|Overall Study|Death|2|||
129104562|NCT02588092|464677211|FG000|Overall Study|Withdrawal by Subject|0|||
129104563|NCT02588092|464677212|FG001|Overall Study|Withdrawal by Subject|0|||
129104564|NCT02588092|464677213|FG002|Overall Study|Withdrawal by Subject|0|||
129104565|NCT02588092|464677214|FG003|Overall Study|Withdrawal by Subject|0|||
129104566|NCT02588092|464677215|FG004|Overall Study|Withdrawal by Subject|0|||
129104567|NCT02588092|464677216|FG005|Overall Study|Withdrawal by Subject|1|||
129104568|NCT02588092|464677217|FG006|Overall Study|Withdrawal by Subject|1|||
128763146|NCT00615264|463422751|FG001|Overall Study|Lost to Follow-up|13|||
129104569|NCT02588092|464677218|FG007|Overall Study|Withdrawal by Subject|2|||
129104570|NCT02588092|464677219|FG008|Overall Study|Withdrawal by Subject|0|||
129104571|NCT02588092|464677220|FG009|Overall Study|Withdrawal by Subject|0|||
129104572|NCT02588092|464677211|FG000|Overall Study|Started Another Treatment|0|||
129104573|NCT02588092|464677212|FG001|Overall Study|Started Another Treatment|0|||
129104574|NCT02588092|464677213|FG002|Overall Study|Started Another Treatment|0|||
129104575|NCT02588092|464677214|FG003|Overall Study|Started Another Treatment|0|||
129104576|NCT02588092|464677215|FG004|Overall Study|Started Another Treatment|1|||
129104577|NCT02588092|464677216|FG005|Overall Study|Started Another Treatment|0|||
128879649|NCT02354508|463854897|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
128879650|NCT02354508|463854898|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
128879651|NCT02354508|463854899|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
129016235|NCT00184600|464353415|FG002|Overall Study|Protocol Violation|3|||
129016236|NCT00184600|464353413|FG000|Overall Study|Withdrawal by Subject|20|||
129016237|NCT00184600|464353414|FG001|Overall Study|Withdrawal by Subject|28|||
129016238|NCT00184600|464353415|FG002|Overall Study|Withdrawal by Subject|12|||
129016239|NCT00184600|464353413|FG000|Overall Study|Unclassified|4|||
129016240|NCT00184600|464353414|FG001|Overall Study|Unclassified|5|||
129016241|NCT00184600|464353415|FG002|Overall Study|Unclassified|3|||
129016242|NCT01536405|464353416|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
129016243|NCT01536405|464353417|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
129016244|NCT01536405|464353416|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
129016245|NCT01536405|464353417|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
129016246|NCT01536405|464353416|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
129016247|NCT01536405|464353417|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
129016248|NCT01536405|464353416|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
129016249|NCT01536405|464353417|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
129016250|NCT01536405|464353416|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
129016251|NCT01536405|464353417|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
129016252|NCT01536405|464353416|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
129016253|NCT01536405|464353417|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
129016254|NCT01536405|464353416|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
129016255|NCT01536405|464353417|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
129016256|NCT01536405|464353416|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
129016257|NCT01536405|464353417|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
129016258|NCT01536405|464353416|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
129016259|NCT01536405|464353417|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
129016260|NCT01536405|464353416|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
129016261|NCT01536405|464353417|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
129016262|NCT01536405|464353416|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
129016263|NCT01536405|464353417|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
129016264|NCT01536405|464353416|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
129016265|NCT01536405|464353417|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
129016266|NCT01536405|464353416|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
129016267|NCT01536405|464353417|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
129016268|NCT02336165|464353418|FG000|Overall Study|Death|3|||
129016269|NCT02336165|464353419|FG001|Overall Study|Death|0|||
129016270|NCT02336165|464353420|FG002|Overall Study|Death|0|||
129016271|NCT02336165|464353421|FG003|Overall Study|Death|0|||
129016272|NCT02336165|464353422|FG004|Overall Study|Death|1|||
129016273|NCT02336165|464353418|FG000|Overall Study|Physician Decision|2|||
129016274|NCT02336165|464353419|FG001|Overall Study|Physician Decision|2|||
129016275|NCT02336165|464353420|FG002|Overall Study|Physician Decision|1|||
129016276|NCT02336165|464353421|FG003|Overall Study|Physician Decision|1|||
129016277|NCT02336165|464353422|FG004|Overall Study|Physician Decision|0|||
129016278|NCT02336165|464353418|FG000|Overall Study|Withdrawal by Subject|0|||
129016279|NCT02336165|464353419|FG001|Overall Study|Withdrawal by Subject|0|||
129016280|NCT02336165|464353420|FG002|Overall Study|Withdrawal by Subject|1|||
129016281|NCT02336165|464353421|FG003|Overall Study|Withdrawal by Subject|0|||
129016282|NCT02336165|464353422|FG004|Overall Study|Withdrawal by Subject|1|||
129016283|NCT02336165|464353418|FG000|Overall Study|Adverse Event|4|||
129016284|NCT02336165|464353419|FG001|Overall Study|Adverse Event|1|||
129016285|NCT02336165|464353420|FG002|Overall Study|Adverse Event|2|||
129016286|NCT02336165|464353421|FG003|Overall Study|Adverse Event|4|||
129016287|NCT02336165|464353422|FG004|Overall Study|Adverse Event|1|||
129016288|NCT02336165|464353418|FG000|Overall Study|Progressive disease|23|||
129016289|NCT02336165|464353419|FG001|Overall Study|Progressive disease|22|||
129016290|NCT02336165|464353420|FG002|Overall Study|Progressive disease|27|||
129016291|NCT02336165|464353421|FG003|Overall Study|Progressive disease|24|||
129016292|NCT02336165|464353422|FG004|Overall Study|Progressive disease|19|||
129016293|NCT02336165|464353418|FG000|Overall Study|Non-compliance|1|||
129016294|NCT02336165|464353419|FG001|Overall Study|Non-compliance|0|||
129016295|NCT02336165|464353420|FG002|Overall Study|Non-compliance|0|||
129016296|NCT02336165|464353421|FG003|Overall Study|Non-compliance|1|||
129016297|NCT02336165|464353422|FG004|Overall Study|Non-compliance|0|||
129016298|NCT02336165|464353418|FG000|Overall Study|Other|1|||
129016299|NCT02336165|464353419|FG001|Overall Study|Other|0|||
129016300|NCT02336165|464353420|FG002|Overall Study|Other|0|||
129016301|NCT02336165|464353421|FG003|Overall Study|Other|1|||
129016302|NCT02336165|464353422|FG004|Overall Study|Other|0|||
129016303|NCT00552669|464353428|FG000|Overall Study|Death|3|||
129016304|NCT00552669|464353429|FG001|Overall Study|Death|7|||
128879652|NCT00372229|463854900|FG000|Study Phase|Graft loss|0|||
129016305|NCT01844375|464353430|FG000|Overall Study|Protocol Violation|1|||
128682744|NCT03324581|463137454|FG001|Overall Study|Lost to Follow-up|3|||
128682745|NCT03324581|463137455|FG002|Overall Study|Lost to Follow-up|6|||
128682746|NCT03324581|463137453|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
128682747|NCT03324581|463137454|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
128682748|NCT03324581|463137455|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
128682749|NCT03324581|463137453|FG000|Overall Study|Physician Decision|0|||
128682750|NCT03324581|463137454|FG001|Overall Study|Physician Decision|1|||
128682751|NCT03324581|463137455|FG002|Overall Study|Physician Decision|2|||
128682752|NCT03324581|463137453|FG000|Overall Study|Protocol Deviation|8|||
128682753|NCT03324581|463137454|FG001|Overall Study|Protocol Deviation|9|||
128682754|NCT03324581|463137455|FG002|Overall Study|Protocol Deviation|4|||
128682755|NCT03324581|463137453|FG000|Overall Study|Withdrawal by Subject|6|||
128682756|NCT03324581|463137454|FG001|Overall Study|Withdrawal by Subject|8|||
128682757|NCT03324581|463137455|FG002|Overall Study|Withdrawal by Subject|6|||
128682758|NCT03324581|463137453|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
128682759|NCT03324581|463137454|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
128682760|NCT03324581|463137455|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
128682761|NCT04473482|463137456|FG000|Overall Study|Death|0|||
128682762|NCT04473482|463137457|FG001|Overall Study|Death|3|||
128682763|NCT04473482|463137456|FG000|Overall Study|Lost to Follow-up|9|||
128682764|NCT04473482|463137457|FG001|Overall Study|Lost to Follow-up|7|||
128682765|NCT04473482|463137456|FG000|Overall Study|Withdrawal by Subject|2|||
128682766|NCT04473482|463137457|FG001|Overall Study|Withdrawal by Subject|1|||
128682767|NCT03455764|463137458|FG000|Overall Study|Adverse Event|1|||
128682768|NCT03455764|463137459|FG001|Overall Study|Adverse Event|0|||
128682769|NCT03455764|463137460|FG002|Overall Study|Adverse Event|0|||
128682770|NCT03455764|463137461|FG003|Overall Study|Adverse Event|0|||
128682771|NCT03455764|463137462|FG004|Overall Study|Adverse Event|0|||
128682772|NCT03455764|463137458|FG000|Overall Study|Disease Progression|4|||
128682773|NCT03455764|463137459|FG001|Overall Study|Disease Progression|0|||
128682774|NCT03455764|463137460|FG002|Overall Study|Disease Progression|0|||
128682775|NCT03455764|463137461|FG003|Overall Study|Disease Progression|0|||
128682776|NCT03455764|463137462|FG004|Overall Study|Disease Progression|0|||
128682777|NCT03455764|463137458|FG000|Overall Study|On Treatment|1|||
128682778|NCT03455764|463137459|FG001|Overall Study|On Treatment|0|||
128682779|NCT03455764|463137460|FG002|Overall Study|On Treatment|0|||
128682780|NCT03455764|463137461|FG003|Overall Study|On Treatment|0|||
128682781|NCT03455764|463137462|FG004|Overall Study|On Treatment|0|||
128682782|NCT00989573|463137466|FG000|Overall Study|Adverse Event|8|||
129016306|NCT01844375|464353431|FG001|Overall Study|Protocol Violation|1|||
129016307|NCT03020615|464353432|FG000|Overall Study|Physician Decision|3|||
129016308|NCT03020615|464353433|FG001|Overall Study|Physician Decision|1|||
129016309|NCT03020615|464353434|FG002|Overall Study|Physician Decision|2|||
129016310|NCT03020615|464353432|FG000|Overall Study|Parent/guardian/patient choice|3|||
129016311|NCT03020615|464353433|FG001|Overall Study|Parent/guardian/patient choice|0|||
129016312|NCT03020615|464353434|FG002|Overall Study|Parent/guardian/patient choice|4|||
129016313|NCT03020615|464353432|FG000|Overall Study|Screen failure|0|||
129016314|NCT03020615|464353433|FG001|Overall Study|Screen failure|0|||
129016315|NCT03020615|464353434|FG002|Overall Study|Screen failure|1|||
129016316|NCT03020615|464353432|FG000|Overall Study|Death|1|||
129016317|NCT03020615|464353433|FG001|Overall Study|Death|0|||
129016318|NCT03020615|464353434|FG002|Overall Study|Death|0|||
129016319|NCT03020615|464353432|FG000|Overall Study|Lost to Follow-up|0|||
129016320|NCT03020615|464353433|FG001|Overall Study|Lost to Follow-up|1|||
129016321|NCT03020615|464353434|FG002|Overall Study|Lost to Follow-up|0|||
129016322|NCT00252720|464353436|FG000|Overall Study|Withdrawal by Subject|95|||
129016323|NCT00252720|464353437|FG001|Overall Study|Withdrawal by Subject|97|||
129016324|NCT00252720|464353436|FG000|Overall Study|Death|7|||
129016325|NCT00252720|464353437|FG001|Overall Study|Death|8|||
129016326|NCT00252720|464353436|FG000|Overall Study|Moving|23|||
129016327|NCT00252720|464353437|FG001|Overall Study|Moving|42|||
129016328|NCT00252720|464353436|FG000|Overall Study|Mainly patients lost to follow-up|7|||
129016329|NCT00252720|464353437|FG001|Overall Study|Mainly patients lost to follow-up|18|||
129016330|NCT02514122|464353443|FG000|Overall Study|Withdrawal by Subject|2|||
129104578|NCT02588092|464677217|FG006|Overall Study|Started Another Treatment|0|||
128682783|NCT00989573|463137467|FG001|Overall Study|Adverse Event|12|||
129016331|NCT02514122|464353444|FG001|Overall Study|Withdrawal by Subject|0|||
129016332|NCT04239872|464353445|FG000|Overall Study|Lost to Follow-up|0|||
129016333|NCT04239872|464353446|FG001|Overall Study|Lost to Follow-up|1|||
129016334|NCT01472341|464353447|FG000|Overall Study|Started insulin therapy|55|||
128682784|NCT00989573|463137468|FG002|Overall Study|Adverse Event|4|||
128682785|NCT00989573|463137466|FG000|Overall Study|Physician Decision|0|||
128682786|NCT00989573|463137467|FG001|Overall Study|Physician Decision|2|||
128682787|NCT00989573|463137468|FG002|Overall Study|Physician Decision|0|||
128682788|NCT00989573|463137466|FG000|Overall Study|Protocol Violation|1|||
128682789|NCT00989573|463137467|FG001|Overall Study|Protocol Violation|1|||
128682790|NCT00989573|463137468|FG002|Overall Study|Protocol Violation|1|||
128682791|NCT00989573|463137466|FG000|Overall Study|Withdrawal by Subject|4|||
129104579|NCT02588092|464677218|FG007|Overall Study|Started Another Treatment|1|||
129104580|NCT02588092|464677219|FG008|Overall Study|Started Another Treatment|0|||
129104581|NCT02588092|464677220|FG009|Overall Study|Started Another Treatment|0|||
129104582|NCT02588092|464677211|FG000|Overall Study|Sponsor Decision|0|||
129104583|NCT02588092|464677212|FG001|Overall Study|Sponsor Decision|0|||
129104584|NCT02588092|464677213|FG002|Overall Study|Sponsor Decision|0|||
129104585|NCT02588092|464677214|FG003|Overall Study|Sponsor Decision|0|||
129104586|NCT02588092|464677215|FG004|Overall Study|Sponsor Decision|0|||
129104587|NCT02588092|464677216|FG005|Overall Study|Sponsor Decision|0|||
129104588|NCT02588092|464677217|FG006|Overall Study|Sponsor Decision|0|||
129104589|NCT02588092|464677218|FG007|Overall Study|Sponsor Decision|0|||
129104590|NCT02588092|464677219|FG008|Overall Study|Sponsor Decision|1|||
129104591|NCT02588092|464677220|FG009|Overall Study|Sponsor Decision|1|||
129104592|NCT01030718|464677221|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
129104593|NCT01030718|464677222|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
129104594|NCT01030718|464677223|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
129104595|NCT01030718|464677221|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
129104596|NCT01030718|464677222|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
129104597|NCT01030718|464677223|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
128682792|NCT00989573|463137467|FG001|Overall Study|Withdrawal by Subject|7|||
128682793|NCT00989573|463137468|FG002|Overall Study|Withdrawal by Subject|3|||
128682794|NCT05080660|463137471|FG000|Overall Study|Adverse Event|4|||
128682795|NCT05080660|463137472|FG001|Overall Study|Adverse Event|0|||
128682796|NCT05080660|463137471|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
128682797|NCT05080660|463137472|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
128682798|NCT05080660|463137471|FG000|Overall Study|Physician Decision|1|||
128682799|NCT05080660|463137472|FG001|Overall Study|Physician Decision|0|||
128682800|NCT05080660|463137471|FG000|Overall Study|Protocol Deviation|2|||
128682801|NCT05080660|463137472|FG001|Overall Study|Protocol Deviation|0|||
128682802|NCT05080660|463137471|FG000|Overall Study|Withdrawal by Subject|5|||
128682803|NCT05080660|463137472|FG001|Overall Study|Withdrawal by Subject|2|||
128682804|NCT03687970|463137483|FG000|Overall Study|visit scheduling conflicts|2|||
128682805|NCT03687970|463137484|FG001|Overall Study|visit scheduling conflicts|0|||
128682806|NCT00282347|463137485|FG000|Treatment Period|Death|2|||
128682807|NCT00282347|463137486|FG001|Treatment Period|Death|0|||
128682808|NCT00282347|463137485|FG000|Treatment Period|Lost to Follow-up|2|||
128682809|NCT00282347|463137486|FG001|Treatment Period|Lost to Follow-up|5|||
128682810|NCT00282347|463137485|FG000|Treatment Period|Withdrawal by Subject|1|||
128682811|NCT00282347|463137486|FG001|Treatment Period|Withdrawal by Subject|3|||
129104598|NCT01030718|464677221|FG000|Studies CA180-031 and -036 Combined|Death|0|||
129104599|NCT01030718|464677222|FG001|Studies CA180-031 and -036 Combined|Death|1|||
129104600|NCT01030718|464677223|FG002|Studies CA180-031 and -036 Combined|Death|0|||
129104601|NCT01030718|464677221|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
129104602|NCT01030718|464677222|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
129104603|NCT01030718|464677223|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
129104604|NCT01030718|464677221|FG000|Study CA180-036 Only|insufficient effect|1|||
129104605|NCT01030718|464677222|FG001|Study CA180-036 Only|insufficient effect|1|||
129104606|NCT01030718|464677223|FG002|Study CA180-036 Only|insufficient effect|5|||
129104607|NCT01030718|464677221|FG000|Study CA180-036 Only|Adverse Event|2|||
129104608|NCT01030718|464677222|FG001|Study CA180-036 Only|Adverse Event|3|||
129104609|NCT01030718|464677223|FG002|Study CA180-036 Only|Adverse Event|0|||
129104610|NCT01030718|464677221|FG000|Study CA180-036 Only|Death|0|||
129104611|NCT01030718|464677222|FG001|Study CA180-036 Only|Death|1|||
129104612|NCT01030718|464677223|FG002|Study CA180-036 Only|Death|0|||
129104613|NCT01030718|464677221|FG000|Study CA180-036 Only|Other Reasons|0|||
129104614|NCT01030718|464677222|FG001|Study CA180-036 Only|Other Reasons|2|||
129104615|NCT01030718|464677223|FG002|Study CA180-036 Only|Other Reasons|0|||
129104616|NCT00099632|464677226|FG000|Overall Study|Lost to Follow-up|1|||
129104617|NCT00099632|464677227|FG001|Overall Study|Lost to Follow-up|0|||
129104618|NCT00099632|464677228|FG002|Overall Study|Lost to Follow-up|3|||
128682812|NCT00282347|463137485|FG000|Treatment Period|Physician Decision|0|||
128763147|NCT00615264|463422750|FG000|Overall Study|Adverse Event|8|||
129104619|NCT00099632|464677229|FG003|Overall Study|Lost to Follow-up|1|||
129104620|NCT00099632|464677230|FG004|Overall Study|Lost to Follow-up|1|||
129104621|NCT00099632|464677231|FG005|Overall Study|Lost to Follow-up|0|||
129104622|NCT00099632|464677226|FG000|Overall Study|Withdrawal by Subject|0|||
129104623|NCT00099632|464677227|FG001|Overall Study|Withdrawal by Subject|1|||
129104624|NCT00099632|464677228|FG002|Overall Study|Withdrawal by Subject|0|||
129104625|NCT00099632|464677229|FG003|Overall Study|Withdrawal by Subject|0|||
129104626|NCT00099632|464677230|FG004|Overall Study|Withdrawal by Subject|0|||
129104627|NCT00099632|464677231|FG005|Overall Study|Withdrawal by Subject|1|||
128682813|NCT00282347|463137486|FG001|Treatment Period|Physician Decision|1|||
128682814|NCT00282347|463137485|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
128682815|NCT00282347|463137486|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
128682816|NCT00282347|463137485|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
128682817|NCT00282347|463137486|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
128879653|NCT00372229|463854901|FG001|Study Phase|Graft loss|3|||
128879654|NCT00372229|463854900|FG000|Study Phase|Protocol Violation|3|||
128879655|NCT00372229|463854901|FG001|Study Phase|Protocol Violation|4|||
128879656|NCT00372229|463854900|FG000|Study Phase|Consent withdrawn|16|||
128879657|NCT00372229|463854901|FG001|Study Phase|Consent withdrawn|14|||
128879658|NCT00372229|463854900|FG000|Study Phase|Refused treatment/did not cooperate|3|||
128879659|NCT00372229|463854901|FG001|Study Phase|Refused treatment/did not cooperate|1|||
128879660|NCT00372229|463854900|FG000|Study Phase|Death|3|||
128879661|NCT00372229|463854901|FG001|Study Phase|Death|2|||
128879662|NCT00372229|463854900|FG000|Study Phase|Reason not specified|3|||
128879663|NCT00372229|463854901|FG001|Study Phase|Reason not specified|2|||
128879664|NCT00372229|463854900|FG000|Study Phase|Lost to Follow-up|3|||
128879665|NCT00372229|463854901|FG001|Study Phase|Lost to Follow-up|3|||
128879666|NCT00372229|463854900|FG000|Follow-Up Phase|Graft loss|8|||
128879667|NCT00372229|463854901|FG001|Follow-Up Phase|Graft loss|7|||
128879668|NCT00372229|463854900|FG000|Follow-Up Phase|Consent withdrawn|13|||
128879669|NCT00372229|463854901|FG001|Follow-Up Phase|Consent withdrawn|19|||
128879670|NCT00372229|463854900|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
128879671|NCT00372229|463854901|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
128879672|NCT00372229|463854900|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
128879673|NCT00372229|463854901|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
128879674|NCT00372229|463854900|FG000|Follow-Up Phase|Death|9|||
128879675|NCT00372229|463854901|FG001|Follow-Up Phase|Death|12|||
128879676|NCT00372229|463854900|FG000|Follow-Up Phase|Administrative|1|||
128879677|NCT00372229|463854901|FG001|Follow-Up Phase|Administrative|0|||
128879678|NCT00372229|463854900|FG000|Follow-Up Phase|Reason not specified|2|||
128879679|NCT00372229|463854901|FG001|Follow-Up Phase|Reason not specified|3|||
128879680|NCT00372229|463854900|FG000|Follow-Up Phase|Lost to Follow-up|12|||
128879681|NCT00372229|463854901|FG001|Follow-Up Phase|Lost to Follow-up|10|||
128879682|NCT00319839|463854904|FG000|Overall Study|Adverse Event|5|||
128879683|NCT00319839|463854904|FG000|Overall Study|Withdrawal by Subject|1|||
128879684|NCT01577745|463854905|FG000|Overall Study|Withdrawal by Subject|0|||
128879685|NCT01577745|463854906|FG001|Overall Study|Withdrawal by Subject|1|||
128879686|NCT01577745|463854907|FG002|Overall Study|Withdrawal by Subject|0|||
128879687|NCT01577745|463854908|FG003|Overall Study|Withdrawal by Subject|3|||
128879688|NCT01577745|463854909|FG004|Overall Study|Withdrawal by Subject|2|||
128879689|NCT01577745|463854910|FG005|Overall Study|Withdrawal by Subject|0|||
128879690|NCT01577745|463854905|FG000|Overall Study|Death|3|||
128879691|NCT01577745|463854906|FG001|Overall Study|Death|2|||
128879692|NCT01577745|463854907|FG002|Overall Study|Death|2|||
128879693|NCT01577745|463854908|FG003|Overall Study|Death|1|||
128879694|NCT01577745|463854909|FG004|Overall Study|Death|1|||
128879695|NCT01577745|463854910|FG005|Overall Study|Death|3|||
128879696|NCT01577745|463854905|FG000|Overall Study|Physician Decision|0|||
129016335|NCT01472341|464353447|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
129016336|NCT01472341|464353447|FG000|Overall Study|Withdrawal by Subject|39|||
129016337|NCT01472341|464353447|FG000|Overall Study|Lost to Follow-up|52|||
128682818|NCT00282347|463137485|FG000|Safety Follow-up Period|Physician Decision|1|||
128682819|NCT00282347|463137486|FG001|Safety Follow-up Period|Physician Decision|1|||
128682820|NCT00282347|463137485|FG000|Safety Follow-up Period|Protocol Deviation|0|||
128682821|NCT00282347|463137486|FG001|Safety Follow-up Period|Protocol Deviation|2|||
128682822|NCT00282347|463137485|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
128682823|NCT00282347|463137486|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
128682824|NCT00282347|463137485|FG000|B Cell Follow-up Period|Physician Decision|1|||
128682825|NCT00282347|463137486|FG001|B Cell Follow-up Period|Physician Decision|0|||
128682826|NCT00282347|463137485|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
128682827|NCT00282347|463137486|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
128682828|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
128682829|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
128682830|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
128682831|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
128682832|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
128682833|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
128682834|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
128682835|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
128763148|NCT00615264|463422751|FG001|Overall Study|Adverse Event|5|||
128879697|NCT01577745|463854906|FG001|Overall Study|Physician Decision|0|||
128879698|NCT01577745|463854907|FG002|Overall Study|Physician Decision|0|||
128879699|NCT01577745|463854908|FG003|Overall Study|Physician Decision|1|||
128879700|NCT01577745|463854909|FG004|Overall Study|Physician Decision|1|||
128879701|NCT01577745|463854910|FG005|Overall Study|Physician Decision|0|||
128879702|NCT01577745|463854905|FG000|Overall Study|Lost to Follow-up|0|||
128879703|NCT01577745|463854906|FG001|Overall Study|Lost to Follow-up|0|||
128879704|NCT01577745|463854907|FG002|Overall Study|Lost to Follow-up|0|||
128879705|NCT01577745|463854908|FG003|Overall Study|Lost to Follow-up|0|||
128879706|NCT01577745|463854909|FG004|Overall Study|Lost to Follow-up|0|||
128879707|NCT01577745|463854910|FG005|Overall Study|Lost to Follow-up|1|||
128879708|NCT01577745|463854905|FG000|Overall Study|Alternative Therapy|0|||
128879709|NCT01577745|463854906|FG001|Overall Study|Alternative Therapy|0|||
128879710|NCT01577745|463854907|FG002|Overall Study|Alternative Therapy|0|||
128879711|NCT01577745|463854908|FG003|Overall Study|Alternative Therapy|1|||
128879712|NCT01577745|463854909|FG004|Overall Study|Alternative Therapy|1|||
128879713|NCT01577745|463854910|FG005|Overall Study|Alternative Therapy|0|||
128879714|NCT00262951|463854911|FG000|Overall Study|Progressive disease/relapse|3|||
128879715|NCT00262951|463854911|FG000|Overall Study|Adverse Event|7|||
128879716|NCT00262951|463854911|FG000|Overall Study|Death|1|||
128879717|NCT00262951|463854911|FG000|Overall Study|Withdrawal by Subject|1|||
128879718|NCT00262951|463854911|FG000|Overall Study|Alternative treatment|3|||
128879719|NCT00262951|463854911|FG000|Overall Study|Off treatment for other disease|1|||
128879720|NCT02483585|463854912|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
128879721|NCT02483585|463854913|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
128879722|NCT02483585|463854912|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
128879723|NCT02483585|463854913|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
128879724|NCT02483585|463854912|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
128879725|NCT02483585|463854913|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
128879726|NCT02483585|463854912|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
128879727|NCT02483585|463854913|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
128879728|NCT02483585|463854912|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
128879729|NCT02483585|463854913|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
128879730|NCT02483585|463854912|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
128879731|NCT02483585|463854913|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
128879732|NCT02483585|463854912|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
128879733|NCT02483585|463854913|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
128879734|NCT01324440|463854918|FG000|Overall Study|Subject moved|0|||
128879735|NCT01324440|463854919|FG001|Overall Study|Subject moved|1|||
128879736|NCT00903630|463854920|FG000|Phase 2|Adverse Event|0|||
128879737|NCT00903630|463854921|FG001|Phase 2|Adverse Event|0|||
128879738|NCT00903630|463854922|FG002|Phase 2|Adverse Event|1|||
128879739|NCT02325557|463854923|FG000|Overall Study|Progressive disease|1|||
128879740|NCT02325557|463854924|FG001|Overall Study|Progressive disease|0|||
128879741|NCT02325557|463854925|FG002|Overall Study|Progressive disease|0|||
128879742|NCT02325557|463854926|FG003|Overall Study|Progressive disease|0|||
128879743|NCT02325557|463854923|FG000|Overall Study|Withdrawal by Subject|4|||
128879744|NCT02325557|463854924|FG001|Overall Study|Withdrawal by Subject|0|||
128879745|NCT02325557|463854925|FG002|Overall Study|Withdrawal by Subject|0|||
128879746|NCT02325557|463854926|FG003|Overall Study|Withdrawal by Subject|15|||
128879747|NCT02325557|463854923|FG000|Overall Study|Death|5|||
128879748|NCT02325557|463854924|FG001|Overall Study|Death|1|||
128879749|NCT02325557|463854925|FG002|Overall Study|Death|1|||
128879750|NCT02325557|463854926|FG003|Overall Study|Death|16|||
128682836|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
128682837|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
128682838|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
128682839|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
128682840|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
128682841|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
128682842|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
128682843|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
128682844|NCT00491556|463137487|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
128682845|NCT00491556|463137488|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
128682846|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
128682847|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
128682848|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
128682849|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
128682850|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
128682851|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
128682852|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
128682853|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
128682854|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
128682855|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
128682856|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
128682857|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
128879751|NCT02325557|463854923|FG000|Overall Study|Lost to Follow-up|0|||
128879752|NCT02325557|463854924|FG001|Overall Study|Lost to Follow-up|0|||
128879753|NCT02325557|463854925|FG002|Overall Study|Lost to Follow-up|1|||
128879754|NCT02325557|463854926|FG003|Overall Study|Lost to Follow-up|1|||
128879755|NCT02325557|463854923|FG000|Overall Study|Other|0|||
128879756|NCT02325557|463854924|FG001|Overall Study|Other|0|||
128879757|NCT02325557|463854925|FG002|Overall Study|Other|0|||
129016338|NCT01472341|464353447|FG000|Overall Study|Laboratory parameters unavailable|25|||
129016339|NCT01472341|464353447|FG000|Overall Study|Death|9|||
129016340|NCT00112463|464353450|FG000|Overall Study|Physician Decision|1|||
129016341|NCT00112463|464353450|FG000|Overall Study|Progression|30|||
129016342|NCT00112463|464353450|FG000|Overall Study|Second Primary|1|||
129016343|NCT00112463|464353450|FG000|Overall Study|Toxicity|3|||
129016344|NCT00112463|464353450|FG000|Overall Study|Withdrawal by Subject|2|||
129016345|NCT00112463|464353450|FG000|Overall Study|Never started treatment|2|||
129016346|NCT01118312|464353457|FG000|Overall Study|Lost to Follow-up|33|||
129016347|NCT01118312|464353458|FG001|Overall Study|Lost to Follow-up|32|||
129016348|NCT01118312|464353457|FG000|Overall Study|Withdrawal by Subject|1|||
129016349|NCT01118312|464353458|FG001|Overall Study|Withdrawal by Subject|3|||
129016350|NCT00296647|464353459|FG000|Overall Study|Death|4|||
129016351|NCT00296647|464353460|FG001|Overall Study|Death|1|||
129016352|NCT00296647|464353461|FG002|Overall Study|Death|2|||
129016353|NCT00296647|464353462|FG003|Overall Study|Death|1|||
129016354|NCT00296647|464353463|FG004|Overall Study|Death|1|||
129016355|NCT00296647|464353459|FG000|Overall Study|Withdrawal by Subject|28|||
129016356|NCT00296647|464353460|FG001|Overall Study|Withdrawal by Subject|27|||
129016357|NCT00296647|464353461|FG002|Overall Study|Withdrawal by Subject|32|||
129016358|NCT00296647|464353462|FG003|Overall Study|Withdrawal by Subject|16|||
129016359|NCT00296647|464353463|FG004|Overall Study|Withdrawal by Subject|19|||
129016360|NCT01629381|464353464|FG000|Overall Study|Withdrawal by Subject|2|||
129016361|NCT01629381|464353465|FG001|Overall Study|Withdrawal by Subject|5|||
128682858|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
128682859|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
128682860|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
128682861|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
128682862|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
128682863|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
128682864|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
128682865|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
128682866|NCT00491556|463137487|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
128682867|NCT00491556|463137488|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
128682868|NCT04285580|463138697|FG000|Overall Study|Protocol Violation|0|||
128682869|NCT04285580|463138698|FG001|Overall Study|Protocol Violation|1|||
128682870|NCT00076024|463138699|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
128682871|NCT00076024|463138700|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
128682872|NCT00076024|463138701|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
128682873|NCT00076024|463138702|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
128682874|NCT00076024|463138699|FG000|Phase 1, Lead-in|Adverse Event|1|||
128682875|NCT00076024|463138700|FG001|Phase 1, Lead-in|Adverse Event|0|||
128682876|NCT00076024|463138701|FG002|Phase 1, Lead-in|Adverse Event|0|||
128682877|NCT00076024|463138702|FG003|Phase 1, Lead-in|Adverse Event|0|||
128682878|NCT00076024|463138699|FG000|Phase 1, Lead-in|Clinical progression|1|||
128682879|NCT00076024|463138700|FG001|Phase 1, Lead-in|Clinical progression|0|||
128682880|NCT00076024|463138701|FG002|Phase 1, Lead-in|Clinical progression|0|||
128682881|NCT00076024|463138702|FG003|Phase 1, Lead-in|Clinical progression|0|||
128682882|NCT00076024|463138699|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
128682883|NCT00076024|463138700|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
128682884|NCT00076024|463138701|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
128682885|NCT00076024|463138702|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
128682886|NCT00076024|463138699|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
128682887|NCT00076024|463138700|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
128682888|NCT00076024|463138701|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
128682889|NCT00076024|463138702|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
128682890|NCT00076024|463138699|FG000|Phase 2, Double-blind|Adverse Event|0|||
128682891|NCT00076024|463138700|FG001|Phase 2, Double-blind|Adverse Event|25|||
128682892|NCT00076024|463138701|FG002|Phase 2, Double-blind|Adverse Event|6|||
128682893|NCT00076024|463138702|FG003|Phase 2, Double-blind|Adverse Event|0|||
128682894|NCT00076024|463138699|FG000|Phase 2, Double-blind|Un-specified|0|||
128682895|NCT00076024|463138700|FG001|Phase 2, Double-blind|Un-specified|14|||
128682896|NCT00076024|463138701|FG002|Phase 2, Double-blind|Un-specified|6|||
128682897|NCT00076024|463138702|FG003|Phase 2, Double-blind|Un-specified|0|||
128682898|NCT00076024|463138699|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
128682899|NCT00076024|463138700|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
128682900|NCT00076024|463138701|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
128682901|NCT00076024|463138702|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
129016362|NCT00735904|464353466|FG000|Overall Study|Adverse Event|3|||
129016363|NCT00735904|464353466|FG000|Overall Study|Death|20|||
129016364|NCT00735904|464353466|FG000|Overall Study|Protocol Violation|1|||
129016365|NCT00735904|464353466|FG000|Overall Study|Withdrawal by Subject|1|||
129016366|NCT00735904|464353466|FG000|Overall Study|Study Terminated by Sponsor|5|||
129016367|NCT00735904|464353466|FG000|Overall Study|Other|8|||
128682902|NCT00076024|463138699|FG000|Phase 2, Open-label|Adverse Event|0|||
128682903|NCT00076024|463138700|FG001|Phase 2, Open-label|Adverse Event|0|||
128682904|NCT00076024|463138701|FG002|Phase 2, Open-label|Adverse Event|0|||
128682905|NCT00076024|463138702|FG003|Phase 2, Open-label|Adverse Event|2|||
128682906|NCT00076024|463138699|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
128682907|NCT00076024|463138700|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
128682908|NCT00076024|463138701|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
128682909|NCT00076024|463138702|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
128879758|NCT02325557|463854926|FG003|Overall Study|Other|5|||
128879759|NCT01136772|463854929|FG000|Overall Study|Adverse Event|15|||
128879760|NCT01136772|463854930|FG001|Overall Study|Adverse Event|14|||
128879761|NCT01136772|463854929|FG000|Overall Study|Lack of Efficacy|42|||
128879762|NCT01136772|463854930|FG001|Overall Study|Lack of Efficacy|39|||
128879763|NCT01136772|463854929|FG000|Overall Study|Administrative|14|||
128879764|NCT01136772|463854930|FG001|Overall Study|Administrative|12|||
128879765|NCT01136772|463854929|FG000|Overall Study|Withdrawal by Subject|33|||
128879766|NCT01136772|463854930|FG001|Overall Study|Withdrawal by Subject|36|||
128682910|NCT00076024|463138699|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
128682911|NCT00076024|463138700|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
128682912|NCT00076024|463138701|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
128879767|NCT01136772|463854929|FG000|Overall Study|Did not receive injection|10|||
128879768|NCT01136772|463854930|FG001|Overall Study|Did not receive injection|7|||
129016368|NCT01390844|464353467|FG000|Treatment Phase|Adverse Event|12|||
129016369|NCT01390844|464353468|FG001|Treatment Phase|Adverse Event|2|||
129016370|NCT01390844|464353469|FG002|Treatment Phase|Adverse Event|3|||
129016371|NCT01390844|464353470|FG003|Treatment Phase|Adverse Event|2|||
129016372|NCT01390844|464353467|FG000|Treatment Phase|Treatment Failure|23|||
129016373|NCT01390844|464353468|FG001|Treatment Phase|Treatment Failure|25|||
129016374|NCT01390844|464353469|FG002|Treatment Phase|Treatment Failure|10|||
129016375|NCT01390844|464353470|FG003|Treatment Phase|Treatment Failure|13|||
129016376|NCT01390844|464353467|FG000|Treatment Phase|Non-Medical Reasons|5|||
129016377|NCT01390844|464353468|FG001|Treatment Phase|Non-Medical Reasons|1|||
129016378|NCT01390844|464353469|FG002|Treatment Phase|Non-Medical Reasons|8|||
129016379|NCT01390844|464353470|FG003|Treatment Phase|Non-Medical Reasons|1|||
129016380|NCT01390844|464353467|FG000|Treatment Phase|Non-GCP Compliant|0|||
129016381|NCT01390844|464353468|FG001|Treatment Phase|Non-GCP Compliant|0|||
129016382|NCT01390844|464353469|FG002|Treatment Phase|Non-GCP Compliant|10|||
129016383|NCT01390844|464353470|FG003|Treatment Phase|Non-GCP Compliant|3|||
129016384|NCT01390844|464353467|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
129016385|NCT01390844|464353468|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
129016386|NCT01390844|464353469|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
129016387|NCT01390844|464353470|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
129016388|NCT03204539|464353473|FG000|Overall Study|Loss of funding|0|||
129016389|NCT03204539|464353474|FG001|Overall Study|Loss of funding|1|||
129016390|NCT03693430|464353477|FG000|Overall Study|Lost to Follow-up|3|||
129016391|NCT03693430|464353478|FG001|Overall Study|Lost to Follow-up|14|||
129016392|NCT03693430|464353477|FG000|Overall Study|Death|1|||
129016393|NCT03693430|464353478|FG001|Overall Study|Death|0|||
129016394|NCT03693430|464353477|FG000|Overall Study|Withdrawal by Subject|0|||
129016395|NCT03693430|464353478|FG001|Overall Study|Withdrawal by Subject|4|||
129016396|NCT04185909|464353479|FG000|Overall Study|Lost to Follow-up|1|||
129016397|NCT01417078|464353480|FG000|Overall Study|Withdrawal by Subject|1|||
129016398|NCT00626548|464353481|FG000|Overall Study|Adverse Event|164|||
129016399|NCT00626548|464353482|FG001|Overall Study|Adverse Event|44|||
129016400|NCT00626548|464353481|FG000|Overall Study|Withdrawal by Subject|42|||
129016401|NCT00626548|464353482|FG001|Overall Study|Withdrawal by Subject|46|||
129016402|NCT00626548|464353481|FG000|Overall Study|Protocol Violation|4|||
129016403|NCT00626548|464353482|FG001|Overall Study|Protocol Violation|11|||
129016404|NCT00626548|464353481|FG000|Overall Study|Lost to Follow-up|2|||
129016405|NCT00626548|464353482|FG001|Overall Study|Lost to Follow-up|2|||
129016406|NCT00626548|464353481|FG000|Overall Study|Other termination reason|493|||
129016407|NCT00626548|464353482|FG001|Overall Study|Other termination reason|613|||
129016408|NCT00048581|464353483|FG000|Double-Blind Period|Adverse Event|9|||
129016409|NCT00048581|464353484|FG001|Double-Blind Period|Adverse Event|5|||
129016410|NCT00048581|464353485|FG002|Double-Blind Period|Adverse Event|0|||
129016411|NCT00048581|464353483|FG000|Double-Blind Period|Lack of Efficacy|14|||
129016412|NCT00048581|464353484|FG001|Double-Blind Period|Lack of Efficacy|27|||
129016413|NCT00048581|464353485|FG002|Double-Blind Period|Lack of Efficacy|0|||
129016414|NCT00048581|464353483|FG000|Double-Blind Period|Lost to Follow-up|5|||
129016415|NCT00048581|464353484|FG001|Double-Blind Period|Lost to Follow-up|0|||
129016416|NCT00048581|464353485|FG002|Double-Blind Period|Lost to Follow-up|0|||
129016417|NCT00048581|464353483|FG000|Double-Blind Period|Withdrawal by Subject|5|||
129016418|NCT00048581|464353484|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129016419|NCT00048581|464353485|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129016420|NCT00048581|464353483|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
129016421|NCT00048581|464353484|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
129016422|NCT00048581|464353485|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
129016423|NCT00048581|464353483|FG000|Double-Blind Period|Investigator Decision|1|||
128879769|NCT01136772|463854929|FG000|Overall Study|Did not follow up after first injection|2|||
128879770|NCT01136772|463854930|FG001|Overall Study|Did not follow up after first injection|2|||
128879771|NCT01602562|463854931|FG000|Overall Study|Adverse Event|3|||
128879772|NCT01602562|463854932|FG001|Overall Study|Adverse Event|1|||
128879773|NCT01602562|463854931|FG000|Overall Study|Physician Decision|1|||
128879774|NCT01602562|463854932|FG001|Overall Study|Physician Decision|1|||
129016424|NCT00048581|464353484|FG001|Double-Blind Period|Investigator Decision|0|||
129016425|NCT00048581|464353485|FG002|Double-Blind Period|Investigator Decision|0|||
129016426|NCT00048581|464353483|FG000|Open-Label Period|Death|0|||
129016427|NCT00048581|464353484|FG001|Open-Label Period|Death|0|||
129016428|NCT00048581|464353485|FG002|Open-Label Period|Death|4|||
129016429|NCT00048581|464353483|FG000|Open-Label Period|Adverse Event|0|||
129016430|NCT00048581|464353484|FG001|Open-Label Period|Adverse Event|0|||
129016431|NCT00048581|464353485|FG002|Open-Label Period|Adverse Event|37|||
129016432|NCT00048581|464353483|FG000|Open-Label Period|Lack of Efficacy|0|||
129016433|NCT00048581|464353484|FG001|Open-Label Period|Lack of Efficacy|0|||
129016434|NCT00048581|464353485|FG002|Open-Label Period|Lack of Efficacy|69|||
129016435|NCT00048581|464353483|FG000|Open-Label Period|Lost to Follow-up|0|||
129016436|NCT00048581|464353484|FG001|Open-Label Period|Lost to Follow-up|0|||
129016437|NCT00048581|464353485|FG002|Open-Label Period|Lost to Follow-up|14|||
129016438|NCT00048581|464353483|FG000|Open-Label Period|Withdrawal by Subject|0|||
129016439|NCT00048581|464353484|FG001|Open-Label Period|Withdrawal by Subject|0|||
129016440|NCT00048581|464353485|FG002|Open-Label Period|Withdrawal by Subject|20|||
129016441|NCT00048581|464353483|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
129016442|NCT00048581|464353484|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
129016443|NCT00048581|464353485|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
129016444|NCT00048581|464353483|FG000|Open-Label Period|Poor/Non-compliance|0|||
129016445|NCT00048581|464353484|FG001|Open-Label Period|Poor/Non-compliance|0|||
129016446|NCT00048581|464353485|FG002|Open-Label Period|Poor/Non-compliance|5|||
129016447|NCT00048581|464353483|FG000|Open-Label Period|Pregnancy|0|||
129016448|NCT00048581|464353484|FG001|Open-Label Period|Pregnancy|0|||
129016449|NCT00048581|464353485|FG002|Open-Label Period|Pregnancy|7|||
129016450|NCT00048581|464353483|FG000|Open-Label Period|Study Site Closure|0|||
129016451|NCT00048581|464353484|FG001|Open-Label Period|Study Site Closure|0|||
129016452|NCT00048581|464353485|FG002|Open-Label Period|Study Site Closure|2|||
129016453|NCT00048581|464353483|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
129016454|NCT00048581|464353484|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
129016455|NCT00048581|464353485|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
129016456|NCT00048581|464353483|FG000|Open-Label Period|Problem With Transportation To Site|0|||
129016457|NCT00048581|464353484|FG001|Open-Label Period|Problem With Transportation To Site|0|||
129016458|NCT00048581|464353485|FG002|Open-Label Period|Problem With Transportation To Site|1|||
129016459|NCT00048581|464353483|FG000|Open-Label Period|Primary Investigator Retired|0|||
129016460|NCT00048581|464353484|FG001|Open-Label Period|Primary Investigator Retired|0|||
129016461|NCT00048581|464353485|FG002|Open-Label Period|Primary Investigator Retired|2|||
129016462|NCT00048581|464353483|FG000|Open-Label Period|Study Ended By Sponsor|0|||
129016463|NCT00048581|464353484|FG001|Open-Label Period|Study Ended By Sponsor|0|||
129016464|NCT00048581|464353485|FG002|Open-Label Period|Study Ended By Sponsor|1|||
129016465|NCT01059903|464353487|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
129016466|NCT01059903|464353488|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
129016467|NCT00385593|464353495|FG000|Overall Study|Adverse Event|3|||
129016468|NCT00385593|464353496|FG001|Overall Study|Adverse Event|2|||
129016469|NCT00385593|464353495|FG000|Overall Study|Withdrawal by Subject|17|||
129016470|NCT00385593|464353496|FG001|Overall Study|Withdrawal by Subject|7|||
129016471|NCT00385593|464353495|FG000|Overall Study|Lost to Follow-up|12|||
129016472|NCT00385593|464353496|FG001|Overall Study|Lost to Follow-up|8|||
129016473|NCT00385593|464353495|FG000|Overall Study|Protocol Violation|7|||
129016474|NCT00385593|464353496|FG001|Overall Study|Protocol Violation|4|||
129016475|NCT00385593|464353495|FG000|Overall Study|Several reasons|17|||
129016476|NCT00385593|464353496|FG001|Overall Study|Several reasons|15|||
129016477|NCT00385593|464353495|FG000|Overall Study|Incorrect inclusion|2|||
129016478|NCT00385593|464353496|FG001|Overall Study|Incorrect inclusion|0|||
129016479|NCT00385593|464353495|FG000|Overall Study|Incorrect randomization|0|||
129016480|NCT00385593|464353496|FG001|Overall Study|Incorrect randomization|1|||
129016481|NCT00319735|464353497|FG000|Overall Study|Death|2|||
129016482|NCT01049334|464354935|FG000|Overall Study|Withdrawal by Subject|5|||
129016483|NCT01049334|464354936|FG001|Overall Study|Withdrawal by Subject|3|||
129016484|NCT01049334|464354935|FG000|Overall Study|Adverse Event|2|||
129016485|NCT01049334|464354936|FG001|Overall Study|Adverse Event|3|||
129016486|NCT01049334|464354935|FG000|Overall Study|Physician Decision|2|||
129016487|NCT01049334|464354936|FG001|Overall Study|Physician Decision|0|||
129016488|NCT01049334|464354935|FG000|Overall Study|Protocol Violation|0|||
129016489|NCT01049334|464354936|FG001|Overall Study|Protocol Violation|1|||
129016490|NCT00667095|464354949|FG000|Overall Study|Withdrawal by Subject|0|||
129016491|NCT00667095|464354950|FG001|Overall Study|Withdrawal by Subject|1|||
129016492|NCT03447262|464354951|FG000|Overall Study|Adverse Event|7|||
129104628|NCT00099632|464677226|FG000|Overall Study|Protocol Violation|0|||
128879775|NCT01602562|463854931|FG000|Overall Study|Withdrawal by Subject|1|||
128879776|NCT01602562|463854932|FG001|Overall Study|Withdrawal by Subject|1|||
128879777|NCT01959516|463854933|FG000|Epoch 1|Adverse Event|4|||
128879778|NCT01959516|463854934|FG001|Epoch 1|Adverse Event|1|||
128879779|NCT01959516|463854933|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
128879780|NCT01959516|463854934|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
128879781|NCT01959516|463854933|FG000|Epoch 1|Subject withdrew consent|3|||
128879782|NCT01959516|463854934|FG001|Epoch 1|Subject withdrew consent|2|||
128879783|NCT01959516|463854933|FG000|Epoch 1|Administrative problems|1|||
128879784|NCT01959516|463854934|FG001|Epoch 1|Administrative problems|0|||
128879785|NCT01959516|463854933|FG000|Epoch 1|Use of prohibited treatment|1|||
128879786|NCT01959516|463854934|FG001|Epoch 1|Use of prohibited treatment|0|||
128879787|NCT01959516|463854933|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
128879788|NCT01959516|463854934|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
128879789|NCT01959516|463854933|FG000|Epoch 1|Protocol deviation|0|||
128682913|NCT00076024|463138702|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
128682914|NCT00076024|463138699|FG000|Phase 2, Open-label|Other|0|||
128682915|NCT00076024|463138700|FG001|Phase 2, Open-label|Other|0|||
128682916|NCT00076024|463138701|FG002|Phase 2, Open-label|Other|0|||
128682917|NCT00076024|463138702|FG003|Phase 2, Open-label|Other|2|||
128682918|NCT01155219|463138703|FG000|Overall Study|Adverse Event|3|||
128682919|NCT01155219|463138704|FG001|Overall Study|Adverse Event|1|||
128682920|NCT01155219|463138703|FG000|Overall Study|non-medical reason|1|||
128682921|NCT01155219|463138704|FG001|Overall Study|non-medical reason|2|||
128682922|NCT00719264|463138705|FG000|Overall Study|Adverse Event|41|||
128682923|NCT00719264|463138706|FG001|Overall Study|Adverse Event|49|||
128682924|NCT00719264|463138705|FG000|Overall Study|Death|13|||
128682925|NCT00719264|463138706|FG001|Overall Study|Death|10|||
128682926|NCT00719264|463138705|FG000|Overall Study|Administrative Problems|6|||
128682927|NCT00719264|463138706|FG001|Overall Study|Administrative Problems|4|||
128682928|NCT00719264|463138705|FG000|Overall Study|Lost to Follow-up|1|||
128682929|NCT00719264|463138706|FG001|Overall Study|Lost to Follow-up|1|||
128682930|NCT00719264|463138705|FG000|Overall Study|Withdrawal by Subject|12|||
128682931|NCT00719264|463138706|FG001|Overall Study|Withdrawal by Subject|7|||
128682932|NCT00719264|463138705|FG000|Overall Study|Protocol Deviation|1|||
128682933|NCT00719264|463138706|FG001|Overall Study|Protocol Deviation|3|||
128682934|NCT00719264|463138705|FG000|Overall Study|New Cancer Therapy|4|||
128682935|NCT00719264|463138706|FG001|Overall Study|New Cancer Therapy|2|||
128879790|NCT01959516|463854934|FG001|Epoch 1|Protocol deviation|1|||
128879791|NCT01959516|463854933|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
128879792|NCT01959516|463854934|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
128879793|NCT01959516|463854933|FG000|Epoch 2|Subject withdrew consent|1|||
128879794|NCT01959516|463854934|FG001|Epoch 2|Subject withdrew consent|0|||
128879795|NCT01959516|463854933|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
128879796|NCT01959516|463854934|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
128879797|NCT01477333|463854935|FG000|Overall Study|Adverse Event|1|||
128879798|NCT01477333|463854935|FG000|Overall Study|Withdrawal by Subject|1|||
128879799|NCT01477333|463854935|FG000|Overall Study|Clinical Deterioration|1|||
128879800|NCT00928746|463854936|FG000|Overall Study|Adverse Event|2|||
128879801|NCT00928746|463854936|FG000|Overall Study|Protocol Violation|1|||
128879802|NCT00928746|463854936|FG000|Overall Study|Withdrawal by Subject|1|||
128879803|NCT00928746|463854936|FG000|Overall Study|Other|2|||
128879804|NCT02004353|463854942|FG000|Overall Study|Voluntary participation|1334|||
128879805|NCT02581631|463854943|FG000|Overall Study|Disease progression|29|||
128879806|NCT02581631|463854944|FG001|Overall Study|Disease progression|19|||
128879807|NCT02581631|463854945|FG002|Overall Study|Disease progression|13|||
128879808|NCT02581631|463854946|FG003|Overall Study|Disease progression|5|||
128879809|NCT02581631|463854947|FG004|Overall Study|Disease progression|8|||
128879810|NCT02581631|463854943|FG000|Overall Study|Study drug toxicity|4|||
128879811|NCT02581631|463854944|FG001|Overall Study|Study drug toxicity|6|||
129016493|NCT03447262|464354951|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
129016494|NCT03447262|464354951|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
129016495|NCT03447262|464354951|FG000|Overall Study|Death|2|||
129016496|NCT03447262|464354951|FG000|Overall Study|Study Termination by Sponsor|455|||
129016497|NCT03447262|464354951|FG000|Overall Study|Other|4|||
129016498|NCT01882257|464354953|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
129016499|NCT01882257|464354954|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
129016500|NCT01882257|464354955|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
128682936|NCT00719264|463138705|FG000|Overall Study|Disease Progression|104|||
128879812|NCT02581631|463854945|FG002|Overall Study|Study drug toxicity|7|||
128879813|NCT02581631|463854946|FG003|Overall Study|Study drug toxicity|0|||
128879814|NCT02581631|463854947|FG004|Overall Study|Study drug toxicity|3|||
128682937|NCT00719264|463138706|FG001|Overall Study|Disease Progression|107|||
128682938|NCT03981822|463138713|FG000|Overall Study|Lost to Follow-up|0|||
128682939|NCT03981822|463138714|FG001|Overall Study|Lost to Follow-up|1|||
128682940|NCT03981822|463138715|FG002|Overall Study|Lost to Follow-up|1|||
128879815|NCT02581631|463854943|FG000|Overall Study|AE unrelated to study drug|3|||
128879816|NCT02581631|463854944|FG001|Overall Study|AE unrelated to study drug|1|||
128682941|NCT03981822|463138716|FG003|Overall Study|Lost to Follow-up|0|||
128682942|NCT03981822|463138717|FG004|Overall Study|Lost to Follow-up|6|||
128682943|NCT03981822|463138718|FG005|Overall Study|Lost to Follow-up|4|||
128682944|NCT03981822|463138719|FG006|Overall Study|Lost to Follow-up|4|||
128682945|NCT03981822|463138720|FG007|Overall Study|Lost to Follow-up|2|||
128682946|NCT03981822|463138713|FG000|Overall Study|Withdrawal by Subject|0|||
128682947|NCT03981822|463138714|FG001|Overall Study|Withdrawal by Subject|1|||
128682948|NCT03981822|463138715|FG002|Overall Study|Withdrawal by Subject|0|||
128682949|NCT03981822|463138716|FG003|Overall Study|Withdrawal by Subject|0|||
128682950|NCT03981822|463138717|FG004|Overall Study|Withdrawal by Subject|0|||
128682951|NCT03981822|463138718|FG005|Overall Study|Withdrawal by Subject|1|||
128682952|NCT03981822|463138719|FG006|Overall Study|Withdrawal by Subject|0|||
128682953|NCT03981822|463138720|FG007|Overall Study|Withdrawal by Subject|2|||
128682954|NCT03981822|463138713|FG000|Overall Study|COVID-19 Related|0|||
128682955|NCT03981822|463138714|FG001|Overall Study|COVID-19 Related|0|||
128682956|NCT03981822|463138715|FG002|Overall Study|COVID-19 Related|0|||
128682957|NCT03981822|463138716|FG003|Overall Study|COVID-19 Related|0|||
128682958|NCT03981822|463138717|FG004|Overall Study|COVID-19 Related|2|||
128682959|NCT03981822|463138718|FG005|Overall Study|COVID-19 Related|1|||
128682960|NCT03981822|463138719|FG006|Overall Study|COVID-19 Related|2|||
128682961|NCT03981822|463138720|FG007|Overall Study|COVID-19 Related|1|||
128682962|NCT06460493|463138721|FG000|Overall Study|Withdrawal by Subject|2|||
128682963|NCT02987660|463138724|FG000|Overall Study|Study terminated by sponsor|10|||
128682964|NCT02987660|463138725|FG001|Overall Study|Study terminated by sponsor|10|||
128682965|NCT03707184|463138726|FG000|Overall Study|Withdrawal by Subject|2|||
128682966|NCT04704154|463138727|FG000|Overall Study|Adverse Event|3|||
128682967|NCT04704154|463138728|FG001|Overall Study|Adverse Event|2|||
128682968|NCT04704154|463138729|FG002|Overall Study|Adverse Event|4|||
128682969|NCT04704154|463138730|FG003|Overall Study|Adverse Event|2|||
128682970|NCT04704154|463138731|FG004|Overall Study|Adverse Event|3|||
128682971|NCT04704154|463138732|FG005|Overall Study|Adverse Event|0|||
128682972|NCT04704154|463138727|FG000|Overall Study|Death|3|||
128682973|NCT04704154|463138728|FG001|Overall Study|Death|0|||
128682974|NCT04704154|463138729|FG002|Overall Study|Death|0|||
128682975|NCT04704154|463138730|FG003|Overall Study|Death|0|||
128682976|NCT04704154|463138731|FG004|Overall Study|Death|3|||
128682977|NCT04704154|463138732|FG005|Overall Study|Death|0|||
128682978|NCT04704154|463138727|FG000|Overall Study|Physician Decision|1|||
128682979|NCT04704154|463138728|FG001|Overall Study|Physician Decision|0|||
128682980|NCT04704154|463138729|FG002|Overall Study|Physician Decision|1|||
128682981|NCT04704154|463138730|FG003|Overall Study|Physician Decision|0|||
128682982|NCT04704154|463138731|FG004|Overall Study|Physician Decision|2|||
128682983|NCT04704154|463138732|FG005|Overall Study|Physician Decision|0|||
128682984|NCT04704154|463138727|FG000|Overall Study|Participant Decision|1|||
128682985|NCT04704154|463138728|FG001|Overall Study|Participant Decision|1|||
128682986|NCT04704154|463138729|FG002|Overall Study|Participant Decision|0|||
128682987|NCT04704154|463138730|FG003|Overall Study|Participant Decision|0|||
128682988|NCT04704154|463138731|FG004|Overall Study|Participant Decision|0|||
128682989|NCT04704154|463138732|FG005|Overall Study|Participant Decision|0|||
128682990|NCT04704154|463138727|FG000|Overall Study|Progressive Disease|19|||
128682991|NCT04704154|463138728|FG001|Overall Study|Progressive Disease|17|||
128682992|NCT04704154|463138729|FG002|Overall Study|Progressive Disease|20|||
128682993|NCT04704154|463138730|FG003|Overall Study|Progressive Disease|18|||
128682994|NCT04704154|463138731|FG004|Overall Study|Progressive Disease|36|||
128682995|NCT04704154|463138732|FG005|Overall Study|Progressive Disease|30|||
128682996|NCT04704154|463138727|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
128682997|NCT04704154|463138728|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
128682998|NCT04704154|463138729|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
129104629|NCT00099632|464677227|FG001|Overall Study|Protocol Violation|0|||
128682999|NCT04704154|463138730|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
128683000|NCT04704154|463138731|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
128683001|NCT04704154|463138732|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
128683002|NCT04704154|463138727|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
129104630|NCT00099632|464677228|FG002|Overall Study|Protocol Violation|0|||
128683003|NCT04704154|463138728|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
128683004|NCT04704154|463138729|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
128683005|NCT04704154|463138730|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
128683006|NCT04704154|463138731|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
128683007|NCT04704154|463138732|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
128683008|NCT01653782|463138733|FG000|Overall Study|Withdrawal by Subject|9|||
129104631|NCT00099632|464677229|FG003|Overall Study|Protocol Violation|0|||
128683009|NCT01653782|463138734|FG001|Overall Study|Withdrawal by Subject|15|||
128683010|NCT01653782|463138735|FG002|Overall Study|Withdrawal by Subject|4|||
129104632|NCT00099632|464677230|FG004|Overall Study|Protocol Violation|0|||
129104633|NCT00099632|464677231|FG005|Overall Study|Protocol Violation|1|||
129104634|NCT00423813|464677232|FG000|Overall Study|Adverse Event|11|||
129104635|NCT00423813|464677233|FG001|Overall Study|Adverse Event|30|||
129104636|NCT00423813|464677234|FG002|Overall Study|Adverse Event|40|||
128683011|NCT01653782|463138733|FG000|Overall Study|Lost to Follow-up|7|||
129104637|NCT00423813|464677232|FG000|Overall Study|Withdrawal by Subject|6|||
129104638|NCT00423813|464677233|FG001|Overall Study|Withdrawal by Subject|8|||
129104639|NCT00423813|464677234|FG002|Overall Study|Withdrawal by Subject|5|||
129104640|NCT00423813|464677232|FG000|Overall Study|Lost to Follow-up|5|||
129104641|NCT00423813|464677233|FG001|Overall Study|Lost to Follow-up|4|||
129104642|NCT00423813|464677234|FG002|Overall Study|Lost to Follow-up|4|||
129104643|NCT00423813|464677232|FG000|Overall Study|Lack of Efficacy|23|||
129104644|NCT00423813|464677233|FG001|Overall Study|Lack of Efficacy|18|||
129104645|NCT00423813|464677234|FG002|Overall Study|Lack of Efficacy|19|||
129104646|NCT00423813|464677232|FG000|Overall Study|Physician Decision|2|||
129104647|NCT00423813|464677233|FG001|Overall Study|Physician Decision|0|||
128683012|NCT01653782|463138734|FG001|Overall Study|Lost to Follow-up|3|||
128683013|NCT01653782|463138735|FG002|Overall Study|Lost to Follow-up|2|||
128683014|NCT01142128|463138736|FG000|Overall Study|Physician Decision|1|||
128683015|NCT01142128|463138736|FG000|Overall Study|Lost to Follow-up|1|||
128683016|NCT01142128|463138736|FG000|Overall Study|Withdrawal by Subject|2|||
128683017|NCT00442468|463138737|FG000|Overall Study|Adverse Event|4|||
128683018|NCT00442468|463138737|FG000|Overall Study|Withdrawal by Subject|91|||
128683019|NCT00442468|463138737|FG000|Overall Study|Did not complete all study procedures|88|||
128683020|NCT05442775|463138740|FG000|Overall Study|Trial terminated|61|||
128683021|NCT05442775|463138740|FG000|Overall Study|Lack of Efficacy|4|||
128683022|NCT05442775|463138740|FG000|Overall Study|Withdrawal by Subject|4|||
128683023|NCT05442775|463138740|FG000|Overall Study|Death|1|||
128683024|NCT05442775|463138740|FG000|Overall Study|Participant removed at Sponsor request|1|||
128683025|NCT01439347|463138741|FG000|Overall Study|Death|10|||
128683026|NCT01439347|463138742|FG001|Overall Study|Death|9|||
128683027|NCT01439347|463138741|FG000|Overall Study|Withdrawal by Subject|0|||
128683028|NCT01439347|463138742|FG001|Overall Study|Withdrawal by Subject|1|||
128683029|NCT01439347|463138741|FG000|Overall Study|Physician Decision|1|||
128683030|NCT01439347|463138742|FG001|Overall Study|Physician Decision|0|||
128683031|NCT01439347|463138741|FG000|Overall Study|Sponsor Terminated Study|2|||
128683032|NCT01439347|463138742|FG001|Overall Study|Sponsor Terminated Study|3|||
128683033|NCT03519386|463138743|FG000|Overall Study|Withdrawal by Subject|4|||
128683034|NCT03519386|463138744|FG001|Overall Study|Withdrawal by Subject|1|||
128683035|NCT03519386|463138745|FG002|Overall Study|Withdrawal by Subject|2|||
128683036|NCT03519386|463138743|FG000|Overall Study|Physician Decision|1|||
128683037|NCT03519386|463138744|FG001|Overall Study|Physician Decision|1|||
128683038|NCT03519386|463138745|FG002|Overall Study|Physician Decision|1|||
128683039|NCT03519386|463138743|FG000|Overall Study|Lost to Follow-up|0|||
128683040|NCT03519386|463138744|FG001|Overall Study|Lost to Follow-up|1|||
128683041|NCT03519386|463138745|FG002|Overall Study|Lost to Follow-up|1|||
128683042|NCT03519386|463138743|FG000|Overall Study|Death|1|||
128683043|NCT03519386|463138744|FG001|Overall Study|Death|0|||
128683044|NCT03519386|463138745|FG002|Overall Study|Death|4|||
128683045|NCT03519386|463138743|FG000|Overall Study|Adverse Event|2|||
128683046|NCT03519386|463138744|FG001|Overall Study|Adverse Event|1|||
128683047|NCT03519386|463138745|FG002|Overall Study|Adverse Event|2|||
128683048|NCT03519386|463138743|FG000|Overall Study|Explanted|2|||
128683049|NCT03519386|463138744|FG001|Overall Study|Explanted|1|||
128683050|NCT03519386|463138745|FG002|Overall Study|Explanted|0|||
128683051|NCT03519386|463138743|FG000|Overall Study|Ongoing in study|190|||
128683052|NCT03519386|463138744|FG001|Overall Study|Ongoing in study|192|||
128683053|NCT03519386|463138745|FG002|Overall Study|Ongoing in study|183|||
128683054|NCT04341662|463138747|FG000|Overall Study|Did not have source-verified blood loss data|423|||
128683055|NCT04341662|463138748|FG001|Overall Study|Did not have source-verified blood loss data|514|||
128683056|NCT03101267|463138749|FG000|Primary Study Period|Withdrawal by Subject|1|||
128683057|NCT03101267|463138750|FG001|Primary Study Period|Withdrawal by Subject|2|||
128683058|NCT03101267|463138751|FG002|Primary Study Period|Withdrawal by Subject|3|||
128683059|NCT03101267|463138749|FG000|Primary Study Period|Miscellaneous|2|||
128683060|NCT03101267|463138750|FG001|Primary Study Period|Miscellaneous|0|||
128683061|NCT03101267|463138751|FG002|Primary Study Period|Miscellaneous|0|||
128683062|NCT01222403|463138752|FG000|Overall Study|Inappropriate enrollment|0|||
128683063|NCT01222403|463138753|FG001|Overall Study|Inappropriate enrollment|2|||
128683064|NCT02398227|463138754|FG000|Overall Study|Lost to Follow-up|21|||
128683065|NCT02398227|463138755|FG001|Overall Study|Lost to Follow-up|12|||
128683066|NCT02398227|463138754|FG000|Overall Study|Withdrawal by Subject|5|||
128683067|NCT02398227|463138755|FG001|Overall Study|Withdrawal by Subject|6|||
129104648|NCT00423813|464677234|FG002|Overall Study|Physician Decision|0|||
129104649|NCT00423813|464677232|FG000|Overall Study|Sponsor Decision|0|||
129104650|NCT00423813|464677233|FG001|Overall Study|Sponsor Decision|1|||
129104651|NCT00423813|464677234|FG002|Overall Study|Sponsor Decision|0|||
129104652|NCT00423813|464677232|FG000|Overall Study|Protocol Violation|9|||
129104653|NCT00423813|464677233|FG001|Overall Study|Protocol Violation|4|||
128879817|NCT02581631|463854945|FG002|Overall Study|AE unrelated to study drug|1|||
128879818|NCT02581631|463854946|FG003|Overall Study|AE unrelated to study drug|0|||
128879819|NCT02581631|463854947|FG004|Overall Study|AE unrelated to study drug|2|||
128879820|NCT02581631|463854943|FG000|Overall Study|Request to discontinue|1|||
128879821|NCT02581631|463854944|FG001|Overall Study|Request to discontinue|0|||
128879822|NCT02581631|463854945|FG002|Overall Study|Request to discontinue|3|||
128879823|NCT02581631|463854946|FG003|Overall Study|Request to discontinue|0|||
128879824|NCT02581631|463854947|FG004|Overall Study|Request to discontinue|1|||
128879825|NCT02581631|463854943|FG000|Overall Study|participant withdrew consent|3|||
128879826|NCT02581631|463854944|FG001|Overall Study|participant withdrew consent|0|||
128879827|NCT02581631|463854945|FG002|Overall Study|participant withdrew consent|1|||
128879828|NCT02581631|463854946|FG003|Overall Study|participant withdrew consent|0|||
128879829|NCT02581631|463854947|FG004|Overall Study|participant withdrew consent|0|||
128879830|NCT02581631|463854943|FG000|Overall Study|Maximum clinical benefit|1|||
128879831|NCT02581631|463854944|FG001|Overall Study|Maximum clinical benefit|7|||
128879832|NCT02581631|463854945|FG002|Overall Study|Maximum clinical benefit|1|||
128879833|NCT02581631|463854946|FG003|Overall Study|Maximum clinical benefit|3|||
128879834|NCT02581631|463854947|FG004|Overall Study|Maximum clinical benefit|13|||
128879835|NCT02581631|463854943|FG000|Overall Study|Other Reasons|1|||
128879836|NCT02581631|463854944|FG001|Overall Study|Other Reasons|0|||
128879837|NCT02581631|463854945|FG002|Overall Study|Other Reasons|2|||
128879838|NCT02581631|463854946|FG003|Overall Study|Other Reasons|2|||
128879839|NCT02581631|463854947|FG004|Overall Study|Other Reasons|3|||
128879840|NCT02581631|463854943|FG000|Overall Study|Poor/Non-Compliance|0|||
128879841|NCT02581631|463854944|FG001|Overall Study|Poor/Non-Compliance|0|||
128879842|NCT02581631|463854945|FG002|Overall Study|Poor/Non-Compliance|1|||
128879843|NCT02581631|463854946|FG003|Overall Study|Poor/Non-Compliance|0|||
128879844|NCT02581631|463854947|FG004|Overall Study|Poor/Non-Compliance|0|||
128879845|NCT00819390|463854948|FG000|Overall Study|Lost to Follow-up|1|||
128879846|NCT00819390|463854949|FG001|Overall Study|Lost to Follow-up|1|||
128879847|NCT00819390|463854950|FG002|Overall Study|Lost to Follow-up|0|||
128879848|NCT00819390|463854951|FG003|Overall Study|Lost to Follow-up|0|||
128879849|NCT00819390|463854948|FG000|Overall Study|Withdrawal by Subject|2|||
128879850|NCT00819390|463854949|FG001|Overall Study|Withdrawal by Subject|0|||
128879851|NCT00819390|463854950|FG002|Overall Study|Withdrawal by Subject|0|||
128879852|NCT00819390|463854951|FG003|Overall Study|Withdrawal by Subject|0|||
128879853|NCT00819390|463854948|FG000|Overall Study|Adverse Event|0|||
128879854|NCT00819390|463854949|FG001|Overall Study|Adverse Event|0|||
128879855|NCT00819390|463854950|FG002|Overall Study|Adverse Event|1|||
128879856|NCT00819390|463854951|FG003|Overall Study|Adverse Event|0|||
128879857|NCT03801915|463854959|FG000|Overall Study|Screen failure|0|||
128879858|NCT03801915|463854960|FG001|Overall Study|Screen failure|0|||
128879859|NCT03801915|463854961|FG002|Overall Study|Screen failure|1|||
128879860|NCT03801915|463854959|FG000|Overall Study|Ineligible|1|||
128879861|NCT03801915|463854960|FG001|Overall Study|Ineligible|0|||
128879862|NCT03801915|463854961|FG002|Overall Study|Ineligible|0|||
128879863|NCT03801915|463854959|FG000|Overall Study|Physician Decision|2|||
128879864|NCT03801915|463854960|FG001|Overall Study|Physician Decision|1|||
128879865|NCT03801915|463854961|FG002|Overall Study|Physician Decision|0|||
128879866|NCT01211288|463854962|FG000|Overall Study|Lost to Follow-up|1|||
128879867|NCT01211288|463854963|FG001|Overall Study|Lost to Follow-up|1|||
128879868|NCT01270971|463854964|FG000|Overall Study|Withdrawal by Subject|24|||
128879869|NCT01270971|463854965|FG001|Overall Study|Withdrawal by Subject|11|||
128879870|NCT01270971|463854964|FG000|Overall Study|Lost to Follow-up|18|||
128879871|NCT01270971|463854965|FG001|Overall Study|Lost to Follow-up|5|||
128879872|NCT01270971|463854964|FG000|Overall Study|Adverse Event|1|||
128879873|NCT01270971|463854965|FG001|Overall Study|Adverse Event|2|||
129104654|NCT00423813|464677234|FG002|Overall Study|Protocol Violation|4|||
129104655|NCT00423813|464677232|FG000|Overall Study|Pregnancy|0|||
128879874|NCT01270971|463854964|FG000|Overall Study|Non compliance|2|||
128879875|NCT01270971|463854965|FG001|Overall Study|Non compliance|2|||
128879876|NCT01270971|463854964|FG000|Overall Study|Non-specific|7|||
129104656|NCT00423813|464677233|FG001|Overall Study|Pregnancy|0|||
128763149|NCT00615264|463422750|FG000|Overall Study|Death|1|||
128879877|NCT01270971|463854965|FG001|Overall Study|Non-specific|3|||
128879878|NCT02003573|463854979|FG000|Overall Study|Progressive disease|2|||
128879879|NCT02003573|463854980|FG001|Overall Study|Progressive disease|0|||
128879880|NCT02003573|463854981|FG002|Overall Study|Progressive disease|1|||
128879881|NCT02003573|463854979|FG000|Overall Study|Other Adverse event|0|||
128879882|NCT02003573|463854980|FG001|Overall Study|Other Adverse event|1|||
128879883|NCT02003573|463854981|FG002|Overall Study|Other Adverse event|1|||
128879884|NCT02003573|463854979|FG000|Overall Study|Refuse to take trial medication|0|||
128879885|NCT02003573|463854980|FG001|Overall Study|Refuse to take trial medication|1|||
128879886|NCT02003573|463854981|FG002|Overall Study|Refuse to take trial medication|1|||
128879887|NCT02003573|463854979|FG000|Overall Study|Other than specified|1|||
128879888|NCT02003573|463854980|FG001|Overall Study|Other than specified|2|||
128879889|NCT02003573|463854981|FG002|Overall Study|Other than specified|3|||
129104657|NCT00423813|464677234|FG002|Overall Study|Pregnancy|1|||
129104658|NCT00423813|464677232|FG000|Overall Study|Subject started night shift work|1|||
128879890|NCT02112708|463854984|FG000|Baseline|Physician Decision|16|||
128879891|NCT02112708|463854985|FG001|Baseline|Physician Decision|11|||
128879892|NCT02112708|463854984|FG000|Baseline|Lost to Follow-up|12|||
128879893|NCT02112708|463854985|FG001|Baseline|Lost to Follow-up|0|||
128879894|NCT02112708|463854984|FG000|4 Month|Death|0|||
128879895|NCT02112708|463854985|FG001|4 Month|Death|1|||
128879896|NCT02112708|463854984|FG000|4 Month|Withdrawal by Subject|12|||
128879897|NCT02112708|463854985|FG001|4 Month|Withdrawal by Subject|0|||
128879898|NCT00928018|463854990|FG000|Overall Study|Withdrawal by Subject|1|||
128879899|NCT00928018|463854991|FG001|Overall Study|Withdrawal by Subject|0|||
128879900|NCT00126503|463854992|FG000|Overall Study|disease progression|23|||
128879901|NCT00126503|463854993|FG001|Overall Study|disease progression|14|||
128879902|NCT00126503|463854992|FG000|Overall Study|Withdrawal by Subject|0|||
128879903|NCT00126503|463854993|FG001|Overall Study|Withdrawal by Subject|1|||
128879904|NCT00126503|463854992|FG000|Overall Study|alternative therapy|1|||
128879905|NCT00126503|463854993|FG001|Overall Study|alternative therapy|1|||
128879906|NCT00126503|463854992|FG000|Overall Study|other complicating disease|4|||
128879907|NCT00126503|463854993|FG001|Overall Study|other complicating disease|1|||
128879908|NCT00126503|463854992|FG000|Overall Study|Death|3|||
128879909|NCT00126503|463854993|FG001|Overall Study|Death|0|||
128879910|NCT00126503|463854992|FG000|Overall Study|Adverse Event|13|||
128879911|NCT00126503|463854993|FG001|Overall Study|Adverse Event|3|||
128879912|NCT00126503|463854992|FG000|Overall Study|non-compliant|1|||
128879913|NCT00126503|463854993|FG001|Overall Study|non-compliant|0|||
128879914|NCT00126503|463854992|FG000|Overall Study|Physician Decision|2|||
128879915|NCT00126503|463854993|FG001|Overall Study|Physician Decision|1|||
128879916|NCT02457559|463854994|FG000|Overall Study|Progressive Disease|1|||
128879917|NCT02457559|463854995|FG001|Overall Study|Progressive Disease|2|||
128879918|NCT02457559|463854996|FG002|Overall Study|Progressive Disease|3|||
128879919|NCT02457559|463854997|FG003|Overall Study|Progressive Disease|0|||
128879920|NCT02457559|463854998|FG004|Overall Study|Progressive Disease|0|||
128879921|NCT02457559|463854999|FG005|Overall Study|Progressive Disease|2|||
128879922|NCT02457559|463855000|FG006|Overall Study|Progressive Disease|1|||
128879923|NCT02457559|463855001|FG007|Overall Study|Progressive Disease|0|||
128879924|NCT02457559|463855002|FG008|Overall Study|Progressive Disease|1|||
128879925|NCT02457559|463855003|FG009|Overall Study|Progressive Disease|1|||
128879926|NCT02457559|463855004|FG010|Overall Study|Progressive Disease|1|||
128879927|NCT02457559|463854994|FG000|Overall Study|Investigator's Discretion|0|||
128879928|NCT02457559|463854995|FG001|Overall Study|Investigator's Discretion|0|||
128879929|NCT02457559|463854996|FG002|Overall Study|Investigator's Discretion|2|||
128879930|NCT02457559|463854997|FG003|Overall Study|Investigator's Discretion|0|||
128879931|NCT02457559|463854998|FG004|Overall Study|Investigator's Discretion|1|||
128879932|NCT02457559|463854999|FG005|Overall Study|Investigator's Discretion|0|||
128879933|NCT02457559|463855000|FG006|Overall Study|Investigator's Discretion|1|||
128879934|NCT02457559|463855001|FG007|Overall Study|Investigator's Discretion|0|||
128879935|NCT02457559|463855002|FG008|Overall Study|Investigator's Discretion|1|||
128879936|NCT02457559|463855003|FG009|Overall Study|Investigator's Discretion|0|||
128879937|NCT02457559|463855004|FG010|Overall Study|Investigator's Discretion|1|||
128879938|NCT02457559|463854994|FG000|Overall Study|Adverse Event|0|||
128879939|NCT02457559|463854995|FG001|Overall Study|Adverse Event|1|||
128879940|NCT02457559|463854996|FG002|Overall Study|Adverse Event|2|||
128879941|NCT02457559|463854997|FG003|Overall Study|Adverse Event|0|||
128879942|NCT02457559|463854998|FG004|Overall Study|Adverse Event|0|||
128879943|NCT02457559|463854999|FG005|Overall Study|Adverse Event|0|||
128879944|NCT02457559|463855000|FG006|Overall Study|Adverse Event|0|||
129104659|NCT00423813|464677233|FG001|Overall Study|Subject started night shift work|0|||
129104660|NCT00423813|464677234|FG002|Overall Study|Subject started night shift work|0|||
129104661|NCT00423813|464677232|FG000|Overall Study|Will start exclusionary medications|0|||
129104662|NCT00423813|464677233|FG001|Overall Study|Will start exclusionary medications|1|||
129104663|NCT00423813|464677234|FG002|Overall Study|Will start exclusionary medications|0|||
129104664|NCT00423813|464677232|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
128879945|NCT02457559|463855001|FG007|Overall Study|Adverse Event|0|||
128879946|NCT02457559|463855002|FG008|Overall Study|Adverse Event|0|||
128879947|NCT02457559|463855003|FG009|Overall Study|Adverse Event|0|||
128879948|NCT02457559|463855004|FG010|Overall Study|Adverse Event|0|||
128879949|NCT02457559|463854994|FG000|Overall Study|Reason not Specified|1|||
128879950|NCT02457559|463854995|FG001|Overall Study|Reason not Specified|0|||
128879951|NCT02457559|463854996|FG002|Overall Study|Reason not Specified|0|||
128879952|NCT02457559|463854997|FG003|Overall Study|Reason not Specified|0|||
128879953|NCT02457559|463854998|FG004|Overall Study|Reason not Specified|0|||
128879954|NCT02457559|463854999|FG005|Overall Study|Reason not Specified|0|||
128879955|NCT02457559|463855000|FG006|Overall Study|Reason not Specified|0|||
128879956|NCT02457559|463855001|FG007|Overall Study|Reason not Specified|0|||
128879957|NCT02457559|463855002|FG008|Overall Study|Reason not Specified|0|||
128879958|NCT02457559|463855003|FG009|Overall Study|Reason not Specified|2|||
128879959|NCT02457559|463855004|FG010|Overall Study|Reason not Specified|0|||
128879960|NCT02457559|463854994|FG000|Overall Study|Death|0|||
129104665|NCT00423813|464677233|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
128879961|NCT02457559|463854995|FG001|Overall Study|Death|0|||
128879962|NCT02457559|463854996|FG002|Overall Study|Death|0|||
128879963|NCT02457559|463854997|FG003|Overall Study|Death|0|||
128879964|NCT02457559|463854998|FG004|Overall Study|Death|0|||
128879965|NCT02457559|463854999|FG005|Overall Study|Death|0|||
128879966|NCT02457559|463855000|FG006|Overall Study|Death|0|||
128879967|NCT02457559|463855001|FG007|Overall Study|Death|0|||
128879968|NCT02457559|463855002|FG008|Overall Study|Death|1|||
128879969|NCT02457559|463855003|FG009|Overall Study|Death|1|||
128879970|NCT02457559|463855004|FG010|Overall Study|Death|0|||
128879971|NCT00998335|463855007|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
128879972|NCT00998335|463855008|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
128879973|NCT02374671|463855009|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
128879974|NCT02374671|463855010|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
128879975|NCT02374671|463855011|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
128879976|NCT02374671|463855009|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
128879977|NCT02374671|463855010|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
128879978|NCT02374671|463855011|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
128879979|NCT02374671|463855009|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
128879980|NCT02374671|463855010|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
128879981|NCT02374671|463855011|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
128879982|NCT02374671|463855009|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
128879983|NCT02374671|463855010|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
128879984|NCT02374671|463855011|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
128879985|NCT02374671|463855009|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
128763150|NCT00615264|463422751|FG001|Overall Study|Death|1|||
128879986|NCT02374671|463855010|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
128879987|NCT02374671|463855011|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
128879988|NCT03866473|463855014|FG000|Phase 1|Death|1|||
128879989|NCT03866473|463855015|FG001|Phase 1|Death|0|||
128879990|NCT03866473|463855014|FG000|Phase 2|Death|0|||
128879991|NCT03866473|463855015|FG001|Phase 2|Death|2|||
128879992|NCT03866473|463855014|FG000|Phase 2|Dropped|1|||
128879993|NCT03866473|463855015|FG001|Phase 2|Dropped|1|||
128879994|NCT03866473|463855014|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
128879995|NCT03866473|463855015|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
128879996|NCT03169101|463855016|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
128879997|NCT03169101|463855017|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
128879998|NCT03169101|463855018|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
128879999|NCT03169101|463855019|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
128880000|NCT02641496|463855020|FG000|Overall Study|Lost to Follow-up|13|||
128880001|NCT02641496|463855021|FG001|Overall Study|Lost to Follow-up|12|||
128880002|NCT02641496|463855020|FG000|Overall Study|Withdrawal by Subject|1|||
128880003|NCT02641496|463855021|FG001|Overall Study|Withdrawal by Subject|0|||
128880004|NCT02523599|463855022|FG000|Overall Study|Adverse Event|1|||
128880005|NCT02523599|463855023|FG001|Overall Study|Adverse Event|0|||
128880006|NCT02523599|463855022|FG000|Overall Study|Physician Decision|1|||
128880007|NCT02523599|463855023|FG001|Overall Study|Physician Decision|0|||
128880008|NCT02523599|463855022|FG000|Overall Study|Lost to Follow-up|4|||
128880009|NCT02523599|463855023|FG001|Overall Study|Lost to Follow-up|1|||
128880010|NCT02523599|463855022|FG000|Overall Study|Did not return for Day 30 visit|2|||
128880011|NCT02523599|463855023|FG001|Overall Study|Did not return for Day 30 visit|0|||
128880012|NCT00790751|463855024|FG000|Overall Study|Protocol non-compliance|16|||
128880013|NCT00790751|463855025|FG001|Overall Study|Protocol non-compliance|16|||
128880014|NCT00790751|463855026|FG002|Overall Study|Protocol non-compliance|10|||
128763151|NCT00615264|463422750|FG000|Overall Study|Protocol Violation|11|||
128880015|NCT00790751|463855027|FG003|Overall Study|Protocol non-compliance|11|||
128880016|NCT00790751|463855024|FG000|Overall Study|Lost to Follow-up|4|||
128880017|NCT00790751|463855025|FG001|Overall Study|Lost to Follow-up|9|||
128880018|NCT00790751|463855026|FG002|Overall Study|Lost to Follow-up|4|||
128880019|NCT00790751|463855027|FG003|Overall Study|Lost to Follow-up|5|||
128880020|NCT00790751|463855024|FG000|Overall Study|Adverse Event|5|||
128880021|NCT00790751|463855025|FG001|Overall Study|Adverse Event|3|||
128880022|NCT00790751|463855026|FG002|Overall Study|Adverse Event|5|||
128880023|NCT00790751|463855027|FG003|Overall Study|Adverse Event|4|||
128880024|NCT00790751|463855024|FG000|Overall Study|Requirement for restricted medication|0|||
129016501|NCT01882257|464354953|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
129016502|NCT01882257|464354954|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
129016503|NCT01882257|464354955|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
129016504|NCT00496964|464354961|FG000|Overall Study|Withdrawal by Subject|0|||
129016505|NCT00496964|464354962|FG001|Overall Study|Withdrawal by Subject|1|||
129016506|NCT02058498|464354963|FG000|Overall Study|Withdrawal by Subject|4|||
129016507|NCT03351335|464354965|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
129016508|NCT03351335|464354966|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
128880025|NCT00790751|463855025|FG001|Overall Study|Requirement for restricted medication|2|||
128880026|NCT00790751|463855026|FG002|Overall Study|Requirement for restricted medication|0|||
128880027|NCT00790751|463855027|FG003|Overall Study|Requirement for restricted medication|0|||
128880028|NCT00790751|463855024|FG000|Overall Study|Death|0|||
128880029|NCT00790751|463855025|FG001|Overall Study|Death|0|||
128880030|NCT00790751|463855026|FG002|Overall Study|Death|1|||
128880031|NCT00790751|463855027|FG003|Overall Study|Death|0|||
128880032|NCT00790751|463855024|FG000|Overall Study|Physician Decision|0|||
128880033|NCT00790751|463855025|FG001|Overall Study|Physician Decision|0|||
128880034|NCT00790751|463855026|FG002|Overall Study|Physician Decision|0|||
128880035|NCT00790751|463855027|FG003|Overall Study|Physician Decision|1|||
128880036|NCT05330312|463855028|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
128880037|NCT05330312|463855029|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
128880038|NCT05330312|463855030|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
128880039|NCT05330312|463855028|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
128880040|NCT05330312|463855029|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
128880041|NCT05330312|463855030|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
128880042|NCT05330312|463855028|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
128880043|NCT05330312|463855029|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
128880044|NCT05330312|463855030|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
128880045|NCT05330312|463855028|FG000|Pivotal Investigation - Part 2|Death|1|||
128880046|NCT05330312|463855029|FG001|Pivotal Investigation - Part 2|Death|4|||
128880047|NCT05330312|463855030|FG002|Pivotal Investigation - Part 2|Death|0|||
128880048|NCT01078454|463855033|FG000|Overall Study|Adverse Event|1|||
128880049|NCT01078454|463855034|FG001|Overall Study|Adverse Event|1|||
128880050|NCT01078454|463855033|FG000|Overall Study|Death|0|||
128880051|NCT01078454|463855034|FG001|Overall Study|Death|1|||
128880052|NCT01775124|463855041|FG000|Core Period|Disease Progression|0|||
128880053|NCT01775124|463855042|FG001|Core Period|Disease Progression|1|||
128880054|NCT01775124|463855041|FG000|Core Period|Physician Decision|1|||
128880055|NCT01775124|463855042|FG001|Core Period|Physician Decision|1|||
128880056|NCT01775124|463855041|FG000|Core Period|Death|0|||
128880057|NCT01775124|463855042|FG001|Core Period|Death|1|||
128880058|NCT01775124|463855041|FG000|Core Period|Administrative problems|1|||
128880059|NCT01775124|463855042|FG001|Core Period|Administrative problems|0|||
128880060|NCT01775124|463855041|FG000|Core Period|Withdrawal by Subject|4|||
128880061|NCT01775124|463855042|FG001|Core Period|Withdrawal by Subject|2|||
128880062|NCT01775124|463855041|FG000|Core Period|Adverse Event|5|||
128880063|NCT01775124|463855042|FG001|Core Period|Adverse Event|5|||
128880064|NCT01775124|463855041|FG000|Extension Period|Adverse Event|3|||
128880065|NCT01775124|463855042|FG001|Extension Period|Adverse Event|2|||
128880066|NCT01775124|463855041|FG000|Extension Period|Physician Decision|0|||
128880067|NCT01775124|463855042|FG001|Extension Period|Physician Decision|2|||
128880068|NCT01775124|463855041|FG000|Extension Period|Administrative problems|0|||
128880069|NCT01775124|463855042|FG001|Extension Period|Administrative problems|1|||
128880070|NCT01775124|463855041|FG000|Extension Period|Lost to Follow-up|0|||
128880071|NCT01775124|463855042|FG001|Extension Period|Lost to Follow-up|1|||
128880072|NCT01775124|463855041|FG000|Extension Period|Withdrawal by Subject|9|||
128880073|NCT01775124|463855042|FG001|Extension Period|Withdrawal by Subject|12|||
128880074|NCT00346268|463856872|FG000|Overall Study|Adverse Event|1|||
128880075|NCT00346268|463856873|FG001|Overall Study|Adverse Event|0|||
129016509|NCT03351335|464354967|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
129016510|NCT00469417|464354968|FG000|Overall Study|Treatment failure all lesions|18|||
129016511|NCT00469417|464354969|FG001|Overall Study|Treatment failure all lesions|11|||
129016512|NCT00469417|464354968|FG000|Overall Study|Consent withdrawn|1|||
129016513|NCT00469417|464354969|FG001|Overall Study|Consent withdrawn|1|||
129016514|NCT00469417|464354968|FG000|Overall Study|Adverse Event|8|||
129016515|NCT00469417|464354969|FG001|Overall Study|Adverse Event|2|||
129016516|NCT00469417|464354968|FG000|Overall Study|Lost to Follow-up|1|||
128683068|NCT02398227|463138754|FG000|Overall Study|Removed from treatment and dropped out|1|||
128683069|NCT02398227|463138755|FG001|Overall Study|Removed from treatment and dropped out|0|||
128683070|NCT01028378|463138757|FG000|Overall Study|Lost to Follow-up|12|||
128763152|NCT00615264|463422751|FG001|Overall Study|Protocol Violation|7|||
128880076|NCT00346268|463856872|FG000|Overall Study|Protocol Violation|1|||
128880077|NCT00346268|463856873|FG001|Overall Study|Protocol Violation|0|||
128880078|NCT00346268|463856872|FG000|Overall Study|Participant refused|0|||
128880079|NCT00346268|463856873|FG001|Overall Study|Participant refused|3|||
128880080|NCT01036763|463856874|FG000|Overall Study|Adverse Event|25|||
128880081|NCT01036763|463856874|FG000|Overall Study|Lost to Follow-up|28|||
128880082|NCT01036763|463856874|FG000|Overall Study|Other reason (not specified)|40|||
128880083|NCT00743275|463856875|FG000|Overall Study|Protocol Violation|0|||
128880084|NCT00743275|463856876|FG001|Overall Study|Protocol Violation|1|||
128880085|NCT01672723|463856877|FG000|First Intervention|Adverse Event|3|||
128880086|NCT01672723|463856878|FG001|First Intervention|Adverse Event|0|||
128880087|NCT02502097|463856888|FG000|Period 1|Adverse Event|0|||
128880088|NCT02502097|463856889|FG001|Period 1|Adverse Event|0|||
128880089|NCT02502097|463856890|FG002|Period 1|Adverse Event|1|||
128880090|NCT02502097|463856891|FG003|Period 1|Adverse Event|0|||
128880091|NCT02502097|463856888|FG000|Wash Out Period|Adverse Event|0|||
128880092|NCT02502097|463856889|FG001|Wash Out Period|Adverse Event|1|||
128880093|NCT02502097|463856890|FG002|Wash Out Period|Adverse Event|1|||
128880094|NCT02502097|463856891|FG003|Wash Out Period|Adverse Event|1|||
128880095|NCT02502097|463856888|FG000|Period 2|Adverse Event|0|||
128880096|NCT02502097|463856889|FG001|Period 2|Adverse Event|0|||
128880097|NCT02502097|463856890|FG002|Period 2|Adverse Event|1|||
128880098|NCT02502097|463856891|FG003|Period 2|Adverse Event|0|||
128880099|NCT02186223|463856892|FG000|Overall Study|Not eligible for device placement|6|||
128880100|NCT02186223|463856892|FG000|Overall Study|Unable to obtain femoral access|3|||
128880101|NCT02186223|463856892|FG000|Overall Study|Death|3|||
128880102|NCT02186223|463856892|FG000|Overall Study|Device in place less than 48 hours|9|||
128880103|NCT01201317|463856893|FG000|Overall Study|Withdrawal by Subject|5|||
128880104|NCT01201317|463856894|FG001|Overall Study|Withdrawal by Subject|0|||
128880105|NCT01201317|463856895|FG002|Overall Study|Withdrawal by Subject|3|||
128880106|NCT01201317|463856893|FG000|Overall Study|Adverse Event|2|||
128880107|NCT01201317|463856894|FG001|Overall Study|Adverse Event|2|||
128880108|NCT01201317|463856895|FG002|Overall Study|Adverse Event|2|||
128880109|NCT01201317|463856893|FG000|Overall Study|Screen failure|1|||
128880110|NCT01201317|463856894|FG001|Overall Study|Screen failure|1|||
128880111|NCT01201317|463856895|FG002|Overall Study|Screen failure|0|||
128880112|NCT01201317|463856893|FG000|Overall Study|Protocol Violation|0|||
128880113|NCT01201317|463856894|FG001|Overall Study|Protocol Violation|1|||
128880114|NCT01201317|463856895|FG002|Overall Study|Protocol Violation|1|||
128880115|NCT01201317|463856893|FG000|Overall Study|Death|0|||
128880116|NCT01201317|463856894|FG001|Overall Study|Death|1|||
128880117|NCT01201317|463856895|FG002|Overall Study|Death|0|||
128880118|NCT01201317|463856893|FG000|Overall Study|Study-specific withdrawal criteria|0|||
128880119|NCT01201317|463856894|FG001|Overall Study|Study-specific withdrawal criteria|0|||
128880120|NCT01201317|463856895|FG002|Overall Study|Study-specific withdrawal criteria|1|||
128880121|NCT01201317|463856893|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
128880122|NCT01201317|463856894|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
128880123|NCT01201317|463856895|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
128880124|NCT01201317|463856893|FG000|Overall Study|Decrease in renal function|0|||
128880125|NCT01201317|463856894|FG001|Overall Study|Decrease in renal function|1|||
128880126|NCT01201317|463856895|FG002|Overall Study|Decrease in renal function|0|||
128880127|NCT01201317|463856893|FG000|Overall Study|Lack of Efficacy|1|||
128880128|NCT01201317|463856894|FG001|Overall Study|Lack of Efficacy|0|||
128880129|NCT01201317|463856895|FG002|Overall Study|Lack of Efficacy|0|||
128880130|NCT01201317|463856893|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
128880131|NCT01201317|463856894|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
128880132|NCT01201317|463856895|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
128880133|NCT00252733|463856896|FG000|Overall Study|Withdrawal by Subject|73|||
128880134|NCT00252733|463856897|FG001|Overall Study|Withdrawal by Subject|67|||
128880135|NCT00252733|463856896|FG000|Overall Study|Death|7|||
128880136|NCT00252733|463856897|FG001|Overall Study|Death|5|||
128880137|NCT00252733|463856896|FG000|Overall Study|Lost to Follow-up|12|||
128880138|NCT00252733|463856897|FG001|Overall Study|Lost to Follow-up|6|||
128880139|NCT00252733|463856896|FG000|Overall Study|Multiple Reasons|14|||
128880140|NCT00252733|463856897|FG001|Overall Study|Multiple Reasons|14|||
128880141|NCT01491672|463856898|FG000|Overall Study|Lost to Follow-up|0|||
128880142|NCT01491672|463856899|FG001|Overall Study|Lost to Follow-up|4|||
129016517|NCT00469417|464354969|FG001|Overall Study|Lost to Follow-up|2|||
129016518|NCT00469417|464354968|FG000|Overall Study|Intercurrent disease|0|||
129016519|NCT00469417|464354969|FG001|Overall Study|Intercurrent disease|1|||
129016520|NCT00469417|464354968|FG000|Overall Study|Randomized but not treated|2|||
129016521|NCT00469417|464354969|FG001|Overall Study|Randomized but not treated|0|||
129016522|NCT00834743|464354972|FG000|Second Intervention|Withdrawal by Subject|1|||
128880143|NCT01491672|463856900|FG002|Overall Study|Lost to Follow-up|1|||
128880144|NCT01491672|463856898|FG000|Overall Study|Withdrawal by Subject|6|||
128880145|NCT01491672|463856899|FG001|Overall Study|Withdrawal by Subject|7|||
128880146|NCT01491672|463856900|FG002|Overall Study|Withdrawal by Subject|0|||
128880147|NCT01491672|463856898|FG000|Overall Study|Adverse Event|8|||
128880148|NCT01491672|463856899|FG001|Overall Study|Adverse Event|10|||
128880149|NCT01491672|463856900|FG002|Overall Study|Adverse Event|4|||
128880150|NCT01491672|463856898|FG000|Overall Study|Disease progression|42|||
128880151|NCT01491672|463856899|FG001|Overall Study|Disease progression|34|||
128880152|NCT01491672|463856900|FG002|Overall Study|Disease progression|6|||
128880153|NCT01491672|463856898|FG000|Overall Study|Protocol deviation|0|||
128880154|NCT01491672|463856899|FG001|Overall Study|Protocol deviation|1|||
128880155|NCT01491672|463856900|FG002|Overall Study|Protocol deviation|0|||
128880156|NCT01491672|463856898|FG000|Overall Study|Death|0|||
129016523|NCT00834743|464354973|FG001|Second Intervention|Withdrawal by Subject|0|||
129016524|NCT00086996|464354975|FG000|Overall Study|Adverse Event|29|||
129016525|NCT00086996|464354975|FG000|Overall Study|Death|4|||
128880157|NCT01491672|463856899|FG001|Overall Study|Death|4|||
128880158|NCT01491672|463856900|FG002|Overall Study|Death|0|||
128880159|NCT03310268|463856904|FG000|Overall Study|(Not specified)|1|||
128880160|NCT03310268|463856905|FG001|Overall Study|(Not specified)|5|||
128880161|NCT03310268|463856906|FG002|Overall Study|(Not specified)|0|||
128880162|NCT00706433|463856909|FG000|Overall Study|Lost to Follow-up|3|||
128880163|NCT00706433|463856910|FG001|Overall Study|Lost to Follow-up|1|||
128880164|NCT00706433|463856911|FG002|Overall Study|Lost to Follow-up|6|||
128880165|NCT00706433|463856912|FG003|Overall Study|Lost to Follow-up|0|||
128880166|NCT00706433|463856909|FG000|Overall Study|Withdrawal by Subject|1|||
128880167|NCT00706433|463856910|FG001|Overall Study|Withdrawal by Subject|2|||
128880168|NCT00706433|463856911|FG002|Overall Study|Withdrawal by Subject|3|||
128880169|NCT00706433|463856912|FG003|Overall Study|Withdrawal by Subject|1|||
128880170|NCT00706433|463856909|FG000|Overall Study|Adverse Event|0|||
128880171|NCT00706433|463856910|FG001|Overall Study|Adverse Event|0|||
128880172|NCT00706433|463856911|FG002|Overall Study|Adverse Event|1|||
128880173|NCT00706433|463856912|FG003|Overall Study|Adverse Event|0|||
128880174|NCT00706433|463856909|FG000|Overall Study|Protocol Violation|1|||
128880175|NCT00706433|463856910|FG001|Overall Study|Protocol Violation|0|||
128880176|NCT00706433|463856911|FG002|Overall Study|Protocol Violation|0|||
128880177|NCT00706433|463856912|FG003|Overall Study|Protocol Violation|0|||
128880178|NCT00706433|463856909|FG000|Overall Study|new job|0|||
128880179|NCT00706433|463856910|FG001|Overall Study|new job|0|||
128880180|NCT00706433|463856911|FG002|Overall Study|new job|0|||
128880181|NCT00706433|463856912|FG003|Overall Study|new job|1|||
128880182|NCT01236365|463856913|FG000|Overall Study|Lost to Follow-up|0|||
128880183|NCT01236365|463856914|FG001|Overall Study|Lost to Follow-up|2|||
128880184|NCT01236365|463856913|FG000|Overall Study|Moved Out of State|1|||
128880185|NCT01236365|463856914|FG001|Overall Study|Moved Out of State|0|||
128880186|NCT01236365|463856913|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
128880187|NCT01236365|463856914|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
128880188|NCT00717067|463856915|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
128880189|NCT00717067|463856916|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
128880190|NCT00717067|463856917|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
128880191|NCT00717067|463856918|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
128880192|NCT00717067|463856919|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
128880193|NCT01689337|463856920|FG000|Overall Study|Study Discontinuation|1|||
128880194|NCT00824161|463856921|FG000|Overall Study|Withdrawal by Subject|1|||
128880195|NCT00824161|463856921|FG000|Overall Study|Screen Failure|1|||
128880196|NCT04882995|463856922|FG000|Overall Study|Withdrawal by Subject|1|||
128880197|NCT04882995|463856923|FG001|Overall Study|Withdrawal by Subject|2|||
128880198|NCT04882995|463856922|FG000|Overall Study|Protocol Violation|4|||
128880199|NCT04882995|463856923|FG001|Overall Study|Protocol Violation|4|||
128880200|NCT04882995|463856922|FG000|Overall Study|Surgery postponed due to COVID|1|||
128880201|NCT04882995|463856923|FG001|Overall Study|Surgery postponed due to COVID|1|||
128880202|NCT02572882|463856924|FG000|Overall Study|Withdrawal by Subject|1|||
128880203|NCT02572882|463856924|FG000|Overall Study|Participant received kidney transplant|1|||
128880204|NCT04371198|463856928|FG000|Overall Study|inadequate sample|4|||
128880205|NCT03536143|463856929|FG000|Overall Study|Early termination, Sponsor decision|1|||
128880206|NCT04754477|463856930|FG000|Overall Study|Withdrawal by Subject|1|||
128880207|NCT01347762|463856931|FG000|Overall Study|Lost to Follow-up|0|||
128880208|NCT01347762|463856932|FG001|Overall Study|Lost to Follow-up|1|||
128880209|NCT01347762|463856933|FG002|Overall Study|Lost to Follow-up|6|||
128880210|NCT01347762|463856934|FG003|Overall Study|Lost to Follow-up|5|||
128880211|NCT01347762|463856931|FG000|Overall Study|Withdrawal by Subject|4|||
128880212|NCT01347762|463856932|FG001|Overall Study|Withdrawal by Subject|1|||
128880213|NCT01347762|463856933|FG002|Overall Study|Withdrawal by Subject|3|||
128880214|NCT01347762|463856934|FG003|Overall Study|Withdrawal by Subject|3|||
128880215|NCT01590017|463856935|FG000|Overall Study|Adverse Event|1|||
128880216|NCT01590017|463856935|FG000|Overall Study|Withdrawal by Subject|1|||
128880217|NCT01590017|463856935|FG000|Overall Study|Lack of Efficacy|1|||
128880218|NCT01590017|463856935|FG000|Overall Study|Physician Decision|1|||
128880219|NCT00871780|463856936|FG000|Overall Study|Enrolled But Not Treated|6|||
128880220|NCT00871780|463856936|FG000|Overall Study|Withdrawal by Subject|9|||
128880221|NCT00871780|463856936|FG000|Overall Study|Adverse Event|6|||
128880222|NCT00871780|463856936|FG000|Overall Study|Voluntary Discontinuation|4|||
128880223|NCT00871780|463856936|FG000|Overall Study|Death|1|||
128880224|NCT00871780|463856936|FG000|Overall Study|Physician Decision|1|||
128880225|NCT03406260|463856937|FG000|Period 1|Adverse Event|0|||
128880226|NCT03406260|463856938|FG001|Period 1|Adverse Event|0|||
128880227|NCT03406260|463856939|FG002|Period 1|Adverse Event|0|||
128880228|NCT03406260|463856940|FG003|Period 1|Adverse Event|0|||
128880229|NCT03406260|463856941|FG004|Period 1|Adverse Event|1|||
128880230|NCT03406260|463856942|FG005|Period 1|Adverse Event|0|||
128880231|NCT02527343|463856943|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
128880232|NCT02527343|463856944|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
128880233|NCT02527343|463856945|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
128880234|NCT02527343|463856946|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
128880235|NCT02527343|463856947|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
128880236|NCT02527343|463856948|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
128880237|NCT02527343|463856943|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
129016526|NCT00086996|464354975|FG000|Overall Study|progression/relapse|7|||
128880238|NCT02527343|463856944|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
128880239|NCT02527343|463856945|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
128880240|NCT02527343|463856946|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
128880241|NCT02527343|463856947|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
128880242|NCT02527343|463856948|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
128880243|NCT02527343|463856943|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
128880244|NCT02527343|463856944|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
128880245|NCT02527343|463856945|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
128880246|NCT02527343|463856946|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
128880247|NCT02527343|463856947|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
128880248|NCT02527343|463856948|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
128880249|NCT02527343|463856943|FG000|RT Period: Weeks 1 to 52|Other|4|||
128880250|NCT02527343|463856944|FG001|RT Period: Weeks 1 to 52|Other|3|||
128880251|NCT02527343|463856945|FG002|RT Period: Weeks 1 to 52|Other|0|||
128880252|NCT02527343|463856946|FG003|RT Period: Weeks 1 to 52|Other|0|||
128880253|NCT02527343|463856947|FG004|RT Period: Weeks 1 to 52|Other|0|||
128880254|NCT02527343|463856948|FG005|RT Period: Weeks 1 to 52|Other|0|||
128880255|NCT02527343|463856943|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
128880256|NCT02527343|463856944|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
128880257|NCT02527343|463856945|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
128880258|NCT02527343|463856946|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
128880259|NCT02527343|463856947|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
128880260|NCT02527343|463856948|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
128880261|NCT02527343|463856943|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
128880262|NCT02527343|463856944|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
128880263|NCT02527343|463856945|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
128880264|NCT02527343|463856946|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
128880265|NCT02527343|463856947|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
128880266|NCT02527343|463856948|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
128880267|NCT02527343|463856943|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
128880268|NCT02527343|463856944|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
128880269|NCT02527343|463856945|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
128880270|NCT02527343|463856946|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
128880271|NCT02527343|463856947|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
128880272|NCT02527343|463856948|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
128880273|NCT02527343|463856943|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
128880274|NCT02527343|463856944|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
128880275|NCT02527343|463856945|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
128880276|NCT02527343|463856946|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
128880277|NCT02527343|463856947|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
128880278|NCT02527343|463856948|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
128880279|NCT02527343|463856943|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
128880280|NCT02527343|463856944|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
128880281|NCT02527343|463856945|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
128880282|NCT02527343|463856946|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
128880283|NCT02527343|463856947|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
128880284|NCT02527343|463856948|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
128880285|NCT02527343|463856943|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
128880286|NCT02527343|463856944|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
128880287|NCT02527343|463856945|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
128880288|NCT02527343|463856946|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
128880289|NCT02527343|463856947|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
128880290|NCT02527343|463856948|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
128880291|NCT02527343|463856943|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
129016527|NCT00086996|464354975|FG000|Overall Study|Withdrawal by Subject|13|||
129016528|NCT00086996|464354975|FG000|Overall Study|Other|6|||
129016529|NCT00086996|464354975|FG000|Overall Study|not eligible|5|||
129016530|NCT00004562|464354976|FG000|Overall Study|Lost to Follow-up|102|||
129016531|NCT00004562|464354977|FG001|Overall Study|Lost to Follow-up|91|||
129016532|NCT04274686|464354979|FG000|Overall Study|Physician Decision|1|||
129016533|NCT04274686|464354980|FG001|Overall Study|Physician Decision|0|||
129016534|NCT00376623|464354981|FG000|Overall Study|Progressive disease|35|||
128683071|NCT01028378|463138757|FG000|Overall Study|Withdrawal by Subject|1|||
128683072|NCT01028378|463138757|FG000|Overall Study|Adminstrative Reasons|4|||
128880292|NCT02527343|463856944|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
128880293|NCT02527343|463856945|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
129016535|NCT00376623|464354982|FG001|Overall Study|Progressive disease|22|||
129016536|NCT00376623|464354983|FG002|Overall Study|Progressive disease|17|||
129016537|NCT00376623|464354981|FG000|Overall Study|Lost to Follow-up|0|||
128683073|NCT01262352|463138758|FG000|Period 1|Illness after randomization|1|||
128880294|NCT02527343|463856946|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
128880295|NCT02527343|463856947|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
128880296|NCT02527343|463856948|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
128880297|NCT02527343|463856943|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
128880298|NCT02527343|463856944|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
128880299|NCT02527343|463856945|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
128880300|NCT02527343|463856946|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
128880301|NCT02527343|463856947|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
128880302|NCT02527343|463856948|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
128880303|NCT02527343|463856943|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
128880304|NCT02527343|463856944|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
128880305|NCT02527343|463856945|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
128880306|NCT02527343|463856946|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
128880307|NCT02527343|463856947|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
128880308|NCT02527343|463856948|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
128880309|NCT00701220|463856949|FG000|Overall Study|Withdrawal by Subject|0|||
128880310|NCT00701220|463856950|FG001|Overall Study|Withdrawal by Subject|2|||
128880311|NCT00701220|463856949|FG000|Overall Study|Protocol Violation|2|||
128880312|NCT00701220|463856950|FG001|Overall Study|Protocol Violation|0|||
128880313|NCT03235284|463856951|FG000|Overall Study|Adverse Event|1|||
128880314|NCT03235284|463856952|FG001|Overall Study|Adverse Event|2|||
128880315|NCT03235284|463856953|FG002|Overall Study|Adverse Event|1|||
128880316|NCT00440999|463856956|FG000|Overall Study|Adverse Event|0|||
128880317|NCT00440999|463856957|FG001|Overall Study|Adverse Event|2|||
128880318|NCT00440999|463856956|FG000|Overall Study|Lack of Efficacy|6|||
128880319|NCT00440999|463856957|FG001|Overall Study|Lack of Efficacy|7|||
128880320|NCT00440999|463856956|FG000|Overall Study|Lost to Follow-up|19|||
128880321|NCT00440999|463856957|FG001|Overall Study|Lost to Follow-up|12|||
128880322|NCT00440999|463856956|FG000|Overall Study|Protocol Violation|1|||
128880323|NCT00440999|463856957|FG001|Overall Study|Protocol Violation|0|||
128880324|NCT00440999|463856956|FG000|Overall Study|Withdrawal by Subject|2|||
128880325|NCT00440999|463856957|FG001|Overall Study|Withdrawal by Subject|5|||
128880326|NCT00440999|463856956|FG000|Overall Study|Subjets missed the visit|1|||
128880327|NCT00440999|463856957|FG001|Overall Study|Subjets missed the visit|0|||
128880328|NCT00440999|463856956|FG000|Overall Study|Mixed infection at entry|1|||
128880329|NCT00440999|463856957|FG001|Overall Study|Mixed infection at entry|0|||
128880330|NCT00440999|463856956|FG000|Overall Study|P. falciparum malaria|5|||
128880331|NCT00440999|463856957|FG001|Overall Study|P. falciparum malaria|14|||
128880332|NCT00440999|463856956|FG000|Overall Study|Subj left hosp without inform staff|0|||
128880333|NCT00440999|463856957|FG001|Overall Study|Subj left hosp without inform staff|1|||
128880334|NCT04745026|463856960|FG000|Overall Study|Physician Decision|1|||
128880335|NCT04745026|463856961|FG001|Overall Study|Physician Decision|0|||
128880336|NCT04745026|463856960|FG000|Overall Study|Adverse Event|2|||
128880337|NCT04745026|463856961|FG001|Overall Study|Adverse Event|2|||
128880338|NCT04745026|463856960|FG000|Overall Study|Protocol Violation|1|||
128880339|NCT04745026|463856961|FG001|Overall Study|Protocol Violation|3|||
128880340|NCT04745026|463856960|FG000|Overall Study|Lost to Follow-up|4|||
128880341|NCT04745026|463856961|FG001|Overall Study|Lost to Follow-up|3|||
128880342|NCT04745026|463856960|FG000|Overall Study|Withdrawal by Subject|5|||
129016538|NCT00376623|464354982|FG001|Overall Study|Lost to Follow-up|1|||
129016539|NCT00376623|464354983|FG002|Overall Study|Lost to Follow-up|0|||
129016540|NCT00376623|464354981|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
129016541|NCT00376623|464354982|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
129016542|NCT00376623|464354983|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
129016543|NCT00376623|464354981|FG000|Overall Study|Not treated with BI 2536|1|||
129016544|NCT00376623|464354982|FG001|Overall Study|Not treated with BI 2536|0|||
129016545|NCT00376623|464354983|FG002|Overall Study|Not treated with BI 2536|0|||
129016546|NCT00376623|464354981|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
129016547|NCT00376623|464354982|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129016548|NCT00376623|464354983|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129016549|NCT00376623|464354981|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
129016550|NCT00376623|464354982|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
129016551|NCT00376623|464354983|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
128880343|NCT04745026|463856961|FG001|Overall Study|Withdrawal by Subject|5|||
128880344|NCT05041101|463856962|FG000|Overall Study|Adverse Event|1|||
128880345|NCT05041101|463856963|FG001|Overall Study|Adverse Event|0|||
128880346|NCT05041101|463856964|FG002|Overall Study|Adverse Event|0|||
128880347|NCT05041101|463856962|FG000|Overall Study|Diease Progression|5|||
128880348|NCT05041101|463856963|FG001|Overall Study|Diease Progression|0|||
128880349|NCT05041101|463856964|FG002|Overall Study|Diease Progression|0|||
129016552|NCT00376623|464354981|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
128880350|NCT01205152|463856965|FG000|Overall Study|Death|1|||
128880351|NCT04426851|463856966|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
128880352|NCT04426851|463856967|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
128880353|NCT04426851|463856966|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
128880354|NCT04426851|463856967|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
128880355|NCT00249002|463856968|FG000|Overall Study|Adverse Event|2|||
128880356|NCT00249002|463856968|FG000|Overall Study|Study cancellation|3|||
128880357|NCT00249002|463856968|FG000|Overall Study|Other|2|||
128880358|NCT03256851|463856969|FG000|Overall Study|Withdrawal by Subject|1|||
128880359|NCT03256851|463856970|FG001|Overall Study|Withdrawal by Subject|0|||
128880360|NCT02208999|463856972|FG000|Overall Study|Lost to Follow-up|1|||
128880361|NCT00825916|463856973|FG000|Overall Study|Lost to Follow-up|4|||
128880362|NCT00825916|463856974|FG001|Overall Study|Lost to Follow-up|2|||
128880363|NCT00825916|463856975|FG002|Overall Study|Lost to Follow-up|1|||
128880364|NCT01778023|463856976|FG000|Overall Study|Withdrawal by Subject|0|||
128880365|NCT01778023|463856977|FG001|Overall Study|Withdrawal by Subject|3|||
128880366|NCT01990560|463856978|FG000|Overall Study|Withdrawal by Subject|1|||
128880367|NCT01098097|463856979|FG000|Overall Study|Adverse Event|17|||
128880368|NCT01098097|463856979|FG000|Overall Study|Lost to Follow-up|18|||
128880369|NCT01098097|463856979|FG000|Overall Study|Status unknown|16|||
128880370|NCT01098097|463856979|FG000|Overall Study|No reason reported|31|||
128880371|NCT01588496|463856980|FG000|Overall Study|Withdrawal by Subject|0|||
128880372|NCT01588496|463856981|FG001|Overall Study|Withdrawal by Subject|1|||
128880373|NCT01588496|463856982|FG002|Overall Study|Withdrawal by Subject|0|||
128880374|NCT01242800|463856985|FG000|Overall Study|Patient refusal|0|||
128880375|NCT01242800|463856986|FG001|Overall Study|Patient refusal|10|||
128880376|NCT01242800|463856985|FG000|Overall Study|Physician Decision|0|||
128880377|NCT01242800|463856986|FG001|Overall Study|Physician Decision|1|||
128880378|NCT01242800|463856985|FG000|Overall Study|Disease progression|0|||
128880379|NCT01242800|463856986|FG001|Overall Study|Disease progression|3|||
128880380|NCT01242800|463856985|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
128880381|NCT01242800|463856986|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
128880382|NCT01242800|463856985|FG000|Overall Study|Reasons not reported|0|||
128880383|NCT01242800|463856986|FG001|Overall Study|Reasons not reported|4|||
128880384|NCT00953745|463856987|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
128880385|NCT00953745|463856988|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
128880386|NCT00953745|463856987|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
128880387|NCT00953745|463856988|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
128880388|NCT00953745|463856987|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
128880389|NCT00953745|463856988|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
128880390|NCT00953745|463856987|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
128880391|NCT00953745|463856988|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
128880392|NCT00953745|463856987|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
128880393|NCT00953745|463856988|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
128880394|NCT00953745|463856987|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
128880395|NCT00953745|463856988|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
128880396|NCT02640157|463856992|FG000|Overall Study|Adverse Event|2|||
128880397|NCT02640157|463856993|FG001|Overall Study|Adverse Event|2|||
128880398|NCT02640157|463856994|FG002|Overall Study|Adverse Event|1|||
128880399|NCT02640157|463856992|FG000|Overall Study|Withdrew consent|2|||
128880400|NCT02640157|463856993|FG001|Overall Study|Withdrew consent|0|||
128880401|NCT02640157|463856994|FG002|Overall Study|Withdrew consent|2|||
128880402|NCT02640157|463856992|FG000|Overall Study|Lost to Follow-up|9|||
128880403|NCT02640157|463856993|FG001|Overall Study|Lost to Follow-up|2|||
128880404|NCT02640157|463856994|FG002|Overall Study|Lost to Follow-up|7|||
128880405|NCT02640157|463856992|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
128880406|NCT02640157|463856993|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
128880407|NCT02640157|463856994|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
128880408|NCT01679405|463856996|FG000|Overall Study|Death|2|||
128880409|NCT01679405|463856997|FG001|Overall Study|Death|5|||
128880410|NCT04677179|463856998|FG000|Induction Treatment Period|Adverse Event|1|||
128880411|NCT04677179|463856999|FG001|Induction Treatment Period|Adverse Event|0|||
128880412|NCT04677179|463857000|FG002|Induction Treatment Period|Adverse Event|0|||
128880413|NCT04677179|463857001|FG003|Induction Treatment Period|Adverse Event|0|||
128880414|NCT04677179|463857002|FG004|Induction Treatment Period|Adverse Event|0|||
128880415|NCT04677179|463857003|FG005|Induction Treatment Period|Adverse Event|0|||
128880416|NCT04677179|463857004|FG006|Induction Treatment Period|Adverse Event|0|||
128880417|NCT04677179|463857005|FG007|Induction Treatment Period|Adverse Event|0|||
128880418|NCT04677179|463857006|FG008|Induction Treatment Period|Adverse Event|0|||
128880419|NCT04677179|463857007|FG009|Induction Treatment Period|Adverse Event|0|||
128880420|NCT04677179|463856998|FG000|Induction Treatment Period|Physician Decision|1|||
128880421|NCT04677179|463856999|FG001|Induction Treatment Period|Physician Decision|0|||
128880422|NCT04677179|463857000|FG002|Induction Treatment Period|Physician Decision|1|||
128880423|NCT04677179|463857001|FG003|Induction Treatment Period|Physician Decision|0|||
128880424|NCT04677179|463857002|FG004|Induction Treatment Period|Physician Decision|0|||
128880425|NCT04677179|463857003|FG005|Induction Treatment Period|Physician Decision|0|||
128880426|NCT04677179|463857004|FG006|Induction Treatment Period|Physician Decision|0|||
128880427|NCT04677179|463857005|FG007|Induction Treatment Period|Physician Decision|0|||
128880428|NCT04677179|463857006|FG008|Induction Treatment Period|Physician Decision|0|||
128880429|NCT04677179|463857007|FG009|Induction Treatment Period|Physician Decision|0|||
128880430|NCT04677179|463856998|FG000|Induction Treatment Period|Protocol Violation|0|||
128880431|NCT04677179|463856999|FG001|Induction Treatment Period|Protocol Violation|1|||
128880432|NCT04677179|463857000|FG002|Induction Treatment Period|Protocol Violation|0|||
128880433|NCT04677179|463857001|FG003|Induction Treatment Period|Protocol Violation|0|||
129016553|NCT00376623|464354982|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
129016554|NCT00376623|464354983|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
129016555|NCT00376623|464354981|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
129016556|NCT00376623|464354982|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
129016557|NCT00376623|464354983|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
129016558|NCT00376623|464354981|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129016559|NCT00376623|464354982|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129016560|NCT00376623|464354983|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
129016561|NCT00376623|464354981|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
129016562|NCT00376623|464354982|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
129016563|NCT00376623|464354983|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
129016564|NCT00376623|464354981|FG000|Overall Study|Increase of tumour markers|0|||
129016565|NCT00376623|464354982|FG001|Overall Study|Increase of tumour markers|1|||
129016566|NCT00376623|464354983|FG002|Overall Study|Increase of tumour markers|0|||
129016567|NCT00376623|464354981|FG000|Overall Study|Bone metastasis|1|||
129016568|NCT00376623|464354982|FG001|Overall Study|Bone metastasis|0|||
129016569|NCT00376623|464354983|FG002|Overall Study|Bone metastasis|0|||
129016570|NCT00286754|464354984|FG000|Overall Study|Adverse Event|2|||
129016571|NCT00286754|464354985|FG001|Overall Study|Adverse Event|2|||
129016572|NCT00286754|464354986|FG002|Overall Study|Adverse Event|3|||
129016573|NCT00286754|464354984|FG000|Overall Study|Withdrawal by Subject|6|||
129016574|NCT00286754|464354985|FG001|Overall Study|Withdrawal by Subject|2|||
129016575|NCT00286754|464354986|FG002|Overall Study|Withdrawal by Subject|0|||
129016576|NCT00286754|464354984|FG000|Overall Study|Lost to Follow-up|12|||
129016577|NCT00286754|464354985|FG001|Overall Study|Lost to Follow-up|14|||
129016578|NCT00286754|464354986|FG002|Overall Study|Lost to Follow-up|6|||
129016579|NCT00286754|464354984|FG000|Overall Study|Moved out of state|0|||
129016580|NCT00286754|464354985|FG001|Overall Study|Moved out of state|0|||
129016581|NCT00286754|464354986|FG002|Overall Study|Moved out of state|1|||
129016582|NCT00910663|464354991|FG000|Period 1|Withdrawal by Subject|0|||
129016583|NCT00910663|464354992|FG001|Period 1|Withdrawal by Subject|1|||
129016584|NCT02865850|464354993|FG000|Overall Study|Death|15|||
129016585|NCT02865850|464354994|FG001|Overall Study|Death|19|||
129016586|NCT02865850|464354993|FG000|Overall Study|Withdrawal by Subject|3|||
129016587|NCT02865850|464354994|FG001|Overall Study|Withdrawal by Subject|2|||
129016588|NCT02865850|464354993|FG000|Overall Study|Lost to Follow-up|3|||
129016589|NCT02865850|464354994|FG001|Overall Study|Lost to Follow-up|2|||
129016590|NCT02726581|464354995|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129016591|NCT02726581|464354996|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
129016592|NCT02726581|464354997|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129016593|NCT02726581|464354995|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
129016594|NCT02726581|464354996|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
129016595|NCT02726581|464354997|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
129016596|NCT02726581|464354995|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129016597|NCT02726581|464354996|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129016598|NCT02726581|464354997|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129016599|NCT02726581|464354995|FG000|Treatment Period|Disease progression|47|||
129016600|NCT02726581|464354996|FG001|Treatment Period|Disease progression|50|||
129016601|NCT02726581|464354997|FG002|Treatment Period|Disease progression|16|||
129016602|NCT02726581|464354995|FG000|Treatment Period|Other reasons|9|||
129016603|NCT02726581|464354996|FG001|Treatment Period|Other reasons|8|||
129016604|NCT02726581|464354997|FG002|Treatment Period|Other reasons|2|||
128880434|NCT04677179|463857002|FG004|Induction Treatment Period|Protocol Violation|0|||
129016605|NCT02726581|464354995|FG000|Treatment Period|Study drug toxicity|6|||
129016606|NCT02726581|464354996|FG001|Treatment Period|Study drug toxicity|3|||
129016607|NCT02726581|464354997|FG002|Treatment Period|Study drug toxicity|2|||
129016608|NCT02726581|464354995|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
129016609|NCT02726581|464354996|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
128880435|NCT04677179|463857003|FG005|Induction Treatment Period|Protocol Violation|0|||
129016610|NCT02726581|464354997|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
129016611|NCT02726581|464354995|FG000|Treatment Period|Participant withdrew consent|3|||
128683074|NCT01262352|463138759|FG001|Period 1|Illness after randomization|0|||
128683075|NCT01262352|463138758|FG000|Washout|Adverse Event|1|||
128683076|NCT01262352|463138759|FG001|Washout|Adverse Event|1|||
128683077|NCT01262352|463138758|FG000|Washout|Extended Washout|0|||
129104666|NCT00423813|464677234|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
129104667|NCT01386944|464677236|FG000|Overall Study|Adverse Event|26|||
129104668|NCT01386944|464677236|FG000|Overall Study|Lack of Efficacy|14|||
129104669|NCT01386944|464677236|FG000|Overall Study|Lost to Follow-up|8|||
129104670|NCT01386944|464677236|FG000|Overall Study|Unspecified reason|8|||
129104671|NCT03883477|464677237|FG000|Overall Study|Death|1|||
129104672|NCT03883477|464677238|FG001|Overall Study|Death|0|||
129104673|NCT03883477|464677237|FG000|Overall Study|Protocol Violation|0|||
129104674|NCT03883477|464677238|FG001|Overall Study|Protocol Violation|1|||
129104675|NCT03853291|464677239|FG000|Overall Study|Lost to Follow-up|1|||
129104676|NCT03853291|464677240|FG001|Overall Study|Lost to Follow-up|2|||
129104677|NCT03853291|464677241|FG002|Overall Study|Lost to Follow-up|0|||
129104678|NCT03853291|464677242|FG003|Overall Study|Lost to Follow-up|0|||
129104679|NCT03853291|464677243|FG004|Overall Study|Lost to Follow-up|0|||
129104680|NCT03853291|464677244|FG005|Overall Study|Lost to Follow-up|0|||
129104681|NCT03853291|464677239|FG000|Overall Study|Determined to be ineligible|1|||
129104682|NCT03853291|464677240|FG001|Overall Study|Determined to be ineligible|1|||
129104683|NCT03853291|464677241|FG002|Overall Study|Determined to be ineligible|0|||
129104684|NCT03853291|464677242|FG003|Overall Study|Determined to be ineligible|0|||
129104685|NCT03853291|464677243|FG004|Overall Study|Determined to be ineligible|0|||
129104686|NCT03853291|464677244|FG005|Overall Study|Determined to be ineligible|0|||
129104687|NCT03762681|464677250|FG000|Part 1|Withdrawal by Subject|0|||
129104688|NCT03762681|464677251|FG001|Part 1|Withdrawal by Subject|0|||
129104689|NCT03762681|464677252|FG002|Part 1|Withdrawal by Subject|0|||
129104690|NCT03762681|464677253|FG003|Part 1|Withdrawal by Subject|1|||
129104691|NCT03762681|464677254|FG004|Part 1|Withdrawal by Subject|0|||
129104692|NCT03762681|464677255|FG005|Part 1|Withdrawal by Subject|0|||
129104693|NCT03762681|464677256|FG006|Part 1|Withdrawal by Subject|0|||
129104694|NCT03762681|464677257|FG007|Part 1|Withdrawal by Subject|0|||
129104695|NCT03762681|464677250|FG000|Part 2a|Pandemic Travel Restrictions|0|||
129104696|NCT03762681|464677251|FG001|Part 2a|Pandemic Travel Restrictions|0|||
129104697|NCT03762681|464677252|FG002|Part 2a|Pandemic Travel Restrictions|0|||
129104698|NCT03762681|464677253|FG003|Part 2a|Pandemic Travel Restrictions|0|||
129104699|NCT03762681|464677254|FG004|Part 2a|Pandemic Travel Restrictions|0|||
129104700|NCT03762681|464677255|FG005|Part 2a|Pandemic Travel Restrictions|0|||
129104701|NCT03762681|464677256|FG006|Part 2a|Pandemic Travel Restrictions|0|||
129104702|NCT03762681|464677257|FG007|Part 2a|Pandemic Travel Restrictions|1|||
128683078|NCT01262352|463138759|FG001|Washout|Extended Washout|1|||
128683079|NCT01185834|463138763|FG000|Overall Study|Lost to Follow-up|2|||
128683080|NCT01185834|463138763|FG000|Overall Study|Discomfort|4|||
128683081|NCT01185834|463138763|FG000|Overall Study|Biomicroscopy|4|||
128683082|NCT01185834|463138763|FG000|Overall Study|Time/Job Conflict|2|||
128683083|NCT01185834|463138763|FG000|Overall Study|Early exit - Site error|2|||
128683084|NCT00107952|463138764|FG000|Overall Study|Death|75|||
129016612|NCT02726581|464354996|FG001|Treatment Period|Participant withdrew consent|1|||
129016613|NCT02726581|464354997|FG002|Treatment Period|Participant withdrew consent|1|||
129016614|NCT02726581|464354995|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
129016615|NCT02726581|464354996|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
129016616|NCT02726581|464354997|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
129016617|NCT02726581|464354995|FG000|Treatment Period|Maximum clinical benefit|0|||
129016618|NCT02726581|464354996|FG001|Treatment Period|Maximum clinical benefit|2|||
129016619|NCT02726581|464354997|FG002|Treatment Period|Maximum clinical benefit|0|||
129016620|NCT02726581|464354995|FG000|Treatment Period|Death|1|||
129016621|NCT02726581|464354996|FG001|Treatment Period|Death|0|||
129016622|NCT02726581|464354997|FG002|Treatment Period|Death|0|||
129016623|NCT02726581|464354995|FG000|Treatment Period|Poor/non-compliance|1|||
129016624|NCT02726581|464354996|FG001|Treatment Period|Poor/non-compliance|0|||
129016625|NCT02726581|464354997|FG002|Treatment Period|Poor/non-compliance|0|||
129016626|NCT02726581|464354995|FG000|Treatment Period|Participant no longer meets study criteria|0|||
129016627|NCT02726581|464354996|FG001|Treatment Period|Participant no longer meets study criteria|1|||
129016628|NCT02726581|464354997|FG002|Treatment Period|Participant no longer meets study criteria|0|||
129016629|NCT01772537|464354999|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
129104703|NCT02137226|464677258|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
129104704|NCT02137226|464677259|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
129104705|NCT02137226|464677260|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
129104706|NCT02137226|464677261|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
129104707|NCT02137226|464677262|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
129104708|NCT02137226|464677258|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
129104709|NCT02137226|464677259|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
129104710|NCT02137226|464677260|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
129104711|NCT02137226|464677261|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
128880436|NCT04677179|463857004|FG006|Induction Treatment Period|Protocol Violation|0|||
128880437|NCT04677179|463857005|FG007|Induction Treatment Period|Protocol Violation|0|||
128880438|NCT04677179|463857006|FG008|Induction Treatment Period|Protocol Violation|0|||
128880439|NCT04677179|463857007|FG009|Induction Treatment Period|Protocol Violation|0|||
128880440|NCT04677179|463856998|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
128880441|NCT04677179|463856999|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
128880442|NCT04677179|463857000|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
128683085|NCT00107952|463138765|FG001|Overall Study|Death|61|||
128683086|NCT00107952|463138764|FG000|Overall Study|Lost to Follow-up|0|||
128683087|NCT00107952|463138765|FG001|Overall Study|Lost to Follow-up|3|||
128683088|NCT00107952|463138764|FG000|Overall Study|Withdrawal by Subject|9|||
128683089|NCT00107952|463138765|FG001|Overall Study|Withdrawal by Subject|6|||
128683090|NCT00107952|463138764|FG000|Overall Study|Other|2|||
128683091|NCT00107952|463138765|FG001|Overall Study|Other|5|||
128683092|NCT00107952|463138764|FG000|Overall Study|Never received study treatment|9|||
128683093|NCT00107952|463138765|FG001|Overall Study|Never received study treatment|6|||
128683094|NCT01975831|463138766|FG000|Overall Study|Adverse Event|1|||
128683095|NCT01975831|463138767|FG001|Overall Study|Adverse Event|2|||
128683096|NCT01975831|463138768|FG002|Overall Study|Adverse Event|2|||
128683097|NCT01975831|463138769|FG003|Overall Study|Adverse Event|0|||
128683098|NCT01975831|463138770|FG004|Overall Study|Adverse Event|1|||
128683099|NCT01975831|463138771|FG005|Overall Study|Adverse Event|1|||
128683100|NCT01975831|463138772|FG006|Overall Study|Adverse Event|3|||
128683101|NCT01975831|463138773|FG007|Overall Study|Adverse Event|4|||
128683102|NCT01975831|463138774|FG008|Overall Study|Adverse Event|1|||
128683103|NCT01975831|463138766|FG000|Overall Study|Death|1|||
128683104|NCT01975831|463138767|FG001|Overall Study|Death|1|||
128683105|NCT01975831|463138768|FG002|Overall Study|Death|0|||
128683106|NCT01975831|463138769|FG003|Overall Study|Death|0|||
128683107|NCT01975831|463138770|FG004|Overall Study|Death|1|||
128683108|NCT01975831|463138771|FG005|Overall Study|Death|0|||
128683109|NCT01975831|463138772|FG006|Overall Study|Death|1|||
128683110|NCT01975831|463138773|FG007|Overall Study|Death|0|||
128683111|NCT01975831|463138774|FG008|Overall Study|Death|0|||
128683112|NCT01975831|463138766|FG000|Overall Study|Progressive Disease|1|||
128683113|NCT01975831|463138767|FG001|Overall Study|Progressive Disease|3|||
128683114|NCT01975831|463138768|FG002|Overall Study|Progressive Disease|2|||
128683115|NCT01975831|463138769|FG003|Overall Study|Progressive Disease|4|||
128683116|NCT01975831|463138770|FG004|Overall Study|Progressive Disease|13|||
128683117|NCT01975831|463138771|FG005|Overall Study|Progressive Disease|9|||
128683118|NCT01975831|463138772|FG006|Overall Study|Progressive Disease|10|||
128880443|NCT04677179|463857001|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
128880444|NCT04677179|463857002|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
129016630|NCT01772537|464355000|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
129016631|NCT01772537|464355001|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
129016632|NCT03195491|464355002|FG000|Overall Study|Study drug toxicity|25|||
129016633|NCT03195491|464355003|FG001|Overall Study|Study drug toxicity|3|||
129016634|NCT03195491|464355002|FG000|Overall Study|Maximum clinical benefit|5|||
129016635|NCT03195491|464355003|FG001|Overall Study|Maximum clinical benefit|0|||
129016636|NCT03195491|464355002|FG000|Overall Study|Lost to Follow-up|1|||
129016637|NCT03195491|464355003|FG001|Overall Study|Lost to Follow-up|0|||
129016638|NCT03195491|464355002|FG000|Overall Study|Death|3|||
129016639|NCT03195491|464355003|FG001|Overall Study|Death|0|||
129016640|NCT03195491|464355002|FG000|Overall Study|Adverse event unrelated to study drug|19|||
129016641|NCT03195491|464355003|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129016642|NCT03195491|464355002|FG000|Overall Study|Disease progression|266|||
129016643|NCT03195491|464355003|FG001|Overall Study|Disease progression|8|||
129016644|NCT03195491|464355002|FG000|Overall Study|Other reasons|10|||
129016645|NCT03195491|464355003|FG001|Overall Study|Other reasons|0|||
129016646|NCT03195491|464355002|FG000|Overall Study|Participant withdrew consent|8|||
129016647|NCT03195491|464355003|FG001|Overall Study|Participant withdrew consent|1|||
129016648|NCT03195491|464355002|FG000|Overall Study|Participant no longer meets study criteria|0|||
129016649|NCT03195491|464355003|FG001|Overall Study|Participant no longer meets study criteria|1|||
128683119|NCT01975831|463138773|FG007|Overall Study|Progressive Disease|8|||
128683120|NCT01975831|463138774|FG008|Overall Study|Progressive Disease|10|||
128683121|NCT01975831|463138766|FG000|Overall Study|Withdrawal by Subject|0|||
128880445|NCT04677179|463857003|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
129016650|NCT03195491|464355002|FG000|Overall Study|Participant request to discontinue study treatment|10|||
129016651|NCT03195491|464355003|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129016652|NCT01263704|464355004|FG000|Overall Study|Progressive disease|18|||
129016653|NCT01263704|464355004|FG000|Overall Study|Adverse Event|3|||
128683122|NCT01975831|463138767|FG001|Overall Study|Withdrawal by Subject|3|||
128683123|NCT01975831|463138768|FG002|Overall Study|Withdrawal by Subject|0|||
128683124|NCT01975831|463138769|FG003|Overall Study|Withdrawal by Subject|0|||
128683125|NCT01975831|463138770|FG004|Overall Study|Withdrawal by Subject|3|||
128683126|NCT01975831|463138771|FG005|Overall Study|Withdrawal by Subject|1|||
128683127|NCT01975831|463138772|FG006|Overall Study|Withdrawal by Subject|1|||
128880446|NCT04677179|463857004|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
128880447|NCT04677179|463857005|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
128880448|NCT04677179|463857006|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
128880449|NCT04677179|463857007|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
128880450|NCT04677179|463856998|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
128880451|NCT04677179|463856999|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
128880452|NCT04677179|463857000|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
128880453|NCT04677179|463857001|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
128880454|NCT04677179|463857002|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
128880455|NCT04677179|463857003|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
128880456|NCT04677179|463857004|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
128880457|NCT04677179|463857005|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
129104712|NCT02137226|464677262|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
129104713|NCT02137226|464677258|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
129104714|NCT02137226|464677259|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
129104715|NCT02137226|464677260|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
129104716|NCT02137226|464677261|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
129104717|NCT02137226|464677262|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
129104718|NCT02137226|464677258|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
129104719|NCT02137226|464677259|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
129104720|NCT02137226|464677260|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
129104721|NCT02137226|464677261|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
129104722|NCT02137226|464677262|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
128683128|NCT01975831|463138773|FG007|Overall Study|Withdrawal by Subject|0|||
128683129|NCT01975831|463138774|FG008|Overall Study|Withdrawal by Subject|0|||
128880458|NCT04677179|463857006|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
129016654|NCT01263704|464355004|FG000|Overall Study|Death|2|||
129016655|NCT01263704|464355004|FG000|Overall Study|Patient withdrew consent|2|||
129016656|NCT01263704|464355004|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
129016657|NCT01263704|464355004|FG000|Overall Study|Lost to Follow-up|1|||
129016658|NCT01263704|464355004|FG000|Overall Study|Colon metastases|1|||
129016659|NCT01263704|464355004|FG000|Overall Study|Principal Investigator (PI) decision|1|||
129016660|NCT01185821|464355010|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129016661|NCT01185821|464355011|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129016662|NCT01185821|464355012|FG002|Overall Study|Abnormal laboratory value(s)|1|||
129016663|NCT01185821|464355013|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129016664|NCT01185821|464355014|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129016665|NCT01185821|464355010|FG000|Overall Study|Protocol Violation|0|||
129016666|NCT01185821|464355011|FG001|Overall Study|Protocol Violation|0|||
129016667|NCT01185821|464355012|FG002|Overall Study|Protocol Violation|0|||
129016668|NCT01185821|464355013|FG003|Overall Study|Protocol Violation|1|||
129016669|NCT01185821|464355014|FG004|Overall Study|Protocol Violation|1|||
129016670|NCT01185821|464355010|FG000|Overall Study|Abnormal test procedure result|0|||
129016671|NCT01185821|464355011|FG001|Overall Study|Abnormal test procedure result|0|||
129016672|NCT01185821|464355012|FG002|Overall Study|Abnormal test procedure result|0|||
129016673|NCT01185821|464355013|FG003|Overall Study|Abnormal test procedure result|0|||
129016674|NCT01185821|464355014|FG004|Overall Study|Abnormal test procedure result|1|||
129016675|NCT01185821|464355010|FG000|Overall Study|Death|0|||
129016676|NCT01185821|464355011|FG001|Overall Study|Death|1|||
129016677|NCT01185821|464355012|FG002|Overall Study|Death|0|||
129016678|NCT01185821|464355013|FG003|Overall Study|Death|0|||
129016679|NCT01185821|464355014|FG004|Overall Study|Death|0|||
129016680|NCT01185821|464355010|FG000|Overall Study|Condition no longer required study drug|0|||
129016681|NCT01185821|464355011|FG001|Overall Study|Condition no longer required study drug|0|||
129016682|NCT01185821|464355012|FG002|Overall Study|Condition no longer required study drug|0|||
129016683|NCT01185821|464355013|FG003|Overall Study|Condition no longer required study drug|0|||
129016684|NCT01185821|464355014|FG004|Overall Study|Condition no longer required study drug|1|||
129016685|NCT01185821|464355010|FG000|Overall Study|Adverse Event|2|||
129016686|NCT01185821|464355011|FG001|Overall Study|Adverse Event|3|||
129016687|NCT01185821|464355012|FG002|Overall Study|Adverse Event|1|||
129016688|NCT01185821|464355013|FG003|Overall Study|Adverse Event|2|||
129016689|NCT01185821|464355014|FG004|Overall Study|Adverse Event|5|||
129016690|NCT01185821|464355010|FG000|Overall Study|Lack of Efficacy|0|||
129016691|NCT01185821|464355011|FG001|Overall Study|Lack of Efficacy|0|||
129016692|NCT01185821|464355012|FG002|Overall Study|Lack of Efficacy|3|||
129016693|NCT01185821|464355013|FG003|Overall Study|Lack of Efficacy|0|||
129016694|NCT01185821|464355014|FG004|Overall Study|Lack of Efficacy|9|||
129016695|NCT01185821|464355010|FG000|Overall Study|Withdrawal by Subject|3|||
129016696|NCT01185821|464355011|FG001|Overall Study|Withdrawal by Subject|2|||
129016697|NCT01185821|464355012|FG002|Overall Study|Withdrawal by Subject|2|||
129016698|NCT01185821|464355013|FG003|Overall Study|Withdrawal by Subject|1|||
129016699|NCT01185821|464355014|FG004|Overall Study|Withdrawal by Subject|3|||
128880459|NCT04677179|463857007|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
128880460|NCT04677179|463856998|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
128880461|NCT04677179|463856999|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
128880462|NCT04677179|463857000|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
128880463|NCT04677179|463857001|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
128880464|NCT04677179|463857002|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
128880465|NCT04677179|463857003|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
128880466|NCT04677179|463857004|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
128880467|NCT04677179|463857005|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
128880468|NCT04677179|463857006|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
128880469|NCT04677179|463857007|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
128880470|NCT04677179|463856998|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880471|NCT04677179|463856999|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880472|NCT04677179|463857000|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880473|NCT04677179|463857001|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
128880474|NCT04677179|463857002|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880475|NCT04677179|463857003|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880476|NCT04677179|463857004|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880477|NCT04677179|463857005|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880478|NCT04677179|463857006|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880479|NCT04677179|463857007|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
128880480|NCT04677179|463856998|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
128880481|NCT04677179|463856999|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
128880482|NCT04677179|463857000|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
128880483|NCT04677179|463857001|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
128880484|NCT04677179|463857002|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
128880485|NCT04677179|463857003|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
128880486|NCT04677179|463857004|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
128880487|NCT04677179|463857005|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
128880488|NCT04677179|463857006|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
128880489|NCT04677179|463857007|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
128880490|NCT04677179|463856998|FG000|Extension Treatment Period|Lack of Efficacy|0|||
128880491|NCT04677179|463856999|FG001|Extension Treatment Period|Lack of Efficacy|0|||
129016700|NCT01185821|464355010|FG000|Overall Study|Lost to Follow-up|1|||
129016701|NCT01185821|464355011|FG001|Overall Study|Lost to Follow-up|1|||
129016702|NCT01185821|464355012|FG002|Overall Study|Lost to Follow-up|2|||
129016703|NCT01185821|464355013|FG003|Overall Study|Lost to Follow-up|1|||
129016704|NCT01185821|464355014|FG004|Overall Study|Lost to Follow-up|2|||
129016705|NCT01185821|464355010|FG000|Overall Study|Administrative problems|0|||
129016706|NCT01185821|464355011|FG001|Overall Study|Administrative problems|0|||
129016707|NCT01185821|464355012|FG002|Overall Study|Administrative problems|1|||
129016708|NCT01185821|464355013|FG003|Overall Study|Administrative problems|1|||
129016709|NCT01185821|464355014|FG004|Overall Study|Administrative problems|2|||
129016710|NCT01546545|464355016|FG000|Overall Study|Withdrawal by Subject|1|||
129016711|NCT04060147|464355017|FG000|Overall Study|Withdrew consent|1|||
129016712|NCT02057458|464355021|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
129016713|NCT02057458|464355022|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
129016714|NCT02057458|464355023|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
129016715|NCT02057458|464355021|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
129016716|NCT02057458|464355022|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
129016717|NCT02057458|464355023|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
129016718|NCT02057458|464355021|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
129016719|NCT02057458|464355022|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
129016720|NCT02057458|464355023|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
129016721|NCT00585689|464355024|FG000|Overall Study|Received different ABI-007 schedule|3|||
129016722|NCT00585689|464355024|FG000|Overall Study|Adverse Event|1|||
129016723|NCT00585689|464355024|FG000|Overall Study|Patient Declined Surgery|1|||
129016724|NCT00585689|464355024|FG000|Overall Study|Patient had unresectable disease|1|||
129016725|NCT00585689|464355024|FG000|Overall Study|Death|1|||
129016726|NCT00550537|464355025|FG000|Overall Study|Death|18|||
129016727|NCT00550537|464355025|FG000|Overall Study|Adverse Event|20|||
129104723|NCT02137226|464677258|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
129104724|NCT02137226|464677259|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
128880492|NCT04677179|463857000|FG002|Extension Treatment Period|Lack of Efficacy|0|||
129016728|NCT00550537|464355025|FG000|Overall Study|Disease progression before|46|||
129016729|NCT00550537|464355025|FG000|Overall Study|Withdrawal by Subject|7|||
128880493|NCT04677179|463857001|FG003|Extension Treatment Period|Lack of Efficacy|0|||
129016730|NCT00550537|464355025|FG000|Overall Study|Change in treatment plan|4|||
129016731|NCT00550537|464355025|FG000|Overall Study|Other complicating ilness|3|||
129104725|NCT02137226|464677260|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
128880494|NCT04677179|463857002|FG004|Extension Treatment Period|Lack of Efficacy|0|||
128880495|NCT04677179|463857003|FG005|Extension Treatment Period|Lack of Efficacy|0|||
128880496|NCT04677179|463857004|FG006|Extension Treatment Period|Lack of Efficacy|6|||
128880497|NCT04677179|463857005|FG007|Extension Treatment Period|Lack of Efficacy|0|||
128880498|NCT04677179|463857006|FG008|Extension Treatment Period|Lack of Efficacy|0|||
128880499|NCT04677179|463857007|FG009|Extension Treatment Period|Lack of Efficacy|0|||
128880500|NCT04677179|463856998|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
128880501|NCT04677179|463856999|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
128880502|NCT04677179|463857000|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
128880503|NCT04677179|463857001|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
128880504|NCT04677179|463857002|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
128880505|NCT04677179|463857003|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
128880506|NCT04677179|463857004|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
128880507|NCT04677179|463857005|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
128880508|NCT04677179|463857006|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
128880509|NCT04677179|463857007|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
128880510|NCT04677179|463856998|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
128880511|NCT04677179|463856999|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
128880512|NCT04677179|463857000|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
128880513|NCT04677179|463857001|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
128880514|NCT04677179|463857002|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
128880515|NCT04677179|463857003|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
128880516|NCT04677179|463857004|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
128880517|NCT04677179|463857005|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
128880518|NCT04677179|463857006|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
128880519|NCT04677179|463857007|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
128880520|NCT04677179|463856998|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
128880521|NCT04677179|463856999|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
128880522|NCT04677179|463857000|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
128880523|NCT04677179|463857001|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
128880524|NCT04677179|463857002|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
128880525|NCT04677179|463857003|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
128880526|NCT04677179|463857004|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
128880527|NCT04677179|463857005|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
128880528|NCT04677179|463857006|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
128880529|NCT04677179|463857007|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
128880530|NCT04677179|463856998|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880531|NCT04677179|463856999|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880532|NCT04677179|463857000|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880533|NCT04677179|463857001|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880534|NCT04677179|463857002|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880535|NCT04677179|463857003|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880536|NCT04677179|463857004|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880537|NCT04677179|463857005|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
128880538|NCT04677179|463857006|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
128880539|NCT04677179|463857007|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
128880540|NCT04677179|463856998|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880541|NCT04677179|463856999|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880542|NCT04677179|463857000|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880543|NCT04677179|463857001|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880544|NCT04677179|463857002|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880545|NCT04677179|463857003|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880546|NCT04677179|463857004|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880547|NCT04677179|463857005|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
128880548|NCT04677179|463857006|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880549|NCT04677179|463857007|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
128880550|NCT04677179|463856998|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129016732|NCT00550537|464355025|FG000|Overall Study|Declining performance status|2|||
129016733|NCT00550537|464355025|FG000|Overall Study|Treated closer to home|4|||
129016734|NCT00617305|464355026|FG000|Overall Study|Adverse Event|4|||
129016735|NCT00617305|464355027|FG001|Overall Study|Adverse Event|0|||
129016736|NCT00617305|464355028|FG002|Overall Study|Adverse Event|0|||
129016737|NCT00617305|464355026|FG000|Overall Study|Death|1|||
129016738|NCT00617305|464355027|FG001|Overall Study|Death|0|||
128880551|NCT04677179|463856999|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128880552|NCT04677179|463857000|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129016739|NCT00617305|464355028|FG002|Overall Study|Death|0|||
129016740|NCT00617305|464355026|FG000|Overall Study|Physician Decision|1|||
128880553|NCT04677179|463857001|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128880554|NCT04677179|463857002|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128880555|NCT04677179|463857003|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128880556|NCT04677179|463857004|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128880557|NCT04677179|463857005|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
128880558|NCT04677179|463857006|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
128880559|NCT04677179|463857007|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128880560|NCT04677179|463856998|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
128880561|NCT04677179|463856999|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
128880562|NCT04677179|463857000|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
128880563|NCT04677179|463857001|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
128880564|NCT04677179|463857002|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
128880565|NCT04677179|463857003|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
128880566|NCT04677179|463857004|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
128880567|NCT04677179|463857005|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
128880568|NCT04677179|463857006|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
128880569|NCT04677179|463857007|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
128880570|NCT03110185|463857010|FG000|Overall Study|Death|0|||
128880571|NCT03110185|463857011|FG001|Overall Study|Death|1|||
128880572|NCT03110185|463857010|FG000|Overall Study|Withdrawal by Subject|2|||
128880573|NCT03110185|463857011|FG001|Overall Study|Withdrawal by Subject|7|||
128880574|NCT03110185|463857010|FG000|Overall Study|Time Constraints|0|||
128880575|NCT03110185|463857011|FG001|Overall Study|Time Constraints|6|||
128880576|NCT03110185|463857010|FG000|Overall Study|Conflict with care|5|||
128880577|NCT03110185|463857011|FG001|Overall Study|Conflict with care|12|||
128880578|NCT03110185|463857010|FG000|Overall Study|Protocol Violation|1|||
128880579|NCT03110185|463857011|FG001|Overall Study|Protocol Violation|4|||
128880580|NCT03110185|463857010|FG000|Overall Study|MRI Incompatible|2|||
128880581|NCT03110185|463857011|FG001|Overall Study|MRI Incompatible|0|||
128880582|NCT03110185|463857010|FG000|Overall Study|Patient Refusal|0|||
128880583|NCT03110185|463857011|FG001|Overall Study|Patient Refusal|1|||
128880584|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
128880585|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
128880586|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
128880587|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
128880588|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
128880589|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
128880590|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
128880591|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
128880592|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
128880593|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
128880594|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
128880595|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
128880596|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
128880597|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
128880598|NCT00600886|463857014|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
128880599|NCT00600886|463857015|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
128880600|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
128880601|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
128880602|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
128880603|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
128880604|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
128880605|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
128880606|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
128880607|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
128880608|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
128880609|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
128880610|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
128880611|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
128880612|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Death|1|||
128880613|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Death|1|||
128880614|NCT00600886|463857014|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
128880615|NCT00600886|463857015|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
128880616|NCT00600886|463857014|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
128880617|NCT00600886|463857015|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
128880618|NCT00600886|463857014|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
128880619|NCT00600886|463857015|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
128880620|NCT00600886|463857014|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
128880621|NCT00600886|463857015|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
128683130|NCT01975831|463138766|FG000|Overall Study|Physician Decision|0|||
128880622|NCT00600886|463857014|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
128880623|NCT00600886|463857015|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
128880624|NCT00600886|463857014|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
128880625|NCT00600886|463857015|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
128880626|NCT00600886|463857014|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
128880627|NCT00600886|463857015|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
128880628|NCT00600886|463857014|FG000|Extension - After Crossover (CAS)|Death|1|||
128880629|NCT00600886|463857015|FG001|Extension - After Crossover (CAS)|Death|0|||
128880630|NCT03075410|463857016|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
128880631|NCT03075410|463857017|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
128880632|NCT03075410|463857018|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
128880633|NCT03075410|463857019|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
128880634|NCT03075410|463857020|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
128880635|NCT03075410|463857021|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
128880636|NCT03075410|463857022|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
128880637|NCT03075410|463857023|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
128880638|NCT03075410|463857024|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
128880639|NCT03075410|463857016|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
128880640|NCT03075410|463857017|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880641|NCT03075410|463857018|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880642|NCT03075410|463857019|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880643|NCT03075410|463857020|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880644|NCT03075410|463857021|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880645|NCT03075410|463857022|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880646|NCT03075410|463857023|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880647|NCT03075410|463857024|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
128880648|NCT01427751|463857025|FG000|Overall Study|Adverse Event|18|||
128880649|NCT01427751|463857026|FG001|Overall Study|Adverse Event|2|||
129016741|NCT00617305|464355027|FG001|Overall Study|Physician Decision|0|||
129016742|NCT00617305|464355028|FG002|Overall Study|Physician Decision|0|||
129016743|NCT00617305|464355026|FG000|Overall Study|Protocol Violation|1|||
129016744|NCT00617305|464355027|FG001|Overall Study|Protocol Violation|0|||
129016745|NCT00617305|464355028|FG002|Overall Study|Protocol Violation|1|||
129016746|NCT00617305|464355026|FG000|Overall Study|Withdrawal by Subject|1|||
129016747|NCT00617305|464355027|FG001|Overall Study|Withdrawal by Subject|0|||
129016748|NCT00617305|464355028|FG002|Overall Study|Withdrawal by Subject|0|||
129016749|NCT04510285|464355029|FG000|Overall Study|Death|1|||
129016750|NCT03555305|464355032|FG000|Period 1|Physician Decision|0|||
129016751|NCT03555305|464355033|FG001|Period 1|Physician Decision|1|||
129016752|NCT03555305|464355032|FG000|Period 1|Adverse Event|0|||
129016753|NCT03555305|464355033|FG001|Period 1|Adverse Event|1|||
129016754|NCT03586726|464355034|FG000|Overall Study|Withdrawal by Subject|1|||
129016755|NCT02100228|464355037|FG000|Overall Study|Other|19|||
129016756|NCT02100228|464355038|FG001|Overall Study|Other|19|||
129016757|NCT02100228|464355037|FG000|Overall Study|Administrative reason|0|||
129016758|NCT02100228|464355038|FG001|Overall Study|Administrative reason|1|||
129016759|NCT02100228|464355037|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
129016760|NCT02100228|464355038|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
129016761|NCT02100228|464355037|FG000|Overall Study|Non-compliance|0|||
129016762|NCT02100228|464355038|FG001|Overall Study|Non-compliance|3|||
129016763|NCT02100228|464355037|FG000|Overall Study|Lost to Follow-up|0|||
129016764|NCT02100228|464355038|FG001|Overall Study|Lost to Follow-up|1|||
129016765|NCT02100228|464355037|FG000|Overall Study|Withdrawal by Subject|27|||
129016766|NCT02100228|464355038|FG001|Overall Study|Withdrawal by Subject|37|||
129016767|NCT02100228|464355037|FG000|Overall Study|Adverse Event|16|||
129016768|NCT02100228|464355038|FG001|Overall Study|Adverse Event|12|||
128880650|NCT01427751|463857025|FG000|Overall Study|No further treatment benefit expected|5|||
128880651|NCT01427751|463857026|FG001|Overall Study|No further treatment benefit expected|1|||
128880652|NCT01427751|463857025|FG000|Overall Study|Lost to Follow-up|3|||
129016769|NCT02100228|464355037|FG000|Overall Study|Death|1|||
129016770|NCT02100228|464355038|FG001|Overall Study|Death|1|||
129016771|NCT03420300|464355044|FG000|Overall Study|Death|2|||
129016772|NCT02421952|464355045|FG000|Overall Study|Diary Not Returned|93|||
129016773|NCT02421952|464355045|FG000|Overall Study|Failed seriation task|13|||
129016774|NCT02421952|464355045|FG000|Overall Study|Subject uncooperative for baseline test|2|||
129016775|NCT02421952|464355045|FG000|Overall Study|Surgery cancelled|1|||
129016776|NCT00854100|464355046|FG000|Overall Study|Inability to complete the study visits|0|||
129016777|NCT00854100|464355047|FG001|Overall Study|Inability to complete the study visits|0|||
129104726|NCT02137226|464677261|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
128880653|NCT01427751|463857026|FG001|Overall Study|Lost to Follow-up|1|||
129016778|NCT00854100|464355048|FG002|Overall Study|Inability to complete the study visits|1|||
129016779|NCT00854100|464355046|FG000|Overall Study|Lost to Follow-up|2|||
129016780|NCT00854100|464355047|FG001|Overall Study|Lost to Follow-up|0|||
128880654|NCT01427751|463857025|FG000|Overall Study|Withdrawal of consent|2|||
128880655|NCT01427751|463857026|FG001|Overall Study|Withdrawal of consent|2|||
128880656|NCT01427751|463857025|FG000|Overall Study|Protocol Violation|6|||
128880657|NCT01427751|463857026|FG001|Overall Study|Protocol Violation|4|||
128880658|NCT01427751|463857025|FG000|Overall Study|Death|2|||
128880659|NCT01427751|463857026|FG001|Overall Study|Death|0|||
128880660|NCT01427751|463857025|FG000|Overall Study|Other miscellaneous reasons|6|||
128880661|NCT01427751|463857026|FG001|Overall Study|Other miscellaneous reasons|4|||
128880662|NCT03319849|463857035|FG000|Overall Study|Adverse Event|1|||
128880663|NCT03319849|463857036|FG001|Overall Study|Adverse Event|0|||
128880664|NCT03319849|463857035|FG000|Overall Study|Physician Decision|0|||
128880665|NCT03319849|463857036|FG001|Overall Study|Physician Decision|1|||
128880666|NCT03319849|463857035|FG000|Overall Study|Withdrawal by Subject|0|||
128880667|NCT03319849|463857036|FG001|Overall Study|Withdrawal by Subject|1|||
128880668|NCT03319849|463857035|FG000|Overall Study|COVID-19|0|||
128880669|NCT03319849|463857036|FG001|Overall Study|COVID-19|1|||
128880670|NCT03319849|463857035|FG000|Overall Study|Other|1|||
128880671|NCT03319849|463857036|FG001|Overall Study|Other|2|||
128880672|NCT03319849|463857035|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
128880673|NCT03319849|463857036|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
128880674|NCT03319849|463857035|FG000|Overall Study|Lost to Follow-up|0|||
128880675|NCT03319849|463857036|FG001|Overall Study|Lost to Follow-up|2|||
128880676|NCT03938545|463858403|FG000|Overall Study|Lost to Follow-up|0|||
128880677|NCT03938545|463858404|FG001|Overall Study|Lost to Follow-up|0|||
128880678|NCT03938545|463858405|FG002|Overall Study|Lost to Follow-up|0|||
128880679|NCT03938545|463858406|FG003|Overall Study|Lost to Follow-up|1|||
128880680|NCT03938545|463858403|FG000|Overall Study|Non-compliance with study drug|0|||
128880681|NCT03938545|463858404|FG001|Overall Study|Non-compliance with study drug|0|||
128880682|NCT03938545|463858405|FG002|Overall Study|Non-compliance with study drug|1|||
128880683|NCT03938545|463858406|FG003|Overall Study|Non-compliance with study drug|0|||
128880684|NCT03938545|463858403|FG000|Overall Study|Pregnancy|1|||
128880685|NCT03938545|463858404|FG001|Overall Study|Pregnancy|0|||
128880686|NCT03938545|463858405|FG002|Overall Study|Pregnancy|0|||
128880687|NCT03938545|463858406|FG003|Overall Study|Pregnancy|0|||
128880688|NCT03938545|463858403|FG000|Overall Study|Study terminated by sponsor|6|||
128880689|NCT03938545|463858404|FG001|Overall Study|Study terminated by sponsor|4|||
128880690|NCT03938545|463858405|FG002|Overall Study|Study terminated by sponsor|2|||
128880691|NCT03938545|463858406|FG003|Overall Study|Study terminated by sponsor|4|||
128880692|NCT03938545|463858403|FG000|Overall Study|Withdrawal by Subject|0|||
128880693|NCT03938545|463858404|FG001|Overall Study|Withdrawal by Subject|1|||
128880694|NCT03938545|463858405|FG002|Overall Study|Withdrawal by Subject|0|||
128880695|NCT03938545|463858406|FG003|Overall Study|Withdrawal by Subject|0|||
128880696|NCT03938545|463858403|FG000|Overall Study|Adverse Event|1|||
128880697|NCT03938545|463858404|FG001|Overall Study|Adverse Event|0|||
128880698|NCT03938545|463858405|FG002|Overall Study|Adverse Event|0|||
128880699|NCT03938545|463858406|FG003|Overall Study|Adverse Event|0|||
128880700|NCT01060540|463858407|FG000|Overall Study|Withdrawal by Subject|10|||
128880701|NCT01060540|463858408|FG001|Overall Study|Withdrawal by Subject|20|||
128880702|NCT01060540|463858407|FG000|Overall Study|Lost to Follow-up|52|||
128880703|NCT01060540|463858408|FG001|Overall Study|Lost to Follow-up|43|||
128880704|NCT01060540|463858407|FG000|Overall Study|Death|2|||
128880705|NCT01060540|463858408|FG001|Overall Study|Death|1|||
128880706|NCT01060540|463858407|FG000|Overall Study|Physician Decision|0|||
128880707|NCT01060540|463858408|FG001|Overall Study|Physician Decision|1|||
129016781|NCT00854100|464355048|FG002|Overall Study|Lost to Follow-up|3|||
129016782|NCT00854100|464355046|FG000|Overall Study|Withdrawal by Subject|3|||
129016783|NCT00854100|464355047|FG001|Overall Study|Withdrawal by Subject|1|||
129016784|NCT00854100|464355048|FG002|Overall Study|Withdrawal by Subject|2|||
129016785|NCT00854100|464355046|FG000|Overall Study|Protocol Violation|2|||
129016786|NCT00854100|464355047|FG001|Overall Study|Protocol Violation|4|||
129016787|NCT00854100|464355048|FG002|Overall Study|Protocol Violation|3|||
129016788|NCT00854100|464355046|FG000|Overall Study|Adverse Event|2|||
129016789|NCT00854100|464355047|FG001|Overall Study|Adverse Event|1|||
129016790|NCT00854100|464355048|FG002|Overall Study|Adverse Event|2|||
128683131|NCT01975831|463138767|FG001|Overall Study|Physician Decision|0|||
128880708|NCT02401867|463858414|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
128880709|NCT02401867|463858414|FG000|Analysis|Cervical assay could not be conducted|9|||
128880710|NCT01557283|463858415|FG000|Overall Study|Lost to Follow-up|7|||
128880711|NCT01557283|463858415|FG000|Overall Study|Non-responder|19|||
128880712|NCT01557283|463858415|FG000|Overall Study|Adverse Event|7|||
128880713|NCT01557283|463858415|FG000|Overall Study|Lack of Efficacy|1|||
128880714|NCT01557283|463858415|FG000|Overall Study|Non-compliance|1|||
128880715|NCT01557283|463858415|FG000|Overall Study|Withdrawal by Subject|1|||
128880716|NCT01557283|463858415|FG000|Overall Study|Participant's weight too high for dose|1|||
128880717|NCT01557283|463858415|FG000|Overall Study|Worsening of psoriasis|1|||
128880718|NCT01557283|463858415|FG000|Overall Study|Other|6|||
128880719|NCT02808143|463858418|FG000|Maintenance Phase|Disease recurrence|1|||
129016791|NCT02216071|464355059|FG000|Overall Study|Withdrawal by Subject|7|||
129016792|NCT02216071|464355060|FG001|Overall Study|Withdrawal by Subject|2|||
128880720|NCT02808143|463858419|FG001|Maintenance Phase|Disease recurrence|3|||
128880721|NCT02808143|463858418|FG000|Maintenance Phase|Disease progression|1|||
128880722|NCT02808143|463858419|FG001|Maintenance Phase|Disease progression|2|||
128880723|NCT02808143|463858418|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
128880724|NCT02808143|463858419|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
128880725|NCT02808143|463858418|FG000|Survival Follow-Up|Disease recurrence|0|||
128880726|NCT02808143|463858419|FG001|Survival Follow-Up|Disease recurrence|2|||
128880727|NCT02808143|463858418|FG000|Survival Follow-Up|Adverse Event|0|||
128880728|NCT02808143|463858419|FG001|Survival Follow-Up|Adverse Event|1|||
128880729|NCT02808143|463858418|FG000|Survival Follow-Up|Death|1|||
128880730|NCT02808143|463858419|FG001|Survival Follow-Up|Death|0|||
128880731|NCT04964388|463858420|FG000|Overall Study|Lost to Follow-up|3|||
128880732|NCT04964388|463858421|FG001|Overall Study|Lost to Follow-up|2|||
128880733|NCT00250679|463858422|FG000|Overall Study|Adverse Event|12|||
128880734|NCT00250679|463858423|FG001|Overall Study|Adverse Event|15|||
128880735|NCT00250679|463858424|FG002|Overall Study|Adverse Event|16|||
128880736|NCT00250679|463858422|FG000|Overall Study|Protocol Violation|2|||
128880737|NCT00250679|463858423|FG001|Overall Study|Protocol Violation|4|||
128880738|NCT00250679|463858424|FG002|Overall Study|Protocol Violation|3|||
128880739|NCT00250679|463858422|FG000|Overall Study|Withdrawal by Subject|15|||
128880740|NCT00250679|463858423|FG001|Overall Study|Withdrawal by Subject|18|||
128880741|NCT00250679|463858424|FG002|Overall Study|Withdrawal by Subject|15|||
128880742|NCT00250679|463858422|FG000|Overall Study|Lost to Follow-up|3|||
128880743|NCT00250679|463858423|FG001|Overall Study|Lost to Follow-up|4|||
128880744|NCT00250679|463858424|FG002|Overall Study|Lost to Follow-up|2|||
128880745|NCT00250679|463858422|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
128880746|NCT00250679|463858423|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
128880747|NCT00250679|463858424|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
128880748|NCT00250679|463858422|FG000|Overall Study|Lack of Efficacy|0|||
128880749|NCT00250679|463858423|FG001|Overall Study|Lack of Efficacy|1|||
128880750|NCT00250679|463858424|FG002|Overall Study|Lack of Efficacy|3|||
128880751|NCT00250679|463858422|FG000|Overall Study|Technical Holter issues|1|||
128880752|NCT00250679|463858423|FG001|Overall Study|Technical Holter issues|0|||
128880753|NCT00250679|463858424|FG002|Overall Study|Technical Holter issues|2|||
128880754|NCT00250679|463858422|FG000|Overall Study|Moved|1|||
128880755|NCT00250679|463858423|FG001|Overall Study|Moved|1|||
128880756|NCT00250679|463858424|FG002|Overall Study|Moved|0|||
128880757|NCT00250679|463858422|FG000|Overall Study|Non-compliance|1|||
129016793|NCT02216071|464355059|FG000|Overall Study|Lost to Follow-up|3|||
128880758|NCT00250679|463858423|FG001|Overall Study|Non-compliance|1|||
129016794|NCT02216071|464355060|FG001|Overall Study|Lost to Follow-up|3|||
129016795|NCT02216071|464355059|FG000|Overall Study|Protocol Violation|3|||
129016796|NCT02216071|464355060|FG001|Overall Study|Protocol Violation|5|||
129016797|NCT02216071|464355059|FG000|Overall Study|Other|2|||
129016798|NCT02216071|464355060|FG001|Overall Study|Other|2|||
129016799|NCT00389064|464355061|FG000|Overall Study|Adverse Event|11|||
129016800|NCT00389064|464355062|FG001|Overall Study|Adverse Event|3|||
129016801|NCT00389064|464355061|FG000|Overall Study|Lack of Efficacy|3|||
129016802|NCT00389064|464355062|FG001|Overall Study|Lack of Efficacy|14|||
129016803|NCT00389064|464355061|FG000|Overall Study|Withdrawal by Subject|17|||
129016804|NCT00389064|464355062|FG001|Overall Study|Withdrawal by Subject|27|||
129016805|NCT00389064|464355061|FG000|Overall Study|Physician Decision|2|||
129016806|NCT00389064|464355062|FG001|Overall Study|Physician Decision|2|||
129016807|NCT00389064|464355061|FG000|Overall Study|Lost to Follow-up|1|||
129016808|NCT00389064|464355062|FG001|Overall Study|Lost to Follow-up|2|||
129016809|NCT00389064|464355061|FG000|Overall Study|Protocol Violation|2|||
129016810|NCT00389064|464355062|FG001|Overall Study|Protocol Violation|0|||
129016811|NCT00389064|464355061|FG000|Overall Study|Multiple Reasons|9|||
129016812|NCT00389064|464355062|FG001|Overall Study|Multiple Reasons|11|||
129016813|NCT01387737|464356437|FG000|Overall Study|Adverse Event|20|||
129016814|NCT01387737|464356438|FG001|Overall Study|Adverse Event|30|||
128880759|NCT00250679|463858424|FG002|Overall Study|Non-compliance|0|||
128880760|NCT00250679|463858422|FG000|Overall Study|various single events: hip surgery,diary|3|||
128880761|NCT00250679|463858423|FG001|Overall Study|various single events: hip surgery,diary|1|||
128880762|NCT00250679|463858424|FG002|Overall Study|various single events: hip surgery,diary|1|||
129016815|NCT01387737|464356437|FG000|Overall Study|Lack of Efficacy|1|||
129016816|NCT01387737|464356438|FG001|Overall Study|Lack of Efficacy|0|||
129016817|NCT01387737|464356437|FG000|Overall Study|Physician Decision|3|||
128880763|NCT00448279|463858425|FG000|Overall Study|Lost to Follow-up|2|||
128683132|NCT01975831|463138768|FG002|Overall Study|Physician Decision|0|||
128880764|NCT00448279|463858426|FG001|Overall Study|Lost to Follow-up|2|||
128880765|NCT00448279|463858425|FG000|Overall Study|Adverse Event|1|||
128880766|NCT00448279|463858426|FG001|Overall Study|Adverse Event|1|||
128880767|NCT00448279|463858425|FG000|Overall Study|Disease progression|16|||
129016818|NCT01387737|464356438|FG001|Overall Study|Physician Decision|10|||
129016819|NCT01387737|464356437|FG000|Overall Study|Withdrawal by Subject|27|||
129016820|NCT01387737|464356438|FG001|Overall Study|Withdrawal by Subject|31|||
129016821|NCT01387737|464356437|FG000|Overall Study|Clearly not eligible for the study|1|||
129016822|NCT01387737|464356438|FG001|Overall Study|Clearly not eligible for the study|3|||
129104727|NCT02137226|464677262|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
129104728|NCT02137226|464677258|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
129104729|NCT02137226|464677259|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
129104730|NCT02137226|464677260|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
129104731|NCT02137226|464677261|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
129104732|NCT02137226|464677262|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
129104733|NCT02137226|464677258|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
129104734|NCT02137226|464677259|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
129104735|NCT02137226|464677260|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
129104736|NCT02137226|464677261|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
128683133|NCT01975831|463138769|FG003|Overall Study|Physician Decision|0|||
128683134|NCT01975831|463138770|FG004|Overall Study|Physician Decision|0|||
128683135|NCT01975831|463138771|FG005|Overall Study|Physician Decision|1|||
128683136|NCT01975831|463138772|FG006|Overall Study|Physician Decision|0|||
128683137|NCT01975831|463138773|FG007|Overall Study|Physician Decision|1|||
128683138|NCT01975831|463138774|FG008|Overall Study|Physician Decision|0|||
129104737|NCT02137226|464677262|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
129104738|NCT02137226|464677258|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
129104739|NCT02137226|464677259|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
129104740|NCT02137226|464677260|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
129104741|NCT02137226|464677261|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
129104742|NCT02137226|464677262|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
129104743|NCT02137226|464677258|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
129104744|NCT02137226|464677259|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
129104745|NCT02137226|464677260|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
129104746|NCT02137226|464677261|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
129104747|NCT02137226|464677262|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
129104748|NCT02137226|464677258|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129104749|NCT02137226|464677259|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129104750|NCT02137226|464677260|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
129104751|NCT02137226|464677261|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129104752|NCT02137226|464677262|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129104753|NCT02137226|464677258|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129104754|NCT02137226|464677259|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129104755|NCT02137226|464677260|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
129104756|NCT02137226|464677261|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129104757|NCT02137226|464677262|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129104758|NCT02137226|464677258|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
129104759|NCT02137226|464677259|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
129104760|NCT02137226|464677260|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
129104761|NCT02137226|464677261|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
129104762|NCT02137226|464677262|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
129104763|NCT03148067|464677265|FG000|Overall Study|Lost to Follow-up|3|||
129104764|NCT03148067|464677265|FG000|Overall Study|Death|1|||
129104765|NCT05305989|464677270|FG000|Overall Study|Other|3|||
129104766|NCT05305989|464677271|FG001|Overall Study|Other|2|||
129104767|NCT05305989|464677272|FG002|Overall Study|Other|0|||
129104768|NCT05305989|464677270|FG000|Overall Study|Sponsor decision|2|||
128683139|NCT01975831|463138766|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
128763153|NCT00615264|463422750|FG000|Overall Study|Not defined|7|||
129104769|NCT05305989|464677271|FG001|Overall Study|Sponsor decision|1|||
129104770|NCT05305989|464677272|FG002|Overall Study|Sponsor decision|0|||
129104771|NCT05305989|464677270|FG000|Overall Study|Protocol Violation|0|||
129104772|NCT05305989|464677271|FG001|Overall Study|Protocol Violation|1|||
129104773|NCT05305989|464677272|FG002|Overall Study|Protocol Violation|0|||
129104774|NCT05305989|464677270|FG000|Overall Study|Investigator decision|1|||
129104775|NCT05305989|464677271|FG001|Overall Study|Investigator decision|2|||
129104776|NCT05305989|464677272|FG002|Overall Study|Investigator decision|0|||
129104777|NCT05305989|464677270|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
129104778|NCT05305989|464677271|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
129104779|NCT05305989|464677272|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
129104780|NCT05305989|464677270|FG000|Overall Study|Adverse Event|1|||
129104781|NCT05305989|464677271|FG001|Overall Study|Adverse Event|1|||
129104782|NCT05305989|464677272|FG002|Overall Study|Adverse Event|0|||
129104783|NCT05305989|464677270|FG000|Overall Study|Enrolled but never dosed|3|||
129104784|NCT05305989|464677271|FG001|Overall Study|Enrolled but never dosed|2|||
128683140|NCT01975831|463138767|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
128683141|NCT01975831|463138768|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
129104785|NCT05305989|464677272|FG002|Overall Study|Enrolled but never dosed|1|||
129104786|NCT03162328|464677273|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
129104787|NCT03162328|464677274|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
129104788|NCT03162328|464677275|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
128880768|NCT00448279|463858426|FG001|Overall Study|Disease progression|18|||
128880769|NCT00448279|463858425|FG000|Overall Study|Withdrawal by Subject|4|||
128880770|NCT00448279|463858426|FG001|Overall Study|Withdrawal by Subject|3|||
128880771|NCT00448279|463858425|FG000|Overall Study|Other|6|||
128880772|NCT00448279|463858426|FG001|Overall Study|Other|4|||
128880773|NCT00448279|463858425|FG000|Overall Study|Protocol Violation|0|||
128880774|NCT00448279|463858426|FG001|Overall Study|Protocol Violation|1|||
128880775|NCT01174160|463858427|FG000|Overall Study|Adverse Event|1|||
128880776|NCT01174160|463858428|FG001|Overall Study|Adverse Event|0|||
128880777|NCT01174160|463858427|FG000|Overall Study|Lost to Follow-up|1|||
128880778|NCT01174160|463858428|FG001|Overall Study|Lost to Follow-up|0|||
128880779|NCT01174160|463858427|FG000|Overall Study|Physician Decision|1|||
128880780|NCT01174160|463858428|FG001|Overall Study|Physician Decision|0|||
128880781|NCT01174160|463858427|FG000|Overall Study|Protocol Violation|4|||
128880782|NCT01174160|463858428|FG001|Overall Study|Protocol Violation|6|||
128880783|NCT01174160|463858427|FG000|Overall Study|Withdrawal by Subject|1|||
128880784|NCT01174160|463858428|FG001|Overall Study|Withdrawal by Subject|0|||
128880785|NCT00986674|463858429|FG000|Overall Study|Lack of Efficacy|28|||
128880786|NCT00986674|463858430|FG001|Overall Study|Lack of Efficacy|25|||
128880787|NCT00986674|463858431|FG002|Overall Study|Lack of Efficacy|23|||
128880788|NCT00986674|463858429|FG000|Overall Study|Adverse Event|4|||
128880789|NCT00986674|463858430|FG001|Overall Study|Adverse Event|8|||
128880790|NCT00986674|463858431|FG002|Overall Study|Adverse Event|9|||
128880791|NCT00986674|463858429|FG000|Overall Study|Death|5|||
128880792|NCT00986674|463858430|FG001|Overall Study|Death|0|||
128880793|NCT00986674|463858431|FG002|Overall Study|Death|4|||
128880794|NCT00986674|463858429|FG000|Overall Study|Withdrawal by Subject|6|||
128880795|NCT00986674|463858430|FG001|Overall Study|Withdrawal by Subject|2|||
128880796|NCT00986674|463858431|FG002|Overall Study|Withdrawal by Subject|1|||
128880797|NCT00986674|463858429|FG000|Overall Study|alternative therapy|0|||
128880798|NCT00986674|463858430|FG001|Overall Study|alternative therapy|0|||
128880799|NCT00986674|463858431|FG002|Overall Study|alternative therapy|1|||
128880800|NCT00986674|463858429|FG000|Overall Study|not start protocol therapy|4|||
128880801|NCT00986674|463858430|FG001|Overall Study|not start protocol therapy|3|||
128880802|NCT00986674|463858431|FG002|Overall Study|not start protocol therapy|1|||
128880803|NCT00986674|463858429|FG000|Overall Study|unknown/not specify|0|||
128880804|NCT00986674|463858430|FG001|Overall Study|unknown/not specify|7|||
128880805|NCT00986674|463858431|FG002|Overall Study|unknown/not specify|9|||
128880806|NCT02128542|463858432|FG000|Overall Study|Lost to Follow-up|3|||
128880807|NCT02128542|463858433|FG001|Overall Study|Lost to Follow-up|0|||
128880808|NCT02128542|463858432|FG000|Overall Study|Withdrew Consent|1|||
128880809|NCT02128542|463858433|FG001|Overall Study|Withdrew Consent|0|||
128880810|NCT01853137|463858434|FG000|Overall Study|Lost to Follow-up|4|||
128880811|NCT01853137|463858435|FG001|Overall Study|Lost to Follow-up|1|||
128880812|NCT01411215|463858436|FG000|Overall Study|Adverse Event|1|||
128880813|NCT01411215|463858437|FG001|Overall Study|Adverse Event|2|||
128880814|NCT01411215|463858436|FG000|Overall Study|Lack of Efficacy|2|||
128880815|NCT01411215|463858437|FG001|Overall Study|Lack of Efficacy|4|||
129104789|NCT03162328|464677273|FG000|Screening Period|Withdrawal by Subject|1|||
129104790|NCT03162328|464677274|FG001|Screening Period|Withdrawal by Subject|0|||
128880816|NCT01411215|463858436|FG000|Overall Study|Lost to Follow-up|12|||
128880817|NCT01411215|463858437|FG001|Overall Study|Lost to Follow-up|18|||
128880818|NCT01411215|463858436|FG000|Overall Study|Did not meet entrance criteria|0|||
128880819|NCT01411215|463858437|FG001|Overall Study|Did not meet entrance criteria|1|||
128880820|NCT01411215|463858436|FG000|Overall Study|Study terminated by sponsor|2|||
128880821|NCT01411215|463858437|FG001|Overall Study|Study terminated by sponsor|15|||
128880822|NCT01411215|463858436|FG000|Overall Study|Protocol Violation|3|||
128880823|NCT01411215|463858437|FG001|Overall Study|Protocol Violation|5|||
128880824|NCT01411215|463858436|FG000|Overall Study|Withdrawal by Subject|34|||
128880825|NCT01411215|463858437|FG001|Overall Study|Withdrawal by Subject|21|||
128880826|NCT01411215|463858436|FG000|Overall Study|Other|12|||
128880827|NCT01411215|463858437|FG001|Overall Study|Other|17|||
128880828|NCT01411215|463858436|FG000|Overall Study|Screen failure|0|||
128880829|NCT01411215|463858437|FG001|Overall Study|Screen failure|1|||
128880830|NCT00848926|463858438|FG000|Treatment Period|Progressive disease|45|||
128880831|NCT00848926|463858438|FG000|Treatment Period|Adverse Event|20|||
128880832|NCT00848926|463858438|FG000|Treatment Period|Physician Decision|12|||
128880833|NCT00848926|463858438|FG000|Treatment Period|Withdrawal by Subject|7|||
128880834|NCT00848926|463858438|FG000|Follow-up Period|Lost to Follow-up|7|||
128880835|NCT00848926|463858438|FG000|Follow-up Period|Withdrawal by Subject|3|||
128880836|NCT00848926|463858438|FG000|Follow-up Period|Other|2|||
128880837|NCT04025580|463858439|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
128763154|NCT00615264|463422751|FG001|Overall Study|Not defined|4|||
128880838|NCT04025580|463858440|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
128880839|NCT04025580|463858441|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
128880840|NCT04507126|463858444|FG000|Overall Study|Withdrawal by Subject|1|||
128880841|NCT04507126|463858444|FG000|Overall Study|Protocol Violation|2|||
128880842|NCT04507126|463858444|FG000|Overall Study|Physician Decision|1|||
128880843|NCT02924064|463858445|FG000|Overall Study|Adverse Event|2|||
128880844|NCT02924064|463858446|FG001|Overall Study|Adverse Event|2|||
128880845|NCT02924064|463858445|FG000|Overall Study|Lost to Follow-up|0|||
128683142|NCT01975831|463138769|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
128880846|NCT02924064|463858446|FG001|Overall Study|Lost to Follow-up|2|||
128880847|NCT02924064|463858445|FG000|Overall Study|Physician Decision|0|||
128880848|NCT02924064|463858446|FG001|Overall Study|Physician Decision|2|||
128880849|NCT02924064|463858445|FG000|Overall Study|Protocol Violation|1|||
128880850|NCT02924064|463858446|FG001|Overall Study|Protocol Violation|3|||
128880851|NCT02924064|463858445|FG000|Overall Study|Withdrawal by Subject|4|||
128880852|NCT02924064|463858446|FG001|Overall Study|Withdrawal by Subject|5|||
128880853|NCT02924064|463858445|FG000|Overall Study|Other|17|||
128880854|NCT02924064|463858446|FG001|Overall Study|Other|29|||
128880855|NCT00966277|463858449|FG000|Overall Study|Withdrawal by Subject|3|||
128880856|NCT00966277|463858450|FG001|Overall Study|Withdrawal by Subject|0|||
128880857|NCT00966277|463858449|FG000|Overall Study|Ineligible|1|||
128880858|NCT00966277|463858450|FG001|Overall Study|Ineligible|3|||
128880859|NCT00966277|463858449|FG000|Overall Study|Treatment Plan Changed|0|||
128880860|NCT00966277|463858450|FG001|Overall Study|Treatment Plan Changed|1|||
128880861|NCT00138671|463858451|FG000|Overall Study|Death|0|||
128880862|NCT00138671|463858452|FG001|Overall Study|Death|3|||
128880863|NCT00138671|463858451|FG000|Overall Study|Adverse Event|6|||
128880864|NCT00138671|463858452|FG001|Overall Study|Adverse Event|3|||
128880865|NCT00138671|463858451|FG000|Overall Study|Lost to Follow-up|1|||
128880866|NCT00138671|463858452|FG001|Overall Study|Lost to Follow-up|2|||
128880867|NCT00138671|463858451|FG000|Overall Study|Withdrawal by Subject|3|||
128880868|NCT00138671|463858452|FG001|Overall Study|Withdrawal by Subject|5|||
128880869|NCT00138671|463858451|FG000|Overall Study|Other|3|||
128880870|NCT00138671|463858452|FG001|Overall Study|Other|3|||
128880871|NCT01488487|463858453|FG000|Overall Study|Adverse Event|6|||
128880872|NCT01488487|463858453|FG000|Overall Study|Death|1|||
128880873|NCT01488487|463858453|FG000|Overall Study|Withdrawal by Subject|2|||
128880874|NCT01952054|463858454|FG000|Overall Study|Physician Decision|1|||
128880875|NCT01100034|463858455|FG000|Overall Study|Lost to Follow-up|11|||
128880876|NCT01100034|463858455|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
128880877|NCT01100034|463858455|FG000|Overall Study|Withdrawal by Subject|4|||
128683143|NCT01975831|463138770|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
128880878|NCT01100034|463858455|FG000|Overall Study|Sponsor decision|21|||
128880879|NCT01100034|463858455|FG000|Overall Study|Participated in another clinical trial|1|||
128880880|NCT01100034|463858455|FG000|Overall Study|Participants moved to another hospital|4|||
128880881|NCT01100034|463858455|FG000|Overall Study|Site closed due to non-responsiveness|1|||
128880882|NCT01831856|463858456|FG000|Overall Study|Adverse Event|5|||
128880883|NCT01831856|463858457|FG001|Overall Study|Adverse Event|8|||
128880884|NCT01831856|463858456|FG000|Overall Study|Lack of Efficacy|13|||
128880885|NCT01831856|463858457|FG001|Overall Study|Lack of Efficacy|11|||
128880886|NCT01831856|463858456|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
128880887|NCT01831856|463858457|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
128880888|NCT00836095|463858460|FG000|Overall Study|Physician Decision|0|||
128880889|NCT00836095|463858461|FG001|Overall Study|Physician Decision|3|||
128880890|NCT04620811|463858464|FG000|Overall Study|Withdrawal by Subject|18|||
128880891|NCT04620811|463858465|FG001|Overall Study|Withdrawal by Subject|15|||
128880892|NCT04620811|463858464|FG000|Overall Study|Adverse Event|6|||
128880893|NCT04620811|463858465|FG001|Overall Study|Adverse Event|11|||
128880894|NCT04620811|463858464|FG000|Overall Study|Lost to Follow-up|4|||
128880895|NCT04620811|463858465|FG001|Overall Study|Lost to Follow-up|8|||
129016823|NCT01215981|464356439|FG000|Overall Study|Physician Decision|0|||
129016824|NCT01215981|464356440|FG001|Overall Study|Physician Decision|1|||
129016825|NCT01215981|464356439|FG000|Overall Study|Protocol Violation|1|||
129016826|NCT01215981|464356440|FG001|Overall Study|Protocol Violation|0|||
129016827|NCT01215981|464356439|FG000|Overall Study|Withdrawal by Subject|1|||
129016828|NCT01215981|464356440|FG001|Overall Study|Withdrawal by Subject|0|||
129016829|NCT00840632|464356446|FG000|First Intervention|Withdrawal by Subject|0|||
129016830|NCT00840632|464356447|FG001|First Intervention|Withdrawal by Subject|1|||
129016831|NCT00840632|464356446|FG000|Washout|Withdrawal by Subject|1|||
129016832|NCT00840632|464356447|FG001|Washout|Withdrawal by Subject|1|||
129016833|NCT01725529|464356451|FG000|Overall Study|Adverse Event|1|||
129016834|NCT01725529|464356452|FG001|Overall Study|Adverse Event|0|||
129016835|NCT01725529|464356453|FG002|Overall Study|Adverse Event|0|||
129016836|NCT01725529|464356451|FG000|Overall Study|Lost to Follow-up|2|||
129016837|NCT01725529|464356452|FG001|Overall Study|Lost to Follow-up|1|||
129016838|NCT01725529|464356453|FG002|Overall Study|Lost to Follow-up|1|||
129016839|NCT01725529|464356451|FG000|Overall Study|Protocol Violation|0|||
129016840|NCT01725529|464356452|FG001|Overall Study|Protocol Violation|1|||
129016841|NCT01725529|464356453|FG002|Overall Study|Protocol Violation|1|||
128880896|NCT04620811|463858464|FG000|Overall Study|Physician Decision|1|||
129016842|NCT01725529|464356451|FG000|Overall Study|Withdrawal by Subject|12|||
129016843|NCT01725529|464356452|FG001|Overall Study|Withdrawal by Subject|14|||
129016844|NCT01725529|464356453|FG002|Overall Study|Withdrawal by Subject|8|||
129016845|NCT01948258|464356459|FG000|Overall Study|Pregnancy|41|||
129016846|NCT01948258|464356459|FG000|Overall Study|Did not complete by cut-off date|35|||
129016847|NCT01948258|464356459|FG000|Overall Study|Lost to Follow-up|27|||
129016848|NCT01948258|464356459|FG000|Overall Study|Withdrawal by SPD|8|||
129016849|NCT01948258|464356459|FG000|Overall Study|Withdrawal by Subject|6|||
129016850|NCT01948258|464356459|FG000|Overall Study|Health Care Professional|43|||
129016851|NCT01948258|464356459|FG000|Overall Study|Removed from statistical analysis|2|||
129016852|NCT01811953|464356460|FG000|Overall Study|Adverse Event|0|||
129016853|NCT01811953|464356461|FG001|Overall Study|Adverse Event|0|||
129016854|NCT01811953|464356462|FG002|Overall Study|Adverse Event|0|||
129016855|NCT01811953|464356463|FG003|Overall Study|Adverse Event|1|||
129016856|NCT01811953|464356464|FG004|Overall Study|Adverse Event|0|||
129016857|NCT01811953|464356465|FG005|Overall Study|Adverse Event|1|||
129016858|NCT01811953|464356460|FG000|Overall Study|Protocol Violation|0|||
129016859|NCT01811953|464356461|FG001|Overall Study|Protocol Violation|0|||
129016860|NCT01811953|464356462|FG002|Overall Study|Protocol Violation|0|||
129016861|NCT01811953|464356463|FG003|Overall Study|Protocol Violation|0|||
129016862|NCT01811953|464356464|FG004|Overall Study|Protocol Violation|1|||
129016863|NCT01811953|464356465|FG005|Overall Study|Protocol Violation|0|||
129016864|NCT02262377|464356467|FG000|Overall Study|Lost to Follow-up|5|||
129016865|NCT02262377|464356468|FG001|Overall Study|Lost to Follow-up|6|||
129016866|NCT02262377|464356467|FG000|Overall Study|Found ineligible after enrollment|3|||
129016867|NCT02262377|464356468|FG001|Overall Study|Found ineligible after enrollment|0|||
129016868|NCT02262377|464356467|FG000|Overall Study|Withdrawal by Subject|4|||
129016869|NCT02262377|464356468|FG001|Overall Study|Withdrawal by Subject|0|||
129016870|NCT00371839|464356470|FG000|Overall Study|Death|4|||
129016871|NCT00371839|464356471|FG001|Overall Study|Death|0|||
129016872|NCT00371839|464356472|FG002|Overall Study|Death|0|||
129016873|NCT00371839|464356470|FG000|Overall Study|Withdrawal by Subject|7|||
129016874|NCT00371839|464356471|FG001|Overall Study|Withdrawal by Subject|4|||
129016875|NCT00371839|464356472|FG002|Overall Study|Withdrawal by Subject|0|||
129016876|NCT00371839|464356470|FG000|Overall Study|Lost to Follow-up|6|||
129016877|NCT00371839|464356471|FG001|Overall Study|Lost to Follow-up|3|||
129016878|NCT00371839|464356472|FG002|Overall Study|Lost to Follow-up|2|||
129016879|NCT00723528|464356473|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
129016880|NCT00723528|464356474|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
129016881|NCT00723528|464356475|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
129016882|NCT00723528|464356476|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
129016883|NCT00723528|464356477|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
129016884|NCT00723528|464356478|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
129016885|NCT00723528|464356479|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
129016886|NCT00723528|464356473|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
129016887|NCT00723528|464356474|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129016888|NCT00723528|464356475|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129016889|NCT00723528|464356476|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129016890|NCT00723528|464356477|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129016891|NCT00723528|464356478|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129016892|NCT00723528|464356479|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129016893|NCT00723528|464356473|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
129016894|NCT00723528|464356474|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
129016895|NCT00723528|464356475|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
129016896|NCT00723528|464356476|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
129016897|NCT00723528|464356477|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
129016898|NCT00723528|464356478|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
129016899|NCT00723528|464356479|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
129016900|NCT00723528|464356473|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129016901|NCT00723528|464356474|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129016902|NCT00723528|464356475|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
129016903|NCT00723528|464356476|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129016904|NCT00723528|464356477|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129016905|NCT00723528|464356478|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129016906|NCT00723528|464356479|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129016907|NCT00723528|464356473|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
129016908|NCT00723528|464356474|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129016909|NCT00723528|464356475|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
129016910|NCT00723528|464356476|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129016911|NCT00723528|464356477|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129016912|NCT00723528|464356478|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129016913|NCT00723528|464356479|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129016914|NCT00723528|464356473|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
129016915|NCT00723528|464356474|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
128880897|NCT04620811|463858465|FG001|Overall Study|Physician Decision|4|||
128880898|NCT04620811|463858464|FG000|Overall Study|Sponsor Decision|0|||
128880899|NCT04620811|463858465|FG001|Overall Study|Sponsor Decision|1|||
128880900|NCT04620811|463858464|FG000|Overall Study|Elevation of ALT or AST|1|||
128880901|NCT04620811|463858465|FG001|Overall Study|Elevation of ALT or AST|0|||
128880902|NCT04620811|463858464|FG000|Overall Study|Other|3|||
128880903|NCT04620811|463858465|FG001|Overall Study|Other|5|||
128880904|NCT01078675|463858466|FG000|Overall Study|Withdrawal by Subject|7|||
128880905|NCT01078675|463858467|FG001|Overall Study|Withdrawal by Subject|3|||
129016916|NCT00723528|464356475|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
129016917|NCT00723528|464356476|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
129016918|NCT00723528|464356477|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
129016919|NCT00723528|464356478|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
129016920|NCT00723528|464356479|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
129016921|NCT00723528|464356473|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129016922|NCT00723528|464356474|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129016923|NCT00723528|464356475|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129016924|NCT00723528|464356476|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129016925|NCT00723528|464356477|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129016926|NCT00723528|464356478|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
129016927|NCT00723528|464356479|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129016928|NCT00723528|464356473|FG000|Period 2: After Controlled Period|Other|0|||
129016929|NCT00723528|464356474|FG001|Period 2: After Controlled Period|Other|0|||
129016930|NCT00723528|464356475|FG002|Period 2: After Controlled Period|Other|0|||
129016931|NCT00723528|464356476|FG003|Period 2: After Controlled Period|Other|0|||
129016932|NCT00723528|464356477|FG004|Period 2: After Controlled Period|Other|1|||
129016933|NCT00723528|464356478|FG005|Period 2: After Controlled Period|Other|4|||
129016934|NCT00723528|464356479|FG006|Period 2: After Controlled Period|Other|0|||
129016935|NCT00723528|464356473|FG000|Period 2: After Controlled Period|Adverse Event|0|||
129016936|NCT00723528|464356474|FG001|Period 2: After Controlled Period|Adverse Event|0|||
129016937|NCT00723528|464356475|FG002|Period 2: After Controlled Period|Adverse Event|0|||
129016938|NCT00723528|464356476|FG003|Period 2: After Controlled Period|Adverse Event|0|||
129016939|NCT00723528|464356477|FG004|Period 2: After Controlled Period|Adverse Event|1|||
129016940|NCT00723528|464356478|FG005|Period 2: After Controlled Period|Adverse Event|0|||
129016941|NCT00723528|464356479|FG006|Period 2: After Controlled Period|Adverse Event|1|||
129016942|NCT00723528|464356473|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129016943|NCT00723528|464356474|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129016944|NCT00723528|464356475|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129016945|NCT00723528|464356476|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129016946|NCT00723528|464356477|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129016947|NCT00723528|464356478|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129016948|NCT00723528|464356479|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
129016949|NCT00723528|464356473|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129016950|NCT00723528|464356474|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129016951|NCT00723528|464356475|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129016952|NCT00723528|464356476|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129016953|NCT00723528|464356477|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129016954|NCT00723528|464356478|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129016955|NCT00723528|464356479|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
129016956|NCT01993030|464356480|FG000|Overall Study|Adverse Event|0|||
129016957|NCT01993030|464356481|FG001|Overall Study|Adverse Event|4|||
129016958|NCT01710657|464356482|FG000|Overall Study|Lost to Follow-up|2|||
129016959|NCT01710657|464356483|FG001|Overall Study|Lost to Follow-up|0|||
129016960|NCT01710657|464356484|FG002|Overall Study|Lost to Follow-up|1|||
129016961|NCT01710657|464356482|FG000|Overall Study|Protocol Violation|2|||
129016962|NCT01710657|464356483|FG001|Overall Study|Protocol Violation|2|||
129016963|NCT01710657|464356484|FG002|Overall Study|Protocol Violation|0|||
129016964|NCT01710657|464356482|FG000|Overall Study|Adverse Event|14|||
129016965|NCT01710657|464356483|FG001|Overall Study|Adverse Event|8|||
129016966|NCT01710657|464356484|FG002|Overall Study|Adverse Event|28|||
129016967|NCT01710657|464356482|FG000|Overall Study|Withdrawal by Subject|0|||
129016968|NCT01710657|464356483|FG001|Overall Study|Withdrawal by Subject|1|||
129016969|NCT01710657|464356484|FG002|Overall Study|Withdrawal by Subject|2|||
129016970|NCT01710657|464356482|FG000|Overall Study|Lack of Efficacy|0|||
129016971|NCT01710657|464356483|FG001|Overall Study|Lack of Efficacy|1|||
129016972|NCT01710657|464356484|FG002|Overall Study|Lack of Efficacy|1|||
129016973|NCT01591785|464356487|FG000|Overall Study|worsening condition|1|||
128880906|NCT01078675|463858466|FG000|Overall Study|Protocol Violation|56|||
128880907|NCT01078675|463858467|FG001|Overall Study|Protocol Violation|0|||
128880908|NCT01078675|463858466|FG000|Overall Study|Provided in CRF for specific reasons|2|||
128880909|NCT01078675|463858467|FG001|Overall Study|Provided in CRF for specific reasons|3|||
128880910|NCT01078675|463858466|FG000|Overall Study|Adverse Event|3|||
128880911|NCT01078675|463858467|FG001|Overall Study|Adverse Event|0|||
128880912|NCT01759368|463858470|FG000|Overall Study|Lost to Follow-up|1|||
128880913|NCT01759368|463858471|FG001|Overall Study|Lost to Follow-up|0|||
128880914|NCT01191268|463858472|FG000|Overall Study|Withdrawal by Subject|19|||
128880915|NCT01191268|463858473|FG001|Overall Study|Withdrawal by Subject|25|||
128880916|NCT01191268|463858474|FG002|Overall Study|Withdrawal by Subject|21|||
128880917|NCT01191268|463858472|FG000|Overall Study|Adverse Event|21|||
128880918|NCT01191268|463858473|FG001|Overall Study|Adverse Event|13|||
128880919|NCT01191268|463858474|FG002|Overall Study|Adverse Event|8|||
128880920|NCT01191268|463858472|FG000|Overall Study|Physician Decision|6|||
128880921|NCT01191268|463858473|FG001|Overall Study|Physician Decision|8|||
128880922|NCT01191268|463858474|FG002|Overall Study|Physician Decision|9|||
128880923|NCT01191268|463858472|FG000|Overall Study|Lost to Follow-up|8|||
128880924|NCT01191268|463858473|FG001|Overall Study|Lost to Follow-up|5|||
128880925|NCT01191268|463858474|FG002|Overall Study|Lost to Follow-up|9|||
128880926|NCT01191268|463858472|FG000|Overall Study|Entry Criteria Not Met|3|||
128880927|NCT01191268|463858473|FG001|Overall Study|Entry Criteria Not Met|1|||
128880928|NCT01191268|463858474|FG002|Overall Study|Entry Criteria Not Met|1|||
128880929|NCT01191268|463858472|FG000|Overall Study|Death|0|||
128880930|NCT01191268|463858473|FG001|Overall Study|Death|1|||
128880931|NCT01191268|463858474|FG002|Overall Study|Death|3|||
128880932|NCT01191268|463858472|FG000|Overall Study|Protocol Violation|1|||
128880933|NCT01191268|463858473|FG001|Overall Study|Protocol Violation|0|||
128880934|NCT01191268|463858474|FG002|Overall Study|Protocol Violation|1|||
128880935|NCT01191268|463858472|FG000|Overall Study|Sponsor Decision|0|||
128880936|NCT01191268|463858473|FG001|Overall Study|Sponsor Decision|2|||
128880937|NCT01191268|463858474|FG002|Overall Study|Sponsor Decision|0|||
128880938|NCT02294227|463858477|FG000|Overall Study|Death|0|||
128880939|NCT02294227|463858478|FG001|Overall Study|Death|0|||
128880940|NCT02294227|463858479|FG002|Overall Study|Death|1|||
128880941|NCT02294227|463858477|FG000|Overall Study|Subject/Guardian Decision|6|||
128880942|NCT02294227|463858478|FG001|Overall Study|Subject/Guardian Decision|3|||
128880943|NCT02294227|463858479|FG002|Overall Study|Subject/Guardian Decision|7|||
128880944|NCT02294227|463858477|FG000|Overall Study|Physician Decision|1|||
128880945|NCT02294227|463858478|FG001|Overall Study|Physician Decision|2|||
128880946|NCT02294227|463858479|FG002|Overall Study|Physician Decision|1|||
128880947|NCT02294227|463858477|FG000|Overall Study|Lost to Follow-up|1|||
128880948|NCT02294227|463858478|FG001|Overall Study|Lost to Follow-up|0|||
128880949|NCT02294227|463858479|FG002|Overall Study|Lost to Follow-up|0|||
128880950|NCT02294227|463858477|FG000|Overall Study|Lack of Efficacy|11|||
128880951|NCT02294227|463858478|FG001|Overall Study|Lack of Efficacy|12|||
128880952|NCT02294227|463858479|FG002|Overall Study|Lack of Efficacy|8|||
128880953|NCT02294227|463858477|FG000|Overall Study|Adverse Event|6|||
128880954|NCT02294227|463858478|FG001|Overall Study|Adverse Event|8|||
128880955|NCT02294227|463858479|FG002|Overall Study|Adverse Event|2|||
128880956|NCT01768637|463858482|FG000|Overall Study|Lost to Follow-up|2|||
128880957|NCT01768637|463858483|FG001|Overall Study|Lost to Follow-up|7|||
128880958|NCT01768637|463858482|FG000|Overall Study|Difficult blood draw|1|||
128880959|NCT01768637|463858483|FG001|Overall Study|Difficult blood draw|0|||
128880960|NCT00887432|463858484|FG000|Overall Study|Start Excluded Therapy|3|||
128880961|NCT00887432|463858485|FG001|Overall Study|Start Excluded Therapy|0|||
128880962|NCT00887432|463858484|FG000|Overall Study|Did not complete treatment|6|||
128880963|NCT00887432|463858485|FG001|Overall Study|Did not complete treatment|8|||
128880964|NCT00887432|463858484|FG000|Overall Study|Protocol Violation|2|||
128880965|NCT00887432|463858485|FG001|Overall Study|Protocol Violation|3|||
128880966|NCT00887432|463858484|FG000|Overall Study|Withdrawal by Subject|3|||
129016974|NCT01591785|464356488|FG001|Overall Study|worsening condition|2|||
129016975|NCT01591785|464356487|FG000|Overall Study|Protocol Violation|2|||
128880967|NCT00887432|463858485|FG001|Overall Study|Withdrawal by Subject|2|||
128880968|NCT00887432|463858484|FG000|Overall Study|Lost to Follow-up|1|||
128880969|NCT00887432|463858485|FG001|Overall Study|Lost to Follow-up|0|||
128880970|NCT00887432|463858484|FG000|Overall Study|No reason provided|0|||
128880971|NCT00887432|463858485|FG001|Overall Study|No reason provided|1|||
128880972|NCT00899548|463858486|FG000|Overall Study|Physician Decision|3|||
128880973|NCT01636960|463858487|FG000|Induction Phase|Adverse Event|2|||
128880974|NCT01636960|463858487|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
128880975|NCT01636960|463858487|FG000|Maintenance Phase|Adverse Event|3|||
128880976|NCT01636960|463858487|FG000|Maintenance Phase|Progressive disease|1|||
128880977|NCT01209780|463858488|FG000|Overall Study|Adverse Event|0|||
128880978|NCT01209780|463858489|FG001|Overall Study|Adverse Event|1|||
128880979|NCT01209780|463858490|FG002|Overall Study|Adverse Event|0|||
128880980|NCT01209780|463858491|FG003|Overall Study|Adverse Event|0|||
128880981|NCT01209780|463858492|FG004|Overall Study|Adverse Event|0|||
128880982|NCT01209780|463858488|FG000|Overall Study|Withdrawal by Subject|9|||
128880983|NCT01209780|463858489|FG001|Overall Study|Withdrawal by Subject|2|||
128880984|NCT01209780|463858490|FG002|Overall Study|Withdrawal by Subject|1|||
128880985|NCT01209780|463858491|FG003|Overall Study|Withdrawal by Subject|1|||
128880986|NCT01209780|463858492|FG004|Overall Study|Withdrawal by Subject|0|||
128880987|NCT01209780|463858488|FG000|Overall Study|Lost to Follow-up|17|||
128880988|NCT01209780|463858489|FG001|Overall Study|Lost to Follow-up|12|||
128880989|NCT01209780|463858490|FG002|Overall Study|Lost to Follow-up|3|||
128880990|NCT01209780|463858491|FG003|Overall Study|Lost to Follow-up|9|||
128880991|NCT01209780|463858492|FG004|Overall Study|Lost to Follow-up|4|||
128880992|NCT01209780|463858488|FG000|Overall Study|Protocol Violation|0|||
128880993|NCT01209780|463858489|FG001|Overall Study|Protocol Violation|1|||
128880994|NCT01209780|463858490|FG002|Overall Study|Protocol Violation|0|||
128880995|NCT01209780|463858491|FG003|Overall Study|Protocol Violation|0|||
128880996|NCT01209780|463858492|FG004|Overall Study|Protocol Violation|0|||
128880997|NCT01209780|463858488|FG000|Overall Study|Inappropriate enrollment|0|||
128880998|NCT01209780|463858489|FG001|Overall Study|Inappropriate enrollment|2|||
128880999|NCT01209780|463858490|FG002|Overall Study|Inappropriate enrollment|0|||
128881000|NCT01209780|463858491|FG003|Overall Study|Inappropriate enrollment|0|||
128881001|NCT01209780|463858492|FG004|Overall Study|Inappropriate enrollment|1|||
128881002|NCT00511472|463858493|FG000|Overall Study|Clinical Adverse Event|1|||
128881003|NCT00511472|463858494|FG001|Overall Study|Clinical Adverse Event|2|||
128881004|NCT00511472|463858493|FG000|Overall Study|Laboratory Adverse Event|0|||
128881005|NCT00511472|463858494|FG001|Overall Study|Laboratory Adverse Event|2|||
128881006|NCT00511472|463858493|FG000|Overall Study|Not reported|2|||
128881007|NCT00511472|463858494|FG001|Overall Study|Not reported|2|||
128881008|NCT02709096|463858495|FG000|Overall Study|non-compliance|1|||
128881009|NCT02709096|463858496|FG001|Overall Study|non-compliance|1|||
128881010|NCT00505284|463858497|FG000|Overall Study|Adverse Event|3|||
128881011|NCT00505284|463858498|FG001|Overall Study|Adverse Event|7|||
128881012|NCT00505284|463858499|FG002|Overall Study|Adverse Event|9|||
129104791|NCT03162328|464677275|FG002|Screening Period|Withdrawal by Subject|0|||
129104792|NCT03162328|464677273|FG000|Study Period|Withdrawal by Subject|0|||
129104793|NCT03162328|464677274|FG001|Study Period|Withdrawal by Subject|0|||
129104794|NCT03162328|464677275|FG002|Study Period|Withdrawal by Subject|1|||
129104795|NCT00492232|464677276|FG000|Placebo Run-in|Adverse Event|0|||
129104796|NCT00492232|464677277|FG001|Placebo Run-in|Adverse Event|2|||
129104797|NCT00492232|464677276|FG000|Placebo Run-in|Protocol Violation|0|||
129104798|NCT00492232|464677277|FG001|Placebo Run-in|Protocol Violation|3|||
129104799|NCT00492232|464677276|FG000|Placebo Run-in|Lost to Follow-up|0|||
129104800|NCT00492232|464677277|FG001|Placebo Run-in|Lost to Follow-up|3|||
129104801|NCT00492232|464677276|FG000|Placebo Run-in|Withdrawal by Subject|0|||
129016976|NCT01591785|464356488|FG001|Overall Study|Protocol Violation|0|||
129016977|NCT01591785|464356487|FG000|Overall Study|Lost to Follow-up|1|||
129016978|NCT01591785|464356488|FG001|Overall Study|Lost to Follow-up|0|||
129016979|NCT00909610|464356492|FG000|Period: First Intervention|Adverse Event|0|||
129016980|NCT00909610|464356493|FG001|Period: First Intervention|Adverse Event|1|||
129016981|NCT00909610|464356492|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
129016982|NCT00909610|464356493|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
129016983|NCT00909610|464356492|FG000|Period: Second Intervention|Adverse Event|1|||
129016984|NCT00909610|464356493|FG001|Period: Second Intervention|Adverse Event|0|||
129016985|NCT05612724|464356499|FG000|Overall Study|Lost to Follow-up|4|||
129016986|NCT02128997|464356501|FG000|Overall Study|Lost to Follow-up|6|||
129016987|NCT02128997|464356502|FG001|Overall Study|Lost to Follow-up|11|||
129016988|NCT04000815|464356505|FG000|Overall Study|Lost to Follow-up|9|||
129016989|NCT04000815|464356506|FG001|Overall Study|Lost to Follow-up|2|||
129016990|NCT04000815|464356507|FG002|Overall Study|Lost to Follow-up|3|||
129016991|NCT04000815|464356505|FG000|Overall Study|Withdrawal by Subject|4|||
129016992|NCT04000815|464356506|FG001|Overall Study|Withdrawal by Subject|3|||
129016993|NCT04000815|464356507|FG002|Overall Study|Withdrawal by Subject|2|||
129016994|NCT04000815|464356505|FG000|Overall Study|Right ovarian cyst occured|1|||
129016995|NCT04000815|464356506|FG001|Overall Study|Right ovarian cyst occured|0|||
129016996|NCT04000815|464356507|FG002|Overall Study|Right ovarian cyst occured|0|||
129016997|NCT04000815|464356505|FG000|Overall Study|Hypertension occured on follow up|0|||
129016998|NCT04000815|464356506|FG001|Overall Study|Hypertension occured on follow up|0|||
129016999|NCT04000815|464356507|FG002|Overall Study|Hypertension occured on follow up|2|||
129017000|NCT00239577|464356508|FG000|Primary Phase|Adverse Event|0|||
129017001|NCT00239577|464356509|FG001|Primary Phase|Adverse Event|0|||
129104802|NCT00492232|464677277|FG001|Placebo Run-in|Withdrawal by Subject|8|||
128881013|NCT00505284|463858500|FG003|Overall Study|Adverse Event|14|||
128881014|NCT00505284|463858501|FG004|Overall Study|Adverse Event|22|||
128881015|NCT00505284|463858497|FG000|Overall Study|Protocol Violation|0|||
128881016|NCT00505284|463858498|FG001|Overall Study|Protocol Violation|1|||
129017002|NCT00239577|464356510|FG002|Primary Phase|Adverse Event|1|||
128881017|NCT00505284|463858499|FG002|Overall Study|Protocol Violation|1|||
128881018|NCT00505284|463858500|FG003|Overall Study|Protocol Violation|0|||
128881019|NCT00505284|463858501|FG004|Overall Study|Protocol Violation|0|||
129017003|NCT00239577|464356511|FG003|Primary Phase|Adverse Event|0|||
129017004|NCT00239577|464356508|FG000|Primary Phase|Other|5|||
129017005|NCT00239577|464356509|FG001|Primary Phase|Other|3|||
129104803|NCT00492232|464677276|FG000|Placebo Run-in|Pregnancy|0|||
129104804|NCT00492232|464677277|FG001|Placebo Run-in|Pregnancy|1|||
129104805|NCT00492232|464677276|FG000|Placebo Run-in|Entrance criteria not met|0|||
128881020|NCT00505284|463858497|FG000|Overall Study|Withdrawal by Subject|2|||
128881021|NCT00505284|463858498|FG001|Overall Study|Withdrawal by Subject|6|||
128881022|NCT00505284|463858499|FG002|Overall Study|Withdrawal by Subject|1|||
128881023|NCT00505284|463858500|FG003|Overall Study|Withdrawal by Subject|0|||
128881024|NCT00505284|463858501|FG004|Overall Study|Withdrawal by Subject|6|||
128881025|NCT00505284|463858497|FG000|Overall Study|Lack of Efficacy|0|||
128881026|NCT00505284|463858498|FG001|Overall Study|Lack of Efficacy|1|||
128881027|NCT00505284|463858499|FG002|Overall Study|Lack of Efficacy|1|||
128881028|NCT00505284|463858500|FG003|Overall Study|Lack of Efficacy|1|||
128881029|NCT00505284|463858501|FG004|Overall Study|Lack of Efficacy|1|||
128881030|NCT00505284|463858497|FG000|Overall Study|Physician Decision|0|||
128881031|NCT00505284|463858498|FG001|Overall Study|Physician Decision|1|||
128881032|NCT00505284|463858499|FG002|Overall Study|Physician Decision|0|||
128881033|NCT00505284|463858500|FG003|Overall Study|Physician Decision|0|||
128881034|NCT00505284|463858501|FG004|Overall Study|Physician Decision|0|||
128881035|NCT00505284|463858497|FG000|Overall Study|Other|5|||
128881036|NCT00505284|463858498|FG001|Overall Study|Other|0|||
128881037|NCT00505284|463858499|FG002|Overall Study|Other|0|||
128881038|NCT00505284|463858500|FG003|Overall Study|Other|4|||
128881039|NCT00505284|463858501|FG004|Overall Study|Other|4|||
128881040|NCT00731120|463858502|FG000|Overall Study|Adverse Event|7|||
128881041|NCT00731120|463858503|FG001|Overall Study|Adverse Event|6|||
128881042|NCT00731120|463858504|FG002|Overall Study|Adverse Event|8|||
128881043|NCT00731120|463858502|FG000|Overall Study|Lack of Efficacy|4|||
128881044|NCT00731120|463858503|FG001|Overall Study|Lack of Efficacy|5|||
128881045|NCT00731120|463858504|FG002|Overall Study|Lack of Efficacy|4|||
128881046|NCT00731120|463858502|FG000|Overall Study|Noncompliance with Study Drug|3|||
128881047|NCT00731120|463858503|FG001|Overall Study|Noncompliance with Study Drug|3|||
128881048|NCT00731120|463858504|FG002|Overall Study|Noncompliance with Study Drug|1|||
128881049|NCT00731120|463858502|FG000|Overall Study|Protocol Deviations|1|||
128881050|NCT00731120|463858503|FG001|Overall Study|Protocol Deviations|6|||
128881051|NCT00731120|463858504|FG002|Overall Study|Protocol Deviations|1|||
128881052|NCT00731120|463858502|FG000|Overall Study|Withdrawal of Consent|13|||
128881053|NCT00731120|463858503|FG001|Overall Study|Withdrawal of Consent|8|||
128881054|NCT00731120|463858504|FG002|Overall Study|Withdrawal of Consent|4|||
128881055|NCT00731120|463858502|FG000|Overall Study|Lost to Follow-up|10|||
128881056|NCT00731120|463858503|FG001|Overall Study|Lost to Follow-up|15|||
128881057|NCT00731120|463858504|FG002|Overall Study|Lost to Follow-up|17|||
128881058|NCT00731120|463858502|FG000|Overall Study|Other|4|||
128881059|NCT00731120|463858503|FG001|Overall Study|Other|0|||
128881060|NCT00731120|463858504|FG002|Overall Study|Other|1|||
128881061|NCT01551212|463858508|FG000|Overall Study|Graft loss/Retransplantation|0|||
128881062|NCT01551212|463858509|FG001|Overall Study|Graft loss/Retransplantation|1|||
128881063|NCT01551212|463858508|FG000|Overall Study|Administrative problems|1|||
128881064|NCT01551212|463858509|FG001|Overall Study|Administrative problems|2|||
128881065|NCT01551212|463858508|FG000|Overall Study|Lost to Follow-up|0|||
128881066|NCT01551212|463858509|FG001|Overall Study|Lost to Follow-up|1|||
128881067|NCT01551212|463858508|FG000|Overall Study|Protocol Violation|0|||
128881068|NCT01551212|463858509|FG001|Overall Study|Protocol Violation|1|||
128881069|NCT01551212|463858508|FG000|Overall Study|Withdrawal by Subject|0|||
128881070|NCT01551212|463858509|FG001|Overall Study|Withdrawal by Subject|7|||
128881071|NCT01551212|463858508|FG000|Overall Study|Death|2|||
128881072|NCT01551212|463858509|FG001|Overall Study|Death|4|||
128881073|NCT01551212|463858508|FG000|Overall Study|Never Received Study Treatment|2|||
128881074|NCT01551212|463858509|FG001|Overall Study|Never Received Study Treatment|4|||
128881075|NCT00705523|463858510|FG000|Overall Study|Lost to Follow-up|2|||
128881076|NCT00705523|463858511|FG001|Overall Study|Lost to Follow-up|3|||
128881077|NCT01013285|463858512|FG000|Overall Study|Death|48|||
128881078|NCT01013285|463858513|FG001|Overall Study|Death|89|||
128881079|NCT01575028|463858514|FG000|Overall Study|Physician Decision|0|||
128881080|NCT01575028|463858515|FG001|Overall Study|Physician Decision|1|||
128881081|NCT03534284|463858518|FG000|Overall Study|Death|2|||
128881082|NCT03534284|463858519|FG001|Overall Study|Death|3|||
129017006|NCT00239577|464356510|FG002|Primary Phase|Other|2|||
129017007|NCT00239577|464356511|FG003|Primary Phase|Other|0|||
129017008|NCT03988803|464356514|FG000|Period 2|Prematurely discontinued from medication|2|||
128683144|NCT01975831|463138771|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
128683145|NCT01975831|463138772|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
128881083|NCT03534284|463858520|FG002|Overall Study|Death|3|||
129017009|NCT03988803|464356514|FG000|Period 2|Adverse Event|1|||
128683146|NCT01975831|463138773|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
128881084|NCT03534284|463858518|FG000|Overall Study|Withdrawal by Subject|5|||
128881085|NCT03534284|463858519|FG001|Overall Study|Withdrawal by Subject|0|||
128881086|NCT03534284|463858520|FG002|Overall Study|Withdrawal by Subject|0|||
128881087|NCT04737187|463858522|FG000|Overall Study|Switched to marketed drug|32|||
128881088|NCT04737187|463858523|FG001|Overall Study|Switched to marketed drug|4|||
128881089|NCT04737187|463858522|FG000|Overall Study|Radiological Progressive Disease|145|||
128881090|NCT04737187|463858523|FG001|Overall Study|Radiological Progressive Disease|146|||
129017010|NCT02736721|464356515|FG000|Overall Study|Adverse Event|8|||
128881091|NCT04737187|463858522|FG000|Overall Study|Clinical Progressive Disease|20|||
128881092|NCT04737187|463858523|FG001|Overall Study|Clinical Progressive Disease|20|||
128881093|NCT04737187|463858522|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
128881094|NCT04737187|463858523|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
128881095|NCT04737187|463858522|FG000|Overall Study|Adverse Event|16|||
128881096|NCT04737187|463858523|FG001|Overall Study|Adverse Event|16|||
128881097|NCT04737187|463858522|FG000|Overall Study|Physician Decision|2|||
128881098|NCT04737187|463858523|FG001|Overall Study|Physician Decision|0|||
128881099|NCT04737187|463858522|FG000|Overall Study|Withdrawal by Subject|5|||
128881100|NCT04737187|463858523|FG001|Overall Study|Withdrawal by Subject|8|||
128881101|NCT03756129|463858524|FG000|Overall Study|Adverse Event|1|||
128881102|NCT03756129|463858525|FG001|Overall Study|Adverse Event|1|||
128881103|NCT03756129|463858526|FG002|Overall Study|Adverse Event|0|||
128881104|NCT03756129|463858527|FG003|Overall Study|Adverse Event|2|||
128881105|NCT03756129|463858528|FG004|Overall Study|Adverse Event|0|||
128881106|NCT03756129|463858529|FG005|Overall Study|Adverse Event|0|||
128881107|NCT03756129|463858524|FG000|Overall Study|Withdrawal by Subject|2|||
128881108|NCT03756129|463858525|FG001|Overall Study|Withdrawal by Subject|1|||
128881109|NCT03756129|463858526|FG002|Overall Study|Withdrawal by Subject|3|||
128881110|NCT03756129|463858527|FG003|Overall Study|Withdrawal by Subject|1|||
128881111|NCT03756129|463858528|FG004|Overall Study|Withdrawal by Subject|1|||
128881112|NCT03756129|463858529|FG005|Overall Study|Withdrawal by Subject|3|||
128881113|NCT03756129|463858524|FG000|Overall Study|Lost to Follow-up|0|||
128881114|NCT03756129|463858525|FG001|Overall Study|Lost to Follow-up|0|||
128881115|NCT03756129|463858526|FG002|Overall Study|Lost to Follow-up|0|||
128881116|NCT03756129|463858527|FG003|Overall Study|Lost to Follow-up|0|||
128881117|NCT03756129|463858528|FG004|Overall Study|Lost to Follow-up|0|||
128881118|NCT03756129|463858529|FG005|Overall Study|Lost to Follow-up|1|||
128881119|NCT03756129|463858524|FG000|Overall Study|Physician Decision|0|||
128881120|NCT03756129|463858525|FG001|Overall Study|Physician Decision|0|||
128881121|NCT03756129|463858526|FG002|Overall Study|Physician Decision|0|||
128881122|NCT03756129|463858527|FG003|Overall Study|Physician Decision|0|||
128881123|NCT03756129|463858528|FG004|Overall Study|Physician Decision|0|||
128881124|NCT03756129|463858529|FG005|Overall Study|Physician Decision|1|||
128881125|NCT03035201|463858530|FG000|Overall Study|Death|9|||
128881126|NCT03035201|463858531|FG001|Overall Study|Death|12|||
128881127|NCT03035201|463858532|FG002|Overall Study|Death|9|||
128881128|NCT03035201|463858533|FG003|Overall Study|Death|10|||
128881129|NCT03035201|463858530|FG000|Overall Study|Withdrawal by Subject|51|||
128881130|NCT03035201|463858531|FG001|Overall Study|Withdrawal by Subject|49|||
128881131|NCT03035201|463858532|FG002|Overall Study|Withdrawal by Subject|37|||
128881132|NCT03035201|463858533|FG003|Overall Study|Withdrawal by Subject|46|||
128881133|NCT03035201|463858530|FG000|Overall Study|Lost to Follow-up|67|||
128881134|NCT03035201|463858531|FG001|Overall Study|Lost to Follow-up|51|||
128881135|NCT03035201|463858532|FG002|Overall Study|Lost to Follow-up|64|||
128881136|NCT03035201|463858533|FG003|Overall Study|Lost to Follow-up|69|||
128881137|NCT03727438|463858539|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
128881138|NCT03727438|463858540|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
128881139|NCT03727438|463858539|FG000|Intervention Period|Excluded (health)|1|||
128881140|NCT03727438|463858540|FG001|Intervention Period|Excluded (health)|0|||
128881141|NCT03727438|463858539|FG000|Intervention Period|Withdrawal by Subject|3|||
128881142|NCT03727438|463858540|FG001|Intervention Period|Withdrawal by Subject|1|||
128881143|NCT03727438|463858539|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
128881144|NCT03727438|463858540|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
128881145|NCT03727438|463858539|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
128881146|NCT03727438|463858540|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
128881147|NCT03727438|463858539|FG000|8 Week Assessment|Withdrawal by Subject|6|||
128881148|NCT03727438|463858540|FG001|8 Week Assessment|Withdrawal by Subject|1|||
128881149|NCT03727438|463858539|FG000|6 mo Assessment|did not complete assessment|10|||
128881150|NCT03727438|463858540|FG001|6 mo Assessment|did not complete assessment|11|||
128881151|NCT01222507|463859901|FG000|Overall Study|Physician Decision|1|||
128881152|NCT01222507|463859901|FG000|Overall Study|Withdrawal by Subject|1|||
128881153|NCT02795429|463859902|FG000|Overall Study|Adverse Event|1|||
128881154|NCT02795429|463859903|FG001|Overall Study|Adverse Event|2|||
128881155|NCT02795429|463859904|FG002|Overall Study|Adverse Event|1|||
128881156|NCT02795429|463859905|FG003|Overall Study|Adverse Event|2|||
129017011|NCT02736721|464356515|FG000|Overall Study|Lost to Follow-up|3|||
128763155|NCT00615264|463422750|FG000|Overall Study|Dermal Hypersensitivity|0|||
128881157|NCT02795429|463859906|FG004|Overall Study|Adverse Event|1|||
129017012|NCT02736721|464356515|FG000|Overall Study|Other|5|||
128881158|NCT02795429|463859902|FG000|Overall Study|Death|1|||
128881159|NCT02795429|463859903|FG001|Overall Study|Death|0|||
128881160|NCT02795429|463859904|FG002|Overall Study|Death|1|||
128881161|NCT02795429|463859905|FG003|Overall Study|Death|2|||
128881162|NCT02795429|463859906|FG004|Overall Study|Death|1|||
128881163|NCT02795429|463859902|FG000|Overall Study|Physician Decision|0|||
129017013|NCT03021018|464356519|FG000|Overall Study|Adverse Event|1|||
128881164|NCT02795429|463859903|FG001|Overall Study|Physician Decision|0|||
128881165|NCT02795429|463859904|FG002|Overall Study|Physician Decision|2|||
128881166|NCT02795429|463859905|FG003|Overall Study|Physician Decision|1|||
128881167|NCT02795429|463859906|FG004|Overall Study|Physician Decision|5|||
128881168|NCT02795429|463859902|FG000|Overall Study|Progressive disease|3|||
128881169|NCT02795429|463859903|FG001|Overall Study|Progressive disease|7|||
128881170|NCT02795429|463859904|FG002|Overall Study|Progressive disease|6|||
128881171|NCT02795429|463859905|FG003|Overall Study|Progressive disease|26|||
128881172|NCT02795429|463859906|FG004|Overall Study|Progressive disease|20|||
128881173|NCT02795429|463859902|FG000|Overall Study|Subject/guardian decision|1|||
128881174|NCT02795429|463859903|FG001|Overall Study|Subject/guardian decision|1|||
128881175|NCT02795429|463859904|FG002|Overall Study|Subject/guardian decision|1|||
128881176|NCT02795429|463859905|FG003|Overall Study|Subject/guardian decision|1|||
128881177|NCT02795429|463859906|FG004|Overall Study|Subject/guardian decision|3|||
128881178|NCT01640054|463859909|FG000|Overall Study|Study-specific disc criteria|1|||
128881179|NCT01640054|463859909|FG000|Overall Study|Lack of Efficacy|3|||
128881180|NCT01640054|463859909|FG000|Overall Study|Adverse Event|2|||
128881181|NCT05220254|463859911|FG000|Overall Study|Withdrawal by Subject|4|||
128881182|NCT05220254|463859911|FG000|Overall Study|Removed due to ineligibility|1|||
128881183|NCT05220254|463859911|FG000|Overall Study|Lost to Follow-up|7|||
128881184|NCT02080221|463859912|FG000|Overall Study|Withdrawal by Subject|1|||
128881185|NCT02080221|463859912|FG000|Overall Study|Clinical Progression of Disease|1|||
128881186|NCT01386788|463859915|FG000|Overall Study|Lost to Follow-up|2|||
128881187|NCT00120406|463859916|FG000|Overall Study|Death|9|||
128881188|NCT00120406|463859917|FG001|Overall Study|Death|4|||
128881189|NCT00120406|463859916|FG000|Overall Study|Withdrawal by Subject|5|||
128881190|NCT00120406|463859917|FG001|Overall Study|Withdrawal by Subject|7|||
128881191|NCT00120406|463859916|FG000|Overall Study|Lost to Follow-up|5|||
128881192|NCT00120406|463859917|FG001|Overall Study|Lost to Follow-up|2|||
128881193|NCT00120406|463859916|FG000|Overall Study|received non-study stent|0|||
128881194|NCT00120406|463859917|FG001|Overall Study|received non-study stent|2|||
128881195|NCT00120406|463859916|FG000|Overall Study|patient moved but has not withdrawn|0|||
128881196|NCT00120406|463859917|FG001|Overall Study|patient moved but has not withdrawn|1|||
128881197|NCT03907410|463859919|FG000|Overall Study|Lost to Follow-up|4|||
128881198|NCT03907410|463859920|FG001|Overall Study|Lost to Follow-up|1|||
128881199|NCT03907410|463859921|FG002|Overall Study|Lost to Follow-up|1|||
128881200|NCT03907410|463859919|FG000|Overall Study|Lost to follow-up and research burden|0|||
128881201|NCT03907410|463859920|FG001|Overall Study|Lost to follow-up and research burden|0|||
128881202|NCT03907410|463859921|FG002|Overall Study|Lost to follow-up and research burden|1|||
128881203|NCT03718533|463859922|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
128881204|NCT03718533|463859922|FG000|Overall Study|Protocol deviation|1|||
128881205|NCT03718533|463859922|FG000|Overall Study|Disease progression|1|||
128881206|NCT03718533|463859922|FG000|Overall Study|Relapse|1|||
128881207|NCT03718533|463859922|FG000|Overall Study|Physician Decision|2|||
128881208|NCT03718533|463859922|FG000|Overall Study|Physician Decision and Adverse Event|1|||
128881209|NCT01295034|463859923|FG000|Overall Study|Lost to Follow-up|5|||
128881210|NCT01295034|463859924|FG001|Overall Study|Lost to Follow-up|5|||
128881211|NCT01313637|463859927|FG000|Overall Study|Adverse Event|17|||
128881212|NCT01313637|463859928|FG001|Overall Study|Adverse Event|24|||
128881213|NCT01313637|463859929|FG002|Overall Study|Adverse Event|25|||
128881214|NCT01313637|463859930|FG003|Overall Study|Adverse Event|18|||
128881215|NCT01313637|463859927|FG000|Overall Study|Lack of Efficacy|44|||
128881216|NCT01313637|463859928|FG001|Overall Study|Lack of Efficacy|38|||
128881217|NCT01313637|463859929|FG002|Overall Study|Lack of Efficacy|37|||
128881218|NCT01313637|463859930|FG003|Overall Study|Lack of Efficacy|24|||
128881219|NCT01313637|463859927|FG000|Overall Study|Protocol Violation|4|||
128881220|NCT01313637|463859928|FG001|Overall Study|Protocol Violation|3|||
128881221|NCT01313637|463859929|FG002|Overall Study|Protocol Violation|11|||
128881222|NCT01313637|463859930|FG003|Overall Study|Protocol Violation|5|||
129017014|NCT03021018|464356520|FG001|Overall Study|Adverse Event|0|||
129017015|NCT03021018|464356521|FG002|Overall Study|Adverse Event|0|||
129017016|NCT03021018|464356519|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
129017017|NCT03021018|464356520|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
129017018|NCT03021018|464356521|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
128683147|NCT01975831|463138774|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
128683148|NCT01975831|463138766|FG000|Overall Study|Entered Hospice|0|||
128881223|NCT01313637|463859927|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
128881224|NCT01313637|463859928|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
128881225|NCT01313637|463859929|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
128881226|NCT01313637|463859930|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
128881227|NCT01313637|463859927|FG000|Overall Study|Lost to Follow-up|0|||
128881228|NCT01313637|463859928|FG001|Overall Study|Lost to Follow-up|2|||
128881229|NCT01313637|463859929|FG002|Overall Study|Lost to Follow-up|1|||
128881230|NCT01313637|463859930|FG003|Overall Study|Lost to Follow-up|3|||
128881231|NCT01313637|463859927|FG000|Overall Study|Withdrawal by Subject|11|||
128881232|NCT01313637|463859928|FG001|Overall Study|Withdrawal by Subject|13|||
129017019|NCT04123548|464356530|FG000|Overall Study|Withdrawal by Subject|1|||
128881233|NCT01313637|463859929|FG002|Overall Study|Withdrawal by Subject|18|||
128881234|NCT01313637|463859930|FG003|Overall Study|Withdrawal by Subject|15|||
128881235|NCT04218084|463859932|FG000|Overall Study|Adverse Event|7|||
128881236|NCT04218084|463859933|FG001|Overall Study|Adverse Event|2|||
128881237|NCT04218084|463859932|FG000|Overall Study|Withdrawal of Consent|4|||
128881238|NCT04218084|463859933|FG001|Overall Study|Withdrawal of Consent|5|||
128881239|NCT04218084|463859932|FG000|Overall Study|Physician Decision|1|||
128881240|NCT04218084|463859933|FG001|Overall Study|Physician Decision|1|||
128881241|NCT04218084|463859932|FG000|Overall Study|Lost to Follow-up|1|||
128881242|NCT04218084|463859933|FG001|Overall Study|Lost to Follow-up|1|||
128881243|NCT04218084|463859932|FG000|Overall Study|Non-compliance with study drug|1|||
128881244|NCT04218084|463859933|FG001|Overall Study|Non-compliance with study drug|1|||
128881245|NCT04218084|463859932|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
128881246|NCT04218084|463859933|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
128881247|NCT04218084|463859932|FG000|Overall Study|Other|0|||
128881248|NCT04218084|463859933|FG001|Overall Study|Other|1|||
128881249|NCT04218084|463859932|FG000|Overall Study|Ongoing at data cut-off date|62|||
128881250|NCT04218084|463859933|FG001|Overall Study|Ongoing at data cut-off date|58|||
128881251|NCT05580588|463859934|FG000|Overall Study|Lack of Efficacy|12|||
128881252|NCT00211185|463859937|FG000|Overall Study|Death|2|||
128881253|NCT00211185|463859937|FG000|Overall Study|Disease progression|7|||
128881254|NCT00211185|463859937|FG000|Overall Study|Withdrawal by Subject|6|||
128881255|NCT00211185|463859937|FG000|Overall Study|Physician Decision|5|||
128881256|NCT00712673|463859938|FG000|Overall Study|Adverse Event|3|||
128881257|NCT00712673|463859939|FG001|Overall Study|Adverse Event|3|||
128881258|NCT00712673|463859940|FG002|Overall Study|Adverse Event|21|||
128881259|NCT00712673|463859941|FG003|Overall Study|Adverse Event|26|||
128881260|NCT00712673|463859938|FG000|Overall Study|Lack of Efficacy|2|||
128881261|NCT00712673|463859939|FG001|Overall Study|Lack of Efficacy|8|||
128881262|NCT00712673|463859940|FG002|Overall Study|Lack of Efficacy|8|||
128881263|NCT00712673|463859941|FG003|Overall Study|Lack of Efficacy|6|||
128881264|NCT00712673|463859938|FG000|Overall Study|Poor Compliance to Protocol|3|||
128881265|NCT00712673|463859939|FG001|Overall Study|Poor Compliance to Protocol|3|||
128881266|NCT00712673|463859940|FG002|Overall Study|Poor Compliance to Protocol|4|||
128881267|NCT00712673|463859941|FG003|Overall Study|Poor Compliance to Protocol|16|||
128881268|NCT00712673|463859938|FG000|Overall Study|Lost to Follow-up|1|||
128881269|NCT00712673|463859939|FG001|Overall Study|Lost to Follow-up|0|||
128881270|NCT00712673|463859940|FG002|Overall Study|Lost to Follow-up|2|||
128881271|NCT00712673|463859941|FG003|Overall Study|Lost to Follow-up|0|||
128881272|NCT00712673|463859938|FG000|Overall Study|Withdrawal by Subject|6|||
128881273|NCT00712673|463859939|FG001|Overall Study|Withdrawal by Subject|7|||
128881274|NCT00712673|463859940|FG002|Overall Study|Withdrawal by Subject|15|||
128881275|NCT00712673|463859941|FG003|Overall Study|Withdrawal by Subject|20|||
128881276|NCT00712673|463859938|FG000|Overall Study|Familial and Personal Reasons|5|||
128881277|NCT00712673|463859939|FG001|Overall Study|Familial and Personal Reasons|0|||
128881278|NCT00712673|463859940|FG002|Overall Study|Familial and Personal Reasons|5|||
128881279|NCT00712673|463859941|FG003|Overall Study|Familial and Personal Reasons|2|||
128881280|NCT00712673|463859938|FG000|Overall Study|Investigator's Decision|1|||
128881281|NCT00712673|463859939|FG001|Overall Study|Investigator's Decision|0|||
128881282|NCT00712673|463859940|FG002|Overall Study|Investigator's Decision|0|||
128881283|NCT00712673|463859941|FG003|Overall Study|Investigator's Decision|0|||
128881284|NCT00712673|463859938|FG000|Overall Study|Protocol Violation|0|||
128881285|NCT00712673|463859939|FG001|Overall Study|Protocol Violation|0|||
128881286|NCT00712673|463859940|FG002|Overall Study|Protocol Violation|2|||
128881287|NCT00712673|463859941|FG003|Overall Study|Protocol Violation|0|||
129017020|NCT04123548|464356530|FG000|Overall Study|Lost to Follow-up|8|||
129017021|NCT04123548|464356530|FG000|Overall Study|Death|4|||
129017022|NCT04123548|464356530|FG000|Overall Study|Reason Not Specified|1|||
129017023|NCT00418184|464356533|FG000|Double-blind Phase|Withdrawal by Subject|22|||
129017024|NCT00418184|464356534|FG001|Double-blind Phase|Withdrawal by Subject|9|||
129017025|NCT00418184|464356533|FG000|Double-blind Phase|Adverse Event|2|||
129017026|NCT00418184|464356534|FG001|Double-blind Phase|Adverse Event|1|||
129017027|NCT00418184|464356533|FG000|Double-blind Phase|Poor compliance|3|||
129017028|NCT00418184|464356534|FG001|Double-blind Phase|Poor compliance|1|||
129017029|NCT02472366|464356535|FG000|Overall Study|Lost to Follow-up|1|||
129017030|NCT02472366|464356536|FG001|Overall Study|Lost to Follow-up|0|||
129017031|NCT02728102|464356537|FG000|Overall Study|Death|3|||
128881288|NCT03603028|463859942|FG000|Overall Study|Withdrawal by Subject|1|||
128881289|NCT00842985|463859947|FG000|Screening|Did not meet entrance requirements|27|||
128881290|NCT00842985|463859947|FG000|First Intervention|Withdrawal by Subject|3|||
128881291|NCT00842985|463859947|FG000|First Intervention|Protocol Violation|3|||
128881292|NCT00842985|463859947|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
128881293|NCT00842985|463859947|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
128881294|NCT01037244|463859948|FG000|Overall Study|Adverse Event|3|||
128881295|NCT01037244|463859949|FG001|Overall Study|Adverse Event|2|||
128881296|NCT01037244|463859950|FG002|Overall Study|Adverse Event|6|||
129017032|NCT02728102|464356538|FG001|Overall Study|Death|0|||
129017033|NCT02728102|464356539|FG002|Overall Study|Death|1|||
128881297|NCT01037244|463859951|FG003|Overall Study|Adverse Event|3|||
128881298|NCT01037244|463859948|FG000|Overall Study|Lack of Efficacy|1|||
128881299|NCT01037244|463859949|FG001|Overall Study|Lack of Efficacy|1|||
128881300|NCT01037244|463859950|FG002|Overall Study|Lack of Efficacy|0|||
128881301|NCT01037244|463859951|FG003|Overall Study|Lack of Efficacy|1|||
128881302|NCT01037244|463859948|FG000|Overall Study|Lost to Follow-up|3|||
128881303|NCT01037244|463859949|FG001|Overall Study|Lost to Follow-up|3|||
128881304|NCT01037244|463859950|FG002|Overall Study|Lost to Follow-up|4|||
128881305|NCT01037244|463859951|FG003|Overall Study|Lost to Follow-up|4|||
128881306|NCT01037244|463859948|FG000|Overall Study|Withdrawal by Subject|1|||
128881307|NCT01037244|463859949|FG001|Overall Study|Withdrawal by Subject|5|||
128881308|NCT01037244|463859950|FG002|Overall Study|Withdrawal by Subject|3|||
128881309|NCT01037244|463859951|FG003|Overall Study|Withdrawal by Subject|5|||
128881310|NCT01037244|463859948|FG000|Overall Study|Partner Withdrew Consent|2|||
128881311|NCT01037244|463859949|FG001|Overall Study|Partner Withdrew Consent|1|||
128881312|NCT01037244|463859950|FG002|Overall Study|Partner Withdrew Consent|0|||
128881313|NCT01037244|463859951|FG003|Overall Study|Partner Withdrew Consent|0|||
128881314|NCT01037244|463859948|FG000|Overall Study|Various|3|||
128881315|NCT01037244|463859949|FG001|Overall Study|Various|2|||
128881316|NCT01037244|463859950|FG002|Overall Study|Various|1|||
128881317|NCT01037244|463859951|FG003|Overall Study|Various|1|||
128881318|NCT01249274|463859952|FG000|Overall Study|Lost to Follow-up|3|||
128881319|NCT01249274|463859953|FG001|Overall Study|Lost to Follow-up|4|||
128881320|NCT01249274|463859952|FG000|Overall Study|Received inpatient substance treatment|1|||
128881321|NCT01249274|463859953|FG001|Overall Study|Received inpatient substance treatment|2|||
128881322|NCT01000636|463859954|FG000|Overall Study|Withdrawal by Subject|1|||
128881323|NCT01000636|463859954|FG000|Overall Study|Adverse Event|1|||
128881324|NCT03305731|463859955|FG000|Overall Study|Protocol Violation|1|||
128881325|NCT01498653|463859957|FG000|Overall Study|Adverse Event|2|||
128881326|NCT01498653|463859958|FG001|Overall Study|Adverse Event|2|||
128881327|NCT01498653|463859957|FG000|Overall Study|Lack of Efficacy|12|||
128881328|NCT01498653|463859958|FG001|Overall Study|Lack of Efficacy|26|||
128881329|NCT01498653|463859957|FG000|Overall Study|Protocol Violation|0|||
128881330|NCT01498653|463859958|FG001|Overall Study|Protocol Violation|4|||
128881331|NCT01498653|463859957|FG000|Overall Study|Lost to Follow-up|1|||
128881332|NCT01498653|463859958|FG001|Overall Study|Lost to Follow-up|0|||
128881333|NCT01498653|463859957|FG000|Overall Study|Physician Decision|2|||
128881334|NCT01498653|463859958|FG001|Overall Study|Physician Decision|0|||
128881335|NCT01498653|463859957|FG000|Overall Study|Withdrawal by Subject|2|||
128881336|NCT01498653|463859958|FG001|Overall Study|Withdrawal by Subject|3|||
128881337|NCT05208866|463859959|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
128881338|NCT02070588|463859960|FG000|Overall Study|Withdrawal by Subject|29|||
128881339|NCT02070588|463859961|FG001|Overall Study|Withdrawal by Subject|1|||
128881340|NCT02070588|463859962|FG002|Overall Study|Withdrawal by Subject|0|||
128881341|NCT02070588|463859960|FG000|Overall Study|Writhdrawal due to early termination|9|||
128881342|NCT02070588|463859961|FG001|Overall Study|Writhdrawal due to early termination|0|||
128881343|NCT02070588|463859962|FG002|Overall Study|Writhdrawal due to early termination|0|||
128881344|NCT02070588|463859960|FG000|Overall Study|Adverse Event|1|||
128881345|NCT02070588|463859961|FG001|Overall Study|Adverse Event|0|||
128881346|NCT02070588|463859962|FG002|Overall Study|Adverse Event|0|||
128881347|NCT02216357|463859963|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
128881348|NCT02216357|463859964|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
128881349|NCT04964414|463859966|FG000|Overall Study|Lost to Follow-up|10|||
128881350|NCT04964414|463859967|FG001|Overall Study|Lost to Follow-up|8|||
128881351|NCT04964414|463859966|FG000|Overall Study|Withdrawal by Subject|1|||
128881352|NCT04964414|463859967|FG001|Overall Study|Withdrawal by Subject|1|||
128881353|NCT01718353|463859968|FG000|Overall Study|Lost to Follow-up|0|||
128881354|NCT01718353|463859969|FG001|Overall Study|Lost to Follow-up|1|||
128881355|NCT01718353|463859968|FG000|Overall Study|Principal Investigator's Decision|10|||
128881356|NCT01718353|463859969|FG001|Overall Study|Principal Investigator's Decision|4|||
128881357|NCT01718353|463859968|FG000|Overall Study|Randomized but not treated|2|||
128881358|NCT01718353|463859969|FG001|Overall Study|Randomized but not treated|0|||
128881359|NCT00455325|463859970|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
128881360|NCT00455325|463859971|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
128881361|NCT00455325|463859972|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
128881362|NCT00455325|463859973|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
128881363|NCT00455325|463859970|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
128881364|NCT00455325|463859971|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
128881365|NCT00455325|463859972|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
129017034|NCT02728102|464356537|FG000|Overall Study|Withdrawal by Subject|0|||
128881366|NCT00455325|463859973|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
128881367|NCT00455325|463859970|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
128881368|NCT00455325|463859971|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
128881369|NCT00455325|463859972|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
128881370|NCT00455325|463859973|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
128881371|NCT00455325|463859970|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
129104806|NCT00492232|464677277|FG001|Placebo Run-in|Entrance criteria not met|45|||
129017035|NCT02728102|464356538|FG001|Overall Study|Withdrawal by Subject|2|||
129017036|NCT02728102|464356539|FG002|Overall Study|Withdrawal by Subject|3|||
129104807|NCT00492232|464677276|FG000|Placebo Run-in|Other|0|||
129104808|NCT00492232|464677277|FG001|Placebo Run-in|Other|6|||
129104809|NCT00492232|464677276|FG000|Placebo Run-in|Missing|0|||
129104810|NCT00492232|464677277|FG001|Placebo Run-in|Missing|2|||
129104811|NCT00492232|464677276|FG000|Double-Blind Treatment|Adverse Event|1|||
129104812|NCT00492232|464677277|FG001|Double-Blind Treatment|Adverse Event|2|||
129104813|NCT00492232|464677276|FG000|Double-Blind Treatment|Protocol Violation|3|||
129104814|NCT00492232|464677277|FG001|Double-Blind Treatment|Protocol Violation|7|||
129104815|NCT00492232|464677276|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
129104816|NCT00492232|464677277|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
129104817|NCT00492232|464677276|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
129104818|NCT00492232|464677277|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
129104819|NCT00492232|464677276|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
129104820|NCT00492232|464677277|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
129104821|NCT00492232|464677276|FG000|Double-Blind Treatment|Other|6|||
129104822|NCT00492232|464677277|FG001|Double-Blind Treatment|Other|5|||
129104823|NCT00492232|464677276|FG000|Double-Blind Treatment|Randomized not treated|1|||
129104824|NCT00492232|464677277|FG001|Double-Blind Treatment|Randomized not treated|0|||
129104825|NCT00492232|464677276|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
129104826|NCT00492232|464677277|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129104827|NCT01216332|464677278|FG000|Overall Study|Withdrawal by Subject|4|||
129104828|NCT01216332|464677279|FG001|Overall Study|Withdrawal by Subject|0|||
129104829|NCT00636636|464677280|FG000|Overall Study|Other reason|4|||
129104830|NCT00636636|464677281|FG001|Overall Study|Other reason|6|||
129104831|NCT00636636|464677280|FG000|Overall Study|Adverse Event|19|||
129104832|NCT00636636|464677281|FG001|Overall Study|Adverse Event|8|||
129104833|NCT00636636|464677280|FG000|Overall Study|Lack of Efficacy|7|||
129104834|NCT00636636|464677281|FG001|Overall Study|Lack of Efficacy|12|||
129104835|NCT00636636|464677280|FG000|Overall Study|Protocol Violation|2|||
129104836|NCT00636636|464677281|FG001|Overall Study|Protocol Violation|2|||
129104837|NCT00636636|464677280|FG000|Overall Study|Lost to Follow-up|0|||
129104838|NCT00636636|464677281|FG001|Overall Study|Lost to Follow-up|1|||
129104839|NCT00636636|464677280|FG000|Overall Study|Death|0|||
129104840|NCT00636636|464677281|FG001|Overall Study|Death|1|||
129104841|NCT00636636|464677280|FG000|Overall Study|Withdrawal by Subject|4|||
129104842|NCT00636636|464677281|FG001|Overall Study|Withdrawal by Subject|9|||
129104843|NCT00524173|464677282|FG000|Overall Study|Lost to Follow-up|0|||
129104844|NCT00524173|464677283|FG001|Overall Study|Lost to Follow-up|1|||
129104845|NCT00524173|464677282|FG000|Overall Study|Death|1|||
129104846|NCT00524173|464677283|FG001|Overall Study|Death|0|||
129104847|NCT00524173|464677282|FG000|Overall Study|Had not reached endpoint at study close|4|||
129017037|NCT02728102|464356537|FG000|Overall Study|Physician Decision|1|||
129017038|NCT02728102|464356538|FG001|Overall Study|Physician Decision|1|||
129017039|NCT02728102|464356539|FG002|Overall Study|Physician Decision|0|||
129017040|NCT02728102|464356537|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
129017041|NCT02728102|464356538|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
129017042|NCT02728102|464356539|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
129017043|NCT02728102|464356537|FG000|Overall Study|Covid|0|||
129017044|NCT02728102|464356538|FG001|Overall Study|Covid|0|||
129017045|NCT02728102|464356539|FG002|Overall Study|Covid|1|||
129017046|NCT01182415|464356540|FG000|Overall Study|Lost to Follow-up|1|||
129017047|NCT02587962|464356541|FG000|Overall Study|Adverse Event|0|||
129017048|NCT02587962|464356542|FG001|Overall Study|Adverse Event|0|||
129017049|NCT02587962|464356543|FG002|Overall Study|Adverse Event|1|||
129017050|NCT02587962|464356544|FG003|Overall Study|Adverse Event|0|||
129017051|NCT02587962|464356545|FG004|Overall Study|Adverse Event|0|||
129017052|NCT02587962|464356541|FG000|Overall Study|Withdrawal by Subject|0|||
129017053|NCT02587962|464356542|FG001|Overall Study|Withdrawal by Subject|0|||
129104848|NCT00524173|464677283|FG001|Overall Study|Had not reached endpoint at study close|1|||
129104849|NCT03746405|464678786|FG000|Overall Study|Withdrawal by Subject|3|||
129104850|NCT03746405|464678787|FG001|Overall Study|Withdrawal by Subject|0|||
129017054|NCT02587962|464356543|FG002|Overall Study|Withdrawal by Subject|1|||
129017055|NCT02587962|464356544|FG003|Overall Study|Withdrawal by Subject|1|||
129017056|NCT02587962|464356545|FG004|Overall Study|Withdrawal by Subject|4|||
129017057|NCT02587962|464356541|FG000|Overall Study|Radiological progression|2|||
129104851|NCT03746405|464678786|FG000|Overall Study|technical difficulties|0|||
129104852|NCT03746405|464678787|FG001|Overall Study|technical difficulties|2|||
129104853|NCT03479008|464678788|FG000|Overall Study|Withdrawal by Subject|3|||
129104854|NCT01310127|464678789|FG000|Overall Study|Protocol Violation|1|||
129104855|NCT01310127|464678790|FG001|Overall Study|Protocol Violation|1|||
129104856|NCT01310127|464678789|FG000|Overall Study|advanced psc cataract outlier|1|||
129104857|NCT01310127|464678790|FG001|Overall Study|advanced psc cataract outlier|0|||
129104858|NCT00412932|464678791|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
129104859|NCT00412932|464678791|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
129017058|NCT02587962|464356542|FG001|Overall Study|Radiological progression|2|||
129017059|NCT02587962|464356543|FG002|Overall Study|Radiological progression|2|||
129017060|NCT02587962|464356544|FG003|Overall Study|Radiological progression|5|||
129017061|NCT02587962|464356545|FG004|Overall Study|Radiological progression|10|||
129017062|NCT02587962|464356541|FG000|Overall Study|Clinical progression|0|||
129017063|NCT02587962|464356542|FG001|Overall Study|Clinical progression|1|||
129017064|NCT02587962|464356543|FG002|Overall Study|Clinical progression|2|||
129017065|NCT02587962|464356544|FG003|Overall Study|Clinical progression|0|||
129017066|NCT02587962|464356545|FG004|Overall Study|Clinical progression|1|||
129017067|NCT01422538|464356549|FG000|Overall Study|Lost to Follow-up|0|||
129017068|NCT01422538|464356550|FG001|Overall Study|Lost to Follow-up|1|||
129017069|NCT01422538|464356551|FG002|Overall Study|Lost to Follow-up|1|||
129017070|NCT01422538|464356549|FG000|Overall Study|Missed visit|0|||
129017071|NCT01422538|464356550|FG001|Overall Study|Missed visit|1|||
129017072|NCT01422538|464356551|FG002|Overall Study|Missed visit|1|||
129017073|NCT02770820|464356552|FG000|Overall Study|Death|1|||
129017074|NCT02770820|464356552|FG000|Overall Study|Physician Decision|2|||
129017075|NCT02098876|464356555|FG000|Overall Study|Withdrawal by Subject|5|||
129017076|NCT02098876|464356556|FG001|Overall Study|Withdrawal by Subject|5|||
129017077|NCT01061866|464356557|FG000|Overall Study|Adverse Event|2|||
129017078|NCT00834756|464356558|FG000|First Intervention|Adverse Event|1|||
129017079|NCT00834756|464356559|FG001|First Intervention|Adverse Event|0|||
129017080|NCT00834756|464356558|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
129017081|NCT00834756|464356559|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
129017082|NCT02979353|464356565|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
129017083|NCT02979353|464356566|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
129017084|NCT02979353|464356565|FG000|Overall Study|Withdrawal by Subject|16|||
129017085|NCT02979353|464356566|FG001|Overall Study|Withdrawal by Subject|12|||
129017086|NCT02979353|464356565|FG000|Overall Study|Death|10|||
129017087|NCT02979353|464356566|FG001|Overall Study|Death|11|||
129017088|NCT02979353|464356565|FG000|Overall Study|Transfer to Hospice Care|19|||
129017089|NCT02979353|464356566|FG001|Overall Study|Transfer to Hospice Care|14|||
129017090|NCT02979353|464356565|FG000|Overall Study|Lost to Follow-up|1|||
129017091|NCT02979353|464356566|FG001|Overall Study|Lost to Follow-up|5|||
129017092|NCT01079988|464356567|FG000|Overall Study|Lost to Follow-up|0|||
129017093|NCT01079988|464356568|FG001|Overall Study|Lost to Follow-up|0|||
129017094|NCT01079988|464356569|FG002|Overall Study|Lost to Follow-up|0|||
129017095|NCT01079988|464356570|FG003|Overall Study|Lost to Follow-up|1|||
129017096|NCT01079988|464356571|FG004|Overall Study|Lost to Follow-up|0|||
129017097|NCT01079988|464356567|FG000|Overall Study|Lack of Efficacy|1|||
129017098|NCT01079988|464356568|FG001|Overall Study|Lack of Efficacy|0|||
129017099|NCT01079988|464356569|FG002|Overall Study|Lack of Efficacy|0|||
129017100|NCT01079988|464356570|FG003|Overall Study|Lack of Efficacy|0|||
129017101|NCT01079988|464356571|FG004|Overall Study|Lack of Efficacy|0|||
129017102|NCT01079988|464356567|FG000|Overall Study|Other|0|||
129017103|NCT01079988|464356568|FG001|Overall Study|Other|0|||
129017104|NCT01079988|464356569|FG002|Overall Study|Other|0|||
129017105|NCT01079988|464356570|FG003|Overall Study|Other|2|||
129017106|NCT01079988|464356571|FG004|Overall Study|Other|1|||
129017107|NCT00268905|464356572|FG000|Overall Study|Adverse Event|3|||
129017108|NCT00268905|464356573|FG001|Overall Study|Adverse Event|0|||
129017109|NCT00268905|464356574|FG002|Overall Study|Adverse Event|4|||
129017110|NCT00268905|464356572|FG000|Overall Study|Lost to Follow-up|0|||
129017111|NCT00268905|464356573|FG001|Overall Study|Lost to Follow-up|1|||
129017112|NCT00268905|464356574|FG002|Overall Study|Lost to Follow-up|0|||
129017113|NCT00268905|464356572|FG000|Overall Study|Withdrawal by Subject|0|||
129017114|NCT00268905|464356573|FG001|Overall Study|Withdrawal by Subject|0|||
129017115|NCT00268905|464356574|FG002|Overall Study|Withdrawal by Subject|3|||
129017116|NCT00268905|464356572|FG000|Overall Study|Progressive Disease|28|||
129017117|NCT00268905|464356573|FG001|Overall Study|Progressive Disease|4|||
129017118|NCT00268905|464356574|FG002|Overall Study|Progressive Disease|3|||
129017119|NCT00268905|464356572|FG000|Overall Study|Physician Decision|3|||
129017120|NCT00268905|464356573|FG001|Overall Study|Physician Decision|0|||
129017121|NCT00268905|464356574|FG002|Overall Study|Physician Decision|1|||
129017122|NCT00268905|464356572|FG000|Overall Study|Clinical Progression|9|||
129017123|NCT00268905|464356573|FG001|Overall Study|Clinical Progression|4|||
129017124|NCT00268905|464356574|FG002|Overall Study|Clinical Progression|1|||
129017125|NCT02392000|464356577|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
129017126|NCT02392000|464356577|FG000|Overall Study|Withdrawal by Subject|1|||
129017127|NCT02392000|464356577|FG000|Overall Study|Lost to Follow-up|8|||
129017128|NCT04384978|464356578|FG000|Overall Study|Withdrawal by Subject|4|||
129017129|NCT04384978|464356579|FG001|Overall Study|Withdrawal by Subject|0|||
129017130|NCT01066143|464358009|FG000|Overall Study|ineligible for the study|8|||
129017131|NCT01124175|464358010|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129017132|NCT01124175|464358011|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
129017133|NCT00942968|464358014|FG000|Overall Study|Adverse Event|60|||
129017134|NCT00942968|464358014|FG000|Overall Study|Death|76|||
129017135|NCT00942968|464358014|FG000|Overall Study|Protocol Violation|9|||
129017136|NCT00942968|464358014|FG000|Overall Study|Lost to Follow-up|4|||
128881372|NCT00455325|463859971|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
128881373|NCT00455325|463859972|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
128881374|NCT00455325|463859973|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
128881375|NCT00455325|463859970|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
128881376|NCT00455325|463859971|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
128881377|NCT00455325|463859972|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
128881378|NCT00455325|463859973|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
128881379|NCT00455325|463859970|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
128881380|NCT00455325|463859971|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
128881381|NCT00455325|463859972|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
128881382|NCT00455325|463859973|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
128881383|NCT00455325|463859970|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
128881384|NCT00455325|463859971|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
128881385|NCT00455325|463859972|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
128881386|NCT00455325|463859973|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
128881387|NCT02745392|463859982|FG000|Overall Study|Lost to Follow-up|0|||
128881388|NCT02745392|463859983|FG001|Overall Study|Lost to Follow-up|1|||
128881389|NCT02745392|463859984|FG002|Overall Study|Lost to Follow-up|0|||
128881390|NCT02745392|463859985|FG003|Overall Study|Lost to Follow-up|0|||
128881391|NCT01691768|463859986|FG000|Overall Study|Death|0|||
128881392|NCT01691768|463859987|FG001|Overall Study|Death|2|||
128881393|NCT01691768|463859986|FG000|Overall Study|Lost to Follow-up|4|||
128881394|NCT01691768|463859987|FG001|Overall Study|Lost to Follow-up|3|||
128881395|NCT01691768|463859986|FG000|Overall Study|Withdrawal by Subject|10|||
128881396|NCT01691768|463859987|FG001|Overall Study|Withdrawal by Subject|9|||
128881397|NCT01691768|463859986|FG000|Overall Study|Relocated|0|||
128881398|NCT01691768|463859987|FG001|Overall Study|Relocated|1|||
128881399|NCT01691768|463859986|FG000|Overall Study|Investigator decision|1|||
128881400|NCT01691768|463859987|FG001|Overall Study|Investigator decision|1|||
128881401|NCT01959334|463859988|FG000|Second Dose|Adverse Event|1|||
128881402|NCT01959334|463859989|FG001|Second Dose|Adverse Event|0|||
128881403|NCT01959334|463859988|FG000|Third Dose|Adverse Event|0|||
128881404|NCT01959334|463859989|FG001|Third Dose|Adverse Event|1|||
128881405|NCT04781387|463859990|FG000|Overall Study|Withdrawal by Subject|1|||
128881406|NCT04781387|463859991|FG001|Overall Study|Withdrawal by Subject|0|||
128881407|NCT04781387|463859992|FG002|Overall Study|Withdrawal by Subject|1|||
128881408|NCT04781387|463859990|FG000|Overall Study|Lost to Follow-up|1|||
128881409|NCT04781387|463859991|FG001|Overall Study|Lost to Follow-up|0|||
128881410|NCT04781387|463859992|FG002|Overall Study|Lost to Follow-up|0|||
128881411|NCT01275131|463860000|FG000|Period 1|Withdrawal by Subject|1|||
128881412|NCT01275131|463860001|FG001|Period 1|Withdrawal by Subject|0|||
128881413|NCT01275131|463860002|FG002|Period 1|Withdrawal by Subject|3|||
128881414|NCT01275131|463860003|FG003|Period 1|Withdrawal by Subject|2|||
128881415|NCT01275131|463860000|FG000|Period 1|Physician Decision|1|||
128881416|NCT01275131|463860001|FG001|Period 1|Physician Decision|0|||
128881417|NCT01275131|463860002|FG002|Period 1|Physician Decision|0|||
128881418|NCT01275131|463860003|FG003|Period 1|Physician Decision|0|||
128881419|NCT01275131|463860000|FG000|Period 2 (Crossover)|Adverse Event|0|||
128881420|NCT01275131|463860001|FG001|Period 2 (Crossover)|Adverse Event|1|||
128881421|NCT01275131|463860002|FG002|Period 2 (Crossover)|Adverse Event|0|||
128881422|NCT01275131|463860003|FG003|Period 2 (Crossover)|Adverse Event|0|||
128881423|NCT01275131|463860000|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
128881424|NCT01275131|463860001|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
128881425|NCT01275131|463860002|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
128881426|NCT01275131|463860003|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
128881427|NCT00529958|463860004|FG000|2-Year Follow-up|Lost to Follow-up|1|||
128881428|NCT00529958|463860005|FG001|2-Year Follow-up|Lost to Follow-up|2|||
128881429|NCT00529958|463860006|FG002|2-Year Follow-up|Lost to Follow-up|2|||
128881430|NCT00529958|463860004|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
128881431|NCT00529958|463860005|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
128881432|NCT00529958|463860006|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
129017137|NCT00942968|464358014|FG000|Overall Study|Withdrawal by Subject|44|||
129017138|NCT00942968|464358014|FG000|Overall Study|Sponsor request|5|||
129017139|NCT00942968|464358014|FG000|Overall Study|Physician Decision|11|||
129017140|NCT00942968|464358014|FG000|Overall Study|Progression of disease|12|||
128881433|NCT00529958|463860004|FG000|5-Year Follow-up|Lost to Follow-up|2|||
128881434|NCT00529958|463860005|FG001|5-Year Follow-up|Lost to Follow-up|3|||
129017141|NCT00942968|464358014|FG000|Overall Study|Inferior vena cava filter placement|4|||
129017142|NCT00942968|464358014|FG000|Overall Study|Pulmonary embolism (PE)|1|||
128881435|NCT00529958|463860006|FG002|5-Year Follow-up|Lost to Follow-up|1|||
128881436|NCT00529958|463860004|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
128881437|NCT00529958|463860005|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
128881438|NCT00529958|463860006|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
128881439|NCT03316300|463860007|FG000|Overall Study|Withdrawal by Subject|3|||
128881440|NCT03316300|463860008|FG001|Overall Study|Withdrawal by Subject|2|||
128881441|NCT03316300|463860007|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
128881442|NCT03316300|463860008|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
128881443|NCT03316300|463860007|FG000|Overall Study|Adverse Event|1|||
128881444|NCT03316300|463860008|FG001|Overall Study|Adverse Event|0|||
128881445|NCT03316300|463860007|FG000|Overall Study|COVID-19|0|||
128881446|NCT03316300|463860008|FG001|Overall Study|COVID-19|1|||
128881447|NCT01315353|463860009|FG000|Overall Study|Death|2|||
128881448|NCT01315353|463860010|FG001|Overall Study|Death|1|||
128881449|NCT01315353|463860011|FG002|Overall Study|Death|0|||
128881450|NCT01315353|463860009|FG000|Overall Study|Withdrawal by Subject|2|||
128881451|NCT01315353|463860010|FG001|Overall Study|Withdrawal by Subject|6|||
128881452|NCT01315353|463860011|FG002|Overall Study|Withdrawal by Subject|1|||
128881453|NCT01315353|463860009|FG000|Overall Study|Lost to Follow-up|13|||
128881454|NCT01315353|463860010|FG001|Overall Study|Lost to Follow-up|6|||
128881455|NCT01315353|463860011|FG002|Overall Study|Lost to Follow-up|6|||
128881456|NCT01315353|463860009|FG000|Overall Study|Unwilling to adhere to requirements|5|||
128881457|NCT01315353|463860010|FG001|Overall Study|Unwilling to adhere to requirements|5|||
128881458|NCT01315353|463860011|FG002|Overall Study|Unwilling to adhere to requirements|4|||
128881459|NCT01315353|463860009|FG000|Overall Study|Site closing|7|||
128881460|NCT01315353|463860010|FG001|Overall Study|Site closing|4|||
128881461|NCT01315353|463860011|FG002|Overall Study|Site closing|0|||
128881462|NCT01315353|463860009|FG000|Overall Study|Taken off study by site in error|0|||
128881463|NCT01315353|463860010|FG001|Overall Study|Taken off study by site in error|1|||
128881464|NCT01315353|463860011|FG002|Overall Study|Taken off study by site in error|0|||
128881465|NCT01315353|463860009|FG000|Overall Study|Inadvertent randomization/assignment|0|||
128881466|NCT01315353|463860010|FG001|Overall Study|Inadvertent randomization/assignment|0|||
128881467|NCT01315353|463860011|FG002|Overall Study|Inadvertent randomization/assignment|2|||
128881468|NCT03567434|463860012|FG000|Overall Study|Lost to Follow-up|1|||
128881469|NCT03567434|463860013|FG001|Overall Study|Lost to Follow-up|3|||
128881470|NCT01050790|463860015|FG000|Overall Study|Adverse Event|1|||
128881471|NCT03705832|463860016|FG000|Overall Study|Physician Decision|0|||
128881472|NCT03705832|463860017|FG001|Overall Study|Physician Decision|1|||
128881473|NCT03705832|463860016|FG000|Overall Study|Withdrawal by Subject|1|||
128881474|NCT03705832|463860017|FG001|Overall Study|Withdrawal by Subject|0|||
128881475|NCT01880528|463860018|FG000|Overall Study|Other|1|||
128881476|NCT01880528|463860019|FG001|Overall Study|Other|1|||
129017143|NCT00942968|464358014|FG000|Overall Study|Participant required pancreatic biopsy|1|||
129017144|NCT00942968|464358014|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
129017145|NCT01466166|464358017|FG000|Overall Study|Death|1|||
129017146|NCT01466166|464358017|FG000|Overall Study|Lost to Follow-up|7|||
129017147|NCT01466166|464358017|FG000|Overall Study|Infusion Reaction (IR)|27|||
129017148|NCT01466166|464358017|FG000|Overall Study|Adverse Event (Other than IR)|11|||
129017149|NCT01466166|464358017|FG000|Overall Study|Elevated Serum Uric Acid|78|||
129017150|NCT01466166|464358017|FG000|Overall Study|Withdrawal by Subject|13|||
129017151|NCT01466166|464358017|FG000|Overall Study|Sponsor Decision|4|||
129017152|NCT01466166|464358017|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
129017153|NCT01466166|464358017|FG000|Overall Study|Other|20|||
129017154|NCT01340495|464358024|FG000|Overall Study|Withdrawal by Subject|1|||
129017155|NCT00070291|464358025|FG000|Step 1|Withdrawal by Subject|1|||
129017156|NCT00070291|464358025|FG000|Step 1|Adverse Event|1|||
129017157|NCT00070291|464358025|FG000|Step 2|Adverse Event|1|||
129017158|NCT00667862|464358028|FG000|Overall Study|Adverse Event|9|||
129017159|NCT00667862|464358028|FG000|Overall Study|Death|1|||
129017160|NCT00667862|464358028|FG000|Overall Study|Disease Progression|22|||
129017161|NCT00667862|464358028|FG000|Overall Study|Withdrawal by Subject|3|||
129017162|NCT02495857|464358030|FG000|Overall Study|Adverse Event|5|||
129017163|NCT02495857|464358031|FG001|Overall Study|Adverse Event|0|||
129017164|NCT02495857|464358032|FG002|Overall Study|Adverse Event|1|||
129017165|NCT02495857|464358030|FG000|Overall Study|Withdrawal by Subject|9|||
129017166|NCT02495857|464358031|FG001|Overall Study|Withdrawal by Subject|6|||
128881477|NCT01439360|463860020|FG000|Overall Study|Adverse Event|4|||
128881478|NCT01439360|463860021|FG001|Overall Study|Adverse Event|16|||
128881479|NCT01439360|463860020|FG000|Overall Study|Lost to Follow-up|43|||
128881480|NCT01439360|463860021|FG001|Overall Study|Lost to Follow-up|58|||
128881481|NCT01439360|463860020|FG000|Overall Study|Others|10|||
128881482|NCT01439360|463860021|FG001|Overall Study|Others|5|||
128881483|NCT01439360|463860020|FG000|Overall Study|Protocol Violation|1|||
129017167|NCT02495857|464358032|FG002|Overall Study|Withdrawal by Subject|10|||
129017168|NCT02495857|464358030|FG000|Overall Study|Physician Decision|0|||
129017169|NCT02495857|464358031|FG001|Overall Study|Physician Decision|1|||
129017170|NCT02495857|464358032|FG002|Overall Study|Physician Decision|0|||
128881484|NCT01439360|463860021|FG001|Overall Study|Protocol Violation|0|||
128881485|NCT01439360|463860020|FG000|Overall Study|Withdrawal by Subject|140|||
128881486|NCT01439360|463860021|FG001|Overall Study|Withdrawal by Subject|129|||
129104860|NCT00412932|464678791|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
128881487|NCT01912456|463861457|FG000|Period 1|Physician Decision|0|||
129017171|NCT02495857|464358030|FG000|Overall Study|Protocol Violation|1|||
129017172|NCT02495857|464358031|FG001|Overall Study|Protocol Violation|1|||
128881488|NCT01912456|463861458|FG001|Period 1|Physician Decision|0|||
128881489|NCT01912456|463861459|FG002|Period 1|Physician Decision|1|||
128881490|NCT01912456|463861460|FG003|Period 1|Physician Decision|0|||
128881491|NCT01912456|463861457|FG000|Period 1|non-compliance|1|||
128881492|NCT01912456|463861458|FG001|Period 1|non-compliance|0|||
128881493|NCT01912456|463861459|FG002|Period 1|non-compliance|0|||
128881494|NCT01912456|463861460|FG003|Period 1|non-compliance|1|||
128881495|NCT01912456|463861457|FG000|Period 1|Adverse Event|1|||
128881496|NCT01912456|463861458|FG001|Period 1|Adverse Event|0|||
128881497|NCT01912456|463861459|FG002|Period 1|Adverse Event|0|||
128881498|NCT01912456|463861460|FG003|Period 1|Adverse Event|1|||
128881499|NCT01912456|463861457|FG000|Period 1|Withdrawal by Subject|0|||
128881500|NCT01912456|463861458|FG001|Period 1|Withdrawal by Subject|1|||
128881501|NCT01912456|463861459|FG002|Period 1|Withdrawal by Subject|1|||
128881502|NCT01912456|463861460|FG003|Period 1|Withdrawal by Subject|1|||
128881503|NCT01912456|463861457|FG000|Period 2|Lack of Efficacy|0|||
128881504|NCT01912456|463861458|FG001|Period 2|Lack of Efficacy|2|||
128881505|NCT01912456|463861459|FG002|Period 2|Lack of Efficacy|0|||
128881506|NCT01912456|463861460|FG003|Period 2|Lack of Efficacy|0|||
128881507|NCT01912456|463861457|FG000|Period 2|Adverse Event|0|||
128881508|NCT01912456|463861458|FG001|Period 2|Adverse Event|0|||
128881509|NCT01912456|463861459|FG002|Period 2|Adverse Event|0|||
128881510|NCT01912456|463861460|FG003|Period 2|Adverse Event|1|||
128881511|NCT01201343|463861461|FG000|Overall Study|Adverse Event|6|||
128881512|NCT01201343|463861461|FG000|Overall Study|Withdrawal by Subject|5|||
128881513|NCT01201343|463861461|FG000|Overall Study|Lost to Follow-up|2|||
128881514|NCT01201343|463861461|FG000|Overall Study|Lack of Efficacy|2|||
128881515|NCT01201343|463861461|FG000|Overall Study|Participant wrongly included in trial|1|||
128881516|NCT01201343|463861461|FG000|Overall Study|Randomized, not treated|3|||
128881517|NCT01440374|463861464|FG000|Part 1: Open-label Phase|Adverse Event|5|||
128881518|NCT01440374|463861465|FG001|Part 1: Open-label Phase|Adverse Event|0|||
128881519|NCT01440374|463861466|FG002|Part 1: Open-label Phase|Adverse Event|0|||
128881520|NCT01440374|463861467|FG003|Part 1: Open-label Phase|Adverse Event|0|||
128881521|NCT01440374|463861464|FG000|Part 1: Open-label Phase|Physician Decision|1|||
128881522|NCT01440374|463861465|FG001|Part 1: Open-label Phase|Physician Decision|0|||
128881523|NCT01440374|463861466|FG002|Part 1: Open-label Phase|Physician Decision|0|||
128881524|NCT01440374|463861467|FG003|Part 1: Open-label Phase|Physician Decision|0|||
128881525|NCT01440374|463861464|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
128881526|NCT01440374|463861465|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
128881527|NCT01440374|463861466|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
128881528|NCT01440374|463861467|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
128881529|NCT01440374|463861464|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
128881530|NCT01440374|463861465|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
128881531|NCT01440374|463861466|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
128881532|NCT01440374|463861467|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
128881533|NCT01440374|463861464|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
128881534|NCT01440374|463861465|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
128881535|NCT01440374|463861466|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
128881536|NCT01440374|463861467|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
128881537|NCT01440374|463861464|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
128881538|NCT01440374|463861465|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
128881539|NCT01440374|463861466|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
128881540|NCT01440374|463861467|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
128881541|NCT01440374|463861464|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
128881542|NCT01440374|463861465|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
128881543|NCT01440374|463861466|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
128881544|NCT01440374|463861467|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
128881545|NCT01440374|463861464|FG000|Part 2; Double-blind Phase|Not treated|0|||
128881546|NCT01440374|463861465|FG001|Part 2; Double-blind Phase|Not treated|0|||
128881547|NCT01440374|463861466|FG002|Part 2; Double-blind Phase|Not treated|1|||
128881548|NCT01440374|463861467|FG003|Part 2; Double-blind Phase|Not treated|0|||
128881549|NCT01440374|463861464|FG000|Part 3: Extension|Withdrawal by Subject|0|||
129017173|NCT02495857|464358032|FG002|Overall Study|Protocol Violation|2|||
129017174|NCT02495857|464358030|FG000|Overall Study|Lost to Follow-up|4|||
129017175|NCT02495857|464358031|FG001|Overall Study|Lost to Follow-up|5|||
129017176|NCT02495857|464358032|FG002|Overall Study|Lost to Follow-up|3|||
129017177|NCT02495857|464358030|FG000|Overall Study|Other|3|||
128881550|NCT01440374|463861465|FG001|Part 3: Extension|Withdrawal by Subject|0|||
128881551|NCT01440374|463861466|FG002|Part 3: Extension|Withdrawal by Subject|0|||
128881552|NCT01440374|463861467|FG003|Part 3: Extension|Withdrawal by Subject|5|||
128881553|NCT01440374|463861464|FG000|Part 3: Extension|Adverse Event|0|||
128881554|NCT01440374|463861465|FG001|Part 3: Extension|Adverse Event|0|||
128881555|NCT01440374|463861466|FG002|Part 3: Extension|Adverse Event|0|||
128881556|NCT01440374|463861467|FG003|Part 3: Extension|Adverse Event|13|||
129017178|NCT02495857|464358031|FG001|Overall Study|Other|3|||
129017179|NCT02495857|464358032|FG002|Overall Study|Other|2|||
129017180|NCT00396279|464358033|FG000|Overall Study|Ongoing in study|26|||
129017181|NCT00396279|464358033|FG000|Overall Study|Disease progression|2|||
128881557|NCT01440374|463861464|FG000|Part 3: Extension|Physician Decision|0|||
128881558|NCT01440374|463861465|FG001|Part 3: Extension|Physician Decision|0|||
128881559|NCT01440374|463861466|FG002|Part 3: Extension|Physician Decision|0|||
128881560|NCT01440374|463861467|FG003|Part 3: Extension|Physician Decision|14|||
128881561|NCT01177722|463861473|FG000|Overall Study|Serious Adverse Event|0|||
128881562|NCT01177722|463861474|FG001|Overall Study|Serious Adverse Event|0|||
128881563|NCT01177722|463861475|FG002|Overall Study|Serious Adverse Event|1|||
128881564|NCT01177722|463861476|FG003|Overall Study|Serious Adverse Event|0|||
128881565|NCT01177722|463861473|FG000|Overall Study|Protocol Violation|0|||
128881566|NCT01177722|463861474|FG001|Overall Study|Protocol Violation|0|||
128881567|NCT01177722|463861475|FG002|Overall Study|Protocol Violation|1|||
128881568|NCT01177722|463861476|FG003|Overall Study|Protocol Violation|0|||
128881569|NCT01177722|463861473|FG000|Overall Study|Lost to Follow-up|3|||
128881570|NCT01177722|463861474|FG001|Overall Study|Lost to Follow-up|4|||
128881571|NCT01177722|463861475|FG002|Overall Study|Lost to Follow-up|3|||
128881572|NCT01177722|463861476|FG003|Overall Study|Lost to Follow-up|1|||
128881573|NCT01177722|463861473|FG000|Overall Study|Withdrawal by Subject|10|||
128881574|NCT01177722|463861474|FG001|Overall Study|Withdrawal by Subject|6|||
128881575|NCT01177722|463861475|FG002|Overall Study|Withdrawal by Subject|4|||
128881576|NCT01177722|463861476|FG003|Overall Study|Withdrawal by Subject|6|||
128881577|NCT02647320|463861477|FG000|Overall Study|Adverse Event|0|||
128881578|NCT02647320|463861478|FG001|Overall Study|Adverse Event|1|||
128881579|NCT02647320|463861479|FG002|Overall Study|Adverse Event|3|||
128881580|NCT02647320|463861480|FG003|Overall Study|Adverse Event|2|||
128881581|NCT02647320|463861481|FG004|Overall Study|Adverse Event|1|||
128881582|NCT02647320|463861477|FG000|Overall Study|Protocol Violation|0|||
128881583|NCT02647320|463861478|FG001|Overall Study|Protocol Violation|0|||
128881584|NCT02647320|463861479|FG002|Overall Study|Protocol Violation|3|||
128881585|NCT02647320|463861480|FG003|Overall Study|Protocol Violation|0|||
128881586|NCT02647320|463861481|FG004|Overall Study|Protocol Violation|0|||
128881587|NCT02647320|463861477|FG000|Overall Study|Withdrawal by Subject|7|||
128881588|NCT02647320|463861478|FG001|Overall Study|Withdrawal by Subject|4|||
128881589|NCT02647320|463861479|FG002|Overall Study|Withdrawal by Subject|2|||
128881590|NCT02647320|463861480|FG003|Overall Study|Withdrawal by Subject|2|||
128881591|NCT02647320|463861481|FG004|Overall Study|Withdrawal by Subject|7|||
128881592|NCT02647320|463861477|FG000|Overall Study|Persistent hyperglycemia|0|||
128881593|NCT02647320|463861478|FG001|Overall Study|Persistent hyperglycemia|1|||
128881594|NCT02647320|463861479|FG002|Overall Study|Persistent hyperglycemia|1|||
128881595|NCT02647320|463861480|FG003|Overall Study|Persistent hyperglycemia|1|||
128881596|NCT02647320|463861481|FG004|Overall Study|Persistent hyperglycemia|1|||
128881597|NCT02647320|463861477|FG000|Overall Study|Study terminated by sponsor|1|||
128881598|NCT02647320|463861478|FG001|Overall Study|Study terminated by sponsor|1|||
128881599|NCT02647320|463861479|FG002|Overall Study|Study terminated by sponsor|1|||
128881600|NCT02647320|463861480|FG003|Overall Study|Study terminated by sponsor|1|||
128881601|NCT02647320|463861481|FG004|Overall Study|Study terminated by sponsor|2|||
128881602|NCT02647320|463861477|FG000|Overall Study|Reason not provided|0|||
128881603|NCT02647320|463861478|FG001|Overall Study|Reason not provided|0|||
128881604|NCT02647320|463861479|FG002|Overall Study|Reason not provided|1|||
128881605|NCT02647320|463861480|FG003|Overall Study|Reason not provided|0|||
128881606|NCT02647320|463861481|FG004|Overall Study|Reason not provided|2|||
128881607|NCT02647320|463861477|FG000|Overall Study|Lost to Follow-up|1|||
128881608|NCT02647320|463861478|FG001|Overall Study|Lost to Follow-up|1|||
128881609|NCT02647320|463861479|FG002|Overall Study|Lost to Follow-up|0|||
128881610|NCT02647320|463861480|FG003|Overall Study|Lost to Follow-up|0|||
129017182|NCT00396279|464358033|FG000|Overall Study|Withdrawal by Subject|1|||
129017183|NCT00396279|464358033|FG000|Overall Study|Physician Decision|1|||
129017184|NCT02883452|464358034|FG000|Overall Study|Withdrawal by Subject|1|||
129017185|NCT02883452|464358035|FG001|Overall Study|Withdrawal by Subject|1|||
128881611|NCT02647320|463861481|FG004|Overall Study|Lost to Follow-up|0|||
128881612|NCT02647320|463861477|FG000|Overall Study|Develop anemia|1|||
128881613|NCT02647320|463861478|FG001|Overall Study|Develop anemia|0|||
128881614|NCT02647320|463861479|FG002|Overall Study|Develop anemia|0|||
128881615|NCT02647320|463861480|FG003|Overall Study|Develop anemia|0|||
128881616|NCT02647320|463861481|FG004|Overall Study|Develop anemia|0|||
129017186|NCT02883452|464358036|FG002|Overall Study|Withdrawal by Subject|3|||
129017187|NCT02883452|464358037|FG003|Overall Study|Withdrawal by Subject|0|||
129017188|NCT02883452|464358038|FG004|Overall Study|Withdrawal by Subject|2|||
128881617|NCT02647320|463861477|FG000|Overall Study|Lack of Efficacy|0|||
128881618|NCT02647320|463861478|FG001|Overall Study|Lack of Efficacy|0|||
128881619|NCT02647320|463861479|FG002|Overall Study|Lack of Efficacy|0|||
128881620|NCT02647320|463861480|FG003|Overall Study|Lack of Efficacy|1|||
129017189|NCT02883452|464358039|FG005|Overall Study|Withdrawal by Subject|5|||
129017190|NCT02883452|464358034|FG000|Overall Study|Disease progression|1|||
128881621|NCT02647320|463861481|FG004|Overall Study|Lack of Efficacy|0|||
128881622|NCT02647320|463861477|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
128881623|NCT02647320|463861478|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
128881624|NCT02647320|463861479|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
129017191|NCT02883452|464358035|FG001|Overall Study|Disease progression|0|||
128881625|NCT02647320|463861480|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
128881626|NCT02647320|463861481|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
128881627|NCT00596427|463861482|FG000|Overall Study|Withdrawal by Subject|2|||
128881628|NCT00596427|463861483|FG001|Overall Study|Withdrawal by Subject|2|||
128881629|NCT00596427|463861482|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
128881630|NCT00596427|463861483|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
128881631|NCT00596427|463861482|FG000|Overall Study|Protocol Violation|1|||
128881632|NCT00596427|463861483|FG001|Overall Study|Protocol Violation|0|||
128881633|NCT00320541|463861484|FG000|Overall Study|Adverse Event|21|||
128881634|NCT00320541|463861485|FG001|Overall Study|Adverse Event|19|||
128881635|NCT00320541|463861484|FG000|Overall Study|Protocol Violation|0|||
128881636|NCT00320541|463861485|FG001|Overall Study|Protocol Violation|1|||
128881637|NCT00320541|463861484|FG000|Overall Study|Withdrawal by Subject|12|||
128881638|NCT00320541|463861485|FG001|Overall Study|Withdrawal by Subject|16|||
128881639|NCT00320541|463861484|FG000|Overall Study|Physician Decision|9|||
128881640|NCT00320541|463861485|FG001|Overall Study|Physician Decision|13|||
128881641|NCT00320541|463861484|FG000|Overall Study|Other|3|||
128881642|NCT00320541|463861485|FG001|Overall Study|Other|4|||
128881643|NCT00320541|463861484|FG000|Overall Study|Sponsor Decision|2|||
128881644|NCT00320541|463861485|FG001|Overall Study|Sponsor Decision|1|||
128881645|NCT00320541|463861484|FG000|Overall Study|Death due to Study Disease|1|||
128881646|NCT00320541|463861485|FG001|Overall Study|Death due to Study Disease|3|||
128881647|NCT00320541|463861484|FG000|Overall Study|Death due to Adverse Event(s)|1|||
128881648|NCT00320541|463861485|FG001|Overall Study|Death due to Adverse Event(s)|0|||
128881649|NCT00320541|463861484|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
128881650|NCT00320541|463861485|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
128881651|NCT03057977|463861486|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
128881652|NCT03057977|463861487|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
128881653|NCT03057977|463861486|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
128881654|NCT03057977|463861487|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
128881655|NCT03057977|463861486|FG000|Discontinuation From Treatment|Protocol Violation|6|||
128881656|NCT03057977|463861487|FG001|Discontinuation From Treatment|Protocol Violation|5|||
128881657|NCT03057977|463861486|FG000|Discontinuation From Treatment|Not treated|4|||
128881658|NCT03057977|463861487|FG001|Discontinuation From Treatment|Not treated|0|||
128881659|NCT03057977|463861486|FG000|Discontinuation From Treatment|Adverse Event|343|||
128881660|NCT03057977|463861487|FG001|Discontinuation From Treatment|Adverse Event|337|||
128881661|NCT03057977|463861486|FG000|Discontinuation From Treatment|Reason Unknown|0|||
128881662|NCT03057977|463861487|FG001|Discontinuation From Treatment|Reason Unknown|1|||
128881663|NCT03057977|463861486|FG000|Discontinuation From Treatment|Personal Reasons|1|||
128881664|NCT03057977|463861487|FG001|Discontinuation From Treatment|Personal Reasons|1|||
128881665|NCT03057977|463861486|FG000|Discontinuation From Treatment|Unblinded medication|1|||
128881666|NCT03057977|463861487|FG001|Discontinuation From Treatment|Unblinded medication|0|||
128881667|NCT03057977|463861486|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
128881668|NCT03057977|463861487|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
128881669|NCT03057977|463861486|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
128881670|NCT03057977|463861487|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
128881671|NCT03057977|463861486|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
128881672|NCT03057977|463861487|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
128881673|NCT03057977|463861486|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
128881674|NCT03057977|463861487|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
129017192|NCT02883452|464358036|FG002|Overall Study|Disease progression|0|||
129017193|NCT02883452|464358037|FG003|Overall Study|Disease progression|1|||
129017194|NCT02883452|464358038|FG004|Overall Study|Disease progression|4|||
129017195|NCT02883452|464358039|FG005|Overall Study|Disease progression|5|||
129017196|NCT02883452|464358034|FG000|Overall Study|Adverse Event|2|||
129017197|NCT02883452|464358035|FG001|Overall Study|Adverse Event|1|||
129017198|NCT02883452|464358036|FG002|Overall Study|Adverse Event|1|||
129017199|NCT02883452|464358037|FG003|Overall Study|Adverse Event|1|||
129017200|NCT02883452|464358038|FG004|Overall Study|Adverse Event|1|||
129017201|NCT02883452|464358039|FG005|Overall Study|Adverse Event|3|||
129017202|NCT02883452|464358034|FG000|Overall Study|Physician Decision|0|||
129017203|NCT02883452|464358035|FG001|Overall Study|Physician Decision|0|||
129104861|NCT00412932|464678791|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
128683149|NCT01975831|463138767|FG001|Overall Study|Entered Hospice|0|||
128881675|NCT03057977|463861486|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
128881676|NCT03057977|463861487|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
128881677|NCT03057977|463861486|FG000|Discontinuation From Treatment|Not attending study visit|3|||
128881678|NCT03057977|463861487|FG001|Discontinuation From Treatment|Not attending study visit|10|||
128881679|NCT03057977|463861486|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
129017204|NCT02883452|464358036|FG002|Overall Study|Physician Decision|0|||
129017205|NCT02883452|464358037|FG003|Overall Study|Physician Decision|0|||
129017206|NCT02883452|464358038|FG004|Overall Study|Physician Decision|4|||
128881680|NCT03057977|463861487|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
128881681|NCT03057977|463861486|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
128881682|NCT03057977|463861487|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
128881683|NCT03057977|463861486|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
128881684|NCT03057977|463861487|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
128881685|NCT03057977|463861486|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
128881686|NCT03057977|463861487|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
128881687|NCT03057977|463861486|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
128881688|NCT03057977|463861487|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
128881689|NCT01650246|463861490|FG000|Overall Study|Adverse Event|23|||
128881690|NCT01650246|463861490|FG000|Overall Study|Protocol Violation|5|||
128881691|NCT01650246|463861490|FG000|Overall Study|Sponsor terminated study|53|||
128881692|NCT01650246|463861490|FG000|Overall Study|Lost to Follow-up|5|||
128881693|NCT01650246|463861490|FG000|Overall Study|Withdrawal by Subject|26|||
128881694|NCT01650246|463861490|FG000|Overall Study|Death|1|||
128881695|NCT01650246|463861490|FG000|Overall Study|Lack of Efficacy|30|||
128881696|NCT00953407|463861491|FG000|Overall Study|Failed inclusion criteria|1|||
128881697|NCT00953407|463861492|FG001|Overall Study|Failed inclusion criteria|1|||
128881698|NCT00953407|463861493|FG002|Overall Study|Failed inclusion criteria|1|||
128881699|NCT00953407|463861494|FG003|Overall Study|Failed inclusion criteria|1|||
128881700|NCT00953407|463861495|FG004|Overall Study|Failed inclusion criteria|1|||
128881701|NCT00953407|463861491|FG000|Overall Study|Lost to Follow-up|0|||
128881702|NCT00953407|463861492|FG001|Overall Study|Lost to Follow-up|0|||
128881703|NCT00953407|463861493|FG002|Overall Study|Lost to Follow-up|0|||
128881704|NCT00953407|463861494|FG003|Overall Study|Lost to Follow-up|1|||
128881705|NCT00953407|463861495|FG004|Overall Study|Lost to Follow-up|0|||
128881706|NCT03435497|463861497|FG000|Overall Study|Lost to Follow-up|1|||
128881707|NCT03435497|463861498|FG001|Overall Study|Lost to Follow-up|0|||
128881708|NCT03435497|463861497|FG000|Overall Study|Death|1|||
128881709|NCT03435497|463861498|FG001|Overall Study|Death|0|||
128881710|NCT03435497|463861497|FG000|Overall Study|Withdrawal by Subject|0|||
128881711|NCT03435497|463861498|FG001|Overall Study|Withdrawal by Subject|4|||
128881712|NCT03435497|463861497|FG000|Overall Study|Wrong survey administered|0|||
128881713|NCT03435497|463861498|FG001|Overall Study|Wrong survey administered|2|||
128881714|NCT00701779|463861499|FG000|Overall Study|Adverse Event|6|||
128881715|NCT00701779|463861499|FG000|Overall Study|Lost to Follow-up|1|||
128881716|NCT00701779|463861499|FG000|Overall Study|Withdrawal by Subject|2|||
128881717|NCT03645057|463861500|FG000|Randomization to Baseline|Lost to Follow-up|1|||
128881718|NCT03645057|463861501|FG001|Randomization to Baseline|Lost to Follow-up|0|||
128881719|NCT03645057|463861502|FG002|Randomization to Baseline|Lost to Follow-up|1|||
128881720|NCT03645057|463861503|FG003|Randomization to Baseline|Lost to Follow-up|0|||
128881721|NCT03645057|463861500|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
128881722|NCT03645057|463861501|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
128881723|NCT03645057|463861502|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
128881724|NCT03645057|463861503|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
128881725|NCT03645057|463861500|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
128881726|NCT03645057|463861501|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
128881727|NCT03645057|463861502|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
128881728|NCT03645057|463861503|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
128881729|NCT03645057|463861500|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
128881730|NCT03645057|463861501|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
128881731|NCT03645057|463861502|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
128881732|NCT03645057|463861503|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
128881733|NCT01873495|463861504|FG000|Overall Study|Withdrawal by Subject|1|||
128881734|NCT01873495|463861504|FG000|Overall Study|Physician Decision|3|||
128881735|NCT01873495|463861504|FG000|Overall Study|Adverse Event|1|||
128881736|NCT01873495|463861504|FG000|Overall Study|Removed for Transplantation|1|||
128881737|NCT01873495|463861504|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
128881738|NCT01206777|463861505|FG000|Overall Study|Death|1|||
128881739|NCT01206777|463861505|FG000|Overall Study|Adverse Event|1|||
128881740|NCT02986334|463861506|FG000|Overall Study|Withdrawal by Subject|0|||
128881741|NCT02986334|463861507|FG001|Overall Study|Withdrawal by Subject|1|||
128881742|NCT02986334|463861508|FG002|Overall Study|Withdrawal by Subject|2|||
128881743|NCT02986334|463861506|FG000|Overall Study|Lost to Follow-up|1|||
128881744|NCT02986334|463861507|FG001|Overall Study|Lost to Follow-up|2|||
128881745|NCT02986334|463861508|FG002|Overall Study|Lost to Follow-up|1|||
128881746|NCT02986334|463861506|FG000|Overall Study|Adverse Event|0|||
128881747|NCT02986334|463861507|FG001|Overall Study|Adverse Event|2|||
128881748|NCT02986334|463861508|FG002|Overall Study|Adverse Event|1|||
128881749|NCT02986334|463861506|FG000|Overall Study|non compliance in phone ratings|2|||
128683150|NCT01975831|463138768|FG002|Overall Study|Entered Hospice|0|||
128881750|NCT02986334|463861507|FG001|Overall Study|non compliance in phone ratings|1|||
128881751|NCT02986334|463861508|FG002|Overall Study|non compliance in phone ratings|2|||
128881752|NCT02986334|463861506|FG000|Overall Study|undisclosed comorbidities|0|||
128683151|NCT01975831|463138769|FG003|Overall Study|Entered Hospice|0|||
128881753|NCT02986334|463861507|FG001|Overall Study|undisclosed comorbidities|1|||
128881754|NCT02986334|463861508|FG002|Overall Study|undisclosed comorbidities|1|||
128881755|NCT03864146|463861509|FG000|Overall Study|Lost to Follow-up|14|||
128881756|NCT03864146|463861510|FG001|Overall Study|Lost to Follow-up|23|||
128881757|NCT03864146|463861509|FG000|Overall Study|Withdrawal by Subject|3|||
128881758|NCT03864146|463861510|FG001|Overall Study|Withdrawal by Subject|2|||
128881759|NCT00690820|463861514|FG000|Period 1|Withdrawal by Subject|0|||
128881760|NCT00690820|463861515|FG001|Period 1|Withdrawal by Subject|1|||
128881761|NCT01768117|463861517|FG000|Overall Study|Lost to Follow-up|1|||
128881762|NCT01768117|463861517|FG000|Overall Study|Withdrawal by Subject|2|||
128881763|NCT01768117|463861517|FG000|Overall Study|Protocol Violation|3|||
128881764|NCT03451162|463861520|FG000|Overall Study|Lost to Follow-up|1|||
128881765|NCT03451162|463861521|FG001|Overall Study|Lost to Follow-up|0|||
128881766|NCT03451162|463861522|FG002|Overall Study|Lost to Follow-up|0|||
128881767|NCT03451162|463861523|FG003|Overall Study|Lost to Follow-up|0|||
128881768|NCT03451162|463861524|FG004|Overall Study|Lost to Follow-up|0|||
128881769|NCT03451162|463861520|FG000|Overall Study|Physician Decision|0|||
128881770|NCT03451162|463861521|FG001|Overall Study|Physician Decision|1|||
128881771|NCT03451162|463861522|FG002|Overall Study|Physician Decision|0|||
128881772|NCT03451162|463861523|FG003|Overall Study|Physician Decision|0|||
128881773|NCT03451162|463861524|FG004|Overall Study|Physician Decision|0|||
128881774|NCT03451162|463861520|FG000|Overall Study|Withdrawal by Subject|1|||
128881775|NCT03451162|463861521|FG001|Overall Study|Withdrawal by Subject|1|||
128881776|NCT03451162|463861522|FG002|Overall Study|Withdrawal by Subject|0|||
128881777|NCT03451162|463861523|FG003|Overall Study|Withdrawal by Subject|0|||
128881778|NCT03451162|463861524|FG004|Overall Study|Withdrawal by Subject|0|||
128881779|NCT03658668|463861525|FG000|Overall Study|Time Commitment|1|||
128881780|NCT03658668|463861526|FG001|Overall Study|Time Commitment|1|||
128881781|NCT01127139|463861527|FG000|Overall Study|Adverse Event|40|||
128881782|NCT01127139|463861527|FG000|Overall Study|Incompliance|12|||
128881783|NCT01127139|463861527|FG000|Overall Study|Lack of Efficacy|4|||
128881784|NCT01127139|463861527|FG000|Overall Study|Reason not specified|1|||
128881785|NCT01580969|463861529|FG000|Overall Study|Physician Decision|3|||
128881786|NCT01580969|463861530|FG001|Overall Study|Physician Decision|0|||
128881787|NCT01580969|463861531|FG002|Overall Study|Physician Decision|0|||
128881788|NCT01079741|463861537|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
128881789|NCT01079741|463861538|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
128881790|NCT01079741|463861539|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
128881791|NCT01079741|463861540|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129017207|NCT02883452|464358039|FG005|Overall Study|Physician Decision|1|||
129017208|NCT02883452|464358034|FG000|Overall Study|Death|1|||
129017209|NCT02883452|464358035|FG001|Overall Study|Death|0|||
129017210|NCT02883452|464358036|FG002|Overall Study|Death|1|||
129017211|NCT02883452|464358037|FG003|Overall Study|Death|0|||
129017212|NCT02883452|464358038|FG004|Overall Study|Death|0|||
129017213|NCT02883452|464358039|FG005|Overall Study|Death|0|||
129017214|NCT02883452|464358034|FG000|Overall Study|Other|0|||
129017215|NCT02883452|464358035|FG001|Overall Study|Other|0|||
129017216|NCT02883452|464358036|FG002|Overall Study|Other|0|||
129017217|NCT02883452|464358037|FG003|Overall Study|Other|0|||
129017218|NCT02883452|464358038|FG004|Overall Study|Other|0|||
129017219|NCT02883452|464358039|FG005|Overall Study|Other|1|||
129017220|NCT00830206|464358040|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
129017221|NCT00830206|464358041|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
129017222|NCT00905346|464358043|FG000|Period 1|Withdrawal by Subject|1|||
129017223|NCT00905346|464358044|FG001|Period 1|Withdrawal by Subject|0|||
129017224|NCT01435265|464358045|FG000|Overall Study|Lost to Follow-up|0|||
129017225|NCT01435265|464358046|FG001|Overall Study|Lost to Follow-up|1|||
129017226|NCT04605094|464358047|FG000|Overall Study|Adverse Event|2|||
129017227|NCT04605094|464358048|FG001|Overall Study|Adverse Event|2|||
129017228|NCT04605094|464358047|FG000|Overall Study|Lost to Follow-up|1|||
129017229|NCT04605094|464358048|FG001|Overall Study|Lost to Follow-up|4|||
129017230|NCT04605094|464358047|FG000|Overall Study|Physician Decision|2|||
129017231|NCT04605094|464358048|FG001|Overall Study|Physician Decision|2|||
129017232|NCT04605094|464358047|FG000|Overall Study|Study terminated by Sponsor|31|||
129017233|NCT04605094|464358048|FG001|Overall Study|Study terminated by Sponsor|33|||
128683152|NCT01975831|463138770|FG004|Overall Study|Entered Hospice|0|||
128683153|NCT01975831|463138771|FG005|Overall Study|Entered Hospice|1|||
128881792|NCT01079741|463861541|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
128881793|NCT01079741|463861537|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
128881794|NCT01079741|463861538|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
128881795|NCT01079741|463861539|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
128881796|NCT01079741|463861540|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
128881797|NCT01079741|463861541|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
128881798|NCT00446992|463861542|FG000|Overall Study|Adverse Event|11|||
129017234|NCT04605094|464358047|FG000|Overall Study|Withdrawal by Subject|22|||
129017235|NCT04605094|464358048|FG001|Overall Study|Withdrawal by Subject|19|||
129017236|NCT04605094|464358047|FG000|Overall Study|Other|1|||
129017237|NCT04605094|464358048|FG001|Overall Study|Other|1|||
128881799|NCT00446992|463861542|FG000|Overall Study|Lost to Follow-up|5|||
128881800|NCT02076178|463861543|FG000|Oral Phase|Adverse Event|0|||
128881801|NCT02076178|463861544|FG001|Oral Phase|Adverse Event|7|||
128881802|NCT02076178|463861543|FG000|Oral Phase|Withdrawal by Subject|0|||
128881803|NCT02076178|463861544|FG001|Oral Phase|Withdrawal by Subject|4|||
128881804|NCT02076178|463861543|FG000|Oral Phase|Physician Decision|0|||
128881805|NCT02076178|463861544|FG001|Oral Phase|Physician Decision|1|||
128881806|NCT02076178|463861543|FG000|Injection Phase|Protocol defined stopping criteria|1|||
128881807|NCT02076178|463861544|FG001|Injection Phase|Protocol defined stopping criteria|0|||
128881808|NCT02076178|463861543|FG000|Injection Phase|Withdrawal by Subject|0|||
128881809|NCT02076178|463861544|FG001|Injection Phase|Withdrawal by Subject|3|||
128881810|NCT02076178|463861543|FG000|Injection Phase|Physician Decision|0|||
128881811|NCT02076178|463861544|FG001|Injection Phase|Physician Decision|3|||
128881812|NCT02076178|463861543|FG000|Injection Phase|Lost to Follow-up|0|||
128881813|NCT02076178|463861544|FG001|Injection Phase|Lost to Follow-up|1|||
128881814|NCT02434939|463861552|FG000|Overall Study|Lack of Efficacy|34|||
128881815|NCT02434939|463861553|FG001|Overall Study|Lack of Efficacy|48|||
128881816|NCT02434939|463861552|FG000|Overall Study|Withdrawal by Subject|3|||
128881817|NCT02434939|463861553|FG001|Overall Study|Withdrawal by Subject|0|||
128881818|NCT02434939|463861552|FG000|Overall Study|Adverse Event|0|||
128881819|NCT02434939|463861553|FG001|Overall Study|Adverse Event|1|||
128881820|NCT03021954|463861556|FG000|Overall Study|Lost to Follow-up|10|||
128881821|NCT03021954|463861557|FG001|Overall Study|Lost to Follow-up|43|||
128881822|NCT03021954|463861556|FG000|Overall Study|Subjects had avulsion trauma|4|||
128881823|NCT03021954|463861557|FG001|Overall Study|Subjects had avulsion trauma|1|||
128881824|NCT00069238|463861560|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
128881825|NCT00069238|463861561|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
128881826|NCT00069238|463861562|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
128881827|NCT00069238|463861560|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
128881828|NCT00069238|463861561|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
128881829|NCT00069238|463861562|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
128881830|NCT00069238|463861560|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
128881831|NCT00069238|463861561|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
128881832|NCT00069238|463861562|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
128881833|NCT01001832|463861563|FG000|Short-term Period|Adverse Event|2|||
128881834|NCT01001832|463861564|FG001|Short-term Period|Adverse Event|3|||
128881835|NCT01001832|463861563|FG000|Long-term Period|Adverse Event|2|||
128881836|NCT01001832|463861564|FG001|Long-term Period|Adverse Event|1|||
128881837|NCT01001832|463861563|FG000|Long-term Period|Withdrawal by Subject|1|||
128881838|NCT01001832|463861564|FG001|Long-term Period|Withdrawal by Subject|0|||
128881839|NCT01001832|463861563|FG000|Long-term Period|Lack of Efficacy|0|||
128881840|NCT01001832|463861564|FG001|Long-term Period|Lack of Efficacy|2|||
128881841|NCT01001832|463861563|FG000|Long-term Period|Other|1|||
128881842|NCT01001832|463861564|FG001|Long-term Period|Other|2|||
128881843|NCT01001832|463861563|FG000|Follow-up Period|Withdrawal by Subject|1|||
128881844|NCT01001832|463861564|FG001|Follow-up Period|Withdrawal by Subject|0|||
128881845|NCT01001832|463861563|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
128881846|NCT01001832|463861564|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
128881847|NCT01001832|463861563|FG000|Follow-up Period|Other|2|||
128881848|NCT01001832|463861564|FG001|Follow-up Period|Other|1|||
128881849|NCT00710021|463861573|FG000|Overall Study|Lost to Follow-up|1|||
128881850|NCT00710021|463861574|FG001|Overall Study|Lost to Follow-up|0|||
128881851|NCT00710021|463861575|FG002|Overall Study|Lost to Follow-up|0|||
128881852|NCT00710021|463861573|FG000|Overall Study|Subject's Decision|0|||
128881853|NCT00710021|463861574|FG001|Overall Study|Subject's Decision|1|||
128881854|NCT00710021|463861575|FG002|Overall Study|Subject's Decision|0|||
128881855|NCT00710021|463861573|FG000|Overall Study|Subject misrandomized|0|||
128881856|NCT00710021|463861574|FG001|Overall Study|Subject misrandomized|1|||
128881857|NCT00710021|463861575|FG002|Overall Study|Subject misrandomized|1|||
128881858|NCT00710021|463861573|FG000|Overall Study|Physician Decision|0|||
128881859|NCT00710021|463861574|FG001|Overall Study|Physician Decision|1|||
128881860|NCT00710021|463861575|FG002|Overall Study|Physician Decision|0|||
129017238|NCT02724462|464358049|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
129017239|NCT02724462|464358050|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
129017240|NCT02724462|464358049|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
128881861|NCT01536015|463861576|FG000|Overall Study|Adverse Event|1|||
128881862|NCT01536015|463861577|FG001|Overall Study|Adverse Event|4|||
128881863|NCT01536015|463861576|FG000|Overall Study|Lost to Follow-up|0|||
128881864|NCT01536015|463861577|FG001|Overall Study|Lost to Follow-up|1|||
128881865|NCT01536015|463861576|FG000|Overall Study|Inclusion Criterion not met|2|||
128881866|NCT01536015|463861577|FG001|Overall Study|Inclusion Criterion not met|0|||
128881867|NCT01536015|463861576|FG000|Overall Study|Study closure|5|||
128881868|NCT01536015|463861577|FG001|Overall Study|Study closure|5|||
128881869|NCT03581825|463861579|FG000|Period 1|Lens Discomfort|1|||
128881870|NCT03581825|463861580|FG001|Period 1|Lens Discomfort|0|||
128881871|NCT03581825|463861579|FG000|Period 2|Unsatisfactory Vision to Test|0|||
129017241|NCT02724462|464358050|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
128881872|NCT03581825|463861580|FG001|Period 2|Unsatisfactory Vision to Test|1|||
128881873|NCT01668667|463861581|FG000|Overall Study|Adverse Event|3|||
128881874|NCT01668667|463861582|FG001|Overall Study|Adverse Event|6|||
128881875|NCT01668667|463861583|FG002|Overall Study|Adverse Event|4|||
128881876|NCT01668667|463861584|FG003|Overall Study|Adverse Event|4|||
128881877|NCT01668667|463861581|FG000|Overall Study|Lack of Efficacy|3|||
128881878|NCT01668667|463861582|FG001|Overall Study|Lack of Efficacy|2|||
128881879|NCT01668667|463861583|FG002|Overall Study|Lack of Efficacy|2|||
128881880|NCT01668667|463861584|FG003|Overall Study|Lack of Efficacy|3|||
128881881|NCT01668667|463861581|FG000|Overall Study|Protocol Violation|6|||
128881882|NCT01668667|463861582|FG001|Overall Study|Protocol Violation|10|||
128881883|NCT01668667|463861583|FG002|Overall Study|Protocol Violation|12|||
128881884|NCT01668667|463861584|FG003|Overall Study|Protocol Violation|5|||
128881885|NCT01668667|463861581|FG000|Overall Study|Lost to Follow-up|9|||
128881886|NCT01668667|463861582|FG001|Overall Study|Lost to Follow-up|4|||
128881887|NCT01668667|463861583|FG002|Overall Study|Lost to Follow-up|7|||
128881888|NCT01668667|463861584|FG003|Overall Study|Lost to Follow-up|6|||
129017242|NCT02724462|464358049|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
129017243|NCT02724462|464358050|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
129017244|NCT02724462|464358049|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
129017245|NCT02724462|464358050|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
129017246|NCT02724462|464358049|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
129017247|NCT02724462|464358050|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
129017248|NCT02724462|464358049|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
129017249|NCT02724462|464358050|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
129017250|NCT01900691|464358051|FG000|Overall Study|Death|7|||
129017251|NCT01900691|464358051|FG000|Overall Study|Lost to Follow-up|4|||
129017252|NCT01900691|464358051|FG000|Overall Study|Study Device Not Placed|3|||
129017253|NCT01900691|464358051|FG000|Overall Study|Non study stent placed|2|||
129017254|NCT01900691|464358051|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
129017255|NCT01900691|464358051|FG000|Overall Study|Complete stent migration through digestive tract|1|||
129017256|NCT00328926|464358064|FG000|Overall Study|Pregnancy|2|||
129017257|NCT00328926|464358065|FG001|Overall Study|Pregnancy|1|||
129017258|NCT00328926|464358066|FG002|Overall Study|Pregnancy|0|||
129017259|NCT00328926|464358064|FG000|Overall Study|Lost to Follow-up|0|||
129017260|NCT00328926|464358065|FG001|Overall Study|Lost to Follow-up|1|||
129017261|NCT00328926|464358066|FG002|Overall Study|Lost to Follow-up|0|||
129017262|NCT00328926|464358064|FG000|Overall Study|Death|0|||
129017263|NCT00328926|464358065|FG001|Overall Study|Death|0|||
129017264|NCT00328926|464358066|FG002|Overall Study|Death|1|||
129017265|NCT00328926|464358064|FG000|Overall Study|In vitro fertilization treatment|0|||
129017266|NCT00328926|464358065|FG001|Overall Study|In vitro fertilization treatment|0|||
129017267|NCT00328926|464358066|FG002|Overall Study|In vitro fertilization treatment|1|||
129017268|NCT00328926|464358064|FG000|Overall Study|Lack of ovarian response|0|||
129017269|NCT00328926|464358065|FG001|Overall Study|Lack of ovarian response|1|||
129017270|NCT00328926|464358066|FG002|Overall Study|Lack of ovarian response|0|||
129017271|NCT02269657|464358069|FG000|Overall Study|Protocol Violation|3|||
129017272|NCT00620074|464358070|FG000|Overall Study|Adverse Event|1|||
129017273|NCT00573066|464358071|FG000|Overall Study|Exclusion criteria|18|||
129017274|NCT00573066|464358071|FG000|Overall Study|IV malfunction|1|||
129017275|NCT00573066|464358071|FG000|Overall Study|Postoperative bleeding|1|||
129017276|NCT01838941|464358072|FG000|Overall Study|Adverse Event|1|||
129017277|NCT01838941|464358072|FG000|Overall Study|Withdrawal by Subject|1|||
129017278|NCT02822235|464358073|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
129017279|NCT02822235|464358074|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
129017280|NCT02822235|464358073|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
129017281|NCT02822235|464358074|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
129017282|NCT02822235|464358073|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
129017283|NCT02822235|464358074|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
129017284|NCT02822235|464358073|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
129017285|NCT02822235|464358074|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
129017286|NCT02822235|464358073|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
129017287|NCT02822235|464358074|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
129017288|NCT02822235|464358073|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
128881889|NCT01668667|463861581|FG000|Overall Study|Physician Decision|3|||
128881890|NCT01668667|463861582|FG001|Overall Study|Physician Decision|0|||
128881891|NCT01668667|463861583|FG002|Overall Study|Physician Decision|1|||
129104862|NCT00412932|464678791|FG000|Olmesartan (Olm) 20 mg|Other|1|||
129104863|NCT00412932|464678791|FG000|Olmesartan 40 mg|Adverse Event|4|||
128881892|NCT01668667|463861584|FG003|Overall Study|Physician Decision|0|||
128881893|NCT01668667|463861581|FG000|Overall Study|Withdrawal by Subject|7|||
128881894|NCT01668667|463861582|FG001|Overall Study|Withdrawal by Subject|4|||
128881895|NCT01668667|463861583|FG002|Overall Study|Withdrawal by Subject|5|||
128881896|NCT01668667|463861584|FG003|Overall Study|Withdrawal by Subject|5|||
128881897|NCT00511901|463861585|FG000|Overall Study|Withdrawal by Subject|1|||
128881898|NCT00511901|463861586|FG001|Overall Study|Withdrawal by Subject|3|||
128881899|NCT02447172|463861587|FG000|Overall Study|Adverse Event|11|||
128881900|NCT02447172|463861588|FG001|Overall Study|Adverse Event|8|||
128881901|NCT02447172|463861589|FG002|Overall Study|Adverse Event|7|||
128881902|NCT02447172|463861587|FG000|Overall Study|Death|3|||
128881903|NCT02447172|463861588|FG001|Overall Study|Death|1|||
128881904|NCT02447172|463861589|FG002|Overall Study|Death|0|||
128881905|NCT02447172|463861587|FG000|Overall Study|Protocol Violation|2|||
128881906|NCT02447172|463861588|FG001|Overall Study|Protocol Violation|1|||
128881907|NCT02447172|463861589|FG002|Overall Study|Protocol Violation|2|||
128881908|NCT02447172|463861587|FG000|Overall Study|Lost to Follow-up|7|||
128881909|NCT02447172|463861588|FG001|Overall Study|Lost to Follow-up|4|||
128881910|NCT02447172|463861589|FG002|Overall Study|Lost to Follow-up|4|||
128881911|NCT02447172|463861587|FG000|Overall Study|Withdrawal by Subject|5|||
128881912|NCT02447172|463861588|FG001|Overall Study|Withdrawal by Subject|1|||
128881913|NCT02447172|463861589|FG002|Overall Study|Withdrawal by Subject|3|||
128881914|NCT02447172|463861587|FG000|Overall Study|protocol specific treatment unrelated|3|||
128881915|NCT02447172|463861588|FG001|Overall Study|protocol specific treatment unrelated|0|||
128881916|NCT02447172|463861589|FG002|Overall Study|protocol specific treatment unrelated|2|||
128881917|NCT03343301|463861590|FG000|Overall Study|Withdrawal by Subject|1|||
128881918|NCT03343301|463861591|FG001|Overall Study|Withdrawal by Subject|1|||
128881919|NCT03343301|463861590|FG000|Overall Study|Death|0|||
128881920|NCT03343301|463861591|FG001|Overall Study|Death|2|||
128881921|NCT03343301|463861590|FG000|Overall Study|Other|0|||
128881922|NCT03343301|463861591|FG001|Overall Study|Other|6|||
128881923|NCT03343301|463861590|FG000|Overall Study|Missing|2|||
128881924|NCT03343301|463861591|FG001|Overall Study|Missing|0|||
128881925|NCT00345293|463861602|FG000|Overall Study|Unable to access line for sample|1|||
128881926|NCT00345293|463861603|FG001|Overall Study|Unable to access line for sample|0|||
128881927|NCT00345293|463861602|FG000|Overall Study|Withdrawal by Subject|1|||
128881928|NCT00345293|463861603|FG001|Overall Study|Withdrawal by Subject|0|||
128881929|NCT02390245|463861604|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
128881930|NCT02390245|463861605|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
128881931|NCT02390245|463861606|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
128881932|NCT02390245|463861604|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
128881933|NCT02390245|463861605|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
128881934|NCT02390245|463861606|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
128881935|NCT01328717|463863196|FG000|Overall Study|Adverse Event|1|||
128881936|NCT03440320|463863197|FG000|Overall Study|Withdrawal by Subject|0|||
128881937|NCT03440320|463863198|FG001|Overall Study|Withdrawal by Subject|1|||
128881938|NCT00001962|463863199|FG000|Overall Study|Lack of Efficacy|18|||
129017289|NCT02822235|464358074|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
129017290|NCT03214952|464358075|FG000|Overall Study|Protocol Deviation|45|||
129017291|NCT03214952|464358075|FG000|Overall Study|Case Report Forms Uncollected|13|||
129017292|NCT03769896|464358078|FG000|Open-label Phase|Lack of Efficacy|5|||
129017293|NCT03769896|464358079|FG001|Open-label Phase|Lack of Efficacy|0|||
129017294|NCT03769896|464358078|FG000|Open-label Phase|Adverse Event|3|||
129017295|NCT03769896|464358079|FG001|Open-label Phase|Adverse Event|0|||
129017296|NCT03769896|464358078|FG000|Open-label Phase|Withdrawal by Subject|1|||
129017297|NCT03769896|464358079|FG001|Open-label Phase|Withdrawal by Subject|0|||
129017298|NCT00377260|464358080|FG000|Overall Study|Lost to Follow-up|0|||
129017299|NCT00377260|464358081|FG001|Overall Study|Lost to Follow-up|1|||
129017300|NCT00377260|464358080|FG000|Overall Study|Withdrawal by Subject|2|||
129017301|NCT00377260|464358081|FG001|Overall Study|Withdrawal by Subject|4|||
129017302|NCT00829530|464358082|FG000|First Intervention|Adverse Event|0|||
129017303|NCT00829530|464358083|FG001|First Intervention|Adverse Event|1|||
129017304|NCT00829530|464358082|FG000|First Intervention|Intolerance to Venopuncture|0|||
129017305|NCT00829530|464358083|FG001|First Intervention|Intolerance to Venopuncture|1|||
129017306|NCT00829530|464358082|FG000|Second Intervention|Intolerance to Venopuncture|1|||
129017307|NCT00829530|464358083|FG001|Second Intervention|Intolerance to Venopuncture|0|||
129017308|NCT01015625|464358086|FG000|Overall Study|Lost to Follow-up|3|||
129104864|NCT00412932|464678791|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
128881939|NCT00001962|463863199|FG000|Overall Study|Lack of Accrual|6|||
129017309|NCT01015625|464358087|FG001|Overall Study|Lost to Follow-up|1|||
129017310|NCT01015625|464358086|FG000|Overall Study|Withdrawal by Subject|2|||
129017311|NCT01015625|464358087|FG001|Overall Study|Withdrawal by Subject|3|||
129017312|NCT01015625|464358086|FG000|Overall Study|Physician Decision|2|||
128881940|NCT00001962|463863199|FG000|Overall Study|Death|1|||
128881941|NCT00001962|463863199|FG000|Overall Study|Lost to Follow-up|2|||
128881942|NCT00001962|463863199|FG000|Overall Study|Adverse Event|1|||
128881943|NCT04281004|463863213|FG000|Overall Study|Physician Decision|1|||
128881944|NCT04281004|463863214|FG001|Overall Study|Physician Decision|0|||
128881945|NCT03628898|463863215|FG000|Overall Study|Device deficiency|1|||
128881946|NCT03442985|463863216|FG000|Overall Study|Sponsor Request|55|||
129017313|NCT01015625|464358087|FG001|Overall Study|Physician Decision|0|||
129017314|NCT01015625|464358086|FG000|Overall Study|Death|30|||
128881947|NCT03442985|463863217|FG001|Overall Study|Sponsor Request|60|||
128881948|NCT03442985|463863218|FG002|Overall Study|Sponsor Request|54|||
128881949|NCT03442985|463863216|FG000|Overall Study|Lost to Follow-up|5|||
128881950|NCT03442985|463863217|FG001|Overall Study|Lost to Follow-up|2|||
128881951|NCT03442985|463863218|FG002|Overall Study|Lost to Follow-up|7|||
128881952|NCT03442985|463863216|FG000|Overall Study|Withdrawal by Subject|2|||
128881953|NCT03442985|463863217|FG001|Overall Study|Withdrawal by Subject|3|||
128881954|NCT03442985|463863218|FG002|Overall Study|Withdrawal by Subject|4|||
128881955|NCT03442985|463863216|FG000|Overall Study|Adverse Event|0|||
128881956|NCT03442985|463863217|FG001|Overall Study|Adverse Event|1|||
128881957|NCT03442985|463863218|FG002|Overall Study|Adverse Event|0|||
128881958|NCT01217957|463863219|FG000|Phase 1|Withdrawal by Patient|1|||
128881959|NCT01217957|463863220|FG001|Phase 1|Withdrawal by Patient|0|||
128881960|NCT01217957|463863221|FG002|Phase 1|Withdrawal by Patient|1|||
128881961|NCT01217957|463863222|FG003|Phase 1|Withdrawal by Patient|1|||
128881962|NCT01217957|463863223|FG004|Phase 1|Withdrawal by Patient|0|||
128881963|NCT01217957|463863219|FG000|Phase 2|Withdrawal by Patient|0|||
128881964|NCT01217957|463863220|FG001|Phase 2|Withdrawal by Patient|0|||
128881965|NCT01217957|463863221|FG002|Phase 2|Withdrawal by Patient|0|||
128881966|NCT01217957|463863222|FG003|Phase 2|Withdrawal by Patient|0|||
128881967|NCT01217957|463863223|FG004|Phase 2|Withdrawal by Patient|1|||
128881968|NCT01716117|463863229|FG000|Overall Study|Death|5|||
128881969|NCT01716117|463863230|FG001|Overall Study|Death|2|||
128881970|NCT01716117|463863229|FG000|Overall Study|Withdrawal by Subject|2|||
128881971|NCT01716117|463863230|FG001|Overall Study|Withdrawal by Subject|0|||
128881972|NCT00762970|463863234|FG000|Overall Study|Withdrawal by Subject|7|||
128881973|NCT00762970|463863235|FG001|Overall Study|Withdrawal by Subject|4|||
128881974|NCT00762970|463863236|FG002|Overall Study|Withdrawal by Subject|0|||
128881975|NCT00762970|463863234|FG000|Overall Study|Protocol Violation|3|||
128881976|NCT00762970|463863235|FG001|Overall Study|Protocol Violation|1|||
128881977|NCT00762970|463863236|FG002|Overall Study|Protocol Violation|1|||
128881978|NCT00762970|463863234|FG000|Overall Study|Lost to Follow-up|1|||
128881979|NCT00762970|463863235|FG001|Overall Study|Lost to Follow-up|2|||
128881980|NCT00762970|463863236|FG002|Overall Study|Lost to Follow-up|0|||
128881981|NCT00762970|463863234|FG000|Overall Study|Difficulty of handling lens|1|||
128881982|NCT00762970|463863235|FG001|Overall Study|Difficulty of handling lens|2|||
128881983|NCT00762970|463863236|FG002|Overall Study|Difficulty of handling lens|0|||
128881984|NCT00846391|463863239|FG000|Overall Study|Physician Decision|0|||
128881985|NCT00846391|463863240|FG001|Overall Study|Physician Decision|0|||
128881986|NCT00846391|463863241|FG002|Overall Study|Physician Decision|1|||
128881987|NCT00846391|463863239|FG000|Overall Study|Study Terminated by Sponsor|1|||
128881988|NCT00846391|463863240|FG001|Overall Study|Study Terminated by Sponsor|2|||
128881989|NCT00846391|463863241|FG002|Overall Study|Study Terminated by Sponsor|2|||
129104865|NCT00412932|464678791|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
129104866|NCT00412932|464678791|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
129104867|NCT00412932|464678791|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
129104868|NCT00412932|464678791|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
129104869|NCT00412932|464678791|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
129104870|NCT01490840|464678795|FG000|Phase 1|Lost to Follow-up|1|||
129104871|NCT01490840|464678796|FG001|Phase 1|Lost to Follow-up|0|||
129104872|NCT01490840|464678795|FG000|Phase 1|Adverse Event|2|||
129104873|NCT01490840|464678796|FG001|Phase 1|Adverse Event|1|||
129104874|NCT01490840|464678795|FG000|Phase 1|Withdrawal by Subject|6|||
129104875|NCT01490840|464678796|FG001|Phase 1|Withdrawal by Subject|5|||
129104876|NCT01490840|464678795|FG000|Phase 1|Visit 6a omitted|1|||
129104877|NCT01490840|464678796|FG001|Phase 1|Visit 6a omitted|0|||
129104878|NCT01490840|464678795|FG000|Phase 2|Withdrawal by Subject|4|||
129104879|NCT01490840|464678796|FG001|Phase 2|Withdrawal by Subject|3|||
129104880|NCT01490840|464678795|FG000|Phase 2|Permanent interruption of fingolimod|0|||
129104881|NCT01490840|464678796|FG001|Phase 2|Permanent interruption of fingolimod|1|||
129104882|NCT01490840|464678795|FG000|Phase 2|Lost to Follow-up|1|||
128881990|NCT04634825|463863243|FG000|Overall Study|Death|10|||
128881991|NCT04634825|463863244|FG001|Overall Study|Death|3|||
128881992|NCT04634825|463863243|FG000|Overall Study|Lost to Follow-up|1|||
128881993|NCT04634825|463863244|FG001|Overall Study|Lost to Follow-up|0|||
128881994|NCT04634825|463863243|FG000|Overall Study|Study terminated by sponsor|35|||
128881995|NCT04634825|463863244|FG001|Overall Study|Study terminated by sponsor|11|||
128881996|NCT04634825|463863243|FG000|Overall Study|Withdrawal by Subject|2|||
128881997|NCT04634825|463863244|FG001|Overall Study|Withdrawal by Subject|0|||
128881998|NCT01337115|463863251|FG000|Overall Study|Protocol Violation|2|||
128881999|NCT01337115|463863252|FG001|Overall Study|Protocol Violation|0|||
128882000|NCT00551460|463863258|FG000|Overall Study|Adverse Event|1|||
128882001|NCT00551460|463863258|FG000|Overall Study|Withdrawal by Subject|1|||
128882002|NCT00551460|463863258|FG000|Overall Study|Physician Decision|1|||
129104883|NCT01490840|464678796|FG001|Phase 2|Lost to Follow-up|1|||
129104884|NCT01490840|464678795|FG000|Phase 2|Adverse Event|1|||
129104885|NCT01490840|464678796|FG001|Phase 2|Adverse Event|1|||
129104886|NCT01025284|464678800|FG000|Overall Study|Investigator Decision|0|||
129104887|NCT01025284|464678801|FG001|Overall Study|Investigator Decision|1|||
129017315|NCT01015625|464358087|FG001|Overall Study|Death|22|||
129017316|NCT04112823|464358088|FG000|Overall Study|Lost to Follow-up|2|||
129017317|NCT04112823|464358089|FG001|Overall Study|Lost to Follow-up|3|||
129017318|NCT00625443|464358090|FG000|Overall Study|Adverse Event|1|||
129017319|NCT00625443|464358091|FG001|Overall Study|Adverse Event|4|||
129017320|NCT00625443|464358092|FG002|Overall Study|Adverse Event|0|||
129017321|NCT00625443|464358090|FG000|Overall Study|Non-compliance with protocol|0|||
129017322|NCT00625443|464358091|FG001|Overall Study|Non-compliance with protocol|1|||
129017323|NCT00625443|464358092|FG002|Overall Study|Non-compliance with protocol|0|||
129017324|NCT00625443|464358090|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
129017325|NCT00625443|464358091|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
129017326|NCT00625443|464358092|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
129017327|NCT00625443|464358090|FG000|Overall Study|Withdrawal by Subject|0|||
129017328|NCT00625443|464358091|FG001|Overall Study|Withdrawal by Subject|1|||
129017329|NCT00625443|464358092|FG002|Overall Study|Withdrawal by Subject|2|||
129017330|NCT00625443|464358090|FG000|Overall Study|Physician Decision|0|||
129017331|NCT00625443|464358091|FG001|Overall Study|Physician Decision|4|||
129017332|NCT00625443|464358092|FG002|Overall Study|Physician Decision|2|||
129017333|NCT00625443|464358090|FG000|Overall Study|Other|0|||
129017334|NCT00625443|464358091|FG001|Overall Study|Other|1|||
129017335|NCT00625443|464358092|FG002|Overall Study|Other|1|||
129017336|NCT02924883|464358093|FG000|Overall Study|Death|39|||
129017337|NCT02924883|464358094|FG001|Overall Study|Death|20|||
129017338|NCT02924883|464358093|FG000|Overall Study|Lost to Follow-up|1|||
129017339|NCT02924883|464358094|FG001|Overall Study|Lost to Follow-up|0|||
129017340|NCT02924883|464358093|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
129017341|NCT02924883|464358094|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
129017342|NCT02924883|464358093|FG000|Overall Study|Protocol Violation|1|||
129017343|NCT02924883|464358094|FG001|Overall Study|Protocol Violation|0|||
129017344|NCT02924883|464358093|FG000|Overall Study|Withdrawal by Subject|22|||
129017345|NCT02924883|464358094|FG001|Overall Study|Withdrawal by Subject|16|||
129017346|NCT02924883|464358093|FG000|Overall Study|Progressive Disease|1|||
129017347|NCT02924883|464358094|FG001|Overall Study|Progressive Disease|0|||
129017348|NCT02924883|464358093|FG000|Overall Study|Study Terminated by Sponsor|69|||
129017349|NCT02924883|464358094|FG001|Overall Study|Study Terminated by Sponsor|32|||
129017350|NCT00772941|464358098|FG000|Overall Study|CRFs not available|195|||
129017351|NCT00772941|464358098|FG000|Overall Study|Study not completed|16|||
129017352|NCT00772941|464358098|FG000|Overall Study|Missed Visits|374|||
129017353|NCT00772941|464358098|FG000|Overall Study|Poor Compliance|7|||
129017354|NCT00772941|464358098|FG000|Overall Study|GPSP Violation|90|||
129017355|NCT04786184|464358099|FG000|Overall Study|Adverse Event|4|||
129017356|NCT04786184|464358100|FG001|Overall Study|Adverse Event|0|||
129017357|NCT04786184|464358099|FG000|Overall Study|Withdrawal by Subject|3|||
129017358|NCT04786184|464358100|FG001|Overall Study|Withdrawal by Subject|1|||
129017359|NCT04786184|464358099|FG000|Overall Study|Lost to Follow-up|4|||
129017360|NCT04786184|464358100|FG001|Overall Study|Lost to Follow-up|2|||
129017361|NCT01702987|464358110|FG000|Overall Study|Withdrawal by Subject|1|||
129017362|NCT01702987|464358111|FG001|Overall Study|Withdrawal by Subject|0|||
129017363|NCT02017223|464358112|FG000|Overall Study|Algorithm problems|2|||
129017364|NCT04263649|464358114|FG000|Overall Study|Adverse Event|53|||
129017365|NCT04263649|464358114|FG000|Overall Study|Lost to Follow-up|3|||
129017366|NCT04263649|464358114|FG000|Overall Study|Death|29|||
129017367|NCT04263649|464358114|FG000|Overall Study|Device deficiency|19|||
129017368|NCT04263649|464358114|FG000|Overall Study|other reasons|11|||
129017369|NCT01534520|464358115|FG000|Overall Study|Adverse Event|0|||
129017370|NCT01534520|464358116|FG001|Overall Study|Adverse Event|1|||
129017371|NCT05169710|464358119|FG000|Overall Study|Adverse Event|1|||
129017372|NCT05169710|464358120|FG001|Overall Study|Adverse Event|2|||
129017373|NCT05169710|464358121|FG002|Overall Study|Adverse Event|2|||
129017374|NCT05169710|464358119|FG000|Overall Study|Lost to Follow-up|0|||
129017375|NCT05169710|464358120|FG001|Overall Study|Lost to Follow-up|0|||
129017376|NCT05169710|464358121|FG002|Overall Study|Lost to Follow-up|1|||
129017377|NCT05169710|464358119|FG000|Overall Study|Withdrawal by Subject|2|||
129017378|NCT05169710|464358120|FG001|Overall Study|Withdrawal by Subject|1|||
129017379|NCT05169710|464358121|FG002|Overall Study|Withdrawal by Subject|0|||
129017380|NCT05169710|464358119|FG000|Overall Study|Other Study Discontinuation Reason|0|||
129017381|NCT05169710|464358120|FG001|Overall Study|Other Study Discontinuation Reason|2|||
129017382|NCT05169710|464358121|FG002|Overall Study|Other Study Discontinuation Reason|0|||
129017383|NCT01686438|464358126|FG000|Overall Study|Lost to Follow-up|8|||
129017384|NCT01686438|464358127|FG001|Overall Study|Lost to Follow-up|9|||
129017385|NCT01686438|464358128|FG002|Overall Study|Lost to Follow-up|10|||
129017386|NCT01686438|464358126|FG000|Overall Study|Adverse Event|0|||
128683154|NCT01975831|463138772|FG006|Overall Study|Entered Hospice|0|||
128683155|NCT01975831|463138773|FG007|Overall Study|Entered Hospice|0|||
129017387|NCT01686438|464358127|FG001|Overall Study|Adverse Event|0|||
129017388|NCT01686438|464358128|FG002|Overall Study|Adverse Event|1|||
129017389|NCT01686438|464358126|FG000|Overall Study|Protocol Violation|0|||
129017390|NCT01686438|464358127|FG001|Overall Study|Protocol Violation|0|||
129104888|NCT01025284|464678802|FG002|Overall Study|Investigator Decision|0|||
129104889|NCT01025284|464678800|FG000|Overall Study|Withdrawal by Subject|0|||
129104890|NCT01025284|464678801|FG001|Overall Study|Withdrawal by Subject|1|||
129104891|NCT01025284|464678802|FG002|Overall Study|Withdrawal by Subject|0|||
129104892|NCT00905567|464678804|FG000|Washout|Withdrawal by Subject|0|||
129104893|NCT00905567|464678805|FG001|Washout|Withdrawal by Subject|1|||
129104894|NCT01465230|464678806|FG000|Overall Study|Withdrawal by Subject|2|||
129104895|NCT02753816|464678807|FG000|Overall Study|Protocol Violation|0|||
129104896|NCT02753816|464678808|FG001|Overall Study|Protocol Violation|1|||
129104897|NCT02753816|464678809|FG002|Overall Study|Protocol Violation|0|||
129104898|NCT02542397|464678810|FG000|Overall Study|Death|2|||
129104899|NCT02542397|464678810|FG000|Overall Study|Physician Decision|6|||
129104900|NCT02542397|464678810|FG000|Overall Study|Withdrawal by Subject|6|||
129104901|NCT02542397|464678810|FG000|Overall Study|Lost to Follow-up|2|||
129104902|NCT01738919|464678817|FG000|Overall Study|Lost to Follow-up|1|||
129104903|NCT01738919|464678818|FG001|Overall Study|Lost to Follow-up|0|||
129104904|NCT01738919|464678817|FG000|Overall Study|Immigrated|0|||
129104905|NCT01738919|464678818|FG001|Overall Study|Immigrated|1|||
129104906|NCT01738919|464678817|FG000|Overall Study|Withdrawal by Subject|0|||
129104907|NCT01738919|464678818|FG001|Overall Study|Withdrawal by Subject|1|||
129104908|NCT01738919|464678817|FG000|Overall Study|Not treated in accordance to guidelines|0|||
129104909|NCT01738919|464678818|FG001|Overall Study|Not treated in accordance to guidelines|1|||
129104910|NCT01473940|464678822|FG000|Induction Therapy|Death|0|||
129104911|NCT01473940|464678823|FG001|Induction Therapy|Death|0|||
129104912|NCT01473940|464678824|FG002|Induction Therapy|Death|1|||
129104913|NCT01473940|464678825|FG003|Induction Therapy|Death|1|||
129104914|NCT01473940|464678822|FG000|Induction Therapy|Progressive Disease|0|||
129104915|NCT01473940|464678823|FG001|Induction Therapy|Progressive Disease|1|||
129104916|NCT01473940|464678824|FG002|Induction Therapy|Progressive Disease|1|||
129104917|NCT01473940|464678825|FG003|Induction Therapy|Progressive Disease|0|||
129104918|NCT01473940|464678822|FG000|Maintenance Therapy|Progressive Disease|1|||
129104919|NCT01473940|464678823|FG001|Maintenance Therapy|Progressive Disease|2|||
129104920|NCT01473940|464678824|FG002|Maintenance Therapy|Progressive Disease|1|||
129104921|NCT01473940|464678825|FG003|Maintenance Therapy|Progressive Disease|4|||
129104922|NCT00547248|464678826|FG000|Overall Study|Protocol Violation|0|||
129104923|NCT00547248|464678827|FG001|Overall Study|Protocol Violation|0|||
129104924|NCT00547248|464678828|FG002|Overall Study|Protocol Violation|1|||
129104925|NCT00547248|464678829|FG003|Overall Study|Protocol Violation|1|||
129104926|NCT00547248|464678826|FG000|Overall Study|Migrated/moved from study area|0|||
129104927|NCT00547248|464678827|FG001|Overall Study|Migrated/moved from study area|0|||
129104928|NCT00547248|464678828|FG002|Overall Study|Migrated/moved from study area|2|||
129104929|NCT00547248|464678829|FG003|Overall Study|Migrated/moved from study area|0|||
129104930|NCT00547248|464678826|FG000|Overall Study|Withdrawal by Subject|0|||
129104931|NCT00547248|464678827|FG001|Overall Study|Withdrawal by Subject|0|||
129104932|NCT00547248|464678828|FG002|Overall Study|Withdrawal by Subject|7|||
129104933|NCT00547248|464678829|FG003|Overall Study|Withdrawal by Subject|1|||
129104934|NCT00534248|464678830|FG000|Overall Study|Adverse Event|19|||
129104935|NCT00534248|464678831|FG001|Overall Study|Adverse Event|29|||
129104936|NCT00534248|464678830|FG000|Overall Study|Lost to Follow-up|353|||
129104937|NCT00534248|464678831|FG001|Overall Study|Lost to Follow-up|375|||
129104938|NCT00534248|464678830|FG000|Overall Study|Other protocol specified criteria|13|||
129104939|NCT00534248|464678831|FG001|Overall Study|Other protocol specified criteria|3|||
129104940|NCT00534248|464678830|FG000|Overall Study|Physician Decision|10|||
129104941|NCT00534248|464678831|FG001|Overall Study|Physician Decision|7|||
129104942|NCT00534248|464678830|FG000|Overall Study|Protocol Violation|3|||
129104943|NCT00534248|464678831|FG001|Overall Study|Protocol Violation|4|||
129104944|NCT00534248|464678830|FG000|Overall Study|Withdrawal by Subject|263|||
129104945|NCT00534248|464678831|FG001|Overall Study|Withdrawal by Subject|255|||
129104946|NCT02532257|464678834|FG000|Overall Study|Adverse Event|2|||
129104947|NCT02532257|464678834|FG000|Overall Study|Physician Decision|4|||
129104948|NCT02532257|464678834|FG000|Overall Study|Withdrawal by Subject|3|||
129104949|NCT02532257|464678834|FG000|Overall Study|Progressive Disease|10|||
129104950|NCT02849171|464678835|FG000|Overall Study|Withdrawal by Subject|1|||
129104951|NCT02849171|464678835|FG000|Overall Study|Not treated|1|||
129104952|NCT02259400|464678838|FG000|Overall Study|Death|0|||
128683156|NCT01975831|463138774|FG008|Overall Study|Entered Hospice|0|||
129104953|NCT02259400|464678839|FG001|Overall Study|Death|2|||
129104954|NCT00697593|464678843|FG000|Overall Study|Adverse Event|3|||
129104955|NCT00697593|464678843|FG000|Overall Study|Protocol Violation|1|||
129104956|NCT00697593|464678843|FG000|Overall Study|Lack of Efficacy|3|||
128683157|NCT01975831|463138766|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
129104957|NCT00697593|464678843|FG000|Overall Study|Suspension of the study by sponsor|12|||
129104958|NCT02964338|464678844|FG000|Overall Study|Sponsor terminated study for futility|12|||
129104959|NCT02964338|464678845|FG001|Overall Study|Sponsor terminated study for futility|15|||
129104960|NCT02964338|464678846|FG002|Overall Study|Sponsor terminated study for futility|14|||
129104961|NCT02964338|464678844|FG000|Overall Study|Lack of Efficacy|0|||
129104962|NCT02964338|464678845|FG001|Overall Study|Lack of Efficacy|3|||
129104963|NCT02964338|464678846|FG002|Overall Study|Lack of Efficacy|0|||
129017391|NCT01686438|464358128|FG002|Overall Study|Protocol Violation|1|||
129017392|NCT01686438|464358126|FG000|Overall Study|Withdrawal by Subject|0|||
129017393|NCT01686438|464358127|FG001|Overall Study|Withdrawal by Subject|0|||
129017394|NCT01686438|464358128|FG002|Overall Study|Withdrawal by Subject|1|||
129017395|NCT02601560|464358132|FG000|Overall Study|Other|0|||
129017396|NCT02601560|464358133|FG001|Overall Study|Other|0|||
129017397|NCT02601560|464358134|FG002|Overall Study|Other|0|||
129017398|NCT02601560|464358135|FG003|Overall Study|Other|0|||
129017399|NCT02601560|464358136|FG004|Overall Study|Other|0|||
129017400|NCT02601560|464358137|FG005|Overall Study|Other|0|||
129017401|NCT02601560|464358138|FG006|Overall Study|Other|1|||
129017402|NCT02601560|464358139|FG007|Overall Study|Other|0|||
129017403|NCT03459807|464358140|FG000|Overall Study|Withdrawal due to transplant|0|||
129017404|NCT03459807|464358141|FG001|Overall Study|Withdrawal due to transplant|1|||
129017405|NCT01406795|464358142|FG000|Overall Study|Withdrawal by Subject|1|||
129017406|NCT03897088|464358145|FG000|Overall Study|Withdrawal by Subject|12|||
129017407|NCT03897088|464358146|FG001|Overall Study|Withdrawal by Subject|12|||
129017408|NCT03897088|464358145|FG000|Overall Study|Lost to Follow-up|7|||
129017409|NCT03897088|464358146|FG001|Overall Study|Lost to Follow-up|15|||
129017410|NCT03897088|464358145|FG000|Overall Study|Sponsor Decision|1|||
129017411|NCT03897088|464358146|FG001|Overall Study|Sponsor Decision|2|||
129017412|NCT03897088|464358145|FG000|Overall Study|COVID-19|2|||
129017413|NCT03897088|464358146|FG001|Overall Study|COVID-19|0|||
129017414|NCT03897088|464358145|FG000|Overall Study|Other|3|||
129017415|NCT03897088|464358146|FG001|Overall Study|Other|0|||
129017416|NCT03897088|464358145|FG000|Overall Study|Non-compliance with Study Drug|1|||
129017417|NCT03897088|464358146|FG001|Overall Study|Non-compliance with Study Drug|1|||
129017418|NCT03897088|464358145|FG000|Overall Study|Pregnancy|0|||
129017419|NCT03897088|464358146|FG001|Overall Study|Pregnancy|1|||
129017420|NCT00855738|464358147|FG000|Overall Study|Lost to Follow-up|2|||
129017421|NCT00855738|464358147|FG000|Overall Study|Adverse Event|1|||
129017422|NCT00855738|464358147|FG000|Overall Study|Subject Defaulted|1|||
129017423|NCT00855738|464358147|FG000|Overall Study|Death|1|||
129017424|NCT03500692|464358151|FG000|Overall Study|Death|163|||
129017425|NCT03500692|464358151|FG000|Overall Study|Lost to Follow-up|75|||
129017426|NCT03500692|464358151|FG000|Overall Study|Termination Reasons|3|||
129017427|NCT03707912|464358154|FG000|Overall Study|Violation of inclusion criteria|1|||
129017428|NCT03707912|464358155|FG001|Overall Study|Violation of inclusion criteria|0|||
129017429|NCT01802320|464358156|FG000|Overall Study|Death|1|||
129017430|NCT01802320|464358156|FG000|Overall Study|Withdrawal by Subject|1|||
129017431|NCT06358820|464359571|FG000|Overall Study|Adverse Event|11|||
129017432|NCT06358820|464359571|FG000|Overall Study|kidney transplantation|3|||
129017433|NCT06358820|464359571|FG000|Overall Study|patient voluntary withdrawal|6|||
129017434|NCT06358820|464359571|FG000|Overall Study|Physician Decision|1|||
129017435|NCT05376319|464359572|FG000|Overall Study|Funding termination|2|||
129017436|NCT05376319|464359573|FG001|Overall Study|Funding termination|4|||
129017437|NCT00218257|464359577|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
129017438|NCT00218257|464359578|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
129017439|NCT02028715|464359579|FG000|Overall Study|Adverse Event|2|||
129017440|NCT02028715|464359580|FG001|Overall Study|Adverse Event|2|||
129017441|NCT02028715|464359579|FG000|Overall Study|Physician Decision|1|||
129017442|NCT02028715|464359580|FG001|Overall Study|Physician Decision|0|||
129017443|NCT02028715|464359579|FG000|Overall Study|Did not complete satisfaction surveys|2|||
129017444|NCT02028715|464359580|FG001|Overall Study|Did not complete satisfaction surveys|2|||
129017445|NCT00520130|464359581|FG000|Overall Study|Disease progression on study|4|||
129017446|NCT00520130|464359582|FG001|Overall Study|Disease progression on study|0|||
129017447|NCT00520130|464359581|FG000|Overall Study|Physician Decision|1|||
129017448|NCT00520130|464359582|FG001|Overall Study|Physician Decision|1|||
129017449|NCT01954394|464359583|FG000|Overall Study|Enrolled but not treated|1|||
129017450|NCT01954394|464359584|FG001|Overall Study|Enrolled but not treated|0|||
129017451|NCT01954394|464359583|FG000|Overall Study|Adverse Event|10|||
129017452|NCT01954394|464359584|FG001|Overall Study|Adverse Event|23|||
129017453|NCT01954394|464359583|FG000|Overall Study|Poor compliance to protocol|7|||
129017454|NCT01954394|464359584|FG001|Overall Study|Poor compliance to protocol|7|||
129017455|NCT01954394|464359583|FG000|Overall Study|Participant Moved|0|||
129017456|NCT01954394|464359584|FG001|Overall Study|Participant Moved|4|||
129017457|NCT01954394|464359583|FG000|Overall Study|Related to Study Drug administration|2|||
129017458|NCT01954394|464359584|FG001|Overall Study|Related to Study Drug administration|2|||
129017459|NCT01954394|464359583|FG000|Overall Study|Other than specified above|10|||
129017460|NCT01954394|464359584|FG001|Overall Study|Other than specified above|21|||
129017461|NCT02422264|464359590|FG000|Overall Study|Serious Adverse Event|1|||
129017462|NCT02422264|464359591|FG001|Overall Study|Serious Adverse Event|0|||
129017463|NCT02422264|464359590|FG000|Overall Study|Withdrawal by Subject|1|||
129017464|NCT02422264|464359591|FG001|Overall Study|Withdrawal by Subject|2|||
129017465|NCT02422264|464359590|FG000|Overall Study|Migrated/moved from study area|3|||
129017466|NCT02422264|464359591|FG001|Overall Study|Migrated/moved from study area|1|||
129017467|NCT02422264|464359590|FG000|Overall Study|Subject vaccinated outside of the study|0|||
129017468|NCT02422264|464359591|FG001|Overall Study|Subject vaccinated outside of the study|1|||
129104964|NCT02964338|464678844|FG000|Overall Study|Lost to Follow-up|1|||
129104965|NCT02964338|464678845|FG001|Overall Study|Lost to Follow-up|0|||
129104966|NCT02964338|464678846|FG002|Overall Study|Lost to Follow-up|3|||
129104967|NCT02964338|464678844|FG000|Overall Study|Protocol Violation|0|||
129104968|NCT02964338|464678845|FG001|Overall Study|Protocol Violation|1|||
129104969|NCT02964338|464678846|FG002|Overall Study|Protocol Violation|0|||
129104970|NCT02964338|464678844|FG000|Overall Study|Withdrawal by Subject|1|||
129104971|NCT02964338|464678845|FG001|Overall Study|Withdrawal by Subject|3|||
129104972|NCT02964338|464678846|FG002|Overall Study|Withdrawal by Subject|1|||
129104973|NCT02964338|464678844|FG000|Overall Study|Adverse Event|2|||
129104974|NCT02964338|464678845|FG001|Overall Study|Adverse Event|1|||
129104975|NCT02964338|464678846|FG002|Overall Study|Adverse Event|1|||
129104976|NCT02964338|464678844|FG000|Overall Study|Non-compliant with e-diary|0|||
129104977|NCT02964338|464678845|FG001|Overall Study|Non-compliant with e-diary|1|||
129104978|NCT02964338|464678846|FG002|Overall Study|Non-compliant with e-diary|0|||
129104979|NCT02964338|464678844|FG000|Overall Study|Did not meet criteria|1|||
129104980|NCT02964338|464678845|FG001|Overall Study|Did not meet criteria|0|||
129104981|NCT02964338|464678846|FG002|Overall Study|Did not meet criteria|0|||
129104982|NCT02372383|464678850|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
129104983|NCT02372383|464678851|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
129104984|NCT02372383|464678852|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
129104985|NCT02630563|464678855|FG000|Overall Study|Administrative|1|||
129104986|NCT02239640|464678856|FG000|Overall Study|Withdrawal by Subject|3|||
129104987|NCT02239640|464678856|FG000|Overall Study|Lost to Follow-up|72|||
129104988|NCT02239640|464678856|FG000|Overall Study|Death|142|||
129104989|NCT00621257|464678857|FG000|Overall Study|Lost to Follow-up|4|||
129104990|NCT00621257|464678858|FG001|Overall Study|Lost to Follow-up|0|||
129104991|NCT00621257|464678859|FG002|Overall Study|Lost to Follow-up|2|||
129104992|NCT00621257|464678860|FG003|Overall Study|Lost to Follow-up|4|||
129104993|NCT00621257|464678861|FG004|Overall Study|Lost to Follow-up|7|||
129104994|NCT00621257|464678857|FG000|Overall Study|Adverse Event|0|||
129104995|NCT00621257|464678858|FG001|Overall Study|Adverse Event|1|||
129104996|NCT00621257|464678859|FG002|Overall Study|Adverse Event|1|||
129104997|NCT00621257|464678860|FG003|Overall Study|Adverse Event|0|||
129104998|NCT00621257|464678861|FG004|Overall Study|Adverse Event|0|||
129104999|NCT00621257|464678857|FG000|Overall Study|Physician Decision|0|||
129105000|NCT00621257|464678858|FG001|Overall Study|Physician Decision|2|||
129105001|NCT00621257|464678859|FG002|Overall Study|Physician Decision|0|||
129105002|NCT00621257|464678860|FG003|Overall Study|Physician Decision|1|||
129105003|NCT00621257|464678861|FG004|Overall Study|Physician Decision|1|||
129105004|NCT00621257|464678857|FG000|Overall Study|Withdrawal by Subject|0|||
129105005|NCT00621257|464678858|FG001|Overall Study|Withdrawal by Subject|0|||
129105006|NCT00621257|464678859|FG002|Overall Study|Withdrawal by Subject|0|||
129105007|NCT00621257|464678860|FG003|Overall Study|Withdrawal by Subject|1|||
129105008|NCT00621257|464678861|FG004|Overall Study|Withdrawal by Subject|1|||
129105009|NCT00741598|464678865|FG000|Overall Study|Lost to Follow-up|3|||
129105010|NCT00741598|464678866|FG001|Overall Study|Lost to Follow-up|4|||
129105011|NCT00741598|464678865|FG000|Overall Study|Lack of Efficacy|1|||
129105012|NCT00741598|464678866|FG001|Overall Study|Lack of Efficacy|2|||
129105013|NCT00741598|464678865|FG000|Overall Study|Physician Decision|1|||
129105014|NCT00741598|464678866|FG001|Overall Study|Physician Decision|1|||
129105015|NCT00741598|464678865|FG000|Overall Study|Pregnancy|1|||
129105016|NCT00741598|464678866|FG001|Overall Study|Pregnancy|0|||
129105017|NCT00741598|464678865|FG000|Overall Study|Withdrawal by Subject|3|||
129105018|NCT00741598|464678866|FG001|Overall Study|Withdrawal by Subject|2|||
129105019|NCT00003896|464678876|FG000|Overall Study|Adverse Event|16|||
129105020|NCT00003896|464678876|FG000|Overall Study|Withdrawal by Subject|1|||
129105021|NCT00003896|464678876|FG000|Overall Study|Lack of Efficacy|1|||
129105022|NCT00003896|464678876|FG000|Overall Study|Death|3|||
129105023|NCT00003896|464678876|FG000|Overall Study|not protocol specified|3|||
129105024|NCT00003896|464678876|FG000|Overall Study|ineligible|5|||
129105025|NCT01398358|464678877|FG000|Overall Study|Lost to Follow-up|11|||
129105026|NCT01398358|464678878|FG001|Overall Study|Lost to Follow-up|21|||
129105027|NCT01398358|464678879|FG002|Overall Study|Lost to Follow-up|18|||
129105028|NCT01398358|464678877|FG000|Overall Study|Withdrawal by Subject|3|||
129105029|NCT01398358|464678878|FG001|Overall Study|Withdrawal by Subject|2|||
129105030|NCT01398358|464678879|FG002|Overall Study|Withdrawal by Subject|2|||
129105031|NCT01398358|464678877|FG000|Overall Study|no longer eligible|1|||
129105032|NCT01398358|464678878|FG001|Overall Study|no longer eligible|0|||
129105033|NCT01398358|464678879|FG002|Overall Study|no longer eligible|1|||
129105034|NCT00985686|464678881|FG000|Overall Study|Lost to Follow-up|1|||
129105035|NCT00985686|464678882|FG001|Overall Study|Lost to Follow-up|1|||
129105036|NCT00985686|464678883|FG002|Overall Study|Lost to Follow-up|0|||
129105037|NCT00985686|464678884|FG003|Overall Study|Lost to Follow-up|2|||
129105038|NCT01670045|464678885|FG000|Overall Study|Withdrawal by Subject|3|||
129105039|NCT01670045|464678885|FG000|Overall Study|Adverse Event|1|||
129105040|NCT01670045|464678885|FG000|Overall Study|Death|1|||
129105041|NCT01670045|464678885|FG000|Overall Study|Lost to Follow-up|11|||
129105042|NCT02559570|464678887|FG000|Overall Study|Adverse Event|0|||
129105043|NCT02559570|464678888|FG001|Overall Study|Adverse Event|2|||
129105044|NCT02559570|464678889|FG002|Overall Study|Adverse Event|0|||
129105045|NCT02559570|464678890|FG003|Overall Study|Adverse Event|1|||
129105046|NCT02559570|464678891|FG004|Overall Study|Adverse Event|0|||
129105047|NCT02559570|464678887|FG000|Overall Study|Withdrawal of Consent|0|||
129105048|NCT02559570|464678888|FG001|Overall Study|Withdrawal of Consent|0|||
129105049|NCT02559570|464678889|FG002|Overall Study|Withdrawal of Consent|1|||
129105050|NCT02559570|464678890|FG003|Overall Study|Withdrawal of Consent|2|||
129105051|NCT02559570|464678891|FG004|Overall Study|Withdrawal of Consent|1|||
129105052|NCT02559570|464678887|FG000|Overall Study|Lost to Follow-up|1|||
129017469|NCT00851877|464359592|FG000|Phase I-1|Death|1|||
129017470|NCT00851877|464359593|FG001|Phase I-1|Death|0|||
129017471|NCT00851877|464359594|FG002|Phase I-1|Death|0|||
129017472|NCT00851877|464359592|FG000|Phase II|Withdrawal by Subject|0|||
129017473|NCT00851877|464359593|FG001|Phase II|Withdrawal by Subject|0|||
129017474|NCT00851877|464359594|FG002|Phase II|Withdrawal by Subject|3|||
129017475|NCT00829673|464359595|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129017476|NCT00829673|464359596|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129017477|NCT03450057|464359597|FG000|Overall Study|Death|17|||
129017478|NCT03450057|464359597|FG000|Overall Study|ICF withdrawal|4|||
129017479|NCT03450057|464359597|FG000|Overall Study|Lost to Follow-up|2|||
129017480|NCT01034358|464359598|FG000|Overall Study|Withdrawal by Subject|1|||
129017481|NCT01034358|464359598|FG000|Overall Study|Protocol Violation|1|||
129017482|NCT00829790|464359601|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
129017483|NCT00829790|464359602|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
129017484|NCT02246166|464359603|FG000|Overall Study|Protocol Violation|1|||
129017485|NCT02246166|464359604|FG001|Overall Study|Protocol Violation|0|||
129017486|NCT00627016|464359605|FG000|Overall Study|Adverse Event|1|||
129017487|NCT00627016|464359606|FG001|Overall Study|Adverse Event|1|||
129017488|NCT00627016|464359605|FG000|Overall Study|Protocol Violation|0|||
129017489|NCT00627016|464359606|FG001|Overall Study|Protocol Violation|2|||
129017490|NCT00627016|464359605|FG000|Overall Study|Lost to Follow-up|0|||
129017491|NCT00627016|464359606|FG001|Overall Study|Lost to Follow-up|1|||
129017492|NCT00627016|464359605|FG000|Overall Study|Withdrawal by Subject|2|||
129017493|NCT00627016|464359606|FG001|Overall Study|Withdrawal by Subject|1|||
129017494|NCT00627016|464359605|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129017495|NCT00627016|464359606|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
129017496|NCT00627016|464359605|FG000|Overall Study|Lack of Efficacy|1|||
129017497|NCT00627016|464359606|FG001|Overall Study|Lack of Efficacy|0|||
129017498|NCT00627016|464359605|FG000|Overall Study|Placed on Excluded Drugs|1|||
129017499|NCT00627016|464359606|FG001|Overall Study|Placed on Excluded Drugs|0|||
129017500|NCT00627016|464359605|FG000|Overall Study|Pregnancy|1|||
129017501|NCT00627016|464359606|FG001|Overall Study|Pregnancy|0|||
129017502|NCT01256684|464359609|FG000|Overall Study|Adverse Event|1|||
129017503|NCT01256684|464359610|FG001|Overall Study|Adverse Event|4|||
129017504|NCT01256684|464359611|FG002|Overall Study|Adverse Event|2|||
129017505|NCT01256684|464359609|FG000|Overall Study|Withdrawal by Subject|4|||
129017506|NCT01256684|464359610|FG001|Overall Study|Withdrawal by Subject|0|||
129017507|NCT01256684|464359611|FG002|Overall Study|Withdrawal by Subject|2|||
129017508|NCT01256684|464359609|FG000|Overall Study|Physician Decision|0|||
129017509|NCT01256684|464359610|FG001|Overall Study|Physician Decision|1|||
129017510|NCT01256684|464359611|FG002|Overall Study|Physician Decision|0|||
129017511|NCT01256684|464359609|FG000|Overall Study|Lack of Efficacy|0|||
129017512|NCT01256684|464359610|FG001|Overall Study|Lack of Efficacy|1|||
129017513|NCT01256684|464359611|FG002|Overall Study|Lack of Efficacy|1|||
129017514|NCT01256684|464359609|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
129017515|NCT01256684|464359610|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
129017516|NCT01256684|464359611|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
129017517|NCT02678286|464359613|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
129017518|NCT02678286|464359614|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
129017519|NCT02678286|464359613|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
129017520|NCT02678286|464359614|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
129017521|NCT02678286|464359613|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
129017522|NCT02678286|464359614|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
129105053|NCT02559570|464678888|FG001|Overall Study|Lost to Follow-up|0|||
129105054|NCT02559570|464678889|FG002|Overall Study|Lost to Follow-up|0|||
129105055|NCT02559570|464678890|FG003|Overall Study|Lost to Follow-up|0|||
129105056|NCT02559570|464678891|FG004|Overall Study|Lost to Follow-up|0|||
129105057|NCT02559570|464678887|FG000|Overall Study|Protocol Violation|1|||
129105058|NCT02559570|464678888|FG001|Overall Study|Protocol Violation|0|||
129105059|NCT02559570|464678889|FG002|Overall Study|Protocol Violation|0|||
129017523|NCT02678286|464359613|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
129017524|NCT02678286|464359614|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
129017525|NCT02678286|464359613|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
129105060|NCT02559570|464678890|FG003|Overall Study|Protocol Violation|0|||
129017526|NCT02678286|464359614|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
129017527|NCT02331394|464359615|FG000|Overall Study|Disease progression|1|||
128882003|NCT00551460|463863258|FG000|Overall Study|Death|7|||
129017528|NCT01313273|464359616|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
129017529|NCT01313273|464359617|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
129017530|NCT01313273|464359616|FG000|Overall Study|Withdrawal by Subject|1|||
129017531|NCT01313273|464359617|FG001|Overall Study|Withdrawal by Subject|0|||
129017532|NCT01313273|464359616|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
129017533|NCT01313273|464359617|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
129017534|NCT03687736|464359618|FG000|Overall Study|Lost to Follow-up|7|||
129017535|NCT03687736|464359618|FG000|Overall Study|Withdrawal by Subject|3|||
129017536|NCT01270503|464359619|FG000|Overall Study|Lost to Follow-up|1|||
129017537|NCT02459951|464359620|FG000|Overall Study|Unable to meet holding requirement|1|||
129017538|NCT02481830|464359624|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
129017539|NCT02481830|464359625|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
129017540|NCT02481830|464359624|FG000|Pre-treatment|Withdrawal by Subject|0|||
129017541|NCT02481830|464359625|FG001|Pre-treatment|Withdrawal by Subject|10|||
129017542|NCT02481830|464359624|FG000|Pre-treatment|Disease Progression|1|||
129017543|NCT02481830|464359625|FG001|Pre-treatment|Disease Progression|1|||
129017544|NCT02481830|464359624|FG000|Pre-treatment|Other reasons|0|||
129017545|NCT02481830|464359625|FG001|Pre-treatment|Other reasons|1|||
129017546|NCT02481830|464359624|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
129017547|NCT02481830|464359625|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
129017548|NCT02481830|464359624|FG000|Treatment|Disease Progression|233|||
129017549|NCT02481830|464359625|FG001|Treatment|Disease Progression|171|||
129017550|NCT02481830|464359624|FG000|Treatment|Study drug toxicity|18|||
129017551|NCT02481830|464359625|FG001|Treatment|Study drug toxicity|38|||
129017552|NCT02481830|464359624|FG000|Treatment|Death|1|||
129017553|NCT02481830|464359625|FG001|Treatment|Death|1|||
129017554|NCT02481830|464359624|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
129017555|NCT02481830|464359625|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
129017556|NCT02481830|464359624|FG000|Treatment|Participants request to discontinue Study treatment|6|||
129017557|NCT02481830|464359625|FG001|Treatment|Participants request to discontinue Study treatment|34|||
129017558|NCT02481830|464359624|FG000|Treatment|Withdrawal by Subject|2|||
129017559|NCT02481830|464359625|FG001|Treatment|Withdrawal by Subject|3|||
129017560|NCT02481830|464359624|FG000|Treatment|Lost to Follow-up|1|||
129017561|NCT02481830|464359625|FG001|Treatment|Lost to Follow-up|0|||
129017562|NCT02481830|464359624|FG000|Treatment|Maximum Clinical Benefit|0|||
129017563|NCT02481830|464359625|FG001|Treatment|Maximum Clinical Benefit|5|||
129017564|NCT02481830|464359624|FG000|Treatment|Administrative reason by sponsor|1|||
129017565|NCT02481830|464359625|FG001|Treatment|Administrative reason by sponsor|1|||
129017566|NCT02481830|464359624|FG000|Treatment|Other reasons|6|||
129017567|NCT02481830|464359625|FG001|Treatment|Other reasons|1|||
129017568|NCT00102440|464359626|FG000|Overall Study|Lost to Follow-up|25|||
129017569|NCT00102440|464359627|FG001|Overall Study|Lost to Follow-up|18|||
129017570|NCT00102440|464359628|FG002|Overall Study|Lost to Follow-up|21|||
129017571|NCT00102440|464359626|FG000|Overall Study|Adverse Event|16|||
129017572|NCT00102440|464359627|FG001|Overall Study|Adverse Event|23|||
129017573|NCT00102440|464359628|FG002|Overall Study|Adverse Event|8|||
129017574|NCT00102440|464359626|FG000|Overall Study|Gout Flare|10|||
129017575|NCT00102440|464359627|FG001|Overall Study|Gout Flare|28|||
129017576|NCT00102440|464359628|FG002|Overall Study|Gout Flare|9|||
129017577|NCT00102440|464359626|FG000|Overall Study|Personal Reason(s)|19|||
129017578|NCT00102440|464359627|FG001|Overall Study|Personal Reason(s)|13|||
129017579|NCT00102440|464359628|FG002|Overall Study|Personal Reason(s)|13|||
129017580|NCT00102440|464359626|FG000|Overall Study|Other|11|||
129017581|NCT00102440|464359627|FG001|Overall Study|Other|14|||
129017582|NCT00102440|464359628|FG002|Overall Study|Other|14|||
129017583|NCT00102440|464359626|FG000|Overall Study|Protocol Violation|7|||
129017584|NCT00102440|464359627|FG001|Overall Study|Protocol Violation|2|||
129017585|NCT00102440|464359628|FG002|Overall Study|Protocol Violation|1|||
129017586|NCT01010542|464359634|FG000|Overall Study|Adverse Event|0|||
129017587|NCT01010542|464359635|FG001|Overall Study|Adverse Event|1|||
129017588|NCT01010542|464359636|FG002|Overall Study|Adverse Event|0|||
129017589|NCT01010542|464359634|FG000|Overall Study|Lost to Follow-up|0|||
129017590|NCT01010542|464359635|FG001|Overall Study|Lost to Follow-up|1|||
129017591|NCT01010542|464359636|FG002|Overall Study|Lost to Follow-up|0|||
129017592|NCT01010542|464359634|FG000|Overall Study|Withdrawal by Subject|0|||
129017593|NCT01010542|464359635|FG001|Overall Study|Withdrawal by Subject|3|||
129017594|NCT01010542|464359636|FG002|Overall Study|Withdrawal by Subject|2|||
129017595|NCT01745120|464359637|FG000|Overall Study|Investigator decision|1|||
129017596|NCT01745120|464359638|FG001|Overall Study|Investigator decision|0|||
129017597|NCT03956862|464359639|FG000|Overall Study|Lost to Follow-up|1|||
129017598|NCT03956862|464359640|FG001|Overall Study|Lost to Follow-up|1|||
129017599|NCT03956862|464359639|FG000|Overall Study|Withdrawal by Subject|1|||
129017600|NCT03956862|464359640|FG001|Overall Study|Withdrawal by Subject|1|||
129017601|NCT00579670|464359644|FG000|Overall Study|Death|1|||
129017602|NCT00579670|464359645|FG001|Overall Study|Death|0|||
129017603|NCT00579670|464359646|FG002|Overall Study|Death|0|||
129017604|NCT00579670|464359647|FG003|Overall Study|Death|0|||
129017605|NCT00579670|464359648|FG004|Overall Study|Death|0|||
129017606|NCT00579670|464359644|FG000|Overall Study|Adverse Event|1|||
129017607|NCT00579670|464359645|FG001|Overall Study|Adverse Event|0|||
129017608|NCT00579670|464359646|FG002|Overall Study|Adverse Event|1|||
129017609|NCT00579670|464359647|FG003|Overall Study|Adverse Event|2|||
129017610|NCT00579670|464359648|FG004|Overall Study|Adverse Event|0|||
129017611|NCT00579670|464359644|FG000|Overall Study|Lack of Efficacy|0|||
129017612|NCT00579670|464359645|FG001|Overall Study|Lack of Efficacy|0|||
129017613|NCT00579670|464359646|FG002|Overall Study|Lack of Efficacy|1|||
129017614|NCT00579670|464359647|FG003|Overall Study|Lack of Efficacy|14|||
129017615|NCT00579670|464359648|FG004|Overall Study|Lack of Efficacy|0|||
129017616|NCT00579670|464359644|FG000|Overall Study|Lost to Follow-up|0|||
129017617|NCT00579670|464359645|FG001|Overall Study|Lost to Follow-up|1|||
129017618|NCT00579670|464359646|FG002|Overall Study|Lost to Follow-up|0|||
129017619|NCT00579670|464359647|FG003|Overall Study|Lost to Follow-up|4|||
129017620|NCT00579670|464359648|FG004|Overall Study|Lost to Follow-up|0|||
129017621|NCT00579670|464359644|FG000|Overall Study|Other|0|||
129017622|NCT00579670|464359645|FG001|Overall Study|Other|0|||
129017623|NCT00579670|464359646|FG002|Overall Study|Other|1|||
129017624|NCT00579670|464359647|FG003|Overall Study|Other|2|||
129017625|NCT00579670|464359648|FG004|Overall Study|Other|0|||
129017626|NCT00579670|464359644|FG000|Overall Study|Withdrawal by Subject|0|||
129017627|NCT00579670|464359645|FG001|Overall Study|Withdrawal by Subject|0|||
129017628|NCT00579670|464359646|FG002|Overall Study|Withdrawal by Subject|1|||
129017629|NCT00579670|464359647|FG003|Overall Study|Withdrawal by Subject|0|||
129017630|NCT00579670|464359648|FG004|Overall Study|Withdrawal by Subject|0|||
129017631|NCT00850174|464359652|FG000|Washout: One Week|Withdrawal by Subject|0|||
129017632|NCT00850174|464359653|FG001|Washout: One Week|Withdrawal by Subject|2|||
129017633|NCT00850174|464359652|FG000|Second Intervention|Withdrawal by Subject|1|||
129017634|NCT00850174|464359653|FG001|Second Intervention|Withdrawal by Subject|0|||
129017635|NCT01363765|464359656|FG000|Overall Study|non-diagnostic|2621|||
129017636|NCT01363765|464359657|FG001|Overall Study|non-diagnostic|1124|||
129017637|NCT01363765|464359656|FG000|Overall Study|duplicate records|736|||
129017638|NCT01363765|464359657|FG001|Overall Study|duplicate records|3177|||
129017639|NCT01363765|464359656|FG000|Overall Study|non-resident|156|||
129017640|NCT01363765|464359657|FG001|Overall Study|non-resident|76|||
129017641|NCT01363765|464359656|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
129017642|NCT01363765|464359657|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
129017643|NCT01363765|464359656|FG000|Overall Study|smear during intervention|2170|||
129017644|NCT01363765|464359657|FG001|Overall Study|smear during intervention|0|||
129017645|NCT01900626|464359658|FG000|Overall Study|study was closed due to low enrollment|1|||
129017646|NCT01900626|464359659|FG001|Overall Study|study was closed due to low enrollment|1|||
129017647|NCT00635492|464359660|FG000|Overall Study|Death|12|||
129017648|NCT00635492|464359661|FG001|Overall Study|Death|40|||
129017649|NCT00635492|464359660|FG000|Overall Study|Lost to Follow-up|151|||
129017650|NCT00635492|464359661|FG001|Overall Study|Lost to Follow-up|172|||
129017651|NCT00635492|464359660|FG000|Overall Study|Physician Decision|32|||
129017652|NCT00635492|464359661|FG001|Overall Study|Physician Decision|22|||
129017653|NCT00635492|464359660|FG000|Overall Study|Sponsor decision|2|||
129017654|NCT00635492|464359661|FG001|Overall Study|Sponsor decision|3|||
129017655|NCT00635492|464359660|FG000|Overall Study|Withdrawal by Subject|82|||
129017656|NCT00635492|464359661|FG001|Overall Study|Withdrawal by Subject|45|||
129017657|NCT02682784|464359662|FG000|Overall Study|Withdrawal by Subject|0|||
129017658|NCT02682784|464359663|FG001|Overall Study|Withdrawal by Subject|2|||
129017659|NCT02682784|464359664|FG002|Overall Study|Withdrawal by Subject|1|||
129017660|NCT02682784|464359665|FG003|Overall Study|Withdrawal by Subject|2|||
129017661|NCT02682784|464359662|FG000|Overall Study|Physician Decision|1|||
129017662|NCT02682784|464359663|FG001|Overall Study|Physician Decision|0|||
129017663|NCT02682784|464359664|FG002|Overall Study|Physician Decision|1|||
129017664|NCT02682784|464359665|FG003|Overall Study|Physician Decision|1|||
129017665|NCT00836056|464359675|FG000|First Intervention|Adverse Event|1|||
129017666|NCT00836056|464359676|FG001|First Intervention|Adverse Event|0|||
129017667|NCT00846495|464359677|FG000|Overall Study|Lost to Follow-up|1|||
129017668|NCT00846495|464359678|FG001|Overall Study|Lost to Follow-up|0|||
129017669|NCT00846495|464359677|FG000|Overall Study|Adverse Event|5|||
129017670|NCT00846495|464359678|FG001|Overall Study|Adverse Event|1|||
129017671|NCT00846495|464359677|FG000|Overall Study|Lack of Efficacy|1|||
129017672|NCT00846495|464359678|FG001|Overall Study|Lack of Efficacy|2|||
129017673|NCT00846495|464359677|FG000|Overall Study|Physician Decision|1|||
129017674|NCT00846495|464359678|FG001|Overall Study|Physician Decision|0|||
129017675|NCT01265056|464359679|FG000|Initial Study Period|Withdrawal by Subject|1|||
129017676|NCT01265056|464359680|FG001|Initial Study Period|Withdrawal by Subject|1|||
129017677|NCT01265056|464359679|FG000|Initial Study Period|Withdrawal by Subject|1|||
129017678|NCT01265056|464359680|FG001|Initial Study Period|Withdrawal by Subject|1|||
129017679|NCT01265056|464359679|FG000|Follow up|Lost to Follow-up|7|||
129017680|NCT01265056|464359680|FG001|Follow up|Lost to Follow-up|3|||
129017681|NCT03725605|464359684|FG000|Overall Study|Unsuccessful TIL expansion|2|||
129017682|NCT00965185|464359685|FG000|Overall Study|Lost to Follow-up|2|||
129017683|NCT00965185|464359686|FG001|Overall Study|Lost to Follow-up|0|||
129105061|NCT02559570|464678891|FG004|Overall Study|Protocol Violation|1|||
129105062|NCT02559570|464678887|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129105063|NCT02559570|464678888|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129105064|NCT02559570|464678889|FG002|Overall Study|Other Miscellaneous Reasons|1|||
129105065|NCT02559570|464678890|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129105066|NCT02559570|464678891|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129105067|NCT00396383|464678901|FG000|Overall Study|Death|2|||
129105068|NCT00396383|464678901|FG000|Overall Study|Lost to Follow-up|1|||
129105069|NCT00282152|464678902|FG000|Overall Study|Withdrawal by Subject|1|||
129105070|NCT00282152|464678903|FG001|Overall Study|Withdrawal by Subject|0|||
129105071|NCT00585325|464678904|FG000|Overall Study|Withdrawal by Subject|1|||
129105072|NCT00585325|464678905|FG001|Overall Study|Withdrawal by Subject|1|||
129105073|NCT03301831|464678906|FG000|Overall Study|Lost to Follow-up|5|||
129105074|NCT03301831|464678907|FG001|Overall Study|Lost to Follow-up|3|||
129105075|NCT03301831|464678906|FG000|Overall Study|Protocol Violation|4|||
129105076|NCT03301831|464678907|FG001|Overall Study|Protocol Violation|0|||
129105077|NCT03301831|464678906|FG000|Overall Study|Withdrawal by Subject|11|||
129105078|NCT03301831|464678907|FG001|Overall Study|Withdrawal by Subject|0|||
129105079|NCT03092791|464678908|FG000|Overall Study|Lost to Follow-up|0|||
129105080|NCT03092791|464678909|FG001|Overall Study|Lost to Follow-up|0|||
129105081|NCT03092791|464678910|FG002|Overall Study|Lost to Follow-up|0|||
129105082|NCT03092791|464678911|FG003|Overall Study|Lost to Follow-up|0|||
129105083|NCT03092791|464678912|FG004|Overall Study|Lost to Follow-up|0|||
129105084|NCT03092791|464678913|FG005|Overall Study|Lost to Follow-up|0|||
129105085|NCT03092791|464678914|FG006|Overall Study|Lost to Follow-up|1|||
129105086|NCT03092791|464678915|FG007|Overall Study|Lost to Follow-up|0|||
129105087|NCT03092791|464678908|FG000|Overall Study|Withdrawal of Consent|0|||
129105088|NCT03092791|464678909|FG001|Overall Study|Withdrawal of Consent|0|||
129105089|NCT03092791|464678910|FG002|Overall Study|Withdrawal of Consent|0|||
129105090|NCT03092791|464678911|FG003|Overall Study|Withdrawal of Consent|0|||
129105091|NCT03092791|464678912|FG004|Overall Study|Withdrawal of Consent|4|||
129105092|NCT03092791|464678913|FG005|Overall Study|Withdrawal of Consent|12|||
129105093|NCT03092791|464678914|FG006|Overall Study|Withdrawal of Consent|6|||
129105094|NCT03092791|464678915|FG007|Overall Study|Withdrawal of Consent|4|||
129105095|NCT03092791|464678908|FG000|Overall Study|Study Termination|0|||
129105096|NCT03092791|464678909|FG001|Overall Study|Study Termination|0|||
129105097|NCT03092791|464678910|FG002|Overall Study|Study Termination|0|||
129105098|NCT03092791|464678911|FG003|Overall Study|Study Termination|0|||
129105099|NCT03092791|464678912|FG004|Overall Study|Study Termination|55|||
129105100|NCT03092791|464678913|FG005|Overall Study|Study Termination|46|||
129105101|NCT03092791|464678914|FG006|Overall Study|Study Termination|53|||
129105102|NCT03092791|464678915|FG007|Overall Study|Study Termination|55|||
129105103|NCT03092791|464678908|FG000|Overall Study|Death|0|||
129105104|NCT03092791|464678909|FG001|Overall Study|Death|0|||
129105105|NCT03092791|464678910|FG002|Overall Study|Death|0|||
129105106|NCT03092791|464678911|FG003|Overall Study|Death|0|||
129105107|NCT03092791|464678912|FG004|Overall Study|Death|0|||
129105108|NCT03092791|464678913|FG005|Overall Study|Death|1|||
129105109|NCT03092791|464678914|FG006|Overall Study|Death|0|||
129105110|NCT03092791|464678915|FG007|Overall Study|Death|1|||
129105111|NCT03092791|464678908|FG000|Overall Study|Reason Not Specified|0|||
129105112|NCT03092791|464678909|FG001|Overall Study|Reason Not Specified|0|||
129105113|NCT03092791|464678910|FG002|Overall Study|Reason Not Specified|0|||
129105114|NCT03092791|464678911|FG003|Overall Study|Reason Not Specified|0|||
129105115|NCT03092791|464678912|FG004|Overall Study|Reason Not Specified|1|||
129105116|NCT03092791|464678913|FG005|Overall Study|Reason Not Specified|1|||
129105117|NCT03092791|464678914|FG006|Overall Study|Reason Not Specified|0|||
129105118|NCT03092791|464678915|FG007|Overall Study|Reason Not Specified|0|||
129105119|NCT00792116|464678917|FG000|Overall Study|Lost to Follow-up|0|||
129105120|NCT00792116|464678918|FG001|Overall Study|Lost to Follow-up|1|||
129105121|NCT00792116|464678917|FG000|Overall Study|Discontnued intervention|1|||
129105122|NCT00792116|464678918|FG001|Overall Study|Discontnued intervention|0|||
129105123|NCT00980655|464678919|FG000|Overall Study|Adverse Event|13|||
129105124|NCT00980655|464678920|FG001|Overall Study|Adverse Event|31|||
129105125|NCT00980655|464678919|FG000|Overall Study|Death|0|||
129105126|NCT00980655|464678920|FG001|Overall Study|Death|7|||
129105127|NCT00980655|464678919|FG000|Overall Study|Protocol Violation|2|||
128683158|NCT01975831|463138767|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
129105128|NCT00980655|464678920|FG001|Overall Study|Protocol Violation|7|||
129105129|NCT00980655|464678919|FG000|Overall Study|Withdrawal by Subject|0|||
129105130|NCT00980655|464678920|FG001|Overall Study|Withdrawal by Subject|4|||
129105131|NCT00980655|464678919|FG000|Overall Study|Lost to Follow-up|0|||
129105132|NCT00980655|464678920|FG001|Overall Study|Lost to Follow-up|1|||
129105133|NCT00980655|464678919|FG000|Overall Study|Parent/legal guardian request|1|||
129105134|NCT00980655|464678920|FG001|Overall Study|Parent/legal guardian request|0|||
128683159|NCT01975831|463138768|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
129105135|NCT00980655|464678919|FG000|Overall Study|Other|0|||
129105136|NCT00980655|464678920|FG001|Overall Study|Other|1|||
129105137|NCT00845676|464678926|FG000|Overall Study|Virologic breakthrough at week 20|1|||
129105138|NCT00845676|464678926|FG000|Overall Study|Adverse Event|1|||
129105139|NCT00481767|464678928|FG000|Overall Study|Withdrawal by Subject|16|||
129105140|NCT00481767|464678929|FG001|Overall Study|Withdrawal by Subject|11|||
129105141|NCT00481767|464678928|FG000|Overall Study|Lost to Follow-up|16|||
129105142|NCT00481767|464678929|FG001|Overall Study|Lost to Follow-up|10|||
129105143|NCT01941537|464678930|FG000|Overall Study|Lack of Efficacy|1|||
129105144|NCT01941537|464678931|FG001|Overall Study|Lack of Efficacy|2|||
129105145|NCT01941537|464678930|FG000|Overall Study|Lost to Follow-up|1|||
129105146|NCT01941537|464678931|FG001|Overall Study|Lost to Follow-up|0|||
129105147|NCT01941537|464678930|FG000|Overall Study|Pregnancy|1|||
129105148|NCT01941537|464678931|FG001|Overall Study|Pregnancy|0|||
129105149|NCT01941537|464678930|FG000|Overall Study|Adverse Event|1|||
129105150|NCT01941537|464678931|FG001|Overall Study|Adverse Event|0|||
129105151|NCT01941537|464678930|FG000|Overall Study|Withdrawal by Subject|0|||
129105152|NCT01941537|464678931|FG001|Overall Study|Withdrawal by Subject|1|||
129105153|NCT02557516|464678933|FG000|Overall Study|Adverse Event|1|||
129105154|NCT02557516|464678934|FG001|Overall Study|Adverse Event|0|||
129105155|NCT02557516|464678935|FG002|Overall Study|Adverse Event|2|||
129105156|NCT02557516|464678936|FG003|Overall Study|Adverse Event|1|||
129105157|NCT02557516|464678933|FG000|Overall Study|Disease progression|0|||
129105158|NCT02557516|464678934|FG001|Overall Study|Disease progression|2|||
129105159|NCT02557516|464678935|FG002|Overall Study|Disease progression|0|||
129105160|NCT02557516|464678936|FG003|Overall Study|Disease progression|0|||
129105161|NCT02557516|464678933|FG000|Overall Study|Physician Decision|0|||
129105162|NCT02557516|464678934|FG001|Overall Study|Physician Decision|2|||
129105163|NCT02557516|464678935|FG002|Overall Study|Physician Decision|0|||
129105164|NCT02557516|464678936|FG003|Overall Study|Physician Decision|0|||
129105165|NCT02557516|464678933|FG000|Overall Study|Sponsor decision|0|||
129105166|NCT02557516|464678934|FG001|Overall Study|Sponsor decision|1|||
129105167|NCT02557516|464678935|FG002|Overall Study|Sponsor decision|2|||
129105168|NCT02557516|464678936|FG003|Overall Study|Sponsor decision|8|||
129105169|NCT01255904|464680948|FG000|Overall Study|Physician Decision|1|||
129105170|NCT01255904|464680949|FG001|Overall Study|Physician Decision|4|||
129105171|NCT02061813|464680950|FG000|Overall Study|Withdrawal by Subject|1|||
129105172|NCT02061813|464680950|FG000|Overall Study|Protocol Violation|2|||
129105173|NCT01705080|464680953|FG000|Overall Study|Missed visit|10|||
129105174|NCT01705080|464680954|FG001|Overall Study|Missed visit|4|||
129105175|NCT01705080|464680955|FG002|Overall Study|Missed visit|1|||
129105176|NCT01705080|464680953|FG000|Overall Study|Death|4|||
129105177|NCT01705080|464680954|FG001|Overall Study|Death|4|||
129105178|NCT01705080|464680955|FG002|Overall Study|Death|6|||
129105179|NCT01705080|464680953|FG000|Overall Study|Withdrawal by Subject|61|||
129105180|NCT01705080|464680954|FG001|Overall Study|Withdrawal by Subject|44|||
129105181|NCT01705080|464680955|FG002|Overall Study|Withdrawal by Subject|9|||
129105182|NCT00206427|464680957|FG000|Overall Study|Adverse Event|2|||
129105183|NCT00632125|464680961|FG000|Overall Study|Death|82|||
129105184|NCT00632125|464680961|FG000|Overall Study|Withdrawal by Subject|44|||
129105185|NCT00632125|464680961|FG000|Overall Study|Adverse Event|36|||
129105186|NCT00632125|464680961|FG000|Overall Study|Renal transplantation|17|||
129105187|NCT00632125|464680961|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
129105188|NCT00632125|464680961|FG000|Overall Study|Non-compliance|8|||
129105189|NCT00632125|464680961|FG000|Overall Study|Development of uncontrolled hypertension|5|||
129105190|NCT00632125|464680961|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
129105191|NCT03130959|464680974|FG000|Overall Study|Disease progression|19|||
129105192|NCT03130959|464680975|FG001|Overall Study|Disease progression|7|||
129105193|NCT03130959|464680976|FG002|Overall Study|Disease progression|12|||
129105194|NCT03130959|464680977|FG003|Overall Study|Disease progression|7|||
129105195|NCT03130959|464680978|FG004|Overall Study|Disease progression|12|||
129105196|NCT03130959|464680979|FG005|Overall Study|Disease progression|3|||
129105197|NCT03130959|464680980|FG006|Overall Study|Disease progression|6|||
129105198|NCT03130959|464680981|FG007|Overall Study|Disease progression|3|||
129105199|NCT03130959|464680982|FG008|Overall Study|Disease progression|15|||
129105200|NCT03130959|464680983|FG009|Overall Study|Disease progression|8|||
129105201|NCT03130959|464680974|FG000|Overall Study|Study drug toxicity|2|||
129105202|NCT03130959|464680975|FG001|Overall Study|Study drug toxicity|2|||
129105203|NCT03130959|464680976|FG002|Overall Study|Study drug toxicity|1|||
129105204|NCT03130959|464680977|FG003|Overall Study|Study drug toxicity|2|||
129105205|NCT03130959|464680978|FG004|Overall Study|Study drug toxicity|1|||
129105206|NCT03130959|464680979|FG005|Overall Study|Study drug toxicity|1|||
129105207|NCT03130959|464680980|FG006|Overall Study|Study drug toxicity|3|||
129105208|NCT03130959|464680981|FG007|Overall Study|Study drug toxicity|0|||
129105209|NCT03130959|464680982|FG008|Overall Study|Study drug toxicity|3|||
129105210|NCT03130959|464680983|FG009|Overall Study|Study drug toxicity|3|||
129105211|NCT03130959|464680974|FG000|Overall Study|Other reasons|0|||
129105212|NCT03130959|464680975|FG001|Overall Study|Other reasons|0|||
129105213|NCT03130959|464680976|FG002|Overall Study|Other reasons|0|||
129105214|NCT03130959|464680977|FG003|Overall Study|Other reasons|0|||
129105215|NCT03130959|464680978|FG004|Overall Study|Other reasons|0|||
129105216|NCT03130959|464680979|FG005|Overall Study|Other reasons|1|||
129105217|NCT03130959|464680980|FG006|Overall Study|Other reasons|1|||
128882004|NCT00551460|463863258|FG000|Overall Study|Ineligible|4|||
128882005|NCT00551460|463863258|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
128882006|NCT01745848|463863259|FG000|Overall Study|Adverse Event|6|||
129017684|NCT00965185|464359685|FG000|Overall Study|Withdrawal by Subject|0|||
129017685|NCT00965185|464359686|FG001|Overall Study|Withdrawal by Subject|1|||
129017686|NCT02272777|464359688|FG000|Overall Study|Adverse Event|0|||
129017687|NCT02272777|464359689|FG001|Overall Study|Adverse Event|1|||
129017688|NCT02272777|464359688|FG000|Overall Study|Withdrawal by Subject|0|||
129017689|NCT02272777|464359689|FG001|Overall Study|Withdrawal by Subject|3|||
129017690|NCT02272777|464359688|FG000|Overall Study|Lost to Follow-up|2|||
129017691|NCT02272777|464359689|FG001|Overall Study|Lost to Follow-up|0|||
129017692|NCT02272777|464359688|FG000|Overall Study|Other|2|||
129017693|NCT02272777|464359689|FG001|Overall Study|Other|0|||
129017694|NCT05275205|464359690|FG000|Overall Study|Adverse Event|1|||
129017695|NCT05275205|464359691|FG001|Overall Study|Adverse Event|2|||
129017696|NCT05275205|464359690|FG000|Overall Study|Physician Decision|1|||
129017697|NCT05275205|464359691|FG001|Overall Study|Physician Decision|1|||
129017698|NCT05275205|464359690|FG000|Overall Study|Withdrawal by Subject|2|||
129017699|NCT05275205|464359691|FG001|Overall Study|Withdrawal by Subject|3|||
129017700|NCT05275205|464359690|FG000|Overall Study|Death|1|||
129017701|NCT05275205|464359691|FG001|Overall Study|Death|0|||
129017702|NCT05275205|464359690|FG000|Overall Study|Patient unable to attend visits|1|||
129017703|NCT05275205|464359691|FG001|Overall Study|Patient unable to attend visits|0|||
129017704|NCT02066922|464359692|FG000|Overall Study|Adverse Event|1|||
129017705|NCT00440297|464359693|FG000|Overall Study|Adverse Event|8|||
129017706|NCT00440297|464359694|FG001|Overall Study|Adverse Event|5|||
129017707|NCT00440297|464359693|FG000|Overall Study|Lost to Follow-up|1|||
129017708|NCT00440297|464359694|FG001|Overall Study|Lost to Follow-up|0|||
129017709|NCT00440297|464359693|FG000|Overall Study|Physician Decision|1|||
129017710|NCT00440297|464359694|FG001|Overall Study|Physician Decision|0|||
129017711|NCT00440297|464359693|FG000|Overall Study|Protocol Violation|11|||
129017712|NCT00440297|464359694|FG001|Overall Study|Protocol Violation|7|||
129017713|NCT00440297|464359693|FG000|Overall Study|Withdrawal by Subject|1|||
129017714|NCT00440297|464359694|FG001|Overall Study|Withdrawal by Subject|6|||
129017715|NCT00440297|464359693|FG000|Overall Study|Randomized by mistake|1|||
129017716|NCT00440297|464359694|FG001|Overall Study|Randomized by mistake|0|||
129017717|NCT03020641|464359695|FG000|Overall Study|Lost to Follow-up|0|||
129017718|NCT03020641|464359696|FG001|Overall Study|Lost to Follow-up|1|||
129017719|NCT03020641|464359695|FG000|Overall Study|Converted to open surgery|2|||
129017720|NCT03020641|464359696|FG001|Overall Study|Converted to open surgery|1|||
129017721|NCT03020641|464359695|FG000|Overall Study|for surgery not performed|0|||
129017722|NCT03020641|464359696|FG001|Overall Study|for surgery not performed|1|||
129017723|NCT02039908|464359700|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
129017724|NCT02039908|464359701|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
129017725|NCT02039908|464359702|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
129017726|NCT02039908|464359703|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
129017727|NCT02039908|464359700|FG000|Phase 1-Summer|Protocol Violation|6|||
129017728|NCT02039908|464359701|FG001|Phase 1-Summer|Protocol Violation|0|||
129017729|NCT02039908|464359702|FG002|Phase 1-Summer|Protocol Violation|0|||
129017730|NCT02039908|464359703|FG003|Phase 1-Summer|Protocol Violation|0|||
129017731|NCT02039908|464359700|FG000|Phase 2-School Year|Lost to Follow-up|0|||
129017732|NCT02039908|464359701|FG001|Phase 2-School Year|Lost to Follow-up|0|||
129017733|NCT02039908|464359702|FG002|Phase 2-School Year|Lost to Follow-up|1|||
129017734|NCT02039908|464359703|FG003|Phase 2-School Year|Lost to Follow-up|3|||
129017735|NCT02039908|464359700|FG000|Phase 2-School Year|Protocol Violation|0|||
129017736|NCT02039908|464359701|FG001|Phase 2-School Year|Protocol Violation|0|||
129017737|NCT02039908|464359702|FG002|Phase 2-School Year|Protocol Violation|3|||
129017738|NCT02039908|464359703|FG003|Phase 2-School Year|Protocol Violation|0|||
129017739|NCT02039908|464359700|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
129017740|NCT02039908|464359701|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
129017741|NCT02039908|464359702|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
129017742|NCT02039908|464359703|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
129017743|NCT04915755|464361485|FG000|Overall Study|Physician Decision|3|||
129017744|NCT04915755|464361486|FG001|Overall Study|Physician Decision|2|||
129017745|NCT04915755|464361485|FG000|Overall Study|Withdrawal by Subject|1|||
129017746|NCT04915755|464361486|FG001|Overall Study|Withdrawal by Subject|1|||
128882007|NCT00679627|463863260|FG000|Overall Study|Death|41|||
129017747|NCT04915755|464361485|FG000|Overall Study|Ongoing for PACT|3|||
129017748|NCT04915755|464361486|FG001|Overall Study|Ongoing for PACT|2|||
129017749|NCT04915755|464361485|FG000|Overall Study|Other|7|||
129017750|NCT04915755|464361486|FG001|Overall Study|Other|11|||
129017751|NCT02533258|464361487|FG000|Overall Study|Adverse Event|1|||
129017752|NCT02533258|464361487|FG000|Overall Study|Death|2|||
129017753|NCT02533258|464361487|FG000|Overall Study|Other|1|||
129017754|NCT02533258|464361487|FG000|Overall Study|Economic factor|1|||
129017755|NCT02533258|464361487|FG000|Overall Study|Progression of pleural effusion|1|||
129017756|NCT02533258|464361487|FG000|Overall Study|Lack of Efficacy|2|||
129017757|NCT01534663|464361488|FG000|Overall Study|Lost to Follow-up|0|||
129017758|NCT01534663|464361489|FG001|Overall Study|Lost to Follow-up|2|||
129105218|NCT03130959|464680981|FG007|Overall Study|Other reasons|0|||
129105219|NCT03130959|464680982|FG008|Overall Study|Other reasons|0|||
129105220|NCT03130959|464680983|FG009|Overall Study|Other reasons|0|||
129105221|NCT03130959|464680974|FG000|Overall Study|Subject request to discontinue therapy|0|||
129105222|NCT03130959|464680975|FG001|Overall Study|Subject request to discontinue therapy|0|||
129105223|NCT03130959|464680976|FG002|Overall Study|Subject request to discontinue therapy|1|||
129105224|NCT03130959|464680977|FG003|Overall Study|Subject request to discontinue therapy|1|||
129105225|NCT03130959|464680978|FG004|Overall Study|Subject request to discontinue therapy|0|||
129105226|NCT03130959|464680979|FG005|Overall Study|Subject request to discontinue therapy|0|||
129105227|NCT03130959|464680980|FG006|Overall Study|Subject request to discontinue therapy|1|||
129105228|NCT03130959|464680981|FG007|Overall Study|Subject request to discontinue therapy|1|||
128683160|NCT01975831|463138769|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
128683161|NCT01975831|463138770|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
128683162|NCT01975831|463138771|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
128683163|NCT01975831|463138772|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
128683164|NCT01975831|463138773|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
128683165|NCT01975831|463138774|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
129105229|NCT03130959|464680982|FG008|Overall Study|Subject request to discontinue therapy|0|||
129105230|NCT03130959|464680983|FG009|Overall Study|Subject request to discontinue therapy|0|||
129105231|NCT03130959|464680974|FG000|Overall Study|Not reported|0|||
129105232|NCT03130959|464680975|FG001|Overall Study|Not reported|0|||
129105233|NCT03130959|464680976|FG002|Overall Study|Not reported|0|||
129105234|NCT03130959|464680977|FG003|Overall Study|Not reported|1|||
129105235|NCT03130959|464680978|FG004|Overall Study|Not reported|0|||
129105236|NCT03130959|464680979|FG005|Overall Study|Not reported|1|||
129105237|NCT03130959|464680980|FG006|Overall Study|Not reported|0|||
129105238|NCT03130959|464680981|FG007|Overall Study|Not reported|0|||
129105239|NCT03130959|464680982|FG008|Overall Study|Not reported|0|||
129105240|NCT03130959|464680983|FG009|Overall Study|Not reported|1|||
129105241|NCT03130959|464680974|FG000|Overall Study|Adverse Event unrelated to drug|0|||
129105242|NCT03130959|464680975|FG001|Overall Study|Adverse Event unrelated to drug|0|||
129105243|NCT03130959|464680976|FG002|Overall Study|Adverse Event unrelated to drug|1|||
129105244|NCT03130959|464680977|FG003|Overall Study|Adverse Event unrelated to drug|1|||
129105245|NCT03130959|464680978|FG004|Overall Study|Adverse Event unrelated to drug|1|||
129105246|NCT03130959|464680979|FG005|Overall Study|Adverse Event unrelated to drug|0|||
129105247|NCT03130959|464680980|FG006|Overall Study|Adverse Event unrelated to drug|1|||
129105248|NCT03130959|464680981|FG007|Overall Study|Adverse Event unrelated to drug|0|||
129105249|NCT03130959|464680982|FG008|Overall Study|Adverse Event unrelated to drug|1|||
129105250|NCT03130959|464680983|FG009|Overall Study|Adverse Event unrelated to drug|1|||
129105251|NCT03130959|464680974|FG000|Overall Study|Participant withdrew consent|0|||
129105252|NCT03130959|464680975|FG001|Overall Study|Participant withdrew consent|1|||
129105253|NCT03130959|464680976|FG002|Overall Study|Participant withdrew consent|0|||
129105254|NCT03130959|464680977|FG003|Overall Study|Participant withdrew consent|2|||
129105255|NCT03130959|464680978|FG004|Overall Study|Participant withdrew consent|1|||
129105256|NCT03130959|464680979|FG005|Overall Study|Participant withdrew consent|0|||
129105257|NCT03130959|464680980|FG006|Overall Study|Participant withdrew consent|0|||
129105258|NCT03130959|464680981|FG007|Overall Study|Participant withdrew consent|0|||
129105259|NCT03130959|464680982|FG008|Overall Study|Participant withdrew consent|0|||
129105260|NCT03130959|464680983|FG009|Overall Study|Participant withdrew consent|2|||
129105261|NCT03130959|464680974|FG000|Overall Study|Administrative reason by sponsor|1|||
129105262|NCT03130959|464680975|FG001|Overall Study|Administrative reason by sponsor|0|||
129105263|NCT03130959|464680976|FG002|Overall Study|Administrative reason by sponsor|1|||
129105264|NCT03130959|464680977|FG003|Overall Study|Administrative reason by sponsor|0|||
129105265|NCT03130959|464680978|FG004|Overall Study|Administrative reason by sponsor|0|||
129105266|NCT03130959|464680979|FG005|Overall Study|Administrative reason by sponsor|0|||
129105267|NCT03130959|464680980|FG006|Overall Study|Administrative reason by sponsor|0|||
129105268|NCT03130959|464680981|FG007|Overall Study|Administrative reason by sponsor|0|||
129105269|NCT03130959|464680982|FG008|Overall Study|Administrative reason by sponsor|0|||
129105270|NCT03130959|464680983|FG009|Overall Study|Administrative reason by sponsor|0|||
129105271|NCT03130959|464680974|FG000|Overall Study|Lost to Follow-up|1|||
129105272|NCT03130959|464680975|FG001|Overall Study|Lost to Follow-up|0|||
129105273|NCT03130959|464680976|FG002|Overall Study|Lost to Follow-up|0|||
129105274|NCT03130959|464680977|FG003|Overall Study|Lost to Follow-up|0|||
129105275|NCT03130959|464680978|FG004|Overall Study|Lost to Follow-up|0|||
129105276|NCT03130959|464680979|FG005|Overall Study|Lost to Follow-up|0|||
129105277|NCT03130959|464680980|FG006|Overall Study|Lost to Follow-up|0|||
129105278|NCT03130959|464680981|FG007|Overall Study|Lost to Follow-up|0|||
129105279|NCT03130959|464680982|FG008|Overall Study|Lost to Follow-up|0|||
129105280|NCT03130959|464680983|FG009|Overall Study|Lost to Follow-up|0|||
129105281|NCT02384538|464680984|FG000|Overall Study|Adverse Event|1|||
128683166|NCT01401959|463138775|FG000|Enrolled|Withdrawal by Subject|1|||
128683167|NCT01401959|463138776|FG001|Enrolled|Withdrawal by Subject|0|||
129105282|NCT02384538|464680985|FG001|Overall Study|Adverse Event|4|||
129105283|NCT02384538|464680984|FG000|Overall Study|Lack of Efficacy|4|||
129105284|NCT02384538|464680985|FG001|Overall Study|Lack of Efficacy|4|||
129105285|NCT02384538|464680984|FG000|Overall Study|Withdrew Consent|0|||
129105286|NCT02384538|464680985|FG001|Overall Study|Withdrew Consent|4|||
129105287|NCT02384538|464680984|FG000|Overall Study|Other|1|||
129105288|NCT02384538|464680985|FG001|Overall Study|Other|3|||
129105289|NCT00313586|464680988|FG000|Overall Study|Disease progression|14|||
129105290|NCT00313586|464680989|FG001|Overall Study|Disease progression|19|||
129105291|NCT00313586|464680990|FG002|Overall Study|Disease progression|10|||
129105292|NCT00313586|464680991|FG003|Overall Study|Disease progression|3|||
129105293|NCT00313586|464680988|FG000|Overall Study|Adverse Event|12|||
129105294|NCT00313586|464680989|FG001|Overall Study|Adverse Event|18|||
129105295|NCT00313586|464680990|FG002|Overall Study|Adverse Event|3|||
129105296|NCT00313586|464680991|FG003|Overall Study|Adverse Event|10|||
129105297|NCT00313586|464680988|FG000|Overall Study|Death|11|||
129105298|NCT00313586|464680989|FG001|Overall Study|Death|8|||
129105299|NCT00313586|464680990|FG002|Overall Study|Death|1|||
129105300|NCT00313586|464680991|FG003|Overall Study|Death|7|||
129105301|NCT00313586|464680988|FG000|Overall Study|Withdrawal by Subject|13|||
129105302|NCT00313586|464680989|FG001|Overall Study|Withdrawal by Subject|6|||
129105303|NCT00313586|464680990|FG002|Overall Study|Withdrawal by Subject|6|||
129105304|NCT00313586|464680991|FG003|Overall Study|Withdrawal by Subject|2|||
129105305|NCT00313586|464680988|FG000|Overall Study|Alternative therapy|3|||
129105306|NCT00313586|464680989|FG001|Overall Study|Alternative therapy|6|||
129105307|NCT00313586|464680990|FG002|Overall Study|Alternative therapy|2|||
129105308|NCT00313586|464680991|FG003|Overall Study|Alternative therapy|0|||
129105309|NCT00313586|464680988|FG000|Overall Study|Other complicating disease|2|||
129105310|NCT00313586|464680989|FG001|Overall Study|Other complicating disease|2|||
129105311|NCT00313586|464680990|FG002|Overall Study|Other complicating disease|0|||
129105312|NCT00313586|464680991|FG003|Overall Study|Other complicating disease|0|||
129105313|NCT00313586|464680988|FG000|Overall Study|Did not achieve HI-major/better response|10|||
129105314|NCT00313586|464680989|FG001|Overall Study|Did not achieve HI-major/better response|7|||
129105315|NCT00313586|464680990|FG002|Overall Study|Did not achieve HI-major/better response|2|||
129105316|NCT00313586|464680991|FG003|Overall Study|Did not achieve HI-major/better response|1|||
129105317|NCT00313586|464680988|FG000|Overall Study|Physician Decision|2|||
129105318|NCT00313586|464680989|FG001|Overall Study|Physician Decision|1|||
129105319|NCT00313586|464680990|FG002|Overall Study|Physician Decision|0|||
129105320|NCT00313586|464680991|FG003|Overall Study|Physician Decision|0|||
129105321|NCT00313586|464680988|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
129105322|NCT00313586|464680989|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
129105323|NCT00313586|464680990|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
129105324|NCT00313586|464680991|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
129105325|NCT00313586|464680988|FG000|Overall Study|Lost insurance|0|||
129105326|NCT00313586|464680989|FG001|Overall Study|Lost insurance|1|||
129105327|NCT00313586|464680990|FG002|Overall Study|Lost insurance|0|||
129105328|NCT00313586|464680991|FG003|Overall Study|Lost insurance|0|||
129105329|NCT00313586|464680988|FG000|Overall Study|Moved|0|||
129105330|NCT00313586|464680989|FG001|Overall Study|Moved|1|||
129105331|NCT00313586|464680990|FG002|Overall Study|Moved|0|||
129105332|NCT00313586|464680991|FG003|Overall Study|Moved|0|||
129105333|NCT00313586|464680988|FG000|Overall Study|Death before starting treatment|1|||
129105334|NCT00313586|464680989|FG001|Overall Study|Death before starting treatment|0|||
129105335|NCT00313586|464680990|FG002|Overall Study|Death before starting treatment|0|||
129105336|NCT00313586|464680991|FG003|Overall Study|Death before starting treatment|0|||
129105337|NCT03076996|464680992|FG000|Overall Study|Withdrawal by Subject|2|||
129105338|NCT03076996|464680992|FG000|Overall Study|Lost to Follow-up|3|||
129105339|NCT03076996|464680992|FG000|Overall Study|Literacy precluded participation|1|||
129105340|NCT03117361|464680994|FG000|Overall Study|Progressive disease|5|||
129105341|NCT03117361|464680994|FG000|Overall Study|Death|1|||
129105342|NCT03117361|464680994|FG000|Overall Study|Physician Decision|2|||
129105343|NCT03117361|464680994|FG000|Overall Study|On study treatment at the end of study|1|||
129105344|NCT03117361|464680994|FG000|Overall Study|Treatment-related adverse event|1|||
129105345|NCT00540644|464680998|FG000|Overall Study|Adverse Event|3|||
129105346|NCT00540644|464680999|FG001|Overall Study|Adverse Event|1|||
129105347|NCT00540644|464680998|FG000|Overall Study|Disease Progression|3|||
129105348|NCT00540644|464680999|FG001|Overall Study|Disease Progression|1|||
129105349|NCT00540644|464680998|FG000|Overall Study|Physician Decision|0|||
129105350|NCT00540644|464680999|FG001|Overall Study|Physician Decision|5|||
128683168|NCT01401959|463138777|FG002|Enrolled|Withdrawal by Subject|0|||
129105351|NCT00540644|464680998|FG000|Overall Study|Withdrawal by Subject|2|||
129105352|NCT00540644|464680999|FG001|Overall Study|Withdrawal by Subject|2|||
129105353|NCT00540644|464680998|FG000|Overall Study|Noncomplilance|1|||
129105354|NCT00540644|464680999|FG001|Overall Study|Noncomplilance|0|||
129105355|NCT03280056|464681000|FG000|Overall Study|Withdrawal by Subject|12|||
129105356|NCT03280056|464681001|FG001|Overall Study|Withdrawal by Subject|14|||
129105357|NCT03280056|464681000|FG000|Overall Study|Death|9|||
128683169|NCT01401959|463138775|FG000|Treated|Disease Progression|2|||
129105358|NCT03280056|464681001|FG001|Overall Study|Death|2|||
129105359|NCT03280056|464681000|FG000|Overall Study|Adverse Event|1|||
129105360|NCT03280056|464681001|FG001|Overall Study|Adverse Event|3|||
129105361|NCT03280056|464681000|FG000|Overall Study|Lost to Follow-up|1|||
129105362|NCT03280056|464681001|FG001|Overall Study|Lost to Follow-up|1|||
129105363|NCT03280056|464681000|FG000|Overall Study|Physician Decision|0|||
129105364|NCT03280056|464681001|FG001|Overall Study|Physician Decision|1|||
129105365|NCT03280056|464681000|FG000|Overall Study|Early Discontinuation|1|||
129105366|NCT03280056|464681001|FG001|Overall Study|Early Discontinuation|0|||
129105367|NCT02144077|464681002|FG000|Overall Study|Withdrawal by Subject|3|||
129105368|NCT02144077|464681003|FG001|Overall Study|Withdrawal by Subject|3|||
129105369|NCT02144077|464681002|FG000|Overall Study|Adverse Event|2|||
129105370|NCT02144077|464681003|FG001|Overall Study|Adverse Event|3|||
129105371|NCT02144077|464681002|FG000|Overall Study|Lost to Follow-up|2|||
129105372|NCT02144077|464681003|FG001|Overall Study|Lost to Follow-up|2|||
129105373|NCT02144077|464681002|FG000|Overall Study|Protocol Violation|1|||
129105374|NCT02144077|464681003|FG001|Overall Study|Protocol Violation|2|||
129105375|NCT02144077|464681002|FG000|Overall Study|Death|0|||
129105376|NCT02144077|464681003|FG001|Overall Study|Death|1|||
129105377|NCT02144077|464681002|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
129105378|NCT02144077|464681003|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
129105379|NCT00610168|464681004|FG000|Overall Study|Withdrawal by Subject|2|||
129105380|NCT00610168|464681005|FG001|Overall Study|Withdrawal by Subject|0|||
129105381|NCT00943592|464681006|FG000|Overall Study|Death|3|||
129105382|NCT01247350|464681007|FG000|Overall Study|Adverse Event|0|||
129105383|NCT01247350|464681008|FG001|Overall Study|Adverse Event|0|||
129105384|NCT01247350|464681009|FG002|Overall Study|Adverse Event|1|||
129105385|NCT01247350|464681010|FG003|Overall Study|Adverse Event|0|||
129105386|NCT01247350|464681011|FG004|Overall Study|Adverse Event|0|||
129105387|NCT01247350|464681007|FG000|Overall Study|Withdrawal by Subject|0|||
129105388|NCT01247350|464681008|FG001|Overall Study|Withdrawal by Subject|0|||
129105389|NCT01247350|464681009|FG002|Overall Study|Withdrawal by Subject|0|||
129105390|NCT01247350|464681010|FG003|Overall Study|Withdrawal by Subject|1|||
129105391|NCT01247350|464681011|FG004|Overall Study|Withdrawal by Subject|0|||
129105392|NCT01247350|464681007|FG000|Overall Study|Entry criteria not met|0|||
129105393|NCT01247350|464681008|FG001|Overall Study|Entry criteria not met|0|||
129105394|NCT01247350|464681009|FG002|Overall Study|Entry criteria not met|0|||
129105395|NCT01247350|464681010|FG003|Overall Study|Entry criteria not met|0|||
129105396|NCT01247350|464681011|FG004|Overall Study|Entry criteria not met|1|||
129105397|NCT00169104|464681012|FG000|Overall Study|Withdrawal by Subject|2|||
129105398|NCT00169104|464681013|FG001|Overall Study|Withdrawal by Subject|0|||
129105399|NCT00169104|464681012|FG000|Overall Study|Protocol Violation|0|||
129105400|NCT00169104|464681013|FG001|Overall Study|Protocol Violation|1|||
129105401|NCT00169104|464681012|FG000|Overall Study|Physician Decision|0|||
129105402|NCT00169104|464681013|FG001|Overall Study|Physician Decision|1|||
129105403|NCT01540981|464681019|FG000|Overall Study|Withdrawal by Subject|1|||
129105404|NCT01540981|464681020|FG001|Overall Study|Withdrawal by Subject|0|||
129105405|NCT00809094|464681022|FG000|Overall Study|Lost to Follow-up|0|||
129105406|NCT00809094|464681023|FG001|Overall Study|Lost to Follow-up|1|||
129105407|NCT00397189|464681024|FG000|3 Weeks Period|Lost to Follow-up|5|||
129105408|NCT00397189|464681025|FG001|3 Weeks Period|Lost to Follow-up|4|||
129105409|NCT00397189|464681024|FG000|3 Weeks Period|Adverse Event|3|||
129105410|NCT00397189|464681025|FG001|3 Weeks Period|Adverse Event|2|||
129105411|NCT00397189|464681024|FG000|3 Weeks Period|Withdrawal by Subject|13|||
129105412|NCT00397189|464681025|FG001|3 Weeks Period|Withdrawal by Subject|9|||
129105413|NCT00397189|464681024|FG000|3 Weeks Period|Physician Decision|0|||
129105414|NCT00397189|464681025|FG001|3 Weeks Period|Physician Decision|2|||
129105415|NCT00397189|464681024|FG000|3 Weeks Period|Protocol Violation|0|||
129105416|NCT00397189|464681025|FG001|3 Weeks Period|Protocol Violation|3|||
129105417|NCT00397189|464681024|FG000|3 Weeks Period|Other|0|||
129105418|NCT00397189|464681025|FG001|3 Weeks Period|Other|2|||
129105419|NCT01535443|464681026|FG000|Overall Study|Physician Decision|3|||
129105420|NCT00232557|464681029|FG000|Overall Study|Lost to Follow-up|3|||
129105421|NCT00232557|464681030|FG001|Overall Study|Lost to Follow-up|5|||
129105422|NCT00141518|464681033|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
129105423|NCT00141518|464681034|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
129105424|NCT00141518|464681035|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
129105425|NCT00141518|464681033|FG000|Overall Study|Adverse Event|7|||
129105426|NCT00141518|464681034|FG001|Overall Study|Adverse Event|5|||
129105427|NCT00141518|464681035|FG002|Overall Study|Adverse Event|2|||
129105428|NCT00141518|464681033|FG000|Overall Study|Withdrawal by Subject|2|||
129105429|NCT00141518|464681034|FG001|Overall Study|Withdrawal by Subject|0|||
129105430|NCT00141518|464681035|FG002|Overall Study|Withdrawal by Subject|2|||
129105431|NCT00141518|464681033|FG000|Overall Study|Protocol Violation|1|||
129105432|NCT00141518|464681034|FG001|Overall Study|Protocol Violation|1|||
129105433|NCT00141518|464681035|FG002|Overall Study|Protocol Violation|2|||
129105434|NCT00141518|464681033|FG000|Overall Study|Lack of Efficacy|5|||
129105435|NCT00141518|464681034|FG001|Overall Study|Lack of Efficacy|0|||
128683170|NCT01401959|463138776|FG001|Treated|Disease Progression|2|||
128683171|NCT01401959|463138777|FG002|Treated|Disease Progression|1|||
128882008|NCT00679627|463863261|FG001|Overall Study|Death|29|||
129105436|NCT00141518|464681035|FG002|Overall Study|Lack of Efficacy|0|||
128683172|NCT01401959|463138775|FG000|Treated|Adverse Event|4|||
128683173|NCT01401959|463138776|FG001|Treated|Adverse Event|3|||
128683174|NCT01401959|463138777|FG002|Treated|Adverse Event|2|||
128683175|NCT01401959|463138775|FG000|Treated|Withdrawal by Subject|1|||
128683176|NCT01401959|463138776|FG001|Treated|Withdrawal by Subject|2|||
128683177|NCT01401959|463138777|FG002|Treated|Withdrawal by Subject|2|||
128683178|NCT01401959|463138775|FG000|Treated|Protocol Violation|0|||
128683179|NCT01401959|463138776|FG001|Treated|Protocol Violation|1|||
128683180|NCT01401959|463138777|FG002|Treated|Protocol Violation|0|||
128683181|NCT00887744|463138778|FG000|Overall Study|Adverse Event|3|||
128683182|NCT00887744|463138778|FG000|Overall Study|Death|1|||
128683183|NCT00887744|463138778|FG000|Overall Study|Lost to Follow-up|3|||
128683184|NCT00887744|463138778|FG000|Overall Study|Withdrawal by Subject|18|||
128683185|NCT00887744|463138778|FG000|Overall Study|Various reasons|9|||
128683186|NCT00450385|463138783|FG000|Overall Study|Death|3|||
128683187|NCT00450385|463138783|FG000|Overall Study|Protocol Violation|1|||
128683188|NCT00450385|463138783|FG000|Overall Study|Withdrawal by Subject|2|||
128683189|NCT00450385|463138783|FG000|Overall Study|Lack of Efficacy|2|||
128683190|NCT00450385|463138783|FG000|Overall Study|Adverse Event|1|||
128683191|NCT00450385|463138783|FG000|Overall Study|Physician Decision|1|||
128683192|NCT00450385|463138783|FG000|Overall Study|Other|3|||
128882009|NCT00679627|463863260|FG000|Overall Study|Adverse Event|43|||
128882010|NCT00679627|463863261|FG001|Overall Study|Adverse Event|53|||
128882011|NCT00679627|463863260|FG000|Overall Study|Withdrawal by Subject|168|||
128882012|NCT00679627|463863261|FG001|Overall Study|Withdrawal by Subject|172|||
128882013|NCT00679627|463863260|FG000|Overall Study|Lost to Follow-up|22|||
128882014|NCT00679627|463863261|FG001|Overall Study|Lost to Follow-up|26|||
128882015|NCT00679627|463863260|FG000|Overall Study|Early Study Closure|425|||
128882016|NCT00679627|463863261|FG001|Overall Study|Early Study Closure|405|||
128882017|NCT00448123|463863262|FG000|Overall Study|Lost to Follow-up|9|||
128882018|NCT00448123|463863263|FG001|Overall Study|Lost to Follow-up|6|||
128882019|NCT00448123|463863262|FG000|Overall Study|Physician Decision|6|||
128882020|NCT00448123|463863263|FG001|Overall Study|Physician Decision|6|||
128882021|NCT02027623|463863265|FG000|Overall Study|Lost to Follow-up|3|||
128882022|NCT02027623|463863266|FG001|Overall Study|Lost to Follow-up|3|||
128882023|NCT02027623|463863265|FG000|Overall Study|Withdrawal by Subject|6|||
128882024|NCT02027623|463863266|FG001|Overall Study|Withdrawal by Subject|9|||
128882025|NCT01886378|463863267|FG000|Overall Study|Adverse Event|1|||
128882026|NCT01886378|463863267|FG000|Overall Study|Withdrawal by Subject|4|||
128882027|NCT00406653|463863272|FG000|Induction Period|Adverse Event|1|||
128882028|NCT00406653|463863273|FG001|Induction Period|Adverse Event|10|||
128882029|NCT00406653|463863274|FG002|Induction Period|Adverse Event|4|||
128882030|NCT00406653|463863275|FG003|Induction Period|Adverse Event|11|||
128882031|NCT00406653|463863276|FG004|Induction Period|Adverse Event|0|||
128882032|NCT00406653|463863277|FG005|Induction Period|Adverse Event|0|||
128882033|NCT00406653|463863278|FG006|Induction Period|Adverse Event|0|||
128882034|NCT00406653|463863272|FG000|Induction Period|Lack of Efficacy|11|||
128882035|NCT00406653|463863273|FG001|Induction Period|Lack of Efficacy|14|||
128882036|NCT00406653|463863274|FG002|Induction Period|Lack of Efficacy|8|||
128882037|NCT00406653|463863275|FG003|Induction Period|Lack of Efficacy|10|||
128882038|NCT00406653|463863276|FG004|Induction Period|Lack of Efficacy|0|||
128882039|NCT00406653|463863277|FG005|Induction Period|Lack of Efficacy|0|||
128882040|NCT00406653|463863278|FG006|Induction Period|Lack of Efficacy|0|||
128882041|NCT00406653|463863272|FG000|Induction Period|Lost to Follow-up|0|||
128882042|NCT00406653|463863273|FG001|Induction Period|Lost to Follow-up|2|||
128882043|NCT00406653|463863274|FG002|Induction Period|Lost to Follow-up|0|||
128882044|NCT00406653|463863275|FG003|Induction Period|Lost to Follow-up|0|||
128882045|NCT00406653|463863276|FG004|Induction Period|Lost to Follow-up|0|||
128882046|NCT00406653|463863277|FG005|Induction Period|Lost to Follow-up|0|||
128882047|NCT00406653|463863278|FG006|Induction Period|Lost to Follow-up|0|||
128882048|NCT00406653|463863272|FG000|Induction Period|Withdrawal of Consent|2|||
128882049|NCT00406653|463863273|FG001|Induction Period|Withdrawal of Consent|5|||
128882050|NCT00406653|463863274|FG002|Induction Period|Withdrawal of Consent|1|||
128882051|NCT00406653|463863275|FG003|Induction Period|Withdrawal of Consent|2|||
128882052|NCT00406653|463863276|FG004|Induction Period|Withdrawal of Consent|0|||
128882053|NCT00406653|463863277|FG005|Induction Period|Withdrawal of Consent|0|||
128882054|NCT00406653|463863278|FG006|Induction Period|Withdrawal of Consent|0|||
128882055|NCT00406653|463863272|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
128882056|NCT00406653|463863273|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
128882057|NCT00406653|463863274|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
128882058|NCT00406653|463863275|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
128882059|NCT00406653|463863276|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
128683193|NCT01390220|463138789|FG000|Test Dose Phase|Adverse Event|17|||
128683194|NCT01390220|463138790|FG001|Test Dose Phase|Adverse Event|0|||
128683195|NCT01390220|463138791|FG002|Test Dose Phase|Adverse Event|0|||
128683196|NCT01390220|463138789|FG000|Test Dose Phase|Withdrawal by Subject|8|||
129105437|NCT01806168|464681036|FG000|Overall Study|Adverse Event|1|||
129105438|NCT01806168|464681037|FG001|Overall Study|Adverse Event|0|||
129105439|NCT01806168|464681038|FG002|Overall Study|Adverse Event|0|||
129105440|NCT01806168|464681036|FG000|Overall Study|Withdrawal by Subject|0|||
129105441|NCT01806168|464681037|FG001|Overall Study|Withdrawal by Subject|1|||
129105442|NCT01806168|464681038|FG002|Overall Study|Withdrawal by Subject|2|||
129105443|NCT01806168|464681036|FG000|Overall Study|Protocol Violation|0|||
129105444|NCT01806168|464681037|FG001|Overall Study|Protocol Violation|0|||
129105445|NCT01806168|464681038|FG002|Overall Study|Protocol Violation|1|||
129105446|NCT01029262|464681039|FG000|Overall Study|Adverse Event|9|||
129105447|NCT01029262|464681040|FG001|Overall Study|Adverse Event|52|||
129105448|NCT01029262|464681039|FG000|Overall Study|Lack of therapeutic effect|57|||
129105449|NCT01029262|464681040|FG001|Overall Study|Lack of therapeutic effect|76|||
129105450|NCT01029262|464681039|FG000|Overall Study|Withdrawal by Subject|10|||
129105451|NCT01029262|464681040|FG001|Overall Study|Withdrawal by Subject|17|||
129105452|NCT01029262|464681039|FG000|Overall Study|Protocol Violation|2|||
129105453|NCT01029262|464681040|FG001|Overall Study|Protocol Violation|3|||
129105454|NCT01029262|464681039|FG000|Overall Study|Miscellaneous|1|||
129105455|NCT01029262|464681040|FG001|Overall Study|Miscellaneous|9|||
129105456|NCT01029262|464681039|FG000|Overall Study|Death|0|||
129105457|NCT01029262|464681040|FG001|Overall Study|Death|3|||
129105458|NCT02438280|464681041|FG000|Overall Study|Physician Decision|1|||
129105459|NCT02438280|464681042|FG001|Overall Study|Physician Decision|0|||
129105460|NCT02260817|464681043|FG000|Overall Study|Lost to Follow-up|0|||
129105461|NCT02260817|464681044|FG001|Overall Study|Lost to Follow-up|14|||
129105462|NCT02260817|464681043|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
129105463|NCT02260817|464681044|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
129105464|NCT02260817|464681043|FG000|Overall Study|Observation, no biopsy|0|||
129105465|NCT02260817|464681044|FG001|Overall Study|Observation, no biopsy|1|||
129105466|NCT02260817|464681043|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
129105467|NCT02260817|464681044|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
129105468|NCT02260817|464681043|FG000|Overall Study|Protocol Violation|0|||
129105469|NCT02260817|464681044|FG001|Overall Study|Protocol Violation|14|||
129105470|NCT03299101|464681045|FG000|Overall Study|Lost to Follow-up|1|||
129105471|NCT03299101|464681045|FG000|Overall Study|Withdrawal by Subject|5|||
129105472|NCT03299101|464681045|FG000|Overall Study|Surgery was changed|3|||
129105473|NCT03299101|464681045|FG000|Overall Study|Not enough time to complete prehab|1|||
129105474|NCT02091414|464681047|FG000|Overall Study|Withdrawal by Subject|2|||
129105475|NCT02091414|464681047|FG000|Overall Study|Death|2|||
129105476|NCT00435461|464681048|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
129105477|NCT00435461|464681049|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
129105478|NCT00435461|464681050|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
129105479|NCT00435461|464681048|FG000|Overall Study|Protocol Violation|6|||
129105480|NCT00435461|464681049|FG001|Overall Study|Protocol Violation|9|||
129105481|NCT00435461|464681050|FG002|Overall Study|Protocol Violation|10|||
128882060|NCT00406653|463863277|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
129105482|NCT00435461|464681048|FG000|Overall Study|Participant randomized(inadequate score)|1|||
129105483|NCT00435461|464681049|FG001|Overall Study|Participant randomized(inadequate score)|0|||
129105484|NCT00435461|464681050|FG002|Overall Study|Participant randomized(inadequate score)|0|||
129105485|NCT00435461|464681048|FG000|Overall Study|Compliance less than 80 percent|1|||
129105486|NCT00435461|464681049|FG001|Overall Study|Compliance less than 80 percent|0|||
129105487|NCT00435461|464681050|FG002|Overall Study|Compliance less than 80 percent|0|||
129105488|NCT00435461|464681048|FG000|Overall Study|In error, two study medications switched|1|||
129105489|NCT00435461|464681049|FG001|Overall Study|In error, two study medications switched|0|||
129105490|NCT00435461|464681050|FG002|Overall Study|In error, two study medications switched|0|||
129105491|NCT00435461|464681048|FG000|Overall Study|Lack of Efficacy|2|||
129105492|NCT00435461|464681049|FG001|Overall Study|Lack of Efficacy|1|||
129105493|NCT00435461|464681050|FG002|Overall Study|Lack of Efficacy|0|||
129105494|NCT00435461|464681048|FG000|Overall Study|Withdrawal by Subject|1|||
129105495|NCT00435461|464681049|FG001|Overall Study|Withdrawal by Subject|0|||
128882061|NCT00406653|463863278|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
128882062|NCT00406653|463863272|FG000|Induction Period|Pregnancy|1|||
129105496|NCT00435461|464681050|FG002|Overall Study|Withdrawal by Subject|2|||
129105497|NCT00435461|464681048|FG000|Overall Study|Randomized in error|1|||
129105498|NCT00435461|464681049|FG001|Overall Study|Randomized in error|0|||
128683197|NCT01390220|463138790|FG001|Test Dose Phase|Withdrawal by Subject|0|||
129105499|NCT00435461|464681050|FG002|Overall Study|Randomized in error|0|||
129105500|NCT00435461|464681048|FG000|Overall Study|Participant could not tolerate symptoms|0|||
129105501|NCT00435461|464681049|FG001|Overall Study|Participant could not tolerate symptoms|0|||
129105502|NCT00435461|464681050|FG002|Overall Study|Participant could not tolerate symptoms|1|||
129105503|NCT00435461|464681048|FG000|Overall Study|Participant could not swallow capsule|0|||
129105504|NCT00435461|464681049|FG001|Overall Study|Participant could not swallow capsule|0|||
129105505|NCT00435461|464681050|FG002|Overall Study|Participant could not swallow capsule|1|||
128882063|NCT00406653|463863273|FG001|Induction Period|Pregnancy|0|||
128882064|NCT00406653|463863274|FG002|Induction Period|Pregnancy|0|||
129017759|NCT01534663|464361488|FG000|Overall Study|Adverse Event|2|||
129017760|NCT01534663|464361489|FG001|Overall Study|Adverse Event|1|||
129017761|NCT03107091|464361490|FG000|Overall Study|Physician Decision|1|||
129017762|NCT04567186|464361495|FG000|Period 1|COVID-19 related|1|||
129017763|NCT04567186|464361496|FG001|Period 1|COVID-19 related|0|||
129017764|NCT04567186|464361495|FG000|Period 1|Protocol Violation|0|||
129017765|NCT04567186|464361496|FG001|Period 1|Protocol Violation|1|||
129017766|NCT04567186|464361495|FG000|Period 1|Adverse Event|0|||
129017767|NCT04567186|464361496|FG001|Period 1|Adverse Event|2|||
129017768|NCT04567186|464361495|FG000|Period 2|COVID-19 Related|0|||
129017769|NCT04567186|464361496|FG001|Period 2|COVID-19 Related|1|||
129017770|NCT04567186|464361495|FG000|Period 2|Protocol Violation|0|||
129017771|NCT04567186|464361496|FG001|Period 2|Protocol Violation|1|||
129017772|NCT04567186|464361495|FG000|Period 2|Lost to Follow-up|0|||
129017773|NCT04567186|464361496|FG001|Period 2|Lost to Follow-up|1|||
129017774|NCT04567186|464361495|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
129017775|NCT04567186|464361496|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
129017776|NCT01185548|464361499|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
129017777|NCT04627038|464361500|FG000|Overall Study|Adverse Event|36|||
129017778|NCT04627038|464361501|FG001|Overall Study|Adverse Event|8|||
129017779|NCT04627038|464361500|FG000|Overall Study|Lost to Follow-up|1|||
129017780|NCT04627038|464361501|FG001|Overall Study|Lost to Follow-up|0|||
129017781|NCT04627038|464361500|FG000|Overall Study|Physician Decision|0|||
129017782|NCT04627038|464361501|FG001|Overall Study|Physician Decision|1|||
129017783|NCT04627038|464361500|FG000|Overall Study|Protocol Violation|3|||
129017784|NCT04627038|464361501|FG001|Overall Study|Protocol Violation|1|||
129017785|NCT04627038|464361500|FG000|Overall Study|Withdrawal by Subject|13|||
129017786|NCT04627038|464361501|FG001|Overall Study|Withdrawal by Subject|3|||
129017787|NCT04627038|464361500|FG000|Overall Study|Non-compliance with study drug|0|||
129017788|NCT04627038|464361501|FG001|Overall Study|Non-compliance with study drug|1|||
129017789|NCT04627038|464361500|FG000|Overall Study|Prohibited Concomitant Medication|1|||
129017790|NCT04627038|464361501|FG001|Overall Study|Prohibited Concomitant Medication|0|||
129017791|NCT02255097|464361502|FG000|Overall Study|Death|151|||
129017792|NCT02255097|464361502|FG000|Overall Study|Lost to Follow-up|5|||
129017793|NCT02255097|464361502|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
129017794|NCT02255097|464361502|FG000|Overall Study|Withdrawal by Subject|7|||
129017795|NCT02255097|464361502|FG000|Overall Study|Allocated but not treated|1|||
129017796|NCT03375463|464361503|FG000|Period 1|Lost to Follow-up|0|||
129017797|NCT03375463|464361504|FG001|Period 1|Lost to Follow-up|0|||
129017798|NCT03375463|464361505|FG002|Period 1|Lost to Follow-up|1|||
129017799|NCT03375463|464361506|FG003|Period 1|Lost to Follow-up|0|||
129017800|NCT03375463|464361507|FG004|Period 1|Lost to Follow-up|0|||
129017801|NCT03375463|464361508|FG005|Period 1|Lost to Follow-up|0|||
129017802|NCT03375463|464361503|FG000|Period 1|Adverse Event|0|||
129017803|NCT03375463|464361504|FG001|Period 1|Adverse Event|0|||
129017804|NCT03375463|464361505|FG002|Period 1|Adverse Event|0|||
129017805|NCT03375463|464361506|FG003|Period 1|Adverse Event|0|||
129017806|NCT03375463|464361507|FG004|Period 1|Adverse Event|1|||
129017807|NCT03375463|464361508|FG005|Period 1|Adverse Event|0|||
129017808|NCT03375463|464361503|FG000|Period 2|Lost to Follow-up|1|||
129017809|NCT03375463|464361504|FG001|Period 2|Lost to Follow-up|1|||
129017810|NCT03375463|464361505|FG002|Period 2|Lost to Follow-up|0|||
129017811|NCT03375463|464361506|FG003|Period 2|Lost to Follow-up|0|||
129017812|NCT03375463|464361507|FG004|Period 2|Lost to Follow-up|0|||
129017813|NCT03375463|464361508|FG005|Period 2|Lost to Follow-up|0|||
129017814|NCT01602419|464361509|FG000|Overall Study|Not treated with Wilate|9|||
129017815|NCT01602419|464361509|FG000|Overall Study|Adverse Drug Reaction|4|||
129017816|NCT01602419|464361509|FG000|Overall Study|Insurance issues|3|||
129017817|NCT01602419|464361509|FG000|Overall Study|Changed treatment centre|1|||
129017818|NCT01602419|464361509|FG000|Overall Study|Treatment centre closed|1|||
129017819|NCT01602419|464361509|FG000|Overall Study|Withdrawal by Subject|5|||
129017820|NCT01602419|464361509|FG000|Overall Study|Lost to Follow-up|6|||
129017821|NCT01792635|464361510|FG000|Part B|Adverse Event|0|||
129017822|NCT01792635|464361511|FG001|Part B|Adverse Event|0|||
129017823|NCT01792635|464361512|FG002|Part B|Adverse Event|1|||
129017824|NCT01792635|464361510|FG000|Part B|Study terminated|0|||
129017825|NCT01792635|464361511|FG001|Part B|Study terminated|4|||
129017826|NCT01792635|464361512|FG002|Part B|Study terminated|3|||
129017827|NCT01513174|464361515|FG000|Overall Study|Inclusion Error|1|||
129017828|NCT01513174|464361516|FG001|Overall Study|Inclusion Error|7|||
128683198|NCT01390220|463138791|FG002|Test Dose Phase|Withdrawal by Subject|0|||
128683199|NCT01390220|463138789|FG000|Test Dose Phase|Lost to Follow-up|2|||
129017829|NCT01513174|464361515|FG000|Overall Study|Not receive study treatment|3|||
129017830|NCT01513174|464361516|FG001|Overall Study|Not receive study treatment|1|||
129017831|NCT00467363|464361517|FG000|Overall Study|Lost to Follow-up|80|||
129017832|NCT00467363|464361518|FG001|Overall Study|Lost to Follow-up|70|||
129017833|NCT04533594|464361519|FG000|Overall Study|Death|26|||
129017834|NCT03138967|464361523|FG000|Overall Study|Death|0|||
129017835|NCT03138967|464361524|FG001|Overall Study|Death|1|||
129017836|NCT03138967|464361523|FG000|Overall Study|Physician Decision|1|||
129017837|NCT03138967|464361524|FG001|Overall Study|Physician Decision|3|||
129017838|NCT01029340|464361526|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
129017839|NCT01029340|464361527|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
129017840|NCT01029340|464361528|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
129017841|NCT01029340|464361529|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
129017842|NCT01029340|464361530|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
129017843|NCT01029340|464361531|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
129017844|NCT01029340|464361526|FG000|Part B Treatment Period|Protocol Violation|0|||
129017845|NCT01029340|464361527|FG001|Part B Treatment Period|Protocol Violation|0|||
129017846|NCT01029340|464361528|FG002|Part B Treatment Period|Protocol Violation|1|||
129017847|NCT01029340|464361529|FG003|Part B Treatment Period|Protocol Violation|0|||
129017848|NCT01029340|464361530|FG004|Part B Treatment Period|Protocol Violation|0|||
129017849|NCT01029340|464361531|FG005|Part B Treatment Period|Protocol Violation|0|||
129017850|NCT01029340|464361526|FG000|Extension Period|Adverse Event|0|||
129017851|NCT01029340|464361527|FG001|Extension Period|Adverse Event|0|||
129017852|NCT01029340|464361528|FG002|Extension Period|Adverse Event|0|||
129017853|NCT01029340|464361529|FG003|Extension Period|Adverse Event|0|||
129017854|NCT01029340|464361530|FG004|Extension Period|Adverse Event|0|||
129017855|NCT01029340|464361531|FG005|Extension Period|Adverse Event|1|||
129017856|NCT01029340|464361526|FG000|Extension Period|starting another study|0|||
129017857|NCT01029340|464361527|FG001|Extension Period|starting another study|0|||
129017858|NCT01029340|464361528|FG002|Extension Period|starting another study|0|||
129017859|NCT01029340|464361529|FG003|Extension Period|starting another study|0|||
129017860|NCT01029340|464361530|FG004|Extension Period|starting another study|0|||
129017861|NCT01029340|464361531|FG005|Extension Period|starting another study|8|||
129017862|NCT01029340|464361526|FG000|Extension Period|non-compliance|0|||
129017863|NCT01029340|464361527|FG001|Extension Period|non-compliance|0|||
129017864|NCT01029340|464361528|FG002|Extension Period|non-compliance|0|||
128683200|NCT01390220|463138790|FG001|Test Dose Phase|Lost to Follow-up|0|||
128683201|NCT01390220|463138791|FG002|Test Dose Phase|Lost to Follow-up|0|||
128683202|NCT01390220|463138789|FG000|Test Dose Phase|Protocol Violation|8|||
128683203|NCT01390220|463138790|FG001|Test Dose Phase|Protocol Violation|0|||
128683204|NCT01390220|463138791|FG002|Test Dose Phase|Protocol Violation|0|||
128683205|NCT01390220|463138789|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
128683206|NCT01390220|463138790|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
128683207|NCT01390220|463138791|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
128683208|NCT01390220|463138789|FG000|Test Dose Phase|Study/Site closure|6|||
128683209|NCT01390220|463138790|FG001|Test Dose Phase|Study/Site closure|0|||
128683210|NCT01390220|463138791|FG002|Test Dose Phase|Study/Site closure|0|||
128683211|NCT01390220|463138789|FG000|Test Dose Phase|Caregiver no longer available|5|||
128683212|NCT01390220|463138790|FG001|Test Dose Phase|Caregiver no longer available|0|||
128683213|NCT01390220|463138791|FG002|Test Dose Phase|Caregiver no longer available|0|||
128683214|NCT01390220|463138789|FG000|Test Dose Phase|Noncompliance|2|||
128683215|NCT01390220|463138790|FG001|Test Dose Phase|Noncompliance|0|||
128683216|NCT01390220|463138791|FG002|Test Dose Phase|Noncompliance|0|||
128683217|NCT01390220|463138789|FG000|Test Dose Phase|Logistical|6|||
128683218|NCT01390220|463138790|FG001|Test Dose Phase|Logistical|0|||
128683219|NCT01390220|463138791|FG002|Test Dose Phase|Logistical|0|||
128683220|NCT01390220|463138789|FG000|Comparative Phase|Withdrawal by Subject|0|||
128683221|NCT01390220|463138790|FG001|Comparative Phase|Withdrawal by Subject|1|||
128683222|NCT01390220|463138791|FG002|Comparative Phase|Withdrawal by Subject|0|||
128683223|NCT03063203|463138792|FG000|Overall Study|Chose alternative therapy|3|||
128683224|NCT03063203|463138792|FG000|Overall Study|Death|2|||
129017865|NCT01029340|464361529|FG003|Extension Period|non-compliance|0|||
129017866|NCT01029340|464361530|FG004|Extension Period|non-compliance|0|||
129017867|NCT01029340|464361531|FG005|Extension Period|non-compliance|1|||
129017868|NCT01029340|464361526|FG000|Extension Period|Withdrawal by Subject|0|||
129017869|NCT01029340|464361527|FG001|Extension Period|Withdrawal by Subject|0|||
129017870|NCT01029340|464361528|FG002|Extension Period|Withdrawal by Subject|0|||
129017871|NCT01029340|464361529|FG003|Extension Period|Withdrawal by Subject|0|||
129017872|NCT01029340|464361530|FG004|Extension Period|Withdrawal by Subject|0|||
129017873|NCT01029340|464361531|FG005|Extension Period|Withdrawal by Subject|1|||
129017874|NCT01029340|464361526|FG000|Extension Period|Physician Decision|0|||
129017875|NCT01029340|464361527|FG001|Extension Period|Physician Decision|0|||
129017876|NCT01029340|464361528|FG002|Extension Period|Physician Decision|0|||
129017877|NCT01029340|464361529|FG003|Extension Period|Physician Decision|0|||
129017878|NCT01029340|464361530|FG004|Extension Period|Physician Decision|0|||
129017879|NCT01029340|464361531|FG005|Extension Period|Physician Decision|1|||
129017880|NCT02648347|464361532|FG000|Overall Study|Death|174|||
129017881|NCT02648347|464361533|FG001|Overall Study|Death|167|||
129017882|NCT02648347|464361532|FG000|Overall Study|Withdrawal by Subject|16|||
128683225|NCT03063203|463138792|FG000|Overall Study|Disease progression|4|||
128683226|NCT03063203|463138792|FG000|Overall Study|Physician Decision|5|||
128683227|NCT02045303|463138793|FG000|Overall Study|Protocol Violation|2|||
128683228|NCT02045303|463138794|FG001|Overall Study|Protocol Violation|1|||
128683229|NCT02045303|463138795|FG002|Overall Study|Protocol Violation|0|||
129017883|NCT02648347|464361533|FG001|Overall Study|Withdrawal by Subject|9|||
129017884|NCT02648347|464361532|FG000|Overall Study|Lost to Follow-up|18|||
129017885|NCT02648347|464361533|FG001|Overall Study|Lost to Follow-up|21|||
129017886|NCT02648347|464361532|FG000|Overall Study|Missing|1|||
129017887|NCT02648347|464361533|FG001|Overall Study|Missing|0|||
129017888|NCT03546842|464361535|FG000|Overall Study|Protocol Violation|1|||
129017889|NCT03546842|464361535|FG000|Overall Study|Withdrawal by Subject|2|||
129017890|NCT02711852|464361547|FG000|Overall Study|Death|5|||
129017891|NCT02711852|464361547|FG000|Overall Study|Lost to Follow-up|1|||
129017892|NCT02711852|464361547|FG000|Overall Study|Completed follow-up|3|||
129017893|NCT02711852|464361547|FG000|Overall Study|Withdrawal by Subject|1|||
129017894|NCT02453386|464361553|FG000|Overall Study|Adverse Event|22|||
129017895|NCT02453386|464361554|FG001|Overall Study|Adverse Event|30|||
129017896|NCT02453386|464361555|FG002|Overall Study|Adverse Event|15|||
129017897|NCT02453386|464361553|FG000|Overall Study|Protocol Violation|1|||
129017898|NCT02453386|464361554|FG001|Overall Study|Protocol Violation|0|||
129017899|NCT02453386|464361555|FG002|Overall Study|Protocol Violation|1|||
129017900|NCT02453386|464361553|FG000|Overall Study|Withdrawal by Subject|10|||
129017901|NCT02453386|464361554|FG001|Overall Study|Withdrawal by Subject|9|||
129017902|NCT02453386|464361555|FG002|Overall Study|Withdrawal by Subject|9|||
129017903|NCT02453386|464361553|FG000|Overall Study|Sponsor Terminated Study|14|||
129017904|NCT02453386|464361554|FG001|Overall Study|Sponsor Terminated Study|8|||
129017905|NCT02453386|464361555|FG002|Overall Study|Sponsor Terminated Study|11|||
129017906|NCT02453386|464361553|FG000|Overall Study|Subject Terminated by Sponsor|1|||
129017907|NCT02453386|464361554|FG001|Overall Study|Subject Terminated by Sponsor|1|||
129017908|NCT02453386|464361555|FG002|Overall Study|Subject Terminated by Sponsor|1|||
129017909|NCT02453386|464361553|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
129017910|NCT02453386|464361554|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
129017911|NCT02453386|464361555|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
129017912|NCT02453386|464361553|FG000|Overall Study|Lost to Follow-up|0|||
129017913|NCT02453386|464361554|FG001|Overall Study|Lost to Follow-up|0|||
129017914|NCT02453386|464361555|FG002|Overall Study|Lost to Follow-up|1|||
129017915|NCT02453386|464361553|FG000|Overall Study|Other|1|||
129017916|NCT02453386|464361554|FG001|Overall Study|Other|0|||
129017917|NCT02453386|464361555|FG002|Overall Study|Other|1|||
129017918|NCT00833937|464361558|FG000|Washout|Withdrawal by Subject|1|||
129017919|NCT00833937|464361559|FG001|Washout|Withdrawal by Subject|0|||
129017920|NCT03233724|464361567|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129017921|NCT03233724|464361568|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129017922|NCT03233724|464361569|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129017923|NCT03233724|464361570|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129017924|NCT03233724|464361571|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
129017925|NCT03233724|464361567|FG000|Phase I Dose Escalation|Best interest of participant|1|||
129017926|NCT03233724|464361568|FG001|Phase I Dose Escalation|Best interest of participant|1|||
129017927|NCT03233724|464361569|FG002|Phase I Dose Escalation|Best interest of participant|1|||
129017928|NCT03233724|464361570|FG003|Phase I Dose Escalation|Best interest of participant|0|||
129017929|NCT03233724|464361571|FG004|Phase I Dose Escalation|Best interest of participant|0|||
129017930|NCT03233724|464361567|FG000|Phase I Dose Escalation|Physician Decision|0|||
129017931|NCT03233724|464361568|FG001|Phase I Dose Escalation|Physician Decision|0|||
129017932|NCT03233724|464361569|FG002|Phase I Dose Escalation|Physician Decision|1|||
129017933|NCT03233724|464361570|FG003|Phase I Dose Escalation|Physician Decision|0|||
129017934|NCT03233724|464361571|FG004|Phase I Dose Escalation|Physician Decision|0|||
129017935|NCT03233724|464361567|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129017936|NCT03233724|464361568|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129017937|NCT03233724|464361569|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
129017938|NCT03233724|464361570|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129017939|NCT03233724|464361571|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129017940|NCT02388191|464361573|FG000|Overall Study|Patient did not receive IUD|1|||
129017941|NCT02388191|464361574|FG001|Overall Study|Patient did not receive IUD|0|||
129017942|NCT03135834|464361575|FG000|Stage 1|Adverse Event|1|||
129017943|NCT03135834|464361576|FG001|Stage 1|Adverse Event|2|||
129017944|NCT03135834|464361577|FG002|Stage 1|Adverse Event|2|||
129017945|NCT03135834|464361578|FG003|Stage 1|Adverse Event|1|||
129017946|NCT03135834|464361575|FG000|Stage 1|Death|1|||
129017947|NCT03135834|464361576|FG001|Stage 1|Death|0|||
129017948|NCT03135834|464361577|FG002|Stage 1|Death|0|||
129017949|NCT03135834|464361578|FG003|Stage 1|Death|0|||
129017950|NCT03135834|464361575|FG000|Stage 1|Lost to Follow-up|17|||
129017951|NCT03135834|464361576|FG001|Stage 1|Lost to Follow-up|24|||
129017952|NCT03135834|464361577|FG002|Stage 1|Lost to Follow-up|21|||
129017953|NCT03135834|464361578|FG003|Stage 1|Lost to Follow-up|38|||
129017954|NCT03135834|464361575|FG000|Stage 1|No longer met eligibility criteria|1|||
129017955|NCT03135834|464361576|FG001|Stage 1|No longer met eligibility criteria|6|||
129017956|NCT03135834|464361577|FG002|Stage 1|No longer met eligibility criteria|2|||
129017957|NCT03135834|464361578|FG003|Stage 1|No longer met eligibility criteria|5|||
129017958|NCT03135834|464361575|FG000|Stage 1|Other|0|||
129017959|NCT03135834|464361576|FG001|Stage 1|Other|2|||
129017960|NCT03135834|464361577|FG002|Stage 1|Other|1|||
129017961|NCT03135834|464361578|FG003|Stage 1|Other|0|||
129017962|NCT03135834|464361575|FG000|Stage 1|Physician Decision|0|||
129017963|NCT03135834|464361576|FG001|Stage 1|Physician Decision|1|||
129017964|NCT03135834|464361577|FG002|Stage 1|Physician Decision|0|||
129017965|NCT03135834|464361578|FG003|Stage 1|Physician Decision|0|||
129017966|NCT03135834|464361575|FG000|Stage 1|Pregnancy|0|||
129017967|NCT03135834|464361576|FG001|Stage 1|Pregnancy|4|||
129017968|NCT03135834|464361577|FG002|Stage 1|Pregnancy|2|||
129017969|NCT03135834|464361578|FG003|Stage 1|Pregnancy|4|||
129017970|NCT03135834|464361575|FG000|Stage 1|Protocol Violation|1|||
129017971|NCT03135834|464361576|FG001|Stage 1|Protocol Violation|1|||
129017972|NCT03135834|464361577|FG002|Stage 1|Protocol Violation|2|||
129017973|NCT03135834|464361578|FG003|Stage 1|Protocol Violation|1|||
129017974|NCT03135834|464361575|FG000|Stage 1|Withdrawal by parent/guardian|2|||
129017975|NCT03135834|464361576|FG001|Stage 1|Withdrawal by parent/guardian|10|||
129017976|NCT03135834|464361577|FG002|Stage 1|Withdrawal by parent/guardian|2|||
129017977|NCT03135834|464361578|FG003|Stage 1|Withdrawal by parent/guardian|1|||
129017978|NCT03135834|464361575|FG000|Stage 1|Withdrawal by Subject|16|||
129017979|NCT03135834|464361576|FG001|Stage 1|Withdrawal by Subject|22|||
129017980|NCT03135834|464361577|FG002|Stage 1|Withdrawal by Subject|7|||
129017981|NCT03135834|464361578|FG003|Stage 1|Withdrawal by Subject|10|||
129017982|NCT03135834|464361575|FG000|Stage 1|Randomized but not Vaccinated|0|||
129017983|NCT03135834|464361576|FG001|Stage 1|Randomized but not Vaccinated|3|||
129017984|NCT03135834|464361577|FG002|Stage 1|Randomized but not Vaccinated|1|||
129017985|NCT03135834|464361578|FG003|Stage 1|Randomized but not Vaccinated|6|||
129017986|NCT03135834|464361575|FG000|Stage 2|Lost to Follow-up|0|||
129017987|NCT03135834|464361576|FG001|Stage 2|Lost to Follow-up|1|||
129017988|NCT03135834|464361577|FG002|Stage 2|Lost to Follow-up|0|||
129017989|NCT03135834|464361578|FG003|Stage 2|Lost to Follow-up|0|||
129017990|NCT03135834|464361575|FG000|Stage 2|Withdrawal by Subject|0|||
129017991|NCT03135834|464361576|FG001|Stage 2|Withdrawal by Subject|1|||
129017992|NCT03135834|464361577|FG002|Stage 2|Withdrawal by Subject|0|||
129017993|NCT03135834|464361578|FG003|Stage 2|Withdrawal by Subject|0|||
129017994|NCT03135834|464361575|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
129017995|NCT03135834|464361576|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
129017996|NCT03135834|464361577|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
129017997|NCT03135834|464361578|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
129017998|NCT03135834|464361575|FG000|Stage 2|Did not receive Booster Vaccination|1|||
129017999|NCT03135834|464361576|FG001|Stage 2|Did not receive Booster Vaccination|1|||
129018000|NCT03135834|464361577|FG002|Stage 2|Did not receive Booster Vaccination|0|||
129018001|NCT03135834|464361578|FG003|Stage 2|Did not receive Booster Vaccination|0|||
129018002|NCT03197883|464361579|FG000|Overall Study|Adverse Event|1|||
129018003|NCT03197883|464361580|FG001|Overall Study|Adverse Event|1|||
129018004|NCT03197883|464361579|FG000|Overall Study|Lost to Follow-up|1|||
129018005|NCT03197883|464361580|FG001|Overall Study|Lost to Follow-up|0|||
129018006|NCT03197883|464361579|FG000|Overall Study|Protocol Violation|1|||
129018007|NCT03197883|464361580|FG001|Overall Study|Protocol Violation|0|||
129018008|NCT03197883|464361579|FG000|Overall Study|Other (Not Specified)|0|||
129018009|NCT03197883|464361580|FG001|Overall Study|Other (Not Specified)|5|||
129018010|NCT03686033|464361581|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
129018011|NCT03686033|464361582|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
129018012|NCT03686033|464361583|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
129018013|NCT03686033|464361584|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
129018014|NCT03686033|464361585|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
129018015|NCT03686033|464361586|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
129018016|NCT01045161|464361587|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
129018017|NCT01045161|464361588|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
129018018|NCT01045161|464361589|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
129018019|NCT01045161|464361587|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
128683230|NCT02045303|463138793|FG000|Overall Study|Withdrawal by Subject|0|||
128683231|NCT02045303|463138794|FG001|Overall Study|Withdrawal by Subject|2|||
129018020|NCT01045161|464361588|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
129018021|NCT01045161|464361589|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
129018022|NCT01045161|464361587|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
129018023|NCT01045161|464361588|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
129018024|NCT01045161|464361589|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
129018025|NCT01045161|464361587|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
129018026|NCT01045161|464361588|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
129018027|NCT01045161|464361589|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
129018028|NCT01045161|464361587|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
129018029|NCT01045161|464361588|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
129018030|NCT01045161|464361589|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
129105506|NCT00435461|464681048|FG000|Overall Study|Pregnancy|2|||
129105507|NCT00435461|464681049|FG001|Overall Study|Pregnancy|0|||
129105508|NCT00435461|464681050|FG002|Overall Study|Pregnancy|0|||
129105509|NCT00435461|464681048|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
129105510|NCT00435461|464681049|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
129105511|NCT00435461|464681050|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
129105512|NCT00435461|464681048|FG000|Overall Study|Participant ended study one day early|1|||
129105513|NCT00435461|464681049|FG001|Overall Study|Participant ended study one day early|0|||
129105514|NCT00435461|464681050|FG002|Overall Study|Participant ended study one day early|0|||
129105515|NCT00435461|464681048|FG000|Overall Study|Noncompliance with study requirements|1|||
129105516|NCT00435461|464681049|FG001|Overall Study|Noncompliance with study requirements|1|||
129105517|NCT00435461|464681050|FG002|Overall Study|Noncompliance with study requirements|1|||
129105518|NCT00435461|464681048|FG000|Overall Study|Adverse Event|1|||
129105519|NCT00435461|464681049|FG001|Overall Study|Adverse Event|2|||
129018031|NCT01045161|464361587|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
129018032|NCT01045161|464361588|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
129018033|NCT01045161|464361589|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
129018034|NCT01045161|464361587|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
129018035|NCT01045161|464361588|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
129018036|NCT01045161|464361589|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
129018037|NCT01045161|464361587|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
129018038|NCT01045161|464361588|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
129018039|NCT01045161|464361589|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
129018040|NCT01045161|464361587|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
129018041|NCT01045161|464361588|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
129018042|NCT01045161|464361589|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
129018043|NCT01045161|464361587|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
129018044|NCT01045161|464361588|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
129018045|NCT01045161|464361589|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
129018046|NCT01045161|464361587|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
129018047|NCT01045161|464361588|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
129018048|NCT01045161|464361589|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
129018049|NCT01045161|464361587|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
129018050|NCT01045161|464361588|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
129018051|NCT01045161|464361589|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
129018052|NCT01045161|464361587|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
129018053|NCT01045161|464361588|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
129018054|NCT01045161|464361589|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
129018055|NCT01045161|464361587|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
129018056|NCT01045161|464361588|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
129018057|NCT01045161|464361589|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
129018058|NCT00858845|464361590|FG000|Overall Study|Patient underwent heart transplant.|0|||
129018059|NCT00858845|464361591|FG001|Overall Study|Patient underwent heart transplant.|1|||
129018060|NCT03031847|464361592|FG000|Overall Study|Death|1|||
129018061|NCT03031847|464361593|FG001|Overall Study|Death|1|||
129018062|NCT03031847|464361594|FG002|Overall Study|Death|2|||
129018063|NCT03031847|464361595|FG003|Overall Study|Death|3|||
129018064|NCT03031847|464361592|FG000|Overall Study|Lost to Follow-up|1|||
129018065|NCT03031847|464361593|FG001|Overall Study|Lost to Follow-up|1|||
129018066|NCT03031847|464361594|FG002|Overall Study|Lost to Follow-up|2|||
129018067|NCT03031847|464361595|FG003|Overall Study|Lost to Follow-up|3|||
129018068|NCT01353664|464361598|FG000|Overall Study|Other|3|||
129018069|NCT01353664|464361598|FG000|Overall Study|Disease Progression|16|||
129018070|NCT02605928|464361601|FG000|Overall Study|Model tuning phase|28|||
129018071|NCT02605928|464361601|FG000|Overall Study|Lack of Efficacy|5|||
129018072|NCT02612337|464361609|FG000|Overall Study|Lack of Efficacy|1|||
129018073|NCT02612337|464361610|FG001|Overall Study|Lack of Efficacy|0|||
129018074|NCT02612337|464361609|FG000|Overall Study|Withdrawal by Subject|2|||
129018075|NCT02612337|464361610|FG001|Overall Study|Withdrawal by Subject|2|||
129018076|NCT02612337|464361609|FG000|Overall Study|Did not receive study drug|0|||
129018077|NCT02612337|464361610|FG001|Overall Study|Did not receive study drug|1|||
129018078|NCT02242201|464361611|FG000|Overall Study|preoperative identified neuropathy|2|||
129018079|NCT02242201|464361612|FG001|Overall Study|preoperative identified neuropathy|0|||
129018080|NCT02242201|464361613|FG002|Overall Study|preoperative identified neuropathy|0|||
129018081|NCT02242201|464361611|FG000|Overall Study|planned post-op anticoagulation|1|||
129018082|NCT02242201|464361612|FG001|Overall Study|planned post-op anticoagulation|0|||
129105520|NCT00435461|464681050|FG002|Overall Study|Adverse Event|6|||
129105521|NCT00435461|464681048|FG000|Overall Study|Non-Compliance of diary|2|||
129105522|NCT00435461|464681049|FG001|Overall Study|Non-Compliance of diary|0|||
129105523|NCT00435461|464681050|FG002|Overall Study|Non-Compliance of diary|1|||
129105524|NCT00435461|464681048|FG000|Overall Study|Lost to Follow-up|1|||
129105525|NCT00435461|464681049|FG001|Overall Study|Lost to Follow-up|1|||
129105526|NCT00435461|464681050|FG002|Overall Study|Lost to Follow-up|2|||
129105527|NCT05446142|464681063|FG000|Period 2|Adverse Event|1|||
129105528|NCT05446142|464681064|FG001|Period 2|Adverse Event|0|||
129105529|NCT05446142|464681065|FG002|Period 2|Adverse Event|0|||
129105530|NCT05446142|464681066|FG003|Period 2|Adverse Event|0|||
129105531|NCT05446142|464681067|FG004|Period 2|Adverse Event|0|||
129105532|NCT05446142|464681068|FG005|Period 2|Adverse Event|0|||
129105533|NCT02098395|464681069|FG000|Overall Study|Protocol Violation|2|||
129105534|NCT02098395|464681070|FG001|Overall Study|Protocol Violation|2|||
129105535|NCT02098395|464681071|FG002|Overall Study|Protocol Violation|0|||
129105536|NCT02098395|464681072|FG003|Overall Study|Protocol Violation|7|||
129105537|NCT02098395|464681069|FG000|Overall Study|Withdrawal by Subject|10|||
129105538|NCT02098395|464681070|FG001|Overall Study|Withdrawal by Subject|10|||
129105539|NCT02098395|464681071|FG002|Overall Study|Withdrawal by Subject|5|||
129105540|NCT02098395|464681072|FG003|Overall Study|Withdrawal by Subject|13|||
129105541|NCT02098395|464681069|FG000|Overall Study|Adverse Event|12|||
129105542|NCT02098395|464681070|FG001|Overall Study|Adverse Event|19|||
129105543|NCT02098395|464681071|FG002|Overall Study|Adverse Event|34|||
129105544|NCT02098395|464681072|FG003|Overall Study|Adverse Event|2|||
129105545|NCT02098395|464681069|FG000|Overall Study|Lost to Follow-up|2|||
129105546|NCT02098395|464681070|FG001|Overall Study|Lost to Follow-up|1|||
129105547|NCT02098395|464681071|FG002|Overall Study|Lost to Follow-up|0|||
129105548|NCT02098395|464681072|FG003|Overall Study|Lost to Follow-up|3|||
129105549|NCT02098395|464681069|FG000|Overall Study|Unclassified|0|||
129105550|NCT02098395|464681070|FG001|Overall Study|Unclassified|0|||
129105551|NCT02098395|464681071|FG002|Overall Study|Unclassified|3|||
129105552|NCT02098395|464681072|FG003|Overall Study|Unclassified|2|||
129105553|NCT00110357|464681075|FG000|Overall Study|Deterioration without progression|2|||
129105554|NCT00110357|464681076|FG001|Overall Study|Deterioration without progression|0|||
129105555|NCT00110357|464681075|FG000|Overall Study|Disease progression/relapse|20|||
129105556|NCT00110357|464681076|FG001|Overall Study|Disease progression/relapse|15|||
129105557|NCT00110357|464681075|FG000|Overall Study|Study Closure|1|||
129105558|NCT00110357|464681076|FG001|Overall Study|Study Closure|0|||
129105559|NCT00110357|464681075|FG000|Overall Study|Study Drug Toxicity|1|||
129105560|NCT00110357|464681076|FG001|Overall Study|Study Drug Toxicity|3|||
129105561|NCT00110357|464681075|FG000|Overall Study|Withdrawal by Subject|3|||
129105562|NCT00110357|464681076|FG001|Overall Study|Withdrawal by Subject|1|||
129105563|NCT03382418|464681077|FG000|Overall Study|Withdrawal by Subject|1|||
129105564|NCT03382418|464681078|FG001|Overall Study|Withdrawal by Subject|0|||
129105565|NCT03382418|464681079|FG002|Overall Study|Withdrawal by Subject|0|||
129105566|NCT03382418|464681077|FG000|Overall Study|Lost to Follow-up|2|||
129105567|NCT03382418|464681078|FG001|Overall Study|Lost to Follow-up|3|||
129105568|NCT03382418|464681079|FG002|Overall Study|Lost to Follow-up|0|||
129105569|NCT04633226|464681080|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129105570|NCT04633226|464681080|FG000|Overall Study|Randomized by mistake without study treatment|1|||
129105571|NCT01151345|464681082|FG000|First Intervention Period|Protocol Violation|0|||
129105572|NCT01151345|464681083|FG001|First Intervention Period|Protocol Violation|1|||
129105573|NCT01348100|464681085|FG000|Overall Study|Subject Withdrew Consent|0|||
129105574|NCT01348100|464681086|FG001|Overall Study|Subject Withdrew Consent|0|||
129105575|NCT01348100|464681087|FG002|Overall Study|Subject Withdrew Consent|2|||
129105576|NCT01348100|464681088|FG003|Overall Study|Subject Withdrew Consent|0|||
129105577|NCT01348100|464681089|FG004|Overall Study|Subject Withdrew Consent|1|||
129105578|NCT01348100|464681090|FG005|Overall Study|Subject Withdrew Consent|0|||
129105579|NCT01348100|464681091|FG006|Overall Study|Subject Withdrew Consent|1|||
129105580|NCT01348100|464681085|FG000|Overall Study|Protocol Deviation|0|||
129105581|NCT01348100|464681086|FG001|Overall Study|Protocol Deviation|0|||
129105582|NCT01348100|464681087|FG002|Overall Study|Protocol Deviation|0|||
129105583|NCT01348100|464681088|FG003|Overall Study|Protocol Deviation|1|||
129105584|NCT01348100|464681089|FG004|Overall Study|Protocol Deviation|0|||
128882065|NCT00406653|463863275|FG003|Induction Period|Pregnancy|0|||
128882066|NCT00406653|463863276|FG004|Induction Period|Pregnancy|0|||
129105585|NCT01348100|464681090|FG005|Overall Study|Protocol Deviation|0|||
129105586|NCT01348100|464681091|FG006|Overall Study|Protocol Deviation|0|||
129105587|NCT01348100|464681085|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129105588|NCT01348100|464681086|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129105589|NCT01348100|464681087|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129105590|NCT01348100|464681088|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129105591|NCT01348100|464681089|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129105592|NCT01348100|464681090|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129105593|NCT01348100|464681091|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129105594|NCT01348100|464681085|FG000|Overall Study|Lost to Follow-up|0|||
129105595|NCT01348100|464681086|FG001|Overall Study|Lost to Follow-up|0|||
129105596|NCT01348100|464681087|FG002|Overall Study|Lost to Follow-up|0|||
129105597|NCT01348100|464681088|FG003|Overall Study|Lost to Follow-up|0|||
129105598|NCT01348100|464681089|FG004|Overall Study|Lost to Follow-up|0|||
129105599|NCT01348100|464681090|FG005|Overall Study|Lost to Follow-up|0|||
129105600|NCT01348100|464681091|FG006|Overall Study|Lost to Follow-up|1|||
129105601|NCT01348100|464681085|FG000|Overall Study|Administrative Problems|0|||
129105602|NCT01348100|464681086|FG001|Overall Study|Administrative Problems|0|||
129105603|NCT01348100|464681087|FG002|Overall Study|Administrative Problems|0|||
129105604|NCT01348100|464681088|FG003|Overall Study|Administrative Problems|0|||
129105605|NCT01348100|464681089|FG004|Overall Study|Administrative Problems|0|||
129105606|NCT01348100|464681090|FG005|Overall Study|Administrative Problems|1|||
129105607|NCT01348100|464681091|FG006|Overall Study|Administrative Problems|1|||
129105608|NCT03882957|464681094|FG000|Overall Study|Did not complete all three arms|1|||
129105609|NCT01134393|464681097|FG000|Overall Study|Adverse Event|18|||
129105610|NCT01134393|464681097|FG000|Overall Study|Lack of Efficacy|2|||
129105611|NCT01134393|464681097|FG000|Overall Study|Protocol Violation|12|||
129105612|NCT01134393|464681097|FG000|Overall Study|Lost to Follow-up|3|||
129105613|NCT01134393|464681097|FG000|Overall Study|Withdrawal by Subject|11|||
129105614|NCT01134393|464681097|FG000|Overall Study|Other|6|||
129105615|NCT03134911|464681098|FG000|Overall Study|Screen failure|31|||
129105616|NCT03134911|464681098|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
129105617|NCT00420628|464681103|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
129105618|NCT00420628|464681104|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
129105619|NCT00420628|464681103|FG000|Overall Study|Lost to Follow-up|3|||
129105620|NCT00420628|464681104|FG001|Overall Study|Lost to Follow-up|2|||
129105621|NCT00420628|464681103|FG000|Overall Study|Adverse Event|1|||
129105622|NCT00420628|464681104|FG001|Overall Study|Adverse Event|0|||
129105623|NCT02787083|464681106|FG000|Overall Study|Adverse Event|1|||
129105624|NCT02787083|464681107|FG001|Overall Study|Adverse Event|0|||
129105625|NCT02787083|464681106|FG000|Overall Study|Withdrawal by Subject|2|||
129105626|NCT02787083|464681107|FG001|Overall Study|Withdrawal by Subject|2|||
129105627|NCT02710084|464681108|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
129105628|NCT02710084|464681109|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
129105629|NCT02182830|464681110|FG000|Overall Study|Not Treated|1|||
129105630|NCT02182830|464681111|FG001|Overall Study|Not Treated|1|||
129105631|NCT02182830|464681110|FG000|Overall Study|Trial stopped, reason missing|3|||
129105632|NCT02182830|464681111|FG001|Overall Study|Trial stopped, reason missing|3|||
129105633|NCT02182830|464681110|FG000|Overall Study|Consent withdrawn|8|||
129105634|NCT02182830|464681111|FG001|Overall Study|Consent withdrawn|8|||
129105635|NCT02182830|464681110|FG000|Overall Study|Lost to Follow-up|3|||
129105636|NCT02182830|464681111|FG001|Overall Study|Lost to Follow-up|3|||
129105637|NCT00154375|464681112|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
129105638|NCT00154375|464681113|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
129105639|NCT00154375|464681112|FG000|Overall Study|Adverse Event|18|||
129105640|NCT00154375|464681113|FG001|Overall Study|Adverse Event|20|||
129105641|NCT00154375|464681112|FG000|Overall Study|Withdrawal by Subject|14|||
129105642|NCT00154375|464681113|FG001|Overall Study|Withdrawal by Subject|10|||
129105643|NCT00154375|464681112|FG000|Overall Study|Death|5|||
129105644|NCT00154375|464681113|FG001|Overall Study|Death|13|||
129105645|NCT00154375|464681112|FG000|Overall Study|Study drug no longer required|5|||
129105646|NCT00154375|464681113|FG001|Overall Study|Study drug no longer required|3|||
129105647|NCT00154375|464681112|FG000|Overall Study|Lost to Follow-up|2|||
129105648|NCT00154375|464681113|FG001|Overall Study|Lost to Follow-up|1|||
129105649|NCT00154375|464681112|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129105650|NCT00154375|464681113|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129105651|NCT00154375|464681112|FG000|Overall Study|Protocol Violation|0|||
129105652|NCT00154375|464681113|FG001|Overall Study|Protocol Violation|1|||
129105653|NCT00154375|464681112|FG000|Overall Study|Suspected progression of disease|44|||
129105654|NCT00154375|464681113|FG001|Overall Study|Suspected progression of disease|30|||
129105655|NCT02348008|464681114|FG000|Overall Study|Adverse Event|2|||
129105656|NCT02348008|464681115|FG001|Overall Study|Adverse Event|3|||
129105657|NCT02348008|464681116|FG002|Overall Study|Adverse Event|3|||
129105658|NCT02348008|464681114|FG000|Overall Study|Disease Progression|1|||
129105659|NCT02348008|464681115|FG001|Overall Study|Disease Progression|5|||
129105660|NCT02348008|464681116|FG002|Overall Study|Disease Progression|16|||
129105661|NCT02348008|464681114|FG000|Overall Study|Withdrawal by Subject|0|||
129105662|NCT02348008|464681115|FG001|Overall Study|Withdrawal by Subject|1|||
129105663|NCT02348008|464681116|FG002|Overall Study|Withdrawal by Subject|0|||
129105664|NCT02348008|464681114|FG000|Overall Study|Symptomatic Deterioration|0|||
129105665|NCT02348008|464681115|FG001|Overall Study|Symptomatic Deterioration|1|||
129105666|NCT02348008|464681116|FG002|Overall Study|Symptomatic Deterioration|0|||
129105667|NCT00334295|464681121|FG000|Overall Study|Patients received fewer than 3 injection|5|||
129105668|NCT03268005|464681122|FG000|Overall Study|Death|2|||
129105669|NCT03268005|464681123|FG001|Overall Study|Death|1|||
129105670|NCT03268005|464681122|FG000|Overall Study|Lost to Follow-up|2|||
129105671|NCT03268005|464681123|FG001|Overall Study|Lost to Follow-up|2|||
129105672|NCT03268005|464681122|FG000|Overall Study|Withdrawal by Subject|11|||
129105673|NCT03268005|464681123|FG001|Overall Study|Withdrawal by Subject|11|||
129105674|NCT04378569|464682972|FG000|Overall Study|Adverse Event|0|||
129105675|NCT04378569|464682973|FG001|Overall Study|Adverse Event|0|||
129105676|NCT04378569|464682974|FG002|Overall Study|Adverse Event|2|||
129105677|NCT04378569|464682975|FG003|Overall Study|Adverse Event|0|||
129105678|NCT04378569|464682976|FG004|Overall Study|Adverse Event|3|||
129105679|NCT04378569|464682977|FG005|Overall Study|Adverse Event|3|||
129105680|NCT04378569|464682972|FG000|Overall Study|Lost to Follow-up|0|||
129105681|NCT04378569|464682973|FG001|Overall Study|Lost to Follow-up|3|||
129105682|NCT04378569|464682974|FG002|Overall Study|Lost to Follow-up|1|||
129105683|NCT04378569|464682975|FG003|Overall Study|Lost to Follow-up|0|||
129105684|NCT04378569|464682976|FG004|Overall Study|Lost to Follow-up|1|||
129105685|NCT04378569|464682977|FG005|Overall Study|Lost to Follow-up|1|||
129105686|NCT04378569|464682972|FG000|Overall Study|Protocol Violation|0|||
129105687|NCT04378569|464682973|FG001|Overall Study|Protocol Violation|0|||
129105688|NCT04378569|464682974|FG002|Overall Study|Protocol Violation|0|||
129105689|NCT04378569|464682975|FG003|Overall Study|Protocol Violation|0|||
129105690|NCT04378569|464682976|FG004|Overall Study|Protocol Violation|0|||
129105691|NCT04378569|464682977|FG005|Overall Study|Protocol Violation|1|||
129105692|NCT04378569|464682972|FG000|Overall Study|Withdrawal by Subject|0|||
129105693|NCT04378569|464682973|FG001|Overall Study|Withdrawal by Subject|6|||
129105694|NCT04378569|464682974|FG002|Overall Study|Withdrawal by Subject|7|||
129105695|NCT04378569|464682975|FG003|Overall Study|Withdrawal by Subject|4|||
129105696|NCT04378569|464682976|FG004|Overall Study|Withdrawal by Subject|5|||
129105697|NCT04378569|464682977|FG005|Overall Study|Withdrawal by Subject|4|||
129105698|NCT04378569|464682972|FG000|Overall Study|Lack of response|0|||
129105699|NCT04378569|464682973|FG001|Overall Study|Lack of response|0|||
129105700|NCT04378569|464682974|FG002|Overall Study|Lack of response|1|||
129105701|NCT04378569|464682975|FG003|Overall Study|Lack of response|0|||
129105702|NCT04378569|464682976|FG004|Overall Study|Lack of response|1|||
129105703|NCT04378569|464682977|FG005|Overall Study|Lack of response|1|||
129105704|NCT01962948|464682978|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
129105705|NCT01962948|464682979|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
129105706|NCT01962948|464682980|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
129105707|NCT01962948|464682981|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
129105708|NCT01059773|464682988|FG000|Overall Study|Adverse Event|2|||
129105709|NCT01059773|464682989|FG001|Overall Study|Adverse Event|2|||
129105710|NCT01059773|464682988|FG000|Overall Study|Withdrawal by Subject|1|||
129105711|NCT01059773|464682989|FG001|Overall Study|Withdrawal by Subject|5|||
129105712|NCT01059773|464682988|FG000|Overall Study|Lost to Follow-up|1|||
129105713|NCT01059773|464682989|FG001|Overall Study|Lost to Follow-up|1|||
129105714|NCT01059773|464682988|FG000|Overall Study|Pregnancy|1|||
129105715|NCT01059773|464682989|FG001|Overall Study|Pregnancy|1|||
129105716|NCT01059773|464682988|FG000|Overall Study|Protocol Violation|6|||
129105717|NCT01059773|464682989|FG001|Overall Study|Protocol Violation|2|||
129105718|NCT01059773|464682988|FG000|Overall Study|Physician Decision|5|||
129105719|NCT01059773|464682989|FG001|Overall Study|Physician Decision|4|||
129105720|NCT01059773|464682988|FG000|Overall Study|Lack of Efficacy|3|||
129105721|NCT01059773|464682989|FG001|Overall Study|Lack of Efficacy|3|||
129105722|NCT01059773|464682988|FG000|Overall Study|Death|0|||
129105723|NCT01059773|464682989|FG001|Overall Study|Death|1|||
129105724|NCT01059773|464682988|FG000|Overall Study|Malignancy including squamous cell skin|0|||
129105725|NCT01059773|464682989|FG001|Overall Study|Malignancy including squamous cell skin|1|||
129105726|NCT01059773|464682988|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
129105727|NCT01059773|464682989|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
129105728|NCT01059773|464682988|FG000|Overall Study|Other|1|||
129105729|NCT01059773|464682989|FG001|Overall Study|Other|3|||
129105730|NCT03410992|464682996|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105731|NCT03410992|464682997|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
129105732|NCT03410992|464682998|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105733|NCT03410992|464682999|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105734|NCT03410992|464683000|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105735|NCT03410992|464683001|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105736|NCT03410992|464683002|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105737|NCT03410992|464683003|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105738|NCT03410992|464683004|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105739|NCT03410992|464683005|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105740|NCT03410992|464683006|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129105741|NCT03410992|464682996|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
129105742|NCT03410992|464682997|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
129105743|NCT03410992|464682998|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105744|NCT03410992|464682999|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105745|NCT03410992|464683000|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105746|NCT03410992|464683001|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105747|NCT03410992|464683002|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105748|NCT03410992|464683003|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105749|NCT03410992|464683004|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105750|NCT03410992|464683005|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105751|NCT03410992|464683006|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129105752|NCT03410992|464682996|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
129105753|NCT03410992|464682997|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
129105754|NCT03410992|464682998|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105755|NCT03410992|464682999|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105756|NCT03410992|464683000|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105757|NCT03410992|464683001|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105758|NCT03410992|464683002|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105759|NCT03410992|464683003|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105760|NCT03410992|464683004|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105761|NCT03410992|464683005|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105762|NCT03410992|464683006|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129105763|NCT03410992|464682996|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
129105764|NCT03410992|464682997|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105765|NCT03410992|464682998|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105766|NCT03410992|464682999|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105767|NCT03410992|464683000|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105768|NCT03410992|464683001|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105769|NCT03410992|464683002|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105770|NCT03410992|464683003|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105771|NCT03410992|464683004|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105772|NCT03410992|464683005|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105773|NCT03410992|464683006|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129105774|NCT03410992|464682996|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
129105775|NCT03410992|464682997|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
129105776|NCT03410992|464682998|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105777|NCT03410992|464682999|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105778|NCT03410992|464683000|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105779|NCT03410992|464683001|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105780|NCT03410992|464683002|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105781|NCT03410992|464683003|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105782|NCT03410992|464683004|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105783|NCT03410992|464683005|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105784|NCT03410992|464683006|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129105785|NCT03410992|464682996|FG000|Week 16 Assessment|Incorrect escapers|0|||
129105786|NCT03410992|464682997|FG001|Week 16 Assessment|Incorrect escapers|6|||
129105787|NCT03410992|464682998|FG002|Week 16 Assessment|Incorrect escapers|0|||
129105788|NCT03410992|464682999|FG003|Week 16 Assessment|Incorrect escapers|0|||
129105789|NCT03410992|464683000|FG004|Week 16 Assessment|Incorrect escapers|0|||
129105790|NCT03410992|464683001|FG005|Week 16 Assessment|Incorrect escapers|0|||
129105791|NCT03410992|464683002|FG006|Week 16 Assessment|Incorrect escapers|0|||
129105792|NCT03410992|464683003|FG007|Week 16 Assessment|Incorrect escapers|0|||
129105793|NCT03410992|464683004|FG008|Week 16 Assessment|Incorrect escapers|0|||
129105794|NCT03410992|464683005|FG009|Week 16 Assessment|Incorrect escapers|0|||
129105795|NCT03410992|464683006|FG010|Week 16 Assessment|Incorrect escapers|0|||
129105796|NCT03410992|464682996|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105797|NCT03410992|464682997|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105798|NCT03410992|464682998|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105799|NCT03410992|464682999|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
129105800|NCT03410992|464683000|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
129105801|NCT03410992|464683001|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105802|NCT03410992|464683002|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105803|NCT03410992|464683003|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105804|NCT03410992|464683004|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105805|NCT03410992|464683005|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105806|NCT03410992|464683006|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129105807|NCT03410992|464682996|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129105808|NCT03410992|464682997|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129105809|NCT03410992|464682998|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129105810|NCT03410992|464682999|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
129105811|NCT03410992|464683000|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
129105812|NCT03410992|464683001|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
129105813|NCT03410992|464683002|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129018083|NCT02242201|464361613|FG002|Overall Study|planned post-op anticoagulation|0|||
129018084|NCT02242201|464361611|FG000|Overall Study|changed surgical procedure|1|||
129018085|NCT02242201|464361612|FG001|Overall Study|changed surgical procedure|0|||
129018086|NCT02242201|464361613|FG002|Overall Study|changed surgical procedure|0|||
129018087|NCT02242201|464361611|FG000|Overall Study|postponed surgery|0|||
129018088|NCT02242201|464361612|FG001|Overall Study|postponed surgery|0|||
129018089|NCT02242201|464361613|FG002|Overall Study|postponed surgery|1|||
129018090|NCT02242201|464361611|FG000|Overall Study|preoperative opioid consumption|0|||
129018091|NCT02242201|464361612|FG001|Overall Study|preoperative opioid consumption|1|||
129018092|NCT02242201|464361613|FG002|Overall Study|preoperative opioid consumption|0|||
129018093|NCT02374853|464361617|FG000|Overall Study|Surgery Cancelled|5|||
129018094|NCT02374853|464361618|FG001|Overall Study|Surgery Cancelled|11|||
129018095|NCT02281084|464361619|FG000|Overall Study|Death|21|||
129018096|NCT02281084|464361620|FG001|Overall Study|Death|18|||
129018097|NCT02281084|464361621|FG002|Overall Study|Death|3|||
129018098|NCT02281084|464361622|FG003|Overall Study|Death|5|||
129018099|NCT02281084|464361619|FG000|Overall Study|Adverse Event|1|||
129018100|NCT02281084|464361620|FG001|Overall Study|Adverse Event|0|||
129018101|NCT02281084|464361621|FG002|Overall Study|Adverse Event|0|||
129018102|NCT02281084|464361622|FG003|Overall Study|Adverse Event|0|||
129018103|NCT02281084|464361619|FG000|Overall Study|Withdrawal by Subject|2|||
129018104|NCT02281084|464361620|FG001|Overall Study|Withdrawal by Subject|2|||
129018105|NCT02281084|464361621|FG002|Overall Study|Withdrawal by Subject|0|||
129018106|NCT02281084|464361622|FG003|Overall Study|Withdrawal by Subject|0|||
129018107|NCT02281084|464361619|FG000|Overall Study|Site Closure by Sponsor|5|||
129018108|NCT02281084|464361620|FG001|Overall Study|Site Closure by Sponsor|1|||
129018109|NCT02281084|464361621|FG002|Overall Study|Site Closure by Sponsor|2|||
129018110|NCT02281084|464361622|FG003|Overall Study|Site Closure by Sponsor|0|||
129018111|NCT01697696|464361623|FG000|Overall Study|Study terminated by sponsor|0|||
129018112|NCT01697696|464361624|FG001|Overall Study|Study terminated by sponsor|3|||
129018113|NCT01697696|464361623|FG000|Overall Study|Protocol deviation|1|||
129018114|NCT01697696|464361624|FG001|Overall Study|Protocol deviation|0|||
129018115|NCT01697696|464361623|FG000|Overall Study|Physician Decision|1|||
129018116|NCT01697696|464361624|FG001|Overall Study|Physician Decision|0|||
129018117|NCT01697696|464361623|FG000|Overall Study|Death|4|||
129018118|NCT01697696|464361624|FG001|Overall Study|Death|2|||
129018119|NCT01697696|464361623|FG000|Overall Study|Lost to Follow-up|10|||
129018120|NCT01697696|464361624|FG001|Overall Study|Lost to Follow-up|7|||
129018121|NCT01697696|464361623|FG000|Overall Study|Subject/guardian decision|31|||
129018122|NCT01697696|464361624|FG001|Overall Study|Subject/guardian decision|35|||
129018123|NCT01424644|464361625|FG000|Overall Study|Adverse Event|2|||
129018124|NCT01424644|464361626|FG001|Overall Study|Adverse Event|0|||
129018125|NCT01424644|464361625|FG000|Overall Study|Withdrawal by Subject|9|||
129018126|NCT01424644|464361626|FG001|Overall Study|Withdrawal by Subject|12|||
129018127|NCT01424644|464361625|FG000|Overall Study|Lost to Follow-up|16|||
129018128|NCT01424644|464361626|FG001|Overall Study|Lost to Follow-up|12|||
129018129|NCT01424644|464361625|FG000|Overall Study|Protocol Violation|4|||
129018130|NCT01424644|464361626|FG001|Overall Study|Protocol Violation|3|||
129018131|NCT01424644|464361625|FG000|Overall Study|Administrative Reason|1|||
129018132|NCT01424644|464361626|FG001|Overall Study|Administrative Reason|0|||
129018133|NCT01424644|464361625|FG000|Overall Study|Unable to Classify|1|||
129018134|NCT01424644|464361626|FG001|Overall Study|Unable to Classify|0|||
129018135|NCT05593965|464361627|FG000|1st Intervention (1 Day)|Technical error|1|||
129018136|NCT05593965|464361628|FG001|1st Intervention (1 Day)|Technical error|0|||
129018137|NCT01880593|464361641|FG000|Overall Study|Adverse Event|1|||
129018138|NCT01880593|464361642|FG001|Overall Study|Adverse Event|0|||
129018139|NCT01880593|464361641|FG000|Overall Study|Lack of Efficacy|1|||
129018140|NCT01880593|464361642|FG001|Overall Study|Lack of Efficacy|5|||
129018141|NCT01880593|464361641|FG000|Overall Study|Withdrawal by Subject|6|||
129018142|NCT01880593|464361642|FG001|Overall Study|Withdrawal by Subject|1|||
129018143|NCT02445339|464361650|FG000|Overall Study|Physician Decision|1|||
129018144|NCT02445339|464361651|FG001|Overall Study|Physician Decision|0|||
129018145|NCT02445339|464361650|FG000|Overall Study|Lost to Follow-up|11|||
129018146|NCT02445339|464361651|FG001|Overall Study|Lost to Follow-up|15|||
129018147|NCT02024932|464361652|FG000|Overall Study|Adverse Event|2|||
129018148|NCT02024932|464361653|FG001|Overall Study|Adverse Event|3|||
129018149|NCT02024932|464361654|FG002|Overall Study|Adverse Event|0|||
129018150|NCT02024932|464361655|FG003|Overall Study|Adverse Event|0|||
129018151|NCT02024932|464361656|FG004|Overall Study|Adverse Event|2|||
128763156|NCT00615264|463422751|FG001|Overall Study|Dermal Hypersensitivity|3|||
128763157|NCT00860067|463422765|FG000|Overall Study|Lost to Follow-up|46|||
128763158|NCT00860067|463422766|FG001|Overall Study|Lost to Follow-up|9|||
128763159|NCT00860067|463422767|FG002|Overall Study|Lost to Follow-up|9|||
129018152|NCT02024932|464361657|FG005|Overall Study|Adverse Event|0|||
129018153|NCT02024932|464361652|FG000|Overall Study|Abnormal laboratory value|0|||
129018154|NCT02024932|464361653|FG001|Overall Study|Abnormal laboratory value|0|||
129018155|NCT02024932|464361654|FG002|Overall Study|Abnormal laboratory value|0|||
129018156|NCT02024932|464361655|FG003|Overall Study|Abnormal laboratory value|2|||
129018157|NCT02024932|464361656|FG004|Overall Study|Abnormal laboratory value|0|||
129105814|NCT03410992|464683003|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129105815|NCT03410992|464683004|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129105816|NCT03410992|464683005|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129105817|NCT03410992|464683006|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129105818|NCT03410992|464682996|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105819|NCT03410992|464682997|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105820|NCT03410992|464682998|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105821|NCT03410992|464682999|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105822|NCT03410992|464683000|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105823|NCT03410992|464683001|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
129105824|NCT03410992|464683002|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105825|NCT03410992|464683003|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105826|NCT03410992|464683004|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105827|NCT03410992|464683005|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105828|NCT03410992|464683006|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129105829|NCT03410992|464682996|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105830|NCT03410992|464682997|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105831|NCT03410992|464682998|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105832|NCT03410992|464682999|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
129105833|NCT03410992|464683000|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
129105834|NCT03410992|464683001|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
129105835|NCT03410992|464683002|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105836|NCT03410992|464683003|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105837|NCT03410992|464683004|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105838|NCT03410992|464683005|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105839|NCT03410992|464683006|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129105840|NCT03410992|464682996|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105841|NCT03410992|464682997|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105842|NCT03410992|464682998|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105843|NCT03410992|464682999|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105844|NCT03410992|464683000|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105845|NCT03410992|464683001|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105846|NCT03410992|464683002|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105847|NCT03410992|464683003|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
129105848|NCT03410992|464683004|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105849|NCT03410992|464683005|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105850|NCT03410992|464683006|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
129105851|NCT03410992|464682996|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105852|NCT03410992|464682997|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105853|NCT03410992|464682998|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105854|NCT03410992|464682999|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105855|NCT03410992|464683000|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105856|NCT03410992|464683001|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105857|NCT03410992|464683002|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105858|NCT03410992|464683003|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105859|NCT03410992|464683004|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
129105860|NCT03410992|464683005|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105861|NCT03410992|464683006|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129105862|NCT01300247|464683009|FG000|Overall Study|Death|1|||
129105863|NCT01300247|464683010|FG001|Overall Study|Death|1|||
129105864|NCT01300247|464683009|FG000|Overall Study|Lost to Follow-up|2|||
129105865|NCT01300247|464683010|FG001|Overall Study|Lost to Follow-up|0|||
129105866|NCT01300247|464683009|FG000|Overall Study|Withdrawal by Subject|1|||
129105867|NCT01300247|464683010|FG001|Overall Study|Withdrawal by Subject|0|||
129105868|NCT01300247|464683009|FG000|Overall Study|Non-Compliance|0|||
129105869|NCT01300247|464683010|FG001|Overall Study|Non-Compliance|1|||
129105870|NCT01556932|464683011|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
129105871|NCT01556932|464683012|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
129105872|NCT01882803|464683013|FG000|Overall Study|Disease Progression|1|||
129105873|NCT01882803|464683013|FG000|Overall Study|Withdrawal by Subject|9|||
129105874|NCT01882803|464683013|FG000|Overall Study|Death|68|||
129105875|NCT01882803|464683013|FG000|Overall Study|Physician Decision|3|||
129105876|NCT01882803|464683013|FG000|Overall Study|Lost to Follow-up|3|||
129105877|NCT01882803|464683013|FG000|Overall Study|Follow-up Completed|39|||
129105878|NCT01882803|464683013|FG000|Overall Study|Study Terminated by the Sponsor|6|||
128763160|NCT00860067|463422765|FG000|Overall Study|Withdrawal by Subject|4|||
128882067|NCT00406653|463863277|FG005|Induction Period|Pregnancy|0|||
128882068|NCT00406653|463863278|FG006|Induction Period|Pregnancy|0|||
129105879|NCT01563913|464683014|FG000|Overall Study|Physician Decision|1|||
129105880|NCT01563913|464683015|FG001|Overall Study|Physician Decision|0|||
129105881|NCT01563913|464683014|FG000|Overall Study|Spouse Passed Away|1|||
129105882|NCT01563913|464683015|FG001|Overall Study|Spouse Passed Away|0|||
129105883|NCT03066778|464683016|FG000|Overall Study|Death|195|||
129105884|NCT03066778|464683017|FG001|Overall Study|Death|205|||
129105885|NCT03066778|464683016|FG000|Overall Study|Withdrawal by Subject|5|||
129105886|NCT03066778|464683017|FG001|Overall Study|Withdrawal by Subject|7|||
129105887|NCT02328937|464683018|FG000|Period 1|Lost to Follow-up|0|||
129105888|NCT02328937|464683019|FG001|Period 1|Lost to Follow-up|0|||
129105889|NCT02328937|464683020|FG002|Period 1|Lost to Follow-up|0|||
129105890|NCT02328937|464683021|FG003|Period 1|Lost to Follow-up|1|||
129105891|NCT02328937|464683022|FG004|Period 1|Lost to Follow-up|0|||
129105892|NCT02328937|464683023|FG005|Period 1|Lost to Follow-up|0|||
129105893|NCT02328937|464683018|FG000|Period 2|Adverse Event|0|||
129105894|NCT02328937|464683019|FG001|Period 2|Adverse Event|0|||
129105895|NCT02328937|464683020|FG002|Period 2|Adverse Event|1|||
129105896|NCT02328937|464683021|FG003|Period 2|Adverse Event|0|||
129105897|NCT02328937|464683022|FG004|Period 2|Adverse Event|0|||
129105898|NCT02328937|464683023|FG005|Period 2|Adverse Event|0|||
129105899|NCT03665077|464683024|FG000|Overall Study|Lost to Follow-up|2|||
129105900|NCT03665077|464683024|FG000|Overall Study|Physician Decision|2|||
129105901|NCT03231306|464683029|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
129105902|NCT03231306|464683029|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
129105903|NCT03231306|464683029|FG000|Overall Study|Treatment delay > 21 days|2|||
129105904|NCT03231306|464683029|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
129105905|NCT03231306|464683029|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
129105906|NCT03231306|464683029|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
129105907|NCT03231306|464683029|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
129105908|NCT03231306|464683029|FG000|Overall Study|More than 1 Reason|2|||
129105909|NCT02306850|464683030|FG000|Overall Study|Lack of Efficacy|2|||
129105910|NCT00237692|464683031|FG000|Overall Study|Lost to Follow-up|9|||
129105911|NCT00237692|464683032|FG001|Overall Study|Lost to Follow-up|3|||
129105912|NCT00237692|464683033|FG002|Overall Study|Lost to Follow-up|5|||
129105913|NCT00237692|464683034|FG003|Overall Study|Lost to Follow-up|3|||
129105914|NCT00237692|464683031|FG000|Overall Study|Death|1|||
129105915|NCT00237692|464683032|FG001|Overall Study|Death|2|||
129105916|NCT00237692|464683033|FG002|Overall Study|Death|2|||
129105917|NCT00237692|464683034|FG003|Overall Study|Death|3|||
129105918|NCT00237692|464683031|FG000|Overall Study|Excluded - did not meet criteria|4|||
129105919|NCT00237692|464683032|FG001|Overall Study|Excluded - did not meet criteria|3|||
129105920|NCT00237692|464683033|FG002|Overall Study|Excluded - did not meet criteria|5|||
129105921|NCT00237692|464683034|FG003|Overall Study|Excluded - did not meet criteria|9|||
129105922|NCT00237692|464683031|FG000|Overall Study|Withdrawal by Subject|4|||
129105923|NCT00237692|464683032|FG001|Overall Study|Withdrawal by Subject|6|||
129105924|NCT00237692|464683033|FG002|Overall Study|Withdrawal by Subject|10|||
129105925|NCT00237692|464683034|FG003|Overall Study|Withdrawal by Subject|4|||
129105926|NCT02420262|464683035|FG000|Overall Study|Adverse Event|1|||
129105927|NCT02420262|464683036|FG001|Overall Study|Adverse Event|0|||
129105928|NCT02420262|464683035|FG000|Overall Study|Withdrawal by Subject|1|||
129105929|NCT02420262|464683036|FG001|Overall Study|Withdrawal by Subject|4|||
129105930|NCT02420262|464683035|FG000|Overall Study|Unclassified|0|||
129105931|NCT02420262|464683036|FG001|Overall Study|Unclassified|1|||
129105932|NCT00685360|464683040|FG000|Overall Study|Lost to Follow-up|0|||
129105933|NCT00685360|464683041|FG001|Overall Study|Lost to Follow-up|1|||
129105934|NCT00685360|464683042|FG002|Overall Study|Lost to Follow-up|2|||
129105935|NCT00685360|464683040|FG000|Overall Study|Adverse Event|4|||
129105936|NCT00685360|464683041|FG001|Overall Study|Adverse Event|6|||
129105937|NCT00685360|464683042|FG002|Overall Study|Adverse Event|4|||
129105938|NCT00685360|464683040|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
129105939|NCT00685360|464683041|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
129105940|NCT00685360|464683042|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
129105941|NCT00685360|464683040|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
129105942|NCT00685360|464683041|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
129105943|NCT00685360|464683042|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
129105944|NCT00685360|464683040|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
129105945|NCT00685360|464683041|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
129105946|NCT00685360|464683042|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
129105947|NCT00685360|464683040|FG000|Overall Study|Protocol Deviation|0|||
129105948|NCT00685360|464683041|FG001|Overall Study|Protocol Deviation|1|||
129105949|NCT00685360|464683042|FG002|Overall Study|Protocol Deviation|1|||
129105950|NCT04865419|464683043|FG000|Overall Study|Other|1|||
129105951|NCT04865419|464683044|FG001|Overall Study|Other|2|||
129105952|NCT04865419|464683045|FG002|Overall Study|Other|2|||
129105953|NCT04865419|464683046|FG003|Overall Study|Other|1|||
129105954|NCT04865419|464683047|FG004|Overall Study|Other|3|||
129105955|NCT04865419|464683048|FG005|Overall Study|Other|0|||
129105956|NCT04865419|464683049|FG006|Overall Study|Other|0|||
129105957|NCT04865419|464683050|FG007|Overall Study|Other|1|||
129105958|NCT04865419|464683051|FG008|Overall Study|Other|0|||
129105959|NCT04865419|464683052|FG009|Overall Study|Other|0|||
129105960|NCT04865419|464683053|FG010|Overall Study|Other|0|||
129105961|NCT04865419|464683043|FG000|Overall Study|Withdrawal by Subject|0|||
129105962|NCT04865419|464683044|FG001|Overall Study|Withdrawal by Subject|1|||
129105963|NCT04865419|464683045|FG002|Overall Study|Withdrawal by Subject|1|||
129105964|NCT04865419|464683046|FG003|Overall Study|Withdrawal by Subject|0|||
129105965|NCT04865419|464683047|FG004|Overall Study|Withdrawal by Subject|0|||
129105966|NCT04865419|464683048|FG005|Overall Study|Withdrawal by Subject|0|||
129105967|NCT04865419|464683049|FG006|Overall Study|Withdrawal by Subject|0|||
129105968|NCT04865419|464683050|FG007|Overall Study|Withdrawal by Subject|1|||
129105969|NCT04865419|464683051|FG008|Overall Study|Withdrawal by Subject|2|||
129105970|NCT04865419|464683052|FG009|Overall Study|Withdrawal by Subject|1|||
129105971|NCT04865419|464683053|FG010|Overall Study|Withdrawal by Subject|0|||
129105972|NCT04865419|464683043|FG000|Overall Study|Study terminated by Sponsor|0|||
129105973|NCT04865419|464683044|FG001|Overall Study|Study terminated by Sponsor|0|||
129105974|NCT04865419|464683045|FG002|Overall Study|Study terminated by Sponsor|0|||
129105975|NCT04865419|464683046|FG003|Overall Study|Study terminated by Sponsor|2|||
129105976|NCT04865419|464683047|FG004|Overall Study|Study terminated by Sponsor|2|||
129105977|NCT04865419|464683048|FG005|Overall Study|Study terminated by Sponsor|0|||
129105978|NCT04865419|464683049|FG006|Overall Study|Study terminated by Sponsor|0|||
129105979|NCT04865419|464683050|FG007|Overall Study|Study terminated by Sponsor|0|||
129105980|NCT04865419|464683051|FG008|Overall Study|Study terminated by Sponsor|0|||
129105981|NCT04865419|464683052|FG009|Overall Study|Study terminated by Sponsor|0|||
129105982|NCT04865419|464683053|FG010|Overall Study|Study terminated by Sponsor|1|||
129105983|NCT04865419|464683043|FG000|Overall Study|Death|3|||
129105984|NCT04865419|464683044|FG001|Overall Study|Death|1|||
129105985|NCT04865419|464683045|FG002|Overall Study|Death|4|||
129105986|NCT04865419|464683046|FG003|Overall Study|Death|2|||
129105987|NCT04865419|464683047|FG004|Overall Study|Death|5|||
129105988|NCT04865419|464683048|FG005|Overall Study|Death|2|||
129105989|NCT04865419|464683049|FG006|Overall Study|Death|1|||
129105990|NCT04865419|464683050|FG007|Overall Study|Death|1|||
129105991|NCT04865419|464683051|FG008|Overall Study|Death|2|||
129105992|NCT04865419|464683052|FG009|Overall Study|Death|2|||
129105993|NCT04865419|464683053|FG010|Overall Study|Death|1|||
129105994|NCT04865419|464683043|FG000|Overall Study|Lost to Follow-up|0|||
129105995|NCT04865419|464683044|FG001|Overall Study|Lost to Follow-up|0|||
129105996|NCT04865419|464683045|FG002|Overall Study|Lost to Follow-up|0|||
129105997|NCT04865419|464683046|FG003|Overall Study|Lost to Follow-up|0|||
129105998|NCT04865419|464683047|FG004|Overall Study|Lost to Follow-up|0|||
129105999|NCT04865419|464683048|FG005|Overall Study|Lost to Follow-up|0|||
129106000|NCT04865419|464683049|FG006|Overall Study|Lost to Follow-up|0|||
129106001|NCT04865419|464683050|FG007|Overall Study|Lost to Follow-up|0|||
129106002|NCT04865419|464683051|FG008|Overall Study|Lost to Follow-up|0|||
129106003|NCT04865419|464683052|FG009|Overall Study|Lost to Follow-up|1|||
129106004|NCT04865419|464683053|FG010|Overall Study|Lost to Follow-up|0|||
129106005|NCT00547157|464683054|FG000|Overall Study|Other|1|||
129106006|NCT00547157|464683055|FG001|Overall Study|Other|0|||
129106007|NCT00547157|464683054|FG000|Overall Study|Death|38|||
129106008|NCT00547157|464683055|FG001|Overall Study|Death|18|||
129106009|NCT00547157|464683054|FG000|Overall Study|Withdrawal by Subject|3|||
129106010|NCT00547157|464683055|FG001|Overall Study|Withdrawal by Subject|1|||
129106011|NCT00547157|464683054|FG000|Overall Study|Administrative decision|3|||
129106012|NCT00547157|464683055|FG001|Overall Study|Administrative decision|2|||
129106013|NCT00547157|464683054|FG000|Overall Study|Lost to Follow-up|4|||
129106014|NCT00547157|464683055|FG001|Overall Study|Lost to Follow-up|2|||
129106015|NCT04208412|464683056|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
129106016|NCT04208412|464683057|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
129106017|NCT04208412|464683056|FG000|Overall Study|Withdrawal by Subject|1|||
129106018|NCT04208412|464683057|FG001|Overall Study|Withdrawal by Subject|0|||
129106019|NCT04208412|464683056|FG000|Overall Study|Lost to Follow-up|0|||
129106020|NCT04208412|464683057|FG001|Overall Study|Lost to Follow-up|1|||
129106021|NCT05415462|464683060|FG000|Overall Study|Death|18|||
129106022|NCT05415462|464683061|FG001|Overall Study|Death|10|||
129106023|NCT05415462|464683060|FG000|Overall Study|Lost to Follow-up|72|||
129106024|NCT05415462|464683061|FG001|Overall Study|Lost to Follow-up|64|||
129106025|NCT05415462|464683060|FG000|Overall Study|Physician Decision|5|||
129106026|NCT05415462|464683061|FG001|Overall Study|Physician Decision|5|||
129106027|NCT05415462|464683060|FG000|Overall Study|Protocol Deviation|1|||
129106028|NCT05415462|464683061|FG001|Overall Study|Protocol Deviation|0|||
129106029|NCT05415462|464683060|FG000|Overall Study|Withdrawal by Subject|129|||
129106030|NCT05415462|464683061|FG001|Overall Study|Withdrawal by Subject|101|||
129106031|NCT05415462|464683060|FG000|Overall Study|Other Than Specified|8|||
129106032|NCT05415462|464683061|FG001|Overall Study|Other Than Specified|8|||
129106033|NCT04186221|464683062|FG000|Overall Study|Death|1|||
129106034|NCT01904032|464683071|FG000|Overall Study|Adverse Event|3|||
129106035|NCT01904032|464683072|FG001|Overall Study|Adverse Event|1|||
129106036|NCT01904032|464683071|FG000|Overall Study|Lost to Follow-up|4|||
129106037|NCT01904032|464683072|FG001|Overall Study|Lost to Follow-up|2|||
129106038|NCT00531947|464683073|FG000|Overall Study|Adverse Event|5|||
129106039|NCT00531947|464683074|FG001|Overall Study|Adverse Event|10|||
129106040|NCT00531947|464683073|FG000|Overall Study|Lost to Follow-up|12|||
129106041|NCT00531947|464683074|FG001|Overall Study|Lost to Follow-up|9|||
129106042|NCT00531947|464683073|FG000|Overall Study|Withdrawal by Subject|14|||
129106043|NCT00531947|464683074|FG001|Overall Study|Withdrawal by Subject|19|||
129106044|NCT00531947|464683073|FG000|Overall Study|Protocol Violation|2|||
129106045|NCT00531947|464683074|FG001|Overall Study|Protocol Violation|1|||
129106046|NCT00531947|464683073|FG000|Overall Study|Non-Compliance|4|||
129106047|NCT00531947|464683074|FG001|Overall Study|Non-Compliance|7|||
129106048|NCT00531947|464683073|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
129106049|NCT00531947|464683074|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
129106050|NCT01087203|464683079|FG000|Overall Study|Lost to Follow-up|2|||
129106051|NCT01087203|464683080|FG001|Overall Study|Lost to Follow-up|0|||
129106052|NCT01087203|464683079|FG000|Overall Study|Withdrawal by Subject|2|||
129106053|NCT01087203|464683080|FG001|Overall Study|Withdrawal by Subject|6|||
129106054|NCT01087203|464683079|FG000|Overall Study|Lack of Efficacy|1|||
129106055|NCT01087203|464683080|FG001|Overall Study|Lack of Efficacy|2|||
129106056|NCT01087203|464683079|FG000|Overall Study|Study terminated by sponsor|27|||
129106057|NCT01087203|464683080|FG001|Overall Study|Study terminated by sponsor|27|||
129106058|NCT04074330|464683092|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
129106059|NCT04074330|464683093|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
129106060|NCT04074330|464683094|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
129106061|NCT04074330|464683095|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
129106062|NCT04074330|464683096|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
129106063|NCT04074330|464683097|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
129106064|NCT04074330|464683098|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
129106065|NCT04074330|464683099|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
129106066|NCT04074330|464683100|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
129106067|NCT04074330|464683101|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
129106068|NCT04074330|464683092|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129106069|NCT04074330|464683093|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129106070|NCT04074330|464683094|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129106071|NCT04074330|464683095|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
129106072|NCT04074330|464683096|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129106073|NCT04074330|464683097|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129106074|NCT04074330|464683098|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
129106075|NCT04074330|464683099|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129106076|NCT04074330|464683100|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129106077|NCT04074330|464683101|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129106078|NCT04074330|464683092|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106079|NCT04074330|464683093|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106080|NCT04074330|464683094|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
129106081|NCT04074330|464683095|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106082|NCT04074330|464683096|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106083|NCT04074330|464683097|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106084|NCT04074330|464683098|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106085|NCT04074330|464683099|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106086|NCT04074330|464683100|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106087|NCT04074330|464683101|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129106088|NCT04074330|464683092|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106089|NCT04074330|464683093|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106090|NCT04074330|464683094|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106091|NCT04074330|464683095|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106092|NCT04074330|464683096|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106093|NCT04074330|464683097|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
129106094|NCT04074330|464683098|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106095|NCT04074330|464683099|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
129106096|NCT04074330|464683100|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106097|NCT04074330|464683101|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129106098|NCT04074330|464683092|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
128683232|NCT02045303|463138795|FG002|Overall Study|Withdrawal by Subject|0|||
129106099|NCT04074330|464683093|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
129106100|NCT04074330|464683094|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
129106101|NCT04074330|464683095|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129106102|NCT04074330|464683096|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
129106103|NCT04074330|464683097|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
129106104|NCT04074330|464683098|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129106105|NCT04074330|464683099|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129106106|NCT04074330|464683100|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129106107|NCT04074330|464683101|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129106108|NCT04074330|464683092|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129106109|NCT04074330|464683093|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129106110|NCT04074330|464683094|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129106111|NCT04074330|464683095|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129106112|NCT04074330|464683096|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129106113|NCT04074330|464683097|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129106114|NCT04074330|464683098|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129106115|NCT04074330|464683099|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129106116|NCT04074330|464683100|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129106117|NCT04074330|464683101|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129106118|NCT04074330|464683092|FG000|Dose Expansion (up to 42 Months)|Death|0|||
129106119|NCT04074330|464683093|FG001|Dose Expansion (up to 42 Months)|Death|0|||
129106120|NCT04074330|464683094|FG002|Dose Expansion (up to 42 Months)|Death|0|||
129106121|NCT04074330|464683095|FG003|Dose Expansion (up to 42 Months)|Death|0|||
129106122|NCT04074330|464683096|FG004|Dose Expansion (up to 42 Months)|Death|0|||
129106123|NCT04074330|464683097|FG005|Dose Expansion (up to 42 Months)|Death|0|||
129106124|NCT04074330|464683098|FG006|Dose Expansion (up to 42 Months)|Death|0|||
129106125|NCT04074330|464683099|FG007|Dose Expansion (up to 42 Months)|Death|0|||
129106126|NCT04074330|464683100|FG008|Dose Expansion (up to 42 Months)|Death|1|||
129106127|NCT04074330|464683101|FG009|Dose Expansion (up to 42 Months)|Death|0|||
129106128|NCT04074330|464683092|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106129|NCT04074330|464683093|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106130|NCT04074330|464683094|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106131|NCT04074330|464683095|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106132|NCT04074330|464683096|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106133|NCT04074330|464683097|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106134|NCT04074330|464683098|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106135|NCT04074330|464683099|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129106136|NCT04074330|464683100|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
129106137|NCT04074330|464683101|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
129106138|NCT00184093|464683102|FG000|Overall Study|Adverse Event|3|||
129106139|NCT00184093|464683102|FG000|Overall Study|Lost to Follow-up|3|||
129106140|NCT00184093|464683102|FG000|Overall Study|Physician Decision|1|||
129106141|NCT00184093|464683102|FG000|Overall Study|Withdrawal by Subject|2|||
129106142|NCT05095311|464683105|FG000|Overall Study|Lost to Follow-up|7|||
129106143|NCT05095311|464683106|FG001|Overall Study|Lost to Follow-up|0|||
129106144|NCT05095311|464683107|FG002|Overall Study|Lost to Follow-up|0|||
129106145|NCT00972283|464683109|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
129106146|NCT00972283|464683110|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
129106147|NCT00972283|464683109|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
129106148|NCT00972283|464683110|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
129106149|NCT00972283|464683109|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
129106150|NCT00972283|464683110|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
129106151|NCT00972283|464683109|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
129106152|NCT00972283|464683110|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
129106153|NCT00972283|464683109|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
129106154|NCT00972283|464683110|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
129106155|NCT00972283|464683109|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
129106156|NCT00972283|464683110|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
129106157|NCT00972283|464683109|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
129106158|NCT00972283|464683110|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
129106159|NCT00972283|464683109|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
129106160|NCT00972283|464683110|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
129106161|NCT00972283|464683109|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
129106162|NCT00972283|464683110|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
129106163|NCT00972283|464683109|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
129106164|NCT00972283|464683110|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
129106165|NCT01868165|464683114|FG000|Overall Study|Withdrawal by Subject|36|||
129106166|NCT01868165|464683114|FG000|Overall Study|Physician Decision|2|||
129106167|NCT01868165|464683114|FG000|Overall Study|Lost to Follow-up|3|||
129106168|NCT01868165|464683114|FG000|Overall Study|Death|4|||
129106169|NCT02588664|464683117|FG000|Overall Study|Death|56|||
129106170|NCT02588664|464683118|FG001|Overall Study|Death|55|||
129106171|NCT02588664|464683117|FG000|Overall Study|Lost to Follow-up|1305|||
129106172|NCT02588664|464683118|FG001|Overall Study|Lost to Follow-up|990|||
129106173|NCT01429298|464683119|FG000|Overall Study|Protocol Violation|4|||
129106174|NCT01429298|464683120|FG001|Overall Study|Protocol Violation|6|||
129106175|NCT02903420|464683121|FG000|Overall Study|Death|3|||
129106176|NCT01124292|464683125|FG000|Overall Study|Lost to Follow-up|2|||
129106177|NCT01124292|464683126|FG001|Overall Study|Lost to Follow-up|4|||
129106178|NCT01124292|464683127|FG002|Overall Study|Lost to Follow-up|3|||
129106179|NCT01124292|464683125|FG000|Overall Study|Physician Decision|0|||
129106180|NCT01124292|464683126|FG001|Overall Study|Physician Decision|3|||
129106181|NCT01124292|464683127|FG002|Overall Study|Physician Decision|2|||
129106182|NCT01124292|464683125|FG000|Overall Study|Withdrawal by Subject|0|||
129106183|NCT01124292|464683126|FG001|Overall Study|Withdrawal by Subject|6|||
129106184|NCT01124292|464683127|FG002|Overall Study|Withdrawal by Subject|2|||
129106185|NCT01124292|464683125|FG000|Overall Study|medical issue unrelated to the study|0|||
129106186|NCT01124292|464683126|FG001|Overall Study|medical issue unrelated to the study|0|||
129106187|NCT01124292|464683127|FG002|Overall Study|medical issue unrelated to the study|2|||
129106188|NCT01124292|464683125|FG000|Overall Study|piercing track closed|0|||
129106189|NCT01124292|464683126|FG001|Overall Study|piercing track closed|2|||
129106190|NCT01124292|464683127|FG002|Overall Study|piercing track closed|1|||
129106191|NCT03373461|464683128|FG000|Part 2|Adverse Event|0|||
129106192|NCT03373461|464683129|FG001|Part 2|Adverse Event|1|||
129106193|NCT03373461|464683130|FG002|Part 2|Adverse Event|0|||
129106194|NCT03373461|464683131|FG003|Part 2|Adverse Event|0|||
129106195|NCT03373461|464683132|FG004|Part 2|Adverse Event|1|||
129106196|NCT03300180|464683133|FG000|Baseline|Withdrawal by Subject|4|||
129106197|NCT03300180|464683134|FG001|Baseline|Withdrawal by Subject|6|||
129106198|NCT03300180|464683135|FG002|Baseline|Withdrawal by Subject|4|||
129106199|NCT03300180|464683133|FG000|6 Month Outcome|Withdrawal by Subject|12|||
129106200|NCT03300180|464683134|FG001|6 Month Outcome|Withdrawal by Subject|12|||
129106201|NCT03300180|464683135|FG002|6 Month Outcome|Withdrawal by Subject|19|||
129106202|NCT03300180|464683133|FG000|6 Month Outcome|Death|2|||
129106203|NCT03300180|464683134|FG001|6 Month Outcome|Death|4|||
129106204|NCT03300180|464683135|FG002|6 Month Outcome|Death|3|||
129106205|NCT03300180|464683133|FG000|6 Month Outcome|Missed Assessment|43|||
129106206|NCT03300180|464683134|FG001|6 Month Outcome|Missed Assessment|52|||
129106207|NCT03300180|464683135|FG002|6 Month Outcome|Missed Assessment|46|||
129106208|NCT03300180|464683133|FG000|12 Month Outcome|Withdrawal by Subject|3|||
129106209|NCT03300180|464683134|FG001|12 Month Outcome|Withdrawal by Subject|6|||
129106210|NCT03300180|464683135|FG002|12 Month Outcome|Withdrawal by Subject|6|||
129106211|NCT03300180|464683133|FG000|12 Month Outcome|Death|9|||
129106212|NCT03300180|464683134|FG001|12 Month Outcome|Death|6|||
129106213|NCT03300180|464683135|FG002|12 Month Outcome|Death|6|||
129106214|NCT03300180|464683133|FG000|12 Month Outcome|Missed Assessment|62|||
129106215|NCT03300180|464683134|FG001|12 Month Outcome|Missed Assessment|59|||
129106216|NCT03300180|464683135|FG002|12 Month Outcome|Missed Assessment|58|||
129106217|NCT03300180|464683133|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
129106218|NCT03300180|464683134|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
129106219|NCT03300180|464683135|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
129106220|NCT03300180|464683133|FG000|18 Month Outcome Assessment|Death|8|||
129106221|NCT03300180|464683134|FG001|18 Month Outcome Assessment|Death|5|||
129106222|NCT03300180|464683135|FG002|18 Month Outcome Assessment|Death|5|||
129106223|NCT03300180|464683133|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
129106224|NCT03300180|464683134|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
129106225|NCT03300180|464683135|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
129106226|NCT03300180|464683133|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
129106227|NCT03300180|464683134|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
129106228|NCT03300180|464683135|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
129106229|NCT03300180|464683133|FG000|24 Month Outcome Assessment|Death|13|||
129106230|NCT03300180|464683134|FG001|24 Month Outcome Assessment|Death|13|||
129106231|NCT03300180|464683135|FG002|24 Month Outcome Assessment|Death|3|||
129106232|NCT03300180|464683133|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
129106233|NCT03300180|464683134|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
129106234|NCT03300180|464683135|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
129106235|NCT03654729|464684608|FG000|Overall Study|Death|9|||
129106236|NCT03654729|464684609|FG001|Overall Study|Death|9|||
129106237|NCT03654729|464684610|FG002|Overall Study|Death|16|||
129106238|NCT03654729|464684608|FG000|Overall Study|Withdrawal by Subject|8|||
129106239|NCT03654729|464684609|FG001|Overall Study|Withdrawal by Subject|6|||
129106240|NCT03654729|464684610|FG002|Overall Study|Withdrawal by Subject|4|||
129106241|NCT03654729|464684608|FG000|Overall Study|Study terminated by Sponsor|3|||
129106242|NCT03654729|464684609|FG001|Overall Study|Study terminated by Sponsor|5|||
129106243|NCT03654729|464684610|FG002|Overall Study|Study terminated by Sponsor|4|||
129018158|NCT02024932|464361657|FG005|Overall Study|Abnormal laboratory value|0|||
129018159|NCT00939003|464361659|FG000|Double-blind Treatment Period|Adverse Event|1|||
129018160|NCT00939003|464361660|FG001|Double-blind Treatment Period|Adverse Event|1|||
129018161|NCT00939003|464361659|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129018162|NCT00939003|464361660|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
129018163|NCT00939003|464361659|FG000|Double-blind Treatment Period|Pregnancy|0|||
129018164|NCT00939003|464361660|FG001|Double-blind Treatment Period|Pregnancy|1|||
129018165|NCT00939003|464361659|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
129018166|NCT00939003|464361660|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
129018167|NCT00939003|464361659|FG000|Open-label Treatment Period|Adverse Event|4|||
129018168|NCT00939003|464361660|FG001|Open-label Treatment Period|Adverse Event|8|||
129018169|NCT00939003|464361659|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
129018170|NCT00939003|464361660|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
129018171|NCT00939003|464361659|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
129018172|NCT00939003|464361660|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
129018173|NCT00939003|464361659|FG000|Open-label Treatment Period|Pregnancy|1|||
129018174|NCT00939003|464361660|FG001|Open-label Treatment Period|Pregnancy|1|||
129018175|NCT00939003|464361659|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
129018176|NCT00939003|464361660|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
129018177|NCT00939003|464361659|FG000|Open-label Treatment Period|Site Closure|3|||
129018178|NCT00939003|464361660|FG001|Open-label Treatment Period|Site Closure|4|||
129018179|NCT02131129|464361661|FG000|Overall Study|Withdrawal by Subject|1|||
129018180|NCT02131129|464361662|FG001|Overall Study|Withdrawal by Subject|0|||
129018181|NCT02865122|464361663|FG000|Overall Study|Adverse Event|1|||
129018182|NCT02865122|464361664|FG001|Overall Study|Adverse Event|0|||
129018183|NCT02865122|464361665|FG002|Overall Study|Adverse Event|0|||
129018184|NCT03880266|464361666|FG000|Overall Study|Withdrawal by Subject|0|||
129018185|NCT03880266|464361667|FG001|Overall Study|Withdrawal by Subject|1|||
129018186|NCT03880266|464361668|FG002|Overall Study|Withdrawal by Subject|1|||
129018187|NCT03880266|464361669|FG003|Overall Study|Withdrawal by Subject|0|||
129018188|NCT03880266|464361670|FG004|Overall Study|Withdrawal by Subject|0|||
129018189|NCT03880266|464361671|FG005|Overall Study|Withdrawal by Subject|0|||
129018190|NCT03880266|464361672|FG006|Overall Study|Withdrawal by Subject|0|||
129018191|NCT03880266|464361673|FG007|Overall Study|Withdrawal by Subject|0|||
129018192|NCT03161405|464361674|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
129018193|NCT00837486|464361675|FG000|Blinded-treatment Phase|Physician Decision|1|||
129018194|NCT00837486|464361676|FG001|Blinded-treatment Phase|Physician Decision|0|||
129018195|NCT00837486|464361675|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
129018196|NCT00837486|464361676|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
129018197|NCT00837486|464361675|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
129018198|NCT00837486|464361676|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
129018199|NCT00837486|464361675|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
129018200|NCT00837486|464361676|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
129018201|NCT00462345|464363552|FG000|Overall Study|Withdrawal by Subject|2|||
129018202|NCT00462345|464363552|FG000|Overall Study|Did not complete second course|1|||
129018203|NCT01149473|464363553|FG000|First Intervention|Adverse Event|1|||
129018204|NCT01149473|464363554|FG001|First Intervention|Adverse Event|1|||
129018205|NCT01149473|464363553|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129018206|NCT01149473|464363554|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129018207|NCT04089735|464363555|FG000|Overall Study|Adverse Event|1|||
129018208|NCT04089735|464363556|FG001|Overall Study|Adverse Event|0|||
129018209|NCT04089735|464363557|FG002|Overall Study|Adverse Event|1|||
129018210|NCT04089735|464363558|FG003|Overall Study|Adverse Event|1|||
129018211|NCT04089735|464363559|FG004|Overall Study|Adverse Event|0|||
129018212|NCT04089735|464363560|FG005|Overall Study|Adverse Event|0|||
129018213|NCT04089735|464363555|FG000|Overall Study|Physician Decision|0|||
129018214|NCT04089735|464363556|FG001|Overall Study|Physician Decision|3|||
129018215|NCT04089735|464363557|FG002|Overall Study|Physician Decision|0|||
129018216|NCT04089735|464363558|FG003|Overall Study|Physician Decision|0|||
129018217|NCT04089735|464363559|FG004|Overall Study|Physician Decision|0|||
129018218|NCT04089735|464363560|FG005|Overall Study|Physician Decision|0|||
129018219|NCT04089735|464363555|FG000|Overall Study|Withdrawal by Subject|0|||
129018220|NCT04089735|464363556|FG001|Overall Study|Withdrawal by Subject|0|||
129018221|NCT04089735|464363557|FG002|Overall Study|Withdrawal by Subject|1|||
129018222|NCT04089735|464363558|FG003|Overall Study|Withdrawal by Subject|0|||
129018223|NCT04089735|464363559|FG004|Overall Study|Withdrawal by Subject|0|||
129018224|NCT04089735|464363560|FG005|Overall Study|Withdrawal by Subject|0|||
129018225|NCT04089735|464363555|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
129018226|NCT04089735|464363556|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
129018227|NCT04089735|464363557|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
129018228|NCT04089735|464363558|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
129106244|NCT03654729|464684608|FG000|Overall Study|Not reported|2|||
129106245|NCT03654729|464684609|FG001|Overall Study|Not reported|4|||
129106246|NCT03654729|464684610|FG002|Overall Study|Not reported|5|||
129106247|NCT03654729|464684608|FG000|Overall Study|Progressive disease|3|||
129106248|NCT03654729|464684609|FG001|Overall Study|Progressive disease|0|||
129106249|NCT03654729|464684610|FG002|Overall Study|Progressive disease|0|||
129106250|NCT03654729|464684608|FG000|Overall Study|Lost to Follow-up|2|||
129106251|NCT03654729|464684609|FG001|Overall Study|Lost to Follow-up|0|||
129106252|NCT03654729|464684610|FG002|Overall Study|Lost to Follow-up|0|||
129106253|NCT03654729|464684608|FG000|Overall Study|Physician Decision|2|||
129106254|NCT03654729|464684609|FG001|Overall Study|Physician Decision|0|||
129106255|NCT03654729|464684610|FG002|Overall Study|Physician Decision|0|||
129106256|NCT03654729|464684608|FG000|Overall Study|Protocol Violation|1|||
129106257|NCT03654729|464684609|FG001|Overall Study|Protocol Violation|1|||
129106258|NCT03654729|464684610|FG002|Overall Study|Protocol Violation|0|||
129106259|NCT03654729|464684608|FG000|Overall Study|Non-compliance with study drug|0|||
129106260|NCT03654729|464684609|FG001|Overall Study|Non-compliance with study drug|1|||
129106261|NCT03654729|464684610|FG002|Overall Study|Non-compliance with study drug|0|||
129106262|NCT03654729|464684608|FG000|Overall Study|Site terminated by Sponsor|1|||
129106263|NCT03654729|464684609|FG001|Overall Study|Site terminated by Sponsor|0|||
129106264|NCT03654729|464684610|FG002|Overall Study|Site terminated by Sponsor|0|||
129106265|NCT04530838|464684611|FG000|Overall Study|Other|2|||
129106266|NCT04530838|464684612|FG001|Overall Study|Other|1|||
129106267|NCT04530838|464684613|FG002|Overall Study|Other|0|||
129106268|NCT04530838|464684611|FG000|Overall Study|Physician Decision|0|||
129106269|NCT04530838|464684612|FG001|Overall Study|Physician Decision|0|||
129106270|NCT04530838|464684613|FG002|Overall Study|Physician Decision|1|||
129106271|NCT04530838|464684611|FG000|Overall Study|Death|0|||
129106272|NCT04530838|464684612|FG001|Overall Study|Death|0|||
129106273|NCT04530838|464684613|FG002|Overall Study|Death|1|||
129106274|NCT04530838|464684611|FG000|Overall Study|Adverse Event|0|||
129106275|NCT04530838|464684612|FG001|Overall Study|Adverse Event|1|||
129106276|NCT04530838|464684613|FG002|Overall Study|Adverse Event|0|||
129106277|NCT04530838|464684611|FG000|Overall Study|No longer meets eligibility criteria|1|||
129106278|NCT04530838|464684612|FG001|Overall Study|No longer meets eligibility criteria|0|||
129106279|NCT04530838|464684613|FG002|Overall Study|No longer meets eligibility criteria|2|||
129106280|NCT04530838|464684611|FG000|Overall Study|Withdrawal by parent/guardian|5|||
129106281|NCT04530838|464684612|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129106282|NCT04530838|464684613|FG002|Overall Study|Withdrawal by parent/guardian|2|||
129106283|NCT00803712|464684614|FG000|Overall Study|Noncompliance|3|||
129106284|NCT00803712|464684615|FG001|Overall Study|Noncompliance|0|||
129106285|NCT00803712|464684614|FG000|Overall Study|Adverse Event|5|||
129106286|NCT00803712|464684615|FG001|Overall Study|Adverse Event|0|||
129106287|NCT00803712|464684614|FG000|Overall Study|Death|8|||
129106288|NCT00803712|464684615|FG001|Overall Study|Death|7|||
129106289|NCT00803712|464684614|FG000|Overall Study|Lost to Follow-up|3|||
129106290|NCT00803712|464684615|FG001|Overall Study|Lost to Follow-up|1|||
129106291|NCT00803712|464684614|FG000|Overall Study|Withdrawal by Subject|2|||
129106292|NCT00803712|464684615|FG001|Overall Study|Withdrawal by Subject|4|||
129106293|NCT00803712|464684614|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
129106294|NCT00803712|464684615|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
129106295|NCT00803712|464684614|FG000|Overall Study|Protocol criteria (other)|0|||
129106296|NCT00803712|464684615|FG001|Overall Study|Protocol criteria (other)|2|||
129106297|NCT00803712|464684614|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
129106298|NCT00803712|464684615|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
129106299|NCT00803712|464684614|FG000|Overall Study|Administrative decision|2|||
129106300|NCT00803712|464684615|FG001|Overall Study|Administrative decision|3|||
129106301|NCT00803712|464684614|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
129106302|NCT00803712|464684615|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
129106303|NCT01919164|464684626|FG000|Overall Study|Adverse Event|6|||
129106304|NCT01919164|464684627|FG001|Overall Study|Adverse Event|4|||
129106305|NCT01919164|464684628|FG002|Overall Study|Adverse Event|9|||
129106306|NCT01919164|464684629|FG003|Overall Study|Adverse Event|3|||
129106307|NCT01919164|464684630|FG004|Overall Study|Adverse Event|2|||
129106308|NCT01919164|464684626|FG000|Overall Study|Lost to Follow-up|2|||
129106309|NCT01919164|464684627|FG001|Overall Study|Lost to Follow-up|2|||
129106310|NCT01919164|464684628|FG002|Overall Study|Lost to Follow-up|2|||
129106311|NCT01919164|464684629|FG003|Overall Study|Lost to Follow-up|0|||
129106312|NCT01919164|464684630|FG004|Overall Study|Lost to Follow-up|4|||
129106313|NCT01919164|464684626|FG000|Overall Study|Death|1|||
129106314|NCT01919164|464684627|FG001|Overall Study|Death|0|||
129106315|NCT01919164|464684628|FG002|Overall Study|Death|0|||
129106316|NCT01919164|464684629|FG003|Overall Study|Death|0|||
129106317|NCT01919164|464684630|FG004|Overall Study|Death|0|||
129106318|NCT01919164|464684626|FG000|Overall Study|Protocol Violation|6|||
129106319|NCT01919164|464684627|FG001|Overall Study|Protocol Violation|0|||
129106320|NCT01919164|464684628|FG002|Overall Study|Protocol Violation|3|||
129106321|NCT01919164|464684629|FG003|Overall Study|Protocol Violation|2|||
129106322|NCT01919164|464684630|FG004|Overall Study|Protocol Violation|2|||
129018229|NCT04089735|464363559|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
129018230|NCT04089735|464363560|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
129018231|NCT01439880|464363562|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
129018232|NCT01439880|464363563|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
129018233|NCT01439880|464363562|FG000|SOC-controlled Period (Year 1)|Death|2|||
129018234|NCT01439880|464363563|FG001|SOC-controlled Period (Year 1)|Death|1|||
129018235|NCT01439880|464363562|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
129018236|NCT01439880|464363563|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
129018237|NCT01439880|464363562|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
129018238|NCT01439880|464363563|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
129018239|NCT01439880|464363562|FG000|SOC-controlled Period (Year 1)|Other|8|||
129018240|NCT01439880|464363563|FG001|SOC-controlled Period (Year 1)|Other|13|||
129018241|NCT01439880|464363562|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
129018242|NCT01439880|464363563|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
129018243|NCT01439880|464363562|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
129018244|NCT01439880|464363563|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
129018245|NCT01439880|464363562|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
129018246|NCT01439880|464363563|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
129018247|NCT01439880|464363562|FG000|All-IP Period (Years 2 to 5)|Death|3|||
129018248|NCT01439880|464363563|FG001|All-IP Period (Years 2 to 5)|Death|13|||
129018249|NCT01439880|464363562|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
129018250|NCT01439880|464363563|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
129018251|NCT01439880|464363562|FG000|All-IP Period (Years 2 to 5)|Other|14|||
129018252|NCT01439880|464363563|FG001|All-IP Period (Years 2 to 5)|Other|31|||
129018253|NCT01439880|464363562|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
129018254|NCT01439880|464363563|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
129018255|NCT03874715|464363565|FG000|Overall Study|Adverse Event|2|||
129018256|NCT03874715|464363566|FG001|Overall Study|Adverse Event|0|||
129018257|NCT03874715|464363565|FG000|Overall Study|Poor compliance to protocol|5|||
129018258|NCT03874715|464363566|FG001|Overall Study|Poor compliance to protocol|1|||
129018259|NCT03874715|464363565|FG000|Overall Study|Withdrawal by Subject|1|||
129018260|NCT03874715|464363566|FG001|Overall Study|Withdrawal by Subject|0|||
129018261|NCT03874715|464363565|FG000|Overall Study|Other-unspecified|1|||
129018262|NCT03874715|464363566|FG001|Overall Study|Other-unspecified|0|||
129018263|NCT02956460|464363569|FG000|Lens 1|Lost to Follow-up|1|||
129018264|NCT02956460|464363570|FG001|Lens 1|Lost to Follow-up|0|||
129018265|NCT00834067|464363573|FG000|Washout of 21 Days|Protocol Violation|0|||
129018266|NCT00834067|464363574|FG001|Washout of 21 Days|Protocol Violation|1|||
129018267|NCT04129346|464363575|FG000|Overall Study|Death|1|||
129018268|NCT04129346|464363576|FG001|Overall Study|Death|0|||
129018269|NCT01083693|464363577|FG000|Overall Study|Adverse Event|1|||
129018270|NCT01083693|464363578|FG001|Overall Study|Adverse Event|1|||
129018271|NCT01083693|464363579|FG002|Overall Study|Adverse Event|0|||
129018272|NCT01083693|464363577|FG000|Overall Study|Lost to Follow-up|2|||
129018273|NCT01083693|464363578|FG001|Overall Study|Lost to Follow-up|0|||
129018274|NCT01083693|464363579|FG002|Overall Study|Lost to Follow-up|2|||
129018275|NCT01083693|464363577|FG000|Overall Study|Lack of effectiveness|13|||
129018276|NCT01083693|464363578|FG001|Overall Study|Lack of effectiveness|2|||
129018277|NCT01083693|464363579|FG002|Overall Study|Lack of effectiveness|2|||
129018278|NCT01083693|464363577|FG000|Overall Study|Patient Moved|0|||
129018279|NCT01083693|464363578|FG001|Overall Study|Patient Moved|1|||
129018280|NCT01083693|464363579|FG002|Overall Study|Patient Moved|0|||
129018281|NCT01083693|464363577|FG000|Overall Study|Complete remission|0|||
129018282|NCT01083693|464363578|FG001|Overall Study|Complete remission|1|||
129018283|NCT01083693|464363579|FG002|Overall Study|Complete remission|0|||
129018284|NCT01083693|464363577|FG000|Overall Study|Other medical condition/surgery|1|||
129018285|NCT01083693|464363578|FG001|Overall Study|Other medical condition/surgery|1|||
129018286|NCT01083693|464363579|FG002|Overall Study|Other medical condition/surgery|0|||
129018287|NCT01083693|464363577|FG000|Overall Study|Withdrawal by Subject|3|||
129018288|NCT01083693|464363578|FG001|Overall Study|Withdrawal by Subject|0|||
129018289|NCT01083693|464363579|FG002|Overall Study|Withdrawal by Subject|2|||
129018290|NCT01083693|464363577|FG000|Overall Study|Reason unknown|0|||
129018291|NCT01083693|464363578|FG001|Overall Study|Reason unknown|0|||
129018292|NCT01083693|464363579|FG002|Overall Study|Reason unknown|1|||
129018293|NCT01705574|464363580|FG000|Double-Blind Phase|Lost to Follow-up|12|||
129018294|NCT01705574|464363581|FG001|Double-Blind Phase|Lost to Follow-up|16|||
129018295|NCT01705574|464363582|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129018296|NCT01705574|464363583|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129018297|NCT01705574|464363580|FG000|Double-Blind Phase|Adverse Event|3|||
129018298|NCT01705574|464363581|FG001|Double-Blind Phase|Adverse Event|10|||
129018299|NCT01705574|464363582|FG002|Double-Blind Phase|Adverse Event|0|||
129018300|NCT01705574|464363583|FG003|Double-Blind Phase|Adverse Event|0|||
129018301|NCT01705574|464363580|FG000|Double-Blind Phase|Withdrew Consent|8|||
129018302|NCT01705574|464363581|FG001|Double-Blind Phase|Withdrew Consent|5|||
128882069|NCT00406653|463863272|FG000|Induction Period|Declined participation but followup done|0|||
128882070|NCT00406653|463863273|FG001|Induction Period|Declined participation but followup done|2|||
128882071|NCT00406653|463863274|FG002|Induction Period|Declined participation but followup done|1|||
128882072|NCT00406653|463863275|FG003|Induction Period|Declined participation but followup done|1|||
128882073|NCT00406653|463863276|FG004|Induction Period|Declined participation but followup done|0|||
128882074|NCT00406653|463863277|FG005|Induction Period|Declined participation but followup done|0|||
128882075|NCT00406653|463863278|FG006|Induction Period|Declined participation but followup done|0|||
128882076|NCT00406653|463863272|FG000|Induction Period|Given prohibited drug|0|||
128882077|NCT00406653|463863273|FG001|Induction Period|Given prohibited drug|1|||
128882078|NCT00406653|463863274|FG002|Induction Period|Given prohibited drug|2|||
129018303|NCT01705574|464363582|FG002|Double-Blind Phase|Withdrew Consent|0|||
129018304|NCT01705574|464363583|FG003|Double-Blind Phase|Withdrew Consent|0|||
129018305|NCT01705574|464363580|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
129018306|NCT01705574|464363581|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
129018307|NCT01705574|464363582|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
129018308|NCT01705574|464363583|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
129018309|NCT01705574|464363580|FG000|Double-Blind Phase|Pregnancy|1|||
129018310|NCT01705574|464363581|FG001|Double-Blind Phase|Pregnancy|1|||
129018311|NCT01705574|464363582|FG002|Double-Blind Phase|Pregnancy|0|||
129018312|NCT01705574|464363583|FG003|Double-Blind Phase|Pregnancy|0|||
129018313|NCT01705574|464363580|FG000|Double-Blind Phase|Protocol Violation|1|||
129018314|NCT01705574|464363581|FG001|Double-Blind Phase|Protocol Violation|0|||
129018315|NCT01705574|464363582|FG002|Double-Blind Phase|Protocol Violation|0|||
129018316|NCT01705574|464363583|FG003|Double-Blind Phase|Protocol Violation|0|||
129018317|NCT01705574|464363580|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
129018318|NCT01705574|464363581|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
129018319|NCT01705574|464363582|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
129018320|NCT01705574|464363583|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
129018321|NCT01705574|464363580|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
129018322|NCT01705574|464363581|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129018323|NCT01705574|464363582|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
129018324|NCT01705574|464363583|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
129018325|NCT01705574|464363580|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
129018326|NCT01705574|464363581|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
129018327|NCT01705574|464363582|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
129018328|NCT01705574|464363583|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
129018329|NCT01705574|464363580|FG000|Open-Label Extension Phase|Adverse Event|3|||
129018330|NCT01705574|464363581|FG001|Open-Label Extension Phase|Adverse Event|0|||
129018331|NCT01705574|464363582|FG002|Open-Label Extension Phase|Adverse Event|0|||
129018332|NCT01705574|464363583|FG003|Open-Label Extension Phase|Adverse Event|1|||
129018333|NCT01705574|464363580|FG000|Open-Label Extension Phase|Death|2|||
129018334|NCT01705574|464363581|FG001|Open-Label Extension Phase|Death|0|||
129018335|NCT01705574|464363582|FG002|Open-Label Extension Phase|Death|1|||
129018336|NCT01705574|464363583|FG003|Open-Label Extension Phase|Death|0|||
129018337|NCT01705574|464363580|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
129018338|NCT01705574|464363581|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
129018339|NCT01705574|464363582|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
129018340|NCT01705574|464363583|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
129018341|NCT01705574|464363580|FG000|Open-Label Extension Phase|Physician Decision|0|||
129018342|NCT01705574|464363581|FG001|Open-Label Extension Phase|Physician Decision|0|||
129018343|NCT01705574|464363582|FG002|Open-Label Extension Phase|Physician Decision|2|||
129018344|NCT01705574|464363583|FG003|Open-Label Extension Phase|Physician Decision|0|||
129018345|NCT01705574|464363580|FG000|Open-Label Extension Phase|Pregnancy|0|||
129018346|NCT01705574|464363581|FG001|Open-Label Extension Phase|Pregnancy|0|||
129018347|NCT01705574|464363582|FG002|Open-Label Extension Phase|Pregnancy|1|||
129018348|NCT01705574|464363583|FG003|Open-Label Extension Phase|Pregnancy|1|||
129018349|NCT02543203|464363584|FG000|Overall Study|Unpalatable Fragrance|2|||
129018350|NCT02543203|464363585|FG001|Overall Study|Unpalatable Fragrance|2|||
129018351|NCT02543203|464363584|FG000|Overall Study|Lost to Follow-up|1|||
129018352|NCT02543203|464363585|FG001|Overall Study|Lost to Follow-up|0|||
129018353|NCT02543203|464363584|FG000|Overall Study|Increased Irritability|1|||
129018354|NCT02543203|464363585|FG001|Overall Study|Increased Irritability|0|||
128882079|NCT00406653|463863275|FG003|Induction Period|Given prohibited drug|0|||
128882080|NCT00406653|463863276|FG004|Induction Period|Given prohibited drug|0|||
129018355|NCT02543203|464363584|FG000|Overall Study|Family|1|||
129018356|NCT02543203|464363585|FG001|Overall Study|Family|2|||
129018357|NCT02543203|464363584|FG000|Overall Study|Negative Behavior|1|||
129018358|NCT02543203|464363585|FG001|Overall Study|Negative Behavior|0|||
129018359|NCT02543203|464363584|FG000|Overall Study|Withdrawal by Subject|0|||
129018360|NCT02543203|464363585|FG001|Overall Study|Withdrawal by Subject|1|||
129018361|NCT00089661|464363586|FG000|Overall Study|Adverse Event|0|||
129018362|NCT00089661|464363587|FG001|Overall Study|Adverse Event|2|||
129018363|NCT00089661|464363586|FG000|Overall Study|Death|1|||
129018364|NCT00089661|464363587|FG001|Overall Study|Death|0|||
128882081|NCT00406653|463863277|FG005|Induction Period|Given prohibited drug|0|||
128882082|NCT00406653|463863278|FG006|Induction Period|Given prohibited drug|0|||
128882083|NCT00406653|463863272|FG000|Induction Period|Incarcerated|0|||
128882084|NCT00406653|463863273|FG001|Induction Period|Incarcerated|0|||
128882085|NCT00406653|463863274|FG002|Induction Period|Incarcerated|1|||
128882086|NCT00406653|463863275|FG003|Induction Period|Incarcerated|0|||
128882087|NCT00406653|463863276|FG004|Induction Period|Incarcerated|0|||
128882088|NCT00406653|463863277|FG005|Induction Period|Incarcerated|0|||
128882089|NCT00406653|463863278|FG006|Induction Period|Incarcerated|0|||
128882090|NCT00406653|463863272|FG000|Induction Period|Patient relocated|0|||
128882091|NCT00406653|463863273|FG001|Induction Period|Patient relocated|0|||
128882092|NCT00406653|463863274|FG002|Induction Period|Patient relocated|1|||
128882093|NCT00406653|463863275|FG003|Induction Period|Patient relocated|0|||
128882094|NCT00406653|463863276|FG004|Induction Period|Patient relocated|0|||
128882095|NCT00406653|463863277|FG005|Induction Period|Patient relocated|0|||
128882096|NCT00406653|463863278|FG006|Induction Period|Patient relocated|0|||
129018365|NCT00089661|464363586|FG000|Overall Study|Lost to Follow-up|0|||
129018366|NCT00089661|464363587|FG001|Overall Study|Lost to Follow-up|3|||
129018367|NCT00089661|464363586|FG000|Overall Study|Withdrawal by Subject|11|||
129018368|NCT00089661|464363587|FG001|Overall Study|Withdrawal by Subject|9|||
129018369|NCT00089661|464363586|FG000|Overall Study|Disease progression|1|||
129018370|NCT00089661|464363587|FG001|Overall Study|Disease progression|3|||
129018371|NCT00089661|464363586|FG000|Overall Study|Ineligibility determined|4|||
129018372|NCT00089661|464363587|FG001|Overall Study|Ineligibility determined|4|||
129018373|NCT00089661|464363586|FG000|Overall Study|Noncompliance|2|||
129018374|NCT00089661|464363587|FG001|Overall Study|Noncompliance|4|||
129018375|NCT00089661|464363586|FG000|Overall Study|Other|2|||
129018376|NCT00089661|464363587|FG001|Overall Study|Other|1|||
129018377|NCT01273805|464363588|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
129018378|NCT01273805|464363589|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
129018379|NCT02647944|464363590|FG000|Overall Study|Withdrawal by Subject|0|||
129018380|NCT02647944|464363591|FG001|Overall Study|Withdrawal by Subject|3|||
129018381|NCT02647944|464363590|FG000|Overall Study|Adverse Event|2|||
129018382|NCT02647944|464363591|FG001|Overall Study|Adverse Event|0|||
129018383|NCT02077465|464363592|FG000|Overall Study|Withdrew Consent|0|||
129018384|NCT02077465|464363593|FG001|Overall Study|Withdrew Consent|1|||
129018385|NCT02077465|464363592|FG000|Overall Study|Lost to Follow-up|1|||
129018386|NCT02077465|464363593|FG001|Overall Study|Lost to Follow-up|0|||
129018387|NCT02760368|464363595|FG000|Overall Study|Withdrawal by Subject|8|||
129018388|NCT02760368|464363596|FG001|Overall Study|Withdrawal by Subject|12|||
129018389|NCT02760368|464363597|FG002|Overall Study|Withdrawal by Subject|9|||
129018390|NCT02760368|464363595|FG000|Overall Study|Screen Failure|0|||
129018391|NCT02760368|464363596|FG001|Overall Study|Screen Failure|0|||
129018392|NCT02760368|464363597|FG002|Overall Study|Screen Failure|1|||
129018393|NCT02760368|464363595|FG000|Overall Study|Death|0|||
129018394|NCT02760368|464363596|FG001|Overall Study|Death|1|||
129018395|NCT02760368|464363597|FG002|Overall Study|Death|0|||
129018396|NCT02760368|464363595|FG000|Overall Study|Withdrawal by Sponsor|0|||
129018397|NCT02760368|464363596|FG001|Overall Study|Withdrawal by Sponsor|0|||
129018398|NCT02760368|464363597|FG002|Overall Study|Withdrawal by Sponsor|1|||
129018399|NCT01827163|464363598|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
129018400|NCT01827163|464363598|FG000|Overall Study|Adverse Event|9|||
129018401|NCT02294604|464363599|FG000|Overall Study|Did not provide samples for culture|0|||
129018402|NCT02294604|464363600|FG001|Overall Study|Did not provide samples for culture|1|||
129018403|NCT02294604|464363601|FG002|Overall Study|Did not provide samples for culture|0|||
129018404|NCT02294604|464363599|FG000|Overall Study|Culture contamination|1|||
129018405|NCT02294604|464363600|FG001|Overall Study|Culture contamination|2|||
129018406|NCT02294604|464363601|FG002|Overall Study|Culture contamination|0|||
128882097|NCT00406653|463863272|FG000|Maintenance Period|Adverse Event|0|||
128882098|NCT00406653|463863273|FG001|Maintenance Period|Adverse Event|0|||
128882099|NCT00406653|463863274|FG002|Maintenance Period|Adverse Event|0|||
129018407|NCT02902211|464363604|FG000|First Three Months|Withdrawal by Subject|7|||
129018408|NCT02902211|464363605|FG001|First Three Months|Withdrawal by Subject|3|||
129018409|NCT01401647|464363613|FG000|Overall Study|Withdrawal by Subject|1|||
129018410|NCT01401647|464363614|FG001|Overall Study|Withdrawal by Subject|5|||
129018411|NCT01401647|464363615|FG002|Overall Study|Withdrawal by Subject|2|||
129018412|NCT01401647|464363613|FG000|Overall Study|Lost to Follow-up|3|||
129018413|NCT01401647|464363614|FG001|Overall Study|Lost to Follow-up|3|||
129018414|NCT01401647|464363615|FG002|Overall Study|Lost to Follow-up|1|||
129018415|NCT00473330|464363619|FG000|Core Study|Adverse Event|4|||
129018416|NCT00473330|464363620|FG001|Core Study|Adverse Event|4|||
129018417|NCT00473330|464363621|FG002|Core Study|Adverse Event|1|||
129106323|NCT01919164|464684626|FG000|Overall Study|Disease progression|2|||
128882100|NCT00406653|463863275|FG003|Maintenance Period|Adverse Event|0|||
128882101|NCT00406653|463863276|FG004|Maintenance Period|Adverse Event|1|||
128882102|NCT00406653|463863277|FG005|Maintenance Period|Adverse Event|1|||
129018418|NCT00473330|464363619|FG000|Core Study|Death|6|||
129018419|NCT00473330|464363620|FG001|Core Study|Death|4|||
129018420|NCT00473330|464363621|FG002|Core Study|Death|4|||
129018421|NCT00473330|464363619|FG000|Core Study|Lost to Follow-up|5|||
129018422|NCT00473330|464363620|FG001|Core Study|Lost to Follow-up|5|||
129018423|NCT00473330|464363621|FG002|Core Study|Lost to Follow-up|10|||
129018424|NCT00473330|464363619|FG000|Core Study|Physician Decision|2|||
129018425|NCT00473330|464363620|FG001|Core Study|Physician Decision|1|||
129018426|NCT00473330|464363621|FG002|Core Study|Physician Decision|3|||
129018427|NCT00473330|464363619|FG000|Core Study|Subject Non-compliance|1|||
129018428|NCT00473330|464363620|FG001|Core Study|Subject Non-compliance|2|||
129018429|NCT00473330|464363621|FG002|Core Study|Subject Non-compliance|1|||
129018430|NCT00473330|464363619|FG000|Core Study|Subject Required Other Therapy|0|||
129018431|NCT00473330|464363620|FG001|Core Study|Subject Required Other Therapy|1|||
129106324|NCT01919164|464684627|FG001|Overall Study|Disease progression|2|||
129106325|NCT01919164|464684628|FG002|Overall Study|Disease progression|1|||
129106326|NCT01919164|464684629|FG003|Overall Study|Disease progression|2|||
129106327|NCT01919164|464684630|FG004|Overall Study|Disease progression|1|||
129106328|NCT01919164|464684626|FG000|Overall Study|Withdrew consent|13|||
129106329|NCT01919164|464684627|FG001|Overall Study|Withdrew consent|13|||
129106330|NCT01919164|464684628|FG002|Overall Study|Withdrew consent|14|||
129106331|NCT01919164|464684629|FG003|Overall Study|Withdrew consent|14|||
129106332|NCT01919164|464684630|FG004|Overall Study|Withdrew consent|9|||
129106333|NCT01919164|464684626|FG000|Overall Study|Other Un-specified|13|||
129106334|NCT01919164|464684627|FG001|Overall Study|Other Un-specified|9|||
129106335|NCT01919164|464684628|FG002|Overall Study|Other Un-specified|8|||
129106336|NCT01919164|464684629|FG003|Overall Study|Other Un-specified|7|||
129106337|NCT01919164|464684630|FG004|Overall Study|Other Un-specified|15|||
129106338|NCT00588146|464684632|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
129106339|NCT00588146|464684633|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
129106340|NCT02100839|464684634|FG000|Multiple Ascending Dose|Adverse Event|2|||
129106341|NCT02100839|464684635|FG001|Multiple Ascending Dose|Adverse Event|0|||
129106342|NCT02100839|464684634|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
129106343|NCT02100839|464684635|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
129106344|NCT02823470|464684636|FG000|Overall Study|Adverse Event|1|||
129106345|NCT02823470|464684637|FG001|Overall Study|Adverse Event|0|||
129106346|NCT02823470|464684636|FG000|Overall Study|Study terminated by sponsor|8|||
129106347|NCT02823470|464684637|FG001|Overall Study|Study terminated by sponsor|15|||
129106348|NCT00463801|464684643|FG000|Overall Study|Protocol Violation|1|||
129106349|NCT00463801|464684643|FG000|Overall Study|Lack of Efficacy|2|||
129106350|NCT00463801|464684643|FG000|Overall Study|Adverse Event|4|||
129106351|NCT00463801|464684643|FG000|Overall Study|Lost to Follow-up|5|||
129106352|NCT00463801|464684643|FG000|Overall Study|No longer require therapy|1|||
129106353|NCT00669318|464684644|FG000|Overall Study|Withdrawal by Subject|2|||
129106354|NCT02315664|464684645|FG000|Overall Study|Lost to Follow-up|1|||
129106355|NCT02315664|464684646|FG001|Overall Study|Lost to Follow-up|1|||
129106356|NCT02315664|464684645|FG000|Overall Study|Withdrawal by Subject|0|||
129106357|NCT02315664|464684646|FG001|Overall Study|Withdrawal by Subject|3|||
129106358|NCT02501161|464684649|FG000|Overall Study|Adverse Event|2|||
129106359|NCT02501161|464684650|FG001|Overall Study|Adverse Event|6|||
129106360|NCT02501161|464684649|FG000|Overall Study|Lost to Follow-up|7|||
129106361|NCT02501161|464684650|FG001|Overall Study|Lost to Follow-up|4|||
129106362|NCT02501161|464684649|FG000|Overall Study|Withdrawal by Subject|10|||
129106363|NCT02501161|464684650|FG001|Overall Study|Withdrawal by Subject|15|||
129106364|NCT02501161|464684649|FG000|Overall Study|Other|3|||
129106365|NCT02501161|464684650|FG001|Overall Study|Other|0|||
129106366|NCT00667992|464684651|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
128683233|NCT01856023|463138796|FG000|Overall Study|Death|1|||
128683234|NCT01856023|463138797|FG001|Overall Study|Death|2|||
128683235|NCT01856023|463138796|FG000|Overall Study|Adverse Event|2|||
129106367|NCT00667992|464684652|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
129106368|NCT00667992|464684651|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
129106369|NCT00667992|464684652|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
129106370|NCT00667992|464684651|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
129106371|NCT00667992|464684652|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
129106372|NCT00667992|464684651|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
129106373|NCT00667992|464684652|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
129106374|NCT00667992|464684651|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
129018432|NCT00473330|464363621|FG002|Core Study|Subject Required Other Therapy|3|||
129106375|NCT00667992|464684652|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
129106376|NCT00667992|464684651|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
129106377|NCT00667992|464684652|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
129106378|NCT00667992|464684651|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
129106379|NCT00667992|464684652|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
129106380|NCT00667992|464684651|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
128882103|NCT00406653|463863278|FG006|Maintenance Period|Adverse Event|0|||
129018433|NCT00473330|464363619|FG000|Core Study|Subject's Decision|9|||
129018434|NCT00473330|464363620|FG001|Core Study|Subject's Decision|8|||
128882104|NCT00406653|463863272|FG000|Maintenance Period|Lack of Efficacy|0|||
128882105|NCT00406653|463863273|FG001|Maintenance Period|Lack of Efficacy|0|||
129018435|NCT00473330|464363621|FG002|Core Study|Subject's Decision|19|||
129018436|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
129018437|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
129018438|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
129018439|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Death|2|||
129018440|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Death|0|||
129018441|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Death|0|||
129018442|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
129018443|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
129018444|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
129018445|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
129018446|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
129018447|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
129018448|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
129018449|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
129018450|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
129018451|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
129018452|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
129018453|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
129018454|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
129018455|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
129018456|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
129018457|NCT00473330|464363619|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
129018458|NCT00473330|464363620|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
129018459|NCT00473330|464363621|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
129018460|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
129018461|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
129018462|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
129018463|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Death|2|||
129018464|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Death|2|||
129018465|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Death|1|||
129018466|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
129018467|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
129018468|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
129018469|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
129018470|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
129018471|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
129018472|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
129018473|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
129018474|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
129018475|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
129018476|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
129018477|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
129018478|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
129018479|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
129018480|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
129018481|NCT00473330|464363619|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
129018482|NCT00473330|464363620|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
129018483|NCT00473330|464363621|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
129018484|NCT01975948|464363622|FG000|Overall Study|Withdrawal by Subject|17|||
129018485|NCT01975948|464363623|FG001|Overall Study|Withdrawal by Subject|21|||
129018486|NCT01975948|464363624|FG002|Overall Study|Withdrawal by Subject|7|||
129018487|NCT01975948|464363625|FG003|Overall Study|Withdrawal by Subject|6|||
129018488|NCT01675765|464363626|FG000|Overall Study|Progressive disease|4|||
129018489|NCT01675765|464363627|FG001|Overall Study|Progressive disease|4|||
129018490|NCT01675765|464363626|FG000|Overall Study|Adverse Event|1|||
129018491|NCT01675765|464363627|FG001|Overall Study|Adverse Event|2|||
129018492|NCT01675765|464363626|FG000|Overall Study|Withdrawal by Subject|2|||
129018493|NCT01675765|464363627|FG001|Overall Study|Withdrawal by Subject|0|||
129018494|NCT01675765|464363626|FG000|Overall Study|Death|1|||
128882106|NCT00406653|463863274|FG002|Maintenance Period|Lack of Efficacy|0|||
129018495|NCT01675765|464363627|FG001|Overall Study|Death|0|||
129018496|NCT01675765|464363626|FG000|Overall Study|Clinical progression|3|||
128882107|NCT00406653|463863275|FG003|Maintenance Period|Lack of Efficacy|0|||
129106381|NCT00667992|464684652|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
129106382|NCT00667992|464684651|FG000|Wash-out|Not within one doubling dilution|4|||
129106383|NCT00667992|464684652|FG001|Wash-out|Not within one doubling dilution|3|||
129106384|NCT00667992|464684651|FG000|Wash-out|Failure to wash-out|2|||
129106385|NCT00667992|464684652|FG001|Wash-out|Failure to wash-out|2|||
129106386|NCT00667992|464684651|FG000|Wash-out|Withdrawal by Subject|1|||
129106387|NCT00667992|464684652|FG001|Wash-out|Withdrawal by Subject|0|||
129106388|NCT00667992|464684651|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
129106389|NCT00667992|464684652|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
129106390|NCT00667992|464684651|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
129106391|NCT00667992|464684652|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
129106392|NCT02748057|464684656|FG000|Overall Study|Adverse Event|1|||
129106393|NCT02748057|464684657|FG001|Overall Study|Adverse Event|0|||
129106394|NCT02748057|464684656|FG000|Overall Study|Physician Decision|0|||
129106395|NCT02748057|464684657|FG001|Overall Study|Physician Decision|1|||
129106396|NCT02748057|464684656|FG000|Overall Study|Protocol Violation|2|||
129106397|NCT02748057|464684657|FG001|Overall Study|Protocol Violation|1|||
129106398|NCT02748057|464684656|FG000|Overall Study|Participant Moved|1|||
129106399|NCT02748057|464684657|FG001|Overall Study|Participant Moved|0|||
129106400|NCT02748057|464684656|FG000|Overall Study|Withdrawal by Subject|1|||
129106401|NCT02748057|464684657|FG001|Overall Study|Withdrawal by Subject|0|||
129106402|NCT01990573|464684658|FG000|Overall Study|Physician Decision|0|||
129106403|NCT01990573|464684659|FG001|Overall Study|Physician Decision|0|||
129106404|NCT01990573|464684660|FG002|Overall Study|Physician Decision|1|||
129106405|NCT03335813|464684665|FG000|Overall Study|Withdrawal by Subject|1|||
129106406|NCT02492165|464684668|FG000|Overall Study|Withdrawal by Subject|0|||
129106407|NCT02492165|464684669|FG001|Overall Study|Withdrawal by Subject|1|||
129106408|NCT02492165|464684670|FG002|Overall Study|Withdrawal by Subject|0|||
129106409|NCT02492165|464684671|FG003|Overall Study|Withdrawal by Subject|0|||
129106410|NCT01957579|464684673|FG000|Overall Study|Withdrawal of concent|0|||
129106411|NCT01957579|464684674|FG001|Overall Study|Withdrawal of concent|1|||
129106412|NCT01957579|464684675|FG002|Overall Study|Withdrawal of concent|0|||
129106413|NCT01957579|464684676|FG003|Overall Study|Withdrawal of concent|0|||
129106414|NCT01957579|464684673|FG000|Overall Study|Death|0|||
129106415|NCT01957579|464684674|FG001|Overall Study|Death|0|||
129106416|NCT01957579|464684675|FG002|Overall Study|Death|2|||
129106417|NCT01957579|464684676|FG003|Overall Study|Death|0|||
129106418|NCT01000974|464684677|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
129106419|NCT01000974|464684678|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
129106420|NCT01000974|464684679|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
129106421|NCT01000974|464684677|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
129106422|NCT01000974|464684678|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
129106423|NCT01000974|464684679|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
129106424|NCT01000974|464684677|FG000|Primary Vaccination Phase|Protocol Violation|40|||
129106425|NCT01000974|464684678|FG001|Primary Vaccination Phase|Protocol Violation|3|||
129106426|NCT01000974|464684679|FG002|Primary Vaccination Phase|Protocol Violation|2|||
129106427|NCT01000974|464684677|FG000|Primary Vaccination Phase|Adverse Event|14|||
129106428|NCT01000974|464684678|FG001|Primary Vaccination Phase|Adverse Event|2|||
129106429|NCT01000974|464684679|FG002|Primary Vaccination Phase|Adverse Event|2|||
129106430|NCT01000974|464684677|FG000|Primary Vaccination Phase|Other|4|||
129106431|NCT01000974|464684678|FG001|Primary Vaccination Phase|Other|9|||
129106432|NCT01000974|464684679|FG002|Primary Vaccination Phase|Other|12|||
129106433|NCT01000974|464684677|FG000|Booster Vaccination Phase|Protocol Violation|0|||
129106434|NCT01000974|464684678|FG001|Booster Vaccination Phase|Protocol Violation|0|||
129106435|NCT01000974|464684679|FG002|Booster Vaccination Phase|Protocol Violation|2|||
129106436|NCT01000974|464684677|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
129106437|NCT01000974|464684678|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
129106438|NCT01000974|464684679|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
129106439|NCT01000974|464684677|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
129106440|NCT01000974|464684678|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
129106441|NCT01000974|464684679|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
129106442|NCT01000974|464684677|FG000|Booster Vaccination Phase|Other|24|||
129106443|NCT01000974|464684678|FG001|Booster Vaccination Phase|Other|6|||
129106444|NCT01000974|464684679|FG002|Booster Vaccination Phase|Other|4|||
129106445|NCT01639144|464684680|FG000|Overall Study|Withdrawal by Subject|4|||
129106446|NCT01639144|464684681|FG001|Overall Study|Withdrawal by Subject|2|||
129106447|NCT01639144|464684680|FG000|Overall Study|Physician Decision|2|||
129106448|NCT01639144|464684681|FG001|Overall Study|Physician Decision|0|||
129106449|NCT01639144|464684680|FG000|Overall Study|Met postoperative exclusion criteria|4|||
129106450|NCT01639144|464684681|FG001|Overall Study|Met postoperative exclusion criteria|3|||
129106451|NCT02750332|464684684|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129106452|NCT02750332|464684685|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129106453|NCT02485483|464684690|FG000|Overall Study|Depression at baseline|15|||
129106454|NCT02485483|464684691|FG001|Overall Study|Depression at baseline|0|||
129106455|NCT02485483|464684690|FG000|Overall Study|Discontinued after baseline|39|||
129106456|NCT02485483|464684691|FG001|Overall Study|Discontinued after baseline|0|||
129106457|NCT01724177|464684693|FG000|Overall Study|Adverse Event|8|||
129106458|NCT01724177|464684693|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
129106459|NCT01724177|464684693|FG000|Overall Study|Nervous participant|1|||
129106460|NCT01724177|464684693|FG000|Overall Study|Serious Adverse Event Related|1|||
129106461|NCT00281697|464684698|FG000|Overall Study|> 60 days since last dose of study drug|4|||
129106462|NCT00281697|464684699|FG001|Overall Study|> 60 days since last dose of study drug|4|||
129106463|NCT00281697|464684698|FG000|Overall Study|Adverse Event|54|||
129106464|NCT00281697|464684699|FG001|Overall Study|Adverse Event|15|||
129106465|NCT00281697|464684698|FG000|Overall Study|Death|8|||
129106466|NCT00281697|464684699|FG001|Overall Study|Death|3|||
129106467|NCT00281697|464684698|FG000|Overall Study|Disease progression|279|||
129106468|NCT00281697|464684699|FG001|Overall Study|Disease progression|149|||
129106469|NCT00281697|464684698|FG000|Overall Study|Other|5|||
129106470|NCT00281697|464684699|FG001|Overall Study|Other|6|||
129106471|NCT00281697|464684698|FG000|Overall Study|Physician's decision to withdraw|15|||
129106472|NCT00281697|464684699|FG001|Overall Study|Physician's decision to withdraw|12|||
129106473|NCT00281697|464684698|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
129106474|NCT00281697|464684699|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
129106475|NCT00281697|464684698|FG000|Overall Study|Did not receive study drug|3|||
129106476|NCT00281697|464684699|FG001|Overall Study|Did not receive study drug|2|||
129106477|NCT04446429|464684700|FG000|Overall Study|Lost to Follow-up|6|||
129106478|NCT04446429|464684701|FG001|Overall Study|Lost to Follow-up|0|||
129106479|NCT02256917|464684702|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
129106480|NCT02256917|464684702|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
129106481|NCT02256917|464684702|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
129106482|NCT02256917|464684702|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
129106483|NCT02256917|464684702|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
129106484|NCT00715299|464684704|FG000|Overall Study|Withdrawal by Subject|1|||
129106485|NCT00715299|464684704|FG000|Overall Study|Adverse Event|3|||
129106486|NCT00715299|464684704|FG000|Overall Study|failed the pre-screen exercise test|2|||
129106487|NCT02982863|464684705|FG000|Overall Study|Not eligible patients|809|||
129106488|NCT02982863|464684706|FG001|Overall Study|Not eligible patients|4261|||
129106489|NCT02982863|464684707|FG002|Overall Study|Not eligible patients|1852|||
129106490|NCT02982863|464684708|FG003|Overall Study|Not eligible patients|1400|||
129106491|NCT02982863|464684709|FG004|Overall Study|Not eligible patients|492|||
129106492|NCT02457195|464684710|FG000|Overall Study|Adverse Event|3|||
129106493|NCT02457195|464684710|FG000|Overall Study|Protocol Violation|2|||
129106494|NCT02457195|464684710|FG000|Overall Study|Withdrawal by Subject|4|||
129106495|NCT01896193|464684711|FG000|Overall Study|Lack of Efficacy|20|||
129106496|NCT01896193|464684712|FG001|Overall Study|Lack of Efficacy|11|||
129106497|NCT01896193|464684711|FG000|Overall Study|Protocol Violation|0|||
129106498|NCT01896193|464684712|FG001|Overall Study|Protocol Violation|1|||
129106499|NCT01896193|464684711|FG000|Overall Study|Withdrew Consent|1|||
129106500|NCT01896193|464684712|FG001|Overall Study|Withdrew Consent|0|||
129106501|NCT05359952|464684713|FG000|Overall Study|Lost to Follow-up|1|||
129106502|NCT05359952|464684714|FG001|Overall Study|Lost to Follow-up|0|||
129106503|NCT00996034|464684719|FG000|Overall Study|Lost to Follow-up|2|||
129106504|NCT00996034|464684719|FG000|Overall Study|withdrawn by PI|1|||
129106505|NCT00158262|464684720|FG000|Overall Study|Lost to Follow-up|1|||
129106506|NCT00158262|464684721|FG001|Overall Study|Lost to Follow-up|1|||
129106507|NCT02959918|464684722|FG000|Overall Study|Adverse Event|1|||
129106508|NCT02959918|464684723|FG001|Overall Study|Adverse Event|1|||
129106509|NCT02959918|464684724|FG002|Overall Study|Adverse Event|2|||
129106510|NCT02959918|464684725|FG003|Overall Study|Adverse Event|0|||
129106511|NCT02959918|464684726|FG004|Overall Study|Adverse Event|0|||
129106512|NCT02959918|464684727|FG005|Overall Study|Adverse Event|2|||
129106513|NCT02959918|464684728|FG006|Overall Study|Adverse Event|2|||
129106514|NCT02959918|464684729|FG007|Overall Study|Adverse Event|1|||
129106515|NCT02959918|464684730|FG008|Overall Study|Adverse Event|2|||
129106516|NCT02959918|464684731|FG009|Overall Study|Adverse Event|1|||
129106517|NCT02959918|464684732|FG010|Overall Study|Adverse Event|1|||
129106518|NCT02959918|464684733|FG011|Overall Study|Adverse Event|3|||
129106519|NCT02959918|464684734|FG012|Overall Study|Adverse Event|2|||
129106520|NCT02959918|464684735|FG013|Overall Study|Adverse Event|4|||
129106521|NCT02959918|464684722|FG000|Overall Study|Lost to Follow-up|0|||
129106522|NCT02959918|464684723|FG001|Overall Study|Lost to Follow-up|0|||
129106523|NCT02959918|464684724|FG002|Overall Study|Lost to Follow-up|0|||
129106524|NCT02959918|464684725|FG003|Overall Study|Lost to Follow-up|0|||
129106525|NCT02959918|464684726|FG004|Overall Study|Lost to Follow-up|0|||
128683236|NCT01856023|463138797|FG001|Overall Study|Adverse Event|1|||
129106526|NCT02959918|464684727|FG005|Overall Study|Lost to Follow-up|0|||
129106527|NCT02959918|464684728|FG006|Overall Study|Lost to Follow-up|0|||
129106528|NCT02959918|464684729|FG007|Overall Study|Lost to Follow-up|0|||
129106529|NCT02959918|464684730|FG008|Overall Study|Lost to Follow-up|0|||
129106530|NCT02959918|464684731|FG009|Overall Study|Lost to Follow-up|1|||
129106531|NCT02959918|464684732|FG010|Overall Study|Lost to Follow-up|0|||
129106532|NCT02959918|464684733|FG011|Overall Study|Lost to Follow-up|0|||
129106533|NCT02959918|464684734|FG012|Overall Study|Lost to Follow-up|1|||
129106534|NCT02959918|464684735|FG013|Overall Study|Lost to Follow-up|0|||
129106535|NCT02959918|464684722|FG000|Overall Study|Withdrawal by Subject|0|||
129106536|NCT02959918|464684723|FG001|Overall Study|Withdrawal by Subject|0|||
129106537|NCT02959918|464684724|FG002|Overall Study|Withdrawal by Subject|1|||
129106538|NCT02959918|464684725|FG003|Overall Study|Withdrawal by Subject|2|||
129106539|NCT02959918|464684726|FG004|Overall Study|Withdrawal by Subject|0|||
129106540|NCT02959918|464684727|FG005|Overall Study|Withdrawal by Subject|0|||
129106541|NCT02959918|464684728|FG006|Overall Study|Withdrawal by Subject|1|||
129106542|NCT02959918|464684729|FG007|Overall Study|Withdrawal by Subject|0|||
129106543|NCT02959918|464684730|FG008|Overall Study|Withdrawal by Subject|1|||
128882108|NCT00406653|463863276|FG004|Maintenance Period|Lack of Efficacy|20|||
128882109|NCT00406653|463863277|FG005|Maintenance Period|Lack of Efficacy|26|||
128882110|NCT00406653|463863278|FG006|Maintenance Period|Lack of Efficacy|0|||
129018497|NCT01675765|464363627|FG001|Overall Study|Clinical progression|2|||
129018498|NCT00365846|464363629|FG000|Overall Study|Lost to Follow-up|1|||
129018499|NCT04405570|464363630|FG000|Overall Study|Adverse Event|0|||
129018500|NCT04405570|464363631|FG001|Overall Study|Adverse Event|1|||
129018501|NCT04405570|464363632|FG002|Overall Study|Adverse Event|1|||
129018502|NCT04405570|464363633|FG003|Overall Study|Adverse Event|1|||
129018503|NCT04405570|464363630|FG000|Overall Study|Lost to Follow-up|0|||
129018504|NCT04405570|464363631|FG001|Overall Study|Lost to Follow-up|1|||
129018505|NCT04405570|464363632|FG002|Overall Study|Lost to Follow-up|0|||
129018506|NCT04405570|464363633|FG003|Overall Study|Lost to Follow-up|0|||
129018507|NCT04405570|464363630|FG000|Overall Study|Physician Decision|0|||
129018508|NCT04405570|464363631|FG001|Overall Study|Physician Decision|0|||
129018509|NCT04405570|464363632|FG002|Overall Study|Physician Decision|1|||
129018510|NCT04405570|464363633|FG003|Overall Study|Physician Decision|0|||
129018511|NCT04405570|464363630|FG000|Overall Study|Withdrawal by Subject|0|||
129018512|NCT04405570|464363631|FG001|Overall Study|Withdrawal by Subject|1|||
129018513|NCT04405570|464363632|FG002|Overall Study|Withdrawal by Subject|1|||
129018514|NCT04405570|464363633|FG003|Overall Study|Withdrawal by Subject|0|||
129018515|NCT04405570|464363630|FG000|Overall Study|Randomized not dosed|0|||
129018516|NCT04405570|464363631|FG001|Overall Study|Randomized not dosed|2|||
129018517|NCT04405570|464363632|FG002|Overall Study|Randomized not dosed|0|||
129018518|NCT04405570|464363633|FG003|Overall Study|Randomized not dosed|0|||
129018519|NCT04499963|464363634|FG000|Overall Study|Adverse Event|3|||
129018520|NCT04499963|464363635|FG001|Overall Study|Adverse Event|0|||
129018521|NCT04499963|464363634|FG000|Overall Study|Death|3|||
129018522|NCT04499963|464363635|FG001|Overall Study|Death|0|||
129018523|NCT04499963|464363634|FG000|Overall Study|Lack of Efficacy|7|||
129018524|NCT04499963|464363635|FG001|Overall Study|Lack of Efficacy|0|||
129018525|NCT04499963|464363634|FG000|Overall Study|Lost to Follow-up|2|||
129018526|NCT04499963|464363635|FG001|Overall Study|Lost to Follow-up|0|||
129018527|NCT00984126|464363641|FG000|Overall Study|Protocol Violation|0|||
129018528|NCT00984126|464363642|FG001|Overall Study|Protocol Violation|0|||
129018529|NCT00984126|464363643|FG002|Overall Study|Protocol Violation|1|||
129018530|NCT00984126|464363644|FG003|Overall Study|Protocol Violation|2|||
129018531|NCT00984126|464363641|FG000|Overall Study|Adverse Event|0|||
129018532|NCT00984126|464363642|FG001|Overall Study|Adverse Event|0|||
129018533|NCT00984126|464363643|FG002|Overall Study|Adverse Event|0|||
129018534|NCT00984126|464363644|FG003|Overall Study|Adverse Event|2|||
129018535|NCT00984126|464363641|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
129018536|NCT00984126|464363642|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
129018537|NCT00984126|464363643|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
129018538|NCT00984126|464363644|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
129018539|NCT00984126|464363641|FG000|Overall Study|Withdrawal criteria|0|||
129018540|NCT00984126|464363642|FG001|Overall Study|Withdrawal criteria|1|||
129018541|NCT00984126|464363643|FG002|Overall Study|Withdrawal criteria|3|||
129018542|NCT00984126|464363644|FG003|Overall Study|Withdrawal criteria|9|||
129018543|NCT01001208|464363645|FG000|Overall Study|Adverse Event|10|||
129018544|NCT01001208|464363646|FG001|Overall Study|Adverse Event|5|||
129018545|NCT01001208|464363645|FG000|Overall Study|Lost to Follow-up|5|||
129018546|NCT01001208|464363646|FG001|Overall Study|Lost to Follow-up|9|||
129018547|NCT01001208|464363645|FG000|Overall Study|Physician Decision|1|||
129018548|NCT01001208|464363646|FG001|Overall Study|Physician Decision|0|||
129106544|NCT02959918|464684731|FG009|Overall Study|Withdrawal by Subject|1|||
129106545|NCT02959918|464684732|FG010|Overall Study|Withdrawal by Subject|2|||
129106546|NCT02959918|464684733|FG011|Overall Study|Withdrawal by Subject|3|||
129018549|NCT01001208|464363645|FG000|Overall Study|Withdrawal by Subject|4|||
129106547|NCT02959918|464684734|FG012|Overall Study|Withdrawal by Subject|1|||
129018550|NCT01001208|464363646|FG001|Overall Study|Withdrawal by Subject|5|||
129018551|NCT01001208|464363645|FG000|Overall Study|Ineligibility Determined|4|||
129018552|NCT01001208|464363646|FG001|Overall Study|Ineligibility Determined|2|||
129018553|NCT01001208|464363645|FG000|Overall Study|Noncompliance|4|||
129106548|NCT02959918|464684735|FG013|Overall Study|Withdrawal by Subject|1|||
129106549|NCT02959918|464684722|FG000|Overall Study|Protocol Violation|0|||
129106550|NCT02959918|464684723|FG001|Overall Study|Protocol Violation|0|||
129106551|NCT02959918|464684724|FG002|Overall Study|Protocol Violation|1|||
129106552|NCT02959918|464684725|FG003|Overall Study|Protocol Violation|0|||
129106553|NCT02959918|464684726|FG004|Overall Study|Protocol Violation|0|||
129106554|NCT02959918|464684727|FG005|Overall Study|Protocol Violation|1|||
129106555|NCT02959918|464684728|FG006|Overall Study|Protocol Violation|0|||
129106556|NCT02959918|464684729|FG007|Overall Study|Protocol Violation|0|||
129106557|NCT02959918|464684730|FG008|Overall Study|Protocol Violation|2|||
129106558|NCT02959918|464684731|FG009|Overall Study|Protocol Violation|1|||
129106559|NCT02959918|464684732|FG010|Overall Study|Protocol Violation|0|||
129106560|NCT02959918|464684733|FG011|Overall Study|Protocol Violation|1|||
129106561|NCT02959918|464684734|FG012|Overall Study|Protocol Violation|1|||
129106562|NCT02959918|464684735|FG013|Overall Study|Protocol Violation|0|||
129106563|NCT02959918|464684722|FG000|Overall Study|Stopping Rule Met|1|||
129106564|NCT02959918|464684723|FG001|Overall Study|Stopping Rule Met|0|||
129106565|NCT02959918|464684724|FG002|Overall Study|Stopping Rule Met|3|||
129106566|NCT02959918|464684725|FG003|Overall Study|Stopping Rule Met|4|||
129106567|NCT02959918|464684726|FG004|Overall Study|Stopping Rule Met|5|||
129106568|NCT02959918|464684727|FG005|Overall Study|Stopping Rule Met|3|||
129106569|NCT02959918|464684728|FG006|Overall Study|Stopping Rule Met|2|||
129106570|NCT02959918|464684729|FG007|Overall Study|Stopping Rule Met|4|||
129106571|NCT02959918|464684730|FG008|Overall Study|Stopping Rule Met|1|||
129106572|NCT02959918|464684731|FG009|Overall Study|Stopping Rule Met|1|||
129106573|NCT02959918|464684732|FG010|Overall Study|Stopping Rule Met|3|||
129106574|NCT02959918|464684733|FG011|Overall Study|Stopping Rule Met|5|||
129106575|NCT02959918|464684734|FG012|Overall Study|Stopping Rule Met|2|||
129106576|NCT02959918|464684735|FG013|Overall Study|Stopping Rule Met|1|||
129106577|NCT02959918|464684722|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
129106578|NCT02959918|464684723|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
129106579|NCT02959918|464684724|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
129106580|NCT02959918|464684725|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
129106581|NCT02959918|464684726|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106582|NCT02959918|464684727|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106583|NCT02959918|464684728|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106584|NCT02959918|464684729|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106585|NCT02959918|464684730|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106586|NCT02959918|464684731|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106587|NCT02959918|464684732|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106588|NCT02959918|464684733|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106589|NCT02959918|464684734|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106590|NCT02959918|464684735|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129106591|NCT02959918|464684722|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106592|NCT02959918|464684723|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106593|NCT02959918|464684724|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106594|NCT02959918|464684725|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106595|NCT02959918|464684726|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106596|NCT02959918|464684727|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106597|NCT02959918|464684728|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106598|NCT02959918|464684729|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
129106599|NCT02959918|464684730|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106600|NCT02959918|464684731|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106601|NCT02959918|464684732|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129215091|NCT02760498|465089438|FG002|Overall Study|Other than specified|0|||
129215092|NCT02760498|465089439|FG003|Overall Study|Other than specified|3|||
129106602|NCT02959918|464684733|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106603|NCT02959918|464684734|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106604|NCT02959918|464684735|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129106605|NCT02959918|464684722|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106606|NCT02959918|464684723|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106607|NCT02959918|464684724|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106608|NCT02959918|464684725|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106609|NCT02959918|464684726|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106610|NCT02959918|464684727|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106611|NCT02959918|464684728|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106612|NCT02959918|464684729|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106613|NCT02959918|464684730|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
129106614|NCT02959918|464684731|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106615|NCT02959918|464684732|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106616|NCT02959918|464684733|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129215093|NCT02760498|465089440|FG004|Overall Study|Other than specified|1|||
129106617|NCT02959918|464684734|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106618|NCT02959918|464684735|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129106619|NCT02959918|464684722|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106620|NCT02959918|464684723|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106621|NCT02959918|464684724|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106622|NCT02959918|464684725|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106623|NCT02959918|464684726|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106624|NCT02959918|464684727|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106625|NCT02959918|464684728|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106626|NCT02959918|464684729|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106627|NCT02959918|464684730|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106628|NCT02959918|464684731|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
129106629|NCT02959918|464684732|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106630|NCT02959918|464684733|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106631|NCT02959918|464684734|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106632|NCT02959918|464684735|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129106633|NCT02585713|464684737|FG000|Overall Study|Withdrew prior to treatment|2|||
129106634|NCT02585713|464684738|FG001|Overall Study|Withdrew prior to treatment|7|||
129106635|NCT02585713|464684737|FG000|Overall Study|Other|3|||
129106636|NCT02585713|464684738|FG001|Overall Study|Other|1|||
129106637|NCT03173456|464684743|FG000|Baseline|Medication dispensing system malfunction'|0|||
129106638|NCT03173456|464684744|FG001|Baseline|Medication dispensing system malfunction'|1|||
129106639|NCT03173456|464684745|FG002|Baseline|Medication dispensing system malfunction'|0|||
129106640|NCT03173456|464684746|FG003|Baseline|Medication dispensing system malfunction'|0|||
129106641|NCT03173456|464684747|FG004|Baseline|Medication dispensing system malfunction'|2|||
129106642|NCT03173456|464684743|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
129106643|NCT03173456|464684744|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
129106644|NCT03173456|464684745|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
129106645|NCT03173456|464684746|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
129106646|NCT03173456|464684747|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
129106647|NCT01733121|464684748|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
129106648|NCT01733121|464684749|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
129106649|NCT01733121|464684748|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
129106650|NCT01733121|464684749|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
129106651|NCT01733121|464684748|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
129106652|NCT01733121|464684749|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
129106653|NCT01733121|464684748|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
129106654|NCT01733121|464684749|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
129106655|NCT04501952|464684758|FG000|Overall Study|Adverse Event|0|||
129106656|NCT04501952|464684759|FG001|Overall Study|Adverse Event|3|||
129106657|NCT04501952|464684758|FG000|Overall Study|Investigator's Discretion|0|||
129106658|NCT04501952|464684759|FG001|Overall Study|Investigator's Discretion|1|||
129106659|NCT04501952|464684758|FG000|Overall Study|Protocol Violation|1|||
129106660|NCT04501952|464684759|FG001|Overall Study|Protocol Violation|1|||
129106661|NCT04501952|464684758|FG000|Overall Study|Withdrew Consent|5|||
129106662|NCT04501952|464684759|FG001|Overall Study|Withdrew Consent|4|||
129106663|NCT04501952|464684758|FG000|Overall Study|Lost to Follow-up|7|||
129106664|NCT04501952|464684759|FG001|Overall Study|Lost to Follow-up|2|||
129106665|NCT04501952|464684758|FG000|Overall Study|Randomized and Never Treated|13|||
129106666|NCT04501952|464684759|FG001|Overall Study|Randomized and Never Treated|9|||
129106667|NCT01903993|464684760|FG000|Overall Study|Death|118|||
129106668|NCT01903993|464684761|FG001|Overall Study|Death|121|||
129106669|NCT01903993|464684760|FG000|Overall Study|Withdrawal by Subject|15|||
129106670|NCT01903993|464684761|FG001|Overall Study|Withdrawal by Subject|4|||
129106671|NCT01903993|464684760|FG000|Overall Study|Lost to Follow-up|2|||
129106672|NCT01903993|464684761|FG001|Overall Study|Lost to Follow-up|3|||
129106673|NCT01903993|464684760|FG000|Overall Study|Study Terminated by Sponsor|8|||
129106674|NCT01903993|464684761|FG001|Overall Study|Study Terminated by Sponsor|14|||
129106675|NCT01903993|464684760|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
129106676|NCT01903993|464684761|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
129106677|NCT01243177|464684764|FG000|Overall Study|Lack of Efficacy|47|||
129106678|NCT01243177|464684765|FG001|Overall Study|Lack of Efficacy|31|||
129106679|NCT01243177|464684764|FG000|Overall Study|Protocol Violation|11|||
129106680|NCT01243177|464684765|FG001|Overall Study|Protocol Violation|10|||
129106681|NCT01243177|464684764|FG000|Overall Study|Lost to Follow-up|15|||
129106682|NCT01243177|464684765|FG001|Overall Study|Lost to Follow-up|18|||
129106683|NCT01243177|464684764|FG000|Overall Study|Withdrawal by Subject|46|||
129106684|NCT01243177|464684765|FG001|Overall Study|Withdrawal by Subject|38|||
129106685|NCT01243177|464684764|FG000|Overall Study|AE, serious fatal|0|||
129106686|NCT01243177|464684765|FG001|Overall Study|AE, serious fatal|1|||
129106687|NCT01243177|464684764|FG000|Overall Study|SAE, non-fatal|7|||
129106688|NCT01243177|464684765|FG001|Overall Study|SAE, non-fatal|9|||
129106689|NCT01243177|464684764|FG000|Overall Study|AE, non-serious non-fatal|40|||
129106690|NCT01243177|464684765|FG001|Overall Study|AE, non-serious non-fatal|58|||
129106691|NCT01243177|464684764|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
129106692|NCT01243177|464684765|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
129106693|NCT01243177|464684764|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129106694|NCT01243177|464684765|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
129106695|NCT01243177|464684764|FG000|Overall Study|Other Reason|11|||
129106696|NCT01243177|464684765|FG001|Overall Study|Other Reason|12|||
129106697|NCT01073163|464686618|FG000|Overall Study|Adverse Event|1|||
129106698|NCT01073163|464686618|FG000|Overall Study|Disease Progression|1|||
129106699|NCT01073163|464686618|FG000|Overall Study|Early termination|1|||
129106700|NCT00703677|464686619|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
129106701|NCT00940888|464686620|FG000|Overall Study|Unsuccessful Implant|4|||
129106702|NCT00940888|464686620|FG000|Overall Study|Death|461|||
129106703|NCT00940888|464686620|FG000|Overall Study|Withdrawn - Non-Death|364|||
129106704|NCT00940888|464686620|FG000|Overall Study|Lost to Follow-up|6|||
129106705|NCT04441788|464686623|FG000|Overall Study|Voluntary Withdrawl|0|||
129106706|NCT04441788|464686624|FG001|Overall Study|Voluntary Withdrawl|1|||
129106707|NCT04441788|464686625|FG002|Overall Study|Voluntary Withdrawl|0|||
129106708|NCT04441788|464686623|FG000|Overall Study|Ineligibility|1|||
129106709|NCT04441788|464686624|FG001|Overall Study|Ineligibility|0|||
129106710|NCT04441788|464686625|FG002|Overall Study|Ineligibility|0|||
129106711|NCT04441788|464686623|FG000|Overall Study|Adverse Event|0|||
129106712|NCT04441788|464686624|FG001|Overall Study|Adverse Event|0|||
129106713|NCT04441788|464686625|FG002|Overall Study|Adverse Event|4|||
129106714|NCT04441788|464686623|FG000|Overall Study|Study Terminated by Sponsor|16|||
129106715|NCT04441788|464686624|FG001|Overall Study|Study Terminated by Sponsor|16|||
129106716|NCT04441788|464686625|FG002|Overall Study|Study Terminated by Sponsor|12|||
129106717|NCT03859648|464686630|FG000|Overall Study|Lost to Follow-up|1|||
129106718|NCT03859648|464686630|FG000|Overall Study|Adverse Event|1|||
129106719|NCT01677182|464686631|FG000|Overall Study|Adverse Event|2|||
129106720|NCT01677182|464686632|FG001|Overall Study|Adverse Event|1|||
129106721|NCT01677182|464686633|FG002|Overall Study|Adverse Event|8|||
129106722|NCT01677182|464686631|FG000|Overall Study|Protocol Violation|5|||
129106723|NCT01677182|464686632|FG001|Overall Study|Protocol Violation|1|||
129106724|NCT01677182|464686633|FG002|Overall Study|Protocol Violation|4|||
129106725|NCT01677182|464686631|FG000|Overall Study|Lost to Follow-up|4|||
129106726|NCT01677182|464686632|FG001|Overall Study|Lost to Follow-up|0|||
129106727|NCT01677182|464686633|FG002|Overall Study|Lost to Follow-up|3|||
129106728|NCT01677182|464686631|FG000|Overall Study|Withdrawal by Subject|7|||
129106729|NCT01677182|464686632|FG001|Overall Study|Withdrawal by Subject|12|||
129106730|NCT01677182|464686633|FG002|Overall Study|Withdrawal by Subject|10|||
129106731|NCT01677182|464686631|FG000|Overall Study|Study termination|12|||
129106732|NCT01677182|464686632|FG001|Overall Study|Study termination|9|||
129106733|NCT01677182|464686633|FG002|Overall Study|Study termination|11|||
129106734|NCT01677182|464686631|FG000|Overall Study|Lack of Efficacy|3|||
129106735|NCT01677182|464686632|FG001|Overall Study|Lack of Efficacy|0|||
129106736|NCT01677182|464686633|FG002|Overall Study|Lack of Efficacy|1|||
129106737|NCT01677182|464686631|FG000|Overall Study|Other reasons|1|||
129106738|NCT01677182|464686632|FG001|Overall Study|Other reasons|5|||
129106739|NCT01677182|464686633|FG002|Overall Study|Other reasons|2|||
129106740|NCT00762762|464686638|FG000|Overall Study|Did not return for appointments|6|||
129106741|NCT00762762|464686639|FG001|Overall Study|Did not return for appointments|8|||
129106742|NCT02489448|464686640|FG000|Overall Study|Death|3|||
129106743|NCT02489448|464686640|FG000|Overall Study|Withdrawal by Subject|2|||
129106744|NCT00524771|464686649|FG000|Overall Study|Protocol Violation|220|||
129106745|NCT00524771|464686650|FG001|Overall Study|Protocol Violation|585|||
129106746|NCT02781818|464686651|FG000|Overall Study|Lost to Follow-up|4|||
129106747|NCT02781818|464686652|FG001|Overall Study|Lost to Follow-up|2|||
129106748|NCT02781818|464686653|FG002|Overall Study|Lost to Follow-up|1|||
129106749|NCT01223404|464686654|FG000|First Intervention (1 Day)|Adverse Event|0|||
129106750|NCT01223404|464686655|FG001|First Intervention (1 Day)|Adverse Event|0|||
129106751|NCT01223404|464686656|FG002|First Intervention (1 Day)|Adverse Event|0|||
129106752|NCT01223404|464686657|FG003|First Intervention (1 Day)|Adverse Event|1|||
129106753|NCT01223404|464686658|FG004|First Intervention (1 Day)|Adverse Event|0|||
129106754|NCT01223404|464686659|FG005|First Intervention (1 Day)|Adverse Event|0|||
129106755|NCT01223404|464686654|FG000|Second Intervention (1 Day)|Adverse Event|1|||
129106756|NCT01223404|464686655|FG001|Second Intervention (1 Day)|Adverse Event|0|||
129106757|NCT01223404|464686656|FG002|Second Intervention (1 Day)|Adverse Event|0|||
129106758|NCT01223404|464686657|FG003|Second Intervention (1 Day)|Adverse Event|0|||
129106759|NCT01223404|464686658|FG004|Second Intervention (1 Day)|Adverse Event|0|||
129215094|NCT02760498|465089441|FG005|Overall Study|Other than specified|0|||
129106760|NCT01223404|464686659|FG005|Second Intervention (1 Day)|Adverse Event|0|||
129106761|NCT01223404|464686654|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129106762|NCT01223404|464686655|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129106763|NCT01223404|464686656|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129215095|NCT02760498|465089436|FG000|Overall Study|Not treated|0|||
129106764|NCT01223404|464686657|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
129106765|NCT01223404|464686658|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129106766|NCT01223404|464686659|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129106767|NCT00707057|464686660|FG000|Overall Study|Withdrawal by Subject|8|||
129106768|NCT00707057|464686661|FG001|Overall Study|Withdrawal by Subject|3|||
129106769|NCT00707057|464686660|FG000|Overall Study|Dosed incorrectly|0|||
129106770|NCT00707057|464686661|FG001|Overall Study|Dosed incorrectly|1|||
129106771|NCT00872521|464686667|FG000|Completed PAD Induction|Patient choice|0|||
129106772|NCT00872521|464686668|FG001|Completed PAD Induction|Patient choice|1|||
129106773|NCT00872521|464686669|FG002|Completed PAD Induction|Patient choice|0|||
129106774|NCT00872521|464686667|FG000|Completed PAD Induction|Disease progression|0|||
129106775|NCT00872521|464686668|FG001|Completed PAD Induction|Disease progression|2|||
129106776|NCT00872521|464686669|FG002|Completed PAD Induction|Disease progression|0|||
129106777|NCT00872521|464686667|FG000|Completed PAD Induction|Adverse Event|4|||
129106778|NCT00872521|464686668|FG001|Completed PAD Induction|Adverse Event|0|||
129106779|NCT00872521|464686669|FG002|Completed PAD Induction|Adverse Event|0|||
129106780|NCT00872521|464686667|FG000|Completed PAD Induction|Death|1|||
129106781|NCT00872521|464686668|FG001|Completed PAD Induction|Death|1|||
129106782|NCT00872521|464686669|FG002|Completed PAD Induction|Death|0|||
129106783|NCT00872521|464686667|FG000|Primary Endpoint Analysis|Other|1|||
129106784|NCT00872521|464686668|FG001|Primary Endpoint Analysis|Other|2|||
129106785|NCT00872521|464686669|FG002|Primary Endpoint Analysis|Other|0|||
129106786|NCT00872521|464686667|FG000|Primary Endpoint Analysis|Patient choice|0|||
129106787|NCT00872521|464686668|FG001|Primary Endpoint Analysis|Patient choice|1|||
129106788|NCT00872521|464686669|FG002|Primary Endpoint Analysis|Patient choice|0|||
129106789|NCT00872521|464686667|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
129106790|NCT00872521|464686668|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
129106791|NCT00872521|464686669|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
129106792|NCT00872521|464686667|FG000|Primary Endpoint Analysis|Patient response missing|0|||
129106793|NCT00872521|464686668|FG001|Primary Endpoint Analysis|Patient response missing|0|||
129106794|NCT00872521|464686669|FG002|Primary Endpoint Analysis|Patient response missing|1|||
129106795|NCT00872521|464686667|FG000|Completed 3-month Follow up|Other|0|||
129106796|NCT00872521|464686668|FG001|Completed 3-month Follow up|Other|2|||
129106797|NCT00872521|464686669|FG002|Completed 3-month Follow up|Other|0|||
129106798|NCT00872521|464686667|FG000|Completed 3-month Follow up|Physician Decision|0|||
129106799|NCT00872521|464686668|FG001|Completed 3-month Follow up|Physician Decision|1|||
129106800|NCT00872521|464686669|FG002|Completed 3-month Follow up|Physician Decision|0|||
129106801|NCT00872521|464686667|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
129106802|NCT00872521|464686668|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
129106803|NCT00872521|464686669|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
129106804|NCT04819438|464686670|FG000|Overall Study|Withdrawal by Subject|1|||
129106805|NCT04819438|464686671|FG001|Overall Study|Withdrawal by Subject|0|||
129106806|NCT04819438|464686670|FG000|Overall Study|Adverse Event|0|||
129106807|NCT04819438|464686671|FG001|Overall Study|Adverse Event|1|||
129106808|NCT04819438|464686670|FG000|Overall Study|Protocol Violation|0|||
129106809|NCT04819438|464686671|FG001|Overall Study|Protocol Violation|1|||
129106810|NCT03465709|464686672|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
129106811|NCT03465709|464686672|FG000|Overall Study|Withdrawal by Subject|3|||
129106812|NCT03060291|464686673|FG000|3-month Follow-up|Declined to respond|8|||
129106813|NCT03060291|464686674|FG001|3-month Follow-up|Declined to respond|10|||
129106814|NCT03060291|464686675|FG002|3-month Follow-up|Declined to respond|2|||
129106815|NCT03060291|464686673|FG000|6-month Follow-up|Declined to respond|7|||
129106816|NCT03060291|464686674|FG001|6-month Follow-up|Declined to respond|13|||
129106817|NCT03060291|464686675|FG002|6-month Follow-up|Declined to respond|4|||
129106818|NCT03060291|464686673|FG000|12-month Follow-up|Declined to respond|7|||
129106819|NCT03060291|464686674|FG001|12-month Follow-up|Declined to respond|16|||
129106820|NCT03060291|464686675|FG002|12-month Follow-up|Declined to respond|6|||
129106821|NCT01720524|464686676|FG000|Part A|Insufficient Clinical Response|2|||
129106822|NCT01720524|464686677|FG001|Part A|Insufficient Clinical Response|4|||
129106823|NCT01720524|464686676|FG000|Part A|Adverse Event|2|||
129106824|NCT01720524|464686677|FG001|Part A|Adverse Event|2|||
129106825|NCT01720524|464686676|FG000|Part A|Death|2|||
129106826|NCT01720524|464686677|FG001|Part A|Death|1|||
129106827|NCT01720524|464686676|FG000|Part A|Lost to Follow-up|0|||
129106828|NCT01720524|464686677|FG001|Part A|Lost to Follow-up|1|||
129106829|NCT01720524|464686676|FG000|Part A|Missed 28 day follow-up visit|1|||
128882111|NCT00406653|463863272|FG000|Maintenance Period|Lost to Follow-up|0|||
129106830|NCT01720524|464686677|FG001|Part A|Missed 28 day follow-up visit|1|||
129106831|NCT01720524|464686676|FG000|Part A|Withdrawal by Subject|0|||
129106832|NCT01720524|464686677|FG001|Part A|Withdrawal by Subject|1|||
129106833|NCT01720524|464686676|FG000|Part A|Other|0|||
129106834|NCT01720524|464686677|FG001|Part A|Other|1|||
129106835|NCT01720524|464686676|FG000|Part A|Lost to Follow-up|0|||
129106836|NCT01720524|464686677|FG001|Part A|Lost to Follow-up|1|||
129106837|NCT01720524|464686676|FG000|Part B|No longer willing to participate in study|1|||
129106838|NCT01720524|464686677|FG001|Part B|No longer willing to participate in study|4|||
129106839|NCT01720524|464686676|FG000|Part B|Other|2|||
129106840|NCT01720524|464686677|FG001|Part B|Other|0|||
129106841|NCT01720524|464686676|FG000|Part B|Lost to Follow-up|2|||
129106842|NCT01720524|464686677|FG001|Part B|Lost to Follow-up|3|||
129106843|NCT01720524|464686676|FG000|Part B|Death|0|||
129106844|NCT01720524|464686677|FG001|Part B|Death|2|||
129106845|NCT02105285|464686683|FG000|Overall Study|Adverse Event|1|||
129106846|NCT02105285|464686684|FG001|Overall Study|Adverse Event|1|||
129106847|NCT02105285|464686685|FG002|Overall Study|Adverse Event|0|||
129106848|NCT02105285|464686683|FG000|Overall Study|Protocol Violation|0|||
129106849|NCT02105285|464686684|FG001|Overall Study|Protocol Violation|1|||
129106850|NCT02105285|464686685|FG002|Overall Study|Protocol Violation|0|||
129106851|NCT02105285|464686683|FG000|Overall Study|Withdrawal by Subject|1|||
129106852|NCT02105285|464686684|FG001|Overall Study|Withdrawal by Subject|0|||
128882112|NCT00406653|463863273|FG001|Maintenance Period|Lost to Follow-up|0|||
128882113|NCT00406653|463863274|FG002|Maintenance Period|Lost to Follow-up|0|||
128882114|NCT00406653|463863275|FG003|Maintenance Period|Lost to Follow-up|0|||
128882115|NCT00406653|463863276|FG004|Maintenance Period|Lost to Follow-up|2|||
128882116|NCT00406653|463863277|FG005|Maintenance Period|Lost to Follow-up|1|||
128882117|NCT00406653|463863278|FG006|Maintenance Period|Lost to Follow-up|0|||
128882118|NCT00406653|463863272|FG000|Maintenance Period|Withdrawal of Consent|0|||
128882119|NCT00406653|463863273|FG001|Maintenance Period|Withdrawal of Consent|0|||
128882120|NCT00406653|463863274|FG002|Maintenance Period|Withdrawal of Consent|0|||
128882121|NCT00406653|463863275|FG003|Maintenance Period|Withdrawal of Consent|0|||
128882122|NCT00406653|463863276|FG004|Maintenance Period|Withdrawal of Consent|2|||
128882123|NCT00406653|463863277|FG005|Maintenance Period|Withdrawal of Consent|0|||
128882124|NCT00406653|463863278|FG006|Maintenance Period|Withdrawal of Consent|0|||
128882125|NCT00406653|463863272|FG000|Maintenance Period|Pregnancy|0|||
128882126|NCT00406653|463863273|FG001|Maintenance Period|Pregnancy|0|||
128882127|NCT00406653|463863274|FG002|Maintenance Period|Pregnancy|0|||
128882128|NCT00406653|463863275|FG003|Maintenance Period|Pregnancy|0|||
128882129|NCT00406653|463863276|FG004|Maintenance Period|Pregnancy|0|||
128882130|NCT00406653|463863277|FG005|Maintenance Period|Pregnancy|1|||
128882131|NCT00406653|463863278|FG006|Maintenance Period|Pregnancy|0|||
128882132|NCT00406653|463863272|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
128882133|NCT00406653|463863273|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
128882134|NCT00406653|463863274|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
128882135|NCT00406653|463863275|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
128882136|NCT00406653|463863276|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
128882137|NCT00406653|463863277|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
128882138|NCT00406653|463863278|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
128882139|NCT00406653|463863272|FG000|Maintenance Period|Error in disease score evaluation|0|||
128882140|NCT00406653|463863273|FG001|Maintenance Period|Error in disease score evaluation|0|||
128882141|NCT00406653|463863274|FG002|Maintenance Period|Error in disease score evaluation|0|||
128882142|NCT00406653|463863275|FG003|Maintenance Period|Error in disease score evaluation|0|||
128882143|NCT00406653|463863276|FG004|Maintenance Period|Error in disease score evaluation|1|||
128882144|NCT00406653|463863277|FG005|Maintenance Period|Error in disease score evaluation|0|||
128882145|NCT00406653|463863278|FG006|Maintenance Period|Error in disease score evaluation|0|||
128882146|NCT00406653|463863272|FG000|Open-Label Period|Death|0|||
128882147|NCT00406653|463863273|FG001|Open-Label Period|Death|0|||
128882148|NCT00406653|463863274|FG002|Open-Label Period|Death|0|||
128882149|NCT00406653|463863275|FG003|Open-Label Period|Death|0|||
128882150|NCT00406653|463863276|FG004|Open-Label Period|Death|0|||
128882151|NCT00406653|463863277|FG005|Open-Label Period|Death|0|||
128882152|NCT00406653|463863278|FG006|Open-Label Period|Death|1|||
128882153|NCT00406653|463863272|FG000|Open-Label Period|Adverse Event|0|||
128882154|NCT00406653|463863273|FG001|Open-Label Period|Adverse Event|0|||
128882155|NCT00406653|463863274|FG002|Open-Label Period|Adverse Event|0|||
128882156|NCT00406653|463863275|FG003|Open-Label Period|Adverse Event|0|||
128882157|NCT00406653|463863276|FG004|Open-Label Period|Adverse Event|0|||
128882158|NCT00406653|463863277|FG005|Open-Label Period|Adverse Event|0|||
128882159|NCT00406653|463863278|FG006|Open-Label Period|Adverse Event|18|||
129106853|NCT02105285|464686685|FG002|Overall Study|Withdrawal by Subject|0|||
129106854|NCT01421641|464686686|FG000|Overall Study|Protocol Violation|2|||
129106855|NCT01421641|464686687|FG001|Overall Study|Protocol Violation|2|||
128882160|NCT00406653|463863272|FG000|Open-Label Period|Lack of Efficacy|0|||
129106856|NCT03061188|464686689|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
128882161|NCT00406653|463863273|FG001|Open-Label Period|Lack of Efficacy|0|||
128882162|NCT00406653|463863274|FG002|Open-Label Period|Lack of Efficacy|0|||
128882163|NCT00406653|463863275|FG003|Open-Label Period|Lack of Efficacy|0|||
128882164|NCT00406653|463863276|FG004|Open-Label Period|Lack of Efficacy|0|||
128882165|NCT00406653|463863277|FG005|Open-Label Period|Lack of Efficacy|0|||
128882166|NCT00406653|463863278|FG006|Open-Label Period|Lack of Efficacy|160|||
129106857|NCT03061188|464686690|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
129106858|NCT03061188|464686691|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
129106859|NCT03061188|464686692|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
129106860|NCT03061188|464686689|FG000|On Follow-up for 3 Years|Death|0|||
128882167|NCT00406653|463863272|FG000|Open-Label Period|Lost to Follow-up|0|||
128882168|NCT00406653|463863273|FG001|Open-Label Period|Lost to Follow-up|0|||
128882169|NCT00406653|463863274|FG002|Open-Label Period|Lost to Follow-up|0|||
128882170|NCT00406653|463863275|FG003|Open-Label Period|Lost to Follow-up|0|||
128882171|NCT00406653|463863276|FG004|Open-Label Period|Lost to Follow-up|0|||
128882172|NCT00406653|463863277|FG005|Open-Label Period|Lost to Follow-up|0|||
128882173|NCT00406653|463863278|FG006|Open-Label Period|Lost to Follow-up|6|||
128882174|NCT00406653|463863272|FG000|Open-Label Period|Withdrawal of Consent|0|||
128882175|NCT00406653|463863273|FG001|Open-Label Period|Withdrawal of Consent|0|||
128882176|NCT00406653|463863274|FG002|Open-Label Period|Withdrawal of Consent|0|||
128882177|NCT00406653|463863275|FG003|Open-Label Period|Withdrawal of Consent|0|||
128882178|NCT00406653|463863276|FG004|Open-Label Period|Withdrawal of Consent|0|||
128882179|NCT00406653|463863277|FG005|Open-Label Period|Withdrawal of Consent|0|||
128882180|NCT00406653|463863278|FG006|Open-Label Period|Withdrawal of Consent|11|||
128882181|NCT00406653|463863272|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
128882182|NCT00406653|463863273|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
128882183|NCT00406653|463863274|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
128882184|NCT00406653|463863275|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
128882185|NCT00406653|463863276|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
128882186|NCT00406653|463863277|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
128882187|NCT00406653|463863278|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
128882188|NCT00406653|463863272|FG000|Open-Label Period|Pregnancy|0|||
128882189|NCT00406653|463863273|FG001|Open-Label Period|Pregnancy|0|||
128882190|NCT00406653|463863274|FG002|Open-Label Period|Pregnancy|0|||
128882191|NCT00406653|463863275|FG003|Open-Label Period|Pregnancy|0|||
128882192|NCT00406653|463863276|FG004|Open-Label Period|Pregnancy|0|||
128882193|NCT00406653|463863277|FG005|Open-Label Period|Pregnancy|0|||
128882194|NCT00406653|463863278|FG006|Open-Label Period|Pregnancy|2|||
128882195|NCT00406653|463863272|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
128882196|NCT00406653|463863273|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
128882197|NCT00406653|463863274|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
128882198|NCT00406653|463863275|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
128882199|NCT00406653|463863276|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
128882200|NCT00406653|463863277|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
128882201|NCT00406653|463863278|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
128882202|NCT00406653|463863272|FG000|Open-Label Period|Declined participation but followup done|0|||
128882203|NCT00406653|463863273|FG001|Open-Label Period|Declined participation but followup done|0|||
128882204|NCT00406653|463863274|FG002|Open-Label Period|Declined participation but followup done|0|||
128882205|NCT00406653|463863275|FG003|Open-Label Period|Declined participation but followup done|0|||
128882206|NCT00406653|463863276|FG004|Open-Label Period|Declined participation but followup done|0|||
128882207|NCT00406653|463863277|FG005|Open-Label Period|Declined participation but followup done|0|||
128882208|NCT00406653|463863278|FG006|Open-Label Period|Declined participation but followup done|8|||
128882209|NCT00406653|463863272|FG000|Open-Label Period|Discontinued by Sponsor|0|||
128882210|NCT00406653|463863273|FG001|Open-Label Period|Discontinued by Sponsor|0|||
128882211|NCT00406653|463863274|FG002|Open-Label Period|Discontinued by Sponsor|0|||
128882212|NCT00406653|463863275|FG003|Open-Label Period|Discontinued by Sponsor|0|||
128882213|NCT00406653|463863276|FG004|Open-Label Period|Discontinued by Sponsor|0|||
128882214|NCT00406653|463863277|FG005|Open-Label Period|Discontinued by Sponsor|0|||
128882215|NCT00406653|463863278|FG006|Open-Label Period|Discontinued by Sponsor|1|||
128882216|NCT00406653|463863272|FG000|Open-Label Period|Refused followup|0|||
128882217|NCT00406653|463863273|FG001|Open-Label Period|Refused followup|0|||
128882218|NCT00406653|463863274|FG002|Open-Label Period|Refused followup|0|||
128882219|NCT00406653|463863275|FG003|Open-Label Period|Refused followup|0|||
128882220|NCT00406653|463863276|FG004|Open-Label Period|Refused followup|0|||
128882221|NCT00406653|463863277|FG005|Open-Label Period|Refused followup|0|||
128882222|NCT00406653|463863278|FG006|Open-Label Period|Refused followup|1|||
128882223|NCT00818649|463863279|FG000|Overall Study|Declining performance status|2|||
128882224|NCT00818649|463863279|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
128882225|NCT00818649|463863279|FG000|Overall Study|Adverse Event|1|||
128882226|NCT03513588|463863280|FG000|Overall Study|Lost to Follow-up|0|||
128882227|NCT03513588|463863281|FG001|Overall Study|Lost to Follow-up|1|||
128882228|NCT03513588|463863282|FG002|Overall Study|Lost to Follow-up|1|||
128882229|NCT03513588|463863280|FG000|Overall Study|Study dosing paused by sponsor|1|||
128882230|NCT03513588|463863281|FG001|Overall Study|Study dosing paused by sponsor|1|||
128882231|NCT03513588|463863282|FG002|Overall Study|Study dosing paused by sponsor|0|||
128882232|NCT03513588|463863280|FG000|Overall Study|Death|0|||
128882233|NCT03513588|463863281|FG001|Overall Study|Death|0|||
128882234|NCT03513588|463863282|FG002|Overall Study|Death|1|||
128882235|NCT00940108|463863283|FG000|Overall Study|Adverse Event|2|||
128882236|NCT00940108|463863284|FG001|Overall Study|Adverse Event|4|||
128882237|NCT00940108|463863285|FG002|Overall Study|Adverse Event|0|||
128882238|NCT00940108|463863286|FG003|Overall Study|Adverse Event|2|||
129106861|NCT03061188|464686690|FG001|On Follow-up for 3 Years|Death|3|||
128882239|NCT00940108|463863283|FG000|Overall Study|Withdrew Consent|2|||
128882240|NCT00940108|463863284|FG001|Overall Study|Withdrew Consent|1|||
128882241|NCT00940108|463863285|FG002|Overall Study|Withdrew Consent|0|||
128882242|NCT00940108|463863286|FG003|Overall Study|Withdrew Consent|1|||
128882243|NCT00940108|463863283|FG000|Overall Study|Dose 2 contraindicated|1|||
128882244|NCT00940108|463863284|FG001|Overall Study|Dose 2 contraindicated|1|||
128882245|NCT00940108|463863285|FG002|Overall Study|Dose 2 contraindicated|0|||
128882246|NCT00940108|463863286|FG003|Overall Study|Dose 2 contraindicated|1|||
128882247|NCT00940108|463863283|FG000|Overall Study|Declined further vaccination|0|||
128882248|NCT00940108|463863284|FG001|Overall Study|Declined further vaccination|1|||
128882249|NCT00940108|463863285|FG002|Overall Study|Declined further vaccination|3|||
128882250|NCT00940108|463863286|FG003|Overall Study|Declined further vaccination|0|||
128882251|NCT00940108|463863283|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
128882252|NCT00940108|463863284|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
128882253|NCT00940108|463863285|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
128882254|NCT00940108|463863286|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
128882255|NCT00940108|463863283|FG000|Overall Study|Viral illness after Dose 1|0|||
128882256|NCT00940108|463863284|FG001|Overall Study|Viral illness after Dose 1|1|||
128882257|NCT00940108|463863285|FG002|Overall Study|Viral illness after Dose 1|0|||
128882258|NCT00940108|463863286|FG003|Overall Study|Viral illness after Dose 1|0|||
128882259|NCT00940108|463863283|FG000|Overall Study|Diagnosed with H1N1|0|||
128882260|NCT00940108|463863284|FG001|Overall Study|Diagnosed with H1N1|0|||
128882261|NCT00940108|463863285|FG002|Overall Study|Diagnosed with H1N1|0|||
128882262|NCT00940108|463863286|FG003|Overall Study|Diagnosed with H1N1|1|||
128882263|NCT02075541|463863290|FG000|Overall Study|Serious Adverse Event|1|||
128882264|NCT02075541|463863291|FG001|Overall Study|Serious Adverse Event|4|||
128882265|NCT02075541|463863290|FG000|Overall Study|Protocol Violation|1|||
128882266|NCT02075541|463863291|FG001|Overall Study|Protocol Violation|0|||
128882267|NCT02075541|463863290|FG000|Overall Study|Withdrawal by Subject|1|||
128882268|NCT02075541|463863291|FG001|Overall Study|Withdrawal by Subject|3|||
128882269|NCT02075541|463863290|FG000|Overall Study|Sponsor study termination|0|||
128882270|NCT02075541|463863291|FG001|Overall Study|Sponsor study termination|1|||
128882271|NCT02075541|463863290|FG000|Overall Study|Other- unable to perform study procedure|1|||
128882272|NCT02075541|463863291|FG001|Overall Study|Other- unable to perform study procedure|0|||
128882273|NCT01142596|463863293|FG000|Overall Study|Withdrawal by Subject|9|||
128882274|NCT01142596|463863294|FG001|Overall Study|Withdrawal by Subject|35|||
128882275|NCT01142596|463863293|FG000|Overall Study|Adverse Event|8|||
128882276|NCT01142596|463863294|FG001|Overall Study|Adverse Event|35|||
128882277|NCT01142596|463863293|FG000|Overall Study|Lack of Efficacy|5|||
128882278|NCT01142596|463863294|FG001|Overall Study|Lack of Efficacy|9|||
128882279|NCT01142596|463863293|FG000|Overall Study|Lost to Follow-up|2|||
128882280|NCT01142596|463863294|FG001|Overall Study|Lost to Follow-up|3|||
128882281|NCT01142596|463863293|FG000|Overall Study|Other reason (not specified)|5|||
128882282|NCT01142596|463863294|FG001|Overall Study|Other reason (not specified)|4|||
128882283|NCT01013597|463863295|FG000|Overall Study|Withdrawal by Subject|1|||
128882284|NCT00427895|463863296|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
128882285|NCT00427895|463863297|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
128882286|NCT00427895|463863298|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
128882287|NCT00427895|463863299|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
128882288|NCT00427895|463863300|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
128882289|NCT00427895|463863301|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
128882290|NCT00427895|463863302|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
128882291|NCT00427895|463863303|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
128882292|NCT00427895|463863296|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
128882293|NCT00427895|463863297|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
128882294|NCT00427895|463863298|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
128882295|NCT00427895|463863299|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
128882296|NCT00427895|463863300|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129106862|NCT03061188|464686691|FG002|On Follow-up for 3 Years|Death|5|||
129106863|NCT03061188|464686692|FG003|On Follow-up for 3 Years|Death|4|||
129106864|NCT03061188|464686689|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
128683237|NCT01856023|463138796|FG000|Overall Study|Lack of Efficacy|5|||
128882297|NCT00427895|463863301|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
128882298|NCT00427895|463863302|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
128882299|NCT00427895|463863303|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
128882300|NCT00427895|463863296|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
128882301|NCT00427895|463863297|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
128882302|NCT00427895|463863298|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
128882303|NCT00427895|463863299|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
128882304|NCT00427895|463863300|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
128882305|NCT00427895|463863301|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
129106865|NCT03061188|464686690|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
128683238|NCT01856023|463138797|FG001|Overall Study|Lack of Efficacy|5|||
128882306|NCT00427895|463863302|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
128882307|NCT00427895|463863303|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
128882308|NCT00427895|463863296|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
128882309|NCT00427895|463863297|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
128882310|NCT00427895|463863298|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
128882311|NCT00427895|463863299|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
128882312|NCT00427895|463863300|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
128882313|NCT00427895|463863301|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
128882314|NCT00427895|463863302|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
128882315|NCT00427895|463863303|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
128882316|NCT00427895|463863296|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
128882317|NCT00427895|463863297|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
128882318|NCT00427895|463863298|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
128882319|NCT00427895|463863299|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
128882320|NCT00427895|463863300|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129018554|NCT01001208|464363646|FG001|Overall Study|Noncompliance|7|||
129018555|NCT01001208|464363645|FG000|Overall Study|Disease Progression|0|||
129018556|NCT01001208|464363646|FG001|Overall Study|Disease Progression|3|||
129018557|NCT01001208|464363645|FG000|Overall Study|Other|0|||
129018558|NCT01001208|464363646|FG001|Overall Study|Other|2|||
129018559|NCT01864174|464363647|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
129018560|NCT01864174|464363648|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
129018561|NCT01864174|464363647|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
129018562|NCT01864174|464363648|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
129018563|NCT01864174|464363647|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
129018564|NCT01864174|464363648|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
129018565|NCT01864174|464363647|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
129018566|NCT01864174|464363648|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
129018567|NCT01864174|464363647|FG000|Double Blind - Compliant Randomized|Death|1|||
129018568|NCT01864174|464363648|FG001|Double Blind - Compliant Randomized|Death|0|||
129018569|NCT01864174|464363647|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
129018570|NCT01864174|464363648|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
129018571|NCT01864174|464363647|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
129018572|NCT01864174|464363648|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
129018573|NCT01864174|464363647|FG000|Double Blind - Compliant Randomized|Other|6|||
129018574|NCT01864174|464363648|FG001|Double Blind - Compliant Randomized|Other|10|||
129018575|NCT01864174|464363647|FG000|Off Treatment Follow-Up|Other|2|||
129018576|NCT01864174|464363648|FG001|Off Treatment Follow-Up|Other|0|||
129018577|NCT01864174|464363647|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
129018578|NCT01864174|464363648|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
129018579|NCT01723397|464363652|FG000|Study Period 1|Protocol Violation|0|||
129018580|NCT01723397|464363653|FG001|Study Period 1|Protocol Violation|1|||
129018581|NCT01723397|464363652|FG000|Study Period 2|Protocol Violation|0|||
129018582|NCT01723397|464363653|FG001|Study Period 2|Protocol Violation|1|||
129018583|NCT00468286|464363654|FG000|Overall Study|Adverse Event|1|||
129018584|NCT00468286|464363655|FG001|Overall Study|Adverse Event|6|||
129018585|NCT00468286|464363654|FG000|Overall Study|Protocol Violation|2|||
129018586|NCT00468286|464363655|FG001|Overall Study|Protocol Violation|2|||
129018587|NCT00468286|464363654|FG000|Overall Study|Withdrawal by Subject|4|||
129018588|NCT00468286|464363655|FG001|Overall Study|Withdrawal by Subject|3|||
129018589|NCT00468286|464363654|FG000|Overall Study|Physician Decision|0|||
129018590|NCT00468286|464363655|FG001|Overall Study|Physician Decision|1|||
129018591|NCT02196675|464363656|FG000|Overall Study|Withdrawal by Subject|1|||
129018592|NCT02196675|464363657|FG001|Overall Study|Withdrawal by Subject|0|||
129018593|NCT02196675|464363658|FG002|Overall Study|Withdrawal by Subject|0|||
129018594|NCT02196675|464363656|FG000|Overall Study|Intra-operative surgical exclusion|1|||
129018595|NCT02196675|464363657|FG001|Overall Study|Intra-operative surgical exclusion|1|||
129018596|NCT02196675|464363658|FG002|Overall Study|Intra-operative surgical exclusion|0|||
129018597|NCT02196675|464363656|FG000|Overall Study|Protocol Violation|0|||
129018598|NCT02196675|464363657|FG001|Overall Study|Protocol Violation|1|||
129018599|NCT02196675|464363658|FG002|Overall Study|Protocol Violation|0|||
129018600|NCT02196675|464363656|FG000|Overall Study|Death|0|||
129018601|NCT02196675|464363657|FG001|Overall Study|Death|0|||
129018602|NCT02196675|464363658|FG002|Overall Study|Death|1|||
129018603|NCT02158663|464363659|FG000|Overall Study|Withdrawal by Subject|5|||
129018604|NCT02158663|464363660|FG001|Overall Study|Withdrawal by Subject|4|||
129018605|NCT00537979|464363661|FG000|Overall Study|Adverse Event|2|||
129018606|NCT00537979|464363662|FG001|Overall Study|Adverse Event|2|||
129018607|NCT00537979|464363661|FG000|Overall Study|Withdrawal by Subject|1|||
129018608|NCT00537979|464363662|FG001|Overall Study|Withdrawal by Subject|4|||
129018609|NCT00537979|464363661|FG000|Overall Study|Lost to Follow-up|1|||
129018610|NCT00537979|464363662|FG001|Overall Study|Lost to Follow-up|4|||
129018611|NCT00537979|464363661|FG000|Overall Study|Lack of Efficacy|0|||
129018612|NCT00537979|464363662|FG001|Overall Study|Lack of Efficacy|1|||
129018613|NCT00537979|464363661|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
129018614|NCT00537979|464363662|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
129018615|NCT00537979|464363661|FG000|Overall Study|Death|0|||
129018616|NCT00537979|464363662|FG001|Overall Study|Death|3|||
129018617|NCT00537979|464363661|FG000|Overall Study|Kidney transplant|0|||
129018618|NCT00537979|464363662|FG001|Overall Study|Kidney transplant|3|||
129018619|NCT00537979|464363661|FG000|Overall Study|Heart failure|0|||
129018620|NCT00537979|464363662|FG001|Overall Study|Heart failure|1|||
129018621|NCT02009163|464363663|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
129018622|NCT02009163|464363664|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
129018623|NCT02009163|464363665|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
129018624|NCT02009163|464363663|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
129018625|NCT02009163|464363664|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
129018626|NCT02009163|464363665|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
129018627|NCT02009163|464363663|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
129018628|NCT02009163|464363664|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
129018629|NCT02009163|464363665|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
129018630|NCT02009163|464363663|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
129018631|NCT02009163|464363664|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
129018632|NCT02009163|464363665|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
129018633|NCT02009163|464363663|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
129018634|NCT02009163|464363664|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
129018635|NCT02009163|464363665|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
129018636|NCT02009163|464363663|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
129018637|NCT02009163|464363664|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
129018638|NCT02009163|464363665|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
129018639|NCT02009163|464363663|FG000|Open-label Period (Non-randomized)|Other|13|||
129018640|NCT02009163|464363664|FG001|Open-label Period (Non-randomized)|Other|0|||
129018641|NCT02009163|464363665|FG002|Open-label Period (Non-randomized)|Other|0|||
129018642|NCT02009163|464363663|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
129018643|NCT02009163|464363664|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
129018644|NCT02009163|464363665|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
129018645|NCT02009163|464363663|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
129018646|NCT02009163|464363664|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
129018647|NCT02009163|464363665|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
129018648|NCT02009163|464363663|FG000|Randomized-withdrawal Period|Adverse Event|0|||
129018649|NCT02009163|464363664|FG001|Randomized-withdrawal Period|Adverse Event|0|||
129018650|NCT02009163|464363665|FG002|Randomized-withdrawal Period|Adverse Event|6|||
129018651|NCT02009163|464363663|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
129018652|NCT02009163|464363664|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
129018653|NCT02009163|464363665|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
129018654|NCT02009163|464363663|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
129018655|NCT02009163|464363664|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
129018656|NCT02009163|464363665|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
129018657|NCT02009163|464363663|FG000|Randomized-withdrawal Period|Pregnancy|0|||
129018658|NCT02009163|464363664|FG001|Randomized-withdrawal Period|Pregnancy|0|||
129018659|NCT02009163|464363665|FG002|Randomized-withdrawal Period|Pregnancy|2|||
129018660|NCT02009163|464363663|FG000|Randomized-withdrawal Period|Other|0|||
129018661|NCT02009163|464363664|FG001|Randomized-withdrawal Period|Other|9|||
129018662|NCT02009163|464363665|FG002|Randomized-withdrawal Period|Other|5|||
129018663|NCT04419311|464363670|FG000|Overall Study|Lost to Follow-up|1|||
129018664|NCT04419311|464363671|FG001|Overall Study|Lost to Follow-up|0|||
129018665|NCT00465270|464363674|FG000|Overall Study|Death|7|||
129018666|NCT00465270|464363675|FG001|Overall Study|Death|11|||
129018667|NCT00465270|464363674|FG000|Overall Study|Withdrawal by Subject|34|||
129018668|NCT00465270|464363675|FG001|Overall Study|Withdrawal by Subject|78|||
129018669|NCT00465270|464363674|FG000|Overall Study|Lost to Follow-up|60|||
129018670|NCT00465270|464363675|FG001|Overall Study|Lost to Follow-up|67|||
129018671|NCT00465270|464363674|FG000|Overall Study|Investigator request|3|||
129018672|NCT00465270|464363675|FG001|Overall Study|Investigator request|4|||
129018673|NCT02089997|464363691|FG000|Overall Study|Case report forms uncollected|99|||
129018674|NCT02089997|464363691|FG000|Overall Study|Protocol Violation|147|||
129018675|NCT02441309|464363692|FG000|Overall Study|Disease progression|2|||
129018676|NCT02441309|464363693|FG001|Overall Study|Disease progression|1|||
129018677|NCT02441309|464363694|FG002|Overall Study|Disease progression|2|||
129018678|NCT02441309|464363692|FG000|Overall Study|Adverse Event|0|||
129018679|NCT02441309|464363693|FG001|Overall Study|Adverse Event|1|||
129018680|NCT02441309|464363694|FG002|Overall Study|Adverse Event|0|||
129018681|NCT02441309|464363692|FG000|Overall Study|Withdrawal by Subject|1|||
129018682|NCT02441309|464363693|FG001|Overall Study|Withdrawal by Subject|0|||
129018683|NCT02441309|464363694|FG002|Overall Study|Withdrawal by Subject|1|||
129215096|NCT02760498|465089437|FG001|Overall Study|Not treated|0|||
129215097|NCT02760498|465089438|FG002|Overall Study|Not treated|0|||
129106866|NCT03061188|464686691|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
129106867|NCT03061188|464686692|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
129106868|NCT02609984|464686693|FG000|Overall Study|Death|29|||
129106869|NCT02609984|464686694|FG001|Overall Study|Death|26|||
129106870|NCT02609984|464686693|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
129106871|NCT02609984|464686694|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
129106872|NCT02609984|464686693|FG000|Overall Study|Lost to Follow-up|1|||
129106873|NCT02609984|464686694|FG001|Overall Study|Lost to Follow-up|2|||
129106874|NCT02609984|464686693|FG000|Overall Study|Withdrawal by Subject|0|||
129106875|NCT02609984|464686694|FG001|Overall Study|Withdrawal by Subject|1|||
129106876|NCT02609984|464686693|FG000|Overall Study|Disease Progression|2|||
129106877|NCT02609984|464686694|FG001|Overall Study|Disease Progression|0|||
129106878|NCT02504320|464686695|FG000|Treatment Period 1|Positive Drug Screen|0|||
129106879|NCT02504320|464686696|FG001|Treatment Period 1|Positive Drug Screen|0|||
129106880|NCT02504320|464686697|FG002|Treatment Period 1|Positive Drug Screen|1|||
129106881|NCT02504320|464686698|FG003|Treatment Period 1|Positive Drug Screen|0|||
129106882|NCT02504320|464686695|FG000|Treatment Period 2|Positive Drug Screen|0|||
129106883|NCT02504320|464686696|FG001|Treatment Period 2|Positive Drug Screen|1|||
129106884|NCT02504320|464686697|FG002|Treatment Period 2|Positive Drug Screen|0|||
129106885|NCT02504320|464686698|FG003|Treatment Period 2|Positive Drug Screen|0|||
129106886|NCT02504320|464686695|FG000|Treatment Period 3|Positive Drug Screen|0|||
129106887|NCT02504320|464686696|FG001|Treatment Period 3|Positive Drug Screen|0|||
129106888|NCT02504320|464686697|FG002|Treatment Period 3|Positive Drug Screen|0|||
129106889|NCT02504320|464686698|FG003|Treatment Period 3|Positive Drug Screen|1|||
129106890|NCT02504320|464686695|FG000|Treatment Period 3|Adverse Event|0|||
129106891|NCT02504320|464686696|FG001|Treatment Period 3|Adverse Event|0|||
129106892|NCT02504320|464686697|FG002|Treatment Period 3|Adverse Event|1|||
129106893|NCT02504320|464686698|FG003|Treatment Period 3|Adverse Event|0|||
129106894|NCT01210222|464686699|FG000|Overall Study|Ineligible|2|||
129106895|NCT01210222|464686699|FG000|Overall Study|Never treated|1|||
129106896|NCT00941304|464686700|FG000|Overall Study|Lost to Follow-up|1|||
129106897|NCT00941304|464686701|FG001|Overall Study|Lost to Follow-up|0|||
129106898|NCT00941304|464686702|FG002|Overall Study|Lost to Follow-up|0|||
129106899|NCT00941304|464686703|FG003|Overall Study|Lost to Follow-up|0|||
129106900|NCT00941304|464686704|FG004|Overall Study|Lost to Follow-up|0|||
129106901|NCT03293394|464686705|FG000|Follow-up (6 Months)|Adverse Event|4|||
129106902|NCT03293394|464686706|FG001|Follow-up (6 Months)|Adverse Event|2|||
129106903|NCT00436826|464686709|FG000|Double Blind Period (DBP)|Adverse Event|2|||
129106904|NCT00436826|464686710|FG001|Double Blind Period (DBP)|Adverse Event|0|||
129106905|NCT00436826|464686711|FG002|Double Blind Period (DBP)|Adverse Event|0|||
129106906|NCT00436826|464686712|FG003|Double Blind Period (DBP)|Adverse Event|0|||
129106907|NCT00436826|464686713|FG004|Double Blind Period (DBP)|Adverse Event|0|||
129106908|NCT00436826|464686714|FG005|Double Blind Period (DBP)|Adverse Event|0|||
129106909|NCT00436826|464686709|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
129106910|NCT00436826|464686710|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
129106911|NCT00436826|464686711|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
129106912|NCT00436826|464686712|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
129106913|NCT00436826|464686713|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
129106914|NCT00436826|464686714|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
129106915|NCT00436826|464686709|FG000|Double Blind Period (DBP)|Other|10|||
129106916|NCT00436826|464686710|FG001|Double Blind Period (DBP)|Other|11|||
129106917|NCT00436826|464686711|FG002|Double Blind Period (DBP)|Other|0|||
129106918|NCT00436826|464686712|FG003|Double Blind Period (DBP)|Other|0|||
129106919|NCT00436826|464686713|FG004|Double Blind Period (DBP)|Other|0|||
129106920|NCT00436826|464686714|FG005|Double Blind Period (DBP)|Other|0|||
129106921|NCT00436826|464686709|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129106922|NCT00436826|464686710|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129106923|NCT00436826|464686711|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129106924|NCT00436826|464686712|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
129106925|NCT00436826|464686713|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129106926|NCT00436826|464686714|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129106927|NCT00436826|464686709|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129106928|NCT00436826|464686710|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129106929|NCT00436826|464686711|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
129106930|NCT00436826|464686712|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
129215098|NCT02760498|465089439|FG003|Overall Study|Not treated|0|||
129106931|NCT00436826|464686713|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129106932|NCT00436826|464686714|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129106933|NCT00436826|464686709|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129106934|NCT00436826|464686710|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129106935|NCT00436826|464686711|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129106936|NCT00436826|464686712|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129215099|NCT02760498|465089440|FG004|Overall Study|Not treated|0|||
128683239|NCT01856023|463138796|FG000|Overall Study|non compliance, study closure|1|||
128683240|NCT01856023|463138797|FG001|Overall Study|non compliance, study closure|3|||
128683241|NCT01856023|463138796|FG000|Overall Study|Withdrawal by Subject|1|||
128683242|NCT01856023|463138797|FG001|Overall Study|Withdrawal by Subject|1|||
128683243|NCT00829283|463138800|FG000|Overall Study|Lost to Follow-up|7|||
128683244|NCT00829283|463138801|FG001|Overall Study|Lost to Follow-up|25|||
128683245|NCT02632838|463138805|FG000|Overall Study|Withdrawal by Subject|3|||
128683246|NCT02632838|463138806|FG001|Overall Study|Withdrawal by Subject|0|||
128683247|NCT02632838|463138805|FG000|Overall Study|Lost to Follow-up|0|||
128683248|NCT02632838|463138806|FG001|Overall Study|Lost to Follow-up|2|||
129018684|NCT02335658|464363699|FG000|Overall Study|Adverse Event|18|||
129018685|NCT02335658|464363700|FG001|Overall Study|Adverse Event|12|||
129018686|NCT02335658|464363699|FG000|Overall Study|Lack of Efficacy|4|||
129018687|NCT02335658|464363700|FG001|Overall Study|Lack of Efficacy|5|||
129018688|NCT02335658|464363699|FG000|Overall Study|Pregnancy|1|||
129018689|NCT02335658|464363700|FG001|Overall Study|Pregnancy|0|||
129018690|NCT02335658|464363699|FG000|Overall Study|Withdrawal by Subject|13|||
129018691|NCT02335658|464363700|FG001|Overall Study|Withdrawal by Subject|21|||
129018692|NCT02335658|464363699|FG000|Overall Study|non-compliance|2|||
129018693|NCT02335658|464363700|FG001|Overall Study|non-compliance|3|||
129018694|NCT02335658|464363699|FG000|Overall Study|other reason|2|||
129018695|NCT02335658|464363700|FG001|Overall Study|other reason|3|||
129018696|NCT02305758|464363701|FG000|Overall Study|Death|27|||
129018697|NCT02305758|464363702|FG001|Overall Study|Death|27|||
129018698|NCT02305758|464363701|FG000|Overall Study|Withdrew consent|9|||
129018699|NCT02305758|464363702|FG001|Overall Study|Withdrew consent|2|||
129018700|NCT02305758|464363701|FG000|Overall Study|Lost to Follow-up|6|||
129018701|NCT02305758|464363702|FG001|Overall Study|Lost to Follow-up|1|||
129018702|NCT02305758|464363701|FG000|Overall Study|Study Terminated by Sponsor|21|||
129018703|NCT02305758|464363702|FG001|Overall Study|Study Terminated by Sponsor|34|||
129018704|NCT02305758|464363701|FG000|Overall Study|Other, not specified|2|||
129018705|NCT02305758|464363702|FG001|Overall Study|Other, not specified|1|||
129018706|NCT02032888|464363705|FG000|Treatment Period|Poor compliance/noncompliance|1|||
129018707|NCT02032888|464363706|FG001|Treatment Period|Poor compliance/noncompliance|1|||
129018708|NCT02032888|464363707|FG002|Treatment Period|Poor compliance/noncompliance|0|||
129018709|NCT02032888|464363705|FG000|Treatment Period|Other|1|||
129018710|NCT02032888|464363706|FG001|Treatment Period|Other|1|||
129018711|NCT02032888|464363707|FG002|Treatment Period|Other|0|||
129018712|NCT02032888|464363705|FG000|Follow-up Period|Lost to Follow-up|1|||
129018713|NCT02032888|464363706|FG001|Follow-up Period|Lost to Follow-up|1|||
129018714|NCT02032888|464363707|FG002|Follow-up Period|Lost to Follow-up|0|||
129018715|NCT02032888|464363705|FG000|Follow-up Period|Death|1|||
129018716|NCT02032888|464363706|FG001|Follow-up Period|Death|1|||
129018717|NCT02032888|464363707|FG002|Follow-up Period|Death|0|||
129018718|NCT02032888|464363705|FG000|Follow-up Period|Other|1|||
129018719|NCT02032888|464363706|FG001|Follow-up Period|Other|0|||
129018720|NCT02032888|464363707|FG002|Follow-up Period|Other|0|||
129018721|NCT03616106|464363710|FG000|Overall Study|Removed by PI|6|||
129018722|NCT03616106|464363711|FG001|Overall Study|Removed by PI|0|||
129018723|NCT03616106|464363710|FG000|Overall Study|Withdrawal by Subject|1|||
129018724|NCT03616106|464363711|FG001|Overall Study|Withdrawal by Subject|1|||
129018725|NCT03616106|464363710|FG000|Overall Study|Lost to Follow-up|7|||
129018726|NCT03616106|464363711|FG001|Overall Study|Lost to Follow-up|0|||
129018727|NCT03206177|464363712|FG000|Overall Study|Withdrawal by Subject|1|||
129018728|NCT03041025|464363713|FG000|Overall Study|Adverse Event|0|||
129018729|NCT03041025|464363714|FG001|Overall Study|Adverse Event|0|||
129018730|NCT03041025|464363715|FG002|Overall Study|Adverse Event|1|||
129018731|NCT03041025|464363713|FG000|Overall Study|Lost to Follow-up|1|||
129018732|NCT03041025|464363714|FG001|Overall Study|Lost to Follow-up|0|||
129018733|NCT03041025|464363715|FG002|Overall Study|Lost to Follow-up|0|||
129018734|NCT03041025|464363713|FG000|Overall Study|Withdrawal by Subject|0|||
129018735|NCT03041025|464363714|FG001|Overall Study|Withdrawal by Subject|0|||
129018736|NCT03041025|464363715|FG002|Overall Study|Withdrawal by Subject|1|||
129018737|NCT02963259|464363716|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
129018738|NCT02963259|464363716|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
129018739|NCT02963259|464363716|FG000|Overall Study|Death|1|||
129018740|NCT02963259|464363716|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
129018741|NCT04611789|464363718|FG000|Overall Study|Lost to Follow-up|1|||
129018742|NCT04611789|464363719|FG001|Overall Study|Lost to Follow-up|0|||
129018743|NCT04611789|464363720|FG002|Overall Study|Lost to Follow-up|0|||
129018744|NCT00727961|464363721|FG000|Overall Study|Lost to Follow-up|1|||
129018745|NCT00727961|464363721|FG000|Overall Study|Adverse Event|4|||
129018746|NCT00727961|464363721|FG000|Overall Study|Patient's refusal|2|||
129018747|NCT00727961|464363721|FG000|Overall Study|Progression|30|||
129018748|NCT02655679|464363724|FG000|Overall Study|Adverse Event|0|||
129018749|NCT02655679|464363725|FG001|Overall Study|Adverse Event|1|||
128683249|NCT03783702|463138809|FG000|Overall Study|Lost to Follow-up|6|||
129018750|NCT02655679|464363726|FG002|Overall Study|Adverse Event|0|||
129018751|NCT02655679|464363727|FG003|Overall Study|Adverse Event|0|||
128882321|NCT00427895|463863301|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
128882322|NCT00427895|463863302|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
128882323|NCT00427895|463863303|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
128882324|NCT00427895|463863296|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
128882325|NCT00427895|463863297|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
128882326|NCT00427895|463863298|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
128882327|NCT00427895|463863299|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
128882328|NCT00427895|463863300|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
128882329|NCT00427895|463863301|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
128882330|NCT00427895|463863302|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
128882331|NCT00427895|463863303|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
128882332|NCT00427895|463863296|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
128882333|NCT00427895|463863297|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
128882334|NCT00427895|463863298|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
128882335|NCT00427895|463863299|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
128882336|NCT00427895|463863300|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
128882337|NCT00427895|463863301|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
128882338|NCT00427895|463863302|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
128882339|NCT00427895|463863303|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
128882340|NCT00427895|463863296|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
128882341|NCT00427895|463863297|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
128882342|NCT00427895|463863298|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
128882343|NCT00427895|463863299|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
128882344|NCT00427895|463863300|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
128882345|NCT00427895|463863301|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
128882346|NCT00427895|463863302|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
128882347|NCT00427895|463863303|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
128882348|NCT00427895|463863296|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
128882349|NCT00427895|463863297|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129018752|NCT02655679|464363728|FG004|Overall Study|Adverse Event|0|||
129018753|NCT02655679|464363724|FG000|Overall Study|Withdrawal by Subject|1|||
129018754|NCT02655679|464363725|FG001|Overall Study|Withdrawal by Subject|1|||
129018755|NCT02655679|464363726|FG002|Overall Study|Withdrawal by Subject|0|||
129018756|NCT02655679|464363727|FG003|Overall Study|Withdrawal by Subject|3|||
129018757|NCT02655679|464363728|FG004|Overall Study|Withdrawal by Subject|1|||
129018758|NCT02655679|464363724|FG000|Overall Study|Inability to Comply with the Protocol|1|||
129018759|NCT02655679|464363725|FG001|Overall Study|Inability to Comply with the Protocol|0|||
129018760|NCT02655679|464363726|FG002|Overall Study|Inability to Comply with the Protocol|0|||
129018761|NCT02655679|464363727|FG003|Overall Study|Inability to Comply with the Protocol|0|||
129018762|NCT02655679|464363728|FG004|Overall Study|Inability to Comply with the Protocol|0|||
129018763|NCT02655679|464363724|FG000|Overall Study|Lost to Follow-up|0|||
129018764|NCT02655679|464363725|FG001|Overall Study|Lost to Follow-up|1|||
129018765|NCT02655679|464363726|FG002|Overall Study|Lost to Follow-up|1|||
129018766|NCT02655679|464363727|FG003|Overall Study|Lost to Follow-up|1|||
129018767|NCT02655679|464363728|FG004|Overall Study|Lost to Follow-up|0|||
128882350|NCT00427895|463863298|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
128882351|NCT00427895|463863299|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
128882352|NCT00427895|463863300|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
128882353|NCT00427895|463863301|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
128882354|NCT00427895|463863302|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
128882355|NCT00427895|463863303|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
128882356|NCT00427895|463863296|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
128882357|NCT00427895|463863297|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
128882358|NCT00427895|463863298|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
128882359|NCT00427895|463863299|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
128882360|NCT00427895|463863300|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
128882361|NCT00427895|463863301|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
128882362|NCT00427895|463863302|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
128882363|NCT00427895|463863303|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
128882364|NCT00427895|463863296|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
128882365|NCT00427895|463863297|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
128882366|NCT00427895|463863298|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
128882367|NCT00427895|463863299|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
128882368|NCT00427895|463863300|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
128882369|NCT00427895|463863301|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
128882370|NCT00427895|463863302|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
128882371|NCT00427895|463863303|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
128882372|NCT00427895|463863296|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129215100|NCT02760498|465089441|FG005|Overall Study|Not treated|2|||
128683250|NCT03783702|463138810|FG001|Overall Study|Lost to Follow-up|8|||
128683251|NCT03783702|463138809|FG000|Overall Study|Protocol Violation|1|||
128882373|NCT00427895|463863297|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
128882374|NCT00427895|463863298|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
128882375|NCT00427895|463863299|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
128882376|NCT00427895|463863300|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
128882377|NCT00427895|463863301|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
128882378|NCT00427895|463863302|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
128882379|NCT00427895|463863303|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
128882380|NCT00427895|463863296|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
128683252|NCT03783702|463138810|FG001|Overall Study|Protocol Violation|3|||
128683253|NCT02274038|463138811|FG000|Overall Study|Death|1|||
128683254|NCT00321893|463138813|FG000|Overall Study|Non-Compliance/Refusal|16|||
128683255|NCT00321893|463138814|FG001|Overall Study|Non-Compliance/Refusal|10|||
128683256|NCT00321893|463138813|FG000|Overall Study|Lost to Follow-up|2|||
128683257|NCT00321893|463138814|FG001|Overall Study|Lost to Follow-up|1|||
128683258|NCT00321893|463138813|FG000|Overall Study|Adverse Event|6|||
128683259|NCT00321893|463138814|FG001|Overall Study|Adverse Event|3|||
128683260|NCT00769483|463138815|FG000|Overall Study|Withdrawal by Subject|0|||
128683261|NCT00769483|463138816|FG001|Overall Study|Withdrawal by Subject|1|||
128882381|NCT00427895|463863297|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
128882382|NCT00427895|463863298|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
128882383|NCT00427895|463863299|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
128882384|NCT00427895|463863300|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
128882385|NCT00427895|463863301|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
128882386|NCT00427895|463863302|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
128882387|NCT00427895|463863303|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
128882388|NCT00427895|463863296|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
128882389|NCT00427895|463863297|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
128882390|NCT00427895|463863298|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
128882391|NCT00427895|463863299|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
128882392|NCT00427895|463863300|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
128882393|NCT00427895|463863301|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129018768|NCT02655679|464363724|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129018769|NCT02655679|464363725|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129018770|NCT02655679|464363726|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129018771|NCT02655679|464363727|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129018772|NCT02655679|464363728|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129018773|NCT01577381|464363729|FG000|Overall Study|Discontinued|2|||
129018774|NCT01577381|464363730|FG001|Overall Study|Discontinued|1|||
129018775|NCT01577381|464363731|FG002|Overall Study|Discontinued|2|||
129018776|NCT01577381|464363732|FG003|Overall Study|Discontinued|2|||
129018777|NCT01577381|464363729|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
129018778|NCT01577381|464363730|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
129018779|NCT01577381|464363731|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
129018780|NCT01577381|464363732|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
129018781|NCT01421277|464363733|FG000|Overall Study|Lack of qualifying event|0|||
129018782|NCT01421277|464363734|FG001|Overall Study|Lack of qualifying event|61|||
129018783|NCT01421277|464363733|FG000|Overall Study|Incomplete baseline data|0|||
129018784|NCT01421277|464363734|FG001|Overall Study|Incomplete baseline data|31|||
129018785|NCT02186821|464363735|FG000|Overall Study|Adverse Event|9|||
129018786|NCT02186821|464363735|FG000|Overall Study|Death|2|||
129018787|NCT02186821|464363735|FG000|Overall Study|Disease progression|32|||
129018788|NCT02186821|464363735|FG000|Overall Study|Protocol Violation|1|||
129018789|NCT02186821|464363735|FG000|Overall Study|Physician Decision|1|||
129018790|NCT02186821|464363735|FG000|Overall Study|Study terminated by sponsor|2|||
129018791|NCT00819741|464363742|FG000|Overall Study|Adverse Event|5|||
129018792|NCT00819741|464363743|FG001|Overall Study|Adverse Event|2|||
129018793|NCT00819741|464363742|FG000|Overall Study|Lack of Efficacy|0|||
129018794|NCT00819741|464363743|FG001|Overall Study|Lack of Efficacy|2|||
129018795|NCT00819741|464363742|FG000|Overall Study|Lost to Follow-up|3|||
129018796|NCT00819741|464363743|FG001|Overall Study|Lost to Follow-up|1|||
129018797|NCT00819741|464363742|FG000|Overall Study|Protocol Violation|3|||
129018798|NCT00819741|464363743|FG001|Overall Study|Protocol Violation|4|||
129018799|NCT00819741|464363742|FG000|Overall Study|Withdrawal by Subject|2|||
128683262|NCT00769483|463138817|FG002|Overall Study|Withdrawal by Subject|0|||
128683263|NCT00769483|463138818|FG003|Overall Study|Withdrawal by Subject|0|||
128882394|NCT00427895|463863302|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
128882395|NCT00427895|463863303|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
128882396|NCT00427895|463863296|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
128882397|NCT00427895|463863297|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
129018800|NCT00819741|464363743|FG001|Overall Study|Withdrawal by Subject|2|||
129018801|NCT00819741|464363742|FG000|Overall Study|Unclassified|6|||
129018802|NCT00819741|464363743|FG001|Overall Study|Unclassified|0|||
129018803|NCT00819741|464363742|FG000|Overall Study|Reasons unknown|3|||
129018804|NCT00819741|464363743|FG001|Overall Study|Reasons unknown|3|||
129018805|NCT00119015|464363744|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
129018806|NCT00119015|464363745|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
129018807|NCT00119015|464363746|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
129018808|NCT01597245|464363747|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
129018809|NCT01597245|464363748|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
129018810|NCT01597245|464363749|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
129018811|NCT01597245|464363750|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
129018812|NCT01597245|464363751|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018813|NCT01597245|464363752|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018814|NCT01597245|464363753|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018815|NCT01597245|464363754|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018816|NCT01597245|464363755|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018817|NCT01597245|464363756|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018818|NCT01597245|464363757|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018819|NCT01597245|464363758|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018820|NCT01597245|464363759|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018821|NCT01597245|464363760|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018822|NCT01597245|464363761|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018823|NCT01597245|464363762|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018824|NCT01597245|464363763|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018825|NCT01597245|464363764|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018826|NCT01597245|464363765|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018827|NCT01597245|464363766|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018828|NCT01597245|464363767|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129018829|NCT01597245|464363747|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
129018830|NCT01597245|464363748|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
129018831|NCT01597245|464363749|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
129018832|NCT01597245|464363750|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
129018833|NCT01597245|464363751|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018834|NCT01597245|464363752|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018835|NCT01597245|464363753|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018836|NCT01597245|464363754|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018837|NCT01597245|464363755|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018838|NCT01597245|464363756|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018839|NCT01597245|464363757|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018840|NCT01597245|464363758|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018841|NCT01597245|464363759|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018842|NCT01597245|464363760|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018843|NCT01597245|464363761|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018844|NCT01597245|464363762|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018845|NCT01597245|464363763|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018846|NCT01597245|464363764|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018847|NCT01597245|464363765|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018848|NCT01597245|464363766|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018849|NCT01597245|464363767|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129018850|NCT01597245|464363747|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
129018851|NCT01597245|464363748|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
129018852|NCT01597245|464363749|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
129018853|NCT01597245|464363750|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
129018854|NCT01597245|464363751|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018855|NCT01597245|464363752|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018856|NCT01597245|464363753|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018857|NCT01597245|464363754|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018858|NCT01597245|464363755|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018859|NCT01597245|464363756|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018860|NCT01597245|464363757|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018861|NCT01597245|464363758|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018862|NCT01597245|464363759|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018863|NCT01597245|464363760|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018864|NCT01597245|464363761|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018865|NCT01597245|464363762|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018866|NCT01597245|464363763|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018867|NCT01597245|464363764|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018868|NCT01597245|464363765|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018869|NCT01597245|464363766|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018870|NCT01597245|464363767|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129018871|NCT01597245|464363747|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
128683264|NCT00769483|463138819|FG004|Overall Study|Withdrawal by Subject|1|||
128882398|NCT00427895|463863298|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
128882399|NCT00427895|463863299|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
128882400|NCT00427895|463863300|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
128882401|NCT00427895|463863301|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
128882402|NCT00427895|463863302|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
128882403|NCT00427895|463863303|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
128882404|NCT00427895|463863296|FG000|Vax 1/Year 1 Follow-up|Death|1|||
128882405|NCT00427895|463863297|FG001|Vax 1/Year 1 Follow-up|Death|0|||
128882406|NCT00427895|463863298|FG002|Vax 1/Year 1 Follow-up|Death|0|||
128882407|NCT00427895|463863299|FG003|Vax 1/Year 1 Follow-up|Death|0|||
128882408|NCT00427895|463863300|FG004|Vax 1/Year 1 Follow-up|Death|0|||
128882409|NCT00427895|463863301|FG005|Vax 1/Year 1 Follow-up|Death|0|||
128882410|NCT00427895|463863302|FG006|Vax 1/Year 1 Follow-up|Death|0|||
128882411|NCT00427895|463863303|FG007|Vax 1/Year 1 Follow-up|Death|0|||
128882412|NCT00427895|463863296|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
128882413|NCT00427895|463863297|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
128882414|NCT00427895|463863298|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
128882415|NCT00427895|463863299|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
128882416|NCT00427895|463863300|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
128882417|NCT00427895|463863301|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
128882418|NCT00427895|463863302|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
128882419|NCT00427895|463863303|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
128882420|NCT00427895|463863296|FG000|Vax 1/Year 1 Follow-up|Other|0|||
128882421|NCT00427895|463863297|FG001|Vax 1/Year 1 Follow-up|Other|0|||
128882422|NCT00427895|463863298|FG002|Vax 1/Year 1 Follow-up|Other|0|||
128882423|NCT00427895|463863299|FG003|Vax 1/Year 1 Follow-up|Other|2|||
128882424|NCT00427895|463863300|FG004|Vax 1/Year 1 Follow-up|Other|0|||
128882425|NCT00427895|463863301|FG005|Vax 1/Year 1 Follow-up|Other|0|||
128882426|NCT00427895|463863302|FG006|Vax 1/Year 1 Follow-up|Other|0|||
128882427|NCT00427895|463863303|FG007|Vax 1/Year 1 Follow-up|Other|0|||
128882428|NCT00427895|463863296|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
128882429|NCT00427895|463863297|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
128882430|NCT00427895|463863298|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
128882431|NCT00427895|463863299|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
128882432|NCT00427895|463863300|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
128882433|NCT00427895|463863301|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
128882434|NCT00427895|463863302|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
128882435|NCT00427895|463863303|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
128882436|NCT00585195|463863306|FG000|Overall Study|Adverse Event|0|||
128882437|NCT00585195|463863307|FG001|Overall Study|Adverse Event|0|||
128882438|NCT00585195|463863308|FG002|Overall Study|Adverse Event|0|||
128882439|NCT00585195|463863309|FG003|Overall Study|Adverse Event|0|||
128882440|NCT00585195|463863310|FG004|Overall Study|Adverse Event|2|||
128882441|NCT00585195|463863311|FG005|Overall Study|Adverse Event|1|||
128882442|NCT00585195|463863312|FG006|Overall Study|Adverse Event|0|||
128882443|NCT00585195|463863313|FG007|Overall Study|Adverse Event|1|||
128882444|NCT00585195|463863314|FG008|Overall Study|Adverse Event|0|||
128882445|NCT00585195|463863315|FG009|Overall Study|Adverse Event|0|||
128882446|NCT00585195|463863316|FG010|Overall Study|Adverse Event|3|||
128882447|NCT00585195|463863317|FG011|Overall Study|Adverse Event|0|||
128882448|NCT00585195|463863318|FG012|Overall Study|Adverse Event|8|||
128882449|NCT00585195|463863319|FG013|Overall Study|Adverse Event|6|||
128882450|NCT00585195|463863320|FG014|Overall Study|Adverse Event|4|||
128882451|NCT00585195|463863321|FG015|Overall Study|Adverse Event|1|||
128882452|NCT00585195|463863322|FG016|Overall Study|Adverse Event|14|||
128882453|NCT00585195|463863323|FG017|Overall Study|Adverse Event|9|||
128882454|NCT00585195|463863324|FG018|Overall Study|Adverse Event|2|||
128882455|NCT00585195|463863325|FG019|Overall Study|Adverse Event|3|||
128882456|NCT00585195|463863326|FG020|Overall Study|Adverse Event|1|||
128882457|NCT00585195|463863306|FG000|Overall Study|Progressive Disease|2|||
128882458|NCT00585195|463863307|FG001|Overall Study|Progressive Disease|2|||
128882459|NCT00585195|463863308|FG002|Overall Study|Progressive Disease|5|||
128882460|NCT00585195|463863309|FG003|Overall Study|Progressive Disease|4|||
128882461|NCT00585195|463863310|FG004|Overall Study|Progressive Disease|6|||
128882462|NCT00585195|463863311|FG005|Overall Study|Progressive Disease|4|||
128882463|NCT00585195|463863312|FG006|Overall Study|Progressive Disease|6|||
128882464|NCT00585195|463863313|FG007|Overall Study|Progressive Disease|3|||
128882465|NCT00585195|463863314|FG008|Overall Study|Progressive Disease|0|||
128882466|NCT00585195|463863315|FG009|Overall Study|Progressive Disease|5|||
128882467|NCT00585195|463863316|FG010|Overall Study|Progressive Disease|2|||
128882468|NCT00585195|463863317|FG011|Overall Study|Progressive Disease|25|||
128882469|NCT00585195|463863318|FG012|Overall Study|Progressive Disease|29|||
128882470|NCT00585195|463863319|FG013|Overall Study|Progressive Disease|26|||
128882471|NCT00585195|463863320|FG014|Overall Study|Progressive Disease|21|||
128882472|NCT00585195|463863321|FG015|Overall Study|Progressive Disease|12|||
128882473|NCT00585195|463863322|FG016|Overall Study|Progressive Disease|94|||
128882474|NCT00585195|463863323|FG017|Overall Study|Progressive Disease|42|||
129018872|NCT01597245|464363748|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
129018873|NCT01597245|464363749|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
129018874|NCT01597245|464363750|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018875|NCT01597245|464363751|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018876|NCT01597245|464363752|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018877|NCT01597245|464363753|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018878|NCT01597245|464363754|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018879|NCT01597245|464363755|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018880|NCT01597245|464363756|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018881|NCT01597245|464363757|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018882|NCT01597245|464363758|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018883|NCT01597245|464363759|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018884|NCT01597245|464363760|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018885|NCT01597245|464363761|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018886|NCT01597245|464363762|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018887|NCT01597245|464363763|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018888|NCT01597245|464363764|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018889|NCT01597245|464363765|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018890|NCT01597245|464363766|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018891|NCT01597245|464363767|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129018892|NCT01597245|464363747|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
129018893|NCT01597245|464363748|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018894|NCT01597245|464363749|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018895|NCT01597245|464363750|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
129018896|NCT01597245|464363751|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018897|NCT01597245|464363752|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018898|NCT01597245|464363753|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018899|NCT01597245|464363754|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018900|NCT01597245|464363755|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018901|NCT01597245|464363756|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018902|NCT01597245|464363757|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018903|NCT01597245|464363758|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018904|NCT01597245|464363759|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018905|NCT01597245|464363760|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018906|NCT01597245|464363761|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018907|NCT01597245|464363762|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018908|NCT01597245|464363763|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018909|NCT01597245|464363764|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018910|NCT01597245|464363765|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018911|NCT01597245|464363766|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018912|NCT01597245|464363767|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129018913|NCT01597245|464363747|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
129018914|NCT01597245|464363748|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
129018915|NCT01597245|464363749|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
129018916|NCT01597245|464363750|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018917|NCT01597245|464363751|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018918|NCT01597245|464363752|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018919|NCT01597245|464363753|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018920|NCT01597245|464363754|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018921|NCT01597245|464363755|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018922|NCT01597245|464363756|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018923|NCT01597245|464363757|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018924|NCT01597245|464363758|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018925|NCT01597245|464363759|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018926|NCT01597245|464363760|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018927|NCT01597245|464363761|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018928|NCT01597245|464363762|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018929|NCT01597245|464363763|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018930|NCT01597245|464363764|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018931|NCT01597245|464363765|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018932|NCT01597245|464363766|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018933|NCT01597245|464363767|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129018934|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018935|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018936|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
128882475|NCT00585195|463863324|FG018|Overall Study|Progressive Disease|4|||
128882476|NCT00585195|463863325|FG019|Overall Study|Progressive Disease|9|||
128882477|NCT00585195|463863326|FG020|Overall Study|Progressive Disease|8|||
128882478|NCT00585195|463863306|FG000|Overall Study|Withdrawal by Subject|1|||
128882479|NCT00585195|463863307|FG001|Overall Study|Withdrawal by Subject|1|||
128882480|NCT00585195|463863308|FG002|Overall Study|Withdrawal by Subject|2|||
128882481|NCT00585195|463863309|FG003|Overall Study|Withdrawal by Subject|2|||
128882482|NCT00585195|463863310|FG004|Overall Study|Withdrawal by Subject|0|||
128882483|NCT00585195|463863311|FG005|Overall Study|Withdrawal by Subject|0|||
128882484|NCT00585195|463863312|FG006|Overall Study|Withdrawal by Subject|0|||
128882485|NCT00585195|463863313|FG007|Overall Study|Withdrawal by Subject|1|||
128882486|NCT00585195|463863314|FG008|Overall Study|Withdrawal by Subject|0|||
128882487|NCT00585195|463863315|FG009|Overall Study|Withdrawal by Subject|0|||
128882488|NCT00585195|463863316|FG010|Overall Study|Withdrawal by Subject|3|||
128882489|NCT00585195|463863317|FG011|Overall Study|Withdrawal by Subject|8|||
128882490|NCT00585195|463863318|FG012|Overall Study|Withdrawal by Subject|15|||
128882491|NCT00585195|463863319|FG013|Overall Study|Withdrawal by Subject|0|||
128882492|NCT00585195|463863320|FG014|Overall Study|Withdrawal by Subject|3|||
128882493|NCT00585195|463863321|FG015|Overall Study|Withdrawal by Subject|0|||
128882494|NCT00585195|463863322|FG016|Overall Study|Withdrawal by Subject|7|||
128882495|NCT00585195|463863323|FG017|Overall Study|Withdrawal by Subject|1|||
128882496|NCT00585195|463863324|FG018|Overall Study|Withdrawal by Subject|2|||
128882497|NCT00585195|463863325|FG019|Overall Study|Withdrawal by Subject|2|||
128882498|NCT00585195|463863326|FG020|Overall Study|Withdrawal by Subject|0|||
128882499|NCT00585195|463863306|FG000|Overall Study|Other|0|||
128882500|NCT00585195|463863307|FG001|Overall Study|Other|1|||
128882501|NCT00585195|463863308|FG002|Overall Study|Other|1|||
128882502|NCT00585195|463863309|FG003|Overall Study|Other|1|||
128882503|NCT00585195|463863310|FG004|Overall Study|Other|0|||
128882504|NCT00585195|463863311|FG005|Overall Study|Other|1|||
128882505|NCT00585195|463863312|FG006|Overall Study|Other|0|||
128882506|NCT00585195|463863313|FG007|Overall Study|Other|0|||
128882507|NCT00585195|463863314|FG008|Overall Study|Other|2|||
128882508|NCT00585195|463863315|FG009|Overall Study|Other|1|||
128882509|NCT00585195|463863316|FG010|Overall Study|Other|0|||
128882510|NCT00585195|463863317|FG011|Overall Study|Other|19|||
128882511|NCT00585195|463863318|FG012|Overall Study|Other|24|||
128882512|NCT00585195|463863319|FG013|Overall Study|Other|7|||
128882513|NCT00585195|463863320|FG014|Overall Study|Other|11|||
128882514|NCT00585195|463863321|FG015|Overall Study|Other|3|||
128882515|NCT00585195|463863322|FG016|Overall Study|Other|28|||
128882516|NCT00585195|463863323|FG017|Overall Study|Other|12|||
128882517|NCT00585195|463863324|FG018|Overall Study|Other|10|||
128882518|NCT00585195|463863325|FG019|Overall Study|Other|4|||
128882519|NCT00585195|463863326|FG020|Overall Study|Other|2|||
128882520|NCT00585195|463863306|FG000|Overall Study|Randomized not treated|0|||
128882521|NCT00585195|463863307|FG001|Overall Study|Randomized not treated|0|||
128882522|NCT00585195|463863308|FG002|Overall Study|Randomized not treated|1|||
128882523|NCT00585195|463863309|FG003|Overall Study|Randomized not treated|0|||
128882524|NCT00585195|463863310|FG004|Overall Study|Randomized not treated|1|||
128882525|NCT00585195|463863311|FG005|Overall Study|Randomized not treated|0|||
128882526|NCT00585195|463863312|FG006|Overall Study|Randomized not treated|1|||
128882527|NCT00585195|463863313|FG007|Overall Study|Randomized not treated|0|||
128882528|NCT00585195|463863314|FG008|Overall Study|Randomized not treated|0|||
128882529|NCT00585195|463863315|FG009|Overall Study|Randomized not treated|0|||
128882530|NCT00585195|463863316|FG010|Overall Study|Randomized not treated|2|||
128882531|NCT00585195|463863317|FG011|Overall Study|Randomized not treated|0|||
128882532|NCT00585195|463863318|FG012|Overall Study|Randomized not treated|0|||
128882533|NCT00585195|463863319|FG013|Overall Study|Randomized not treated|0|||
128882534|NCT00585195|463863320|FG014|Overall Study|Randomized not treated|0|||
128882535|NCT00585195|463863321|FG015|Overall Study|Randomized not treated|1|||
128882536|NCT00585195|463863322|FG016|Overall Study|Randomized not treated|0|||
128882537|NCT00585195|463863323|FG017|Overall Study|Randomized not treated|1|||
128882538|NCT00585195|463863324|FG018|Overall Study|Randomized not treated|3|||
128882539|NCT00585195|463863325|FG019|Overall Study|Randomized not treated|0|||
128882540|NCT00585195|463863326|FG020|Overall Study|Randomized not treated|2|||
128882541|NCT00585195|463863306|FG000|Overall Study|Death|0|||
128882542|NCT00585195|463863307|FG001|Overall Study|Death|0|||
128882543|NCT00585195|463863308|FG002|Overall Study|Death|0|||
128882544|NCT00585195|463863309|FG003|Overall Study|Death|0|||
128882545|NCT00585195|463863310|FG004|Overall Study|Death|0|||
128882546|NCT00585195|463863311|FG005|Overall Study|Death|0|||
128882547|NCT00585195|463863312|FG006|Overall Study|Death|0|||
128882548|NCT00585195|463863313|FG007|Overall Study|Death|0|||
128882549|NCT00585195|463863314|FG008|Overall Study|Death|1|||
128882550|NCT00585195|463863315|FG009|Overall Study|Death|0|||
128882551|NCT00585195|463863316|FG010|Overall Study|Death|1|||
128882552|NCT00585195|463863317|FG011|Overall Study|Death|1|||
128882553|NCT00585195|463863318|FG012|Overall Study|Death|7|||
128882554|NCT00585195|463863319|FG013|Overall Study|Death|2|||
128882555|NCT00585195|463863320|FG014|Overall Study|Death|8|||
128882556|NCT00585195|463863321|FG015|Overall Study|Death|2|||
128882557|NCT00585195|463863322|FG016|Overall Study|Death|11|||
128882558|NCT00585195|463863323|FG017|Overall Study|Death|0|||
128882559|NCT00585195|463863324|FG018|Overall Study|Death|0|||
128882560|NCT00585195|463863325|FG019|Overall Study|Death|0|||
128882561|NCT00585195|463863326|FG020|Overall Study|Death|1|||
128882562|NCT00585195|463863306|FG000|Overall Study|Lost to Follow-up|0|||
128882563|NCT00585195|463863307|FG001|Overall Study|Lost to Follow-up|0|||
128882564|NCT00585195|463863308|FG002|Overall Study|Lost to Follow-up|0|||
128882565|NCT00585195|463863309|FG003|Overall Study|Lost to Follow-up|0|||
129106937|NCT00436826|464686713|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
129106938|NCT00436826|464686714|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
129106939|NCT00784719|464686715|FG000|Overall Study|Adverse Event|0|||
129106940|NCT00784719|464686716|FG001|Overall Study|Adverse Event|2|||
129106941|NCT00784719|464686717|FG002|Overall Study|Adverse Event|0|||
129106942|NCT00784719|464686718|FG003|Overall Study|Adverse Event|0|||
129106943|NCT00784719|464686719|FG004|Overall Study|Adverse Event|1|||
129106944|NCT00784719|464686720|FG005|Overall Study|Adverse Event|1|||
129106945|NCT00784719|464686721|FG006|Overall Study|Adverse Event|1|||
129106946|NCT00784719|464686715|FG000|Overall Study|Lost to Follow-up|0|||
129106947|NCT00784719|464686716|FG001|Overall Study|Lost to Follow-up|0|||
129106948|NCT00784719|464686717|FG002|Overall Study|Lost to Follow-up|0|||
129106949|NCT00784719|464686718|FG003|Overall Study|Lost to Follow-up|0|||
129106950|NCT00784719|464686719|FG004|Overall Study|Lost to Follow-up|1|||
129106951|NCT00784719|464686720|FG005|Overall Study|Lost to Follow-up|1|||
129106952|NCT00784719|464686721|FG006|Overall Study|Lost to Follow-up|0|||
129106953|NCT00784719|464686715|FG000|Overall Study|Other|2|||
129106954|NCT00784719|464686716|FG001|Overall Study|Other|1|||
129106955|NCT00784719|464686717|FG002|Overall Study|Other|1|||
129106956|NCT00784719|464686718|FG003|Overall Study|Other|0|||
129106957|NCT00784719|464686719|FG004|Overall Study|Other|2|||
129106958|NCT00784719|464686720|FG005|Overall Study|Other|1|||
129106959|NCT00784719|464686721|FG006|Overall Study|Other|3|||
129106960|NCT00784719|464686715|FG000|Overall Study|Withdrawal by Subject|1|||
129106961|NCT00784719|464686716|FG001|Overall Study|Withdrawal by Subject|0|||
129106962|NCT00784719|464686717|FG002|Overall Study|Withdrawal by Subject|0|||
129106963|NCT00784719|464686718|FG003|Overall Study|Withdrawal by Subject|0|||
129106964|NCT00784719|464686719|FG004|Overall Study|Withdrawal by Subject|2|||
129106965|NCT00784719|464686720|FG005|Overall Study|Withdrawal by Subject|0|||
129106966|NCT00784719|464686721|FG006|Overall Study|Withdrawal by Subject|1|||
129106967|NCT04978337|464686722|FG000|Overall Study|Withdrawal by Subject|0|||
129106968|NCT04978337|464686723|FG001|Overall Study|Withdrawal by Subject|1|||
129106969|NCT01408901|464686726|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
129106970|NCT01408901|464686727|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
129106971|NCT01408901|464686728|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
129106972|NCT01408901|464686729|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
129106973|NCT01408901|464686726|FG000|6-Week Follow-Up|Death|1|||
129106974|NCT01408901|464686727|FG001|6-Week Follow-Up|Death|0|||
129106975|NCT01408901|464686728|FG002|6-Week Follow-Up|Death|0|||
129106976|NCT01408901|464686729|FG003|6-Week Follow-Up|Death|0|||
129106977|NCT01408901|464686726|FG000|6-Week Follow-Up|Cancelled visit|0|||
129106978|NCT01408901|464686727|FG001|6-Week Follow-Up|Cancelled visit|1|||
129106979|NCT01408901|464686728|FG002|6-Week Follow-Up|Cancelled visit|0|||
129106980|NCT01408901|464686729|FG003|6-Week Follow-Up|Cancelled visit|2|||
129106981|NCT01408901|464686726|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
129106982|NCT01408901|464686727|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
129106983|NCT01408901|464686728|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
129106984|NCT01408901|464686729|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
129106985|NCT01408901|464686726|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
129106986|NCT01408901|464686727|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
129106987|NCT01408901|464686728|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
128882566|NCT00585195|463863310|FG004|Overall Study|Lost to Follow-up|0|||
128882567|NCT00585195|463863311|FG005|Overall Study|Lost to Follow-up|0|||
128882568|NCT00585195|463863312|FG006|Overall Study|Lost to Follow-up|0|||
129106988|NCT01408901|464686729|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
129106989|NCT01408901|464686726|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
129106990|NCT01408901|464686727|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
129106991|NCT01408901|464686728|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
129106992|NCT01408901|464686729|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
129106993|NCT01408901|464686726|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
129106994|NCT01408901|464686727|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
129106995|NCT01408901|464686728|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
129106996|NCT01408901|464686729|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
129106997|NCT01408901|464686726|FG000|26-Week Follow-Up|Death|0|||
128882569|NCT00585195|463863313|FG007|Overall Study|Lost to Follow-up|0|||
128882570|NCT00585195|463863314|FG008|Overall Study|Lost to Follow-up|0|||
128882571|NCT00585195|463863315|FG009|Overall Study|Lost to Follow-up|0|||
128882572|NCT00585195|463863316|FG010|Overall Study|Lost to Follow-up|0|||
128882573|NCT00585195|463863317|FG011|Overall Study|Lost to Follow-up|0|||
128882574|NCT00585195|463863318|FG012|Overall Study|Lost to Follow-up|1|||
128882575|NCT00585195|463863319|FG013|Overall Study|Lost to Follow-up|0|||
128882576|NCT00585195|463863320|FG014|Overall Study|Lost to Follow-up|0|||
128882577|NCT00585195|463863321|FG015|Overall Study|Lost to Follow-up|0|||
128882578|NCT00585195|463863322|FG016|Overall Study|Lost to Follow-up|0|||
128882579|NCT00585195|463863323|FG017|Overall Study|Lost to Follow-up|2|||
128882580|NCT00585195|463863324|FG018|Overall Study|Lost to Follow-up|0|||
128882581|NCT00585195|463863325|FG019|Overall Study|Lost to Follow-up|0|||
128882582|NCT00585195|463863326|FG020|Overall Study|Lost to Follow-up|0|||
128882583|NCT00585195|463863306|FG000|Overall Study|Site Terminated by Sponsor|0|||
128882584|NCT00585195|463863307|FG001|Overall Study|Site Terminated by Sponsor|0|||
128882585|NCT00585195|463863308|FG002|Overall Study|Site Terminated by Sponsor|0|||
128882586|NCT00585195|463863309|FG003|Overall Study|Site Terminated by Sponsor|0|||
128882587|NCT00585195|463863310|FG004|Overall Study|Site Terminated by Sponsor|0|||
128882588|NCT00585195|463863311|FG005|Overall Study|Site Terminated by Sponsor|0|||
128882589|NCT00585195|463863312|FG006|Overall Study|Site Terminated by Sponsor|0|||
128882590|NCT00585195|463863313|FG007|Overall Study|Site Terminated by Sponsor|0|||
128882591|NCT00585195|463863314|FG008|Overall Study|Site Terminated by Sponsor|0|||
128882592|NCT00585195|463863315|FG009|Overall Study|Site Terminated by Sponsor|0|||
128882593|NCT00585195|463863316|FG010|Overall Study|Site Terminated by Sponsor|0|||
128882594|NCT00585195|463863317|FG011|Overall Study|Site Terminated by Sponsor|0|||
128882595|NCT00585195|463863318|FG012|Overall Study|Site Terminated by Sponsor|1|||
128882596|NCT00585195|463863319|FG013|Overall Study|Site Terminated by Sponsor|0|||
128882597|NCT00585195|463863320|FG014|Overall Study|Site Terminated by Sponsor|0|||
128882598|NCT00585195|463863321|FG015|Overall Study|Site Terminated by Sponsor|0|||
128882599|NCT00585195|463863322|FG016|Overall Study|Site Terminated by Sponsor|0|||
128882600|NCT00585195|463863323|FG017|Overall Study|Site Terminated by Sponsor|0|||
128882601|NCT00585195|463863324|FG018|Overall Study|Site Terminated by Sponsor|0|||
128882602|NCT00585195|463863325|FG019|Overall Study|Site Terminated by Sponsor|0|||
128882603|NCT00585195|463863326|FG020|Overall Study|Site Terminated by Sponsor|0|||
128882604|NCT00585195|463863306|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
128882605|NCT00585195|463863307|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
128882606|NCT00585195|463863308|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
128882607|NCT00585195|463863309|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
128882608|NCT00585195|463863310|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
128882609|NCT00585195|463863311|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
128882610|NCT00585195|463863312|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
128882611|NCT00585195|463863313|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
128882612|NCT00585195|463863314|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
128882613|NCT00585195|463863315|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
128882614|NCT00585195|463863316|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
128882615|NCT00585195|463863317|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
128882616|NCT00585195|463863318|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
128882617|NCT00585195|463863319|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
128882618|NCT00585195|463863320|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
128882619|NCT00585195|463863321|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
128882620|NCT00585195|463863322|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
128882621|NCT00585195|463863323|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
128882622|NCT00585195|463863324|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
128882623|NCT00585195|463863325|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
128882624|NCT00585195|463863326|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
128882625|NCT02796560|463863327|FG000|Overall Study|Adverse Event|2|||
128882626|NCT02796560|463863328|FG001|Overall Study|Adverse Event|0|||
128882627|NCT02796560|463863327|FG000|Overall Study|Withdrawal by Subject|2|||
128882628|NCT02796560|463863328|FG001|Overall Study|Withdrawal by Subject|2|||
128882629|NCT02533570|463863330|FG000|Overall Study|Adverse Event|0|||
128882630|NCT02533570|463863331|FG001|Overall Study|Adverse Event|1|||
128882631|NCT02533570|463863332|FG002|Overall Study|Adverse Event|1|||
128882632|NCT00423930|463863333|FG000|Overall Study|Withdrawal by Subject|2|||
128882633|NCT04002401|463863334|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
128882634|NCT04002401|463863334|FG000|Overall Study|Death|10|||
128882635|NCT04002401|463863334|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
128882636|NCT04002401|463863334|FG000|Overall Study|Enrolled but Never Treated|1|||
128882637|NCT04002401|463863334|FG000|Overall Study|Lost to Follow-up|1|||
128882638|NCT01009580|463863338|FG000|Overall Study|Adverse Event|4|||
128882639|NCT01009580|463863339|FG001|Overall Study|Adverse Event|4|||
128882640|NCT01009580|463863338|FG000|Overall Study|Lack of Efficacy|0|||
128882641|NCT01009580|463863339|FG001|Overall Study|Lack of Efficacy|1|||
128882642|NCT01009580|463863338|FG000|Overall Study|Protocol Violation|2|||
128882643|NCT01009580|463863339|FG001|Overall Study|Protocol Violation|3|||
128882644|NCT01009580|463863338|FG000|Overall Study|Withdrawal Criteria|4|||
128882645|NCT01009580|463863339|FG001|Overall Study|Withdrawal Criteria|6|||
128882646|NCT01009580|463863338|FG000|Overall Study|Unclassified|17|||
128882647|NCT01009580|463863339|FG001|Overall Study|Unclassified|21|||
128882648|NCT02881957|463863344|FG000|Overall Study|Comfort care|0|||
128882649|NCT02881957|463863345|FG001|Overall Study|Comfort care|1|||
128882650|NCT02881957|463863344|FG000|Overall Study|Concurrent trial enrollment|0|||
128882651|NCT02881957|463863345|FG001|Overall Study|Concurrent trial enrollment|1|||
128882652|NCT02881957|463863344|FG000|Overall Study|Discharged within 48 hours|0|||
128882653|NCT02881957|463863345|FG001|Overall Study|Discharged within 48 hours|1|||
128882654|NCT02881957|463863344|FG000|Overall Study|Withdrawal by Subject|2|||
128882655|NCT02881957|463863345|FG001|Overall Study|Withdrawal by Subject|1|||
128882656|NCT02881957|463863344|FG000|Overall Study|Protocol Violation|1|||
128882657|NCT02881957|463863345|FG001|Overall Study|Protocol Violation|0|||
128882658|NCT05269355|463863346|FG000|Overall Study|Progressive Disease|104|||
128882659|NCT05269355|463863347|FG001|Overall Study|Progressive Disease|68|||
128882660|NCT05269355|463863346|FG000|Overall Study|Study Terminated by Sponsor|87|||
128882661|NCT05269355|463863347|FG001|Overall Study|Study Terminated by Sponsor|29|||
128882662|NCT05269355|463863346|FG000|Overall Study|Adverse Event|15|||
128882663|NCT05269355|463863347|FG001|Overall Study|Adverse Event|8|||
128882664|NCT05269355|463863346|FG000|Overall Study|Withdrawal by Subject|18|||
128882665|NCT05269355|463863347|FG001|Overall Study|Withdrawal by Subject|5|||
128882666|NCT05269355|463863346|FG000|Overall Study|Physician Decision|6|||
128882667|NCT05269355|463863347|FG001|Overall Study|Physician Decision|4|||
128882668|NCT05269355|463863346|FG000|Overall Study|Death|3|||
128882669|NCT05269355|463863347|FG001|Overall Study|Death|5|||
128882670|NCT05269355|463863346|FG000|Overall Study|Other Than Specified|5|||
128882671|NCT05269355|463863347|FG001|Overall Study|Other Than Specified|1|||
128882672|NCT05269355|463863346|FG000|Overall Study|Randomized But Not Treated|1|||
128882673|NCT05269355|463863347|FG001|Overall Study|Randomized But Not Treated|0|||
128882674|NCT00081497|463863348|FG000|Overall Study|Adverse Event|2|||
128882675|NCT00081497|463863349|FG001|Overall Study|Adverse Event|0|||
128882676|NCT00081497|463863348|FG000|Overall Study|Death|0|||
128882677|NCT00081497|463863349|FG001|Overall Study|Death|1|||
128882678|NCT00081497|463863348|FG000|Overall Study|Withdrawal by Subject|1|||
128882679|NCT00081497|463863349|FG001|Overall Study|Withdrawal by Subject|0|||
128882680|NCT00081497|463863348|FG000|Overall Study|Non-compliance|0|||
128882681|NCT00081497|463863349|FG001|Overall Study|Non-compliance|1|||
128882682|NCT01786174|463865036|FG000|Overall Study|Discontinued Study Drug|2|||
128882683|NCT01786174|463865037|FG001|Overall Study|Discontinued Study Drug|0|||
128882684|NCT01620255|463865038|FG000|Overall Study|Withdrawal by Subject|4|||
128882685|NCT01620255|463865039|FG001|Overall Study|Withdrawal by Subject|1|||
128882686|NCT01620255|463865040|FG002|Overall Study|Withdrawal by Subject|1|||
128882687|NCT01620255|463865041|FG003|Overall Study|Withdrawal by Subject|2|||
128882688|NCT01620255|463865042|FG004|Overall Study|Withdrawal by Subject|4|||
128882689|NCT01620255|463865038|FG000|Overall Study|Participant underwent fecal transplant|0|||
128882690|NCT01620255|463865039|FG001|Overall Study|Participant underwent fecal transplant|0|||
128882691|NCT01620255|463865040|FG002|Overall Study|Participant underwent fecal transplant|1|||
128882692|NCT01620255|463865041|FG003|Overall Study|Participant underwent fecal transplant|0|||
128882693|NCT01620255|463865042|FG004|Overall Study|Participant underwent fecal transplant|0|||
128882694|NCT01620255|463865038|FG000|Overall Study|Non-compliance|0|||
128882695|NCT01620255|463865039|FG001|Overall Study|Non-compliance|1|||
128882696|NCT01620255|463865040|FG002|Overall Study|Non-compliance|0|||
128882697|NCT01620255|463865041|FG003|Overall Study|Non-compliance|0|||
128882698|NCT01620255|463865042|FG004|Overall Study|Non-compliance|0|||
128882699|NCT01620255|463865038|FG000|Overall Study|Adverse Event|0|||
128882700|NCT01620255|463865039|FG001|Overall Study|Adverse Event|4|||
128882701|NCT01620255|463865040|FG002|Overall Study|Adverse Event|0|||
128882702|NCT01620255|463865041|FG003|Overall Study|Adverse Event|1|||
128882703|NCT01620255|463865042|FG004|Overall Study|Adverse Event|1|||
128882704|NCT01620255|463865038|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
128882705|NCT01620255|463865039|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
128882706|NCT01620255|463865040|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
128882707|NCT01620255|463865041|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
129106998|NCT01408901|464686727|FG001|26-Week Follow-Up|Death|1|||
129106999|NCT01408901|464686728|FG002|26-Week Follow-Up|Death|0|||
129107000|NCT01408901|464686729|FG003|26-Week Follow-Up|Death|0|||
129107001|NCT01436227|464686733|FG000|Overall Study|Adverse Event|7|||
129107002|NCT01436227|464686733|FG000|Overall Study|Death|1|||
129107003|NCT01436227|464686733|FG000|Overall Study|Lack of Efficacy|1|||
129107004|NCT01436227|464686733|FG000|Overall Study|Lost to Follow-up|3|||
129107005|NCT01436227|464686733|FG000|Overall Study|Physician Decision|1|||
128882708|NCT01620255|463865042|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
128882709|NCT01155375|463865051|FG000|Overall Study|Adverse Event|1|||
128882710|NCT01155375|463865052|FG001|Overall Study|Adverse Event|0|||
128882711|NCT01480674|463865056|FG000|Overall Study|Death|23|||
128882712|NCT01480674|463865056|FG000|Overall Study|Lost to Follow-up|2|||
129107006|NCT01436227|464686733|FG000|Overall Study|Withdrawal by Subject|7|||
128882713|NCT01480674|463865056|FG000|Overall Study|visit not done|10|||
128882714|NCT03818204|463865057|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882715|NCT03818204|463865058|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129107007|NCT01436227|464686733|FG000|Overall Study|Disease progression, relapse|6|||
129107008|NCT04004260|464686736|FG000|Overall Study|Withdrawal by Subject|7|||
128882716|NCT03818204|463865059|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882717|NCT03818204|463865060|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882718|NCT03818204|463865061|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
128882719|NCT03818204|463865062|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882720|NCT03818204|463865063|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882721|NCT03818204|463865064|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882722|NCT03818204|463865065|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882723|NCT03818204|463865066|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882724|NCT03818204|463865067|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882725|NCT03818204|463865068|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882726|NCT03818204|463865069|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882727|NCT03818204|463865070|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
128882728|NCT03818204|463865071|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129107009|NCT04004260|464686737|FG001|Overall Study|Withdrawal by Subject|3|||
129107010|NCT04004260|464686736|FG000|Overall Study|Lost to Follow-up|22|||
129107011|NCT04004260|464686737|FG001|Overall Study|Lost to Follow-up|12|||
129107012|NCT04004260|464686736|FG000|Overall Study|Did not engage in intervention|13|||
129107013|NCT04004260|464686737|FG001|Overall Study|Did not engage in intervention|17|||
129107014|NCT05464420|464686738|FG000|Overall Study|Death|0|||
129107015|NCT05464420|464686739|FG001|Overall Study|Death|0|||
129107016|NCT05464420|464686740|FG002|Overall Study|Death|0|||
128683265|NCT00769483|463138820|FG005|Overall Study|Withdrawal by Subject|0|||
128683266|NCT01306877|463138821|FG000|Overall Study|Lost to Follow-up|3|||
128683267|NCT01306877|463138822|FG001|Overall Study|Lost to Follow-up|3|||
128683268|NCT01306877|463138821|FG000|Overall Study|Physician Decision|0|||
128683269|NCT01306877|463138822|FG001|Overall Study|Physician Decision|1|||
128683270|NCT00006389|463138823|FG000|Overall Study|Adverse Event|1|||
128683271|NCT00999921|463138828|FG000|Overall Study|Lost to Follow-up|10|||
128683272|NCT00999921|463138829|FG001|Overall Study|Lost to Follow-up|19|||
128683273|NCT01076075|463138830|FG000|Overall Study|Adverse Event|3|||
128683274|NCT01076075|463138831|FG001|Overall Study|Adverse Event|9|||
128683275|NCT01076075|463138830|FG000|Overall Study|Lack of Efficacy|5|||
129107017|NCT05464420|464686741|FG003|Overall Study|Death|1|||
129107018|NCT05464420|464686738|FG000|Overall Study|Lost to Follow-up|16|||
129107019|NCT05464420|464686739|FG001|Overall Study|Lost to Follow-up|11|||
129107020|NCT05464420|464686740|FG002|Overall Study|Lost to Follow-up|11|||
129107021|NCT05464420|464686741|FG003|Overall Study|Lost to Follow-up|11|||
129107022|NCT05464420|464686738|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
129107023|NCT05464420|464686739|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
129107024|NCT05464420|464686740|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
129107025|NCT05464420|464686741|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
129107026|NCT05464420|464686738|FG000|Overall Study|Withdrawal by Subject|4|||
129107027|NCT05464420|464686739|FG001|Overall Study|Withdrawal by Subject|8|||
129107028|NCT05464420|464686740|FG002|Overall Study|Withdrawal by Subject|3|||
129107029|NCT05464420|464686741|FG003|Overall Study|Withdrawal by Subject|1|||
128683276|NCT01076075|463138831|FG001|Overall Study|Lack of Efficacy|4|||
128683277|NCT01076075|463138830|FG000|Overall Study|Lost to Follow-up|6|||
128683278|NCT01076075|463138831|FG001|Overall Study|Lost to Follow-up|5|||
128683279|NCT01076075|463138830|FG000|Overall Study|other|19|||
128683280|NCT01076075|463138831|FG001|Overall Study|other|9|||
128683281|NCT01076075|463138830|FG000|Overall Study|Protocol Violation|0|||
128683282|NCT01076075|463138831|FG001|Overall Study|Protocol Violation|1|||
128683283|NCT01076075|463138830|FG000|Overall Study|Withdrawal by Subject|8|||
128683284|NCT01076075|463138831|FG001|Overall Study|Withdrawal by Subject|19|||
128683285|NCT01445886|463138840|FG000|Overall Study|Lost to Follow-up|2|||
128683286|NCT01445886|463138840|FG000|Overall Study|Protocol Violation|3|||
128683287|NCT00995865|463138843|FG000|Overall Study|Protocol Violation|2|||
128683288|NCT00995865|463138844|FG001|Overall Study|Protocol Violation|0|||
128683289|NCT00995865|463138845|FG002|Overall Study|Protocol Violation|0|||
128683290|NCT00995865|463138843|FG000|Overall Study|Lost to Follow-up|0|||
128683291|NCT00995865|463138844|FG001|Overall Study|Lost to Follow-up|0|||
128683292|NCT00995865|463138845|FG002|Overall Study|Lost to Follow-up|1|||
128882729|NCT03818204|463865072|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882730|NCT03818204|463865073|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129107030|NCT05464420|464686738|FG000|Overall Study|Protocol Violation|0|||
128683293|NCT04221230|463138846|FG000|Overall Study|Lost to Follow-up|12|||
128683294|NCT04221230|463138847|FG001|Overall Study|Lost to Follow-up|12|||
128683295|NCT04221230|463138846|FG000|Overall Study|Protocol Violation|2|||
128683296|NCT04221230|463138847|FG001|Overall Study|Protocol Violation|2|||
128683297|NCT04221230|463138846|FG000|Overall Study|Adverse Event|0|||
128683298|NCT04221230|463138847|FG001|Overall Study|Adverse Event|8|||
128683299|NCT04221230|463138846|FG000|Overall Study|Physician Decision|1|||
128683300|NCT04221230|463138847|FG001|Overall Study|Physician Decision|0|||
128683301|NCT04221230|463138846|FG000|Overall Study|Withdrawal by Subject|13|||
128683302|NCT04221230|463138847|FG001|Overall Study|Withdrawal by Subject|11|||
128882731|NCT03818204|463865074|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882732|NCT03818204|463865075|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
128882733|NCT03818204|463865057|FG000|Overall Study|Physician Decision|0|||
128882734|NCT03818204|463865058|FG001|Overall Study|Physician Decision|0|||
128882735|NCT03818204|463865059|FG002|Overall Study|Physician Decision|0|||
128882736|NCT03818204|463865060|FG003|Overall Study|Physician Decision|0|||
128882737|NCT03818204|463865061|FG004|Overall Study|Physician Decision|0|||
128882738|NCT03818204|463865062|FG005|Overall Study|Physician Decision|0|||
128882739|NCT03818204|463865063|FG006|Overall Study|Physician Decision|0|||
128882740|NCT03818204|463865064|FG007|Overall Study|Physician Decision|0|||
128882741|NCT03818204|463865065|FG008|Overall Study|Physician Decision|0|||
128882742|NCT03818204|463865066|FG009|Overall Study|Physician Decision|0|||
128882743|NCT03818204|463865067|FG010|Overall Study|Physician Decision|0|||
128882744|NCT03818204|463865068|FG011|Overall Study|Physician Decision|0|||
128882745|NCT03818204|463865069|FG012|Overall Study|Physician Decision|0|||
128882746|NCT03818204|463865070|FG013|Overall Study|Physician Decision|0|||
128882747|NCT03818204|463865071|FG014|Overall Study|Physician Decision|1|||
128882748|NCT03818204|463865072|FG015|Overall Study|Physician Decision|0|||
128882749|NCT03818204|463865073|FG016|Overall Study|Physician Decision|0|||
128882750|NCT03818204|463865074|FG017|Overall Study|Physician Decision|0|||
128882751|NCT03818204|463865075|FG018|Overall Study|Physician Decision|0|||
128882752|NCT00887250|463865076|FG000|Overall Study|Adverse Event|3|||
128882753|NCT00887250|463865077|FG001|Overall Study|Adverse Event|0|||
128882754|NCT00887250|463865078|FG002|Overall Study|Adverse Event|7|||
128882755|NCT00887250|463865076|FG000|Overall Study|Lack of Efficacy|9|||
128882756|NCT00887250|463865077|FG001|Overall Study|Lack of Efficacy|6|||
128882757|NCT00887250|463865078|FG002|Overall Study|Lack of Efficacy|1|||
128882758|NCT00887250|463865076|FG000|Overall Study|Lost to Follow-up|2|||
128882759|NCT00887250|463865077|FG001|Overall Study|Lost to Follow-up|3|||
128882760|NCT00887250|463865078|FG002|Overall Study|Lost to Follow-up|1|||
128882761|NCT00887250|463865076|FG000|Overall Study|Protocol Violation|2|||
128882762|NCT00887250|463865077|FG001|Overall Study|Protocol Violation|2|||
128882763|NCT00887250|463865078|FG002|Overall Study|Protocol Violation|1|||
128882764|NCT00887250|463865076|FG000|Overall Study|Withdrawal by Subject|2|||
128882765|NCT00887250|463865077|FG001|Overall Study|Withdrawal by Subject|1|||
128882766|NCT00887250|463865078|FG002|Overall Study|Withdrawal by Subject|2|||
128882767|NCT00887250|463865076|FG000|Overall Study|Patient uncooperative|0|||
128882768|NCT00887250|463865077|FG001|Overall Study|Patient uncooperative|0|||
128882769|NCT00887250|463865078|FG002|Overall Study|Patient uncooperative|1|||
128882770|NCT01933113|463865079|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
128882771|NCT00879762|463865080|FG000|Overall Study|Lost to Follow-up|3|||
128882772|NCT00879762|463865081|FG001|Overall Study|Lost to Follow-up|1|||
128882773|NCT04981366|463865082|FG000|Overall Study|Withdrawal by Subject|5|||
129107031|NCT05464420|464686739|FG001|Overall Study|Protocol Violation|0|||
129107032|NCT05464420|464686740|FG002|Overall Study|Protocol Violation|1|||
129107033|NCT05464420|464686741|FG003|Overall Study|Protocol Violation|1|||
129107034|NCT05464420|464686738|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
129107035|NCT05464420|464686739|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
129107036|NCT05464420|464686740|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
129107037|NCT05464420|464686741|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
129107038|NCT01383018|464686742|FG000|Overall Study|Adverse Event|14|||
129107039|NCT01383018|464686742|FG000|Overall Study|Death|10|||
129107040|NCT01383018|464686742|FG000|Overall Study|Lost to Follow-up|5|||
129107041|NCT01383018|464686742|FG000|Overall Study|Physician Decision|5|||
129107042|NCT01383018|464686742|FG000|Overall Study|Withdrawal by Subject|9|||
129107043|NCT01383018|464686742|FG000|Overall Study|Subject not implanted|76|||
129107044|NCT01383018|464686742|FG000|Overall Study|Missed Visit|247|||
129107045|NCT01383018|464686742|FG000|Overall Study|Site closed early-not compliance related|7|||
128882774|NCT04981366|463865083|FG001|Overall Study|Withdrawal by Subject|4|||
128882775|NCT04981366|463865084|FG002|Overall Study|Withdrawal by Subject|8|||
128882776|NCT04981366|463865082|FG000|Overall Study|Health issues unrelated to the trial|1|||
128882777|NCT04981366|463865083|FG001|Overall Study|Health issues unrelated to the trial|2|||
128882778|NCT04981366|463865084|FG002|Overall Study|Health issues unrelated to the trial|0|||
128882779|NCT00881608|463865085|FG000|Overall Study|Study prematurely terminated|11|||
128882780|NCT03214094|463865086|FG000|Overall Study|Case Report Forms Uncollected|14|||
129107046|NCT01383018|464686742|FG000|Overall Study|Patient moved away from site|1|||
129107047|NCT01383018|464686742|FG000|Overall Study|Subject Incarcerated|1|||
128882781|NCT03214094|463865086|FG000|Overall Study|Protocol Deviation|46|||
128882782|NCT00795951|463865092|FG000|Overall Study|Lost to Follow-up|1|||
129107048|NCT01765569|464686745|FG000|Period B|Withdrawal by Subject|1|||
129107049|NCT01765569|464686745|FG000|Period C|Death|1|||
128882783|NCT00795951|463865092|FG000|Overall Study|Withdrawal by Subject|1|||
128882784|NCT00655486|463865098|FG000|Overall Study|Adverse Event|10|||
128882785|NCT00655486|463865098|FG000|Overall Study|Lack of Efficacy|8|||
128882786|NCT00655486|463865098|FG000|Overall Study|Withdrawal by Subject|4|||
128882787|NCT00655486|463865098|FG000|Overall Study|Protocol Violation|1|||
128882788|NCT00655486|463865098|FG000|Overall Study|Unsatisfactory compliance|2|||
128882789|NCT00655486|463865098|FG000|Overall Study|Other: Pregnancy|1|||
128882790|NCT00655486|463865098|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
128882791|NCT00655486|463865098|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
128882792|NCT02768870|463865109|FG000|Overall Study|Death|1|||
128882793|NCT02768870|463865109|FG000|Overall Study|Reoperation|6|||
128882794|NCT02768870|463865109|FG000|Overall Study|Lost to Follow-up|1|||
128882795|NCT02768870|463865109|FG000|Overall Study|Exit|4|||
128882796|NCT03401229|463865110|FG000|Overall Study|Lost to Follow-up|2|||
128882797|NCT03401229|463865111|FG001|Overall Study|Lost to Follow-up|1|||
128882798|NCT03401229|463865110|FG000|Overall Study|Other|1|||
128882799|NCT03401229|463865111|FG001|Overall Study|Other|3|||
128882800|NCT03401229|463865110|FG000|Overall Study|Adverse Event|8|||
128882801|NCT03401229|463865111|FG001|Overall Study|Adverse Event|6|||
128882802|NCT03401229|463865110|FG000|Overall Study|Withdrawal by Subject|29|||
128882803|NCT03401229|463865111|FG001|Overall Study|Withdrawal by Subject|26|||
128882804|NCT03401229|463865110|FG000|Overall Study|COVID-19|0|||
128882805|NCT03401229|463865111|FG001|Overall Study|COVID-19|1|||
128882806|NCT01122862|463865112|FG000|Period 1|Protocol Violation|0|||
128882807|NCT01122862|463865113|FG001|Period 1|Protocol Violation|1|||
128882808|NCT01122862|463865114|FG002|Period 1|Protocol Violation|0|||
128882809|NCT01122862|463865112|FG000|Period 2|Adverse Event|0|||
128882810|NCT01122862|463865113|FG001|Period 2|Adverse Event|0|||
128882811|NCT01122862|463865114|FG002|Period 2|Adverse Event|1|||
128882812|NCT02699983|463865115|FG000|Overall Study|Withdrawal by Subject|1|||
128882813|NCT02699983|463865116|FG001|Overall Study|Withdrawal by Subject|0|||
128882814|NCT01054846|463865117|FG000|Overall Study|Lost to Follow-up|76|||
128882815|NCT01054846|463865118|FG001|Overall Study|Lost to Follow-up|17|||
128882816|NCT02446886|463865119|FG000|Overall Study|Adverse Event|1|||
128882817|NCT02446886|463865120|FG001|Overall Study|Adverse Event|3|||
128882818|NCT02446886|463865119|FG000|Overall Study|Withdrawal by Subject|1|||
128882819|NCT02446886|463865120|FG001|Overall Study|Withdrawal by Subject|1|||
128882820|NCT00928447|463865121|FG000|Overall Study|Withdrawal by Subject|1|||
128882821|NCT00928447|463865121|FG000|Overall Study|Investigator's decision|1|||
128882822|NCT01259284|463865122|FG000|Overall Study|Study Termination|2|||
128882823|NCT01259284|463865123|FG001|Overall Study|Study Termination|0|||
128882824|NCT01259284|463865124|FG002|Overall Study|Study Termination|0|||
128882825|NCT01971203|463865125|FG000|Overall Study|Protocol Violation|3|||
128882826|NCT01971203|463865126|FG001|Overall Study|Protocol Violation|2|||
128882827|NCT01971203|463865125|FG000|Overall Study|Withdrawal by Subject|5|||
128882828|NCT01971203|463865126|FG001|Overall Study|Withdrawal by Subject|6|||
128882829|NCT01971203|463865125|FG000|Overall Study|Adverse Event|1|||
128882830|NCT01971203|463865126|FG001|Overall Study|Adverse Event|0|||
128882831|NCT00807235|463865127|FG000|Overall Study|Adverse Event|1|||
128882832|NCT00807235|463865128|FG001|Overall Study|Adverse Event|0|||
128882833|NCT01765179|463865129|FG000|Overall Study|Adverse Event|3|||
128882834|NCT01765179|463865129|FG000|Overall Study|Lost to Follow-up|5|||
128882835|NCT01765179|463865129|FG000|Overall Study|Non-compliance with study drug|2|||
128882836|NCT01765179|463865129|FG000|Overall Study|Protocol Violation|1|||
128882837|NCT01765179|463865129|FG000|Overall Study|Withdrawal by Subject|8|||
128882838|NCT01765179|463865129|FG000|Overall Study|Hematocrit >54%|3|||
128882839|NCT01765179|463865129|FG000|Overall Study|prohibited med|1|||
128882840|NCT01765179|463865129|FG000|Overall Study|Out of country unable to finish study|1|||
128882841|NCT01765179|463865129|FG000|Overall Study|lack of venous access|1|||
128882842|NCT01765179|463865129|FG000|Overall Study|work conflict|1|||
128882843|NCT01765179|463865129|FG000|Overall Study|Ca elevated 10.6|1|||
128882844|NCT02988622|463865130|FG000|Overall Study|Lost to Follow-up|17|||
128882845|NCT00178126|463865131|FG000|Overall Study|Lost to Follow-up|21|||
128882846|NCT00178126|463865132|FG001|Overall Study|Lost to Follow-up|21|||
128882847|NCT00178126|463865131|FG000|Overall Study|did not receive intervention|4|||
128882848|NCT00178126|463865132|FG001|Overall Study|did not receive intervention|6|||
128882849|NCT03562247|463865136|FG000|Overall Study|Lost to Follow-up|3|||
128882850|NCT03562247|463865137|FG001|Overall Study|Lost to Follow-up|1|||
128882851|NCT03562247|463865138|FG002|Overall Study|Lost to Follow-up|1|||
128882852|NCT01204398|463865139|FG000|Overall Study|Adverse Event|1|||
128882853|NCT00983931|463865140|FG000|14 Day Washout Period|Physician Decision|1|||
128882854|NCT01281969|463865143|FG000|Overall Study|not randomized didn't meet criteria|0|||
128882855|NCT01281969|463865144|FG001|Overall Study|not randomized didn't meet criteria|0|||
128882856|NCT01281969|463865145|FG002|Overall Study|not randomized didn't meet criteria|7|||
128882857|NCT01281969|463865143|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
128882858|NCT01281969|463865144|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
128882859|NCT01281969|463865145|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
128882860|NCT01281969|463865143|FG000|Overall Study|not randomized, child consent not given|0|||
128683303|NCT04221230|463138846|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128882861|NCT01281969|463865144|FG001|Overall Study|not randomized, child consent not given|0|||
128882862|NCT01281969|463865145|FG002|Overall Study|not randomized, child consent not given|2|||
128882863|NCT01201265|463865150|FG000|Overall Study|Death|14|||
128882864|NCT01201265|463865150|FG000|Overall Study|Insufficient Therapeutic Response|3|||
128882865|NCT01201265|463865150|FG000|Overall Study|Lost to Follow-up|10|||
128882866|NCT01201265|463865150|FG000|Overall Study|Withdrawal by Subject|7|||
128882867|NCT01201265|463865150|FG000|Overall Study|Disease Progression|4|||
128882868|NCT04640077|463865151|FG000|Period 1|Withdrawal by Subject|4|||
128882869|NCT04640077|463865152|FG001|Period 1|Withdrawal by Subject|5|||
128882870|NCT04640077|463865153|FG002|Period 1|Withdrawal by Subject|0|||
128882871|NCT04640077|463865151|FG000|Period 1|Adverse Event|1|||
128882872|NCT04640077|463865152|FG001|Period 1|Adverse Event|1|||
128882873|NCT04640077|463865153|FG002|Period 1|Adverse Event|0|||
128882874|NCT04640077|463865151|FG000|Period 1|Screen Failure|2|||
128882875|NCT04640077|463865152|FG001|Period 1|Screen Failure|0|||
128882876|NCT04640077|463865153|FG002|Period 1|Screen Failure|0|||
128882877|NCT04640077|463865151|FG000|Period 2|Withdrawal by Subject|0|||
128882878|NCT04640077|463865152|FG001|Period 2|Withdrawal by Subject|0|||
128882879|NCT04640077|463865153|FG002|Period 2|Withdrawal by Subject|18|||
128882880|NCT04640077|463865151|FG000|Period 2|Adverse Event|0|||
128882881|NCT04640077|463865152|FG001|Period 2|Adverse Event|0|||
128882882|NCT04640077|463865153|FG002|Period 2|Adverse Event|6|||
128882883|NCT04640077|463865151|FG000|Period 2|Lost to Follow-up|0|||
128882884|NCT04640077|463865152|FG001|Period 2|Lost to Follow-up|0|||
128882885|NCT04640077|463865153|FG002|Period 2|Lost to Follow-up|2|||
128882886|NCT04640077|463865151|FG000|Period 2|Death|0|||
128882887|NCT04640077|463865152|FG001|Period 2|Death|0|||
128882888|NCT04640077|463865153|FG002|Period 2|Death|2|||
128882889|NCT04640077|463865151|FG000|Period 2|Progressive Disease|0|||
128882890|NCT04640077|463865152|FG001|Period 2|Progressive Disease|0|||
128882891|NCT04640077|463865153|FG002|Period 2|Progressive Disease|1|||
128882892|NCT04640077|463865151|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
128882893|NCT04640077|463865152|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
128882894|NCT04640077|463865153|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
128882895|NCT01257425|463865154|FG000|Overall Study|Lack of Efficacy|3|||
128882896|NCT01257425|463865155|FG001|Overall Study|Lack of Efficacy|3|||
128882897|NCT01257425|463865154|FG000|Overall Study|Adverse Event|1|||
128882898|NCT01257425|463865155|FG001|Overall Study|Adverse Event|1|||
128882899|NCT01257425|463865154|FG000|Overall Study|Protocol Violation|1|||
128882900|NCT01257425|463865155|FG001|Overall Study|Protocol Violation|1|||
128882901|NCT01257425|463865154|FG000|Overall Study|Withdrawal by Subject|0|||
128882902|NCT01257425|463865155|FG001|Overall Study|Withdrawal by Subject|1|||
128882903|NCT01257425|463865154|FG000|Overall Study|Death|1|||
128882904|NCT01257425|463865155|FG001|Overall Study|Death|0|||
128882905|NCT01182194|463865156|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
128882906|NCT01182194|463865157|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
128882907|NCT00368992|463865159|FG000|Overall Study|Ineligible|5|||
128882908|NCT00368992|463865159|FG000|Overall Study|Refused treatment|3|||
128882909|NCT00368992|463865159|FG000|Overall Study|Lack of Efficacy|63|||
128882910|NCT00368992|463865159|FG000|Overall Study|Adverse Event|26|||
128882911|NCT00368992|463865159|FG000|Overall Study|Death|4|||
128882912|NCT00368992|463865159|FG000|Overall Study|Other|9|||
128882913|NCT02668185|463865160|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
128882914|NCT02668185|463865161|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
128882915|NCT02668185|463865160|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
129107050|NCT03414229|464686746|FG000|Overall Study|Adverse Event|1|||
128882916|NCT02668185|463865161|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
128882917|NCT02668185|463865160|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
128882918|NCT02668185|463865161|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
128882919|NCT02668185|463865160|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
128882920|NCT02668185|463865161|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
128882921|NCT00723021|463865166|FG000|Intervention Period 4|Adverse Event|0|||
128882922|NCT00723021|463865167|FG001|Intervention Period 4|Adverse Event|0|||
128882923|NCT00723021|463865168|FG002|Intervention Period 4|Adverse Event|0|||
128882924|NCT00723021|463865169|FG003|Intervention Period 4|Adverse Event|0|||
129018937|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018938|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018939|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
129018940|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
129018941|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018942|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018943|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018944|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018945|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
128882925|NCT00723021|463865170|FG004|Intervention Period 4|Adverse Event|1|||
128882926|NCT00770341|463865172|FG000|Overall Study|Did not meet eligibility criteria|1|||
128882927|NCT00770341|463865173|FG001|Overall Study|Did not meet eligibility criteria|0|||
128882928|NCT00770341|463865174|FG002|Overall Study|Did not meet eligibility criteria|0|||
128882929|NCT00770341|463865172|FG000|Overall Study|Withdrawal by Subject|0|||
128882930|NCT00770341|463865173|FG001|Overall Study|Withdrawal by Subject|1|||
128882931|NCT00770341|463865174|FG002|Overall Study|Withdrawal by Subject|0|||
129107051|NCT03414229|464686747|FG001|Overall Study|Adverse Event|0|||
129107052|NCT03414229|464686748|FG002|Overall Study|Adverse Event|2|||
129107053|NCT03414229|464686749|FG003|Overall Study|Adverse Event|1|||
129107054|NCT03414229|464686746|FG000|Overall Study|Lack of Efficacy|7|||
129107055|NCT03414229|464686747|FG001|Overall Study|Lack of Efficacy|4|||
129107056|NCT03414229|464686748|FG002|Overall Study|Lack of Efficacy|1|||
129107057|NCT03414229|464686749|FG003|Overall Study|Lack of Efficacy|9|||
129107058|NCT03414229|464686746|FG000|Overall Study|Change in therapy|1|||
129107059|NCT03414229|464686747|FG001|Overall Study|Change in therapy|0|||
129107060|NCT03414229|464686748|FG002|Overall Study|Change in therapy|0|||
129107061|NCT03414229|464686749|FG003|Overall Study|Change in therapy|0|||
129107062|NCT03414229|464686746|FG000|Overall Study|Pregnancy|0|||
129107063|NCT03414229|464686747|FG001|Overall Study|Pregnancy|0|||
129107064|NCT03414229|464686748|FG002|Overall Study|Pregnancy|1|||
128683304|NCT04221230|463138847|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128683305|NCT04221230|463138846|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
128683306|NCT04221230|463138847|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
128683307|NCT04221230|463138846|FG000|Overall Study|Pregnancy|0|||
128683308|NCT04221230|463138847|FG001|Overall Study|Pregnancy|1|||
128683309|NCT04221230|463138846|FG000|Overall Study|Other|1|||
128683310|NCT04221230|463138847|FG001|Overall Study|Other|2|||
128683311|NCT02582255|463140624|FG000|Overall Study|Protocol Violation|0|||
128683312|NCT02582255|463140625|FG001|Overall Study|Protocol Violation|3|||
128683313|NCT03034200|463140630|FG000|Overall Study|Disease progression|8|||
128683314|NCT03034200|463140631|FG001|Overall Study|Disease progression|10|||
128683315|NCT03034200|463140632|FG002|Overall Study|Disease progression|4|||
128683316|NCT03034200|463140630|FG000|Overall Study|Physician Decision|2|||
128683317|NCT03034200|463140631|FG001|Overall Study|Physician Decision|0|||
128683318|NCT03034200|463140632|FG002|Overall Study|Physician Decision|3|||
128683319|NCT03034200|463140630|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
128683320|NCT03034200|463140631|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
128683321|NCT03034200|463140632|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
128683322|NCT03034200|463140630|FG000|Overall Study|Adjuvant Therapy|0|||
128683323|NCT03034200|463140631|FG001|Overall Study|Adjuvant Therapy|0|||
128683324|NCT03034200|463140632|FG002|Overall Study|Adjuvant Therapy|1|||
128683325|NCT02278341|463140633|FG000|Overall Study|Randomized but never received study drug|1|||
128683326|NCT02278341|463140634|FG001|Overall Study|Randomized but never received study drug|1|||
128683327|NCT02278341|463140633|FG000|Overall Study|Adverse Event|3|||
128683328|NCT02278341|463140634|FG001|Overall Study|Adverse Event|0|||
128683329|NCT02278341|463140633|FG000|Overall Study|Death|68|||
128683330|NCT02278341|463140634|FG001|Overall Study|Death|56|||
128683331|NCT02278341|463140633|FG000|Overall Study|Withdrawal by Subject|30|||
128683332|NCT02278341|463140634|FG001|Overall Study|Withdrawal by Subject|19|||
128683333|NCT02278341|463140633|FG000|Overall Study|Lost to Follow-up|0|||
128683334|NCT02278341|463140634|FG001|Overall Study|Lost to Follow-up|1|||
128683335|NCT02278341|463140633|FG000|Overall Study|Physician Decision|1|||
128683336|NCT02278341|463140634|FG001|Overall Study|Physician Decision|1|||
128683337|NCT02278341|463140633|FG000|Overall Study|Miscellaneous|15|||
128882932|NCT00770341|463865172|FG000|Overall Study|Clinical Adverse Event|3|||
128882933|NCT00770341|463865173|FG001|Overall Study|Clinical Adverse Event|1|||
129107065|NCT03414229|464686749|FG003|Overall Study|Pregnancy|0|||
129107066|NCT03414229|464686746|FG000|Overall Study|Withdrawal by Subject|0|||
129107067|NCT03414229|464686747|FG001|Overall Study|Withdrawal by Subject|1|||
129107068|NCT03414229|464686748|FG002|Overall Study|Withdrawal by Subject|1|||
129107069|NCT03414229|464686749|FG003|Overall Study|Withdrawal by Subject|0|||
129107070|NCT04533438|464686750|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
129107071|NCT04533438|464686751|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
129107072|NCT00869128|464686760|FG000|Overall Study|lack of Compliance|6|||
129107073|NCT00869128|464686761|FG001|Overall Study|lack of Compliance|6|||
128683338|NCT02278341|463140634|FG001|Overall Study|Miscellaneous|14|||
128683339|NCT03190369|463140638|FG000|Overall Study|Poor compliance to protocol|0|||
128683340|NCT03190369|463140639|FG001|Overall Study|Poor compliance to protocol|1|||
128683341|NCT03190369|463140638|FG000|Overall Study|Withdraw before treatment|1|||
128683342|NCT03190369|463140639|FG001|Overall Study|Withdraw before treatment|5|||
128683343|NCT03190369|463140638|FG000|Overall Study|Randomized but not treated|0|||
128683344|NCT03190369|463140639|FG001|Overall Study|Randomized but not treated|2|||
128683345|NCT01289782|463140640|FG000|Overall Study|Lost to Follow-up|14|||
128683346|NCT01289782|463140641|FG001|Overall Study|Lost to Follow-up|7|||
128683347|NCT01289782|463140640|FG000|Overall Study|Protocol Violation|1|||
128683348|NCT01289782|463140641|FG001|Overall Study|Protocol Violation|1|||
129107074|NCT02716584|464686767|FG000|Overall Study|Lost to Follow-up|8|||
129107075|NCT02716584|464686768|FG001|Overall Study|Lost to Follow-up|5|||
128683349|NCT01289782|463140640|FG000|Overall Study|Withdrawal by Subject|8|||
128683350|NCT01289782|463140641|FG001|Overall Study|Withdrawal by Subject|2|||
128683351|NCT01289782|463140640|FG000|Overall Study|Sponsor's Decision|1|||
128882934|NCT00770341|463865174|FG002|Overall Study|Clinical Adverse Event|2|||
129107076|NCT02282163|464686775|FG000|Overall Study|Protocol Violation|1|||
129107077|NCT01603407|464686776|FG000|Overall Study|Adverse Event|1|||
128882935|NCT00770341|463865172|FG000|Overall Study|Laboratory adverse event|3|||
128882936|NCT00770341|463865173|FG001|Overall Study|Laboratory adverse event|3|||
128882937|NCT00770341|463865174|FG002|Overall Study|Laboratory adverse event|0|||
128882938|NCT00770341|463865172|FG000|Overall Study|Lack of Efficacy|3|||
128882939|NCT00770341|463865173|FG001|Overall Study|Lack of Efficacy|0|||
128882940|NCT00770341|463865174|FG002|Overall Study|Lack of Efficacy|1|||
128882941|NCT00770341|463865172|FG000|Overall Study|Other|1|||
128882942|NCT00770341|463865173|FG001|Overall Study|Other|0|||
128882943|NCT00770341|463865174|FG002|Overall Study|Other|0|||
128882944|NCT00770341|463865172|FG000|Overall Study|Not treated|1|||
128882945|NCT00770341|463865173|FG001|Overall Study|Not treated|0|||
128882946|NCT00770341|463865174|FG002|Overall Study|Not treated|0|||
128882947|NCT00960531|463865180|FG000|Overall Study|Lack of Efficacy|1|||
128882948|NCT00960531|463865181|FG001|Overall Study|Lack of Efficacy|0|||
128882949|NCT00960531|463865182|FG002|Overall Study|Lack of Efficacy|0|||
128882950|NCT00960531|463865183|FG003|Overall Study|Lack of Efficacy|0|||
128882951|NCT00960531|463865184|FG004|Overall Study|Lack of Efficacy|0|||
128882952|NCT00960531|463865185|FG005|Overall Study|Lack of Efficacy|0|||
129018946|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018947|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
128882953|NCT00960531|463865186|FG006|Overall Study|Lack of Efficacy|0|||
129107078|NCT01603407|464686777|FG001|Overall Study|Adverse Event|1|||
129107079|NCT01603407|464686778|FG002|Overall Study|Adverse Event|1|||
129107080|NCT01603407|464686776|FG000|Overall Study|Protocol Violation|2|||
129107081|NCT01603407|464686777|FG001|Overall Study|Protocol Violation|2|||
129107082|NCT01603407|464686778|FG002|Overall Study|Protocol Violation|0|||
129107083|NCT01603407|464686776|FG000|Overall Study|Withdrawal by Subject|8|||
129107084|NCT01603407|464686777|FG001|Overall Study|Withdrawal by Subject|5|||
129107085|NCT01603407|464686778|FG002|Overall Study|Withdrawal by Subject|7|||
129107086|NCT01603407|464686776|FG000|Overall Study|Lost to Follow-up|0|||
129107087|NCT01603407|464686777|FG001|Overall Study|Lost to Follow-up|3|||
129107088|NCT01603407|464686778|FG002|Overall Study|Lost to Follow-up|2|||
129107089|NCT02500719|464686779|FG000|Overall Study|Lost to Follow-up|2|||
129107090|NCT02500719|464686780|FG001|Overall Study|Lost to Follow-up|3|||
129107091|NCT02500719|464686779|FG000|Overall Study|Trauma history|1|||
129107092|NCT02500719|464686780|FG001|Overall Study|Trauma history|0|||
129107093|NCT02500719|464686779|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
129107094|NCT02500719|464686780|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
129107095|NCT02500719|464686779|FG000|Overall Study|Did not meet criteria for PTSD|0|||
129107096|NCT02500719|464686780|FG001|Overall Study|Did not meet criteria for PTSD|1|||
129107097|NCT02500719|464686779|FG000|Overall Study|Claustrophobia|0|||
129107098|NCT02500719|464686780|FG001|Overall Study|Claustrophobia|1|||
129107099|NCT02500719|464686779|FG000|Overall Study|History of head trauma|0|||
129107100|NCT02500719|464686780|FG001|Overall Study|History of head trauma|1|||
129107101|NCT01990768|464686781|FG000|Intervention Started|Found to be ineligible|14|||
129107102|NCT01990768|464686782|FG001|Intervention Started|Found to be ineligible|13|||
129107103|NCT01990768|464686783|FG002|Intervention Started|Found to be ineligible|11|||
129107104|NCT01990768|464686781|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
129107105|NCT01990768|464686782|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
129107106|NCT01990768|464686783|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
129107107|NCT01990768|464686781|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
128882954|NCT00960531|463865187|FG007|Overall Study|Lack of Efficacy|0|||
129018948|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018949|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018950|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018951|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018952|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018953|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129018954|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129107108|NCT01990768|464686782|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
129107109|NCT01990768|464686783|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
129107110|NCT01990768|464686781|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
129107111|NCT01990768|464686782|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
129107112|NCT01990768|464686783|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
129107113|NCT01990768|464686781|FG000|Intervention Started|Patient care priority|1|||
129107114|NCT01990768|464686782|FG001|Intervention Started|Patient care priority|2|||
129107115|NCT01990768|464686783|FG002|Intervention Started|Patient care priority|3|||
128882955|NCT00960531|463865188|FG008|Overall Study|Lack of Efficacy|0|||
128882956|NCT00960531|463865189|FG009|Overall Study|Lack of Efficacy|0|||
128882957|NCT00960531|463865180|FG000|Overall Study|Withdrawal by Subject|1|||
128882958|NCT00960531|463865181|FG001|Overall Study|Withdrawal by Subject|0|||
128882959|NCT00960531|463865182|FG002|Overall Study|Withdrawal by Subject|5|||
128882960|NCT00960531|463865183|FG003|Overall Study|Withdrawal by Subject|2|||
128882961|NCT00960531|463865184|FG004|Overall Study|Withdrawal by Subject|0|||
128882962|NCT00960531|463865185|FG005|Overall Study|Withdrawal by Subject|0|||
128882963|NCT00960531|463865186|FG006|Overall Study|Withdrawal by Subject|2|||
128882964|NCT00960531|463865187|FG007|Overall Study|Withdrawal by Subject|0|||
128882965|NCT00960531|463865188|FG008|Overall Study|Withdrawal by Subject|1|||
128882966|NCT00960531|463865189|FG009|Overall Study|Withdrawal by Subject|0|||
128882967|NCT00960531|463865180|FG000|Overall Study|Caregiver Request|2|||
128882968|NCT00960531|463865181|FG001|Overall Study|Caregiver Request|0|||
128882969|NCT00960531|463865182|FG002|Overall Study|Caregiver Request|6|||
128882970|NCT00960531|463865183|FG003|Overall Study|Caregiver Request|5|||
128882971|NCT00960531|463865184|FG004|Overall Study|Caregiver Request|0|||
128882972|NCT00960531|463865185|FG005|Overall Study|Caregiver Request|2|||
128882973|NCT00960531|463865186|FG006|Overall Study|Caregiver Request|3|||
128882974|NCT00960531|463865187|FG007|Overall Study|Caregiver Request|1|||
128882975|NCT00960531|463865188|FG008|Overall Study|Caregiver Request|3|||
128882976|NCT00960531|463865189|FG009|Overall Study|Caregiver Request|0|||
128882977|NCT00960531|463865180|FG000|Overall Study|Investigator Request|0|||
128882978|NCT00960531|463865181|FG001|Overall Study|Investigator Request|0|||
128882979|NCT00960531|463865182|FG002|Overall Study|Investigator Request|1|||
128882980|NCT00960531|463865183|FG003|Overall Study|Investigator Request|0|||
128882981|NCT00960531|463865184|FG004|Overall Study|Investigator Request|0|||
128882982|NCT00960531|463865185|FG005|Overall Study|Investigator Request|0|||
128882983|NCT00960531|463865186|FG006|Overall Study|Investigator Request|0|||
128882984|NCT00960531|463865187|FG007|Overall Study|Investigator Request|0|||
128882985|NCT00960531|463865188|FG008|Overall Study|Investigator Request|0|||
128882986|NCT00960531|463865189|FG009|Overall Study|Investigator Request|0|||
128882987|NCT00960531|463865180|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
128882988|NCT00960531|463865181|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
128882989|NCT00960531|463865182|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
128882990|NCT00960531|463865183|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
128882991|NCT00960531|463865184|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
128882992|NCT00960531|463865185|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
128882993|NCT00960531|463865186|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
128882994|NCT00960531|463865187|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
128882995|NCT00960531|463865188|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
128882996|NCT00960531|463865189|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
128882997|NCT00960531|463865180|FG000|Overall Study|Lost to Follow-up|0|||
128882998|NCT00960531|463865181|FG001|Overall Study|Lost to Follow-up|0|||
128882999|NCT00960531|463865182|FG002|Overall Study|Lost to Follow-up|1|||
128883000|NCT00960531|463865183|FG003|Overall Study|Lost to Follow-up|0|||
128883001|NCT00960531|463865184|FG004|Overall Study|Lost to Follow-up|0|||
128883002|NCT00960531|463865185|FG005|Overall Study|Lost to Follow-up|0|||
128883003|NCT00960531|463865186|FG006|Overall Study|Lost to Follow-up|1|||
128883004|NCT00960531|463865187|FG007|Overall Study|Lost to Follow-up|0|||
128883005|NCT00960531|463865188|FG008|Overall Study|Lost to Follow-up|0|||
128883006|NCT00960531|463865189|FG009|Overall Study|Lost to Follow-up|0|||
128883007|NCT00960531|463865180|FG000|Overall Study|Failed to Return|2|||
128883008|NCT00960531|463865181|FG001|Overall Study|Failed to Return|0|||
128883009|NCT00960531|463865182|FG002|Overall Study|Failed to Return|0|||
128883010|NCT00960531|463865183|FG003|Overall Study|Failed to Return|0|||
128883011|NCT00960531|463865184|FG004|Overall Study|Failed to Return|0|||
128883012|NCT00960531|463865185|FG005|Overall Study|Failed to Return|0|||
128883013|NCT00960531|463865186|FG006|Overall Study|Failed to Return|0|||
128883014|NCT00960531|463865187|FG007|Overall Study|Failed to Return|2|||
128883015|NCT00960531|463865188|FG008|Overall Study|Failed to Return|0|||
128883016|NCT00960531|463865189|FG009|Overall Study|Failed to Return|0|||
128883017|NCT00960531|463865180|FG000|Overall Study|Adverse Event (AE)|2|||
128883018|NCT00960531|463865181|FG001|Overall Study|Adverse Event (AE)|0|||
128883019|NCT00960531|463865182|FG002|Overall Study|Adverse Event (AE)|0|||
129018955|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018956|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018957|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018958|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018959|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
129018960|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
128883020|NCT00960531|463865183|FG003|Overall Study|Adverse Event (AE)|0|||
128883021|NCT00960531|463865184|FG004|Overall Study|Adverse Event (AE)|0|||
128883022|NCT00960531|463865185|FG005|Overall Study|Adverse Event (AE)|1|||
128883023|NCT00960531|463865186|FG006|Overall Study|Adverse Event (AE)|2|||
128883024|NCT00960531|463865187|FG007|Overall Study|Adverse Event (AE)|0|||
128883025|NCT00960531|463865188|FG008|Overall Study|Adverse Event (AE)|2|||
128883026|NCT00960531|463865189|FG009|Overall Study|Adverse Event (AE)|0|||
128883027|NCT00960531|463865180|FG000|Overall Study|Reason not Specified|2|||
128883028|NCT00960531|463865181|FG001|Overall Study|Reason not Specified|1|||
129018961|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
129018962|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
128883029|NCT00960531|463865182|FG002|Overall Study|Reason not Specified|13|||
128883030|NCT00960531|463865183|FG003|Overall Study|Reason not Specified|1|||
128883031|NCT00960531|463865184|FG004|Overall Study|Reason not Specified|2|||
128883032|NCT00960531|463865185|FG005|Overall Study|Reason not Specified|0|||
128883033|NCT00960531|463865186|FG006|Overall Study|Reason not Specified|16|||
128883034|NCT00960531|463865187|FG007|Overall Study|Reason not Specified|0|||
128883035|NCT00960531|463865188|FG008|Overall Study|Reason not Specified|8|||
128883036|NCT00960531|463865189|FG009|Overall Study|Reason not Specified|1|||
128883037|NCT01163916|463865192|FG000|Overall Study|Withdrawal by Subject|2|||
128883038|NCT01163916|463865193|FG001|Overall Study|Withdrawal by Subject|0|||
128883039|NCT01163916|463865194|FG002|Overall Study|Withdrawal by Subject|2|||
128883040|NCT01163916|463865192|FG000|Overall Study|Adverse Event|2|||
128883041|NCT01163916|463865193|FG001|Overall Study|Adverse Event|0|||
128883042|NCT01163916|463865194|FG002|Overall Study|Adverse Event|1|||
128883043|NCT01163916|463865192|FG000|Overall Study|Lack of Efficacy|2|||
128883044|NCT01163916|463865193|FG001|Overall Study|Lack of Efficacy|0|||
128883045|NCT01163916|463865194|FG002|Overall Study|Lack of Efficacy|1|||
128883046|NCT01163916|463865192|FG000|Overall Study|Other|24|||
128883047|NCT01163916|463865193|FG001|Overall Study|Other|4|||
128883048|NCT01163916|463865194|FG002|Overall Study|Other|16|||
128883049|NCT00883051|463865195|FG000|Overall Study|Lost to Follow-up|0|||
128883050|NCT00883051|463865196|FG001|Overall Study|Lost to Follow-up|0|||
128883051|NCT00883051|463865197|FG002|Overall Study|Lost to Follow-up|0|||
128883052|NCT00883051|463865198|FG003|Overall Study|Lost to Follow-up|0|||
128883053|NCT00883051|463865199|FG004|Overall Study|Lost to Follow-up|1|||
128883054|NCT00883051|463865195|FG000|Overall Study|Did not use study medication|24|||
128883055|NCT00883051|463865196|FG001|Overall Study|Did not use study medication|22|||
128883056|NCT00883051|463865197|FG002|Overall Study|Did not use study medication|29|||
128883057|NCT00883051|463865198|FG003|Overall Study|Did not use study medication|29|||
128883058|NCT00883051|463865199|FG004|Overall Study|Did not use study medication|17|||
128883059|NCT02337751|463865200|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
129018963|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018964|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
129018965|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018966|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018967|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018968|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018969|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018970|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018971|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018972|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018973|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018974|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018975|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129018976|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018977|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018978|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018979|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018980|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018981|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
129018982|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018983|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018984|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
129018985|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018986|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
129018987|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
129018988|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
129018989|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018990|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018991|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018992|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018993|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018994|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018995|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018996|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129018997|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129018998|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
128883060|NCT02337751|463865201|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
128883061|NCT02337751|463865200|FG000|Overall Study|Voluntary Withdrawal|6|||
128883062|NCT02337751|463865201|FG001|Overall Study|Voluntary Withdrawal|8|||
128883063|NCT02337751|463865200|FG000|Overall Study|Lack of Efficacy|2|||
128883064|NCT02337751|463865201|FG001|Overall Study|Lack of Efficacy|5|||
129018999|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
128883065|NCT02337751|463865200|FG000|Overall Study|Investigator's Judgement|1|||
128883066|NCT02337751|463865201|FG001|Overall Study|Investigator's Judgement|0|||
128883067|NCT01910181|463865208|FG000|Overall Study|Death|37|||
128883068|NCT01910181|463865208|FG000|Overall Study|Lost to Follow-up|3|||
128883069|NCT01910181|463865208|FG000|Overall Study|Study Terminated by Sponsor|6|||
128883070|NCT02656823|463865209|FG000|Overall Study|Adverse Event|3|||
128883071|NCT02656823|463865209|FG000|Overall Study|Lost to Follow-up|2|||
128883072|NCT00959647|463865213|FG000|Overall Study|Adverse Event|2|||
128883073|NCT00959647|463865213|FG000|Overall Study|Progressive disease|6|||
128883074|NCT00959647|463865213|FG000|Overall Study|Study terminated by sponsor|4|||
128883075|NCT00959647|463865213|FG000|Overall Study|Withdrawal by Subject|7|||
128883076|NCT02963610|463867219|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
128883077|NCT01774110|463867220|FG000|Overall Study|Lost to Follow-up|7|||
128883078|NCT00640016|463867221|FG000|Overall Study|Withdrawal by Subject|0|||
128883079|NCT00640016|463867222|FG001|Overall Study|Withdrawal by Subject|1|||
128883080|NCT00640016|463867223|FG002|Overall Study|Withdrawal by Subject|0|||
128883081|NCT00640016|463867224|FG003|Overall Study|Withdrawal by Subject|0|||
128883082|NCT00640016|463867221|FG000|Overall Study|Study termination|2|||
128883083|NCT00640016|463867222|FG001|Overall Study|Study termination|1|||
128883084|NCT00640016|463867223|FG002|Overall Study|Study termination|3|||
128883085|NCT00640016|463867224|FG003|Overall Study|Study termination|2|||
128883086|NCT00640016|463867221|FG000|Overall Study|Adverse Event|0|||
128883087|NCT00640016|463867222|FG001|Overall Study|Adverse Event|0|||
128883088|NCT00640016|463867223|FG002|Overall Study|Adverse Event|0|||
128883089|NCT00640016|463867224|FG003|Overall Study|Adverse Event|1|||
128883090|NCT03575143|463867227|FG000|Overall Study|Lost to Follow-up|0|||
128883091|NCT03575143|463867228|FG001|Overall Study|Lost to Follow-up|0|||
128883092|NCT03575143|463867229|FG002|Overall Study|Lost to Follow-up|4|||
128883093|NCT03575143|463867227|FG000|Overall Study|Withdrawal by Subject|0|||
128883094|NCT03575143|463867228|FG001|Overall Study|Withdrawal by Subject|0|||
128883095|NCT03575143|463867229|FG002|Overall Study|Withdrawal by Subject|5|||
128883096|NCT03575143|463867227|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
128883097|NCT03575143|463867228|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
128883098|NCT03575143|463867229|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
128883099|NCT01287065|463867232|FG000|Treatment Period 1|Adverse Event|0|||
128883100|NCT01287065|463867233|FG001|Treatment Period 1|Adverse Event|0|||
128883101|NCT01287065|463867234|FG002|Treatment Period 1|Adverse Event|0|||
128883102|NCT01287065|463867235|FG003|Treatment Period 1|Adverse Event|0|||
128883103|NCT01287065|463867236|FG004|Treatment Period 1|Adverse Event|1|||
128883104|NCT01287065|463867237|FG005|Treatment Period 1|Adverse Event|0|||
128883105|NCT01287065|463867232|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128883106|NCT01287065|463867233|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128883107|NCT01287065|463867234|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128883108|NCT01287065|463867235|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128883109|NCT01287065|463867236|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128883110|NCT01287065|463867237|FG005|Treatment Period 1|Withdrawal by Subject|1|||
128883111|NCT02875977|463867238|FG000|Overall Study|Lost to Follow-up|42|||
128883112|NCT02875977|463867239|FG001|Overall Study|Lost to Follow-up|29|||
128883113|NCT01259726|463867240|FG000|Overall Study|Death|1|||
128883114|NCT01259726|463867241|FG001|Overall Study|Death|0|||
129019000|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129019001|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
129019002|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
129019003|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
129019004|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
129019005|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
129019006|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
129019007|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
129019008|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
129019009|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
128883115|NCT01259726|463867242|FG002|Overall Study|Death|0|||
128883116|NCT01259726|463867243|FG003|Overall Study|Death|0|||
128883117|NCT01259726|463867240|FG000|Overall Study|Physician Decision|2|||
128883118|NCT01259726|463867241|FG001|Overall Study|Physician Decision|0|||
128883119|NCT01259726|463867242|FG002|Overall Study|Physician Decision|1|||
128883120|NCT01259726|463867243|FG003|Overall Study|Physician Decision|1|||
128883121|NCT01259726|463867240|FG000|Overall Study|Withdrawal by Subject|1|||
128883122|NCT01259726|463867241|FG001|Overall Study|Withdrawal by Subject|3|||
128883123|NCT01259726|463867242|FG002|Overall Study|Withdrawal by Subject|2|||
128883124|NCT01259726|463867243|FG003|Overall Study|Withdrawal by Subject|1|||
128883125|NCT01259726|463867240|FG000|Overall Study|Lost to Follow-up|1|||
128883126|NCT01259726|463867241|FG001|Overall Study|Lost to Follow-up|1|||
128883127|NCT01259726|463867242|FG002|Overall Study|Lost to Follow-up|1|||
129019010|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129107116|NCT01990768|464686781|FG000|Intervention Started|IV lost|2|||
128883128|NCT01259726|463867243|FG003|Overall Study|Lost to Follow-up|3|||
128883129|NCT03421431|463867251|FG000|Overall Study|Adverse Event|2|||
128883130|NCT03421431|463867252|FG001|Overall Study|Adverse Event|1|||
128883131|NCT03421431|463867253|FG002|Overall Study|Adverse Event|12|||
128883132|NCT03421431|463867251|FG000|Overall Study|Lost to Follow-up|1|||
128883133|NCT03421431|463867252|FG001|Overall Study|Lost to Follow-up|1|||
128883134|NCT03421431|463867253|FG002|Overall Study|Lost to Follow-up|1|||
128883135|NCT03421431|463867251|FG000|Overall Study|Withdrawal by Subject|3|||
128883136|NCT03421431|463867252|FG001|Overall Study|Withdrawal by Subject|2|||
128883137|NCT03421431|463867253|FG002|Overall Study|Withdrawal by Subject|1|||
128883138|NCT03421431|463867251|FG000|Overall Study|Protocol Violation|0|||
128883139|NCT03421431|463867252|FG001|Overall Study|Protocol Violation|1|||
128883140|NCT03421431|463867253|FG002|Overall Study|Protocol Violation|0|||
128883141|NCT03421431|463867251|FG000|Overall Study|Participant met Stopping Rules|0|||
128883142|NCT03421431|463867252|FG001|Overall Study|Participant met Stopping Rules|1|||
128883143|NCT03421431|463867253|FG002|Overall Study|Participant met Stopping Rules|0|||
128883144|NCT00141726|463867257|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
128883145|NCT00235326|463867262|FG000|Overall Study|Lost to Follow-up|746|||
128883146|NCT00235326|463867263|FG001|Overall Study|Lost to Follow-up|1400|||
128883147|NCT01790126|463867264|FG000|Overall Study|PSA Progression|12|||
128883148|NCT01790126|463867265|FG001|Overall Study|PSA Progression|16|||
128883149|NCT01790126|463867266|FG002|Overall Study|PSA Progression|16|||
128883150|NCT01790126|463867264|FG000|Overall Study|Other|5|||
128883151|NCT01790126|463867265|FG001|Overall Study|Other|4|||
128883152|NCT01790126|463867266|FG002|Overall Study|Other|8|||
128883153|NCT01790126|463867264|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
128883154|NCT01790126|463867265|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
128883155|NCT01790126|463867266|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
128883156|NCT01790126|463867264|FG000|Overall Study|Withdrawal by Physician|1|||
129019011|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129019012|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129019013|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129019014|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129107117|NCT01990768|464686782|FG001|Intervention Started|IV lost|2|||
129107118|NCT01990768|464686783|FG002|Intervention Started|IV lost|2|||
128883157|NCT01790126|463867265|FG001|Overall Study|Withdrawal by Physician|1|||
129019015|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129019016|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129019017|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129019018|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019019|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019020|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019021|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019022|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
129019023|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
129019024|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
129019025|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019026|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
129019027|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
129019028|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
129019029|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
129019030|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
129019031|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019032|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019033|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019034|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019035|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019036|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019037|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019038|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129019039|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129107119|NCT01990768|464686781|FG000|Intervention Started|Required CPR|1|||
128883158|NCT01790126|463867266|FG002|Overall Study|Withdrawal by Physician|2|||
128883159|NCT01790126|463867264|FG000|Overall Study|Withdrawal by Subject|3|||
128883160|NCT01790126|463867265|FG001|Overall Study|Withdrawal by Subject|1|||
129019040|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129107120|NCT01990768|464686782|FG001|Intervention Started|Required CPR|1|||
128883161|NCT01790126|463867266|FG002|Overall Study|Withdrawal by Subject|2|||
128883162|NCT01790126|463867264|FG000|Overall Study|Lost to Follow-up|1|||
128883163|NCT01790126|463867265|FG001|Overall Study|Lost to Follow-up|0|||
129019041|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019042|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019043|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
129019044|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019045|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019046|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019047|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
129019048|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
129019049|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
129019050|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019051|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
129019052|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019053|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019054|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019055|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019056|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019057|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019058|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019059|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129019060|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019061|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019062|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019063|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019064|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
129019065|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
129019066|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
129019067|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019068|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
129019069|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
129019070|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
129019071|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
129019072|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
129019073|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019074|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019075|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019076|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019077|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019078|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019079|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019080|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129019081|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019082|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019083|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019084|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019085|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019086|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129019087|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019088|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019089|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129019090|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129019091|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129019092|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129019093|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019094|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019095|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019096|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019097|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019098|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019099|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019100|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019101|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129019102|NCT01597245|464363747|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019103|NCT01597245|464363748|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129107121|NCT01990768|464686783|FG002|Intervention Started|Required CPR|0|||
129107122|NCT01990768|464686781|FG000|Intervention Started|Seizure or hx of seizure|0|||
129107123|NCT01990768|464686782|FG001|Intervention Started|Seizure or hx of seizure|0|||
129107124|NCT01990768|464686783|FG002|Intervention Started|Seizure or hx of seizure|2|||
129107125|NCT01990768|464686781|FG000|Intervention Started|Discovered to be pregnant|0|||
129107126|NCT01990768|464686782|FG001|Intervention Started|Discovered to be pregnant|1|||
129107127|NCT01990768|464686783|FG002|Intervention Started|Discovered to be pregnant|0|||
129107128|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
129107129|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
129107130|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
129107131|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
128683352|NCT01289782|463140641|FG001|Overall Study|Sponsor's Decision|0|||
128683353|NCT01289782|463140640|FG000|Overall Study|Reason not specified|1|||
128683354|NCT01289782|463140641|FG001|Overall Study|Reason not specified|2|||
128683355|NCT01241240|463140642|FG000|Overall Study|Adverse Event|5|||
129107132|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
129107133|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
129107134|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
129107135|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
129107136|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
129107137|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
129107138|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
129107139|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
129107140|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Death|3|||
129107141|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Death|1|||
129107142|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Death|1|||
129107143|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Discharged|2|||
129107144|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Discharged|1|||
129107145|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Discharged|0|||
129107146|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
129107147|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
129107148|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
129107149|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
128683356|NCT01241240|463140643|FG001|Overall Study|Adverse Event|4|||
128683357|NCT01241240|463140642|FG000|Overall Study|Lost to Follow-up|2|||
128683358|NCT01241240|463140643|FG001|Overall Study|Lost to Follow-up|4|||
128683359|NCT01241240|463140642|FG000|Overall Study|Personal Reasons|1|||
128683360|NCT01241240|463140643|FG001|Overall Study|Personal Reasons|1|||
128683361|NCT01025154|463140647|FG000|Overall Study|Lost to Follow-up|1|||
128683362|NCT01025154|463140647|FG000|Overall Study|Withdrawal by Subject|1|||
128683363|NCT00542451|463140652|FG000|Overall Study|Adverse Event|31|||
128683364|NCT00542451|463140652|FG000|Overall Study|Withdrawal by Subject|30|||
128683365|NCT00542451|463140652|FG000|Overall Study|Physician Decision|4|||
128683366|NCT00542451|463140652|FG000|Overall Study|Recurrent disease|1|||
128683367|NCT00542451|463140652|FG000|Overall Study|unknown reason|1|||
128683368|NCT00542451|463140652|FG000|Overall Study|Death|2|||
128683369|NCT00542451|463140652|FG000|Overall Study|Lost to Follow-up|10|||
128683370|NCT05153473|463140653|FG000|Overall Study|Death|46|||
128683371|NCT05153473|463140653|FG000|Overall Study|Lost to Follow-up|3|||
128683372|NCT01582854|463140654|FG000|Overall Study|Death|8|||
128683373|NCT01582854|463140655|FG001|Overall Study|Death|5|||
128683374|NCT01582854|463140654|FG000|Overall Study|Adverse Event|2|||
128683375|NCT01582854|463140655|FG001|Overall Study|Adverse Event|3|||
128683376|NCT01582854|463140654|FG000|Overall Study|Withdrawal by Participant|8|||
128683377|NCT01582854|463140655|FG001|Overall Study|Withdrawal by Participant|11|||
128683378|NCT01582854|463140654|FG000|Overall Study|Lost to Follow-up|1|||
128683379|NCT01582854|463140655|FG001|Overall Study|Lost to Follow-up|2|||
129107150|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
129107151|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
129107152|NCT01990768|464686781|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
129107153|NCT01990768|464686782|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
129107154|NCT01990768|464686783|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
129107155|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
129107156|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
129107157|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
129107158|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
128683380|NCT01582854|463140654|FG000|Overall Study|Physician Decision|0|||
128683381|NCT01582854|463140655|FG001|Overall Study|Physician Decision|1|||
128683382|NCT01582854|463140654|FG000|Overall Study|Recurrent Stroke|13|||
128683383|NCT01582854|463140655|FG001|Overall Study|Recurrent Stroke|8|||
128683384|NCT01582854|463140654|FG000|Overall Study|Disallowed Concomitant Medication|3|||
128683385|NCT01582854|463140655|FG001|Overall Study|Disallowed Concomitant Medication|2|||
128683386|NCT01582854|463140654|FG000|Overall Study|Carotid or Neurosurgery|0|||
128883164|NCT01790126|463867266|FG002|Overall Study|Lost to Follow-up|1|||
128883165|NCT01790126|463867264|FG000|Overall Study|Adverse Event|0|||
128883166|NCT01790126|463867265|FG001|Overall Study|Adverse Event|2|||
128883167|NCT01790126|463867266|FG002|Overall Study|Adverse Event|0|||
128883168|NCT01790126|463867264|FG000|Overall Study|Death|2|||
128883169|NCT01790126|463867265|FG001|Overall Study|Death|0|||
128883170|NCT01790126|463867266|FG002|Overall Study|Death|0|||
128883171|NCT01790126|463867264|FG000|Overall Study|Radiographic Progression|3|||
128883172|NCT01790126|463867265|FG001|Overall Study|Radiographic Progression|1|||
128883173|NCT01790126|463867266|FG002|Overall Study|Radiographic Progression|0|||
128883174|NCT01128738|463867267|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
128883175|NCT01128738|463867268|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
128883176|NCT01128738|463867267|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
128883177|NCT01128738|463867268|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
128883178|NCT01128738|463867267|FG000|Second TP|Lost to Follow-up|0|||
128883179|NCT01128738|463867268|FG001|Second TP|Lost to Follow-up|1|||
128883180|NCT01128738|463867267|FG000|Second TP|Withdrawal by Subject|0|||
128883181|NCT01128738|463867268|FG001|Second TP|Withdrawal by Subject|2|||
128883182|NCT01178671|463867269|FG000|Overall Study|Adverse Event|4|||
128883183|NCT01178671|463867270|FG001|Overall Study|Adverse Event|6|||
128883184|NCT01178671|463867269|FG000|Overall Study|Protocol Violation|1|||
128883185|NCT01178671|463867270|FG001|Overall Study|Protocol Violation|1|||
128883186|NCT01178671|463867269|FG000|Overall Study|Lack of Efficacy|0|||
129107159|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
129107160|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
128883187|NCT01178671|463867270|FG001|Overall Study|Lack of Efficacy|1|||
128883188|NCT01178671|463867269|FG000|Overall Study|Lost to Follow-up|3|||
128883189|NCT01178671|463867270|FG001|Overall Study|Lost to Follow-up|1|||
128883190|NCT01178671|463867269|FG000|Overall Study|Physician Decision|4|||
128883191|NCT01178671|463867270|FG001|Overall Study|Physician Decision|6|||
128883192|NCT02435966|463867271|FG000|Overall Study|Withdrawal by Subject|0|||
128883193|NCT02435966|463867272|FG001|Overall Study|Withdrawal by Subject|1|||
128883194|NCT02435966|463867273|FG002|Overall Study|Withdrawal by Subject|0|||
128883195|NCT01211197|463867277|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128883196|NCT01211197|463867278|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128883197|NCT01211197|463867279|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
128883198|NCT01211197|463867280|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128883199|NCT01211197|463867281|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128883200|NCT01211197|463867282|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
128883201|NCT01211197|463867277|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
128883202|NCT01211197|463867278|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
128883203|NCT01211197|463867279|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
128883204|NCT01211197|463867280|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
128883205|NCT01211197|463867281|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
128883206|NCT01211197|463867282|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
128883207|NCT02349451|463867283|FG000|Overall Study|Withdrawal by Subject|0|||
128883208|NCT02349451|463867284|FG001|Overall Study|Withdrawal by Subject|1|||
128883209|NCT02349451|463867285|FG002|Overall Study|Withdrawal by Subject|2|||
128883210|NCT02349451|463867286|FG003|Overall Study|Withdrawal by Subject|1|||
128883211|NCT05116046|463867289|FG000|Overall Study|Withdrawal by parent/guardian|2|||
128883212|NCT05116046|463867290|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128883213|NCT05116046|463867291|FG002|Overall Study|Withdrawal by parent/guardian|1|||
128883214|NCT05116046|463867289|FG000|Overall Study|Study terminated by sponsor|14|||
128883215|NCT05116046|463867290|FG001|Overall Study|Study terminated by sponsor|16|||
128883216|NCT05116046|463867291|FG002|Overall Study|Study terminated by sponsor|1|||
128883217|NCT02683941|463867292|FG000|Double-blind Phase|Adverse Event|0|||
129107161|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
129107162|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
129107163|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
129107164|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
129107165|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
129107166|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
129107167|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
129107168|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
129107169|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
128883218|NCT02683941|463867293|FG001|Double-blind Phase|Adverse Event|1|||
128883219|NCT02683941|463867292|FG000|Double-blind Phase|Withdrawal by Subject|4|||
129107170|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
128883220|NCT02683941|463867293|FG001|Double-blind Phase|Withdrawal by Subject|2|||
128883221|NCT02683941|463867292|FG000|Double-blind Phase|Lost to Follow-up|1|||
128883222|NCT02683941|463867293|FG001|Double-blind Phase|Lost to Follow-up|0|||
128883223|NCT02683941|463867292|FG000|Double-blind Phase|Disease Progression|5|||
128883224|NCT02683941|463867293|FG001|Double-blind Phase|Disease Progression|2|||
128883225|NCT02683941|463867292|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
128883226|NCT02683941|463867293|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
128883227|NCT02683941|463867292|FG000|Open-label Treatment Phase|Disease Progression|1|||
128883228|NCT02683941|463867293|FG001|Open-label Treatment Phase|Disease Progression|2|||
128883229|NCT02683941|463867292|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
128883230|NCT02683941|463867293|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
128883231|NCT02683941|463867292|FG000|Open-label Treatment Phase|Other|1|||
128883232|NCT02683941|463867293|FG001|Open-label Treatment Phase|Other|0|||
128883233|NCT02683941|463867292|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
128883234|NCT02683941|463867293|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
128883235|NCT02683941|463867292|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
128883236|NCT02683941|463867293|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
128883237|NCT02683941|463867292|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
128883238|NCT02683941|463867293|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
128883239|NCT02683941|463867292|FG000|Open-label Follow-up Phase|Other|8|||
128883240|NCT02683941|463867293|FG001|Open-label Follow-up Phase|Other|1|||
128883241|NCT00261846|463867294|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
128883242|NCT00261846|463867295|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
128883243|NCT00261846|463867296|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
128883244|NCT00261846|463867297|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883245|NCT00261846|463867298|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883246|NCT00261846|463867299|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883247|NCT00261846|463867300|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883248|NCT00261846|463867301|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883249|NCT00261846|463867302|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883250|NCT00261846|463867303|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883251|NCT00261846|463867304|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883252|NCT00261846|463867305|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
128883253|NCT00261846|463867294|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883254|NCT00261846|463867295|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883255|NCT00261846|463867296|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883256|NCT00261846|463867297|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
128883257|NCT00261846|463867298|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883258|NCT00261846|463867299|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883259|NCT00261846|463867300|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883260|NCT00261846|463867301|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883261|NCT00261846|463867302|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
128883262|NCT00261846|463867303|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883263|NCT00261846|463867304|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883264|NCT00261846|463867305|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
128883265|NCT00261846|463867294|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
128883266|NCT00261846|463867295|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
128883267|NCT00261846|463867296|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
128883268|NCT00261846|463867297|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
128883269|NCT00261846|463867298|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
128883270|NCT00261846|463867299|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
128883271|NCT00261846|463867300|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
128883272|NCT00261846|463867301|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
128883273|NCT00261846|463867302|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
128883274|NCT00261846|463867303|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
128883275|NCT00261846|463867304|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
128883276|NCT00261846|463867305|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
128883277|NCT00261846|463867294|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
128883278|NCT00261846|463867295|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
128883279|NCT00261846|463867296|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
128883280|NCT00261846|463867297|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
128883281|NCT00261846|463867298|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
128883282|NCT00261846|463867299|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
128883283|NCT00261846|463867300|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
128883284|NCT00261846|463867301|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
128883285|NCT00261846|463867302|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
128883286|NCT00261846|463867303|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
128883287|NCT00261846|463867304|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
128883288|NCT00261846|463867305|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
128883289|NCT00261846|463867294|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
128883290|NCT00261846|463867295|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
128883291|NCT00261846|463867296|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
128883292|NCT00261846|463867297|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
128883293|NCT00261846|463867298|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
128883294|NCT00261846|463867299|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
128883295|NCT00261846|463867300|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
128883296|NCT00261846|463867301|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
128883297|NCT00261846|463867302|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
128883298|NCT00261846|463867303|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
128883299|NCT00261846|463867304|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
128883300|NCT00261846|463867305|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
129019104|NCT01597245|464363749|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019105|NCT01597245|464363750|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019106|NCT01597245|464363751|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019107|NCT01597245|464363752|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019108|NCT01597245|464363753|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019109|NCT01597245|464363754|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019110|NCT01597245|464363755|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019111|NCT01597245|464363756|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019112|NCT01597245|464363757|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
129019113|NCT01597245|464363758|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019114|NCT01597245|464363759|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019115|NCT01597245|464363760|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019116|NCT01597245|464363761|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019117|NCT01597245|464363762|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019118|NCT01597245|464363763|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019119|NCT01597245|464363764|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019120|NCT01597245|464363765|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019121|NCT01597245|464363766|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019122|NCT01597245|464363767|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129019123|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019124|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019125|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019126|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019127|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019128|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019129|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019130|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019131|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019132|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019133|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019134|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019135|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019136|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
129019137|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
129019138|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
129019139|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019140|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019141|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019142|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019143|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129019144|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019145|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019146|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019147|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019148|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019149|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019150|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019151|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019152|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019153|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019154|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019155|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019156|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019157|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
129019158|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
129019159|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
128883301|NCT00261846|463867294|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
128883302|NCT00261846|463867295|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
128883303|NCT00261846|463867296|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
129107171|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
129107172|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
129107173|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
129107174|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
129107175|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
129107176|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
129107177|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
129107178|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
129107179|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
129107180|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
129107181|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
129107182|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
129107183|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
129107184|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
129107185|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
129107186|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
129107187|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
129107188|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
129107189|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
129107190|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
129107191|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
129107192|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
129107193|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
129107194|NCT01990768|464686781|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
129107195|NCT01990768|464686782|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
129107196|NCT01990768|464686783|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
129107197|NCT01990768|464686781|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
129107198|NCT01990768|464686782|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
129107199|NCT01990768|464686783|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
129107200|NCT01990768|464686781|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
129107201|NCT01990768|464686782|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
129107202|NCT01990768|464686783|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
129107203|NCT01990768|464686781|FG000|6-Month Follow-up|No contact information|5|||
129107204|NCT01990768|464686782|FG001|6-Month Follow-up|No contact information|6|||
129107205|NCT01990768|464686783|FG002|6-Month Follow-up|No contact information|5|||
129107206|NCT01990768|464686781|FG000|6-Month Follow-up|Homeless|4|||
129107207|NCT01990768|464686782|FG001|6-Month Follow-up|Homeless|3|||
129107208|NCT01990768|464686783|FG002|6-Month Follow-up|Homeless|6|||
129107209|NCT01990768|464686781|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
129107210|NCT01990768|464686782|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
129107211|NCT01990768|464686783|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
129107212|NCT01990768|464686781|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
129107213|NCT01990768|464686782|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
129107214|NCT01990768|464686783|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
129107215|NCT01990768|464686781|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
129107216|NCT01990768|464686782|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
129107217|NCT01990768|464686783|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
129107218|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
129107219|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
129107220|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
129107221|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
129107222|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
129107223|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
129107224|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
129107225|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
129107226|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
129107227|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
129107228|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
129107229|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
129107230|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
129107231|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
129107232|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
129107233|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
129107234|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
129107235|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
129107236|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
128883304|NCT00261846|463867297|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
128883305|NCT00261846|463867298|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
128883306|NCT00261846|463867299|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
128883307|NCT00261846|463867300|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
128883308|NCT00261846|463867301|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
128883309|NCT00261846|463867302|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
128883310|NCT00261846|463867303|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
128883311|NCT00261846|463867304|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
128883312|NCT00261846|463867305|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
128883313|NCT00261846|463867294|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
128883314|NCT00261846|463867295|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
128883315|NCT00261846|463867296|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
128883316|NCT00261846|463867297|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
128883317|NCT00261846|463867298|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
128883318|NCT00261846|463867299|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
128883319|NCT00261846|463867300|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
128883320|NCT00261846|463867301|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
128883321|NCT00261846|463867302|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
128883322|NCT00261846|463867303|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
128883323|NCT00261846|463867304|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
128883324|NCT00261846|463867305|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
128883325|NCT00325039|463867306|FG000|Overall Study|Lost to Follow-up|18|||
128883326|NCT00325039|463867307|FG001|Overall Study|Lost to Follow-up|14|||
128883327|NCT01009203|463867308|FG000|Overall Study|Withdrawal by Subject|1|||
128883328|NCT01009203|463867308|FG000|Overall Study|Adverse Event|5|||
128883329|NCT01009203|463867308|FG000|Overall Study|Treatment-unrelated death|1|||
128883330|NCT00892723|463867309|FG000|Overall Study|Lost to Follow-up|1|||
128883331|NCT00892723|463867310|FG001|Overall Study|Lost to Follow-up|3|||
128883332|NCT00892723|463867311|FG002|Overall Study|Lost to Follow-up|1|||
128883333|NCT00892723|463867309|FG000|Overall Study|Withdrawal by Subject|1|||
128883334|NCT00892723|463867310|FG001|Overall Study|Withdrawal by Subject|1|||
128883335|NCT00892723|463867311|FG002|Overall Study|Withdrawal by Subject|1|||
128883336|NCT02974088|463867312|FG000|Overall Study|Lost to Follow-up|0|||
128883337|NCT02974088|463867313|FG001|Overall Study|Lost to Follow-up|2|||
128883338|NCT02974088|463867312|FG000|Overall Study|Adverse Event|0|||
128883339|NCT02974088|463867313|FG001|Overall Study|Adverse Event|1|||
128883340|NCT00150969|463867314|FG000|24 Month Main Study|Adverse Event|3|||
128883341|NCT00150969|463867315|FG001|24 Month Main Study|Adverse Event|4|||
128883342|NCT00150969|463867314|FG000|24 Month Main Study|Death|1|||
128883343|NCT00150969|463867315|FG001|24 Month Main Study|Death|1|||
128883344|NCT00150969|463867314|FG000|24 Month Main Study|Lack of Efficacy|1|||
128883345|NCT00150969|463867315|FG001|24 Month Main Study|Lack of Efficacy|8|||
128883346|NCT00150969|463867314|FG000|24 Month Main Study|Lost to Follow-up|3|||
128883347|NCT00150969|463867315|FG001|24 Month Main Study|Lost to Follow-up|2|||
128883348|NCT00150969|463867314|FG000|24 Month Main Study|Protocol Violation|4|||
128883349|NCT00150969|463867315|FG001|24 Month Main Study|Protocol Violation|2|||
128883350|NCT00150969|463867314|FG000|24 Month Main Study|Withdrawal by Subject|7|||
128883351|NCT00150969|463867315|FG001|24 Month Main Study|Withdrawal by Subject|4|||
129019160|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019161|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019162|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019163|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019164|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129019165|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019166|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019167|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019168|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019169|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019170|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019171|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019172|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019173|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
128883352|NCT00150969|463867314|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
128883353|NCT00150969|463867315|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
128883354|NCT00150969|463867314|FG000|24-48 Month Extension|Lack of Efficacy|0|||
128883355|NCT00150969|463867315|FG001|24-48 Month Extension|Lack of Efficacy|1|||
128883356|NCT00150969|463867314|FG000|24-48 Month Extension|Adverse Event|1|||
128883357|NCT00150969|463867315|FG001|24-48 Month Extension|Adverse Event|3|||
128883358|NCT00150969|463867314|FG000|24-48 Month Extension|Other Reason|81|||
128883359|NCT00150969|463867315|FG001|24-48 Month Extension|Other Reason|91|||
128883360|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
128883361|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
128883362|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
128883363|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
128883364|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
128883365|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
128883366|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
128883367|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
128883368|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
128883369|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
128883370|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
128883371|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
128883372|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
128883373|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
128883374|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
128883375|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
128883376|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
128883377|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
128883378|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
128883379|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
128883380|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
128883381|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
128883382|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
128883383|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
128883384|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
128883385|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
128883386|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
128883387|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
128883388|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
128883389|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
128883390|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Other|10|||
128883391|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Other|7|||
128883392|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Other|8|||
128883393|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Other|8|||
128883394|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Other|0|||
128883395|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
128883396|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
128883397|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
128883398|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
128883399|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
128883400|NCT00615836|463867316|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
128883401|NCT00615836|463867317|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
128883402|NCT00615836|463867318|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
128883403|NCT00615836|463867319|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129019174|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129107237|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
129107238|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
129107239|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
128683387|NCT01582854|463140655|FG001|Overall Study|Carotid or Neurosurgery|1|||
129019175|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019176|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019177|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019178|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019179|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
129019180|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
129019181|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019182|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019183|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019184|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019185|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129019186|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019187|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019188|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019189|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019190|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019191|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
128683388|NCT01582854|463140654|FG000|Overall Study|General Anaesthesia|0|||
128883404|NCT00615836|463867320|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
128883405|NCT01313689|463867321|FG000|24-Week Randomization 1|Adverse Event|10|||
128883406|NCT01313689|463867322|FG001|24-Week Randomization 1|Adverse Event|5|||
128883407|NCT01313689|463867323|FG002|24-Week Randomization 1|Adverse Event|0|||
128883408|NCT01313689|463867324|FG003|24-Week Randomization 1|Adverse Event|0|||
128883409|NCT01313689|463867325|FG004|24-Week Randomization 1|Adverse Event|0|||
128883410|NCT01313689|463867321|FG000|24-Week Randomization 1|Physician Decision|4|||
128883411|NCT01313689|463867322|FG001|24-Week Randomization 1|Physician Decision|5|||
129019192|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
128683389|NCT01582854|463140655|FG001|Overall Study|General Anaesthesia|1|||
128683390|NCT01582854|463140654|FG000|Overall Study|Other Miscellaneous Reason|1|||
128683391|NCT01582854|463140655|FG001|Overall Study|Other Miscellaneous Reason|0|||
128683392|NCT00064298|463140666|FG000|Overall Study|Withdrawal by Subject|2|||
128683393|NCT00064298|463140667|FG001|Overall Study|Withdrawal by Subject|1|||
128683394|NCT00064298|463140666|FG000|Overall Study|Lost to Follow-up|2|||
128683395|NCT00064298|463140667|FG001|Overall Study|Lost to Follow-up|2|||
128683396|NCT00064298|463140666|FG000|Overall Study|Death|0|||
128683397|NCT00064298|463140667|FG001|Overall Study|Death|1|||
128683398|NCT00064298|463140666|FG000|Overall Study|Disease Progression|2|||
128683399|NCT00064298|463140667|FG001|Overall Study|Disease Progression|1|||
128683400|NCT03614975|463140668|FG000|Overall Study|Physician Decision|7|||
128683401|NCT03614975|463140669|FG001|Overall Study|Physician Decision|5|||
128683402|NCT03614975|463140668|FG000|Overall Study|Withdrawal by Subject|2|||
128683403|NCT03614975|463140669|FG001|Overall Study|Withdrawal by Subject|2|||
128683404|NCT03614975|463140668|FG000|Overall Study|Specimens not in lab batch shipment|1|||
128683405|NCT03614975|463140669|FG001|Overall Study|Specimens not in lab batch shipment|1|||
128683406|NCT01569464|463140670|FG000|Overall Study|Adverse Event|4|||
128683407|NCT01569464|463140671|FG001|Overall Study|Adverse Event|0|||
128683408|NCT01569464|463140670|FG000|Overall Study|Lack of Efficacy|1|||
128683409|NCT01569464|463140671|FG001|Overall Study|Lack of Efficacy|0|||
128683410|NCT01569464|463140670|FG000|Overall Study|Protocol Violation|1|||
128683411|NCT01569464|463140671|FG001|Overall Study|Protocol Violation|0|||
128683412|NCT01569464|463140670|FG000|Overall Study|Lost to Follow-up|2|||
128683413|NCT01569464|463140671|FG001|Overall Study|Lost to Follow-up|3|||
128683414|NCT01569464|463140670|FG000|Overall Study|Withdrawal by Subject|1|||
128683415|NCT01569464|463140671|FG001|Overall Study|Withdrawal by Subject|1|||
128683416|NCT01569464|463140670|FG000|Overall Study|Other|1|||
128683417|NCT01569464|463140671|FG001|Overall Study|Other|1|||
128683418|NCT04718103|463140672|FG000|Overall Study|Adverse Event|1|||
128683419|NCT04718103|463140673|FG001|Overall Study|Adverse Event|1|||
128683420|NCT04718103|463140672|FG000|Overall Study|Lack of Efficacy|4|||
129019193|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019194|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019195|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019196|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019197|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019198|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019199|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019200|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
129019201|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
129019202|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019203|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019204|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019205|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019206|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129019207|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019208|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019209|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019210|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019211|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019212|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019213|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019214|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019215|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
128683421|NCT04718103|463140673|FG001|Overall Study|Lack of Efficacy|1|||
128683422|NCT04718103|463140672|FG000|Overall Study|Lost to Follow-up|2|||
128683423|NCT04718103|463140673|FG001|Overall Study|Lost to Follow-up|2|||
128683424|NCT04718103|463140672|FG000|Overall Study|Physician Decision|2|||
128683425|NCT04718103|463140673|FG001|Overall Study|Physician Decision|0|||
128683426|NCT04718103|463140672|FG000|Overall Study|Pregnancy|0|||
128683427|NCT04718103|463140673|FG001|Overall Study|Pregnancy|1|||
128683428|NCT04718103|463140672|FG000|Overall Study|Withdrawal by Subject|10|||
128683429|NCT04718103|463140673|FG001|Overall Study|Withdrawal by Subject|6|||
129107240|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
129107241|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
129107242|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
129107243|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
129107244|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
129107245|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
129107246|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
129107247|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
129107248|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
129107249|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
129107250|NCT03538691|464686784|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
129107251|NCT03538691|464686785|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
129107252|NCT03538691|464686786|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
129107253|NCT03538691|464686787|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
129107254|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
129107255|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
129107256|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
129107257|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
129107258|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
129107259|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
129215101|NCT01467960|465089442|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
128683430|NCT04718103|463140672|FG000|Overall Study|Randomized, not treated|4|||
128683431|NCT04718103|463140673|FG001|Overall Study|Randomized, not treated|1|||
128683432|NCT04718103|463140672|FG000|Overall Study|GCP violations|7|||
128683433|NCT04718103|463140673|FG001|Overall Study|GCP violations|5|||
128683434|NCT00136604|463140674|FG000|Overall Study|Lost to Follow-up|1|||
128683435|NCT00136604|463140675|FG001|Overall Study|Lost to Follow-up|0|||
128683436|NCT00136604|463140676|FG002|Overall Study|Lost to Follow-up|0|||
128683437|NCT00136604|463140677|FG003|Overall Study|Lost to Follow-up|0|||
128683438|NCT00136604|463140678|FG004|Overall Study|Lost to Follow-up|1|||
128683439|NCT00136604|463140674|FG000|Overall Study|Migrated/moved from study area|0|||
128683440|NCT00136604|463140675|FG001|Overall Study|Migrated/moved from study area|1|||
128683441|NCT00136604|463140676|FG002|Overall Study|Migrated/moved from study area|0|||
128683442|NCT00136604|463140677|FG003|Overall Study|Migrated/moved from study area|0|||
128683443|NCT00136604|463140678|FG004|Overall Study|Migrated/moved from study area|0|||
128683444|NCT00322153|463140679|FG000|Overall Study|Adverse Event|21|||
128683445|NCT00322153|463140680|FG001|Overall Study|Adverse Event|34|||
128683446|NCT00322153|463140679|FG000|Overall Study|Protocol Violation|6|||
128683447|NCT00322153|463140680|FG001|Overall Study|Protocol Violation|14|||
128683448|NCT00322153|463140679|FG000|Overall Study|Withdrawal by Subject|18|||
128683449|NCT00322153|463140680|FG001|Overall Study|Withdrawal by Subject|10|||
128683450|NCT00322153|463140679|FG000|Overall Study|Lack of Efficacy|8|||
128683451|NCT00322153|463140680|FG001|Overall Study|Lack of Efficacy|3|||
128683452|NCT00322153|463140679|FG000|Overall Study|Lost to Follow-up|5|||
128683453|NCT00322153|463140680|FG001|Overall Study|Lost to Follow-up|4|||
128683454|NCT00322153|463140679|FG000|Overall Study|Withdrawn for other reasons|5|||
128683455|NCT00322153|463140680|FG001|Overall Study|Withdrawn for other reasons|4|||
128683456|NCT01309893|463140682|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
128683457|NCT01309893|463140683|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
128683458|NCT01309893|463140682|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
128683459|NCT01309893|463140683|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
128683460|NCT00591578|463140684|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
128683461|NCT00591578|463140685|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
128683462|NCT00591578|463140686|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
128683463|NCT00591578|463140684|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
128683464|NCT00591578|463140685|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
128683465|NCT00591578|463140686|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
128683466|NCT00591578|463140684|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
128883412|NCT01313689|463867323|FG002|24-Week Randomization 1|Physician Decision|0|||
128883413|NCT01313689|463867324|FG003|24-Week Randomization 1|Physician Decision|0|||
128683467|NCT00591578|463140685|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
128683468|NCT00591578|463140686|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
128683469|NCT00591578|463140684|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
128683470|NCT00591578|463140685|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
128683471|NCT00591578|463140686|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
128683472|NCT00591578|463140684|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
128683473|NCT00591578|463140685|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
128683474|NCT00591578|463140686|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
128883414|NCT01313689|463867325|FG004|24-Week Randomization 1|Physician Decision|0|||
128883415|NCT01313689|463867321|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
128883416|NCT01313689|463867322|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
128883417|NCT01313689|463867323|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
128883418|NCT01313689|463867324|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
128883419|NCT01313689|463867325|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
128883420|NCT01313689|463867321|FG000|24-Week Randomization 2|Adverse Event|0|||
128883421|NCT01313689|463867322|FG001|24-Week Randomization 2|Adverse Event|0|||
128883422|NCT01313689|463867323|FG002|24-Week Randomization 2|Adverse Event|2|||
128883423|NCT01313689|463867324|FG003|24-Week Randomization 2|Adverse Event|0|||
128883424|NCT01313689|463867325|FG004|24-Week Randomization 2|Adverse Event|8|||
128883425|NCT01313689|463867321|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
128883426|NCT01313689|463867322|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
128883427|NCT01313689|463867323|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
128883428|NCT01313689|463867324|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
128883429|NCT01313689|463867325|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
128883430|NCT01313689|463867321|FG000|24-Week Randomization 2|Physician Decision|0|||
128883431|NCT01313689|463867322|FG001|24-Week Randomization 2|Physician Decision|0|||
128883432|NCT01313689|463867323|FG002|24-Week Randomization 2|Physician Decision|0|||
128883433|NCT01313689|463867324|FG003|24-Week Randomization 2|Physician Decision|0|||
129107260|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
129107261|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
129107262|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
128683475|NCT00591578|463140684|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
128683476|NCT00591578|463140685|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
128683477|NCT00591578|463140686|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
128683478|NCT00591578|463140684|FG000|Double-Blind Treatment Phase|Other|4|||
128683479|NCT00591578|463140685|FG001|Double-Blind Treatment Phase|Other|9|||
128683480|NCT00591578|463140686|FG002|Double-Blind Treatment Phase|Other|4|||
128683481|NCT00591578|463140684|FG000|Open-Label Extension Phase|Adverse Event|3|||
128683482|NCT00591578|463140685|FG001|Open-Label Extension Phase|Adverse Event|5|||
128683483|NCT00591578|463140686|FG002|Open-Label Extension Phase|Adverse Event|0|||
128683484|NCT00591578|463140684|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
128683485|NCT00591578|463140685|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
128683486|NCT00591578|463140686|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
128683487|NCT00591578|463140684|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
128683488|NCT00591578|463140685|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
128683489|NCT00591578|463140686|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
128683490|NCT00591578|463140684|FG000|Open-Label Extension Phase|Other|1|||
128683491|NCT00591578|463140685|FG001|Open-Label Extension Phase|Other|0|||
128683492|NCT00591578|463140686|FG002|Open-Label Extension Phase|Other|0|||
128683493|NCT03631355|463140687|FG000|Overall Study|Lost to Follow-up|1|||
128683494|NCT03631355|463140688|FG001|Overall Study|Lost to Follow-up|2|||
128683495|NCT02810340|463140689|FG000|Overall Study|Withdrawal by Subject|1|||
128683496|NCT02810340|463140690|FG001|Overall Study|Withdrawal by Subject|0|||
128683497|NCT02810340|463140691|FG002|Overall Study|Withdrawal by Subject|0|||
129107263|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
129107264|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
129107265|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
129107266|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
129107267|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
129107268|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
129107269|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
129107270|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
129107271|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
129107272|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
129107273|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
129107274|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
129107275|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
129107276|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
129107277|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
129107278|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
129107279|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
129107280|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
128683498|NCT02810340|463140689|FG000|Overall Study|Incarceration|0|||
128683499|NCT02810340|463140690|FG001|Overall Study|Incarceration|1|||
128683500|NCT02810340|463140691|FG002|Overall Study|Incarceration|0|||
128683501|NCT02810340|463140689|FG000|Overall Study|Lost to Follow-up|0|||
128883434|NCT01313689|463867325|FG004|24-Week Randomization 2|Physician Decision|4|||
129107281|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
129107282|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
129107283|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
129107284|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
129107285|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
129107286|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
129107287|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
129107288|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
129107289|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
129107290|NCT03538691|464686784|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129107291|NCT03538691|464686785|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
129107292|NCT03538691|464686786|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129107293|NCT03538691|464686787|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129107294|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
129107295|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
129107296|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
128683502|NCT02810340|463140690|FG001|Overall Study|Lost to Follow-up|0|||
128683503|NCT02810340|463140691|FG002|Overall Study|Lost to Follow-up|1|||
128683504|NCT03945175|463140692|FG000|Overall Study|Did not meet inclusion criteria|31|||
128683505|NCT03945175|463140692|FG000|Overall Study|Withdrew consent|2|||
128683506|NCT03945175|463140692|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
128683507|NCT03945175|463140692|FG000|Overall Study|Early termination during Mydayis treatment|1|||
128683508|NCT00870233|463140693|FG000|Overall Study|Withdrawal by Subject|18|||
128683509|NCT00870233|463140693|FG000|Overall Study|Did not undergo laparotomy|3|||
128683510|NCT00870233|463140693|FG000|Overall Study|Incompatible internet browser|2|||
128683511|NCT00870233|463140693|FG000|Overall Study|Death|1|||
128683512|NCT00378079|463140695|FG000|Overall Study|Lost to Follow-up|6|||
128683513|NCT00378079|463140696|FG001|Overall Study|Lost to Follow-up|1|||
128683514|NCT00378079|463140697|FG002|Overall Study|Lost to Follow-up|0|||
128683515|NCT01233687|463140698|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
128683516|NCT01233687|463140698|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
128683517|NCT01233687|463140698|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
128683518|NCT03500679|463140699|FG000|Overall Study|Lost to Follow-up|6|||
128683519|NCT03500679|463140700|FG001|Overall Study|Lost to Follow-up|3|||
128683520|NCT03500679|463140699|FG000|Overall Study|Withdrawal by Subject|3|||
128683521|NCT03500679|463140700|FG001|Overall Study|Withdrawal by Subject|0|||
128683522|NCT01962922|463140701|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
128683523|NCT01962922|463140702|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
128683524|NCT01962922|463140701|FG000|PK Portion Day 7|non-compliance|1|||
128683525|NCT01962922|463140702|FG001|PK Portion Day 7|non-compliance|0|||
128683526|NCT01962922|463140701|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
128683527|NCT01962922|463140702|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
128683528|NCT01962922|463140701|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
128683529|NCT01962922|463140702|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
128683530|NCT00495131|463140703|FG000|Overall Study|Adverse Event|6|||
128683531|NCT00495131|463140704|FG001|Overall Study|Adverse Event|2|||
128683532|NCT00495131|463140703|FG000|Overall Study|Lack of Efficacy|0|||
128683533|NCT00495131|463140704|FG001|Overall Study|Lack of Efficacy|2|||
128683534|NCT00495131|463140703|FG000|Overall Study|Lost to Follow-up|0|||
128683535|NCT00495131|463140704|FG001|Overall Study|Lost to Follow-up|2|||
128683536|NCT00495131|463140703|FG000|Overall Study|Withdrawal by Subject|1|||
128683537|NCT00495131|463140704|FG001|Overall Study|Withdrawal by Subject|0|||
128683538|NCT00744471|463140705|FG000|Overall Study|Randomized but not treated|1|||
128683539|NCT00744471|463140706|FG001|Overall Study|Randomized but not treated|1|||
128683540|NCT00744471|463140707|FG002|Overall Study|Randomized but not treated|4|||
128683541|NCT00744471|463140708|FG003|Overall Study|Randomized but not treated|0|||
128683542|NCT00744471|463140705|FG000|Overall Study|Death|0|||
128683543|NCT00744471|463140706|FG001|Overall Study|Death|0|||
128683544|NCT00744471|463140707|FG002|Overall Study|Death|0|||
128683545|NCT00744471|463140708|FG003|Overall Study|Death|1|||
128683546|NCT00744471|463140705|FG000|Overall Study|Adverse Event|6|||
128683547|NCT00744471|463140706|FG001|Overall Study|Adverse Event|7|||
128683548|NCT00744471|463140707|FG002|Overall Study|Adverse Event|5|||
128683549|NCT00744471|463140708|FG003|Overall Study|Adverse Event|9|||
128683550|NCT00744471|463140705|FG000|Overall Study|Withdrawal by Subject|9|||
128683551|NCT00744471|463140706|FG001|Overall Study|Withdrawal by Subject|9|||
128683552|NCT00744471|463140707|FG002|Overall Study|Withdrawal by Subject|15|||
128683553|NCT00744471|463140708|FG003|Overall Study|Withdrawal by Subject|12|||
128683554|NCT00744471|463140705|FG000|Overall Study|Protocol Violation|1|||
128683555|NCT00744471|463140706|FG001|Overall Study|Protocol Violation|4|||
128683556|NCT00744471|463140707|FG002|Overall Study|Protocol Violation|1|||
128683557|NCT00744471|463140708|FG003|Overall Study|Protocol Violation|2|||
128883435|NCT00687973|463867326|FG000|Overall Study|Adverse Event|18|||
128883436|NCT00687973|463867327|FG001|Overall Study|Adverse Event|28|||
128883437|NCT00687973|463867326|FG000|Overall Study|Lack of Efficacy|2|||
128883438|NCT00687973|463867327|FG001|Overall Study|Lack of Efficacy|3|||
128883439|NCT00687973|463867326|FG000|Overall Study|Protocol Violation|1|||
128883440|NCT00687973|463867327|FG001|Overall Study|Protocol Violation|2|||
128883441|NCT00687973|463867326|FG000|Overall Study|Administrative Reasons|0|||
128883442|NCT00687973|463867327|FG001|Overall Study|Administrative Reasons|2|||
128883443|NCT00687973|463867326|FG000|Overall Study|Withdrawal by Subject|3|||
128883444|NCT00687973|463867327|FG001|Overall Study|Withdrawal by Subject|3|||
128883445|NCT01007448|463867328|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
128883446|NCT01007448|463867329|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
128883447|NCT01007448|463867328|FG000|Overall Study|Staph Skin Infection Flare|1|||
128883448|NCT01007448|463867329|FG001|Overall Study|Staph Skin Infection Flare|0|||
128883449|NCT01007448|463867328|FG000|Overall Study|Participant Leaving the Country|1|||
128883450|NCT01007448|463867329|FG001|Overall Study|Participant Leaving the Country|0|||
128883451|NCT01007448|463867328|FG000|Overall Study|Participant Given Prohibited Medication|1|||
128883452|NCT01007448|463867329|FG001|Overall Study|Participant Given Prohibited Medication|0|||
128883453|NCT01007448|463867328|FG000|Overall Study|Progressive Disease|1|||
128883454|NCT01007448|463867329|FG001|Overall Study|Progressive Disease|2|||
128883455|NCT01007448|463867328|FG000|Overall Study|Lack of Efficacy|2|||
128883456|NCT01007448|463867329|FG001|Overall Study|Lack of Efficacy|0|||
128883457|NCT01007448|463867328|FG000|Overall Study|Withdrawal by Subject|2|||
128883458|NCT01007448|463867329|FG001|Overall Study|Withdrawal by Subject|3|||
128883459|NCT01007448|463867328|FG000|Overall Study|Adverse Event|1|||
128883460|NCT01007448|463867329|FG001|Overall Study|Adverse Event|4|||
128883461|NCT02121834|463867331|FG000|Overall Study|Protocol Violation|0|||
128883462|NCT02121834|463867332|FG001|Overall Study|Protocol Violation|1|||
128883463|NCT02121834|463867333|FG002|Overall Study|Protocol Violation|0|||
128883464|NCT02121834|463867334|FG003|Overall Study|Protocol Violation|0|||
128883465|NCT02121834|463867335|FG004|Overall Study|Protocol Violation|0|||
128883466|NCT02121834|463867336|FG005|Overall Study|Protocol Violation|0|||
128883467|NCT02121834|463867337|FG006|Overall Study|Protocol Violation|0|||
128883468|NCT02121834|463867331|FG000|Overall Study|Withdrawal by Subject|0|||
128683558|NCT00744471|463140705|FG000|Overall Study|Entered extension study|41|||
128683559|NCT00744471|463140706|FG001|Overall Study|Entered extension study|84|||
128683560|NCT00744471|463140707|FG002|Overall Study|Entered extension study|100|||
128683561|NCT00744471|463140708|FG003|Overall Study|Entered extension study|91|||
128683562|NCT00744471|463140705|FG000|Overall Study|Other|2|||
128683563|NCT00744471|463140706|FG001|Overall Study|Other|3|||
128683564|NCT00744471|463140707|FG002|Overall Study|Other|6|||
128683565|NCT00744471|463140708|FG003|Overall Study|Other|2|||
128683566|NCT00744471|463140705|FG000|Overall Study|Lack of Efficacy|83|||
128683567|NCT00744471|463140706|FG001|Overall Study|Lack of Efficacy|37|||
128683568|NCT00744471|463140707|FG002|Overall Study|Lack of Efficacy|19|||
128683569|NCT00744471|463140708|FG003|Overall Study|Lack of Efficacy|31|||
128683570|NCT00744471|463140705|FG000|Overall Study|Lost to Follow-up|0|||
128683571|NCT00744471|463140706|FG001|Overall Study|Lost to Follow-up|0|||
128683572|NCT00744471|463140707|FG002|Overall Study|Lost to Follow-up|2|||
128683573|NCT00744471|463140708|FG003|Overall Study|Lost to Follow-up|0|||
128683574|NCT03224546|463140709|FG000|Overall Study|Lost to Follow-up|9|||
128683575|NCT03224546|463140710|FG001|Overall Study|Lost to Follow-up|8|||
128683576|NCT03224546|463140711|FG002|Overall Study|Lost to Follow-up|3|||
128683577|NCT03224546|463140709|FG000|Overall Study|Withdrawal by Subject|7|||
128683578|NCT03224546|463140710|FG001|Overall Study|Withdrawal by Subject|14|||
128683579|NCT03224546|463140711|FG002|Overall Study|Withdrawal by Subject|12|||
128883469|NCT02121834|463867332|FG001|Overall Study|Withdrawal by Subject|1|||
128883470|NCT02121834|463867333|FG002|Overall Study|Withdrawal by Subject|1|||
129019216|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019217|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019218|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019219|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
128683580|NCT04706416|463140716|FG000|Overall Study|Lost to Follow-up|2|||
128683581|NCT04706416|463140717|FG001|Overall Study|Lost to Follow-up|0|||
128883471|NCT02121834|463867334|FG003|Overall Study|Withdrawal by Subject|0|||
129019220|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
128683582|NCT01539317|463140721|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
128883472|NCT02121834|463867335|FG004|Overall Study|Withdrawal by Subject|0|||
128883473|NCT02121834|463867336|FG005|Overall Study|Withdrawal by Subject|0|||
128883474|NCT02121834|463867337|FG006|Overall Study|Withdrawal by Subject|0|||
128883475|NCT02121834|463867331|FG000|Overall Study|Lost to Follow-up|0|||
128883476|NCT02121834|463867332|FG001|Overall Study|Lost to Follow-up|0|||
128883477|NCT02121834|463867333|FG002|Overall Study|Lost to Follow-up|1|||
128683583|NCT01539317|463140722|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
128683584|NCT00976573|463140729|FG000|Overall Study|Ineligible|0|||
128883478|NCT02121834|463867334|FG003|Overall Study|Lost to Follow-up|0|||
128883479|NCT02121834|463867335|FG004|Overall Study|Lost to Follow-up|0|||
128883480|NCT02121834|463867336|FG005|Overall Study|Lost to Follow-up|0|||
128883481|NCT02121834|463867337|FG006|Overall Study|Lost to Follow-up|0|||
128883482|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
128883483|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
128883484|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Death|0|||
128883485|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Death|2|||
128883486|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
128883487|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
128883488|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
128883489|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
128883490|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
128883491|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
128883492|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
128883493|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
128883494|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
128883495|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
128883496|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
128883497|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
128883498|NCT00343252|463867338|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
128883499|NCT00343252|463867339|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
128883500|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
128883501|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
128883502|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Death|3|||
128883503|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Death|3|||
128883504|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
128883505|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
128883506|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
128883507|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
128883508|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
128883509|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
128883510|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
128883511|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
128883512|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
128883513|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
128883514|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
128883515|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
128883516|NCT00343252|463867338|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
128883517|NCT00343252|463867339|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
128883518|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
128883519|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
128883520|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Death|4|||
128883521|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Death|5|||
128883522|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
128883523|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
128883524|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
128883525|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
128883526|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
128883527|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
128883528|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
128883529|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
128883530|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
128883531|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
128883532|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
128883533|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
128883534|NCT00343252|463867338|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
129107297|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
129107298|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
129107299|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
129107300|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
129107301|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
129107302|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
129107303|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
128883535|NCT00343252|463867339|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
129107304|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
129107305|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
128883536|NCT01740323|463867340|FG000|Overall Study|Adverse Event|1|||
128883537|NCT01740323|463867341|FG001|Overall Study|Adverse Event|0|||
128883538|NCT01740323|463867340|FG000|Overall Study|Randomized but did not take study drug|1|||
128883539|NCT01740323|463867341|FG001|Overall Study|Randomized but did not take study drug|0|||
128883540|NCT03353350|463867351|FG000|30-week Core Treatment Period|Protocol Violation|1|||
128883541|NCT03353350|463867352|FG001|30-week Core Treatment Period|Protocol Violation|1|||
128883542|NCT03353350|463867353|FG002|30-week Core Treatment Period|Protocol Violation|1|||
128883543|NCT03353350|463867354|FG003|30-week Core Treatment Period|Protocol Violation|0|||
128883544|NCT03353350|463867351|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
128883545|NCT03353350|463867352|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
128883546|NCT03353350|463867353|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
128883547|NCT03353350|463867354|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
128883548|NCT03353350|463867351|FG000|30-week Core Treatment Period|Adverse Event|0|||
128883549|NCT03353350|463867352|FG001|30-week Core Treatment Period|Adverse Event|4|||
128883550|NCT03353350|463867353|FG002|30-week Core Treatment Period|Adverse Event|2|||
128883551|NCT03353350|463867354|FG003|30-week Core Treatment Period|Adverse Event|3|||
128883552|NCT03353350|463867351|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
128883553|NCT03353350|463867352|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
128883554|NCT03353350|463867353|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
128883555|NCT03353350|463867354|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
128883556|NCT03353350|463867351|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
128883557|NCT03353350|463867352|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
128883558|NCT03353350|463867353|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
128883559|NCT03353350|463867354|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
128883560|NCT03353350|463867351|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
128883561|NCT03353350|463867352|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
128883562|NCT03353350|463867353|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
128883563|NCT03353350|463867354|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
128883564|NCT03353350|463867351|FG000|26-week Treatment Extension Period|Adverse Event|1|||
128883565|NCT03353350|463867352|FG001|26-week Treatment Extension Period|Adverse Event|0|||
128883566|NCT03353350|463867353|FG002|26-week Treatment Extension Period|Adverse Event|0|||
128883567|NCT03353350|463867354|FG003|26-week Treatment Extension Period|Adverse Event|1|||
128883568|NCT03353350|463867351|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
128883569|NCT03353350|463867352|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
128883570|NCT03353350|463867353|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
128883571|NCT03353350|463867354|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
128883572|NCT01423253|463867356|FG000|Overall Study|Adverse Event|2|||
128883573|NCT01423253|463867356|FG000|Overall Study|Lack of Efficacy|2|||
128883574|NCT01423253|463867356|FG000|Overall Study|Lost to Follow-up|1|||
128883575|NCT01423253|463867356|FG000|Overall Study|Protocol Violation|2|||
128883576|NCT01423253|463867356|FG000|Overall Study|Withdrawal by Subject|2|||
128883577|NCT00307125|463867359|FG000|Screening Phase|Adverse Event|1|||
128883578|NCT00307125|463867360|FG001|Screening Phase|Adverse Event|0|||
128883579|NCT00307125|463867361|FG002|Screening Phase|Adverse Event|0|||
128883580|NCT00307125|463867359|FG000|Screening Phase|Protocol Violation|27|||
128883581|NCT00307125|463867360|FG001|Screening Phase|Protocol Violation|0|||
128883582|NCT00307125|463867361|FG002|Screening Phase|Protocol Violation|0|||
128883583|NCT00307125|463867359|FG000|Screening Phase|Lost to Follow-up|87|||
128883584|NCT00307125|463867360|FG001|Screening Phase|Lost to Follow-up|0|||
128883585|NCT00307125|463867361|FG002|Screening Phase|Lost to Follow-up|0|||
128883586|NCT00307125|463867359|FG000|Screening Phase|Death|10|||
128883587|NCT00307125|463867360|FG001|Screening Phase|Death|0|||
128883588|NCT00307125|463867361|FG002|Screening Phase|Death|0|||
129107306|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
128883589|NCT00307125|463867359|FG000|Screening Phase|Withdrawal by Subject|77|||
128883590|NCT00307125|463867360|FG001|Screening Phase|Withdrawal by Subject|0|||
128883591|NCT00307125|463867361|FG002|Screening Phase|Withdrawal by Subject|0|||
128883592|NCT00307125|463867359|FG000|Screening Phase|Physician Decision|26|||
128683585|NCT00976573|463140730|FG001|Overall Study|Ineligible|1|||
128883593|NCT00307125|463867360|FG001|Screening Phase|Physician Decision|0|||
128883594|NCT00307125|463867361|FG002|Screening Phase|Physician Decision|0|||
128883595|NCT00307125|463867359|FG000|Screening Phase|Sponsor Decision|4|||
128883596|NCT00307125|463867360|FG001|Screening Phase|Sponsor Decision|0|||
128883597|NCT00307125|463867361|FG002|Screening Phase|Sponsor Decision|0|||
128883598|NCT00307125|463867359|FG000|Screening Phase|Study Terminated|17|||
128883599|NCT00307125|463867360|FG001|Screening Phase|Study Terminated|0|||
128883600|NCT00307125|463867361|FG002|Screening Phase|Study Terminated|0|||
128883601|NCT00307125|463867359|FG000|Screening Phase|Graft Loss|3|||
129107307|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
129107308|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
129107309|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
129215102|NCT01467960|465089443|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
129215103|NCT01467960|465089444|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
129215104|NCT01467960|465089445|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
129215105|NCT01467960|465089446|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
129215106|NCT01467960|465089447|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
128683586|NCT00976573|463140729|FG000|Overall Study|Cancel prior to receiving treatment|4|||
128683587|NCT00976573|463140730|FG001|Overall Study|Cancel prior to receiving treatment|2|||
128683588|NCT02117427|463140731|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
128683589|NCT02117427|463140732|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
128683590|NCT02117427|463140733|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
128683591|NCT02117427|463140731|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
128683592|NCT02117427|463140732|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
128683593|NCT02117427|463140733|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
128683594|NCT02117427|463140731|FG000|Overall Study|Physician Decision|0|||
128683595|NCT02117427|463140732|FG001|Overall Study|Physician Decision|2|||
128683596|NCT02117427|463140733|FG002|Overall Study|Physician Decision|0|||
128683597|NCT02117427|463140731|FG000|Overall Study|No longer meets inclusion criteria|0|||
128683598|NCT02117427|463140732|FG001|Overall Study|No longer meets inclusion criteria|1|||
128683599|NCT02117427|463140733|FG002|Overall Study|No longer meets inclusion criteria|0|||
128683600|NCT02117427|463140731|FG000|Overall Study|Death|0|||
128683601|NCT02117427|463140732|FG001|Overall Study|Death|1|||
128683602|NCT02117427|463140733|FG002|Overall Study|Death|0|||
128683603|NCT02730208|463140734|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
128683604|NCT02730208|463140735|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
128683605|NCT00510952|463140741|FG000|Overall Study|Adverse Event|1|||
128683606|NCT00510952|463140742|FG001|Overall Study|Adverse Event|0|||
128683607|NCT00510952|463140741|FG000|Overall Study|Entry Criteria Not Met|3|||
128683608|NCT00510952|463140742|FG001|Overall Study|Entry Criteria Not Met|1|||
128683609|NCT00510952|463140741|FG000|Overall Study|Lost to Follow-up|5|||
128683610|NCT00510952|463140742|FG001|Overall Study|Lost to Follow-up|3|||
128683611|NCT00510952|463140741|FG000|Overall Study|Physician Decision|1|||
128683612|NCT00510952|463140742|FG001|Overall Study|Physician Decision|1|||
128683613|NCT00510952|463140741|FG000|Overall Study|Protocol Violation|7|||
128683614|NCT00510952|463140742|FG001|Overall Study|Protocol Violation|4|||
128683615|NCT00510952|463140741|FG000|Overall Study|Sponsor Decision|1|||
128683616|NCT00510952|463140742|FG001|Overall Study|Sponsor Decision|0|||
128683617|NCT00510952|463140741|FG000|Overall Study|Withdrawal by Subject|6|||
128683618|NCT00510952|463140742|FG001|Overall Study|Withdrawal by Subject|7|||
128683619|NCT00510952|463140741|FG000|Overall Study|Did Not Receive Study Drug|2|||
128683620|NCT00510952|463140742|FG001|Overall Study|Did Not Receive Study Drug|0|||
128683621|NCT02793128|463140752|FG000|Overall Study|Death|4|||
128683622|NCT02793128|463140752|FG000|Overall Study|Withdrawal by Subject|2|||
128683623|NCT02793128|463140752|FG000|Overall Study|Physician Decision|1|||
128683624|NCT02793128|463140752|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
128683625|NCT02793128|463140752|FG000|Overall Study|Patient elected nephroureterectomy|1|||
128683626|NCT02359851|463140753|FG000|Overall Study|Death|1|||
128683627|NCT02359851|463140753|FG000|Overall Study|Disease progression|1|||
128683628|NCT01888003|463140754|FG000|Overall Study|Study Terminated|5|||
128683629|NCT01888003|463140755|FG001|Overall Study|Study Terminated|6|||
128683630|NCT01888003|463140756|FG002|Overall Study|Study Terminated|40|||
128683631|NCT00055471|463140757|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
128683632|NCT00055471|463140758|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
128683633|NCT00055471|463140759|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
128683634|NCT00055471|463140757|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
128683635|NCT00055471|463140758|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
128683636|NCT00055471|463140759|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
128683637|NCT00055471|463140757|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
128683638|NCT00055471|463140758|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
128683639|NCT00055471|463140759|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
128683640|NCT01854944|463140760|FG000|Overall Study|Withdrawal by Subject|0|||
128683641|NCT01854944|463140761|FG001|Overall Study|Withdrawal by Subject|0|||
129215107|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
129215108|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
128683642|NCT01854944|463140762|FG002|Overall Study|Withdrawal by Subject|1|||
128683643|NCT02101112|463140763|FG000|Overall Study|Adverse Event|0|||
128683644|NCT02101112|463140764|FG001|Overall Study|Adverse Event|0|||
128683645|NCT02101112|463140765|FG002|Overall Study|Adverse Event|1|||
129215109|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
129215110|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
128683646|NCT02101112|463140766|FG003|Overall Study|Adverse Event|0|||
128683647|NCT02101112|463140767|FG004|Overall Study|Adverse Event|0|||
129215111|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Adverse Event|2|||
128683648|NCT02101112|463140768|FG005|Overall Study|Adverse Event|0|||
128683649|NCT02101112|463140763|FG000|Overall Study|Withdrawal by Subject|0|||
128683650|NCT02101112|463140764|FG001|Overall Study|Withdrawal by Subject|0|||
128683651|NCT02101112|463140765|FG002|Overall Study|Withdrawal by Subject|0|||
128683652|NCT02101112|463140766|FG003|Overall Study|Withdrawal by Subject|0|||
128683653|NCT02101112|463140767|FG004|Overall Study|Withdrawal by Subject|1|||
128683654|NCT02101112|463140768|FG005|Overall Study|Withdrawal by Subject|0|||
128683655|NCT02125604|463140769|FG000|Overall Study|Other|4|||
128683656|NCT02125604|463140769|FG000|Overall Study|Investigator Decision|1|||
128683657|NCT02125604|463140769|FG000|Overall Study|Lost to Follow-up|2|||
128683658|NCT02125604|463140769|FG000|Overall Study|Consent Withdrawn|4|||
128683659|NCT02125604|463140769|FG000|Overall Study|Adverse Event|20|||
128683660|NCT04340063|463140770|FG000|Overall Study|Withdrawal by Subject|1|||
128683661|NCT04340063|463140771|FG001|Overall Study|Withdrawal by Subject|2|||
128683662|NCT04340063|463140770|FG000|Overall Study|Lost to Follow-up|3|||
128683663|NCT04340063|463140771|FG001|Overall Study|Lost to Follow-up|1|||
128883602|NCT00307125|463867360|FG001|Screening Phase|Graft Loss|0|||
128883603|NCT00307125|463867361|FG002|Screening Phase|Graft Loss|0|||
128883604|NCT00307125|463867359|FG000|Screening Phase|Graft Failure|8|||
128883605|NCT00307125|463867360|FG001|Screening Phase|Graft Failure|0|||
128883606|NCT00307125|463867361|FG002|Screening Phase|Graft Failure|0|||
128883607|NCT00307125|463867359|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
128883608|NCT00307125|463867360|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
128883609|NCT00307125|463867361|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
128883610|NCT00307125|463867359|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
128883611|NCT00307125|463867360|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
128883612|NCT00307125|463867361|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
128883613|NCT00307125|463867359|FG000|Screening Phase|Moved or transferred facilities|34|||
128883614|NCT00307125|463867360|FG001|Screening Phase|Moved or transferred facilities|0|||
128883615|NCT00307125|463867361|FG002|Screening Phase|Moved or transferred facilities|0|||
128883616|NCT00307125|463867359|FG000|Screening Phase|Received Pancreas Transplant|8|||
128883617|NCT00307125|463867360|FG001|Screening Phase|Received Pancreas Transplant|0|||
128883618|NCT00307125|463867361|FG002|Screening Phase|Received Pancreas Transplant|0|||
128883619|NCT00307125|463867359|FG000|Screening Phase|Ineligible for pilot|4|||
128883620|NCT00307125|463867360|FG001|Screening Phase|Ineligible for pilot|0|||
128883621|NCT00307125|463867361|FG002|Screening Phase|Ineligible for pilot|0|||
128883622|NCT00307125|463867359|FG000|Screening Phase|Try to get pregnant|1|||
128883623|NCT00307125|463867360|FG001|Screening Phase|Try to get pregnant|0|||
128883624|NCT00307125|463867361|FG002|Screening Phase|Try to get pregnant|0|||
128883625|NCT00307125|463867359|FG000|Screening Phase|Developed acute leukemia|1|||
128883626|NCT00307125|463867360|FG001|Screening Phase|Developed acute leukemia|0|||
128883627|NCT00307125|463867361|FG002|Screening Phase|Developed acute leukemia|0|||
128883628|NCT00307125|463867359|FG000|Screening Phase|Metastatic colon cancer|1|||
128883629|NCT00307125|463867360|FG001|Screening Phase|Metastatic colon cancer|0|||
128883630|NCT00307125|463867361|FG002|Screening Phase|Metastatic colon cancer|0|||
128883631|NCT00307125|463867359|FG000|Screening Phase|Malignancy|1|||
128883632|NCT00307125|463867360|FG001|Screening Phase|Malignancy|0|||
128883633|NCT00307125|463867361|FG002|Screening Phase|Malignancy|0|||
128883634|NCT00307125|463867359|FG000|Screening Phase|PAK|1|||
128883635|NCT00307125|463867360|FG001|Screening Phase|PAK|0|||
128883636|NCT00307125|463867361|FG002|Screening Phase|PAK|0|||
128883637|NCT00307125|463867359|FG000|Screening Phase|Ineligible|1|||
128883638|NCT00307125|463867360|FG001|Screening Phase|Ineligible|0|||
128883639|NCT00307125|463867361|FG002|Screening Phase|Ineligible|0|||
128883640|NCT00307125|463867359|FG000|Screening Phase|Screen Error|1|||
128883641|NCT00307125|463867360|FG001|Screening Phase|Screen Error|0|||
128883642|NCT00307125|463867361|FG002|Screening Phase|Screen Error|0|||
128883643|NCT00307125|463867359|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
128883644|NCT00307125|463867360|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
128883645|NCT00307125|463867361|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
128883646|NCT00307125|463867359|FG000|Screening Phase|AMR and treated with rituximab|1|||
128683664|NCT04340063|463140770|FG000|Overall Study|Protocol Violation|0|||
128683665|NCT04340063|463140771|FG001|Overall Study|Protocol Violation|1|||
128883647|NCT00307125|463867360|FG001|Screening Phase|AMR and treated with rituximab|0|||
128883648|NCT00307125|463867361|FG002|Screening Phase|AMR and treated with rituximab|0|||
128883649|NCT00307125|463867359|FG000|Screening Phase|Coronary artery bypass|1|||
128883650|NCT00307125|463867360|FG001|Screening Phase|Coronary artery bypass|0|||
128883651|NCT00307125|463867361|FG002|Screening Phase|Coronary artery bypass|0|||
128883652|NCT00307125|463867359|FG000|Pilot Phase|Lost to Follow-up|0|||
128883653|NCT00307125|463867360|FG001|Pilot Phase|Lost to Follow-up|1|||
128883654|NCT00307125|463867361|FG002|Pilot Phase|Lost to Follow-up|0|||
128683666|NCT01876810|463140772|FG000|Overall Study|Physician Decision|0|||
128683667|NCT01876810|463140773|FG001|Overall Study|Physician Decision|1|||
128683668|NCT03670836|463140774|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
128883655|NCT00307125|463867359|FG000|Pilot Phase|Withdrawal by Subject|0|||
128883656|NCT00307125|463867360|FG001|Pilot Phase|Withdrawal by Subject|1|||
128883657|NCT00307125|463867361|FG002|Pilot Phase|Withdrawal by Subject|1|||
129019221|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
129215112|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Adverse Event|5|||
129215113|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Adverse Event|1|||
129215114|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Adverse Event|2|||
129215115|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Death|13|||
129215116|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Death|17|||
129215117|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Death|1|||
129215118|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Death|0|||
129215119|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
129215120|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
129107310|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
129107311|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
129107312|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
129107313|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
129107314|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
129107315|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
129107316|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
129107317|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
129107318|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
129107319|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
129107320|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
129215121|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
129215122|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
128683669|NCT03670836|463140775|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
128683670|NCT03670836|463140774|FG000|Per Protocol Population (PP)|Physician Decision|9|||
128683671|NCT03670836|463140775|FG001|Per Protocol Population (PP)|Physician Decision|10|||
128683672|NCT03670836|463140774|FG000|Per Protocol Population (PP)|Physician Decision|4|||
128683673|NCT03670836|463140775|FG001|Per Protocol Population (PP)|Physician Decision|6|||
128683674|NCT03670836|463140774|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
128683675|NCT03670836|463140775|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
128683676|NCT00543855|463142502|FG000|Overall Study|Adverse Event|3|||
128683677|NCT00543855|463142503|FG001|Overall Study|Adverse Event|1|||
128683678|NCT00543855|463142504|FG002|Overall Study|Adverse Event|3|||
128683679|NCT00543855|463142505|FG003|Overall Study|Adverse Event|4|||
128683680|NCT00543855|463142502|FG000|Overall Study|Lost to Follow-up|0|||
128683681|NCT00543855|463142503|FG001|Overall Study|Lost to Follow-up|0|||
128683682|NCT00543855|463142504|FG002|Overall Study|Lost to Follow-up|1|||
128683683|NCT00543855|463142505|FG003|Overall Study|Lost to Follow-up|0|||
128683684|NCT00543855|463142502|FG000|Overall Study|Withdrawal by Subject|0|||
128683685|NCT00543855|463142503|FG001|Overall Study|Withdrawal by Subject|1|||
128683686|NCT00543855|463142504|FG002|Overall Study|Withdrawal by Subject|2|||
128683687|NCT00543855|463142505|FG003|Overall Study|Withdrawal by Subject|0|||
128683688|NCT00543855|463142502|FG000|Overall Study|Protocol Violation|1|||
128683689|NCT00543855|463142503|FG001|Overall Study|Protocol Violation|0|||
128683690|NCT00543855|463142504|FG002|Overall Study|Protocol Violation|0|||
129019222|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
129019223|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019224|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019225|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019226|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019227|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129019228|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019229|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019230|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019231|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019232|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019233|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019234|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019235|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019236|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019237|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019238|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019239|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019240|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019241|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019242|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
129019243|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
128683691|NCT00543855|463142505|FG003|Overall Study|Protocol Violation|0|||
128683692|NCT04444895|463142507|FG000|Overall Study|Adverse Event|2|||
128683693|NCT04444895|463142507|FG000|Overall Study|Lost to Follow-up|2|||
128883658|NCT00147823|463867364|FG000|Overall Study|Lost to Follow-up|6|||
128883659|NCT00147823|463867365|FG001|Overall Study|Lost to Follow-up|12|||
128883660|NCT00147823|463867364|FG000|Overall Study|Physician Decision|1|||
128883661|NCT00147823|463867365|FG001|Overall Study|Physician Decision|0|||
128883662|NCT00147823|463867364|FG000|Overall Study|Withdrawal by Subject|0|||
128883663|NCT00147823|463867365|FG001|Overall Study|Withdrawal by Subject|1|||
128883664|NCT00147823|463867364|FG000|Overall Study|Did not receive vitoss due to infection|6|||
128883665|NCT00147823|463867365|FG001|Overall Study|Did not receive vitoss due to infection|2|||
128883666|NCT01012713|463867366|FG000|Overall Study|Lack of Efficacy|3|||
128883667|NCT02571049|463867367|FG000|Screening|Did not meet entry criteria|2|||
128883668|NCT02571049|463867368|FG001|Screening|Did not meet entry criteria|2|||
128883669|NCT02571049|463867367|FG000|Randomization|No migraine attack|0|||
128883670|NCT02571049|463867368|FG001|Randomization|No migraine attack|1|||
128883671|NCT02571049|463867367|FG000|Randomization|Adverse Event|0|||
128883672|NCT02571049|463867368|FG001|Randomization|Adverse Event|1|||
128883673|NCT01055262|463867369|FG000|Overall Study|Adverse Event|5|||
128883674|NCT01055262|463867369|FG000|Overall Study|Protocol Violation|3|||
128883675|NCT01055262|463867369|FG000|Overall Study|Uncooperativeness|1|||
128883676|NCT03370471|463867370|FG000|Overall Study|Withdrawal by Subject|6|||
128883677|NCT03370471|463867371|FG001|Overall Study|Withdrawal by Subject|1|||
128883678|NCT03370471|463867370|FG000|Overall Study|Unable to access veins for blood draw|0|||
128883679|NCT03370471|463867371|FG001|Overall Study|Unable to access veins for blood draw|1|||
128883680|NCT03370471|463867370|FG000|Overall Study|Screen fail|1|||
128883681|NCT03370471|463867371|FG001|Overall Study|Screen fail|0|||
128883682|NCT00561951|463867372|FG000|Overall Study|Adverse Event|11|||
128883683|NCT00561951|463867373|FG001|Overall Study|Adverse Event|14|||
128883684|NCT00561951|463867374|FG002|Overall Study|Adverse Event|14|||
128883685|NCT00561951|463867372|FG000|Overall Study|Lack of Efficacy|5|||
128883686|NCT00561951|463867373|FG001|Overall Study|Lack of Efficacy|3|||
128883687|NCT00561951|463867374|FG002|Overall Study|Lack of Efficacy|2|||
128883688|NCT00561951|463867372|FG000|Overall Study|Lost to Follow-up|1|||
128883689|NCT00561951|463867373|FG001|Overall Study|Lost to Follow-up|1|||
128883690|NCT00561951|463867374|FG002|Overall Study|Lost to Follow-up|0|||
128883691|NCT00561951|463867372|FG000|Overall Study|Withdrawal by Subject|10|||
128883692|NCT00561951|463867373|FG001|Overall Study|Withdrawal by Subject|9|||
128883693|NCT00561951|463867374|FG002|Overall Study|Withdrawal by Subject|10|||
128883694|NCT00561951|463867372|FG000|Overall Study|Protocol Violation|4|||
128883695|NCT00561951|463867373|FG001|Overall Study|Protocol Violation|3|||
128883696|NCT00561951|463867374|FG002|Overall Study|Protocol Violation|4|||
128883697|NCT00561951|463867372|FG000|Overall Study|Physician Decision|1|||
128883698|NCT00561951|463867373|FG001|Overall Study|Physician Decision|0|||
128883699|NCT00561951|463867374|FG002|Overall Study|Physician Decision|0|||
128883700|NCT00561951|463867372|FG000|Overall Study|Pregnancy|0|||
128883701|NCT00561951|463867373|FG001|Overall Study|Pregnancy|1|||
128883702|NCT00561951|463867374|FG002|Overall Study|Pregnancy|0|||
129019244|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019245|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019246|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019247|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019248|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
129019249|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019250|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019251|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019252|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019253|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019254|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019255|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019256|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019257|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019258|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019259|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129107321|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
128883703|NCT00561951|463867372|FG000|Overall Study|Meet Withdrawal Criterion|0|||
128883704|NCT00561951|463867373|FG001|Overall Study|Meet Withdrawal Criterion|1|||
128883705|NCT00561951|463867374|FG002|Overall Study|Meet Withdrawal Criterion|1|||
128883706|NCT00561951|463867372|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
128883707|NCT00561951|463867373|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
128883708|NCT00561951|463867374|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
128883709|NCT00392327|463867386|FG000|Overall Study|Death|1|||
128883710|NCT00392327|463867387|FG001|Overall Study|Death|0|||
128883711|NCT00392327|463867388|FG002|Overall Study|Death|1|||
128883712|NCT00392327|463867389|FG003|Overall Study|Death|0|||
128883713|NCT00392327|463867390|FG004|Overall Study|Death|0|||
128883714|NCT00392327|463867391|FG005|Overall Study|Death|0|||
128883715|NCT00392327|463867392|FG006|Overall Study|Death|0|||
128883716|NCT00392327|463867393|FG007|Overall Study|Death|0|||
128883717|NCT00392327|463867386|FG000|Overall Study|Lack of Efficacy|8|||
128883718|NCT00392327|463867387|FG001|Overall Study|Lack of Efficacy|8|||
128883719|NCT00392327|463867388|FG002|Overall Study|Lack of Efficacy|9|||
128883720|NCT00392327|463867389|FG003|Overall Study|Lack of Efficacy|6|||
128883721|NCT00392327|463867390|FG004|Overall Study|Lack of Efficacy|3|||
128883722|NCT00392327|463867391|FG005|Overall Study|Lack of Efficacy|3|||
128883723|NCT00392327|463867392|FG006|Overall Study|Lack of Efficacy|3|||
128883724|NCT00392327|463867393|FG007|Overall Study|Lack of Efficacy|3|||
128883725|NCT00392327|463867386|FG000|Overall Study|Physician Decision|3|||
128883726|NCT00392327|463867387|FG001|Overall Study|Physician Decision|5|||
128883727|NCT00392327|463867388|FG002|Overall Study|Physician Decision|2|||
128883728|NCT00392327|463867389|FG003|Overall Study|Physician Decision|2|||
128883729|NCT00392327|463867390|FG004|Overall Study|Physician Decision|0|||
128883730|NCT00392327|463867391|FG005|Overall Study|Physician Decision|1|||
128883731|NCT00392327|463867392|FG006|Overall Study|Physician Decision|5|||
128883732|NCT00392327|463867393|FG007|Overall Study|Physician Decision|3|||
128883733|NCT00392327|463867386|FG000|Overall Study|Protocol Violation|0|||
128883734|NCT00392327|463867387|FG001|Overall Study|Protocol Violation|0|||
128883735|NCT00392327|463867388|FG002|Overall Study|Protocol Violation|1|||
128883736|NCT00392327|463867389|FG003|Overall Study|Protocol Violation|0|||
128883737|NCT00392327|463867390|FG004|Overall Study|Protocol Violation|0|||
128883738|NCT00392327|463867391|FG005|Overall Study|Protocol Violation|0|||
128883739|NCT00392327|463867392|FG006|Overall Study|Protocol Violation|0|||
128883740|NCT00392327|463867393|FG007|Overall Study|Protocol Violation|0|||
128883741|NCT00392327|463867386|FG000|Overall Study|Withdrawal by Subject|3|||
128883742|NCT00392327|463867387|FG001|Overall Study|Withdrawal by Subject|2|||
128883743|NCT00392327|463867388|FG002|Overall Study|Withdrawal by Subject|4|||
128883744|NCT00392327|463867389|FG003|Overall Study|Withdrawal by Subject|6|||
128883745|NCT00392327|463867390|FG004|Overall Study|Withdrawal by Subject|0|||
128883746|NCT00392327|463867391|FG005|Overall Study|Withdrawal by Subject|1|||
128883747|NCT00392327|463867392|FG006|Overall Study|Withdrawal by Subject|1|||
128883748|NCT00392327|463867393|FG007|Overall Study|Withdrawal by Subject|5|||
128883749|NCT00392327|463867386|FG000|Overall Study|Ineligible|0|||
128883750|NCT00392327|463867387|FG001|Overall Study|Ineligible|4|||
128883751|NCT00392327|463867388|FG002|Overall Study|Ineligible|3|||
128883752|NCT00392327|463867389|FG003|Overall Study|Ineligible|2|||
128883753|NCT00392327|463867390|FG004|Overall Study|Ineligible|0|||
128883754|NCT00392327|463867391|FG005|Overall Study|Ineligible|0|||
128883755|NCT00392327|463867392|FG006|Overall Study|Ineligible|0|||
128883756|NCT00392327|463867393|FG007|Overall Study|Ineligible|0|||
128883757|NCT04508023|463867394|FG000|Overall Study|Withdrawal by Subject|1|||
128883758|NCT04508023|463867395|FG001|Overall Study|Withdrawal by Subject|2|||
128883759|NCT03261700|463867400|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
128883760|NCT03261700|463867401|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
128883761|NCT01340196|463869239|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
128883762|NCT00171704|463869242|FG000|Overall Study|Adverse Event|24|||
128883763|NCT00171704|463869243|FG001|Overall Study|Adverse Event|33|||
128883764|NCT00171704|463869242|FG000|Overall Study|Disease Progression|14|||
128883765|NCT00171704|463869243|FG001|Overall Study|Disease Progression|9|||
128883766|NCT00171704|463869242|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
128883767|NCT00171704|463869243|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
128883768|NCT00171704|463869242|FG000|Overall Study|Administrative Problems|2|||
128883769|NCT00171704|463869243|FG001|Overall Study|Administrative Problems|1|||
128883770|NCT00171704|463869242|FG000|Overall Study|Death|2|||
128883771|NCT00171704|463869243|FG001|Overall Study|Death|2|||
128883772|NCT00171704|463869242|FG000|Overall Study|Withdrawal by Subject|1|||
128883773|NCT00171704|463869243|FG001|Overall Study|Withdrawal by Subject|3|||
128883774|NCT00171704|463869242|FG000|Overall Study|Protocol Violation|0|||
128883775|NCT00171704|463869243|FG001|Overall Study|Protocol Violation|1|||
128883776|NCT02141984|463869244|FG000|Overall Study|Lack of Efficacy|2|||
128883777|NCT00816400|463869248|FG000|Overall Study|Death|2|||
128763161|NCT00860067|463422766|FG001|Overall Study|Withdrawal by Subject|0|||
128883778|NCT00816400|463869249|FG001|Overall Study|Death|3|||
128883779|NCT00816400|463869250|FG002|Overall Study|Death|3|||
128763162|NCT00860067|463422767|FG002|Overall Study|Withdrawal by Subject|0|||
128883780|NCT00816400|463869251|FG003|Overall Study|Death|3|||
128883781|NCT00816400|463869252|FG004|Overall Study|Death|2|||
128883782|NCT00816400|463869253|FG005|Overall Study|Death|3|||
128883783|NCT00816400|463869254|FG006|Overall Study|Death|2|||
128883784|NCT00816400|463869255|FG007|Overall Study|Death|5|||
128883785|NCT00816400|463869256|FG008|Overall Study|Death|6|||
128883786|NCT00816400|463869248|FG000|Overall Study|In hospice care at the end of the study|0|||
129019260|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
128883787|NCT00816400|463869249|FG001|Overall Study|In hospice care at the end of the study|0|||
128883788|NCT00816400|463869250|FG002|Overall Study|In hospice care at the end of the study|2|||
128883789|NCT00816400|463869251|FG003|Overall Study|In hospice care at the end of the study|0|||
128883790|NCT00816400|463869252|FG004|Overall Study|In hospice care at the end of the study|0|||
128883791|NCT00816400|463869253|FG005|Overall Study|In hospice care at the end of the study|0|||
128883792|NCT00816400|463869254|FG006|Overall Study|In hospice care at the end of the study|0|||
128883793|NCT00816400|463869255|FG007|Overall Study|In hospice care at the end of the study|0|||
128883794|NCT00816400|463869256|FG008|Overall Study|In hospice care at the end of the study|0|||
128883795|NCT00081770|463869257|FG000|Overall Study|Adverse Event|130|||
128883796|NCT00081770|463869258|FG001|Overall Study|Adverse Event|98|||
128883797|NCT00081770|463869259|FG002|Overall Study|Adverse Event|136|||
128883798|NCT00081770|463869257|FG000|Overall Study|Lack of Efficacy|262|||
129107322|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
129107323|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
129107324|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
129107325|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
129107326|NCT03538691|464686784|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129107327|NCT03538691|464686785|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129107328|NCT03538691|464686786|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
129107329|NCT03538691|464686787|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
129107330|NCT06597084|464686788|FG000|Overall Study|Withdrawal by Subject|4|||
129107331|NCT06597084|464686789|FG001|Overall Study|Withdrawal by Subject|9|||
129107332|NCT06597084|464686788|FG000|Overall Study|Consent was not given by the patient until V2|0|||
129107333|NCT06597084|464686789|FG001|Overall Study|Consent was not given by the patient until V2|3|||
129107334|NCT06597084|464686788|FG000|Overall Study|Physician Decision|1|||
128883799|NCT00081770|463869258|FG001|Overall Study|Lack of Efficacy|357|||
128883800|NCT00081770|463869259|FG002|Overall Study|Lack of Efficacy|211|||
128683694|NCT04444895|463142507|FG000|Overall Study|Withdrawal by Subject|5|||
128683695|NCT05523323|463142508|FG000|Overall Study|Death|26|||
128683696|NCT05523323|463142509|FG001|Overall Study|Death|21|||
128683697|NCT05523323|463142508|FG000|Overall Study|Ongoing participants|35|||
128683698|NCT05523323|463142509|FG001|Overall Study|Ongoing participants|30|||
128683699|NCT03435640|463142510|FG000|Overall Study|Withdrawal by Subject|0|||
128683700|NCT03435640|463142511|FG001|Overall Study|Withdrawal by Subject|1|||
128683701|NCT03435640|463142512|FG002|Overall Study|Withdrawal by Subject|0|||
128683702|NCT03435640|463142513|FG003|Overall Study|Withdrawal by Subject|2|||
128683703|NCT03435640|463142514|FG004|Overall Study|Withdrawal by Subject|0|||
128683704|NCT03435640|463142515|FG005|Overall Study|Withdrawal by Subject|0|||
128683705|NCT03435640|463142516|FG006|Overall Study|Withdrawal by Subject|3|||
128683706|NCT03435640|463142517|FG007|Overall Study|Withdrawal by Subject|0|||
128683707|NCT03435640|463142518|FG008|Overall Study|Withdrawal by Subject|0|||
128683708|NCT03435640|463142519|FG009|Overall Study|Withdrawal by Subject|2|||
128683709|NCT03435640|463142520|FG010|Overall Study|Withdrawal by Subject|3|||
129107335|NCT06597084|464686789|FG001|Overall Study|Physician Decision|0|||
129107336|NCT06597084|464686788|FG000|Overall Study|Adverse Event|3|||
129107337|NCT06597084|464686789|FG001|Overall Study|Adverse Event|2|||
129107338|NCT06597084|464686788|FG000|Overall Study|Death|4|||
129107339|NCT06597084|464686789|FG001|Overall Study|Death|0|||
129107340|NCT06597084|464686788|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
129107341|NCT06597084|464686789|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
129107342|NCT06597084|464686788|FG000|Overall Study|Lost to Follow-up|4|||
129107343|NCT06597084|464686789|FG001|Overall Study|Lost to Follow-up|2|||
129107344|NCT06597084|464686788|FG000|Overall Study|Other. Not specified|1|||
129107345|NCT06597084|464686789|FG001|Overall Study|Other. Not specified|0|||
129107346|NCT01588405|464686790|FG000|Overall Study|Adverse Event|1|||
129107347|NCT01588405|464686790|FG000|Overall Study|Clinical Worsening|1|||
129107348|NCT02029274|464686796|FG000|Overall Study|Adverse Event|1|||
129107349|NCT02029274|464686797|FG001|Overall Study|Adverse Event|0|||
129107350|NCT02029274|464686798|FG002|Overall Study|Adverse Event|2|||
129107351|NCT02029274|464686799|FG003|Overall Study|Adverse Event|2|||
129107352|NCT05251233|464688391|FG000|Overall Study|Disease progression - did not start treatment|0|||
129107353|NCT05251233|464688392|FG001|Overall Study|Disease progression - did not start treatment|0|||
129107354|NCT05251233|464688393|FG002|Overall Study|Disease progression - did not start treatment|5|||
128683710|NCT03435640|463142510|FG000|Overall Study|Lost to Follow-up|0|||
128683711|NCT03435640|463142511|FG001|Overall Study|Lost to Follow-up|0|||
128683712|NCT03435640|463142512|FG002|Overall Study|Lost to Follow-up|1|||
128683713|NCT03435640|463142513|FG003|Overall Study|Lost to Follow-up|0|||
128883801|NCT00081770|463869257|FG000|Overall Study|Lost to Follow-up|45|||
129107355|NCT05251233|464688391|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
129107356|NCT05251233|464688392|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
129107357|NCT05251233|464688393|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
128683714|NCT03435640|463142514|FG004|Overall Study|Lost to Follow-up|0|||
128683715|NCT03435640|463142515|FG005|Overall Study|Lost to Follow-up|0|||
128683716|NCT03435640|463142516|FG006|Overall Study|Lost to Follow-up|0|||
128683717|NCT03435640|463142517|FG007|Overall Study|Lost to Follow-up|0|||
128683718|NCT03435640|463142518|FG008|Overall Study|Lost to Follow-up|0|||
128683719|NCT03435640|463142519|FG009|Overall Study|Lost to Follow-up|0|||
129107358|NCT05251233|464688391|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
129107359|NCT05251233|464688392|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
129107360|NCT05251233|464688393|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
129107361|NCT05251233|464688391|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
129107362|NCT05251233|464688392|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
129107363|NCT05251233|464688393|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
129107364|NCT05251233|464688391|FG000|Overall Study|Death - did not start treatment|3|||
129107365|NCT05251233|464688392|FG001|Overall Study|Death - did not start treatment|0|||
129107366|NCT05251233|464688393|FG002|Overall Study|Death - did not start treatment|0|||
129107367|NCT05251233|464688391|FG000|Overall Study|Withdrawal by Subject|2|||
129107368|NCT05251233|464688392|FG001|Overall Study|Withdrawal by Subject|2|||
129107369|NCT05251233|464688393|FG002|Overall Study|Withdrawal by Subject|0|||
129107370|NCT05251233|464688391|FG000|Overall Study|Other complicating disease|2|||
129107371|NCT05251233|464688392|FG001|Overall Study|Other complicating disease|1|||
129107372|NCT05251233|464688393|FG002|Overall Study|Other complicating disease|0|||
129107373|NCT05251233|464688391|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
129107374|NCT05251233|464688392|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
129107375|NCT05251233|464688393|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
129107376|NCT05251233|464688391|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
128683720|NCT03435640|463142520|FG010|Overall Study|Lost to Follow-up|0|||
128683721|NCT00920829|463142528|FG000|Allocation|No post randomization data|3|||
128683722|NCT00920829|463142529|FG001|Allocation|No post randomization data|1|||
128683723|NCT00920829|463142530|FG002|Allocation|No post randomization data|0|||
128683724|NCT00920829|463142531|FG003|Allocation|No post randomization data|2|||
128683725|NCT00920829|463142528|FG000|Available for Analysis|Withdrawal by Subject|6|||
128683726|NCT00920829|463142529|FG001|Available for Analysis|Withdrawal by Subject|6|||
128683727|NCT00920829|463142530|FG002|Available for Analysis|Withdrawal by Subject|6|||
128683728|NCT00920829|463142531|FG003|Available for Analysis|Withdrawal by Subject|10|||
128683729|NCT00920829|463142528|FG000|Available for Analysis|Required Medical Treatment|0|||
128683730|NCT00920829|463142529|FG001|Available for Analysis|Required Medical Treatment|1|||
128683731|NCT00920829|463142530|FG002|Available for Analysis|Required Medical Treatment|2|||
128683732|NCT00920829|463142531|FG003|Available for Analysis|Required Medical Treatment|0|||
128683733|NCT00920829|463142528|FG000|Available for Analysis|Adverse Event|1|||
128683734|NCT00920829|463142529|FG001|Available for Analysis|Adverse Event|2|||
128683735|NCT00920829|463142530|FG002|Available for Analysis|Adverse Event|1|||
128683736|NCT00920829|463142531|FG003|Available for Analysis|Adverse Event|0|||
128683737|NCT00920829|463142528|FG000|Available for Analysis|Death|1|||
128683738|NCT00920829|463142529|FG001|Available for Analysis|Death|0|||
128683739|NCT00920829|463142530|FG002|Available for Analysis|Death|0|||
128683740|NCT00920829|463142531|FG003|Available for Analysis|Death|0|||
128683741|NCT00920829|463142528|FG000|Available for Analysis|Protocol Violation|0|||
128683742|NCT00920829|463142529|FG001|Available for Analysis|Protocol Violation|0|||
128683743|NCT00920829|463142530|FG002|Available for Analysis|Protocol Violation|1|||
128683744|NCT00920829|463142531|FG003|Available for Analysis|Protocol Violation|0|||
128683745|NCT00920829|463142528|FG000|Available for Analysis|Required more treatment|0|||
128683746|NCT00920829|463142529|FG001|Available for Analysis|Required more treatment|2|||
128683747|NCT00920829|463142530|FG002|Available for Analysis|Required more treatment|0|||
128683748|NCT00920829|463142531|FG003|Available for Analysis|Required more treatment|1|||
128683749|NCT04533880|463142532|FG000|Overall Study|Lost to Follow-up|0|||
128683750|NCT04533880|463142533|FG001|Overall Study|Lost to Follow-up|1|||
128683751|NCT04533880|463142534|FG002|Overall Study|Lost to Follow-up|1|||
128683752|NCT01711879|463142539|FG000|Overall Study|Death|1|||
128683753|NCT01711879|463142540|FG001|Overall Study|Death|0|||
128683754|NCT02239224|463142545|FG000|Overall Study|Administrative|0|||
128683755|NCT02239224|463142546|FG001|Overall Study|Administrative|0|||
128683756|NCT02239224|463142547|FG002|Overall Study|Administrative|3|||
128683757|NCT02239224|463142548|FG003|Overall Study|Administrative|1|||
128683758|NCT03183778|463142549|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
128683759|NCT01466179|463142551|FG000|Overall Study|Ongoing in core study|2|||
128683760|NCT01466179|463142551|FG000|Overall Study|Physician Decision|46|||
128683761|NCT01466179|463142551|FG000|Overall Study|Progressive disease|43|||
128683762|NCT01466179|463142551|FG000|Overall Study|Adverse Event|32|||
128683763|NCT01466179|463142551|FG000|Overall Study|Disease relapse|23|||
128683764|NCT01466179|463142551|FG000|Overall Study|Lack of Efficacy|14|||
128683765|NCT01466179|463142551|FG000|Overall Study|Death|7|||
128683766|NCT01466179|463142551|FG000|Overall Study|Withdrawal by Subject|7|||
128683767|NCT01466179|463142551|FG000|Overall Study|Protocol Violation|2|||
128683768|NCT01466179|463142551|FG000|Overall Study|Other|3|||
128683769|NCT00749580|463142552|FG000|Overall Study|Lost to Follow-up|4|||
128683770|NCT00749580|463142553|FG001|Overall Study|Lost to Follow-up|8|||
128683771|NCT00749580|463142552|FG000|Overall Study|Adverse Event|0|||
128683772|NCT00749580|463142553|FG001|Overall Study|Adverse Event|1|||
128683773|NCT03489551|463142560|FG000|Overall Study|Withdrawal by Subject|2|||
128683774|NCT00054717|463142561|FG000|Overall Study|Randomized but not treated|2|||
128683775|NCT00054717|463142562|FG001|Overall Study|Randomized but not treated|8|||
128683776|NCT00054717|463142561|FG000|Overall Study|Adverse Event|70|||
128683777|NCT00054717|463142562|FG001|Overall Study|Adverse Event|22|||
128683778|NCT00054717|463142561|FG000|Overall Study|Protocol Violation|18|||
128883802|NCT00081770|463869258|FG001|Overall Study|Lost to Follow-up|34|||
128883803|NCT00081770|463869259|FG002|Overall Study|Lost to Follow-up|45|||
128883804|NCT00081770|463869257|FG000|Overall Study|Protocol Violation|15|||
128883805|NCT00081770|463869258|FG001|Overall Study|Protocol Violation|10|||
128883806|NCT00081770|463869259|FG002|Overall Study|Protocol Violation|10|||
128883807|NCT00081770|463869257|FG000|Overall Study|Withdrawal by Subject|45|||
128883808|NCT00081770|463869258|FG001|Overall Study|Withdrawal by Subject|40|||
128883809|NCT00081770|463869259|FG002|Overall Study|Withdrawal by Subject|42|||
128883810|NCT00081770|463869257|FG000|Overall Study|Did not meet protocol eligibility|2|||
128883811|NCT00081770|463869258|FG001|Overall Study|Did not meet protocol eligibility|0|||
128883812|NCT00081770|463869259|FG002|Overall Study|Did not meet protocol eligibility|3|||
128883813|NCT00081770|463869257|FG000|Overall Study|Administrative|1|||
128883814|NCT00081770|463869258|FG001|Overall Study|Administrative|0|||
128883815|NCT00081770|463869259|FG002|Overall Study|Administrative|1|||
128883816|NCT00081770|463869257|FG000|Overall Study|Other|2|||
128883817|NCT00081770|463869258|FG001|Overall Study|Other|7|||
128883818|NCT00081770|463869259|FG002|Overall Study|Other|8|||
128883819|NCT00601419|463869260|FG000|Overall Study|Lost to Follow-up|3|||
128883820|NCT00601419|463869260|FG000|Overall Study|Missed Visits|1|||
128883821|NCT01614197|463869261|FG000|Overall Study|Withdrawal by Subject|0|||
128883822|NCT01614197|463869262|FG001|Overall Study|Withdrawal by Subject|1|||
128883823|NCT01614197|463869263|FG002|Overall Study|Withdrawal by Subject|0|||
128883824|NCT01614197|463869264|FG003|Overall Study|Withdrawal by Subject|0|||
128883825|NCT00288509|463869267|FG000|Treatment Cycle 1|Adverse Event|1|||
128883826|NCT00288509|463869267|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
128883827|NCT00288509|463869267|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
128883828|NCT00288509|463869267|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
128883829|NCT00288509|463869267|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
128883830|NCT00288509|463869267|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
128883831|NCT00288509|463869267|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
128883832|NCT00288509|463869267|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
128883833|NCT00288509|463869267|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
128883834|NCT00288509|463869267|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
128883835|NCT00288509|463869267|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
128883836|NCT00288509|463869267|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
128883837|NCT00288509|463869267|FG000|Treatment Cycle 4|Physician Decision|4|||
128883838|NCT00288509|463869267|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
128883839|NCT02864381|463869272|FG000|Overall Study|Death|58|||
128883840|NCT02864381|463869273|FG001|Overall Study|Death|61|||
128883841|NCT02864381|463869272|FG000|Overall Study|Withdrew Consent|5|||
128883842|NCT02864381|463869273|FG001|Overall Study|Withdrew Consent|6|||
128883843|NCT02864381|463869272|FG000|Overall Study|Reason Unknown|7|||
128883844|NCT02864381|463869273|FG001|Overall Study|Reason Unknown|3|||
128883845|NCT02864381|463869272|FG000|Overall Study|Lost to Follow-up|1|||
128883846|NCT02864381|463869273|FG001|Overall Study|Lost to Follow-up|1|||
128883847|NCT02864381|463869272|FG000|Overall Study|Investigator's Discretion|1|||
128883848|NCT02864381|463869273|FG001|Overall Study|Investigator's Discretion|0|||
128883849|NCT02864381|463869272|FG000|Overall Study|Protocol Violation|0|||
128883850|NCT02864381|463869273|FG001|Overall Study|Protocol Violation|1|||
128883851|NCT01146054|463869274|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
129107377|NCT05251233|464688392|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
129107378|NCT05251233|464688393|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
129107379|NCT03272347|464688398|FG000|Overall Study|Death|0|||
128683779|NCT00054717|463142562|FG001|Overall Study|Protocol Violation|19|||
128883852|NCT01146054|463869274|FG000|Overall Study|Rapid tumor progression|2|||
128883853|NCT01146054|463869274|FG000|Overall Study|Other illness precluded treatment|2|||
128883854|NCT01146054|463869274|FG000|Overall Study|Lost to Follow-up|1|||
128883855|NCT04335812|463869275|FG000|Overall Study|Withdrawal by Subject|1|||
129107380|NCT03272347|464688399|FG001|Overall Study|Death|0|||
129107381|NCT03272347|464688400|FG002|Overall Study|Death|0|||
129107382|NCT03272347|464688401|FG003|Overall Study|Death|1|||
128883856|NCT04335812|463869276|FG001|Overall Study|Withdrawal by Subject|3|||
128683780|NCT00054717|463142561|FG000|Overall Study|Lost to Follow-up|23|||
128683781|NCT00054717|463142562|FG001|Overall Study|Lost to Follow-up|13|||
128883857|NCT04335812|463869275|FG000|Overall Study|Lost to Follow-up|12|||
128883858|NCT04335812|463869276|FG001|Overall Study|Lost to Follow-up|12|||
128883859|NCT04335812|463869275|FG000|Overall Study|Did not engage in the intervention|22|||
128883860|NCT04335812|463869276|FG001|Overall Study|Did not engage in the intervention|18|||
128883861|NCT03840486|463869292|FG000|Overall Study|Withdrawal by Subject|0|||
128883862|NCT03840486|463869293|FG001|Overall Study|Withdrawal by Subject|1|||
128883863|NCT03840486|463869294|FG002|Overall Study|Withdrawal by Subject|0|||
128883864|NCT03840486|463869295|FG003|Overall Study|Withdrawal by Subject|0|||
128883865|NCT03840486|463869296|FG004|Overall Study|Withdrawal by Subject|0|||
128883866|NCT03840486|463869297|FG005|Overall Study|Withdrawal by Subject|0|||
128883867|NCT03840486|463869298|FG006|Overall Study|Withdrawal by Subject|0|||
128883868|NCT03840486|463869299|FG007|Overall Study|Withdrawal by Subject|0|||
128883869|NCT03840486|463869300|FG008|Overall Study|Withdrawal by Subject|0|||
128883870|NCT03840486|463869301|FG009|Overall Study|Withdrawal by Subject|0|||
128883871|NCT03840486|463869302|FG010|Overall Study|Withdrawal by Subject|0|||
128883872|NCT03840486|463869303|FG011|Overall Study|Withdrawal by Subject|0|||
128883873|NCT01139021|463869304|FG000|Overall Study|Adverse Event|0|||
128883874|NCT01139021|463869305|FG001|Overall Study|Adverse Event|0|||
128883875|NCT01139021|463869306|FG002|Overall Study|Adverse Event|0|||
128883876|NCT01139021|463869307|FG003|Overall Study|Adverse Event|0|||
128883877|NCT01139021|463869308|FG004|Overall Study|Adverse Event|1|||
128883878|NCT01139021|463869309|FG005|Overall Study|Adverse Event|0|||
128883879|NCT01139021|463869304|FG000|Overall Study|Lost to Follow-up|0|||
128883880|NCT01139021|463869305|FG001|Overall Study|Lost to Follow-up|0|||
128883881|NCT01139021|463869306|FG002|Overall Study|Lost to Follow-up|0|||
128883882|NCT01139021|463869307|FG003|Overall Study|Lost to Follow-up|0|||
128883883|NCT01139021|463869308|FG004|Overall Study|Lost to Follow-up|2|||
128883884|NCT01139021|463869309|FG005|Overall Study|Lost to Follow-up|0|||
128883885|NCT01139021|463869304|FG000|Overall Study|Protocol Violation|1|||
128883886|NCT01139021|463869305|FG001|Overall Study|Protocol Violation|0|||
128883887|NCT01139021|463869306|FG002|Overall Study|Protocol Violation|0|||
128883888|NCT01139021|463869307|FG003|Overall Study|Protocol Violation|0|||
128883889|NCT01139021|463869308|FG004|Overall Study|Protocol Violation|2|||
128883890|NCT01139021|463869309|FG005|Overall Study|Protocol Violation|0|||
128883891|NCT01139021|463869304|FG000|Overall Study|Withdrawal by Subject|0|||
128883892|NCT01139021|463869305|FG001|Overall Study|Withdrawal by Subject|0|||
128883893|NCT01139021|463869306|FG002|Overall Study|Withdrawal by Subject|0|||
128883894|NCT01139021|463869307|FG003|Overall Study|Withdrawal by Subject|1|||
128883895|NCT01139021|463869308|FG004|Overall Study|Withdrawal by Subject|4|||
128883896|NCT01139021|463869309|FG005|Overall Study|Withdrawal by Subject|0|||
128883897|NCT01978262|463869310|FG000|Overall Study|Withdrawal by Subject|9|||
128883898|NCT01978262|463869310|FG000|Overall Study|Lost to Follow-up|2|||
128883899|NCT02168842|463869312|FG000|Overall Study|Withdrawal by Subject|5|||
128883900|NCT02168842|463869313|FG001|Overall Study|Withdrawal by Subject|3|||
128883901|NCT02168842|463869312|FG000|Overall Study|Lost to Follow-up|0|||
128883902|NCT02168842|463869313|FG001|Overall Study|Lost to Follow-up|2|||
128883903|NCT02168842|463869312|FG000|Overall Study|Death|2|||
128883904|NCT02168842|463869313|FG001|Overall Study|Death|1|||
128883905|NCT02168842|463869312|FG000|Overall Study|Physician Decision|1|||
128883906|NCT02168842|463869313|FG001|Overall Study|Physician Decision|2|||
128883907|NCT02019927|463869318|FG000|Overall Study|Lost to Follow-up|2|||
128883908|NCT02019927|463869319|FG001|Overall Study|Lost to Follow-up|4|||
128883909|NCT02019927|463869320|FG002|Overall Study|Lost to Follow-up|1|||
128883910|NCT02019927|463869321|FG003|Overall Study|Lost to Follow-up|2|||
128883911|NCT02019927|463869322|FG004|Overall Study|Lost to Follow-up|3|||
128883912|NCT02019927|463869323|FG005|Overall Study|Lost to Follow-up|1|||
128883913|NCT03945825|463869326|FG000|Overall Study|Enrolled but treatment not administered|0|||
128883914|NCT03945825|463869327|FG001|Overall Study|Enrolled but treatment not administered|0|||
128883915|NCT03945825|463869328|FG002|Overall Study|Enrolled but treatment not administered|0|||
128883916|NCT03945825|463869329|FG003|Overall Study|Enrolled but treatment not administered|0|||
128883917|NCT03945825|463869330|FG004|Overall Study|Enrolled but treatment not administered|1|||
128883918|NCT03945825|463869331|FG005|Overall Study|Enrolled but treatment not administered|0|||
128883919|NCT03945825|463869326|FG000|Overall Study|Lost to Follow-up|1|||
129019261|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019262|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019263|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
129019264|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
129019265|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019266|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019267|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019268|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
128883920|NCT03945825|463869327|FG001|Overall Study|Lost to Follow-up|5|||
128883921|NCT03945825|463869328|FG002|Overall Study|Lost to Follow-up|0|||
128883922|NCT03945825|463869329|FG003|Overall Study|Lost to Follow-up|1|||
128883923|NCT03945825|463869330|FG004|Overall Study|Lost to Follow-up|2|||
128883924|NCT03945825|463869331|FG005|Overall Study|Lost to Follow-up|2|||
128883925|NCT03945825|463869326|FG000|Overall Study|Withdrawal by Subject|1|||
128883926|NCT03945825|463869327|FG001|Overall Study|Withdrawal by Subject|0|||
128883927|NCT03945825|463869328|FG002|Overall Study|Withdrawal by Subject|1|||
128883928|NCT03945825|463869329|FG003|Overall Study|Withdrawal by Subject|1|||
128883929|NCT03945825|463869330|FG004|Overall Study|Withdrawal by Subject|0|||
128883930|NCT03945825|463869331|FG005|Overall Study|Withdrawal by Subject|1|||
128883931|NCT01592864|463869334|FG000|Overall Study|Withdrawal by Subject|0|||
128883932|NCT01592864|463869335|FG001|Overall Study|Withdrawal by Subject|1|||
128883933|NCT00051363|463869341|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
128883934|NCT00051363|463869342|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
128883935|NCT00051363|463869341|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
128883936|NCT00051363|463869342|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
128883937|NCT00051363|463869341|FG000|Overall Study|Death|2|||
128883938|NCT00051363|463869342|FG001|Overall Study|Death|2|||
128883939|NCT00051363|463869341|FG000|Overall Study|Excluded Pre-Randomization|2|||
128883940|NCT00051363|463869342|FG001|Overall Study|Excluded Pre-Randomization|5|||
128883941|NCT01032382|463869343|FG000|Overall Study|Disease dissemination|1|||
128883942|NCT01032382|463869344|FG001|Overall Study|Disease dissemination|1|||
128883943|NCT01032382|463869343|FG000|Overall Study|Treatment failure|3|||
128883944|NCT01032382|463869344|FG001|Overall Study|Treatment failure|1|||
128883945|NCT01032382|463869343|FG000|Overall Study|Index lesion relapse|1|||
128883946|NCT01032382|463869344|FG001|Overall Study|Index lesion relapse|3|||
128883947|NCT00412971|463869345|FG000|Overall Study|Lost to Follow-up|17|||
128883948|NCT00412971|463869346|FG001|Overall Study|Lost to Follow-up|9|||
128883949|NCT00412971|463869345|FG000|Overall Study|Protocol Violation|13|||
128883950|NCT00412971|463869346|FG001|Overall Study|Protocol Violation|1|||
128883951|NCT00985153|463869347|FG000|Overall Study|Lost to Follow-up|16|||
128883952|NCT00985153|463869348|FG001|Overall Study|Lost to Follow-up|19|||
128883953|NCT00985153|463869349|FG002|Overall Study|Lost to Follow-up|17|||
128883954|NCT00985153|463869350|FG003|Overall Study|Lost to Follow-up|20|||
128883955|NCT00985153|463869347|FG000|Overall Study|Protocol Violation|3|||
128883956|NCT00985153|463869348|FG001|Overall Study|Protocol Violation|2|||
128883957|NCT00985153|463869349|FG002|Overall Study|Protocol Violation|4|||
128883958|NCT00985153|463869350|FG003|Overall Study|Protocol Violation|3|||
128883959|NCT00985153|463869347|FG000|Overall Study|Withdrawal by Subject|6|||
128883960|NCT00985153|463869348|FG001|Overall Study|Withdrawal by Subject|11|||
128883961|NCT00985153|463869349|FG002|Overall Study|Withdrawal by Subject|11|||
128883962|NCT00985153|463869350|FG003|Overall Study|Withdrawal by Subject|10|||
128883963|NCT00985153|463869347|FG000|Overall Study|Missed One or More Bleeds|7|||
128883964|NCT00985153|463869348|FG001|Overall Study|Missed One or More Bleeds|7|||
128883965|NCT00985153|463869349|FG002|Overall Study|Missed One or More Bleeds|8|||
128883966|NCT00985153|463869350|FG003|Overall Study|Missed One or More Bleeds|10|||
128883967|NCT00985153|463869347|FG000|Overall Study|Incomplete Safety Follow-up|3|||
128883968|NCT00985153|463869348|FG001|Overall Study|Incomplete Safety Follow-up|5|||
128883969|NCT00985153|463869349|FG002|Overall Study|Incomplete Safety Follow-up|4|||
128883970|NCT00985153|463869350|FG003|Overall Study|Incomplete Safety Follow-up|4|||
128883971|NCT01596621|463869352|FG000|Overall Study|Death|4|||
128883972|NCT01596621|463869352|FG000|Overall Study|Withdrawal by Subject|9|||
128883973|NCT01596621|463869352|FG000|Overall Study|Disease Progression|49|||
128883974|NCT01596621|463869352|FG000|Overall Study|Lost to Follow-up|3|||
128883975|NCT01596621|463869352|FG000|Overall Study|Other than specified|13|||
128883976|NCT00421707|463869357|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
128883977|NCT00421707|463869358|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
128883978|NCT00421707|463869357|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
128883979|NCT00421707|463869358|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
128883980|NCT00421707|463869357|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
128883981|NCT00421707|463869358|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
128883982|NCT00421707|463869357|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
128883983|NCT00421707|463869358|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
128883984|NCT00421707|463869357|FG000|Period 2: Washout|Adverse Event|1|||
128883985|NCT00421707|463869358|FG001|Period 2: Washout|Adverse Event|1|||
128883986|NCT00421707|463869357|FG000|Period 2: Washout|Withdrawal by Subject|0|||
128883987|NCT00421707|463869358|FG001|Period 2: Washout|Withdrawal by Subject|1|||
128883988|NCT00421707|463869357|FG000|Period 2: Washout|Lost to Follow-up|0|||
128883989|NCT00421707|463869358|FG001|Period 2: Washout|Lost to Follow-up|1|||
128883990|NCT00421707|463869357|FG000|Period 2: Washout|Other: Pregnancy|0|||
129107383|NCT03272347|464688398|FG000|Overall Study|Lost to Follow-up|1|||
129107384|NCT03272347|464688399|FG001|Overall Study|Lost to Follow-up|3|||
129107385|NCT03272347|464688400|FG002|Overall Study|Lost to Follow-up|5|||
128883991|NCT00421707|463869358|FG001|Period 2: Washout|Other: Pregnancy|1|||
128883992|NCT00421707|463869357|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
128883993|NCT00421707|463869358|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
128883994|NCT00421707|463869357|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
128883995|NCT00421707|463869358|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
128883996|NCT00421707|463869357|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
128883997|NCT00421707|463869358|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
128883998|NCT01074216|463869359|FG000|Overall Study|Physician Decision|1|||
128883999|NCT01074216|463869359|FG000|Overall Study|Not Treated|12|||
128884000|NCT01723254|463869360|FG000|Overall Study|Conflict with work schedule|0|||
128884001|NCT01723254|463869361|FG001|Overall Study|Conflict with work schedule|0|||
128884002|NCT01723254|463869362|FG002|Overall Study|Conflict with work schedule|0|||
128884003|NCT01723254|463869363|FG003|Overall Study|Conflict with work schedule|0|||
128884004|NCT01723254|463869364|FG004|Overall Study|Conflict with work schedule|0|||
128884005|NCT01723254|463869365|FG005|Overall Study|Conflict with work schedule|0|||
128884006|NCT01723254|463869366|FG006|Overall Study|Conflict with work schedule|0|||
128884007|NCT01723254|463869367|FG007|Overall Study|Conflict with work schedule|1|||
128884008|NCT01723254|463869360|FG000|Overall Study|Personal issues|0|||
128884009|NCT01723254|463869361|FG001|Overall Study|Personal issues|0|||
128884010|NCT01723254|463869362|FG002|Overall Study|Personal issues|0|||
128884011|NCT01723254|463869363|FG003|Overall Study|Personal issues|0|||
128884012|NCT01723254|463869364|FG004|Overall Study|Personal issues|0|||
128884013|NCT01723254|463869365|FG005|Overall Study|Personal issues|1|||
128884014|NCT01723254|463869366|FG006|Overall Study|Personal issues|0|||
128884015|NCT01723254|463869367|FG007|Overall Study|Personal issues|0|||
128884016|NCT01723254|463869360|FG000|Overall Study|No longer have time to participate|0|||
128884017|NCT01723254|463869361|FG001|Overall Study|No longer have time to participate|0|||
128884018|NCT01723254|463869362|FG002|Overall Study|No longer have time to participate|0|||
128884019|NCT01723254|463869363|FG003|Overall Study|No longer have time to participate|1|||
128884020|NCT01723254|463869364|FG004|Overall Study|No longer have time to participate|0|||
128884021|NCT01723254|463869365|FG005|Overall Study|No longer have time to participate|0|||
128884022|NCT01723254|463869366|FG006|Overall Study|No longer have time to participate|0|||
128884023|NCT01723254|463869367|FG007|Overall Study|No longer have time to participate|0|||
128884024|NCT01723254|463869360|FG000|Overall Study|Move/Left to another country/city|0|||
128884025|NCT01723254|463869361|FG001|Overall Study|Move/Left to another country/city|0|||
128884026|NCT01723254|463869362|FG002|Overall Study|Move/Left to another country/city|2|||
128884027|NCT01723254|463869363|FG003|Overall Study|Move/Left to another country/city|1|||
128884028|NCT01723254|463869364|FG004|Overall Study|Move/Left to another country/city|1|||
128884029|NCT01723254|463869365|FG005|Overall Study|Move/Left to another country/city|0|||
128884030|NCT01723254|463869366|FG006|Overall Study|Move/Left to another country/city|0|||
128884031|NCT01723254|463869367|FG007|Overall Study|Move/Left to another country/city|0|||
128884032|NCT01723254|463869360|FG000|Overall Study|Protocol Violation|0|||
129019269|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129019270|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019271|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019272|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019273|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019274|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019275|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019276|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019277|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019278|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019279|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019280|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019281|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019282|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019283|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019284|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
129019285|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
129019286|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019287|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019288|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019289|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019290|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129019291|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019292|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019293|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019294|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019295|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019296|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019297|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019298|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019299|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019300|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
128884033|NCT01723254|463869361|FG001|Overall Study|Protocol Violation|1|||
128884034|NCT01723254|463869362|FG002|Overall Study|Protocol Violation|0|||
128884035|NCT01723254|463869363|FG003|Overall Study|Protocol Violation|0|||
128884036|NCT01723254|463869364|FG004|Overall Study|Protocol Violation|0|||
128884037|NCT01723254|463869365|FG005|Overall Study|Protocol Violation|0|||
128884038|NCT01723254|463869366|FG006|Overall Study|Protocol Violation|0|||
128884039|NCT01723254|463869367|FG007|Overall Study|Protocol Violation|0|||
128884040|NCT01723254|463869360|FG000|Overall Study|Withdrawal by Subject|1|||
128884041|NCT01723254|463869361|FG001|Overall Study|Withdrawal by Subject|2|||
128884042|NCT01723254|463869362|FG002|Overall Study|Withdrawal by Subject|1|||
128884043|NCT01723254|463869363|FG003|Overall Study|Withdrawal by Subject|0|||
128884044|NCT01723254|463869364|FG004|Overall Study|Withdrawal by Subject|1|||
128884045|NCT01723254|463869365|FG005|Overall Study|Withdrawal by Subject|1|||
128884046|NCT01723254|463869366|FG006|Overall Study|Withdrawal by Subject|1|||
128884047|NCT01723254|463869367|FG007|Overall Study|Withdrawal by Subject|2|||
128884048|NCT01323634|463869368|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
128884049|NCT01323634|463869369|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
128884050|NCT01323634|463869370|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
128884051|NCT01323634|463869368|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
128884052|NCT01323634|463869369|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
128884053|NCT01323634|463869370|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
128884054|NCT01323634|463869368|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
128884055|NCT01323634|463869369|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
128884056|NCT01323634|463869370|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
128884057|NCT01323634|463869368|FG000|2-week Run-in Period|Physician Decision|5|||
128884058|NCT01323634|463869369|FG001|2-week Run-in Period|Physician Decision|0|||
128884059|NCT01323634|463869370|FG002|2-week Run-in Period|Physician Decision|0|||
128884060|NCT01323634|463869368|FG000|2-week Run-in Period|Protocol Violation|1|||
128884061|NCT01323634|463869369|FG001|2-week Run-in Period|Protocol Violation|0|||
128884062|NCT01323634|463869370|FG002|2-week Run-in Period|Protocol Violation|0|||
128884063|NCT01323634|463869368|FG000|2-week Run-in Period|Adverse Event|1|||
128884064|NCT01323634|463869369|FG001|2-week Run-in Period|Adverse Event|0|||
128884065|NCT01323634|463869370|FG002|2-week Run-in Period|Adverse Event|0|||
128884066|NCT01323634|463869368|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
128884067|NCT01323634|463869369|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
128884068|NCT01323634|463869370|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
128884069|NCT01323634|463869368|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
128884070|NCT01323634|463869369|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
128884071|NCT01323634|463869370|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
128884072|NCT01323634|463869368|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
128884073|NCT01323634|463869369|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
128884074|NCT01323634|463869370|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
128884075|NCT01323634|463869368|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
128884076|NCT01323634|463869369|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
128884077|NCT01323634|463869370|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
128884078|NCT01323634|463869368|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
128884079|NCT01323634|463869369|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
128884080|NCT01323634|463869370|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
128884081|NCT01323634|463869368|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
128884082|NCT01323634|463869369|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
128884083|NCT01323634|463869370|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
128884084|NCT01323634|463869368|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
128884085|NCT01323634|463869369|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
128884086|NCT01323634|463869370|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
128884087|NCT05056987|463869371|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
128884088|NCT05056987|463869372|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
128884089|NCT05056987|463869371|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
128884090|NCT05056987|463869372|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
128884091|NCT02409368|463869373|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
128683782|NCT00054717|463142561|FG000|Overall Study|Withdrawal by Subject|32|||
128683783|NCT00054717|463142562|FG001|Overall Study|Withdrawal by Subject|20|||
128683784|NCT00054717|463142561|FG000|Overall Study|Other reason not defined above|117|||
128683785|NCT00054717|463142562|FG001|Overall Study|Other reason not defined above|217|||
128683786|NCT04565236|463142563|FG000|Overall Study|Patient/Guardian Decision|0|||
128683787|NCT04565236|463142564|FG001|Overall Study|Patient/Guardian Decision|0|||
128683788|NCT04565236|463142565|FG002|Overall Study|Patient/Guardian Decision|1|||
128884092|NCT02409368|463869374|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
128884093|NCT02409368|463869375|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
128884094|NCT02409368|463869376|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
128884095|NCT02409368|463869373|FG000|ECOG Reclassification|Death|1|||
128884096|NCT02409368|463869374|FG001|ECOG Reclassification|Death|5|||
128884097|NCT02409368|463869375|FG002|ECOG Reclassification|Death|0|||
128884098|NCT02409368|463869376|FG003|ECOG Reclassification|Death|0|||
128683789|NCT04565236|463142566|FG003|Overall Study|Patient/Guardian Decision|0|||
128683790|NCT04209426|463142567|FG000|Overall Study|Lost to Follow-up|3|||
128683791|NCT04209426|463142568|FG001|Overall Study|Lost to Follow-up|2|||
128683792|NCT04423939|463142569|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
128683793|NCT04423939|463142570|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
128683794|NCT04423939|463142569|FG000|Overall Study|Death|3|||
128683795|NCT04423939|463142570|FG001|Overall Study|Death|0|||
128683796|NCT04423939|463142569|FG000|Overall Study|Withdrawal by Subject|3|||
128683797|NCT04423939|463142570|FG001|Overall Study|Withdrawal by Subject|0|||
129107386|NCT03272347|464688401|FG003|Overall Study|Lost to Follow-up|1|||
129107387|NCT03272347|464688398|FG000|Overall Study|Physician Decision|4|||
129107388|NCT03272347|464688399|FG001|Overall Study|Physician Decision|2|||
129107389|NCT03272347|464688400|FG002|Overall Study|Physician Decision|5|||
129107390|NCT03272347|464688401|FG003|Overall Study|Physician Decision|4|||
129107391|NCT03272347|464688398|FG000|Overall Study|Screen Failure|1|||
129107392|NCT03272347|464688399|FG001|Overall Study|Screen Failure|0|||
129107393|NCT03272347|464688400|FG002|Overall Study|Screen Failure|0|||
129107394|NCT03272347|464688401|FG003|Overall Study|Screen Failure|0|||
129107395|NCT03272347|464688398|FG000|Overall Study|Withdrawal by Subject|5|||
129107396|NCT03272347|464688399|FG001|Overall Study|Withdrawal by Subject|1|||
129107397|NCT03272347|464688400|FG002|Overall Study|Withdrawal by Subject|2|||
129107398|NCT03272347|464688401|FG003|Overall Study|Withdrawal by Subject|1|||
129107399|NCT00391872|464688404|FG000|Overall Study|Protocol Violation|7|||
129107400|NCT00391872|464688405|FG001|Overall Study|Protocol Violation|2|||
129107401|NCT00391872|464688404|FG000|Overall Study|Withdrawal by Subject|296|||
129107402|NCT00391872|464688405|FG001|Overall Study|Withdrawal by Subject|249|||
129107403|NCT00391872|464688404|FG000|Overall Study|Reason unknown|2|||
129107404|NCT00391872|464688405|FG001|Overall Study|Reason unknown|4|||
129107405|NCT00391872|464688404|FG000|Overall Study|Lost to Follow-up|2|||
129107406|NCT00391872|464688405|FG001|Overall Study|Lost to Follow-up|0|||
129107407|NCT01239394|464688407|FG000|Overall Study|Adverse Event|1|||
129107408|NCT02861664|464688408|FG000|Overall Study|Withdrawal of Consent|0|||
129107409|NCT02861664|464688409|FG001|Overall Study|Withdrawal of Consent|1|||
129107410|NCT00905632|464688411|FG000|Overall Study|Adverse Event|0|||
129107411|NCT00905632|464688412|FG001|Overall Study|Adverse Event|0|||
129107412|NCT00905632|464688413|FG002|Overall Study|Adverse Event|0|||
129107413|NCT00905632|464688414|FG003|Overall Study|Adverse Event|0|||
129107414|NCT00905632|464688415|FG004|Overall Study|Adverse Event|0|||
129107415|NCT00905632|464688416|FG005|Overall Study|Adverse Event|1|||
129107416|NCT00905632|464688417|FG006|Overall Study|Adverse Event|4|||
129107417|NCT01307891|464688419|FG000|Overall Study|Progressive Disease|3|||
129107418|NCT01307891|464688420|FG001|Overall Study|Progressive Disease|1|||
129107419|NCT02937740|464688421|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
129107420|NCT02937740|464688422|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
129107421|NCT02937740|464688421|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
129107422|NCT02937740|464688422|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
129107423|NCT02937740|464688421|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
129107424|NCT02937740|464688422|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
129107425|NCT02937740|464688421|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
129107426|NCT02937740|464688422|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
129107427|NCT02937740|464688421|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
129107428|NCT02937740|464688422|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
129107429|NCT02937740|464688421|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
129107430|NCT02937740|464688422|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
129107431|NCT00305227|464688425|FG000|Overall Study|Lost to Follow-up|7|||
128683798|NCT04423939|463142569|FG000|Overall Study|Caregiver to patient who died|0|||
128683799|NCT04423939|463142570|FG001|Overall Study|Caregiver to patient who died|3|||
128683800|NCT04423939|463142569|FG000|Overall Study|Caregiver to patient who withdrew|0|||
128683801|NCT04423939|463142570|FG001|Overall Study|Caregiver to patient who withdrew|3|||
128683802|NCT04626310|463142573|FG000|Overall Study|4-miss from treatment|6|||
128683803|NCT04626310|463142574|FG001|Overall Study|4-miss from treatment|5|||
128683804|NCT04626310|463142575|FG002|Overall Study|4-miss from treatment|5|||
129107432|NCT00305227|464688426|FG001|Overall Study|Lost to Follow-up|6|||
129107433|NCT04085601|464688427|FG000|Overall Study|Lost to Follow-up|1|||
129107434|NCT04085601|464688428|FG001|Overall Study|Lost to Follow-up|0|||
129107435|NCT04085601|464688427|FG000|Overall Study|Death|1|||
129107436|NCT04085601|464688428|FG001|Overall Study|Death|1|||
129107437|NCT03492437|464688429|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129107438|NCT03492437|464688430|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129107439|NCT02915159|464688431|FG000|Overall Study|Participant no longer meets criteria|2|||
129107440|NCT02915159|464688432|FG001|Overall Study|Participant no longer meets criteria|0|||
129107441|NCT02915159|464688431|FG000|Overall Study|poor/non-compliance|1|||
129107442|NCT02915159|464688432|FG001|Overall Study|poor/non-compliance|0|||
129107443|NCT02915159|464688431|FG000|Overall Study|Participant withdrew consent|5|||
128683805|NCT04626310|463142573|FG000|Overall Study|Withdrawal by Subject|1|||
128683806|NCT04626310|463142574|FG001|Overall Study|Withdrawal by Subject|0|||
128683807|NCT04626310|463142575|FG002|Overall Study|Withdrawal by Subject|3|||
128884099|NCT02409368|463869373|FG000|ECOG Reclassification|Disease Progression|113|||
128884100|NCT02409368|463869374|FG001|ECOG Reclassification|Disease Progression|382|||
128884101|NCT02409368|463869375|FG002|ECOG Reclassification|Disease Progression|70|||
128884102|NCT02409368|463869376|FG003|ECOG Reclassification|Disease Progression|1|||
128884103|NCT02409368|463869373|FG000|ECOG Reclassification|Lost to Follow-up|1|||
128884104|NCT02409368|463869374|FG001|ECOG Reclassification|Lost to Follow-up|5|||
128884105|NCT02409368|463869375|FG002|ECOG Reclassification|Lost to Follow-up|0|||
128884106|NCT02409368|463869376|FG003|ECOG Reclassification|Lost to Follow-up|0|||
128884107|NCT02409368|463869373|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
128884108|NCT02409368|463869374|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
128884109|NCT02409368|463869375|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
128884110|NCT02409368|463869376|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
128884111|NCT02409368|463869373|FG000|ECOG Reclassification|Poor/non-compliance|0|||
128884112|NCT02409368|463869374|FG001|ECOG Reclassification|Poor/non-compliance|3|||
128884113|NCT02409368|463869375|FG002|ECOG Reclassification|Poor/non-compliance|2|||
128884114|NCT02409368|463869376|FG003|ECOG Reclassification|Poor/non-compliance|0|||
128884115|NCT02409368|463869373|FG000|ECOG Reclassification|Study drug toxicity|17|||
128884116|NCT02409368|463869374|FG001|ECOG Reclassification|Study drug toxicity|42|||
128884117|NCT02409368|463869375|FG002|ECOG Reclassification|Study drug toxicity|7|||
128884118|NCT02409368|463869376|FG003|ECOG Reclassification|Study drug toxicity|0|||
128884119|NCT02409368|463869373|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
128884120|NCT02409368|463869374|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
128884121|NCT02409368|463869375|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
128884122|NCT02409368|463869376|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
128884123|NCT02409368|463869373|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
128884124|NCT02409368|463869374|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
128884125|NCT02409368|463869375|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
128884126|NCT02409368|463869376|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
128884127|NCT02409368|463869373|FG000|ECOG Reclassification|Participant withdrew consent|2|||
128884128|NCT02409368|463869374|FG001|ECOG Reclassification|Participant withdrew consent|3|||
128884129|NCT02409368|463869375|FG002|ECOG Reclassification|Participant withdrew consent|4|||
128884130|NCT02409368|463869376|FG003|ECOG Reclassification|Participant withdrew consent|0|||
128884131|NCT02409368|463869373|FG000|ECOG Reclassification|Other Reasons|5|||
128884132|NCT02409368|463869374|FG001|ECOG Reclassification|Other Reasons|26|||
128884133|NCT02409368|463869375|FG002|ECOG Reclassification|Other Reasons|2|||
128884134|NCT02409368|463869376|FG003|ECOG Reclassification|Other Reasons|0|||
128884135|NCT02409368|463869373|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
128884136|NCT02409368|463869374|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
128884137|NCT02409368|463869375|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
128884138|NCT02409368|463869376|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
128884139|NCT02041520|463869377|FG000|Overall Study|Adverse Event|2|||
128884140|NCT02041520|463869378|FG001|Overall Study|Adverse Event|1|||
128884141|NCT02041520|463869377|FG000|Overall Study|Withdrawal by Subject|3|||
128884142|NCT02041520|463869378|FG001|Overall Study|Withdrawal by Subject|4|||
128884143|NCT02041520|463869377|FG000|Overall Study|Protocol Violation|1|||
128884144|NCT02041520|463869378|FG001|Overall Study|Protocol Violation|0|||
128884145|NCT02041520|463869377|FG000|Overall Study|Lost to Follow-up|0|||
128884146|NCT02041520|463869378|FG001|Overall Study|Lost to Follow-up|1|||
128884147|NCT02041520|463869377|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
128884148|NCT02041520|463869378|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
128884149|NCT01759407|463869381|FG000|Overall Study|Protocol Violation|0|||
128884150|NCT01759407|463869382|FG001|Overall Study|Protocol Violation|2|||
129107444|NCT02915159|464688432|FG001|Overall Study|Participant withdrew consent|1|||
129107445|NCT02915159|464688431|FG000|Overall Study|Request to discontinue treatment|1|||
129107446|NCT02915159|464688432|FG001|Overall Study|Request to discontinue treatment|2|||
128884151|NCT02678247|463869383|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
128884152|NCT02678247|463869384|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
128884153|NCT02678247|463869383|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
128884154|NCT02678247|463869384|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
128884155|NCT02678247|463869383|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
128884156|NCT02678247|463869384|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
128884157|NCT02678247|463869383|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
128884158|NCT02678247|463869384|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
128884159|NCT02678247|463869383|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
128884160|NCT02678247|463869384|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
128884161|NCT02678247|463869383|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
128884162|NCT02678247|463869384|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
128884163|NCT00026208|463869387|FG000|Overall Study|Complications of auto accident|1|||
129107447|NCT02915159|464688431|FG000|Overall Study|Adverse Event|2|||
129107448|NCT02915159|464688432|FG001|Overall Study|Adverse Event|2|||
129107449|NCT02915159|464688431|FG000|Overall Study|Lack of Efficacy|0|||
128884164|NCT00026208|463869388|FG001|Overall Study|Complications of auto accident|0|||
128884165|NCT02225353|463869389|FG000|Overall Study|Lost to Follow-up|0|||
128884166|NCT02225353|463869390|FG001|Overall Study|Lost to Follow-up|1|||
128884167|NCT02225353|463869391|FG002|Overall Study|Lost to Follow-up|3|||
128884168|NCT02225353|463869389|FG000|Overall Study|Protocol Violation|4|||
128884169|NCT02225353|463869390|FG001|Overall Study|Protocol Violation|5|||
128884170|NCT02225353|463869391|FG002|Overall Study|Protocol Violation|12|||
128884171|NCT03604523|463869392|FG000|Overall Study|Physician Decision|1|||
128884172|NCT03604523|463869393|FG001|Overall Study|Physician Decision|0|||
128884173|NCT04223856|463869397|FG000|Overall Study|Progressive disease|153|||
128884174|NCT04223856|463869398|FG001|Overall Study|Progressive disease|73|||
128884175|NCT04223856|463869397|FG000|Overall Study|Adverse Event|97|||
128884176|NCT04223856|463869398|FG001|Overall Study|Adverse Event|62|||
128884177|NCT04223856|463869397|FG000|Overall Study|Physician Decision|9|||
128884178|NCT04223856|463869398|FG001|Overall Study|Physician Decision|28|||
128884179|NCT04223856|463869397|FG000|Overall Study|Withdrawal by Subject|22|||
128884180|NCT04223856|463869398|FG001|Overall Study|Withdrawal by Subject|24|||
128884181|NCT04223856|463869397|FG000|Overall Study|Other|7|||
128884182|NCT04223856|463869398|FG001|Overall Study|Other|2|||
128884183|NCT04223856|463869397|FG000|Overall Study|Randomized but not treated|2|||
128884184|NCT04223856|463869398|FG001|Overall Study|Randomized but not treated|11|||
128884185|NCT04223856|463869397|FG000|Overall Study|On-treatment|144|||
128884186|NCT04223856|463869398|FG001|Overall Study|On-treatment|0|||
128884187|NCT03226275|463869399|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
128884188|NCT03226275|463869400|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129107450|NCT02915159|464688432|FG001|Overall Study|Lack of Efficacy|3|||
129107451|NCT04534517|464688434|FG000|Overall Study|Adverse Event|1|||
128884189|NCT03226275|463869401|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
129107452|NCT04534517|464688434|FG000|Overall Study|Withdrawal by Subject|1|||
129107453|NCT04534517|464688434|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129107454|NCT04534517|464688434|FG000|Overall Study|COVID-19 Related|1|||
129107455|NCT03872843|464688435|FG000|Overall Study|Lost to Follow-up|5|||
129107456|NCT03872843|464688436|FG001|Overall Study|Lost to Follow-up|7|||
129107457|NCT00823264|464688437|FG000|Overall Study|Protocol Violation|2|||
129107458|NCT00823264|464688438|FG001|Overall Study|Protocol Violation|0|||
129107459|NCT05133323|464688439|FG000|Overall Study|Lack of Efficacy|0|||
129107460|NCT05133323|464688440|FG001|Overall Study|Lack of Efficacy|0|||
129107461|NCT05133323|464688441|FG002|Overall Study|Lack of Efficacy|1|||
129107462|NCT05133323|464688439|FG000|Overall Study|Withdrawal by Subject|2|||
129107463|NCT05133323|464688440|FG001|Overall Study|Withdrawal by Subject|1|||
129107464|NCT05133323|464688441|FG002|Overall Study|Withdrawal by Subject|0|||
129107465|NCT00113295|464688442|FG000|Overall Study|Adverse Event|4|||
129107466|NCT00113295|464688443|FG001|Overall Study|Adverse Event|1|||
129107467|NCT00113295|464688442|FG000|Overall Study|Unrelated Medical Illness|1|||
129107468|NCT00113295|464688443|FG001|Overall Study|Unrelated Medical Illness|0|||
129107469|NCT01714544|464688444|FG000|Overall Study|Lost to Follow-up|1|||
129107470|NCT01714544|464688444|FG000|Overall Study|Physician Decision|1|||
129107471|NCT01714544|464688444|FG000|Overall Study|Withdrawal by Subject|1|||
129107472|NCT00577772|464688453|FG000|Overall Study|Lost to Follow-up|0|||
129107473|NCT00577772|464688454|FG001|Overall Study|Lost to Follow-up|1|||
129107474|NCT00572455|464688455|FG000|Stage I (14 Days)|Adverse Event|0|||
129107475|NCT00572455|464688456|FG001|Stage I (14 Days)|Adverse Event|0|||
129107476|NCT00572455|464688457|FG002|Stage I (14 Days)|Adverse Event|0|||
129107477|NCT00572455|464688458|FG003|Stage I (14 Days)|Adverse Event|0|||
129107478|NCT00572455|464688459|FG004|Stage I (14 Days)|Adverse Event|0|||
129107479|NCT00572455|464688460|FG005|Stage I (14 Days)|Adverse Event|3|||
129107480|NCT00572455|464688461|FG006|Stage I (14 Days)|Adverse Event|0|||
129107481|NCT00572455|464688462|FG007|Stage I (14 Days)|Adverse Event|0|||
129107482|NCT00572455|464688463|FG008|Stage I (14 Days)|Adverse Event|0|||
129107483|NCT00572455|464688464|FG009|Stage I (14 Days)|Adverse Event|0|||
129107484|NCT00572455|464688465|FG010|Stage I (14 Days)|Adverse Event|0|||
128884190|NCT03226275|463869402|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129107485|NCT00572455|464688466|FG011|Stage I (14 Days)|Adverse Event|0|||
129107486|NCT00572455|464688467|FG012|Stage I (14 Days)|Adverse Event|0|||
129107487|NCT00572455|464688468|FG013|Stage I (14 Days)|Adverse Event|0|||
128884191|NCT03226275|463869399|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
128884192|NCT03226275|463869400|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
128884193|NCT03226275|463869401|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
128884194|NCT03226275|463869402|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
128884195|NCT03442114|463869403|FG000|Overall Study|Lost to Follow-up|13|||
129107488|NCT00572455|464688455|FG000|Stage I (14 Days)|Other|0|||
129107489|NCT00572455|464688456|FG001|Stage I (14 Days)|Other|0|||
129107490|NCT00572455|464688457|FG002|Stage I (14 Days)|Other|0|||
128884196|NCT03442114|463869404|FG001|Overall Study|Lost to Follow-up|13|||
129107491|NCT00572455|464688458|FG003|Stage I (14 Days)|Other|0|||
129107492|NCT00572455|464688459|FG004|Stage I (14 Days)|Other|1|||
129107493|NCT00572455|464688460|FG005|Stage I (14 Days)|Other|0|||
129107494|NCT00572455|464688461|FG006|Stage I (14 Days)|Other|0|||
128683808|NCT04902326|463142576|FG000|Overall Study|Withdrawal by Subject|1|||
128683809|NCT04902326|463142577|FG001|Overall Study|Withdrawal by Subject|3|||
128683810|NCT04902326|463142578|FG002|Overall Study|Withdrawal by Subject|0|||
128683811|NCT04902326|463142579|FG003|Overall Study|Withdrawal by Subject|1|||
128683812|NCT04902326|463142576|FG000|Overall Study|Lost to Follow-up|14|||
128683813|NCT04902326|463142577|FG001|Overall Study|Lost to Follow-up|14|||
128683814|NCT04902326|463142578|FG002|Overall Study|Lost to Follow-up|14|||
129019301|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019302|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019303|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019304|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019305|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
129019306|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
129019307|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019308|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019309|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019310|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019311|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129019312|NCT01597245|464363747|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019313|NCT01597245|464363748|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019314|NCT01597245|464363749|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019315|NCT01597245|464363750|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019316|NCT01597245|464363751|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019317|NCT01597245|464363752|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019318|NCT01597245|464363753|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019319|NCT01597245|464363754|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019320|NCT01597245|464363755|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019321|NCT01597245|464363756|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019322|NCT01597245|464363757|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019323|NCT01597245|464363758|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019324|NCT01597245|464363759|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019325|NCT01597245|464363760|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
129019326|NCT01597245|464363761|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019327|NCT01597245|464363762|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019328|NCT01597245|464363763|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019329|NCT01597245|464363764|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019330|NCT01597245|464363765|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019331|NCT01597245|464363766|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019332|NCT01597245|464363767|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129019333|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019334|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019335|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019336|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019337|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019338|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019339|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019340|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019341|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019342|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019343|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019344|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019345|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019346|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019347|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019348|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129019349|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
129019350|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
129019351|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
129019352|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
129019353|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
129019354|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019355|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019356|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
128683815|NCT04902326|463142579|FG003|Overall Study|Lost to Follow-up|6|||
128683816|NCT02604017|463142580|FG000|Overall Study|Withdrew Consent|0|||
129019357|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019358|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019359|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019360|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019361|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019362|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019363|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019364|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019365|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019366|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019367|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019368|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019369|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019370|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129019371|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
129019372|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
129019373|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
129019374|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
129019375|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019376|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019377|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019378|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019379|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019380|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019381|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019382|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019383|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019384|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019385|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019386|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019387|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019388|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019389|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019390|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019391|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
129019392|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019393|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129019394|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
129019395|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
129019396|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019397|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019398|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019399|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019400|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019401|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019402|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019403|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019404|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019405|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019406|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019407|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019408|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019409|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019410|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019411|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019412|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019413|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129019414|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
129019415|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
129019416|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
129019417|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019418|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019419|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
128884197|NCT03442114|463869403|FG000|Overall Study|Physician Decision|2|||
128884198|NCT03442114|463869404|FG001|Overall Study|Physician Decision|2|||
128884199|NCT03442114|463869403|FG000|Overall Study|Protocol Violation|0|||
128884200|NCT03442114|463869404|FG001|Overall Study|Protocol Violation|2|||
128884201|NCT03442114|463869403|FG000|Overall Study|Withdrawal by Subject|1|||
128884202|NCT03442114|463869404|FG001|Overall Study|Withdrawal by Subject|3|||
128884203|NCT03442114|463869403|FG000|Overall Study|Guardianship Change|0|||
128884204|NCT03442114|463869404|FG001|Overall Study|Guardianship Change|1|||
128884205|NCT02903368|463869405|FG000|Part 1|Adverse Event|3|||
128884206|NCT02903368|463869406|FG001|Part 1|Adverse Event|0|||
128884207|NCT02903368|463869407|FG002|Part 1|Adverse Event|0|||
128884208|NCT02903368|463869408|FG003|Part 1|Adverse Event|0|||
128884209|NCT02903368|463869405|FG000|Part 1|Withdrawal by Subject|1|||
128884210|NCT02903368|463869406|FG001|Part 1|Withdrawal by Subject|0|||
128884211|NCT02903368|463869407|FG002|Part 1|Withdrawal by Subject|0|||
128884212|NCT02903368|463869408|FG003|Part 1|Withdrawal by Subject|0|||
128884213|NCT02903368|463869405|FG000|Part 2|Adverse Event|0|||
128884214|NCT02903368|463869406|FG001|Part 2|Adverse Event|0|||
128884215|NCT02903368|463869407|FG002|Part 2|Adverse Event|5|||
128884216|NCT02903368|463869408|FG003|Part 2|Adverse Event|0|||
128884217|NCT02903368|463869405|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
128884218|NCT02903368|463869406|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
128884219|NCT02903368|463869407|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
128884220|NCT02903368|463869408|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
128884221|NCT02903368|463869405|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
128884222|NCT02903368|463869406|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
128884223|NCT02903368|463869407|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
128884224|NCT02903368|463869408|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
128884225|NCT02903368|463869405|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
128884226|NCT02903368|463869406|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
128884227|NCT02903368|463869407|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
128884228|NCT02903368|463869408|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
128884229|NCT02245672|463871250|FG000|Overall Study|Adverse Event|4|||
128884230|NCT02245672|463871251|FG001|Overall Study|Adverse Event|4|||
128884231|NCT02245672|463871252|FG002|Overall Study|Adverse Event|4|||
128884232|NCT02245672|463871250|FG000|Overall Study|Lost to Follow-up|3|||
128884233|NCT02245672|463871251|FG001|Overall Study|Lost to Follow-up|5|||
128884234|NCT02245672|463871252|FG002|Overall Study|Lost to Follow-up|1|||
128884235|NCT02245672|463871250|FG000|Overall Study|Withdrawal by Subject|6|||
128884236|NCT02245672|463871251|FG001|Overall Study|Withdrawal by Subject|3|||
128884237|NCT02245672|463871252|FG002|Overall Study|Withdrawal by Subject|0|||
128884238|NCT02245672|463871250|FG000|Overall Study|Randomized in error (not treated)|0|||
128884239|NCT02245672|463871251|FG001|Overall Study|Randomized in error (not treated)|1|||
128884240|NCT02245672|463871252|FG002|Overall Study|Randomized in error (not treated)|0|||
128884241|NCT00971932|463871253|FG000|Overall Study|Withdrawal by Subject|1|||
128884242|NCT00971932|463871253|FG000|Overall Study|Investigator's decision|2|||
128884243|NCT00971932|463871253|FG000|Overall Study|Ongoing|4|||
128884244|NCT01765192|463871254|FG000|Treatment Period 1|Adverse Event|0|||
128884245|NCT01765192|463871255|FG001|Treatment Period 1|Adverse Event|1|||
128884246|NCT01765192|463871254|FG000|Washout Period|Voluntary Withdrawal|1|||
128884247|NCT01765192|463871255|FG001|Washout Period|Voluntary Withdrawal|1|||
128884248|NCT01765192|463871254|FG000|Washout Period|Reason not specified|1|||
128884249|NCT01765192|463871255|FG001|Washout Period|Reason not specified|0|||
129107495|NCT00572455|464688462|FG007|Stage I (14 Days)|Other|0|||
129107496|NCT00572455|464688463|FG008|Stage I (14 Days)|Other|0|||
129107497|NCT00572455|464688464|FG009|Stage I (14 Days)|Other|0|||
129107498|NCT00572455|464688465|FG010|Stage I (14 Days)|Other|0|||
129107499|NCT00572455|464688466|FG011|Stage I (14 Days)|Other|0|||
128683817|NCT02604017|463142581|FG001|Overall Study|Withdrew Consent|2|||
128683818|NCT02604017|463142580|FG000|Overall Study|Lost to Follow-up|5|||
128884250|NCT01765192|463871254|FG000|Treatment Period 2|Reason not specified|0|||
128884251|NCT01765192|463871255|FG001|Treatment Period 2|Reason not specified|2|||
128884252|NCT01765192|463871254|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
128884253|NCT01765192|463871255|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
128884254|NCT00876694|463871260|FG000|Overall Study|Adverse Event|10|||
128884255|NCT00876694|463871261|FG001|Overall Study|Adverse Event|7|||
128884256|NCT00876694|463871260|FG000|Overall Study|Subject withdrew consent|6|||
128884257|NCT00876694|463871261|FG001|Overall Study|Subject withdrew consent|4|||
128884258|NCT00876694|463871260|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129107500|NCT00572455|464688467|FG012|Stage I (14 Days)|Other|0|||
129107501|NCT00572455|464688468|FG013|Stage I (14 Days)|Other|0|||
129107502|NCT00572455|464688455|FG000|Stage II (28 Days)|Adverse Event|0|||
129107503|NCT00572455|464688456|FG001|Stage II (28 Days)|Adverse Event|0|||
129107504|NCT00572455|464688457|FG002|Stage II (28 Days)|Adverse Event|0|||
128683819|NCT02604017|463142581|FG001|Overall Study|Lost to Follow-up|6|||
128884259|NCT00876694|463871261|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128884260|NCT00876694|463871260|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128884261|NCT00876694|463871261|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128884262|NCT00876694|463871260|FG000|Overall Study|Administrative problems|1|||
128884263|NCT00876694|463871261|FG001|Overall Study|Administrative problems|1|||
128884264|NCT00876694|463871260|FG000|Overall Study|Death|1|||
128884265|NCT00876694|463871261|FG001|Overall Study|Death|0|||
128884266|NCT01215422|463871262|FG000|Overall Study|Relocation|1|||
128884267|NCT01215422|463871263|FG001|Overall Study|Relocation|0|||
128884268|NCT01215422|463871264|FG002|Overall Study|Relocation|0|||
128884269|NCT01215422|463871265|FG003|Overall Study|Relocation|0|||
128884270|NCT01215422|463871262|FG000|Overall Study|Failed intubations|0|||
128884271|NCT01215422|463871263|FG001|Overall Study|Failed intubations|0|||
128884272|NCT01215422|463871264|FG002|Overall Study|Failed intubations|3|||
128884273|NCT01215422|463871265|FG003|Overall Study|Failed intubations|8|||
128884274|NCT01215422|463871262|FG000|Overall Study|Did not complete all intubations|7|||
128884275|NCT01215422|463871263|FG001|Overall Study|Did not complete all intubations|0|||
128884276|NCT01215422|463871264|FG002|Overall Study|Did not complete all intubations|0|||
128884277|NCT01215422|463871265|FG003|Overall Study|Did not complete all intubations|0|||
128884278|NCT00294554|463871268|FG000|Overall Study|Lack of Efficacy|0|||
128884279|NCT00294554|463871269|FG001|Overall Study|Lack of Efficacy|1|||
128884280|NCT00294554|463871268|FG000|Overall Study|Physician Decision|0|||
128884281|NCT00294554|463871269|FG001|Overall Study|Physician Decision|1|||
128884282|NCT00462865|463871270|FG000|Overall Study|Adverse Event|1|||
128884283|NCT04142450|463871271|FG000|Overall Study|Screen Failure|1|||
128884284|NCT04142450|463871271|FG000|Overall Study|Lost to Follow-up|1|||
128884285|NCT02901041|463871276|FG000|Overall Study|Withdrawal by PI|4|||
128884286|NCT02901041|463871277|FG001|Overall Study|Withdrawal by PI|8|||
128884287|NCT02901041|463871276|FG000|Overall Study|Withdrawal by Subject|7|||
128884288|NCT02901041|463871277|FG001|Overall Study|Withdrawal by Subject|3|||
128884289|NCT00975507|463871281|FG000|Overall Study|Adverse Event|1|||
128884290|NCT00975507|463871282|FG001|Overall Study|Adverse Event|0|||
128884291|NCT00975507|463871281|FG000|Overall Study|Lost to Follow-up|7|||
129019420|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019421|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019422|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019423|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019424|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019425|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019426|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019427|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019428|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019429|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019430|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019431|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019432|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019433|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
129019434|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019435|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129019436|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
129019437|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
129019438|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019439|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019440|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019441|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019442|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019443|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019444|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019445|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019446|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019447|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
128884292|NCT00975507|463871282|FG001|Overall Study|Lost to Follow-up|1|||
128884293|NCT00975507|463871281|FG000|Overall Study|Protocol Violation|2|||
128884294|NCT00975507|463871282|FG001|Overall Study|Protocol Violation|0|||
128884295|NCT00975507|463871281|FG000|Overall Study|Withdrawal by Subject|10|||
128884296|NCT00975507|463871282|FG001|Overall Study|Withdrawal by Subject|3|||
128884297|NCT03249714|463871283|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
128884298|NCT03249714|463871284|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
128884299|NCT03249714|463871283|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
128884300|NCT03249714|463871284|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
129107505|NCT00572455|464688458|FG003|Stage II (28 Days)|Adverse Event|0|||
129107506|NCT00572455|464688459|FG004|Stage II (28 Days)|Adverse Event|0|||
129107507|NCT00572455|464688460|FG005|Stage II (28 Days)|Adverse Event|0|||
129107508|NCT00572455|464688461|FG006|Stage II (28 Days)|Adverse Event|0|||
129107509|NCT00572455|464688462|FG007|Stage II (28 Days)|Adverse Event|0|||
129107510|NCT00572455|464688463|FG008|Stage II (28 Days)|Adverse Event|1|||
129107511|NCT00572455|464688464|FG009|Stage II (28 Days)|Adverse Event|3|||
129107512|NCT00572455|464688465|FG010|Stage II (28 Days)|Adverse Event|3|||
129107513|NCT00572455|464688466|FG011|Stage II (28 Days)|Adverse Event|4|||
129107514|NCT00572455|464688467|FG012|Stage II (28 Days)|Adverse Event|5|||
129107515|NCT00572455|464688468|FG013|Stage II (28 Days)|Adverse Event|1|||
129107516|NCT00572455|464688455|FG000|Stage II (28 Days)|Death|0|||
129107517|NCT00572455|464688456|FG001|Stage II (28 Days)|Death|0|||
129107518|NCT00572455|464688457|FG002|Stage II (28 Days)|Death|0|||
129107519|NCT00572455|464688458|FG003|Stage II (28 Days)|Death|0|||
129107520|NCT00572455|464688459|FG004|Stage II (28 Days)|Death|0|||
129107521|NCT00572455|464688460|FG005|Stage II (28 Days)|Death|0|||
129107522|NCT00572455|464688461|FG006|Stage II (28 Days)|Death|0|||
129107523|NCT00572455|464688462|FG007|Stage II (28 Days)|Death|0|||
128683820|NCT02604017|463142580|FG000|Overall Study|Other|1|||
128683821|NCT02604017|463142581|FG001|Overall Study|Other|0|||
128683822|NCT00740246|463142582|FG000|Overall Study|Received Blood Transfusion|0|||
128683823|NCT00740246|463142583|FG001|Overall Study|Received Blood Transfusion|1|||
128683824|NCT00740246|463142582|FG000|Overall Study|Adverse Event|1|||
128683825|NCT00740246|463142583|FG001|Overall Study|Adverse Event|2|||
128683826|NCT00740246|463142582|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
128683827|NCT00740246|463142583|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
128683828|NCT00740246|463142582|FG000|Overall Study|Lost to Follow-up|2|||
128683829|NCT00740246|463142583|FG001|Overall Study|Lost to Follow-up|2|||
128683830|NCT00740246|463142582|FG000|Overall Study|Withdrawal by Subject|4|||
128683831|NCT00740246|463142583|FG001|Overall Study|Withdrawal by Subject|3|||
128683832|NCT00740246|463142582|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
128683833|NCT00740246|463142583|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
128683834|NCT00740246|463142582|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
128683835|NCT00740246|463142583|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
128683836|NCT00740246|463142582|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
128683837|NCT00740246|463142583|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
128683838|NCT00740246|463142582|FG000|Overall Study|Unable To Comply With Study Visits|2|||
128683839|NCT00740246|463142583|FG001|Overall Study|Unable To Comply With Study Visits|0|||
128683840|NCT00740246|463142582|FG000|Overall Study|Unable to Access Vein|0|||
128683841|NCT00740246|463142583|FG001|Overall Study|Unable to Access Vein|2|||
128683842|NCT00740246|463142582|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
128683843|NCT00740246|463142583|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
128683844|NCT01117051|463142586|FG000|Overall Study|Withdrawal by Subject|5|||
128683845|NCT01117051|463142587|FG001|Overall Study|Withdrawal by Subject|3|||
128683846|NCT01117051|463142586|FG000|Overall Study|Adverse Event|4|||
128683847|NCT01117051|463142587|FG001|Overall Study|Adverse Event|3|||
128683848|NCT01117051|463142586|FG000|Overall Study|Lost to Follow-up|0|||
128683849|NCT01117051|463142587|FG001|Overall Study|Lost to Follow-up|1|||
128683850|NCT01117051|463142586|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
128683851|NCT01117051|463142587|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
128683852|NCT01117051|463142586|FG000|Overall Study|Sponsor's decision|3|||
128683853|NCT01117051|463142587|FG001|Overall Study|Sponsor's decision|1|||
128683854|NCT01117051|463142586|FG000|Overall Study|Surgical procedure|0|||
128683855|NCT01117051|463142587|FG001|Overall Study|Surgical procedure|1|||
128683856|NCT01117051|463142586|FG000|Overall Study|Randomized by mistake|0|||
128683857|NCT01117051|463142587|FG001|Overall Study|Randomized by mistake|1|||
128683858|NCT01117051|463142586|FG000|Overall Study|Convenience issue|1|||
128683859|NCT01117051|463142587|FG001|Overall Study|Convenience issue|0|||
128683860|NCT00366340|463142591|FG000|Infant Series|Protocol Violation|3|||
128884301|NCT03249714|463871283|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
128884302|NCT03249714|463871284|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
128884303|NCT03249714|463871283|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
128884304|NCT03249714|463871284|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
128884305|NCT01112306|463871287|FG000|Overall Study|Death|175|||
129107524|NCT00572455|464688463|FG008|Stage II (28 Days)|Death|1|||
129107525|NCT00572455|464688464|FG009|Stage II (28 Days)|Death|0|||
129107526|NCT00572455|464688465|FG010|Stage II (28 Days)|Death|0|||
129107527|NCT00572455|464688466|FG011|Stage II (28 Days)|Death|0|||
129107528|NCT00572455|464688467|FG012|Stage II (28 Days)|Death|0|||
128683861|NCT00366340|463142592|FG001|Infant Series|Protocol Violation|4|||
128683862|NCT00366340|463142591|FG000|Infant Series|Withdrawal by Subject|3|||
128683863|NCT00366340|463142592|FG001|Infant Series|Withdrawal by Subject|3|||
128683864|NCT00366340|463142591|FG000|Infant Series|Adverse Event|0|||
129107529|NCT00572455|464688468|FG013|Stage II (28 Days)|Death|0|||
129107530|NCT00572455|464688455|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
128884306|NCT01112306|463871287|FG000|Overall Study|Lost to Follow-up|9|||
128884307|NCT01112306|463871287|FG000|Overall Study|Withdrawal by Subject|31|||
128884308|NCT01112306|463871287|FG000|Overall Study|Other|70|||
128884309|NCT01607554|463871289|FG000|Overall Study|Disease progression|2|||
128884310|NCT03952806|463871290|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
128884311|NCT03952806|463871291|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
128884312|NCT03952806|463871290|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
128884313|NCT03952806|463871291|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
128884314|NCT03952806|463871290|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
128884315|NCT03952806|463871291|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
128884316|NCT03952806|463871290|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
128884317|NCT03952806|463871291|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
128884318|NCT03952806|463871290|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
128884319|NCT03952806|463871291|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
128884320|NCT03952806|463871290|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
128884321|NCT03952806|463871291|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
128884322|NCT03952806|463871290|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
128884323|NCT03952806|463871291|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
128884324|NCT03952806|463871290|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
128884325|NCT03952806|463871291|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
128884326|NCT03952806|463871290|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
128884327|NCT03952806|463871291|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
128884328|NCT03952806|463871290|FG000|OLE Phase (48 Weeks)|Other|16|||
128884329|NCT03952806|463871291|FG001|OLE Phase (48 Weeks)|Other|13|||
128884330|NCT01138007|463871292|FG000|Overall Study|Adverse Event|4|||
128884331|NCT01138007|463871293|FG001|Overall Study|Adverse Event|12|||
128884332|NCT01138007|463871294|FG002|Overall Study|Adverse Event|9|||
128884333|NCT01138007|463871292|FG000|Overall Study|Lack of Efficacy|2|||
128884334|NCT01138007|463871293|FG001|Overall Study|Lack of Efficacy|0|||
128884335|NCT01138007|463871294|FG002|Overall Study|Lack of Efficacy|6|||
128884336|NCT01138007|463871292|FG000|Overall Study|Protocol Violation|2|||
128884337|NCT01138007|463871293|FG001|Overall Study|Protocol Violation|3|||
128884338|NCT01138007|463871294|FG002|Overall Study|Protocol Violation|2|||
128884339|NCT01138007|463871292|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
129019448|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019449|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019450|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019451|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019452|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019453|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019454|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
129019455|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019456|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129019457|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
129019458|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
129019459|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019460|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019461|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019462|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019463|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019464|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019465|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019466|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019467|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019468|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019469|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019470|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019471|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019472|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019473|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019474|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019475|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
129019476|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129215123|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Disease Progression|2|||
128884340|NCT01138007|463871293|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
128884341|NCT01138007|463871294|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
128884342|NCT01138007|463871292|FG000|Overall Study|Lost to Follow-up|3|||
128884343|NCT01138007|463871293|FG001|Overall Study|Lost to Follow-up|3|||
128884344|NCT01138007|463871294|FG002|Overall Study|Lost to Follow-up|5|||
128884345|NCT01138007|463871292|FG000|Overall Study|Physician Decision|0|||
128884346|NCT01138007|463871293|FG001|Overall Study|Physician Decision|5|||
128884347|NCT01138007|463871294|FG002|Overall Study|Physician Decision|3|||
128884348|NCT01138007|463871292|FG000|Overall Study|Withdrawal by Subject|5|||
128884349|NCT01138007|463871293|FG001|Overall Study|Withdrawal by Subject|6|||
128884350|NCT01138007|463871294|FG002|Overall Study|Withdrawal by Subject|15|||
128884351|NCT04661878|463871295|FG000|Overall Study|Lost to Follow-up|6|||
128884352|NCT04661878|463871296|FG001|Overall Study|Lost to Follow-up|5|||
128884353|NCT04442737|463871297|FG000|Overall Study|Lost to Follow-up|1|||
128884354|NCT04442737|463871298|FG001|Overall Study|Lost to Follow-up|3|||
128884355|NCT04442737|463871297|FG000|Overall Study|Withdrawal by Subject|3|||
128884356|NCT04442737|463871298|FG001|Overall Study|Withdrawal by Subject|2|||
128884357|NCT04442737|463871297|FG000|Overall Study|Adverse Event|3|||
128884358|NCT04442737|463871298|FG001|Overall Study|Adverse Event|2|||
128884359|NCT04442737|463871297|FG000|Overall Study|Death|0|||
128884360|NCT04442737|463871298|FG001|Overall Study|Death|1|||
128884361|NCT04442737|463871297|FG000|Overall Study|Protocol Violation|0|||
128884362|NCT04442737|463871298|FG001|Overall Study|Protocol Violation|2|||
128884363|NCT04442737|463871297|FG000|Overall Study|Other|1|||
128884364|NCT04442737|463871298|FG001|Overall Study|Other|1|||
128884365|NCT00744523|463871299|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
129107531|NCT00572455|464688456|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
129107532|NCT00572455|464688457|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
128683865|NCT00366340|463142592|FG001|Infant Series|Adverse Event|2|||
128683866|NCT00366340|463142591|FG000|Infant Series|Lost to Follow-up|1|||
128884366|NCT00744523|463871300|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
129107533|NCT00572455|464688458|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
129107534|NCT00572455|464688459|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
129107535|NCT00572455|464688460|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
129107536|NCT00572455|464688461|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
129107537|NCT00572455|464688462|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
129107538|NCT00572455|464688463|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
129107539|NCT00572455|464688464|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
129107540|NCT00572455|464688465|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
129107541|NCT00572455|464688466|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
129107542|NCT00572455|464688467|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
129107543|NCT00572455|464688468|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
129107544|NCT00572455|464688455|FG000|Stage II (28 Days)|Other|0|||
129107545|NCT00572455|464688456|FG001|Stage II (28 Days)|Other|0|||
129107546|NCT00572455|464688457|FG002|Stage II (28 Days)|Other|0|||
129107547|NCT00572455|464688458|FG003|Stage II (28 Days)|Other|0|||
129107548|NCT00572455|464688459|FG004|Stage II (28 Days)|Other|0|||
129107549|NCT00572455|464688460|FG005|Stage II (28 Days)|Other|0|||
129107550|NCT00572455|464688461|FG006|Stage II (28 Days)|Other|0|||
129107551|NCT00572455|464688462|FG007|Stage II (28 Days)|Other|0|||
129107552|NCT00572455|464688463|FG008|Stage II (28 Days)|Other|1|||
129107553|NCT00572455|464688464|FG009|Stage II (28 Days)|Other|0|||
129107554|NCT00572455|464688465|FG010|Stage II (28 Days)|Other|0|||
129107555|NCT00572455|464688466|FG011|Stage II (28 Days)|Other|0|||
129107556|NCT00572455|464688467|FG012|Stage II (28 Days)|Other|0|||
129107557|NCT00572455|464688468|FG013|Stage II (28 Days)|Other|0|||
129107558|NCT00572455|464688455|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
129107559|NCT00572455|464688456|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
129107560|NCT00572455|464688457|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
129107561|NCT00572455|464688458|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
129107562|NCT00572455|464688459|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
129107563|NCT00572455|464688460|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
129107564|NCT00572455|464688461|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
129107565|NCT00572455|464688462|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
129107566|NCT00572455|464688463|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
128884367|NCT05333224|463871303|FG000|Overall Study - Infants|Lost to Follow-up|1|||
128884368|NCT05333224|463871304|FG001|Overall Study - Infants|Lost to Follow-up|1|||
128884369|NCT00063154|463871305|FG000|Overall Study|Disease progression|27|||
129107567|NCT00572455|464688464|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
129107568|NCT00572455|464688465|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
129107569|NCT00572455|464688466|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
129107570|NCT00572455|464688467|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
128683867|NCT00366340|463142592|FG001|Infant Series|Lost to Follow-up|1|||
128884370|NCT00063154|463871305|FG000|Overall Study|Adverse Event|2|||
128884371|NCT00063154|463871305|FG000|Overall Study|Physician Decision|10|||
128884372|NCT00063154|463871305|FG000|Overall Study|Death|3|||
129107571|NCT00572455|464688468|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
129107572|NCT02824224|464688469|FG000|Overall Study|Discontinued, IUS expulsion|0|||
128683868|NCT00366340|463142591|FG000|Infant Series|Failure to return|1|||
129107573|NCT02824224|464688470|FG001|Overall Study|Discontinued, IUS expulsion|1|||
129107574|NCT02824224|464688469|FG000|Overall Study|Did not show up for allocation visit|2|||
128884373|NCT00063154|463871305|FG000|Overall Study|Reason unspecified|1|||
128884374|NCT00063154|463871305|FG000|Overall Study|Did not receive treatment|8|||
128884375|NCT03588728|463871306|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
128884376|NCT03588728|463871307|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
128884377|NCT03588728|463871308|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
128884378|NCT03588728|463871309|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
128884379|NCT03588728|463871306|FG000|Overall Study|Lab shut down due to COVID-19|0|||
128884380|NCT03588728|463871307|FG001|Overall Study|Lab shut down due to COVID-19|0|||
128884381|NCT03588728|463871308|FG002|Overall Study|Lab shut down due to COVID-19|0|||
128884382|NCT03588728|463871309|FG003|Overall Study|Lab shut down due to COVID-19|1|||
128884383|NCT03588728|463871306|FG000|Overall Study|multiple technical issues|1|||
128884384|NCT03588728|463871307|FG001|Overall Study|multiple technical issues|0|||
128884385|NCT03588728|463871308|FG002|Overall Study|multiple technical issues|0|||
128884386|NCT03588728|463871309|FG003|Overall Study|multiple technical issues|0|||
128884387|NCT03588728|463871306|FG000|Overall Study|Hospitalized for COVID|1|||
128884388|NCT03588728|463871307|FG001|Overall Study|Hospitalized for COVID|0|||
128884389|NCT03588728|463871308|FG002|Overall Study|Hospitalized for COVID|0|||
128884390|NCT03588728|463871309|FG003|Overall Study|Hospitalized for COVID|0|||
128884391|NCT03588728|463871306|FG000|Overall Study|Schedule change unable to attend sessions|1|||
128884392|NCT03588728|463871307|FG001|Overall Study|Schedule change unable to attend sessions|0|||
128884393|NCT03588728|463871308|FG002|Overall Study|Schedule change unable to attend sessions|0|||
128884394|NCT03588728|463871309|FG003|Overall Study|Schedule change unable to attend sessions|0|||
128884395|NCT02027701|463871310|FG000|Overall Study|Adverse Event|3|||
128884396|NCT02027701|463871310|FG000|Overall Study|Lack of Efficacy|8|||
128884397|NCT02027701|463871310|FG000|Overall Study|Physician Decision|2|||
128884398|NCT02027701|463871310|FG000|Overall Study|Withdrawal by Subject|3|||
128884399|NCT00887679|463871311|FG000|Overall Study|Withdrawal by Subject|1|||
128884400|NCT00887679|463871311|FG000|Overall Study|Lost to Follow-up|4|||
128683869|NCT00366340|463142592|FG001|Infant Series|Failure to return|0|||
128683870|NCT00366340|463142591|FG000|After the Infant Series|Parent/legal guardian request|1|||
128683871|NCT00366340|463142592|FG001|After the Infant Series|Parent/legal guardian request|1|||
128683872|NCT00366340|463142591|FG000|After the Infant Series|Failed to return|0|||
128683873|NCT00366340|463142592|FG001|After the Infant Series|Failed to return|1|||
128683874|NCT00366340|463142591|FG000|After the Infant Series|Protocol Violation|2|||
128683875|NCT00366340|463142592|FG001|After the Infant Series|Protocol Violation|2|||
128683876|NCT00366340|463142591|FG000|After the Infant Series|Adverse Event|0|||
128683877|NCT00366340|463142592|FG001|After the Infant Series|Adverse Event|1|||
128683878|NCT00366340|463142591|FG000|After the Infant Series|Lost to Follow-up|0|||
128683879|NCT00366340|463142592|FG001|After the Infant Series|Lost to Follow-up|1|||
128683880|NCT00366340|463142591|FG000|Toddler Dose|Failed to return|1|||
128683881|NCT00366340|463142592|FG001|Toddler Dose|Failed to return|0|||
128683882|NCT00366340|463142591|FG000|Toddler Dose|Parent/legal guardian request|0|||
128683883|NCT00366340|463142592|FG001|Toddler Dose|Parent/legal guardian request|1|||
128683884|NCT03355664|463142593|FG000|Overall Study|Adverse Event|1|||
128683885|NCT03355664|463142594|FG001|Overall Study|Adverse Event|2|||
128683886|NCT03355664|463142593|FG000|Overall Study|Lost to Follow-up|11|||
128683887|NCT03355664|463142594|FG001|Overall Study|Lost to Follow-up|7|||
128683888|NCT03355664|463142593|FG000|Overall Study|Protocol Violation|1|||
128683889|NCT03355664|463142594|FG001|Overall Study|Protocol Violation|2|||
129107575|NCT02824224|464688470|FG001|Overall Study|Did not show up for allocation visit|0|||
129107576|NCT02821416|464688473|FG000|Overall Study|Adverse Event|0|||
129107577|NCT02821416|464688474|FG001|Overall Study|Adverse Event|1|||
129107578|NCT02821416|464688473|FG000|Overall Study|Withdrawal by Subject|2|||
129107579|NCT02821416|464688474|FG001|Overall Study|Withdrawal by Subject|0|||
129107580|NCT02821416|464688473|FG000|Overall Study|Lost to Follow-up|1|||
128683890|NCT03355664|463142593|FG000|Overall Study|Withdrawal by Subject|2|||
128683891|NCT03355664|463142594|FG001|Overall Study|Withdrawal by Subject|1|||
128683892|NCT01315236|463142600|FG000|Double-blind Phase|Death|1|||
128683893|NCT01315236|463142601|FG001|Double-blind Phase|Death|0|||
128683894|NCT01315236|463142600|FG000|Double-blind Phase|Adverse Event|1|||
128683895|NCT01315236|463142601|FG001|Double-blind Phase|Adverse Event|0|||
128683896|NCT01315236|463142600|FG000|Double-blind Phase|Withdrawal of Consent|1|||
128683897|NCT01315236|463142601|FG001|Double-blind Phase|Withdrawal of Consent|0|||
128683898|NCT01315236|463142600|FG000|Double-blind Phase|Lost to Follow-up|1|||
128683899|NCT01315236|463142601|FG001|Double-blind Phase|Lost to Follow-up|0|||
128884401|NCT00887679|463871311|FG000|Overall Study|Physician Decision|5|||
128884402|NCT01026454|463871312|FG000|Second Intervention|Pregnancy|1|||
128884403|NCT01026454|463871313|FG001|Second Intervention|Pregnancy|1|||
129107581|NCT02821416|464688474|FG001|Overall Study|Lost to Follow-up|0|||
129107582|NCT04152083|464688477|FG000|Overall Study|Lost to Follow-up|2|||
128683900|NCT01315236|463142600|FG000|Open-label Phase|Death|1|||
128683901|NCT01315236|463142601|FG001|Open-label Phase|Death|0|||
128683902|NCT01315236|463142600|FG000|Open-label Phase|Adverse Event|0|||
128683903|NCT01315236|463142601|FG001|Open-label Phase|Adverse Event|1|||
128683904|NCT01315236|463142600|FG000|Open-label Phase|Other|0|||
128683905|NCT01315236|463142601|FG001|Open-label Phase|Other|1|||
128884404|NCT00394953|463871314|FG000|First Treatment Period|Adverse Event|1|||
128884405|NCT00394953|463871315|FG001|First Treatment Period|Adverse Event|2|||
128884406|NCT00394953|463871314|FG000|First Treatment Period|Death|6|||
128884407|NCT00394953|463871315|FG001|First Treatment Period|Death|7|||
128884408|NCT00394953|463871314|FG000|First Treatment Period|Lack of Efficacy|1|||
128884409|NCT00394953|463871315|FG001|First Treatment Period|Lack of Efficacy|1|||
128884410|NCT00394953|463871314|FG000|First Treatment Period|Withdrawal by Subject|6|||
128884411|NCT00394953|463871315|FG001|First Treatment Period|Withdrawal by Subject|3|||
128884412|NCT00394953|463871314|FG000|First Treatment Period|Lost to Follow-up|0|||
128884413|NCT00394953|463871315|FG001|First Treatment Period|Lost to Follow-up|1|||
128884414|NCT00394953|463871314|FG000|First Treatment Period|Renal transplant|11|||
128884415|NCT00394953|463871315|FG001|First Treatment Period|Renal transplant|7|||
128884416|NCT00394953|463871314|FG000|First Treatment Period|Not defined|4|||
128884417|NCT00394953|463871315|FG001|First Treatment Period|Not defined|1|||
128884418|NCT00394953|463871314|FG000|Second Treatment Period|Adverse Event|2|||
128884419|NCT00394953|463871315|FG001|Second Treatment Period|Adverse Event|5|||
128884420|NCT00394953|463871314|FG000|Second Treatment Period|Death|8|||
128884421|NCT00394953|463871315|FG001|Second Treatment Period|Death|4|||
128884422|NCT00394953|463871314|FG000|Second Treatment Period|Lack of Efficacy|9|||
128884423|NCT00394953|463871315|FG001|Second Treatment Period|Lack of Efficacy|47|||
128884424|NCT00394953|463871314|FG000|Second Treatment Period|Withdrawal by Subject|3|||
128884425|NCT00394953|463871315|FG001|Second Treatment Period|Withdrawal by Subject|3|||
128884426|NCT00394953|463871314|FG000|Second Treatment Period|Lost to Follow-up|0|||
128884427|NCT00394953|463871315|FG001|Second Treatment Period|Lost to Follow-up|1|||
128884428|NCT00394953|463871314|FG000|Second Treatment Period|Renal transplant|4|||
128884429|NCT00394953|463871315|FG001|Second Treatment Period|Renal transplant|6|||
128884430|NCT00394953|463871314|FG000|Second Treatment Period|Not defined|3|||
128884431|NCT00394953|463871315|FG001|Second Treatment Period|Not defined|8|||
128884432|NCT02196714|463871319|FG000|Overall Study|Protocol Violation|0|||
128884433|NCT02196714|463871320|FG001|Overall Study|Protocol Violation|0|||
128884434|NCT02196714|463871321|FG002|Overall Study|Protocol Violation|1|||
128884435|NCT02196714|463871322|FG003|Overall Study|Protocol Violation|0|||
128884436|NCT04079803|463871325|FG000|Overall Study|Withdrawal by Subject|0|||
128884437|NCT04079803|463871326|FG001|Overall Study|Withdrawal by Subject|0|||
128884438|NCT04079803|463871327|FG002|Overall Study|Withdrawal by Subject|1|||
128884439|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
128884440|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
128884441|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
128884442|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
128884443|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
128884444|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
128884445|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
128884446|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
128884447|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
128884448|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
128884449|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
128884450|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
128884451|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
128884452|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
128884453|NCT01294683|463871328|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
128884454|NCT01294683|463871329|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
128884455|NCT01294683|463871328|FG000|Post Crossover (Period III)|Adverse Event|6|||
128884456|NCT01294683|463871329|FG001|Post Crossover (Period III)|Adverse Event|6|||
128884457|NCT01294683|463871328|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
129019477|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019478|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
129019479|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129019480|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019481|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019482|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019483|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
128884458|NCT01294683|463871329|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
128884459|NCT01294683|463871328|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
128884460|NCT01294683|463871329|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
128884461|NCT01294683|463871328|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
128884462|NCT01294683|463871329|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
128884463|NCT01881750|463871330|FG000|Overall Study|Changes in concomitant therapies|2|||
128884464|NCT01881750|463871331|FG001|Overall Study|Changes in concomitant therapies|3|||
128884465|NCT01881750|463871330|FG000|Overall Study|Lost to Follow-up|0|||
129019484|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019485|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129107583|NCT04152083|464688478|FG001|Overall Study|Lost to Follow-up|1|||
128884466|NCT01881750|463871331|FG001|Overall Study|Lost to Follow-up|1|||
128884467|NCT03737474|463871333|FG000|Overall Study|Adverse Event|18|||
128884468|NCT03737474|463871334|FG001|Overall Study|Adverse Event|48|||
128884469|NCT03737474|463871333|FG000|Overall Study|Lack of Efficacy|1|||
128683906|NCT01315236|463142600|FG000|12-Month Follow-up Period|Death|0|||
128884470|NCT03737474|463871334|FG001|Overall Study|Lack of Efficacy|3|||
128884471|NCT03737474|463871333|FG000|Overall Study|Protocol Violation|0|||
128884472|NCT03737474|463871334|FG001|Overall Study|Protocol Violation|8|||
128884473|NCT03737474|463871333|FG000|Overall Study|Withdrawal by Subject|5|||
128884474|NCT03737474|463871334|FG001|Overall Study|Withdrawal by Subject|20|||
128884475|NCT03737474|463871333|FG000|Overall Study|Non-compliance With Study Drug|0|||
128884476|NCT03737474|463871334|FG001|Overall Study|Non-compliance With Study Drug|1|||
128683907|NCT01315236|463142601|FG001|12-Month Follow-up Period|Death|1|||
128683908|NCT01315236|463142600|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
128683909|NCT01315236|463142601|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
128683910|NCT01751802|463142602|FG000|Overall Study|Adverse Event|4|||
128683911|NCT01751802|463142603|FG001|Overall Study|Adverse Event|2|||
128683912|NCT00589784|463142607|FG000|Overall Study|Withdrawal by Subject|0|||
128683913|NCT00589784|463142608|FG001|Overall Study|Withdrawal by Subject|6|||
128683914|NCT00589784|463142607|FG000|Overall Study|Patient inevaluable|1|||
128683915|NCT00589784|463142608|FG001|Overall Study|Patient inevaluable|0|||
128683916|NCT00589784|463142607|FG000|Overall Study|Adverse Event|0|||
128683917|NCT00589784|463142608|FG001|Overall Study|Adverse Event|4|||
128683918|NCT00521001|463142610|FG000|Overall Study|Ineligible|1|||
128683919|NCT02821910|463142611|FG000|Overall Study|Withdrawal by Subject|0|||
128683920|NCT02821910|463142612|FG001|Overall Study|Withdrawal by Subject|0|||
128683921|NCT02821910|463142613|FG002|Overall Study|Withdrawal by Subject|1|||
128683922|NCT02821910|463142614|FG003|Overall Study|Withdrawal by Subject|0|||
128683923|NCT02821910|463142615|FG004|Overall Study|Withdrawal by Subject|0|||
128683924|NCT02821910|463142616|FG005|Overall Study|Withdrawal by Subject|1|||
128683925|NCT02821910|463142611|FG000|Overall Study|Other than specified|1|||
128683926|NCT02821910|463142612|FG001|Overall Study|Other than specified|0|||
128683927|NCT02821910|463142613|FG002|Overall Study|Other than specified|1|||
128683928|NCT02821910|463142614|FG003|Overall Study|Other than specified|0|||
128683929|NCT02821910|463142615|FG004|Overall Study|Other than specified|0|||
128683930|NCT02821910|463142616|FG005|Overall Study|Other than specified|0|||
128683931|NCT00287079|463142617|FG000|Overall Study|Qualifying relapse|12|||
128683932|NCT00287079|463142618|FG001|Overall Study|Qualifying relapse|1|||
128683933|NCT00287079|463142617|FG000|Overall Study|Non-qualifying relapse|1|||
128683934|NCT00287079|463142618|FG001|Overall Study|Non-qualifying relapse|0|||
128683935|NCT00287079|463142617|FG000|Overall Study|Adverse Event|5|||
128683936|NCT00287079|463142618|FG001|Overall Study|Adverse Event|0|||
128683937|NCT00287079|463142617|FG000|Overall Study|Protocol Violation|1|||
128683938|NCT00287079|463142618|FG001|Overall Study|Protocol Violation|0|||
128683939|NCT00287079|463142617|FG000|Overall Study|Other|3|||
128683940|NCT00287079|463142618|FG001|Overall Study|Other|0|||
128683941|NCT00423670|463142619|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
128683942|NCT00423670|463142620|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
128683943|NCT00423670|463142621|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
128683944|NCT00423670|463142622|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
128683945|NCT00423670|463142623|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
128683946|NCT00423670|463142624|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
128683947|NCT00423670|463142625|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
128683948|NCT00423670|463142626|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
128683949|NCT00423670|463142619|FG000|Treatment Period|Adverse Event|8|||
128683950|NCT00423670|463142620|FG001|Treatment Period|Adverse Event|12|||
128683951|NCT00423670|463142621|FG002|Treatment Period|Adverse Event|15|||
128683952|NCT00423670|463142622|FG003|Treatment Period|Adverse Event|20|||
128683953|NCT00423670|463142623|FG004|Treatment Period|Adverse Event|9|||
128683954|NCT00423670|463142624|FG005|Treatment Period|Adverse Event|4|||
128683955|NCT00423670|463142625|FG006|Treatment Period|Adverse Event|7|||
128683956|NCT00423670|463142626|FG007|Treatment Period|Adverse Event|2|||
128683957|NCT00423670|463142619|FG000|Treatment Period|Protocol-defined clinical event|0|||
128884477|NCT03737474|463871333|FG000|Overall Study|Physician Decision|1|||
128884478|NCT03737474|463871334|FG001|Overall Study|Physician Decision|4|||
128683958|NCT00423670|463142620|FG001|Treatment Period|Protocol-defined clinical event|7|||
128683959|NCT00423670|463142621|FG002|Treatment Period|Protocol-defined clinical event|4|||
128683960|NCT00423670|463142622|FG003|Treatment Period|Protocol-defined clinical event|12|||
128683961|NCT00423670|463142623|FG004|Treatment Period|Protocol-defined clinical event|5|||
128683962|NCT00423670|463142624|FG005|Treatment Period|Protocol-defined clinical event|4|||
128683963|NCT00423670|463142625|FG006|Treatment Period|Protocol-defined clinical event|16|||
128683964|NCT00423670|463142626|FG007|Treatment Period|Protocol-defined clinical event|15|||
128683965|NCT00423670|463142619|FG000|Treatment Period|Lost to Follow-up|2|||
128683966|NCT00423670|463142620|FG001|Treatment Period|Lost to Follow-up|1|||
128683967|NCT00423670|463142621|FG002|Treatment Period|Lost to Follow-up|3|||
128884479|NCT02513745|463871335|FG000|Overall Study|Criteria at time of surgery not met.|3|||
128884480|NCT02513745|463871336|FG001|Overall Study|Criteria at time of surgery not met.|3|||
128884481|NCT01209143|463871337|FG000|Overall Study|Adverse Event|2|||
128884482|NCT01209143|463871338|FG001|Overall Study|Adverse Event|1|||
128884483|NCT01209143|463871337|FG000|Overall Study|Death|0|||
128884484|NCT01209143|463871338|FG001|Overall Study|Death|1|||
128884485|NCT01209143|463871337|FG000|Overall Study|Physician Decision|3|||
128884486|NCT01209143|463871338|FG001|Overall Study|Physician Decision|1|||
128884487|NCT01209143|463871337|FG000|Overall Study|Lost to Follow-up|1|||
128884488|NCT01209143|463871338|FG001|Overall Study|Lost to Follow-up|0|||
128884489|NCT01209143|463871337|FG000|Overall Study|Withdrawal by Subject|2|||
128884490|NCT01209143|463871338|FG001|Overall Study|Withdrawal by Subject|1|||
128884491|NCT01209143|463871337|FG000|Overall Study|Disease progression|11|||
128884492|NCT01209143|463871338|FG001|Overall Study|Disease progression|16|||
128884493|NCT00753272|463871342|FG000|Overall Study|Adverse Event|878|||
128884494|NCT00753272|463871343|FG001|Overall Study|Adverse Event|869|||
128884495|NCT00753272|463871342|FG000|Overall Study|Protocol Violation|28|||
128884496|NCT00753272|463871343|FG001|Overall Study|Protocol Violation|46|||
128884497|NCT00753272|463871342|FG000|Overall Study|Withdrawal by Subject|2481|||
128884498|NCT00753272|463871343|FG001|Overall Study|Withdrawal by Subject|2407|||
128884499|NCT00753272|463871342|FG000|Overall Study|Lost to Follow-up|491|||
128884500|NCT00753272|463871343|FG001|Overall Study|Lost to Follow-up|497|||
128884501|NCT00753272|463871342|FG000|Overall Study|Other|1104|||
128884502|NCT00753272|463871343|FG001|Overall Study|Other|1088|||
128884503|NCT00971243|463871344|FG000|Double Blind Period|Adverse Event|2|||
128884504|NCT00971243|463871345|FG001|Double Blind Period|Adverse Event|3|||
128884505|NCT00971243|463871346|FG002|Double Blind Period|Adverse Event|2|||
128884506|NCT00971243|463871347|FG003|Double Blind Period|Adverse Event|2|||
128884507|NCT00971243|463871348|FG004|Double Blind Period|Adverse Event|3|||
128884508|NCT00971243|463871344|FG000|Double Blind Period|Lost to Follow-up|0|||
128884509|NCT00971243|463871345|FG001|Double Blind Period|Lost to Follow-up|1|||
128884510|NCT00971243|463871346|FG002|Double Blind Period|Lost to Follow-up|1|||
128884511|NCT00971243|463871347|FG003|Double Blind Period|Lost to Follow-up|0|||
128884512|NCT00971243|463871348|FG004|Double Blind Period|Lost to Follow-up|1|||
128884513|NCT00971243|463871344|FG000|Double Blind Period|Physician Decision|10|||
128884514|NCT00971243|463871345|FG001|Double Blind Period|Physician Decision|6|||
128884515|NCT00971243|463871346|FG002|Double Blind Period|Physician Decision|7|||
128884516|NCT00971243|463871347|FG003|Double Blind Period|Physician Decision|6|||
128884517|NCT00971243|463871348|FG004|Double Blind Period|Physician Decision|7|||
128884518|NCT00971243|463871344|FG000|Double Blind Period|Protocol Violation|2|||
128884519|NCT00971243|463871345|FG001|Double Blind Period|Protocol Violation|0|||
128884520|NCT00971243|463871346|FG002|Double Blind Period|Protocol Violation|3|||
128884521|NCT00971243|463871347|FG003|Double Blind Period|Protocol Violation|2|||
128884522|NCT00971243|463871348|FG004|Double Blind Period|Protocol Violation|2|||
128884523|NCT00971243|463871344|FG000|Double Blind Period|Withdrawal by Subject|4|||
128884524|NCT00971243|463871345|FG001|Double Blind Period|Withdrawal by Subject|1|||
128884525|NCT00971243|463871346|FG002|Double Blind Period|Withdrawal by Subject|4|||
128884526|NCT00971243|463871347|FG003|Double Blind Period|Withdrawal by Subject|4|||
128884527|NCT00971243|463871348|FG004|Double Blind Period|Withdrawal by Subject|4|||
128884528|NCT00971243|463871344|FG000|Double Blind Period|Other reasons|1|||
128884529|NCT00971243|463871345|FG001|Double Blind Period|Other reasons|0|||
128884530|NCT00971243|463871346|FG002|Double Blind Period|Other reasons|2|||
128884531|NCT00971243|463871347|FG003|Double Blind Period|Other reasons|0|||
128884532|NCT00971243|463871348|FG004|Double Blind Period|Other reasons|1|||
128884533|NCT00971243|463871344|FG000|Open-label Period|Adverse Event|1|||
128884534|NCT00971243|463871345|FG001|Open-label Period|Adverse Event|0|||
128884535|NCT00971243|463871346|FG002|Open-label Period|Adverse Event|1|||
128884536|NCT00971243|463871347|FG003|Open-label Period|Adverse Event|1|||
128884537|NCT00971243|463871348|FG004|Open-label Period|Adverse Event|0|||
128884538|NCT00971243|463871344|FG000|Open-label Period|Physician Decision|5|||
128884539|NCT00971243|463871345|FG001|Open-label Period|Physician Decision|9|||
128763163|NCT00860067|463422765|FG000|Overall Study|Pregnancy|1|||
128884540|NCT00971243|463871346|FG002|Open-label Period|Physician Decision|3|||
128884541|NCT00971243|463871347|FG003|Open-label Period|Physician Decision|7|||
128884542|NCT00971243|463871348|FG004|Open-label Period|Physician Decision|2|||
128884543|NCT00971243|463871344|FG000|Open-label Period|Protocol Violation|1|||
128884544|NCT00971243|463871345|FG001|Open-label Period|Protocol Violation|1|||
128884545|NCT00971243|463871346|FG002|Open-label Period|Protocol Violation|1|||
128884546|NCT00971243|463871347|FG003|Open-label Period|Protocol Violation|0|||
128884547|NCT00971243|463871348|FG004|Open-label Period|Protocol Violation|1|||
128884548|NCT00971243|463871344|FG000|Open-label Period|Withdrawal by Subject|1|||
128884549|NCT00971243|463871345|FG001|Open-label Period|Withdrawal by Subject|0|||
128884550|NCT00971243|463871346|FG002|Open-label Period|Withdrawal by Subject|0|||
128884551|NCT00971243|463871347|FG003|Open-label Period|Withdrawal by Subject|2|||
128884552|NCT00971243|463871348|FG004|Open-label Period|Withdrawal by Subject|1|||
128884553|NCT00971243|463871344|FG000|Open-label Period|Other reason|0|||
128884554|NCT00971243|463871345|FG001|Open-label Period|Other reason|0|||
128763164|NCT00860067|463422766|FG001|Overall Study|Pregnancy|0|||
128884555|NCT00971243|463871346|FG002|Open-label Period|Other reason|0|||
128884556|NCT00971243|463871347|FG003|Open-label Period|Other reason|0|||
128884557|NCT00971243|463871348|FG004|Open-label Period|Other reason|2|||
128884558|NCT05266586|463871349|FG000|Overall Study|Adverse Event|2|||
128884559|NCT05266586|463871350|FG001|Overall Study|Adverse Event|2|||
128884560|NCT05266586|463871351|FG002|Overall Study|Adverse Event|1|||
128884561|NCT05266586|463871349|FG000|Overall Study|Withdrawal by Subject|1|||
128884562|NCT05266586|463871350|FG001|Overall Study|Withdrawal by Subject|0|||
128884563|NCT05266586|463871351|FG002|Overall Study|Withdrawal by Subject|1|||
128884564|NCT05266586|463871349|FG000|Overall Study|Non-compliance with study drug|0|||
128884565|NCT05266586|463871350|FG001|Overall Study|Non-compliance with study drug|1|||
128884566|NCT05266586|463871351|FG002|Overall Study|Non-compliance with study drug|0|||
128884567|NCT05266586|463871349|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
128884568|NCT05266586|463871350|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
128884569|NCT05266586|463871351|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
128884570|NCT02730598|463871354|FG000|Overall Study|Withdrawal by Subject|3|||
128884571|NCT02730598|463871355|FG001|Overall Study|Withdrawal by Subject|3|||
128884572|NCT02730598|463871354|FG000|Overall Study|Protocol Violation|0|||
128884573|NCT02730598|463871355|FG001|Overall Study|Protocol Violation|1|||
128884574|NCT02730598|463871354|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
128884575|NCT02730598|463871355|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
128884576|NCT03282240|463871356|FG000|Overall Study|Adverse Event|2|||
128884577|NCT03282240|463871357|FG001|Overall Study|Adverse Event|2|||
128884578|NCT03282240|463871358|FG002|Overall Study|Adverse Event|0|||
128884579|NCT03282240|463871356|FG000|Overall Study|Lost to Follow-up|3|||
128884580|NCT03282240|463871357|FG001|Overall Study|Lost to Follow-up|0|||
128884581|NCT03282240|463871358|FG002|Overall Study|Lost to Follow-up|0|||
128884582|NCT03282240|463871356|FG000|Overall Study|Protocol Deviation|4|||
128884583|NCT03282240|463871357|FG001|Overall Study|Protocol Deviation|1|||
128884584|NCT03282240|463871358|FG002|Overall Study|Protocol Deviation|2|||
128884585|NCT03282240|463871356|FG000|Overall Study|Withdrawal by Subject|1|||
128884586|NCT03282240|463871357|FG001|Overall Study|Withdrawal by Subject|0|||
128884587|NCT03282240|463871358|FG002|Overall Study|Withdrawal by Subject|1|||
128884588|NCT01675479|463871359|FG000|Overall Study|Lost to Follow-up|11|||
128884589|NCT03254485|463871360|FG000|Overall Study|Adverse Event|3|||
128884590|NCT03254485|463871361|FG001|Overall Study|Adverse Event|0|||
128884591|NCT03254485|463871362|FG002|Overall Study|Adverse Event|0|||
128884592|NCT03254485|463871363|FG003|Overall Study|Adverse Event|6|||
128884593|NCT03254485|463871360|FG000|Overall Study|Protocol Violation|6|||
128884594|NCT03254485|463871361|FG001|Overall Study|Protocol Violation|0|||
128884595|NCT03254485|463871362|FG002|Overall Study|Protocol Violation|0|||
128884596|NCT03254485|463871363|FG003|Overall Study|Protocol Violation|2|||
128884597|NCT03254485|463871360|FG000|Overall Study|Withdrawal by Subject|1|||
128884598|NCT03254485|463871361|FG001|Overall Study|Withdrawal by Subject|0|||
128884599|NCT03254485|463871362|FG002|Overall Study|Withdrawal by Subject|0|||
128884600|NCT03254485|463871363|FG003|Overall Study|Withdrawal by Subject|4|||
128884601|NCT03254485|463871360|FG000|Overall Study|Death|0|||
128884602|NCT03254485|463871361|FG001|Overall Study|Death|0|||
128884603|NCT03254485|463871362|FG002|Overall Study|Death|0|||
128884604|NCT03254485|463871363|FG003|Overall Study|Death|1|||
128884605|NCT03254485|463871360|FG000|Overall Study|Lost to Follow-up|1|||
128884606|NCT03254485|463871361|FG001|Overall Study|Lost to Follow-up|0|||
128884607|NCT03254485|463871362|FG002|Overall Study|Lost to Follow-up|0|||
128884608|NCT03254485|463871363|FG003|Overall Study|Lost to Follow-up|0|||
128884609|NCT03254485|463871360|FG000|Overall Study|Other|1|||
128884610|NCT03254485|463871361|FG001|Overall Study|Other|0|||
128884611|NCT03254485|463871362|FG002|Overall Study|Other|0|||
128884612|NCT03254485|463871363|FG003|Overall Study|Other|2|||
128884613|NCT02146326|463871364|FG000|Overall Study|Lost to Follow-up|3|||
128884614|NCT02146326|463871365|FG001|Overall Study|Lost to Follow-up|3|||
128884615|NCT02146326|463871366|FG002|Overall Study|Lost to Follow-up|11|||
128884616|NCT02146326|463871367|FG003|Overall Study|Lost to Follow-up|19|||
128884617|NCT02146326|463871364|FG000|Overall Study|Withdrawal by Subject|2|||
128884618|NCT02146326|463871365|FG001|Overall Study|Withdrawal by Subject|1|||
128884619|NCT02146326|463871366|FG002|Overall Study|Withdrawal by Subject|15|||
128884620|NCT02146326|463871367|FG003|Overall Study|Withdrawal by Subject|11|||
128884621|NCT02146326|463871364|FG000|Overall Study|Separated from mental health center|23|||
128884622|NCT02146326|463871365|FG001|Overall Study|Separated from mental health center|33|||
128884623|NCT02146326|463871366|FG002|Overall Study|Separated from mental health center|0|||
128884624|NCT02146326|463871367|FG003|Overall Study|Separated from mental health center|0|||
128884625|NCT02146326|463871364|FG000|Overall Study|Incarcerated|0|||
128884626|NCT02146326|463871365|FG001|Overall Study|Incarcerated|0|||
128884627|NCT02146326|463871366|FG002|Overall Study|Incarcerated|3|||
128884628|NCT02146326|463871367|FG003|Overall Study|Incarcerated|8|||
129107584|NCT04152083|464688477|FG000|Overall Study|Adverse Event|1|||
128884629|NCT02146326|463871364|FG000|Overall Study|Death|0|||
128884630|NCT02146326|463871365|FG001|Overall Study|Death|0|||
128884631|NCT02146326|463871366|FG002|Overall Study|Death|4|||
128884632|NCT02146326|463871367|FG003|Overall Study|Death|4|||
129107585|NCT04152083|464688478|FG001|Overall Study|Adverse Event|0|||
129107586|NCT04152083|464688477|FG000|Overall Study|Randomized but not treated|3|||
129107587|NCT04152083|464688478|FG001|Overall Study|Randomized but not treated|2|||
129107588|NCT00856999|464688479|FG000|Overall Study|Withdrawal by Subject|5|||
129107589|NCT02465437|464688484|FG000|Overall Study|Physician Decision|0|||
129107590|NCT02465437|464688485|FG001|Overall Study|Physician Decision|0|||
129107591|NCT02465437|464688486|FG002|Overall Study|Physician Decision|1|||
129107592|NCT02465437|464688487|FG003|Overall Study|Physician Decision|0|||
129107593|NCT02465437|464688484|FG000|Overall Study|Withdrawal by Subject|1|||
129107594|NCT02465437|464688485|FG001|Overall Study|Withdrawal by Subject|0|||
129107595|NCT02465437|464688486|FG002|Overall Study|Withdrawal by Subject|0|||
129107596|NCT02465437|464688487|FG003|Overall Study|Withdrawal by Subject|1|||
129107597|NCT02465437|464688484|FG000|Overall Study|Adverse Event|0|||
129107598|NCT02465437|464688485|FG001|Overall Study|Adverse Event|1|||
129107599|NCT02465437|464688486|FG002|Overall Study|Adverse Event|0|||
129107600|NCT02465437|464688487|FG003|Overall Study|Adverse Event|0|||
129107601|NCT00003483|464688488|FG000|Overall Study|Not evaluable|1|||
129107602|NCT02609386|464688491|FG000|Overall Study|Withdrawal by Subject|6|||
129107603|NCT02609386|464688492|FG001|Overall Study|Withdrawal by Subject|1|||
129107604|NCT02609386|464688491|FG000|Overall Study|Lost to Follow-up|3|||
129107605|NCT02609386|464688492|FG001|Overall Study|Lost to Follow-up|5|||
129107606|NCT02609386|464688491|FG000|Overall Study|Death|19|||
129107607|NCT02609386|464688492|FG001|Overall Study|Death|9|||
129107608|NCT02609386|464688491|FG000|Overall Study|Physician Decision|0|||
129107609|NCT02609386|464688492|FG001|Overall Study|Physician Decision|2|||
129107610|NCT01001520|464688502|FG000|Medication Period 1|Withdrawal by Subject|2|||
129107611|NCT01001520|464688503|FG001|Medication Period 1|Withdrawal by Subject|2|||
129107612|NCT01001520|464688502|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
129107613|NCT01001520|464688503|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
129107614|NCT01001520|464688502|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
129107615|NCT01001520|464688503|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
129107616|NCT01001520|464688502|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
129107617|NCT01001520|464688503|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
129107618|NCT01001520|464688502|FG000|Washout Period|Withdrawal by Subject|2|||
129107619|NCT01001520|464688503|FG001|Washout Period|Withdrawal by Subject|1|||
129107620|NCT01001520|464688502|FG000|Medication Period 2|Withdrawal by Subject|0|||
129107621|NCT01001520|464688503|FG001|Medication Period 2|Withdrawal by Subject|3|||
129107622|NCT00878800|464688516|FG000|Overall Study|Adverse Event|0|||
129107623|NCT00878800|464688517|FG001|Overall Study|Adverse Event|0|||
129107624|NCT00878800|464688518|FG002|Overall Study|Adverse Event|2|||
129107625|NCT00878800|464688519|FG003|Overall Study|Adverse Event|0|||
129107626|NCT00878800|464688520|FG004|Overall Study|Adverse Event|1|||
129107627|NCT00878800|464688516|FG000|Overall Study|Progressive disease|1|||
129107628|NCT00878800|464688517|FG001|Overall Study|Progressive disease|5|||
129107629|NCT00878800|464688518|FG002|Overall Study|Progressive disease|6|||
129107630|NCT00878800|464688519|FG003|Overall Study|Progressive disease|5|||
129107631|NCT00878800|464688520|FG004|Overall Study|Progressive disease|13|||
129107632|NCT00878800|464688516|FG000|Overall Study|Withdrew consent|1|||
129107633|NCT00878800|464688517|FG001|Overall Study|Withdrew consent|1|||
129107634|NCT00878800|464688518|FG002|Overall Study|Withdrew consent|0|||
129107635|NCT00878800|464688519|FG003|Overall Study|Withdrew consent|1|||
129107636|NCT00878800|464688520|FG004|Overall Study|Withdrew consent|1|||
129107637|NCT00878800|464688516|FG000|Overall Study|Death|0|||
129107638|NCT00878800|464688517|FG001|Overall Study|Death|0|||
129107639|NCT00878800|464688518|FG002|Overall Study|Death|1|||
129107640|NCT00878800|464688519|FG003|Overall Study|Death|0|||
129107641|NCT00878800|464688520|FG004|Overall Study|Death|0|||
129107642|NCT00878800|464688516|FG000|Overall Study|Other|1|||
129107643|NCT00878800|464688517|FG001|Overall Study|Other|1|||
129107644|NCT00878800|464688518|FG002|Overall Study|Other|0|||
129107645|NCT00878800|464688519|FG003|Overall Study|Other|0|||
129107646|NCT00878800|464688520|FG004|Overall Study|Other|1|||
129107647|NCT00613821|464688521|FG000|Overall Study|Withdrawal by Subject|1|||
129107648|NCT00613821|464688522|FG001|Overall Study|Withdrawal by Subject|0|||
129107649|NCT00613821|464688521|FG000|Overall Study|Physician Decision|1|||
129107650|NCT00613821|464688522|FG001|Overall Study|Physician Decision|1|||
129107651|NCT02302846|464688523|FG000|Overall Study|Withdrawal by Subject|1|||
129107652|NCT01468454|464688524|FG000|Overall Study|Did not have surgery after PET|9|||
129107653|NCT04435808|464688525|FG000|Overall Study|Study stopped by DSMB|0|||
129107654|NCT04435808|464688526|FG001|Overall Study|Study stopped by DSMB|1|||
129107655|NCT02620787|464688527|FG000|Overall Study|Adverse Event|1|||
129107656|NCT02620787|464688528|FG001|Overall Study|Adverse Event|0|||
129107657|NCT02620787|464688527|FG000|Overall Study|Eligibility Criteria Not Met|1|||
129107658|NCT02620787|464688528|FG001|Overall Study|Eligibility Criteria Not Met|0|||
129107659|NCT00807612|464688531|FG000|Overall Study|Death|8|||
129107660|NCT00807612|464688531|FG000|Overall Study|Study early termination|5|||
129107661|NCT00807612|464688531|FG000|Overall Study|Withdrawal by Subject|1|||
129107662|NCT02258659|464688533|FG000|Overall Study|Withdrawal by Subject|1|||
128683968|NCT00423670|463142622|FG003|Treatment Period|Lost to Follow-up|1|||
128683969|NCT00423670|463142623|FG004|Treatment Period|Lost to Follow-up|6|||
128683970|NCT00423670|463142624|FG005|Treatment Period|Lost to Follow-up|0|||
129107663|NCT04892446|464688534|FG000|Overall Study|Death|4|||
129107664|NCT04892446|464688535|FG001|Overall Study|Death|4|||
129107665|NCT04892446|464688536|FG002|Overall Study|Death|0|||
129107666|NCT04892446|464688534|FG000|Overall Study|Withdrew consent|3|||
129107667|NCT04892446|464688535|FG001|Overall Study|Withdrew consent|0|||
129107668|NCT04892446|464688536|FG002|Overall Study|Withdrew consent|1|||
129107669|NCT04892446|464688534|FG000|Overall Study|Investigator's discretion|1|||
129107670|NCT04892446|464688535|FG001|Overall Study|Investigator's discretion|1|||
129107671|NCT04892446|464688536|FG002|Overall Study|Investigator's discretion|0|||
129107672|NCT04892446|464688534|FG000|Overall Study|Study terminated by sponsor|0|||
129107673|NCT04892446|464688535|FG001|Overall Study|Study terminated by sponsor|0|||
129107674|NCT04892446|464688536|FG002|Overall Study|Study terminated by sponsor|2|||
129107675|NCT00272844|464688537|FG000|Overall Study|Withdrawal by Subject|5|||
129107676|NCT00705341|464688540|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
129107677|NCT00705341|464688541|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
129107678|NCT00705341|464688542|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
129107679|NCT00705341|464688543|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
129107680|NCT00705341|464688540|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
129107681|NCT00705341|464688541|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
129107682|NCT00705341|464688542|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
129107683|NCT00705341|464688543|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
129107684|NCT00791700|464688544|FG000|Overall Study|Insufficient clinical response|1|||
129107685|NCT00791700|464688545|FG001|Overall Study|Insufficient clinical response|4|||
129107686|NCT00791700|464688546|FG002|Overall Study|Insufficient clinical response|1|||
129107687|NCT00791700|464688547|FG003|Overall Study|Insufficient clinical response|8|||
129107688|NCT00791700|464688544|FG000|Overall Study|No longer willing to participate|1|||
129107689|NCT00791700|464688545|FG001|Overall Study|No longer willing to participate|1|||
129107690|NCT00791700|464688546|FG002|Overall Study|No longer willing to participate|0|||
129107691|NCT00791700|464688547|FG003|Overall Study|No longer willing to participate|8|||
129107692|NCT00791700|464688544|FG000|Overall Study|Non-compliance with study treatment|0|||
129107693|NCT00791700|464688545|FG001|Overall Study|Non-compliance with study treatment|2|||
129107694|NCT00791700|464688546|FG002|Overall Study|Non-compliance with study treatment|0|||
129107695|NCT00791700|464688547|FG003|Overall Study|Non-compliance with study treatment|4|||
129107696|NCT00791700|464688544|FG000|Overall Study|Withdrawn due to pregnancy|0|||
129107697|NCT00791700|464688545|FG001|Overall Study|Withdrawn due to pregnancy|0|||
129107698|NCT00791700|464688546|FG002|Overall Study|Withdrawn due to pregnancy|0|||
129107699|NCT00791700|464688547|FG003|Overall Study|Withdrawn due to pregnancy|1|||
129107700|NCT00791700|464688544|FG000|Overall Study|Other|0|||
129107701|NCT00791700|464688545|FG001|Overall Study|Other|1|||
129107702|NCT00791700|464688546|FG002|Overall Study|Other|0|||
129107703|NCT00791700|464688547|FG003|Overall Study|Other|1|||
129107704|NCT00791700|464688544|FG000|Overall Study|Death|0|||
129107705|NCT00791700|464688545|FG001|Overall Study|Death|0|||
129107706|NCT00791700|464688546|FG002|Overall Study|Death|0|||
129107707|NCT00791700|464688547|FG003|Overall Study|Death|1|||
129107708|NCT00791700|464688544|FG000|Overall Study|Lost to Follow-up|4|||
129107709|NCT00791700|464688545|FG001|Overall Study|Lost to Follow-up|3|||
129107710|NCT00791700|464688546|FG002|Overall Study|Lost to Follow-up|4|||
129107711|NCT00791700|464688547|FG003|Overall Study|Lost to Follow-up|6|||
129107712|NCT00791700|464688544|FG000|Overall Study|Adverse Event|0|||
129107713|NCT00791700|464688545|FG001|Overall Study|Adverse Event|0|||
129107714|NCT00791700|464688546|FG002|Overall Study|Adverse Event|1|||
129107715|NCT00791700|464688547|FG003|Overall Study|Adverse Event|1|||
129107716|NCT00527826|464688550|FG000|Overall Study|Adverse Event|10|||
129107717|NCT00527826|464688551|FG001|Overall Study|Adverse Event|10|||
129107718|NCT00527826|464688550|FG000|Overall Study|Lost to Follow-up|3|||
129107719|NCT00527826|464688551|FG001|Overall Study|Lost to Follow-up|2|||
129107720|NCT00527826|464688550|FG000|Overall Study|Withdrawal by Subject|5|||
129107721|NCT00527826|464688551|FG001|Overall Study|Withdrawal by Subject|8|||
129215124|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Disease Progression|0|||
129107722|NCT00527826|464688550|FG000|Overall Study|Inclusion Criteria Not Met|3|||
129107723|NCT00527826|464688551|FG001|Overall Study|Inclusion Criteria Not Met|3|||
129107724|NCT00527826|464688550|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
129107725|NCT00527826|464688551|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
129107726|NCT00527826|464688550|FG000|Overall Study|Additional Intake of Viani forte|0|||
129107727|NCT00527826|464688551|FG001|Overall Study|Additional Intake of Viani forte|1|||
129215125|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Disease Progression|0|||
129215126|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Disease Progression|0|||
128683971|NCT00423670|463142625|FG006|Treatment Period|Lost to Follow-up|3|||
128683972|NCT00423670|463142626|FG007|Treatment Period|Lost to Follow-up|1|||
129107728|NCT00527826|464688550|FG000|Overall Study|Participant moved away|0|||
129107729|NCT00527826|464688551|FG001|Overall Study|Participant moved away|1|||
129107730|NCT05568797|464688561|FG000|Overall Study|Adverse Event|0|||
128884633|NCT02146326|463871364|FG000|Overall Study|Unable to complete interview|0|||
128884634|NCT02146326|463871365|FG001|Overall Study|Unable to complete interview|0|||
128884635|NCT02146326|463871366|FG002|Overall Study|Unable to complete interview|10|||
128884636|NCT02146326|463871367|FG003|Overall Study|Unable to complete interview|6|||
128884637|NCT02910739|463871368|FG000|Overall Study|Adverse Event|1|||
128884638|NCT02910739|463871369|FG001|Overall Study|Adverse Event|0|||
128884639|NCT02910739|463871370|FG002|Overall Study|Adverse Event|0|||
128884640|NCT02910739|463871371|FG003|Overall Study|Adverse Event|0|||
128884641|NCT01340651|463871373|FG000|Overall Study|Adverse Event|3|||
128884642|NCT01340651|463871373|FG000|Overall Study|Consent Withdrawn|2|||
128884643|NCT01340651|463871373|FG000|Overall Study|Commercial Supply per Sponsor|12|||
128884644|NCT01696942|463871378|FG000|Overall Study|Withdrawal by Subject|1|||
128884645|NCT01696942|463871379|FG001|Overall Study|Withdrawal by Subject|0|||
128884646|NCT01696942|463871378|FG000|Overall Study|Protocol Violation|1|||
128884647|NCT01696942|463871379|FG001|Overall Study|Protocol Violation|2|||
128884648|NCT01696942|463871378|FG000|Overall Study|screen failure|0|||
128884649|NCT01696942|463871379|FG001|Overall Study|screen failure|1|||
128884650|NCT01598311|463871384|FG000|Overall Study|Physician Decision|4|||
128884651|NCT01598311|463871385|FG001|Overall Study|Physician Decision|5|||
128884652|NCT01598311|463871384|FG000|Overall Study|Adverse Event|9|||
128884653|NCT01598311|463871385|FG001|Overall Study|Adverse Event|13|||
128884654|NCT01598311|463871384|FG000|Overall Study|Lost to Follow-up|7|||
128884655|NCT01598311|463871385|FG001|Overall Study|Lost to Follow-up|12|||
128884656|NCT01598311|463871384|FG000|Overall Study|Withdrawal by Subject|9|||
128884657|NCT01598311|463871385|FG001|Overall Study|Withdrawal by Subject|13|||
128884658|NCT01598311|463871384|FG000|Overall Study|No reason provided.|0|||
128884659|NCT01598311|463871385|FG001|Overall Study|No reason provided.|5|||
128884660|NCT01598311|463871384|FG000|Overall Study|Randomized but never treated|8|||
128884661|NCT01598311|463871385|FG001|Overall Study|Randomized but never treated|5|||
128884662|NCT01598311|463871384|FG000|Overall Study|Treated but no confirmed CDAD|9|||
128884663|NCT01598311|463871385|FG001|Overall Study|Treated but no confirmed CDAD|8|||
128884664|NCT01598311|463871384|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
128884665|NCT01598311|463871385|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
128884666|NCT00688103|463871386|FG000|Overall Study|Adverse Event|4|||
128884667|NCT00688103|463871387|FG001|Overall Study|Adverse Event|1|||
128884668|NCT00688103|463871386|FG000|Overall Study|Lack of Efficacy|11|||
128884669|NCT00688103|463871387|FG001|Overall Study|Lack of Efficacy|1|||
128884670|NCT00688103|463871386|FG000|Overall Study|Withdrawal by Subject|4|||
128884671|NCT00688103|463871387|FG001|Overall Study|Withdrawal by Subject|2|||
128884672|NCT00688103|463871386|FG000|Overall Study|complex reasons|11|||
128884673|NCT00688103|463871387|FG001|Overall Study|complex reasons|9|||
128884674|NCT01313117|463871388|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
128884675|NCT01313117|463871388|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
128884676|NCT03602261|463871391|FG000|Overall Study|Adverse Event|5|||
128884677|NCT03602261|463871392|FG001|Overall Study|Adverse Event|1|||
128884678|NCT03602261|463871391|FG000|Overall Study|Physician Decision|1|||
128884679|NCT03602261|463871392|FG001|Overall Study|Physician Decision|0|||
128884680|NCT03602261|463871391|FG000|Overall Study|Withdrawal by Subject|1|||
128884681|NCT03602261|463871392|FG001|Overall Study|Withdrawal by Subject|1|||
128884682|NCT03602261|463871391|FG000|Overall Study|Lack of Efficacy|0|||
128884683|NCT03602261|463871392|FG001|Overall Study|Lack of Efficacy|1|||
128884684|NCT03602261|463871391|FG000|Overall Study|Subject moving out of state|1|||
128683973|NCT00423670|463142619|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
128884685|NCT03602261|463871392|FG001|Overall Study|Subject moving out of state|0|||
128884686|NCT02101034|463874065|FG000|Overall Study|Enrolled but did not start treatment|0|||
128884687|NCT02101034|463874066|FG001|Overall Study|Enrolled but did not start treatment|0|||
128884688|NCT02101034|463874067|FG002|Overall Study|Enrolled but did not start treatment|1|||
129019486|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019487|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019488|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019489|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019490|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019491|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019492|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019493|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019494|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019495|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
128884689|NCT02101034|463874068|FG003|Overall Study|Enrolled but did not start treatment|0|||
128884690|NCT02101034|463874069|FG004|Overall Study|Enrolled but did not start treatment|0|||
128884691|NCT01103245|463874074|FG000|Overall Study|Withdrawal by Subject|1|||
128884692|NCT01103245|463874075|FG001|Overall Study|Withdrawal by Subject|0|||
128884693|NCT01103245|463874076|FG002|Overall Study|Withdrawal by Subject|3|||
128884694|NCT01103245|463874077|FG003|Overall Study|Withdrawal by Subject|0|||
128884695|NCT01103245|463874074|FG000|Overall Study|Inadequate IV access|1|||
128884696|NCT01103245|463874075|FG001|Overall Study|Inadequate IV access|0|||
128884697|NCT01103245|463874076|FG002|Overall Study|Inadequate IV access|0|||
128884698|NCT01103245|463874077|FG003|Overall Study|Inadequate IV access|0|||
128884699|NCT01103245|463874074|FG000|Overall Study|Adverse Event|0|||
128884700|NCT01103245|463874075|FG001|Overall Study|Adverse Event|2|||
128884701|NCT01103245|463874076|FG002|Overall Study|Adverse Event|1|||
128884702|NCT01103245|463874077|FG003|Overall Study|Adverse Event|0|||
128884703|NCT01103245|463874074|FG000|Overall Study|Physician Decision|1|||
128884704|NCT01103245|463874075|FG001|Overall Study|Physician Decision|0|||
128884705|NCT01103245|463874076|FG002|Overall Study|Physician Decision|0|||
128884706|NCT01103245|463874077|FG003|Overall Study|Physician Decision|0|||
128884707|NCT01101477|463874079|FG000|Overall Study|Protocol Violation|5|||
128884708|NCT01101477|463874080|FG001|Overall Study|Protocol Violation|3|||
128884709|NCT01101477|463874081|FG002|Overall Study|Protocol Violation|1|||
128884710|NCT00720941|463874082|FG000|Overall Study|Protocol Violation|1|||
128884711|NCT00720941|463874083|FG001|Overall Study|Protocol Violation|2|||
128884712|NCT00720941|463874082|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
128884713|NCT00720941|463874083|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
128884714|NCT00720941|463874082|FG000|Overall Study|Lost to Follow-up|20|||
128884715|NCT00720941|463874083|FG001|Overall Study|Lost to Follow-up|15|||
128884716|NCT00720941|463874082|FG000|Overall Study|Physician Decision|14|||
128884717|NCT00720941|463874083|FG001|Overall Study|Physician Decision|12|||
128884718|NCT00720941|463874082|FG000|Overall Study|Withdrawal by Subject|29|||
128884719|NCT00720941|463874083|FG001|Overall Study|Withdrawal by Subject|36|||
128884720|NCT00604279|463874084|FG000|Overall Study|Lack of Efficacy|22|||
128884721|NCT00604279|463874085|FG001|Overall Study|Lack of Efficacy|9|||
128884722|NCT00604279|463874084|FG000|Overall Study|Lost to Follow-up|9|||
128884723|NCT00604279|463874085|FG001|Overall Study|Lost to Follow-up|14|||
128884724|NCT00604279|463874084|FG000|Overall Study|Pregnancy|2|||
128884725|NCT00604279|463874085|FG001|Overall Study|Pregnancy|0|||
128884726|NCT00604279|463874084|FG000|Overall Study|Protocol Violation|3|||
128884727|NCT00604279|463874085|FG001|Overall Study|Protocol Violation|1|||
128884728|NCT00604279|463874084|FG000|Overall Study|Withdrawal by Subject|16|||
128884729|NCT00604279|463874085|FG001|Overall Study|Withdrawal by Subject|5|||
128884730|NCT00604279|463874084|FG000|Overall Study|Adverse Event|4|||
129019496|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
129107731|NCT05568797|464688562|FG001|Overall Study|Adverse Event|8|||
129107732|NCT05568797|464688561|FG000|Overall Study|Lost to Follow-up|2|||
128884731|NCT00604279|463874085|FG001|Overall Study|Adverse Event|5|||
129019497|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019498|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019499|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
129019500|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129019501|NCT01597245|464363747|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019502|NCT01597245|464363748|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019503|NCT01597245|464363749|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019504|NCT01597245|464363750|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019505|NCT01597245|464363751|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019506|NCT01597245|464363752|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019507|NCT01597245|464363753|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019508|NCT01597245|464363754|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019509|NCT01597245|464363755|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019510|NCT01597245|464363756|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019511|NCT01597245|464363757|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019512|NCT01597245|464363758|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019513|NCT01597245|464363759|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019514|NCT01597245|464363760|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019515|NCT01597245|464363761|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019516|NCT01597245|464363762|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019517|NCT01597245|464363763|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019518|NCT01597245|464363764|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129107733|NCT05568797|464688562|FG001|Overall Study|Lost to Follow-up|3|||
129107734|NCT05568797|464688561|FG000|Overall Study|Withdrawal by Subject|1|||
129107735|NCT05568797|464688562|FG001|Overall Study|Withdrawal by Subject|10|||
128884732|NCT00604279|463874084|FG000|Overall Study|Other|8|||
128884733|NCT00604279|463874085|FG001|Overall Study|Other|4|||
128884734|NCT00355056|463874086|FG000|Randomization Period|Early Termination|4|||
128884735|NCT00355056|463874087|FG001|Randomization Period|Early Termination|6|||
128884736|NCT01072877|463874093|FG000|Overall Study|Lost to Follow-up|1|||
128884737|NCT01072877|463874094|FG001|Overall Study|Lost to Follow-up|1|||
128884738|NCT01072877|463874095|FG002|Overall Study|Lost to Follow-up|0|||
128884739|NCT01072877|463874096|FG003|Overall Study|Lost to Follow-up|2|||
128884740|NCT01072877|463874097|FG004|Overall Study|Lost to Follow-up|0|||
128884741|NCT02382016|463874100|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
128884742|NCT02382016|463874101|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
128884743|NCT02382016|463874100|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
128884744|NCT02382016|463874101|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
128884745|NCT02382016|463874100|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
128884746|NCT02382016|463874101|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
128884747|NCT02382016|463874100|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
128884748|NCT02382016|463874101|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
128884749|NCT02382016|463874100|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
128884750|NCT02382016|463874101|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
128884751|NCT02382016|463874100|FG000|Open-label (OL) Treatment Period|Death|4|||
128884752|NCT02382016|463874101|FG001|Open-label (OL) Treatment Period|Death|0|||
128884753|NCT02382016|463874100|FG000|OL Extension Period|Physician Decision|3|||
128884754|NCT02382016|463874101|FG001|OL Extension Period|Physician Decision|0|||
128884755|NCT02382016|463874100|FG000|OL Extension Period|Death|2|||
128884756|NCT02382016|463874101|FG001|OL Extension Period|Death|0|||
128884757|NCT02382016|463874100|FG000|OL Extension Period|Withdrawal by Subject|1|||
128884758|NCT02382016|463874101|FG001|OL Extension Period|Withdrawal by Subject|0|||
128884759|NCT00084266|463874102|FG000|Overall Study|Death|42|||
128884760|NCT00084266|463874103|FG001|Overall Study|Death|39|||
128884761|NCT00084266|463874102|FG000|Overall Study|Adverse Event|8|||
128884762|NCT00084266|463874103|FG001|Overall Study|Adverse Event|5|||
128884763|NCT00084266|463874102|FG000|Overall Study|Lack of Efficacy|2|||
128884764|NCT00084266|463874103|FG001|Overall Study|Lack of Efficacy|4|||
128884765|NCT00084266|463874102|FG000|Overall Study|Lost to Follow-up|5|||
128884766|NCT00084266|463874103|FG001|Overall Study|Lost to Follow-up|3|||
128884767|NCT00084266|463874102|FG000|Overall Study|Participant not willing to participate|3|||
128884768|NCT00084266|463874103|FG001|Overall Study|Participant not willing to participate|8|||
128884769|NCT00084266|463874102|FG000|Overall Study|Other|360|||
128884770|NCT00084266|463874103|FG001|Overall Study|Other|344|||
128884771|NCT00084266|463874102|FG000|Overall Study|Randomized not treated|21|||
128884772|NCT00084266|463874103|FG001|Overall Study|Randomized not treated|20|||
128884773|NCT00730171|463874104|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
128884774|NCT00730171|463874104|FG000|Overall Study|Adverse Event|193|||
128884775|NCT00730171|463874104|FG000|Overall Study|Protocol Violation|48|||
128884776|NCT00730171|463874104|FG000|Overall Study|Withdrawal by Subject|202|||
128884777|NCT00730171|463874104|FG000|Overall Study|Lost to Follow-up|121|||
128884778|NCT00730171|463874104|FG000|Overall Study|Insufficient Therapeutic Response|141|||
128884779|NCT00730171|463874104|FG000|Overall Study|Other|61|||
128884780|NCT01729156|463874105|FG000|Overall Study|Withdrawal by Subject|1|||
128884781|NCT01729156|463874106|FG001|Overall Study|Withdrawal by Subject|0|||
128884782|NCT01729156|463874107|FG002|Overall Study|Withdrawal by Subject|0|||
128884783|NCT02544217|463874112|FG000|Overall Study|Withdrawal by Subject|1|||
128884784|NCT02544217|463874113|FG001|Overall Study|Withdrawal by Subject|1|||
128884785|NCT02544217|463874114|FG002|Overall Study|Withdrawal by Subject|0|||
128884786|NCT02544217|463874115|FG003|Overall Study|Withdrawal by Subject|0|||
128884787|NCT02544217|463874116|FG004|Overall Study|Withdrawal by Subject|0|||
128884788|NCT02544217|463874117|FG005|Overall Study|Withdrawal by Subject|0|||
128884789|NCT00655863|463874118|FG000|Overall Study|Lost to Follow-up|0|||
128884790|NCT00655863|463874119|FG001|Overall Study|Lost to Follow-up|0|||
128884791|NCT00655863|463874120|FG002|Overall Study|Lost to Follow-up|1|||
128884792|NCT02982187|463874128|FG000|Overall Study|Withdrawal by Subject|0|||
128884793|NCT02982187|463874129|FG001|Overall Study|Withdrawal by Subject|0|||
128884794|NCT02982187|463874130|FG002|Overall Study|Withdrawal by Subject|0|||
128884795|NCT02982187|463874131|FG003|Overall Study|Withdrawal by Subject|0|||
128683974|NCT00423670|463142620|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
128683975|NCT00423670|463142621|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
128884796|NCT02982187|463874132|FG004|Overall Study|Withdrawal by Subject|0|||
129019519|NCT01597245|464363765|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019520|NCT01597245|464363766|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
129019521|NCT01597245|464363767|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129019522|NCT01313780|464363768|FG000|Overall Study|Lack of Efficacy|4|||
129019523|NCT01313780|464363769|FG001|Overall Study|Lack of Efficacy|2|||
129019524|NCT01313780|464363768|FG000|Overall Study|Adverse Event|6|||
129019525|NCT01313780|464363769|FG001|Overall Study|Adverse Event|11|||
129019526|NCT01313780|464363768|FG000|Overall Study|Withdrawal by Subject|2|||
129019527|NCT01313780|464363769|FG001|Overall Study|Withdrawal by Subject|8|||
128884797|NCT02982187|463874133|FG005|Overall Study|Withdrawal by Subject|0|||
128884798|NCT02982187|463874134|FG006|Overall Study|Withdrawal by Subject|1|||
128884799|NCT02982187|463874135|FG007|Overall Study|Withdrawal by Subject|0|||
128884800|NCT03285178|463874136|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
128884801|NCT03285178|463874137|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129019528|NCT01313780|464363768|FG000|Overall Study|Protocol Violation|10|||
128884802|NCT03285178|463874138|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
128884803|NCT03285178|463874139|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
128884804|NCT03285178|463874140|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
128884805|NCT03285178|463874141|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
128884806|NCT03285178|463874142|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
128884807|NCT03285178|463874136|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
128884808|NCT03285178|463874137|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
128884809|NCT03285178|463874138|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
128884810|NCT03285178|463874139|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
128884811|NCT03285178|463874140|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
128884812|NCT03285178|463874141|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
128884813|NCT03285178|463874142|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
128884814|NCT03285178|463874136|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
128884815|NCT03285178|463874137|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
128884816|NCT03285178|463874138|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
128884817|NCT03285178|463874139|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
128884818|NCT03285178|463874140|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
128884819|NCT03285178|463874141|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
128884820|NCT03285178|463874142|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
128884821|NCT03285178|463874136|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
128884822|NCT03285178|463874137|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
128884823|NCT03285178|463874138|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
128884824|NCT03285178|463874139|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
128884825|NCT03285178|463874140|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
128884826|NCT03285178|463874141|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
128884827|NCT03285178|463874142|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
128884828|NCT03285178|463874136|FG000|Single-Blind Run-In Period|Physician Decision|2|||
128884829|NCT03285178|463874137|FG001|Single-Blind Run-In Period|Physician Decision|0|||
128884830|NCT03285178|463874138|FG002|Single-Blind Run-In Period|Physician Decision|0|||
128884831|NCT03285178|463874139|FG003|Single-Blind Run-In Period|Physician Decision|0|||
128884832|NCT03285178|463874140|FG004|Single-Blind Run-In Period|Physician Decision|0|||
128884833|NCT03285178|463874141|FG005|Single-Blind Run-In Period|Physician Decision|0|||
128884834|NCT03285178|463874142|FG006|Single-Blind Run-In Period|Physician Decision|0|||
128884835|NCT03285178|463874136|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
128884836|NCT03285178|463874137|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
128884837|NCT03285178|463874138|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
128884838|NCT03285178|463874139|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
128683976|NCT00423670|463142622|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
128683977|NCT00423670|463142623|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
128683978|NCT00423670|463142624|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
128683979|NCT00423670|463142625|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
128683980|NCT00423670|463142626|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
128884839|NCT03285178|463874140|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
128884840|NCT03285178|463874141|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
128884841|NCT03285178|463874142|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
128884842|NCT03285178|463874136|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128884843|NCT03285178|463874137|FG001|Double-Blind Treatment Period|Adverse Event|0|||
128884844|NCT03285178|463874138|FG002|Double-Blind Treatment Period|Adverse Event|0|||
128884845|NCT03285178|463874139|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129019529|NCT01313780|464363769|FG001|Overall Study|Protocol Violation|4|||
129215127|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
128884846|NCT03285178|463874140|FG004|Double-Blind Treatment Period|Adverse Event|0|||
128884847|NCT03285178|463874141|FG005|Double-Blind Treatment Period|Adverse Event|0|||
128884848|NCT03285178|463874142|FG006|Double-Blind Treatment Period|Adverse Event|2|||
128884849|NCT03285178|463874136|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128884850|NCT03285178|463874137|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
128884851|NCT03285178|463874138|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
128884852|NCT03285178|463874139|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
128884853|NCT03285178|463874140|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
128884854|NCT03285178|463874141|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
128683981|NCT00423670|463142619|FG000|Treatment Period|Investigator decision|0|||
129107736|NCT05568797|464688561|FG000|Overall Study|Other|2|||
128683982|NCT00423670|463142620|FG001|Treatment Period|Investigator decision|0|||
128683983|NCT00423670|463142621|FG002|Treatment Period|Investigator decision|0|||
128683984|NCT00423670|463142622|FG003|Treatment Period|Investigator decision|0|||
128683985|NCT00423670|463142623|FG004|Treatment Period|Investigator decision|0|||
128683986|NCT00423670|463142624|FG005|Treatment Period|Investigator decision|0|||
128683987|NCT00423670|463142625|FG006|Treatment Period|Investigator decision|0|||
128683988|NCT00423670|463142626|FG007|Treatment Period|Investigator decision|1|||
128683989|NCT00423670|463142619|FG000|Treatment Period|Non-compliance with protocol|3|||
128683990|NCT00423670|463142620|FG001|Treatment Period|Non-compliance with protocol|1|||
128683991|NCT00423670|463142621|FG002|Treatment Period|Non-compliance with protocol|1|||
128683992|NCT00423670|463142622|FG003|Treatment Period|Non-compliance with protocol|3|||
128683993|NCT00423670|463142623|FG004|Treatment Period|Non-compliance with protocol|2|||
128683994|NCT00423670|463142624|FG005|Treatment Period|Non-compliance with protocol|0|||
128683995|NCT00423670|463142625|FG006|Treatment Period|Non-compliance with protocol|2|||
128683996|NCT00423670|463142626|FG007|Treatment Period|Non-compliance with protocol|2|||
128683997|NCT00423670|463142619|FG000|Follow-up Period|Lost to Follow-up|0|||
128683998|NCT00423670|463142620|FG001|Follow-up Period|Lost to Follow-up|12|||
128683999|NCT00423670|463142621|FG002|Follow-up Period|Lost to Follow-up|8|||
128684000|NCT00423670|463142622|FG003|Follow-up Period|Lost to Follow-up|3|||
128684001|NCT00423670|463142623|FG004|Follow-up Period|Lost to Follow-up|1|||
128684002|NCT00423670|463142624|FG005|Follow-up Period|Lost to Follow-up|0|||
128684003|NCT00423670|463142625|FG006|Follow-up Period|Lost to Follow-up|5|||
128684004|NCT00423670|463142626|FG007|Follow-up Period|Lost to Follow-up|0|||
128684005|NCT00423670|463142619|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
128684006|NCT00423670|463142620|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
128684007|NCT00423670|463142621|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
128684008|NCT00423670|463142622|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
128684009|NCT00423670|463142623|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
128684010|NCT00423670|463142624|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
128684011|NCT00423670|463142625|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
128684012|NCT00423670|463142626|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
128684013|NCT00423670|463142619|FG000|Follow-up Period|Non-compliance with protocol|2|||
128684014|NCT00423670|463142620|FG001|Follow-up Period|Non-compliance with protocol|0|||
128684015|NCT00423670|463142621|FG002|Follow-up Period|Non-compliance with protocol|1|||
128684016|NCT00423670|463142622|FG003|Follow-up Period|Non-compliance with protocol|1|||
128684017|NCT00423670|463142623|FG004|Follow-up Period|Non-compliance with protocol|0|||
128684018|NCT00423670|463142624|FG005|Follow-up Period|Non-compliance with protocol|0|||
128684019|NCT00423670|463142625|FG006|Follow-up Period|Non-compliance with protocol|3|||
128684020|NCT00423670|463142626|FG007|Follow-up Period|Non-compliance with protocol|2|||
128684021|NCT01082640|463142629|FG000|Overall Study|Adverse Event|9|||
128684022|NCT01082640|463142630|FG001|Overall Study|Adverse Event|5|||
128684023|NCT01082640|463142631|FG002|Overall Study|Adverse Event|3|||
128684024|NCT01082640|463142629|FG000|Overall Study|Withdrawal by Subject|3|||
128684025|NCT01082640|463142630|FG001|Overall Study|Withdrawal by Subject|3|||
128684026|NCT01082640|463142631|FG002|Overall Study|Withdrawal by Subject|2|||
128684027|NCT01082640|463142629|FG000|Overall Study|Major protocol deviation|3|||
128684028|NCT01082640|463142630|FG001|Overall Study|Major protocol deviation|3|||
128684029|NCT01082640|463142631|FG002|Overall Study|Major protocol deviation|0|||
128684030|NCT01082640|463142629|FG000|Overall Study|Lost to Follow-up|0|||
128684031|NCT01082640|463142630|FG001|Overall Study|Lost to Follow-up|3|||
128684032|NCT01082640|463142631|FG002|Overall Study|Lost to Follow-up|0|||
128684033|NCT01082640|463142629|FG000|Overall Study|Other|2|||
129107737|NCT05568797|464688562|FG001|Overall Study|Other|2|||
129107738|NCT03131687|464688563|FG000|Overall Study|Adverse Event|0|||
129107739|NCT03131687|464688564|FG001|Overall Study|Adverse Event|1|||
129107740|NCT03131687|464688565|FG002|Overall Study|Adverse Event|0|||
129107741|NCT03131687|464688566|FG003|Overall Study|Adverse Event|1|||
129107742|NCT03131687|464688567|FG004|Overall Study|Adverse Event|2|||
129107743|NCT03131687|464688568|FG005|Overall Study|Adverse Event|2|||
129107744|NCT03131687|464688563|FG000|Overall Study|Death|1|||
129107745|NCT03131687|464688564|FG001|Overall Study|Death|0|||
129107746|NCT03131687|464688565|FG002|Overall Study|Death|0|||
129107747|NCT03131687|464688566|FG003|Overall Study|Death|0|||
129107748|NCT03131687|464688567|FG004|Overall Study|Death|0|||
129107749|NCT03131687|464688568|FG005|Overall Study|Death|0|||
128684034|NCT01082640|463142630|FG001|Overall Study|Other|1|||
128684035|NCT01082640|463142631|FG002|Overall Study|Other|3|||
128684036|NCT02011893|463142633|FG000|Enrollment to Randomization|Adverse Event|2|||
128684037|NCT02011893|463142634|FG001|Enrollment to Randomization|Adverse Event|0|||
129107750|NCT03131687|464688563|FG000|Overall Study|Withdrawal by Subject|3|||
129107751|NCT03131687|464688564|FG001|Overall Study|Withdrawal by Subject|3|||
129107752|NCT03131687|464688565|FG002|Overall Study|Withdrawal by Subject|3|||
129107753|NCT03131687|464688566|FG003|Overall Study|Withdrawal by Subject|1|||
129107754|NCT03131687|464688567|FG004|Overall Study|Withdrawal by Subject|2|||
128884855|NCT03285178|463874142|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
128884856|NCT03285178|463874136|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128884857|NCT03285178|463874137|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128884858|NCT03285178|463874138|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128884859|NCT03285178|463874139|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128884860|NCT03285178|463874140|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128884861|NCT03285178|463874141|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
128884862|NCT03285178|463874142|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128884863|NCT03285178|463874136|FG000|Double-Blind Treatment Period|COVID-19|0|||
128884864|NCT03285178|463874137|FG001|Double-Blind Treatment Period|COVID-19|0|||
128884865|NCT03285178|463874138|FG002|Double-Blind Treatment Period|COVID-19|1|||
128884866|NCT03285178|463874139|FG003|Double-Blind Treatment Period|COVID-19|0|||
128884867|NCT03285178|463874140|FG004|Double-Blind Treatment Period|COVID-19|0|||
128884868|NCT03285178|463874141|FG005|Double-Blind Treatment Period|COVID-19|0|||
128884869|NCT03285178|463874142|FG006|Double-Blind Treatment Period|COVID-19|0|||
128884870|NCT01388790|463874143|FG000|Overall Study|Ongoing at data cut-off date|8|||
128884871|NCT01128894|463874144|FG000|Overall Study|Adverse Event|31|||
128884872|NCT01128894|463874145|FG001|Overall Study|Adverse Event|41|||
128884873|NCT01128894|463874144|FG000|Overall Study|Protocol Violation|2|||
128884874|NCT01128894|463874145|FG001|Overall Study|Protocol Violation|1|||
128884875|NCT01128894|463874144|FG000|Overall Study|Noncompliance|4|||
128884876|NCT01128894|463874145|FG001|Overall Study|Noncompliance|5|||
128884877|NCT01128894|463874144|FG000|Overall Study|Lost to Follow-up|8|||
128884878|NCT01128894|463874145|FG001|Overall Study|Lost to Follow-up|8|||
128884879|NCT01128894|463874144|FG000|Overall Study|Withdrawal by Subject|10|||
128884880|NCT01128894|463874145|FG001|Overall Study|Withdrawal by Subject|12|||
128884881|NCT01128894|463874144|FG000|Overall Study|Physician Decision|2|||
128884882|NCT01128894|463874145|FG001|Overall Study|Physician Decision|1|||
128884883|NCT01128894|463874144|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
128884884|NCT01128894|463874145|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
128884885|NCT00195507|463874146|FG000|Overall Study|Adverse Event|24|||
128884886|NCT00195507|463874147|FG001|Overall Study|Adverse Event|13|||
128884887|NCT00195507|463874146|FG000|Overall Study|Death|0|||
128884888|NCT00195507|463874147|FG001|Overall Study|Death|1|||
128884889|NCT00195507|463874146|FG000|Overall Study|Failed to Return|4|||
128884890|NCT00195507|463874147|FG001|Overall Study|Failed to Return|3|||
128884891|NCT00195507|463874146|FG000|Overall Study|Physician Decision|1|||
128884892|NCT00195507|463874147|FG001|Overall Study|Physician Decision|2|||
128884893|NCT00195507|463874146|FG000|Overall Study|Lost to Follow-up|3|||
128884894|NCT00195507|463874147|FG001|Overall Study|Lost to Follow-up|2|||
128884895|NCT00195507|463874146|FG000|Overall Study|Protocol Violation|5|||
128884896|NCT00195507|463874147|FG001|Overall Study|Protocol Violation|4|||
128884897|NCT00195507|463874146|FG000|Overall Study|Lack of Efficacy|40|||
128884898|NCT00195507|463874147|FG001|Overall Study|Lack of Efficacy|67|||
128884899|NCT00195507|463874146|FG000|Overall Study|Withdrawal by Subject|16|||
128884900|NCT00195507|463874147|FG001|Overall Study|Withdrawal by Subject|23|||
128884901|NCT00195507|463874146|FG000|Overall Study|Protocol Deviation|6|||
128884902|NCT00195507|463874147|FG001|Overall Study|Protocol Deviation|3|||
128884903|NCT00973362|463874148|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
128884904|NCT00973362|463874149|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
128884905|NCT00973362|463874148|FG000|Baseline Evaluation|No colposcopy visit|62|||
128884906|NCT00973362|463874149|FG001|Baseline Evaluation|No colposcopy visit|0|||
128884907|NCT00973362|463874148|FG000|Baseline Evaluation|Inevaluable|686|||
129019530|NCT01313780|464363768|FG000|Overall Study|missing data|3|||
129019531|NCT01313780|464363769|FG001|Overall Study|missing data|3|||
129019532|NCT00731783|464363770|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
129019533|NCT00731783|464363771|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
129019534|NCT00731783|464363770|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
129019535|NCT00731783|464363771|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
129019536|NCT00731783|464363770|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
129019537|NCT00731783|464363771|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
129019538|NCT00731783|464363770|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
129019539|NCT00731783|464363771|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
129019540|NCT02847650|464365137|FG000|Overall Study|Adverse Event|2|||
129019541|NCT02847650|464365138|FG001|Overall Study|Adverse Event|4|||
128763165|NCT00860067|463422767|FG002|Overall Study|Pregnancy|0|||
128884908|NCT00973362|463874149|FG001|Baseline Evaluation|Inevaluable|223|||
128884909|NCT00973362|463874148|FG000|3-Year Follow-up|Lost to Follow-up|17|||
129019542|NCT02847650|464365137|FG000|Overall Study|Lost to Follow-up|1|||
129019543|NCT02847650|464365138|FG001|Overall Study|Lost to Follow-up|0|||
128884910|NCT00973362|463874149|FG001|3-Year Follow-up|Lost to Follow-up|0|||
128884911|NCT01630434|463874156|FG000|Overall Study|Donor lungs turned down|1|||
128884912|NCT01630434|463874157|FG001|Overall Study|Donor lungs turned down|0|||
128884913|NCT01630434|463874156|FG000|Overall Study|Protocol Violation|9|||
128884914|NCT01630434|463874157|FG001|Overall Study|Protocol Violation|4|||
128884915|NCT01630434|463874156|FG000|Overall Study|Death|20|||
128684038|NCT02011893|463142635|FG002|Enrollment to Randomization|Adverse Event|0|||
128684039|NCT02011893|463142633|FG000|Enrollment to Randomization|Physician Decision|10|||
128684040|NCT02011893|463142634|FG001|Enrollment to Randomization|Physician Decision|0|||
128684041|NCT02011893|463142635|FG002|Enrollment to Randomization|Physician Decision|0|||
128684042|NCT02011893|463142633|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
128684043|NCT02011893|463142634|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
128684044|NCT02011893|463142635|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
128684045|NCT02011893|463142633|FG000|Enrollment to Randomization|Screening Failure|29|||
128684046|NCT02011893|463142634|FG001|Enrollment to Randomization|Screening Failure|0|||
128684047|NCT02011893|463142635|FG002|Enrollment to Randomization|Screening Failure|0|||
128684048|NCT02011893|463142633|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
128684049|NCT02011893|463142634|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
128684050|NCT02011893|463142635|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
128684051|NCT02011893|463142633|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
128684052|NCT02011893|463142634|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
128684053|NCT02011893|463142635|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
128684054|NCT02011893|463142633|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
128684055|NCT02011893|463142634|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
128684056|NCT02011893|463142635|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
128684057|NCT02011893|463142633|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
128684058|NCT02011893|463142634|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
128684059|NCT02011893|463142635|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
128684060|NCT02011893|463142633|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
128684061|NCT02011893|463142634|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
128684062|NCT02011893|463142635|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
128684063|NCT00450112|463142636|FG000|Overall Study|Other Treatment Required|5|||
128684064|NCT00450112|463142637|FG001|Overall Study|Other Treatment Required|1|||
128763166|NCT01148862|463422770|FG000|Second Intervention|Withdrawal by Subject|0|||
128763167|NCT01148862|463422771|FG001|Second Intervention|Withdrawal by Subject|2|||
128684065|NCT00450112|463142636|FG000|Overall Study|Withdrawal by Subject|4|||
128684066|NCT00450112|463142637|FG001|Overall Study|Withdrawal by Subject|1|||
128684067|NCT00450112|463142636|FG000|Overall Study|Lost to Follow-up|2|||
128684068|NCT00450112|463142637|FG001|Overall Study|Lost to Follow-up|1|||
128684069|NCT00450112|463142636|FG000|Overall Study|Others|2|||
128684070|NCT00450112|463142637|FG001|Overall Study|Others|3|||
128684071|NCT02962765|463142638|FG000|Overall Study|Protocol Violation|9|||
128684072|NCT02962765|463142638|FG000|Overall Study|Withdrawal by Subject|3|||
128684073|NCT02962765|463142638|FG000|Overall Study|Lost to Follow-up|1|||
128684074|NCT02962765|463142638|FG000|Overall Study|Death|1|||
128684075|NCT02962765|463142638|FG000|Overall Study|Limited access to study medication|3|||
128684076|NCT03533686|463142643|FG000|Overall Study|Withdrawal by Subject|1|||
128684077|NCT03533686|463142644|FG001|Overall Study|Withdrawal by Subject|0|||
128684078|NCT03533686|463142645|FG002|Overall Study|Withdrawal by Subject|0|||
128684079|NCT03533686|463142646|FG003|Overall Study|Withdrawal by Subject|3|||
128684080|NCT03533686|463142647|FG004|Overall Study|Withdrawal by Subject|5|||
128684081|NCT03533686|463142648|FG005|Overall Study|Withdrawal by Subject|1|||
128684082|NCT03533686|463142643|FG000|Overall Study|Lost to Follow-up|0|||
128684083|NCT03533686|463142644|FG001|Overall Study|Lost to Follow-up|1|||
128684084|NCT03533686|463142645|FG002|Overall Study|Lost to Follow-up|0|||
128684085|NCT03533686|463142646|FG003|Overall Study|Lost to Follow-up|0|||
128684086|NCT03533686|463142647|FG004|Overall Study|Lost to Follow-up|2|||
128684087|NCT03533686|463142648|FG005|Overall Study|Lost to Follow-up|0|||
128684088|NCT03533686|463142643|FG000|Overall Study|Screen Failure|0|||
128684089|NCT03533686|463142644|FG001|Overall Study|Screen Failure|0|||
128684090|NCT03533686|463142645|FG002|Overall Study|Screen Failure|0|||
128684091|NCT03533686|463142646|FG003|Overall Study|Screen Failure|2|||
128684092|NCT03533686|463142647|FG004|Overall Study|Screen Failure|0|||
129019544|NCT02847650|464365137|FG000|Overall Study|Protocol Violation|0|||
129019545|NCT02847650|464365138|FG001|Overall Study|Protocol Violation|1|||
129019546|NCT02847650|464365137|FG000|Overall Study|Withdrawal by Subject|1|||
129019547|NCT02847650|464365138|FG001|Overall Study|Withdrawal by Subject|1|||
129019548|NCT03818581|464365141|FG000|Overall Study|Adverse Event|1|||
129019549|NCT03818581|464365142|FG001|Overall Study|Adverse Event|0|||
128684093|NCT03533686|463142648|FG005|Overall Study|Screen Failure|0|||
128684094|NCT00245583|463142649|FG000|Overall Study|Lost to Follow-up|1|||
128684095|NCT00245583|463142650|FG001|Overall Study|Lost to Follow-up|5|||
128684096|NCT00245583|463142649|FG000|Overall Study|Adverse Event|2|||
128684097|NCT00245583|463142650|FG001|Overall Study|Adverse Event|1|||
128684098|NCT00245583|463142649|FG000|Overall Study|Lack of Efficacy|1|||
128684099|NCT00245583|463142650|FG001|Overall Study|Lack of Efficacy|0|||
128684100|NCT00245583|463142649|FG000|Overall Study|Withdrawal by Subject|2|||
128684101|NCT00245583|463142650|FG001|Overall Study|Withdrawal by Subject|3|||
128684102|NCT02414139|463142651|FG000|Treatment Period|Adverse Event|11|||
129019550|NCT03818581|464365143|FG002|Overall Study|Adverse Event|0|||
128884916|NCT01630434|463874157|FG001|Overall Study|Death|26|||
128884917|NCT02578862|463874158|FG000|Overall Study|Withdrawal by Subject|0|||
128884918|NCT02578862|463874159|FG001|Overall Study|Withdrawal by Subject|1|||
128884919|NCT02578862|463874158|FG000|Overall Study|Unplanned unilateral procedure|0|||
128884920|NCT02578862|463874159|FG001|Overall Study|Unplanned unilateral procedure|1|||
128884921|NCT02893930|463874160|FG000|Overall Study|Adverse Event|3|||
128884922|NCT02893930|463874160|FG000|Overall Study|Death|1|||
128884923|NCT02893930|463874160|FG000|Overall Study|Disease progression|5|||
128884924|NCT02893930|463874160|FG000|Overall Study|Withdrawal by Subject|2|||
128884925|NCT02893930|463874160|FG000|Overall Study|Physician Decision|1|||
128884926|NCT02893930|463874160|FG000|Overall Study|Ineligible|1|||
128884927|NCT03181451|463874161|FG000|Overall Study|Adverse Event|0|||
128884928|NCT03181451|463874162|FG001|Overall Study|Adverse Event|1|||
128884929|NCT03181451|463874163|FG002|Overall Study|Adverse Event|0|||
128884930|NCT03181451|463874161|FG000|Overall Study|Withdrawal by Subject|0|||
128884931|NCT03181451|463874162|FG001|Overall Study|Withdrawal by Subject|1|||
129107755|NCT03131687|464688568|FG005|Overall Study|Withdrawal by Subject|1|||
129107756|NCT03131687|464688563|FG000|Overall Study|Lost to Follow-up|1|||
129107757|NCT03131687|464688564|FG001|Overall Study|Lost to Follow-up|4|||
129107758|NCT03131687|464688565|FG002|Overall Study|Lost to Follow-up|0|||
129107759|NCT03131687|464688566|FG003|Overall Study|Lost to Follow-up|1|||
129107760|NCT03131687|464688567|FG004|Overall Study|Lost to Follow-up|4|||
129107761|NCT03131687|464688568|FG005|Overall Study|Lost to Follow-up|2|||
129107762|NCT03131687|464688563|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
129107763|NCT03131687|464688564|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
129107764|NCT03131687|464688565|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
129107765|NCT03131687|464688566|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
129107766|NCT03131687|464688567|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
129107767|NCT03131687|464688568|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
129107768|NCT03131687|464688563|FG000|Overall Study|Principle Investigator Decision|0|||
129107769|NCT03131687|464688564|FG001|Overall Study|Principle Investigator Decision|1|||
129107770|NCT03131687|464688565|FG002|Overall Study|Principle Investigator Decision|0|||
129107771|NCT03131687|464688566|FG003|Overall Study|Principle Investigator Decision|0|||
129107772|NCT03131687|464688567|FG004|Overall Study|Principle Investigator Decision|0|||
129107773|NCT03131687|464688568|FG005|Overall Study|Principle Investigator Decision|0|||
129107774|NCT03131687|464688563|FG000|Overall Study|Inadvertent Enrollment|0|||
129107775|NCT03131687|464688564|FG001|Overall Study|Inadvertent Enrollment|0|||
129107776|NCT03131687|464688565|FG002|Overall Study|Inadvertent Enrollment|0|||
129107777|NCT03131687|464688566|FG003|Overall Study|Inadvertent Enrollment|1|||
129107778|NCT03131687|464688567|FG004|Overall Study|Inadvertent Enrollment|0|||
129107779|NCT03131687|464688568|FG005|Overall Study|Inadvertent Enrollment|0|||
129107780|NCT02998996|464688569|FG000|Overall Study|Lost to Follow-up|0|||
129107781|NCT02998996|464688570|FG001|Overall Study|Lost to Follow-up|0|||
129107782|NCT02998996|464688571|FG002|Overall Study|Lost to Follow-up|1|||
129107783|NCT02998996|464688572|FG003|Overall Study|Lost to Follow-up|0|||
129107784|NCT02998996|464688573|FG004|Overall Study|Lost to Follow-up|0|||
129107785|NCT02998996|464688574|FG005|Overall Study|Lost to Follow-up|0|||
129107786|NCT02998996|464688569|FG000|Overall Study|Pregnancy|0|||
129107787|NCT02998996|464688570|FG001|Overall Study|Pregnancy|1|||
129107788|NCT02998996|464688571|FG002|Overall Study|Pregnancy|0|||
129107789|NCT02998996|464688572|FG003|Overall Study|Pregnancy|0|||
129107790|NCT02998996|464688573|FG004|Overall Study|Pregnancy|0|||
129107791|NCT02998996|464688574|FG005|Overall Study|Pregnancy|0|||
129107792|NCT02998996|464688569|FG000|Overall Study|Family reasons|0|||
129107793|NCT02998996|464688570|FG001|Overall Study|Family reasons|0|||
129107794|NCT02998996|464688571|FG002|Overall Study|Family reasons|0|||
129107795|NCT02998996|464688572|FG003|Overall Study|Family reasons|0|||
129107796|NCT02998996|464688573|FG004|Overall Study|Family reasons|1|||
128884932|NCT03181451|463874163|FG002|Overall Study|Withdrawal by Subject|0|||
128884933|NCT01326533|463874167|FG000|Overall Study|Lost to Follow-up|2|||
128884934|NCT01326533|463874168|FG001|Overall Study|Lost to Follow-up|0|||
128884935|NCT01326533|463874167|FG000|Overall Study|Withdrawal by Subject|1|||
128884936|NCT01326533|463874168|FG001|Overall Study|Withdrawal by Subject|0|||
128684103|NCT02414139|463142652|FG001|Treatment Period|Adverse Event|6|||
128884937|NCT01326533|463874167|FG000|Overall Study|Adverse Event|1|||
128884938|NCT01326533|463874168|FG001|Overall Study|Adverse Event|0|||
128884939|NCT00926211|463874169|FG000|Overall Study|Lost to Follow-up|1|||
128884940|NCT02804178|463874172|FG000|Overall Study|Adverse Event|1|||
128884941|NCT01106404|463874173|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
128884942|NCT01106404|463874174|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
129107797|NCT02998996|464688574|FG005|Overall Study|Family reasons|0|||
129107798|NCT01118663|464688575|FG000|Overall Study|Adverse Event|2|||
129107799|NCT01118663|464688576|FG001|Overall Study|Adverse Event|1|||
129107800|NCT01118663|464688575|FG000|Overall Study|Withdrawal by Subject|0|||
129107801|NCT01118663|464688576|FG001|Overall Study|Withdrawal by Subject|1|||
129107802|NCT05279131|464688577|FG000|Overall Study|Lost to Follow-up|1|||
129107803|NCT05279131|464688577|FG000|Overall Study|Death|1|||
129107804|NCT05279131|464688577|FG000|Overall Study|Physician Decision|1|||
128884943|NCT01106404|463874173|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
128884944|NCT01106404|463874174|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
128884945|NCT01106404|463874173|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
128884946|NCT01106404|463874174|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
128884947|NCT01106404|463874173|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
128884948|NCT01106404|463874174|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
128884949|NCT01290601|463874175|FG000|Overall Study|Adverse Event|0|||
128884950|NCT01290601|463874176|FG001|Overall Study|Adverse Event|2|||
128884951|NCT01290601|463874177|FG002|Overall Study|Adverse Event|0|||
128884952|NCT01290601|463874178|FG003|Overall Study|Adverse Event|0|||
128884953|NCT01290601|463874175|FG000|Overall Study|Lack of Efficacy|2|||
128884954|NCT01290601|463874176|FG001|Overall Study|Lack of Efficacy|1|||
128884955|NCT01290601|463874177|FG002|Overall Study|Lack of Efficacy|0|||
128884956|NCT01290601|463874178|FG003|Overall Study|Lack of Efficacy|0|||
128884957|NCT01290601|463874175|FG000|Overall Study|Lost to Follow-up|7|||
128884958|NCT01290601|463874176|FG001|Overall Study|Lost to Follow-up|2|||
128884959|NCT01290601|463874177|FG002|Overall Study|Lost to Follow-up|0|||
128884960|NCT01290601|463874178|FG003|Overall Study|Lost to Follow-up|0|||
128884961|NCT01290601|463874175|FG000|Overall Study|Other|1|||
128884962|NCT01290601|463874176|FG001|Overall Study|Other|0|||
128884963|NCT01290601|463874177|FG002|Overall Study|Other|0|||
128884964|NCT01290601|463874178|FG003|Overall Study|Other|0|||
128884965|NCT01290601|463874175|FG000|Overall Study|Protocol Violation|1|||
128884966|NCT01290601|463874176|FG001|Overall Study|Protocol Violation|0|||
128884967|NCT01290601|463874177|FG002|Overall Study|Protocol Violation|0|||
128884968|NCT01290601|463874178|FG003|Overall Study|Protocol Violation|0|||
128884969|NCT00775450|463874179|FG000|Overall Study|Serious Adverse Event|2|||
128884970|NCT00775450|463874180|FG001|Overall Study|Serious Adverse Event|0|||
128884971|NCT00775450|463874181|FG002|Overall Study|Serious Adverse Event|0|||
128884972|NCT00775450|463874182|FG003|Overall Study|Serious Adverse Event|0|||
128884973|NCT00775450|463874183|FG004|Overall Study|Serious Adverse Event|0|||
128884974|NCT00775450|463874179|FG000|Overall Study|Protocol Violation|0|||
128884975|NCT00775450|463874180|FG001|Overall Study|Protocol Violation|0|||
128884976|NCT00775450|463874181|FG002|Overall Study|Protocol Violation|0|||
128884977|NCT00775450|463874182|FG003|Overall Study|Protocol Violation|0|||
128884978|NCT00775450|463874183|FG004|Overall Study|Protocol Violation|1|||
128884979|NCT00775450|463874179|FG000|Overall Study|Withdrawal by Subject|1|||
128884980|NCT00775450|463874180|FG001|Overall Study|Withdrawal by Subject|0|||
129107805|NCT00954122|464689841|FG000|Overall Study|Withdrawal by Subject|5|||
128884981|NCT00775450|463874181|FG002|Overall Study|Withdrawal by Subject|0|||
128884982|NCT00775450|463874182|FG003|Overall Study|Withdrawal by Subject|0|||
128884983|NCT00775450|463874183|FG004|Overall Study|Withdrawal by Subject|1|||
128884984|NCT01749540|463874184|FG000|Overall Study|Protocol Violation|0|||
128884985|NCT01749540|463874185|FG001|Overall Study|Protocol Violation|0|||
128884986|NCT01749540|463874186|FG002|Overall Study|Protocol Violation|0|||
128884987|NCT01749540|463874187|FG003|Overall Study|Protocol Violation|0|||
128884988|NCT01749540|463874188|FG004|Overall Study|Protocol Violation|0|||
129107806|NCT00954122|464689841|FG000|Overall Study|Adverse Event|1|||
129107807|NCT00954122|464689841|FG000|Overall Study|Safety Reason|1|||
129107808|NCT02121795|464689844|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
129107809|NCT02121795|464689845|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
128884989|NCT01749540|463874189|FG005|Overall Study|Protocol Violation|1|||
128884990|NCT01749540|463874190|FG006|Overall Study|Protocol Violation|1|||
128884991|NCT01749540|463874184|FG000|Overall Study|Withdrawal by Subject|0|||
128884992|NCT01749540|463874185|FG001|Overall Study|Withdrawal by Subject|0|||
128884993|NCT01749540|463874186|FG002|Overall Study|Withdrawal by Subject|0|||
128884994|NCT01749540|463874187|FG003|Overall Study|Withdrawal by Subject|1|||
128884995|NCT01749540|463874188|FG004|Overall Study|Withdrawal by Subject|0|||
128884996|NCT01749540|463874189|FG005|Overall Study|Withdrawal by Subject|0|||
128884997|NCT01749540|463874190|FG006|Overall Study|Withdrawal by Subject|0|||
129107810|NCT02121795|464689844|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
128884998|NCT01749540|463874184|FG000|Overall Study|Initiated into extension study A536-06|0|||
128884999|NCT01749540|463874185|FG001|Overall Study|Initiated into extension study A536-06|0|||
128885000|NCT01749540|463874186|FG002|Overall Study|Initiated into extension study A536-06|0|||
128885001|NCT01749540|463874187|FG003|Overall Study|Initiated into extension study A536-06|0|||
128885002|NCT01749540|463874188|FG004|Overall Study|Initiated into extension study A536-06|0|||
128885003|NCT01749540|463874189|FG005|Overall Study|Initiated into extension study A536-06|2|||
128885004|NCT01749540|463874190|FG006|Overall Study|Initiated into extension study A536-06|24|||
128885005|NCT00564018|463874191|FG000|Overall Study|Withdrawal by Subject|2|||
128885006|NCT00564018|463874192|FG001|Overall Study|Withdrawal by Subject|3|||
128885007|NCT00564018|463874193|FG002|Overall Study|Withdrawal by Subject|1|||
128885008|NCT01296347|463874194|FG000|Allocation|Withdrawal by Subject|1|||
128885009|NCT01296347|463874195|FG001|Allocation|Withdrawal by Subject|2|||
128885010|NCT01296347|463874194|FG000|Allocation|Lack of Efficacy|1|||
129107811|NCT02121795|464689845|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
129107812|NCT02121795|464689844|FG000|Double-Blind Phase|Lost to Follow-up|7|||
128885011|NCT01296347|463874195|FG001|Allocation|Lack of Efficacy|2|||
128885012|NCT01296347|463874194|FG000|Allocation|not received infusion|1|||
128885013|NCT01296347|463874195|FG001|Allocation|not received infusion|0|||
128885014|NCT01296347|463874194|FG000|6 Week Follow up|Death|0|||
128885015|NCT01296347|463874195|FG001|6 Week Follow up|Death|1|||
128885016|NCT01296347|463874194|FG000|3 Month Follow up|Death|1|||
128885017|NCT01296347|463874195|FG001|3 Month Follow up|Death|0|||
128885018|NCT01296347|463874194|FG000|3 Month Follow up|Lost to Follow-up|0|||
128885019|NCT01296347|463874195|FG001|3 Month Follow up|Lost to Follow-up|1|||
128885020|NCT01296347|463874194|FG000|6 Month Follow up|Death|2|||
128885021|NCT01296347|463874195|FG001|6 Month Follow up|Death|1|||
128885022|NCT01296347|463874194|FG000|6 Month Follow up|Lost to Follow-up|0|||
128885023|NCT01296347|463874195|FG001|6 Month Follow up|Lost to Follow-up|1|||
128885024|NCT01296347|463874194|FG000|12 Month Follow up|Lost to Follow-up|3|||
128885025|NCT01296347|463874195|FG001|12 Month Follow up|Lost to Follow-up|1|||
128885026|NCT01296347|463874194|FG000|12 Month Follow up|Death|1|||
128885027|NCT01296347|463874195|FG001|12 Month Follow up|Death|1|||
128885028|NCT01296347|463874194|FG000|12 Month Follow up|Withdrawal by Subject|0|||
128885029|NCT01296347|463874195|FG001|12 Month Follow up|Withdrawal by Subject|1|||
128885030|NCT02240693|463874196|FG000|Overall Study|Adverse Event|0|||
128885031|NCT02240693|463874197|FG001|Overall Study|Adverse Event|0|||
128885032|NCT02240693|463874198|FG002|Overall Study|Adverse Event|0|||
128885033|NCT02240693|463874199|FG003|Overall Study|Adverse Event|0|||
128885034|NCT02240693|463874200|FG004|Overall Study|Adverse Event|1|||
128885035|NCT02240693|463874196|FG000|Overall Study|Withdrawal by Subject|0|||
128885036|NCT02240693|463874197|FG001|Overall Study|Withdrawal by Subject|0|||
128885037|NCT02240693|463874198|FG002|Overall Study|Withdrawal by Subject|2|||
128885038|NCT02240693|463874199|FG003|Overall Study|Withdrawal by Subject|1|||
128885039|NCT02240693|463874200|FG004|Overall Study|Withdrawal by Subject|0|||
128885040|NCT02240693|463874196|FG000|Overall Study|Other than specified|0|||
128885041|NCT02240693|463874197|FG001|Overall Study|Other than specified|0|||
128885042|NCT02240693|463874198|FG002|Overall Study|Other than specified|2|||
128885043|NCT02240693|463874199|FG003|Overall Study|Other than specified|0|||
128885044|NCT02240693|463874200|FG004|Overall Study|Other than specified|0|||
128885045|NCT01585987|463874201|FG000|Randomized|Withdrawal by Subject|0|||
128885046|NCT01585987|463874202|FG001|Randomized|Withdrawal by Subject|4|||
128885047|NCT01585987|463874201|FG000|Randomized|No longer met criteria|0|||
128885048|NCT01585987|463874202|FG001|Randomized|No longer met criteria|2|||
128885049|NCT01585987|463874201|FG000|Treated|Disease Progression|39|||
128885050|NCT01585987|463874202|FG001|Treated|Disease Progression|36|||
128885051|NCT01585987|463874201|FG000|Treated|Study Drug Toxicity|9|||
128885052|NCT01585987|463874202|FG001|Treated|Study Drug Toxicity|5|||
128885053|NCT01585987|463874201|FG000|Treated|Adverse Event|3|||
128885054|NCT01585987|463874202|FG001|Treated|Adverse Event|0|||
128885055|NCT01585987|463874201|FG000|Treated|Withdrawal by Subject|1|||
128885056|NCT01585987|463874202|FG001|Treated|Withdrawal by Subject|2|||
128885057|NCT01585987|463874201|FG000|Treated|Death|1|||
128885058|NCT01585987|463874202|FG001|Treated|Death|0|||
128885059|NCT01585987|463874201|FG000|Treated|Lost to Follow-up|0|||
128885060|NCT01585987|463874202|FG001|Treated|Lost to Follow-up|1|||
128885061|NCT01585987|463874201|FG000|Treated|Maximum Clinical Benefit|0|||
128885062|NCT01585987|463874202|FG001|Treated|Maximum Clinical Benefit|1|||
129107813|NCT02121795|464689845|FG001|Double-Blind Phase|Lost to Follow-up|4|||
129107814|NCT02121795|464689844|FG000|Double-Blind Phase|Physician Decision|2|||
128684104|NCT02414139|463142653|FG002|Treatment Period|Adverse Event|8|||
128684105|NCT02414139|463142654|FG003|Treatment Period|Adverse Event|5|||
128684106|NCT02414139|463142655|FG004|Treatment Period|Adverse Event|14|||
128684107|NCT02414139|463142656|FG005|Treatment Period|Adverse Event|3|||
128885063|NCT01585987|463874201|FG000|Treated|Non-Specified|1|||
129107815|NCT02121795|464689845|FG001|Double-Blind Phase|Physician Decision|5|||
129107816|NCT02121795|464689844|FG000|Double-Blind Phase|Adverse Event|5|||
129107817|NCT02121795|464689845|FG001|Double-Blind Phase|Adverse Event|0|||
129107818|NCT02121795|464689844|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
129107819|NCT02121795|464689845|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
129107820|NCT02121795|464689844|FG000|Double-Blind Phase|Protocol Violation|0|||
129107821|NCT02121795|464689845|FG001|Double-Blind Phase|Protocol Violation|3|||
129107822|NCT02121795|464689844|FG000|Double-Blind Phase|Death|1|||
128885064|NCT01585987|463874202|FG001|Treated|Non-Specified|2|||
128885065|NCT01585987|463874201|FG000|Treated|Subject Request|0|||
128684108|NCT02414139|463142657|FG006|Treatment Period|Adverse Event|6|||
128885066|NCT01585987|463874202|FG001|Treated|Subject Request|1|||
128885067|NCT01585987|463874201|FG000|Treated|Poor/Non-Compliance|0|||
128885068|NCT01585987|463874202|FG001|Treated|Poor/Non-Compliance|1|||
128885069|NCT00413972|463874206|FG000|Overall Study|Adverse Event|2|||
128885070|NCT00413972|463874207|FG001|Overall Study|Adverse Event|1|||
128885071|NCT00413972|463874208|FG002|Overall Study|Adverse Event|0|||
128885072|NCT00413972|463874209|FG003|Overall Study|Adverse Event|0|||
128885073|NCT00413972|463874206|FG000|Overall Study|Lost to Follow-up|1|||
128885074|NCT00413972|463874207|FG001|Overall Study|Lost to Follow-up|2|||
129107823|NCT02121795|464689845|FG001|Double-Blind Phase|Death|1|||
129107824|NCT02121795|464689844|FG000|Open-Label Phase|Physician Decision|8|||
128885075|NCT00413972|463874208|FG002|Overall Study|Lost to Follow-up|1|||
128885076|NCT00413972|463874209|FG003|Overall Study|Lost to Follow-up|0|||
128885077|NCT00413972|463874206|FG000|Overall Study|Withdrawal by Subject|4|||
128885078|NCT00413972|463874207|FG001|Overall Study|Withdrawal by Subject|5|||
128885079|NCT00413972|463874208|FG002|Overall Study|Withdrawal by Subject|7|||
128885080|NCT00413972|463874209|FG003|Overall Study|Withdrawal by Subject|2|||
128885081|NCT00413972|463874206|FG000|Overall Study|Protocol Violation|0|||
128885082|NCT00413972|463874207|FG001|Overall Study|Protocol Violation|0|||
128885083|NCT00413972|463874208|FG002|Overall Study|Protocol Violation|2|||
128885084|NCT00413972|463874209|FG003|Overall Study|Protocol Violation|0|||
128885085|NCT00413972|463874206|FG000|Overall Study|Other|0|||
128885086|NCT00413972|463874207|FG001|Overall Study|Other|0|||
128885087|NCT00413972|463874208|FG002|Overall Study|Other|0|||
128885088|NCT00413972|463874209|FG003|Overall Study|Other|1|||
128885089|NCT01145755|463874210|FG000|Overall Study|Adverse Event|2|||
128885090|NCT01145755|463874211|FG001|Overall Study|Adverse Event|4|||
128885091|NCT01145755|463874212|FG002|Overall Study|Adverse Event|2|||
128885092|NCT01145755|463874210|FG000|Overall Study|Withdrawal by Subject|2|||
128885093|NCT01145755|463874211|FG001|Overall Study|Withdrawal by Subject|2|||
128885094|NCT01145755|463874212|FG002|Overall Study|Withdrawal by Subject|2|||
128885095|NCT01145755|463874210|FG000|Overall Study|Lost to Follow-up|2|||
128885096|NCT01145755|463874211|FG001|Overall Study|Lost to Follow-up|3|||
128885097|NCT01145755|463874212|FG002|Overall Study|Lost to Follow-up|1|||
128885098|NCT01145755|463874210|FG000|Overall Study|Protocol Violation|0|||
128885099|NCT01145755|463874211|FG001|Overall Study|Protocol Violation|3|||
128885100|NCT01145755|463874212|FG002|Overall Study|Protocol Violation|1|||
128885101|NCT01145755|463874210|FG000|Overall Study|Study Closure|14|||
128885102|NCT01145755|463874211|FG001|Overall Study|Study Closure|14|||
128885103|NCT01145755|463874212|FG002|Overall Study|Study Closure|17|||
128885104|NCT01145755|463874210|FG000|Overall Study|Lack of Efficacy|0|||
128885105|NCT01145755|463874211|FG001|Overall Study|Lack of Efficacy|1|||
128885106|NCT01145755|463874212|FG002|Overall Study|Lack of Efficacy|0|||
128885107|NCT01145755|463874210|FG000|Overall Study|Patient could not swollow medication|0|||
128885108|NCT01145755|463874211|FG001|Overall Study|Patient could not swollow medication|0|||
128885109|NCT01145755|463874212|FG002|Overall Study|Patient could not swollow medication|1|||
128885110|NCT01145755|463874210|FG000|Overall Study|Withdrawal by Subject|0|||
128885111|NCT01145755|463874211|FG001|Overall Study|Withdrawal by Subject|0|||
128885112|NCT01145755|463874212|FG002|Overall Study|Withdrawal by Subject|1|||
128885113|NCT01145755|463874210|FG000|Overall Study|Positive urine ethanol|0|||
128885114|NCT01145755|463874211|FG001|Overall Study|Positive urine ethanol|1|||
128885115|NCT01145755|463874212|FG002|Overall Study|Positive urine ethanol|0|||
129019551|NCT03818581|464365144|FG003|Overall Study|Adverse Event|0|||
129019552|NCT03818581|464365145|FG004|Overall Study|Adverse Event|0|||
129019553|NCT03818581|464365141|FG000|Overall Study|Covid-19|2|||
129019554|NCT03818581|464365142|FG001|Overall Study|Covid-19|0|||
129019555|NCT03818581|464365143|FG002|Overall Study|Covid-19|0|||
129019556|NCT03818581|464365144|FG003|Overall Study|Covid-19|0|||
129019557|NCT03818581|464365145|FG004|Overall Study|Covid-19|1|||
129019558|NCT03818581|464365141|FG000|Overall Study|Withdrawal by Subject|0|||
129019559|NCT03818581|464365142|FG001|Overall Study|Withdrawal by Subject|0|||
129019560|NCT03818581|464365143|FG002|Overall Study|Withdrawal by Subject|0|||
129019561|NCT03818581|464365144|FG003|Overall Study|Withdrawal by Subject|0|||
129019562|NCT03818581|464365145|FG004|Overall Study|Withdrawal by Subject|1|||
129019563|NCT03818581|464365141|FG000|Overall Study|No longer met study criteria|0|||
129019564|NCT03818581|464365142|FG001|Overall Study|No longer met study criteria|0|||
129019565|NCT03818581|464365143|FG002|Overall Study|No longer met study criteria|0|||
129019566|NCT03818581|464365144|FG003|Overall Study|No longer met study criteria|0|||
129019567|NCT03818581|464365145|FG004|Overall Study|No longer met study criteria|1|||
129019568|NCT00834249|464365148|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129019569|NCT00834249|464365149|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
129019570|NCT00834249|464365148|FG000|Second Intervention|Adverse Event|1|||
129019571|NCT00834249|464365149|FG001|Second Intervention|Adverse Event|0|||
129019572|NCT01015703|464365152|FG000|Overall Study|Withdrawal by Subject|0|||
129019573|NCT01015703|464365153|FG001|Overall Study|Withdrawal by Subject|1|||
129019574|NCT01015703|464365154|FG002|Overall Study|Withdrawal by Subject|0|||
129107825|NCT02121795|464689845|FG001|Open-Label Phase|Physician Decision|8|||
129107826|NCT02121795|464689844|FG000|Open-Label Phase|Withdrawal by Subject|3|||
128885116|NCT02092220|463874218|FG000|Period 1|Unrelated Illness|0|||
128885117|NCT02092220|463874219|FG001|Period 1|Unrelated Illness|2|||
128885118|NCT02092220|463874218|FG000|Period 2|Severe Hypoglycaemia|1|||
128885119|NCT02092220|463874219|FG001|Period 2|Severe Hypoglycaemia|0|||
128885120|NCT02092220|463874218|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
128885121|NCT02092220|463874219|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
128885122|NCT02739360|463874220|FG000|Overall Study|Adverse Event|1|||
128885123|NCT02739360|463874220|FG000|Overall Study|Study terminated by Sponsor|2|||
129019575|NCT01015703|464365155|FG003|Overall Study|Withdrawal by Subject|0|||
129019576|NCT01015703|464365156|FG004|Overall Study|Withdrawal by Subject|0|||
129019577|NCT01015703|464365152|FG000|Overall Study|Adverse Event|1|||
128684109|NCT02414139|463142658|FG007|Treatment Period|Adverse Event|1|||
128684110|NCT02414139|463142659|FG008|Treatment Period|Adverse Event|6|||
128684111|NCT02414139|463142660|FG009|Treatment Period|Adverse Event|8|||
128684112|NCT02414139|463142651|FG000|Treatment Period|Death|0|||
128684113|NCT02414139|463142652|FG001|Treatment Period|Death|0|||
128684114|NCT02414139|463142653|FG002|Treatment Period|Death|1|||
128684115|NCT02414139|463142654|FG003|Treatment Period|Death|1|||
128684116|NCT02414139|463142655|FG004|Treatment Period|Death|0|||
128684117|NCT02414139|463142656|FG005|Treatment Period|Death|0|||
128684118|NCT02414139|463142657|FG006|Treatment Period|Death|0|||
128684119|NCT02414139|463142658|FG007|Treatment Period|Death|0|||
128684120|NCT02414139|463142659|FG008|Treatment Period|Death|0|||
128684121|NCT02414139|463142660|FG009|Treatment Period|Death|1|||
128684122|NCT02414139|463142651|FG000|Treatment Period|Physician Decision|5|||
128684123|NCT02414139|463142652|FG001|Treatment Period|Physician Decision|4|||
128684124|NCT02414139|463142653|FG002|Treatment Period|Physician Decision|6|||
128684125|NCT02414139|463142654|FG003|Treatment Period|Physician Decision|1|||
128684126|NCT02414139|463142655|FG004|Treatment Period|Physician Decision|4|||
128684127|NCT02414139|463142656|FG005|Treatment Period|Physician Decision|0|||
128684128|NCT02414139|463142657|FG006|Treatment Period|Physician Decision|2|||
128684129|NCT02414139|463142658|FG007|Treatment Period|Physician Decision|0|||
128885124|NCT01193920|463874221|FG000|Overall Study|Withdrawal by Subject|1|||
129019578|NCT01015703|464365153|FG001|Overall Study|Adverse Event|0|||
129019579|NCT01015703|464365154|FG002|Overall Study|Adverse Event|0|||
129019580|NCT01015703|464365155|FG003|Overall Study|Adverse Event|0|||
129019581|NCT01015703|464365156|FG004|Overall Study|Adverse Event|0|||
129019582|NCT01015703|464365152|FG000|Overall Study|Protocol Violation|1|||
129019583|NCT01015703|464365153|FG001|Overall Study|Protocol Violation|0|||
129019584|NCT01015703|464365154|FG002|Overall Study|Protocol Violation|0|||
129019585|NCT01015703|464365155|FG003|Overall Study|Protocol Violation|0|||
129019586|NCT01015703|464365156|FG004|Overall Study|Protocol Violation|0|||
129019587|NCT03122535|464365157|FG000|Overall Study|Lost to Follow-up|68|||
129019588|NCT03122535|464365158|FG001|Overall Study|Lost to Follow-up|68|||
129019589|NCT03122535|464365157|FG000|Overall Study|Physician Decision|3|||
129019590|NCT03122535|464365158|FG001|Overall Study|Physician Decision|3|||
129019591|NCT03122535|464365157|FG000|Overall Study|Withdrawal by Subject|2|||
129019592|NCT03122535|464365158|FG001|Overall Study|Withdrawal by Subject|2|||
129019593|NCT02718326|464365159|FG000|Overall Study|Adverse Event|4|||
129019594|NCT02718326|464365160|FG001|Overall Study|Adverse Event|9|||
129019595|NCT02718326|464365161|FG002|Overall Study|Adverse Event|0|||
129019596|NCT02718326|464365159|FG000|Overall Study|Death|8|||
129019597|NCT02718326|464365160|FG001|Overall Study|Death|1|||
129019598|NCT02718326|464365161|FG002|Overall Study|Death|2|||
129019599|NCT02718326|464365159|FG000|Overall Study|Withdrawal by Subject|4|||
129019600|NCT02718326|464365160|FG001|Overall Study|Withdrawal by Subject|9|||
129019601|NCT02718326|464365161|FG002|Overall Study|Withdrawal by Subject|6|||
129019602|NCT02718326|464365159|FG000|Overall Study|Lost to Follow-up|18|||
129019603|NCT02718326|464365160|FG001|Overall Study|Lost to Follow-up|5|||
129019604|NCT02718326|464365161|FG002|Overall Study|Lost to Follow-up|14|||
129019605|NCT02718326|464365159|FG000|Overall Study|Protocol Deviation|1|||
129019606|NCT02718326|464365160|FG001|Overall Study|Protocol Deviation|0|||
129019607|NCT02718326|464365161|FG002|Overall Study|Protocol Deviation|0|||
129019608|NCT02718326|464365159|FG000|Overall Study|Pregnancy|1|||
129019609|NCT02718326|464365160|FG001|Overall Study|Pregnancy|0|||
129019610|NCT02718326|464365161|FG002|Overall Study|Pregnancy|0|||
129019611|NCT00834418|464365167|FG000|Overall Study|Adverse Event|0|||
129019612|NCT00834418|464365168|FG001|Overall Study|Adverse Event|2|||
129019613|NCT00777023|464365169|FG000|Overall Study|Adverse Event|15|||
129019614|NCT00777023|464365170|FG001|Overall Study|Adverse Event|21|||
129019615|NCT00777023|464365171|FG002|Overall Study|Adverse Event|8|||
129019616|NCT00777023|464365169|FG000|Overall Study|Lack of Efficacy|1|||
129019617|NCT00777023|464365170|FG001|Overall Study|Lack of Efficacy|0|||
129019618|NCT00777023|464365171|FG002|Overall Study|Lack of Efficacy|14|||
129019619|NCT00777023|464365169|FG000|Overall Study|Protocol Violation|2|||
129019620|NCT00777023|464365170|FG001|Overall Study|Protocol Violation|1|||
129019621|NCT00777023|464365171|FG002|Overall Study|Protocol Violation|1|||
129019622|NCT00777023|464365169|FG000|Overall Study|Lost to Follow-up|2|||
129019623|NCT00777023|464365170|FG001|Overall Study|Lost to Follow-up|3|||
129019624|NCT00777023|464365171|FG002|Overall Study|Lost to Follow-up|3|||
129019625|NCT00777023|464365169|FG000|Overall Study|Death|0|||
129019626|NCT00777023|464365170|FG001|Overall Study|Death|1|||
128684130|NCT02414139|463142659|FG008|Treatment Period|Physician Decision|1|||
128684131|NCT02414139|463142660|FG009|Treatment Period|Physician Decision|4|||
128684132|NCT02414139|463142651|FG000|Treatment Period|Progressive disease|48|||
129019627|NCT00777023|464365171|FG002|Overall Study|Death|0|||
129215128|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
128684133|NCT02414139|463142652|FG001|Treatment Period|Progressive disease|31|||
129019628|NCT00777023|464365169|FG000|Overall Study|Withdrawal by Subject|7|||
129019629|NCT00777023|464365170|FG001|Overall Study|Withdrawal by Subject|7|||
128763168|NCT00895622|463422772|FG000|Overall Study|Protocol Violation|5|||
129019630|NCT00777023|464365171|FG002|Overall Study|Withdrawal by Subject|8|||
128885125|NCT01193920|463874222|FG001|Overall Study|Withdrawal by Subject|0|||
128885126|NCT01193920|463874223|FG002|Overall Study|Withdrawal by Subject|5|||
128885127|NCT01193920|463874224|FG003|Overall Study|Withdrawal by Subject|1|||
128885128|NCT01193920|463874225|FG004|Overall Study|Withdrawal by Subject|3|||
128885129|NCT01193920|463874226|FG005|Overall Study|Withdrawal by Subject|1|||
128885130|NCT01193920|463874227|FG006|Overall Study|Withdrawal by Subject|3|||
128885131|NCT01193920|463874228|FG007|Overall Study|Withdrawal by Subject|0|||
128885132|NCT01193920|463874229|FG008|Overall Study|Withdrawal by Subject|1|||
128885133|NCT01193920|463874230|FG009|Overall Study|Withdrawal by Subject|0|||
128885134|NCT01193920|463874221|FG000|Overall Study|Lost to Follow-up|1|||
128885135|NCT01193920|463874222|FG001|Overall Study|Lost to Follow-up|0|||
128684134|NCT02414139|463142653|FG002|Treatment Period|Progressive disease|37|||
128684135|NCT02414139|463142654|FG003|Treatment Period|Progressive disease|21|||
128684136|NCT02414139|463142655|FG004|Treatment Period|Progressive disease|43|||
128684137|NCT02414139|463142656|FG005|Treatment Period|Progressive disease|12|||
128684138|NCT02414139|463142657|FG006|Treatment Period|Progressive disease|16|||
128684139|NCT02414139|463142658|FG007|Treatment Period|Progressive disease|2|||
128684140|NCT02414139|463142659|FG008|Treatment Period|Progressive disease|20|||
128684141|NCT02414139|463142660|FG009|Treatment Period|Progressive disease|14|||
128684142|NCT02414139|463142651|FG000|Treatment Period|Protocol deviation|0|||
129019631|NCT00777023|464365169|FG000|Overall Study|Missing data|1|||
129019632|NCT00777023|464365170|FG001|Overall Study|Missing data|1|||
129019633|NCT00777023|464365171|FG002|Overall Study|Missing data|0|||
129019634|NCT00777023|464365169|FG000|Overall Study|Reasons not specified|4|||
129019635|NCT00777023|464365170|FG001|Overall Study|Reasons not specified|4|||
129019636|NCT00777023|464365171|FG002|Overall Study|Reasons not specified|2|||
129019637|NCT00777023|464365169|FG000|Overall Study|Last dose date unknown|3|||
129019638|NCT00777023|464365170|FG001|Overall Study|Last dose date unknown|3|||
129019639|NCT00777023|464365171|FG002|Overall Study|Last dose date unknown|1|||
129019640|NCT02659150|464365174|FG000|Subject Enrollment|Physician Decision|3|||
129019641|NCT02659150|464365174|FG000|Subject Enrollment|Withdrawal by Subject|2|||
129019642|NCT02659150|464365174|FG000|Baseline Imaging|Withdrawal by Subject|1|||
129019643|NCT02659150|464365174|FG000|Baseline Imaging|Physician Decision|1|||
129019644|NCT02659150|464365174|FG000|Study Drug Dosing|Adverse Event|1|||
129019645|NCT01200810|464365179|FG000|Overall Study|Physician Decision|1|||
129019646|NCT01200810|464365180|FG001|Overall Study|Physician Decision|0|||
129019647|NCT01200810|464365179|FG000|Overall Study|Withdrawal by Subject|1|||
129019648|NCT01200810|464365180|FG001|Overall Study|Withdrawal by Subject|2|||
129019649|NCT01200810|464365179|FG000|Overall Study|Sponsor stopped making study drug|3|||
129019650|NCT01200810|464365180|FG001|Overall Study|Sponsor stopped making study drug|3|||
129019651|NCT00960297|464365182|FG000|Overall Study|Physician Decision|1|||
129019652|NCT00960297|464365182|FG000|Overall Study|Venous port infection|1|||
129019653|NCT00960297|464365182|FG000|Overall Study|Disease progression|1|||
129019654|NCT03965091|464365190|FG000|Overall Study|Adverse Event|0|||
129019655|NCT03965091|464365191|FG001|Overall Study|Adverse Event|2|||
129019656|NCT03965091|464365192|FG002|Overall Study|Adverse Event|3|||
129019657|NCT03965091|464365190|FG000|Overall Study|Withdrawal by Subject|11|||
129019658|NCT03965091|464365191|FG001|Overall Study|Withdrawal by Subject|3|||
129019659|NCT03965091|464365192|FG002|Overall Study|Withdrawal by Subject|5|||
129019660|NCT03965091|464365190|FG000|Overall Study|Non-compliance with study drug|0|||
129019661|NCT03965091|464365191|FG001|Overall Study|Non-compliance with study drug|0|||
129019662|NCT03965091|464365192|FG002|Overall Study|Non-compliance with study drug|1|||
129019663|NCT03965091|464365190|FG000|Overall Study|Lost to Follow-up|1|||
129019664|NCT03965091|464365191|FG001|Overall Study|Lost to Follow-up|1|||
129019665|NCT03965091|464365192|FG002|Overall Study|Lost to Follow-up|1|||
129019666|NCT03965091|464365190|FG000|Overall Study|Lack of Efficacy|2|||
129019667|NCT03965091|464365191|FG001|Overall Study|Lack of Efficacy|0|||
129019668|NCT03965091|464365192|FG002|Overall Study|Lack of Efficacy|0|||
129019669|NCT03965091|464365190|FG000|Overall Study|Other than specified|9|||
129019670|NCT03965091|464365191|FG001|Overall Study|Other than specified|11|||
129019671|NCT03965091|464365192|FG002|Overall Study|Other than specified|8|||
129019672|NCT02576938|464365194|FG000|Overall Study|Adverse Event|5|||
129019673|NCT02576938|464365195|FG001|Overall Study|Adverse Event|3|||
129019674|NCT02576938|464365196|FG002|Overall Study|Adverse Event|6|||
129019675|NCT02576938|464365194|FG000|Overall Study|Protocol Violation|1|||
129019676|NCT02576938|464365195|FG001|Overall Study|Protocol Violation|1|||
129019677|NCT02576938|464365196|FG002|Overall Study|Protocol Violation|1|||
129215129|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
128684143|NCT02414139|463142652|FG001|Treatment Period|Protocol deviation|0|||
128684144|NCT02414139|463142653|FG002|Treatment Period|Protocol deviation|1|||
128684145|NCT02414139|463142654|FG003|Treatment Period|Protocol deviation|0|||
128885136|NCT01193920|463874223|FG002|Overall Study|Lost to Follow-up|1|||
129019678|NCT02576938|464365194|FG000|Overall Study|Withdrawal by Subject|3|||
129019679|NCT02576938|464365195|FG001|Overall Study|Withdrawal by Subject|2|||
129019680|NCT02576938|464365196|FG002|Overall Study|Withdrawal by Subject|4|||
129019681|NCT02576938|464365194|FG000|Overall Study|Lack of Efficacy|9|||
129019682|NCT02576938|464365195|FG001|Overall Study|Lack of Efficacy|4|||
128885137|NCT01193920|463874224|FG003|Overall Study|Lost to Follow-up|1|||
128885138|NCT01193920|463874225|FG004|Overall Study|Lost to Follow-up|3|||
128885139|NCT01193920|463874226|FG005|Overall Study|Lost to Follow-up|3|||
128885140|NCT01193920|463874227|FG006|Overall Study|Lost to Follow-up|1|||
128885141|NCT01193920|463874228|FG007|Overall Study|Lost to Follow-up|0|||
128885142|NCT01193920|463874229|FG008|Overall Study|Lost to Follow-up|2|||
128885143|NCT01193920|463874230|FG009|Overall Study|Lost to Follow-up|3|||
128885144|NCT01193920|463874221|FG000|Overall Study|Protocol Violation|1|||
128885145|NCT01193920|463874222|FG001|Overall Study|Protocol Violation|0|||
128885146|NCT01193920|463874223|FG002|Overall Study|Protocol Violation|0|||
128885147|NCT01193920|463874224|FG003|Overall Study|Protocol Violation|0|||
128885148|NCT01193920|463874225|FG004|Overall Study|Protocol Violation|0|||
128885149|NCT01193920|463874226|FG005|Overall Study|Protocol Violation|0|||
128885150|NCT01193920|463874227|FG006|Overall Study|Protocol Violation|0|||
128885151|NCT01193920|463874228|FG007|Overall Study|Protocol Violation|0|||
128885152|NCT01193920|463874229|FG008|Overall Study|Protocol Violation|0|||
128885153|NCT01193920|463874230|FG009|Overall Study|Protocol Violation|0|||
128885154|NCT01193920|463874221|FG000|Overall Study|Death|0|||
128885155|NCT01193920|463874222|FG001|Overall Study|Death|0|||
128885156|NCT01193920|463874223|FG002|Overall Study|Death|0|||
128885157|NCT01193920|463874224|FG003|Overall Study|Death|1|||
128885158|NCT01193920|463874225|FG004|Overall Study|Death|0|||
128885159|NCT01193920|463874226|FG005|Overall Study|Death|0|||
128885160|NCT01193920|463874227|FG006|Overall Study|Death|2|||
128885161|NCT01193920|463874228|FG007|Overall Study|Death|3|||
128885162|NCT01193920|463874229|FG008|Overall Study|Death|2|||
128885163|NCT01193920|463874230|FG009|Overall Study|Death|4|||
128885164|NCT01193920|463874221|FG000|Overall Study|Unable to classify|0|||
128885165|NCT01193920|463874222|FG001|Overall Study|Unable to classify|0|||
128885166|NCT01193920|463874223|FG002|Overall Study|Unable to classify|0|||
128885167|NCT01193920|463874224|FG003|Overall Study|Unable to classify|1|||
128885168|NCT01193920|463874225|FG004|Overall Study|Unable to classify|0|||
128885169|NCT01193920|463874226|FG005|Overall Study|Unable to classify|0|||
128885170|NCT01193920|463874227|FG006|Overall Study|Unable to classify|0|||
128885171|NCT01193920|463874228|FG007|Overall Study|Unable to classify|1|||
128885172|NCT01193920|463874229|FG008|Overall Study|Unable to classify|0|||
128885173|NCT01193920|463874230|FG009|Overall Study|Unable to classify|0|||
128885174|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
128885175|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
128885176|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
128885177|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
128885178|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
128885179|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
128885180|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
128885181|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
128885182|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
128885183|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
128885184|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
128885185|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
128885186|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
128885187|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
128885188|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
128885189|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
128885190|NCT01231516|463874233|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
128885191|NCT01231516|463874234|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
128885192|NCT01231516|463874233|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
128885193|NCT01231516|463874234|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
128885194|NCT01231516|463874233|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
128885195|NCT01231516|463874234|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
128885196|NCT01231516|463874233|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
128885197|NCT01231516|463874234|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
128885198|NCT01231516|463874233|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
128885199|NCT01231516|463874234|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
129019683|NCT02576938|464365196|FG002|Overall Study|Lack of Efficacy|0|||
129019684|NCT02576938|464365194|FG000|Overall Study|Lost to Follow-up|2|||
129019685|NCT02576938|464365195|FG001|Overall Study|Lost to Follow-up|0|||
129019686|NCT02576938|464365196|FG002|Overall Study|Lost to Follow-up|1|||
129019687|NCT02576938|464365194|FG000|Overall Study|Physician Decision|0|||
129019688|NCT02576938|464365195|FG001|Overall Study|Physician Decision|1|||
129019689|NCT02576938|464365196|FG002|Overall Study|Physician Decision|0|||
129019690|NCT02576938|464365194|FG000|Overall Study|Met Exclusion Criteria|0|||
129019691|NCT02576938|464365195|FG001|Overall Study|Met Exclusion Criteria|1|||
129019692|NCT02576938|464365196|FG002|Overall Study|Met Exclusion Criteria|0|||
128885200|NCT01231516|463874233|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
128885201|NCT01231516|463874234|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
128885202|NCT01231516|463874233|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
128885203|NCT01231516|463874234|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
128885204|NCT01231516|463874233|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
128885205|NCT01231516|463874234|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
128885206|NCT03170154|463874235|FG000|Overall Study|Lost to Follow-up|4|||
128885207|NCT03170154|463874235|FG000|Overall Study|Death|2|||
128885208|NCT03170154|463874235|FG000|Overall Study|Withdrawal by Subject|2|||
128885209|NCT01117857|463874236|FG000|Overall Study|Lost to Follow-up|4|||
128885210|NCT01117857|463874236|FG000|Overall Study|Withdrawal by Subject|4|||
128885211|NCT01117857|463874236|FG000|Overall Study|Physician Decision|1|||
128885212|NCT00633061|463874237|FG000|Overall Study|Study closed|86|||
128885213|NCT00633061|463874238|FG001|Overall Study|Study closed|0|||
128885214|NCT05245097|463874239|FG000|Overall Study|Adverse Event|13|||
128885215|NCT05245097|463874240|FG001|Overall Study|Adverse Event|2|||
128885216|NCT05245097|463874239|FG000|Overall Study|Protocol Violation|8|||
128885217|NCT05245097|463874240|FG001|Overall Study|Protocol Violation|6|||
128885218|NCT05245097|463874239|FG000|Overall Study|Withdrawal by Subject|18|||
128885219|NCT05245097|463874240|FG001|Overall Study|Withdrawal by Subject|0|||
128885220|NCT05245097|463874239|FG000|Overall Study|Death|6|||
128885221|NCT05245097|463874240|FG001|Overall Study|Death|7|||
128885222|NCT05245097|463874239|FG000|Overall Study|Physician Decision|6|||
128885223|NCT05245097|463874240|FG001|Overall Study|Physician Decision|0|||
128885224|NCT05245097|463874239|FG000|Overall Study|Relocation|4|||
128885225|NCT05245097|463874240|FG001|Overall Study|Relocation|3|||
128885226|NCT00607022|463874248|FG000|Overall Study|Withdrawal by Subject|1|||
128885227|NCT00607022|463874249|FG001|Overall Study|Withdrawal by Subject|0|||
128885228|NCT00607022|463874250|FG002|Overall Study|Withdrawal by Subject|0|||
128885229|NCT00810394|463874251|FG000|Overall Study|Withdrawal by Subject|3|||
128885230|NCT05677893|463875902|FG000|Overall Study|Withdrawal by Subject|0|||
128885231|NCT05677893|463875903|FG001|Overall Study|Withdrawal by Subject|0|||
128885232|NCT05677893|463875904|FG002|Overall Study|Withdrawal by Subject|0|||
128885233|NCT05677893|463875905|FG003|Overall Study|Withdrawal by Subject|0|||
128885234|NCT05677893|463875906|FG004|Overall Study|Withdrawal by Subject|1|||
128885235|NCT05677893|463875907|FG005|Overall Study|Withdrawal by Subject|1|||
128885236|NCT05677893|463875908|FG006|Overall Study|Withdrawal by Subject|0|||
128885237|NCT05677893|463875902|FG000|Overall Study|Others|1|||
128885238|NCT05677893|463875903|FG001|Overall Study|Others|0|||
128885239|NCT05677893|463875904|FG002|Overall Study|Others|0|||
128885240|NCT05677893|463875905|FG003|Overall Study|Others|0|||
128885241|NCT05677893|463875906|FG004|Overall Study|Others|0|||
128885242|NCT05677893|463875907|FG005|Overall Study|Others|0|||
128885243|NCT05677893|463875908|FG006|Overall Study|Others|0|||
128885244|NCT01485354|463875909|FG000|Overall Study|Withdrawal by Subject|5|||
128885245|NCT00995020|463875910|FG000|Overall Study|margin analysis not performed|2|||
128885246|NCT00995020|463875911|FG001|Overall Study|margin analysis not performed|5|||
128885247|NCT00995020|463875910|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
128885248|NCT00995020|463875911|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
128885249|NCT02720536|463875912|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
128885250|NCT02720536|463875912|FG000|Overall Study|PR - pregnancy|2|||
128885251|NCT02720536|463875912|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
128885252|NCT02720536|463875912|FG000|Overall Study|PR - death|1|||
128885253|NCT02720536|463875912|FG000|Overall Study|PR - adverse event|1|||
128885254|NCT02720536|463875912|FG000|Overall Study|PR - abnormal lab value(s)|1|||
128885255|NCT02720536|463875912|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
128885256|NCT00719563|463875914|FG000|Overall Study|Adverse Event|16|||
128885257|NCT00719563|463875915|FG001|Overall Study|Adverse Event|13|||
128885258|NCT00719563|463875914|FG000|Overall Study|Medical condition changed|3|||
128885259|NCT00719563|463875915|FG001|Overall Study|Medical condition changed|5|||
128885260|NCT00719563|463875914|FG000|Overall Study|Lack of Efficacy|3|||
128885261|NCT00719563|463875915|FG001|Overall Study|Lack of Efficacy|7|||
128684146|NCT02414139|463142655|FG004|Treatment Period|Protocol deviation|0|||
128885262|NCT00719563|463875914|FG000|Overall Study|Personal reasons|6|||
128885263|NCT00719563|463875915|FG001|Overall Study|Personal reasons|7|||
128684147|NCT02414139|463142656|FG005|Treatment Period|Protocol deviation|0|||
128885264|NCT00719563|463875914|FG000|Overall Study|Unknown reasons|4|||
128885265|NCT00719563|463875915|FG001|Overall Study|Unknown reasons|6|||
128885266|NCT00719563|463875914|FG000|Overall Study|Noncompliant|1|||
128885267|NCT00719563|463875915|FG001|Overall Study|Noncompliant|1|||
128885268|NCT00719563|463875914|FG000|Overall Study|Lost to Follow-up|5|||
128885269|NCT00719563|463875915|FG001|Overall Study|Lost to Follow-up|3|||
128885270|NCT00792805|463875918|FG000|Overall Study|Adverse Event|12|||
128885271|NCT00792805|463875919|FG001|Overall Study|Adverse Event|10|||
128885272|NCT00792805|463875920|FG002|Overall Study|Adverse Event|10|||
128885273|NCT00792805|463875918|FG000|Overall Study|Subject withdrew consent|5|||
128885274|NCT00792805|463875919|FG001|Overall Study|Subject withdrew consent|6|||
129107827|NCT02121795|464689845|FG001|Open-Label Phase|Withdrawal by Subject|2|||
129107828|NCT02121795|464689844|FG000|Open-Label Phase|Lost to Follow-up|1|||
129107829|NCT02121795|464689845|FG001|Open-Label Phase|Lost to Follow-up|0|||
129107830|NCT00666211|464689846|FG000|Overall Study|Withdrawal by Subject|10|||
129107831|NCT00666211|464689847|FG001|Overall Study|Withdrawal by Subject|13|||
129107832|NCT00666211|464689846|FG000|Overall Study|went off medication, no more pain|1|||
129107833|NCT00666211|464689847|FG001|Overall Study|went off medication, no more pain|0|||
129107834|NCT00666211|464689846|FG000|Overall Study|patient non-compliant|6|||
129107835|NCT00666211|464689847|FG001|Overall Study|patient non-compliant|6|||
129107836|NCT00666211|464689846|FG000|Overall Study|disease progression|1|||
129107837|NCT00666211|464689847|FG001|Overall Study|disease progression|8|||
129107838|NCT00666211|464689846|FG000|Overall Study|Lost to Follow-up|2|||
129107839|NCT00666211|464689847|FG001|Overall Study|Lost to Follow-up|0|||
129107840|NCT00666211|464689846|FG000|Overall Study|toxicity|0|||
129107841|NCT00666211|464689847|FG001|Overall Study|toxicity|2|||
129107842|NCT00666211|464689846|FG000|Overall Study|hospital admission|0|||
129107843|NCT00666211|464689847|FG001|Overall Study|hospital admission|5|||
129107844|NCT00666211|464689846|FG000|Overall Study|Death|0|||
129107845|NCT00666211|464689847|FG001|Overall Study|Death|2|||
129107846|NCT00666211|464689846|FG000|Overall Study|off tx for other complicating disease|0|||
129107847|NCT00666211|464689847|FG001|Overall Study|off tx for other complicating disease|1|||
129107848|NCT00666211|464689846|FG000|Overall Study|Physician Decision|0|||
129107849|NCT00666211|464689847|FG001|Overall Study|Physician Decision|1|||
129107850|NCT02299388|464689848|FG000|Overall Study|Withdrawal by Subject|0|||
129107851|NCT02299388|464689849|FG001|Overall Study|Withdrawal by Subject|1|||
129107852|NCT03334188|464689852|FG000|Overall Study|Withdrawal by Subject|0|||
129107853|NCT03334188|464689853|FG001|Overall Study|Withdrawal by Subject|1|||
129107854|NCT03334188|464689852|FG000|Overall Study|Death|1|||
129107855|NCT03334188|464689853|FG001|Overall Study|Death|0|||
129107856|NCT03334188|464689852|FG000|Overall Study|Never had qualifying clinic visit|7|||
129107857|NCT03334188|464689853|FG001|Overall Study|Never had qualifying clinic visit|7|||
129107858|NCT03373760|464689856|FG000|Overall Study|Adverse Event|8|||
129107859|NCT03373760|464689856|FG000|Overall Study|Disease Progression|46|||
129107860|NCT03373760|464689856|FG000|Overall Study|Death|4|||
129107861|NCT01093586|464689857|FG000|Overall Study|Failed to engraft|3|||
129107862|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
129107863|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
129107864|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
129107865|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
129107866|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
129107867|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
129107868|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
129107869|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
129107870|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
129107871|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
129107872|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
129107873|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
129107874|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
129107875|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
129107876|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Death|1|||
129107877|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Death|0|||
129107878|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
129107879|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
129107880|NCT00105989|464689858|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
129107881|NCT00105989|464689859|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
129107882|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
129107883|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
129107884|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
129107885|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
129107886|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
129107887|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
129107888|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
129107889|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
129107890|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
129107891|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
129107892|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
129107893|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
129107894|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
129107895|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
129107896|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Death|0|||
129107897|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Death|0|||
128684148|NCT02414139|463142657|FG006|Treatment Period|Protocol deviation|0|||
129019693|NCT03500341|464365197|FG000|Overall Study|Withdrawn prior to Completion|2|||
129019694|NCT00838630|464365201|FG000|First Intervention|Adverse Event|1|||
129019695|NCT00838630|464365202|FG001|First Intervention|Adverse Event|0|||
129019696|NCT00838630|464365201|FG000|Washout: 7 Days|Protocol Violation|1|||
129019697|NCT00838630|464365202|FG001|Washout: 7 Days|Protocol Violation|0|||
129019698|NCT02159950|464365216|FG000|Overall Study|Adverse Event|0|||
129019699|NCT02159950|464365217|FG001|Overall Study|Adverse Event|1|||
129019700|NCT02159950|464365216|FG000|Overall Study|Progression|0|||
129019701|NCT02159950|464365217|FG001|Overall Study|Progression|1|||
129019702|NCT00003659|464365218|FG000|Overall Study|Withdrawal by Subject|3|||
129019703|NCT04022954|464365219|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
129019704|NCT04022954|464365219|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
129019705|NCT04022954|464365219|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
129019706|NCT03017885|464365220|FG000|Overall Study|Adverse Event|2|||
129019707|NCT03017885|464365221|FG001|Overall Study|Adverse Event|0|||
129019708|NCT03017885|464365222|FG002|Overall Study|Adverse Event|0|||
129019709|NCT03017885|464365223|FG003|Overall Study|Adverse Event|0|||
129019710|NCT03017885|464365224|FG004|Overall Study|Adverse Event|0|||
129019711|NCT03017885|464365225|FG005|Overall Study|Adverse Event|0|||
129019712|NCT03017885|464365220|FG000|Overall Study|Progression of disease|4|||
129019713|NCT03017885|464365221|FG001|Overall Study|Progression of disease|3|||
129019714|NCT03017885|464365222|FG002|Overall Study|Progression of disease|4|||
129019715|NCT03017885|464365223|FG003|Overall Study|Progression of disease|0|||
129019716|NCT03017885|464365224|FG004|Overall Study|Progression of disease|0|||
129019717|NCT03017885|464365225|FG005|Overall Study|Progression of disease|0|||
129019718|NCT03017885|464365220|FG000|Overall Study|Other than listed|1|||
129019719|NCT03017885|464365221|FG001|Overall Study|Other than listed|2|||
129019720|NCT03017885|464365222|FG002|Overall Study|Other than listed|1|||
129019721|NCT03017885|464365223|FG003|Overall Study|Other than listed|0|||
129019722|NCT03017885|464365224|FG004|Overall Study|Other than listed|0|||
129019723|NCT03017885|464365225|FG005|Overall Study|Other than listed|0|||
129019724|NCT03017885|464365220|FG000|Overall Study|Lost to Follow-up|2|||
129019725|NCT03017885|464365221|FG001|Overall Study|Lost to Follow-up|0|||
129019726|NCT03017885|464365222|FG002|Overall Study|Lost to Follow-up|3|||
129019727|NCT03017885|464365223|FG003|Overall Study|Lost to Follow-up|0|||
129019728|NCT03017885|464365224|FG004|Overall Study|Lost to Follow-up|0|||
129019729|NCT03017885|464365225|FG005|Overall Study|Lost to Follow-up|0|||
129019730|NCT03017885|464365220|FG000|Overall Study|Change to other anti-cancer therapy|0|||
129019731|NCT03017885|464365221|FG001|Overall Study|Change to other anti-cancer therapy|0|||
129019732|NCT03017885|464365222|FG002|Overall Study|Change to other anti-cancer therapy|1|||
129019733|NCT03017885|464365223|FG003|Overall Study|Change to other anti-cancer therapy|0|||
129019734|NCT03017885|464365224|FG004|Overall Study|Change to other anti-cancer therapy|0|||
129019735|NCT03017885|464365225|FG005|Overall Study|Change to other anti-cancer therapy|0|||
129019736|NCT04400890|464365226|FG000|Overall Study|Withdrawal by Subject|3|||
129019737|NCT04400890|464365227|FG001|Overall Study|Withdrawal by Subject|2|||
129019738|NCT03925532|464365228|FG000|Overall Study|Lost to Follow-up|1|||
129019739|NCT00723710|464365229|FG000|Overall Study|Disease progression|48|||
129019740|NCT00723710|464365229|FG000|Overall Study|Adverse Event|88|||
129019741|NCT00723710|464365229|FG000|Overall Study|Withdrawal by Subject|36|||
129019742|NCT00723710|464365229|FG000|Overall Study|Physician Decision|2|||
129019743|NCT01208337|464365232|FG000|Overall Study|Death|3|||
129019744|NCT03663179|464365236|FG000|Overall Study|Withdrawal by Subject|2|||
129019745|NCT03663179|464365237|FG001|Overall Study|Withdrawal by Subject|0|||
129019746|NCT03663179|464365236|FG000|Overall Study|Lost to Follow-up|1|||
129019747|NCT03663179|464365237|FG001|Overall Study|Lost to Follow-up|1|||
129019748|NCT03663179|464365236|FG000|Overall Study|Revealed exclusionary condition|1|||
129019749|NCT03663179|464365237|FG001|Overall Study|Revealed exclusionary condition|0|||
129019750|NCT01615198|464365238|FG000|Overall Study|Withdrawal by Subject|5|||
129019751|NCT01615198|464365239|FG001|Overall Study|Withdrawal by Subject|5|||
129019752|NCT01615198|464365238|FG000|Overall Study|Protocol deviation|1|||
129019753|NCT01615198|464365239|FG001|Overall Study|Protocol deviation|1|||
129019754|NCT01615198|464365238|FG000|Overall Study|Physician Decision|5|||
129019755|NCT01615198|464365239|FG001|Overall Study|Physician Decision|1|||
129019756|NCT01615198|464365238|FG000|Overall Study|Lost to Follow-up|1|||
129019757|NCT01615198|464365239|FG001|Overall Study|Lost to Follow-up|1|||
129019758|NCT01615198|464365238|FG000|Overall Study|Lack of Efficacy|1|||
129019759|NCT01615198|464365239|FG001|Overall Study|Lack of Efficacy|6|||
129019760|NCT01615198|464365238|FG000|Overall Study|Adverse Event|11|||
129019761|NCT01615198|464365239|FG001|Overall Study|Adverse Event|5|||
129019762|NCT02414152|464365240|FG000|Overall Study|Withdrawal by Subject|1|||
129019763|NCT02414152|464365240|FG000|Overall Study|Lack of Efficacy|1|||
129019764|NCT01289262|464365241|FG000|Overall Study|Lost to Follow-up|29|||
129019765|NCT01289262|464365242|FG001|Overall Study|Lost to Follow-up|16|||
129019766|NCT01289262|464365241|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
129019767|NCT01289262|464365242|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
129019768|NCT00838279|464365243|FG000|Washout|Protocol Violation|1|||
128885275|NCT00792805|463875920|FG002|Overall Study|Subject withdrew consent|5|||
128885276|NCT00792805|463875918|FG000|Overall Study|Administrative problems|2|||
128885277|NCT00792805|463875919|FG001|Overall Study|Administrative problems|0|||
128885278|NCT00792805|463875920|FG002|Overall Study|Administrative problems|4|||
128885279|NCT00792805|463875918|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128885280|NCT00792805|463875919|FG001|Overall Study|Abnormal test procedure result(s)|2|||
128885281|NCT00792805|463875920|FG002|Overall Study|Abnormal test procedure result(s)|0|||
128885282|NCT00792805|463875918|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128885283|NCT00792805|463875919|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
128885284|NCT00792805|463875920|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
128885285|NCT00792805|463875918|FG000|Overall Study|Lost to Follow-up|1|||
128885286|NCT00792805|463875919|FG001|Overall Study|Lost to Follow-up|1|||
128885287|NCT00792805|463875920|FG002|Overall Study|Lost to Follow-up|6|||
128885288|NCT00792805|463875918|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128885289|NCT00792805|463875919|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128885290|NCT00792805|463875920|FG002|Overall Study|Abnormal laboratory value(s)|1|||
128885291|NCT00792805|463875918|FG000|Overall Study|Protocol deviation|0|||
128885292|NCT00792805|463875919|FG001|Overall Study|Protocol deviation|1|||
128885293|NCT00792805|463875920|FG002|Overall Study|Protocol deviation|1|||
128885294|NCT03224325|463875921|FG000|Overall Study|Adverse Event|1|||
128885295|NCT03224325|463875922|FG001|Overall Study|Adverse Event|0|||
128885296|NCT03224325|463875923|FG002|Overall Study|Adverse Event|0|||
128885297|NCT03224325|463875924|FG003|Overall Study|Adverse Event|0|||
128885298|NCT03224325|463875925|FG004|Overall Study|Adverse Event|0|||
128885299|NCT03224325|463875926|FG005|Overall Study|Adverse Event|0|||
128885300|NCT03224325|463875927|FG006|Overall Study|Adverse Event|1|||
128885301|NCT03224325|463875921|FG000|Overall Study|Withdrawal by Subject|0|||
128885302|NCT03224325|463875922|FG001|Overall Study|Withdrawal by Subject|0|||
128885303|NCT03224325|463875923|FG002|Overall Study|Withdrawal by Subject|0|||
128885304|NCT03224325|463875924|FG003|Overall Study|Withdrawal by Subject|1|||
129107898|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
129107899|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
129107900|NCT00105989|464689858|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
129107901|NCT00105989|464689859|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
129107902|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
129107903|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
129107904|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
129107905|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
128885305|NCT03224325|463875925|FG004|Overall Study|Withdrawal by Subject|0|||
128885306|NCT03224325|463875926|FG005|Overall Study|Withdrawal by Subject|0|||
128885307|NCT03224325|463875927|FG006|Overall Study|Withdrawal by Subject|0|||
128885308|NCT02120625|463875929|FG000|Overall Study|Physician Decision|2|||
128763169|NCT00895622|463422773|FG001|Overall Study|Protocol Violation|4|||
128885309|NCT02952001|463875932|FG000|Overall Study|Adverse Event|3|||
128885310|NCT02952001|463875933|FG001|Overall Study|Adverse Event|0|||
128885311|NCT02952001|463875932|FG000|Overall Study|Prohibited therapy|10|||
128885312|NCT02952001|463875933|FG001|Overall Study|Prohibited therapy|3|||
128885313|NCT02952001|463875932|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
129019769|NCT00838279|464365244|FG001|Washout|Protocol Violation|0|||
129019770|NCT00838279|464365243|FG000|Washout|Withdrawal by Subject|0|||
129019771|NCT00838279|464365244|FG001|Washout|Withdrawal by Subject|1|||
129019772|NCT01218867|464365245|FG000|Overall Study|Death during treatment|0|||
129019773|NCT01218867|464365246|FG001|Overall Study|Death during treatment|0|||
129019774|NCT01218867|464365247|FG002|Overall Study|Death during treatment|0|||
129019775|NCT01218867|464365248|FG003|Overall Study|Death during treatment|0|||
129019776|NCT01218867|464365249|FG004|Overall Study|Death during treatment|0|||
129019777|NCT01218867|464365250|FG005|Overall Study|Death during treatment|0|||
129019778|NCT01218867|464365251|FG006|Overall Study|Death during treatment|1|||
129019779|NCT01218867|464365252|FG007|Overall Study|Death during treatment|0|||
129019780|NCT01218867|464365253|FG008|Overall Study|Death during treatment|0|||
129019781|NCT01218867|464365254|FG009|Overall Study|Death during treatment|0|||
129019782|NCT01218867|464365255|FG010|Overall Study|Death during treatment|0|||
129019783|NCT03792477|464365256|FG000|Overall Study|Adverse Event|0|||
129019784|NCT03792477|464365257|FG001|Overall Study|Adverse Event|0|||
129019785|NCT03792477|464365258|FG002|Overall Study|Adverse Event|0|||
129019786|NCT03792477|464365259|FG003|Overall Study|Adverse Event|1|||
129019787|NCT03792477|464365260|FG004|Overall Study|Adverse Event|0|||
129019788|NCT03792477|464365256|FG000|Overall Study|Lost to Follow-up|0|||
129019789|NCT03792477|464365257|FG001|Overall Study|Lost to Follow-up|0|||
129019790|NCT03792477|464365258|FG002|Overall Study|Lost to Follow-up|2|||
129019791|NCT03792477|464365259|FG003|Overall Study|Lost to Follow-up|0|||
129019792|NCT03792477|464365260|FG004|Overall Study|Lost to Follow-up|0|||
129019793|NCT03792477|464365256|FG000|Overall Study|Other|0|||
129019794|NCT03792477|464365257|FG001|Overall Study|Other|0|||
129215130|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
129215131|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
129215132|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
129215133|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
129215134|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
129215135|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
129215136|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
129215137|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
129215138|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
129215139|NCT03955146|465089450|FG000|DB Period (48 Weeks)|Participant Decision|9|||
129215140|NCT03955146|465089451|FG001|DB Period (48 Weeks)|Participant Decision|12|||
129215141|NCT03955146|465089452|FG002|DB Period (48 Weeks)|Participant Decision|1|||
129215142|NCT03955146|465089453|FG003|DB Period (48 Weeks)|Participant Decision|1|||
129215143|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
128684149|NCT02414139|463142658|FG007|Treatment Period|Protocol deviation|0|||
128684150|NCT02414139|463142659|FG008|Treatment Period|Protocol deviation|0|||
128684151|NCT02414139|463142660|FG009|Treatment Period|Protocol deviation|0|||
128684152|NCT02414139|463142651|FG000|Treatment Period|Subject/Guardian decision|5|||
128684153|NCT02414139|463142652|FG001|Treatment Period|Subject/Guardian decision|1|||
128684154|NCT02414139|463142653|FG002|Treatment Period|Subject/Guardian decision|1|||
128684155|NCT02414139|463142654|FG003|Treatment Period|Subject/Guardian decision|2|||
128684156|NCT02414139|463142655|FG004|Treatment Period|Subject/Guardian decision|5|||
128684157|NCT02414139|463142656|FG005|Treatment Period|Subject/Guardian decision|0|||
128684158|NCT02414139|463142657|FG006|Treatment Period|Subject/Guardian decision|2|||
128684159|NCT02414139|463142658|FG007|Treatment Period|Subject/Guardian decision|0|||
128684160|NCT02414139|463142659|FG008|Treatment Period|Subject/Guardian decision|1|||
128684161|NCT02414139|463142660|FG009|Treatment Period|Subject/Guardian decision|1|||
128684162|NCT02414139|463142651|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
128684163|NCT02414139|463142652|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
128684164|NCT02414139|463142653|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
128684165|NCT02414139|463142654|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
128684166|NCT02414139|463142655|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
128684167|NCT02414139|463142656|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
128684168|NCT02414139|463142657|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
128684169|NCT02414139|463142658|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
128684170|NCT02414139|463142659|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
128684171|NCT02414139|463142660|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
128684172|NCT02414139|463142651|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
128684173|NCT02414139|463142652|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684174|NCT02414139|463142653|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684175|NCT02414139|463142654|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684176|NCT02414139|463142655|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
128684177|NCT02414139|463142656|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684178|NCT02414139|463142657|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684179|NCT02414139|463142658|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684180|NCT02414139|463142659|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684181|NCT02414139|463142660|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128684182|NCT02414139|463142651|FG000|Post-treatment Efficacy Follow-up|Death|0|||
128684183|NCT02414139|463142652|FG001|Post-treatment Efficacy Follow-up|Death|1|||
128684184|NCT02414139|463142653|FG002|Post-treatment Efficacy Follow-up|Death|0|||
128684185|NCT02414139|463142654|FG003|Post-treatment Efficacy Follow-up|Death|0|||
128684186|NCT02414139|463142655|FG004|Post-treatment Efficacy Follow-up|Death|1|||
128684187|NCT02414139|463142656|FG005|Post-treatment Efficacy Follow-up|Death|0|||
128684188|NCT02414139|463142657|FG006|Post-treatment Efficacy Follow-up|Death|0|||
128684189|NCT02414139|463142658|FG007|Post-treatment Efficacy Follow-up|Death|0|||
128684190|NCT02414139|463142659|FG008|Post-treatment Efficacy Follow-up|Death|0|||
128684191|NCT02414139|463142660|FG009|Post-treatment Efficacy Follow-up|Death|1|||
128684192|NCT02414139|463142651|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
128684193|NCT02414139|463142652|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684194|NCT02414139|463142653|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684195|NCT02414139|463142654|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684196|NCT02414139|463142655|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684197|NCT02414139|463142656|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684198|NCT02414139|463142657|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684199|NCT02414139|463142658|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684200|NCT02414139|463142659|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684201|NCT02414139|463142660|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128684202|NCT02414139|463142651|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
129215144|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
128885314|NCT02952001|463875933|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
128885315|NCT00937833|463875936|FG000|Overall Study|Protocol Violation|1|||
128885316|NCT00937833|463875937|FG001|Overall Study|Protocol Violation|2|||
128885317|NCT00937833|463875936|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
128885318|NCT00937833|463875937|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
128885319|NCT00937833|463875936|FG000|Overall Study|Lost to Follow-up|10|||
128885320|NCT00937833|463875937|FG001|Overall Study|Lost to Follow-up|8|||
128885321|NCT00937833|463875936|FG000|Overall Study|Withdrawal by Subject|4|||
128885322|NCT00937833|463875937|FG001|Overall Study|Withdrawal by Subject|6|||
128885323|NCT03278106|463875939|FG000|Overall Study|No protocol treatment|1|||
128885324|NCT00818389|463875940|FG000|Overall Study|Death|1|||
128885325|NCT00818389|463875941|FG001|Overall Study|Death|3|||
128885326|NCT00818389|463875940|FG000|Overall Study|ALS Disease Progression|1|||
128885327|NCT00818389|463875941|FG001|Overall Study|ALS Disease Progression|0|||
128885328|NCT00818389|463875940|FG000|Overall Study|Withdrawal by Subject|2|||
128885329|NCT00818389|463875941|FG001|Overall Study|Withdrawal by Subject|2|||
128885330|NCT00818389|463875940|FG000|Overall Study|Adverse Event|0|||
128885331|NCT00818389|463875941|FG001|Overall Study|Adverse Event|1|||
128885332|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
128885333|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
128885334|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
128885335|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
128885336|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
128885337|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
128885338|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
128885339|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
128885340|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
128885341|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
128885342|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
128885343|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
128885344|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
128885345|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
128885346|NCT03548987|463875942|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
128885347|NCT03548987|463875943|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
128885348|NCT03548987|463875942|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
128885349|NCT03548987|463875943|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
128885350|NCT03548987|463875942|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
128885351|NCT03548987|463875943|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
128885352|NCT03548987|463875942|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
128885353|NCT03548987|463875943|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
128885354|NCT03548987|463875942|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
128885355|NCT03548987|463875943|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
128885356|NCT03548987|463875942|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
128885357|NCT03548987|463875943|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
128885358|NCT03548987|463875942|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
128885359|NCT03548987|463875943|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
128885360|NCT00756470|463875944|FG000|Overall Study|Withdrawal by Subject|1|||
128885361|NCT00756470|463875944|FG000|Overall Study|Adverse Event|4|||
128885362|NCT00820027|463875945|FG000|Overall Study|Adverse Event|15|||
128885363|NCT00820027|463875946|FG001|Overall Study|Adverse Event|8|||
128885364|NCT00820027|463875947|FG002|Overall Study|Adverse Event|10|||
128885365|NCT00820027|463875948|FG003|Overall Study|Adverse Event|5|||
128885366|NCT00820027|463875945|FG000|Overall Study|Lack of Efficacy|2|||
128885367|NCT00820027|463875946|FG001|Overall Study|Lack of Efficacy|1|||
128885368|NCT00820027|463875947|FG002|Overall Study|Lack of Efficacy|2|||
128885369|NCT00820027|463875948|FG003|Overall Study|Lack of Efficacy|2|||
128885370|NCT00820027|463875945|FG000|Overall Study|Physician Decision|0|||
128885371|NCT00820027|463875946|FG001|Overall Study|Physician Decision|1|||
128885372|NCT00820027|463875947|FG002|Overall Study|Physician Decision|1|||
128885373|NCT00820027|463875948|FG003|Overall Study|Physician Decision|0|||
128885374|NCT00820027|463875945|FG000|Overall Study|Protocol Violation|3|||
128885375|NCT00820027|463875946|FG001|Overall Study|Protocol Violation|0|||
128885376|NCT00820027|463875947|FG002|Overall Study|Protocol Violation|4|||
129019795|NCT03792477|464365258|FG002|Overall Study|Other|0|||
129019796|NCT03792477|464365259|FG003|Overall Study|Other|0|||
129019797|NCT03792477|464365260|FG004|Overall Study|Other|1|||
129019798|NCT01474551|464365261|FG000|Overall Study|Death|1|||
129019799|NCT01921062|464365262|FG000|Overall Study|Withdrawal by Subject|0|||
129019800|NCT01921062|464365263|FG001|Overall Study|Withdrawal by Subject|7|||
129019801|NCT01921062|464365262|FG000|Overall Study|Adverse Event|5|||
129019802|NCT01921062|464365263|FG001|Overall Study|Adverse Event|6|||
129019803|NCT01921062|464365262|FG000|Overall Study|Protocol Violation|0|||
128885377|NCT00820027|463875948|FG003|Overall Study|Protocol Violation|0|||
129019804|NCT01921062|464365263|FG001|Overall Study|Protocol Violation|1|||
128684203|NCT02414139|463142652|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
128684204|NCT02414139|463142653|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
128684205|NCT02414139|463142654|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
128684206|NCT02414139|463142655|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
128684207|NCT02414139|463142656|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
128684208|NCT02414139|463142657|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
128885378|NCT00820027|463875945|FG000|Overall Study|Withdrawal by Subject|6|||
128885379|NCT00820027|463875946|FG001|Overall Study|Withdrawal by Subject|4|||
128885380|NCT00820027|463875947|FG002|Overall Study|Withdrawal by Subject|4|||
128885381|NCT00820027|463875948|FG003|Overall Study|Withdrawal by Subject|6|||
128885382|NCT02604433|463875949|FG000|Overall Study|Withdrawal by Subject|37|||
128885383|NCT02604433|463875950|FG001|Overall Study|Withdrawal by Subject|16|||
128885384|NCT02604433|463875949|FG000|Overall Study|Adverse Event|4|||
128885385|NCT02604433|463875950|FG001|Overall Study|Adverse Event|0|||
128885386|NCT02604433|463875949|FG000|Overall Study|Other reasons|3|||
128885387|NCT02604433|463875950|FG001|Overall Study|Other reasons|5|||
128885388|NCT02604433|463875949|FG000|Overall Study|Death|4|||
128885389|NCT02604433|463875950|FG001|Overall Study|Death|1|||
128885390|NCT02604433|463875949|FG000|Overall Study|Transition to Rollover Protocol|169|||
128885391|NCT02604433|463875950|FG001|Overall Study|Transition to Rollover Protocol|82|||
128885392|NCT02604433|463875949|FG000|Overall Study|Physician Decision|1|||
128885393|NCT02604433|463875950|FG001|Overall Study|Physician Decision|1|||
128885394|NCT02604433|463875949|FG000|Overall Study|Lack of Efficacy|0|||
128885395|NCT02604433|463875950|FG001|Overall Study|Lack of Efficacy|1|||
128885396|NCT03437278|463875951|FG000|Overall Study|Adverse Event|0|||
128885397|NCT03437278|463875952|FG001|Overall Study|Adverse Event|0|||
128885398|NCT03437278|463875953|FG002|Overall Study|Adverse Event|1|||
128885399|NCT03437278|463875951|FG000|Overall Study|Progressive disease|1|||
128885400|NCT03437278|463875952|FG001|Overall Study|Progressive disease|0|||
129019805|NCT01921062|464365262|FG000|Overall Study|VMIQ score > 72|4|||
129019806|NCT01921062|464365263|FG001|Overall Study|VMIQ score > 72|1|||
129019807|NCT01921062|464365262|FG000|Overall Study|Logistic error|0|||
129019808|NCT01921062|464365263|FG001|Overall Study|Logistic error|1|||
129019809|NCT00576056|464365264|FG000|Overall Study|Adverse Event|1|||
129019810|NCT00576056|464365264|FG000|Overall Study|Death|1|||
129019811|NCT00576056|464365264|FG000|Overall Study|Lack of Efficacy|1|||
129019812|NCT00576056|464365264|FG000|Overall Study|Withdrawal by Subject|2|||
129019813|NCT00576056|464365264|FG000|Overall Study|did not meet eligibility criteria|8|||
129019814|NCT00576056|464365264|FG000|Overall Study|Physician Decision|1|||
129019815|NCT01854047|464365265|FG000|Overall Study|Lack of Efficacy|1|||
129019816|NCT01854047|464365266|FG001|Overall Study|Lack of Efficacy|0|||
129019817|NCT01854047|464365267|FG002|Overall Study|Lack of Efficacy|0|||
129019818|NCT01854047|464365268|FG003|Overall Study|Lack of Efficacy|0|||
129019819|NCT01854047|464365269|FG004|Overall Study|Lack of Efficacy|0|||
129019820|NCT01854047|464365265|FG000|Overall Study|Poor compliance to protocol|3|||
129019821|NCT01854047|464365266|FG001|Overall Study|Poor compliance to protocol|0|||
129019822|NCT01854047|464365267|FG002|Overall Study|Poor compliance to protocol|2|||
129019823|NCT01854047|464365268|FG003|Overall Study|Poor compliance to protocol|0|||
129019824|NCT01854047|464365269|FG004|Overall Study|Poor compliance to protocol|0|||
129019825|NCT01854047|464365265|FG000|Overall Study|Adverse Event|5|||
129019826|NCT01854047|464365266|FG001|Overall Study|Adverse Event|4|||
129019827|NCT01854047|464365267|FG002|Overall Study|Adverse Event|6|||
129019828|NCT01854047|464365268|FG003|Overall Study|Adverse Event|10|||
129019829|NCT01854047|464365269|FG004|Overall Study|Adverse Event|7|||
129019830|NCT01854047|464365265|FG000|Overall Study|Randomized but not treated|0|||
129019831|NCT01854047|464365266|FG001|Overall Study|Randomized but not treated|1|||
129019832|NCT01854047|464365267|FG002|Overall Study|Randomized but not treated|2|||
129019833|NCT01854047|464365268|FG003|Overall Study|Randomized but not treated|0|||
129019834|NCT01854047|464365269|FG004|Overall Study|Randomized but not treated|4|||
129019835|NCT01854047|464365265|FG000|Overall Study|Other than specified above|3|||
129019836|NCT01854047|464365266|FG001|Overall Study|Other than specified above|3|||
129019837|NCT01854047|464365267|FG002|Overall Study|Other than specified above|3|||
129019838|NCT01854047|464365268|FG003|Overall Study|Other than specified above|5|||
129019839|NCT01854047|464365269|FG004|Overall Study|Other than specified above|8|||
129019840|NCT03273153|464365270|FG000|Overall Study|Adverse Event|1|||
129019841|NCT03273153|464365271|FG001|Overall Study|Adverse Event|2|||
129019842|NCT03273153|464365270|FG000|Overall Study|Missing|0|||
128885401|NCT03437278|463875953|FG002|Overall Study|Progressive disease|0|||
128885402|NCT03437278|463875951|FG000|Overall Study|Physician Decision|1|||
129019843|NCT03273153|464365271|FG001|Overall Study|Missing|2|||
129019844|NCT03273153|464365270|FG000|Overall Study|Other|3|||
129019845|NCT03273153|464365271|FG001|Overall Study|Other|2|||
129019846|NCT03273153|464365270|FG000|Overall Study|Symptomatic Deterioration|0|||
129019847|NCT03273153|464365271|FG001|Overall Study|Symptomatic Deterioration|1|||
129019848|NCT03273153|464365270|FG000|Overall Study|Progressive Disease|6|||
128885403|NCT03437278|463875952|FG001|Overall Study|Physician Decision|0|||
128885404|NCT03437278|463875953|FG002|Overall Study|Physician Decision|1|||
128885405|NCT02202551|463875954|FG000|Overall Study|Adverse Event|8|||
129215145|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
129215146|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
129215147|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
129215148|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
129215149|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
129215150|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
129215151|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
129215152|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
129215153|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
129215154|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
129215155|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
129215156|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
129215157|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
129215158|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
129215159|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
129215160|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
129215161|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
129215162|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
129215163|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
129215164|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
129107906|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
129107907|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
129107908|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
129107909|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
129107910|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
129107911|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
129107912|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
129107913|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
129107914|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
129107915|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
129107916|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
129107917|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
129107918|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
129107919|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
129107920|NCT00105989|464689858|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
129107921|NCT00105989|464689859|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
129107922|NCT03442088|464689860|FG000|Overall Study|Adverse Event|1|||
129107923|NCT03442088|464689860|FG000|Overall Study|Lack of Efficacy|2|||
129107924|NCT03442088|464689860|FG000|Overall Study|Lost to Follow-up|2|||
129107925|NCT00357877|464689861|FG000|Overall Study|Death|2|||
129107926|NCT00357877|464689862|FG001|Overall Study|Death|1|||
129107927|NCT00357877|464689861|FG000|Overall Study|Lost to Follow-up|20|||
129107928|NCT00357877|464689862|FG001|Overall Study|Lost to Follow-up|23|||
129107929|NCT00357877|464689861|FG000|Overall Study|Withdrawal by Subject|3|||
129107930|NCT00357877|464689862|FG001|Overall Study|Withdrawal by Subject|3|||
129107931|NCT00357877|464689861|FG000|Overall Study|Administrative withdrawal|1|||
129107932|NCT00357877|464689862|FG001|Overall Study|Administrative withdrawal|1|||
129107933|NCT00357877|464689861|FG000|Overall Study|Other|0|||
129107934|NCT00357877|464689862|FG001|Overall Study|Other|2|||
129107935|NCT04668209|464689863|FG000|Overall Study|Withdrawal by Subject|2|||
129107936|NCT04668209|464689864|FG001|Overall Study|Withdrawal by Subject|2|||
129107937|NCT04668209|464689863|FG000|Overall Study|Lost to Follow-up|3|||
129107938|NCT04668209|464689864|FG001|Overall Study|Lost to Follow-up|4|||
129107939|NCT04668209|464689863|FG000|Overall Study|Subject Expired|2|||
129107940|NCT04668209|464689864|FG001|Overall Study|Subject Expired|0|||
129107941|NCT04668209|464689863|FG000|Overall Study|Withdrawn from study|0|||
129107942|NCT04668209|464689864|FG001|Overall Study|Withdrawn from study|1|||
129107943|NCT04668209|464689863|FG000|Overall Study|Adverse Event|0|||
129107944|NCT04668209|464689864|FG001|Overall Study|Adverse Event|1|||
129107945|NCT01869777|464689871|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
129107946|NCT00613366|464689874|FG000|Overall Study|Withdrawal by Subject|3|||
129107947|NCT00613366|464689875|FG001|Overall Study|Withdrawal by Subject|2|||
129107948|NCT00766597|464689876|FG000|Overall Study|Unexpected closure of study|4|||
129107949|NCT00766597|464689876|FG000|Overall Study|Without CCR5-tropic virus|5|||
129107950|NCT01135524|464689880|FG000|Overall Study|Withdrawal by Subject|14|||
129107951|NCT01135524|464689880|FG000|Overall Study|Adverse Event|20|||
129107952|NCT01135524|464689880|FG000|Overall Study|Lost to Follow-up|3|||
129107953|NCT01135524|464689880|FG000|Overall Study|Administrative|151|||
129215165|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
129215166|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
129215167|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
129107954|NCT01135524|464689880|FG000|Overall Study|Lack of Efficacy|8|||
128885406|NCT02202551|463875955|FG001|Overall Study|Adverse Event|19|||
128885407|NCT02202551|463875956|FG002|Overall Study|Adverse Event|5|||
128885408|NCT02202551|463875957|FG003|Overall Study|Adverse Event|9|||
128885409|NCT02202551|463875954|FG000|Overall Study|Death|3|||
129107955|NCT03318003|464689881|FG000|Overall Study|Withdrawal by Subject|1|||
129107956|NCT03318003|464689882|FG001|Overall Study|Withdrawal by Subject|1|||
129107957|NCT03318003|464689881|FG000|Overall Study|fetal loss|0|||
129107958|NCT03318003|464689882|FG001|Overall Study|fetal loss|1|||
129107959|NCT02907463|464689884|FG000|Overall Study|Lost to Follow-up|17|||
129107960|NCT02907463|464689884|FG000|Overall Study|Death|10|||
129107961|NCT02907463|464689884|FG000|Overall Study|Withdrawal by Subject|4|||
129107962|NCT02907463|464689884|FG000|Overall Study|MIS Approach was not used|2|||
129107963|NCT02907463|464689884|FG000|Overall Study|Not Implanted with Study Device|2|||
129107964|NCT02907463|464689884|FG000|Overall Study|Device Explanted|1|||
129107965|NCT02907463|464689884|FG000|Overall Study|Missing Exit Form|1|||
129107966|NCT01266824|464689885|FG000|Overall Study|Study terminated prior to completion|2|||
129107967|NCT01266824|464689886|FG001|Overall Study|Study terminated prior to completion|3|||
129107968|NCT00411450|464689887|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
129107969|NCT01716663|464689888|FG000|Overall Study|Withdrawn prior to procedure|4|||
129107970|NCT01716663|464689888|FG000|Overall Study|Treated with non-study catheter|2|||
129107971|NCT03006562|464689891|FG000|Overall Study|Lost to Follow-up|0|||
129107972|NCT03006562|464689892|FG001|Overall Study|Lost to Follow-up|1|||
129107973|NCT00614874|464689893|FG000|Overall Study|Protocol Violation|1|||
128684209|NCT02414139|463142658|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
128684210|NCT02414139|463142659|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
128684211|NCT02414139|463142660|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
128684212|NCT02414139|463142651|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
128684213|NCT02414139|463142652|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
129107974|NCT00614874|464689893|FG000|Overall Study|Withdrawal by Subject|1|||
129107975|NCT00511810|464689895|FG000|Overall Study|Lost to Follow-up|1|||
129107976|NCT00511810|464689896|FG001|Overall Study|Lost to Follow-up|2|||
129107977|NCT00511810|464689895|FG000|Overall Study|Lack of Efficacy|0|||
129107978|NCT00511810|464689896|FG001|Overall Study|Lack of Efficacy|2|||
129107979|NCT00511810|464689895|FG000|Overall Study|Refused second scn|0|||
129107980|NCT00511810|464689896|FG001|Overall Study|Refused second scn|1|||
129107981|NCT02427841|464689897|FG000|Overall Study|Lack of Efficacy|5|||
129107982|NCT02427841|464689897|FG000|Overall Study|Physician Decision|2|||
129107983|NCT02427841|464689897|FG000|Overall Study|Withdrawal by Subject|1|||
129107984|NCT02028507|464689900|FG000|Overall Study|Progressive Disease|122|||
129107985|NCT02028507|464689901|FG001|Overall Study|Progressive Disease|90|||
129107986|NCT02028507|464689902|FG002|Overall Study|Progressive Disease|102|||
129107987|NCT02028507|464689903|FG003|Overall Study|Progressive Disease|89|||
129107988|NCT02028507|464689900|FG000|Overall Study|Adverse Event|8|||
129107989|NCT02028507|464689901|FG001|Overall Study|Adverse Event|25|||
129107990|NCT02028507|464689902|FG002|Overall Study|Adverse Event|3|||
129107991|NCT02028507|464689903|FG003|Overall Study|Adverse Event|16|||
129107992|NCT02028507|464689900|FG000|Overall Study|Withdrawal by Subject|6|||
129107993|NCT02028507|464689901|FG001|Overall Study|Withdrawal by Subject|8|||
129107994|NCT02028507|464689902|FG002|Overall Study|Withdrawal by Subject|5|||
129107995|NCT02028507|464689903|FG003|Overall Study|Withdrawal by Subject|9|||
129107996|NCT02028507|464689900|FG000|Overall Study|Protocol Violation|2|||
129107997|NCT02028507|464689901|FG001|Overall Study|Protocol Violation|4|||
129107998|NCT02028507|464689902|FG002|Overall Study|Protocol Violation|1|||
129107999|NCT02028507|464689903|FG003|Overall Study|Protocol Violation|3|||
129108000|NCT02028507|464689900|FG000|Overall Study|Physician Decision|0|||
129108001|NCT02028507|464689901|FG001|Overall Study|Physician Decision|4|||
129108002|NCT02028507|464689902|FG002|Overall Study|Physician Decision|0|||
129108003|NCT02028507|464689903|FG003|Overall Study|Physician Decision|0|||
129108004|NCT02028507|464689900|FG000|Overall Study|Death|1|||
129108005|NCT02028507|464689901|FG001|Overall Study|Death|0|||
129108006|NCT02028507|464689902|FG002|Overall Study|Death|1|||
129108007|NCT02028507|464689903|FG003|Overall Study|Death|3|||
129108008|NCT02028507|464689900|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
129108009|NCT02028507|464689901|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
129108010|NCT02028507|464689902|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
129108011|NCT02028507|464689903|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
129108012|NCT02028507|464689900|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
128684214|NCT02414139|463142653|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
129108013|NCT02028507|464689901|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
129108014|NCT02028507|464689902|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
128684215|NCT02414139|463142654|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
128885410|NCT02202551|463875955|FG001|Overall Study|Death|2|||
129108015|NCT02028507|464689903|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
129108016|NCT02028507|464689900|FG000|Overall Study|Randomized But Not Treated|3|||
129108017|NCT02028507|464689901|FG001|Overall Study|Randomized But Not Treated|6|||
129108018|NCT02028507|464689902|FG002|Overall Study|Randomized But Not Treated|0|||
129108019|NCT02028507|464689903|FG003|Overall Study|Randomized But Not Treated|4|||
129108020|NCT02028507|464689900|FG000|Overall Study|Enzyme defect|0|||
129108021|NCT02028507|464689901|FG001|Overall Study|Enzyme defect|0|||
129108022|NCT02028507|464689902|FG002|Overall Study|Enzyme defect|0|||
129108023|NCT02028507|464689903|FG003|Overall Study|Enzyme defect|1|||
129108024|NCT02028507|464689900|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
129108025|NCT02028507|464689901|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
129108026|NCT02028507|464689902|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
129108027|NCT02028507|464689903|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
129108028|NCT02028507|464689900|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
129108029|NCT02028507|464689901|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
129108030|NCT02028507|464689902|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
129108031|NCT02028507|464689903|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
129108032|NCT01502033|464689905|FG000|Overall Study|1 participant had scalp discomfort|1|||
129108033|NCT01502033|464689905|FG000|Overall Study|1 participant had worsening depression|1|||
129108034|NCT01502033|464689905|FG000|Overall Study|1 participant went back to school|1|||
129108035|NCT01808261|464689906|FG000|Overall Study|Physician Decision|0|||
129108036|NCT01808261|464689907|FG001|Overall Study|Physician Decision|2|||
129108037|NCT01808261|464689906|FG000|Overall Study|Study Closed/Terminated|25|||
129108038|NCT01808261|464689907|FG001|Overall Study|Study Closed/Terminated|23|||
129108039|NCT01808261|464689906|FG000|Overall Study|Adverse event, non-fatal|2|||
129108040|NCT01808261|464689907|FG001|Overall Study|Adverse event, non-fatal|0|||
129108041|NCT01808261|464689906|FG000|Overall Study|Consent withdrawn by subject|6|||
129108042|NCT01808261|464689907|FG001|Overall Study|Consent withdrawn by subject|7|||
129108043|NCT01808261|464689906|FG000|Overall Study|Lost to Follow-up|3|||
129108044|NCT01808261|464689907|FG001|Overall Study|Lost to Follow-up|1|||
129108045|NCT02797678|464689930|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
129108046|NCT02797678|464689931|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
129108047|NCT02797678|464689932|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
129108048|NCT02797678|464689933|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
129108049|NCT02797678|464689930|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
129108050|NCT02797678|464689931|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
129108051|NCT02797678|464689932|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
129108052|NCT02797678|464689933|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
129108053|NCT02797678|464689930|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
129108054|NCT02797678|464689931|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
129108055|NCT02797678|464689932|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
129108056|NCT02797678|464689933|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
129108057|NCT02401035|464689934|FG000|Overall Study|Withdrawal by Subject|1|||
129108058|NCT02401035|464689935|FG001|Overall Study|Withdrawal by Subject|0|||
129108059|NCT03046953|464689937|FG000|Overall Study|Relapse/progressive disease|21|||
129108060|NCT03046953|464689937|FG000|Overall Study|Death|2|||
129108061|NCT03046953|464689937|FG000|Overall Study|Withdrawal by Subject|3|||
129108062|NCT04039204|464689938|FG000|Overall Study|Withdrawal by Subject|0|||
129108063|NCT04039204|464689939|FG001|Overall Study|Withdrawal by Subject|2|||
129108064|NCT01189461|464689940|FG000|Overall Study|Lack of Efficacy|13|||
129108065|NCT01189461|464689940|FG000|Overall Study|Lost to Follow-up|1|||
129108066|NCT01189461|464689940|FG000|Overall Study|Withdrawal by Subject|6|||
129108067|NCT01189461|464689940|FG000|Overall Study|Protocol Violation|1|||
129108068|NCT01189461|464689940|FG000|Overall Study|Adverse Event|2|||
129108069|NCT01189461|464689940|FG000|Overall Study|Did not meet entrance criteria|3|||
129108070|NCT01189461|464689940|FG000|Overall Study|Other|8|||
129108071|NCT00656175|464689942|FG000|Overall Study|Adverse Event|1|||
129108072|NCT00656175|464689943|FG001|Overall Study|Adverse Event|0|||
129108073|NCT00656175|464689942|FG000|Overall Study|Transportation issues|0|||
129108074|NCT00656175|464689943|FG001|Overall Study|Transportation issues|1|||
129108075|NCT01066871|464689956|FG000|Overall Study|Lost to Follow-up|0|||
129108076|NCT01066871|464689957|FG001|Overall Study|Lost to Follow-up|2|||
129108077|NCT01066871|464689958|FG002|Overall Study|Lost to Follow-up|2|||
129108078|NCT01066871|464689959|FG003|Overall Study|Lost to Follow-up|0|||
129108079|NCT01066871|464689956|FG000|Overall Study|Protocol Violation|1|||
129108080|NCT01066871|464689957|FG001|Overall Study|Protocol Violation|0|||
129108081|NCT01066871|464689958|FG002|Overall Study|Protocol Violation|3|||
129108082|NCT01066871|464689959|FG003|Overall Study|Protocol Violation|2|||
129108083|NCT01066871|464689956|FG000|Overall Study|Lack of Efficacy|0|||
129108084|NCT01066871|464689957|FG001|Overall Study|Lack of Efficacy|0|||
129108085|NCT01066871|464689958|FG002|Overall Study|Lack of Efficacy|0|||
129108086|NCT01066871|464689959|FG003|Overall Study|Lack of Efficacy|1|||
129108087|NCT01066871|464689956|FG000|Overall Study|Withdrawal by Subject|3|||
129108088|NCT01066871|464689957|FG001|Overall Study|Withdrawal by Subject|1|||
129108089|NCT01066871|464689958|FG002|Overall Study|Withdrawal by Subject|0|||
129108090|NCT01066871|464689959|FG003|Overall Study|Withdrawal by Subject|0|||
128885411|NCT02202551|463875956|FG002|Overall Study|Death|1|||
128885412|NCT02202551|463875957|FG003|Overall Study|Death|1|||
128885413|NCT02202551|463875954|FG000|Overall Study|Lost to Follow-up|0|||
128885414|NCT02202551|463875955|FG001|Overall Study|Lost to Follow-up|1|||
128885415|NCT02202551|463875956|FG002|Overall Study|Lost to Follow-up|0|||
128885416|NCT02202551|463875957|FG003|Overall Study|Lost to Follow-up|1|||
128885417|NCT02202551|463875954|FG000|Overall Study|Needed to take excluded medication|0|||
128885418|NCT02202551|463875955|FG001|Overall Study|Needed to take excluded medication|2|||
128885419|NCT02202551|463875956|FG002|Overall Study|Needed to take excluded medication|0|||
128885420|NCT02202551|463875957|FG003|Overall Study|Needed to take excluded medication|1|||
128885421|NCT02202551|463875954|FG000|Overall Study|Subject moved away|0|||
128885422|NCT02202551|463875955|FG001|Overall Study|Subject moved away|1|||
128885423|NCT02202551|463875956|FG002|Overall Study|Subject moved away|0|||
128885424|NCT02202551|463875957|FG003|Overall Study|Subject moved away|0|||
128885425|NCT02202551|463875954|FG000|Overall Study|DBS surgery|3|||
128885426|NCT02202551|463875955|FG001|Overall Study|DBS surgery|0|||
128885427|NCT02202551|463875956|FG002|Overall Study|DBS surgery|0|||
128885428|NCT02202551|463875957|FG003|Overall Study|DBS surgery|0|||
128885429|NCT02202551|463875954|FG000|Overall Study|Dyskinesia upon taper|1|||
128885430|NCT02202551|463875955|FG001|Overall Study|Dyskinesia upon taper|0|||
128885431|NCT02202551|463875956|FG002|Overall Study|Dyskinesia upon taper|0|||
128885432|NCT02202551|463875957|FG003|Overall Study|Dyskinesia upon taper|0|||
128885433|NCT02202551|463875954|FG000|Overall Study|Lack of Efficacy|0|||
128885434|NCT02202551|463875955|FG001|Overall Study|Lack of Efficacy|1|||
128885435|NCT02202551|463875956|FG002|Overall Study|Lack of Efficacy|0|||
128885436|NCT02202551|463875957|FG003|Overall Study|Lack of Efficacy|0|||
128885437|NCT02202551|463875954|FG000|Overall Study|Physician Decision|1|||
128885438|NCT02202551|463875955|FG001|Overall Study|Physician Decision|0|||
128885439|NCT02202551|463875956|FG002|Overall Study|Physician Decision|0|||
128885440|NCT02202551|463875957|FG003|Overall Study|Physician Decision|0|||
128885441|NCT02202551|463875954|FG000|Overall Study|Site closure|3|||
128885442|NCT02202551|463875955|FG001|Overall Study|Site closure|0|||
128885443|NCT02202551|463875956|FG002|Overall Study|Site closure|0|||
128885444|NCT02202551|463875957|FG003|Overall Study|Site closure|1|||
128885445|NCT02202551|463875954|FG000|Overall Study|Unable to complete visits per protocol|1|||
128885446|NCT02202551|463875955|FG001|Overall Study|Unable to complete visits per protocol|0|||
128885447|NCT02202551|463875956|FG002|Overall Study|Unable to complete visits per protocol|0|||
128885448|NCT02202551|463875957|FG003|Overall Study|Unable to complete visits per protocol|0|||
128885449|NCT02202551|463875954|FG000|Overall Study|Worsening Dyskinesia|0|||
128885450|NCT02202551|463875955|FG001|Overall Study|Worsening Dyskinesia|0|||
128885451|NCT02202551|463875956|FG002|Overall Study|Worsening Dyskinesia|0|||
128885452|NCT02202551|463875957|FG003|Overall Study|Worsening Dyskinesia|1|||
128885453|NCT02202551|463875954|FG000|Overall Study|Protocol Violation|0|||
128885454|NCT02202551|463875955|FG001|Overall Study|Protocol Violation|1|||
128885455|NCT02202551|463875956|FG002|Overall Study|Protocol Violation|0|||
128885456|NCT02202551|463875957|FG003|Overall Study|Protocol Violation|0|||
128885457|NCT02202551|463875954|FG000|Overall Study|Sponsor's decision|2|||
128885458|NCT02202551|463875955|FG001|Overall Study|Sponsor's decision|0|||
128885459|NCT02202551|463875956|FG002|Overall Study|Sponsor's decision|0|||
128885460|NCT02202551|463875957|FG003|Overall Study|Sponsor's decision|0|||
128885461|NCT02202551|463875954|FG000|Overall Study|Subject unwilling to proceed|1|||
128885462|NCT02202551|463875955|FG001|Overall Study|Subject unwilling to proceed|5|||
128885463|NCT02202551|463875956|FG002|Overall Study|Subject unwilling to proceed|3|||
128885464|NCT02202551|463875957|FG003|Overall Study|Subject unwilling to proceed|5|||
128885465|NCT02202551|463875954|FG000|Overall Study|Subject consent withdrawn|0|||
128885466|NCT02202551|463875955|FG001|Overall Study|Subject consent withdrawn|3|||
128885467|NCT02202551|463875956|FG002|Overall Study|Subject consent withdrawn|1|||
129019849|NCT03273153|464365271|FG001|Overall Study|Progressive Disease|5|||
129019850|NCT03273153|464365270|FG000|Overall Study|Physician Decision|1|||
129019851|NCT03273153|464365271|FG001|Overall Study|Physician Decision|3|||
129019852|NCT03273153|464365270|FG000|Overall Study|Study Terminated by Sponsor|112|||
129019853|NCT03273153|464365271|FG001|Overall Study|Study Terminated by Sponsor|102|||
129019854|NCT03273153|464365270|FG000|Overall Study|Withdrawal by Subject|26|||
129019855|NCT03273153|464365271|FG001|Overall Study|Withdrawal by Subject|25|||
129019856|NCT03273153|464365270|FG000|Overall Study|Protocol Deviation|3|||
129019857|NCT03273153|464365271|FG001|Overall Study|Protocol Deviation|0|||
129019858|NCT03273153|464365270|FG000|Overall Study|Lost to Follow-up|6|||
129019859|NCT03273153|464365271|FG001|Overall Study|Lost to Follow-up|11|||
129019860|NCT03273153|464365270|FG000|Overall Study|Death|66|||
129019861|NCT03273153|464365271|FG001|Overall Study|Death|69|||
129019862|NCT05323396|464365272|FG000|Overall Study|Lost to Follow-up|1|||
129019863|NCT05323396|464365273|FG001|Overall Study|Lost to Follow-up|35|||
128885468|NCT02202551|463875957|FG003|Overall Study|Subject consent withdrawn|2|||
128885469|NCT02202551|463875954|FG000|Overall Study|eGFR<50mL/min/m2|2|||
128885470|NCT02202551|463875955|FG001|Overall Study|eGFR<50mL/min/m2|2|||
128885471|NCT02202551|463875956|FG002|Overall Study|eGFR<50mL/min/m2|0|||
128885472|NCT02202551|463875957|FG003|Overall Study|eGFR<50mL/min/m2|1|||
128885473|NCT02349360|463875960|FG000|Overall Study|Withdrawal by Subject|0|||
128684216|NCT02414139|463142655|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
128684217|NCT02414139|463142656|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
128684218|NCT02414139|463142657|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
128684219|NCT02414139|463142658|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
128684220|NCT02414139|463142659|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
128684221|NCT02414139|463142660|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
128684222|NCT02414139|463142651|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
128684223|NCT02414139|463142652|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
128684224|NCT02414139|463142653|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
128684225|NCT02414139|463142654|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
128684226|NCT02414139|463142655|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129108091|NCT01066871|464689956|FG000|Overall Study|Other|0|||
129108092|NCT01066871|464689957|FG001|Overall Study|Other|2|||
129108093|NCT01066871|464689958|FG002|Overall Study|Other|1|||
129108094|NCT01066871|464689959|FG003|Overall Study|Other|2|||
129108095|NCT04162795|464689960|FG000|Overall Study|Other|16|||
129108096|NCT04162795|464689960|FG000|Overall Study|Screen failures|10|||
129108097|NCT05259163|464691743|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
129108098|NCT05259163|464691744|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
129108099|NCT01381926|464691747|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
129108100|NCT01381926|464691748|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
129108101|NCT01381926|464691747|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
129108102|NCT01381926|464691748|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
129108103|NCT02624947|464691749|FG000|Maternal Participants|Adverse Event|5|||
129108104|NCT02624947|464691750|FG001|Maternal Participants|Adverse Event|0|||
129108105|NCT02624947|464691749|FG000|Maternal Participants|Investigator Decision|5|||
129108106|NCT02624947|464691750|FG001|Maternal Participants|Investigator Decision|3|||
129108107|NCT02624947|464691749|FG000|Maternal Participants|Lost to Follow-up|54|||
129108108|NCT02624947|464691750|FG001|Maternal Participants|Lost to Follow-up|24|||
129108109|NCT02624947|464691749|FG000|Maternal Participants|Non Compliance|8|||
129108110|NCT02624947|464691750|FG001|Maternal Participants|Non Compliance|5|||
129108111|NCT02624947|464691749|FG000|Maternal Participants|Sponsor Request|1|||
129108112|NCT02624947|464691750|FG001|Maternal Participants|Sponsor Request|1|||
129108113|NCT02624947|464691749|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
129108114|NCT02624947|464691750|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
129108115|NCT02624947|464691749|FG000|Maternal Participants|Miscellaneous|23|||
129108116|NCT02624947|464691750|FG001|Maternal Participants|Miscellaneous|15|||
129108117|NCT02624947|464691749|FG000|Infant Participants|Adverse Event|18|||
129108118|NCT02624947|464691750|FG001|Infant Participants|Adverse Event|11|||
129108119|NCT02624947|464691749|FG000|Infant Participants|Investigator Decision|5|||
129108120|NCT02624947|464691750|FG001|Infant Participants|Investigator Decision|4|||
129108121|NCT02624947|464691749|FG000|Infant Participants|Lost to Follow-up|93|||
129108122|NCT02624947|464691750|FG001|Infant Participants|Lost to Follow-up|58|||
129108123|NCT02624947|464691749|FG000|Infant Participants|Non Compliance|17|||
129108124|NCT02624947|464691750|FG001|Infant Participants|Non Compliance|7|||
129108125|NCT02624947|464691749|FG000|Infant Participants|Sponsor Request|0|||
129108126|NCT02624947|464691750|FG001|Infant Participants|Sponsor Request|1|||
129108127|NCT02624947|464691749|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
129108128|NCT02624947|464691750|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
129108129|NCT02624947|464691749|FG000|Infant Participants|Miscellaneous|50|||
129108130|NCT02624947|464691750|FG001|Infant Participants|Miscellaneous|26|||
129108131|NCT01971567|464691764|FG000|Overall Study|Withdrawal by Subject|3|||
129108132|NCT01971567|464691765|FG001|Overall Study|Withdrawal by Subject|2|||
129108133|NCT01971567|464691764|FG000|Overall Study|Lost to Follow-up|1|||
129108134|NCT01971567|464691765|FG001|Overall Study|Lost to Follow-up|0|||
128684227|NCT02414139|463142656|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129019864|NCT05323396|464365272|FG000|Overall Study|Pregnancy|1|||
129019865|NCT05323396|464365273|FG001|Overall Study|Pregnancy|0|||
129019866|NCT04646213|464365274|FG000|Overall Study|Physician Decision|3|||
129019867|NCT04646213|464365274|FG000|Overall Study|Withdrawal by Subject|2|||
129019868|NCT00415363|464365279|FG000|Overall Study|Withdrawal by Subject|4|||
129019869|NCT00415363|464365280|FG001|Overall Study|Withdrawal by Subject|4|||
129019870|NCT00415363|464365279|FG000|Overall Study|Adverse Event|4|||
129019871|NCT00415363|464365280|FG001|Overall Study|Adverse Event|4|||
129019872|NCT00415363|464365279|FG000|Overall Study|Lost to Follow-up|2|||
129019873|NCT00415363|464365280|FG001|Overall Study|Lost to Follow-up|1|||
129019874|NCT00415363|464365279|FG000|Overall Study|Physician Decision|3|||
129019875|NCT00415363|464365280|FG001|Overall Study|Physician Decision|1|||
129019876|NCT00415363|464365279|FG000|Overall Study|Death|16|||
129019877|NCT00415363|464365280|FG001|Overall Study|Death|12|||
129108135|NCT01409915|464691766|FG000|Overall Study|Adverse Event|0|||
129108136|NCT01409915|464691767|FG001|Overall Study|Adverse Event|2|||
128885474|NCT02349360|463875961|FG001|Overall Study|Withdrawal by Subject|1|||
128885475|NCT01176773|463875962|FG000|Overall Study|Screen Failure|2|||
128885476|NCT01176773|463875962|FG000|Overall Study|Withdrew consent|1|||
128885477|NCT00752622|463875990|FG000|Induction Phase|Adverse Event|3|||
128885478|NCT00752622|463875990|FG000|Induction Phase|Other|3|||
128885479|NCT00752622|463875990|FG000|Induction Phase|Non-responder|14|||
128885480|NCT00752622|463875990|FG000|Induction Phase|Withdrawal by Subject|1|||
128885481|NCT00752622|463875990|FG000|Induction Phase|Premature study termination|14|||
128885482|NCT00752622|463875990|FG000|Observational Phase|Premature Study Termination|36|||
128885483|NCT00752622|463875990|FG000|Observational Phase|Non-responder|2|||
128885484|NCT00752622|463875990|FG000|Observational Phase|Withdrawal by Subject|2|||
128885485|NCT00752622|463875990|FG000|Observational Phase|Adverse Event|1|||
128885486|NCT00752622|463875990|FG000|Observational Phase|Other|2|||
128885487|NCT00752622|463875990|FG000|Interventional Phase|Non-responder|2|||
128885488|NCT00752622|463875990|FG000|Interventional Phase|Physician Decision|1|||
128885489|NCT00752622|463875990|FG000|Interventional Phase|Premature Study Termination|5|||
128885490|NCT00576836|463875991|FG000|Overall Study|Death|0|||
128885491|NCT00576836|463875992|FG001|Overall Study|Death|1|||
128885492|NCT00576836|463875991|FG000|Overall Study|Physician Decision|0|||
128885493|NCT00576836|463875992|FG001|Overall Study|Physician Decision|1|||
128885494|NCT00894686|463875993|FG000|Overall Study|Withdrawal by Subject|50|||
128885495|NCT00894686|463875993|FG000|Overall Study|Physician Decision|1|||
128885496|NCT00894686|463875993|FG000|Overall Study|Other|5|||
128885497|NCT03267940|463875996|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
128885498|NCT03267940|463875997|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
128885499|NCT03267940|463875998|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
128885500|NCT03267940|463875999|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
128885501|NCT03267940|463876000|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
128885502|NCT03267940|463876001|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
128885503|NCT03267940|463875996|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
128885504|NCT03267940|463875997|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
128885505|NCT03267940|463875998|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
128885506|NCT03267940|463875999|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
128885507|NCT03267940|463876000|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
128885508|NCT03267940|463876001|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
128885509|NCT03267940|463875996|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
128885510|NCT03267940|463875997|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
128885511|NCT03267940|463875998|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
128885512|NCT03267940|463875999|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
128885513|NCT03267940|463876000|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
128885514|NCT03267940|463876001|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
128885515|NCT03267940|463875996|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
128885516|NCT03267940|463875997|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
128885517|NCT03267940|463875998|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
128885518|NCT03267940|463875999|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
128885519|NCT03267940|463876000|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
128885520|NCT03267940|463876001|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
128885521|NCT03267940|463875996|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
128885522|NCT03267940|463875997|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
128885523|NCT03267940|463875998|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
128885524|NCT03267940|463875999|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
128885525|NCT03267940|463876000|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
128885526|NCT03267940|463876001|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
128885527|NCT03267940|463875996|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
128885528|NCT03267940|463875997|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
128885529|NCT03267940|463875998|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
128885530|NCT03267940|463875999|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
128885531|NCT03267940|463876000|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
128885532|NCT03267940|463876001|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
128885533|NCT03267940|463875996|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
128885534|NCT03267940|463875997|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
128885535|NCT03267940|463875998|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
129019878|NCT00415363|464365279|FG000|Overall Study|Progressive disease|26|||
129019879|NCT00415363|464365280|FG001|Overall Study|Progressive disease|32|||
129019880|NCT00095212|464365281|FG000|Overall Study|Withdrawal by Subject|1|||
129019881|NCT00095212|464365282|FG001|Overall Study|Withdrawal by Subject|3|||
129019882|NCT05341622|464365283|FG000|Overall Study|Death|0|||
129019883|NCT05341622|464365284|FG001|Overall Study|Death|0|||
128684228|NCT02414139|463142657|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
128684229|NCT02414139|463142658|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
128684230|NCT02414139|463142659|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
128684231|NCT02414139|463142660|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
128684232|NCT02414139|463142651|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
128684233|NCT02414139|463142652|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
128684234|NCT02414139|463142653|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
128684235|NCT02414139|463142654|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
128684236|NCT02414139|463142655|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
128684237|NCT02414139|463142656|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
128684238|NCT02414139|463142657|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
128684239|NCT02414139|463142658|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
128684240|NCT02414139|463142659|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
128684241|NCT02414139|463142660|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
128684242|NCT01017575|463142664|FG000|Overall Study|Lack of Efficacy|0|||
128684243|NCT01017575|463142665|FG001|Overall Study|Lack of Efficacy|1|||
128684244|NCT01017575|463142666|FG002|Overall Study|Lack of Efficacy|0|||
128684245|NCT01017575|463142667|FG003|Overall Study|Lack of Efficacy|1|||
128684246|NCT01017575|463142668|FG004|Overall Study|Lack of Efficacy|1|||
128684247|NCT01017575|463142664|FG000|Overall Study|Adverse Event|0|||
128684248|NCT01017575|463142665|FG001|Overall Study|Adverse Event|1|||
128684249|NCT01017575|463142666|FG002|Overall Study|Adverse Event|0|||
128684250|NCT01017575|463142667|FG003|Overall Study|Adverse Event|0|||
128684251|NCT01017575|463142668|FG004|Overall Study|Adverse Event|2|||
128684252|NCT01017575|463142664|FG000|Overall Study|Withdrawal by Subject|1|||
128684253|NCT01017575|463142665|FG001|Overall Study|Withdrawal by Subject|0|||
128684254|NCT01017575|463142666|FG002|Overall Study|Withdrawal by Subject|0|||
128684255|NCT01017575|463142667|FG003|Overall Study|Withdrawal by Subject|0|||
128684256|NCT01017575|463142668|FG004|Overall Study|Withdrawal by Subject|0|||
128684257|NCT04271280|463142669|FG000|Overall Study|Lost to Follow-up|300|||
128684258|NCT04271280|463142669|FG000|Overall Study|Death|153|||
128684259|NCT04271280|463142669|FG000|Overall Study|Withdrawal of consent by patient|59|||
128684260|NCT04271280|463142669|FG000|Overall Study|Other|51|||
128684261|NCT04271280|463142669|FG000|Overall Study|No end of study information|42|||
128684262|NCT01857583|463142672|FG000|Overall Study|Adverse Event|0|||
128684263|NCT01857583|463142673|FG001|Overall Study|Adverse Event|0|||
128684264|NCT01857583|463142674|FG002|Overall Study|Adverse Event|1|||
128684265|NCT01857583|463142675|FG003|Overall Study|Adverse Event|1|||
128684266|NCT01857583|463142672|FG000|Overall Study|Death|0|||
128684267|NCT01857583|463142673|FG001|Overall Study|Death|1|||
128684268|NCT01857583|463142674|FG002|Overall Study|Death|1|||
128684269|NCT01857583|463142675|FG003|Overall Study|Death|0|||
128684270|NCT01857583|463142672|FG000|Overall Study|Physician Decision|0|||
128684271|NCT01857583|463142673|FG001|Overall Study|Physician Decision|0|||
128684272|NCT01857583|463142674|FG002|Overall Study|Physician Decision|0|||
128684273|NCT01857583|463142675|FG003|Overall Study|Physician Decision|1|||
128684274|NCT01857583|463142672|FG000|Overall Study|Withdrawal by Subject|1|||
128684275|NCT01857583|463142673|FG001|Overall Study|Withdrawal by Subject|0|||
128684276|NCT01857583|463142674|FG002|Overall Study|Withdrawal by Subject|1|||
129019884|NCT05341622|464365285|FG002|Overall Study|Death|0|||
129019885|NCT05341622|464365286|FG003|Overall Study|Death|0|||
129019886|NCT05341622|464365287|FG004|Overall Study|Death|1|||
129019887|NCT05341622|464365288|FG005|Overall Study|Death|0|||
129019888|NCT05341622|464365289|FG006|Overall Study|Death|0|||
129019889|NCT05341622|464365290|FG007|Overall Study|Death|1|||
129019890|NCT05341622|464365283|FG000|Overall Study|Invalid Address|0|||
129019891|NCT05341622|464365284|FG001|Overall Study|Invalid Address|1|||
129019892|NCT05341622|464365285|FG002|Overall Study|Invalid Address|0|||
129019893|NCT05341622|464365286|FG003|Overall Study|Invalid Address|0|||
129019894|NCT05341622|464365287|FG004|Overall Study|Invalid Address|0|||
129019895|NCT05341622|464365288|FG005|Overall Study|Invalid Address|0|||
129019896|NCT05341622|464365289|FG006|Overall Study|Invalid Address|0|||
129019897|NCT05341622|464365290|FG007|Overall Study|Invalid Address|0|||
129019898|NCT05341622|464365283|FG000|Overall Study|Ineligible|26|||
129019899|NCT05341622|464365284|FG001|Overall Study|Ineligible|21|||
129019900|NCT05341622|464365285|FG002|Overall Study|Ineligible|28|||
128684277|NCT01857583|463142675|FG003|Overall Study|Withdrawal by Subject|2|||
128684278|NCT00458536|463142678|FG000|Overall Study|Disease progression prior to treatment|7|||
128684279|NCT00458536|463142678|FG000|Overall Study|Unable to make vaccine|3|||
128684280|NCT00458536|463142678|FG000|Overall Study|No measurable disease after surgery|2|||
128684281|NCT00458536|463142678|FG000|Overall Study|Did not have renal cell carcinoma|2|||
129019901|NCT05341622|464365286|FG003|Overall Study|Ineligible|24|||
129019902|NCT05341622|464365287|FG004|Overall Study|Ineligible|29|||
129019903|NCT05341622|464365288|FG005|Overall Study|Ineligible|31|||
128684282|NCT00458536|463142678|FG000|Overall Study|Patient did not have surgery|1|||
129019904|NCT05341622|464365289|FG006|Overall Study|Ineligible|28|||
129019905|NCT05341622|464365290|FG007|Overall Study|Ineligible|26|||
128885536|NCT03267940|463875999|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
128885537|NCT03267940|463876000|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
128885538|NCT03267940|463876001|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
128885539|NCT03267940|463875996|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
128885540|NCT03267940|463875997|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
128885541|NCT03267940|463875998|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
128885542|NCT03267940|463875999|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
128885543|NCT03267940|463876000|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
128885544|NCT03267940|463876001|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
128885545|NCT03267940|463875996|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
128885546|NCT03267940|463875997|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
128885547|NCT03267940|463875998|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
128885548|NCT03267940|463875999|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
128885549|NCT03267940|463876000|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
128885550|NCT03267940|463876001|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
128885551|NCT00388154|463876008|FG000|Overall Study|Withdrawal by Subject|1|||
128885552|NCT01948908|463876011|FG000|Overall Study|Protocol Violation|1|||
128885553|NCT01948908|463876012|FG001|Overall Study|Protocol Violation|0|||
128885554|NCT01948908|463876013|FG002|Overall Study|Protocol Violation|2|||
128885555|NCT03291587|463876014|FG000|Overall Study|Lost to Follow-up|62|||
128885556|NCT03291587|463876015|FG001|Overall Study|Lost to Follow-up|43|||
128885557|NCT03291587|463876014|FG000|Overall Study|Refused to Answer|5|||
128885558|NCT03291587|463876015|FG001|Overall Study|Refused to Answer|2|||
128885559|NCT03291587|463876014|FG000|Overall Study|Death|2|||
128885560|NCT03291587|463876015|FG001|Overall Study|Death|4|||
128885561|NCT03291587|463876014|FG000|Overall Study|Not interested in participating|8|||
128885562|NCT03291587|463876015|FG001|Overall Study|Not interested in participating|6|||
128885563|NCT03291587|463876014|FG000|Overall Study|Too busy to participate|4|||
128885564|NCT03291587|463876015|FG001|Overall Study|Too busy to participate|2|||
128885565|NCT00796120|463876017|FG000|Overall Study|Death|3|||
128885566|NCT00796120|463876018|FG001|Overall Study|Death|0|||
128885567|NCT00796120|463876017|FG000|Overall Study|Adverse Event|11|||
128885568|NCT00796120|463876018|FG001|Overall Study|Adverse Event|6|||
128885569|NCT00796120|463876017|FG000|Overall Study|Progressive disease|22|||
128885570|NCT00796120|463876018|FG001|Overall Study|Progressive disease|13|||
128885571|NCT00796120|463876017|FG000|Overall Study|Participant refusal|3|||
128885572|NCT00796120|463876018|FG001|Overall Study|Participant refusal|4|||
128885573|NCT00796120|463876017|FG000|Overall Study|Other|6|||
128885574|NCT00796120|463876018|FG001|Overall Study|Other|17|||
128885575|NCT00796120|463876017|FG000|Overall Study|Physician Decision|16|||
128885576|NCT00796120|463876018|FG001|Overall Study|Physician Decision|17|||
128885577|NCT00796120|463876017|FG000|Overall Study|Randomized but not treated|0|||
128885578|NCT00796120|463876018|FG001|Overall Study|Randomized but not treated|3|||
128885579|NCT02520284|463876019|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
128885580|NCT02520284|463876020|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
128885581|NCT02520284|463876021|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
128885582|NCT02520284|463876019|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
128885583|NCT02520284|463876020|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
128885584|NCT02520284|463876021|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
128885585|NCT02520284|463876019|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
129019906|NCT02658084|464365291|FG000|Overall Study|Withdrawal by Subject|1|||
129019907|NCT02658084|464365292|FG001|Overall Study|Withdrawal by Subject|0|||
129019908|NCT02658084|464365291|FG000|Overall Study|Study Termination|1|||
129019909|NCT02658084|464365292|FG001|Overall Study|Study Termination|0|||
129019910|NCT05472038|464366989|FG000|Overall Study|Adverse Event|0|||
129019911|NCT05472038|464366990|FG001|Overall Study|Adverse Event|0|||
129019912|NCT05472038|464366991|FG002|Overall Study|Adverse Event|1|||
129019913|NCT05472038|464366992|FG003|Overall Study|Adverse Event|0|||
129019914|NCT05472038|464366993|FG004|Overall Study|Adverse Event|0|||
129019915|NCT05472038|464366994|FG005|Overall Study|Adverse Event|0|||
129019916|NCT05472038|464366995|FG006|Overall Study|Adverse Event|0|||
129019917|NCT05472038|464366996|FG007|Overall Study|Adverse Event|0|||
129019918|NCT05472038|464366997|FG008|Overall Study|Adverse Event|0|||
129019919|NCT05472038|464366998|FG009|Overall Study|Adverse Event|0|||
128885586|NCT02520284|463876020|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
128885587|NCT02520284|463876021|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
128885588|NCT02520284|463876019|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
128885589|NCT02520284|463876020|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
128885590|NCT02520284|463876021|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
128885591|NCT02520284|463876019|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
128885592|NCT02520284|463876020|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
129019920|NCT05472038|464366999|FG010|Overall Study|Adverse Event|0|||
129019921|NCT05472038|464367000|FG011|Overall Study|Adverse Event|0|||
128885593|NCT02520284|463876021|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
128885594|NCT02520284|463876019|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
128885595|NCT02520284|463876020|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
128885596|NCT02520284|463876021|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
128885597|NCT02520284|463876019|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
128885598|NCT02520284|463876020|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
128885599|NCT02520284|463876021|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
128885600|NCT02520284|463876019|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
128885601|NCT02520284|463876020|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
128885602|NCT02520284|463876021|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
128885603|NCT02520284|463876019|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
128885604|NCT02520284|463876020|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
128885605|NCT02520284|463876021|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
128885606|NCT02520284|463876019|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
128885607|NCT02520284|463876020|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
128885608|NCT02520284|463876021|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
128885609|NCT02520284|463876019|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
128885610|NCT02520284|463876020|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
128885611|NCT02520284|463876021|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
128885612|NCT01898923|463876022|FG000|Overall Study|Lack of Efficacy|5|||
128885613|NCT01898923|463876023|FG001|Overall Study|Lack of Efficacy|6|||
128885614|NCT01898923|463876022|FG000|Overall Study|Adverse Event|3|||
128885615|NCT01898923|463876023|FG001|Overall Study|Adverse Event|1|||
128885616|NCT01898923|463876022|FG000|Overall Study|Lost to Follow-up|0|||
128885617|NCT01898923|463876023|FG001|Overall Study|Lost to Follow-up|1|||
128885618|NCT01898923|463876022|FG000|Overall Study|Withdrawal by Subject|4|||
128885619|NCT01898923|463876023|FG001|Overall Study|Withdrawal by Subject|7|||
128885620|NCT01898923|463876022|FG000|Overall Study|Physician Decision|3|||
128885621|NCT01898923|463876023|FG001|Overall Study|Physician Decision|4|||
128885622|NCT01898923|463876022|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
128885623|NCT01898923|463876023|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
128885624|NCT00381303|463876028|FG000|Overall Study|Lost to Follow-up|25|||
128885625|NCT00381303|463876029|FG001|Overall Study|Lost to Follow-up|9|||
128885626|NCT00381303|463876028|FG000|Overall Study|AE/HIV-related event|22|||
128885627|NCT00381303|463876029|FG001|Overall Study|AE/HIV-related event|6|||
128885628|NCT00381303|463876028|FG000|Overall Study|Non-Adherence|13|||
128885629|NCT00381303|463876029|FG001|Overall Study|Non-Adherence|6|||
128885630|NCT00381303|463876028|FG000|Overall Study|Withdrawal by Subject|13|||
128885631|NCT00381303|463876029|FG001|Overall Study|Withdrawal by Subject|6|||
128885632|NCT00381303|463876028|FG000|Overall Study|Virologic failure|6|||
128885633|NCT00381303|463876029|FG001|Overall Study|Virologic failure|4|||
128885634|NCT00381303|463876028|FG000|Overall Study|Ineligible to continue the trial|2|||
128885635|NCT00381303|463876029|FG001|Overall Study|Ineligible to continue the trial|1|||
128885636|NCT00381303|463876028|FG000|Overall Study|Pregnancy|2|||
128885637|NCT00381303|463876029|FG001|Overall Study|Pregnancy|0|||
128885638|NCT00381303|463876028|FG000|Overall Study|Physician Decision|1|||
128885639|NCT00381303|463876029|FG001|Overall Study|Physician Decision|0|||
128885640|NCT00381303|463876028|FG000|Overall Study|Physician's decision to close the site|3|||
128885641|NCT00381303|463876029|FG001|Overall Study|Physician's decision to close the site|1|||
128885642|NCT00381303|463876028|FG000|Overall Study|Subject moved out of state|2|||
128885643|NCT00381303|463876029|FG001|Overall Study|Subject moved out of state|0|||
128885644|NCT00381303|463876028|FG000|Overall Study|Subject taking too many different meds|1|||
128885645|NCT00381303|463876029|FG001|Overall Study|Subject taking too many different meds|0|||
129019922|NCT05472038|464366989|FG000|Overall Study|Death|0|||
129019923|NCT05472038|464366990|FG001|Overall Study|Death|0|||
129019924|NCT05472038|464366991|FG002|Overall Study|Death|0|||
129019925|NCT05472038|464366992|FG003|Overall Study|Death|0|||
129019926|NCT05472038|464366993|FG004|Overall Study|Death|0|||
129019927|NCT05472038|464366994|FG005|Overall Study|Death|1|||
129019928|NCT05472038|464366995|FG006|Overall Study|Death|0|||
129019929|NCT05472038|464366996|FG007|Overall Study|Death|0|||
129019930|NCT05472038|464366997|FG008|Overall Study|Death|0|||
129019931|NCT05472038|464366998|FG009|Overall Study|Death|0|||
129019932|NCT05472038|464366999|FG010|Overall Study|Death|0|||
129019933|NCT05472038|464367000|FG011|Overall Study|Death|0|||
129019934|NCT05472038|464366989|FG000|Overall Study|Lost to Follow-up|1|||
128885646|NCT00381303|463876028|FG000|Overall Study|No virologic response by week 12|1|||
128885647|NCT00381303|463876029|FG001|Overall Study|No virologic response by week 12|0|||
129019935|NCT05472038|464366990|FG001|Overall Study|Lost to Follow-up|3|||
129019936|NCT05472038|464366991|FG002|Overall Study|Lost to Follow-up|3|||
129019937|NCT05472038|464366992|FG003|Overall Study|Lost to Follow-up|9|||
129019938|NCT05472038|464366993|FG004|Overall Study|Lost to Follow-up|2|||
129019939|NCT05472038|464366994|FG005|Overall Study|Lost to Follow-up|2|||
129019940|NCT05472038|464366995|FG006|Overall Study|Lost to Follow-up|1|||
129019941|NCT05472038|464366996|FG007|Overall Study|Lost to Follow-up|0|||
128885648|NCT00381303|463876028|FG000|Overall Study|Subject was too busy for appointments|1|||
128885649|NCT00381303|463876029|FG001|Overall Study|Subject was too busy for appointments|0|||
128885650|NCT00381303|463876028|FG000|Overall Study|Subject did not continue visits|1|||
128885651|NCT00381303|463876029|FG001|Overall Study|Subject did not continue visits|0|||
128885652|NCT00381303|463876028|FG000|Overall Study|Subject primary physician's decision|1|||
128885653|NCT00381303|463876029|FG001|Overall Study|Subject primary physician's decision|0|||
128885654|NCT01211522|463876030|FG000|Overall Study|Withdrawal by Subject|3|||
128885655|NCT01211522|463876031|FG001|Overall Study|Withdrawal by Subject|7|||
128885656|NCT01211522|463876032|FG002|Overall Study|Withdrawal by Subject|5|||
128885657|NCT01116882|463876039|FG000|30-day|Lost to Follow-up|50|||
128885658|NCT01116882|463876040|FG001|30-day|Lost to Follow-up|21|||
128885659|NCT01116882|463876039|FG000|30-day|Withdrawal by Subject|2|||
128885660|NCT01116882|463876040|FG001|30-day|Withdrawal by Subject|4|||
128885661|NCT01116882|463876039|FG000|30-day|Other Reasons|16|||
128885662|NCT01116882|463876040|FG001|30-day|Other Reasons|6|||
128885663|NCT01116882|463876039|FG000|12-month|Lost to Follow-up|111|||
128885664|NCT01116882|463876040|FG001|12-month|Lost to Follow-up|42|||
128885665|NCT01116882|463876039|FG000|12-month|Other Reasons|151|||
128885666|NCT01116882|463876040|FG001|12-month|Other Reasons|49|||
128885667|NCT01116882|463876039|FG000|12-month|Withdrawal by Subject|5|||
128885668|NCT01116882|463876040|FG001|12-month|Withdrawal by Subject|8|||
128885669|NCT00547365|463876041|FG000|Overall Study|Physician Decision|1|||
128885670|NCT00547365|463876041|FG000|Overall Study|Lost to Follow-up|1|||
128885671|NCT00547365|463876041|FG000|Overall Study|Protocol Violation|2|||
128885672|NCT00547365|463876041|FG000|Overall Study|death (not related to study)|4|||
128885673|NCT01139658|463876044|FG000|Overall Study|Adverse Event|10|||
128885674|NCT01139658|463876045|FG001|Overall Study|Adverse Event|27|||
128885675|NCT01139658|463876044|FG000|Overall Study|Lack of Efficacy|15|||
128885676|NCT01139658|463876045|FG001|Overall Study|Lack of Efficacy|7|||
128885677|NCT01139658|463876044|FG000|Overall Study|Withdrawal by Subject|2|||
128885678|NCT01139658|463876045|FG001|Overall Study|Withdrawal by Subject|4|||
128885679|NCT01139658|463876044|FG000|Overall Study|No documentation of treatment|1|||
128885680|NCT01139658|463876045|FG001|Overall Study|No documentation of treatment|0|||
128885681|NCT01139658|463876044|FG000|Overall Study|Other|28|||
128885682|NCT01139658|463876045|FG001|Overall Study|Other|75|||
128885683|NCT00504881|463876046|FG000|Overall Study|Lack of Efficacy|1|||
128885684|NCT00504881|463876047|FG001|Overall Study|Lack of Efficacy|5|||
128885685|NCT00504881|463876046|FG000|Overall Study|Lost to Follow-up|0|||
128885686|NCT00504881|463876047|FG001|Overall Study|Lost to Follow-up|2|||
128885687|NCT00504881|463876046|FG000|Overall Study|Withdrawal by Subject|1|||
128885688|NCT00504881|463876047|FG001|Overall Study|Withdrawal by Subject|4|||
128885689|NCT00504881|463876046|FG000|Overall Study|Non-Compliance|1|||
128885690|NCT00504881|463876047|FG001|Overall Study|Non-Compliance|0|||
128885691|NCT00504881|463876046|FG000|Overall Study|No Birth Control|0|||
128885692|NCT00504881|463876047|FG001|Overall Study|No Birth Control|1|||
129019942|NCT05472038|464366997|FG008|Overall Study|Lost to Follow-up|1|||
129019943|NCT05472038|464366998|FG009|Overall Study|Lost to Follow-up|0|||
129019944|NCT05472038|464366999|FG010|Overall Study|Lost to Follow-up|2|||
128684283|NCT00458536|463142678|FG000|Overall Study|Ineligible due to toxicity|1|||
129019945|NCT05472038|464367000|FG011|Overall Study|Lost to Follow-up|1|||
129019946|NCT05472038|464366989|FG000|Overall Study|Physician Decision|0|||
129019947|NCT05472038|464366990|FG001|Overall Study|Physician Decision|0|||
129019948|NCT05472038|464366991|FG002|Overall Study|Physician Decision|0|||
129019949|NCT05472038|464366992|FG003|Overall Study|Physician Decision|0|||
129019950|NCT05472038|464366993|FG004|Overall Study|Physician Decision|1|||
129019951|NCT05472038|464366994|FG005|Overall Study|Physician Decision|0|||
129019952|NCT05472038|464366995|FG006|Overall Study|Physician Decision|0|||
129019953|NCT05472038|464366996|FG007|Overall Study|Physician Decision|0|||
129019954|NCT05472038|464366997|FG008|Overall Study|Physician Decision|0|||
129108137|NCT01409915|464691766|FG000|Overall Study|Withdrawal by Subject|0|||
129108138|NCT01409915|464691767|FG001|Overall Study|Withdrawal by Subject|1|||
128885693|NCT00504881|463876046|FG000|Overall Study|Safety Visit not performed|0|||
128885694|NCT00504881|463876047|FG001|Overall Study|Safety Visit not performed|1|||
128885695|NCT00504881|463876046|FG000|Overall Study|AE, serious fatal|0|||
128885696|NCT00504881|463876047|FG001|Overall Study|AE, serious fatal|1|||
128885697|NCT00504881|463876046|FG000|Overall Study|SAE, non-fatal|2|||
128885698|NCT00504881|463876047|FG001|Overall Study|SAE, non-fatal|6|||
128885699|NCT00504881|463876046|FG000|Overall Study|AE, non-serious non-fatal|4|||
128885700|NCT00504881|463876047|FG001|Overall Study|AE, non-serious non-fatal|14|||
128885701|NCT00504881|463876046|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
128885702|NCT00504881|463876047|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
128885703|NCT00504881|463876046|FG000|Overall Study|AE of unknown type|1|||
129019955|NCT05472038|464366998|FG009|Overall Study|Physician Decision|0|||
129019956|NCT05472038|464366999|FG010|Overall Study|Physician Decision|0|||
129019957|NCT05472038|464367000|FG011|Overall Study|Physician Decision|0|||
129019958|NCT05472038|464366989|FG000|Overall Study|Withdrawal by Subject|1|||
128885704|NCT00504881|463876047|FG001|Overall Study|AE of unknown type|0|||
128885705|NCT01777269|463876048|FG000|Overall Study|Adverse Event|24|||
128885706|NCT01777269|463876049|FG001|Overall Study|Adverse Event|33|||
128885707|NCT01777269|463876048|FG000|Overall Study|Lack of Efficacy|8|||
128885708|NCT01777269|463876049|FG001|Overall Study|Lack of Efficacy|10|||
128885709|NCT01777269|463876048|FG000|Overall Study|Protocol Violation|4|||
128885710|NCT01777269|463876049|FG001|Overall Study|Protocol Violation|4|||
128885711|NCT01777269|463876048|FG000|Overall Study|Participants reached stopping criteria|1|||
128885712|NCT01777269|463876049|FG001|Overall Study|Participants reached stopping criteria|1|||
128885713|NCT01777269|463876048|FG000|Overall Study|Lost to Follow-up|4|||
128885714|NCT01777269|463876049|FG001|Overall Study|Lost to Follow-up|0|||
128885715|NCT01777269|463876048|FG000|Overall Study|Physician Decision|5|||
128885716|NCT01777269|463876049|FG001|Overall Study|Physician Decision|2|||
128885717|NCT01777269|463876048|FG000|Overall Study|Withdrawal by Subject|9|||
128885718|NCT01777269|463876049|FG001|Overall Study|Withdrawal by Subject|9|||
128885719|NCT01966471|463876050|FG000|Overall Study|Death|44|||
128885720|NCT01966471|463876051|FG001|Overall Study|Death|56|||
128885721|NCT01966471|463876050|FG000|Overall Study|Lost to Follow-up|46|||
128885722|NCT01966471|463876051|FG001|Overall Study|Lost to Follow-up|39|||
128885723|NCT01966471|463876050|FG000|Overall Study|Various reasons|4|||
128885724|NCT01966471|463876051|FG001|Overall Study|Various reasons|4|||
128885725|NCT01966471|463876050|FG000|Overall Study|Physician Decision|7|||
128885726|NCT01966471|463876051|FG001|Overall Study|Physician Decision|5|||
128885727|NCT01966471|463876050|FG000|Overall Study|Study Terminated By Sponsor|758|||
128885728|NCT01966471|463876051|FG001|Overall Study|Study Terminated By Sponsor|773|||
128885729|NCT01966471|463876050|FG000|Overall Study|Withdrawal by Subject|59|||
128885730|NCT01966471|463876051|FG001|Overall Study|Withdrawal by Subject|51|||
128885731|NCT01030198|463876052|FG000|Overall Study|Could not measure efficacy accurately|0|||
128885732|NCT01030198|463876053|FG001|Overall Study|Could not measure efficacy accurately|7|||
128885733|NCT02370043|463876054|FG000|Overall Study|Withdrawal by Subject|0|||
128885734|NCT02370043|463876055|FG001|Overall Study|Withdrawal by Subject|0|||
128885735|NCT02370043|463876056|FG002|Overall Study|Withdrawal by Subject|0|||
128885736|NCT02370043|463876057|FG003|Overall Study|Withdrawal by Subject|0|||
129108139|NCT01409915|464691766|FG000|Overall Study|Protocol Violation|1|||
129108140|NCT01409915|464691767|FG001|Overall Study|Protocol Violation|0|||
129108141|NCT04826484|464691768|FG000|Overall Study|Lost to Follow-up|2|||
129108142|NCT04826484|464691769|FG001|Overall Study|Lost to Follow-up|0|||
129108143|NCT02250300|464691771|FG000|Expansion Phase|Death|6|||
129108144|NCT02250300|464691772|FG001|Expansion Phase|Death|7|||
129108145|NCT02250300|464691773|FG002|Expansion Phase|Death|0|||
129108146|NCT02250300|464691774|FG003|Expansion Phase|Death|0|||
129108147|NCT00215644|464691777|FG000|Overall Study|Disease Progression|28|||
129108148|NCT00215644|464691778|FG001|Overall Study|Disease Progression|10|||
129108149|NCT00215644|464691777|FG000|Overall Study|Adverse Event|2|||
129108150|NCT00215644|464691778|FG001|Overall Study|Adverse Event|9|||
129108151|NCT00215644|464691777|FG000|Overall Study|Death|1|||
129108152|NCT00215644|464691778|FG001|Overall Study|Death|2|||
129108153|NCT00215644|464691777|FG000|Overall Study|Withdrawal by Subject|1|||
129108154|NCT00215644|464691778|FG001|Overall Study|Withdrawal by Subject|0|||
129108155|NCT00215644|464691777|FG000|Overall Study|Other|3|||
129108156|NCT00215644|464691778|FG001|Overall Study|Other|15|||
129108157|NCT00215644|464691777|FG000|Overall Study|Randomized but Not Treated|1|||
129108158|NCT00215644|464691778|FG001|Overall Study|Randomized but Not Treated|0|||
129108159|NCT03569098|464691779|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
129108160|NCT03569098|464691780|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
129108161|NCT03569098|464691781|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
129108162|NCT03569098|464691779|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
129215168|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
128885737|NCT02370043|463876058|FG004|Overall Study|Withdrawal by Subject|1|||
128885738|NCT02370043|463876059|FG005|Overall Study|Withdrawal by Subject|1|||
128885739|NCT00688181|463876060|FG000|Overall Study|Lost to Follow-up|17|||
128885740|NCT00688181|463876060|FG000|Overall Study|Unknown Reason|4|||
128885741|NCT00688181|463876060|FG000|Overall Study|Non-clinical Reason|2|||
128885742|NCT01050205|463876061|FG000|Overall Study|Lost to Follow-up|7|||
128885743|NCT01050205|463876062|FG001|Overall Study|Lost to Follow-up|1|||
128885744|NCT01050205|463876061|FG000|Overall Study|Withdrawal by Subject|1|||
128885745|NCT01050205|463876062|FG001|Overall Study|Withdrawal by Subject|1|||
128885746|NCT01050205|463876061|FG000|Overall Study|Relocated from area|1|||
128885747|NCT01050205|463876062|FG001|Overall Study|Relocated from area|2|||
129108163|NCT03569098|464691780|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
129108164|NCT03569098|464691781|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
129108165|NCT03569098|464691779|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
129108166|NCT03569098|464691780|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
128885748|NCT01050205|463876061|FG000|Overall Study|Discontinued Intervention|2|||
128885749|NCT01050205|463876062|FG001|Overall Study|Discontinued Intervention|0|||
129108167|NCT03569098|464691781|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
128885750|NCT01119001|463876063|FG000|Overall Study|Withdrawal by Subject|2|||
128885751|NCT00954421|463876064|FG000|Screening|screen failures|3|||
128885752|NCT00954421|463876064|FG000|6 Months of DBS|Withdrawal by Subject|1|||
128885753|NCT00954421|463876064|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
128885754|NCT00777946|463876065|FG000|Overall Study|Adverse Event|11|||
128885755|NCT00777946|463876066|FG001|Overall Study|Adverse Event|1|||
128885756|NCT00777946|463876067|FG002|Overall Study|Adverse Event|3|||
128885757|NCT00777946|463876065|FG000|Overall Study|Lack of Efficacy|0|||
128885758|NCT00777946|463876066|FG001|Overall Study|Lack of Efficacy|0|||
128885759|NCT00777946|463876067|FG002|Overall Study|Lack of Efficacy|9|||
128885760|NCT00777946|463876065|FG000|Overall Study|Condition no longer required study drug|1|||
128885761|NCT00777946|463876066|FG001|Overall Study|Condition no longer required study drug|0|||
128885762|NCT00777946|463876067|FG002|Overall Study|Condition no longer required study drug|0|||
128885763|NCT00777946|463876065|FG000|Overall Study|Patient withdrew consent|3|||
128885764|NCT00777946|463876066|FG001|Overall Study|Patient withdrew consent|2|||
128885765|NCT00777946|463876067|FG002|Overall Study|Patient withdrew consent|3|||
128885766|NCT00777946|463876065|FG000|Overall Study|Lost to Follow-up|3|||
128885767|NCT00777946|463876066|FG001|Overall Study|Lost to Follow-up|1|||
128885768|NCT00777946|463876067|FG002|Overall Study|Lost to Follow-up|0|||
128885769|NCT00777946|463876065|FG000|Overall Study|Protocol deviation|2|||
128885770|NCT00777946|463876066|FG001|Overall Study|Protocol deviation|1|||
128885771|NCT00777946|463876067|FG002|Overall Study|Protocol deviation|1|||
128885772|NCT00777946|463876065|FG000|Overall Study|Randomized in error|1|||
128885773|NCT00777946|463876066|FG001|Overall Study|Randomized in error|1|||
128885774|NCT00777946|463876067|FG002|Overall Study|Randomized in error|0|||
128885775|NCT00567268|463877341|FG000|Overall Study|Protocol Violation|7|||
128885776|NCT00567268|463877341|FG000|Overall Study|Lost to Follow-up|36|||
128885777|NCT00567268|463877341|FG000|Overall Study|No Visit After First Day of Treatment|2|||
128885778|NCT00567268|463877341|FG000|Overall Study|No Drug Administration|4|||
128885779|NCT00567268|463877341|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
128885780|NCT01717989|463877342|FG000|Overall Study|Ineligibility determined|6|||
128885781|NCT01717989|463877342|FG000|Overall Study|Protocol deviation|6|||
128885782|NCT01717989|463877342|FG000|Overall Study|Withdrawal by Subject|11|||
128885783|NCT01717989|463877342|FG000|Overall Study|Physician Decision|2|||
128885784|NCT01717989|463877342|FG000|Overall Study|Lost to Follow-up|11|||
128885785|NCT01717989|463877342|FG000|Overall Study|Death|439|||
128885786|NCT01717989|463877342|FG000|Overall Study|Protocol-specified criteria|551|||
128885787|NCT01717989|463877342|FG000|Overall Study|Other|40|||
128885788|NCT02147353|463877345|FG000|Overall Study|Lost to Follow-up|2|||
128885789|NCT02147353|463877346|FG001|Overall Study|Lost to Follow-up|0|||
128885790|NCT02147353|463877345|FG000|Overall Study|unable to make visits|4|||
128885791|NCT02147353|463877346|FG001|Overall Study|unable to make visits|0|||
128885792|NCT02147353|463877345|FG000|Overall Study|medication noncompliance|3|||
128885793|NCT02147353|463877346|FG001|Overall Study|medication noncompliance|0|||
128885794|NCT01776424|463877351|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
128885795|NCT01776424|463877352|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
128885796|NCT01776424|463877353|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
128885797|NCT01776424|463877351|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
128885798|NCT01776424|463877352|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
128885799|NCT01776424|463877353|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
128885800|NCT01776424|463877351|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
129019959|NCT05472038|464366990|FG001|Overall Study|Withdrawal by Subject|3|||
129019960|NCT05472038|464366991|FG002|Overall Study|Withdrawal by Subject|1|||
129019961|NCT05472038|464366992|FG003|Overall Study|Withdrawal by Subject|6|||
128684284|NCT00458536|463142678|FG000|Overall Study|Withdrawal by Subject|1|||
129019962|NCT05472038|464366993|FG004|Overall Study|Withdrawal by Subject|1|||
129019963|NCT05472038|464366994|FG005|Overall Study|Withdrawal by Subject|3|||
129019964|NCT05472038|464366995|FG006|Overall Study|Withdrawal by Subject|0|||
128684285|NCT00458536|463142678|FG000|Overall Study|Progressive disease during treatment|2|||
128885801|NCT01776424|463877352|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
128885802|NCT01776424|463877353|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
129019965|NCT05472038|464366996|FG007|Overall Study|Withdrawal by Subject|2|||
128684286|NCT03287635|463142681|FG000|Overall Study|Lost to Follow-up|5|||
128684287|NCT03287635|463142681|FG000|Overall Study|Withdrawal by Subject|1|||
128885803|NCT01776424|463877351|FG000|LTOLE Part (Open Label)|Refused|5|||
128885804|NCT01776424|463877352|FG001|LTOLE Part (Open Label)|Refused|2|||
129019966|NCT05472038|464366997|FG008|Overall Study|Withdrawal by Subject|3|||
128885805|NCT01776424|463877353|FG002|LTOLE Part (Open Label)|Refused|11|||
128885806|NCT01776424|463877351|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
128885807|NCT01776424|463877352|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
128885808|NCT01776424|463877353|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
128885809|NCT00146757|463877354|FG000|Overall Study|Death|1|||
128885810|NCT00146757|463877355|FG001|Overall Study|Death|0|||
128885811|NCT00146757|463877354|FG000|Overall Study|Adverse Event|1|||
128885812|NCT00146757|463877355|FG001|Overall Study|Adverse Event|0|||
128885813|NCT03037619|463877367|FG000|Overall Study|Lost to Follow-up|0|||
128885814|NCT03037619|463877368|FG001|Overall Study|Lost to Follow-up|1|||
128885815|NCT01498289|463877369|FG000|Overall Study|Adverse Event|16|||
128885816|NCT01498289|463877370|FG001|Overall Study|Adverse Event|18|||
128885817|NCT01498289|463877369|FG000|Overall Study|Death|6|||
128885818|NCT01498289|463877370|FG001|Overall Study|Death|8|||
128885819|NCT01498289|463877369|FG000|Overall Study|Withdrawal unrelated to AE|16|||
128885820|NCT01498289|463877370|FG001|Overall Study|Withdrawal unrelated to AE|16|||
128885821|NCT01498289|463877369|FG000|Overall Study|Progression/relapse|53|||
128885822|NCT01498289|463877370|FG001|Overall Study|Progression/relapse|59|||
128885823|NCT01498289|463877369|FG000|Overall Study|Not protocol specified|7|||
128885824|NCT01498289|463877370|FG001|Overall Study|Not protocol specified|2|||
128885825|NCT01498289|463877369|FG000|Overall Study|Reason under review|0|||
128885826|NCT01498289|463877370|FG001|Overall Study|Reason under review|1|||
128885827|NCT01794923|463877371|FG000|Overall Study|Adverse Event|0|||
128885828|NCT01794923|463877372|FG001|Overall Study|Adverse Event|0|||
128885829|NCT01794923|463877373|FG002|Overall Study|Adverse Event|1|||
128885830|NCT00803270|463877388|FG000|Overall Study|Lost to Follow-up|1|||
128885831|NCT00803270|463877389|FG001|Overall Study|Lost to Follow-up|2|||
128885832|NCT00593957|463877393|FG000|Overall Study|Physician Decision|0|||
128885833|NCT00593957|463877394|FG001|Overall Study|Physician Decision|1|||
128885834|NCT00593957|463877395|FG002|Overall Study|Physician Decision|2|||
128885835|NCT00494481|463877398|FG000|Overall Study|Condition under investigation worsened|11|||
128885836|NCT00494481|463877399|FG001|Overall Study|Condition under investigation worsened|13|||
128885837|NCT00494481|463877398|FG000|Overall Study|Adverse Event|15|||
128885838|NCT00494481|463877399|FG001|Overall Study|Adverse Event|11|||
128885839|NCT00494481|463877398|FG000|Overall Study|Other|1|||
128885840|NCT00494481|463877399|FG001|Overall Study|Other|0|||
128885841|NCT00494481|463877398|FG000|Overall Study|Never received IP|2|||
129108168|NCT03569098|464691779|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
129108169|NCT03569098|464691780|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
129108170|NCT03569098|464691781|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
129108171|NCT03569098|464691779|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
129108172|NCT03569098|464691780|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
129108173|NCT03569098|464691781|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
129108174|NCT03569098|464691779|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
129108175|NCT03569098|464691780|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
129108176|NCT03569098|464691781|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
129108177|NCT03569098|464691779|FG000|Double-Blind Treatment Cycle 1|Other|1|||
129108178|NCT03569098|464691780|FG001|Double-Blind Treatment Cycle 1|Other|0|||
129108179|NCT03569098|464691781|FG002|Double-Blind Treatment Cycle 1|Other|1|||
129108180|NCT03569098|464691779|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
129108181|NCT03569098|464691780|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
129108182|NCT03569098|464691781|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
128885842|NCT00494481|463877399|FG001|Overall Study|Never received IP|0|||
128885843|NCT02973048|463877400|FG000|Overall Study|Epidural catheter insertion failure|1|||
128885844|NCT02973048|463877401|FG001|Overall Study|Epidural catheter insertion failure|0|||
128885845|NCT02973048|463877400|FG000|Overall Study|Withdrawal by Subject|0|||
128885846|NCT02973048|463877401|FG001|Overall Study|Withdrawal by Subject|3|||
128885847|NCT00332189|463877402|FG000|Overall Study|Adverse Event|3|||
128885848|NCT00332189|463877402|FG000|Overall Study|Uncooperative/Noncompliant|3|||
128885849|NCT00332189|463877402|FG000|Overall Study|Withdrawal by Subject|9|||
128885850|NCT00332189|463877402|FG000|Overall Study|Lack of Efficacy|4|||
128885851|NCT00332189|463877402|FG000|Overall Study|Moved out of country|2|||
128885852|NCT02279862|463877404|FG000|Overall Study|Study drug toxicity|3|||
128885853|NCT02279862|463877405|FG001|Overall Study|Study drug toxicity|6|||
128885854|NCT02279862|463877404|FG000|Overall Study|No longer meets criteria|0|||
128885855|NCT02279862|463877405|FG001|Overall Study|No longer meets criteria|1|||
128885856|NCT02279862|463877404|FG000|Overall Study|Administrative reason by sponsor|0|||
128885857|NCT02279862|463877405|FG001|Overall Study|Administrative reason by sponsor|1|||
128885858|NCT02279862|463877404|FG000|Overall Study|Disease progression|5|||
128885859|NCT02279862|463877405|FG001|Overall Study|Disease progression|2|||
128885860|NCT02279862|463877404|FG000|Overall Study|Study closed by sponsor|16|||
128885861|NCT02279862|463877405|FG001|Overall Study|Study closed by sponsor|13|||
128885862|NCT02279862|463877404|FG000|Overall Study|Other|1|||
129108183|NCT03569098|464691779|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
129108184|NCT03569098|464691780|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
129108185|NCT03569098|464691781|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
128885863|NCT02279862|463877405|FG001|Overall Study|Other|2|||
128885864|NCT02279862|463877404|FG000|Overall Study|Withdrawal by Subject|1|||
128885865|NCT02279862|463877405|FG001|Overall Study|Withdrawal by Subject|0|||
128885866|NCT03707925|463877407|FG000|Overall Study|Inevaluable|1|||
128885867|NCT03431857|463877409|FG000|Overall Study|Death|6|||
128885868|NCT03431857|463877409|FG000|Overall Study|Lost to Follow-up|41|||
129108186|NCT03569098|464691779|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
129108187|NCT03569098|464691780|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
128885869|NCT03431857|463877409|FG000|Overall Study|Adverse Event|6|||
128885870|NCT03431857|463877409|FG000|Overall Study|Withdrawal by Subject|1|||
128684288|NCT03287635|463142681|FG000|Overall Study|Physician Decision|1|||
128684289|NCT00323869|463142682|FG000|Overall Study|Death|1|||
128684290|NCT01683019|463144078|FG000|Overall Study|Withdrawal by Subject|2|||
128684291|NCT01683019|463144079|FG001|Overall Study|Withdrawal by Subject|1|||
128684292|NCT01683019|463144080|FG002|Overall Study|Withdrawal by Subject|4|||
128684293|NCT03954041|463144086|FG000|Overall Study|Lost to Follow-up|3|||
128684294|NCT03954041|463144087|FG001|Overall Study|Lost to Follow-up|3|||
128684295|NCT03954041|463144088|FG002|Overall Study|Lost to Follow-up|6|||
128684296|NCT03954041|463144086|FG000|Overall Study|Death|4|||
128684297|NCT03954041|463144087|FG001|Overall Study|Death|0|||
128684298|NCT03954041|463144088|FG002|Overall Study|Death|1|||
128684299|NCT03954041|463144086|FG000|Overall Study|Death by neurologic criteria|0|||
128684300|NCT03954041|463144087|FG001|Overall Study|Death by neurologic criteria|0|||
128684301|NCT03954041|463144088|FG002|Overall Study|Death by neurologic criteria|1|||
128684302|NCT03954041|463144086|FG000|Overall Study|Reason not specified|7|||
128684303|NCT03954041|463144087|FG001|Overall Study|Reason not specified|4|||
128684304|NCT03954041|463144088|FG002|Overall Study|Reason not specified|2|||
128684305|NCT03954041|463144086|FG000|Overall Study|Withdrew prior to dosing|4|||
128684306|NCT03954041|463144087|FG001|Overall Study|Withdrew prior to dosing|2|||
128684307|NCT03954041|463144088|FG002|Overall Study|Withdrew prior to dosing|0|||
128684308|NCT03868124|463144089|FG000|Overall Study|Withdrawal by Subject|4|||
128684309|NCT03868124|463144090|FG001|Overall Study|Withdrawal by Subject|0|||
128684310|NCT03868124|463144091|FG002|Overall Study|Withdrawal by Subject|1|||
128684311|NCT03868124|463144089|FG000|Overall Study|Physician Decision|1|||
128684312|NCT03868124|463144090|FG001|Overall Study|Physician Decision|0|||
128684313|NCT03868124|463144091|FG002|Overall Study|Physician Decision|1|||
128684314|NCT03868124|463144089|FG000|Overall Study|Lost to Follow-up|1|||
128684315|NCT03868124|463144090|FG001|Overall Study|Lost to Follow-up|1|||
128885871|NCT01163721|463877412|FG000|Overall Study|Adverse Event|5|||
128885872|NCT01163721|463877413|FG001|Overall Study|Adverse Event|6|||
129019967|NCT05472038|464366998|FG009|Overall Study|Withdrawal by Subject|1|||
129019968|NCT05472038|464366999|FG010|Overall Study|Withdrawal by Subject|2|||
129019969|NCT05472038|464367000|FG011|Overall Study|Withdrawal by Subject|2|||
129019970|NCT05472038|464366989|FG000|Overall Study|Protocol Violation|0|||
129019971|NCT05472038|464366990|FG001|Overall Study|Protocol Violation|0|||
129019972|NCT05472038|464366991|FG002|Overall Study|Protocol Violation|0|||
129019973|NCT05472038|464366992|FG003|Overall Study|Protocol Violation|0|||
129019974|NCT05472038|464366993|FG004|Overall Study|Protocol Violation|0|||
129019975|NCT05472038|464366994|FG005|Overall Study|Protocol Violation|0|||
129019976|NCT05472038|464366995|FG006|Overall Study|Protocol Violation|0|||
129019977|NCT05472038|464366996|FG007|Overall Study|Protocol Violation|1|||
129019978|NCT05472038|464366997|FG008|Overall Study|Protocol Violation|1|||
129019979|NCT05472038|464366998|FG009|Overall Study|Protocol Violation|1|||
129019980|NCT05472038|464366999|FG010|Overall Study|Protocol Violation|1|||
129019981|NCT05472038|464367000|FG011|Overall Study|Protocol Violation|1|||
129019982|NCT05472038|464366989|FG000|Overall Study|Not vaccinated|0|||
129019983|NCT05472038|464366990|FG001|Overall Study|Not vaccinated|0|||
129019984|NCT05472038|464366991|FG002|Overall Study|Not vaccinated|0|||
129019985|NCT05472038|464366992|FG003|Overall Study|Not vaccinated|1|||
129019986|NCT05472038|464366993|FG004|Overall Study|Not vaccinated|0|||
129019987|NCT05472038|464366994|FG005|Overall Study|Not vaccinated|0|||
129019988|NCT05472038|464366995|FG006|Overall Study|Not vaccinated|0|||
129019989|NCT05472038|464366996|FG007|Overall Study|Not vaccinated|0|||
129019990|NCT05472038|464366997|FG008|Overall Study|Not vaccinated|0|||
129019991|NCT05472038|464366998|FG009|Overall Study|Not vaccinated|0|||
129019992|NCT05472038|464366999|FG010|Overall Study|Not vaccinated|0|||
129019993|NCT05472038|464367000|FG011|Overall Study|Not vaccinated|0|||
129019994|NCT05369208|464367003|FG000|Core Phase|Prohibited Medication Required|2|||
129019995|NCT05369208|464367003|FG000|Core Phase|Adverse Event|1|||
129019996|NCT05369208|464367003|FG000|Core Phase|Lack of Efficacy|1|||
128885873|NCT01163721|463877412|FG000|Overall Study|Withdrawal by Subject|3|||
128885874|NCT01163721|463877413|FG001|Overall Study|Withdrawal by Subject|4|||
129019997|NCT03235739|464367006|FG000|Overall Study|Withdrawal by Subject|2|||
129019998|NCT03235739|464367007|FG001|Overall Study|Withdrawal by Subject|2|||
128684316|NCT03868124|463144091|FG002|Overall Study|Lost to Follow-up|2|||
128684317|NCT03868124|463144089|FG000|Overall Study|Death|1|||
128684318|NCT03868124|463144090|FG001|Overall Study|Death|1|||
129019999|NCT03235739|464367006|FG000|Overall Study|Physician Decision|0|||
129020000|NCT03235739|464367007|FG001|Overall Study|Physician Decision|1|||
129020001|NCT00467896|464367008|FG000|Overall Study|Consent Withdrawal|18|||
129020002|NCT00467896|464367008|FG000|Overall Study|Adverse Event|7|||
129020003|NCT00467896|464367008|FG000|Overall Study|Serious Adverse Event|13|||
129108188|NCT03569098|464691781|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
128684319|NCT03868124|463144091|FG002|Overall Study|Death|2|||
128684320|NCT03868124|463144089|FG000|Overall Study|Adverse Event|0|||
128684321|NCT03868124|463144090|FG001|Overall Study|Adverse Event|0|||
129020004|NCT00467896|464367008|FG000|Overall Study|Non-compliance|3|||
129020005|NCT00467896|464367008|FG000|Overall Study|Changed therapy|2|||
129020006|NCT00467896|464367008|FG000|Overall Study|Patient received transplant|2|||
128885875|NCT01163721|463877412|FG000|Overall Study|Lost to Follow-up|0|||
128885876|NCT01163721|463877413|FG001|Overall Study|Lost to Follow-up|1|||
128885877|NCT01163721|463877412|FG000|Overall Study|Physician Decision|0|||
128885878|NCT01163721|463877413|FG001|Overall Study|Physician Decision|1|||
128885879|NCT01472380|463877416|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
128885880|NCT01472380|463877416|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
128885881|NCT02511678|463877417|FG000|Overall Study|Withdrawal by Subject|2|||
128885882|NCT02511678|463877417|FG000|Overall Study|Lost to Follow-up|4|||
128885883|NCT02511678|463877417|FG000|Overall Study|Death|19|||
128885884|NCT02511678|463877417|FG000|Overall Study|Adverse Event|1|||
128885885|NCT02511678|463877417|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
128885886|NCT02511678|463877417|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
128885887|NCT02511678|463877417|FG000|Overall Study|Required Radiofrequency Ablation|1|||
128885888|NCT02511678|463877417|FG000|Overall Study|Biopsy was Negative|1|||
128885889|NCT02511678|463877417|FG000|Overall Study|Protocol Violation|1|||
128885890|NCT02511678|463877417|FG000|Overall Study|Received Radiation Treatment|1|||
128885891|NCT01295281|463877418|FG000|First Intervention (7 Days)|Death|0|||
128885892|NCT01295281|463877419|FG001|First Intervention (7 Days)|Death|1|||
128885893|NCT00292461|463877420|FG000|Overall Study|Adverse Event|4|||
128885894|NCT00292461|463877421|FG001|Overall Study|Adverse Event|2|||
128885895|NCT00292461|463877420|FG000|Overall Study|Lack of Efficacy|1|||
128885896|NCT00292461|463877421|FG001|Overall Study|Lack of Efficacy|0|||
128885897|NCT00292461|463877420|FG000|Overall Study|Withdrawal by Subject|0|||
128885898|NCT00292461|463877421|FG001|Overall Study|Withdrawal by Subject|1|||
128885899|NCT00292461|463877420|FG000|Overall Study|Protocol Violation|4|||
128885900|NCT00292461|463877421|FG001|Overall Study|Protocol Violation|3|||
128885901|NCT00292461|463877420|FG000|Overall Study|Lost to Follow-up|1|||
128885902|NCT00292461|463877421|FG001|Overall Study|Lost to Follow-up|0|||
128885903|NCT01411839|463877426|FG000|Overall Study|Lost to Follow-up|4|||
128885904|NCT01411839|463877427|FG001|Overall Study|Lost to Follow-up|3|||
128885905|NCT05461794|463877430|FG000|Overall Study|Withdrawal by Subject|1|||
128885906|NCT05461794|463877431|FG001|Overall Study|Withdrawal by Subject|1|||
128885907|NCT05461794|463877432|FG002|Overall Study|Withdrawal by Subject|3|||
128885908|NCT05461794|463877430|FG000|Overall Study|Study Terminated By Sponsor|18|||
128885909|NCT05461794|463877431|FG001|Overall Study|Study Terminated By Sponsor|13|||
128885910|NCT05461794|463877432|FG002|Overall Study|Study Terminated By Sponsor|16|||
128885911|NCT05461794|463877430|FG000|Overall Study|Death|20|||
128885912|NCT05461794|463877431|FG001|Overall Study|Death|5|||
128885913|NCT05461794|463877432|FG002|Overall Study|Death|19|||
128885914|NCT00467285|463877433|FG000|Overall Study|Lost to Follow-up|4|||
128885915|NCT00467285|463877434|FG001|Overall Study|Lost to Follow-up|4|||
128885916|NCT01853982|463877435|FG000|Overall Study|Withdrawal by Subject|1|||
128885917|NCT01853982|463877436|FG001|Overall Study|Withdrawal by Subject|0|||
128885918|NCT01853982|463877435|FG000|Overall Study|Death|1|||
128885919|NCT01853982|463877436|FG001|Overall Study|Death|0|||
128885920|NCT01853982|463877435|FG000|Overall Study|Lost to Follow-up|0|||
128885921|NCT01853982|463877436|FG001|Overall Study|Lost to Follow-up|1|||
128885922|NCT05066724|463877442|FG000|Overall Study|Adverse Event|1|||
129108189|NCT03569098|464691779|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
129108190|NCT03569098|464691780|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
129108191|NCT03569098|464691781|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
129108192|NCT03569098|464691779|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
129108193|NCT03569098|464691780|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
129108194|NCT03569098|464691781|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
129108195|NCT03569098|464691779|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
129108196|NCT03569098|464691780|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
129108197|NCT03569098|464691781|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
129108198|NCT00758498|464691782|FG000|Overall Study|Adverse Event|2|||
128885923|NCT05066724|463877442|FG000|Overall Study|Non-Compliance With Study Drug|5|||
128885924|NCT05066724|463877442|FG000|Overall Study|Withdrawal by Subject|6|||
128885925|NCT05066724|463877442|FG000|Overall Study|Physician Decision|2|||
128885926|NCT00475033|463877445|FG000|Infant Series|Failed to return|3|||
128885927|NCT00475033|463877446|FG001|Infant Series|Failed to return|4|||
128885928|NCT00475033|463877445|FG000|Infant Series|Parent or legal guardian request|1|||
128885929|NCT00475033|463877446|FG001|Infant Series|Parent or legal guardian request|5|||
128885930|NCT00475033|463877445|FG000|Infant Series|Protocol Violation|1|||
128885931|NCT00475033|463877446|FG001|Infant Series|Protocol Violation|2|||
128885932|NCT00475033|463877445|FG000|Infant Series|Lost to Follow-up|2|||
128885933|NCT00475033|463877446|FG001|Infant Series|Lost to Follow-up|0|||
128885934|NCT00475033|463877445|FG000|Infant Series|Adverse Event|0|||
128885935|NCT00475033|463877446|FG001|Infant Series|Adverse Event|2|||
128885936|NCT00475033|463877445|FG000|After the Infant Series|Adverse Event|0|||
128885937|NCT00475033|463877446|FG001|After the Infant Series|Adverse Event|4|||
128885938|NCT00475033|463877445|FG000|After the Infant Series|Parent or legal guardian request|2|||
128885939|NCT00475033|463877446|FG001|After the Infant Series|Parent or legal guardian request|2|||
128885940|NCT00475033|463877445|FG000|After the Infant Series|Failed to return|2|||
128885941|NCT00475033|463877446|FG001|After the Infant Series|Failed to return|1|||
128885942|NCT00475033|463877445|FG000|After the Infant Series|Protocol Violation|1|||
128885943|NCT00475033|463877446|FG001|After the Infant Series|Protocol Violation|0|||
128885944|NCT00475033|463877445|FG000|After the Infant Series|Lost to Follow-up|1|||
128885945|NCT00475033|463877446|FG001|After the Infant Series|Lost to Follow-up|0|||
128885946|NCT00475033|463877445|FG000|After the Infant Series|Other|0|||
128885947|NCT00475033|463877446|FG001|After the Infant Series|Other|1|||
128885948|NCT00475033|463877445|FG000|Toddler Dose|Parent or legal guardian request|2|||
128885949|NCT00475033|463877446|FG001|Toddler Dose|Parent or legal guardian request|0|||
128885950|NCT00475033|463877445|FG000|Toddler Dose|Failed to return|1|||
128885951|NCT00475033|463877446|FG001|Toddler Dose|Failed to return|0|||
128885952|NCT00475033|463877445|FG000|Toddler Dose|Lost to Follow-up|1|||
128885953|NCT00475033|463877446|FG001|Toddler Dose|Lost to Follow-up|0|||
128885954|NCT03444324|463877449|FG000|Overall Study|Withdrawal by Subject|0|||
128885955|NCT03444324|463877450|FG001|Overall Study|Withdrawal by Subject|1|||
128885956|NCT03444324|463877449|FG000|Overall Study|Lost to Follow-up|4|||
128885957|NCT03444324|463877450|FG001|Overall Study|Lost to Follow-up|2|||
128885958|NCT03444324|463877449|FG000|Overall Study|Protocol Violation|0|||
128885959|NCT03444324|463877450|FG001|Overall Study|Protocol Violation|1|||
128885960|NCT03444324|463877449|FG000|Overall Study|Lack of Trial Compliance|1|||
128885961|NCT03444324|463877450|FG001|Overall Study|Lack of Trial Compliance|1|||
128885962|NCT03444324|463877449|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
128885963|NCT03444324|463877450|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
128885964|NCT00658684|463877451|FG000|Overall Study|Adverse Event|10|||
128885965|NCT00658684|463877452|FG001|Overall Study|Adverse Event|8|||
128885966|NCT00658684|463877453|FG002|Overall Study|Adverse Event|2|||
128885967|NCT00658684|463877454|FG003|Overall Study|Adverse Event|0|||
128885968|NCT00658684|463877451|FG000|Overall Study|Withdrawal by Subject|6|||
128885969|NCT00658684|463877452|FG001|Overall Study|Withdrawal by Subject|4|||
129020007|NCT00467896|464367008|FG000|Overall Study|Patient had atrial septostomy|1|||
129020008|NCT00467896|464367008|FG000|Overall Study|Patient weaned off iloprost|1|||
129020009|NCT00467896|464367008|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
129020010|NCT00467896|464367008|FG000|Overall Study|Started intravenous prostacyclin|1|||
129020011|NCT00467896|464367008|FG000|Overall Study|Started inhaled Remodulin|1|||
129020012|NCT00467896|464367008|FG000|Overall Study|Patient had no improvement|1|||
129020013|NCT03772522|464367009|FG000|Pre-intervention|Withdrawal by Subject|3|||
129020014|NCT03772522|464367010|FG001|Pre-intervention|Withdrawal by Subject|4|||
129020015|NCT03772522|464367009|FG000|Intervention|Withdrawal by Subject|1|||
129020016|NCT03772522|464367010|FG001|Intervention|Withdrawal by Subject|0|||
129020017|NCT03772522|464367009|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
129020018|NCT03772522|464367010|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
129020019|NCT02175095|464367011|FG000|Overall Study|Withdrawal by Subject|3|||
129020020|NCT02096211|464367012|FG000|Overall Study|Death|2|||
129020021|NCT02096211|464367012|FG000|Overall Study|Withdrawal by Subject|8|||
129020022|NCT02096211|464367012|FG000|Overall Study|Revision of implant|7|||
129020023|NCT02096211|464367012|FG000|Overall Study|Lost to Follow-up|43|||
129020024|NCT00519194|464367015|FG000|Overall Study|Withdrawal by Subject|9|||
129020025|NCT00519194|464367015|FG000|Overall Study|Death|9|||
129020026|NCT00519194|464367015|FG000|Overall Study|Lost to Follow-up|3|||
129020027|NCT03165994|464367016|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
129020028|NCT03165994|464367016|FG000|Overall Study|Death|2|||
129020029|NCT03165994|464367016|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
129020030|NCT03165994|464367016|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
129020031|NCT03165994|464367016|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
129020032|NCT03165994|464367016|FG000|Overall Study|Miscellaneous|1|||
129020033|NCT00461786|464367023|FG000|Overall Study|Entry Criteria Not Met|2|||
129020034|NCT00461786|464367023|FG000|Overall Study|Inevaluable (Never Treated)|1|||
129020035|NCT00934050|464367024|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
128684322|NCT03868124|463144091|FG002|Overall Study|Adverse Event|3|||
128885970|NCT00658684|463877453|FG002|Overall Study|Withdrawal by Subject|1|||
128885971|NCT00658684|463877454|FG003|Overall Study|Withdrawal by Subject|1|||
129020036|NCT00934050|464367025|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129020037|NCT00934050|464367026|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129020038|NCT00934050|464367027|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
129020039|NCT00934050|464367028|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129020040|NCT00934050|464367029|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129215169|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
129020041|NCT00934050|464367024|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
128684323|NCT03868124|463144089|FG000|Overall Study|Explanted|2|||
128885972|NCT00658684|463877451|FG000|Overall Study|Lack of Efficacy|1|||
128885973|NCT00658684|463877452|FG001|Overall Study|Lack of Efficacy|1|||
128885974|NCT00658684|463877453|FG002|Overall Study|Lack of Efficacy|0|||
128885975|NCT00658684|463877454|FG003|Overall Study|Lack of Efficacy|0|||
129020042|NCT00934050|464367025|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
128885976|NCT00658684|463877451|FG000|Overall Study|Protocol Violation|1|||
128885977|NCT00658684|463877452|FG001|Overall Study|Protocol Violation|1|||
128885978|NCT00658684|463877453|FG002|Overall Study|Protocol Violation|0|||
128885979|NCT00658684|463877454|FG003|Overall Study|Protocol Violation|0|||
128885980|NCT00658684|463877451|FG000|Overall Study|Pregnancy|1|||
128885981|NCT00658684|463877452|FG001|Overall Study|Pregnancy|1|||
128885982|NCT00658684|463877453|FG002|Overall Study|Pregnancy|0|||
128885983|NCT00658684|463877454|FG003|Overall Study|Pregnancy|0|||
128885984|NCT06515483|463877457|FG000|Overall Study|Subject withdraw due to family issues|1|||
128885985|NCT06515483|463877458|FG001|Overall Study|Subject withdraw due to family issues|0|||
128885986|NCT01390181|463879072|FG000|Overall Study|Lost to Follow-up|1|||
128885987|NCT01390181|463879072|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
128885988|NCT02805725|463879073|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
128885989|NCT02805725|463879074|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
128684324|NCT03868124|463144090|FG001|Overall Study|Explanted|1|||
128684325|NCT03868124|463144091|FG002|Overall Study|Explanted|0|||
128885990|NCT02805725|463879075|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
129020043|NCT00934050|464367026|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
129020044|NCT00934050|464367027|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
129020045|NCT00934050|464367028|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
129020046|NCT00934050|464367029|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
129020047|NCT00934050|464367024|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129020048|NCT00934050|464367025|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129020049|NCT00934050|464367026|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
129020050|NCT00934050|464367027|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129020051|NCT00934050|464367028|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129020052|NCT00934050|464367029|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129020053|NCT00934050|464367024|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
129020054|NCT00934050|464367025|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
129020055|NCT00934050|464367026|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
129020056|NCT00934050|464367027|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
129020057|NCT00934050|464367028|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
129020058|NCT00934050|464367029|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
129020059|NCT00934050|464367024|FG000|Enrolled After 15 Dec 2009|Death|0|||
129020060|NCT00934050|464367025|FG001|Enrolled After 15 Dec 2009|Death|0|||
129020061|NCT00934050|464367026|FG002|Enrolled After 15 Dec 2009|Death|0|||
129020062|NCT00934050|464367027|FG003|Enrolled After 15 Dec 2009|Death|0|||
129020063|NCT00934050|464367028|FG004|Enrolled After 15 Dec 2009|Death|0|||
129020064|NCT00934050|464367029|FG005|Enrolled After 15 Dec 2009|Death|1|||
129020065|NCT00934050|464367024|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129020066|NCT00934050|464367025|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129020067|NCT00934050|464367026|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129020068|NCT00934050|464367027|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129020069|NCT00934050|464367028|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129020070|NCT00934050|464367029|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
129020071|NCT00934050|464367024|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129020072|NCT00934050|464367025|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129020073|NCT00934050|464367026|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129020074|NCT00934050|464367027|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129020075|NCT00934050|464367028|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
129020076|NCT00934050|464367029|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
129020077|NCT00835991|464367030|FG000|First Intervention|Adverse Event|0|||
129020078|NCT00835991|464367031|FG001|First Intervention|Adverse Event|1|||
129020079|NCT00835991|464367030|FG000|Washout|Protocol Violation|0|||
129020080|NCT00835991|464367031|FG001|Washout|Protocol Violation|2|||
129020081|NCT00835991|464367030|FG000|Washout|Withdrawal by Subject|3|||
129020082|NCT00835991|464367031|FG001|Washout|Withdrawal by Subject|1|||
129020083|NCT02149420|464367032|FG000|Core Study|Administrative problems|0|||
129020084|NCT02149420|464367033|FG001|Core Study|Administrative problems|1|||
129020085|NCT02149420|464367034|FG002|Core Study|Administrative problems|2|||
129020086|NCT02149420|464367032|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
129020087|NCT02149420|464367033|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
129020088|NCT02149420|464367034|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
129020089|NCT01111461|464367035|FG000|Overall Study|Adverse Event|32|||
129020090|NCT01111461|464367035|FG000|Overall Study|Participant choice|11|||
129020091|NCT01111461|464367035|FG000|Overall Study|Lost to Follow-up|1|||
129020092|NCT01111461|464367035|FG000|Overall Study|Withdrawal by Subject|1|||
129020093|NCT01111461|464367035|FG000|Overall Study|Other|6|||
129020094|NCT02378935|464367036|FG000|Overall Study|Lack of Efficacy|10|||
129108199|NCT00758498|464691783|FG001|Overall Study|Adverse Event|2|||
128885991|NCT02805725|463879076|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
128684326|NCT03868124|463144089|FG000|Overall Study|Ongoing in study|176|||
128885992|NCT02805725|463879077|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
128885993|NCT02805725|463879073|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
129108200|NCT00758498|464691784|FG002|Overall Study|Adverse Event|3|||
129108201|NCT00758498|464691782|FG000|Overall Study|Subject legally detained out of state|1|||
129108202|NCT00758498|464691783|FG001|Overall Study|Subject legally detained out of state|0|||
129108203|NCT00758498|464691784|FG002|Overall Study|Subject legally detained out of state|0|||
129108204|NCT00758498|464691782|FG000|Overall Study|Withdrawal by Subject|0|||
129108205|NCT00758498|464691783|FG001|Overall Study|Withdrawal by Subject|0|||
129108206|NCT00758498|464691784|FG002|Overall Study|Withdrawal by Subject|1|||
129108207|NCT00758498|464691782|FG000|Overall Study|Noncompliance to study procedures|0|||
129108208|NCT00758498|464691783|FG001|Overall Study|Noncompliance to study procedures|0|||
129108209|NCT00758498|464691784|FG002|Overall Study|Noncompliance to study procedures|1|||
129108210|NCT01516736|464691789|FG000|Overall Study|Withdrawal by Subject|10|||
129108211|NCT01516736|464691790|FG001|Overall Study|Withdrawal by Subject|4|||
129108212|NCT01516736|464691789|FG000|Overall Study|Adverse Event|4|||
129108213|NCT01516736|464691790|FG001|Overall Study|Adverse Event|5|||
129108214|NCT01516736|464691789|FG000|Overall Study|Death|3|||
129108215|NCT01516736|464691790|FG001|Overall Study|Death|1|||
129108216|NCT01516736|464691789|FG000|Overall Study|Physician Decision|2|||
129108217|NCT01516736|464691790|FG001|Overall Study|Physician Decision|1|||
129108218|NCT01516736|464691789|FG000|Overall Study|Lack of Efficacy|1|||
129108219|NCT01516736|464691790|FG001|Overall Study|Lack of Efficacy|0|||
129108220|NCT01516736|464691789|FG000|Overall Study|Protocol Violation|0|||
129108221|NCT01516736|464691790|FG001|Overall Study|Protocol Violation|1|||
129108222|NCT01516736|464691789|FG000|Overall Study|Other (not specified)|0|||
129108223|NCT01516736|464691790|FG001|Overall Study|Other (not specified)|1|||
129108224|NCT01697800|464691791|FG000|Overall Study|Death|0|||
129108225|NCT01697800|464691792|FG001|Overall Study|Death|1|||
129108226|NCT03365934|464691799|FG000|Overall Study|Adverse Event|1|||
129108227|NCT03365934|464691799|FG000|Overall Study|Withdrawal by Subject|1|||
129108228|NCT04194489|464691800|FG000|Overall Study|Withdrawal by Subject|5|||
129108229|NCT04194489|464691800|FG000|Overall Study|Lost to Follow-up|48|||
129108230|NCT00522548|464691807|FG000|Overall Study|Adverse Event|2|||
129108231|NCT00522548|464691808|FG001|Overall Study|Adverse Event|2|||
129108232|NCT00522548|464691807|FG000|Overall Study|Withdrawal by Subject|0|||
129108233|NCT00522548|464691808|FG001|Overall Study|Withdrawal by Subject|2|||
129108234|NCT02683239|464691809|FG000|Overall Study|Protocol Violation|35|||
129108235|NCT02683239|464691810|FG001|Overall Study|Protocol Violation|23|||
129108236|NCT02683239|464691811|FG002|Overall Study|Protocol Violation|26|||
129108237|NCT02683239|464691812|FG003|Overall Study|Protocol Violation|4|||
129108238|NCT02683239|464691813|FG004|Overall Study|Protocol Violation|35|||
129108239|NCT02683239|464691814|FG005|Overall Study|Protocol Violation|4|||
129108240|NCT02683239|464691815|FG006|Overall Study|Protocol Violation|5|||
129108241|NCT02683239|464691809|FG000|Overall Study|Adverse Event|64|||
129108242|NCT02683239|464691810|FG001|Overall Study|Adverse Event|39|||
129108243|NCT02683239|464691811|FG002|Overall Study|Adverse Event|42|||
129108244|NCT02683239|464691812|FG003|Overall Study|Adverse Event|16|||
129108245|NCT02683239|464691813|FG004|Overall Study|Adverse Event|189|||
129108246|NCT02683239|464691814|FG005|Overall Study|Adverse Event|9|||
129108247|NCT02683239|464691815|FG006|Overall Study|Adverse Event|9|||
129108248|NCT02683239|464691809|FG000|Overall Study|Physician Decision|38|||
129108249|NCT02683239|464691810|FG001|Overall Study|Physician Decision|19|||
129108250|NCT02683239|464691811|FG002|Overall Study|Physician Decision|14|||
129108251|NCT02683239|464691812|FG003|Overall Study|Physician Decision|73|||
129108252|NCT02683239|464691813|FG004|Overall Study|Physician Decision|143|||
129108253|NCT02683239|464691814|FG005|Overall Study|Physician Decision|14|||
129108254|NCT02683239|464691815|FG006|Overall Study|Physician Decision|15|||
129108255|NCT02683239|464691809|FG000|Overall Study|Withdrawal by Subject|187|||
129108256|NCT02683239|464691810|FG001|Overall Study|Withdrawal by Subject|99|||
129108257|NCT02683239|464691811|FG002|Overall Study|Withdrawal by Subject|91|||
129108258|NCT02683239|464691812|FG003|Overall Study|Withdrawal by Subject|18|||
129108259|NCT02683239|464691813|FG004|Overall Study|Withdrawal by Subject|248|||
129108260|NCT02683239|464691814|FG005|Overall Study|Withdrawal by Subject|22|||
129108261|NCT02683239|464691815|FG006|Overall Study|Withdrawal by Subject|28|||
129108262|NCT02683239|464691809|FG000|Overall Study|Lost to Follow-up|77|||
129108263|NCT02683239|464691810|FG001|Overall Study|Lost to Follow-up|24|||
129108264|NCT02683239|464691811|FG002|Overall Study|Lost to Follow-up|25|||
129108265|NCT02683239|464691812|FG003|Overall Study|Lost to Follow-up|7|||
129108266|NCT02683239|464691813|FG004|Overall Study|Lost to Follow-up|88|||
129108267|NCT02683239|464691814|FG005|Overall Study|Lost to Follow-up|8|||
129108268|NCT02683239|464691815|FG006|Overall Study|Lost to Follow-up|11|||
129108269|NCT02683239|464691809|FG000|Overall Study|Death|9|||
129108270|NCT02683239|464691810|FG001|Overall Study|Death|5|||
129108271|NCT02683239|464691811|FG002|Overall Study|Death|8|||
129108272|NCT02683239|464691812|FG003|Overall Study|Death|0|||
129108273|NCT02683239|464691813|FG004|Overall Study|Death|12|||
129108274|NCT02683239|464691814|FG005|Overall Study|Death|1|||
129108275|NCT02683239|464691815|FG006|Overall Study|Death|0|||
129108276|NCT02683239|464691809|FG000|Overall Study|Lack of Efficacy|50|||
129108277|NCT02683239|464691810|FG001|Overall Study|Lack of Efficacy|23|||
129108278|NCT02683239|464691811|FG002|Overall Study|Lack of Efficacy|12|||
128885994|NCT02805725|463879074|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
128885995|NCT02805725|463879075|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
128885996|NCT02805725|463879076|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
128885997|NCT02805725|463879077|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
128885998|NCT02805725|463879073|FG000|Phase II|Protocol Violation|0|||
128885999|NCT02805725|463879074|FG001|Phase II|Protocol Violation|0|||
128886000|NCT02805725|463879075|FG002|Phase II|Protocol Violation|0|||
128886001|NCT02805725|463879076|FG003|Phase II|Protocol Violation|0|||
128886002|NCT02805725|463879077|FG004|Phase II|Protocol Violation|6|||
128886003|NCT01195545|463879078|FG000|Overall Study|Protocol Violation|4|||
128886004|NCT02425644|463879079|FG000|Overall Study|Lost to Follow-up|2|||
128886005|NCT02425644|463879080|FG001|Overall Study|Lost to Follow-up|3|||
128886006|NCT02425644|463879079|FG000|Overall Study|Withdrawal by Subject|41|||
128886007|NCT02425644|463879080|FG001|Overall Study|Withdrawal by Subject|36|||
128886008|NCT02425644|463879079|FG000|Overall Study|Lack of Efficacy|3|||
128886009|NCT02425644|463879080|FG001|Overall Study|Lack of Efficacy|10|||
128886010|NCT02425644|463879079|FG000|Overall Study|Adverse Event|13|||
128886011|NCT02425644|463879080|FG001|Overall Study|Adverse Event|3|||
128886012|NCT02425644|463879079|FG000|Overall Study|Death|0|||
128886013|NCT02425644|463879080|FG001|Overall Study|Death|2|||
128886014|NCT02425644|463879079|FG000|Overall Study|Other|18|||
128886015|NCT02425644|463879080|FG001|Overall Study|Other|17|||
128886016|NCT01256658|463879081|FG000|Period 1|Lost to Follow-up|837|||
128886017|NCT01256658|463879082|FG001|Period 1|Lost to Follow-up|661|||
128886018|NCT01256658|463879081|FG000|Period 1|Withdrawal by Subject|35|||
128886019|NCT01256658|463879082|FG001|Period 1|Withdrawal by Subject|43|||
128886020|NCT01256658|463879081|FG000|Period 1|Death|48|||
128886021|NCT01256658|463879082|FG001|Period 1|Death|44|||
128886022|NCT00909792|463879083|FG000|Period 1|Did not meet inclusion criteria|0|||
128886023|NCT00909792|463879084|FG001|Period 1|Did not meet inclusion criteria|1|||
128886024|NCT00909792|463879083|FG000|Period 2|Biomicroscopy|1|||
128886025|NCT00909792|463879084|FG001|Period 2|Biomicroscopy|0|||
128886026|NCT00909792|463879083|FG000|Period 2|Lost to Follow-up|0|||
128886027|NCT00909792|463879084|FG001|Period 2|Lost to Follow-up|1|||
128886028|NCT02525861|463879090|FG000|Overall Study|Adverse Event|1|||
128886029|NCT02525861|463879091|FG001|Overall Study|Adverse Event|0|||
128886030|NCT02525861|463879090|FG000|Overall Study|Withdrawal by Subject|0|||
128886031|NCT02525861|463879091|FG001|Overall Study|Withdrawal by Subject|1|||
128886032|NCT02525861|463879090|FG000|Overall Study|Physician Decision|0|||
128886033|NCT02525861|463879091|FG001|Overall Study|Physician Decision|1|||
128886034|NCT01794520|463879092|FG000|Overall Study|Adverse events- related to progression|0|||
128886035|NCT01794520|463879093|FG001|Overall Study|Adverse events- related to progression|0|||
128886036|NCT01794520|463879094|FG002|Overall Study|Adverse events- related to progression|1|||
128886037|NCT01794520|463879095|FG003|Overall Study|Adverse events- related to progression|2|||
128886038|NCT01794520|463879096|FG004|Overall Study|Adverse events- related to progression|0|||
128886039|NCT01794520|463879097|FG005|Overall Study|Adverse events- related to progression|1|||
128886040|NCT01794520|463879098|FG006|Overall Study|Adverse events- related to progression|0|||
128886041|NCT01794520|463879092|FG000|Overall Study|Adverse event- not related to progression|1|||
128886042|NCT01794520|463879093|FG001|Overall Study|Adverse event- not related to progression|1|||
128886043|NCT01794520|463879094|FG002|Overall Study|Adverse event- not related to progression|0|||
128886044|NCT01794520|463879095|FG003|Overall Study|Adverse event- not related to progression|0|||
128886045|NCT01794520|463879096|FG004|Overall Study|Adverse event- not related to progression|2|||
129020095|NCT02378935|464367037|FG001|Overall Study|Lack of Efficacy|0|||
129020096|NCT02378935|464367038|FG002|Overall Study|Lack of Efficacy|2|||
129020097|NCT02378935|464367039|FG003|Overall Study|Lack of Efficacy|6|||
129020098|NCT02378935|464367040|FG004|Overall Study|Lack of Efficacy|0|||
129020099|NCT02378935|464367041|FG005|Overall Study|Lack of Efficacy|0|||
129020100|NCT02378935|464367042|FG006|Overall Study|Lack of Efficacy|0|||
129020101|NCT02378935|464367036|FG000|Overall Study|Death|0|||
129020102|NCT02378935|464367037|FG001|Overall Study|Death|0|||
129020103|NCT02378935|464367038|FG002|Overall Study|Death|1|||
129020104|NCT02378935|464367039|FG003|Overall Study|Death|0|||
129020105|NCT02378935|464367040|FG004|Overall Study|Death|0|||
129020106|NCT02378935|464367041|FG005|Overall Study|Death|0|||
129020107|NCT02378935|464367042|FG006|Overall Study|Death|0|||
129020108|NCT03616535|464367043|FG000|Overall Study|Death|2|||
129020109|NCT03616535|464367044|FG001|Overall Study|Death|0|||
128886046|NCT01794520|463879097|FG005|Overall Study|Adverse event- not related to progression|0|||
128886047|NCT01794520|463879098|FG006|Overall Study|Adverse event- not related to progression|0|||
128886048|NCT01794520|463879092|FG000|Overall Study|Progressive disease|5|||
128886049|NCT01794520|463879093|FG001|Overall Study|Progressive disease|6|||
128886050|NCT01794520|463879094|FG002|Overall Study|Progressive disease|2|||
128886051|NCT01794520|463879095|FG003|Overall Study|Progressive disease|5|||
128886052|NCT01794520|463879096|FG004|Overall Study|Progressive disease|27|||
128886053|NCT01794520|463879097|FG005|Overall Study|Progressive disease|18|||
128886054|NCT01794520|463879098|FG006|Overall Study|Progressive disease|0|||
129020110|NCT03616535|464367045|FG002|Overall Study|Death|0|||
129020111|NCT03616535|464367046|FG003|Overall Study|Death|1|||
128886055|NCT01794520|463879092|FG000|Overall Study|Withdrew consent|0|||
128886056|NCT01794520|463879093|FG001|Overall Study|Withdrew consent|0|||
128886057|NCT01794520|463879094|FG002|Overall Study|Withdrew consent|1|||
128886058|NCT01794520|463879095|FG003|Overall Study|Withdrew consent|1|||
128886059|NCT01794520|463879096|FG004|Overall Study|Withdrew consent|0|||
128886060|NCT01794520|463879097|FG005|Overall Study|Withdrew consent|0|||
128886061|NCT01794520|463879098|FG006|Overall Study|Withdrew consent|0|||
129108279|NCT02683239|464691812|FG003|Overall Study|Lack of Efficacy|2|||
129108280|NCT02683239|464691813|FG004|Overall Study|Lack of Efficacy|29|||
129108281|NCT02683239|464691814|FG005|Overall Study|Lack of Efficacy|2|||
129108282|NCT02683239|464691815|FG006|Overall Study|Lack of Efficacy|3|||
128886062|NCT01794520|463879092|FG000|Overall Study|Lost to Follow-up|0|||
128886063|NCT01794520|463879093|FG001|Overall Study|Lost to Follow-up|0|||
128886064|NCT01794520|463879094|FG002|Overall Study|Lost to Follow-up|0|||
128886065|NCT01794520|463879095|FG003|Overall Study|Lost to Follow-up|0|||
128886066|NCT01794520|463879096|FG004|Overall Study|Lost to Follow-up|1|||
128886067|NCT01794520|463879097|FG005|Overall Study|Lost to Follow-up|0|||
128886068|NCT01794520|463879098|FG006|Overall Study|Lost to Follow-up|0|||
128886069|NCT01794520|463879092|FG000|Overall Study|Toxicity|0|||
128886070|NCT01794520|463879093|FG001|Overall Study|Toxicity|2|||
128886071|NCT01794520|463879094|FG002|Overall Study|Toxicity|0|||
128886072|NCT01794520|463879095|FG003|Overall Study|Toxicity|0|||
128886073|NCT01794520|463879096|FG004|Overall Study|Toxicity|0|||
128886074|NCT01794520|463879097|FG005|Overall Study|Toxicity|0|||
128886075|NCT01794520|463879098|FG006|Overall Study|Toxicity|0|||
128886076|NCT01794520|463879092|FG000|Overall Study|Study terminated by sponsor|0|||
129108283|NCT02683239|464691809|FG000|Overall Study|Missing data|0|||
128886077|NCT01794520|463879093|FG001|Overall Study|Study terminated by sponsor|0|||
128886078|NCT01794520|463879094|FG002|Overall Study|Study terminated by sponsor|1|||
128886079|NCT01794520|463879095|FG003|Overall Study|Study terminated by sponsor|0|||
128886080|NCT01794520|463879096|FG004|Overall Study|Study terminated by sponsor|1|||
128886081|NCT01794520|463879097|FG005|Overall Study|Study terminated by sponsor|0|||
128886082|NCT01794520|463879098|FG006|Overall Study|Study terminated by sponsor|7|||
128886083|NCT01794520|463879092|FG000|Overall Study|Death|0|||
128886084|NCT01794520|463879093|FG001|Overall Study|Death|0|||
128886085|NCT01794520|463879094|FG002|Overall Study|Death|0|||
128886086|NCT01794520|463879095|FG003|Overall Study|Death|0|||
128886087|NCT01794520|463879096|FG004|Overall Study|Death|1|||
128886088|NCT01794520|463879097|FG005|Overall Study|Death|0|||
128886089|NCT01794520|463879098|FG006|Overall Study|Death|22|||
128886090|NCT01794520|463879092|FG000|Overall Study|Other, not specified|0|||
128886091|NCT01794520|463879093|FG001|Overall Study|Other, not specified|0|||
129108284|NCT02683239|464691810|FG001|Overall Study|Missing data|1|||
129108285|NCT02683239|464691811|FG002|Overall Study|Missing data|1|||
129108286|NCT02683239|464691812|FG003|Overall Study|Missing data|0|||
129108287|NCT02683239|464691813|FG004|Overall Study|Missing data|1|||
129108288|NCT02683239|464691814|FG005|Overall Study|Missing data|0|||
129108289|NCT02683239|464691815|FG006|Overall Study|Missing data|0|||
129108290|NCT00873730|464691818|FG000|Overall Study|Protocol Deviation|5|||
129108291|NCT00873730|464691819|FG001|Overall Study|Protocol Deviation|2|||
129108292|NCT00873730|464691818|FG000|Overall Study|Adverse Event|0|||
129108293|NCT00873730|464691819|FG001|Overall Study|Adverse Event|2|||
129108294|NCT00873730|464691818|FG000|Overall Study|Withdrawal by Subject|0|||
129108295|NCT00873730|464691819|FG001|Overall Study|Withdrawal by Subject|1|||
129108296|NCT00873730|464691818|FG000|Overall Study|Sponsor decision|1|||
129108297|NCT00873730|464691819|FG001|Overall Study|Sponsor decision|0|||
129108298|NCT00103662|464691820|FG000|Overall Study|Entered Rescue Procedure|0|||
129108299|NCT00103662|464691821|FG001|Overall Study|Entered Rescue Procedure|7|||
129108300|NCT00103662|464691820|FG000|Overall Study|Death|7|||
129108301|NCT00103662|464691821|FG001|Overall Study|Death|7|||
129108302|NCT00103662|464691820|FG000|Overall Study|Elective Withdrawal|5|||
129108303|NCT00103662|464691821|FG001|Overall Study|Elective Withdrawal|5|||
129108304|NCT00103662|464691820|FG000|Overall Study|Lost to Follow-up|0|||
128684327|NCT03868124|463144090|FG001|Overall Study|Ongoing in study|180|||
128886092|NCT01794520|463879094|FG002|Overall Study|Other, not specified|1|||
128886093|NCT01794520|463879095|FG003|Overall Study|Other, not specified|1|||
128886094|NCT01794520|463879096|FG004|Overall Study|Other, not specified|4|||
128684328|NCT03868124|463144091|FG002|Overall Study|Ongoing in study|183|||
129108305|NCT00103662|464691821|FG001|Overall Study|Lost to Follow-up|1|||
129108306|NCT00103662|464691820|FG000|Overall Study|Other|6|||
129108307|NCT00103662|464691821|FG001|Overall Study|Other|9|||
128684329|NCT00206076|463144093|FG000|Overall Study|Physician Decision|2|||
128886095|NCT01794520|463879097|FG005|Overall Study|Other, not specified|1|||
128886096|NCT01794520|463879098|FG006|Overall Study|Other, not specified|2|||
128886097|NCT04796896|463879100|FG000|Overall Study|Adverse Event|1|||
128886098|NCT04796896|463879101|FG001|Overall Study|Adverse Event|0|||
129108308|NCT00103662|464691820|FG000|Overall Study|Failed mobilization|0|||
128886099|NCT04796896|463879102|FG002|Overall Study|Adverse Event|0|||
128886100|NCT04796896|463879103|FG003|Overall Study|Adverse Event|0|||
128886101|NCT04796896|463879104|FG004|Overall Study|Adverse Event|0|||
128886102|NCT04796896|463879105|FG005|Overall Study|Adverse Event|1|||
128886103|NCT04796896|463879106|FG006|Overall Study|Adverse Event|1|||
128886104|NCT04796896|463879107|FG007|Overall Study|Adverse Event|0|||
128886105|NCT04796896|463879108|FG008|Overall Study|Adverse Event|1|||
128886106|NCT04796896|463879109|FG009|Overall Study|Adverse Event|1|||
128886107|NCT04796896|463879110|FG010|Overall Study|Adverse Event|1|||
128886108|NCT04796896|463879111|FG011|Overall Study|Adverse Event|0|||
128886109|NCT04796896|463879100|FG000|Overall Study|Lost to Follow-up|24|||
128886110|NCT04796896|463879101|FG001|Overall Study|Lost to Follow-up|15|||
128886111|NCT04796896|463879102|FG002|Overall Study|Lost to Follow-up|6|||
128886112|NCT04796896|463879103|FG003|Overall Study|Lost to Follow-up|4|||
128886113|NCT04796896|463879104|FG004|Overall Study|Lost to Follow-up|21|||
128886114|NCT04796896|463879105|FG005|Overall Study|Lost to Follow-up|55|||
128886115|NCT04796896|463879106|FG006|Overall Study|Lost to Follow-up|237|||
128886116|NCT04796896|463879107|FG007|Overall Study|Lost to Follow-up|52|||
128886117|NCT04796896|463879108|FG008|Overall Study|Lost to Follow-up|221|||
128886118|NCT04796896|463879109|FG009|Overall Study|Lost to Follow-up|43|||
128886119|NCT04796896|463879110|FG010|Overall Study|Lost to Follow-up|142|||
128886120|NCT04796896|463879111|FG011|Overall Study|Lost to Follow-up|18|||
129108309|NCT00103662|464691821|FG001|Overall Study|Failed mobilization|4|||
129108310|NCT00103662|464691820|FG000|Overall Study|Intercurrent illness|1|||
129108311|NCT00103662|464691821|FG001|Overall Study|Intercurrent illness|0|||
129108312|NCT00943397|464691822|FG000|Overall Study|Adverse Event|0|||
129108313|NCT00943397|464691823|FG001|Overall Study|Adverse Event|6|||
129108314|NCT00943397|464691822|FG000|Overall Study|Lost to Follow-up|0|||
129108315|NCT00943397|464691823|FG001|Overall Study|Lost to Follow-up|4|||
129108316|NCT00943397|464691822|FG000|Overall Study|Protocol Violation|2|||
129108317|NCT00943397|464691823|FG001|Overall Study|Protocol Violation|5|||
129108318|NCT00943397|464691822|FG000|Overall Study|Withdrawal by Subject|1|||
129108319|NCT00943397|464691823|FG001|Overall Study|Withdrawal by Subject|1|||
129108320|NCT00943397|464691822|FG000|Overall Study|Site terminated and other|12|||
128886121|NCT04796896|463879100|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
128886122|NCT04796896|463879101|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
128886123|NCT04796896|463879102|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
128886124|NCT04796896|463879103|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
128886125|NCT04796896|463879104|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
128886126|NCT04796896|463879105|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
128886127|NCT04796896|463879106|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
129108321|NCT00943397|464691823|FG001|Overall Study|Site terminated and other|56|||
129108322|NCT04878055|464691824|FG000|Overall Study|Patient transferred in another department|0|||
129108323|NCT04878055|464691825|FG001|Overall Study|Patient transferred in another department|2|||
129108324|NCT04878055|464691824|FG000|Overall Study|Physician Decision|1|||
129108325|NCT04878055|464691825|FG001|Overall Study|Physician Decision|1|||
129108326|NCT04878055|464691824|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
128886128|NCT04796896|463879107|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
128886129|NCT04796896|463879108|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
128886130|NCT04796896|463879109|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
128886131|NCT04796896|463879110|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
128886132|NCT04796896|463879111|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
128886133|NCT04796896|463879100|FG000|Overall Study|Physician Decision|1|||
128886134|NCT04796896|463879101|FG001|Overall Study|Physician Decision|0|||
128886135|NCT04796896|463879102|FG002|Overall Study|Physician Decision|0|||
128886136|NCT04796896|463879103|FG003|Overall Study|Physician Decision|0|||
128886137|NCT04796896|463879104|FG004|Overall Study|Physician Decision|0|||
128886138|NCT04796896|463879105|FG005|Overall Study|Physician Decision|3|||
128886139|NCT04796896|463879106|FG006|Overall Study|Physician Decision|18|||
128886140|NCT04796896|463879107|FG007|Overall Study|Physician Decision|1|||
128886141|NCT04796896|463879108|FG008|Overall Study|Physician Decision|7|||
128886142|NCT04796896|463879109|FG009|Overall Study|Physician Decision|0|||
128886143|NCT04796896|463879110|FG010|Overall Study|Physician Decision|5|||
128886144|NCT04796896|463879111|FG011|Overall Study|Physician Decision|0|||
128886145|NCT04796896|463879100|FG000|Overall Study|Withdrawal by Subject|36|||
129108327|NCT04878055|464691825|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
129108328|NCT04878055|464691824|FG000|Overall Study|Adverse Event|12|||
129108329|NCT04878055|464691825|FG001|Overall Study|Adverse Event|7|||
129215170|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
128684330|NCT00206076|463144094|FG001|Overall Study|Physician Decision|0|||
128886146|NCT04796896|463879101|FG001|Overall Study|Withdrawal by Subject|31|||
128886147|NCT04796896|463879102|FG002|Overall Study|Withdrawal by Subject|11|||
128886148|NCT04796896|463879103|FG003|Overall Study|Withdrawal by Subject|8|||
129108330|NCT04878055|464691824|FG000|Overall Study|Other|5|||
129108331|NCT04878055|464691825|FG001|Overall Study|Other|0|||
129108332|NCT04878055|464691824|FG000|Overall Study|Withdrawal by Subject|7|||
128684331|NCT00206076|463144093|FG000|Overall Study|Withdrawal by Subject|1|||
128886149|NCT04796896|463879104|FG004|Overall Study|Withdrawal by Subject|16|||
128886150|NCT04796896|463879105|FG005|Overall Study|Withdrawal by Subject|162|||
129108333|NCT04878055|464691825|FG001|Overall Study|Withdrawal by Subject|3|||
129108334|NCT04878055|464691824|FG000|Overall Study|Lost to Follow-up|10|||
129108335|NCT04878055|464691825|FG001|Overall Study|Lost to Follow-up|1|||
129108336|NCT01968811|464691826|FG000|Overall Study|Protocol Violation|4|||
129108337|NCT01968811|464691826|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
129108338|NCT02254772|464691831|FG000|Overall Study|Ineligible|1|||
129108339|NCT02254772|464691831|FG000|Overall Study|Withdrawal by Subject|1|||
129108340|NCT05225558|464691832|FG000|Overall Study|Withdrawal by Subject|4|||
129108341|NCT05225558|464691833|FG001|Overall Study|Withdrawal by Subject|3|||
129108342|NCT05225558|464691832|FG000|Overall Study|Adverse Event|1|||
129108343|NCT05225558|464691833|FG001|Overall Study|Adverse Event|0|||
129108344|NCT05225558|464691832|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
129108345|NCT05225558|464691833|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
129108346|NCT05225558|464691832|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
129108347|NCT05225558|464691833|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
129108348|NCT01001910|464691834|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
129108349|NCT03904420|464691835|FG000|Overall Study|Study terminated|2|||
129108350|NCT03904420|464691836|FG001|Overall Study|Study terminated|2|||
129108351|NCT01089127|464691841|FG000|Overall Study|Adverse Event|5|||
129108352|NCT01089127|464691842|FG001|Overall Study|Adverse Event|1|||
128886151|NCT04796896|463879106|FG006|Overall Study|Withdrawal by Subject|299|||
128886152|NCT04796896|463879107|FG007|Overall Study|Withdrawal by Subject|149|||
128886153|NCT04796896|463879108|FG008|Overall Study|Withdrawal by Subject|303|||
128886154|NCT04796896|463879109|FG009|Overall Study|Withdrawal by Subject|94|||
128886155|NCT04796896|463879110|FG010|Overall Study|Withdrawal by Subject|192|||
128886156|NCT04796896|463879111|FG011|Overall Study|Withdrawal by Subject|16|||
128886157|NCT04796896|463879100|FG000|Overall Study|Other Than Specified|6|||
128886158|NCT04796896|463879101|FG001|Overall Study|Other Than Specified|5|||
128886159|NCT04796896|463879102|FG002|Overall Study|Other Than Specified|3|||
128886160|NCT04796896|463879103|FG003|Overall Study|Other Than Specified|2|||
128886161|NCT04796896|463879104|FG004|Overall Study|Other Than Specified|6|||
129108353|NCT01089127|464691843|FG002|Overall Study|Adverse Event|1|||
129108354|NCT01089127|464691844|FG003|Overall Study|Adverse Event|0|||
129108355|NCT01089127|464691845|FG004|Overall Study|Adverse Event|0|||
129108356|NCT01089127|464691846|FG005|Overall Study|Adverse Event|1|||
129108357|NCT01089127|464691841|FG000|Overall Study|Subject withdrew consent|0|||
129108358|NCT01089127|464691842|FG001|Overall Study|Subject withdrew consent|1|||
129108359|NCT01089127|464691843|FG002|Overall Study|Subject withdrew consent|1|||
129108360|NCT01089127|464691844|FG003|Overall Study|Subject withdrew consent|1|||
129108361|NCT01089127|464691845|FG004|Overall Study|Subject withdrew consent|0|||
129108362|NCT01089127|464691846|FG005|Overall Study|Subject withdrew consent|2|||
129108363|NCT01089127|464691841|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129108364|NCT01089127|464691842|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129108365|NCT01089127|464691843|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129108366|NCT01089127|464691844|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129108367|NCT01089127|464691845|FG004|Overall Study|Abnormal test procedure result(s)|0|||
129108368|NCT01089127|464691846|FG005|Overall Study|Abnormal test procedure result(s)|0|||
129108369|NCT01089127|464691841|FG000|Overall Study|Lost to Follow-up|1|||
129108370|NCT01089127|464691842|FG001|Overall Study|Lost to Follow-up|1|||
129108371|NCT01089127|464691843|FG002|Overall Study|Lost to Follow-up|0|||
129108372|NCT01089127|464691844|FG003|Overall Study|Lost to Follow-up|0|||
129108373|NCT01089127|464691845|FG004|Overall Study|Lost to Follow-up|1|||
129108374|NCT01089127|464691846|FG005|Overall Study|Lost to Follow-up|0|||
129108375|NCT01089127|464691841|FG000|Overall Study|Protocol deviation|0|||
129108376|NCT01089127|464691842|FG001|Overall Study|Protocol deviation|1|||
128684332|NCT00206076|463144094|FG001|Overall Study|Withdrawal by Subject|1|||
129108377|NCT01089127|464691843|FG002|Overall Study|Protocol deviation|0|||
129108378|NCT01089127|464691844|FG003|Overall Study|Protocol deviation|0|||
129108379|NCT01089127|464691845|FG004|Overall Study|Protocol deviation|1|||
129108380|NCT01089127|464691846|FG005|Overall Study|Protocol deviation|0|||
129108381|NCT01841970|464691849|FG000|Overall Study|Withdrawal by Subject|1|||
129108382|NCT01841970|464691849|FG000|Overall Study|Physician Decision|2|||
129108383|NCT01841970|464691849|FG000|Overall Study|Lost to Follow-up|8|||
129108384|NCT02592447|464691850|FG000|Overall Study|Lost to Follow-up|1|||
129108385|NCT02592447|464691851|FG001|Overall Study|Lost to Follow-up|0|||
128684333|NCT00750880|463144097|FG000|Overall Study|Adverse Event|76|||
129108386|NCT02592447|464691850|FG000|Overall Study|Ineligible after randomization|1|||
129108387|NCT02592447|464691851|FG001|Overall Study|Ineligible after randomization|0|||
129108388|NCT02592447|464691850|FG000|Overall Study|Withdrawal by Subject|0|||
128886162|NCT04796896|463879105|FG005|Overall Study|Other Than Specified|31|||
128886163|NCT04796896|463879106|FG006|Overall Study|Other Than Specified|86|||
128886164|NCT04796896|463879107|FG007|Overall Study|Other Than Specified|66|||
129108389|NCT02592447|464691851|FG001|Overall Study|Withdrawal by Subject|1|||
128886165|NCT04796896|463879108|FG008|Overall Study|Other Than Specified|388|||
129108390|NCT01048541|464691856|FG000|Overall Study|Withdrawal by Subject|1|||
129108391|NCT01048541|464691857|FG001|Overall Study|Withdrawal by Subject|0|||
129108392|NCT00627497|464691858|FG000|Overall Study|Lost to Follow-up|1|||
129108393|NCT00627497|464691859|FG001|Overall Study|Lost to Follow-up|1|||
129108394|NCT00627497|464691860|FG002|Overall Study|Lost to Follow-up|0|||
129108395|NCT00627497|464691861|FG003|Overall Study|Lost to Follow-up|0|||
129108396|NCT00327717|464691862|FG000|Overall Study|Adverse Event|6|||
129108397|NCT00327717|464691863|FG001|Overall Study|Adverse Event|6|||
129108398|NCT00327717|464691862|FG000|Overall Study|Lack of Efficacy|0|||
129108399|NCT00327717|464691863|FG001|Overall Study|Lack of Efficacy|1|||
129108400|NCT00327717|464691862|FG000|Overall Study|Withdrawal by Subject|3|||
129108401|NCT00327717|464691863|FG001|Overall Study|Withdrawal by Subject|7|||
128886166|NCT04796896|463879109|FG009|Overall Study|Other Than Specified|48|||
128886167|NCT04796896|463879110|FG010|Overall Study|Other Than Specified|258|||
128886168|NCT04796896|463879111|FG011|Overall Study|Other Than Specified|4|||
128886169|NCT04796896|463879100|FG000|Overall Study|Protocol Deviation|0|||
128886170|NCT04796896|463879101|FG001|Overall Study|Protocol Deviation|0|||
128886171|NCT04796896|463879102|FG002|Overall Study|Protocol Deviation|0|||
128886172|NCT04796896|463879103|FG003|Overall Study|Protocol Deviation|1|||
128886173|NCT04796896|463879104|FG004|Overall Study|Protocol Deviation|1|||
128886174|NCT04796896|463879105|FG005|Overall Study|Protocol Deviation|2|||
128886175|NCT04796896|463879106|FG006|Overall Study|Protocol Deviation|2|||
129108402|NCT02080364|464691864|FG000|Baseline Period|Protocol Violation|2|||
129108403|NCT02080364|464691865|FG001|Baseline Period|Protocol Violation|1|||
129108404|NCT02080364|464691866|FG002|Baseline Period|Protocol Violation|0|||
129108405|NCT02080364|464691867|FG003|Baseline Period|Protocol Violation|0|||
129108406|NCT02080364|464691864|FG000|Baseline Period|Other|0|||
129108407|NCT02080364|464691865|FG001|Baseline Period|Other|1|||
129108408|NCT02080364|464691866|FG002|Baseline Period|Other|1|||
129108409|NCT02080364|464691867|FG003|Baseline Period|Other|0|||
129108410|NCT02080364|464691864|FG000|Treatment Period|Adverse Event|10|||
129108411|NCT02080364|464691865|FG001|Treatment Period|Adverse Event|15|||
129108412|NCT02080364|464691866|FG002|Treatment Period|Adverse Event|11|||
129108413|NCT02080364|464691867|FG003|Treatment Period|Adverse Event|14|||
129108414|NCT02080364|464691864|FG000|Treatment Period|Lost to Follow-up|2|||
129108415|NCT02080364|464691865|FG001|Treatment Period|Lost to Follow-up|3|||
129108416|NCT02080364|464691866|FG002|Treatment Period|Lost to Follow-up|5|||
129108417|NCT02080364|464691867|FG003|Treatment Period|Lost to Follow-up|0|||
129108418|NCT02080364|464691864|FG000|Treatment Period|Protocol Violation|5|||
129108419|NCT02080364|464691865|FG001|Treatment Period|Protocol Violation|3|||
129108420|NCT02080364|464691866|FG002|Treatment Period|Protocol Violation|5|||
129108421|NCT02080364|464691867|FG003|Treatment Period|Protocol Violation|1|||
129108422|NCT02080364|464691864|FG000|Treatment Period|Withdrawal by Subject|16|||
129108423|NCT02080364|464691865|FG001|Treatment Period|Withdrawal by Subject|16|||
129108424|NCT02080364|464691866|FG002|Treatment Period|Withdrawal by Subject|15|||
129108425|NCT02080364|464691867|FG003|Treatment Period|Withdrawal by Subject|10|||
129108426|NCT02080364|464691864|FG000|Treatment Period|Study Terminated by Sponsor|0|||
129108427|NCT02080364|464691865|FG001|Treatment Period|Study Terminated by Sponsor|0|||
129108428|NCT02080364|464691866|FG002|Treatment Period|Study Terminated by Sponsor|180|||
129108429|NCT02080364|464691867|FG003|Treatment Period|Study Terminated by Sponsor|183|||
129108430|NCT02080364|464691864|FG000|Treatment Period|Other|14|||
129108431|NCT02080364|464691865|FG001|Treatment Period|Other|12|||
129108432|NCT02080364|464691866|FG002|Treatment Period|Other|21|||
129108433|NCT02080364|464691867|FG003|Treatment Period|Other|16|||
129108434|NCT01737879|464691868|FG000|Overall Study|Death|1|||
129108435|NCT01737879|464691868|FG000|Overall Study|Sponsor decision|40|||
129108436|NCT02497404|464691869|FG000|Overall Study|Adverse Event|1|||
129108437|NCT05285787|464691871|FG000|Overall Study|Withdrawal by Subject|1|||
129108438|NCT02360280|464691875|FG000|Overall Study|Withdrawal by Subject|2|||
129108439|NCT02360280|464691876|FG001|Overall Study|Withdrawal by Subject|0|||
129108440|NCT02360280|464691875|FG000|Overall Study|Adverse Event|0|||
129108441|NCT02360280|464691876|FG001|Overall Study|Adverse Event|1|||
129108442|NCT02360280|464691875|FG000|Overall Study|Lost to Follow-up|1|||
129108443|NCT02360280|464691876|FG001|Overall Study|Lost to Follow-up|0|||
129108444|NCT02472886|464691877|FG000|Overall Study|Lack of Efficacy|0|||
129108445|NCT02472886|464691878|FG001|Overall Study|Lack of Efficacy|2|||
129108446|NCT02472886|464691879|FG002|Overall Study|Lack of Efficacy|1|||
129108447|NCT00320788|464691880|FG000|Overall Study|Adverse Event|0|||
129108448|NCT00320788|464691881|FG001|Overall Study|Adverse Event|0|||
129108449|NCT00320788|464691882|FG002|Overall Study|Adverse Event|0|||
129108450|NCT00320788|464691883|FG003|Overall Study|Adverse Event|1|||
128886176|NCT04796896|463879107|FG007|Overall Study|Protocol Deviation|2|||
128886177|NCT04796896|463879108|FG008|Overall Study|Protocol Deviation|2|||
129108451|NCT00320788|464691884|FG004|Overall Study|Adverse Event|0|||
129108452|NCT00320788|464691880|FG000|Overall Study|Death|0|||
129108453|NCT00320788|464691881|FG001|Overall Study|Death|0|||
129108454|NCT00320788|464691882|FG002|Overall Study|Death|1|||
128886178|NCT04796896|463879109|FG009|Overall Study|Protocol Deviation|1|||
129108455|NCT00320788|464691883|FG003|Overall Study|Death|0|||
129108456|NCT00320788|464691884|FG004|Overall Study|Death|1|||
129108457|NCT00320788|464691880|FG000|Overall Study|Lost to Follow-up|0|||
129108458|NCT00320788|464691881|FG001|Overall Study|Lost to Follow-up|2|||
129108459|NCT00320788|464691882|FG002|Overall Study|Lost to Follow-up|1|||
129108460|NCT00320788|464691883|FG003|Overall Study|Lost to Follow-up|0|||
129108461|NCT00320788|464691884|FG004|Overall Study|Lost to Follow-up|0|||
129108462|NCT00320788|464691880|FG000|Overall Study|Decision by the Sponsor|1|||
129108463|NCT00320788|464691881|FG001|Overall Study|Decision by the Sponsor|1|||
129108464|NCT00320788|464691882|FG002|Overall Study|Decision by the Sponsor|0|||
129108465|NCT00320788|464691883|FG003|Overall Study|Decision by the Sponsor|0|||
129108466|NCT00320788|464691884|FG004|Overall Study|Decision by the Sponsor|1|||
129108467|NCT00320788|464691880|FG000|Overall Study|Other|1|||
129108468|NCT00320788|464691881|FG001|Overall Study|Other|2|||
129108469|NCT00320788|464691882|FG002|Overall Study|Other|1|||
129108470|NCT00320788|464691883|FG003|Overall Study|Other|1|||
129108471|NCT00320788|464691884|FG004|Overall Study|Other|1|||
129108472|NCT00320788|464691880|FG000|Overall Study|Physician Decision|1|||
129108473|NCT00320788|464691881|FG001|Overall Study|Physician Decision|1|||
129108474|NCT00320788|464691882|FG002|Overall Study|Physician Decision|0|||
129108475|NCT00320788|464691883|FG003|Overall Study|Physician Decision|0|||
129108476|NCT00320788|464691884|FG004|Overall Study|Physician Decision|0|||
129108477|NCT00320788|464691880|FG000|Overall Study|Protocol Violation|0|||
129108478|NCT00320788|464691881|FG001|Overall Study|Protocol Violation|0|||
129108479|NCT00320788|464691882|FG002|Overall Study|Protocol Violation|0|||
129108480|NCT00320788|464691883|FG003|Overall Study|Protocol Violation|0|||
129108481|NCT00320788|464691884|FG004|Overall Study|Protocol Violation|1|||
129108482|NCT00320788|464691880|FG000|Overall Study|Withdrawal by Subject|3|||
129108483|NCT00320788|464691881|FG001|Overall Study|Withdrawal by Subject|0|||
129108484|NCT00320788|464691882|FG002|Overall Study|Withdrawal by Subject|0|||
129108485|NCT00320788|464691883|FG003|Overall Study|Withdrawal by Subject|3|||
129108486|NCT00320788|464691884|FG004|Overall Study|Withdrawal by Subject|1|||
129108487|NCT00534638|464691885|FG000|Overall Study|Withdrawal by Subject|3|||
129108488|NCT00534638|464691886|FG001|Overall Study|Withdrawal by Subject|4|||
129108489|NCT00534638|464691885|FG000|Overall Study|Migrated/moved from study area|13|||
129108490|NCT00534638|464691886|FG001|Overall Study|Migrated/moved from study area|11|||
129108491|NCT00534638|464691885|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
129108492|NCT00534638|464691886|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
129108493|NCT00534638|464691885|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
129108494|NCT00534638|464691886|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
129108495|NCT00534638|464691885|FG000|Overall Study|Other|1685|||
129108496|NCT00534638|464691886|FG001|Overall Study|Other|902|||
129108497|NCT00181883|464691887|FG000|Overall Study|Lack of Efficacy|2|||
129108498|NCT00181883|464691887|FG000|Overall Study|Treatment Limiting AEs|3|||
129108499|NCT00181883|464691887|FG000|Overall Study|Withdrawal by Subject|4|||
129108500|NCT00181883|464691887|FG000|Overall Study|Lost to Follow-up|1|||
129108501|NCT00765817|464691888|FG000|Overall Study|Adverse Event|13|||
129108502|NCT00765817|464691889|FG001|Overall Study|Adverse Event|1|||
129108503|NCT00765817|464691888|FG000|Overall Study|Death|0|||
129108504|NCT00765817|464691889|FG001|Overall Study|Death|1|||
128886179|NCT04796896|463879110|FG010|Overall Study|Protocol Deviation|0|||
128886180|NCT04796896|463879111|FG011|Overall Study|Protocol Deviation|0|||
128886181|NCT04796896|463879100|FG000|Overall Study|Missing|0|||
129108505|NCT00765817|464691888|FG000|Overall Study|Entry criteria not met|2|||
129108506|NCT00765817|464691889|FG001|Overall Study|Entry criteria not met|2|||
129108507|NCT00765817|464691888|FG000|Overall Study|Loss of glucose control|0|||
129108508|NCT00765817|464691889|FG001|Overall Study|Loss of glucose control|2|||
129108509|NCT00765817|464691888|FG000|Overall Study|Lost to Follow-up|1|||
129108510|NCT00765817|464691889|FG001|Overall Study|Lost to Follow-up|3|||
129108511|NCT00765817|464691888|FG000|Overall Study|Physician Decision|2|||
129108512|NCT00765817|464691889|FG001|Overall Study|Physician Decision|1|||
128684334|NCT00750880|463144097|FG000|Overall Study|Death|4|||
128684335|NCT00750880|463144097|FG000|Overall Study|Lack of Efficacy|46|||
128684336|NCT00750880|463144097|FG000|Overall Study|Lost to Follow-up|10|||
128886182|NCT04796896|463879101|FG001|Overall Study|Missing|0|||
128886183|NCT04796896|463879102|FG002|Overall Study|Missing|0|||
128886184|NCT04796896|463879103|FG003|Overall Study|Missing|0|||
129108513|NCT00765817|464691888|FG000|Overall Study|Protocol Violation|1|||
129108514|NCT00765817|464691889|FG001|Overall Study|Protocol Violation|1|||
129108515|NCT00765817|464691888|FG000|Overall Study|Subject decision|7|||
129108516|NCT00765817|464691889|FG001|Overall Study|Subject decision|11|||
129108517|NCT01302418|464693532|FG000|Overall Study|Protocol Violation|9|||
129108518|NCT01302418|464693532|FG000|Overall Study|Non-evaluable|9|||
129108519|NCT00377637|464693533|FG000|Induction Phase|Adverse Event|12|||
129108520|NCT00377637|464693534|FG001|Induction Phase|Adverse Event|21|||
129108521|NCT00377637|464693535|FG002|Induction Phase|Adverse Event|0|||
129108522|NCT00377637|464693536|FG003|Induction Phase|Adverse Event|0|||
129108523|NCT00377637|464693533|FG000|Induction Phase|Deterioration/serum creatinine|2|||
128886185|NCT04796896|463879104|FG004|Overall Study|Missing|0|||
129108524|NCT00377637|464693534|FG001|Induction Phase|Deterioration/serum creatinine|0|||
129108525|NCT00377637|464693535|FG002|Induction Phase|Deterioration/serum creatinine|0|||
128684337|NCT00750880|463144097|FG000|Overall Study|Protocol Violation|15|||
128684338|NCT00750880|463144097|FG000|Overall Study|Withdrawal by Subject|33|||
128684339|NCT00750880|463144097|FG000|Overall Study|Physician Decision|20|||
128684340|NCT00750880|463144097|FG000|Overall Study|Administrative|11|||
128684341|NCT02964507|463144101|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
128684342|NCT02964507|463144102|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
128684343|NCT02964507|463144103|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
128684344|NCT02964507|463144104|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
128684345|NCT02964507|463144105|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
128684346|NCT02964507|463144106|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
128684347|NCT02964507|463144107|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
128684348|NCT02964507|463144108|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
128684349|NCT02964507|463144101|FG000|Overall Study|Study terminated by Sponsor|9|||
128684350|NCT02964507|463144102|FG001|Overall Study|Study terminated by Sponsor|1|||
128684351|NCT02964507|463144103|FG002|Overall Study|Study terminated by Sponsor|9|||
128684352|NCT02964507|463144104|FG003|Overall Study|Study terminated by Sponsor|3|||
128684353|NCT02964507|463144105|FG004|Overall Study|Study terminated by Sponsor|3|||
128684354|NCT02964507|463144106|FG005|Overall Study|Study terminated by Sponsor|2|||
128684355|NCT02964507|463144107|FG006|Overall Study|Study terminated by Sponsor|0|||
128684356|NCT02964507|463144108|FG007|Overall Study|Study terminated by Sponsor|0|||
128684357|NCT02964507|463144101|FG000|Overall Study|Other|3|||
128684358|NCT02964507|463144102|FG001|Overall Study|Other|0|||
128684359|NCT02964507|463144103|FG002|Overall Study|Other|0|||
128684360|NCT02964507|463144104|FG003|Overall Study|Other|0|||
128684361|NCT02964507|463144105|FG004|Overall Study|Other|1|||
128684362|NCT02964507|463144106|FG005|Overall Study|Other|0|||
128684363|NCT02964507|463144107|FG006|Overall Study|Other|0|||
128684364|NCT02964507|463144108|FG007|Overall Study|Other|0|||
128684365|NCT02964507|463144101|FG000|Overall Study|Death|11|||
128684366|NCT02964507|463144102|FG001|Overall Study|Death|9|||
128684367|NCT02964507|463144103|FG002|Overall Study|Death|12|||
128684368|NCT02964507|463144104|FG003|Overall Study|Death|2|||
128684369|NCT02964507|463144105|FG004|Overall Study|Death|10|||
128684370|NCT02964507|463144106|FG005|Overall Study|Death|5|||
128684371|NCT02964507|463144107|FG006|Overall Study|Death|0|||
128684372|NCT02964507|463144108|FG007|Overall Study|Death|0|||
128684373|NCT02964507|463144101|FG000|Overall Study|Withdrawal by Subject|1|||
129020112|NCT03616535|464367043|FG000|Overall Study|Lost to Follow-up|2|||
129020113|NCT03616535|464367044|FG001|Overall Study|Lost to Follow-up|1|||
129020114|NCT03616535|464367045|FG002|Overall Study|Lost to Follow-up|0|||
129020115|NCT03616535|464367046|FG003|Overall Study|Lost to Follow-up|2|||
129020116|NCT03616535|464367043|FG000|Overall Study|Withdrawal by Subject|1|||
129020117|NCT03616535|464367044|FG001|Overall Study|Withdrawal by Subject|2|||
129020118|NCT03616535|464367045|FG002|Overall Study|Withdrawal by Subject|5|||
129020119|NCT03616535|464367046|FG003|Overall Study|Withdrawal by Subject|1|||
129020120|NCT03616535|464367043|FG000|Overall Study|Not specified or change in eligibility|2|||
129020121|NCT03616535|464367044|FG001|Overall Study|Not specified or change in eligibility|3|||
129020122|NCT03616535|464367045|FG002|Overall Study|Not specified or change in eligibility|3|||
129020123|NCT03616535|464367046|FG003|Overall Study|Not specified or change in eligibility|1|||
129020124|NCT02146105|464367049|FG000|Overall Study|Adverse Event|1|||
129020125|NCT02146105|464367049|FG000|Overall Study|Withdrawal by Subject|5|||
129020126|NCT05755282|464367050|FG000|Overall Study|Protocol Violation|0|||
129020127|NCT05755282|464367051|FG001|Overall Study|Protocol Violation|1|||
129020128|NCT03935880|464367053|FG000|Overall Study|Lost to Follow-up|0|||
129020129|NCT03935880|464367054|FG001|Overall Study|Lost to Follow-up|1|||
129020130|NCT02476994|464367055|FG000|Overall Study|Based on feedback from FDA|1|||
129020131|NCT02476994|464367056|FG001|Overall Study|Based on feedback from FDA|0|||
129020132|NCT02563561|464367057|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
129020133|NCT02563561|464367058|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
129020134|NCT02563561|464367059|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
129020135|NCT02563561|464367057|FG000|Overall Study|Withdrew of Consent|1|||
129020136|NCT02563561|464367058|FG001|Overall Study|Withdrew of Consent|1|||
129020137|NCT02563561|464367059|FG002|Overall Study|Withdrew of Consent|2|||
129020138|NCT02563561|464367057|FG000|Overall Study|Lost to Follow-up|1|||
129020139|NCT02563561|464367058|FG001|Overall Study|Lost to Follow-up|1|||
128684374|NCT02964507|463144102|FG001|Overall Study|Withdrawal by Subject|0|||
128684375|NCT02964507|463144103|FG002|Overall Study|Withdrawal by Subject|1|||
128684376|NCT02964507|463144104|FG003|Overall Study|Withdrawal by Subject|1|||
128684377|NCT02964507|463144105|FG004|Overall Study|Withdrawal by Subject|0|||
129020140|NCT02563561|464367059|FG002|Overall Study|Lost to Follow-up|0|||
129020141|NCT02563561|464367057|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
129020142|NCT02563561|464367058|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
128684378|NCT02964507|463144106|FG005|Overall Study|Withdrawal by Subject|1|||
128684379|NCT02964507|463144107|FG006|Overall Study|Withdrawal by Subject|0|||
128684380|NCT02964507|463144108|FG007|Overall Study|Withdrawal by Subject|0|||
128684381|NCT02964507|463144101|FG000|Overall Study|Physician Decision|2|||
128886186|NCT04796896|463879105|FG005|Overall Study|Missing|0|||
128886187|NCT04796896|463879106|FG006|Overall Study|Missing|2|||
128886188|NCT04796896|463879107|FG007|Overall Study|Missing|1|||
128886189|NCT04796896|463879108|FG008|Overall Study|Missing|2|||
128886190|NCT04796896|463879109|FG009|Overall Study|Missing|1|||
128886191|NCT04796896|463879110|FG010|Overall Study|Missing|1|||
128886192|NCT04796896|463879111|FG011|Overall Study|Missing|0|||
128886193|NCT04796896|463879100|FG000|Overall Study|Death|0|||
128886194|NCT04796896|463879101|FG001|Overall Study|Death|0|||
128886195|NCT04796896|463879102|FG002|Overall Study|Death|0|||
128886196|NCT04796896|463879103|FG003|Overall Study|Death|0|||
128886197|NCT04796896|463879104|FG004|Overall Study|Death|0|||
128886198|NCT04796896|463879105|FG005|Overall Study|Death|0|||
128886199|NCT04796896|463879106|FG006|Overall Study|Death|0|||
128886200|NCT04796896|463879107|FG007|Overall Study|Death|0|||
128886201|NCT04796896|463879108|FG008|Overall Study|Death|1|||
129020143|NCT02563561|464367059|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
129020144|NCT02563561|464367057|FG000|Overall Study|Investigator Decision|3|||
129020145|NCT02563561|464367058|FG001|Overall Study|Investigator Decision|4|||
129020146|NCT02563561|464367059|FG002|Overall Study|Investigator Decision|2|||
129020147|NCT02563561|464367057|FG000|Overall Study|Sponsor Decision|5|||
129020148|NCT02563561|464367058|FG001|Overall Study|Sponsor Decision|2|||
129020149|NCT02563561|464367059|FG002|Overall Study|Sponsor Decision|4|||
129020150|NCT02563561|464367057|FG000|Overall Study|Other|1|||
129020151|NCT02563561|464367058|FG001|Overall Study|Other|5|||
129020152|NCT02563561|464367059|FG002|Overall Study|Other|2|||
129020153|NCT02646124|464367062|FG000|Overall Study|Lost to Follow-up|0|||
129020154|NCT02646124|464367063|FG001|Overall Study|Lost to Follow-up|2|||
129020155|NCT03154047|464367064|FG000|Overall Study|Death|1|||
129020156|NCT03154047|464367064|FG000|Overall Study|Study terminated by sponsor|76|||
129020157|NCT03154047|464367064|FG000|Overall Study|Withdrawal by Subject|3|||
129020158|NCT00857454|464367065|FG000|Overall Study|Withdrawal by Subject|2|||
129020159|NCT00857454|464367065|FG000|Overall Study|Lost to Follow-up|1|||
129020160|NCT00857454|464367065|FG000|Overall Study|Adverse Event|2|||
129020161|NCT00857454|464367065|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
129020162|NCT00857454|464367065|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
129020163|NCT00857454|464367065|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
129020164|NCT00365365|464367066|FG000|Overall Study|Randomized but not treated|0|||
129020165|NCT00365365|464367067|FG001|Overall Study|Randomized but not treated|2|||
129020166|NCT00365365|464367068|FG002|Overall Study|Randomized but not treated|0|||
129020167|NCT00365365|464367066|FG000|Overall Study|Poor compliance to protocol|0|||
129020168|NCT00365365|464367067|FG001|Overall Study|Poor compliance to protocol|1|||
129020169|NCT00365365|464367068|FG002|Overall Study|Poor compliance to protocol|0|||
129020170|NCT00365365|464367066|FG000|Overall Study|Lost to Follow-up|3|||
129020171|NCT00365365|464367067|FG001|Overall Study|Lost to Follow-up|3|||
129020172|NCT00365365|464367068|FG002|Overall Study|Lost to Follow-up|3|||
129020173|NCT00365365|464367066|FG000|Overall Study|Death|1|||
129020174|NCT00365365|464367067|FG001|Overall Study|Death|3|||
129020175|NCT00365365|464367068|FG002|Overall Study|Death|0|||
129020176|NCT00365365|464367066|FG000|Overall Study|Subject's request|11|||
129020177|NCT00365365|464367067|FG001|Overall Study|Subject's request|13|||
129020178|NCT00365365|464367068|FG002|Overall Study|Subject's request|1|||
129020179|NCT00365365|464367066|FG000|Overall Study|Disease progression/relapse|9|||
129020180|NCT00365365|464367067|FG001|Overall Study|Disease progression/relapse|6|||
129020181|NCT00365365|464367068|FG002|Overall Study|Disease progression/relapse|7|||
129020182|NCT00365365|464367066|FG000|Overall Study|Adverse Event|6|||
129020183|NCT00365365|464367067|FG001|Overall Study|Adverse Event|6|||
129020184|NCT00365365|464367068|FG002|Overall Study|Adverse Event|3|||
129020185|NCT00365365|464367066|FG000|Overall Study|Moved|2|||
129020186|NCT00365365|464367067|FG001|Overall Study|Moved|0|||
129020187|NCT00365365|464367068|FG002|Overall Study|Moved|0|||
129020188|NCT00365365|464367066|FG000|Overall Study|New cancer|1|||
129020189|NCT00365365|464367067|FG001|Overall Study|New cancer|0|||
129020190|NCT00365365|464367068|FG002|Overall Study|New cancer|0|||
128886202|NCT04796896|463879109|FG009|Overall Study|Death|0|||
128886203|NCT04796896|463879110|FG010|Overall Study|Death|0|||
128886204|NCT04796896|463879111|FG011|Overall Study|Death|0|||
128886205|NCT04356183|463879112|FG000|Overall Study|Lost to Follow-up|1|||
129020191|NCT00365365|464367066|FG000|Overall Study|Withdrew consent|1|||
129020192|NCT00365365|464367067|FG001|Overall Study|Withdrew consent|1|||
129020193|NCT00365365|464367068|FG002|Overall Study|Withdrew consent|0|||
129020194|NCT00365365|464367066|FG000|Overall Study|Second malignancy|0|||
129020195|NCT00365365|464367067|FG001|Overall Study|Second malignancy|1|||
129020196|NCT00365365|464367068|FG002|Overall Study|Second malignancy|0|||
129020197|NCT00365365|464367066|FG000|Overall Study|Patient/physician decision|0|||
128886206|NCT04356183|463879113|FG001|Overall Study|Lost to Follow-up|0|||
128886207|NCT04356183|463879112|FG000|Overall Study|Withdrawal by Subject|1|||
128886208|NCT04356183|463879113|FG001|Overall Study|Withdrawal by Subject|1|||
128886209|NCT01177787|463879114|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
129020198|NCT00365365|464367067|FG001|Overall Study|Patient/physician decision|0|||
129020199|NCT00365365|464367068|FG002|Overall Study|Patient/physician decision|1|||
129108526|NCT00377637|464693536|FG003|Induction Phase|Deterioration/serum creatinine|0|||
129108527|NCT00377637|464693533|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
129108528|NCT00377637|464693534|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
129108529|NCT00377637|464693535|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
129108530|NCT00377637|464693536|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
129108531|NCT00377637|464693533|FG000|Induction Phase|Lost to Follow-up|2|||
129108532|NCT00377637|464693534|FG001|Induction Phase|Lost to Follow-up|1|||
129108533|NCT00377637|464693535|FG002|Induction Phase|Lost to Follow-up|0|||
129108534|NCT00377637|464693536|FG003|Induction Phase|Lost to Follow-up|0|||
129108535|NCT00377637|464693533|FG000|Induction Phase|Death|1|||
129108536|NCT00377637|464693534|FG001|Induction Phase|Death|3|||
129108537|NCT00377637|464693535|FG002|Induction Phase|Death|0|||
129108538|NCT00377637|464693536|FG003|Induction Phase|Death|0|||
129108539|NCT00377637|464693533|FG000|Induction Phase|Withdrawal by Subject|5|||
129108540|NCT00377637|464693534|FG001|Induction Phase|Withdrawal by Subject|6|||
129108541|NCT00377637|464693535|FG002|Induction Phase|Withdrawal by Subject|0|||
129108542|NCT00377637|464693536|FG003|Induction Phase|Withdrawal by Subject|0|||
129108543|NCT00377637|464693533|FG000|Induction Phase|Physician Decision|3|||
129108544|NCT00377637|464693534|FG001|Induction Phase|Physician Decision|1|||
129108545|NCT00377637|464693535|FG002|Induction Phase|Physician Decision|0|||
129108546|NCT00377637|464693536|FG003|Induction Phase|Physician Decision|0|||
129108547|NCT00377637|464693533|FG000|Induction Phase|Sponsor decision|1|||
129108548|NCT00377637|464693534|FG001|Induction Phase|Sponsor decision|2|||
129108549|NCT00377637|464693535|FG002|Induction Phase|Sponsor decision|0|||
129108550|NCT00377637|464693536|FG003|Induction Phase|Sponsor decision|0|||
129108551|NCT00377637|464693533|FG000|Induction Phase|Non-Compliance|1|||
129108552|NCT00377637|464693534|FG001|Induction Phase|Non-Compliance|0|||
129108553|NCT00377637|464693535|FG002|Induction Phase|Non-Compliance|0|||
129108554|NCT00377637|464693536|FG003|Induction Phase|Non-Compliance|0|||
129108555|NCT00377637|464693533|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
129108556|NCT00377637|464693534|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
129108557|NCT00377637|464693535|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
129108558|NCT00377637|464693536|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
129108559|NCT00377637|464693533|FG000|Maintenance Phase|Adverse Event|0|||
129108560|NCT00377637|464693534|FG001|Maintenance Phase|Adverse Event|0|||
129108561|NCT00377637|464693535|FG002|Maintenance Phase|Adverse Event|29|||
129108562|NCT00377637|464693536|FG003|Maintenance Phase|Adverse Event|43|||
129108563|NCT00377637|464693533|FG000|Maintenance Phase|Physician Decision|0|||
129108564|NCT00377637|464693534|FG001|Maintenance Phase|Physician Decision|0|||
129108565|NCT00377637|464693535|FG002|Maintenance Phase|Physician Decision|5|||
129108566|NCT00377637|464693536|FG003|Maintenance Phase|Physician Decision|4|||
129108567|NCT00377637|464693533|FG000|Maintenance Phase|Lost to Follow-up|0|||
129108568|NCT00377637|464693534|FG001|Maintenance Phase|Lost to Follow-up|0|||
129108569|NCT00377637|464693535|FG002|Maintenance Phase|Lost to Follow-up|3|||
129108570|NCT00377637|464693536|FG003|Maintenance Phase|Lost to Follow-up|1|||
128684382|NCT02964507|463144102|FG001|Overall Study|Physician Decision|0|||
128684383|NCT02964507|463144103|FG002|Overall Study|Physician Decision|3|||
128684384|NCT02964507|463144104|FG003|Overall Study|Physician Decision|0|||
128684385|NCT02964507|463144105|FG004|Overall Study|Physician Decision|1|||
128684386|NCT02964507|463144106|FG005|Overall Study|Physician Decision|0|||
128684387|NCT02964507|463144107|FG006|Overall Study|Physician Decision|0|||
128684388|NCT02964507|463144108|FG007|Overall Study|Physician Decision|0|||
128684389|NCT02495233|463144109|FG000|Overall Study|Miscellaneous|0|||
128684390|NCT02495233|463144110|FG001|Overall Study|Miscellaneous|1|||
128684391|NCT03880461|463144111|FG000|Overall Study|Determined ineligible after enrollment|45|||
129108571|NCT00377637|464693533|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129108572|NCT00377637|464693534|FG001|Maintenance Phase|Withdrawal by Subject|0|||
128684392|NCT03880461|463144112|FG001|Overall Study|Determined ineligible after enrollment|44|||
128684393|NCT03880461|463144111|FG000|Overall Study|No weight measurement after enrollment|24|||
128684394|NCT03880461|463144112|FG001|Overall Study|No weight measurement after enrollment|17|||
128684395|NCT02652767|463144114|FG000|Overall Study|Death|2|||
128684396|NCT02652767|463144114|FG000|Overall Study|Lost to Follow-up|1|||
128684397|NCT02652767|463144114|FG000|Overall Study|Withdrawal by Subject|1|||
128684398|NCT01642407|463144116|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
128684399|NCT01642407|463144116|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
128684400|NCT01642407|463144116|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
129108573|NCT00377637|464693535|FG002|Maintenance Phase|Withdrawal by Subject|3|||
129108574|NCT00377637|464693536|FG003|Maintenance Phase|Withdrawal by Subject|3|||
129108575|NCT00377637|464693533|FG000|Maintenance Phase|Sponsor decision|0|||
129108576|NCT00377637|464693534|FG001|Maintenance Phase|Sponsor decision|0|||
129108577|NCT00377637|464693535|FG002|Maintenance Phase|Sponsor decision|2|||
129108578|NCT00377637|464693536|FG003|Maintenance Phase|Sponsor decision|3|||
129108579|NCT00377637|464693533|FG000|Maintenance Phase|Non-compliance|0|||
129108580|NCT00377637|464693534|FG001|Maintenance Phase|Non-compliance|0|||
129108581|NCT00377637|464693535|FG002|Maintenance Phase|Non-compliance|1|||
129108582|NCT00377637|464693536|FG003|Maintenance Phase|Non-compliance|1|||
128886210|NCT01177787|463879114|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
128886211|NCT01177787|463879114|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
129020200|NCT00984022|464367069|FG000|Overall Study|Lost to Follow-up|10|||
129020201|NCT00984022|464367070|FG001|Overall Study|Lost to Follow-up|14|||
129020202|NCT00573443|464367074|FG000|Double-Blind Phase|Lost to Follow-up|1|||
129020203|NCT00573443|464367075|FG001|Double-Blind Phase|Lost to Follow-up|3|||
129020204|NCT00573443|464367076|FG002|Double-Blind Phase|Lost to Follow-up|2|||
129020205|NCT00573443|464367074|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
129020206|NCT00573443|464367075|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
129020207|NCT00573443|464367076|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
129020208|NCT00573443|464367074|FG000|Double-Blind Phase|Adverse Event|1|||
129020209|NCT00573443|464367075|FG001|Double-Blind Phase|Adverse Event|5|||
129020210|NCT00573443|464367076|FG002|Double-Blind Phase|Adverse Event|0|||
129020211|NCT00573443|464367074|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
129020212|NCT00573443|464367075|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
129020213|NCT00573443|464367076|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
129020214|NCT00573443|464367074|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
129020215|NCT00573443|464367075|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
129020216|NCT00573443|464367076|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
129020217|NCT00573443|464367074|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129020218|NCT00573443|464367075|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
129020219|NCT00573443|464367076|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
129020220|NCT00573443|464367074|FG000|Double-Blind Phase|Protocol Violation|0|||
129020221|NCT00573443|464367075|FG001|Double-Blind Phase|Protocol Violation|2|||
129020222|NCT00573443|464367076|FG002|Double-Blind Phase|Protocol Violation|1|||
129020223|NCT00573443|464367074|FG000|Double-Blind Phase|Other|0|||
129020224|NCT00573443|464367075|FG001|Double-Blind Phase|Other|2|||
129020225|NCT00573443|464367076|FG002|Double-Blind Phase|Other|3|||
128886212|NCT00402363|463879117|FG000|Overall Study|Adverse Event|9|||
128886213|NCT00402363|463879118|FG001|Overall Study|Adverse Event|14|||
128886214|NCT00402363|463879119|FG002|Overall Study|Adverse Event|2|||
128886215|NCT00402363|463879120|FG003|Overall Study|Adverse Event|2|||
128886216|NCT00402363|463879117|FG000|Overall Study|Withdrew Consent|10|||
128886217|NCT00402363|463879118|FG001|Overall Study|Withdrew Consent|5|||
128886218|NCT00402363|463879119|FG002|Overall Study|Withdrew Consent|2|||
128886219|NCT00402363|463879120|FG003|Overall Study|Withdrew Consent|1|||
128886220|NCT00402363|463879117|FG000|Overall Study|Protocol Violation|3|||
128886221|NCT00402363|463879118|FG001|Overall Study|Protocol Violation|5|||
129020226|NCT00573443|464367074|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
129020227|NCT00573443|464367075|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129020228|NCT00573443|464367076|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129020229|NCT00573443|464367074|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
129020230|NCT00573443|464367075|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
129020231|NCT00573443|464367076|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
129020232|NCT00573443|464367074|FG000|Open-Label Extension Phase|Adverse Event|3|||
129020233|NCT00573443|464367075|FG001|Open-Label Extension Phase|Adverse Event|0|||
129020234|NCT00573443|464367076|FG002|Open-Label Extension Phase|Adverse Event|0|||
129020235|NCT00573443|464367074|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
129020236|NCT00573443|464367075|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
129020237|NCT00573443|464367076|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
129020238|NCT00573443|464367074|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
129020239|NCT00573443|464367075|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
129020240|NCT00573443|464367076|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
129020241|NCT00573443|464367074|FG000|Open-Label Extension Phase|Protocol Violation|2|||
129020242|NCT00573443|464367075|FG001|Open-Label Extension Phase|Protocol Violation|0|||
129020243|NCT00573443|464367076|FG002|Open-Label Extension Phase|Protocol Violation|0|||
129020244|NCT00573443|464367074|FG000|Open-Label Extension Phase|Other|2|||
129020245|NCT00573443|464367075|FG001|Open-Label Extension Phase|Other|0|||
129020246|NCT00573443|464367076|FG002|Open-Label Extension Phase|Other|0|||
129020247|NCT00905606|464367077|FG000|Period 1|Adverse Event|0|||
129020248|NCT00905606|464367078|FG001|Period 1|Adverse Event|1|||
129020249|NCT00905606|464367077|FG000|Washout|Withdrawal by Subject|1|||
129020250|NCT00905606|464367078|FG001|Washout|Withdrawal by Subject|0|||
129020251|NCT00804856|464367081|FG000|Overall Study|Progressive Disease|3|||
129020252|NCT00804856|464367082|FG001|Overall Study|Progressive Disease|2|||
129020253|NCT00804856|464367083|FG002|Overall Study|Progressive Disease|4|||
129020254|NCT00804856|464367084|FG003|Overall Study|Progressive Disease|6|||
129108583|NCT00377637|464693533|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
129020255|NCT00804856|464367085|FG004|Overall Study|Progressive Disease|4|||
129020256|NCT00804856|464367086|FG005|Overall Study|Progressive Disease|1|||
129020257|NCT00804856|464367087|FG006|Overall Study|Progressive Disease|8|||
129020258|NCT00804856|464367088|FG007|Overall Study|Progressive Disease|2|||
129020259|NCT00804856|464367089|FG008|Overall Study|Progressive Disease|4|||
129020260|NCT00804856|464367090|FG009|Overall Study|Progressive Disease|5|||
129020261|NCT00804856|464367091|FG010|Overall Study|Progressive Disease|12|||
129020262|NCT00804856|464367092|FG011|Overall Study|Progressive Disease|2|||
128886222|NCT00402363|463879119|FG002|Overall Study|Protocol Violation|0|||
128886223|NCT00402363|463879120|FG003|Overall Study|Protocol Violation|3|||
128886224|NCT00402363|463879117|FG000|Overall Study|Lost to Follow-up|5|||
128886225|NCT00402363|463879118|FG001|Overall Study|Lost to Follow-up|4|||
128886226|NCT00402363|463879119|FG002|Overall Study|Lost to Follow-up|0|||
128886227|NCT00402363|463879120|FG003|Overall Study|Lost to Follow-up|2|||
128886228|NCT00402363|463879117|FG000|Overall Study|"Captured as Other"|6|||
128886229|NCT00402363|463879118|FG001|Overall Study|"Captured as Other"|2|||
128886230|NCT00402363|463879119|FG002|Overall Study|"Captured as Other"|2|||
128886231|NCT00402363|463879120|FG003|Overall Study|"Captured as Other"|2|||
128886232|NCT00293722|463879121|FG000|Overall Study|Other|427|||
128886233|NCT02634346|463879123|FG000|Overall Study|Withdrawal by Subject|8|||
128886234|NCT02634346|463879124|FG001|Overall Study|Withdrawal by Subject|9|||
128886235|NCT02634346|463879125|FG002|Overall Study|Withdrawal by Subject|8|||
128886236|NCT02634346|463879123|FG000|Overall Study|Adverse Event|2|||
128886237|NCT02634346|463879124|FG001|Overall Study|Adverse Event|2|||
128886238|NCT02634346|463879125|FG002|Overall Study|Adverse Event|7|||
128886239|NCT02634346|463879123|FG000|Overall Study|Lack of Efficacy|1|||
128886240|NCT02634346|463879124|FG001|Overall Study|Lack of Efficacy|2|||
128886241|NCT02634346|463879125|FG002|Overall Study|Lack of Efficacy|8|||
128886242|NCT02634346|463879123|FG000|Overall Study|Lost to Follow-up|1|||
128886243|NCT02634346|463879124|FG001|Overall Study|Lost to Follow-up|0|||
128886244|NCT02634346|463879125|FG002|Overall Study|Lost to Follow-up|0|||
128886245|NCT02634346|463879123|FG000|Overall Study|Protocol Violation|0|||
128886246|NCT02634346|463879124|FG001|Overall Study|Protocol Violation|1|||
128886247|NCT02634346|463879125|FG002|Overall Study|Protocol Violation|0|||
129108584|NCT00377637|464693534|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
129108585|NCT00377637|464693535|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
129108586|NCT00377637|464693536|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
129108587|NCT00377637|464693533|FG000|Maintenance Phase|Death|0|||
129108588|NCT00377637|464693534|FG001|Maintenance Phase|Death|0|||
129108589|NCT00377637|464693535|FG002|Maintenance Phase|Death|0|||
129108590|NCT00377637|464693536|FG003|Maintenance Phase|Death|1|||
129108591|NCT04147247|464693538|FG000|Overall Study|Progressive disease|3|||
129108592|NCT04147247|464693539|FG001|Overall Study|Progressive disease|3|||
129108593|NCT04147247|464693540|FG002|Overall Study|Progressive disease|4|||
129108594|NCT04147247|464693541|FG003|Overall Study|Progressive disease|4|||
129108595|NCT04147247|464693542|FG004|Overall Study|Progressive disease|3|||
129108596|NCT04147247|464693538|FG000|Overall Study|Physician Decision|0|||
129108597|NCT04147247|464693539|FG001|Overall Study|Physician Decision|1|||
129108598|NCT04147247|464693540|FG002|Overall Study|Physician Decision|0|||
129108599|NCT04147247|464693541|FG003|Overall Study|Physician Decision|0|||
129108600|NCT04147247|464693542|FG004|Overall Study|Physician Decision|0|||
129108601|NCT04147247|464693538|FG000|Overall Study|Clinical Disease Progression|0|||
129108602|NCT04147247|464693539|FG001|Overall Study|Clinical Disease Progression|0|||
129108603|NCT04147247|464693540|FG002|Overall Study|Clinical Disease Progression|0|||
129108604|NCT04147247|464693541|FG003|Overall Study|Clinical Disease Progression|0|||
129108605|NCT04147247|464693542|FG004|Overall Study|Clinical Disease Progression|1|||
129108606|NCT04147247|464693538|FG000|Overall Study|Adverse Event|0|||
129108607|NCT04147247|464693539|FG001|Overall Study|Adverse Event|0|||
129108608|NCT04147247|464693540|FG002|Overall Study|Adverse Event|1|||
129108609|NCT04147247|464693541|FG003|Overall Study|Adverse Event|0|||
129108610|NCT04147247|464693542|FG004|Overall Study|Adverse Event|1|||
129108611|NCT00994110|464693543|FG000|Overall Study|Withdrawal by Subject|9|||
129108612|NCT00994110|464693544|FG001|Overall Study|Withdrawal by Subject|9|||
129108613|NCT00994110|464693543|FG000|Overall Study|Not Treated|4|||
129108614|NCT00994110|464693544|FG001|Overall Study|Not Treated|8|||
129108615|NCT00994110|464693543|FG000|Overall Study|Adverse Event|1|||
129108616|NCT00994110|464693544|FG001|Overall Study|Adverse Event|0|||
128684401|NCT01369485|463144118|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
128886248|NCT02824263|463879126|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
128886249|NCT02824263|463879127|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
128886250|NCT02824263|463879126|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
128886251|NCT02824263|463879127|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
129108617|NCT00994110|464693543|FG000|Overall Study|Patient not resected|41|||
129108618|NCT00994110|464693544|FG001|Overall Study|Patient not resected|52|||
129108619|NCT00994110|464693543|FG000|Overall Study|Pt not eligible|10|||
129108620|NCT00994110|464693544|FG001|Overall Study|Pt not eligible|5|||
129108621|NCT01111565|464693545|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
129108622|NCT01111565|464693546|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
129108623|NCT01111565|464693547|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
129108624|NCT01111565|464693548|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
129108625|NCT01111565|464693549|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
128886252|NCT00568321|463879128|FG000|Overall Study|Adverse Event|1|||
128886253|NCT00568321|463879129|FG001|Overall Study|Adverse Event|0|||
128886254|NCT00568321|463879130|FG002|Overall Study|Adverse Event|0|||
128886255|NCT00568321|463879128|FG000|Overall Study|Lack of Efficacy|8|||
129108626|NCT01111565|464693545|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
128684402|NCT01369485|463144119|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
128684403|NCT01369485|463144118|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
128684404|NCT01369485|463144119|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
128684405|NCT01369485|463144118|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
128684406|NCT01369485|463144119|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
128684407|NCT01369485|463144118|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
128684408|NCT01369485|463144119|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
128886256|NCT00568321|463879129|FG001|Overall Study|Lack of Efficacy|5|||
128886257|NCT00568321|463879130|FG002|Overall Study|Lack of Efficacy|6|||
128886258|NCT00568321|463879128|FG000|Overall Study|Lost to Follow-up|0|||
129020263|NCT00804856|464367093|FG012|Overall Study|Progressive Disease|2|||
129020264|NCT00804856|464367094|FG013|Overall Study|Progressive Disease|26|||
129020265|NCT00804856|464367095|FG014|Overall Study|Progressive Disease|20|||
129020266|NCT00804856|464367081|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020267|NCT00804856|464367082|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020268|NCT00804856|464367083|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020269|NCT00804856|464367084|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020270|NCT00804856|464367085|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129020271|NCT00804856|464367086|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020272|NCT00804856|464367087|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020273|NCT00804856|464367088|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020274|NCT00804856|464367089|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020275|NCT00804856|464367090|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020276|NCT00804856|464367091|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020277|NCT00804856|464367092|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020278|NCT00804856|464367093|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020279|NCT00804856|464367094|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129020280|NCT00804856|464367095|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129020281|NCT00804856|464367081|FG000|Overall Study|Other Adverse Event|1|||
129020282|NCT00804856|464367082|FG001|Overall Study|Other Adverse Event|1|||
129020283|NCT00804856|464367083|FG002|Overall Study|Other Adverse Event|1|||
129020284|NCT00804856|464367084|FG003|Overall Study|Other Adverse Event|2|||
129020285|NCT00804856|464367085|FG004|Overall Study|Other Adverse Event|2|||
129020286|NCT00804856|464367086|FG005|Overall Study|Other Adverse Event|1|||
129020287|NCT00804856|464367087|FG006|Overall Study|Other Adverse Event|3|||
129020288|NCT00804856|464367088|FG007|Overall Study|Other Adverse Event|0|||
129020289|NCT00804856|464367089|FG008|Overall Study|Other Adverse Event|0|||
129020290|NCT00804856|464367090|FG009|Overall Study|Other Adverse Event|1|||
129020291|NCT00804856|464367091|FG010|Overall Study|Other Adverse Event|5|||
129020292|NCT00804856|464367092|FG011|Overall Study|Other Adverse Event|2|||
129020293|NCT00804856|464367093|FG012|Overall Study|Other Adverse Event|0|||
129020294|NCT00804856|464367094|FG013|Overall Study|Other Adverse Event|6|||
129020295|NCT00804856|464367095|FG014|Overall Study|Other Adverse Event|13|||
129020296|NCT00804856|464367081|FG000|Overall Study|Non compliance with protocol|0|||
129020297|NCT00804856|464367082|FG001|Overall Study|Non compliance with protocol|0|||
129020298|NCT00804856|464367083|FG002|Overall Study|Non compliance with protocol|0|||
129020299|NCT00804856|464367084|FG003|Overall Study|Non compliance with protocol|0|||
129020300|NCT00804856|464367085|FG004|Overall Study|Non compliance with protocol|0|||
129020301|NCT00804856|464367086|FG005|Overall Study|Non compliance with protocol|0|||
129020302|NCT00804856|464367087|FG006|Overall Study|Non compliance with protocol|0|||
129020303|NCT00804856|464367088|FG007|Overall Study|Non compliance with protocol|0|||
129020304|NCT00804856|464367089|FG008|Overall Study|Non compliance with protocol|0|||
129020305|NCT00804856|464367090|FG009|Overall Study|Non compliance with protocol|0|||
129020306|NCT00804856|464367091|FG010|Overall Study|Non compliance with protocol|0|||
129020307|NCT00804856|464367092|FG011|Overall Study|Non compliance with protocol|0|||
129020308|NCT00804856|464367093|FG012|Overall Study|Non compliance with protocol|0|||
129020309|NCT00804856|464367094|FG013|Overall Study|Non compliance with protocol|2|||
129020310|NCT00804856|464367095|FG014|Overall Study|Non compliance with protocol|0|||
129020311|NCT00804856|464367081|FG000|Overall Study|Refused to continue medication|0|||
129020312|NCT00804856|464367082|FG001|Overall Study|Refused to continue medication|0|||
129020313|NCT00804856|464367083|FG002|Overall Study|Refused to continue medication|0|||
129020314|NCT00804856|464367084|FG003|Overall Study|Refused to continue medication|1|||
129020315|NCT00804856|464367085|FG004|Overall Study|Refused to continue medication|1|||
129020316|NCT00804856|464367086|FG005|Overall Study|Refused to continue medication|0|||
129020317|NCT00804856|464367087|FG006|Overall Study|Refused to continue medication|0|||
129020318|NCT00804856|464367088|FG007|Overall Study|Refused to continue medication|0|||
129020319|NCT00804856|464367089|FG008|Overall Study|Refused to continue medication|0|||
129020320|NCT00804856|464367090|FG009|Overall Study|Refused to continue medication|0|||
129020321|NCT00804856|464367091|FG010|Overall Study|Refused to continue medication|3|||
129020322|NCT00804856|464367092|FG011|Overall Study|Refused to continue medication|0|||
129020323|NCT00804856|464367093|FG012|Overall Study|Refused to continue medication|1|||
129020324|NCT00804856|464367094|FG013|Overall Study|Refused to continue medication|1|||
128886259|NCT00568321|463879129|FG001|Overall Study|Lost to Follow-up|0|||
129108627|NCT01111565|464693546|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129108628|NCT01111565|464693547|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129108629|NCT01111565|464693548|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129108630|NCT01111565|464693549|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129108631|NCT01111565|464693545|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
129108632|NCT01111565|464693546|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129108633|NCT01111565|464693547|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129108634|NCT01111565|464693548|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129108635|NCT01111565|464693549|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129108636|NCT01111565|464693545|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
129108637|NCT01111565|464693546|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129108638|NCT01111565|464693547|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129108639|NCT01111565|464693548|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129108640|NCT01111565|464693549|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129108641|NCT01111565|464693545|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
129108642|NCT01111565|464693546|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129108643|NCT01111565|464693547|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129108644|NCT01111565|464693548|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129108645|NCT01111565|464693549|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129108646|NCT01111565|464693545|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
129108647|NCT01111565|464693546|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129108648|NCT01111565|464693547|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129108649|NCT01111565|464693548|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129108650|NCT01111565|464693549|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129108651|NCT01111565|464693545|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
129108652|NCT01111565|464693546|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129108653|NCT01111565|464693547|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129108654|NCT01111565|464693548|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129108655|NCT01111565|464693549|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129108656|NCT01111565|464693545|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129108657|NCT01111565|464693546|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129108658|NCT01111565|464693547|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129108659|NCT01111565|464693548|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
129108660|NCT01111565|464693549|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129108661|NCT01111565|464693545|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129108662|NCT01111565|464693546|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129108663|NCT01111565|464693547|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
129108664|NCT01111565|464693548|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129108665|NCT01111565|464693549|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129108666|NCT01111565|464693545|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
129108667|NCT01111565|464693546|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
129108668|NCT01111565|464693547|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
129108669|NCT01111565|464693548|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
129108670|NCT01111565|464693549|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
129108671|NCT01111565|464693545|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
128886260|NCT00568321|463879130|FG002|Overall Study|Lost to Follow-up|1|||
128886261|NCT00568321|463879128|FG000|Overall Study|Withdrawal by Subject|2|||
128886262|NCT00568321|463879129|FG001|Overall Study|Withdrawal by Subject|0|||
128886263|NCT00568321|463879130|FG002|Overall Study|Withdrawal by Subject|0|||
128886264|NCT00568321|463879128|FG000|Overall Study|Protocol Violation|0|||
128886265|NCT00568321|463879129|FG001|Overall Study|Protocol Violation|0|||
128886266|NCT00568321|463879130|FG002|Overall Study|Protocol Violation|1|||
129108672|NCT01111565|464693546|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
129108673|NCT01111565|464693547|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
129108674|NCT01111565|464693548|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
129108675|NCT01111565|464693549|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
129108676|NCT01111565|464693545|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129108677|NCT01111565|464693546|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129108678|NCT01111565|464693547|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129108679|NCT01111565|464693548|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129108680|NCT01111565|464693549|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
129108681|NCT00368108|464693550|FG000|Overall Study|Adverse Event|38|||
129108682|NCT00368108|464693551|FG001|Overall Study|Adverse Event|26|||
128886267|NCT00568321|463879128|FG000|Overall Study|Randomized, not treated|2|||
128886268|NCT00568321|463879129|FG001|Overall Study|Randomized, not treated|0|||
128763170|NCT00895622|463422774|FG002|Overall Study|Protocol Violation|4|||
128886269|NCT00568321|463879130|FG002|Overall Study|Randomized, not treated|1|||
128886270|NCT00667355|463879131|FG000|Overall Study|Adverse Event|5|||
128886271|NCT00667355|463879131|FG000|Overall Study|Lost to Follow-up|1|||
128886272|NCT00667355|463879131|FG000|Overall Study|Other reason was not specified|5|||
128886273|NCT01676909|463879133|FG000|Overall Study|Withdrawal by Subject|3|||
128886274|NCT01676909|463879134|FG001|Overall Study|Withdrawal by Subject|5|||
128886275|NCT01676909|463879133|FG000|Overall Study|Lost to Follow-up|15|||
128886276|NCT01676909|463879134|FG001|Overall Study|Lost to Follow-up|9|||
128886277|NCT02175004|463879138|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
128886278|NCT02175004|463879139|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
128886279|NCT02175004|463879138|FG000|Overall Study|Investigator Judgment|1|||
128886280|NCT02175004|463879139|FG001|Overall Study|Investigator Judgment|4|||
128886281|NCT02175004|463879138|FG000|Overall Study|Voluntary Withdrawal|6|||
128886282|NCT02175004|463879139|FG001|Overall Study|Voluntary Withdrawal|19|||
128886283|NCT02175004|463879138|FG000|Overall Study|Liver Transplant|1|||
128886284|NCT02175004|463879139|FG001|Overall Study|Liver Transplant|0|||
128886285|NCT02175004|463879138|FG000|Overall Study|Disease Progression|1|||
128886286|NCT02175004|463879139|FG001|Overall Study|Disease Progression|0|||
128886287|NCT02175004|463879138|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
129020325|NCT00804856|464367095|FG014|Overall Study|Refused to continue medication|5|||
129020326|NCT00804856|464367081|FG000|Overall Study|Other reason than listed above|0|||
129108683|NCT00368108|464693552|FG002|Overall Study|Adverse Event|44|||
129108684|NCT00368108|464693550|FG000|Overall Study|Abnormal Laboratory Value|0|||
129108685|NCT00368108|464693551|FG001|Overall Study|Abnormal Laboratory Value|0|||
129108686|NCT00368108|464693552|FG002|Overall Study|Abnormal Laboratory Value|3|||
128886288|NCT02175004|463879139|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
129020327|NCT00804856|464367082|FG001|Overall Study|Other reason than listed above|0|||
129020328|NCT00804856|464367083|FG002|Overall Study|Other reason than listed above|0|||
129020329|NCT00804856|464367084|FG003|Overall Study|Other reason than listed above|0|||
129020330|NCT00804856|464367085|FG004|Overall Study|Other reason than listed above|0|||
129020331|NCT00804856|464367086|FG005|Overall Study|Other reason than listed above|1|||
129020332|NCT00804856|464367087|FG006|Overall Study|Other reason than listed above|0|||
129020333|NCT00804856|464367088|FG007|Overall Study|Other reason than listed above|0|||
129020334|NCT00804856|464367089|FG008|Overall Study|Other reason than listed above|1|||
129020335|NCT00804856|464367090|FG009|Overall Study|Other reason than listed above|0|||
129020336|NCT00804856|464367091|FG010|Overall Study|Other reason than listed above|3|||
129020337|NCT00804856|464367092|FG011|Overall Study|Other reason than listed above|1|||
129020338|NCT00804856|464367093|FG012|Overall Study|Other reason than listed above|1|||
129020339|NCT00804856|464367094|FG013|Overall Study|Other reason than listed above|10|||
129020340|NCT00804856|464367095|FG014|Overall Study|Other reason than listed above|3|||
129020341|NCT01796171|464367096|FG000|Enrolled|Death|0|||
129020342|NCT01796171|464367097|FG001|Enrolled|Death|0|||
129020343|NCT01796171|464367098|FG002|Enrolled|Death|0|||
129020344|NCT01796171|464367099|FG003|Enrolled|Death|0|||
129020345|NCT01796171|464367100|FG004|Enrolled|Death|0|||
129020346|NCT01796171|464367101|FG005|Enrolled|Death|0|||
129020347|NCT01796171|464367102|FG006|Enrolled|Death|0|||
129020348|NCT01796171|464367103|FG007|Enrolled|Death|0|||
129020349|NCT01796171|464367104|FG008|Enrolled|Death|0|||
129020350|NCT01796171|464367105|FG009|Enrolled|Death|0|||
129020351|NCT01796171|464367106|FG010|Enrolled|Death|0|||
129020352|NCT01796171|464367107|FG011|Enrolled|Death|0|||
129020353|NCT01796171|464367108|FG012|Enrolled|Death|0|||
129020354|NCT01796171|464367109|FG013|Enrolled|Death|0|||
129020355|NCT01796171|464367110|FG014|Enrolled|Death|1|||
129020356|NCT01796171|464367096|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
129020357|NCT01796171|464367097|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
129020358|NCT01796171|464367098|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
129020359|NCT01796171|464367099|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
129020360|NCT01796171|464367100|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
129020361|NCT01796171|464367101|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
129020362|NCT01796171|464367102|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
129020363|NCT01796171|464367103|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
129020364|NCT01796171|464367104|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
129020365|NCT01796171|464367105|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
129020366|NCT01796171|464367106|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
128886289|NCT00221195|463879140|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
128886290|NCT00221195|463879141|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
128886291|NCT00221195|463879140|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
129020367|NCT01796171|464367107|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
129020368|NCT01796171|464367108|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
129020369|NCT01796171|464367109|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
129020370|NCT01796171|464367110|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
129020371|NCT01796171|464367096|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020372|NCT01796171|464367097|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020373|NCT01796171|464367098|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129108687|NCT00368108|464693550|FG000|Overall Study|Protocol Violation|5|||
129108688|NCT00368108|464693551|FG001|Overall Study|Protocol Violation|9|||
129108689|NCT00368108|464693552|FG002|Overall Study|Protocol Violation|9|||
129108690|NCT00368108|464693550|FG000|Overall Study|Withdrawal by Subject|9|||
129108691|NCT00368108|464693551|FG001|Overall Study|Withdrawal by Subject|3|||
129108692|NCT00368108|464693552|FG002|Overall Study|Withdrawal by Subject|5|||
129108693|NCT00368108|464693550|FG000|Overall Study|Lack of Efficacy|7|||
129108694|NCT00368108|464693551|FG001|Overall Study|Lack of Efficacy|8|||
129108695|NCT00368108|464693552|FG002|Overall Study|Lack of Efficacy|5|||
129108696|NCT00368108|464693550|FG000|Overall Study|Physician Decision|2|||
129108697|NCT00368108|464693551|FG001|Overall Study|Physician Decision|0|||
129108698|NCT00368108|464693552|FG002|Overall Study|Physician Decision|1|||
129108699|NCT00368108|464693550|FG000|Overall Study|Other|3|||
129108700|NCT00368108|464693551|FG001|Overall Study|Other|7|||
129108701|NCT00368108|464693552|FG002|Overall Study|Other|1|||
129108702|NCT04131712|464693553|FG000|Overall Study|COVID related|0|||
129108703|NCT04131712|464693554|FG001|Overall Study|COVID related|0|||
129108704|NCT04131712|464693555|FG002|Overall Study|COVID related|2|||
129108705|NCT04131712|464693556|FG003|Overall Study|COVID related|0|||
129108706|NCT04131712|464693553|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
129108707|NCT04131712|464693554|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
129108708|NCT04131712|464693555|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
129108709|NCT04131712|464693556|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
129108710|NCT00130689|464693557|FG000|Overall Study|Progressive Disease|29|||
129108711|NCT00130689|464693557|FG000|Overall Study|Death|1|||
129108712|NCT00130689|464693557|FG000|Overall Study|Clinical Deterioration|4|||
129108713|NCT00130689|464693557|FG000|Overall Study|Withdrawal by Subject|3|||
129108714|NCT00130689|464693557|FG000|Overall Study|Ineligible|6|||
129108715|NCT01254656|464693558|FG000|Overall Study|Discontinued due to termination of study|40|||
129108716|NCT01254656|464693559|FG001|Overall Study|Discontinued due to termination of study|39|||
129108717|NCT01254656|464693560|FG002|Overall Study|Discontinued due to termination of study|13|||
129108718|NCT01254656|464693558|FG000|Overall Study|Lack of Efficacy|3|||
129108719|NCT01254656|464693559|FG001|Overall Study|Lack of Efficacy|0|||
129108720|NCT01254656|464693560|FG002|Overall Study|Lack of Efficacy|0|||
129108721|NCT01254656|464693558|FG000|Overall Study|Lost to Follow-up|1|||
129108722|NCT01254656|464693559|FG001|Overall Study|Lost to Follow-up|0|||
129108723|NCT01254656|464693560|FG002|Overall Study|Lost to Follow-up|2|||
129108724|NCT01254656|464693558|FG000|Overall Study|Withdrawal by Subject|2|||
129108725|NCT01254656|464693559|FG001|Overall Study|Withdrawal by Subject|2|||
129108726|NCT01254656|464693560|FG002|Overall Study|Withdrawal by Subject|1|||
129108727|NCT01254656|464693558|FG000|Overall Study|Pregnancy|0|||
129108728|NCT01254656|464693559|FG001|Overall Study|Pregnancy|0|||
129108729|NCT01254656|464693560|FG002|Overall Study|Pregnancy|2|||
129108730|NCT01254656|464693558|FG000|Overall Study|Adverse Event|1|||
129108731|NCT01254656|464693559|FG001|Overall Study|Adverse Event|1|||
129108732|NCT01254656|464693560|FG002|Overall Study|Adverse Event|0|||
129108733|NCT01254656|464693558|FG000|Overall Study|Death|0|||
129108734|NCT01254656|464693559|FG001|Overall Study|Death|1|||
129108735|NCT01254656|464693560|FG002|Overall Study|Death|0|||
129108736|NCT03200548|464693561|FG000|Overall Study|Withdrawal by Subject|5|||
129108737|NCT03200548|464693562|FG001|Overall Study|Withdrawal by Subject|11|||
129108738|NCT03200548|464693563|FG002|Overall Study|Withdrawal by Subject|7|||
129108739|NCT03200548|464693564|FG003|Overall Study|Withdrawal by Subject|6|||
129108740|NCT00716456|464693565|FG000|Overall Study|Adverse Event|0|||
129108741|NCT00716456|464693566|FG001|Overall Study|Adverse Event|2|||
129108742|NCT00716456|464693567|FG002|Overall Study|Adverse Event|0|||
129108743|NCT00447772|464693568|FG000|Overall Study|Lack of Efficacy|3|||
129108744|NCT00447772|464693568|FG000|Overall Study|Insufficient compliance|6|||
129108745|NCT00447772|464693568|FG000|Overall Study|Discontinuation of drug therapy|1|||
129108746|NCT00447772|464693568|FG000|Overall Study|Lost to Follow-up|9|||
129108747|NCT00447772|464693568|FG000|Overall Study|Withdrawal by Subject|1|||
129108748|NCT00447772|464693568|FG000|Overall Study|Unable to attend all study visits|2|||
129108749|NCT00447772|464693568|FG000|Overall Study|Adverse Event|1|||
129108750|NCT00447772|464693568|FG000|Overall Study|Patient relocated|1|||
129108751|NCT00447772|464693568|FG000|Overall Study|Incomplete documentation at visit 1|1|||
129108752|NCT00447772|464693568|FG000|Overall Study|Chemotherapy for lung cancer|1|||
129108753|NCT00447772|464693568|FG000|Overall Study|Premature re-injection required|1|||
129108754|NCT00875563|464693573|FG000|Overall Study|Death|4|||
129108755|NCT00875563|464693573|FG000|Overall Study|Withdrawal by Subject|7|||
129108756|NCT00875563|464693573|FG000|Overall Study|No long-term (3-5 year) consent|6|||
129108757|NCT00875563|464693573|FG000|Overall Study|Still be eligible for follow-up|7|||
129108758|NCT02896569|464693576|FG000|Overall Study|Lost to Follow-up|2|||
129108759|NCT02896569|464693577|FG001|Overall Study|Lost to Follow-up|1|||
129108760|NCT02896569|464693576|FG000|Overall Study|Physician Decision|1|||
129108761|NCT02896569|464693577|FG001|Overall Study|Physician Decision|3|||
129108762|NCT02896569|464693576|FG000|Overall Study|Adverse Event|0|||
129108763|NCT02896569|464693577|FG001|Overall Study|Adverse Event|1|||
129108764|NCT02896569|464693576|FG000|Overall Study|Withdrawal by Subject|1|||
129108765|NCT02896569|464693577|FG001|Overall Study|Withdrawal by Subject|0|||
129108766|NCT00970489|464693580|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
129108767|NCT00970489|464693581|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
129108768|NCT05417412|464693582|FG000|Overall Study|Lost to Follow-up|2|||
129108769|NCT03478371|464693585|FG000|Overall Study|non-compliance|1|||
129108770|NCT03478371|464693585|FG000|Overall Study|Lost to Follow-up|4|||
129108771|NCT02849743|464693586|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
129108772|NCT02849743|464693587|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
129108773|NCT02849743|464693586|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
129108774|NCT02849743|464693587|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129108775|NCT03874013|464693594|FG000|Overall Study|Adverse Event|0|||
129108776|NCT03874013|464693595|FG001|Overall Study|Adverse Event|1|||
129108777|NCT01096160|464693599|FG000|Overall Study|Adverse Event|0|||
129108778|NCT01096160|464693600|FG001|Overall Study|Adverse Event|0|||
129108779|NCT01096160|464693601|FG002|Overall Study|Adverse Event|1|||
129108780|NCT01096160|464693602|FG003|Overall Study|Adverse Event|0|||
129108781|NCT01096160|464693603|FG004|Overall Study|Adverse Event|0|||
129108782|NCT01096160|464693604|FG005|Overall Study|Adverse Event|0|||
129108783|NCT01096160|464693605|FG006|Overall Study|Adverse Event|0|||
129108784|NCT01096160|464693606|FG007|Overall Study|Adverse Event|0|||
129108785|NCT01096160|464693607|FG008|Overall Study|Adverse Event|0|||
129108786|NCT01096160|464693608|FG009|Overall Study|Adverse Event|1|||
129108787|NCT01096160|464693599|FG000|Overall Study|Met stopping criteria per protocol|0|||
129108788|NCT01096160|464693600|FG001|Overall Study|Met stopping criteria per protocol|0|||
129108789|NCT01096160|464693601|FG002|Overall Study|Met stopping criteria per protocol|0|||
129108790|NCT01096160|464693602|FG003|Overall Study|Met stopping criteria per protocol|0|||
129108791|NCT01096160|464693603|FG004|Overall Study|Met stopping criteria per protocol|1|||
129108792|NCT01096160|464693604|FG005|Overall Study|Met stopping criteria per protocol|0|||
129108793|NCT01096160|464693605|FG006|Overall Study|Met stopping criteria per protocol|2|||
128886292|NCT00221195|463879141|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
128886293|NCT00221195|463879140|FG000|Washout Period (Months 7-9)|Death|0|||
128886294|NCT00221195|463879141|FG001|Washout Period (Months 7-9)|Death|1|||
128886295|NCT00221195|463879140|FG000|Therapy 2 (Months 10-15)|Death|1|||
129108794|NCT01096160|464693606|FG007|Overall Study|Met stopping criteria per protocol|0|||
129108795|NCT01096160|464693607|FG008|Overall Study|Met stopping criteria per protocol|2|||
129108796|NCT01096160|464693608|FG009|Overall Study|Met stopping criteria per protocol|0|||
129108797|NCT00922116|464693610|FG000|Overall Study|Adverse Event|4|||
129108798|NCT00922116|464693610|FG000|Overall Study|Death|1|||
128684409|NCT01369485|463144118|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
128684410|NCT01369485|463144119|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
128684411|NCT01369485|463144118|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
128684412|NCT01369485|463144119|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
128684413|NCT01369485|463144118|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
128684414|NCT01369485|463144119|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
128684415|NCT01369485|463144118|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
128684416|NCT01369485|463144119|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
128684417|NCT01369485|463144118|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
128684418|NCT01369485|463144119|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
128684419|NCT01369485|463144118|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
128684420|NCT01369485|463144119|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
128684421|NCT01484938|463144120|FG000|Overall Study|Adverse Event|2|||
128684422|NCT01484938|463144120|FG000|Overall Study|Lost to Follow-up|1|||
128684423|NCT01484938|463144120|FG000|Overall Study|Noncompliance|1|||
128684424|NCT02942576|463144122|FG000|Overall Study|Adverse Event|28|||
128684425|NCT02942576|463144123|FG001|Overall Study|Adverse Event|6|||
128684426|NCT02942576|463144122|FG000|Overall Study|Withdrawal by Subject|7|||
128684427|NCT02942576|463144123|FG001|Overall Study|Withdrawal by Subject|5|||
128684428|NCT02942576|463144122|FG000|Overall Study|Physician Decision|1|||
128886296|NCT00221195|463879141|FG001|Therapy 2 (Months 10-15)|Death|0|||
128886297|NCT00221195|463879140|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
128886298|NCT00221195|463879141|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
128886299|NCT00823901|463879142|FG000|Overall Study|Adverse Event|1|||
128886300|NCT00823901|463879143|FG001|Overall Study|Adverse Event|1|||
128886301|NCT00823901|463879142|FG000|Overall Study|Lack of Efficacy|1|||
128886302|NCT00823901|463879143|FG001|Overall Study|Lack of Efficacy|0|||
128886303|NCT00823901|463879142|FG000|Overall Study|Lost to Follow-up|2|||
129108799|NCT00922116|464693610|FG000|Overall Study|Lost to Follow-up|1|||
128886304|NCT00823901|463879143|FG001|Overall Study|Lost to Follow-up|1|||
129108800|NCT00922116|464693610|FG000|Overall Study|Withdrawal by Subject|4|||
129108801|NCT00922116|464693610|FG000|Overall Study|Other|5|||
129108802|NCT04607135|464693611|FG000|Overall Study|Physician Decision|1|||
129108803|NCT04607135|464693611|FG000|Overall Study|Withdrawal by Subject|1|||
129108804|NCT04607135|464693611|FG000|Overall Study|Equipment not working|3|||
129108805|NCT06060496|464693612|FG000|Overall Study|Withdrawal by Subject|2|||
129108806|NCT06060496|464693612|FG000|Overall Study|Lost to Follow-up|2|||
129108807|NCT03990051|464693613|FG000|Masked Period|Lost to Follow-up|1|||
129108808|NCT03990051|464693614|FG001|Masked Period|Lost to Follow-up|0|||
129108809|NCT03990051|464693613|FG000|Long Term Period|Death|1|||
129108810|NCT03990051|464693614|FG001|Long Term Period|Death|1|||
129108811|NCT03990051|464693613|FG000|Long Term Period|Lost to Follow-up|7|||
129108812|NCT03990051|464693614|FG001|Long Term Period|Lost to Follow-up|2|||
129108813|NCT00618826|464693616|FG000|Overall Study|Adverse Event|1|||
129108814|NCT01509664|464693617|FG000|Overall Study|Lost to Follow-up|15|||
129108815|NCT01509664|464693618|FG001|Overall Study|Lost to Follow-up|21|||
129108816|NCT01026948|464693619|FG000|Overall Study|Physician Decision|8|||
129108817|NCT00627926|464693620|FG000|Overall Study|Adverse Event|26|||
129108818|NCT00627926|464693621|FG001|Overall Study|Adverse Event|37|||
129108819|NCT00627926|464693622|FG002|Overall Study|Adverse Event|36|||
129108820|NCT00627926|464693620|FG000|Overall Study|Death|1|||
129108821|NCT00627926|464693621|FG001|Overall Study|Death|0|||
129108822|NCT00627926|464693622|FG002|Overall Study|Death|0|||
129108823|NCT00627926|464693620|FG000|Overall Study|Lost to Follow-up|4|||
129108824|NCT00627926|464693621|FG001|Overall Study|Lost to Follow-up|3|||
129108825|NCT00627926|464693622|FG002|Overall Study|Lost to Follow-up|4|||
129108826|NCT00627926|464693620|FG000|Overall Study|Withdrawal by Subject|2|||
129108827|NCT00627926|464693621|FG001|Overall Study|Withdrawal by Subject|1|||
129108828|NCT00627926|464693622|FG002|Overall Study|Withdrawal by Subject|0|||
129108829|NCT00627926|464693620|FG000|Overall Study|Lack of Efficacy|118|||
129108830|NCT00627926|464693621|FG001|Overall Study|Lack of Efficacy|40|||
129108831|NCT00627926|464693622|FG002|Overall Study|Lack of Efficacy|38|||
129108832|NCT00627926|464693620|FG000|Overall Study|Noncompliance/unspecified|8|||
129108833|NCT00627926|464693621|FG001|Overall Study|Noncompliance/unspecified|23|||
129108834|NCT00627926|464693622|FG002|Overall Study|Noncompliance/unspecified|17|||
129108835|NCT03360019|464693630|FG000|Overall Study|Withdrawal by Subject|2|||
129108836|NCT03360019|464693631|FG001|Overall Study|Withdrawal by Subject|0|||
129108837|NCT03360019|464693632|FG002|Overall Study|Withdrawal by Subject|0|||
129108838|NCT03360019|464693630|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
129108839|NCT03360019|464693631|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
129108840|NCT03360019|464693632|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
129108841|NCT01462110|464693633|FG000|Overall Study|Adverse Event|1|||
129108842|NCT01462110|464693634|FG001|Overall Study|Adverse Event|0|||
129108843|NCT00753675|464693635|FG000|Overall Study|other reason|11|||
129108844|NCT00753675|464693636|FG001|Overall Study|other reason|12|||
129108845|NCT00753675|464693637|FG002|Overall Study|other reason|13|||
129108846|NCT00753675|464693635|FG000|Overall Study|Death|1|||
129108847|NCT00753675|464693636|FG001|Overall Study|Death|2|||
129108848|NCT00753675|464693637|FG002|Overall Study|Death|4|||
129108849|NCT00753675|464693635|FG000|Overall Study|Adverse Event|11|||
129108850|NCT00753675|464693636|FG001|Overall Study|Adverse Event|9|||
129108851|NCT00753675|464693637|FG002|Overall Study|Adverse Event|4|||
129108852|NCT00753675|464693635|FG000|Overall Study|Objective progression of disease|35|||
129108853|NCT00753675|464693636|FG001|Overall Study|Objective progression of disease|35|||
129108854|NCT00753675|464693637|FG002|Overall Study|Objective progression of disease|35|||
129108855|NCT00753675|464693635|FG000|Overall Study|Withdrawal by Subject|0|||
129108856|NCT00753675|464693636|FG001|Overall Study|Withdrawal by Subject|1|||
129108857|NCT00753675|464693637|FG002|Overall Study|Withdrawal by Subject|0|||
129108858|NCT00753675|464693635|FG000|Overall Study|Lost to Follow-up|1|||
129108859|NCT00753675|464693636|FG001|Overall Study|Lost to Follow-up|0|||
129108860|NCT00753675|464693637|FG002|Overall Study|Lost to Follow-up|0|||
129108861|NCT02149264|464693643|FG000|Overall Study|Withdrawal by Subject|9|||
129108862|NCT02149264|464693643|FG000|Overall Study|Adverse Event|7|||
129108863|NCT02149264|464693643|FG000|Overall Study|Physician Decision|3|||
128684429|NCT02942576|463144123|FG001|Overall Study|Physician Decision|4|||
128684430|NCT02942576|463144122|FG000|Overall Study|Other|10|||
128684431|NCT02942576|463144123|FG001|Overall Study|Other|8|||
128684432|NCT00938964|463144124|FG000|Overall Study|Death|3|||
128684433|NCT00938964|463144125|FG001|Overall Study|Death|3|||
128684434|NCT00938964|463144124|FG000|Overall Study|Lost to Follow-up|2|||
128684435|NCT00938964|463144125|FG001|Overall Study|Lost to Follow-up|3|||
129108864|NCT02149264|464693643|FG000|Overall Study|Protocol Violation|1|||
129108865|NCT03283930|464693644|FG000|Overall Study|Scheduling conflict|8|||
129108866|NCT03283930|464693645|FG001|Overall Study|Scheduling conflict|10|||
129108867|NCT03283930|464693644|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
129108868|NCT03283930|464693645|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
129108869|NCT03283930|464693644|FG000|Overall Study|Technical software issue|2|||
129108870|NCT03283930|464693645|FG001|Overall Study|Technical software issue|2|||
128684436|NCT00938964|463144124|FG000|Overall Study|Withdrawal by Subject|22|||
129108871|NCT00805129|464693646|FG000|Overall Study|Not treated|1|||
129108872|NCT02499120|464693647|FG000|Overall Study|Death|52|||
129108873|NCT02499120|464693648|FG001|Overall Study|Death|43|||
129108874|NCT02499120|464693647|FG000|Overall Study|Lost to Follow-up|1|||
129108875|NCT02499120|464693648|FG001|Overall Study|Lost to Follow-up|2|||
129108876|NCT02499120|464693647|FG000|Overall Study|Participant refused further follow-up|1|||
128684437|NCT00938964|463144125|FG001|Overall Study|Withdrawal by Subject|18|||
128684438|NCT00938964|463144124|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
128684439|NCT00938964|463144125|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
128684440|NCT01858636|463144126|FG000|Overall Study|No Device Deployment Attempted|24|||
128684441|NCT01858636|463144126|FG000|Overall Study|Physician Decision|1|||
128684442|NCT01858636|463144126|FG000|Overall Study|Death|1|||
128684443|NCT01858636|463144126|FG000|Overall Study|Lost to Follow-up|1|||
128684444|NCT01858636|463144126|FG000|Overall Study|Withdrawal by Subject|1|||
128684445|NCT03523000|463144130|FG000|Overall Study|Withdrawal by Subject|3|||
128684446|NCT03523000|463144131|FG001|Overall Study|Withdrawal by Subject|0|||
128684447|NCT03523000|463144130|FG000|Overall Study|Unsuccessful trial|2|||
128684448|NCT03523000|463144131|FG001|Overall Study|Unsuccessful trial|0|||
128684449|NCT01227564|463144137|FG000|Overall Study|No Longer Willing to Participate|4|||
128684450|NCT01227564|463144138|FG001|Overall Study|No Longer Willing to Participate|2|||
128684451|NCT01227564|463144139|FG002|Overall Study|No Longer Willing to Participate|5|||
128684452|NCT01227564|463144137|FG000|Overall Study|Participant moved to another town|0|||
128684453|NCT01227564|463144138|FG001|Overall Study|Participant moved to another town|0|||
128684454|NCT01227564|463144139|FG002|Overall Study|Participant moved to another town|1|||
128684455|NCT02862600|463144145|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
128684456|NCT02862600|463144145|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
128684457|NCT02862600|463144145|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
128684458|NCT02862600|463144145|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
128684459|NCT00772070|463144167|FG000|Overall Study|Lost to Follow-up|0|||
128684460|NCT00772070|463144168|FG001|Overall Study|Lost to Follow-up|8|||
128684461|NCT00772070|463144167|FG000|Overall Study|Withdrawal by Subject|0|||
128684462|NCT00772070|463144168|FG001|Overall Study|Withdrawal by Subject|2|||
128684463|NCT00772070|463144167|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
128684464|NCT00772070|463144168|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
128684465|NCT01309308|463144169|FG000|Overall Study|Lost to Follow-up|6|||
128684466|NCT01309308|463144170|FG001|Overall Study|Lost to Follow-up|4|||
128684467|NCT01476644|463144171|FG000|Overall Study|Death|5|||
128684468|NCT01476644|463144171|FG000|Overall Study|moved to another state|2|||
128684469|NCT01476644|463144171|FG000|Overall Study|Lost to Follow-up|19|||
128684470|NCT01476644|463144171|FG000|Overall Study|Withdrawal by Subject|13|||
128684471|NCT00095628|463144172|FG000|Overall Study|Disease progression prior to treatment|1|||
128684472|NCT00937391|463144181|FG000|Stage 2|Withdrawal by Subject|1|||
128886305|NCT01369511|463879144|FG000|Overall Study|Adverse Event|1|||
128886306|NCT01369511|463879145|FG001|Overall Study|Adverse Event|1|||
129020374|NCT01796171|464367099|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020375|NCT01796171|464367100|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020376|NCT01796171|464367101|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020377|NCT01796171|464367102|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020378|NCT01796171|464367103|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020379|NCT01796171|464367104|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020380|NCT01796171|464367105|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020381|NCT01796171|464367106|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020382|NCT01796171|464367107|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020383|NCT01796171|464367108|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020384|NCT01796171|464367109|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
129020385|NCT01796171|464367110|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129020386|NCT01796171|464367096|FG000|Treatment Period With Betalutin|Progressive disease|0|||
129020387|NCT01796171|464367097|FG001|Treatment Period With Betalutin|Progressive disease|1|||
129020388|NCT01796171|464367098|FG002|Treatment Period With Betalutin|Progressive disease|0|||
129020389|NCT01796171|464367099|FG003|Treatment Period With Betalutin|Progressive disease|0|||
129020390|NCT01796171|464367100|FG004|Treatment Period With Betalutin|Progressive disease|0|||
129020391|NCT01796171|464367101|FG005|Treatment Period With Betalutin|Progressive disease|0|||
129020392|NCT01796171|464367102|FG006|Treatment Period With Betalutin|Progressive disease|0|||
129020393|NCT01796171|464367103|FG007|Treatment Period With Betalutin|Progressive disease|0|||
129020394|NCT01796171|464367104|FG008|Treatment Period With Betalutin|Progressive disease|0|||
129020395|NCT01796171|464367105|FG009|Treatment Period With Betalutin|Progressive disease|0|||
129020396|NCT01796171|464367106|FG010|Treatment Period With Betalutin|Progressive disease|0|||
129020397|NCT01796171|464367107|FG011|Treatment Period With Betalutin|Progressive disease|0|||
129020398|NCT01796171|464367108|FG012|Treatment Period With Betalutin|Progressive disease|0|||
129020399|NCT01796171|464367109|FG013|Treatment Period With Betalutin|Progressive disease|0|||
128684473|NCT03194490|463144200|FG000|Overall Study|Lost to Follow-up|1|||
128684474|NCT03194490|463144201|FG001|Overall Study|Lost to Follow-up|3|||
128684475|NCT03194490|463144200|FG000|Overall Study|participant developed specific neck pain|1|||
128684476|NCT03194490|463144201|FG001|Overall Study|participant developed specific neck pain|0|||
128684477|NCT01758289|463144202|FG000|Overall Study|Premature Study Termination|44|||
128684478|NCT01758289|463144202|FG000|Overall Study|Adverse Event|9|||
128684479|NCT01574079|463144203|FG000|Overall Study|Physician Decision|0|||
128886307|NCT01369511|463879146|FG002|Overall Study|Adverse Event|5|||
128886308|NCT01369511|463879147|FG003|Overall Study|Adverse Event|0|||
128886309|NCT01369511|463879144|FG000|Overall Study|Entry criteria not met|2|||
128886310|NCT01369511|463879145|FG001|Overall Study|Entry criteria not met|0|||
128886311|NCT01369511|463879146|FG002|Overall Study|Entry criteria not met|0|||
128886312|NCT01369511|463879147|FG003|Overall Study|Entry criteria not met|1|||
128886313|NCT01369511|463879144|FG000|Overall Study|Lost to Follow-up|0|||
128886314|NCT01369511|463879145|FG001|Overall Study|Lost to Follow-up|1|||
128886315|NCT01369511|463879146|FG002|Overall Study|Lost to Follow-up|1|||
128886316|NCT01369511|463879147|FG003|Overall Study|Lost to Follow-up|2|||
128886317|NCT01369511|463879144|FG000|Overall Study|Protocol Violation|0|||
128886318|NCT01369511|463879145|FG001|Overall Study|Protocol Violation|1|||
128886319|NCT01369511|463879146|FG002|Overall Study|Protocol Violation|0|||
128886320|NCT01369511|463879147|FG003|Overall Study|Protocol Violation|2|||
128886321|NCT01369511|463879144|FG000|Overall Study|Physician Decision|3|||
128886322|NCT01369511|463879145|FG001|Overall Study|Physician Decision|4|||
128886323|NCT01369511|463879146|FG002|Overall Study|Physician Decision|0|||
128886324|NCT01369511|463879147|FG003|Overall Study|Physician Decision|0|||
128886325|NCT01369511|463879144|FG000|Overall Study|Sponsor decision|2|||
128886326|NCT01369511|463879145|FG001|Overall Study|Sponsor decision|0|||
128886327|NCT01369511|463879146|FG002|Overall Study|Sponsor decision|1|||
128886328|NCT01369511|463879147|FG003|Overall Study|Sponsor decision|0|||
128886329|NCT01369511|463879144|FG000|Overall Study|Withdrawal by Subject|5|||
128886330|NCT01369511|463879145|FG001|Overall Study|Withdrawal by Subject|6|||
128886331|NCT01369511|463879146|FG002|Overall Study|Withdrawal by Subject|4|||
129020400|NCT01796171|464367110|FG014|Treatment Period With Betalutin|Progressive disease|0|||
129020401|NCT01796171|464367096|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020402|NCT01796171|464367097|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020403|NCT01796171|464367098|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020404|NCT01796171|464367099|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020405|NCT01796171|464367100|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020406|NCT01796171|464367101|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020407|NCT01796171|464367102|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020408|NCT01796171|464367103|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020409|NCT01796171|464367104|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
129020410|NCT01796171|464367105|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020411|NCT01796171|464367106|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
129020412|NCT01796171|464367107|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
129020413|NCT01796171|464367108|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020414|NCT01796171|464367109|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020415|NCT01796171|464367110|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129020416|NCT01796171|464367096|FG000|Treatment Period With Betalutin|Physician Decision|0|||
129020417|NCT01796171|464367097|FG001|Treatment Period With Betalutin|Physician Decision|0|||
129020418|NCT01796171|464367098|FG002|Treatment Period With Betalutin|Physician Decision|0|||
129020419|NCT01796171|464367099|FG003|Treatment Period With Betalutin|Physician Decision|0|||
129020420|NCT01796171|464367100|FG004|Treatment Period With Betalutin|Physician Decision|0|||
129020421|NCT01796171|464367101|FG005|Treatment Period With Betalutin|Physician Decision|0|||
129020422|NCT01796171|464367102|FG006|Treatment Period With Betalutin|Physician Decision|0|||
129020423|NCT01796171|464367103|FG007|Treatment Period With Betalutin|Physician Decision|0|||
129020424|NCT01796171|464367104|FG008|Treatment Period With Betalutin|Physician Decision|0|||
129020425|NCT01796171|464367105|FG009|Treatment Period With Betalutin|Physician Decision|0|||
129020426|NCT01796171|464367106|FG010|Treatment Period With Betalutin|Physician Decision|5|||
129020427|NCT01796171|464367107|FG011|Treatment Period With Betalutin|Physician Decision|1|||
129020428|NCT01796171|464367108|FG012|Treatment Period With Betalutin|Physician Decision|1|||
129020429|NCT01796171|464367109|FG013|Treatment Period With Betalutin|Physician Decision|0|||
129020430|NCT01796171|464367110|FG014|Treatment Period With Betalutin|Physician Decision|0|||
129020431|NCT01796171|464367096|FG000|Treatment Period With Betalutin|Death|0|||
129020432|NCT01796171|464367097|FG001|Treatment Period With Betalutin|Death|0|||
129020433|NCT01796171|464367098|FG002|Treatment Period With Betalutin|Death|0|||
129020434|NCT01796171|464367099|FG003|Treatment Period With Betalutin|Death|0|||
129020435|NCT01796171|464367100|FG004|Treatment Period With Betalutin|Death|0|||
129020436|NCT01796171|464367101|FG005|Treatment Period With Betalutin|Death|0|||
129020437|NCT01796171|464367102|FG006|Treatment Period With Betalutin|Death|0|||
129215171|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
128886332|NCT01369511|463879147|FG003|Overall Study|Withdrawal by Subject|6|||
128886333|NCT01376349|463879150|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
128886334|NCT01376349|463879151|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
128886335|NCT01376349|463879152|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
128886336|NCT01376349|463879150|FG000|Raondomized Treatment|Adverse Event|13|||
128886337|NCT01376349|463879151|FG001|Raondomized Treatment|Adverse Event|17|||
128886338|NCT01376349|463879152|FG002|Raondomized Treatment|Adverse Event|14|||
128886339|NCT01376349|463879150|FG000|Raondomized Treatment|Unkown|1|||
128886340|NCT01376349|463879151|FG001|Raondomized Treatment|Unkown|2|||
128886341|NCT01376349|463879152|FG002|Raondomized Treatment|Unkown|1|||
128886342|NCT01376349|463879150|FG000|Raondomized Treatment|Alternative Treatment|0|||
128886343|NCT01376349|463879151|FG001|Raondomized Treatment|Alternative Treatment|0|||
128886344|NCT01376349|463879152|FG002|Raondomized Treatment|Alternative Treatment|1|||
128886345|NCT01180998|463879153|FG000|Overall Study|Poor Vision|0|||
128886346|NCT01180998|463879154|FG001|Overall Study|Poor Vision|2|||
128886347|NCT01180998|463879155|FG002|Overall Study|Poor Vision|2|||
128886348|NCT01180998|463879153|FG000|Overall Study|Lost to Follow-up|0|||
128886349|NCT01180998|463879154|FG001|Overall Study|Lost to Follow-up|0|||
128886350|NCT01180998|463879155|FG002|Overall Study|Lost to Follow-up|1|||
128886351|NCT01180998|463879153|FG000|Overall Study|Protocol Violation|1|||
128886352|NCT01180998|463879154|FG001|Overall Study|Protocol Violation|2|||
128886353|NCT01180998|463879155|FG002|Overall Study|Protocol Violation|0|||
128886354|NCT01180998|463879153|FG000|Overall Study|Withdrawal by Subject|0|||
128886355|NCT01180998|463879154|FG001|Overall Study|Withdrawal by Subject|0|||
128684480|NCT01574079|463144204|FG001|Overall Study|Physician Decision|2|||
128684481|NCT01574079|463144203|FG000|Overall Study|Lost to Follow-up|1|||
128684482|NCT01574079|463144204|FG001|Overall Study|Lost to Follow-up|0|||
128684483|NCT03640559|463144207|FG000|Overall Study|Physician Decision|1|||
128684484|NCT03640559|463144208|FG001|Overall Study|Physician Decision|1|||
128684485|NCT03640559|463144207|FG000|Overall Study|Withdrawal by Subject|1|||
128684486|NCT03640559|463144208|FG001|Overall Study|Withdrawal by Subject|0|||
128684487|NCT01436162|463144209|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
128684488|NCT01436162|463144210|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
128684489|NCT01436162|463144211|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
128684490|NCT01436162|463144209|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
128684491|NCT01436162|463144210|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
128886356|NCT01180998|463879155|FG002|Overall Study|Withdrawal by Subject|1|||
128886357|NCT01180998|463879153|FG000|Overall Study|Poor comfort|3|||
128886358|NCT01180998|463879154|FG001|Overall Study|Poor comfort|0|||
128886359|NCT01180998|463879155|FG002|Overall Study|Poor comfort|4|||
128886360|NCT01180998|463879153|FG000|Overall Study|Poor lens handling|0|||
128886361|NCT01180998|463879154|FG001|Overall Study|Poor lens handling|0|||
128886362|NCT01180998|463879155|FG002|Overall Study|Poor lens handling|2|||
128886363|NCT00162032|463879156|FG000|Overall Study|Lost to Follow-up|4|||
128886364|NCT00162032|463879157|FG001|Overall Study|Lost to Follow-up|2|||
128684492|NCT01436162|463144211|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
128684493|NCT01436162|463144209|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
128684494|NCT01436162|463144210|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
128684495|NCT01436162|463144211|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
128684496|NCT01436162|463144209|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
128684497|NCT01436162|463144210|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
128684498|NCT01436162|463144211|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
128684499|NCT01436162|463144209|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
128684500|NCT01436162|463144210|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
128684501|NCT01436162|463144211|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
128684502|NCT01436162|463144209|FG000|Single-blind Lead-in Phase|Other|107|||
128684503|NCT01436162|463144210|FG001|Single-blind Lead-in Phase|Other|0|||
128684504|NCT01436162|463144211|FG002|Single-blind Lead-in Phase|Other|0|||
128684505|NCT01436162|463144209|FG000|Randomized Phase|Adverse Event|1|||
128684506|NCT01436162|463144210|FG001|Randomized Phase|Adverse Event|5|||
128684507|NCT01436162|463144211|FG002|Randomized Phase|Adverse Event|6|||
128684508|NCT01436162|463144209|FG000|Randomized Phase|Protocol Violation|4|||
128886365|NCT00162032|463879156|FG000|Overall Study|Reason not specified|1|||
128886366|NCT00162032|463879157|FG001|Overall Study|Reason not specified|0|||
128886367|NCT01176968|463879158|FG000|Overall Study|Adverse Event|10|||
128886368|NCT01176968|463879159|FG001|Overall Study|Adverse Event|11|||
129108877|NCT02499120|464693648|FG001|Overall Study|Participant refused further follow-up|0|||
128763171|NCT03724396|463422775|FG000|Overall Study|Lost to Follow-up|1|||
128684509|NCT01436162|463144210|FG001|Randomized Phase|Protocol Violation|4|||
128684510|NCT01436162|463144211|FG002|Randomized Phase|Protocol Violation|2|||
128684511|NCT01436162|463144209|FG000|Randomized Phase|Withdrawal by Subject|16|||
128684512|NCT01436162|463144210|FG001|Randomized Phase|Withdrawal by Subject|9|||
128684513|NCT01436162|463144211|FG002|Randomized Phase|Withdrawal by Subject|8|||
128684514|NCT01436162|463144209|FG000|Randomized Phase|Lost to Follow-up|17|||
128684515|NCT01436162|463144210|FG001|Randomized Phase|Lost to Follow-up|5|||
128886369|NCT01176968|463879158|FG000|Overall Study|Death|2|||
128886370|NCT01176968|463879159|FG001|Overall Study|Death|3|||
128886371|NCT01176968|463879158|FG000|Overall Study|Lack of Efficacy|0|||
128886372|NCT01176968|463879159|FG001|Overall Study|Lack of Efficacy|1|||
128886373|NCT01176968|463879158|FG000|Overall Study|Lost to Follow-up|16|||
128886374|NCT01176968|463879159|FG001|Overall Study|Lost to Follow-up|14|||
128886375|NCT01176968|463879158|FG000|Overall Study|Withdrawal by Subject|48|||
128684516|NCT01436162|463144211|FG002|Randomized Phase|Lost to Follow-up|4|||
128684517|NCT01436162|463144209|FG000|Randomized Phase|Lack of Efficacy|0|||
128684518|NCT01436162|463144210|FG001|Randomized Phase|Lack of Efficacy|1|||
128684519|NCT01436162|463144211|FG002|Randomized Phase|Lack of Efficacy|1|||
128684520|NCT01436162|463144209|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
128684521|NCT01436162|463144210|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
128684522|NCT01436162|463144211|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
128684523|NCT01436162|463144209|FG000|Randomized Phase|Other|2|||
128684524|NCT01436162|463144210|FG001|Randomized Phase|Other|5|||
128684525|NCT01436162|463144211|FG002|Randomized Phase|Other|4|||
128684526|NCT01931202|463144214|FG000|Overall Study|Withdrawal by Subject|0|||
128684527|NCT01931202|463144215|FG001|Overall Study|Withdrawal by Subject|0|||
128684528|NCT01931202|463144216|FG002|Overall Study|Withdrawal by Subject|2|||
128684529|NCT01931202|463144214|FG000|Overall Study|Lost to Follow-up|0|||
128684530|NCT01931202|463144215|FG001|Overall Study|Lost to Follow-up|5|||
128684531|NCT01931202|463144216|FG002|Overall Study|Lost to Follow-up|2|||
128684532|NCT02294773|463146045|FG000|Overall Study|Withdrawal by Subject|0|||
128684533|NCT02294773|463146046|FG001|Overall Study|Withdrawal by Subject|2|||
128684534|NCT03052764|463146047|FG000|Double-Blind Treatment Period|Adverse Event|2|||
128684535|NCT03052764|463146048|FG001|Double-Blind Treatment Period|Adverse Event|0|||
128684536|NCT03052764|463146047|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
128684537|NCT03052764|463146048|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
128684538|NCT03052764|463146047|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
128684539|NCT03052764|463146048|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
129020438|NCT01796171|464367103|FG007|Treatment Period With Betalutin|Death|0|||
129020439|NCT01796171|464367104|FG008|Treatment Period With Betalutin|Death|0|||
129020440|NCT01796171|464367105|FG009|Treatment Period With Betalutin|Death|0|||
129020441|NCT01796171|464367106|FG010|Treatment Period With Betalutin|Death|2|||
129020442|NCT01796171|464367107|FG011|Treatment Period With Betalutin|Death|0|||
129020443|NCT01796171|464367108|FG012|Treatment Period With Betalutin|Death|0|||
129020444|NCT01796171|464367109|FG013|Treatment Period With Betalutin|Death|0|||
129020445|NCT01796171|464367110|FG014|Treatment Period With Betalutin|Death|0|||
129020446|NCT01796171|464367096|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
129020447|NCT01796171|464367097|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
129020448|NCT01796171|464367098|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
129020449|NCT01796171|464367099|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
129020450|NCT01796171|464367100|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
129020451|NCT01796171|464367101|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
129020452|NCT01796171|464367102|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
129020453|NCT01796171|464367103|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
129020454|NCT01796171|464367104|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
129020455|NCT01796171|464367105|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
129020456|NCT01796171|464367106|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
129020457|NCT01796171|464367107|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
129020458|NCT01796171|464367108|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
129020459|NCT01796171|464367109|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
129020460|NCT01796171|464367110|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
129020461|NCT01796171|464367096|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020462|NCT01796171|464367097|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020463|NCT01796171|464367098|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020464|NCT01796171|464367099|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020465|NCT01796171|464367100|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020466|NCT01796171|464367101|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020467|NCT01796171|464367102|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020468|NCT01796171|464367103|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020469|NCT01796171|464367104|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020470|NCT01796171|464367105|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020471|NCT01796171|464367106|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
129020472|NCT01796171|464367107|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
129020473|NCT01796171|464367108|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020474|NCT01796171|464367109|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020475|NCT01796171|464367110|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129020476|NCT01796171|464367096|FG000|Follow-up Period|Start of further anticancer therapy|4|||
129020477|NCT01796171|464367097|FG001|Follow-up Period|Start of further anticancer therapy|25|||
129020478|NCT01796171|464367098|FG002|Follow-up Period|Start of further anticancer therapy|2|||
129020479|NCT01796171|464367099|FG003|Follow-up Period|Start of further anticancer therapy|1|||
129020480|NCT01796171|464367100|FG004|Follow-up Period|Start of further anticancer therapy|2|||
128684540|NCT03052764|463146047|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
128684541|NCT03052764|463146048|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128684542|NCT03052764|463146047|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
128684543|NCT03052764|463146048|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
128684544|NCT05828095|463146049|FG000|Overall Study|Lost to Follow-up|1|||
128684545|NCT05828095|463146050|FG001|Overall Study|Lost to Follow-up|0|||
128684546|NCT05828095|463146049|FG000|Overall Study|Reactogenicity symptom|0|||
128684547|NCT05828095|463146050|FG001|Overall Study|Reactogenicity symptom|1|||
128684548|NCT03206073|463146051|FG000|Overall Study|Participant Noncompliance|0|||
128684549|NCT03206073|463146052|FG001|Overall Study|Participant Noncompliance|1|||
128684550|NCT03206073|463146053|FG002|Overall Study|Participant Noncompliance|0|||
128684551|NCT03206073|463146054|FG003|Overall Study|Participant Noncompliance|0|||
128886376|NCT01176968|463879159|FG001|Overall Study|Withdrawal by Subject|48|||
128886377|NCT01176968|463879158|FG000|Overall Study|Protocol Violation|2|||
128886378|NCT01176968|463879159|FG001|Overall Study|Protocol Violation|1|||
128886379|NCT01176968|463879158|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
128886380|NCT01176968|463879159|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
128886381|NCT01176968|463879158|FG000|Overall Study|Study terminated by sponsor|0|||
128886382|NCT01176968|463879159|FG001|Overall Study|Study terminated by sponsor|1|||
128886383|NCT01176968|463879158|FG000|Overall Study|Reason not defined|5|||
128886384|NCT01176968|463879159|FG001|Overall Study|Reason not defined|3|||
128886385|NCT00833911|463879160|FG000|Titration|Adverse Event|18|||
128886386|NCT00833911|463879160|FG000|Titration|Withdrawal by Subject|3|||
128886387|NCT00833911|463879160|FG000|Maintenance Phase I|Adverse Event|73|||
128886388|NCT00833911|463879160|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
128886389|NCT00833911|463879160|FG000|Maintenance Phase I|Physician Decision|10|||
128886390|NCT00833911|463879160|FG000|Maintenance Phase I|Lack of Efficacy|4|||
128886391|NCT00833911|463879160|FG000|Maintenance Phase II|Adverse Event|6|||
128886392|NCT00833911|463879160|FG000|Maintenance Phase II|Physician Decision|2|||
128886393|NCT00833911|463879160|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
128886394|NCT00833911|463879160|FG000|Maintenance Phase II|Lack of Efficacy|1|||
128886395|NCT00718640|463879161|FG000|Overall Study|Adverse Event|4|||
128886396|NCT00718640|463879161|FG000|Overall Study|Death|1|||
128886397|NCT00718640|463879161|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
128886398|NCT01137955|463879164|FG000|Overall Study|Withdrawal by Subject|5|||
128886399|NCT01137955|463879165|FG001|Overall Study|Withdrawal by Subject|4|||
128886400|NCT01207596|463879166|FG000|Overall Study|Physician Decision|4|||
128886401|NCT01207596|463879166|FG000|Overall Study|Lack of Efficacy|1|||
128886402|NCT01207596|463879166|FG000|Overall Study|Adverse Event|3|||
128886403|NCT01207596|463879166|FG000|Overall Study|Withdrawal by Subject|1|||
128886404|NCT00216203|463879169|FG000|Overall Study|Withdrawal by Subject|2|||
128886405|NCT00068588|463879170|FG000|Overall Study|Adverse Event|0|||
128886406|NCT00068588|463879171|FG001|Overall Study|Adverse Event|0|||
128886407|NCT00068588|463879172|FG002|Overall Study|Adverse Event|2|||
128886408|NCT00068588|463879170|FG000|Overall Study|Withdrawal by Subject|0|||
128886409|NCT00068588|463879171|FG001|Overall Study|Withdrawal by Subject|0|||
128886410|NCT00068588|463879172|FG002|Overall Study|Withdrawal by Subject|1|||
128886411|NCT00068588|463879170|FG000|Overall Study|Poor KPS|0|||
128886412|NCT00068588|463879171|FG001|Overall Study|Poor KPS|0|||
128886413|NCT00068588|463879172|FG002|Overall Study|Poor KPS|1|||
128886414|NCT05193500|463879173|FG000|Overall Study|Withdrawal by Subject|7|||
128886415|NCT05193500|463879174|FG001|Overall Study|Withdrawal by Subject|4|||
128886416|NCT05193500|463879175|FG002|Overall Study|Withdrawal by Subject|3|||
128886417|NCT05193500|463879176|FG003|Overall Study|Withdrawal by Subject|5|||
128886418|NCT04098068|463879177|FG000|Overall Study|Disease Progression|7|||
128886419|NCT04098068|463879177|FG000|Overall Study|Withdrawal by Subject|2|||
128886420|NCT04098068|463879177|FG000|Overall Study|New Cancer Diagnosis|1|||
128886421|NCT03871829|463879178|FG000|Overall Study|Lost to Follow-up|0|||
128886422|NCT03871829|463879179|FG001|Overall Study|Lost to Follow-up|1|||
128886423|NCT03871829|463879178|FG000|Overall Study|Withdrawal by Subject|1|||
128886424|NCT03871829|463879179|FG001|Overall Study|Withdrawal by Subject|1|||
128886425|NCT03871829|463879178|FG000|Overall Study|Death|12|||
128886426|NCT03871829|463879179|FG001|Overall Study|Death|8|||
128886427|NCT03871829|463879178|FG000|Overall Study|Study terminated by sponsor|31|||
128886428|NCT03871829|463879179|FG001|Overall Study|Study terminated by sponsor|34|||
128886429|NCT01106014|463879180|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
128886430|NCT01106014|463879181|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
128886431|NCT01106014|463879180|FG000|Overall Study|Adverse Event|78|||
128886432|NCT01106014|463879181|FG001|Overall Study|Adverse Event|42|||
128886433|NCT01106014|463879180|FG000|Overall Study|Withdrawal by Subject|43|||
128684552|NCT03206073|463146051|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
128886434|NCT01106014|463879181|FG001|Overall Study|Withdrawal by Subject|37|||
128886435|NCT01106014|463879180|FG000|Overall Study|Administrative reason|7|||
128684553|NCT03206073|463146052|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
128886436|NCT01106014|463879181|FG001|Overall Study|Administrative reason|6|||
128886437|NCT01106014|463879180|FG000|Overall Study|Lost to Follow-up|2|||
128886438|NCT01106014|463879181|FG001|Overall Study|Lost to Follow-up|3|||
128886439|NCT00784693|463879187|FG000|Overall Study|Lost to Follow-up|0|||
128886440|NCT00784693|463879188|FG001|Overall Study|Lost to Follow-up|1|||
128886441|NCT00784693|463879187|FG000|Overall Study|Lack of Efficacy|1|||
128886442|NCT00784693|463879188|FG001|Overall Study|Lack of Efficacy|1|||
128886443|NCT00784693|463879187|FG000|Overall Study|Withdrawal by Subject|0|||
128886444|NCT00784693|463879188|FG001|Overall Study|Withdrawal by Subject|4|||
128886445|NCT00784693|463879187|FG000|Overall Study|Randomized but not Treated|1|||
128886446|NCT00784693|463879188|FG001|Overall Study|Randomized but not Treated|0|||
128886447|NCT00784693|463879187|FG000|Overall Study|Other|1|||
128886448|NCT00784693|463879188|FG001|Overall Study|Other|0|||
128886449|NCT05458479|463879189|FG000|Overall Study|Lost to Follow-up|1|||
128886450|NCT00908232|463879190|FG000|Cycle 1 to 4|Death|5|||
128886451|NCT00908232|463879191|FG001|Cycle 1 to 4|Death|0|||
128886452|NCT00908232|463879192|FG002|Cycle 1 to 4|Death|0|||
128886453|NCT00908232|463879193|FG003|Cycle 1 to 4|Death|0|||
128886454|NCT00908232|463879190|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
128886455|NCT00908232|463879191|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
128886456|NCT00908232|463879192|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
128886457|NCT00908232|463879193|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
128886458|NCT00908232|463879190|FG000|Cycle 1 to 4|Progressive Disease|6|||
128886459|NCT00908232|463879191|FG001|Cycle 1 to 4|Progressive Disease|0|||
128886460|NCT00908232|463879192|FG002|Cycle 1 to 4|Progressive Disease|0|||
128886461|NCT00908232|463879193|FG003|Cycle 1 to 4|Progressive Disease|0|||
128886462|NCT00908232|463879190|FG000|Cycle 1 to 4|Adverse Event|12|||
128886463|NCT00908232|463879191|FG001|Cycle 1 to 4|Adverse Event|0|||
128886464|NCT00908232|463879192|FG002|Cycle 1 to 4|Adverse Event|0|||
128886465|NCT00908232|463879193|FG003|Cycle 1 to 4|Adverse Event|0|||
128886466|NCT00908232|463879190|FG000|Cycle 1 to 4|Other|1|||
128886467|NCT00908232|463879191|FG001|Cycle 1 to 4|Other|0|||
128886468|NCT00908232|463879192|FG002|Cycle 1 to 4|Other|0|||
128886469|NCT00908232|463879193|FG003|Cycle 1 to 4|Other|0|||
128886470|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
128886471|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
128886472|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
128886473|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
128886474|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
128886475|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
128886476|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
128886477|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
128886478|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
128886479|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
128886480|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
128886481|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
128886482|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
128886483|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
128886484|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
128886485|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
128886486|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
128886487|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
128886488|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
128886489|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
128886490|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
128886491|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
128886492|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
128886493|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
128886494|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
128886495|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
128886496|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
128886497|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
128886498|NCT00908232|463879190|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
128886499|NCT00908232|463879191|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
128886500|NCT00908232|463879192|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
129108878|NCT02499120|464693647|FG000|Overall Study|Withdrawal by Subject|2|||
128684554|NCT03206073|463146053|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
128684555|NCT03206073|463146054|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
128684556|NCT03206073|463146051|FG000|Overall Study|Death|0|||
128886501|NCT00908232|463879193|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
128684557|NCT03206073|463146052|FG001|Overall Study|Death|0|||
128684558|NCT03206073|463146053|FG002|Overall Study|Death|1|||
128684559|NCT03206073|463146054|FG003|Overall Study|Death|0|||
128684560|NCT03206073|463146051|FG000|Overall Study|Taken off active treatment|0|||
128886502|NCT02260882|463879194|FG000|Overall Study|Protocol Violation|0|||
128684561|NCT03206073|463146052|FG001|Overall Study|Taken off active treatment|0|||
128684562|NCT03206073|463146053|FG002|Overall Study|Taken off active treatment|3|||
128886503|NCT02260882|463879195|FG001|Overall Study|Protocol Violation|1|||
128886504|NCT02119325|463879196|FG000|Washout Period 1|Adverse Event|0|||
128886505|NCT02119325|463879197|FG001|Washout Period 1|Adverse Event|1|||
128886506|NCT01386658|463879198|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
128886507|NCT01386658|463879199|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
128886508|NCT01386658|463879198|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
128886509|NCT01386658|463879199|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
128886510|NCT00954174|463879200|FG000|Overall Study|Adverse Event|28|||
128886511|NCT00954174|463879201|FG001|Overall Study|Adverse Event|23|||
128886512|NCT00954174|463879202|FG002|Overall Study|Adverse Event|4|||
128886513|NCT00954174|463879203|FG003|Overall Study|Adverse Event|9|||
128886514|NCT00954174|463879200|FG000|Overall Study|Death|4|||
128886515|NCT00954174|463879201|FG001|Overall Study|Death|2|||
128886516|NCT00954174|463879202|FG002|Overall Study|Death|0|||
128886517|NCT00954174|463879203|FG003|Overall Study|Death|0|||
128886518|NCT00954174|463879200|FG000|Overall Study|Lack of Efficacy|32|||
128886519|NCT00954174|463879201|FG001|Overall Study|Lack of Efficacy|22|||
128886520|NCT00954174|463879202|FG002|Overall Study|Lack of Efficacy|8|||
128886521|NCT00954174|463879203|FG003|Overall Study|Lack of Efficacy|6|||
128886522|NCT00954174|463879200|FG000|Overall Study|Withdrawal by Subject|14|||
128886523|NCT00954174|463879201|FG001|Overall Study|Withdrawal by Subject|10|||
128886524|NCT00954174|463879202|FG002|Overall Study|Withdrawal by Subject|4|||
128886525|NCT00954174|463879203|FG003|Overall Study|Withdrawal by Subject|3|||
128886526|NCT00954174|463879200|FG000|Overall Study|Medical Reason|4|||
128886527|NCT00954174|463879201|FG001|Overall Study|Medical Reason|2|||
128886528|NCT00954174|463879202|FG002|Overall Study|Medical Reason|1|||
128886529|NCT00954174|463879203|FG003|Overall Study|Medical Reason|0|||
128886530|NCT00954174|463879200|FG000|Overall Study|Ineligible|40|||
128886531|NCT00954174|463879201|FG001|Overall Study|Ineligible|47|||
128886532|NCT00954174|463879202|FG002|Overall Study|Ineligible|7|||
128886533|NCT00954174|463879203|FG003|Overall Study|Ineligible|4|||
128886534|NCT00954174|463879200|FG000|Overall Study|Never Treated|4|||
128886535|NCT00954174|463879201|FG001|Overall Study|Never Treated|17|||
128886536|NCT00954174|463879202|FG002|Overall Study|Never Treated|0|||
128886537|NCT00954174|463879203|FG003|Overall Study|Never Treated|3|||
128886538|NCT02030405|463879204|FG000|Overall Study|Withdrawal by Subject|1|||
128886539|NCT02030405|463879204|FG000|Overall Study|Lost to Follow-up|1|||
128886540|NCT04484259|463879217|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
128886541|NCT04484259|463879218|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
128886542|NCT04484259|463879219|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
128886543|NCT04484259|463879220|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
128886544|NCT04484259|463879221|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
128886545|NCT04484259|463879217|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
128886546|NCT04484259|463879218|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
128886547|NCT04484259|463879219|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
128886548|NCT04484259|463879220|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
128886549|NCT04484259|463879221|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
128886550|NCT04484259|463879217|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
128886551|NCT04484259|463879218|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
128886552|NCT04484259|463879219|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
128886553|NCT04484259|463879220|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
128886554|NCT04484259|463879221|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
128886555|NCT04484259|463879217|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
128886556|NCT04484259|463879218|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
128886557|NCT04484259|463879219|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
128886558|NCT04484259|463879220|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
128886559|NCT04484259|463879221|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
128886560|NCT04484259|463879217|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
128886561|NCT04484259|463879218|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
128886562|NCT04484259|463879219|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
128886563|NCT04484259|463879220|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
128886564|NCT04484259|463879221|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
128886565|NCT04484259|463879217|FG000|Randomized Treatment|Withdrawal by Subject|1|||
129020481|NCT01796171|464367101|FG005|Follow-up Period|Start of further anticancer therapy|2|||
129020482|NCT01796171|464367102|FG006|Follow-up Period|Start of further anticancer therapy|1|||
129020483|NCT01796171|464367103|FG007|Follow-up Period|Start of further anticancer therapy|15|||
128886566|NCT04484259|463879218|FG001|Randomized Treatment|Withdrawal by Subject|0|||
128886567|NCT04484259|463879219|FG002|Randomized Treatment|Withdrawal by Subject|0|||
128886568|NCT04484259|463879220|FG003|Randomized Treatment|Withdrawal by Subject|0|||
128886569|NCT04484259|463879221|FG004|Randomized Treatment|Withdrawal by Subject|0|||
128886570|NCT04908189|463879222|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
128886571|NCT04908189|463879223|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
129020484|NCT01796171|464367104|FG008|Follow-up Period|Start of further anticancer therapy|2|||
128886572|NCT04908189|463879224|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
128886573|NCT04908189|463879222|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
128886574|NCT04908189|463879223|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
128886575|NCT04908189|463879224|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
128886576|NCT04908189|463879222|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
128886577|NCT04908189|463879223|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
128886578|NCT04908189|463879224|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
128886579|NCT04908189|463879222|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
128886580|NCT04908189|463879223|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
128886581|NCT04908189|463879224|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
128886582|NCT04908189|463879222|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
128886583|NCT04908189|463879223|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
128886584|NCT04908189|463879224|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
128886585|NCT04908189|463879222|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
128886586|NCT04908189|463879223|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
128886587|NCT04908189|463879224|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
128886588|NCT04908189|463879222|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
128886589|NCT04908189|463879223|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
128886590|NCT04908189|463879224|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
128886591|NCT04908189|463879222|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
128886592|NCT04908189|463879223|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
128886593|NCT04908189|463879224|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
128886594|NCT04908189|463879222|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
128886595|NCT04908189|463879223|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
128886596|NCT04908189|463879224|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
128886597|NCT04908189|463879222|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
128886598|NCT04908189|463879223|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
128886599|NCT04908189|463879224|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
128886600|NCT04908189|463879222|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
128886601|NCT04908189|463879223|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
128886602|NCT04908189|463879224|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
128886603|NCT04908189|463879222|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
128886604|NCT04908189|463879223|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
128886605|NCT04908189|463879224|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
128886606|NCT02684357|463879227|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
128886607|NCT02684357|463879228|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
128886608|NCT02684357|463879229|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
128886609|NCT02684357|463879230|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
128886610|NCT02684357|463879231|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
128886611|NCT02684357|463879232|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
128886612|NCT02684357|463879227|FG000|Part A|Lost to Follow-up|0|||
128886613|NCT02684357|463879228|FG001|Part A|Lost to Follow-up|2|||
128886614|NCT02684357|463879229|FG002|Part A|Lost to Follow-up|2|||
128886615|NCT02684357|463879230|FG003|Part A|Lost to Follow-up|0|||
128886616|NCT02684357|463879231|FG004|Part A|Lost to Follow-up|0|||
128886617|NCT02684357|463879232|FG005|Part A|Lost to Follow-up|0|||
128886618|NCT02684357|463879227|FG000|Part A|Withdrawal by Subject|3|||
128886619|NCT02684357|463879228|FG001|Part A|Withdrawal by Subject|0|||
128886620|NCT02684357|463879229|FG002|Part A|Withdrawal by Subject|0|||
128886621|NCT02684357|463879230|FG003|Part A|Withdrawal by Subject|0|||
128886622|NCT02684357|463879231|FG004|Part A|Withdrawal by Subject|0|||
128886623|NCT02684357|463879232|FG005|Part A|Withdrawal by Subject|0|||
128886624|NCT02684357|463879227|FG000|Part A|Other|0|||
128886625|NCT02684357|463879228|FG001|Part A|Other|1|||
128886626|NCT02684357|463879229|FG002|Part A|Other|0|||
128886627|NCT02684357|463879230|FG003|Part A|Other|0|||
128886628|NCT02684357|463879231|FG004|Part A|Other|0|||
128886629|NCT02684357|463879232|FG005|Part A|Other|0|||
128886630|NCT02684357|463879227|FG000|Part B|Adverse Event (Other)|0|||
128886631|NCT02684357|463879228|FG001|Part B|Adverse Event (Other)|0|||
128886632|NCT02684357|463879229|FG002|Part B|Adverse Event (Other)|0|||
128886633|NCT02684357|463879230|FG003|Part B|Adverse Event (Other)|1|||
128886634|NCT02684357|463879231|FG004|Part B|Adverse Event (Other)|1|||
128886635|NCT02684357|463879232|FG005|Part B|Adverse Event (Other)|1|||
128886636|NCT02684357|463879227|FG000|Part B|Lost to Follow-up|0|||
128886637|NCT02684357|463879228|FG001|Part B|Lost to Follow-up|0|||
128886638|NCT02684357|463879229|FG002|Part B|Lost to Follow-up|0|||
128886639|NCT02684357|463879230|FG003|Part B|Lost to Follow-up|1|||
128763172|NCT03724396|463422776|FG001|Overall Study|Lost to Follow-up|1|||
128886640|NCT02684357|463879231|FG004|Part B|Lost to Follow-up|1|||
128886641|NCT02684357|463879232|FG005|Part B|Lost to Follow-up|7|||
128886642|NCT02684357|463879227|FG000|Part B|Withdrawal by Subject|0|||
128886643|NCT02684357|463879228|FG001|Part B|Withdrawal by Subject|0|||
128886644|NCT02684357|463879229|FG002|Part B|Withdrawal by Subject|0|||
128886645|NCT02684357|463879230|FG003|Part B|Withdrawal by Subject|0|||
128886646|NCT02684357|463879231|FG004|Part B|Withdrawal by Subject|2|||
128886647|NCT02684357|463879232|FG005|Part B|Withdrawal by Subject|4|||
128886648|NCT02684357|463879227|FG000|Part B|Other|0|||
128886649|NCT02684357|463879228|FG001|Part B|Other|0|||
128886650|NCT02684357|463879229|FG002|Part B|Other|0|||
128886651|NCT02684357|463879230|FG003|Part B|Other|1|||
128886652|NCT02684357|463879231|FG004|Part B|Other|0|||
128886653|NCT02684357|463879232|FG005|Part B|Other|1|||
128886654|NCT01079130|463879233|FG000|Overall Study|Adverse Event|1|||
128886655|NCT01079130|463879234|FG001|Overall Study|Adverse Event|1|||
128886656|NCT01079130|463879235|FG002|Overall Study|Adverse Event|0|||
128886657|NCT01079130|463879236|FG003|Overall Study|Adverse Event|1|||
128886658|NCT01079130|463879237|FG004|Overall Study|Adverse Event|5|||
128886659|NCT01079130|463879238|FG005|Overall Study|Adverse Event|1|||
128886660|NCT01079130|463879233|FG000|Overall Study|Administrative problems|1|||
128886661|NCT01079130|463879234|FG001|Overall Study|Administrative problems|3|||
128886662|NCT01079130|463879235|FG002|Overall Study|Administrative problems|0|||
128886663|NCT01079130|463879236|FG003|Overall Study|Administrative problems|0|||
128886664|NCT01079130|463879237|FG004|Overall Study|Administrative problems|0|||
128886665|NCT01079130|463879238|FG005|Overall Study|Administrative problems|1|||
128886666|NCT01079130|463879233|FG000|Overall Study|Withdrawal by Subject|0|||
128886667|NCT01079130|463879234|FG001|Overall Study|Withdrawal by Subject|1|||
128886668|NCT01079130|463879235|FG002|Overall Study|Withdrawal by Subject|0|||
128886669|NCT01079130|463879236|FG003|Overall Study|Withdrawal by Subject|0|||
128886670|NCT01079130|463879237|FG004|Overall Study|Withdrawal by Subject|1|||
128886671|NCT01079130|463879238|FG005|Overall Study|Withdrawal by Subject|3|||
128886672|NCT01079130|463879233|FG000|Overall Study|Protocol deviation|0|||
128886673|NCT01079130|463879234|FG001|Overall Study|Protocol deviation|2|||
128886674|NCT01079130|463879235|FG002|Overall Study|Protocol deviation|1|||
128886675|NCT01079130|463879236|FG003|Overall Study|Protocol deviation|2|||
128886676|NCT01079130|463879237|FG004|Overall Study|Protocol deviation|0|||
128886677|NCT01079130|463879238|FG005|Overall Study|Protocol deviation|0|||
128886678|NCT01079130|463879233|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128886679|NCT01079130|463879234|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128886680|NCT01079130|463879235|FG002|Overall Study|Abnormal test procedure result(s)|0|||
128886681|NCT01079130|463879236|FG003|Overall Study|Abnormal test procedure result(s)|0|||
128886682|NCT01079130|463879237|FG004|Overall Study|Abnormal test procedure result(s)|1|||
128886683|NCT01079130|463879238|FG005|Overall Study|Abnormal test procedure result(s)|0|||
128886684|NCT01079130|463879233|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128886685|NCT01079130|463879234|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128886686|NCT01079130|463879235|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
128886687|NCT01079130|463879236|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129108879|NCT02499120|464693648|FG001|Overall Study|Withdrawal by Subject|5|||
129108880|NCT02499120|464693647|FG000|Overall Study|Other|9|||
129108881|NCT02499120|464693648|FG001|Overall Study|Other|10|||
129108882|NCT00571662|464693653|FG000|Overall Study|Withdrawal by Subject|2|||
128886688|NCT01079130|463879237|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
128886689|NCT01079130|463879238|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
128886690|NCT01079130|463879233|FG000|Overall Study|Lost to Follow-up|0|||
128886691|NCT01079130|463879234|FG001|Overall Study|Lost to Follow-up|0|||
128886692|NCT01079130|463879235|FG002|Overall Study|Lost to Follow-up|0|||
128886693|NCT01079130|463879236|FG003|Overall Study|Lost to Follow-up|0|||
128886694|NCT01079130|463879237|FG004|Overall Study|Lost to Follow-up|1|||
128886695|NCT01079130|463879238|FG005|Overall Study|Lost to Follow-up|0|||
128886696|NCT01839487|463879239|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
128886697|NCT01839487|463879240|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
128886698|NCT01839487|463879241|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
128886699|NCT01839487|463879242|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
128886700|NCT01839487|463879243|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
128886701|NCT01839487|463879244|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129108883|NCT00571662|464693653|FG000|Overall Study|psychiatric instability|1|||
129108884|NCT00571662|464693653|FG000|Overall Study|Adverse Event|5|||
129108885|NCT01839916|464693658|FG000|Overall Study|Death|9|||
128886702|NCT01839487|463879239|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
128886703|NCT01839487|463879240|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
128886704|NCT01839487|463879241|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
128886705|NCT01839487|463879242|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
128886706|NCT01839487|463879243|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
128886707|NCT01839487|463879244|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
128886708|NCT01839487|463879239|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
128886709|NCT01839487|463879240|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
129108886|NCT01839916|464693658|FG000|Overall Study|Physician Decision|17|||
128886710|NCT01839487|463879241|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
128886711|NCT01839487|463879242|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
128886712|NCT01839487|463879243|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
128886713|NCT01839487|463879244|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
128886714|NCT01839487|463879239|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
128886715|NCT01839487|463879240|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
128886716|NCT01839487|463879241|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
128886717|NCT01839487|463879242|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
128886718|NCT01839487|463879243|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
128886719|NCT01839487|463879244|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
128886720|NCT01839487|463879239|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
128886721|NCT01839487|463879240|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
128886722|NCT01839487|463879241|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
128886723|NCT01839487|463879242|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
128886724|NCT01839487|463879243|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
128886725|NCT01839487|463879244|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
128886726|NCT01839487|463879239|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
128886727|NCT01839487|463879240|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
128886728|NCT01839487|463879241|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
128886729|NCT01839487|463879242|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
128886730|NCT01839487|463879243|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
128886731|NCT01839487|463879244|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
128886732|NCT01839487|463879239|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
128886733|NCT01839487|463879240|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
128886734|NCT01839487|463879241|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
128886735|NCT01839487|463879242|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
128886736|NCT01839487|463879243|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
128886737|NCT01839487|463879244|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
128886738|NCT01839487|463879239|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
128886739|NCT01839487|463879240|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
128886740|NCT01839487|463879241|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
128886741|NCT01839487|463879242|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
128886742|NCT01839487|463879243|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
128886743|NCT01839487|463879244|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
128886744|NCT01839487|463879239|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
128886745|NCT01839487|463879240|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
128886746|NCT01839487|463879241|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
128886747|NCT01839487|463879242|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
128886748|NCT01839487|463879243|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
128886749|NCT01839487|463879244|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
128886750|NCT01658826|463879255|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
128886751|NCT01658826|463879256|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
128886752|NCT01658826|463879255|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
128886753|NCT01658826|463879256|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
128886754|NCT01658826|463879255|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
128886755|NCT01658826|463879256|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
128886756|NCT01658826|463879255|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
128886757|NCT01658826|463879256|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
128886758|NCT01658826|463879255|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
128886759|NCT01658826|463879256|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
128886760|NCT01658826|463879255|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
128886761|NCT01658826|463879256|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
128886762|NCT01658826|463879255|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
128886763|NCT01658826|463879256|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
128886764|NCT01658826|463879255|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
129108887|NCT01839916|464693658|FG000|Overall Study|Relapse|12|||
129108888|NCT01839916|464693658|FG000|Overall Study|GVHD|2|||
129108889|NCT01839916|464693658|FG000|Overall Study|Graft Failure|1|||
129108890|NCT00964028|464693659|FG000|Overall Study|Withdrawal by Subject|0|||
129108891|NCT00964028|464693660|FG001|Overall Study|Withdrawal by Subject|1|||
129108892|NCT02385110|464693663|FG000|Overall Study|Early Death|1|||
129108893|NCT02385110|464693664|FG001|Overall Study|Early Death|0|||
129108894|NCT03472521|464693665|FG000|Overall Study|Lost to Follow-up|3|||
129108895|NCT03472521|464693666|FG001|Overall Study|Lost to Follow-up|2|||
129108896|NCT03472521|464693665|FG000|Overall Study|Discontinued intervention|3|||
128684563|NCT03206073|463146054|FG003|Overall Study|Taken off active treatment|0|||
128684564|NCT03332771|463146055|FG000|Overall Study|Adverse Event|6|||
128684565|NCT03332771|463146056|FG001|Overall Study|Adverse Event|4|||
128684566|NCT03332771|463146057|FG002|Overall Study|Adverse Event|1|||
128684567|NCT03332771|463146058|FG003|Overall Study|Adverse Event|3|||
128684568|NCT03332771|463146055|FG000|Overall Study|Poor Compliance to Protocol|0|||
128684569|NCT03332771|463146056|FG001|Overall Study|Poor Compliance to Protocol|1|||
128684570|NCT03332771|463146057|FG002|Overall Study|Poor Compliance to Protocol|0|||
128684571|NCT03332771|463146058|FG003|Overall Study|Poor Compliance to Protocol|1|||
128684572|NCT03332771|463146055|FG000|Overall Study|Lost to Follow-up|2|||
128684573|NCT03332771|463146056|FG001|Overall Study|Lost to Follow-up|2|||
128684574|NCT03332771|463146057|FG002|Overall Study|Lost to Follow-up|1|||
128684575|NCT03332771|463146058|FG003|Overall Study|Lost to Follow-up|2|||
128684576|NCT03332771|463146055|FG000|Overall Study|At the Participant's own request|20|||
128684577|NCT03332771|463146056|FG001|Overall Study|At the Participant's own request|26|||
128684578|NCT03332771|463146057|FG002|Overall Study|At the Participant's own request|14|||
128684579|NCT03332771|463146058|FG003|Overall Study|At the Participant's own request|23|||
128684580|NCT03332771|463146055|FG000|Overall Study|Reason Not Specified|6|||
128684581|NCT03332771|463146056|FG001|Overall Study|Reason Not Specified|18|||
128684582|NCT03332771|463146057|FG002|Overall Study|Reason Not Specified|16|||
128684583|NCT03332771|463146058|FG003|Overall Study|Reason Not Specified|19|||
128684584|NCT00096954|463146059|FG000|Overall Study|Adverse Event|3|||
128684585|NCT00096954|463146060|FG001|Overall Study|Adverse Event|1|||
128684586|NCT00096954|463146059|FG000|Overall Study|Withdrawal by Subject|9|||
128684587|NCT00096954|463146060|FG001|Overall Study|Withdrawal by Subject|8|||
128684588|NCT00096954|463146059|FG000|Overall Study|Physician Decision|1|||
128684589|NCT00096954|463146060|FG001|Overall Study|Physician Decision|1|||
128684590|NCT00096954|463146059|FG000|Overall Study|Sponsors Decision|1|||
128684591|NCT00096954|463146060|FG001|Overall Study|Sponsors Decision|1|||
128684592|NCT00096954|463146059|FG000|Overall Study|Pregnancy|1|||
128684593|NCT00096954|463146060|FG001|Overall Study|Pregnancy|1|||
128684594|NCT00096954|463146059|FG000|Overall Study|Initiation of immunotherapy|1|||
128684595|NCT00096954|463146060|FG001|Overall Study|Initiation of immunotherapy|0|||
128684596|NCT00096954|463146059|FG000|Overall Study|Non-compliance|0|||
128684597|NCT00096954|463146060|FG001|Overall Study|Non-compliance|3|||
128684598|NCT00096954|463146059|FG000|Overall Study|Lost to Follow-up|8|||
128684599|NCT00096954|463146060|FG001|Overall Study|Lost to Follow-up|5|||
128684600|NCT04478123|463146062|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
128684601|NCT04478123|463146062|FG000|Overall Study|NE|1|||
128684602|NCT03581786|463146065|FG000|Overall Study|Death|67|||
128684603|NCT03581786|463146066|FG001|Overall Study|Death|47|||
128684604|NCT03581786|463146065|FG000|Overall Study|Withdrawal by Subject|2|||
128684605|NCT03581786|463146066|FG001|Overall Study|Withdrawal by Subject|5|||
128684606|NCT03581786|463146065|FG000|Overall Study|Lost to Follow-up|7|||
128684607|NCT03581786|463146066|FG001|Overall Study|Lost to Follow-up|4|||
128684608|NCT03581786|463146065|FG000|Overall Study|reason other than specified above|0|||
128684609|NCT03581786|463146066|FG001|Overall Study|reason other than specified above|1|||
128684610|NCT01347307|463146069|FG000|Overall Study|Death|0|||
128684611|NCT01347307|463146070|FG001|Overall Study|Death|4|||
128684612|NCT01347307|463146069|FG000|Overall Study|Physician Decision|0|||
128684613|NCT01347307|463146070|FG001|Overall Study|Physician Decision|1|||
128684614|NCT04123665|463146073|FG000|Overall Study|Withdrawal by Subject|7|||
128684615|NCT04123665|463146074|FG001|Overall Study|Withdrawal by Subject|0|||
128684616|NCT04123665|463146073|FG000|Overall Study|Lost to Follow-up|1|||
128684617|NCT04123665|463146074|FG001|Overall Study|Lost to Follow-up|0|||
128684618|NCT02237911|463146075|FG000|Overall Study|Withdrawal by Subject|4|||
128684619|NCT02237911|463146076|FG001|Overall Study|Withdrawal by Subject|7|||
128684620|NCT02237911|463146077|FG002|Overall Study|Withdrawal by Subject|2|||
128684621|NCT02237911|463146075|FG000|Overall Study|Lost to Follow-up|3|||
128684622|NCT02237911|463146076|FG001|Overall Study|Lost to Follow-up|1|||
128684623|NCT02237911|463146077|FG002|Overall Study|Lost to Follow-up|1|||
128684624|NCT00053365|463146078|FG000|Overall Study|Incorrect cell type|1|||
128684625|NCT00053365|463146078|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
129020485|NCT01796171|464367105|FG009|Follow-up Period|Start of further anticancer therapy|0|||
129215172|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
128684626|NCT00053365|463146078|FG000|Overall Study|Never treated|4|||
128684627|NCT00958789|463146083|FG000|Overall Study|Death|5|||
128684628|NCT00958789|463146083|FG000|Overall Study|Lost to Follow-up|14|||
128684629|NCT00958789|463146083|FG000|Overall Study|Withdrawal by Subject|17|||
128684630|NCT00958789|463146083|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
128684631|NCT00958789|463146083|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
128684632|NCT00958789|463146083|FG000|Overall Study|Subject terminated|2|||
128684633|NCT00958789|463146083|FG000|Overall Study|Revision|7|||
128684634|NCT00721123|463146084|FG000|Overall Study|Adverse Event|96|||
128684635|NCT00721123|463146084|FG000|Overall Study|Death|10|||
128684636|NCT00721123|463146084|FG000|Overall Study|Insufficient Therapeutic Response|21|||
128684637|NCT00721123|463146084|FG000|Overall Study|Protocol Violation|1|||
128684638|NCT00721123|463146084|FG000|Overall Study|Refused Treatment|41|||
128886765|NCT01658826|463879256|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
128886766|NCT01658826|463879255|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
128886767|NCT01658826|463879256|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
128886768|NCT04821869|463879257|FG000|Overall Study|Adverse Event|4|||
128886769|NCT04821869|463879257|FG000|Overall Study|Withdrawal by Subject|2|||
128886770|NCT04821869|463879257|FG000|Overall Study|Did not meet FEV1 criteria|1|||
128886771|NCT03217266|463880526|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
128886772|NCT03217266|463880527|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
128886773|NCT03217266|463880528|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
128886774|NCT03217266|463880529|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
128886775|NCT03217266|463880526|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
128886776|NCT03217266|463880527|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
128886777|NCT03217266|463880528|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
128886778|NCT03217266|463880529|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
128886779|NCT03217266|463880526|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
128886780|NCT03217266|463880527|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
128886781|NCT03217266|463880528|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
128886782|NCT03217266|463880529|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
128886783|NCT03511053|463880535|FG000|Overall Study|Withdrawal by Subject|1|||
128886784|NCT01128361|463880536|FG000|Overall Study|Lost to Follow-up|0|||
128886785|NCT01128361|463880537|FG001|Overall Study|Lost to Follow-up|1|||
128886786|NCT01128361|463880536|FG000|Overall Study|Withdrawal by Subject|5|||
128886787|NCT01128361|463880537|FG001|Overall Study|Withdrawal by Subject|2|||
128886788|NCT01929980|463880538|FG000|Overall Study|Physician Decision|1|||
128886789|NCT00985166|463880539|FG000|Overall Study|Lost to Follow-up|3|||
128886790|NCT00985166|463880540|FG001|Overall Study|Lost to Follow-up|2|||
128886791|NCT00985166|463880541|FG002|Overall Study|Lost to Follow-up|2|||
128886792|NCT00985166|463880539|FG000|Overall Study|Withdrawal by Subject|3|||
128886793|NCT00985166|463880540|FG001|Overall Study|Withdrawal by Subject|2|||
128886794|NCT00985166|463880541|FG002|Overall Study|Withdrawal by Subject|0|||
128886795|NCT00985166|463880539|FG000|Overall Study|Test not done|2|||
128886796|NCT00985166|463880540|FG001|Overall Study|Test not done|0|||
128886797|NCT00985166|463880541|FG002|Overall Study|Test not done|4|||
128886798|NCT00985166|463880539|FG000|Overall Study|Other|1|||
128886799|NCT00985166|463880540|FG001|Overall Study|Other|0|||
128886800|NCT00985166|463880541|FG002|Overall Study|Other|1|||
128886801|NCT01028222|463880542|FG000|Overall Study|Protocol deviation|1|||
128886802|NCT01028222|463880543|FG001|Overall Study|Protocol deviation|0|||
128886803|NCT01028222|463880542|FG000|Overall Study|Disease progression|33|||
128886804|NCT01028222|463880543|FG001|Overall Study|Disease progression|9|||
128886805|NCT01028222|463880542|FG000|Overall Study|Administrative problems|1|||
128886806|NCT01028222|463880543|FG001|Overall Study|Administrative problems|1|||
128886807|NCT01028222|463880542|FG000|Overall Study|Lost to Follow-up|0|||
128886808|NCT01028222|463880543|FG001|Overall Study|Lost to Follow-up|1|||
128886809|NCT01028222|463880542|FG000|Overall Study|Withdrawal by Subject|1|||
128886810|NCT01028222|463880543|FG001|Overall Study|Withdrawal by Subject|0|||
128886811|NCT01028222|463880542|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
128886812|NCT01028222|463880543|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
128886813|NCT01028222|463880542|FG000|Overall Study|Adverse Event|2|||
128886814|NCT01028222|463880543|FG001|Overall Study|Adverse Event|0|||
128886815|NCT00146328|463880546|FG000|Overall Study|Adverse Event|39|||
128886816|NCT00146328|463880547|FG001|Overall Study|Adverse Event|48|||
128886817|NCT00146328|463880548|FG002|Overall Study|Adverse Event|79|||
128886818|NCT00146328|463880546|FG000|Overall Study|Protocol Violation|11|||
128886819|NCT00146328|463880547|FG001|Overall Study|Protocol Violation|6|||
128886820|NCT00146328|463880548|FG002|Overall Study|Protocol Violation|12|||
128886821|NCT00146328|463880546|FG000|Overall Study|Lost to Follow-up|7|||
128886822|NCT00146328|463880547|FG001|Overall Study|Lost to Follow-up|4|||
128886823|NCT00146328|463880548|FG002|Overall Study|Lost to Follow-up|7|||
128886824|NCT00146328|463880546|FG000|Overall Study|Withdrawal by Subject|16|||
129020486|NCT01796171|464367106|FG010|Follow-up Period|Start of further anticancer therapy|0|||
128886825|NCT00146328|463880547|FG001|Overall Study|Withdrawal by Subject|16|||
129020487|NCT01796171|464367107|FG011|Follow-up Period|Start of further anticancer therapy|0|||
128886826|NCT00146328|463880548|FG002|Overall Study|Withdrawal by Subject|22|||
128886827|NCT00146328|463880546|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
128886828|NCT00146328|463880547|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
129020488|NCT01796171|464367108|FG012|Follow-up Period|Start of further anticancer therapy|0|||
129020489|NCT01796171|464367109|FG013|Follow-up Period|Start of further anticancer therapy|0|||
129020490|NCT01796171|464367110|FG014|Follow-up Period|Start of further anticancer therapy|0|||
128886829|NCT00146328|463880548|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
128886830|NCT00146328|463880546|FG000|Overall Study|Trial ended/site closed|8|||
128886831|NCT00146328|463880547|FG001|Overall Study|Trial ended/site closed|2|||
128886832|NCT00146328|463880548|FG002|Overall Study|Trial ended/site closed|19|||
129020491|NCT01796171|464367096|FG000|Follow-up Period|Progressive disease|0|||
128886833|NCT00146328|463880546|FG000|Overall Study|Patient decision to end|0|||
128886834|NCT00146328|463880547|FG001|Overall Study|Patient decision to end|1|||
128886835|NCT00146328|463880548|FG002|Overall Study|Patient decision to end|6|||
128886836|NCT00146328|463880546|FG000|Overall Study|Enroll into other trial|2|||
128886837|NCT00146328|463880547|FG001|Overall Study|Enroll into other trial|4|||
128886838|NCT00146328|463880548|FG002|Overall Study|Enroll into other trial|2|||
128886839|NCT00146328|463880546|FG000|Overall Study|Death|0|||
128886840|NCT00146328|463880547|FG001|Overall Study|Death|1|||
128886841|NCT00146328|463880548|FG002|Overall Study|Death|1|||
128886842|NCT00146328|463880546|FG000|Overall Study|Moved|2|||
128886843|NCT00146328|463880547|FG001|Overall Study|Moved|0|||
128886844|NCT00146328|463880548|FG002|Overall Study|Moved|0|||
128886845|NCT00146328|463880546|FG000|Overall Study|Interaction with other medication|2|||
128886846|NCT00146328|463880547|FG001|Overall Study|Interaction with other medication|0|||
128886847|NCT00146328|463880548|FG002|Overall Study|Interaction with other medication|1|||
128886848|NCT00300781|463880549|FG000|Overall Study|Disease Progression|55|||
128886849|NCT00300781|463880550|FG001|Overall Study|Disease Progression|52|||
128886850|NCT00300781|463880549|FG000|Overall Study|Adverse Event|5|||
128886851|NCT00300781|463880550|FG001|Overall Study|Adverse Event|6|||
128886852|NCT00300781|463880549|FG000|Overall Study|Withdrawal by Subject|1|||
128886853|NCT00300781|463880550|FG001|Overall Study|Withdrawal by Subject|2|||
128886854|NCT00300781|463880549|FG000|Overall Study|Physician Decision|1|||
128886855|NCT00300781|463880550|FG001|Overall Study|Physician Decision|0|||
128886856|NCT00300781|463880549|FG000|Overall Study|Not Recorded|0|||
128886857|NCT00300781|463880550|FG001|Overall Study|Not Recorded|1|||
128886858|NCT00300781|463880549|FG000|Overall Study|Symptomatic Deterioration|1|||
128886859|NCT00300781|463880550|FG001|Overall Study|Symptomatic Deterioration|0|||
128886860|NCT00300781|463880549|FG000|Overall Study|Lost to Follow-up|0|||
128886861|NCT00300781|463880550|FG001|Overall Study|Lost to Follow-up|1|||
128886862|NCT02072434|463880551|FG000|Overall Study|Protocol Violation|10|||
128886863|NCT02072434|463880552|FG001|Overall Study|Protocol Violation|9|||
128886864|NCT02072434|463880551|FG000|Overall Study|Physician Decision|5|||
128886865|NCT02072434|463880552|FG001|Overall Study|Physician Decision|10|||
128886866|NCT02072434|463880551|FG000|Overall Study|Adverse event, serious fatal|1|||
128886867|NCT02072434|463880552|FG001|Overall Study|Adverse event, serious fatal|6|||
128886868|NCT02072434|463880551|FG000|Overall Study|Adverse Event|7|||
128886869|NCT02072434|463880552|FG001|Overall Study|Adverse Event|6|||
128886870|NCT02072434|463880551|FG000|Overall Study|Withdrawal by Subject|17|||
128886871|NCT02072434|463880552|FG001|Overall Study|Withdrawal by Subject|29|||
128886872|NCT02072434|463880551|FG000|Overall Study|Other|14|||
128886873|NCT02072434|463880552|FG001|Overall Study|Other|29|||
128886874|NCT02072434|463880551|FG000|Overall Study|Lost to Follow-up|0|||
128886875|NCT02072434|463880552|FG001|Overall Study|Lost to Follow-up|1|||
128886876|NCT01324323|463880553|FG000|Overall Study|Withdrawal by Subject|1|||
128886877|NCT03153137|463880554|FG000|Overall Study|Lost to Follow-up|1|||
128886878|NCT03153137|463880555|FG001|Overall Study|Lost to Follow-up|0|||
128886879|NCT03153137|463880554|FG000|Overall Study|Withdrawal by Subject|2|||
128886880|NCT03153137|463880555|FG001|Overall Study|Withdrawal by Subject|1|||
128886881|NCT03153137|463880554|FG000|Overall Study|Physician Decision|0|||
128886882|NCT03153137|463880555|FG001|Overall Study|Physician Decision|3|||
128886883|NCT00993915|463880562|FG000|Overall Study|Insufficient clinical response|3|||
128886884|NCT00993915|463880562|FG000|Overall Study|Withdrawal by Subject|2|||
128886885|NCT00993915|463880562|FG000|Overall Study|Other|1|||
128886886|NCT00993915|463880562|FG000|Overall Study|Ongoing|3|||
128886887|NCT04209621|463880570|FG000|Overall Study|Death|1|||
128886888|NCT04209621|463880570|FG000|Overall Study|Study Terminated Early|2|||
128886889|NCT02249767|463880571|FG000|Overall Study|Did not use medication|8|||
128886890|NCT02249767|463880572|FG001|Overall Study|Did not use medication|9|||
128886891|NCT02249767|463880573|FG002|Overall Study|Did not use medication|8|||
128684639|NCT00721123|463146084|FG000|Overall Study|Failure to Return|9|||
128684640|NCT00721123|463146084|FG000|Overall Study|Withdrawal by Subject|5|||
128684641|NCT04177355|463146086|FG000|Overall Study|Lost to Follow-up|0|||
128886892|NCT01372410|463880574|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
128886893|NCT01372410|463880575|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
128886894|NCT01372410|463880576|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
128886895|NCT01372410|463880577|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
128886896|NCT01372410|463880578|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
128886897|NCT01372410|463880579|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
128886898|NCT01372410|463880580|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
128684642|NCT04177355|463146087|FG001|Overall Study|Lost to Follow-up|2|||
128886899|NCT01372410|463880581|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
128886900|NCT01372410|463880574|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
128886901|NCT01372410|463880575|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
128886902|NCT01372410|463880576|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
128886903|NCT01372410|463880577|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
128886904|NCT01372410|463880578|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
128886905|NCT01372410|463880579|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
128886906|NCT01372410|463880580|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
128886907|NCT01372410|463880581|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
128886908|NCT01372410|463880574|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128886909|NCT01372410|463880575|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128886910|NCT01372410|463880576|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128886911|NCT01372410|463880577|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128886912|NCT01372410|463880578|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
128886913|NCT01372410|463880579|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128886914|NCT01372410|463880580|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128886915|NCT01372410|463880581|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128886916|NCT01372410|463880574|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
128886917|NCT01372410|463880575|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
128886918|NCT01372410|463880576|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
128886919|NCT01372410|463880577|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
128886920|NCT01372410|463880578|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
128886921|NCT01372410|463880579|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
128886922|NCT01372410|463880580|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
128886923|NCT01372410|463880581|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
128886924|NCT01372410|463880574|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
128886925|NCT01372410|463880575|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128886926|NCT01372410|463880576|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128886927|NCT01372410|463880577|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128886928|NCT01372410|463880578|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128886929|NCT01372410|463880579|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128886930|NCT01372410|463880580|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
128886931|NCT01372410|463880581|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
128886932|NCT01372410|463880574|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128886933|NCT01372410|463880575|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128886934|NCT01372410|463880576|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128886935|NCT01372410|463880577|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128886936|NCT01372410|463880578|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
128886937|NCT01372410|463880579|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128886938|NCT01372410|463880580|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128886939|NCT01372410|463880581|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
128886940|NCT01372410|463880574|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
128886941|NCT01372410|463880575|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
128886942|NCT01372410|463880576|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
128886943|NCT01372410|463880577|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
128886944|NCT01372410|463880578|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
128886945|NCT01372410|463880579|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
128886946|NCT01372410|463880580|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
128886947|NCT01372410|463880581|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
128886948|NCT01372410|463880574|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
128886949|NCT01372410|463880575|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
128886950|NCT01372410|463880576|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
128886951|NCT01372410|463880577|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
128886952|NCT01372410|463880578|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
128886953|NCT01372410|463880579|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
128886954|NCT01372410|463880580|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
128886955|NCT01372410|463880581|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
128886956|NCT01372410|463880574|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
128886957|NCT01372410|463880575|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
128886958|NCT01372410|463880576|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
128886959|NCT01372410|463880577|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
128886960|NCT01372410|463880578|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
128886961|NCT01372410|463880579|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
128886962|NCT01372410|463880580|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
128886963|NCT01372410|463880581|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
128886964|NCT01372410|463880574|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128886965|NCT01372410|463880575|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128886966|NCT01372410|463880576|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128886967|NCT01372410|463880577|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128886968|NCT01372410|463880578|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128886969|NCT01372410|463880579|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
129020492|NCT01796171|464367097|FG001|Follow-up Period|Progressive disease|1|||
129020493|NCT01796171|464367098|FG002|Follow-up Period|Progressive disease|0|||
129020494|NCT01796171|464367099|FG003|Follow-up Period|Progressive disease|0|||
129020495|NCT01796171|464367100|FG004|Follow-up Period|Progressive disease|0|||
129020496|NCT01796171|464367101|FG005|Follow-up Period|Progressive disease|0|||
128684643|NCT04177355|463146088|FG002|Overall Study|Lost to Follow-up|0|||
128684644|NCT04177355|463146089|FG003|Overall Study|Lost to Follow-up|1|||
128684645|NCT04177355|463146090|FG004|Overall Study|Lost to Follow-up|2|||
128684646|NCT04177355|463146091|FG005|Overall Study|Lost to Follow-up|0|||
128684647|NCT04177355|463146092|FG006|Overall Study|Lost to Follow-up|1|||
128684648|NCT04177355|463146093|FG007|Overall Study|Lost to Follow-up|0|||
128684649|NCT04177355|463146094|FG008|Overall Study|Lost to Follow-up|0|||
128684650|NCT04177355|463146095|FG009|Overall Study|Lost to Follow-up|0|||
128684651|NCT04177355|463146096|FG010|Overall Study|Lost to Follow-up|0|||
128684652|NCT04177355|463146086|FG000|Overall Study|Withdrawal by Subject|0|||
128684653|NCT04177355|463146087|FG001|Overall Study|Withdrawal by Subject|0|||
128684654|NCT04177355|463146088|FG002|Overall Study|Withdrawal by Subject|0|||
128684655|NCT04177355|463146089|FG003|Overall Study|Withdrawal by Subject|1|||
128684656|NCT04177355|463146090|FG004|Overall Study|Withdrawal by Subject|1|||
128684657|NCT04177355|463146091|FG005|Overall Study|Withdrawal by Subject|0|||
128886970|NCT01372410|463880580|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
128886971|NCT01372410|463880581|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129020497|NCT01796171|464367102|FG006|Follow-up Period|Progressive disease|0|||
128684658|NCT04177355|463146092|FG006|Overall Study|Withdrawal by Subject|0|||
128684659|NCT04177355|463146093|FG007|Overall Study|Withdrawal by Subject|0|||
128684660|NCT04177355|463146094|FG008|Overall Study|Withdrawal by Subject|1|||
128684661|NCT04177355|463146095|FG009|Overall Study|Withdrawal by Subject|0|||
128684662|NCT04177355|463146096|FG010|Overall Study|Withdrawal by Subject|0|||
128684663|NCT00433511|463146097|FG000|Step 1|Adverse Event|50|||
128684664|NCT00433511|463146098|FG001|Step 1|Adverse Event|157|||
128684665|NCT00433511|463146099|FG002|Step 1|Adverse Event|153|||
128684666|NCT00433511|463146097|FG000|Step 1|Withdrawal by Subject|45|||
128684667|NCT00433511|463146098|FG001|Step 1|Withdrawal by Subject|143|||
128684668|NCT00433511|463146099|FG002|Step 1|Withdrawal by Subject|154|||
128684669|NCT00433511|463146097|FG000|Step 1|Death|3|||
128684670|NCT00433511|463146098|FG001|Step 1|Death|1|||
128684671|NCT00433511|463146099|FG002|Step 1|Death|1|||
128684672|NCT00433511|463146097|FG000|Step 1|Physician Decision|1|||
128684673|NCT00433511|463146098|FG001|Step 1|Physician Decision|4|||
128684674|NCT00433511|463146099|FG002|Step 1|Physician Decision|3|||
128684675|NCT00433511|463146097|FG000|Step 1|Never started protocol therapy|28|||
128684676|NCT00433511|463146098|FG001|Step 1|Never started protocol therapy|64|||
128684677|NCT00433511|463146099|FG002|Step 1|Never started protocol therapy|66|||
128684678|NCT00433511|463146097|FG000|Step 1|Alternative therapy|2|||
128684679|NCT00433511|463146098|FG001|Step 1|Alternative therapy|1|||
128684680|NCT00433511|463146099|FG002|Step 1|Alternative therapy|3|||
128684681|NCT00433511|463146097|FG000|Step 1|Disease progression, relapse|5|||
128684682|NCT00433511|463146098|FG001|Step 1|Disease progression, relapse|3|||
128684683|NCT00433511|463146099|FG002|Step 1|Disease progression, relapse|3|||
128684684|NCT00433511|463146097|FG000|Step 1|Other complicating disease|2|||
128684685|NCT00433511|463146098|FG001|Step 1|Other complicating disease|6|||
128684686|NCT00433511|463146099|FG002|Step 1|Other complicating disease|3|||
128684687|NCT00433511|463146097|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
128684688|NCT00433511|463146098|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
128684689|NCT00433511|463146099|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
128684690|NCT00433511|463146097|FG000|Step 1|Suspected recurrence|0|||
128684691|NCT00433511|463146098|FG001|Step 1|Suspected recurrence|1|||
128684692|NCT00433511|463146099|FG002|Step 1|Suspected recurrence|0|||
128763173|NCT03724396|463422775|FG000|Overall Study|Withdrawal by Subject|1|||
128763174|NCT03724396|463422776|FG001|Overall Study|Withdrawal by Subject|0|||
128763175|NCT01490125|463422777|FG000|Period I|Adverse Event|4|||
128763176|NCT01490125|463422778|FG001|Period I|Adverse Event|1|||
128763177|NCT01490125|463422779|FG002|Period I|Adverse Event|1|||
128763178|NCT01490125|463422780|FG003|Period I|Adverse Event|3|||
128763179|NCT01490125|463422781|FG004|Period I|Adverse Event|2|||
128763180|NCT01490125|463422782|FG005|Period I|Adverse Event|4|||
128763181|NCT01490125|463422777|FG000|Period I|Protocol Violation|1|||
129020498|NCT01796171|464367103|FG007|Follow-up Period|Progressive disease|3|||
129020499|NCT01796171|464367104|FG008|Follow-up Period|Progressive disease|0|||
129020500|NCT01796171|464367105|FG009|Follow-up Period|Progressive disease|0|||
129020501|NCT01796171|464367106|FG010|Follow-up Period|Progressive disease|0|||
129020502|NCT01796171|464367107|FG011|Follow-up Period|Progressive disease|0|||
128684693|NCT00433511|463146097|FG000|Step 1|Insurance/drug distribution issues|0|||
128684694|NCT00433511|463146098|FG001|Step 1|Insurance/drug distribution issues|1|||
128684695|NCT00433511|463146099|FG002|Step 1|Insurance/drug distribution issues|2|||
128684696|NCT00433511|463146097|FG000|Step 1|Patient moved|0|||
128684697|NCT00433511|463146098|FG001|Step 1|Patient moved|0|||
129020503|NCT01796171|464367108|FG012|Follow-up Period|Progressive disease|0|||
128684698|NCT00433511|463146099|FG002|Step 1|Patient moved|1|||
128684699|NCT00433511|463146097|FG000|Step 2 (Arm D)|Adverse Event|0|||
128684700|NCT00433511|463146098|FG001|Step 2 (Arm D)|Adverse Event|0|||
128684701|NCT00433511|463146099|FG002|Step 2 (Arm D)|Adverse Event|135|||
128684702|NCT00433511|463146097|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
128763182|NCT01490125|463422778|FG001|Period I|Protocol Violation|1|||
129020504|NCT01796171|464367109|FG013|Follow-up Period|Progressive disease|0|||
128684703|NCT00433511|463146098|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
128684704|NCT00433511|463146099|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
128684705|NCT00433511|463146097|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
128684706|NCT00433511|463146098|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
128684707|NCT00433511|463146099|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
128684708|NCT00433511|463146097|FG000|Step 2 (Arm D)|Physician Decision|0|||
128684709|NCT00433511|463146098|FG001|Step 2 (Arm D)|Physician Decision|0|||
128684710|NCT00433511|463146099|FG002|Step 2 (Arm D)|Physician Decision|9|||
128684711|NCT00433511|463146097|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
128684712|NCT00433511|463146098|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
128684713|NCT00433511|463146099|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
128684714|NCT00433511|463146097|FG000|Step 2 (Arm D)|Other complicating disease|0|||
128684715|NCT00433511|463146098|FG001|Step 2 (Arm D)|Other complicating disease|0|||
128684716|NCT00433511|463146099|FG002|Step 2 (Arm D)|Other complicating disease|3|||
128684717|NCT00433511|463146097|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
128684718|NCT00433511|463146098|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
128684719|NCT00433511|463146099|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
128684720|NCT00433511|463146097|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
128684721|NCT00433511|463146098|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
128684722|NCT00433511|463146099|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
128684723|NCT00433511|463146097|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
128684724|NCT00433511|463146098|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
128684725|NCT00433511|463146099|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
128684726|NCT00433511|463146097|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
128684727|NCT00433511|463146098|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
128684728|NCT00433511|463146099|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
128684729|NCT05007717|463146100|FG000|Overall Study|Death|3|||
128684730|NCT05007717|463146101|FG001|Overall Study|Death|2|||
128684731|NCT02806973|463146103|FG000|Period 1|Withdrawal by Subject|0|||
128684732|NCT02806973|463146104|FG001|Period 1|Withdrawal by Subject|2|||
128684733|NCT02806973|463146105|FG002|Period 1|Withdrawal by Subject|1|||
128684734|NCT02806973|463146106|FG003|Period 1|Withdrawal by Subject|1|||
128684735|NCT02806973|463146103|FG000|Period 1|Adverse Event|0|||
128684736|NCT02806973|463146104|FG001|Period 1|Adverse Event|0|||
128684737|NCT02806973|463146105|FG002|Period 1|Adverse Event|0|||
128684738|NCT02806973|463146106|FG003|Period 1|Adverse Event|1|||
128684739|NCT02806973|463146103|FG000|Period 3|Withdrawal by Subject|0|||
128684740|NCT02806973|463146104|FG001|Period 3|Withdrawal by Subject|0|||
128684741|NCT02806973|463146105|FG002|Period 3|Withdrawal by Subject|0|||
128684742|NCT02806973|463146106|FG003|Period 3|Withdrawal by Subject|3|||
128684743|NCT02806973|463146103|FG000|Period 3|Adverse Event|0|||
128684744|NCT02806973|463146104|FG001|Period 3|Adverse Event|0|||
128684745|NCT02806973|463146105|FG002|Period 3|Adverse Event|1|||
128684746|NCT02806973|463146106|FG003|Period 3|Adverse Event|0|||
128684747|NCT00427960|463146112|FG000|Overall Study|Adverse Event|2|||
128684748|NCT00427960|463146113|FG001|Overall Study|Adverse Event|0|||
128684749|NCT00427960|463146112|FG000|Overall Study|Withdrawal by Subject|0|||
128684750|NCT00427960|463146113|FG001|Overall Study|Withdrawal by Subject|3|||
128684751|NCT00427960|463146112|FG000|Overall Study|Other|0|||
128684752|NCT00427960|463146113|FG001|Overall Study|Other|1|||
128684753|NCT03282565|463146116|FG000|Overall Study|COVID-19 Research Shutdown|0|||
128684754|NCT03282565|463146117|FG001|Overall Study|COVID-19 Research Shutdown|2|||
128684755|NCT03282565|463146118|FG002|Overall Study|COVID-19 Research Shutdown|2|||
128684756|NCT04163718|463146119|FG000|Overall Study|Study terminated|12|||
128684757|NCT02131532|463146120|FG000|Overall Study|Withdrawal by Subject|1|||
128684758|NCT02131532|463146120|FG000|Overall Study|Physician Decision|1|||
128684759|NCT02131532|463146120|FG000|Overall Study|Other health conditions|2|||
128684760|NCT01466595|463146121|FG000|Overall Study|Withdrawal by Subject|0|||
128684761|NCT01466595|463146122|FG001|Overall Study|Withdrawal by Subject|1|||
128684762|NCT01264016|463146123|FG000|Overall Study|Withdrawal by Subject|1|||
128684763|NCT01264016|463146123|FG000|Overall Study|Felt faint at sight of blood|1|||
128684764|NCT02147184|463146124|FG000|Overall Study|Lost to Follow-up|28|||
128684765|NCT02147184|463146125|FG001|Overall Study|Lost to Follow-up|15|||
129108897|NCT03472521|464693666|FG001|Overall Study|Discontinued intervention|1|||
129108898|NCT04235504|464693673|FG000|Study Phase|Withdrawal by Subject|5|||
129108899|NCT04235504|464693674|FG001|Study Phase|Withdrawal by Subject|2|||
129108900|NCT04235504|464693675|FG002|Study Phase|Withdrawal by Subject|0|||
129108901|NCT04235504|464693676|FG003|Study Phase|Withdrawal by Subject|0|||
128684766|NCT02147184|463146124|FG000|Overall Study|Study Burden|11|||
128684767|NCT02147184|463146125|FG001|Overall Study|Study Burden|7|||
128684768|NCT02147184|463146124|FG000|Overall Study|Pregnancy|6|||
128684769|NCT02147184|463146125|FG001|Overall Study|Pregnancy|0|||
128684770|NCT02147184|463146124|FG000|Overall Study|Moved out of state|3|||
129108902|NCT04235504|464693673|FG000|Continuation Phase|Withdrawal by Subject|0|||
128684771|NCT02147184|463146125|FG001|Overall Study|Moved out of state|3|||
128684772|NCT02147184|463146124|FG000|Overall Study|Physician Decision|0|||
128684773|NCT02147184|463146125|FG001|Overall Study|Physician Decision|2|||
129108903|NCT04235504|464693674|FG001|Continuation Phase|Withdrawal by Subject|4|||
129108904|NCT04235504|464693675|FG002|Continuation Phase|Withdrawal by Subject|0|||
128684774|NCT02147184|463146124|FG000|Overall Study|Other|1|||
128684775|NCT02147184|463146125|FG001|Overall Study|Other|0|||
128684776|NCT02117414|463146126|FG000|Overall Study|Death|5|||
128684777|NCT02117414|463146127|FG001|Overall Study|Death|2|||
128684778|NCT02117414|463146126|FG000|Overall Study|Withdrawal by Subject|10|||
128684779|NCT02117414|463146127|FG001|Overall Study|Withdrawal by Subject|4|||
128684780|NCT00417482|463146128|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
128684781|NCT00417482|463146129|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
128684782|NCT00417482|463146130|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
128684783|NCT00417482|463146128|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
128684784|NCT00417482|463146129|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
128684785|NCT00417482|463146130|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
128684786|NCT00417482|463146128|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
128684787|NCT00417482|463146129|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
128684788|NCT00417482|463146130|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
128684789|NCT00417482|463146128|FG000|Phase B 1st 16 Weeks|Death|1|||
128684790|NCT00417482|463146129|FG001|Phase B 1st 16 Weeks|Death|0|||
128684791|NCT00417482|463146130|FG002|Phase B 1st 16 Weeks|Death|0|||
128684792|NCT00417482|463146128|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
128684793|NCT00417482|463146129|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
128684794|NCT00417482|463146130|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
128684795|NCT00417482|463146128|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
128684796|NCT00417482|463146129|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
128684797|NCT00417482|463146130|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
128684798|NCT00417482|463146128|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
128684799|NCT00417482|463146129|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
128684800|NCT00417482|463146130|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
128684801|NCT00417482|463146128|FG000|Phase B 2nd 16 Weeks|Death|1|||
128684802|NCT00417482|463146129|FG001|Phase B 2nd 16 Weeks|Death|1|||
128684803|NCT00417482|463146130|FG002|Phase B 2nd 16 Weeks|Death|0|||
128684804|NCT06400979|463146133|FG000|Overall Study|Lost to Follow-up|29|||
128684805|NCT06400979|463146133|FG000|Overall Study|Withdrawal by Subject|1|||
128684806|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
128684807|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
128684808|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
128684809|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
128684810|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
128684811|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
128684812|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
128684813|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
128684814|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
128684815|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
128684816|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
128684817|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
128684818|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
128684819|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
128684820|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
128684821|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
128684822|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Program Termination|3|||
128684823|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Program Termination|0|||
128684824|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Program Termination|1|||
128684825|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Program Termination|1|||
128684826|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
128684827|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
128684828|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
128684829|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
128684830|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
129108905|NCT04235504|464693676|FG003|Continuation Phase|Withdrawal by Subject|0|||
129108906|NCT04235504|464693673|FG000|Continuation Phase|Adverse Event|0|||
129108907|NCT04235504|464693674|FG001|Continuation Phase|Adverse Event|1|||
129108908|NCT04235504|464693675|FG002|Continuation Phase|Adverse Event|0|||
129108909|NCT04235504|464693676|FG003|Continuation Phase|Adverse Event|0|||
129108910|NCT04235504|464693673|FG000|Continuation Phase|Physician Decision|1|||
129108911|NCT04235504|464693674|FG001|Continuation Phase|Physician Decision|2|||
129108912|NCT04235504|464693675|FG002|Continuation Phase|Physician Decision|1|||
128684831|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
128684832|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
128684833|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
129108913|NCT04235504|464693676|FG003|Continuation Phase|Physician Decision|0|||
129108914|NCT02106351|464693683|FG000|Treatment Cycle 1|Adverse Event|2|||
129108915|NCT02106351|464693684|FG001|Treatment Cycle 1|Adverse Event|0|||
128763183|NCT01490125|463422779|FG002|Period I|Protocol Violation|1|||
128763184|NCT01490125|463422780|FG003|Period I|Protocol Violation|1|||
128886972|NCT04585646|463880582|FG000|First Intervention|Physician Decision|1|||
128886973|NCT04585646|463880583|FG001|First Intervention|Physician Decision|0|||
128886974|NCT04585646|463880582|FG000|First Intervention|Lost to Follow-up|0|||
128684834|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
128684835|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
128684836|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
128684837|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
128684838|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
128684839|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
128684840|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
128684841|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
128684842|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
128684843|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
128684844|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
128684845|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
128684846|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
128684847|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
128684848|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
128684849|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
128684850|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
128684851|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
128684852|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
128684853|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
128684854|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
128684855|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
128684856|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
128684857|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
128684858|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
128684859|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
128684860|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
128684861|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
128684862|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
128684863|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
128684864|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
128684865|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
128684866|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
128684867|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
128684868|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
128684869|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
128684870|NCT03739840|463146134|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
128684871|NCT03739840|463146135|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
128684872|NCT03739840|463146136|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
128684873|NCT03739840|463146137|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
128684874|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
128684875|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
128684876|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
128684877|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
128684878|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
128684879|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
128684880|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
128684881|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
128684882|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
128684883|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
128684884|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
128684885|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
128684886|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
128684887|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
128684888|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
128684889|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
128684890|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
128684891|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
128684892|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
128684893|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
128684894|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
128684895|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
128886975|NCT04585646|463880583|FG001|First Intervention|Lost to Follow-up|3|||
128886976|NCT04585646|463880582|FG000|First Intervention|Withdrawal by Subject|0|||
128684896|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
128684897|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
128684898|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
128684899|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
128684900|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
128684901|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
128684902|NCT03739840|463146134|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
128684903|NCT03739840|463146135|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
128684904|NCT03739840|463146136|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
128684905|NCT03739840|463146137|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
128684906|NCT01058265|463146140|FG000|Overall Study|Lost to Follow-up|11|||
128684907|NCT01058265|463146141|FG001|Overall Study|Lost to Follow-up|12|||
128684908|NCT02869438|463146142|FG000|Overall Study|Lost to Follow-up|1|||
128684909|NCT02869438|463146143|FG001|Overall Study|Lost to Follow-up|0|||
128684910|NCT02869438|463146142|FG000|Overall Study|Adverse Event|1|||
128684911|NCT02869438|463146143|FG001|Overall Study|Adverse Event|0|||
128684912|NCT02869438|463146142|FG000|Overall Study|Withdrawal by Subject|1|||
128684913|NCT02869438|463146143|FG001|Overall Study|Withdrawal by Subject|2|||
128684914|NCT02169284|463146146|FG000|Overall Study|Physician Decision|0|||
128684915|NCT02169284|463146147|FG001|Overall Study|Physician Decision|1|||
128684916|NCT00984568|463146148|FG000|Overall Study|Withdrawal by Subject|1|||
128684917|NCT00984568|463146149|FG001|Overall Study|Withdrawal by Subject|2|||
128684918|NCT00984568|463146148|FG000|Overall Study|Lack of Efficacy|2|||
128684919|NCT00984568|463146149|FG001|Overall Study|Lack of Efficacy|0|||
128684920|NCT00984568|463146148|FG000|Overall Study|Adverse Event|2|||
128684921|NCT00984568|463146149|FG001|Overall Study|Adverse Event|0|||
128684922|NCT00984568|463146148|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
128684923|NCT00984568|463146149|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
128684924|NCT00984568|463146148|FG000|Overall Study|Lost to Follow-up|0|||
128684925|NCT00984568|463146149|FG001|Overall Study|Lost to Follow-up|1|||
128684926|NCT00984568|463146148|FG000|Overall Study|Opportunistic Infection|1|||
128684927|NCT00984568|463146149|FG001|Overall Study|Opportunistic Infection|0|||
128684928|NCT00984568|463146148|FG000|Overall Study|Unknown Reason|1|||
128684929|NCT00984568|463146149|FG001|Overall Study|Unknown Reason|3|||
128684930|NCT03583073|463146150|FG000|Overall Study|Lost to Follow-up|8|||
128684931|NCT03583073|463146151|FG001|Overall Study|Lost to Follow-up|12|||
128684932|NCT01367119|463146152|FG000|Overall Study|Adverse Event|1|||
128684933|NCT01367119|463146153|FG001|Overall Study|Adverse Event|0|||
128684934|NCT01367119|463146152|FG000|Overall Study|Withdrawal by Subject|1|||
128684935|NCT01367119|463146153|FG001|Overall Study|Withdrawal by Subject|1|||
128684936|NCT03180684|463146154|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
128684937|NCT03180684|463146155|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
128684938|NCT03180684|463146154|FG000|Overall Study|Physician Decision|1|||
128684939|NCT03180684|463146155|FG001|Overall Study|Physician Decision|0|||
128684940|NCT03180684|463146154|FG000|Overall Study|Lost to Follow-up|1|||
128684941|NCT03180684|463146155|FG001|Overall Study|Lost to Follow-up|0|||
128684942|NCT03180684|463146154|FG000|Overall Study|Progressive Disease|1|||
128684943|NCT03180684|463146155|FG001|Overall Study|Progressive Disease|0|||
128684944|NCT02675231|463146156|FG000|Overall Study|Withdrawal by Subject|2|||
128684945|NCT02675231|463146157|FG001|Overall Study|Withdrawal by Subject|4|||
128684946|NCT02675231|463146158|FG002|Overall Study|Withdrawal by Subject|2|||
128684947|NCT02675231|463146156|FG000|Overall Study|Lost to Follow-up|3|||
128684948|NCT02675231|463146157|FG001|Overall Study|Lost to Follow-up|4|||
128684949|NCT02675231|463146158|FG002|Overall Study|Lost to Follow-up|3|||
128684950|NCT04025710|463146163|FG000|Overall Study|Death|3|||
128684951|NCT04025710|463146163|FG000|Overall Study|Lost to Follow-up|5|||
128684952|NCT04025710|463146163|FG000|Overall Study|Withdrawal by Subject|1|||
128684953|NCT04025710|463146163|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
128684954|NCT04025710|463146163|FG000|Overall Study|Drop-out according to protocol|34|||
128684955|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
128684956|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
128684957|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
128684958|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
128886977|NCT04585646|463880583|FG001|First Intervention|Withdrawal by Subject|1|||
129020505|NCT01796171|464367110|FG014|Follow-up Period|Progressive disease|0|||
128684959|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
128684960|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
128684961|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
128684962|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
128684963|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
128684964|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
128684965|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
129108916|NCT02106351|464693685|FG002|Treatment Cycle 1|Adverse Event|0|||
129108917|NCT02106351|464693683|FG000|Treatment Cycle 1|Consent withdrawn|1|||
129108918|NCT02106351|464693684|FG001|Treatment Cycle 1|Consent withdrawn|0|||
129108919|NCT02106351|464693685|FG002|Treatment Cycle 1|Consent withdrawn|2|||
129108920|NCT02106351|464693683|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
129108921|NCT02106351|464693684|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
129108922|NCT02106351|464693685|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
129108923|NCT02106351|464693683|FG000|Treatment Cycle 1|Other|0|||
129108924|NCT02106351|464693684|FG001|Treatment Cycle 1|Other|3|||
129108925|NCT02106351|464693685|FG002|Treatment Cycle 1|Other|1|||
129108926|NCT02106351|464693683|FG000|Treatment Cycle 1|Randomised but not treated|1|||
129108927|NCT02106351|464693684|FG001|Treatment Cycle 1|Randomised but not treated|0|||
129108928|NCT02106351|464693685|FG002|Treatment Cycle 1|Randomised but not treated|1|||
129108929|NCT02106351|464693683|FG000|Treatment Cycle 2|Adverse Event|0|||
129108930|NCT02106351|464693684|FG001|Treatment Cycle 2|Adverse Event|2|||
129108931|NCT02106351|464693685|FG002|Treatment Cycle 2|Adverse Event|0|||
129108932|NCT02106351|464693683|FG000|Treatment Cycle 2|Consent withdrawn|0|||
129108933|NCT02106351|464693684|FG001|Treatment Cycle 2|Consent withdrawn|1|||
129108934|NCT02106351|464693685|FG002|Treatment Cycle 2|Consent withdrawn|1|||
129108935|NCT02106351|464693683|FG000|Treatment Cycle 2|Other|0|||
129108936|NCT02106351|464693684|FG001|Treatment Cycle 2|Other|2|||
129108937|NCT02106351|464693685|FG002|Treatment Cycle 2|Other|2|||
129108938|NCT02106351|464693683|FG000|Treatment Cycle 3|Adverse Event|0|||
128684966|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
128684967|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
128684968|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
128684969|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
128684970|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
128684971|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
128684972|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
128684973|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
128684974|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
128684975|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
128684976|NCT02431247|463146164|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
128684977|NCT02431247|463146165|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
128684978|NCT02431247|463146166|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
128684979|NCT02431247|463146164|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
128684980|NCT02431247|463146165|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
128684981|NCT02431247|463146166|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
128684982|NCT02431247|463146164|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
128684983|NCT02431247|463146165|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129108939|NCT02106351|464693684|FG001|Treatment Cycle 3|Adverse Event|1|||
129108940|NCT02106351|464693685|FG002|Treatment Cycle 3|Adverse Event|0|||
129108941|NCT02106351|464693683|FG000|Treatment Cycle 3|Consent withdrawn|0|||
129108942|NCT02106351|464693684|FG001|Treatment Cycle 3|Consent withdrawn|0|||
129108943|NCT02106351|464693685|FG002|Treatment Cycle 3|Consent withdrawn|2|||
129108944|NCT02106351|464693683|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
129108945|NCT02106351|464693684|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
129108946|NCT02106351|464693685|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
129108947|NCT02106351|464693683|FG000|Treatment Cycle 3|Other|0|||
129108948|NCT02106351|464693684|FG001|Treatment Cycle 3|Other|2|||
129108949|NCT02106351|464693685|FG002|Treatment Cycle 3|Other|3|||
129108950|NCT02106351|464693683|FG000|Treatment Cycle 4|Consent withdrawn|0|||
129108951|NCT02106351|464693684|FG001|Treatment Cycle 4|Consent withdrawn|0|||
128684984|NCT02431247|463146166|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
128684985|NCT02431247|463146164|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
128684986|NCT02431247|463146165|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
128684987|NCT02431247|463146166|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
128684988|NCT02431247|463146164|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
128684989|NCT02431247|463146165|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
128684990|NCT02431247|463146166|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
128684991|NCT02431247|463146164|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
128684992|NCT02431247|463146165|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129108952|NCT02106351|464693685|FG002|Treatment Cycle 4|Consent withdrawn|2|||
129108953|NCT02106351|464693683|FG000|Treatment Cycle 4|Other|0|||
129108954|NCT02106351|464693684|FG001|Treatment Cycle 4|Other|1|||
129108955|NCT02106351|464693685|FG002|Treatment Cycle 4|Other|0|||
129108956|NCT00101868|464693686|FG000|Overall Study|Death|10|||
129108957|NCT00101868|464693687|FG001|Overall Study|Death|10|||
129108958|NCT00101868|464693686|FG000|Overall Study|Withdrawal by Subject|8|||
128684993|NCT02431247|463146166|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
128684994|NCT02431247|463146164|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129108959|NCT00101868|464693687|FG001|Overall Study|Withdrawal by Subject|9|||
129108960|NCT00101868|464693686|FG000|Overall Study|Protocol Violation|3|||
128684995|NCT02431247|463146165|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
128684996|NCT02431247|463146166|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
128684997|NCT01562873|463146167|FG000|Overall Study|Disease Progression per RECIST|10|||
128684998|NCT01562873|463146168|FG001|Overall Study|Disease Progression per RECIST|0|||
128684999|NCT01562873|463146167|FG000|Overall Study|Adverse Event|1|||
128685000|NCT01562873|463146168|FG001|Overall Study|Adverse Event|0|||
128685001|NCT01562873|463146167|FG000|Overall Study|Clinical Disease Progression|9|||
128685002|NCT01562873|463146168|FG001|Overall Study|Clinical Disease Progression|0|||
128685003|NCT01562873|463146167|FG000|Overall Study|Clinical PD and adverse event|1|||
128685004|NCT01562873|463146168|FG001|Overall Study|Clinical PD and adverse event|0|||
128685005|NCT00194675|463146169|FG000|Overall Study|Lost to Follow-up|1|||
128685006|NCT00194675|463146170|FG001|Overall Study|Lost to Follow-up|1|||
128685007|NCT00194675|463146169|FG000|Overall Study|lack of interest|1|||
128685008|NCT00194675|463146170|FG001|Overall Study|lack of interest|1|||
128685009|NCT00194675|463146169|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
128685010|NCT00194675|463146170|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
128685011|NCT00194675|463146169|FG000|Overall Study|Protocol Violation|1|||
128685012|NCT00194675|463146170|FG001|Overall Study|Protocol Violation|0|||
128685013|NCT00194675|463146169|FG000|Overall Study|Death|1|||
128685014|NCT00194675|463146170|FG001|Overall Study|Death|0|||
128685015|NCT02280473|463146174|FG000|Overall Study|Adverse Event|1|||
128685016|NCT02280473|463146175|FG001|Overall Study|Adverse Event|1|||
128685017|NCT02280473|463146174|FG000|Overall Study|Lack of Efficacy|0|||
128685018|NCT02280473|463146175|FG001|Overall Study|Lack of Efficacy|1|||
128685019|NCT02280473|463146174|FG000|Overall Study|Lost to Follow-up|0|||
128685020|NCT02280473|463146175|FG001|Overall Study|Lost to Follow-up|1|||
128685021|NCT00410202|463146176|FG000|On-Treatment|Continuing treatment|69|||
128685022|NCT00410202|463146177|FG001|On-Treatment|Continuing treatment|71|||
128685023|NCT00410202|463146178|FG002|On-Treatment|Continuing treatment|66|||
128685024|NCT00410202|463146176|FG000|On-Treatment|Adverse Event|1|||
128685025|NCT00410202|463146177|FG001|On-Treatment|Adverse Event|3|||
128685026|NCT00410202|463146178|FG002|On-Treatment|Adverse Event|2|||
128685027|NCT00410202|463146176|FG000|On-Treatment|Death|1|||
128685028|NCT00410202|463146177|FG001|On-Treatment|Death|0|||
128685029|NCT00410202|463146178|FG002|On-Treatment|Death|0|||
128685030|NCT00410202|463146176|FG000|On-Treatment|Lost to Follow-up|1|||
128685031|NCT00410202|463146177|FG001|On-Treatment|Lost to Follow-up|0|||
128685032|NCT00410202|463146178|FG002|On-Treatment|Lost to Follow-up|1|||
128685033|NCT00410202|463146176|FG000|On-Treatment|Lack of Efficacy|1|||
128685034|NCT00410202|463146177|FG001|On-Treatment|Lack of Efficacy|4|||
128685035|NCT00410202|463146178|FG002|On-Treatment|Lack of Efficacy|0|||
128685036|NCT00410202|463146176|FG000|On-Treatment|Withdrawal by Subject|2|||
128685037|NCT00410202|463146177|FG001|On-Treatment|Withdrawal by Subject|1|||
128685038|NCT00410202|463146178|FG002|On-Treatment|Withdrawal by Subject|1|||
128685039|NCT00410202|463146176|FG000|On-Treatment|Other Reason|0|||
128685040|NCT00410202|463146177|FG001|On-Treatment|Other Reason|0|||
128685041|NCT00410202|463146178|FG002|On-Treatment|Other Reason|1|||
128685042|NCT00410202|463146176|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
128685043|NCT00410202|463146177|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
128685044|NCT00410202|463146178|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
128685045|NCT00410202|463146176|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
128685046|NCT00410202|463146177|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
128685047|NCT00410202|463146178|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
128685048|NCT00410202|463146176|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
128685049|NCT00410202|463146177|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
128685050|NCT00410202|463146178|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
128685051|NCT02211638|463146183|FG000|Overall Study|Case Report Forms Uncollected|291|||
128685052|NCT02211638|463146183|FG000|Overall Study|Protocol Violation|692|||
128685053|NCT02775903|463146186|FG000|Overall Study|Death|7|||
128685054|NCT02775903|463146187|FG001|Overall Study|Death|11|||
128886978|NCT02465463|463880585|FG000|Overall Study|Lost to Follow-up|2|||
128886979|NCT02465463|463880586|FG001|Overall Study|Lost to Follow-up|1|||
129020506|NCT01796171|464367096|FG000|Follow-up Period|Physician Decision|0|||
129020507|NCT01796171|464367097|FG001|Follow-up Period|Physician Decision|2|||
128685055|NCT02775903|463146188|FG002|Overall Study|Death|12|||
128685056|NCT02775903|463146189|FG003|Overall Study|Death|11|||
128685057|NCT02775903|463146186|FG000|Overall Study|Adverse Event|0|||
128685058|NCT02775903|463146187|FG001|Overall Study|Adverse Event|1|||
128685059|NCT02775903|463146188|FG002|Overall Study|Adverse Event|12|||
128685060|NCT02775903|463146189|FG003|Overall Study|Adverse Event|3|||
128685061|NCT02775903|463146186|FG000|Overall Study|Progressive disease|15|||
128685062|NCT02775903|463146187|FG001|Overall Study|Progressive disease|14|||
128685063|NCT02775903|463146188|FG002|Overall Study|Progressive disease|30|||
129020508|NCT01796171|464367098|FG002|Follow-up Period|Physician Decision|0|||
129020509|NCT01796171|464367099|FG003|Follow-up Period|Physician Decision|0|||
128685064|NCT02775903|463146189|FG003|Overall Study|Progressive disease|20|||
128685065|NCT02775903|463146186|FG000|Overall Study|Lack of Efficacy|2|||
129108961|NCT00101868|464693687|FG001|Overall Study|Protocol Violation|0|||
128685066|NCT02775903|463146187|FG001|Overall Study|Lack of Efficacy|2|||
128685067|NCT02775903|463146188|FG002|Overall Study|Lack of Efficacy|2|||
128685068|NCT02775903|463146189|FG003|Overall Study|Lack of Efficacy|6|||
128685069|NCT02775903|463146186|FG000|Overall Study|Withdrawal by Subject|7|||
128685070|NCT02775903|463146187|FG001|Overall Study|Withdrawal by Subject|5|||
128685071|NCT02775903|463146188|FG002|Overall Study|Withdrawal by Subject|5|||
128685072|NCT02775903|463146189|FG003|Overall Study|Withdrawal by Subject|8|||
128685073|NCT02775903|463146186|FG000|Overall Study|Other reasons|7|||
128685074|NCT02775903|463146187|FG001|Overall Study|Other reasons|8|||
128685075|NCT02775903|463146188|FG002|Overall Study|Other reasons|2|||
128685076|NCT02775903|463146189|FG003|Overall Study|Other reasons|12|||
128685077|NCT04041700|463146190|FG000|Overall Study|Pregnancy|1|||
128685078|NCT04041700|463146190|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
128685079|NCT04571515|463146193|FG000|Overall Study|Physician Decision|0|||
128685080|NCT04571515|463146194|FG001|Overall Study|Physician Decision|0|||
128685081|NCT04571515|463146195|FG002|Overall Study|Physician Decision|0|||
128685082|NCT04571515|463146196|FG003|Overall Study|Physician Decision|0|||
128685083|NCT04571515|463146197|FG004|Overall Study|Physician Decision|1|||
128685084|NCT04571515|463146193|FG000|Overall Study|Withdrawal by Subject|0|||
128685085|NCT04571515|463146194|FG001|Overall Study|Withdrawal by Subject|0|||
128685086|NCT04571515|463146195|FG002|Overall Study|Withdrawal by Subject|0|||
128685087|NCT04571515|463146196|FG003|Overall Study|Withdrawal by Subject|0|||
128685088|NCT04571515|463146197|FG004|Overall Study|Withdrawal by Subject|1|||
128685089|NCT04571515|463146193|FG000|Overall Study|insufficient pain|1|||
128685090|NCT04571515|463146194|FG001|Overall Study|insufficient pain|0|||
128685091|NCT04571515|463146195|FG002|Overall Study|insufficient pain|0|||
128685092|NCT04571515|463146196|FG003|Overall Study|insufficient pain|0|||
128685093|NCT04571515|463146197|FG004|Overall Study|insufficient pain|1|||
128685094|NCT05140382|463146198|FG000|Overall Study|Death|3|||
128685095|NCT05140382|463146199|FG001|Overall Study|Death|0|||
128685096|NCT05140382|463146200|FG002|Overall Study|Death|0|||
128763185|NCT01490125|463422781|FG004|Period I|Protocol Violation|0|||
128763186|NCT01490125|463422782|FG005|Period I|Protocol Violation|0|||
128763187|NCT01490125|463422777|FG000|Period I|Withdrawal by Subject|1|||
128763188|NCT01490125|463422778|FG001|Period I|Withdrawal by Subject|3|||
128763189|NCT01490125|463422779|FG002|Period I|Withdrawal by Subject|2|||
128763190|NCT01490125|463422780|FG003|Period I|Withdrawal by Subject|1|||
128763191|NCT01490125|463422781|FG004|Period I|Withdrawal by Subject|2|||
128763192|NCT01490125|463422782|FG005|Period I|Withdrawal by Subject|1|||
128763193|NCT01490125|463422777|FG000|Period II|Adverse Event|2|||
128763194|NCT01490125|463422778|FG001|Period II|Adverse Event|3|||
128763195|NCT01490125|463422779|FG002|Period II|Adverse Event|2|||
128763196|NCT01490125|463422780|FG003|Period II|Adverse Event|2|||
128763197|NCT01490125|463422781|FG004|Period II|Adverse Event|4|||
128763198|NCT01490125|463422782|FG005|Period II|Adverse Event|2|||
128763199|NCT01490125|463422777|FG000|Period II|Protocol Violation|0|||
128763200|NCT01490125|463422778|FG001|Period II|Protocol Violation|0|||
128763201|NCT01490125|463422779|FG002|Period II|Protocol Violation|1|||
128763202|NCT01490125|463422780|FG003|Period II|Protocol Violation|1|||
128763203|NCT01490125|463422781|FG004|Period II|Protocol Violation|0|||
128763204|NCT01490125|463422782|FG005|Period II|Protocol Violation|0|||
128763205|NCT01490125|463422777|FG000|Period II|Lost to Follow-up|0|||
128763206|NCT01490125|463422778|FG001|Period II|Lost to Follow-up|1|||
128763207|NCT01490125|463422779|FG002|Period II|Lost to Follow-up|0|||
128763208|NCT01490125|463422780|FG003|Period II|Lost to Follow-up|0|||
128763209|NCT01490125|463422781|FG004|Period II|Lost to Follow-up|0|||
128763210|NCT01490125|463422782|FG005|Period II|Lost to Follow-up|0|||
128763211|NCT01490125|463422777|FG000|Period II|Withdrawal by Subject|1|||
128763212|NCT01490125|463422778|FG001|Period II|Withdrawal by Subject|0|||
128763213|NCT01490125|463422779|FG002|Period II|Withdrawal by Subject|0|||
128763214|NCT01490125|463422780|FG003|Period II|Withdrawal by Subject|0|||
128763215|NCT01490125|463422781|FG004|Period II|Withdrawal by Subject|0|||
128763216|NCT01490125|463422782|FG005|Period II|Withdrawal by Subject|0|||
128763217|NCT01490125|463422777|FG000|Period III|Adverse Event|3|||
128763218|NCT01490125|463422778|FG001|Period III|Adverse Event|1|||
128763219|NCT01490125|463422779|FG002|Period III|Adverse Event|0|||
128763220|NCT01490125|463422780|FG003|Period III|Adverse Event|1|||
128763221|NCT01490125|463422781|FG004|Period III|Adverse Event|0|||
128685097|NCT05140382|463146198|FG000|Overall Study|Investigator decision|1|||
128685098|NCT05140382|463146199|FG001|Overall Study|Investigator decision|0|||
128685099|NCT05140382|463146200|FG002|Overall Study|Investigator decision|0|||
128763222|NCT01490125|463422782|FG005|Period III|Adverse Event|0|||
128763223|NCT01490125|463422777|FG000|Period III|Death|0|||
128685100|NCT05140382|463146198|FG000|Overall Study|Other|4|||
128685101|NCT05140382|463146199|FG001|Overall Study|Other|0|||
128763224|NCT01490125|463422778|FG001|Period III|Death|0|||
128763225|NCT01490125|463422779|FG002|Period III|Death|0|||
128763226|NCT01490125|463422780|FG003|Period III|Death|1|||
128763227|NCT01490125|463422781|FG004|Period III|Death|0|||
128763228|NCT01490125|463422782|FG005|Period III|Death|0|||
128763229|NCT01490125|463422777|FG000|Period III|Lack of Efficacy|0|||
128763230|NCT01490125|463422778|FG001|Period III|Lack of Efficacy|0|||
128685102|NCT05140382|463146200|FG002|Overall Study|Other|1|||
128685103|NCT05140382|463146198|FG000|Overall Study|Progressive disease|20|||
128685104|NCT05140382|463146199|FG001|Overall Study|Progressive disease|1|||
128685105|NCT05140382|463146200|FG002|Overall Study|Progressive disease|12|||
128685106|NCT05140382|463146198|FG000|Overall Study|Subjective disease progression|2|||
128685107|NCT05140382|463146199|FG001|Overall Study|Subjective disease progression|1|||
128685108|NCT05140382|463146200|FG002|Overall Study|Subjective disease progression|0|||
128685109|NCT05140382|463146198|FG000|Overall Study|Unknown at data cut-off|0|||
128685110|NCT05140382|463146199|FG001|Overall Study|Unknown at data cut-off|0|||
128685111|NCT05140382|463146200|FG002|Overall Study|Unknown at data cut-off|1|||
128685112|NCT05140382|463146198|FG000|Overall Study|Withdrawal by Subject|1|||
128685113|NCT05140382|463146199|FG001|Overall Study|Withdrawal by Subject|0|||
128685114|NCT05140382|463146200|FG002|Overall Study|Withdrawal by Subject|4|||
128685115|NCT05140382|463146198|FG000|Overall Study|Withdrawal of consent|0|||
128685116|NCT05140382|463146199|FG001|Overall Study|Withdrawal of consent|0|||
128685117|NCT05140382|463146200|FG002|Overall Study|Withdrawal of consent|1|||
128685118|NCT01659658|463147611|FG000|Overall Study|Withdrawal by Patient|18|||
128685119|NCT01659658|463147612|FG001|Overall Study|Withdrawal by Patient|4|||
128685120|NCT01659658|463147613|FG002|Overall Study|Withdrawal by Patient|2|||
128685121|NCT01659658|463147614|FG003|Overall Study|Withdrawal by Patient|0|||
128685122|NCT01659658|463147615|FG004|Overall Study|Withdrawal by Patient|11|||
128685123|NCT01659658|463147611|FG000|Overall Study|Study Terminated by Sponsor|9|||
128685124|NCT01659658|463147612|FG001|Overall Study|Study Terminated by Sponsor|7|||
128685125|NCT01659658|463147613|FG002|Overall Study|Study Terminated by Sponsor|0|||
128685126|NCT01659658|463147614|FG003|Overall Study|Study Terminated by Sponsor|1|||
128685127|NCT01659658|463147615|FG004|Overall Study|Study Terminated by Sponsor|4|||
128685128|NCT01659658|463147611|FG000|Overall Study|Reason not Specified|61|||
128685129|NCT01659658|463147612|FG001|Overall Study|Reason not Specified|15|||
128685130|NCT01659658|463147613|FG002|Overall Study|Reason not Specified|8|||
128685131|NCT01659658|463147614|FG003|Overall Study|Reason not Specified|1|||
128685132|NCT01659658|463147615|FG004|Overall Study|Reason not Specified|34|||
128685133|NCT01659658|463147611|FG000|Overall Study|Lost to Follow-up|2|||
128886980|NCT02465463|463880585|FG000|Overall Study|Death|1|||
128886981|NCT02465463|463880586|FG001|Overall Study|Death|0|||
128886982|NCT02465463|463880585|FG000|Overall Study|Protocol Violation|1|||
128886983|NCT02465463|463880586|FG001|Overall Study|Protocol Violation|0|||
128886984|NCT03294109|463880591|FG000|Overall Study|Withdrawal by Subject|6|||
128886985|NCT03294109|463880592|FG001|Overall Study|Withdrawal by Subject|5|||
128886986|NCT04744285|463880593|FG000|Overall Study|Withdrawal by Subject|1|||
128886987|NCT04744285|463880594|FG001|Overall Study|Withdrawal by Subject|1|||
128763231|NCT01490125|463422779|FG002|Period III|Lack of Efficacy|0|||
128763232|NCT01490125|463422780|FG003|Period III|Lack of Efficacy|0|||
128763233|NCT01490125|463422781|FG004|Period III|Lack of Efficacy|1|||
128763234|NCT01490125|463422782|FG005|Period III|Lack of Efficacy|0|||
128763235|NCT02237508|463422784|FG000|Overall Study|Withdrawal by Subject|0|||
128763236|NCT02237508|463422785|FG001|Overall Study|Withdrawal by Subject|2|||
128763237|NCT02237508|463422786|FG002|Overall Study|Withdrawal by Subject|0|||
128763238|NCT02237508|463422787|FG003|Overall Study|Withdrawal by Subject|1|||
128763239|NCT02237508|463422788|FG004|Overall Study|Withdrawal by Subject|0|||
128763240|NCT02237508|463422789|FG005|Overall Study|Withdrawal by Subject|1|||
128763241|NCT02237508|463422790|FG006|Overall Study|Withdrawal by Subject|1|||
128763242|NCT02237508|463422791|FG007|Overall Study|Withdrawal by Subject|0|||
128763243|NCT02237508|463422792|FG008|Overall Study|Withdrawal by Subject|1|||
128763244|NCT02237508|463422793|FG009|Overall Study|Withdrawal by Subject|0|||
128763245|NCT02237508|463422784|FG000|Overall Study|Physician Decision|0|||
128763246|NCT02237508|463422785|FG001|Overall Study|Physician Decision|1|||
128763247|NCT02237508|463422786|FG002|Overall Study|Physician Decision|0|||
128763248|NCT02237508|463422787|FG003|Overall Study|Physician Decision|0|||
128763249|NCT02237508|463422788|FG004|Overall Study|Physician Decision|0|||
128763250|NCT02237508|463422789|FG005|Overall Study|Physician Decision|0|||
128763251|NCT02237508|463422790|FG006|Overall Study|Physician Decision|0|||
128763252|NCT02237508|463422791|FG007|Overall Study|Physician Decision|0|||
128763253|NCT02237508|463422792|FG008|Overall Study|Physician Decision|0|||
128763254|NCT02237508|463422793|FG009|Overall Study|Physician Decision|0|||
128763255|NCT02237508|463422784|FG000|Overall Study|Protocol Violation|0|||
128763256|NCT02237508|463422785|FG001|Overall Study|Protocol Violation|0|||
128685134|NCT01659658|463147612|FG001|Overall Study|Lost to Follow-up|0|||
128763257|NCT02237508|463422786|FG002|Overall Study|Protocol Violation|1|||
128685135|NCT01659658|463147613|FG002|Overall Study|Lost to Follow-up|0|||
128763258|NCT02237508|463422787|FG003|Overall Study|Protocol Violation|0|||
128886988|NCT04744285|463880595|FG002|Overall Study|Withdrawal by Subject|2|||
129108962|NCT00101868|464693686|FG000|Overall Study|Lost to Follow-up|8|||
128685136|NCT01659658|463147614|FG003|Overall Study|Lost to Follow-up|0|||
128763259|NCT02237508|463422788|FG004|Overall Study|Protocol Violation|0|||
128763260|NCT02237508|463422789|FG005|Overall Study|Protocol Violation|0|||
128763261|NCT02237508|463422790|FG006|Overall Study|Protocol Violation|0|||
128886989|NCT04744285|463880596|FG003|Overall Study|Withdrawal by Subject|1|||
128886990|NCT01774084|463880597|FG000|Overall Study|Personal reasons|1|||
129108963|NCT00101868|464693687|FG001|Overall Study|Lost to Follow-up|13|||
129108964|NCT00069823|464693688|FG000|Overall Study|Did not have follow-up diary cards|6|||
129108965|NCT00069823|464693689|FG001|Overall Study|Did not have follow-up diary cards|3|||
129108966|NCT00520039|464693690|FG000|Overall Study|Exclusion criteria met at first visit|7|||
129108967|NCT00520039|464693691|FG001|Overall Study|Exclusion criteria met at first visit|5|||
129108968|NCT02329327|464693692|FG000|Overall Study|Death|78|||
129108969|NCT02329327|464693693|FG001|Overall Study|Death|0|||
129108970|NCT02329327|464693692|FG000|Overall Study|Withdrawal by Subject|3|||
129108971|NCT02329327|464693693|FG001|Overall Study|Withdrawal by Subject|0|||
129108972|NCT02329327|464693692|FG000|Overall Study|Lost to Follow-up|4|||
129108973|NCT02329327|464693693|FG001|Overall Study|Lost to Follow-up|0|||
129108974|NCT03560869|464693694|FG000|Overall Study|Withdrawal by Subject|3|||
129108975|NCT03560869|464693695|FG001|Overall Study|Withdrawal by Subject|4|||
129108976|NCT03560869|464693694|FG000|Overall Study|Screening failure|4|||
129108977|NCT03560869|464693695|FG001|Overall Study|Screening failure|4|||
129108978|NCT03560869|464693694|FG000|Overall Study|Withdrawal by PI|0|||
129108979|NCT03560869|464693695|FG001|Overall Study|Withdrawal by PI|1|||
129108980|NCT01801111|464693696|FG000|Overall Study|Adverse Event|12|||
129108981|NCT01801111|464693696|FG000|Overall Study|Death|8|||
129108982|NCT01801111|464693696|FG000|Overall Study|Physician Decision|5|||
129108983|NCT01801111|464693696|FG000|Overall Study|Other|1|||
129108984|NCT01801111|464693696|FG000|Overall Study|Withdrawal by Subject|4|||
129108985|NCT01801111|464693696|FG000|Overall Study|Study Terminated by Sponsor|27|||
129108986|NCT01801111|464693696|FG000|Overall Study|Progressive Disease|81|||
129108987|NCT01210482|464693697|FG000|Overall Study|Protocol Violation|1|||
129108988|NCT01210482|464693697|FG000|Overall Study|Case Report Forms were not collected|18|||
129108989|NCT01210482|464693697|FG000|Overall Study|Duplicated|2|||
129108990|NCT01210482|464693697|FG000|Overall Study|No Drug Administration|28|||
129108991|NCT01223937|464693698|FG000|Overall Study|Withdrawal by Subject|3|||
129108992|NCT01223937|464693699|FG001|Overall Study|Withdrawal by Subject|2|||
129108993|NCT01223937|464693698|FG000|Overall Study|Lost to Follow-up|1|||
129108994|NCT01223937|464693699|FG001|Overall Study|Lost to Follow-up|4|||
129108995|NCT01223937|464693698|FG000|Overall Study|Adverse Event|1|||
129108996|NCT01223937|464693699|FG001|Overall Study|Adverse Event|4|||
129108997|NCT01223937|464693698|FG000|Overall Study|Protocol Violation|8|||
129108998|NCT01223937|464693699|FG001|Overall Study|Protocol Violation|7|||
129108999|NCT01223937|464693698|FG000|Overall Study|Other|4|||
129109000|NCT01223937|464693699|FG001|Overall Study|Other|1|||
129109001|NCT05176717|464693701|FG000|Overall Study|Sponsor Decision|1|||
129109002|NCT05176717|464693702|FG001|Overall Study|Sponsor Decision|2|||
129109003|NCT05176717|464693703|FG002|Overall Study|Sponsor Decision|2|||
129109004|NCT03284853|464693704|FG000|Overall Study|Adverse Event|40|||
129109005|NCT03284853|464693705|FG001|Overall Study|Adverse Event|4|||
128763262|NCT02237508|463422791|FG007|Overall Study|Protocol Violation|0|||
128763263|NCT02237508|463422792|FG008|Overall Study|Protocol Violation|0|||
128763264|NCT02237508|463422793|FG009|Overall Study|Protocol Violation|0|||
128763265|NCT04954586|463422794|FG000|Overall Study|Withdrawal by Subject|5|||
128763266|NCT04000594|463422795|FG000|Overall Study|Withdrawal by Subject|1|||
128763267|NCT04000594|463422796|FG001|Overall Study|Withdrawal by Subject|0|||
128763268|NCT04000594|463422797|FG002|Overall Study|Withdrawal by Subject|0|||
128763269|NCT04522180|463422798|FG000|Overall Study|Investigator judgement|3|||
128763270|NCT04522180|463422799|FG001|Overall Study|Investigator judgement|4|||
128763271|NCT04522180|463422798|FG000|Overall Study|Voluntary withdrawal|1|||
128763272|NCT04522180|463422799|FG001|Overall Study|Voluntary withdrawal|0|||
128763273|NCT04522180|463422798|FG000|Overall Study|Pregnancy|0|||
128763274|NCT04522180|463422799|FG001|Overall Study|Pregnancy|1|||
128763275|NCT04522180|463422798|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
128763276|NCT04522180|463422799|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
128763277|NCT04522180|463422798|FG000|Overall Study|Reason not specified|8|||
128763278|NCT04522180|463422799|FG001|Overall Study|Reason not specified|5|||
128763279|NCT01905046|463422800|FG000|Months 13-24|Withdrawal by Subject|10|||
128763280|NCT01905046|463422801|FG001|Months 13-24|Withdrawal by Subject|10|||
128763281|NCT01905046|463422800|FG000|Months 13-24|Adverse Event|3|||
128763282|NCT01905046|463422801|FG001|Months 13-24|Adverse Event|2|||
128763283|NCT01905046|463422800|FG000|Months 13-24|Protocol Violation|3|||
129109006|NCT03284853|464693704|FG000|Overall Study|Withdrawal by Subject|5|||
129109007|NCT03284853|464693705|FG001|Overall Study|Withdrawal by Subject|1|||
129109008|NCT03284853|464693704|FG000|Overall Study|Lost to Follow-up|1|||
129109009|NCT03284853|464693705|FG001|Overall Study|Lost to Follow-up|0|||
129109010|NCT03284853|464693704|FG000|Overall Study|Lack of Efficacy|1|||
128763284|NCT01905046|463422801|FG001|Months 13-24|Protocol Violation|3|||
128763285|NCT01905046|463422800|FG000|Months 13-24|Physician Decision|1|||
128763286|NCT01905046|463422801|FG001|Months 13-24|Physician Decision|0|||
128763287|NCT03489057|463422806|FG000|Overall Study|Lost to Follow-up|16|||
129109011|NCT03284853|464693705|FG001|Overall Study|Lack of Efficacy|0|||
129109012|NCT03284853|464693704|FG000|Overall Study|Disallowed Concurrent Medication|1|||
129109013|NCT03284853|464693705|FG001|Overall Study|Disallowed Concurrent Medication|1|||
129109014|NCT03284853|464693704|FG000|Overall Study|Protocol Violation|3|||
128685137|NCT01659658|463147615|FG004|Overall Study|Lost to Follow-up|0|||
128685138|NCT00084838|463147616|FG000|Overall Study|Death|1|||
128685139|NCT00084838|463147616|FG000|Overall Study|Adverse Event|2|||
128685140|NCT00084838|463147616|FG000|Overall Study|Withdrawal by Subject|1|||
128685141|NCT00084838|463147616|FG000|Overall Study|Progressive Disease|4|||
128685142|NCT00084838|463147616|FG000|Overall Study|Pt Non-Compliance|1|||
128685143|NCT00084838|463147616|FG000|Overall Study|Ineligible|4|||
128685144|NCT00122278|463147617|FG000|Overall Study|Lost to Follow-up|2|||
128685145|NCT00122278|463147618|FG001|Overall Study|Lost to Follow-up|0|||
128685146|NCT01994590|463147619|FG000|Overall Study|Adverse Event|1|||
128685147|NCT01994590|463147619|FG000|Overall Study|Trial Terminated|1|||
128685148|NCT00397943|463147625|FG000|Overall Study|Unspecified reasons|12|||
128685149|NCT00397943|463147626|FG001|Overall Study|Unspecified reasons|9|||
128685150|NCT00397943|463147627|FG002|Overall Study|Unspecified reasons|0|||
128685151|NCT00397943|463147628|FG003|Overall Study|Unspecified reasons|0|||
128685152|NCT00397943|463147629|FG004|Overall Study|Unspecified reasons|0|||
128685153|NCT04521777|463147630|FG000|Overall Study|Death|2|||
128685154|NCT04521777|463147630|FG000|Overall Study|Withdrawal by Subject|2|||
128685155|NCT03139604|463147633|FG000|Overall Study|Other|7|||
128685156|NCT03139604|463147634|FG001|Overall Study|Other|3|||
128685157|NCT03139604|463147633|FG000|Overall Study|Withdrawal by Subject|16|||
128685158|NCT03139604|463147634|FG001|Overall Study|Withdrawal by Subject|17|||
128685159|NCT03139604|463147633|FG000|Overall Study|Physician Decision|1|||
128685160|NCT03139604|463147634|FG001|Overall Study|Physician Decision|2|||
128685161|NCT03139604|463147633|FG000|Overall Study|Lost to Follow-up|3|||
128685162|NCT03139604|463147634|FG001|Overall Study|Lost to Follow-up|1|||
128685163|NCT03139604|463147633|FG000|Overall Study|Death|65|||
128685164|NCT03139604|463147634|FG001|Overall Study|Death|67|||
128685165|NCT03139604|463147633|FG000|Overall Study|Study Terminated by Sponsor|122|||
128685166|NCT03139604|463147634|FG001|Overall Study|Study Terminated by Sponsor|127|||
128685167|NCT03139604|463147633|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
128685168|NCT03139604|463147634|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
128685169|NCT04950608|463147635|FG000|Overall Study|Withdrawal by Subject|2|||
128685170|NCT04950608|463147635|FG000|Overall Study|Physician Decision|3|||
128685171|NCT02007512|463147636|FG000|Double Blind Treatment Period|Adverse Event|4|||
128685172|NCT02007512|463147637|FG001|Double Blind Treatment Period|Adverse Event|6|||
128685173|NCT02007512|463147638|FG002|Double Blind Treatment Period|Adverse Event|2|||
128685174|NCT02007512|463147639|FG003|Double Blind Treatment Period|Adverse Event|2|||
128685175|NCT02007512|463147636|FG000|Double Blind Treatment Period|Death|1|||
128685176|NCT02007512|463147637|FG001|Double Blind Treatment Period|Death|0|||
128685177|NCT02007512|463147638|FG002|Double Blind Treatment Period|Death|0|||
128685178|NCT02007512|463147639|FG003|Double Blind Treatment Period|Death|0|||
128685179|NCT02007512|463147636|FG000|Double Blind Treatment Period|Disease progression|51|||
128685180|NCT02007512|463147637|FG001|Double Blind Treatment Period|Disease progression|50|||
128685181|NCT02007512|463147638|FG002|Double Blind Treatment Period|Disease progression|57|||
128685182|NCT02007512|463147639|FG003|Double Blind Treatment Period|Disease progression|52|||
128685183|NCT02007512|463147636|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
128685184|NCT02007512|463147637|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
128685185|NCT02007512|463147638|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
128685186|NCT02007512|463147639|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
128685187|NCT02007512|463147636|FG000|Double Blind Treatment Period|Protocol Violation|1|||
128685188|NCT02007512|463147637|FG001|Double Blind Treatment Period|Protocol Violation|0|||
128685189|NCT02007512|463147638|FG002|Double Blind Treatment Period|Protocol Violation|0|||
128685190|NCT02007512|463147639|FG003|Double Blind Treatment Period|Protocol Violation|1|||
128685191|NCT02007512|463147636|FG000|Double Blind Treatment Period|Other|2|||
129109015|NCT03284853|464693705|FG001|Overall Study|Protocol Violation|3|||
129109016|NCT03284853|464693704|FG000|Overall Study|Death|0|||
129109017|NCT03284853|464693705|FG001|Overall Study|Death|1|||
129109018|NCT03284853|464693704|FG000|Overall Study|Other - Reason not reported in CSR|4|||
129109019|NCT03284853|464693705|FG001|Overall Study|Other - Reason not reported in CSR|3|||
129109020|NCT02308228|464693707|FG000|Overall Study|Adverse Event|3|||
129109021|NCT02308228|464693708|FG001|Overall Study|Adverse Event|4|||
129109022|NCT02308228|464693707|FG000|Overall Study|Withdrawal by Subject|5|||
129109023|NCT02308228|464693708|FG001|Overall Study|Withdrawal by Subject|3|||
129109024|NCT03999749|464693711|FG000|Overall Study|Toxicity|16|||
128685192|NCT02007512|463147637|FG001|Double Blind Treatment Period|Other|1|||
128685193|NCT02007512|463147638|FG002|Double Blind Treatment Period|Other|1|||
129109025|NCT03999749|464693711|FG000|Overall Study|Withdrawal by Subject|3|||
129109026|NCT03999749|464693711|FG000|Overall Study|Disease progression|26|||
128685194|NCT02007512|463147639|FG003|Double Blind Treatment Period|Other|2|||
129109027|NCT03999749|464693711|FG000|Overall Study|Physician Decision|4|||
129109028|NCT03999749|464693711|FG000|Overall Study|Death|5|||
128685195|NCT02007512|463147636|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
128685196|NCT02007512|463147637|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
128685197|NCT02007512|463147638|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
128685198|NCT02007512|463147639|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
128685199|NCT02007512|463147636|FG000|Open Label Treatment Period|Adverse Event|1|||
128685200|NCT02007512|463147637|FG001|Open Label Treatment Period|Adverse Event|0|||
128685201|NCT02007512|463147638|FG002|Open Label Treatment Period|Adverse Event|0|||
128685202|NCT02007512|463147639|FG003|Open Label Treatment Period|Adverse Event|0|||
128685203|NCT02007512|463147636|FG000|Open Label Treatment Period|Other|1|||
128685204|NCT02007512|463147637|FG001|Open Label Treatment Period|Other|1|||
128685205|NCT02007512|463147638|FG002|Open Label Treatment Period|Other|0|||
128685206|NCT02007512|463147639|FG003|Open Label Treatment Period|Other|0|||
128685207|NCT02007512|463147636|FG000|Open Label Treatment Period|Disease progression|23|||
128685208|NCT02007512|463147637|FG001|Open Label Treatment Period|Disease progression|11|||
128685209|NCT02007512|463147638|FG002|Open Label Treatment Period|Disease progression|0|||
128685210|NCT02007512|463147639|FG003|Open Label Treatment Period|Disease progression|0|||
128685211|NCT00900601|463147644|FG000|Overall Study|Physician Decision|1|||
128685212|NCT00608543|463147645|FG000|Overall Study|Adverse Event|4|||
128685213|NCT03026088|463147646|FG000|Overall Study|Study termination|20|||
128685214|NCT01869725|463147648|FG000|Overall Study|ineligible after registration|1|||
128685215|NCT01869725|463147648|FG000|Overall Study|Death|1|||
128685216|NCT01869725|463147648|FG000|Overall Study|Lost to Follow-up|2|||
128685217|NCT01143207|463147649|FG000|Overall Study|Lost to Follow-up|2|||
128685218|NCT03463031|463147662|FG000|Overall Study|Withdrawal by Subject|4|||
128685219|NCT03463031|463147663|FG001|Overall Study|Withdrawal by Subject|2|||
128685220|NCT03463031|463147662|FG000|Overall Study|Investigator/Sponsor Decision|0|||
128685221|NCT03463031|463147663|FG001|Overall Study|Investigator/Sponsor Decision|1|||
128685222|NCT03463031|463147662|FG000|Overall Study|Lost to Follow-up|1|||
128886991|NCT01774084|463880598|FG001|Overall Study|Personal reasons|0|||
128886992|NCT00821431|463880599|FG000|Overall Study|Adverse Event|6|||
128886993|NCT00821431|463880600|FG001|Overall Study|Adverse Event|3|||
128886994|NCT00821431|463880599|FG000|Overall Study|Withdrawal by Subject|5|||
128886995|NCT00821431|463880600|FG001|Overall Study|Withdrawal by Subject|0|||
128886996|NCT00821431|463880599|FG000|Overall Study|Lost to Follow-up|1|||
129020510|NCT01796171|464367100|FG004|Follow-up Period|Physician Decision|0|||
129020511|NCT01796171|464367101|FG005|Follow-up Period|Physician Decision|0|||
129020512|NCT01796171|464367102|FG006|Follow-up Period|Physician Decision|0|||
129020513|NCT01796171|464367103|FG007|Follow-up Period|Physician Decision|0|||
129020514|NCT01796171|464367104|FG008|Follow-up Period|Physician Decision|0|||
129020515|NCT01796171|464367105|FG009|Follow-up Period|Physician Decision|0|||
129020516|NCT01796171|464367106|FG010|Follow-up Period|Physician Decision|5|||
129020517|NCT01796171|464367107|FG011|Follow-up Period|Physician Decision|0|||
129020518|NCT01796171|464367108|FG012|Follow-up Period|Physician Decision|0|||
129020519|NCT01796171|464367109|FG013|Follow-up Period|Physician Decision|0|||
129020520|NCT01796171|464367110|FG014|Follow-up Period|Physician Decision|0|||
129020521|NCT01796171|464367096|FG000|Follow-up Period|Withdrawal by Subject|0|||
129020522|NCT01796171|464367097|FG001|Follow-up Period|Withdrawal by Subject|1|||
129020523|NCT01796171|464367098|FG002|Follow-up Period|Withdrawal by Subject|0|||
129020524|NCT01796171|464367099|FG003|Follow-up Period|Withdrawal by Subject|0|||
129020525|NCT01796171|464367100|FG004|Follow-up Period|Withdrawal by Subject|0|||
129020526|NCT01796171|464367101|FG005|Follow-up Period|Withdrawal by Subject|1|||
129020527|NCT01796171|464367102|FG006|Follow-up Period|Withdrawal by Subject|0|||
129020528|NCT01796171|464367103|FG007|Follow-up Period|Withdrawal by Subject|0|||
129020529|NCT01796171|464367104|FG008|Follow-up Period|Withdrawal by Subject|0|||
129020530|NCT01796171|464367105|FG009|Follow-up Period|Withdrawal by Subject|0|||
129020531|NCT01796171|464367106|FG010|Follow-up Period|Withdrawal by Subject|3|||
129020532|NCT01796171|464367107|FG011|Follow-up Period|Withdrawal by Subject|1|||
129020533|NCT01796171|464367108|FG012|Follow-up Period|Withdrawal by Subject|0|||
129020534|NCT01796171|464367109|FG013|Follow-up Period|Withdrawal by Subject|0|||
129020535|NCT01796171|464367110|FG014|Follow-up Period|Withdrawal by Subject|0|||
129020536|NCT01796171|464367096|FG000|Follow-up Period|Death|0|||
129020537|NCT01796171|464367097|FG001|Follow-up Period|Death|0|||
129020538|NCT01796171|464367098|FG002|Follow-up Period|Death|0|||
129215173|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
129215174|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
129215175|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
129215176|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
129215177|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
129215178|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
129215179|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
129215180|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
128685223|NCT03463031|463147663|FG001|Overall Study|Lost to Follow-up|1|||
128685224|NCT03463031|463147662|FG000|Overall Study|Adverse Event|4|||
128685225|NCT03463031|463147663|FG001|Overall Study|Adverse Event|1|||
128763288|NCT03489057|463422807|FG001|Overall Study|Lost to Follow-up|16|||
129215181|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
129020539|NCT01796171|464367099|FG003|Follow-up Period|Death|0|||
128886997|NCT00821431|463880600|FG001|Overall Study|Lost to Follow-up|0|||
128685226|NCT03463031|463147662|FG000|Overall Study|Use of prohibited medication by subject|1|||
128685227|NCT03463031|463147663|FG001|Overall Study|Use of prohibited medication by subject|0|||
128685228|NCT00057954|463147669|FG000|Overall Study|Death|1|||
128685229|NCT00057954|463147669|FG000|Overall Study|Disease progression|1|||
128685230|NCT00214500|463147674|FG000|Treatment Period|Adverse Event|1|||
128685231|NCT00214500|463147674|FG000|Extension Period|Withdrawal by Subject|2|||
128685232|NCT02537574|463147676|FG000|Overall Study|Adverse Event|1|||
128685233|NCT02537574|463147677|FG001|Overall Study|Adverse Event|3|||
128685234|NCT02537574|463147678|FG002|Overall Study|Adverse Event|2|||
128685235|NCT02537574|463147676|FG000|Overall Study|Lost to Follow-up|40|||
128685236|NCT02537574|463147677|FG001|Overall Study|Lost to Follow-up|51|||
128685237|NCT02537574|463147678|FG002|Overall Study|Lost to Follow-up|55|||
128685238|NCT02537574|463147676|FG000|Overall Study|Noncompliance with study drug|0|||
128685239|NCT02537574|463147677|FG001|Overall Study|Noncompliance with study drug|1|||
128685240|NCT02537574|463147678|FG002|Overall Study|Noncompliance with study drug|1|||
128685241|NCT02537574|463147676|FG000|Overall Study|Physician Decision|2|||
128685242|NCT02537574|463147677|FG001|Overall Study|Physician Decision|0|||
128685243|NCT02537574|463147678|FG002|Overall Study|Physician Decision|0|||
128685244|NCT02537574|463147676|FG000|Overall Study|Protocol Violation|4|||
128685245|NCT02537574|463147677|FG001|Overall Study|Protocol Violation|2|||
128685246|NCT02537574|463147678|FG002|Overall Study|Protocol Violation|3|||
128685247|NCT02537574|463147676|FG000|Overall Study|Withdrawal by Subject|37|||
128685248|NCT02537574|463147677|FG001|Overall Study|Withdrawal by Subject|27|||
128685249|NCT02537574|463147678|FG002|Overall Study|Withdrawal by Subject|29|||
128685250|NCT02537574|463147676|FG000|Overall Study|Lack of Efficacy|14|||
128685251|NCT02537574|463147677|FG001|Overall Study|Lack of Efficacy|16|||
128685252|NCT02537574|463147678|FG002|Overall Study|Lack of Efficacy|15|||
128685253|NCT02537574|463147676|FG000|Overall Study|Duplicate Patient|1|||
128685254|NCT02537574|463147677|FG001|Overall Study|Duplicate Patient|0|||
128685255|NCT02537574|463147678|FG002|Overall Study|Duplicate Patient|0|||
128685256|NCT02537574|463147676|FG000|Overall Study|Patient not Stable|0|||
128685257|NCT02537574|463147677|FG001|Overall Study|Patient not Stable|1|||
128685258|NCT02537574|463147678|FG002|Overall Study|Patient not Stable|0|||
128685259|NCT02537574|463147676|FG000|Overall Study|Incarceration|0|||
128685260|NCT02537574|463147677|FG001|Overall Study|Incarceration|1|||
128685261|NCT02537574|463147678|FG002|Overall Study|Incarceration|0|||
128685262|NCT02537574|463147676|FG000|Overall Study|Failed Naloxone Challenge|0|||
128685263|NCT02537574|463147677|FG001|Overall Study|Failed Naloxone Challenge|1|||
128685264|NCT02537574|463147678|FG002|Overall Study|Failed Naloxone Challenge|0|||
128685265|NCT02537574|463147676|FG000|Overall Study|Transportation Issues|0|||
129109029|NCT03999749|464693711|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
129109030|NCT00255164|464693712|FG000|Overall Study|Adverse Event|10|||
129109031|NCT00255164|464693713|FG001|Overall Study|Adverse Event|6|||
129109032|NCT00255164|464693714|FG002|Overall Study|Adverse Event|9|||
128685266|NCT02537574|463147677|FG001|Overall Study|Transportation Issues|0|||
128685267|NCT02537574|463147678|FG002|Overall Study|Transportation Issues|1|||
128685268|NCT02537574|463147676|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
128685269|NCT02537574|463147677|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
129109033|NCT00255164|464693712|FG000|Overall Study|Lost to Follow-up|4|||
129109034|NCT00255164|464693713|FG001|Overall Study|Lost to Follow-up|3|||
129109035|NCT00255164|464693714|FG002|Overall Study|Lost to Follow-up|4|||
129109036|NCT00255164|464693712|FG000|Overall Study|Withdrawal by Subject|18|||
129109037|NCT00255164|464693713|FG001|Overall Study|Withdrawal by Subject|17|||
129109038|NCT00255164|464693714|FG002|Overall Study|Withdrawal by Subject|8|||
129109039|NCT00255164|464693712|FG000|Overall Study|Noncompliance|0|||
129109040|NCT00255164|464693713|FG001|Overall Study|Noncompliance|1|||
129109041|NCT00255164|464693714|FG002|Overall Study|Noncompliance|2|||
129109042|NCT00255164|464693712|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
129109043|NCT00255164|464693713|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
129109044|NCT00255164|464693714|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
129109045|NCT00255164|464693712|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
128685270|NCT02537574|463147678|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
128685271|NCT02537574|463147676|FG000|Overall Study|Noncompliance with Protocol|0|||
128685272|NCT02537574|463147677|FG001|Overall Study|Noncompliance with Protocol|0|||
128685273|NCT02537574|463147678|FG002|Overall Study|Noncompliance with Protocol|1|||
128685274|NCT02663687|463147679|FG000|Overall Study|Adverse Event|1|||
128685275|NCT02663687|463147680|FG001|Overall Study|Adverse Event|0|||
128685276|NCT02663687|463147681|FG002|Overall Study|Adverse Event|0|||
128685277|NCT02663687|463147682|FG003|Overall Study|Adverse Event|0|||
128685278|NCT02663687|463147683|FG004|Overall Study|Adverse Event|0|||
128685279|NCT02663687|463147679|FG000|Overall Study|Other|1|||
128685280|NCT02663687|463147680|FG001|Overall Study|Other|0|||
128685281|NCT02663687|463147681|FG002|Overall Study|Other|1|||
128685282|NCT02663687|463147682|FG003|Overall Study|Other|0|||
128685283|NCT02663687|463147683|FG004|Overall Study|Other|0|||
129109046|NCT00255164|464693713|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
129109047|NCT00255164|464693714|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
128685284|NCT03595774|463147684|FG000|Overall Study|Adverse Event|1|||
128685285|NCT03595774|463147685|FG001|Overall Study|Adverse Event|0|||
128685286|NCT03595774|463147686|FG002|Overall Study|Adverse Event|1|||
128685287|NCT03595774|463147687|FG003|Overall Study|Adverse Event|0|||
128685288|NCT03595774|463147684|FG000|Overall Study|screen failure|0|||
128685289|NCT03595774|463147685|FG001|Overall Study|screen failure|1|||
128685290|NCT03595774|463147686|FG002|Overall Study|screen failure|0|||
128685291|NCT03595774|463147687|FG003|Overall Study|screen failure|1|||
128685292|NCT03555435|463147688|FG000|Overall Study|Lost to Follow-up|17|||
128685293|NCT03555435|463147689|FG001|Overall Study|Lost to Follow-up|19|||
128685294|NCT03555435|463147690|FG002|Overall Study|Lost to Follow-up|8|||
128685295|NCT01115803|463147698|FG000|Overall Study|Withdrawal by Subject|0|||
128685296|NCT01115803|463147699|FG001|Overall Study|Withdrawal by Subject|0|||
128685297|NCT01115803|463147700|FG002|Overall Study|Withdrawal by Subject|0|||
128685298|NCT01115803|463147701|FG003|Overall Study|Withdrawal by Subject|0|||
128685299|NCT01115803|463147702|FG004|Overall Study|Withdrawal by Subject|0|||
128685300|NCT01115803|463147703|FG005|Overall Study|Withdrawal by Subject|0|||
128685301|NCT01115803|463147704|FG006|Overall Study|Withdrawal by Subject|1|||
128685302|NCT01115803|463147698|FG000|Overall Study|Lost to Follow-up|0|||
128685303|NCT01115803|463147699|FG001|Overall Study|Lost to Follow-up|0|||
128685304|NCT01115803|463147700|FG002|Overall Study|Lost to Follow-up|1|||
128685305|NCT01115803|463147701|FG003|Overall Study|Lost to Follow-up|0|||
128685306|NCT01115803|463147702|FG004|Overall Study|Lost to Follow-up|0|||
128685307|NCT01115803|463147703|FG005|Overall Study|Lost to Follow-up|0|||
128685308|NCT01115803|463147704|FG006|Overall Study|Lost to Follow-up|0|||
128685309|NCT01115803|463147698|FG000|Overall Study|Progressive Disease during Cycle1|0|||
128685310|NCT01115803|463147699|FG001|Overall Study|Progressive Disease during Cycle1|0|||
128685311|NCT01115803|463147700|FG002|Overall Study|Progressive Disease during Cycle1|0|||
128685312|NCT01115803|463147701|FG003|Overall Study|Progressive Disease during Cycle1|0|||
128685313|NCT01115803|463147702|FG004|Overall Study|Progressive Disease during Cycle1|0|||
128685314|NCT01115803|463147703|FG005|Overall Study|Progressive Disease during Cycle1|0|||
128685315|NCT01115803|463147704|FG006|Overall Study|Progressive Disease during Cycle1|1|||
128685316|NCT03475875|463147705|FG000|Period 1|Lost to Follow-up|1|||
128685317|NCT03475875|463147706|FG001|Period 1|Lost to Follow-up|0|||
128685318|NCT03475875|463147705|FG000|Period 1|Adverse Event|2|||
128685319|NCT03475875|463147706|FG001|Period 1|Adverse Event|1|||
128685320|NCT03475875|463147705|FG000|Period 2|Adverse Event|3|||
128685321|NCT03475875|463147706|FG001|Period 2|Adverse Event|0|||
128685322|NCT03475875|463147705|FG000|Period 2|Protocol Violation|0|||
128685323|NCT03475875|463147706|FG001|Period 2|Protocol Violation|1|||
128685324|NCT00704808|463147717|FG000|Overall Study|Discontinued prior to starting treatment|14|||
128685325|NCT00704808|463147717|FG000|Overall Study|Death|7|||
128685326|NCT00704808|463147717|FG000|Overall Study|Tumor progression|80|||
128685327|NCT00704808|463147717|FG000|Overall Study|Patient's decision|11|||
129109048|NCT00255164|464693712|FG000|Overall Study|Possible Barrett's Esophagus|1|||
129109049|NCT00255164|464693713|FG001|Overall Study|Possible Barrett's Esophagus|3|||
129109050|NCT00255164|464693714|FG002|Overall Study|Possible Barrett's Esophagus|8|||
129109051|NCT00255164|464693712|FG000|Overall Study|Esophageal Stricture|0|||
129109052|NCT00255164|464693713|FG001|Overall Study|Esophageal Stricture|0|||
129109053|NCT00255164|464693714|FG002|Overall Study|Esophageal Stricture|1|||
129109054|NCT00255164|464693712|FG000|Overall Study|Therapeutic Failure|11|||
129109055|NCT00255164|464693713|FG001|Overall Study|Therapeutic Failure|2|||
129109056|NCT00255164|464693714|FG002|Overall Study|Therapeutic Failure|3|||
129109057|NCT05219968|464693715|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
129109058|NCT05219968|464693716|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129109059|NCT05219968|464693717|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129109060|NCT05219968|464693718|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129109061|NCT05219968|464693719|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129109062|NCT05219968|464693715|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
129109063|NCT05219968|464693716|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
129109064|NCT05219968|464693717|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
128685328|NCT00704808|463147717|FG000|Overall Study|Early therapy discontinuation|16|||
128685329|NCT00704808|463147717|FG000|Overall Study|Adverse Event|1|||
128685330|NCT00704808|463147717|FG000|Overall Study|Lost to Follow-up|1|||
128685331|NCT00704808|463147717|FG000|Overall Study|Treatment change|1|||
128685332|NCT01285960|463147718|FG000|Overall Study|Withdrawal by Subject|2|||
128685333|NCT01285960|463147718|FG000|Overall Study|Lost to Follow-up|2|||
128685334|NCT01285960|463147718|FG000|Overall Study|2 subjects received less 10 sonications|2|||
128685335|NCT01484054|463147719|FG000|Period 1|Withdrawal by Subject|0|||
128685336|NCT01484054|463147720|FG001|Period 1|Withdrawal by Subject|1|||
128685337|NCT01610271|463147721|FG000|Overall Study|Surgery not complete|0|||
128685338|NCT01610271|463147722|FG001|Overall Study|Surgery not complete|1|||
128685339|NCT01610271|463147721|FG000|Overall Study|Prosthesis not implanted|2|||
128685340|NCT01610271|463147722|FG001|Overall Study|Prosthesis not implanted|3|||
128685341|NCT00364130|463147723|FG000|Intervention Period|Lost to Follow-up|4|||
129109065|NCT05219968|464693718|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
129109066|NCT05219968|464693719|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
129109067|NCT05219968|464693715|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
129109068|NCT05219968|464693716|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
129109069|NCT05219968|464693717|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
129109070|NCT05219968|464693718|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
129109071|NCT05219968|464693719|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
129109072|NCT05219968|464693715|FG000|Week 24 Treatment Period|Adverse Event|3|||
129109073|NCT05219968|464693716|FG001|Week 24 Treatment Period|Adverse Event|0|||
129109074|NCT05219968|464693717|FG002|Week 24 Treatment Period|Adverse Event|0|||
129109075|NCT05219968|464693718|FG003|Week 24 Treatment Period|Adverse Event|0|||
129109076|NCT05219968|464693719|FG004|Week 24 Treatment Period|Adverse Event|0|||
129109077|NCT05219968|464693715|FG000|Week 24 Treatment Period|Physician Decision|0|||
129109078|NCT05219968|464693716|FG001|Week 24 Treatment Period|Physician Decision|1|||
129109079|NCT05219968|464693717|FG002|Week 24 Treatment Period|Physician Decision|0|||
129109080|NCT05219968|464693718|FG003|Week 24 Treatment Period|Physician Decision|0|||
129109081|NCT05219968|464693719|FG004|Week 24 Treatment Period|Physician Decision|0|||
129109082|NCT05219968|464693715|FG000|Week 24 Treatment Period|Other, not specified|3|||
129109083|NCT05219968|464693716|FG001|Week 24 Treatment Period|Other, not specified|0|||
129109084|NCT05219968|464693717|FG002|Week 24 Treatment Period|Other, not specified|0|||
129109085|NCT05219968|464693718|FG003|Week 24 Treatment Period|Other, not specified|0|||
129109086|NCT05219968|464693719|FG004|Week 24 Treatment Period|Other, not specified|0|||
129109087|NCT05219968|464693715|FG000|Safety Extension Period|Treatment administration failure|0|||
129109088|NCT05219968|464693716|FG001|Safety Extension Period|Treatment administration failure|0|||
129109089|NCT05219968|464693717|FG002|Safety Extension Period|Treatment administration failure|0|||
129109090|NCT05219968|464693718|FG003|Safety Extension Period|Treatment administration failure|1|||
129109091|NCT05219968|464693719|FG004|Safety Extension Period|Treatment administration failure|4|||
129109092|NCT05219968|464693715|FG000|Safety Extension Period|Bilateral dislodgement|0|||
128685342|NCT00364130|463147724|FG001|Intervention Period|Lost to Follow-up|3|||
128685343|NCT00364130|463147723|FG000|Intervention Period|Pregnancy|1|||
129109093|NCT05219968|464693716|FG001|Safety Extension Period|Bilateral dislodgement|0|||
129109094|NCT05219968|464693717|FG002|Safety Extension Period|Bilateral dislodgement|4|||
129109095|NCT05219968|464693718|FG003|Safety Extension Period|Bilateral dislodgement|0|||
129109096|NCT05219968|464693719|FG004|Safety Extension Period|Bilateral dislodgement|1|||
129109097|NCT05219968|464693715|FG000|Safety Extension Period|Withdrawal by Subject|0|||
129109098|NCT05219968|464693716|FG001|Safety Extension Period|Withdrawal by Subject|0|||
129109099|NCT05219968|464693717|FG002|Safety Extension Period|Withdrawal by Subject|2|||
129109100|NCT05219968|464693718|FG003|Safety Extension Period|Withdrawal by Subject|0|||
129109101|NCT05219968|464693719|FG004|Safety Extension Period|Withdrawal by Subject|4|||
129109102|NCT05219968|464693715|FG000|Safety Extension Period|Adverse Event|0|||
129109103|NCT05219968|464693716|FG001|Safety Extension Period|Adverse Event|0|||
129109104|NCT05219968|464693717|FG002|Safety Extension Period|Adverse Event|2|||
129109105|NCT05219968|464693718|FG003|Safety Extension Period|Adverse Event|1|||
129109106|NCT05219968|464693719|FG004|Safety Extension Period|Adverse Event|1|||
128685344|NCT00364130|463147724|FG001|Intervention Period|Pregnancy|0|||
128685345|NCT00364130|463147723|FG000|Intervention Period|Withdrawal by Subject|4|||
128685346|NCT00364130|463147724|FG001|Intervention Period|Withdrawal by Subject|5|||
128685347|NCT00364130|463147723|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
128685348|NCT00364130|463147724|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
128685349|NCT05281601|463147725|FG000|Overall Study|Physician Decision|2|||
128685350|NCT05281601|463147726|FG001|Overall Study|Physician Decision|0|||
128685351|NCT05281601|463147725|FG000|Overall Study|Lost to Follow-up|2|||
128685352|NCT05281601|463147726|FG001|Overall Study|Lost to Follow-up|0|||
128685353|NCT05281601|463147725|FG000|Overall Study|Death|1|||
128685354|NCT05281601|463147726|FG001|Overall Study|Death|0|||
128685355|NCT05281601|463147725|FG000|Overall Study|Withdrawal by parent/guardian|2|||
128685356|NCT05281601|463147726|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128685357|NCT00586846|463147727|FG000|Overall Study|Physician Decision|1|||
128685358|NCT00586846|463147727|FG000|Overall Study|Death|1|||
128685359|NCT00586846|463147727|FG000|Overall Study|Evaluable for Toxicity Only|4|||
129109107|NCT05219968|464693715|FG000|Safety Extension Period|Lost to Follow-up|0|||
129109108|NCT05219968|464693716|FG001|Safety Extension Period|Lost to Follow-up|0|||
129109109|NCT05219968|464693717|FG002|Safety Extension Period|Lost to Follow-up|0|||
129109110|NCT05219968|464693718|FG003|Safety Extension Period|Lost to Follow-up|1|||
129109111|NCT05219968|464693719|FG004|Safety Extension Period|Lost to Follow-up|0|||
129109112|NCT04587336|464693720|FG000|Overall Study|Lost to Follow-up|1|||
129109113|NCT04587336|464693721|FG001|Overall Study|Lost to Follow-up|0|||
129109114|NCT00103285|464695847|FG000|Induction|Adverse Event|14|||
128685360|NCT00144027|463147729|FG000|Overall Study|Lost to Follow-up|1|||
128685361|NCT00144027|463147730|FG001|Overall Study|Lost to Follow-up|3|||
128685362|NCT00144027|463147729|FG000|Overall Study|Withdrawal by Subject|2|||
128763289|NCT03489057|463422808|FG002|Overall Study|Lost to Follow-up|14|||
129109115|NCT00103285|464695848|FG001|Induction|Adverse Event|0|||
129109116|NCT00103285|464695849|FG002|Induction|Adverse Event|0|||
128685363|NCT00144027|463147730|FG001|Overall Study|Withdrawal by Subject|2|||
128685364|NCT00144027|463147729|FG000|Overall Study|did not complete baseline assessment|0|||
128685365|NCT00144027|463147730|FG001|Overall Study|did not complete baseline assessment|6|||
128685366|NCT04597918|463147731|FG000|Overall Study|Withdrawal by Subject|6|||
128685367|NCT04597918|463147731|FG000|Overall Study|Lost to Follow-up|3|||
128685368|NCT04597918|463147731|FG000|Overall Study|Death|1|||
128685369|NCT00395538|463147732|FG000|Overall Study|Did not re-consent to revised protocol|1|||
128685370|NCT00395538|463147733|FG001|Overall Study|Did not re-consent to revised protocol|10|||
128685371|NCT00395538|463147734|FG002|Overall Study|Did not re-consent to revised protocol|0|||
128685372|NCT00395538|463147732|FG000|Overall Study|FDA partial hold on PTH|0|||
128685373|NCT00395538|463147733|FG001|Overall Study|FDA partial hold on PTH|0|||
128685374|NCT00395538|463147734|FG002|Overall Study|FDA partial hold on PTH|11|||
128685375|NCT00395538|463147732|FG000|Overall Study|Failed screening|0|||
128685376|NCT00395538|463147733|FG001|Overall Study|Failed screening|0|||
128685377|NCT00395538|463147734|FG002|Overall Study|Failed screening|4|||
128685378|NCT00395538|463147732|FG000|Overall Study|Switch to Natpara|0|||
128685379|NCT00395538|463147733|FG001|Overall Study|Switch to Natpara|0|||
128685380|NCT00395538|463147734|FG002|Overall Study|Switch to Natpara|3|||
128685381|NCT00395538|463147732|FG000|Overall Study|Adverse Event|1|||
128685382|NCT00395538|463147733|FG001|Overall Study|Adverse Event|0|||
128685383|NCT00395538|463147734|FG002|Overall Study|Adverse Event|2|||
128685384|NCT00395538|463147732|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
128685385|NCT00395538|463147733|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
128685386|NCT00395538|463147734|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
128685387|NCT00395538|463147732|FG000|Overall Study|Non-compliance with study protocol|0|||
128685388|NCT00395538|463147733|FG001|Overall Study|Non-compliance with study protocol|1|||
128685389|NCT00395538|463147734|FG002|Overall Study|Non-compliance with study protocol|0|||
128685390|NCT00395538|463147732|FG000|Overall Study|PTH resistance|0|||
128685391|NCT00395538|463147733|FG001|Overall Study|PTH resistance|0|||
128685392|NCT00395538|463147734|FG002|Overall Study|PTH resistance|1|||
128685393|NCT00395538|463147732|FG000|Overall Study|Pregnancy|1|||
128685394|NCT00395538|463147733|FG001|Overall Study|Pregnancy|0|||
128685395|NCT00395538|463147734|FG002|Overall Study|Pregnancy|0|||
128685396|NCT00395538|463147732|FG000|Overall Study|Partial recovery of parathyroid function|0|||
128685397|NCT00395538|463147733|FG001|Overall Study|Partial recovery of parathyroid function|0|||
128685398|NCT00395538|463147734|FG002|Overall Study|Partial recovery of parathyroid function|1|||
128685399|NCT00395538|463147732|FG000|Overall Study|Participant elected to discontinue|0|||
128685400|NCT00395538|463147733|FG001|Overall Study|Participant elected to discontinue|0|||
128685401|NCT00395538|463147734|FG002|Overall Study|Participant elected to discontinue|1|||
128685402|NCT00285207|463147735|FG000|Overall Study|Lost to Follow-up|3|||
128685403|NCT00285207|463147736|FG001|Overall Study|Lost to Follow-up|2|||
128685404|NCT00285207|463147735|FG000|Overall Study|Withdrawal by Subject|5|||
128685405|NCT00285207|463147736|FG001|Overall Study|Withdrawal by Subject|2|||
128685406|NCT00285207|463147735|FG000|Overall Study|Pregnancy|1|||
128685407|NCT00285207|463147736|FG001|Overall Study|Pregnancy|1|||
128685408|NCT00285207|463147735|FG000|Overall Study|non-compliance|0|||
128685409|NCT00285207|463147736|FG001|Overall Study|non-compliance|1|||
128763290|NCT03489057|463422809|FG003|Overall Study|Lost to Follow-up|14|||
129109117|NCT00103285|464695850|FG003|Induction|Adverse Event|0|||
128685410|NCT05063318|463147737|FG000|Overall Study|Progressive disease|2|||
128685411|NCT05063318|463147738|FG001|Overall Study|Progressive disease|0|||
128685412|NCT05063318|463147739|FG002|Overall Study|Progressive disease|3|||
128763291|NCT03489057|463422806|FG000|Overall Study|Withdrawal by Subject|12|||
128763292|NCT03489057|463422807|FG001|Overall Study|Withdrawal by Subject|12|||
128763293|NCT03489057|463422808|FG002|Overall Study|Withdrawal by Subject|8|||
128763294|NCT03489057|463422809|FG003|Overall Study|Withdrawal by Subject|8|||
128763295|NCT03489057|463422806|FG000|Overall Study|Protocol Violation|7|||
128763296|NCT03489057|463422807|FG001|Overall Study|Protocol Violation|7|||
128763297|NCT03489057|463422808|FG002|Overall Study|Protocol Violation|2|||
128763298|NCT03489057|463422809|FG003|Overall Study|Protocol Violation|2|||
128763299|NCT01368900|463422812|FG000|Overall Study|Lost to Follow-up|7|||
128763300|NCT02034708|463422815|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
128763301|NCT02034708|463422816|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
128685413|NCT05063318|463147737|FG000|Overall Study|Compassionate use|1|||
128685414|NCT05063318|463147738|FG001|Overall Study|Compassionate use|3|||
129109118|NCT00103285|464695851|FG004|Induction|Adverse Event|0|||
129109119|NCT00103285|464695852|FG005|Induction|Adverse Event|0|||
128685415|NCT05063318|463147739|FG002|Overall Study|Compassionate use|3|||
128685416|NCT05063318|463147737|FG000|Overall Study|Adverse Event|0|||
128685417|NCT05063318|463147738|FG001|Overall Study|Adverse Event|1|||
128685418|NCT05063318|463147739|FG002|Overall Study|Adverse Event|0|||
128685419|NCT05063318|463147737|FG000|Overall Study|Withdrawal by Subject|0|||
128763302|NCT02034708|463422815|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
128763303|NCT02034708|463422816|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
128763304|NCT02034708|463422815|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
129109120|NCT00103285|464695853|FG006|Induction|Adverse Event|0|||
128685420|NCT05063318|463147738|FG001|Overall Study|Withdrawal by Subject|1|||
128685421|NCT05063318|463147739|FG002|Overall Study|Withdrawal by Subject|0|||
128685422|NCT00215683|463149398|FG000|Overall Study|Adverse Event|15|||
128685423|NCT00215683|463149399|FG001|Overall Study|Adverse Event|16|||
128685424|NCT00215683|463149400|FG002|Overall Study|Adverse Event|15|||
128685425|NCT00215683|463149398|FG000|Overall Study|Lack of Efficacy|5|||
128685426|NCT00215683|463149399|FG001|Overall Study|Lack of Efficacy|1|||
128685427|NCT00215683|463149400|FG002|Overall Study|Lack of Efficacy|2|||
128685428|NCT00215683|463149398|FG000|Overall Study|Lost to Follow-up|0|||
128685429|NCT00215683|463149399|FG001|Overall Study|Lost to Follow-up|2|||
128685430|NCT00215683|463149400|FG002|Overall Study|Lost to Follow-up|1|||
128685431|NCT00215683|463149398|FG000|Overall Study|Withdrawal by Subject|9|||
128685432|NCT00215683|463149399|FG001|Overall Study|Withdrawal by Subject|4|||
128685433|NCT00215683|463149400|FG002|Overall Study|Withdrawal by Subject|13|||
128685434|NCT00215683|463149398|FG000|Overall Study|Physician Decision|0|||
128685435|NCT00215683|463149399|FG001|Overall Study|Physician Decision|0|||
128685436|NCT00215683|463149400|FG002|Overall Study|Physician Decision|1|||
128685437|NCT00215683|463149398|FG000|Overall Study|Difficult to attend visits|0|||
128685438|NCT00215683|463149399|FG001|Overall Study|Difficult to attend visits|1|||
128685439|NCT00215683|463149400|FG002|Overall Study|Difficult to attend visits|0|||
128685440|NCT00215683|463149398|FG000|Overall Study|No study drug available|0|||
128685441|NCT00215683|463149399|FG001|Overall Study|No study drug available|1|||
128685442|NCT00215683|463149400|FG002|Overall Study|No study drug available|0|||
128685443|NCT00215683|463149398|FG000|Overall Study|Intermittent therapy required|0|||
128685444|NCT00215683|463149399|FG001|Overall Study|Intermittent therapy required|1|||
128685445|NCT00215683|463149400|FG002|Overall Study|Intermittent therapy required|0|||
128685446|NCT04493333|463149407|FG000|Overall Study|Withdrawal by Subject|1|||
128685447|NCT04493333|463149408|FG001|Overall Study|Withdrawal by Subject|1|||
128685448|NCT04493333|463149407|FG000|Overall Study|Ineligible|0|||
128685449|NCT04493333|463149408|FG001|Overall Study|Ineligible|1|||
128685450|NCT04493333|463149407|FG000|Overall Study|Noncompliance|2|||
128685451|NCT04493333|463149408|FG001|Overall Study|Noncompliance|1|||
128685452|NCT00451451|463149409|FG000|Overall Study|Adverse Event|11|||
128685453|NCT00451451|463149410|FG001|Overall Study|Adverse Event|21|||
128685454|NCT00451451|463149411|FG002|Overall Study|Adverse Event|26|||
128685455|NCT00451451|463149412|FG003|Overall Study|Adverse Event|10|||
128685456|NCT00451451|463149409|FG000|Overall Study|Lost to Follow-up|11|||
128685457|NCT00451451|463149410|FG001|Overall Study|Lost to Follow-up|9|||
128685458|NCT00451451|463149411|FG002|Overall Study|Lost to Follow-up|8|||
128685459|NCT00451451|463149412|FG003|Overall Study|Lost to Follow-up|11|||
128685460|NCT00451451|463149409|FG000|Overall Study|Consent Withdrawn|14|||
128685461|NCT00451451|463149410|FG001|Overall Study|Consent Withdrawn|9|||
128685462|NCT00451451|463149411|FG002|Overall Study|Consent Withdrawn|17|||
128685463|NCT00451451|463149412|FG003|Overall Study|Consent Withdrawn|17|||
128685464|NCT00451451|463149409|FG000|Overall Study|Investigator Decision|6|||
128685465|NCT00451451|463149410|FG001|Overall Study|Investigator Decision|2|||
128685466|NCT00451451|463149411|FG002|Overall Study|Investigator Decision|1|||
128685467|NCT00451451|463149412|FG003|Overall Study|Investigator Decision|2|||
128685468|NCT00451451|463149409|FG000|Overall Study|Subject Non-Compliance|8|||
128685469|NCT00451451|463149410|FG001|Overall Study|Subject Non-Compliance|4|||
128685470|NCT00451451|463149411|FG002|Overall Study|Subject Non-Compliance|3|||
128685471|NCT00451451|463149412|FG003|Overall Study|Subject Non-Compliance|3|||
128685472|NCT00451451|463149409|FG000|Overall Study|Death|1|||
128685473|NCT00451451|463149410|FG001|Overall Study|Death|0|||
128685474|NCT00451451|463149411|FG002|Overall Study|Death|0|||
128685475|NCT00451451|463149412|FG003|Overall Study|Death|1|||
128685476|NCT00451451|463149409|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
128685477|NCT00451451|463149410|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
128685478|NCT00451451|463149411|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
128685479|NCT00451451|463149412|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
129109121|NCT00103285|464695854|FG007|Induction|Adverse Event|0|||
129109122|NCT00103285|464695847|FG000|Induction|Death|24|||
128685480|NCT01865084|463149413|FG000|Double Blind Period (DB)|Adverse Event|2|||
129109123|NCT00103285|464695848|FG001|Induction|Death|0|||
128685481|NCT01865084|463149414|FG001|Double Blind Period (DB)|Adverse Event|2|||
128685482|NCT01865084|463149415|FG002|Double Blind Period (DB)|Adverse Event|1|||
128685483|NCT01865084|463149413|FG000|Double Blind Period (DB)|Protocol Violation|0|||
128685484|NCT01865084|463149414|FG001|Double Blind Period (DB)|Protocol Violation|0|||
128685485|NCT01865084|463149415|FG002|Double Blind Period (DB)|Protocol Violation|1|||
128685486|NCT01865084|463149413|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
128685487|NCT01865084|463149414|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
128685488|NCT01865084|463149415|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
128685489|NCT01865084|463149413|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
128685490|NCT01865084|463149414|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
128685491|NCT01865084|463149415|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
128685492|NCT01865084|463149413|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
129109124|NCT00103285|464695849|FG002|Induction|Death|0|||
128685493|NCT01865084|463149414|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
128685494|NCT01865084|463149415|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
128685495|NCT01865084|463149413|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
128685496|NCT01865084|463149414|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
128685497|NCT01865084|463149415|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
128685498|NCT01865084|463149413|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
129109125|NCT00103285|464695850|FG003|Induction|Death|0|||
129109126|NCT00103285|464695851|FG004|Induction|Death|0|||
129109127|NCT00103285|464695852|FG005|Induction|Death|0|||
129109128|NCT00103285|464695853|FG006|Induction|Death|0|||
129109129|NCT00103285|464695854|FG007|Induction|Death|0|||
129109130|NCT00103285|464695847|FG000|Induction|Physician Decision|103|||
129109131|NCT00103285|464695848|FG001|Induction|Physician Decision|0|||
129109132|NCT00103285|464695849|FG002|Induction|Physician Decision|0|||
129109133|NCT00103285|464695850|FG003|Induction|Physician Decision|0|||
129109134|NCT00103285|464695851|FG004|Induction|Physician Decision|0|||
129109135|NCT00103285|464695852|FG005|Induction|Physician Decision|0|||
129109136|NCT00103285|464695853|FG006|Induction|Physician Decision|0|||
129109137|NCT00103285|464695854|FG007|Induction|Physician Decision|0|||
129109138|NCT00103285|464695847|FG000|Induction|Withdrawal by Subject|1|||
129109139|NCT00103285|464695848|FG001|Induction|Withdrawal by Subject|0|||
129109140|NCT00103285|464695849|FG002|Induction|Withdrawal by Subject|0|||
129109141|NCT00103285|464695850|FG003|Induction|Withdrawal by Subject|0|||
129109142|NCT00103285|464695851|FG004|Induction|Withdrawal by Subject|0|||
129109143|NCT00103285|464695852|FG005|Induction|Withdrawal by Subject|0|||
129109144|NCT00103285|464695853|FG006|Induction|Withdrawal by Subject|0|||
129109145|NCT00103285|464695854|FG007|Induction|Withdrawal by Subject|0|||
129109146|NCT00103285|464695847|FG000|Induction|Ineligible|43|||
129109147|NCT00103285|464695848|FG001|Induction|Ineligible|0|||
129109148|NCT00103285|464695849|FG002|Induction|Ineligible|0|||
129109149|NCT00103285|464695850|FG003|Induction|Ineligible|0|||
129109150|NCT00103285|464695851|FG004|Induction|Ineligible|0|||
129109151|NCT00103285|464695852|FG005|Induction|Ineligible|0|||
129109152|NCT00103285|464695853|FG006|Induction|Ineligible|0|||
129109153|NCT00103285|464695854|FG007|Induction|Ineligible|0|||
129109154|NCT00103285|464695847|FG000|Induction|Refusal|906|||
129109155|NCT00103285|464695848|FG001|Induction|Refusal|0|||
129109156|NCT00103285|464695849|FG002|Induction|Refusal|0|||
129109157|NCT00103285|464695850|FG003|Induction|Refusal|0|||
129109158|NCT00103285|464695851|FG004|Induction|Refusal|0|||
129109159|NCT00103285|464695852|FG005|Induction|Refusal|0|||
129109160|NCT00103285|464695853|FG006|Induction|Refusal|0|||
129109161|NCT00103285|464695854|FG007|Induction|Refusal|0|||
129109162|NCT00103285|464695847|FG000|Induction|Other|258|||
129109163|NCT00103285|464695848|FG001|Induction|Other|0|||
129109164|NCT00103285|464695849|FG002|Induction|Other|0|||
129109165|NCT00103285|464695850|FG003|Induction|Other|0|||
129109166|NCT00103285|464695851|FG004|Induction|Other|0|||
129109167|NCT00103285|464695852|FG005|Induction|Other|0|||
129109168|NCT00103285|464695853|FG006|Induction|Other|0|||
129109169|NCT00103285|464695854|FG007|Induction|Other|0|||
129109170|NCT00103285|464695847|FG000|Response Assignment|Adverse Event|0|||
129109171|NCT00103285|464695848|FG001|Response Assignment|Adverse Event|8|||
129109172|NCT00103285|464695849|FG002|Response Assignment|Adverse Event|3|||
129109173|NCT00103285|464695850|FG003|Response Assignment|Adverse Event|2|||
129109174|NCT00103285|464695851|FG004|Response Assignment|Adverse Event|3|||
129109175|NCT00103285|464695852|FG005|Response Assignment|Adverse Event|1|||
129109176|NCT00103285|464695853|FG006|Response Assignment|Adverse Event|1|||
129109177|NCT00103285|464695854|FG007|Response Assignment|Adverse Event|2|||
129109178|NCT00103285|464695847|FG000|Response Assignment|Death|0|||
129109179|NCT00103285|464695848|FG001|Response Assignment|Death|5|||
129109180|NCT00103285|464695849|FG002|Response Assignment|Death|2|||
129109181|NCT00103285|464695850|FG003|Response Assignment|Death|2|||
129109182|NCT00103285|464695851|FG004|Response Assignment|Death|3|||
128685499|NCT01865084|463149414|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
129109183|NCT00103285|464695852|FG005|Response Assignment|Death|1|||
129109184|NCT00103285|464695853|FG006|Response Assignment|Death|0|||
129109185|NCT00103285|464695854|FG007|Response Assignment|Death|8|||
129109186|NCT00103285|464695847|FG000|Response Assignment|Lost to Follow-up|0|||
129109187|NCT00103285|464695848|FG001|Response Assignment|Lost to Follow-up|9|||
129109188|NCT00103285|464695849|FG002|Response Assignment|Lost to Follow-up|5|||
129109189|NCT00103285|464695850|FG003|Response Assignment|Lost to Follow-up|5|||
129109190|NCT00103285|464695851|FG004|Response Assignment|Lost to Follow-up|1|||
129109191|NCT00103285|464695852|FG005|Response Assignment|Lost to Follow-up|2|||
129109192|NCT00103285|464695853|FG006|Response Assignment|Lost to Follow-up|2|||
129109193|NCT00103285|464695854|FG007|Response Assignment|Lost to Follow-up|5|||
129109194|NCT00103285|464695847|FG000|Response Assignment|Physician Decision|0|||
129109195|NCT00103285|464695848|FG001|Response Assignment|Physician Decision|13|||
129109196|NCT00103285|464695849|FG002|Response Assignment|Physician Decision|14|||
129109197|NCT00103285|464695850|FG003|Response Assignment|Physician Decision|9|||
129109198|NCT00103285|464695851|FG004|Response Assignment|Physician Decision|13|||
129109199|NCT00103285|464695852|FG005|Response Assignment|Physician Decision|7|||
129109200|NCT00103285|464695853|FG006|Response Assignment|Physician Decision|4|||
129109201|NCT00103285|464695854|FG007|Response Assignment|Physician Decision|35|||
129109202|NCT00103285|464695847|FG000|Response Assignment|Protocol Violation|0|||
129109203|NCT00103285|464695848|FG001|Response Assignment|Protocol Violation|2|||
129109204|NCT00103285|464695849|FG002|Response Assignment|Protocol Violation|0|||
129109205|NCT00103285|464695850|FG003|Response Assignment|Protocol Violation|0|||
129109206|NCT00103285|464695851|FG004|Response Assignment|Protocol Violation|0|||
129109207|NCT00103285|464695852|FG005|Response Assignment|Protocol Violation|0|||
129109208|NCT00103285|464695853|FG006|Response Assignment|Protocol Violation|0|||
129109209|NCT00103285|464695854|FG007|Response Assignment|Protocol Violation|0|||
129109210|NCT00103285|464695847|FG000|Response Assignment|Withdrawal by Subject|0|||
129109211|NCT00103285|464695848|FG001|Response Assignment|Withdrawal by Subject|4|||
129109212|NCT00103285|464695849|FG002|Response Assignment|Withdrawal by Subject|1|||
129109213|NCT00103285|464695850|FG003|Response Assignment|Withdrawal by Subject|1|||
129109214|NCT00103285|464695851|FG004|Response Assignment|Withdrawal by Subject|2|||
129109215|NCT00103285|464695852|FG005|Response Assignment|Withdrawal by Subject|2|||
129109216|NCT00103285|464695853|FG006|Response Assignment|Withdrawal by Subject|0|||
129109217|NCT00103285|464695854|FG007|Response Assignment|Withdrawal by Subject|2|||
129109218|NCT00103285|464695847|FG000|Response Assignment|Ineligible|0|||
129109219|NCT00103285|464695848|FG001|Response Assignment|Ineligible|8|||
129109220|NCT00103285|464695849|FG002|Response Assignment|Ineligible|6|||
129109221|NCT00103285|464695850|FG003|Response Assignment|Ineligible|2|||
129109222|NCT00103285|464695851|FG004|Response Assignment|Ineligible|0|||
129109223|NCT00103285|464695852|FG005|Response Assignment|Ineligible|3|||
129109224|NCT00103285|464695853|FG006|Response Assignment|Ineligible|1|||
129109225|NCT00103285|464695854|FG007|Response Assignment|Ineligible|5|||
129109226|NCT00103285|464695847|FG000|Response Assignment|Refusal|0|||
129109227|NCT00103285|464695848|FG001|Response Assignment|Refusal|53|||
129109228|NCT00103285|464695849|FG002|Response Assignment|Refusal|5|||
129109229|NCT00103285|464695850|FG003|Response Assignment|Refusal|3|||
129109230|NCT00103285|464695851|FG004|Response Assignment|Refusal|25|||
129109231|NCT00103285|464695852|FG005|Response Assignment|Refusal|15|||
129109232|NCT00103285|464695853|FG006|Response Assignment|Refusal|30|||
129109233|NCT00103285|464695854|FG007|Response Assignment|Refusal|10|||
129109234|NCT00103285|464695847|FG000|Response Assignment|Other|0|||
129109235|NCT00103285|464695848|FG001|Response Assignment|Other|30|||
129109236|NCT00103285|464695849|FG002|Response Assignment|Other|48|||
129109237|NCT00103285|464695850|FG003|Response Assignment|Other|38|||
129109238|NCT00103285|464695851|FG004|Response Assignment|Other|37|||
129109239|NCT00103285|464695852|FG005|Response Assignment|Other|17|||
129109240|NCT00103285|464695853|FG006|Response Assignment|Other|11|||
129109241|NCT00103285|464695854|FG007|Response Assignment|Other|53|||
129109242|NCT00452439|464695856|FG000|Overall Study|Lost to Follow-up|1|||
129109243|NCT00452439|464695857|FG001|Overall Study|Lost to Follow-up|1|||
129109244|NCT00452439|464695856|FG000|Overall Study|Refused Treatment|4|||
129109245|NCT00452439|464695857|FG001|Overall Study|Refused Treatment|3|||
129109246|NCT00452439|464695856|FG000|Overall Study|Death|3|||
129109247|NCT00452439|464695857|FG001|Overall Study|Death|1|||
129109248|NCT00452439|464695856|FG000|Overall Study|Bone Marrow Transplant|0|||
129109249|NCT00452439|464695857|FG001|Overall Study|Bone Marrow Transplant|1|||
129109250|NCT00452439|464695856|FG000|Overall Study|Too Ill to Continue|0|||
129109251|NCT00452439|464695857|FG001|Overall Study|Too Ill to Continue|1|||
129109252|NCT00452439|464695856|FG000|Overall Study|Failed to achieve complete response|2|||
129109253|NCT00452439|464695857|FG001|Overall Study|Failed to achieve complete response|0|||
129109254|NCT00452439|464695856|FG000|Overall Study|Relapse|3|||
129109255|NCT00452439|464695857|FG001|Overall Study|Relapse|0|||
129109256|NCT00452439|464695856|FG000|Overall Study|Fracture|1|||
129109257|NCT00452439|464695857|FG001|Overall Study|Fracture|0|||
129109258|NCT03512353|464695859|FG000|Overall Study|Sponsor Decision|3|||
129109259|NCT03512353|464695859|FG000|Overall Study|Death|1|||
129109260|NCT01845597|464695860|FG000|Overall Study|Death|8|||
129109261|NCT01845597|464695860|FG000|Overall Study|Lost to Follow-up|22|||
129109262|NCT02581488|464695864|FG000|Overall Study|Adverse Event|6|||
129109263|NCT02581488|464695865|FG001|Overall Study|Adverse Event|7|||
129109264|NCT02581488|464695864|FG000|Overall Study|Lost to Follow-up|1|||
129109265|NCT02581488|464695865|FG001|Overall Study|Lost to Follow-up|0|||
129109266|NCT02581488|464695864|FG000|Overall Study|Withdrawal by Subject|1|||
129109267|NCT02581488|464695865|FG001|Overall Study|Withdrawal by Subject|0|||
129109268|NCT02581488|464695864|FG000|Overall Study|Non-Compliance|1|||
129109269|NCT02581488|464695865|FG001|Overall Study|Non-Compliance|0|||
129109270|NCT02581488|464695864|FG000|Overall Study|Protocol Violation|0|||
129109271|NCT02581488|464695865|FG001|Overall Study|Protocol Violation|4|||
129109272|NCT01877668|464695866|FG000|Overall Study|Death|0|||
129109273|NCT01877668|464695867|FG001|Overall Study|Death|0|||
129109274|NCT01877668|464695868|FG002|Overall Study|Death|0|||
129109275|NCT01877668|464695869|FG003|Overall Study|Death|1|||
129109276|NCT01877668|464695870|FG004|Overall Study|Death|0|||
129109277|NCT01877668|464695866|FG000|Overall Study|No longer met study criteria|1|||
129109278|NCT01877668|464695867|FG001|Overall Study|No longer met study criteria|0|||
129109279|NCT01877668|464695868|FG002|Overall Study|No longer met study criteria|1|||
129109280|NCT01877668|464695869|FG003|Overall Study|No longer met study criteria|0|||
128685500|NCT01865084|463149415|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
128685501|NCT01865084|463149413|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
128685502|NCT01865084|463149414|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
128685503|NCT01865084|463149415|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
128685504|NCT01865084|463149413|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
128685505|NCT01865084|463149414|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
128685506|NCT01865084|463149415|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
128685507|NCT02428608|463149425|FG000|Overall Study|Pregnancy|2|||
128685508|NCT02428608|463149425|FG000|Overall Study|Lost to Follow-up|37|||
128685509|NCT02428608|463149425|FG000|Overall Study|Withdrawal by Subject|2|||
128685510|NCT02428608|463149425|FG000|Overall Study|scheduling conflicts|15|||
128685511|NCT02428608|463149425|FG000|Overall Study|moved away|10|||
128685512|NCT02428608|463149425|FG000|Overall Study|Death|1|||
128685513|NCT02428608|463149425|FG000|Overall Study|various|16|||
128685514|NCT03468985|463149426|FG000|Overall Study|Adverse Event|0|||
128685515|NCT03468985|463149427|FG001|Overall Study|Adverse Event|2|||
128685516|NCT03468985|463149428|FG002|Overall Study|Adverse Event|0|||
128685517|NCT03468985|463149429|FG003|Overall Study|Adverse Event|0|||
128685518|NCT03468985|463149426|FG000|Overall Study|Withdrawal by Subject|0|||
128685519|NCT03468985|463149427|FG001|Overall Study|Withdrawal by Subject|0|||
128685520|NCT03468985|463149428|FG002|Overall Study|Withdrawal by Subject|0|||
128685521|NCT03468985|463149429|FG003|Overall Study|Withdrawal by Subject|1|||
128685522|NCT03416374|463149430|FG000|Between Treatment Period I and II|Other|0|||
128685523|NCT03416374|463149431|FG001|Between Treatment Period I and II|Other|9|||
128685524|NCT03416374|463149430|FG000|Treatment Period II|Lack of Efficacy|3|||
128685525|NCT03416374|463149431|FG001|Treatment Period II|Lack of Efficacy|11|||
128685526|NCT03416374|463149430|FG000|Treatment Period II|Adverse Event|1|||
128685527|NCT03416374|463149431|FG001|Treatment Period II|Adverse Event|4|||
128685528|NCT03416374|463149430|FG000|Treatment Period II|Death|0|||
128685529|NCT03416374|463149431|FG001|Treatment Period II|Death|1|||
128685530|NCT03416374|463149430|FG000|Treatment Period II|Other|0|||
128685531|NCT03416374|463149431|FG001|Treatment Period II|Other|2|||
128685532|NCT01933217|463149432|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
128685533|NCT01933217|463149433|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
128685534|NCT01933217|463149432|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
128685535|NCT01933217|463149433|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
128685536|NCT03583164|463149436|FG000|Overall Study|Death in Main Phase|35|||
128685537|NCT03583164|463149436|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
128685538|NCT03583164|463149436|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
128685539|NCT03583164|463149436|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
128685540|NCT03583164|463149436|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
128685541|NCT03583164|463149436|FG000|Overall Study|Physician decision in Main Phase|1|||
128685542|NCT03583164|463149436|FG000|Overall Study|Physician decision in Extended Phase|2|||
129109281|NCT01877668|464695870|FG004|Overall Study|No longer met study criteria|0|||
129109282|NCT01877668|464695866|FG000|Overall Study|Insufficient clinical response|0|||
129109283|NCT01877668|464695867|FG001|Overall Study|Insufficient clinical response|1|||
129109284|NCT01877668|464695868|FG002|Overall Study|Insufficient clinical response|2|||
129109285|NCT01877668|464695869|FG003|Overall Study|Insufficient clinical response|2|||
129109286|NCT01877668|464695870|FG004|Overall Study|Insufficient clinical response|0|||
129109287|NCT01877668|464695866|FG000|Overall Study|Lost to Follow-up|0|||
129109288|NCT01877668|464695867|FG001|Overall Study|Lost to Follow-up|2|||
129109289|NCT01877668|464695868|FG002|Overall Study|Lost to Follow-up|1|||
129109290|NCT01877668|464695869|FG003|Overall Study|Lost to Follow-up|0|||
129109291|NCT01877668|464695870|FG004|Overall Study|Lost to Follow-up|0|||
129109292|NCT01877668|464695866|FG000|Overall Study|Withdrawal by Subject|2|||
129109293|NCT01877668|464695867|FG001|Overall Study|Withdrawal by Subject|0|||
129109294|NCT01877668|464695868|FG002|Overall Study|Withdrawal by Subject|3|||
129109295|NCT01877668|464695869|FG003|Overall Study|Withdrawal by Subject|2|||
129109296|NCT01877668|464695870|FG004|Overall Study|Withdrawal by Subject|2|||
129109297|NCT01877668|464695866|FG000|Overall Study|Other|1|||
129109298|NCT01877668|464695867|FG001|Overall Study|Other|1|||
129109299|NCT01877668|464695868|FG002|Overall Study|Other|1|||
129109300|NCT01877668|464695869|FG003|Overall Study|Other|1|||
129109301|NCT01877668|464695870|FG004|Overall Study|Other|3|||
129109302|NCT01877668|464695866|FG000|Overall Study|Protocol Violation|1|||
129109303|NCT01877668|464695867|FG001|Overall Study|Protocol Violation|1|||
129109304|NCT01877668|464695868|FG002|Overall Study|Protocol Violation|0|||
129109305|NCT01877668|464695869|FG003|Overall Study|Protocol Violation|0|||
129109306|NCT01877668|464695870|FG004|Overall Study|Protocol Violation|3|||
129109307|NCT01877668|464695866|FG000|Overall Study|Adverse event related to study drug|2|||
129109308|NCT01877668|464695867|FG001|Overall Study|Adverse event related to study drug|2|||
128685543|NCT03583164|463149436|FG000|Overall Study|Death in Extended Phase|13|||
129109309|NCT01877668|464695868|FG002|Overall Study|Adverse event related to study drug|2|||
128685544|NCT03583164|463149436|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
129109310|NCT01877668|464695869|FG003|Overall Study|Adverse event related to study drug|2|||
128685545|NCT03583164|463149436|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
128685546|NCT03583164|463149436|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
128685547|NCT03583164|463149436|FG000|Overall Study|Treatment failure in Main Phase|2|||
128685548|NCT03583164|463149436|FG000|Overall Study|Treatment failure in Extended Phase|4|||
128685549|NCT03583164|463149436|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
128685550|NCT03583164|463149436|FG000|Overall Study|Other not specified reason in Main Phase|2|||
128685551|NCT00559754|463149437|FG000|Overall Study|Disease progression|1|||
128685552|NCT00559754|463149437|FG000|Overall Study|Adverse Event|5|||
128685553|NCT00559754|463149437|FG000|Overall Study|Protocol Violation|1|||
128685554|NCT00559754|463149437|FG000|Overall Study|Investigator criteria|2|||
128685555|NCT00559754|463149437|FG000|Overall Study|Withdrawal by Subject|2|||
128685556|NCT00147251|463149438|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
128685557|NCT00147251|463149439|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
128685558|NCT01629706|463149440|FG000|Phase 1 PureVision|Screen Failure|4|||
128685559|NCT01629706|463149440|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
128685560|NCT01629706|463149440|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
128685561|NCT01629706|463149440|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
128685562|NCT01629706|463149440|FG000|Phase 2 Habitual|Screen Failure|6|||
128685563|NCT01629706|463149440|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
128685564|NCT01629706|463149440|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
128685565|NCT01629706|463149440|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
128685566|NCT01629706|463149440|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
128685567|NCT01151098|463149441|FG000|Overall Study|Adverse Event|82|||
128685568|NCT01151098|463149441|FG000|Overall Study|Lost to Follow-up|6|||
128685569|NCT01151098|463149441|FG000|Overall Study|Lack of Efficacy|15|||
128685570|NCT01151098|463149441|FG000|Overall Study|Protocol Violation|1|||
128685571|NCT01151098|463149441|FG000|Overall Study|Miscellaneous|13|||
128685572|NCT03343067|463149448|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
128685573|NCT03343067|463149449|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
128685574|NCT03343067|463149450|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
128685575|NCT00116168|463149451|FG000|Overall Study|Lost to Follow-up|6|||
128685576|NCT00116168|463149452|FG001|Overall Study|Lost to Follow-up|5|||
128685577|NCT00116168|463149453|FG002|Overall Study|Lost to Follow-up|0|||
128685578|NCT00116168|463149454|FG003|Overall Study|Lost to Follow-up|0|||
128685579|NCT02788474|463149455|FG000|Double Blind Treatment Period|Not treated|1|||
128685580|NCT02788474|463149456|FG001|Double Blind Treatment Period|Not treated|0|||
128685581|NCT02788474|463149455|FG000|Double Blind Treatment Period|Patient's refusal|3|||
128685582|NCT02788474|463149456|FG001|Double Blind Treatment Period|Patient's refusal|0|||
128685583|NCT02788474|463149455|FG000|Double Blind Treatment Period|Adverse Event|6|||
128685584|NCT02788474|463149456|FG001|Double Blind Treatment Period|Adverse Event|4|||
128685585|NCT02788474|463149455|FG000|Open Label Treatment Period|Adverse Event|29|||
128685586|NCT02788474|463149456|FG001|Open Label Treatment Period|Adverse Event|9|||
128685587|NCT02788474|463149455|FG000|Open Label Treatment Period|Other than reason specified|1|||
128685588|NCT02788474|463149456|FG001|Open Label Treatment Period|Other than reason specified|0|||
128886998|NCT00821431|463880599|FG000|Overall Study|Protocol Violation|3|||
128886999|NCT00821431|463880600|FG001|Overall Study|Protocol Violation|1|||
128763305|NCT02034708|463422816|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
128763306|NCT02034708|463422815|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
128763307|NCT02034708|463422816|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
128763308|NCT01552954|463422817|FG000|Overall Study|Adverse Event|1|||
128763309|NCT01552954|463422818|FG001|Overall Study|Adverse Event|2|||
128763310|NCT01552954|463422817|FG000|Overall Study|Lost to Follow-up|1|||
128763311|NCT01552954|463422818|FG001|Overall Study|Lost to Follow-up|1|||
128763312|NCT01552954|463422817|FG000|Overall Study|Withdrawal by Subject|1|||
128763313|NCT01552954|463422818|FG001|Overall Study|Withdrawal by Subject|1|||
128763314|NCT01552954|463422817|FG000|Overall Study|Protocol Violation|1|||
128763315|NCT01552954|463422818|FG001|Overall Study|Protocol Violation|2|||
128763316|NCT01552954|463422817|FG000|Overall Study|diagnosed DM|1|||
128763317|NCT01552954|463422818|FG001|Overall Study|diagnosed DM|0|||
128763318|NCT04843930|463422819|FG000|Randomization|Withdrawal by Subject|6|||
128763319|NCT04843930|463422820|FG001|Randomization|Withdrawal by Subject|6|||
128763320|NCT04843930|463422821|FG002|Randomization|Withdrawal by Subject|0|||
128763321|NCT04843930|463422822|FG003|Randomization|Withdrawal by Subject|0|||
128763322|NCT04843930|463422819|FG000|Week 6 Assessment|Adverse Event|3|||
128763323|NCT04843930|463422820|FG001|Week 6 Assessment|Adverse Event|0|||
128685589|NCT02788474|463149455|FG000|Open Label Treatment Period|Patient's refusal|1|||
128685590|NCT02788474|463149456|FG001|Open Label Treatment Period|Patient's refusal|3|||
128763324|NCT04843930|463422821|FG002|Week 6 Assessment|Adverse Event|0|||
128763325|NCT04843930|463422822|FG003|Week 6 Assessment|Adverse Event|0|||
128763326|NCT04843930|463422819|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
128763327|NCT04843930|463422820|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
128763328|NCT04843930|463422821|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
128763329|NCT04843930|463422822|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
128685591|NCT02788474|463149455|FG000|Open Label Treatment Period|Non-compliance|1|||
128685592|NCT02788474|463149456|FG001|Open Label Treatment Period|Non-compliance|0|||
128685593|NCT00117286|463149457|FG000|Overall Study|Adverse Event|12|||
128685594|NCT00117286|463149458|FG001|Overall Study|Adverse Event|6|||
128685595|NCT00117286|463149457|FG000|Overall Study|Lost to Follow-up|2|||
128685596|NCT00117286|463149458|FG001|Overall Study|Lost to Follow-up|0|||
128685597|NCT00117286|463149457|FG000|Overall Study|Protocol Violation|3|||
128685598|NCT00117286|463149458|FG001|Overall Study|Protocol Violation|3|||
128685599|NCT00117286|463149457|FG000|Overall Study|Withdrawal by Subject|6|||
128685600|NCT00117286|463149458|FG001|Overall Study|Withdrawal by Subject|2|||
128685601|NCT00117286|463149457|FG000|Overall Study|Physician Decision|3|||
128685602|NCT00117286|463149458|FG001|Overall Study|Physician Decision|7|||
128685603|NCT00117286|463149457|FG000|Overall Study|Lack of Efficacy|2|||
128685604|NCT00117286|463149458|FG001|Overall Study|Lack of Efficacy|1|||
128685605|NCT00117286|463149457|FG000|Overall Study|Research site closing|0|||
128685606|NCT00117286|463149458|FG001|Overall Study|Research site closing|2|||
128685607|NCT00048061|463149460|FG000|Overall Study|Adverse Event|41|||
128685608|NCT00048061|463149461|FG001|Overall Study|Adverse Event|32|||
128685609|NCT00048061|463149462|FG002|Overall Study|Adverse Event|44|||
128685610|NCT00048061|463149463|FG003|Overall Study|Adverse Event|37|||
128685611|NCT00048061|463149460|FG000|Overall Study|Lost to Follow-up|3|||
128685612|NCT00048061|463149461|FG001|Overall Study|Lost to Follow-up|2|||
128685613|NCT00048061|463149462|FG002|Overall Study|Lost to Follow-up|4|||
128685614|NCT00048061|463149463|FG003|Overall Study|Lost to Follow-up|5|||
128685615|NCT00048061|463149460|FG000|Overall Study|Withdrawal by Subject|20|||
128685616|NCT00048061|463149461|FG001|Overall Study|Withdrawal by Subject|29|||
128685617|NCT00048061|463149462|FG002|Overall Study|Withdrawal by Subject|29|||
128685618|NCT00048061|463149463|FG003|Overall Study|Withdrawal by Subject|32|||
128685619|NCT00048061|463149460|FG000|Overall Study|Did not follow-up|5|||
128685620|NCT00048061|463149461|FG001|Overall Study|Did not follow-up|5|||
128685621|NCT00048061|463149462|FG002|Overall Study|Did not follow-up|4|||
128685622|NCT00048061|463149463|FG003|Overall Study|Did not follow-up|5|||
128685623|NCT00048061|463149460|FG000|Overall Study|Early improvement|6|||
128685624|NCT00048061|463149461|FG001|Overall Study|Early improvement|5|||
128685625|NCT00048061|463149462|FG002|Overall Study|Early improvement|3|||
128685626|NCT00048061|463149463|FG003|Overall Study|Early improvement|0|||
128685627|NCT01323946|463149464|FG000|Overall Study|Lost to Follow-up|0|||
128685628|NCT01323946|463149465|FG001|Overall Study|Lost to Follow-up|1|||
128685629|NCT01323946|463149466|FG002|Overall Study|Lost to Follow-up|0|||
128685630|NCT01323946|463149464|FG000|Overall Study|Parents refused the last blood draw|1|||
128685631|NCT01323946|463149465|FG001|Overall Study|Parents refused the last blood draw|0|||
128685632|NCT01323946|463149466|FG002|Overall Study|Parents refused the last blood draw|0|||
128685633|NCT01323946|463149464|FG000|Overall Study|Withdrawal by Subject|2|||
128685634|NCT01323946|463149465|FG001|Overall Study|Withdrawal by Subject|2|||
128685635|NCT01323946|463149466|FG002|Overall Study|Withdrawal by Subject|0|||
128685636|NCT01272661|463149469|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
128685637|NCT01272661|463149470|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
128685638|NCT01272661|463149471|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
128685639|NCT01243671|463149472|FG000|Overall Study|Adverse Event|3|||
128685640|NCT01243671|463149472|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
128685641|NCT01243671|463149472|FG000|Overall Study|Other|1|||
128685642|NCT00573248|463149473|FG000|Overall Study|scheduling conflicts|15|||
128685643|NCT00573248|463149474|FG001|Overall Study|scheduling conflicts|11|||
128685644|NCT05342532|463149477|FG000|Overall Study|Adverse Event|5|||
128685645|NCT05342532|463149478|FG001|Overall Study|Adverse Event|20|||
128685646|NCT05342532|463149477|FG000|Overall Study|Lost to Follow-up|10|||
128685647|NCT05342532|463149478|FG001|Overall Study|Lost to Follow-up|15|||
128685648|NCT02057393|463149479|FG000|Overall Study|Withdrawal by Subject|1|||
128685649|NCT02057393|463149479|FG000|Overall Study|Patient did not meet criteria|1|||
128685650|NCT02017171|463149480|FG000|Overall Study|Death|10|||
128685651|NCT02017171|463149481|FG001|Overall Study|Death|4|||
128685652|NCT02017171|463149480|FG000|Overall Study|Withdrawal by Subject|23|||
128685653|NCT02017171|463149481|FG001|Overall Study|Withdrawal by Subject|17|||
128685654|NCT02017171|463149480|FG000|Overall Study|Lost to Follow-up|21|||
128763330|NCT04843930|463422819|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
128763331|NCT04843930|463422820|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
128763332|NCT04843930|463422821|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
128763333|NCT04843930|463422822|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
128763334|NCT02719990|463422823|FG000|Overall Study|Physician Decision|2|||
128763335|NCT02719990|463422823|FG000|Overall Study|Withdrawal by Subject|2|||
128763336|NCT02719990|463422823|FG000|Overall Study|Study Terminated By Sponsor|32|||
128685655|NCT02017171|463149481|FG001|Overall Study|Lost to Follow-up|20|||
128685656|NCT02017171|463149480|FG000|Overall Study|ESKD|6|||
128685657|NCT02017171|463149481|FG001|Overall Study|ESKD|2|||
128685658|NCT02017171|463149480|FG000|Overall Study|Miscellaneous|2|||
128763337|NCT01547299|463422827|FG000|Overall Study|Withdrawal by Subject|2|||
128763338|NCT01547299|463422828|FG001|Overall Study|Withdrawal by Subject|2|||
128685659|NCT02017171|463149481|FG001|Overall Study|Miscellaneous|3|||
128685660|NCT03091777|463149482|FG000|Overall Study|Pregnancy|2|||
128685661|NCT03091777|463149483|FG001|Overall Study|Pregnancy|1|||
128685662|NCT03091777|463149484|FG002|Overall Study|Pregnancy|0|||
128685663|NCT03091777|463149482|FG000|Overall Study|Adverse Event|2|||
128685664|NCT03091777|463149483|FG001|Overall Study|Adverse Event|1|||
128685665|NCT03091777|463149484|FG002|Overall Study|Adverse Event|4|||
128685666|NCT03091777|463149482|FG000|Overall Study|Withdrawal by Subject|4|||
128685667|NCT03091777|463149483|FG001|Overall Study|Withdrawal by Subject|2|||
128685668|NCT03091777|463149484|FG002|Overall Study|Withdrawal by Subject|6|||
128685669|NCT03091777|463149482|FG000|Overall Study|Protocol Violation|2|||
128685670|NCT03091777|463149483|FG001|Overall Study|Protocol Violation|1|||
128685671|NCT03091777|463149484|FG002|Overall Study|Protocol Violation|1|||
128685672|NCT03091777|463149482|FG000|Overall Study|Lost to Follow-up|12|||
128685673|NCT03091777|463149483|FG001|Overall Study|Lost to Follow-up|14|||
128685674|NCT03091777|463149484|FG002|Overall Study|Lost to Follow-up|7|||
128685675|NCT03091777|463149482|FG000|Overall Study|Lack of Efficacy|0|||
128685676|NCT03091777|463149483|FG001|Overall Study|Lack of Efficacy|0|||
128685677|NCT03091777|463149484|FG002|Overall Study|Lack of Efficacy|5|||
128685678|NCT03091777|463149482|FG000|Overall Study|Noncompliance with study drug|2|||
128685679|NCT03091777|463149483|FG001|Overall Study|Noncompliance with study drug|3|||
128685680|NCT03091777|463149484|FG002|Overall Study|Noncompliance with study drug|1|||
128685681|NCT03091777|463149482|FG000|Overall Study|Physician Decision|1|||
128685682|NCT03091777|463149483|FG001|Overall Study|Physician Decision|0|||
128685683|NCT03091777|463149484|FG002|Overall Study|Physician Decision|1|||
128685684|NCT03091777|463149482|FG000|Overall Study|Abnormal Laboratory Value|7|||
128685685|NCT03091777|463149483|FG001|Overall Study|Abnormal Laboratory Value|11|||
128685686|NCT03091777|463149484|FG002|Overall Study|Abnormal Laboratory Value|12|||
128685687|NCT03370289|463149485|FG000|Overall Study|Screen Failure|1|||
128685688|NCT03370289|463149485|FG000|Overall Study|Sample Size Sufficient|4|||
128685689|NCT02220998|463149487|FG000|Overall Study|Randomized but Never Treated|1|||
128685690|NCT02220998|463149488|FG001|Overall Study|Randomized but Never Treated|2|||
128685691|NCT02220998|463149487|FG000|Overall Study|Death|2|||
128685692|NCT02220998|463149488|FG001|Overall Study|Death|0|||
128685693|NCT02220998|463149487|FG000|Overall Study|Lack of Efficacy|0|||
128685694|NCT02220998|463149488|FG001|Overall Study|Lack of Efficacy|5|||
128685695|NCT02220998|463149487|FG000|Overall Study|Lost to Follow-up|4|||
128685696|NCT02220998|463149488|FG001|Overall Study|Lost to Follow-up|4|||
128685697|NCT02314143|463149489|FG000|Overall Study|Adverse Event|0|||
128685698|NCT02314143|463149490|FG001|Overall Study|Adverse Event|6|||
128685699|NCT02314143|463149491|FG002|Overall Study|Adverse Event|4|||
128685700|NCT02314143|463149489|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
128685701|NCT02314143|463149490|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
128685702|NCT02314143|463149491|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
128685703|NCT02314143|463149489|FG000|Overall Study|Physician Decision|2|||
128685704|NCT02314143|463149490|FG001|Overall Study|Physician Decision|1|||
128685705|NCT02314143|463149491|FG002|Overall Study|Physician Decision|0|||
128685706|NCT02314143|463149489|FG000|Overall Study|Withdrawal by Subject|1|||
128685707|NCT02314143|463149490|FG001|Overall Study|Withdrawal by Subject|0|||
128685708|NCT02314143|463149491|FG002|Overall Study|Withdrawal by Subject|1|||
128685709|NCT00873860|463149492|FG000|Overall Study|Lost to Follow-up|1|||
128685710|NCT00873860|463149493|FG001|Overall Study|Lost to Follow-up|0|||
128685711|NCT00873860|463149494|FG002|Overall Study|Lost to Follow-up|0|||
128685712|NCT00873860|463149495|FG003|Overall Study|Lost to Follow-up|1|||
128685713|NCT00873860|463149492|FG000|Overall Study|Withdrawal by Subject|1|||
128685714|NCT00873860|463149493|FG001|Overall Study|Withdrawal by Subject|0|||
128685715|NCT00873860|463149494|FG002|Overall Study|Withdrawal by Subject|2|||
128685716|NCT00873860|463149495|FG003|Overall Study|Withdrawal by Subject|0|||
128685717|NCT00873860|463149492|FG000|Overall Study|Death|1|||
128685718|NCT00873860|463149493|FG001|Overall Study|Death|0|||
128685719|NCT00873860|463149494|FG002|Overall Study|Death|0|||
128685720|NCT00873860|463149495|FG003|Overall Study|Death|0|||
128685721|NCT00873860|463149492|FG000|Overall Study|Other|1|||
128685722|NCT00873860|463149493|FG001|Overall Study|Other|0|||
128685723|NCT00873860|463149494|FG002|Overall Study|Other|1|||
128887000|NCT00821431|463880599|FG000|Overall Study|Physician Decision|0|||
128887001|NCT00821431|463880600|FG001|Overall Study|Physician Decision|1|||
128685724|NCT00873860|463149495|FG003|Overall Study|Other|0|||
128685725|NCT02140775|463149501|FG000|Overall Study|Withdrawal by Subject|30|||
128685726|NCT02140775|463149502|FG001|Overall Study|Withdrawal by Subject|7|||
128685727|NCT01172275|463149505|FG000|Overall Study|Lost to Follow-up|1|||
128685728|NCT01172275|463149506|FG001|Overall Study|Lost to Follow-up|0|||
128685729|NCT01172275|463149505|FG000|Overall Study|Protocol Violation|1|||
128685730|NCT01172275|463149506|FG001|Overall Study|Protocol Violation|0|||
128685731|NCT04650854|463149511|FG000|Overall Study|Adverse Event|1|||
128685732|NCT04650854|463149512|FG001|Overall Study|Adverse Event|12|||
128685733|NCT04650854|463149513|FG002|Overall Study|Adverse Event|14|||
128685734|NCT04650854|463149511|FG000|Overall Study|Lack of Efficacy|1|||
128887002|NCT00986440|463880606|FG000|Overall Study|Progressive disease|27|||
128685735|NCT04650854|463149512|FG001|Overall Study|Lack of Efficacy|3|||
128685736|NCT04650854|463149513|FG002|Overall Study|Lack of Efficacy|6|||
128685737|NCT04650854|463149511|FG000|Overall Study|Lost to Follow-up|1|||
128685738|NCT04650854|463149512|FG001|Overall Study|Lost to Follow-up|1|||
128685739|NCT04650854|463149513|FG002|Overall Study|Lost to Follow-up|0|||
128685740|NCT04650854|463149511|FG000|Overall Study|Withdrawal by Subject|2|||
129109311|NCT01877668|464695870|FG004|Overall Study|Adverse event related to study drug|1|||
129109312|NCT01877668|464695866|FG000|Overall Study|Adverse event unrelated to study drug|4|||
129109313|NCT01877668|464695867|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129109314|NCT01877668|464695868|FG002|Overall Study|Adverse event unrelated to study drug|2|||
129109315|NCT01877668|464695869|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129109316|NCT01877668|464695870|FG004|Overall Study|Adverse event unrelated to study drug|1|||
128685741|NCT04650854|463149512|FG001|Overall Study|Withdrawal by Subject|17|||
128685742|NCT04650854|463149513|FG002|Overall Study|Withdrawal by Subject|9|||
128685743|NCT04650854|463149511|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
128685744|NCT04650854|463149512|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
128685745|NCT04650854|463149513|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
128685746|NCT04650854|463149511|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
128685747|NCT04650854|463149512|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
128685748|NCT04650854|463149513|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
128685749|NCT04650854|463149511|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
128685750|NCT04650854|463149512|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
128685751|NCT04650854|463149513|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
128685752|NCT04650854|463149511|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
128685753|NCT04650854|463149512|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
128685754|NCT04650854|463149513|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
128685755|NCT04650854|463149511|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
128685756|NCT04650854|463149512|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
128685757|NCT04650854|463149513|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
128685758|NCT04650854|463149511|FG000|Overall Study|Use of Rescue Medication|0|||
128685759|NCT04650854|463149512|FG001|Overall Study|Use of Rescue Medication|0|||
128685760|NCT04650854|463149513|FG002|Overall Study|Use of Rescue Medication|1|||
128685761|NCT04650854|463149511|FG000|Overall Study|Last Treatment Per Sponsor|0|||
128685762|NCT04650854|463149512|FG001|Overall Study|Last Treatment Per Sponsor|0|||
128685763|NCT04650854|463149513|FG002|Overall Study|Last Treatment Per Sponsor|2|||
128685764|NCT04650854|463149511|FG000|Overall Study|Rescue Medication|0|||
129109317|NCT03286218|464695902|FG000|Qualification Phase Period 1|Adverse Event|1|||
129109318|NCT03286218|464695903|FG001|Qualification Phase Period 1|Adverse Event|0|||
129109319|NCT03286218|464695904|FG002|Qualification Phase Period 1|Adverse Event|0|||
129109320|NCT03286218|464695905|FG003|Qualification Phase Period 1|Adverse Event|0|||
129109321|NCT03286218|464695906|FG004|Qualification Phase Period 1|Adverse Event|0|||
129109322|NCT03286218|464695907|FG005|Qualification Phase Period 1|Adverse Event|0|||
129109323|NCT03286218|464695908|FG006|Qualification Phase Period 1|Adverse Event|0|||
129109324|NCT03286218|464695909|FG007|Qualification Phase Period 1|Adverse Event|0|||
129109325|NCT03286218|464695910|FG008|Qualification Phase Period 1|Adverse Event|0|||
129109326|NCT03286218|464695911|FG009|Qualification Phase Period 1|Adverse Event|0|||
129109327|NCT03286218|464695912|FG010|Qualification Phase Period 1|Adverse Event|0|||
129109328|NCT03286218|464695913|FG011|Qualification Phase Period 1|Adverse Event|0|||
129109329|NCT03286218|464695902|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109330|NCT03286218|464695903|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
129109331|NCT03286218|464695904|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109332|NCT03286218|464695905|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109333|NCT03286218|464695906|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109334|NCT03286218|464695907|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109335|NCT03286218|464695908|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109336|NCT03286218|464695909|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109337|NCT03286218|464695910|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
128685765|NCT04650854|463149512|FG001|Overall Study|Rescue Medication|0|||
128685766|NCT04650854|463149513|FG002|Overall Study|Rescue Medication|1|||
128685767|NCT04650854|463149511|FG000|Overall Study|Participant Want to Start a Family|0|||
128685768|NCT04650854|463149512|FG001|Overall Study|Participant Want to Start a Family|0|||
128685769|NCT04650854|463149513|FG002|Overall Study|Participant Want to Start a Family|1|||
129109338|NCT03286218|464695911|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109339|NCT03286218|464695912|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109340|NCT03286218|464695913|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
129109341|NCT03286218|464695902|FG000|Qualification Phase Period 2|Adverse Event|0|||
129109342|NCT03286218|464695903|FG001|Qualification Phase Period 2|Adverse Event|1|||
128685770|NCT04650854|463149511|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
128685771|NCT04650854|463149512|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
128887003|NCT00986440|463880607|FG001|Overall Study|Progressive disease|37|||
129109343|NCT03286218|464695904|FG002|Qualification Phase Period 2|Adverse Event|0|||
129109344|NCT03286218|464695905|FG003|Qualification Phase Period 2|Adverse Event|0|||
129109345|NCT03286218|464695906|FG004|Qualification Phase Period 2|Adverse Event|0|||
129109346|NCT03286218|464695907|FG005|Qualification Phase Period 2|Adverse Event|0|||
129109347|NCT03286218|464695908|FG006|Qualification Phase Period 2|Adverse Event|0|||
129109348|NCT03286218|464695909|FG007|Qualification Phase Period 2|Adverse Event|0|||
129109349|NCT03286218|464695910|FG008|Qualification Phase Period 2|Adverse Event|0|||
129109350|NCT03286218|464695911|FG009|Qualification Phase Period 2|Adverse Event|0|||
129109351|NCT03286218|464695912|FG010|Qualification Phase Period 2|Adverse Event|0|||
129109352|NCT03286218|464695913|FG011|Qualification Phase Period 2|Adverse Event|0|||
129109353|NCT03286218|464695902|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
129109354|NCT03286218|464695903|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
129109355|NCT03286218|464695904|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109356|NCT03286218|464695905|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109357|NCT03286218|464695906|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109358|NCT03286218|464695907|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109359|NCT03286218|464695908|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109360|NCT03286218|464695909|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109361|NCT03286218|464695910|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109362|NCT03286218|464695911|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109363|NCT03286218|464695912|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109364|NCT03286218|464695913|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129109365|NCT03286218|464695902|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
129109366|NCT03286218|464695903|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
129109367|NCT03286218|464695904|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
129109368|NCT03286218|464695905|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
129109369|NCT03286218|464695906|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
129109370|NCT03286218|464695907|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
129109371|NCT03286218|464695908|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
129109372|NCT03286218|464695909|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
129109373|NCT03286218|464695910|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
129109374|NCT03286218|464695911|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
129109375|NCT03286218|464695912|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
129109376|NCT03286218|464695913|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
129109377|NCT03286218|464695902|FG000|Qualification Phase Period 2|Protocol Violation|2|||
129109378|NCT03286218|464695903|FG001|Qualification Phase Period 2|Protocol Violation|0|||
129109379|NCT03286218|464695904|FG002|Qualification Phase Period 2|Protocol Violation|0|||
129109380|NCT03286218|464695905|FG003|Qualification Phase Period 2|Protocol Violation|0|||
128685772|NCT04650854|463149513|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
128685773|NCT04650854|463149511|FG000|Overall Study|Participant Screened For MG0020|0|||
128685774|NCT04650854|463149512|FG001|Overall Study|Participant Screened For MG0020|2|||
128685775|NCT04650854|463149513|FG002|Overall Study|Participant Screened For MG0020|3|||
128685776|NCT04650854|463149511|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
128685777|NCT04650854|463149512|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
128887004|NCT00986440|463880606|FG000|Overall Study|Serious adverse event or adverse event|9|||
128887005|NCT00986440|463880607|FG001|Overall Study|Serious adverse event or adverse event|2|||
129109381|NCT03286218|464695906|FG004|Qualification Phase Period 2|Protocol Violation|0|||
129109382|NCT03286218|464695907|FG005|Qualification Phase Period 2|Protocol Violation|0|||
129109383|NCT03286218|464695908|FG006|Qualification Phase Period 2|Protocol Violation|0|||
129109384|NCT03286218|464695909|FG007|Qualification Phase Period 2|Protocol Violation|0|||
129109385|NCT03286218|464695910|FG008|Qualification Phase Period 2|Protocol Violation|0|||
129109386|NCT03286218|464695911|FG009|Qualification Phase Period 2|Protocol Violation|0|||
129109387|NCT03286218|464695912|FG010|Qualification Phase Period 2|Protocol Violation|0|||
129109388|NCT03286218|464695913|FG011|Qualification Phase Period 2|Protocol Violation|0|||
129109389|NCT03286218|464695902|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
129109390|NCT03286218|464695903|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
129109391|NCT03286218|464695904|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
128685778|NCT04650854|463149513|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
128685779|NCT04650854|463149511|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
128685780|NCT04650854|463149512|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
128887006|NCT00986440|463880606|FG000|Overall Study|Withdrawal by Subject|1|||
129109392|NCT03286218|464695905|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109393|NCT03286218|464695906|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109394|NCT03286218|464695907|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
128887007|NCT00986440|463880607|FG001|Overall Study|Withdrawal by Subject|2|||
128685781|NCT04650854|463149513|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
128685782|NCT04650854|463149511|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
128685783|NCT04650854|463149512|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
128685784|NCT04650854|463149513|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
128685785|NCT04650854|463149511|FG000|Overall Study|End Of Study|0|||
128685786|NCT04650854|463149512|FG001|Overall Study|End Of Study|2|||
128685787|NCT04650854|463149513|FG002|Overall Study|End Of Study|1|||
128685788|NCT04650854|463149511|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
128685789|NCT04650854|463149512|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
128685790|NCT04650854|463149513|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
128685791|NCT04650854|463149511|FG000|Overall Study|Participant Received Rescue Medication|0|||
128685792|NCT04650854|463149512|FG001|Overall Study|Participant Received Rescue Medication|1|||
128685793|NCT04650854|463149513|FG002|Overall Study|Participant Received Rescue Medication|0|||
128685794|NCT04650854|463149511|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
128887008|NCT00986440|463880606|FG000|Overall Study|Screen failure (not dosed)|4|||
128887009|NCT00986440|463880607|FG001|Overall Study|Screen failure (not dosed)|2|||
128887010|NCT04526197|463880608|FG000|Period 1|Adverse Event|0|||
128887011|NCT04526197|463880609|FG001|Period 1|Adverse Event|1|||
128887012|NCT04526197|463880608|FG000|Period 1|Withdrawal by Subject|1|||
128685795|NCT04650854|463149512|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
128685796|NCT04650854|463149513|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
128685797|NCT04650854|463149511|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
128685798|NCT04650854|463149512|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
128685799|NCT04650854|463149513|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
128685800|NCT04650854|463149511|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
128685801|NCT04650854|463149512|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
128685802|NCT04650854|463149513|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
128685803|NCT04650854|463149511|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
128685804|NCT04650854|463149512|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
128685805|NCT04650854|463149513|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
128685806|NCT04650854|463149511|FG000|Overall Study|Enrollment Cup|0|||
128685807|NCT04650854|463149512|FG001|Overall Study|Enrollment Cup|0|||
128685808|NCT04650854|463149513|FG002|Overall Study|Enrollment Cup|1|||
128685809|NCT05308290|463149514|FG000|Overall Study|Death|1|||
128685810|NCT05308290|463149515|FG001|Overall Study|Death|0|||
128685811|NCT05308290|463149514|FG000|Overall Study|Lost to Follow-up|2|||
128685812|NCT05308290|463149515|FG001|Overall Study|Lost to Follow-up|1|||
128685813|NCT05308290|463149514|FG000|Overall Study|still in study followup|0|||
128685814|NCT05308290|463149515|FG001|Overall Study|still in study followup|1|||
128685815|NCT04437368|463149516|FG000|Overall Study|Death|3|||
128685816|NCT04437368|463149517|FG001|Overall Study|Death|0|||
128685817|NCT04437368|463149518|FG002|Overall Study|Death|2|||
128685818|NCT04437368|463149516|FG000|Overall Study|Study terminated by sponsor|16|||
128685819|NCT04437368|463149517|FG001|Overall Study|Study terminated by sponsor|1|||
128685820|NCT04437368|463149518|FG002|Overall Study|Study terminated by sponsor|25|||
128685821|NCT04437368|463149516|FG000|Overall Study|Withdrawal by Subject|4|||
128685822|NCT04437368|463149517|FG001|Overall Study|Withdrawal by Subject|0|||
128685823|NCT04437368|463149518|FG002|Overall Study|Withdrawal by Subject|3|||
128685824|NCT04437368|463149516|FG000|Overall Study|Sponsor instructions|23|||
128685825|NCT04437368|463149517|FG001|Overall Study|Sponsor instructions|0|||
128685826|NCT04437368|463149518|FG002|Overall Study|Sponsor instructions|0|||
128685827|NCT01982331|463149519|FG000|Received Vaccination 2|Adverse Event|1|||
128685828|NCT01982331|463149520|FG001|Received Vaccination 2|Adverse Event|2|||
128685829|NCT01982331|463149519|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
128685830|NCT01982331|463149520|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
128685831|NCT01982331|463149519|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
128685832|NCT01982331|463149520|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
128685833|NCT01280955|463149530|FG000|Overall Study|Death|2|||
128685834|NCT01280955|463149530|FG000|Overall Study|Withdrawal by Subject|1|||
128685835|NCT04223232|463149531|FG000|Overall Study|Withdrawal by Subject|1|||
128685836|NCT02393690|463149533|FG000|Overall Study|Ineligible|0|||
128685837|NCT02393690|463149534|FG001|Overall Study|Ineligible|1|||
128685838|NCT01674634|463149535|FG000|Overall Study|Withdrawal by Subject|3|||
128685839|NCT01674634|463149535|FG000|Overall Study|Lost to Follow-up|3|||
128685840|NCT01074047|463149536|FG000|Treatment Phase|Adverse Event|89|||
128685841|NCT01074047|463149537|FG001|Treatment Phase|Adverse Event|66|||
128685842|NCT01074047|463149536|FG000|Treatment Phase|Disease Progression|16|||
128685843|NCT01074047|463149537|FG001|Treatment Phase|Disease Progression|21|||
128685844|NCT01074047|463149536|FG000|Treatment Phase|Withdrawal by Subject|27|||
128685845|NCT01074047|463149537|FG001|Treatment Phase|Withdrawal by Subject|48|||
128685846|NCT01074047|463149536|FG000|Treatment Phase|Death|53|||
128685847|NCT01074047|463149537|FG001|Treatment Phase|Death|58|||
128887013|NCT04526197|463880609|FG001|Period 1|Withdrawal by Subject|0|||
128887014|NCT04526197|463880608|FG000|Period 2|Adverse Event|0|||
128685848|NCT01074047|463149536|FG000|Treatment Phase|Lost to Follow-up|0|||
128685849|NCT01074047|463149537|FG001|Treatment Phase|Lost to Follow-up|1|||
128685850|NCT01074047|463149536|FG000|Treatment Phase|Protocol Violation|0|||
128685851|NCT01074047|463149537|FG001|Treatment Phase|Protocol Violation|1|||
128685852|NCT01074047|463149536|FG000|Treatment Phase|Miscellaneous|32|||
128685853|NCT01074047|463149537|FG001|Treatment Phase|Miscellaneous|39|||
128685854|NCT01074047|463149536|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
128685855|NCT01074047|463149537|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
128685856|NCT01074047|463149536|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
128685857|NCT01074047|463149537|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
128685858|NCT01074047|463149536|FG000|Survival Follow-Up Phase|Death|116|||
128685859|NCT01074047|463149537|FG001|Survival Follow-Up Phase|Death|124|||
128685860|NCT01074047|463149536|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
128685861|NCT01074047|463149537|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
128685862|NCT01074047|463149536|FG000|Extension Phase|Physician Decision|1|||
128685863|NCT01074047|463149537|FG001|Extension Phase|Physician Decision|0|||
128685864|NCT01074047|463149536|FG000|Extension Phase|Adverse Event|5|||
128685865|NCT01074047|463149537|FG001|Extension Phase|Adverse Event|0|||
128685866|NCT01074047|463149536|FG000|Extension Phase|Disease Progression|9|||
128685867|NCT01074047|463149537|FG001|Extension Phase|Disease Progression|0|||
128685868|NCT01074047|463149536|FG000|Extension Phase|Withdrawal by Subject|2|||
128685869|NCT01074047|463149537|FG001|Extension Phase|Withdrawal by Subject|0|||
128685870|NCT01074047|463149536|FG000|Extension Phase|Death|5|||
128685871|NCT01074047|463149537|FG001|Extension Phase|Death|0|||
128685872|NCT03172910|463151333|FG000|Overall Study|Adverse Event|0|||
128685873|NCT03172910|463151334|FG001|Overall Study|Adverse Event|0|||
128685874|NCT03172910|463151335|FG002|Overall Study|Adverse Event|0|||
128685875|NCT03172910|463151336|FG003|Overall Study|Adverse Event|0|||
128685876|NCT03172910|463151337|FG004|Overall Study|Adverse Event|1|||
128685877|NCT01927341|463151340|FG000|Phase 1b|Lost to Follow-up|1|||
128685878|NCT01927341|463151341|FG001|Phase 1b|Lost to Follow-up|0|||
128685879|NCT01927341|463151342|FG002|Phase 1b|Lost to Follow-up|0|||
128685880|NCT01927341|463151343|FG003|Phase 1b|Lost to Follow-up|0|||
128685881|NCT01927341|463151344|FG004|Phase 1b|Lost to Follow-up|0|||
128685882|NCT01927341|463151340|FG000|Phase 1b|Death|2|||
128685883|NCT01927341|463151341|FG001|Phase 1b|Death|0|||
128685884|NCT01927341|463151342|FG002|Phase 1b|Death|0|||
128685885|NCT01927341|463151343|FG003|Phase 1b|Death|0|||
128685886|NCT01927341|463151344|FG004|Phase 1b|Death|0|||
128685887|NCT01927341|463151340|FG000|Phase 1b|Follow-up completed|7|||
128685888|NCT01927341|463151341|FG001|Phase 1b|Follow-up completed|0|||
128685889|NCT01927341|463151342|FG002|Phase 1b|Follow-up completed|0|||
128685890|NCT01927341|463151343|FG003|Phase 1b|Follow-up completed|0|||
128685891|NCT01927341|463151344|FG004|Phase 1b|Follow-up completed|0|||
128685892|NCT01927341|463151340|FG000|Phase 2|Lost to Follow-up|0|||
128685893|NCT01927341|463151341|FG001|Phase 2|Lost to Follow-up|1|||
128685894|NCT01927341|463151342|FG002|Phase 2|Lost to Follow-up|0|||
128685895|NCT01927341|463151343|FG003|Phase 2|Lost to Follow-up|0|||
128685896|NCT01927341|463151344|FG004|Phase 2|Lost to Follow-up|0|||
128685897|NCT01927341|463151340|FG000|Phase 2|Participant withdrew consent|0|||
128685898|NCT01927341|463151341|FG001|Phase 2|Participant withdrew consent|2|||
128685899|NCT01927341|463151342|FG002|Phase 2|Participant withdrew consent|1|||
128685900|NCT01927341|463151343|FG003|Phase 2|Participant withdrew consent|2|||
128685901|NCT01927341|463151344|FG004|Phase 2|Participant withdrew consent|3|||
128685902|NCT01927341|463151340|FG000|Phase 2|Death|0|||
128685903|NCT01927341|463151341|FG001|Phase 2|Death|4|||
128685904|NCT01927341|463151342|FG002|Phase 2|Death|0|||
128685905|NCT01927341|463151343|FG003|Phase 2|Death|3|||
128685906|NCT01927341|463151344|FG004|Phase 2|Death|2|||
128685907|NCT01927341|463151340|FG000|Phase 2|New cancer therapy|0|||
128685908|NCT01927341|463151341|FG001|Phase 2|New cancer therapy|1|||
128685909|NCT01927341|463151342|FG002|Phase 2|New cancer therapy|0|||
128685910|NCT01927341|463151343|FG003|Phase 2|New cancer therapy|4|||
128685911|NCT01927341|463151344|FG004|Phase 2|New cancer therapy|1|||
128685912|NCT01927341|463151340|FG000|Phase 2|Disease progression|0|||
128685913|NCT01927341|463151341|FG001|Phase 2|Disease progression|1|||
128685914|NCT01927341|463151342|FG002|Phase 2|Disease progression|1|||
128685915|NCT01927341|463151343|FG003|Phase 2|Disease progression|1|||
128685916|NCT01927341|463151344|FG004|Phase 2|Disease progression|0|||
128685917|NCT01927341|463151340|FG000|Phase 2|Follow-up completed|0|||
128685918|NCT01927341|463151341|FG001|Phase 2|Follow-up completed|6|||
128685919|NCT01927341|463151342|FG002|Phase 2|Follow-up completed|3|||
128685920|NCT01927341|463151343|FG003|Phase 2|Follow-up completed|5|||
128685921|NCT01927341|463151344|FG004|Phase 2|Follow-up completed|2|||
128685922|NCT01397201|463151345|FG000|Overall Study|Not treated|0|||
128685923|NCT01397201|463151346|FG001|Overall Study|Not treated|0|||
128685924|NCT01397201|463151347|FG002|Overall Study|Not treated|1|||
128685925|NCT01397201|463151348|FG003|Overall Study|Not treated|0|||
128685926|NCT01397201|463151349|FG004|Overall Study|Not treated|0|||
128685927|NCT01397201|463151345|FG000|Overall Study|Not yet defined|3|||
128685928|NCT01397201|463151346|FG001|Overall Study|Not yet defined|6|||
128685929|NCT01397201|463151347|FG002|Overall Study|Not yet defined|5|||
128685930|NCT01397201|463151348|FG003|Overall Study|Not yet defined|5|||
128685931|NCT01397201|463151349|FG004|Overall Study|Not yet defined|4|||
128685932|NCT01397201|463151345|FG000|Overall Study|Adverse Event|2|||
128685933|NCT01397201|463151346|FG001|Overall Study|Adverse Event|0|||
128685934|NCT01397201|463151347|FG002|Overall Study|Adverse Event|0|||
128685935|NCT01397201|463151348|FG003|Overall Study|Adverse Event|0|||
128685936|NCT01397201|463151349|FG004|Overall Study|Adverse Event|0|||
128685937|NCT01083485|463151350|FG000|Overall Study|Adverse Event|0|||
128685938|NCT01083485|463151351|FG001|Overall Study|Adverse Event|1|||
128685939|NCT01083485|463151350|FG000|Overall Study|Protocol Violation|1|||
128685940|NCT01083485|463151351|FG001|Overall Study|Protocol Violation|0|||
128685941|NCT01083485|463151350|FG000|Overall Study|Withdrawal by Subject|5|||
128685942|NCT01083485|463151351|FG001|Overall Study|Withdrawal by Subject|2|||
128685943|NCT01083485|463151350|FG000|Overall Study|Other|1|||
128685944|NCT01083485|463151351|FG001|Overall Study|Other|0|||
128685945|NCT03607422|463151354|FG000|Overall Study|Adverse Event|7|||
128685946|NCT03607422|463151355|FG001|Overall Study|Adverse Event|3|||
128685947|NCT03607422|463151356|FG002|Overall Study|Adverse Event|2|||
128685948|NCT03607422|463151357|FG003|Overall Study|Adverse Event|0|||
128685949|NCT03607422|463151358|FG004|Overall Study|Adverse Event|2|||
128685950|NCT03607422|463151359|FG005|Overall Study|Adverse Event|0|||
128685951|NCT03607422|463151354|FG000|Overall Study|Withdrawal by Subject|11|||
128685952|NCT03607422|463151355|FG001|Overall Study|Withdrawal by Subject|3|||
128685953|NCT03607422|463151356|FG002|Overall Study|Withdrawal by Subject|6|||
128685954|NCT03607422|463151357|FG003|Overall Study|Withdrawal by Subject|2|||
128685955|NCT03607422|463151358|FG004|Overall Study|Withdrawal by Subject|0|||
128685956|NCT03607422|463151359|FG005|Overall Study|Withdrawal by Subject|0|||
128685957|NCT03607422|463151354|FG000|Overall Study|Lost to Follow-up|0|||
128685958|NCT03607422|463151355|FG001|Overall Study|Lost to Follow-up|0|||
128685959|NCT03607422|463151356|FG002|Overall Study|Lost to Follow-up|1|||
128685960|NCT03607422|463151357|FG003|Overall Study|Lost to Follow-up|0|||
128685961|NCT03607422|463151358|FG004|Overall Study|Lost to Follow-up|0|||
128685962|NCT03607422|463151359|FG005|Overall Study|Lost to Follow-up|0|||
128685963|NCT03607422|463151354|FG000|Overall Study|Other|12|||
129109395|NCT03286218|464695908|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109396|NCT03286218|464695909|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109397|NCT03286218|464695910|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109398|NCT03286218|464695911|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109399|NCT03286218|464695912|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109400|NCT03286218|464695913|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
129109401|NCT03286218|464695902|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109402|NCT03286218|464695903|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109403|NCT03286218|464695904|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
129109404|NCT03286218|464695905|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
129109405|NCT03286218|464695906|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109406|NCT03286218|464695907|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
129109407|NCT03286218|464695908|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109408|NCT03286218|464695909|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109409|NCT03286218|464695910|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109410|NCT03286218|464695911|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109411|NCT03286218|464695912|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
129109412|NCT03286218|464695913|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
129109413|NCT03286218|464695902|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109414|NCT03286218|464695903|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109415|NCT03286218|464695904|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109416|NCT03286218|464695905|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109417|NCT03286218|464695906|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109418|NCT03286218|464695907|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109419|NCT03286218|464695908|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
128685964|NCT03607422|463151355|FG001|Overall Study|Other|4|||
128685965|NCT03607422|463151356|FG002|Overall Study|Other|1|||
128685966|NCT03607422|463151357|FG003|Overall Study|Other|2|||
128685967|NCT03607422|463151358|FG004|Overall Study|Other|0|||
128685968|NCT03607422|463151359|FG005|Overall Study|Other|2|||
128887015|NCT04526197|463880609|FG001|Period 2|Adverse Event|1|||
129109420|NCT03286218|464695909|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
128685969|NCT03607422|463151354|FG000|Overall Study|Ongoing at Time of Analysis|8|||
128887016|NCT04526197|463880608|FG000|Period 2|Withdrawal by Subject|0|||
129109421|NCT03286218|464695910|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
128685970|NCT03607422|463151355|FG001|Overall Study|Ongoing at Time of Analysis|0|||
128685971|NCT03607422|463151356|FG002|Overall Study|Ongoing at Time of Analysis|2|||
128685972|NCT03607422|463151357|FG003|Overall Study|Ongoing at Time of Analysis|1|||
128685973|NCT03607422|463151358|FG004|Overall Study|Ongoing at Time of Analysis|1|||
128685974|NCT03607422|463151359|FG005|Overall Study|Ongoing at Time of Analysis|1|||
128685975|NCT03693170|463151360|FG000|Overall Study|Disease Progression|48|||
128887017|NCT04526197|463880609|FG001|Period 2|Withdrawal by Subject|1|||
128887018|NCT00372385|463880610|FG000|Overall Study|Adverse Event|6|||
128887019|NCT00372385|463880611|FG001|Overall Study|Adverse Event|11|||
128763339|NCT01576718|463422829|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
128763340|NCT01576718|463422830|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128763341|NCT01576718|463422831|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128763342|NCT01576718|463422832|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128763343|NCT01576718|463422833|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128763344|NCT01576718|463422834|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128763345|NCT01576718|463422835|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128763346|NCT01576718|463422829|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
128763347|NCT01576718|463422830|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128763348|NCT01576718|463422831|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128763349|NCT01576718|463422832|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128763350|NCT01576718|463422833|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128763351|NCT01576718|463422834|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128763352|NCT01576718|463422835|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128763353|NCT01576718|463422829|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
128763354|NCT01576718|463422830|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128763355|NCT01576718|463422831|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128763356|NCT01576718|463422832|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128763357|NCT01576718|463422833|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128763358|NCT01576718|463422834|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128763359|NCT01576718|463422835|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128763360|NCT01576718|463422829|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
128763361|NCT01576718|463422830|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128763362|NCT01576718|463422831|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128763363|NCT01576718|463422832|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128763364|NCT01576718|463422833|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128763365|NCT01576718|463422834|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128763366|NCT01576718|463422835|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128763367|NCT01576718|463422829|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
128763368|NCT01576718|463422830|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128763369|NCT01576718|463422831|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128763370|NCT01576718|463422832|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128763371|NCT01576718|463422833|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128763372|NCT01576718|463422834|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128763373|NCT01576718|463422835|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128763374|NCT01576718|463422829|FG000|Treatment Period|Adverse Event|0|||
128763375|NCT01576718|463422830|FG001|Treatment Period|Adverse Event|1|||
128763376|NCT01576718|463422831|FG002|Treatment Period|Adverse Event|1|||
128763377|NCT01576718|463422832|FG003|Treatment Period|Adverse Event|1|||
128763378|NCT01576718|463422833|FG004|Treatment Period|Adverse Event|1|||
128763379|NCT01576718|463422834|FG005|Treatment Period|Adverse Event|1|||
128763380|NCT01576718|463422835|FG006|Treatment Period|Adverse Event|0|||
128763381|NCT01576718|463422829|FG000|Treatment Period|Withdrawal by Subject|0|||
128763382|NCT01576718|463422830|FG001|Treatment Period|Withdrawal by Subject|1|||
128763383|NCT01576718|463422831|FG002|Treatment Period|Withdrawal by Subject|1|||
128763384|NCT01576718|463422832|FG003|Treatment Period|Withdrawal by Subject|0|||
128763385|NCT01576718|463422833|FG004|Treatment Period|Withdrawal by Subject|2|||
128763386|NCT01576718|463422834|FG005|Treatment Period|Withdrawal by Subject|4|||
128763387|NCT01576718|463422835|FG006|Treatment Period|Withdrawal by Subject|2|||
128763388|NCT01576718|463422829|FG000|Treatment Period|Physician Decision|0|||
128763389|NCT01576718|463422830|FG001|Treatment Period|Physician Decision|1|||
128763390|NCT01576718|463422831|FG002|Treatment Period|Physician Decision|1|||
128763391|NCT01576718|463422832|FG003|Treatment Period|Physician Decision|1|||
128763392|NCT01576718|463422833|FG004|Treatment Period|Physician Decision|1|||
128763393|NCT01576718|463422834|FG005|Treatment Period|Physician Decision|0|||
128763394|NCT01576718|463422835|FG006|Treatment Period|Physician Decision|0|||
128763395|NCT01576718|463422829|FG000|Treatment Period|Protocol Violation|0|||
128763396|NCT01576718|463422830|FG001|Treatment Period|Protocol Violation|5|||
128763397|NCT01576718|463422831|FG002|Treatment Period|Protocol Violation|4|||
128763398|NCT01576718|463422832|FG003|Treatment Period|Protocol Violation|10|||
128763399|NCT01576718|463422833|FG004|Treatment Period|Protocol Violation|6|||
128763400|NCT01576718|463422834|FG005|Treatment Period|Protocol Violation|8|||
128763401|NCT01576718|463422835|FG006|Treatment Period|Protocol Violation|12|||
128763402|NCT01576718|463422829|FG000|Treatment Period|Sponsor request|0|||
128763403|NCT01576718|463422830|FG001|Treatment Period|Sponsor request|1|||
128887020|NCT00372385|463880612|FG002|Overall Study|Adverse Event|9|||
128887021|NCT00372385|463880613|FG003|Overall Study|Adverse Event|7|||
129109422|NCT03286218|464695911|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109423|NCT03286218|464695912|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
129109424|NCT03286218|464695913|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
129109425|NCT02532374|464695914|FG000|Overall Study|Withdrawal by Subject|1|||
129109426|NCT02532374|464695914|FG000|Overall Study|Physician Decision|1|||
129109427|NCT01348139|464695915|FG000|Period 1|Adverse Event|1|||
129109428|NCT01348139|464695916|FG001|Period 1|Adverse Event|0|||
129109429|NCT01348139|464695917|FG002|Period 1|Adverse Event|0|||
129109430|NCT01348139|464695918|FG003|Period 1|Adverse Event|0|||
129109431|NCT01348139|464695919|FG004|Period 1|Adverse Event|0|||
129109432|NCT01348139|464695920|FG005|Period 1|Adverse Event|0|||
129109433|NCT02762084|464695921|FG000|Overall Study|Withdrawal by Subject|1|||
129109434|NCT02762084|464695922|FG001|Overall Study|Withdrawal by Subject|0|||
129109435|NCT02762084|464695923|FG002|Overall Study|Withdrawal by Subject|0|||
129109436|NCT02762084|464695921|FG000|Overall Study|Adverse Event|0|||
129109437|NCT02762084|464695922|FG001|Overall Study|Adverse Event|0|||
129109438|NCT02762084|464695923|FG002|Overall Study|Adverse Event|1|||
129109439|NCT01781962|464695930|FG000|Overall Study|Other Miscellaneous Reasons|5|||
129109440|NCT01462630|464695931|FG000|Overall Study|Did not initiate therapy|3|||
129109441|NCT01462630|464695931|FG000|Overall Study|Death|1|||
129109442|NCT01462630|464695931|FG000|Overall Study|Protocol Violation|2|||
129109443|NCT01462630|464695931|FG000|Overall Study|Adverse Event|1|||
129109444|NCT01765296|464695932|FG000|Overall Study|Protocol Violation|0|||
129109445|NCT01765296|464695933|FG001|Overall Study|Protocol Violation|5|||
129109446|NCT01765296|464695934|FG002|Overall Study|Protocol Violation|4|||
129109447|NCT01765296|464695932|FG000|Overall Study|Withdrawal by Subject|4|||
129109448|NCT01765296|464695933|FG001|Overall Study|Withdrawal by Subject|2|||
129109449|NCT01765296|464695934|FG002|Overall Study|Withdrawal by Subject|2|||
129109450|NCT01765296|464695932|FG000|Overall Study|Adverse Event|1|||
129109451|NCT01765296|464695933|FG001|Overall Study|Adverse Event|13|||
129109452|NCT01765296|464695934|FG002|Overall Study|Adverse Event|5|||
129109453|NCT01765296|464695932|FG000|Overall Study|Lack of Efficacy|0|||
129109454|NCT01765296|464695933|FG001|Overall Study|Lack of Efficacy|0|||
129109455|NCT01765296|464695934|FG002|Overall Study|Lack of Efficacy|2|||
129109456|NCT03257436|464695935|FG000|Overall Study|Withdrawal by Subject|76|||
129109457|NCT03257436|464695935|FG000|Overall Study|Death|19|||
129109458|NCT01619852|464695936|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
129109459|NCT01619852|464695937|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
129109460|NCT01619852|464695936|FG000|3 Month Follow up|Lost to Follow-up|31|||
129109461|NCT01619852|464695937|FG001|3 Month Follow up|Lost to Follow-up|34|||
129109462|NCT03933449|464695938|FG000|Overall Study|Adverse Event|6|||
129109463|NCT03933449|464695939|FG001|Overall Study|Adverse Event|4|||
129109464|NCT03933449|464695938|FG000|Overall Study|Death|55|||
129109465|NCT03933449|464695939|FG001|Overall Study|Death|57|||
129109466|NCT03933449|464695938|FG000|Overall Study|Sponsor Decision|1|||
129109467|NCT03933449|464695939|FG001|Overall Study|Sponsor Decision|0|||
129109468|NCT02659943|464695940|FG000|Overall Study|Switched to alternative treatment|1|||
129109469|NCT02659943|464695941|FG001|Overall Study|Switched to alternative treatment|1|||
129109470|NCT02659943|464695942|FG002|Overall Study|Switched to alternative treatment|0|||
129109471|NCT02659943|464695943|FG003|Overall Study|Switched to alternative treatment|2|||
129109472|NCT02659943|464695944|FG004|Overall Study|Switched to alternative treatment|1|||
129109473|NCT02659943|464695945|FG005|Overall Study|Switched to alternative treatment|0|||
129109474|NCT02659943|464695946|FG006|Overall Study|Switched to alternative treatment|1|||
129109475|NCT02659943|464695940|FG000|Overall Study|Disease progression on study|0|||
129109476|NCT02659943|464695941|FG001|Overall Study|Disease progression on study|1|||
129109477|NCT02659943|464695942|FG002|Overall Study|Disease progression on study|1|||
129109478|NCT02659943|464695943|FG003|Overall Study|Disease progression on study|1|||
129109479|NCT02659943|464695944|FG004|Overall Study|Disease progression on study|1|||
129109480|NCT02659943|464695945|FG005|Overall Study|Disease progression on study|4|||
129109481|NCT02659943|464695946|FG006|Overall Study|Disease progression on study|0|||
128685976|NCT03693170|463151360|FG000|Overall Study|Adverse Event|16|||
129109482|NCT02659943|464695940|FG000|Overall Study|Patient's condition per principal investigator|0|||
129109483|NCT02659943|464695941|FG001|Overall Study|Patient's condition per principal investigator|0|||
129109484|NCT02659943|464695942|FG002|Overall Study|Patient's condition per principal investigator|0|||
129109485|NCT02659943|464695943|FG003|Overall Study|Patient's condition per principal investigator|0|||
129109486|NCT02659943|464695944|FG004|Overall Study|Patient's condition per principal investigator|0|||
129109487|NCT02659943|464695945|FG005|Overall Study|Patient's condition per principal investigator|1|||
129109488|NCT02659943|464695946|FG006|Overall Study|Patient's condition per principal investigator|0|||
129109489|NCT02659943|464695940|FG000|Overall Study|Ineligible|0|||
129109490|NCT02659943|464695941|FG001|Overall Study|Ineligible|0|||
129109491|NCT02659943|464695942|FG002|Overall Study|Ineligible|0|||
129109492|NCT02659943|464695943|FG003|Overall Study|Ineligible|0|||
129109493|NCT02659943|464695944|FG004|Overall Study|Ineligible|0|||
129109494|NCT02659943|464695945|FG005|Overall Study|Ineligible|0|||
129109495|NCT02659943|464695946|FG006|Overall Study|Ineligible|1|||
129109496|NCT02659943|464695940|FG000|Overall Study|No longer meets eligibility|0|||
129109497|NCT02659943|464695941|FG001|Overall Study|No longer meets eligibility|0|||
129109498|NCT02659943|464695942|FG002|Overall Study|No longer meets eligibility|0|||
129109499|NCT02659943|464695943|FG003|Overall Study|No longer meets eligibility|0|||
129109500|NCT02659943|464695944|FG004|Overall Study|No longer meets eligibility|0|||
129109501|NCT02659943|464695945|FG005|Overall Study|No longer meets eligibility|0|||
129109502|NCT02659943|464695946|FG006|Overall Study|No longer meets eligibility|1|||
129109503|NCT02659943|464695940|FG000|Overall Study|No treatment, per protocol|0|||
129109504|NCT02659943|464695941|FG001|Overall Study|No treatment, per protocol|0|||
129109505|NCT02659943|464695942|FG002|Overall Study|No treatment, per protocol|0|||
129109506|NCT02659943|464695943|FG003|Overall Study|No treatment, per protocol|0|||
129109507|NCT02659943|464695944|FG004|Overall Study|No treatment, per protocol|0|||
129109508|NCT02659943|464695945|FG005|Overall Study|No treatment, per protocol|0|||
128685977|NCT03693170|463151360|FG000|Overall Study|Physician Decision|6|||
128685978|NCT03693170|463151360|FG000|Overall Study|Protocol Violation|2|||
128685979|NCT03693170|463151360|FG000|Overall Study|Death|1|||
128685980|NCT03693170|463151360|FG000|Overall Study|Non compliance with study drug|1|||
128685981|NCT03693170|463151360|FG000|Overall Study|Withdrawal by Subject|1|||
128685982|NCT01442038|463151361|FG000|Overall Study|Death|35|||
128685983|NCT01442038|463151362|FG001|Overall Study|Death|29|||
128685984|NCT01442038|463151361|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
128685985|NCT01442038|463151362|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
128685986|NCT01442038|463151361|FG000|Overall Study|Participant Withdrew Consent|137|||
128685987|NCT01442038|463151362|FG001|Overall Study|Participant Withdrew Consent|102|||
128685988|NCT01442038|463151361|FG000|Overall Study|Lost to Follow-up|37|||
128685989|NCT01442038|463151362|FG001|Overall Study|Lost to Follow-up|51|||
128685990|NCT01442038|463151361|FG000|Overall Study|Adverse Event|26|||
128685991|NCT01442038|463151362|FG001|Overall Study|Adverse Event|15|||
128685992|NCT01442038|463151361|FG000|Overall Study|Protocol Deviation|9|||
128685993|NCT01442038|463151362|FG001|Overall Study|Protocol Deviation|20|||
128685994|NCT01442038|463151361|FG000|Overall Study|Investigator's Discretion|13|||
128685995|NCT01442038|463151362|FG001|Overall Study|Investigator's Discretion|16|||
128685996|NCT01442038|463151361|FG000|Overall Study|Study Terminated By Sponsor|2|||
128685997|NCT01442038|463151362|FG001|Overall Study|Study Terminated By Sponsor|3|||
128685998|NCT00089284|463151363|FG000|Overall Study|Adverse event before starting treatment|0|||
128685999|NCT00089284|463151364|FG001|Overall Study|Adverse event before starting treatment|0|||
128686000|NCT00089284|463151365|FG002|Overall Study|Adverse event before starting treatment|0|||
128686001|NCT00089284|463151366|FG003|Overall Study|Adverse event before starting treatment|0|||
128686002|NCT00089284|463151367|FG004|Overall Study|Adverse event before starting treatment|0|||
128686003|NCT00089284|463151368|FG005|Overall Study|Adverse event before starting treatment|0|||
128686004|NCT00089284|463151369|FG006|Overall Study|Adverse event before starting treatment|1|||
128686005|NCT03228420|463151372|FG000|Overall Study|Lost to Follow-up|5|||
128686006|NCT03228420|463151373|FG001|Overall Study|Lost to Follow-up|3|||
128686007|NCT03228420|463151372|FG000|Overall Study|Withdrawal by Subject|10|||
128686008|NCT03228420|463151373|FG001|Overall Study|Withdrawal by Subject|0|||
128686009|NCT03228420|463151372|FG000|Overall Study|Adverse Event|5|||
128686010|NCT03228420|463151373|FG001|Overall Study|Adverse Event|2|||
128686011|NCT00085709|463151374|FG000|Overall Study|Adverse Event|8|||
128686012|NCT00085709|463151375|FG001|Overall Study|Adverse Event|0|||
128686013|NCT00085709|463151374|FG000|Overall Study|Death|8|||
128686014|NCT00085709|463151375|FG001|Overall Study|Death|2|||
128686015|NCT00085709|463151374|FG000|Overall Study|Refusal unrelated to adverse events|1|||
128686016|NCT00085709|463151375|FG001|Overall Study|Refusal unrelated to adverse events|2|||
128686017|NCT00085709|463151374|FG000|Overall Study|Progression|3|||
128686018|NCT00085709|463151375|FG001|Overall Study|Progression|4|||
128686019|NCT00085709|463151374|FG000|Overall Study|Not protocol specified|12|||
128686020|NCT00085709|463151375|FG001|Overall Study|Not protocol specified|22|||
128686021|NCT00085709|463151374|FG000|Overall Study|Not eligible|19|||
128887022|NCT00372385|463880610|FG000|Overall Study|Noncompliance|0|||
128887023|NCT00372385|463880611|FG001|Overall Study|Noncompliance|1|||
128887024|NCT00372385|463880612|FG002|Overall Study|Noncompliance|1|||
128887025|NCT00372385|463880613|FG003|Overall Study|Noncompliance|1|||
128887026|NCT00372385|463880610|FG000|Overall Study|Physician Decision|1|||
129109509|NCT02659943|464695946|FG006|Overall Study|No treatment, per protocol|3|||
129109510|NCT01576575|464695947|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
129109511|NCT01576575|464695947|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
128686022|NCT00085709|463151375|FG001|Overall Study|Not eligible|19|||
128887027|NCT00372385|463880611|FG001|Overall Study|Physician Decision|0|||
129109512|NCT01576575|464695947|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
128686023|NCT00085709|463151374|FG000|Overall Study|Withdrawal by Subject|2|||
128686024|NCT00085709|463151375|FG001|Overall Study|Withdrawal by Subject|1|||
128686025|NCT03646643|463151376|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
128686026|NCT03646643|463151377|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
128686027|NCT03646643|463151376|FG000|Overall Study|Lost to Follow-up|0|||
128686028|NCT03646643|463151377|FG001|Overall Study|Lost to Follow-up|1|||
128887028|NCT00372385|463880612|FG002|Overall Study|Physician Decision|0|||
128686029|NCT04131556|463151378|FG000|Overall Study|Adverse Event|1|||
128686030|NCT04131556|463151378|FG000|Overall Study|Withdrawal by Subject|1|||
128686031|NCT04060862|463151381|FG000|Overall Study|Symptomatic Deterioration|1|||
128686032|NCT04060862|463151381|FG000|Overall Study|Un-specified|6|||
128686033|NCT04060862|463151381|FG000|Overall Study|Progressive disease|12|||
128686034|NCT04060862|463151381|FG000|Overall Study|Physician Decision|1|||
128686035|NCT01052844|463151382|FG000|Overall Study|Adverse Event|0|||
128686036|NCT01052844|463151383|FG001|Overall Study|Adverse Event|1|||
128686037|NCT01068652|463151387|FG000|Overall Study|Adverse Event|4|||
128887029|NCT00372385|463880613|FG003|Overall Study|Physician Decision|0|||
128887030|NCT00372385|463880610|FG000|Overall Study|Lost to Follow-up|2|||
128887031|NCT00372385|463880611|FG001|Overall Study|Lost to Follow-up|0|||
128887032|NCT00372385|463880612|FG002|Overall Study|Lost to Follow-up|0|||
128887033|NCT00372385|463880613|FG003|Overall Study|Lost to Follow-up|0|||
128887034|NCT00372385|463880610|FG000|Overall Study|Withdrawal by Subject|2|||
128887035|NCT00372385|463880611|FG001|Overall Study|Withdrawal by Subject|1|||
128887036|NCT00372385|463880612|FG002|Overall Study|Withdrawal by Subject|0|||
128763404|NCT01576718|463422831|FG002|Treatment Period|Sponsor request|0|||
128763405|NCT01576718|463422832|FG003|Treatment Period|Sponsor request|0|||
128763406|NCT01576718|463422833|FG004|Treatment Period|Sponsor request|0|||
128763407|NCT01576718|463422834|FG005|Treatment Period|Sponsor request|1|||
128763408|NCT01576718|463422835|FG006|Treatment Period|Sponsor request|0|||
128763409|NCT01576718|463422829|FG000|Treatment Period|Met stopping criteria|0|||
128763410|NCT01576718|463422830|FG001|Treatment Period|Met stopping criteria|16|||
128763411|NCT01576718|463422831|FG002|Treatment Period|Met stopping criteria|13|||
128763412|NCT01576718|463422832|FG003|Treatment Period|Met stopping criteria|19|||
128763413|NCT01576718|463422833|FG004|Treatment Period|Met stopping criteria|16|||
128763414|NCT01576718|463422834|FG005|Treatment Period|Met stopping criteria|33|||
128763415|NCT01576718|463422835|FG006|Treatment Period|Met stopping criteria|15|||
128763416|NCT01576718|463422829|FG000|Treatment Period|Lost to Follow-up|0|||
128763417|NCT01576718|463422830|FG001|Treatment Period|Lost to Follow-up|0|||
128763418|NCT01576718|463422831|FG002|Treatment Period|Lost to Follow-up|0|||
128763419|NCT01576718|463422832|FG003|Treatment Period|Lost to Follow-up|0|||
128763420|NCT01576718|463422833|FG004|Treatment Period|Lost to Follow-up|1|||
128763421|NCT01576718|463422834|FG005|Treatment Period|Lost to Follow-up|0|||
128763422|NCT01576718|463422835|FG006|Treatment Period|Lost to Follow-up|0|||
128763423|NCT01576718|463422829|FG000|Treatment Period|Noncompliance to study medication|0|||
128763424|NCT01576718|463422830|FG001|Treatment Period|Noncompliance to study medication|0|||
128763425|NCT01576718|463422831|FG002|Treatment Period|Noncompliance to study medication|0|||
128763426|NCT01576718|463422832|FG003|Treatment Period|Noncompliance to study medication|0|||
128763427|NCT01576718|463422833|FG004|Treatment Period|Noncompliance to study medication|0|||
128763428|NCT01576718|463422834|FG005|Treatment Period|Noncompliance to study medication|1|||
128763429|NCT01576718|463422835|FG006|Treatment Period|Noncompliance to study medication|1|||
128763430|NCT01833143|463422841|FG000|Overall Study|Not Treated|1|||
128763431|NCT03995784|463422842|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
128763432|NCT00045708|463425682|FG000|Phase 1|early progressive disease|0|||
128763433|NCT00045708|463425683|FG001|Phase 1|early progressive disease|1|||
128763434|NCT00045708|463425684|FG002|Phase 1|early progressive disease|0|||
128763435|NCT00284141|463425686|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
128763436|NCT00284141|463425686|FG000|Overall Study|Adverse Event|19|||
128763437|NCT00284141|463425686|FG000|Overall Study|Participant's request|9|||
128763438|NCT00284141|463425686|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
128763439|NCT00284141|463425686|FG000|Overall Study|Clinical deterioration / death|2|||
128763440|NCT00284141|463425686|FG000|Overall Study|General decline|1|||
128763441|NCT00284141|463425686|FG000|Overall Study|Pneumonia|1|||
128763442|NCT00284141|463425686|FG000|Overall Study|Did not take study medication|2|||
128763443|NCT00284141|463425686|FG000|Overall Study|Ongoing treatment|2|||
128763444|NCT00975221|463425688|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
128763445|NCT00975221|463425689|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
128763446|NCT00975221|463425688|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
128763447|NCT00975221|463425689|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
128887037|NCT00372385|463880613|FG003|Overall Study|Withdrawal by Subject|0|||
128887038|NCT00372385|463880610|FG000|Overall Study|Refusal of Treatment|3|||
129215182|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
128686038|NCT01068652|463151388|FG001|Overall Study|Adverse Event|0|||
128763448|NCT00975221|463425688|FG000|Titration Phase (Weeks 1-12)|Other|0|||
128763449|NCT00975221|463425689|FG001|Titration Phase (Weeks 1-12)|Other|1|||
128763450|NCT00975221|463425688|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
128763451|NCT00975221|463425689|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
128763452|NCT00975221|463425688|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
128763453|NCT00975221|463425689|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
128887039|NCT00372385|463880611|FG001|Overall Study|Refusal of Treatment|6|||
128887040|NCT00372385|463880612|FG002|Overall Study|Refusal of Treatment|0|||
128686039|NCT01068652|463151387|FG000|Overall Study|Lack of Efficacy|0|||
129109513|NCT01723072|464695948|FG000|Overall Study|Withdrawal by Subject|7|||
129109514|NCT01723072|464695949|FG001|Overall Study|Withdrawal by Subject|13|||
129109515|NCT01723072|464695948|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
129109516|NCT01723072|464695949|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
129109517|NCT01723072|464695948|FG000|Overall Study|Other|4|||
129109518|NCT01723072|464695949|FG001|Overall Study|Other|3|||
129109519|NCT03428100|464695950|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
129109520|NCT03428100|464695951|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109521|NCT03428100|464695952|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
129109522|NCT03428100|464695953|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
129109523|NCT03428100|464695954|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109524|NCT03428100|464695955|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109525|NCT03428100|464695956|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
128686040|NCT01068652|463151388|FG001|Overall Study|Lack of Efficacy|2|||
128686041|NCT01068652|463151387|FG000|Overall Study|Lost to Follow-up|2|||
128686042|NCT01068652|463151388|FG001|Overall Study|Lost to Follow-up|1|||
128686043|NCT01068652|463151387|FG000|Overall Study|Protocol Violation|3|||
128686044|NCT01068652|463151388|FG001|Overall Study|Protocol Violation|6|||
128686045|NCT01068652|463151387|FG000|Overall Study|Withdrawal criteria|1|||
128887041|NCT00372385|463880613|FG003|Overall Study|Refusal of Treatment|0|||
129109526|NCT03428100|464695957|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109527|NCT03428100|464695958|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109528|NCT03428100|464695959|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109529|NCT03428100|464695960|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109530|NCT03428100|464695961|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109531|NCT03428100|464695962|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109532|NCT03428100|464695963|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109533|NCT03428100|464695964|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109534|NCT03428100|464695965|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109535|NCT03428100|464695966|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109536|NCT03428100|464695967|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109537|NCT03428100|464695968|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129109538|NCT03428100|464695950|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
129109539|NCT03428100|464695951|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
129109540|NCT03428100|464695952|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
129109541|NCT03428100|464695953|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
129109542|NCT03428100|464695954|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109543|NCT03428100|464695955|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109544|NCT03428100|464695956|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109545|NCT03428100|464695957|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109546|NCT03428100|464695958|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109547|NCT03428100|464695959|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109548|NCT03428100|464695960|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109549|NCT03428100|464695961|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109550|NCT03428100|464695962|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109551|NCT03428100|464695963|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109552|NCT03428100|464695964|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109553|NCT03428100|464695965|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109554|NCT03428100|464695966|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109555|NCT03428100|464695967|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109556|NCT03428100|464695968|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129109557|NCT03428100|464695950|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109558|NCT03428100|464695951|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
129109559|NCT03428100|464695952|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
129109560|NCT03428100|464695953|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109561|NCT03428100|464695954|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109562|NCT03428100|464695955|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109563|NCT03428100|464695956|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109564|NCT03428100|464695957|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109565|NCT03428100|464695958|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109566|NCT03428100|464695959|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109567|NCT03428100|464695960|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109568|NCT03428100|464695961|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109569|NCT03428100|464695962|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109570|NCT03428100|464695963|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
128686046|NCT01068652|463151388|FG001|Overall Study|Withdrawal criteria|2|||
128887042|NCT00372385|463880610|FG000|Overall Study|No Response|1|||
129109571|NCT03428100|464695964|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109572|NCT03428100|464695965|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109573|NCT03428100|464695966|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109574|NCT03428100|464695967|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
128686047|NCT01068652|463151387|FG000|Overall Study|Patient was not eligible|1|||
128686048|NCT01068652|463151388|FG001|Overall Study|Patient was not eligible|0|||
128686049|NCT01068652|463151387|FG000|Overall Study|Unclassified|7|||
128686050|NCT01068652|463151388|FG001|Overall Study|Unclassified|4|||
128686051|NCT05323656|463151392|FG000|Overall Study|Still On-Treatment|6|||
128686052|NCT05323656|463151393|FG001|Overall Study|Still On-Treatment|6|||
128686053|NCT05323656|463151392|FG000|Overall Study|Progressive Disease|15|||
128686054|NCT05323656|463151393|FG001|Overall Study|Progressive Disease|14|||
128686055|NCT05323656|463151392|FG000|Overall Study|Adverse Event|2|||
128686056|NCT05323656|463151393|FG001|Overall Study|Adverse Event|3|||
128686057|NCT05323656|463151392|FG000|Overall Study|Death|1|||
128686058|NCT05323656|463151393|FG001|Overall Study|Death|2|||
128686059|NCT05323656|463151392|FG000|Overall Study|Withdrawal by Subject|1|||
128686060|NCT05323656|463151393|FG001|Overall Study|Withdrawal by Subject|0|||
128686061|NCT05323656|463151392|FG000|Overall Study|Clinical disease progression|0|||
128686062|NCT05323656|463151393|FG001|Overall Study|Clinical disease progression|1|||
128686063|NCT05323656|463151392|FG000|Overall Study|Patient and Investigator decision|1|||
128686064|NCT05323656|463151393|FG001|Overall Study|Patient and Investigator decision|0|||
128686065|NCT05323656|463151392|FG000|Overall Study|Physician Decision|0|||
128686066|NCT05323656|463151393|FG001|Overall Study|Physician Decision|1|||
128686067|NCT02536833|463151394|FG000|Overall Study|Discontinued Before Treatment|0|||
128686068|NCT02536833|463151395|FG001|Overall Study|Discontinued Before Treatment|0|||
128686069|NCT02536833|463151396|FG002|Overall Study|Discontinued Before Treatment|1|||
128686070|NCT02536833|463151397|FG003|Overall Study|Discontinued Before Treatment|2|||
128686071|NCT02536833|463151394|FG000|Overall Study|Adverse Event|1|||
128686072|NCT02536833|463151395|FG001|Overall Study|Adverse Event|3|||
128686073|NCT02536833|463151396|FG002|Overall Study|Adverse Event|4|||
128686074|NCT02536833|463151397|FG003|Overall Study|Adverse Event|1|||
129109575|NCT03428100|464695968|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129109576|NCT03428100|464695950|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
129109577|NCT03428100|464695951|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109578|NCT03428100|464695952|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109579|NCT03428100|464695953|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109580|NCT03428100|464695954|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109581|NCT03428100|464695955|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109582|NCT03428100|464695956|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109583|NCT03428100|464695957|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109584|NCT03428100|464695958|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109585|NCT03428100|464695959|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109586|NCT03428100|464695960|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109587|NCT03428100|464695961|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109588|NCT03428100|464695962|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109589|NCT03428100|464695963|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109590|NCT03428100|464695964|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109591|NCT03428100|464695965|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109592|NCT03428100|464695966|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109593|NCT03428100|464695967|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109594|NCT03428100|464695968|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129109595|NCT03428100|464695950|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109596|NCT03428100|464695951|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
129109597|NCT03428100|464695952|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
128686075|NCT02536833|463151394|FG000|Overall Study|Lost to Follow-up|2|||
128686076|NCT02536833|463151395|FG001|Overall Study|Lost to Follow-up|1|||
128686077|NCT02536833|463151396|FG002|Overall Study|Lost to Follow-up|2|||
128686078|NCT02536833|463151397|FG003|Overall Study|Lost to Follow-up|2|||
128686079|NCT02536833|463151394|FG000|Overall Study|Physician Decision|0|||
128686080|NCT02536833|463151395|FG001|Overall Study|Physician Decision|0|||
128686081|NCT02536833|463151396|FG002|Overall Study|Physician Decision|0|||
128686082|NCT02536833|463151397|FG003|Overall Study|Physician Decision|1|||
128686083|NCT02536833|463151394|FG000|Overall Study|Site Terminated by Sponsor|2|||
128686084|NCT02536833|463151395|FG001|Overall Study|Site Terminated by Sponsor|2|||
128686085|NCT02536833|463151396|FG002|Overall Study|Site Terminated by Sponsor|2|||
128686086|NCT02536833|463151397|FG003|Overall Study|Site Terminated by Sponsor|2|||
128686087|NCT02536833|463151394|FG000|Overall Study|Subject Non-Compliance|0|||
128887043|NCT00372385|463880611|FG001|Overall Study|No Response|1|||
129109598|NCT03428100|464695953|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109599|NCT03428100|464695954|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109600|NCT03428100|464695955|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109601|NCT03428100|464695956|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109602|NCT03428100|464695957|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109603|NCT03428100|464695958|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109604|NCT03428100|464695959|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109605|NCT03428100|464695960|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
128686088|NCT02536833|463151395|FG001|Overall Study|Subject Non-Compliance|1|||
128686089|NCT02536833|463151396|FG002|Overall Study|Subject Non-Compliance|1|||
128686090|NCT02536833|463151397|FG003|Overall Study|Subject Non-Compliance|0|||
128686091|NCT02536833|463151394|FG000|Overall Study|Withdrawal by Subject|4|||
128686092|NCT02536833|463151395|FG001|Overall Study|Withdrawal by Subject|3|||
128686093|NCT02536833|463151396|FG002|Overall Study|Withdrawal by Subject|5|||
128686094|NCT02536833|463151397|FG003|Overall Study|Withdrawal by Subject|11|||
128686095|NCT02764190|463151398|FG000|Overall Study|Lost to Follow-up|17|||
128686096|NCT02764190|463151399|FG001|Overall Study|Lost to Follow-up|13|||
128887044|NCT00372385|463880612|FG002|Overall Study|No Response|0|||
129109606|NCT03428100|464695961|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109607|NCT03428100|464695962|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
128686097|NCT02961218|463151400|FG000|Overall Study|Lost to Follow-up|0|||
128686098|NCT02961218|463151401|FG001|Overall Study|Lost to Follow-up|2|||
128686099|NCT02961218|463151400|FG000|Overall Study|Physician Decision|0|||
128686100|NCT02961218|463151401|FG001|Overall Study|Physician Decision|2|||
128686101|NCT02961218|463151400|FG000|Overall Study|Subject/Guardian Decision|3|||
128686102|NCT02961218|463151401|FG001|Overall Study|Subject/Guardian Decision|1|||
128686103|NCT00591266|463151402|FG000|Overall Study|Adverse Event|2|||
129109608|NCT03428100|464695963|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109609|NCT03428100|464695964|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109610|NCT03428100|464695965|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109611|NCT03428100|464695966|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109612|NCT03428100|464695967|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109613|NCT03428100|464695968|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129109614|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109615|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109616|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109617|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109618|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109619|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
129109620|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129109621|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
129109622|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129109623|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109624|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129109625|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
128686104|NCT00591266|463151403|FG001|Overall Study|Adverse Event|2|||
128686105|NCT00591266|463151404|FG002|Overall Study|Adverse Event|3|||
128686106|NCT00591266|463151402|FG000|Overall Study|Lost to Follow-up|0|||
128686107|NCT00591266|463151403|FG001|Overall Study|Lost to Follow-up|1|||
128686108|NCT00591266|463151404|FG002|Overall Study|Lost to Follow-up|0|||
128686109|NCT00591266|463151402|FG000|Overall Study|Protocol Violation|0|||
128686110|NCT00591266|463151403|FG001|Overall Study|Protocol Violation|0|||
128686111|NCT00591266|463151404|FG002|Overall Study|Protocol Violation|1|||
128686112|NCT00591266|463151402|FG000|Overall Study|Withdrawal by Subject|6|||
128686113|NCT00591266|463151403|FG001|Overall Study|Withdrawal by Subject|2|||
128686114|NCT00591266|463151404|FG002|Overall Study|Withdrawal by Subject|5|||
128686115|NCT00591266|463151402|FG000|Overall Study|Lack of Efficacy|0|||
128686116|NCT00591266|463151403|FG001|Overall Study|Lack of Efficacy|2|||
128686117|NCT00591266|463151404|FG002|Overall Study|Lack of Efficacy|0|||
128686118|NCT00591266|463151402|FG000|Overall Study|Other|1|||
128686119|NCT00591266|463151403|FG001|Overall Study|Other|4|||
129109626|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
128686120|NCT00591266|463151404|FG002|Overall Study|Other|5|||
128686121|NCT03488927|463151405|FG000|Overall Study|Withdrawal by Subject|44|||
128686122|NCT03488927|463151406|FG001|Overall Study|Withdrawal by Subject|118|||
128686123|NCT03488927|463151407|FG002|Overall Study|Withdrawal by Subject|217|||
128686124|NCT00901927|463151410|FG000|Overall Study|Lack of Efficacy|1|||
128686125|NCT00901927|463151410|FG000|Overall Study|Protocol Violation|3|||
128686126|NCT00901927|463151410|FG000|Overall Study|Withdrawal by Subject|2|||
128887045|NCT00372385|463880613|FG003|Overall Study|No Response|0|||
128887046|NCT00372385|463880610|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
128887047|NCT00372385|463880611|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
129109627|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
128686127|NCT05298306|463151411|FG000|Overall Study|Physician Decision|0|||
128686128|NCT05298306|463151412|FG001|Overall Study|Physician Decision|0|||
128686129|NCT05298306|463151413|FG002|Overall Study|Physician Decision|0|||
128686130|NCT05298306|463151414|FG003|Overall Study|Physician Decision|1|||
128686131|NCT05298306|463151415|FG004|Overall Study|Physician Decision|0|||
128686132|NCT05298306|463151416|FG005|Overall Study|Physician Decision|0|||
128686133|NCT02676466|463151421|FG000|Overall Study|Death|0|||
128686134|NCT02676466|463151422|FG001|Overall Study|Death|2|||
128686135|NCT02676466|463151423|FG002|Overall Study|Death|1|||
128686136|NCT02676466|463151424|FG003|Overall Study|Death|0|||
128686137|NCT02676466|463151425|FG004|Overall Study|Death|0|||
128686138|NCT02676466|463151426|FG005|Overall Study|Death|0|||
128686139|NCT02676466|463151427|FG006|Overall Study|Death|0|||
128686140|NCT02676466|463151428|FG007|Overall Study|Death|0|||
128686141|NCT02676466|463151421|FG000|Overall Study|Withdrawal by Subject|4|||
128686142|NCT02676466|463151422|FG001|Overall Study|Withdrawal by Subject|3|||
128686143|NCT02676466|463151423|FG002|Overall Study|Withdrawal by Subject|1|||
128686144|NCT02676466|463151424|FG003|Overall Study|Withdrawal by Subject|0|||
128686145|NCT02676466|463151425|FG004|Overall Study|Withdrawal by Subject|3|||
128686146|NCT02676466|463151426|FG005|Overall Study|Withdrawal by Subject|1|||
128686147|NCT02676466|463151427|FG006|Overall Study|Withdrawal by Subject|1|||
128686148|NCT02676466|463151428|FG007|Overall Study|Withdrawal by Subject|1|||
128686149|NCT01178073|463151431|FG000|Overall Study|Adverse Event|34|||
128686150|NCT01178073|463151432|FG001|Overall Study|Adverse Event|27|||
128686151|NCT01178073|463151433|FG002|Overall Study|Adverse Event|24|||
128686152|NCT01178073|463151431|FG000|Overall Study|Protocol Violation|1|||
128686153|NCT01178073|463151432|FG001|Overall Study|Protocol Violation|1|||
128686154|NCT01178073|463151433|FG002|Overall Study|Protocol Violation|1|||
128686155|NCT01178073|463151431|FG000|Overall Study|Lost to Follow-up|2|||
128686156|NCT01178073|463151432|FG001|Overall Study|Lost to Follow-up|0|||
128686157|NCT01178073|463151433|FG002|Overall Study|Lost to Follow-up|3|||
128686158|NCT01178073|463151431|FG000|Overall Study|Physician Decision|14|||
128686159|NCT01178073|463151432|FG001|Overall Study|Physician Decision|10|||
128686160|NCT01178073|463151433|FG002|Overall Study|Physician Decision|10|||
128686161|NCT01178073|463151431|FG000|Overall Study|Withdrawal by Subject|10|||
128686162|NCT01178073|463151432|FG001|Overall Study|Withdrawal by Subject|6|||
128686163|NCT01178073|463151433|FG002|Overall Study|Withdrawal by Subject|8|||
128686164|NCT01178073|463151431|FG000|Overall Study|Missing Completion Status|1|||
128686165|NCT01178073|463151432|FG001|Overall Study|Missing Completion Status|0|||
128686166|NCT01178073|463151433|FG002|Overall Study|Missing Completion Status|0|||
128686167|NCT01721070|463151434|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
128686168|NCT03497676|463151435|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
128686169|NCT03497676|463151436|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
128686170|NCT03497676|463151437|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
128686171|NCT03497676|463151438|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
128686172|NCT03497676|463151435|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
128686173|NCT03497676|463151436|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
128686174|NCT03497676|463151437|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
128686175|NCT03497676|463151438|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
128686176|NCT03497676|463151435|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
128686177|NCT03497676|463151436|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
128686178|NCT03497676|463151437|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
128686179|NCT03497676|463151438|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
128686180|NCT03497676|463151435|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
128686181|NCT03497676|463151436|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
128686182|NCT03497676|463151437|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
128686183|NCT03497676|463151438|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
128686184|NCT03497676|463151435|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
128686185|NCT03497676|463151436|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
128686186|NCT03497676|463151437|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
128686187|NCT03497676|463151438|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
128686188|NCT03497676|463151435|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
128686189|NCT03497676|463151436|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
128686190|NCT03497676|463151437|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
128686191|NCT03497676|463151438|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
128686192|NCT03497676|463151435|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
128686193|NCT03497676|463151436|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
128686194|NCT03497676|463151437|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
128686195|NCT03497676|463151438|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
129109628|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129109629|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129109630|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
129109631|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109632|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129109633|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
129109634|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
129109635|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
129109636|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
129109637|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
129109638|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
129109639|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
128686196|NCT03497676|463151435|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
128686197|NCT03497676|463151436|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
128686198|NCT03497676|463151437|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
128686199|NCT03497676|463151438|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
128686200|NCT01226043|463151448|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
128686201|NCT01226043|463151449|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
128686202|NCT01226043|463151450|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
128686203|NCT01226043|463151451|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
128686204|NCT01226043|463151448|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
128686205|NCT01226043|463151449|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
128686206|NCT01226043|463151450|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
128686207|NCT01226043|463151451|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
128686208|NCT01226043|463151448|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
128686209|NCT01226043|463151449|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
128686210|NCT01226043|463151450|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
128686211|NCT01226043|463151451|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
128686212|NCT01226043|463151448|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
128686213|NCT01226043|463151449|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
128686214|NCT01226043|463151450|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
128686215|NCT01226043|463151451|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
128686216|NCT01226043|463151448|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
128686217|NCT01226043|463151449|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
128686218|NCT01226043|463151450|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
128686219|NCT01226043|463151451|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
128686220|NCT01226043|463151448|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
128686221|NCT01226043|463151449|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
128686222|NCT01226043|463151450|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
128686223|NCT01226043|463151451|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
128686224|NCT01226043|463151448|FG000|6-week Re-randomization Phase|Adverse Event|0|||
128686225|NCT01226043|463151449|FG001|6-week Re-randomization Phase|Adverse Event|0|||
128686226|NCT01226043|463151450|FG002|6-week Re-randomization Phase|Adverse Event|1|||
128686227|NCT01226043|463151451|FG003|6-week Re-randomization Phase|Adverse Event|1|||
128686228|NCT01226043|463151448|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
128686229|NCT01226043|463151449|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
128686230|NCT01226043|463151450|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
128686231|NCT01226043|463151451|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
128686232|NCT01226043|463151448|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
128686233|NCT01226043|463151449|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
128686234|NCT01226043|463151450|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
128686235|NCT01226043|463151451|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
128686236|NCT01226043|463151448|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
128686237|NCT01226043|463151449|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
128686238|NCT01226043|463151450|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
128686239|NCT01226043|463151451|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
128686240|NCT01226043|463151448|FG000|6-week Re-randomization Phase|Physician Decision|0|||
128686241|NCT01226043|463151449|FG001|6-week Re-randomization Phase|Physician Decision|0|||
128686242|NCT01226043|463151450|FG002|6-week Re-randomization Phase|Physician Decision|3|||
128686243|NCT01226043|463151451|FG003|6-week Re-randomization Phase|Physician Decision|2|||
128686244|NCT01226043|463151448|FG000|6-week Re-randomization Phase|completed in error|0|||
128686245|NCT01226043|463151449|FG001|6-week Re-randomization Phase|completed in error|0|||
128686246|NCT01226043|463151450|FG002|6-week Re-randomization Phase|completed in error|0|||
128686247|NCT01226043|463151451|FG003|6-week Re-randomization Phase|completed in error|1|||
128686248|NCT01226043|463151448|FG000|30-week Observational Phase|Adverse Event|0|||
128686249|NCT01226043|463151449|FG001|30-week Observational Phase|Adverse Event|0|||
129109640|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
128887048|NCT00372385|463880612|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
128686250|NCT01226043|463151450|FG002|30-week Observational Phase|Adverse Event|1|||
128686251|NCT01226043|463151451|FG003|30-week Observational Phase|Adverse Event|1|||
128686252|NCT01226043|463151448|FG000|30-week Observational Phase|Protocol Violation|0|||
128686253|NCT01226043|463151449|FG001|30-week Observational Phase|Protocol Violation|0|||
128686254|NCT01226043|463151450|FG002|30-week Observational Phase|Protocol Violation|0|||
128686255|NCT01226043|463151451|FG003|30-week Observational Phase|Protocol Violation|1|||
128686256|NCT01226043|463151448|FG000|30-week Observational Phase|Lost to Follow-up|0|||
128686257|NCT01226043|463151449|FG001|30-week Observational Phase|Lost to Follow-up|0|||
128686258|NCT01226043|463151450|FG002|30-week Observational Phase|Lost to Follow-up|2|||
128686259|NCT01226043|463151451|FG003|30-week Observational Phase|Lost to Follow-up|2|||
128686260|NCT01226043|463151448|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
128686261|NCT01226043|463151449|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
128686262|NCT01226043|463151450|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
128686263|NCT01226043|463151451|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
128686264|NCT01226043|463151448|FG000|30-week Observational Phase|Physician Decision|0|||
128686265|NCT01226043|463151449|FG001|30-week Observational Phase|Physician Decision|0|||
128686266|NCT01226043|463151450|FG002|30-week Observational Phase|Physician Decision|2|||
128686267|NCT01226043|463151451|FG003|30-week Observational Phase|Physician Decision|2|||
128686268|NCT02204007|463151452|FG000|Overall Study|Surgery Canceled|1|||
128686269|NCT02204007|463151453|FG001|Overall Study|Surgery Canceled|1|||
128686270|NCT00910988|463151454|FG000|Overall Study|Lost to Follow-up|2|||
128686271|NCT00910988|463151455|FG001|Overall Study|Lost to Follow-up|4|||
128686272|NCT00910988|463151456|FG002|Overall Study|Lost to Follow-up|3|||
128686273|NCT00910988|463151457|FG003|Overall Study|Lost to Follow-up|0|||
128686274|NCT03004443|463151458|FG000|Overall Study|Pregnancy|0|||
128686275|NCT03004443|463151459|FG001|Overall Study|Pregnancy|1|||
128686276|NCT00828854|463151460|FG000|Overall Study|Disease Progression|17|||
128686277|NCT00828854|463151460|FG000|Overall Study|Adverse Event|9|||
128686278|NCT00828854|463151460|FG000|Overall Study|Reason not Specified|1|||
128686279|NCT00191646|463151462|FG000|Overall Study|Toxicity|26|||
128686280|NCT00191646|463151463|FG001|Overall Study|Toxicity|37|||
128686281|NCT00191646|463151462|FG000|Overall Study|Disease Progression|5|||
128686282|NCT00191646|463151463|FG001|Overall Study|Disease Progression|6|||
128686283|NCT00191646|463151462|FG000|Overall Study|Physician Decision|20|||
128686284|NCT00191646|463151463|FG001|Overall Study|Physician Decision|11|||
128686285|NCT00191646|463151462|FG000|Overall Study|Withdrawal by Subject|58|||
128686286|NCT00191646|463151463|FG001|Overall Study|Withdrawal by Subject|39|||
128686287|NCT00191646|463151462|FG000|Overall Study|Protocol Violation|5|||
128686288|NCT00191646|463151463|FG001|Overall Study|Protocol Violation|7|||
128686289|NCT00191646|463151462|FG000|Overall Study|Death|6|||
128686290|NCT00191646|463151463|FG001|Overall Study|Death|8|||
128686291|NCT00191646|463151462|FG000|Overall Study|Other|33|||
128686292|NCT00191646|463151463|FG001|Overall Study|Other|34|||
128686293|NCT00191646|463151462|FG000|Overall Study|Missing Data|18|||
128686294|NCT00191646|463151463|FG001|Overall Study|Missing Data|11|||
128686295|NCT05211284|463151468|FG000|Overall Study|Study Terminated|3|||
128686296|NCT05211284|463151469|FG001|Overall Study|Study Terminated|1|||
128686297|NCT03911843|463151470|FG000|Overall Study|Adverse Event|2|||
128686298|NCT03911843|463151471|FG001|Overall Study|Adverse Event|0|||
128686299|NCT03911843|463151470|FG000|Overall Study|Protocol Violation|2|||
128686300|NCT03911843|463151471|FG001|Overall Study|Protocol Violation|0|||
128686301|NCT03911843|463151470|FG000|Overall Study|Lost to Follow-up|0|||
128686302|NCT03911843|463151471|FG001|Overall Study|Lost to Follow-up|1|||
128686303|NCT01907100|463151472|FG000|Overall Study|PD based on modified RECIST criteria|31|||
128686304|NCT01907100|463151473|FG001|Overall Study|PD based on modified RECIST criteria|32|||
128686305|NCT01907100|463151474|FG002|Overall Study|PD based on modified RECIST criteria|95|||
128686306|NCT01907100|463151475|FG003|Overall Study|PD based on modified RECIST criteria|92|||
128686307|NCT01907100|463151472|FG000|Overall Study|Withdrawal by Subject|2|||
128686308|NCT01907100|463151473|FG001|Overall Study|Withdrawal by Subject|5|||
128686309|NCT01907100|463151474|FG002|Overall Study|Withdrawal by Subject|10|||
128686310|NCT01907100|463151475|FG003|Overall Study|Withdrawal by Subject|13|||
128686311|NCT01907100|463151472|FG000|Overall Study|Protocol Violation|0|||
128686312|NCT01907100|463151473|FG001|Overall Study|Protocol Violation|0|||
128686313|NCT01907100|463151474|FG002|Overall Study|Protocol Violation|1|||
128686314|NCT01907100|463151475|FG003|Overall Study|Protocol Violation|1|||
128686315|NCT01907100|463151472|FG000|Overall Study|Lost to Follow-up|0|||
128686316|NCT01907100|463151473|FG001|Overall Study|Lost to Follow-up|0|||
128686317|NCT01907100|463151474|FG002|Overall Study|Lost to Follow-up|0|||
128686318|NCT01907100|463151475|FG003|Overall Study|Lost to Follow-up|1|||
128686319|NCT01907100|463151472|FG000|Overall Study|Not treated|2|||
128686320|NCT01907100|463151473|FG001|Overall Study|Not treated|0|||
128686321|NCT01907100|463151474|FG002|Overall Study|Not treated|1|||
128686322|NCT01907100|463151475|FG003|Overall Study|Not treated|2|||
128686323|NCT01907100|463151472|FG000|Overall Study|Other than reasons specified|1|||
128686324|NCT01907100|463151473|FG001|Overall Study|Other than reasons specified|0|||
128686325|NCT01907100|463151474|FG002|Overall Study|Other than reasons specified|10|||
128686326|NCT01907100|463151475|FG003|Overall Study|Other than reasons specified|6|||
128686327|NCT01907100|463151472|FG000|Overall Study|Adverse event (AE)|6|||
128686328|NCT01907100|463151473|FG001|Overall Study|Adverse event (AE)|3|||
128686329|NCT01907100|463151474|FG002|Overall Study|Adverse event (AE)|22|||
128686330|NCT01907100|463151475|FG003|Overall Study|Adverse event (AE)|23|||
128686331|NCT01907100|463151472|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
128686332|NCT01907100|463151473|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
128686333|NCT01907100|463151474|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
128686334|NCT01907100|463151475|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
128686335|NCT02059005|463151476|FG000|Overall Study|Death|1|||
128686336|NCT02059005|463151477|FG001|Overall Study|Death|3|||
128686337|NCT02059005|463151476|FG000|Overall Study|Lost to Follow-up|19|||
128686338|NCT02059005|463151477|FG001|Overall Study|Lost to Follow-up|19|||
128686339|NCT02059005|463151476|FG000|Overall Study|Incarceration|0|||
128686340|NCT02059005|463151477|FG001|Overall Study|Incarceration|1|||
128686341|NCT02059005|463151476|FG000|Overall Study|Inpatient|0|||
128686342|NCT02059005|463151477|FG001|Overall Study|Inpatient|1|||
128686343|NCT00739596|463151478|FG000|Overall Study|Adverse Event|12|||
128686344|NCT00739596|463151479|FG001|Overall Study|Adverse Event|6|||
128686345|NCT00739596|463151478|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
128686346|NCT00739596|463151479|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
128686347|NCT00739596|463151478|FG000|Overall Study|Patient Withdrew Consent|8|||
128686348|NCT00739596|463151479|FG001|Overall Study|Patient Withdrew Consent|8|||
128686349|NCT00739596|463151478|FG000|Overall Study|Lost to Follow-up|0|||
128686350|NCT00739596|463151479|FG001|Overall Study|Lost to Follow-up|2|||
128686351|NCT00739596|463151478|FG000|Overall Study|Protocol Deviation|1|||
128686352|NCT00739596|463151479|FG001|Overall Study|Protocol Deviation|1|||
128686353|NCT00908011|463151484|FG000|Overall Study|Withdrawal by Subject|2|||
128686354|NCT00908011|463151485|FG001|Overall Study|Withdrawal by Subject|2|||
128686355|NCT00644228|463151486|FG000|Randomization & Eligibility|Ineligible|31|||
128686356|NCT00644228|463151487|FG001|Randomization & Eligibility|Ineligible|21|||
128686357|NCT00644228|463151486|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
128686358|NCT00644228|463151487|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
128686359|NCT00644228|463151486|FG000|Randomization & Eligibility|Invalid Consent|0|||
128686360|NCT00644228|463151487|FG001|Randomization & Eligibility|Invalid Consent|1|||
128686361|NCT00644228|463151486|FG000|Induction Therapy|Adverse Event|22|||
128686362|NCT00644228|463151487|FG001|Induction Therapy|Adverse Event|55|||
128686363|NCT00644228|463151486|FG000|Induction Therapy|Withdrawal by Subject|10|||
128686364|NCT00644228|463151487|FG001|Induction Therapy|Withdrawal by Subject|3|||
128686365|NCT00644228|463151486|FG000|Induction Therapy|Progression/Relapse|24|||
128686366|NCT00644228|463151487|FG001|Induction Therapy|Progression/Relapse|12|||
128686367|NCT00644228|463151486|FG000|Induction Therapy|Death|3|||
128686368|NCT00644228|463151487|FG001|Induction Therapy|Death|7|||
128686369|NCT00644228|463151486|FG000|Induction Therapy|Not Protocol-Specified|24|||
128686370|NCT00644228|463151487|FG001|Induction Therapy|Not Protocol-Specified|28|||
128686371|NCT00644228|463151486|FG000|Maintenance|Adverse Event|27|||
128686372|NCT00644228|463151487|FG001|Maintenance|Adverse Event|31|||
128686373|NCT00644228|463151486|FG000|Maintenance|Withdrawal by Subject|6|||
128686374|NCT00644228|463151487|FG001|Maintenance|Withdrawal by Subject|4|||
128686375|NCT00644228|463151486|FG000|Maintenance|Progression/Relapse|67|||
128686376|NCT00644228|463151487|FG001|Maintenance|Progression/Relapse|42|||
128686377|NCT00644228|463151486|FG000|Maintenance|Death|3|||
128686378|NCT00644228|463151487|FG001|Maintenance|Death|3|||
128686379|NCT00644228|463151486|FG000|Maintenance|Not Protocol-Specified|14|||
128686380|NCT00644228|463151487|FG001|Maintenance|Not Protocol-Specified|15|||
128686381|NCT00644228|463151486|FG000|Maintenance|On Treatment|26|||
128686382|NCT00644228|463151487|FG001|Maintenance|On Treatment|40|||
128686383|NCT00760084|463151488|FG000|Overall Study|Physician Decision|5|||
128686384|NCT00760084|463151488|FG000|Overall Study|Withdrawal by Subject|2|||
128686385|NCT00760084|463151488|FG000|Overall Study|Progressive Disease|3|||
128686386|NCT02567552|463151489|FG000|Overall Study|Adverse Event|0|||
128686387|NCT02567552|463151490|FG001|Overall Study|Adverse Event|1|||
128686388|NCT03187756|463151491|FG000|Overall Study|Termination of study|4|||
128686389|NCT02142803|463151492|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
128686390|NCT02142803|463151493|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
128686391|NCT02142803|463151494|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
128686392|NCT02142803|463151495|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
128686393|NCT02718300|463151501|FG000|Overall Study|Death|4|||
128686394|NCT02718300|463151502|FG001|Overall Study|Death|5|||
128686395|NCT02718300|463151503|FG002|Overall Study|Death|17|||
128686396|NCT02718300|463151501|FG000|Overall Study|Lost to Follow-up|1|||
128686397|NCT02718300|463151502|FG001|Overall Study|Lost to Follow-up|0|||
128686398|NCT02718300|463151503|FG002|Overall Study|Lost to Follow-up|2|||
128686399|NCT02718300|463151501|FG000|Overall Study|Physician Decision|1|||
128686400|NCT02718300|463151502|FG001|Overall Study|Physician Decision|0|||
128686401|NCT02718300|463151503|FG002|Overall Study|Physician Decision|2|||
128686402|NCT02718300|463151501|FG000|Overall Study|Study Terminated by Sponsor|6|||
128686403|NCT02718300|463151502|FG001|Overall Study|Study Terminated by Sponsor|3|||
128686404|NCT02718300|463151503|FG002|Overall Study|Study Terminated by Sponsor|4|||
128686405|NCT02718300|463151501|FG000|Overall Study|Withdrawal by Subject|0|||
128686406|NCT02718300|463151502|FG001|Overall Study|Withdrawal by Subject|4|||
128686407|NCT02718300|463151503|FG002|Overall Study|Withdrawal by Subject|3|||
128686408|NCT02718300|463151501|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
128686409|NCT02718300|463151502|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
128686410|NCT02718300|463151503|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
128686411|NCT01002482|463152851|FG000|Overall Study|Withdrawal by Subject|14|||
128686412|NCT01002482|463152852|FG001|Overall Study|Withdrawal by Subject|21|||
128686413|NCT01002482|463152851|FG000|Overall Study|Included twice|1|||
128686414|NCT01002482|463152852|FG001|Overall Study|Included twice|0|||
128686415|NCT02545075|463152864|FG000|Randomization|Lost to Follow-up|0|||
128686416|NCT02545075|463152865|FG001|Randomization|Lost to Follow-up|1|||
128686417|NCT02545075|463152864|FG000|Randomization|Withdrawal by Subject|0|||
128686418|NCT02545075|463152865|FG001|Randomization|Withdrawal by Subject|6|||
128686419|NCT02545075|463152864|FG000|Treatment|Disease progression|71|||
128686420|NCT02545075|463152865|FG001|Treatment|Disease progression|32|||
128686421|NCT02545075|463152864|FG000|Treatment|Participant dicontinued study treatment|7|||
128686422|NCT02545075|463152865|FG001|Treatment|Participant dicontinued study treatment|9|||
128686423|NCT02545075|463152864|FG000|Treatment|Withdrawal by Subject|1|||
128686424|NCT02545075|463152865|FG001|Treatment|Withdrawal by Subject|0|||
128686425|NCT02545075|463152864|FG000|Treatment|Adverse event not related to study drug|1|||
128686426|NCT02545075|463152865|FG001|Treatment|Adverse event not related to study drug|0|||
128686427|NCT02545075|463152864|FG000|Treatment|Death|1|||
128686428|NCT02545075|463152865|FG001|Treatment|Death|0|||
128686429|NCT02545075|463152864|FG000|Treatment|Participant drug toxicity|1|||
128686430|NCT02545075|463152865|FG001|Treatment|Participant drug toxicity|0|||
128686431|NCT02545075|463152864|FG000|Treatment|Completed treatment|40|||
128686432|NCT02545075|463152865|FG001|Treatment|Completed treatment|12|||
128686433|NCT00736879|463152868|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
128686434|NCT00736879|463152869|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
128686435|NCT00736879|463152870|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
128686436|NCT00736879|463152871|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
128686437|NCT00736879|463152868|FG000|Double Blind Treatment Period|Adverse Event|0|||
128686438|NCT00736879|463152869|FG001|Double Blind Treatment Period|Adverse Event|1|||
128686439|NCT00736879|463152870|FG002|Double Blind Treatment Period|Adverse Event|1|||
128686440|NCT00736879|463152871|FG003|Double Blind Treatment Period|Adverse Event|0|||
128686441|NCT00736879|463152868|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
128686442|NCT00736879|463152869|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
128686443|NCT00736879|463152870|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
128686444|NCT00736879|463152871|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
128686445|NCT00736879|463152868|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
128686446|NCT00736879|463152869|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
128686447|NCT00736879|463152870|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
128686448|NCT00736879|463152871|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
128686449|NCT00736879|463152868|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
128686450|NCT00736879|463152869|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
128686451|NCT00736879|463152870|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
128686452|NCT00736879|463152871|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
128686453|NCT00736879|463152868|FG000|Double Blind Treatment Period|No longer met criteria|0|||
128686454|NCT00736879|463152869|FG001|Double Blind Treatment Period|No longer met criteria|1|||
128686455|NCT00736879|463152870|FG002|Double Blind Treatment Period|No longer met criteria|0|||
128686456|NCT00736879|463152871|FG003|Double Blind Treatment Period|No longer met criteria|0|||
128686457|NCT00736879|463152868|FG000|Double Blind Treatment Period|non-specified|0|||
128686458|NCT00736879|463152869|FG001|Double Blind Treatment Period|non-specified|1|||
128686459|NCT00736879|463152870|FG002|Double Blind Treatment Period|non-specified|0|||
128686460|NCT00736879|463152871|FG003|Double Blind Treatment Period|non-specified|0|||
128686461|NCT00736879|463152868|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
128686462|NCT00736879|463152869|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
128686463|NCT00736879|463152870|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
128686464|NCT00736879|463152871|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
128686465|NCT00736879|463152868|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
128686466|NCT00736879|463152869|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
128686467|NCT00736879|463152870|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
128686468|NCT00736879|463152871|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
128686469|NCT01810432|463152872|FG000|Washout|Protocol Violation|0|||
128686470|NCT01810432|463152873|FG001|Washout|Protocol Violation|1|||
128686471|NCT01810432|463152872|FG000|Washout|Adverse Event|1|||
128686472|NCT01810432|463152873|FG001|Washout|Adverse Event|0|||
128887049|NCT00372385|463880613|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
128887050|NCT00372385|463880610|FG000|Overall Study|Virologic Stopping Rule|17|||
129109641|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
129109642|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
129109643|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
129109644|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
129109645|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
129109646|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
129109647|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
129109648|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
129109649|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
129109650|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
129109651|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
129109652|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129215183|NCT03955146|465089450|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
128686473|NCT01810432|463152872|FG000|Period 2|Withdrawal by Subject|2|||
128686474|NCT01810432|463152873|FG001|Period 2|Withdrawal by Subject|1|||
128686475|NCT01810432|463152872|FG000|Period 2|Physician Decision|1|||
128686476|NCT01810432|463152873|FG001|Period 2|Physician Decision|0|||
128686477|NCT01810432|463152872|FG000|Period 2|Lost to Follow-up|1|||
128686478|NCT01810432|463152873|FG001|Period 2|Lost to Follow-up|1|||
128686479|NCT02360111|463152874|FG000|Overall Study|Death|2|||
128686480|NCT03923738|463152877|FG000|Period 1|Adverse Event|1|||
128686481|NCT03923738|463152877|FG000|Period 1|Withdrawal by Subject|1|||
128686482|NCT00735254|463152879|FG000|Overall Study|Protocol Violation|1|||
128686483|NCT00735254|463152880|FG001|Overall Study|Protocol Violation|1|||
128686484|NCT00735254|463152881|FG002|Overall Study|Protocol Violation|1|||
128686485|NCT00735254|463152882|FG003|Overall Study|Protocol Violation|0|||
128686486|NCT01251744|463152883|FG000|Overall Study|Lost to Follow-up|1|||
128686487|NCT01251744|463152884|FG001|Overall Study|Lost to Follow-up|0|||
128686488|NCT00751621|463152885|FG000|Overall Study|Adverse Event|1|||
128686489|NCT00751621|463152885|FG000|Overall Study|Withdrawal by Subject|1|||
128686490|NCT00751621|463152885|FG000|Overall Study|Subject moved to another country|1|||
128686491|NCT00751621|463152885|FG000|Overall Study|Poor adherence to asthma treatment|1|||
128686492|NCT02694523|463152886|FG000|Part A|Adverse Event|7|||
128686493|NCT02694523|463152887|FG001|Part A|Adverse Event|3|||
128686494|NCT02694523|463152888|FG002|Part A|Adverse Event|0|||
128686495|NCT02694523|463152889|FG003|Part A|Adverse Event|0|||
128686496|NCT02694523|463152890|FG004|Part A|Adverse Event|0|||
128686497|NCT02694523|463152891|FG005|Part A|Adverse Event|0|||
128686498|NCT02694523|463152892|FG006|Part A|Adverse Event|0|||
128686499|NCT02694523|463152886|FG000|Part A|Protocol Violation|1|||
128686500|NCT02694523|463152887|FG001|Part A|Protocol Violation|0|||
128686501|NCT02694523|463152888|FG002|Part A|Protocol Violation|0|||
128686502|NCT02694523|463152889|FG003|Part A|Protocol Violation|0|||
128686503|NCT02694523|463152890|FG004|Part A|Protocol Violation|0|||
128686504|NCT02694523|463152891|FG005|Part A|Protocol Violation|0|||
128686505|NCT02694523|463152892|FG006|Part A|Protocol Violation|0|||
128686506|NCT02694523|463152886|FG000|Part A|Lost to Follow-up|1|||
128686507|NCT02694523|463152887|FG001|Part A|Lost to Follow-up|2|||
128686508|NCT02694523|463152888|FG002|Part A|Lost to Follow-up|0|||
128686509|NCT02694523|463152889|FG003|Part A|Lost to Follow-up|0|||
128686510|NCT02694523|463152890|FG004|Part A|Lost to Follow-up|0|||
128686511|NCT02694523|463152891|FG005|Part A|Lost to Follow-up|0|||
128686512|NCT02694523|463152892|FG006|Part A|Lost to Follow-up|0|||
128686513|NCT02694523|463152886|FG000|Part A|Withdrawal by Subject|3|||
128686514|NCT02694523|463152887|FG001|Part A|Withdrawal by Subject|1|||
128686515|NCT02694523|463152888|FG002|Part A|Withdrawal by Subject|0|||
128686516|NCT02694523|463152889|FG003|Part A|Withdrawal by Subject|0|||
128686517|NCT02694523|463152890|FG004|Part A|Withdrawal by Subject|0|||
128686518|NCT02694523|463152891|FG005|Part A|Withdrawal by Subject|0|||
128686519|NCT02694523|463152892|FG006|Part A|Withdrawal by Subject|0|||
128686520|NCT02694523|463152886|FG000|Part A|Other|1|||
128686521|NCT02694523|463152887|FG001|Part A|Other|1|||
128686522|NCT02694523|463152888|FG002|Part A|Other|0|||
128686523|NCT02694523|463152889|FG003|Part A|Other|0|||
129215184|NCT03955146|465089451|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
128686524|NCT02694523|463152890|FG004|Part A|Other|0|||
128686525|NCT02694523|463152891|FG005|Part A|Other|0|||
128686526|NCT02694523|463152892|FG006|Part A|Other|0|||
128686527|NCT02694523|463152886|FG000|Part B|Adverse Event|0|||
128686528|NCT02694523|463152887|FG001|Part B|Adverse Event|0|||
128686529|NCT02694523|463152888|FG002|Part B|Adverse Event|7|||
128686530|NCT02694523|463152889|FG003|Part B|Adverse Event|1|||
128686531|NCT02694523|463152890|FG004|Part B|Adverse Event|1|||
128686532|NCT02694523|463152891|FG005|Part B|Adverse Event|2|||
128686533|NCT02694523|463152892|FG006|Part B|Adverse Event|0|||
128686534|NCT02694523|463152886|FG000|Part B|Protocol Violation|0|||
128686535|NCT02694523|463152887|FG001|Part B|Protocol Violation|0|||
128686536|NCT02694523|463152888|FG002|Part B|Protocol Violation|1|||
128686537|NCT02694523|463152889|FG003|Part B|Protocol Violation|0|||
128686538|NCT02694523|463152890|FG004|Part B|Protocol Violation|0|||
128686539|NCT02694523|463152891|FG005|Part B|Protocol Violation|0|||
128686540|NCT02694523|463152892|FG006|Part B|Protocol Violation|0|||
128686541|NCT02694523|463152886|FG000|Part B|Lost to Follow-up|0|||
128686542|NCT02694523|463152887|FG001|Part B|Lost to Follow-up|0|||
128686543|NCT02694523|463152888|FG002|Part B|Lost to Follow-up|2|||
128686544|NCT02694523|463152889|FG003|Part B|Lost to Follow-up|3|||
128686545|NCT02694523|463152890|FG004|Part B|Lost to Follow-up|2|||
128686546|NCT02694523|463152891|FG005|Part B|Lost to Follow-up|0|||
128686547|NCT02694523|463152892|FG006|Part B|Lost to Follow-up|1|||
128686548|NCT02694523|463152886|FG000|Part B|Withdrawal by Subject|0|||
128686549|NCT02694523|463152887|FG001|Part B|Withdrawal by Subject|0|||
128686550|NCT02694523|463152888|FG002|Part B|Withdrawal by Subject|9|||
128686551|NCT02694523|463152889|FG003|Part B|Withdrawal by Subject|0|||
128686552|NCT02694523|463152890|FG004|Part B|Withdrawal by Subject|1|||
128686553|NCT02694523|463152891|FG005|Part B|Withdrawal by Subject|3|||
128686554|NCT02694523|463152892|FG006|Part B|Withdrawal by Subject|0|||
128686555|NCT02694523|463152886|FG000|Part B|Other|0|||
128686556|NCT02694523|463152887|FG001|Part B|Other|0|||
128686557|NCT02694523|463152888|FG002|Part B|Other|1|||
128686558|NCT02694523|463152889|FG003|Part B|Other|0|||
128686559|NCT02694523|463152890|FG004|Part B|Other|0|||
128686560|NCT02694523|463152891|FG005|Part B|Other|0|||
128686561|NCT02694523|463152892|FG006|Part B|Other|1|||
128686562|NCT04505540|463152894|FG000|Baseline|Protocol Violation|10|||
128686563|NCT04505540|463152894|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
128686564|NCT04505540|463152894|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
128686565|NCT04505540|463152894|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
128686566|NCT04505540|463152894|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
128686567|NCT04505540|463152894|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
128686568|NCT04505540|463152894|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
128686569|NCT04505540|463152894|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
128686570|NCT04505540|463152894|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
128686571|NCT04505540|463152894|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
128686572|NCT04505540|463152894|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
128686573|NCT04505540|463152894|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
128686574|NCT04505540|463152894|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
128686575|NCT02310321|463152895|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
128686576|NCT02310321|463152896|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
128686577|NCT02310321|463152897|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
128686578|NCT02310321|463152895|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
128686579|NCT02310321|463152896|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
128686580|NCT02310321|463152897|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
128686581|NCT02310321|463152895|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
128686582|NCT02310321|463152896|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
128686583|NCT02310321|463152897|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
128686584|NCT02310321|463152895|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
128686585|NCT02310321|463152896|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
128686586|NCT02310321|463152897|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
128686587|NCT02310321|463152895|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
128686588|NCT02310321|463152896|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
128686589|NCT02310321|463152897|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
128686590|NCT02310321|463152895|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
128686591|NCT02310321|463152896|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
128686592|NCT02310321|463152897|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
128686593|NCT02310321|463152895|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
128686594|NCT02310321|463152896|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
129109653|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
128686595|NCT02310321|463152897|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
128686596|NCT02310321|463152895|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
128686597|NCT02310321|463152896|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
128686598|NCT02310321|463152897|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
128686599|NCT02310321|463152895|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
128686600|NCT02310321|463152896|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
128686601|NCT02310321|463152897|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
128686602|NCT02310321|463152895|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
128686603|NCT02310321|463152896|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
128686604|NCT02310321|463152897|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
128686605|NCT02310321|463152895|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
128686606|NCT02310321|463152896|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
128686607|NCT02310321|463152897|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
128686608|NCT02310321|463152895|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
128686609|NCT02310321|463152896|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
128686610|NCT02310321|463152897|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
128686611|NCT02310321|463152895|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
128686612|NCT02310321|463152896|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
128686613|NCT02310321|463152897|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
128686614|NCT02310321|463152895|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
128686615|NCT02310321|463152896|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
128686616|NCT02310321|463152897|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
128686617|NCT02310321|463152895|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
128686618|NCT02310321|463152896|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
128686619|NCT02310321|463152897|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
128686620|NCT02310321|463152895|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
128686621|NCT02310321|463152896|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
128686622|NCT02310321|463152897|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
128686623|NCT02310321|463152895|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
128686624|NCT02310321|463152896|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
128686625|NCT02310321|463152897|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
128686626|NCT02310321|463152895|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
128686627|NCT02310321|463152896|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
128686628|NCT02310321|463152897|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
128686629|NCT02310321|463152895|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
128686630|NCT02310321|463152896|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
128686631|NCT02310321|463152897|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
128686632|NCT02310321|463152895|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
128686633|NCT02310321|463152896|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
128686634|NCT02310321|463152897|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
128686635|NCT02310321|463152895|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
128686636|NCT02310321|463152896|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
128686637|NCT02310321|463152897|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
128686638|NCT02310321|463152895|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
128686639|NCT02310321|463152896|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
128686640|NCT02310321|463152897|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
128686641|NCT02310321|463152895|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
128686642|NCT02310321|463152896|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
128686643|NCT02310321|463152897|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
128686644|NCT01698905|463152898|FG000|Overall Study|Adverse Event|4|||
128686645|NCT01698905|463152898|FG000|Overall Study|Physician Decision|2|||
128686646|NCT01698905|463152898|FG000|Overall Study|Pregnancy|1|||
128686647|NCT01698905|463152898|FG000|Overall Study|Protocol Violation|1|||
128686648|NCT01698905|463152898|FG000|Overall Study|Subject/guardian decision|2|||
128686649|NCT01698905|463152898|FG000|Overall Study|Death|1|||
128686650|NCT02325791|463152901|FG000|Overall Study|Adverse Event|0|||
128686651|NCT02325791|463152902|FG001|Overall Study|Adverse Event|1|||
128686652|NCT02325791|463152903|FG002|Overall Study|Adverse Event|1|||
128686653|NCT02325791|463152904|FG003|Overall Study|Adverse Event|0|||
128686654|NCT02325791|463152901|FG000|Overall Study|Death|0|||
128686655|NCT02325791|463152902|FG001|Overall Study|Death|3|||
128686656|NCT02325791|463152903|FG002|Overall Study|Death|0|||
128686657|NCT02325791|463152904|FG003|Overall Study|Death|1|||
128686658|NCT02325791|463152901|FG000|Overall Study|Lost to Follow-up|0|||
128686659|NCT02325791|463152902|FG001|Overall Study|Lost to Follow-up|15|||
128686660|NCT02325791|463152903|FG002|Overall Study|Lost to Follow-up|14|||
128686661|NCT02325791|463152904|FG003|Overall Study|Lost to Follow-up|9|||
128686662|NCT02325791|463152901|FG000|Overall Study|Physician Decision|0|||
128686663|NCT02325791|463152902|FG001|Overall Study|Physician Decision|1|||
128686664|NCT02325791|463152903|FG002|Overall Study|Physician Decision|1|||
128686665|NCT02325791|463152904|FG003|Overall Study|Physician Decision|0|||
128686666|NCT02325791|463152901|FG000|Overall Study|Protocol Violation|0|||
128686667|NCT02325791|463152902|FG001|Overall Study|Protocol Violation|0|||
128686668|NCT02325791|463152903|FG002|Overall Study|Protocol Violation|1|||
128686669|NCT02325791|463152904|FG003|Overall Study|Protocol Violation|0|||
128686670|NCT02325791|463152901|FG000|Overall Study|Withdrawal by Subject|0|||
128686671|NCT02325791|463152902|FG001|Overall Study|Withdrawal by Subject|5|||
128686672|NCT02325791|463152903|FG002|Overall Study|Withdrawal by Subject|8|||
128686673|NCT02325791|463152904|FG003|Overall Study|Withdrawal by Subject|16|||
128686674|NCT03953183|463152905|FG000|Overall Study|Physician Decision|0|||
128686675|NCT03953183|463152906|FG001|Overall Study|Physician Decision|1|||
128686676|NCT03953183|463152905|FG000|Overall Study|Withdrawal by Subject|0|||
128686677|NCT03953183|463152906|FG001|Overall Study|Withdrawal by Subject|1|||
128686678|NCT00249288|463152907|FG000|Overall Study|Lost to Follow-up|3|||
128686679|NCT00249288|463152908|FG001|Overall Study|Lost to Follow-up|3|||
128686680|NCT00249288|463152907|FG000|Overall Study|Withdrawal by Subject|2|||
128686681|NCT00249288|463152908|FG001|Overall Study|Withdrawal by Subject|2|||
128686682|NCT03059446|463152909|FG000|Overall Study|Adverse Event|11|||
128686683|NCT03059446|463152909|FG000|Overall Study|Withdrawal of Consent|16|||
128686684|NCT03059446|463152909|FG000|Overall Study|Lost to Follow-up|3|||
128686685|NCT03059446|463152909|FG000|Overall Study|Protocol Violation|1|||
128887051|NCT00372385|463880611|FG001|Overall Study|Virologic Stopping Rule|0|||
128887052|NCT00372385|463880612|FG002|Overall Study|Virologic Stopping Rule|0|||
128686686|NCT03059446|463152909|FG000|Overall Study|Study Terminated by Sponsor|131|||
128686687|NCT03059446|463152909|FG000|Overall Study|Reason not Specified|5|||
128686688|NCT02273739|463152910|FG000|Overall Study|Progression of Disease|3|||
128686689|NCT02273739|463152911|FG001|Overall Study|Progression of Disease|4|||
128686690|NCT02273739|463152912|FG002|Overall Study|Progression of Disease|5|||
128686691|NCT02273739|463152913|FG003|Overall Study|Progression of Disease|2|||
128686692|NCT02273739|463152910|FG000|Overall Study|Death|0|||
128686693|NCT02273739|463152911|FG001|Overall Study|Death|0|||
128686694|NCT02273739|463152912|FG002|Overall Study|Death|0|||
128686695|NCT02273739|463152913|FG003|Overall Study|Death|2|||
128686696|NCT02273739|463152910|FG000|Overall Study|Adverse Event|0|||
128686697|NCT02273739|463152911|FG001|Overall Study|Adverse Event|0|||
128686698|NCT02273739|463152912|FG002|Overall Study|Adverse Event|0|||
128686699|NCT02273739|463152913|FG003|Overall Study|Adverse Event|1|||
128686700|NCT02273739|463152910|FG000|Overall Study|Withdrawal by Subject|0|||
128686701|NCT02273739|463152911|FG001|Overall Study|Withdrawal by Subject|0|||
128686702|NCT02273739|463152912|FG002|Overall Study|Withdrawal by Subject|2|||
128686703|NCT02273739|463152913|FG003|Overall Study|Withdrawal by Subject|1|||
128686704|NCT02273739|463152910|FG000|Overall Study|Physician Decision|0|||
128686705|NCT02273739|463152911|FG001|Overall Study|Physician Decision|0|||
128763454|NCT00975221|463425688|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
128686706|NCT02273739|463152912|FG002|Overall Study|Physician Decision|0|||
128763455|NCT00975221|463425689|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
128763456|NCT01492686|463425694|FG000|Double-blind Phase|Adverse Event|0|||
128763457|NCT01492686|463425695|FG001|Double-blind Phase|Adverse Event|2|||
128763458|NCT01492686|463425694|FG000|Double-blind Phase|Physician Decision|0|||
128763459|NCT01492686|463425695|FG001|Double-blind Phase|Physician Decision|1|||
128763460|NCT01492686|463425694|FG000|Double-blind Phase|Withdrawal by Subject|0|||
128763461|NCT01492686|463425695|FG001|Double-blind Phase|Withdrawal by Subject|2|||
128763462|NCT01492686|463425694|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
128763463|NCT01492686|463425695|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
128763464|NCT01492686|463425694|FG000|Open-label Phase|Adverse Event|1|||
128763465|NCT01492686|463425695|FG001|Open-label Phase|Adverse Event|2|||
128763466|NCT01492686|463425694|FG000|Open-label Phase|Physician Decision|1|||
128763467|NCT01492686|463425695|FG001|Open-label Phase|Physician Decision|0|||
128763468|NCT01492686|463425694|FG000|Open-label Phase|Withdrawal by Subject|6|||
128763469|NCT01492686|463425695|FG001|Open-label Phase|Withdrawal by Subject|7|||
128763470|NCT01492686|463425694|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
128763471|NCT01492686|463425695|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
128763472|NCT04887948|463425700|FG000|Overall Study|Death|1|||
128763473|NCT04887948|463425701|FG001|Overall Study|Death|0|||
128763474|NCT04887948|463425702|FG002|Overall Study|Death|0|||
128763475|NCT04887948|463425700|FG000|Overall Study|Lost to Follow-up|1|||
128763476|NCT04887948|463425701|FG001|Overall Study|Lost to Follow-up|0|||
128763477|NCT04887948|463425702|FG002|Overall Study|Lost to Follow-up|3|||
128763478|NCT04887948|463425700|FG000|Overall Study|Physician Decision|0|||
128763479|NCT04887948|463425701|FG001|Overall Study|Physician Decision|4|||
128763480|NCT04887948|463425702|FG002|Overall Study|Physician Decision|1|||
128763481|NCT04887948|463425700|FG000|Overall Study|Protocol Violation|1|||
128763482|NCT04887948|463425701|FG001|Overall Study|Protocol Violation|1|||
128763483|NCT04887948|463425702|FG002|Overall Study|Protocol Violation|0|||
128763484|NCT04887948|463425700|FG000|Overall Study|Withdrawal by Subject|0|||
128763485|NCT04887948|463425701|FG001|Overall Study|Withdrawal by Subject|6|||
128763486|NCT04887948|463425702|FG002|Overall Study|Withdrawal by Subject|1|||
128763487|NCT04887948|463425700|FG000|Overall Study|No longer met eligibility criteria|1|||
128763488|NCT04887948|463425701|FG001|Overall Study|No longer met eligibility criteria|2|||
128763489|NCT04887948|463425702|FG002|Overall Study|No longer met eligibility criteria|1|||
128763490|NCT04887948|463425700|FG000|Overall Study|Other|2|||
128763491|NCT04887948|463425701|FG001|Overall Study|Other|1|||
128686707|NCT02273739|463152913|FG003|Overall Study|Physician Decision|1|||
128686708|NCT04795622|463152914|FG000|Overall Study|Adverse Event|1|||
128686709|NCT04795622|463152915|FG001|Overall Study|Adverse Event|0|||
128686710|NCT04795622|463152914|FG000|Overall Study|Withdrawal by Subject|3|||
128686711|NCT04795622|463152915|FG001|Overall Study|Withdrawal by Subject|3|||
128686712|NCT04795622|463152914|FG000|Overall Study|Protocol Violation|0|||
128686713|NCT04795622|463152915|FG001|Overall Study|Protocol Violation|2|||
128686714|NCT04795622|463152914|FG000|Overall Study|Lost to Follow-up|2|||
128686715|NCT04795622|463152915|FG001|Overall Study|Lost to Follow-up|3|||
128686716|NCT04795622|463152914|FG000|Overall Study|Other|7|||
128763492|NCT04887948|463425702|FG002|Overall Study|Other|1|||
128887053|NCT00372385|463880613|FG003|Overall Study|Virologic Stopping Rule|0|||
128887054|NCT02411578|463880616|FG000|Crossover Trial Phase|Pregnancy|0|||
129109654|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129109655|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129109656|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
129109657|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
129109658|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
129109659|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129109660|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129109661|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129109662|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129109663|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129109664|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
129109665|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
129109666|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
129109667|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
129109668|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129109669|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129109670|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
129109671|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109672|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109673|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109674|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109675|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109676|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109677|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109678|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
129109679|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109680|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109681|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109682|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
129109683|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
129109684|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109685|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
129109686|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109687|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109688|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
129109689|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129109690|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
129109691|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
129109692|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
129109693|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
129109694|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
129109695|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
129109696|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
129109697|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
129109698|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
129109699|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
129109700|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
129109701|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
128686717|NCT04795622|463152915|FG001|Overall Study|Other|8|||
128686718|NCT03309046|463152919|FG000|Overall Study|Withdrawal by Subject|4|||
128686719|NCT03309046|463152920|FG001|Overall Study|Withdrawal by Subject|17|||
128686720|NCT00089674|463152922|FG000|Overall Study|Physician Decision|4|||
128686721|NCT00089674|463152923|FG001|Overall Study|Physician Decision|2|||
128686722|NCT00089674|463152922|FG000|Overall Study|Adverse Event|23|||
128686723|NCT00089674|463152923|FG001|Overall Study|Adverse Event|29|||
128686724|NCT00089674|463152922|FG000|Overall Study|Withdrawal by Subject|143|||
128686725|NCT00089674|463152923|FG001|Overall Study|Withdrawal by Subject|127|||
128686726|NCT00089674|463152922|FG000|Overall Study|Death|43|||
128686727|NCT00089674|463152923|FG001|Overall Study|Death|43|||
128686728|NCT00089674|463152922|FG000|Overall Study|Disease progression|21|||
128686729|NCT00089674|463152923|FG001|Overall Study|Disease progression|23|||
128887055|NCT02411578|463880617|FG001|Crossover Trial Phase|Pregnancy|1|||
129109702|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
129109703|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
129109704|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
128686730|NCT00089674|463152922|FG000|Overall Study|Ineligibility determined|8|||
128686731|NCT00089674|463152923|FG001|Overall Study|Ineligibility determined|10|||
128686732|NCT00089674|463152922|FG000|Overall Study|Lost to Follow-up|21|||
128887056|NCT00651157|463880620|FG000|Overall Study|Death|1|||
128686733|NCT00089674|463152923|FG001|Overall Study|Lost to Follow-up|17|||
128686734|NCT00089674|463152922|FG000|Overall Study|Noncompliance|7|||
128686735|NCT00089674|463152923|FG001|Overall Study|Noncompliance|3|||
128686736|NCT00089674|463152922|FG000|Overall Study|Other|5|||
128686737|NCT00089674|463152923|FG001|Overall Study|Other|9|||
128686738|NCT00089674|463152922|FG000|Overall Study|Requirement for alternative therapy|14|||
128686739|NCT00089674|463152923|FG001|Overall Study|Requirement for alternative therapy|4|||
128686740|NCT03963401|463152924|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
128686741|NCT03963401|463152925|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
128686742|NCT03963401|463152926|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
128686743|NCT03963401|463152927|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
128686744|NCT03963401|463152928|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
128686745|NCT03963401|463152929|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
128686746|NCT03963401|463152924|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
128686747|NCT03963401|463152925|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
128686748|NCT03963401|463152926|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
128686749|NCT03963401|463152927|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
128686750|NCT03963401|463152928|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
128686751|NCT03963401|463152929|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
128686752|NCT03963401|463152924|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
128686753|NCT03963401|463152925|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
128686754|NCT03963401|463152926|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
128686755|NCT03963401|463152927|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
128686756|NCT03963401|463152928|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
128686757|NCT03963401|463152929|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
128686758|NCT03963401|463152924|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
128686759|NCT03963401|463152925|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
128686760|NCT03963401|463152926|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
128686761|NCT03963401|463152927|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
128686762|NCT03963401|463152928|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
128686763|NCT03963401|463152929|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
128686764|NCT03963401|463152924|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
128686765|NCT03963401|463152925|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
128686766|NCT03963401|463152926|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
128686767|NCT03963401|463152927|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
128686768|NCT03963401|463152928|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
128686769|NCT03963401|463152929|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
128686770|NCT03963401|463152924|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
128686771|NCT03963401|463152925|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
128686772|NCT03963401|463152926|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
128686773|NCT03963401|463152927|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
128686774|NCT03963401|463152928|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
128686775|NCT03963401|463152929|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
128686776|NCT03963401|463152924|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
128686777|NCT03963401|463152925|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
128686778|NCT03963401|463152926|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
128686779|NCT03963401|463152927|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
128686780|NCT03963401|463152928|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
128686781|NCT03963401|463152929|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
128686782|NCT03963401|463152924|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
128686783|NCT03963401|463152925|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
128686784|NCT03963401|463152926|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
128686785|NCT03963401|463152927|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
128686786|NCT03963401|463152928|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
128686787|NCT03963401|463152929|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
128686788|NCT03963401|463152924|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
128686789|NCT03963401|463152925|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
128686790|NCT03963401|463152926|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
128686791|NCT03963401|463152927|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
128686792|NCT03963401|463152928|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
128686793|NCT03963401|463152929|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
128686794|NCT03963401|463152924|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
128686795|NCT03963401|463152925|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
128686796|NCT03963401|463152926|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
128686797|NCT03963401|463152927|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
128763493|NCT00638235|463425706|FG000|Overall Study|Lost to Follow-up|31|||
128686798|NCT03963401|463152928|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
128686799|NCT03963401|463152929|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
128686800|NCT03963401|463152924|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
128686801|NCT03963401|463152925|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
128686802|NCT03963401|463152926|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
128686803|NCT03963401|463152927|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
128686804|NCT03963401|463152928|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
128686805|NCT03963401|463152929|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
128686806|NCT01070043|463152930|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
128686807|NCT01070043|463152931|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
128686808|NCT01070043|463152932|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
128686809|NCT01070043|463152930|FG000|Double-Blind Treatment|Adverse Event|0|||
128686810|NCT01070043|463152931|FG001|Double-Blind Treatment|Adverse Event|0|||
128686811|NCT01070043|463152932|FG002|Double-Blind Treatment|Adverse Event|2|||
128686812|NCT00473746|463152934|FG000|Period 1 (Phase 1)|Adverse Event|1|||
128686813|NCT00473746|463152935|FG001|Period 1 (Phase 1)|Adverse Event|0|||
128686814|NCT00473746|463152936|FG002|Period 1 (Phase 1)|Adverse Event|0|||
128686815|NCT00473746|463152937|FG003|Period 1 (Phase 1)|Adverse Event|0|||
128686816|NCT00473746|463152938|FG004|Period 1 (Phase 1)|Adverse Event|0|||
128686817|NCT00473746|463152934|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
128686818|NCT00473746|463152935|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
128686819|NCT00473746|463152936|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
128686820|NCT00473746|463152937|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
128686821|NCT00473746|463152938|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
128686822|NCT00473746|463152934|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
128686823|NCT00473746|463152935|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
128686824|NCT00473746|463152936|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
128686825|NCT00473746|463152937|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
128686826|NCT00473746|463152938|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
128686827|NCT00473746|463152934|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
128686828|NCT00473746|463152935|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
128686829|NCT00473746|463152936|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
128686830|NCT00473746|463152937|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
128686831|NCT00473746|463152938|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
128686832|NCT00473746|463152934|FG000|Period 1 (Phase 1)|Reason not specified|0|||
128686833|NCT00473746|463152935|FG001|Period 1 (Phase 1)|Reason not specified|1|||
128686834|NCT00473746|463152936|FG002|Period 1 (Phase 1)|Reason not specified|0|||
128686835|NCT00473746|463152937|FG003|Period 1 (Phase 1)|Reason not specified|0|||
128686836|NCT00473746|463152938|FG004|Period 1 (Phase 1)|Reason not specified|0|||
128686837|NCT00473746|463152934|FG000|Period 2 (Phase 2)|Adverse Event|0|||
128686838|NCT00473746|463152935|FG001|Period 2 (Phase 2)|Adverse Event|0|||
128686839|NCT00473746|463152936|FG002|Period 2 (Phase 2)|Adverse Event|0|||
128686840|NCT00473746|463152937|FG003|Period 2 (Phase 2)|Adverse Event|0|||
128686841|NCT00473746|463152938|FG004|Period 2 (Phase 2)|Adverse Event|3|||
128686842|NCT00473746|463152934|FG000|Period 2 (Phase 2)|Death|0|||
128686843|NCT00473746|463152935|FG001|Period 2 (Phase 2)|Death|0|||
128686844|NCT00473746|463152936|FG002|Period 2 (Phase 2)|Death|0|||
128686845|NCT00473746|463152937|FG003|Period 2 (Phase 2)|Death|0|||
128686846|NCT00473746|463152938|FG004|Period 2 (Phase 2)|Death|1|||
128686847|NCT00473746|463152934|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
128686848|NCT00473746|463152935|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
128686849|NCT00473746|463152936|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
128686850|NCT00473746|463152937|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
128686851|NCT00473746|463152938|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
128686852|NCT00473746|463152934|FG000|Period 2 (Phase 2)|Reason not specified|0|||
128686853|NCT00473746|463152935|FG001|Period 2 (Phase 2)|Reason not specified|0|||
128686854|NCT00473746|463152936|FG002|Period 2 (Phase 2)|Reason not specified|0|||
128686855|NCT00473746|463152937|FG003|Period 2 (Phase 2)|Reason not specified|0|||
128686856|NCT00473746|463152938|FG004|Period 2 (Phase 2)|Reason not specified|3|||
128686857|NCT00667420|463152942|FG000|Overall Study|Adverse Event|2|||
128686858|NCT00667420|463152942|FG000|Overall Study|Lack of Efficacy|5|||
128686859|NCT00667420|463152942|FG000|Overall Study|Physician Decision|1|||
129020540|NCT01796171|464367100|FG004|Follow-up Period|Death|0|||
128686860|NCT00667420|463152942|FG000|Overall Study|Withdrawal by Subject|2|||
128686861|NCT03635788|463152950|FG000|Step 1|Death|1|||
128686862|NCT03635788|463152951|FG001|Step 1|Death|0|||
128686863|NCT03635788|463152952|FG002|Step 1|Death|0|||
128686864|NCT03635788|463152950|FG000|Step 1|Lost to Follow-up|31|||
128686865|NCT03635788|463152951|FG001|Step 1|Lost to Follow-up|0|||
128686866|NCT03635788|463152952|FG002|Step 1|Lost to Follow-up|0|||
128686867|NCT03635788|463152950|FG000|Step 1|Pregnancy|1|||
128686868|NCT03635788|463152951|FG001|Step 1|Pregnancy|0|||
128686869|NCT03635788|463152952|FG002|Step 1|Pregnancy|0|||
128686870|NCT03635788|463152950|FG000|Step 1|Protocol Violation|8|||
128686871|NCT03635788|463152951|FG001|Step 1|Protocol Violation|0|||
128686872|NCT03635788|463152952|FG002|Step 1|Protocol Violation|0|||
128686873|NCT03635788|463152950|FG000|Step 1|Withdrawal by Subject|13|||
129020541|NCT01796171|464367101|FG005|Follow-up Period|Death|0|||
128686874|NCT03635788|463152951|FG001|Step 1|Withdrawal by Subject|0|||
128686875|NCT03635788|463152952|FG002|Step 1|Withdrawal by Subject|0|||
128686876|NCT03635788|463152950|FG000|Step 1|Other reasons|12|||
128686877|NCT03635788|463152951|FG001|Step 1|Other reasons|0|||
128686878|NCT03635788|463152952|FG002|Step 1|Other reasons|0|||
128686879|NCT03635788|463152950|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
128686880|NCT03635788|463152951|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
128686881|NCT03635788|463152952|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
128686882|NCT03635788|463152950|FG000|Step 2|Lost to Follow-up|0|||
128686883|NCT03635788|463152951|FG001|Step 2|Lost to Follow-up|8|||
128686884|NCT03635788|463152952|FG002|Step 2|Lost to Follow-up|15|||
128686885|NCT03635788|463152950|FG000|Step 2|Withdrawal by Subject|0|||
128686886|NCT03635788|463152951|FG001|Step 2|Withdrawal by Subject|6|||
128686887|NCT03635788|463152952|FG002|Step 2|Withdrawal by Subject|6|||
128686888|NCT03635788|463152950|FG000|Step 2|Death|0|||
128686889|NCT03635788|463152951|FG001|Step 2|Death|2|||
128686890|NCT03635788|463152952|FG002|Step 2|Death|0|||
128686891|NCT03635788|463152950|FG000|Step 2|Incarceration|0|||
128686892|NCT03635788|463152951|FG001|Step 2|Incarceration|2|||
128686893|NCT03635788|463152952|FG002|Step 2|Incarceration|0|||
128686894|NCT03635788|463152950|FG000|Step 2|Non-Compliance With Study Requirements|0|||
128686895|NCT03635788|463152951|FG001|Step 2|Non-Compliance With Study Requirements|1|||
128686896|NCT03635788|463152952|FG002|Step 2|Non-Compliance With Study Requirements|1|||
128686897|NCT03635788|463152950|FG000|Step 2|Confounding Medical Condition|0|||
128686898|NCT03635788|463152951|FG001|Step 2|Confounding Medical Condition|0|||
128686899|NCT03635788|463152952|FG002|Step 2|Confounding Medical Condition|1|||
128686900|NCT03635788|463152950|FG000|Step 2|Out Of State With No Plan To Return|0|||
128686901|NCT03635788|463152951|FG001|Step 2|Out Of State With No Plan To Return|1|||
128686902|NCT03635788|463152952|FG002|Step 2|Out Of State With No Plan To Return|0|||
128686903|NCT03635788|463152950|FG000|Step 2|Switched To Injectables|0|||
128686904|NCT03635788|463152951|FG001|Step 2|Switched To Injectables|0|||
128686905|NCT03635788|463152952|FG002|Step 2|Switched To Injectables|1|||
128686906|NCT03635788|463152950|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
128686907|NCT03635788|463152951|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
128686908|NCT03635788|463152952|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
128686909|NCT04669535|463152953|FG000|Overall Study|Death|1|||
128686910|NCT04669535|463152954|FG001|Overall Study|Death|1|||
128686911|NCT04669535|463152955|FG002|Overall Study|Death|0|||
128686912|NCT04669535|463152956|FG003|Overall Study|Death|0|||
128686913|NCT04382755|463152957|FG000|Overall Study|Withdrawal by Subject|1|||
128686914|NCT04382755|463152958|FG001|Overall Study|Withdrawal by Subject|0|||
128686915|NCT04382755|463152957|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
128686916|NCT04382755|463152958|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
128686917|NCT04382755|463152957|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
128686918|NCT04382755|463152958|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
128686919|NCT02452697|463152963|FG000|Overall Study|Physician Decision|4|||
129020542|NCT01796171|464367102|FG006|Follow-up Period|Death|1|||
129020543|NCT01796171|464367103|FG007|Follow-up Period|Death|0|||
129020544|NCT01796171|464367104|FG008|Follow-up Period|Death|0|||
129020545|NCT01796171|464367105|FG009|Follow-up Period|Death|0|||
129020546|NCT01796171|464367106|FG010|Follow-up Period|Death|17|||
129020547|NCT01796171|464367107|FG011|Follow-up Period|Death|9|||
129020548|NCT01796171|464367108|FG012|Follow-up Period|Death|1|||
129020549|NCT01796171|464367109|FG013|Follow-up Period|Death|0|||
129020550|NCT01796171|464367110|FG014|Follow-up Period|Death|0|||
129020551|NCT01796171|464367096|FG000|Follow-up Period|Patient transferred to other hospital|0|||
129020552|NCT01796171|464367097|FG001|Follow-up Period|Patient transferred to other hospital|1|||
129020553|NCT01796171|464367098|FG002|Follow-up Period|Patient transferred to other hospital|0|||
129020554|NCT01796171|464367099|FG003|Follow-up Period|Patient transferred to other hospital|0|||
129020555|NCT01796171|464367100|FG004|Follow-up Period|Patient transferred to other hospital|0|||
129020556|NCT01796171|464367101|FG005|Follow-up Period|Patient transferred to other hospital|0|||
129020557|NCT01796171|464367102|FG006|Follow-up Period|Patient transferred to other hospital|0|||
129020558|NCT01796171|464367103|FG007|Follow-up Period|Patient transferred to other hospital|0|||
129020559|NCT01796171|464367104|FG008|Follow-up Period|Patient transferred to other hospital|0|||
129020560|NCT01796171|464367105|FG009|Follow-up Period|Patient transferred to other hospital|0|||
129020561|NCT01796171|464367106|FG010|Follow-up Period|Patient transferred to other hospital|0|||
129020562|NCT01796171|464367107|FG011|Follow-up Period|Patient transferred to other hospital|0|||
129020563|NCT01796171|464367108|FG012|Follow-up Period|Patient transferred to other hospital|0|||
128686920|NCT02452697|463152964|FG001|Overall Study|Physician Decision|4|||
128686921|NCT02452697|463152965|FG002|Overall Study|Physician Decision|3|||
128686922|NCT02452697|463152966|FG003|Overall Study|Physician Decision|2|||
128686923|NCT02452697|463152963|FG000|Overall Study|Withdrawal by Subject|1|||
128686924|NCT02452697|463152964|FG001|Overall Study|Withdrawal by Subject|0|||
128686925|NCT02452697|463152965|FG002|Overall Study|Withdrawal by Subject|0|||
128686926|NCT02452697|463152966|FG003|Overall Study|Withdrawal by Subject|0|||
128686927|NCT02452697|463152963|FG000|Overall Study|still in follow-up|2|||
128686928|NCT02452697|463152964|FG001|Overall Study|still in follow-up|2|||
128686929|NCT02452697|463152965|FG002|Overall Study|still in follow-up|1|||
128686930|NCT02452697|463152966|FG003|Overall Study|still in follow-up|3|||
128686931|NCT03552965|463152967|FG000|Overall Study|Death|1|||
128686932|NCT03552965|463152968|FG001|Overall Study|Death|1|||
128686933|NCT03552965|463152967|FG000|Overall Study|Lost to Follow-up|1|||
128686934|NCT03552965|463152968|FG001|Overall Study|Lost to Follow-up|1|||
128686935|NCT03552965|463152967|FG000|Overall Study|Physician Decision|1|||
128686936|NCT03552965|463152968|FG001|Overall Study|Physician Decision|1|||
128686937|NCT03552965|463152967|FG000|Overall Study|Withdrawal by Subject|0|||
128686938|NCT03552965|463152968|FG001|Overall Study|Withdrawal by Subject|2|||
128686939|NCT03552965|463152967|FG000|Overall Study|Continuation not in patient best interest|1|||
128686940|NCT03552965|463152968|FG001|Overall Study|Continuation not in patient best interest|0|||
128686941|NCT03552965|463152967|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
128686942|NCT03552965|463152968|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
128686943|NCT03120624|463152969|FG000|Overall Study|Withdrawal by Subject|0|||
128686944|NCT03120624|463152970|FG001|Overall Study|Withdrawal by Subject|1|||
128686945|NCT03120624|463152971|FG002|Overall Study|Withdrawal by Subject|0|||
128686946|NCT03120624|463152972|FG003|Overall Study|Withdrawal by Subject|0|||
128686947|NCT03120624|463152973|FG004|Overall Study|Withdrawal by Subject|0|||
128686948|NCT03120624|463152974|FG005|Overall Study|Withdrawal by Subject|0|||
128686949|NCT03120624|463152975|FG006|Overall Study|Withdrawal by Subject|0|||
129109705|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
128686950|NCT03120624|463152976|FG007|Overall Study|Withdrawal by Subject|0|||
128686951|NCT02160782|463154524|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
128686952|NCT02160782|463154525|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
128686953|NCT02160782|463154526|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
128686954|NCT02160782|463154527|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
128686955|NCT02160782|463154528|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
128686956|NCT02160782|463154524|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
128686957|NCT02160782|463154525|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
128686958|NCT02160782|463154526|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
128686959|NCT02160782|463154527|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
128686960|NCT02160782|463154528|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
128686961|NCT02160782|463154524|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
128686962|NCT02160782|463154525|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
128686963|NCT02160782|463154526|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
128686964|NCT02160782|463154527|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
128686965|NCT02160782|463154528|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
128686966|NCT02160782|463154524|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
128686967|NCT02160782|463154525|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
128686968|NCT02160782|463154526|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
128686969|NCT02160782|463154527|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
128686970|NCT02160782|463154528|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
128686971|NCT02160782|463154524|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
128686972|NCT02160782|463154525|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
128686973|NCT02160782|463154526|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
128686974|NCT02160782|463154527|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
128686975|NCT02160782|463154528|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
128686976|NCT02160782|463154524|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
128686977|NCT02160782|463154525|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
128686978|NCT02160782|463154526|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
128686979|NCT02160782|463154527|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
128686980|NCT02160782|463154528|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
128686981|NCT02160782|463154524|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
128686982|NCT02160782|463154525|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
128686983|NCT02160782|463154526|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
128686984|NCT02160782|463154527|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
128686985|NCT02160782|463154528|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
128686986|NCT01104701|463154531|FG000|Overall Study|Withdrawal by Subject|0|||
128686987|NCT01104701|463154532|FG001|Overall Study|Withdrawal by Subject|1|||
128686988|NCT01104701|463154533|FG002|Overall Study|Withdrawal by Subject|2|||
128686989|NCT01104701|463154534|FG003|Overall Study|Withdrawal by Subject|1|||
128686990|NCT01104701|463154531|FG000|Overall Study|Adverse Event|0|||
128686991|NCT01104701|463154532|FG001|Overall Study|Adverse Event|0|||
128686992|NCT01104701|463154533|FG002|Overall Study|Adverse Event|0|||
128686993|NCT01104701|463154534|FG003|Overall Study|Adverse Event|1|||
128686994|NCT01104701|463154531|FG000|Overall Study|Physician Decision|0|||
128686995|NCT01104701|463154532|FG001|Overall Study|Physician Decision|2|||
128686996|NCT01104701|463154533|FG002|Overall Study|Physician Decision|0|||
128686997|NCT01104701|463154534|FG003|Overall Study|Physician Decision|0|||
128686998|NCT03437512|463154535|FG000|Randomized|Withdrawal by Subject|0|||
128686999|NCT03437512|463154536|FG001|Randomized|Withdrawal by Subject|2|||
128687000|NCT03437512|463154535|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
128687001|NCT03437512|463154536|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
128687002|NCT00674973|463154537|FG000|Overall Study|Insufficient Therapeutic Response|77|||
128687003|NCT00674973|463154538|FG001|Overall Study|Insufficient Therapeutic Response|72|||
128687004|NCT00674973|463154537|FG000|Overall Study|Refused Treatment|1|||
128687005|NCT00674973|463154538|FG001|Overall Study|Refused Treatment|5|||
128687006|NCT00674973|463154537|FG000|Overall Study|Failure to Return|1|||
128687007|NCT00674973|463154538|FG001|Overall Study|Failure to Return|0|||
128687008|NCT00674973|463154537|FG000|Overall Study|Adverse Event|2|||
128687009|NCT00674973|463154538|FG001|Overall Study|Adverse Event|9|||
128687010|NCT00674973|463154537|FG000|Overall Study|Death|19|||
128687011|NCT00674973|463154538|FG001|Overall Study|Death|15|||
128687012|NCT00674973|463154537|FG000|Overall Study|Protocol Violation|0|||
128687013|NCT00674973|463154538|FG001|Overall Study|Protocol Violation|1|||
128687014|NCT05036369|463154541|FG000|Overall Study|Run In non compliance|1|||
128687015|NCT05036369|463154542|FG001|Overall Study|Run In non compliance|2|||
128687016|NCT05036369|463154541|FG000|Overall Study|Change in eligibility criteria|0|||
128687017|NCT05036369|463154542|FG001|Overall Study|Change in eligibility criteria|1|||
128687018|NCT00401531|463154543|FG000|Overall Study|Adverse Event|2|||
128687019|NCT00401531|463154544|FG001|Overall Study|Adverse Event|0|||
128687020|NCT00401531|463154543|FG000|Overall Study|Protocol Violation|3|||
128687021|NCT00401531|463154544|FG001|Overall Study|Protocol Violation|7|||
128687022|NCT00401531|463154543|FG000|Overall Study|Lost to Follow-up|1|||
128687023|NCT00401531|463154544|FG001|Overall Study|Lost to Follow-up|1|||
128687024|NCT00401531|463154543|FG000|Overall Study|Withdrawal by Subject|3|||
128687025|NCT00401531|463154544|FG001|Overall Study|Withdrawal by Subject|2|||
128687026|NCT01801072|463154545|FG000|Overall Study|Lost to Follow-up|17|||
128687027|NCT01801072|463154546|FG001|Overall Study|Lost to Follow-up|14|||
128687028|NCT01801072|463154545|FG000|Overall Study|Physician Decision|2|||
128687029|NCT01801072|463154546|FG001|Overall Study|Physician Decision|3|||
128687030|NCT01801072|463154545|FG000|Overall Study|Withdrawal by Subject|1|||
128687031|NCT01801072|463154546|FG001|Overall Study|Withdrawal by Subject|0|||
128687032|NCT01801072|463154545|FG000|Overall Study|Protocol Violation|2|||
128687033|NCT01801072|463154546|FG001|Overall Study|Protocol Violation|0|||
128687034|NCT01801072|463154545|FG000|Overall Study|Death|7|||
128687035|NCT01801072|463154546|FG001|Overall Study|Death|8|||
128687036|NCT02247531|463154547|FG000|Overall Study|Adverse Event|3|||
128687037|NCT02247531|463154548|FG001|Overall Study|Adverse Event|4|||
128687038|NCT02247531|463154549|FG002|Overall Study|Adverse Event|9|||
128687039|NCT02247531|463154547|FG000|Overall Study|Death|8|||
128763494|NCT00638235|463425707|FG001|Overall Study|Lost to Follow-up|3|||
128763495|NCT00638235|463425708|FG002|Overall Study|Lost to Follow-up|18|||
128763496|NCT00638235|463425709|FG003|Overall Study|Lost to Follow-up|10|||
128763497|NCT00638235|463425710|FG004|Overall Study|Lost to Follow-up|13|||
128763498|NCT00638235|463425711|FG005|Overall Study|Lost to Follow-up|26|||
128763499|NCT00638235|463425712|FG006|Overall Study|Lost to Follow-up|0|||
128763500|NCT00638235|463425713|FG007|Overall Study|Lost to Follow-up|1|||
128763501|NCT00638235|463425714|FG008|Overall Study|Lost to Follow-up|18|||
128763502|NCT02569437|463425721|FG000|Overall Study|Lost to Follow-up|12|||
128763503|NCT02569437|463425722|FG001|Overall Study|Lost to Follow-up|14|||
128763504|NCT00509236|463425723|FG000|Overall Study|Adverse Event|7|||
128763505|NCT00509236|463425724|FG001|Overall Study|Adverse Event|9|||
128763506|NCT00509236|463425723|FG000|Overall Study|Withdrawal by Subject|5|||
128763507|NCT00509236|463425724|FG001|Overall Study|Withdrawal by Subject|10|||
128763508|NCT00509236|463425723|FG000|Overall Study|Protocol Violation|3|||
128687040|NCT02247531|463154548|FG001|Overall Study|Death|9|||
128687041|NCT02247531|463154549|FG002|Overall Study|Death|5|||
128687042|NCT02247531|463154547|FG000|Overall Study|Lost to Follow-up|1|||
128763509|NCT00509236|463425724|FG001|Overall Study|Protocol Violation|0|||
128763510|NCT00509236|463425723|FG000|Overall Study|Excluded Medication|1|||
128763511|NCT00509236|463425724|FG001|Overall Study|Excluded Medication|1|||
128687043|NCT02247531|463154548|FG001|Overall Study|Lost to Follow-up|8|||
128687044|NCT02247531|463154549|FG002|Overall Study|Lost to Follow-up|3|||
128687045|NCT02247531|463154547|FG000|Overall Study|Non-compliance|2|||
128687046|NCT02247531|463154548|FG001|Overall Study|Non-compliance|2|||
128687047|NCT02247531|463154549|FG002|Overall Study|Non-compliance|0|||
128687048|NCT02247531|463154547|FG000|Overall Study|Withdrawal by Subject|26|||
128687049|NCT02247531|463154548|FG001|Overall Study|Withdrawal by Subject|31|||
128687050|NCT02247531|463154549|FG002|Overall Study|Withdrawal by Subject|25|||
128687051|NCT02247531|463154547|FG000|Overall Study|Study Terminated by Sponsor|64|||
128687052|NCT02247531|463154548|FG001|Overall Study|Study Terminated by Sponsor|66|||
128687053|NCT02247531|463154549|FG002|Overall Study|Study Terminated by Sponsor|62|||
128687054|NCT02247531|463154547|FG000|Overall Study|Physician Decision|0|||
128687055|NCT02247531|463154548|FG001|Overall Study|Physician Decision|2|||
128687056|NCT02247531|463154549|FG002|Overall Study|Physician Decision|2|||
128687057|NCT02247531|463154547|FG000|Overall Study|Unspecified Reason|2|||
128687058|NCT02247531|463154548|FG001|Overall Study|Unspecified Reason|3|||
128687059|NCT02247531|463154549|FG002|Overall Study|Unspecified Reason|4|||
128687060|NCT03906461|463154550|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
128687061|NCT03906461|463154550|FG000|Completed 12-month Follow-up|Missed Visit|6|||
128687062|NCT00510874|463154551|FG000|Overall Study|Withdrawal by Subject|1|||
128687063|NCT00510874|463154552|FG001|Overall Study|Withdrawal by Subject|1|||
128687064|NCT00510874|463154553|FG002|Overall Study|Withdrawal by Subject|0|||
128687065|NCT00510874|463154554|FG003|Overall Study|Withdrawal by Subject|0|||
128687066|NCT00510874|463154555|FG004|Overall Study|Withdrawal by Subject|3|||
128687067|NCT00510874|463154556|FG005|Overall Study|Withdrawal by Subject|0|||
128687068|NCT00510874|463154557|FG006|Overall Study|Withdrawal by Subject|0|||
128687069|NCT00510874|463154551|FG000|Overall Study|Lost to Follow-up|2|||
128687070|NCT00510874|463154552|FG001|Overall Study|Lost to Follow-up|3|||
128687071|NCT00510874|463154553|FG002|Overall Study|Lost to Follow-up|1|||
128687072|NCT00510874|463154554|FG003|Overall Study|Lost to Follow-up|3|||
128687073|NCT00510874|463154555|FG004|Overall Study|Lost to Follow-up|4|||
128687074|NCT00510874|463154556|FG005|Overall Study|Lost to Follow-up|0|||
128687075|NCT00510874|463154557|FG006|Overall Study|Lost to Follow-up|1|||
128687076|NCT03875118|463154558|FG000|Overall Study|Withdrawal by Subject|4|||
128687077|NCT03875118|463154559|FG001|Overall Study|Withdrawal by Subject|4|||
128687078|NCT02423109|463154562|FG000|Lens 1|Adverse Event|1|||
128687079|NCT02423109|463154563|FG001|Lens 1|Adverse Event|0|||
128687080|NCT03956056|463154564|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
128687081|NCT03956056|463154564|FG000|Overall Study|Lack of Efficacy|1|||
128687082|NCT03403374|463154565|FG000|Overall Study|Lost to Follow-up|1|||
128687083|NCT04622735|463154566|FG000|Overall Study|Lost to Follow-up|1|||
128687084|NCT04622735|463154567|FG001|Overall Study|Lost to Follow-up|2|||
128687085|NCT04622735|463154568|FG002|Overall Study|Lost to Follow-up|1|||
128687086|NCT04622735|463154566|FG000|Overall Study|Adverse Event|0|||
128687087|NCT04622735|463154567|FG001|Overall Study|Adverse Event|0|||
128687088|NCT04622735|463154568|FG002|Overall Study|Adverse Event|1|||
128687089|NCT04622735|463154566|FG000|Overall Study|Protocol Violation|1|||
128687090|NCT04622735|463154567|FG001|Overall Study|Protocol Violation|0|||
128687091|NCT04622735|463154568|FG002|Overall Study|Protocol Violation|0|||
128687092|NCT05314478|463154569|FG000|Overall Study|Physician Decision|1|||
128687093|NCT04629508|463154570|FG000|Overall Study|Adverse Event|1|||
128687094|NCT04629508|463154570|FG000|Overall Study|Death|2|||
128687095|NCT04629508|463154570|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
128687096|NCT04073368|463154571|FG000|Overall Study|Adverse Event|2|||
128687097|NCT04073368|463154572|FG001|Overall Study|Adverse Event|0|||
128687098|NCT04073368|463154573|FG002|Overall Study|Adverse Event|1|||
128687099|NCT04073368|463154574|FG003|Overall Study|Adverse Event|1|||
128687100|NCT04073368|463154571|FG000|Overall Study|Withdrawal by Subject|2|||
128687101|NCT04073368|463154572|FG001|Overall Study|Withdrawal by Subject|2|||
128687102|NCT04073368|463154573|FG002|Overall Study|Withdrawal by Subject|1|||
128687103|NCT04073368|463154574|FG003|Overall Study|Withdrawal by Subject|1|||
128687104|NCT04073368|463154571|FG000|Overall Study|Lost to Follow-up|1|||
128687105|NCT04073368|463154572|FG001|Overall Study|Lost to Follow-up|1|||
128687106|NCT04073368|463154573|FG002|Overall Study|Lost to Follow-up|1|||
128687107|NCT04073368|463154574|FG003|Overall Study|Lost to Follow-up|0|||
128687108|NCT04073368|463154571|FG000|Overall Study|Protocol Violation|0|||
128687109|NCT04073368|463154572|FG001|Overall Study|Protocol Violation|1|||
128687110|NCT04073368|463154573|FG002|Overall Study|Protocol Violation|0|||
128687111|NCT04073368|463154574|FG003|Overall Study|Protocol Violation|0|||
128763512|NCT00509236|463425723|FG000|Overall Study|Scheduled Kidney Transplant|1|||
128763513|NCT00509236|463425724|FG001|Overall Study|Scheduled Kidney Transplant|0|||
128763514|NCT00792103|463425725|FG000|Overall Study|Enrolled, not treated|15|||
128763515|NCT00792103|463425725|FG000|Overall Study|Lost to Follow-up|17|||
128763516|NCT00792103|463425725|FG000|Overall Study|Adverse Event|25|||
128763517|NCT00792103|463425725|FG000|Overall Study|Withdrawal by Subject|52|||
128763518|NCT00792103|463425725|FG000|Overall Study|Protocol Violation|10|||
128687112|NCT04073368|463154571|FG000|Overall Study|Subject noncompliance|7|||
128687113|NCT04073368|463154572|FG001|Overall Study|Subject noncompliance|4|||
128687114|NCT04073368|463154573|FG002|Overall Study|Subject noncompliance|0|||
128687115|NCT04073368|463154574|FG003|Overall Study|Subject noncompliance|0|||
128687116|NCT01229397|463154575|FG000|Overall Study|Withdrawal by Subject|3|||
128763519|NCT00792103|463425725|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
128687117|NCT01229397|463154576|FG001|Overall Study|Withdrawal by Subject|3|||
128687118|NCT01229397|463154575|FG000|Overall Study|Lost to Follow-up|7|||
128687119|NCT01229397|463154576|FG001|Overall Study|Lost to Follow-up|6|||
128687120|NCT01229397|463154575|FG000|Overall Study|Migrated/moved from study area|1|||
128687121|NCT01229397|463154576|FG001|Overall Study|Migrated/moved from study area|0|||
128687122|NCT02476422|463154580|FG000|Overall Study|Subject/guardian decision|0|||
129109706|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
129109707|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
129109708|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
129109709|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109710|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109711|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109712|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109713|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109714|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109715|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
129109716|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109717|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109718|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109719|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109720|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109721|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109722|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109723|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109724|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109725|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129109726|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
128687123|NCT02476422|463154581|FG001|Overall Study|Subject/guardian decision|1|||
128687124|NCT00760214|463154583|FG000|Overall Study|Adverse Event|8|||
128687125|NCT00760214|463154584|FG001|Overall Study|Adverse Event|9|||
128687126|NCT00760214|463154585|FG002|Overall Study|Adverse Event|12|||
128687127|NCT00760214|463154583|FG000|Overall Study|Protocol Violation|3|||
128687128|NCT00760214|463154584|FG001|Overall Study|Protocol Violation|0|||
128687129|NCT00760214|463154585|FG002|Overall Study|Protocol Violation|3|||
128687130|NCT00760214|463154583|FG000|Overall Study|Lost to Follow-up|0|||
128687131|NCT00760214|463154584|FG001|Overall Study|Lost to Follow-up|0|||
128687132|NCT00760214|463154585|FG002|Overall Study|Lost to Follow-up|1|||
128687133|NCT00760214|463154583|FG000|Overall Study|Withdrawal by Subject|12|||
128687134|NCT00760214|463154584|FG001|Overall Study|Withdrawal by Subject|14|||
128687135|NCT00760214|463154585|FG002|Overall Study|Withdrawal by Subject|13|||
128687136|NCT00760214|463154583|FG000|Overall Study|Lack of Efficacy|3|||
128687137|NCT00760214|463154584|FG001|Overall Study|Lack of Efficacy|2|||
128687138|NCT00760214|463154585|FG002|Overall Study|Lack of Efficacy|4|||
128687139|NCT00760214|463154583|FG000|Overall Study|Pregnancy|0|||
128687140|NCT00760214|463154584|FG001|Overall Study|Pregnancy|0|||
128687141|NCT00760214|463154585|FG002|Overall Study|Pregnancy|1|||
128687142|NCT00760214|463154583|FG000|Overall Study|Physician Decision|1|||
128687143|NCT00760214|463154584|FG001|Overall Study|Physician Decision|1|||
128687144|NCT00760214|463154585|FG002|Overall Study|Physician Decision|1|||
128687145|NCT00760214|463154583|FG000|Overall Study|Other|3|||
128687146|NCT00760214|463154584|FG001|Overall Study|Other|4|||
128687147|NCT00760214|463154585|FG002|Overall Study|Other|6|||
128687148|NCT01134315|463154586|FG000|Overall Study|Adverse Event|1|||
128687149|NCT01134315|463154587|FG001|Overall Study|Adverse Event|2|||
128687150|NCT01134315|463154586|FG000|Overall Study|Other Reason|8|||
128687151|NCT01134315|463154587|FG001|Overall Study|Other Reason|17|||
128687152|NCT03960554|463154592|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
128687153|NCT03960554|463154593|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
128687154|NCT05896748|463154594|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
128687155|NCT05896748|463154594|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
128687156|NCT05896748|463154594|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
128687157|NCT05896748|463154594|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
128687158|NCT05896748|463154594|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
128687159|NCT04508140|463154595|FG000|Overall Study|Adverse Event|2|||
128687160|NCT04508140|463154596|FG001|Overall Study|Adverse Event|2|||
128687161|NCT04508140|463154595|FG000|Overall Study|Withdrawal by Subject|0|||
128687162|NCT04508140|463154596|FG001|Overall Study|Withdrawal by Subject|2|||
128687163|NCT04508140|463154595|FG000|Overall Study|progressive disease|9|||
128687164|NCT04508140|463154596|FG001|Overall Study|progressive disease|3|||
128687165|NCT01465191|463154597|FG000|Overall Study|Protocol Violation|6|||
128687166|NCT01465191|463154598|FG001|Overall Study|Protocol Violation|3|||
128687167|NCT01465191|463154599|FG002|Overall Study|Protocol Violation|3|||
128687168|NCT01465191|463154597|FG000|Overall Study|Lost to Follow-up|3|||
128687169|NCT01465191|463154598|FG001|Overall Study|Lost to Follow-up|6|||
128687170|NCT01465191|463154599|FG002|Overall Study|Lost to Follow-up|4|||
128687171|NCT01298193|463154600|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
128687172|NCT01298193|463154600|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
128763520|NCT01287520|463425727|FG000|Overall Study|Adverse Event|2|||
128687173|NCT01298193|463154600|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
128687174|NCT01298193|463154600|FG000|Efficacy Phase (Second Cycle)|Death|1|||
128687175|NCT04010539|463154601|FG000|Overall Study|Withdrawal by Subject|4|||
128687176|NCT04010539|463154602|FG001|Overall Study|Withdrawal by Subject|1|||
128687177|NCT04010539|463154601|FG000|Overall Study|Physician Decision|0|||
128687178|NCT04010539|463154602|FG001|Overall Study|Physician Decision|2|||
128687179|NCT04010539|463154601|FG000|Overall Study|Lost to Follow-up|10|||
128687180|NCT04010539|463154602|FG001|Overall Study|Lost to Follow-up|14|||
128687181|NCT04010539|463154601|FG000|Overall Study|Adverse Event|3|||
128687182|NCT04010539|463154602|FG001|Overall Study|Adverse Event|0|||
128687183|NCT04010539|463154601|FG000|Overall Study|Participant Did Not Receive IP|0|||
128687184|NCT04010539|463154602|FG001|Overall Study|Participant Did Not Receive IP|1|||
128687185|NCT04010539|463154601|FG000|Overall Study|Protocol Deviation|0|||
128687186|NCT04010539|463154602|FG001|Overall Study|Protocol Deviation|1|||
128687187|NCT04010539|463154601|FG000|Overall Study|Randomized in Error/ Mistake|2|||
128687188|NCT04010539|463154602|FG001|Overall Study|Randomized in Error/ Mistake|0|||
128687189|NCT04010539|463154601|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
128687190|NCT04010539|463154602|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
128687191|NCT01528215|463154603|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
128687192|NCT01528215|463154604|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
128687193|NCT01528215|463154603|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
128687194|NCT01528215|463154604|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
128687195|NCT01528215|463154603|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
128687196|NCT01528215|463154604|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
128687197|NCT01528215|463154603|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
128687198|NCT01528215|463154604|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
128687199|NCT01462227|463154605|FG000|Second Assignment|Lost to Follow-up|1|||
128687200|NCT01462227|463154606|FG001|Second Assignment|Lost to Follow-up|0|||
128687201|NCT01462227|463154607|FG002|Second Assignment|Lost to Follow-up|0|||
128687202|NCT01462227|463154608|FG003|Second Assignment|Lost to Follow-up|0|||
128687203|NCT01462227|463154605|FG000|Second Assignment|Protocol Violation|0|||
128687204|NCT01462227|463154606|FG001|Second Assignment|Protocol Violation|1|||
128687205|NCT01462227|463154607|FG002|Second Assignment|Protocol Violation|1|||
128687206|NCT01462227|463154608|FG003|Second Assignment|Protocol Violation|0|||
128687207|NCT00620464|463154614|FG000|Overall Study|Adverse Event|15|||
128687208|NCT00620464|463154615|FG001|Overall Study|Adverse Event|17|||
128687209|NCT00620464|463154614|FG000|Overall Study|Lost to Follow-up|1|||
128687210|NCT00620464|463154615|FG001|Overall Study|Lost to Follow-up|1|||
128687211|NCT00620464|463154614|FG000|Overall Study|Planning Pregnancy|1|||
128687212|NCT00620464|463154615|FG001|Overall Study|Planning Pregnancy|4|||
128687213|NCT00620464|463154614|FG000|Overall Study|Personal|2|||
128687214|NCT00620464|463154615|FG001|Overall Study|Personal|2|||
128687215|NCT00620464|463154614|FG000|Overall Study|Used prohibited medication|1|||
128687216|NCT00620464|463154615|FG001|Overall Study|Used prohibited medication|0|||
128687217|NCT00586066|463154616|FG000|Overall Study|Lost to Follow-up|6|||
128687218|NCT00586066|463154617|FG001|Overall Study|Lost to Follow-up|3|||
128687219|NCT00586066|463154616|FG000|Overall Study|Lack of Efficacy|5|||
128687220|NCT00586066|463154617|FG001|Overall Study|Lack of Efficacy|3|||
128687221|NCT00586066|463154616|FG000|Overall Study|Adverse Event|2|||
128687222|NCT00586066|463154617|FG001|Overall Study|Adverse Event|2|||
128687223|NCT00586066|463154616|FG000|Overall Study|Physician Decision|1|||
128687224|NCT00586066|463154617|FG001|Overall Study|Physician Decision|0|||
128687225|NCT00586066|463154616|FG000|Overall Study|Withdrawal of consent|4|||
128687226|NCT00586066|463154617|FG001|Overall Study|Withdrawal of consent|2|||
128687227|NCT00467610|463154618|FG000|Overall Study|Withdrawal by Subject|1|||
128687228|NCT01369615|463154619|FG000|Overall Study|Withdrawal by Subject|0|||
128687229|NCT01369615|463154620|FG001|Overall Study|Withdrawal by Subject|1|||
128687230|NCT01369615|463154619|FG000|Overall Study|Lost to Follow-up|0|||
128687231|NCT01369615|463154620|FG001|Overall Study|Lost to Follow-up|1|||
128763521|NCT01287520|463425728|FG001|Overall Study|Adverse Event|2|||
128763522|NCT01287520|463425729|FG002|Overall Study|Adverse Event|2|||
128763523|NCT01287520|463425730|FG003|Overall Study|Adverse Event|1|||
128763524|NCT01287520|463425731|FG004|Overall Study|Adverse Event|1|||
128763525|NCT01287520|463425732|FG005|Overall Study|Adverse Event|2|||
128763526|NCT01287520|463425733|FG006|Overall Study|Adverse Event|0|||
128763527|NCT01287520|463425734|FG007|Overall Study|Adverse Event|2|||
128687232|NCT02035475|463154621|FG000|Overall Study|Withdrawal by Subject|4|||
128687233|NCT02035475|463154621|FG000|Overall Study|Physician Decision|1|||
128687234|NCT02035475|463154621|FG000|Overall Study|Equipment Error|1|||
128687235|NCT01231347|463154622|FG000|Overall Study|Full Consent withdrawn|19|||
128687236|NCT01231347|463154623|FG001|Overall Study|Full Consent withdrawn|19|||
128687237|NCT01231347|463154624|FG002|Overall Study|Full Consent withdrawn|11|||
128687238|NCT01231347|463154622|FG000|Overall Study|Lost to Follow-up|4|||
128687239|NCT01231347|463154623|FG001|Overall Study|Lost to Follow-up|2|||
128687240|NCT01231347|463154624|FG002|Overall Study|Lost to Follow-up|2|||
128687241|NCT01231347|463154622|FG000|Overall Study|Death|202|||
129109727|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
129109728|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129109729|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129109730|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129109731|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129109732|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
129109733|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
129109734|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
129109735|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
129109736|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
129109737|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
129109738|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
129109739|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
129109740|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
129109741|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
129109742|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
129109743|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
129109744|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
129109745|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
129109746|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
129109747|NCT03428100|464695950|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109748|NCT03428100|464695951|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109749|NCT03428100|464695952|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109750|NCT03428100|464695953|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109751|NCT03428100|464695954|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129109752|NCT03428100|464695955|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109753|NCT03428100|464695956|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
129109754|NCT03428100|464695957|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129109755|NCT03428100|464695958|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109756|NCT03428100|464695959|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
129109757|NCT03428100|464695960|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
129109758|NCT03428100|464695961|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
129109759|NCT03428100|464695962|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129109760|NCT03428100|464695963|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
129109761|NCT03428100|464695964|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
129109762|NCT03428100|464695965|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109763|NCT03428100|464695966|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
129109764|NCT03428100|464695967|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129109765|NCT03428100|464695968|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129109766|NCT04556760|464695969|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129109767|NCT04556760|464695970|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
129109768|NCT04556760|464695971|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129109769|NCT04556760|464695972|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129109770|NCT04556760|464695973|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129109771|NCT04556760|464695974|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129109772|NCT04556760|464695969|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129109773|NCT04556760|464695970|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129109774|NCT04556760|464695971|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129109775|NCT04556760|464695972|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
129109776|NCT04556760|464695973|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129109777|NCT04556760|464695974|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129215185|NCT03955146|465089452|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
128687242|NCT01231347|463154623|FG001|Overall Study|Death|210|||
128687243|NCT01231347|463154624|FG002|Overall Study|Death|101|||
128687244|NCT01231347|463154622|FG000|Overall Study|other event|7|||
128687245|NCT01231347|463154623|FG001|Overall Study|other event|9|||
128687246|NCT01231347|463154624|FG002|Overall Study|other event|3|||
128687247|NCT01702571|463154625|FG000|Overall Study|Death|1067|||
128687248|NCT01702571|463154626|FG001|Overall Study|Death|76|||
128687249|NCT01702571|463154625|FG000|Overall Study|Lost to Follow-up|144|||
128687250|NCT01702571|463154626|FG001|Overall Study|Lost to Follow-up|10|||
128687251|NCT01702571|463154625|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
128687252|NCT01702571|463154626|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
128687253|NCT01702571|463154625|FG000|Overall Study|Investigator Decision|5|||
128687254|NCT01702571|463154626|FG001|Overall Study|Investigator Decision|0|||
128687255|NCT01702571|463154625|FG000|Overall Study|Not Classifiable|1|||
128687256|NCT01702571|463154626|FG001|Overall Study|Not Classifiable|0|||
128687257|NCT01702571|463154625|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
128687258|NCT01702571|463154626|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
128687259|NCT01702571|463154625|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
128687260|NCT01702571|463154626|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
128687261|NCT01702571|463154625|FG000|Overall Study|Progressive Disease|3|||
128687262|NCT01702571|463154626|FG001|Overall Study|Progressive Disease|0|||
128687263|NCT01702571|463154625|FG000|Overall Study|Protocol Violation|2|||
128687264|NCT01702571|463154626|FG001|Overall Study|Protocol Violation|0|||
128687265|NCT01702571|463154625|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
128687266|NCT01702571|463154626|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
128687267|NCT01702571|463154625|FG000|Overall Study|Termination By Sponsor|4|||
128687268|NCT01702571|463154626|FG001|Overall Study|Termination By Sponsor|0|||
128687269|NCT01702571|463154625|FG000|Overall Study|Withdrawal by Subject|177|||
128687270|NCT01702571|463154626|FG001|Overall Study|Withdrawal by Subject|29|||
128687271|NCT02322021|463154627|FG000|Core Phase|Adverse Event|1|||
128687272|NCT02322021|463154628|FG001|Core Phase|Adverse Event|3|||
128687273|NCT02322021|463154629|FG002|Core Phase|Adverse Event|4|||
128687274|NCT02322021|463154630|FG003|Core Phase|Adverse Event|2|||
128687275|NCT02322021|463154631|FG004|Core Phase|Adverse Event|0|||
128687276|NCT02322021|463154627|FG000|Core Phase|Participant Choice|4|||
128687277|NCT02322021|463154628|FG001|Core Phase|Participant Choice|5|||
128687278|NCT02322021|463154629|FG002|Core Phase|Participant Choice|4|||
128687279|NCT02322021|463154630|FG003|Core Phase|Participant Choice|2|||
128687280|NCT02322021|463154631|FG004|Core Phase|Participant Choice|0|||
128687281|NCT02322021|463154627|FG000|Core Phase|Lost to Follow-up|0|||
128687282|NCT02322021|463154628|FG001|Core Phase|Lost to Follow-up|0|||
128687283|NCT02322021|463154629|FG002|Core Phase|Lost to Follow-up|0|||
128687284|NCT02322021|463154630|FG003|Core Phase|Lost to Follow-up|1|||
128687285|NCT02322021|463154631|FG004|Core Phase|Lost to Follow-up|0|||
128687286|NCT02322021|463154627|FG000|Core Phase|Other|0|||
128687287|NCT02322021|463154628|FG001|Core Phase|Other|0|||
128687288|NCT02322021|463154629|FG002|Core Phase|Other|1|||
128687289|NCT02322021|463154630|FG003|Core Phase|Other|0|||
128687290|NCT02322021|463154631|FG004|Core Phase|Other|0|||
128687291|NCT02322021|463154627|FG000|Extension Phase|Adverse Event|0|||
128687292|NCT02322021|463154628|FG001|Extension Phase|Adverse Event|0|||
128687293|NCT02322021|463154629|FG002|Extension Phase|Adverse Event|0|||
128687294|NCT02322021|463154630|FG003|Extension Phase|Adverse Event|0|||
128687295|NCT02322021|463154631|FG004|Extension Phase|Adverse Event|3|||
128687296|NCT02322021|463154627|FG000|Extension Phase|Participant Choice|0|||
128687297|NCT02322021|463154628|FG001|Extension Phase|Participant Choice|0|||
128687298|NCT02322021|463154629|FG002|Extension Phase|Participant Choice|0|||
128687299|NCT02322021|463154630|FG003|Extension Phase|Participant Choice|0|||
128687300|NCT02322021|463154631|FG004|Extension Phase|Participant Choice|6|||
128687301|NCT02322021|463154627|FG000|Extension Phase|Other|0|||
128687302|NCT02322021|463154628|FG001|Extension Phase|Other|0|||
128687303|NCT02322021|463154629|FG002|Extension Phase|Other|0|||
128687304|NCT02322021|463154630|FG003|Extension Phase|Other|0|||
128687305|NCT02322021|463154631|FG004|Extension Phase|Other|3|||
128687306|NCT02322021|463154627|FG000|Extension Phase|Lost to Follow-up|0|||
128687307|NCT02322021|463154628|FG001|Extension Phase|Lost to Follow-up|0|||
128687308|NCT02322021|463154629|FG002|Extension Phase|Lost to Follow-up|0|||
128687309|NCT02322021|463154630|FG003|Extension Phase|Lost to Follow-up|0|||
128687310|NCT02322021|463154631|FG004|Extension Phase|Lost to Follow-up|1|||
128687311|NCT02322021|463154627|FG000|Extension Phase|Study terminated by sponsor|0|||
128687312|NCT02322021|463154628|FG001|Extension Phase|Study terminated by sponsor|0|||
128687313|NCT02322021|463154629|FG002|Extension Phase|Study terminated by sponsor|0|||
128687314|NCT02322021|463154630|FG003|Extension Phase|Study terminated by sponsor|0|||
128687315|NCT02322021|463154631|FG004|Extension Phase|Study terminated by sponsor|28|||
128687316|NCT02047227|463154632|FG000|Overall Study|Adverse Event|2|||
128687317|NCT02047227|463154633|FG001|Overall Study|Adverse Event|4|||
128763528|NCT01287520|463425735|FG008|Overall Study|Adverse Event|0|||
128687318|NCT02047227|463154632|FG000|Overall Study|Lost to Follow-up|0|||
128687319|NCT02047227|463154633|FG001|Overall Study|Lost to Follow-up|3|||
128687320|NCT02047227|463154632|FG000|Overall Study|Protocol Violation|1|||
128687321|NCT02047227|463154633|FG001|Overall Study|Protocol Violation|0|||
128687322|NCT02047227|463154632|FG000|Overall Study|Spontaneous pregnancy|1|||
128687323|NCT02047227|463154633|FG001|Overall Study|Spontaneous pregnancy|0|||
128687324|NCT02047227|463154632|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
128687325|NCT02047227|463154633|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
128687326|NCT02047227|463154632|FG000|Overall Study|No oocytes retrieved|21|||
128687327|NCT02047227|463154633|FG001|Overall Study|No oocytes retrieved|20|||
128687328|NCT02047227|463154632|FG000|Overall Study|No fertilization|61|||
128687329|NCT02047227|463154633|FG001|Overall Study|No fertilization|51|||
128887057|NCT00651157|463880620|FG000|Overall Study|Protocol Violation|1|||
128887058|NCT00364156|463880621|FG000|Overall Study|Withdrawal by Subject|73|||
128763529|NCT01287520|463425727|FG000|Overall Study|Physician Decision|1|||
128763530|NCT01287520|463425728|FG001|Overall Study|Physician Decision|1|||
128687330|NCT02047227|463154632|FG000|Overall Study|Intention to freeze all embryos|1|||
128687331|NCT02047227|463154633|FG001|Overall Study|Intention to freeze all embryos|0|||
128687332|NCT02047227|463154632|FG000|Overall Study|All embryos discarded|12|||
128687333|NCT02047227|463154633|FG001|Overall Study|All embryos discarded|11|||
128687334|NCT02047227|463154632|FG000|Overall Study|Other|10|||
128687335|NCT02047227|463154633|FG001|Overall Study|Other|9|||
128687336|NCT02819518|463154646|FG000|Overall Study|Death|9|||
128687337|NCT02819518|463154647|FG001|Overall Study|Death|12|||
128687338|NCT02819518|463154648|FG002|Overall Study|Death|9|||
128687339|NCT02819518|463154649|FG003|Overall Study|Death|475|||
128687340|NCT02819518|463154650|FG004|Overall Study|Death|244|||
128687341|NCT02819518|463154646|FG000|Overall Study|Withdrawal by Subject|0|||
128687342|NCT02819518|463154647|FG001|Overall Study|Withdrawal by Subject|0|||
128687343|NCT02819518|463154648|FG002|Overall Study|Withdrawal by Subject|0|||
128687344|NCT02819518|463154649|FG003|Overall Study|Withdrawal by Subject|25|||
128687345|NCT02819518|463154650|FG004|Overall Study|Withdrawal by Subject|8|||
128687346|NCT02819518|463154646|FG000|Overall Study|Lost to Follow-up|0|||
128687347|NCT02819518|463154647|FG001|Overall Study|Lost to Follow-up|0|||
128687348|NCT02819518|463154648|FG002|Overall Study|Lost to Follow-up|0|||
128687349|NCT02819518|463154649|FG003|Overall Study|Lost to Follow-up|0|||
128687350|NCT02819518|463154650|FG004|Overall Study|Lost to Follow-up|1|||
128687351|NCT02819518|463154646|FG000|Overall Study|Sponsor Decision|1|||
128687352|NCT02819518|463154647|FG001|Overall Study|Sponsor Decision|1|||
128687353|NCT02819518|463154648|FG002|Overall Study|Sponsor Decision|0|||
128763531|NCT01287520|463425729|FG002|Overall Study|Physician Decision|2|||
128763532|NCT01287520|463425730|FG003|Overall Study|Physician Decision|0|||
128763533|NCT01287520|463425731|FG004|Overall Study|Physician Decision|1|||
128763534|NCT01287520|463425732|FG005|Overall Study|Physician Decision|1|||
128763535|NCT01287520|463425733|FG006|Overall Study|Physician Decision|0|||
128763536|NCT01287520|463425734|FG007|Overall Study|Physician Decision|1|||
128763537|NCT01287520|463425735|FG008|Overall Study|Physician Decision|0|||
128763538|NCT01287520|463425727|FG000|Overall Study|Progressive disease|0|||
128687354|NCT02819518|463154649|FG003|Overall Study|Sponsor Decision|34|||
128687355|NCT02819518|463154650|FG004|Overall Study|Sponsor Decision|17|||
128687356|NCT02819518|463154646|FG000|Overall Study|Transferred to extension study|1|||
128687357|NCT02819518|463154647|FG001|Overall Study|Transferred to extension study|1|||
128687358|NCT02819518|463154648|FG002|Overall Study|Transferred to extension study|1|||
128687359|NCT02819518|463154649|FG003|Overall Study|Transferred to extension study|32|||
128687360|NCT02819518|463154650|FG004|Overall Study|Transferred to extension study|11|||
128687361|NCT00880165|463154651|FG000|Overall Study|Withdrawal by Subject|27|||
128687362|NCT00880165|463154652|FG001|Overall Study|Withdrawal by Subject|23|||
128687363|NCT00880165|463154651|FG000|Overall Study|Not diagnosed with OSA|14|||
128687364|NCT00880165|463154652|FG001|Overall Study|Not diagnosed with OSA|8|||
128687365|NCT00880165|463154651|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
128687366|NCT00880165|463154652|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
128687367|NCT00880165|463154651|FG000|Overall Study|Lost to follow|9|||
128687368|NCT00880165|463154652|FG001|Overall Study|Lost to follow|15|||
128687369|NCT00667602|463154653|FG000|Overall Study|Withdrawal by Subject|4|||
128687370|NCT00667602|463154654|FG001|Overall Study|Withdrawal by Subject|9|||
128687371|NCT00667602|463154655|FG002|Overall Study|Withdrawal by Subject|10|||
128687372|NCT00667602|463154653|FG000|Overall Study|Lost to Follow-up|4|||
128687373|NCT00667602|463154654|FG001|Overall Study|Lost to Follow-up|5|||
128687374|NCT00667602|463154655|FG002|Overall Study|Lost to Follow-up|6|||
128687375|NCT00667602|463154653|FG000|Overall Study|Administrative reason|0|||
128687376|NCT00667602|463154654|FG001|Overall Study|Administrative reason|0|||
128687377|NCT00667602|463154655|FG002|Overall Study|Administrative reason|2|||
128687378|NCT00667602|463154653|FG000|Overall Study|Protocol Violation|0|||
128687379|NCT00667602|463154654|FG001|Overall Study|Protocol Violation|1|||
128763539|NCT01287520|463425728|FG001|Overall Study|Progressive disease|4|||
128763540|NCT01287520|463425729|FG002|Overall Study|Progressive disease|1|||
128687380|NCT00667602|463154655|FG002|Overall Study|Protocol Violation|0|||
128687381|NCT00973349|463154662|FG000|Overall Study|Adverse Event|0|||
128687382|NCT00973349|463154663|FG001|Overall Study|Adverse Event|0|||
128687383|NCT00973349|463154664|FG002|Overall Study|Adverse Event|0|||
128687384|NCT00973349|463154665|FG003|Overall Study|Adverse Event|0|||
128687385|NCT00973349|463154666|FG004|Overall Study|Adverse Event|1|||
128687386|NCT00973349|463154667|FG005|Overall Study|Adverse Event|0|||
128687387|NCT00973349|463154668|FG006|Overall Study|Adverse Event|0|||
128687388|NCT00973349|463154669|FG007|Overall Study|Adverse Event|0|||
128687389|NCT00973349|463154670|FG008|Overall Study|Adverse Event|1|||
128687390|NCT00973349|463154671|FG009|Overall Study|Adverse Event|0|||
128687391|NCT00973349|463154672|FG010|Overall Study|Adverse Event|0|||
128687392|NCT00973349|463154673|FG011|Overall Study|Adverse Event|0|||
128763541|NCT01287520|463425730|FG003|Overall Study|Progressive disease|6|||
128887059|NCT00364156|463880622|FG001|Overall Study|Withdrawal by Subject|80|||
128887060|NCT00364156|463880621|FG000|Overall Study|Protocol Violation|6|||
128887061|NCT00364156|463880622|FG001|Overall Study|Protocol Violation|1|||
128887062|NCT05125679|463880629|FG000|Overall Study|Study Terminated by Sponsor|2|||
128887063|NCT05125679|463880630|FG001|Overall Study|Study Terminated by Sponsor|5|||
128887064|NCT04683731|463880635|FG000|Overall Study|Withdrawal by Subject|1|||
128887065|NCT04683731|463880636|FG001|Overall Study|Withdrawal by Subject|0|||
128887066|NCT04683731|463880637|FG002|Overall Study|Withdrawal by Subject|3|||
128887067|NCT04683731|463880638|FG003|Overall Study|Withdrawal by Subject|2|||
128887068|NCT04683731|463880635|FG000|Overall Study|Determined patient was not eligible|3|||
128887069|NCT04683731|463880636|FG001|Overall Study|Determined patient was not eligible|3|||
128887070|NCT04683731|463880637|FG002|Overall Study|Determined patient was not eligible|12|||
128887071|NCT04683731|463880638|FG003|Overall Study|Determined patient was not eligible|3|||
128887072|NCT00458341|463880641|FG000|Cycle 1|Adverse Event|1|||
128887073|NCT00458341|463880642|FG001|Cycle 1|Adverse Event|0|||
128887074|NCT01210118|463880643|FG000|Overall Study|Lost to Follow-up|1|||
128887075|NCT01210118|463880644|FG001|Overall Study|Lost to Follow-up|1|||
128887076|NCT01210118|463880643|FG000|Overall Study|Protocol Violation|1|||
128887077|NCT01210118|463880644|FG001|Overall Study|Protocol Violation|1|||
128887078|NCT01210118|463880643|FG000|Overall Study|Spontaneous abortion|1|||
128887079|NCT01210118|463880644|FG001|Overall Study|Spontaneous abortion|3|||
128887080|NCT02958267|463880647|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
128887081|NCT02958267|463880648|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
128887082|NCT02958267|463880647|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
128887083|NCT02958267|463880648|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
128887084|NCT02958267|463880647|FG000|Follow-up Visits|Additional treatment pursued|2|||
128887085|NCT02958267|463880648|FG001|Follow-up Visits|Additional treatment pursued|1|||
128687393|NCT00973349|463154674|FG012|Overall Study|Adverse Event|0|||
128687394|NCT00973349|463154675|FG013|Overall Study|Adverse Event|0|||
128687395|NCT00973349|463154676|FG014|Overall Study|Adverse Event|1|||
128687396|NCT00973349|463154677|FG015|Overall Study|Adverse Event|0|||
128687397|NCT00973349|463154662|FG000|Overall Study|Withdrawal by Subject|1|||
128887086|NCT01422850|463880651|FG000|Overall Study|Physician Decision|3|||
128887087|NCT04484831|463880652|FG000|Overall Study|Withdrawal by Subject|1|||
128887088|NCT04484831|463880653|FG001|Overall Study|Withdrawal by Subject|0|||
128887089|NCT02244996|463880654|FG000|Overall Study|Lack of Efficacy|2|||
128887090|NCT02244996|463880655|FG001|Overall Study|Lack of Efficacy|6|||
128887091|NCT01335009|463880656|FG000|Overall Study|Too ill to travel to study sites|1|||
128887092|NCT01335009|463880657|FG001|Overall Study|Too ill to travel to study sites|0|||
128887093|NCT01335009|463880656|FG000|Overall Study|Death|28|||
128887094|NCT01335009|463880657|FG001|Overall Study|Death|32|||
128887095|NCT01335009|463880656|FG000|Overall Study|Withdrawal by Subject|1|||
128887096|NCT01335009|463880657|FG001|Overall Study|Withdrawal by Subject|1|||
128887097|NCT01335009|463880656|FG000|Overall Study|Lost to Follow-up|1|||
128687398|NCT00973349|463154663|FG001|Overall Study|Withdrawal by Subject|2|||
128687399|NCT00973349|463154664|FG002|Overall Study|Withdrawal by Subject|2|||
128687400|NCT00973349|463154665|FG003|Overall Study|Withdrawal by Subject|3|||
128687401|NCT00973349|463154666|FG004|Overall Study|Withdrawal by Subject|2|||
128687402|NCT00973349|463154667|FG005|Overall Study|Withdrawal by Subject|0|||
128687403|NCT00973349|463154668|FG006|Overall Study|Withdrawal by Subject|2|||
128687404|NCT00973349|463154669|FG007|Overall Study|Withdrawal by Subject|2|||
128687405|NCT00973349|463154670|FG008|Overall Study|Withdrawal by Subject|0|||
128687406|NCT00973349|463154671|FG009|Overall Study|Withdrawal by Subject|2|||
128687407|NCT00973349|463154672|FG010|Overall Study|Withdrawal by Subject|0|||
128687408|NCT00973349|463154673|FG011|Overall Study|Withdrawal by Subject|1|||
128687409|NCT00973349|463154674|FG012|Overall Study|Withdrawal by Subject|0|||
128687410|NCT00973349|463154675|FG013|Overall Study|Withdrawal by Subject|0|||
128687411|NCT00973349|463154676|FG014|Overall Study|Withdrawal by Subject|0|||
128687412|NCT00973349|463154677|FG015|Overall Study|Withdrawal by Subject|0|||
128687413|NCT00973349|463154662|FG000|Overall Study|Lost to Follow-up|3|||
128687414|NCT00973349|463154663|FG001|Overall Study|Lost to Follow-up|1|||
128687415|NCT00973349|463154664|FG002|Overall Study|Lost to Follow-up|2|||
128687416|NCT00973349|463154665|FG003|Overall Study|Lost to Follow-up|2|||
128687417|NCT00973349|463154666|FG004|Overall Study|Lost to Follow-up|1|||
128687418|NCT00973349|463154667|FG005|Overall Study|Lost to Follow-up|3|||
128687419|NCT00973349|463154668|FG006|Overall Study|Lost to Follow-up|0|||
128687420|NCT00973349|463154669|FG007|Overall Study|Lost to Follow-up|1|||
128687421|NCT00973349|463154670|FG008|Overall Study|Lost to Follow-up|2|||
128687422|NCT00973349|463154671|FG009|Overall Study|Lost to Follow-up|1|||
128887098|NCT01335009|463880657|FG001|Overall Study|Lost to Follow-up|0|||
128887099|NCT03971422|463881965|FG000|Overall Study|Lost to Follow-up|0|||
128887100|NCT03971422|463881966|FG001|Overall Study|Lost to Follow-up|1|||
128887101|NCT03971422|463881967|FG002|Overall Study|Lost to Follow-up|0|||
128887102|NCT03971422|463881965|FG000|Overall Study|Lack of Efficacy|5|||
128887103|NCT03971422|463881966|FG001|Overall Study|Lack of Efficacy|1|||
128887104|NCT03971422|463881967|FG002|Overall Study|Lack of Efficacy|1|||
128887105|NCT03971422|463881965|FG000|Overall Study|Adverse event, not fatal|2|||
128887106|NCT03971422|463881966|FG001|Overall Study|Adverse event, not fatal|2|||
128887107|NCT03971422|463881967|FG002|Overall Study|Adverse event, not fatal|5|||
128887108|NCT03971422|463881965|FG000|Overall Study|Worsening of MG Symptoms|1|||
128887109|NCT03971422|463881966|FG001|Overall Study|Worsening of MG Symptoms|4|||
128887110|NCT03971422|463881967|FG002|Overall Study|Worsening of MG Symptoms|2|||
128887111|NCT03971422|463881965|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
128887112|NCT03971422|463881966|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
128887113|NCT03971422|463881967|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
128887114|NCT03971422|463881965|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
128887115|NCT03971422|463881966|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
128887116|NCT03971422|463881967|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
128887117|NCT03971422|463881965|FG000|Overall Study|Due to COVID-19 pandemic|0|||
128887118|NCT03971422|463881966|FG001|Overall Study|Due to COVID-19 pandemic|1|||
128887119|NCT03971422|463881967|FG002|Overall Study|Due to COVID-19 pandemic|1|||
128887120|NCT04751656|463881970|FG000|Overall Study|Lost to Follow-up|1|||
128887121|NCT03566810|463881971|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
128887122|NCT03566810|463881972|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
128887123|NCT03566810|463881973|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
128887124|NCT03566810|463881974|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
128887125|NCT01955122|463881982|FG000|Overall Study|Physician Decision|5|||
128887126|NCT01955122|463881983|FG001|Overall Study|Physician Decision|5|||
128887127|NCT00826111|463881984|FG000|Overall Study|Lost to Follow-up|0|||
128887128|NCT00826111|463881985|FG001|Overall Study|Lost to Follow-up|1|||
128887129|NCT00826111|463881984|FG000|Overall Study|Protocol Violation|1|||
128887130|NCT00826111|463881985|FG001|Overall Study|Protocol Violation|0|||
128887131|NCT00826111|463881984|FG000|Overall Study|Withdrawal by Subject|5|||
128887132|NCT00826111|463881985|FG001|Overall Study|Withdrawal by Subject|0|||
128887133|NCT00826111|463881984|FG000|Overall Study|Physician Decision|1|||
128887134|NCT00826111|463881985|FG001|Overall Study|Physician Decision|1|||
128887135|NCT01672788|463881986|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
128887136|NCT01672788|463881987|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
128887137|NCT01672788|463881988|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
128887138|NCT01672788|463881989|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
128887139|NCT01117454|463881994|FG000|Overall Study|Pregnancy|0|||
128887140|NCT01117454|463881995|FG001|Overall Study|Pregnancy|1|||
128887141|NCT00888433|463881996|FG000|Overall Study|Withdrawal by Subject|1|||
129020564|NCT01796171|464367109|FG013|Follow-up Period|Patient transferred to other hospital|0|||
129020565|NCT01796171|464367110|FG014|Follow-up Period|Patient transferred to other hospital|0|||
128687423|NCT00973349|463154672|FG010|Overall Study|Lost to Follow-up|0|||
128887142|NCT00888433|463881997|FG001|Overall Study|Withdrawal by Subject|2|||
128887143|NCT00888433|463881996|FG000|Overall Study|Missed Visit|2|||
128887144|NCT00888433|463881997|FG001|Overall Study|Missed Visit|1|||
128887145|NCT01681628|463881998|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
128887146|NCT01681628|463881999|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
128887147|NCT01681628|463881998|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
128887148|NCT01681628|463881999|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
128887149|NCT01681628|463881998|FG000|19 Months Follow-up|Death|1|||
128687424|NCT00973349|463154673|FG011|Overall Study|Lost to Follow-up|1|||
128687425|NCT00973349|463154674|FG012|Overall Study|Lost to Follow-up|0|||
128687426|NCT00973349|463154675|FG013|Overall Study|Lost to Follow-up|0|||
128687427|NCT00973349|463154676|FG014|Overall Study|Lost to Follow-up|0|||
128687428|NCT00973349|463154677|FG015|Overall Study|Lost to Follow-up|1|||
128687429|NCT00973349|463154662|FG000|Overall Study|Inappropriate enrolment|0|||
128687430|NCT00973349|463154663|FG001|Overall Study|Inappropriate enrolment|0|||
128687431|NCT00973349|463154664|FG002|Overall Study|Inappropriate enrolment|1|||
128687432|NCT00973349|463154665|FG003|Overall Study|Inappropriate enrolment|0|||
128687433|NCT00973349|463154666|FG004|Overall Study|Inappropriate enrolment|0|||
128687434|NCT00973349|463154667|FG005|Overall Study|Inappropriate enrolment|0|||
128687435|NCT00973349|463154668|FG006|Overall Study|Inappropriate enrolment|0|||
128687436|NCT00973349|463154669|FG007|Overall Study|Inappropriate enrolment|0|||
128687437|NCT00973349|463154670|FG008|Overall Study|Inappropriate enrolment|0|||
128687438|NCT00973349|463154671|FG009|Overall Study|Inappropriate enrolment|2|||
128687439|NCT00973349|463154672|FG010|Overall Study|Inappropriate enrolment|0|||
128687440|NCT00973349|463154673|FG011|Overall Study|Inappropriate enrolment|0|||
128687441|NCT00973349|463154674|FG012|Overall Study|Inappropriate enrolment|1|||
128687442|NCT00973349|463154675|FG013|Overall Study|Inappropriate enrolment|0|||
128687443|NCT00973349|463154676|FG014|Overall Study|Inappropriate enrolment|1|||
128687444|NCT00973349|463154677|FG015|Overall Study|Inappropriate enrolment|1|||
128687445|NCT00973349|463154662|FG000|Overall Study|Protocol Violation|0|||
128687446|NCT00973349|463154663|FG001|Overall Study|Protocol Violation|0|||
128687447|NCT00973349|463154664|FG002|Overall Study|Protocol Violation|0|||
128687448|NCT00973349|463154665|FG003|Overall Study|Protocol Violation|0|||
128687449|NCT00973349|463154666|FG004|Overall Study|Protocol Violation|0|||
128687450|NCT00973349|463154667|FG005|Overall Study|Protocol Violation|0|||
128687451|NCT00973349|463154668|FG006|Overall Study|Protocol Violation|0|||
128887150|NCT01681628|463881999|FG001|19 Months Follow-up|Death|0|||
128887151|NCT01681628|463881998|FG000|19 Months Follow-up|Lost to Follow-up|61|||
128887152|NCT01681628|463881999|FG001|19 Months Follow-up|Lost to Follow-up|43|||
128887153|NCT01637623|463882008|FG000|Overall Study|Lost to Follow-up|0|||
128887154|NCT01637623|463882009|FG001|Overall Study|Lost to Follow-up|0|||
128887155|NCT01637623|463882010|FG002|Overall Study|Lost to Follow-up|2|||
128887156|NCT01637623|463882008|FG000|Overall Study|Physician Decision|1|||
128887157|NCT01637623|463882009|FG001|Overall Study|Physician Decision|0|||
128887158|NCT01637623|463882010|FG002|Overall Study|Physician Decision|1|||
128887159|NCT02170389|463882017|FG000|Overall Study|Study terminated prior to start of treat|1|||
128887160|NCT01008696|463882019|FG000|Overall Study|Participant's evasion of hospital visit|5|||
128887161|NCT01008696|463882020|FG001|Overall Study|Participant's evasion of hospital visit|4|||
128887162|NCT01008696|463882019|FG000|Overall Study|Withdrawal by Subject|2|||
128887163|NCT01008696|463882020|FG001|Overall Study|Withdrawal by Subject|4|||
128887164|NCT01008696|463882019|FG000|Overall Study|Physician Decision|5|||
128887165|NCT01008696|463882020|FG001|Overall Study|Physician Decision|1|||
128887166|NCT01008696|463882019|FG000|Overall Study|Adverse Event|1|||
128887167|NCT01008696|463882020|FG001|Overall Study|Adverse Event|0|||
128887168|NCT01008696|463882019|FG000|Overall Study|Participants' non-cooperation|2|||
128887169|NCT01008696|463882020|FG001|Overall Study|Participants' non-cooperation|3|||
128887170|NCT01008696|463882019|FG000|Overall Study|Other|2|||
128887171|NCT01008696|463882020|FG001|Overall Study|Other|3|||
128887172|NCT01008696|463882019|FG000|Overall Study|Other|0|||
128887173|NCT01008696|463882020|FG001|Overall Study|Other|2|||
128887174|NCT02960854|463882021|FG000|Overall Study|Not Disclosed|2|||
128887175|NCT02960854|463882022|FG001|Overall Study|Not Disclosed|2|||
128887176|NCT02960854|463882021|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
128887177|NCT02960854|463882022|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
128887178|NCT02960854|463882021|FG000|Overall Study|Subject Withdrew Consent|0|||
128887179|NCT02960854|463882022|FG001|Overall Study|Subject Withdrew Consent|1|||
128687452|NCT00973349|463154669|FG007|Overall Study|Protocol Violation|0|||
128687453|NCT00973349|463154670|FG008|Overall Study|Protocol Violation|1|||
128687454|NCT00973349|463154671|FG009|Overall Study|Protocol Violation|0|||
128687455|NCT00973349|463154672|FG010|Overall Study|Protocol Violation|0|||
128687456|NCT00973349|463154673|FG011|Overall Study|Protocol Violation|0|||
128687457|NCT00973349|463154674|FG012|Overall Study|Protocol Violation|0|||
128887180|NCT02960854|463882021|FG000|Overall Study|Death|4|||
128887181|NCT02960854|463882022|FG001|Overall Study|Death|6|||
128887182|NCT04263909|463882023|FG000|Overall Study|Physician Decision|1|||
129109778|NCT02168491|464695976|FG000|Overall Study|Withdrawal by Subject|1|||
129109779|NCT01610037|464695978|FG000|All Patients|Adverse Event|27|||
129109780|NCT01610037|464695979|FG001|All Patients|Adverse Event|22|||
129109781|NCT01610037|464695980|FG002|All Patients|Adverse Event|26|||
129109782|NCT01610037|464695978|FG000|All Patients|Withdrawal by Subject|12|||
129109783|NCT01610037|464695979|FG001|All Patients|Withdrawal by Subject|10|||
129109784|NCT01610037|464695980|FG002|All Patients|Withdrawal by Subject|20|||
129109785|NCT01610037|464695978|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
129109786|NCT01610037|464695979|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
129109787|NCT01610037|464695980|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
129109788|NCT01610037|464695978|FG000|All Patients|Death|4|||
129109789|NCT01610037|464695979|FG001|All Patients|Death|2|||
129109790|NCT01610037|464695980|FG002|All Patients|Death|1|||
129109791|NCT01610037|464695978|FG000|All Patients|Protocol deviation|4|||
129109792|NCT01610037|464695979|FG001|All Patients|Protocol deviation|3|||
129109793|NCT01610037|464695980|FG002|All Patients|Protocol deviation|3|||
129109794|NCT01610037|464695978|FG000|All Patients|Abnormal laboratory value|1|||
129109795|NCT01610037|464695979|FG001|All Patients|Abnormal laboratory value|1|||
129109796|NCT01610037|464695980|FG002|All Patients|Abnormal laboratory value|0|||
128687458|NCT00973349|463154675|FG013|Overall Study|Protocol Violation|0|||
128687459|NCT00973349|463154676|FG014|Overall Study|Protocol Violation|0|||
128687460|NCT00973349|463154677|FG015|Overall Study|Protocol Violation|0|||
128687461|NCT00973349|463154662|FG000|Overall Study|Unable to classify|0|||
128687462|NCT00973349|463154663|FG001|Overall Study|Unable to classify|0|||
128887183|NCT04263909|463882024|FG001|Overall Study|Physician Decision|0|||
128687463|NCT00973349|463154664|FG002|Overall Study|Unable to classify|0|||
128687464|NCT00973349|463154665|FG003|Overall Study|Unable to classify|0|||
128687465|NCT00973349|463154666|FG004|Overall Study|Unable to classify|1|||
128887184|NCT04263909|463882025|FG002|Overall Study|Physician Decision|0|||
128887185|NCT04263909|463882023|FG000|Overall Study|Adverse Event|3|||
128887186|NCT04263909|463882024|FG001|Overall Study|Adverse Event|0|||
128887187|NCT04263909|463882025|FG002|Overall Study|Adverse Event|0|||
128887188|NCT04263909|463882023|FG000|Overall Study|Protocol Violation|5|||
128887189|NCT04263909|463882024|FG001|Overall Study|Protocol Violation|0|||
128887190|NCT04263909|463882025|FG002|Overall Study|Protocol Violation|0|||
129109797|NCT01610037|464695978|FG000|All Patients|Administrative problems|1|||
129109798|NCT01610037|464695979|FG001|All Patients|Administrative problems|4|||
129109799|NCT01610037|464695980|FG002|All Patients|Administrative problems|4|||
129109800|NCT01610037|464695978|FG000|All Patients|Lost to Follow-up|1|||
129109801|NCT01610037|464695979|FG001|All Patients|Lost to Follow-up|0|||
128887191|NCT04288778|463882026|FG000|Overall Study|Withdrawal by Subject|2|||
128887192|NCT04288778|463882026|FG000|Overall Study|Adverse Event|5|||
128887193|NCT04288778|463882026|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128887194|NCT04288778|463882026|FG000|Overall Study|Other|1|||
128887195|NCT04288778|463882026|FG000|Overall Study|Started but not treated|2|||
128887196|NCT03118674|463882027|FG000|Overall Study|Lost to Follow-up|2|||
128887197|NCT03118674|463882027|FG000|Overall Study|Screen Faliure|8|||
128887198|NCT03118674|463882027|FG000|Overall Study|Withdrawal by Subject|5|||
128887199|NCT01067326|463882032|FG000|Overall Study|Adverse Event|0|||
128887200|NCT01067326|463882033|FG001|Overall Study|Adverse Event|2|||
128887201|NCT01067326|463882032|FG000|Overall Study|Withdrawal by Subject|1|||
128887202|NCT01067326|463882033|FG001|Overall Study|Withdrawal by Subject|0|||
128887203|NCT01067326|463882032|FG000|Overall Study|Early Study Termination|1|||
128887204|NCT01067326|463882033|FG001|Overall Study|Early Study Termination|1|||
128887205|NCT01230788|463882040|FG000|Overall Study|Prescribed exclusion drug|1|||
128887206|NCT00769860|463882041|FG000|Overall Study|Withdrawal by Subject|2|||
128887207|NCT00769860|463882042|FG001|Overall Study|Withdrawal by Subject|0|||
128887208|NCT01603082|463882043|FG000|Overall Study|Adverse Event|0|||
128887209|NCT01603082|463882044|FG001|Overall Study|Adverse Event|1|||
128887210|NCT01603082|463882043|FG000|Overall Study|Withdrawal by Subject|1|||
128887211|NCT01603082|463882044|FG001|Overall Study|Withdrawal by Subject|0|||
128887212|NCT01603082|463882043|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
128887213|NCT01603082|463882044|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
128887214|NCT01019317|463882047|FG000|Overall Study|Not Eligible|4|||
128887215|NCT01699789|463882050|FG000|Overall Study|Withdrawal by Subject|18|||
128887216|NCT01699789|463882051|FG001|Overall Study|Withdrawal by Subject|23|||
128887217|NCT01699789|463882050|FG000|Overall Study|Death|1|||
128887218|NCT01699789|463882051|FG001|Overall Study|Death|2|||
128887219|NCT01699789|463882050|FG000|Overall Study|Lost to Follow-up|83|||
128887220|NCT01699789|463882051|FG001|Overall Study|Lost to Follow-up|101|||
128887221|NCT01323621|463882052|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
128887222|NCT01323621|463882053|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
128887223|NCT01323621|463882054|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
128887224|NCT01323621|463882052|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
128887225|NCT01323621|463882053|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
128887226|NCT01323621|463882054|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
128887227|NCT01323621|463882052|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
128887228|NCT01323621|463882053|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
128687466|NCT00973349|463154667|FG005|Overall Study|Unable to classify|1|||
128763542|NCT01287520|463425731|FG004|Overall Study|Progressive disease|1|||
128763543|NCT01287520|463425732|FG005|Overall Study|Progressive disease|0|||
128763544|NCT01287520|463425733|FG006|Overall Study|Progressive disease|2|||
128687467|NCT00973349|463154668|FG006|Overall Study|Unable to classify|0|||
128687468|NCT00973349|463154669|FG007|Overall Study|Unable to classify|0|||
128687469|NCT00973349|463154670|FG008|Overall Study|Unable to classify|0|||
128687470|NCT00973349|463154671|FG009|Overall Study|Unable to classify|1|||
128687471|NCT00973349|463154672|FG010|Overall Study|Unable to classify|0|||
128687472|NCT00973349|463154673|FG011|Overall Study|Unable to classify|0|||
128687473|NCT00973349|463154674|FG012|Overall Study|Unable to classify|0|||
128763545|NCT01287520|463425734|FG007|Overall Study|Progressive disease|2|||
128763546|NCT01287520|463425735|FG008|Overall Study|Progressive disease|4|||
128763547|NCT01287520|463425727|FG000|Overall Study|Withdrawal by Subject|0|||
128763548|NCT01287520|463425728|FG001|Overall Study|Withdrawal by Subject|0|||
128763549|NCT01287520|463425729|FG002|Overall Study|Withdrawal by Subject|0|||
128687474|NCT00973349|463154675|FG013|Overall Study|Unable to classify|0|||
128763550|NCT01287520|463425730|FG003|Overall Study|Withdrawal by Subject|0|||
128763551|NCT01287520|463425731|FG004|Overall Study|Withdrawal by Subject|0|||
128763552|NCT01287520|463425732|FG005|Overall Study|Withdrawal by Subject|1|||
128763553|NCT01287520|463425733|FG006|Overall Study|Withdrawal by Subject|0|||
128763554|NCT01287520|463425734|FG007|Overall Study|Withdrawal by Subject|0|||
128763555|NCT01287520|463425735|FG008|Overall Study|Withdrawal by Subject|1|||
128763556|NCT03673462|463425736|FG000|Overall Study|Adverse Event|11|||
128763557|NCT03673462|463425737|FG001|Overall Study|Adverse Event|1|||
128763558|NCT03673462|463425736|FG000|Overall Study|Protocol Violation|25|||
128763559|NCT03673462|463425737|FG001|Overall Study|Protocol Violation|11|||
128887229|NCT01323621|463882054|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
128887230|NCT01323621|463882052|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
128887231|NCT01323621|463882053|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
128887232|NCT01323621|463882054|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
128887233|NCT01323621|463882052|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
128887234|NCT01323621|463882053|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
129020566|NCT01796171|464367096|FG000|Follow-up Period|Sponsor Decision|0|||
128687475|NCT00973349|463154676|FG014|Overall Study|Unable to classify|0|||
128763560|NCT03673462|463425736|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
128687476|NCT00973349|463154677|FG015|Overall Study|Unable to classify|0|||
128687477|NCT02301988|463154678|FG000|Overall Study|Withdrawal by Subject|2|||
128687478|NCT02301988|463154679|FG001|Overall Study|Withdrawal by Subject|1|||
128687479|NCT02301988|463154678|FG000|Overall Study|Physician Decision|2|||
128687480|NCT02301988|463154679|FG001|Overall Study|Physician Decision|2|||
128687481|NCT02301988|463154678|FG000|Overall Study|Unknown Reason|1|||
128687482|NCT02301988|463154679|FG001|Overall Study|Unknown Reason|3|||
128687483|NCT02301988|463154678|FG000|Overall Study|Lack of Efficacy|3|||
128687484|NCT02301988|463154679|FG001|Overall Study|Lack of Efficacy|2|||
128687485|NCT02301988|463154678|FG000|Overall Study|Death|1|||
128687486|NCT02301988|463154679|FG001|Overall Study|Death|0|||
128687487|NCT02301988|463154678|FG000|Overall Study|Adverse Event|1|||
128687488|NCT02301988|463154679|FG001|Overall Study|Adverse Event|1|||
128687489|NCT02750943|463154680|FG000|Overall Study|Lost to Follow-up|1|||
128687490|NCT02750943|463154681|FG001|Overall Study|Lost to Follow-up|2|||
128687491|NCT02750943|463154680|FG000|Overall Study|Withdrawal by Subject|5|||
128687492|NCT02750943|463154681|FG001|Overall Study|Withdrawal by Subject|7|||
128687493|NCT00171054|463154682|FG000|Overall Study|Protocol Violation|1|||
128687494|NCT00171054|463154683|FG001|Overall Study|Protocol Violation|2|||
128687495|NCT00171054|463154682|FG000|Overall Study|Patient withdrew consent|1|||
128687496|NCT00171054|463154683|FG001|Overall Study|Patient withdrew consent|0|||
128687497|NCT00171054|463154682|FG000|Overall Study|Lost to Follow-up|0|||
128687498|NCT00171054|463154683|FG001|Overall Study|Lost to Follow-up|1|||
128687499|NCT00171054|463154682|FG000|Overall Study|Adverse Event|8|||
128687500|NCT00171054|463154683|FG001|Overall Study|Adverse Event|8|||
128687501|NCT00171054|463154682|FG000|Overall Study|Condition no longer required study drug|0|||
128687502|NCT00171054|463154683|FG001|Overall Study|Condition no longer required study drug|1|||
128687503|NCT02477696|463154684|FG000|Overall Study|Death|89|||
128687504|NCT02477696|463154685|FG001|Overall Study|Death|106|||
128687505|NCT02477696|463154684|FG000|Overall Study|Lost to Follow-up|7|||
128687506|NCT02477696|463154685|FG001|Overall Study|Lost to Follow-up|5|||
128687507|NCT02477696|463154684|FG000|Overall Study|Withdrawal by Subject|37|||
128687508|NCT02477696|463154685|FG001|Overall Study|Withdrawal by Subject|34|||
128687509|NCT02477696|463154684|FG000|Overall Study|Physician Decision|7|||
128687510|NCT02477696|463154685|FG001|Overall Study|Physician Decision|9|||
128687511|NCT02477696|463154684|FG000|Overall Study|Study terminated by sponsor|103|||
128687512|NCT02477696|463154685|FG001|Overall Study|Study terminated by sponsor|99|||
128687513|NCT02477696|463154684|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
128687514|NCT02477696|463154685|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
128687515|NCT02477696|463154684|FG000|Overall Study|Missing/Unknown|2|||
128687516|NCT02477696|463154685|FG001|Overall Study|Missing/Unknown|0|||
128687517|NCT05419908|463154687|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
128687518|NCT05419908|463154688|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
128687519|NCT05419908|463154687|FG000|Overall Study|Serious Adverse Event|0|||
128687520|NCT05419908|463154688|FG001|Overall Study|Serious Adverse Event|2|||
128687521|NCT05419908|463154687|FG000|Overall Study|Withdrawal by Subject|2|||
128687522|NCT05419908|463154688|FG001|Overall Study|Withdrawal by Subject|0|||
128687523|NCT05419908|463154687|FG000|Overall Study|Miscellaneous|1|||
128687524|NCT05419908|463154688|FG001|Overall Study|Miscellaneous|1|||
128687525|NCT05098938|463154692|FG000|Overall Study|Adverse Event|4|||
128687526|NCT05098938|463154693|FG001|Overall Study|Adverse Event|3|||
128687527|NCT05098938|463154692|FG000|Overall Study|inclusion/exclusion criteria change|11|||
128687528|NCT05098938|463154693|FG001|Overall Study|inclusion/exclusion criteria change|5|||
128687529|NCT05098938|463154692|FG000|Overall Study|lack of compliance|26|||
128687530|NCT05098938|463154693|FG001|Overall Study|lack of compliance|19|||
128687531|NCT05098938|463154692|FG000|Overall Study|Lost to Follow-up|37|||
128687532|NCT05098938|463154693|FG001|Overall Study|Lost to Follow-up|40|||
128687533|NCT05098938|463154692|FG000|Overall Study|Lost in treatment period|17|||
128687534|NCT05098938|463154693|FG001|Overall Study|Lost in treatment period|13|||
129020567|NCT01796171|464367097|FG001|Follow-up Period|Sponsor Decision|0|||
128687535|NCT05098938|463154692|FG000|Overall Study|Met an exclusion criterion|0|||
128687536|NCT05098938|463154693|FG001|Overall Study|Met an exclusion criterion|3|||
128687537|NCT05098938|463154692|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
128687538|NCT05098938|463154693|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
128687539|NCT05098938|463154692|FG000|Overall Study|Physician Decision|25|||
128687540|NCT05098938|463154693|FG001|Overall Study|Physician Decision|32|||
128687541|NCT05098938|463154692|FG000|Overall Study|Run in failure in treatment phase|1|||
128687542|NCT05098938|463154693|FG001|Overall Study|Run in failure in treatment phase|1|||
128687543|NCT05098938|463154692|FG000|Overall Study|Withdrawal by Subject|0|||
128687544|NCT05098938|463154693|FG001|Overall Study|Withdrawal by Subject|3|||
128687545|NCT05098938|463154692|FG000|Overall Study|Run-in Failure in early study|505|||
129020568|NCT01796171|464367098|FG002|Follow-up Period|Sponsor Decision|0|||
129020569|NCT01796171|464367099|FG003|Follow-up Period|Sponsor Decision|0|||
129020570|NCT01796171|464367100|FG004|Follow-up Period|Sponsor Decision|0|||
129020571|NCT01796171|464367101|FG005|Follow-up Period|Sponsor Decision|0|||
129020572|NCT01796171|464367102|FG006|Follow-up Period|Sponsor Decision|0|||
129020573|NCT01796171|464367103|FG007|Follow-up Period|Sponsor Decision|0|||
128887235|NCT01323621|463882054|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
128887236|NCT01323621|463882052|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
128887237|NCT01323621|463882053|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
128887238|NCT01323621|463882054|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
128887239|NCT01323621|463882052|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
128887240|NCT01323621|463882053|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
128887241|NCT01323621|463882054|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
128887242|NCT01323621|463882052|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
128887243|NCT01323621|463882053|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
128887244|NCT01323621|463882054|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
128887245|NCT01323621|463882052|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
128887246|NCT01323621|463882053|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
128887247|NCT01323621|463882054|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
128887248|NCT01323621|463882052|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128763561|NCT03673462|463425737|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
128763562|NCT03673462|463425736|FG000|Overall Study|Lost to Follow-up|102|||
128763563|NCT03673462|463425737|FG001|Overall Study|Lost to Follow-up|19|||
128763564|NCT02768662|463425738|FG000|Overall Study|Adverse Event|1|||
128763565|NCT02768662|463425738|FG000|Overall Study|Lost to Follow-up|4|||
128763566|NCT02768662|463425738|FG000|Overall Study|Withdrawal by Subject|3|||
128763567|NCT02768662|463425738|FG000|Overall Study|Study terminated by Sponsor|78|||
128763568|NCT00708435|463425739|FG000|Overall Study|Death / Serious Adverse Event|10|||
128763569|NCT00708435|463425740|FG001|Overall Study|Death / Serious Adverse Event|5|||
128763570|NCT00708435|463425739|FG000|Overall Study|Lost to Follow-up|9|||
128763571|NCT00708435|463425740|FG001|Overall Study|Lost to Follow-up|4|||
128763572|NCT00708435|463425739|FG000|Overall Study|Withdrawal by Subject|3|||
128763573|NCT00708435|463425740|FG001|Overall Study|Withdrawal by Subject|7|||
128763574|NCT00708435|463425739|FG000|Overall Study|Adverse Event|1|||
128763575|NCT00708435|463425740|FG001|Overall Study|Adverse Event|0|||
128763576|NCT00708435|463425739|FG000|Overall Study|Protocol Violation|0|||
128763577|NCT00708435|463425740|FG001|Overall Study|Protocol Violation|1|||
128763578|NCT00708435|463425739|FG000|Overall Study|Intervention by primary care physician|1|||
128763579|NCT00708435|463425740|FG001|Overall Study|Intervention by primary care physician|0|||
128763580|NCT00708435|463425739|FG000|Overall Study|Refused hospitalization|1|||
128763581|NCT00708435|463425740|FG001|Overall Study|Refused hospitalization|0|||
128763582|NCT05061537|463425741|FG000|Treatment Phase|Progressive disease|0|||
128763583|NCT05061537|463425742|FG001|Treatment Phase|Progressive disease|1|||
128763584|NCT05061537|463425743|FG002|Treatment Phase|Progressive disease|2|||
128763585|NCT05061537|463425744|FG003|Treatment Phase|Progressive disease|0|||
128763586|NCT05061537|463425745|FG004|Treatment Phase|Progressive disease|0|||
128763587|NCT05061537|463425741|FG000|Treatment Phase|Adverse Event|0|||
128763588|NCT05061537|463425742|FG001|Treatment Phase|Adverse Event|0|||
128763589|NCT05061537|463425743|FG002|Treatment Phase|Adverse Event|2|||
128763590|NCT05061537|463425744|FG003|Treatment Phase|Adverse Event|0|||
128763591|NCT05061537|463425745|FG004|Treatment Phase|Adverse Event|0|||
128763592|NCT05061537|463425741|FG000|Treatment Phase|Global deterioration of health status|0|||
128763593|NCT05061537|463425742|FG001|Treatment Phase|Global deterioration of health status|1|||
128763594|NCT05061537|463425743|FG002|Treatment Phase|Global deterioration of health status|0|||
128763595|NCT05061537|463425744|FG003|Treatment Phase|Global deterioration of health status|0|||
128763596|NCT05061537|463425745|FG004|Treatment Phase|Global deterioration of health status|0|||
128763597|NCT05061537|463425741|FG000|Follow up|Other|2|||
128763598|NCT05061537|463425742|FG001|Follow up|Other|0|||
128763599|NCT05061537|463425743|FG002|Follow up|Other|2|||
128763600|NCT05061537|463425744|FG003|Follow up|Other|0|||
128763601|NCT05061537|463425745|FG004|Follow up|Other|0|||
128763602|NCT05061537|463425741|FG000|Follow up|Study terminated by sponsor|0|||
128763603|NCT05061537|463425742|FG001|Follow up|Study terminated by sponsor|0|||
128763604|NCT05061537|463425743|FG002|Follow up|Study terminated by sponsor|2|||
128763605|NCT05061537|463425744|FG003|Follow up|Study terminated by sponsor|0|||
128763606|NCT05061537|463425745|FG004|Follow up|Study terminated by sponsor|0|||
128763607|NCT05061537|463425741|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
128763608|NCT05061537|463425742|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
128763609|NCT05061537|463425743|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
128763610|NCT05061537|463425744|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
128763611|NCT05061537|463425745|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
128887249|NCT01323621|463882053|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
128763612|NCT05061537|463425741|FG000|Long-term Follow-up|Death|0|||
128763613|NCT05061537|463425742|FG001|Long-term Follow-up|Death|1|||
128763614|NCT05061537|463425743|FG002|Long-term Follow-up|Death|0|||
128763615|NCT05061537|463425744|FG003|Long-term Follow-up|Death|0|||
128763616|NCT05061537|463425745|FG004|Long-term Follow-up|Death|0|||
128763617|NCT03502616|463425746|FG000|Up to Week 16|Withdrawal by Subject|1|||
128763618|NCT03502616|463425747|FG001|Up to Week 16|Withdrawal by Subject|2|||
128763619|NCT03502616|463425746|FG000|Up to Week 16|Lost to Follow-up|0|||
128887250|NCT01323621|463882054|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128887251|NCT01323621|463882052|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
128887252|NCT01323621|463882053|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
128887253|NCT01323621|463882054|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
128887254|NCT01323621|463882052|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
128887255|NCT01323621|463882053|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
128887256|NCT01323621|463882054|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
128887257|NCT01557348|463882055|FG000|Overall Study|Adverse Event|6|||
128887258|NCT01557348|463882056|FG001|Overall Study|Adverse Event|16|||
128887259|NCT01557348|463882055|FG000|Overall Study|Infusion reaction event|5|||
128887260|NCT01557348|463882056|FG001|Overall Study|Infusion reaction event|5|||
128887261|NCT01557348|463882055|FG000|Overall Study|Death|7|||
128887262|NCT01557348|463882056|FG001|Overall Study|Death|4|||
128887263|NCT01557348|463882055|FG000|Overall Study|Insufficient Therapeutic Response|13|||
128887264|NCT01557348|463882056|FG001|Overall Study|Insufficient Therapeutic Response|28|||
128887265|NCT01557348|463882055|FG000|Overall Study|Withdrawal by Subject|5|||
128887266|NCT01557348|463882056|FG001|Overall Study|Withdrawal by Subject|4|||
128887267|NCT01557348|463882055|FG000|Overall Study|Lost to Follow-up|26|||
128887268|NCT01557348|463882056|FG001|Overall Study|Lost to Follow-up|22|||
128887269|NCT01557348|463882055|FG000|Overall Study|Administrative|18|||
128887270|NCT01557348|463882056|FG001|Overall Study|Administrative|11|||
128887271|NCT01891721|463882057|FG000|Overall Study|Lost to Follow-up|10|||
128887272|NCT01891721|463882058|FG001|Overall Study|Lost to Follow-up|5|||
128887273|NCT01891721|463882059|FG002|Overall Study|Lost to Follow-up|1|||
128887274|NCT02000427|463882060|FG000|Overall Study|Death|22|||
128887275|NCT04343248|463882061|FG000|Overall Study|Withdrawal by Subject|5|||
128887276|NCT04343248|463882062|FG001|Overall Study|Withdrawal by Subject|6|||
128887277|NCT04343248|463882061|FG000|Overall Study|Death|1|||
128887278|NCT04343248|463882062|FG001|Overall Study|Death|2|||
128887279|NCT04343248|463882061|FG000|Overall Study|Lost to Follow-up|9|||
128887280|NCT04343248|463882062|FG001|Overall Study|Lost to Follow-up|6|||
128887281|NCT04343248|463882061|FG000|Overall Study|Physician Decision|0|||
128887282|NCT04343248|463882062|FG001|Overall Study|Physician Decision|1|||
129109802|NCT01610037|464695980|FG002|All Patients|Lost to Follow-up|0|||
129109803|NCT01610037|464695978|FG000|All Patients|Abnormal test procedure result(s)|0|||
129109804|NCT01610037|464695979|FG001|All Patients|Abnormal test procedure result(s)|1|||
129109805|NCT01610037|464695980|FG002|All Patients|Abnormal test procedure result(s)|3|||
129109806|NCT01610037|464695978|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
129109807|NCT01610037|464695979|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
129109808|NCT01610037|464695980|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
129109809|NCT01610037|464695978|FG000|Treatment and Follow up Period|Death|10|||
129109810|NCT01610037|464695979|FG001|Treatment and Follow up Period|Death|5|||
129109811|NCT01610037|464695980|FG002|Treatment and Follow up Period|Death|4|||
129109812|NCT01610037|464695978|FG000|Treatment and Follow up Period|Administrative problems|1|||
129109813|NCT01610037|464695979|FG001|Treatment and Follow up Period|Administrative problems|3|||
129109814|NCT01610037|464695980|FG002|Treatment and Follow up Period|Administrative problems|2|||
129109815|NCT01610037|464695978|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
129109816|NCT01610037|464695979|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
129109817|NCT01610037|464695980|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
129109818|NCT00705757|464695981|FG000|Overall Study|Lack of Efficacy|5|||
129109819|NCT00705757|464695982|FG001|Overall Study|Lack of Efficacy|1|||
129109820|NCT00705757|464695983|FG002|Overall Study|Lack of Efficacy|3|||
129109821|NCT00705757|464695981|FG000|Overall Study|Lost to Follow-up|7|||
129109822|NCT00705757|464695982|FG001|Overall Study|Lost to Follow-up|6|||
129109823|NCT00705757|464695983|FG002|Overall Study|Lost to Follow-up|6|||
129109824|NCT00705757|464695981|FG000|Overall Study|Withdrawal by Subject|1|||
129109825|NCT00705757|464695982|FG001|Overall Study|Withdrawal by Subject|1|||
129109826|NCT00705757|464695983|FG002|Overall Study|Withdrawal by Subject|2|||
129109827|NCT01411852|464695984|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
129109828|NCT01411852|464695985|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
129109829|NCT01411852|464695984|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
128887283|NCT04343248|463882061|FG000|Overall Study|Adverse Event|1|||
129109830|NCT01411852|464695985|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
129109831|NCT01411852|464695984|FG000|Prehospital Intervention Phase|Found to be under age|0|||
129109832|NCT01411852|464695985|FG001|Prehospital Intervention Phase|Found to be under age|1|||
129109833|NCT01411852|464695984|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
129109834|NCT01411852|464695985|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
128887284|NCT04343248|463882062|FG001|Overall Study|Adverse Event|0|||
128887285|NCT02708095|463882063|FG000|Overall Study|Adverse Event|4|||
128887286|NCT02708095|463882064|FG001|Overall Study|Adverse Event|10|||
128887287|NCT02708095|463882065|FG002|Overall Study|Adverse Event|11|||
128887288|NCT02708095|463882063|FG000|Overall Study|Lack of Efficacy|9|||
128887289|NCT02708095|463882064|FG001|Overall Study|Lack of Efficacy|3|||
128887290|NCT02708095|463882065|FG002|Overall Study|Lack of Efficacy|0|||
128887291|NCT02708095|463882063|FG000|Overall Study|Lost to Follow-up|2|||
128887292|NCT02708095|463882064|FG001|Overall Study|Lost to Follow-up|0|||
128887293|NCT02708095|463882065|FG002|Overall Study|Lost to Follow-up|0|||
128687546|NCT05098938|463154693|FG001|Overall Study|Run-in Failure in early study|514|||
128887294|NCT02708095|463882063|FG000|Overall Study|Physician Decision|2|||
128887295|NCT02708095|463882064|FG001|Overall Study|Physician Decision|3|||
128887296|NCT02708095|463882065|FG002|Overall Study|Physician Decision|2|||
128887297|NCT02708095|463882063|FG000|Overall Study|Protocol Violation|0|||
128887298|NCT02708095|463882064|FG001|Overall Study|Protocol Violation|0|||
128887299|NCT02708095|463882065|FG002|Overall Study|Protocol Violation|1|||
128887300|NCT02708095|463882063|FG000|Overall Study|Withdrawal by Subject|5|||
128887301|NCT02708095|463882064|FG001|Overall Study|Withdrawal by Subject|3|||
128887302|NCT02708095|463882065|FG002|Overall Study|Withdrawal by Subject|4|||
128887303|NCT01313650|463882068|FG000|Overall Study|Adverse Event|9|||
128887304|NCT01313650|463882069|FG001|Overall Study|Adverse Event|34|||
128887305|NCT01313650|463882070|FG002|Overall Study|Adverse Event|24|||
128887306|NCT01313650|463882071|FG003|Overall Study|Adverse Event|23|||
128887307|NCT01313650|463882068|FG000|Overall Study|Lack of Efficacy|37|||
128887308|NCT01313650|463882069|FG001|Overall Study|Lack of Efficacy|20|||
128887309|NCT01313650|463882070|FG002|Overall Study|Lack of Efficacy|32|||
128887310|NCT01313650|463882071|FG003|Overall Study|Lack of Efficacy|20|||
128887311|NCT01313650|463882068|FG000|Overall Study|Lost to Follow-up|1|||
128887312|NCT01313650|463882069|FG001|Overall Study|Lost to Follow-up|0|||
128887313|NCT01313650|463882070|FG002|Overall Study|Lost to Follow-up|3|||
128887314|NCT01313650|463882071|FG003|Overall Study|Lost to Follow-up|2|||
128887315|NCT01313650|463882068|FG000|Overall Study|Withdrawal by Subject|16|||
128887316|NCT01313650|463882069|FG001|Overall Study|Withdrawal by Subject|20|||
128887317|NCT01313650|463882070|FG002|Overall Study|Withdrawal by Subject|15|||
128887318|NCT01313650|463882071|FG003|Overall Study|Withdrawal by Subject|15|||
128887319|NCT01313650|463882068|FG000|Overall Study|Protocol Violation|4|||
128887320|NCT01313650|463882069|FG001|Overall Study|Protocol Violation|7|||
128887321|NCT01313650|463882070|FG002|Overall Study|Protocol Violation|5|||
128887322|NCT01313650|463882071|FG003|Overall Study|Protocol Violation|6|||
128887323|NCT01313650|463882068|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
128687547|NCT05098938|463154692|FG000|Overall Study|IMP delivery missed|1|||
128687548|NCT05098938|463154693|FG001|Overall Study|IMP delivery missed|5|||
128687549|NCT05098938|463154692|FG000|Overall Study|6 months visit was missed|2|||
128887324|NCT01313650|463882069|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
128887325|NCT01313650|463882070|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
128687550|NCT05098938|463154693|FG001|Overall Study|6 months visit was missed|0|||
128687551|NCT05098938|463154692|FG000|Overall Study|fit for use was not completed within window|3|||
128687552|NCT05098938|463154693|FG001|Overall Study|fit for use was not completed within window|0|||
128687553|NCT05098938|463154692|FG000|Overall Study|V2 visit was not completed within window|0|||
128687554|NCT05098938|463154693|FG001|Overall Study|V2 visit was not completed within window|1|||
128687555|NCT05098938|463154692|FG000|Overall Study|exclusionary medication use|1|||
128687556|NCT05098938|463154693|FG001|Overall Study|exclusionary medication use|2|||
128687557|NCT05098938|463154692|FG000|Overall Study|change in medication|1|||
128687558|NCT05098938|463154693|FG001|Overall Study|change in medication|0|||
128687559|NCT05098938|463154692|FG000|Overall Study|treatment failure|2|||
128687560|NCT05098938|463154693|FG001|Overall Study|treatment failure|1|||
128687561|NCT01397162|463155917|FG000|Overall Study|Adverse Event|4|||
128687562|NCT01397162|463155918|FG001|Overall Study|Adverse Event|0|||
128687563|NCT01397162|463155919|FG002|Overall Study|Adverse Event|0|||
128687564|NCT01397162|463155920|FG003|Overall Study|Adverse Event|0|||
128687565|NCT01397162|463155921|FG004|Overall Study|Adverse Event|0|||
128687566|NCT01397162|463155917|FG000|Overall Study|Not yet defined|3|||
128687567|NCT01397162|463155918|FG001|Overall Study|Not yet defined|4|||
128687568|NCT01397162|463155919|FG002|Overall Study|Not yet defined|3|||
128687569|NCT01397162|463155920|FG003|Overall Study|Not yet defined|5|||
128687570|NCT01397162|463155921|FG004|Overall Study|Not yet defined|3|||
128687571|NCT00426231|463155926|FG000|Overall Study|Withdrawal by Subject|9|||
128687572|NCT00426231|463155927|FG001|Overall Study|Withdrawal by Subject|12|||
128687573|NCT01795638|463155928|FG000|Overall Study|Death|0|||
128687574|NCT01795638|463155929|FG001|Overall Study|Death|3|||
128687575|NCT01795638|463155928|FG000|Overall Study|transferred to quaternary hospital|2|||
128687576|NCT01795638|463155929|FG001|Overall Study|transferred to quaternary hospital|3|||
128687577|NCT01795638|463155928|FG000|Overall Study|Protocol Violation|3|||
128763620|NCT03502616|463425747|FG001|Up to Week 16|Lost to Follow-up|1|||
128887326|NCT01313650|463882071|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
128887327|NCT05393037|463882072|FG000|Part A|Death|1|||
128887328|NCT05393037|463882073|FG001|Part A|Death|0|||
128687578|NCT01795638|463155929|FG001|Overall Study|Protocol Violation|0|||
128687579|NCT01795638|463155928|FG000|Overall Study|discharged from hospital|7|||
128687580|NCT01795638|463155929|FG001|Overall Study|discharged from hospital|5|||
128687581|NCT01795638|463155928|FG000|Overall Study|Withdrawal by Subject|1|||
128687582|NCT01795638|463155929|FG001|Overall Study|Withdrawal by Subject|0|||
128687583|NCT01298531|463155930|FG000|Overall Study|Lack of Efficacy|0|||
129109835|NCT01411852|464695984|FG000|Hospital Intervention Phase|Severe head injury|5|||
129109836|NCT01411852|464695985|FG001|Hospital Intervention Phase|Severe head injury|4|||
129109837|NCT01411852|464695984|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
129109838|NCT01411852|464695985|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
129109839|NCT01411852|464695984|FG000|Hospital Intervention Phase|Miscommunication error|1|||
129109840|NCT01411852|464695985|FG001|Hospital Intervention Phase|Miscommunication error|2|||
129109841|NCT01411852|464695984|FG000|Hospital Intervention Phase|CPR administered|3|||
129109842|NCT01411852|464695985|FG001|Hospital Intervention Phase|CPR administered|1|||
129109843|NCT01411852|464695984|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
129109844|NCT01411852|464695985|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
129109845|NCT01411852|464695984|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
129109846|NCT01411852|464695985|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
129109847|NCT01411852|464695984|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
129109848|NCT01411852|464695985|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
129109849|NCT01411852|464695984|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
129109850|NCT01411852|464695985|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
129215186|NCT03955146|465089453|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
128687584|NCT01298531|463155931|FG001|Overall Study|Lack of Efficacy|1|||
128687585|NCT01298531|463155930|FG000|Overall Study|Lost to Follow-up|2|||
128687586|NCT01298531|463155931|FG001|Overall Study|Lost to Follow-up|0|||
128687587|NCT01298531|463155930|FG000|Overall Study|Protocol Violation|1|||
128687588|NCT01298531|463155931|FG001|Overall Study|Protocol Violation|1|||
128687589|NCT01298531|463155930|FG000|Overall Study|Adverse Event|4|||
128687590|NCT01298531|463155931|FG001|Overall Study|Adverse Event|3|||
128687591|NCT01298531|463155930|FG000|Overall Study|Does not meet entrance criteria|0|||
128687592|NCT01298531|463155931|FG001|Overall Study|Does not meet entrance criteria|1|||
128687593|NCT01298531|463155930|FG000|Overall Study|Other|2|||
128687594|NCT01298531|463155931|FG001|Overall Study|Other|1|||
128687595|NCT02360995|463155932|FG000|Overall Study|Lost to Follow-up|2|||
128687596|NCT02360995|463155933|FG001|Overall Study|Lost to Follow-up|0|||
128687597|NCT02360995|463155934|FG002|Overall Study|Lost to Follow-up|2|||
128687598|NCT02360995|463155932|FG000|Overall Study|Withdrawal by Subject|0|||
128687599|NCT02360995|463155933|FG001|Overall Study|Withdrawal by Subject|1|||
128687600|NCT02360995|463155934|FG002|Overall Study|Withdrawal by Subject|0|||
128687601|NCT02611960|463155935|FG000|Overall Study|Adverse Event|7|||
128687602|NCT02611960|463155936|FG001|Overall Study|Adverse Event|8|||
128687603|NCT02611960|463155935|FG000|Overall Study|Death|98|||
128687604|NCT02611960|463155936|FG001|Overall Study|Death|92|||
128687605|NCT02611960|463155935|FG000|Overall Study|Withdrawal by Subject|1|||
128687606|NCT02611960|463155936|FG001|Overall Study|Withdrawal by Subject|5|||
128687607|NCT02611960|463155935|FG000|Overall Study|Sponsor Decision|11|||
128687608|NCT02611960|463155936|FG001|Overall Study|Sponsor Decision|11|||
128687609|NCT02395666|463155937|FG000|Overall Study|Physician Decision|3|||
128687610|NCT02395666|463155938|FG001|Overall Study|Physician Decision|0|||
128687611|NCT02395666|463155937|FG000|Overall Study|Lost to Follow-up|1|||
128687612|NCT02395666|463155938|FG001|Overall Study|Lost to Follow-up|0|||
128687613|NCT02395666|463155937|FG000|Overall Study|Withdrawal by Subject|2|||
128687614|NCT02395666|463155938|FG001|Overall Study|Withdrawal by Subject|1|||
128687615|NCT01409434|463155939|FG000|Overall Study|Protocol Violation|4|||
128687616|NCT00293215|463155940|FG000|Overall Study|Progressive disease|3|||
128687617|NCT00293215|463155941|FG001|Overall Study|Progressive disease|1|||
128687618|NCT00293215|463155940|FG000|Overall Study|Adverse Event|2|||
128687619|NCT00293215|463155941|FG001|Overall Study|Adverse Event|2|||
128687620|NCT01229371|463155944|FG000|Overall Study|Withdrawal by Subject|0|||
128687621|NCT01229371|463155945|FG001|Overall Study|Withdrawal by Subject|1|||
128687622|NCT01229371|463155946|FG002|Overall Study|Withdrawal by Subject|0|||
128687623|NCT01229371|463155947|FG003|Overall Study|Withdrawal by Subject|0|||
128687624|NCT02213042|463155948|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
128687625|NCT02213042|463155949|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
128687626|NCT02213042|463155950|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
128687627|NCT02213042|463155948|FG000|Overall Study|Adverse Event|2|||
128687628|NCT02213042|463155949|FG001|Overall Study|Adverse Event|1|||
128687629|NCT02213042|463155950|FG002|Overall Study|Adverse Event|0|||
128687630|NCT02213042|463155948|FG000|Overall Study|Withdrawal by Subject|0|||
128687631|NCT02213042|463155949|FG001|Overall Study|Withdrawal by Subject|1|||
129109851|NCT01411852|464695984|FG000|Hospital Intervention Phase|Other ineligible|2|||
128687632|NCT02213042|463155950|FG002|Overall Study|Withdrawal by Subject|1|||
128687633|NCT02213042|463155948|FG000|Overall Study|Protocol Violation|1|||
128687634|NCT02213042|463155949|FG001|Overall Study|Protocol Violation|0|||
128687635|NCT02213042|463155950|FG002|Overall Study|Protocol Violation|0|||
128687636|NCT02213042|463155948|FG000|Overall Study|Investigator discretion|0|||
128687637|NCT02213042|463155949|FG001|Overall Study|Investigator discretion|0|||
128687638|NCT02213042|463155950|FG002|Overall Study|Investigator discretion|1|||
128687639|NCT00925990|463155951|FG000|Overall Study|Adverse Event|1|||
128887329|NCT05393037|463882072|FG000|Part A|Lost to Follow-up|1|||
128887330|NCT05393037|463882073|FG001|Part A|Lost to Follow-up|1|||
128887331|NCT05393037|463882072|FG000|Part A|Withdrawal by Subject|2|||
128887332|NCT05393037|463882073|FG001|Part A|Withdrawal by Subject|4|||
128887333|NCT05393037|463882072|FG000|Part B|Lost to Follow-up|1|||
128887334|NCT05393037|463882073|FG001|Part B|Lost to Follow-up|0|||
128887335|NCT04540133|463882074|FG000|Overall Study|Lost to Follow-up|1|||
128887336|NCT04540133|463882075|FG001|Overall Study|Lost to Follow-up|0|||
128887337|NCT03153111|463882076|FG000|Overall Study|Death|2|||
128887338|NCT03153111|463882077|FG001|Overall Study|Death|5|||
128887339|NCT03153111|463882076|FG000|Overall Study|Lost to Follow-up|1|||
128887340|NCT03153111|463882077|FG001|Overall Study|Lost to Follow-up|0|||
128887341|NCT03153111|463882076|FG000|Overall Study|Physician Decision|5|||
128763621|NCT03502616|463425746|FG000|Up to Week 16|Randomized, but not treated|1|||
128887342|NCT03153111|463882077|FG001|Overall Study|Physician Decision|1|||
128887343|NCT03153111|463882076|FG000|Overall Study|Withdrawal by Subject|3|||
128887344|NCT03153111|463882077|FG001|Overall Study|Withdrawal by Subject|3|||
128887345|NCT03891524|463882078|FG000|Overall Study|Death|0|||
128887346|NCT03891524|463882079|FG001|Overall Study|Death|0|||
128763622|NCT03502616|463425747|FG001|Up to Week 16|Randomized, but not treated|0|||
128763623|NCT03502616|463425746|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
128763624|NCT03502616|463425747|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
129109852|NCT01411852|464695985|FG001|Hospital Intervention Phase|Other ineligible|2|||
129109853|NCT01411852|464695984|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
129109854|NCT01411852|464695985|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
129109855|NCT01411852|464695984|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
129109856|NCT01411852|464695985|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
129109857|NCT01411852|464695984|FG000|Hospital Intervention Phase|Vascular access failed|1|||
129109858|NCT01411852|464695985|FG001|Hospital Intervention Phase|Vascular access failed|0|||
129109859|NCT03193047|464695986|FG000|Overall Study|Physician Decision|1|||
129109860|NCT03193047|464695987|FG001|Overall Study|Physician Decision|0|||
129109861|NCT03193047|464695986|FG000|Overall Study|Participant Left State|1|||
129109862|NCT03193047|464695987|FG001|Overall Study|Participant Left State|0|||
129109863|NCT03743025|464695992|FG000|Overall Study|Surgery was cancelled|2|||
129109864|NCT03743025|464695993|FG001|Overall Study|Surgery was cancelled|1|||
129109865|NCT02420119|464695998|FG000|Overall Study|insufficient laboratory data|5|||
129109866|NCT00149396|464695999|FG000|Overall Study|Death|15|||
129109867|NCT00149396|464695999|FG000|Overall Study|Withdrawal by Subject|1|||
129109868|NCT00149396|464695999|FG000|Overall Study|Subject noncompliance|2|||
129109869|NCT00149396|464695999|FG000|Overall Study|other treatment|5|||
129109870|NCT00807885|464696000|FG000|Overall Study|Lost to Follow-up|0|||
129109871|NCT00807885|464696001|FG001|Overall Study|Lost to Follow-up|0|||
129109872|NCT00807885|464696002|FG002|Overall Study|Lost to Follow-up|0|||
129109873|NCT00807885|464696003|FG003|Overall Study|Lost to Follow-up|0|||
129109874|NCT00807885|464696004|FG004|Overall Study|Lost to Follow-up|0|||
129109875|NCT00807885|464696005|FG005|Overall Study|Lost to Follow-up|1|||
128887347|NCT03891524|463882080|FG002|Overall Study|Death|0|||
128887348|NCT03891524|463882081|FG003|Overall Study|Death|0|||
128887349|NCT03891524|463882082|FG004|Overall Study|Death|0|||
128887350|NCT03891524|463882083|FG005|Overall Study|Death|0|||
128887351|NCT03891524|463882084|FG006|Overall Study|Death|0|||
128763625|NCT03502616|463425746|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
128763626|NCT03502616|463425747|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
128763627|NCT00988221|463425760|FG000|Part I|Adverse Event|0|||
128763628|NCT00988221|463425761|FG001|Part I|Adverse Event|1|||
128763629|NCT00988221|463425762|FG002|Part I|Adverse Event|2|||
128763630|NCT00988221|463425763|FG003|Part I|Adverse Event|0|||
128763631|NCT00988221|463425760|FG000|Part I|Insufficient Therapeutic Response|4|||
128763632|NCT00988221|463425761|FG001|Part I|Insufficient Therapeutic Response|6|||
128763633|NCT00988221|463425762|FG002|Part I|Insufficient Therapeutic Response|5|||
128763634|NCT00988221|463425763|FG003|Part I|Insufficient Therapeutic Response|0|||
128763635|NCT00988221|463425760|FG000|Part I|Refused Treatment|0|||
128763636|NCT00988221|463425761|FG001|Part I|Refused Treatment|2|||
128763637|NCT00988221|463425762|FG002|Part I|Refused Treatment|1|||
128763638|NCT00988221|463425763|FG003|Part I|Refused Treatment|0|||
129109876|NCT00807885|464696006|FG006|Overall Study|Lost to Follow-up|0|||
128763639|NCT00988221|463425760|FG000|Part I|Lost to Follow-up|0|||
128763640|NCT00988221|463425761|FG001|Part I|Lost to Follow-up|1|||
128763641|NCT00988221|463425762|FG002|Part I|Lost to Follow-up|0|||
128887352|NCT03891524|463882085|FG007|Overall Study|Death|1|||
128887353|NCT03891524|463882078|FG000|Overall Study|Withdrawal by Subject|0|||
128887354|NCT03891524|463882079|FG001|Overall Study|Withdrawal by Subject|1|||
128887355|NCT03891524|463882080|FG002|Overall Study|Withdrawal by Subject|2|||
129109877|NCT00807885|464696007|FG007|Overall Study|Lost to Follow-up|0|||
128763642|NCT00988221|463425763|FG003|Part I|Lost to Follow-up|0|||
128763643|NCT00988221|463425760|FG000|Part II|Adverse Event|1|||
128763644|NCT00988221|463425761|FG001|Part II|Adverse Event|0|||
128763645|NCT00988221|463425762|FG002|Part II|Adverse Event|0|||
128887356|NCT03891524|463882081|FG003|Overall Study|Withdrawal by Subject|1|||
128887357|NCT03891524|463882082|FG004|Overall Study|Withdrawal by Subject|2|||
128887358|NCT03891524|463882083|FG005|Overall Study|Withdrawal by Subject|2|||
128887359|NCT03891524|463882084|FG006|Overall Study|Withdrawal by Subject|2|||
128887360|NCT03891524|463882085|FG007|Overall Study|Withdrawal by Subject|1|||
128887361|NCT03471871|463882089|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
128887362|NCT03471871|463882090|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
128887363|NCT03471871|463882091|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
128887364|NCT03471871|463882092|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
128887365|NCT03471871|463882093|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
128887366|NCT03471871|463882089|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
128887367|NCT03471871|463882090|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
128887368|NCT03471871|463882091|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
128887369|NCT03471871|463882092|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
128887370|NCT03471871|463882093|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
128887371|NCT03471871|463882089|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
128887372|NCT03471871|463882090|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
128887373|NCT03471871|463882091|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
128887374|NCT03471871|463882092|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
128887375|NCT03471871|463882093|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
128887376|NCT03471871|463882089|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
128887377|NCT03471871|463882090|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
128887378|NCT03471871|463882091|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
128887379|NCT03471871|463882092|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
128887380|NCT03471871|463882093|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
128887381|NCT03471871|463882089|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
128887382|NCT03471871|463882090|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
128887383|NCT03471871|463882091|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
128887384|NCT03471871|463882092|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
128887385|NCT03471871|463882093|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
128887386|NCT03040622|463882094|FG000|Overall Study|unable to implant device|3|||
128887387|NCT01572922|463882095|FG000|Overall Study|Adverse Event|1|||
128887388|NCT01572922|463882095|FG000|Overall Study|Protocol Violation|1|||
128887389|NCT01572922|463882095|FG000|Overall Study|Death|1|||
128887390|NCT00445068|463882096|FG000|Overall Study|Disease progression|26|||
128887391|NCT00445068|463882096|FG000|Overall Study|Adverse Event|5|||
128887392|NCT00445068|463882096|FG000|Overall Study|Abnormal laboratory value|2|||
128887393|NCT00445068|463882096|FG000|Overall Study|Withdrawal by Subject|2|||
128887394|NCT00445068|463882096|FG000|Overall Study|Death|1|||
128887395|NCT04091451|463882097|FG000|Overall Study|Adverse Event|15|||
128887396|NCT04091451|463882098|FG001|Overall Study|Adverse Event|10|||
128887397|NCT04091451|463882097|FG000|Overall Study|Lost to Follow-up|8|||
128887398|NCT04091451|463882098|FG001|Overall Study|Lost to Follow-up|8|||
128887399|NCT04091451|463882097|FG000|Overall Study|Protocol Violation|5|||
128887400|NCT04091451|463882098|FG001|Overall Study|Protocol Violation|4|||
128887401|NCT04091451|463882097|FG000|Overall Study|Withdrawal by Subject|21|||
128887402|NCT04091451|463882098|FG001|Overall Study|Withdrawal by Subject|27|||
128887403|NCT04091451|463882097|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
128887404|NCT04091451|463882098|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
128887405|NCT04091451|463882097|FG000|Overall Study|Migrated/moved from the study area|3|||
129109878|NCT00807885|464696008|FG008|Overall Study|Lost to Follow-up|0|||
129109879|NCT02364388|464696009|FG000|Overall Study|Protocol Violation|1|||
129109880|NCT02364388|464696009|FG000|Overall Study|Technical Failure|3|||
129109881|NCT02364388|464696009|FG000|Overall Study|No OA/US data|2|||
129109882|NCT02364388|464696009|FG000|Overall Study|No Biopsy|2|||
129109883|NCT00186485|464696012|FG000|Overall Study|Lost to Follow-up|3|||
129109884|NCT03126786|464696013|FG000|Overall Study|Adverse Event|3|||
128687640|NCT00925990|463155952|FG001|Overall Study|Adverse Event|3|||
128687641|NCT00925990|463155951|FG000|Overall Study|Withdrawal by Subject|2|||
128687642|NCT00925990|463155952|FG001|Overall Study|Withdrawal by Subject|2|||
128687643|NCT00925990|463155951|FG000|Overall Study|Lost to Follow-up|1|||
128687644|NCT00925990|463155952|FG001|Overall Study|Lost to Follow-up|3|||
128687645|NCT00925990|463155951|FG000|Overall Study|Physician Decision|1|||
128687646|NCT00925990|463155952|FG001|Overall Study|Physician Decision|1|||
128687647|NCT00925990|463155951|FG000|Overall Study|moved out of state, missed medication|0|||
128887406|NCT04091451|463882098|FG001|Overall Study|Migrated/moved from the study area|5|||
128887407|NCT04091451|463882097|FG000|Overall Study|Suspected HZ episode|1|||
128687648|NCT00925990|463155952|FG001|Overall Study|moved out of state, missed medication|2|||
128687649|NCT02791594|463155955|FG000|Overall Study|Physician Decision|2|||
128887408|NCT04091451|463882098|FG001|Overall Study|Suspected HZ episode|0|||
129109885|NCT03126786|464696014|FG001|Overall Study|Adverse Event|0|||
129109886|NCT03126786|464696013|FG000|Overall Study|Lost to Follow-up|0|||
128687650|NCT00857415|463155957|FG000|Overall Study|Image acquisition failure|2|||
129109887|NCT03126786|464696014|FG001|Overall Study|Lost to Follow-up|1|||
129109888|NCT03126786|464696013|FG000|Overall Study|Withdrawal by Subject|3|||
129109889|NCT03126786|464696014|FG001|Overall Study|Withdrawal by Subject|1|||
129109890|NCT00991289|464696015|FG000|Overall Study|Adverse Event|1|||
129109891|NCT00991289|464696015|FG000|Overall Study|Physician Decision|2|||
129109892|NCT00991289|464696015|FG000|Overall Study|Withdrawal by Subject|3|||
129109893|NCT00991289|464696015|FG000|Overall Study|Lost to Follow-up|4|||
129109894|NCT00991289|464696015|FG000|Overall Study|Protocol Violation|2|||
129109895|NCT00905424|464696016|FG000|Overall Study|Lost to Follow-up|3|||
129109896|NCT00905424|464696017|FG001|Overall Study|Lost to Follow-up|3|||
128687651|NCT00857415|463155958|FG001|Overall Study|Image acquisition failure|0|||
128687652|NCT00857415|463155957|FG000|Overall Study|Invalid image or not imaged|3|||
128687653|NCT00857415|463155958|FG001|Overall Study|Invalid image or not imaged|0|||
128687654|NCT00857415|463155957|FG000|Overall Study|Subject still living at end of study|110|||
128687655|NCT00857415|463155958|FG001|Overall Study|Subject still living at end of study|0|||
128687656|NCT00857415|463155957|FG000|Overall Study|Deceased with no autopsy|2|||
128687657|NCT00857415|463155958|FG001|Overall Study|Deceased with no autopsy|0|||
128687658|NCT01130103|463155959|FG000|Randomized Treatment|Adverse Event|1|||
128687659|NCT01130103|463155960|FG001|Randomized Treatment|Adverse Event|1|||
128687660|NCT01130103|463155959|FG000|Randomized Treatment|Lost to Follow-up|1|||
128687661|NCT01130103|463155960|FG001|Randomized Treatment|Lost to Follow-up|0|||
128687662|NCT01130103|463155959|FG000|Randomized Treatment|Protocol Violation|3|||
128687663|NCT01130103|463155960|FG001|Randomized Treatment|Protocol Violation|2|||
128687664|NCT01130103|463155959|FG000|Randomized Treatment|Withdrawal by Subject|1|||
128687665|NCT01130103|463155960|FG001|Randomized Treatment|Withdrawal by Subject|2|||
128687666|NCT01130103|463155959|FG000|Maintenance Treatment|Lack of Efficacy|0|||
128687667|NCT01130103|463155960|FG001|Maintenance Treatment|Lack of Efficacy|1|||
128687668|NCT01130103|463155959|FG000|Maintenance Treatment|Lost to Follow-up|1|||
128687669|NCT01130103|463155960|FG001|Maintenance Treatment|Lost to Follow-up|1|||
128687670|NCT01130103|463155959|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
128687671|NCT01130103|463155960|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
128687672|NCT00764504|463155961|FG000|Overall Study|Death|12|||
128687673|NCT00764504|463155962|FG001|Overall Study|Death|6|||
128687674|NCT00764504|463155963|FG002|Overall Study|Death|13|||
128687675|NCT00764504|463155961|FG000|Overall Study|Revision of Device|12|||
128687676|NCT00764504|463155962|FG001|Overall Study|Revision of Device|23|||
128687677|NCT00764504|463155963|FG002|Overall Study|Revision of Device|14|||
128687678|NCT00764504|463155961|FG000|Overall Study|Physician Decision|1|||
128687679|NCT00764504|463155962|FG001|Overall Study|Physician Decision|0|||
128687680|NCT00764504|463155963|FG002|Overall Study|Physician Decision|0|||
128687681|NCT00764504|463155961|FG000|Overall Study|Withdrawal by Subject|1|||
128687682|NCT00764504|463155962|FG001|Overall Study|Withdrawal by Subject|7|||
128687683|NCT00764504|463155963|FG002|Overall Study|Withdrawal by Subject|4|||
128687684|NCT00764504|463155961|FG000|Overall Study|Lost to Follow-up|40|||
128687685|NCT00764504|463155962|FG001|Overall Study|Lost to Follow-up|34|||
128687686|NCT00764504|463155963|FG002|Overall Study|Lost to Follow-up|72|||
128687687|NCT02992132|463155967|FG000|Overall Study|Adverse Event|4|||
128687688|NCT02992132|463155968|FG001|Overall Study|Adverse Event|1|||
128687689|NCT02992132|463155969|FG002|Overall Study|Adverse Event|3|||
128687690|NCT02992132|463155967|FG000|Overall Study|Lack of Efficacy|2|||
128687691|NCT02992132|463155968|FG001|Overall Study|Lack of Efficacy|0|||
128687692|NCT02992132|463155969|FG002|Overall Study|Lack of Efficacy|0|||
128687693|NCT02992132|463155967|FG000|Overall Study|Non-compliance with study drug|2|||
128687694|NCT02992132|463155968|FG001|Overall Study|Non-compliance with study drug|0|||
128687695|NCT02992132|463155969|FG002|Overall Study|Non-compliance with study drug|0|||
128687696|NCT02992132|463155967|FG000|Overall Study|Progressive disease|1|||
128687697|NCT02992132|463155968|FG001|Overall Study|Progressive disease|0|||
128687698|NCT02992132|463155969|FG002|Overall Study|Progressive disease|0|||
128687699|NCT02992132|463155967|FG000|Overall Study|Protocol Violation|2|||
128687700|NCT02992132|463155968|FG001|Overall Study|Protocol Violation|2|||
128687701|NCT02992132|463155969|FG002|Overall Study|Protocol Violation|0|||
128687702|NCT02992132|463155967|FG000|Overall Study|Caregiver withdrew consent|2|||
128687703|NCT02992132|463155968|FG001|Overall Study|Caregiver withdrew consent|3|||
128687704|NCT02992132|463155969|FG002|Overall Study|Caregiver withdrew consent|2|||
129109897|NCT00905424|464696016|FG000|Overall Study|Withdrawal by Subject|1|||
129109898|NCT00905424|464696017|FG001|Overall Study|Withdrawal by Subject|2|||
129109899|NCT00905424|464696016|FG000|Overall Study|Adverse Event|4|||
128687705|NCT02992132|463155967|FG000|Overall Study|Withdrawal by Subject|0|||
128687706|NCT02992132|463155968|FG001|Overall Study|Withdrawal by Subject|2|||
128687707|NCT02992132|463155969|FG002|Overall Study|Withdrawal by Subject|1|||
128687708|NCT02992132|463155967|FG000|Overall Study|Physician Decision|0|||
128687709|NCT02992132|463155968|FG001|Overall Study|Physician Decision|0|||
128687710|NCT02992132|463155969|FG002|Overall Study|Physician Decision|1|||
128687711|NCT01437878|463155973|FG000|Overall Study|Withdrawal by Subject|1|||
128687712|NCT01437878|463155974|FG001|Overall Study|Withdrawal by Subject|0|||
128687713|NCT03538431|463155975|FG000|Overall Study|Physician Decision|0|||
128687714|NCT03538431|463155976|FG001|Overall Study|Physician Decision|1|||
128887409|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
128887410|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
128887411|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
128887412|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
128887413|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
128887414|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
128887415|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
128887416|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
128887417|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
128887418|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
128887419|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
128887420|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
128887421|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Death|3|||
128887422|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Death|1|||
128887423|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
128887424|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
128887425|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Adverse Event|7|||
128887426|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Adverse Event|8|||
128887427|NCT03236246|463883979|FG000|24-Week Dose Titration Period|Captured as Other|1|||
128887428|NCT03236246|463883980|FG001|24-Week Dose Titration Period|Captured as Other|2|||
128887429|NCT03236246|463883979|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
128887430|NCT03236246|463883980|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
128887431|NCT03236246|463883979|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
128887432|NCT03236246|463883980|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
128887433|NCT03236246|463883979|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
128887434|NCT03236246|463883980|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
128887435|NCT03236246|463883979|FG000|24-Week Dose Maintenance Period|Death|0|||
128887436|NCT03236246|463883980|FG001|24-Week Dose Maintenance Period|Death|1|||
128887437|NCT03236246|463883979|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
128887438|NCT03236246|463883980|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
128887439|NCT02598557|463883981|FG000|Overall Study|Withdrawal by Subject|1|||
128887440|NCT02598557|463883982|FG001|Overall Study|Withdrawal by Subject|0|||
128887441|NCT02598557|463883983|FG002|Overall Study|Withdrawal by Subject|1|||
128887442|NCT02598557|463883981|FG000|Overall Study|Participant did not start treatment|2|||
128887443|NCT02598557|463883982|FG001|Overall Study|Participant did not start treatment|1|||
128887444|NCT02598557|463883983|FG002|Overall Study|Participant did not start treatment|1|||
128887445|NCT02598557|463883981|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
128887446|NCT02598557|463883982|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
128887447|NCT02598557|463883983|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
128887448|NCT02598557|463883981|FG000|Overall Study|Adverse Event|1|||
128887449|NCT02598557|463883982|FG001|Overall Study|Adverse Event|1|||
128887450|NCT02598557|463883983|FG002|Overall Study|Adverse Event|0|||
128887451|NCT02076113|463883986|FG000|Overall Study|Lost to Follow-up|4|||
128887452|NCT02076113|463883987|FG001|Overall Study|Lost to Follow-up|1|||
128887453|NCT02076113|463883986|FG000|Overall Study|Withdrawal by Subject|2|||
128887454|NCT02076113|463883987|FG001|Overall Study|Withdrawal by Subject|3|||
128887455|NCT02076113|463883986|FG000|Overall Study|Death|1|||
128887456|NCT02076113|463883987|FG001|Overall Study|Death|3|||
128887457|NCT01383161|463883990|FG000|Overall Study|Adverse Event|5|||
128887458|NCT01383161|463883991|FG001|Overall Study|Adverse Event|1|||
128887459|NCT01383161|463883990|FG000|Overall Study|Withdrawal by Subject|0|||
128887460|NCT01383161|463883991|FG001|Overall Study|Withdrawal by Subject|2|||
128887461|NCT01383161|463883990|FG000|Overall Study|Lack of Efficacy|0|||
128887462|NCT01383161|463883991|FG001|Overall Study|Lack of Efficacy|1|||
128887463|NCT03942406|463883998|FG000|Overall Study|Lost to Follow-up|4|||
128887464|NCT03942406|463883999|FG001|Overall Study|Lost to Follow-up|5|||
128887465|NCT03942406|463884000|FG002|Overall Study|Lost to Follow-up|3|||
128887466|NCT03942406|463884001|FG003|Overall Study|Lost to Follow-up|7|||
128887467|NCT03942406|463884002|FG004|Overall Study|Lost to Follow-up|1|||
128887468|NCT03942406|463884003|FG005|Overall Study|Lost to Follow-up|0|||
128887469|NCT03942406|463884004|FG006|Overall Study|Lost to Follow-up|0|||
128887470|NCT03942406|463883998|FG000|Overall Study|Withdrawal by Subject|3|||
128887471|NCT03942406|463883999|FG001|Overall Study|Withdrawal by Subject|1|||
128887472|NCT03942406|463884000|FG002|Overall Study|Withdrawal by Subject|1|||
128887473|NCT03942406|463884001|FG003|Overall Study|Withdrawal by Subject|3|||
128887474|NCT03942406|463884002|FG004|Overall Study|Withdrawal by Subject|0|||
128887475|NCT03942406|463884003|FG005|Overall Study|Withdrawal by Subject|0|||
128887476|NCT03942406|463884004|FG006|Overall Study|Withdrawal by Subject|0|||
128887477|NCT03942406|463883998|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
128887478|NCT03942406|463883999|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
128887479|NCT03942406|463884000|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
129020574|NCT01796171|464367104|FG008|Follow-up Period|Sponsor Decision|0|||
128687715|NCT03538431|463155975|FG000|Overall Study|Withdrawal by Subject|1|||
128687716|NCT03538431|463155976|FG001|Overall Study|Withdrawal by Subject|0|||
128687717|NCT04263454|463155979|FG000|Overall Study|Adverse Event|0|||
128687718|NCT04263454|463155980|FG001|Overall Study|Adverse Event|2|||
128687719|NCT04263454|463155979|FG000|Overall Study|Physician Decision|3|||
128687720|NCT04263454|463155980|FG001|Overall Study|Physician Decision|5|||
128687721|NCT04263454|463155979|FG000|Overall Study|Poor Data Quality|0|||
128687722|NCT04263454|463155980|FG001|Overall Study|Poor Data Quality|1|||
128687723|NCT03911154|463155981|FG000|Overall Study|Withdrawal by Subject|1|||
128687724|NCT00986479|463155982|FG000|Period 1|Improved mood|1|||
128687725|NCT00986479|463155983|FG001|Period 1|Improved mood|0|||
128687726|NCT00986479|463155982|FG000|Period 1|Administrative reasons|1|||
128687727|NCT00986479|463155983|FG001|Period 1|Administrative reasons|0|||
128687728|NCT01977937|463155984|FG000|Overall Study|Withdrawal by Subject|2|||
128687729|NCT01977937|463155985|FG001|Overall Study|Withdrawal by Subject|1|||
128687730|NCT01977937|463155984|FG000|Overall Study|Adverse Event|1|||
128687731|NCT01977937|463155985|FG001|Overall Study|Adverse Event|0|||
128687732|NCT01977937|463155984|FG000|Overall Study|Physician Decision|0|||
128687733|NCT01977937|463155985|FG001|Overall Study|Physician Decision|1|||
128687734|NCT00915356|463155986|FG000|Overall Study|Withdrawal by Subject|1|||
128687735|NCT00915356|463155987|FG001|Overall Study|Withdrawal by Subject|0|||
128687736|NCT00915356|463155988|FG002|Overall Study|Withdrawal by Subject|0|||
128687737|NCT00915356|463155989|FG003|Overall Study|Withdrawal by Subject|0|||
128687738|NCT00915356|463155990|FG004|Overall Study|Withdrawal by Subject|0|||
128687739|NCT01278160|463155995|FG000|Overall Study|Adverse Event|1|||
128687740|NCT01278160|463155996|FG001|Overall Study|Adverse Event|1|||
128687741|NCT01278160|463155995|FG000|Overall Study|Lost to Follow-up|0|||
128687742|NCT01278160|463155996|FG001|Overall Study|Lost to Follow-up|1|||
128687743|NCT01278160|463155995|FG000|Overall Study|Withdrawal by Subject|3|||
128687744|NCT01278160|463155996|FG001|Overall Study|Withdrawal by Subject|2|||
128687745|NCT01278160|463155995|FG000|Overall Study|Unclassified|1|||
128687746|NCT01278160|463155996|FG001|Overall Study|Unclassified|2|||
128687747|NCT01505647|463156000|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
128687748|NCT01505647|463156001|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
128687749|NCT01505647|463156000|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
128687750|NCT01505647|463156001|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
128687751|NCT01505647|463156000|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
128687752|NCT01505647|463156001|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
128687753|NCT01505647|463156000|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
128687754|NCT01505647|463156001|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
128687755|NCT01505647|463156000|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
128687756|NCT01505647|463156001|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
128687757|NCT02898116|463156007|FG000|Overall Study|Adverse Event|1|||
128687758|NCT02898116|463156007|FG000|Overall Study|Progressive disease|1|||
128687759|NCT05597020|463156008|FG000|Washout|Forbidden medication|2|||
128687760|NCT05597020|463156009|FG001|Washout|Forbidden medication|0|||
128687761|NCT05597020|463156008|FG000|Treatment Period II|Advice from primary care physician|1|||
128687762|NCT05597020|463156009|FG001|Treatment Period II|Advice from primary care physician|0|||
128687763|NCT05597020|463156008|FG000|Treatment Period II|Subject lost investigational product|1|||
128687764|NCT05597020|463156009|FG001|Treatment Period II|Subject lost investigational product|0|||
128687765|NCT05597020|463156008|FG000|Treatment Period II|Private reasons|0|||
128687766|NCT05597020|463156009|FG001|Treatment Period II|Private reasons|1|||
128687767|NCT05169567|463156010|FG000|Overall Study|On study treatment|116|||
128687768|NCT05169567|463156011|FG001|Overall Study|On study treatment|128|||
128763646|NCT00988221|463425763|FG003|Part II|Adverse Event|1|||
128763647|NCT00988221|463425760|FG000|Part II|Withdrawal by Subject|0|||
128763648|NCT00988221|463425761|FG001|Part II|Withdrawal by Subject|0|||
128763649|NCT00988221|463425762|FG002|Part II|Withdrawal by Subject|2|||
128763650|NCT00988221|463425763|FG003|Part II|Withdrawal by Subject|2|||
128763651|NCT00988221|463425760|FG000|Part II|Reason not Specified|0|||
128763652|NCT00988221|463425761|FG001|Part II|Reason not Specified|0|||
128763653|NCT00988221|463425762|FG002|Part II|Reason not Specified|1|||
128763654|NCT00988221|463425763|FG003|Part II|Reason not Specified|0|||
129020575|NCT01796171|464367105|FG009|Follow-up Period|Sponsor Decision|0|||
129215187|NCT02002598|465089456|FG000|Dose Level 1|Withdrawal by Subject|1|||
128687769|NCT05169567|463156010|FG000|Overall Study|Lost to Follow-up|1|||
128687770|NCT05169567|463156011|FG001|Overall Study|Lost to Follow-up|0|||
128687771|NCT05169567|463156010|FG000|Overall Study|Withdrawal by Subject|25|||
128687772|NCT05169567|463156011|FG001|Overall Study|Withdrawal by Subject|21|||
128687773|NCT01015131|463156012|FG000|Overall Study|Physician Decision|1|||
128687774|NCT01015131|463156012|FG000|Overall Study|Protocol Violation|1|||
128687775|NCT01015131|463156012|FG000|Overall Study|Withdrawal by Subject|2|||
128687776|NCT01015131|463156012|FG000|Overall Study|Other Protocol Specified Criteria|4|||
128687777|NCT05430022|463156013|FG000|Overall Study|Withdrawal by Subject|4|||
128687778|NCT05430022|463156014|FG001|Overall Study|Withdrawal by Subject|4|||
128687779|NCT02445391|463156025|FG000|Overall Study|No active protocol treatment|3|||
128763655|NCT00988221|463425760|FG000|Part III|Adverse Event|1|||
128887480|NCT03942406|463884001|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
128887481|NCT03942406|463884002|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
128887482|NCT03942406|463884003|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
128887483|NCT03942406|463884004|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
128887484|NCT01054144|463884005|FG000|Overall Study|Death|2|||
128887485|NCT05628285|463884006|FG000|Overall Study|Lost to Follow-up|1|||
128887486|NCT03801902|463884008|FG000|Overall Study|Did not receive protocol treatment.|1|||
128887487|NCT03801902|463884009|FG001|Overall Study|Did not receive protocol treatment.|0|||
128887488|NCT03801902|463884010|FG002|Overall Study|Did not receive protocol treatment.|0|||
128887489|NCT03801902|463884011|FG003|Overall Study|Did not receive protocol treatment.|0|||
128887490|NCT02310672|463884014|FG000|Overall Study|Death|1|||
128887491|NCT02310672|463884014|FG000|Overall Study|Lost to Follow-up|1|||
128887492|NCT02310672|463884014|FG000|Overall Study|Withdrawal by Subject|1|||
128887493|NCT02310672|463884014|FG000|Overall Study|Sponsor's decision|12|||
128887494|NCT04614662|463884015|FG000|Overall Study|Withdrawal by Subject|0|||
128887495|NCT04614662|463884016|FG001|Overall Study|Withdrawal by Subject|1|||
128887496|NCT01717768|463884019|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887497|NCT01717768|463884020|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
128887498|NCT01717768|463884021|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887499|NCT01717768|463884022|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887500|NCT01717768|463884023|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887501|NCT01717768|463884024|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887502|NCT01717768|463884025|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887503|NCT01717768|463884026|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887504|NCT01717768|463884027|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887505|NCT01717768|463884028|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887506|NCT01717768|463884029|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887507|NCT01717768|463884030|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
128887508|NCT01717768|463884019|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887509|NCT01717768|463884020|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887510|NCT01717768|463884021|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887511|NCT01717768|463884022|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887512|NCT01717768|463884023|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887513|NCT01717768|463884024|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887514|NCT01717768|463884025|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887515|NCT01717768|463884026|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887516|NCT01717768|463884027|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887517|NCT01717768|463884028|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887518|NCT01717768|463884029|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
128887519|NCT01717768|463884030|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
128887520|NCT01717768|463884019|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887521|NCT01717768|463884020|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887522|NCT01717768|463884021|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887523|NCT01717768|463884022|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887524|NCT01717768|463884023|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887525|NCT01717768|463884024|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887526|NCT01717768|463884025|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887527|NCT01717768|463884026|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
128887528|NCT01717768|463884027|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887529|NCT01717768|463884028|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887530|NCT01717768|463884029|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887531|NCT01717768|463884030|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
128887532|NCT01717768|463884019|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887533|NCT01717768|463884020|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887534|NCT01717768|463884021|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887535|NCT01717768|463884022|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887536|NCT01717768|463884023|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887537|NCT01717768|463884024|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887538|NCT01717768|463884025|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887539|NCT01717768|463884026|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887540|NCT01717768|463884027|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128687780|NCT02445391|463156026|FG001|Overall Study|No active protocol treatment|0|||
128687781|NCT02445391|463156027|FG002|Overall Study|No active protocol treatment|0|||
128687782|NCT02445391|463156025|FG000|Overall Study|Adverse Event|0|||
128687783|NCT02445391|463156026|FG001|Overall Study|Adverse Event|21|||
128687784|NCT02445391|463156027|FG002|Overall Study|Adverse Event|12|||
128887541|NCT01717768|463884028|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
128887542|NCT01717768|463884029|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887543|NCT01717768|463884030|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
128887544|NCT04195581|463884033|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
128887545|NCT04195581|463884033|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
128887546|NCT04195581|463884033|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
128887547|NCT04195581|463884033|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
128887548|NCT04195581|463884033|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
128887549|NCT04195581|463884033|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
128887550|NCT01237340|463884034|FG000|Overall Study|Adverse Event|3|||
128887551|NCT01237340|463884034|FG000|Overall Study|Withdrawal by Subject|1|||
128887552|NCT01237340|463884034|FG000|Overall Study|Early termination of the trial|36|||
128887553|NCT01843218|463884035|FG000|Overall Study|Withdrawal by Subject|5|||
128887554|NCT01136811|463884036|FG000|Overall Study|Physician Decision|11|||
128887555|NCT01906346|463884039|FG000|Overall Study|AEs|1|||
128887556|NCT04226833|463884040|FG000|Overall Study|Death|0|||
128887557|NCT04226833|463884041|FG001|Overall Study|Death|0|||
128887558|NCT04226833|463884042|FG002|Overall Study|Death|1|||
128887559|NCT04226833|463884043|FG003|Overall Study|Death|0|||
128887560|NCT02876835|463884046|FG000|Treatment Period (51.1 Month)|Other|1|||
128887561|NCT02876835|463884047|FG001|Treatment Period (51.1 Month)|Other|0|||
128887562|NCT02876835|463884046|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
128887563|NCT02876835|463884047|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
128887564|NCT02876835|463884046|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
128887565|NCT02876835|463884047|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
128887566|NCT02876835|463884046|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
128887567|NCT02876835|463884047|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
128687785|NCT02445391|463156025|FG000|Overall Study|Alternative therapy|0|||
128687786|NCT02445391|463156026|FG001|Overall Study|Alternative therapy|0|||
128687787|NCT02445391|463156027|FG002|Overall Study|Alternative therapy|1|||
128687788|NCT02445391|463156025|FG000|Overall Study|Disease progression|0|||
128687789|NCT02445391|463156026|FG001|Overall Study|Disease progression|7|||
128687790|NCT02445391|463156027|FG002|Overall Study|Disease progression|22|||
128687791|NCT02445391|463156025|FG000|Overall Study|Complicating disease|0|||
128687792|NCT02445391|463156026|FG001|Overall Study|Complicating disease|2|||
128687793|NCT02445391|463156027|FG002|Overall Study|Complicating disease|1|||
128687794|NCT02445391|463156025|FG000|Overall Study|Withdrawal by Subject|0|||
128687795|NCT02445391|463156026|FG001|Overall Study|Withdrawal by Subject|4|||
128687796|NCT02445391|463156027|FG002|Overall Study|Withdrawal by Subject|9|||
128687797|NCT02445391|463156025|FG000|Overall Study|Financial issue|0|||
128687798|NCT02445391|463156026|FG001|Overall Study|Financial issue|0|||
128687799|NCT02445391|463156027|FG002|Overall Study|Financial issue|2|||
128687800|NCT02445391|463156025|FG000|Overall Study|Still on treatment|0|||
128687801|NCT02445391|463156026|FG001|Overall Study|Still on treatment|7|||
128687802|NCT02445391|463156027|FG002|Overall Study|Still on treatment|16|||
128687803|NCT02445391|463156025|FG000|Overall Study|Not start protocol therapy|0|||
128687804|NCT02445391|463156026|FG001|Overall Study|Not start protocol therapy|12|||
128687805|NCT02445391|463156027|FG002|Overall Study|Not start protocol therapy|9|||
128687806|NCT05069259|463156031|FG000|Overall Study|Withdrawal by Subject|1|||
128687807|NCT05069259|463156031|FG000|Overall Study|Sponsor decision|1|||
128687808|NCT03148275|463156032|FG000|Overall Study|Death|6|||
128687809|NCT03148275|463156032|FG000|Overall Study|Adverse Event|3|||
128687810|NCT03148275|463156032|FG000|Overall Study|Liver transplant|2|||
128687811|NCT03148275|463156032|FG000|Overall Study|Patient decision|5|||
128687812|NCT03148275|463156032|FG000|Overall Study|transition to commercial drug|1|||
128687813|NCT03148275|463156032|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
128687814|NCT01828320|463156033|FG000|Overall Study|Lost to Follow-up|1|||
128687815|NCT01828320|463156034|FG001|Overall Study|Lost to Follow-up|3|||
128687816|NCT01828320|463156033|FG000|Overall Study|Withdrawal by Subject|7|||
128887568|NCT02540538|463884049|FG000|Overall Study|Pregnancy|0|||
128887569|NCT02540538|463884050|FG001|Overall Study|Pregnancy|1|||
128887570|NCT02540538|463884051|FG002|Overall Study|Pregnancy|0|||
128887571|NCT00403754|463884057|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
128887572|NCT00403754|463884058|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
129109900|NCT00905424|464696017|FG001|Overall Study|Adverse Event|2|||
129109901|NCT00905424|464696016|FG000|Overall Study|Non-compliance with study medication|2|||
129109902|NCT00905424|464696017|FG001|Overall Study|Non-compliance with study medication|0|||
129109903|NCT00905424|464696016|FG000|Overall Study|Sponsor decision|1|||
129109904|NCT00905424|464696017|FG001|Overall Study|Sponsor decision|0|||
128687817|NCT01828320|463156034|FG001|Overall Study|Withdrawal by Subject|2|||
128687818|NCT00492050|463156035|FG000|Overall Study|Adverse Event|1|||
128687819|NCT00492050|463156035|FG000|Overall Study|Lack of Efficacy|1|||
128687820|NCT00492050|463156035|FG000|Overall Study|Withdrawal by Subject|3|||
128687821|NCT00492050|463156035|FG000|Overall Study|Unable to collect SCT|2|||
128687822|NCT00492050|463156035|FG000|Overall Study|Progressive Disease|2|||
128887573|NCT00403754|463884059|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
128887574|NCT00403754|463884060|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
128887575|NCT00403754|463884057|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
128887576|NCT00403754|463884058|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
128887577|NCT00403754|463884059|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
128887578|NCT00403754|463884060|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
128887579|NCT03829319|463884063|FG000|Overall Study|Sponsor's Decision|4|||
128887580|NCT03829319|463884064|FG001|Overall Study|Sponsor's Decision|90|||
128887581|NCT03829319|463884065|FG002|Overall Study|Sponsor's Decision|102|||
128887582|NCT03829319|463884063|FG000|Overall Study|Withdrawal by Subject|1|||
128887583|NCT03829319|463884064|FG001|Overall Study|Withdrawal by Subject|5|||
128887584|NCT03829319|463884065|FG002|Overall Study|Withdrawal by Subject|4|||
128887585|NCT03829319|463884063|FG000|Overall Study|Physician Decision|0|||
128887586|NCT03829319|463884064|FG001|Overall Study|Physician Decision|3|||
128763656|NCT00988221|463425761|FG001|Part III|Adverse Event|0|||
128763657|NCT00988221|463425762|FG002|Part III|Adverse Event|1|||
128763658|NCT00988221|463425763|FG003|Part III|Adverse Event|0|||
128763659|NCT00988221|463425760|FG000|Part III|Insufficient Therapeutic Response|0|||
128763660|NCT00988221|463425761|FG001|Part III|Insufficient Therapeutic Response|1|||
128763661|NCT00988221|463425762|FG002|Part III|Insufficient Therapeutic Response|1|||
128763662|NCT00988221|463425763|FG003|Part III|Insufficient Therapeutic Response|0|||
128763663|NCT00988221|463425760|FG000|Part III|Refused Treatment|0|||
128763664|NCT00988221|463425761|FG001|Part III|Refused Treatment|0|||
128763665|NCT00988221|463425762|FG002|Part III|Refused Treatment|1|||
128763666|NCT00988221|463425763|FG003|Part III|Refused Treatment|0|||
128763667|NCT02756832|463425766|FG000|Overall Study|Lost for Observation after Baseline|6|||
128763668|NCT02756832|463425766|FG000|Overall Study|Lost for Observation|13|||
128763669|NCT02756832|463425766|FG000|Overall Study|Patient's Unwillingness|12|||
128763670|NCT02756832|463425766|FG000|Overall Study|Insufficient Efficacy|2|||
128763671|NCT02756832|463425766|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
128763672|NCT02756832|463425766|FG000|Overall Study|Reason not Specified|9|||
128763673|NCT02756832|463425766|FG000|Overall Study|Protocol Deviation|10|||
128763674|NCT01364597|463425767|FG000|Overall Study|Adverse Event|4|||
128763675|NCT01364597|463425768|FG001|Overall Study|Adverse Event|5|||
128763676|NCT01364597|463425769|FG002|Overall Study|Adverse Event|16|||
128763677|NCT01364597|463425770|FG003|Overall Study|Adverse Event|7|||
128763678|NCT01364597|463425767|FG000|Overall Study|Lack of Efficacy|4|||
128763679|NCT01364597|463425768|FG001|Overall Study|Lack of Efficacy|4|||
128763680|NCT01364597|463425769|FG002|Overall Study|Lack of Efficacy|23|||
128763681|NCT01364597|463425770|FG003|Overall Study|Lack of Efficacy|8|||
128763682|NCT01364597|463425767|FG000|Overall Study|Protocol Violation|0|||
128763683|NCT01364597|463425768|FG001|Overall Study|Protocol Violation|0|||
128763684|NCT01364597|463425769|FG002|Overall Study|Protocol Violation|2|||
128763685|NCT01364597|463425770|FG003|Overall Study|Protocol Violation|0|||
128763686|NCT01364597|463425767|FG000|Overall Study|Lost to Follow-up|0|||
128763687|NCT01364597|463425768|FG001|Overall Study|Lost to Follow-up|0|||
128763688|NCT01364597|463425769|FG002|Overall Study|Lost to Follow-up|5|||
128763689|NCT01364597|463425770|FG003|Overall Study|Lost to Follow-up|3|||
128763690|NCT01364597|463425767|FG000|Overall Study|Withdrawal by Subject|4|||
128763691|NCT01364597|463425768|FG001|Overall Study|Withdrawal by Subject|1|||
128763692|NCT01364597|463425769|FG002|Overall Study|Withdrawal by Subject|18|||
128763693|NCT01364597|463425770|FG003|Overall Study|Withdrawal by Subject|6|||
128763694|NCT01364597|463425767|FG000|Overall Study|Non compliance|1|||
128763695|NCT01364597|463425768|FG001|Overall Study|Non compliance|0|||
128763696|NCT01364597|463425769|FG002|Overall Study|Non compliance|1|||
128763697|NCT01364597|463425770|FG003|Overall Study|Non compliance|0|||
128763698|NCT01364597|463425767|FG000|Overall Study|Lack of compliance|1|||
128763699|NCT01364597|463425768|FG001|Overall Study|Lack of compliance|0|||
128763700|NCT01364597|463425769|FG002|Overall Study|Lack of compliance|0|||
128763701|NCT01364597|463425770|FG003|Overall Study|Lack of compliance|0|||
128763702|NCT01364597|463425767|FG000|Overall Study|End of treatment epilepsy|1|||
128763703|NCT01364597|463425768|FG001|Overall Study|End of treatment epilepsy|0|||
128763704|NCT01364597|463425769|FG002|Overall Study|End of treatment epilepsy|0|||
128763705|NCT01364597|463425770|FG003|Overall Study|End of treatment epilepsy|0|||
128763706|NCT01364597|463425767|FG000|Overall Study|No Seizures|1|||
128763707|NCT01364597|463425768|FG001|Overall Study|No Seizures|0|||
128763708|NCT01364597|463425769|FG002|Overall Study|No Seizures|0|||
128763709|NCT01364597|463425770|FG003|Overall Study|No Seizures|0|||
128763710|NCT01364597|463425767|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
128763711|NCT01364597|463425768|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
128763712|NCT01364597|463425769|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
128763713|NCT01364597|463425770|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
128763714|NCT01364597|463425767|FG000|Overall Study|Cure|1|||
128763715|NCT01364597|463425768|FG001|Overall Study|Cure|0|||
128763716|NCT01364597|463425769|FG002|Overall Study|Cure|0|||
128887587|NCT03829319|463884065|FG002|Overall Study|Physician Decision|0|||
128887588|NCT03829319|463884063|FG000|Overall Study|Lost to Follow-up|0|||
128887589|NCT03829319|463884064|FG001|Overall Study|Lost to Follow-up|0|||
128887590|NCT03829319|463884065|FG002|Overall Study|Lost to Follow-up|1|||
128887591|NCT03829319|463884063|FG000|Overall Study|Death|8|||
128887592|NCT03829319|463884064|FG001|Overall Study|Death|277|||
128887593|NCT03829319|463884065|FG002|Overall Study|Death|266|||
128887594|NCT04498832|463884066|FG000|Overall Study|Adverse Event|1|||
128887595|NCT04498832|463884067|FG001|Overall Study|Adverse Event|3|||
128887596|NCT04498832|463884066|FG000|Overall Study|Withdrawal by Subject|0|||
128887597|NCT04498832|463884067|FG001|Overall Study|Withdrawal by Subject|1|||
128887598|NCT01012739|463884068|FG000|Treatment Period 1|Adverse Event|0|||
128887599|NCT01012739|463884069|FG001|Treatment Period 1|Adverse Event|0|||
128887600|NCT01012739|463884070|FG002|Treatment Period 1|Adverse Event|0|||
128887601|NCT01012739|463884071|FG003|Treatment Period 1|Adverse Event|1|||
128887602|NCT01012739|463884068|FG000|Treatment Period 2|Abnormal test procedure results|0|||
128887603|NCT01012739|463884069|FG001|Treatment Period 2|Abnormal test procedure results|0|||
128887604|NCT01012739|463884070|FG002|Treatment Period 2|Abnormal test procedure results|0|||
128887605|NCT01012739|463884071|FG003|Treatment Period 2|Abnormal test procedure results|1|||
128887606|NCT03049735|463884076|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
128887607|NCT03049735|463884077|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
128887608|NCT03049735|463884078|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
128887609|NCT03049735|463884076|FG000|Overall Study|Other|5|||
128887610|NCT03049735|463884077|FG001|Overall Study|Other|3|||
128887611|NCT03049735|463884078|FG002|Overall Study|Other|1|||
128887612|NCT03049735|463884076|FG000|Overall Study|Lack of Efficacy|4|||
128887613|NCT03049735|463884077|FG001|Overall Study|Lack of Efficacy|0|||
128887614|NCT03049735|463884078|FG002|Overall Study|Lack of Efficacy|3|||
128887615|NCT03049735|463884076|FG000|Overall Study|Protocol deviation|1|||
128887616|NCT03049735|463884077|FG001|Overall Study|Protocol deviation|0|||
128887617|NCT03049735|463884078|FG002|Overall Study|Protocol deviation|0|||
128887618|NCT03049735|463884076|FG000|Overall Study|Pregnancy|0|||
128887619|NCT03049735|463884077|FG001|Overall Study|Pregnancy|0|||
128887620|NCT03049735|463884078|FG002|Overall Study|Pregnancy|1|||
128887621|NCT03049735|463884076|FG000|Overall Study|Adverse Event|7|||
128887622|NCT03049735|463884077|FG001|Overall Study|Adverse Event|18|||
128887623|NCT03049735|463884078|FG002|Overall Study|Adverse Event|5|||
128887624|NCT03049735|463884076|FG000|Overall Study|Withdrawal by Subject|10|||
128887625|NCT03049735|463884077|FG001|Overall Study|Withdrawal by Subject|3|||
128887626|NCT03049735|463884078|FG002|Overall Study|Withdrawal by Subject|7|||
128887627|NCT03049735|463884076|FG000|Overall Study|Lost to Follow-up|1|||
128887628|NCT03049735|463884077|FG001|Overall Study|Lost to Follow-up|5|||
128887629|NCT03049735|463884078|FG002|Overall Study|Lost to Follow-up|5|||
128887630|NCT00390910|463884079|FG000|Overall Study|Adverse Event|1|||
128887631|NCT00390910|463884080|FG001|Overall Study|Adverse Event|0|||
128887632|NCT00390910|463884081|FG002|Overall Study|Adverse Event|0|||
128887633|NCT00390910|463884079|FG000|Overall Study|Lost to Follow-up|0|||
129109905|NCT00905424|464696016|FG000|Overall Study|Positive urine drug screen|0|||
129109906|NCT00905424|464696017|FG001|Overall Study|Positive urine drug screen|1|||
129109907|NCT00905424|464696016|FG000|Overall Study|Non-adherence to visit schedule|0|||
129109908|NCT00905424|464696017|FG001|Overall Study|Non-adherence to visit schedule|1|||
129109909|NCT00227539|464696018|FG000|Overall Study|Protocol Violation|1|||
129109910|NCT00426764|464696019|FG000|Overall Study|Protocol Violation|1|||
129109911|NCT00426764|464696019|FG000|Overall Study|Withdrawal by Subject|4|||
129109912|NCT00426764|464696019|FG000|Overall Study|Physician Decision|6|||
129109913|NCT00426764|464696019|FG000|Overall Study|Compassionate Use|1|||
129109914|NCT00426764|464696019|FG000|Overall Study|Progressive Disease|83|||
129109915|NCT00426764|464696019|FG000|Overall Study|Adverse Event|24|||
129109916|NCT00426764|464696019|FG000|Overall Study|Other|1|||
128687823|NCT00518687|463157022|FG000|Overall Study|Adverse Event|201|||
128687824|NCT00518687|463157023|FG001|Overall Study|Adverse Event|177|||
128687825|NCT00518687|463157022|FG000|Overall Study|Lost to Follow-up|144|||
128687826|NCT00518687|463157023|FG001|Overall Study|Lost to Follow-up|155|||
128887634|NCT00390910|463884080|FG001|Overall Study|Lost to Follow-up|1|||
128887635|NCT00390910|463884081|FG002|Overall Study|Lost to Follow-up|5|||
128887636|NCT00390910|463884079|FG000|Overall Study|Withdrawal by Subject|1|||
128887637|NCT00390910|463884080|FG001|Overall Study|Withdrawal by Subject|3|||
129109917|NCT00426764|464696019|FG000|Overall Study|Death|1|||
128687827|NCT00518687|463157022|FG000|Overall Study|Physician Decision|42|||
128687828|NCT00518687|463157023|FG001|Overall Study|Physician Decision|48|||
128687829|NCT00518687|463157022|FG000|Overall Study|Progressive disease|2|||
128687830|NCT00518687|463157023|FG001|Overall Study|Progressive disease|2|||
128687831|NCT00518687|463157022|FG000|Overall Study|Protocol Violation|8|||
128887638|NCT00390910|463884081|FG002|Overall Study|Withdrawal by Subject|2|||
128887639|NCT00390910|463884079|FG000|Overall Study|Migrated/moved from study area|0|||
128887640|NCT00390910|463884080|FG001|Overall Study|Migrated/moved from study area|0|||
128887641|NCT00390910|463884081|FG002|Overall Study|Migrated/moved from study area|3|||
128887642|NCT00174265|463884086|FG000|Overall Study|Adverse Event|7|||
129109918|NCT00426764|464696019|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
129109919|NCT00379899|464696020|FG000|Overall Study|Adverse Event|7|||
128687832|NCT00518687|463157023|FG001|Overall Study|Protocol Violation|10|||
128687833|NCT00518687|463157022|FG000|Overall Study|Study terminated by sponsor|930|||
128687834|NCT00518687|463157023|FG001|Overall Study|Study terminated by sponsor|918|||
128687835|NCT00518687|463157022|FG000|Overall Study|Withdrawal by Subject|110|||
128687836|NCT00518687|463157023|FG001|Overall Study|Withdrawal by Subject|110|||
128687837|NCT05108922|463157024|FG000|Overall Study|Adverse Event|2|||
128687838|NCT05108922|463157025|FG001|Overall Study|Adverse Event|3|||
128687839|NCT05108922|463157024|FG000|Overall Study|Lost to Follow-up|2|||
128687840|NCT05108922|463157025|FG001|Overall Study|Lost to Follow-up|1|||
128687841|NCT05108922|463157024|FG000|Overall Study|Inadvertent enrollment|0|||
128687842|NCT05108922|463157025|FG001|Overall Study|Inadvertent enrollment|1|||
128687843|NCT05108922|463157024|FG000|Overall Study|Physician Decision|2|||
128687844|NCT05108922|463157025|FG001|Overall Study|Physician Decision|3|||
128763717|NCT01364597|463425770|FG003|Overall Study|Cure|0|||
128763718|NCT01364597|463425767|FG000|Overall Study|Patient was moving|0|||
128763719|NCT01364597|463425768|FG001|Overall Study|Patient was moving|1|||
128763720|NCT01364597|463425769|FG002|Overall Study|Patient was moving|0|||
128763721|NCT01364597|463425770|FG003|Overall Study|Patient was moving|0|||
128763722|NCT01364597|463425767|FG000|Overall Study|Seizures resolved|0|||
128763723|NCT01364597|463425768|FG001|Overall Study|Seizures resolved|0|||
128763724|NCT01364597|463425769|FG002|Overall Study|Seizures resolved|1|||
128763725|NCT01364597|463425770|FG003|Overall Study|Seizures resolved|0|||
128763726|NCT01364597|463425767|FG000|Overall Study|Patient became seizure-free after surgery|0|||
128763727|NCT01364597|463425768|FG001|Overall Study|Patient became seizure-free after surgery|0|||
128763728|NCT01364597|463425769|FG002|Overall Study|Patient became seizure-free after surgery|1|||
128763729|NCT01364597|463425770|FG003|Overall Study|Patient became seizure-free after surgery|0|||
128763730|NCT01364597|463425767|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
128763731|NCT01364597|463425768|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
128763732|NCT01364597|463425769|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
128763733|NCT01364597|463425770|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
128763734|NCT01364597|463425767|FG000|Overall Study|Patient cured from Epilepsy|0|||
128763735|NCT01364597|463425768|FG001|Overall Study|Patient cured from Epilepsy|0|||
128763736|NCT01364597|463425769|FG002|Overall Study|Patient cured from Epilepsy|1|||
128763737|NCT01364597|463425770|FG003|Overall Study|Patient cured from Epilepsy|0|||
128763738|NCT01364597|463425767|FG000|Overall Study|Investigator decision|0|||
128763739|NCT01364597|463425768|FG001|Overall Study|Investigator decision|0|||
128763740|NCT01364597|463425769|FG002|Overall Study|Investigator decision|1|||
128763741|NCT01364597|463425770|FG003|Overall Study|Investigator decision|0|||
128763742|NCT01364597|463425767|FG000|Overall Study|Sponsor recommended discontinuation|0|||
128763743|NCT01364597|463425768|FG001|Overall Study|Sponsor recommended discontinuation|0|||
128763744|NCT01364597|463425769|FG002|Overall Study|Sponsor recommended discontinuation|0|||
128763745|NCT01364597|463425770|FG003|Overall Study|Sponsor recommended discontinuation|1|||
128763746|NCT01364597|463425767|FG000|Overall Study|Parents went abroad with the patient|0|||
128763747|NCT01364597|463425768|FG001|Overall Study|Parents went abroad with the patient|0|||
128763748|NCT01364597|463425769|FG002|Overall Study|Parents went abroad with the patient|1|||
128763749|NCT01364597|463425770|FG003|Overall Study|Parents went abroad with the patient|0|||
128763750|NCT01364597|463425767|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
128763751|NCT01364597|463425768|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
128763752|NCT01364597|463425769|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
128763753|NCT01364597|463425770|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
128763754|NCT01364597|463425767|FG000|Overall Study|BRV administration dropout|0|||
128763755|NCT01364597|463425768|FG001|Overall Study|BRV administration dropout|0|||
128763756|NCT01364597|463425769|FG002|Overall Study|BRV administration dropout|1|||
128763757|NCT01364597|463425770|FG003|Overall Study|BRV administration dropout|0|||
128763758|NCT01364597|463425767|FG000|Overall Study|Dropout|0|||
128763759|NCT01364597|463425768|FG001|Overall Study|Dropout|0|||
128763760|NCT01364597|463425769|FG002|Overall Study|Dropout|3|||
128763761|NCT01364597|463425770|FG003|Overall Study|Dropout|1|||
128763762|NCT01364597|463425767|FG000|Overall Study|Unreliable subject|0|||
128763763|NCT01364597|463425768|FG001|Overall Study|Unreliable subject|0|||
128763764|NCT01364597|463425769|FG002|Overall Study|Unreliable subject|0|||
128763765|NCT01364597|463425770|FG003|Overall Study|Unreliable subject|1|||
128763766|NCT01364597|463425767|FG000|Overall Study|Other|0|||
128763767|NCT01364597|463425768|FG001|Overall Study|Other|0|||
128763768|NCT01364597|463425769|FG002|Overall Study|Other|0|||
128763769|NCT01364597|463425770|FG003|Overall Study|Other|1|||
128763770|NCT01498822|463425771|FG000|Overall Study|Protocol Violation|8|||
128763771|NCT01498822|463425772|FG001|Overall Study|Protocol Violation|4|||
128763772|NCT01498822|463425771|FG000|Overall Study|Other Reason|5|||
128763773|NCT01498822|463425772|FG001|Overall Study|Other Reason|2|||
128763774|NCT01498822|463425771|FG000|Overall Study|Lack of Efficacy|7|||
128687845|NCT05108922|463157024|FG000|Overall Study|Protocol deviation|1|||
128687846|NCT05108922|463157025|FG001|Overall Study|Protocol deviation|0|||
128687847|NCT05108922|463157024|FG000|Overall Study|Screen failure|1|||
128687848|NCT05108922|463157025|FG001|Overall Study|Screen failure|0|||
129109920|NCT00379899|464696021|FG001|Overall Study|Adverse Event|3|||
129109921|NCT00379899|464696020|FG000|Overall Study|Death|10|||
129109922|NCT00379899|464696021|FG001|Overall Study|Death|10|||
129109923|NCT00379899|464696020|FG000|Overall Study|Lost to Follow-up|2|||
128887643|NCT00174265|463884087|FG001|Overall Study|Adverse Event|4|||
128887644|NCT00174265|463884086|FG000|Overall Study|Lack of Efficacy|2|||
128887645|NCT00174265|463884087|FG001|Overall Study|Lack of Efficacy|2|||
128887646|NCT00174265|463884086|FG000|Overall Study|Withdrawal by Subject|3|||
128887647|NCT00174265|463884087|FG001|Overall Study|Withdrawal by Subject|5|||
128887648|NCT00174265|463884086|FG000|Overall Study|Lost to Follow-up|1|||
128887649|NCT00174265|463884087|FG001|Overall Study|Lost to Follow-up|0|||
128887650|NCT00174265|463884086|FG000|Overall Study|Other (Not specified)|16|||
128887651|NCT00174265|463884087|FG001|Overall Study|Other (Not specified)|10|||
128887652|NCT03231943|463884089|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887653|NCT03231943|463884090|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
128887654|NCT03231943|463884091|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
128887655|NCT03231943|463884092|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887656|NCT03231943|463884093|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887657|NCT03231943|463884094|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887658|NCT03231943|463884095|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887659|NCT03231943|463884096|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887660|NCT03231943|463884097|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887661|NCT03231943|463884098|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887662|NCT03231943|463884099|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887663|NCT03231943|463884100|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887664|NCT03231943|463884101|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
128887665|NCT03231943|463884089|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887666|NCT03231943|463884090|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
128887667|NCT03231943|463884091|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887668|NCT03231943|463884092|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887669|NCT03231943|463884093|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887670|NCT03231943|463884094|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887671|NCT03231943|463884095|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887672|NCT03231943|463884096|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887673|NCT03231943|463884097|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887674|NCT03231943|463884098|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887675|NCT03231943|463884099|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887676|NCT03231943|463884100|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887677|NCT03231943|463884101|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
128887678|NCT03231943|463884089|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
128887679|NCT03231943|463884090|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887680|NCT03231943|463884091|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887681|NCT03231943|463884092|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887682|NCT03231943|463884093|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887683|NCT03231943|463884094|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887684|NCT03231943|463884095|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887685|NCT03231943|463884096|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887686|NCT03231943|463884097|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887687|NCT03231943|463884098|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887688|NCT03231943|463884099|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887689|NCT03231943|463884100|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887690|NCT03231943|463884101|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
128887691|NCT03231943|463884089|FG000|Part 2|Adverse Event|0|||
128887692|NCT03231943|463884090|FG001|Part 2|Adverse Event|0|||
128887693|NCT03231943|463884091|FG002|Part 2|Adverse Event|0|||
128887694|NCT03231943|463884092|FG003|Part 2|Adverse Event|0|||
128887695|NCT03231943|463884093|FG004|Part 2|Adverse Event|0|||
128887696|NCT03231943|463884094|FG005|Part 2|Adverse Event|0|||
128887697|NCT03231943|463884095|FG006|Part 2|Adverse Event|0|||
129109924|NCT00379899|464696021|FG001|Overall Study|Lost to Follow-up|4|||
129109925|NCT00379899|464696020|FG000|Overall Study|Physician Decision|3|||
128687849|NCT05108922|463157024|FG000|Overall Study|Withdrawal by Subject|11|||
128687850|NCT05108922|463157025|FG001|Overall Study|Withdrawal by Subject|8|||
128887698|NCT03231943|463884096|FG007|Part 2|Adverse Event|0|||
128887699|NCT03231943|463884097|FG008|Part 2|Adverse Event|0|||
128887700|NCT03231943|463884098|FG009|Part 2|Adverse Event|0|||
128887701|NCT03231943|463884099|FG010|Part 2|Adverse Event|1|||
128887702|NCT03231943|463884100|FG011|Part 2|Adverse Event|0|||
128887703|NCT03231943|463884101|FG012|Part 2|Adverse Event|0|||
128887704|NCT03231943|463884089|FG000|Part 2|Withdrawal by Subject|0|||
128887705|NCT03231943|463884090|FG001|Part 2|Withdrawal by Subject|0|||
129109926|NCT00379899|464696021|FG001|Overall Study|Physician Decision|4|||
129109927|NCT00379899|464696020|FG000|Overall Study|Withdrawal by Subject|5|||
129109928|NCT00379899|464696021|FG001|Overall Study|Withdrawal by Subject|5|||
128887706|NCT03231943|463884091|FG002|Part 2|Withdrawal by Subject|0|||
128887707|NCT03231943|463884092|FG003|Part 2|Withdrawal by Subject|0|||
128887708|NCT03231943|463884093|FG004|Part 2|Withdrawal by Subject|0|||
128887709|NCT03231943|463884094|FG005|Part 2|Withdrawal by Subject|0|||
128887710|NCT03231943|463884095|FG006|Part 2|Withdrawal by Subject|0|||
128887711|NCT03231943|463884096|FG007|Part 2|Withdrawal by Subject|0|||
128887712|NCT03231943|463884097|FG008|Part 2|Withdrawal by Subject|0|||
128887713|NCT03231943|463884098|FG009|Part 2|Withdrawal by Subject|0|||
128887714|NCT03231943|463884099|FG010|Part 2|Withdrawal by Subject|0|||
128887715|NCT03231943|463884100|FG011|Part 2|Withdrawal by Subject|1|||
128887716|NCT03231943|463884101|FG012|Part 2|Withdrawal by Subject|0|||
128887717|NCT04824521|463884105|FG000|Overall Study|Lost to Follow-up|1|||
128887718|NCT00447382|463884106|FG000|Overall Study|Adverse Event|1|||
128887719|NCT00447382|463884107|FG001|Overall Study|Adverse Event|1|||
128887720|NCT00447382|463884106|FG000|Overall Study|Lack of Efficacy|1|||
128887721|NCT00447382|463884107|FG001|Overall Study|Lack of Efficacy|0|||
128887722|NCT00447382|463884106|FG000|Overall Study|Protocol Violation|2|||
128887723|NCT00447382|463884107|FG001|Overall Study|Protocol Violation|0|||
128887724|NCT00447382|463884106|FG000|Overall Study|Unclassified|2|||
128887725|NCT00447382|463884107|FG001|Overall Study|Unclassified|5|||
128887726|NCT04600336|463884108|FG000|Initial Treatment|Withdrawal by Subject|1|||
128887727|NCT04600336|463884109|FG001|Initial Treatment|Withdrawal by Subject|2|||
128887728|NCT04600336|463884110|FG002|Initial Treatment|Withdrawal by Subject|0|||
128887729|NCT04600336|463884111|FG003|Initial Treatment|Withdrawal by Subject|0|||
128887730|NCT04600336|463884108|FG000|Initial Treatment|Adverse Event|0|||
128887731|NCT04600336|463884109|FG001|Initial Treatment|Adverse Event|2|||
128887732|NCT04600336|463884110|FG002|Initial Treatment|Adverse Event|0|||
128887733|NCT04600336|463884111|FG003|Initial Treatment|Adverse Event|0|||
128887734|NCT04600336|463884108|FG000|Initial Treatment|Other complicating disease|0|||
128887735|NCT04600336|463884109|FG001|Initial Treatment|Other complicating disease|0|||
128887736|NCT04600336|463884110|FG002|Initial Treatment|Other complicating disease|1|||
128887737|NCT04600336|463884111|FG003|Initial Treatment|Other complicating disease|0|||
128887738|NCT04600336|463884108|FG000|Crossover Treatment|Withdrawal by Subject|0|||
128887739|NCT04600336|463884109|FG001|Crossover Treatment|Withdrawal by Subject|0|||
128887740|NCT04600336|463884110|FG002|Crossover Treatment|Withdrawal by Subject|2|||
128887741|NCT04600336|463884111|FG003|Crossover Treatment|Withdrawal by Subject|1|||
128887742|NCT04600336|463884108|FG000|Crossover Treatment|Adverse Event|0|||
128887743|NCT04600336|463884109|FG001|Crossover Treatment|Adverse Event|0|||
128887744|NCT04600336|463884110|FG002|Crossover Treatment|Adverse Event|1|||
128887745|NCT04600336|463884111|FG003|Crossover Treatment|Adverse Event|1|||
128887746|NCT03144804|463884112|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
128887747|NCT03769181|463885645|FG000|Overall Study|Adverse Event|1|||
128887748|NCT03769181|463885646|FG001|Overall Study|Adverse Event|0|||
128887749|NCT03769181|463885647|FG002|Overall Study|Adverse Event|2|||
128887750|NCT03769181|463885648|FG003|Overall Study|Adverse Event|4|||
128887751|NCT03769181|463885645|FG000|Overall Study|Withdrawal by Subject|1|||
128887752|NCT03769181|463885646|FG001|Overall Study|Withdrawal by Subject|0|||
128887753|NCT03769181|463885647|FG002|Overall Study|Withdrawal by Subject|2|||
128887754|NCT03769181|463885648|FG003|Overall Study|Withdrawal by Subject|1|||
128887755|NCT03769181|463885645|FG000|Overall Study|Progressive disease|9|||
128887756|NCT03769181|463885646|FG001|Overall Study|Progressive disease|7|||
128887757|NCT03769181|463885647|FG002|Overall Study|Progressive disease|13|||
128887758|NCT03769181|463885648|FG003|Overall Study|Progressive disease|6|||
128887759|NCT03769181|463885645|FG000|Overall Study|Other - Unspecified|2|||
128887760|NCT03769181|463885646|FG001|Overall Study|Other - Unspecified|1|||
128887761|NCT03769181|463885647|FG002|Overall Study|Other - Unspecified|0|||
128887762|NCT03769181|463885648|FG003|Overall Study|Other - Unspecified|0|||
128763775|NCT01498822|463425772|FG001|Overall Study|Lack of Efficacy|2|||
128763776|NCT01498822|463425771|FG000|Overall Study|AE, non-serious non-fatal|8|||
128763777|NCT01498822|463425772|FG001|Overall Study|AE, non-serious non-fatal|17|||
128763778|NCT01498822|463425771|FG000|Overall Study|SAE, non-fatal|2|||
128763779|NCT01498822|463425772|FG001|Overall Study|SAE, non-fatal|2|||
128763780|NCT01498822|463425771|FG000|Overall Study|Adverse Event, serious fatal|1|||
128763781|NCT01498822|463425772|FG001|Overall Study|Adverse Event, serious fatal|1|||
128763782|NCT01498822|463425771|FG000|Overall Study|Withdrawal by Subject|15|||
128763783|NCT01498822|463425772|FG001|Overall Study|Withdrawal by Subject|25|||
128763784|NCT01498822|463425771|FG000|Overall Study|Lost to Follow-up|8|||
128763785|NCT01498822|463425772|FG001|Overall Study|Lost to Follow-up|3|||
128887763|NCT03078907|463885651|FG000|Overall Study|Adverse Event|2|||
128887764|NCT03078907|463885652|FG001|Overall Study|Adverse Event|0|||
128887765|NCT03078907|463885651|FG000|Overall Study|Other|1|||
128887766|NCT03078907|463885652|FG001|Overall Study|Other|0|||
128887767|NCT03078907|463885651|FG000|Overall Study|Protocol Violation|0|||
128887768|NCT03078907|463885652|FG001|Overall Study|Protocol Violation|1|||
128887769|NCT03338192|463885653|FG000|Year One to Year Two|High Blood Pressure|7|||
128887770|NCT03338192|463885654|FG001|Year One to Year Two|High Blood Pressure|1|||
128887771|NCT03338192|463885653|FG000|Year One to Year Two|HIV +|1|||
128887772|NCT03338192|463885654|FG001|Year One to Year Two|HIV +|0|||
128887773|NCT03338192|463885653|FG000|Year Two to Year Four|High Blood Pressure|1|||
128887774|NCT03338192|463885654|FG001|Year Two to Year Four|High Blood Pressure|0|||
128887775|NCT03338192|463885653|FG000|Year Two to Year Four|HIV +|2|||
128887776|NCT03338192|463885654|FG001|Year Two to Year Four|HIV +|0|||
128887777|NCT03338192|463885653|FG000|Year Four to Year Six|High Blood Pressure|2|||
128887778|NCT03338192|463885654|FG001|Year Four to Year Six|High Blood Pressure|1|||
128887779|NCT03808688|463885655|FG000|Overall Study|Adverse Event|13|||
128887780|NCT03808688|463885656|FG001|Overall Study|Adverse Event|17|||
128887781|NCT03808688|463885655|FG000|Overall Study|Lack of Efficacy|2|||
128887782|NCT03808688|463885656|FG001|Overall Study|Lack of Efficacy|0|||
128887783|NCT03808688|463885655|FG000|Overall Study|Lost to Follow-up|0|||
128887784|NCT03808688|463885656|FG001|Overall Study|Lost to Follow-up|2|||
128887785|NCT03808688|463885655|FG000|Overall Study|Withdrawal by Subject|1|||
128887786|NCT03808688|463885656|FG001|Overall Study|Withdrawal by Subject|0|||
128887787|NCT03808688|463885655|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
128887788|NCT03808688|463885656|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
128887789|NCT03808688|463885655|FG000|Overall Study|IOP Too High|1|||
128887790|NCT03808688|463885656|FG001|Overall Study|IOP Too High|1|||
128887791|NCT03808688|463885655|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
128887792|NCT03808688|463885656|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
128887793|NCT03808688|463885655|FG000|Overall Study|Visit Out of Window|0|||
128887794|NCT03808688|463885656|FG001|Overall Study|Visit Out of Window|1|||
128887795|NCT03808688|463885655|FG000|Overall Study|Medication Non-Compliance|0|||
128887796|NCT03808688|463885656|FG001|Overall Study|Medication Non-Compliance|1|||
128887797|NCT03329196|463885657|FG000|Overall Study|Adverse Event|10|||
128887798|NCT03329196|463885658|FG001|Overall Study|Adverse Event|5|||
128887799|NCT03329196|463885657|FG000|Overall Study|Physician Decision|2|||
128887800|NCT03329196|463885658|FG001|Overall Study|Physician Decision|2|||
128887801|NCT03329196|463885657|FG000|Overall Study|Withdrawal by Subject|11|||
128887802|NCT03329196|463885658|FG001|Overall Study|Withdrawal by Subject|3|||
128887803|NCT03329196|463885657|FG000|Overall Study|Hepatic function abnormalities|0|||
128887804|NCT03329196|463885658|FG001|Overall Study|Hepatic function abnormalities|1|||
128887805|NCT03329196|463885657|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
128687851|NCT00282412|463157026|FG000|Overall Study|Death|2|||
128687852|NCT00537238|463157027|FG000|Overall Study|Death|1|||
128687853|NCT00537238|463157028|FG001|Overall Study|Death|2|||
128687854|NCT00537238|463157027|FG000|Overall Study|Adverse Event|31|||
128687855|NCT00537238|463157028|FG001|Overall Study|Adverse Event|22|||
128687856|NCT00537238|463157027|FG000|Overall Study|Lack of Efficacy|20|||
128687857|NCT00537238|463157028|FG001|Overall Study|Lack of Efficacy|21|||
128687858|NCT00537238|463157027|FG000|Overall Study|Lost to Follow-up|12|||
128687859|NCT00537238|463157028|FG001|Overall Study|Lost to Follow-up|8|||
128687860|NCT00537238|463157027|FG000|Overall Study|Withdrawal by Subject|51|||
128687861|NCT00537238|463157028|FG001|Overall Study|Withdrawal by Subject|47|||
128687862|NCT00537238|463157027|FG000|Overall Study|Protocol Violation|15|||
128687863|NCT00537238|463157028|FG001|Overall Study|Protocol Violation|19|||
128687864|NCT00537238|463157027|FG000|Overall Study|Does not meet entrance criteria|0|||
128687865|NCT00537238|463157028|FG001|Overall Study|Does not meet entrance criteria|2|||
128687866|NCT00537238|463157027|FG000|Overall Study|Other|44|||
128687867|NCT00537238|463157028|FG001|Overall Study|Other|52|||
128687868|NCT00736957|463157031|FG000|Overall Study|Adverse Event|43|||
128687869|NCT00736957|463157031|FG000|Overall Study|Withdrawal by Subject|49|||
128687870|NCT00736957|463157031|FG000|Overall Study|violation of eligibility criteria|2|||
128687871|NCT00736957|463157031|FG000|Overall Study|did not attend hospital appointments|1|||
128763786|NCT03579290|463425780|FG000|Overall Study|Lost to Follow-up|9|||
128763787|NCT03131960|463425783|FG000|Overall Study|Adverse Event|0|||
128763788|NCT03131960|463425784|FG001|Overall Study|Adverse Event|1|||
128763789|NCT01781390|463425785|FG000|Overall Study|Withdrawal of Consent|0|||
128763790|NCT01781390|463425786|FG001|Overall Study|Withdrawal of Consent|3|||
128763791|NCT01781390|463425787|FG002|Overall Study|Withdrawal of Consent|1|||
128763792|NCT01781390|463425785|FG000|Overall Study|Lost to Follow-up|1|||
128763793|NCT01781390|463425786|FG001|Overall Study|Lost to Follow-up|1|||
128763794|NCT01781390|463425787|FG002|Overall Study|Lost to Follow-up|1|||
128887806|NCT03329196|463885658|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
128763795|NCT01781390|463425785|FG000|Overall Study|Adverse Event|1|||
128763796|NCT01781390|463425786|FG001|Overall Study|Adverse Event|2|||
128763797|NCT01781390|463425787|FG002|Overall Study|Adverse Event|1|||
128763798|NCT01781390|463425785|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
128763799|NCT01781390|463425786|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
128763800|NCT01781390|463425787|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
128887807|NCT03329196|463885657|FG000|Overall Study|Difficult to control Hb|2|||
128687872|NCT00736957|463157031|FG000|Overall Study|not eligible for Treatment Period I|22|||
128687873|NCT00736957|463157031|FG000|Overall Study|Physician Decision|5|||
128687874|NCT02923427|463157037|FG000|Overall Study|convert to laparatomy|2|||
128687875|NCT02923427|463157038|FG001|Overall Study|convert to laparatomy|2|||
128687876|NCT02923427|463157037|FG000|Overall Study|destaturation|1|||
128887808|NCT03329196|463885658|FG001|Overall Study|Difficult to control Hb|3|||
128887809|NCT03329196|463885657|FG000|Overall Study|Dialysis or renal transplant|13|||
128887810|NCT03329196|463885658|FG001|Overall Study|Dialysis or renal transplant|15|||
128887811|NCT04175808|463885662|FG000|Part A|Miscellaneous|2|||
128887812|NCT04175808|463885663|FG001|Part A|Miscellaneous|0|||
128887813|NCT04175808|463885664|FG002|Part A|Miscellaneous|0|||
128887814|NCT04175808|463885665|FG003|Part A|Miscellaneous|0|||
128887815|NCT04175808|463885666|FG004|Part A|Miscellaneous|0|||
128887816|NCT04175808|463885667|FG005|Part A|Miscellaneous|0|||
128887817|NCT04175808|463885668|FG006|Part A|Miscellaneous|0|||
128887818|NCT02021292|463885672|FG000|Overall Study|Physician Decision|0|||
128887819|NCT02021292|463885673|FG001|Overall Study|Physician Decision|1|||
128887820|NCT02021292|463885672|FG000|Overall Study|Lost to Follow-up|0|||
128887821|NCT02021292|463885673|FG001|Overall Study|Lost to Follow-up|1|||
128887822|NCT02021292|463885672|FG000|Overall Study|Death|0|||
128887823|NCT02021292|463885673|FG001|Overall Study|Death|1|||
128887824|NCT05972733|463885674|FG000|Overall Study|Lost to Follow-up|2|||
128887825|NCT05972733|463885674|FG000|Overall Study|Withdrawal by Subject|1|||
128887826|NCT04982588|463885677|FG000|Overall Study|Withdrawal by Subject|2|||
128887827|NCT02366728|463885678|FG000|Overall Study|Death|0|||
128887828|NCT02366728|463885679|FG001|Overall Study|Death|0|||
128887829|NCT02366728|463885680|FG002|Overall Study|Death|1|||
128887830|NCT02366728|463885678|FG000|Overall Study|Adverse Event|1|||
128887831|NCT02366728|463885679|FG001|Overall Study|Adverse Event|0|||
128887832|NCT02366728|463885680|FG002|Overall Study|Adverse Event|0|||
128887833|NCT02366728|463885678|FG000|Overall Study|Screen Failure|2|||
128887834|NCT02366728|463885679|FG001|Overall Study|Screen Failure|1|||
128887835|NCT02366728|463885680|FG002|Overall Study|Screen Failure|0|||
128887836|NCT02366728|463885678|FG000|Overall Study|Only yielded 2 vaccines|1|||
128887837|NCT02366728|463885679|FG001|Overall Study|Only yielded 2 vaccines|0|||
128887838|NCT02366728|463885680|FG002|Overall Study|Only yielded 2 vaccines|0|||
128887839|NCT00992511|463885682|FG000|Overall Study|Migrated/moved from study area|1|||
128887840|NCT00992511|463885683|FG001|Overall Study|Migrated/moved from study area|0|||
128887841|NCT00992511|463885684|FG002|Overall Study|Migrated/moved from study area|1|||
128887842|NCT00992511|463885685|FG003|Overall Study|Migrated/moved from study area|2|||
128887843|NCT00992511|463885682|FG000|Overall Study|Lost to Follow-up|1|||
128887844|NCT00992511|463885683|FG001|Overall Study|Lost to Follow-up|0|||
128887845|NCT00992511|463885684|FG002|Overall Study|Lost to Follow-up|0|||
128887846|NCT00992511|463885685|FG003|Overall Study|Lost to Follow-up|2|||
128887847|NCT00992511|463885682|FG000|Overall Study|Withdrawal by Subject|0|||
128887848|NCT00992511|463885683|FG001|Overall Study|Withdrawal by Subject|0|||
128887849|NCT00992511|463885684|FG002|Overall Study|Withdrawal by Subject|1|||
128887850|NCT00992511|463885685|FG003|Overall Study|Withdrawal by Subject|1|||
128887851|NCT04498169|463885686|FG000|Study Completion|Adverse Event|1|||
128887852|NCT04498169|463885687|FG001|Study Completion|Adverse Event|1|||
128887853|NCT04615247|463885688|FG000|Overall Study|Adverse Event|0|||
128887854|NCT04615247|463885689|FG001|Overall Study|Adverse Event|2|||
128887855|NCT04615247|463885688|FG000|Overall Study|Withdrawal by Subject|1|||
128887856|NCT04615247|463885689|FG001|Overall Study|Withdrawal by Subject|1|||
128887857|NCT02993523|463885694|FG000|Overall Study|Withdrew Consent|0|||
128887858|NCT02993523|463885695|FG001|Overall Study|Withdrew Consent|0|||
128887859|NCT02993523|463885696|FG002|Overall Study|Withdrew Consent|2|||
128887860|NCT02993523|463885697|FG003|Overall Study|Withdrew Consent|9|||
128887861|NCT02993523|463885698|FG004|Overall Study|Withdrew Consent|0|||
128887862|NCT02993523|463885694|FG000|Overall Study|Lost to Follow-up|0|||
128887863|NCT02993523|463885695|FG001|Overall Study|Lost to Follow-up|0|||
128887864|NCT02993523|463885696|FG002|Overall Study|Lost to Follow-up|3|||
128887865|NCT02993523|463885697|FG003|Overall Study|Lost to Follow-up|6|||
128887866|NCT02993523|463885698|FG004|Overall Study|Lost to Follow-up|0|||
128887867|NCT02993523|463885694|FG000|Overall Study|Death|1|||
129109929|NCT00379899|464696020|FG000|Overall Study|Ineligibility determined|0|||
129109930|NCT00379899|464696021|FG001|Overall Study|Ineligibility determined|1|||
129109931|NCT00379899|464696020|FG000|Overall Study|Noncompliance|1|||
128687877|NCT02923427|463157038|FG001|Overall Study|destaturation|0|||
128887868|NCT02993523|463885695|FG001|Overall Study|Death|1|||
129109932|NCT00379899|464696021|FG001|Overall Study|Noncompliance|1|||
128887869|NCT02993523|463885696|FG002|Overall Study|Death|138|||
128887870|NCT02993523|463885697|FG003|Overall Study|Death|222|||
128887871|NCT02993523|463885698|FG004|Overall Study|Death|6|||
128887872|NCT02993523|463885694|FG000|Overall Study|Reason not Specified|0|||
128687878|NCT02923427|463157037|FG000|Overall Study|can not replace LMA|1|||
128887873|NCT02993523|463885695|FG001|Overall Study|Reason not Specified|0|||
128887874|NCT02993523|463885696|FG002|Overall Study|Reason not Specified|1|||
128887875|NCT02993523|463885697|FG003|Overall Study|Reason not Specified|1|||
128887876|NCT02993523|463885698|FG004|Overall Study|Reason not Specified|0|||
129109933|NCT00379899|464696020|FG000|Overall Study|Parathyroidectomy|0|||
128887877|NCT03694418|463885699|FG000|Overall Study|Lost to Follow-up|115|||
128887878|NCT03694418|463885700|FG001|Overall Study|Lost to Follow-up|23|||
128887879|NCT03694418|463885701|FG002|Overall Study|Lost to Follow-up|12|||
128887880|NCT03694418|463885702|FG003|Overall Study|Lost to Follow-up|12|||
128887881|NCT03694418|463885703|FG004|Overall Study|Lost to Follow-up|13|||
128887882|NCT00528866|463885711|FG000|Overall Study|Protocol Violation|6|||
128887883|NCT01601847|463885712|FG000|Overall Study|Death|1|||
128887884|NCT01601847|463885713|FG001|Overall Study|Death|0|||
128887885|NCT01601847|463885712|FG000|Overall Study|Withdrawal by Subject|11|||
128887886|NCT01601847|463885713|FG001|Overall Study|Withdrawal by Subject|7|||
128887887|NCT01601847|463885712|FG000|Overall Study|Lost to Follow-up|1|||
128887888|NCT01601847|463885713|FG001|Overall Study|Lost to Follow-up|3|||
128887889|NCT01284062|463885714|FG000|Overall Study|Adverse Event|4|||
128887890|NCT01284062|463885715|FG001|Overall Study|Adverse Event|5|||
128887891|NCT01284062|463885716|FG002|Overall Study|Adverse Event|0|||
128887892|NCT01284062|463885717|FG003|Overall Study|Adverse Event|5|||
128887893|NCT01284062|463885714|FG000|Overall Study|Lack of Efficacy|3|||
128887894|NCT01284062|463885715|FG001|Overall Study|Lack of Efficacy|2|||
128887895|NCT01284062|463885716|FG002|Overall Study|Lack of Efficacy|2|||
128887896|NCT01284062|463885717|FG003|Overall Study|Lack of Efficacy|1|||
128887897|NCT01284062|463885714|FG000|Overall Study|Medication error without adverse event|0|||
128887898|NCT01284062|463885715|FG001|Overall Study|Medication error without adverse event|0|||
128887899|NCT01284062|463885716|FG002|Overall Study|Medication error without adverse event|1|||
128887900|NCT01284062|463885717|FG003|Overall Study|Medication error without adverse event|0|||
128887901|NCT01284062|463885714|FG000|Overall Study|Protocol Violation|1|||
128887902|NCT01284062|463885715|FG001|Overall Study|Protocol Violation|0|||
128887903|NCT01284062|463885716|FG002|Overall Study|Protocol Violation|0|||
128887904|NCT01284062|463885717|FG003|Overall Study|Protocol Violation|2|||
128887905|NCT01284062|463885714|FG000|Overall Study|Withdrawal by Subject|3|||
128887906|NCT01284062|463885715|FG001|Overall Study|Withdrawal by Subject|1|||
128887907|NCT01284062|463885716|FG002|Overall Study|Withdrawal by Subject|2|||
128887908|NCT01284062|463885717|FG003|Overall Study|Withdrawal by Subject|5|||
128887909|NCT01284062|463885714|FG000|Overall Study|Other|0|||
128887910|NCT01284062|463885715|FG001|Overall Study|Other|0|||
128887911|NCT01284062|463885716|FG002|Overall Study|Other|0|||
128887912|NCT01284062|463885717|FG003|Overall Study|Other|1|||
128887913|NCT01284062|463885714|FG000|Overall Study|Site Closed|0|||
128887914|NCT01284062|463885715|FG001|Overall Study|Site Closed|0|||
128887915|NCT01284062|463885716|FG002|Overall Study|Site Closed|1|||
128887916|NCT01284062|463885717|FG003|Overall Study|Site Closed|0|||
128887917|NCT02234323|463885718|FG000|All Enrolled|Not Treated: Completed study in database|2|||
128887918|NCT02234323|463885718|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
128887919|NCT02234323|463885718|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
128887920|NCT02234323|463885718|FG000|All Treated|Death|1|||
128887921|NCT02234323|463885718|FG000|All Treated|Physician Decision|5|||
128887922|NCT02234323|463885718|FG000|All Treated|Lack of Efficacy|3|||
128887923|NCT02234323|463885718|FG000|All Treated|Exceeded lab value limit|2|||
128887924|NCT02234323|463885718|FG000|All Treated|Other|7|||
128887925|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
128887926|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
128887927|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
128887928|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
128887929|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
128887930|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
128887931|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
128887932|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
128887933|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Death|1|||
128887934|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Death|1|||
128887935|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
128887936|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
128887937|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
128887938|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
128887939|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
128887940|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
128887941|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
128763801|NCT04404478|463425788|FG000|Overall Study|Withdrawal by Subject|1|||
128763802|NCT04404478|463425789|FG001|Overall Study|Withdrawal by Subject|3|||
128763803|NCT01674621|463425794|FG000|Overall Study|Adverse Event|3|||
128763804|NCT01674621|463425795|FG001|Overall Study|Adverse Event|2|||
128887942|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
128887943|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
128887944|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
128887945|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
128887946|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
128887947|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
128887948|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
128763805|NCT01674621|463425796|FG002|Overall Study|Adverse Event|5|||
128887949|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
128887950|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
128887951|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
128887952|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
128887953|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
128887954|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
128887955|NCT00559585|463885719|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
128887956|NCT00559585|463885720|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
128887957|NCT00559585|463885719|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
128887958|NCT00559585|463885720|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
128887959|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
128887960|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
128887961|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
128887962|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
128887963|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
128887964|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
128887965|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
128887966|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
128887967|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
128887968|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
128887969|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
128887970|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
128887971|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
128887972|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
128887973|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
128887974|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
128887975|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
128887976|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
128887977|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
128887978|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
128887979|NCT00559585|463885719|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
128887980|NCT00559585|463885720|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
128887981|NCT02644941|463885721|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
128887982|NCT02644941|463885722|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
128887983|NCT00448435|463885724|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
128887984|NCT00448435|463885725|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
128887985|NCT01387230|463885726|FG000|Overall Study|Adverse Event|0|||
128887986|NCT01387230|463885727|FG001|Overall Study|Adverse Event|1|||
128887987|NCT01387230|463885728|FG002|Overall Study|Adverse Event|3|||
128887988|NCT01387230|463885726|FG000|Overall Study|Lack of Efficacy|8|||
128887989|NCT01387230|463885727|FG001|Overall Study|Lack of Efficacy|5|||
128887990|NCT01387230|463885728|FG002|Overall Study|Lack of Efficacy|4|||
128887991|NCT01387230|463885726|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
128887992|NCT01387230|463885727|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
128887993|NCT01387230|463885728|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
128887994|NCT01387230|463885726|FG000|Overall Study|Lost to Follow-up|0|||
128887995|NCT01387230|463885727|FG001|Overall Study|Lost to Follow-up|0|||
128887996|NCT01387230|463885728|FG002|Overall Study|Lost to Follow-up|1|||
128887997|NCT01387230|463885726|FG000|Overall Study|Withdrawal by Subject|4|||
128887998|NCT01387230|463885727|FG001|Overall Study|Withdrawal by Subject|1|||
128887999|NCT01387230|463885728|FG002|Overall Study|Withdrawal by Subject|0|||
128888000|NCT01009554|463885740|FG000|Overall Study|Adverse Event|1|||
128888001|NCT01009554|463885741|FG001|Overall Study|Adverse Event|1|||
128888002|NCT01009554|463885740|FG000|Overall Study|Withdrawal by Subject|1|||
128888003|NCT01009554|463885741|FG001|Overall Study|Withdrawal by Subject|3|||
128888004|NCT01009554|463885740|FG000|Overall Study|Noncompliant with Study Product|0|||
128888005|NCT01009554|463885741|FG001|Overall Study|Noncompliant with Study Product|3|||
128888006|NCT01605253|463885742|FG000|Overall Study|Physician Decision|3|||
129109934|NCT00379899|464696021|FG001|Overall Study|Parathyroidectomy|2|||
129109935|NCT00379899|464696020|FG000|Overall Study|Renal transplantation|5|||
129109936|NCT00379899|464696021|FG001|Overall Study|Renal transplantation|4|||
129109937|NCT00379899|464696020|FG000|Overall Study|Coronary artery bypass graft|1|||
129109938|NCT00379899|464696021|FG001|Overall Study|Coronary artery bypass graft|1|||
129109939|NCT00379899|464696020|FG000|Overall Study|Other protocol-specified criteria|3|||
129109940|NCT00379899|464696021|FG001|Overall Study|Other protocol-specified criteria|4|||
129109941|NCT00379899|464696020|FG000|Overall Study|Other|3|||
129109942|NCT00379899|464696021|FG001|Overall Study|Other|1|||
129109943|NCT05225389|464696024|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
129109944|NCT03804268|464696025|FG000|Overall Study|Adverse Event|2|||
129109945|NCT03804268|464696026|FG001|Overall Study|Adverse Event|2|||
128888007|NCT01605253|463885743|FG001|Overall Study|Physician Decision|2|||
128888008|NCT01605253|463885742|FG000|Overall Study|Lost to Follow-up|3|||
128888009|NCT01605253|463885743|FG001|Overall Study|Lost to Follow-up|1|||
128888010|NCT03434353|463887269|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
128888011|NCT03434353|463887270|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
128888012|NCT03434353|463887271|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
128888013|NCT03434353|463887272|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
128888014|NCT03434353|463887273|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
128888015|NCT03434353|463887269|FG000|Overall Study|Withdrew consent|1|||
128888016|NCT03434353|463887270|FG001|Overall Study|Withdrew consent|0|||
128888017|NCT03434353|463887271|FG002|Overall Study|Withdrew consent|3|||
128888018|NCT03434353|463887272|FG003|Overall Study|Withdrew consent|0|||
128888019|NCT03434353|463887273|FG004|Overall Study|Withdrew consent|0|||
128888020|NCT03434353|463887269|FG000|Overall Study|Adverse Event|1|||
128888021|NCT03434353|463887270|FG001|Overall Study|Adverse Event|0|||
128888022|NCT03434353|463887271|FG002|Overall Study|Adverse Event|0|||
128888023|NCT03434353|463887272|FG003|Overall Study|Adverse Event|0|||
128888024|NCT03434353|463887273|FG004|Overall Study|Adverse Event|1|||
128888025|NCT03434353|463887269|FG000|Overall Study|Lost to Follow-up|2|||
128888026|NCT03434353|463887270|FG001|Overall Study|Lost to Follow-up|0|||
128888027|NCT03434353|463887271|FG002|Overall Study|Lost to Follow-up|0|||
128888028|NCT03434353|463887272|FG003|Overall Study|Lost to Follow-up|0|||
128888029|NCT03434353|463887273|FG004|Overall Study|Lost to Follow-up|0|||
128888030|NCT01990534|463887276|FG000|Overall Study|Death|22|||
128888031|NCT01990534|463887276|FG000|Overall Study|Progressive disease|3|||
128888032|NCT01990534|463887276|FG000|Overall Study|Protocol Violation|1|||
128888033|NCT01990534|463887276|FG000|Overall Study|Withdrawal of Informed Consent|2|||
128888034|NCT01990534|463887276|FG000|Overall Study|Symptomatic Deterioration|1|||
128888035|NCT01990534|463887276|FG000|Overall Study|Withdrawal by Subject|3|||
128888036|NCT01990534|463887276|FG000|Overall Study|Reason not Specified|2|||
128888037|NCT01990534|463887276|FG000|Overall Study|Lost to Follow-up|1|||
128888038|NCT00234494|463887277|FG000|Overall Study|Protocol Violation|2|||
128888039|NCT01831544|463887280|FG000|Overall Study|Death|1|||
128888040|NCT01831544|463887280|FG000|Overall Study|Still on original MVAD device|2|||
128888041|NCT01521897|463887283|FG000|Overall Study|Protocol Violation|18|||
128888042|NCT01521897|463887283|FG000|Overall Study|Lost to Follow-up|5|||
128888043|NCT02194062|463887290|FG000|Overall Study|Lost to Follow-up|2|||
128888044|NCT02194062|463887291|FG001|Overall Study|Lost to Follow-up|2|||
128888045|NCT02194062|463887292|FG002|Overall Study|Lost to Follow-up|5|||
128888046|NCT02276872|463887293|FG000|Overall Study|Adverse Event|1|||
128888047|NCT02276872|463887294|FG001|Overall Study|Adverse Event|0|||
128888048|NCT02276872|463887295|FG002|Overall Study|Adverse Event|0|||
128888049|NCT04147234|463887296|FG000|Overall Study|Clinical deterioration|0|||
128888050|NCT04147234|463887297|FG001|Overall Study|Clinical deterioration|0|||
128888051|NCT04147234|463887298|FG002|Overall Study|Clinical deterioration|1|||
128888052|NCT04147234|463887299|FG003|Overall Study|Clinical deterioration|0|||
128888053|NCT04147234|463887300|FG004|Overall Study|Clinical deterioration|0|||
128888054|NCT04147234|463887301|FG005|Overall Study|Clinical deterioration|0|||
128888055|NCT04147234|463887302|FG006|Overall Study|Clinical deterioration|0|||
128888056|NCT04147234|463887296|FG000|Overall Study|Withdrawal by Subject|0|||
128888057|NCT04147234|463887297|FG001|Overall Study|Withdrawal by Subject|1|||
128888058|NCT04147234|463887298|FG002|Overall Study|Withdrawal by Subject|1|||
128888059|NCT04147234|463887299|FG003|Overall Study|Withdrawal by Subject|0|||
128888060|NCT04147234|463887300|FG004|Overall Study|Withdrawal by Subject|0|||
128888061|NCT04147234|463887301|FG005|Overall Study|Withdrawal by Subject|0|||
128888062|NCT04147234|463887302|FG006|Overall Study|Withdrawal by Subject|0|||
128888063|NCT04147234|463887296|FG000|Overall Study|Clinical disease progression|1|||
128888064|NCT04147234|463887297|FG001|Overall Study|Clinical disease progression|3|||
128888065|NCT04147234|463887298|FG002|Overall Study|Clinical disease progression|1|||
128888066|NCT04147234|463887299|FG003|Overall Study|Clinical disease progression|1|||
128888067|NCT04147234|463887300|FG004|Overall Study|Clinical disease progression|0|||
128888068|NCT04147234|463887301|FG005|Overall Study|Clinical disease progression|1|||
128888069|NCT04147234|463887302|FG006|Overall Study|Clinical disease progression|0|||
128888070|NCT04147234|463887296|FG000|Overall Study|Objective disease progression|6|||
128888071|NCT04147234|463887297|FG001|Overall Study|Objective disease progression|4|||
128888072|NCT04147234|463887298|FG002|Overall Study|Objective disease progression|3|||
128888073|NCT04147234|463887299|FG003|Overall Study|Objective disease progression|3|||
128888074|NCT04147234|463887300|FG004|Overall Study|Objective disease progression|5|||
128888075|NCT04147234|463887301|FG005|Overall Study|Objective disease progression|2|||
128888076|NCT04147234|463887302|FG006|Overall Study|Objective disease progression|3|||
128888077|NCT04147234|463887296|FG000|Overall Study|Adverse Event|0|||
128888078|NCT04147234|463887297|FG001|Overall Study|Adverse Event|0|||
128888079|NCT04147234|463887298|FG002|Overall Study|Adverse Event|0|||
128888080|NCT04147234|463887299|FG003|Overall Study|Adverse Event|0|||
128888081|NCT04147234|463887300|FG004|Overall Study|Adverse Event|1|||
128888082|NCT04147234|463887301|FG005|Overall Study|Adverse Event|0|||
128888083|NCT04147234|463887302|FG006|Overall Study|Adverse Event|0|||
128888084|NCT02596620|463887303|FG000|Overall Study|Lost to Follow-up|1|||
128888085|NCT02596620|463887304|FG001|Overall Study|Lost to Follow-up|1|||
128888086|NCT02066051|463887305|FG000|Overall Study|Subject developed active GVHD|1|||
128888087|NCT03027557|463887306|FG000|Overall Study|Adverse Event|1|||
128888088|NCT03027557|463887307|FG001|Overall Study|Adverse Event|0|||
128888089|NCT03027557|463887308|FG002|Overall Study|Adverse Event|0|||
128888090|NCT01610687|463887309|FG000|Overall Study|Lack of Efficacy|26|||
128888091|NCT01610687|463887309|FG000|Overall Study|Adverse Event|18|||
128888092|NCT01610687|463887309|FG000|Overall Study|Moved out of area|6|||
128888093|NCT01610687|463887309|FG000|Overall Study|Withdrawal by Subject|7|||
128888094|NCT01610687|463887309|FG000|Overall Study|Lost to Follow-up|4|||
128888095|NCT01610687|463887309|FG000|Overall Study|Symptom control without study medication|2|||
128888096|NCT01610687|463887309|FG000|Overall Study|Unable to make journey|1|||
128888097|NCT01610687|463887309|FG000|Overall Study|Death|1|||
128888098|NCT01610687|463887309|FG000|Overall Study|Cannabis affecting job|1|||
128888099|NCT01610687|463887309|FG000|Overall Study|Felt more alter without study medication|1|||
128888100|NCT03836807|463887310|FG000|Overall Study|Physician Decision|1|||
128888101|NCT03836807|463887311|FG001|Overall Study|Physician Decision|0|||
128888102|NCT02430051|463887312|FG000|Overall Study|Withdrawal by Subject|6|||
128888103|NCT02430051|463887313|FG001|Overall Study|Withdrawal by Subject|3|||
128888104|NCT02430051|463887312|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
128888105|NCT02430051|463887313|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
128888106|NCT02430051|463887312|FG000|Overall Study|Protocol Violation|1|||
128888107|NCT02430051|463887313|FG001|Overall Study|Protocol Violation|0|||
128888108|NCT02846532|463887320|FG000|Overall Study|Lost to Follow-up|0|||
128888109|NCT02846532|463887321|FG001|Overall Study|Lost to Follow-up|1|||
128888110|NCT02846532|463887322|FG002|Overall Study|Lost to Follow-up|1|||
128888111|NCT02846532|463887320|FG000|Overall Study|Withdrawal by Subject|1|||
128888112|NCT02846532|463887321|FG001|Overall Study|Withdrawal by Subject|2|||
128888113|NCT02846532|463887322|FG002|Overall Study|Withdrawal by Subject|0|||
128888114|NCT03951220|463887323|FG000|Overall Study|Withdrawal by Subject|9|||
128888115|NCT03951220|463887324|FG001|Overall Study|Withdrawal by Subject|2|||
128888116|NCT03951220|463887325|FG002|Overall Study|Withdrawal by Subject|0|||
128888117|NCT06132425|463887326|FG000|Overall Study|Withdrawal by Subject|3|||
128888118|NCT06132425|463887327|FG001|Overall Study|Withdrawal by Subject|0|||
128888119|NCT06132425|463887326|FG000|Overall Study|Did not follow study instructions|0|||
128888120|NCT06132425|463887327|FG001|Overall Study|Did not follow study instructions|2|||
128888121|NCT06132425|463887326|FG000|Overall Study|Lost to Follow-up|3|||
128888122|NCT06132425|463887327|FG001|Overall Study|Lost to Follow-up|5|||
128888123|NCT04598477|463887329|FG000|Overall Study|Adverse Event|2|||
128888124|NCT04598477|463887330|FG001|Overall Study|Adverse Event|0|||
128888125|NCT04598477|463887329|FG000|Overall Study|Death|0|||
128888126|NCT04598477|463887330|FG001|Overall Study|Death|1|||
128888127|NCT04598477|463887329|FG000|Overall Study|Lost to Follow-up|1|||
128888128|NCT04598477|463887330|FG001|Overall Study|Lost to Follow-up|0|||
128888129|NCT04598477|463887329|FG000|Overall Study|Physician Decision|7|||
128888130|NCT04598477|463887330|FG001|Overall Study|Physician Decision|2|||
128888131|NCT04598477|463887329|FG000|Overall Study|Pregnancy|0|||
128888132|NCT04598477|463887330|FG001|Overall Study|Pregnancy|1|||
128888133|NCT04598477|463887329|FG000|Overall Study|Requires Prohibited Medication|0|||
128888134|NCT04598477|463887330|FG001|Overall Study|Requires Prohibited Medication|1|||
128888135|NCT04598477|463887329|FG000|Overall Study|Study Terminated by Sponsor|18|||
128687879|NCT02923427|463157038|FG001|Overall Study|can not replace LMA|0|||
128687880|NCT01325623|463157039|FG000|Overall Study|Withdrawal by Subject|3|||
128687881|NCT00950911|463157041|FG000|Overall Study|Adverse Event|0|||
128687882|NCT00950911|463157042|FG001|Overall Study|Adverse Event|2|||
128687883|NCT00950911|463157041|FG000|Overall Study|Death|4|||
128687884|NCT00950911|463157042|FG001|Overall Study|Death|6|||
128687885|NCT00950911|463157041|FG000|Overall Study|Disease progression|2|||
128888136|NCT04598477|463887330|FG001|Overall Study|Study Terminated by Sponsor|12|||
128888137|NCT04598477|463887329|FG000|Overall Study|Withdrawal by Subject|16|||
128888138|NCT04598477|463887330|FG001|Overall Study|Withdrawal by Subject|12|||
128888139|NCT04598477|463887329|FG000|Overall Study|Other|15|||
128888140|NCT04598477|463887330|FG001|Overall Study|Other|8|||
128888141|NCT05579990|463887338|FG000|Overall Study|Lost to Follow-up|3|||
128687886|NCT00950911|463157042|FG001|Overall Study|Disease progression|2|||
128687887|NCT00950911|463157041|FG000|Overall Study|Consent withdrawn|1|||
128888142|NCT02499770|463887341|FG000|Overall Study|Death|17|||
128888143|NCT02499770|463887342|FG001|Overall Study|Death|56|||
128888144|NCT02499770|463887341|FG000|Overall Study|Study completion|1|||
128888145|NCT02499770|463887342|FG001|Overall Study|Study completion|10|||
128888146|NCT02499770|463887341|FG000|Overall Study|Withdrawal by Subject|0|||
128888147|NCT02499770|463887342|FG001|Overall Study|Withdrawal by Subject|7|||
128888148|NCT02499770|463887341|FG000|Overall Study|Lost to Follow-up|0|||
128888149|NCT02499770|463887342|FG001|Overall Study|Lost to Follow-up|2|||
128888150|NCT02499770|463887341|FG000|Overall Study|Subject declined further treatment|1|||
128687888|NCT00950911|463157042|FG001|Overall Study|Consent withdrawn|3|||
128888151|NCT02499770|463887342|FG001|Overall Study|Subject declined further treatment|0|||
128888152|NCT02499770|463887341|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
128888153|NCT02499770|463887342|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
128888154|NCT02499770|463887341|FG000|Overall Study|Randomized but not enrolled|0|||
128888155|NCT02499770|463887342|FG001|Overall Study|Randomized but not enrolled|1|||
128888156|NCT01019980|463887345|FG000|Overall Study|Drug not available.|2|||
128888157|NCT01019980|463887346|FG001|Overall Study|Drug not available.|0|||
128888158|NCT02038920|463887362|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
128888159|NCT02038920|463887363|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
128888160|NCT02038920|463887364|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
128888161|NCT02038920|463887365|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
128888162|NCT02038920|463887366|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
128888163|NCT02038920|463887367|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
128888164|NCT02038920|463887362|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
128888165|NCT02038920|463887363|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
128888166|NCT02038920|463887364|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
128888167|NCT02038920|463887365|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
128888168|NCT02038920|463887366|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
128888169|NCT02038920|463887367|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
128888170|NCT02038920|463887362|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
128888171|NCT02038920|463887363|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
128888172|NCT02038920|463887364|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
128888173|NCT02038920|463887365|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
128888174|NCT02038920|463887366|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
128888175|NCT02038920|463887367|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
128888176|NCT02038920|463887362|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
128888177|NCT02038920|463887363|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
128888178|NCT02038920|463887364|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
128888179|NCT02038920|463887365|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
128888180|NCT02038920|463887366|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
128888181|NCT02038920|463887367|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
128888182|NCT02038920|463887362|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
128888183|NCT02038920|463887363|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
128888184|NCT02038920|463887364|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
128888185|NCT02038920|463887365|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
128888186|NCT02038920|463887366|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
128888187|NCT02038920|463887367|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
128888188|NCT02038920|463887362|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
128888189|NCT02038920|463887363|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
128888190|NCT02038920|463887364|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
128888191|NCT02038920|463887365|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
128888192|NCT02038920|463887366|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
128888193|NCT02038920|463887367|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
128888194|NCT02038920|463887362|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
128888195|NCT02038920|463887363|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
128888196|NCT02038920|463887364|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
128888197|NCT02038920|463887365|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
128888198|NCT02038920|463887366|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
128888199|NCT02038920|463887367|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
128888200|NCT02038920|463887362|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
128888201|NCT02038920|463887363|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
128888202|NCT02038920|463887364|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
128888203|NCT02038920|463887365|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
128888204|NCT02038920|463887366|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
128888205|NCT02038920|463887367|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
128888206|NCT02038920|463887362|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
128888207|NCT02038920|463887363|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
128888208|NCT02038920|463887364|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129109946|NCT03804268|464696025|FG000|Overall Study|Withdrawal by Subject|2|||
128763806|NCT01674621|463425797|FG003|Overall Study|Adverse Event|5|||
128763807|NCT01674621|463425798|FG004|Overall Study|Adverse Event|1|||
128763808|NCT01674621|463425794|FG000|Overall Study|Inability to Complete Study Procedures|0|||
128763809|NCT01674621|463425795|FG001|Overall Study|Inability to Complete Study Procedures|0|||
128763810|NCT01674621|463425796|FG002|Overall Study|Inability to Complete Study Procedures|0|||
128763811|NCT01674621|463425797|FG003|Overall Study|Inability to Complete Study Procedures|0|||
128888209|NCT02038920|463887365|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
128888210|NCT02038920|463887366|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
128888211|NCT02038920|463887367|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
128888212|NCT02038920|463887362|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
128888213|NCT02038920|463887363|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
128687889|NCT00950911|463157041|FG000|Overall Study|Administrative decision|3|||
128687890|NCT00950911|463157042|FG001|Overall Study|Administrative decision|1|||
128687891|NCT00950911|463157041|FG000|Overall Study|Ineligibility determined|1|||
128687892|NCT00950911|463157042|FG001|Overall Study|Ineligibility determined|0|||
128687893|NCT00950911|463157041|FG000|Overall Study|Noncompliance|1|||
128687894|NCT00950911|463157042|FG001|Overall Study|Noncompliance|0|||
128687895|NCT00950911|463157041|FG000|Overall Study|Poor performance status|0|||
128687896|NCT00950911|463157042|FG001|Overall Study|Poor performance status|1|||
128687897|NCT02600351|463157045|FG000|Overall Study|Lack of Efficacy|3|||
128687898|NCT02600351|463157046|FG001|Overall Study|Lack of Efficacy|0|||
128687899|NCT02600351|463157047|FG002|Overall Study|Lack of Efficacy|5|||
128888214|NCT02038920|463887364|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
128888215|NCT02038920|463887365|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
128888216|NCT02038920|463887366|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
128888217|NCT02038920|463887367|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
128888218|NCT02038920|463887362|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
128888219|NCT02038920|463887363|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
128888220|NCT02038920|463887364|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
128888221|NCT02038920|463887365|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
128888222|NCT02038920|463887366|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
128888223|NCT02038920|463887367|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
128888224|NCT02038920|463887362|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
128888225|NCT02038920|463887363|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
128888226|NCT02038920|463887364|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
128888227|NCT02038920|463887365|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
128888228|NCT02038920|463887366|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
128888229|NCT02038920|463887367|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
128888230|NCT02383589|463887368|FG000|Treatment Period|Adverse Event|1|||
128888231|NCT02383589|463887369|FG001|Treatment Period|Adverse Event|3|||
128888232|NCT02383589|463887368|FG000|Treatment Period|Lost to Follow-up|0|||
128888233|NCT02383589|463887369|FG001|Treatment Period|Lost to Follow-up|1|||
128888234|NCT02383589|463887368|FG000|Treatment Period|Withdrawal by Subject|0|||
128888235|NCT02383589|463887369|FG001|Treatment Period|Withdrawal by Subject|5|||
128888236|NCT02383589|463887368|FG000|Treatment Period|Non-compliance with study drug|0|||
128888237|NCT02383589|463887369|FG001|Treatment Period|Non-compliance with study drug|1|||
128888238|NCT02383589|463887368|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
128888239|NCT02383589|463887369|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
128888240|NCT02383589|463887368|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
128888241|NCT02383589|463887369|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
128888242|NCT02383589|463887368|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
128888243|NCT02383589|463887369|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
128888244|NCT00047320|463887370|FG000|Overall Study|Lack of Efficacy|8|||
128888245|NCT00047320|463887370|FG000|Overall Study|Lost to Follow-up|1|||
128888246|NCT00047320|463887370|FG000|Overall Study|Physician Decision|8|||
128888247|NCT00047320|463887370|FG000|Overall Study|Withdrawal by Subject|9|||
128888248|NCT00047320|463887370|FG000|Overall Study|Ineligible|2|||
128888249|NCT00866697|463887371|FG000|Overall Study|Study closed/terminated|156|||
128888250|NCT00866697|463887372|FG001|Overall Study|Study closed/terminated|138|||
128888251|NCT00866697|463887371|FG000|Overall Study|Lost to Follow-up|22|||
128888252|NCT00866697|463887372|FG001|Overall Study|Lost to Follow-up|28|||
128888253|NCT00866697|463887371|FG000|Overall Study|Physician Decision|3|||
128888254|NCT00866697|463887372|FG001|Overall Study|Physician Decision|5|||
128888255|NCT00866697|463887371|FG000|Overall Study|Withdrawal by Subject|33|||
128888256|NCT00866697|463887372|FG001|Overall Study|Withdrawal by Subject|57|||
128888257|NCT02906787|463887373|FG000|Overall Study|Withdrawal by Subject|12|||
128888258|NCT02906787|463887374|FG001|Overall Study|Withdrawal by Subject|10|||
128888259|NCT02906787|463887373|FG000|Overall Study|Missed|24|||
128888260|NCT02906787|463887374|FG001|Overall Study|Missed|22|||
128888261|NCT04376060|463887375|FG000|Overall Study|Physician Decision|1|||
128888262|NCT02818920|463887376|FG000|Overall Study|Unresectable|4|||
128888263|NCT02818920|463887376|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
128687900|NCT02600351|463157048|FG003|Overall Study|Lack of Efficacy|2|||
128687901|NCT02600351|463157045|FG000|Overall Study|Lost to Follow-up|1|||
128888264|NCT02818920|463887376|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
128888265|NCT02818920|463887376|FG000|Overall Study|Adverse Event|3|||
129020576|NCT01796171|464367106|FG010|Follow-up Period|Sponsor Decision|40|||
128687902|NCT02600351|463157046|FG001|Overall Study|Lost to Follow-up|0|||
128687903|NCT02600351|463157047|FG002|Overall Study|Lost to Follow-up|0|||
128687904|NCT02600351|463157048|FG003|Overall Study|Lost to Follow-up|0|||
128888266|NCT02818920|463887376|FG000|Overall Study|Developed Other Disease|1|||
128888267|NCT02818920|463887376|FG000|Overall Study|Refused Further Treatment|1|||
128888268|NCT04275297|463887377|FG000|Overall Study|Lost to Follow-up|1|||
128888269|NCT04275297|463887378|FG001|Overall Study|Lost to Follow-up|1|||
128888270|NCT02673619|463887379|FG000|Overall Study|Lost to Follow-up|1|||
128888271|NCT02673619|463887380|FG001|Overall Study|Lost to Follow-up|0|||
128888272|NCT02673619|463887381|FG002|Overall Study|Lost to Follow-up|0|||
128888273|NCT02673619|463887382|FG003|Overall Study|Lost to Follow-up|0|||
128888274|NCT02673619|463887379|FG000|Overall Study|Withdrawal by Subject|1|||
128888275|NCT02673619|463887380|FG001|Overall Study|Withdrawal by Subject|1|||
128888276|NCT02673619|463887381|FG002|Overall Study|Withdrawal by Subject|1|||
128888277|NCT02673619|463887382|FG003|Overall Study|Withdrawal by Subject|0|||
128888278|NCT02673619|463887379|FG000|Overall Study|Adverse Event|0|||
128888279|NCT02673619|463887380|FG001|Overall Study|Adverse Event|0|||
128888280|NCT02673619|463887381|FG002|Overall Study|Adverse Event|1|||
128888281|NCT02673619|463887382|FG003|Overall Study|Adverse Event|0|||
128888282|NCT02673619|463887379|FG000|Overall Study|Lack of Efficacy|0|||
128888283|NCT02673619|463887380|FG001|Overall Study|Lack of Efficacy|0|||
128888284|NCT02673619|463887381|FG002|Overall Study|Lack of Efficacy|1|||
128888285|NCT02673619|463887382|FG003|Overall Study|Lack of Efficacy|0|||
128888286|NCT04225806|463887385|FG000|Overall Study|Trial termination|15|||
128888287|NCT02408861|463887386|FG000|Overall Study|Death|0|||
128888288|NCT02408861|463887387|FG001|Overall Study|Death|3|||
128888289|NCT02408861|463887388|FG002|Overall Study|Death|1|||
128888290|NCT02408861|463887389|FG003|Overall Study|Death|2|||
128888291|NCT02408861|463887390|FG004|Overall Study|Death|4|||
128888292|NCT02408861|463887391|FG005|Overall Study|Death|1|||
128888293|NCT02408861|463887392|FG006|Overall Study|Death|0|||
128888294|NCT02408861|463887386|FG000|Overall Study|Lost to Follow-up|0|||
128888295|NCT02408861|463887387|FG001|Overall Study|Lost to Follow-up|0|||
128888296|NCT02408861|463887388|FG002|Overall Study|Lost to Follow-up|1|||
128888297|NCT02408861|463887389|FG003|Overall Study|Lost to Follow-up|1|||
128888298|NCT02408861|463887390|FG004|Overall Study|Lost to Follow-up|4|||
128888299|NCT02408861|463887391|FG005|Overall Study|Lost to Follow-up|2|||
128888300|NCT02408861|463887392|FG006|Overall Study|Lost to Follow-up|1|||
128888301|NCT02408861|463887386|FG000|Overall Study|Disease Progression|0|||
128888302|NCT02408861|463887387|FG001|Overall Study|Disease Progression|0|||
128888303|NCT02408861|463887388|FG002|Overall Study|Disease Progression|1|||
128888304|NCT02408861|463887389|FG003|Overall Study|Disease Progression|0|||
128888305|NCT02408861|463887390|FG004|Overall Study|Disease Progression|3|||
128888306|NCT02408861|463887391|FG005|Overall Study|Disease Progression|1|||
128888307|NCT02408861|463887392|FG006|Overall Study|Disease Progression|1|||
128888308|NCT02408861|463887386|FG000|Overall Study|Adverse Event|1|||
128888309|NCT02408861|463887387|FG001|Overall Study|Adverse Event|0|||
128888310|NCT02408861|463887388|FG002|Overall Study|Adverse Event|1|||
128888311|NCT02408861|463887389|FG003|Overall Study|Adverse Event|0|||
128888312|NCT02408861|463887390|FG004|Overall Study|Adverse Event|2|||
128888313|NCT02408861|463887391|FG005|Overall Study|Adverse Event|0|||
128888314|NCT02408861|463887392|FG006|Overall Study|Adverse Event|0|||
128888315|NCT02408861|463887386|FG000|Overall Study|Physician Decision|1|||
128888316|NCT02408861|463887387|FG001|Overall Study|Physician Decision|1|||
128888317|NCT02408861|463887388|FG002|Overall Study|Physician Decision|1|||
128888318|NCT02408861|463887389|FG003|Overall Study|Physician Decision|0|||
128888319|NCT02408861|463887390|FG004|Overall Study|Physician Decision|0|||
128888320|NCT02408861|463887391|FG005|Overall Study|Physician Decision|1|||
128888321|NCT02408861|463887392|FG006|Overall Study|Physician Decision|0|||
128888322|NCT02408861|463887386|FG000|Overall Study|Protocol Violation|1|||
128888323|NCT02408861|463887387|FG001|Overall Study|Protocol Violation|0|||
128888324|NCT02408861|463887388|FG002|Overall Study|Protocol Violation|0|||
128888325|NCT02408861|463887389|FG003|Overall Study|Protocol Violation|0|||
128888326|NCT02408861|463887390|FG004|Overall Study|Protocol Violation|0|||
128888327|NCT02408861|463887391|FG005|Overall Study|Protocol Violation|0|||
128687905|NCT02600351|463157045|FG000|Overall Study|Randomized but Not Treated|1|||
128888328|NCT02408861|463887392|FG006|Overall Study|Protocol Violation|0|||
128888329|NCT02408861|463887386|FG000|Overall Study|Withdrawal by Subject|0|||
128888330|NCT02408861|463887387|FG001|Overall Study|Withdrawal by Subject|0|||
128888331|NCT02408861|463887388|FG002|Overall Study|Withdrawal by Subject|0|||
128687906|NCT02600351|463157046|FG001|Overall Study|Randomized but Not Treated|0|||
128687907|NCT02600351|463157047|FG002|Overall Study|Randomized but Not Treated|1|||
128687908|NCT02600351|463157048|FG003|Overall Study|Randomized but Not Treated|3|||
128687909|NCT04087213|463157049|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
128687910|NCT04087213|463157049|FG000|In-Facility Introduction|Adverse Event|1|||
128687911|NCT04087213|463157049|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
128687912|NCT04087213|463157049|FG000|Assisted Evaluable Period|Personal reasons|3|||
128687913|NCT04087213|463157049|FG000|Transition Period B|Renal Transplantation|1|||
128687914|NCT02556203|463157056|FG000|Overall Study|Withdrawal by Subject|21|||
128888332|NCT02408861|463887389|FG003|Overall Study|Withdrawal by Subject|0|||
128888333|NCT02408861|463887390|FG004|Overall Study|Withdrawal by Subject|1|||
128888334|NCT02408861|463887391|FG005|Overall Study|Withdrawal by Subject|1|||
128888335|NCT02408861|463887392|FG006|Overall Study|Withdrawal by Subject|0|||
128888336|NCT02408861|463887386|FG000|Overall Study|Other Treatment|0|||
128888337|NCT02408861|463887387|FG001|Overall Study|Other Treatment|0|||
128888338|NCT02408861|463887388|FG002|Overall Study|Other Treatment|0|||
128888339|NCT02408861|463887389|FG003|Overall Study|Other Treatment|0|||
128888340|NCT02408861|463887390|FG004|Overall Study|Other Treatment|0|||
128888341|NCT02408861|463887391|FG005|Overall Study|Other Treatment|1|||
128888342|NCT02408861|463887392|FG006|Overall Study|Other Treatment|1|||
128888343|NCT04124614|463887393|FG000|Placebo Run-in Period|Not Randomized|34|||
128888344|NCT04124614|463887394|FG001|Placebo Run-in Period|Not Randomized|0|||
128888345|NCT04124614|463887395|FG002|Placebo Run-in Period|Not Randomized|0|||
128888346|NCT04124614|463887393|FG000|Double Blind Treatment Period|Adverse Event|0|||
128888347|NCT04124614|463887394|FG001|Double Blind Treatment Period|Adverse Event|7|||
128888348|NCT04124614|463887395|FG002|Double Blind Treatment Period|Adverse Event|22|||
128888349|NCT04124614|463887393|FG000|Double Blind Treatment Period|Death|0|||
128888350|NCT04124614|463887394|FG001|Double Blind Treatment Period|Death|0|||
128888351|NCT04124614|463887395|FG002|Double Blind Treatment Period|Death|1|||
128888352|NCT04124614|463887393|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
128888353|NCT04124614|463887394|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
128888354|NCT04124614|463887395|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
128888355|NCT04124614|463887393|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
128888356|NCT04124614|463887394|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
128888357|NCT04124614|463887395|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
128888358|NCT04124614|463887393|FG000|Double Blind Treatment Period|Physician Decision|0|||
128888359|NCT04124614|463887394|FG001|Double Blind Treatment Period|Physician Decision|0|||
128888360|NCT04124614|463887395|FG002|Double Blind Treatment Period|Physician Decision|3|||
128888361|NCT04124614|463887393|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
128888362|NCT04124614|463887394|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
128888363|NCT04124614|463887395|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
128888364|NCT04124614|463887393|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
128888365|NCT04124614|463887394|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
128888366|NCT04124614|463887395|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
128888367|NCT04124614|463887393|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
128888368|NCT04124614|463887394|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
128888369|NCT04124614|463887395|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
128888370|NCT01179672|463888649|FG000|Overall Study|Adverse Event|17|||
128888371|NCT01179672|463888650|FG001|Overall Study|Adverse Event|8|||
128888372|NCT01179672|463888649|FG000|Overall Study|Withdrawal by Subject|10|||
128888373|NCT01179672|463888650|FG001|Overall Study|Withdrawal by Subject|12|||
128888374|NCT01179672|463888649|FG000|Overall Study|Entry Criteria Not Met|0|||
128888375|NCT01179672|463888650|FG001|Overall Study|Entry Criteria Not Met|2|||
128888376|NCT01179672|463888649|FG000|Overall Study|Lost to Follow-up|0|||
128888377|NCT01179672|463888650|FG001|Overall Study|Lost to Follow-up|1|||
128888378|NCT01179672|463888649|FG000|Overall Study|Protocol Violation|2|||
128888379|NCT01179672|463888650|FG001|Overall Study|Protocol Violation|2|||
128888380|NCT01179672|463888649|FG000|Overall Study|Physician Decision|1|||
128888381|NCT01179672|463888650|FG001|Overall Study|Physician Decision|1|||
128888382|NCT02748018|463888653|FG000|Study Period|Adverse Event|1|||
128888383|NCT02748018|463888654|FG001|Study Period|Adverse Event|3|||
128888384|NCT02748018|463888655|FG002|Study Period|Adverse Event|4|||
128888385|NCT02748018|463888656|FG003|Study Period|Adverse Event|0|||
128888386|NCT02748018|463888657|FG004|Study Period|Adverse Event|3|||
128888387|NCT02748018|463888658|FG005|Study Period|Adverse Event|3|||
128888388|NCT02748018|463888653|FG000|Study Period|Withdrawal by Subject|7|||
128888389|NCT02748018|463888654|FG001|Study Period|Withdrawal by Subject|4|||
128888390|NCT02748018|463888655|FG002|Study Period|Withdrawal by Subject|4|||
128888391|NCT02748018|463888656|FG003|Study Period|Withdrawal by Subject|11|||
128888392|NCT02748018|463888657|FG004|Study Period|Withdrawal by Subject|12|||
128888393|NCT02748018|463888658|FG005|Study Period|Withdrawal by Subject|10|||
128888394|NCT02748018|463888653|FG000|Study Period|Pregnancy|0|||
128888395|NCT02748018|463888654|FG001|Study Period|Pregnancy|1|||
128888396|NCT02748018|463888655|FG002|Study Period|Pregnancy|0|||
129109947|NCT03804268|464696026|FG001|Overall Study|Withdrawal by Subject|0|||
129109948|NCT03804268|464696025|FG000|Overall Study|Lost to Follow-up|1|||
128888397|NCT02748018|463888656|FG003|Study Period|Pregnancy|0|||
128888398|NCT02748018|463888657|FG004|Study Period|Pregnancy|1|||
128888399|NCT02748018|463888658|FG005|Study Period|Pregnancy|0|||
128888400|NCT02748018|463888653|FG000|Study Period|Physician Decision|2|||
128888401|NCT02748018|463888654|FG001|Study Period|Physician Decision|2|||
129109949|NCT03804268|464696026|FG001|Overall Study|Lost to Follow-up|0|||
129109950|NCT03804268|464696025|FG000|Overall Study|Physician Decision|2|||
128888402|NCT02748018|463888655|FG002|Study Period|Physician Decision|1|||
128888403|NCT02748018|463888656|FG003|Study Period|Physician Decision|0|||
128888404|NCT02748018|463888657|FG004|Study Period|Physician Decision|2|||
128888405|NCT02748018|463888658|FG005|Study Period|Physician Decision|0|||
128687915|NCT02556203|463157057|FG001|Overall Study|Withdrawal by Subject|21|||
129109951|NCT03804268|464696026|FG001|Overall Study|Physician Decision|0|||
128888406|NCT02748018|463888653|FG000|Study Period|Lost to Follow-up|0|||
128888407|NCT02748018|463888654|FG001|Study Period|Lost to Follow-up|0|||
128888408|NCT02748018|463888655|FG002|Study Period|Lost to Follow-up|0|||
128888409|NCT02748018|463888656|FG003|Study Period|Lost to Follow-up|2|||
128888410|NCT02748018|463888657|FG004|Study Period|Lost to Follow-up|0|||
128888411|NCT02748018|463888658|FG005|Study Period|Lost to Follow-up|1|||
128888412|NCT02748018|463888653|FG000|Continuation Period|Adverse Event|2|||
128888413|NCT02748018|463888654|FG001|Continuation Period|Adverse Event|0|||
128888414|NCT02748018|463888655|FG002|Continuation Period|Adverse Event|1|||
128888415|NCT02748018|463888656|FG003|Continuation Period|Adverse Event|1|||
128888416|NCT02748018|463888657|FG004|Continuation Period|Adverse Event|1|||
128888417|NCT02748018|463888658|FG005|Continuation Period|Adverse Event|4|||
128888418|NCT02748018|463888653|FG000|Continuation Period|Withdrawal by Subject|3|||
128888419|NCT02748018|463888654|FG001|Continuation Period|Withdrawal by Subject|5|||
128888420|NCT02748018|463888655|FG002|Continuation Period|Withdrawal by Subject|3|||
128888421|NCT02748018|463888656|FG003|Continuation Period|Withdrawal by Subject|9|||
128888422|NCT02748018|463888657|FG004|Continuation Period|Withdrawal by Subject|11|||
128888423|NCT02748018|463888658|FG005|Continuation Period|Withdrawal by Subject|1|||
128888424|NCT02748018|463888653|FG000|Continuation Period|Lost to Follow-up|0|||
128888425|NCT02748018|463888654|FG001|Continuation Period|Lost to Follow-up|2|||
128888426|NCT02748018|463888655|FG002|Continuation Period|Lost to Follow-up|1|||
128888427|NCT02748018|463888656|FG003|Continuation Period|Lost to Follow-up|0|||
128888428|NCT02748018|463888657|FG004|Continuation Period|Lost to Follow-up|1|||
128888429|NCT02748018|463888658|FG005|Continuation Period|Lost to Follow-up|0|||
128888430|NCT02748018|463888653|FG000|Continuation Period|Pregnancy|1|||
128888431|NCT02748018|463888654|FG001|Continuation Period|Pregnancy|2|||
128888432|NCT02748018|463888655|FG002|Continuation Period|Pregnancy|0|||
128888433|NCT02748018|463888656|FG003|Continuation Period|Pregnancy|0|||
128888434|NCT02748018|463888657|FG004|Continuation Period|Pregnancy|0|||
128888435|NCT02748018|463888658|FG005|Continuation Period|Pregnancy|0|||
128888436|NCT02748018|463888653|FG000|Continuation Period|Physician Decision|0|||
128888437|NCT02748018|463888654|FG001|Continuation Period|Physician Decision|1|||
128888438|NCT02748018|463888655|FG002|Continuation Period|Physician Decision|2|||
128888439|NCT02748018|463888656|FG003|Continuation Period|Physician Decision|0|||
128888440|NCT02748018|463888657|FG004|Continuation Period|Physician Decision|2|||
128888441|NCT02748018|463888658|FG005|Continuation Period|Physician Decision|1|||
128888442|NCT02748018|463888653|FG000|Continuation Period|Protocol Violation|0|||
128888443|NCT02748018|463888654|FG001|Continuation Period|Protocol Violation|1|||
128888444|NCT02748018|463888655|FG002|Continuation Period|Protocol Violation|0|||
128888445|NCT02748018|463888656|FG003|Continuation Period|Protocol Violation|0|||
128888446|NCT02748018|463888657|FG004|Continuation Period|Protocol Violation|0|||
128888447|NCT02748018|463888658|FG005|Continuation Period|Protocol Violation|0|||
128888448|NCT05696236|463888661|FG000|Overall Study|Lost to Follow-up|1|||
128888449|NCT05696236|463888662|FG001|Overall Study|Lost to Follow-up|0|||
128888450|NCT05696236|463888661|FG000|Overall Study|Later determined to not be eligible for participation|0|||
128888451|NCT05696236|463888662|FG001|Overall Study|Later determined to not be eligible for participation|1|||
128888452|NCT05696236|463888661|FG000|Overall Study|Withdrawal by Subject|2|||
128888453|NCT05696236|463888662|FG001|Overall Study|Withdrawal by Subject|2|||
128888454|NCT00867113|463888665|FG000|Treatment Period|Adverse Event|15|||
128687916|NCT02556203|463157056|FG000|Overall Study|Lost to Follow-up|5|||
128687917|NCT02556203|463157057|FG001|Overall Study|Lost to Follow-up|5|||
128687918|NCT02556203|463157056|FG000|Overall Study|Adverse Event|1|||
128687919|NCT02556203|463157057|FG001|Overall Study|Adverse Event|0|||
128687920|NCT03875768|463157061|FG000|Overall Study|Lost to Follow-up|16|||
128687921|NCT03875768|463157062|FG001|Overall Study|Lost to Follow-up|13|||
128687922|NCT03875768|463157061|FG000|Overall Study|Withdrawal by Subject|10|||
128687923|NCT03875768|463157062|FG001|Overall Study|Withdrawal by Subject|21|||
128687924|NCT03875768|463157061|FG000|Overall Study|Did not complete assessment|21|||
128687925|NCT03875768|463157062|FG001|Overall Study|Did not complete assessment|12|||
128687926|NCT03875768|463157061|FG000|Overall Study|Became ineligible|1|||
128687927|NCT03875768|463157062|FG001|Overall Study|Became ineligible|0|||
128687928|NCT00723398|463157063|FG000|Overall Study|Withdrawal by Subject|2|||
128687929|NCT00723398|463157064|FG001|Overall Study|Withdrawal by Subject|6|||
128687930|NCT00723398|463157065|FG002|Overall Study|Withdrawal by Subject|4|||
128687931|NCT00723398|463157066|FG003|Overall Study|Withdrawal by Subject|4|||
128687932|NCT00723398|463157067|FG004|Overall Study|Withdrawal by Subject|4|||
128687933|NCT00723398|463157063|FG000|Overall Study|Protocol Violation|2|||
128687934|NCT00723398|463157064|FG001|Overall Study|Protocol Violation|1|||
128888455|NCT00867113|463888665|FG000|Treatment Period|Death|2|||
128888456|NCT00867113|463888665|FG000|Treatment Period|Withdrawal by Subject|19|||
128888457|NCT00867113|463888665|FG000|Treatment Period|Lost to Follow-up|3|||
128888458|NCT00867113|463888665|FG000|Treatment Period|Administrative problems|1|||
128888459|NCT00867113|463888665|FG000|Treatment Period|Disease progression/relapse|1|||
128888460|NCT00867113|463888665|FG000|Treatment Period|Protocol Violation|4|||
128888461|NCT00867113|463888665|FG000|Post Treatment After Survival Follow-up|Death|1|||
128888462|NCT00867113|463888665|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
128888463|NCT00867113|463888665|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
128888464|NCT00867113|463888665|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
128888465|NCT01145495|463888666|FG000|Overall Study|Adverse Event|6|||
128888466|NCT01145495|463888666|FG000|Overall Study|Withdrawal by Subject|6|||
128888467|NCT01145495|463888666|FG000|Overall Study|Disease progression after respone|2|||
128888468|NCT01886313|463888667|FG000|Overall Study|Adverse Event|1|||
128888469|NCT01886313|463888668|FG001|Overall Study|Adverse Event|1|||
128888470|NCT00312221|463888669|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
128888471|NCT00312221|463888670|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
128888472|NCT00312221|463888671|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
128888473|NCT00312221|463888672|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
128888474|NCT00312221|463888669|FG000|Open-label Run-in Period|Adverse Event|74|||
128888475|NCT00312221|463888670|FG001|Open-label Run-in Period|Adverse Event|0|||
128888476|NCT00312221|463888671|FG002|Open-label Run-in Period|Adverse Event|0|||
128888477|NCT00312221|463888672|FG003|Open-label Run-in Period|Adverse Event|0|||
128888478|NCT00312221|463888669|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
128888479|NCT00312221|463888670|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
128888480|NCT00312221|463888671|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
128888481|NCT00312221|463888672|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
128888482|NCT00312221|463888669|FG000|Open-label Run-in Period|Administrative|42|||
128888483|NCT00312221|463888670|FG001|Open-label Run-in Period|Administrative|0|||
128888484|NCT00312221|463888671|FG002|Open-label Run-in Period|Administrative|0|||
128888485|NCT00312221|463888672|FG003|Open-label Run-in Period|Administrative|0|||
128888486|NCT00312221|463888669|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
128888487|NCT00312221|463888670|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
129109952|NCT02716779|464696027|FG000|Monotherapy|Adverse Event|0|||
129109953|NCT02716779|464696028|FG001|Monotherapy|Adverse Event|1|||
129109954|NCT02716779|464696029|FG002|Monotherapy|Adverse Event|1|||
129109955|NCT02716779|464696027|FG000|Combination Therapy|Adverse Event|0|||
129109956|NCT02716779|464696028|FG001|Combination Therapy|Adverse Event|2|||
129109957|NCT02716779|464696029|FG002|Combination Therapy|Adverse Event|1|||
129109958|NCT01843803|464696032|FG000|Overall Study|not a Veteran, did not see provider|1|||
129109959|NCT01843803|464696033|FG001|Overall Study|not a Veteran, did not see provider|3|||
129109960|NCT03311841|464696034|FG000|14-day Wash-out|Adverse Event|0|||
129109961|NCT03311841|464696035|FG001|14-day Wash-out|Adverse Event|1|||
129109962|NCT03311841|464696036|FG002|14-day Wash-out|Adverse Event|0|||
129109963|NCT03311841|464696037|FG003|14-day Wash-out|Adverse Event|0|||
129109964|NCT03311841|464696038|FG004|14-day Wash-out|Adverse Event|0|||
129109965|NCT03311841|464696034|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
129109966|NCT03311841|464696035|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
129109967|NCT03311841|464696036|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
129109968|NCT03311841|464696037|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
129109969|NCT03311841|464696038|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
129109970|NCT01051817|464696046|FG000|Overall Study|Adverse Event|0|||
129109971|NCT01051817|464696047|FG001|Overall Study|Adverse Event|2|||
129109972|NCT01051817|464696046|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
129109973|NCT01051817|464696047|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
129109974|NCT01051817|464696046|FG000|Overall Study|Withdrawal by Subject|3|||
129109975|NCT01051817|464696047|FG001|Overall Study|Withdrawal by Subject|5|||
129109976|NCT01051817|464696046|FG000|Overall Study|Protocol Violation|0|||
129109977|NCT01051817|464696047|FG001|Overall Study|Protocol Violation|1|||
129109978|NCT02686164|464696048|FG000|Overall Study|Adverse Event|1|||
129109979|NCT02686164|464696048|FG000|Overall Study|Withdrawal of consent|1|||
129109980|NCT02686164|464696048|FG000|Overall Study|Clinical progression|1|||
129109981|NCT00672633|464696051|FG000|Overall Study|Withdrawal by Subject|0|||
129109982|NCT00672633|464696052|FG001|Overall Study|Withdrawal by Subject|1|||
129109983|NCT02824627|464696053|FG000|Overall Study|Adverse Event|1|||
129109984|NCT02824627|464696054|FG001|Overall Study|Adverse Event|2|||
129109985|NCT02824627|464696053|FG000|Overall Study|Lost to Follow-up|2|||
129109986|NCT02824627|464696054|FG001|Overall Study|Lost to Follow-up|1|||
129109987|NCT01519817|464697784|FG000|Overall Study|Withdrawal by Subject|1|||
129109988|NCT01519817|464697785|FG001|Overall Study|Withdrawal by Subject|0|||
129109989|NCT01519817|464697786|FG002|Overall Study|Withdrawal by Subject|0|||
128687935|NCT00723398|463157065|FG002|Overall Study|Protocol Violation|5|||
128888488|NCT00312221|463888671|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
128888489|NCT00312221|463888672|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
129109990|NCT01519817|464697787|FG003|Overall Study|Withdrawal by Subject|0|||
129109991|NCT01519817|464697784|FG000|Overall Study|Off study due to infection|0|||
129109992|NCT01519817|464697785|FG001|Overall Study|Off study due to infection|0|||
129109993|NCT01519817|464697786|FG002|Overall Study|Off study due to infection|0|||
129109994|NCT01519817|464697787|FG003|Overall Study|Off study due to infection|1|||
129109995|NCT03234036|464697792|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
128888490|NCT00312221|463888669|FG000|Open-label Run-in Period|Did not qualify|5|||
128888491|NCT00312221|463888670|FG001|Open-label Run-in Period|Did not qualify|0|||
128888492|NCT00312221|463888671|FG002|Open-label Run-in Period|Did not qualify|0|||
128888493|NCT00312221|463888672|FG003|Open-label Run-in Period|Did not qualify|0|||
128888494|NCT00312221|463888669|FG000|Double-blind Phase|Withdrawal by Subject|0|||
128888495|NCT00312221|463888670|FG001|Double-blind Phase|Withdrawal by Subject|6|||
128888496|NCT00312221|463888671|FG002|Double-blind Phase|Withdrawal by Subject|8|||
128888497|NCT00312221|463888672|FG003|Double-blind Phase|Withdrawal by Subject|7|||
128888498|NCT00312221|463888669|FG000|Double-blind Phase|Adverse Event|0|||
128888499|NCT00312221|463888670|FG001|Double-blind Phase|Adverse Event|10|||
128888500|NCT00312221|463888671|FG002|Double-blind Phase|Adverse Event|19|||
128888501|NCT00312221|463888672|FG003|Double-blind Phase|Adverse Event|18|||
128888502|NCT00312221|463888669|FG000|Double-blind Phase|Lost to Follow-up|0|||
128888503|NCT00312221|463888670|FG001|Double-blind Phase|Lost to Follow-up|0|||
128888504|NCT00312221|463888671|FG002|Double-blind Phase|Lost to Follow-up|2|||
128888505|NCT00312221|463888672|FG003|Double-blind Phase|Lost to Follow-up|2|||
128888506|NCT00312221|463888669|FG000|Double-blind Phase|Administrative|0|||
128888507|NCT00312221|463888670|FG001|Double-blind Phase|Administrative|26|||
128888508|NCT00312221|463888671|FG002|Double-blind Phase|Administrative|37|||
128888509|NCT00312221|463888672|FG003|Double-blind Phase|Administrative|33|||
128888510|NCT00312221|463888669|FG000|Double-blind Phase|Lack of Efficacy|0|||
128888511|NCT00312221|463888670|FG001|Double-blind Phase|Lack of Efficacy|17|||
128888512|NCT00312221|463888671|FG002|Double-blind Phase|Lack of Efficacy|6|||
128888513|NCT00312221|463888672|FG003|Double-blind Phase|Lack of Efficacy|10|||
128888514|NCT02060721|463888673|FG000|Overall Study|Lost to Follow-up|1|||
128888515|NCT02060721|463888673|FG000|Overall Study|Physician Decision|2|||
128888516|NCT02060721|463888673|FG000|Overall Study|Death|14|||
128888517|NCT02060721|463888673|FG000|Overall Study|Withdrawal by Subject|2|||
128888518|NCT02060721|463888673|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
128888519|NCT00117507|463888674|FG000|Overall Study|Adverse Event|4|||
128888520|NCT00117507|463888674|FG000|Overall Study|Abnormal laboratory values|3|||
128888521|NCT00117507|463888674|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128888522|NCT00117507|463888674|FG000|Overall Study|Patient withdrew consent|4|||
128888523|NCT00117507|463888674|FG000|Overall Study|Death|3|||
128888524|NCT05105789|463888675|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
128888525|NCT01003990|463888678|FG000|Overall Study|Adverse Event|8|||
128888526|NCT01003990|463888679|FG001|Overall Study|Adverse Event|5|||
128888527|NCT01003990|463888680|FG002|Overall Study|Adverse Event|11|||
128888528|NCT01003990|463888678|FG000|Overall Study|Death|0|||
128888529|NCT01003990|463888679|FG001|Overall Study|Death|8|||
128888530|NCT01003990|463888680|FG002|Overall Study|Death|1|||
128888531|NCT01003990|463888678|FG000|Overall Study|Lack of Efficacy|10|||
128888532|NCT01003990|463888679|FG001|Overall Study|Lack of Efficacy|2|||
128888533|NCT01003990|463888680|FG002|Overall Study|Lack of Efficacy|3|||
128888534|NCT01003990|463888678|FG000|Overall Study|Lost to Follow-up|30|||
128888535|NCT01003990|463888679|FG001|Overall Study|Lost to Follow-up|12|||
128888536|NCT01003990|463888680|FG002|Overall Study|Lost to Follow-up|7|||
128888537|NCT01003990|463888678|FG000|Overall Study|Reasons Not Identified|14|||
128888538|NCT01003990|463888679|FG001|Overall Study|Reasons Not Identified|13|||
128888539|NCT01003990|463888680|FG002|Overall Study|Reasons Not Identified|8|||
128888540|NCT01003990|463888678|FG000|Overall Study|Poor/Non-compliance|4|||
128888541|NCT01003990|463888679|FG001|Overall Study|Poor/Non-compliance|3|||
128888542|NCT01003990|463888680|FG002|Overall Study|Poor/Non-compliance|2|||
128888543|NCT01003990|463888678|FG000|Overall Study|Pregnancy|10|||
128888544|NCT01003990|463888679|FG001|Overall Study|Pregnancy|2|||
128888545|NCT01003990|463888680|FG002|Overall Study|Pregnancy|4|||
128888546|NCT01003990|463888678|FG000|Overall Study|No Longer Met Study Criteria|4|||
128888547|NCT01003990|463888679|FG001|Overall Study|No Longer Met Study Criteria|1|||
128888548|NCT01003990|463888680|FG002|Overall Study|No Longer Met Study Criteria|0|||
128888549|NCT01003990|463888678|FG000|Overall Study|Subject Withdrew Consent|12|||
128888550|NCT01003990|463888679|FG001|Overall Study|Subject Withdrew Consent|5|||
128888551|NCT01003990|463888680|FG002|Overall Study|Subject Withdrew Consent|7|||
128888552|NCT00634010|463888686|FG000|Overall Study|Adverse Event|2|||
128888553|NCT00634010|463888687|FG001|Overall Study|Adverse Event|5|||
128888554|NCT00634010|463888686|FG000|Overall Study|Withdrawal by Subject|5|||
128888555|NCT00634010|463888687|FG001|Overall Study|Withdrawal by Subject|6|||
128888556|NCT00634010|463888686|FG000|Overall Study|Physician Decision|1|||
128888557|NCT00634010|463888687|FG001|Overall Study|Physician Decision|1|||
128888558|NCT00634010|463888686|FG000|Overall Study|Disease Progression|1|||
128888559|NCT00634010|463888687|FG001|Overall Study|Disease Progression|1|||
128888560|NCT00634010|463888686|FG000|Overall Study|Non-Compliant|1|||
128888561|NCT00634010|463888687|FG001|Overall Study|Non-Compliant|1|||
128888562|NCT03690141|463888691|FG000|Overall Study|Adverse Event|5|||
128888563|NCT03690141|463888691|FG000|Overall Study|Withdrawal by Subject|3|||
128888564|NCT03690141|463888691|FG000|Overall Study|Physician Decision|4|||
128888565|NCT03690141|463888691|FG000|Overall Study|Disease progression|4|||
128888566|NCT01807923|463888692|FG000|Overall Study|Adverse Event|2|||
128888567|NCT01807923|463888693|FG001|Overall Study|Adverse Event|1|||
128888568|NCT01807923|463888694|FG002|Overall Study|Adverse Event|2|||
128888569|NCT01807923|463888692|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
128888570|NCT01807923|463888693|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
128687936|NCT00723398|463157066|FG003|Overall Study|Protocol Violation|0|||
128687937|NCT00723398|463157067|FG004|Overall Study|Protocol Violation|0|||
128687938|NCT00723398|463157063|FG000|Overall Study|Physician Decision|2|||
128687939|NCT00723398|463157064|FG001|Overall Study|Physician Decision|2|||
128687940|NCT00723398|463157065|FG002|Overall Study|Physician Decision|5|||
128687941|NCT00723398|463157066|FG003|Overall Study|Physician Decision|0|||
128687942|NCT00723398|463157067|FG004|Overall Study|Physician Decision|1|||
128687943|NCT00723398|463157063|FG000|Overall Study|Adverse Event|0|||
128687944|NCT00723398|463157064|FG001|Overall Study|Adverse Event|5|||
128687945|NCT00723398|463157065|FG002|Overall Study|Adverse Event|3|||
128687946|NCT00723398|463157066|FG003|Overall Study|Adverse Event|1|||
128687947|NCT00723398|463157067|FG004|Overall Study|Adverse Event|4|||
128687948|NCT00723398|463157063|FG000|Overall Study|Lost to Follow-up|0|||
128687949|NCT00723398|463157064|FG001|Overall Study|Lost to Follow-up|1|||
128687950|NCT00723398|463157065|FG002|Overall Study|Lost to Follow-up|0|||
128687951|NCT00723398|463157066|FG003|Overall Study|Lost to Follow-up|0|||
128687952|NCT00723398|463157067|FG004|Overall Study|Lost to Follow-up|0|||
128687953|NCT01578330|463157070|FG000|Overall Study|Adverse Event|2|||
128687954|NCT01578330|463157070|FG000|Overall Study|Protocol Violation|5|||
128687955|NCT03053271|463157073|FG000|Overall Study|Did not meet randomization criteria|3|||
128687956|NCT03053271|463157073|FG000|Overall Study|Withdrawal by Subject|1|||
128687957|NCT00580970|463157074|FG000|Pre-treatment|Non-compliance|1|||
128687958|NCT00580970|463157074|FG000|Treatment (Lovastatin)|Non-compliance|6|||
128687959|NCT00580970|463157074|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
128687960|NCT00580970|463157074|FG000|Treatment (Lovastatin)|Physician Decision|4|||
128687961|NCT00580970|463157074|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
128687962|NCT00580970|463157074|FG000|Treatment (Lovastatin)|Death|1|||
128687963|NCT01086423|463157075|FG000|Overall Study|Protocol Violation|0|||
128687964|NCT01086423|463157076|FG001|Overall Study|Protocol Violation|0|||
128687965|NCT01086423|463157077|FG002|Overall Study|Protocol Violation|1|||
128687966|NCT01086423|463157075|FG000|Overall Study|Migrated/moved from study area|2|||
128687967|NCT01086423|463157076|FG001|Overall Study|Migrated/moved from study area|0|||
128687968|NCT01086423|463157077|FG002|Overall Study|Migrated/moved from study area|4|||
128687969|NCT01086423|463157075|FG000|Overall Study|Adverse event, fatal|1|||
128687970|NCT01086423|463157076|FG001|Overall Study|Adverse event, fatal|1|||
128687971|NCT01086423|463157077|FG002|Overall Study|Adverse event, fatal|0|||
128687972|NCT01086423|463157075|FG000|Overall Study|Adverse event, non-fatal|2|||
128687973|NCT01086423|463157076|FG001|Overall Study|Adverse event, non-fatal|1|||
128687974|NCT01086423|463157077|FG002|Overall Study|Adverse event, non-fatal|0|||
128687975|NCT01086423|463157075|FG000|Overall Study|Withdrawal by Subject|5|||
128687976|NCT01086423|463157076|FG001|Overall Study|Withdrawal by Subject|1|||
128687977|NCT01086423|463157077|FG002|Overall Study|Withdrawal by Subject|3|||
128687978|NCT01086423|463157075|FG000|Overall Study|Lost to Follow-up|0|||
128687979|NCT01086423|463157076|FG001|Overall Study|Lost to Follow-up|0|||
128687980|NCT01086423|463157077|FG002|Overall Study|Lost to Follow-up|1|||
128687981|NCT03114488|463157078|FG000|Time Period 2|Withdrawal by Subject|1|||
128687982|NCT03114488|463157079|FG001|Time Period 2|Withdrawal by Subject|3|||
128687983|NCT01225887|463157080|FG000|Overall Study|Ineligible:required test not done|2|||
128687984|NCT01225887|463157080|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
128687985|NCT01225887|463157080|FG000|Overall Study|Ineligible:inadequate pathology|2|||
128687986|NCT01669928|463157081|FG000|First Intervention|Withdrawal by Subject|3|||
128687987|NCT01669928|463157082|FG001|First Intervention|Withdrawal by Subject|5|||
128687988|NCT00737438|463157087|FG000|Overall Study|Withdrawal by Subject|2|||
128687989|NCT00737438|463157087|FG000|Overall Study|Patient ineligible|1|||
128687990|NCT04950166|463157093|FG000|Overall Study|Withdrawal by Subject|1|||
128687991|NCT01822678|463157098|FG000|Overall Study|Withdrawal by Subject|5|||
128687992|NCT01822678|463157099|FG001|Overall Study|Withdrawal by Subject|4|||
128687993|NCT01822678|463157100|FG002|Overall Study|Withdrawal by Subject|4|||
128763812|NCT01674621|463425798|FG004|Overall Study|Inability to Complete Study Procedures|2|||
129215188|NCT02002598|465089457|FG001|Dose Level 1|Withdrawal by Subject|0|||
128687994|NCT01822678|463157098|FG000|Overall Study|Adverse Event|4|||
128687995|NCT01822678|463157099|FG001|Overall Study|Adverse Event|3|||
128687996|NCT01822678|463157100|FG002|Overall Study|Adverse Event|1|||
128687997|NCT01822678|463157098|FG000|Overall Study|Lack of Efficacy|3|||
128687998|NCT01822678|463157099|FG001|Overall Study|Lack of Efficacy|6|||
128687999|NCT01822678|463157100|FG002|Overall Study|Lack of Efficacy|5|||
128688000|NCT01822678|463157098|FG000|Overall Study|Lost to Follow-up|0|||
128688001|NCT01822678|463157099|FG001|Overall Study|Lost to Follow-up|2|||
128688002|NCT01822678|463157100|FG002|Overall Study|Lost to Follow-up|1|||
128688003|NCT00381381|463157106|FG000|Overall Study|Adverse Event|3|||
128688004|NCT00381381|463157106|FG000|Overall Study|Lost to Follow-up|52|||
128688005|NCT00381381|463157106|FG000|Overall Study|Withdrawal by Subject|9|||
128688006|NCT01638819|463157113|FG000|Overall Study|Lost to Follow-up|1|||
128688007|NCT01638819|463157114|FG001|Overall Study|Lost to Follow-up|0|||
128688008|NCT00237185|463157115|FG000|Core|Adverse Event|3|||
128688009|NCT00237185|463157116|FG001|Core|Adverse Event|4|||
128688010|NCT00237185|463157115|FG000|Core|Abnormal laboratory value|0|||
128688011|NCT00237185|463157116|FG001|Core|Abnormal laboratory value|4|||
128688012|NCT00237185|463157115|FG000|Core|Abnormal test procedure results|1|||
128688013|NCT00237185|463157116|FG001|Core|Abnormal test procedure results|0|||
128688014|NCT00237185|463157115|FG000|Core|Lack of Efficacy|30|||
128688015|NCT00237185|463157116|FG001|Core|Lack of Efficacy|23|||
128688016|NCT00237185|463157115|FG000|Core|Protocol Violation|1|||
128688017|NCT00237185|463157116|FG001|Core|Protocol Violation|1|||
128688018|NCT00237185|463157115|FG000|Core|Withdrawal by Subject|4|||
128688019|NCT00237185|463157116|FG001|Core|Withdrawal by Subject|4|||
128688020|NCT00237185|463157115|FG000|Core|Administrative problems|0|||
128688021|NCT00237185|463157116|FG001|Core|Administrative problems|1|||
128688022|NCT00237185|463157115|FG000|Core|Death|4|||
128688023|NCT00237185|463157116|FG001|Core|Death|0|||
128688024|NCT00237185|463157115|FG000|Core|Determined ineligible post randomization|1|||
128688025|NCT00237185|463157116|FG001|Core|Determined ineligible post randomization|0|||
128688026|NCT00237185|463157115|FG000|Extension|Adverse Event|1|||
128688027|NCT00237185|463157116|FG001|Extension|Adverse Event|0|||
128688028|NCT00237185|463157115|FG000|Extension|Abnormal laboratory value|0|||
128688029|NCT00237185|463157116|FG001|Extension|Abnormal laboratory value|1|||
128688030|NCT00237185|463157115|FG000|Extension|Lack of Efficacy|9|||
128688031|NCT00237185|463157116|FG001|Extension|Lack of Efficacy|14|||
128688032|NCT00237185|463157115|FG000|Extension|Condition no longer required study drug|0|||
128688033|NCT00237185|463157116|FG001|Extension|Condition no longer required study drug|1|||
128688034|NCT00237185|463157115|FG000|Extension|Withdrawal by Subject|3|||
128688035|NCT00237185|463157116|FG001|Extension|Withdrawal by Subject|2|||
128688036|NCT00237185|463157115|FG000|Extension|Lost to Follow-up|1|||
128688037|NCT00237185|463157116|FG001|Extension|Lost to Follow-up|0|||
128688038|NCT00237185|463157115|FG000|Extension|Administrative problems|1|||
128688039|NCT00237185|463157116|FG001|Extension|Administrative problems|0|||
128688040|NCT00237185|463157115|FG000|Extension|Death|1|||
128688041|NCT00237185|463157116|FG001|Extension|Death|1|||
128688042|NCT02001181|463157122|FG000|Overall Study|Adverse Event|0|||
128688043|NCT02001181|463157123|FG001|Overall Study|Adverse Event|2|||
128688044|NCT02001181|463157122|FG000|Overall Study|Lost to Follow-up|1|||
128688045|NCT02001181|463157123|FG001|Overall Study|Lost to Follow-up|0|||
128688046|NCT02001181|463157122|FG000|Overall Study|Withdrawal by Subject|0|||
128688047|NCT02001181|463157123|FG001|Overall Study|Withdrawal by Subject|1|||
128688048|NCT00292318|463157125|FG000|Overall Study|Study terminated by officials|2|||
128688049|NCT00292318|463157126|FG001|Overall Study|Study terminated by officials|1|||
128688050|NCT00771316|463157127|FG000|Overall Study|Adverse Event|0|||
128688051|NCT00771316|463157128|FG001|Overall Study|Adverse Event|1|||
128688052|NCT00771316|463157127|FG000|Overall Study|Patient withdrew consent|1|||
128688053|NCT00771316|463157128|FG001|Overall Study|Patient withdrew consent|0|||
128688054|NCT00771316|463157127|FG000|Overall Study|Discontinued due to early termination|1|||
128688055|NCT00771316|463157128|FG001|Overall Study|Discontinued due to early termination|0|||
128688056|NCT02027376|463157129|FG000|Overall Study|Death|1|||
128688057|NCT02027376|463157130|FG001|Overall Study|Death|0|||
128688058|NCT02027376|463157131|FG002|Overall Study|Death|0|||
128688059|NCT00843726|463157132|FG000|Overall Study|Death|1|||
128688060|NCT00843726|463157133|FG001|Overall Study|Death|0|||
128688061|NCT00843726|463157132|FG000|Overall Study|Withdrawal by Subject|0|||
128688062|NCT00843726|463157133|FG001|Overall Study|Withdrawal by Subject|1|||
128888571|NCT01807923|463888694|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
128888572|NCT01807923|463888692|FG000|Overall Study|Physician Decision|0|||
128888573|NCT01807923|463888693|FG001|Overall Study|Physician Decision|0|||
128888574|NCT01807923|463888694|FG002|Overall Study|Physician Decision|1|||
128763813|NCT01674621|463425794|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
128763814|NCT01674621|463425795|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
128888575|NCT01807923|463888692|FG000|Overall Study|Not Eligible (Genotype)|0|||
128688063|NCT00406718|463157134|FG000|Overall Study|Withdrawal by Subject|2|||
128688064|NCT00406718|463157135|FG001|Overall Study|Withdrawal by Subject|9|||
128688065|NCT00406718|463157136|FG002|Overall Study|Withdrawal by Subject|4|||
128688066|NCT00406718|463157134|FG000|Overall Study|Lost to Follow-up|2|||
128688067|NCT00406718|463157135|FG001|Overall Study|Lost to Follow-up|5|||
128688068|NCT00406718|463157136|FG002|Overall Study|Lost to Follow-up|4|||
128688069|NCT02891161|463157139|FG000|Study Treatment|Disease Progression|2|||
128688070|NCT02891161|463157140|FG001|Study Treatment|Disease Progression|4|||
128688071|NCT02891161|463157139|FG000|Study Treatment|AE/Side Effects/Complications|1|||
128688072|NCT02891161|463157140|FG001|Study Treatment|AE/Side Effects/Complications|5|||
128688073|NCT02891161|463157139|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
128688074|NCT02891161|463157140|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
128688075|NCT02891161|463157139|FG000|Follow up|Death|4|||
128688076|NCT02891161|463157140|FG001|Follow up|Death|8|||
128688077|NCT02891161|463157139|FG000|Follow up|Refused to Follow up|0|||
128688078|NCT02891161|463157140|FG001|Follow up|Refused to Follow up|2|||
128688079|NCT02891161|463157139|FG000|Follow up|Symptomatic deterioration|0|||
128688080|NCT02891161|463157140|FG001|Follow up|Symptomatic deterioration|1|||
128688081|NCT02891161|463157139|FG000|Follow up|Study terminated|0|||
128688082|NCT02891161|463157140|FG001|Follow up|Study terminated|6|||
128888576|NCT01807923|463888693|FG001|Overall Study|Not Eligible (Genotype)|0|||
128888577|NCT01807923|463888694|FG002|Overall Study|Not Eligible (Genotype)|1|||
128888578|NCT01807923|463888692|FG000|Overall Study|Randomized But Not Treated|3|||
128888579|NCT01807923|463888693|FG001|Overall Study|Randomized But Not Treated|2|||
128888580|NCT01807923|463888694|FG002|Overall Study|Randomized But Not Treated|5|||
128888581|NCT01272947|463888696|FG000|Overall Study|Abnormal Laboratory Value|2|||
128888582|NCT01272947|463888697|FG001|Overall Study|Abnormal Laboratory Value|2|||
128888583|NCT02019420|463888701|FG000|Overall Study|Did not receive study drug|2|||
128888584|NCT02019420|463888702|FG001|Overall Study|Did not receive study drug|2|||
128888585|NCT02019420|463888701|FG000|Overall Study|Withdrawal by Subject|1|||
128888586|NCT02019420|463888702|FG001|Overall Study|Withdrawal by Subject|3|||
128888587|NCT02019420|463888701|FG000|Overall Study|At request of sponsor or investigator|0|||
128888588|NCT02019420|463888702|FG001|Overall Study|At request of sponsor or investigator|1|||
128888589|NCT02019420|463888701|FG000|Overall Study|Death|104|||
128888590|NCT02019420|463888702|FG001|Overall Study|Death|99|||
128888591|NCT02019420|463888701|FG000|Overall Study|Transferred to other care facility|1|||
128888592|NCT02019420|463888702|FG001|Overall Study|Transferred to other care facility|1|||
128888593|NCT02510560|463888703|FG000|Overall Study|Discontinued from Treatment|27|||
128888594|NCT02510560|463888704|FG001|Overall Study|Discontinued from Treatment|18|||
128888595|NCT02510560|463888705|FG002|Overall Study|Discontinued from Treatment|19|||
128888596|NCT02510560|463888703|FG000|Overall Study|Other|4|||
128888597|NCT02510560|463888704|FG001|Overall Study|Other|4|||
128888598|NCT02510560|463888705|FG002|Overall Study|Other|3|||
128888599|NCT00132496|463888706|FG000|Overall Study|Withdrawal by Subject|1|||
128888600|NCT00132496|463888707|FG001|Overall Study|Withdrawal by Subject|2|||
128888601|NCT00132496|463888706|FG000|Overall Study|Physician Decision|1|||
128888602|NCT00132496|463888707|FG001|Overall Study|Physician Decision|0|||
128888603|NCT01093625|463888712|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
128888604|NCT01093625|463888713|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
128888605|NCT01093625|463888712|FG000|2-Week Visit|Withdrawal by Subject|1|||
128888606|NCT01093625|463888713|FG001|2-Week Visit|Withdrawal by Subject|0|||
128888607|NCT01093625|463888712|FG000|1-Month Visit|Lost to Follow-up|2|||
128888608|NCT01093625|463888713|FG001|1-Month Visit|Lost to Follow-up|0|||
128888609|NCT01093625|463888712|FG000|3-Month Visit|Lost to Follow-up|2|||
128888610|NCT01093625|463888713|FG001|3-Month Visit|Lost to Follow-up|0|||
128888611|NCT01093625|463888712|FG000|6-Month Visit|Withdrawal by Subject|6|||
128888612|NCT01093625|463888713|FG001|6-Month Visit|Withdrawal by Subject|7|||
128888613|NCT01093625|463888712|FG000|6-Month Visit|Lost to Follow-up|2|||
128888614|NCT01093625|463888713|FG001|6-Month Visit|Lost to Follow-up|2|||
128888615|NCT01093625|463888712|FG000|1-Year Visit|Lost to Follow-up|5|||
128888616|NCT01093625|463888713|FG001|1-Year Visit|Lost to Follow-up|3|||
128888617|NCT02014740|463888714|FG000|Overall Study|Lost to Follow-up|4|||
128888618|NCT02014740|463888715|FG001|Overall Study|Lost to Follow-up|4|||
128888619|NCT02014740|463888714|FG000|Overall Study|Withdrawal by Subject|2|||
128888620|NCT02014740|463888715|FG001|Overall Study|Withdrawal by Subject|1|||
128888621|NCT01431534|463888716|FG000|Treatment Phase|Adverse Event|0|||
128888622|NCT01431534|463888717|FG001|Treatment Phase|Adverse Event|0|||
128888623|NCT01431534|463888718|FG002|Treatment Phase|Adverse Event|1|||
128888624|NCT01431534|463888716|FG000|Treatment Phase|Progressive Disease|4|||
128888625|NCT01431534|463888717|FG001|Treatment Phase|Progressive Disease|3|||
128888626|NCT01431534|463888718|FG002|Treatment Phase|Progressive Disease|10|||
128888627|NCT02554903|463888721|FG000|Overall Study|Death|1|||
128888628|NCT02554903|463888722|FG001|Overall Study|Death|1|||
128888629|NCT02554903|463888721|FG000|Overall Study|Physician Decision|2|||
128888630|NCT02554903|463888722|FG001|Overall Study|Physician Decision|2|||
128888631|NCT02554903|463888721|FG000|Overall Study|Heart Transplant|1|||
128888632|NCT02554903|463888722|FG001|Overall Study|Heart Transplant|2|||
128888633|NCT02742766|463888723|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888634|NCT02742766|463888724|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888635|NCT02742766|463888725|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888636|NCT02742766|463888726|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888637|NCT02742766|463888727|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888638|NCT02742766|463888728|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128688083|NCT04755283|463157141|FG000|Overall Study|Withdrawal by Subject|14|||
128888639|NCT02742766|463888729|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888640|NCT02742766|463888730|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888641|NCT02742766|463888731|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888642|NCT02742766|463888732|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888643|NCT02742766|463888733|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888644|NCT02742766|463888734|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888645|NCT02742766|463888735|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888646|NCT02742766|463888736|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
128888647|NCT02742766|463888737|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888648|NCT02742766|463888738|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888649|NCT02742766|463888739|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888650|NCT02742766|463888740|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888651|NCT02742766|463888741|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
128888652|NCT02742766|463888723|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888653|NCT02742766|463888724|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888654|NCT02742766|463888725|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888655|NCT02742766|463888726|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888656|NCT02742766|463888727|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888657|NCT02742766|463888728|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888658|NCT02742766|463888729|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888659|NCT02742766|463888730|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888660|NCT02742766|463888731|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888661|NCT02742766|463888732|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888662|NCT02742766|463888733|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888663|NCT02742766|463888734|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888664|NCT02742766|463888735|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
128888665|NCT02742766|463888736|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
128888666|NCT02742766|463888737|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888667|NCT02742766|463888738|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
128888668|NCT02742766|463888739|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888669|NCT02742766|463888740|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888670|NCT02742766|463888741|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
128888671|NCT04427501|463888742|FG000|Overall Study|Death|0|||
128888672|NCT04427501|463888743|FG001|Overall Study|Death|0|||
128888673|NCT04427501|463888744|FG002|Overall Study|Death|0|||
128888674|NCT04427501|463888745|FG003|Overall Study|Death|0|||
128888675|NCT04427501|463888746|FG004|Overall Study|Death|0|||
128888676|NCT04427501|463888747|FG005|Overall Study|Death|15|||
128888677|NCT04427501|463888748|FG006|Overall Study|Death|0|||
128888678|NCT04427501|463888749|FG007|Overall Study|Death|0|||
128888679|NCT04427501|463888750|FG008|Overall Study|Death|0|||
128888680|NCT04427501|463888751|FG009|Overall Study|Death|0|||
128888681|NCT04427501|463888752|FG010|Overall Study|Death|0|||
128888682|NCT04427501|463888753|FG011|Overall Study|Death|0|||
128888683|NCT04427501|463888742|FG000|Overall Study|Lost to Follow-up|5|||
128888684|NCT04427501|463888743|FG001|Overall Study|Lost to Follow-up|1|||
128888685|NCT04427501|463888744|FG002|Overall Study|Lost to Follow-up|2|||
128888686|NCT04427501|463888745|FG003|Overall Study|Lost to Follow-up|0|||
128888687|NCT04427501|463888746|FG004|Overall Study|Lost to Follow-up|2|||
128888688|NCT04427501|463888747|FG005|Overall Study|Lost to Follow-up|11|||
128888689|NCT04427501|463888748|FG006|Overall Study|Lost to Follow-up|10|||
128888690|NCT04427501|463888749|FG007|Overall Study|Lost to Follow-up|10|||
128888691|NCT04427501|463888750|FG008|Overall Study|Lost to Follow-up|2|||
128888692|NCT04427501|463888751|FG009|Overall Study|Lost to Follow-up|5|||
128888693|NCT04427501|463888752|FG010|Overall Study|Lost to Follow-up|2|||
128888694|NCT04427501|463888753|FG011|Overall Study|Lost to Follow-up|0|||
128888695|NCT04427501|463888742|FG000|Overall Study|Physician Decision|0|||
128888696|NCT04427501|463888743|FG001|Overall Study|Physician Decision|3|||
128888697|NCT04427501|463888744|FG002|Overall Study|Physician Decision|0|||
128888698|NCT04427501|463888745|FG003|Overall Study|Physician Decision|0|||
128888699|NCT04427501|463888746|FG004|Overall Study|Physician Decision|0|||
128888700|NCT04427501|463888747|FG005|Overall Study|Physician Decision|0|||
128888701|NCT04427501|463888748|FG006|Overall Study|Physician Decision|2|||
128888702|NCT04427501|463888749|FG007|Overall Study|Physician Decision|0|||
128888703|NCT04427501|463888750|FG008|Overall Study|Physician Decision|0|||
128888704|NCT04427501|463888751|FG009|Overall Study|Physician Decision|0|||
128888705|NCT04427501|463888752|FG010|Overall Study|Physician Decision|0|||
128888706|NCT04427501|463888753|FG011|Overall Study|Physician Decision|0|||
128888707|NCT04427501|463888742|FG000|Overall Study|Withdrawal by Subject|9|||
128888708|NCT04427501|463888743|FG001|Overall Study|Withdrawal by Subject|2|||
128888709|NCT04427501|463888744|FG002|Overall Study|Withdrawal by Subject|2|||
128888710|NCT04427501|463888745|FG003|Overall Study|Withdrawal by Subject|3|||
128888711|NCT04427501|463888746|FG004|Overall Study|Withdrawal by Subject|7|||
128888712|NCT04427501|463888747|FG005|Overall Study|Withdrawal by Subject|25|||
128888713|NCT04427501|463888748|FG006|Overall Study|Withdrawal by Subject|15|||
128888714|NCT04427501|463888749|FG007|Overall Study|Withdrawal by Subject|7|||
128888715|NCT04427501|463888750|FG008|Overall Study|Withdrawal by Subject|4|||
128888716|NCT04427501|463888751|FG009|Overall Study|Withdrawal by Subject|1|||
128888717|NCT04427501|463888752|FG010|Overall Study|Withdrawal by Subject|4|||
128888718|NCT04427501|463888753|FG011|Overall Study|Withdrawal by Subject|0|||
128888719|NCT04427501|463888742|FG000|Overall Study|Other - as reported by the investigator|1|||
128888720|NCT04427501|463888743|FG001|Overall Study|Other - as reported by the investigator|0|||
128888721|NCT04427501|463888744|FG002|Overall Study|Other - as reported by the investigator|0|||
128888722|NCT04427501|463888745|FG003|Overall Study|Other - as reported by the investigator|0|||
128888723|NCT04427501|463888746|FG004|Overall Study|Other - as reported by the investigator|0|||
128888724|NCT04427501|463888747|FG005|Overall Study|Other - as reported by the investigator|6|||
128888725|NCT04427501|463888748|FG006|Overall Study|Other - as reported by the investigator|6|||
128888726|NCT04427501|463888749|FG007|Overall Study|Other - as reported by the investigator|0|||
128888727|NCT04427501|463888750|FG008|Overall Study|Other - as reported by the investigator|0|||
128888728|NCT04427501|463888751|FG009|Overall Study|Other - as reported by the investigator|0|||
128888729|NCT04427501|463888752|FG010|Overall Study|Other - as reported by the investigator|0|||
129109996|NCT03234036|464697793|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
129109997|NCT03234036|464697794|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
129109998|NCT03234036|464697795|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
129109999|NCT02999789|464697796|FG000|Overall Study|Withdrawal by Subject|0|||
129110000|NCT02999789|464697797|FG001|Overall Study|Withdrawal by Subject|1|||
129110001|NCT02999789|464697796|FG000|Overall Study|Became ineligible|1|||
129110002|NCT02999789|464697797|FG001|Overall Study|Became ineligible|2|||
129110003|NCT04613739|464697800|FG000|Overall Study|Lost to Follow-up|6|||
129110004|NCT04613739|464697801|FG001|Overall Study|Lost to Follow-up|9|||
129110005|NCT04613739|464697800|FG000|Overall Study|potentially duplicative/fraudulent|1|||
128688084|NCT04755283|463157142|FG001|Overall Study|Withdrawal by Subject|3|||
128688085|NCT04755283|463157143|FG002|Overall Study|Withdrawal by Subject|6|||
128888730|NCT04427501|463888753|FG011|Overall Study|Other - as reported by the investigator|0|||
128888731|NCT04427501|463888742|FG000|Overall Study|Other|0|||
128888732|NCT04427501|463888743|FG001|Overall Study|Other|0|||
128888733|NCT04427501|463888744|FG002|Overall Study|Other|0|||
128888734|NCT04427501|463888745|FG003|Overall Study|Other|0|||
128888735|NCT04427501|463888746|FG004|Overall Study|Other|0|||
128888736|NCT04427501|463888747|FG005|Overall Study|Other|0|||
128888737|NCT04427501|463888748|FG006|Overall Study|Other|0|||
128888738|NCT04427501|463888749|FG007|Overall Study|Other|0|||
128888739|NCT04427501|463888750|FG008|Overall Study|Other|0|||
128888740|NCT04427501|463888751|FG009|Overall Study|Other|0|||
128888741|NCT04427501|463888752|FG010|Overall Study|Other|0|||
128888742|NCT04427501|463888753|FG011|Overall Study|Other|1|||
128888743|NCT00999713|463888754|FG000|Overall Study|Physician Decision|2|||
128888744|NCT00999713|463888755|FG001|Overall Study|Physician Decision|0|||
128888745|NCT00639223|463888758|FG000|Overall Study|Lost to Follow-up|0|||
128888746|NCT00639223|463888759|FG001|Overall Study|Lost to Follow-up|2|||
128888747|NCT04936841|463888760|FG000|Overall Study|Death|1|||
128888748|NCT03739437|463888761|FG000|Overall Study|Lost to Follow-up|2|||
128888749|NCT03739437|463888762|FG001|Overall Study|Lost to Follow-up|5|||
128888750|NCT01395316|463888765|FG000|Overall Study|Lost to Follow-up|2|||
128888751|NCT01395316|463888765|FG000|Overall Study|poor MRI quality|1|||
128888752|NCT03359590|463888766|FG000|First Intervention|Withdrawal by Subject|1|||
128888753|NCT03359590|463888767|FG001|First Intervention|Withdrawal by Subject|1|||
128888754|NCT03359590|463888766|FG000|First Intervention|Protocol Violation|0|||
128888755|NCT03359590|463888767|FG001|First Intervention|Protocol Violation|1|||
128888756|NCT05460273|463888770|FG000|Overall Study|Death|43|||
128888757|NCT05460273|463888771|FG001|Overall Study|Death|9|||
128888758|NCT05460273|463888770|FG000|Overall Study|Lost to Follow-up|7|||
128888759|NCT05460273|463888771|FG001|Overall Study|Lost to Follow-up|0|||
128888760|NCT05460273|463888770|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
128888761|NCT05460273|463888771|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
128888762|NCT04890054|463890088|FG000|Overall Study|Lost to Follow-up|202|||
128888763|NCT04890054|463890089|FG001|Overall Study|Lost to Follow-up|219|||
128888764|NCT01310803|463890093|FG000|Overall Study|Subject terminated by Sponsor|1|||
128888765|NCT01310803|463890094|FG001|Overall Study|Subject terminated by Sponsor|0|||
128888766|NCT01306890|463890095|FG000|Overall Study|Adverse Event|2|||
128888767|NCT01306890|463890095|FG000|Overall Study|Death|1223|||
128888768|NCT01306890|463890095|FG000|Overall Study|Lost to Follow-up|58|||
128888769|NCT01306890|463890095|FG000|Overall Study|Withdrawal by Subject|88|||
128888770|NCT01306890|463890095|FG000|Overall Study|Unspecified reasons|104|||
128888771|NCT01306890|463890095|FG000|Overall Study|Study Termination|3|||
128888772|NCT01306890|463890095|FG000|Overall Study|No discontinuation documentation|41|||
128888773|NCT03047551|463890100|FG000|Overall Study|Did not receive TAS|1|||
128888774|NCT03047551|463890101|FG001|Overall Study|Did not receive TAS|0|||
128888775|NCT03047551|463890100|FG000|Overall Study|Physician Decision|1|||
128688086|NCT04755283|463157141|FG000|Overall Study|Lost to Follow-up|0|||
128688087|NCT04755283|463157142|FG001|Overall Study|Lost to Follow-up|0|||
128888776|NCT03047551|463890101|FG001|Overall Study|Physician Decision|0|||
128888777|NCT03047551|463890100|FG000|Overall Study|Withdrawal by Subject|0|||
128888778|NCT03047551|463890101|FG001|Overall Study|Withdrawal by Subject|1|||
128888779|NCT03047551|463890100|FG000|Overall Study|Probe malfunction|0|||
128888780|NCT03047551|463890101|FG001|Overall Study|Probe malfunction|1|||
128888781|NCT03047551|463890100|FG000|Overall Study|Ineligible|0|||
129110006|NCT04613739|464697801|FG001|Overall Study|potentially duplicative/fraudulent|3|||
129110007|NCT01064414|464697802|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
129215189|NCT02002598|465089458|FG002|Dose Level 1|Withdrawal by Subject|0|||
129215190|NCT02002598|465089459|FG003|Dose Level 1|Withdrawal by Subject|0|||
128888782|NCT03047551|463890101|FG001|Overall Study|Ineligible|1|||
128888783|NCT00726622|463890102|FG000|Overall Study|Withdrawal by Subject|16|||
128888784|NCT00726622|463890103|FG001|Overall Study|Withdrawal by Subject|2|||
128888785|NCT00726622|463890102|FG000|Overall Study|Physician Decision|0|||
128888786|NCT00726622|463890103|FG001|Overall Study|Physician Decision|1|||
128888787|NCT00726622|463890102|FG000|Overall Study|Metastasis|2|||
128888788|NCT00726622|463890103|FG001|Overall Study|Metastasis|0|||
128688088|NCT04755283|463157143|FG002|Overall Study|Lost to Follow-up|1|||
128688089|NCT04755283|463157141|FG000|Overall Study|Death|31|||
128688090|NCT04755283|463157142|FG001|Overall Study|Death|36|||
128688091|NCT04755283|463157143|FG002|Overall Study|Death|34|||
128688092|NCT00560885|463157151|FG000|Overall Study|Death|7|||
128688093|NCT00560885|463157151|FG000|Overall Study|Withdrawal by Subject|1|||
128688094|NCT03803683|463157152|FG000|Overall Study|Lost to Follow-up|41|||
128688095|NCT03803683|463157153|FG001|Overall Study|Lost to Follow-up|18|||
128688096|NCT03803683|463157154|FG002|Overall Study|Lost to Follow-up|12|||
128688097|NCT03803683|463157152|FG000|Overall Study|Withdrawal by Subject|9|||
128688098|NCT03803683|463157153|FG001|Overall Study|Withdrawal by Subject|1|||
128688099|NCT03803683|463157154|FG002|Overall Study|Withdrawal by Subject|4|||
128688100|NCT01897714|463158882|FG000|Phase I (Dose Escalation)|Disease progression|3|||
128688101|NCT01897714|463158883|FG001|Phase I (Dose Escalation)|Disease progression|5|||
128688102|NCT01897714|463158884|FG002|Phase I (Dose Escalation)|Disease progression|1|||
128688103|NCT01897714|463158885|FG003|Phase I (Dose Escalation)|Disease progression|3|||
128688104|NCT01897714|463158886|FG004|Phase I (Dose Escalation)|Disease progression|0|||
128688105|NCT01897714|463158887|FG005|Phase I (Dose Escalation)|Disease progression|0|||
128688106|NCT01897714|463158882|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
128688107|NCT01897714|463158883|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
128688108|NCT01897714|463158884|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
128688109|NCT01897714|463158885|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
128688110|NCT01897714|463158886|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
128688111|NCT01897714|463158887|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
128688112|NCT01897714|463158882|FG000|Phase I (Dose Escalation)|Other|0|||
128688113|NCT01897714|463158883|FG001|Phase I (Dose Escalation)|Other|1|||
128688114|NCT01897714|463158884|FG002|Phase I (Dose Escalation)|Other|0|||
128688115|NCT01897714|463158885|FG003|Phase I (Dose Escalation)|Other|0|||
128688116|NCT01897714|463158886|FG004|Phase I (Dose Escalation)|Other|0|||
128688117|NCT01897714|463158887|FG005|Phase I (Dose Escalation)|Other|0|||
128688118|NCT01897714|463158882|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
128688119|NCT01897714|463158883|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
128688120|NCT01897714|463158884|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
128688121|NCT01897714|463158885|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
128688122|NCT01897714|463158886|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
128688123|NCT01897714|463158887|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
128688124|NCT01897714|463158882|FG000|Phase II (MTD)|Lost to Follow-up|0|||
128688125|NCT01897714|463158883|FG001|Phase II (MTD)|Lost to Follow-up|0|||
128688126|NCT01897714|463158884|FG002|Phase II (MTD)|Lost to Follow-up|0|||
128688127|NCT01897714|463158885|FG003|Phase II (MTD)|Lost to Follow-up|0|||
128688128|NCT01897714|463158886|FG004|Phase II (MTD)|Lost to Follow-up|1|||
128688129|NCT01897714|463158887|FG005|Phase II (MTD)|Lost to Follow-up|0|||
128688130|NCT01897714|463158882|FG000|Phase II (MTD)|Death|0|||
128688131|NCT01897714|463158883|FG001|Phase II (MTD)|Death|0|||
128688132|NCT01897714|463158884|FG002|Phase II (MTD)|Death|0|||
128688133|NCT01897714|463158885|FG003|Phase II (MTD)|Death|0|||
128688134|NCT01897714|463158886|FG004|Phase II (MTD)|Death|25|||
128688135|NCT01897714|463158887|FG005|Phase II (MTD)|Death|10|||
128688136|NCT01897714|463158882|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
128688137|NCT01897714|463158883|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
128688138|NCT01897714|463158884|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
128688139|NCT01897714|463158885|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
128688140|NCT01897714|463158886|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
128688141|NCT01897714|463158887|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
128688142|NCT01897714|463158882|FG000|Phase II (MTD)|Other|0|||
128688143|NCT01897714|463158883|FG001|Phase II (MTD)|Other|0|||
128688144|NCT01897714|463158884|FG002|Phase II (MTD)|Other|0|||
128688145|NCT01897714|463158885|FG003|Phase II (MTD)|Other|0|||
128688146|NCT01897714|463158886|FG004|Phase II (MTD)|Other|3|||
128688147|NCT01897714|463158887|FG005|Phase II (MTD)|Other|0|||
128688148|NCT00423722|463158888|FG000|Overall Study|Death|4|||
128688149|NCT00423722|463158889|FG001|Overall Study|Death|4|||
128688150|NCT00423722|463158888|FG000|Overall Study|Declined to participate|2|||
128688151|NCT00423722|463158889|FG001|Overall Study|Declined to participate|3|||
128688152|NCT00423722|463158888|FG000|Overall Study|Unable to complete questionnaires|4|||
128688153|NCT00423722|463158889|FG001|Overall Study|Unable to complete questionnaires|4|||
129020577|NCT01796171|464367107|FG011|Follow-up Period|Sponsor Decision|15|||
128688154|NCT00423722|463158888|FG000|Overall Study|Withdrawal by Subject|4|||
128688155|NCT00423722|463158889|FG001|Overall Study|Withdrawal by Subject|2|||
128688156|NCT01846104|463158894|FG000|Overall Study|Withdrawal by Subject|1|||
128688157|NCT00851630|463158898|FG000|Overall Study|Death|2|||
128688158|NCT00851630|463158899|FG001|Overall Study|Death|1|||
128688159|NCT00851630|463158898|FG000|Overall Study|Clinical failure|0|||
128688160|NCT00851630|463158899|FG001|Overall Study|Clinical failure|1|||
128688161|NCT02349061|463158901|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
128688162|NCT02349061|463158902|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
128688163|NCT02349061|463158903|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
128688164|NCT02349061|463158901|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
128888789|NCT01940354|463890104|FG000|Overall Study|Withdrawal by Subject|4|||
128888790|NCT01940354|463890105|FG001|Overall Study|Withdrawal by Subject|2|||
128888791|NCT03872453|463890106|FG000|Overall Study|Adverse Event|1|||
128888792|NCT03872453|463890107|FG001|Overall Study|Adverse Event|1|||
128888793|NCT03872453|463890108|FG002|Overall Study|Adverse Event|0|||
128888794|NCT03872453|463890109|FG003|Overall Study|Adverse Event|0|||
128888795|NCT03872453|463890106|FG000|Overall Study|Lost to Follow-up|8|||
128888796|NCT03872453|463890107|FG001|Overall Study|Lost to Follow-up|7|||
128888797|NCT03872453|463890108|FG002|Overall Study|Lost to Follow-up|4|||
128888798|NCT03872453|463890109|FG003|Overall Study|Lost to Follow-up|4|||
128888799|NCT03872453|463890106|FG000|Overall Study|Never Treated Migraine|19|||
128888800|NCT03872453|463890107|FG001|Overall Study|Never Treated Migraine|17|||
128888801|NCT03872453|463890108|FG002|Overall Study|Never Treated Migraine|13|||
128888802|NCT03872453|463890109|FG003|Overall Study|Never Treated Migraine|12|||
128888803|NCT03872453|463890106|FG000|Overall Study|Pregnancy|1|||
128888804|NCT03872453|463890107|FG001|Overall Study|Pregnancy|0|||
128888805|NCT03872453|463890108|FG002|Overall Study|Pregnancy|0|||
128888806|NCT03872453|463890109|FG003|Overall Study|Pregnancy|0|||
128888807|NCT03872453|463890106|FG000|Overall Study|Protocol Deviation|2|||
128888808|NCT03872453|463890107|FG001|Overall Study|Protocol Deviation|0|||
128888809|NCT03872453|463890108|FG002|Overall Study|Protocol Deviation|0|||
128888810|NCT03872453|463890109|FG003|Overall Study|Protocol Deviation|2|||
128888811|NCT03872453|463890106|FG000|Overall Study|Withdrawal by Subject|0|||
128888812|NCT03872453|463890107|FG001|Overall Study|Withdrawal by Subject|1|||
128888813|NCT03872453|463890108|FG002|Overall Study|Withdrawal by Subject|2|||
128888814|NCT03872453|463890109|FG003|Overall Study|Withdrawal by Subject|0|||
128888815|NCT03872453|463890106|FG000|Overall Study|Other Than Specified|1|||
128888816|NCT03872453|463890107|FG001|Overall Study|Other Than Specified|0|||
128888817|NCT03872453|463890108|FG002|Overall Study|Other Than Specified|0|||
128888818|NCT03872453|463890109|FG003|Overall Study|Other Than Specified|0|||
128888819|NCT00352885|463890110|FG000|Overall Study|Withdrawal by Subject|0|||
128888820|NCT00352885|463890111|FG001|Overall Study|Withdrawal by Subject|3|||
128888821|NCT00352885|463890110|FG000|Overall Study|Development of major depression|0|||
128888822|NCT00352885|463890111|FG001|Overall Study|Development of major depression|1|||
128888823|NCT00352885|463890110|FG000|Overall Study|Progression of metastatic melanoma|5|||
128888824|NCT00352885|463890111|FG001|Overall Study|Progression of metastatic melanoma|3|||
128888825|NCT00352885|463890110|FG000|Overall Study|Side effects of IL-2 administration|1|||
128888826|NCT00352885|463890111|FG001|Overall Study|Side effects of IL-2 administration|0|||
128888827|NCT03873493|463890112|FG000|Overall Study|Withdrawal by Subject|1|||
128888828|NCT03873493|463890112|FG000|Overall Study|Death|9|||
129110008|NCT01064414|464697803|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
128888829|NCT03873493|463890112|FG000|Overall Study|Lost to Follow-up|1|||
128888830|NCT03873493|463890112|FG000|Overall Study|Study Terminated by Sponsor|1|||
128888831|NCT03873493|463890112|FG000|Overall Study|Other|2|||
128888832|NCT03756350|463890114|FG000|Overall Study|Lost to Follow-up|1|||
128888833|NCT00440700|463890117|FG000|Overall Study|Withdrawal by Subject|8|||
128888834|NCT00440700|463890118|FG001|Overall Study|Withdrawal by Subject|8|||
128888835|NCT00440700|463890119|FG002|Overall Study|Withdrawal by Subject|4|||
128888836|NCT01096342|463890120|FG000|Overall Study|Protocol Violation|1|||
128888837|NCT04906616|463890121|FG000|Overall Study|Divorce|3|||
128888838|NCT04906616|463890122|FG001|Overall Study|Divorce|2|||
128888839|NCT03739762|463890123|FG000|Overall Study|Lost to Follow-up|1|||
128888840|NCT03739762|463890124|FG001|Overall Study|Lost to Follow-up|1|||
128888841|NCT03739762|463890123|FG000|Overall Study|Withdrawal by Subject|2|||
129110009|NCT01064414|464697804|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
129110010|NCT01064414|464697802|FG000|Core Period: Baseline to Week 26|Death|0|||
129110011|NCT01064414|464697803|FG001|Core Period: Baseline to Week 26|Death|1|||
129110012|NCT01064414|464697804|FG002|Core Period: Baseline to Week 26|Death|0|||
129110013|NCT01064414|464697802|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
128688165|NCT02349061|463158902|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
128688166|NCT02349061|463158903|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
128888842|NCT03739762|463890124|FG001|Overall Study|Withdrawal by Subject|6|||
128888843|NCT02464228|463890127|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
128888844|NCT02464228|463890128|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
128888845|NCT02464228|463890129|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
128888846|NCT02464228|463890130|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
128888847|NCT02464228|463890127|FG000|Overall Study|Physician Decision|2|||
128888848|NCT02464228|463890128|FG001|Overall Study|Physician Decision|0|||
128888849|NCT02464228|463890129|FG002|Overall Study|Physician Decision|1|||
128888850|NCT02464228|463890130|FG003|Overall Study|Physician Decision|0|||
128888851|NCT02464228|463890127|FG000|Overall Study|Miscellaneous|1|||
128888852|NCT02464228|463890128|FG001|Overall Study|Miscellaneous|0|||
128888853|NCT02464228|463890129|FG002|Overall Study|Miscellaneous|1|||
128888854|NCT02464228|463890130|FG003|Overall Study|Miscellaneous|0|||
128888855|NCT02464228|463890127|FG000|Overall Study|Adverse Event|9|||
128888856|NCT02464228|463890128|FG001|Overall Study|Adverse Event|0|||
129110014|NCT01064414|464697803|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
128888857|NCT02464228|463890129|FG002|Overall Study|Adverse Event|3|||
128888858|NCT02464228|463890130|FG003|Overall Study|Adverse Event|0|||
128888859|NCT02464228|463890127|FG000|Overall Study|Withdrawal by Subject|1|||
128888860|NCT02464228|463890128|FG001|Overall Study|Withdrawal by Subject|1|||
128888861|NCT02464228|463890129|FG002|Overall Study|Withdrawal by Subject|1|||
128888862|NCT02464228|463890130|FG003|Overall Study|Withdrawal by Subject|0|||
128888863|NCT02464228|463890127|FG000|Overall Study|Disease Progression|22|||
128888864|NCT02464228|463890128|FG001|Overall Study|Disease Progression|12|||
129110015|NCT01064414|464697804|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
129110016|NCT01064414|464697802|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
129110017|NCT01064414|464697803|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
129110018|NCT01064414|464697804|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
129110019|NCT01064414|464697802|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129110020|NCT01064414|464697803|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129110021|NCT01064414|464697804|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129110022|NCT01064414|464697802|FG000|Core Period: Baseline to Week 26|Other|4|||
129110023|NCT01064414|464697803|FG001|Core Period: Baseline to Week 26|Other|7|||
129110024|NCT01064414|464697804|FG002|Core Period: Baseline to Week 26|Other|2|||
129110025|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
129110026|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129110027|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
129110028|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Death|0|||
129110029|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Death|1|||
129110030|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Death|0|||
129110031|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
129110032|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129110033|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129110034|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
129110035|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129110036|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129110037|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129110038|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129110039|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129110040|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
129110041|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129110042|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129110043|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129110044|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129110045|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129110046|NCT01064414|464697802|FG000|Extension Period: Week 26 to Week 52|Other|5|||
129110047|NCT01064414|464697803|FG001|Extension Period: Week 26 to Week 52|Other|2|||
129110048|NCT01064414|464697804|FG002|Extension Period: Week 26 to Week 52|Other|1|||
129110049|NCT00249873|464697805|FG000|Overall Study|Not treated|7|||
129110050|NCT00249873|464697806|FG001|Overall Study|Not treated|8|||
129110051|NCT00249873|464697805|FG000|Overall Study|Significant thrombocytopenia|9|||
129110052|NCT00249873|464697806|FG001|Overall Study|Significant thrombocytopenia|8|||
129110053|NCT00249873|464697805|FG000|Overall Study|Severe allergic reaction|8|||
129110054|NCT00249873|464697806|FG001|Overall Study|Severe allergic reaction|1|||
129110055|NCT00249873|464697805|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
129110056|NCT00249873|464697806|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
129110057|NCT00249873|464697805|FG000|Overall Study|Other Serious Adverse Event|86|||
129110058|NCT00249873|464697806|FG001|Overall Study|Other Serious Adverse Event|97|||
129110059|NCT00249873|464697805|FG000|Overall Study|Qualifying condition not present|20|||
129110060|NCT00249873|464697806|FG001|Overall Study|Qualifying condition not present|23|||
129110061|NCT00249873|464697805|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
129110062|NCT00249873|464697806|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
129110063|NCT00249873|464697805|FG000|Overall Study|Withdrawal by Subject|504|||
129110064|NCT00249873|464697806|FG001|Overall Study|Withdrawal by Subject|466|||
129110065|NCT00249873|464697805|FG000|Overall Study|Lost to Follow-up|4|||
129110066|NCT00249873|464697806|FG001|Overall Study|Lost to Follow-up|7|||
129110067|NCT00249873|464697805|FG000|Overall Study|Minor bleeding|99|||
129110068|NCT00249873|464697806|FG001|Overall Study|Minor bleeding|37|||
129110069|NCT00249873|464697805|FG000|Overall Study|Non-compliance|41|||
128888865|NCT02464228|463890129|FG002|Overall Study|Disease Progression|5|||
129110070|NCT00249873|464697806|FG001|Overall Study|Non-compliance|46|||
129110071|NCT00249873|464697805|FG000|Overall Study|Other non serious Adverse Event|112|||
129110072|NCT00249873|464697806|FG001|Overall Study|Other non serious Adverse Event|108|||
129110073|NCT00249873|464697805|FG000|Overall Study|Other contraindicated medication|1|||
128888866|NCT02464228|463890130|FG003|Overall Study|Disease Progression|2|||
128888867|NCT03308942|463890133|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
128888868|NCT03308942|463890134|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
128888869|NCT03308942|463890135|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
128888870|NCT03308942|463890136|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
128888871|NCT03308942|463890137|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
128888872|NCT03308942|463890133|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
128888873|NCT03308942|463890134|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
128888874|NCT03308942|463890135|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
128888875|NCT03308942|463890136|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
128888876|NCT03308942|463890137|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
128888877|NCT03308942|463890133|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
128888878|NCT03308942|463890134|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
128888879|NCT03308942|463890135|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
128888880|NCT03308942|463890136|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
128888881|NCT03308942|463890137|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
128888882|NCT03308942|463890133|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
128888883|NCT03308942|463890134|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
128888884|NCT03308942|463890135|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
128888885|NCT03308942|463890136|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
128888886|NCT03308942|463890137|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
128888887|NCT03308942|463890133|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
128888888|NCT03308942|463890134|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
128888889|NCT03308942|463890135|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
128888890|NCT03308942|463890136|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
128888891|NCT03308942|463890137|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
128888892|NCT03308942|463890133|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
128888893|NCT03308942|463890134|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
128888894|NCT03308942|463890135|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
128888895|NCT03308942|463890136|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
128888896|NCT03308942|463890137|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
128888897|NCT03308942|463890133|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
128888898|NCT03308942|463890134|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
128888899|NCT03308942|463890135|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
128888900|NCT03308942|463890136|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
128888901|NCT03308942|463890137|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
128888902|NCT01131351|463890138|FG000|Overall Study|Adverse Event|0|||
128888903|NCT01131351|463890139|FG001|Overall Study|Adverse Event|2|||
128888904|NCT01131351|463890138|FG000|Overall Study|Protocol Deviation|0|||
128888905|NCT01131351|463890139|FG001|Overall Study|Protocol Deviation|1|||
128888906|NCT02294682|463890140|FG000|Overall Study|Could not swallow pills|1|||
128888907|NCT02294682|463890141|FG001|Overall Study|Could not swallow pills|0|||
128888908|NCT03422172|463890144|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
128888909|NCT03422172|463890144|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
128888910|NCT03422172|463890144|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
128888911|NCT01423812|463890147|FG000|Overall Study|Lost to Follow-up|2|||
128888912|NCT01423812|463890148|FG001|Overall Study|Lost to Follow-up|2|||
128888913|NCT01423812|463890147|FG000|Overall Study|Withdrawal by Subject|1|||
128888914|NCT01423812|463890148|FG001|Overall Study|Withdrawal by Subject|2|||
128888915|NCT01187550|463890149|FG000|Overall Study|Protocol Violation|3|||
128888916|NCT01187550|463890150|FG001|Overall Study|Protocol Violation|1|||
128888917|NCT01187550|463890149|FG000|Overall Study|Other|3|||
128888918|NCT01187550|463890150|FG001|Overall Study|Other|0|||
128888919|NCT01187550|463890149|FG000|Overall Study|Randomized but not treated|8|||
128888920|NCT01187550|463890150|FG001|Overall Study|Randomized but not treated|0|||
128888921|NCT00129623|463890151|FG000|Overall Study|Adverse Event|3|||
128888922|NCT00129623|463890152|FG001|Overall Study|Adverse Event|7|||
128888923|NCT00129623|463890151|FG000|Overall Study|Refused Treatment|5|||
128888924|NCT00129623|463890152|FG001|Overall Study|Refused Treatment|3|||
128888925|NCT00129623|463890151|FG000|Overall Study|Failure to Return|1|||
128888926|NCT00129623|463890152|FG001|Overall Study|Failure to Return|1|||
128888927|NCT00129623|463890151|FG000|Overall Study|Relocated job out of state|1|||
128888928|NCT00129623|463890152|FG001|Overall Study|Relocated job out of state|0|||
128888929|NCT00129623|463890151|FG000|Overall Study|Uncertainty to return|0|||
128888930|NCT00129623|463890152|FG001|Overall Study|Uncertainty to return|1|||
128888931|NCT02616614|463890153|FG000|Overall Study|Withdrawal by Subject|10|||
128888932|NCT02616614|463890154|FG001|Overall Study|Withdrawal by Subject|5|||
128888933|NCT02616614|463890155|FG002|Overall Study|Withdrawal by Subject|6|||
128888934|NCT02616614|463890153|FG000|Overall Study|Physician Decision|2|||
128888935|NCT02616614|463890154|FG001|Overall Study|Physician Decision|1|||
128888936|NCT02616614|463890155|FG002|Overall Study|Physician Decision|0|||
128888937|NCT02616614|463890153|FG000|Overall Study|Adverse Event|1|||
128888938|NCT02616614|463890154|FG001|Overall Study|Adverse Event|4|||
128888939|NCT02616614|463890155|FG002|Overall Study|Adverse Event|1|||
128888940|NCT02616614|463890153|FG000|Overall Study|Protocol Violation|0|||
128888941|NCT02616614|463890154|FG001|Overall Study|Protocol Violation|3|||
128888942|NCT02616614|463890155|FG002|Overall Study|Protocol Violation|1|||
128888943|NCT02616614|463890153|FG000|Overall Study|Prohibited Medication|12|||
128888944|NCT02616614|463890154|FG001|Overall Study|Prohibited Medication|9|||
128888945|NCT02616614|463890155|FG002|Overall Study|Prohibited Medication|5|||
128888946|NCT02616614|463890153|FG000|Overall Study|More than 3 applications missed|6|||
128888947|NCT02616614|463890154|FG001|Overall Study|More than 3 applications missed|8|||
128888948|NCT02616614|463890155|FG002|Overall Study|More than 3 applications missed|1|||
128888949|NCT02616614|463890153|FG000|Overall Study|Lost to Follow-up|31|||
128888950|NCT02616614|463890154|FG001|Overall Study|Lost to Follow-up|28|||
128888951|NCT02616614|463890155|FG002|Overall Study|Lost to Follow-up|13|||
128888952|NCT02616614|463890153|FG000|Overall Study|Pregnancy|2|||
128888953|NCT02616614|463890154|FG001|Overall Study|Pregnancy|0|||
128888954|NCT02616614|463890155|FG002|Overall Study|Pregnancy|1|||
128888955|NCT02616614|463890153|FG000|Overall Study|Other|1|||
128888956|NCT02616614|463890154|FG001|Overall Study|Other|2|||
128888957|NCT02616614|463890155|FG002|Overall Study|Other|1|||
128888958|NCT02315898|463890156|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
128888959|NCT02315898|463890157|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
128888960|NCT02315898|463890158|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
128888961|NCT02315898|463890159|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
128888962|NCT02445755|463890160|FG000|Overall Study|Withdrawal by Subject|2|||
128888963|NCT02445755|463890160|FG000|Overall Study|Protocol Violation|6|||
128888964|NCT02445755|463890160|FG000|Overall Study|Screen Failure|5|||
128888965|NCT03239483|463890161|FG000|Overall Study|Lost to Follow-up|1|||
128888966|NCT03239483|463890162|FG001|Overall Study|Lost to Follow-up|0|||
128888967|NCT03239483|463890161|FG000|Overall Study|Withdrawal by Subject|1|||
128888968|NCT03239483|463890162|FG001|Overall Study|Withdrawal by Subject|0|||
128888969|NCT05352048|463890163|FG000|Overall Study|Lost to Follow-up|1|||
128888970|NCT05352048|463890163|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
128888971|NCT01233869|463890177|FG000|Initial Treatment Period (24 Months)|Death|1|||
128888972|NCT01233869|463890178|FG001|Initial Treatment Period (24 Months)|Death|0|||
128888973|NCT01233869|463890179|FG002|Initial Treatment Period (24 Months)|Death|0|||
128888974|NCT01233869|463890180|FG003|Initial Treatment Period (24 Months)|Death|0|||
128888975|NCT01233869|463890177|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
128888976|NCT01233869|463890178|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
128888977|NCT01233869|463890179|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
128888978|NCT01233869|463890180|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
128888979|NCT01233869|463890177|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
128888980|NCT01233869|463890178|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
128688167|NCT02349061|463158901|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
128888981|NCT01233869|463890179|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
128888982|NCT01233869|463890180|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
128888983|NCT01233869|463890177|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
128888984|NCT01233869|463890178|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
128888985|NCT01233869|463890179|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
128888986|NCT01233869|463890180|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
128888987|NCT01233869|463890177|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
128888988|NCT01233869|463890178|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
128888989|NCT01233869|463890179|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
128888990|NCT01233869|463890180|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
129110074|NCT00249873|464697806|FG001|Overall Study|Other contraindicated medication|0|||
129110075|NCT00249873|464697805|FG000|Overall Study|Patient not wish to continue after May08|3|||
128688168|NCT02349061|463158902|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
128688169|NCT02349061|463158903|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
128688170|NCT02349061|463158901|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
128688171|NCT02349061|463158902|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
128688172|NCT02349061|463158903|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
128688173|NCT02349061|463158901|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
128688174|NCT02349061|463158902|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
128688175|NCT02349061|463158903|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
128688176|NCT02349061|463158901|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
128688177|NCT02349061|463158902|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
128688178|NCT02349061|463158903|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
128688179|NCT02349061|463158901|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
128688180|NCT02349061|463158902|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
128688181|NCT02349061|463158903|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
128688182|NCT02349061|463158901|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
128888991|NCT01233869|463890177|FG000|Extended Treatment Period (46 Months)|Other|3|||
128888992|NCT01233869|463890178|FG001|Extended Treatment Period (46 Months)|Other|0|||
128888993|NCT01233869|463890179|FG002|Extended Treatment Period (46 Months)|Other|0|||
128888994|NCT01233869|463890180|FG003|Extended Treatment Period (46 Months)|Other|3|||
128888995|NCT01233869|463890177|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
128888996|NCT01233869|463890178|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
128888997|NCT01233869|463890179|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
128888998|NCT01233869|463890180|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
128888999|NCT00537485|463890181|FG000|Overall Study|Adverse Event|10|||
128889000|NCT00537485|463890182|FG001|Overall Study|Adverse Event|5|||
128889001|NCT00537485|463890181|FG000|Overall Study|Withdrawal by Subject|3|||
128889002|NCT00537485|463890182|FG001|Overall Study|Withdrawal by Subject|2|||
128889003|NCT00537485|463890181|FG000|Overall Study|Withdrawal by Subject|1|||
128889004|NCT00537485|463890182|FG001|Overall Study|Withdrawal by Subject|3|||
128889005|NCT00537485|463890181|FG000|Overall Study|Physician Decision|1|||
128889006|NCT00537485|463890182|FG001|Overall Study|Physician Decision|0|||
128889007|NCT01296035|463890189|FG000|Overall Study|Withdrawal by Subject|1|||
128889008|NCT02378220|463890192|FG000|Overall Study|Death|6|||
128889009|NCT02378220|463890193|FG001|Overall Study|Death|1|||
128889010|NCT00578786|463890194|FG000|Overall Study|Adverse Event|27|||
128889011|NCT00578786|463890195|FG001|Overall Study|Adverse Event|37|||
128889012|NCT00578786|463890196|FG002|Overall Study|Adverse Event|17|||
128889013|NCT00578786|463890194|FG000|Overall Study|Lack of Efficacy|2|||
128889014|NCT00578786|463890195|FG001|Overall Study|Lack of Efficacy|5|||
128889015|NCT00578786|463890196|FG002|Overall Study|Lack of Efficacy|2|||
128889016|NCT00578786|463890194|FG000|Overall Study|Early Escape from Prior Study|2|||
128889017|NCT00578786|463890195|FG001|Overall Study|Early Escape from Prior Study|1|||
128889018|NCT00578786|463890196|FG002|Overall Study|Early Escape from Prior Study|2|||
128889019|NCT00578786|463890194|FG000|Overall Study|Withdrawal by Subject|7|||
128889020|NCT00578786|463890195|FG001|Overall Study|Withdrawal by Subject|8|||
128889021|NCT00578786|463890196|FG002|Overall Study|Withdrawal by Subject|5|||
128889022|NCT00578786|463890194|FG000|Overall Study|Protocol Violation|0|||
128889023|NCT00578786|463890195|FG001|Overall Study|Protocol Violation|3|||
128763815|NCT01674621|463425796|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
128763816|NCT01674621|463425797|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
128763817|NCT01674621|463425798|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
128763818|NCT01674621|463425794|FG000|Overall Study|Withdrawal by Subject|2|||
128763819|NCT01674621|463425795|FG001|Overall Study|Withdrawal by Subject|5|||
128763820|NCT01674621|463425796|FG002|Overall Study|Withdrawal by Subject|2|||
128763821|NCT01674621|463425797|FG003|Overall Study|Withdrawal by Subject|0|||
128763822|NCT01674621|463425798|FG004|Overall Study|Withdrawal by Subject|1|||
128763823|NCT01674621|463425794|FG000|Overall Study|Other than specified|0|||
128763824|NCT01674621|463425795|FG001|Overall Study|Other than specified|1|||
128763825|NCT01674621|463425796|FG002|Overall Study|Other than specified|0|||
128763826|NCT01674621|463425797|FG003|Overall Study|Other than specified|0|||
128763827|NCT01674621|463425798|FG004|Overall Study|Other than specified|2|||
128763828|NCT01597505|463425804|FG000|Overall Study|Physician Decision|5|||
128763829|NCT01597505|463425805|FG001|Overall Study|Physician Decision|0|||
128763830|NCT01597505|463425804|FG000|Overall Study|Adverse Event|19|||
128763831|NCT01597505|463425805|FG001|Overall Study|Adverse Event|7|||
128763832|NCT01597505|463425804|FG000|Overall Study|Lost to Follow-up|4|||
128763833|NCT01597505|463425805|FG001|Overall Study|Lost to Follow-up|2|||
128763834|NCT01597505|463425804|FG000|Overall Study|Withdrawal by Subject|10|||
128763835|NCT01597505|463425805|FG001|Overall Study|Withdrawal by Subject|18|||
128763836|NCT01597505|463425804|FG000|Overall Study|Other|5|||
128763837|NCT01597505|463425805|FG001|Overall Study|Other|6|||
128763838|NCT01597505|463425804|FG000|Overall Study|Missing|1|||
128763839|NCT01597505|463425805|FG001|Overall Study|Missing|0|||
128763840|NCT05454410|463425806|FG000|Overall Study|Withdrawal by Subject|0|||
128763841|NCT05454410|463425807|FG001|Overall Study|Withdrawal by Subject|0|||
128763842|NCT05454410|463425808|FG002|Overall Study|Withdrawal by Subject|1|||
128763843|NCT05454410|463425809|FG003|Overall Study|Withdrawal by Subject|1|||
128763844|NCT05004688|463425820|FG000|Overall Study|Protocol Violation|7|||
128763845|NCT05004688|463425820|FG000|Overall Study|Physician Decision|2|||
128763846|NCT05004688|463425820|FG000|Overall Study|Withdrawal by Subject|2|||
128763847|NCT03879408|463425821|FG000|Overall Study|Lost to Follow-up|0|||
128889024|NCT00578786|463890196|FG002|Overall Study|Protocol Violation|1|||
128889025|NCT00578786|463890194|FG000|Overall Study|Physician Decision|1|||
128889026|NCT00578786|463890195|FG001|Overall Study|Physician Decision|0|||
128889027|NCT00578786|463890196|FG002|Overall Study|Physician Decision|1|||
128889028|NCT00578786|463890194|FG000|Overall Study|Sponsor Decision|0|||
128889029|NCT00578786|463890195|FG001|Overall Study|Sponsor Decision|0|||
128763848|NCT03879408|463425822|FG001|Overall Study|Lost to Follow-up|3|||
128763849|NCT03879408|463425823|FG002|Overall Study|Lost to Follow-up|2|||
128763850|NCT03879408|463425824|FG003|Overall Study|Lost to Follow-up|1|||
128763851|NCT03879408|463425825|FG004|Overall Study|Lost to Follow-up|0|||
128763852|NCT03879408|463425821|FG000|Overall Study|Withdrawal by Subject|2|||
128889030|NCT00578786|463890196|FG002|Overall Study|Sponsor Decision|1|||
128889031|NCT00578786|463890194|FG000|Overall Study|Lost to Follow-up|0|||
128889032|NCT00578786|463890195|FG001|Overall Study|Lost to Follow-up|4|||
128889033|NCT00578786|463890196|FG002|Overall Study|Lost to Follow-up|0|||
128889034|NCT00578786|463890194|FG000|Overall Study|Pregnancy|0|||
128889035|NCT00578786|463890195|FG001|Overall Study|Pregnancy|1|||
128889036|NCT00578786|463890196|FG002|Overall Study|Pregnancy|0|||
128889037|NCT00578786|463890194|FG000|Overall Study|Not Otherwise Specified|0|||
128889038|NCT00578786|463890195|FG001|Overall Study|Not Otherwise Specified|4|||
128889039|NCT00578786|463890196|FG002|Overall Study|Not Otherwise Specified|1|||
128889040|NCT00578786|463890194|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
128889041|NCT00578786|463890195|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
128889042|NCT00578786|463890196|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
128889043|NCT00866723|463890197|FG000|Overall Study|Withdrawal by Subject|1|||
128889044|NCT00866723|463890197|FG000|Overall Study|Disease Progression|4|||
128889045|NCT00323297|463890198|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
128889046|NCT00323297|463890199|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
128889047|NCT00323297|463890198|FG000|Part A (Double Blind Randomized)|Death|0|||
128889048|NCT00323297|463890199|FG001|Part A (Double Blind Randomized)|Death|1|||
128889049|NCT00323297|463890198|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
128889050|NCT00323297|463890199|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
128889051|NCT00323297|463890198|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
128889052|NCT00323297|463890199|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
128889053|NCT00323297|463890198|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
128889054|NCT00323297|463890199|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
128688183|NCT02349061|463158902|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
128688184|NCT02349061|463158903|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
128889055|NCT00323297|463890198|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
128688185|NCT02349061|463158901|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
128889056|NCT00323297|463890199|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
128889057|NCT00323297|463890198|FG000|Part B (Open-label)|Death|0|||
128889058|NCT00323297|463890199|FG001|Part B (Open-label)|Death|1|||
128889059|NCT00323297|463890198|FG000|Part B (Open-label)|Reason unspecified|0|||
128889060|NCT00323297|463890199|FG001|Part B (Open-label)|Reason unspecified|1|||
128889061|NCT00323297|463890198|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
128889062|NCT00323297|463890199|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
128889063|NCT00323297|463890198|FG000|Part B (Open-label)|Lack of Efficacy|3|||
128688186|NCT02349061|463158902|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
128688187|NCT02349061|463158903|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
128688188|NCT02349061|463158901|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
128688189|NCT02349061|463158902|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
128688190|NCT02349061|463158903|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
128688191|NCT02349061|463158901|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
128688192|NCT02349061|463158902|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
128688193|NCT02349061|463158903|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
128688194|NCT02349061|463158901|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
128688195|NCT02349061|463158902|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
128889064|NCT00323297|463890199|FG001|Part B (Open-label)|Lack of Efficacy|1|||
128889065|NCT00323297|463890198|FG000|Part B (Open-label)|Adverse Event|5|||
128889066|NCT00323297|463890199|FG001|Part B (Open-label)|Adverse Event|5|||
128889067|NCT00323297|463890198|FG000|Part B (Open-label)|Protocol Violation|0|||
128889068|NCT00323297|463890199|FG001|Part B (Open-label)|Protocol Violation|1|||
128889069|NCT01251120|463890201|FG000|Overall Study|Lack of Efficacy|0|||
128889070|NCT01251120|463890202|FG001|Overall Study|Lack of Efficacy|1|||
128889071|NCT01822522|463890203|FG000|Overall Study|Adverse Event|1|||
128889072|NCT01822522|463890204|FG001|Overall Study|Adverse Event|1|||
128889073|NCT01822522|463890205|FG002|Overall Study|Adverse Event|1|||
128889074|NCT01822522|463890206|FG003|Overall Study|Adverse Event|0|||
128889075|NCT01822522|463890207|FG004|Overall Study|Adverse Event|0|||
128889076|NCT01822522|463890208|FG005|Overall Study|Adverse Event|1|||
128889077|NCT01822522|463890203|FG000|Overall Study|Death|3|||
128688196|NCT02349061|463158903|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
128688197|NCT02349061|463158901|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
128688198|NCT02349061|463158902|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
128889078|NCT01822522|463890204|FG001|Overall Study|Death|0|||
128889079|NCT01822522|463890205|FG002|Overall Study|Death|2|||
128889080|NCT01822522|463890206|FG003|Overall Study|Death|0|||
128889081|NCT01822522|463890207|FG004|Overall Study|Death|0|||
128889082|NCT01822522|463890208|FG005|Overall Study|Death|0|||
129110076|NCT00249873|464697806|FG001|Overall Study|Patient not wish to continue after May08|4|||
129110077|NCT00249873|464697805|FG000|Overall Study|Physician withdrew consent|59|||
128688199|NCT02349061|463158903|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
128889083|NCT01822522|463890203|FG000|Overall Study|Lost to Follow-up|0|||
128889084|NCT01822522|463890204|FG001|Overall Study|Lost to Follow-up|0|||
128889085|NCT01822522|463890205|FG002|Overall Study|Lost to Follow-up|1|||
128889086|NCT01822522|463890206|FG003|Overall Study|Lost to Follow-up|1|||
128889087|NCT01822522|463890207|FG004|Overall Study|Lost to Follow-up|0|||
128889088|NCT01822522|463890208|FG005|Overall Study|Lost to Follow-up|1|||
128889089|NCT01822522|463890203|FG000|Overall Study|Withdrawal by Subject|0|||
128889090|NCT01822522|463890204|FG001|Overall Study|Withdrawal by Subject|0|||
128889091|NCT01822522|463890205|FG002|Overall Study|Withdrawal by Subject|0|||
128889092|NCT01822522|463890206|FG003|Overall Study|Withdrawal by Subject|1|||
128889093|NCT01822522|463890207|FG004|Overall Study|Withdrawal by Subject|0|||
128889094|NCT01822522|463890208|FG005|Overall Study|Withdrawal by Subject|0|||
128889095|NCT01822522|463890203|FG000|Overall Study|Lack of Efficacy|0|||
128889096|NCT01822522|463890204|FG001|Overall Study|Lack of Efficacy|0|||
128889097|NCT01822522|463890205|FG002|Overall Study|Lack of Efficacy|0|||
128889098|NCT01822522|463890206|FG003|Overall Study|Lack of Efficacy|0|||
128889099|NCT01822522|463890207|FG004|Overall Study|Lack of Efficacy|0|||
128889100|NCT01822522|463890208|FG005|Overall Study|Lack of Efficacy|2|||
128889101|NCT02558231|463890209|FG000|Overall Study|Death|4|||
128688200|NCT00398411|463158904|FG000|Overall Study|Death|0|||
128688201|NCT00398411|463158905|FG001|Overall Study|Death|1|||
128889102|NCT02558231|463890210|FG001|Overall Study|Death|12|||
128889103|NCT02558231|463890209|FG000|Overall Study|Lost to Follow-up|7|||
128889104|NCT02558231|463890210|FG001|Overall Study|Lost to Follow-up|4|||
128889105|NCT02558231|463890209|FG000|Overall Study|Withdrawal by Subject|7|||
128889106|NCT02558231|463890210|FG001|Overall Study|Withdrawal by Subject|4|||
128889107|NCT02558231|463890209|FG000|Overall Study|Physician Decision|7|||
128889108|NCT02558231|463890210|FG001|Overall Study|Physician Decision|5|||
128889109|NCT02558231|463890209|FG000|Overall Study|Sponsor Decision|0|||
128889110|NCT02558231|463890210|FG001|Overall Study|Sponsor Decision|1|||
128889111|NCT01006265|463890211|FG000|Overall Study|Lost to Follow-up|1|||
128889112|NCT01006265|463890212|FG001|Overall Study|Lost to Follow-up|0|||
128889113|NCT01006265|463890213|FG002|Overall Study|Lost to Follow-up|1|||
128889114|NCT01006265|463890214|FG003|Overall Study|Lost to Follow-up|0|||
128889115|NCT01006265|463890211|FG000|Overall Study|Withdrawal by Subject|4|||
128889116|NCT01006265|463890212|FG001|Overall Study|Withdrawal by Subject|7|||
128889117|NCT01006265|463890213|FG002|Overall Study|Withdrawal by Subject|5|||
128889118|NCT01006265|463890214|FG003|Overall Study|Withdrawal by Subject|5|||
128889119|NCT01006265|463890211|FG000|Overall Study|Administrative reason|1|||
128889120|NCT01006265|463890212|FG001|Overall Study|Administrative reason|2|||
128889121|NCT01006265|463890213|FG002|Overall Study|Administrative reason|3|||
128889122|NCT01006265|463890214|FG003|Overall Study|Administrative reason|0|||
128889123|NCT04233164|463890215|FG000|Overall Study|Unable to obtain specimen|0|||
128889124|NCT04233164|463890216|FG001|Overall Study|Unable to obtain specimen|1|||
128889125|NCT07052682|463890219|FG000|Overall Study|Withdrawal by Subject|4|||
128889126|NCT04667247|463890220|FG000|Overall Study|Withdrawal by Subject|0|||
128889127|NCT04667247|463890221|FG001|Overall Study|Withdrawal by Subject|1|||
128889128|NCT00698451|463892186|FG000|Overall Study|Adverse Event|22|||
128889129|NCT00698451|463892186|FG000|Overall Study|Physician Decision|2|||
128889130|NCT00698451|463892186|FG000|Overall Study|Protocol Violation|6|||
128889131|NCT00698451|463892186|FG000|Overall Study|Withdrawal by Subject|6|||
128889132|NCT00698451|463892186|FG000|Overall Study|Disease progression|3|||
128889133|NCT02224599|463892187|FG000|Overall Study|Physician Decision|1|||
128889134|NCT02224599|463892187|FG000|Overall Study|Progression of Disease|1|||
128889135|NCT00733304|463892188|FG000|Overall Study|Adverse Event|3|||
128688202|NCT02095223|463158906|FG000|Overall Study|Withdrawal by Subject|1|||
128688203|NCT02095223|463158907|FG001|Overall Study|Withdrawal by Subject|0|||
128688204|NCT02339285|463158908|FG000|Overall Study|Withdrawal by Subject|0|||
128688205|NCT02339285|463158909|FG001|Overall Study|Withdrawal by Subject|1|||
128688206|NCT02339285|463158910|FG002|Overall Study|Withdrawal by Subject|1|||
128688207|NCT02339285|463158908|FG000|Overall Study|Lost to Follow-up|1|||
128688208|NCT02339285|463158909|FG001|Overall Study|Lost to Follow-up|1|||
128688209|NCT02339285|463158910|FG002|Overall Study|Lost to Follow-up|1|||
128688210|NCT02339285|463158908|FG000|Overall Study|Protocol Deviation|0|||
128688211|NCT02339285|463158909|FG001|Overall Study|Protocol Deviation|1|||
128688212|NCT02339285|463158910|FG002|Overall Study|Protocol Deviation|0|||
128688213|NCT01507298|463158911|FG000|Overall Study|Protocol Violation|0|||
128688214|NCT01507298|463158912|FG001|Overall Study|Protocol Violation|6|||
128688215|NCT03061097|463158913|FG000|Overall Study|Withdrawal by Subject|0|||
128688216|NCT03061097|463158914|FG001|Overall Study|Withdrawal by Subject|3|||
128688217|NCT03911713|463158915|FG000|Overall Study|Lost to Follow-up|0|||
128688218|NCT03911713|463158916|FG001|Overall Study|Lost to Follow-up|2|||
128688219|NCT03911713|463158917|FG002|Overall Study|Lost to Follow-up|0|||
128688220|NCT03911713|463158918|FG003|Overall Study|Lost to Follow-up|0|||
128688221|NCT03911713|463158919|FG004|Overall Study|Lost to Follow-up|0|||
128688222|NCT03911713|463158915|FG000|Overall Study|Other|0|||
128688223|NCT03911713|463158916|FG001|Overall Study|Other|0|||
128688224|NCT03911713|463158917|FG002|Overall Study|Other|0|||
128889136|NCT00733304|463892189|FG001|Overall Study|Adverse Event|0|||
128889137|NCT00733304|463892190|FG002|Overall Study|Adverse Event|0|||
128889138|NCT00733304|463892188|FG000|Overall Study|Lack of Efficacy|0|||
128889139|NCT00733304|463892189|FG001|Overall Study|Lack of Efficacy|0|||
128889140|NCT00733304|463892190|FG002|Overall Study|Lack of Efficacy|2|||
128889141|NCT00733304|463892188|FG000|Overall Study|Lost to Follow-up|0|||
128889142|NCT00733304|463892189|FG001|Overall Study|Lost to Follow-up|1|||
128889143|NCT00733304|463892190|FG002|Overall Study|Lost to Follow-up|0|||
128889144|NCT00733304|463892188|FG000|Overall Study|Physician Decision|3|||
128889145|NCT00733304|463892189|FG001|Overall Study|Physician Decision|1|||
128889146|NCT00733304|463892190|FG002|Overall Study|Physician Decision|3|||
128889147|NCT00733304|463892188|FG000|Overall Study|Withdrawal by Subject|1|||
128889148|NCT00733304|463892189|FG001|Overall Study|Withdrawal by Subject|1|||
128889149|NCT00733304|463892190|FG002|Overall Study|Withdrawal by Subject|0|||
128889150|NCT03155373|463892191|FG000|Overall Study|No longer required surgery|1|||
128889151|NCT03155373|463892191|FG000|Overall Study|Protocol Violation|1|||
128889152|NCT03155373|463892191|FG000|Overall Study|Death|2|||
128889153|NCT03155373|463892191|FG000|Overall Study|Withdrawal by Subject|3|||
128889154|NCT00596934|463892194|FG000|Overall Study|Protocol Violation|1|||
128889155|NCT00596934|463892194|FG000|Overall Study|Withdrawal by Subject|1|||
128889156|NCT01214187|463892195|FG000|Overall Study|Adverse Event|6|||
128889157|NCT01214187|463892196|FG001|Overall Study|Adverse Event|2|||
128889158|NCT01214187|463892195|FG000|Overall Study|Death|1|||
128889159|NCT01214187|463892196|FG001|Overall Study|Death|1|||
128889160|NCT01214187|463892195|FG000|Overall Study|Withdrawal by Subject|0|||
128889161|NCT01214187|463892196|FG001|Overall Study|Withdrawal by Subject|3|||
128889162|NCT02308007|463892200|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
128889163|NCT02308007|463892201|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
128889164|NCT02308007|463892202|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
128889165|NCT02308007|463892200|FG000|Overall Study|Positive for STD at Baseline|7|||
128889166|NCT02308007|463892201|FG001|Overall Study|Positive for STD at Baseline|11|||
128889167|NCT02308007|463892202|FG002|Overall Study|Positive for STD at Baseline|7|||
128889168|NCT02308007|463892200|FG000|Overall Study|Lost to Follow-up|3|||
128889169|NCT02308007|463892201|FG001|Overall Study|Lost to Follow-up|0|||
128889170|NCT02308007|463892202|FG002|Overall Study|Lost to Follow-up|1|||
128889171|NCT03678103|463892203|FG000|Overall Study|Withdrawn prior to completion|4|||
128889172|NCT01241552|463892208|FG000|Overall Study|Lack of Efficacy|1|||
128889173|NCT01241552|463892209|FG001|Overall Study|Lack of Efficacy|0|||
128889174|NCT01241552|463892210|FG002|Overall Study|Lack of Efficacy|0|||
128889175|NCT01241552|463892211|FG003|Overall Study|Lack of Efficacy|0|||
128889176|NCT01241552|463892208|FG000|Overall Study|Death|26|||
128889177|NCT01241552|463892209|FG001|Overall Study|Death|30|||
128889178|NCT01241552|463892210|FG002|Overall Study|Death|20|||
128889179|NCT01241552|463892211|FG003|Overall Study|Death|25|||
128889180|NCT01241552|463892208|FG000|Overall Study|Adverse Event|1|||
128889181|NCT01241552|463892209|FG001|Overall Study|Adverse Event|1|||
128889182|NCT01241552|463892210|FG002|Overall Study|Adverse Event|0|||
128889183|NCT01241552|463892211|FG003|Overall Study|Adverse Event|0|||
128889184|NCT01241552|463892208|FG000|Overall Study|Technical Problems|2|||
128889185|NCT01241552|463892209|FG001|Overall Study|Technical Problems|0|||
128889186|NCT01241552|463892210|FG002|Overall Study|Technical Problems|2|||
128889187|NCT01241552|463892211|FG003|Overall Study|Technical Problems|2|||
128889188|NCT01241552|463892208|FG000|Overall Study|Progressive Disease|0|||
128889189|NCT01241552|463892209|FG001|Overall Study|Progressive Disease|0|||
128889190|NCT01241552|463892210|FG002|Overall Study|Progressive Disease|1|||
128889191|NCT01241552|463892211|FG003|Overall Study|Progressive Disease|2|||
128889192|NCT01241552|463892208|FG000|Overall Study|Protocol Violation|0|||
128889193|NCT01241552|463892209|FG001|Overall Study|Protocol Violation|2|||
128889194|NCT01241552|463892210|FG002|Overall Study|Protocol Violation|6|||
128889195|NCT01241552|463892211|FG003|Overall Study|Protocol Violation|1|||
128889196|NCT01241552|463892208|FG000|Overall Study|Withdrawal by Subject|7|||
128889197|NCT01241552|463892209|FG001|Overall Study|Withdrawal by Subject|15|||
128889198|NCT01241552|463892210|FG002|Overall Study|Withdrawal by Subject|14|||
128889199|NCT01241552|463892211|FG003|Overall Study|Withdrawal by Subject|15|||
128889200|NCT01241552|463892208|FG000|Overall Study|Physician Decision|2|||
128763853|NCT03879408|463425822|FG001|Overall Study|Withdrawal by Subject|1|||
128763854|NCT03879408|463425823|FG002|Overall Study|Withdrawal by Subject|1|||
128763855|NCT03879408|463425824|FG003|Overall Study|Withdrawal by Subject|0|||
128763856|NCT03879408|463425825|FG004|Overall Study|Withdrawal by Subject|1|||
128763857|NCT00728962|463425829|FG000|Implant Placement Surgery|Adverse Event|8|||
128889201|NCT01241552|463892209|FG001|Overall Study|Physician Decision|4|||
128889202|NCT01241552|463892210|FG002|Overall Study|Physician Decision|2|||
128889203|NCT01241552|463892211|FG003|Overall Study|Physician Decision|3|||
128889204|NCT01241552|463892208|FG000|Overall Study|Lost to Follow-up|2|||
128889205|NCT01241552|463892209|FG001|Overall Study|Lost to Follow-up|11|||
128889206|NCT01241552|463892210|FG002|Overall Study|Lost to Follow-up|15|||
128889207|NCT01241552|463892211|FG003|Overall Study|Lost to Follow-up|16|||
128889208|NCT00528567|463892212|FG000|Overall Study|Death|4|||
128889209|NCT00528567|463892213|FG001|Overall Study|Death|5|||
128889210|NCT00528567|463892212|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
128889211|NCT00528567|463892213|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
128889212|NCT00528567|463892212|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
128889213|NCT00528567|463892213|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
128889214|NCT00528567|463892212|FG000|Overall Study|Violation Criteria at Entry|3|||
128889215|NCT00528567|463892213|FG001|Overall Study|Violation Criteria at Entry|17|||
128889216|NCT00528567|463892212|FG000|Overall Study|Withdrew Consent|59|||
128889217|NCT00528567|463892213|FG001|Overall Study|Withdrew Consent|55|||
128889218|NCT00528567|463892212|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
128889219|NCT00528567|463892213|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
128889220|NCT00528567|463892212|FG000|Overall Study|Failure to Return|1|||
128889221|NCT00528567|463892213|FG001|Overall Study|Failure to Return|4|||
128889222|NCT00528567|463892212|FG000|Overall Study|Other Protocol Violation|5|||
128889223|NCT00528567|463892213|FG001|Overall Study|Other Protocol Violation|21|||
128889224|NCT00528567|463892212|FG000|Overall Study|Administrative/Other|22|||
128889225|NCT00528567|463892213|FG001|Overall Study|Administrative/Other|75|||
128889226|NCT00631189|463892216|FG000|Initial Phase|Protocol Violation|347|||
128889227|NCT00631189|463892217|FG001|Initial Phase|Protocol Violation|0|||
128889228|NCT00631189|463892218|FG002|Initial Phase|Protocol Violation|0|||
128889229|NCT00631189|463892219|FG003|Initial Phase|Protocol Violation|0|||
128889230|NCT00631189|463892216|FG000|Initial Phase|Withdrawal by Subject|4|||
128889231|NCT00631189|463892217|FG001|Initial Phase|Withdrawal by Subject|0|||
128889232|NCT00631189|463892218|FG002|Initial Phase|Withdrawal by Subject|0|||
128889233|NCT00631189|463892219|FG003|Initial Phase|Withdrawal by Subject|0|||
128889234|NCT00631189|463892216|FG000|Treatment Phase|Withdrawal by Subject|0|||
128889235|NCT00631189|463892217|FG001|Treatment Phase|Withdrawal by Subject|2|||
128889236|NCT00631189|463892218|FG002|Treatment Phase|Withdrawal by Subject|1|||
128889237|NCT00631189|463892219|FG003|Treatment Phase|Withdrawal by Subject|1|||
128889238|NCT00631189|463892216|FG000|Treatment Phase|Protocol Violation|0|||
128889239|NCT00631189|463892217|FG001|Treatment Phase|Protocol Violation|1|||
128889240|NCT00631189|463892218|FG002|Treatment Phase|Protocol Violation|6|||
128889241|NCT00631189|463892219|FG003|Treatment Phase|Protocol Violation|2|||
128889242|NCT00631189|463892216|FG000|Treatment Phase|Adverse Event|0|||
128889243|NCT00631189|463892217|FG001|Treatment Phase|Adverse Event|3|||
128889244|NCT00631189|463892218|FG002|Treatment Phase|Adverse Event|2|||
128889245|NCT00631189|463892219|FG003|Treatment Phase|Adverse Event|4|||
128889246|NCT00631189|463892216|FG000|Treatment Phase|Lost to Follow-up|0|||
128889247|NCT00631189|463892217|FG001|Treatment Phase|Lost to Follow-up|1|||
128889248|NCT00631189|463892218|FG002|Treatment Phase|Lost to Follow-up|0|||
128889249|NCT00631189|463892219|FG003|Treatment Phase|Lost to Follow-up|0|||
128889250|NCT00631189|463892216|FG000|Treatment Phase|Pregnancy|0|||
128889251|NCT00631189|463892217|FG001|Treatment Phase|Pregnancy|0|||
128889252|NCT00631189|463892218|FG002|Treatment Phase|Pregnancy|1|||
128889253|NCT00631189|463892219|FG003|Treatment Phase|Pregnancy|0|||
128889254|NCT00631189|463892216|FG000|Treatment Phase|patient did not take pravastatin|0|||
128889255|NCT00631189|463892217|FG001|Treatment Phase|patient did not take pravastatin|0|||
128889256|NCT00631189|463892218|FG002|Treatment Phase|patient did not take pravastatin|1|||
128889257|NCT00631189|463892219|FG003|Treatment Phase|patient did not take pravastatin|0|||
128889258|NCT04464265|463892220|FG000|Overall Study|Physician Decision|2|||
128889259|NCT00974090|463892225|FG000|Period 1: Double Blind Period|Adverse Event|2|||
128889260|NCT00974090|463892226|FG001|Period 1: Double Blind Period|Adverse Event|1|||
128889261|NCT00974090|463892225|FG000|Period 1: Double Blind Period|Physician Decision|1|||
128889262|NCT00974090|463892226|FG001|Period 1: Double Blind Period|Physician Decision|0|||
128889263|NCT00974090|463892225|FG000|Period 2: Open-label Period|Adverse Event|4|||
128889264|NCT00974090|463892226|FG001|Period 2: Open-label Period|Adverse Event|6|||
128889265|NCT00974090|463892225|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
128889266|NCT00974090|463892226|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
128889267|NCT00974090|463892225|FG000|Period 2: Open-label Period|Physician Decision|0|||
128889268|NCT00974090|463892226|FG001|Period 2: Open-label Period|Physician Decision|3|||
128889269|NCT00974090|463892225|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
128889270|NCT00974090|463892226|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
128889271|NCT03189862|463892227|FG000|Overall Study|Withdrawal by Subject|1|||
128889272|NCT03189862|463892228|FG001|Overall Study|Withdrawal by Subject|0|||
128889273|NCT03189862|463892227|FG000|Overall Study|Lost to Follow-up|54|||
128889274|NCT03189862|463892228|FG001|Overall Study|Lost to Follow-up|62|||
128889275|NCT00056862|463892229|FG000|Overall Study|Protocol Violation|1|||
128889276|NCT00056862|463892230|FG001|Overall Study|Protocol Violation|0|||
128889277|NCT01829360|463892231|FG000|Overall Study|Protocol Violation|0|||
128889278|NCT01829360|463892232|FG001|Overall Study|Protocol Violation|0|||
128889279|NCT01829360|463892233|FG002|Overall Study|Protocol Violation|1|||
128688225|NCT03911713|463158918|FG003|Overall Study|Other|1|||
128688226|NCT03911713|463158919|FG004|Overall Study|Other|0|||
128889280|NCT01829360|463892234|FG003|Overall Study|Protocol Violation|0|||
128889281|NCT03838198|463892239|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
128889282|NCT03838198|463892240|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
128889283|NCT03838198|463892241|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
128889284|NCT03838198|463892242|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
128688227|NCT03911713|463158915|FG000|Overall Study|Randomized, Never Dosed|1|||
129110078|NCT00249873|464697806|FG001|Overall Study|Physician withdrew consent|60|||
129110079|NCT00249873|464697805|FG000|Overall Study|Open label clopidogrel required|31|||
129110080|NCT00249873|464697806|FG001|Overall Study|Open label clopidogrel required|42|||
129110081|NCT00249873|464697805|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
129110082|NCT00249873|464697806|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
129110083|NCT00249873|464697805|FG000|Overall Study|Oral anticoagulant required|159|||
128688228|NCT03911713|463158916|FG001|Overall Study|Randomized, Never Dosed|0|||
128688229|NCT03911713|463158917|FG002|Overall Study|Randomized, Never Dosed|0|||
128688230|NCT03911713|463158918|FG003|Overall Study|Randomized, Never Dosed|1|||
128688231|NCT03911713|463158919|FG004|Overall Study|Randomized, Never Dosed|0|||
128688232|NCT02437513|463158920|FG000|Overall Study|Withdrawal by Subject|2|||
128688233|NCT01845818|463158921|FG000|Overall Study|Withdrawal by Subject|0|||
128688234|NCT01845818|463158922|FG001|Overall Study|Withdrawal by Subject|1|||
128688235|NCT01845818|463158921|FG000|Overall Study|Lost to Follow-up|7|||
128688236|NCT01845818|463158922|FG001|Overall Study|Lost to Follow-up|5|||
128688237|NCT01845818|463158921|FG000|Overall Study|Administrative Reasons|3|||
128688238|NCT01845818|463158922|FG001|Overall Study|Administrative Reasons|1|||
128688239|NCT01845818|463158921|FG000|Overall Study|Serious Adverse Event|1|||
128688240|NCT01845818|463158922|FG001|Overall Study|Serious Adverse Event|1|||
128688241|NCT01845818|463158921|FG000|Overall Study|Other|25|||
128688242|NCT01845818|463158922|FG001|Overall Study|Other|8|||
128688243|NCT01845818|463158921|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
128688244|NCT01845818|463158922|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
128688245|NCT01845818|463158921|FG000|Overall Study|No Follow-Up Data Available|4|||
128688246|NCT01845818|463158922|FG001|Overall Study|No Follow-Up Data Available|1|||
128688247|NCT00107783|463158923|FG000|Overall Study|Adverse Event|0|||
128688248|NCT00107783|463158924|FG001|Overall Study|Adverse Event|2|||
128688249|NCT00107783|463158923|FG000|Overall Study|Death|0|||
128688250|NCT00107783|463158924|FG001|Overall Study|Death|1|||
128688251|NCT00107783|463158923|FG000|Overall Study|Withdrawal by Subject|2|||
128688252|NCT00107783|463158924|FG001|Overall Study|Withdrawal by Subject|0|||
128688253|NCT00107783|463158923|FG000|Overall Study|Second hip replacement|1|||
128688254|NCT00107783|463158924|FG001|Overall Study|Second hip replacement|1|||
128688255|NCT00422097|463158925|FG000|Dose Level 2|Still on treatment|0|||
128688256|NCT00422097|463158926|FG001|Dose Level 2|Still on treatment|1|||
128688257|NCT00422097|463158927|FG002|Dose Level 2|Still on treatment|0|||
128688258|NCT00422097|463158928|FG003|Dose Level 2|Still on treatment|0|||
128688259|NCT00422097|463158929|FG004|Dose Level 2|Still on treatment|0|||
128688260|NCT00422097|463158930|FG005|Dose Level 2|Still on treatment|0|||
128688261|NCT00422097|463158931|FG006|Dose Level 2|Still on treatment|0|||
128688262|NCT00422097|463158932|FG007|Dose Level 2|Still on treatment|0|||
128688263|NCT00137631|463158934|FG000|Overall Study|Lost to Follow-up|37|||
128688264|NCT00137631|463158935|FG001|Overall Study|Lost to Follow-up|41|||
128688265|NCT05061966|463158947|FG000|Overall Study|Lost to Follow-up|13|||
128688266|NCT05061966|463158948|FG001|Overall Study|Lost to Follow-up|13|||
128688267|NCT00145600|463158949|FG000|Overall Study|Death|1|||
128688268|NCT00145600|463158950|FG001|Overall Study|Death|2|||
128688269|NCT00145600|463158951|FG002|Overall Study|Death|2|||
128688270|NCT00145600|463158952|FG003|Overall Study|Death|6|||
128688271|NCT00145600|463158949|FG000|Overall Study|Ineligible|3|||
128688272|NCT00145600|463158950|FG001|Overall Study|Ineligible|0|||
128688273|NCT00145600|463158951|FG002|Overall Study|Ineligible|1|||
128688274|NCT00145600|463158952|FG003|Overall Study|Ineligible|5|||
128688275|NCT00145600|463158949|FG000|Overall Study|Lost to Follow-up|2|||
128688276|NCT00145600|463158950|FG001|Overall Study|Lost to Follow-up|6|||
128688277|NCT00145600|463158951|FG002|Overall Study|Lost to Follow-up|2|||
128688278|NCT00145600|463158952|FG003|Overall Study|Lost to Follow-up|4|||
128688279|NCT00145600|463158949|FG000|Overall Study|Noncompliance|1|||
128688280|NCT00145600|463158950|FG001|Overall Study|Noncompliance|0|||
128688281|NCT00145600|463158951|FG002|Overall Study|Noncompliance|0|||
128688282|NCT00145600|463158952|FG003|Overall Study|Noncompliance|0|||
128688283|NCT00145600|463158949|FG000|Overall Study|Withdrawal by Subject|1|||
128688284|NCT00145600|463158950|FG001|Overall Study|Withdrawal by Subject|2|||
128688285|NCT00145600|463158951|FG002|Overall Study|Withdrawal by Subject|0|||
129110084|NCT00249873|464697806|FG001|Overall Study|Oral anticoagulant required|157|||
128688286|NCT00145600|463158952|FG003|Overall Study|Withdrawal by Subject|1|||
128688287|NCT00761579|463158957|FG000|Overall Study|Adverse Event|10|||
128688288|NCT00761579|463158957|FG000|Overall Study|Death|2|||
128688289|NCT00761579|463158957|FG000|Overall Study|Lack of Efficacy|21|||
128688290|NCT00761579|463158957|FG000|Overall Study|Lost to Follow-up|16|||
128688291|NCT00761579|463158957|FG000|Overall Study|Pregnancy|1|||
128688292|NCT00761579|463158957|FG000|Overall Study|Withdrawal by Subject|34|||
128688293|NCT00761579|463158957|FG000|Overall Study|Lack of compliance|2|||
128688294|NCT00761579|463158957|FG000|Overall Study|Protocol deviation|1|||
128688295|NCT00761579|463158957|FG000|Overall Study|Drug overdose|1|||
129110085|NCT00249873|464697805|FG000|Overall Study|Study drug intolerance|5|||
128688296|NCT00761579|463158957|FG000|Overall Study|Aggravation of depression|1|||
128688297|NCT00761579|463158957|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
128688298|NCT00761579|463158957|FG000|Overall Study|Lost survey form|1|||
128889285|NCT03838198|463892239|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
128889286|NCT03838198|463892240|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
128889287|NCT03838198|463892241|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
128889288|NCT03838198|463892242|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
128889289|NCT01271803|463892243|FG000|Overall Study|Progressive disease|0|||
128889290|NCT01271803|463892244|FG001|Overall Study|Progressive disease|0|||
128889291|NCT01271803|463892245|FG002|Overall Study|Progressive disease|2|||
128889292|NCT01271803|463892243|FG000|Overall Study|Death|53|||
128889293|NCT01271803|463892244|FG001|Overall Study|Death|34|||
128889294|NCT01271803|463892245|FG002|Overall Study|Death|0|||
128889295|NCT01271803|463892243|FG000|Overall Study|Withdrawal by Subject|1|||
128889296|NCT01271803|463892244|FG001|Overall Study|Withdrawal by Subject|5|||
128889297|NCT01271803|463892245|FG002|Overall Study|Withdrawal by Subject|0|||
128889298|NCT01271803|463892243|FG000|Overall Study|Lost to Follow-up|1|||
128889299|NCT01271803|463892244|FG001|Overall Study|Lost to Follow-up|0|||
128889300|NCT01271803|463892245|FG002|Overall Study|Lost to Follow-up|0|||
128889301|NCT02178553|463892251|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
128889302|NCT02178553|463892252|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
128889303|NCT02178553|463892251|FG000|Overall Study|Physician Decision|0|||
128889304|NCT02178553|463892252|FG001|Overall Study|Physician Decision|4|||
128889305|NCT02178553|463892251|FG000|Overall Study|Technical problem with injection|1|||
128889306|NCT02178553|463892252|FG001|Overall Study|Technical problem with injection|3|||
128889307|NCT02187809|463892253|FG000|Overall Study|The study was terminated|3|||
128889308|NCT05085665|463892254|FG000|Overall Study|Physician Decision|2|||
128889309|NCT01641809|463892255|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
128889310|NCT01641809|463892256|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
128889311|NCT01641809|463892257|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
128889312|NCT01641809|463892258|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
128889313|NCT01641809|463892255|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
128889314|NCT01641809|463892256|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
128889315|NCT01641809|463892257|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
128889316|NCT01641809|463892258|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
128889317|NCT01641809|463892255|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
128889318|NCT01641809|463892256|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
128889319|NCT01641809|463892257|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
128889320|NCT01641809|463892258|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
128889321|NCT01641809|463892255|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
128889322|NCT01641809|463892256|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
128889323|NCT01641809|463892257|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
128889324|NCT01641809|463892258|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
128889325|NCT01641809|463892255|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
128889326|NCT01641809|463892256|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
128889327|NCT01641809|463892257|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
128889328|NCT01641809|463892258|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
128889329|NCT01641809|463892255|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
128889330|NCT01641809|463892256|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
128889331|NCT01641809|463892257|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
128889332|NCT01641809|463892258|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
128889333|NCT01641809|463892255|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
128889334|NCT01641809|463892256|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
128889335|NCT01641809|463892257|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
128889336|NCT01641809|463892258|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
128889337|NCT01641809|463892255|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
128889338|NCT01641809|463892256|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
128889339|NCT01641809|463892257|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
128889340|NCT01641809|463892258|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
129110086|NCT00249873|464697806|FG001|Overall Study|Study drug intolerance|0|||
129110087|NCT00249873|464697805|FG000|Overall Study|Surgery/ procedure|9|||
129110088|NCT00249873|464697806|FG001|Overall Study|Surgery/ procedure|9|||
129110089|NCT00249873|464697805|FG000|Overall Study|Event related to cardiac condition|12|||
129110090|NCT00249873|464697806|FG001|Overall Study|Event related to cardiac condition|21|||
129110091|NCT00249873|464697805|FG000|Overall Study|Thromboembolic/outcome event|82|||
129110092|NCT00249873|464697806|FG001|Overall Study|Thromboembolic/outcome event|122|||
129110093|NCT03131167|464697807|FG000|Overall Study|Other (Unspecified)|0|||
129110094|NCT03131167|464697808|FG001|Overall Study|Other (Unspecified)|0|||
128889341|NCT01641809|463892255|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
128889342|NCT01641809|463892256|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
128889343|NCT01641809|463892257|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
128889344|NCT01641809|463892258|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
128889345|NCT01641809|463892255|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
128889346|NCT01641809|463892256|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
128889347|NCT01641809|463892257|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
128889348|NCT01641809|463892258|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
128889349|NCT01641809|463892255|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
128889350|NCT01641809|463892256|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
128889351|NCT01641809|463892257|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
128889352|NCT01641809|463892258|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
128889353|NCT01641809|463892255|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
128889354|NCT01641809|463892256|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
128889355|NCT01641809|463892257|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
128889356|NCT01641809|463892258|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
128889357|NCT01641809|463892255|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
128889358|NCT01641809|463892256|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
128889359|NCT01641809|463892257|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
128889360|NCT01641809|463892258|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
128889361|NCT01641809|463892255|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
128889362|NCT01641809|463892256|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
128889363|NCT01641809|463892257|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
128889364|NCT01641809|463892258|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
128889365|NCT01641809|463892255|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
128889366|NCT01641809|463892256|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
128889367|NCT01641809|463892257|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
128889368|NCT01641809|463892258|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
128889369|NCT01641809|463892255|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
128889370|NCT01641809|463892256|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
129110095|NCT03131167|464697809|FG002|Overall Study|Other (Unspecified)|0|||
129110096|NCT03131167|464697810|FG003|Overall Study|Other (Unspecified)|0|||
129110097|NCT03131167|464697811|FG004|Overall Study|Other (Unspecified)|0|||
129110098|NCT03131167|464697812|FG005|Overall Study|Other (Unspecified)|1|||
129110099|NCT03131167|464697813|FG006|Overall Study|Other (Unspecified)|0|||
129110100|NCT03131167|464697814|FG007|Overall Study|Other (Unspecified)|0|||
129110101|NCT03131167|464697815|FG008|Overall Study|Other (Unspecified)|0|||
129110102|NCT03131167|464697816|FG009|Overall Study|Other (Unspecified)|0|||
129110103|NCT03131167|464697817|FG010|Overall Study|Other (Unspecified)|0|||
129110104|NCT03131167|464697818|FG011|Overall Study|Other (Unspecified)|0|||
129110105|NCT03131167|464697819|FG012|Overall Study|Other (Unspecified)|0|||
129110106|NCT00165503|464697820|FG000|Overall Study|Death|1|||
129110107|NCT00165503|464697820|FG000|Overall Study|Lost to Follow-up|12|||
129110108|NCT00165503|464697820|FG000|Overall Study|Unresectable|3|||
129110109|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Death|20|||
129110110|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Death|26|||
129110111|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
129110112|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
129110113|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
129110114|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
129110115|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
129110116|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
129110117|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
129110118|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
129110119|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
129110120|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
129110121|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
129110122|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
129110123|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
129110124|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
129110125|NCT00643201|464697821|FG000|Randomized, Completed 6 Months of Study|Other|107|||
129110126|NCT00643201|464697822|FG001|Randomized, Completed 6 Months of Study|Other|107|||
129110127|NCT00643201|464697821|FG000|Completed Study Follow Up|Death|28|||
129110128|NCT00643201|464697822|FG001|Completed Study Follow Up|Death|34|||
129110129|NCT00643201|464697821|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
129110130|NCT00643201|464697822|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
129110131|NCT00643201|464697821|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
129110132|NCT00643201|464697822|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
129215191|NCT02002598|465089460|FG004|Dose Level 1|Withdrawal by Subject|0|||
128889371|NCT01641809|463892257|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
128889372|NCT01641809|463892258|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
128889373|NCT01641809|463892255|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
128889374|NCT01641809|463892256|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
128889375|NCT01641809|463892257|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
128889376|NCT01641809|463892258|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
128889377|NCT01641809|463892255|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
128889378|NCT01641809|463892256|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
128889379|NCT01641809|463892257|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
128889380|NCT01641809|463892258|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
128889381|NCT00778622|463892259|FG000|Overall Study|Adverse Event|5|||
128889382|NCT00778622|463892260|FG001|Overall Study|Adverse Event|4|||
128889383|NCT00778622|463892261|FG002|Overall Study|Adverse Event|7|||
128889384|NCT00778622|463892259|FG000|Overall Study|Withdrawal by Subject|4|||
128889385|NCT00778622|463892260|FG001|Overall Study|Withdrawal by Subject|5|||
128889386|NCT00778622|463892261|FG002|Overall Study|Withdrawal by Subject|5|||
128889387|NCT00778622|463892259|FG000|Overall Study|Lost to Follow-up|3|||
128889388|NCT00778622|463892260|FG001|Overall Study|Lost to Follow-up|3|||
128889389|NCT00778622|463892261|FG002|Overall Study|Lost to Follow-up|2|||
128889390|NCT00778622|463892259|FG000|Overall Study|Protocol Violation|0|||
128889391|NCT00778622|463892260|FG001|Overall Study|Protocol Violation|3|||
128889392|NCT00778622|463892261|FG002|Overall Study|Protocol Violation|0|||
128889393|NCT00778622|463892259|FG000|Overall Study|Lack of Efficacy|2|||
128889394|NCT00778622|463892260|FG001|Overall Study|Lack of Efficacy|0|||
128889395|NCT00778622|463892261|FG002|Overall Study|Lack of Efficacy|0|||
128889396|NCT00778622|463892259|FG000|Overall Study|immigration|1|||
128889397|NCT00778622|463892260|FG001|Overall Study|immigration|0|||
128889398|NCT00778622|463892261|FG002|Overall Study|immigration|0|||
128889399|NCT00778622|463892259|FG000|Overall Study|Other|1|||
128889400|NCT00778622|463892260|FG001|Overall Study|Other|0|||
128889401|NCT00778622|463892261|FG002|Overall Study|Other|1|||
128889402|NCT00890929|463892262|FG000|Overall Study|Death before treatment|2|||
128889403|NCT00890929|463892262|FG000|Overall Study|Withdrawal by Subject|3|||
128889404|NCT00890929|463892262|FG000|Overall Study|Physician Decision|1|||
128889405|NCT01840605|463892265|FG000|Overall Study|Adverse Event|0|||
128889406|NCT01840605|463892266|FG001|Overall Study|Adverse Event|1|||
128889407|NCT01840605|463892265|FG000|Overall Study|Physician Decision|2|||
128889408|NCT01840605|463892266|FG001|Overall Study|Physician Decision|1|||
128889409|NCT03065023|463892267|FG000|Overall Study|Progressive Disease|0|||
128889410|NCT03065023|463892268|FG001|Overall Study|Progressive Disease|1|||
128889411|NCT03065023|463892269|FG002|Overall Study|Progressive Disease|0|||
128889412|NCT03065023|463892270|FG003|Overall Study|Progressive Disease|0|||
128889413|NCT03065023|463892271|FG004|Overall Study|Progressive Disease|0|||
128889414|NCT03065023|463892267|FG000|Overall Study|Death|2|||
128889415|NCT03065023|463892268|FG001|Overall Study|Death|0|||
128889416|NCT03065023|463892269|FG002|Overall Study|Death|1|||
128889417|NCT03065023|463892270|FG003|Overall Study|Death|1|||
128889418|NCT03065023|463892271|FG004|Overall Study|Death|0|||
128889419|NCT03065023|463892267|FG000|Overall Study|Lost to Follow-up|0|||
128889420|NCT03065023|463892268|FG001|Overall Study|Lost to Follow-up|1|||
128889421|NCT03065023|463892269|FG002|Overall Study|Lost to Follow-up|0|||
128889422|NCT03065023|463892270|FG003|Overall Study|Lost to Follow-up|0|||
128889423|NCT03065023|463892271|FG004|Overall Study|Lost to Follow-up|0|||
128889424|NCT03065023|463892267|FG000|Overall Study|Participant Decision|0|||
128889425|NCT03065023|463892268|FG001|Overall Study|Participant Decision|0|||
128889426|NCT03065023|463892269|FG002|Overall Study|Participant Decision|0|||
128889427|NCT03065023|463892270|FG003|Overall Study|Participant Decision|1|||
128889428|NCT03065023|463892271|FG004|Overall Study|Participant Decision|0|||
128889429|NCT03065023|463892267|FG000|Overall Study|Withdrawal by Subject|0|||
128889430|NCT03065023|463892268|FG001|Overall Study|Withdrawal by Subject|0|||
128763858|NCT00728962|463425829|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
128763859|NCT00728962|463425829|FG000|Implant Placement Surgery|Protocol Violation|1|||
128763860|NCT00728962|463425829|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
128763861|NCT00728962|463425829|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
128763862|NCT05807919|463425830|FG000|Overall Study|Received antibiotics - excluded|0|||
128763863|NCT05807919|463425831|FG001|Overall Study|Received antibiotics - excluded|1|||
128763864|NCT05807919|463425830|FG000|Overall Study|Withdrawal by Subject|0|||
128763865|NCT05807919|463425831|FG001|Overall Study|Withdrawal by Subject|3|||
128763866|NCT05807919|463425830|FG000|Overall Study|Adverse Event|1|||
128763867|NCT05807919|463425831|FG001|Overall Study|Adverse Event|1|||
128763868|NCT04027348|463425832|FG000|Overall Study|Adverse Event|2|||
128763869|NCT02487472|463425833|FG000|Overall Study|Did not complete telephonic interviews|9|||
128763870|NCT02487472|463425833|FG000|Overall Study|Other|2|||
128763871|NCT01931735|463425836|FG000|Randomized Phase|Lost to Follow-up|2|||
128889431|NCT03065023|463892269|FG002|Overall Study|Withdrawal by Subject|0|||
128889432|NCT03065023|463892270|FG003|Overall Study|Withdrawal by Subject|1|||
128889433|NCT03065023|463892271|FG004|Overall Study|Withdrawal by Subject|0|||
128889434|NCT04029961|463892272|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
128889435|NCT04029961|463892273|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
128889436|NCT04029961|463892272|FG000|Overall Study|Change in Treatment Course|0|||
128889437|NCT04029961|463892273|FG001|Overall Study|Change in Treatment Course|1|||
128889438|NCT03427125|463892274|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
128889439|NCT03427125|463892275|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
128889440|NCT03427125|463892276|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
128889441|NCT05975840|463892277|FG000|Overall Study|Other|1|||
128889442|NCT05975840|463892278|FG001|Overall Study|Other|0|||
128889443|NCT05975840|463892279|FG002|Overall Study|Other|0|||
128889444|NCT05975840|463892280|FG003|Overall Study|Other|0|||
128889445|NCT05975840|463892281|FG004|Overall Study|Other|1|||
128889446|NCT05975840|463892282|FG005|Overall Study|Other|0|||
128889447|NCT05975840|463892283|FG006|Overall Study|Other|0|||
128889448|NCT05975840|463892284|FG007|Overall Study|Other|0|||
128889449|NCT05975840|463892277|FG000|Overall Study|Lost to Follow-up|3|||
128889450|NCT05975840|463892278|FG001|Overall Study|Lost to Follow-up|6|||
128889451|NCT05975840|463892279|FG002|Overall Study|Lost to Follow-up|3|||
128889452|NCT05975840|463892280|FG003|Overall Study|Lost to Follow-up|1|||
128889453|NCT05975840|463892281|FG004|Overall Study|Lost to Follow-up|4|||
128889454|NCT05975840|463892282|FG005|Overall Study|Lost to Follow-up|1|||
128889455|NCT05975840|463892283|FG006|Overall Study|Lost to Follow-up|2|||
128889456|NCT05975840|463892284|FG007|Overall Study|Lost to Follow-up|4|||
128889457|NCT05975840|463892277|FG000|Overall Study|Migrated/moved from the study area|1|||
128889458|NCT05975840|463892278|FG001|Overall Study|Migrated/moved from the study area|0|||
128889459|NCT05975840|463892279|FG002|Overall Study|Migrated/moved from the study area|0|||
128889460|NCT05975840|463892280|FG003|Overall Study|Migrated/moved from the study area|0|||
128889461|NCT05975840|463892281|FG004|Overall Study|Migrated/moved from the study area|0|||
128889462|NCT05975840|463892282|FG005|Overall Study|Migrated/moved from the study area|0|||
128889463|NCT05975840|463892283|FG006|Overall Study|Migrated/moved from the study area|0|||
128889464|NCT05975840|463892284|FG007|Overall Study|Migrated/moved from the study area|0|||
128889465|NCT05975840|463892277|FG000|Overall Study|Withdrawal by Subject|0|||
128889466|NCT05975840|463892278|FG001|Overall Study|Withdrawal by Subject|5|||
128889467|NCT05975840|463892279|FG002|Overall Study|Withdrawal by Subject|2|||
128889468|NCT05975840|463892280|FG003|Overall Study|Withdrawal by Subject|2|||
128889469|NCT05975840|463892281|FG004|Overall Study|Withdrawal by Subject|0|||
128889470|NCT05975840|463892282|FG005|Overall Study|Withdrawal by Subject|2|||
128889471|NCT05975840|463892283|FG006|Overall Study|Withdrawal by Subject|2|||
128889472|NCT05975840|463892284|FG007|Overall Study|Withdrawal by Subject|1|||
128889473|NCT05975840|463892277|FG000|Overall Study|Protocol Violation|0|||
128889474|NCT05975840|463892278|FG001|Overall Study|Protocol Violation|1|||
128889475|NCT05975840|463892279|FG002|Overall Study|Protocol Violation|0|||
128889476|NCT05975840|463892280|FG003|Overall Study|Protocol Violation|0|||
128889477|NCT05975840|463892281|FG004|Overall Study|Protocol Violation|0|||
128889478|NCT05975840|463892282|FG005|Overall Study|Protocol Violation|0|||
128889479|NCT05975840|463892283|FG006|Overall Study|Protocol Violation|0|||
128889480|NCT05975840|463892284|FG007|Overall Study|Protocol Violation|0|||
128889481|NCT05975840|463892277|FG000|Overall Study|Adverse Event|0|||
128889482|NCT05975840|463892278|FG001|Overall Study|Adverse Event|0|||
128889483|NCT05975840|463892279|FG002|Overall Study|Adverse Event|0|||
128889484|NCT05975840|463892280|FG003|Overall Study|Adverse Event|1|||
128889485|NCT05975840|463892281|FG004|Overall Study|Adverse Event|0|||
128889486|NCT05975840|463892282|FG005|Overall Study|Adverse Event|0|||
128889487|NCT05975840|463892283|FG006|Overall Study|Adverse Event|0|||
128889488|NCT05975840|463892284|FG007|Overall Study|Adverse Event|0|||
128889489|NCT05975840|463892277|FG000|Overall Study|Death|0|||
128889490|NCT05975840|463892278|FG001|Overall Study|Death|1|||
128889491|NCT05975840|463892279|FG002|Overall Study|Death|0|||
128889492|NCT05975840|463892280|FG003|Overall Study|Death|0|||
128889493|NCT05975840|463892281|FG004|Overall Study|Death|0|||
128889494|NCT05975840|463892282|FG005|Overall Study|Death|0|||
128763872|NCT01931735|463425837|FG001|Randomized Phase|Lost to Follow-up|2|||
128763873|NCT01931735|463425838|FG002|Randomized Phase|Lost to Follow-up|5|||
128763874|NCT01931735|463425839|FG003|Randomized Phase|Lost to Follow-up|0|||
128763875|NCT01931735|463425836|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
128763876|NCT01931735|463425837|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
128763877|NCT01931735|463425838|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
128763878|NCT01931735|463425839|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
128889495|NCT05975840|463892283|FG006|Overall Study|Death|0|||
128889496|NCT05975840|463892284|FG007|Overall Study|Death|1|||
128889497|NCT04014361|463892287|FG000|Period 2|Physician Decision|0|||
128889498|NCT04014361|463892288|FG001|Period 2|Physician Decision|0|||
128889499|NCT04014361|463892289|FG002|Period 2|Physician Decision|0|||
128889500|NCT04014361|463892290|FG003|Period 2|Physician Decision|1|||
128889501|NCT04014361|463892291|FG004|Period 2|Physician Decision|0|||
128889502|NCT04014361|463892292|FG005|Period 2|Physician Decision|0|||
128889503|NCT04014361|463892293|FG006|Period 2|Physician Decision|0|||
128889504|NCT04014361|463892294|FG007|Period 2|Physician Decision|0|||
128889505|NCT01130051|463892296|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
128889506|NCT01130051|463892297|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
128889507|NCT01130051|463892296|FG000|Washout Period of 14 Days|Protocol Violation|1|||
128889508|NCT01130051|463892297|FG001|Washout Period of 14 Days|Protocol Violation|1|||
128889509|NCT04252287|463892299|FG000|Overall Study|Death|5|||
128889510|NCT04252287|463892300|FG001|Overall Study|Death|3|||
128889511|NCT04252287|463892299|FG000|Overall Study|Lost to Follow-up|4|||
128889512|NCT04252287|463892300|FG001|Overall Study|Lost to Follow-up|6|||
128889513|NCT04252287|463892299|FG000|Overall Study|Withdrawal by Subject|19|||
128889514|NCT04252287|463892300|FG001|Overall Study|Withdrawal by Subject|16|||
128889515|NCT04252287|463892299|FG000|Overall Study|Protocol Violation|3|||
128889516|NCT04252287|463892300|FG001|Overall Study|Protocol Violation|4|||
128889517|NCT01298518|463892307|FG000|Overall Study|Withdrawal by Subject|0|||
128889518|NCT01298518|463892308|FG001|Overall Study|Withdrawal by Subject|0|||
128889519|NCT01298518|463892309|FG002|Overall Study|Withdrawal by Subject|1|||
128889520|NCT02273726|463892310|FG000|Overall Study|Death|70|||
128889521|NCT02273726|463892311|FG001|Overall Study|Death|62|||
128889522|NCT02273726|463892310|FG000|Overall Study|Withdrawal by Subject|41|||
128889523|NCT02273726|463892311|FG001|Overall Study|Withdrawal by Subject|29|||
128889524|NCT02273726|463892310|FG000|Overall Study|Kidney transplant|31|||
128889525|NCT02273726|463892311|FG001|Overall Study|Kidney transplant|39|||
128889526|NCT02273726|463892310|FG000|Overall Study|Physician Decision|30|||
128889527|NCT02273726|463892311|FG001|Overall Study|Physician Decision|15|||
128889528|NCT02273726|463892310|FG000|Overall Study|Adverse Event|27|||
128889529|NCT02273726|463892311|FG001|Overall Study|Adverse Event|9|||
128889530|NCT02273726|463892310|FG000|Overall Study|Lost to Follow-up|6|||
128889531|NCT02273726|463892311|FG001|Overall Study|Lost to Follow-up|3|||
128889532|NCT02273726|463892310|FG000|Overall Study|Lack of Efficacy|6|||
128889533|NCT02273726|463892311|FG001|Overall Study|Lack of Efficacy|1|||
128889534|NCT02273726|463892310|FG000|Overall Study|Protocol Violation|4|||
128889535|NCT02273726|463892311|FG001|Overall Study|Protocol Violation|0|||
128889536|NCT02273726|463892310|FG000|Overall Study|Other than specified|28|||
128889537|NCT02273726|463892311|FG001|Overall Study|Other than specified|30|||
128889538|NCT02129205|463892312|FG000|Overall Study|Withdrawal by Subject|0|||
128889539|NCT02129205|463892313|FG001|Overall Study|Withdrawal by Subject|0|||
128889540|NCT02129205|463892314|FG002|Overall Study|Withdrawal by Subject|0|||
128889541|NCT02129205|463892315|FG003|Overall Study|Withdrawal by Subject|0|||
128889542|NCT02129205|463892316|FG004|Overall Study|Withdrawal by Subject|1|||
128889543|NCT02129205|463892317|FG005|Overall Study|Withdrawal by Subject|1|||
128889544|NCT02129205|463892318|FG006|Overall Study|Withdrawal by Subject|1|||
128889545|NCT02129205|463892319|FG007|Overall Study|Withdrawal by Subject|0|||
128889546|NCT02129205|463892320|FG008|Overall Study|Withdrawal by Subject|1|||
128889547|NCT02129205|463892321|FG009|Overall Study|Withdrawal by Subject|0|||
128889548|NCT02129205|463892312|FG000|Overall Study|Other|1|||
128889549|NCT02129205|463892313|FG001|Overall Study|Other|0|||
128889550|NCT02129205|463892314|FG002|Overall Study|Other|0|||
128889551|NCT02129205|463892315|FG003|Overall Study|Other|0|||
128889552|NCT02129205|463892316|FG004|Overall Study|Other|2|||
128889553|NCT02129205|463892317|FG005|Overall Study|Other|3|||
128889554|NCT02129205|463892318|FG006|Overall Study|Other|3|||
128889555|NCT02129205|463892319|FG007|Overall Study|Other|2|||
128889556|NCT02129205|463892320|FG008|Overall Study|Other|1|||
128889557|NCT02129205|463892321|FG009|Overall Study|Other|0|||
128889558|NCT02877927|463892322|FG000|Overall Study|Adverse Event|1|||
128889559|NCT02877927|463892323|FG001|Overall Study|Adverse Event|0|||
128889560|NCT02877927|463892322|FG000|Overall Study|Lost to Follow-up|37|||
128889561|NCT02877927|463892323|FG001|Overall Study|Lost to Follow-up|38|||
128889562|NCT02877927|463892322|FG000|Overall Study|Withdrawal by Subject|11|||
128889563|NCT02877927|463892323|FG001|Overall Study|Withdrawal by Subject|12|||
128889564|NCT02877927|463892322|FG000|Overall Study|Physician Decision|0|||
128889565|NCT02877927|463892323|FG001|Overall Study|Physician Decision|1|||
128889566|NCT02877927|463892322|FG000|Overall Study|Missed EOT/PTE Visit|5|||
128889567|NCT02877927|463892323|FG001|Overall Study|Missed EOT/PTE Visit|6|||
128889568|NCT01810016|463892324|FG000|Overall Study|Progressive disease|1|||
128889569|NCT01810016|463892325|FG001|Overall Study|Progressive disease|1|||
128889570|NCT01810016|463892326|FG002|Overall Study|Progressive disease|0|||
128889571|NCT01810016|463892324|FG000|Overall Study|Death|0|||
128688299|NCT00761579|463158957|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
128688300|NCT00598702|463158958|FG000|Overall Study|Other|0|||
128688301|NCT00598702|463158959|FG001|Overall Study|Other|2|||
128688302|NCT00598702|463158960|FG002|Overall Study|Other|0|||
128889572|NCT01810016|463892325|FG001|Overall Study|Death|0|||
128889573|NCT01810016|463892326|FG002|Overall Study|Death|1|||
128889574|NCT00708175|463892327|FG000|Overall Study|Adverse Event|4|||
128688303|NCT00598702|463158961|FG003|Overall Study|Other|0|||
128889575|NCT00708175|463892328|FG001|Overall Study|Adverse Event|5|||
128889576|NCT00708175|463892327|FG000|Overall Study|Protocol Violation|2|||
128889577|NCT00708175|463892328|FG001|Overall Study|Protocol Violation|3|||
128889578|NCT00708175|463892327|FG000|Overall Study|Lost to Follow-up|5|||
128889579|NCT00708175|463892328|FG001|Overall Study|Lost to Follow-up|3|||
128889580|NCT00708175|463892327|FG000|Overall Study|Withdrawal by Subject|5|||
128889581|NCT00708175|463892328|FG001|Overall Study|Withdrawal by Subject|7|||
128889582|NCT00708175|463892327|FG000|Overall Study|BMD loss >7%|2|||
128889583|NCT00708175|463892328|FG001|Overall Study|BMD loss >7%|3|||
128889584|NCT04435782|463892334|FG000|Overall Study|Study terminated by sponsor|4|||
128889585|NCT03672461|463892335|FG000|Overall Study|COVID Related|4|||
128889586|NCT03672461|463892336|FG001|Overall Study|COVID Related|2|||
128889587|NCT03672461|463892335|FG000|Overall Study|Adverse Event|2|||
128889588|NCT03672461|463892336|FG001|Overall Study|Adverse Event|0|||
128889589|NCT03672461|463892335|FG000|Overall Study|Serious Adverse Event|0|||
128889590|NCT03672461|463892336|FG001|Overall Study|Serious Adverse Event|1|||
128889591|NCT03672461|463892335|FG000|Overall Study|Too Busy|3|||
128889592|NCT03672461|463892336|FG001|Overall Study|Too Busy|1|||
128889593|NCT03672461|463892335|FG000|Overall Study|Lost to Follow-up|1|||
128889594|NCT03672461|463892336|FG001|Overall Study|Lost to Follow-up|2|||
128889595|NCT03672461|463892335|FG000|Overall Study|Family|2|||
128889596|NCT03672461|463892336|FG001|Overall Study|Family|2|||
128889597|NCT03672461|463892335|FG000|Overall Study|No remote technology access|0|||
128889598|NCT03672461|463892336|FG001|Overall Study|No remote technology access|1|||
128889599|NCT03672461|463892335|FG000|Overall Study|Withdrawal by Subject|1|||
128889600|NCT03672461|463892336|FG001|Overall Study|Withdrawal by Subject|0|||
128889601|NCT03672461|463892335|FG000|Overall Study|Cannot tolerate intervention|1|||
128889602|NCT03672461|463892336|FG001|Overall Study|Cannot tolerate intervention|0|||
128889603|NCT03672461|463892335|FG000|Overall Study|Incomplete outcome data|6|||
128889604|NCT03672461|463892336|FG001|Overall Study|Incomplete outcome data|1|||
128889605|NCT01444651|463893867|FG000|Overall Study|Adverse Event|3|||
128889606|NCT01444651|463893868|FG001|Overall Study|Adverse Event|2|||
128889607|NCT01444651|463893867|FG000|Overall Study|Lost to Follow-up|5|||
128889608|NCT01444651|463893868|FG001|Overall Study|Lost to Follow-up|5|||
128889609|NCT01444651|463893867|FG000|Overall Study|Non-fasting|2|||
129110133|NCT00643201|464697821|FG000|Completed Study Follow Up|non-specified|1|||
129110134|NCT00643201|464697822|FG001|Completed Study Follow Up|non-specified|0|||
129110135|NCT02976519|464697823|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129110136|NCT02976519|464697824|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
129110137|NCT02976519|464697825|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129110138|NCT02976519|464697826|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129110139|NCT02976519|464697827|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129110140|NCT02976519|464697828|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129110141|NCT02976519|464697829|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129110142|NCT02976519|464697823|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129110143|NCT02976519|464697824|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129110144|NCT02976519|464697825|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129110145|NCT02976519|464697826|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
129110146|NCT02976519|464697827|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129110147|NCT02976519|464697828|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129110148|NCT02976519|464697829|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129110149|NCT02976519|464697823|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129110150|NCT02976519|464697824|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129110151|NCT02976519|464697825|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129110152|NCT02976519|464697826|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129110153|NCT02976519|464697827|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129110154|NCT02976519|464697828|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129110155|NCT02976519|464697829|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
129110156|NCT02976519|464697823|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129110157|NCT02976519|464697824|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129110158|NCT02976519|464697825|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129110159|NCT02976519|464697826|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129110160|NCT02976519|464697827|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129110161|NCT02976519|464697828|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129110162|NCT02976519|464697829|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
128688304|NCT00598702|463158962|FG004|Overall Study|Other|0|||
128889610|NCT01444651|463893868|FG001|Overall Study|Non-fasting|1|||
128889611|NCT01444651|463893867|FG000|Overall Study|Missing data|1|||
128889612|NCT01444651|463893868|FG001|Overall Study|Missing data|1|||
128889613|NCT01436071|463893869|FG000|Overall Study|Adverse Event|1|||
128889614|NCT01436071|463893870|FG001|Overall Study|Adverse Event|0|||
128889615|NCT01436071|463893869|FG000|Overall Study|Lack of Efficacy|16|||
128889616|NCT01436071|463893870|FG001|Overall Study|Lack of Efficacy|7|||
129110163|NCT02976519|464697823|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129110164|NCT02976519|464697824|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129110165|NCT02976519|464697825|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129110166|NCT02976519|464697826|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129110167|NCT02976519|464697827|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
128688305|NCT00598702|463158963|FG005|Overall Study|Other|1|||
128889617|NCT01436071|463893869|FG000|Overall Study|Protocol Violation|0|||
128889618|NCT01436071|463893870|FG001|Overall Study|Protocol Violation|1|||
129110168|NCT02976519|464697828|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129110169|NCT02976519|464697829|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
129110170|NCT02346708|464697830|FG000|Overall Study|Adverse Event|2|||
129110171|NCT02346708|464697831|FG001|Overall Study|Adverse Event|0|||
129110172|NCT02346708|464697830|FG000|Overall Study|Protocol Violation|0|||
129110173|NCT02346708|464697831|FG001|Overall Study|Protocol Violation|1|||
129110174|NCT00928434|464697832|FG000|Overall Study|Adverse Event|14|||
129110175|NCT00928434|464697833|FG001|Overall Study|Adverse Event|5|||
129110176|NCT00928434|464697834|FG002|Overall Study|Adverse Event|18|||
129110177|NCT00928434|464697832|FG000|Overall Study|Protocol Violation|5|||
129110178|NCT00928434|464697833|FG001|Overall Study|Protocol Violation|0|||
129110179|NCT00928434|464697834|FG002|Overall Study|Protocol Violation|8|||
129110180|NCT00928434|464697832|FG000|Overall Study|Physician Decision|2|||
129110181|NCT00928434|464697833|FG001|Overall Study|Physician Decision|0|||
129110182|NCT00928434|464697834|FG002|Overall Study|Physician Decision|3|||
129110183|NCT00928434|464697832|FG000|Overall Study|Lost to Follow-up|1|||
129110184|NCT00928434|464697833|FG001|Overall Study|Lost to Follow-up|0|||
129110185|NCT00928434|464697834|FG002|Overall Study|Lost to Follow-up|3|||
129110186|NCT00928434|464697832|FG000|Overall Study|Withdrawal by Subject|5|||
129110187|NCT00928434|464697833|FG001|Overall Study|Withdrawal by Subject|3|||
129110188|NCT00928434|464697834|FG002|Overall Study|Withdrawal by Subject|2|||
129110189|NCT00928434|464697832|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
129110190|NCT00928434|464697833|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
129110191|NCT00928434|464697834|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
129110192|NCT00928434|464697832|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
129110193|NCT00928434|464697833|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
129110194|NCT00928434|464697834|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
129110195|NCT00928434|464697832|FG000|Overall Study|Other (not meeting above criteria)|5|||
129110196|NCT00928434|464697833|FG001|Overall Study|Other (not meeting above criteria)|1|||
129110197|NCT00928434|464697834|FG002|Overall Study|Other (not meeting above criteria)|2|||
129110198|NCT01278342|464697837|FG000|Overall Study|Physician Decision|0|||
129110199|NCT01278342|464697838|FG001|Overall Study|Physician Decision|1|||
129110200|NCT01278342|464697839|FG002|Overall Study|Physician Decision|0|||
129110201|NCT01278342|464697837|FG000|Overall Study|Lost to Follow-up|1|||
129110202|NCT01278342|464697838|FG001|Overall Study|Lost to Follow-up|0|||
129110203|NCT01278342|464697839|FG002|Overall Study|Lost to Follow-up|0|||
129110204|NCT01278342|464697837|FG000|Overall Study|Administrative problems|2|||
129110205|NCT01278342|464697838|FG001|Overall Study|Administrative problems|0|||
129110206|NCT01278342|464697839|FG002|Overall Study|Administrative problems|0|||
129110207|NCT01278342|464697837|FG000|Overall Study|Other|1|||
129110208|NCT01278342|464697838|FG001|Overall Study|Other|0|||
129110209|NCT01278342|464697839|FG002|Overall Study|Other|0|||
129110210|NCT00313846|464697845|FG000|Overall Study|Withdrawal by Subject|2|||
129110211|NCT00313846|464697846|FG001|Overall Study|Withdrawal by Subject|0|||
129110212|NCT00313846|464697845|FG000|Overall Study|Adverse Event|1|||
129110213|NCT00313846|464697846|FG001|Overall Study|Adverse Event|8|||
129110214|NCT00313846|464697845|FG000|Overall Study|Administrative|2|||
129110215|NCT00313846|464697846|FG001|Overall Study|Administrative|3|||
129110216|NCT02221648|464697850|FG000|Overall Study|Withdrawal by Subject|3|||
129110217|NCT02221648|464697851|FG001|Overall Study|Withdrawal by Subject|3|||
129110218|NCT01922258|464697857|FG000|Overall Study|Lost to Follow-up|1|||
129110219|NCT01922258|464697858|FG001|Overall Study|Lost to Follow-up|1|||
129110220|NCT01922258|464697857|FG000|Overall Study|Adverse Event|9|||
129110221|NCT01922258|464697858|FG001|Overall Study|Adverse Event|2|||
129110222|NCT01922258|464697857|FG000|Overall Study|Met Withdrawal Criteria|0|||
129110223|NCT01922258|464697858|FG001|Overall Study|Met Withdrawal Criteria|4|||
129110224|NCT01922258|464697857|FG000|Overall Study|Withdrawn by the Investigator|1|||
129110225|NCT01922258|464697858|FG001|Overall Study|Withdrawn by the Investigator|4|||
129110226|NCT01922258|464697857|FG000|Overall Study|Withdrawal by participant|5|||
129110227|NCT01922258|464697858|FG001|Overall Study|Withdrawal by participant|5|||
129110228|NCT00673257|464697859|FG000|Overall Study|Withdrawal by Subject|4|||
129110229|NCT00673257|464697859|FG000|Overall Study|Unable to obtain specimen|1|||
129110230|NCT04552132|464697860|FG000|Overall Study|Lost to Follow-up|4|||
129110231|NCT04552132|464697861|FG001|Overall Study|Lost to Follow-up|3|||
129110232|NCT04552132|464697860|FG000|Overall Study|Protocol Violation|1|||
129110233|NCT04552132|464697861|FG001|Overall Study|Protocol Violation|0|||
129110234|NCT02256839|464697862|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
129110235|NCT02256839|464697863|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
129110236|NCT01951417|464697878|FG000|Overall Study|Withdrawal by Subject|1|||
129110237|NCT01951417|464697878|FG000|Overall Study|Protocol Violation|2|||
129110238|NCT01951417|464697878|FG000|Overall Study|Lost to Follow-up|6|||
128688306|NCT00598702|463158964|FG006|Overall Study|Other|0|||
129110239|NCT01598610|464697883|FG000|Overall Study|Adverse Event|1|||
129110240|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
129110241|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
129110242|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Adverse Event|57|||
129110243|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Adverse Event|49|||
128688307|NCT00598702|463158965|FG007|Overall Study|Other|0|||
128688308|NCT00598702|463158958|FG000|Overall Study|Early discharge from hospital|0|||
128688309|NCT00598702|463158959|FG001|Overall Study|Early discharge from hospital|0|||
128688310|NCT00598702|463158960|FG002|Overall Study|Early discharge from hospital|2|||
128688311|NCT00598702|463158961|FG003|Overall Study|Early discharge from hospital|5|||
128688312|NCT00598702|463158962|FG004|Overall Study|Early discharge from hospital|0|||
128688313|NCT00598702|463158963|FG005|Overall Study|Early discharge from hospital|10|||
128688314|NCT00598702|463158964|FG006|Overall Study|Early discharge from hospital|1|||
128688315|NCT00598702|463158965|FG007|Overall Study|Early discharge from hospital|0|||
128688316|NCT00598702|463158958|FG000|Overall Study|Adverse Event|0|||
128688317|NCT00598702|463158959|FG001|Overall Study|Adverse Event|0|||
128688318|NCT00598702|463158960|FG002|Overall Study|Adverse Event|0|||
128688319|NCT00598702|463158961|FG003|Overall Study|Adverse Event|1|||
128688320|NCT00598702|463158962|FG004|Overall Study|Adverse Event|0|||
128688321|NCT00598702|463158963|FG005|Overall Study|Adverse Event|0|||
128688322|NCT00598702|463158964|FG006|Overall Study|Adverse Event|0|||
128688323|NCT00598702|463158965|FG007|Overall Study|Adverse Event|0|||
128688324|NCT00598702|463158958|FG000|Overall Study|Withdrawal by Subject|0|||
128688325|NCT00598702|463158959|FG001|Overall Study|Withdrawal by Subject|0|||
128688326|NCT00598702|463158960|FG002|Overall Study|Withdrawal by Subject|0|||
128688327|NCT00598702|463158961|FG003|Overall Study|Withdrawal by Subject|1|||
128688328|NCT00598702|463158962|FG004|Overall Study|Withdrawal by Subject|1|||
128688329|NCT00598702|463158963|FG005|Overall Study|Withdrawal by Subject|0|||
128688330|NCT00598702|463158964|FG006|Overall Study|Withdrawal by Subject|0|||
128688331|NCT00598702|463158965|FG007|Overall Study|Withdrawal by Subject|0|||
128688332|NCT00598702|463158958|FG000|Overall Study|Physician Decision|0|||
128688333|NCT00598702|463158959|FG001|Overall Study|Physician Decision|0|||
128688334|NCT00598702|463158960|FG002|Overall Study|Physician Decision|0|||
128688335|NCT00598702|463158961|FG003|Overall Study|Physician Decision|0|||
128688336|NCT00598702|463158962|FG004|Overall Study|Physician Decision|1|||
128688337|NCT00598702|463158963|FG005|Overall Study|Physician Decision|0|||
128688338|NCT00598702|463158964|FG006|Overall Study|Physician Decision|0|||
128688339|NCT00598702|463158965|FG007|Overall Study|Physician Decision|0|||
128688340|NCT00598702|463158958|FG000|Overall Study|Dose limiting toxicity|0|||
128688341|NCT00598702|463158959|FG001|Overall Study|Dose limiting toxicity|0|||
128688342|NCT00598702|463158960|FG002|Overall Study|Dose limiting toxicity|0|||
128688343|NCT00598702|463158961|FG003|Overall Study|Dose limiting toxicity|1|||
128688344|NCT00598702|463158962|FG004|Overall Study|Dose limiting toxicity|1|||
128688345|NCT00598702|463158963|FG005|Overall Study|Dose limiting toxicity|1|||
128688346|NCT00598702|463158964|FG006|Overall Study|Dose limiting toxicity|0|||
128688347|NCT00598702|463158965|FG007|Overall Study|Dose limiting toxicity|0|||
128688348|NCT01859143|463158968|FG000|Overall Study|Lost to Follow-up|2|||
128688349|NCT01859143|463158969|FG001|Overall Study|Lost to Follow-up|0|||
128688350|NCT02413372|463158973|FG000|Treatment|Lost to Follow-up|0|||
128688351|NCT02413372|463158974|FG001|Treatment|Lost to Follow-up|2|||
128688352|NCT02413372|463158975|FG002|Treatment|Lost to Follow-up|1|||
128688353|NCT02413372|463158973|FG000|Treatment|Withdrawal by Subject|1|||
128688354|NCT02413372|463158974|FG001|Treatment|Withdrawal by Subject|0|||
128688355|NCT02413372|463158975|FG002|Treatment|Withdrawal by Subject|0|||
128688356|NCT02413372|463158973|FG000|Follow-up|Lost to Follow-up|1|||
128688357|NCT02413372|463158974|FG001|Follow-up|Lost to Follow-up|1|||
128688358|NCT02413372|463158975|FG002|Follow-up|Lost to Follow-up|0|||
128763879|NCT01931735|463425836|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
128763880|NCT01931735|463425837|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
128688359|NCT02413372|463158973|FG000|Follow-up|Subject Withdrew Consent|1|||
128688360|NCT02413372|463158974|FG001|Follow-up|Subject Withdrew Consent|0|||
128688361|NCT02413372|463158975|FG002|Follow-up|Subject Withdrew Consent|1|||
128688362|NCT02413372|463158973|FG000|Follow-up|Subject unable to return for visit|0|||
128688363|NCT02413372|463158974|FG001|Follow-up|Subject unable to return for visit|0|||
128688364|NCT02413372|463158975|FG002|Follow-up|Subject unable to return for visit|1|||
128688365|NCT04587271|463158976|FG000|Overall Study|Lost to Follow-up|2|||
128688366|NCT04587271|463158977|FG001|Overall Study|Lost to Follow-up|2|||
128763881|NCT01931735|463425838|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
128763882|NCT01931735|463425839|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
128763883|NCT02552238|463425842|FG000|Overall Study|Withdrawal by Subject|2|||
128763884|NCT02552238|463425842|FG000|Overall Study|Adverse Event|2|||
128763885|NCT05158296|463425843|FG000|Overall Study|Sponsor Decision|2|||
128763886|NCT05158296|463425844|FG001|Overall Study|Sponsor Decision|3|||
128763887|NCT05158296|463425845|FG002|Overall Study|Sponsor Decision|2|||
128688367|NCT04587271|463158978|FG002|Overall Study|Lost to Follow-up|0|||
128763888|NCT02036645|463425853|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128889619|NCT01436071|463893869|FG000|Overall Study|Lost to Follow-up|3|||
128688368|NCT04587271|463158979|FG003|Overall Study|Lost to Follow-up|2|||
128688369|NCT04587271|463158980|FG004|Overall Study|Lost to Follow-up|2|||
128688370|NCT04587271|463158981|FG005|Overall Study|Lost to Follow-up|0|||
128763889|NCT02036645|463425854|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128889620|NCT01436071|463893870|FG001|Overall Study|Lost to Follow-up|1|||
128889621|NCT01436071|463893869|FG000|Overall Study|Physician Decision|1|||
128889622|NCT01436071|463893870|FG001|Overall Study|Physician Decision|0|||
128889623|NCT01436071|463893869|FG000|Overall Study|Withdrawal by Subject|2|||
128889624|NCT01436071|463893870|FG001|Overall Study|Withdrawal by Subject|2|||
128889625|NCT01436071|463893869|FG000|Overall Study|Did Not Receive Trial Medication|3|||
128889626|NCT01436071|463893870|FG001|Overall Study|Did Not Receive Trial Medication|3|||
128889627|NCT02462928|463893874|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
128889628|NCT02462928|463893875|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
128889629|NCT02462928|463893876|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
128889630|NCT02462928|463893874|FG000|Overall Study|Adverse Event|47|||
128889631|NCT02462928|463893875|FG001|Overall Study|Adverse Event|51|||
128889632|NCT02462928|463893876|FG002|Overall Study|Adverse Event|25|||
128889633|NCT02462928|463893874|FG000|Overall Study|Lack of Efficacy|3|||
128889634|NCT02462928|463893875|FG001|Overall Study|Lack of Efficacy|8|||
128889635|NCT02462928|463893876|FG002|Overall Study|Lack of Efficacy|3|||
128889636|NCT02462928|463893874|FG000|Overall Study|Lost to Follow-up|4|||
128889637|NCT02462928|463893875|FG001|Overall Study|Lost to Follow-up|4|||
128889638|NCT02462928|463893876|FG002|Overall Study|Lost to Follow-up|1|||
128889639|NCT02462928|463893874|FG000|Overall Study|Withdrawal by Patient|31|||
128889640|NCT02462928|463893875|FG001|Overall Study|Withdrawal by Patient|21|||
128889641|NCT02462928|463893876|FG002|Overall Study|Withdrawal by Patient|21|||
128889642|NCT02462928|463893874|FG000|Overall Study|Protocol Violation|0|||
128889643|NCT02462928|463893875|FG001|Overall Study|Protocol Violation|1|||
128889644|NCT02462928|463893876|FG002|Overall Study|Protocol Violation|0|||
128889645|NCT02462928|463893874|FG000|Overall Study|Reason not Specified|4|||
128889646|NCT02462928|463893875|FG001|Overall Study|Reason not Specified|6|||
128889647|NCT02462928|463893876|FG002|Overall Study|Reason not Specified|5|||
128889648|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
128889649|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
128889650|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
128889651|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
128889652|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
128889653|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
128889654|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
128889655|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
128889656|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
128889657|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
128889658|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
128889659|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
128889660|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
128889661|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
128889662|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
128889663|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
128889664|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
128889665|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
128889666|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Early termination|0|||
128889667|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Early termination|0|||
128889668|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Early termination|34|||
128889669|NCT01493557|463893877|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
128889670|NCT01493557|463893878|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
128889671|NCT01493557|463893879|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
128889672|NCT01493557|463893877|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
128889673|NCT01493557|463893878|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
128889674|NCT01493557|463893879|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
128889675|NCT01493557|463893877|FG000|Randomized to Management Strategies|Other adverse event|8|||
128889676|NCT01493557|463893878|FG001|Randomized to Management Strategies|Other adverse event|5|||
128889677|NCT01493557|463893879|FG002|Randomized to Management Strategies|Other adverse event|0|||
129020578|NCT01796171|464367108|FG012|Follow-up Period|Sponsor Decision|7|||
129020579|NCT01796171|464367109|FG013|Follow-up Period|Sponsor Decision|0|||
128763890|NCT02036645|463425855|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763891|NCT02036645|463425856|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763892|NCT02036645|463425857|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763893|NCT02036645|463425858|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763894|NCT02036645|463425859|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
128763895|NCT02036645|463425860|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763896|NCT02036645|463425861|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763897|NCT02036645|463425862|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128889678|NCT01493557|463893877|FG000|Randomized to Management Strategies|Protocol Violation|3|||
128889679|NCT01493557|463893878|FG001|Randomized to Management Strategies|Protocol Violation|0|||
128889680|NCT01493557|463893879|FG002|Randomized to Management Strategies|Protocol Violation|0|||
128889681|NCT01493557|463893877|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
128889682|NCT01493557|463893878|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
128889683|NCT01493557|463893879|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
128889684|NCT01493557|463893877|FG000|Randomized to Management Strategies|Other than stated above|1|||
128889685|NCT01493557|463893878|FG001|Randomized to Management Strategies|Other than stated above|3|||
128889686|NCT01493557|463893879|FG002|Randomized to Management Strategies|Other than stated above|0|||
128889687|NCT01493557|463893877|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
128889688|NCT01493557|463893878|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
128889689|NCT01493557|463893879|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
128889690|NCT01493557|463893877|FG000|Adding the Second Strategy|Other adverse event|1|||
128889691|NCT01493557|463893878|FG001|Adding the Second Strategy|Other adverse event|2|||
128889692|NCT01493557|463893879|FG002|Adding the Second Strategy|Other adverse event|0|||
128889693|NCT01493557|463893877|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
128889694|NCT01493557|463893878|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
128889695|NCT01493557|463893879|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
128889696|NCT01890148|463893894|FG000|Overall Study|Adverse Event|1|||
128889697|NCT01215175|463893895|FG000|Overall Study|Lost to Follow-up|0|||
128889698|NCT01215175|463893896|FG001|Overall Study|Lost to Follow-up|1|||
128889699|NCT01215175|463893897|FG002|Overall Study|Lost to Follow-up|0|||
128889700|NCT01215175|463893898|FG003|Overall Study|Lost to Follow-up|1|||
128889701|NCT01215175|463893899|FG004|Overall Study|Lost to Follow-up|0|||
128889702|NCT01678209|463893900|FG000|Overall Study|could not scan twice|1|||
128889703|NCT01678209|463893901|FG001|Overall Study|could not scan twice|1|||
128889704|NCT01678209|463893902|FG002|Overall Study|could not scan twice|1|||
128889705|NCT01678209|463893900|FG000|Overall Study|scheduling conflicts|0|||
128889706|NCT01678209|463893901|FG001|Overall Study|scheduling conflicts|0|||
128889707|NCT01678209|463893902|FG002|Overall Study|scheduling conflicts|1|||
128889708|NCT01678209|463893900|FG000|Overall Study|screen fail|16|||
128889709|NCT01678209|463893901|FG001|Overall Study|screen fail|17|||
128889710|NCT01678209|463893902|FG002|Overall Study|screen fail|16|||
128889711|NCT00702845|463893903|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
128889712|NCT00702845|463893904|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
128889713|NCT00702845|463893903|FG000|Overall Study|Too high ovarian response|5|||
128889714|NCT00702845|463893904|FG001|Overall Study|Too high ovarian response|1|||
128889715|NCT00702845|463893903|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
128889716|NCT00702845|463893904|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
128889717|NCT00702845|463893903|FG000|Overall Study|Insufficient ovarian response|1|||
128889718|NCT00702845|463893904|FG001|Overall Study|Insufficient ovarian response|0|||
128889719|NCT00702845|463893903|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
128889720|NCT00702845|463893904|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
128889721|NCT00702845|463893903|FG000|Overall Study|No or abnormal fertilization|4|||
128889722|NCT00702845|463893904|FG001|Overall Study|No or abnormal fertilization|2|||
128889723|NCT00702845|463893903|FG000|Overall Study|Patient's decision|2|||
128889724|NCT00702845|463893904|FG001|Overall Study|Patient's decision|1|||
128889725|NCT00702845|463893903|FG000|Overall Study|Not randomized|0|||
128889726|NCT00702845|463893904|FG001|Overall Study|Not randomized|1|||
128889727|NCT02973425|463893908|FG000|Overall Study|Lost to Follow-up|49|||
128889728|NCT02973425|463893909|FG001|Overall Study|Lost to Follow-up|53|||
128889729|NCT03876171|463893910|FG000|Overall Study|Withdrawal by Subject|3|||
128889730|NCT03876171|463893911|FG001|Overall Study|Withdrawal by Subject|3|||
128889731|NCT03876171|463893910|FG000|Overall Study|Re-arrest|0|||
128889732|NCT03876171|463893911|FG001|Overall Study|Re-arrest|4|||
128889733|NCT03503513|463893912|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
128889734|NCT03503513|463893912|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
129110244|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
129110245|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
129110246|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Site closure|3|||
129110247|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Site closure|2|||
129110248|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
128688371|NCT04587271|463158976|FG000|Overall Study|Caregiver brought child to visits|0|||
128688372|NCT04587271|463158977|FG001|Overall Study|Caregiver brought child to visits|0|||
128688373|NCT04587271|463158978|FG002|Overall Study|Caregiver brought child to visits|0|||
128889735|NCT03503513|463893912|FG000|Overall Study|Physician Decision|3|||
128889736|NCT03503513|463893912|FG000|Overall Study|Withdrawal by Subject|2|||
128889737|NCT03503513|463893912|FG000|Overall Study|Lost to Follow-up|1|||
128889738|NCT00929656|463893917|FG000|Overall Study|Lost to Follow-up|0|||
128889739|NCT00929656|463893918|FG001|Overall Study|Lost to Follow-up|1|||
128889740|NCT00607880|463893919|FG000|Overall Study|Unable to place port due to occlusion|1|||
129110249|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
128889741|NCT00607880|463893920|FG001|Overall Study|Unable to place port due to occlusion|0|||
128889742|NCT01170039|463893921|FG000|Overall Study|Withdrawal by Subject|5|||
128889743|NCT01170039|463893922|FG001|Overall Study|Withdrawal by Subject|3|||
128889744|NCT01170039|463893921|FG000|Overall Study|Lack of funding, drug not available|3|||
128889745|NCT01170039|463893922|FG001|Overall Study|Lack of funding, drug not available|3|||
128889746|NCT00908583|463893923|FG000|Phase 1|Withdrawal by Subject|1|||
128889747|NCT00908583|463893923|FG000|Phase 1|Adverse Event|4|||
128889748|NCT00908583|463893923|FG000|Phase 2|Physician Decision|1|||
128889749|NCT00908583|463893923|FG000|Phase 2|Adverse Event|1|||
128889750|NCT00908583|463893923|FG000|Phase 3|Adverse Event|2|||
128889751|NCT00908583|463893923|FG000|Phase 4|Adverse Event|1|||
128889752|NCT00908583|463893923|FG000|Phase 4|Physician Decision|1|||
128889753|NCT00908583|463893923|FG000|Phase 5|Adverse Event|3|||
128889754|NCT00860951|463893924|FG000|Overall Study|Withdrawal by Subject|2|||
128889755|NCT00860951|463893924|FG000|Overall Study|Lost to Follow-up|5|||
128889756|NCT00727649|463893925|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
128889757|NCT00727649|463893926|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
128889758|NCT00727649|463893925|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
128889759|NCT00727649|463893926|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
128889760|NCT00727649|463893925|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
128889761|NCT00727649|463893926|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
128889762|NCT00727649|463893925|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
128889763|NCT00727649|463893926|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
128889764|NCT00727649|463893925|FG000|Second Intervention (4-weeks)|Death|1|||
128763898|NCT02036645|463425863|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763899|NCT02036645|463425864|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
128763900|NCT02036645|463425853|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763901|NCT02036645|463425854|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763902|NCT02036645|463425855|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763903|NCT02036645|463425856|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
128889765|NCT00727649|463893926|FG001|Second Intervention (4-weeks)|Death|0|||
128889766|NCT00727649|463893925|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
128889767|NCT00727649|463893926|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
128889768|NCT00727649|463893925|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
128889769|NCT00727649|463893926|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
128889770|NCT00385203|463893928|FG000|Overall Study|Adverse Event|5|||
128889771|NCT00385203|463893929|FG001|Overall Study|Adverse Event|4|||
128889772|NCT00385203|463893928|FG000|Overall Study|Death|1|||
128889773|NCT00385203|463893929|FG001|Overall Study|Death|0|||
128889774|NCT00385203|463893928|FG000|Overall Study|Condition under investigation worsened|18|||
128889775|NCT00385203|463893929|FG001|Overall Study|Condition under investigation worsened|3|||
128889776|NCT00385203|463893928|FG000|Overall Study|Incorrect enrollment|2|||
128889777|NCT00385203|463893929|FG001|Overall Study|Incorrect enrollment|0|||
128889778|NCT03823404|463893930|FG000|Overall Study|Lost to Follow-up|1|||
128889779|NCT03823404|463893931|FG001|Overall Study|Lost to Follow-up|2|||
128889780|NCT03823404|463893932|FG002|Overall Study|Lost to Follow-up|3|||
128889781|NCT03823404|463893930|FG000|Overall Study|Protocol Violation|2|||
128889782|NCT03823404|463893931|FG001|Overall Study|Protocol Violation|0|||
128889783|NCT03823404|463893932|FG002|Overall Study|Protocol Violation|2|||
128889784|NCT03823404|463893930|FG000|Overall Study|Adverse Event|35|||
128889785|NCT03823404|463893931|FG001|Overall Study|Adverse Event|38|||
128889786|NCT03823404|463893932|FG002|Overall Study|Adverse Event|8|||
128889787|NCT03823404|463893930|FG000|Overall Study|Withdrawal by Subject|38|||
128889788|NCT03823404|463893931|FG001|Overall Study|Withdrawal by Subject|40|||
128763904|NCT02036645|463425857|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763905|NCT02036645|463425858|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763906|NCT02036645|463425859|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128889789|NCT03823404|463893932|FG002|Overall Study|Withdrawal by Subject|35|||
128889790|NCT03823404|463893930|FG000|Overall Study|Death|4|||
128889791|NCT03823404|463893931|FG001|Overall Study|Death|0|||
128889792|NCT03823404|463893932|FG002|Overall Study|Death|0|||
128889793|NCT03823404|463893930|FG000|Overall Study|Other: Various reasons provided|5|||
128763907|NCT02036645|463425860|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763908|NCT02036645|463425861|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763909|NCT02036645|463425862|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763910|NCT02036645|463425863|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128889794|NCT03823404|463893931|FG001|Overall Study|Other: Various reasons provided|5|||
128889795|NCT03823404|463893932|FG002|Overall Study|Other: Various reasons provided|6|||
128889796|NCT03383289|463893935|FG000|Overall Study|Death|83|||
128889797|NCT03383289|463893936|FG001|Overall Study|Death|78|||
128889798|NCT03383289|463893935|FG000|Overall Study|discharge from facility|84|||
128889799|NCT03383289|463893936|FG001|Overall Study|discharge from facility|84|||
129020580|NCT01796171|464367110|FG014|Follow-up Period|Sponsor Decision|0|||
129020581|NCT00418561|464367111|FG000|Overall Study|Participant's (guardian's) decision|0|||
129020582|NCT00418561|464367112|FG001|Overall Study|Participant's (guardian's) decision|1|||
128889800|NCT03383289|463893935|FG000|Overall Study|Withdrawal by Subject|4|||
128889801|NCT03383289|463893936|FG001|Overall Study|Withdrawal by Subject|1|||
128889802|NCT00832117|463893937|FG000|Overall Study|Death|1|||
128889803|NCT00832117|463893937|FG000|Overall Study|Disease Progression|11|||
128889804|NCT00404066|463893938|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
128889805|NCT00404066|463893938|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
128889806|NCT01524133|463893941|FG000|Treatment Phase|Withdrawal by Subject|13|||
128889807|NCT01524133|463893942|FG001|Treatment Phase|Withdrawal by Subject|28|||
128889808|NCT01524133|463893943|FG002|Treatment Phase|Withdrawal by Subject|31|||
128889809|NCT01524133|463893941|FG000|Treatment Phase|Physician Decision|6|||
128889810|NCT01524133|463893942|FG001|Treatment Phase|Physician Decision|3|||
128889811|NCT01524133|463893943|FG002|Treatment Phase|Physician Decision|3|||
128889812|NCT01524133|463893941|FG000|Treatment Phase|Lost to Follow-up|0|||
128889813|NCT01524133|463893942|FG001|Treatment Phase|Lost to Follow-up|1|||
128889814|NCT01524133|463893943|FG002|Treatment Phase|Lost to Follow-up|2|||
128889815|NCT01524133|463893941|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
128889816|NCT01524133|463893942|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
128889817|NCT01524133|463893943|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
128889818|NCT01524133|463893941|FG000|Overall Study 52 Weeks|Physician Decision|1|||
128889819|NCT01524133|463893942|FG001|Overall Study 52 Weeks|Physician Decision|0|||
128889820|NCT01524133|463893943|FG002|Overall Study 52 Weeks|Physician Decision|2|||
128889821|NCT01524133|463893941|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
128889822|NCT01524133|463893942|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
128889823|NCT01524133|463893943|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
128889824|NCT00059839|463893950|FG000|Overall Study|Death|1|||
128889825|NCT00059839|463893951|FG001|Overall Study|Death|1|||
128889826|NCT00059839|463893950|FG000|Overall Study|Lack of Efficacy|6|||
128889827|NCT00059839|463893951|FG001|Overall Study|Lack of Efficacy|5|||
128889828|NCT00059839|463893950|FG000|Overall Study|Lost to Follow-up|2|||
128889829|NCT00059839|463893951|FG001|Overall Study|Lost to Follow-up|0|||
128889830|NCT00059839|463893950|FG000|Overall Study|Physician Decision|1|||
128889831|NCT00059839|463893951|FG001|Overall Study|Physician Decision|2|||
128889832|NCT00059839|463893950|FG000|Overall Study|Withdrawal by Subject|1|||
128889833|NCT00059839|463893951|FG001|Overall Study|Withdrawal by Subject|6|||
128889834|NCT00059839|463893950|FG000|Overall Study|Ineligible|1|||
128889835|NCT00059839|463893951|FG001|Overall Study|Ineligible|3|||
128889836|NCT03842163|463893952|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
128889837|NCT03842163|463893952|FG000|Overall Study|Scintigraphy was not performed|44|||
128889838|NCT03829241|463893953|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
128889839|NCT03829241|463893954|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
128889840|NCT03829241|463893953|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
128889841|NCT03829241|463893954|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
128889842|NCT03829241|463893953|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
128889843|NCT03829241|463893954|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
128889844|NCT03829241|463893953|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
128889845|NCT03829241|463893954|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
128889846|NCT03829241|463893953|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
128889847|NCT03829241|463893954|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
128889848|NCT03829241|463893953|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
128889849|NCT03829241|463893954|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
128889850|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
128763911|NCT02036645|463425864|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
128763912|NCT02404389|463425865|FG000|Overall Study|Adverse Event|1|||
128763913|NCT02404389|463425866|FG001|Overall Study|Adverse Event|0|||
128763914|NCT02404389|463425867|FG002|Overall Study|Adverse Event|1|||
128763915|NCT02404389|463425868|FG003|Overall Study|Adverse Event|0|||
128763916|NCT02404389|463425869|FG004|Overall Study|Adverse Event|2|||
128763917|NCT02404389|463425865|FG000|Overall Study|Subject/guardian decision|1|||
128763918|NCT02404389|463425866|FG001|Overall Study|Subject/guardian decision|0|||
128763919|NCT02404389|463425867|FG002|Overall Study|Subject/guardian decision|0|||
129215192|NCT02628873|465089461|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
128889851|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
128889852|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
128889853|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
128889854|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
128889855|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
128889856|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
128889857|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
128763920|NCT02404389|463425868|FG003|Overall Study|Subject/guardian decision|1|||
128763921|NCT02404389|463425869|FG004|Overall Study|Subject/guardian decision|1|||
128889858|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
128763922|NCT00652938|463425870|FG000|Overall Study|Adverse Event|1|||
129215193|NCT02628873|465089462|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
128889859|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
128889860|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
128889861|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
128889862|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
128889863|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
128889864|NCT03829241|463893953|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
128889865|NCT03829241|463893954|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
128889866|NCT01862640|463893968|FG000|Overall Study|Adverse Event|4|||
128889867|NCT01862640|463893969|FG001|Overall Study|Adverse Event|10|||
128889868|NCT01862640|463893970|FG002|Overall Study|Adverse Event|6|||
128889869|NCT01862640|463893971|FG003|Overall Study|Adverse Event|8|||
128889870|NCT01862640|463893968|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
128889871|NCT01862640|463893969|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
128889872|NCT01862640|463893970|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
128889873|NCT01862640|463893971|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
128889874|NCT01862640|463893968|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
128889875|NCT01862640|463893969|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
128889876|NCT01862640|463893970|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
128889877|NCT01862640|463893971|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
128889878|NCT01862640|463893968|FG000|Overall Study|Withdrawal by Subject|2|||
128889879|NCT01862640|463893969|FG001|Overall Study|Withdrawal by Subject|4|||
128889880|NCT01862640|463893970|FG002|Overall Study|Withdrawal by Subject|8|||
128889881|NCT01862640|463893971|FG003|Overall Study|Withdrawal by Subject|5|||
128889882|NCT01862640|463893968|FG000|Overall Study|Protocol Deviation|0|||
128889883|NCT01862640|463893969|FG001|Overall Study|Protocol Deviation|0|||
128889884|NCT01862640|463893970|FG002|Overall Study|Protocol Deviation|1|||
128889885|NCT01862640|463893971|FG003|Overall Study|Protocol Deviation|0|||
128889886|NCT05211739|463893972|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
128889887|NCT05211739|463893973|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
128889888|NCT05211739|463893972|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
128889889|NCT05211739|463893973|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
128889890|NCT05211739|463893972|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
128889891|NCT05211739|463893973|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
128889892|NCT05211739|463893972|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
128889893|NCT05211739|463893973|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
128889894|NCT01975428|463893974|FG000|Overall Study|Lost to Follow-up|17|||
128889895|NCT01975428|463893975|FG001|Overall Study|Lost to Follow-up|4|||
128889896|NCT01975428|463893974|FG000|Overall Study|Withdrawal by Subject|3|||
128889897|NCT01975428|463893975|FG001|Overall Study|Withdrawal by Subject|10|||
128889898|NCT02536755|463893984|FG000|Overall Study|Adverse Event|4|||
128688374|NCT04587271|463158979|FG003|Overall Study|Caregiver brought child to visits|1|||
128688375|NCT04587271|463158980|FG004|Overall Study|Caregiver brought child to visits|0|||
128688376|NCT04587271|463158981|FG005|Overall Study|Caregiver brought child to visits|0|||
128688377|NCT02180165|463158985|FG000|Overall Study|Not Treated|0|||
128688378|NCT02180165|463158986|FG001|Overall Study|Not Treated|0|||
128688379|NCT02180165|463158987|FG002|Overall Study|Not Treated|1|||
128688380|NCT02180165|463158988|FG003|Overall Study|Not Treated|0|||
128688381|NCT02180165|463158985|FG000|Overall Study|Adverse Event|7|||
128688382|NCT02180165|463158986|FG001|Overall Study|Adverse Event|0|||
128688383|NCT02180165|463158987|FG002|Overall Study|Adverse Event|18|||
128889899|NCT02301936|463893985|FG000|Overall Study|Lost to Follow-up|1|||
128889900|NCT02301936|463893986|FG001|Overall Study|Lost to Follow-up|0|||
128889901|NCT01174238|463893987|FG000|Overall Study|Lost to Follow-up|2|||
128763923|NCT00652938|463425871|FG001|Overall Study|Adverse Event|0|||
128763924|NCT00652938|463425872|FG002|Overall Study|Adverse Event|2|||
128763925|NCT00652938|463425870|FG000|Overall Study|Withdrawal by Subject|0|||
128763926|NCT00652938|463425871|FG001|Overall Study|Withdrawal by Subject|6|||
128763927|NCT00652938|463425872|FG002|Overall Study|Withdrawal by Subject|1|||
128763928|NCT00652938|463425870|FG000|Overall Study|Lost to Follow-up|0|||
128763929|NCT00652938|463425871|FG001|Overall Study|Lost to Follow-up|0|||
128763930|NCT00652938|463425872|FG002|Overall Study|Lost to Follow-up|2|||
128763931|NCT00652938|463425870|FG000|Overall Study|fear of blood sampling|0|||
128763932|NCT00652938|463425871|FG001|Overall Study|fear of blood sampling|1|||
128763933|NCT00652938|463425872|FG002|Overall Study|fear of blood sampling|0|||
128763934|NCT03324880|463425873|FG000|Overall Study|Adverse Event|0|||
128763935|NCT03324880|463425874|FG001|Overall Study|Adverse Event|2|||
128763936|NCT03324880|463425873|FG000|Overall Study|Withdrawal by Subject|2|||
128889902|NCT01102803|463893989|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
128889903|NCT01102803|463893990|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
128763937|NCT03324880|463425874|FG001|Overall Study|Withdrawal by Subject|2|||
128763938|NCT03324880|463425873|FG000|Overall Study|Lost to Follow-up|0|||
128763939|NCT03324880|463425874|FG001|Overall Study|Lost to Follow-up|1|||
128688384|NCT02180165|463158988|FG003|Overall Study|Adverse Event|3|||
128688385|NCT02180165|463158985|FG000|Overall Study|Lack of Efficacy|0|||
128889904|NCT01102803|463893989|FG000|Post to Follow-Up|Lost to Follow-up|1|||
128889905|NCT01102803|463893990|FG001|Post to Follow-Up|Lost to Follow-up|3|||
128889906|NCT02733185|463893991|FG000|Overall Study|Withdrawal by Subject|12|||
128889907|NCT02733185|463893992|FG001|Overall Study|Withdrawal by Subject|10|||
128889908|NCT02733185|463893993|FG002|Overall Study|Withdrawal by Subject|17|||
128889909|NCT02733185|463893994|FG003|Overall Study|Withdrawal by Subject|21|||
128889910|NCT02733185|463893991|FG000|Overall Study|Death|46|||
128889911|NCT02733185|463893992|FG001|Overall Study|Death|34|||
128889912|NCT02733185|463893993|FG002|Overall Study|Death|35|||
128889913|NCT02733185|463893994|FG003|Overall Study|Death|43|||
128889914|NCT02733185|463893991|FG000|Overall Study|Lost to Follow-up|17|||
128889915|NCT02733185|463893992|FG001|Overall Study|Lost to Follow-up|18|||
128889916|NCT02733185|463893993|FG002|Overall Study|Lost to Follow-up|16|||
128889917|NCT02733185|463893994|FG003|Overall Study|Lost to Follow-up|11|||
128889918|NCT02593786|463893995|FG000|Overall Study|Disease progression|12|||
128889919|NCT02593786|463893996|FG001|Overall Study|Disease progression|16|||
128889920|NCT02593786|463893997|FG002|Overall Study|Disease progression|10|||
128889921|NCT02593786|463893998|FG003|Overall Study|Disease progression|7|||
128889922|NCT02593786|463893995|FG000|Overall Study|Study drug toxicity|1|||
128889923|NCT02593786|463893996|FG001|Overall Study|Study drug toxicity|0|||
128889924|NCT02593786|463893997|FG002|Overall Study|Study drug toxicity|0|||
128889925|NCT02593786|463893998|FG003|Overall Study|Study drug toxicity|0|||
128889926|NCT02593786|463893995|FG000|Overall Study|Adverse event unrelated to study drug|1|||
128889927|NCT02593786|463893996|FG001|Overall Study|Adverse event unrelated to study drug|1|||
128889928|NCT02593786|463893997|FG002|Overall Study|Adverse event unrelated to study drug|1|||
128889929|NCT02593786|463893998|FG003|Overall Study|Adverse event unrelated to study drug|0|||
128889930|NCT02593786|463893995|FG000|Overall Study|Participant request to discontinue study therapy|0|||
128889931|NCT02593786|463893996|FG001|Overall Study|Participant request to discontinue study therapy|2|||
128889932|NCT02593786|463893997|FG002|Overall Study|Participant request to discontinue study therapy|0|||
128889933|NCT02593786|463893998|FG003|Overall Study|Participant request to discontinue study therapy|0|||
128889934|NCT02593786|463893995|FG000|Overall Study|Other reasons|1|||
128889935|NCT02593786|463893996|FG001|Overall Study|Other reasons|1|||
128889936|NCT02593786|463893997|FG002|Overall Study|Other reasons|0|||
128889937|NCT02593786|463893998|FG003|Overall Study|Other reasons|5|||
128889938|NCT00835120|463894001|FG000|Overall Study|Lack of Efficacy|1|||
128889939|NCT00835120|463894001|FG000|Overall Study|Lost to Follow-up|3|||
128889940|NCT00835120|463894001|FG000|Overall Study|Adverse Event|2|||
128889941|NCT00835120|463894001|FG000|Overall Study|Withdrawal by Subject|2|||
128889942|NCT03610165|463894002|FG000|Overall Study|Device didn't work|0|||
128889943|NCT03610165|463894003|FG001|Overall Study|Device didn't work|1|||
128889944|NCT00671554|463894004|FG000|Overall Study|Disease progression|3|||
128889945|NCT03828292|463894007|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
128889946|NCT03828292|463894008|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
128889947|NCT03828292|463894009|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
128889948|NCT03828292|463894010|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
128889949|NCT03828292|463894011|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
128889950|NCT03828292|463894012|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
128889951|NCT03828292|463894007|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
128889952|NCT03828292|463894008|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
128889953|NCT03828292|463894009|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
128889954|NCT03828292|463894010|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
128889955|NCT03828292|463894011|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
128688386|NCT02180165|463158986|FG001|Overall Study|Lack of Efficacy|1|||
128688387|NCT02180165|463158987|FG002|Overall Study|Lack of Efficacy|3|||
128688388|NCT02180165|463158988|FG003|Overall Study|Lack of Efficacy|2|||
128688389|NCT02180165|463158985|FG000|Overall Study|Physician Decision|1|||
128688390|NCT02180165|463158986|FG001|Overall Study|Physician Decision|0|||
128688391|NCT02180165|463158987|FG002|Overall Study|Physician Decision|5|||
128889956|NCT03828292|463894012|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
128889957|NCT03828292|463894007|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
128889958|NCT03828292|463894008|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
128889959|NCT03828292|463894009|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
129110250|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Physician Decision|48|||
128889960|NCT03828292|463894010|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
129110251|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Physician Decision|38|||
129110252|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
128889961|NCT03828292|463894011|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
129110253|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
128889962|NCT03828292|463894012|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
128889963|NCT03828292|463894007|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
128889964|NCT03828292|463894008|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
128889965|NCT03828292|463894009|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
129110254|NCT01705977|464697886|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
128889966|NCT03828292|463894010|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
128889967|NCT03828292|463894011|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
128889968|NCT03828292|463894012|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
128889969|NCT03828292|463894007|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
128889970|NCT03828292|463894008|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
128889971|NCT03828292|463894009|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
128889972|NCT03828292|463894010|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
128889973|NCT03828292|463894011|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
128889974|NCT03828292|463894012|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
128889975|NCT06950879|463894013|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
128889976|NCT00993954|463895649|FG000|Overall Study|Protocol Violation|21|||
128889977|NCT00993954|463895650|FG001|Overall Study|Protocol Violation|2|||
128889978|NCT04439071|463895659|FG000|Overall Study|Lost to Follow-up|0|||
128889979|NCT04439071|463895660|FG001|Overall Study|Lost to Follow-up|3|||
128889980|NCT04439071|463895659|FG000|Overall Study|Withdrawal by Subject|3|||
128889981|NCT04439071|463895660|FG001|Overall Study|Withdrawal by Subject|8|||
128889982|NCT04439071|463895659|FG000|Overall Study|Death|6|||
128889983|NCT04439071|463895660|FG001|Overall Study|Death|4|||
128889984|NCT04439071|463895659|FG000|Overall Study|Other than specified|3|||
128889985|NCT04439071|463895660|FG001|Overall Study|Other than specified|3|||
128889986|NCT04439071|463895659|FG000|Overall Study|Randomized but not treated|2|||
128889987|NCT04439071|463895660|FG001|Overall Study|Randomized but not treated|0|||
128889988|NCT03085758|463895661|FG000|Overall Study|Death|26|||
128889989|NCT03085758|463895662|FG001|Overall Study|Death|24|||
128889990|NCT03085758|463895663|FG002|Overall Study|Death|53|||
128889991|NCT03085758|463895661|FG000|Overall Study|Lost to Follow-up|1|||
128889992|NCT03085758|463895662|FG001|Overall Study|Lost to Follow-up|1|||
128889993|NCT03085758|463895663|FG002|Overall Study|Lost to Follow-up|1|||
128889994|NCT03085758|463895661|FG000|Overall Study|Withdrawal by Subject|2|||
128889995|NCT03085758|463895662|FG001|Overall Study|Withdrawal by Subject|2|||
128889996|NCT03085758|463895663|FG002|Overall Study|Withdrawal by Subject|1|||
128889997|NCT03085758|463895661|FG000|Overall Study|Refusal to recall it up to day 90|0|||
128889998|NCT03085758|463895662|FG001|Overall Study|Refusal to recall it up to day 90|0|||
128889999|NCT03085758|463895663|FG002|Overall Study|Refusal to recall it up to day 90|1|||
128890000|NCT03085758|463895661|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
128890001|NCT03085758|463895662|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
128890002|NCT03085758|463895663|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
128688392|NCT02180165|463158988|FG003|Overall Study|Physician Decision|0|||
128688393|NCT02180165|463158985|FG000|Overall Study|Withdrawal by Subject|3|||
128688394|NCT02180165|463158986|FG001|Overall Study|Withdrawal by Subject|0|||
128688395|NCT02180165|463158987|FG002|Overall Study|Withdrawal by Subject|2|||
128688396|NCT02180165|463158988|FG003|Overall Study|Withdrawal by Subject|1|||
128688397|NCT02943460|463158989|FG000|Blinded Study Phase|Adverse Event|3|||
128688398|NCT02943460|463158990|FG001|Blinded Study Phase|Adverse Event|0|||
128688399|NCT02943460|463158991|FG002|Blinded Study Phase|Adverse Event|0|||
128688400|NCT02943460|463158989|FG000|Blinded Study Phase|Withdrew Consent|0|||
128688401|NCT02943460|463158990|FG001|Blinded Study Phase|Withdrew Consent|1|||
128688402|NCT02943460|463158991|FG002|Blinded Study Phase|Withdrew Consent|0|||
128890003|NCT04004429|463895666|FG000|Overall Study|Protocol Violation|1|||
128688403|NCT02943460|463158989|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
128688404|NCT02943460|463158990|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
128688405|NCT02943460|463158991|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
128890004|NCT04004429|463895667|FG001|Overall Study|Protocol Violation|0|||
128763940|NCT03324880|463425873|FG000|Overall Study|Product Recall|0|||
128763941|NCT03324880|463425874|FG001|Overall Study|Product Recall|1|||
128763942|NCT01412801|463425875|FG000|Overall Study|Death|0|||
128763943|NCT01412801|463425876|FG001|Overall Study|Death|1|||
128763944|NCT01412801|463425877|FG002|Overall Study|Death|0|||
128763945|NCT01412801|463425878|FG003|Overall Study|Death|4|||
128763946|NCT01412801|463425879|FG004|Overall Study|Death|2|||
128763947|NCT01412801|463425880|FG005|Overall Study|Death|2|||
128763948|NCT01412801|463425875|FG000|Overall Study|Lost to Follow-up|1|||
128763949|NCT01412801|463425876|FG001|Overall Study|Lost to Follow-up|2|||
128763950|NCT01412801|463425877|FG002|Overall Study|Lost to Follow-up|4|||
128763951|NCT01412801|463425878|FG003|Overall Study|Lost to Follow-up|0|||
128890005|NCT04004429|463895668|FG002|Overall Study|Protocol Violation|0|||
128890006|NCT04004429|463895666|FG000|Overall Study|Physician Decision|0|||
128890007|NCT04004429|463895667|FG001|Overall Study|Physician Decision|1|||
128890008|NCT04004429|463895668|FG002|Overall Study|Physician Decision|1|||
128890009|NCT04004429|463895666|FG000|Overall Study|Withdrawal by Subject|1|||
128890010|NCT04004429|463895667|FG001|Overall Study|Withdrawal by Subject|1|||
129110255|NCT01705977|464697887|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
128688406|NCT02943460|463158989|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
128763952|NCT01412801|463425879|FG004|Overall Study|Lost to Follow-up|1|||
128763953|NCT01412801|463425880|FG005|Overall Study|Lost to Follow-up|1|||
128763954|NCT01412801|463425875|FG000|Overall Study|Withdrawal by Subject|3|||
128890011|NCT04004429|463895668|FG002|Overall Study|Withdrawal by Subject|1|||
128890012|NCT01122576|463895669|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
128890013|NCT01122576|463895670|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
128890014|NCT01122576|463895671|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
128890015|NCT01122576|463895669|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
128890016|NCT01122576|463895670|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
128890017|NCT01122576|463895671|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
128890018|NCT01122576|463895669|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
128890019|NCT01122576|463895670|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
128890020|NCT01122576|463895671|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
128890021|NCT00381563|463895676|FG000|Overall Study|Withdrawal by Subject|5|||
128890022|NCT00381563|463895677|FG001|Overall Study|Withdrawal by Subject|5|||
128890023|NCT00381563|463895676|FG000|Overall Study|Lost to Follow-up|2|||
128890024|NCT00381563|463895677|FG001|Overall Study|Lost to Follow-up|0|||
128890025|NCT00381563|463895676|FG000|Overall Study|Protocol Violation|0|||
128890026|NCT00381563|463895677|FG001|Overall Study|Protocol Violation|1|||
128890027|NCT00931944|463895679|FG000|Overall Study|Adverse Event|4|||
128890028|NCT00931944|463895679|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
128890029|NCT00931944|463895679|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
128890030|NCT00931944|463895679|FG000|Overall Study|Death|28|||
128890031|NCT00931944|463895679|FG000|Overall Study|Other|2|||
128890032|NCT01109173|463895680|FG000|Overall Study|Adverse Event|15|||
128890033|NCT01109173|463895681|FG001|Overall Study|Adverse Event|17|||
128890034|NCT01109173|463895682|FG002|Overall Study|Adverse Event|9|||
128890035|NCT01109173|463895683|FG003|Overall Study|Adverse Event|6|||
128890036|NCT01109173|463895680|FG000|Overall Study|Lost to Follow-up|0|||
128890037|NCT01109173|463895681|FG001|Overall Study|Lost to Follow-up|1|||
128890038|NCT01109173|463895682|FG002|Overall Study|Lost to Follow-up|0|||
128890039|NCT01109173|463895683|FG003|Overall Study|Lost to Follow-up|0|||
128890040|NCT01109173|463895680|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
128890041|NCT01109173|463895681|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
128890042|NCT01109173|463895682|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
128890043|NCT01109173|463895683|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
128890044|NCT01109173|463895680|FG000|Overall Study|Noncompliance|0|||
128890045|NCT01109173|463895681|FG001|Overall Study|Noncompliance|1|||
128890046|NCT01109173|463895682|FG002|Overall Study|Noncompliance|0|||
128890047|NCT01109173|463895683|FG003|Overall Study|Noncompliance|0|||
128890048|NCT01109173|463895680|FG000|Overall Study|Treatment Failure|25|||
128890049|NCT01109173|463895681|FG001|Overall Study|Treatment Failure|32|||
128890050|NCT01109173|463895682|FG002|Overall Study|Treatment Failure|69|||
128890051|NCT01109173|463895683|FG003|Overall Study|Treatment Failure|64|||
128890052|NCT01109173|463895680|FG000|Overall Study|Protocol Violation|4|||
128890053|NCT01109173|463895681|FG001|Overall Study|Protocol Violation|5|||
128890054|NCT01109173|463895682|FG002|Overall Study|Protocol Violation|1|||
128890055|NCT01109173|463895683|FG003|Overall Study|Protocol Violation|2|||
128890056|NCT01109173|463895680|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
128890057|NCT01109173|463895681|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
128890058|NCT01109173|463895682|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
128890059|NCT01109173|463895683|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
128890060|NCT01109173|463895680|FG000|Overall Study|Not Specifiied|5|||
128890061|NCT01109173|463895681|FG001|Overall Study|Not Specifiied|4|||
128890062|NCT01109173|463895682|FG002|Overall Study|Not Specifiied|9|||
128890063|NCT01109173|463895683|FG003|Overall Study|Not Specifiied|14|||
128890064|NCT01132612|463895684|FG000|Overall Study|Death|0|||
128890065|NCT01132612|463895685|FG001|Overall Study|Death|0|||
128890066|NCT01132612|463895686|FG002|Overall Study|Death|1|||
128890067|NCT01132612|463895684|FG000|Overall Study|Protocol deviation|0|||
128890068|NCT01132612|463895685|FG001|Overall Study|Protocol deviation|0|||
128890069|NCT01132612|463895686|FG002|Overall Study|Protocol deviation|3|||
128890070|NCT01132612|463895684|FG000|Overall Study|Lost to Follow-up|2|||
128890071|NCT01132612|463895685|FG001|Overall Study|Lost to Follow-up|2|||
128763955|NCT01412801|463425876|FG001|Overall Study|Withdrawal by Subject|2|||
128763956|NCT01412801|463425877|FG002|Overall Study|Withdrawal by Subject|1|||
128890072|NCT01132612|463895686|FG002|Overall Study|Lost to Follow-up|7|||
128890073|NCT01132612|463895684|FG000|Overall Study|Adverse Event|5|||
128890074|NCT01132612|463895685|FG001|Overall Study|Adverse Event|2|||
128890075|NCT01132612|463895686|FG002|Overall Study|Adverse Event|15|||
128890076|NCT01132612|463895684|FG000|Overall Study|Withdrawal by Subject|5|||
128890077|NCT01132612|463895685|FG001|Overall Study|Withdrawal by Subject|8|||
128763957|NCT01412801|463425878|FG003|Overall Study|Withdrawal by Subject|0|||
128890078|NCT01132612|463895686|FG002|Overall Study|Withdrawal by Subject|19|||
128890079|NCT01132612|463895684|FG000|Overall Study|Administrative problems|5|||
128890080|NCT01132612|463895685|FG001|Overall Study|Administrative problems|1|||
128890081|NCT01132612|463895686|FG002|Overall Study|Administrative problems|52|||
128890082|NCT01132612|463895684|FG000|Overall Study|Lack of Efficacy|23|||
128890083|NCT01132612|463895685|FG001|Overall Study|Lack of Efficacy|22|||
128763958|NCT01412801|463425879|FG004|Overall Study|Withdrawal by Subject|0|||
128890084|NCT01132612|463895686|FG002|Overall Study|Lack of Efficacy|73|||
128890085|NCT02252536|463895687|FG000|Overall Study|Lost to Follow-up|5|||
128890086|NCT02252536|463895688|FG001|Overall Study|Lost to Follow-up|3|||
128890087|NCT01438151|463895690|FG000|Overall Study|study terminated|8|||
128890088|NCT00006392|463895704|FG000|Overall Study|Ineligible|11|||
128890089|NCT00006392|463895705|FG001|Overall Study|Ineligible|3|||
128890090|NCT00006392|463895706|FG002|Overall Study|Ineligible|5|||
128890091|NCT00006392|463895707|FG003|Overall Study|Ineligible|5|||
128890092|NCT00006392|463895704|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
128890093|NCT00006392|463895705|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
128890094|NCT00006392|463895706|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
128890095|NCT00006392|463895707|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
128890096|NCT02459769|463895708|FG000|Overall Study|Withdrawal by Subject|7|||
128890097|NCT02459769|463895709|FG001|Overall Study|Withdrawal by Subject|4|||
128890098|NCT02459769|463895710|FG002|Overall Study|Withdrawal by Subject|8|||
128890099|NCT02459769|463895711|FG003|Overall Study|Withdrawal by Subject|5|||
128890100|NCT02459769|463895708|FG000|Overall Study|Lost to Follow-up|1|||
128890101|NCT02459769|463895709|FG001|Overall Study|Lost to Follow-up|0|||
128890102|NCT02459769|463895710|FG002|Overall Study|Lost to Follow-up|1|||
128890103|NCT02459769|463895711|FG003|Overall Study|Lost to Follow-up|0|||
128890104|NCT01186796|463895712|FG000|Overall Study|Adverse Event|3|||
128890105|NCT01186796|463895713|FG001|Overall Study|Adverse Event|0|||
128890106|NCT01186796|463895712|FG000|Overall Study|Withdrawal by Subject|1|||
128890107|NCT01186796|463895713|FG001|Overall Study|Withdrawal by Subject|1|||
128890108|NCT01186796|463895712|FG000|Overall Study|Protocol Violation|0|||
128890109|NCT01186796|463895713|FG001|Overall Study|Protocol Violation|1|||
128890110|NCT01287364|463895715|FG000|Overall Study|Adverse Event|0|||
128890111|NCT01287364|463895716|FG001|Overall Study|Adverse Event|3|||
128890112|NCT01287364|463895715|FG000|Overall Study|Protocol Violation|5|||
128890113|NCT01287364|463895716|FG001|Overall Study|Protocol Violation|5|||
128890114|NCT01287364|463895715|FG000|Overall Study|Other Reason|4|||
128890115|NCT01287364|463895716|FG001|Overall Study|Other Reason|2|||
128890116|NCT01026142|463895728|FG000|Overall Study|Death|136|||
128890117|NCT01026142|463895729|FG001|Overall Study|Death|134|||
128890118|NCT01026142|463895728|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
128890119|NCT01026142|463895729|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
129110256|NCT01705977|464697886|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
129110257|NCT01705977|464697887|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
129110258|NCT01705977|464697886|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
129110259|NCT01705977|464697887|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
129110260|NCT01705977|464697886|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
129110261|NCT01705977|464697887|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
129110262|NCT01705977|464697886|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
129110263|NCT01705977|464697887|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
129110264|NCT03066830|464697888|FG000|Overall Study|At the Participant's own Request|16|||
129110265|NCT03066830|464697889|FG001|Overall Study|At the Participant's own Request|17|||
129110266|NCT03066830|464697888|FG000|Overall Study|Other|3|||
129110267|NCT03066830|464697889|FG001|Overall Study|Other|0|||
129110268|NCT03066830|464697888|FG000|Overall Study|Poor Compliance to Protocol|1|||
129110269|NCT03066830|464697889|FG001|Overall Study|Poor Compliance to Protocol|0|||
129110270|NCT03066830|464697888|FG000|Overall Study|Adverse Event|2|||
129110271|NCT03066830|464697889|FG001|Overall Study|Adverse Event|2|||
129110272|NCT03066830|464697888|FG000|Overall Study|Lost to Follow-up|11|||
129110273|NCT03066830|464697889|FG001|Overall Study|Lost to Follow-up|3|||
129110274|NCT02989402|464697890|FG000|Overall Study|Adverse event, or serious adverse event|4|||
129110275|NCT02989402|464697890|FG000|Overall Study|Death|2|||
129110276|NCT02989402|464697890|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
129110277|NCT02989402|464697890|FG000|Overall Study|Lost to Follow-up|8|||
129110278|NCT02989402|464697890|FG000|Overall Study|Patient no longer on monotherapy|1|||
129110279|NCT02989402|464697890|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
129110280|NCT02989402|464697890|FG000|Overall Study|Withdrawal by Subject|7|||
128763959|NCT01412801|463425880|FG005|Overall Study|Withdrawal by Subject|0|||
128763960|NCT01412801|463425875|FG000|Overall Study|Relocated to another area|0|||
128890120|NCT03681951|463895730|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
128890121|NCT03681951|463895731|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
128890122|NCT03681951|463895732|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
128890123|NCT03681951|463895733|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
128890124|NCT03681951|463895734|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
128890125|NCT03681951|463895735|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
128890126|NCT03681951|463895736|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129110281|NCT02989402|464697890|FG000|Overall Study|Other|2|||
129110282|NCT01938846|464697892|FG000|Overall Study|Progressive disease|26|||
129110283|NCT01938846|464697893|FG001|Overall Study|Progressive disease|18|||
129110284|NCT01938846|464697894|FG002|Overall Study|Progressive disease|16|||
128890127|NCT03681951|463895737|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
128890128|NCT03681951|463895730|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
128890129|NCT03681951|463895731|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128890130|NCT03681951|463895732|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128890131|NCT03681951|463895733|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128890132|NCT03681951|463895734|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128890133|NCT03681951|463895735|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128890134|NCT03681951|463895736|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128890135|NCT03681951|463895737|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
128890136|NCT03681951|463895730|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
128890137|NCT03681951|463895731|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
128890138|NCT03681951|463895732|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
128890139|NCT03681951|463895733|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
128890140|NCT03681951|463895734|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
128890141|NCT03681951|463895735|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
128890142|NCT03681951|463895736|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
128890143|NCT03681951|463895737|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
128890144|NCT00628251|463895738|FG000|Randomised Part|Withdrawal by Subject|0|||
128890145|NCT00628251|463895739|FG001|Randomised Part|Withdrawal by Subject|0|||
128890146|NCT00628251|463895740|FG002|Randomised Part|Withdrawal by Subject|1|||
128890147|NCT00628251|463895738|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
128890148|NCT00628251|463895739|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
128890149|NCT00628251|463895740|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
128890150|NCT00628251|463895738|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
128890151|NCT00628251|463895739|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
128890152|NCT00628251|463895740|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
128890153|NCT00628251|463895738|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
128890154|NCT00628251|463895739|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
128890155|NCT00628251|463895740|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
128890156|NCT00628251|463895738|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
128890157|NCT00628251|463895739|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
128890158|NCT00628251|463895740|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
128890159|NCT00628251|463895738|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
128890160|NCT00628251|463895739|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
128890161|NCT00628251|463895740|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
128890162|NCT01020448|463895741|FG000|Pre-assignment|Adverse Event|6|||
128890163|NCT01020448|463895741|FG000|Pre-assignment|Withdrawal by Subject|5|||
128890164|NCT01020448|463895741|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
128890165|NCT01020448|463895741|FG000|Treatment|Adverse Event|11|||
128890166|NCT01020448|463895741|FG000|Treatment|Consent Withdrawn|3|||
128890167|NCT01020448|463895741|FG000|Treatment|Disease Progression|2|||
128890168|NCT01020448|463895741|FG000|Treatment|Lack of Efficacy|8|||
128890169|NCT01020448|463895741|FG000|Treatment|Lost to Follow-up|2|||
128890170|NCT00728481|463895742|FG000|Overall Study|Withdrawal by Subject|0|||
128890171|NCT00728481|463895743|FG001|Overall Study|Withdrawal by Subject|1|||
128890172|NCT00728481|463895742|FG000|Overall Study|Adverse Event|0|||
128890173|NCT00728481|463895743|FG001|Overall Study|Adverse Event|1|||
128890174|NCT00728481|463895742|FG000|Overall Study|Study medication non-compliance|0|||
128890175|NCT00728481|463895743|FG001|Overall Study|Study medication non-compliance|2|||
128890176|NCT00728481|463895742|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
128890177|NCT00728481|463895743|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
128890178|NCT02545322|463895744|FG000|Overall Study|Withdrawal by Subject|3|||
128890179|NCT00041067|463895745|FG000|Overall Study|Adverse Event|20|||
128890180|NCT00041067|463895745|FG000|Overall Study|Progression|19|||
128890181|NCT00041067|463895745|FG000|Overall Study|Patient refusal|12|||
128890182|NCT00041067|463895745|FG000|Overall Study|Other reasons|23|||
128890183|NCT00041067|463895745|FG000|Overall Study|Ineligible|2|||
128890184|NCT01505010|463895746|FG000|Overall Study|Protocol Violation|0|||
128890185|NCT01505010|463895747|FG001|Overall Study|Protocol Violation|1|||
128890186|NCT01505010|463895746|FG000|Overall Study|Lost to Follow-up|0|||
128890187|NCT01505010|463895747|FG001|Overall Study|Lost to Follow-up|1|||
128890188|NCT01968070|463895749|FG000|Period 1|Withdrawal by Subject|0|||
128890189|NCT01968070|463895750|FG001|Period 1|Withdrawal by Subject|1|||
128688407|NCT02943460|463158990|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
128688408|NCT02943460|463158991|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
128688409|NCT02943460|463158989|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
128688410|NCT02943460|463158990|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
128890190|NCT01968070|463895751|FG002|Period 1|Withdrawal by Subject|0|||
128890191|NCT01968070|463895752|FG003|Period 1|Withdrawal by Subject|0|||
128890192|NCT01968070|463895753|FG004|Period 1|Withdrawal by Subject|0|||
128890193|NCT01968070|463895754|FG005|Period 1|Withdrawal by Subject|0|||
128688411|NCT02943460|463158991|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
128688412|NCT01925274|463158992|FG000|Overall Study|Death|1|||
128688413|NCT01925274|463158993|FG001|Overall Study|Death|0|||
128688414|NCT01925274|463158994|FG002|Overall Study|Death|0|||
128688415|NCT01925274|463158992|FG000|Overall Study|Lost to Follow-up|0|||
128688416|NCT01925274|463158993|FG001|Overall Study|Lost to Follow-up|1|||
128688417|NCT01925274|463158994|FG002|Overall Study|Lost to Follow-up|0|||
128688418|NCT01925274|463158992|FG000|Overall Study|Withdrawal by Subject|1|||
128688419|NCT01925274|463158993|FG001|Overall Study|Withdrawal by Subject|2|||
128688420|NCT01925274|463158994|FG002|Overall Study|Withdrawal by Subject|0|||
128688421|NCT01925274|463158992|FG000|Overall Study|Study terminated by sponsor|4|||
128688422|NCT01925274|463158993|FG001|Overall Study|Study terminated by sponsor|0|||
128688423|NCT01925274|463158994|FG002|Overall Study|Study terminated by sponsor|0|||
128688424|NCT01925274|463158992|FG000|Overall Study|Protocol amendment|1|||
128688425|NCT01925274|463158993|FG001|Overall Study|Protocol amendment|3|||
128688426|NCT01925274|463158994|FG002|Overall Study|Protocol amendment|6|||
128688427|NCT01031381|463158997|FG000|Overall Study|Physician Decision|3|||
128688428|NCT01031381|463158997|FG000|Overall Study|Withdrawal by Subject|6|||
128688429|NCT00122109|463158998|FG000|Overall Study|Did not meet criteria|6|||
128688430|NCT00122109|463158999|FG001|Overall Study|Did not meet criteria|7|||
128688431|NCT00267189|463159003|FG000|Overall Study|Patient withdrew consent|1|||
128688432|NCT00267189|463159004|FG001|Overall Study|Patient withdrew consent|1|||
128688433|NCT00267189|463159003|FG000|Overall Study|Death|1|||
128688434|NCT00267189|463159004|FG001|Overall Study|Death|0|||
128688435|NCT00267189|463159003|FG000|Overall Study|Missing|3|||
128763961|NCT01412801|463425876|FG001|Overall Study|Relocated to another area|0|||
128688436|NCT00267189|463159004|FG001|Overall Study|Missing|0|||
128688437|NCT00777205|463159005|FG000|Overall Study|Lost to Follow-up|25|||
128688438|NCT00777205|463159006|FG001|Overall Study|Lost to Follow-up|9|||
128688439|NCT00777205|463159005|FG000|Overall Study|Withdrawal by Subject|6|||
128688440|NCT00777205|463159006|FG001|Overall Study|Withdrawal by Subject|4|||
128688441|NCT00777205|463159005|FG000|Overall Study|Death|0|||
128688442|NCT00777205|463159006|FG001|Overall Study|Death|2|||
128688443|NCT00777205|463159005|FG000|Overall Study|Protocol Violation|0|||
128688444|NCT00777205|463159006|FG001|Overall Study|Protocol Violation|56|||
128688445|NCT00100178|463159007|FG000|Overall Study|Lost to Follow-up|0|||
128688446|NCT00100178|463159008|FG001|Overall Study|Lost to Follow-up|6|||
128763962|NCT01412801|463425877|FG002|Overall Study|Relocated to another area|2|||
128763963|NCT01412801|463425878|FG003|Overall Study|Relocated to another area|0|||
128763964|NCT01412801|463425879|FG004|Overall Study|Relocated to another area|0|||
128763965|NCT01412801|463425880|FG005|Overall Study|Relocated to another area|0|||
128763966|NCT00116272|463425881|FG000|Overall Study|Lost to Follow-up|11|||
128763967|NCT00116272|463425882|FG001|Overall Study|Lost to Follow-up|6|||
128763968|NCT00782496|463425885|FG000|Overall Study|Lost to Follow-up|14|||
128763969|NCT00782496|463425886|FG001|Overall Study|Lost to Follow-up|15|||
128763970|NCT00990340|463425889|FG000|First 14-day Treatment|Not Compliant|2|||
128763971|NCT00990340|463425890|FG001|First 14-day Treatment|Not Compliant|1|||
128763972|NCT00990340|463425889|FG000|First 14-day Treatment|Lost to Follow-up|2|||
128763973|NCT00990340|463425890|FG001|First 14-day Treatment|Lost to Follow-up|1|||
128763974|NCT00990340|463425889|FG000|First 14-day Treatment|Protocol Violation|2|||
128763975|NCT00990340|463425890|FG001|First 14-day Treatment|Protocol Violation|2|||
128763976|NCT01987817|463425892|FG000|Overall Study|Adverse Event|4|||
128763977|NCT01987817|463425893|FG001|Overall Study|Adverse Event|0|||
128763978|NCT01987817|463425892|FG000|Overall Study|Withdrawal by Subject|1|||
128763979|NCT01987817|463425893|FG001|Overall Study|Withdrawal by Subject|1|||
128763980|NCT01987817|463425892|FG000|Overall Study|Physician Decision|1|||
128763981|NCT01987817|463425893|FG001|Overall Study|Physician Decision|0|||
128763982|NCT02070484|463425894|FG000|Overall Study|Withdrawal by Subject|1|||
128763983|NCT02070484|463425895|FG001|Overall Study|Withdrawal by Subject|0|||
128763984|NCT00682643|463425896|FG000|Overall Study|Adverse Event|12|||
128763985|NCT00682643|463425897|FG001|Overall Study|Adverse Event|23|||
128763986|NCT00682643|463425896|FG000|Overall Study|Lack of Efficacy|2|||
128763987|NCT00682643|463425897|FG001|Overall Study|Lack of Efficacy|0|||
129110285|NCT01938846|464697892|FG000|Overall Study|Adverse Event|8|||
129110286|NCT01938846|464697893|FG001|Overall Study|Adverse Event|4|||
128688447|NCT00100178|463159009|FG002|Overall Study|Lost to Follow-up|5|||
128763988|NCT00682643|463425896|FG000|Overall Study|Protocol Violation|38|||
128763989|NCT00682643|463425897|FG001|Overall Study|Protocol Violation|76|||
128763990|NCT00682643|463425896|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
129110287|NCT01938846|464697894|FG002|Overall Study|Adverse Event|3|||
128763991|NCT00682643|463425897|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
128763992|NCT00682643|463425896|FG000|Overall Study|Lost to Follow-up|1|||
128688448|NCT00100178|463159007|FG000|Overall Study|Adverse Event|2|||
128688449|NCT00100178|463159008|FG001|Overall Study|Adverse Event|2|||
128688450|NCT00100178|463159009|FG002|Overall Study|Adverse Event|1|||
128688451|NCT00100178|463159007|FG000|Overall Study|Withdrawal by Subject|1|||
128688452|NCT00100178|463159008|FG001|Overall Study|Withdrawal by Subject|1|||
128688453|NCT00100178|463159009|FG002|Overall Study|Withdrawal by Subject|1|||
128890194|NCT01968070|463895755|FG006|Period 1|Withdrawal by Subject|1|||
128890195|NCT01968070|463895756|FG007|Period 1|Withdrawal by Subject|0|||
128890196|NCT01968070|463895757|FG008|Period 1|Withdrawal by Subject|0|||
128890197|NCT01968070|463895758|FG009|Period 1|Withdrawal by Subject|0|||
128890198|NCT01968070|463895759|FG010|Period 1|Withdrawal by Subject|0|||
128890199|NCT01968070|463895760|FG011|Period 1|Withdrawal by Subject|0|||
128890200|NCT01968070|463895761|FG012|Period 1|Withdrawal by Subject|0|||
128890201|NCT01968070|463895762|FG013|Period 1|Withdrawal by Subject|0|||
128890202|NCT01968070|463895763|FG014|Period 1|Withdrawal by Subject|0|||
128890203|NCT01968070|463895764|FG015|Period 1|Withdrawal by Subject|1|||
128890204|NCT01968070|463895765|FG016|Period 1|Withdrawal by Subject|0|||
128890205|NCT01968070|463895766|FG017|Period 1|Withdrawal by Subject|0|||
128890206|NCT01968070|463895749|FG000|Period 1|Protocol Violation|0|||
128890207|NCT01968070|463895750|FG001|Period 1|Protocol Violation|0|||
128890208|NCT01968070|463895751|FG002|Period 1|Protocol Violation|0|||
128890209|NCT01968070|463895752|FG003|Period 1|Protocol Violation|1|||
128890210|NCT01968070|463895753|FG004|Period 1|Protocol Violation|1|||
128890211|NCT01968070|463895754|FG005|Period 1|Protocol Violation|0|||
128890212|NCT01968070|463895755|FG006|Period 1|Protocol Violation|0|||
128890213|NCT01968070|463895756|FG007|Period 1|Protocol Violation|0|||
128890214|NCT01968070|463895757|FG008|Period 1|Protocol Violation|0|||
128890215|NCT01968070|463895758|FG009|Period 1|Protocol Violation|0|||
128890216|NCT01968070|463895759|FG010|Period 1|Protocol Violation|0|||
128890217|NCT01968070|463895760|FG011|Period 1|Protocol Violation|0|||
128890218|NCT01968070|463895761|FG012|Period 1|Protocol Violation|0|||
128890219|NCT01968070|463895762|FG013|Period 1|Protocol Violation|0|||
128890220|NCT01968070|463895763|FG014|Period 1|Protocol Violation|0|||
128890221|NCT01968070|463895764|FG015|Period 1|Protocol Violation|0|||
128890222|NCT01968070|463895765|FG016|Period 1|Protocol Violation|0|||
128890223|NCT01968070|463895766|FG017|Period 1|Protocol Violation|0|||
128890224|NCT01968070|463895749|FG000|Period 1|Lost to Follow-up|0|||
128890225|NCT01968070|463895750|FG001|Period 1|Lost to Follow-up|0|||
128890226|NCT01968070|463895751|FG002|Period 1|Lost to Follow-up|0|||
128890227|NCT01968070|463895752|FG003|Period 1|Lost to Follow-up|1|||
128890228|NCT01968070|463895753|FG004|Period 1|Lost to Follow-up|0|||
128890229|NCT01968070|463895754|FG005|Period 1|Lost to Follow-up|0|||
128890230|NCT01968070|463895755|FG006|Period 1|Lost to Follow-up|0|||
128890231|NCT01968070|463895756|FG007|Period 1|Lost to Follow-up|0|||
128890232|NCT01968070|463895757|FG008|Period 1|Lost to Follow-up|0|||
128890233|NCT01968070|463895758|FG009|Period 1|Lost to Follow-up|0|||
128890234|NCT01968070|463895759|FG010|Period 1|Lost to Follow-up|0|||
128890235|NCT01968070|463895760|FG011|Period 1|Lost to Follow-up|0|||
128890236|NCT01968070|463895761|FG012|Period 1|Lost to Follow-up|0|||
128890237|NCT01968070|463895762|FG013|Period 1|Lost to Follow-up|0|||
128890238|NCT01968070|463895763|FG014|Period 1|Lost to Follow-up|0|||
128890239|NCT01968070|463895764|FG015|Period 1|Lost to Follow-up|0|||
128890240|NCT01968070|463895765|FG016|Period 1|Lost to Follow-up|0|||
128890241|NCT01968070|463895766|FG017|Period 1|Lost to Follow-up|0|||
128890242|NCT01968070|463895749|FG000|Period 1|Adverse Event|0|||
128890243|NCT01968070|463895750|FG001|Period 1|Adverse Event|0|||
128890244|NCT01968070|463895751|FG002|Period 1|Adverse Event|0|||
128890245|NCT01968070|463895752|FG003|Period 1|Adverse Event|0|||
128890246|NCT01968070|463895753|FG004|Period 1|Adverse Event|0|||
128890247|NCT01968070|463895754|FG005|Period 1|Adverse Event|0|||
128890248|NCT01968070|463895755|FG006|Period 1|Adverse Event|1|||
128890249|NCT01968070|463895756|FG007|Period 1|Adverse Event|0|||
128763993|NCT00682643|463425897|FG001|Overall Study|Lost to Follow-up|6|||
128890250|NCT01968070|463895757|FG008|Period 1|Adverse Event|0|||
128890251|NCT01968070|463895758|FG009|Period 1|Adverse Event|0|||
128890252|NCT01968070|463895759|FG010|Period 1|Adverse Event|0|||
128890253|NCT01968070|463895760|FG011|Period 1|Adverse Event|0|||
128890254|NCT01968070|463895761|FG012|Period 1|Adverse Event|0|||
128890255|NCT01968070|463895762|FG013|Period 1|Adverse Event|0|||
128890256|NCT01968070|463895763|FG014|Period 1|Adverse Event|0|||
128890257|NCT01968070|463895764|FG015|Period 1|Adverse Event|0|||
128890258|NCT01968070|463895765|FG016|Period 1|Adverse Event|0|||
128890259|NCT01968070|463895766|FG017|Period 1|Adverse Event|0|||
128890260|NCT01968070|463895749|FG000|Period 1|Physician Decision|0|||
128890261|NCT01968070|463895750|FG001|Period 1|Physician Decision|0|||
128890262|NCT01968070|463895751|FG002|Period 1|Physician Decision|0|||
128890263|NCT01968070|463895752|FG003|Period 1|Physician Decision|0|||
128890264|NCT01968070|463895753|FG004|Period 1|Physician Decision|0|||
128890265|NCT01968070|463895754|FG005|Period 1|Physician Decision|0|||
128890266|NCT01968070|463895755|FG006|Period 1|Physician Decision|0|||
128890267|NCT01968070|463895756|FG007|Period 1|Physician Decision|0|||
128890268|NCT01968070|463895757|FG008|Period 1|Physician Decision|0|||
128890269|NCT01968070|463895758|FG009|Period 1|Physician Decision|0|||
128890270|NCT01968070|463895759|FG010|Period 1|Physician Decision|0|||
128890271|NCT01968070|463895760|FG011|Period 1|Physician Decision|1|||
128890272|NCT01968070|463895761|FG012|Period 1|Physician Decision|0|||
128890273|NCT01968070|463895762|FG013|Period 1|Physician Decision|0|||
128890274|NCT01968070|463895763|FG014|Period 1|Physician Decision|0|||
128890275|NCT01968070|463895764|FG015|Period 1|Physician Decision|0|||
128890276|NCT01968070|463895765|FG016|Period 1|Physician Decision|0|||
128890277|NCT01968070|463895766|FG017|Period 1|Physician Decision|0|||
128890278|NCT01968070|463895749|FG000|Period 2|Withdrawal by Subject|0|||
128890279|NCT01968070|463895750|FG001|Period 2|Withdrawal by Subject|0|||
128890280|NCT01968070|463895751|FG002|Period 2|Withdrawal by Subject|0|||
128890281|NCT01968070|463895752|FG003|Period 2|Withdrawal by Subject|0|||
128890282|NCT01968070|463895753|FG004|Period 2|Withdrawal by Subject|1|||
128890283|NCT01968070|463895754|FG005|Period 2|Withdrawal by Subject|0|||
128890284|NCT01968070|463895755|FG006|Period 2|Withdrawal by Subject|0|||
128890285|NCT01968070|463895756|FG007|Period 2|Withdrawal by Subject|0|||
128890286|NCT01968070|463895757|FG008|Period 2|Withdrawal by Subject|0|||
128890287|NCT01968070|463895758|FG009|Period 2|Withdrawal by Subject|0|||
128890288|NCT01968070|463895759|FG010|Period 2|Withdrawal by Subject|0|||
128890289|NCT01968070|463895760|FG011|Period 2|Withdrawal by Subject|0|||
128890290|NCT01968070|463895761|FG012|Period 2|Withdrawal by Subject|0|||
128890291|NCT01968070|463895762|FG013|Period 2|Withdrawal by Subject|0|||
128890292|NCT01968070|463895763|FG014|Period 2|Withdrawal by Subject|0|||
128890293|NCT01968070|463895764|FG015|Period 2|Withdrawal by Subject|0|||
128890294|NCT01968070|463895765|FG016|Period 2|Withdrawal by Subject|0|||
128890295|NCT01968070|463895766|FG017|Period 2|Withdrawal by Subject|0|||
128890296|NCT00108069|463895771|FG000|Overall Study|Never rec'd study drug|0|||
128890297|NCT00108069|463895772|FG001|Overall Study|Never rec'd study drug|1|||
128890298|NCT00108069|463895771|FG000|Overall Study|Adverse Event|1|||
128890299|NCT00108069|463895772|FG001|Overall Study|Adverse Event|1|||
128688454|NCT00100178|463159007|FG000|Overall Study|Physician Decision|6|||
128688455|NCT00100178|463159008|FG001|Overall Study|Physician Decision|1|||
128890300|NCT00108069|463895771|FG000|Overall Study|Withdrawal by Subject|1|||
128890301|NCT00108069|463895772|FG001|Overall Study|Withdrawal by Subject|0|||
128890302|NCT00108069|463895771|FG000|Overall Study|Death|1|||
128890303|NCT00108069|463895772|FG001|Overall Study|Death|0|||
128890304|NCT00108069|463895771|FG000|Overall Study|Progessive disease|27|||
128890305|NCT00108069|463895772|FG001|Overall Study|Progessive disease|11|||
128890306|NCT00995007|463895773|FG000|Overall Study|Withdrew consent|1|||
128890307|NCT00995007|463895774|FG001|Overall Study|Withdrew consent|0|||
128890308|NCT00995007|463895773|FG000|Overall Study|Refused further treatment|8|||
128890309|NCT00995007|463895774|FG001|Overall Study|Refused further treatment|2|||
128890310|NCT00995007|463895773|FG000|Overall Study|Toxicity|8|||
128890311|NCT00995007|463895774|FG001|Overall Study|Toxicity|0|||
128890312|NCT01910116|463895776|FG000|Overall Study|Adverse Event|0|||
128890313|NCT01910116|463895777|FG001|Overall Study|Adverse Event|3|||
128890314|NCT01910116|463895776|FG000|Overall Study|Lack of Efficacy|3|||
128890315|NCT01910116|463895777|FG001|Overall Study|Lack of Efficacy|4|||
128890316|NCT01910116|463895776|FG000|Overall Study|Lost to Follow-up|1|||
128890317|NCT01910116|463895777|FG001|Overall Study|Lost to Follow-up|0|||
128890318|NCT01910116|463895776|FG000|Overall Study|Protocol Violation|1|||
128890319|NCT01910116|463895777|FG001|Overall Study|Protocol Violation|2|||
128890320|NCT01910116|463895776|FG000|Overall Study|Withdrawal by Subject|8|||
128890321|NCT01910116|463895777|FG001|Overall Study|Withdrawal by Subject|3|||
128890322|NCT01910116|463895776|FG000|Overall Study|uncertain allocation|1|||
128890323|NCT01910116|463895777|FG001|Overall Study|uncertain allocation|3|||
128890324|NCT01910116|463895776|FG000|Overall Study|incomplete data|0|||
128890325|NCT01910116|463895777|FG001|Overall Study|incomplete data|1|||
128890326|NCT03606980|463895778|FG000|Overall Study|Lost to Follow-up|3|||
128890327|NCT03606980|463895779|FG001|Overall Study|Lost to Follow-up|2|||
128890328|NCT03606980|463895780|FG002|Overall Study|Lost to Follow-up|3|||
128890329|NCT03606980|463895778|FG000|Overall Study|Withdrawal by Subject|1|||
128890330|NCT03606980|463895779|FG001|Overall Study|Withdrawal by Subject|0|||
128890331|NCT03606980|463895780|FG002|Overall Study|Withdrawal by Subject|4|||
128890332|NCT02469896|463895783|FG000|Overall Study|Withdrawal by Subject|2|||
128890333|NCT02469896|463895784|FG001|Overall Study|Withdrawal by Subject|0|||
128890334|NCT01294150|463895785|FG000|Overall Study|Physician Decision|2|||
128688456|NCT00100178|463159009|FG002|Overall Study|Physician Decision|3|||
128890335|NCT01294150|463895786|FG001|Overall Study|Physician Decision|2|||
128890336|NCT03675776|463895787|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
128890337|NCT03675776|463895788|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
128890338|NCT03675776|463895789|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
128890339|NCT03675776|463895787|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
128890340|NCT03675776|463895788|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
129110288|NCT01938846|464697892|FG000|Overall Study|Withdrawal by Subject|2|||
129110289|NCT01938846|464697893|FG001|Overall Study|Withdrawal by Subject|2|||
128890341|NCT03675776|463895789|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
128890342|NCT02401412|463895790|FG000|Overall Study|Lost to Follow-up|1|||
128890343|NCT02401412|463895791|FG001|Overall Study|Lost to Follow-up|0|||
128890344|NCT02401412|463895790|FG000|Overall Study|Discontinued Intervention|15|||
128890345|NCT02401412|463895791|FG001|Overall Study|Discontinued Intervention|21|||
128890346|NCT02401412|463895790|FG000|Overall Study|Withdrawal by Subject|4|||
128688457|NCT01439568|463159014|FG000|Overall Study|Lost to Follow-up|1|||
128890347|NCT02401412|463895791|FG001|Overall Study|Withdrawal by Subject|4|||
128890348|NCT02401412|463895790|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
128890349|NCT02401412|463895791|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
128890350|NCT02401412|463895790|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
128890351|NCT02401412|463895791|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
128890352|NCT00882310|463895792|FG000|Overall Study|Screen Failure|10|||
128890353|NCT00882310|463895792|FG000|Overall Study|Never received treatment|1|||
128890354|NCT00882310|463895792|FG000|Overall Study|Death|6|||
128890355|NCT00882310|463895792|FG000|Overall Study|Progression of disease|4|||
128890356|NCT00882310|463895792|FG000|Overall Study|Adverse Event|1|||
128890357|NCT01351623|463895796|FG000|Overall Study|Protocol Violation|2|||
128890358|NCT01351623|463895796|FG000|Overall Study|Adverse Event|4|||
128890359|NCT01351623|463895796|FG000|Overall Study|Withdrawal by Subject|1|||
128890360|NCT01351623|463895796|FG000|Overall Study|Death|2|||
128890361|NCT01130974|463895797|FG000|Overall Study|Protocol Violation|10|||
128890362|NCT01130974|463895798|FG001|Overall Study|Protocol Violation|10|||
128890363|NCT01130974|463895797|FG000|Overall Study|Withdrawal by Subject|0|||
128890364|NCT01130974|463895798|FG001|Overall Study|Withdrawal by Subject|1|||
128890365|NCT01130974|463895797|FG000|Overall Study|Ineligibility criteria|5|||
128890366|NCT01130974|463895798|FG001|Overall Study|Ineligibility criteria|2|||
128890367|NCT01184053|463895799|FG000|Overall Study|progression while on treatment|3|||
128890368|NCT04399122|463895800|FG000|Overall Study|Lost to Follow-up|2|||
128890369|NCT04399122|463895801|FG001|Overall Study|Lost to Follow-up|0|||
128890370|NCT04399122|463895800|FG000|Overall Study|Withdrawal by Subject|1|||
128890371|NCT04399122|463895801|FG001|Overall Study|Withdrawal by Subject|0|||
128890372|NCT02684279|463895802|FG000|Overall Study|Adverse Event|87|||
128890373|NCT02684279|463895802|FG000|Overall Study|Lack of Efficacy|4|||
128890374|NCT02684279|463895802|FG000|Overall Study|Lost to Follow-up|61|||
128890375|NCT02684279|463895802|FG000|Overall Study|Protocol Violation|6|||
128890376|NCT02684279|463895802|FG000|Overall Study|Pregnancy|8|||
128890377|NCT02684279|463895802|FG000|Overall Study|Withdrawal by Subject|92|||
128890378|NCT02684279|463895802|FG000|Overall Study|non-compliance with study drug|9|||
128890379|NCT02684279|463895802|FG000|Overall Study|non compliance with study visits|2|||
128890380|NCT02684279|463895802|FG000|Overall Study|subject to have surgery|1|||
128890381|NCT02684279|463895802|FG000|Overall Study|family emergency|1|||
128890382|NCT02684279|463895802|FG000|Overall Study|Site closures|7|||
128890383|NCT02684279|463895802|FG000|Overall Study|Physician Decision|1|||
128890384|NCT01624259|463895803|FG000|Overall Study|Adverse Event|18|||
128890385|NCT01624259|463895804|FG001|Overall Study|Adverse Event|18|||
128890386|NCT01624259|463895803|FG000|Overall Study|Protocol Violation|1|||
128890387|NCT01624259|463895804|FG001|Overall Study|Protocol Violation|2|||
128890388|NCT01624259|463895803|FG000|Overall Study|Withdrawal by Subject|5|||
128890389|NCT01624259|463895804|FG001|Overall Study|Withdrawal by Subject|7|||
128890390|NCT01624259|463895803|FG000|Overall Study|Physician Decision|1|||
128890391|NCT01624259|463895804|FG001|Overall Study|Physician Decision|1|||
128890392|NCT01624259|463895803|FG000|Overall Study|Lost to Follow-up|2|||
128890393|NCT01624259|463895804|FG001|Overall Study|Lost to Follow-up|3|||
128890394|NCT01624259|463895803|FG000|Overall Study|Abnormal laboratory measure|3|||
128890395|NCT01624259|463895804|FG001|Overall Study|Abnormal laboratory measure|0|||
128890396|NCT04313153|463897347|FG000|Overall Study|Adverse Event (includes Death)|14|||
128890397|NCT04313153|463897348|FG001|Overall Study|Adverse Event (includes Death)|19|||
128890398|NCT04313153|463897349|FG002|Overall Study|Adverse Event (includes Death)|10|||
128890399|NCT04313153|463897347|FG000|Overall Study|Physician Decision|4|||
128890400|NCT04313153|463897348|FG001|Overall Study|Physician Decision|2|||
128890401|NCT04313153|463897349|FG002|Overall Study|Physician Decision|1|||
128890402|NCT04313153|463897347|FG000|Overall Study|Withdrawal by Subject|7|||
129110290|NCT01938846|464697894|FG002|Overall Study|Withdrawal by Subject|1|||
128688458|NCT01439568|463159015|FG001|Overall Study|Lost to Follow-up|0|||
128688459|NCT01439568|463159014|FG000|Overall Study|Withdrawal by Subject|2|||
128688460|NCT01439568|463159015|FG001|Overall Study|Withdrawal by Subject|2|||
128688461|NCT01676727|463159016|FG000|Overall Study|Death|18|||
128688462|NCT01676727|463159016|FG000|Overall Study|Withdrawal by Subject|6|||
128688463|NCT01676727|463159016|FG000|Overall Study|Screening failure|5|||
128890403|NCT04313153|463897348|FG001|Overall Study|Withdrawal by Subject|6|||
128890404|NCT04313153|463897349|FG002|Overall Study|Withdrawal by Subject|2|||
128890405|NCT04313153|463897347|FG000|Overall Study|Lack of Efficacy|3|||
128890406|NCT04313153|463897348|FG001|Overall Study|Lack of Efficacy|3|||
128890407|NCT04313153|463897349|FG002|Overall Study|Lack of Efficacy|0|||
128890408|NCT04313153|463897347|FG000|Overall Study|Lost to Follow-up|1|||
128890409|NCT04313153|463897348|FG001|Overall Study|Lost to Follow-up|0|||
128890410|NCT04313153|463897349|FG002|Overall Study|Lost to Follow-up|2|||
128890411|NCT04313153|463897347|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
128890412|NCT04313153|463897348|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
128688464|NCT01676727|463159016|FG000|Overall Study|Not willing to attend 1-year visit|2|||
128890413|NCT04313153|463897349|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
129110291|NCT01938846|464697892|FG000|Overall Study|Other than listed|5|||
128688465|NCT01676727|463159016|FG000|Overall Study|Valve explanted|1|||
129110292|NCT01938846|464697893|FG001|Overall Study|Other than listed|1|||
129110293|NCT01938846|464697894|FG002|Overall Study|Other than listed|4|||
129110294|NCT02324361|464697897|FG000|Overall Study|Lost to Follow-up|5|||
129110295|NCT02324361|464697898|FG001|Overall Study|Lost to Follow-up|2|||
129110296|NCT01931397|464697908|FG000|Overall Study|Physician Decision|2|||
129110297|NCT01931397|464697908|FG000|Overall Study|Withdrawal by Subject|8|||
129110298|NCT01931397|464697908|FG000|Overall Study|moved out of state|1|||
129110299|NCT02058589|464697912|FG000|Overall Study|Serious Adverse Event|1|||
129110300|NCT02058589|464697913|FG001|Overall Study|Serious Adverse Event|1|||
129110301|NCT02058589|464697912|FG000|Overall Study|Non-Serious Adverse Event|1|||
129110302|NCT02058589|464697913|FG001|Overall Study|Non-Serious Adverse Event|0|||
129110303|NCT02058589|464697912|FG000|Overall Study|Withdrawal by Subject|0|||
129110304|NCT02058589|464697913|FG001|Overall Study|Withdrawal by Subject|1|||
129110305|NCT02143024|464697914|FG000|Overall Study|Lost to Follow-up|1|||
129110306|NCT02143024|464697915|FG001|Overall Study|Lost to Follow-up|1|||
129110307|NCT02143024|464697914|FG000|Overall Study|Withdrawal by Subject|1|||
129110308|NCT02143024|464697915|FG001|Overall Study|Withdrawal by Subject|0|||
129110309|NCT01945944|464697916|FG000|Overall Study|Adverse Event|0|||
129110310|NCT01945944|464697917|FG001|Overall Study|Adverse Event|2|||
129110311|NCT01945944|464697916|FG000|Overall Study|Physician Decision|1|||
129110312|NCT01945944|464697917|FG001|Overall Study|Physician Decision|0|||
129110313|NCT01945944|464697916|FG000|Overall Study|Withdrawal by Subject|0|||
129110314|NCT01945944|464697917|FG001|Overall Study|Withdrawal by Subject|1|||
129110315|NCT01212094|464699763|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
129110316|NCT01212094|464699764|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
129110317|NCT01212094|464699765|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
129110318|NCT01212094|464699763|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
129110319|NCT01212094|464699764|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
129110320|NCT01212094|464699765|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
129110321|NCT01212094|464699763|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
129110322|NCT01212094|464699764|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
129110323|NCT01212094|464699765|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
129110324|NCT01212094|464699763|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
129110325|NCT01212094|464699764|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
129110326|NCT01212094|464699765|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
129110327|NCT01212094|464699763|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
129110328|NCT01212094|464699764|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
129110329|NCT01212094|464699765|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
129110330|NCT01212094|464699763|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
129110331|NCT01212094|464699764|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
129110332|NCT01212094|464699765|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
129110333|NCT02019550|464699768|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129110334|NCT02019550|464699769|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
129110335|NCT04771013|464699772|FG000|Overall Study|Withdrawal by Subject|2|||
129110336|NCT04771013|464699773|FG001|Overall Study|Withdrawal by Subject|0|||
129110337|NCT04771013|464699772|FG000|Overall Study|Death|0|||
129110338|NCT04771013|464699773|FG001|Overall Study|Death|5|||
129110339|NCT04771013|464699772|FG000|Overall Study|Referred to another hospital before day 20|0|||
129110340|NCT04771013|464699773|FG001|Overall Study|Referred to another hospital before day 20|1|||
129110341|NCT00823134|464699775|FG000|Overall Study|Invalid measurement|1|||
129110342|NCT02291029|464699776|FG000|Overall Study|Withdrawal by Subject|0|||
129110343|NCT02291029|464699777|FG001|Overall Study|Withdrawal by Subject|0|||
129110344|NCT02291029|464699778|FG002|Overall Study|Withdrawal by Subject|1|||
129110345|NCT02291029|464699779|FG003|Overall Study|Withdrawal by Subject|0|||
129110346|NCT02291029|464699780|FG004|Overall Study|Withdrawal by Subject|0|||
129110347|NCT02291029|464699781|FG005|Overall Study|Withdrawal by Subject|0|||
129110348|NCT02291029|464699776|FG000|Overall Study|Adverse Event|0|||
129110349|NCT02291029|464699777|FG001|Overall Study|Adverse Event|1|||
129110350|NCT02291029|464699778|FG002|Overall Study|Adverse Event|0|||
129110351|NCT02291029|464699779|FG003|Overall Study|Adverse Event|0|||
129110352|NCT02291029|464699780|FG004|Overall Study|Adverse Event|0|||
129110353|NCT02291029|464699781|FG005|Overall Study|Adverse Event|0|||
129110354|NCT00493012|464699786|FG000|Overall Study|Lost to Follow-up|18|||
129110355|NCT00493012|464699787|FG001|Overall Study|Lost to Follow-up|17|||
129110356|NCT02922153|464699788|FG000|Overall Study|Death|8|||
129110357|NCT02922153|464699789|FG001|Overall Study|Death|1|||
129110358|NCT02922153|464699788|FG000|Overall Study|Lost to Follow-up|1|||
129110359|NCT02922153|464699789|FG001|Overall Study|Lost to Follow-up|0|||
129110360|NCT02922153|464699788|FG000|Overall Study|Physician Decision|1|||
129110361|NCT02922153|464699789|FG001|Overall Study|Physician Decision|1|||
129110362|NCT02692586|464699792|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
129110363|NCT02692586|464699792|FG000|Overall Study|Received adjunctive thrombolytics|2|||
129110364|NCT04547140|464699795|FG000|Overall Study|Adverse Event|0|||
129110365|NCT04547140|464699796|FG001|Overall Study|Adverse Event|1|||
128890414|NCT04313153|463897347|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
128890415|NCT04313153|463897348|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
128890416|NCT04313153|463897349|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
128890417|NCT04313153|463897347|FG000|Overall Study|Change in Dialysis Modality|0|||
128890418|NCT04313153|463897348|FG001|Overall Study|Change in Dialysis Modality|1|||
128890419|NCT04313153|463897349|FG002|Overall Study|Change in Dialysis Modality|2|||
128890420|NCT04313153|463897347|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
128890421|NCT04313153|463897348|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
128890422|NCT04313153|463897349|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
128890423|NCT04313153|463897347|FG000|Overall Study|Other|5|||
128890424|NCT04313153|463897348|FG001|Overall Study|Other|3|||
128890425|NCT04313153|463897349|FG002|Overall Study|Other|2|||
128890426|NCT04752475|463897350|FG000|Overall Study|Withdrawal by Subject|1|||
128890427|NCT04752475|463897351|FG001|Overall Study|Withdrawal by Subject|1|||
128890428|NCT02113579|463897354|FG000|Overall Study|Adverse Event|1|||
128890429|NCT02113579|463897355|FG001|Overall Study|Adverse Event|0|||
128890430|NCT02113579|463897354|FG000|Overall Study|Withdrawal by Subject|3|||
128890431|NCT02113579|463897355|FG001|Overall Study|Withdrawal by Subject|2|||
128890432|NCT02113579|463897354|FG000|Overall Study|Lost to Follow-up|6|||
128890433|NCT02113579|463897355|FG001|Overall Study|Lost to Follow-up|2|||
128890434|NCT00594516|463897358|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
128890435|NCT00594516|463897359|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
128890436|NCT00594516|463897360|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
128890437|NCT00594516|463897358|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
128890438|NCT00594516|463897359|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
128890439|NCT00594516|463897360|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
128890440|NCT00594516|463897358|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
128890441|NCT00594516|463897359|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
128890442|NCT00594516|463897360|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
128890443|NCT00594516|463897358|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
128890444|NCT00594516|463897359|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
128890445|NCT00594516|463897360|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
128890446|NCT00594516|463897358|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
128890447|NCT00594516|463897359|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
128890448|NCT00594516|463897360|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
128890449|NCT00594516|463897358|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
128890450|NCT00594516|463897359|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
128890451|NCT00594516|463897360|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
128890452|NCT00594516|463897358|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
128890453|NCT00594516|463897359|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
128890454|NCT00594516|463897360|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
128890455|NCT00594516|463897358|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
128890456|NCT00594516|463897359|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
128890457|NCT00594516|463897360|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
128890458|NCT00594516|463897358|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
128890459|NCT00594516|463897359|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
128890460|NCT00594516|463897360|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
128890461|NCT02217436|463897361|FG000|Overall Study|Protocol Violation|1|||
128890462|NCT02217436|463897362|FG001|Overall Study|Protocol Violation|1|||
128890463|NCT02217436|463897361|FG000|Overall Study|Incomplete data|0|||
128890464|NCT02217436|463897362|FG001|Overall Study|Incomplete data|1|||
128890465|NCT04641299|463897365|FG000|Overall Study|Adverse Event|0|||
128890466|NCT04641299|463897366|FG001|Overall Study|Adverse Event|0|||
128890467|NCT04641299|463897367|FG002|Overall Study|Adverse Event|2|||
128890468|NCT04641299|463897368|FG003|Overall Study|Adverse Event|0|||
128890469|NCT04641299|463897365|FG000|Overall Study|Lost to Follow-up|0|||
128890470|NCT04641299|463897366|FG001|Overall Study|Lost to Follow-up|1|||
128890471|NCT04641299|463897367|FG002|Overall Study|Lost to Follow-up|0|||
128890472|NCT04641299|463897368|FG003|Overall Study|Lost to Follow-up|0|||
129110366|NCT04547140|464699795|FG000|Overall Study|Withdrawal by Subject|0|||
129110367|NCT04547140|464699796|FG001|Overall Study|Withdrawal by Subject|1|||
129110368|NCT04547140|464699795|FG000|Overall Study|Lost to Follow-up|3|||
128890473|NCT04641299|463897365|FG000|Overall Study|Withdrawal by Subject|1|||
128890474|NCT04641299|463897366|FG001|Overall Study|Withdrawal by Subject|0|||
129110369|NCT04547140|464699796|FG001|Overall Study|Lost to Follow-up|1|||
128890475|NCT04641299|463897367|FG002|Overall Study|Withdrawal by Subject|0|||
128890476|NCT04641299|463897368|FG003|Overall Study|Withdrawal by Subject|0|||
128890477|NCT04641299|463897365|FG000|Overall Study|Reason not given|1|||
128890478|NCT04641299|463897366|FG001|Overall Study|Reason not given|0|||
128890479|NCT04641299|463897367|FG002|Overall Study|Reason not given|0|||
128890480|NCT04641299|463897368|FG003|Overall Study|Reason not given|0|||
129110370|NCT04547140|464699795|FG000|Overall Study|Death|2|||
128890481|NCT01016964|463897371|FG000|Overall Study|Lost to Follow-up|3|||
128688466|NCT04137224|463159018|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
128688467|NCT04137224|463159019|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
128688468|NCT04137224|463159018|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
128890482|NCT01016964|463897372|FG001|Overall Study|Lost to Follow-up|3|||
128890483|NCT01920594|463897373|FG000|Overall Study|Adverse Event|4|||
128890484|NCT01920594|463897374|FG001|Overall Study|Adverse Event|2|||
128688469|NCT04137224|463159019|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
128688470|NCT04137224|463159018|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
128688471|NCT04137224|463159019|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
128688472|NCT00566501|463159022|FG000|Overall Study|Adverse Event|68|||
128688473|NCT00566501|463159023|FG001|Overall Study|Adverse Event|59|||
128688474|NCT00566501|463159022|FG000|Overall Study|Medication Non-compliance|5|||
128688475|NCT00566501|463159023|FG001|Overall Study|Medication Non-compliance|0|||
128688476|NCT00566501|463159022|FG000|Overall Study|Protocol Violation|2|||
128688477|NCT00566501|463159023|FG001|Overall Study|Protocol Violation|2|||
128688478|NCT00566501|463159022|FG000|Overall Study|Request of Investigator or Sponsor|6|||
128688479|NCT00566501|463159023|FG001|Overall Study|Request of Investigator or Sponsor|7|||
128688480|NCT00566501|463159022|FG000|Overall Study|Withdrawal by Subject|33|||
128688481|NCT00566501|463159023|FG001|Overall Study|Withdrawal by Subject|30|||
128688482|NCT00566501|463159022|FG000|Overall Study|Lack of Efficacy|8|||
128688483|NCT00566501|463159023|FG001|Overall Study|Lack of Efficacy|3|||
128688484|NCT00566501|463159022|FG000|Overall Study|Other|25|||
128688485|NCT00566501|463159023|FG001|Overall Study|Other|21|||
128688486|NCT00679055|463159026|FG000|Overall Study|Adverse Event|0|||
128688487|NCT00679055|463159027|FG001|Overall Study|Adverse Event|1|||
128688488|NCT00679055|463159026|FG000|Overall Study|Other|0|||
128688489|NCT00679055|463159027|FG001|Overall Study|Other|3|||
128688490|NCT00679055|463159026|FG000|Overall Study|Study Terminated|2|||
128688491|NCT00679055|463159027|FG001|Overall Study|Study Terminated|1|||
128688492|NCT01368432|463159028|FG000|Overall Study|Lost to Follow-up|0|||
128688493|NCT01368432|463159029|FG001|Overall Study|Lost to Follow-up|1|||
128688494|NCT01008150|463159030|FG000|Overall Study|did not receive study drug|1|||
128688495|NCT01008150|463159031|FG001|Overall Study|did not receive study drug|1|||
128688496|NCT01008150|463159032|FG002|Overall Study|did not receive study drug|1|||
128688497|NCT01008150|463159033|FG003|Overall Study|did not receive study drug|0|||
128688498|NCT01938573|463159034|FG000|Overall Study|Lack of Efficacy|1|||
128688499|NCT01938573|463159035|FG001|Overall Study|Lack of Efficacy|0|||
128688500|NCT01938573|463159034|FG000|Overall Study|Operation at other hospital|1|||
128688501|NCT01938573|463159035|FG001|Overall Study|Operation at other hospital|0|||
128688502|NCT03845543|463159037|FG000|Overall Study|Death|25|||
128688503|NCT03845543|463159037|FG000|Overall Study|Withdrawal by Subject|2|||
128688504|NCT03845543|463159037|FG000|Overall Study|Lost to Follow-up|12|||
128688505|NCT03845543|463159037|FG000|Overall Study|Adverse Event|17|||
128688506|NCT01400815|463159040|FG000|Overall Study|Adverse Event|3|||
128688507|NCT01400815|463159041|FG001|Overall Study|Adverse Event|0|||
128688508|NCT01400815|463159040|FG000|Overall Study|Death|0|||
128688509|NCT01400815|463159041|FG001|Overall Study|Death|1|||
128688510|NCT01400815|463159040|FG000|Overall Study|Lost to Follow-up|18|||
128688511|NCT01400815|463159041|FG001|Overall Study|Lost to Follow-up|11|||
128688512|NCT01400815|463159040|FG000|Overall Study|Protocol Violation|0|||
128688513|NCT01400815|463159041|FG001|Overall Study|Protocol Violation|1|||
128688514|NCT01400815|463159040|FG000|Overall Study|Physician Decision|1|||
128688515|NCT01400815|463159041|FG001|Overall Study|Physician Decision|0|||
128688516|NCT01400815|463159040|FG000|Overall Study|Withdrawal by Subject|15|||
128688517|NCT01400815|463159041|FG001|Overall Study|Withdrawal by Subject|8|||
128688518|NCT01400815|463159040|FG000|Overall Study|Subject in jail|1|||
128688519|NCT01400815|463159041|FG001|Overall Study|Subject in jail|0|||
128688520|NCT01123850|463159045|FG000|Overall Study|Slow enrollment|45|||
128688521|NCT01199731|463159047|FG000|Overall Study|Adverse Event|0|||
128688522|NCT01199731|463159048|FG001|Overall Study|Adverse Event|1|||
128688523|NCT01199731|463159049|FG002|Overall Study|Adverse Event|0|||
128688524|NCT01199731|463159047|FG000|Overall Study|Study closed/terminated|7|||
128688525|NCT01199731|463159048|FG001|Overall Study|Study closed/terminated|9|||
128688526|NCT01199731|463159049|FG002|Overall Study|Study closed/terminated|7|||
128688527|NCT01199731|463159047|FG000|Overall Study|Lost to Follow-up|0|||
128688528|NCT01199731|463159048|FG001|Overall Study|Lost to Follow-up|0|||
128688529|NCT01199731|463159049|FG002|Overall Study|Lost to Follow-up|2|||
128688530|NCT01199731|463159047|FG000|Overall Study|Physician Decision|0|||
128688531|NCT01199731|463159048|FG001|Overall Study|Physician Decision|1|||
128688532|NCT01199731|463159049|FG002|Overall Study|Physician Decision|1|||
128688533|NCT01199731|463159047|FG000|Overall Study|Withdrawal by Subject|2|||
128688534|NCT01199731|463159048|FG001|Overall Study|Withdrawal by Subject|0|||
128688535|NCT01199731|463159049|FG002|Overall Study|Withdrawal by Subject|0|||
128688536|NCT00943124|463159050|FG000|Period 1|Withdrawal by Subject|1|||
128688537|NCT00943124|463159051|FG001|Period 1|Withdrawal by Subject|1|||
128688538|NCT00943124|463159050|FG000|Period 1|Did Not Follow Study Procedures|1|||
128688539|NCT00943124|463159051|FG001|Period 1|Did Not Follow Study Procedures|0|||
128890485|NCT01920594|463897373|FG000|Overall Study|Lost to Follow-up|1|||
128890486|NCT01920594|463897374|FG001|Overall Study|Lost to Follow-up|0|||
128890487|NCT01920594|463897373|FG000|Overall Study|Recovery|2|||
128890488|NCT01920594|463897374|FG001|Overall Study|Recovery|0|||
128890489|NCT01920594|463897373|FG000|Overall Study|Investigator discretion|0|||
128890490|NCT01920594|463897374|FG001|Overall Study|Investigator discretion|1|||
128890491|NCT00928564|463897375|FG000|Overall Study|Lost to Follow-up|6|||
128890492|NCT00928564|463897376|FG001|Overall Study|Lost to Follow-up|0|||
128890493|NCT02460497|463897380|FG000|Overall Study|Participant Requested Withdrawal|4|||
128890494|NCT02460497|463897380|FG000|Overall Study|Non-Compliance|1|||
128890495|NCT02460497|463897380|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
128890496|NCT02460497|463897380|FG000|Overall Study|Lost to Follow-up|2|||
128890497|NCT02460497|463897380|FG000|Overall Study|Investigator Decision|1|||
128890498|NCT01448213|463897385|FG000|Overall Study|Lost to Follow-up|12|||
128890499|NCT01448213|463897386|FG001|Overall Study|Lost to Follow-up|10|||
128890500|NCT01448213|463897385|FG000|Overall Study|Adverse Event|4|||
128890501|NCT01448213|463897386|FG001|Overall Study|Adverse Event|10|||
128890502|NCT01448213|463897385|FG000|Overall Study|Protocol Violation|1|||
128890503|NCT01448213|463897386|FG001|Overall Study|Protocol Violation|2|||
128890504|NCT02012296|463897387|FG000|Overall Study|Lack of Efficacy|0|||
128890505|NCT02012296|463897388|FG001|Overall Study|Lack of Efficacy|0|||
128890506|NCT02012296|463897389|FG002|Overall Study|Lack of Efficacy|15|||
128890507|NCT02012296|463897387|FG000|Overall Study|Adverse Event|0|||
128890508|NCT02012296|463897388|FG001|Overall Study|Adverse Event|0|||
128890509|NCT02012296|463897389|FG002|Overall Study|Adverse Event|2|||
128890510|NCT02012296|463897387|FG000|Overall Study|Early study closure|0|||
128890511|NCT02012296|463897388|FG001|Overall Study|Early study closure|0|||
128890512|NCT02012296|463897389|FG002|Overall Study|Early study closure|5|||
128890513|NCT02012296|463897387|FG000|Overall Study|Protocol Violation|0|||
128890514|NCT02012296|463897388|FG001|Overall Study|Protocol Violation|1|||
128890515|NCT02012296|463897389|FG002|Overall Study|Protocol Violation|0|||
128890516|NCT01330914|463897390|FG000|Overall Study|Withdrawal by Subject|4|||
128890517|NCT01330914|463897390|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
128890518|NCT02615470|463897391|FG000|Overall Study|Lost to Follow-up|21|||
128890519|NCT02615470|463897392|FG001|Overall Study|Lost to Follow-up|32|||
128890520|NCT01650285|463897395|FG000|Overall Study|Adverse Event|1|||
128890521|NCT00659529|463897396|FG000|Overall Study|Withdrawal by Subject|4|||
128890522|NCT00659529|463897396|FG000|Overall Study|Protocol Violation|3|||
128890523|NCT00659529|463897396|FG000|Overall Study|Screen failure|9|||
128890524|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
128890525|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
128890526|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
128890527|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
128890528|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
128890529|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
128890530|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
128890531|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
128890532|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
128890533|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
128890534|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
128890535|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
128890536|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
128890537|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
128890538|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
128890539|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
128890540|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
128890541|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
128890542|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
128890543|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
128890544|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
128763994|NCT00682643|463425896|FG000|Overall Study|Physician Decision|2|||
128890545|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
128890546|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
128763995|NCT00682643|463425897|FG001|Overall Study|Physician Decision|6|||
128763996|NCT00682643|463425896|FG000|Overall Study|Withdrawal by Subject|19|||
128763997|NCT00682643|463425897|FG001|Overall Study|Withdrawal by Subject|53|||
128763998|NCT00682643|463425896|FG000|Overall Study|Did Not Receive Study Drug|1|||
128890547|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
128890548|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
128890549|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
128890550|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
128890551|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
129110371|NCT04547140|464699796|FG001|Overall Study|Death|1|||
129110372|NCT04547140|464699795|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
129110373|NCT04547140|464699796|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
129110374|NCT04547140|464699795|FG000|Overall Study|Pregnancy|1|||
129110375|NCT04547140|464699796|FG001|Overall Study|Pregnancy|0|||
129110376|NCT04547140|464699795|FG000|Overall Study|Reason Not Specified|4|||
129110377|NCT04547140|464699796|FG001|Overall Study|Reason Not Specified|1|||
129110378|NCT00003537|464699797|FG000|Overall Study|Not evalauable|1|||
129110379|NCT01051557|464699798|FG000|Overall Study|Physician Decision|1|||
129110380|NCT01051557|464699799|FG001|Overall Study|Physician Decision|0|||
129110381|NCT01051557|464699800|FG002|Overall Study|Physician Decision|0|||
129110382|NCT01051557|464699801|FG003|Overall Study|Physician Decision|0|||
129110383|NCT01051557|464699802|FG004|Overall Study|Physician Decision|0|||
129110384|NCT01051557|464699803|FG005|Overall Study|Physician Decision|0|||
129110385|NCT01051557|464699804|FG006|Overall Study|Physician Decision|0|||
129110386|NCT01051557|464699798|FG000|Overall Study|disease progression|3|||
129110387|NCT01051557|464699799|FG001|Overall Study|disease progression|3|||
129110388|NCT01051557|464699800|FG002|Overall Study|disease progression|5|||
129110389|NCT01051557|464699801|FG003|Overall Study|disease progression|2|||
129110390|NCT01051557|464699802|FG004|Overall Study|disease progression|4|||
129110391|NCT01051557|464699803|FG005|Overall Study|disease progression|3|||
129110392|NCT01051557|464699804|FG006|Overall Study|disease progression|1|||
129110393|NCT01051557|464699798|FG000|Overall Study|Withdrawal by Subject|0|||
129110394|NCT01051557|464699799|FG001|Overall Study|Withdrawal by Subject|0|||
129110395|NCT01051557|464699800|FG002|Overall Study|Withdrawal by Subject|1|||
129110396|NCT01051557|464699801|FG003|Overall Study|Withdrawal by Subject|0|||
129110397|NCT01051557|464699802|FG004|Overall Study|Withdrawal by Subject|2|||
129110398|NCT01051557|464699803|FG005|Overall Study|Withdrawal by Subject|0|||
129110399|NCT01051557|464699804|FG006|Overall Study|Withdrawal by Subject|1|||
129110400|NCT01051557|464699798|FG000|Overall Study|Adverse Event|0|||
129110401|NCT01051557|464699799|FG001|Overall Study|Adverse Event|0|||
129110402|NCT01051557|464699800|FG002|Overall Study|Adverse Event|0|||
129110403|NCT01051557|464699801|FG003|Overall Study|Adverse Event|1|||
129110404|NCT01051557|464699802|FG004|Overall Study|Adverse Event|1|||
129110405|NCT01051557|464699803|FG005|Overall Study|Adverse Event|3|||
129110406|NCT01051557|464699804|FG006|Overall Study|Adverse Event|4|||
129110407|NCT04110314|464699806|FG000|Overall Study|Did not meet inclusion criteria|35255|||
129110408|NCT04110314|464699807|FG001|Overall Study|Did not meet inclusion criteria|35104|||
129110409|NCT04110314|464699808|FG002|Overall Study|Did not meet inclusion criteria|35636|||
129110410|NCT04110314|464699809|FG003|Overall Study|Did not meet inclusion criteria|35135|||
129110411|NCT04110314|464699810|FG004|Overall Study|Did not meet inclusion criteria|35247|||
129110412|NCT04110314|464699811|FG005|Overall Study|Did not meet inclusion criteria|35727|||
129110413|NCT01178125|464699820|FG000|Overall Study|Lost to Follow-up|397|||
129110414|NCT01178125|464699820|FG000|Overall Study|Adverse Event|244|||
129110415|NCT01178125|464699820|FG000|Overall Study|Withdrawal by Subject|209|||
129110416|NCT01178125|464699820|FG000|Overall Study|Noncompliance|184|||
129110417|NCT01178125|464699820|FG000|Overall Study|Pregnancy|55|||
129110418|NCT01178125|464699820|FG000|Overall Study|Other Reason|39|||
129110419|NCT01178125|464699820|FG000|Overall Study|Sponsor Decision|28|||
129110420|NCT01178125|464699820|FG000|Overall Study|Protocol Violation|17|||
129110421|NCT01178125|464699820|FG000|Overall Study|Investigator Decision|5|||
129110422|NCT02948829|464699821|FG000|Overall Study|Lost to Follow-up|2|||
129110423|NCT02948829|464699821|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
129110424|NCT02948829|464699821|FG000|Overall Study|Pregnancy|1|||
128688540|NCT00943124|463159050|FG000|Period 1|Personal Reasons|0|||
128688541|NCT00943124|463159051|FG001|Period 1|Personal Reasons|1|||
128688542|NCT00470847|463159055|FG000|Overall Study|Pt still receiving treatment|1|||
128688543|NCT01912963|463159058|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
128688544|NCT01912963|463159059|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
128688545|NCT01912963|463159060|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
128688546|NCT01912963|463159058|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
128688547|NCT01912963|463159059|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
128688548|NCT01912963|463159060|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
128688549|NCT01912963|463159058|FG000|Overall Study|Adverse Event|0|||
128688550|NCT01912963|463159059|FG001|Overall Study|Adverse Event|1|||
129110425|NCT02948829|464699821|FG000|Overall Study|Other: Reason not Specified|8|||
129110426|NCT01004978|464699822|FG000|Overall Study|Disease progression|31|||
129110427|NCT01004978|464699823|FG001|Overall Study|Disease progression|48|||
129110428|NCT01004978|464699822|FG000|Overall Study|Adverse Event|42|||
129110429|NCT01004978|464699823|FG001|Overall Study|Adverse Event|22|||
129110430|NCT01004978|464699822|FG000|Overall Study|Death|3|||
129110431|NCT01004978|464699823|FG001|Overall Study|Death|2|||
129110432|NCT01004978|464699822|FG000|Overall Study|Withdrawal by Subject|16|||
129110433|NCT01004978|464699823|FG001|Overall Study|Withdrawal by Subject|16|||
129110434|NCT01004978|464699822|FG000|Overall Study|Alternative therapy|4|||
129110435|NCT01004978|464699823|FG001|Overall Study|Alternative therapy|8|||
128688551|NCT01912963|463159060|FG002|Overall Study|Adverse Event|1|||
128688552|NCT01912963|463159058|FG000|Overall Study|Withdrawal by Subject|0|||
128688553|NCT01912963|463159059|FG001|Overall Study|Withdrawal by Subject|1|||
128688554|NCT01912963|463159060|FG002|Overall Study|Withdrawal by Subject|0|||
128688555|NCT01912963|463159058|FG000|Overall Study|Sought treatment locally|0|||
128688556|NCT01912963|463159059|FG001|Overall Study|Sought treatment locally|1|||
128688557|NCT01912963|463159060|FG002|Overall Study|Sought treatment locally|0|||
128688558|NCT03112590|463159062|FG000|Overall Study|Adverse Event|0|||
128688559|NCT03112590|463159063|FG001|Overall Study|Adverse Event|1|||
128688560|NCT03112590|463159064|FG002|Overall Study|Adverse Event|0|||
128688561|NCT05156073|463159065|FG000|Overall Study|Patient canceled appointment with PCP|1|||
128688562|NCT02734433|463159066|FG000|Overall Study|Disease progression|1|||
128688563|NCT02734433|463159067|FG001|Overall Study|Disease progression|5|||
128688564|NCT02734433|463159066|FG000|Overall Study|Clinical progression|0|||
128688565|NCT02734433|463159067|FG001|Overall Study|Clinical progression|1|||
128688566|NCT02734433|463159066|FG000|Overall Study|Withdrawal by Subject|1|||
128688567|NCT02734433|463159067|FG001|Overall Study|Withdrawal by Subject|2|||
128688568|NCT03805646|463159069|FG000|Overall Study|Death|40|||
128688569|NCT03805646|463159070|FG001|Overall Study|Death|49|||
128688570|NCT03805646|463159069|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
128688571|NCT03805646|463159070|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
128688572|NCT05521906|463159071|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
128688573|NCT05521906|463159072|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
128688574|NCT00891462|463161425|FG000|Overall Study|Withdrawal by Subject|9|||
128688575|NCT00891462|463161426|FG001|Overall Study|Withdrawal by Subject|6|||
128688576|NCT00891462|463161427|FG002|Overall Study|Withdrawal by Subject|7|||
128688577|NCT00891462|463161425|FG000|Overall Study|Adverse Event|7|||
128688578|NCT00891462|463161426|FG001|Overall Study|Adverse Event|8|||
128688579|NCT00891462|463161427|FG002|Overall Study|Adverse Event|7|||
128688580|NCT00891462|463161425|FG000|Overall Study|Lack of Efficacy|10|||
128688581|NCT00891462|463161426|FG001|Overall Study|Lack of Efficacy|5|||
128688582|NCT00891462|463161427|FG002|Overall Study|Lack of Efficacy|1|||
128688583|NCT00891462|463161425|FG000|Overall Study|COPD exacerbation|7|||
128688584|NCT00891462|463161426|FG001|Overall Study|COPD exacerbation|4|||
128688585|NCT00891462|463161427|FG002|Overall Study|COPD exacerbation|1|||
128688586|NCT00891462|463161425|FG000|Overall Study|Other Reason|2|||
128688587|NCT00891462|463161426|FG001|Overall Study|Other Reason|5|||
128688588|NCT00891462|463161427|FG002|Overall Study|Other Reason|3|||
128688589|NCT00891462|463161425|FG000|Overall Study|Protocol Violation|2|||
128688590|NCT00891462|463161426|FG001|Overall Study|Protocol Violation|1|||
128688591|NCT00891462|463161427|FG002|Overall Study|Protocol Violation|3|||
128688592|NCT00891462|463161425|FG000|Overall Study|Inclusion/exclusion criteria|0|||
128688593|NCT00891462|463161426|FG001|Overall Study|Inclusion/exclusion criteria|2|||
128688594|NCT00891462|463161427|FG002|Overall Study|Inclusion/exclusion criteria|2|||
128688595|NCT00891462|463161425|FG000|Overall Study|Lost to Follow-up|0|||
128688596|NCT00891462|463161426|FG001|Overall Study|Lost to Follow-up|2|||
128688597|NCT00891462|463161427|FG002|Overall Study|Lost to Follow-up|0|||
128688598|NCT02171065|463161431|FG000|Overall Study|Withdrawal by Subject|1|||
128688599|NCT02171065|463161432|FG001|Overall Study|Withdrawal by Subject|0|||
128688600|NCT02171065|463161433|FG002|Overall Study|Withdrawal by Subject|0|||
128688601|NCT02171065|463161431|FG000|Overall Study|Lost to Follow-up|0|||
128688602|NCT02171065|463161432|FG001|Overall Study|Lost to Follow-up|0|||
128763999|NCT00682643|463425897|FG001|Overall Study|Did Not Receive Study Drug|1|||
128764000|NCT01852058|463425900|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
128764001|NCT01852058|463425901|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764002|NCT01852058|463425902|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764003|NCT01852058|463425903|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764004|NCT01852058|463425904|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764005|NCT01852058|463425905|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764006|NCT01852058|463425906|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764007|NCT01852058|463425907|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764008|NCT01852058|463425908|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764009|NCT01852058|463425909|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764010|NCT01852058|463425910|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764011|NCT01852058|463425911|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
128764012|NCT01852058|463425900|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764013|NCT01852058|463425901|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764014|NCT01852058|463425902|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129215194|NCT02628873|465089461|FG000|Second Test (1 Hour)|Physician Decision|1|||
128688603|NCT02171065|463161433|FG002|Overall Study|Lost to Follow-up|1|||
128688604|NCT01614600|463161436|FG000|Overall Study|Unacceptable fit|1|||
128688605|NCT01614600|463161436|FG000|Overall Study|Discomfort|1|||
128688606|NCT01614600|463161436|FG000|Overall Study|Unable to remove lens at the end of day|1|||
128688607|NCT01614600|463161436|FG000|Overall Study|Protocol deviation|1|||
128890552|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
128890553|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
128890554|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
128890555|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
128890556|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
128890557|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
128890558|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
128890559|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
128890560|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
128890561|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
128890562|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
128890563|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
128890564|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
128890565|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
128890566|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
128890567|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
128890568|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
128890569|NCT03627767|463897401|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
128890570|NCT03627767|463897402|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
128890571|NCT03627767|463897403|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
128890572|NCT03627767|463897404|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
128890573|NCT03627767|463897405|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
128890574|NCT03627767|463897401|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
128890575|NCT03627767|463897402|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
128890576|NCT03627767|463897403|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
128890577|NCT03627767|463897404|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
128890578|NCT03627767|463897405|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
129110436|NCT01004978|464699822|FG000|Overall Study|Physician Decision|6|||
128688608|NCT03347188|463161437|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
128688609|NCT03347188|463161438|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
128688610|NCT03347188|463161437|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
128688611|NCT03347188|463161438|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
128688612|NCT03347188|463161437|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
128688613|NCT03347188|463161438|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
128688614|NCT03347188|463161437|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
128688615|NCT03347188|463161438|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
128688616|NCT03347188|463161437|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
128688617|NCT03347188|463161438|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
128688618|NCT03347188|463161437|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
128688619|NCT03347188|463161438|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
128688620|NCT03347188|463161437|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
128688621|NCT03347188|463161438|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
128688622|NCT03347188|463161437|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
128688623|NCT03347188|463161438|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
128688624|NCT02186873|463161439|FG000|Overall Study|Adverse Event|1|||
128688625|NCT02186873|463161440|FG001|Overall Study|Adverse Event|3|||
128688626|NCT02186873|463161439|FG000|Overall Study|Lack of Efficacy|0|||
128688627|NCT02186873|463161440|FG001|Overall Study|Lack of Efficacy|1|||
128688628|NCT02186873|463161439|FG000|Overall Study|Lost to Follow-up|1|||
128688629|NCT02186873|463161440|FG001|Overall Study|Lost to Follow-up|2|||
128688630|NCT02186873|463161439|FG000|Overall Study|Withdrawal by Subject|7|||
128688631|NCT02186873|463161440|FG001|Overall Study|Withdrawal by Subject|2|||
128688632|NCT01680965|463161441|FG000|Overall Study|Death|0|||
128688633|NCT01680965|463161442|FG001|Overall Study|Death|0|||
128688634|NCT01680965|463161443|FG002|Overall Study|Death|0|||
128688635|NCT01680965|463161444|FG003|Overall Study|Death|6|||
128688636|NCT02231918|463161445|FG000|Overall Study|Withdrawal by Subject|0|||
128688637|NCT02231918|463161446|FG001|Overall Study|Withdrawal by Subject|1|||
128688638|NCT02231918|463161447|FG002|Overall Study|Withdrawal by Subject|0|||
128688639|NCT02231918|463161445|FG000|Overall Study|Adverse Event|0|||
128688640|NCT02231918|463161446|FG001|Overall Study|Adverse Event|0|||
128688641|NCT02231918|463161447|FG002|Overall Study|Adverse Event|1|||
128688642|NCT00331864|463161448|FG000|Overall Study|Adverse Event|30|||
128688643|NCT00331864|463161449|FG001|Overall Study|Adverse Event|1|||
128688644|NCT00331864|463161448|FG000|Overall Study|Lack of Efficacy|4|||
128688645|NCT00331864|463161449|FG001|Overall Study|Lack of Efficacy|0|||
129110437|NCT01004978|464699823|FG001|Overall Study|Physician Decision|3|||
129110438|NCT01004978|464699822|FG000|Overall Study|Other complicating disease|2|||
129110439|NCT01004978|464699823|FG001|Overall Study|Other complicating disease|2|||
129110440|NCT01004978|464699822|FG000|Overall Study|Protocol Violation|2|||
129110441|NCT01004978|464699823|FG001|Overall Study|Protocol Violation|3|||
129110442|NCT01004978|464699822|FG000|Overall Study|Non-compliance|3|||
129110443|NCT01004978|464699823|FG001|Overall Study|Non-compliance|2|||
129110444|NCT01004978|464699822|FG000|Overall Study|Ineligible|1|||
129110445|NCT01004978|464699823|FG001|Overall Study|Ineligible|0|||
129110446|NCT01004978|464699822|FG000|Overall Study|Unblinded|0|||
129110447|NCT01004978|464699823|FG001|Overall Study|Unblinded|1|||
129110448|NCT01004978|464699822|FG000|Overall Study|Performance status worsening|0|||
129110449|NCT01004978|464699823|FG001|Overall Study|Performance status worsening|1|||
129110450|NCT01004978|464699822|FG000|Overall Study|Never started treatment|8|||
129110451|NCT01004978|464699823|FG001|Overall Study|Never started treatment|9|||
129110452|NCT00369915|464699824|FG000|Overall Study|expected side effects|2|||
129110453|NCT00369915|464699825|FG001|Overall Study|expected side effects|1|||
129110454|NCT00369915|464699824|FG000|Overall Study|Withdrawal by Subject|4|||
129110455|NCT00369915|464699825|FG001|Overall Study|Withdrawal by Subject|1|||
129110456|NCT00369915|464699824|FG000|Overall Study|W/drawl by investigators|0|||
129110457|NCT00369915|464699825|FG001|Overall Study|W/drawl by investigators|1|||
129110458|NCT01711983|464699826|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
129110459|NCT01711983|464699826|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
129110460|NCT01711983|464699826|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
129110461|NCT01711983|464699826|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
129110462|NCT00737100|464699831|FG000|Overall Study|Adverse Event|6|||
129110463|NCT00737100|464699832|FG001|Overall Study|Adverse Event|5|||
129110464|NCT00737100|464699833|FG002|Overall Study|Adverse Event|3|||
129110465|NCT00737100|464699831|FG000|Overall Study|Lost to Follow-up|0|||
129110466|NCT00737100|464699832|FG001|Overall Study|Lost to Follow-up|1|||
129110467|NCT00737100|464699833|FG002|Overall Study|Lost to Follow-up|0|||
129110468|NCT00737100|464699831|FG000|Overall Study|Withdrawal by Subject|0|||
129110469|NCT00737100|464699832|FG001|Overall Study|Withdrawal by Subject|0|||
129110470|NCT00737100|464699833|FG002|Overall Study|Withdrawal by Subject|3|||
129110471|NCT00737100|464699831|FG000|Overall Study|Reason discontinued not explained above|1|||
129110472|NCT00737100|464699832|FG001|Overall Study|Reason discontinued not explained above|1|||
129110473|NCT00737100|464699833|FG002|Overall Study|Reason discontinued not explained above|1|||
129110474|NCT01447407|464699834|FG000|Overall Study|Withdrawal by Subject|2|||
129110475|NCT01447407|464699835|FG001|Overall Study|Withdrawal by Subject|0|||
129110476|NCT01447407|464699836|FG002|Overall Study|Withdrawal by Subject|0|||
129110477|NCT01447407|464699837|FG003|Overall Study|Withdrawal by Subject|1|||
129110478|NCT01447407|464699834|FG000|Overall Study|Physician Decision|0|||
129110479|NCT01447407|464699835|FG001|Overall Study|Physician Decision|0|||
129110480|NCT01447407|464699836|FG002|Overall Study|Physician Decision|1|||
129110481|NCT01447407|464699837|FG003|Overall Study|Physician Decision|1|||
129110482|NCT01265394|464699840|FG000|Overall Study|Subjects withdrawn|37|||
129110483|NCT00735943|464699841|FG000|Overall Study|Lost to Follow-up|1|||
129110484|NCT00735943|464699841|FG000|Overall Study|Adverse Event|1|||
129110485|NCT00268983|464699846|FG000|Overall Study|Death|3|||
129110486|NCT00268983|464699847|FG001|Overall Study|Death|0|||
129110487|NCT01719380|464699848|FG000|Overall Study|Adverse Event|0|||
129110488|NCT01719380|464699849|FG001|Overall Study|Adverse Event|0|||
129110489|NCT01719380|464699850|FG002|Overall Study|Adverse Event|1|||
128688646|NCT00331864|463161448|FG000|Overall Study|Protocol Violation|3|||
128688647|NCT00331864|463161449|FG001|Overall Study|Protocol Violation|0|||
128688648|NCT00331864|463161448|FG000|Overall Study|Withdrawal by Subject|10|||
128688649|NCT00331864|463161449|FG001|Overall Study|Withdrawal by Subject|0|||
128688650|NCT00331864|463161448|FG000|Overall Study|Lost to Follow-up|4|||
128688651|NCT00331864|463161449|FG001|Overall Study|Lost to Follow-up|3|||
128688652|NCT00331864|463161448|FG000|Overall Study|Administrative Problems|1|||
128688653|NCT00331864|463161449|FG001|Overall Study|Administrative Problems|0|||
129110490|NCT01719380|464699851|FG003|Overall Study|Adverse Event|2|||
129110491|NCT01719380|464699852|FG004|Overall Study|Adverse Event|0|||
129110492|NCT01719380|464699853|FG005|Overall Study|Adverse Event|1|||
129110493|NCT01719380|464699854|FG006|Overall Study|Adverse Event|0|||
129110494|NCT01719380|464699855|FG007|Overall Study|Adverse Event|1|||
129110495|NCT01719380|464699856|FG008|Overall Study|Adverse Event|4|||
129110496|NCT01719380|464699857|FG009|Overall Study|Adverse Event|3|||
129110497|NCT01719380|464699848|FG000|Overall Study|Death|0|||
129110498|NCT01719380|464699849|FG001|Overall Study|Death|1|||
129110499|NCT01719380|464699850|FG002|Overall Study|Death|0|||
129110500|NCT01719380|464699851|FG003|Overall Study|Death|0|||
129110501|NCT01719380|464699852|FG004|Overall Study|Death|0|||
129110502|NCT01719380|464699853|FG005|Overall Study|Death|0|||
129110503|NCT01719380|464699854|FG006|Overall Study|Death|0|||
129110504|NCT01719380|464699855|FG007|Overall Study|Death|0|||
129110505|NCT01719380|464699856|FG008|Overall Study|Death|3|||
128688654|NCT00331864|463161448|FG000|Overall Study|Death|6|||
129110506|NCT01719380|464699857|FG009|Overall Study|Death|3|||
129110507|NCT01719380|464699848|FG000|Overall Study|Participant/Guardian Decision|0|||
129110508|NCT01719380|464699849|FG001|Overall Study|Participant/Guardian Decision|0|||
129110509|NCT01719380|464699850|FG002|Overall Study|Participant/Guardian Decision|1|||
129110510|NCT01719380|464699851|FG003|Overall Study|Participant/Guardian Decision|0|||
129110511|NCT01719380|464699852|FG004|Overall Study|Participant/Guardian Decision|0|||
129110512|NCT01719380|464699853|FG005|Overall Study|Participant/Guardian Decision|0|||
129110513|NCT01719380|464699854|FG006|Overall Study|Participant/Guardian Decision|0|||
129110514|NCT01719380|464699855|FG007|Overall Study|Participant/Guardian Decision|0|||
129110515|NCT01719380|464699856|FG008|Overall Study|Participant/Guardian Decision|2|||
129110516|NCT01719380|464699857|FG009|Overall Study|Participant/Guardian Decision|2|||
129110517|NCT01719380|464699848|FG000|Overall Study|Physician Decision|0|||
129110518|NCT01719380|464699849|FG001|Overall Study|Physician Decision|0|||
129110519|NCT01719380|464699850|FG002|Overall Study|Physician Decision|2|||
129110520|NCT01719380|464699851|FG003|Overall Study|Physician Decision|0|||
129110521|NCT01719380|464699852|FG004|Overall Study|Physician Decision|0|||
129110522|NCT01719380|464699853|FG005|Overall Study|Physician Decision|0|||
129110523|NCT01719380|464699854|FG006|Overall Study|Physician Decision|0|||
129110524|NCT01719380|464699855|FG007|Overall Study|Physician Decision|0|||
129110525|NCT01719380|464699856|FG008|Overall Study|Physician Decision|1|||
129110526|NCT01719380|464699857|FG009|Overall Study|Physician Decision|1|||
129110527|NCT01719380|464699848|FG000|Overall Study|Lack of Efficacy|2|||
129110528|NCT01719380|464699849|FG001|Overall Study|Lack of Efficacy|6|||
129110529|NCT01719380|464699850|FG002|Overall Study|Lack of Efficacy|5|||
129110530|NCT01719380|464699851|FG003|Overall Study|Lack of Efficacy|6|||
129110531|NCT01719380|464699852|FG004|Overall Study|Lack of Efficacy|3|||
129110532|NCT01719380|464699853|FG005|Overall Study|Lack of Efficacy|7|||
129110533|NCT01719380|464699854|FG006|Overall Study|Lack of Efficacy|10|||
129110534|NCT01719380|464699855|FG007|Overall Study|Lack of Efficacy|6|||
129110535|NCT01719380|464699856|FG008|Overall Study|Lack of Efficacy|39|||
129110536|NCT01719380|464699857|FG009|Overall Study|Lack of Efficacy|42|||
128890579|NCT03627767|463897401|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129110537|NCT01719380|464699848|FG000|Overall Study|Progressive Disease|0|||
129110538|NCT01719380|464699849|FG001|Overall Study|Progressive Disease|0|||
129110539|NCT01719380|464699850|FG002|Overall Study|Progressive Disease|0|||
129110540|NCT01719380|464699851|FG003|Overall Study|Progressive Disease|0|||
129110541|NCT01719380|464699852|FG004|Overall Study|Progressive Disease|0|||
129110542|NCT01719380|464699853|FG005|Overall Study|Progressive Disease|0|||
129110543|NCT01719380|464699854|FG006|Overall Study|Progressive Disease|0|||
129110544|NCT01719380|464699855|FG007|Overall Study|Progressive Disease|0|||
129110545|NCT01719380|464699856|FG008|Overall Study|Progressive Disease|1|||
129110546|NCT01719380|464699857|FG009|Overall Study|Progressive Disease|0|||
128688655|NCT00331864|463161449|FG001|Overall Study|Death|0|||
128688656|NCT01092507|463161450|FG000|Overall Study|Withdrawal by Subject|2|||
128890580|NCT03627767|463897402|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
128890581|NCT03627767|463897403|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
128890582|NCT03627767|463897404|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
128890583|NCT03627767|463897405|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
128890584|NCT03627767|463897401|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
128688657|NCT01092507|463161451|FG001|Overall Study|Withdrawal by Subject|0|||
128688658|NCT01871142|463161453|FG000|Overall Study|Adverse Event|1|||
128890585|NCT03627767|463897402|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
128890586|NCT03627767|463897403|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
128890587|NCT03627767|463897404|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
128890588|NCT03627767|463897405|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
128890589|NCT03627767|463897401|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
128890590|NCT03627767|463897402|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
129110547|NCT00321906|464699861|FG000|Overall Study|Adverse Event|36|||
129110548|NCT00321906|464699862|FG001|Overall Study|Adverse Event|44|||
129110549|NCT00321906|464699861|FG000|Overall Study|Death|9|||
128688659|NCT01539642|463161459|FG000|Overall Study|Lack of Efficacy|20|||
128688660|NCT01539642|463161460|FG001|Overall Study|Lack of Efficacy|18|||
128688661|NCT01539642|463161459|FG000|Overall Study|Patient ready for early discharge|8|||
128688662|NCT01539642|463161460|FG001|Overall Study|Patient ready for early discharge|7|||
128688663|NCT01539642|463161459|FG000|Overall Study|Adverse Event|6|||
128688664|NCT01539642|463161460|FG001|Overall Study|Adverse Event|4|||
129110550|NCT00321906|464699862|FG001|Overall Study|Death|6|||
129110551|NCT00321906|464699861|FG000|Overall Study|Lost to Follow-up|1|||
129110552|NCT00321906|464699862|FG001|Overall Study|Lost to Follow-up|2|||
129110553|NCT00321906|464699861|FG000|Overall Study|Withdrawal by Subject|0|||
129110554|NCT00321906|464699862|FG001|Overall Study|Withdrawal by Subject|4|||
129110555|NCT00838097|464699865|FG000|Overall Study|Ineligibility determined|6|||
129110556|NCT00838097|464699865|FG000|Overall Study|Adverse Event|2|||
129110557|NCT00838097|464699865|FG000|Overall Study|Withdrawal by Subject|3|||
129110558|NCT00838097|464699865|FG000|Overall Study|Requirement for alternative therapy|2|||
129110559|NCT00838097|464699865|FG000|Overall Study|Physician Decision|4|||
129110560|NCT00838097|464699865|FG000|Overall Study|Lost to Follow-up|11|||
128764015|NCT01852058|463425903|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764016|NCT01852058|463425904|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
128764017|NCT01852058|463425905|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764018|NCT01852058|463425906|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764019|NCT01852058|463425907|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764020|NCT01852058|463425908|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764021|NCT01852058|463425909|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764022|NCT01852058|463425910|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764023|NCT01852058|463425911|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
128764024|NCT01852058|463425900|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764025|NCT01852058|463425901|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764026|NCT01852058|463425902|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764027|NCT01852058|463425903|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764028|NCT01852058|463425904|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
128764029|NCT01852058|463425905|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
128764030|NCT01852058|463425906|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764031|NCT01852058|463425907|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764032|NCT01852058|463425908|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764033|NCT01852058|463425909|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764034|NCT01852058|463425910|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764035|NCT01852058|463425911|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
128764036|NCT01852058|463425900|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764037|NCT01852058|463425901|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764038|NCT01852058|463425902|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764039|NCT01852058|463425903|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128688665|NCT01539642|463161459|FG000|Overall Study|Withdrawal by Subject|2|||
128688666|NCT01539642|463161460|FG001|Overall Study|Withdrawal by Subject|2|||
128688667|NCT03611010|463161461|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
128688668|NCT03611010|463161462|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
128688669|NCT03611010|463161463|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
128688670|NCT03611010|463161464|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
128688671|NCT02063880|463161465|FG000|Overall Study|Death|21|||
128688672|NCT02063880|463161466|FG001|Overall Study|Death|18|||
128688673|NCT02063880|463161465|FG000|Overall Study|Lost to Follow-up|7|||
128688674|NCT02063880|463161466|FG001|Overall Study|Lost to Follow-up|7|||
128688675|NCT02063880|463161465|FG000|Overall Study|Ineligible|0|||
128688676|NCT02063880|463161466|FG001|Overall Study|Ineligible|2|||
128688677|NCT02106910|463161469|FG000|Overall Study|Lost to Follow-up|1|||
128688678|NCT02106910|463161470|FG001|Overall Study|Lost to Follow-up|1|||
128688679|NCT00567593|463161471|FG000|Overall Study|Adverse Event|1|||
128688680|NCT00567593|463161471|FG000|Overall Study|Physician Decision|1|||
128688681|NCT01675427|463161472|FG000|Overall Study|Withdrawal by Subject|7|||
128688682|NCT01675427|463161472|FG000|Overall Study|Participant Refused Sample Collection|18|||
128688683|NCT01675427|463161472|FG000|Overall Study|Sample not Collected by Mistake|2|||
128688684|NCT01675427|463161472|FG000|Overall Study|Lost to Follow-up|5|||
128688685|NCT01675427|463161472|FG000|Overall Study|Other|2|||
128688686|NCT00700570|463161473|FG000|Overall Study|Adverse Event|2|||
128688687|NCT00700570|463161474|FG001|Overall Study|Adverse Event|6|||
128688688|NCT00700570|463161473|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
128688689|NCT00700570|463161474|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
128688690|NCT00700570|463161473|FG000|Overall Study|Disease Progression|8|||
128688691|NCT00700570|463161474|FG001|Overall Study|Disease Progression|11|||
128688692|NCT00700570|463161473|FG000|Overall Study|Withdrawal by Subject|1|||
128688693|NCT00700570|463161474|FG001|Overall Study|Withdrawal by Subject|6|||
128688694|NCT00611533|463161475|FG000|First Intervention (6 Weeks)|Never started study|0|||
128688695|NCT00611533|463161476|FG001|First Intervention (6 Weeks)|Never started study|1|||
128688696|NCT00611533|463161475|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
128688697|NCT00611533|463161476|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
128688698|NCT00611533|463161475|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
128688699|NCT00611533|463161476|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
128688700|NCT05246397|463161479|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
128688701|NCT04327674|463161485|FG000|Overall Study|Protocol Violation|19|||
128688702|NCT01461980|463161486|FG000|Overall Study|Other|9|||
128688703|NCT01461980|463161487|FG001|Overall Study|Other|8|||
128688704|NCT01461980|463161488|FG002|Overall Study|Other|6|||
128764040|NCT01852058|463425904|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
128764041|NCT01852058|463425905|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129110561|NCT00838097|464699865|FG000|Overall Study|Death|6|||
129110562|NCT00838097|464699865|FG000|Overall Study|Protocol-specified criteria|142|||
128688705|NCT01461980|463161486|FG000|Overall Study|Medication error|7|||
128688706|NCT01461980|463161487|FG001|Overall Study|Medication error|5|||
128688707|NCT01461980|463161488|FG002|Overall Study|Medication error|6|||
128688708|NCT01461980|463161486|FG000|Overall Study|Adverse Event|12|||
128688709|NCT01461980|463161487|FG001|Overall Study|Adverse Event|5|||
128688710|NCT01461980|463161488|FG002|Overall Study|Adverse Event|6|||
128688711|NCT01461980|463161486|FG000|Overall Study|Protocol Violation|12|||
128688712|NCT01461980|463161487|FG001|Overall Study|Protocol Violation|19|||
128688713|NCT01461980|463161488|FG002|Overall Study|Protocol Violation|16|||
128688714|NCT01461980|463161486|FG000|Overall Study|No longer meets eligibility criteria|18|||
128688715|NCT01461980|463161487|FG001|Overall Study|No longer meets eligibility criteria|9|||
128688716|NCT01461980|463161488|FG002|Overall Study|No longer meets eligibility criteria|19|||
128688717|NCT01461980|463161486|FG000|Overall Study|Lost to Follow-up|52|||
128688718|NCT01461980|463161487|FG001|Overall Study|Lost to Follow-up|53|||
128688719|NCT01461980|463161488|FG002|Overall Study|Lost to Follow-up|51|||
128688720|NCT01461980|463161486|FG000|Overall Study|No longer willing to participate|52|||
128688721|NCT01461980|463161487|FG001|Overall Study|No longer willing to participate|38|||
128688722|NCT01461980|463161488|FG002|Overall Study|No longer willing to participate|54|||
128688723|NCT01461980|463161486|FG000|Overall Study|Randomized but not vaccinated|4|||
128688724|NCT01461980|463161487|FG001|Overall Study|Randomized but not vaccinated|8|||
128688725|NCT01461980|463161488|FG002|Overall Study|Randomized but not vaccinated|7|||
128688726|NCT00809354|463161493|FG000|Overall Study|Adverse Event|32|||
128688727|NCT00809354|463161494|FG001|Overall Study|Adverse Event|45|||
128688728|NCT00809354|463161495|FG002|Overall Study|Adverse Event|37|||
128688729|NCT00809354|463161496|FG003|Overall Study|Adverse Event|53|||
128688730|NCT00809354|463161497|FG004|Overall Study|Adverse Event|26|||
128688731|NCT00809354|463161498|FG005|Overall Study|Adverse Event|33|||
128688732|NCT00809354|463161499|FG006|Overall Study|Adverse Event|44|||
128764042|NCT01852058|463425906|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128688733|NCT00809354|463161500|FG007|Overall Study|Adverse Event|40|||
128688734|NCT00809354|463161501|FG008|Overall Study|Adverse Event|46|||
128688735|NCT00809354|463161502|FG009|Overall Study|Adverse Event|26|||
128688736|NCT00809354|463161493|FG000|Overall Study|Lack of Efficacy|23|||
128688737|NCT00809354|463161494|FG001|Overall Study|Lack of Efficacy|23|||
128688738|NCT00809354|463161495|FG002|Overall Study|Lack of Efficacy|22|||
128688739|NCT00809354|463161496|FG003|Overall Study|Lack of Efficacy|15|||
128688740|NCT00809354|463161497|FG004|Overall Study|Lack of Efficacy|40|||
128688741|NCT00809354|463161498|FG005|Overall Study|Lack of Efficacy|19|||
128688742|NCT00809354|463161499|FG006|Overall Study|Lack of Efficacy|21|||
128688743|NCT00809354|463161500|FG007|Overall Study|Lack of Efficacy|15|||
128688744|NCT00809354|463161501|FG008|Overall Study|Lack of Efficacy|18|||
128688745|NCT00809354|463161502|FG009|Overall Study|Lack of Efficacy|38|||
128688746|NCT00809354|463161493|FG000|Overall Study|Lost to Follow-up|10|||
128688747|NCT00809354|463161494|FG001|Overall Study|Lost to Follow-up|11|||
128764043|NCT01852058|463425907|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764044|NCT01852058|463425908|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764045|NCT01852058|463425909|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764046|NCT01852058|463425910|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764047|NCT01852058|463425911|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
128764048|NCT01852058|463425900|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764049|NCT01852058|463425901|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764050|NCT01852058|463425902|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764051|NCT01852058|463425903|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764052|NCT01852058|463425904|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
128764053|NCT01852058|463425905|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
128764054|NCT01852058|463425906|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764055|NCT01852058|463425907|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764056|NCT01852058|463425908|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764057|NCT01852058|463425909|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764058|NCT01852058|463425910|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764059|NCT01852058|463425911|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
128764060|NCT01852058|463425900|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764061|NCT01852058|463425901|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764062|NCT01852058|463425902|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764063|NCT01852058|463425903|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
128764064|NCT01852058|463425904|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129020583|NCT00418561|464367113|FG002|Overall Study|Participant's (guardian's) decision|0|||
129020584|NCT00829309|464367114|FG000|Washout: 7 Days|Protocol Violation|1|||
129020585|NCT00829309|464367115|FG001|Washout: 7 Days|Protocol Violation|0|||
128688748|NCT00809354|463161495|FG002|Overall Study|Lost to Follow-up|8|||
128688749|NCT00809354|463161496|FG003|Overall Study|Lost to Follow-up|13|||
128688750|NCT00809354|463161497|FG004|Overall Study|Lost to Follow-up|6|||
128688751|NCT00809354|463161498|FG005|Overall Study|Lost to Follow-up|2|||
128688752|NCT00809354|463161499|FG006|Overall Study|Lost to Follow-up|0|||
128890591|NCT03627767|463897403|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
128890592|NCT03627767|463897404|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
128890593|NCT03627767|463897405|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
128890594|NCT03627767|463897401|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
128890595|NCT03627767|463897402|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
128890596|NCT03627767|463897403|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
128890597|NCT03627767|463897404|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
128890598|NCT03627767|463897405|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
128890599|NCT03627767|463897401|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
128890600|NCT03627767|463897402|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
128890601|NCT03627767|463897403|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
128890602|NCT03627767|463897404|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
128890603|NCT03627767|463897405|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
128890604|NCT03627767|463897401|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
128890605|NCT03627767|463897402|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
128890606|NCT03627767|463897403|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
128890607|NCT03627767|463897404|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
128890608|NCT03627767|463897405|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
128890609|NCT03627767|463897401|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
128890610|NCT03627767|463897402|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
128890611|NCT03627767|463897403|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
128890612|NCT03627767|463897404|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
128890613|NCT03627767|463897405|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
128890614|NCT03627767|463897401|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
128890615|NCT03627767|463897402|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
128890616|NCT03627767|463897403|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
128890617|NCT03627767|463897404|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
128890618|NCT03627767|463897405|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
128890619|NCT03627767|463897401|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
128890620|NCT03627767|463897402|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
128890621|NCT03627767|463897403|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
128890622|NCT03627767|463897404|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
128890623|NCT03627767|463897405|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
128890624|NCT04163900|463897408|FG000|Overall Study|Radiological disease progression|112|||
128890625|NCT04163900|463897409|FG001|Overall Study|Radiological disease progression|127|||
128890626|NCT04163900|463897408|FG000|Overall Study|Study closure|98|||
128890627|NCT04163900|463897409|FG001|Overall Study|Study closure|133|||
128890628|NCT04163900|463897408|FG000|Overall Study|Adverse Event|78|||
128890629|NCT04163900|463897409|FG001|Overall Study|Adverse Event|32|||
128890630|NCT04163900|463897408|FG000|Overall Study|Withdrawal by Subject|37|||
128890631|NCT04163900|463897409|FG001|Overall Study|Withdrawal by Subject|34|||
128890632|NCT04163900|463897408|FG000|Overall Study|Death|29|||
128890633|NCT04163900|463897409|FG001|Overall Study|Death|16|||
128890634|NCT04163900|463897408|FG000|Overall Study|Physician Decision|17|||
128890635|NCT04163900|463897409|FG001|Overall Study|Physician Decision|25|||
128890636|NCT04163900|463897408|FG000|Overall Study|Clinical disease progression|14|||
128890637|NCT04163900|463897409|FG001|Overall Study|Clinical disease progression|13|||
128890638|NCT04163900|463897408|FG000|Overall Study|Protocol Violation|3|||
128890639|NCT04163900|463897409|FG001|Overall Study|Protocol Violation|4|||
128890640|NCT04163900|463897408|FG000|Overall Study|Lost to Follow-up|0|||
128890641|NCT04163900|463897409|FG001|Overall Study|Lost to Follow-up|1|||
128890642|NCT01873417|463897410|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
128890643|NCT01873417|463897410|FG000|Overall Study|Adverse Event|24|||
128890644|NCT01873417|463897410|FG000|Overall Study|Lost to Follow-up|2|||
128890645|NCT01873417|463897410|FG000|Overall Study|Withdrawal by Subject|2|||
128890646|NCT01873417|463897410|FG000|Overall Study|Physician Decision|3|||
128890647|NCT00785044|463897411|FG000|Overall Study|Dosed at non-participating sites|152|||
128890648|NCT00785044|463897411|FG000|Overall Study|Death|77|||
128890649|NCT00785044|463897411|FG000|Overall Study|Lost to Follow-up|266|||
128890650|NCT00785044|463897411|FG000|Overall Study|Withdrawal by Subject|1|||
128890651|NCT01830855|463897412|FG000|Overall Study|Other|7|||
128890652|NCT01830855|463897413|FG001|Overall Study|Other|1|||
128890653|NCT01830855|463897414|FG002|Overall Study|Other|4|||
128890654|NCT01830855|463897415|FG003|Overall Study|Other|4|||
128890655|NCT01830855|463897412|FG000|Overall Study|Medication error without associated AE|1|||
129020586|NCT01558635|464367118|FG000|Overall Study|Death|1|||
129020587|NCT01558635|464367118|FG000|Overall Study|Withdrawal by Subject|2|||
129020588|NCT01558635|464367118|FG000|Overall Study|Physician Decision|1|||
128890656|NCT01830855|463897413|FG001|Overall Study|Medication error without associated AE|0|||
128890657|NCT01830855|463897414|FG002|Overall Study|Medication error without associated AE|0|||
128890658|NCT01830855|463897415|FG003|Overall Study|Medication error without associated AE|1|||
128890659|NCT01830855|463897412|FG000|Overall Study|Pregnancy|3|||
128890660|NCT01830855|463897413|FG001|Overall Study|Pregnancy|1|||
128890661|NCT01830855|463897414|FG002|Overall Study|Pregnancy|2|||
128890662|NCT01830855|463897415|FG003|Overall Study|Pregnancy|1|||
128890663|NCT01830855|463897412|FG000|Overall Study|No longer meets eligibility criteria|11|||
128890664|NCT01830855|463897413|FG001|Overall Study|No longer meets eligibility criteria|2|||
128890665|NCT01830855|463897414|FG002|Overall Study|No longer meets eligibility criteria|3|||
128890666|NCT01830855|463897415|FG003|Overall Study|No longer meets eligibility criteria|5|||
128890667|NCT01830855|463897412|FG000|Overall Study|Adverse Event|11|||
128890668|NCT01830855|463897413|FG001|Overall Study|Adverse Event|5|||
128890669|NCT01830855|463897414|FG002|Overall Study|Adverse Event|6|||
128890670|NCT01830855|463897415|FG003|Overall Study|Adverse Event|3|||
128890671|NCT01830855|463897412|FG000|Overall Study|Protocol deviation|10|||
128890672|NCT01830855|463897413|FG001|Overall Study|Protocol deviation|5|||
128890673|NCT01830855|463897414|FG002|Overall Study|Protocol deviation|6|||
128890674|NCT01830855|463897415|FG003|Overall Study|Protocol deviation|6|||
128890675|NCT01830855|463897412|FG000|Overall Study|Withdrawal by Subject|33|||
128890676|NCT01830855|463897413|FG001|Overall Study|Withdrawal by Subject|14|||
128890677|NCT01830855|463897414|FG002|Overall Study|Withdrawal by Subject|10|||
128890678|NCT01830855|463897415|FG003|Overall Study|Withdrawal by Subject|12|||
128890679|NCT01830855|463897412|FG000|Overall Study|No longer willing to participate|32|||
128890680|NCT01830855|463897413|FG001|Overall Study|No longer willing to participate|13|||
128890681|NCT01830855|463897414|FG002|Overall Study|No longer willing to participate|12|||
128890682|NCT01830855|463897415|FG003|Overall Study|No longer willing to participate|17|||
128890683|NCT01830855|463897412|FG000|Overall Study|Lost to Follow-up|47|||
128890684|NCT01830855|463897413|FG001|Overall Study|Lost to Follow-up|20|||
128890685|NCT01830855|463897414|FG002|Overall Study|Lost to Follow-up|23|||
128890686|NCT01830855|463897415|FG003|Overall Study|Lost to Follow-up|33|||
128890687|NCT01667081|463897416|FG000|Overall Study|Death|43|||
128890688|NCT01667081|463897417|FG001|Overall Study|Death|3|||
128890689|NCT01667081|463897416|FG000|Overall Study|Lost to Follow-up|99|||
128890690|NCT01667081|463897417|FG001|Overall Study|Lost to Follow-up|48|||
128890691|NCT01667081|463897416|FG000|Overall Study|Physician Decision|16|||
128890692|NCT01667081|463897417|FG001|Overall Study|Physician Decision|2|||
128890693|NCT01667081|463897416|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
128890694|NCT01667081|463897417|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
128890695|NCT01667081|463897416|FG000|Overall Study|Withdrawal by Subject|90|||
128890696|NCT01667081|463897417|FG001|Overall Study|Withdrawal by Subject|35|||
128890697|NCT03034460|463897418|FG000|Overall Study|Adverse Event|0|||
128890698|NCT03034460|463897419|FG001|Overall Study|Adverse Event|1|||
128890699|NCT03034460|463897418|FG000|Overall Study|Withdrawal by Subject|2|||
128890700|NCT03034460|463897419|FG001|Overall Study|Withdrawal by Subject|2|||
128890701|NCT03034460|463897418|FG000|Overall Study|Personal Reasons|1|||
128890702|NCT03034460|463897419|FG001|Overall Study|Personal Reasons|0|||
128890703|NCT00295633|463897420|FG000|Overall Study|Lack of Efficacy|19|||
128890704|NCT00295633|463897421|FG001|Overall Study|Lack of Efficacy|7|||
128890705|NCT00295633|463897422|FG002|Overall Study|Lack of Efficacy|16|||
128890706|NCT00295633|463897420|FG000|Overall Study|Withdrawal of consent by subject|16|||
128890707|NCT00295633|463897421|FG001|Overall Study|Withdrawal of consent by subject|16|||
128890708|NCT00295633|463897422|FG002|Overall Study|Withdrawal of consent by subject|26|||
128890709|NCT00295633|463897420|FG000|Overall Study|Adverse Event|9|||
128890710|NCT00295633|463897421|FG001|Overall Study|Adverse Event|17|||
128890711|NCT00295633|463897422|FG002|Overall Study|Adverse Event|9|||
128890712|NCT00295633|463897420|FG000|Overall Study|Lost to Follow-up|6|||
128890713|NCT00295633|463897421|FG001|Overall Study|Lost to Follow-up|11|||
128890714|NCT00295633|463897422|FG002|Overall Study|Lost to Follow-up|7|||
128890715|NCT00295633|463897420|FG000|Overall Study|Physician Decision|9|||
128890716|NCT00295633|463897421|FG001|Overall Study|Physician Decision|10|||
128890717|NCT00295633|463897422|FG002|Overall Study|Physician Decision|8|||
128890718|NCT00295633|463897420|FG000|Overall Study|Poor/Noncompliance|2|||
128890719|NCT00295633|463897421|FG001|Overall Study|Poor/Noncompliance|2|||
128890720|NCT00295633|463897422|FG002|Overall Study|Poor/Noncompliance|6|||
128890721|NCT00295633|463897420|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
129110563|NCT00871234|464699866|FG000|Overall Study|Adverse Event|2|||
129110564|NCT00871234|464699866|FG000|Overall Study|Lost to Follow-up|3|||
128890722|NCT00295633|463897421|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
128890723|NCT00295633|463897422|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
129110565|NCT03380377|464699869|FG000|Overall Study|Physician Decision|1|||
128890724|NCT00295633|463897420|FG000|Overall Study|Death|1|||
128890725|NCT00295633|463897421|FG001|Overall Study|Death|1|||
128890726|NCT00295633|463897422|FG002|Overall Study|Death|0|||
128890727|NCT00295633|463897420|FG000|Overall Study|Administrative reason by sponsor|0|||
128890728|NCT00295633|463897421|FG001|Overall Study|Administrative reason by sponsor|0|||
128890729|NCT00295633|463897422|FG002|Overall Study|Administrative reason by sponsor|1|||
128890730|NCT01950247|463897423|FG000|Overall Study|Withdrawal by Subject|28|||
128890731|NCT01950247|463897424|FG001|Overall Study|Withdrawal by Subject|13|||
128890732|NCT01950247|463897423|FG000|Overall Study|Lost to Follow-up|18|||
128890733|NCT01950247|463897424|FG001|Overall Study|Lost to Follow-up|16|||
128890734|NCT01950247|463897423|FG000|Overall Study|Physician Decision|3|||
128890735|NCT01950247|463897424|FG001|Overall Study|Physician Decision|4|||
128890736|NCT01950247|463897423|FG000|Overall Study|Adverse Event|3|||
128890737|NCT01950247|463897424|FG001|Overall Study|Adverse Event|2|||
128890738|NCT01950247|463897423|FG000|Overall Study|Death|1|||
128890739|NCT01950247|463897424|FG001|Overall Study|Death|1|||
128890740|NCT01950247|463897423|FG000|Overall Study|Not Defined|4|||
128890741|NCT01950247|463897424|FG001|Overall Study|Not Defined|10|||
128890742|NCT01798992|463897425|FG000|Overall Study|Administrative withdrawal|0|||
128890743|NCT01798992|463897426|FG001|Overall Study|Administrative withdrawal|1|||
128890744|NCT01798992|463897427|FG002|Overall Study|Administrative withdrawal|0|||
128890745|NCT01798992|463897428|FG003|Overall Study|Administrative withdrawal|1|||
128890746|NCT01798992|463897425|FG000|Overall Study|Lost to Follow-up|0|||
128890747|NCT01798992|463897426|FG001|Overall Study|Lost to Follow-up|1|||
128890748|NCT01798992|463897427|FG002|Overall Study|Lost to Follow-up|1|||
128890749|NCT01798992|463897428|FG003|Overall Study|Lost to Follow-up|0|||
128890750|NCT01798992|463897425|FG000|Overall Study|Insufficient biopsy tissue|0|||
128890751|NCT01798992|463897426|FG001|Overall Study|Insufficient biopsy tissue|0|||
128890752|NCT01798992|463897427|FG002|Overall Study|Insufficient biopsy tissue|1|||
128890753|NCT01798992|463897428|FG003|Overall Study|Insufficient biopsy tissue|0|||
128890754|NCT00763971|463897429|FG000|Overall Study|Adverse Event|5|||
128890755|NCT00763971|463897430|FG001|Overall Study|Adverse Event|2|||
128890756|NCT00763971|463897431|FG002|Overall Study|Adverse Event|4|||
128890757|NCT00763971|463897429|FG000|Overall Study|Protocol Violation|3|||
128890758|NCT00763971|463897430|FG001|Overall Study|Protocol Violation|3|||
128890759|NCT00763971|463897431|FG002|Overall Study|Protocol Violation|2|||
128890760|NCT00763971|463897429|FG000|Overall Study|Withdrawal by Subject|4|||
128890761|NCT00763971|463897430|FG001|Overall Study|Withdrawal by Subject|5|||
128890762|NCT00763971|463897431|FG002|Overall Study|Withdrawal by Subject|5|||
128890763|NCT00763971|463897429|FG000|Overall Study|Lost to Follow-up|0|||
128890764|NCT00763971|463897430|FG001|Overall Study|Lost to Follow-up|1|||
128890765|NCT00763971|463897431|FG002|Overall Study|Lost to Follow-up|0|||
128890766|NCT00763971|463897429|FG000|Overall Study|Lack of Efficacy|11|||
128890767|NCT00763971|463897430|FG001|Overall Study|Lack of Efficacy|22|||
128890768|NCT00763971|463897431|FG002|Overall Study|Lack of Efficacy|54|||
128890769|NCT00763971|463897429|FG000|Overall Study|Unable to swallow capsule|2|||
128890770|NCT00763971|463897430|FG001|Overall Study|Unable to swallow capsule|1|||
128890771|NCT00763971|463897431|FG002|Overall Study|Unable to swallow capsule|1|||
128890772|NCT00763971|463897429|FG000|Overall Study|Personal reason|3|||
128890773|NCT00763971|463897430|FG001|Overall Study|Personal reason|0|||
128890774|NCT00763971|463897431|FG002|Overall Study|Personal reason|0|||
128890775|NCT00763971|463897429|FG000|Overall Study|Exclusion criteria met|1|||
128890776|NCT00763971|463897430|FG001|Overall Study|Exclusion criteria met|0|||
128890777|NCT00763971|463897431|FG002|Overall Study|Exclusion criteria met|0|||
128890778|NCT00763971|463897429|FG000|Overall Study|Sponsor decision|1|||
129020589|NCT01558635|464367118|FG000|Overall Study|Subject received other treatment|1|||
129020590|NCT01558635|464367118|FG000|Overall Study|Reveal XT was explanted|1|||
128688753|NCT00809354|463161500|FG007|Overall Study|Lost to Follow-up|5|||
128688754|NCT00809354|463161501|FG008|Overall Study|Lost to Follow-up|4|||
128688755|NCT00809354|463161502|FG009|Overall Study|Lost to Follow-up|0|||
128688756|NCT00809354|463161493|FG000|Overall Study|Protocol Violation|7|||
128688757|NCT00809354|463161494|FG001|Overall Study|Protocol Violation|14|||
128688758|NCT00809354|463161495|FG002|Overall Study|Protocol Violation|14|||
128688759|NCT00809354|463161496|FG003|Overall Study|Protocol Violation|12|||
128688760|NCT00809354|463161497|FG004|Overall Study|Protocol Violation|14|||
128890779|NCT00763971|463897430|FG001|Overall Study|Sponsor decision|0|||
128890780|NCT00763971|463897431|FG002|Overall Study|Sponsor decision|0|||
128890781|NCT00763971|463897429|FG000|Overall Study|Due to holiday season|2|||
129020591|NCT00455312|464367119|FG000|Overall Study|Death|0|||
129020592|NCT00455312|464367120|FG001|Overall Study|Death|1|||
129020593|NCT01693523|464367121|FG000|Overall Study|Adverse Event|2|||
129020594|NCT01693523|464367122|FG001|Overall Study|Adverse Event|1|||
129020595|NCT01693523|464367123|FG002|Overall Study|Adverse Event|0|||
129020596|NCT01693523|464367121|FG000|Overall Study|Death|0|||
129020597|NCT01693523|464367122|FG001|Overall Study|Death|1|||
129020598|NCT01693523|464367123|FG002|Overall Study|Death|1|||
129020599|NCT01693523|464367121|FG000|Overall Study|Lost to Follow-up|0|||
129020600|NCT01693523|464367122|FG001|Overall Study|Lost to Follow-up|0|||
129020601|NCT01693523|464367123|FG002|Overall Study|Lost to Follow-up|4|||
128688761|NCT00809354|463161498|FG005|Overall Study|Protocol Violation|6|||
128688762|NCT00809354|463161499|FG006|Overall Study|Protocol Violation|4|||
128890782|NCT00763971|463897430|FG001|Overall Study|Due to holiday season|0|||
128890783|NCT00763971|463897431|FG002|Overall Study|Due to holiday season|1|||
128890784|NCT00763971|463897429|FG000|Overall Study|Randomization error|0|||
128890785|NCT00763971|463897430|FG001|Overall Study|Randomization error|0|||
129020602|NCT01693523|464367121|FG000|Overall Study|Physician Decision|0|||
129020603|NCT01693523|464367122|FG001|Overall Study|Physician Decision|0|||
129020604|NCT01693523|464367123|FG002|Overall Study|Physician Decision|1|||
129020605|NCT01693523|464367121|FG000|Overall Study|Withdrawal by Subject|1|||
128890786|NCT00763971|463897431|FG002|Overall Study|Randomization error|1|||
128890787|NCT00763971|463897429|FG000|Overall Study|Medical monitor decision|0|||
128890788|NCT00763971|463897430|FG001|Overall Study|Medical monitor decision|0|||
128890789|NCT00763971|463897431|FG002|Overall Study|Medical monitor decision|1|||
128890790|NCT00763971|463897429|FG000|Overall Study|Moved to another country|0|||
128890791|NCT00763971|463897430|FG001|Overall Study|Moved to another country|1|||
128890792|NCT00763971|463897431|FG002|Overall Study|Moved to another country|0|||
128890793|NCT00763971|463897429|FG000|Overall Study|Subject wanted dose reduction|0|||
128890794|NCT00763971|463897430|FG001|Overall Study|Subject wanted dose reduction|1|||
128890795|NCT00763971|463897431|FG002|Overall Study|Subject wanted dose reduction|0|||
128890796|NCT00763971|463897429|FG000|Overall Study|Lack of availability|0|||
128890797|NCT00763971|463897430|FG001|Overall Study|Lack of availability|1|||
128890798|NCT00763971|463897431|FG002|Overall Study|Lack of availability|0|||
128890799|NCT00763971|463897429|FG000|Overall Study|Performed final visit on phone|0|||
128890800|NCT00763971|463897430|FG001|Overall Study|Performed final visit on phone|1|||
128890801|NCT00763971|463897431|FG002|Overall Study|Performed final visit on phone|0|||
128890802|NCT00763971|463897429|FG000|Overall Study|Participation in 489-326 required|1|||
128890803|NCT00763971|463897430|FG001|Overall Study|Participation in 489-326 required|0|||
128890804|NCT00763971|463897431|FG002|Overall Study|Participation in 489-326 required|0|||
128890805|NCT03334409|463897433|FG000|Overall Study|Did not meet inclusion criteria|1|||
128890806|NCT03334409|463897434|FG001|Overall Study|Did not meet inclusion criteria|0|||
128890807|NCT05372653|463897437|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
128890808|NCT05372653|463897438|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
128890809|NCT05372653|463897437|FG000|Overall Study|Adverse Event|0|||
128890810|NCT05372653|463897438|FG001|Overall Study|Adverse Event|1|||
128890811|NCT03740997|463897442|FG000|Overall Study|Withdrawal by Subject|1|||
128890812|NCT03740997|463897443|FG001|Overall Study|Withdrawal by Subject|0|||
128890813|NCT03740997|463897442|FG000|Overall Study|Participant was unable to complete study procedures|1|||
128890814|NCT03740997|463897443|FG001|Overall Study|Participant was unable to complete study procedures|0|||
128890815|NCT04246801|463897444|FG000|Overall Study|Adverse Event|1|||
128890816|NCT04246801|463897445|FG001|Overall Study|Adverse Event|1|||
128890817|NCT04246801|463897444|FG000|Overall Study|Protocol Violation|1|||
128890818|NCT04246801|463897445|FG001|Overall Study|Protocol Violation|1|||
128890819|NCT04246801|463897444|FG000|Overall Study|Lack of Efficacy|0|||
128890820|NCT04246801|463897445|FG001|Overall Study|Lack of Efficacy|2|||
128890821|NCT04246801|463897444|FG000|Overall Study|Lost to Follow-up|1|||
128890822|NCT04246801|463897445|FG001|Overall Study|Lost to Follow-up|1|||
128890823|NCT04246801|463897444|FG000|Overall Study|Withdrawal by Subject|2|||
128890824|NCT04246801|463897445|FG001|Overall Study|Withdrawal by Subject|1|||
128890825|NCT03684642|463897446|FG000|Overall Study|Adverse Event|6|||
128890826|NCT03684642|463897447|FG001|Overall Study|Adverse Event|15|||
128890827|NCT03684642|463897448|FG002|Overall Study|Adverse Event|11|||
128890828|NCT03684642|463897446|FG000|Overall Study|Withdrawal by Subject|35|||
128890829|NCT03684642|463897447|FG001|Overall Study|Withdrawal by Subject|53|||
128890830|NCT03684642|463897448|FG002|Overall Study|Withdrawal by Subject|23|||
128890831|NCT03684642|463897446|FG000|Overall Study|Lack of Efficacy|0|||
128890832|NCT03684642|463897447|FG001|Overall Study|Lack of Efficacy|0|||
128764065|NCT01852058|463425905|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764066|NCT01852058|463425906|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764067|NCT01852058|463425907|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764068|NCT01852058|463425908|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764069|NCT01852058|463425909|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764070|NCT01852058|463425910|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764071|NCT01852058|463425911|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
128764072|NCT01852058|463425900|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128764073|NCT01852058|463425901|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128764074|NCT01852058|463425902|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128890833|NCT03684642|463897448|FG002|Overall Study|Lack of Efficacy|1|||
128890834|NCT03684642|463897446|FG000|Overall Study|Poor compliance to protocol|0|||
128890835|NCT03684642|463897447|FG001|Overall Study|Poor compliance to protocol|4|||
128890836|NCT03684642|463897448|FG002|Overall Study|Poor compliance to protocol|1|||
128890837|NCT03684642|463897446|FG000|Overall Study|Other than specified|62|||
128890838|NCT03684642|463897447|FG001|Overall Study|Other than specified|60|||
128890839|NCT03684642|463897448|FG002|Overall Study|Other than specified|67|||
128890840|NCT03684642|463897446|FG000|Overall Study|Randomized and not treated|0|||
128764075|NCT01852058|463425903|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128890841|NCT03684642|463897447|FG001|Overall Study|Randomized and not treated|0|||
128890842|NCT03684642|463897448|FG002|Overall Study|Randomized and not treated|1|||
128890843|NCT03684642|463897446|FG000|Overall Study|Missing completion status but alive at last contact|0|||
128890844|NCT03684642|463897447|FG001|Overall Study|Missing completion status but alive at last contact|1|||
129020606|NCT01693523|464367122|FG001|Overall Study|Withdrawal by Subject|2|||
129020607|NCT01693523|464367123|FG002|Overall Study|Withdrawal by Subject|2|||
128890845|NCT03684642|463897448|FG002|Overall Study|Missing completion status but alive at last contact|2|||
128890846|NCT04201821|463897459|FG000|Overall Study|Withdrawal by Subject|2|||
128890847|NCT00387764|463897460|FG000|Overall Study|Adverse Event|12|||
128890848|NCT00387764|463897460|FG000|Overall Study|Withdrawal by Subject|8|||
128890849|NCT00387764|463897460|FG000|Overall Study|Sponsor Terminated Study|1|||
128890850|NCT00387764|463897460|FG000|Overall Study|Physician Decision|1|||
128890851|NCT00387764|463897460|FG000|Overall Study|Other|2|||
128890852|NCT00387764|463897460|FG000|Overall Study|Death|7|||
128890853|NCT02966223|463897461|FG000|Overall Study|Physician Decision|3|||
128890854|NCT02966223|463897461|FG000|Overall Study|Withdrawal by Subject|11|||
128890855|NCT02966223|463897461|FG000|Overall Study|Lost to Follow-up|1|||
128890856|NCT01326728|463897462|FG000|Overall Study|Death|13|||
128890857|NCT01326728|463897463|FG001|Overall Study|Death|0|||
128890858|NCT01326728|463897462|FG000|Overall Study|Early closure of study|34|||
128890859|NCT01326728|463897463|FG001|Overall Study|Early closure of study|9|||
128890860|NCT03785678|463897466|FG000|Overall Study|Death|44|||
128890861|NCT03785678|463897467|FG001|Overall Study|Death|42|||
128890862|NCT03785678|463897466|FG000|Overall Study|Lost to Follow-up|4|||
128890863|NCT03785678|463897467|FG001|Overall Study|Lost to Follow-up|2|||
128890864|NCT03785678|463897466|FG000|Overall Study|Physician Decision|0|||
128890865|NCT03785678|463897467|FG001|Overall Study|Physician Decision|2|||
128890866|NCT03785678|463897466|FG000|Overall Study|Withdrawal by Subject|5|||
128890867|NCT03785678|463897467|FG001|Overall Study|Withdrawal by Subject|3|||
128890868|NCT02374021|463897471|FG000|Overall Study|Adverse Event|1|||
128890869|NCT02374021|463897472|FG001|Overall Study|Adverse Event|0|||
128890870|NCT02374021|463897471|FG000|Overall Study|Lost to Follow-up|3|||
128890871|NCT02374021|463897472|FG001|Overall Study|Lost to Follow-up|2|||
128890872|NCT02374021|463897471|FG000|Overall Study|Physician Decision|0|||
128890873|NCT02374021|463897472|FG001|Overall Study|Physician Decision|3|||
128890874|NCT02374021|463897471|FG000|Overall Study|Withdrawal by Subject|6|||
128890875|NCT02374021|463897472|FG001|Overall Study|Withdrawal by Subject|5|||
128890876|NCT02374021|463897471|FG000|Overall Study|Poor Adherence|0|||
128890877|NCT02374021|463897472|FG001|Overall Study|Poor Adherence|1|||
128890878|NCT02374021|463897471|FG000|Overall Study|Scan protocol not followed|0|||
128890879|NCT02374021|463897472|FG001|Overall Study|Scan protocol not followed|1|||
128890880|NCT02374021|463897471|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
128890881|NCT02374021|463897472|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
128890882|NCT00805025|463897473|FG000|Overall Study|Screened but not enrolled/treated|42|||
128890883|NCT00805025|463897473|FG000|Overall Study|Adverse Event|4|||
128890884|NCT00805025|463897473|FG000|Overall Study|Withdrawal by Subject|2|||
128890885|NCT00805025|463897473|FG000|Overall Study|Physician Decision|1|||
128890886|NCT00375219|463897474|FG000|Overall Study|Failure to achieve a response|16|||
128890887|NCT00375219|463897475|FG001|Overall Study|Failure to achieve a response|2|||
128890888|NCT00375219|463897476|FG002|Overall Study|Failure to achieve a response|0|||
128890889|NCT00375219|463897474|FG000|Overall Study|Adverse Event|8|||
128890890|NCT00375219|463897475|FG001|Overall Study|Adverse Event|2|||
128890891|NCT00375219|463897476|FG002|Overall Study|Adverse Event|1|||
128890892|NCT00375219|463897474|FG000|Overall Study|Protocol Violation|1|||
128890893|NCT00375219|463897475|FG001|Overall Study|Protocol Violation|0|||
128890894|NCT00375219|463897476|FG002|Overall Study|Protocol Violation|1|||
128890895|NCT00375219|463897474|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
128890896|NCT00375219|463897475|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
128890897|NCT00375219|463897476|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
128890898|NCT00375219|463897474|FG000|Overall Study|Lost to Follow-up|1|||
128890899|NCT00375219|463897475|FG001|Overall Study|Lost to Follow-up|1|||
128890900|NCT00375219|463897476|FG002|Overall Study|Lost to Follow-up|0|||
128890901|NCT00375219|463897474|FG000|Overall Study|Disease progression|18|||
128890902|NCT00375219|463897475|FG001|Overall Study|Disease progression|9|||
128890903|NCT00375219|463897476|FG002|Overall Study|Disease progression|12|||
128890904|NCT00375219|463897474|FG000|Overall Study|Death|4|||
128890905|NCT00375219|463897475|FG001|Overall Study|Death|3|||
128688763|NCT00809354|463161500|FG007|Overall Study|Protocol Violation|6|||
128890906|NCT00375219|463897476|FG002|Overall Study|Death|7|||
128890907|NCT00375219|463897474|FG000|Overall Study|Hematologic resistance|1|||
128890908|NCT00375219|463897475|FG001|Overall Study|Hematologic resistance|0|||
128890909|NCT00375219|463897476|FG002|Overall Study|Hematologic resistance|0|||
128890910|NCT00375219|463897474|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
128890911|NCT00375219|463897475|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
128890912|NCT00375219|463897476|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
128688764|NCT00809354|463161501|FG008|Overall Study|Protocol Violation|9|||
128890913|NCT00375219|463897474|FG000|Overall Study|Allograft|2|||
128890914|NCT00375219|463897475|FG001|Overall Study|Allograft|0|||
128890915|NCT00375219|463897476|FG002|Overall Study|Allograft|0|||
128890916|NCT00375219|463897474|FG000|Overall Study|Cord blood transplantation|1|||
128890917|NCT00375219|463897475|FG001|Overall Study|Cord blood transplantation|0|||
128890918|NCT00375219|463897476|FG002|Overall Study|Cord blood transplantation|0|||
128890919|NCT00375219|463897474|FG000|Overall Study|Withdrawal by Subject|1|||
128890920|NCT00375219|463897475|FG001|Overall Study|Withdrawal by Subject|0|||
128890921|NCT00375219|463897476|FG002|Overall Study|Withdrawal by Subject|0|||
128890922|NCT01667107|463897477|FG000|Overall Study|Adverse Event|4|||
128890923|NCT01667107|463897478|FG001|Overall Study|Adverse Event|3|||
128890924|NCT01667107|463897477|FG000|Overall Study|Tolerability issues|0|||
128890925|NCT01667107|463897478|FG001|Overall Study|Tolerability issues|2|||
128890926|NCT01667107|463897477|FG000|Overall Study|Protocol Violation|0|||
128890927|NCT01667107|463897478|FG001|Overall Study|Protocol Violation|1|||
128890928|NCT01667107|463897477|FG000|Overall Study|Lack of Efficacy|0|||
128890929|NCT01667107|463897478|FG001|Overall Study|Lack of Efficacy|1|||
128890930|NCT01162239|463897481|FG000|Treatment Phase|Withdrawal by Subject|1|||
128890931|NCT01162239|463897482|FG001|Treatment Phase|Withdrawal by Subject|3|||
128890932|NCT01162239|463897483|FG002|Treatment Phase|Withdrawal by Subject|2|||
128890933|NCT01162239|463897484|FG003|Treatment Phase|Withdrawal by Subject|3|||
128890934|NCT01162239|463897481|FG000|Treatment Phase|Death|0|||
128890935|NCT01162239|463897482|FG001|Treatment Phase|Death|0|||
128890936|NCT01162239|463897483|FG002|Treatment Phase|Death|0|||
128890937|NCT01162239|463897484|FG003|Treatment Phase|Death|1|||
128890938|NCT01162239|463897481|FG000|Treatment Phase|Lost to Follow-up|5|||
128890939|NCT01162239|463897482|FG001|Treatment Phase|Lost to Follow-up|4|||
128890940|NCT01162239|463897483|FG002|Treatment Phase|Lost to Follow-up|2|||
128890941|NCT01162239|463897484|FG003|Treatment Phase|Lost to Follow-up|1|||
128890942|NCT01162239|463897481|FG000|Extended Follow-up|Lost to Follow-up|8|||
128890943|NCT01162239|463897482|FG001|Extended Follow-up|Lost to Follow-up|13|||
128890944|NCT01162239|463897483|FG002|Extended Follow-up|Lost to Follow-up|8|||
128890945|NCT01162239|463897484|FG003|Extended Follow-up|Lost to Follow-up|6|||
128890946|NCT00228566|463897485|FG000|Overall Study|Adverse Event|31|||
128890947|NCT00228566|463897485|FG000|Overall Study|Lack of Efficacy|14|||
128890948|NCT00228566|463897485|FG000|Overall Study|Lost to Follow-up|16|||
128890949|NCT00228566|463897485|FG000|Overall Study|Physician Decision|5|||
128890950|NCT00228566|463897485|FG000|Overall Study|Withdrawal by Subject|4|||
128890951|NCT00228566|463897485|FG000|Overall Study|Miscellaneous|1|||
128890952|NCT04448756|463897488|FG000|Overall Study|Adverse Event|0|||
128890953|NCT04448756|463897489|FG001|Overall Study|Adverse Event|1|||
128890954|NCT04448756|463897490|FG002|Overall Study|Adverse Event|0|||
128890955|NCT04448756|463897488|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
128890956|NCT04448756|463897489|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
128890957|NCT04448756|463897490|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
128890958|NCT04448756|463897488|FG000|Overall Study|Withdrawal by Subject|0|||
128890959|NCT04448756|463897489|FG001|Overall Study|Withdrawal by Subject|3|||
128890960|NCT04448756|463897490|FG002|Overall Study|Withdrawal by Subject|1|||
128890961|NCT04448756|463897488|FG000|Overall Study|Death|2|||
128890962|NCT04448756|463897489|FG001|Overall Study|Death|1|||
128890963|NCT04448756|463897490|FG002|Overall Study|Death|0|||
128890964|NCT00232141|463897491|FG000|Overall Study|Adverse Event|9|||
128890965|NCT00232141|463897492|FG001|Overall Study|Adverse Event|4|||
128890966|NCT00232141|463897491|FG000|Overall Study|Lack of Efficacy|0|||
128890967|NCT00232141|463897492|FG001|Overall Study|Lack of Efficacy|3|||
128890968|NCT00232141|463897491|FG000|Overall Study|Lost to Follow-up|9|||
128890969|NCT00232141|463897492|FG001|Overall Study|Lost to Follow-up|6|||
128890970|NCT00232141|463897491|FG000|Overall Study|Other|8|||
128890971|NCT00232141|463897492|FG001|Overall Study|Other|10|||
128890972|NCT00232141|463897491|FG000|Overall Study|Withdrawal by Subject|5|||
128890973|NCT00232141|463897492|FG001|Overall Study|Withdrawal by Subject|3|||
128890974|NCT01479829|463897496|FG000|Overall Study|Withdrawal by Subject|8|||
128890975|NCT01479829|463897497|FG001|Overall Study|Withdrawal by Subject|10|||
128890976|NCT00601250|463897498|FG000|Overall Study|Adverse Event|3|||
128890977|NCT00601250|463897499|FG001|Overall Study|Adverse Event|9|||
128890978|NCT00601250|463897498|FG000|Overall Study|Protocol Violation|3|||
128890979|NCT00601250|463897499|FG001|Overall Study|Protocol Violation|2|||
128890980|NCT00601250|463897498|FG000|Overall Study|Lost to Follow-up|2|||
128890981|NCT00601250|463897499|FG001|Overall Study|Lost to Follow-up|6|||
128890982|NCT00601250|463897498|FG000|Overall Study|Withdrawal by Subject|4|||
128890983|NCT00601250|463897499|FG001|Overall Study|Withdrawal by Subject|13|||
128890984|NCT00601250|463897498|FG000|Overall Study|Other incl. lack of efficacy|2|||
128890985|NCT00601250|463897499|FG001|Overall Study|Other incl. lack of efficacy|9|||
128890986|NCT01791803|463897504|FG000|Overall Study|Withdrawal by Subject|0|||
128890987|NCT01791803|463897505|FG001|Overall Study|Withdrawal by Subject|0|||
128890988|NCT01791803|463897506|FG002|Overall Study|Withdrawal by Subject|0|||
128890989|NCT01791803|463897507|FG003|Overall Study|Withdrawal by Subject|2|||
128890990|NCT01791803|463897504|FG000|Overall Study|Physician Decision|0|||
128890991|NCT01791803|463897505|FG001|Overall Study|Physician Decision|2|||
128890992|NCT01791803|463897506|FG002|Overall Study|Physician Decision|0|||
128890993|NCT01791803|463897507|FG003|Overall Study|Physician Decision|1|||
128890994|NCT01791803|463897504|FG000|Overall Study|Death|0|||
128890995|NCT01791803|463897505|FG001|Overall Study|Death|0|||
128890996|NCT01791803|463897506|FG002|Overall Study|Death|2|||
128890997|NCT01791803|463897507|FG003|Overall Study|Death|2|||
128890998|NCT04572854|463897508|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
128890999|NCT04572854|463897509|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
128891000|NCT04572854|463897510|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
128891001|NCT04572854|463897511|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
128891002|NCT04572854|463897508|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
128891003|NCT04572854|463897509|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
128891004|NCT04572854|463897510|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
128891005|NCT04572854|463897511|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
128891006|NCT00972777|463897513|FG000|Overall Study|Adverse Event|3|||
128891007|NCT00972777|463897514|FG001|Overall Study|Adverse Event|2|||
128891008|NCT00972777|463897513|FG000|Overall Study|Lost to Follow-up|0|||
128891009|NCT00972777|463897514|FG001|Overall Study|Lost to Follow-up|4|||
128891010|NCT00972777|463897513|FG000|Overall Study|Withdrawal by Subject|4|||
128891011|NCT00972777|463897514|FG001|Overall Study|Withdrawal by Subject|5|||
129110566|NCT03380377|464699869|FG000|Overall Study|Withdrawal by Subject|1|||
129110567|NCT02600923|464699872|FG000|Overall Study|Death|10|||
129110568|NCT02600923|464699872|FG000|Overall Study|Adverse Event|3|||
129110569|NCT02600923|464699872|FG000|Overall Study|Global deterioration of health status|2|||
129110570|NCT02600923|464699872|FG000|Overall Study|Insufficient clinical response|6|||
129110571|NCT02600923|464699872|FG000|Overall Study|Lost to Follow-up|1|||
129110572|NCT02600923|464699872|FG000|Overall Study|Withdrawal by Subject|5|||
129110573|NCT02600923|464699872|FG000|Overall Study|Objective progression or relapse|50|||
129110574|NCT02600923|464699872|FG000|Overall Study|Study terminated by Sponsor|53|||
129110575|NCT02600923|464699872|FG000|Overall Study|Not treated|1|||
129110576|NCT00792909|464699873|FG000|Overall Study|Withdrawal by Subject|0|||
129110577|NCT00792909|464699874|FG001|Overall Study|Withdrawal by Subject|1|||
129110578|NCT00792909|464699875|FG002|Overall Study|Withdrawal by Subject|0|||
129110579|NCT00128661|464699878|FG000|Overall Study|Adverse Event|14|||
129110580|NCT00128661|464699879|FG001|Overall Study|Adverse Event|11|||
129110581|NCT00128661|464699878|FG000|Overall Study|Lost to Follow-up|10|||
129110582|NCT00128661|464699879|FG001|Overall Study|Lost to Follow-up|7|||
129110583|NCT00128661|464699878|FG000|Overall Study|Withdrawal by Subject|243|||
129110584|NCT00128661|464699879|FG001|Overall Study|Withdrawal by Subject|232|||
129110585|NCT00128661|464699878|FG000|Overall Study|Other|7|||
129110586|NCT00128661|464699879|FG001|Overall Study|Other|8|||
128688765|NCT00809354|463161502|FG009|Overall Study|Protocol Violation|3|||
128688766|NCT00809354|463161493|FG000|Overall Study|Withdrawal by Subject|32|||
128688767|NCT00809354|463161494|FG001|Overall Study|Withdrawal by Subject|27|||
128688768|NCT00809354|463161495|FG002|Overall Study|Withdrawal by Subject|31|||
128688769|NCT00809354|463161496|FG003|Overall Study|Withdrawal by Subject|33|||
128688770|NCT00809354|463161497|FG004|Overall Study|Withdrawal by Subject|34|||
128688771|NCT00809354|463161498|FG005|Overall Study|Withdrawal by Subject|29|||
128688772|NCT00809354|463161499|FG006|Overall Study|Withdrawal by Subject|27|||
128688773|NCT00809354|463161500|FG007|Overall Study|Withdrawal by Subject|19|||
128688774|NCT00809354|463161501|FG008|Overall Study|Withdrawal by Subject|18|||
128688775|NCT00809354|463161502|FG009|Overall Study|Withdrawal by Subject|20|||
128688776|NCT00809354|463161493|FG000|Overall Study|Other|10|||
128688777|NCT00809354|463161494|FG001|Overall Study|Other|2|||
128688778|NCT00809354|463161495|FG002|Overall Study|Other|7|||
128688779|NCT00809354|463161496|FG003|Overall Study|Other|10|||
128688780|NCT00809354|463161497|FG004|Overall Study|Other|5|||
128688781|NCT00809354|463161498|FG005|Overall Study|Other|3|||
128688782|NCT00809354|463161499|FG006|Overall Study|Other|2|||
128688783|NCT00809354|463161500|FG007|Overall Study|Other|3|||
128688784|NCT00809354|463161501|FG008|Overall Study|Other|4|||
128688785|NCT00809354|463161502|FG009|Overall Study|Other|3|||
128688786|NCT00809354|463161493|FG000|Overall Study|Study terminated by sponsor|138|||
128688787|NCT00809354|463161494|FG001|Overall Study|Study terminated by sponsor|134|||
128688788|NCT00809354|463161495|FG002|Overall Study|Study terminated by sponsor|129|||
128688789|NCT00809354|463161496|FG003|Overall Study|Study terminated by sponsor|120|||
128688790|NCT00809354|463161497|FG004|Overall Study|Study terminated by sponsor|126|||
128688791|NCT00809354|463161498|FG005|Overall Study|Study terminated by sponsor|133|||
128688792|NCT00809354|463161499|FG006|Overall Study|Study terminated by sponsor|124|||
128688793|NCT00809354|463161500|FG007|Overall Study|Study terminated by sponsor|148|||
128688794|NCT00809354|463161501|FG008|Overall Study|Study terminated by sponsor|127|||
128891012|NCT00972777|463897513|FG000|Overall Study|Physician Decision|4|||
128891013|NCT00972777|463897514|FG001|Overall Study|Physician Decision|0|||
128688795|NCT00809354|463161502|FG009|Overall Study|Study terminated by sponsor|135|||
128688796|NCT00809354|463161493|FG000|Overall Study|Withdrawn due to pregnancy|0|||
128688797|NCT00809354|463161494|FG001|Overall Study|Withdrawn due to pregnancy|1|||
128891014|NCT00972777|463897513|FG000|Overall Study|Protocol Violation|0|||
128688798|NCT00809354|463161495|FG002|Overall Study|Withdrawn due to pregnancy|0|||
128688799|NCT00809354|463161496|FG003|Overall Study|Withdrawn due to pregnancy|0|||
128688800|NCT00809354|463161497|FG004|Overall Study|Withdrawn due to pregnancy|0|||
128688801|NCT00809354|463161498|FG005|Overall Study|Withdrawn due to pregnancy|0|||
128688802|NCT00809354|463161499|FG006|Overall Study|Withdrawn due to pregnancy|0|||
129110587|NCT01261390|464699881|FG000|Overall Study|Significant Concurrent Illness|1|||
129110588|NCT01261390|464699882|FG001|Overall Study|Significant Concurrent Illness|0|||
128891015|NCT00972777|463897514|FG001|Overall Study|Protocol Violation|2|||
128891016|NCT00972777|463897513|FG000|Overall Study|Screening Failure|2|||
128891017|NCT00972777|463897514|FG001|Overall Study|Screening Failure|1|||
128891018|NCT00972777|463897513|FG000|Overall Study|Missed visit|1|||
128891019|NCT00972777|463897514|FG001|Overall Study|Missed visit|0|||
128891020|NCT01093326|463897515|FG000|Overall Study|Death|0|||
128891021|NCT01093326|463897516|FG001|Overall Study|Death|1|||
128891022|NCT01093326|463897517|FG002|Overall Study|Death|0|||
128891023|NCT01093326|463897515|FG000|Overall Study|Lack of Efficacy|7|||
128891024|NCT01093326|463897516|FG001|Overall Study|Lack of Efficacy|6|||
128891025|NCT01093326|463897517|FG002|Overall Study|Lack of Efficacy|3|||
128891026|NCT01093326|463897515|FG000|Overall Study|Lost to Follow-up|2|||
128891027|NCT01093326|463897516|FG001|Overall Study|Lost to Follow-up|5|||
128891028|NCT01093326|463897517|FG002|Overall Study|Lost to Follow-up|4|||
128891029|NCT01093326|463897515|FG000|Overall Study|Physician Decision|3|||
128891030|NCT01093326|463897516|FG001|Overall Study|Physician Decision|1|||
128891031|NCT01093326|463897517|FG002|Overall Study|Physician Decision|3|||
128891032|NCT01093326|463897515|FG000|Overall Study|Withdrawal by Subject|30|||
128891033|NCT01093326|463897516|FG001|Overall Study|Withdrawal by Subject|27|||
128891034|NCT01093326|463897517|FG002|Overall Study|Withdrawal by Subject|26|||
128891035|NCT01093326|463897515|FG000|Overall Study|Adverse Event|2|||
128891036|NCT01093326|463897516|FG001|Overall Study|Adverse Event|1|||
128891037|NCT01093326|463897517|FG002|Overall Study|Adverse Event|4|||
128891038|NCT01093326|463897515|FG000|Overall Study|Other|0|||
128891039|NCT01093326|463897516|FG001|Overall Study|Other|0|||
128891040|NCT01093326|463897517|FG002|Overall Study|Other|1|||
128891041|NCT01444456|463897518|FG000|Overall Study|Withdrawal by Subject|21|||
128891042|NCT01444456|463897518|FG000|Overall Study|Physician Decision|9|||
128891043|NCT01444456|463897518|FG000|Overall Study|Lost to Follow-up|37|||
128891044|NCT01444456|463897518|FG000|Overall Study|Death|73|||
128891045|NCT01444456|463897518|FG000|Overall Study|Ineligibility determined|23|||
128891046|NCT01444456|463897518|FG000|Overall Study|Other|18|||
129020608|NCT01693523|464367121|FG000|Overall Study|Lack of compliance study medication|1|||
129020609|NCT01693523|464367122|FG001|Overall Study|Lack of compliance study medication|2|||
129020610|NCT01693523|464367123|FG002|Overall Study|Lack of compliance study medication|0|||
129020611|NCT01693523|464367121|FG000|Overall Study|Chemotherapy was held|1|||
129020612|NCT01693523|464367122|FG001|Overall Study|Chemotherapy was held|2|||
129020613|NCT01693523|464367123|FG002|Overall Study|Chemotherapy was held|0|||
129020614|NCT03343535|464367124|FG000|Overall Study|Lost to Follow-up|1|||
129020615|NCT03343535|464367124|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
129020616|NCT03343535|464367124|FG000|Overall Study|Death|12|||
129020617|NCT03699020|464367126|FG000|Overall Study|Withdrawal by Subject|3|||
129020618|NCT03699020|464367127|FG001|Overall Study|Withdrawal by Subject|2|||
129020619|NCT02246920|464367128|FG000|Overall Study|Adverse Event|3|||
129020620|NCT02246920|464367129|FG001|Overall Study|Adverse Event|1|||
129020621|NCT02246920|464367130|FG002|Overall Study|Adverse Event|1|||
129020622|NCT02246920|464367128|FG000|Overall Study|Lost to Follow-up|2|||
129020623|NCT02246920|464367129|FG001|Overall Study|Lost to Follow-up|1|||
129020624|NCT02246920|464367130|FG002|Overall Study|Lost to Follow-up|0|||
129020625|NCT02246920|464367128|FG000|Overall Study|Protocol Violation|2|||
129020626|NCT02246920|464367129|FG001|Overall Study|Protocol Violation|5|||
129020627|NCT02246920|464367130|FG002|Overall Study|Protocol Violation|1|||
129020628|NCT02246920|464367128|FG000|Overall Study|Withdrawal by Subject|0|||
129020629|NCT02246920|464367129|FG001|Overall Study|Withdrawal by Subject|0|||
129020630|NCT02246920|464367130|FG002|Overall Study|Withdrawal by Subject|1|||
129020631|NCT00448019|464367133|FG000|Overall Study|Withdrawal by Subject|3|||
129020632|NCT00448019|464367133|FG000|Overall Study|Disease progression|1|||
129020633|NCT00448019|464367133|FG000|Overall Study|Death|2|||
129020634|NCT00448019|464367133|FG000|Overall Study|Insurance Issues|1|||
129020635|NCT03620747|464367135|FG000|Overall Study|Participant decision|7|||
129020636|NCT03620747|464367135|FG000|Overall Study|Adverse Event|6|||
129020637|NCT03620747|464367135|FG000|Overall Study|Lack of Efficacy|1|||
129020638|NCT03620747|464367135|FG000|Overall Study|Poor compliance to protocol|2|||
129020639|NCT03620747|464367135|FG000|Overall Study|Other-unspecified|3|||
129020640|NCT02714062|464367136|FG000|Overall Study|Adverse Event|0|||
129020641|NCT02714062|464367137|FG001|Overall Study|Adverse Event|0|||
129020642|NCT02714062|464367138|FG002|Overall Study|Adverse Event|2|||
129020643|NCT02714062|464367136|FG000|Overall Study|Withdrawal by Subject|1|||
129020644|NCT02714062|464367137|FG001|Overall Study|Withdrawal by Subject|0|||
129020645|NCT02714062|464367138|FG002|Overall Study|Withdrawal by Subject|1|||
128891047|NCT01444456|463897518|FG000|Overall Study|Not treated|104|||
128891048|NCT04263896|463897519|FG000|Overall Study|Withdrawal by Subject|2|||
128891049|NCT04263896|463897520|FG001|Overall Study|Withdrawal by Subject|4|||
128891050|NCT04263896|463897519|FG000|Overall Study|converted to open procedure|0|||
128891051|NCT04263896|463897520|FG001|Overall Study|converted to open procedure|1|||
128891052|NCT04263896|463897519|FG000|Overall Study|Lost to Follow-up|9|||
129020646|NCT02714062|464367136|FG000|Overall Study|Protocol Violation|0|||
129020647|NCT02714062|464367137|FG001|Overall Study|Protocol Violation|1|||
129020648|NCT02714062|464367138|FG002|Overall Study|Protocol Violation|0|||
129020649|NCT00904215|464367140|FG000|Overall Study|Adverse Event|25|||
128891053|NCT04263896|463897520|FG001|Overall Study|Lost to Follow-up|11|||
128891054|NCT04263896|463897519|FG000|Overall Study|surveys lost in mail|5|||
128891055|NCT04263896|463897520|FG001|Overall Study|surveys lost in mail|3|||
128891056|NCT04263896|463897519|FG000|Overall Study|excluded from analysis|1|||
128891057|NCT04263896|463897520|FG001|Overall Study|excluded from analysis|0|||
128891058|NCT03523728|463898831|FG000|Stage 1 (24 Months)|Adverse Event|2|||
128891059|NCT03523728|463898832|FG001|Stage 1 (24 Months)|Adverse Event|2|||
128891060|NCT03523728|463898833|FG002|Stage 1 (24 Months)|Adverse Event|4|||
128891061|NCT03523728|463898834|FG003|Stage 1 (24 Months)|Adverse Event|0|||
128891062|NCT03523728|463898835|FG004|Stage 1 (24 Months)|Adverse Event|0|||
128891063|NCT03523728|463898831|FG000|Stage 1 (24 Months)|Progressive disease|0|||
128891064|NCT03523728|463898832|FG001|Stage 1 (24 Months)|Progressive disease|0|||
128891065|NCT03523728|463898833|FG002|Stage 1 (24 Months)|Progressive disease|1|||
128891066|NCT03523728|463898834|FG003|Stage 1 (24 Months)|Progressive disease|0|||
128891067|NCT03523728|463898835|FG004|Stage 1 (24 Months)|Progressive disease|0|||
128891068|NCT03523728|463898831|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
128891069|NCT03523728|463898832|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
128891070|NCT03523728|463898833|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
128891071|NCT03523728|463898834|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
128891072|NCT03523728|463898835|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
128891073|NCT03523728|463898831|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
128891074|NCT03523728|463898832|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
128891075|NCT03523728|463898833|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
128891076|NCT03523728|463898834|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
128891077|NCT03523728|463898835|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
128891078|NCT03523728|463898831|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
128891079|NCT03523728|463898832|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
128891080|NCT03523728|463898833|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
128891081|NCT03523728|463898834|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
128891082|NCT03523728|463898835|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
128891083|NCT03523728|463898831|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
128891084|NCT03523728|463898832|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
128891085|NCT03523728|463898833|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
128891086|NCT03523728|463898834|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
128891087|NCT03523728|463898835|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
128891088|NCT03523728|463898831|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
128891089|NCT03523728|463898832|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
128891090|NCT03523728|463898833|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
128891091|NCT03523728|463898834|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
128891092|NCT03523728|463898835|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
128891093|NCT03523728|463898831|FG000|Stage 2 (24 Months)|Adverse Event|0|||
128891094|NCT03523728|463898832|FG001|Stage 2 (24 Months)|Adverse Event|0|||
128891095|NCT03523728|463898833|FG002|Stage 2 (24 Months)|Adverse Event|0|||
128891096|NCT03523728|463898834|FG003|Stage 2 (24 Months)|Adverse Event|1|||
128891097|NCT03523728|463898835|FG004|Stage 2 (24 Months)|Adverse Event|2|||
128891098|NCT03523728|463898831|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
128891099|NCT03523728|463898832|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
128891100|NCT03523728|463898833|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
128891101|NCT03523728|463898834|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
128891102|NCT03523728|463898835|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
128891103|NCT03523728|463898831|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
128891104|NCT03523728|463898832|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
128891105|NCT03523728|463898833|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
128891106|NCT03523728|463898834|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
128891107|NCT03523728|463898835|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
128891108|NCT03523728|463898831|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
128891109|NCT03523728|463898832|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
128891110|NCT03523728|463898833|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
128891111|NCT03523728|463898834|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
128891112|NCT03523728|463898835|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
128891113|NCT03523728|463898831|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
128891114|NCT03523728|463898832|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
128891115|NCT03523728|463898833|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
128891116|NCT03523728|463898834|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
128891117|NCT03523728|463898835|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
128891118|NCT00621751|463898836|FG000|Overall Study|Adverse Event|0|||
128891119|NCT00621751|463898837|FG001|Overall Study|Adverse Event|1|||
128891120|NCT00419120|463898839|FG000|Long Term Follow up Period|study ongoing|10|||
128891121|NCT00710879|463898840|FG000|Overall Study|Lost to Follow-up|2|||
128891122|NCT00710879|463898841|FG001|Overall Study|Lost to Follow-up|1|||
128891123|NCT00710879|463898840|FG000|Overall Study|Protocol Violation|0|||
128891124|NCT00710879|463898841|FG001|Overall Study|Protocol Violation|3|||
128891125|NCT01809132|463898842|FG000|Overall Study|Withdrawal by Subject|0|||
129215195|NCT02628873|465089462|FG001|Second Test (1 Hour)|Physician Decision|0|||
128891126|NCT01809132|463898843|FG001|Overall Study|Withdrawal by Subject|0|||
128891127|NCT01809132|463898844|FG002|Overall Study|Withdrawal by Subject|1|||
128891128|NCT03349775|463898845|FG000|Overall Study|Side Effects|1|||
128891129|NCT03349775|463898846|FG001|Overall Study|Side Effects|2|||
128891130|NCT03349775|463898845|FG000|Overall Study|Withdrawal by Subject|1|||
128891131|NCT03349775|463898846|FG001|Overall Study|Withdrawal by Subject|1|||
128891132|NCT03349775|463898845|FG000|Overall Study|No primary outcome measurements|0|||
128891133|NCT03349775|463898846|FG001|Overall Study|No primary outcome measurements|1|||
128891134|NCT01516970|463898847|FG000|Overall Study|Lost to Follow-up|7|||
128891135|NCT01516970|463898848|FG001|Overall Study|Lost to Follow-up|8|||
128891136|NCT01516970|463898847|FG000|Overall Study|Adverse Event|1|||
128891137|NCT01516970|463898848|FG001|Overall Study|Adverse Event|5|||
128891138|NCT01516970|463898847|FG000|Overall Study|Withdrawal by Subject|1|||
128891139|NCT01516970|463898848|FG001|Overall Study|Withdrawal by Subject|1|||
128891140|NCT01516970|463898847|FG000|Overall Study|Other|9|||
128891141|NCT01516970|463898848|FG001|Overall Study|Other|7|||
128891142|NCT00434421|463898849|FG000|Overall Study|Withdrawal by Subject|1|||
128891143|NCT00434421|463898849|FG000|Overall Study|Non-compliance with study treatment|1|||
128891144|NCT01756040|463898850|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
128891145|NCT01756040|463898850|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
128891146|NCT01756040|463898850|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
128891147|NCT01205438|463898851|FG000|Overall Study|Adverse Event|19|||
128891148|NCT01205438|463898852|FG001|Overall Study|Adverse Event|17|||
128891149|NCT01205438|463898853|FG002|Overall Study|Adverse Event|24|||
128891150|NCT01205438|463898851|FG000|Overall Study|Death|1|||
128891151|NCT01205438|463898852|FG001|Overall Study|Death|1|||
128891152|NCT01205438|463898853|FG002|Overall Study|Death|3|||
128891153|NCT01205438|463898851|FG000|Overall Study|Entry Criteria Not Met|16|||
128891154|NCT01205438|463898852|FG001|Overall Study|Entry Criteria Not Met|15|||
128891155|NCT01205438|463898853|FG002|Overall Study|Entry Criteria Not Met|13|||
128891156|NCT01205438|463898851|FG000|Overall Study|Lack of Efficacy|14|||
128891157|NCT01205438|463898852|FG001|Overall Study|Lack of Efficacy|11|||
128891158|NCT01205438|463898853|FG002|Overall Study|Lack of Efficacy|14|||
128891159|NCT01205438|463898851|FG000|Overall Study|Lost to Follow-up|6|||
128891160|NCT01205438|463898852|FG001|Overall Study|Lost to Follow-up|7|||
128891161|NCT01205438|463898853|FG002|Overall Study|Lost to Follow-up|8|||
128891162|NCT01205438|463898851|FG000|Overall Study|Withdrawal by Subject|19|||
128891163|NCT01205438|463898852|FG001|Overall Study|Withdrawal by Subject|25|||
128891164|NCT01205438|463898853|FG002|Overall Study|Withdrawal by Subject|19|||
128891165|NCT01205438|463898851|FG000|Overall Study|Physician Decision|0|||
128891166|NCT01205438|463898852|FG001|Overall Study|Physician Decision|3|||
128891167|NCT01205438|463898853|FG002|Overall Study|Physician Decision|2|||
128891168|NCT01205438|463898851|FG000|Overall Study|Protocol Violation|2|||
128891169|NCT01205438|463898852|FG001|Overall Study|Protocol Violation|7|||
128891170|NCT01205438|463898853|FG002|Overall Study|Protocol Violation|4|||
128891171|NCT01205438|463898851|FG000|Overall Study|Sponsor Decision|0|||
128891172|NCT01205438|463898852|FG001|Overall Study|Sponsor Decision|1|||
128891173|NCT01205438|463898853|FG002|Overall Study|Sponsor Decision|1|||
128891174|NCT03631667|463898858|FG000|Overall Study|Withdrawal by Subject|3|||
128891175|NCT00892177|463898859|FG000|Phase II|Ineligible|0|||
128891176|NCT00892177|463898860|FG001|Phase II|Ineligible|0|||
128891177|NCT00892177|463898861|FG002|Phase II|Ineligible|0|||
128891178|NCT00892177|463898862|FG003|Phase II|Ineligible|0|||
128891179|NCT00892177|463898863|FG004|Phase II|Ineligible|1|||
128891180|NCT00892177|463898864|FG005|Phase II|Ineligible|1|||
128891181|NCT00892177|463898859|FG000|Phase II|Withdrawal by Subject|0|||
128891182|NCT00892177|463898860|FG001|Phase II|Withdrawal by Subject|0|||
128891183|NCT00892177|463898861|FG002|Phase II|Withdrawal by Subject|0|||
128891184|NCT00892177|463898862|FG003|Phase II|Withdrawal by Subject|0|||
128891185|NCT00892177|463898863|FG004|Phase II|Withdrawal by Subject|4|||
129020650|NCT00904215|464367140|FG000|Overall Study|Protocol Violation|10|||
129020651|NCT00904215|464367140|FG000|Overall Study|Lost to Follow-up|63|||
129020652|NCT00904215|464367140|FG000|Overall Study|Withdrawal by Subject|9|||
129020653|NCT00904215|464367140|FG000|Overall Study|Other|28|||
129020654|NCT00244764|464367141|FG000|Overall Study|Adverse Event|37|||
129020655|NCT00244764|464367141|FG000|Overall Study|Lost to Follow-up|23|||
128688803|NCT00809354|463161500|FG007|Overall Study|Withdrawn due to pregnancy|0|||
128688804|NCT00809354|463161501|FG008|Overall Study|Withdrawn due to pregnancy|0|||
128688805|NCT00809354|463161502|FG009|Overall Study|Withdrawn due to pregnancy|0|||
128891186|NCT00892177|463898864|FG005|Phase II|Withdrawal by Subject|1|||
128891187|NCT01446016|463898867|FG000|Overall Study|Lost to Follow-up|3|||
128891188|NCT01446016|463898867|FG000|Overall Study|Withdrawal by Subject|1|||
128688806|NCT00809354|463161493|FG000|Overall Study|Randomized but not Treated|3|||
128891189|NCT01446016|463898867|FG000|Overall Study|Toxicity|3|||
128891190|NCT01087957|463898877|FG000|Overall Study|Death|2|||
128891191|NCT01087957|463898878|FG001|Overall Study|Death|2|||
128891192|NCT01087957|463898877|FG000|Overall Study|Lost to Follow-up|3|||
128891193|NCT01087957|463898878|FG001|Overall Study|Lost to Follow-up|4|||
128891194|NCT01087957|463898877|FG000|Overall Study|Protocol Violation|13|||
128891195|NCT01087957|463898878|FG001|Overall Study|Protocol Violation|25|||
128891196|NCT01087957|463898877|FG000|Overall Study|Withdrawal by Subject|18|||
128891197|NCT01087957|463898878|FG001|Overall Study|Withdrawal by Subject|15|||
128891198|NCT01087957|463898877|FG000|Overall Study|Physician Decision|5|||
128891199|NCT01087957|463898878|FG001|Overall Study|Physician Decision|9|||
128891200|NCT01186939|463898879|FG000|Overall Study|Death|7|||
128891201|NCT01186939|463898879|FG000|Overall Study|Withdrawal by Subject|2|||
128891202|NCT01186939|463898879|FG000|Overall Study|No longer receiving clinical benefit|17|||
128891203|NCT01186939|463898879|FG000|Overall Study|Program closed|5|||
128891204|NCT01186939|463898879|FG000|Overall Study|Sponsor decision|4|||
128891205|NCT01186939|463898879|FG000|Overall Study|Started additional treatment|1|||
128891206|NCT01186939|463898879|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
128891207|NCT01186939|463898879|FG000|Overall Study|Myocardial infarction|1|||
128891208|NCT01186939|463898879|FG000|Overall Study|Bone marrow transplant|1|||
128891209|NCT01186939|463898879|FG000|Overall Study|Transformation to AML|1|||
128891210|NCT00616434|463898880|FG000|Overall Study|Adverse Event|5|||
128891211|NCT00616434|463898881|FG001|Overall Study|Adverse Event|2|||
128891212|NCT00616434|463898880|FG000|Overall Study|Physician Decision|0|||
128891213|NCT00616434|463898881|FG001|Overall Study|Physician Decision|4|||
128891214|NCT00616434|463898880|FG000|Overall Study|Withdrawal by Subject|1|||
128891215|NCT00616434|463898881|FG001|Overall Study|Withdrawal by Subject|1|||
128891216|NCT00616434|463898880|FG000|Overall Study|Protocol deviation|0|||
128891217|NCT00616434|463898881|FG001|Overall Study|Protocol deviation|1|||
128891218|NCT01754857|463898882|FG000|Overall Study|Adverse Event|7|||
128891219|NCT01754857|463898882|FG000|Overall Study|Disease progression|3|||
128891220|NCT01754857|463898882|FG000|Overall Study|Physician Decision|2|||
128891221|NCT01754857|463898882|FG000|Overall Study|Withdrawal by Subject|3|||
128891222|NCT01754857|463898882|FG000|Overall Study|other complicating disease|1|||
128891223|NCT01754857|463898882|FG000|Overall Study|ineligible to continue onto maintenance|1|||
128891224|NCT01754857|463898882|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
128891225|NCT01754857|463898882|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
128891226|NCT01509079|463898883|FG000|Overall Study|Lack of Efficacy|0|||
128891227|NCT01509079|463898884|FG001|Overall Study|Lack of Efficacy|2|||
128891228|NCT01509079|463898883|FG000|Overall Study|started an excluded medication|0|||
128891229|NCT01509079|463898884|FG001|Overall Study|started an excluded medication|1|||
128891230|NCT01399190|463898887|FG000|Overall Study|Not Eligible for Final Analysis|5|||
128891231|NCT01399190|463898887|FG000|Overall Study|Adverse Event|8|||
128891232|NCT01399190|463898887|FG000|Overall Study|Participant's Request|5|||
128891233|NCT01399190|463898887|FG000|Overall Study|Physician Decision|2|||
128891234|NCT00436618|463898891|FG000|Overall Study|Withdrawal by Subject|5|||
128891235|NCT00436618|463898892|FG001|Overall Study|Withdrawal by Subject|8|||
128891236|NCT00436618|463898893|FG002|Overall Study|Withdrawal by Subject|11|||
128688807|NCT00809354|463161494|FG001|Overall Study|Randomized but not Treated|1|||
128891237|NCT00436618|463898891|FG000|Overall Study|Adverse Event|8|||
128891238|NCT00436618|463898892|FG001|Overall Study|Adverse Event|8|||
128891239|NCT00436618|463898893|FG002|Overall Study|Adverse Event|9|||
128891240|NCT00436618|463898891|FG000|Overall Study|Alternate Treatment|3|||
128891241|NCT00436618|463898892|FG001|Overall Study|Alternate Treatment|4|||
129020656|NCT00244764|464367141|FG000|Overall Study|Withdrawal by Subject|12|||
129020657|NCT00244764|464367141|FG000|Overall Study|Disease Progression|13|||
129020658|NCT00244764|464367141|FG000|Overall Study|Protocol Violation|2|||
129020659|NCT00244764|464367141|FG000|Overall Study|Death|1|||
129020660|NCT00244764|464367141|FG000|Overall Study|Off Study Medication for >21 Days|1|||
129020661|NCT00244764|464367141|FG000|Overall Study|Declining Performance Status|1|||
129020662|NCT00244764|464367141|FG000|Overall Study|Participant was Hospitalized until Death|1|||
129020663|NCT00244764|464367141|FG000|Overall Study|Primary Investigator Discretion|2|||
129020664|NCT00244764|464367141|FG000|Overall Study|Sponsor Terminated Study|2|||
129020665|NCT00244764|464367141|FG000|Overall Study|Developed Secondary Malignancy|1|||
129020666|NCT03872128|464367144|FG000|Overall Study|Dropped out before treatment|1|||
129020667|NCT03872128|464367145|FG001|Overall Study|Dropped out before treatment|0|||
129020668|NCT03872128|464367146|FG002|Overall Study|Dropped out before treatment|4|||
129020669|NCT03872128|464367144|FG000|Overall Study|Lost to Follow-up|2|||
129020670|NCT03872128|464367145|FG001|Overall Study|Lost to Follow-up|5|||
129020671|NCT03872128|464367146|FG002|Overall Study|Lost to Follow-up|8|||
129020672|NCT03285594|464367148|FG000|Overall Study|At the Participant's Own Request|10|||
129020673|NCT03285594|464367149|FG001|Overall Study|At the Participant's Own Request|5|||
129020674|NCT03285594|464367150|FG002|Overall Study|At the Participant's Own Request|21|||
129020675|NCT03285594|464367148|FG000|Overall Study|Adverse Event|2|||
129020676|NCT03285594|464367149|FG001|Overall Study|Adverse Event|2|||
129020677|NCT03285594|464367150|FG002|Overall Study|Adverse Event|6|||
129020678|NCT03285594|464367148|FG000|Overall Study|Poor Compliance to Protocol|0|||
128688808|NCT00809354|463161495|FG002|Overall Study|Randomized but not Treated|6|||
129020679|NCT03285594|464367149|FG001|Overall Study|Poor Compliance to Protocol|0|||
129020680|NCT03285594|464367150|FG002|Overall Study|Poor Compliance to Protocol|1|||
128688809|NCT00809354|463161496|FG003|Overall Study|Randomized but not Treated|0|||
128688810|NCT00809354|463161497|FG004|Overall Study|Randomized but not Treated|5|||
128891242|NCT00436618|463898893|FG002|Overall Study|Alternate Treatment|12|||
128688811|NCT00809354|463161498|FG005|Overall Study|Randomized but not Treated|0|||
128688812|NCT00809354|463161499|FG006|Overall Study|Randomized but not Treated|1|||
128688813|NCT00809354|463161500|FG007|Overall Study|Randomized but not Treated|1|||
128688814|NCT00809354|463161501|FG008|Overall Study|Randomized but not Treated|2|||
128688815|NCT00809354|463161502|FG009|Overall Study|Randomized but not Treated|1|||
128688816|NCT00809354|463161493|FG000|Overall Study|Death|0|||
128688817|NCT00809354|463161494|FG001|Overall Study|Death|0|||
128688818|NCT00809354|463161495|FG002|Overall Study|Death|0|||
128688819|NCT00809354|463161496|FG003|Overall Study|Death|0|||
128688820|NCT00809354|463161497|FG004|Overall Study|Death|0|||
128688821|NCT00809354|463161498|FG005|Overall Study|Death|0|||
128688822|NCT00809354|463161499|FG006|Overall Study|Death|0|||
128688823|NCT00809354|463161500|FG007|Overall Study|Death|1|||
128688824|NCT00809354|463161501|FG008|Overall Study|Death|0|||
128688825|NCT00809354|463161502|FG009|Overall Study|Death|0|||
128688826|NCT03257371|463161503|FG000|Overall Study|Lost to Follow-up|1|||
128688827|NCT02477839|463161504|FG000|Overall Study|Adverse Event|0|||
128688828|NCT02477839|463161505|FG001|Overall Study|Adverse Event|1|||
128688829|NCT02477839|463161504|FG000|Overall Study|Protocol Violation|0|||
128688830|NCT02477839|463161505|FG001|Overall Study|Protocol Violation|2|||
128688831|NCT02477839|463161504|FG000|Overall Study|Withdrawal by Subject|3|||
128688832|NCT02477839|463161505|FG001|Overall Study|Withdrawal by Subject|3|||
128688833|NCT02477839|463161504|FG000|Overall Study|Participant had PGS during V6|0|||
128688834|NCT02477839|463161505|FG001|Overall Study|Participant had PGS during V6|1|||
128688835|NCT02477839|463161504|FG000|Overall Study|Parents decided to stop medication|0|||
128688836|NCT02477839|463161505|FG001|Overall Study|Parents decided to stop medication|1|||
128688837|NCT02477839|463161504|FG000|Overall Study|Lack of tolerability|0|||
128688838|NCT02477839|463161505|FG001|Overall Study|Lack of tolerability|1|||
128688839|NCT02477839|463161504|FG000|Overall Study|Exclusion criterion|0|||
128688840|NCT02477839|463161505|FG001|Overall Study|Exclusion criterion|1|||
128688841|NCT03198078|463161510|FG000|Overall Study|Adverse Event|0|||
128688842|NCT03198078|463161511|FG001|Overall Study|Adverse Event|1|||
128688843|NCT03198078|463161512|FG002|Overall Study|Adverse Event|2|||
128688844|NCT03198078|463161510|FG000|Overall Study|Lack of Efficacy|0|||
128688845|NCT03198078|463161511|FG001|Overall Study|Lack of Efficacy|0|||
128688846|NCT03198078|463161512|FG002|Overall Study|Lack of Efficacy|3|||
128688847|NCT03198078|463161510|FG000|Overall Study|Lost to Follow-up|1|||
128688848|NCT03198078|463161511|FG001|Overall Study|Lost to Follow-up|0|||
128688849|NCT03198078|463161512|FG002|Overall Study|Lost to Follow-up|0|||
128688850|NCT03198078|463161510|FG000|Overall Study|Pregnancy|0|||
128688851|NCT03198078|463161511|FG001|Overall Study|Pregnancy|1|||
128688852|NCT03198078|463161512|FG002|Overall Study|Pregnancy|0|||
128688853|NCT03198078|463161510|FG000|Overall Study|Withdrawal by Subject|1|||
128688854|NCT03198078|463161511|FG001|Overall Study|Withdrawal by Subject|0|||
128688855|NCT03198078|463161512|FG002|Overall Study|Withdrawal by Subject|2|||
128688856|NCT03198078|463161510|FG000|Overall Study|Withdrawal by Caregiver|1|||
128688857|NCT03198078|463161511|FG001|Overall Study|Withdrawal by Caregiver|3|||
128688858|NCT03198078|463161512|FG002|Overall Study|Withdrawal by Caregiver|5|||
128688859|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
128688860|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
128688861|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
128688862|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
128688863|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
128688864|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
128688865|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
128688866|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
128688867|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
128688868|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
128688869|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
128688870|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
128764076|NCT01852058|463425904|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
128764077|NCT01852058|463425905|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
128891243|NCT00436618|463898891|FG000|Overall Study|Other Medical Problems|3|||
128891244|NCT00436618|463898892|FG001|Overall Study|Other Medical Problems|1|||
128891245|NCT00436618|463898893|FG002|Overall Study|Other Medical Problems|7|||
128688871|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
128764078|NCT01852058|463425906|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128891246|NCT00436618|463898891|FG000|Overall Study|Death|4|||
128688872|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
128688873|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
128688874|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
129110589|NCT01261390|464699883|FG002|Overall Study|Significant Concurrent Illness|1|||
128688875|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
128688876|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
128688877|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
129020681|NCT03285594|464367148|FG000|Overall Study|Lost to Follow-up|0|||
129020682|NCT03285594|464367149|FG001|Overall Study|Lost to Follow-up|0|||
128688878|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
128688879|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
128688880|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
128688881|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
128688882|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
128688883|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Death|2|||
128688884|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Death|1|||
128688885|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Death|0|||
128688886|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Death|0|||
128688887|NCT02607930|463161513|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
128688888|NCT02607930|463161514|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
128688889|NCT02607930|463161515|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
128688890|NCT02607930|463161516|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
128688891|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
128688892|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
128688893|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
128688894|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
128688895|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
128688896|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
128688897|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
128688898|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
128688899|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
128688900|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
128688901|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
128688902|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
128688903|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
128688904|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
128688905|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
128688906|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
128688907|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
128688908|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
128688909|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
128688910|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
128688911|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
128688912|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
128688913|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
128688914|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
128688915|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
128688916|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
128688917|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
128688918|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
128688919|NCT02607930|463161513|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
128688920|NCT02607930|463161514|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
128688921|NCT02607930|463161515|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
128688922|NCT02607930|463161516|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
128688923|NCT00057876|463161517|FG000|Overall Study|Adverse Event|8|||
128688924|NCT00057876|463161518|FG001|Overall Study|Adverse Event|8|||
128688925|NCT00057876|463161517|FG000|Overall Study|Death|2|||
128688926|NCT00057876|463161518|FG001|Overall Study|Death|1|||
128688927|NCT00057876|463161517|FG000|Overall Study|Withdrawal by Subject|5|||
128688928|NCT00057876|463161518|FG001|Overall Study|Withdrawal by Subject|6|||
128688929|NCT00057876|463161517|FG000|Overall Study|Lack of Efficacy|10|||
128688930|NCT00057876|463161518|FG001|Overall Study|Lack of Efficacy|8|||
128688931|NCT00057876|463161517|FG000|Overall Study|Ineligible|1|||
129020683|NCT03285594|464367150|FG002|Overall Study|Lost to Follow-up|1|||
129020684|NCT03285594|464367148|FG000|Overall Study|Reason Not Specified|3|||
129020685|NCT03285594|464367149|FG001|Overall Study|Reason Not Specified|4|||
129020686|NCT03285594|464367150|FG002|Overall Study|Reason Not Specified|8|||
128688932|NCT00057876|463161518|FG001|Overall Study|Ineligible|2|||
128688933|NCT00057876|463161517|FG000|Overall Study|other reason|2|||
128688934|NCT00057876|463161518|FG001|Overall Study|other reason|2|||
128688935|NCT00057876|463161517|FG000|Overall Study|other complicating disease|1|||
128688936|NCT00057876|463161518|FG001|Overall Study|other complicating disease|0|||
128688937|NCT00437320|463161520|FG000|Overall Study|Participant request|2|||
128688938|NCT00437320|463161521|FG001|Overall Study|Participant request|1|||
128688939|NCT00437320|463161522|FG002|Overall Study|Participant request|4|||
128688940|NCT01649804|463161531|FG000|Overall Study|Administrative/Other|8|||
129020687|NCT02648438|464367154|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129020688|NCT02648438|464367155|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
128891247|NCT00436618|463898892|FG001|Overall Study|Death|2|||
128891248|NCT00436618|463898893|FG002|Overall Study|Death|3|||
128891249|NCT00436618|463898891|FG000|Overall Study|New Primary or Other Reasons|6|||
128891250|NCT00436618|463898892|FG001|Overall Study|New Primary or Other Reasons|2|||
128891251|NCT00436618|463898893|FG002|Overall Study|New Primary or Other Reasons|12|||
128891252|NCT00436618|463898891|FG000|Overall Study|Still on treatment|1|||
128891253|NCT00436618|463898892|FG001|Overall Study|Still on treatment|2|||
128891254|NCT00436618|463898893|FG002|Overall Study|Still on treatment|7|||
128891255|NCT00698204|463898894|FG000|Overall Study|Withdrawal by Subject|1|||
128891256|NCT00698204|463898895|FG001|Overall Study|Withdrawal by Subject|0|||
128891257|NCT03083847|463898896|FG000|Main|Physician Decision|0|||
128891258|NCT03083847|463898897|FG001|Main|Physician Decision|0|||
128891259|NCT03083847|463898898|FG002|Main|Physician Decision|0|||
128891260|NCT03083847|463898899|FG003|Main|Physician Decision|0|||
128891261|NCT03083847|463898900|FG004|Main|Physician Decision|0|||
128891262|NCT03083847|463898901|FG005|Main|Physician Decision|1|||
128891263|NCT03083847|463898902|FG006|Main|Physician Decision|0|||
128891264|NCT03083847|463898903|FG007|Main|Physician Decision|0|||
128891265|NCT03083847|463898904|FG008|Main|Physician Decision|0|||
128891266|NCT03083847|463898905|FG009|Main|Physician Decision|0|||
128891267|NCT03083847|463898896|FG000|Main|Pregnancy|0|||
128891268|NCT03083847|463898897|FG001|Main|Pregnancy|0|||
128891269|NCT03083847|463898898|FG002|Main|Pregnancy|0|||
128891270|NCT03083847|463898899|FG003|Main|Pregnancy|0|||
128891271|NCT03083847|463898900|FG004|Main|Pregnancy|0|||
129215196|NCT02195518|465089463|FG000|Overall Study|Adverse Event|1|||
129215197|NCT02195518|465089463|FG000|Overall Study|Protocol Violation|4|||
128891272|NCT03083847|463898901|FG005|Main|Pregnancy|0|||
128891273|NCT03083847|463898902|FG006|Main|Pregnancy|0|||
128891274|NCT03083847|463898903|FG007|Main|Pregnancy|1|||
128891275|NCT03083847|463898904|FG008|Main|Pregnancy|0|||
128891276|NCT03083847|463898905|FG009|Main|Pregnancy|0|||
128891277|NCT03083847|463898896|FG000|Main|Adverse Event|0|||
128891278|NCT03083847|463898897|FG001|Main|Adverse Event|0|||
128891279|NCT03083847|463898898|FG002|Main|Adverse Event|0|||
128891280|NCT03083847|463898899|FG003|Main|Adverse Event|0|||
128891281|NCT03083847|463898900|FG004|Main|Adverse Event|0|||
128891282|NCT03083847|463898901|FG005|Main|Adverse Event|0|||
128891283|NCT03083847|463898902|FG006|Main|Adverse Event|0|||
128891284|NCT03083847|463898903|FG007|Main|Adverse Event|2|||
128891285|NCT03083847|463898904|FG008|Main|Adverse Event|0|||
128891286|NCT03083847|463898905|FG009|Main|Adverse Event|0|||
128891287|NCT03083847|463898896|FG000|Main|Withdrawal by Subject|0|||
128891288|NCT03083847|463898897|FG001|Main|Withdrawal by Subject|0|||
128891289|NCT03083847|463898898|FG002|Main|Withdrawal by Subject|0|||
128891290|NCT03083847|463898899|FG003|Main|Withdrawal by Subject|0|||
128891291|NCT03083847|463898900|FG004|Main|Withdrawal by Subject|0|||
128891292|NCT03083847|463898901|FG005|Main|Withdrawal by Subject|0|||
128891293|NCT03083847|463898902|FG006|Main|Withdrawal by Subject|1|||
128891294|NCT03083847|463898903|FG007|Main|Withdrawal by Subject|1|||
128891295|NCT03083847|463898904|FG008|Main|Withdrawal by Subject|0|||
128891296|NCT03083847|463898905|FG009|Main|Withdrawal by Subject|0|||
128891297|NCT01949155|463898907|FG000|Overall Study|Lost to Follow-up|1|||
128891298|NCT01949155|463898908|FG001|Overall Study|Lost to Follow-up|0|||
128891299|NCT01949155|463898907|FG000|Overall Study|Protocol Violation|1|||
128891300|NCT01949155|463898908|FG001|Overall Study|Protocol Violation|0|||
128891301|NCT00314249|463898909|FG000|Overall Study|Adverse Event|73|||
128891302|NCT00314249|463898910|FG001|Overall Study|Adverse Event|94|||
128891303|NCT00314249|463898909|FG000|Overall Study|Lack of Efficacy|33|||
128891304|NCT00314249|463898910|FG001|Overall Study|Lack of Efficacy|24|||
128891305|NCT00314249|463898909|FG000|Overall Study|Withdrawal by Subject|21|||
128891306|NCT00314249|463898910|FG001|Overall Study|Withdrawal by Subject|28|||
128891307|NCT00314249|463898909|FG000|Overall Study|Lost to Follow-up|15|||
128891308|NCT00314249|463898910|FG001|Overall Study|Lost to Follow-up|9|||
128891309|NCT00314249|463898909|FG000|Overall Study|Physician Decision|1|||
128891310|NCT00314249|463898910|FG001|Overall Study|Physician Decision|1|||
128891311|NCT00314249|463898909|FG000|Overall Study|Withdrawn for other reasons|4|||
128891312|NCT00314249|463898910|FG001|Overall Study|Withdrawn for other reasons|1|||
128891313|NCT00314249|463898909|FG000|Overall Study|Non-Compliant|5|||
128891314|NCT00314249|463898910|FG001|Overall Study|Non-Compliant|6|||
128688941|NCT02448810|463161533|FG000|Overall Study|Adverse Event|0|||
128891315|NCT00210184|463898911|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
128688942|NCT02448810|463161534|FG001|Overall Study|Adverse Event|0|||
128688943|NCT02448810|463161535|FG002|Overall Study|Adverse Event|1|||
128891316|NCT01118325|463898914|FG000|Overall Study|Adverse Event|1|||
128891317|NCT01118325|463898915|FG001|Overall Study|Adverse Event|0|||
128891318|NCT01118325|463898916|FG002|Overall Study|Adverse Event|1|||
128891319|NCT00975715|463898917|FG000|Titration Period|Adverse Event|6|||
128891320|NCT00975715|463898918|FG001|Titration Period|Adverse Event|0|||
128891321|NCT00975715|463898917|FG000|Titration Period|Protocol Violation|1|||
128891322|NCT00975715|463898918|FG001|Titration Period|Protocol Violation|0|||
128891323|NCT00975715|463898917|FG000|Maintenance Period|Adverse Event|2|||
128891324|NCT00975715|463898918|FG001|Maintenance Period|Adverse Event|1|||
129020689|NCT02648438|464367156|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129020690|NCT02648438|464367154|FG000|Overall Study|Protocol Violation|2|||
129020691|NCT02648438|464367155|FG001|Overall Study|Protocol Violation|0|||
129020692|NCT02648438|464367156|FG002|Overall Study|Protocol Violation|0|||
129020693|NCT02648438|464367154|FG000|Overall Study|Withdrawal by Subject|1|||
129020694|NCT02648438|464367155|FG001|Overall Study|Withdrawal by Subject|1|||
128688944|NCT02448810|463161536|FG003|Overall Study|Adverse Event|0|||
128688945|NCT02448810|463161537|FG004|Overall Study|Adverse Event|0|||
128688946|NCT02448810|463161538|FG005|Overall Study|Adverse Event|0|||
128688947|NCT02448810|463161539|FG006|Overall Study|Adverse Event|0|||
128688948|NCT02448810|463161540|FG007|Overall Study|Adverse Event|0|||
128688949|NCT02448810|463161533|FG000|Overall Study|Withdrawal by Subject|0|||
128688950|NCT02448810|463161534|FG001|Overall Study|Withdrawal by Subject|0|||
128688951|NCT02448810|463161535|FG002|Overall Study|Withdrawal by Subject|1|||
128688952|NCT02448810|463161536|FG003|Overall Study|Withdrawal by Subject|0|||
128688953|NCT02448810|463161537|FG004|Overall Study|Withdrawal by Subject|3|||
128688954|NCT02448810|463161538|FG005|Overall Study|Withdrawal by Subject|5|||
128688955|NCT02448810|463161539|FG006|Overall Study|Withdrawal by Subject|0|||
128688956|NCT02448810|463161540|FG007|Overall Study|Withdrawal by Subject|2|||
128688957|NCT02448810|463161533|FG000|Overall Study|Other (study terminated by sponsor)|0|||
128688958|NCT02448810|463161534|FG001|Overall Study|Other (study terminated by sponsor)|0|||
128688959|NCT02448810|463161535|FG002|Overall Study|Other (study terminated by sponsor)|0|||
128688960|NCT02448810|463161536|FG003|Overall Study|Other (study terminated by sponsor)|0|||
128688961|NCT02448810|463161537|FG004|Overall Study|Other (study terminated by sponsor)|4|||
128688962|NCT02448810|463161538|FG005|Overall Study|Other (study terminated by sponsor)|2|||
128688963|NCT02448810|463161539|FG006|Overall Study|Other (study terminated by sponsor)|2|||
128688964|NCT02448810|463161540|FG007|Overall Study|Other (study terminated by sponsor)|1|||
128688965|NCT02448810|463161533|FG000|Overall Study|Death|1|||
128688966|NCT02448810|463161534|FG001|Overall Study|Death|0|||
128688967|NCT02448810|463161535|FG002|Overall Study|Death|1|||
128688968|NCT02448810|463161536|FG003|Overall Study|Death|0|||
128688969|NCT02448810|463161537|FG004|Overall Study|Death|1|||
128688970|NCT02448810|463161538|FG005|Overall Study|Death|0|||
128688971|NCT02448810|463161539|FG006|Overall Study|Death|0|||
128688972|NCT02448810|463161540|FG007|Overall Study|Death|0|||
128688973|NCT02448810|463161533|FG000|Overall Study|Other (Progressive disease)|2|||
128688974|NCT02448810|463161534|FG001|Overall Study|Other (Progressive disease)|2|||
128688975|NCT02448810|463161535|FG002|Overall Study|Other (Progressive disease)|0|||
128688976|NCT02448810|463161536|FG003|Overall Study|Other (Progressive disease)|3|||
128688977|NCT02448810|463161537|FG004|Overall Study|Other (Progressive disease)|23|||
128688978|NCT02448810|463161538|FG005|Overall Study|Other (Progressive disease)|9|||
128688979|NCT02448810|463161539|FG006|Overall Study|Other (Progressive disease)|14|||
128688980|NCT02448810|463161540|FG007|Overall Study|Other (Progressive disease)|5|||
128688981|NCT02448810|463161533|FG000|Overall Study|Lost to Follow-up|0|||
128688982|NCT02448810|463161534|FG001|Overall Study|Lost to Follow-up|1|||
128688983|NCT02448810|463161535|FG002|Overall Study|Lost to Follow-up|0|||
128688984|NCT02448810|463161536|FG003|Overall Study|Lost to Follow-up|0|||
128688985|NCT02448810|463161537|FG004|Overall Study|Lost to Follow-up|0|||
128688986|NCT02448810|463161538|FG005|Overall Study|Lost to Follow-up|0|||
128688987|NCT02448810|463161539|FG006|Overall Study|Lost to Follow-up|0|||
128688988|NCT02448810|463161540|FG007|Overall Study|Lost to Follow-up|0|||
128688989|NCT02448810|463161533|FG000|Overall Study|Other (unspecified)|0|||
128688990|NCT02448810|463161534|FG001|Overall Study|Other (unspecified)|0|||
128688991|NCT02448810|463161535|FG002|Overall Study|Other (unspecified)|0|||
128688992|NCT02448810|463161536|FG003|Overall Study|Other (unspecified)|0|||
128688993|NCT02448810|463161537|FG004|Overall Study|Other (unspecified)|0|||
128688994|NCT02448810|463161538|FG005|Overall Study|Other (unspecified)|0|||
128688995|NCT02448810|463161539|FG006|Overall Study|Other (unspecified)|2|||
128688996|NCT02448810|463161540|FG007|Overall Study|Other (unspecified)|0|||
128688997|NCT01916967|463161546|FG000|Overall Study|Adverse Event|0|||
128688998|NCT01916967|463161547|FG001|Overall Study|Adverse Event|0|||
128688999|NCT01916967|463161548|FG002|Overall Study|Adverse Event|2|||
128689000|NCT01916967|463161546|FG000|Overall Study|Lack of Efficacy|0|||
129020695|NCT02648438|464367156|FG002|Overall Study|Withdrawal by Subject|0|||
129020696|NCT02258074|464367157|FG000|Overall Study|Withdrawal by Subject|1|||
129020697|NCT02258074|464367158|FG001|Overall Study|Withdrawal by Subject|0|||
129020698|NCT02258074|464367159|FG002|Overall Study|Withdrawal by Subject|0|||
128689001|NCT01916967|463161547|FG001|Overall Study|Lack of Efficacy|0|||
128689002|NCT01916967|463161548|FG002|Overall Study|Lack of Efficacy|6|||
128689003|NCT01916967|463161546|FG000|Overall Study|Physician Decision|0|||
128689004|NCT01916967|463161547|FG001|Overall Study|Physician Decision|0|||
128689005|NCT01916967|463161548|FG002|Overall Study|Physician Decision|1|||
128689006|NCT01916967|463161546|FG000|Overall Study|Protocol Violation|0|||
129020699|NCT02258074|464367160|FG003|Overall Study|Withdrawal by Subject|0|||
128689007|NCT01916967|463161547|FG001|Overall Study|Protocol Violation|1|||
128689008|NCT01916967|463161548|FG002|Overall Study|Protocol Violation|0|||
128689009|NCT00568685|463161555|FG000|Overall Study|Adverse Event|2|||
128689010|NCT00568685|463161556|FG001|Overall Study|Adverse Event|3|||
129020700|NCT02739997|464367161|FG000|Overall Study|Death|1|||
128891325|NCT01674712|463898925|FG000|Overall Study|Adverse Event|5|||
128891326|NCT01674712|463898926|FG001|Overall Study|Adverse Event|6|||
128891327|NCT01674712|463898927|FG002|Overall Study|Adverse Event|3|||
128891328|NCT01674712|463898928|FG003|Overall Study|Adverse Event|4|||
128891329|NCT01674712|463898929|FG004|Overall Study|Adverse Event|6|||
128891330|NCT01674712|463898925|FG000|Overall Study|Lost to Follow-up|1|||
128891331|NCT01674712|463898926|FG001|Overall Study|Lost to Follow-up|0|||
128891332|NCT01674712|463898927|FG002|Overall Study|Lost to Follow-up|0|||
128891333|NCT01674712|463898928|FG003|Overall Study|Lost to Follow-up|0|||
128891334|NCT01674712|463898929|FG004|Overall Study|Lost to Follow-up|0|||
128891335|NCT01674712|463898925|FG000|Overall Study|Protocol Violation|2|||
128891336|NCT01674712|463898926|FG001|Overall Study|Protocol Violation|0|||
128891337|NCT01674712|463898927|FG002|Overall Study|Protocol Violation|0|||
128891338|NCT01674712|463898928|FG003|Overall Study|Protocol Violation|0|||
128891339|NCT01674712|463898929|FG004|Overall Study|Protocol Violation|0|||
128891340|NCT01674712|463898925|FG000|Overall Study|Withdrawal by Subject|2|||
128891341|NCT01674712|463898926|FG001|Overall Study|Withdrawal by Subject|2|||
128891342|NCT01674712|463898927|FG002|Overall Study|Withdrawal by Subject|5|||
128891343|NCT01674712|463898928|FG003|Overall Study|Withdrawal by Subject|4|||
128891344|NCT01674712|463898929|FG004|Overall Study|Withdrawal by Subject|3|||
128891345|NCT01674712|463898925|FG000|Overall Study|Administrative|0|||
128891346|NCT01674712|463898926|FG001|Overall Study|Administrative|1|||
128891347|NCT01674712|463898927|FG002|Overall Study|Administrative|0|||
128891348|NCT01674712|463898928|FG003|Overall Study|Administrative|0|||
128891349|NCT01674712|463898929|FG004|Overall Study|Administrative|1|||
128891350|NCT01674712|463898925|FG000|Overall Study|Lack of Efficacy|0|||
128891351|NCT01674712|463898926|FG001|Overall Study|Lack of Efficacy|0|||
128891352|NCT01674712|463898927|FG002|Overall Study|Lack of Efficacy|1|||
128891353|NCT01674712|463898928|FG003|Overall Study|Lack of Efficacy|0|||
128891354|NCT01674712|463898929|FG004|Overall Study|Lack of Efficacy|1|||
128891355|NCT00874770|463898930|FG000|Overall Study|Lack of Efficacy|2|||
128891356|NCT00874770|463898931|FG001|Overall Study|Lack of Efficacy|0|||
128891357|NCT00874770|463898932|FG002|Overall Study|Lack of Efficacy|0|||
128891358|NCT00874770|463898933|FG003|Overall Study|Lack of Efficacy|2|||
128891359|NCT00874770|463898930|FG000|Overall Study|Adverse Event|1|||
128891360|NCT00874770|463898931|FG001|Overall Study|Adverse Event|1|||
128891361|NCT00874770|463898932|FG002|Overall Study|Adverse Event|4|||
128891362|NCT00874770|463898933|FG003|Overall Study|Adverse Event|2|||
128891363|NCT00874770|463898930|FG000|Overall Study|Lost to Follow-up|1|||
128891364|NCT00874770|463898931|FG001|Overall Study|Lost to Follow-up|0|||
128891365|NCT00874770|463898932|FG002|Overall Study|Lost to Follow-up|0|||
128891366|NCT00874770|463898933|FG003|Overall Study|Lost to Follow-up|1|||
128891367|NCT00874770|463898930|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
128891368|NCT00874770|463898931|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
128891369|NCT00874770|463898932|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
128891370|NCT00874770|463898933|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
128891371|NCT05395104|463898934|FG000|Overall Study|Met Liver Stopping Criteria|1|||
128891372|NCT05395104|463898934|FG000|Overall Study|Withdrawal by Subject|1|||
128891373|NCT03974334|463898935|FG000|Overall Study|Lost to Follow-up|1|||
128891374|NCT00024167|463898936|FG000|Overall Study|Death|53|||
128891375|NCT00024167|463898937|FG001|Overall Study|Death|47|||
128891376|NCT01379573|463898952|FG000|Overall Study|Lost to Follow-up|1|||
129020701|NCT02739997|464367161|FG000|Overall Study|Withdrawal by Subject|1|||
129020702|NCT03552393|464367164|FG000|Core Period|Kidney Transplant|1|||
129020703|NCT03552393|464367164|FG000|Core Period|Prohibited Medication|1|||
129020704|NCT03552393|464367164|FG000|Safety Extension Period|Kidney Transplant|4|||
129020705|NCT02601625|464367165|FG000|Overall Study|Lost to Follow-up|0|||
129020706|NCT02601625|464367166|FG001|Overall Study|Lost to Follow-up|0|||
129020707|NCT02601625|464367167|FG002|Overall Study|Lost to Follow-up|1|||
129020708|NCT02601625|464367168|FG003|Overall Study|Lost to Follow-up|1|||
129020709|NCT00359281|464367170|FG000|Overall Study|Adverse Event|1|||
129020710|NCT00359281|464367171|FG001|Overall Study|Adverse Event|0|||
129020711|NCT00359281|464367172|FG002|Overall Study|Adverse Event|0|||
129020712|NCT00359281|464367173|FG003|Overall Study|Adverse Event|0|||
129020713|NCT00359281|464367174|FG004|Overall Study|Adverse Event|0|||
129020714|NCT00359281|464367175|FG005|Overall Study|Adverse Event|0|||
129020715|NCT00359281|464367176|FG006|Overall Study|Adverse Event|1|||
128891377|NCT01379573|463898952|FG000|Overall Study|Screen Failure|10|||
129020716|NCT00359281|464367177|FG007|Overall Study|Adverse Event|0|||
129020717|NCT00359281|464367178|FG008|Overall Study|Adverse Event|0|||
129020718|NCT00359281|464367170|FG000|Overall Study|Withdrawal by Subject|0|||
128891378|NCT00962390|463898953|FG000|Overall Study|Adverse Event|0|||
128891379|NCT00962390|463898954|FG001|Overall Study|Adverse Event|0|||
128891380|NCT00962390|463898955|FG002|Overall Study|Adverse Event|3|||
128891381|NCT00962390|463898956|FG003|Overall Study|Adverse Event|1|||
128891382|NCT00962390|463898953|FG000|Overall Study|Lost to Follow-up|2|||
129020719|NCT00359281|464367171|FG001|Overall Study|Withdrawal by Subject|0|||
128891383|NCT00962390|463898954|FG001|Overall Study|Lost to Follow-up|2|||
128891384|NCT00962390|463898955|FG002|Overall Study|Lost to Follow-up|0|||
128891385|NCT00962390|463898956|FG003|Overall Study|Lost to Follow-up|0|||
128891386|NCT00962390|463898953|FG000|Overall Study|Protocol Violation|1|||
128891387|NCT00962390|463898954|FG001|Overall Study|Protocol Violation|0|||
128891388|NCT00962390|463898955|FG002|Overall Study|Protocol Violation|0|||
128891389|NCT00962390|463898956|FG003|Overall Study|Protocol Violation|0|||
128891390|NCT00962390|463898953|FG000|Overall Study|Withdrawal by Subject|1|||
128891391|NCT00962390|463898954|FG001|Overall Study|Withdrawal by Subject|1|||
128891392|NCT00962390|463898955|FG002|Overall Study|Withdrawal by Subject|1|||
128891393|NCT00962390|463898956|FG003|Overall Study|Withdrawal by Subject|0|||
128891394|NCT02613884|463898957|FG000|Overall Study|Death|1|||
128891395|NCT02613884|463898957|FG000|Overall Study|Lost to Follow-up|1|||
128891396|NCT00770770|463898958|FG000|Overall Study|Lost to Follow-up|1|||
128891397|NCT00770770|463898959|FG001|Overall Study|Lost to Follow-up|0|||
128891398|NCT00770770|463898958|FG000|Overall Study|Withdrawal by Subject|1|||
128891399|NCT00770770|463898959|FG001|Overall Study|Withdrawal by Subject|0|||
128891400|NCT00770770|463898958|FG000|Overall Study|Death|0|||
128891401|NCT00770770|463898959|FG001|Overall Study|Death|1|||
128891402|NCT00770770|463898958|FG000|Overall Study|Study Terminated|8|||
128891403|NCT00770770|463898959|FG001|Overall Study|Study Terminated|0|||
128891404|NCT00711529|463898970|FG000|Overall Study|Protocol Violation|2|||
128891405|NCT00711529|463898971|FG001|Overall Study|Protocol Violation|0|||
128891406|NCT00711529|463898970|FG000|Overall Study|Withdrawal by Subject|2|||
128891407|NCT00711529|463898971|FG001|Overall Study|Withdrawal by Subject|6|||
128891408|NCT01829425|463898973|FG000|Overall Study|Withdrawal by Subject|4|||
128891409|NCT01829425|463898974|FG001|Overall Study|Withdrawal by Subject|3|||
128891410|NCT01829425|463898973|FG000|Overall Study|Lost to Follow-up|2|||
128891411|NCT01829425|463898974|FG001|Overall Study|Lost to Follow-up|1|||
128891412|NCT04178967|463898975|FG000|Induction Period|Adverse Event|4|||
128891413|NCT04178967|463898976|FG001|Induction Period|Adverse Event|6|||
128891414|NCT04178967|463898977|FG002|Induction Period|Adverse Event|0|||
128891415|NCT04178967|463898978|FG003|Induction Period|Adverse Event|0|||
128891416|NCT04178967|463898979|FG004|Induction Period|Adverse Event|0|||
128891417|NCT04178967|463898980|FG005|Induction Period|Adverse Event|0|||
128891418|NCT04178967|463898981|FG006|Induction Period|Adverse Event|0|||
128891419|NCT04178967|463898982|FG007|Induction Period|Adverse Event|0|||
128891420|NCT04178967|463898983|FG008|Induction Period|Adverse Event|0|||
128891421|NCT04178967|463898984|FG009|Induction Period|Adverse Event|0|||
128891422|NCT04178967|463898985|FG010|Induction Period|Adverse Event|0|||
128891423|NCT04178967|463898975|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
128891424|NCT04178967|463898976|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
128891425|NCT04178967|463898977|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
128891426|NCT04178967|463898978|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
128891427|NCT04178967|463898979|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
128891428|NCT04178967|463898980|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
128891429|NCT04178967|463898981|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
128891430|NCT04178967|463898982|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
128891431|NCT04178967|463898983|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
128891432|NCT04178967|463898984|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
128891433|NCT04178967|463898985|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
128891434|NCT04178967|463898975|FG000|Induction Period|Lack of Efficacy|4|||
128891435|NCT04178967|463898976|FG001|Induction Period|Lack of Efficacy|1|||
128891436|NCT04178967|463898977|FG002|Induction Period|Lack of Efficacy|0|||
129020720|NCT00359281|464367172|FG002|Overall Study|Withdrawal by Subject|0|||
129020721|NCT00359281|464367173|FG003|Overall Study|Withdrawal by Subject|0|||
129020722|NCT00359281|464367174|FG004|Overall Study|Withdrawal by Subject|0|||
129020723|NCT00359281|464367175|FG005|Overall Study|Withdrawal by Subject|0|||
129020724|NCT00359281|464367176|FG006|Overall Study|Withdrawal by Subject|1|||
129020725|NCT00359281|464367177|FG007|Overall Study|Withdrawal by Subject|0|||
129020726|NCT00359281|464367178|FG008|Overall Study|Withdrawal by Subject|0|||
129020727|NCT00840411|464367182|FG000|First Intervention|Adverse Event|1|||
129020728|NCT00840411|464367183|FG001|First Intervention|Adverse Event|0|||
129020729|NCT00840411|464367182|FG000|Washout|Withdrawal by Subject|1|||
129020730|NCT00840411|464367183|FG001|Washout|Withdrawal by Subject|0|||
129020731|NCT02674152|464368552|FG000|Overall Study|Personal Reasons|1|||
129020732|NCT02674152|464368553|FG001|Overall Study|Personal Reasons|0|||
129020733|NCT02674152|464368554|FG002|Overall Study|Personal Reasons|0|||
129020734|NCT02674152|464368555|FG003|Overall Study|Personal Reasons|1|||
128891437|NCT04178967|463898978|FG003|Induction Period|Lack of Efficacy|0|||
128891438|NCT04178967|463898979|FG004|Induction Period|Lack of Efficacy|0|||
128891439|NCT04178967|463898980|FG005|Induction Period|Lack of Efficacy|0|||
128891440|NCT04178967|463898981|FG006|Induction Period|Lack of Efficacy|0|||
128891441|NCT04178967|463898982|FG007|Induction Period|Lack of Efficacy|0|||
128891442|NCT04178967|463898983|FG008|Induction Period|Lack of Efficacy|0|||
129020735|NCT02674152|464368556|FG004|Overall Study|Personal Reasons|1|||
128891443|NCT04178967|463898984|FG009|Induction Period|Lack of Efficacy|0|||
128891444|NCT04178967|463898985|FG010|Induction Period|Lack of Efficacy|0|||
128891445|NCT04178967|463898975|FG000|Induction Period|Protocol Violation|0|||
129020736|NCT02674152|464368552|FG000|Overall Study|Other adverse event or clinical progression|0|||
129020737|NCT02674152|464368553|FG001|Overall Study|Other adverse event or clinical progression|1|||
128891446|NCT04178967|463898976|FG001|Induction Period|Protocol Violation|6|||
128891447|NCT04178967|463898977|FG002|Induction Period|Protocol Violation|0|||
128891448|NCT04178967|463898978|FG003|Induction Period|Protocol Violation|0|||
128891449|NCT04178967|463898979|FG004|Induction Period|Protocol Violation|0|||
128891450|NCT04178967|463898980|FG005|Induction Period|Protocol Violation|0|||
128891451|NCT04178967|463898981|FG006|Induction Period|Protocol Violation|0|||
128891452|NCT04178967|463898982|FG007|Induction Period|Protocol Violation|0|||
128891453|NCT04178967|463898983|FG008|Induction Period|Protocol Violation|0|||
128891454|NCT04178967|463898984|FG009|Induction Period|Protocol Violation|0|||
128891455|NCT04178967|463898985|FG010|Induction Period|Protocol Violation|0|||
128891456|NCT04178967|463898975|FG000|Induction Period|Withdrawal by Subject|6|||
128891457|NCT04178967|463898976|FG001|Induction Period|Withdrawal by Subject|4|||
128891458|NCT04178967|463898977|FG002|Induction Period|Withdrawal by Subject|0|||
128891459|NCT04178967|463898978|FG003|Induction Period|Withdrawal by Subject|0|||
128891460|NCT04178967|463898979|FG004|Induction Period|Withdrawal by Subject|0|||
128891461|NCT04178967|463898980|FG005|Induction Period|Withdrawal by Subject|0|||
128891462|NCT04178967|463898981|FG006|Induction Period|Withdrawal by Subject|0|||
128891463|NCT04178967|463898982|FG007|Induction Period|Withdrawal by Subject|0|||
128891464|NCT04178967|463898983|FG008|Induction Period|Withdrawal by Subject|0|||
128891465|NCT04178967|463898984|FG009|Induction Period|Withdrawal by Subject|0|||
128891466|NCT04178967|463898985|FG010|Induction Period|Withdrawal by Subject|0|||
128891467|NCT04178967|463898975|FG000|Induction Period|Lost to Follow-up|2|||
128891468|NCT04178967|463898976|FG001|Induction Period|Lost to Follow-up|0|||
128891469|NCT04178967|463898977|FG002|Induction Period|Lost to Follow-up|0|||
128891470|NCT04178967|463898978|FG003|Induction Period|Lost to Follow-up|0|||
128891471|NCT04178967|463898979|FG004|Induction Period|Lost to Follow-up|0|||
128891472|NCT04178967|463898980|FG005|Induction Period|Lost to Follow-up|0|||
128891473|NCT04178967|463898981|FG006|Induction Period|Lost to Follow-up|0|||
128891474|NCT04178967|463898982|FG007|Induction Period|Lost to Follow-up|0|||
128891475|NCT04178967|463898983|FG008|Induction Period|Lost to Follow-up|0|||
128891476|NCT04178967|463898984|FG009|Induction Period|Lost to Follow-up|0|||
128891477|NCT04178967|463898985|FG010|Induction Period|Lost to Follow-up|0|||
128891478|NCT04178967|463898975|FG000|Induction Period|Participant Missed Study Visits|0|||
128891479|NCT04178967|463898976|FG001|Induction Period|Participant Missed Study Visits|1|||
128891480|NCT04178967|463898977|FG002|Induction Period|Participant Missed Study Visits|0|||
128891481|NCT04178967|463898978|FG003|Induction Period|Participant Missed Study Visits|0|||
128891482|NCT04178967|463898979|FG004|Induction Period|Participant Missed Study Visits|0|||
128891483|NCT04178967|463898980|FG005|Induction Period|Participant Missed Study Visits|0|||
128891484|NCT04178967|463898981|FG006|Induction Period|Participant Missed Study Visits|0|||
128891485|NCT04178967|463898982|FG007|Induction Period|Participant Missed Study Visits|0|||
128891486|NCT04178967|463898983|FG008|Induction Period|Participant Missed Study Visits|0|||
128891487|NCT04178967|463898984|FG009|Induction Period|Participant Missed Study Visits|0|||
128891488|NCT04178967|463898985|FG010|Induction Period|Participant Missed Study Visits|0|||
128891489|NCT04178967|463898975|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891490|NCT04178967|463898976|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891491|NCT04178967|463898977|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891492|NCT04178967|463898978|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891493|NCT04178967|463898979|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891494|NCT04178967|463898980|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
128891495|NCT04178967|463898981|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
128891496|NCT04178967|463898982|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
128891497|NCT04178967|463898983|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891498|NCT04178967|463898984|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891499|NCT04178967|463898985|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
128891500|NCT04178967|463898975|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891501|NCT04178967|463898976|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891502|NCT04178967|463898977|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891503|NCT04178967|463898978|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891504|NCT04178967|463898979|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891505|NCT04178967|463898980|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
128891506|NCT04178967|463898981|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891507|NCT04178967|463898982|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891508|NCT04178967|463898983|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891509|NCT04178967|463898984|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891510|NCT04178967|463898985|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
128891511|NCT04178967|463898975|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891512|NCT04178967|463898976|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891513|NCT04178967|463898977|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891514|NCT04178967|463898978|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
128891515|NCT04178967|463898979|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891516|NCT04178967|463898980|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891517|NCT04178967|463898981|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891518|NCT04178967|463898982|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891519|NCT04178967|463898983|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891520|NCT04178967|463898984|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891521|NCT04178967|463898985|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128891522|NCT04178967|463898975|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891523|NCT04178967|463898976|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891524|NCT04178967|463898977|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891525|NCT04178967|463898978|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891526|NCT04178967|463898979|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891527|NCT04178967|463898980|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891528|NCT04178967|463898981|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
128891529|NCT04178967|463898982|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891530|NCT04178967|463898983|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891531|NCT04178967|463898984|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891532|NCT04178967|463898985|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
128891533|NCT04178967|463898975|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891534|NCT04178967|463898976|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891535|NCT04178967|463898977|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891536|NCT04178967|463898978|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891537|NCT04178967|463898979|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
128891538|NCT04178967|463898980|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
128891539|NCT04178967|463898981|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891540|NCT04178967|463898982|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
128891541|NCT04178967|463898983|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891542|NCT04178967|463898984|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891543|NCT04178967|463898985|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
128891544|NCT04178967|463898975|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
128891545|NCT04178967|463898976|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
128891546|NCT04178967|463898977|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
128891547|NCT04178967|463898978|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
128891548|NCT04178967|463898979|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
128891549|NCT04178967|463898980|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
128891550|NCT04178967|463898981|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
128891551|NCT04178967|463898982|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
128891552|NCT04178967|463898983|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
128891553|NCT04178967|463898984|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
128891554|NCT04178967|463898985|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
128891555|NCT04178967|463898975|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
128891556|NCT04178967|463898976|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
128891557|NCT04178967|463898977|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
128891558|NCT04178967|463898978|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
128891559|NCT04178967|463898979|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
128891560|NCT04178967|463898980|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
128891561|NCT04178967|463898981|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
128891562|NCT04178967|463898982|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
128891563|NCT04178967|463898983|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
128891564|NCT04178967|463898984|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
128891565|NCT04178967|463898985|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129020738|NCT02674152|464368554|FG002|Overall Study|Other adverse event or clinical progression|0|||
129020739|NCT02674152|464368555|FG003|Overall Study|Other adverse event or clinical progression|3|||
129020740|NCT02674152|464368556|FG004|Overall Study|Other adverse event or clinical progression|0|||
129020741|NCT02674152|464368552|FG000|Overall Study|Dose-limiting toxicity|0|||
129020742|NCT02674152|464368553|FG001|Overall Study|Dose-limiting toxicity|0|||
129020743|NCT02674152|464368554|FG002|Overall Study|Dose-limiting toxicity|0|||
129020744|NCT02674152|464368555|FG003|Overall Study|Dose-limiting toxicity|0|||
129020745|NCT02674152|464368556|FG004|Overall Study|Dose-limiting toxicity|1|||
129020746|NCT02674152|464368552|FG000|Overall Study|Progressive Disease|2|||
129020747|NCT02674152|464368553|FG001|Overall Study|Progressive Disease|1|||
129020748|NCT02674152|464368554|FG002|Overall Study|Progressive Disease|1|||
129020749|NCT02674152|464368555|FG003|Overall Study|Progressive Disease|13|||
129020750|NCT02674152|464368556|FG004|Overall Study|Progressive Disease|2|||
129020751|NCT02674152|464368552|FG000|Overall Study|Adverse Event|0|||
129020752|NCT02674152|464368553|FG001|Overall Study|Adverse Event|0|||
129020753|NCT02674152|464368554|FG002|Overall Study|Adverse Event|1|||
129020754|NCT02674152|464368555|FG003|Overall Study|Adverse Event|0|||
128891566|NCT04178967|463898975|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891567|NCT04178967|463898976|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891568|NCT04178967|463898977|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891569|NCT04178967|463898978|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891570|NCT04178967|463898979|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891571|NCT04178967|463898980|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891572|NCT04178967|463898981|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891573|NCT04178967|463898982|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891574|NCT04178967|463898983|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
128891575|NCT04178967|463898984|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
128891576|NCT04178967|463898985|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
128891577|NCT04178967|463898975|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891578|NCT04178967|463898976|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891579|NCT04178967|463898977|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891580|NCT04178967|463898978|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891581|NCT04178967|463898979|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891582|NCT04178967|463898980|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891583|NCT04178967|463898981|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891584|NCT04178967|463898982|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128891585|NCT04178967|463898983|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
128891586|NCT04178967|463898984|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
128891587|NCT04178967|463898985|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
128891588|NCT04178967|463898975|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891589|NCT04178967|463898976|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891590|NCT04178967|463898977|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891591|NCT04178967|463898978|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891592|NCT04178967|463898979|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891593|NCT04178967|463898980|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891594|NCT04178967|463898981|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891595|NCT04178967|463898982|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891596|NCT04178967|463898983|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891597|NCT04178967|463898984|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
128891598|NCT04178967|463898985|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128891599|NCT04178967|463898975|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891600|NCT04178967|463898976|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891601|NCT04178967|463898977|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891602|NCT04178967|463898978|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891603|NCT04178967|463898979|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891604|NCT04178967|463898980|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891605|NCT04178967|463898981|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891606|NCT04178967|463898982|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128891607|NCT04178967|463898983|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
128891608|NCT04178967|463898984|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
128891609|NCT04178967|463898985|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
128891610|NCT04178967|463898975|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891611|NCT04178967|463898976|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891612|NCT04178967|463898977|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891613|NCT04178967|463898978|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891614|NCT04178967|463898979|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891615|NCT04178967|463898980|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891616|NCT04178967|463898981|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891617|NCT04178967|463898982|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891618|NCT04178967|463898983|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129020755|NCT02674152|464368556|FG004|Overall Study|Adverse Event|1|||
129020756|NCT04934722|464368557|FG000|Overall Study|Death|4|||
129020757|NCT04934722|464368558|FG001|Overall Study|Death|3|||
129020758|NCT04934722|464368557|FG000|Overall Study|Participants Ongoing|88|||
129020759|NCT04934722|464368558|FG001|Overall Study|Participants Ongoing|91|||
129020760|NCT05265624|464368559|FG000|Overall Study|Lost to Follow-up|3|||
129020761|NCT05265624|464368560|FG001|Overall Study|Lost to Follow-up|0|||
129020762|NCT05265624|464368559|FG000|Overall Study|Withdrawal by Subject|1|||
129020763|NCT05265624|464368560|FG001|Overall Study|Withdrawal by Subject|0|||
129020764|NCT03697109|464368561|FG000|Open-label (OL) Phase|Adverse Event|24|||
128891619|NCT04178967|463898984|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
128891620|NCT04178967|463898985|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
128891621|NCT04178967|463898975|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129020765|NCT03697109|464368562|FG001|Open-label (OL) Phase|Adverse Event|0|||
129020766|NCT03697109|464368563|FG002|Open-label (OL) Phase|Adverse Event|0|||
128891622|NCT04178967|463898976|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891623|NCT04178967|463898977|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891624|NCT04178967|463898978|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891625|NCT04178967|463898979|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891626|NCT04178967|463898980|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891627|NCT04178967|463898981|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891628|NCT04178967|463898982|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891629|NCT04178967|463898983|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891630|NCT04178967|463898984|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
128891631|NCT04178967|463898985|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
128891632|NCT01230554|463898986|FG000|Overall Study|Lost to Follow-up|2|||
128891633|NCT01230554|463898986|FG000|Overall Study|Inability to maintain visit schedule|1|||
128891634|NCT03933397|463898987|FG000|Overall Study|No emergency department visit|65|||
128891635|NCT03933397|463898988|FG001|Overall Study|No emergency department visit|71|||
128891636|NCT03933397|463898987|FG000|Overall Study|Missed emergency department visit|25|||
128891637|NCT03933397|463898988|FG001|Overall Study|Missed emergency department visit|30|||
128891638|NCT03933397|463898987|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
128891639|NCT03933397|463898988|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
128891640|NCT03933397|463898987|FG000|Overall Study|Withdrawal by Subject|1|||
128891641|NCT03933397|463898988|FG001|Overall Study|Withdrawal by Subject|0|||
128891642|NCT03933397|463898987|FG000|Overall Study|Physician Decision|1|||
128891643|NCT03933397|463898988|FG001|Overall Study|Physician Decision|1|||
128891644|NCT03933397|463898987|FG000|Overall Study|missing pain score|1|||
128891645|NCT03933397|463898988|FG001|Overall Study|missing pain score|1|||
128891646|NCT03933397|463898987|FG000|Overall Study|Confirmed COVID-19|1|||
128891647|NCT03933397|463898988|FG001|Overall Study|Confirmed COVID-19|2|||
128891648|NCT00685685|463898989|FG000|Washout Period of 7 Days|Adverse Event|2|||
128891649|NCT00685685|463898990|FG001|Washout Period of 7 Days|Adverse Event|0|||
128891650|NCT00685685|463898989|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
128891651|NCT00685685|463898990|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
128891652|NCT04029116|463898991|FG000|Overall Study|Adverse Event|0|||
128891653|NCT04029116|463898992|FG001|Overall Study|Adverse Event|2|||
128891654|NCT04029116|463898991|FG000|Overall Study|Lost to Follow-up|3|||
128891655|NCT04029116|463898992|FG001|Overall Study|Lost to Follow-up|5|||
128891656|NCT04029116|463898991|FG000|Overall Study|Physician Decision|2|||
128891657|NCT04029116|463898992|FG001|Overall Study|Physician Decision|0|||
128891658|NCT04029116|463898991|FG000|Overall Study|Pregnancy|1|||
128891659|NCT04029116|463898992|FG001|Overall Study|Pregnancy|2|||
128891660|NCT04029116|463898991|FG000|Overall Study|Withdrawal by Subject|4|||
128891661|NCT04029116|463898992|FG001|Overall Study|Withdrawal by Subject|6|||
128891662|NCT04029116|463898991|FG000|Overall Study|Other|2|||
129110590|NCT01261390|464699884|FG003|Overall Study|Significant Concurrent Illness|0|||
129110591|NCT01261390|464699881|FG000|Overall Study|Dissatisfaction with Treatment|2|||
129110592|NCT01261390|464699882|FG001|Overall Study|Dissatisfaction with Treatment|1|||
129110593|NCT01261390|464699883|FG002|Overall Study|Dissatisfaction with Treatment|1|||
129110594|NCT01261390|464699884|FG003|Overall Study|Dissatisfaction with Treatment|2|||
129110595|NCT01261390|464699881|FG000|Overall Study|Relocation|0|||
129110596|NCT01261390|464699882|FG001|Overall Study|Relocation|1|||
129110597|NCT01261390|464699883|FG002|Overall Study|Relocation|0|||
129110598|NCT01261390|464699884|FG003|Overall Study|Relocation|0|||
129110599|NCT01261390|464699881|FG000|Overall Study|Loss of Interest in the Study|3|||
129110600|NCT01261390|464699882|FG001|Overall Study|Loss of Interest in the Study|1|||
129110601|NCT01261390|464699883|FG002|Overall Study|Loss of Interest in the Study|0|||
129110602|NCT01261390|464699884|FG003|Overall Study|Loss of Interest in the Study|0|||
129110603|NCT01261390|464699881|FG000|Overall Study|Lost to Follow-up|1|||
129110604|NCT01261390|464699882|FG001|Overall Study|Lost to Follow-up|6|||
129110605|NCT01261390|464699883|FG002|Overall Study|Lost to Follow-up|5|||
129110606|NCT01261390|464699884|FG003|Overall Study|Lost to Follow-up|6|||
129110607|NCT00977613|464699890|FG000|Overall Study|Lost to Follow-up|16|||
129110608|NCT01497067|464699891|FG000|Overall Study|Lost to Follow-up|56|||
129110609|NCT01497067|464699891|FG000|Overall Study|Adverse Event|3|||
129110610|NCT01497067|464699891|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
129110611|NCT01497067|464699891|FG000|Overall Study|Other|13|||
129215198|NCT02195518|465089463|FG000|Overall Study|Pregnancy|2|||
128891663|NCT04029116|463898992|FG001|Overall Study|Other|1|||
128891664|NCT04513665|463898993|FG000|Overall Study|Adverse Event|2|||
128891665|NCT04513665|463898994|FG001|Overall Study|Adverse Event|0|||
128891666|NCT04513665|463898993|FG000|Overall Study|Lack of Efficacy|14|||
128891667|NCT04513665|463898994|FG001|Overall Study|Lack of Efficacy|0|||
128891668|NCT02608879|463898996|FG000|Overall Study|Lost to Follow-up|1|||
128891669|NCT02608879|463898997|FG001|Overall Study|Lost to Follow-up|0|||
128891670|NCT02608879|463898998|FG002|Overall Study|Lost to Follow-up|0|||
128891671|NCT02608879|463898996|FG000|Overall Study|Did not meet continuation criteria|0|||
129110612|NCT04346199|464699894|FG000|Overall Study|Death|8|||
128891672|NCT02608879|463898997|FG001|Overall Study|Did not meet continuation criteria|0|||
128891673|NCT02608879|463898998|FG002|Overall Study|Did not meet continuation criteria|3|||
128891674|NCT05586269|463900166|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
128891675|NCT05586269|463900167|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
128891676|NCT05586269|463900168|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
128891677|NCT05586269|463900169|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
128891678|NCT05586269|463900166|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
128891679|NCT05586269|463900167|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
128891680|NCT05586269|463900168|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
128891681|NCT05586269|463900169|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
128891682|NCT00523718|463900171|FG000|Overall Study|Withdrawal by Subject|1|||
128891683|NCT00523718|463900172|FG001|Overall Study|Withdrawal by Subject|0|||
128891684|NCT00523718|463900171|FG000|Overall Study|Protocol Violation|2|||
128891685|NCT00523718|463900172|FG001|Overall Study|Protocol Violation|0|||
128891686|NCT00332839|463900173|FG000|Core (Months 0 - 12)|Administrative problems|1|||
128891687|NCT00332839|463900174|FG001|Core (Months 0 - 12)|Administrative problems|1|||
128891688|NCT00332839|463900173|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
128891689|NCT00332839|463900174|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
128891690|NCT00332839|463900173|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
128891691|NCT00332839|463900174|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
128891692|NCT00332839|463900173|FG000|Core (Months 0 - 12)|Adverse Event|5|||
128891693|NCT00332839|463900174|FG001|Core (Months 0 - 12)|Adverse Event|15|||
128891694|NCT00332839|463900173|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
128891695|NCT00332839|463900174|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
128891696|NCT00332839|463900173|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
128891697|NCT00332839|463900174|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
128891698|NCT00332839|463900173|FG000|Follow-up (Months 12 - 60)|Death|1|||
128891699|NCT00332839|463900174|FG001|Follow-up (Months 12 - 60)|Death|1|||
128891700|NCT03441334|463900176|FG000|Overall Study|Withdrawal by Subject|1|||
128891701|NCT03441334|463900177|FG001|Overall Study|Withdrawal by Subject|0|||
128891702|NCT00088907|463900178|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
128891703|NCT00088907|463900179|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
128891704|NCT00088907|463900178|FG000|Randomized Study (Step 1)|Adverse Event|14|||
128891705|NCT00088907|463900179|FG001|Randomized Study (Step 1)|Adverse Event|19|||
128891706|NCT00088907|463900178|FG000|Randomized Study (Step 1)|Death|11|||
128891707|NCT00088907|463900179|FG001|Randomized Study (Step 1)|Death|12|||
128891708|NCT00088907|463900178|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
128891709|NCT00088907|463900179|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
128891710|NCT00088907|463900178|FG000|Randomized Study (Step 1)|complicating disease|3|||
128891711|NCT00088907|463900179|FG001|Randomized Study (Step 1)|complicating disease|1|||
128891712|NCT00088907|463900178|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
128891713|NCT00088907|463900179|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
128891714|NCT00088907|463900178|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
128891715|NCT00088907|463900179|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
128891716|NCT00088907|463900178|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
128891717|NCT00088907|463900179|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
128891718|NCT00088907|463900178|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
128891719|NCT00088907|463900179|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
128891720|NCT00088907|463900178|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
128891721|NCT00088907|463900179|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
128891722|NCT00088907|463900178|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
128891723|NCT00088907|463900179|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
128891724|NCT03426787|463900184|FG000|Overall Study|Withdrawal by Subject|6|||
128891725|NCT03426787|463900184|FG000|Overall Study|Lost to Follow-up|7|||
128891726|NCT03426787|463900184|FG000|Overall Study|Unrelated to intervention death|1|||
128891727|NCT00395863|463900185|FG000|Overall Study|Patients did not complete both exams|2|||
128891728|NCT00395863|463900186|FG001|Overall Study|Patients did not complete both exams|3|||
128891729|NCT02592551|463900189|FG000|Overall Study|Not evaluable|1|||
128891730|NCT02592551|463900190|FG001|Overall Study|Not evaluable|3|||
129020767|NCT03697109|464368561|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
129020768|NCT03697109|464368562|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
129020769|NCT03697109|464368563|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
129020770|NCT03697109|464368561|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
128891731|NCT02592551|463900191|FG002|Overall Study|Not evaluable|0|||
128891732|NCT01876251|463900192|FG000|Overall Study|Clinical progression|1|||
128891733|NCT01876251|463900193|FG001|Overall Study|Clinical progression|0|||
128891734|NCT01876251|463900194|FG002|Overall Study|Clinical progression|0|||
128891735|NCT01876251|463900192|FG000|Overall Study|Death|2|||
128891736|NCT01876251|463900193|FG001|Overall Study|Death|0|||
128891737|NCT01876251|463900194|FG002|Overall Study|Death|1|||
128891738|NCT01876251|463900192|FG000|Overall Study|Participant started new treatment|1|||
128891739|NCT01876251|463900193|FG001|Overall Study|Participant started new treatment|0|||
128891740|NCT01876251|463900194|FG002|Overall Study|Participant started new treatment|1|||
128891741|NCT01876251|463900192|FG000|Overall Study|Participant refused further follow-up|0|||
128891742|NCT01876251|463900193|FG001|Overall Study|Participant refused further follow-up|0|||
128891743|NCT01876251|463900194|FG002|Overall Study|Participant refused further follow-up|1|||
128891744|NCT01876251|463900192|FG000|Overall Study|Study terminated|1|||
128891745|NCT01876251|463900193|FG001|Overall Study|Study terminated|0|||
128891746|NCT01876251|463900194|FG002|Overall Study|Study terminated|0|||
128891747|NCT01876251|463900192|FG000|Overall Study|Objective progression or relapse|10|||
128891748|NCT01876251|463900193|FG001|Overall Study|Objective progression or relapse|3|||
128891749|NCT01876251|463900194|FG002|Overall Study|Objective progression or relapse|8|||
128891750|NCT00268437|463900195|FG000|Overall Study|Ineligible|1|||
128891751|NCT02020863|463900199|FG000|Overall Study|Discovery of Metastatic disease|4|||
128891752|NCT02020863|463900199|FG000|Overall Study|Team chose not to place an a line|1|||
128891753|NCT00907257|463900203|FG000|Overall Study|Adverse Event|0|||
128891754|NCT00907257|463900204|FG001|Overall Study|Adverse Event|4|||
128891755|NCT00907257|463900203|FG000|Overall Study|Protocol Violation|1|||
128891756|NCT00907257|463900204|FG001|Overall Study|Protocol Violation|2|||
128891757|NCT00907257|463900203|FG000|Overall Study|Lost to Follow-up|3|||
128891758|NCT00907257|463900204|FG001|Overall Study|Lost to Follow-up|3|||
128891759|NCT00907257|463900203|FG000|Overall Study|Withdrawal by Subject|1|||
128891760|NCT00907257|463900204|FG001|Overall Study|Withdrawal by Subject|2|||
128891761|NCT00907257|463900203|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
128891762|NCT00907257|463900204|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
128891763|NCT00907257|463900203|FG000|Overall Study|Moved|1|||
128891764|NCT00907257|463900204|FG001|Overall Study|Moved|0|||
128891765|NCT00907257|463900203|FG000|Overall Study|Personal Reasons|6|||
128891766|NCT00907257|463900204|FG001|Overall Study|Personal Reasons|1|||
128891767|NCT00283049|463900205|FG000|Overall Study|Adverse Event|6|||
128891768|NCT00283049|463900206|FG001|Overall Study|Adverse Event|1|||
128891769|NCT00283049|463900207|FG002|Overall Study|Adverse Event|4|||
128891770|NCT00283049|463900205|FG000|Overall Study|Protocol Violation|3|||
128891771|NCT00283049|463900206|FG001|Overall Study|Protocol Violation|0|||
128891772|NCT00283049|463900207|FG002|Overall Study|Protocol Violation|3|||
128891773|NCT00283049|463900205|FG000|Overall Study|Death|1|||
128891774|NCT00283049|463900206|FG001|Overall Study|Death|1|||
128891775|NCT00283049|463900207|FG002|Overall Study|Death|1|||
128891776|NCT00283049|463900205|FG000|Overall Study|Lack of Efficacy|0|||
128891777|NCT00283049|463900206|FG001|Overall Study|Lack of Efficacy|1|||
128891778|NCT00283049|463900207|FG002|Overall Study|Lack of Efficacy|1|||
128891779|NCT00283049|463900205|FG000|Overall Study|Lost to Follow-up|4|||
128891780|NCT00283049|463900206|FG001|Overall Study|Lost to Follow-up|2|||
128891781|NCT00283049|463900207|FG002|Overall Study|Lost to Follow-up|5|||
128891782|NCT00283049|463900205|FG000|Overall Study|Withdrawal by Subject|26|||
128891783|NCT00283049|463900206|FG001|Overall Study|Withdrawal by Subject|24|||
128891784|NCT00283049|463900207|FG002|Overall Study|Withdrawal by Subject|19|||
128891785|NCT00283049|463900205|FG000|Overall Study|Discontinuation of Study|18|||
128891786|NCT00283049|463900206|FG001|Overall Study|Discontinuation of Study|16|||
128891787|NCT00283049|463900207|FG002|Overall Study|Discontinuation of Study|20|||
128891788|NCT00283049|463900205|FG000|Overall Study|No longer requires study treatment|0|||
128891789|NCT00283049|463900206|FG001|Overall Study|No longer requires study treatment|0|||
128891790|NCT00283049|463900207|FG002|Overall Study|No longer requires study treatment|1|||
128891791|NCT01628107|463900208|FG000|Overall Study|Withdrawal by Subject|17|||
128891792|NCT01628107|463900208|FG000|Overall Study|Lost to Follow-up|4|||
128891793|NCT01628107|463900208|FG000|Overall Study|Adverse Event|33|||
128891794|NCT01628107|463900208|FG000|Overall Study|Physician Decision|2|||
128891795|NCT01628107|463900208|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
128891796|NCT01628107|463900208|FG000|Overall Study|Non-compliant with Study Procedures|10|||
129110613|NCT04346199|464699895|FG001|Overall Study|Death|9|||
128689011|NCT00568685|463161557|FG002|Overall Study|Adverse Event|3|||
128689012|NCT00568685|463161555|FG000|Overall Study|Withdrawal by Subject|7|||
128689013|NCT00568685|463161556|FG001|Overall Study|Withdrawal by Subject|2|||
128689014|NCT00568685|463161557|FG002|Overall Study|Withdrawal by Subject|2|||
128891797|NCT01628107|463900208|FG000|Overall Study|Not Treated|8|||
128891798|NCT01628107|463900208|FG000|Overall Study|Sponsor Decision|11|||
128891799|NCT01628107|463900208|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
128891800|NCT01628107|463900208|FG000|Overall Study|Relocated|8|||
128891801|NCT01628107|463900208|FG000|Overall Study|Kidney Transplant|9|||
128891802|NCT01628107|463900208|FG000|Overall Study|Use of Standard of Care|9|||
128891803|NCT01086410|463900209|FG000|Overall Study|Adverse Event|1|||
128891804|NCT01086410|463900210|FG001|Overall Study|Adverse Event|0|||
128891805|NCT01086410|463900211|FG002|Overall Study|Adverse Event|0|||
128891806|NCT01086410|463900212|FG003|Overall Study|Adverse Event|2|||
128891807|NCT01086410|463900209|FG000|Overall Study|Lack of Efficacy|1|||
128891808|NCT01086410|463900210|FG001|Overall Study|Lack of Efficacy|1|||
128891809|NCT01086410|463900211|FG002|Overall Study|Lack of Efficacy|0|||
128891810|NCT01086410|463900212|FG003|Overall Study|Lack of Efficacy|0|||
128891811|NCT01086410|463900209|FG000|Overall Study|Protocol Violation|1|||
128689015|NCT00568685|463161555|FG000|Overall Study|Protocol Violation|1|||
128891812|NCT01086410|463900210|FG001|Overall Study|Protocol Violation|1|||
128891813|NCT01086410|463900211|FG002|Overall Study|Protocol Violation|0|||
128891814|NCT01086410|463900212|FG003|Overall Study|Protocol Violation|0|||
128891815|NCT01086410|463900209|FG000|Overall Study|Lost to Follow-up|0|||
128891816|NCT01086410|463900210|FG001|Overall Study|Lost to Follow-up|0|||
128891817|NCT01086410|463900211|FG002|Overall Study|Lost to Follow-up|1|||
128891818|NCT01086410|463900212|FG003|Overall Study|Lost to Follow-up|0|||
128891819|NCT02953639|463900213|FG000|Overall Study|Adverse Event|2|||
128891820|NCT02953639|463900214|FG001|Overall Study|Adverse Event|0|||
128891821|NCT02953639|463900215|FG002|Overall Study|Adverse Event|1|||
128891822|NCT02953639|463900213|FG000|Overall Study|Lost to Follow-up|8|||
128891823|NCT02953639|463900214|FG001|Overall Study|Lost to Follow-up|4|||
128891824|NCT02953639|463900215|FG002|Overall Study|Lost to Follow-up|3|||
128891825|NCT02953639|463900213|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128891826|NCT02953639|463900214|FG001|Overall Study|Non-Compliance With Study Drug|2|||
128891827|NCT02953639|463900215|FG002|Overall Study|Non-Compliance With Study Drug|1|||
128891828|NCT02953639|463900213|FG000|Overall Study|Multiple Reasons|1|||
128891829|NCT02953639|463900214|FG001|Overall Study|Multiple Reasons|0|||
128891830|NCT02953639|463900215|FG002|Overall Study|Multiple Reasons|1|||
128891831|NCT02953639|463900213|FG000|Overall Study|Physician Decision|1|||
128891832|NCT02953639|463900214|FG001|Overall Study|Physician Decision|0|||
128891833|NCT02953639|463900215|FG002|Overall Study|Physician Decision|0|||
128891834|NCT02953639|463900213|FG000|Overall Study|Withdrawal by Subject|7|||
128891835|NCT02953639|463900214|FG001|Overall Study|Withdrawal by Subject|8|||
128891836|NCT02953639|463900215|FG002|Overall Study|Withdrawal by Subject|10|||
128891837|NCT02953639|463900213|FG000|Overall Study|Completed or Discontinued information is missing|1|||
128891838|NCT02953639|463900214|FG001|Overall Study|Completed or Discontinued information is missing|0|||
128891839|NCT02953639|463900215|FG002|Overall Study|Completed or Discontinued information is missing|0|||
128891840|NCT04196803|463900216|FG000|Overall Study|Withdrawal by Subject|1|||
128891841|NCT04196803|463900217|FG001|Overall Study|Withdrawal by Subject|3|||
128891842|NCT04196803|463900216|FG000|Overall Study|Adverse Event|4|||
128891843|NCT04196803|463900217|FG001|Overall Study|Adverse Event|2|||
128891844|NCT04196803|463900216|FG000|Overall Study|Lost to Follow-up|0|||
128891845|NCT04196803|463900217|FG001|Overall Study|Lost to Follow-up|1|||
128891846|NCT01022996|463900218|FG000|Overall Study|Adverse Event|14|||
128891847|NCT01022996|463900218|FG000|Overall Study|Withdrawal by Subject|3|||
128891848|NCT01022996|463900218|FG000|Overall Study|Lost to Follow-up|1|||
128891849|NCT01022996|463900218|FG000|Overall Study|Administrative problems|6|||
128891850|NCT01022996|463900218|FG000|Overall Study|Disease Progression|32|||
128891851|NCT01022996|463900218|FG000|Overall Study|Protocol Violation|1|||
128891852|NCT00930722|463900219|FG000|Overall Study|Lost to Follow-up|16|||
128891853|NCT00930722|463900219|FG000|Overall Study|No longer willing to participate|9|||
128891854|NCT00930722|463900219|FG000|Overall Study|Study terminated by sponsor|2|||
128891855|NCT01069120|463900220|FG000|Overall Study|Study prematurely terminated|27|||
128891856|NCT00884325|463900221|FG000|Overall Study|Lost to Follow-up|1|||
128891857|NCT00884325|463900222|FG001|Overall Study|Lost to Follow-up|2|||
128891858|NCT00884325|463900221|FG000|Overall Study|Lack of Efficacy|0|||
128891859|NCT00884325|463900222|FG001|Overall Study|Lack of Efficacy|1|||
128891860|NCT00884325|463900221|FG000|Overall Study|Withdrawal by Subject|1|||
128891861|NCT00884325|463900222|FG001|Overall Study|Withdrawal by Subject|1|||
128891862|NCT00884325|463900221|FG000|Overall Study|Not provided|1|||
128891863|NCT00884325|463900222|FG001|Overall Study|Not provided|0|||
128891864|NCT05097716|463900227|FG000|Period 1|Adverse Event|1|||
128891865|NCT05097716|463900227|FG000|Period 1|Close contact with highly-transmissible infection|1|||
128891866|NCT03945591|463900230|FG000|Overall Study|Participant not transplanted|1|||
128891867|NCT03945591|463900230|FG000|Overall Study|Change in treatment plan|3|||
128891868|NCT03945591|463900230|FG000|Overall Study|Adverse Event|1|||
129020771|NCT03697109|464368562|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
129020772|NCT03697109|464368563|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
129020773|NCT03697109|464368561|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
129020774|NCT03697109|464368562|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
129020775|NCT03697109|464368563|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
129020776|NCT03697109|464368561|FG000|Open-label (OL) Phase|Physician Decision|2|||
128891869|NCT00760669|463900231|FG000|Overall Study|Not assessed for overall improvement|18|||
129020777|NCT03697109|464368562|FG001|Open-label (OL) Phase|Physician Decision|0|||
128891870|NCT00760669|463900231|FG000|Overall Study|Participants missing efficacy assessment|6|||
128891871|NCT00760669|463900231|FG000|Overall Study|Participants with overlapping cases|1|||
128891872|NCT00760669|463900231|FG000|Overall Study|Took drug before entering in contract|5|||
128891873|NCT01572675|463900232|FG000|Overall Study|End of prescribed treatment|140|||
128891874|NCT01572675|463900233|FG001|Overall Study|End of prescribed treatment|118|||
128891875|NCT01572675|463900232|FG000|Overall Study|Recovery|16|||
129020778|NCT03697109|464368563|FG002|Open-label (OL) Phase|Physician Decision|0|||
128891876|NCT01572675|463900233|FG001|Overall Study|Recovery|23|||
128891877|NCT01572675|463900232|FG000|Overall Study|Lack of Efficacy|31|||
128891878|NCT01572675|463900233|FG001|Overall Study|Lack of Efficacy|31|||
128891879|NCT01572675|463900232|FG000|Overall Study|Intolerance|6|||
128891880|NCT01572675|463900233|FG001|Overall Study|Intolerance|5|||
128891881|NCT01572675|463900232|FG000|Overall Study|Improved symptoms|8|||
128891882|NCT01572675|463900233|FG001|Overall Study|Improved symptoms|2|||
128891883|NCT01572675|463900232|FG000|Overall Study|Surgical intervention|3|||
128891884|NCT01572675|463900233|FG001|Overall Study|Surgical intervention|6|||
128891885|NCT01572675|463900232|FG000|Overall Study|Withdrawal by Subject|5|||
128891886|NCT01572675|463900233|FG001|Overall Study|Withdrawal by Subject|1|||
128891887|NCT01572675|463900232|FG000|Overall Study|Physician Decision|2|||
128891888|NCT01572675|463900233|FG001|Overall Study|Physician Decision|2|||
128891889|NCT01572675|463900232|FG000|Overall Study|Death unrelated to coxibs|1|||
128891890|NCT01572675|463900233|FG001|Overall Study|Death unrelated to coxibs|1|||
128891891|NCT01572675|463900232|FG000|Overall Study|Other disease detected|1|||
128891892|NCT01572675|463900233|FG001|Overall Study|Other disease detected|1|||
128891893|NCT01572675|463900232|FG000|Overall Study|Unknown reason|1|||
128891894|NCT01572675|463900233|FG001|Overall Study|Unknown reason|1|||
128891895|NCT01572675|463900232|FG000|Overall Study|Rheumatologist new evaluation|0|||
128891896|NCT01572675|463900233|FG001|Overall Study|Rheumatologist new evaluation|1|||
128891897|NCT01572675|463900232|FG000|Overall Study|Missing data|1|||
128891898|NCT01572675|463900233|FG001|Overall Study|Missing data|4|||
128891899|NCT01572675|463900232|FG000|Overall Study|Lost to Follow-up|22|||
128891900|NCT01572675|463900233|FG001|Overall Study|Lost to Follow-up|27|||
128891901|NCT02003014|463900234|FG000|Overall Study|Case report forms uncollected|9|||
128891902|NCT02003014|463900234|FG000|Overall Study|Treatment started after contract period|1|||
128891903|NCT02003014|463900234|FG000|Overall Study|Patient did not visit the study site|5|||
128891904|NCT02003014|463900234|FG000|Overall Study|Investigator's transfer|4|||
128891905|NCT01660451|463900235|FG000|Overall Study|Protocol Violation|0|||
128891906|NCT01660451|463900236|FG001|Overall Study|Protocol Violation|1|||
128891907|NCT01660451|463900237|FG002|Overall Study|Protocol Violation|1|||
128891908|NCT01660451|463900235|FG000|Overall Study|AE not associated with clinical disease progression|13|||
128891909|NCT01660451|463900236|FG001|Overall Study|AE not associated with clinical disease progression|10|||
128891910|NCT01660451|463900237|FG002|Overall Study|AE not associated with clinical disease progression|40|||
128891911|NCT01660451|463900235|FG000|Overall Study|AE associated with clinical disease progression|1|||
128891912|NCT01660451|463900236|FG001|Overall Study|AE associated with clinical disease progression|3|||
128891913|NCT01660451|463900237|FG002|Overall Study|AE associated with clinical disease progression|11|||
128891914|NCT01660451|463900235|FG000|Overall Study|Sponsor Decision|0|||
128891915|NCT01660451|463900236|FG001|Overall Study|Sponsor Decision|0|||
128891916|NCT01660451|463900237|FG002|Overall Study|Sponsor Decision|1|||
128891917|NCT01660451|463900235|FG000|Overall Study|Protocol Deviation|0|||
128891918|NCT01660451|463900236|FG001|Overall Study|Protocol Deviation|0|||
128891919|NCT01660451|463900237|FG002|Overall Study|Protocol Deviation|1|||
128891920|NCT01660451|463900235|FG000|Overall Study|Physician Decision|1|||
128891921|NCT01660451|463900236|FG001|Overall Study|Physician Decision|2|||
128891922|NCT01660451|463900237|FG002|Overall Study|Physician Decision|5|||
128891923|NCT01660451|463900235|FG000|Overall Study|Withdrawal by Subject|1|||
128891924|NCT01660451|463900236|FG001|Overall Study|Withdrawal by Subject|1|||
128891925|NCT01660451|463900237|FG002|Overall Study|Withdrawal by Subject|20|||
128891926|NCT01660451|463900235|FG000|Overall Study|Trial closure.|0|||
128891927|NCT01660451|463900236|FG001|Overall Study|Trial closure.|0|||
128891928|NCT01660451|463900237|FG002|Overall Study|Trial closure.|1|||
128891929|NCT01660451|463900235|FG000|Overall Study|Switching to other therapy|0|||
128891930|NCT01660451|463900236|FG001|Overall Study|Switching to other therapy|1|||
128891931|NCT01660451|463900237|FG002|Overall Study|Switching to other therapy|1|||
128891932|NCT01660451|463900235|FG000|Overall Study|Progressive disease - clinical progression|4|||
128891933|NCT01660451|463900236|FG001|Overall Study|Progressive disease - clinical progression|10|||
128891934|NCT01660451|463900237|FG002|Overall Study|Progressive disease - clinical progression|9|||
128891935|NCT01660451|463900235|FG000|Overall Study|Progressive disease - radiological progression|12|||
128891936|NCT01660451|463900236|FG001|Overall Study|Progressive disease - radiological progression|23|||
128891937|NCT01660451|463900237|FG002|Overall Study|Progressive disease - radiological progression|50|||
128891938|NCT01660451|463900235|FG000|Overall Study|Death|1|||
128891939|NCT01660451|463900236|FG001|Overall Study|Death|0|||
128891940|NCT01660451|463900237|FG002|Overall Study|Death|1|||
128891941|NCT01660451|463900235|FG000|Overall Study|Other|0|||
129020779|NCT03697109|464368561|FG000|Open-label (OL) Phase|Death|2|||
128891942|NCT01660451|463900236|FG001|Overall Study|Other|0|||
128891943|NCT01660451|463900237|FG002|Overall Study|Other|1|||
128891944|NCT02281357|463900238|FG000|Overall Study|Adverse Event|2|||
128891945|NCT02281357|463900239|FG001|Overall Study|Adverse Event|1|||
128891946|NCT02281357|463900238|FG000|Overall Study|Lost to Follow-up|1|||
128891947|NCT02281357|463900239|FG001|Overall Study|Lost to Follow-up|0|||
128891948|NCT02281357|463900238|FG000|Overall Study|Withdrawal by Subject|4|||
128891949|NCT02281357|463900239|FG001|Overall Study|Withdrawal by Subject|3|||
129020780|NCT03697109|464368562|FG001|Open-label (OL) Phase|Death|0|||
128891950|NCT00482703|463900242|FG000|Overall Study|Poor compliance|1|||
128891951|NCT00482703|463900243|FG001|Overall Study|Poor compliance|0|||
128891952|NCT04223791|463900246|FG000|Overall Study|Lost to Follow-up|0|||
128891953|NCT04223791|463900247|FG001|Overall Study|Lost to Follow-up|4|||
128891954|NCT04223791|463900246|FG000|Overall Study|Physician Decision|5|||
128891955|NCT04223791|463900247|FG001|Overall Study|Physician Decision|1|||
128891956|NCT04223791|463900246|FG000|Overall Study|Protocol Violation|1|||
128891957|NCT04223791|463900247|FG001|Overall Study|Protocol Violation|1|||
128891958|NCT04223791|463900246|FG000|Overall Study|Withdrawal by Subject|10|||
128891959|NCT04223791|463900247|FG001|Overall Study|Withdrawal by Subject|12|||
128891960|NCT04223791|463900246|FG000|Overall Study|Pregnancy|1|||
128891961|NCT04223791|463900247|FG001|Overall Study|Pregnancy|1|||
128891962|NCT04223791|463900246|FG000|Overall Study|Ongoing in Study|305|||
128891963|NCT04223791|463900247|FG001|Overall Study|Ongoing in Study|302|||
128891964|NCT00729378|463901770|FG000|Baseline|Did not complete study measurements|72|||
128891965|NCT00729378|463901771|FG001|Baseline|Did not complete study measurements|33|||
128891966|NCT00729378|463901770|FG000|Baseline|Withdrawal by Subject|66|||
128891967|NCT00729378|463901771|FG001|Baseline|Withdrawal by Subject|59|||
128891968|NCT00729378|463901770|FG000|12-months|Lost to Follow-up|100|||
128891969|NCT00729378|463901771|FG001|12-months|Lost to Follow-up|65|||
128891970|NCT00729378|463901770|FG000|24-months|Lost to Follow-up|72|||
128891971|NCT00729378|463901771|FG001|24-months|Lost to Follow-up|51|||
128891972|NCT00729378|463901770|FG000|36-months|Lost to Follow-up|15|||
128891973|NCT00729378|463901771|FG001|36-months|Lost to Follow-up|6|||
128891974|NCT02246582|463901774|FG000|Overall Study|Withdrawal by Subject|3|||
128891975|NCT02246582|463901775|FG001|Overall Study|Withdrawal by Subject|4|||
128891976|NCT02060383|463901776|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
128891977|NCT02060383|463901777|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
128891978|NCT02060383|463901778|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
128891979|NCT02060383|463901779|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
128891980|NCT02060383|463901780|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
128891981|NCT02060383|463901776|FG000|Core Phase|Adverse Event|2|||
128891982|NCT02060383|463901777|FG001|Core Phase|Adverse Event|0|||
128891983|NCT02060383|463901778|FG002|Core Phase|Adverse Event|0|||
128891984|NCT02060383|463901779|FG003|Core Phase|Adverse Event|2|||
128891985|NCT02060383|463901780|FG004|Core Phase|Adverse Event|6|||
128891986|NCT02060383|463901776|FG000|Core Phase|Administrative problems|0|||
128891987|NCT02060383|463901777|FG001|Core Phase|Administrative problems|1|||
128891988|NCT02060383|463901778|FG002|Core Phase|Administrative problems|0|||
128891989|NCT02060383|463901779|FG003|Core Phase|Administrative problems|0|||
128891990|NCT02060383|463901780|FG004|Core Phase|Administrative problems|0|||
128891991|NCT02060383|463901776|FG000|Core Phase|Protocol Violation|0|||
128891992|NCT02060383|463901777|FG001|Core Phase|Protocol Violation|0|||
128891993|NCT02060383|463901778|FG002|Core Phase|Protocol Violation|0|||
128891994|NCT02060383|463901779|FG003|Core Phase|Protocol Violation|1|||
128891995|NCT02060383|463901780|FG004|Core Phase|Protocol Violation|0|||
128891996|NCT02060383|463901776|FG000|Core Phase|Withdrawal by Subject|0|||
128891997|NCT02060383|463901777|FG001|Core Phase|Withdrawal by Subject|0|||
128891998|NCT02060383|463901778|FG002|Core Phase|Withdrawal by Subject|0|||
128891999|NCT02060383|463901779|FG003|Core Phase|Withdrawal by Subject|4|||
128892000|NCT02060383|463901780|FG004|Core Phase|Withdrawal by Subject|2|||
128892001|NCT02060383|463901776|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
128892002|NCT02060383|463901777|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
128892003|NCT02060383|463901778|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
129020781|NCT03697109|464368563|FG002|Open-label (OL) Phase|Death|0|||
129020782|NCT03697109|464368561|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
129020783|NCT03697109|464368562|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
129020784|NCT03697109|464368563|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
129020785|NCT03697109|464368561|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
129020786|NCT03697109|464368562|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
129020787|NCT03697109|464368563|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
129020788|NCT03697109|464368561|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
129020789|NCT03697109|464368562|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
129020790|NCT03697109|464368563|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
129020791|NCT00834522|464368564|FG000|Washout|Adverse Event|1|||
128689016|NCT00568685|463161556|FG001|Overall Study|Protocol Violation|0|||
128892004|NCT02060383|463901779|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
128892005|NCT02060383|463901780|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
128892006|NCT02060383|463901776|FG000|Extension Phase|Adverse Event|1|||
128892007|NCT02060383|463901777|FG001|Extension Phase|Adverse Event|1|||
128892008|NCT02060383|463901778|FG002|Extension Phase|Adverse Event|2|||
128892009|NCT02060383|463901779|FG003|Extension Phase|Adverse Event|0|||
128892010|NCT02060383|463901780|FG004|Extension Phase|Adverse Event|1|||
128892011|NCT02060383|463901776|FG000|Extension Phase|Withdrawal by Subject|0|||
128892012|NCT02060383|463901777|FG001|Extension Phase|Withdrawal by Subject|1|||
128892013|NCT02060383|463901778|FG002|Extension Phase|Withdrawal by Subject|0|||
128892014|NCT02060383|463901779|FG003|Extension Phase|Withdrawal by Subject|0|||
128892015|NCT02060383|463901780|FG004|Extension Phase|Withdrawal by Subject|2|||
129020792|NCT00834522|464368565|FG001|Washout|Adverse Event|0|||
129020793|NCT00834522|464368564|FG000|Washout|Withdrawal by Subject|2|||
128689017|NCT00568685|463161557|FG002|Overall Study|Protocol Violation|0|||
128892016|NCT02060383|463901776|FG000|Extension Phase|Administrative problems|1|||
128892017|NCT02060383|463901777|FG001|Extension Phase|Administrative problems|0|||
128892018|NCT02060383|463901778|FG002|Extension Phase|Administrative problems|0|||
128892019|NCT02060383|463901779|FG003|Extension Phase|Administrative problems|0|||
128892020|NCT02060383|463901780|FG004|Extension Phase|Administrative problems|0|||
128892021|NCT02060383|463901776|FG000|Extension Phase|Death|0|||
128689018|NCT01147172|463161559|FG000|Overall Study|Withdrawal by Subject|2|||
128689019|NCT01147172|463161559|FG000|Overall Study|Lost to Follow-up|2|||
128689020|NCT02787551|463161560|FG000|Core Period: 26 Weeks|Adverse Event|10|||
128689021|NCT02787551|463161561|FG001|Core Period: 26 Weeks|Adverse Event|0|||
128689022|NCT02787551|463161560|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
128689023|NCT02787551|463161561|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
128689024|NCT02787551|463161560|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
128689025|NCT02787551|463161561|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
128689026|NCT02787551|463161560|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
128689027|NCT02787551|463161561|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
128689028|NCT02787551|463161560|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
128689029|NCT02787551|463161561|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
128689030|NCT02787551|463161560|FG000|Core Period: 26 Weeks|Other than specified|3|||
128689031|NCT02787551|463161561|FG001|Core Period: 26 Weeks|Other than specified|1|||
128689032|NCT02787551|463161560|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
128689033|NCT02787551|463161561|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
128892022|NCT02060383|463901777|FG001|Extension Phase|Death|0|||
128892023|NCT02060383|463901778|FG002|Extension Phase|Death|1|||
128689034|NCT02787551|463161560|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
128689035|NCT02787551|463161561|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
128689036|NCT02787551|463161560|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
128689037|NCT02787551|463161561|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
128689038|NCT02038452|463161562|FG000|Overall Study|Withdrawal by Subject|7|||
128689039|NCT02038452|463161563|FG001|Overall Study|Withdrawal by Subject|9|||
128689040|NCT02038452|463161562|FG000|Overall Study|Lost to Follow-up|31|||
128689041|NCT02038452|463161563|FG001|Overall Study|Lost to Follow-up|28|||
128689042|NCT01090973|463161568|FG000|Overall Study|Disease progression|1|||
128689043|NCT01626495|463161570|FG000|Overall Study|Adverse Event|3|||
128892024|NCT02060383|463901779|FG003|Extension Phase|Death|0|||
128892025|NCT02060383|463901780|FG004|Extension Phase|Death|1|||
128892026|NCT02060383|463901776|FG000|Extension Phase|Protocol Violation|0|||
128892027|NCT02060383|463901777|FG001|Extension Phase|Protocol Violation|0|||
128892028|NCT02060383|463901778|FG002|Extension Phase|Protocol Violation|0|||
128892029|NCT02060383|463901779|FG003|Extension Phase|Protocol Violation|0|||
128689044|NCT01626495|463161570|FG000|Overall Study|Disease progression|27|||
128689045|NCT01626495|463161570|FG000|Overall Study|Withdrawal by Subject|1|||
128892030|NCT02060383|463901780|FG004|Extension Phase|Protocol Violation|1|||
128892031|NCT00791258|463901786|FG000|Overall Study|Adverse Event|87|||
128892032|NCT00791258|463901786|FG000|Overall Study|Lost to Follow-up|18|||
128892033|NCT00791258|463901786|FG000|Overall Study|Protocol Violation|109|||
128892034|NCT00791258|463901786|FG000|Overall Study|Withdrawal by Subject|40|||
128892035|NCT00791258|463901786|FG000|Overall Study|Did not take medication for >3 days|1|||
128689046|NCT01626495|463161570|FG000|Overall Study|Administrative problem|1|||
128892036|NCT00791258|463901786|FG000|Overall Study|subject left area|2|||
128892037|NCT00791258|463901786|FG000|Overall Study|non-compliance|3|||
128689047|NCT01626495|463161570|FG000|Overall Study|Death|2|||
128689048|NCT01626495|463161570|FG000|Overall Study|Physician Decision|1|||
128689049|NCT01626495|463161570|FG000|Overall Study|New cancer therapy|16|||
128892038|NCT00791258|463901786|FG000|Overall Study|Subject incarcerated|1|||
128892039|NCT00791258|463901786|FG000|Overall Study|Subject required restricted medication|1|||
128892040|NCT00791258|463901786|FG000|Overall Study|Lack of Efficacy|1|||
128892041|NCT00058552|463901787|FG000|Overall Study|Died prior to receiving treatment|4|||
128892042|NCT00058552|463901788|FG001|Overall Study|Died prior to receiving treatment|2|||
128892043|NCT00058552|463901787|FG000|Overall Study|Disease progression|52|||
128892044|NCT00058552|463901788|FG001|Overall Study|Disease progression|44|||
128892045|NCT00058552|463901787|FG000|Overall Study|Adverse Event|4|||
128892046|NCT00058552|463901788|FG001|Overall Study|Adverse Event|2|||
128892047|NCT00058552|463901787|FG000|Overall Study|Withdrawal by Subject|3|||
128689050|NCT01626495|463161570|FG000|Overall Study|Manufacturing failure|1|||
128689051|NCT02887859|463161573|FG000|Overall Study|Ongoing|6|||
128689052|NCT02887859|463161573|FG000|Overall Study|Adverse Event|7|||
128689053|NCT02887859|463161573|FG000|Overall Study|Death|1|||
128689054|NCT02887859|463161573|FG000|Overall Study|Physician Decision|1|||
128689055|NCT00257608|463162865|FG000|Chemotherapy Phase|Adverse Event|138|||
128689056|NCT00257608|463162866|FG001|Chemotherapy Phase|Adverse Event|0|||
128689057|NCT00257608|463162867|FG002|Chemotherapy Phase|Adverse Event|0|||
128892048|NCT00058552|463901788|FG001|Overall Study|Withdrawal by Subject|5|||
128892049|NCT00058552|463901787|FG000|Overall Study|Physician Decision|2|||
128892050|NCT00058552|463901788|FG001|Overall Study|Physician Decision|5|||
128892051|NCT00058552|463901787|FG000|Overall Study|Clinical disease progression|0|||
128892052|NCT00058552|463901788|FG001|Overall Study|Clinical disease progression|4|||
128892053|NCT02319668|463901789|FG000|Overall Study|Other (Not specified)|0|||
128892054|NCT02319668|463901790|FG001|Overall Study|Other (Not specified)|2|||
128892055|NCT02316340|463901793|FG000|First Progression|Clinical progression|2|||
128892056|NCT02316340|463901794|FG001|First Progression|Clinical progression|1|||
128892057|NCT02316340|463901793|FG000|First Progression|Withdrawal by Subject|1|||
128892058|NCT02316340|463901794|FG001|First Progression|Withdrawal by Subject|0|||
128892059|NCT01986920|463901795|FG000|A- 101 25%|Withdrawal by Subject|1|||
128892060|NCT01986920|463901796|FG001|A- 101 25%|Withdrawal by Subject|0|||
128892061|NCT01986920|463901797|FG002|A- 101 25%|Withdrawal by Subject|0|||
128892062|NCT01986920|463901798|FG003|A- 101 25%|Withdrawal by Subject|0|||
128892063|NCT01986920|463901795|FG000|A-101 32.5%|Withdrawal by Subject|0|||
128892064|NCT01986920|463901796|FG001|A-101 32.5%|Withdrawal by Subject|1|||
128892065|NCT01986920|463901797|FG002|A-101 32.5%|Withdrawal by Subject|0|||
128892066|NCT01986920|463901798|FG003|A-101 32.5%|Withdrawal by Subject|0|||
128892067|NCT01986920|463901795|FG000|A-101 40%|Withdrawal by Subject|0|||
128892068|NCT01986920|463901796|FG001|A-101 40%|Withdrawal by Subject|0|||
128892069|NCT01986920|463901797|FG002|A-101 40%|Withdrawal by Subject|1|||
128892070|NCT01986920|463901798|FG003|A-101 40%|Withdrawal by Subject|0|||
128892071|NCT01986920|463901795|FG000|Placebo|Withdrawal by Subject|0|||
128892072|NCT01986920|463901796|FG001|Placebo|Withdrawal by Subject|0|||
128892073|NCT01986920|463901797|FG002|Placebo|Withdrawal by Subject|0|||
128892074|NCT01986920|463901798|FG003|Placebo|Withdrawal by Subject|1|||
128892075|NCT03781323|463901799|FG000|Overall Study|Withdrawal by Subject|1|||
128892076|NCT01338415|463901800|FG000|Core + Extension|Adverse Event|8|||
128892077|NCT01338415|463901801|FG001|Core + Extension|Adverse Event|6|||
128892078|NCT01338415|463901802|FG002|Core + Extension|Adverse Event|0|||
128892079|NCT01338415|463901800|FG000|Core + Extension|Withdrawal by Subject|1|||
128892080|NCT01338415|463901801|FG001|Core + Extension|Withdrawal by Subject|1|||
128892081|NCT01338415|463901802|FG002|Core + Extension|Withdrawal by Subject|0|||
128892082|NCT01338415|463901800|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
128892083|NCT01338415|463901801|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
128892084|NCT01338415|463901802|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
128892085|NCT01338415|463901800|FG000|Core + Extension|Other (administrative reason)|1|||
128892086|NCT01338415|463901801|FG001|Core + Extension|Other (administrative reason)|0|||
128892087|NCT01338415|463901802|FG002|Core + Extension|Other (administrative reason)|0|||
128892088|NCT01338415|463901800|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
128892089|NCT01338415|463901801|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
128892090|NCT01338415|463901802|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
128892091|NCT01338415|463901800|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
128892092|NCT01338415|463901801|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
128892093|NCT01338415|463901802|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
128892094|NCT01338415|463901800|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
128892095|NCT01338415|463901801|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
128892096|NCT01338415|463901802|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
128892097|NCT01338415|463901800|FG000|Exceptional Use Treatment Period|Death|0|||
128892098|NCT01338415|463901801|FG001|Exceptional Use Treatment Period|Death|0|||
128892099|NCT01338415|463901802|FG002|Exceptional Use Treatment Period|Death|1|||
128892100|NCT04880447|463901806|FG000|Overall Study|No vaccination information|1|||
128892101|NCT04880447|463901806|FG000|Overall Study|No adverse event information (missing information)|1|||
128892102|NCT04880447|463901806|FG000|Overall Study|Disease not covered in this study|35|||
128892103|NCT01970488|463901807|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
128892104|NCT01970488|463901808|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
128892105|NCT01970488|463901809|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
129020794|NCT00834522|464368565|FG001|Washout|Withdrawal by Subject|1|||
129020795|NCT04516967|464368566|FG000|Core Phase|Adverse Event|2|||
129020796|NCT04516967|464368567|FG001|Core Phase|Adverse Event|1|||
129020797|NCT04516967|464368568|FG002|Core Phase|Adverse Event|0|||
129020798|NCT04516967|464368566|FG000|Core Phase|Physician Decision|1|||
129020799|NCT04516967|464368567|FG001|Core Phase|Physician Decision|1|||
129020800|NCT04516967|464368568|FG002|Core Phase|Physician Decision|0|||
129020801|NCT04516967|464368566|FG000|Core Phase|Lack of Efficacy|7|||
129020802|NCT04516967|464368567|FG001|Core Phase|Lack of Efficacy|18|||
129020803|NCT04516967|464368568|FG002|Core Phase|Lack of Efficacy|0|||
129020804|NCT00272779|464368571|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
128892106|NCT01970488|463901810|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
128892107|NCT01970488|463901811|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
128892108|NCT01970488|463901807|FG000|Part 1: Through Week 16|Protocol Violation|1|||
128892109|NCT01970488|463901808|FG001|Part 1: Through Week 16|Protocol Violation|2|||
128892110|NCT01970488|463901809|FG002|Part 1: Through Week 16|Protocol Violation|0|||
128892111|NCT01970488|463901810|FG003|Part 1: Through Week 16|Protocol Violation|0|||
129020805|NCT00272779|464368572|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
129020806|NCT00272779|464368571|FG000|Baseline Through Week 48|Death before Week 48|4|||
128892112|NCT01970488|463901811|FG004|Part 1: Through Week 16|Protocol Violation|0|||
128892113|NCT01970488|463901807|FG000|Part 1: Through Week 16|Adverse Event|6|||
128892114|NCT01970488|463901808|FG001|Part 1: Through Week 16|Adverse Event|5|||
128892115|NCT01970488|463901809|FG002|Part 1: Through Week 16|Adverse Event|0|||
128892116|NCT01970488|463901810|FG003|Part 1: Through Week 16|Adverse Event|0|||
128892117|NCT01970488|463901811|FG004|Part 1: Through Week 16|Adverse Event|0|||
128892118|NCT01970488|463901807|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
128892119|NCT01970488|463901808|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
128892120|NCT01970488|463901809|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
128892121|NCT01970488|463901810|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
128892122|NCT01970488|463901811|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
128892123|NCT01970488|463901807|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
128892124|NCT01970488|463901808|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
128892125|NCT01970488|463901809|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
128892126|NCT01970488|463901810|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
128892127|NCT01970488|463901811|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
128892128|NCT01970488|463901807|FG000|Part 2: Post Week 16|Physician Decision|0|||
128892129|NCT01970488|463901808|FG001|Part 2: Post Week 16|Physician Decision|0|||
128892130|NCT01970488|463901809|FG002|Part 2: Post Week 16|Physician Decision|0|||
128892131|NCT01970488|463901810|FG003|Part 2: Post Week 16|Physician Decision|0|||
128892132|NCT01970488|463901811|FG004|Part 2: Post Week 16|Physician Decision|1|||
128892133|NCT01970488|463901807|FG000|Part 2: Post Week 16|Non-compliance|0|||
128892134|NCT01970488|463901808|FG001|Part 2: Post Week 16|Non-compliance|0|||
128892135|NCT01970488|463901809|FG002|Part 2: Post Week 16|Non-compliance|1|||
128892136|NCT01970488|463901810|FG003|Part 2: Post Week 16|Non-compliance|0|||
128892137|NCT01970488|463901811|FG004|Part 2: Post Week 16|Non-compliance|0|||
128892138|NCT01970488|463901807|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
128892139|NCT01970488|463901808|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
128892140|NCT01970488|463901809|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
128892141|NCT01970488|463901810|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
128892142|NCT01970488|463901811|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
128892143|NCT01970488|463901807|FG000|Part 2: Post Week 16|Adverse Event|0|||
128892144|NCT01970488|463901808|FG001|Part 2: Post Week 16|Adverse Event|0|||
128892145|NCT01970488|463901809|FG002|Part 2: Post Week 16|Adverse Event|5|||
128892146|NCT01970488|463901810|FG003|Part 2: Post Week 16|Adverse Event|1|||
128892147|NCT01970488|463901811|FG004|Part 2: Post Week 16|Adverse Event|1|||
128892148|NCT01970488|463901807|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
128892149|NCT01970488|463901808|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
128892150|NCT01970488|463901809|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
128892151|NCT01970488|463901810|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
128892152|NCT01970488|463901811|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
128892153|NCT01970488|463901807|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
128892154|NCT01970488|463901808|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
128892155|NCT01970488|463901809|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
128892156|NCT01970488|463901810|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
128892157|NCT01970488|463901811|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
128892158|NCT00851682|463901814|FG000|Overall Study|screen failure|5|||
128892159|NCT00851682|463901815|FG001|Overall Study|screen failure|0|||
128892160|NCT04060563|463901816|FG000|Overall Study|Lost to Follow-up|1|||
128892161|NCT04060563|463901817|FG001|Overall Study|Lost to Follow-up|1|||
128892162|NCT04060563|463901816|FG000|Overall Study|Physician Decision|0|||
128892163|NCT04060563|463901817|FG001|Overall Study|Physician Decision|1|||
128892164|NCT02486653|463901818|FG000|Overall Study|Withdrawal by Subject|1|||
128892165|NCT02486653|463901819|FG001|Overall Study|Withdrawal by Subject|3|||
128892166|NCT02486653|463901818|FG000|Overall Study|Protocol Violation|1|||
128892167|NCT02486653|463901819|FG001|Overall Study|Protocol Violation|0|||
128892168|NCT02486653|463901818|FG000|Overall Study|surgery cancelled|4|||
128892169|NCT02486653|463901819|FG001|Overall Study|surgery cancelled|1|||
128892170|NCT01177384|463901821|FG000|Overall Study|Adverse Event|6|||
129020807|NCT00272779|464368572|FG001|Baseline Through Week 48|Death before Week 48|4|||
129020808|NCT00272779|464368571|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
129020809|NCT00272779|464368572|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
129020810|NCT00272779|464368571|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
129020811|NCT00272779|464368572|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
129020812|NCT00272779|464368571|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
129020813|NCT00272779|464368572|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
129020814|NCT00272779|464368571|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
129020815|NCT00272779|464368572|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
129020816|NCT00272779|464368571|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
128892171|NCT01177384|463901822|FG001|Overall Study|Adverse Event|4|||
129020817|NCT00272779|464368572|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
129110614|NCT04346199|464699894|FG000|Overall Study|Lost to Follow-up|0|||
128892172|NCT01177384|463901821|FG000|Overall Study|Lack of Efficacy|0|||
128892173|NCT01177384|463901822|FG001|Overall Study|Lack of Efficacy|1|||
129110615|NCT04346199|464699895|FG001|Overall Study|Lost to Follow-up|1|||
129110616|NCT04346199|464699894|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
129110617|NCT04346199|464699895|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
129110618|NCT04346199|464699894|FG000|Overall Study|Withdrawal by Subject|5|||
129110619|NCT04346199|464699895|FG001|Overall Study|Withdrawal by Subject|1|||
129110620|NCT02039778|464699896|FG000|Overall Study|Death|2|||
129110621|NCT02039778|464699896|FG000|Overall Study|Withdrawal by Subject|1|||
128892174|NCT01177384|463901821|FG000|Overall Study|Lost to Follow-up|3|||
128892175|NCT01177384|463901822|FG001|Overall Study|Lost to Follow-up|4|||
128892176|NCT01177384|463901821|FG000|Overall Study|Physician Decision|0|||
128892177|NCT01177384|463901822|FG001|Overall Study|Physician Decision|3|||
128892178|NCT01177384|463901821|FG000|Overall Study|Protocol Violation|0|||
128892179|NCT01177384|463901822|FG001|Overall Study|Protocol Violation|2|||
128892180|NCT01177384|463901821|FG000|Overall Study|Withdrawal by Subject|5|||
128892181|NCT01177384|463901822|FG001|Overall Study|Withdrawal by Subject|12|||
128892182|NCT01849497|463901823|FG000|Overall Study|Withdrawal by Subject|1|||
128892183|NCT01849497|463901824|FG001|Overall Study|Withdrawal by Subject|2|||
128892184|NCT01849497|463901823|FG000|Overall Study|Sponsor Decision|0|||
128892185|NCT01849497|463901824|FG001|Overall Study|Sponsor Decision|1|||
128892186|NCT01849497|463901823|FG000|Overall Study|Lost to Follow-up|0|||
128892187|NCT01849497|463901824|FG001|Overall Study|Lost to Follow-up|1|||
128892188|NCT01514136|463901825|FG000|Test Period 1; Test A|Protocol Violation|1|||
128892189|NCT01514136|463901826|FG001|Test Period 1; Test A|Protocol Violation|0|||
128892190|NCT01514136|463901827|FG002|Test Period 1; Test A|Protocol Violation|0|||
128892191|NCT01514136|463901828|FG003|Test Period 1; Test A|Protocol Violation|0|||
128892192|NCT01514136|463901829|FG004|Test Period 1; Test A|Protocol Violation|0|||
128892193|NCT01514136|463901830|FG005|Test Period 1; Test A|Protocol Violation|0|||
128892194|NCT01514136|463901831|FG006|Test Period 1; Test A|Protocol Violation|0|||
128892195|NCT01514136|463901832|FG007|Test Period 1; Test A|Protocol Violation|0|||
128892196|NCT01514136|463901825|FG000|Test Period 1; Test A|Break from study holiday|2|||
128892197|NCT01514136|463901826|FG001|Test Period 1; Test A|Break from study holiday|0|||
128892198|NCT01514136|463901827|FG002|Test Period 1; Test A|Break from study holiday|0|||
128892199|NCT01514136|463901828|FG003|Test Period 1; Test A|Break from study holiday|0|||
128892200|NCT01514136|463901829|FG004|Test Period 1; Test A|Break from study holiday|0|||
128892201|NCT01514136|463901830|FG005|Test Period 1; Test A|Break from study holiday|0|||
128892202|NCT01514136|463901831|FG006|Test Period 1; Test A|Break from study holiday|0|||
128892203|NCT01514136|463901832|FG007|Test Period 1; Test A|Break from study holiday|0|||
128892204|NCT01514136|463901825|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
128892205|NCT01514136|463901826|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
128892206|NCT01514136|463901827|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
128892207|NCT01514136|463901828|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
128892208|NCT01514136|463901829|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
128892209|NCT01514136|463901830|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
128892210|NCT01514136|463901831|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
128892211|NCT01514136|463901832|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
128892212|NCT01514136|463901825|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
128892213|NCT01514136|463901826|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
128892214|NCT01514136|463901827|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
128892215|NCT01514136|463901828|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
128892216|NCT01514136|463901829|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
128892217|NCT01514136|463901830|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
129020818|NCT00272779|464368571|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
129020819|NCT00272779|464368572|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
129020820|NCT00272779|464368571|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
129020821|NCT00272779|464368572|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
129020822|NCT00272779|464368571|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
129020823|NCT00272779|464368572|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
129020824|NCT00272779|464368571|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
129020825|NCT00272779|464368572|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
129020826|NCT00272779|464368571|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
129020827|NCT00272779|464368572|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
129020828|NCT00272779|464368571|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
129110622|NCT02039778|464699896|FG000|Overall Study|Never started the protocol treatment|1|||
129110623|NCT00096538|464699907|FG000|Overall Study|Withdrawal by Subject|1|||
128892218|NCT01514136|463901831|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
128892219|NCT01514136|463901832|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
129020829|NCT00272779|464368572|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
128892220|NCT01514136|463901825|FG000|Test Period 2; Test A*|Adverse Event|0|||
128892221|NCT01514136|463901826|FG001|Test Period 2; Test A*|Adverse Event|0|||
128892222|NCT01514136|463901827|FG002|Test Period 2; Test A*|Adverse Event|0|||
128892223|NCT01514136|463901828|FG003|Test Period 2; Test A*|Adverse Event|0|||
128892224|NCT01514136|463901829|FG004|Test Period 2; Test A*|Adverse Event|1|||
128892225|NCT01514136|463901830|FG005|Test Period 2; Test A*|Adverse Event|0|||
128892226|NCT01514136|463901831|FG006|Test Period 2; Test A*|Adverse Event|0|||
128892227|NCT01514136|463901832|FG007|Test Period 2; Test A*|Adverse Event|0|||
128892228|NCT01514136|463901825|FG000|Test Period 2; Test A*|Holiday|0|||
128892229|NCT01514136|463901826|FG001|Test Period 2; Test A*|Holiday|0|||
128892230|NCT01514136|463901827|FG002|Test Period 2; Test A*|Holiday|0|||
128892231|NCT01514136|463901828|FG003|Test Period 2; Test A*|Holiday|0|||
128892232|NCT01514136|463901829|FG004|Test Period 2; Test A*|Holiday|1|||
128892233|NCT01514136|463901830|FG005|Test Period 2; Test A*|Holiday|0|||
128892234|NCT01514136|463901831|FG006|Test Period 2; Test A*|Holiday|0|||
128892235|NCT01514136|463901832|FG007|Test Period 2; Test A*|Holiday|0|||
128892236|NCT01514136|463901825|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
128892237|NCT01514136|463901826|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
128892238|NCT01514136|463901827|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
128892239|NCT01514136|463901828|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
128892240|NCT01514136|463901829|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
128892241|NCT01514136|463901830|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
128892242|NCT01514136|463901831|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
128892243|NCT01514136|463901832|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
128892244|NCT01514136|463901825|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
128892245|NCT01514136|463901826|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
128892246|NCT01514136|463901827|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
128892247|NCT01514136|463901828|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
128892248|NCT01514136|463901829|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
128892249|NCT01514136|463901830|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
128892250|NCT01514136|463901831|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
128892251|NCT01514136|463901832|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
128892252|NCT01514136|463901825|FG000|Test Period 2; Test C*|holiday|0|||
128892253|NCT01514136|463901826|FG001|Test Period 2; Test C*|holiday|0|||
128892254|NCT01514136|463901827|FG002|Test Period 2; Test C*|holiday|0|||
128892255|NCT01514136|463901828|FG003|Test Period 2; Test C*|holiday|0|||
128892256|NCT01514136|463901829|FG004|Test Period 2; Test C*|holiday|0|||
128892257|NCT01514136|463901830|FG005|Test Period 2; Test C*|holiday|0|||
128892258|NCT01514136|463901831|FG006|Test Period 2; Test C*|holiday|1|||
128892259|NCT01514136|463901832|FG007|Test Period 2; Test C*|holiday|0|||
128892260|NCT01514136|463901825|FG000|Test Period 2; Test C*|Protocol Violation|0|||
128892261|NCT01514136|463901826|FG001|Test Period 2; Test C*|Protocol Violation|0|||
128892262|NCT01514136|463901827|FG002|Test Period 2; Test C*|Protocol Violation|0|||
128892263|NCT01514136|463901828|FG003|Test Period 2; Test C*|Protocol Violation|0|||
128892264|NCT01514136|463901829|FG004|Test Period 2; Test C*|Protocol Violation|0|||
128892265|NCT01514136|463901830|FG005|Test Period 2; Test C*|Protocol Violation|0|||
128892266|NCT01514136|463901831|FG006|Test Period 2; Test C*|Protocol Violation|1|||
128892267|NCT01514136|463901832|FG007|Test Period 2; Test C*|Protocol Violation|0|||
128892268|NCT02941926|463901833|FG000|Core Phase|Progressive disease|1109|||
128892269|NCT02941926|463901833|FG000|Core Phase|Adverse Event|504|||
128892270|NCT02941926|463901833|FG000|Core Phase|Subject/guardian decision|127|||
128892271|NCT02941926|463901833|FG000|Core Phase|Physician Decision|112|||
128892272|NCT02941926|463901833|FG000|Core Phase|Death|46|||
128892273|NCT02941926|463901833|FG000|Core Phase|Protocol deviation|34|||
128892274|NCT02941926|463901833|FG000|Core Phase|Lost to Follow-up|8|||
128892275|NCT02941926|463901833|FG000|Core Phase|Technical problems|5|||
128892276|NCT02941926|463901833|FG000|Extension Phase|Physician Decision|155|||
128892277|NCT02941926|463901833|FG000|Extension Phase|Progressive disease|115|||
128892278|NCT02941926|463901833|FG000|Extension Phase|Adverse Event|13|||
128892279|NCT02941926|463901833|FG000|Extension Phase|Subject/Guardian decision|12|||
128892280|NCT02941926|463901833|FG000|Extension Phase|Death|6|||
128892281|NCT02729740|463901834|FG000|Overall Study|Early Termination|130|||
128892282|NCT02729740|463901834|FG000|Overall Study|Other|1|||
128892283|NCT00307333|463901835|FG000|Overall Study|Lost to Follow-up|11|||
128892284|NCT00307333|463901836|FG001|Overall Study|Lost to Follow-up|3|||
128892285|NCT00698932|463901840|FG000|Overall Study|Adverse Event|0|||
128892286|NCT00698932|463901841|FG001|Overall Study|Adverse Event|2|||
128892287|NCT00698932|463901840|FG000|Overall Study|Incorrect enrollment|0|||
128892288|NCT00698932|463901841|FG001|Overall Study|Incorrect enrollment|2|||
128892289|NCT00698932|463901840|FG000|Overall Study|Study specific discontinuation criteria|3|||
128892290|NCT00698932|463901841|FG001|Overall Study|Study specific discontinuation criteria|4|||
128892291|NCT00698932|463901840|FG000|Overall Study|Withdrawal by Subject|11|||
128892292|NCT00698932|463901841|FG001|Overall Study|Withdrawal by Subject|23|||
128892293|NCT00698932|463901840|FG000|Overall Study|Lost to Follow-up|6|||
128892294|NCT00698932|463901841|FG001|Overall Study|Lost to Follow-up|1|||
128892295|NCT00698932|463901840|FG000|Overall Study|Severe non-compliance to protocol|1|||
128892296|NCT00698932|463901841|FG001|Overall Study|Severe non-compliance to protocol|2|||
128892297|NCT00698932|463901840|FG000|Overall Study|Safety reasons|0|||
128892298|NCT00698932|463901841|FG001|Overall Study|Safety reasons|2|||
128892299|NCT00698932|463901840|FG000|Overall Study|Death|1|||
128892300|NCT00698932|463901841|FG001|Overall Study|Death|0|||
128892301|NCT00601705|463901842|FG000|Overall Study|Withdrawal by Subject|1|||
128892302|NCT03044249|463901849|FG000|Overall Study|Adverse Event|4|||
128892303|NCT03044249|463901850|FG001|Overall Study|Adverse Event|9|||
128892304|NCT03044249|463901849|FG000|Overall Study|Lost to Follow-up|1|||
128892305|NCT03044249|463901850|FG001|Overall Study|Lost to Follow-up|0|||
128892306|NCT03044249|463901849|FG000|Overall Study|Non-compliance with Study Drug|1|||
128892307|NCT03044249|463901850|FG001|Overall Study|Non-compliance with Study Drug|0|||
128892308|NCT03044249|463901849|FG000|Overall Study|Study Terminated by Sponsor|2|||
128892309|NCT03044249|463901850|FG001|Overall Study|Study Terminated by Sponsor|0|||
128892310|NCT03044249|463901849|FG000|Overall Study|Withdrawal by Subject|2|||
128892311|NCT03044249|463901850|FG001|Overall Study|Withdrawal by Subject|5|||
128892312|NCT02101021|463901851|FG000|Overall Study|Death|4|||
128892313|NCT02101021|463901852|FG001|Overall Study|Death|3|||
128892314|NCT02101021|463901853|FG002|Overall Study|Death|6|||
128892315|NCT02101021|463901854|FG003|Overall Study|Death|0|||
128892316|NCT02101021|463901855|FG004|Overall Study|Death|3|||
128892317|NCT02101021|463901851|FG000|Overall Study|Withdrew Consent from study|1|||
128892318|NCT02101021|463901852|FG001|Overall Study|Withdrew Consent from study|1|||
128892319|NCT02101021|463901853|FG002|Overall Study|Withdrew Consent from study|0|||
128892320|NCT02101021|463901854|FG003|Overall Study|Withdrew Consent from study|2|||
128892321|NCT02101021|463901855|FG004|Overall Study|Withdrew Consent from study|0|||
128892322|NCT02101021|463901851|FG000|Overall Study|Lost to Follow-up|1|||
128892323|NCT02101021|463901852|FG001|Overall Study|Lost to Follow-up|0|||
128892324|NCT02101021|463901853|FG002|Overall Study|Lost to Follow-up|0|||
128892325|NCT02101021|463901854|FG003|Overall Study|Lost to Follow-up|0|||
128892326|NCT02101021|463901855|FG004|Overall Study|Lost to Follow-up|0|||
128892327|NCT02101021|463901851|FG000|Overall Study|Study Terminated by Sponsor|1|||
128892328|NCT02101021|463901852|FG001|Overall Study|Study Terminated by Sponsor|0|||
128892329|NCT02101021|463901853|FG002|Overall Study|Study Terminated by Sponsor|1|||
128892330|NCT02101021|463901854|FG003|Overall Study|Study Terminated by Sponsor|1|||
128892331|NCT02101021|463901855|FG004|Overall Study|Study Terminated by Sponsor|1|||
128892332|NCT01621542|463901856|FG000|Overall Study|Adverse Event|0|||
128892333|NCT01621542|463901857|FG001|Overall Study|Adverse Event|0|||
128892334|NCT01621542|463901858|FG002|Overall Study|Adverse Event|1|||
128892335|NCT01621542|463901859|FG003|Overall Study|Adverse Event|3|||
128892336|NCT01621542|463901860|FG004|Overall Study|Adverse Event|0|||
128892337|NCT01621542|463901861|FG005|Overall Study|Adverse Event|0|||
128892338|NCT01621542|463901856|FG000|Overall Study|Death|0|||
128892339|NCT01621542|463901857|FG001|Overall Study|Death|1|||
128892340|NCT01621542|463901858|FG002|Overall Study|Death|0|||
128892341|NCT01621542|463901859|FG003|Overall Study|Death|0|||
128892342|NCT01621542|463901860|FG004|Overall Study|Death|0|||
128892343|NCT01621542|463901861|FG005|Overall Study|Death|0|||
128892344|NCT01621542|463901856|FG000|Overall Study|Physician Decision|1|||
128892345|NCT01621542|463901857|FG001|Overall Study|Physician Decision|0|||
128892346|NCT01621542|463901858|FG002|Overall Study|Physician Decision|1|||
129020830|NCT00272779|464368571|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
129020831|NCT00272779|464368572|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
129020832|NCT00272779|464368571|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
129020833|NCT00272779|464368572|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
129020834|NCT00272779|464368571|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
129020835|NCT00272779|464368572|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
129020836|NCT00272779|464368571|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
129020837|NCT00272779|464368572|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
129020838|NCT00272779|464368571|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
129020839|NCT00272779|464368572|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
129020840|NCT00272779|464368571|FG000|Baseline Through Week 48|Continuing treatment|385|||
129020841|NCT00272779|464368572|FG001|Baseline Through Week 48|Continuing treatment|368|||
128892347|NCT01621542|463901859|FG003|Overall Study|Physician Decision|13|||
128892348|NCT01621542|463901860|FG004|Overall Study|Physician Decision|3|||
128892349|NCT01621542|463901861|FG005|Overall Study|Physician Decision|1|||
128892350|NCT01621542|463901856|FG000|Overall Study|Withdrawal by Subject|2|||
128892351|NCT01621542|463901857|FG001|Overall Study|Withdrawal by Subject|0|||
128892352|NCT01621542|463901858|FG002|Overall Study|Withdrawal by Subject|1|||
128892353|NCT01621542|463901859|FG003|Overall Study|Withdrawal by Subject|3|||
128892354|NCT01621542|463901860|FG004|Overall Study|Withdrawal by Subject|3|||
128892355|NCT01621542|463901861|FG005|Overall Study|Withdrawal by Subject|3|||
128892356|NCT01621542|463901856|FG000|Overall Study|progression/treatment failure|2|||
128892357|NCT01621542|463901857|FG001|Overall Study|progression/treatment failure|4|||
128892358|NCT01621542|463901858|FG002|Overall Study|progression/treatment failure|3|||
128892359|NCT01621542|463901859|FG003|Overall Study|progression/treatment failure|7|||
128892360|NCT01621542|463901860|FG004|Overall Study|progression/treatment failure|3|||
128892361|NCT01621542|463901861|FG005|Overall Study|progression/treatment failure|5|||
128892362|NCT01621542|463901856|FG000|Overall Study|Protocol Violation|0|||
128892363|NCT01621542|463901857|FG001|Overall Study|Protocol Violation|0|||
128892364|NCT01621542|463901858|FG002|Overall Study|Protocol Violation|0|||
128892365|NCT01621542|463901859|FG003|Overall Study|Protocol Violation|1|||
128892366|NCT01621542|463901860|FG004|Overall Study|Protocol Violation|0|||
128892367|NCT01621542|463901861|FG005|Overall Study|Protocol Violation|0|||
128892368|NCT01621542|463901856|FG000|Overall Study|study stopped by sponsor|0|||
128892369|NCT01621542|463901857|FG001|Overall Study|study stopped by sponsor|0|||
128892370|NCT01621542|463901858|FG002|Overall Study|study stopped by sponsor|0|||
128892371|NCT01621542|463901859|FG003|Overall Study|study stopped by sponsor|1|||
128892372|NCT01621542|463901860|FG004|Overall Study|study stopped by sponsor|0|||
128892373|NCT01621542|463901861|FG005|Overall Study|study stopped by sponsor|0|||
128892374|NCT01368042|463901862|FG000|Overall Study|Death|14|||
128892375|NCT01368042|463901862|FG000|Overall Study|Protocol Violation|11|||
128892376|NCT01368042|463901862|FG000|Overall Study|Lost to Follow-up|4|||
128892377|NCT01368042|463901862|FG000|Overall Study|Transplanted|1|||
128892378|NCT00955279|463901863|FG000|Overall Study|Other|0|||
128892379|NCT00955279|463901864|FG001|Overall Study|Other|0|||
128892380|NCT00955279|463901865|FG002|Overall Study|Other|3|||
128892381|NCT00955279|463901863|FG000|Overall Study|Death|1|||
128892382|NCT00955279|463901864|FG001|Overall Study|Death|1|||
128892383|NCT00955279|463901865|FG002|Overall Study|Death|1|||
128892384|NCT00955279|463901863|FG000|Overall Study|Lost to Follow-up|0|||
128892385|NCT00955279|463901864|FG001|Overall Study|Lost to Follow-up|3|||
128892386|NCT00955279|463901865|FG002|Overall Study|Lost to Follow-up|1|||
128892387|NCT00955279|463901863|FG000|Overall Study|Withdrawal by Subject|2|||
129020842|NCT00272779|464368571|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
129020843|NCT00272779|464368572|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
129020844|NCT00272779|464368571|FG000|Baseline Through Week 48|Never treated|2|||
129020845|NCT00272779|464368572|FG001|Baseline Through Week 48|Never treated|3|||
129020846|NCT00272779|464368571|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
129020847|NCT00272779|464368572|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
129020848|NCT00272779|464368571|FG000|Baseline Through Week 96|Death before Week 96|6|||
129020849|NCT00272779|464368572|FG001|Baseline Through Week 96|Death before Week 96|5|||
129020850|NCT00272779|464368571|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
129020851|NCT00272779|464368572|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
129020852|NCT00272779|464368571|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
129020853|NCT00272779|464368572|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
129020854|NCT00272779|464368571|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
129020855|NCT00272779|464368572|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
129020856|NCT00272779|464368571|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
129020857|NCT00272779|464368572|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
129020858|NCT00272779|464368571|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
129020859|NCT00272779|464368572|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
129020860|NCT00272779|464368571|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
129020861|NCT00272779|464368572|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
129020862|NCT00272779|464368571|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
129020863|NCT00272779|464368572|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
129020864|NCT00272779|464368571|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
129020865|NCT00272779|464368572|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
129020866|NCT00272779|464368571|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
129020867|NCT00272779|464368572|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
129020868|NCT00272779|464368571|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
129020869|NCT00272779|464368572|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
129020870|NCT00272779|464368571|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
129020871|NCT00272779|464368572|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
129020872|NCT00272779|464368571|FG000|Baseline Through Week 96|Never treated|2|||
129020873|NCT00272779|464368572|FG001|Baseline Through Week 96|Never treated|3|||
129020874|NCT00272779|464368571|FG000|Baseline Through Week 96|Continuing on treatment|61|||
129020875|NCT00272779|464368572|FG001|Baseline Through Week 96|Continuing on treatment|38|||
129020876|NCT00440518|464368573|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
129020877|NCT00440518|464368574|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
129020878|NCT00440518|464368575|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
129020879|NCT00440518|464368573|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
129020880|NCT00440518|464368574|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
129020881|NCT00440518|464368575|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
129020882|NCT00440518|464368573|FG000|Randomized /Titration Period|Protocol Deviation|1|||
128892388|NCT00955279|463901864|FG001|Overall Study|Withdrawal by Subject|0|||
128892389|NCT00955279|463901865|FG002|Overall Study|Withdrawal by Subject|3|||
128892390|NCT02632721|463901867|FG000|Overall Study|Adverse Event|0|||
128892391|NCT02632721|463901868|FG001|Overall Study|Adverse Event|0|||
128892392|NCT02632721|463901869|FG002|Overall Study|Adverse Event|2|||
128892393|NCT02632721|463901870|FG003|Overall Study|Adverse Event|5|||
128892394|NCT02632721|463901871|FG004|Overall Study|Adverse Event|3|||
128892395|NCT02632721|463901867|FG000|Overall Study|Dose limiting toxicity|0|||
128892396|NCT02632721|463901868|FG001|Overall Study|Dose limiting toxicity|0|||
128892397|NCT02632721|463901869|FG002|Overall Study|Dose limiting toxicity|0|||
128892398|NCT02632721|463901870|FG003|Overall Study|Dose limiting toxicity|1|||
128892399|NCT02632721|463901871|FG004|Overall Study|Dose limiting toxicity|0|||
128892400|NCT02632721|463901867|FG000|Overall Study|Progressive disease|3|||
128892401|NCT02632721|463901868|FG001|Overall Study|Progressive disease|0|||
128892402|NCT02632721|463901869|FG002|Overall Study|Progressive disease|4|||
128892403|NCT02632721|463901870|FG003|Overall Study|Progressive disease|6|||
128892404|NCT02632721|463901871|FG004|Overall Study|Progressive disease|5|||
128892405|NCT02632721|463901867|FG000|Overall Study|Refused to continue taking trial medication|0|||
128892406|NCT02632721|463901868|FG001|Overall Study|Refused to continue taking trial medication|1|||
128892407|NCT02632721|463901869|FG002|Overall Study|Refused to continue taking trial medication|1|||
128892408|NCT02632721|463901870|FG003|Overall Study|Refused to continue taking trial medication|1|||
128892409|NCT02632721|463901871|FG004|Overall Study|Refused to continue taking trial medication|2|||
128892410|NCT02632721|463901867|FG000|Overall Study|Inadequate clinical condition|0|||
128892411|NCT02632721|463901868|FG001|Overall Study|Inadequate clinical condition|0|||
128892412|NCT02632721|463901869|FG002|Overall Study|Inadequate clinical condition|0|||
128892413|NCT02632721|463901870|FG003|Overall Study|Inadequate clinical condition|0|||
128892414|NCT02632721|463901871|FG004|Overall Study|Inadequate clinical condition|1|||
128892415|NCT02632721|463901867|FG000|Overall Study|No meet eligibility|0|||
128892416|NCT02632721|463901868|FG001|Overall Study|No meet eligibility|0|||
128892417|NCT02632721|463901869|FG002|Overall Study|No meet eligibility|0|||
128892418|NCT02632721|463901870|FG003|Overall Study|No meet eligibility|0|||
128892419|NCT02632721|463901871|FG004|Overall Study|No meet eligibility|1|||
128892420|NCT02632721|463901867|FG000|Overall Study|Allergic reaction|0|||
128892421|NCT02632721|463901868|FG001|Overall Study|Allergic reaction|0|||
128892422|NCT02632721|463901869|FG002|Overall Study|Allergic reaction|0|||
128892423|NCT02632721|463901870|FG003|Overall Study|Allergic reaction|1|||
128892424|NCT02632721|463901871|FG004|Overall Study|Allergic reaction|0|||
128892425|NCT02632721|463901867|FG000|Overall Study|Receiving Decitabine locally|0|||
128892426|NCT02632721|463901868|FG001|Overall Study|Receiving Decitabine locally|0|||
128892427|NCT02632721|463901869|FG002|Overall Study|Receiving Decitabine locally|1|||
128892428|NCT02632721|463901870|FG003|Overall Study|Receiving Decitabine locally|0|||
128892429|NCT02632721|463901871|FG004|Overall Study|Receiving Decitabine locally|0|||
128892430|NCT02632721|463901867|FG000|Overall Study|No benefit from study treatment|1|||
128892431|NCT02632721|463901868|FG001|Overall Study|No benefit from study treatment|1|||
128892432|NCT02632721|463901869|FG002|Overall Study|No benefit from study treatment|0|||
128892433|NCT02632721|463901870|FG003|Overall Study|No benefit from study treatment|0|||
128892434|NCT02632721|463901871|FG004|Overall Study|No benefit from study treatment|1|||
128892435|NCT02632721|463901867|FG000|Overall Study|Patient wish for other treatment|0|||
128892436|NCT02632721|463901868|FG001|Overall Study|Patient wish for other treatment|1|||
128892437|NCT02632721|463901869|FG002|Overall Study|Patient wish for other treatment|0|||
128892438|NCT02632721|463901870|FG003|Overall Study|Patient wish for other treatment|0|||
128892439|NCT02632721|463901871|FG004|Overall Study|Patient wish for other treatment|0|||
128892440|NCT02632721|463901867|FG000|Overall Study|Relapsed Pneumonia|0|||
128892441|NCT02632721|463901868|FG001|Overall Study|Relapsed Pneumonia|0|||
128892442|NCT02632721|463901869|FG002|Overall Study|Relapsed Pneumonia|0|||
128892443|NCT02632721|463901870|FG003|Overall Study|Relapsed Pneumonia|0|||
128892444|NCT02632721|463901871|FG004|Overall Study|Relapsed Pneumonia|1|||
128892445|NCT02632721|463901867|FG000|Overall Study|Therapy refractory AML|0|||
128892446|NCT02632721|463901868|FG001|Overall Study|Therapy refractory AML|0|||
128892447|NCT02632721|463901869|FG002|Overall Study|Therapy refractory AML|0|||
128892448|NCT02632721|463901870|FG003|Overall Study|Therapy refractory AML|0|||
128892449|NCT02632721|463901871|FG004|Overall Study|Therapy refractory AML|1|||
128892450|NCT02632721|463901867|FG000|Overall Study|Increase of white blood cell count|0|||
128892451|NCT02632721|463901868|FG001|Overall Study|Increase of white blood cell count|0|||
128892452|NCT02632721|463901869|FG002|Overall Study|Increase of white blood cell count|0|||
128892453|NCT02632721|463901870|FG003|Overall Study|Increase of white blood cell count|0|||
128892454|NCT02632721|463901871|FG004|Overall Study|Increase of white blood cell count|1|||
128892455|NCT02632721|463901867|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
128892456|NCT02632721|463901868|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
128892457|NCT02632721|463901869|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
128892458|NCT02632721|463901870|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
128892459|NCT02632721|463901871|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
129020883|NCT00440518|464368574|FG001|Randomized /Titration Period|Protocol Deviation|0|||
129020884|NCT00440518|464368575|FG002|Randomized /Titration Period|Protocol Deviation|0|||
128892460|NCT00544648|463901874|FG000|Overall Study|Withdrawal by Subject|1|||
128892461|NCT00544648|463901875|FG001|Overall Study|Withdrawal by Subject|0|||
128892462|NCT00544648|463901874|FG000|Overall Study|Adverse Event|1|||
128892463|NCT00544648|463901875|FG001|Overall Study|Adverse Event|1|||
129020885|NCT00440518|464368573|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
128689058|NCT00257608|463162865|FG000|Chemotherapy Phase|Disease progression|139|||
128689059|NCT00257608|463162866|FG001|Chemotherapy Phase|Disease progression|0|||
128689060|NCT00257608|463162867|FG002|Chemotherapy Phase|Disease progression|0|||
128689061|NCT00257608|463162865|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
128689062|NCT00257608|463162866|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
128689063|NCT00257608|463162867|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
128689064|NCT00257608|463162865|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
128689065|NCT00257608|463162866|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
128689066|NCT00257608|463162867|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
128689067|NCT00257608|463162865|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
128689068|NCT00257608|463162866|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
128689069|NCT00257608|463162867|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
128689070|NCT00257608|463162865|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
128689071|NCT00257608|463162866|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
128689072|NCT00257608|463162867|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
128689073|NCT00257608|463162865|FG000|Chemotherapy Phase|Physician Decision|28|||
128689074|NCT00257608|463162866|FG001|Chemotherapy Phase|Physician Decision|0|||
128689075|NCT00257608|463162867|FG002|Chemotherapy Phase|Physician Decision|0|||
128689076|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Adverse Event|0|||
128689077|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Adverse Event|34|||
128689078|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Adverse Event|38|||
128689079|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Disease progression|0|||
128689080|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Disease progression|204|||
128689081|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Disease progression|168|||
128689082|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
128689083|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
128689084|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
128689085|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
128689086|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
128689087|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
128689088|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
128689089|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
128689090|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
128689091|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
128689092|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
128689093|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
128689094|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
128689095|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
128689096|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
128689097|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Physician Decision|0|||
128689098|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Physician Decision|8|||
128689099|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Physician Decision|11|||
128689100|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
128689101|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
128689102|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
128689103|NCT00257608|463162865|FG000|Post Chemotherapy Phase|Not treated|0|||
128689104|NCT00257608|463162866|FG001|Post Chemotherapy Phase|Not treated|4|||
128689105|NCT00257608|463162867|FG002|Post Chemotherapy Phase|Not treated|7|||
128689106|NCT01920555|463162868|FG000|Overall Study|Physician Decision|1|||
128689107|NCT01920555|463162869|FG001|Overall Study|Physician Decision|2|||
128689108|NCT01920555|463162870|FG002|Overall Study|Physician Decision|1|||
128689109|NCT01920555|463162871|FG003|Overall Study|Physician Decision|2|||
128689110|NCT01920555|463162872|FG004|Overall Study|Physician Decision|0|||
128689111|NCT01920555|463162868|FG000|Overall Study|Lack of Efficacy|2|||
128689112|NCT01920555|463162869|FG001|Overall Study|Lack of Efficacy|0|||
128689113|NCT01920555|463162870|FG002|Overall Study|Lack of Efficacy|0|||
128689114|NCT01920555|463162871|FG003|Overall Study|Lack of Efficacy|0|||
128689115|NCT01920555|463162872|FG004|Overall Study|Lack of Efficacy|0|||
128689116|NCT01920555|463162868|FG000|Overall Study|Travel Difficulties|1|||
128689117|NCT01920555|463162869|FG001|Overall Study|Travel Difficulties|1|||
128689118|NCT01920555|463162870|FG002|Overall Study|Travel Difficulties|0|||
128689119|NCT01920555|463162871|FG003|Overall Study|Travel Difficulties|0|||
128689120|NCT01920555|463162872|FG004|Overall Study|Travel Difficulties|1|||
128689121|NCT01920555|463162868|FG000|Overall Study|Lost to Follow-up|0|||
128689122|NCT01920555|463162869|FG001|Overall Study|Lost to Follow-up|1|||
128689123|NCT01920555|463162870|FG002|Overall Study|Lost to Follow-up|0|||
128689124|NCT01920555|463162871|FG003|Overall Study|Lost to Follow-up|1|||
128689125|NCT01920555|463162872|FG004|Overall Study|Lost to Follow-up|0|||
128689126|NCT03265665|463162875|FG000|24-week Data Collection|Withdrawal by Subject|2|||
128689127|NCT03265665|463162876|FG001|24-week Data Collection|Withdrawal by Subject|2|||
128689128|NCT03265665|463162875|FG000|24-week Data Collection|Lost to Follow-up|4|||
128689129|NCT03265665|463162876|FG001|24-week Data Collection|Lost to Follow-up|5|||
128892464|NCT00544648|463901874|FG000|Overall Study|progression of disease|1|||
128892465|NCT00544648|463901875|FG001|Overall Study|progression of disease|0|||
128892466|NCT02663271|463901876|FG000|Overall Study|Withdrawal by Subject|5|||
128892467|NCT02663271|463901876|FG000|Overall Study|Lack of Efficacy|1|||
128892468|NCT04166383|463901883|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
128892469|NCT04166383|463901883|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
128892470|NCT04166383|463901883|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
128892471|NCT03346057|463901885|FG000|Overall Study|Death|1|||
128892472|NCT03346057|463901886|FG001|Overall Study|Death|2|||
128892473|NCT03346057|463901887|FG002|Overall Study|Death|0|||
128892474|NCT03346057|463901888|FG003|Overall Study|Death|0|||
128892475|NCT03346057|463901885|FG000|Overall Study|Lost to Follow-up|0|||
128892476|NCT03346057|463901886|FG001|Overall Study|Lost to Follow-up|2|||
128892477|NCT03346057|463901887|FG002|Overall Study|Lost to Follow-up|1|||
128892478|NCT03346057|463901888|FG003|Overall Study|Lost to Follow-up|0|||
128892479|NCT03346057|463901885|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
128892480|NCT03346057|463901886|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
128892481|NCT03346057|463901887|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
128892482|NCT03346057|463901888|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
128892483|NCT03346057|463901885|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
128892484|NCT03346057|463901886|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
128892485|NCT03346057|463901887|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
128892486|NCT03346057|463901888|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
128892487|NCT03346057|463901885|FG000|Overall Study|Physician Decision|3|||
128892488|NCT03346057|463901886|FG001|Overall Study|Physician Decision|2|||
128892489|NCT03346057|463901887|FG002|Overall Study|Physician Decision|0|||
128892490|NCT03346057|463901888|FG003|Overall Study|Physician Decision|2|||
128892491|NCT03346057|463901885|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
128892492|NCT03346057|463901886|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
128892493|NCT03346057|463901887|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
128892494|NCT03346057|463901888|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
128892495|NCT03346057|463901885|FG000|Overall Study|Withdrawal by Subject|1|||
128892496|NCT03346057|463901886|FG001|Overall Study|Withdrawal by Subject|0|||
128892497|NCT03346057|463901887|FG002|Overall Study|Withdrawal by Subject|0|||
128892498|NCT03346057|463901888|FG003|Overall Study|Withdrawal by Subject|0|||
128892499|NCT03044886|463901889|FG000|Overall Study|Lost to Follow-up|15|||
128892500|NCT03044886|463901890|FG001|Overall Study|Lost to Follow-up|10|||
128892501|NCT03044886|463901891|FG002|Overall Study|Lost to Follow-up|12|||
128892502|NCT02921269|463901892|FG000|Overall Study|Did not complete DLT period|1|||
128892503|NCT02456662|463901903|FG000|Overall Study|Lost to Follow-up|2|||
128892504|NCT02456662|463901904|FG001|Overall Study|Lost to Follow-up|1|||
128892505|NCT00504153|463901905|FG000|Overall Study|Withdrawal by Subject|1|||
128892506|NCT00504153|463901905|FG000|Overall Study|Adverse Event|4|||
128892507|NCT00504153|463901905|FG000|Overall Study|Death|1|||
128892508|NCT00074581|463901907|FG000|Overall Study|Death|15|||
128892509|NCT00074581|463901908|FG001|Overall Study|Death|16|||
128892510|NCT00074581|463901907|FG000|Overall Study|Withdrawal by Subject|50|||
128892511|NCT00074581|463901908|FG001|Overall Study|Withdrawal by Subject|49|||
128892512|NCT00074581|463901907|FG000|Overall Study|Unable to adhere to visit schedule|13|||
128892513|NCT00074581|463901908|FG001|Overall Study|Unable to adhere to visit schedule|14|||
128892514|NCT00074581|463901907|FG000|Overall Study|Relocated|14|||
128892515|NCT00074581|463901908|FG001|Overall Study|Relocated|9|||
128892516|NCT00074581|463901907|FG000|Overall Study|Were withdrawn by investigator|5|||
128892517|NCT00074581|463901908|FG001|Overall Study|Were withdrawn by investigator|2|||
128892518|NCT00074581|463901907|FG000|Overall Study|Lost to Follow-up|16|||
128892519|NCT00074581|463901908|FG001|Overall Study|Lost to Follow-up|11|||
128892520|NCT00074581|463901907|FG000|Overall Study|Ended relationship w. index participant|117|||
128892521|NCT00074581|463901908|FG001|Overall Study|Ended relationship w. index participant|106|||
129020886|NCT00440518|464368574|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
129020887|NCT00440518|464368575|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
128689130|NCT03265665|463162875|FG000|36-week Data Collection|Lost to Follow-up|6|||
128689131|NCT03265665|463162876|FG001|36-week Data Collection|Lost to Follow-up|8|||
128689132|NCT01193660|463162879|FG000|Overall Study|Withdrawal by Subject|2|||
128689133|NCT01193660|463162880|FG001|Overall Study|Withdrawal by Subject|3|||
128892522|NCT00074581|463901907|FG000|Overall Study|Other|14|||
128892523|NCT00074581|463901908|FG001|Overall Study|Other|19|||
128892524|NCT02322229|463901911|FG000|Overall Study|Physician Decision|2|||
129020888|NCT00440518|464368573|FG000|Randomized /Titration Period|Other|1|||
129020889|NCT00440518|464368574|FG001|Randomized /Titration Period|Other|0|||
128892525|NCT00705432|463901914|FG000|Treatment Period|Adverse Event|45|||
128892526|NCT00705432|463901915|FG001|Treatment Period|Adverse Event|37|||
128892527|NCT00705432|463901916|FG002|Treatment Period|Adverse Event|51|||
128892528|NCT00705432|463901917|FG003|Treatment Period|Adverse Event|12|||
128892529|NCT00705432|463901918|FG004|Treatment Period|Adverse Event|8|||
128892530|NCT00705432|463901919|FG005|Treatment Period|Adverse Event|9|||
129020890|NCT00440518|464368575|FG002|Randomized /Titration Period|Other|0|||
128892531|NCT00705432|463901914|FG000|Treatment Period|Treatment failure|92|||
128892532|NCT00705432|463901915|FG001|Treatment Period|Treatment failure|42|||
128892533|NCT00705432|463901916|FG002|Treatment Period|Treatment failure|33|||
128892534|NCT00705432|463901917|FG003|Treatment Period|Treatment failure|25|||
128892535|NCT00705432|463901918|FG004|Treatment Period|Treatment failure|13|||
128892536|NCT00705432|463901919|FG005|Treatment Period|Treatment failure|14|||
128892537|NCT00705432|463901914|FG000|Treatment Period|Non medical reason|26|||
128892538|NCT00705432|463901915|FG001|Treatment Period|Non medical reason|32|||
128892539|NCT00705432|463901916|FG002|Treatment Period|Non medical reason|37|||
128892540|NCT00705432|463901917|FG003|Treatment Period|Non medical reason|4|||
128892541|NCT00705432|463901918|FG004|Treatment Period|Non medical reason|7|||
128892542|NCT00705432|463901919|FG005|Treatment Period|Non medical reason|7|||
128892543|NCT00705432|463901914|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
128892544|NCT00705432|463901915|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
128892545|NCT00705432|463901916|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
128892546|NCT00705432|463901917|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
128892547|NCT00705432|463901918|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
128892548|NCT00705432|463901919|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
128892549|NCT00705432|463901914|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
128892550|NCT00705432|463901915|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
128892551|NCT00705432|463901916|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
128892552|NCT00705432|463901917|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
128892553|NCT00705432|463901918|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
128892554|NCT00705432|463901919|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
128892555|NCT04411628|463901920|FG000|Overall Study|Withdrawal by Subject|1|||
128892556|NCT04411628|463901921|FG001|Overall Study|Withdrawal by Subject|1|||
128892557|NCT04411628|463901922|FG002|Overall Study|Withdrawal by Subject|2|||
128892558|NCT04411628|463901923|FG003|Overall Study|Withdrawal by Subject|0|||
128892559|NCT04411628|463901920|FG000|Overall Study|Lost to Follow-up|0|||
128892560|NCT04411628|463901921|FG001|Overall Study|Lost to Follow-up|1|||
128892561|NCT04411628|463901922|FG002|Overall Study|Lost to Follow-up|0|||
128892562|NCT04411628|463901923|FG003|Overall Study|Lost to Follow-up|0|||
128892563|NCT00521053|463901924|FG000|Observation Phase|Disease Progression|55|||
128892564|NCT00521053|463901924|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
128892565|NCT00521053|463901924|FG000|Observation Phase|Death|2|||
128892566|NCT00521053|463901924|FG000|Observation Phase|Adverse Event|1|||
128892567|NCT00521053|463901924|FG000|Observation Phase|Other non-study melanoma treatment|1|||
128892568|NCT00521053|463901924|FG000|Observation Phase|Physician Decision|1|||
128892569|NCT00732251|463901925|FG000|Overall Study|Lost to Follow-up|3|||
128892570|NCT00732251|463901925|FG000|Overall Study|Withdrawal by Subject|3|||
128892571|NCT00732251|463901925|FG000|Overall Study|Early Term due to Site Closure|1|||
128892572|NCT01034540|463901926|FG000|Overall Study|Adverse Event|0|||
128892573|NCT01034540|463901927|FG001|Overall Study|Adverse Event|1|||
128892574|NCT03519867|463901932|FG000|Overall Study|Adverse Event|1|||
128892575|NCT03519867|463901933|FG001|Overall Study|Adverse Event|1|||
128892576|NCT03519867|463901934|FG002|Overall Study|Adverse Event|0|||
128892577|NCT03519867|463901935|FG003|Overall Study|Adverse Event|0|||
128892578|NCT03519867|463901936|FG004|Overall Study|Adverse Event|0|||
128892579|NCT03519867|463901937|FG005|Overall Study|Adverse Event|0|||
128892580|NCT03519867|463901938|FG006|Overall Study|Adverse Event|0|||
128892581|NCT03519867|463901939|FG007|Overall Study|Adverse Event|0|||
128892582|NCT03519867|463901940|FG008|Overall Study|Adverse Event|0|||
128892583|NCT03519867|463901941|FG009|Overall Study|Adverse Event|0|||
128892584|NCT03519867|463901932|FG000|Overall Study|Protocol Violation|0|||
128892585|NCT03519867|463901933|FG001|Overall Study|Protocol Violation|0|||
128892586|NCT03519867|463901934|FG002|Overall Study|Protocol Violation|0|||
128892587|NCT03519867|463901935|FG003|Overall Study|Protocol Violation|0|||
128892588|NCT03519867|463901936|FG004|Overall Study|Protocol Violation|0|||
129020891|NCT00440518|464368573|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
128689134|NCT01193660|463162881|FG002|Overall Study|Withdrawal by Subject|1|||
129020892|NCT00440518|464368574|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
129020893|NCT00440518|464368575|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
129020894|NCT00440518|464368573|FG000|Randomized /Titration Period|Adverse Event|2|||
129020895|NCT00440518|464368574|FG001|Randomized /Titration Period|Adverse Event|3|||
128892589|NCT03519867|463901937|FG005|Overall Study|Protocol Violation|1|||
128892590|NCT03519867|463901938|FG006|Overall Study|Protocol Violation|0|||
128892591|NCT03519867|463901939|FG007|Overall Study|Protocol Violation|0|||
128892592|NCT03519867|463901940|FG008|Overall Study|Protocol Violation|0|||
128892593|NCT03519867|463901941|FG009|Overall Study|Protocol Violation|0|||
128892594|NCT03519867|463901932|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892595|NCT03519867|463901933|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892596|NCT03519867|463901934|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892597|NCT03519867|463901935|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892598|NCT03519867|463901936|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129110624|NCT01691378|464699910|FG000|Overall Study|Withdrawal by Subject|2|||
129110625|NCT01691378|464699911|FG001|Overall Study|Withdrawal by Subject|0|||
129110626|NCT01691378|464699910|FG000|Overall Study|Lost to Follow-up|5|||
129110627|NCT01691378|464699911|FG001|Overall Study|Lost to Follow-up|2|||
129110628|NCT01827592|464699912|FG000|Overall Study|Adverse Event|11|||
129110629|NCT01827592|464699913|FG001|Overall Study|Adverse Event|9|||
129110630|NCT01827592|464699914|FG002|Overall Study|Adverse Event|2|||
129110631|NCT01827592|464699912|FG000|Overall Study|Physician Decision|0|||
129110632|NCT01827592|464699913|FG001|Overall Study|Physician Decision|2|||
129110633|NCT01827592|464699914|FG002|Overall Study|Physician Decision|1|||
129110634|NCT01827592|464699912|FG000|Overall Study|Protocol Violation|2|||
129110635|NCT01827592|464699913|FG001|Overall Study|Protocol Violation|1|||
129110636|NCT01827592|464699914|FG002|Overall Study|Protocol Violation|0|||
129110637|NCT01827592|464699912|FG000|Overall Study|Lost to Follow-up|1|||
129110638|NCT01827592|464699913|FG001|Overall Study|Lost to Follow-up|2|||
129110639|NCT01827592|464699914|FG002|Overall Study|Lost to Follow-up|2|||
129110640|NCT01827592|464699912|FG000|Overall Study|Withdrawal by Subject|12|||
128689135|NCT01193660|463162879|FG000|Overall Study|Death|1|||
128689136|NCT01193660|463162880|FG001|Overall Study|Death|0|||
128689137|NCT01193660|463162881|FG002|Overall Study|Death|0|||
128689138|NCT01193660|463162879|FG000|Overall Study|Physician Decision|1|||
128689139|NCT01193660|463162880|FG001|Overall Study|Physician Decision|0|||
128689140|NCT01193660|463162881|FG002|Overall Study|Physician Decision|1|||
128689141|NCT00195273|463162882|FG000|Overall Study|Adverse Event|9|||
128689142|NCT00195273|463162883|FG001|Overall Study|Adverse Event|9|||
128689143|NCT00195273|463162882|FG000|Overall Study|Protocol deviation|0|||
128689144|NCT00195273|463162883|FG001|Overall Study|Protocol deviation|1|||
128689145|NCT00195273|463162882|FG000|Overall Study|Lack of Efficacy|3|||
128689146|NCT00195273|463162883|FG001|Overall Study|Lack of Efficacy|1|||
128689147|NCT00195273|463162882|FG000|Overall Study|Procedural complications|9|||
128689148|NCT00195273|463162883|FG001|Overall Study|Procedural complications|3|||
128689149|NCT00595465|463162884|FG000|Overall Study|Adverse Event|4|||
128689150|NCT00595465|463162885|FG001|Overall Study|Adverse Event|3|||
128689151|NCT00595465|463162886|FG002|Overall Study|Adverse Event|3|||
128689152|NCT00595465|463162884|FG000|Overall Study|Pregnancy|0|||
128689153|NCT00595465|463162885|FG001|Overall Study|Pregnancy|0|||
128689154|NCT00595465|463162886|FG002|Overall Study|Pregnancy|1|||
128689155|NCT00595465|463162884|FG000|Overall Study|Protocol Violation|2|||
128689156|NCT00595465|463162885|FG001|Overall Study|Protocol Violation|1|||
128689157|NCT00595465|463162886|FG002|Overall Study|Protocol Violation|0|||
128689158|NCT00595465|463162884|FG000|Overall Study|Lost to Follow-up|0|||
128689159|NCT00595465|463162885|FG001|Overall Study|Lost to Follow-up|0|||
128689160|NCT00595465|463162886|FG002|Overall Study|Lost to Follow-up|2|||
128689161|NCT00595465|463162884|FG000|Overall Study|administrative reason|0|||
128689162|NCT00595465|463162885|FG001|Overall Study|administrative reason|0|||
128689163|NCT00595465|463162886|FG002|Overall Study|administrative reason|1|||
128689164|NCT02595970|463162887|FG000|Overall Study|Withdrawal by Subject|2|||
128689165|NCT02595970|463162887|FG000|Overall Study|Physician Decision|2|||
128689166|NCT02595970|463162887|FG000|Overall Study|Protocol Violation|4|||
128689167|NCT02595970|463162887|FG000|Overall Study|Adverse Event|5|||
128689168|NCT02595970|463162887|FG000|Overall Study|Lack of Efficacy|7|||
128689169|NCT01886716|463162888|FG000|Week 1|Lost to Follow-up|0|||
128689170|NCT01886716|463162889|FG001|Week 1|Lost to Follow-up|0|||
128689171|NCT01886716|463162890|FG002|Week 1|Lost to Follow-up|2|||
128689172|NCT01886716|463162891|FG003|Week 1|Lost to Follow-up|2|||
128689173|NCT01886716|463162888|FG000|Week 2|Lost to Follow-up|3|||
128689174|NCT01886716|463162889|FG001|Week 2|Lost to Follow-up|2|||
128689175|NCT01886716|463162890|FG002|Week 2|Lost to Follow-up|1|||
128689176|NCT01886716|463162891|FG003|Week 2|Lost to Follow-up|3|||
128689177|NCT01886716|463162888|FG000|Week 3|Lost to Follow-up|1|||
128689178|NCT01886716|463162889|FG001|Week 3|Lost to Follow-up|1|||
128689179|NCT01886716|463162890|FG002|Week 3|Lost to Follow-up|0|||
128689180|NCT01886716|463162891|FG003|Week 3|Lost to Follow-up|1|||
128689181|NCT04879225|463162894|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
128689182|NCT04879225|463162894|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
128689183|NCT02367131|463162897|FG000|Overall Study|Adverse Event|64|||
128689184|NCT02367131|463162897|FG000|Overall Study|No visit since the first visit|3|||
128689185|NCT02367131|463162897|FG000|Overall Study|Request by patient|53|||
128689186|NCT02367131|463162897|FG000|Overall Study|Improvement/remission|2|||
128689187|NCT02367131|463162897|FG000|Overall Study|No change/progressive disease|78|||
128689188|NCT02367131|463162897|FG000|Overall Study|Other than stated above|20|||
128689189|NCT02367131|463162897|FG000|Overall Study|Not treated|2|||
128689190|NCT02572388|463162898|FG000|Overall Study|Withdrawal by Subject|1|||
128689191|NCT02572388|463162899|FG001|Overall Study|Withdrawal by Subject|1|||
128689192|NCT02572388|463162900|FG002|Overall Study|Withdrawal by Subject|2|||
128689193|NCT02572388|463162901|FG003|Overall Study|Withdrawal by Subject|2|||
128689194|NCT01973569|463162902|FG000|Overall Study|Adverse Event|9|||
129110641|NCT01827592|464699913|FG001|Overall Study|Withdrawal by Subject|11|||
129110642|NCT01827592|464699914|FG002|Overall Study|Withdrawal by Subject|11|||
129110643|NCT01827592|464699912|FG000|Overall Study|Patient's substantial non-compliance|1|||
128892599|NCT03519867|463901937|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892600|NCT03519867|463901938|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
128892601|NCT03519867|463901939|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892602|NCT03519867|463901940|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892603|NCT03519867|463901941|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
128892604|NCT03519867|463901932|FG000|Overall Study|Admin. of other reversal agent|1|||
128892605|NCT03519867|463901933|FG001|Overall Study|Admin. of other reversal agent|1|||
128892606|NCT03519867|463901934|FG002|Overall Study|Admin. of other reversal agent|0|||
128892607|NCT03519867|463901935|FG003|Overall Study|Admin. of other reversal agent|0|||
128892608|NCT03519867|463901936|FG004|Overall Study|Admin. of other reversal agent|0|||
128892609|NCT03519867|463901937|FG005|Overall Study|Admin. of other reversal agent|1|||
128892610|NCT03519867|463901938|FG006|Overall Study|Admin. of other reversal agent|0|||
128892611|NCT03519867|463901939|FG007|Overall Study|Admin. of other reversal agent|0|||
128892612|NCT03519867|463901940|FG008|Overall Study|Admin. of other reversal agent|0|||
128892613|NCT03519867|463901941|FG009|Overall Study|Admin. of other reversal agent|0|||
128892614|NCT03519867|463901932|FG000|Overall Study|Reason not provided|1|||
128892615|NCT03519867|463901933|FG001|Overall Study|Reason not provided|1|||
128892616|NCT03519867|463901934|FG002|Overall Study|Reason not provided|1|||
128892617|NCT03519867|463901935|FG003|Overall Study|Reason not provided|1|||
128892618|NCT03519867|463901936|FG004|Overall Study|Reason not provided|0|||
128892619|NCT03519867|463901937|FG005|Overall Study|Reason not provided|1|||
128892620|NCT03519867|463901938|FG006|Overall Study|Reason not provided|0|||
128892621|NCT03519867|463901939|FG007|Overall Study|Reason not provided|1|||
128892622|NCT03519867|463901940|FG008|Overall Study|Reason not provided|1|||
128892623|NCT03519867|463901941|FG009|Overall Study|Reason not provided|0|||
128892624|NCT01252810|463901942|FG000|Overall Study|Withdrawal by Subject|4|||
128892625|NCT01252810|463901943|FG001|Overall Study|Withdrawal by Subject|1|||
128892626|NCT01252810|463901942|FG000|Overall Study|Lost to Follow-up|0|||
128892627|NCT01252810|463901943|FG001|Overall Study|Lost to Follow-up|1|||
128892628|NCT01252810|463901942|FG000|Overall Study|Physician Decision|2|||
128892629|NCT01252810|463901943|FG001|Overall Study|Physician Decision|1|||
128892630|NCT01252810|463901942|FG000|Overall Study|Various reasons|8|||
128892631|NCT01252810|463901943|FG001|Overall Study|Various reasons|0|||
128892632|NCT03007979|463901945|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
128892633|NCT01428661|463901946|FG000|Double-Masked Phase|Protocol Violation|9|||
128892634|NCT01428661|463901947|FG001|Double-Masked Phase|Protocol Violation|4|||
128892635|NCT01428661|463901948|FG002|Double-Masked Phase|Protocol Violation|0|||
128892636|NCT01428661|463901946|FG000|Double-Masked Phase|Adverse Event|13|||
128892637|NCT01428661|463901947|FG001|Double-Masked Phase|Adverse Event|4|||
128892638|NCT01428661|463901948|FG002|Double-Masked Phase|Adverse Event|0|||
128892639|NCT01428661|463901946|FG000|Double-Masked Phase|Lost to Follow-up|14|||
128892640|NCT01428661|463901947|FG001|Double-Masked Phase|Lost to Follow-up|14|||
128892641|NCT01428661|463901948|FG002|Double-Masked Phase|Lost to Follow-up|0|||
129020896|NCT00440518|464368575|FG002|Randomized /Titration Period|Adverse Event|0|||
129020897|NCT00440518|464368573|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
129020898|NCT00440518|464368574|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
129020899|NCT00440518|464368575|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
129020900|NCT00440518|464368573|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
129020901|NCT00440518|464368574|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
129020902|NCT00440518|464368575|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
129020903|NCT00440518|464368573|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
129020904|NCT00440518|464368574|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
129020905|NCT00440518|464368575|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
129020906|NCT00440518|464368573|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
129020907|NCT00440518|464368574|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
129020908|NCT00440518|464368575|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
129020909|NCT00440518|464368573|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
129020910|NCT00440518|464368574|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
129020911|NCT00440518|464368575|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
129020912|NCT00440518|464368573|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
129020913|NCT00440518|464368574|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
129020914|NCT00440518|464368575|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
128689195|NCT01973569|463162903|FG001|Overall Study|Adverse Event|2|||
128892642|NCT01428661|463901946|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
128892643|NCT01428661|463901947|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
128892644|NCT01428661|463901948|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
128892645|NCT01428661|463901946|FG000|Double-Masked Phase|Lack of Efficacy|2|||
128892646|NCT01428661|463901947|FG001|Double-Masked Phase|Lack of Efficacy|1|||
129020915|NCT03570749|464368577|FG000|Overall Study|Ongoing|26|||
129020916|NCT03570749|464368578|FG001|Overall Study|Ongoing|25|||
129215199|NCT02195518|465089463|FG000|Overall Study|Withdrawal by Subject|1|||
128689196|NCT01973569|463162904|FG002|Overall Study|Adverse Event|4|||
128892647|NCT01428661|463901948|FG002|Double-Masked Phase|Lack of Efficacy|0|||
128892648|NCT01428661|463901946|FG000|Double-Masked Phase|*Various|1|||
128892649|NCT01428661|463901947|FG001|Double-Masked Phase|*Various|6|||
128892650|NCT01428661|463901948|FG002|Double-Masked Phase|*Various|0|||
128892651|NCT01428661|463901946|FG000|Open Label Extension|Protocol Violation|0|||
128892652|NCT01428661|463901947|FG001|Open Label Extension|Protocol Violation|0|||
128892653|NCT01428661|463901948|FG002|Open Label Extension|Protocol Violation|9|||
128892654|NCT01428661|463901946|FG000|Open Label Extension|Adverse Event|0|||
128892655|NCT01428661|463901947|FG001|Open Label Extension|Adverse Event|0|||
128892656|NCT01428661|463901948|FG002|Open Label Extension|Adverse Event|15|||
128892657|NCT01428661|463901946|FG000|Open Label Extension|Lost to Follow-up|0|||
128892658|NCT01428661|463901947|FG001|Open Label Extension|Lost to Follow-up|0|||
128892659|NCT01428661|463901948|FG002|Open Label Extension|Lost to Follow-up|38|||
128892660|NCT01428661|463901946|FG000|Open Label Extension|Withdrawal by Subject|0|||
128892661|NCT01428661|463901947|FG001|Open Label Extension|Withdrawal by Subject|0|||
128892662|NCT01428661|463901948|FG002|Open Label Extension|Withdrawal by Subject|49|||
128892663|NCT01428661|463901946|FG000|Open Label Extension|Lack of Efficacy|0|||
128892664|NCT01428661|463901947|FG001|Open Label Extension|Lack of Efficacy|0|||
128892665|NCT01428661|463901948|FG002|Open Label Extension|Lack of Efficacy|24|||
128892666|NCT01428661|463901946|FG000|Open Label Extension|**Various|0|||
128892667|NCT01428661|463901947|FG001|Open Label Extension|**Various|0|||
128892668|NCT01428661|463901948|FG002|Open Label Extension|**Various|185|||
128892669|NCT00761306|463903880|FG000|Overall Study|Adverse Event|5|||
128892670|NCT00761306|463903880|FG000|Overall Study|Lack of Efficacy|4|||
128892671|NCT00761306|463903880|FG000|Overall Study|Protocol Violation|2|||
128892672|NCT00761306|463903880|FG000|Overall Study|Withdrawal of Consent|3|||
128892673|NCT00761306|463903880|FG000|Overall Study|Lost to Follow-up|1|||
128892674|NCT00761306|463903880|FG000|Overall Study|Administrative or Other Reasons|5|||
128892675|NCT05162027|463903881|FG000|Overall Study|Adverse Event|1|||
128892676|NCT05162027|463903882|FG001|Overall Study|Adverse Event|0|||
128892677|NCT03335163|463903883|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
128892678|NCT03335163|463903883|FG000|Overall Study|Withdrawal by Subject|18|||
128892679|NCT03713034|463903884|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
128892680|NCT03713034|463903885|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
128892681|NCT02982239|463903888|FG000|Overall Study|Lost to Follow-up|3|||
128892682|NCT02982239|463903889|FG001|Overall Study|Lost to Follow-up|2|||
128892683|NCT02767323|463903893|FG000|Overall Study|Withdrawal by Subject|17|||
128892684|NCT02767323|463903894|FG001|Overall Study|Withdrawal by Subject|5|||
128892685|NCT02767323|463903895|FG002|Overall Study|Withdrawal by Subject|13|||
128892686|NCT02767323|463903896|FG003|Overall Study|Withdrawal by Subject|0|||
128892687|NCT02767323|463903893|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
128892688|NCT02767323|463903894|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
128892689|NCT02767323|463903895|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
128892690|NCT02767323|463903896|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
128892691|NCT04479436|463903898|FG000|Overall Study|Progressive disease|26|||
128892692|NCT04479436|463903899|FG001|Overall Study|Progressive disease|1|||
128892693|NCT04479436|463903898|FG000|Overall Study|Adverse Event|6|||
128892694|NCT04479436|463903899|FG001|Overall Study|Adverse Event|0|||
128892695|NCT04479436|463903898|FG000|Overall Study|Withdrawal by Subject|5|||
128892696|NCT04479436|463903899|FG001|Overall Study|Withdrawal by Subject|0|||
128892697|NCT04479436|463903898|FG000|Overall Study|Clinical progression|1|||
128892698|NCT04479436|463903899|FG001|Overall Study|Clinical progression|0|||
128892699|NCT04479436|463903898|FG000|Overall Study|Physician Decision|1|||
128892700|NCT04479436|463903899|FG001|Overall Study|Physician Decision|0|||
128892701|NCT01372150|463903902|FG000|Overall Study|Lack of Efficacy|3|||
128892702|NCT01372150|463903903|FG001|Overall Study|Lack of Efficacy|0|||
128892703|NCT01372150|463903904|FG002|Overall Study|Lack of Efficacy|1|||
128892704|NCT01372150|463903902|FG000|Overall Study|Lost to Follow-up|4|||
128892705|NCT01372150|463903903|FG001|Overall Study|Lost to Follow-up|5|||
128892706|NCT01372150|463903904|FG002|Overall Study|Lost to Follow-up|6|||
128892707|NCT01372150|463903902|FG000|Overall Study|Protocol Violation|1|||
128892708|NCT01372150|463903903|FG001|Overall Study|Protocol Violation|0|||
128892709|NCT01372150|463903904|FG002|Overall Study|Protocol Violation|3|||
128892710|NCT01372150|463903902|FG000|Overall Study|Withdrawal by Subject|2|||
128892711|NCT01372150|463903903|FG001|Overall Study|Withdrawal by Subject|7|||
128892712|NCT01372150|463903904|FG002|Overall Study|Withdrawal by Subject|2|||
128892713|NCT01372150|463903902|FG000|Overall Study|Other|1|||
128892714|NCT01372150|463903903|FG001|Overall Study|Other|0|||
128892715|NCT01372150|463903904|FG002|Overall Study|Other|2|||
128892716|NCT01372150|463903902|FG000|Overall Study|Adverse Event|2|||
128892717|NCT01372150|463903903|FG001|Overall Study|Adverse Event|1|||
128892718|NCT01372150|463903904|FG002|Overall Study|Adverse Event|2|||
128892719|NCT01372150|463903902|FG000|Overall Study|Randomized but not treated|0|||
128892720|NCT01372150|463903903|FG001|Overall Study|Randomized but not treated|1|||
128892721|NCT01372150|463903904|FG002|Overall Study|Randomized but not treated|0|||
129020917|NCT03570749|464368579|FG002|Overall Study|Ongoing|25|||
128892722|NCT01526551|463903905|FG000|Overall Study|Lack of returned parental consent form|424|||
128892723|NCT05215262|463903906|FG000|Overall Study|Lost to Follow-up|12|||
128892724|NCT05215262|463903907|FG001|Overall Study|Lost to Follow-up|0|||
128892725|NCT00718549|463903912|FG000|Induction Phase|Disease Progression|1|||
128892726|NCT00718549|463903913|FG001|Induction Phase|Disease Progression|0|||
128892727|NCT00718549|463903914|FG002|Induction Phase|Disease Progression|0|||
128892728|NCT00718549|463903912|FG000|Induction Phase|Eligibility Criteria Violation|2|||
128892729|NCT00718549|463903913|FG001|Induction Phase|Eligibility Criteria Violation|0|||
128892730|NCT00718549|463903914|FG002|Induction Phase|Eligibility Criteria Violation|0|||
128892731|NCT00718549|463903912|FG000|Induction Phase|Early Termination - No Additional Info|59|||
128892732|NCT00718549|463903913|FG001|Induction Phase|Early Termination - No Additional Info|0|||
128892733|NCT00718549|463903914|FG002|Induction Phase|Early Termination - No Additional Info|0|||
128892734|NCT00718549|463903912|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
128892735|NCT00718549|463903913|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
128892736|NCT00718549|463903914|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
128892737|NCT00718549|463903912|FG000|Maintenance/ Observation Phase|Death|0|||
128892738|NCT00718549|463903913|FG001|Maintenance/ Observation Phase|Death|1|||
128892739|NCT00718549|463903914|FG002|Maintenance/ Observation Phase|Death|2|||
128892740|NCT00718549|463903912|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
128892741|NCT00718549|463903913|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
128892742|NCT00718549|463903914|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
128892743|NCT00718549|463903912|FG000|Maintenance/ Observation Phase|Progression|0|||
128892744|NCT00718549|463903913|FG001|Maintenance/ Observation Phase|Progression|5|||
128892745|NCT00718549|463903914|FG002|Maintenance/ Observation Phase|Progression|14|||
128892746|NCT00718549|463903912|FG000|Maintenance/ Observation Phase|Relapse|0|||
128892747|NCT00718549|463903913|FG001|Maintenance/ Observation Phase|Relapse|3|||
128892748|NCT00718549|463903914|FG002|Maintenance/ Observation Phase|Relapse|2|||
128892749|NCT01353508|463903915|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
128892750|NCT01353508|463903916|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
128892751|NCT01353508|463903917|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
128892752|NCT01353508|463903918|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
128892753|NCT01353508|463903915|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
128892754|NCT01353508|463903916|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
128892755|NCT01353508|463903917|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
128892756|NCT01353508|463903918|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
128892757|NCT02092350|463903923|FG000|Overall Study|Adverse Event|0|||
128892758|NCT02092350|463903924|FG001|Overall Study|Adverse Event|3|||
128892759|NCT02092350|463903923|FG000|Overall Study|Death|2|||
128892760|NCT02092350|463903924|FG001|Overall Study|Death|5|||
128892761|NCT02092350|463903923|FG000|Overall Study|Lost to Follow-up|3|||
128892762|NCT02092350|463903924|FG001|Overall Study|Lost to Follow-up|1|||
128689197|NCT01973569|463162902|FG000|Overall Study|Protocol Violation|2|||
128689198|NCT01973569|463162903|FG001|Overall Study|Protocol Violation|1|||
128689199|NCT01973569|463162904|FG002|Overall Study|Protocol Violation|3|||
128689200|NCT01973569|463162902|FG000|Overall Study|Withdrawal by Subject|7|||
128689201|NCT01973569|463162903|FG001|Overall Study|Withdrawal by Subject|5|||
128689202|NCT01973569|463162904|FG002|Overall Study|Withdrawal by Subject|2|||
128689203|NCT01973569|463162902|FG000|Overall Study|Invasive dental treatment|3|||
128689204|NCT01973569|463162903|FG001|Overall Study|Invasive dental treatment|5|||
128689205|NCT01973569|463162904|FG002|Overall Study|Invasive dental treatment|6|||
128689206|NCT01973569|463162902|FG000|Overall Study|Prohibited concomitant d|1|||
128689207|NCT01973569|463162903|FG001|Overall Study|Prohibited concomitant d|5|||
128689208|NCT01973569|463162904|FG002|Overall Study|Prohibited concomitant d|0|||
128892763|NCT02092350|463903923|FG000|Overall Study|Protocol Violation|1|||
128892764|NCT02092350|463903924|FG001|Overall Study|Protocol Violation|0|||
128892765|NCT02092350|463903923|FG000|Overall Study|Physician Decision|1|||
128892766|NCT02092350|463903924|FG001|Overall Study|Physician Decision|1|||
128892767|NCT02092350|463903923|FG000|Overall Study|Screen Failure|1|||
128892768|NCT02092350|463903924|FG001|Overall Study|Screen Failure|0|||
128892769|NCT02092350|463903923|FG000|Overall Study|Withdrawal by Subject|2|||
128892770|NCT02092350|463903924|FG001|Overall Study|Withdrawal by Subject|2|||
128892771|NCT00239226|463903925|FG000|Overall Study|permAF during stabilization period|0|||
128892772|NCT00239226|463903926|FG001|Overall Study|permAF during stabilization period|0|||
128892773|NCT00239226|463903927|FG002|Overall Study|permAF during stabilization period|0|||
128892774|NCT00239226|463903928|FG003|Overall Study|permAF during stabilization period|3|||
128892775|NCT00239226|463903925|FG000|Overall Study|Lost to Follow-up|1|||
128892776|NCT00239226|463903926|FG001|Overall Study|Lost to Follow-up|0|||
128892777|NCT00239226|463903927|FG002|Overall Study|Lost to Follow-up|1|||
128689209|NCT01973569|463162902|FG000|Overall Study|Disease progression|0|||
128689210|NCT01973569|463162903|FG001|Overall Study|Disease progression|3|||
128892778|NCT00239226|463903928|FG003|Overall Study|Lost to Follow-up|0|||
128892779|NCT00646906|463903930|FG000|Crossover Period 1|Withdrawal by Subject|1|||
128689211|NCT01973569|463162904|FG002|Overall Study|Disease progression|0|||
128892780|NCT00646906|463903931|FG001|Crossover Period 1|Withdrawal by Subject|0|||
128892781|NCT00646906|463903932|FG002|Crossover Period 1|Withdrawal by Subject|0|||
128892782|NCT00646906|463903933|FG003|Crossover Period 1|Withdrawal by Subject|0|||
128892783|NCT00646906|463903934|FG004|Crossover Period 1|Withdrawal by Subject|0|||
128892784|NCT00646906|463903935|FG005|Crossover Period 1|Withdrawal by Subject|1|||
128892785|NCT00646906|463903936|FG006|Crossover Period 1|Withdrawal by Subject|0|||
128892786|NCT00646906|463903930|FG000|Crossover Period 2|Withdrawal by Subject|0|||
128892787|NCT00646906|463903931|FG001|Crossover Period 2|Withdrawal by Subject|1|||
128892788|NCT00646906|463903932|FG002|Crossover Period 2|Withdrawal by Subject|2|||
128892789|NCT00646906|463903933|FG003|Crossover Period 2|Withdrawal by Subject|1|||
128892790|NCT00646906|463903934|FG004|Crossover Period 2|Withdrawal by Subject|0|||
128892791|NCT00646906|463903935|FG005|Crossover Period 2|Withdrawal by Subject|0|||
128892792|NCT00646906|463903936|FG006|Crossover Period 2|Withdrawal by Subject|0|||
128892793|NCT00646906|463903930|FG000|Crossover Period 2|Physician Decision|0|||
128892794|NCT00646906|463903931|FG001|Crossover Period 2|Physician Decision|0|||
128892795|NCT00646906|463903932|FG002|Crossover Period 2|Physician Decision|0|||
128892796|NCT00646906|463903933|FG003|Crossover Period 2|Physician Decision|0|||
128892797|NCT00646906|463903934|FG004|Crossover Period 2|Physician Decision|0|||
128892798|NCT00646906|463903935|FG005|Crossover Period 2|Physician Decision|0|||
128892799|NCT00646906|463903936|FG006|Crossover Period 2|Physician Decision|1|||
128892800|NCT02448225|463903937|FG000|Overall Study|Withdrawal by Subject|1|||
128892801|NCT02448225|463903937|FG000|Overall Study|Did not get FSPG scan|18|||
128892802|NCT02448225|463903937|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
128892803|NCT04422990|463903943|FG000|Overall Study|Withdrawal by Subject|0|||
128892804|NCT04422990|463903944|FG001|Overall Study|Withdrawal by Subject|1|||
128892805|NCT04422990|463903943|FG000|Overall Study|Travel|3|||
128892806|NCT04422990|463903944|FG001|Overall Study|Travel|0|||
128892807|NCT00433914|463903947|FG000|Overall Study|Withdrawal by Subject|0|||
128892808|NCT00433914|463903948|FG001|Overall Study|Withdrawal by Subject|2|||
128892809|NCT00433914|463903947|FG000|Overall Study|Lost to Follow-up|0|||
128892810|NCT00433914|463903948|FG001|Overall Study|Lost to Follow-up|1|||
128892811|NCT02844920|463903949|FG000|Overall Study|Lost to Follow-up|2|||
128892812|NCT00800436|463903960|FG000|Overall Study|Withdrawal by Subject|0|||
128892813|NCT00800436|463903961|FG001|Overall Study|Withdrawal by Subject|0|||
128892814|NCT00800436|463903962|FG002|Overall Study|Withdrawal by Subject|1|||
128892815|NCT00800436|463903963|FG003|Overall Study|Withdrawal by Subject|1|||
128892816|NCT00800436|463903964|FG004|Overall Study|Withdrawal by Subject|0|||
128892817|NCT00800436|463903965|FG005|Overall Study|Withdrawal by Subject|0|||
128892818|NCT00800436|463903966|FG006|Overall Study|Withdrawal by Subject|0|||
128892819|NCT00766090|463903967|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892820|NCT00766090|463903968|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892821|NCT00766090|463903969|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892822|NCT00766090|463903970|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892823|NCT00766090|463903971|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892824|NCT00766090|463903972|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892825|NCT00766090|463903973|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892826|NCT00766090|463903974|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892827|NCT00766090|463903975|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
128892828|NCT00766090|463903976|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892829|NCT00766090|463903977|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892830|NCT00766090|463903978|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128892831|NCT00766090|463903967|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
128892832|NCT00766090|463903968|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892833|NCT00766090|463903969|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129110644|NCT01827592|464699913|FG001|Overall Study|Patient's substantial non-compliance|1|||
129110645|NCT01827592|464699914|FG002|Overall Study|Patient's substantial non-compliance|6|||
129110646|NCT01827592|464699912|FG000|Overall Study|Trial terminated by Sponsor|47|||
129110647|NCT01827592|464699913|FG001|Overall Study|Trial terminated by Sponsor|53|||
129110648|NCT01827592|464699914|FG002|Overall Study|Trial terminated by Sponsor|51|||
129110649|NCT01827592|464699912|FG000|Overall Study|Others|0|||
128764079|NCT01852058|463425907|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129110650|NCT01827592|464699913|FG001|Overall Study|Others|1|||
129110651|NCT01827592|464699914|FG002|Overall Study|Others|3|||
128892834|NCT00766090|463903970|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892835|NCT00766090|463903971|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892836|NCT00766090|463903972|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892837|NCT00766090|463903973|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892838|NCT00766090|463903974|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892839|NCT00766090|463903975|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129110652|NCT00808067|464699918|FG000|Overall Study|Major/minor bleed|30|||
128892840|NCT00766090|463903976|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892841|NCT00766090|463903977|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129110653|NCT00808067|464699919|FG001|Overall Study|Major/minor bleed|44|||
129110654|NCT00808067|464699918|FG000|Overall Study|Outcome event - other|33|||
128892842|NCT00766090|463903978|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
128892843|NCT00766090|463903967|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
128892844|NCT00766090|463903968|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892845|NCT00766090|463903969|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892846|NCT00766090|463903970|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
128892847|NCT00766090|463903971|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892848|NCT00766090|463903972|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892849|NCT00766090|463903973|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892850|NCT00766090|463903974|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892851|NCT00766090|463903975|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892852|NCT00766090|463903976|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892853|NCT00766090|463903977|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892854|NCT00766090|463903978|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128892855|NCT00766090|463903967|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892856|NCT00766090|463903968|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892857|NCT00766090|463903969|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
128892858|NCT00766090|463903970|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892859|NCT00766090|463903971|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892860|NCT00766090|463903972|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892861|NCT00766090|463903973|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892862|NCT00766090|463903974|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892863|NCT00766090|463903975|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892864|NCT00766090|463903976|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892865|NCT00766090|463903977|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892866|NCT00766090|463903978|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
128892867|NCT00766090|463903967|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892868|NCT00766090|463903968|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892869|NCT00766090|463903969|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892870|NCT00766090|463903970|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892871|NCT00766090|463903971|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
128892872|NCT00766090|463903972|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892873|NCT00766090|463903973|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892874|NCT00766090|463903974|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892875|NCT00766090|463903975|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892876|NCT00766090|463903976|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892877|NCT00766090|463903977|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892878|NCT00766090|463903978|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128892879|NCT00766090|463903967|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128892880|NCT00766090|463903968|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128892881|NCT00766090|463903969|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
128892882|NCT00766090|463903970|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128892883|NCT00766090|463903971|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128892884|NCT00766090|463903972|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128689212|NCT01973569|463162902|FG000|Overall Study|Other|1|||
128689213|NCT01973569|463162903|FG001|Overall Study|Other|1|||
128689214|NCT01973569|463162904|FG002|Overall Study|Other|0|||
128689215|NCT01973569|463162902|FG000|Overall Study|Did not receive study drug|6|||
128689216|NCT01973569|463162903|FG001|Overall Study|Did not receive study drug|3|||
128689217|NCT01973569|463162904|FG002|Overall Study|Did not receive study drug|3|||
128689218|NCT01051466|463162907|FG000|Overall Study|Adverse Event|1|||
128689219|NCT01051466|463162908|FG001|Overall Study|Adverse Event|0|||
128689220|NCT01051466|463162907|FG000|Overall Study|Lost to Follow-up|1|||
128892885|NCT00766090|463903973|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128689221|NCT01051466|463162908|FG001|Overall Study|Lost to Follow-up|1|||
128689222|NCT01051466|463162907|FG000|Overall Study|Withdrawal by Subject|5|||
128689223|NCT01051466|463162908|FG001|Overall Study|Withdrawal by Subject|1|||
128892886|NCT00766090|463903974|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128892887|NCT00766090|463903975|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128892888|NCT00766090|463903976|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128892889|NCT00766090|463903977|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
128689224|NCT01051466|463162907|FG000|Overall Study|Entry Criteria Not Met|0|||
128689225|NCT01051466|463162908|FG001|Overall Study|Entry Criteria Not Met|3|||
128689226|NCT01051466|463162907|FG000|Overall Study|Physician Decision|1|||
128689227|NCT01051466|463162908|FG001|Overall Study|Physician Decision|0|||
128892890|NCT00766090|463903978|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129020918|NCT03570749|464368580|FG003|Overall Study|Ongoing|26|||
129020919|NCT03570749|464368581|FG004|Overall Study|Ongoing|140|||
129020920|NCT03570749|464368582|FG005|Overall Study|Ongoing|142|||
129020921|NCT03570749|464368583|FG006|Overall Study|Ongoing|220|||
129020922|NCT03570749|464368577|FG000|Overall Study|Adverse Event|0|||
129020923|NCT03570749|464368578|FG001|Overall Study|Adverse Event|0|||
129020924|NCT03570749|464368579|FG002|Overall Study|Adverse Event|0|||
128689228|NCT00810108|463162909|FG000|Overall Study|Withdrawal by Subject|1|||
128689229|NCT00810108|463162910|FG001|Overall Study|Withdrawal by Subject|0|||
128689230|NCT02486302|463162919|FG000|Overall Study|Discontinued prematurely|410|||
128689231|NCT02486302|463162919|FG000|Overall Study|Documentation not completed|255|||
128689232|NCT02486302|463162919|FG000|Overall Study|Excluded due to legal reasons|8|||
128689233|NCT02486302|463162919|FG000|Overall Study|Not treated|3|||
128689234|NCT00570765|463162927|FG000|DB Phase|Withdrawal by Subject|1|||
128689235|NCT00570765|463162928|FG001|DB Phase|Withdrawal by Subject|0|||
128689236|NCT00570765|463162929|FG002|DB Phase|Withdrawal by Subject|0|||
128689237|NCT00570765|463162930|FG003|DB Phase|Withdrawal by Subject|0|||
128689238|NCT00570765|463162927|FG000|DB Phase|Protocol Violation|0|||
128689239|NCT00570765|463162928|FG001|DB Phase|Protocol Violation|1|||
128689240|NCT00570765|463162929|FG002|DB Phase|Protocol Violation|0|||
128689241|NCT00570765|463162930|FG003|DB Phase|Protocol Violation|0|||
128689242|NCT00570765|463162927|FG000|DB Phase|Adverse Event|3|||
128892891|NCT00766090|463903967|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
128892892|NCT00766090|463903968|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
128892893|NCT00766090|463903969|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
128892894|NCT00766090|463903970|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
128892895|NCT00766090|463903971|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
128892896|NCT00766090|463903972|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
128689243|NCT00570765|463162928|FG001|DB Phase|Adverse Event|6|||
128689244|NCT00570765|463162929|FG002|DB Phase|Adverse Event|0|||
128689245|NCT00570765|463162930|FG003|DB Phase|Adverse Event|0|||
128689246|NCT00570765|463162927|FG000|DB Phase|Did Not Receive Study Drug|0|||
128689247|NCT00570765|463162928|FG001|DB Phase|Did Not Receive Study Drug|0|||
128689248|NCT00570765|463162929|FG002|DB Phase|Did Not Receive Study Drug|1|||
128689249|NCT00570765|463162930|FG003|DB Phase|Did Not Receive Study Drug|0|||
128689250|NCT00570765|463162927|FG000|LTSE Phase|Withdrawal by Subject|0|||
128689251|NCT00570765|463162928|FG001|LTSE Phase|Withdrawal by Subject|0|||
128892897|NCT00766090|463903973|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
128892898|NCT00766090|463903974|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
129020925|NCT03570749|464368580|FG003|Overall Study|Adverse Event|0|||
129020926|NCT03570749|464368581|FG004|Overall Study|Adverse Event|2|||
128689252|NCT00570765|463162929|FG002|LTSE Phase|Withdrawal by Subject|0|||
128689253|NCT00570765|463162930|FG003|LTSE Phase|Withdrawal by Subject|1|||
128689254|NCT00570765|463162927|FG000|LTSE Phase|Adverse Event|0|||
128689255|NCT00570765|463162928|FG001|LTSE Phase|Adverse Event|0|||
128689256|NCT00570765|463162929|FG002|LTSE Phase|Adverse Event|0|||
128689257|NCT00570765|463162930|FG003|LTSE Phase|Adverse Event|7|||
128689258|NCT00570765|463162927|FG000|LTSE Phase|Physician Decision|0|||
128689259|NCT00570765|463162928|FG001|LTSE Phase|Physician Decision|0|||
128689260|NCT00570765|463162929|FG002|LTSE Phase|Physician Decision|0|||
128689261|NCT00570765|463162930|FG003|LTSE Phase|Physician Decision|4|||
128689262|NCT03711266|463162931|FG000|Overall Study|Lost to Follow-up|10|||
128689263|NCT02456103|463162933|FG000|Overall Study|Study Closure|207|||
128689264|NCT02456103|463162933|FG000|Overall Study|Physician Decision|1|||
128689265|NCT02456103|463162933|FG000|Overall Study|Required prohibited medications|5|||
128689266|NCT02456103|463162933|FG000|Overall Study|Protocol Violation|1|||
128689267|NCT02456103|463162933|FG000|Overall Study|Adverse Event|5|||
128689268|NCT02456103|463162933|FG000|Overall Study|Abnormal Laboratory Value|2|||
128689269|NCT02456103|463162933|FG000|Overall Study|Lost to Follow-up|1|||
128689270|NCT02456103|463162933|FG000|Overall Study|Withdrawal by Subject|24|||
128689271|NCT02028871|463162936|FG000|Overall Study|Positive urine drug screen|1|||
128689272|NCT02028871|463162937|FG001|Overall Study|Positive urine drug screen|1|||
128689273|NCT02028871|463162936|FG000|Overall Study|Withdrawal by Subject|1|||
128689274|NCT02028871|463162937|FG001|Overall Study|Withdrawal by Subject|2|||
129020927|NCT03570749|464368582|FG005|Overall Study|Adverse Event|3|||
129020928|NCT03570749|464368583|FG006|Overall Study|Adverse Event|6|||
129020929|NCT03570749|464368577|FG000|Overall Study|Lack of Efficacy|0|||
129020930|NCT03570749|464368578|FG001|Overall Study|Lack of Efficacy|0|||
128689275|NCT02028871|463162936|FG000|Overall Study|IV placement difficulty|1|||
128689276|NCT02028871|463162937|FG001|Overall Study|IV placement difficulty|0|||
128689277|NCT02028871|463162936|FG000|Overall Study|Current Illness|1|||
128689278|NCT02028871|463162937|FG001|Overall Study|Current Illness|0|||
128689279|NCT01934972|463162938|FG000|Overall Study|Withdrawal by Subject|9|||
128892899|NCT00766090|463903975|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
128892900|NCT00766090|463903976|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
129020931|NCT03570749|464368579|FG002|Overall Study|Lack of Efficacy|0|||
129020932|NCT03570749|464368580|FG003|Overall Study|Lack of Efficacy|0|||
129020933|NCT03570749|464368581|FG004|Overall Study|Lack of Efficacy|8|||
129020934|NCT03570749|464368582|FG005|Overall Study|Lack of Efficacy|2|||
128689280|NCT01934972|463162939|FG001|Overall Study|Withdrawal by Subject|6|||
128689281|NCT03131453|463162940|FG000|Overall Study|Study terminated by Sponsor|424|||
128689282|NCT03131453|463162941|FG001|Overall Study|Study terminated by Sponsor|222|||
128689283|NCT03131453|463162942|FG002|Overall Study|Study terminated by Sponsor|438|||
128689284|NCT03131453|463162940|FG000|Overall Study|Withdrawal by Subject|18|||
128689285|NCT03131453|463162941|FG001|Overall Study|Withdrawal by Subject|7|||
128689286|NCT03131453|463162942|FG002|Overall Study|Withdrawal by Subject|13|||
128689287|NCT03131453|463162940|FG000|Overall Study|Adverse Event|10|||
128689288|NCT03131453|463162941|FG001|Overall Study|Adverse Event|3|||
128689289|NCT03131453|463162942|FG002|Overall Study|Adverse Event|3|||
128689290|NCT03131453|463162940|FG000|Overall Study|Lost to Follow-up|1|||
128689291|NCT03131453|463162941|FG001|Overall Study|Lost to Follow-up|0|||
128689292|NCT03131453|463162942|FG002|Overall Study|Lost to Follow-up|1|||
128689293|NCT03131453|463162940|FG000|Overall Study|Physician Decision|1|||
128689294|NCT03131453|463162941|FG001|Overall Study|Physician Decision|0|||
128689295|NCT03131453|463162942|FG002|Overall Study|Physician Decision|1|||
128689296|NCT03131453|463162940|FG000|Overall Study|Non-compliance with study treatment|1|||
128689297|NCT03131453|463162941|FG001|Overall Study|Non-compliance with study treatment|0|||
128689298|NCT03131453|463162942|FG002|Overall Study|Non-compliance with study treatment|0|||
128689299|NCT03131453|463162940|FG000|Overall Study|Technical problems|1|||
128689300|NCT03131453|463162941|FG001|Overall Study|Technical problems|0|||
128689301|NCT03131453|463162942|FG002|Overall Study|Technical problems|0|||
128689302|NCT03131453|463162940|FG000|Overall Study|Protocol deviation|0|||
128689303|NCT03131453|463162941|FG001|Overall Study|Protocol deviation|1|||
128689304|NCT03131453|463162942|FG002|Overall Study|Protocol deviation|0|||
128689305|NCT02770170|463162945|FG000|Overall Study|Withdrawal by Subject|0|||
128689306|NCT02770170|463162946|FG001|Overall Study|Withdrawal by Subject|0|||
128689307|NCT02770170|463162947|FG002|Overall Study|Withdrawal by Subject|0|||
128689308|NCT02770170|463162948|FG003|Overall Study|Withdrawal by Subject|2|||
128689309|NCT02770170|463162945|FG000|Overall Study|due to pregnancy|1|||
128689310|NCT02770170|463162946|FG001|Overall Study|due to pregnancy|0|||
128892901|NCT00766090|463903977|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
128892902|NCT00766090|463903978|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
128892903|NCT00766090|463903967|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892904|NCT00766090|463903968|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892905|NCT00766090|463903969|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892906|NCT00766090|463903970|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892907|NCT00766090|463903971|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892908|NCT00766090|463903972|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
128892909|NCT00766090|463903973|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892910|NCT00766090|463903974|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892911|NCT00766090|463903975|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892912|NCT00766090|463903976|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892913|NCT00766090|463903977|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892914|NCT00766090|463903978|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
128892915|NCT00766090|463903967|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128892916|NCT00766090|463903968|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
128892917|NCT00766090|463903969|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129020935|NCT03570749|464368583|FG006|Overall Study|Lack of Efficacy|7|||
129020936|NCT03570749|464368577|FG000|Overall Study|Lost to Follow-up|0|||
129020937|NCT03570749|464368578|FG001|Overall Study|Lost to Follow-up|0|||
129020938|NCT03570749|464368579|FG002|Overall Study|Lost to Follow-up|0|||
129020939|NCT03570749|464368580|FG003|Overall Study|Lost to Follow-up|0|||
129020940|NCT03570749|464368581|FG004|Overall Study|Lost to Follow-up|5|||
129020941|NCT03570749|464368582|FG005|Overall Study|Lost to Follow-up|10|||
129020942|NCT03570749|464368583|FG006|Overall Study|Lost to Follow-up|10|||
129020943|NCT03570749|464368577|FG000|Overall Study|Pregnancy|0|||
129020944|NCT03570749|464368578|FG001|Overall Study|Pregnancy|0|||
129020945|NCT03570749|464368579|FG002|Overall Study|Pregnancy|0|||
129020946|NCT03570749|464368580|FG003|Overall Study|Pregnancy|0|||
129020947|NCT03570749|464368581|FG004|Overall Study|Pregnancy|0|||
129020948|NCT03570749|464368582|FG005|Overall Study|Pregnancy|1|||
129020949|NCT03570749|464368583|FG006|Overall Study|Pregnancy|1|||
129020950|NCT03570749|464368577|FG000|Overall Study|Screen Fail|0|||
129020951|NCT03570749|464368578|FG001|Overall Study|Screen Fail|0|||
129020952|NCT03570749|464368579|FG002|Overall Study|Screen Fail|0|||
128689311|NCT02770170|463162947|FG002|Overall Study|due to pregnancy|0|||
128689312|NCT02770170|463162948|FG003|Overall Study|due to pregnancy|0|||
128689313|NCT02770170|463162945|FG000|Overall Study|Lack of Efficacy|2|||
128689314|NCT02770170|463162946|FG001|Overall Study|Lack of Efficacy|0|||
128892918|NCT00766090|463903970|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
128892919|NCT00766090|463903971|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128892920|NCT00766090|463903972|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129020953|NCT03570749|464368580|FG003|Overall Study|Screen Fail|0|||
129020954|NCT03570749|464368581|FG004|Overall Study|Screen Fail|0|||
129020955|NCT03570749|464368582|FG005|Overall Study|Screen Fail|0|||
129020956|NCT03570749|464368583|FG006|Overall Study|Screen Fail|1|||
129020957|NCT03570749|464368577|FG000|Overall Study|Withdrawal by Subject|2|||
129020958|NCT03570749|464368578|FG001|Overall Study|Withdrawal by Subject|3|||
129020959|NCT03570749|464368579|FG002|Overall Study|Withdrawal by Subject|2|||
128689315|NCT02770170|463162947|FG002|Overall Study|Lack of Efficacy|0|||
128689316|NCT02770170|463162948|FG003|Overall Study|Lack of Efficacy|1|||
128689317|NCT02770170|463162945|FG000|Overall Study|Adverse Event|4|||
129020960|NCT03570749|464368580|FG003|Overall Study|Withdrawal by Subject|1|||
128892921|NCT00766090|463903973|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128892922|NCT00766090|463903974|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128892923|NCT00766090|463903975|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128892924|NCT00766090|463903976|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128892925|NCT00766090|463903977|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
128892926|NCT00766090|463903978|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
128892927|NCT00766090|463903967|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892928|NCT00766090|463903968|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892929|NCT00766090|463903969|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892930|NCT00766090|463903970|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892931|NCT00766090|463903971|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
128892932|NCT00766090|463903972|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892933|NCT00766090|463903973|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892934|NCT00766090|463903974|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892935|NCT00766090|463903975|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892936|NCT00766090|463903976|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892937|NCT00766090|463903977|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892938|NCT00766090|463903978|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
128892939|NCT01106027|463903985|FG000|Overall Study|Lost graft early, discontinued|1|||
128892940|NCT02871778|463903986|FG000|Part A: Treatment Period 1|Adverse Event|1|||
128892941|NCT02871778|463903987|FG001|Part A: Treatment Period 1|Adverse Event|1|||
128892942|NCT02871778|463903988|FG002|Part A: Treatment Period 1|Adverse Event|1|||
128892943|NCT02871778|463903989|FG003|Part A: Treatment Period 1|Adverse Event|0|||
128892944|NCT02871778|463903990|FG004|Part A: Treatment Period 1|Adverse Event|0|||
128892945|NCT02871778|463903991|FG005|Part A: Treatment Period 1|Adverse Event|0|||
129020961|NCT03570749|464368581|FG004|Overall Study|Withdrawal by Subject|17|||
129020962|NCT03570749|464368582|FG005|Overall Study|Withdrawal by Subject|12|||
129020963|NCT03570749|464368583|FG006|Overall Study|Withdrawal by Subject|15|||
129020964|NCT03570749|464368577|FG000|Overall Study|Other|0|||
129020965|NCT03570749|464368578|FG001|Overall Study|Other|0|||
129020966|NCT03570749|464368579|FG002|Overall Study|Other|0|||
129020967|NCT03570749|464368580|FG003|Overall Study|Other|0|||
129020968|NCT03570749|464368581|FG004|Overall Study|Other|17|||
129020969|NCT03570749|464368582|FG005|Overall Study|Other|14|||
129020970|NCT03570749|464368583|FG006|Overall Study|Other|21|||
129020971|NCT00561015|464368584|FG000|Overall Study|Adverse Event|0|||
129020972|NCT00561015|464368585|FG001|Overall Study|Adverse Event|0|||
129020973|NCT00561015|464368586|FG002|Overall Study|Adverse Event|0|||
129020974|NCT00561015|464368587|FG003|Overall Study|Adverse Event|0|||
129020975|NCT00561015|464368588|FG004|Overall Study|Adverse Event|1|||
129020976|NCT00561015|464368589|FG005|Overall Study|Adverse Event|0|||
129020977|NCT00561015|464368584|FG000|Overall Study|Lost to Follow-up|2|||
129020978|NCT00561015|464368585|FG001|Overall Study|Lost to Follow-up|0|||
129020979|NCT00561015|464368586|FG002|Overall Study|Lost to Follow-up|0|||
129020980|NCT00561015|464368587|FG003|Overall Study|Lost to Follow-up|1|||
129020981|NCT00561015|464368588|FG004|Overall Study|Lost to Follow-up|0|||
129020982|NCT00561015|464368589|FG005|Overall Study|Lost to Follow-up|3|||
129020983|NCT00561015|464368584|FG000|Overall Study|Participant non-compliance|2|||
129020984|NCT00561015|464368585|FG001|Overall Study|Participant non-compliance|0|||
129020985|NCT00561015|464368586|FG002|Overall Study|Participant non-compliance|0|||
129020986|NCT00561015|464368587|FG003|Overall Study|Participant non-compliance|0|||
129020987|NCT00561015|464368588|FG004|Overall Study|Participant non-compliance|0|||
129020988|NCT00561015|464368589|FG005|Overall Study|Participant non-compliance|0|||
129020989|NCT02440711|464368590|FG000|Second Intervention|Lost to Follow-up|1|||
129020990|NCT02440711|464368591|FG001|Second Intervention|Lost to Follow-up|0|||
129020991|NCT00163657|464368594|FG000|Overall Study|Death|12|||
129020992|NCT00163657|464368595|FG001|Overall Study|Death|14|||
129020993|NCT00163657|464368596|FG002|Overall Study|Death|19|||
129020994|NCT00163657|464368594|FG000|Overall Study|graft loss|4|||
129020995|NCT00163657|464368595|FG001|Overall Study|graft loss|1|||
129020996|NCT00163657|464368596|FG002|Overall Study|graft loss|2|||
129020997|NCT00163657|464368594|FG000|Overall Study|Withdrawal by Subject|2|||
129020998|NCT00163657|464368595|FG001|Overall Study|Withdrawal by Subject|3|||
129020999|NCT00163657|464368596|FG002|Overall Study|Withdrawal by Subject|2|||
129021000|NCT00163657|464368594|FG000|Overall Study|Physician Decision|0|||
129021001|NCT00163657|464368595|FG001|Overall Study|Physician Decision|1|||
129021002|NCT00163657|464368596|FG002|Overall Study|Physician Decision|1|||
128689318|NCT02770170|463162946|FG001|Overall Study|Adverse Event|3|||
128892946|NCT02871778|463903992|FG006|Part A: Treatment Period 1|Adverse Event|0|||
128892947|NCT02871778|463903993|FG007|Part A: Treatment Period 1|Adverse Event|0|||
128892948|NCT02871778|463903986|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
129021003|NCT00163657|464368594|FG000|Overall Study|Non Compliance|1|||
129021004|NCT00163657|464368595|FG001|Overall Study|Non Compliance|0|||
129021005|NCT00163657|464368596|FG002|Overall Study|Non Compliance|0|||
129021006|NCT00163657|464368594|FG000|Overall Study|Lost to Follow-up|1|||
129021007|NCT00163657|464368595|FG001|Overall Study|Lost to Follow-up|3|||
129021008|NCT00163657|464368596|FG002|Overall Study|Lost to Follow-up|10|||
128689319|NCT02770170|463162947|FG002|Overall Study|Adverse Event|5|||
128689320|NCT02770170|463162948|FG003|Overall Study|Adverse Event|3|||
128689321|NCT02770170|463162945|FG000|Overall Study|due to disease worsening|0|||
128689322|NCT02770170|463162946|FG001|Overall Study|due to disease worsening|0|||
128689323|NCT02770170|463162947|FG002|Overall Study|due to disease worsening|0|||
128689324|NCT02770170|463162948|FG003|Overall Study|due to disease worsening|1|||
128689325|NCT00445978|463162949|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
128689326|NCT00445978|463162949|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
129110655|NCT00808067|464699919|FG001|Overall Study|Outcome event - other|25|||
129110656|NCT00808067|464699918|FG000|Overall Study|Adverse Event|111|||
128689327|NCT00445978|463162949|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
128689328|NCT00445978|463162949|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
128689329|NCT00445978|463162949|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
128689330|NCT00445978|463162949|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
128689331|NCT00445978|463162949|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
128689332|NCT00445978|463162949|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
128689333|NCT00445978|463162949|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
128689334|NCT01822496|463162952|FG000|Overall Study|Protocol Violation|2|||
128689335|NCT01822496|463162953|FG001|Overall Study|Protocol Violation|2|||
128689336|NCT01822496|463162954|FG002|Overall Study|Protocol Violation|0|||
128892949|NCT02871778|463903987|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
128892950|NCT02871778|463903988|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
128892951|NCT02871778|463903989|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
128892952|NCT02871778|463903990|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
128892953|NCT02871778|463903991|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
128892954|NCT02871778|463903992|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
128892955|NCT02871778|463903993|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
128892956|NCT02871778|463903986|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
128892957|NCT02871778|463903987|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
128892958|NCT02871778|463903988|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
129110657|NCT00808067|464699919|FG001|Overall Study|Adverse Event|121|||
129110658|NCT00808067|464699918|FG000|Overall Study|Hospitalization (not including surgery)|18|||
129110659|NCT00808067|464699919|FG001|Overall Study|Hospitalization (not including surgery)|17|||
129110660|NCT00808067|464699918|FG000|Overall Study|Hospitalization due to surgery|37|||
129110661|NCT00808067|464699919|FG001|Overall Study|Hospitalization due to surgery|40|||
129110662|NCT00808067|464699918|FG000|Overall Study|Reduced creatinine clearance|53|||
128689337|NCT01822496|463162955|FG003|Overall Study|Protocol Violation|1|||
128689338|NCT01822496|463162952|FG000|Overall Study|Withdrawal by Subject|0|||
128689339|NCT01822496|463162953|FG001|Overall Study|Withdrawal by Subject|0|||
128689340|NCT01822496|463162954|FG002|Overall Study|Withdrawal by Subject|0|||
128689341|NCT01822496|463162955|FG003|Overall Study|Withdrawal by Subject|3|||
128689342|NCT00304239|463162956|FG000|Overall Study|Protocol Deviations/Violations|15|||
128689343|NCT00304239|463162957|FG001|Overall Study|Protocol Deviations/Violations|0|||
128689344|NCT00304239|463162956|FG000|Overall Study|Adverse Event|2|||
128689345|NCT00304239|463162957|FG001|Overall Study|Adverse Event|0|||
128689346|NCT02979197|463162958|FG000|Overall Study|Adverse Event|4|||
128689347|NCT02979197|463162959|FG001|Overall Study|Adverse Event|2|||
128689348|NCT02979197|463162960|FG002|Overall Study|Adverse Event|0|||
128689349|NCT02979197|463162958|FG000|Overall Study|Protocol Violation|0|||
128689350|NCT02979197|463162959|FG001|Overall Study|Protocol Violation|1|||
128689351|NCT02979197|463162960|FG002|Overall Study|Protocol Violation|0|||
128689352|NCT02979197|463162958|FG000|Overall Study|Subject unable to commit to study dates|0|||
128689353|NCT02979197|463162959|FG001|Overall Study|Subject unable to commit to study dates|1|||
128689354|NCT02979197|463162960|FG002|Overall Study|Subject unable to commit to study dates|0|||
128689355|NCT03643159|463162961|FG000|Overall Study|Adverse Event|1|||
129110663|NCT00808067|464699919|FG001|Overall Study|Reduced creatinine clearance|55|||
129110664|NCT00808067|464699918|FG000|Overall Study|Elevated LFT results|7|||
129110665|NCT00808067|464699919|FG001|Overall Study|Elevated LFT results|3|||
129110666|NCT00808067|464699918|FG000|Overall Study|Patient refused to take study medication|65|||
129110667|NCT00808067|464699919|FG001|Overall Study|Patient refused to take study medication|76|||
129110668|NCT00808067|464699918|FG000|Overall Study|Missing|1|||
129110669|NCT00808067|464699919|FG001|Overall Study|Missing|0|||
128689356|NCT03643159|463162961|FG000|Overall Study|Withdrawal by Subject|1|||
128689357|NCT03438383|463162962|FG000|Overall Study|Protocol Violation|9|||
128689358|NCT03438383|463162963|FG001|Overall Study|Protocol Violation|3|||
128689359|NCT02766465|463162964|FG000|Overall Study|Withdrawal by Subject|0|||
128689360|NCT02766465|463162965|FG001|Overall Study|Withdrawal by Subject|10|||
128689361|NCT01631812|463162966|FG000|Overall Study|Adverse Event|25|||
128689362|NCT01631812|463162966|FG000|Overall Study|Lack of Efficacy|5|||
128689363|NCT01631812|463162966|FG000|Overall Study|Withdrawal by Subject|4|||
128689364|NCT01631812|463162966|FG000|Overall Study|Physician Decision|3|||
128764080|NCT01852058|463425908|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128892959|NCT02871778|463903989|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
128892960|NCT02871778|463903990|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
128892961|NCT02871778|463903991|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
128892962|NCT02871778|463903992|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
128892963|NCT02871778|463903993|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
128892964|NCT02871778|463903986|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
128892965|NCT02871778|463903987|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
128892966|NCT02871778|463903988|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
128892967|NCT02871778|463903989|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
128892968|NCT02871778|463903990|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
128892969|NCT02871778|463903991|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
128892970|NCT02871778|463903992|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
128892971|NCT02871778|463903993|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
128892972|NCT02871778|463903986|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
128892973|NCT02871778|463903987|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
128892974|NCT02871778|463903988|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
128892975|NCT02871778|463903989|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
128892976|NCT02871778|463903990|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
128892977|NCT02871778|463903991|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
129110670|NCT00808067|464699918|FG000|Overall Study|Death|1|||
129110671|NCT00808067|464699919|FG001|Overall Study|Death|1|||
129110672|NCT00808067|464699918|FG000|Overall Study|Procedure|6|||
129110673|NCT00808067|464699919|FG001|Overall Study|Procedure|7|||
129110674|NCT00808067|464699918|FG000|Overall Study|Withdrawal by Subject|21|||
129110675|NCT00808067|464699919|FG001|Overall Study|Withdrawal by Subject|25|||
129110676|NCT00808067|464699918|FG000|Overall Study|Site closed|4|||
129110677|NCT00808067|464699919|FG001|Overall Study|Site closed|3|||
129110678|NCT00808067|464699918|FG000|Overall Study|Physician Decision|47|||
129110679|NCT00808067|464699919|FG001|Overall Study|Physician Decision|38|||
128689365|NCT02435069|463162967|FG000|Dose Response - First Intervention|Adverse Event|0|||
129110680|NCT00808067|464699918|FG000|Overall Study|Protocol Violation|3|||
129110681|NCT00808067|464699919|FG001|Overall Study|Protocol Violation|11|||
129110682|NCT00808067|464699918|FG000|Overall Study|Patient elected|7|||
129110683|NCT00808067|464699919|FG001|Overall Study|Patient elected|9|||
129110684|NCT00808067|464699918|FG000|Overall Study|Site closed for cause|19|||
129110685|NCT00808067|464699919|FG001|Overall Study|Site closed for cause|19|||
129110686|NCT00808067|464699918|FG000|Overall Study|Other reason not defined above|5|||
129110687|NCT00808067|464699919|FG001|Overall Study|Other reason not defined above|5|||
129110688|NCT00808067|464699918|FG000|Overall Study|Excluded from analysis|13|||
129110689|NCT00808067|464699919|FG001|Overall Study|Excluded from analysis|19|||
129110690|NCT02532283|464699922|FG000|Overall Study|Adverse Event|0|||
129110691|NCT02532283|464699923|FG001|Overall Study|Adverse Event|1|||
129110692|NCT02532283|464699922|FG000|Overall Study|Death|1|||
129110693|NCT02532283|464699923|FG001|Overall Study|Death|0|||
129110694|NCT02532283|464699922|FG000|Overall Study|Lost to Follow-up|0|||
129110695|NCT02532283|464699923|FG001|Overall Study|Lost to Follow-up|1|||
129110696|NCT02532283|464699922|FG000|Overall Study|Withdrawal by Subject|8|||
129110697|NCT02532283|464699923|FG001|Overall Study|Withdrawal by Subject|3|||
129110698|NCT00490971|464699928|FG000|Acute/Continuation|Adverse Event|62|||
129110699|NCT00490971|464699929|FG001|Acute/Continuation|Adverse Event|13|||
129110700|NCT00490971|464699930|FG002|Acute/Continuation|Adverse Event|0|||
129110701|NCT00490971|464699931|FG003|Acute/Continuation|Adverse Event|0|||
129110702|NCT00490971|464699932|FG004|Acute/Continuation|Adverse Event|0|||
129110703|NCT00490971|464699928|FG000|Acute/Continuation|Death|2|||
129110704|NCT00490971|464699929|FG001|Acute/Continuation|Death|0|||
128689366|NCT02435069|463162968|FG001|Dose Response - First Intervention|Adverse Event|1|||
128689367|NCT02435069|463162969|FG002|Dose Response - First Intervention|Adverse Event|1|||
128689368|NCT02435069|463162970|FG003|Dose Response - First Intervention|Adverse Event|0|||
128689369|NCT02435069|463162971|FG004|Dose Response - First Intervention|Adverse Event|0|||
128892978|NCT02871778|463903992|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
128892979|NCT02871778|463903993|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
128892980|NCT02871778|463903986|FG000|Part A: Treatment Period 2|Adverse Event|2|||
128892981|NCT02871778|463903987|FG001|Part A: Treatment Period 2|Adverse Event|2|||
128892982|NCT02871778|463903988|FG002|Part A: Treatment Period 2|Adverse Event|0|||
128892983|NCT02871778|463903989|FG003|Part A: Treatment Period 2|Adverse Event|0|||
128892984|NCT02871778|463903990|FG004|Part A: Treatment Period 2|Adverse Event|0|||
129110705|NCT00490971|464699930|FG002|Acute/Continuation|Death|0|||
129110706|NCT00490971|464699931|FG003|Acute/Continuation|Death|0|||
128689370|NCT02435069|463162967|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129110707|NCT00490971|464699932|FG004|Acute/Continuation|Death|0|||
129110708|NCT00490971|464699928|FG000|Acute/Continuation|Lack of Efficacy|106|||
129110709|NCT00490971|464699929|FG001|Acute/Continuation|Lack of Efficacy|12|||
129110710|NCT00490971|464699930|FG002|Acute/Continuation|Lack of Efficacy|0|||
129110711|NCT00490971|464699931|FG003|Acute/Continuation|Lack of Efficacy|0|||
129110712|NCT00490971|464699932|FG004|Acute/Continuation|Lack of Efficacy|0|||
128892985|NCT02871778|463903991|FG005|Part A: Treatment Period 2|Adverse Event|0|||
128892986|NCT02871778|463903992|FG006|Part A: Treatment Period 2|Adverse Event|0|||
128892987|NCT02871778|463903993|FG007|Part A: Treatment Period 2|Adverse Event|0|||
128892988|NCT02871778|463903986|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
128892989|NCT02871778|463903987|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
128892990|NCT02871778|463903988|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
128689371|NCT02435069|463162968|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
128689372|NCT02435069|463162969|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
128689373|NCT02435069|463162970|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
128689374|NCT02435069|463162971|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
128689375|NCT01528033|463162972|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
128689376|NCT01528033|463162973|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
128689377|NCT01528033|463162972|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
128689378|NCT01528033|463162973|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
128689379|NCT01528033|463162972|FG000|Primary Endpoint Assessment ITT|Death|2|||
128892991|NCT02871778|463903989|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
128892992|NCT02871778|463903990|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
128892993|NCT02871778|463903991|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
128892994|NCT02871778|463903992|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
129110713|NCT00490971|464699928|FG000|Acute/Continuation|Lost to Follow-up|23|||
129110714|NCT00490971|464699929|FG001|Acute/Continuation|Lost to Follow-up|7|||
129110715|NCT00490971|464699930|FG002|Acute/Continuation|Lost to Follow-up|0|||
129110716|NCT00490971|464699931|FG003|Acute/Continuation|Lost to Follow-up|0|||
129110717|NCT00490971|464699932|FG004|Acute/Continuation|Lost to Follow-up|0|||
129110718|NCT00490971|464699928|FG000|Acute/Continuation|Protocol Violation|10|||
129110719|NCT00490971|464699929|FG001|Acute/Continuation|Protocol Violation|2|||
129110720|NCT00490971|464699930|FG002|Acute/Continuation|Protocol Violation|0|||
129110721|NCT00490971|464699931|FG003|Acute/Continuation|Protocol Violation|0|||
129110722|NCT00490971|464699932|FG004|Acute/Continuation|Protocol Violation|0|||
129110723|NCT00490971|464699928|FG000|Acute/Continuation|Withdrawal by Subject|92|||
129110724|NCT00490971|464699929|FG001|Acute/Continuation|Withdrawal by Subject|24|||
129110725|NCT00490971|464699930|FG002|Acute/Continuation|Withdrawal by Subject|0|||
129110726|NCT00490971|464699931|FG003|Acute/Continuation|Withdrawal by Subject|0|||
129110727|NCT00490971|464699932|FG004|Acute/Continuation|Withdrawal by Subject|0|||
129110728|NCT00490971|464699928|FG000|Acute/Continuation|Other|11|||
129110729|NCT00490971|464699929|FG001|Acute/Continuation|Other|4|||
129110730|NCT00490971|464699930|FG002|Acute/Continuation|Other|0|||
129110731|NCT00490971|464699931|FG003|Acute/Continuation|Other|0|||
129110732|NCT00490971|464699932|FG004|Acute/Continuation|Other|0|||
129110733|NCT00490971|464699928|FG000|Maintenance|Adverse Event|0|||
129110734|NCT00490971|464699929|FG001|Maintenance|Adverse Event|0|||
129110735|NCT00490971|464699930|FG002|Maintenance|Adverse Event|4|||
129110736|NCT00490971|464699931|FG003|Maintenance|Adverse Event|5|||
129110737|NCT00490971|464699932|FG004|Maintenance|Adverse Event|7|||
129110738|NCT00490971|464699928|FG000|Maintenance|Death|0|||
129110739|NCT00490971|464699929|FG001|Maintenance|Death|0|||
129110740|NCT00490971|464699930|FG002|Maintenance|Death|0|||
129110741|NCT00490971|464699931|FG003|Maintenance|Death|2|||
129110742|NCT00490971|464699932|FG004|Maintenance|Death|0|||
129110743|NCT00490971|464699928|FG000|Maintenance|Lost to Follow-up|0|||
129110744|NCT00490971|464699929|FG001|Maintenance|Lost to Follow-up|0|||
129110745|NCT00490971|464699930|FG002|Maintenance|Lost to Follow-up|5|||
129110746|NCT00490971|464699931|FG003|Maintenance|Lost to Follow-up|8|||
129110747|NCT00490971|464699932|FG004|Maintenance|Lost to Follow-up|10|||
129110748|NCT00490971|464699928|FG000|Maintenance|Pregnancy|0|||
129110749|NCT00490971|464699929|FG001|Maintenance|Pregnancy|0|||
129110750|NCT00490971|464699930|FG002|Maintenance|Pregnancy|1|||
129110751|NCT00490971|464699931|FG003|Maintenance|Pregnancy|0|||
129110752|NCT00490971|464699932|FG004|Maintenance|Pregnancy|0|||
129110753|NCT00490971|464699928|FG000|Maintenance|Protocol Violation|0|||
129110754|NCT00490971|464699929|FG001|Maintenance|Protocol Violation|0|||
129110755|NCT00490971|464699930|FG002|Maintenance|Protocol Violation|4|||
128689380|NCT01528033|463162973|FG001|Primary Endpoint Assessment ITT|Death|2|||
128689381|NCT01528033|463162972|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
128892995|NCT02871778|463903993|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
128892996|NCT02871778|463903986|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
128892997|NCT02871778|463903987|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
128892998|NCT02871778|463903988|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
129110756|NCT00490971|464699931|FG003|Maintenance|Protocol Violation|1|||
129110757|NCT00490971|464699932|FG004|Maintenance|Protocol Violation|1|||
129110758|NCT00490971|464699928|FG000|Maintenance|Withdrawal by Subject|0|||
129110759|NCT00490971|464699929|FG001|Maintenance|Withdrawal by Subject|0|||
129110760|NCT00490971|464699930|FG002|Maintenance|Withdrawal by Subject|26|||
129110761|NCT00490971|464699931|FG003|Maintenance|Withdrawal by Subject|28|||
129110762|NCT00490971|464699932|FG004|Maintenance|Withdrawal by Subject|18|||
129110763|NCT00490971|464699928|FG000|Maintenance|Other|0|||
129110764|NCT00490971|464699929|FG001|Maintenance|Other|0|||
129110765|NCT00490971|464699930|FG002|Maintenance|Other|11|||
128764081|NCT01852058|463425909|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128764082|NCT01852058|463425910|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128764083|NCT01852058|463425911|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
128764084|NCT01852058|463425900|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764085|NCT01852058|463425901|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764086|NCT01852058|463425902|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764087|NCT01852058|463425903|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764088|NCT01852058|463425904|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764089|NCT01852058|463425905|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764090|NCT01852058|463425906|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764091|NCT01852058|463425907|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
128764092|NCT01852058|463425908|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764093|NCT01852058|463425909|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764094|NCT01852058|463425910|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764095|NCT01852058|463425911|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
128764096|NCT01852058|463425900|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764097|NCT01852058|463425901|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764098|NCT01852058|463425902|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764099|NCT01852058|463425903|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764100|NCT01852058|463425904|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764101|NCT01852058|463425905|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764102|NCT01852058|463425906|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764103|NCT01852058|463425907|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764104|NCT01852058|463425908|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
128764105|NCT01852058|463425909|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764106|NCT01852058|463425910|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764107|NCT01852058|463425911|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
128764108|NCT00622180|463425912|FG000|Overall Study|Lost to Follow-up|1|||
128764109|NCT00622180|463425913|FG001|Overall Study|Lost to Follow-up|2|||
128764110|NCT01353222|463425918|FG000|Overall Study|Death|30|||
128764111|NCT01353222|463425919|FG001|Overall Study|Death|30|||
128764112|NCT01353222|463425918|FG000|Overall Study|Withdrawal by Subject|8|||
128764113|NCT01353222|463425919|FG001|Overall Study|Withdrawal by Subject|5|||
128764114|NCT01353222|463425918|FG000|Overall Study|Study Terminated|31|||
128764115|NCT01353222|463425919|FG001|Overall Study|Study Terminated|37|||
128764116|NCT01353222|463425918|FG000|Overall Study|Site closed research department|1|||
128764117|NCT01353222|463425919|FG001|Overall Study|Site closed research department|0|||
128764118|NCT02636270|463425920|FG000|Overall Study|Adverse Event|1|||
128764119|NCT02636270|463425921|FG001|Overall Study|Adverse Event|0|||
128764120|NCT02636270|463425922|FG002|Overall Study|Adverse Event|0|||
128764121|NCT02636270|463425920|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
128764122|NCT02636270|463425921|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
128764123|NCT02636270|463425922|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
128764124|NCT01119898|463425923|FG000|Overall Study|Adverse Event|4|||
128764125|NCT01119898|463425924|FG001|Overall Study|Adverse Event|5|||
128764126|NCT01119898|463425923|FG000|Overall Study|Withdrawal by Subject|1|||
128764127|NCT01119898|463425924|FG001|Overall Study|Withdrawal by Subject|4|||
128892999|NCT02871778|463903989|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
128893000|NCT02871778|463903990|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
128893001|NCT02871778|463903991|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
128893002|NCT02871778|463903992|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
128893003|NCT02871778|463903993|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
128893004|NCT02871778|463903986|FG000|Part B: Treatment Period 3|Adverse Event|0|||
128893005|NCT02871778|463903987|FG001|Part B: Treatment Period 3|Adverse Event|0|||
128893006|NCT02871778|463903988|FG002|Part B: Treatment Period 3|Adverse Event|0|||
128893007|NCT02871778|463903989|FG003|Part B: Treatment Period 3|Adverse Event|0|||
128893008|NCT02871778|463903990|FG004|Part B: Treatment Period 3|Adverse Event|1|||
128893009|NCT02871778|463903991|FG005|Part B: Treatment Period 3|Adverse Event|1|||
128893010|NCT02871778|463903992|FG006|Part B: Treatment Period 3|Adverse Event|1|||
128893011|NCT02871778|463903993|FG007|Part B: Treatment Period 3|Adverse Event|0|||
128893012|NCT02653300|463903995|FG000|Overall Study|Withdrawal by Subject|2|||
129021009|NCT00163657|464368594|FG000|Overall Study|Other reason|0|||
129021010|NCT00163657|464368595|FG001|Overall Study|Other reason|1|||
129021011|NCT00163657|464368596|FG002|Overall Study|Other reason|3|||
128893013|NCT02170779|463904015|FG000|Overall Study|Withdrawal by Subject|1|||
128893014|NCT02170779|463904016|FG001|Overall Study|Withdrawal by Subject|0|||
128893015|NCT02170779|463904015|FG000|Overall Study|Lost to Follow-up|0|||
129021012|NCT02436005|464368597|FG000|Second Intervention|Adverse Event|0|||
128893016|NCT02170779|463904016|FG001|Overall Study|Lost to Follow-up|1|||
128689382|NCT01528033|463162973|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
128689383|NCT01528033|463162972|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
128689384|NCT01528033|463162973|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
128689385|NCT01528033|463162972|FG000|Follow Up|No data available|46|||
128689386|NCT01528033|463162973|FG001|Follow Up|No data available|44|||
128689387|NCT02436681|463162974|FG000|Overall Study|Lost to Follow-up|10|||
128689388|NCT02436681|463162974|FG000|Overall Study|Withdrawal by Subject|2|||
128689389|NCT02436681|463162974|FG000|Overall Study|Death|2|||
128689390|NCT02030938|463162977|FG000|Overall Study|Lost to Follow-up|4|||
128689391|NCT02030938|463162977|FG000|Overall Study|Withdrawal by Subject|1|||
128689392|NCT02520661|463162978|FG000|Overall Study|Lost to Follow-up|7|||
128689393|NCT02520661|463162979|FG001|Overall Study|Lost to Follow-up|3|||
128689394|NCT02520661|463162978|FG000|Overall Study|Admitted from ED|49|||
128689395|NCT02520661|463162979|FG001|Overall Study|Admitted from ED|48|||
128689396|NCT02520661|463162978|FG000|Overall Study|ED greater than 24 hours|29|||
128689397|NCT02520661|463162979|FG001|Overall Study|ED greater than 24 hours|38|||
128689398|NCT02520661|463162978|FG000|Overall Study|other ineligibility|14|||
128689399|NCT02520661|463162979|FG001|Overall Study|other ineligibility|22|||
128689400|NCT02520661|463162978|FG000|Overall Study|Withdrawal by Subject|7|||
128689401|NCT02520661|463162979|FG001|Overall Study|Withdrawal by Subject|16|||
128689402|NCT03954132|463162980|FG000|Overall Study|Adverse Event|2|||
128689403|NCT03954132|463162981|FG001|Overall Study|Adverse Event|0|||
128689404|NCT03954132|463162980|FG000|Overall Study|Patient's wish|5|||
128689405|NCT03954132|463162981|FG001|Overall Study|Patient's wish|0|||
128893017|NCT00369785|463904017|FG000|Overall Study|Physician Decision|3|||
128893018|NCT00369785|463904018|FG001|Overall Study|Physician Decision|2|||
128893019|NCT00369785|463904017|FG000|Overall Study|Death|1|||
128893020|NCT00369785|463904018|FG001|Overall Study|Death|2|||
128893021|NCT00369785|463904017|FG000|Overall Study|Withdrawal by Subject|7|||
128893022|NCT00369785|463904018|FG001|Overall Study|Withdrawal by Subject|6|||
128893023|NCT00369785|463904017|FG000|Overall Study|Toxicity|6|||
128893024|NCT00369785|463904018|FG001|Overall Study|Toxicity|4|||
128893025|NCT00369785|463904017|FG000|Overall Study|Never started|0|||
128893026|NCT00369785|463904018|FG001|Overall Study|Never started|2|||
128689406|NCT03954132|463162980|FG000|Overall Study|Lost to Follow-up|10|||
128689407|NCT03954132|463162981|FG001|Overall Study|Lost to Follow-up|0|||
128689408|NCT03954132|463162980|FG000|Overall Study|Screening failure|0|||
128689409|NCT03954132|463162981|FG001|Overall Study|Screening failure|1|||
128689410|NCT03954132|463162980|FG000|Overall Study|No registration after Visit 1|5|||
128764128|NCT01119898|463425923|FG000|Overall Study|Lack of Efficacy|0|||
128764129|NCT01119898|463425924|FG001|Overall Study|Lack of Efficacy|2|||
128893027|NCT00369785|463904017|FG000|Overall Study|Progression|4|||
128893028|NCT00369785|463904018|FG001|Overall Study|Progression|4|||
128893029|NCT00369785|463904017|FG000|Overall Study|Multiple reasons|6|||
128893030|NCT00369785|463904018|FG001|Overall Study|Multiple reasons|5|||
128893031|NCT00800683|463904019|FG000|Overall Study|Adverse Event|11|||
128893032|NCT00800683|463904020|FG001|Overall Study|Adverse Event|8|||
128893033|NCT00800683|463904019|FG000|Overall Study|Lost to Follow-up|3|||
128893034|NCT00800683|463904020|FG001|Overall Study|Lost to Follow-up|1|||
128893035|NCT00800683|463904019|FG000|Overall Study|Withdrawal by Subject|1|||
128893036|NCT00800683|463904020|FG001|Overall Study|Withdrawal by Subject|7|||
128893037|NCT00800683|463904019|FG000|Overall Study|Lack of Efficacy|1|||
128893038|NCT00800683|463904020|FG001|Overall Study|Lack of Efficacy|1|||
128893039|NCT00800683|463904019|FG000|Overall Study|Other|1|||
129110766|NCT00490971|464699931|FG003|Maintenance|Other|9|||
129110767|NCT00490971|464699932|FG004|Maintenance|Other|3|||
128689411|NCT03954132|463162981|FG001|Overall Study|No registration after Visit 1|2|||
128764130|NCT01119898|463425923|FG000|Overall Study|Protocol Violation|1|||
128764131|NCT01119898|463425924|FG001|Overall Study|Protocol Violation|1|||
128764132|NCT01119898|463425923|FG000|Overall Study|Medical procedure|1|||
128764133|NCT01119898|463425924|FG001|Overall Study|Medical procedure|0|||
128764134|NCT01119898|463425923|FG000|Overall Study|Randomized in error did not participate|1|||
129110768|NCT00419757|464701329|FG000|Overall Study|Adverse Event|1|||
128689412|NCT03954132|463162980|FG000|Overall Study|Other reason than listed|2|||
128689413|NCT03954132|463162981|FG001|Overall Study|Other reason than listed|2|||
128689414|NCT03954132|463162980|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
128689415|NCT03954132|463162981|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
128893040|NCT00800683|463904020|FG001|Overall Study|Other|2|||
128689416|NCT03954132|463162980|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
128689417|NCT03954132|463162981|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
128764135|NCT01119898|463425924|FG001|Overall Study|Randomized in error did not participate|0|||
128764136|NCT01806584|463425925|FG000|Overall Study|Adverse Event|2|||
128764137|NCT01806584|463425926|FG001|Overall Study|Adverse Event|1|||
128893041|NCT02678416|463904021|FG000|Part 1|Withdrawal by Subject|1|||
128893042|NCT02678416|463904021|FG000|Part 2|Adverse Event|2|||
128893043|NCT02678416|463904021|FG000|Part 2|Withdrawal by Subject|1|||
129110769|NCT00419757|464701330|FG001|Overall Study|Adverse Event|4|||
128689418|NCT00932737|463162988|FG000|Overall Study|Not treated in second episode|1|||
128689419|NCT00932737|463162989|FG001|Overall Study|Not treated in second episode|0|||
128689420|NCT00932737|463162988|FG000|Overall Study|Adverse Event|0|||
128689421|NCT00932737|463162989|FG001|Overall Study|Adverse Event|1|||
128689422|NCT02628769|463163000|FG000|First Intervention|Adverse Event|1|||
128689423|NCT02628769|463163001|FG001|First Intervention|Adverse Event|0|||
128689424|NCT02628769|463163000|FG000|First Intervention|Withdrawal by Subject|0|||
128689425|NCT02628769|463163001|FG001|First Intervention|Withdrawal by Subject|1|||
128689426|NCT02628769|463163000|FG000|Second Intervention|Adverse Event|2|||
128689427|NCT02628769|463163001|FG001|Second Intervention|Adverse Event|0|||
128689428|NCT02628769|463163000|FG000|Second Intervention|Physician Decision|0|||
128689429|NCT02628769|463163001|FG001|Second Intervention|Physician Decision|1|||
128689430|NCT02024555|463163002|FG000|Overall Study|Lost to Follow-up|1|||
128689431|NCT02024555|463163003|FG001|Overall Study|Lost to Follow-up|1|||
128689432|NCT02024555|463163002|FG000|Overall Study|Withdrawal by Subject|5|||
128689433|NCT02024555|463163003|FG001|Overall Study|Withdrawal by Subject|1|||
128689434|NCT01066000|463163004|FG000|Overall Study|Protocol Violation|4|||
128689435|NCT01066000|463163004|FG000|Overall Study|Death|3|||
128689436|NCT01066000|463163004|FG000|Overall Study|Withdrawal by Subject|1|||
128689437|NCT01066000|463163004|FG000|Overall Study|Adverse Event|1|||
128689438|NCT05268055|463163005|FG000|Overall Study|Lost to Follow-up|68|||
128689439|NCT05268055|463163006|FG001|Overall Study|Lost to Follow-up|68|||
128689440|NCT05268055|463163005|FG000|Overall Study|Withdrawal by Subject|12|||
128689441|NCT05268055|463163006|FG001|Overall Study|Withdrawal by Subject|8|||
128689442|NCT02598960|463164496|FG000|Treatment Period|Disease Progression|4|||
128689443|NCT02598960|463164497|FG001|Treatment Period|Disease Progression|4|||
128689444|NCT02598960|463164498|FG002|Treatment Period|Disease Progression|4|||
128689445|NCT02598960|463164499|FG003|Treatment Period|Disease Progression|6|||
128689446|NCT02598960|463164500|FG004|Treatment Period|Disease Progression|8|||
128689447|NCT02598960|463164501|FG005|Treatment Period|Disease Progression|2|||
128689448|NCT02598960|463164502|FG006|Treatment Period|Disease Progression|2|||
128689449|NCT02598960|463164503|FG007|Treatment Period|Disease Progression|3|||
128689450|NCT02598960|463164504|FG008|Treatment Period|Disease Progression|7|||
128689451|NCT02598960|463164505|FG009|Treatment Period|Disease Progression|9|||
128689452|NCT02598960|463164506|FG010|Treatment Period|Disease Progression|7|||
128689453|NCT02598960|463164507|FG011|Treatment Period|Disease Progression|143|||
128689454|NCT02598960|463164508|FG012|Treatment Period|Disease Progression|23|||
128689455|NCT02598960|463164496|FG000|Treatment Period|Study drug toxicity|0|||
128689456|NCT02598960|463164497|FG001|Treatment Period|Study drug toxicity|0|||
128689457|NCT02598960|463164498|FG002|Treatment Period|Study drug toxicity|0|||
128689458|NCT02598960|463164499|FG003|Treatment Period|Study drug toxicity|0|||
128689459|NCT02598960|463164500|FG004|Treatment Period|Study drug toxicity|0|||
128689460|NCT02598960|463164501|FG005|Treatment Period|Study drug toxicity|0|||
128689461|NCT02598960|463164502|FG006|Treatment Period|Study drug toxicity|0|||
128689462|NCT02598960|463164503|FG007|Treatment Period|Study drug toxicity|0|||
128689463|NCT02598960|463164504|FG008|Treatment Period|Study drug toxicity|0|||
128689464|NCT02598960|463164505|FG009|Treatment Period|Study drug toxicity|1|||
128689465|NCT02598960|463164506|FG010|Treatment Period|Study drug toxicity|0|||
128689466|NCT02598960|463164507|FG011|Treatment Period|Study drug toxicity|3|||
128689467|NCT02598960|463164508|FG012|Treatment Period|Study drug toxicity|0|||
128689468|NCT02598960|463164496|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
128689469|NCT02598960|463164497|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
128689470|NCT02598960|463164498|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
128689471|NCT02598960|463164499|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
128689472|NCT02598960|463164500|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
128689473|NCT02598960|463164501|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
128689474|NCT02598960|463164502|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
128689475|NCT02598960|463164503|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
128689476|NCT02598960|463164504|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
128689477|NCT02598960|463164505|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
128689478|NCT02598960|463164506|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
128689479|NCT02598960|463164507|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
128689480|NCT02598960|463164508|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
128689481|NCT02598960|463164496|FG000|Treatment Period|participant request to discontinue|0|||
128689482|NCT02598960|463164497|FG001|Treatment Period|participant request to discontinue|1|||
128689483|NCT02598960|463164498|FG002|Treatment Period|participant request to discontinue|0|||
128689484|NCT02598960|463164499|FG003|Treatment Period|participant request to discontinue|0|||
128689485|NCT02598960|463164500|FG004|Treatment Period|participant request to discontinue|1|||
128689486|NCT02598960|463164501|FG005|Treatment Period|participant request to discontinue|0|||
128689487|NCT02598960|463164502|FG006|Treatment Period|participant request to discontinue|0|||
128689488|NCT02598960|463164503|FG007|Treatment Period|participant request to discontinue|0|||
128689489|NCT02598960|463164504|FG008|Treatment Period|participant request to discontinue|0|||
128689490|NCT02598960|463164505|FG009|Treatment Period|participant request to discontinue|0|||
128689491|NCT02598960|463164506|FG010|Treatment Period|participant request to discontinue|1|||
128689492|NCT02598960|463164507|FG011|Treatment Period|participant request to discontinue|4|||
128689493|NCT02598960|463164508|FG012|Treatment Period|participant request to discontinue|0|||
128689494|NCT02598960|463164496|FG000|Treatment Period|participant withdrew consent|0|||
128689495|NCT02598960|463164497|FG001|Treatment Period|participant withdrew consent|0|||
128689496|NCT02598960|463164498|FG002|Treatment Period|participant withdrew consent|0|||
128689497|NCT02598960|463164499|FG003|Treatment Period|participant withdrew consent|0|||
128689498|NCT02598960|463164500|FG004|Treatment Period|participant withdrew consent|0|||
128689499|NCT02598960|463164501|FG005|Treatment Period|participant withdrew consent|0|||
128689500|NCT02598960|463164502|FG006|Treatment Period|participant withdrew consent|0|||
128689501|NCT02598960|463164503|FG007|Treatment Period|participant withdrew consent|0|||
128689502|NCT02598960|463164504|FG008|Treatment Period|participant withdrew consent|0|||
128689503|NCT02598960|463164505|FG009|Treatment Period|participant withdrew consent|0|||
128689504|NCT02598960|463164506|FG010|Treatment Period|participant withdrew consent|0|||
128689505|NCT02598960|463164507|FG011|Treatment Period|participant withdrew consent|3|||
128689506|NCT02598960|463164508|FG012|Treatment Period|participant withdrew consent|0|||
128689507|NCT02598960|463164496|FG000|Treatment Period|No longer meets study criteria|0|||
128689508|NCT02598960|463164497|FG001|Treatment Period|No longer meets study criteria|0|||
128689509|NCT02598960|463164498|FG002|Treatment Period|No longer meets study criteria|0|||
128689510|NCT02598960|463164499|FG003|Treatment Period|No longer meets study criteria|0|||
128689511|NCT02598960|463164500|FG004|Treatment Period|No longer meets study criteria|0|||
128689512|NCT02598960|463164501|FG005|Treatment Period|No longer meets study criteria|0|||
128689513|NCT02598960|463164502|FG006|Treatment Period|No longer meets study criteria|0|||
128689514|NCT02598960|463164503|FG007|Treatment Period|No longer meets study criteria|0|||
128689515|NCT02598960|463164504|FG008|Treatment Period|No longer meets study criteria|0|||
128689516|NCT02598960|463164505|FG009|Treatment Period|No longer meets study criteria|0|||
128689517|NCT02598960|463164506|FG010|Treatment Period|No longer meets study criteria|0|||
128689518|NCT02598960|463164507|FG011|Treatment Period|No longer meets study criteria|1|||
128689519|NCT02598960|463164508|FG012|Treatment Period|No longer meets study criteria|0|||
128689520|NCT02598960|463164496|FG000|Treatment Period|Other Reasons|0|||
128689521|NCT02598960|463164497|FG001|Treatment Period|Other Reasons|0|||
128689522|NCT02598960|463164498|FG002|Treatment Period|Other Reasons|0|||
128689523|NCT02598960|463164499|FG003|Treatment Period|Other Reasons|0|||
128689524|NCT02598960|463164500|FG004|Treatment Period|Other Reasons|0|||
128689525|NCT02598960|463164501|FG005|Treatment Period|Other Reasons|0|||
128689526|NCT02598960|463164502|FG006|Treatment Period|Other Reasons|0|||
128689527|NCT02598960|463164503|FG007|Treatment Period|Other Reasons|0|||
128689528|NCT02598960|463164504|FG008|Treatment Period|Other Reasons|0|||
128689529|NCT02598960|463164505|FG009|Treatment Period|Other Reasons|0|||
128689530|NCT02598960|463164506|FG010|Treatment Period|Other Reasons|0|||
128689531|NCT02598960|463164507|FG011|Treatment Period|Other Reasons|0|||
128689532|NCT02598960|463164508|FG012|Treatment Period|Other Reasons|1|||
128689533|NCT02598960|463164496|FG000|Participants Entering Follow Up Period|Death|1|||
128689534|NCT02598960|463164497|FG001|Participants Entering Follow Up Period|Death|0|||
128689535|NCT02598960|463164498|FG002|Participants Entering Follow Up Period|Death|0|||
128689536|NCT02598960|463164499|FG003|Participants Entering Follow Up Period|Death|0|||
128689537|NCT02598960|463164500|FG004|Participants Entering Follow Up Period|Death|0|||
128689538|NCT02598960|463164501|FG005|Participants Entering Follow Up Period|Death|0|||
128689539|NCT02598960|463164502|FG006|Participants Entering Follow Up Period|Death|0|||
128689540|NCT02598960|463164503|FG007|Participants Entering Follow Up Period|Death|0|||
128689541|NCT02598960|463164504|FG008|Participants Entering Follow Up Period|Death|0|||
128689542|NCT02598960|463164505|FG009|Participants Entering Follow Up Period|Death|1|||
128689543|NCT02598960|463164506|FG010|Participants Entering Follow Up Period|Death|0|||
128689544|NCT02598960|463164507|FG011|Participants Entering Follow Up Period|Death|11|||
128689545|NCT02598960|463164508|FG012|Participants Entering Follow Up Period|Death|2|||
128689546|NCT02598960|463164496|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689547|NCT02598960|463164497|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689548|NCT02598960|463164498|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689549|NCT02598960|463164499|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689550|NCT02598960|463164500|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689551|NCT02598960|463164501|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689552|NCT02598960|463164502|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689553|NCT02598960|463164503|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689554|NCT02598960|463164504|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
129021013|NCT02436005|464368598|FG001|Second Intervention|Adverse Event|1|||
128689555|NCT02598960|463164505|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689556|NCT02598960|463164506|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
128689557|NCT02598960|463164507|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
128689558|NCT02598960|463164508|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
128764138|NCT01806584|463425925|FG000|Overall Study|Death|1|||
128764139|NCT01806584|463425926|FG001|Overall Study|Death|0|||
128764140|NCT01806584|463425925|FG000|Overall Study|Lost to Follow-up|0|||
128764141|NCT01806584|463425926|FG001|Overall Study|Lost to Follow-up|2|||
128764142|NCT01806584|463425925|FG000|Overall Study|Study terminated by sponsor|9|||
128764143|NCT01806584|463425926|FG001|Overall Study|Study terminated by sponsor|14|||
128764144|NCT01806584|463425925|FG000|Overall Study|Withdrawal by Subject|1|||
128764145|NCT01806584|463425926|FG001|Overall Study|Withdrawal by Subject|1|||
128689559|NCT02598960|463164496|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
128764146|NCT01806584|463425925|FG000|Overall Study|Other unspecified|1|||
128764147|NCT01806584|463425926|FG001|Overall Study|Other unspecified|0|||
128764148|NCT04398537|463425933|FG000|Overall Study|Physician Decision|10|||
128764149|NCT04398537|463425934|FG001|Overall Study|Physician Decision|15|||
128764150|NCT03610737|463428212|FG000|Overall Study|Withdrawal by Subject|1|||
128764151|NCT03610737|463428213|FG001|Overall Study|Withdrawal by Subject|5|||
128764152|NCT03610737|463428212|FG000|Overall Study|Death|1|||
128764153|NCT03610737|463428213|FG001|Overall Study|Death|0|||
128764154|NCT03610737|463428212|FG000|Overall Study|Not treated|5|||
128764155|NCT03610737|463428213|FG001|Overall Study|Not treated|2|||
128764156|NCT03610737|463428212|FG000|Overall Study|Missed Visit|1|||
128764157|NCT03610737|463428213|FG001|Overall Study|Missed Visit|2|||
128764158|NCT00871403|463428216|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
128764159|NCT00871403|463428217|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
128764160|NCT00871403|463428218|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
128764161|NCT00871403|463428216|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
128764162|NCT00871403|463428217|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
128764163|NCT00871403|463428218|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
128764164|NCT00871403|463428216|FG000|Combination Treatment Phase|Adverse Event|0|||
128764165|NCT00871403|463428217|FG001|Combination Treatment Phase|Adverse Event|17|||
128764166|NCT00871403|463428218|FG002|Combination Treatment Phase|Adverse Event|2|||
128764167|NCT00871403|463428216|FG000|Combination Treatment Phase|Disease Progression|0|||
128764168|NCT00871403|463428217|FG001|Combination Treatment Phase|Disease Progression|8|||
128764169|NCT00871403|463428218|FG002|Combination Treatment Phase|Disease Progression|5|||
128764170|NCT00871403|463428216|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
128764171|NCT00871403|463428217|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
128764172|NCT00871403|463428218|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
128764173|NCT00871403|463428216|FG000|Combination Treatment Phase|Physician Decision|0|||
128764174|NCT00871403|463428217|FG001|Combination Treatment Phase|Physician Decision|1|||
128764175|NCT00871403|463428218|FG002|Combination Treatment Phase|Physician Decision|3|||
128893044|NCT01848353|463904022|FG000|Phase 1|Withdrawal by Subject|3|||
128893045|NCT01848353|463904023|FG001|Phase 1|Withdrawal by Subject|1|||
128893046|NCT01848353|463904024|FG002|Phase 1|Withdrawal by Subject|0|||
128689560|NCT02598960|463164497|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
128689561|NCT02598960|463164498|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
128689562|NCT02598960|463164499|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
128689563|NCT02598960|463164500|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
128689564|NCT02598960|463164501|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
128689565|NCT02598960|463164502|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
128689566|NCT02598960|463164503|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
128689567|NCT02598960|463164504|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
128689568|NCT02598960|463164505|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
128689569|NCT02598960|463164506|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
128689570|NCT02598960|463164507|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
128689571|NCT02598960|463164508|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
128689572|NCT02598960|463164496|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689573|NCT02598960|463164497|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689574|NCT02598960|463164498|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689575|NCT02598960|463164499|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689576|NCT02598960|463164500|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128764176|NCT00871403|463428216|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
128764177|NCT00871403|463428217|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
128893047|NCT01848353|463904025|FG003|Phase 1|Withdrawal by Subject|0|||
128893048|NCT01848353|463904022|FG000|Phase 2|Withdrawal by Subject|3|||
128893049|NCT01848353|463904023|FG001|Phase 2|Withdrawal by Subject|2|||
128893050|NCT01848353|463904024|FG002|Phase 2|Withdrawal by Subject|0|||
129021014|NCT04247282|464368602|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
129021015|NCT04247282|464368603|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
128764178|NCT00871403|463428218|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
128893051|NCT01848353|463904025|FG003|Phase 2|Withdrawal by Subject|0|||
128893052|NCT01848353|463904022|FG000|Phase 3|Withdrawal by Subject|1|||
129040322|NCT00544817|464440116|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
128689577|NCT02598960|463164501|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689578|NCT02598960|463164502|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689579|NCT02598960|463164503|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689580|NCT02598960|463164504|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689581|NCT02598960|463164505|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689582|NCT02598960|463164506|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689583|NCT02598960|463164507|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
128689584|NCT02598960|463164508|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
128689585|NCT02598960|463164496|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
128689586|NCT02598960|463164497|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
128689587|NCT02598960|463164498|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
128689588|NCT02598960|463164499|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
128689589|NCT02598960|463164500|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
128689590|NCT02598960|463164501|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
128689591|NCT02598960|463164502|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
128689592|NCT02598960|463164503|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
128689593|NCT02598960|463164504|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
128689594|NCT02598960|463164505|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
128689595|NCT02598960|463164506|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
128689596|NCT02598960|463164507|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
128689597|NCT02598960|463164508|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
128689598|NCT01854658|463164511|FG000|Overall Study|Protocol Violation|6|||
128689599|NCT01854658|463164512|FG001|Overall Study|Protocol Violation|2|||
128689600|NCT01854658|463164513|FG002|Overall Study|Protocol Violation|2|||
128689601|NCT01854658|463164514|FG003|Overall Study|Protocol Violation|1|||
128689602|NCT01854658|463164511|FG000|Overall Study|Physician Decision|7|||
128689603|NCT01854658|463164512|FG001|Overall Study|Physician Decision|5|||
128689604|NCT01854658|463164513|FG002|Overall Study|Physician Decision|2|||
128689605|NCT01854658|463164514|FG003|Overall Study|Physician Decision|4|||
128689606|NCT01854658|463164511|FG000|Overall Study|Lost to Follow-up|8|||
128689607|NCT01854658|463164512|FG001|Overall Study|Lost to Follow-up|9|||
128689608|NCT01854658|463164513|FG002|Overall Study|Lost to Follow-up|8|||
128689609|NCT01854658|463164514|FG003|Overall Study|Lost to Follow-up|4|||
128689610|NCT01854658|463164511|FG000|Overall Study|Withdrawal by Subject|28|||
128689611|NCT01854658|463164512|FG001|Overall Study|Withdrawal by Subject|21|||
128689612|NCT01854658|463164513|FG002|Overall Study|Withdrawal by Subject|29|||
128689613|NCT01854658|463164514|FG003|Overall Study|Withdrawal by Subject|15|||
128689614|NCT01854658|463164511|FG000|Overall Study|Protocol-specified criteria|15|||
128689615|NCT01854658|463164512|FG001|Overall Study|Protocol-specified criteria|15|||
128689616|NCT01854658|463164513|FG002|Overall Study|Protocol-specified criteria|10|||
128689617|NCT01854658|463164514|FG003|Overall Study|Protocol-specified criteria|7|||
128689618|NCT01854658|463164511|FG000|Overall Study|Lack of Efficacy|3|||
128689619|NCT01854658|463164512|FG001|Overall Study|Lack of Efficacy|8|||
128689620|NCT01854658|463164513|FG002|Overall Study|Lack of Efficacy|4|||
128689621|NCT01854658|463164514|FG003|Overall Study|Lack of Efficacy|7|||
128689622|NCT01854658|463164511|FG000|Overall Study|Adverse Event|21|||
128689623|NCT01854658|463164512|FG001|Overall Study|Adverse Event|14|||
128689624|NCT01854658|463164513|FG002|Overall Study|Adverse Event|23|||
128689625|NCT01854658|463164514|FG003|Overall Study|Adverse Event|19|||
128689626|NCT01854658|463164511|FG000|Overall Study|Administrative reasons|5|||
128689627|NCT01854658|463164512|FG001|Overall Study|Administrative reasons|1|||
128689628|NCT01854658|463164513|FG002|Overall Study|Administrative reasons|2|||
128689629|NCT01854658|463164514|FG003|Overall Study|Administrative reasons|2|||
128689630|NCT00697073|463164515|FG000|Overall Study|Withdrawal by Subject|2|||
128689631|NCT00697073|463164515|FG000|Overall Study|Pregnancy|1|||
128689632|NCT00697073|463164515|FG000|Overall Study|non compliance and other|6|||
128689633|NCT01858376|463164516|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
128689634|NCT02203071|463164517|FG000|Overall Study|Lost to Follow-up|3|||
128689635|NCT02203071|463164518|FG001|Overall Study|Lost to Follow-up|1|||
128764179|NCT00871403|463428216|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
128893053|NCT01848353|463904023|FG001|Phase 3|Withdrawal by Subject|1|||
128893054|NCT01848353|463904024|FG002|Phase 3|Withdrawal by Subject|0|||
128893055|NCT01848353|463904025|FG003|Phase 3|Withdrawal by Subject|0|||
129021016|NCT04247282|464368604|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
129021017|NCT04247282|464368605|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
128764180|NCT00871403|463428217|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
128764181|NCT00871403|463428218|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
128764182|NCT00787319|463428219|FG000|Overall Study|Lost to Follow-up|2|||
128764183|NCT00787319|463428219|FG000|Overall Study|Withdrawal by Subject|15|||
128764184|NCT00787319|463428219|FG000|Overall Study|Adverse Event|3|||
128893056|NCT00935272|463904026|FG000|Overall Study|Lost to Follow-up|10|||
129021018|NCT04247282|464368602|FG000|Overall Study|Refused further treatment|0|||
128764185|NCT00787319|463428219|FG000|Overall Study|Objective progression or relapse|30|||
128764186|NCT00787319|463428219|FG000|Overall Study|Lack of Efficacy|1|||
128764187|NCT00787319|463428219|FG000|Overall Study|Budget exhausted/exceeded|1|||
128764188|NCT00787319|463428219|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
128764189|NCT00787319|463428219|FG000|Overall Study|No health insurance reimbursement|2|||
128764190|NCT00787319|463428219|FG000|Overall Study|Stabilized disease findings|3|||
128764191|NCT00787319|463428219|FG000|Overall Study|Inactive disease|5|||
128689636|NCT03894046|463164519|FG000|Overall Study|Protocol Violation|1|||
128689637|NCT03894046|463164520|FG001|Overall Study|Protocol Violation|0|||
128689638|NCT03894046|463164521|FG002|Overall Study|Protocol Violation|0|||
128689639|NCT03894046|463164519|FG000|Overall Study|Adverse Event|0|||
128689640|NCT03894046|463164520|FG001|Overall Study|Adverse Event|1|||
128689641|NCT03894046|463164521|FG002|Overall Study|Adverse Event|0|||
128689642|NCT03894046|463164519|FG000|Overall Study|Withdrawal by Subject|2|||
128689643|NCT03894046|463164520|FG001|Overall Study|Withdrawal by Subject|3|||
128689644|NCT03894046|463164521|FG002|Overall Study|Withdrawal by Subject|1|||
128689645|NCT03894046|463164519|FG000|Overall Study|Death|15|||
128689646|NCT03894046|463164520|FG001|Overall Study|Death|21|||
128689647|NCT03894046|463164521|FG002|Overall Study|Death|4|||
128689648|NCT03894046|463164519|FG000|Overall Study|No growth of ABC|2|||
128689649|NCT03894046|463164520|FG001|Overall Study|No growth of ABC|1|||
128764192|NCT01932294|463428220|FG000|Overall Study|Death|43|||
128764193|NCT01932294|463428220|FG000|Overall Study|Lost to Follow-up|8|||
128764194|NCT01932294|463428220|FG000|Overall Study|VAD Implantation|20|||
128764195|NCT01932294|463428220|FG000|Overall Study|Heart Transplantation|16|||
128764196|NCT01932294|463428220|FG000|Overall Study|Transferred to other hospitals|12|||
128689650|NCT03894046|463164521|FG002|Overall Study|No growth of ABC|0|||
128689651|NCT03894046|463164519|FG000|Overall Study|Physician Decision|1|||
128764197|NCT04415151|463428221|FG000|Overall Study|Death|1|||
128764198|NCT04415151|463428222|FG001|Overall Study|Death|1|||
128764199|NCT04415151|463428221|FG000|Overall Study|Withdrawal by Subject|1|||
128764200|NCT04415151|463428222|FG001|Overall Study|Withdrawal by Subject|0|||
128764201|NCT00659984|463428228|FG000|Overall Study|Adverse Event|1|||
128764202|NCT02228395|463428229|FG000|First Intervention Period|No longer willing to participate|1|||
128764203|NCT02228395|463428230|FG001|First Intervention Period|No longer willing to participate|0|||
128764204|NCT02228395|463428231|FG002|First Intervention Period|No longer willing to participate|0|||
128764205|NCT02228395|463428229|FG000|First Intervention Period|Unable to comply with study dates|0|||
128764206|NCT02228395|463428230|FG001|First Intervention Period|Unable to comply with study dates|1|||
128764207|NCT02228395|463428231|FG002|First Intervention Period|Unable to comply with study dates|1|||
128764208|NCT00985985|463428232|FG000|Overall Study|Adverse Event|4|||
128764209|NCT00985985|463428233|FG001|Overall Study|Adverse Event|2|||
128764210|NCT00985985|463428234|FG002|Overall Study|Adverse Event|2|||
128764211|NCT00985985|463428235|FG003|Overall Study|Adverse Event|2|||
128764212|NCT00985985|463428232|FG000|Overall Study|Lost to Follow-up|4|||
128764213|NCT00985985|463428233|FG001|Overall Study|Lost to Follow-up|11|||
128764214|NCT00985985|463428234|FG002|Overall Study|Lost to Follow-up|2|||
128764215|NCT00985985|463428235|FG003|Overall Study|Lost to Follow-up|3|||
128764216|NCT00985985|463428232|FG000|Overall Study|Protocol Violation|1|||
128764217|NCT00985985|463428233|FG001|Overall Study|Protocol Violation|2|||
128764218|NCT00985985|463428234|FG002|Overall Study|Protocol Violation|0|||
128764219|NCT00985985|463428235|FG003|Overall Study|Protocol Violation|1|||
128764220|NCT00985985|463428232|FG000|Overall Study|Lack of Efficacy|5|||
129215200|NCT02195518|465089463|FG000|Overall Study|Lost to Follow-up|1|||
128689652|NCT03894046|463164520|FG001|Overall Study|Physician Decision|1|||
128689653|NCT03894046|463164521|FG002|Overall Study|Physician Decision|1|||
128689654|NCT03894046|463164519|FG000|Overall Study|Prohibited concomitant medication|1|||
128764221|NCT00985985|463428233|FG001|Overall Study|Lack of Efficacy|6|||
128764222|NCT00985985|463428234|FG002|Overall Study|Lack of Efficacy|1|||
128764223|NCT00985985|463428235|FG003|Overall Study|Lack of Efficacy|3|||
128764224|NCT00985985|463428232|FG000|Overall Study|Withdrawal by Subject|4|||
128764225|NCT00985985|463428233|FG001|Overall Study|Withdrawal by Subject|2|||
128764226|NCT00985985|463428234|FG002|Overall Study|Withdrawal by Subject|2|||
128764227|NCT00985985|463428235|FG003|Overall Study|Withdrawal by Subject|2|||
128764228|NCT00985985|463428232|FG000|Overall Study|Other Reason|6|||
128893057|NCT00935272|463904027|FG001|Overall Study|Lost to Follow-up|3|||
128893058|NCT00935272|463904026|FG000|Overall Study|Withdrawal by Subject|8|||
128689655|NCT03894046|463164520|FG001|Overall Study|Prohibited concomitant medication|0|||
128764229|NCT00985985|463428233|FG001|Overall Study|Other Reason|1|||
128764230|NCT00985985|463428234|FG002|Overall Study|Other Reason|4|||
128764231|NCT00985985|463428235|FG003|Overall Study|Other Reason|2|||
128764232|NCT02255357|463428236|FG000|Overall Study|Physician Decision|10|||
128764233|NCT02255357|463428237|FG001|Overall Study|Physician Decision|24|||
128764234|NCT00927355|463428238|FG000|Overall Study|Adverse Event|1|||
128689656|NCT03894046|463164521|FG002|Overall Study|Prohibited concomitant medication|0|||
128689657|NCT03894046|463164519|FG000|Overall Study|Transferred to other arm/group|1|||
128689658|NCT03894046|463164520|FG001|Overall Study|Transferred to other arm/group|1|||
128689659|NCT03894046|463164521|FG002|Overall Study|Transferred to other arm/group|0|||
128689660|NCT02436304|463164528|FG000|Overall Study|Lost to Follow-up|0|||
128689661|NCT02436304|463164529|FG001|Overall Study|Lost to Follow-up|1|||
128689662|NCT02436304|463164530|FG002|Overall Study|Lost to Follow-up|0|||
128689663|NCT02436304|463164528|FG000|Overall Study|Withdrawal by Subject|0|||
128689664|NCT02436304|463164529|FG001|Overall Study|Withdrawal by Subject|1|||
128689665|NCT02436304|463164530|FG002|Overall Study|Withdrawal by Subject|0|||
128689666|NCT02436304|463164528|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
128689667|NCT02436304|463164529|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
128689668|NCT02436304|463164530|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
128689669|NCT03793556|463164531|FG000|Overall Study|Withdrawal by Subject|12|||
128689670|NCT03793556|463164532|FG001|Overall Study|Withdrawal by Subject|1|||
128689671|NCT03793556|463164531|FG000|Overall Study|Lost to Follow-up|1|||
128689672|NCT03793556|463164532|FG001|Overall Study|Lost to Follow-up|1|||
128689673|NCT04416633|463164533|FG000|Overall Study|Death|1|||
128689674|NCT04416633|463164533|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
128689675|NCT04416633|463164533|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
128689676|NCT04416633|463164533|FG000|Overall Study|Adverse Event|6|||
128689677|NCT04416633|463164533|FG000|Overall Study|Withdrawal by Subject|6|||
128689678|NCT04612790|463164534|FG000|DB Period (Up to 36 Weeks)|Death|1|||
128689679|NCT04612790|463164535|FG001|DB Period (Up to 36 Weeks)|Death|1|||
128689680|NCT04612790|463164536|FG002|DB Period (Up to 36 Weeks)|Death|0|||
128689681|NCT04612790|463164537|FG003|DB Period (Up to 36 Weeks)|Death|0|||
128689682|NCT04612790|463164534|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
128689683|NCT04612790|463164535|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
128689684|NCT04612790|463164536|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
128689685|NCT04612790|463164537|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
128689686|NCT04612790|463164534|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
128689687|NCT04612790|463164535|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
128689688|NCT04612790|463164536|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
128689689|NCT04612790|463164537|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
128689690|NCT04612790|463164534|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
128689691|NCT04612790|463164535|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
128689692|NCT04612790|463164536|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
128689693|NCT04612790|463164537|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
128689694|NCT04612790|463164534|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
128689695|NCT04612790|463164535|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
128689696|NCT04612790|463164536|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
128689697|NCT04612790|463164537|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
128689698|NCT04612790|463164534|FG000|DB Period (Up to 36 Weeks)|Other|1|||
128689699|NCT04612790|463164535|FG001|DB Period (Up to 36 Weeks)|Other|0|||
128689700|NCT04612790|463164536|FG002|DB Period (Up to 36 Weeks)|Other|0|||
128689701|NCT04612790|463164537|FG003|DB Period (Up to 36 Weeks)|Other|0|||
128689702|NCT04612790|463164534|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
128689703|NCT04612790|463164535|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
128689704|NCT04612790|463164536|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
128689705|NCT04612790|463164537|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
128689706|NCT04612790|463164534|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
128689707|NCT04612790|463164535|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
128689708|NCT04612790|463164536|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
128689709|NCT04612790|463164537|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
128689710|NCT04612790|463164534|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
128689711|NCT04612790|463164535|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
128689712|NCT04612790|463164536|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
128689713|NCT04612790|463164537|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
128689714|NCT04612790|463164534|FG000|OLE Period (Up to 1 Year)|Other|0|||
128689715|NCT04612790|463164535|FG001|OLE Period (Up to 1 Year)|Other|0|||
128689716|NCT04612790|463164536|FG002|OLE Period (Up to 1 Year)|Other|0|||
128689717|NCT04612790|463164537|FG003|OLE Period (Up to 1 Year)|Other|1|||
129021019|NCT04247282|464368603|FG001|Overall Study|Refused further treatment|1|||
129021020|NCT04247282|464368604|FG002|Overall Study|Refused further treatment|0|||
129021021|NCT04247282|464368605|FG003|Overall Study|Refused further treatment|0|||
129021022|NCT01037114|464368612|FG000|Year 20|Others|1|||
129021023|NCT00968812|464368620|FG000|Overall Study|Adverse Event|30|||
128689718|NCT00785928|463164538|FG000|Treatment Phase|Adverse Event|1|||
128689719|NCT00785928|463164539|FG001|Treatment Phase|Adverse Event|1|||
128689720|NCT00785928|463164540|FG002|Treatment Phase|Adverse Event|2|||
128689721|NCT00785928|463164541|FG003|Treatment Phase|Adverse Event|0|||
128689722|NCT00785928|463164542|FG004|Treatment Phase|Adverse Event|0|||
128689723|NCT00785928|463164543|FG005|Treatment Phase|Adverse Event|0|||
128689724|NCT00785928|463164544|FG006|Treatment Phase|Adverse Event|2|||
128689725|NCT00785928|463164538|FG000|Treatment Phase|Inadequate Response|0|||
128689726|NCT00785928|463164539|FG001|Treatment Phase|Inadequate Response|1|||
129021024|NCT00968812|464368621|FG001|Overall Study|Adverse Event|46|||
129215201|NCT01588522|465089464|FG000|Overall Study|Withdrawal by Subject|1|||
128764235|NCT00927355|463428239|FG001|Overall Study|Adverse Event|1|||
128764236|NCT01572389|463428240|FG000|Overall Study|Death|1|||
128764237|NCT01572389|463428241|FG001|Overall Study|Death|3|||
128764238|NCT01572389|463428240|FG000|Overall Study|Withdrawal by Subject|14|||
128764239|NCT01572389|463428241|FG001|Overall Study|Withdrawal by Subject|2|||
128764240|NCT01572389|463428240|FG000|Overall Study|Lost to Follow-up|25|||
128764241|NCT01572389|463428241|FG001|Overall Study|Lost to Follow-up|14|||
128764242|NCT01572389|463428240|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
128764243|NCT01572389|463428241|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
128764244|NCT03587142|463428242|FG000|Overall Study|Lost to Follow-up|5|||
128764245|NCT03587142|463428243|FG001|Overall Study|Lost to Follow-up|3|||
128764246|NCT03587142|463428242|FG000|Overall Study|Did not complete the f4 visit|3|||
128764247|NCT03587142|463428243|FG001|Overall Study|Did not complete the f4 visit|7|||
128764248|NCT01800201|463428244|FG000|Overall Study|Withdrawal by Subject|2|||
128764249|NCT01800201|463428245|FG001|Overall Study|Withdrawal by Subject|0|||
128764250|NCT01800201|463428244|FG000|Overall Study|patient privacy concerns|1|||
128764251|NCT01800201|463428245|FG001|Overall Study|patient privacy concerns|1|||
128764252|NCT01800201|463428244|FG000|Overall Study|did not want to use device|0|||
128764253|NCT01800201|463428245|FG001|Overall Study|did not want to use device|1|||
128764254|NCT01800201|463428244|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
128764255|NCT01800201|463428245|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
128764256|NCT01691521|463428251|FG000|Overall Study|Adverse Event|4|||
128764257|NCT01691521|463428252|FG001|Overall Study|Adverse Event|0|||
128764258|NCT01691521|463428253|FG002|Overall Study|Adverse Event|1|||
128764259|NCT01691521|463428251|FG000|Overall Study|Lack of Efficacy|1|||
128764260|NCT01691521|463428252|FG001|Overall Study|Lack of Efficacy|1|||
128764261|NCT01691521|463428253|FG002|Overall Study|Lack of Efficacy|2|||
128764262|NCT01691521|463428251|FG000|Overall Study|Protocol Violation|0|||
128764263|NCT01691521|463428252|FG001|Overall Study|Protocol Violation|3|||
128764264|NCT01691521|463428253|FG002|Overall Study|Protocol Violation|0|||
128764265|NCT01691521|463428251|FG000|Overall Study|Lost to Follow-up|0|||
128764266|NCT01691521|463428252|FG001|Overall Study|Lost to Follow-up|2|||
128764267|NCT01691521|463428253|FG002|Overall Study|Lost to Follow-up|2|||
128764268|NCT01691521|463428251|FG000|Overall Study|Physician Decision|2|||
128764269|NCT01691521|463428252|FG001|Overall Study|Physician Decision|1|||
128764270|NCT01691521|463428253|FG002|Overall Study|Physician Decision|0|||
128764271|NCT01691521|463428251|FG000|Overall Study|Withdrawal by Subject|5|||
128764272|NCT01691521|463428252|FG001|Overall Study|Withdrawal by Subject|9|||
128764273|NCT01691521|463428253|FG002|Overall Study|Withdrawal by Subject|4|||
128764274|NCT03541044|463428255|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
128764275|NCT03541044|463428256|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
128764276|NCT03541044|463428255|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
128764277|NCT03541044|463428256|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
128764278|NCT01153269|463428257|FG000|Overall Study|Withdrawal by Subject|1|||
128764279|NCT01153269|463428257|FG000|Overall Study|Antiretroviral therapy break|1|||
128764280|NCT02635724|463428258|FG000|Overall Study|Withdrawal by Subject|0|||
128764281|NCT02635724|463428259|FG001|Overall Study|Withdrawal by Subject|1|||
128764282|NCT02635724|463428260|FG002|Overall Study|Withdrawal by Subject|0|||
128764283|NCT02424591|463428263|FG000|Overall Study|Protocol Violation|2|||
128764284|NCT02424591|463428264|FG001|Overall Study|Protocol Violation|3|||
128764285|NCT01446796|463428265|FG000|Overall Study|Withdrawal by Subject|1|||
128764286|NCT01446796|463428266|FG001|Overall Study|Withdrawal by Subject|0|||
128764287|NCT00312702|463428269|FG000|Immunization Phase|Lost to Follow-up|0|||
128764288|NCT00312702|463428270|FG001|Immunization Phase|Lost to Follow-up|1|||
128764289|NCT00312702|463428271|FG002|Immunization Phase|Lost to Follow-up|0|||
128764290|NCT00770432|463428272|FG000|Overall Study|Other|4|||
128764291|NCT00770432|463428273|FG001|Overall Study|Other|6|||
129021025|NCT00968812|464368622|FG002|Overall Study|Adverse Event|33|||
129021026|NCT00968812|464368620|FG000|Overall Study|Death|2|||
129021027|NCT00968812|464368621|FG001|Overall Study|Death|2|||
129021028|NCT00968812|464368622|FG002|Overall Study|Death|1|||
129021029|NCT00968812|464368620|FG000|Overall Study|Lack of Efficacy|9|||
129021030|NCT00968812|464368621|FG001|Overall Study|Lack of Efficacy|7|||
129021031|NCT00968812|464368622|FG002|Overall Study|Lack of Efficacy|16|||
128764292|NCT00770432|463428272|FG000|Overall Study|Non-compliance|0|||
128764293|NCT00770432|463428273|FG001|Overall Study|Non-compliance|1|||
128764294|NCT04581200|463428276|FG000|Overall Study|Lost to Follow-up|6|||
128764295|NCT04581200|463428277|FG001|Overall Study|Lost to Follow-up|5|||
128764296|NCT01859793|463428281|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
128764297|NCT01859793|463428282|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
129021032|NCT00968812|464368620|FG000|Overall Study|Lost to Follow-up|17|||
128764298|NCT01859793|463428281|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
128764299|NCT01859793|463428282|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
128764300|NCT01859793|463428281|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129021033|NCT00968812|464368621|FG001|Overall Study|Lost to Follow-up|12|||
129021034|NCT00968812|464368622|FG002|Overall Study|Lost to Follow-up|11|||
129021035|NCT00968812|464368620|FG000|Overall Study|Physician Decision|8|||
128689727|NCT00785928|463164540|FG002|Treatment Phase|Inadequate Response|0|||
128689728|NCT00785928|463164541|FG003|Treatment Phase|Inadequate Response|0|||
128689729|NCT00785928|463164542|FG004|Treatment Phase|Inadequate Response|0|||
128689730|NCT00785928|463164543|FG005|Treatment Phase|Inadequate Response|0|||
128689731|NCT00785928|463164544|FG006|Treatment Phase|Inadequate Response|0|||
128689732|NCT00785928|463164538|FG000|Treatment Phase|Lack of Efficacy|0|||
128689733|NCT00785928|463164539|FG001|Treatment Phase|Lack of Efficacy|1|||
128689734|NCT00785928|463164540|FG002|Treatment Phase|Lack of Efficacy|1|||
128689735|NCT00785928|463164541|FG003|Treatment Phase|Lack of Efficacy|0|||
128689736|NCT00785928|463164542|FG004|Treatment Phase|Lack of Efficacy|0|||
128689737|NCT00785928|463164543|FG005|Treatment Phase|Lack of Efficacy|0|||
128689738|NCT00785928|463164544|FG006|Treatment Phase|Lack of Efficacy|0|||
128689739|NCT00785928|463164538|FG000|Treatment Phase|Physician Decision|0|||
128689740|NCT00785928|463164539|FG001|Treatment Phase|Physician Decision|0|||
128689741|NCT00785928|463164540|FG002|Treatment Phase|Physician Decision|0|||
128689742|NCT00785928|463164541|FG003|Treatment Phase|Physician Decision|0|||
128689743|NCT00785928|463164542|FG004|Treatment Phase|Physician Decision|1|||
128689744|NCT00785928|463164543|FG005|Treatment Phase|Physician Decision|0|||
128893059|NCT00935272|463904027|FG001|Overall Study|Withdrawal by Subject|2|||
128893060|NCT00935272|463904026|FG000|Overall Study|Physician Decision|1|||
128893061|NCT00935272|463904027|FG001|Overall Study|Physician Decision|0|||
128893062|NCT00935272|463904026|FG000|Overall Study|Protocol Violation|0|||
128893063|NCT00935272|463904027|FG001|Overall Study|Protocol Violation|1|||
128893064|NCT03492554|463904034|FG000|Overall Study|Protocol Violation|0|||
128893065|NCT03492554|463904035|FG001|Overall Study|Protocol Violation|14|||
128893066|NCT01478360|463904038|FG000|Overall Study|Lost to Follow-up|1|||
128893067|NCT01478360|463904039|FG001|Overall Study|Lost to Follow-up|0|||
128893068|NCT01478360|463904038|FG000|Overall Study|Adverse Event|0|||
128893069|NCT01478360|463904039|FG001|Overall Study|Adverse Event|1|||
128893070|NCT01478360|463904038|FG000|Overall Study|Administrative problems|1|||
128893071|NCT01478360|463904039|FG001|Overall Study|Administrative problems|2|||
128893072|NCT02289352|463904040|FG000|Overall Study|Withdrawal by Subject|1|||
128893073|NCT02289352|463904041|FG001|Overall Study|Withdrawal by Subject|1|||
128893074|NCT02289352|463904042|FG002|Overall Study|Withdrawal by Subject|0|||
128893075|NCT00911625|463904068|FG000|Overall Study|Lost to Follow-up|7|||
128689745|NCT00785928|463164544|FG006|Treatment Phase|Physician Decision|0|||
128689746|NCT00785928|463164538|FG000|Treatment Phase|Sponsor Decision|1|||
128689747|NCT00785928|463164539|FG001|Treatment Phase|Sponsor Decision|0|||
128689748|NCT00785928|463164540|FG002|Treatment Phase|Sponsor Decision|0|||
128689749|NCT00785928|463164541|FG003|Treatment Phase|Sponsor Decision|0|||
128689750|NCT00785928|463164542|FG004|Treatment Phase|Sponsor Decision|0|||
128689751|NCT00785928|463164543|FG005|Treatment Phase|Sponsor Decision|0|||
128689752|NCT00785928|463164544|FG006|Treatment Phase|Sponsor Decision|1|||
128689753|NCT00785928|463164538|FG000|Treatment Phase|Withdrawal by Subject|1|||
128689754|NCT00785928|463164539|FG001|Treatment Phase|Withdrawal by Subject|2|||
128689755|NCT00785928|463164540|FG002|Treatment Phase|Withdrawal by Subject|0|||
128689756|NCT00785928|463164541|FG003|Treatment Phase|Withdrawal by Subject|0|||
128689757|NCT00785928|463164542|FG004|Treatment Phase|Withdrawal by Subject|1|||
128689758|NCT00785928|463164543|FG005|Treatment Phase|Withdrawal by Subject|0|||
128689759|NCT00785928|463164544|FG006|Treatment Phase|Withdrawal by Subject|0|||
128689760|NCT00369122|463164549|FG000|Overall Study|Ineligible|10|||
128689761|NCT00369122|463164549|FG000|Overall Study|No protocol treatment|1|||
129021036|NCT00968812|464368621|FG001|Overall Study|Physician Decision|5|||
129021037|NCT00968812|464368622|FG002|Overall Study|Physician Decision|9|||
129021038|NCT00968812|464368620|FG000|Overall Study|Protocol Violation|7|||
128689762|NCT00408629|463164550|FG000|Overall Study|Adverse Event|13|||
128689763|NCT00408629|463164551|FG001|Overall Study|Adverse Event|27|||
128689764|NCT00408629|463164550|FG000|Overall Study|Withdrawal by Subject|8|||
128689765|NCT00408629|463164551|FG001|Overall Study|Withdrawal by Subject|4|||
128689766|NCT00408629|463164550|FG000|Overall Study|Lost to Follow-up|1|||
128689767|NCT00408629|463164551|FG001|Overall Study|Lost to Follow-up|1|||
128689768|NCT00408629|463164550|FG000|Overall Study|Lack of Efficacy|63|||
128689769|NCT00408629|463164551|FG001|Overall Study|Lack of Efficacy|73|||
128689770|NCT00408629|463164550|FG000|Overall Study|Protocol Violation|1|||
128689771|NCT00408629|463164551|FG001|Overall Study|Protocol Violation|5|||
128689772|NCT00408629|463164550|FG000|Overall Study|Miscellaneous|11|||
128689773|NCT00408629|463164551|FG001|Overall Study|Miscellaneous|15|||
128689774|NCT00191906|463164552|FG000|Study Period II|Adverse Event|0|||
128689775|NCT00191906|463164553|FG001|Study Period II|Adverse Event|1|||
128689776|NCT00191906|463164554|FG002|Study Period II|Adverse Event|0|||
128689777|NCT00191906|463164555|FG003|Study Period II|Adverse Event|0|||
128689778|NCT00191906|463164552|FG000|Study Period II|Withdrawal by Subject|0|||
128689779|NCT00191906|463164553|FG001|Study Period II|Withdrawal by Subject|3|||
128689780|NCT00191906|463164554|FG002|Study Period II|Withdrawal by Subject|0|||
128893076|NCT00911625|463904069|FG001|Overall Study|Lost to Follow-up|0|||
128893077|NCT02463071|463904077|FG000|Overall Study|Adverse Event|3|||
128893078|NCT02463071|463904078|FG001|Overall Study|Adverse Event|5|||
128893079|NCT02463071|463904079|FG002|Overall Study|Adverse Event|1|||
128689781|NCT00191906|463164555|FG003|Study Period II|Withdrawal by Subject|0|||
128689782|NCT00191906|463164552|FG000|Study Period II|Parent/Caregiver Decision|0|||
128689783|NCT00191906|463164553|FG001|Study Period II|Parent/Caregiver Decision|1|||
128689784|NCT00191906|463164554|FG002|Study Period II|Parent/Caregiver Decision|0|||
128689785|NCT00191906|463164555|FG003|Study Period II|Parent/Caregiver Decision|0|||
128689786|NCT00191906|463164552|FG000|Study Period II|Entry Criteria Exclusion|0|||
128689787|NCT00191906|463164553|FG001|Study Period II|Entry Criteria Exclusion|0|||
128689788|NCT00191906|463164554|FG002|Study Period II|Entry Criteria Exclusion|1|||
128689789|NCT00191906|463164555|FG003|Study Period II|Entry Criteria Exclusion|0|||
128689790|NCT00191906|463164552|FG000|Study Period III|Adverse Event|1|||
128689791|NCT00191906|463164553|FG001|Study Period III|Adverse Event|0|||
128689792|NCT00191906|463164554|FG002|Study Period III|Adverse Event|0|||
128689793|NCT00191906|463164555|FG003|Study Period III|Adverse Event|0|||
128689794|NCT00191906|463164552|FG000|Study Period III|Lost to Follow-up|0|||
128689795|NCT00191906|463164553|FG001|Study Period III|Lost to Follow-up|1|||
128689796|NCT00191906|463164554|FG002|Study Period III|Lost to Follow-up|0|||
128689797|NCT00191906|463164555|FG003|Study Period III|Lost to Follow-up|0|||
128689798|NCT00191906|463164552|FG000|Study Period III|Parent/Caregiver Decision|1|||
128689799|NCT00191906|463164553|FG001|Study Period III|Parent/Caregiver Decision|0|||
128689800|NCT00191906|463164554|FG002|Study Period III|Parent/Caregiver Decision|0|||
128689801|NCT00191906|463164555|FG003|Study Period III|Parent/Caregiver Decision|0|||
128689802|NCT00191906|463164552|FG000|Study Period III|Lack of Efficacy|3|||
128689803|NCT00191906|463164553|FG001|Study Period III|Lack of Efficacy|3|||
128689804|NCT00191906|463164554|FG002|Study Period III|Lack of Efficacy|0|||
128689805|NCT00191906|463164555|FG003|Study Period III|Lack of Efficacy|0|||
128689806|NCT00573937|463164556|FG000|Overall Study|Study Terminated|0|||
128689807|NCT00573937|463164557|FG001|Overall Study|Study Terminated|1|||
128689808|NCT00333801|463164558|FG000|Overall Study|Moved to another state|5|||
128689809|NCT00333801|463164559|FG001|Overall Study|Moved to another state|3|||
128689810|NCT00333801|463164558|FG000|Overall Study|Lost to Follow-up|2|||
128689811|NCT00333801|463164559|FG001|Overall Study|Lost to Follow-up|0|||
128689812|NCT00333801|463164558|FG000|Overall Study|Incarcerated|1|||
128689813|NCT00333801|463164559|FG001|Overall Study|Incarcerated|2|||
128689814|NCT00333801|463164558|FG000|Overall Study|Withdrawal by Subject|0|||
128689815|NCT00333801|463164559|FG001|Overall Study|Withdrawal by Subject|1|||
128689816|NCT04171765|463164560|FG000|Overall Study|Adverse Event|2|||
128689817|NCT04171765|463164561|FG001|Overall Study|Adverse Event|0|||
128689818|NCT04171765|463164562|FG002|Overall Study|Adverse Event|1|||
128689819|NCT04171765|463164563|FG003|Overall Study|Adverse Event|0|||
128689820|NCT04171765|463164560|FG000|Overall Study|Lost to Follow-up|0|||
128689821|NCT04171765|463164561|FG001|Overall Study|Lost to Follow-up|2|||
128689822|NCT04171765|463164562|FG002|Overall Study|Lost to Follow-up|2|||
128689823|NCT04171765|463164563|FG003|Overall Study|Lost to Follow-up|2|||
128689824|NCT04171765|463164560|FG000|Overall Study|Week 58 visit missed|0|||
128689825|NCT04171765|463164561|FG001|Overall Study|Week 58 visit missed|0|||
128689826|NCT04171765|463164562|FG002|Overall Study|Week 58 visit missed|1|||
128689827|NCT04171765|463164563|FG003|Overall Study|Week 58 visit missed|0|||
128689828|NCT04171765|463164560|FG000|Overall Study|Study terminated by sponsor|2|||
128689829|NCT04171765|463164561|FG001|Overall Study|Study terminated by sponsor|0|||
128689830|NCT04171765|463164562|FG002|Overall Study|Study terminated by sponsor|0|||
128689831|NCT04171765|463164563|FG003|Overall Study|Study terminated by sponsor|0|||
128689832|NCT04171765|463164560|FG000|Overall Study|Withdrawal by Subject|1|||
128689833|NCT04171765|463164561|FG001|Overall Study|Withdrawal by Subject|0|||
128689834|NCT04171765|463164562|FG002|Overall Study|Withdrawal by Subject|0|||
128689835|NCT04171765|463164563|FG003|Overall Study|Withdrawal by Subject|3|||
128689836|NCT00631696|463164564|FG000|Overall Study|Entered, not randomized to treatment|1|||
128689837|NCT00631696|463164565|FG001|Overall Study|Entered, not randomized to treatment|1|||
128689838|NCT00631696|463164564|FG000|Overall Study|Discontinued after database release date|1|||
128689839|NCT00631696|463164565|FG001|Overall Study|Discontinued after database release date|0|||
128689840|NCT00631696|463164564|FG000|Overall Study|Follow up after database release date|1|||
128689841|NCT00631696|463164565|FG001|Overall Study|Follow up after database release date|0|||
128689842|NCT00631696|463164564|FG000|Overall Study|Lost to Follow-up|7|||
128689843|NCT00631696|463164565|FG001|Overall Study|Lost to Follow-up|10|||
128689844|NCT00631696|463164564|FG000|Overall Study|Withdrawal by Subject|2|||
128689845|NCT00631696|463164565|FG001|Overall Study|Withdrawal by Subject|9|||
128689846|NCT00631696|463164564|FG000|Overall Study|Other|8|||
128689847|NCT00631696|463164565|FG001|Overall Study|Other|8|||
128689848|NCT00631696|463164564|FG000|Overall Study|Protocol Violation|9|||
128689849|NCT00631696|463164565|FG001|Overall Study|Protocol Violation|9|||
128689850|NCT00631696|463164564|FG000|Overall Study|Study terminated by sponsor|3|||
128689851|NCT00631696|463164565|FG001|Overall Study|Study terminated by sponsor|3|||
128689852|NCT00631696|463164564|FG000|Overall Study|Adverse Event|5|||
128689853|NCT00631696|463164565|FG001|Overall Study|Adverse Event|0|||
128689854|NCT01050543|463164566|FG000|Overall Study|Withdrawal by Subject|0|||
128689855|NCT01050543|463164567|FG001|Overall Study|Withdrawal by Subject|2|||
128689856|NCT01050543|463164566|FG000|Overall Study|Protocol Violation|0|||
128689857|NCT01050543|463164567|FG001|Overall Study|Protocol Violation|1|||
128689858|NCT01050543|463164566|FG000|Overall Study|Administrative|4|||
128689859|NCT01050543|463164567|FG001|Overall Study|Administrative|1|||
128689860|NCT01646073|463164568|FG000|Period A (12 Weeks)|Adverse Event|0|||
128689861|NCT01646073|463164569|FG001|Period A (12 Weeks)|Adverse Event|2|||
128689862|NCT01646073|463164568|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
128689863|NCT01646073|463164569|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
128689864|NCT01646073|463164568|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
128689865|NCT01646073|463164569|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
128689866|NCT01646073|463164568|FG000|Period A (12 Weeks)|Protocol Violation|0|||
128689867|NCT01646073|463164569|FG001|Period A (12 Weeks)|Protocol Violation|1|||
128689868|NCT01646073|463164568|FG000|Period A (12 Weeks)|Other|0|||
128689869|NCT01646073|463164569|FG001|Period A (12 Weeks)|Other|1|||
128689870|NCT01646073|463164568|FG000|Period B (12 Weeks)|Adverse Event|0|||
128689871|NCT01646073|463164569|FG001|Period B (12 Weeks)|Adverse Event|7|||
128689872|NCT01646073|463164568|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
128689873|NCT01646073|463164569|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
128689874|NCT01646073|463164568|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
128689875|NCT01646073|463164569|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
128764301|NCT01859793|463428282|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
128764302|NCT01859793|463428281|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
128764303|NCT01859793|463428282|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
128764304|NCT01735396|463428283|FG000|Overall Study|not evaluable|1|||
128764305|NCT02002182|463428284|FG000|Overall Study|Withdraw from study|3|||
128893080|NCT02463071|463904077|FG000|Overall Study|Death|1|||
128893081|NCT02463071|463904078|FG001|Overall Study|Death|0|||
128893082|NCT02463071|463904079|FG002|Overall Study|Death|0|||
128893083|NCT02463071|463904077|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
128893084|NCT02463071|463904078|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128893085|NCT02463071|463904079|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
128893086|NCT02463071|463904077|FG000|Overall Study|Reason not specified|7|||
128893087|NCT02463071|463904078|FG001|Overall Study|Reason not specified|9|||
128893088|NCT02463071|463904079|FG002|Overall Study|Reason not specified|4|||
128893089|NCT02463071|463904077|FG000|Overall Study|Protocol Violation|0|||
128893090|NCT02463071|463904078|FG001|Overall Study|Protocol Violation|2|||
128893091|NCT02463071|463904079|FG002|Overall Study|Protocol Violation|0|||
128893092|NCT02463071|463904077|FG000|Overall Study|Lost to Follow-up|0|||
128893093|NCT02463071|463904078|FG001|Overall Study|Lost to Follow-up|0|||
128893094|NCT02463071|463904079|FG002|Overall Study|Lost to Follow-up|1|||
128893095|NCT01245387|463904080|FG000|Overall Study|Lost to Follow-up|106|||
128893096|NCT01245387|463904080|FG000|Overall Study|Lack of Efficacy|195|||
128893097|NCT01245387|463904080|FG000|Overall Study|Adverse Event|9|||
128893098|NCT01245387|463904080|FG000|Overall Study|Death|3|||
128893099|NCT01245387|463904080|FG000|Overall Study|Other|131|||
128893100|NCT01245387|463904080|FG000|Overall Study|Missing discontinuation status|369|||
128893101|NCT00757003|463904081|FG000|Overall Study|Death|33|||
128893102|NCT00757003|463904081|FG000|Overall Study|Lost to Follow-up|9|||
128893103|NCT00757003|463904081|FG000|Overall Study|Withdrawal by Subject|4|||
128893104|NCT00757003|463904081|FG000|Overall Study|Surgically explanted|2|||
128893105|NCT00757003|463904081|FG000|Overall Study|Not implanted|1|||
128893106|NCT02146599|463904097|FG000|Overall Study|Failed to meet inclusion criteria|5|||
128893107|NCT03061175|463904101|FG000|Baseline|Participant was deemed ineligible|1|||
128893108|NCT03061175|463904102|FG001|Baseline|Participant was deemed ineligible|0|||
128893109|NCT03061175|463904101|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
128893110|NCT03061175|463904102|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
128893111|NCT03061175|463904101|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
128893112|NCT03061175|463904102|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
128893113|NCT03061175|463904101|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
128893114|NCT03061175|463904102|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
128893115|NCT02243865|463904103|FG000|Overall Study|Protocol Violation|1|||
128893116|NCT02243865|463904104|FG001|Overall Study|Protocol Violation|3|||
128689876|NCT02083081|463164572|FG000|Overall Study|Lost to Follow-up|31|||
128689877|NCT02083081|463164573|FG001|Overall Study|Lost to Follow-up|9|||
128689878|NCT01104155|463164574|FG000|Overall Study|Adverse Event|15|||
128689879|NCT01104155|463164575|FG001|Overall Study|Adverse Event|8|||
128689880|NCT01104155|463164574|FG000|Overall Study|Participant choice|6|||
128689881|NCT01104155|463164575|FG001|Overall Study|Participant choice|5|||
128689882|NCT01104155|463164574|FG000|Overall Study|Withdrawal of consent|1|||
128689883|NCT01104155|463164575|FG001|Overall Study|Withdrawal of consent|1|||
128764306|NCT02002182|463428285|FG001|Overall Study|Withdraw from study|1|||
128893117|NCT02243865|463904103|FG000|Overall Study|Lost to Follow-up|1|||
128893118|NCT02243865|463904104|FG001|Overall Study|Lost to Follow-up|1|||
129021039|NCT00968812|464368621|FG001|Overall Study|Protocol Violation|4|||
128689884|NCT01104155|463164574|FG000|Overall Study|Other|3|||
128689885|NCT01104155|463164575|FG001|Overall Study|Other|4|||
128689886|NCT01484132|463164581|FG000|Overall Study|Lost to Follow-up|8|||
128764307|NCT02002182|463428284|FG000|Overall Study|Health Reasons|1|||
128764308|NCT02002182|463428285|FG001|Overall Study|Health Reasons|0|||
128689887|NCT01484132|463164581|FG000|Overall Study|Difficulty with time commitment|2|||
128689888|NCT01484132|463164581|FG000|Overall Study|Ineligible|1|||
128689889|NCT01484132|463164581|FG000|Overall Study|No pre-treatment urine sample collected|1|||
128689890|NCT01484132|463164581|FG000|Overall Study|No post-treatment urine sample collected|10|||
128689891|NCT03799211|463164582|FG000|Overall Study|Lost to Follow-up|2|||
128689892|NCT03799211|463164583|FG001|Overall Study|Lost to Follow-up|13|||
128689893|NCT03799211|463164582|FG000|Overall Study|Withdrawal by Subject|2|||
128689894|NCT03799211|463164583|FG001|Overall Study|Withdrawal by Subject|0|||
128689895|NCT00764491|463164584|FG000|Overall Study|Lost to Follow-up|35|||
128689896|NCT00764491|463164585|FG001|Overall Study|Lost to Follow-up|17|||
128689897|NCT03139279|463164587|FG000|Overall Study|Physician Decision|2|||
128689898|NCT03139279|463164588|FG001|Overall Study|Physician Decision|0|||
128689899|NCT03139279|463164587|FG000|Overall Study|Protocol Violation|5|||
128689900|NCT03139279|463164588|FG001|Overall Study|Protocol Violation|4|||
128689901|NCT03139279|463164587|FG000|Overall Study|Withdrawal by Subject|0|||
128689902|NCT03139279|463164588|FG001|Overall Study|Withdrawal by Subject|2|||
128689903|NCT02337738|463164589|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
128689904|NCT02337738|463164590|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
128689905|NCT02337738|463164591|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
128689906|NCT02337738|463164589|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
128689907|NCT02337738|463164590|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
128689908|NCT02337738|463164591|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
128689909|NCT02337738|463164589|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
128689910|NCT02337738|463164590|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
128689911|NCT02337738|463164591|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
128689912|NCT02337738|463164589|FG000|Overall Study|Voluntary Withdrawal|10|||
128689913|NCT02337738|463164590|FG001|Overall Study|Voluntary Withdrawal|5|||
128689914|NCT02337738|463164591|FG002|Overall Study|Voluntary Withdrawal|2|||
128689915|NCT02337738|463164589|FG000|Overall Study|Lack of Efficacy|2|||
128689916|NCT02337738|463164590|FG001|Overall Study|Lack of Efficacy|4|||
128689917|NCT02337738|463164591|FG002|Overall Study|Lack of Efficacy|0|||
128689918|NCT02337738|463164589|FG000|Overall Study|Investigator's Judgment|1|||
128689919|NCT02337738|463164590|FG001|Overall Study|Investigator's Judgment|1|||
128689920|NCT02337738|463164591|FG002|Overall Study|Investigator's Judgment|3|||
128689921|NCT00406354|463164592|FG000|All Randomized Patients|Protocol Violation|0|||
128689922|NCT00406354|463164593|FG001|All Randomized Patients|Protocol Violation|0|||
128689923|NCT00406354|463164594|FG002|All Randomized Patients|Protocol Violation|1|||
128689924|NCT00406354|463164592|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
128689925|NCT00406354|463164593|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
128689926|NCT00406354|463164594|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
128689927|NCT00406354|463164592|FG000|All Randomized and Treated Patients|Adverse Event|6|||
128689928|NCT00406354|463164593|FG001|All Randomized and Treated Patients|Adverse Event|2|||
128689929|NCT00406354|463164594|FG002|All Randomized and Treated Patients|Adverse Event|1|||
128689930|NCT00406354|463164592|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
128689931|NCT00406354|463164593|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
128689932|NCT00406354|463164594|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
128689933|NCT00406354|463164592|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
128689934|NCT00406354|463164593|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
128689935|NCT00406354|463164594|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
128689936|NCT00406354|463164592|FG000|All Randomized and Treated Patients|Physician Decision|0|||
128689937|NCT00406354|463164593|FG001|All Randomized and Treated Patients|Physician Decision|0|||
128689938|NCT00406354|463164594|FG002|All Randomized and Treated Patients|Physician Decision|1|||
128689939|NCT01460368|463164595|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
128689940|NCT01460368|463164596|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
128689941|NCT01460368|463164597|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
128689942|NCT01460368|463164598|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
128689943|NCT01460368|463164599|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
128689944|NCT01460368|463164600|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
128689945|NCT01460368|463164601|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
128689946|NCT01460368|463164595|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
128689947|NCT01460368|463164596|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
128689948|NCT01460368|463164597|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
128689949|NCT01460368|463164598|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
128689950|NCT01460368|463164599|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
128689951|NCT01460368|463164600|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
128689952|NCT01460368|463164601|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
128689953|NCT01460368|463164595|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128689954|NCT01460368|463164596|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
128893119|NCT02243865|463904103|FG000|Overall Study|Withdrawal by Subject|1|||
128893120|NCT02243865|463904104|FG001|Overall Study|Withdrawal by Subject|0|||
128893121|NCT02243865|463904103|FG000|Overall Study|Adverse Event|1|||
128689955|NCT01460368|463164597|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128689956|NCT01460368|463164598|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128893122|NCT02243865|463904104|FG001|Overall Study|Adverse Event|1|||
128893123|NCT01235793|463904108|FG000|Overall Study|Death|6|||
128893124|NCT01159912|463904109|FG000|Overall Study|Adverse Event|2|||
128689957|NCT01460368|463164599|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128689958|NCT01460368|463164600|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128689959|NCT01460368|463164601|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
128689960|NCT01460368|463164595|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
128689961|NCT01460368|463164596|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
128689962|NCT01460368|463164597|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
128689963|NCT01460368|463164598|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
128689964|NCT01460368|463164599|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
128689965|NCT01460368|463164600|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
128689966|NCT01460368|463164601|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
128689967|NCT01460368|463164595|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
128689968|NCT01460368|463164596|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
128689969|NCT01460368|463164597|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
128689970|NCT01460368|463164598|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
128689971|NCT01460368|463164599|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
128689972|NCT01460368|463164600|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
128689973|NCT01460368|463164601|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
128689974|NCT00747461|463164608|FG000|Overall Study|study terminated by sponsor|5|||
128689975|NCT00299182|463164624|FG000|Overall Study|Withdrawal by Subject|0|||
128689976|NCT00299182|463164625|FG001|Overall Study|Withdrawal by Subject|0|||
128689977|NCT00299182|463164626|FG002|Overall Study|Withdrawal by Subject|1|||
128689978|NCT00299182|463164627|FG003|Overall Study|Withdrawal by Subject|0|||
128689979|NCT00299182|463164628|FG004|Overall Study|Withdrawal by Subject|1|||
128689980|NCT00299182|463164629|FG005|Overall Study|Withdrawal by Subject|2|||
128689981|NCT00299182|463164630|FG006|Overall Study|Withdrawal by Subject|0|||
128689982|NCT00299182|463164624|FG000|Overall Study|Chemotherapy Changed|0|||
128689983|NCT00299182|463164625|FG001|Overall Study|Chemotherapy Changed|0|||
128689984|NCT00299182|463164626|FG002|Overall Study|Chemotherapy Changed|1|||
128689985|NCT00299182|463164627|FG003|Overall Study|Chemotherapy Changed|0|||
128689986|NCT00299182|463164628|FG004|Overall Study|Chemotherapy Changed|1|||
128689987|NCT00299182|463164629|FG005|Overall Study|Chemotherapy Changed|0|||
128689988|NCT00299182|463164630|FG006|Overall Study|Chemotherapy Changed|1|||
128689989|NCT00299182|463164624|FG000|Overall Study|Adverse Event|0|||
128689990|NCT00299182|463164625|FG001|Overall Study|Adverse Event|0|||
128689991|NCT00299182|463164626|FG002|Overall Study|Adverse Event|0|||
128689992|NCT00299182|463164627|FG003|Overall Study|Adverse Event|0|||
128689993|NCT00299182|463164628|FG004|Overall Study|Adverse Event|0|||
128689994|NCT00299182|463164629|FG005|Overall Study|Adverse Event|1|||
128893125|NCT01159912|463904110|FG001|Overall Study|Adverse Event|2|||
128893126|NCT01159912|463904111|FG002|Overall Study|Adverse Event|3|||
128893127|NCT01159912|463904109|FG000|Overall Study|Lack of Efficacy|23|||
128893128|NCT01159912|463904110|FG001|Overall Study|Lack of Efficacy|15|||
128893129|NCT01159912|463904111|FG002|Overall Study|Lack of Efficacy|14|||
128893130|NCT01159912|463904109|FG000|Overall Study|Protocol Violation|1|||
128893131|NCT01159912|463904110|FG001|Overall Study|Protocol Violation|2|||
128893132|NCT01159912|463904111|FG002|Overall Study|Protocol Violation|3|||
128893133|NCT01159912|463904109|FG000|Overall Study|Lost to Follow-up|4|||
128893134|NCT01159912|463904110|FG001|Overall Study|Lost to Follow-up|0|||
128893135|NCT01159912|463904111|FG002|Overall Study|Lost to Follow-up|0|||
128893136|NCT01159912|463904109|FG000|Overall Study|Physician Decision|0|||
128893137|NCT01159912|463904110|FG001|Overall Study|Physician Decision|0|||
128893138|NCT01159912|463904111|FG002|Overall Study|Physician Decision|3|||
128893139|NCT01159912|463904109|FG000|Overall Study|Withdrawal by Subject|10|||
128689995|NCT00299182|463164630|FG006|Overall Study|Adverse Event|0|||
128689996|NCT00299182|463164624|FG000|Overall Study|Not Eligible|0|||
128893140|NCT01159912|463904110|FG001|Overall Study|Withdrawal by Subject|3|||
128689997|NCT00299182|463164625|FG001|Overall Study|Not Eligible|0|||
128689998|NCT00299182|463164626|FG002|Overall Study|Not Eligible|0|||
128893141|NCT01159912|463904111|FG002|Overall Study|Withdrawal by Subject|3|||
128893142|NCT00880555|463906227|FG000|Overall Study|Physician Decision|0|||
128893143|NCT00880555|463906228|FG001|Overall Study|Physician Decision|8|||
128893144|NCT00880555|463906229|FG002|Overall Study|Physician Decision|0|||
128893145|NCT00880555|463906230|FG003|Overall Study|Physician Decision|2|||
129110770|NCT00419757|464701329|FG000|Overall Study|Lost to Follow-up|1|||
128689999|NCT00299182|463164627|FG003|Overall Study|Not Eligible|0|||
128690000|NCT00299182|463164628|FG004|Overall Study|Not Eligible|1|||
128893146|NCT00880555|463906231|FG004|Overall Study|Physician Decision|1|||
128893147|NCT00880555|463906232|FG005|Overall Study|Physician Decision|0|||
128690001|NCT00299182|463164629|FG005|Overall Study|Not Eligible|0|||
128690002|NCT00299182|463164630|FG006|Overall Study|Not Eligible|0|||
128690003|NCT01565642|463164635|FG000|Overall Study|Withdrawal by Subject|2|||
128690004|NCT01565642|463164636|FG001|Overall Study|Withdrawal by Subject|1|||
128690005|NCT01898208|463164639|FG000|Overall Study|Positive blood culture|17|||
128690006|NCT01898208|463164640|FG001|Overall Study|Positive blood culture|23|||
128690007|NCT01898208|463164641|FG002|Overall Study|Positive blood culture|15|||
128690008|NCT01898208|463164639|FG000|Overall Study|Death/comfort care within 24 hours|10|||
128690009|NCT01898208|463164640|FG001|Overall Study|Death/comfort care within 24 hours|9|||
128690010|NCT01898208|463164641|FG002|Overall Study|Death/comfort care within 24 hours|8|||
128690011|NCT01898208|463164639|FG000|Overall Study|Negative Gram Stain|6|||
128690012|NCT01898208|463164640|FG001|Overall Study|Negative Gram Stain|9|||
128690013|NCT01898208|463164641|FG002|Overall Study|Negative Gram Stain|6|||
128690014|NCT01898208|463164639|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
128690015|NCT01898208|463164640|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
128690016|NCT01898208|463164641|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
128690017|NCT01898208|463164639|FG000|Overall Study|System/Technical Error|1|||
128690018|NCT01898208|463164640|FG001|Overall Study|System/Technical Error|2|||
128690019|NCT01898208|463164641|FG002|Overall Study|System/Technical Error|3|||
128690020|NCT01898208|463164639|FG000|Overall Study|Lost to Follow-up|3|||
128690021|NCT01898208|463164640|FG001|Overall Study|Lost to Follow-up|1|||
128690022|NCT01898208|463164641|FG002|Overall Study|Lost to Follow-up|1|||
128690023|NCT00072176|463164647|FG000|Overall Study|Withdrawal by Subject|1|||
128690024|NCT00072176|463164648|FG001|Overall Study|Withdrawal by Subject|0|||
128690025|NCT00072176|463164647|FG000|Overall Study|Protocol Violation|0|||
128690026|NCT00072176|463164648|FG001|Overall Study|Protocol Violation|1|||
128690027|NCT04502979|463164653|FG000|Overall Study|Lost to Follow-up|1|||
128690028|NCT04502979|463164654|FG001|Overall Study|Lost to Follow-up|3|||
128690029|NCT04502979|463164653|FG000|Overall Study|Withdrawal by Subject|2|||
128690030|NCT04502979|463164654|FG001|Overall Study|Withdrawal by Subject|1|||
128690031|NCT02906332|463164661|FG000|Overall Study|Withdrawal by Subject|1|||
128893148|NCT00880555|463906227|FG000|Overall Study|Withdrawal by Subject|1|||
128893149|NCT00880555|463906228|FG001|Overall Study|Withdrawal by Subject|1|||
128893150|NCT00880555|463906229|FG002|Overall Study|Withdrawal by Subject|0|||
128893151|NCT00880555|463906230|FG003|Overall Study|Withdrawal by Subject|0|||
128893152|NCT00880555|463906231|FG004|Overall Study|Withdrawal by Subject|0|||
128893153|NCT00880555|463906232|FG005|Overall Study|Withdrawal by Subject|0|||
128893154|NCT00880555|463906227|FG000|Overall Study|Lack of resources (hired rater)|9|||
128893155|NCT00880555|463906228|FG001|Overall Study|Lack of resources (hired rater)|7|||
128893156|NCT00880555|463906229|FG002|Overall Study|Lack of resources (hired rater)|5|||
128893157|NCT00880555|463906230|FG003|Overall Study|Lack of resources (hired rater)|0|||
128893158|NCT00880555|463906231|FG004|Overall Study|Lack of resources (hired rater)|0|||
128893159|NCT00880555|463906232|FG005|Overall Study|Lack of resources (hired rater)|0|||
128893160|NCT00880555|463906227|FG000|Overall Study|Death|0|||
128893161|NCT00880555|463906228|FG001|Overall Study|Death|0|||
128893162|NCT00880555|463906229|FG002|Overall Study|Death|0|||
128893163|NCT00880555|463906230|FG003|Overall Study|Death|0|||
128893164|NCT00880555|463906231|FG004|Overall Study|Death|0|||
128893165|NCT00880555|463906232|FG005|Overall Study|Death|1|||
128893166|NCT00880555|463906227|FG000|Overall Study|Lost to Follow-up|0|||
128893167|NCT00880555|463906228|FG001|Overall Study|Lost to Follow-up|1|||
128893168|NCT00880555|463906229|FG002|Overall Study|Lost to Follow-up|0|||
128893169|NCT00880555|463906230|FG003|Overall Study|Lost to Follow-up|0|||
128893170|NCT00880555|463906231|FG004|Overall Study|Lost to Follow-up|0|||
128893171|NCT00880555|463906232|FG005|Overall Study|Lost to Follow-up|0|||
128893172|NCT02982590|463906234|FG000|Overall Study|Lost to Follow-up|0|||
128893173|NCT02982590|463906235|FG001|Overall Study|Lost to Follow-up|1|||
128893174|NCT02982590|463906234|FG000|Overall Study|Death|4|||
128893175|NCT02982590|463906235|FG001|Overall Study|Death|0|||
128893176|NCT01480284|463906242|FG000|Overall Study|Withdrawal by Subject|2|||
128690032|NCT02949700|463164662|FG000|Phase I|Withdrawal by Subject|1|||
128893177|NCT01480284|463906243|FG001|Overall Study|Withdrawal by Subject|0|||
128893178|NCT01480284|463906242|FG000|Overall Study|Adverse Event|1|||
128690033|NCT02949700|463164663|FG001|Phase I|Withdrawal by Subject|1|||
128690034|NCT02949700|463164664|FG002|Phase I|Withdrawal by Subject|0|||
128893179|NCT01480284|463906243|FG001|Overall Study|Adverse Event|0|||
128893180|NCT01480284|463906242|FG000|Overall Study|Study closed/terminated|3|||
128690035|NCT02949700|463164665|FG003|Phase I|Withdrawal by Subject|0|||
128690036|NCT02949700|463164662|FG000|Phase I|Protocol Violation|1|||
128690037|NCT02949700|463164663|FG001|Phase I|Protocol Violation|0|||
128690038|NCT02949700|463164664|FG002|Phase I|Protocol Violation|0|||
128690039|NCT02949700|463164665|FG003|Phase I|Protocol Violation|0|||
128690040|NCT02949700|463164662|FG000|Phase II|Withdrawal by Subject|0|||
128690041|NCT02949700|463164663|FG001|Phase II|Withdrawal by Subject|0|||
128690042|NCT02949700|463164664|FG002|Phase II|Withdrawal by Subject|0|||
128893181|NCT01480284|463906243|FG001|Overall Study|Study closed/terminated|0|||
128893182|NCT01480284|463906242|FG000|Overall Study|Lost to Follow-up|1|||
128893183|NCT01480284|463906243|FG001|Overall Study|Lost to Follow-up|0|||
128893184|NCT01480284|463906242|FG000|Overall Study|Physician Decision|1|||
128893185|NCT01480284|463906243|FG001|Overall Study|Physician Decision|0|||
128893186|NCT01641237|463906245|FG000|Period II|Withdrawal by Subject|1|||
128893187|NCT01641237|463906246|FG001|Period II|Withdrawal by Subject|0|||
128893188|NCT01641237|463906247|FG002|Period II|Withdrawal by Subject|0|||
128893189|NCT01641237|463906248|FG003|Period II|Withdrawal by Subject|0|||
128893190|NCT01641237|463906245|FG000|Period III|Lost to Follow-up|1|||
128893191|NCT01641237|463906246|FG001|Period III|Lost to Follow-up|0|||
128893192|NCT01641237|463906247|FG002|Period III|Lost to Follow-up|0|||
128893193|NCT01641237|463906248|FG003|Period III|Lost to Follow-up|0|||
128893194|NCT02716675|463906260|FG000|Overall Study|Death|2|||
129110771|NCT00419757|464701330|FG001|Overall Study|Lost to Follow-up|4|||
129110772|NCT00419757|464701329|FG000|Overall Study|Withdrawal by Subject|7|||
129110773|NCT00419757|464701330|FG001|Overall Study|Withdrawal by Subject|1|||
129110774|NCT00419757|464701329|FG000|Overall Study|Protocol Violation|2|||
128690043|NCT02949700|463164665|FG003|Phase II|Withdrawal by Subject|2|||
128690044|NCT02949700|463164662|FG000|Phase II|Protocol Violation|0|||
128690045|NCT02949700|463164663|FG001|Phase II|Protocol Violation|0|||
128690046|NCT02949700|463164664|FG002|Phase II|Protocol Violation|1|||
128690047|NCT02949700|463164665|FG003|Phase II|Protocol Violation|3|||
128690048|NCT04399837|463164669|FG000|Overall Study|Other than listed|0|||
128690049|NCT04399837|463164670|FG001|Overall Study|Other than listed|2|||
128690050|NCT04399837|463164671|FG002|Overall Study|Other than listed|2|||
128690051|NCT04399837|463164672|FG003|Overall Study|Other than listed|3|||
128690052|NCT04399837|463164669|FG000|Overall Study|Withdrawal by Subject|1|||
128690053|NCT04399837|463164670|FG001|Overall Study|Withdrawal by Subject|2|||
128690054|NCT04399837|463164671|FG002|Overall Study|Withdrawal by Subject|1|||
128690055|NCT04399837|463164672|FG003|Overall Study|Withdrawal by Subject|1|||
129110775|NCT00419757|464701330|FG001|Overall Study|Protocol Violation|3|||
129110776|NCT00419757|464701329|FG000|Overall Study|Study specific discontinuation criteria|4|||
129110777|NCT00419757|464701330|FG001|Overall Study|Study specific discontinuation criteria|8|||
129110778|NCT00419757|464701329|FG000|Overall Study|Multiple reasons|3|||
129110779|NCT00419757|464701330|FG001|Overall Study|Multiple reasons|1|||
129110780|NCT00327340|464701331|FG000|Overall Study|Withdrawal by Subject|1|||
129110781|NCT00327340|464701332|FG001|Overall Study|Withdrawal by Subject|5|||
128690056|NCT02719327|463164676|FG000|Overall Study|Withdrawal by Subject|11|||
128690057|NCT02719327|463164677|FG001|Overall Study|Withdrawal by Subject|8|||
128690058|NCT03350620|463164678|FG000|Stage 2|Adverse Event|0|||
128690059|NCT03350620|463164679|FG001|Stage 2|Adverse Event|1|||
128690060|NCT03350620|463164680|FG002|Stage 2|Adverse Event|1|||
128690061|NCT03350620|463164678|FG000|Stage 2|Lack of Efficacy|0|||
128690062|NCT03350620|463164679|FG001|Stage 2|Lack of Efficacy|2|||
128690063|NCT03350620|463164680|FG002|Stage 2|Lack of Efficacy|0|||
128690064|NCT03350620|463164678|FG000|Stage 2|Lost to Follow-up|1|||
128690065|NCT03350620|463164679|FG001|Stage 2|Lost to Follow-up|2|||
128690066|NCT03350620|463164680|FG002|Stage 2|Lost to Follow-up|2|||
129110782|NCT00327340|464701331|FG000|Overall Study|Physician Decision|1|||
129110783|NCT00327340|464701332|FG001|Overall Study|Physician Decision|1|||
129110784|NCT00327340|464701331|FG000|Overall Study|Disease Progression|10|||
129110785|NCT00327340|464701332|FG001|Overall Study|Disease Progression|19|||
129110786|NCT00327340|464701331|FG000|Overall Study|Symptomatic Disease|0|||
128690067|NCT03350620|463164678|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
128690068|NCT03350620|463164679|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
128690069|NCT03350620|463164680|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
128690070|NCT05021081|463166724|FG000|Phase 2|Subject enrolled in error|1|||
128690071|NCT05021081|463166725|FG001|Phase 2|Subject enrolled in error|1|||
128690072|NCT05021081|463166726|FG002|Phase 2|Subject enrolled in error|0|||
128690073|NCT03633617|463166727|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
128893195|NCT02716675|463906261|FG001|Overall Study|Death|3|||
128893196|NCT02716675|463906262|FG002|Overall Study|Death|0|||
129110787|NCT00327340|464701332|FG001|Overall Study|Symptomatic Disease|2|||
129110788|NCT00327340|464701331|FG000|Overall Study|Adverse Event|3|||
129110789|NCT00327340|464701332|FG001|Overall Study|Adverse Event|3|||
129110790|NCT03316586|464701337|FG000|Overall Study|Adverse Event|2|||
129110791|NCT03316586|464701337|FG000|Overall Study|Physician Decision|3|||
128690074|NCT03633617|463166728|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
128690075|NCT03633617|463166729|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690076|NCT03633617|463166730|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128893197|NCT02716675|463906260|FG000|Overall Study|Physician Decision|2|||
128893198|NCT02716675|463906261|FG001|Overall Study|Physician Decision|1|||
129110792|NCT03316586|464701337|FG000|Overall Study|Lack of Efficacy|10|||
129110793|NCT03316586|464701337|FG000|Overall Study|still on treatment|1|||
128893199|NCT02716675|463906262|FG002|Overall Study|Physician Decision|1|||
129110794|NCT03316586|464701337|FG000|Overall Study|Patient needed radiation therapy|1|||
129110795|NCT03316586|464701337|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
129110796|NCT01396083|464701340|FG000|Overall Study|Adverse Event|2|||
128690077|NCT03633617|463166731|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690078|NCT03633617|463166732|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690079|NCT03633617|463166733|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690080|NCT03633617|463166734|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690081|NCT03633617|463166735|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690082|NCT03633617|463166736|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690083|NCT03633617|463166737|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
128690084|NCT03633617|463166727|FG000|Part A|Unconfirmed early termination visit|1|||
128690085|NCT03633617|463166728|FG001|Part A|Unconfirmed early termination visit|0|||
128690086|NCT03633617|463166729|FG002|Part A|Unconfirmed early termination visit|0|||
128690087|NCT03633617|463166730|FG003|Part A|Unconfirmed early termination visit|0|||
128690088|NCT03633617|463166731|FG004|Part A|Unconfirmed early termination visit|0|||
128690089|NCT03633617|463166732|FG005|Part A|Unconfirmed early termination visit|0|||
128690090|NCT03633617|463166733|FG006|Part A|Unconfirmed early termination visit|0|||
128690091|NCT03633617|463166734|FG007|Part A|Unconfirmed early termination visit|0|||
128690092|NCT03633617|463166735|FG008|Part A|Unconfirmed early termination visit|0|||
128690093|NCT03633617|463166736|FG009|Part A|Unconfirmed early termination visit|0|||
128690094|NCT03633617|463166737|FG010|Part A|Unconfirmed early termination visit|0|||
128690095|NCT03633617|463166727|FG000|Part A|Adverse Event|0|||
128690096|NCT03633617|463166728|FG001|Part A|Adverse Event|1|||
128690097|NCT03633617|463166729|FG002|Part A|Adverse Event|0|||
128690098|NCT03633617|463166730|FG003|Part A|Adverse Event|0|||
128690099|NCT03633617|463166731|FG004|Part A|Adverse Event|0|||
128690100|NCT03633617|463166732|FG005|Part A|Adverse Event|0|||
128690101|NCT03633617|463166733|FG006|Part A|Adverse Event|0|||
128690102|NCT03633617|463166734|FG007|Part A|Adverse Event|0|||
128690103|NCT03633617|463166735|FG008|Part A|Adverse Event|0|||
128690104|NCT03633617|463166736|FG009|Part A|Adverse Event|0|||
128690105|NCT03633617|463166737|FG010|Part A|Adverse Event|0|||
128690106|NCT03633617|463166727|FG000|Part A|Pregnancy|1|||
128690107|NCT03633617|463166728|FG001|Part A|Pregnancy|0|||
128690108|NCT03633617|463166729|FG002|Part A|Pregnancy|0|||
128690109|NCT03633617|463166730|FG003|Part A|Pregnancy|0|||
128690110|NCT03633617|463166731|FG004|Part A|Pregnancy|0|||
128690111|NCT03633617|463166732|FG005|Part A|Pregnancy|0|||
128690112|NCT03633617|463166733|FG006|Part A|Pregnancy|0|||
128690113|NCT03633617|463166734|FG007|Part A|Pregnancy|0|||
128690114|NCT03633617|463166735|FG008|Part A|Pregnancy|0|||
128690115|NCT03633617|463166736|FG009|Part A|Pregnancy|0|||
128690116|NCT03633617|463166737|FG010|Part A|Pregnancy|0|||
128690117|NCT03633617|463166727|FG000|Part A|Withdrawal by Subject|0|||
128690118|NCT03633617|463166728|FG001|Part A|Withdrawal by Subject|1|||
128690119|NCT03633617|463166729|FG002|Part A|Withdrawal by Subject|0|||
128690120|NCT03633617|463166730|FG003|Part A|Withdrawal by Subject|0|||
128690121|NCT03633617|463166731|FG004|Part A|Withdrawal by Subject|0|||
128690122|NCT03633617|463166732|FG005|Part A|Withdrawal by Subject|0|||
128690123|NCT03633617|463166733|FG006|Part A|Withdrawal by Subject|0|||
128690124|NCT03633617|463166734|FG007|Part A|Withdrawal by Subject|0|||
128690125|NCT03633617|463166735|FG008|Part A|Withdrawal by Subject|0|||
128690126|NCT03633617|463166736|FG009|Part A|Withdrawal by Subject|0|||
128690127|NCT03633617|463166737|FG010|Part A|Withdrawal by Subject|0|||
128690128|NCT03633617|463166727|FG000|Part B|Adverse Event|0|||
128690129|NCT03633617|463166728|FG001|Part B|Adverse Event|0|||
128690130|NCT03633617|463166729|FG002|Part B|Adverse Event|2|||
128690131|NCT03633617|463166730|FG003|Part B|Adverse Event|2|||
128690132|NCT03633617|463166731|FG004|Part B|Adverse Event|1|||
128690133|NCT03633617|463166732|FG005|Part B|Adverse Event|0|||
128690134|NCT03633617|463166733|FG006|Part B|Adverse Event|0|||
128690135|NCT03633617|463166734|FG007|Part B|Adverse Event|0|||
128690136|NCT03633617|463166735|FG008|Part B|Adverse Event|0|||
128690137|NCT03633617|463166736|FG009|Part B|Adverse Event|0|||
128690138|NCT03633617|463166737|FG010|Part B|Adverse Event|0|||
128690139|NCT03633617|463166727|FG000|Part B|Withdrawal by Subject|0|||
128690140|NCT03633617|463166728|FG001|Part B|Withdrawal by Subject|0|||
128690141|NCT03633617|463166729|FG002|Part B|Withdrawal by Subject|1|||
128690142|NCT03633617|463166730|FG003|Part B|Withdrawal by Subject|0|||
128690143|NCT03633617|463166731|FG004|Part B|Withdrawal by Subject|2|||
128690144|NCT03633617|463166732|FG005|Part B|Withdrawal by Subject|0|||
128690145|NCT03633617|463166733|FG006|Part B|Withdrawal by Subject|0|||
128690146|NCT03633617|463166734|FG007|Part B|Withdrawal by Subject|0|||
128690147|NCT03633617|463166735|FG008|Part B|Withdrawal by Subject|0|||
128690148|NCT03633617|463166736|FG009|Part B|Withdrawal by Subject|0|||
128690149|NCT03633617|463166737|FG010|Part B|Withdrawal by Subject|0|||
128690150|NCT03633617|463166727|FG000|Part B|Lost to Follow-up|0|||
128690151|NCT03633617|463166728|FG001|Part B|Lost to Follow-up|0|||
128690152|NCT03633617|463166729|FG002|Part B|Lost to Follow-up|0|||
128690153|NCT03633617|463166730|FG003|Part B|Lost to Follow-up|0|||
128690154|NCT03633617|463166731|FG004|Part B|Lost to Follow-up|1|||
128690155|NCT03633617|463166732|FG005|Part B|Lost to Follow-up|0|||
128690156|NCT03633617|463166733|FG006|Part B|Lost to Follow-up|0|||
128690157|NCT03633617|463166734|FG007|Part B|Lost to Follow-up|0|||
128690158|NCT03633617|463166735|FG008|Part B|Lost to Follow-up|0|||
128690159|NCT03633617|463166736|FG009|Part B|Lost to Follow-up|0|||
128690160|NCT03633617|463166737|FG010|Part B|Lost to Follow-up|0|||
128690161|NCT03633617|463166727|FG000|Part B|Physician Decision|0|||
128690162|NCT03633617|463166728|FG001|Part B|Physician Decision|0|||
128690163|NCT03633617|463166729|FG002|Part B|Physician Decision|0|||
128690164|NCT03633617|463166730|FG003|Part B|Physician Decision|0|||
128690165|NCT03633617|463166731|FG004|Part B|Physician Decision|1|||
128690166|NCT03633617|463166732|FG005|Part B|Physician Decision|0|||
128690167|NCT03633617|463166733|FG006|Part B|Physician Decision|0|||
128690168|NCT03633617|463166734|FG007|Part B|Physician Decision|0|||
128690169|NCT03633617|463166735|FG008|Part B|Physician Decision|0|||
128690170|NCT03633617|463166736|FG009|Part B|Physician Decision|0|||
128690171|NCT03633617|463166737|FG010|Part B|Physician Decision|0|||
128690172|NCT03633617|463166727|FG000|Part B|COVID-19 Restrictions|0|||
128690173|NCT03633617|463166728|FG001|Part B|COVID-19 Restrictions|0|||
128690174|NCT03633617|463166729|FG002|Part B|COVID-19 Restrictions|1|||
128690175|NCT03633617|463166730|FG003|Part B|COVID-19 Restrictions|0|||
128690176|NCT03633617|463166731|FG004|Part B|COVID-19 Restrictions|0|||
128690177|NCT03633617|463166732|FG005|Part B|COVID-19 Restrictions|0|||
128690178|NCT03633617|463166733|FG006|Part B|COVID-19 Restrictions|0|||
128690179|NCT03633617|463166734|FG007|Part B|COVID-19 Restrictions|0|||
128690180|NCT03633617|463166735|FG008|Part B|COVID-19 Restrictions|0|||
128690181|NCT03633617|463166736|FG009|Part B|COVID-19 Restrictions|0|||
128690182|NCT03633617|463166737|FG010|Part B|COVID-19 Restrictions|0|||
128690183|NCT03633617|463166727|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690184|NCT03633617|463166728|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690185|NCT03633617|463166729|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
128690186|NCT03633617|463166730|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690187|NCT03633617|463166731|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690188|NCT03633617|463166732|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690189|NCT03633617|463166733|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690190|NCT03633617|463166734|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690191|NCT03633617|463166735|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690192|NCT03633617|463166736|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690193|NCT03633617|463166737|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
128690194|NCT03633617|463166727|FG000|Part C (& Follow-up)|Adverse Event|0|||
128690195|NCT03633617|463166728|FG001|Part C (& Follow-up)|Adverse Event|0|||
128690196|NCT03633617|463166729|FG002|Part C (& Follow-up)|Adverse Event|0|||
128690197|NCT03633617|463166730|FG003|Part C (& Follow-up)|Adverse Event|0|||
128690198|NCT03633617|463166731|FG004|Part C (& Follow-up)|Adverse Event|0|||
128690199|NCT03633617|463166732|FG005|Part C (& Follow-up)|Adverse Event|1|||
128690200|NCT03633617|463166733|FG006|Part C (& Follow-up)|Adverse Event|0|||
128690201|NCT03633617|463166734|FG007|Part C (& Follow-up)|Adverse Event|1|||
128690202|NCT03633617|463166735|FG008|Part C (& Follow-up)|Adverse Event|0|||
128690203|NCT03633617|463166736|FG009|Part C (& Follow-up)|Adverse Event|0|||
128690204|NCT03633617|463166737|FG010|Part C (& Follow-up)|Adverse Event|0|||
128690205|NCT03633617|463166727|FG000|Part C (& Follow-up)|Pregnancy|0|||
128690206|NCT03633617|463166728|FG001|Part C (& Follow-up)|Pregnancy|0|||
128690207|NCT03633617|463166729|FG002|Part C (& Follow-up)|Pregnancy|0|||
128690208|NCT03633617|463166730|FG003|Part C (& Follow-up)|Pregnancy|0|||
128690209|NCT03633617|463166731|FG004|Part C (& Follow-up)|Pregnancy|0|||
128690210|NCT03633617|463166732|FG005|Part C (& Follow-up)|Pregnancy|0|||
128690211|NCT03633617|463166733|FG006|Part C (& Follow-up)|Pregnancy|0|||
128690212|NCT03633617|463166734|FG007|Part C (& Follow-up)|Pregnancy|0|||
128690213|NCT03633617|463166735|FG008|Part C (& Follow-up)|Pregnancy|0|||
128690214|NCT03633617|463166736|FG009|Part C (& Follow-up)|Pregnancy|1|||
128690215|NCT03633617|463166737|FG010|Part C (& Follow-up)|Pregnancy|0|||
128690216|NCT03633617|463166727|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
128690217|NCT03633617|463166728|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
128690218|NCT03633617|463166729|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
129021040|NCT00968812|464368622|FG002|Overall Study|Protocol Violation|3|||
128690219|NCT03633617|463166730|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
128690220|NCT03633617|463166731|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
128690221|NCT03633617|463166732|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
128690222|NCT03633617|463166733|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
128690223|NCT03633617|463166734|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
128690224|NCT03633617|463166735|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
128690225|NCT03633617|463166736|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
128690226|NCT03633617|463166737|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
128690227|NCT03633617|463166727|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
128690228|NCT03633617|463166728|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
128764309|NCT02002182|463428284|FG000|Overall Study|Death|1|||
128690229|NCT03633617|463166729|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
128690230|NCT03633617|463166730|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
128690231|NCT03633617|463166731|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
128690232|NCT03633617|463166732|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
128690233|NCT03633617|463166733|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
128690234|NCT03633617|463166734|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
128690235|NCT03633617|463166735|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
128690236|NCT03633617|463166736|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
128690237|NCT03633617|463166737|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
128690238|NCT03633617|463166727|FG000|Part C (& Follow-up)|Physician Decision|0|||
128690239|NCT03633617|463166728|FG001|Part C (& Follow-up)|Physician Decision|0|||
128690240|NCT03633617|463166729|FG002|Part C (& Follow-up)|Physician Decision|0|||
128690241|NCT03633617|463166730|FG003|Part C (& Follow-up)|Physician Decision|0|||
128690242|NCT03633617|463166731|FG004|Part C (& Follow-up)|Physician Decision|0|||
128690243|NCT03633617|463166732|FG005|Part C (& Follow-up)|Physician Decision|0|||
128690244|NCT03633617|463166733|FG006|Part C (& Follow-up)|Physician Decision|0|||
128690245|NCT03633617|463166734|FG007|Part C (& Follow-up)|Physician Decision|1|||
128690246|NCT03633617|463166735|FG008|Part C (& Follow-up)|Physician Decision|0|||
128690247|NCT03633617|463166736|FG009|Part C (& Follow-up)|Physician Decision|0|||
128690248|NCT03633617|463166737|FG010|Part C (& Follow-up)|Physician Decision|1|||
128690249|NCT03633617|463166727|FG000|Part C (& Follow-up)|COVID-19 related|0|||
128690250|NCT03633617|463166728|FG001|Part C (& Follow-up)|COVID-19 related|0|||
128690251|NCT03633617|463166729|FG002|Part C (& Follow-up)|COVID-19 related|0|||
128690252|NCT03633617|463166730|FG003|Part C (& Follow-up)|COVID-19 related|0|||
128690253|NCT03633617|463166731|FG004|Part C (& Follow-up)|COVID-19 related|0|||
128690254|NCT03633617|463166732|FG005|Part C (& Follow-up)|COVID-19 related|1|||
128690255|NCT03633617|463166733|FG006|Part C (& Follow-up)|COVID-19 related|0|||
128690256|NCT03633617|463166734|FG007|Part C (& Follow-up)|COVID-19 related|0|||
128690257|NCT03633617|463166735|FG008|Part C (& Follow-up)|COVID-19 related|0|||
128690258|NCT03633617|463166736|FG009|Part C (& Follow-up)|COVID-19 related|0|||
128690259|NCT03633617|463166737|FG010|Part C (& Follow-up)|COVID-19 related|0|||
128690260|NCT03633617|463166727|FG000|Part C (& Follow-up)|Protocol Violation|0|||
128690261|NCT03633617|463166728|FG001|Part C (& Follow-up)|Protocol Violation|0|||
128690262|NCT03633617|463166729|FG002|Part C (& Follow-up)|Protocol Violation|0|||
128690263|NCT03633617|463166730|FG003|Part C (& Follow-up)|Protocol Violation|0|||
128690264|NCT03633617|463166731|FG004|Part C (& Follow-up)|Protocol Violation|0|||
128690265|NCT03633617|463166732|FG005|Part C (& Follow-up)|Protocol Violation|0|||
128690266|NCT03633617|463166733|FG006|Part C (& Follow-up)|Protocol Violation|0|||
128690267|NCT03633617|463166734|FG007|Part C (& Follow-up)|Protocol Violation|0|||
128690268|NCT03633617|463166735|FG008|Part C (& Follow-up)|Protocol Violation|0|||
128690269|NCT03633617|463166736|FG009|Part C (& Follow-up)|Protocol Violation|3|||
128690270|NCT03633617|463166737|FG010|Part C (& Follow-up)|Protocol Violation|1|||
128690271|NCT03633617|463166727|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
128690272|NCT03633617|463166728|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
128690273|NCT03633617|463166729|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
128690274|NCT03633617|463166730|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
128690275|NCT03633617|463166731|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
128690276|NCT03633617|463166732|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
128690277|NCT03633617|463166733|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
128690278|NCT03633617|463166734|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
128690279|NCT03633617|463166735|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
128690280|NCT03633617|463166736|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
128690281|NCT03633617|463166737|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
128690282|NCT03387683|463166744|FG000|Overall Study|In receipt of disallowed medication|1|||
128690283|NCT03387683|463166745|FG001|Overall Study|In receipt of disallowed medication|0|||
128764310|NCT02002182|463428285|FG001|Overall Study|Death|0|||
128893200|NCT02716675|463906260|FG000|Overall Study|Lost to Follow-up|100|||
129021041|NCT00968812|464368620|FG000|Overall Study|Withdrawal by Subject|17|||
129021042|NCT00968812|464368621|FG001|Overall Study|Withdrawal by Subject|23|||
129021043|NCT00968812|464368622|FG002|Overall Study|Withdrawal by Subject|25|||
128690284|NCT03387683|463166744|FG000|Overall Study|Did not receive treatment|1|||
128690285|NCT03387683|463166745|FG001|Overall Study|Did not receive treatment|0|||
128690286|NCT01954342|463166746|FG000|Overall Study|Missing data from 13-16week study visit|0|||
128690287|NCT01954342|463166747|FG001|Overall Study|Missing data from 13-16week study visit|0|||
128690288|NCT01954342|463166748|FG002|Overall Study|Missing data from 13-16week study visit|0|||
128690289|NCT01954342|463166749|FG003|Overall Study|Missing data from 13-16week study visit|1|||
128690290|NCT01954342|463166746|FG000|Overall Study|Miscarriage|0|||
128690291|NCT01954342|463166747|FG001|Overall Study|Miscarriage|0|||
128690292|NCT01954342|463166748|FG002|Overall Study|Miscarriage|0|||
128690293|NCT01954342|463166749|FG003|Overall Study|Miscarriage|3|||
128893201|NCT02716675|463906261|FG001|Overall Study|Lost to Follow-up|87|||
129021044|NCT00968812|464368620|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
129021045|NCT00968812|464368621|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
128764311|NCT02277743|463428286|FG000|Overall Study|Protocol Violation|1|||
128764312|NCT02277743|463428287|FG001|Overall Study|Protocol Violation|1|||
128690294|NCT01954342|463166746|FG000|Overall Study|Lost to Follow-up|0|||
128690295|NCT01954342|463166747|FG001|Overall Study|Lost to Follow-up|0|||
128690296|NCT01954342|463166748|FG002|Overall Study|Lost to Follow-up|0|||
128690297|NCT01954342|463166749|FG003|Overall Study|Lost to Follow-up|5|||
128690298|NCT01954342|463166746|FG000|Overall Study|Preterm delivery|0|||
128690299|NCT01954342|463166747|FG001|Overall Study|Preterm delivery|0|||
128690300|NCT01954342|463166748|FG002|Overall Study|Preterm delivery|0|||
128690301|NCT01954342|463166749|FG003|Overall Study|Preterm delivery|3|||
128690302|NCT01954342|463166746|FG000|Overall Study|Pre-eclampsia|0|||
128690303|NCT01954342|463166747|FG001|Overall Study|Pre-eclampsia|0|||
128690304|NCT01954342|463166748|FG002|Overall Study|Pre-eclampsia|0|||
128690305|NCT01954342|463166749|FG003|Overall Study|Pre-eclampsia|4|||
128690306|NCT01954342|463166746|FG000|Overall Study|Unreliable Data|0|||
128690307|NCT01954342|463166747|FG001|Overall Study|Unreliable Data|0|||
128690308|NCT01954342|463166748|FG002|Overall Study|Unreliable Data|0|||
128690309|NCT01954342|463166749|FG003|Overall Study|Unreliable Data|2|||
128690310|NCT01999114|463166750|FG000|Overall Study|Adverse Event|8|||
128690311|NCT01999114|463166751|FG001|Overall Study|Adverse Event|7|||
128690312|NCT01999114|463166752|FG002|Overall Study|Adverse Event|2|||
128690313|NCT01999114|463166753|FG003|Overall Study|Adverse Event|2|||
128690314|NCT01999114|463166754|FG004|Overall Study|Adverse Event|1|||
128690315|NCT01999114|463166750|FG000|Overall Study|Withdrawal by Subject|0|||
128690316|NCT01999114|463166751|FG001|Overall Study|Withdrawal by Subject|0|||
128690317|NCT01999114|463166752|FG002|Overall Study|Withdrawal by Subject|1|||
128690318|NCT01999114|463166753|FG003|Overall Study|Withdrawal by Subject|0|||
128690319|NCT01999114|463166754|FG004|Overall Study|Withdrawal by Subject|1|||
128690320|NCT01999114|463166750|FG000|Overall Study|Lost to Follow-up|0|||
128690321|NCT01999114|463166751|FG001|Overall Study|Lost to Follow-up|0|||
128690322|NCT01999114|463166752|FG002|Overall Study|Lost to Follow-up|1|||
128690323|NCT01999114|463166753|FG003|Overall Study|Lost to Follow-up|0|||
128690324|NCT01999114|463166754|FG004|Overall Study|Lost to Follow-up|0|||
128690325|NCT01999114|463166750|FG000|Overall Study|Administrative|0|||
128690326|NCT01999114|463166751|FG001|Overall Study|Administrative|0|||
128690327|NCT01999114|463166752|FG002|Overall Study|Administrative|1|||
128690328|NCT01999114|463166753|FG003|Overall Study|Administrative|1|||
128690329|NCT01999114|463166754|FG004|Overall Study|Administrative|2|||
128690330|NCT01497275|463166757|FG000|Overall Study|Death|1|||
128690331|NCT01497275|463166757|FG000|Overall Study|Adverse Event|1|||
128690332|NCT01950169|463166758|FG000|Overall Study|Withdrawal by Subject|2|||
128690333|NCT01950169|463166759|FG001|Overall Study|Withdrawal by Subject|8|||
128690334|NCT01950169|463166760|FG002|Overall Study|Withdrawal by Subject|1|||
128690335|NCT01950169|463166758|FG000|Overall Study|Death|1|||
128690336|NCT01950169|463166759|FG001|Overall Study|Death|0|||
128690337|NCT01950169|463166760|FG002|Overall Study|Death|0|||
128690338|NCT02410551|463166763|FG000|Overall Study|Adverse Event|1|||
128690339|NCT02410551|463166763|FG000|Overall Study|Withdrawal by Subject|1|||
128690340|NCT02410551|463166763|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
128690341|NCT01739309|463166764|FG000|Overall Study|Adverse Event|1|||
128690342|NCT01739309|463166764|FG000|Overall Study|Withdrawal by Subject|1|||
128690343|NCT01495975|463166765|FG000|Overall Study|Lost to Follow-up|1|||
128690344|NCT01495975|463166766|FG001|Overall Study|Lost to Follow-up|0|||
128690345|NCT05447897|463166769|FG000|Overall Study|Did not participate in survey|2|||
128690346|NCT00875979|463166772|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
128690347|NCT00875979|463166773|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
128690348|NCT00875979|463166772|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
128690349|NCT00875979|463166773|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
128690350|NCT00875979|463166772|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
128893202|NCT02716675|463906262|FG002|Overall Study|Lost to Follow-up|99|||
129021046|NCT00968812|464368622|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
129021047|NCT00968812|464368620|FG000|Overall Study|Noncompliance with study drug|4|||
129021048|NCT00968812|464368621|FG001|Overall Study|Noncompliance with study drug|1|||
129021049|NCT00968812|464368622|FG002|Overall Study|Noncompliance with study drug|6|||
129021050|NCT00968812|464368620|FG000|Overall Study|Unable to take rescue therapy|12|||
129021051|NCT00968812|464368621|FG001|Overall Study|Unable to take rescue therapy|12|||
129021052|NCT00968812|464368622|FG002|Overall Study|Unable to take rescue therapy|17|||
128690351|NCT00875979|463166773|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
129021053|NCT00968812|464368620|FG000|Overall Study|Other|25|||
129021054|NCT00968812|464368621|FG001|Overall Study|Other|37|||
129021055|NCT00968812|464368622|FG002|Overall Study|Other|40|||
128690352|NCT00875979|463166772|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
128690353|NCT00875979|463166773|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
128690354|NCT00875979|463166772|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
129021056|NCT00448591|464368625|FG000|Overall Study|Withdrawal by Subject|178|||
128690355|NCT00875979|463166773|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
128690356|NCT00875979|463166772|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
128690357|NCT00875979|463166773|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
128690358|NCT00875979|463166772|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
128690359|NCT00875979|463166773|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
128690360|NCT00875979|463166772|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
128690361|NCT00875979|463166773|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
128690362|NCT00875979|463166772|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
128690363|NCT00875979|463166773|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
128690364|NCT04810481|463166775|FG000|Overall Study|Disqualified data sets|10|||
128690365|NCT04810481|463166776|FG001|Overall Study|Disqualified data sets|28|||
128690366|NCT01230710|463166785|FG000|Overall Study|Disease Progression|41|||
128690367|NCT01230710|463166785|FG000|Overall Study|Lost to Follow-up|3|||
128690368|NCT01230710|463166785|FG000|Overall Study|Death|4|||
128690369|NCT01230710|463166785|FG000|Overall Study|Withdrawal of Consent|1|||
128690370|NCT01691898|463166786|FG000|Overall Study|Death|34|||
128690371|NCT01691898|463166787|FG001|Overall Study|Death|32|||
128690372|NCT01691898|463166788|FG002|Overall Study|Death|6|||
128690373|NCT01691898|463166789|FG003|Overall Study|Death|3|||
128690374|NCT01691898|463166790|FG004|Overall Study|Death|8|||
128690375|NCT01691898|463166791|FG005|Overall Study|Death|31|||
128690376|NCT01691898|463166786|FG000|Overall Study|Adverse Event|0|||
128690377|NCT01691898|463166787|FG001|Overall Study|Adverse Event|1|||
128690378|NCT01691898|463166788|FG002|Overall Study|Adverse Event|0|||
128690379|NCT01691898|463166789|FG003|Overall Study|Adverse Event|1|||
128690380|NCT01691898|463166790|FG004|Overall Study|Adverse Event|1|||
128690381|NCT01691898|463166791|FG005|Overall Study|Adverse Event|0|||
128690382|NCT01691898|463166786|FG000|Overall Study|Progression of Disease|1|||
128690383|NCT01691898|463166787|FG001|Overall Study|Progression of Disease|2|||
128690384|NCT01691898|463166788|FG002|Overall Study|Progression of Disease|1|||
128690385|NCT01691898|463166789|FG003|Overall Study|Progression of Disease|0|||
128690386|NCT01691898|463166790|FG004|Overall Study|Progression of Disease|0|||
128690387|NCT01691898|463166791|FG005|Overall Study|Progression of Disease|1|||
128690388|NCT01691898|463166786|FG000|Overall Study|Lost to Follow-up|3|||
128690389|NCT01691898|463166787|FG001|Overall Study|Lost to Follow-up|1|||
128690390|NCT01691898|463166788|FG002|Overall Study|Lost to Follow-up|0|||
128690391|NCT01691898|463166789|FG003|Overall Study|Lost to Follow-up|0|||
128690392|NCT01691898|463166790|FG004|Overall Study|Lost to Follow-up|1|||
128690393|NCT01691898|463166791|FG005|Overall Study|Lost to Follow-up|0|||
128690394|NCT01691898|463166786|FG000|Overall Study|Withdrawal by Subject|9|||
128690395|NCT01691898|463166787|FG001|Overall Study|Withdrawal by Subject|8|||
128690396|NCT01691898|463166788|FG002|Overall Study|Withdrawal by Subject|2|||
128690397|NCT01691898|463166789|FG003|Overall Study|Withdrawal by Subject|1|||
128690398|NCT01691898|463166790|FG004|Overall Study|Withdrawal by Subject|3|||
128690399|NCT01691898|463166791|FG005|Overall Study|Withdrawal by Subject|3|||
128690400|NCT01691898|463166786|FG000|Overall Study|Non-Compliance|0|||
128690401|NCT01691898|463166787|FG001|Overall Study|Non-Compliance|0|||
128690402|NCT01691898|463166788|FG002|Overall Study|Non-Compliance|0|||
128690403|NCT01691898|463166789|FG003|Overall Study|Non-Compliance|0|||
128690404|NCT01691898|463166790|FG004|Overall Study|Non-Compliance|1|||
128690405|NCT01691898|463166791|FG005|Overall Study|Non-Compliance|0|||
128690406|NCT02808650|463166794|FG000|Overall Study|Death|0|||
128690407|NCT02808650|463166795|FG001|Overall Study|Death|0|||
128690408|NCT02808650|463166796|FG002|Overall Study|Death|0|||
128690409|NCT02808650|463166797|FG003|Overall Study|Death|0|||
128690410|NCT02808650|463166798|FG004|Overall Study|Death|1|||
128690411|NCT02808650|463166794|FG000|Overall Study|Lack of Efficacy|5|||
128690412|NCT02808650|463166795|FG001|Overall Study|Lack of Efficacy|5|||
128690413|NCT02808650|463166796|FG002|Overall Study|Lack of Efficacy|6|||
128690414|NCT02808650|463166797|FG003|Overall Study|Lack of Efficacy|5|||
128690415|NCT02808650|463166798|FG004|Overall Study|Lack of Efficacy|4|||
128690416|NCT02808650|463166794|FG000|Overall Study|Physician Decision|1|||
128690417|NCT02808650|463166795|FG001|Overall Study|Physician Decision|1|||
128690418|NCT02808650|463166796|FG002|Overall Study|Physician Decision|0|||
128690419|NCT02808650|463166797|FG003|Overall Study|Physician Decision|0|||
128690420|NCT02808650|463166798|FG004|Overall Study|Physician Decision|0|||
128690421|NCT02808650|463166794|FG000|Overall Study|Withdrawal by Subject|0|||
128690422|NCT02808650|463166795|FG001|Overall Study|Withdrawal by Subject|0|||
128690423|NCT02808650|463166796|FG002|Overall Study|Withdrawal by Subject|0|||
128690424|NCT02808650|463166797|FG003|Overall Study|Withdrawal by Subject|1|||
128690425|NCT02808650|463166798|FG004|Overall Study|Withdrawal by Subject|1|||
128690426|NCT01069627|463166799|FG000|Overall Study|Disease progression|7|||
128690427|NCT01069627|463166799|FG000|Overall Study|Adverse Event|12|||
129110797|NCT01396083|464701341|FG001|Overall Study|Adverse Event|28|||
128690428|NCT01069627|463166799|FG000|Overall Study|Protocol Violation|1|||
128690429|NCT02939079|463166803|FG000|Overall Study|Adverse Event|2|||
128690430|NCT02939079|463166804|FG001|Overall Study|Adverse Event|1|||
128690431|NCT02939079|463166803|FG000|Overall Study|Lost to Follow-up|0|||
128690432|NCT02939079|463166804|FG001|Overall Study|Lost to Follow-up|2|||
128690433|NCT02939079|463166803|FG000|Overall Study|Protocol Violation|1|||
128690434|NCT02939079|463166804|FG001|Overall Study|Protocol Violation|0|||
128690435|NCT02939079|463166803|FG000|Overall Study|Withdrawal by Subject|0|||
128690436|NCT02939079|463166804|FG001|Overall Study|Withdrawal by Subject|1|||
128690437|NCT02939079|463166803|FG000|Overall Study|relapse during the study|1|||
128690438|NCT02939079|463166804|FG001|Overall Study|relapse during the study|1|||
128690439|NCT04093414|463166805|FG000|3 Month Follow up|Physician Decision|0|||
128690440|NCT04093414|463166806|FG001|3 Month Follow up|Physician Decision|1|||
128690441|NCT04093414|463166805|FG000|6month Follow up|Physician Decision|1|||
128690442|NCT04093414|463166806|FG001|6month Follow up|Physician Decision|3|||
128690443|NCT04209348|463166807|FG000|Overall Study|Lost to Follow-up|1|||
128690444|NCT04209348|463166808|FG001|Overall Study|Lost to Follow-up|0|||
128690445|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
128690446|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
128690447|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Death|1|||
128690448|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Death|0|||
128690449|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
128690450|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
128690451|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
128690452|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
128690453|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
128690454|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
128690455|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
128690456|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
128690457|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
128690458|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
128690459|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
128690460|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
128690461|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
128690462|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
128690463|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
128690464|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
128690465|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
128690466|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
128690467|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
128690468|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
128690469|NCT02927262|463166811|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
128690470|NCT02927262|463166812|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
128690471|NCT02927262|463166811|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
128690472|NCT02927262|463166812|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
128690473|NCT02927262|463166811|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
128690474|NCT02927262|463166812|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
128893203|NCT02716675|463906260|FG000|Overall Study|Withdrawal by Subject|22|||
128690475|NCT02927262|463166811|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
128690476|NCT02927262|463166812|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
128690477|NCT00923936|463166813|FG000|Overall Study|progressive disease on study|2|||
128690478|NCT00923936|463166814|FG001|Overall Study|progressive disease on study|1|||
128690479|NCT00923936|463166813|FG000|Overall Study|Adverse Event|2|||
128690480|NCT00923936|463166814|FG001|Overall Study|Adverse Event|1|||
128690481|NCT00923936|463166813|FG000|Overall Study|Lost to follow up|2|||
128690482|NCT00923936|463166814|FG001|Overall Study|Lost to follow up|0|||
128690483|NCT00923936|463166813|FG000|Overall Study|Continuing in follow up period|2|||
128690484|NCT00923936|463166814|FG001|Overall Study|Continuing in follow up period|1|||
128690485|NCT01697358|463166815|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
128690486|NCT01697358|463166816|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
128690487|NCT01697358|463166815|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
128893204|NCT02716675|463906261|FG001|Overall Study|Withdrawal by Subject|25|||
128893205|NCT02716675|463906262|FG002|Overall Study|Withdrawal by Subject|20|||
128893206|NCT02716675|463906260|FG000|Overall Study|Protocol Violation|0|||
128893207|NCT02716675|463906261|FG001|Overall Study|Protocol Violation|3|||
128893208|NCT02716675|463906262|FG002|Overall Study|Protocol Violation|1|||
129021057|NCT00448591|464368625|FG000|Overall Study|Progressive Disease|1382|||
129021058|NCT00448591|464368625|FG000|Overall Study|Adverse Event|382|||
128690488|NCT01697358|463166816|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
128690489|NCT01697358|463166815|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
128690490|NCT01697358|463166816|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
128893209|NCT02716675|463906260|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
129021059|NCT00448591|464368625|FG000|Overall Study|Protocol Violation|41|||
129021060|NCT00448591|464368625|FG000|Overall Study|Lost to Follow-up|19|||
129021061|NCT00448591|464368625|FG000|Overall Study|Treatment Regimen Completed|70|||
128690491|NCT01697358|463166815|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
128690492|NCT01697358|463166816|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
128690493|NCT01697358|463166815|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
128690494|NCT01697358|463166816|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
128690495|NCT01697358|463166815|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
128690496|NCT01697358|463166816|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
128690497|NCT01697358|463166815|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
128690498|NCT01697358|463166816|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
128690499|NCT01697358|463166815|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
128690500|NCT01697358|463166816|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
128690501|NCT01697358|463166815|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
128690502|NCT01697358|463166816|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
128690503|NCT01697358|463166815|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
128690504|NCT01697358|463166816|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
128690505|NCT05394350|463166818|FG000|Overall Study|Death|2|||
128690506|NCT05394350|463166819|FG001|Overall Study|Death|2|||
128690507|NCT05394350|463166820|FG002|Overall Study|Death|4|||
128690508|NCT05394350|463166821|FG003|Overall Study|Death|0|||
128690509|NCT05394350|463166822|FG004|Overall Study|Death|1|||
128690510|NCT05394350|463166823|FG005|Overall Study|Death|0|||
128690511|NCT05394350|463166818|FG000|Overall Study|Study terminated by sponsor|1|||
128690512|NCT05394350|463166819|FG001|Overall Study|Study terminated by sponsor|1|||
128690513|NCT05394350|463166820|FG002|Overall Study|Study terminated by sponsor|7|||
128690514|NCT05394350|463166821|FG003|Overall Study|Study terminated by sponsor|3|||
128690515|NCT05394350|463166822|FG004|Overall Study|Study terminated by sponsor|2|||
128690516|NCT05394350|463166823|FG005|Overall Study|Study terminated by sponsor|4|||
128690517|NCT01336569|463166824|FG000|Overall Study|Lost to Follow-up|4|||
128690518|NCT02963935|463166827|FG000|Overall Study|Adverse Event|12|||
128690519|NCT02963935|463166828|FG001|Overall Study|Adverse Event|6|||
128690520|NCT02963935|463166827|FG000|Overall Study|Protocol Violation|2|||
128690521|NCT02963935|463166828|FG001|Overall Study|Protocol Violation|1|||
128690522|NCT02963935|463166827|FG000|Overall Study|Lack of Efficacy|0|||
128690523|NCT02963935|463166828|FG001|Overall Study|Lack of Efficacy|2|||
128690524|NCT02963935|463166827|FG000|Overall Study|Lost to Follow-up|1|||
128690525|NCT02963935|463166828|FG001|Overall Study|Lost to Follow-up|6|||
128690526|NCT02963935|463166827|FG000|Overall Study|Unclassified|13|||
128690527|NCT02963935|463166828|FG001|Overall Study|Unclassified|22|||
128690528|NCT00464269|463166829|FG000|Overall Study|Lack of Efficacy|1|||
128690529|NCT00464269|463166830|FG001|Overall Study|Lack of Efficacy|0|||
128690530|NCT00464269|463166831|FG002|Overall Study|Lack of Efficacy|0|||
128690531|NCT00464269|463166832|FG003|Overall Study|Lack of Efficacy|0|||
128690532|NCT00464269|463166829|FG000|Overall Study|Lost to Follow-up|0|||
128690533|NCT00464269|463166830|FG001|Overall Study|Lost to Follow-up|4|||
128690534|NCT00464269|463166831|FG002|Overall Study|Lost to Follow-up|0|||
128690535|NCT00464269|463166832|FG003|Overall Study|Lost to Follow-up|1|||
128690536|NCT00464269|463166829|FG000|Overall Study|Withdrawal by Subject|0|||
128690537|NCT00464269|463166830|FG001|Overall Study|Withdrawal by Subject|2|||
129021062|NCT00448591|464368625|FG000|Overall Study|Other|154|||
129021063|NCT00448591|464368625|FG000|Overall Study|Termination of Study|70|||
129021064|NCT00640562|464368626|FG000|Overall Study|Adverse Event|8|||
129021065|NCT00640562|464368627|FG001|Overall Study|Adverse Event|5|||
129021066|NCT00640562|464368626|FG000|Overall Study|Lack of Efficacy|1|||
129021067|NCT00640562|464368627|FG001|Overall Study|Lack of Efficacy|4|||
128690538|NCT00464269|463166831|FG002|Overall Study|Withdrawal by Subject|1|||
128690539|NCT00464269|463166832|FG003|Overall Study|Withdrawal by Subject|1|||
128690540|NCT00464269|463166829|FG000|Overall Study|Other reason|3|||
128690541|NCT00464269|463166830|FG001|Overall Study|Other reason|3|||
128690542|NCT00464269|463166831|FG002|Overall Study|Other reason|1|||
128690543|NCT00464269|463166832|FG003|Overall Study|Other reason|1|||
128690544|NCT00464269|463166829|FG000|Overall Study|AE, serious fatal|0|||
128690545|NCT00464269|463166830|FG001|Overall Study|AE, serious fatal|0|||
128690546|NCT00464269|463166831|FG002|Overall Study|AE, serious fatal|1|||
128690547|NCT00464269|463166832|FG003|Overall Study|AE, serious fatal|1|||
128690548|NCT00464269|463166829|FG000|Overall Study|SAE, non-fatal|0|||
128690549|NCT00464269|463166830|FG001|Overall Study|SAE, non-fatal|0|||
128690550|NCT00464269|463166831|FG002|Overall Study|SAE, non-fatal|0|||
128690551|NCT00464269|463166832|FG003|Overall Study|SAE, non-fatal|1|||
128690552|NCT00464269|463166829|FG000|Overall Study|AE, non-serious non-fatal|2|||
128690553|NCT00464269|463166830|FG001|Overall Study|AE, non-serious non-fatal|8|||
128690554|NCT00464269|463166831|FG002|Overall Study|AE, non-serious non-fatal|3|||
128764313|NCT02277743|463428288|FG002|Overall Study|Protocol Violation|1|||
129021068|NCT00640562|464368626|FG000|Overall Study|Protocol Violation|2|||
129021069|NCT00640562|464368627|FG001|Overall Study|Protocol Violation|4|||
129021070|NCT00640562|464368626|FG000|Overall Study|Withdrawal by Subject|6|||
128690555|NCT00464269|463166832|FG003|Overall Study|AE, non-serious non-fatal|4|||
128690556|NCT00464269|463166829|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
128690557|NCT00464269|463166830|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
128690558|NCT00464269|463166831|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
128690559|NCT00464269|463166832|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
128690560|NCT05055128|463166833|FG000|Overall Study|Adverse Event|0|||
128690561|NCT05055128|463166834|FG001|Overall Study|Adverse Event|0|||
128690562|NCT05055128|463166835|FG002|Overall Study|Adverse Event|0|||
128690563|NCT05055128|463166836|FG003|Overall Study|Adverse Event|1|||
128690564|NCT05055128|463166837|FG004|Overall Study|Adverse Event|1|||
128690565|NCT05055128|463166833|FG000|Overall Study|Protocol Violation|0|||
128690566|NCT05055128|463166834|FG001|Overall Study|Protocol Violation|0|||
128690567|NCT05055128|463166835|FG002|Overall Study|Protocol Violation|0|||
128893210|NCT02716675|463906261|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
128893211|NCT02716675|463906262|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
128893212|NCT02716675|463906260|FG000|Overall Study|Other|38|||
128893213|NCT02716675|463906261|FG001|Overall Study|Other|47|||
128893214|NCT02716675|463906262|FG002|Overall Study|Other|48|||
128893215|NCT00709111|463906263|FG000|Overall Study|Withdrawal by Subject|1|||
128893216|NCT00709111|463906263|FG000|Overall Study|Unable to attend clinic visits|1|||
128893217|NCT03593850|463906272|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
128893218|NCT03593850|463906273|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
128893219|NCT01735279|463906274|FG000|Overall Study|Lost to Follow-up|11|||
128893220|NCT01735279|463906275|FG001|Overall Study|Lost to Follow-up|8|||
128893221|NCT01195090|463906280|FG000|Overall Study|Adverse Event|1|||
128893222|NCT01195090|463906281|FG001|Overall Study|Adverse Event|2|||
128893223|NCT01195090|463906280|FG000|Overall Study|Lost to Follow-up|2|||
128893224|NCT01195090|463906281|FG001|Overall Study|Lost to Follow-up|2|||
128893225|NCT01195090|463906280|FG000|Overall Study|Protocol Violation|3|||
128893226|NCT01195090|463906281|FG001|Overall Study|Protocol Violation|4|||
128893227|NCT05111041|463906282|FG000|Overall Study|Lost to Follow-up|6|||
128893228|NCT05111041|463906283|FG001|Overall Study|Lost to Follow-up|7|||
128893229|NCT05111041|463906282|FG000|Overall Study|Withdrawal by Subject|1|||
128893230|NCT05111041|463906283|FG001|Overall Study|Withdrawal by Subject|0|||
128893231|NCT01205230|463906284|FG000|Overall Study|Adverse Event|4|||
128893232|NCT01205230|463906285|FG001|Overall Study|Adverse Event|0|||
128893233|NCT01205230|463906284|FG000|Overall Study|Physician Decision|1|||
128690568|NCT05055128|463166836|FG003|Overall Study|Protocol Violation|1|||
128690569|NCT05055128|463166837|FG004|Overall Study|Protocol Violation|0|||
128690570|NCT05055128|463166833|FG000|Overall Study|Withdrawal by Subject|5|||
128690571|NCT05055128|463166834|FG001|Overall Study|Withdrawal by Subject|2|||
128690572|NCT05055128|463166835|FG002|Overall Study|Withdrawal by Subject|2|||
128690573|NCT05055128|463166836|FG003|Overall Study|Withdrawal by Subject|4|||
128690574|NCT05055128|463166837|FG004|Overall Study|Withdrawal by Subject|2|||
128690575|NCT05055128|463166833|FG000|Overall Study|Randomized By Mistake|0|||
128690576|NCT05055128|463166834|FG001|Overall Study|Randomized By Mistake|1|||
128690577|NCT05055128|463166835|FG002|Overall Study|Randomized By Mistake|0|||
128690578|NCT05055128|463166836|FG003|Overall Study|Randomized By Mistake|0|||
128690579|NCT05055128|463166837|FG004|Overall Study|Randomized By Mistake|0|||
128690580|NCT05055128|463166833|FG000|Overall Study|Other|1|||
128690581|NCT05055128|463166834|FG001|Overall Study|Other|0|||
128690582|NCT05055128|463166835|FG002|Overall Study|Other|0|||
128690583|NCT05055128|463166836|FG003|Overall Study|Other|0|||
128690584|NCT05055128|463166837|FG004|Overall Study|Other|0|||
128690585|NCT01385371|463166838|FG000|Overall Study|Adverse Event|54|||
128690586|NCT01385371|463166839|FG001|Overall Study|Adverse Event|19|||
128690587|NCT01385371|463166838|FG000|Overall Study|Lost to Follow-up|16|||
128690588|NCT01385371|463166839|FG001|Overall Study|Lost to Follow-up|16|||
128690589|NCT01385371|463166838|FG000|Overall Study|Withdrawal by Subject|52|||
128690590|NCT01385371|463166839|FG001|Overall Study|Withdrawal by Subject|39|||
128690591|NCT01385371|463166838|FG000|Overall Study|Protocol Violation|25|||
128690592|NCT01385371|463166839|FG001|Overall Study|Protocol Violation|21|||
128690593|NCT01385371|463166838|FG000|Overall Study|Administrative|2|||
128690594|NCT01385371|463166839|FG001|Overall Study|Administrative|2|||
128690595|NCT02478372|463166840|FG000|Overall Study|Protocol Violation|12|||
128893234|NCT01205230|463906285|FG001|Overall Study|Physician Decision|0|||
128893235|NCT00922480|463906286|FG000|Main Study|Protocol Violation|3|||
128893236|NCT00922480|463906287|FG001|Main Study|Protocol Violation|6|||
128893237|NCT00922480|463906286|FG000|Main Study|Adverse Event|6|||
128893238|NCT00922480|463906287|FG001|Main Study|Adverse Event|7|||
128893239|NCT00922480|463906286|FG000|Main Study|Lack of Efficacy|3|||
128893240|NCT00922480|463906287|FG001|Main Study|Lack of Efficacy|0|||
128893241|NCT00922480|463906286|FG000|Main Study|Withdrawal by Subject|20|||
128690596|NCT02478372|463166841|FG001|Overall Study|Protocol Violation|8|||
128690597|NCT02478372|463166840|FG000|Overall Study|Lost to Follow-up|1|||
128690598|NCT02478372|463166841|FG001|Overall Study|Lost to Follow-up|4|||
128690599|NCT02478372|463166840|FG000|Overall Study|Death|0|||
128690600|NCT02478372|463166841|FG001|Overall Study|Death|2|||
128690601|NCT02955797|463166844|FG000|Overall Study|Protocol Violation|1|||
128893242|NCT00922480|463906287|FG001|Main Study|Withdrawal by Subject|15|||
128893243|NCT00922480|463906286|FG000|Main Study|Lost to Follow-up|5|||
128893244|NCT00922480|463906287|FG001|Main Study|Lost to Follow-up|0|||
128893245|NCT00922480|463906286|FG000|Main Study|Physician Decision|0|||
128893246|NCT00922480|463906287|FG001|Main Study|Physician Decision|1|||
128893247|NCT00922480|463906286|FG000|Extension Study|Protocol Violation|3|||
128893248|NCT00922480|463906287|FG001|Extension Study|Protocol Violation|0|||
128893249|NCT00922480|463906286|FG000|Extension Study|Adverse Event|1|||
128893250|NCT00922480|463906287|FG001|Extension Study|Adverse Event|1|||
128893251|NCT00922480|463906286|FG000|Extension Study|Withdrawal by Subject|1|||
128893252|NCT00922480|463906287|FG001|Extension Study|Withdrawal by Subject|1|||
128893253|NCT00922480|463906286|FG000|Extension Study|Others|0|||
128893254|NCT00922480|463906287|FG001|Extension Study|Others|1|||
128893255|NCT04784897|463906288|FG000|Overall Study|Death|4|||
128893256|NCT04784897|463906289|FG001|Overall Study|Death|2|||
128893257|NCT04784897|463906290|FG002|Overall Study|Death|1|||
128893258|NCT04784897|463906288|FG000|Overall Study|Withdrawal by Subject|0|||
128893259|NCT04784897|463906289|FG001|Overall Study|Withdrawal by Subject|0|||
128893260|NCT04784897|463906290|FG002|Overall Study|Withdrawal by Subject|1|||
128893261|NCT04667377|463906291|FG000|Dose Escalation Period|Other not specified below|3|||
128893262|NCT04667377|463906292|FG001|Dose Escalation Period|Other not specified below|3|||
128893263|NCT04667377|463906293|FG002|Dose Escalation Period|Other not specified below|2|||
128893264|NCT04667377|463906294|FG003|Dose Escalation Period|Other not specified below|1|||
128893265|NCT04667377|463906295|FG004|Dose Escalation Period|Other not specified below|3|||
128893266|NCT04667377|463906291|FG000|Dose Escalation Period|Protocol Violation|2|||
128893267|NCT04667377|463906292|FG001|Dose Escalation Period|Protocol Violation|2|||
128893268|NCT04667377|463906293|FG002|Dose Escalation Period|Protocol Violation|0|||
128893269|NCT04667377|463906294|FG003|Dose Escalation Period|Protocol Violation|2|||
128893270|NCT04667377|463906295|FG004|Dose Escalation Period|Protocol Violation|1|||
128893271|NCT04667377|463906291|FG000|Dose Escalation Period|Burden of study procedures|2|||
128893272|NCT04667377|463906292|FG001|Dose Escalation Period|Burden of study procedures|1|||
128893273|NCT04667377|463906293|FG002|Dose Escalation Period|Burden of study procedures|1|||
128893274|NCT04667377|463906294|FG003|Dose Escalation Period|Burden of study procedures|1|||
128893275|NCT04667377|463906295|FG004|Dose Escalation Period|Burden of study procedures|5|||
128893276|NCT04667377|463906291|FG000|Dose Escalation Period|Change of residence|0|||
128893277|NCT04667377|463906292|FG001|Dose Escalation Period|Change of residence|0|||
128893278|NCT04667377|463906293|FG002|Dose Escalation Period|Change of residence|1|||
128893279|NCT04667377|463906294|FG003|Dose Escalation Period|Change of residence|0|||
128893280|NCT04667377|463906295|FG004|Dose Escalation Period|Change of residence|0|||
128893281|NCT04667377|463906291|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
128893282|NCT04667377|463906292|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
128893283|NCT04667377|463906293|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
128893284|NCT04667377|463906294|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
128893285|NCT04667377|463906295|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
128893286|NCT04667377|463906291|FG000|Dose Escalation Period|Adverse Event|9|||
128893287|NCT04667377|463906292|FG001|Dose Escalation Period|Adverse Event|10|||
129110798|NCT01396083|464701340|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129110799|NCT01396083|464701341|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
129110800|NCT01396083|464701340|FG000|Overall Study|Consent withdrawn|4|||
129110801|NCT01396083|464701341|FG001|Overall Study|Consent withdrawn|5|||
129110802|NCT01396083|464701340|FG000|Overall Study|Protocol deviation(s)|0|||
129110803|NCT01396083|464701341|FG001|Overall Study|Protocol deviation(s)|1|||
129110804|NCT01396083|464701340|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129110805|NCT01396083|464701341|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129110806|NCT01396083|464701340|FG000|Overall Study|Administrative problems|1|||
129110807|NCT01396083|464701341|FG001|Overall Study|Administrative problems|0|||
129110808|NCT01396083|464701340|FG000|Overall Study|Lost to Follow-up|1|||
129110809|NCT01396083|464701341|FG001|Overall Study|Lost to Follow-up|0|||
129110810|NCT02806713|464701342|FG000|Overall Study|Urethral injury during procedure|1|||
129110811|NCT02806713|464701343|FG001|Overall Study|Urethral injury during procedure|0|||
128690602|NCT02955797|463166845|FG001|Overall Study|Protocol Violation|0|||
129110812|NCT02806713|464701342|FG000|Overall Study|cancelled surgery|1|||
129110813|NCT02806713|464701343|FG001|Overall Study|cancelled surgery|2|||
129110814|NCT00735709|464701344|FG000|Overall Study|Adverse Event|2|||
129110815|NCT00735709|464701345|FG001|Overall Study|Adverse Event|3|||
128690603|NCT02955797|463166846|FG002|Overall Study|Protocol Violation|0|||
128690604|NCT02955797|463166847|FG003|Overall Study|Protocol Violation|1|||
128893288|NCT04667377|463906293|FG002|Dose Escalation Period|Adverse Event|12|||
128893289|NCT04667377|463906294|FG003|Dose Escalation Period|Adverse Event|17|||
128893290|NCT04667377|463906295|FG004|Dose Escalation Period|Adverse Event|3|||
128893291|NCT04667377|463906291|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
128893292|NCT04667377|463906292|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
129110816|NCT00735709|464701346|FG002|Overall Study|Adverse Event|1|||
129110817|NCT00735709|464701347|FG003|Overall Study|Adverse Event|5|||
128690605|NCT02955797|463166844|FG000|Overall Study|Withdrawal by Subject|2|||
128893293|NCT04667377|463906293|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
128893294|NCT04667377|463906294|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
128893295|NCT04667377|463906295|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
128893296|NCT04667377|463906291|FG000|Dose Escalation Period|Not treated|1|||
128893297|NCT04667377|463906292|FG001|Dose Escalation Period|Not treated|0|||
128893298|NCT04667377|463906293|FG002|Dose Escalation Period|Not treated|0|||
128893299|NCT04667377|463906294|FG003|Dose Escalation Period|Not treated|0|||
128893300|NCT04667377|463906295|FG004|Dose Escalation Period|Not treated|0|||
128893301|NCT04667377|463906291|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
128893302|NCT04667377|463906292|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
128893303|NCT04667377|463906293|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
128893304|NCT04667377|463906294|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
128893305|NCT04667377|463906295|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
128893306|NCT04667377|463906291|FG000|Dose Escalation Period|Lost to Follow-up|0|||
128893307|NCT04667377|463906292|FG001|Dose Escalation Period|Lost to Follow-up|1|||
128893308|NCT04667377|463906293|FG002|Dose Escalation Period|Lost to Follow-up|0|||
128893309|NCT04667377|463906294|FG003|Dose Escalation Period|Lost to Follow-up|0|||
128893310|NCT04667377|463906295|FG004|Dose Escalation Period|Lost to Follow-up|0|||
128893311|NCT04667377|463906291|FG000|Maintenance Period|Perceived lack of efficacy|0|||
128893312|NCT04667377|463906292|FG001|Maintenance Period|Perceived lack of efficacy|2|||
128893313|NCT04667377|463906293|FG002|Maintenance Period|Perceived lack of efficacy|1|||
128893314|NCT04667377|463906294|FG003|Maintenance Period|Perceived lack of efficacy|0|||
128893315|NCT04667377|463906295|FG004|Maintenance Period|Perceived lack of efficacy|1|||
128893316|NCT04667377|463906291|FG000|Maintenance Period|Adverse Event|2|||
128893317|NCT04667377|463906292|FG001|Maintenance Period|Adverse Event|8|||
128893318|NCT04667377|463906293|FG002|Maintenance Period|Adverse Event|5|||
128893319|NCT04667377|463906294|FG003|Maintenance Period|Adverse Event|4|||
128893320|NCT04667377|463906295|FG004|Maintenance Period|Adverse Event|1|||
128893321|NCT04667377|463906291|FG000|Maintenance Period|Adverse event: COVID infection|0|||
128893322|NCT04667377|463906292|FG001|Maintenance Period|Adverse event: COVID infection|1|||
128893323|NCT04667377|463906293|FG002|Maintenance Period|Adverse event: COVID infection|0|||
128893324|NCT04667377|463906294|FG003|Maintenance Period|Adverse event: COVID infection|0|||
128690606|NCT02955797|463166845|FG001|Overall Study|Withdrawal by Subject|2|||
128690607|NCT02955797|463166846|FG002|Overall Study|Withdrawal by Subject|0|||
128690608|NCT02955797|463166847|FG003|Overall Study|Withdrawal by Subject|1|||
128690609|NCT02955797|463166844|FG000|Overall Study|Lost to Follow-up|0|||
128690610|NCT02955797|463166845|FG001|Overall Study|Lost to Follow-up|1|||
128690611|NCT02955797|463166846|FG002|Overall Study|Lost to Follow-up|0|||
128690612|NCT02955797|463166847|FG003|Overall Study|Lost to Follow-up|0|||
128690613|NCT01558739|463166850|FG000|Overall Study|Adverse Event|7|||
128690614|NCT01558739|463166850|FG000|Overall Study|Withdrawal by Subject|2|||
128690615|NCT01558739|463166850|FG000|Overall Study|Death|3|||
128690616|NCT01558739|463166850|FG000|Overall Study|Disease Progression|4|||
128690617|NCT01558739|463166850|FG000|Overall Study|Protocol Violation|1|||
128690618|NCT03001882|463166853|FG000|Overall Study|Death|1|||
128690619|NCT03001882|463166854|FG001|Overall Study|Death|0|||
128690620|NCT03001882|463166855|FG002|Overall Study|Death|0|||
128690621|NCT03001882|463166856|FG003|Overall Study|Death|3|||
128690622|NCT03001882|463166853|FG000|Overall Study|Participant withdrew consent|0|||
128690623|NCT03001882|463166854|FG001|Overall Study|Participant withdrew consent|1|||
128690624|NCT03001882|463166855|FG002|Overall Study|Participant withdrew consent|0|||
128690625|NCT03001882|463166856|FG003|Overall Study|Participant withdrew consent|5|||
128690626|NCT03001882|463166853|FG000|Overall Study|Other reasons|1|||
128690627|NCT03001882|463166854|FG001|Overall Study|Other reasons|2|||
128690628|NCT03001882|463166855|FG002|Overall Study|Other reasons|0|||
128690629|NCT03001882|463166856|FG003|Overall Study|Other reasons|5|||
128690630|NCT03001882|463166853|FG000|Overall Study|Administrative reason by sponsor|0|||
128690631|NCT03001882|463166854|FG001|Overall Study|Administrative reason by sponsor|0|||
128690632|NCT03001882|463166855|FG002|Overall Study|Administrative reason by sponsor|0|||
128690633|NCT03001882|463166856|FG003|Overall Study|Administrative reason by sponsor|1|||
128690634|NCT03001882|463166853|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
128893325|NCT04667377|463906295|FG004|Maintenance Period|Adverse event: COVID infection|0|||
129021071|NCT00640562|464368627|FG001|Overall Study|Withdrawal by Subject|10|||
129021072|NCT00640562|464368626|FG000|Overall Study|Known risperidone intolerance|0|||
129021073|NCT00640562|464368627|FG001|Overall Study|Known risperidone intolerance|1|||
129021074|NCT00640562|464368626|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
129021075|NCT00640562|464368627|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
129021076|NCT00640562|464368626|FG000|Overall Study|Low study drug dose|0|||
128893326|NCT04667377|463906291|FG000|Maintenance Period|COVID-related|0|||
128893327|NCT04667377|463906292|FG001|Maintenance Period|COVID-related|0|||
128893328|NCT04667377|463906293|FG002|Maintenance Period|COVID-related|1|||
128893329|NCT04667377|463906294|FG003|Maintenance Period|COVID-related|1|||
128690635|NCT03001882|463166854|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
128690636|NCT03001882|463166855|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
128690637|NCT03001882|463166856|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
128893330|NCT04667377|463906295|FG004|Maintenance Period|COVID-related|0|||
128893331|NCT04667377|463906291|FG000|Maintenance Period|Protocol Violation|1|||
128893332|NCT04667377|463906292|FG001|Maintenance Period|Protocol Violation|0|||
128893333|NCT04667377|463906293|FG002|Maintenance Period|Protocol Violation|0|||
128893334|NCT04667377|463906294|FG003|Maintenance Period|Protocol Violation|0|||
128893335|NCT04667377|463906295|FG004|Maintenance Period|Protocol Violation|1|||
128893336|NCT04667377|463906291|FG000|Maintenance Period|Burden of study procedures|1|||
128893337|NCT04667377|463906292|FG001|Maintenance Period|Burden of study procedures|2|||
128893338|NCT04667377|463906293|FG002|Maintenance Period|Burden of study procedures|0|||
128893339|NCT04667377|463906294|FG003|Maintenance Period|Burden of study procedures|1|||
128893340|NCT04667377|463906295|FG004|Maintenance Period|Burden of study procedures|0|||
128893341|NCT04667377|463906291|FG000|Maintenance Period|Change of residence|0|||
128893342|NCT04667377|463906292|FG001|Maintenance Period|Change of residence|1|||
128893343|NCT04667377|463906293|FG002|Maintenance Period|Change of residence|0|||
128893344|NCT04667377|463906294|FG003|Maintenance Period|Change of residence|0|||
128893345|NCT04667377|463906295|FG004|Maintenance Period|Change of residence|1|||
128893346|NCT04667377|463906291|FG000|Maintenance Period|Missing|1|||
128893347|NCT04667377|463906292|FG001|Maintenance Period|Missing|0|||
128893348|NCT04667377|463906293|FG002|Maintenance Period|Missing|0|||
128893349|NCT04667377|463906294|FG003|Maintenance Period|Missing|0|||
128893350|NCT04667377|463906295|FG004|Maintenance Period|Missing|0|||
128893351|NCT04667377|463906291|FG000|Maintenance Period|Other than listed above|2|||
128893352|NCT04667377|463906292|FG001|Maintenance Period|Other than listed above|0|||
128893353|NCT04667377|463906293|FG002|Maintenance Period|Other than listed above|3|||
128893354|NCT04667377|463906294|FG003|Maintenance Period|Other than listed above|2|||
128893355|NCT04667377|463906295|FG004|Maintenance Period|Other than listed above|6|||
128893356|NCT04667377|463906291|FG000|Maintenance Period|Withdrawal by Subject|0|||
128893357|NCT04667377|463906292|FG001|Maintenance Period|Withdrawal by Subject|1|||
128893358|NCT04667377|463906293|FG002|Maintenance Period|Withdrawal by Subject|0|||
128893359|NCT04667377|463906294|FG003|Maintenance Period|Withdrawal by Subject|0|||
128893360|NCT04667377|463906295|FG004|Maintenance Period|Withdrawal by Subject|0|||
128893361|NCT04667377|463906291|FG000|Maintenance Period|Lost to Follow-up|1|||
128893362|NCT04667377|463906292|FG001|Maintenance Period|Lost to Follow-up|0|||
128893363|NCT04667377|463906293|FG002|Maintenance Period|Lost to Follow-up|1|||
128893364|NCT04667377|463906294|FG003|Maintenance Period|Lost to Follow-up|0|||
128893365|NCT04667377|463906295|FG004|Maintenance Period|Lost to Follow-up|1|||
128893366|NCT01011439|463906296|FG000|Overall Study|Death|37|||
128893367|NCT01011439|463906296|FG000|Overall Study|Lost to Follow-up|4|||
128893368|NCT01011439|463906296|FG000|Overall Study|Withdrawal by Subject|1|||
128893369|NCT01011439|463906296|FG000|Overall Study|Sponsor's decision|15|||
128893370|NCT02428855|463906297|FG000|Overall Study|Withdrawal by Subject|2|||
128893371|NCT02066311|463906298|FG000|Overall Study|Adverse Event|4|||
128893372|NCT02066311|463906298|FG000|Overall Study|Withdrawal by Subject|1|||
128893373|NCT03198520|463906303|FG000|Overall Study|Physician Decision|2|||
128893374|NCT03198520|463906303|FG000|Overall Study|Protocol Violation|2|||
128893375|NCT03198520|463906303|FG000|Overall Study|Withdrawal by Subject|1|||
128893376|NCT03198520|463906303|FG000|Overall Study|Study Ended|1|||
128893377|NCT01670539|463906304|FG000|Overall Study|Death|3|||
128893378|NCT01670539|463906305|FG001|Overall Study|Death|5|||
128893379|NCT01670539|463906304|FG000|Overall Study|Withdrawal by Subject|3|||
128893380|NCT01670539|463906305|FG001|Overall Study|Withdrawal by Subject|0|||
128893381|NCT00536809|463906306|FG000|Phase II|Adverse Event|1|||
128893382|NCT00536809|463906306|FG000|Phase II|Referred for surgical resection|1|||
128893383|NCT02606461|463906307|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
128893384|NCT02606461|463906308|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
128893385|NCT02606461|463906309|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
128893386|NCT02606461|463906310|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
128893387|NCT02606461|463906311|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
128893388|NCT02606461|463906312|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
128893389|NCT01303965|463906313|FG000|Overall Study|Adverse Event|1|||
128893390|NCT01303965|463906314|FG001|Overall Study|Adverse Event|1|||
128893391|NCT01303965|463906313|FG000|Overall Study|Death|0|||
128893392|NCT01303965|463906314|FG001|Overall Study|Death|3|||
128893393|NCT01303965|463906313|FG000|Overall Study|Withdrawal by Subject|1|||
128893394|NCT01303965|463906314|FG001|Overall Study|Withdrawal by Subject|0|||
128893395|NCT01303965|463906313|FG000|Overall Study|Disease Progression|1|||
128893396|NCT01303965|463906314|FG001|Overall Study|Disease Progression|6|||
128893397|NCT01490814|463906320|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
128893398|NCT01490814|463906321|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
128893399|NCT01490814|463906320|FG000|Overall Study|Physician Decision|1|||
128893400|NCT01490814|463906321|FG001|Overall Study|Physician Decision|0|||
128893401|NCT01490814|463906320|FG000|Overall Study|Withdrawal by Subject|0|||
128893402|NCT01490814|463906321|FG001|Overall Study|Withdrawal by Subject|5|||
128893403|NCT03024970|463906325|FG000|First Intervention|Adverse Event|1|||
128893404|NCT03024970|463906326|FG001|First Intervention|Adverse Event|0|||
128893405|NCT03024970|463906325|FG000|Second Intervention|Lost to Follow-up|1|||
128893406|NCT03024970|463906326|FG001|Second Intervention|Lost to Follow-up|0|||
128893407|NCT04556136|463906334|FG000|Overall Study|Lost to Follow-up|6|||
128893408|NCT04556136|463906335|FG001|Overall Study|Lost to Follow-up|6|||
128893409|NCT04556136|463906334|FG000|Overall Study|Physician Decision|2|||
128893410|NCT04556136|463906335|FG001|Overall Study|Physician Decision|1|||
128893411|NCT04556136|463906334|FG000|Overall Study|Withdrawal by Subject|2|||
128893412|NCT04556136|463906335|FG001|Overall Study|Withdrawal by Subject|1|||
128893413|NCT04340557|463906339|FG000|Overall Study|Transferred to ICU and/or death|1|||
128893414|NCT04340557|463906340|FG001|Overall Study|Transferred to ICU and/or death|2|||
128893415|NCT01221727|463906341|FG000|Overall Study|Physician Decision|2|||
128893416|NCT01221727|463906342|FG001|Overall Study|Physician Decision|0|||
128893417|NCT01221727|463906341|FG000|Overall Study|Withdrawal by Subject|1|||
128893418|NCT01221727|463906342|FG001|Overall Study|Withdrawal by Subject|1|||
128893419|NCT00529451|463906345|FG000|Overall Study|Subject withdrew consent|16|||
128893420|NCT00529451|463906346|FG001|Overall Study|Subject withdrew consent|21|||
128893421|NCT00529451|463906347|FG002|Overall Study|Subject withdrew consent|13|||
128893422|NCT00529451|463906348|FG003|Overall Study|Subject withdrew consent|12|||
128893423|NCT00529451|463906345|FG000|Overall Study|Adverse Event|9|||
128893424|NCT00529451|463906346|FG001|Overall Study|Adverse Event|16|||
128893425|NCT00529451|463906347|FG002|Overall Study|Adverse Event|14|||
128893426|NCT00529451|463906348|FG003|Overall Study|Adverse Event|8|||
128893427|NCT00529451|463906345|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
128893428|NCT00529451|463906346|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
128893429|NCT00529451|463906347|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
128893430|NCT00529451|463906348|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
128893431|NCT00529451|463906345|FG000|Overall Study|Lost to Follow-up|4|||
128893432|NCT00529451|463906346|FG001|Overall Study|Lost to Follow-up|7|||
128893433|NCT00529451|463906347|FG002|Overall Study|Lost to Follow-up|4|||
128893434|NCT00529451|463906348|FG003|Overall Study|Lost to Follow-up|4|||
128893435|NCT00529451|463906345|FG000|Overall Study|Protocol deviation|1|||
128893436|NCT00529451|463906346|FG001|Overall Study|Protocol deviation|1|||
128893437|NCT00529451|463906347|FG002|Overall Study|Protocol deviation|4|||
128893438|NCT00529451|463906348|FG003|Overall Study|Protocol deviation|1|||
128893439|NCT00529451|463906345|FG000|Overall Study|Administrative problems|1|||
128893440|NCT00529451|463906346|FG001|Overall Study|Administrative problems|1|||
128893441|NCT00529451|463906347|FG002|Overall Study|Administrative problems|0|||
128893442|NCT00529451|463906348|FG003|Overall Study|Administrative problems|2|||
128893443|NCT01289821|463906349|FG000|Treatment Period|Withdrawal by Subject|1|||
128893444|NCT01289821|463906349|FG000|Treatment Period|Physician Decision|3|||
128893445|NCT01289821|463906349|FG000|Treatment Period|Adverse Event|4|||
128893446|NCT01289821|463906349|FG000|Treatment Period|Radiological Progression|43|||
128893447|NCT01289821|463906349|FG000|Treatment Period|Clinical Progression|2|||
128893448|NCT01289821|463906349|FG000|Treatment Period|Therapeutic procedure required|1|||
128893449|NCT01289821|463906349|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
128893450|NCT01289821|463906349|FG000|Safety Follow-up Period|Protocol Violation|3|||
128893451|NCT01289821|463906349|FG000|Safety Follow-up Period|Unspecified reason|1|||
128893452|NCT01289821|463906349|FG000|Survival Follow-up Period|Protocol Violation|1|||
128893453|NCT01289821|463906349|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
128893454|NCT01289821|463906349|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
128893455|NCT00590044|463906353|FG000|Overall Study|Withdrawal by Subject|2|||
128893456|NCT00590044|463906354|FG001|Overall Study|Withdrawal by Subject|2|||
128893457|NCT00590044|463906353|FG000|Overall Study|wrong insulin arm assigned|1|||
128893458|NCT00590044|463906354|FG001|Overall Study|wrong insulin arm assigned|0|||
128893459|NCT00590044|463906353|FG000|Overall Study|Protocol Violation|1|||
128893460|NCT00590044|463906354|FG001|Overall Study|Protocol Violation|0|||
128893461|NCT00773136|463906357|FG000|Overall Study|Physician Decision|2|||
128893462|NCT01010633|463906358|FG000|Overall Study|Adverse Event|1|||
128893463|NCT01010633|463906359|FG001|Overall Study|Adverse Event|1|||
128893464|NCT01010633|463906358|FG000|Overall Study|Protocol Violation|1|||
128690638|NCT03001882|463166853|FG000|Overall Study|Not reported|0|||
128690639|NCT03001882|463166854|FG001|Overall Study|Not reported|0|||
128893465|NCT01010633|463906359|FG001|Overall Study|Protocol Violation|2|||
128893466|NCT01010633|463906358|FG000|Overall Study|Withdrawal by Subject|2|||
128893467|NCT01010633|463906359|FG001|Overall Study|Withdrawal by Subject|1|||
129021077|NCT00640562|464368627|FG001|Overall Study|Low study drug dose|1|||
129021078|NCT00640562|464368626|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
129021079|NCT00640562|464368627|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
129021080|NCT02937870|464368628|FG000|Overall Study|Adverse Event|1|||
128690640|NCT03001882|463166855|FG002|Overall Study|Not reported|0|||
128690641|NCT03001882|463166856|FG003|Overall Study|Not reported|6|||
128690642|NCT03001882|463166853|FG000|Overall Study|Maximum clinical benefit|2|||
128690643|NCT03001882|463166854|FG001|Overall Study|Maximum clinical benefit|3|||
128893468|NCT01010633|463906358|FG000|Overall Study|Investigator decision|0|||
128690644|NCT03001882|463166855|FG002|Overall Study|Maximum clinical benefit|0|||
128893469|NCT01010633|463906359|FG001|Overall Study|Investigator decision|1|||
128893470|NCT00888381|463906364|FG000|Overall Study|Lost to Follow-up|0|||
128893471|NCT00888381|463906365|FG001|Overall Study|Lost to Follow-up|1|||
128893472|NCT00097773|463906366|FG000|Overall Study|Lost to Follow-up|2|||
128893473|NCT00097773|463906367|FG001|Overall Study|Lost to Follow-up|2|||
128893474|NCT00097773|463906368|FG002|Overall Study|Lost to Follow-up|0|||
128893475|NCT00097773|463906369|FG003|Overall Study|Lost to Follow-up|1|||
128893476|NCT00097773|463906366|FG000|Overall Study|Physician Decision|2|||
128893477|NCT00097773|463906367|FG001|Overall Study|Physician Decision|2|||
128893478|NCT00097773|463906368|FG002|Overall Study|Physician Decision|3|||
128893479|NCT00097773|463906369|FG003|Overall Study|Physician Decision|1|||
128893480|NCT00097773|463906366|FG000|Overall Study|Withdrawal by Subject|3|||
128893481|NCT00097773|463906367|FG001|Overall Study|Withdrawal by Subject|3|||
128893482|NCT00097773|463906368|FG002|Overall Study|Withdrawal by Subject|3|||
128893483|NCT00097773|463906369|FG003|Overall Study|Withdrawal by Subject|1|||
128893484|NCT00097773|463906366|FG000|Overall Study|Adverse Event|0|||
128893485|NCT00097773|463906367|FG001|Overall Study|Adverse Event|1|||
128893486|NCT00097773|463906368|FG002|Overall Study|Adverse Event|0|||
128893487|NCT00097773|463906369|FG003|Overall Study|Adverse Event|0|||
128893488|NCT00097773|463906366|FG000|Overall Study|Other|1|||
128893489|NCT00097773|463906367|FG001|Overall Study|Other|0|||
128893490|NCT00097773|463906368|FG002|Overall Study|Other|2|||
128893491|NCT00097773|463906369|FG003|Overall Study|Other|0|||
128893492|NCT00003702|463906370|FG000|Overall Study|Ineligible cell types|2|||
128893493|NCT00003702|463906371|FG001|Overall Study|Ineligible cell types|2|||
128893494|NCT00003702|463906370|FG000|Overall Study|Did not meet criteria for persistence|8|||
128893495|NCT00003702|463906371|FG001|Overall Study|Did not meet criteria for persistence|5|||
128893496|NCT00003702|463906370|FG000|Overall Study|WHO score > 6|2|||
128893497|NCT00003702|463906371|FG001|Overall Study|WHO score > 6|1|||
128893498|NCT00003702|463906370|FG000|Overall Study|Inadequate documentation of disease|1|||
128893499|NCT00003702|463906371|FG001|Overall Study|Inadequate documentation of disease|3|||
128893500|NCT01009034|463906372|FG000|Overall Study|Lost to Follow-up|2|||
128893501|NCT01009034|463906372|FG000|Overall Study|Withdrawal by Subject|2|||
128893502|NCT01494350|463906373|FG000|Overall Study|Worsening of lesion|1|||
128893503|NCT02054325|463906375|FG000|Overall Study|Lost to Follow-up|8|||
128893504|NCT02054325|463906376|FG001|Overall Study|Lost to Follow-up|5|||
128893505|NCT00617604|463906377|FG000|Overall Study|Death|2|||
128893506|NCT00617604|463906378|FG001|Overall Study|Death|1|||
128893507|NCT00617604|463906377|FG000|Overall Study|Lost to Follow-up|1|||
128893508|NCT00617604|463906378|FG001|Overall Study|Lost to Follow-up|0|||
128893509|NCT00617604|463906377|FG000|Overall Study|Miscellaneous Reasons|8|||
128893510|NCT00617604|463906378|FG001|Overall Study|Miscellaneous Reasons|10|||
128893511|NCT00617604|463906377|FG000|Overall Study|Withdrawal by Subject|4|||
128893512|NCT00617604|463906378|FG001|Overall Study|Withdrawal by Subject|6|||
128893513|NCT00617604|463906377|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
128893514|NCT00617604|463906378|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
128893515|NCT03250832|463906379|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
128893516|NCT03250832|463906380|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
128893517|NCT03250832|463906381|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
128893518|NCT03250832|463906382|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
129110818|NCT00735709|464701344|FG000|Overall Study|Lack of Efficacy|8|||
129110819|NCT00735709|464701345|FG001|Overall Study|Lack of Efficacy|4|||
129110820|NCT00735709|464701346|FG002|Overall Study|Lack of Efficacy|2|||
129110821|NCT00735709|464701347|FG003|Overall Study|Lack of Efficacy|3|||
128893519|NCT03250832|463906383|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
129110822|NCT00735709|464701344|FG000|Overall Study|Noncompliance|0|||
129110823|NCT00735709|464701345|FG001|Overall Study|Noncompliance|0|||
129110824|NCT00735709|464701346|FG002|Overall Study|Noncompliance|1|||
129110825|NCT00735709|464701347|FG003|Overall Study|Noncompliance|0|||
129110826|NCT00735709|464701344|FG000|Overall Study|Protocol deviations|1|||
129110827|NCT00735709|464701345|FG001|Overall Study|Protocol deviations|2|||
129110828|NCT00735709|464701346|FG002|Overall Study|Protocol deviations|1|||
129110829|NCT00735709|464701347|FG003|Overall Study|Protocol deviations|1|||
129110830|NCT00735709|464701344|FG000|Overall Study|Voluntary Withdrawal|1|||
129110831|NCT00735709|464701345|FG001|Overall Study|Voluntary Withdrawal|3|||
128893520|NCT03250832|463906384|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
129110832|NCT00735709|464701346|FG002|Overall Study|Voluntary Withdrawal|5|||
129110833|NCT00735709|464701347|FG003|Overall Study|Voluntary Withdrawal|7|||
129110834|NCT00735709|464701344|FG000|Overall Study|Lost to Follow-up|0|||
128893521|NCT03250832|463906385|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
128893522|NCT03250832|463906386|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
128893523|NCT03250832|463906387|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
128893524|NCT03250832|463906388|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
128893525|NCT03250832|463906389|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
128893526|NCT03250832|463906390|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
129110835|NCT00735709|464701345|FG001|Overall Study|Lost to Follow-up|1|||
128893527|NCT03250832|463906379|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
128893528|NCT03250832|463906380|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
129110836|NCT00735709|464701346|FG002|Overall Study|Lost to Follow-up|1|||
128893529|NCT03250832|463906381|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
128893530|NCT03250832|463906382|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
128893531|NCT03250832|463906383|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
128893532|NCT03250832|463906384|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
128893533|NCT03250832|463906385|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
128893534|NCT03250832|463906386|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
128893535|NCT03250832|463906387|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
128893536|NCT03250832|463906388|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
128893537|NCT03250832|463906389|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
128893538|NCT03250832|463906390|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
128893539|NCT03250832|463906379|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893540|NCT03250832|463906380|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893541|NCT03250832|463906381|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
128893542|NCT03250832|463906382|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893543|NCT03250832|463906383|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893544|NCT03250832|463906384|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893545|NCT03250832|463906385|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893546|NCT03250832|463906386|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893547|NCT03250832|463906387|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893548|NCT03250832|463906388|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893549|NCT03250832|463906389|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893550|NCT03250832|463906390|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
128893551|NCT03250832|463906379|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893552|NCT03250832|463906380|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893553|NCT03250832|463906381|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893554|NCT03250832|463906382|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893555|NCT03250832|463906383|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893556|NCT03250832|463906384|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893557|NCT03250832|463906385|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893558|NCT03250832|463906386|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
128893559|NCT03250832|463906387|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893560|NCT03250832|463906388|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893561|NCT03250832|463906389|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893562|NCT03250832|463906390|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
128893563|NCT03250832|463906379|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893564|NCT03250832|463906380|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893565|NCT03250832|463906381|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893566|NCT03250832|463906382|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893567|NCT03250832|463906383|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893568|NCT03250832|463906384|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893569|NCT03250832|463906385|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893570|NCT03250832|463906386|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
128893571|NCT03250832|463906387|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893572|NCT03250832|463906388|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893573|NCT03250832|463906389|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893574|NCT03250832|463906390|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
128893575|NCT03250832|463906379|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893576|NCT03250832|463906380|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893577|NCT03250832|463906381|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893578|NCT03250832|463906382|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893579|NCT03250832|463906383|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893580|NCT03250832|463906384|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893581|NCT03250832|463906385|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893582|NCT03250832|463906386|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
128893583|NCT03250832|463906387|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
128893584|NCT03250832|463906388|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129110837|NCT00735709|464701347|FG003|Overall Study|Lost to Follow-up|1|||
129110838|NCT00735709|464701344|FG000|Overall Study|Excluded medication|1|||
129110839|NCT00735709|464701345|FG001|Overall Study|Excluded medication|0|||
129110840|NCT00735709|464701346|FG002|Overall Study|Excluded medication|0|||
129110841|NCT00735709|464701347|FG003|Overall Study|Excluded medication|1|||
129110842|NCT01165307|464701349|FG000|Overall Study|Lost to Follow-up|11|||
128893585|NCT03250832|463906389|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129110843|NCT01165307|464701350|FG001|Overall Study|Lost to Follow-up|3|||
129110844|NCT01165307|464701349|FG000|Overall Study|Withdrawal by Subject|2|||
129110845|NCT01165307|464701350|FG001|Overall Study|Withdrawal by Subject|0|||
129110846|NCT01165307|464701349|FG000|Overall Study|Subject not available for contact|1|||
129110847|NCT01165307|464701350|FG001|Overall Study|Subject not available for contact|0|||
129110848|NCT02326272|464701353|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110849|NCT02326272|464701354|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
129110850|NCT02326272|464701355|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
129110851|NCT02326272|464701356|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110852|NCT02326272|464701357|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110853|NCT02326272|464701358|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110854|NCT02326272|464701359|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110855|NCT02326272|464701360|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110856|NCT02326272|464701361|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110857|NCT02326272|464701362|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110858|NCT02326272|464701363|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110859|NCT02326272|464701364|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110860|NCT02326272|464701365|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110861|NCT02326272|464701366|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
128893586|NCT03250832|463906390|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129110862|NCT02326272|464701367|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129110863|NCT02326272|464701353|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
129110864|NCT02326272|464701354|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
129110865|NCT02326272|464701355|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110866|NCT02326272|464701356|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110867|NCT02326272|464701357|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110868|NCT02326272|464701358|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110869|NCT02326272|464701359|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110870|NCT02326272|464701360|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110871|NCT02326272|464701361|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110872|NCT02326272|464701362|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110873|NCT02326272|464701363|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110874|NCT02326272|464701364|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110875|NCT02326272|464701365|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110876|NCT02326272|464701366|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110877|NCT02326272|464701367|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129110878|NCT02326272|464701353|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
129110879|NCT02326272|464701354|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
129110880|NCT02326272|464701355|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
129110881|NCT02326272|464701356|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129110882|NCT02326272|464701357|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129110883|NCT02326272|464701358|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129110884|NCT02326272|464701359|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128690645|NCT03001882|463166856|FG003|Overall Study|Maximum clinical benefit|10|||
128893587|NCT03250832|463906379|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893588|NCT03250832|463906380|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893589|NCT03250832|463906381|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893590|NCT03250832|463906382|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893591|NCT03250832|463906383|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893592|NCT03250832|463906384|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893593|NCT03250832|463906385|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893594|NCT03250832|463906386|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
128893595|NCT03250832|463906387|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893596|NCT03250832|463906388|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893597|NCT03250832|463906389|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893598|NCT03250832|463906390|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
128893599|NCT03250832|463906379|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893600|NCT03250832|463906380|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893601|NCT03250832|463906381|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893602|NCT03250832|463906382|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893603|NCT03250832|463906383|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893604|NCT03250832|463906384|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893605|NCT03250832|463906385|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893606|NCT03250832|463906386|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
128893607|NCT03250832|463906387|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893608|NCT03250832|463906388|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893609|NCT03250832|463906389|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893610|NCT03250832|463906390|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
128893611|NCT03250832|463906379|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
129110885|NCT02326272|464701360|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128893612|NCT03250832|463906380|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893613|NCT03250832|463906381|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893614|NCT03250832|463906382|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893615|NCT03250832|463906383|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893616|NCT03250832|463906384|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893617|NCT03250832|463906385|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893618|NCT03250832|463906386|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893619|NCT03250832|463906387|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
128893620|NCT03250832|463906388|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
128893621|NCT03250832|463906389|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893622|NCT03250832|463906390|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
128893623|NCT03250832|463906379|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893624|NCT03250832|463906380|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893625|NCT03250832|463906381|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893626|NCT03250832|463906382|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893627|NCT03250832|463906383|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893628|NCT03250832|463906384|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893629|NCT03250832|463906385|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893630|NCT03250832|463906386|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893631|NCT03250832|463906387|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
128893632|NCT03250832|463906388|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
128893633|NCT03250832|463906389|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893634|NCT03250832|463906390|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
128893635|NCT03250832|463906379|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893636|NCT03250832|463906380|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893637|NCT03250832|463906381|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893638|NCT03250832|463906382|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893639|NCT03250832|463906383|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893640|NCT03250832|463906384|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893641|NCT03250832|463906385|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893642|NCT03250832|463906386|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893643|NCT03250832|463906387|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
128893644|NCT03250832|463906388|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
128893645|NCT03250832|463906389|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893646|NCT03250832|463906390|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
128893647|NCT03250832|463906379|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129021081|NCT02937870|464368628|FG000|Overall Study|Protocol Deviation|2|||
129021082|NCT00609674|464368632|FG000|Overall Study|Adverse Event|1|||
129021083|NCT00609674|464368633|FG001|Overall Study|Adverse Event|1|||
128764314|NCT02277743|463428286|FG000|Overall Study|Adverse Event|10|||
128893648|NCT03250832|463906380|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893649|NCT03250832|463906381|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893650|NCT03250832|463906382|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893651|NCT03250832|463906383|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129021084|NCT00609674|464368632|FG000|Overall Study|Protocol Violation|3|||
129021085|NCT00609674|464368633|FG001|Overall Study|Protocol Violation|5|||
129021086|NCT00609674|464368632|FG000|Overall Study|Lost to Follow-up|1|||
129021087|NCT00609674|464368633|FG001|Overall Study|Lost to Follow-up|0|||
129021088|NCT00609674|464368632|FG000|Overall Study|Withdrew consent|2|||
129021089|NCT00609674|464368633|FG001|Overall Study|Withdrew consent|1|||
129021090|NCT03098394|464368634|FG000|Overall Study|Pregnancy|0|||
129021091|NCT03098394|464368635|FG001|Overall Study|Pregnancy|1|||
129021092|NCT00571064|464368637|FG000|Overall Study|Adverse Event|13|||
129021093|NCT00571064|464368637|FG000|Overall Study|Protocol Violation|4|||
129021094|NCT00571064|464368637|FG000|Overall Study|Withdrawal by Subject|2|||
129021095|NCT00571064|464368637|FG000|Overall Study|Other|2|||
129021096|NCT04604275|464368638|FG000|Washout-1 Week|Withdrawal by Subject|1|||
129021097|NCT04604275|464368639|FG001|Washout-1 Week|Withdrawal by Subject|0|||
129021098|NCT05615935|464368640|FG000|Overall Study|Lost to Follow-up|1|||
129021099|NCT05615935|464368641|FG001|Overall Study|Lost to Follow-up|1|||
129021100|NCT05446870|464368642|FG000|Overall Study|Death|6|||
129021101|NCT05446870|464368643|FG001|Overall Study|Death|5|||
129021102|NCT05446870|464368642|FG000|Overall Study|Lost to Follow-up|0|||
129021103|NCT05446870|464368643|FG001|Overall Study|Lost to Follow-up|1|||
129021104|NCT05446870|464368642|FG000|Overall Study|Physician Decision|52|||
129021105|NCT05446870|464368643|FG001|Overall Study|Physician Decision|53|||
129021106|NCT05446870|464368642|FG000|Overall Study|Withdrawal by Subject|3|||
129021107|NCT05446870|464368643|FG001|Overall Study|Withdrawal by Subject|3|||
129021108|NCT02689505|464368645|FG000|Overall Study|Progressive disease|2|||
129215202|NCT01588522|465089465|FG001|Overall Study|Withdrawal by Subject|5|||
129215203|NCT01588522|465089466|FG002|Overall Study|Withdrawal by Subject|3|||
128690646|NCT03001882|463166853|FG000|Overall Study|AE unrelated to study drug|3|||
128690647|NCT03001882|463166854|FG001|Overall Study|AE unrelated to study drug|3|||
128690648|NCT03001882|463166855|FG002|Overall Study|AE unrelated to study drug|0|||
128690649|NCT03001882|463166856|FG003|Overall Study|AE unrelated to study drug|11|||
128690650|NCT03001882|463166853|FG000|Overall Study|Study Drug Toxicity|8|||
128690651|NCT03001882|463166854|FG001|Overall Study|Study Drug Toxicity|5|||
128690652|NCT03001882|463166855|FG002|Overall Study|Study Drug Toxicity|0|||
128690653|NCT03001882|463166856|FG003|Overall Study|Study Drug Toxicity|37|||
128690654|NCT03001882|463166853|FG000|Overall Study|Disease progression|16|||
128690655|NCT03001882|463166854|FG001|Overall Study|Disease progression|14|||
128690656|NCT03001882|463166855|FG002|Overall Study|Disease progression|1|||
128690657|NCT03001882|463166856|FG003|Overall Study|Disease progression|90|||
128690658|NCT01067976|463166857|FG000|Overall Study|Study drug never administered|20|||
128690659|NCT01067976|463166857|FG000|Overall Study|Study prematurely discontinued|2|||
128690660|NCT00589290|463166858|FG000|Overall Study|Withdrawal by Subject|1|||
128690661|NCT00566111|463166859|FG000|Overall Study|Adverse Event|0|||
128690662|NCT00566111|463166860|FG001|Overall Study|Adverse Event|2|||
128690663|NCT01554397|463166863|FG000|Overall Study|Withdrawal by Subject|1|||
128690664|NCT01554397|463166864|FG001|Overall Study|Withdrawal by Subject|0|||
128690665|NCT01554397|463166863|FG000|Overall Study|Ineligible|7|||
128690666|NCT01554397|463166864|FG001|Overall Study|Ineligible|0|||
128690667|NCT00734474|463169286|FG000|Overall Study|Entry Criteria Not Met|0|||
128690668|NCT00734474|463169287|FG001|Overall Study|Entry Criteria Not Met|0|||
128690669|NCT00734474|463169288|FG002|Overall Study|Entry Criteria Not Met|5|||
128690670|NCT00734474|463169289|FG003|Overall Study|Entry Criteria Not Met|0|||
128690671|NCT00734474|463169290|FG004|Overall Study|Entry Criteria Not Met|3|||
128690672|NCT00734474|463169291|FG005|Overall Study|Entry Criteria Not Met|1|||
128690673|NCT00734474|463169292|FG006|Overall Study|Entry Criteria Not Met|0|||
128690674|NCT00734474|463169293|FG007|Overall Study|Entry Criteria Not Met|1|||
128690675|NCT00734474|463169294|FG008|Overall Study|Entry Criteria Not Met|1|||
128690676|NCT00734474|463169286|FG000|Overall Study|Lost to Follow-up|1|||
128690677|NCT00734474|463169287|FG001|Overall Study|Lost to Follow-up|0|||
128690678|NCT00734474|463169288|FG002|Overall Study|Lost to Follow-up|13|||
128690679|NCT00734474|463169289|FG003|Overall Study|Lost to Follow-up|0|||
128690680|NCT00734474|463169290|FG004|Overall Study|Lost to Follow-up|11|||
128690681|NCT00734474|463169291|FG005|Overall Study|Lost to Follow-up|1|||
128690682|NCT00734474|463169292|FG006|Overall Study|Lost to Follow-up|0|||
128690683|NCT00734474|463169293|FG007|Overall Study|Lost to Follow-up|9|||
128690684|NCT00734474|463169294|FG008|Overall Study|Lost to Follow-up|4|||
128690685|NCT00734474|463169286|FG000|Overall Study|Withdrawal by Subject|2|||
128690686|NCT00734474|463169287|FG001|Overall Study|Withdrawal by Subject|1|||
128690687|NCT00734474|463169288|FG002|Overall Study|Withdrawal by Subject|18|||
128690688|NCT00734474|463169289|FG003|Overall Study|Withdrawal by Subject|0|||
128690689|NCT00734474|463169290|FG004|Overall Study|Withdrawal by Subject|24|||
128690690|NCT00734474|463169291|FG005|Overall Study|Withdrawal by Subject|2|||
128690691|NCT00734474|463169292|FG006|Overall Study|Withdrawal by Subject|0|||
128690692|NCT00734474|463169293|FG007|Overall Study|Withdrawal by Subject|36|||
128690693|NCT00734474|463169294|FG008|Overall Study|Withdrawal by Subject|21|||
128690694|NCT00734474|463169286|FG000|Overall Study|Physician Decision|0|||
128690695|NCT00734474|463169287|FG001|Overall Study|Physician Decision|0|||
128690696|NCT00734474|463169288|FG002|Overall Study|Physician Decision|4|||
128690697|NCT00734474|463169289|FG003|Overall Study|Physician Decision|1|||
128690698|NCT00734474|463169290|FG004|Overall Study|Physician Decision|11|||
128690699|NCT00734474|463169291|FG005|Overall Study|Physician Decision|0|||
128690700|NCT00734474|463169292|FG006|Overall Study|Physician Decision|0|||
128690701|NCT00734474|463169293|FG007|Overall Study|Physician Decision|9|||
128690702|NCT00734474|463169294|FG008|Overall Study|Physician Decision|9|||
128690703|NCT00734474|463169286|FG000|Overall Study|Adverse Event|4|||
128690704|NCT00734474|463169287|FG001|Overall Study|Adverse Event|4|||
128690705|NCT00734474|463169288|FG002|Overall Study|Adverse Event|63|||
128690706|NCT00734474|463169289|FG003|Overall Study|Adverse Event|1|||
128690707|NCT00734474|463169290|FG004|Overall Study|Adverse Event|64|||
128690708|NCT00734474|463169291|FG005|Overall Study|Adverse Event|0|||
129021109|NCT02689505|464368646|FG001|Overall Study|Progressive disease|2|||
129021110|NCT02689505|464368647|FG002|Overall Study|Progressive disease|3|||
129021111|NCT02689505|464368648|FG003|Overall Study|Progressive disease|9|||
129021112|NCT02689505|464368649|FG004|Overall Study|Progressive disease|1|||
129021113|NCT02689505|464368645|FG000|Overall Study|Dose Limiting Toxicity|0|||
128690709|NCT00734474|463169292|FG006|Overall Study|Adverse Event|1|||
128690710|NCT00734474|463169293|FG007|Overall Study|Adverse Event|65|||
128690711|NCT00734474|463169294|FG008|Overall Study|Adverse Event|39|||
128690712|NCT00734474|463169286|FG000|Overall Study|Protocol Violation|0|||
129021114|NCT02689505|464368646|FG001|Overall Study|Dose Limiting Toxicity|1|||
128690713|NCT00734474|463169287|FG001|Overall Study|Protocol Violation|0|||
128690714|NCT00734474|463169288|FG002|Overall Study|Protocol Violation|4|||
128690715|NCT00734474|463169289|FG003|Overall Study|Protocol Violation|0|||
129021115|NCT02689505|464368647|FG002|Overall Study|Dose Limiting Toxicity|0|||
128690716|NCT00734474|463169290|FG004|Overall Study|Protocol Violation|3|||
128690717|NCT00734474|463169291|FG005|Overall Study|Protocol Violation|0|||
128893652|NCT03250832|463906384|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893653|NCT03250832|463906385|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893654|NCT03250832|463906386|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893655|NCT03250832|463906387|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893656|NCT03250832|463906388|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893657|NCT03250832|463906389|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
128893658|NCT03250832|463906390|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
128893659|NCT02303704|463906391|FG000|Overall Study|Protocol Violation|5|||
128893660|NCT02303704|463906392|FG001|Overall Study|Protocol Violation|9|||
128893661|NCT01984164|463906394|FG000|Overall Study|Withdrawal by Subject|4|||
128893662|NCT01984164|463906395|FG001|Overall Study|Withdrawal by Subject|3|||
128893663|NCT01984164|463906394|FG000|Overall Study|Adverse Event|5|||
128893664|NCT01984164|463906395|FG001|Overall Study|Adverse Event|19|||
128893665|NCT01984164|463906394|FG000|Overall Study|Lost to Follow-up|1|||
128893666|NCT01984164|463906395|FG001|Overall Study|Lost to Follow-up|3|||
128893667|NCT05293743|463906396|FG000|Overall Study|Withdrawal by Subject|1|||
128893668|NCT05293743|463906397|FG001|Overall Study|Withdrawal by Subject|0|||
128893669|NCT00667823|463906398|FG000|Overall Study|Lost to Follow-up|5|||
128893670|NCT00667823|463906398|FG000|Overall Study|Adverse Event|7|||
128893671|NCT00667823|463906398|FG000|Overall Study|Death|182|||
128893672|NCT00667823|463906398|FG000|Overall Study|Withdrawal by Subject|12|||
128893673|NCT00667823|463906398|FG000|Overall Study|Other|8|||
128893674|NCT00667823|463906398|FG000|Overall Study|Missing (completion page missing)|2|||
128893675|NCT00583024|463906399|FG000|Overall Study|Lost to Follow-up|4|||
128893676|NCT04376827|463906405|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
128893677|NCT04376827|463906406|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
128893678|NCT04376827|463906405|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
128893679|NCT04376827|463906406|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
128893680|NCT04376827|463906405|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
128893681|NCT04376827|463906406|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
128893682|NCT04376827|463906405|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
128893683|NCT04376827|463906406|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
128893684|NCT04376827|463906405|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
128893685|NCT04376827|463906406|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
128893686|NCT02229539|463908461|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
128893687|NCT02229539|463908462|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
128893688|NCT02229539|463908463|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
128893689|NCT02229539|463908461|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
128893690|NCT02229539|463908462|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
128893691|NCT02229539|463908463|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
128893692|NCT02229539|463908461|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
128893693|NCT02229539|463908462|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
128893694|NCT02229539|463908463|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
128893695|NCT02229539|463908461|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
128893696|NCT02229539|463908462|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
128893697|NCT02229539|463908463|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
128893698|NCT02229539|463908461|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
128893699|NCT02229539|463908462|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
128893700|NCT02229539|463908463|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
128893701|NCT02229539|463908461|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
128893702|NCT02229539|463908462|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
128893703|NCT02229539|463908463|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
128893704|NCT00682448|463908464|FG000|Overall Study|Adverse Event|1|||
128893705|NCT00682448|463908465|FG001|Overall Study|Adverse Event|2|||
128893706|NCT00682448|463908464|FG000|Overall Study|Lack of Efficacy|1|||
128893707|NCT00682448|463908465|FG001|Overall Study|Lack of Efficacy|0|||
128893708|NCT00682448|463908464|FG000|Overall Study|Lost to Follow-up|1|||
128893709|NCT00682448|463908465|FG001|Overall Study|Lost to Follow-up|3|||
128893710|NCT00682448|463908464|FG000|Overall Study|Pregnancy|0|||
128893711|NCT00682448|463908465|FG001|Overall Study|Pregnancy|1|||
128893712|NCT00682448|463908464|FG000|Overall Study|Withdrawal by Subject|2|||
128893713|NCT00682448|463908465|FG001|Overall Study|Withdrawal by Subject|0|||
128893714|NCT00257166|463908469|FG000|Overall Study|Adverse Event|18|||
128893715|NCT00257166|463908470|FG001|Overall Study|Adverse Event|13|||
129021116|NCT02689505|464368648|FG003|Overall Study|Dose Limiting Toxicity|0|||
129021117|NCT02689505|464368649|FG004|Overall Study|Dose Limiting Toxicity|2|||
128893716|NCT00257166|463908469|FG000|Overall Study|Laboratory abnormality|1|||
128893717|NCT00257166|463908470|FG001|Overall Study|Laboratory abnormality|0|||
129021118|NCT02689505|464368645|FG000|Overall Study|Other AE or clinical progression|0|||
129021119|NCT02689505|464368646|FG001|Overall Study|Other AE or clinical progression|2|||
128893718|NCT00257166|463908469|FG000|Overall Study|Lost to Follow-up|8|||
128893719|NCT00257166|463908470|FG001|Overall Study|Lost to Follow-up|1|||
128893720|NCT00257166|463908469|FG000|Overall Study|Withdrawal by Subject|9|||
129110886|NCT02326272|464701361|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128690718|NCT00734474|463169292|FG006|Overall Study|Protocol Violation|0|||
128690719|NCT00734474|463169293|FG007|Overall Study|Protocol Violation|3|||
128690720|NCT00734474|463169294|FG008|Overall Study|Protocol Violation|1|||
128690721|NCT00734474|463169286|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
128690722|NCT00734474|463169287|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
128690723|NCT00734474|463169288|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
128690724|NCT00734474|463169289|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
128690725|NCT00734474|463169290|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
128690726|NCT00734474|463169291|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
128690727|NCT00734474|463169292|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
128690728|NCT00734474|463169293|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
128690729|NCT00734474|463169294|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
128690730|NCT00734474|463169286|FG000|Overall Study|Sponsor Decision|0|||
128690731|NCT00734474|463169287|FG001|Overall Study|Sponsor Decision|0|||
128690732|NCT00734474|463169288|FG002|Overall Study|Sponsor Decision|0|||
128690733|NCT00734474|463169289|FG003|Overall Study|Sponsor Decision|0|||
128690734|NCT00734474|463169290|FG004|Overall Study|Sponsor Decision|2|||
128690735|NCT00734474|463169291|FG005|Overall Study|Sponsor Decision|0|||
128690736|NCT00734474|463169292|FG006|Overall Study|Sponsor Decision|0|||
128690737|NCT00734474|463169293|FG007|Overall Study|Sponsor Decision|0|||
128690738|NCT00734474|463169294|FG008|Overall Study|Sponsor Decision|0|||
128690739|NCT00734474|463169286|FG000|Overall Study|Death|0|||
128690740|NCT00734474|463169287|FG001|Overall Study|Death|0|||
128690741|NCT00734474|463169288|FG002|Overall Study|Death|1|||
128690742|NCT00734474|463169289|FG003|Overall Study|Death|0|||
128690743|NCT00734474|463169290|FG004|Overall Study|Death|0|||
128690744|NCT00734474|463169291|FG005|Overall Study|Death|0|||
128690745|NCT00734474|463169292|FG006|Overall Study|Death|0|||
128690746|NCT00734474|463169293|FG007|Overall Study|Death|2|||
128690747|NCT00734474|463169294|FG008|Overall Study|Death|1|||
128690748|NCT00734474|463169286|FG000|Overall Study|Lack of Efficacy|0|||
128690749|NCT00734474|463169287|FG001|Overall Study|Lack of Efficacy|0|||
128690750|NCT00734474|463169288|FG002|Overall Study|Lack of Efficacy|4|||
128690751|NCT00734474|463169289|FG003|Overall Study|Lack of Efficacy|0|||
128690752|NCT00734474|463169290|FG004|Overall Study|Lack of Efficacy|0|||
128690753|NCT00734474|463169291|FG005|Overall Study|Lack of Efficacy|0|||
128690754|NCT00734474|463169292|FG006|Overall Study|Lack of Efficacy|0|||
128690755|NCT00734474|463169293|FG007|Overall Study|Lack of Efficacy|4|||
128690756|NCT00734474|463169294|FG008|Overall Study|Lack of Efficacy|6|||
128690757|NCT02570074|463169303|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
128690758|NCT02570074|463169304|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
128690759|NCT02497612|463169305|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
128690760|NCT02497612|463169306|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
128690761|NCT02497612|463169307|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
128690762|NCT02497612|463169308|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
128690763|NCT02497612|463169305|FG000|Overall Study|Participant's request|2|||
128690764|NCT02497612|463169306|FG001|Overall Study|Participant's request|3|||
128690765|NCT02497612|463169307|FG002|Overall Study|Participant's request|4|||
128690766|NCT02497612|463169308|FG003|Overall Study|Participant's request|1|||
128690767|NCT02497612|463169305|FG000|Overall Study|Investigator's judgement|1|||
128690768|NCT02497612|463169306|FG001|Overall Study|Investigator's judgement|0|||
128690769|NCT02497612|463169307|FG002|Overall Study|Investigator's judgement|0|||
128690770|NCT02497612|463169308|FG003|Overall Study|Investigator's judgement|2|||
128690771|NCT02497612|463169305|FG000|Overall Study|Adverse Event|3|||
128690772|NCT02497612|463169306|FG001|Overall Study|Adverse Event|1|||
128690773|NCT02497612|463169307|FG002|Overall Study|Adverse Event|4|||
128893721|NCT00257166|463908470|FG001|Overall Study|Withdrawal by Subject|2|||
128893722|NCT00257166|463908469|FG000|Overall Study|Other|16|||
129110887|NCT02326272|464701362|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128690774|NCT02497612|463169308|FG003|Overall Study|Adverse Event|1|||
128690775|NCT02497612|463169305|FG000|Overall Study|Lost to Follow-up|1|||
129110888|NCT02326272|464701363|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128690776|NCT02497612|463169306|FG001|Overall Study|Lost to Follow-up|1|||
128764315|NCT02277743|463428287|FG001|Overall Study|Adverse Event|6|||
128690777|NCT02497612|463169307|FG002|Overall Study|Lost to Follow-up|0|||
128690778|NCT02497612|463169308|FG003|Overall Study|Lost to Follow-up|1|||
128690779|NCT02497612|463169305|FG000|Overall Study|Other unspecified|1|||
128690780|NCT02497612|463169306|FG001|Overall Study|Other unspecified|1|||
128690781|NCT02497612|463169307|FG002|Overall Study|Other unspecified|2|||
128893723|NCT00257166|463908470|FG001|Overall Study|Other|21|||
128690782|NCT02497612|463169308|FG003|Overall Study|Other unspecified|0|||
128690783|NCT02497612|463169305|FG000|Overall Study|Not eligible|1|||
128690784|NCT02497612|463169306|FG001|Overall Study|Not eligible|0|||
128893724|NCT00257166|463908469|FG000|Overall Study|Randomized, but not treated|1|||
128893725|NCT00257166|463908470|FG001|Overall Study|Randomized, but not treated|0|||
128893726|NCT02737852|463908473|FG000|Overall Study|Withdrawal by Subject|2|||
128893727|NCT04050670|463908476|FG000|Period 3|Physician Decision|0|||
128893728|NCT04050670|463908477|FG001|Period 3|Physician Decision|1|||
128893729|NCT04050670|463908478|FG002|Period 3|Physician Decision|0|||
128893730|NCT00525044|463908485|FG000|Overall Study|Lost to Follow-up|0|||
128893731|NCT00525044|463908486|FG001|Overall Study|Lost to Follow-up|1|||
128893732|NCT02553265|463908488|FG000|Enrollment|Death|0|||
128893733|NCT02553265|463908489|FG001|Enrollment|Death|0|||
128893734|NCT02553265|463908490|FG002|Enrollment|Death|1|||
128893735|NCT02553265|463908488|FG000|First Intervention (28 Days)|Adverse Event|1|||
128893736|NCT02553265|463908489|FG001|First Intervention (28 Days)|Adverse Event|0|||
128893737|NCT02553265|463908490|FG002|First Intervention (28 Days)|Adverse Event|0|||
128893738|NCT02553265|463908488|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
128893739|NCT02553265|463908489|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
128893740|NCT02553265|463908490|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
128893741|NCT02553265|463908488|FG000|Second Intervention (28 Days)|Adverse Event|1|||
128893742|NCT02553265|463908489|FG001|Second Intervention (28 Days)|Adverse Event|0|||
128893743|NCT02553265|463908490|FG002|Second Intervention (28 Days)|Adverse Event|0|||
128893744|NCT02553265|463908488|FG000|Third Intervention (28 Days)|Adverse Event|1|||
128893745|NCT02553265|463908489|FG001|Third Intervention (28 Days)|Adverse Event|0|||
128893746|NCT02553265|463908490|FG002|Third Intervention (28 Days)|Adverse Event|0|||
128893747|NCT02553265|463908488|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
128893748|NCT02553265|463908489|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
128893749|NCT02553265|463908490|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
128893750|NCT04042740|463908493|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
128893751|NCT04042740|463908493|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
128893752|NCT01168973|463908494|FG000|Overall Study|Progressive Disease|341|||
128893753|NCT01168973|463908495|FG001|Overall Study|Progressive Disease|429|||
128893754|NCT01168973|463908494|FG000|Overall Study|Adverse Event|94|||
128893755|NCT01168973|463908495|FG001|Overall Study|Adverse Event|55|||
128893756|NCT01168973|463908494|FG000|Overall Study|Withdrawal by Subject|90|||
128893757|NCT01168973|463908495|FG001|Overall Study|Withdrawal by Subject|53|||
128893758|NCT01168973|463908494|FG000|Overall Study|Death|42|||
128893759|NCT01168973|463908495|FG001|Overall Study|Death|45|||
128893760|NCT01168973|463908494|FG000|Overall Study|Physician Decision|37|||
128893761|NCT01168973|463908495|FG001|Overall Study|Physician Decision|19|||
128893762|NCT01168973|463908494|FG000|Overall Study|Sponsor Decision|2|||
128893763|NCT01168973|463908495|FG001|Overall Study|Sponsor Decision|1|||
128893764|NCT01168973|463908494|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
128893765|NCT01168973|463908495|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
128893766|NCT02230254|463908496|FG000|Overall Study|Lost to Follow-up|3|||
128893767|NCT02023242|463908497|FG000|Overall Study|Lost to Follow-up|3|||
128893768|NCT02023242|463908498|FG001|Overall Study|Lost to Follow-up|1|||
128893769|NCT02023242|463908497|FG000|Overall Study|Death|0|||
128893770|NCT02023242|463908498|FG001|Overall Study|Death|1|||
128893771|NCT00388505|463908502|FG000|Overall Study|Adverse Event or Death|43|||
128893772|NCT00388505|463908503|FG001|Overall Study|Adverse Event or Death|17|||
128893773|NCT00388505|463908502|FG000|Overall Study|Withdrawal by Subject|24|||
128893774|NCT00388505|463908503|FG001|Overall Study|Withdrawal by Subject|9|||
128893775|NCT00388505|463908502|FG000|Overall Study|Lost to Follow-up|5|||
128893776|NCT00388505|463908503|FG001|Overall Study|Lost to Follow-up|3|||
128893777|NCT00388505|463908502|FG000|Overall Study|Inappropriate Enrollment|0|||
128893778|NCT00388505|463908503|FG001|Overall Study|Inappropriate Enrollment|1|||
128893779|NCT00388505|463908502|FG000|Overall Study|Administrative Reason|1|||
128893780|NCT00388505|463908503|FG001|Overall Study|Administrative Reason|0|||
128893781|NCT00388505|463908502|FG000|Overall Study|Protocol Violation|6|||
128893782|NCT00388505|463908503|FG001|Overall Study|Protocol Violation|5|||
128893783|NCT00388505|463908502|FG000|Overall Study|Unable to classify|4|||
128893784|NCT00388505|463908503|FG001|Overall Study|Unable to classify|3|||
128893785|NCT04854434|463908508|FG000|Overall Study|Death|1|||
128893786|NCT04854434|463908509|FG001|Overall Study|Death|3|||
128893787|NCT04854434|463908510|FG002|Overall Study|Death|4|||
128893788|NCT04854434|463908508|FG000|Overall Study|Study Terminated by Sponsor|2|||
128893789|NCT04854434|463908509|FG001|Overall Study|Study Terminated by Sponsor|0|||
128893790|NCT04854434|463908510|FG002|Overall Study|Study Terminated by Sponsor|0|||
128893791|NCT04854434|463908508|FG000|Overall Study|Other|1|||
128893792|NCT04854434|463908509|FG001|Overall Study|Other|1|||
128893793|NCT04854434|463908510|FG002|Overall Study|Other|0|||
128893794|NCT02667275|463908511|FG000|Overall Study|Protocol Violation|11|||
128893795|NCT02667275|463908512|FG001|Overall Study|Protocol Violation|7|||
128893796|NCT02667275|463908511|FG000|Overall Study|Lost to Follow-up|0|||
128893797|NCT02667275|463908512|FG001|Overall Study|Lost to Follow-up|2|||
128893798|NCT02667275|463908511|FG000|Overall Study|Withdrawal by Subject|0|||
128893799|NCT02667275|463908512|FG001|Overall Study|Withdrawal by Subject|5|||
128893800|NCT02667275|463908511|FG000|Overall Study|Discontinued early without completing|0|||
128690785|NCT02497612|463169307|FG002|Overall Study|Not eligible|0|||
128893801|NCT02667275|463908512|FG001|Overall Study|Discontinued early without completing|1|||
128893802|NCT01274715|463908513|FG000|Overall Study|Lost to Follow-up|1|||
128893803|NCT01274715|463908513|FG000|Overall Study|After consent, met exclusion criteria.|1|||
128893804|NCT01274715|463908513|FG000|Overall Study|After consent, met exclusion criteria.|1|||
128893805|NCT01274715|463908513|FG000|Overall Study|After consent, met exclusion criteria.|1|||
128893806|NCT02285920|463908515|FG000|Overall Study|Kidney transplantation|2|||
128893807|NCT02285920|463908516|FG001|Overall Study|Kidney transplantation|2|||
128893808|NCT02285920|463908517|FG002|Overall Study|Kidney transplantation|2|||
128893809|NCT02285920|463908518|FG003|Overall Study|Kidney transplantation|0|||
128893810|NCT02285920|463908515|FG000|Overall Study|Change to peritoneal dialysis|0|||
128893811|NCT02285920|463908516|FG001|Overall Study|Change to peritoneal dialysis|0|||
128893812|NCT02285920|463908517|FG002|Overall Study|Change to peritoneal dialysis|1|||
128893813|NCT02285920|463908518|FG003|Overall Study|Change to peritoneal dialysis|0|||
128893814|NCT02285920|463908515|FG000|Overall Study|Transfer to non-participating unit|0|||
128893815|NCT02285920|463908516|FG001|Overall Study|Transfer to non-participating unit|1|||
128893816|NCT02285920|463908517|FG002|Overall Study|Transfer to non-participating unit|0|||
128893817|NCT02285920|463908518|FG003|Overall Study|Transfer to non-participating unit|0|||
128893818|NCT02285920|463908515|FG000|Overall Study|Dialysis discontinuation|0|||
128893819|NCT02285920|463908516|FG001|Overall Study|Dialysis discontinuation|1|||
128893820|NCT02285920|463908517|FG002|Overall Study|Dialysis discontinuation|0|||
128893821|NCT02285920|463908518|FG003|Overall Study|Dialysis discontinuation|0|||
128893822|NCT02285920|463908515|FG000|Overall Study|Death|2|||
128893823|NCT02285920|463908516|FG001|Overall Study|Death|0|||
128893824|NCT02285920|463908517|FG002|Overall Study|Death|2|||
128893825|NCT02285920|463908518|FG003|Overall Study|Death|1|||
128893826|NCT02357134|463908519|FG000|Overall Study|Lost to Follow-up|1|||
128893827|NCT02357134|463908520|FG001|Overall Study|Lost to Follow-up|0|||
128893828|NCT02357134|463908521|FG002|Overall Study|Lost to Follow-up|0|||
128893829|NCT02357134|463908522|FG003|Overall Study|Lost to Follow-up|0|||
128893830|NCT01301456|463908523|FG000|Stage 1|Withdrawal by Subject|0|||
128893831|NCT01301456|463908524|FG001|Stage 1|Withdrawal by Subject|0|||
128893832|NCT01301456|463908525|FG002|Stage 1|Withdrawal by Subject|1|||
128893833|NCT01301456|463908526|FG003|Stage 1|Withdrawal by Subject|0|||
128893834|NCT01301456|463908527|FG004|Stage 1|Withdrawal by Subject|1|||
128893835|NCT01301456|463908528|FG005|Stage 1|Withdrawal by Subject|0|||
129021120|NCT02689505|464368647|FG002|Overall Study|Other AE or clinical progression|0|||
129021121|NCT02689505|464368648|FG003|Overall Study|Other AE or clinical progression|2|||
129021122|NCT02689505|464368649|FG004|Overall Study|Other AE or clinical progression|0|||
129021123|NCT02446600|464368650|FG000|Overall Study|Never treated|20|||
128690786|NCT02497612|463169308|FG003|Overall Study|Not eligible|1|||
128690787|NCT02651467|463169309|FG000|Overall Study|Withdrawal by Subject|0|||
128690788|NCT02651467|463169310|FG001|Overall Study|Withdrawal by Subject|0|||
128690789|NCT02651467|463169311|FG002|Overall Study|Withdrawal by Subject|2|||
128690790|NCT02651467|463169309|FG000|Overall Study|Other (Not specified)|1|||
128690791|NCT02651467|463169310|FG001|Overall Study|Other (Not specified)|0|||
128690792|NCT02651467|463169311|FG002|Overall Study|Other (Not specified)|2|||
128690793|NCT00004635|463169312|FG000|Period One|refused|2|||
128690794|NCT00004635|463169313|FG001|Period One|refused|1|||
128690795|NCT00004635|463169312|FG000|Period One|Withdrawal by Subject|1|||
128690796|NCT00004635|463169313|FG001|Period One|Withdrawal by Subject|1|||
128690797|NCT00004635|463169312|FG000|Period One|Protocol Violation|1|||
128893836|NCT01301456|463908529|FG006|Stage 1|Withdrawal by Subject|0|||
128893837|NCT01301456|463908530|FG007|Stage 1|Withdrawal by Subject|0|||
128893838|NCT01301456|463908531|FG008|Stage 1|Withdrawal by Subject|0|||
129021124|NCT02446600|464368651|FG001|Overall Study|Never treated|2|||
129021125|NCT02446600|464368652|FG002|Overall Study|Never treated|6|||
129021126|NCT02446600|464368653|FG003|Overall Study|Never treated|0|||
129021127|NCT02446600|464368650|FG000|Overall Study|Withdrawal by Subject|19|||
129110889|NCT02326272|464701364|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129110890|NCT02326272|464701365|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128690798|NCT00004635|463169313|FG001|Period One|Protocol Violation|0|||
128690799|NCT00004635|463169312|FG000|Period One|PSA did not go <5 ng/mL|1|||
128893839|NCT01301456|463908532|FG009|Stage 1|Withdrawal by Subject|0|||
128764316|NCT02277743|463428288|FG002|Overall Study|Adverse Event|6|||
128893840|NCT01301456|463908533|FG010|Stage 1|Withdrawal by Subject|0|||
128893841|NCT01301456|463908534|FG011|Stage 1|Withdrawal by Subject|0|||
128893842|NCT01301456|463908523|FG000|Stage 1|Randomized but not treated|0|||
128893843|NCT01301456|463908524|FG001|Stage 1|Randomized but not treated|0|||
128893844|NCT01301456|463908525|FG002|Stage 1|Randomized but not treated|0|||
128893845|NCT01301456|463908526|FG003|Stage 1|Randomized but not treated|0|||
129021128|NCT02446600|464368651|FG001|Overall Study|Withdrawal by Subject|5|||
129021129|NCT02446600|464368652|FG002|Overall Study|Withdrawal by Subject|17|||
129021130|NCT02446600|464368653|FG003|Overall Study|Withdrawal by Subject|0|||
128690800|NCT00004635|463169313|FG001|Period One|PSA did not go <5 ng/mL|0|||
128690801|NCT00004635|463169312|FG000|Period One|second malignancy|1|||
128893846|NCT01301456|463908527|FG004|Stage 1|Randomized but not treated|0|||
128893847|NCT01301456|463908528|FG005|Stage 1|Randomized but not treated|0|||
128893848|NCT01301456|463908529|FG006|Stage 1|Randomized but not treated|1|||
128893849|NCT01301456|463908530|FG007|Stage 1|Randomized but not treated|0|||
128893850|NCT01301456|463908531|FG008|Stage 1|Randomized but not treated|0|||
128893851|NCT01301456|463908532|FG009|Stage 1|Randomized but not treated|0|||
128893852|NCT01301456|463908533|FG010|Stage 1|Randomized but not treated|0|||
128893853|NCT01301456|463908534|FG011|Stage 1|Randomized but not treated|0|||
128893854|NCT01301456|463908523|FG000|Stage 2|Adverse Event|0|||
128893855|NCT01301456|463908524|FG001|Stage 2|Adverse Event|0|||
128893856|NCT01301456|463908525|FG002|Stage 2|Adverse Event|0|||
128893857|NCT01301456|463908526|FG003|Stage 2|Adverse Event|0|||
128893858|NCT01301456|463908527|FG004|Stage 2|Adverse Event|0|||
128893859|NCT01301456|463908528|FG005|Stage 2|Adverse Event|0|||
128893860|NCT01301456|463908529|FG006|Stage 2|Adverse Event|0|||
128893861|NCT01301456|463908530|FG007|Stage 2|Adverse Event|0|||
128893862|NCT01301456|463908531|FG008|Stage 2|Adverse Event|0|||
128893863|NCT01301456|463908532|FG009|Stage 2|Adverse Event|0|||
128893864|NCT01301456|463908533|FG010|Stage 2|Adverse Event|1|||
128893865|NCT01301456|463908534|FG011|Stage 2|Adverse Event|0|||
128893866|NCT00915772|463908535|FG000|Overall Study|Adverse Event|12|||
128893867|NCT00915772|463908536|FG001|Overall Study|Adverse Event|13|||
128893868|NCT00915772|463908537|FG002|Overall Study|Adverse Event|11|||
128893869|NCT00915772|463908535|FG000|Overall Study|Protocol Violation|4|||
128893870|NCT00915772|463908536|FG001|Overall Study|Protocol Violation|1|||
128893871|NCT00915772|463908537|FG002|Overall Study|Protocol Violation|2|||
128893872|NCT00915772|463908535|FG000|Overall Study|Lost to Follow-up|1|||
128893873|NCT00915772|463908536|FG001|Overall Study|Lost to Follow-up|2|||
128893874|NCT00915772|463908537|FG002|Overall Study|Lost to Follow-up|2|||
128893875|NCT00915772|463908535|FG000|Overall Study|Lack of Efficacy|9|||
128893876|NCT00915772|463908536|FG001|Overall Study|Lack of Efficacy|15|||
128893877|NCT00915772|463908537|FG002|Overall Study|Lack of Efficacy|3|||
128690802|NCT00004635|463169313|FG001|Period One|second malignancy|0|||
128690803|NCT00004635|463169312|FG000|Period One|progressed|0|||
128690804|NCT00004635|463169313|FG001|Period One|progressed|2|||
128893878|NCT00915772|463908535|FG000|Overall Study|Refused to continue trial medication|6|||
128893879|NCT00915772|463908536|FG001|Overall Study|Refused to continue trial medication|8|||
128893880|NCT00915772|463908537|FG002|Overall Study|Refused to continue trial medication|4|||
128893881|NCT00915772|463908535|FG000|Overall Study|Any other reason|4|||
128893882|NCT00915772|463908536|FG001|Overall Study|Any other reason|7|||
128893883|NCT00915772|463908537|FG002|Overall Study|Any other reason|7|||
128893884|NCT03583450|463908538|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
129021131|NCT02446600|464368650|FG000|Overall Study|Ineligible|1|||
129021132|NCT02446600|464368651|FG001|Overall Study|Ineligible|4|||
129021133|NCT02446600|464368652|FG002|Overall Study|Ineligible|4|||
129021134|NCT02446600|464368653|FG003|Overall Study|Ineligible|1|||
129021135|NCT02446600|464368650|FG000|Overall Study|Duplicate Enrollment|0|||
129021136|NCT02446600|464368651|FG001|Overall Study|Duplicate Enrollment|1|||
129021137|NCT02446600|464368652|FG002|Overall Study|Duplicate Enrollment|0|||
129021138|NCT02446600|464368653|FG003|Overall Study|Duplicate Enrollment|0|||
129021139|NCT04108858|464368654|FG000|Overall Study|Adverse Event|1|||
129021140|NCT04887415|464368656|FG000|Overall Study|Lost to Follow-up|2|||
129021141|NCT04608188|464368657|FG000|Overall Study|Withdrawal by Subject|4|||
129021142|NCT04608188|464368658|FG001|Overall Study|Withdrawal by Subject|8|||
129021143|NCT01415986|464368661|FG000|Overall Study|Lost to Follow-up|1|||
129021144|NCT01250912|464368662|FG000|Overall Study|Lost to Follow-up|1|||
129021145|NCT03122457|464368663|FG000|Overall Study|Withdrawal by Subject|6|||
129021146|NCT03071575|464369212|FG000|Overall Study|Death|0|||
129021147|NCT03071575|464369213|FG001|Overall Study|Death|1|||
129021148|NCT03071575|464369212|FG000|Overall Study|Lost to Follow-up|5|||
129021149|NCT03071575|464369213|FG001|Overall Study|Lost to Follow-up|11|||
129021150|NCT03071575|464369212|FG000|Overall Study|Withdrawal by Subject|4|||
129021151|NCT03071575|464369213|FG001|Overall Study|Withdrawal by Subject|2|||
129021152|NCT00834795|464369214|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
129021153|NCT00834795|464369215|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
129021154|NCT00834795|464369214|FG000|Second Intervention|Adverse Event|1|||
129021155|NCT00834795|464369215|FG001|Second Intervention|Adverse Event|0|||
129021156|NCT00579345|464369216|FG000|Overall Study|Withdrawal by Subject|2|||
129021157|NCT00579345|464369217|FG001|Overall Study|Withdrawal by Subject|0|||
129021158|NCT00579345|464369218|FG002|Overall Study|Withdrawal by Subject|0|||
129021159|NCT00579345|464369219|FG003|Overall Study|Withdrawal by Subject|0|||
129021160|NCT00579345|464369220|FG004|Overall Study|Withdrawal by Subject|0|||
129021161|NCT00579345|464369221|FG005|Overall Study|Withdrawal by Subject|0|||
129021162|NCT00579345|464369222|FG006|Overall Study|Withdrawal by Subject|0|||
129021163|NCT00579345|464369223|FG007|Overall Study|Withdrawal by Subject|1|||
129021164|NCT00579345|464369216|FG000|Overall Study|Lost to Follow-up|1|||
129021165|NCT00579345|464369217|FG001|Overall Study|Lost to Follow-up|0|||
129021166|NCT00579345|464369218|FG002|Overall Study|Lost to Follow-up|0|||
129021167|NCT00579345|464369219|FG003|Overall Study|Lost to Follow-up|0|||
129021168|NCT00579345|464369220|FG004|Overall Study|Lost to Follow-up|0|||
128893885|NCT03583450|463908539|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
128893886|NCT03374995|463908540|FG000|Overall Study|Withdrawal by Subject|0|||
128893887|NCT03374995|463908541|FG001|Overall Study|Withdrawal by Subject|1|||
128893888|NCT01383096|463908542|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
128893889|NCT01383096|463908543|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
128893890|NCT01383096|463908544|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
128893891|NCT01383096|463908542|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
128893892|NCT01383096|463908543|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
128893893|NCT01383096|463908544|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
128893894|NCT01383096|463908542|FG000|Third Intervention (8 Days)|Elevated AST|0|||
128893895|NCT01383096|463908543|FG001|Third Intervention (8 Days)|Elevated AST|1|||
128893896|NCT01383096|463908544|FG002|Third Intervention (8 Days)|Elevated AST|0|||
128893897|NCT01383096|463908542|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
128893898|NCT01383096|463908543|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
128893899|NCT01383096|463908544|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
128893900|NCT01383096|463908542|FG000|Third Intervention (8 Days)|Adverse Event|1|||
128893901|NCT01383096|463908543|FG001|Third Intervention (8 Days)|Adverse Event|0|||
128893902|NCT01383096|463908544|FG002|Third Intervention (8 Days)|Adverse Event|0|||
128893903|NCT01383096|463908542|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
128893904|NCT01383096|463908543|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
128893905|NCT01383096|463908544|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
128893906|NCT01383096|463908542|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
128893907|NCT01383096|463908543|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
128893908|NCT01383096|463908544|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
128893909|NCT01383096|463908542|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
128893910|NCT01383096|463908543|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
128893911|NCT01383096|463908544|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
128893912|NCT01383096|463908542|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
128893913|NCT01383096|463908543|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
128893914|NCT01383096|463908544|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
128893915|NCT01383096|463908542|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
128893916|NCT01383096|463908543|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
128893917|NCT01383096|463908544|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
128893918|NCT01383096|463908542|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
128893919|NCT01383096|463908543|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
128893920|NCT01383096|463908544|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
128893921|NCT01211535|463908545|FG000|Overall Study|Adverse Event|0|||
128893922|NCT01211535|463908546|FG001|Overall Study|Adverse Event|1|||
128893923|NCT01380730|463908549|FG000|Overall Study|Death|0|||
128893924|NCT01380730|463908550|FG001|Overall Study|Death|0|||
128893925|NCT01380730|463908551|FG002|Overall Study|Death|0|||
128893926|NCT01380730|463908552|FG003|Overall Study|Death|0|||
128893927|NCT01380730|463908553|FG004|Overall Study|Death|1|||
128893928|NCT01380730|463908554|FG005|Overall Study|Death|0|||
128893929|NCT01380730|463908555|FG006|Overall Study|Death|0|||
128893930|NCT01380730|463908556|FG007|Overall Study|Death|0|||
128893931|NCT00467779|463908557|FG000|Stage 1|Adverse Event|1|||
128893932|NCT00467779|463908558|FG001|Stage 1|Adverse Event|0|||
128893933|NCT00467779|463908559|FG002|Stage 1|Adverse Event|0|||
128893934|NCT00467779|463908560|FG003|Stage 1|Adverse Event|0|||
128893935|NCT00467779|463908561|FG004|Stage 1|Adverse Event|0|||
128893936|NCT00467779|463908562|FG005|Stage 1|Adverse Event|1|||
128893937|NCT00467779|463908563|FG006|Stage 1|Adverse Event|2|||
128893938|NCT00467779|463908564|FG007|Stage 1|Adverse Event|1|||
128893939|NCT00467779|463908565|FG008|Stage 1|Adverse Event|0|||
128893940|NCT00467779|463908566|FG009|Stage 1|Adverse Event|0|||
128893941|NCT00467779|463908567|FG010|Stage 1|Adverse Event|0|||
128893942|NCT00467779|463908568|FG011|Stage 1|Adverse Event|0|||
128893943|NCT00467779|463908569|FG012|Stage 1|Adverse Event|0|||
128893944|NCT00467779|463908570|FG013|Stage 1|Adverse Event|0|||
129021169|NCT00579345|464369221|FG005|Overall Study|Lost to Follow-up|0|||
129021170|NCT00579345|464369222|FG006|Overall Study|Lost to Follow-up|0|||
129021171|NCT00579345|464369223|FG007|Overall Study|Lost to Follow-up|0|||
129021172|NCT00579345|464369216|FG000|Overall Study|Adverse Event|0|||
129021173|NCT00579345|464369217|FG001|Overall Study|Adverse Event|0|||
129021174|NCT00579345|464369218|FG002|Overall Study|Adverse Event|1|||
128893945|NCT00467779|463908571|FG014|Stage 1|Adverse Event|0|||
128893946|NCT00467779|463908557|FG000|Stage 1|Disease Progression|2|||
128893947|NCT00467779|463908558|FG001|Stage 1|Disease Progression|2|||
128893948|NCT00467779|463908559|FG002|Stage 1|Disease Progression|2|||
128893949|NCT00467779|463908560|FG003|Stage 1|Disease Progression|3|||
128893950|NCT00467779|463908561|FG004|Stage 1|Disease Progression|2|||
128893951|NCT00467779|463908562|FG005|Stage 1|Disease Progression|2|||
129021175|NCT00579345|464369219|FG003|Overall Study|Adverse Event|0|||
129021176|NCT00579345|464369220|FG004|Overall Study|Adverse Event|0|||
128893952|NCT00467779|463908563|FG006|Stage 1|Disease Progression|4|||
128893953|NCT00467779|463908564|FG007|Stage 1|Disease Progression|5|||
128893954|NCT00467779|463908565|FG008|Stage 1|Disease Progression|0|||
128893955|NCT00467779|463908566|FG009|Stage 1|Disease Progression|0|||
128893956|NCT00467779|463908567|FG010|Stage 1|Disease Progression|0|||
128893957|NCT00467779|463908568|FG011|Stage 1|Disease Progression|0|||
128893958|NCT00467779|463908569|FG012|Stage 1|Disease Progression|0|||
128893959|NCT00467779|463908570|FG013|Stage 1|Disease Progression|0|||
128893960|NCT00467779|463908571|FG014|Stage 1|Disease Progression|0|||
128893961|NCT00467779|463908557|FG000|Stage 1|Unspecified Reason|1|||
128893962|NCT00467779|463908558|FG001|Stage 1|Unspecified Reason|0|||
128893963|NCT00467779|463908559|FG002|Stage 1|Unspecified Reason|1|||
128893964|NCT00467779|463908560|FG003|Stage 1|Unspecified Reason|0|||
128893965|NCT00467779|463908561|FG004|Stage 1|Unspecified Reason|1|||
128893966|NCT00467779|463908562|FG005|Stage 1|Unspecified Reason|2|||
128893967|NCT00467779|463908563|FG006|Stage 1|Unspecified Reason|0|||
128893968|NCT00467779|463908564|FG007|Stage 1|Unspecified Reason|0|||
128893969|NCT00467779|463908565|FG008|Stage 1|Unspecified Reason|0|||
128893970|NCT00467779|463908566|FG009|Stage 1|Unspecified Reason|0|||
128893971|NCT00467779|463908567|FG010|Stage 1|Unspecified Reason|0|||
128893972|NCT00467779|463908568|FG011|Stage 1|Unspecified Reason|0|||
128893973|NCT00467779|463908569|FG012|Stage 1|Unspecified Reason|0|||
128893974|NCT00467779|463908570|FG013|Stage 1|Unspecified Reason|0|||
128893975|NCT00467779|463908571|FG014|Stage 1|Unspecified Reason|0|||
128893976|NCT00467779|463908557|FG000|Stage 1|Physician Decision|0|||
128893977|NCT00467779|463908558|FG001|Stage 1|Physician Decision|1|||
128893978|NCT00467779|463908559|FG002|Stage 1|Physician Decision|0|||
128893979|NCT00467779|463908560|FG003|Stage 1|Physician Decision|0|||
128893980|NCT00467779|463908561|FG004|Stage 1|Physician Decision|0|||
128893981|NCT00467779|463908562|FG005|Stage 1|Physician Decision|0|||
128893982|NCT00467779|463908563|FG006|Stage 1|Physician Decision|0|||
128893983|NCT00467779|463908564|FG007|Stage 1|Physician Decision|0|||
128893984|NCT00467779|463908565|FG008|Stage 1|Physician Decision|0|||
128893985|NCT00467779|463908566|FG009|Stage 1|Physician Decision|0|||
128893986|NCT00467779|463908567|FG010|Stage 1|Physician Decision|0|||
128893987|NCT00467779|463908568|FG011|Stage 1|Physician Decision|0|||
128893988|NCT00467779|463908569|FG012|Stage 1|Physician Decision|0|||
128893989|NCT00467779|463908570|FG013|Stage 1|Physician Decision|0|||
128893990|NCT00467779|463908571|FG014|Stage 1|Physician Decision|0|||
128893991|NCT00467779|463908557|FG000|Stage 1|Withdrawal by Subject|0|||
128893992|NCT00467779|463908558|FG001|Stage 1|Withdrawal by Subject|0|||
128893993|NCT00467779|463908559|FG002|Stage 1|Withdrawal by Subject|0|||
128893994|NCT00467779|463908560|FG003|Stage 1|Withdrawal by Subject|0|||
128893995|NCT00467779|463908561|FG004|Stage 1|Withdrawal by Subject|0|||
128893996|NCT00467779|463908562|FG005|Stage 1|Withdrawal by Subject|0|||
128893997|NCT00467779|463908563|FG006|Stage 1|Withdrawal by Subject|1|||
128893998|NCT00467779|463908564|FG007|Stage 1|Withdrawal by Subject|1|||
128893999|NCT00467779|463908565|FG008|Stage 1|Withdrawal by Subject|0|||
128894000|NCT00467779|463908566|FG009|Stage 1|Withdrawal by Subject|0|||
128894001|NCT00467779|463908567|FG010|Stage 1|Withdrawal by Subject|0|||
128894002|NCT00467779|463908568|FG011|Stage 1|Withdrawal by Subject|0|||
128894003|NCT00467779|463908569|FG012|Stage 1|Withdrawal by Subject|0|||
128894004|NCT00467779|463908570|FG013|Stage 1|Withdrawal by Subject|0|||
128894005|NCT00467779|463908571|FG014|Stage 1|Withdrawal by Subject|0|||
129021177|NCT00579345|464369221|FG005|Overall Study|Adverse Event|0|||
128764317|NCT02277743|463428286|FG000|Overall Study|Lack of Efficacy|11|||
128764318|NCT02277743|463428287|FG001|Overall Study|Lack of Efficacy|4|||
128764319|NCT02277743|463428288|FG002|Overall Study|Lack of Efficacy|3|||
128764320|NCT02277743|463428286|FG000|Overall Study|Other than specified above|18|||
128764321|NCT02277743|463428287|FG001|Overall Study|Other than specified above|5|||
128764322|NCT02277743|463428288|FG002|Overall Study|Other than specified above|16|||
128894006|NCT00467779|463908557|FG000|Stage 1A|Adverse Event|0|||
128894007|NCT00467779|463908558|FG001|Stage 1A|Adverse Event|0|||
128894008|NCT00467779|463908559|FG002|Stage 1A|Adverse Event|0|||
128894009|NCT00467779|463908560|FG003|Stage 1A|Adverse Event|0|||
128894010|NCT00467779|463908561|FG004|Stage 1A|Adverse Event|0|||
128894011|NCT00467779|463908562|FG005|Stage 1A|Adverse Event|0|||
128894012|NCT00467779|463908563|FG006|Stage 1A|Adverse Event|0|||
128894013|NCT00467779|463908564|FG007|Stage 1A|Adverse Event|0|||
128894014|NCT00467779|463908565|FG008|Stage 1A|Adverse Event|0|||
128894015|NCT00467779|463908566|FG009|Stage 1A|Adverse Event|0|||
128894016|NCT00467779|463908567|FG010|Stage 1A|Adverse Event|0|||
128894017|NCT00467779|463908568|FG011|Stage 1A|Adverse Event|0|||
128894018|NCT00467779|463908569|FG012|Stage 1A|Adverse Event|1|||
128894019|NCT00467779|463908570|FG013|Stage 1A|Adverse Event|0|||
128894020|NCT00467779|463908571|FG014|Stage 1A|Adverse Event|0|||
128894021|NCT00467779|463908557|FG000|Stage 1A|Death|0|||
128764323|NCT01224158|463428289|FG000|Overall Study|Withdrawal by Subject|1|||
128894022|NCT00467779|463908558|FG001|Stage 1A|Death|0|||
128894023|NCT00467779|463908559|FG002|Stage 1A|Death|0|||
128894024|NCT00467779|463908560|FG003|Stage 1A|Death|0|||
128894025|NCT00467779|463908561|FG004|Stage 1A|Death|0|||
128894026|NCT00467779|463908562|FG005|Stage 1A|Death|0|||
128764324|NCT01224158|463428290|FG001|Overall Study|Withdrawal by Subject|0|||
128764325|NCT02055157|463428291|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
128764326|NCT02055157|463428292|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
128764327|NCT02055157|463428293|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
128764328|NCT02055157|463428294|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
128764329|NCT02055157|463428291|FG000|Initial 6 Months|Adverse Event|0|||
128764330|NCT02055157|463428292|FG001|Initial 6 Months|Adverse Event|0|||
128764331|NCT02055157|463428293|FG002|Initial 6 Months|Adverse Event|0|||
128764332|NCT02055157|463428294|FG003|Initial 6 Months|Adverse Event|1|||
128764333|NCT02055157|463428291|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
128764334|NCT02055157|463428292|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
128764335|NCT02055157|463428293|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
128764336|NCT02055157|463428294|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
128764337|NCT02055157|463428291|FG000|18-month Extension|Investigator decision|0|||
128764338|NCT02055157|463428292|FG001|18-month Extension|Investigator decision|1|||
128764339|NCT02055157|463428293|FG002|18-month Extension|Investigator decision|0|||
128764340|NCT02055157|463428294|FG003|18-month Extension|Investigator decision|0|||
128764341|NCT02055157|463428291|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
128764342|NCT02055157|463428292|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
128764343|NCT02055157|463428293|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
128764344|NCT02055157|463428294|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
128764345|NCT03976466|463428295|FG000|Overall Study|Lost to Follow-up|1|||
128764346|NCT03976466|463428296|FG001|Overall Study|Lost to Follow-up|3|||
128764347|NCT00733499|463428301|FG000|Pre-operative|Protocol Violation|0|||
128764348|NCT00733499|463428302|FG001|Pre-operative|Protocol Violation|1|||
128764349|NCT00733499|463428301|FG000|3 Months Follow-up|Death|1|||
128764350|NCT00733499|463428302|FG001|3 Months Follow-up|Death|2|||
128764351|NCT00733499|463428301|FG000|6 Months Follow-up|Death|0|||
128894027|NCT00467779|463908563|FG006|Stage 1A|Death|0|||
128894028|NCT00467779|463908564|FG007|Stage 1A|Death|0|||
128894029|NCT00467779|463908565|FG008|Stage 1A|Death|0|||
128894030|NCT00467779|463908566|FG009|Stage 1A|Death|0|||
128894031|NCT00467779|463908567|FG010|Stage 1A|Death|0|||
128764352|NCT00733499|463428302|FG001|6 Months Follow-up|Death|2|||
128764353|NCT00733499|463428301|FG000|6 Months Follow-up|Adverse Event|0|||
128764354|NCT00733499|463428302|FG001|6 Months Follow-up|Adverse Event|1|||
128764355|NCT00733499|463428301|FG000|12 Months Follow-up|Death|2|||
128764356|NCT00733499|463428302|FG001|12 Months Follow-up|Death|1|||
128764357|NCT00733499|463428301|FG000|24 Months Follow-up|Death|0|||
128764358|NCT00733499|463428302|FG001|24 Months Follow-up|Death|1|||
128764359|NCT00733499|463428301|FG000|5 Year Followup|Adverse Event|2|||
128764360|NCT00733499|463428302|FG001|5 Year Followup|Adverse Event|2|||
128764361|NCT00733499|463428301|FG000|5 Year Followup|Non device related AE|0|||
128764362|NCT00733499|463428302|FG001|5 Year Followup|Non device related AE|1|||
128764363|NCT00733499|463428301|FG000|5 Year Followup|Revision of Study Implant|0|||
128764364|NCT00733499|463428302|FG001|5 Year Followup|Revision of Study Implant|1|||
128764365|NCT00733499|463428301|FG000|5 Year Followup|Lost to Follow-up|2|||
128764366|NCT00733499|463428302|FG001|5 Year Followup|Lost to Follow-up|0|||
128764367|NCT00733499|463428301|FG000|5 Year Followup|Death|13|||
128764368|NCT00733499|463428302|FG001|5 Year Followup|Death|19|||
128764369|NCT00733499|463428301|FG000|5 Year Followup|missing, unable to locate|0|||
128764370|NCT00733499|463428302|FG001|5 Year Followup|missing, unable to locate|1|||
128764371|NCT00733499|463428301|FG000|5 Year Followup|Withdrawal by Subject|4|||
128764372|NCT00733499|463428302|FG001|5 Year Followup|Withdrawal by Subject|1|||
128764373|NCT00733499|463428301|FG000|10 Year Followup|Death|9|||
128764374|NCT00733499|463428302|FG001|10 Year Followup|Death|7|||
128764375|NCT00733499|463428301|FG000|10 Year Followup|Adverse Event|3|||
128764376|NCT00733499|463428302|FG001|10 Year Followup|Adverse Event|3|||
128764377|NCT00733499|463428301|FG000|10 Year Followup|Lost to Follow-up|3|||
128764378|NCT00733499|463428302|FG001|10 Year Followup|Lost to Follow-up|2|||
128764379|NCT00733499|463428301|FG000|10 Year Followup|Withdrawal by Subject|5|||
128894032|NCT00467779|463908568|FG011|Stage 1A|Death|1|||
128894033|NCT00467779|463908569|FG012|Stage 1A|Death|1|||
128894034|NCT00467779|463908570|FG013|Stage 1A|Death|0|||
128764380|NCT00733499|463428302|FG001|10 Year Followup|Withdrawal by Subject|5|||
128764381|NCT00733499|463428301|FG000|10 Year Followup|missing, unable to locate|0|||
128764382|NCT00733499|463428302|FG001|10 Year Followup|missing, unable to locate|2|||
128764383|NCT02739347|463428303|FG000|Overall Study|Adverse Event|3|||
128764384|NCT02739347|463428304|FG001|Overall Study|Adverse Event|0|||
128764385|NCT02739347|463428303|FG000|Overall Study|Protocol Violation|0|||
128764386|NCT02739347|463428304|FG001|Overall Study|Protocol Violation|1|||
128894035|NCT00467779|463908571|FG014|Stage 1A|Death|0|||
128894036|NCT00467779|463908557|FG000|Stage 1A|Disease Progression|0|||
128894037|NCT00467779|463908558|FG001|Stage 1A|Disease Progression|0|||
128764387|NCT02739347|463428303|FG000|Overall Study|Lost to Follow-up|0|||
128764388|NCT02739347|463428304|FG001|Overall Study|Lost to Follow-up|2|||
128894038|NCT00467779|463908559|FG002|Stage 1A|Disease Progression|0|||
128894039|NCT00467779|463908560|FG003|Stage 1A|Disease Progression|0|||
128894040|NCT00467779|463908561|FG004|Stage 1A|Disease Progression|0|||
128690805|NCT00004635|463169312|FG000|Period One|health problem|0|||
128690806|NCT00004635|463169313|FG001|Period One|health problem|1|||
128690807|NCT00004635|463169312|FG000|Period One|discrepancy in data entry|0|||
128690808|NCT00004635|463169313|FG001|Period One|discrepancy in data entry|1|||
128690809|NCT00004635|463169312|FG000|Period Two|progression|2|||
128690810|NCT00004635|463169313|FG001|Period Two|progression|3|||
128690811|NCT00004635|463169312|FG000|Period Two|Adverse Event|1|||
128690812|NCT00004635|463169313|FG001|Period Two|Adverse Event|0|||
128690813|NCT00004635|463169312|FG000|Period Two|refused|0|||
128690814|NCT00004635|463169313|FG001|Period Two|refused|2|||
128690815|NCT00004635|463169312|FG000|Period Two|health problem|1|||
128690816|NCT00004635|463169313|FG001|Period Two|health problem|1|||
128690817|NCT00004635|463169312|FG000|Period Two|travel issues|0|||
128690818|NCT00004635|463169313|FG001|Period Two|travel issues|1|||
128690819|NCT00004635|463169312|FG000|Period Two|secondary malignancy|1|||
128690820|NCT00004635|463169313|FG001|Period Two|secondary malignancy|1|||
128690821|NCT00004635|463169312|FG000|Period Two|Lost to Follow-up|1|||
128690822|NCT00004635|463169313|FG001|Period Two|Lost to Follow-up|0|||
128690823|NCT00004635|463169312|FG000|Period Two|discrepancy in data entry|0|||
128690824|NCT00004635|463169313|FG001|Period Two|discrepancy in data entry|1|||
128690825|NCT01890746|463169314|FG000|Overall Study|Death|39|||
128690826|NCT01890746|463169315|FG001|Overall Study|Death|30|||
128690827|NCT01890746|463169314|FG000|Overall Study|Adverse Event|1|||
128690828|NCT01890746|463169315|FG001|Overall Study|Adverse Event|0|||
128690829|NCT01890746|463169314|FG000|Overall Study|Lost to Follow-up|4|||
128690830|NCT01890746|463169315|FG001|Overall Study|Lost to Follow-up|1|||
128690831|NCT01890746|463169314|FG000|Overall Study|Physician Decision|3|||
128690832|NCT01890746|463169315|FG001|Overall Study|Physician Decision|2|||
128690833|NCT01890746|463169314|FG000|Overall Study|Withdrawal by Subject|5|||
128690834|NCT01890746|463169315|FG001|Overall Study|Withdrawal by Subject|8|||
128690835|NCT02642029|463169316|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
128690836|NCT02642029|463169317|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
128690837|NCT02642029|463169318|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
128690838|NCT02642029|463169319|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
128690839|NCT02642029|463169320|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
128690840|NCT02642029|463169321|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
128690841|NCT02642029|463169316|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
128690842|NCT02642029|463169317|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
128690843|NCT02642029|463169318|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
128690844|NCT02642029|463169319|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
128690845|NCT02642029|463169320|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
128690846|NCT02642029|463169321|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
128690847|NCT02642029|463169316|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
128690848|NCT02642029|463169317|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
128690849|NCT02642029|463169318|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
128690850|NCT02642029|463169319|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
128690851|NCT02642029|463169320|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
128690852|NCT02642029|463169321|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
128690853|NCT02642029|463169316|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
128690854|NCT02642029|463169317|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
128690855|NCT02642029|463169318|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
128690856|NCT02642029|463169319|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
128690857|NCT02642029|463169320|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
128690858|NCT02642029|463169321|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
128690859|NCT02642029|463169316|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
128690860|NCT02642029|463169317|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
128690861|NCT02642029|463169318|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
128690862|NCT02642029|463169319|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
128690863|NCT02642029|463169320|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
128690864|NCT02642029|463169321|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
128690865|NCT02642029|463169316|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
128690866|NCT02642029|463169317|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
128764389|NCT03929562|463428305|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
128690867|NCT02642029|463169318|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
128690868|NCT02642029|463169319|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
128690869|NCT02642029|463169320|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
128690870|NCT02642029|463169321|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
128690871|NCT00676338|463169323|FG000|Overall Study|Adverse Event|6|||
128690872|NCT00676338|463169324|FG001|Overall Study|Adverse Event|6|||
128690873|NCT00676338|463169325|FG002|Overall Study|Adverse Event|5|||
128690874|NCT00676338|463169326|FG003|Overall Study|Adverse Event|1|||
128690875|NCT00676338|463169323|FG000|Overall Study|Lost to Follow-up|4|||
128894041|NCT00467779|463908562|FG005|Stage 1A|Disease Progression|0|||
128894042|NCT00467779|463908563|FG006|Stage 1A|Disease Progression|0|||
128894043|NCT00467779|463908564|FG007|Stage 1A|Disease Progression|0|||
128894044|NCT00467779|463908565|FG008|Stage 1A|Disease Progression|0|||
128894045|NCT00467779|463908566|FG009|Stage 1A|Disease Progression|2|||
128894046|NCT00467779|463908567|FG010|Stage 1A|Disease Progression|2|||
128894047|NCT00467779|463908568|FG011|Stage 1A|Disease Progression|5|||
128894048|NCT00467779|463908569|FG012|Stage 1A|Disease Progression|2|||
128894049|NCT00467779|463908570|FG013|Stage 1A|Disease Progression|0|||
128894050|NCT00467779|463908571|FG014|Stage 1A|Disease Progression|0|||
128894051|NCT00467779|463908557|FG000|Stage 1A|Physician Decision|0|||
128894052|NCT00467779|463908558|FG001|Stage 1A|Physician Decision|0|||
128894053|NCT00467779|463908559|FG002|Stage 1A|Physician Decision|0|||
128894054|NCT00467779|463908560|FG003|Stage 1A|Physician Decision|0|||
128894055|NCT00467779|463908561|FG004|Stage 1A|Physician Decision|0|||
128894056|NCT00467779|463908562|FG005|Stage 1A|Physician Decision|0|||
128894057|NCT00467779|463908563|FG006|Stage 1A|Physician Decision|0|||
128894058|NCT00467779|463908564|FG007|Stage 1A|Physician Decision|0|||
128894059|NCT00467779|463908565|FG008|Stage 1A|Physician Decision|0|||
128894060|NCT00467779|463908566|FG009|Stage 1A|Physician Decision|1|||
128894061|NCT00467779|463908567|FG010|Stage 1A|Physician Decision|0|||
128894062|NCT00467779|463908568|FG011|Stage 1A|Physician Decision|0|||
128894063|NCT00467779|463908569|FG012|Stage 1A|Physician Decision|0|||
128894064|NCT00467779|463908570|FG013|Stage 1A|Physician Decision|0|||
128894065|NCT00467779|463908571|FG014|Stage 1A|Physician Decision|0|||
128894066|NCT00467779|463908557|FG000|Stage 1A|Withdrawal by Subject|0|||
128894067|NCT00467779|463908558|FG001|Stage 1A|Withdrawal by Subject|0|||
128894068|NCT00467779|463908559|FG002|Stage 1A|Withdrawal by Subject|0|||
128894069|NCT00467779|463908560|FG003|Stage 1A|Withdrawal by Subject|0|||
128894070|NCT00467779|463908561|FG004|Stage 1A|Withdrawal by Subject|0|||
128894071|NCT00467779|463908562|FG005|Stage 1A|Withdrawal by Subject|0|||
128894072|NCT00467779|463908563|FG006|Stage 1A|Withdrawal by Subject|0|||
128894073|NCT00467779|463908564|FG007|Stage 1A|Withdrawal by Subject|0|||
128894074|NCT00467779|463908565|FG008|Stage 1A|Withdrawal by Subject|0|||
128894075|NCT00467779|463908566|FG009|Stage 1A|Withdrawal by Subject|0|||
128894076|NCT00467779|463908567|FG010|Stage 1A|Withdrawal by Subject|1|||
128894077|NCT00467779|463908568|FG011|Stage 1A|Withdrawal by Subject|1|||
128894078|NCT00467779|463908569|FG012|Stage 1A|Withdrawal by Subject|1|||
128894079|NCT00467779|463908570|FG013|Stage 1A|Withdrawal by Subject|0|||
128894080|NCT00467779|463908571|FG014|Stage 1A|Withdrawal by Subject|0|||
128894081|NCT00467779|463908557|FG000|Stage 1A|Unspecified Reason|0|||
128894082|NCT00467779|463908558|FG001|Stage 1A|Unspecified Reason|0|||
128894083|NCT00467779|463908559|FG002|Stage 1A|Unspecified Reason|0|||
128894084|NCT00467779|463908560|FG003|Stage 1A|Unspecified Reason|0|||
128894085|NCT00467779|463908561|FG004|Stage 1A|Unspecified Reason|0|||
128894086|NCT00467779|463908562|FG005|Stage 1A|Unspecified Reason|0|||
128894087|NCT00467779|463908563|FG006|Stage 1A|Unspecified Reason|0|||
128894088|NCT00467779|463908564|FG007|Stage 1A|Unspecified Reason|0|||
128894089|NCT00467779|463908565|FG008|Stage 1A|Unspecified Reason|0|||
128894090|NCT00467779|463908566|FG009|Stage 1A|Unspecified Reason|0|||
128894091|NCT00467779|463908567|FG010|Stage 1A|Unspecified Reason|0|||
128894092|NCT00467779|463908568|FG011|Stage 1A|Unspecified Reason|1|||
128894093|NCT00467779|463908569|FG012|Stage 1A|Unspecified Reason|1|||
128894094|NCT00467779|463908570|FG013|Stage 1A|Unspecified Reason|0|||
128894095|NCT00467779|463908571|FG014|Stage 1A|Unspecified Reason|0|||
129021178|NCT00579345|464369222|FG006|Overall Study|Adverse Event|0|||
129021179|NCT00579345|464369223|FG007|Overall Study|Adverse Event|0|||
129021180|NCT00579345|464369216|FG000|Overall Study|Protocol Violation|1|||
128690876|NCT00676338|463169324|FG001|Overall Study|Lost to Follow-up|1|||
128690877|NCT00676338|463169325|FG002|Overall Study|Lost to Follow-up|3|||
128894096|NCT00467779|463908557|FG000|Stage 2|Adverse Event|0|||
128894097|NCT00467779|463908558|FG001|Stage 2|Adverse Event|0|||
128894098|NCT00467779|463908559|FG002|Stage 2|Adverse Event|0|||
128894099|NCT00467779|463908560|FG003|Stage 2|Adverse Event|0|||
128894100|NCT00467779|463908561|FG004|Stage 2|Adverse Event|0|||
129021181|NCT00579345|464369217|FG001|Overall Study|Protocol Violation|0|||
128690878|NCT00676338|463169326|FG003|Overall Study|Lost to Follow-up|4|||
128894101|NCT00467779|463908562|FG005|Stage 2|Adverse Event|0|||
128894102|NCT00467779|463908563|FG006|Stage 2|Adverse Event|0|||
128894103|NCT00467779|463908564|FG007|Stage 2|Adverse Event|0|||
128894104|NCT00467779|463908565|FG008|Stage 2|Adverse Event|1|||
128894105|NCT00467779|463908566|FG009|Stage 2|Adverse Event|0|||
128894106|NCT00467779|463908567|FG010|Stage 2|Adverse Event|0|||
128894107|NCT00467779|463908568|FG011|Stage 2|Adverse Event|0|||
128690879|NCT00676338|463169323|FG000|Overall Study|Physician Decision|3|||
128894108|NCT00467779|463908569|FG012|Stage 2|Adverse Event|0|||
128894109|NCT00467779|463908570|FG013|Stage 2|Adverse Event|0|||
128894110|NCT00467779|463908571|FG014|Stage 2|Adverse Event|0|||
128894111|NCT00467779|463908557|FG000|Stage 2|Death|0|||
128894112|NCT00467779|463908558|FG001|Stage 2|Death|0|||
128894113|NCT00467779|463908559|FG002|Stage 2|Death|0|||
128894114|NCT00467779|463908560|FG003|Stage 2|Death|0|||
128894115|NCT00467779|463908561|FG004|Stage 2|Death|0|||
128894116|NCT00467779|463908562|FG005|Stage 2|Death|0|||
128894117|NCT00467779|463908563|FG006|Stage 2|Death|0|||
128894118|NCT00467779|463908564|FG007|Stage 2|Death|0|||
128894119|NCT00467779|463908565|FG008|Stage 2|Death|1|||
128894120|NCT00467779|463908566|FG009|Stage 2|Death|0|||
128894121|NCT00467779|463908567|FG010|Stage 2|Death|0|||
128894122|NCT00467779|463908568|FG011|Stage 2|Death|0|||
128894123|NCT00467779|463908569|FG012|Stage 2|Death|0|||
128894124|NCT00467779|463908570|FG013|Stage 2|Death|0|||
128894125|NCT00467779|463908571|FG014|Stage 2|Death|0|||
128894126|NCT00467779|463908557|FG000|Stage 2|Disease Progression|0|||
128894127|NCT00467779|463908558|FG001|Stage 2|Disease Progression|0|||
128894128|NCT00467779|463908559|FG002|Stage 2|Disease Progression|0|||
128894129|NCT00467779|463908560|FG003|Stage 2|Disease Progression|0|||
128894130|NCT00467779|463908561|FG004|Stage 2|Disease Progression|0|||
128894131|NCT00467779|463908562|FG005|Stage 2|Disease Progression|0|||
128894132|NCT00467779|463908563|FG006|Stage 2|Disease Progression|0|||
128894133|NCT00467779|463908564|FG007|Stage 2|Disease Progression|0|||
128894134|NCT00467779|463908565|FG008|Stage 2|Disease Progression|16|||
128894135|NCT00467779|463908566|FG009|Stage 2|Disease Progression|0|||
128894136|NCT00467779|463908567|FG010|Stage 2|Disease Progression|0|||
128894137|NCT00467779|463908568|FG011|Stage 2|Disease Progression|0|||
128894138|NCT00467779|463908569|FG012|Stage 2|Disease Progression|0|||
128894139|NCT00467779|463908570|FG013|Stage 2|Disease Progression|0|||
128894140|NCT00467779|463908571|FG014|Stage 2|Disease Progression|0|||
128894141|NCT00467779|463908557|FG000|Stage 2|Unspecified Reason|0|||
128894142|NCT00467779|463908558|FG001|Stage 2|Unspecified Reason|0|||
128894143|NCT00467779|463908559|FG002|Stage 2|Unspecified Reason|0|||
128894144|NCT00467779|463908560|FG003|Stage 2|Unspecified Reason|0|||
128894145|NCT00467779|463908561|FG004|Stage 2|Unspecified Reason|0|||
128894146|NCT00467779|463908562|FG005|Stage 2|Unspecified Reason|0|||
128894147|NCT00467779|463908563|FG006|Stage 2|Unspecified Reason|0|||
128894148|NCT00467779|463908564|FG007|Stage 2|Unspecified Reason|0|||
128894149|NCT00467779|463908565|FG008|Stage 2|Unspecified Reason|3|||
128894150|NCT00467779|463908566|FG009|Stage 2|Unspecified Reason|0|||
128894151|NCT00467779|463908567|FG010|Stage 2|Unspecified Reason|0|||
128894152|NCT00467779|463908568|FG011|Stage 2|Unspecified Reason|0|||
128894153|NCT00467779|463908569|FG012|Stage 2|Unspecified Reason|0|||
128894154|NCT00467779|463908570|FG013|Stage 2|Unspecified Reason|0|||
128894155|NCT00467779|463908571|FG014|Stage 2|Unspecified Reason|0|||
128894156|NCT00467779|463908557|FG000|Stage 2A|Adverse Event|0|||
128894157|NCT00467779|463908558|FG001|Stage 2A|Adverse Event|0|||
128894158|NCT00467779|463908559|FG002|Stage 2A|Adverse Event|0|||
128894159|NCT00467779|463908560|FG003|Stage 2A|Adverse Event|0|||
128894160|NCT00467779|463908561|FG004|Stage 2A|Adverse Event|0|||
128894161|NCT00467779|463908562|FG005|Stage 2A|Adverse Event|0|||
128894162|NCT00467779|463908563|FG006|Stage 2A|Adverse Event|0|||
128894163|NCT00467779|463908564|FG007|Stage 2A|Adverse Event|0|||
128894164|NCT00467779|463908565|FG008|Stage 2A|Adverse Event|0|||
128894165|NCT00467779|463908566|FG009|Stage 2A|Adverse Event|0|||
128894166|NCT00467779|463908567|FG010|Stage 2A|Adverse Event|0|||
128894167|NCT00467779|463908568|FG011|Stage 2A|Adverse Event|0|||
128894168|NCT00467779|463908569|FG012|Stage 2A|Adverse Event|0|||
128894169|NCT00467779|463908570|FG013|Stage 2A|Adverse Event|2|||
128894170|NCT00467779|463908571|FG014|Stage 2A|Adverse Event|0|||
128894171|NCT00467779|463908557|FG000|Stage 2A|Death|0|||
128894172|NCT00467779|463908558|FG001|Stage 2A|Death|0|||
128894173|NCT00467779|463908559|FG002|Stage 2A|Death|0|||
128894174|NCT00467779|463908560|FG003|Stage 2A|Death|0|||
128894175|NCT00467779|463908561|FG004|Stage 2A|Death|0|||
128894176|NCT00467779|463908562|FG005|Stage 2A|Death|0|||
128894177|NCT00467779|463908563|FG006|Stage 2A|Death|0|||
128894178|NCT00467779|463908564|FG007|Stage 2A|Death|0|||
128894179|NCT00467779|463908565|FG008|Stage 2A|Death|0|||
128894180|NCT00467779|463908566|FG009|Stage 2A|Death|0|||
128894181|NCT00467779|463908567|FG010|Stage 2A|Death|0|||
128894182|NCT00467779|463908568|FG011|Stage 2A|Death|0|||
128894183|NCT00467779|463908569|FG012|Stage 2A|Death|0|||
128894184|NCT00467779|463908570|FG013|Stage 2A|Death|1|||
128894185|NCT00467779|463908571|FG014|Stage 2A|Death|0|||
128894186|NCT00467779|463908557|FG000|Stage 2A|Disease Progression|0|||
129021182|NCT00579345|464369218|FG002|Overall Study|Protocol Violation|0|||
128894187|NCT00467779|463908558|FG001|Stage 2A|Disease Progression|0|||
128894188|NCT00467779|463908559|FG002|Stage 2A|Disease Progression|0|||
128894189|NCT00467779|463908560|FG003|Stage 2A|Disease Progression|0|||
128894190|NCT00467779|463908561|FG004|Stage 2A|Disease Progression|0|||
128894191|NCT00467779|463908562|FG005|Stage 2A|Disease Progression|0|||
128894192|NCT00467779|463908563|FG006|Stage 2A|Disease Progression|0|||
128894193|NCT00467779|463908564|FG007|Stage 2A|Disease Progression|0|||
128894194|NCT00467779|463908565|FG008|Stage 2A|Disease Progression|0|||
128894195|NCT00467779|463908566|FG009|Stage 2A|Disease Progression|0|||
128894196|NCT00467779|463908567|FG010|Stage 2A|Disease Progression|0|||
128894197|NCT00467779|463908568|FG011|Stage 2A|Disease Progression|0|||
128894198|NCT00467779|463908569|FG012|Stage 2A|Disease Progression|0|||
128894199|NCT00467779|463908570|FG013|Stage 2A|Disease Progression|10|||
128894200|NCT00467779|463908571|FG014|Stage 2A|Disease Progression|0|||
128894201|NCT00467779|463908557|FG000|Stage 2A|Unspecified Reason|0|||
128894202|NCT00467779|463908558|FG001|Stage 2A|Unspecified Reason|0|||
128894203|NCT00467779|463908559|FG002|Stage 2A|Unspecified Reason|0|||
128894204|NCT00467779|463908560|FG003|Stage 2A|Unspecified Reason|0|||
128894205|NCT00467779|463908561|FG004|Stage 2A|Unspecified Reason|0|||
128894206|NCT00467779|463908562|FG005|Stage 2A|Unspecified Reason|0|||
128894207|NCT00467779|463908563|FG006|Stage 2A|Unspecified Reason|0|||
128894208|NCT00467779|463908564|FG007|Stage 2A|Unspecified Reason|0|||
128894209|NCT00467779|463908565|FG008|Stage 2A|Unspecified Reason|0|||
128894210|NCT00467779|463908566|FG009|Stage 2A|Unspecified Reason|0|||
128894211|NCT00467779|463908567|FG010|Stage 2A|Unspecified Reason|0|||
128894212|NCT00467779|463908568|FG011|Stage 2A|Unspecified Reason|0|||
128894213|NCT00467779|463908569|FG012|Stage 2A|Unspecified Reason|0|||
128894214|NCT00467779|463908570|FG013|Stage 2A|Unspecified Reason|7|||
128894215|NCT00467779|463908571|FG014|Stage 2A|Unspecified Reason|0|||
128894216|NCT00467779|463908557|FG000|Stage 2A|Withdrawal by Subject|0|||
128894217|NCT00467779|463908558|FG001|Stage 2A|Withdrawal by Subject|0|||
128894218|NCT00467779|463908559|FG002|Stage 2A|Withdrawal by Subject|0|||
128894219|NCT00467779|463908560|FG003|Stage 2A|Withdrawal by Subject|0|||
128894220|NCT00467779|463908561|FG004|Stage 2A|Withdrawal by Subject|0|||
128894221|NCT00467779|463908562|FG005|Stage 2A|Withdrawal by Subject|0|||
128894222|NCT00467779|463908563|FG006|Stage 2A|Withdrawal by Subject|0|||
128894223|NCT00467779|463908564|FG007|Stage 2A|Withdrawal by Subject|0|||
128894224|NCT00467779|463908565|FG008|Stage 2A|Withdrawal by Subject|0|||
128894225|NCT00467779|463908566|FG009|Stage 2A|Withdrawal by Subject|0|||
128894226|NCT00467779|463908567|FG010|Stage 2A|Withdrawal by Subject|0|||
128894227|NCT00467779|463908568|FG011|Stage 2A|Withdrawal by Subject|0|||
128894228|NCT00467779|463908569|FG012|Stage 2A|Withdrawal by Subject|0|||
128894229|NCT00467779|463908570|FG013|Stage 2A|Withdrawal by Subject|1|||
128894230|NCT00467779|463908571|FG014|Stage 2A|Withdrawal by Subject|0|||
128894231|NCT00467779|463908557|FG000|Stage 3|Adverse Event|0|||
128894232|NCT00467779|463908558|FG001|Stage 3|Adverse Event|0|||
128894233|NCT00467779|463908559|FG002|Stage 3|Adverse Event|0|||
128894234|NCT00467779|463908560|FG003|Stage 3|Adverse Event|0|||
128894235|NCT00467779|463908561|FG004|Stage 3|Adverse Event|0|||
128894236|NCT00467779|463908562|FG005|Stage 3|Adverse Event|0|||
128894237|NCT00467779|463908563|FG006|Stage 3|Adverse Event|0|||
128894238|NCT00467779|463908564|FG007|Stage 3|Adverse Event|0|||
128894239|NCT00467779|463908565|FG008|Stage 3|Adverse Event|0|||
128894240|NCT00467779|463908566|FG009|Stage 3|Adverse Event|0|||
128894241|NCT00467779|463908567|FG010|Stage 3|Adverse Event|0|||
128894242|NCT00467779|463908568|FG011|Stage 3|Adverse Event|0|||
128894243|NCT00467779|463908569|FG012|Stage 3|Adverse Event|0|||
128894244|NCT00467779|463908570|FG013|Stage 3|Adverse Event|0|||
128894245|NCT00467779|463908571|FG014|Stage 3|Adverse Event|2|||
128894246|NCT00467779|463908557|FG000|Stage 3|Death|0|||
128894247|NCT00467779|463908558|FG001|Stage 3|Death|0|||
128894248|NCT00467779|463908559|FG002|Stage 3|Death|0|||
128894249|NCT00467779|463908560|FG003|Stage 3|Death|0|||
128894250|NCT00467779|463908561|FG004|Stage 3|Death|0|||
128894251|NCT00467779|463908562|FG005|Stage 3|Death|0|||
128894252|NCT00467779|463908563|FG006|Stage 3|Death|0|||
128894253|NCT00467779|463908564|FG007|Stage 3|Death|0|||
128894254|NCT00467779|463908565|FG008|Stage 3|Death|0|||
128894255|NCT00467779|463908566|FG009|Stage 3|Death|0|||
128894256|NCT00467779|463908567|FG010|Stage 3|Death|0|||
128894257|NCT00467779|463908568|FG011|Stage 3|Death|0|||
128894258|NCT00467779|463908569|FG012|Stage 3|Death|0|||
128894259|NCT00467779|463908570|FG013|Stage 3|Death|0|||
128894260|NCT00467779|463908571|FG014|Stage 3|Death|1|||
128894261|NCT00467779|463908557|FG000|Stage 3|Disease Progression|0|||
129110891|NCT02326272|464701366|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128690880|NCT00676338|463169324|FG001|Overall Study|Physician Decision|3|||
128690881|NCT00676338|463169325|FG002|Overall Study|Physician Decision|2|||
128690882|NCT00676338|463169326|FG003|Overall Study|Physician Decision|3|||
128894262|NCT00467779|463908558|FG001|Stage 3|Disease Progression|0|||
128894263|NCT00467779|463908559|FG002|Stage 3|Disease Progression|0|||
128894264|NCT00467779|463908560|FG003|Stage 3|Disease Progression|0|||
128894265|NCT00467779|463908561|FG004|Stage 3|Disease Progression|0|||
128894266|NCT00467779|463908562|FG005|Stage 3|Disease Progression|0|||
128894267|NCT00467779|463908563|FG006|Stage 3|Disease Progression|0|||
128894268|NCT00467779|463908564|FG007|Stage 3|Disease Progression|0|||
128894269|NCT00467779|463908565|FG008|Stage 3|Disease Progression|0|||
128894270|NCT00467779|463908566|FG009|Stage 3|Disease Progression|0|||
128894271|NCT00467779|463908567|FG010|Stage 3|Disease Progression|0|||
128894272|NCT00467779|463908568|FG011|Stage 3|Disease Progression|0|||
128690883|NCT00676338|463169323|FG000|Overall Study|Protocol Violation|5|||
128894273|NCT00467779|463908569|FG012|Stage 3|Disease Progression|0|||
128894274|NCT00467779|463908570|FG013|Stage 3|Disease Progression|0|||
128894275|NCT00467779|463908571|FG014|Stage 3|Disease Progression|9|||
128894276|NCT00467779|463908557|FG000|Stage 3|Unspecified Reason|0|||
128894277|NCT00467779|463908558|FG001|Stage 3|Unspecified Reason|0|||
128894278|NCT00467779|463908559|FG002|Stage 3|Unspecified Reason|0|||
128894279|NCT00467779|463908560|FG003|Stage 3|Unspecified Reason|0|||
128894280|NCT00467779|463908561|FG004|Stage 3|Unspecified Reason|0|||
128894281|NCT00467779|463908562|FG005|Stage 3|Unspecified Reason|0|||
128894282|NCT00467779|463908563|FG006|Stage 3|Unspecified Reason|0|||
128894283|NCT00467779|463908564|FG007|Stage 3|Unspecified Reason|0|||
128894284|NCT00467779|463908565|FG008|Stage 3|Unspecified Reason|0|||
128894285|NCT00467779|463908566|FG009|Stage 3|Unspecified Reason|0|||
128894286|NCT00467779|463908567|FG010|Stage 3|Unspecified Reason|0|||
128894287|NCT00467779|463908568|FG011|Stage 3|Unspecified Reason|0|||
128894288|NCT00467779|463908569|FG012|Stage 3|Unspecified Reason|0|||
128894289|NCT00467779|463908570|FG013|Stage 3|Unspecified Reason|0|||
128894290|NCT00467779|463908571|FG014|Stage 3|Unspecified Reason|5|||
128894291|NCT00041080|463908574|FG000|Overall Study|Adverse Event|21|||
128894292|NCT00041080|463908575|FG001|Overall Study|Adverse Event|1|||
128894293|NCT00041080|463908574|FG000|Overall Study|Withdrawal by Subject|6|||
128894294|NCT00041080|463908575|FG001|Overall Study|Withdrawal by Subject|6|||
128894295|NCT00041080|463908574|FG000|Overall Study|Concommitant Illness/Other|1|||
128894296|NCT00041080|463908575|FG001|Overall Study|Concommitant Illness/Other|2|||
128894297|NCT00041080|463908574|FG000|Overall Study|Did not start therapy|1|||
128894298|NCT00041080|463908575|FG001|Overall Study|Did not start therapy|1|||
128894299|NCT00041080|463908574|FG000|Overall Study|Ineligible|1|||
128894300|NCT00041080|463908575|FG001|Overall Study|Ineligible|0|||
128894301|NCT04353596|463908578|FG000|Overall Study|Protocol Violation|4|||
128894302|NCT04353596|463908579|FG001|Overall Study|Protocol Violation|4|||
128894303|NCT04353596|463908578|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
128894304|NCT04353596|463908579|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
128894305|NCT05418673|463908580|FG000|Overall Study|Study Terminated by Sponsor|2|||
128894306|NCT05418673|463908581|FG001|Overall Study|Study Terminated by Sponsor|4|||
128894307|NCT05418673|463908580|FG000|Overall Study|Lost to Follow-up|1|||
128894308|NCT05418673|463908581|FG001|Overall Study|Lost to Follow-up|0|||
128894309|NCT02665052|463908584|FG000|Overall Study|Lost to Follow-up|1|||
128894310|NCT02665052|463908585|FG001|Overall Study|Lost to Follow-up|0|||
128894311|NCT02665052|463908586|FG002|Overall Study|Lost to Follow-up|0|||
128894312|NCT02665052|463908587|FG003|Overall Study|Lost to Follow-up|0|||
128894313|NCT02665052|463908584|FG000|Overall Study|Withdrawal by Subject|1|||
128894314|NCT02665052|463908585|FG001|Overall Study|Withdrawal by Subject|1|||
128894315|NCT02665052|463908586|FG002|Overall Study|Withdrawal by Subject|0|||
128894316|NCT02665052|463908587|FG003|Overall Study|Withdrawal by Subject|5|||
128894317|NCT02665052|463908584|FG000|Overall Study|Adverse Event|1|||
128894318|NCT02665052|463908585|FG001|Overall Study|Adverse Event|1|||
128894319|NCT02665052|463908586|FG002|Overall Study|Adverse Event|0|||
128894320|NCT02665052|463908587|FG003|Overall Study|Adverse Event|0|||
128894321|NCT00823823|463908588|FG000|Overall Study|Lost to Follow-up|3|||
128894322|NCT00823823|463908589|FG001|Overall Study|Lost to Follow-up|1|||
128894323|NCT00823823|463908588|FG000|Overall Study|Protocol Violation|5|||
128894324|NCT00823823|463908589|FG001|Overall Study|Protocol Violation|5|||
128894325|NCT02234284|463908590|FG000|Overall Study|Death|4|||
128894326|NCT02234284|463908591|FG001|Overall Study|Death|2|||
128894327|NCT02234284|463908590|FG000|Overall Study|Withdrawal by Subject|1|||
128894328|NCT02234284|463908591|FG001|Overall Study|Withdrawal by Subject|0|||
128894329|NCT02234284|463908590|FG000|Overall Study|Lost to Follow-up|20|||
128894330|NCT02234284|463908591|FG001|Overall Study|Lost to Follow-up|7|||
128894331|NCT00233363|463908598|FG000|Overall Study|Adverse Event|1|||
128894332|NCT00233363|463908599|FG001|Overall Study|Adverse Event|2|||
128894333|NCT00233363|463908598|FG000|Overall Study|Lack of Efficacy|0|||
128894334|NCT00233363|463908599|FG001|Overall Study|Lack of Efficacy|2|||
128894335|NCT00233363|463908598|FG000|Overall Study|Withdrawal by Subject|1|||
128894336|NCT00233363|463908599|FG001|Overall Study|Withdrawal by Subject|1|||
128894337|NCT00233363|463908598|FG000|Overall Study|Aggravation of complication|1|||
128894338|NCT00233363|463908599|FG001|Overall Study|Aggravation of complication|0|||
128894339|NCT01576172|463908600|FG000|Overall Study|Ineligible|2|||
128894340|NCT01576172|463908601|FG001|Overall Study|Ineligible|1|||
128894341|NCT01576172|463908600|FG000|Overall Study|Withdrawal by Subject|2|||
128894342|NCT01576172|463908601|FG001|Overall Study|Withdrawal by Subject|0|||
128894343|NCT01576172|463908600|FG000|Overall Study|Insurance issue|1|||
128894344|NCT01576172|463908601|FG001|Overall Study|Insurance issue|0|||
128894345|NCT02790138|463908602|FG000|Overall Study|Adverse Event|5|||
128894346|NCT02790138|463908603|FG001|Overall Study|Adverse Event|2|||
128894347|NCT02790138|463908602|FG000|Overall Study|Significant Protocol Deviation|0|||
128894348|NCT02790138|463908603|FG001|Overall Study|Significant Protocol Deviation|1|||
128894349|NCT02790138|463908602|FG000|Overall Study|Lost to Follow-up|1|||
129110892|NCT02326272|464701367|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128690884|NCT00676338|463169324|FG001|Overall Study|Protocol Violation|9|||
128894350|NCT02790138|463908603|FG001|Overall Study|Lost to Follow-up|0|||
128894351|NCT02790138|463908602|FG000|Overall Study|Voluntary Withdrawal|8|||
128894352|NCT02790138|463908603|FG001|Overall Study|Voluntary Withdrawal|9|||
128894353|NCT02790138|463908602|FG000|Overall Study|Lack of Efficacy|6|||
129110893|NCT02326272|464701353|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
128894354|NCT02790138|463908603|FG001|Overall Study|Lack of Efficacy|7|||
128894355|NCT02790138|463908602|FG000|Overall Study|Reason not Specified|1|||
128894356|NCT02790138|463908603|FG001|Overall Study|Reason not Specified|0|||
128894357|NCT01786603|463908604|FG000|Overall Study|Death|5|||
128894358|NCT01786603|463908605|FG001|Overall Study|Death|1|||
128690885|NCT00676338|463169325|FG002|Overall Study|Protocol Violation|2|||
128690886|NCT00676338|463169326|FG003|Overall Study|Protocol Violation|5|||
128894359|NCT01786603|463908604|FG000|Overall Study|Adverse Event|6|||
128894360|NCT01786603|463908605|FG001|Overall Study|Adverse Event|2|||
128690887|NCT00676338|463169323|FG000|Overall Study|Withdrawal by Subject|17|||
128690888|NCT00676338|463169324|FG001|Overall Study|Withdrawal by Subject|9|||
128690889|NCT00676338|463169325|FG002|Overall Study|Withdrawal by Subject|12|||
128690890|NCT00676338|463169326|FG003|Overall Study|Withdrawal by Subject|6|||
128690891|NCT00676338|463169323|FG000|Overall Study|Entry Criteria Not Met|0|||
128690892|NCT00676338|463169324|FG001|Overall Study|Entry Criteria Not Met|2|||
128690893|NCT00676338|463169325|FG002|Overall Study|Entry Criteria Not Met|1|||
128690894|NCT00676338|463169326|FG003|Overall Study|Entry Criteria Not Met|1|||
128690895|NCT00676338|463169323|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
128690896|NCT00676338|463169324|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
128690897|NCT00676338|463169325|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
128690898|NCT00676338|463169326|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
128690899|NCT02122458|463169327|FG000|Overall Study|Withdrawal by Subject|0|||
128690900|NCT02122458|463169328|FG001|Overall Study|Withdrawal by Subject|0|||
128690901|NCT02122458|463169329|FG002|Overall Study|Withdrawal by Subject|0|||
128690902|NCT02122458|463169330|FG003|Overall Study|Withdrawal by Subject|4|||
128690903|NCT02122458|463169331|FG004|Overall Study|Withdrawal by Subject|4|||
128690904|NCT02122458|463169332|FG005|Overall Study|Withdrawal by Subject|4|||
128690905|NCT02122458|463169333|FG006|Overall Study|Withdrawal by Subject|0|||
128690906|NCT02122458|463169327|FG000|Overall Study|Lost to Follow-up|1|||
128690907|NCT02122458|463169328|FG001|Overall Study|Lost to Follow-up|3|||
128690908|NCT02122458|463169329|FG002|Overall Study|Lost to Follow-up|0|||
128894361|NCT01786603|463908604|FG000|Overall Study|Physician decision to withdraw|6|||
128894362|NCT01786603|463908605|FG001|Overall Study|Physician decision to withdraw|7|||
128894363|NCT01786603|463908604|FG000|Overall Study|Lost to Follow-up|1|||
128894364|NCT01786603|463908605|FG001|Overall Study|Lost to Follow-up|2|||
128894365|NCT01226459|463908606|FG000|Overall Study|Adverse Event|2|||
128690909|NCT02122458|463169330|FG003|Overall Study|Lost to Follow-up|7|||
128690910|NCT02122458|463169331|FG004|Overall Study|Lost to Follow-up|5|||
128894366|NCT01226459|463908607|FG001|Overall Study|Adverse Event|8|||
128894367|NCT01226459|463908606|FG000|Overall Study|Protocol Violation|4|||
128690911|NCT02122458|463169332|FG005|Overall Study|Lost to Follow-up|15|||
128690912|NCT02122458|463169333|FG006|Overall Study|Lost to Follow-up|1|||
128690913|NCT02122458|463169327|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
128690914|NCT02122458|463169328|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
128690915|NCT02122458|463169329|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
128690916|NCT02122458|463169330|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
128764390|NCT03929562|463428306|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
128894368|NCT01226459|463908607|FG001|Overall Study|Protocol Violation|3|||
128894369|NCT01226459|463908606|FG000|Overall Study|Withdrawal by Subject|10|||
128894370|NCT01226459|463908607|FG001|Overall Study|Withdrawal by Subject|13|||
128894371|NCT01226459|463908606|FG000|Overall Study|Lost to Follow-up|4|||
128894372|NCT01226459|463908607|FG001|Overall Study|Lost to Follow-up|8|||
128894373|NCT01226459|463908606|FG000|Overall Study|Pregnancy|1|||
128894374|NCT01226459|463908607|FG001|Overall Study|Pregnancy|0|||
128894375|NCT00474708|463908608|FG000|Overall Study|Lack of Efficacy|11|||
128894376|NCT00474708|463908609|FG001|Overall Study|Lack of Efficacy|5|||
128894377|NCT00474708|463908608|FG000|Overall Study|Suicide ideation/behavior|0|||
128894378|NCT00474708|463908609|FG001|Overall Study|Suicide ideation/behavior|1|||
128894379|NCT00474708|463908608|FG000|Overall Study|Withdrawal by Subject|7|||
128894380|NCT00474708|463908609|FG001|Overall Study|Withdrawal by Subject|0|||
128894381|NCT00474708|463908608|FG000|Overall Study|Lack of compliance|12|||
128894382|NCT00474708|463908609|FG001|Overall Study|Lack of compliance|4|||
129021183|NCT00579345|464369219|FG003|Overall Study|Protocol Violation|0|||
128764391|NCT03929562|463428305|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
128764392|NCT03929562|463428306|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
128894383|NCT00474708|463908608|FG000|Overall Study|Lost to Follow-up|18|||
128894384|NCT00474708|463908609|FG001|Overall Study|Lost to Follow-up|9|||
128690917|NCT02122458|463169331|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
128690918|NCT02122458|463169332|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
128690919|NCT02122458|463169333|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
128690920|NCT02122458|463169327|FG000|Overall Study|Adverse Event|1|||
128690921|NCT02122458|463169328|FG001|Overall Study|Adverse Event|0|||
128894385|NCT00474708|463908608|FG000|Overall Study|Physician Decision|9|||
128894386|NCT00474708|463908609|FG001|Overall Study|Physician Decision|6|||
128894387|NCT03700320|463908613|FG000|Overall Study|Adverse Event|5|||
128894388|NCT03700320|463908614|FG001|Overall Study|Adverse Event|31|||
129021184|NCT00579345|464369220|FG004|Overall Study|Protocol Violation|0|||
128894389|NCT03700320|463908613|FG000|Overall Study|Lack of Efficacy|2|||
128894390|NCT03700320|463908614|FG001|Overall Study|Lack of Efficacy|5|||
128894391|NCT03700320|463908613|FG000|Overall Study|Withdrawal by Subject|29|||
128894392|NCT03700320|463908614|FG001|Overall Study|Withdrawal by Subject|75|||
128894393|NCT03700320|463908613|FG000|Overall Study|Lost to Follow-up|16|||
128894394|NCT03700320|463908614|FG001|Overall Study|Lost to Follow-up|23|||
128894395|NCT03700320|463908613|FG000|Overall Study|Pregnancy|2|||
128894396|NCT03700320|463908614|FG001|Overall Study|Pregnancy|4|||
128894397|NCT03700320|463908613|FG000|Overall Study|Protocol Deviation|7|||
128690922|NCT02122458|463169329|FG002|Overall Study|Adverse Event|0|||
128690923|NCT02122458|463169330|FG003|Overall Study|Adverse Event|0|||
128690924|NCT02122458|463169331|FG004|Overall Study|Adverse Event|0|||
128690925|NCT02122458|463169332|FG005|Overall Study|Adverse Event|0|||
128690926|NCT02122458|463169333|FG006|Overall Study|Adverse Event|0|||
128690927|NCT02122458|463169327|FG000|Overall Study|Experimental Error|0|||
128690928|NCT02122458|463169328|FG001|Overall Study|Experimental Error|0|||
128894398|NCT03700320|463908614|FG001|Overall Study|Protocol Deviation|31|||
128894399|NCT03700320|463908613|FG000|Overall Study|Non-compliance with Study Drug|1|||
128894400|NCT03700320|463908614|FG001|Overall Study|Non-compliance with Study Drug|3|||
128894401|NCT03700320|463908613|FG000|Overall Study|Reason not Specified|0|||
128894402|NCT03700320|463908614|FG001|Overall Study|Reason not Specified|1|||
128894403|NCT00175877|463908615|FG000|Overall Study|Adverse Event|136|||
128894404|NCT00175877|463908615|FG000|Overall Study|Withdrawal by Subject|141|||
128894405|NCT00175877|463908615|FG000|Overall Study|Lost to Follow-up|9|||
128894406|NCT00175877|463908615|FG000|Overall Study|Lack of Efficacy|26|||
128894407|NCT00175877|463908615|FG000|Overall Study|Protocol Violation|15|||
128894408|NCT00175877|463908615|FG000|Overall Study|Other Reason|20|||
128894409|NCT00175877|463908615|FG000|Overall Study|AE & Other|1|||
128894410|NCT00175877|463908615|FG000|Overall Study|Withdrawal by subject & Other|1|||
128894411|NCT01092143|463908618|FG000|Overall Study|Adverse Event|10|||
128894412|NCT01092143|463908619|FG001|Overall Study|Adverse Event|5|||
128894413|NCT01092143|463908620|FG002|Overall Study|Adverse Event|1|||
128894414|NCT01092143|463908621|FG003|Overall Study|Adverse Event|4|||
128690929|NCT02122458|463169329|FG002|Overall Study|Experimental Error|0|||
128690930|NCT02122458|463169330|FG003|Overall Study|Experimental Error|0|||
128690931|NCT02122458|463169331|FG004|Overall Study|Experimental Error|3|||
128690932|NCT02122458|463169332|FG005|Overall Study|Experimental Error|0|||
128690933|NCT02122458|463169333|FG006|Overall Study|Experimental Error|0|||
128690934|NCT02122458|463169327|FG000|Overall Study|Deployed or Moved|0|||
128894415|NCT01092143|463908622|FG004|Overall Study|Adverse Event|3|||
128894416|NCT01092143|463908618|FG000|Overall Study|Lost to Follow-up|1|||
128894417|NCT01092143|463908619|FG001|Overall Study|Lost to Follow-up|0|||
128894418|NCT01092143|463908620|FG002|Overall Study|Lost to Follow-up|1|||
128894419|NCT01092143|463908621|FG003|Overall Study|Lost to Follow-up|0|||
128894420|NCT01092143|463908622|FG004|Overall Study|Lost to Follow-up|0|||
128894421|NCT01092143|463908618|FG000|Overall Study|Consent withdrawn|2|||
129021185|NCT00579345|464369221|FG005|Overall Study|Protocol Violation|0|||
129021186|NCT00579345|464369222|FG006|Overall Study|Protocol Violation|0|||
129021187|NCT00579345|464369223|FG007|Overall Study|Protocol Violation|1|||
129021188|NCT00579345|464369216|FG000|Overall Study|Death|1|||
129021189|NCT00579345|464369217|FG001|Overall Study|Death|1|||
129021190|NCT00579345|464369218|FG002|Overall Study|Death|1|||
129021191|NCT00579345|464369219|FG003|Overall Study|Death|1|||
129021192|NCT00579345|464369220|FG004|Overall Study|Death|0|||
129021193|NCT00579345|464369221|FG005|Overall Study|Death|0|||
128764393|NCT03929562|463428305|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
129021194|NCT00579345|464369222|FG006|Overall Study|Death|0|||
129021195|NCT00579345|464369223|FG007|Overall Study|Death|0|||
129021196|NCT03255733|464369227|FG000|Overall Study|Lost to Follow-up|4|||
128894422|NCT01092143|463908619|FG001|Overall Study|Consent withdrawn|1|||
128894423|NCT01092143|463908620|FG002|Overall Study|Consent withdrawn|0|||
128894424|NCT01092143|463908621|FG003|Overall Study|Consent withdrawn|1|||
129021197|NCT03653507|464369229|FG000|Overall Study|Miscellaneous|28|||
129021198|NCT03653507|464369230|FG001|Overall Study|Miscellaneous|19|||
129021199|NCT03653507|464369229|FG000|Overall Study|Withdrawal by Subject|37|||
129021200|NCT03653507|464369230|FG001|Overall Study|Withdrawal by Subject|22|||
129021201|NCT03653507|464369229|FG000|Overall Study|Protocol Deviation|2|||
128894425|NCT01092143|463908622|FG004|Overall Study|Consent withdrawn|3|||
128690935|NCT02122458|463169328|FG001|Overall Study|Deployed or Moved|0|||
128690936|NCT02122458|463169329|FG002|Overall Study|Deployed or Moved|0|||
128690937|NCT02122458|463169330|FG003|Overall Study|Deployed or Moved|0|||
128690938|NCT02122458|463169331|FG004|Overall Study|Deployed or Moved|1|||
128690939|NCT02122458|463169332|FG005|Overall Study|Deployed or Moved|0|||
128690940|NCT02122458|463169333|FG006|Overall Study|Deployed or Moved|0|||
128690941|NCT02122458|463169327|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
128690942|NCT02122458|463169328|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
128894426|NCT01092143|463908618|FG000|Overall Study|Not treated|0|||
128894427|NCT01092143|463908619|FG001|Overall Study|Not treated|0|||
128894428|NCT01092143|463908620|FG002|Overall Study|Not treated|1|||
129021202|NCT03653507|464369230|FG001|Overall Study|Protocol Deviation|1|||
129021203|NCT03653507|464369229|FG000|Overall Study|Progressive disease|117|||
128894429|NCT01092143|463908621|FG003|Overall Study|Not treated|0|||
128894430|NCT01092143|463908622|FG004|Overall Study|Not treated|0|||
128894431|NCT01092143|463908618|FG000|Overall Study|did not reversibility criteria|0|||
128894432|NCT01092143|463908619|FG001|Overall Study|did not reversibility criteria|0|||
128894433|NCT01092143|463908620|FG002|Overall Study|did not reversibility criteria|1|||
128894434|NCT01092143|463908621|FG003|Overall Study|did not reversibility criteria|0|||
128894435|NCT01092143|463908622|FG004|Overall Study|did not reversibility criteria|0|||
128894436|NCT01092143|463908618|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
128894437|NCT01092143|463908619|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
128894438|NCT01092143|463908620|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
128894439|NCT01092143|463908621|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
128894440|NCT01092143|463908622|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
128894441|NCT01092143|463908618|FG000|Overall Study|Ineligible patient|1|||
128894442|NCT01092143|463908619|FG001|Overall Study|Ineligible patient|0|||
128894443|NCT01092143|463908620|FG002|Overall Study|Ineligible patient|0|||
128894444|NCT01092143|463908621|FG003|Overall Study|Ineligible patient|0|||
128894445|NCT01092143|463908622|FG004|Overall Study|Ineligible patient|0|||
128894446|NCT01092143|463908618|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
128894447|NCT01092143|463908619|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
128894448|NCT01092143|463908620|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
128894449|NCT01092143|463908621|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
128894450|NCT01092143|463908622|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
128894451|NCT01092143|463908618|FG000|Overall Study|Patient travel|0|||
128894452|NCT01092143|463908619|FG001|Overall Study|Patient travel|0|||
128894453|NCT01092143|463908620|FG002|Overall Study|Patient travel|0|||
128894454|NCT01092143|463908621|FG003|Overall Study|Patient travel|0|||
128894455|NCT01092143|463908622|FG004|Overall Study|Patient travel|1|||
128894456|NCT01092143|463908618|FG000|Overall Study|Non compliance with study medication|0|||
128894457|NCT01092143|463908619|FG001|Overall Study|Non compliance with study medication|0|||
128894458|NCT01092143|463908620|FG002|Overall Study|Non compliance with study medication|0|||
128894459|NCT01092143|463908621|FG003|Overall Study|Non compliance with study medication|0|||
128894460|NCT01092143|463908622|FG004|Overall Study|Non compliance with study medication|1|||
128894461|NCT01092143|463908618|FG000|Overall Study|Randomized by mistake|0|||
128894462|NCT01092143|463908619|FG001|Overall Study|Randomized by mistake|0|||
128894463|NCT01092143|463908620|FG002|Overall Study|Randomized by mistake|0|||
128894464|NCT01092143|463908621|FG003|Overall Study|Randomized by mistake|1|||
128894465|NCT01092143|463908622|FG004|Overall Study|Randomized by mistake|0|||
128894466|NCT01092143|463908618|FG000|Overall Study|Pregnancy|0|||
128894467|NCT01092143|463908619|FG001|Overall Study|Pregnancy|0|||
128894468|NCT01092143|463908620|FG002|Overall Study|Pregnancy|0|||
128894469|NCT01092143|463908621|FG003|Overall Study|Pregnancy|1|||
128894470|NCT01092143|463908622|FG004|Overall Study|Pregnancy|0|||
129021204|NCT03653507|464369230|FG001|Overall Study|Progressive disease|168|||
129021205|NCT03653507|464369229|FG000|Overall Study|Lost to Follow-up|1|||
129021206|NCT03653507|464369230|FG001|Overall Study|Lost to Follow-up|1|||
129021207|NCT03653507|464369229|FG000|Overall Study|Death|25|||
129021208|NCT03653507|464369230|FG001|Overall Study|Death|22|||
129021209|NCT03653507|464369229|FG000|Overall Study|Adverse Event|35|||
129021210|NCT03653507|464369230|FG001|Overall Study|Adverse Event|14|||
129021211|NCT01701674|464369231|FG000|Overall Study|Unable to safely complete treatment|1|||
128690943|NCT02122458|463169329|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
128690944|NCT02122458|463169330|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
128690945|NCT02122458|463169331|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
128690946|NCT02122458|463169332|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
128690947|NCT02122458|463169333|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
128690948|NCT02122458|463169327|FG000|Overall Study|Noncompliance|0|||
128690949|NCT02122458|463169328|FG001|Overall Study|Noncompliance|1|||
128894471|NCT03986866|463908623|FG000|Overall Study|Withdrawal by Subject|0|||
128894472|NCT03986866|463908624|FG001|Overall Study|Withdrawal by Subject|3|||
128894473|NCT03986866|463908623|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
128894474|NCT03986866|463908624|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
128894475|NCT05093322|463908627|FG000|Overall Study|Death|6|||
128894476|NCT05093322|463908628|FG001|Overall Study|Death|2|||
128894477|NCT05093322|463908627|FG000|Overall Study|Other|4|||
128894478|NCT05093322|463908628|FG001|Overall Study|Other|1|||
128894479|NCT00397033|463908634|FG000|Overall Study|Adverse Event|7|||
128894480|NCT00397033|463908635|FG001|Overall Study|Adverse Event|10|||
128894481|NCT00397033|463908636|FG002|Overall Study|Adverse Event|4|||
128894482|NCT00397033|463908634|FG000|Overall Study|Lack of Efficacy|22|||
129021212|NCT05604170|464369232|FG000|Overall Study|Lack of Efficacy|5|||
129021213|NCT05604170|464369232|FG000|Overall Study|Adverse Event|6|||
128690950|NCT02122458|463169329|FG002|Overall Study|Noncompliance|0|||
128690951|NCT02122458|463169330|FG003|Overall Study|Noncompliance|0|||
128690952|NCT02122458|463169331|FG004|Overall Study|Noncompliance|0|||
128690953|NCT02122458|463169332|FG005|Overall Study|Noncompliance|0|||
128894483|NCT00397033|463908635|FG001|Overall Study|Lack of Efficacy|12|||
128894484|NCT00397033|463908636|FG002|Overall Study|Lack of Efficacy|9|||
128894485|NCT00397033|463908634|FG000|Overall Study|Lost to Follow-up|3|||
128894486|NCT00397033|463908635|FG001|Overall Study|Lost to Follow-up|3|||
128894487|NCT00397033|463908636|FG002|Overall Study|Lost to Follow-up|3|||
128894488|NCT00397033|463908634|FG000|Overall Study|Withdrawal by Subject|12|||
128894489|NCT00397033|463908635|FG001|Overall Study|Withdrawal by Subject|7|||
128894490|NCT00397033|463908636|FG002|Overall Study|Withdrawal by Subject|5|||
128894491|NCT00397033|463908634|FG000|Overall Study|Other|0|||
128894492|NCT00397033|463908635|FG001|Overall Study|Other|5|||
128894493|NCT00397033|463908636|FG002|Overall Study|Other|2|||
128894494|NCT01994382|463910082|FG000|Overall Study|Informed consent withdrawn|0|||
128894495|NCT01994382|463910083|FG001|Overall Study|Informed consent withdrawn|0|||
128894496|NCT01994382|463910084|FG002|Overall Study|Informed consent withdrawn|0|||
128894497|NCT01994382|463910085|FG003|Overall Study|Informed consent withdrawn|0|||
128894498|NCT01994382|463910086|FG004|Overall Study|Informed consent withdrawn|0|||
128894499|NCT01994382|463910087|FG005|Overall Study|Informed consent withdrawn|0|||
128894500|NCT01994382|463910088|FG006|Overall Study|Informed consent withdrawn|1|||
128894501|NCT01994382|463910089|FG007|Overall Study|Informed consent withdrawn|0|||
128894502|NCT01994382|463910090|FG008|Overall Study|Informed consent withdrawn|0|||
128894503|NCT01994382|463910091|FG009|Overall Study|Informed consent withdrawn|0|||
128894504|NCT01994382|463910092|FG010|Overall Study|Informed consent withdrawn|0|||
128894505|NCT01994382|463910093|FG011|Overall Study|Informed consent withdrawn|0|||
128894506|NCT01994382|463910094|FG012|Overall Study|Informed consent withdrawn|0|||
128894507|NCT01994382|463910095|FG013|Overall Study|Informed consent withdrawn|0|||
128894508|NCT01994382|463910096|FG014|Overall Study|Informed consent withdrawn|0|||
128894509|NCT01994382|463910097|FG015|Overall Study|Informed consent withdrawn|0|||
128894510|NCT01994382|463910098|FG016|Overall Study|Informed consent withdrawn|0|||
128894511|NCT01994382|463910082|FG000|Overall Study|Progressive disease|3|||
128894512|NCT01994382|463910083|FG001|Overall Study|Progressive disease|4|||
128894513|NCT01994382|463910084|FG002|Overall Study|Progressive disease|4|||
128894514|NCT01994382|463910085|FG003|Overall Study|Progressive disease|3|||
128894515|NCT01994382|463910086|FG004|Overall Study|Progressive disease|2|||
128894516|NCT01994382|463910087|FG005|Overall Study|Progressive disease|3|||
128894517|NCT01994382|463910088|FG006|Overall Study|Progressive disease|3|||
128894518|NCT01994382|463910089|FG007|Overall Study|Progressive disease|6|||
128894519|NCT01994382|463910090|FG008|Overall Study|Progressive disease|2|||
128894520|NCT01994382|463910091|FG009|Overall Study|Progressive disease|2|||
128894521|NCT01994382|463910092|FG010|Overall Study|Progressive disease|13|||
128894522|NCT01994382|463910093|FG011|Overall Study|Progressive disease|8|||
128894523|NCT01994382|463910094|FG012|Overall Study|Progressive disease|7|||
128894524|NCT01994382|463910095|FG013|Overall Study|Progressive disease|3|||
128894525|NCT01994382|463910096|FG014|Overall Study|Progressive disease|6|||
128894526|NCT01994382|463910097|FG015|Overall Study|Progressive disease|44|||
128894527|NCT01994382|463910098|FG016|Overall Study|Progressive disease|28|||
128894528|NCT01994382|463910082|FG000|Overall Study|Physician Decision|0|||
128894529|NCT01994382|463910083|FG001|Overall Study|Physician Decision|1|||
128894530|NCT01994382|463910084|FG002|Overall Study|Physician Decision|0|||
128894531|NCT01994382|463910085|FG003|Overall Study|Physician Decision|0|||
128894532|NCT01994382|463910086|FG004|Overall Study|Physician Decision|0|||
129021214|NCT05604170|464369232|FG000|Overall Study|Physician Decision|6|||
129021215|NCT05604170|464369232|FG000|Overall Study|Lost to Follow-up|6|||
129021216|NCT05604170|464369232|FG000|Overall Study|Withdrawal by Subject|11|||
129021217|NCT05604170|464369232|FG000|Overall Study|Early study termination by sponsor|77|||
128764394|NCT03929562|463428306|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
128764395|NCT01778556|463428307|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
128764396|NCT01778556|463428308|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
128764397|NCT01778556|463428307|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
128764398|NCT01778556|463428308|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
128764399|NCT01778556|463428307|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
128764400|NCT01778556|463428308|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
129021218|NCT05604170|464369232|FG000|Overall Study|Other|6|||
128894533|NCT01994382|463910087|FG005|Overall Study|Physician Decision|0|||
128894534|NCT01994382|463910088|FG006|Overall Study|Physician Decision|0|||
129021219|NCT03032172|464369233|FG000|Treatment Period|Adverse Event|0|||
129021220|NCT03032172|464369234|FG001|Treatment Period|Adverse Event|1|||
129215204|NCT01588522|465089467|FG003|Overall Study|Withdrawal by Subject|1|||
128894535|NCT01994382|463910089|FG007|Overall Study|Physician Decision|0|||
128894536|NCT01994382|463910090|FG008|Overall Study|Physician Decision|0|||
128894537|NCT01994382|463910091|FG009|Overall Study|Physician Decision|0|||
128894538|NCT01994382|463910092|FG010|Overall Study|Physician Decision|3|||
128894539|NCT01994382|463910093|FG011|Overall Study|Physician Decision|1|||
128894540|NCT01994382|463910094|FG012|Overall Study|Physician Decision|1|||
128894541|NCT01994382|463910095|FG013|Overall Study|Physician Decision|0|||
128894542|NCT01994382|463910096|FG014|Overall Study|Physician Decision|1|||
128894543|NCT01994382|463910097|FG015|Overall Study|Physician Decision|4|||
128894544|NCT01994382|463910098|FG016|Overall Study|Physician Decision|2|||
129021221|NCT03032172|464369235|FG002|Treatment Period|Adverse Event|0|||
128894545|NCT01994382|463910082|FG000|Overall Study|Death|0|||
128894546|NCT01994382|463910083|FG001|Overall Study|Death|0|||
128894547|NCT01994382|463910084|FG002|Overall Study|Death|0|||
128894548|NCT01994382|463910085|FG003|Overall Study|Death|0|||
128894549|NCT01994382|463910086|FG004|Overall Study|Death|1|||
128894550|NCT01994382|463910087|FG005|Overall Study|Death|0|||
128894551|NCT01994382|463910088|FG006|Overall Study|Death|0|||
128894552|NCT01994382|463910089|FG007|Overall Study|Death|0|||
128894553|NCT01994382|463910090|FG008|Overall Study|Death|1|||
128894554|NCT01994382|463910091|FG009|Overall Study|Death|1|||
128894555|NCT01994382|463910092|FG010|Overall Study|Death|0|||
128894556|NCT01994382|463910093|FG011|Overall Study|Death|0|||
128894557|NCT01994382|463910094|FG012|Overall Study|Death|0|||
128894558|NCT01994382|463910095|FG013|Overall Study|Death|0|||
128894559|NCT01994382|463910096|FG014|Overall Study|Death|0|||
128894560|NCT01994382|463910097|FG015|Overall Study|Death|1|||
128894561|NCT01994382|463910098|FG016|Overall Study|Death|0|||
128894562|NCT01994382|463910082|FG000|Overall Study|Adverse Event|0|||
128894563|NCT01994382|463910083|FG001|Overall Study|Adverse Event|1|||
128894564|NCT01994382|463910084|FG002|Overall Study|Adverse Event|2|||
128894565|NCT01994382|463910085|FG003|Overall Study|Adverse Event|0|||
128894566|NCT01994382|463910086|FG004|Overall Study|Adverse Event|0|||
128894567|NCT01994382|463910087|FG005|Overall Study|Adverse Event|0|||
128894568|NCT01994382|463910088|FG006|Overall Study|Adverse Event|0|||
128894569|NCT01994382|463910089|FG007|Overall Study|Adverse Event|0|||
128894570|NCT01994382|463910090|FG008|Overall Study|Adverse Event|0|||
128894571|NCT01994382|463910091|FG009|Overall Study|Adverse Event|0|||
128894572|NCT01994382|463910092|FG010|Overall Study|Adverse Event|15|||
128894573|NCT01994382|463910093|FG011|Overall Study|Adverse Event|2|||
128894574|NCT01994382|463910094|FG012|Overall Study|Adverse Event|7|||
128894575|NCT01994382|463910095|FG013|Overall Study|Adverse Event|3|||
128894576|NCT01994382|463910096|FG014|Overall Study|Adverse Event|17|||
128894577|NCT01994382|463910097|FG015|Overall Study|Adverse Event|6|||
128894578|NCT01994382|463910098|FG016|Overall Study|Adverse Event|3|||
128894579|NCT01994382|463910082|FG000|Overall Study|Other than specified|0|||
128894580|NCT01994382|463910083|FG001|Overall Study|Other than specified|0|||
128894581|NCT01994382|463910084|FG002|Overall Study|Other than specified|0|||
128894582|NCT01994382|463910085|FG003|Overall Study|Other than specified|0|||
128894583|NCT01994382|463910086|FG004|Overall Study|Other than specified|0|||
128894584|NCT01994382|463910087|FG005|Overall Study|Other than specified|0|||
128894585|NCT01994382|463910088|FG006|Overall Study|Other than specified|0|||
128894586|NCT01994382|463910089|FG007|Overall Study|Other than specified|0|||
128894587|NCT01994382|463910090|FG008|Overall Study|Other than specified|0|||
128894588|NCT01994382|463910091|FG009|Overall Study|Other than specified|0|||
128894589|NCT01994382|463910092|FG010|Overall Study|Other than specified|2|||
128894590|NCT01994382|463910093|FG011|Overall Study|Other than specified|0|||
128894591|NCT01994382|463910094|FG012|Overall Study|Other than specified|2|||
128894592|NCT01994382|463910095|FG013|Overall Study|Other than specified|0|||
128894593|NCT01994382|463910096|FG014|Overall Study|Other than specified|0|||
128894594|NCT01994382|463910097|FG015|Overall Study|Other than specified|4|||
128894595|NCT01994382|463910098|FG016|Overall Study|Other than specified|4|||
128894596|NCT01994382|463910082|FG000|Overall Study|Withdrawal by Subject|0|||
128894597|NCT01994382|463910083|FG001|Overall Study|Withdrawal by Subject|0|||
128894598|NCT01994382|463910084|FG002|Overall Study|Withdrawal by Subject|0|||
128894599|NCT01994382|463910085|FG003|Overall Study|Withdrawal by Subject|0|||
128894600|NCT01994382|463910086|FG004|Overall Study|Withdrawal by Subject|0|||
128894601|NCT01994382|463910087|FG005|Overall Study|Withdrawal by Subject|0|||
128894602|NCT01994382|463910088|FG006|Overall Study|Withdrawal by Subject|0|||
128894603|NCT01994382|463910089|FG007|Overall Study|Withdrawal by Subject|0|||
128894604|NCT01994382|463910090|FG008|Overall Study|Withdrawal by Subject|0|||
128894605|NCT01994382|463910091|FG009|Overall Study|Withdrawal by Subject|0|||
128894606|NCT01994382|463910092|FG010|Overall Study|Withdrawal by Subject|6|||
128894607|NCT01994382|463910093|FG011|Overall Study|Withdrawal by Subject|0|||
128894608|NCT01994382|463910094|FG012|Overall Study|Withdrawal by Subject|2|||
128690954|NCT02122458|463169333|FG006|Overall Study|Noncompliance|0|||
128894609|NCT01994382|463910095|FG013|Overall Study|Withdrawal by Subject|0|||
128894610|NCT01994382|463910096|FG014|Overall Study|Withdrawal by Subject|4|||
128894611|NCT01994382|463910097|FG015|Overall Study|Withdrawal by Subject|3|||
128894612|NCT01994382|463910098|FG016|Overall Study|Withdrawal by Subject|0|||
128894613|NCT01994382|463910082|FG000|Overall Study|Lost to Follow-up|0|||
128894614|NCT01994382|463910083|FG001|Overall Study|Lost to Follow-up|0|||
128894615|NCT01994382|463910084|FG002|Overall Study|Lost to Follow-up|0|||
128894616|NCT01994382|463910085|FG003|Overall Study|Lost to Follow-up|0|||
128894617|NCT01994382|463910086|FG004|Overall Study|Lost to Follow-up|0|||
128894618|NCT01994382|463910087|FG005|Overall Study|Lost to Follow-up|0|||
128894619|NCT01994382|463910088|FG006|Overall Study|Lost to Follow-up|0|||
128894620|NCT01994382|463910089|FG007|Overall Study|Lost to Follow-up|0|||
128894621|NCT01994382|463910090|FG008|Overall Study|Lost to Follow-up|0|||
128894622|NCT01994382|463910091|FG009|Overall Study|Lost to Follow-up|0|||
128894623|NCT01994382|463910092|FG010|Overall Study|Lost to Follow-up|1|||
128894624|NCT01994382|463910093|FG011|Overall Study|Lost to Follow-up|0|||
128894625|NCT01994382|463910094|FG012|Overall Study|Lost to Follow-up|0|||
128894626|NCT01994382|463910095|FG013|Overall Study|Lost to Follow-up|0|||
128894627|NCT01994382|463910096|FG014|Overall Study|Lost to Follow-up|0|||
128894628|NCT01994382|463910097|FG015|Overall Study|Lost to Follow-up|0|||
128894629|NCT01994382|463910098|FG016|Overall Study|Lost to Follow-up|0|||
128894630|NCT01994382|463910082|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894631|NCT01994382|463910083|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894632|NCT01994382|463910084|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894633|NCT01994382|463910085|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894634|NCT01994382|463910086|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894635|NCT01994382|463910087|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894636|NCT01994382|463910088|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894637|NCT01994382|463910089|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894638|NCT01994382|463910090|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894639|NCT01994382|463910091|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894640|NCT01994382|463910092|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
128894641|NCT01994382|463910093|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894642|NCT01994382|463910094|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
128894643|NCT01994382|463910095|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894644|NCT01994382|463910096|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
128894645|NCT01994382|463910097|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
128894646|NCT01994382|463910098|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
128894647|NCT01994382|463910082|FG000|Overall Study|Protocol violation/noncompliance|0|||
128894648|NCT01994382|463910083|FG001|Overall Study|Protocol violation/noncompliance|0|||
128894649|NCT01994382|463910084|FG002|Overall Study|Protocol violation/noncompliance|0|||
128894650|NCT01994382|463910085|FG003|Overall Study|Protocol violation/noncompliance|0|||
128894651|NCT01994382|463910086|FG004|Overall Study|Protocol violation/noncompliance|0|||
128894652|NCT01994382|463910087|FG005|Overall Study|Protocol violation/noncompliance|0|||
128894653|NCT01994382|463910088|FG006|Overall Study|Protocol violation/noncompliance|0|||
128894654|NCT01994382|463910089|FG007|Overall Study|Protocol violation/noncompliance|0|||
128894655|NCT01994382|463910090|FG008|Overall Study|Protocol violation/noncompliance|0|||
128894656|NCT01994382|463910091|FG009|Overall Study|Protocol violation/noncompliance|0|||
128894657|NCT01994382|463910092|FG010|Overall Study|Protocol violation/noncompliance|0|||
128894658|NCT01994382|463910093|FG011|Overall Study|Protocol violation/noncompliance|1|||
128894659|NCT01994382|463910094|FG012|Overall Study|Protocol violation/noncompliance|0|||
128894660|NCT01994382|463910095|FG013|Overall Study|Protocol violation/noncompliance|0|||
128894661|NCT01994382|463910096|FG014|Overall Study|Protocol violation/noncompliance|0|||
128894662|NCT01994382|463910097|FG015|Overall Study|Protocol violation/noncompliance|0|||
128894663|NCT01994382|463910098|FG016|Overall Study|Protocol violation/noncompliance|2|||
128894664|NCT01994382|463910082|FG000|Overall Study|Rolled over to Phase 2a|0|||
128894665|NCT01994382|463910083|FG001|Overall Study|Rolled over to Phase 2a|0|||
128894666|NCT01994382|463910084|FG002|Overall Study|Rolled over to Phase 2a|1|||
128894667|NCT01994382|463910085|FG003|Overall Study|Rolled over to Phase 2a|0|||
128894668|NCT01994382|463910086|FG004|Overall Study|Rolled over to Phase 2a|0|||
128894669|NCT01994382|463910087|FG005|Overall Study|Rolled over to Phase 2a|0|||
128894670|NCT01994382|463910088|FG006|Overall Study|Rolled over to Phase 2a|0|||
128894671|NCT01994382|463910089|FG007|Overall Study|Rolled over to Phase 2a|0|||
128894672|NCT01994382|463910090|FG008|Overall Study|Rolled over to Phase 2a|0|||
128894673|NCT01994382|463910091|FG009|Overall Study|Rolled over to Phase 2a|2|||
128894674|NCT01994382|463910092|FG010|Overall Study|Rolled over to Phase 2a|0|||
128894675|NCT01994382|463910093|FG011|Overall Study|Rolled over to Phase 2a|0|||
128894676|NCT01994382|463910094|FG012|Overall Study|Rolled over to Phase 2a|0|||
128894677|NCT01994382|463910095|FG013|Overall Study|Rolled over to Phase 2a|0|||
128894678|NCT01994382|463910096|FG014|Overall Study|Rolled over to Phase 2a|0|||
128894679|NCT01994382|463910097|FG015|Overall Study|Rolled over to Phase 2a|0|||
128894680|NCT01994382|463910098|FG016|Overall Study|Rolled over to Phase 2a|0|||
128894681|NCT00873366|463910101|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
129021222|NCT03032172|464369236|FG003|Treatment Period|Adverse Event|0|||
129021223|NCT03032172|464369237|FG004|Treatment Period|Adverse Event|0|||
129021224|NCT03032172|464369238|FG005|Treatment Period|Adverse Event|0|||
129021225|NCT03032172|464369239|FG006|Treatment Period|Adverse Event|0|||
129021226|NCT03032172|464369240|FG007|Treatment Period|Adverse Event|0|||
129021227|NCT03032172|464369233|FG000|Treatment Period|Lack of Efficacy|0|||
129021228|NCT03032172|464369234|FG001|Treatment Period|Lack of Efficacy|1|||
129021229|NCT03032172|464369235|FG002|Treatment Period|Lack of Efficacy|0|||
129021230|NCT03032172|464369236|FG003|Treatment Period|Lack of Efficacy|0|||
129021231|NCT03032172|464369237|FG004|Treatment Period|Lack of Efficacy|0|||
129021232|NCT03032172|464369238|FG005|Treatment Period|Lack of Efficacy|0|||
128690955|NCT00412542|463169334|FG000|Overall Study|Withdrawal by Subject|0|||
128690956|NCT00412542|463169335|FG001|Overall Study|Withdrawal by Subject|2|||
128690957|NCT00412542|463169334|FG000|Overall Study|Not Eligible|0|||
128894682|NCT00873366|463910101|FG000|Overall Study|Off tamoxifen due to side effects|2|||
128894683|NCT00873366|463910101|FG000|Overall Study|Refused to continue DM-BT testing|3|||
128894684|NCT01537198|463910108|FG000|Overall Study|RSV infection|2|||
128894685|NCT01537198|463910108|FG000|Overall Study|Adverse Event|4|||
128894686|NCT01537198|463910108|FG000|Overall Study|No Further Visits to the Clinic|37|||
128894687|NCT01537198|463910108|FG000|Overall Study|Other|111|||
128894688|NCT01231659|463910109|FG000|Overall Study|Adverse Event|9|||
128894689|NCT01231659|463910109|FG000|Overall Study|Disease Progression|48|||
128894690|NCT01231659|463910109|FG000|Overall Study|Death|2|||
128894691|NCT01231659|463910109|FG000|Overall Study|Patient refused to complete study visit|1|||
128894692|NCT01231659|463910109|FG000|Overall Study|Other protocol defined criteria|12|||
128894693|NCT02247960|463910110|FG000|Patient Consent and Randomization|Physician Decision|2|||
128894694|NCT02247960|463910111|FG001|Patient Consent and Randomization|Physician Decision|2|||
128894695|NCT02247960|463910110|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
128894696|NCT02247960|463910111|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
128894697|NCT02247960|463910110|FG000|Catheter Removed|Lost to Follow-up|7|||
128894698|NCT02247960|463910111|FG001|Catheter Removed|Lost to Follow-up|10|||
128894699|NCT00356889|463910112|FG000|Overall Study|Protocol Violation|2|||
128894700|NCT00356889|463910112|FG000|Overall Study|Adverse Event|1|||
128894701|NCT00702325|463910113|FG000|Overall Study|Adverse Event|1|||
128894702|NCT00702325|463910114|FG001|Overall Study|Adverse Event|0|||
128894703|NCT00702325|463910113|FG000|Overall Study|Withdrawal by Subject|7|||
128894704|NCT00702325|463910114|FG001|Overall Study|Withdrawal by Subject|7|||
128894705|NCT00702325|463910113|FG000|Overall Study|Lost to Follow-up|3|||
128894706|NCT00702325|463910114|FG001|Overall Study|Lost to Follow-up|4|||
128894707|NCT00702325|463910113|FG000|Overall Study|Incorrect enrollment|5|||
129110894|NCT02326272|464701354|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110895|NCT02326272|464701355|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
129110896|NCT02326272|464701356|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129021233|NCT03032172|464369239|FG006|Treatment Period|Lack of Efficacy|0|||
129021234|NCT03032172|464369240|FG007|Treatment Period|Lack of Efficacy|0|||
129021235|NCT03032172|464369233|FG000|Treatment Period|Non-compliance With Study Drug|0|||
129021236|NCT03032172|464369234|FG001|Treatment Period|Non-compliance With Study Drug|1|||
129021237|NCT03032172|464369235|FG002|Treatment Period|Non-compliance With Study Drug|0|||
129021238|NCT03032172|464369236|FG003|Treatment Period|Non-compliance With Study Drug|0|||
129021239|NCT03032172|464369237|FG004|Treatment Period|Non-compliance With Study Drug|0|||
129021240|NCT03032172|464369238|FG005|Treatment Period|Non-compliance With Study Drug|0|||
129021241|NCT03032172|464369239|FG006|Treatment Period|Non-compliance With Study Drug|0|||
129021242|NCT03032172|464369240|FG007|Treatment Period|Non-compliance With Study Drug|0|||
129021243|NCT03032172|464369233|FG000|Treatment Period|Reason Not Specified|0|||
129021244|NCT03032172|464369234|FG001|Treatment Period|Reason Not Specified|4|||
129021245|NCT03032172|464369235|FG002|Treatment Period|Reason Not Specified|1|||
129021246|NCT03032172|464369236|FG003|Treatment Period|Reason Not Specified|0|||
129021247|NCT03032172|464369237|FG004|Treatment Period|Reason Not Specified|0|||
129021248|NCT03032172|464369238|FG005|Treatment Period|Reason Not Specified|0|||
129021249|NCT03032172|464369239|FG006|Treatment Period|Reason Not Specified|0|||
129021250|NCT03032172|464369240|FG007|Treatment Period|Reason Not Specified|0|||
129021251|NCT03032172|464369233|FG000|Treatment Period|Physician Decision|0|||
129021252|NCT03032172|464369234|FG001|Treatment Period|Physician Decision|2|||
129021253|NCT03032172|464369235|FG002|Treatment Period|Physician Decision|1|||
129021254|NCT03032172|464369236|FG003|Treatment Period|Physician Decision|0|||
129021255|NCT03032172|464369237|FG004|Treatment Period|Physician Decision|0|||
129021256|NCT03032172|464369238|FG005|Treatment Period|Physician Decision|0|||
129021257|NCT03032172|464369239|FG006|Treatment Period|Physician Decision|0|||
129021258|NCT03032172|464369240|FG007|Treatment Period|Physician Decision|0|||
129021259|NCT03032172|464369233|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129021260|NCT03032172|464369234|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
129021261|NCT03032172|464369235|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
129021262|NCT03032172|464369236|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
129110897|NCT02326272|464701357|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129021263|NCT03032172|464369237|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
128894708|NCT00702325|463910114|FG001|Overall Study|Incorrect enrollment|7|||
128894709|NCT00702325|463910113|FG000|Overall Study|Developed study discontinuation criteria|18|||
128894710|NCT00702325|463910114|FG001|Overall Study|Developed study discontinuation criteria|28|||
129021264|NCT03032172|464369238|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129021265|NCT03032172|464369239|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
128690958|NCT00412542|463169335|FG001|Overall Study|Not Eligible|1|||
128894711|NCT00702325|463910113|FG000|Overall Study|Severe noncompliance to protocol|3|||
128894712|NCT00702325|463910114|FG001|Overall Study|Severe noncompliance to protocol|3|||
128894713|NCT00702325|463910113|FG000|Overall Study|Termination due to lab results|1|||
128894714|NCT00702325|463910114|FG001|Overall Study|Termination due to lab results|0|||
128894715|NCT00702325|463910113|FG000|Overall Study|Didn't follow study medication dosage|0|||
128894716|NCT00702325|463910114|FG001|Overall Study|Didn't follow study medication dosage|2|||
128894717|NCT00702325|463910113|FG000|Overall Study|Withdrew consent|0|||
128894718|NCT00702325|463910114|FG001|Overall Study|Withdrew consent|1|||
128894719|NCT00702325|463910113|FG000|Overall Study|Incorrectly Discontinued|0|||
128894720|NCT00702325|463910114|FG001|Overall Study|Incorrectly Discontinued|1|||
128894721|NCT01022502|463910118|FG000|Overall Study|Adverse Event|1|||
128894722|NCT01022502|463910118|FG000|Overall Study|employment related reasons|1|||
128894723|NCT01022502|463910118|FG000|Overall Study|Withdrawal by Subject|1|||
128894724|NCT03716050|463910119|FG000|Overall Study|Lost to Follow-up|0|||
128894725|NCT03716050|463910120|FG001|Overall Study|Lost to Follow-up|0|||
128894726|NCT03716050|463910121|FG002|Overall Study|Lost to Follow-up|1|||
128894727|NCT03716050|463910122|FG003|Overall Study|Lost to Follow-up|0|||
128894728|NCT03716050|463910123|FG004|Overall Study|Lost to Follow-up|0|||
128894729|NCT03716050|463910124|FG005|Overall Study|Lost to Follow-up|0|||
128894730|NCT03716050|463910125|FG006|Overall Study|Lost to Follow-up|0|||
128894731|NCT03716050|463910126|FG007|Overall Study|Lost to Follow-up|0|||
128894732|NCT03716050|463910119|FG000|Overall Study|Physician Decision|0|||
128894733|NCT03716050|463910120|FG001|Overall Study|Physician Decision|0|||
128894734|NCT03716050|463910121|FG002|Overall Study|Physician Decision|0|||
128894735|NCT03716050|463910122|FG003|Overall Study|Physician Decision|1|||
128894736|NCT03716050|463910123|FG004|Overall Study|Physician Decision|0|||
128894737|NCT03716050|463910124|FG005|Overall Study|Physician Decision|0|||
128894738|NCT03716050|463910125|FG006|Overall Study|Physician Decision|0|||
128894739|NCT03716050|463910126|FG007|Overall Study|Physician Decision|0|||
128894740|NCT03716050|463910119|FG000|Overall Study|Protocol Violation|0|||
128894741|NCT03716050|463910120|FG001|Overall Study|Protocol Violation|0|||
128894742|NCT03716050|463910121|FG002|Overall Study|Protocol Violation|0|||
128894743|NCT03716050|463910122|FG003|Overall Study|Protocol Violation|1|||
128894744|NCT03716050|463910123|FG004|Overall Study|Protocol Violation|0|||
128894745|NCT03716050|463910124|FG005|Overall Study|Protocol Violation|0|||
128894746|NCT03716050|463910125|FG006|Overall Study|Protocol Violation|0|||
128894747|NCT03716050|463910126|FG007|Overall Study|Protocol Violation|2|||
128894748|NCT03123250|463910127|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
128894749|NCT01390272|463910128|FG000|Overall Study|Death|3|||
128894750|NCT01390272|463910129|FG001|Overall Study|Death|2|||
128894751|NCT01390272|463910128|FG000|Overall Study|Withdrawal by Subject|9|||
128894752|NCT01390272|463910129|FG001|Overall Study|Withdrawal by Subject|5|||
128894753|NCT01390272|463910128|FG000|Overall Study|Patient moved, no longer eligible|5|||
128894754|NCT01390272|463910129|FG001|Overall Study|Patient moved, no longer eligible|8|||
129110898|NCT02326272|464701358|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110899|NCT02326272|464701359|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
128894755|NCT03199040|463910130|FG000|Overall Study|Lack of Efficacy|2|||
128894756|NCT03199040|463910131|FG001|Overall Study|Lack of Efficacy|0|||
128894757|NCT03199040|463910130|FG000|Overall Study|Withdrawal by Subject|2|||
128894758|NCT03199040|463910131|FG001|Overall Study|Withdrawal by Subject|0|||
128894759|NCT03199040|463910130|FG000|Overall Study|Adverse Event|0|||
128894760|NCT03199040|463910131|FG001|Overall Study|Adverse Event|1|||
128894761|NCT03199040|463910130|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
128894762|NCT03199040|463910131|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
128894763|NCT00199836|463910132|FG000|Overall Study|Progressive Disease|5|||
128894764|NCT00199836|463910132|FG000|Overall Study|Death|1|||
128894765|NCT01854645|463910138|FG000|Overall Study|Protocol-Specified Criteria|13|||
128894766|NCT01854645|463910139|FG001|Overall Study|Protocol-Specified Criteria|10|||
128894767|NCT01854645|463910140|FG002|Overall Study|Protocol-Specified Criteria|8|||
128894768|NCT01854645|463910141|FG003|Overall Study|Protocol-Specified Criteria|5|||
128690959|NCT03161093|463169336|FG000|Overall Study|Protocol Violation|11|||
128690960|NCT03161093|463169337|FG001|Overall Study|Protocol Violation|14|||
128690961|NCT03161093|463169338|FG002|Overall Study|Protocol Violation|6|||
128690962|NCT03161093|463169339|FG003|Overall Study|Protocol Violation|13|||
128894769|NCT01854645|463910142|FG004|Overall Study|Protocol-Specified Criteria|7|||
128894770|NCT01854645|463910138|FG000|Overall Study|Administrative Reasons / Missing|0|||
128894771|NCT01854645|463910139|FG001|Overall Study|Administrative Reasons / Missing|0|||
128894772|NCT01854645|463910140|FG002|Overall Study|Administrative Reasons / Missing|0|||
128894773|NCT01854645|463910141|FG003|Overall Study|Administrative Reasons / Missing|1|||
128690963|NCT03161093|463169340|FG004|Overall Study|Protocol Violation|1|||
128690964|NCT03161093|463169341|FG005|Overall Study|Protocol Violation|0|||
128690965|NCT03161093|463169336|FG000|Overall Study|Adverse Event|5|||
128894774|NCT01854645|463910142|FG004|Overall Study|Administrative Reasons / Missing|1|||
128894775|NCT01854645|463910138|FG000|Overall Study|Protocol Violation|3|||
128894776|NCT01854645|463910139|FG001|Overall Study|Protocol Violation|0|||
128894777|NCT01854645|463910140|FG002|Overall Study|Protocol Violation|5|||
128894778|NCT01854645|463910141|FG003|Overall Study|Protocol Violation|4|||
128690966|NCT03161093|463169337|FG001|Overall Study|Adverse Event|21|||
128690967|NCT03161093|463169338|FG002|Overall Study|Adverse Event|16|||
128690968|NCT03161093|463169339|FG003|Overall Study|Adverse Event|35|||
128690969|NCT03161093|463169340|FG004|Overall Study|Adverse Event|2|||
128690970|NCT03161093|463169341|FG005|Overall Study|Adverse Event|1|||
128690971|NCT03161093|463169336|FG000|Overall Study|Lack of Efficacy|9|||
128690972|NCT03161093|463169337|FG001|Overall Study|Lack of Efficacy|13|||
128690973|NCT03161093|463169338|FG002|Overall Study|Lack of Efficacy|9|||
128764401|NCT01778556|463428307|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
128764402|NCT01778556|463428308|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
128764403|NCT03682705|463428312|FG000|Overall Study|Adverse Event|1|||
128764404|NCT03682705|463428313|FG001|Overall Study|Adverse Event|1|||
128894779|NCT01854645|463910142|FG004|Overall Study|Protocol Violation|1|||
128894780|NCT01854645|463910138|FG000|Overall Study|Lost to Follow-up|10|||
128894781|NCT01854645|463910139|FG001|Overall Study|Lost to Follow-up|7|||
128894782|NCT01854645|463910140|FG002|Overall Study|Lost to Follow-up|8|||
128894783|NCT01854645|463910141|FG003|Overall Study|Lost to Follow-up|5|||
128894784|NCT01854645|463910142|FG004|Overall Study|Lost to Follow-up|0|||
128894785|NCT01854645|463910138|FG000|Overall Study|Physician Decision|1|||
128894786|NCT01854645|463910139|FG001|Overall Study|Physician Decision|5|||
128894787|NCT01854645|463910140|FG002|Overall Study|Physician Decision|3|||
128894788|NCT01854645|463910141|FG003|Overall Study|Physician Decision|3|||
128894789|NCT01854645|463910142|FG004|Overall Study|Physician Decision|7|||
128894790|NCT01854645|463910138|FG000|Overall Study|Withdrawal by Subject|31|||
128894791|NCT01854645|463910139|FG001|Overall Study|Withdrawal by Subject|41|||
128894792|NCT01854645|463910140|FG002|Overall Study|Withdrawal by Subject|30|||
128894793|NCT01854645|463910141|FG003|Overall Study|Withdrawal by Subject|21|||
128894794|NCT01854645|463910142|FG004|Overall Study|Withdrawal by Subject|24|||
128894795|NCT01854645|463910138|FG000|Overall Study|Lack of Efficacy|7|||
128894796|NCT01854645|463910139|FG001|Overall Study|Lack of Efficacy|12|||
128894797|NCT01854645|463910140|FG002|Overall Study|Lack of Efficacy|9|||
128894798|NCT01854645|463910141|FG003|Overall Study|Lack of Efficacy|3|||
128894799|NCT01854645|463910142|FG004|Overall Study|Lack of Efficacy|9|||
128894800|NCT01854645|463910138|FG000|Overall Study|Adverse Event|33|||
128894801|NCT01854645|463910139|FG001|Overall Study|Adverse Event|31|||
128894802|NCT01854645|463910140|FG002|Overall Study|Adverse Event|19|||
128894803|NCT01854645|463910141|FG003|Overall Study|Adverse Event|20|||
128894804|NCT01854645|463910142|FG004|Overall Study|Adverse Event|11|||
128894805|NCT00430482|463910143|FG000|Completed Treatment|Insufficient Treatment|7|||
128894806|NCT00430482|463910144|FG001|Completed Treatment|Insufficient Treatment|11|||
128894807|NCT00545402|463910145|FG000|Overall Study|Discontinuation of treatment|17|||
128894808|NCT00545402|463910146|FG001|Overall Study|Discontinuation of treatment|9|||
128894809|NCT00545402|463910145|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
128894810|NCT00545402|463910146|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
128894811|NCT00545402|463910145|FG000|Overall Study|Death|5|||
128894812|NCT00545402|463910146|FG001|Overall Study|Death|7|||
128894813|NCT00545402|463910145|FG000|Overall Study|Graft loss|2|||
128894814|NCT00545402|463910146|FG001|Overall Study|Graft loss|4|||
128894815|NCT00545402|463910145|FG000|Overall Study|Withdrawal by Subject|0|||
128894816|NCT00545402|463910146|FG001|Overall Study|Withdrawal by Subject|1|||
128894817|NCT00545402|463910145|FG000|Overall Study|Protocol Violation|1|||
128894818|NCT00545402|463910146|FG001|Overall Study|Protocol Violation|0|||
128894819|NCT00545402|463910145|FG000|Overall Study|Reason not specified|1|||
128894820|NCT00545402|463910146|FG001|Overall Study|Reason not specified|1|||
128894821|NCT00555477|463910147|FG000|Overall Study|Adverse Event|0|||
128894822|NCT00555477|463910148|FG001|Overall Study|Adverse Event|9|||
128894823|NCT00555477|463910147|FG000|Overall Study|Withdrawal by Subject|1|||
128894824|NCT00555477|463910148|FG001|Overall Study|Withdrawal by Subject|2|||
128894825|NCT00555477|463910147|FG000|Overall Study|Physician Decision|1|||
128894826|NCT00555477|463910148|FG001|Overall Study|Physician Decision|2|||
128894827|NCT01721876|463910149|FG000|Overall Study|Not treated|1|||
128894828|NCT01721876|463910150|FG001|Overall Study|Not treated|4|||
129110900|NCT02326272|464701360|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110901|NCT02326272|464701361|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
128764405|NCT03682705|463428314|FG002|Overall Study|Adverse Event|1|||
128894829|NCT01721876|463910149|FG000|Overall Study|Disease progression / relapse|123|||
128894830|NCT01721876|463910150|FG001|Overall Study|Disease progression / relapse|156|||
128894831|NCT01721876|463910149|FG000|Overall Study|Death|6|||
128894832|NCT01721876|463910150|FG001|Overall Study|Death|13|||
128894833|NCT01721876|463910149|FG000|Overall Study|Adverse Event|41|||
128894834|NCT01721876|463910150|FG001|Overall Study|Adverse Event|165|||
128894835|NCT01721876|463910149|FG000|Overall Study|Protocol Violation|2|||
128894836|NCT01721876|463910150|FG001|Overall Study|Protocol Violation|1|||
128690974|NCT03161093|463169339|FG003|Overall Study|Lack of Efficacy|24|||
128894837|NCT01721876|463910149|FG000|Overall Study|Withdrawal by Subject|15|||
128894838|NCT01721876|463910150|FG001|Overall Study|Withdrawal by Subject|38|||
128894839|NCT01721876|463910149|FG000|Overall Study|Reason not listed|34|||
128894840|NCT01721876|463910150|FG001|Overall Study|Reason not listed|63|||
128894841|NCT01721876|463910149|FG000|Overall Study|Sponsor terminated trial|0|||
128894842|NCT01721876|463910150|FG001|Overall Study|Sponsor terminated trial|4|||
128690975|NCT03161093|463169340|FG004|Overall Study|Lack of Efficacy|4|||
128690976|NCT03161093|463169341|FG005|Overall Study|Lack of Efficacy|1|||
128690977|NCT03161093|463169336|FG000|Overall Study|Physician Decision|0|||
128690978|NCT03161093|463169337|FG001|Overall Study|Physician Decision|1|||
128690979|NCT03161093|463169338|FG002|Overall Study|Physician Decision|0|||
128690980|NCT03161093|463169339|FG003|Overall Study|Physician Decision|2|||
128894843|NCT01721057|463910153|FG000|Treatment Period|Withdrawal by Subject|11|||
128894844|NCT01721057|463910154|FG001|Treatment Period|Withdrawal by Subject|5|||
128894845|NCT01721057|463910155|FG002|Treatment Period|Withdrawal by Subject|8|||
128894846|NCT01721057|463910156|FG003|Treatment Period|Withdrawal by Subject|0|||
128894847|NCT01721057|463910157|FG004|Treatment Period|Withdrawal by Subject|0|||
128894848|NCT01721057|463910158|FG005|Treatment Period|Withdrawal by Subject|0|||
128894849|NCT01721057|463910159|FG006|Treatment Period|Withdrawal by Subject|0|||
128894850|NCT01721057|463910153|FG000|Treatment Period|Adverse Event|7|||
128894851|NCT01721057|463910154|FG001|Treatment Period|Adverse Event|10|||
128894852|NCT01721057|463910155|FG002|Treatment Period|Adverse Event|12|||
128894853|NCT01721057|463910156|FG003|Treatment Period|Adverse Event|0|||
128894854|NCT01721057|463910157|FG004|Treatment Period|Adverse Event|0|||
128894855|NCT01721057|463910158|FG005|Treatment Period|Adverse Event|0|||
128894856|NCT01721057|463910159|FG006|Treatment Period|Adverse Event|0|||
128894857|NCT01721057|463910153|FG000|Treatment Period|Lack of Efficacy|7|||
128894858|NCT01721057|463910154|FG001|Treatment Period|Lack of Efficacy|3|||
128894859|NCT01721057|463910155|FG002|Treatment Period|Lack of Efficacy|0|||
128894860|NCT01721057|463910156|FG003|Treatment Period|Lack of Efficacy|0|||
128894861|NCT01721057|463910157|FG004|Treatment Period|Lack of Efficacy|0|||
128690981|NCT03161093|463169340|FG004|Overall Study|Physician Decision|17|||
128690982|NCT03161093|463169341|FG005|Overall Study|Physician Decision|15|||
128690983|NCT03161093|463169336|FG000|Overall Study|Withdrawal by Subject|24|||
128690984|NCT03161093|463169337|FG001|Overall Study|Withdrawal by Subject|73|||
128690985|NCT03161093|463169338|FG002|Overall Study|Withdrawal by Subject|44|||
128690986|NCT03161093|463169339|FG003|Overall Study|Withdrawal by Subject|97|||
128690987|NCT03161093|463169340|FG004|Overall Study|Withdrawal by Subject|11|||
128690988|NCT03161093|463169341|FG005|Overall Study|Withdrawal by Subject|10|||
128690989|NCT03161093|463169336|FG000|Overall Study|Lost to Follow-up|3|||
128690990|NCT03161093|463169337|FG001|Overall Study|Lost to Follow-up|12|||
128894862|NCT01721057|463910158|FG005|Treatment Period|Lack of Efficacy|0|||
128690991|NCT03161093|463169338|FG002|Overall Study|Lost to Follow-up|4|||
128894863|NCT01721057|463910159|FG006|Treatment Period|Lack of Efficacy|0|||
128894864|NCT01721057|463910153|FG000|Treatment Period|Lost to Follow-up|1|||
128894865|NCT01721057|463910154|FG001|Treatment Period|Lost to Follow-up|0|||
128894866|NCT01721057|463910155|FG002|Treatment Period|Lost to Follow-up|0|||
128894867|NCT01721057|463910156|FG003|Treatment Period|Lost to Follow-up|0|||
129021266|NCT03032172|464369240|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129021267|NCT03032172|464369233|FG000|Treatment Period|Withdrawal by Subject|2|||
129021268|NCT03032172|464369234|FG001|Treatment Period|Withdrawal by Subject|0|||
129021269|NCT03032172|464369235|FG002|Treatment Period|Withdrawal by Subject|3|||
129021270|NCT03032172|464369236|FG003|Treatment Period|Withdrawal by Subject|0|||
128690992|NCT03161093|463169339|FG003|Overall Study|Lost to Follow-up|7|||
128690993|NCT03161093|463169340|FG004|Overall Study|Lost to Follow-up|8|||
128690994|NCT03161093|463169341|FG005|Overall Study|Lost to Follow-up|13|||
128690995|NCT03161093|463169336|FG000|Overall Study|Death|3|||
128690996|NCT03161093|463169337|FG001|Overall Study|Death|9|||
128690997|NCT03161093|463169338|FG002|Overall Study|Death|7|||
128690998|NCT03161093|463169339|FG003|Overall Study|Death|9|||
128690999|NCT03161093|463169340|FG004|Overall Study|Death|0|||
128691000|NCT03161093|463169341|FG005|Overall Study|Death|0|||
128691001|NCT03161093|463169336|FG000|Overall Study|Unknown - Not reported|0|||
128691002|NCT03161093|463169337|FG001|Overall Study|Unknown - Not reported|1|||
128691003|NCT03161093|463169338|FG002|Overall Study|Unknown - Not reported|0|||
128691004|NCT03161093|463169339|FG003|Overall Study|Unknown - Not reported|0|||
128691005|NCT03161093|463169340|FG004|Overall Study|Unknown - Not reported|0|||
128691006|NCT03161093|463169341|FG005|Overall Study|Unknown - Not reported|1|||
128691007|NCT01797731|463169342|FG000|Overall Study|Didn't have proper radiographs required|3|||
128691008|NCT01797731|463169343|FG001|Overall Study|Didn't have proper radiographs required|3|||
128894868|NCT01721057|463910157|FG004|Treatment Period|Lost to Follow-up|0|||
128894869|NCT01721057|463910158|FG005|Treatment Period|Lost to Follow-up|0|||
128894870|NCT01721057|463910159|FG006|Treatment Period|Lost to Follow-up|0|||
129021271|NCT03032172|464369237|FG004|Treatment Period|Withdrawal by Subject|0|||
129021272|NCT03032172|464369238|FG005|Treatment Period|Withdrawal by Subject|0|||
128691009|NCT00091442|463169345|FG000|Overall Study|Progressive Disease|220|||
128894871|NCT01721057|463910153|FG000|Treatment Period|Physician Decision|0|||
128894872|NCT01721057|463910154|FG001|Treatment Period|Physician Decision|1|||
128894873|NCT01721057|463910155|FG002|Treatment Period|Physician Decision|3|||
128894874|NCT01721057|463910156|FG003|Treatment Period|Physician Decision|0|||
129021273|NCT03032172|464369239|FG006|Treatment Period|Withdrawal by Subject|0|||
128894875|NCT01721057|463910157|FG004|Treatment Period|Physician Decision|0|||
128894876|NCT01721057|463910158|FG005|Treatment Period|Physician Decision|0|||
128894877|NCT01721057|463910159|FG006|Treatment Period|Physician Decision|0|||
128894878|NCT01721057|463910153|FG000|Treatment Period|Death|2|||
128894879|NCT01721057|463910154|FG001|Treatment Period|Death|0|||
128894880|NCT01721057|463910155|FG002|Treatment Period|Death|0|||
128894881|NCT01721057|463910156|FG003|Treatment Period|Death|0|||
128894882|NCT01721057|463910157|FG004|Treatment Period|Death|0|||
128894883|NCT01721057|463910158|FG005|Treatment Period|Death|0|||
128894884|NCT01721057|463910159|FG006|Treatment Period|Death|0|||
128894885|NCT01721057|463910153|FG000|Rescue Period|Adverse Event|0|||
128894886|NCT01721057|463910154|FG001|Rescue Period|Adverse Event|0|||
128894887|NCT01721057|463910155|FG002|Rescue Period|Adverse Event|0|||
128894888|NCT01721057|463910156|FG003|Rescue Period|Adverse Event|1|||
128691010|NCT00091442|463169346|FG001|Overall Study|Progressive Disease|189|||
128691011|NCT00091442|463169345|FG000|Overall Study|Physician Decision|61|||
128894889|NCT01721057|463910157|FG004|Rescue Period|Adverse Event|0|||
128894890|NCT01721057|463910158|FG005|Rescue Period|Adverse Event|0|||
128894891|NCT01721057|463910159|FG006|Rescue Period|Adverse Event|0|||
128894892|NCT01721057|463910153|FG000|Rescue Period|Lack of Efficacy|0|||
128894893|NCT01721057|463910154|FG001|Rescue Period|Lack of Efficacy|0|||
128894894|NCT01721057|463910155|FG002|Rescue Period|Lack of Efficacy|0|||
129021274|NCT03032172|464369240|FG007|Treatment Period|Withdrawal by Subject|0|||
129021275|NCT03032172|464369233|FG000|Open-label Extension Period|Death|0|||
129021276|NCT03032172|464369234|FG001|Open-label Extension Period|Death|0|||
129021277|NCT03032172|464369235|FG002|Open-label Extension Period|Death|0|||
129021278|NCT03032172|464369236|FG003|Open-label Extension Period|Death|0|||
129021279|NCT03032172|464369237|FG004|Open-label Extension Period|Death|0|||
129021280|NCT03032172|464369238|FG005|Open-label Extension Period|Death|0|||
129021281|NCT03032172|464369239|FG006|Open-label Extension Period|Death|0|||
129021282|NCT03032172|464369240|FG007|Open-label Extension Period|Death|2|||
129021283|NCT03032172|464369233|FG000|Open-label Extension Period|Reason Not Specified|0|||
129021284|NCT03032172|464369234|FG001|Open-label Extension Period|Reason Not Specified|0|||
129021285|NCT03032172|464369235|FG002|Open-label Extension Period|Reason Not Specified|0|||
129021286|NCT03032172|464369236|FG003|Open-label Extension Period|Reason Not Specified|0|||
129021287|NCT03032172|464369237|FG004|Open-label Extension Period|Reason Not Specified|0|||
129021288|NCT03032172|464369238|FG005|Open-label Extension Period|Reason Not Specified|5|||
129021289|NCT03032172|464369239|FG006|Open-label Extension Period|Reason Not Specified|3|||
129021290|NCT03032172|464369240|FG007|Open-label Extension Period|Reason Not Specified|0|||
129021291|NCT03032172|464369233|FG000|Open-label Extension Period|Pregnancy|0|||
129021292|NCT03032172|464369234|FG001|Open-label Extension Period|Pregnancy|0|||
129021293|NCT03032172|464369235|FG002|Open-label Extension Period|Pregnancy|0|||
129021294|NCT03032172|464369236|FG003|Open-label Extension Period|Pregnancy|0|||
129021295|NCT03032172|464369237|FG004|Open-label Extension Period|Pregnancy|0|||
129021296|NCT03032172|464369238|FG005|Open-label Extension Period|Pregnancy|0|||
129021297|NCT03032172|464369239|FG006|Open-label Extension Period|Pregnancy|1|||
129021298|NCT03032172|464369240|FG007|Open-label Extension Period|Pregnancy|0|||
129021299|NCT03032172|464369233|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129021300|NCT03032172|464369234|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
129021301|NCT03032172|464369235|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
129021302|NCT03032172|464369236|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
129021303|NCT03032172|464369237|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
129021304|NCT03032172|464369238|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
129021305|NCT03032172|464369239|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
129021306|NCT03032172|464369240|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
129021307|NCT02869867|464369243|FG000|Overall Study|Protocol Violation|1|||
129021308|NCT02869867|464369244|FG001|Overall Study|Protocol Violation|0|||
129021309|NCT02869867|464369243|FG000|Overall Study|Lost to Follow-up|5|||
129021310|NCT02869867|464369244|FG001|Overall Study|Lost to Follow-up|5|||
129021311|NCT01005745|464369245|FG000|Overall Study|No TIL growth|1|||
129021312|NCT01005745|464369245|FG000|Overall Study|Disease progressed during TIL growth|3|||
129021313|NCT01005745|464369245|FG000|Overall Study|Death prior to treatment|1|||
129021314|NCT01005745|464369245|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
129021315|NCT05646251|464369250|FG000|Overall Study|Physician Decision|1|||
129021316|NCT05646251|464369251|FG001|Overall Study|Physician Decision|0|||
128691012|NCT00091442|463169346|FG001|Overall Study|Physician Decision|58|||
128894895|NCT01721057|463910156|FG003|Rescue Period|Lack of Efficacy|2|||
128894896|NCT01721057|463910157|FG004|Rescue Period|Lack of Efficacy|0|||
128894897|NCT01721057|463910158|FG005|Rescue Period|Lack of Efficacy|0|||
128894898|NCT01721057|463910159|FG006|Rescue Period|Lack of Efficacy|0|||
129021317|NCT05646251|464369252|FG002|Overall Study|Physician Decision|2|||
129021318|NCT04659603|464369254|FG000|Overall Study|Study terminated by sponsor|0|||
129021319|NCT04659603|464369255|FG001|Overall Study|Study terminated by sponsor|0|||
129021320|NCT04659603|464369256|FG002|Overall Study|Study terminated by sponsor|2|||
129021321|NCT04659603|464369254|FG000|Overall Study|Withdrawal by Subject|0|||
129021322|NCT04659603|464369255|FG001|Overall Study|Withdrawal by Subject|5|||
129021323|NCT04659603|464369256|FG002|Overall Study|Withdrawal by Subject|0|||
128894899|NCT01202279|463910160|FG000|Overall Study|Adverse Event|8|||
128894900|NCT01202279|463910161|FG001|Overall Study|Adverse Event|6|||
128894901|NCT01202279|463910160|FG000|Overall Study|Withdrawal by Subject|13|||
128894902|NCT01202279|463910161|FG001|Overall Study|Withdrawal by Subject|10|||
128894903|NCT01202279|463910160|FG000|Overall Study|Physician Decision|0|||
128894904|NCT01202279|463910161|FG001|Overall Study|Physician Decision|1|||
128894905|NCT01202279|463910160|FG000|Overall Study|Lost to Follow-up|10|||
128894906|NCT01202279|463910161|FG001|Overall Study|Lost to Follow-up|7|||
128894907|NCT01202279|463910160|FG000|Overall Study|Protocol Violation|1|||
128894908|NCT01202279|463910161|FG001|Overall Study|Protocol Violation|1|||
128894909|NCT01202279|463910160|FG000|Overall Study|study compliance|5|||
128894910|NCT01202279|463910161|FG001|Overall Study|study compliance|2|||
128894911|NCT01177683|463910162|FG000|Study Treatment|Disease Progressions during treatment|2|||
128691013|NCT00091442|463169345|FG000|Overall Study|Withdrawal by Subject|38|||
128691014|NCT00091442|463169346|FG001|Overall Study|Withdrawal by Subject|46|||
128691015|NCT00091442|463169345|FG000|Overall Study|Adverse Event|29|||
128691016|NCT00091442|463169346|FG001|Overall Study|Adverse Event|48|||
128691017|NCT00091442|463169345|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
128691018|NCT00091442|463169346|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
128691019|NCT00091442|463169345|FG000|Overall Study|Death|9|||
128691020|NCT00091442|463169346|FG001|Overall Study|Death|7|||
128691021|NCT00091442|463169345|FG000|Overall Study|Lost to Follow-up|1|||
128691022|NCT00091442|463169346|FG001|Overall Study|Lost to Follow-up|3|||
128691023|NCT00091442|463169345|FG000|Overall Study|Other|2|||
128691024|NCT00091442|463169346|FG001|Overall Study|Other|6|||
128691025|NCT00629772|463169351|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
128691026|NCT00629772|463169352|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
128691027|NCT00629772|463169351|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
128691028|NCT00629772|463169352|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
128691029|NCT01393301|463169353|FG000|Overall Study|Lost to Follow-up|5|||
128691030|NCT01393301|463169354|FG001|Overall Study|Lost to Follow-up|3|||
128691031|NCT01393301|463169353|FG000|Overall Study|Withdrawal by Subject|2|||
128691032|NCT01393301|463169354|FG001|Overall Study|Withdrawal by Subject|0|||
128691033|NCT01393301|463169353|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
128691034|NCT01393301|463169354|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
128691035|NCT00853073|463169355|FG000|Overall Study|Withdrawal by Subject|3|||
128691036|NCT00853073|463169356|FG001|Overall Study|Withdrawal by Subject|2|||
128691037|NCT02758171|463169357|FG000|Wash-out|Withdrawal by Subject|1|||
128691038|NCT02758171|463169358|FG001|Wash-out|Withdrawal by Subject|0|||
128691039|NCT02758171|463169357|FG000|Wash-out|Other reason|1|||
128691040|NCT02758171|463169358|FG001|Wash-out|Other reason|0|||
128691041|NCT00722423|463169359|FG000|Overall Study|Protocol Violation|0|||
128691042|NCT00722423|463169360|FG001|Overall Study|Protocol Violation|1|||
128691043|NCT01309165|463169361|FG000|Overall Study|Lost to Follow-up|4|||
128691044|NCT01309165|463169362|FG001|Overall Study|Lost to Follow-up|3|||
128691045|NCT01309165|463169361|FG000|Overall Study|Return to work|1|||
128691046|NCT01309165|463169362|FG001|Overall Study|Return to work|2|||
128691047|NCT01309165|463169361|FG000|Overall Study|Left country|0|||
128691048|NCT01309165|463169362|FG001|Overall Study|Left country|1|||
128691049|NCT01309165|463169361|FG000|Overall Study|No transportation|0|||
128691050|NCT01309165|463169362|FG001|Overall Study|No transportation|1|||
128691051|NCT01309165|463169361|FG000|Overall Study|Admitted to hospital for second stroke|1|||
128691052|NCT01309165|463169362|FG001|Overall Study|Admitted to hospital for second stroke|0|||
128691053|NCT05085730|463169364|FG000|Overall Study|Withdrawal by Subject|4|||
128691054|NCT05085730|463169364|FG000|Overall Study|Physician Decision|1|||
128691055|NCT02038881|463169365|FG000|Overall Study|Withdrawal by Subject|0|||
128691056|NCT02038881|463169366|FG001|Overall Study|Withdrawal by Subject|0|||
128691057|NCT02038881|463169367|FG002|Overall Study|Withdrawal by Subject|1|||
128691058|NCT02038881|463169365|FG000|Overall Study|Lost to Follow-up|2|||
128894912|NCT01177683|463910163|FG001|Study Treatment|Disease Progressions during treatment|0|||
129021324|NCT04659603|464369254|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
129021325|NCT04659603|464369255|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
129021326|NCT04659603|464369256|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
129021327|NCT01231906|464369259|FG000|Overall Study|Lack of Efficacy|75|||
129021328|NCT01231906|464369260|FG001|Overall Study|Lack of Efficacy|68|||
129021329|NCT01231906|464369259|FG000|Overall Study|Lost to Follow-up|1|||
129021330|NCT01231906|464369260|FG001|Overall Study|Lost to Follow-up|0|||
129021331|NCT01231906|464369259|FG000|Overall Study|Physician Decision|34|||
129021332|NCT01231906|464369260|FG001|Overall Study|Physician Decision|24|||
129021333|NCT01231906|464369259|FG000|Overall Study|Withdrawal by Subject|0|||
129021334|NCT01231906|464369260|FG001|Overall Study|Withdrawal by Subject|4|||
129021335|NCT01231906|464369259|FG000|Overall Study|Ineligible|10|||
129021336|NCT01231906|464369260|FG001|Overall Study|Ineligible|3|||
129021337|NCT01231906|464369259|FG000|Overall Study|No treatment|1|||
129021338|NCT01231906|464369260|FG001|Overall Study|No treatment|2|||
129021339|NCT01754597|464369267|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
128894913|NCT01177683|463910164|FG002|Study Treatment|Disease Progressions during treatment|3|||
128894914|NCT01177683|463910162|FG000|Study Treatment|Adverse Event|0|||
128894915|NCT01177683|463910163|FG001|Study Treatment|Adverse Event|1|||
128894916|NCT01177683|463910164|FG002|Study Treatment|Adverse Event|12|||
128894917|NCT01177683|463910162|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
128894918|NCT01177683|463910163|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
128894919|NCT01177683|463910164|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
128894920|NCT01177683|463910162|FG000|Study Treatment|Alternative therapy|0|||
128894921|NCT01177683|463910163|FG001|Study Treatment|Alternative therapy|0|||
128894922|NCT01177683|463910164|FG002|Study Treatment|Alternative therapy|4|||
128894923|NCT01177683|463910162|FG000|Study Treatment|Physician Decision|1|||
128691059|NCT02038881|463169366|FG001|Overall Study|Lost to Follow-up|0|||
128691060|NCT02038881|463169367|FG002|Overall Study|Lost to Follow-up|0|||
128691061|NCT02038881|463169365|FG000|Overall Study|incarcerated|1|||
128691062|NCT02038881|463169366|FG001|Overall Study|incarcerated|0|||
128691063|NCT02038881|463169367|FG002|Overall Study|incarcerated|0|||
128691064|NCT00333840|463169368|FG000|First-line Treatment Period|Adverse Event|38|||
128691065|NCT00333840|463169369|FG001|First-line Treatment Period|Adverse Event|37|||
128691066|NCT00333840|463169370|FG002|First-line Treatment Period|Adverse Event|0|||
128691067|NCT00333840|463169371|FG003|First-line Treatment Period|Adverse Event|0|||
128691068|NCT00333840|463169368|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
128691069|NCT00333840|463169369|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
128691070|NCT00333840|463169370|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
128691071|NCT00333840|463169371|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
128691072|NCT00333840|463169368|FG000|First-line Treatment Period|Abnormal procedure|2|||
128894924|NCT01177683|463910163|FG001|Study Treatment|Physician Decision|0|||
128894925|NCT01177683|463910164|FG002|Study Treatment|Physician Decision|1|||
128894926|NCT01177683|463910162|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
128894927|NCT01177683|463910163|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
128894928|NCT01177683|463910164|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
128894929|NCT01177683|463910162|FG000|Study Treatment|Symptomatic Deterioration|0|||
129021340|NCT01754597|464369268|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
129021341|NCT01588236|464369269|FG000|Overall Study|Adverse Event|5|||
129021342|NCT01588236|464369270|FG001|Overall Study|Adverse Event|4|||
129021343|NCT01588236|464369271|FG002|Overall Study|Adverse Event|1|||
129021344|NCT01588236|464369269|FG000|Overall Study|Lost to Follow-up|8|||
129021345|NCT01588236|464369270|FG001|Overall Study|Lost to Follow-up|13|||
129021346|NCT01588236|464369271|FG002|Overall Study|Lost to Follow-up|6|||
129021347|NCT01588236|464369269|FG000|Overall Study|Physician Decision|1|||
129021348|NCT01588236|464369270|FG001|Overall Study|Physician Decision|2|||
129021349|NCT01588236|464369271|FG002|Overall Study|Physician Decision|0|||
129021350|NCT01588236|464369269|FG000|Overall Study|Protocol Violation|0|||
129021351|NCT01588236|464369270|FG001|Overall Study|Protocol Violation|1|||
129021352|NCT01588236|464369271|FG002|Overall Study|Protocol Violation|1|||
129021353|NCT01588236|464369269|FG000|Overall Study|Withdrawal by Subject|14|||
129021354|NCT01588236|464369270|FG001|Overall Study|Withdrawal by Subject|16|||
129021355|NCT01588236|464369271|FG002|Overall Study|Withdrawal by Subject|18|||
129021356|NCT01588236|464369269|FG000|Overall Study|Exclusion Criteria met during study|2|||
129021357|NCT01588236|464369270|FG001|Overall Study|Exclusion Criteria met during study|1|||
129021358|NCT01588236|464369271|FG002|Overall Study|Exclusion Criteria met during study|0|||
129021359|NCT01588236|464369269|FG000|Overall Study|sponsor decision|1|||
129021360|NCT01588236|464369270|FG001|Overall Study|sponsor decision|6|||
129021361|NCT01588236|464369271|FG002|Overall Study|sponsor decision|2|||
129021362|NCT04544410|464369272|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129021363|NCT04544410|464369273|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129021364|NCT04544410|464369272|FG000|Double-blind Treatment Period|Adverse Event|1|||
129021365|NCT04544410|464369273|FG001|Double-blind Treatment Period|Adverse Event|0|||
129021366|NCT04544410|464369272|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
129021367|NCT04544410|464369273|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129021368|NCT04544410|464369272|FG000|Double-blind Treatment Period|Protocol Violation|1|||
129021369|NCT04544410|464369273|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129021370|NCT04544410|464369272|FG000|Open-Label Treatment Period|Study Terminated|15|||
129021371|NCT04544410|464369273|FG001|Open-Label Treatment Period|Study Terminated|19|||
129021372|NCT04544410|464369272|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
129021373|NCT04544410|464369273|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
129021374|NCT04544410|464369272|FG000|Open-Label Treatment Period|Adverse Event|0|||
128894930|NCT01177683|463910163|FG001|Study Treatment|Symptomatic Deterioration|0|||
128894931|NCT01177683|463910164|FG002|Study Treatment|Symptomatic Deterioration|1|||
129021375|NCT04544410|464369273|FG001|Open-Label Treatment Period|Adverse Event|1|||
129021376|NCT04544410|464369272|FG000|Open-Label Treatment Period|Physician Decision|1|||
129021377|NCT04544410|464369273|FG001|Open-Label Treatment Period|Physician Decision|0|||
129021378|NCT04544410|464369272|FG000|Open-Label Treatment Period|Other|0|||
129021379|NCT04544410|464369273|FG001|Open-Label Treatment Period|Other|1|||
128691073|NCT00333840|463169369|FG001|First-line Treatment Period|Abnormal procedure|0|||
129021380|NCT04299087|464370432|FG000|Overall Study|Lost to Follow-up|2|||
128691074|NCT00333840|463169370|FG002|First-line Treatment Period|Abnormal procedure|0|||
128691075|NCT00333840|463169371|FG003|First-line Treatment Period|Abnormal procedure|0|||
128691076|NCT00333840|463169368|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
128691077|NCT00333840|463169369|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
128691078|NCT00333840|463169370|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
128691079|NCT00333840|463169371|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
128691080|NCT00333840|463169368|FG000|First-line Treatment Period|No longer required study drug|21|||
128691081|NCT00333840|463169369|FG001|First-line Treatment Period|No longer required study drug|8|||
128691082|NCT00333840|463169370|FG002|First-line Treatment Period|No longer required study drug|0|||
128691083|NCT00333840|463169371|FG003|First-line Treatment Period|No longer required study drug|0|||
128691084|NCT00333840|463169368|FG000|First-line Treatment Period|Protocol Violation|17|||
128691085|NCT00333840|463169369|FG001|First-line Treatment Period|Protocol Violation|17|||
128691086|NCT00333840|463169370|FG002|First-line Treatment Period|Protocol Violation|0|||
128691087|NCT00333840|463169371|FG003|First-line Treatment Period|Protocol Violation|0|||
128691088|NCT00333840|463169368|FG000|First-line Treatment Period|Subject withdrew consent|57|||
128691089|NCT00333840|463169369|FG001|First-line Treatment Period|Subject withdrew consent|77|||
128691090|NCT00333840|463169370|FG002|First-line Treatment Period|Subject withdrew consent|0|||
128691091|NCT00333840|463169371|FG003|First-line Treatment Period|Subject withdrew consent|0|||
128691092|NCT00333840|463169368|FG000|First-line Treatment Period|Lost to Follow-up|15|||
128691093|NCT00333840|463169369|FG001|First-line Treatment Period|Lost to Follow-up|6|||
128691094|NCT00333840|463169370|FG002|First-line Treatment Period|Lost to Follow-up|0|||
128691095|NCT00333840|463169371|FG003|First-line Treatment Period|Lost to Follow-up|0|||
128691096|NCT00333840|463169368|FG000|First-line Treatment Period|Administrative problems|12|||
128691097|NCT00333840|463169369|FG001|First-line Treatment Period|Administrative problems|6|||
128691098|NCT00333840|463169370|FG002|First-line Treatment Period|Administrative problems|0|||
128691099|NCT00333840|463169371|FG003|First-line Treatment Period|Administrative problems|0|||
128691100|NCT00333840|463169368|FG000|First-line Treatment Period|Death|19|||
128691101|NCT00333840|463169369|FG001|First-line Treatment Period|Death|2|||
128691102|NCT00333840|463169370|FG002|First-line Treatment Period|Death|0|||
128691103|NCT00333840|463169371|FG003|First-line Treatment Period|Death|0|||
128691104|NCT00333840|463169368|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
128691105|NCT00333840|463169369|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
128691106|NCT00333840|463169370|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
128691107|NCT00333840|463169371|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
128691108|NCT00333840|463169368|FG000|Second-line Treatment Period|Adverse Event|0|||
128691109|NCT00333840|463169369|FG001|Second-line Treatment Period|Adverse Event|0|||
128691110|NCT00333840|463169370|FG002|Second-line Treatment Period|Adverse Event|3|||
128691111|NCT00333840|463169371|FG003|Second-line Treatment Period|Adverse Event|34|||
128691112|NCT00333840|463169368|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
128691113|NCT00333840|463169369|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
128691114|NCT00333840|463169370|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
128691115|NCT00333840|463169371|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
128691116|NCT00333840|463169368|FG000|Second-line Treatment Period|Abnormal procedure|0|||
128691117|NCT00333840|463169369|FG001|Second-line Treatment Period|Abnormal procedure|0|||
128691118|NCT00333840|463169370|FG002|Second-line Treatment Period|Abnormal procedure|0|||
128691119|NCT00333840|463169371|FG003|Second-line Treatment Period|Abnormal procedure|1|||
128691120|NCT00333840|463169368|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
128691121|NCT00333840|463169369|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
128691122|NCT00333840|463169370|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
128691123|NCT00333840|463169371|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
128691124|NCT00333840|463169368|FG000|Second-line Treatment Period|No longer required study drug|0|||
128691125|NCT00333840|463169369|FG001|Second-line Treatment Period|No longer required study drug|0|||
128691126|NCT00333840|463169370|FG002|Second-line Treatment Period|No longer required study drug|1|||
128691127|NCT00333840|463169371|FG003|Second-line Treatment Period|No longer required study drug|14|||
128691128|NCT00333840|463169368|FG000|Second-line Treatment Period|Protocol Violation|0|||
128691129|NCT00333840|463169369|FG001|Second-line Treatment Period|Protocol Violation|0|||
128894932|NCT01177683|463910162|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
128894933|NCT01177683|463910163|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
128894934|NCT01177683|463910164|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
128894935|NCT01177683|463910162|FG000|Follow up|Patient lost to follow up|0|||
128894936|NCT01177683|463910163|FG001|Follow up|Patient lost to follow up|0|||
128894937|NCT01177683|463910164|FG002|Follow up|Patient lost to follow up|2|||
128894938|NCT01177683|463910162|FG000|Follow up|Death|2|||
128894939|NCT01177683|463910163|FG001|Follow up|Death|1|||
128894940|NCT01177683|463910164|FG002|Follow up|Death|7|||
128894941|NCT01177683|463910162|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
128894942|NCT01177683|463910163|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
129021381|NCT04299087|464370433|FG001|Overall Study|Lost to Follow-up|1|||
128894943|NCT01177683|463910164|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
128894944|NCT02546765|463910168|FG000|Overall Study|Withdrawal by Subject|0|||
128894945|NCT02546765|463910169|FG001|Overall Study|Withdrawal by Subject|1|||
128894946|NCT02546765|463910170|FG002|Overall Study|Withdrawal by Subject|0|||
128894947|NCT02546765|463910171|FG003|Overall Study|Withdrawal by Subject|0|||
128894948|NCT00475722|463910172|FG000|Overall Study|Withdrawal by Subject|12|||
128894949|NCT00475722|463910173|FG001|Overall Study|Withdrawal by Subject|12|||
128894950|NCT00475722|463910172|FG000|Overall Study|Protocol Violation|3|||
128894951|NCT00475722|463910173|FG001|Overall Study|Protocol Violation|0|||
128894952|NCT00916279|463910174|FG000|Overall Study|Death|2|||
128894953|NCT00916279|463910174|FG000|Overall Study|Lost to Follow-up|2|||
128894954|NCT02064920|463910175|FG000|Overall Study|Adverse Event|0|||
128894955|NCT02064920|463910176|FG001|Overall Study|Adverse Event|4|||
129021382|NCT00594035|464370434|FG000|Overall Study|Lost to Follow-up|1|||
129021383|NCT00594035|464370435|FG001|Overall Study|Lost to Follow-up|1|||
129021384|NCT00594035|464370434|FG000|Overall Study|Withdrawal by Subject|1|||
129021385|NCT00594035|464370435|FG001|Overall Study|Withdrawal by Subject|0|||
129021386|NCT00594035|464370434|FG000|Overall Study|Subject transferred to nursing home|0|||
129021387|NCT00594035|464370435|FG001|Overall Study|Subject transferred to nursing home|1|||
129021388|NCT00594035|464370434|FG000|Overall Study|Subject couldn't return due to job|0|||
129021389|NCT00594035|464370435|FG001|Overall Study|Subject couldn't return due to job|1|||
129021390|NCT00795821|464370436|FG000|Acute Treatment Phase|Adverse Event|23|||
129021391|NCT00795821|464370437|FG001|Acute Treatment Phase|Adverse Event|4|||
129021392|NCT00795821|464370436|FG000|Acute Treatment Phase|Death|1|||
129021393|NCT00795821|464370437|FG001|Acute Treatment Phase|Death|0|||
129021394|NCT00795821|464370436|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
129021395|NCT00795821|464370437|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
129021396|NCT00795821|464370436|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
129021397|NCT00795821|464370437|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
129021398|NCT00795821|464370436|FG000|Acute Treatment Phase|Physician Decision|1|||
129021399|NCT00795821|464370437|FG001|Acute Treatment Phase|Physician Decision|1|||
129021400|NCT00795821|464370436|FG000|Acute Treatment Phase|Protocol Violation|1|||
129021401|NCT00795821|464370437|FG001|Acute Treatment Phase|Protocol Violation|2|||
129021402|NCT00795821|464370436|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
129021403|NCT00795821|464370437|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
129021404|NCT00795821|464370436|FG000|Long-term Extension Phase|Adverse Event|25|||
129021405|NCT00795821|464370437|FG001|Long-term Extension Phase|Adverse Event|32|||
129021406|NCT00795821|464370436|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
129021407|NCT00795821|464370437|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
129021408|NCT00795821|464370436|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
129021409|NCT00795821|464370437|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
129021410|NCT00795821|464370436|FG000|Long-term Extension Phase|Physician Decision|1|||
129021411|NCT00795821|464370437|FG001|Long-term Extension Phase|Physician Decision|2|||
129021412|NCT00795821|464370436|FG000|Long-term Extension Phase|Protocol Violation|3|||
129021413|NCT00795821|464370437|FG001|Long-term Extension Phase|Protocol Violation|5|||
129021414|NCT00795821|464370436|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
129021415|NCT00795821|464370437|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
129021416|NCT00795821|464370436|FG000|Taper Phase|Adverse Event|2|||
129021417|NCT00795821|464370437|FG001|Taper Phase|Adverse Event|0|||
129021418|NCT00795821|464370436|FG000|Taper Phase|Lost to Follow-up|1|||
129021419|NCT00795821|464370437|FG001|Taper Phase|Lost to Follow-up|0|||
129021420|NCT00795821|464370436|FG000|Taper Phase|Physician Decision|2|||
129021421|NCT00795821|464370437|FG001|Taper Phase|Physician Decision|0|||
129021422|NCT00795821|464370436|FG000|Taper Phase|Withdrawal by Subject|4|||
129021423|NCT00795821|464370437|FG001|Taper Phase|Withdrawal by Subject|0|||
129021424|NCT06284525|464370442|FG000|Overall Study|Withdrawal by Subject|1|||
129021425|NCT00583453|464370447|FG000|Overall Study|discontinued intervention|0|||
129021426|NCT00583453|464370448|FG001|Overall Study|discontinued intervention|2|||
129021427|NCT03868891|464370451|FG000|Overall Study|Adverse Event|1|||
129021428|NCT03868891|464370452|FG001|Overall Study|Adverse Event|0|||
129021429|NCT03868891|464370451|FG000|Overall Study|Lost to Follow-up|2|||
129021430|NCT03868891|464370452|FG001|Overall Study|Lost to Follow-up|1|||
129021431|NCT03868891|464370451|FG000|Overall Study|COVID-19 Restrictions|1|||
129215205|NCT01588522|465089468|FG004|Overall Study|Withdrawal by Subject|2|||
128764406|NCT03682705|463428315|FG003|Overall Study|Adverse Event|0|||
128764407|NCT03682705|463428316|FG004|Overall Study|Adverse Event|1|||
128764408|NCT03682705|463428317|FG005|Overall Study|Adverse Event|1|||
129021432|NCT03868891|464370452|FG001|Overall Study|COVID-19 Restrictions|2|||
129021433|NCT03123094|464370454|FG000|Overall Study|Withdrawal by Subject|0|||
129021434|NCT03123094|464370455|FG001|Overall Study|Withdrawal by Subject|2|||
129021435|NCT03123094|464370456|FG002|Overall Study|Withdrawal by Subject|1|||
129021436|NCT03123094|464370457|FG003|Overall Study|Withdrawal by Subject|0|||
128894956|NCT02064920|463910175|FG000|Overall Study|Physician Decision|0|||
129021437|NCT03123094|464370458|FG004|Overall Study|Withdrawal by Subject|1|||
128764409|NCT03682705|463428312|FG000|Overall Study|Withdrawal by Subject|1|||
128894957|NCT02064920|463910176|FG001|Overall Study|Physician Decision|1|||
128691130|NCT00333840|463169370|FG002|Second-line Treatment Period|Protocol Violation|1|||
128691131|NCT00333840|463169371|FG003|Second-line Treatment Period|Protocol Violation|10|||
128691132|NCT00333840|463169368|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
128691133|NCT00333840|463169369|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
128691134|NCT00333840|463169370|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
128691135|NCT00333840|463169371|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
128691136|NCT00333840|463169368|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
128691137|NCT00333840|463169369|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
128691138|NCT00333840|463169370|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
128691139|NCT00333840|463169371|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
128691140|NCT00333840|463169368|FG000|Second-line Treatment Period|Administrative problems|0|||
128691141|NCT00333840|463169369|FG001|Second-line Treatment Period|Administrative problems|0|||
128691142|NCT00333840|463169370|FG002|Second-line Treatment Period|Administrative problems|0|||
128691143|NCT00333840|463169371|FG003|Second-line Treatment Period|Administrative problems|7|||
128691144|NCT00333840|463169368|FG000|Second-line Treatment Period|Death|0|||
128691145|NCT00333840|463169369|FG001|Second-line Treatment Period|Death|0|||
128894958|NCT02064920|463910175|FG000|Overall Study|Technical Problems|0|||
128894959|NCT02064920|463910176|FG001|Overall Study|Technical Problems|1|||
128894960|NCT02064920|463910175|FG000|Overall Study|Withdrawal by Subject|1|||
128894961|NCT02064920|463910176|FG001|Overall Study|Withdrawal by Subject|3|||
128691146|NCT00333840|463169370|FG002|Second-line Treatment Period|Death|0|||
128691147|NCT00333840|463169371|FG003|Second-line Treatment Period|Death|9|||
128691148|NCT01453725|463169372|FG000|Overall Study|Adverse Event|3|||
128691149|NCT01453725|463169373|FG001|Overall Study|Adverse Event|3|||
128691150|NCT01453725|463169372|FG000|Overall Study|Lost to Follow-up|4|||
128691151|NCT01453725|463169373|FG001|Overall Study|Lost to Follow-up|0|||
128691152|NCT01453725|463169372|FG000|Overall Study|Non-compliance With Protocol|1|||
128691153|NCT01453725|463169373|FG001|Overall Study|Non-compliance With Protocol|2|||
128691154|NCT01453725|463169372|FG000|Overall Study|Protocol Violation|1|||
128691155|NCT01453725|463169373|FG001|Overall Study|Protocol Violation|0|||
128691156|NCT01453725|463169372|FG000|Overall Study|Withdrawal by Subject|2|||
128691157|NCT01453725|463169373|FG001|Overall Study|Withdrawal by Subject|3|||
128691158|NCT01453725|463169372|FG000|Overall Study|Pregnancy Wish|0|||
128691159|NCT01453725|463169373|FG001|Overall Study|Pregnancy Wish|2|||
128691160|NCT01453725|463169372|FG000|Overall Study|Pregnancy|1|||
128691161|NCT01453725|463169373|FG001|Overall Study|Pregnancy|0|||
128691162|NCT01453725|463169372|FG000|Overall Study|Physician Decision|1|||
128691163|NCT01453725|463169373|FG001|Overall Study|Physician Decision|1|||
128691164|NCT03719586|463169382|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
128691165|NCT03719586|463169383|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
128691166|NCT03719586|463169384|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
128691167|NCT03719586|463169385|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
128691168|NCT00178633|463169386|FG000|Overall Study|Lost to Follow-up|6|||
128691169|NCT00369707|463169387|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
128691170|NCT00369707|463169387|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
128691171|NCT00369707|463169387|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
128691172|NCT00369707|463169387|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
128691173|NCT00369707|463169387|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
128691174|NCT00369707|463169387|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
128691175|NCT00369707|463169387|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
128691176|NCT00369707|463169387|FG000|Follow up for 2 Years After Treatment|Death|1|||
128691177|NCT00369707|463169387|FG000|Follow up for 2 Years After Treatment|Other|2|||
128691178|NCT03605212|463169390|FG000|Treatment Period|Adverse Event|1|||
128691179|NCT03605212|463169391|FG001|Treatment Period|Adverse Event|0|||
128691180|NCT03605212|463169392|FG002|Treatment Period|Adverse Event|0|||
128691181|NCT03605212|463169393|FG003|Treatment Period|Adverse Event|0|||
128691182|NCT03605212|463169394|FG004|Treatment Period|Adverse Event|0|||
128691183|NCT03605212|463169390|FG000|Treatment Period|Physician Decision|0|||
128691184|NCT03605212|463169391|FG001|Treatment Period|Physician Decision|0|||
128691185|NCT03605212|463169392|FG002|Treatment Period|Physician Decision|0|||
128894962|NCT02109562|463910177|FG000|Overall Study|Insufficient clinical response|2|||
128894963|NCT02109562|463910178|FG001|Overall Study|Insufficient clinical response|0|||
128691186|NCT03605212|463169393|FG003|Treatment Period|Physician Decision|0|||
128691187|NCT03605212|463169394|FG004|Treatment Period|Physician Decision|1|||
128691188|NCT01756053|463169395|FG000|Period 1 (10 Days)|Protocol Violation|1|||
128691189|NCT01756053|463169396|FG001|Period 1 (10 Days)|Protocol Violation|1|||
128691190|NCT01756053|463169395|FG000|Period 2 (10 Days)|Protocol Violation|0|||
128691191|NCT01756053|463169396|FG001|Period 2 (10 Days)|Protocol Violation|2|||
128691192|NCT01254292|463169397|FG000|Comparative Phase|Adverse Event|25|||
128691193|NCT01254292|463169398|FG001|Comparative Phase|Adverse Event|25|||
128691194|NCT01254292|463169397|FG000|Comparative Phase|Lost to Follow-up|3|||
128894964|NCT02109562|463910179|FG002|Overall Study|Insufficient clinical response|4|||
128894965|NCT02109562|463910177|FG000|Overall Study|Adverse Event|0|||
128894966|NCT02109562|463910178|FG001|Overall Study|Adverse Event|2|||
128894967|NCT02109562|463910179|FG002|Overall Study|Adverse Event|3|||
128894968|NCT02109562|463910177|FG000|Overall Study|Lost to Follow-up|1|||
128894969|NCT02109562|463910178|FG001|Overall Study|Lost to Follow-up|0|||
129021438|NCT02838420|464370459|FG000|Overall Study|Ongoing in Study|113|||
129021439|NCT02838420|464370460|FG001|Overall Study|Ongoing in Study|45|||
128691195|NCT01254292|463169398|FG001|Comparative Phase|Lost to Follow-up|21|||
128691196|NCT01254292|463169397|FG000|Comparative Phase|Pregnancy|2|||
128691197|NCT01254292|463169398|FG001|Comparative Phase|Pregnancy|6|||
128691198|NCT01254292|463169397|FG000|Comparative Phase|Withdrawal by Subject|20|||
128691199|NCT01254292|463169398|FG001|Comparative Phase|Withdrawal by Subject|21|||
128691200|NCT01254292|463169397|FG000|Comparative Phase|Protocol Violation|1|||
128691201|NCT01254292|463169398|FG001|Comparative Phase|Protocol Violation|2|||
128691202|NCT01254292|463169397|FG000|Comparative Phase|Wish for pregnancy|4|||
128691203|NCT01254292|463169398|FG001|Comparative Phase|Wish for pregnancy|6|||
128691204|NCT01254292|463169397|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
128691205|NCT01254292|463169398|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
128691206|NCT01254292|463169397|FG000|LCS12 Extension Phase|Adverse Event|9|||
128691207|NCT01254292|463169398|FG001|LCS12 Extension Phase|Adverse Event|0|||
128691208|NCT01254292|463169397|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
128691209|NCT01254292|463169398|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
128691210|NCT01254292|463169397|FG000|LCS12 Extension Phase|Other unknown|4|||
128691211|NCT01254292|463169398|FG001|LCS12 Extension Phase|Other unknown|0|||
128691212|NCT01254292|463169397|FG000|LCS12 Extension Phase|Pregnancy|2|||
128691213|NCT01254292|463169398|FG001|LCS12 Extension Phase|Pregnancy|0|||
128691214|NCT01254292|463169397|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
128691215|NCT01254292|463169398|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
128691216|NCT00285818|463169399|FG000|Overall Study|Withdrawal by Subject|3|||
128691217|NCT00285818|463169400|FG001|Overall Study|Withdrawal by Subject|2|||
128691218|NCT00285818|463169399|FG000|Overall Study|Lost to Follow-up|1|||
128691219|NCT00285818|463169400|FG001|Overall Study|Lost to Follow-up|0|||
129021440|NCT02838420|464370459|FG000|Overall Study|Lost to Follow-up|1|||
129021441|NCT02838420|464370460|FG001|Overall Study|Lost to Follow-up|0|||
129021442|NCT02838420|464370459|FG000|Overall Study|Withdrawal by Subject|3|||
129021443|NCT02838420|464370460|FG001|Overall Study|Withdrawal by Subject|4|||
129021444|NCT02838420|464370459|FG000|Overall Study|Death|8|||
129021445|NCT02838420|464370460|FG001|Overall Study|Death|13|||
129021446|NCT00185458|464370461|FG000|Contraception Phase|Adverse Event|37|||
129021447|NCT00185458|464370461|FG000|Contraception Phase|Lost to Follow-up|10|||
129021448|NCT00185458|464370461|FG000|Contraception Phase|Protocol Violation|2|||
129021449|NCT00185458|464370461|FG000|Contraception Phase|Physician Decision|2|||
129021450|NCT00185458|464370461|FG000|Contraception Phase|Withdrawal by Subject|7|||
129021451|NCT00185458|464370461|FG000|HRT Phase|Adverse Event|18|||
129021452|NCT00185458|464370461|FG000|HRT Phase|Lost to Follow-up|4|||
129021453|NCT00185458|464370461|FG000|HRT Phase|Protocol Violation|2|||
129021454|NCT00185458|464370461|FG000|HRT Phase|Withdrawal by Subject|3|||
129021455|NCT00251979|464370462|FG000|Overall Study|Protocol Violation|3|||
129021456|NCT00251979|464370463|FG001|Overall Study|Protocol Violation|5|||
129021457|NCT00251979|464370462|FG000|Overall Study|Adverse Event|11|||
129021458|NCT00251979|464370463|FG001|Overall Study|Adverse Event|17|||
129021459|NCT00251979|464370462|FG000|Overall Study|Withdrawal by Subject|13|||
129021460|NCT00251979|464370463|FG001|Overall Study|Withdrawal by Subject|7|||
129021461|NCT00251979|464370462|FG000|Overall Study|Lost to Follow-up|8|||
129021462|NCT00251979|464370463|FG001|Overall Study|Lost to Follow-up|6|||
129021463|NCT00251979|464370462|FG000|Overall Study|Death|3|||
129021464|NCT00251979|464370463|FG001|Overall Study|Death|5|||
129021465|NCT01576042|464370464|FG000|Overall Study|Physician Decision|2|||
129021466|NCT01576042|464370465|FG001|Overall Study|Physician Decision|0|||
129021467|NCT00835536|464370472|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
129110902|NCT02326272|464701362|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110903|NCT02326272|464701363|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
128691220|NCT01986140|463169401|FG000|Overall Study|Withdrawal by Subject|31|||
128691221|NCT01986140|463169402|FG001|Overall Study|Withdrawal by Subject|25|||
128691222|NCT01986140|463169401|FG000|Overall Study|alternative treatment|1|||
128691223|NCT01986140|463169402|FG001|Overall Study|alternative treatment|1|||
128691224|NCT01986140|463169401|FG000|Overall Study|found not eligible|3|||
128691225|NCT01986140|463169402|FG001|Overall Study|found not eligible|0|||
128691226|NCT01986140|463169401|FG000|Overall Study|Adverse Event|0|||
128691227|NCT01986140|463169402|FG001|Overall Study|Adverse Event|1|||
128691228|NCT01986140|463169401|FG000|Overall Study|progression disease|0|||
128894970|NCT02109562|463910179|FG002|Overall Study|Lost to Follow-up|1|||
128894971|NCT02109562|463910177|FG000|Overall Study|Protocol Violation|0|||
129021468|NCT00835536|464370473|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
129021469|NCT03173547|464370474|FG000|Overall Study|Adverse Event|2|||
129021470|NCT03173547|464370475|FG001|Overall Study|Adverse Event|0|||
129021471|NCT03173547|464370474|FG000|Overall Study|Withdrawal by Subject|2|||
129110904|NCT02326272|464701364|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110905|NCT02326272|464701365|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110906|NCT02326272|464701366|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110907|NCT02326272|464701367|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129110908|NCT02326272|464701353|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110909|NCT02326272|464701354|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110910|NCT02326272|464701355|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
129110911|NCT02326272|464701356|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110912|NCT02326272|464701357|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110913|NCT02326272|464701358|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110914|NCT02326272|464701359|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110915|NCT02326272|464701360|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110916|NCT02326272|464701361|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110917|NCT02326272|464701362|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110918|NCT02326272|464701363|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110919|NCT02326272|464701364|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110920|NCT02326272|464701365|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110921|NCT02326272|464701366|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110922|NCT02326272|464701367|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129110923|NCT02326272|464701353|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110924|NCT02326272|464701354|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110925|NCT02326272|464701355|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
129110926|NCT02326272|464701356|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110927|NCT02326272|464701357|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110928|NCT02326272|464701358|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110929|NCT02326272|464701359|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110930|NCT02326272|464701360|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110931|NCT02326272|464701361|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110932|NCT02326272|464701362|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110933|NCT02326272|464701363|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110934|NCT02326272|464701364|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110935|NCT02326272|464701365|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110936|NCT02326272|464701366|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110937|NCT02326272|464701367|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129110938|NCT02326272|464701353|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110939|NCT02326272|464701354|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110940|NCT02326272|464701355|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
129110941|NCT02326272|464701356|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110942|NCT02326272|464701357|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110943|NCT02326272|464701358|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110944|NCT02326272|464701359|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110945|NCT02326272|464701360|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110946|NCT02326272|464701361|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129021472|NCT03173547|464370475|FG001|Overall Study|Withdrawal by Subject|2|||
129021473|NCT00657553|464370476|FG000|Overall Study|low accrual, no analysis run|5|||
129021474|NCT00657553|464370477|FG001|Overall Study|low accrual, no analysis run|5|||
129021475|NCT00446563|464370478|FG000|Overall Study|Adverse Event|4|||
129021476|NCT00446563|464370479|FG001|Overall Study|Adverse Event|3|||
129021477|NCT00446563|464370478|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129021478|NCT00446563|464370479|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129021479|NCT00446563|464370478|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129021480|NCT00446563|464370479|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129021481|NCT00446563|464370478|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129021482|NCT00446563|464370479|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129021483|NCT00446563|464370478|FG000|Overall Study|Withdrawal by Subject|2|||
129021484|NCT00446563|464370479|FG001|Overall Study|Withdrawal by Subject|1|||
129021485|NCT00446563|464370478|FG000|Overall Study|Administrative problems|0|||
129021486|NCT00446563|464370479|FG001|Overall Study|Administrative problems|1|||
129021487|NCT03769025|464370480|FG000|Overall Study|Withdrawal by Subject|1|||
129021488|NCT03769025|464370481|FG001|Overall Study|Withdrawal by Subject|1|||
129021489|NCT03769025|464370480|FG000|Overall Study|Lost to Follow-up|4|||
129021490|NCT03769025|464370481|FG001|Overall Study|Lost to Follow-up|3|||
128894972|NCT02109562|463910178|FG001|Overall Study|Protocol Violation|3|||
128894973|NCT02109562|463910179|FG002|Overall Study|Protocol Violation|1|||
128894974|NCT02109562|463910177|FG000|Overall Study|Withdrawal by Subject|20|||
128894975|NCT02109562|463910178|FG001|Overall Study|Withdrawal by Subject|25|||
129110947|NCT02326272|464701362|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110948|NCT02326272|464701363|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110949|NCT02326272|464701364|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110950|NCT02326272|464701365|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110951|NCT02326272|464701366|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110952|NCT02326272|464701367|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129110953|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110954|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110955|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110956|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110957|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129110958|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
129110959|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
129110960|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129110961|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129110962|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110963|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110964|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110965|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110966|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110967|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129110968|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110969|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110970|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110971|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110972|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110973|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
129110974|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129110975|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110976|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129110977|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129110978|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110979|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110980|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110981|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110982|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129110983|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110984|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110985|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110986|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110987|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110988|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
129110989|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110990|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
129110991|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110992|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110993|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110994|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110995|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110996|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110997|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129110998|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129110999|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111000|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111001|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129111002|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111003|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
129111004|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
128894976|NCT02109562|463910179|FG002|Overall Study|Withdrawal by Subject|21|||
128894977|NCT02109562|463910177|FG000|Overall Study|Physician Decision|3|||
128894978|NCT02109562|463910178|FG001|Overall Study|Physician Decision|4|||
129021491|NCT01169558|464370482|FG000|Overall Study|Disease progression|98|||
128691229|NCT01986140|463169402|FG001|Overall Study|progression disease|1|||
128691230|NCT00471146|463169411|FG000|Overall Study|Adverse Event|32|||
128691231|NCT00471146|463169412|FG001|Overall Study|Adverse Event|33|||
128691232|NCT00471146|463169411|FG000|Overall Study|Withdrawal by Subject|14|||
128691233|NCT00471146|463169412|FG001|Overall Study|Withdrawal by Subject|11|||
129021492|NCT01169558|464370482|FG000|Overall Study|Adverse Event|25|||
129021493|NCT01169558|464370482|FG000|Overall Study|Withdrawal of Consent|8|||
129021494|NCT01169558|464370482|FG000|Overall Study|Medical Decision|7|||
129021495|NCT01169558|464370482|FG000|Overall Study|Stable Disease|4|||
129021496|NCT01169558|464370482|FG000|Overall Study|Lost to Follow-up|4|||
129021497|NCT01169558|464370482|FG000|Overall Study|Need for Surgery|4|||
129021498|NCT01169558|464370482|FG000|Overall Study|Non-compliance|2|||
129021499|NCT01169558|464370482|FG000|Overall Study|Protocol Violation|2|||
128894979|NCT02109562|463910179|FG002|Overall Study|Physician Decision|5|||
128894980|NCT00310804|463910180|FG000|Overall Study|Lost to Follow-up|2|||
128894981|NCT00310804|463910181|FG001|Overall Study|Lost to Follow-up|0|||
128894982|NCT00310804|463910180|FG000|Overall Study|Withdrawal by Subject|3|||
128894983|NCT00310804|463910181|FG001|Overall Study|Withdrawal by Subject|0|||
128894984|NCT00688155|463910186|FG000|Overall Study|Withdrawal by Subject|2|||
128894985|NCT00688155|463910187|FG001|Overall Study|Withdrawal by Subject|2|||
128894986|NCT00688155|463910188|FG002|Overall Study|Withdrawal by Subject|1|||
128894987|NCT00688155|463910189|FG003|Overall Study|Withdrawal by Subject|1|||
128894988|NCT01889238|463910193|FG000|Overall Study|Death|1|||
128894989|NCT01889238|463910193|FG000|Overall Study|Withdrawal by Subject|1|||
129021500|NCT01169558|464370482|FG000|Overall Study|Partial response|2|||
129021501|NCT02409355|464370488|FG000|Overall Study|Withdrawal by Subject|1|||
129021502|NCT02409355|464370489|FG001|Overall Study|Withdrawal by Subject|0|||
129021503|NCT02409355|464370488|FG000|Overall Study|Death|1|||
129021504|NCT02409355|464370489|FG001|Overall Study|Death|1|||
129021505|NCT02409355|464370488|FG000|Overall Study|Study terminated by Sponsor|2|||
129021506|NCT02409355|464370489|FG001|Overall Study|Study terminated by Sponsor|3|||
129021507|NCT00838539|464370490|FG000|Overall Study|Disease Progression|2|||
129021508|NCT00838539|464370491|FG001|Overall Study|Disease Progression|4|||
129021509|NCT00838539|464370492|FG002|Overall Study|Disease Progression|3|||
129021510|NCT00838539|464370493|FG003|Overall Study|Disease Progression|2|||
129021511|NCT00838539|464370494|FG004|Overall Study|Disease Progression|4|||
129021512|NCT00838539|464370495|FG005|Overall Study|Disease Progression|2|||
129021513|NCT00838539|464370496|FG006|Overall Study|Disease Progression|3|||
129021514|NCT00838539|464370497|FG007|Overall Study|Disease Progression|4|||
129021515|NCT00838539|464370498|FG008|Overall Study|Disease Progression|4|||
129021516|NCT00838539|464370499|FG009|Overall Study|Disease Progression|5|||
129021517|NCT00838539|464370500|FG010|Overall Study|Disease Progression|1|||
129021518|NCT00838539|464370501|FG011|Overall Study|Disease Progression|4|||
129021519|NCT00838539|464370490|FG000|Overall Study|Adverse Event|1|||
129021520|NCT00838539|464370491|FG001|Overall Study|Adverse Event|1|||
129021521|NCT00838539|464370492|FG002|Overall Study|Adverse Event|1|||
129021522|NCT00838539|464370493|FG003|Overall Study|Adverse Event|1|||
129021523|NCT00838539|464370494|FG004|Overall Study|Adverse Event|2|||
129021524|NCT00838539|464370495|FG005|Overall Study|Adverse Event|1|||
129021525|NCT00838539|464370496|FG006|Overall Study|Adverse Event|0|||
129021526|NCT00838539|464370497|FG007|Overall Study|Adverse Event|2|||
129021527|NCT00838539|464370498|FG008|Overall Study|Adverse Event|0|||
129021528|NCT00838539|464370499|FG009|Overall Study|Adverse Event|1|||
129021529|NCT00838539|464370500|FG010|Overall Study|Adverse Event|2|||
129021530|NCT00838539|464370501|FG011|Overall Study|Adverse Event|0|||
129021531|NCT00838539|464370490|FG000|Overall Study|Withdrawal by Subject|0|||
129021532|NCT00838539|464370491|FG001|Overall Study|Withdrawal by Subject|1|||
129021533|NCT00838539|464370492|FG002|Overall Study|Withdrawal by Subject|0|||
129021534|NCT00838539|464370493|FG003|Overall Study|Withdrawal by Subject|0|||
129021535|NCT00838539|464370494|FG004|Overall Study|Withdrawal by Subject|0|||
128691234|NCT00471146|463169411|FG000|Overall Study|Death|11|||
128691235|NCT00471146|463169412|FG001|Overall Study|Death|12|||
128691236|NCT00471146|463169411|FG000|Overall Study|Lost to Follow-up|4|||
128691237|NCT00471146|463169412|FG001|Overall Study|Lost to Follow-up|2|||
128691238|NCT00471146|463169411|FG000|Overall Study|Protocol Violation|2|||
128691239|NCT00471146|463169412|FG001|Overall Study|Protocol Violation|2|||
128894990|NCT01889238|463910193|FG000|Overall Study|Adverse Event|6|||
128894991|NCT01889238|463910193|FG000|Overall Study|Disease Progression|104|||
129021536|NCT00838539|464370495|FG005|Overall Study|Withdrawal by Subject|0|||
129021537|NCT00838539|464370496|FG006|Overall Study|Withdrawal by Subject|0|||
129021538|NCT00838539|464370497|FG007|Overall Study|Withdrawal by Subject|0|||
129021539|NCT00838539|464370498|FG008|Overall Study|Withdrawal by Subject|0|||
129021540|NCT00838539|464370499|FG009|Overall Study|Withdrawal by Subject|1|||
129021541|NCT00838539|464370500|FG010|Overall Study|Withdrawal by Subject|2|||
129021542|NCT00838539|464370501|FG011|Overall Study|Withdrawal by Subject|0|||
129021543|NCT00838539|464370490|FG000|Overall Study|Death|0|||
129021544|NCT00838539|464370491|FG001|Overall Study|Death|0|||
129021545|NCT00838539|464370492|FG002|Overall Study|Death|0|||
128691240|NCT00471146|463169411|FG000|Overall Study|Objective progression or relapse|84|||
128691241|NCT00471146|463169412|FG001|Overall Study|Objective progression or relapse|87|||
128691242|NCT00471146|463169411|FG000|Overall Study|Global deterioration of health status|12|||
128691243|NCT00471146|463169412|FG001|Overall Study|Global deterioration of health status|14|||
128691244|NCT00471146|463169411|FG000|Overall Study|Randomized but not treated|9|||
128691245|NCT00471146|463169412|FG001|Overall Study|Randomized but not treated|8|||
128691246|NCT00471146|463169411|FG000|Overall Study|Other|4|||
128691247|NCT00471146|463169412|FG001|Overall Study|Other|5|||
128691248|NCT02149875|463169413|FG000|Overall Study|Lost to Follow-up|3|||
128691249|NCT02149875|463169414|FG001|Overall Study|Lost to Follow-up|4|||
128764410|NCT03682705|463428313|FG001|Overall Study|Withdrawal by Subject|3|||
128894992|NCT01889238|463910193|FG000|Overall Study|Other|6|||
128894993|NCT04136184|463910194|FG000|Overall Study|Lost to Follow-up|0|||
128894994|NCT04136184|463910195|FG001|Overall Study|Lost to Follow-up|3|||
128894995|NCT04136184|463910194|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
128894996|NCT04136184|463910195|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
128894997|NCT03318978|463910199|FG000|Overall Study|Withdrawal by Subject|1|||
128894998|NCT02844816|463910200|FG000|Overall Study|No protocol treatment received|5|||
128894999|NCT02844816|463910201|FG001|Overall Study|No protocol treatment received|1|||
129021546|NCT00838539|464370493|FG003|Overall Study|Death|0|||
129021547|NCT00838539|464370494|FG004|Overall Study|Death|0|||
129021548|NCT00838539|464370495|FG005|Overall Study|Death|0|||
129021549|NCT00838539|464370496|FG006|Overall Study|Death|1|||
129021550|NCT00838539|464370497|FG007|Overall Study|Death|0|||
129021551|NCT00838539|464370498|FG008|Overall Study|Death|0|||
129021552|NCT00838539|464370499|FG009|Overall Study|Death|0|||
129021553|NCT00838539|464370500|FG010|Overall Study|Death|0|||
129021554|NCT00838539|464370501|FG011|Overall Study|Death|0|||
129021555|NCT00838539|464370490|FG000|Overall Study|Physician Decision|0|||
129021556|NCT00838539|464370491|FG001|Overall Study|Physician Decision|0|||
129021557|NCT00838539|464370492|FG002|Overall Study|Physician Decision|0|||
129021558|NCT00838539|464370493|FG003|Overall Study|Physician Decision|0|||
129021559|NCT00838539|464370494|FG004|Overall Study|Physician Decision|0|||
129021560|NCT00838539|464370495|FG005|Overall Study|Physician Decision|0|||
129021561|NCT00838539|464370496|FG006|Overall Study|Physician Decision|0|||
129021562|NCT00838539|464370497|FG007|Overall Study|Physician Decision|0|||
129021563|NCT00838539|464370498|FG008|Overall Study|Physician Decision|1|||
129021564|NCT00838539|464370499|FG009|Overall Study|Physician Decision|0|||
129021565|NCT00838539|464370500|FG010|Overall Study|Physician Decision|0|||
129021566|NCT00838539|464370501|FG011|Overall Study|Physician Decision|0|||
129021567|NCT00838539|464370490|FG000|Overall Study|Clinical Progression|0|||
129021568|NCT00838539|464370491|FG001|Overall Study|Clinical Progression|0|||
129021569|NCT00838539|464370492|FG002|Overall Study|Clinical Progression|0|||
129021570|NCT00838539|464370493|FG003|Overall Study|Clinical Progression|0|||
129021571|NCT00838539|464370494|FG004|Overall Study|Clinical Progression|0|||
129021572|NCT00838539|464370495|FG005|Overall Study|Clinical Progression|0|||
129021573|NCT00838539|464370496|FG006|Overall Study|Clinical Progression|1|||
129021574|NCT00838539|464370497|FG007|Overall Study|Clinical Progression|0|||
129021575|NCT00838539|464370498|FG008|Overall Study|Clinical Progression|0|||
129021576|NCT00838539|464370499|FG009|Overall Study|Clinical Progression|0|||
129021577|NCT00838539|464370500|FG010|Overall Study|Clinical Progression|0|||
129021578|NCT00838539|464370501|FG011|Overall Study|Clinical Progression|0|||
129021579|NCT00838539|464370490|FG000|Overall Study|Symptomatic Deterioration|0|||
129021580|NCT00838539|464370491|FG001|Overall Study|Symptomatic Deterioration|0|||
129021581|NCT00838539|464370492|FG002|Overall Study|Symptomatic Deterioration|1|||
129021582|NCT00838539|464370493|FG003|Overall Study|Symptomatic Deterioration|1|||
129021583|NCT00838539|464370494|FG004|Overall Study|Symptomatic Deterioration|0|||
129021584|NCT00838539|464370495|FG005|Overall Study|Symptomatic Deterioration|1|||
129021585|NCT00838539|464370496|FG006|Overall Study|Symptomatic Deterioration|0|||
129021586|NCT00838539|464370497|FG007|Overall Study|Symptomatic Deterioration|0|||
129021587|NCT00838539|464370498|FG008|Overall Study|Symptomatic Deterioration|0|||
129021588|NCT00838539|464370499|FG009|Overall Study|Symptomatic Deterioration|1|||
129021589|NCT00838539|464370500|FG010|Overall Study|Symptomatic Deterioration|0|||
128691250|NCT02149875|463169415|FG002|Overall Study|Lost to Follow-up|5|||
128895000|NCT02844816|463910200|FG000|Overall Study|Ineligible|22|||
128691251|NCT02149875|463169413|FG000|Overall Study|Withdrawal by Subject|3|||
128691252|NCT02149875|463169414|FG001|Overall Study|Withdrawal by Subject|2|||
128691253|NCT02149875|463169415|FG002|Overall Study|Withdrawal by Subject|2|||
128691254|NCT02149875|463169413|FG000|Overall Study|Physician Decision|1|||
128691255|NCT02149875|463169414|FG001|Overall Study|Physician Decision|2|||
128691256|NCT02149875|463169415|FG002|Overall Study|Physician Decision|2|||
129021590|NCT00838539|464370501|FG011|Overall Study|Symptomatic Deterioration|0|||
129021591|NCT01908205|464370502|FG000|Overall Study|Lost to Follow-up|2|||
129021592|NCT01908205|464370503|FG001|Overall Study|Lost to Follow-up|0|||
129021593|NCT01908205|464370502|FG000|Overall Study|Withdrawal by Subject|3|||
129021594|NCT01908205|464370503|FG001|Overall Study|Withdrawal by Subject|1|||
129021595|NCT03134222|464370508|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
129021596|NCT03134222|464370509|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
128764411|NCT03682705|463428314|FG002|Overall Study|Withdrawal by Subject|2|||
128764412|NCT03682705|463428315|FG003|Overall Study|Withdrawal by Subject|4|||
128764413|NCT03682705|463428316|FG004|Overall Study|Withdrawal by Subject|0|||
128764414|NCT03682705|463428317|FG005|Overall Study|Withdrawal by Subject|1|||
128764415|NCT03682705|463428312|FG000|Overall Study|Other, not specified|0|||
128764416|NCT03682705|463428313|FG001|Overall Study|Other, not specified|0|||
128764417|NCT03682705|463428314|FG002|Overall Study|Other, not specified|0|||
128764418|NCT03682705|463428315|FG003|Overall Study|Other, not specified|1|||
128895001|NCT02844816|463910201|FG001|Overall Study|Ineligible|15|||
128895002|NCT02844816|463910200|FG000|Overall Study|Participant refusal|5|||
128764419|NCT03682705|463428316|FG004|Overall Study|Other, not specified|2|||
128895003|NCT02844816|463910201|FG001|Overall Study|Participant refusal|5|||
128895004|NCT02844816|463910200|FG000|Overall Study|Adverse Event|5|||
128895005|NCT02844816|463910201|FG001|Overall Study|Adverse Event|4|||
128895006|NCT02844816|463910200|FG000|Overall Study|Death|0|||
128895007|NCT02844816|463910201|FG001|Overall Study|Death|1|||
128895008|NCT02844816|463910200|FG000|Overall Study|Disease progression/recurrence|50|||
128895009|NCT02844816|463910201|FG001|Overall Study|Disease progression/recurrence|24|||
128895010|NCT02844816|463910200|FG000|Overall Study|Physician Decision|1|||
128895011|NCT02844816|463910201|FG001|Overall Study|Physician Decision|1|||
128895012|NCT02717754|463910203|FG000|Overall Study|Incorrect Infusion Duration|0|||
128895013|NCT02717754|463910204|FG001|Overall Study|Incorrect Infusion Duration|0|||
128895014|NCT02717754|463910205|FG002|Overall Study|Incorrect Infusion Duration|0|||
128895015|NCT02717754|463910206|FG003|Overall Study|Incorrect Infusion Duration|10|||
128895016|NCT02717754|463910207|FG004|Overall Study|Incorrect Infusion Duration|20|||
128895017|NCT02717754|463910208|FG005|Overall Study|Incorrect Infusion Duration|20|||
128895018|NCT01200238|463910209|FG000|Overall Study|Adverse Event|2|||
128895019|NCT01200238|463910210|FG001|Overall Study|Adverse Event|1|||
128895020|NCT01200238|463910209|FG000|Overall Study|Progressive Disease|5|||
128895021|NCT01200238|463910210|FG001|Overall Study|Progressive Disease|8|||
128895022|NCT01200238|463910209|FG000|Overall Study|Withdrawal by Subject|0|||
128895023|NCT01200238|463910210|FG001|Overall Study|Withdrawal by Subject|1|||
128895024|NCT03734016|463910214|FG000|Overall Study|Sponsor Ended Study|225|||
128895025|NCT03734016|463910215|FG001|Overall Study|Sponsor Ended Study|200|||
128895026|NCT03734016|463910214|FG000|Overall Study|Death|69|||
128895027|NCT03734016|463910215|FG001|Overall Study|Death|83|||
128895028|NCT03734016|463910214|FG000|Overall Study|Withdrawal by Subject|21|||
128895029|NCT03734016|463910215|FG001|Overall Study|Withdrawal by Subject|27|||
128895030|NCT03734016|463910214|FG000|Overall Study|Physician Decision|1|||
128895031|NCT03734016|463910215|FG001|Overall Study|Physician Decision|12|||
128895032|NCT03734016|463910214|FG000|Overall Study|Lost to Follow-up|6|||
129021597|NCT03134222|464370510|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
129021598|NCT03134222|464370511|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
129021599|NCT03134222|464370512|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
128764420|NCT03682705|463428317|FG005|Overall Study|Other, not specified|0|||
128895033|NCT03734016|463910215|FG001|Overall Study|Lost to Follow-up|2|||
128895034|NCT03734016|463910214|FG000|Overall Study|Miscellaneous|5|||
129021600|NCT03134222|464370508|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
129021601|NCT03134222|464370509|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
129021602|NCT03134222|464370510|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
129021603|NCT03134222|464370511|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
129021604|NCT03134222|464370512|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
129021605|NCT03134222|464370508|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129021606|NCT03134222|464370509|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
129021607|NCT03134222|464370510|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129021608|NCT03134222|464370511|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129021609|NCT03134222|464370512|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129021610|NCT03134222|464370508|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
129021611|NCT03134222|464370509|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
129021612|NCT03134222|464370510|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
129021613|NCT03134222|464370511|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
129021614|NCT03134222|464370512|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
129021615|NCT03134222|464370508|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
129215206|NCT01588522|465089469|FG005|Overall Study|Withdrawal by Subject|0|||
128895035|NCT03734016|463910215|FG001|Overall Study|Miscellaneous|1|||
128895036|NCT01979835|463910216|FG000|Primary Outcome SA Measurment|failed insertion|18|||
128895037|NCT01979835|463910216|FG000|Follow-up|Lost to Follow-up|32|||
128764421|NCT03682705|463428312|FG000|Overall Study|Lost to Follow-up|0|||
128895038|NCT02592018|463910219|FG000|Overall Study|Adverse Event|1|||
128895039|NCT02592018|463910219|FG000|Overall Study|Lost to Follow-up|1|||
128895040|NCT02710136|463910222|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
128895041|NCT02710136|463910223|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
128895042|NCT00418665|463910224|FG000|Treatment Period|Ineligibility determined|1|||
128895043|NCT00418665|463910225|FG001|Treatment Period|Ineligibility determined|1|||
128895044|NCT00418665|463910226|FG002|Treatment Period|Ineligibility determined|0|||
128895045|NCT00418665|463910224|FG000|Treatment Period|Adverse Event|2|||
128895046|NCT00418665|463910225|FG001|Treatment Period|Adverse Event|2|||
128895047|NCT00418665|463910226|FG002|Treatment Period|Adverse Event|0|||
128895048|NCT00418665|463910224|FG000|Treatment Period|Withdrawal by Subject|0|||
129111005|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129111006|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111007|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129111008|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111009|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111010|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111011|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111012|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129111013|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111014|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111015|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111016|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111017|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111018|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111019|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111020|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
129111021|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111022|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111023|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111024|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111025|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111026|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111027|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129111028|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111029|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111030|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111031|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111032|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111033|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111034|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
129111035|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
128691257|NCT02711345|463169417|FG000|Overall Study|Adverse Event|0|||
128691258|NCT02711345|463169418|FG001|Overall Study|Adverse Event|0|||
128691259|NCT02711345|463169419|FG002|Overall Study|Adverse Event|0|||
128691260|NCT02711345|463169420|FG003|Overall Study|Adverse Event|1|||
128691261|NCT02711345|463169421|FG004|Overall Study|Adverse Event|1|||
128691262|NCT02711345|463169422|FG005|Overall Study|Adverse Event|2|||
128691263|NCT02711345|463169423|FG006|Overall Study|Adverse Event|1|||
128691264|NCT02711345|463169424|FG007|Overall Study|Adverse Event|0|||
128691265|NCT02711345|463169425|FG008|Overall Study|Adverse Event|0|||
128691266|NCT02711345|463169426|FG009|Overall Study|Adverse Event|2|||
128691267|NCT02711345|463169417|FG000|Overall Study|Physician Decision|0|||
128691268|NCT02711345|463169418|FG001|Overall Study|Physician Decision|0|||
128691269|NCT02711345|463169419|FG002|Overall Study|Physician Decision|1|||
128691270|NCT02711345|463169420|FG003|Overall Study|Physician Decision|0|||
128691271|NCT02711345|463169421|FG004|Overall Study|Physician Decision|0|||
128691272|NCT02711345|463169422|FG005|Overall Study|Physician Decision|0|||
128691273|NCT02711345|463169423|FG006|Overall Study|Physician Decision|0|||
128691274|NCT02711345|463169424|FG007|Overall Study|Physician Decision|0|||
128691275|NCT02711345|463169425|FG008|Overall Study|Physician Decision|1|||
128691276|NCT02711345|463169426|FG009|Overall Study|Physician Decision|0|||
128691277|NCT02711345|463169417|FG000|Overall Study|Progressive disease|1|||
128691278|NCT02711345|463169418|FG001|Overall Study|Progressive disease|3|||
128691279|NCT02711345|463169419|FG002|Overall Study|Progressive disease|5|||
128691280|NCT02711345|463169420|FG003|Overall Study|Progressive disease|3|||
128691281|NCT02711345|463169421|FG004|Overall Study|Progressive disease|7|||
128691282|NCT02711345|463169422|FG005|Overall Study|Progressive disease|2|||
128691283|NCT02711345|463169423|FG006|Overall Study|Progressive disease|8|||
128691284|NCT02711345|463169424|FG007|Overall Study|Progressive disease|4|||
128895049|NCT00418665|463910225|FG001|Treatment Period|Withdrawal by Subject|3|||
128895050|NCT00418665|463910226|FG002|Treatment Period|Withdrawal by Subject|1|||
128691285|NCT02711345|463169425|FG008|Overall Study|Progressive disease|5|||
128691286|NCT02711345|463169426|FG009|Overall Study|Progressive disease|6|||
128691287|NCT02711345|463169417|FG000|Overall Study|Subject/guardian decision|0|||
128691288|NCT02711345|463169418|FG001|Overall Study|Subject/guardian decision|0|||
129111036|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111037|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111038|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111039|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111040|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111041|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111042|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129111043|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111044|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111045|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111046|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111047|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111048|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111049|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111050|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111051|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
129111052|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111053|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111054|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111055|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111056|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111057|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129111058|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111059|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111060|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111061|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111062|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111063|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
129111064|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
129111065|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
129111066|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
129111067|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111068|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111069|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111070|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111071|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111072|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129111073|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111074|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111075|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111076|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111077|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111078|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
129111079|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111080|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111081|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
128691289|NCT02711345|463169419|FG002|Overall Study|Subject/guardian decision|0|||
128691290|NCT02711345|463169420|FG003|Overall Study|Subject/guardian decision|0|||
128691291|NCT02711345|463169421|FG004|Overall Study|Subject/guardian decision|0|||
128691292|NCT02711345|463169422|FG005|Overall Study|Subject/guardian decision|2|||
128895051|NCT00418665|463910224|FG000|Treatment Period|Requirement for alternative therapy|1|||
128895052|NCT00418665|463910225|FG001|Treatment Period|Requirement for alternative therapy|0|||
128895053|NCT00418665|463910226|FG002|Treatment Period|Requirement for alternative therapy|0|||
128895054|NCT00418665|463910224|FG000|Treatment Period|Physician Decision|1|||
128895055|NCT00418665|463910225|FG001|Treatment Period|Physician Decision|0|||
129111082|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111083|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111084|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111085|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111086|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129111087|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
128895056|NCT00418665|463910226|FG002|Treatment Period|Physician Decision|3|||
128691293|NCT02711345|463169423|FG006|Overall Study|Subject/guardian decision|3|||
128691294|NCT02711345|463169424|FG007|Overall Study|Subject/guardian decision|1|||
128691295|NCT02711345|463169425|FG008|Overall Study|Subject/guardian decision|0|||
128691296|NCT02711345|463169426|FG009|Overall Study|Subject/guardian decision|4|||
128691297|NCT02711345|463169417|FG000|Overall Study|Death|1|||
128691298|NCT02711345|463169418|FG001|Overall Study|Death|0|||
128691299|NCT02711345|463169419|FG002|Overall Study|Death|0|||
128691300|NCT02711345|463169420|FG003|Overall Study|Death|0|||
128691301|NCT02711345|463169421|FG004|Overall Study|Death|0|||
128691302|NCT02711345|463169422|FG005|Overall Study|Death|0|||
128691303|NCT02711345|463169423|FG006|Overall Study|Death|0|||
128691304|NCT02711345|463169424|FG007|Overall Study|Death|1|||
128691305|NCT02711345|463169425|FG008|Overall Study|Death|0|||
128691306|NCT02711345|463169426|FG009|Overall Study|Death|0|||
128691307|NCT00961649|463169427|FG000|Overall Study|Adverse Event|4|||
128691308|NCT00961649|463169428|FG001|Overall Study|Adverse Event|0|||
128691309|NCT00961649|463169429|FG002|Overall Study|Adverse Event|0|||
128691310|NCT00961649|463169430|FG003|Overall Study|Adverse Event|2|||
128691311|NCT00961649|463169427|FG000|Overall Study|Inadequate control of IOP|0|||
128691312|NCT00961649|463169428|FG001|Overall Study|Inadequate control of IOP|0|||
128691313|NCT00961649|463169429|FG002|Overall Study|Inadequate control of IOP|0|||
128691314|NCT00961649|463169430|FG003|Overall Study|Inadequate control of IOP|1|||
128691315|NCT00961649|463169427|FG000|Overall Study|Patient has travel plans during holidays|0|||
128895057|NCT00418665|463910224|FG000|Treatment Extension|Adverse Event|1|||
128895058|NCT00418665|463910225|FG001|Treatment Extension|Adverse Event|0|||
128895059|NCT00418665|463910226|FG002|Treatment Extension|Adverse Event|0|||
128691316|NCT00961649|463169428|FG001|Overall Study|Patient has travel plans during holidays|0|||
128691317|NCT00961649|463169429|FG002|Overall Study|Patient has travel plans during holidays|1|||
128691318|NCT00961649|463169430|FG003|Overall Study|Patient has travel plans during holidays|0|||
128691319|NCT00961649|463169427|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
128691320|NCT00961649|463169428|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
128691321|NCT00961649|463169429|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
128691322|NCT00961649|463169430|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
128691323|NCT00961649|463169427|FG000|Overall Study|Study terminated by sponsor|4|||
128691324|NCT00961649|463169428|FG001|Overall Study|Study terminated by sponsor|4|||
128691325|NCT00961649|463169429|FG002|Overall Study|Study terminated by sponsor|4|||
128691326|NCT00961649|463169430|FG003|Overall Study|Study terminated by sponsor|1|||
128691327|NCT04043728|463169431|FG000|Overall Study|Lost to Follow-up|1|||
128691328|NCT04043728|463169432|FG001|Overall Study|Lost to Follow-up|2|||
128691329|NCT04043728|463169433|FG002|Overall Study|Lost to Follow-up|0|||
128691330|NCT01033851|463169434|FG000|Overall Study|Withdrawal by Subject|3|||
128691331|NCT01033851|463169435|FG001|Overall Study|Withdrawal by Subject|7|||
128691332|NCT02349542|463169436|FG000|Overall Study|Withdrawal by Subject|5|||
128691333|NCT02919696|463169439|FG000|Overall Study|Adverse Event|1|||
128691334|NCT02919696|463169440|FG001|Overall Study|Adverse Event|2|||
128691335|NCT02919696|463169439|FG000|Overall Study|Withdrawal by Subject|2|||
128691336|NCT02919696|463169440|FG001|Overall Study|Withdrawal by Subject|1|||
128691337|NCT02919696|463169439|FG000|Overall Study|Sponsor Decision|1|||
128691338|NCT02919696|463169440|FG001|Overall Study|Sponsor Decision|1|||
129021616|NCT03134222|464370509|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
129021617|NCT03134222|464370510|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
129021618|NCT03134222|464370511|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
129021619|NCT03134222|464370512|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
129021620|NCT03134222|464370508|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
129021621|NCT03134222|464370509|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129021622|NCT03134222|464370510|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129021623|NCT03134222|464370511|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129021624|NCT03134222|464370512|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129021625|NCT03134222|464370508|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129021626|NCT03134222|464370509|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129021627|NCT03134222|464370510|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129021628|NCT03134222|464370511|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
129021629|NCT03134222|464370512|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129021630|NCT03134222|464370508|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
128895060|NCT00418665|463910224|FG000|Treatment Extension|Withdrawal by Subject|1|||
129021631|NCT03134222|464370509|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
129021632|NCT03134222|464370510|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
128691339|NCT02919696|463169439|FG000|Overall Study|Never Treated|0|||
128691340|NCT02919696|463169440|FG001|Overall Study|Never Treated|1|||
129021633|NCT03134222|464370511|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
128691341|NCT04308304|463169441|FG000|Overall Study|Withdrawal by Subject|4|||
128691342|NCT04308304|463169442|FG001|Overall Study|Withdrawal by Subject|0|||
128691343|NCT04308304|463169441|FG000|Overall Study|Protocol Violation|1|||
128691344|NCT04308304|463169442|FG001|Overall Study|Protocol Violation|0|||
128691345|NCT00945555|463169443|FG000|Overall Study|Referred to another hospital|5|||
128691346|NCT00945555|463169443|FG000|Overall Study|Worsening condition, intensive care unit|1|||
128691347|NCT00945555|463169443|FG000|Overall Study|Withdrawal by Subject|2|||
129111088|NCT02326272|464701353|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111089|NCT02326272|464701354|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111090|NCT02326272|464701355|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111091|NCT02326272|464701356|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111092|NCT02326272|464701357|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111093|NCT02326272|464701358|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111094|NCT02326272|464701359|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
129111095|NCT02326272|464701360|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111096|NCT02326272|464701361|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111097|NCT02326272|464701362|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111098|NCT02326272|464701363|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111099|NCT02326272|464701364|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111100|NCT02326272|464701365|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111101|NCT02326272|464701366|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111102|NCT02326272|464701367|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129111103|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
129111104|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
129111105|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
129111106|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
129111107|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
129111108|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
129111109|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
129111110|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
129111111|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
129111112|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
129111113|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
129111114|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
129111115|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
129111116|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
129111117|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
129111118|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111119|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111120|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111121|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111122|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129215207|NCT01588522|465089464|FG000|Overall Study|Lack of Efficacy|0|||
128691348|NCT00945555|463169443|FG000|Overall Study|Participant continued treatment at home|1|||
128691349|NCT00945555|463169443|FG000|Overall Study|Death|18|||
128691350|NCT00945555|463169443|FG000|Overall Study|Other|1|||
128691351|NCT01686828|463169444|FG000|Overall Study|Physician Decision|1|||
129021634|NCT03134222|464370512|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
129021635|NCT03482882|464370515|FG000|Overall Study|Adverse Event|3|||
129021636|NCT03482882|464370515|FG000|Overall Study|Lost to Follow-up|1|||
129021637|NCT03482882|464370515|FG000|Overall Study|Protocol Violation|2|||
129021638|NCT03482882|464370515|FG000|Overall Study|Not further specified|1|||
129021639|NCT01110005|464370520|FG000|Overall Study|ineligible|1|||
129021640|NCT01110005|464370521|FG001|Overall Study|ineligible|2|||
129021641|NCT01110005|464370520|FG000|Overall Study|missing consent|3|||
129021642|NCT01110005|464370521|FG001|Overall Study|missing consent|2|||
129021643|NCT01110005|464370520|FG000|Overall Study|Withdrawal by Subject|0|||
129021644|NCT01110005|464370521|FG001|Overall Study|Withdrawal by Subject|1|||
129021645|NCT03123471|464370522|FG000|Placebo-controlled Phase|Adverse Event|3|||
129021646|NCT03123471|464370523|FG001|Placebo-controlled Phase|Adverse Event|8|||
129021647|NCT03123471|464370522|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
129021648|NCT03123471|464370523|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
129021649|NCT03123471|464370522|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
129021650|NCT03123471|464370523|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
129021651|NCT03123471|464370522|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
129021652|NCT03123471|464370523|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
129021653|NCT03123471|464370522|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
128691352|NCT01686828|463169445|FG001|Overall Study|Physician Decision|0|||
129021654|NCT03123471|464370523|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
129021655|NCT03123471|464370522|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
129021656|NCT03123471|464370523|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
129021657|NCT03123471|464370522|FG000|Placebo-controlled Phase|Miscellaneous|0|||
129021658|NCT03123471|464370523|FG001|Placebo-controlled Phase|Miscellaneous|1|||
128691353|NCT01686828|463169446|FG002|Overall Study|Physician Decision|0|||
128691354|NCT01686828|463169447|FG003|Overall Study|Physician Decision|0|||
128691355|NCT01686828|463169444|FG000|Overall Study|New Job|0|||
128691356|NCT01686828|463169445|FG001|Overall Study|New Job|1|||
128691357|NCT01686828|463169446|FG002|Overall Study|New Job|0|||
128691358|NCT01686828|463169447|FG003|Overall Study|New Job|0|||
128691359|NCT01686828|463169444|FG000|Overall Study|Weight Loss|0|||
128691360|NCT01686828|463169445|FG001|Overall Study|Weight Loss|0|||
128691361|NCT01686828|463169446|FG002|Overall Study|Weight Loss|1|||
128691362|NCT01686828|463169447|FG003|Overall Study|Weight Loss|0|||
128691363|NCT01467583|463169448|FG000|Overall Study|Death|1|||
128691364|NCT01467583|463169449|FG001|Overall Study|Death|1|||
128691365|NCT01467583|463169450|FG002|Overall Study|Death|0|||
128691366|NCT01467583|463169448|FG000|Overall Study|Withdrawal by Subject|1|||
128691367|NCT01467583|463169449|FG001|Overall Study|Withdrawal by Subject|0|||
128691368|NCT01467583|463169450|FG002|Overall Study|Withdrawal by Subject|0|||
128691369|NCT01467583|463169448|FG000|Overall Study|Protocol Violation|0|||
128895061|NCT00418665|463910225|FG001|Treatment Extension|Withdrawal by Subject|0|||
128691370|NCT01467583|463169449|FG001|Overall Study|Protocol Violation|0|||
128691371|NCT01467583|463169450|FG002|Overall Study|Protocol Violation|2|||
128691372|NCT02484690|463169451|FG000|Overall Study|Adverse Event|1|||
128691373|NCT02484690|463169452|FG001|Overall Study|Adverse Event|3|||
128691374|NCT02484690|463169453|FG002|Overall Study|Adverse Event|0|||
128691375|NCT02484690|463169454|FG003|Overall Study|Adverse Event|0|||
128895062|NCT00418665|463910226|FG002|Treatment Extension|Withdrawal by Subject|0|||
128895063|NCT00418665|463910224|FG000|Treatment Extension|Requirement for alternative therapy|2|||
128895064|NCT00418665|463910225|FG001|Treatment Extension|Requirement for alternative therapy|2|||
128895065|NCT00418665|463910226|FG002|Treatment Extension|Requirement for alternative therapy|0|||
128895066|NCT00418665|463910224|FG000|Treatment Extension|Physician Decision|2|||
128895067|NCT00418665|463910225|FG001|Treatment Extension|Physician Decision|2|||
128895068|NCT00418665|463910226|FG002|Treatment Extension|Physician Decision|1|||
128895069|NCT00418665|463910224|FG000|Treatment Extension|Death|0|||
128895070|NCT00418665|463910225|FG001|Treatment Extension|Death|0|||
128895071|NCT00418665|463910226|FG002|Treatment Extension|Death|1|||
128895072|NCT01133379|463910229|FG000|Overall Study|Withdrawal by Subject|0|||
128895073|NCT01133379|463910230|FG001|Overall Study|Withdrawal by Subject|1|||
128895074|NCT01133379|463910231|FG002|Overall Study|Withdrawal by Subject|1|||
128895075|NCT01133379|463910229|FG000|Overall Study|Lost to Follow-up|1|||
128895076|NCT01133379|463910230|FG001|Overall Study|Lost to Follow-up|1|||
129021659|NCT03123471|464370522|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
129021660|NCT03123471|464370523|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
129021661|NCT03123471|464370522|FG000|Apremilast Extension Phase|Adverse Event|1|||
129021662|NCT03123471|464370523|FG001|Apremilast Extension Phase|Adverse Event|5|||
129021663|NCT03123471|464370522|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
129021664|NCT03123471|464370523|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
129021665|NCT03123471|464370522|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
129021666|NCT03123471|464370523|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
129021667|NCT03681470|464370526|FG000|Overall Study|Lack of Efficacy|3|||
129021668|NCT03681470|464370526|FG000|Overall Study|Lost to Follow-up|1|||
129021669|NCT03681470|464370526|FG000|Overall Study|Protocol Violation|3|||
129021670|NCT03681470|464370526|FG000|Overall Study|Withdrawal by Subject|1|||
129021671|NCT01686477|464370527|FG000|Feeding Intervention|Death|1|||
129021672|NCT01686477|464370528|FG001|Feeding Intervention|Death|0|||
129021673|NCT01686477|464370529|FG002|Feeding Intervention|Death|1|||
129021674|NCT01686477|464370527|FG000|Feeding Intervention|Withdrawal by Subject|0|||
129021675|NCT01686477|464370528|FG001|Feeding Intervention|Withdrawal by Subject|6|||
129021676|NCT01686477|464370529|FG002|Feeding Intervention|Withdrawal by Subject|0|||
129021677|NCT01686477|464370527|FG000|Feeding Intervention|Physician Decision|1|||
129021678|NCT01686477|464370528|FG001|Feeding Intervention|Physician Decision|2|||
129021679|NCT01686477|464370529|FG002|Feeding Intervention|Physician Decision|0|||
129021680|NCT01686477|464370527|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
129021681|NCT01686477|464370528|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
129021682|NCT01686477|464370529|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
129021683|NCT01686477|464370527|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
129021684|NCT01686477|464370528|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
129021685|NCT01686477|464370529|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
129021686|NCT01686477|464370527|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
129021687|NCT01686477|464370528|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
129215208|NCT01588522|465089465|FG001|Overall Study|Lack of Efficacy|0|||
128691376|NCT02484690|463169455|FG004|Overall Study|Adverse Event|5|||
128691377|NCT02484690|463169451|FG000|Overall Study|Death|0|||
128895077|NCT01133379|463910231|FG002|Overall Study|Lost to Follow-up|1|||
128895078|NCT00591214|463910232|FG000|Overall Study|Physician Decision|7|||
128895079|NCT00591214|463910232|FG000|Overall Study|Withdrawal by Subject|1|||
128895080|NCT01129921|463910235|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
128691378|NCT02484690|463169452|FG001|Overall Study|Death|0|||
128691379|NCT02484690|463169453|FG002|Overall Study|Death|0|||
128691380|NCT02484690|463169454|FG003|Overall Study|Death|0|||
128895081|NCT01129921|463910236|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
128895082|NCT01129921|463910235|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
129021688|NCT01686477|464370529|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
129021689|NCT01686477|464370527|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
129021690|NCT01686477|464370528|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
129021691|NCT01686477|464370529|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
129111123|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111124|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111125|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111126|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111127|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111128|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
129111129|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
129111130|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
129111131|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129111132|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
129111133|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111134|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111135|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111136|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111137|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111138|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111139|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111140|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111141|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111142|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111143|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129111144|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111145|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129111146|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111147|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129111148|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111149|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111150|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111151|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111152|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111153|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111154|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111155|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111156|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111157|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111158|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
128691381|NCT02484690|463169455|FG004|Overall Study|Death|1|||
128691382|NCT02484690|463169451|FG000|Overall Study|Withdrawal by Subject|1|||
128691383|NCT02484690|463169452|FG001|Overall Study|Withdrawal by Subject|3|||
128691384|NCT02484690|463169453|FG002|Overall Study|Withdrawal by Subject|1|||
128691385|NCT02484690|463169454|FG003|Overall Study|Withdrawal by Subject|2|||
128691386|NCT02484690|463169455|FG004|Overall Study|Withdrawal by Subject|0|||
128691387|NCT02484690|463169451|FG000|Overall Study|Physician Decision|2|||
128691388|NCT02484690|463169452|FG001|Overall Study|Physician Decision|0|||
128691389|NCT02484690|463169453|FG002|Overall Study|Physician Decision|1|||
128691390|NCT02484690|463169454|FG003|Overall Study|Physician Decision|0|||
128691391|NCT02484690|463169455|FG004|Overall Study|Physician Decision|0|||
128691392|NCT02484690|463169451|FG000|Overall Study|Lost to Follow-up|0|||
128691393|NCT02484690|463169452|FG001|Overall Study|Lost to Follow-up|0|||
128691394|NCT02484690|463169453|FG002|Overall Study|Lost to Follow-up|1|||
128691395|NCT02484690|463169454|FG003|Overall Study|Lost to Follow-up|0|||
129021692|NCT01686477|464370527|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
129021693|NCT01686477|464370528|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
129021694|NCT01686477|464370529|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
129021695|NCT01686477|464370527|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
129021696|NCT01686477|464370528|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
129021697|NCT01686477|464370529|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
129021698|NCT01686477|464370527|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
129021699|NCT01686477|464370528|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
129021700|NCT01686477|464370529|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
128691396|NCT02484690|463169455|FG004|Overall Study|Lost to Follow-up|0|||
128895083|NCT01129921|463910236|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
128895084|NCT01129921|463910235|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
128895085|NCT01129921|463910236|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
128895086|NCT01129921|463910235|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
128895087|NCT01129921|463910236|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
128895088|NCT05050318|463911619|FG000|Overall Study|Protocol Deviation|1|||
128895089|NCT05050318|463911620|FG001|Overall Study|Protocol Deviation|0|||
128895090|NCT05050318|463911621|FG002|Overall Study|Protocol Deviation|0|||
128895091|NCT00574145|463911626|FG000|Overall Study|Withdrawal by Subject|2|||
128895092|NCT00574145|463911627|FG001|Overall Study|Withdrawal by Subject|1|||
128691397|NCT04916769|463169459|FG000|Period 1|Physician Decision|0|||
128691398|NCT04916769|463169460|FG001|Period 1|Physician Decision|0|||
128691399|NCT04916769|463169461|FG002|Period 1|Physician Decision|0|||
128691400|NCT04916769|463169462|FG003|Period 1|Physician Decision|0|||
128691401|NCT04916769|463169463|FG004|Period 1|Physician Decision|0|||
128691402|NCT04916769|463169464|FG005|Period 1|Physician Decision|1|||
128691403|NCT04916769|463169459|FG000|Period 2|Physician Decision|0|||
128691404|NCT04916769|463169460|FG001|Period 2|Physician Decision|1|||
128691405|NCT04916769|463169461|FG002|Period 2|Physician Decision|0|||
128691406|NCT04916769|463169462|FG003|Period 2|Physician Decision|0|||
128691407|NCT04916769|463169463|FG004|Period 2|Physician Decision|0|||
128691408|NCT04916769|463169464|FG005|Period 2|Physician Decision|0|||
128691409|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
128691410|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
128691411|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
128691412|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
128691413|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
128691414|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
128691415|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
128691416|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
128691417|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
128691418|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
128764422|NCT03682705|463428313|FG001|Overall Study|Lost to Follow-up|0|||
128764423|NCT03682705|463428314|FG002|Overall Study|Lost to Follow-up|0|||
128764424|NCT03682705|463428315|FG003|Overall Study|Lost to Follow-up|0|||
128764425|NCT03682705|463428316|FG004|Overall Study|Lost to Follow-up|3|||
129021701|NCT03290781|464370531|FG000|Overall Study|Adverse Event|5|||
129021702|NCT03290781|464370532|FG001|Overall Study|Adverse Event|7|||
129021703|NCT03290781|464370533|FG002|Overall Study|Adverse Event|4|||
129021704|NCT03290781|464370534|FG003|Overall Study|Adverse Event|1|||
129021705|NCT03290781|464370535|FG004|Overall Study|Adverse Event|0|||
129021706|NCT03290781|464370536|FG005|Overall Study|Adverse Event|0|||
129021707|NCT03290781|464370537|FG006|Overall Study|Adverse Event|0|||
129021708|NCT03290781|464370531|FG000|Overall Study|Death|0|||
129021709|NCT03290781|464370532|FG001|Overall Study|Death|0|||
129021710|NCT03290781|464370533|FG002|Overall Study|Death|1|||
129021711|NCT03290781|464370534|FG003|Overall Study|Death|0|||
129021712|NCT03290781|464370535|FG004|Overall Study|Death|1|||
129021713|NCT03290781|464370536|FG005|Overall Study|Death|0|||
129021714|NCT03290781|464370537|FG006|Overall Study|Death|0|||
129021715|NCT03290781|464370531|FG000|Overall Study|Withdrawal by Subject|6|||
129021716|NCT03290781|464370532|FG001|Overall Study|Withdrawal by Subject|5|||
129021717|NCT03290781|464370533|FG002|Overall Study|Withdrawal by Subject|9|||
129021718|NCT03290781|464370534|FG003|Overall Study|Withdrawal by Subject|10|||
129021719|NCT03290781|464370535|FG004|Overall Study|Withdrawal by Subject|1|||
129021720|NCT03290781|464370536|FG005|Overall Study|Withdrawal by Subject|2|||
129021721|NCT03290781|464370537|FG006|Overall Study|Withdrawal by Subject|0|||
129021722|NCT03290781|464370531|FG000|Overall Study|Physician Decision|0|||
129021723|NCT03290781|464370532|FG001|Overall Study|Physician Decision|1|||
129021724|NCT03290781|464370533|FG002|Overall Study|Physician Decision|0|||
129021725|NCT03290781|464370534|FG003|Overall Study|Physician Decision|0|||
129021726|NCT03290781|464370535|FG004|Overall Study|Physician Decision|0|||
129021727|NCT03290781|464370536|FG005|Overall Study|Physician Decision|0|||
129021728|NCT03290781|464370537|FG006|Overall Study|Physician Decision|0|||
129021729|NCT03290781|464370531|FG000|Overall Study|Site Terminated by Sponsor|1|||
128764426|NCT03682705|463428317|FG005|Overall Study|Lost to Follow-up|0|||
128895093|NCT03227471|463911631|FG000|Overall Study|Withdrawal by Subject|0|||
129021730|NCT03290781|464370532|FG001|Overall Study|Site Terminated by Sponsor|0|||
129021731|NCT03290781|464370533|FG002|Overall Study|Site Terminated by Sponsor|2|||
129021732|NCT03290781|464370534|FG003|Overall Study|Site Terminated by Sponsor|1|||
129021733|NCT03290781|464370535|FG004|Overall Study|Site Terminated by Sponsor|0|||
129111159|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
129021734|NCT03290781|464370536|FG005|Overall Study|Site Terminated by Sponsor|0|||
129021735|NCT03290781|464370537|FG006|Overall Study|Site Terminated by Sponsor|0|||
129021736|NCT03290781|464370531|FG000|Overall Study|Lost to Follow-up|0|||
129021737|NCT03290781|464370532|FG001|Overall Study|Lost to Follow-up|0|||
129021738|NCT03290781|464370533|FG002|Overall Study|Lost to Follow-up|0|||
129021739|NCT03290781|464370534|FG003|Overall Study|Lost to Follow-up|1|||
129021740|NCT03290781|464370535|FG004|Overall Study|Lost to Follow-up|0|||
129021741|NCT03290781|464370536|FG005|Overall Study|Lost to Follow-up|0|||
129021742|NCT03290781|464370537|FG006|Overall Study|Lost to Follow-up|0|||
129021743|NCT03290781|464370531|FG000|Overall Study|Protocol Deviation|2|||
129111160|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111161|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111162|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129111163|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111164|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111165|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111166|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111167|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111168|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111169|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111170|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111171|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111172|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111173|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129111174|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111175|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
129111176|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129111177|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
129111178|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111179|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129021744|NCT03290781|464370532|FG001|Overall Study|Protocol Deviation|0|||
129021745|NCT03290781|464370533|FG002|Overall Study|Protocol Deviation|0|||
129021746|NCT03290781|464370534|FG003|Overall Study|Protocol Deviation|1|||
129021747|NCT03290781|464370535|FG004|Overall Study|Protocol Deviation|0|||
129021748|NCT03290781|464370536|FG005|Overall Study|Protocol Deviation|0|||
129021749|NCT03290781|464370537|FG006|Overall Study|Protocol Deviation|0|||
129111180|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111181|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111182|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111183|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111184|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111185|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111186|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111187|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111188|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129215209|NCT01588522|465089466|FG002|Overall Study|Lack of Efficacy|0|||
128691419|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
128691420|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129021750|NCT03290781|464370531|FG000|Overall Study|Disease Relapse|32|||
129021751|NCT03290781|464370532|FG001|Overall Study|Disease Relapse|5|||
129021752|NCT03290781|464370533|FG002|Overall Study|Disease Relapse|38|||
129021753|NCT03290781|464370534|FG003|Overall Study|Disease Relapse|7|||
128691421|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
128691422|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
128691423|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
128691424|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
128691425|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
128691426|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
128691427|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
128691428|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
128717822|NCT00529542|463264055|FG001|Overall Study|Withdrawal by Subject|0|||
129021754|NCT03290781|464370535|FG004|Overall Study|Disease Relapse|3|||
129021755|NCT03290781|464370536|FG005|Overall Study|Disease Relapse|1|||
129111189|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
129111190|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111191|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129111192|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
129111193|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111194|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111195|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111196|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111197|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111198|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111199|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111200|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111201|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111202|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111203|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111204|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
129111205|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
129111206|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129111207|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
129111208|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111209|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111210|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111211|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111212|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111213|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111214|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111215|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111216|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111217|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111218|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111219|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
129111220|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111221|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111222|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129111223|NCT02326272|464701353|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111224|NCT02326272|464701354|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111225|NCT02326272|464701355|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111226|NCT02326272|464701356|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111227|NCT02326272|464701357|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111228|NCT02326272|464701358|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111229|NCT02326272|464701359|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111230|NCT02326272|464701360|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111231|NCT02326272|464701361|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111232|NCT02326272|464701362|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111233|NCT02326272|464701363|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111234|NCT02326272|464701364|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111235|NCT02326272|464701365|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
129111236|NCT02326272|464701366|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111237|NCT02326272|464701367|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129111238|NCT03113968|464701380|FG000|Overall Study|Withdrawal by Subject|31|||
129111239|NCT03113968|464701381|FG001|Overall Study|Withdrawal by Subject|4|||
129111240|NCT04805671|464701382|FG000|Overall Study|Death|2|||
129111241|NCT04805671|464701383|FG001|Overall Study|Death|7|||
129111242|NCT04805671|464701382|FG000|Overall Study|Lost to Follow-up|1|||
129111243|NCT04805671|464701383|FG001|Overall Study|Lost to Follow-up|0|||
129111244|NCT04805671|464701382|FG000|Overall Study|Withdrawal by Subject|9|||
129111245|NCT04805671|464701383|FG001|Overall Study|Withdrawal by Subject|7|||
129111246|NCT04805671|464701382|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
129111247|NCT04805671|464701383|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
128691429|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
128691430|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
129111248|NCT02111174|464701390|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
129111249|NCT02111174|464701391|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
129111250|NCT02111174|464701390|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
128717823|NCT00529542|463264054|FG000|Overall Study|Lost to Follow-up|0|||
128691431|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
128691432|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
128691433|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
128895094|NCT03227471|463911632|FG001|Overall Study|Withdrawal by Subject|0|||
128895095|NCT03227471|463911633|FG002|Overall Study|Withdrawal by Subject|0|||
128691434|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
128691435|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
128895096|NCT03227471|463911634|FG003|Overall Study|Withdrawal by Subject|0|||
129021756|NCT03290781|464370537|FG006|Overall Study|Disease Relapse|4|||
129021757|NCT03290781|464370531|FG000|Overall Study|Other|3|||
129021758|NCT03290781|464370532|FG001|Overall Study|Other|0|||
129021759|NCT03290781|464370533|FG002|Overall Study|Other|2|||
129021760|NCT03290781|464370534|FG003|Overall Study|Other|2|||
129021761|NCT03290781|464370535|FG004|Overall Study|Other|0|||
129021762|NCT03290781|464370536|FG005|Overall Study|Other|0|||
129021763|NCT03290781|464370537|FG006|Overall Study|Other|0|||
129021764|NCT02957942|464370538|FG000|Overall Study|Withdrawal by Subject|0|||
129021765|NCT02957942|464370539|FG001|Overall Study|Withdrawal by Subject|1|||
129021766|NCT02957942|464370538|FG000|Overall Study|Practicing experiment protocol|0|||
129021767|NCT02957942|464370539|FG001|Overall Study|Practicing experiment protocol|6|||
129021768|NCT01136174|464370540|FG000|Overall Study|Adverse Event|0|||
129021769|NCT01136174|464370541|FG001|Overall Study|Adverse Event|0|||
129021770|NCT01136174|464370542|FG002|Overall Study|Adverse Event|0|||
129021771|NCT01136174|464370543|FG003|Overall Study|Adverse Event|4|||
129021772|NCT03238781|464370544|FG000|Overall Study|Adverse Event|1|||
129021773|NCT03238781|464370545|FG001|Overall Study|Adverse Event|1|||
129021774|NCT03238781|464370546|FG002|Overall Study|Adverse Event|2|||
129021775|NCT03238781|464370544|FG000|Overall Study|Lost to Follow-up|2|||
129021776|NCT03238781|464370545|FG001|Overall Study|Lost to Follow-up|1|||
129021777|NCT03238781|464370546|FG002|Overall Study|Lost to Follow-up|2|||
129021778|NCT03238781|464370544|FG000|Overall Study|Withdrawal by Subject|23|||
129021779|NCT03238781|464370545|FG001|Overall Study|Withdrawal by Subject|14|||
129021780|NCT03238781|464370546|FG002|Overall Study|Withdrawal by Subject|16|||
129021781|NCT03238781|464370544|FG000|Overall Study|Decision by sponsor|0|||
129021782|NCT03238781|464370545|FG001|Overall Study|Decision by sponsor|1|||
129021783|NCT03238781|464370546|FG002|Overall Study|Decision by sponsor|0|||
129021784|NCT00811655|464370560|FG000|Overall Study|Physician Decision|1|||
129021785|NCT00813592|464370561|FG000|Overall Study|Disease assessment was not completed per|2|||
129021786|NCT03761173|464370565|FG000|Overall Study|Lost to Follow-up|93|||
129021787|NCT03761173|464370565|FG000|Overall Study|Withdrawal by Subject|74|||
129021788|NCT03761173|464370565|FG000|Overall Study|Death|45|||
129021789|NCT03761173|464370565|FG000|Overall Study|Withdrawal for Other Reasons|29|||
129021790|NCT03761173|464370565|FG000|Overall Study|Protocol Violation|1|||
129021791|NCT02301975|464372465|FG000|Overall Study|Adverse Event|8|||
129021792|NCT02301975|464372466|FG001|Overall Study|Adverse Event|3|||
129021793|NCT02301975|464372467|FG002|Overall Study|Adverse Event|2|||
129021794|NCT02301975|464372465|FG000|Overall Study|Lack of Efficacy|1|||
129021795|NCT02301975|464372466|FG001|Overall Study|Lack of Efficacy|1|||
129021796|NCT02301975|464372467|FG002|Overall Study|Lack of Efficacy|1|||
129021797|NCT02301975|464372465|FG000|Overall Study|Protocol Violation|3|||
129021798|NCT02301975|464372466|FG001|Overall Study|Protocol Violation|5|||
129021799|NCT02301975|464372467|FG002|Overall Study|Protocol Violation|3|||
129021800|NCT02301975|464372465|FG000|Overall Study|Lost to Follow-up|0|||
129021801|NCT02301975|464372466|FG001|Overall Study|Lost to Follow-up|2|||
129021802|NCT02301975|464372467|FG002|Overall Study|Lost to Follow-up|2|||
129021803|NCT02301975|464372465|FG000|Overall Study|Physician Decision|4|||
129021804|NCT02301975|464372466|FG001|Overall Study|Physician Decision|2|||
129021805|NCT02301975|464372467|FG002|Overall Study|Physician Decision|3|||
129021806|NCT02301975|464372465|FG000|Overall Study|Withdrawal by Subject|15|||
129021807|NCT02301975|464372466|FG001|Overall Study|Withdrawal by Subject|12|||
129021808|NCT02301975|464372467|FG002|Overall Study|Withdrawal by Subject|11|||
129021809|NCT03606174|464372470|FG000|Overall Study|Death|37|||
129021810|NCT03606174|464372471|FG001|Overall Study|Death|15|||
129021811|NCT03606174|464372472|FG002|Overall Study|Death|15|||
128717824|NCT00529542|463264055|FG001|Overall Study|Lost to Follow-up|1|||
128895097|NCT03227471|463911635|FG004|Overall Study|Withdrawal by Subject|1|||
129021812|NCT03606174|464372473|FG003|Overall Study|Death|7|||
129021813|NCT03606174|464372474|FG004|Overall Study|Death|35|||
129021814|NCT03606174|464372475|FG005|Overall Study|Death|12|||
129021815|NCT03606174|464372476|FG006|Overall Study|Death|35|||
129021816|NCT03606174|464372477|FG007|Overall Study|Death|8|||
129021817|NCT03606174|464372478|FG008|Overall Study|Death|5|||
129021818|NCT03606174|464372479|FG009|Overall Study|Death|3|||
129021819|NCT03606174|464372480|FG010|Overall Study|Death|0|||
129021820|NCT03606174|464372470|FG000|Overall Study|Lost to Follow-up|0|||
129021821|NCT03606174|464372471|FG001|Overall Study|Lost to Follow-up|0|||
129021822|NCT03606174|464372472|FG002|Overall Study|Lost to Follow-up|0|||
129021823|NCT03606174|464372473|FG003|Overall Study|Lost to Follow-up|0|||
129021824|NCT03606174|464372474|FG004|Overall Study|Lost to Follow-up|1|||
128691436|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
128691437|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
128691438|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
128691439|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
128691440|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
128691441|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
128691442|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
128691443|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
128691444|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
128691445|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
128691446|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
128691447|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
128895098|NCT03227471|463911636|FG005|Overall Study|Withdrawal by Subject|0|||
129111251|NCT02111174|464701391|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
129111252|NCT02111174|464701390|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
129111253|NCT02111174|464701391|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
129111254|NCT02111174|464701390|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
129111255|NCT02111174|464701391|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
129111256|NCT01657162|464701392|FG000|Overall Study|Adverse Event|26|||
129111257|NCT01657162|464701393|FG001|Overall Study|Adverse Event|36|||
129111258|NCT01657162|464701392|FG000|Overall Study|Withdrawal by Subject|13|||
129111259|NCT01657162|464701393|FG001|Overall Study|Withdrawal by Subject|13|||
129111260|NCT01657162|464701392|FG000|Overall Study|Continuing Significant Deterioration|9|||
129111261|NCT01657162|464701393|FG001|Overall Study|Continuing Significant Deterioration|3|||
129111262|NCT01657162|464701392|FG000|Overall Study|Refusal of Treatment|4|||
129111263|NCT01657162|464701393|FG001|Overall Study|Refusal of Treatment|6|||
129111264|NCT01657162|464701392|FG000|Overall Study|Lost to Follow-up|3|||
128895099|NCT03227471|463911637|FG006|Overall Study|Withdrawal by Subject|0|||
128895100|NCT03227471|463911638|FG007|Overall Study|Withdrawal by Subject|0|||
128895101|NCT03227471|463911639|FG008|Overall Study|Withdrawal by Subject|0|||
129111265|NCT01657162|464701393|FG001|Overall Study|Lost to Follow-up|4|||
129111266|NCT01657162|464701392|FG000|Overall Study|Death|2|||
129111267|NCT01657162|464701393|FG001|Overall Study|Death|3|||
129111268|NCT01657162|464701392|FG000|Overall Study|Inability to Complete Study Procedures|1|||
129111269|NCT01657162|464701393|FG001|Overall Study|Inability to Complete Study Procedures|7|||
129111270|NCT01657162|464701392|FG000|Overall Study|Protocol Violation|1|||
129111271|NCT01657162|464701393|FG001|Overall Study|Protocol Violation|0|||
129111272|NCT01657162|464701392|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
129111273|NCT01657162|464701393|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
129111274|NCT01657162|464701392|FG000|Overall Study|Other than Specified|0|||
129111275|NCT01657162|464701393|FG001|Overall Study|Other than Specified|2|||
129111276|NCT00901342|464701394|FG000|Overall Study|Adverse Event|1|||
129111277|NCT00901342|464701394|FG000|Overall Study|Death|4|||
129111278|NCT00901342|464701394|FG000|Overall Study|Disease progression|1|||
129111279|NCT00901342|464701394|FG000|Overall Study|Withdrawal by Subject|9|||
129111280|NCT00751140|464701403|FG000|Overall Study|benign angioma excluded from analysis|1|||
129111281|NCT04001803|464701404|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
129111282|NCT04001803|464701404|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
129111283|NCT04001803|464701404|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
129111284|NCT04001803|464701404|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
129111285|NCT04001803|464701404|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
129111286|NCT04001803|464701404|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
129111287|NCT04001803|464701404|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
129111288|NCT04001803|464701404|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
129111289|NCT04001803|464701404|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
129111290|NCT04001803|464701404|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
129111291|NCT02493517|464701405|FG000|Overall Study|Protocol Violation|1|||
129111292|NCT02493517|464701406|FG001|Overall Study|Protocol Violation|2|||
129111293|NCT02493517|464701405|FG000|Overall Study|Withdrawal by Subject|1|||
129111294|NCT02493517|464701406|FG001|Overall Study|Withdrawal by Subject|2|||
129111295|NCT02493517|464701405|FG000|Overall Study|Adverse Event|0|||
129111296|NCT02493517|464701406|FG001|Overall Study|Adverse Event|2|||
129111297|NCT02493517|464701405|FG000|Overall Study|Missed study visit|0|||
129111298|NCT02493517|464701406|FG001|Overall Study|Missed study visit|1|||
129111299|NCT03718429|464701408|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
129111300|NCT03718429|464701409|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
128691448|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
128691449|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129111301|NCT03718429|464701410|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
129111302|NCT03718429|464701411|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
129111303|NCT05404711|464701413|FG000|Completed Study Visit|Withdrawal by Subject|1|||
129111304|NCT05404711|464701413|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
129111305|NCT05404711|464701413|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
129111306|NCT05404711|464701413|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
129111307|NCT05404711|464701413|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
129111308|NCT05404711|464701413|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
129111309|NCT00325819|464701414|FG000|Overall Study|Study product lost in mail|2|||
129111310|NCT00325819|464701415|FG001|Overall Study|Study product lost in mail|1|||
129111311|NCT00325819|464701414|FG000|Overall Study|Did not take a dose of study product|4|||
129111312|NCT00325819|464701415|FG001|Overall Study|Did not take a dose of study product|9|||
129111313|NCT00325819|464701414|FG000|Overall Study|Lost to Follow-up|3|||
129111314|NCT00325819|464701415|FG001|Overall Study|Lost to Follow-up|3|||
129111315|NCT02346877|464701416|FG000|Overall Study|Adverse Event|1|||
129111316|NCT02346877|464701417|FG001|Overall Study|Adverse Event|0|||
129111317|NCT02346877|464701416|FG000|Overall Study|Administrative Decision|1|||
129111318|NCT02346877|464701417|FG001|Overall Study|Administrative Decision|0|||
129111319|NCT02346877|464701416|FG000|Overall Study|Sponsor Decision|12|||
129111320|NCT02346877|464701417|FG001|Overall Study|Sponsor Decision|0|||
129111321|NCT02346877|464701416|FG000|Overall Study|Missing|5|||
129111322|NCT02346877|464701417|FG001|Overall Study|Missing|0|||
129111323|NCT04376515|464701420|FG000|Overall Study|Found to have been vaccinated before study start|6|||
129111324|NCT04376515|464701421|FG001|Overall Study|Found to have been vaccinated before study start|6|||
129111325|NCT03811821|464701422|FG000|Overall Study|Adverse Event|1|||
129111326|NCT03811821|464701423|FG001|Overall Study|Adverse Event|1|||
129111327|NCT03811821|464701422|FG000|Overall Study|Withdrawal by Subject|5|||
129111328|NCT03811821|464701423|FG001|Overall Study|Withdrawal by Subject|4|||
129111329|NCT03811821|464701422|FG000|Overall Study|Lost to Follow-up|2|||
129111330|NCT03811821|464701423|FG001|Overall Study|Lost to Follow-up|2|||
129111331|NCT03811821|464701422|FG000|Overall Study|Contraindication for treatment|0|||
129111332|NCT03811821|464701423|FG001|Overall Study|Contraindication for treatment|1|||
129111333|NCT03811821|464701422|FG000|Overall Study|Tolerability|0|||
129111334|NCT03811821|464701423|FG001|Overall Study|Tolerability|3|||
129111335|NCT03811821|464701422|FG000|Overall Study|Comorbidities|0|||
129111336|NCT03811821|464701423|FG001|Overall Study|Comorbidities|2|||
129111337|NCT01683604|464701425|FG000|Overall Study|Adverse Event|2|||
129111338|NCT01683604|464701425|FG000|Overall Study|Lack of Efficacy|1|||
129111339|NCT01683604|464701425|FG000|Overall Study|Other|2|||
129111340|NCT04888494|464701427|FG000|Overall Study|Lost to Follow-up|2|||
129111341|NCT04888494|464701428|FG001|Overall Study|Lost to Follow-up|3|||
129111342|NCT04888494|464701427|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
129111343|NCT04888494|464701428|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
129111344|NCT03430856|464701431|FG000|Overall Study|Adverse Event|0|||
129111345|NCT03430856|464701432|FG001|Overall Study|Adverse Event|1|||
129111346|NCT03430856|464701433|FG002|Overall Study|Adverse Event|0|||
129111347|NCT03430856|464701431|FG000|Overall Study|Rescue criteria|1|||
129111348|NCT03430856|464701432|FG001|Overall Study|Rescue criteria|1|||
129111349|NCT03430856|464701433|FG002|Overall Study|Rescue criteria|0|||
129111350|NCT03430856|464701431|FG000|Overall Study|Voluntary withdrawal of consent|1|||
129111351|NCT03430856|464701432|FG001|Overall Study|Voluntary withdrawal of consent|1|||
129111352|NCT03430856|464701433|FG002|Overall Study|Voluntary withdrawal of consent|1|||
129111353|NCT01949142|464701438|FG000|Overall Study|Withdrawal of consent|1|||
129111354|NCT01949142|464701439|FG001|Overall Study|Withdrawal of consent|0|||
129111355|NCT01949142|464701438|FG000|Overall Study|Lost to Follow-up|1|||
129111356|NCT01949142|464701439|FG001|Overall Study|Lost to Follow-up|1|||
129111357|NCT01949142|464701438|FG000|Overall Study|Parent changed their mind|1|||
129111358|NCT01949142|464701439|FG001|Overall Study|Parent changed their mind|0|||
129111359|NCT00565604|464701441|FG000|Overall Study|Failure to treat|2|||
129111360|NCT00565604|464701441|FG000|Overall Study|Lost to Follow-up|2|||
129111361|NCT05027815|464701442|FG000|Overall Study|Death|2|||
129111362|NCT05027815|464701443|FG001|Overall Study|Death|1|||
129111363|NCT01395810|464701444|FG000|Overall Study|Adverse Event|0|||
129111364|NCT01395810|464701445|FG001|Overall Study|Adverse Event|1|||
129111365|NCT01395810|464701446|FG002|Overall Study|Adverse Event|0|||
129111366|NCT01395810|464701447|FG003|Overall Study|Adverse Event|0|||
129111367|NCT01395810|464701444|FG000|Overall Study|Lack of Efficacy|0|||
129111368|NCT01395810|464701445|FG001|Overall Study|Lack of Efficacy|1|||
129111369|NCT01395810|464701446|FG002|Overall Study|Lack of Efficacy|0|||
128691450|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
128717825|NCT01082965|463264056|FG000|Overall Study|Protocol Violation|0|||
129111370|NCT01395810|464701447|FG003|Overall Study|Lack of Efficacy|0|||
129111371|NCT01395810|464701444|FG000|Overall Study|Withdrawal criteria|0|||
129111372|NCT01395810|464701445|FG001|Overall Study|Withdrawal criteria|2|||
129111373|NCT01395810|464701446|FG002|Overall Study|Withdrawal criteria|0|||
129111374|NCT01395810|464701447|FG003|Overall Study|Withdrawal criteria|0|||
129111375|NCT01395810|464701444|FG000|Overall Study|Unclassified|2|||
129111376|NCT01395810|464701445|FG001|Overall Study|Unclassified|0|||
129111377|NCT01395810|464701446|FG002|Overall Study|Unclassified|0|||
129111378|NCT01395810|464701447|FG003|Overall Study|Unclassified|0|||
129111379|NCT03677869|464701453|FG000|Overall Study|Withdrawal by Subject|1|||
129111380|NCT04265261|464701455|FG000|Overall Study|Adverse Event|2|||
129111381|NCT04265261|464701456|FG001|Overall Study|Adverse Event|0|||
129111382|NCT04265261|464701457|FG002|Overall Study|Adverse Event|0|||
129111383|NCT04265261|464701455|FG000|Overall Study|Death|1|||
129111384|NCT04265261|464701456|FG001|Overall Study|Death|0|||
129111385|NCT04265261|464701457|FG002|Overall Study|Death|0|||
129111386|NCT04265261|464701455|FG000|Overall Study|Lost to Follow-up|4|||
129111387|NCT04265261|464701456|FG001|Overall Study|Lost to Follow-up|1|||
129111388|NCT04265261|464701457|FG002|Overall Study|Lost to Follow-up|3|||
129111389|NCT04265261|464701455|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129111390|NCT04265261|464701456|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129111391|NCT04265261|464701457|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129111392|NCT04265261|464701455|FG000|Overall Study|Physician Decision|0|||
129111393|NCT04265261|464701456|FG001|Overall Study|Physician Decision|0|||
129111394|NCT04265261|464701457|FG002|Overall Study|Physician Decision|1|||
129111395|NCT04265261|464701455|FG000|Overall Study|Protocol Deviation|0|||
129111396|NCT04265261|464701456|FG001|Overall Study|Protocol Deviation|2|||
129111397|NCT04265261|464701457|FG002|Overall Study|Protocol Deviation|0|||
129111398|NCT04265261|464701455|FG000|Overall Study|Withdrawal by Subject|2|||
129111399|NCT04265261|464701456|FG001|Overall Study|Withdrawal by Subject|1|||
129111400|NCT04265261|464701457|FG002|Overall Study|Withdrawal by Subject|4|||
129111401|NCT03877224|464701458|FG000|Overall Study|Death|3|||
129111402|NCT03877224|464701459|FG001|Overall Study|Death|2|||
129111403|NCT03877224|464701458|FG000|Overall Study|Withdrawal by Subject|1|||
129111404|NCT03877224|464701459|FG001|Overall Study|Withdrawal by Subject|6|||
129111405|NCT03877224|464701458|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
129111406|NCT03877224|464701459|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
129111407|NCT00447902|464701460|FG000|Overall Study|Adverse Event|0|||
129021825|NCT03606174|464372475|FG005|Overall Study|Lost to Follow-up|1|||
129021826|NCT03606174|464372476|FG006|Overall Study|Lost to Follow-up|0|||
129021827|NCT03606174|464372477|FG007|Overall Study|Lost to Follow-up|0|||
129021828|NCT03606174|464372478|FG008|Overall Study|Lost to Follow-up|0|||
129021829|NCT03606174|464372479|FG009|Overall Study|Lost to Follow-up|0|||
129021830|NCT03606174|464372480|FG010|Overall Study|Lost to Follow-up|0|||
129021831|NCT03606174|464372470|FG000|Overall Study|Withdrawal by Subject|6|||
129021832|NCT03606174|464372471|FG001|Overall Study|Withdrawal by Subject|0|||
129021833|NCT03606174|464372472|FG002|Overall Study|Withdrawal by Subject|0|||
129111408|NCT00447902|464701461|FG001|Overall Study|Adverse Event|3|||
129111409|NCT00447902|464701460|FG000|Overall Study|Protocol Violation|1|||
129111410|NCT00447902|464701461|FG001|Overall Study|Protocol Violation|0|||
129111411|NCT00447902|464701460|FG000|Overall Study|Withdrawal by Subject|0|||
129111412|NCT00447902|464701461|FG001|Overall Study|Withdrawal by Subject|1|||
129111413|NCT00447902|464701460|FG000|Overall Study|included patients who discontinued|1|||
129111414|NCT00447902|464701461|FG001|Overall Study|included patients who discontinued|1|||
128691451|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
128691452|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
128691453|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
128691454|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
128691455|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
128691456|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
128691457|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
128691458|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
128691459|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
128717826|NCT01082965|463264057|FG001|Overall Study|Protocol Violation|1|||
129021834|NCT03606174|464372473|FG003|Overall Study|Withdrawal by Subject|1|||
129021835|NCT03606174|464372474|FG004|Overall Study|Withdrawal by Subject|2|||
129111415|NCT00447902|464701460|FG000|Overall Study|Lack of Efficacy|2|||
129111416|NCT00447902|464701461|FG001|Overall Study|Lack of Efficacy|1|||
129111417|NCT04754542|464701462|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
129111418|NCT04754542|464701463|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
129111419|NCT02317991|464703130|FG000|Overall Study|Adverse Event|12|||
128691460|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
128691461|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
128691462|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
128691463|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129021836|NCT03606174|464372475|FG005|Overall Study|Withdrawal by Subject|1|||
129021837|NCT03606174|464372476|FG006|Overall Study|Withdrawal by Subject|4|||
129021838|NCT03606174|464372477|FG007|Overall Study|Withdrawal by Subject|0|||
129021839|NCT03606174|464372478|FG008|Overall Study|Withdrawal by Subject|0|||
129021840|NCT03606174|464372479|FG009|Overall Study|Withdrawal by Subject|0|||
129021841|NCT03606174|464372480|FG010|Overall Study|Withdrawal by Subject|1|||
129021842|NCT03606174|464372470|FG000|Overall Study|Study Terminated by Sponsor|5|||
129021843|NCT03606174|464372471|FG001|Overall Study|Study Terminated by Sponsor|7|||
129021844|NCT03606174|464372472|FG002|Overall Study|Study Terminated by Sponsor|3|||
129021845|NCT03606174|464372473|FG003|Overall Study|Study Terminated by Sponsor|0|||
129021846|NCT03606174|464372474|FG004|Overall Study|Study Terminated by Sponsor|11|||
129021847|NCT03606174|464372475|FG005|Overall Study|Study Terminated by Sponsor|6|||
129021848|NCT03606174|464372476|FG006|Overall Study|Study Terminated by Sponsor|12|||
129021849|NCT03606174|464372477|FG007|Overall Study|Study Terminated by Sponsor|1|||
129021850|NCT03606174|464372478|FG008|Overall Study|Study Terminated by Sponsor|3|||
129021851|NCT03606174|464372479|FG009|Overall Study|Study Terminated by Sponsor|1|||
129021852|NCT03606174|464372480|FG010|Overall Study|Study Terminated by Sponsor|2|||
129021853|NCT03606174|464372470|FG000|Overall Study|Miscellaneous|1|||
129021854|NCT03606174|464372471|FG001|Overall Study|Miscellaneous|1|||
129021855|NCT03606174|464372472|FG002|Overall Study|Miscellaneous|0|||
129021856|NCT03606174|464372473|FG003|Overall Study|Miscellaneous|1|||
129021857|NCT03606174|464372474|FG004|Overall Study|Miscellaneous|4|||
129021858|NCT03606174|464372475|FG005|Overall Study|Miscellaneous|7|||
129021859|NCT03606174|464372476|FG006|Overall Study|Miscellaneous|5|||
129021860|NCT03606174|464372477|FG007|Overall Study|Miscellaneous|0|||
129021861|NCT03606174|464372478|FG008|Overall Study|Miscellaneous|0|||
129021862|NCT03606174|464372479|FG009|Overall Study|Miscellaneous|0|||
129021863|NCT03606174|464372480|FG010|Overall Study|Miscellaneous|1|||
129021864|NCT03049748|464372481|FG000|Overall Study|Lost to Follow-up|1|||
129021865|NCT03049748|464372482|FG001|Overall Study|Lost to Follow-up|0|||
129021866|NCT03049748|464372481|FG000|Overall Study|Death|3|||
129021867|NCT03049748|464372482|FG001|Overall Study|Death|0|||
129021868|NCT03049748|464372481|FG000|Overall Study|Withdrawal by Subject|0|||
129021869|NCT03049748|464372482|FG001|Overall Study|Withdrawal by Subject|3|||
129021870|NCT03049748|464372481|FG000|Overall Study|Protocol Violation|0|||
129021871|NCT03049748|464372482|FG001|Overall Study|Protocol Violation|2|||
129021872|NCT03049748|464372481|FG000|Overall Study|Moved out of state (relocation)|0|||
129021873|NCT03049748|464372482|FG001|Overall Study|Moved out of state (relocation)|1|||
129021874|NCT00905840|464372485|FG000|Overall Study|Lost to Follow-up|11|||
129021875|NCT00905840|464372485|FG000|Overall Study|Death|3|||
129021876|NCT00905840|464372485|FG000|Overall Study|Withdrawal by Subject|1|||
129021877|NCT00905840|464372485|FG000|Overall Study|Adverse Event|1|||
129021878|NCT03496623|464372486|FG000|Run-In Period (2 Weeks)|Death|1|||
129021879|NCT03496623|464372487|FG001|Run-In Period (2 Weeks)|Death|0|||
129021880|NCT03496623|464372488|FG002|Run-In Period (2 Weeks)|Death|0|||
129021881|NCT03496623|464372489|FG003|Run-In Period (2 Weeks)|Death|0|||
129021882|NCT03496623|464372490|FG004|Run-In Period (2 Weeks)|Death|0|||
129021883|NCT03496623|464372486|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
129021884|NCT03496623|464372487|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129021885|NCT03496623|464372488|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129021886|NCT03496623|464372489|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129021887|NCT03496623|464372490|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129021888|NCT03496623|464372486|FG000|Period 1 (12 Weeks)|Death|0|||
129021889|NCT03496623|464372487|FG001|Period 1 (12 Weeks)|Death|3|||
129021890|NCT03496623|464372488|FG002|Period 1 (12 Weeks)|Death|0|||
129021891|NCT03496623|464372489|FG003|Period 1 (12 Weeks)|Death|0|||
129021892|NCT03496623|464372490|FG004|Period 1 (12 Weeks)|Death|0|||
129021893|NCT03496623|464372486|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
129021894|NCT03496623|464372487|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
129021895|NCT03496623|464372488|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
128717827|NCT01082965|463264056|FG000|Overall Study|Other|1|||
129021896|NCT03496623|464372489|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
129021897|NCT03496623|464372490|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
129021898|NCT03496623|464372486|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129021899|NCT03496623|464372487|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
129021900|NCT03496623|464372488|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
129021901|NCT03496623|464372489|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129021902|NCT03496623|464372490|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129021903|NCT03496623|464372486|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
129111420|NCT02317991|464703130|FG000|Overall Study|Death|4|||
128895102|NCT03227471|463911640|FG009|Overall Study|Withdrawal by Subject|0|||
128895103|NCT03227471|463911641|FG010|Overall Study|Withdrawal by Subject|0|||
128895104|NCT03227471|463911642|FG011|Overall Study|Withdrawal by Subject|0|||
128895105|NCT03227471|463911643|FG012|Overall Study|Withdrawal by Subject|1|||
128895106|NCT03227471|463911644|FG013|Overall Study|Withdrawal by Subject|0|||
128895107|NCT03227471|463911645|FG014|Overall Study|Withdrawal by Subject|0|||
128895108|NCT03227471|463911631|FG000|Overall Study|Randomized, Never Dosed|0|||
128895109|NCT03227471|463911632|FG001|Overall Study|Randomized, Never Dosed|0|||
129111421|NCT02317991|464703130|FG000|Overall Study|Withdrawal by Subject|8|||
129111422|NCT02317991|464703130|FG000|Overall Study|Progressive Disease|41|||
129111423|NCT01716806|464703131|FG000|Overall Study|Patient withdrawal of consent|4|||
129111424|NCT01716806|464703132|FG001|Overall Study|Patient withdrawal of consent|2|||
129111425|NCT01716806|464703133|FG002|Overall Study|Patient withdrawal of consent|4|||
129111426|NCT01716806|464703134|FG003|Overall Study|Patient withdrawal of consent|3|||
129111427|NCT01716806|464703135|FG004|Overall Study|Patient withdrawal of consent|2|||
129111428|NCT01716806|464703136|FG005|Overall Study|Patient withdrawal of consent|0|||
129111429|NCT01716806|464703131|FG000|Overall Study|Lost to Follow-up|3|||
129111430|NCT01716806|464703132|FG001|Overall Study|Lost to Follow-up|3|||
129111431|NCT01716806|464703133|FG002|Overall Study|Lost to Follow-up|0|||
129111432|NCT01716806|464703134|FG003|Overall Study|Lost to Follow-up|2|||
129111433|NCT01716806|464703135|FG004|Overall Study|Lost to Follow-up|1|||
129111434|NCT01716806|464703136|FG005|Overall Study|Lost to Follow-up|0|||
129111435|NCT01716806|464703131|FG000|Overall Study|Death|13|||
129111436|NCT01716806|464703132|FG001|Overall Study|Death|9|||
129111437|NCT01716806|464703133|FG002|Overall Study|Death|12|||
129111438|NCT01716806|464703134|FG003|Overall Study|Death|4|||
129111439|NCT01716806|464703135|FG004|Overall Study|Death|10|||
129111440|NCT01716806|464703136|FG005|Overall Study|Death|5|||
129111441|NCT01716806|464703131|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129111442|NCT01716806|464703132|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129111443|NCT01716806|464703133|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129111444|NCT01716806|464703134|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129111445|NCT01716806|464703135|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
129111446|NCT01716806|464703136|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
129111447|NCT01716806|464703131|FG000|Overall Study|PI decision|0|||
129111448|NCT01716806|464703132|FG001|Overall Study|PI decision|0|||
129111449|NCT01716806|464703133|FG002|Overall Study|PI decision|0|||
129111450|NCT01716806|464703134|FG003|Overall Study|PI decision|0|||
129111451|NCT01716806|464703135|FG004|Overall Study|PI decision|1|||
129111452|NCT01716806|464703136|FG005|Overall Study|PI decision|0|||
129111453|NCT01716806|464703131|FG000|Overall Study|Change in performance status|1|||
129111454|NCT01716806|464703132|FG001|Overall Study|Change in performance status|0|||
129111455|NCT01716806|464703133|FG002|Overall Study|Change in performance status|0|||
129111456|NCT01716806|464703134|FG003|Overall Study|Change in performance status|0|||
129111457|NCT01716806|464703135|FG004|Overall Study|Change in performance status|0|||
129111458|NCT01716806|464703136|FG005|Overall Study|Change in performance status|0|||
129111459|NCT01716806|464703131|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
129111460|NCT01716806|464703132|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
129111461|NCT01716806|464703133|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
129111462|NCT01716806|464703134|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
129111463|NCT01716806|464703135|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
129111464|NCT01716806|464703136|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
129111465|NCT01716806|464703131|FG000|Overall Study|Sponsor direction|7|||
129111466|NCT01716806|464703132|FG001|Overall Study|Sponsor direction|8|||
129111467|NCT01716806|464703133|FG002|Overall Study|Sponsor direction|5|||
128691464|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
128691465|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
128895110|NCT03227471|463911633|FG002|Overall Study|Randomized, Never Dosed|0|||
128895111|NCT03227471|463911634|FG003|Overall Study|Randomized, Never Dosed|0|||
128895112|NCT03227471|463911635|FG004|Overall Study|Randomized, Never Dosed|0|||
128895113|NCT03227471|463911636|FG005|Overall Study|Randomized, Never Dosed|0|||
129111468|NCT01716806|464703134|FG003|Overall Study|Sponsor direction|12|||
129111469|NCT01716806|464703135|FG004|Overall Study|Sponsor direction|16|||
129111470|NCT01716806|464703136|FG005|Overall Study|Sponsor direction|1|||
129111471|NCT03506438|464703137|FG000|Overall Study|Lost to Follow-up|8|||
129111472|NCT03506438|464703138|FG001|Overall Study|Lost to Follow-up|7|||
128895114|NCT03227471|463911637|FG006|Overall Study|Randomized, Never Dosed|0|||
128895115|NCT03227471|463911638|FG007|Overall Study|Randomized, Never Dosed|0|||
129111473|NCT03506438|464703139|FG002|Overall Study|Lost to Follow-up|8|||
129111474|NCT03506438|464703140|FG003|Overall Study|Lost to Follow-up|7|||
129215210|NCT01588522|465089467|FG003|Overall Study|Lack of Efficacy|0|||
128691466|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129021904|NCT03496623|464372487|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
129021905|NCT03496623|464372488|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
129021906|NCT03496623|464372489|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
129021907|NCT03496623|464372490|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
129021908|NCT03496623|464372486|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129021909|NCT03496623|464372487|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129021910|NCT03496623|464372488|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
129021911|NCT03496623|464372489|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129021912|NCT03496623|464372490|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129021913|NCT03496623|464372486|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129021914|NCT03496623|464372487|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129021915|NCT03496623|464372488|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
129021916|NCT03496623|464372489|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129021917|NCT03496623|464372490|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129021918|NCT03496623|464372486|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129021919|NCT03496623|464372487|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
129021920|NCT03496623|464372488|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129021921|NCT03496623|464372489|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129021922|NCT03496623|464372490|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129021923|NCT00794963|464372491|FG000|Overall Study|Withdrawal by Subject|1|||
129021924|NCT00794963|464372492|FG001|Overall Study|Withdrawal by Subject|4|||
129021925|NCT03181594|464372501|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
129021926|NCT03181594|464372501|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
129021927|NCT03181594|464372501|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
129021928|NCT03181594|464372501|FG000|Initial Study Protocol (12-month FU)|Death|1|||
129021929|NCT03181594|464372501|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
129021930|NCT03181594|464372501|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
129021931|NCT01527006|464372502|FG000|Core Study|Adverse Event|0|||
129021932|NCT01527006|464372503|FG001|Core Study|Adverse Event|2|||
129021933|NCT01527006|464372502|FG000|Core Study|Lost to Follow-up|0|||
129021934|NCT01527006|464372503|FG001|Core Study|Lost to Follow-up|1|||
129021935|NCT01527006|464372502|FG000|Core Study|Subject Choice|1|||
129021936|NCT01527006|464372503|FG001|Core Study|Subject Choice|0|||
129021937|NCT01527006|464372502|FG000|Core Study|Inadequate Therapeutic Effect|1|||
129021938|NCT01527006|464372503|FG001|Core Study|Inadequate Therapeutic Effect|0|||
129021939|NCT01527006|464372502|FG000|Core Study|Withdrawal by Subject|0|||
129021940|NCT01527006|464372503|FG001|Core Study|Withdrawal by Subject|1|||
129021941|NCT01527006|464372502|FG000|Core Study|Other|0|||
129021942|NCT01527006|464372503|FG001|Core Study|Other|2|||
129021943|NCT01527006|464372502|FG000|Extension Phase|Adverse Event|4|||
129021944|NCT01527006|464372503|FG001|Extension Phase|Adverse Event|2|||
129021945|NCT01527006|464372502|FG000|Extension Phase|Lost to Follow-up|0|||
129021946|NCT01527006|464372503|FG001|Extension Phase|Lost to Follow-up|1|||
129021947|NCT01527006|464372502|FG000|Extension Phase|Subject Choice|1|||
129021948|NCT01527006|464372503|FG001|Extension Phase|Subject Choice|1|||
129021949|NCT01527006|464372502|FG000|Extension Phase|Inadequate therapeutic effect|1|||
129021950|NCT01527006|464372503|FG001|Extension Phase|Inadequate therapeutic effect|1|||
129021951|NCT01527006|464372502|FG000|Extension Phase|Other|0|||
129215211|NCT01588522|465089468|FG004|Overall Study|Lack of Efficacy|1|||
129215212|NCT01588522|465089469|FG005|Overall Study|Lack of Efficacy|0|||
129215213|NCT01588522|465089464|FG000|Overall Study|Adverse Event|0|||
129215214|NCT01588522|465089465|FG001|Overall Study|Adverse Event|0|||
129215215|NCT01588522|465089466|FG002|Overall Study|Adverse Event|0|||
129215216|NCT01588522|465089467|FG003|Overall Study|Adverse Event|1|||
129215217|NCT01588522|465089468|FG004|Overall Study|Adverse Event|0|||
129215218|NCT01588522|465089469|FG005|Overall Study|Adverse Event|0|||
129215219|NCT01588522|465089464|FG000|Overall Study|Grade 2 alopecia|1|||
129215220|NCT01588522|465089465|FG001|Overall Study|Grade 2 alopecia|0|||
129215221|NCT01588522|465089466|FG002|Overall Study|Grade 2 alopecia|0|||
129215222|NCT01588522|465089467|FG003|Overall Study|Grade 2 alopecia|0|||
129215223|NCT01588522|465089468|FG004|Overall Study|Grade 2 alopecia|0|||
129215224|NCT01588522|465089469|FG005|Overall Study|Grade 2 alopecia|0|||
128717828|NCT01082965|463264057|FG001|Overall Study|Other|1|||
129215225|NCT01588522|465089464|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
129215226|NCT01588522|465089465|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
129215227|NCT01588522|465089466|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
129215228|NCT01588522|465089467|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
129215229|NCT01588522|465089468|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
129215230|NCT01588522|465089469|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
129215231|NCT01588522|465089464|FG000|Overall Study|Taken off taxane-based regimen|0|||
129215232|NCT01588522|465089465|FG001|Overall Study|Taken off taxane-based regimen|0|||
129215233|NCT01588522|465089466|FG002|Overall Study|Taken off taxane-based regimen|0|||
129215234|NCT01588522|465089467|FG003|Overall Study|Taken off taxane-based regimen|1|||
129215235|NCT01588522|465089468|FG004|Overall Study|Taken off taxane-based regimen|0|||
128895116|NCT03227471|463911639|FG008|Overall Study|Randomized, Never Dosed|0|||
129111475|NCT03506438|464703141|FG004|Overall Study|Lost to Follow-up|0|||
129111476|NCT03506438|464703142|FG005|Overall Study|Lost to Follow-up|0|||
129111477|NCT03527277|464703143|FG000|Overall Study|Withdrawal by Subject|5|||
129111478|NCT03527277|464703144|FG001|Overall Study|Withdrawal by Subject|0|||
129111479|NCT03527277|464703143|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
129111480|NCT03527277|464703144|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
129111481|NCT03527277|464703143|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
129111482|NCT03527277|464703144|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
129111483|NCT01128296|464703145|FG000|Overall Study|Physician Decision|0|||
129111484|NCT01128296|464703146|FG001|Overall Study|Physician Decision|0|||
129111485|NCT01128296|464703147|FG002|Overall Study|Physician Decision|0|||
129111486|NCT01128296|464703148|FG003|Overall Study|Physician Decision|0|||
129111487|NCT01128296|464703149|FG004|Overall Study|Physician Decision|0|||
129111488|NCT01128296|464703150|FG005|Overall Study|Physician Decision|3|||
129111489|NCT01128296|464703145|FG000|Overall Study|Withdrawal by Subject|0|||
129111490|NCT01128296|464703146|FG001|Overall Study|Withdrawal by Subject|0|||
128691467|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
128691468|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
128691469|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129111491|NCT01128296|464703147|FG002|Overall Study|Withdrawal by Subject|0|||
129111492|NCT01128296|464703148|FG003|Overall Study|Withdrawal by Subject|0|||
129111493|NCT01128296|464703149|FG004|Overall Study|Withdrawal by Subject|0|||
129111494|NCT01128296|464703150|FG005|Overall Study|Withdrawal by Subject|2|||
129111495|NCT04155463|464703153|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
128691470|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
128691471|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
128691472|NCT04526509|463169477|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
128691473|NCT04526509|463169478|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
128691474|NCT04526509|463169479|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
128691475|NCT04526509|463169480|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
128691476|NCT04526509|463169481|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
128691477|NCT04526509|463169482|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
128691478|NCT04526509|463169483|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
128691479|NCT04526509|463169477|FG000|Enrolled|Study Terminated by Sponsor|0|||
128691480|NCT04526509|463169478|FG001|Enrolled|Study Terminated by Sponsor|0|||
128691481|NCT04526509|463169479|FG002|Enrolled|Study Terminated by Sponsor|0|||
128691482|NCT04526509|463169480|FG003|Enrolled|Study Terminated by Sponsor|0|||
128691483|NCT04526509|463169481|FG004|Enrolled|Study Terminated by Sponsor|0|||
128691484|NCT04526509|463169482|FG005|Enrolled|Study Terminated by Sponsor|0|||
128691485|NCT04526509|463169483|FG006|Enrolled|Study Terminated by Sponsor|1|||
128691486|NCT04526509|463169477|FG000|Enrolled|Death prior to lymphodepletion|0|||
128691487|NCT04526509|463169478|FG001|Enrolled|Death prior to lymphodepletion|0|||
128691488|NCT04526509|463169479|FG002|Enrolled|Death prior to lymphodepletion|0|||
128691489|NCT04526509|463169480|FG003|Enrolled|Death prior to lymphodepletion|1|||
128691490|NCT04526509|463169481|FG004|Enrolled|Death prior to lymphodepletion|0|||
128691491|NCT04526509|463169482|FG005|Enrolled|Death prior to lymphodepletion|0|||
128691492|NCT04526509|463169483|FG006|Enrolled|Death prior to lymphodepletion|0|||
128691493|NCT04526509|463169477|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
128691494|NCT04526509|463169478|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
128691495|NCT04526509|463169479|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
128691496|NCT04526509|463169480|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
128691497|NCT04526509|463169481|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
128691498|NCT04526509|463169482|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
128691499|NCT04526509|463169483|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
128691500|NCT04526509|463169477|FG000|Enrolled|Physician Decision|0|||
128691501|NCT04526509|463169478|FG001|Enrolled|Physician Decision|1|||
128691502|NCT04526509|463169479|FG002|Enrolled|Physician Decision|0|||
128691503|NCT04526509|463169480|FG003|Enrolled|Physician Decision|0|||
128691504|NCT04526509|463169481|FG004|Enrolled|Physician Decision|0|||
128895117|NCT03227471|463911640|FG009|Overall Study|Randomized, Never Dosed|0|||
128895118|NCT03227471|463911641|FG010|Overall Study|Randomized, Never Dosed|0|||
129111496|NCT04155463|464703154|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
129111497|NCT03934216|464703157|FG000|Overall Study|Other Reasons|5|||
128764427|NCT01919970|463428319|FG000|Overall Study|Withdrawal by Subject|3|||
128764428|NCT01919970|463428320|FG001|Overall Study|Withdrawal by Subject|0|||
128764429|NCT04043962|463428321|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
128764430|NCT04043962|463428321|FG000|Post-Treatment|Withdrawal by Subject|5|||
128764431|NCT04043962|463428321|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
128764432|NCT04615182|463428322|FG000|Overall Study|Re-transplanted|2|||
128764433|NCT04615182|463428322|FG000|Overall Study|Protocol Violation|6|||
128764434|NCT04615182|463428322|FG000|Overall Study|Death|6|||
128764435|NCT04615182|463428322|FG000|Overall Study|Death and protocol violation|1|||
128764436|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
128764437|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
128764438|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
128764439|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
128764440|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
128764441|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
128764442|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
128764443|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
128764444|NCT01336621|463428323|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
128764445|NCT01336621|463428323|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
128764446|NCT01336621|463428323|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
128764447|NCT01336621|463428323|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
128764448|NCT01336621|463428323|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
128764449|NCT01336621|463428323|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
128764450|NCT01126060|463428326|FG000|Overall Study|Protocol Violation|0|||
128764451|NCT01126060|463428327|FG001|Overall Study|Protocol Violation|2|||
128764452|NCT01874145|463428328|FG000|Core Period|Non-compliance|1|||
128764453|NCT01874145|463428329|FG001|Core Period|Non-compliance|0|||
128764454|NCT01874145|463428328|FG000|Core Period|Protocol Violation|1|||
128764455|NCT01874145|463428329|FG001|Core Period|Protocol Violation|1|||
128764456|NCT01874145|463428328|FG000|Core Period|Physician Decision|1|||
128764457|NCT01874145|463428329|FG001|Core Period|Physician Decision|1|||
128764458|NCT01874145|463428328|FG000|Core Period|Adverse Event|0|||
128895119|NCT03227471|463911642|FG011|Overall Study|Randomized, Never Dosed|0|||
128895120|NCT03227471|463911643|FG012|Overall Study|Randomized, Never Dosed|0|||
128895121|NCT03227471|463911644|FG013|Overall Study|Randomized, Never Dosed|0|||
128895122|NCT03227471|463911645|FG014|Overall Study|Randomized, Never Dosed|1|||
128895123|NCT00382720|463911646|FG000|Overall Study|Adverse Event|21|||
128895124|NCT00382720|463911647|FG001|Overall Study|Adverse Event|23|||
128895125|NCT00382720|463911648|FG002|Overall Study|Adverse Event|15|||
128895126|NCT00382720|463911646|FG000|Overall Study|Protocol Violation|2|||
128895127|NCT00382720|463911647|FG001|Overall Study|Protocol Violation|5|||
128895128|NCT00382720|463911648|FG002|Overall Study|Protocol Violation|1|||
128895129|NCT00382720|463911646|FG000|Overall Study|Death|0|||
128895130|NCT00382720|463911647|FG001|Overall Study|Death|1|||
128895131|NCT00382720|463911648|FG002|Overall Study|Death|2|||
128895132|NCT00382720|463911646|FG000|Overall Study|Progressive disease|37|||
128895133|NCT00382720|463911647|FG001|Overall Study|Progressive disease|28|||
128895134|NCT00382720|463911648|FG002|Overall Study|Progressive disease|38|||
128895135|NCT00382720|463911646|FG000|Overall Study|Withdrew consent|1|||
128895136|NCT00382720|463911647|FG001|Overall Study|Withdrew consent|1|||
128895137|NCT00382720|463911648|FG002|Overall Study|Withdrew consent|2|||
128895138|NCT00382720|463911646|FG000|Overall Study|Withdrawal by Subject|11|||
128895139|NCT00382720|463911647|FG001|Overall Study|Withdrawal by Subject|20|||
128895140|NCT00382720|463911648|FG002|Overall Study|Withdrawal by Subject|12|||
128895141|NCT00382720|463911646|FG000|Overall Study|Surgery|1|||
128895142|NCT00382720|463911647|FG001|Overall Study|Surgery|1|||
128895143|NCT00382720|463911648|FG002|Overall Study|Surgery|4|||
128895144|NCT00382720|463911646|FG000|Overall Study|Patient did not receive study medication|1|||
128895145|NCT00382720|463911647|FG001|Overall Study|Patient did not receive study medication|1|||
128895146|NCT00382720|463911648|FG002|Overall Study|Patient did not receive study medication|4|||
128895147|NCT00382720|463911646|FG000|Overall Study|Clinically progressive disease|0|||
128895148|NCT00382720|463911647|FG001|Overall Study|Clinically progressive disease|1|||
128895149|NCT00382720|463911648|FG002|Overall Study|Clinically progressive disease|0|||
128764459|NCT01874145|463428329|FG001|Core Period|Adverse Event|1|||
128895150|NCT00382720|463911646|FG000|Overall Study|Good prognosis|0|||
128764460|NCT01874145|463428328|FG000|Core Period|Withdrawal by Subject|0|||
128764461|NCT01874145|463428329|FG001|Core Period|Withdrawal by Subject|4|||
128764462|NCT01874145|463428328|FG000|Extension Period|Adverse Event|3|||
128764463|NCT01874145|463428329|FG001|Extension Period|Adverse Event|2|||
128764464|NCT01874145|463428328|FG000|Extension Period|Withdrawal by Subject|2|||
128895151|NCT00382720|463911647|FG001|Overall Study|Good prognosis|1|||
128895152|NCT00382720|463911648|FG002|Overall Study|Good prognosis|0|||
128895153|NCT00382720|463911646|FG000|Overall Study|Investigator/Clinical decision|5|||
128895154|NCT00382720|463911647|FG001|Overall Study|Investigator/Clinical decision|6|||
128895155|NCT00382720|463911648|FG002|Overall Study|Investigator/Clinical decision|6|||
128895156|NCT00382720|463911646|FG000|Overall Study|Discontinued at end of study|0|||
129111498|NCT03934216|464703158|FG001|Overall Study|Other Reasons|5|||
128895157|NCT00382720|463911647|FG001|Overall Study|Discontinued at end of study|1|||
128895158|NCT00382720|463911648|FG002|Overall Study|Discontinued at end of study|2|||
128895159|NCT02142738|463911649|FG000|Overall Study|Adverse Event|13|||
128895160|NCT02142738|463911650|FG001|Overall Study|Adverse Event|9|||
128895161|NCT02142738|463911649|FG000|Overall Study|Death|92|||
129111499|NCT03934216|464703157|FG000|Overall Study|Adverse Event|22|||
129111500|NCT03934216|464703158|FG001|Overall Study|Adverse Event|11|||
129111501|NCT03934216|464703157|FG000|Overall Study|Lack of Efficacy|8|||
129111502|NCT03934216|464703158|FG001|Overall Study|Lack of Efficacy|7|||
129111503|NCT03934216|464703157|FG000|Overall Study|Lost to Follow-up|2|||
129111504|NCT03934216|464703158|FG001|Overall Study|Lost to Follow-up|0|||
128691505|NCT04526509|463169482|FG005|Enrolled|Physician Decision|0|||
128691506|NCT04526509|463169483|FG006|Enrolled|Physician Decision|0|||
128691507|NCT04340193|463169485|FG000|Overall Study|Other reason|0|||
128691508|NCT04340193|463169486|FG001|Overall Study|Other reason|0|||
128691509|NCT04340193|463169487|FG002|Overall Study|Other reason|1|||
128691510|NCT04340193|463169485|FG000|Overall Study|Disease recurrence|0|||
128691511|NCT04340193|463169486|FG001|Overall Study|Disease recurrence|1|||
128895162|NCT02142738|463911650|FG001|Overall Study|Death|112|||
128895163|NCT02142738|463911649|FG000|Overall Study|Lost to Follow-up|0|||
128895164|NCT02142738|463911650|FG001|Overall Study|Lost to Follow-up|3|||
128895165|NCT02142738|463911649|FG000|Overall Study|Withdrawal by Subject|6|||
128895166|NCT02142738|463911650|FG001|Overall Study|Withdrawal by Subject|7|||
128895167|NCT02142738|463911649|FG000|Overall Study|Follow up ended by sponsor|43|||
128895168|NCT02142738|463911650|FG001|Overall Study|Follow up ended by sponsor|20|||
128895169|NCT03688880|463911651|FG000|Overall Study|Withdrawal by Subject|0|||
128895170|NCT03688880|463911652|FG001|Overall Study|Withdrawal by Subject|2|||
128895171|NCT03688880|463911651|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
128895172|NCT03688880|463911652|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
128895173|NCT03688880|463911651|FG000|Overall Study|Lost to Follow-up|4|||
128895174|NCT03688880|463911652|FG001|Overall Study|Lost to Follow-up|7|||
128895175|NCT03688880|463911651|FG000|Overall Study|Adverse Event|0|||
128895176|NCT03688880|463911652|FG001|Overall Study|Adverse Event|2|||
128895177|NCT03688880|463911651|FG000|Overall Study|Device deficiencies|0|||
128895178|NCT03688880|463911652|FG001|Overall Study|Device deficiencies|2|||
128895179|NCT03688880|463911651|FG000|Overall Study|Other|10|||
128895180|NCT03688880|463911652|FG001|Overall Study|Other|16|||
128691512|NCT04340193|463169487|FG002|Overall Study|Disease recurrence|0|||
128691513|NCT04340193|463169485|FG000|Overall Study|Study drug toxicity|1|||
128691514|NCT04340193|463169486|FG001|Overall Study|Study drug toxicity|0|||
128691515|NCT04340193|463169487|FG002|Overall Study|Study drug toxicity|0|||
128691516|NCT04340193|463169485|FG000|Overall Study|Disease progression|1|||
128691517|NCT04340193|463169486|FG001|Overall Study|Disease progression|2|||
128691518|NCT04340193|463169487|FG002|Overall Study|Disease progression|3|||
128691519|NCT04340193|463169485|FG000|Overall Study|Administrative reasons by sponsor|0|||
128691520|NCT04340193|463169486|FG001|Overall Study|Administrative reasons by sponsor|1|||
128691521|NCT04340193|463169487|FG002|Overall Study|Administrative reasons by sponsor|0|||
128691522|NCT04340193|463169485|FG000|Overall Study|Adverse Event|1|||
128691523|NCT04340193|463169486|FG001|Overall Study|Adverse Event|1|||
128691524|NCT04340193|463169487|FG002|Overall Study|Adverse Event|0|||
128691525|NCT01386008|463169488|FG000|Overall Study|exited w/o incident /study discontinued|17|||
128691526|NCT01386008|463169488|FG000|Overall Study|Adverse Event|3|||
128691527|NCT04449861|463169489|FG000|Overall Study|Withdrawal by Subject|4|||
128691528|NCT04449861|463169489|FG000|Overall Study|Lost to Follow-up|5|||
128691529|NCT04449861|463169489|FG000|Overall Study|Death|112|||
128691530|NCT00976677|463169490|FG000|Overall Study|Adverse Event|1|||
128691531|NCT00976677|463169491|FG001|Overall Study|Adverse Event|0|||
128895181|NCT02713542|463911654|FG000|Overall Study|Use of prohibited medication|14|||
128895182|NCT02713542|463911655|FG001|Overall Study|Use of prohibited medication|5|||
128895183|NCT02713542|463911654|FG000|Overall Study|Withdrawal by Subject|4|||
128895184|NCT02713542|463911655|FG001|Overall Study|Withdrawal by Subject|1|||
128691532|NCT00976677|463169490|FG000|Overall Study|Withdrawal by Subject|0|||
128691533|NCT00976677|463169491|FG001|Overall Study|Withdrawal by Subject|2|||
128691534|NCT00976677|463169490|FG000|Overall Study|Disease progression|1|||
128691535|NCT00976677|463169491|FG001|Overall Study|Disease progression|1|||
128691536|NCT00976677|463169490|FG000|Overall Study|Trial unblinded|2|||
128691537|NCT00976677|463169491|FG001|Overall Study|Trial unblinded|2|||
128691538|NCT00976677|463169490|FG000|Overall Study|Unknown/Missing|1|||
128691539|NCT00976677|463169491|FG001|Overall Study|Unknown/Missing|0|||
128895185|NCT00066742|463911656|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
128895186|NCT00066742|463911656|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
128895187|NCT00066742|463911656|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
128895188|NCT00066742|463911656|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
128895189|NCT00066742|463911656|FG000|Induction Chemoradiotherapy|Ineligible|3|||
129111505|NCT03934216|464703157|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129111506|NCT03934216|464703158|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129111507|NCT03934216|464703157|FG000|Overall Study|Pregnancy|1|||
129111508|NCT03934216|464703158|FG001|Overall Study|Pregnancy|0|||
129111509|NCT03934216|464703157|FG000|Overall Study|Withdrawal by Subject|18|||
129111510|NCT03934216|464703158|FG001|Overall Study|Withdrawal by Subject|6|||
129111511|NCT03934216|464703157|FG000|Overall Study|Randomized but not treated|1|||
129111512|NCT03934216|464703158|FG001|Overall Study|Randomized but not treated|1|||
129111513|NCT01914393|464703159|FG000|Overall Study|Protocol Violation|11|||
129111514|NCT01914393|464703160|FG001|Overall Study|Protocol Violation|3|||
129111515|NCT01914393|464703161|FG002|Overall Study|Protocol Violation|19|||
129111516|NCT01914393|464703159|FG000|Overall Study|Lack of Efficacy|11|||
129111517|NCT01914393|464703160|FG001|Overall Study|Lack of Efficacy|16|||
129111518|NCT01914393|464703161|FG002|Overall Study|Lack of Efficacy|5|||
129111519|NCT01914393|464703159|FG000|Overall Study|no reason given|14|||
129111520|NCT01914393|464703160|FG001|Overall Study|no reason given|8|||
129111521|NCT01914393|464703161|FG002|Overall Study|no reason given|16|||
129111522|NCT01914393|464703159|FG000|Overall Study|Adverse Event|29|||
129111523|NCT01914393|464703160|FG001|Overall Study|Adverse Event|18|||
129111524|NCT01914393|464703161|FG002|Overall Study|Adverse Event|31|||
129111525|NCT01914393|464703159|FG000|Overall Study|Withdrawal by Subject|38|||
129111526|NCT01914393|464703160|FG001|Overall Study|Withdrawal by Subject|20|||
129111527|NCT01914393|464703161|FG002|Overall Study|Withdrawal by Subject|47|||
129111528|NCT01914393|464703159|FG000|Overall Study|Lost to Follow-up|12|||
129111529|NCT01914393|464703160|FG001|Overall Study|Lost to Follow-up|6|||
129111530|NCT01914393|464703161|FG002|Overall Study|Lost to Follow-up|19|||
129111531|NCT01914393|464703159|FG000|Overall Study|subject never dosed|0|||
129111532|NCT01914393|464703160|FG001|Overall Study|subject never dosed|0|||
129111533|NCT01914393|464703161|FG002|Overall Study|subject never dosed|1|||
129111534|NCT02163395|464703164|FG000|Overall Study|Withdrawal by Subject|1|||
129111535|NCT02163395|464703164|FG000|Overall Study|Lost to Follow-up|3|||
129111536|NCT02163395|464703164|FG000|Overall Study|Adverse Event|1|||
129111537|NCT00521365|464703168|FG000|Overall Study|Adverse Event|3|||
129111538|NCT00521365|464703168|FG000|Overall Study|Lost to Follow-up|6|||
129111539|NCT00521365|464703168|FG000|Overall Study|Protocol deviation|2|||
129111540|NCT00521365|464703168|FG000|Overall Study|Drug compliance|3|||
129111541|NCT00521365|464703168|FG000|Overall Study|Usage of not allowed drugs|6|||
129111542|NCT03627832|464703169|FG000|Overall Study|Withdrawal by Subject|10|||
128895190|NCT00066742|463911656|FG000|Consolidation Chemotherapy|not protocol specified|1|||
128895191|NCT00066742|463911656|FG000|Consolidation Chemotherapy|Ineligible|2|||
128895192|NCT03861936|463911660|FG000|Overall Study|Withdrawal by Subject|4|||
128895193|NCT03861936|463911661|FG001|Overall Study|Withdrawal by Subject|1|||
128895194|NCT03861936|463911662|FG002|Overall Study|Withdrawal by Subject|3|||
128895195|NCT03861936|463911660|FG000|Overall Study|Lost to Follow-up|5|||
128895196|NCT03861936|463911661|FG001|Overall Study|Lost to Follow-up|3|||
128895197|NCT03861936|463911662|FG002|Overall Study|Lost to Follow-up|3|||
128895198|NCT03861936|463911660|FG000|Overall Study|Physician Decision|0|||
128895199|NCT03861936|463911661|FG001|Overall Study|Physician Decision|1|||
128895200|NCT03861936|463911662|FG002|Overall Study|Physician Decision|0|||
128895201|NCT03861936|463911660|FG000|Overall Study|Protocol Deviation|0|||
128895202|NCT03861936|463911661|FG001|Overall Study|Protocol Deviation|0|||
128895203|NCT03861936|463911662|FG002|Overall Study|Protocol Deviation|1|||
128895204|NCT03861936|463911660|FG000|Overall Study|Reason not Specified|5|||
128895205|NCT03861936|463911661|FG001|Overall Study|Reason not Specified|5|||
128895206|NCT03861936|463911662|FG002|Overall Study|Reason not Specified|3|||
128895207|NCT00359021|463911663|FG000|Overall Study|Adverse Event|26|||
128895208|NCT00359021|463911664|FG001|Overall Study|Adverse Event|8|||
128895209|NCT00359021|463911663|FG000|Overall Study|Subject Non-Compliant|1|||
128895210|NCT00359021|463911664|FG001|Overall Study|Subject Non-Compliant|2|||
128895211|NCT00359021|463911663|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
128895212|NCT00359021|463911664|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
128895213|NCT00359021|463911663|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
128895214|NCT00359021|463911664|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
128895215|NCT00359021|463911663|FG000|Overall Study|Withdrawal by Subject|2|||
128895216|NCT00359021|463911664|FG001|Overall Study|Withdrawal by Subject|9|||
129111543|NCT03627832|464703170|FG001|Overall Study|Withdrawal by Subject|1|||
128691540|NCT03507400|463169492|FG000|Overall Study|discontinued|5|||
128691541|NCT03507400|463169493|FG001|Overall Study|discontinued|1|||
128895217|NCT00359021|463911663|FG000|Overall Study|Lost to Follow-up|1|||
128895218|NCT00359021|463911664|FG001|Overall Study|Lost to Follow-up|0|||
128895219|NCT00359021|463911663|FG000|Overall Study|Other|4|||
129111544|NCT03150082|464703171|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
129111545|NCT03150082|464703172|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
129111546|NCT01718483|464703173|FG000|Overall Study|Withdrawal by Subject|14|||
129111547|NCT01718483|464703174|FG001|Overall Study|Withdrawal by Subject|12|||
129111548|NCT01718483|464703173|FG000|Overall Study|Adverse Event|5|||
129111549|NCT01718483|464703174|FG001|Overall Study|Adverse Event|12|||
129111550|NCT01718483|464703173|FG000|Overall Study|Lost to Follow-up|8|||
129111551|NCT01718483|464703174|FG001|Overall Study|Lost to Follow-up|3|||
129111552|NCT01718483|464703173|FG000|Overall Study|Protocol Violation|4|||
129111553|NCT01718483|464703174|FG001|Overall Study|Protocol Violation|2|||
129111554|NCT01718483|464703173|FG000|Overall Study|Other|1|||
129111555|NCT01718483|464703174|FG001|Overall Study|Other|4|||
129111556|NCT01718483|464703173|FG000|Overall Study|Pregnancy|1|||
129111557|NCT01718483|464703174|FG001|Overall Study|Pregnancy|1|||
129111558|NCT01718483|464703173|FG000|Overall Study|Lack of Efficacy|1|||
129111559|NCT01718483|464703174|FG001|Overall Study|Lack of Efficacy|0|||
129111560|NCT01831427|464703178|FG000|Overall Study|Adverse Event|0|||
129111561|NCT01831427|464703179|FG001|Overall Study|Adverse Event|1|||
129111562|NCT01831427|464703180|FG002|Overall Study|Adverse Event|0|||
129111563|NCT01831427|464703181|FG003|Overall Study|Adverse Event|0|||
129111564|NCT01831427|464703182|FG004|Overall Study|Adverse Event|0|||
129111565|NCT01831427|464703183|FG005|Overall Study|Adverse Event|1|||
129111566|NCT01831427|464703184|FG006|Overall Study|Adverse Event|0|||
129111567|NCT01831427|464703185|FG007|Overall Study|Adverse Event|1|||
129111568|NCT01831427|464703186|FG008|Overall Study|Adverse Event|0|||
129111569|NCT01831427|464703187|FG009|Overall Study|Adverse Event|0|||
129111570|NCT01831427|464703188|FG010|Overall Study|Adverse Event|2|||
129111571|NCT01831427|464703178|FG000|Overall Study|Investigator's Discretion|0|||
129111572|NCT01831427|464703179|FG001|Overall Study|Investigator's Discretion|0|||
129111573|NCT01831427|464703180|FG002|Overall Study|Investigator's Discretion|0|||
129111574|NCT01831427|464703181|FG003|Overall Study|Investigator's Discretion|1|||
129111575|NCT01831427|464703182|FG004|Overall Study|Investigator's Discretion|0|||
129111576|NCT01831427|464703183|FG005|Overall Study|Investigator's Discretion|0|||
129111577|NCT01831427|464703184|FG006|Overall Study|Investigator's Discretion|0|||
129111578|NCT01831427|464703185|FG007|Overall Study|Investigator's Discretion|0|||
129111579|NCT01831427|464703186|FG008|Overall Study|Investigator's Discretion|0|||
129111580|NCT01831427|464703187|FG009|Overall Study|Investigator's Discretion|0|||
129111581|NCT01831427|464703188|FG010|Overall Study|Investigator's Discretion|0|||
129111582|NCT01831427|464703178|FG000|Overall Study|Withdrew Consent|0|||
129111583|NCT01831427|464703179|FG001|Overall Study|Withdrew Consent|0|||
129111584|NCT01831427|464703180|FG002|Overall Study|Withdrew Consent|0|||
129111585|NCT01831427|464703181|FG003|Overall Study|Withdrew Consent|0|||
129111586|NCT01831427|464703182|FG004|Overall Study|Withdrew Consent|0|||
129111587|NCT01831427|464703183|FG005|Overall Study|Withdrew Consent|0|||
129111588|NCT01831427|464703184|FG006|Overall Study|Withdrew Consent|2|||
129111589|NCT01831427|464703185|FG007|Overall Study|Withdrew Consent|0|||
129111590|NCT01831427|464703186|FG008|Overall Study|Withdrew Consent|0|||
129111591|NCT01831427|464703187|FG009|Overall Study|Withdrew Consent|1|||
129111592|NCT01831427|464703188|FG010|Overall Study|Withdrew Consent|1|||
129111593|NCT00536510|464703189|FG000|Overall Study|Adverse Event|27|||
129111594|NCT00536510|464703190|FG001|Overall Study|Adverse Event|4|||
129111595|NCT00536510|464703189|FG000|Overall Study|Lost to Follow-up|11|||
129111596|NCT00536510|464703190|FG001|Overall Study|Lost to Follow-up|8|||
128691542|NCT03507400|463169492|FG000|Overall Study|Lost to Follow-up|8|||
128691543|NCT03507400|463169493|FG001|Overall Study|Lost to Follow-up|6|||
128691544|NCT03507400|463169492|FG000|Overall Study|Protocol Violation|0|||
128691545|NCT03507400|463169493|FG001|Overall Study|Protocol Violation|1|||
128691546|NCT01555983|463169494|FG000|Overall Study|Withdrawal by Subject|1|||
128691547|NCT01555983|463169495|FG001|Overall Study|Withdrawal by Subject|0|||
129111597|NCT00536510|464703189|FG000|Overall Study|Protocol Violation|4|||
129111598|NCT00536510|464703190|FG001|Overall Study|Protocol Violation|5|||
129111599|NCT00536510|464703189|FG000|Overall Study|Withdrawal by Subject|16|||
129111600|NCT00536510|464703190|FG001|Overall Study|Withdrawal by Subject|9|||
129111601|NCT00536510|464703189|FG000|Overall Study|Flushing with Product|20|||
129111602|NCT00536510|464703190|FG001|Overall Study|Flushing with Product|0|||
129111603|NCT00536510|464703189|FG000|Overall Study|Laboratory Adverse Event|2|||
129111604|NCT00536510|464703190|FG001|Overall Study|Laboratory Adverse Event|1|||
129111605|NCT00536510|464703189|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
129111606|NCT00536510|464703190|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
129111607|NCT02169505|464703191|FG000|Overall Study|Withdrawal by Subject|1|||
129111608|NCT00048035|464703192|FG000|Core Period|Early Withdrawals|4|||
129111609|NCT00048035|464703193|FG001|Core Period|Early Withdrawals|2|||
129111610|NCT00048035|464703194|FG002|Core Period|Early Withdrawals|1|||
129111611|NCT00048035|464703195|FG003|Core Period|Early Withdrawals|1|||
129111612|NCT00048035|464703196|FG004|Core Period|Early Withdrawals|1|||
129111613|NCT00048035|464703197|FG005|Core Period|Early Withdrawals|1|||
129111614|NCT00048035|464703198|FG006|Core Period|Early Withdrawals|0|||
129111615|NCT00048035|464703199|FG007|Core Period|Early Withdrawals|0|||
129111616|NCT00048035|464703192|FG000|Extension Year 1|Early Withdrawals|0|||
128691548|NCT01555983|463169496|FG002|Overall Study|Withdrawal by Subject|0|||
129111617|NCT00048035|464703193|FG001|Extension Year 1|Early Withdrawals|0|||
128691549|NCT01555983|463169497|FG003|Overall Study|Withdrawal by Subject|0|||
129111618|NCT00048035|464703194|FG002|Extension Year 1|Early Withdrawals|0|||
129111619|NCT00048035|464703195|FG003|Extension Year 1|Early Withdrawals|0|||
129111620|NCT00048035|464703196|FG004|Extension Year 1|Early Withdrawals|0|||
129111621|NCT00048035|464703197|FG005|Extension Year 1|Early Withdrawals|0|||
129111622|NCT00048035|464703198|FG006|Extension Year 1|Early Withdrawals|11|||
128764465|NCT01874145|463428329|FG001|Extension Period|Withdrawal by Subject|1|||
129215236|NCT01588522|465089469|FG005|Overall Study|Taken off taxane-based regimen|0|||
129111623|NCT00048035|464703199|FG007|Extension Year 1|Early Withdrawals|11|||
129111624|NCT00048035|464703192|FG000|Extension Year 2|Early Withdrawals|0|||
129111625|NCT00048035|464703193|FG001|Extension Year 2|Early Withdrawals|0|||
129111626|NCT00048035|464703194|FG002|Extension Year 2|Early Withdrawals|0|||
129111627|NCT00048035|464703195|FG003|Extension Year 2|Early Withdrawals|0|||
129111628|NCT00048035|464703196|FG004|Extension Year 2|Early Withdrawals|0|||
129111629|NCT00048035|464703197|FG005|Extension Year 2|Early Withdrawals|0|||
129111630|NCT00048035|464703198|FG006|Extension Year 2|Early Withdrawals|3|||
129111631|NCT00048035|464703199|FG007|Extension Year 2|Early Withdrawals|3|||
129111632|NCT05137717|464703200|FG000|Overall Study|Death|2|||
129111633|NCT05137717|464703200|FG000|Overall Study|Withdrawal by Subject|6|||
129111634|NCT02035553|464703201|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
129111635|NCT02035553|464703202|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
129111636|NCT02035553|464703201|FG000|Overall Study|Adverse Event|10|||
129111637|NCT02035553|464703202|FG001|Overall Study|Adverse Event|6|||
129111638|NCT02035553|464703201|FG000|Overall Study|Physician Decision|3|||
129111639|NCT02035553|464703202|FG001|Overall Study|Physician Decision|2|||
129111640|NCT02035553|464703201|FG000|Overall Study|Lack of Efficacy|1|||
129111641|NCT02035553|464703202|FG001|Overall Study|Lack of Efficacy|1|||
129111642|NCT02035553|464703201|FG000|Overall Study|Withdrawal by Subject|4|||
129111643|NCT02035553|464703202|FG001|Overall Study|Withdrawal by Subject|7|||
129111644|NCT02035553|464703201|FG000|Overall Study|Non-compliance with Study Drug|0|||
129111645|NCT02035553|464703202|FG001|Overall Study|Non-compliance with Study Drug|1|||
129111646|NCT02035553|464703201|FG000|Overall Study|Lost to Follow-up|0|||
128764466|NCT01874145|463428328|FG000|Extension Period|Lost to Follow-up|1|||
128764467|NCT01874145|463428329|FG001|Extension Period|Lost to Follow-up|1|||
129215237|NCT01588522|465089464|FG000|Overall Study|Did not initiate chemotherapy|0|||
129215238|NCT01588522|465089465|FG001|Overall Study|Did not initiate chemotherapy|0|||
129021952|NCT01527006|464372503|FG001|Extension Phase|Other|3|||
129021953|NCT03247972|464372504|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
129021954|NCT03247972|464372504|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
129021955|NCT00123734|464372506|FG000|Overall Study|Death|3|||
129021956|NCT00123734|464372506|FG000|Overall Study|Lost to Follow-up|3|||
129021957|NCT00123734|464372506|FG000|Overall Study|Dropout|1|||
129021958|NCT00123734|464372506|FG000|Overall Study|Withdrawal by Subject|1|||
129021959|NCT01175018|464372508|FG000|Overall Study|Adverse Event|3|||
129021960|NCT01175018|464372509|FG001|Overall Study|Adverse Event|1|||
129021961|NCT00840073|464372513|FG000|Second Intervention|Missed 72 hour blood draw|1|||
129021962|NCT00840073|464372514|FG001|Second Intervention|Missed 72 hour blood draw|1|||
129021963|NCT02964039|464372518|FG000|Overall Study|Medical reason unrelated to study participation|1|||
129021964|NCT02964039|464372519|FG001|Overall Study|Medical reason unrelated to study participation|0|||
129021965|NCT02964039|464372520|FG002|Overall Study|Medical reason unrelated to study participation|3|||
129021966|NCT02964039|464372518|FG000|Overall Study|Research shutdown due to pandemic|2|||
129021967|NCT02964039|464372519|FG001|Overall Study|Research shutdown due to pandemic|0|||
129021968|NCT02964039|464372520|FG002|Overall Study|Research shutdown due to pandemic|1|||
129021969|NCT02964039|464372518|FG000|Overall Study|Withdrawal by Subject|0|||
129021970|NCT02964039|464372519|FG001|Overall Study|Withdrawal by Subject|1|||
129021971|NCT02964039|464372520|FG002|Overall Study|Withdrawal by Subject|0|||
129021972|NCT02964039|464372518|FG000|Overall Study|Lost to Follow-up|1|||
129021973|NCT02964039|464372519|FG001|Overall Study|Lost to Follow-up|0|||
129021974|NCT02964039|464372520|FG002|Overall Study|Lost to Follow-up|1|||
129021975|NCT01103713|464372524|FG000|Overall Study|Lost to Follow-up|2|||
129021976|NCT01103713|464372524|FG000|Overall Study|Withdrawal by Subject|8|||
129021977|NCT01103713|464372524|FG000|Overall Study|Study terminated by sponsor|2|||
129021978|NCT01103713|464372524|FG000|Overall Study|Other|1|||
129021979|NCT00505622|464372527|FG000|Overall Study|Adverse Event|5|||
129021980|NCT00505622|464372528|FG001|Overall Study|Adverse Event|6|||
129021981|NCT00505622|464372529|FG002|Overall Study|Adverse Event|4|||
129021982|NCT00505622|464372527|FG000|Overall Study|Protocol Violation|1|||
129021983|NCT00505622|464372528|FG001|Overall Study|Protocol Violation|1|||
129021984|NCT00505622|464372529|FG002|Overall Study|Protocol Violation|0|||
129111647|NCT02035553|464703202|FG001|Overall Study|Lost to Follow-up|1|||
129111648|NCT02035553|464703201|FG000|Overall Study|Other Reason|0|||
128764468|NCT00402337|463428334|FG000|Overall Study|Adverse Event|0|||
129021985|NCT00505622|464372527|FG000|Overall Study|Withdrawal by Subject|0|||
129021986|NCT00505622|464372528|FG001|Overall Study|Withdrawal by Subject|3|||
129021987|NCT00505622|464372529|FG002|Overall Study|Withdrawal by Subject|2|||
129021988|NCT00505622|464372527|FG000|Overall Study|Study termination by sponsor|115|||
129021989|NCT00505622|464372528|FG001|Overall Study|Study termination by sponsor|98|||
129111649|NCT02035553|464703202|FG001|Overall Study|Other Reason|4|||
129111650|NCT02735980|464703204|FG000|Overall Study|Adverse Event|0|||
129111651|NCT02735980|464703205|FG001|Overall Study|Adverse Event|4|||
129111652|NCT02735980|464703206|FG002|Overall Study|Adverse Event|1|||
129021990|NCT00505622|464372529|FG002|Overall Study|Study termination by sponsor|90|||
129021991|NCT03084471|464372532|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
129021992|NCT03084471|464372532|FG000|Overall Study|Condition under investigation worsened|84|||
129021993|NCT03084471|464372532|FG000|Overall Study|Lack of therapeutic response|2|||
129021994|NCT03084471|464372532|FG000|Overall Study|Protocol Violation|1|||
129021995|NCT03084471|464372532|FG000|Overall Study|Adverse Event|73|||
129021996|NCT03084471|464372532|FG000|Overall Study|Withdrawal by Subject|12|||
129021997|NCT03084471|464372532|FG000|Overall Study|Disease relapse|181|||
129021998|NCT03084471|464372532|FG000|Overall Study|Subjective disease progression|359|||
129021999|NCT03084471|464372532|FG000|Overall Study|Other (as recorded)|33|||
129022000|NCT03084471|464372532|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
129022001|NCT00796653|464372533|FG000|Overall Study|Adverse Event|19|||
129022002|NCT00796653|464372534|FG001|Overall Study|Adverse Event|16|||
129022003|NCT00796653|464372535|FG002|Overall Study|Adverse Event|16|||
129022004|NCT00796653|464372536|FG003|Overall Study|Adverse Event|16|||
129022005|NCT00796653|464372533|FG000|Overall Study|Lost to Follow-up|2|||
129022006|NCT00796653|464372534|FG001|Overall Study|Lost to Follow-up|1|||
129022007|NCT00796653|464372535|FG002|Overall Study|Lost to Follow-up|2|||
129022008|NCT00796653|464372536|FG003|Overall Study|Lost to Follow-up|3|||
129022009|NCT00796653|464372533|FG000|Overall Study|Withdrawal by Subject|16|||
129022010|NCT00796653|464372534|FG001|Overall Study|Withdrawal by Subject|8|||
129022011|NCT00796653|464372535|FG002|Overall Study|Withdrawal by Subject|8|||
129022012|NCT00796653|464372536|FG003|Overall Study|Withdrawal by Subject|13|||
129022013|NCT00796653|464372533|FG000|Overall Study|Lack of Efficacy|8|||
129022014|NCT00796653|464372534|FG001|Overall Study|Lack of Efficacy|1|||
129022015|NCT00796653|464372535|FG002|Overall Study|Lack of Efficacy|3|||
129022016|NCT00796653|464372536|FG003|Overall Study|Lack of Efficacy|2|||
129022017|NCT00796653|464372533|FG000|Overall Study|Non compliance with protocol|2|||
129022018|NCT00796653|464372534|FG001|Overall Study|Non compliance with protocol|2|||
129022019|NCT00796653|464372535|FG002|Overall Study|Non compliance with protocol|0|||
129022020|NCT00796653|464372536|FG003|Overall Study|Non compliance with protocol|2|||
129022021|NCT00796653|464372533|FG000|Overall Study|Other reason not described above|4|||
129022022|NCT00796653|464372534|FG001|Overall Study|Other reason not described above|9|||
129022023|NCT00796653|464372535|FG002|Overall Study|Other reason not described above|7|||
129022024|NCT00796653|464372536|FG003|Overall Study|Other reason not described above|4|||
129022025|NCT01848938|464372547|FG000|Overall Study|Lost to Follow-up|1|||
129022026|NCT01848938|464372548|FG001|Overall Study|Lost to Follow-up|1|||
129022027|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
129022028|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
129022029|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
129022030|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
129022031|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
129022032|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
129022033|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129022034|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129022035|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
129022036|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
129022037|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
129022038|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
129022039|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
129022040|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
129022041|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
129022042|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
129022043|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
129022044|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
129022045|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
129022046|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
129022047|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Death|0|||
129022048|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Death|1|||
129022049|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Death|0|||
129022050|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Death|0|||
129022051|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
129022052|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
128717829|NCT02587065|463264059|FG000|Overall Study|Adverse Event|14|||
128717830|NCT02587065|463264059|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
128717831|NCT02587065|463264059|FG000|Overall Study|Non-adherence to the Protocol|3|||
128717832|NCT02587065|463264059|FG000|Overall Study|Discontinuation of Study Medication|2|||
128717833|NCT02587065|463264059|FG000|Overall Study|Reason not Specified|3|||
128717834|NCT00445965|463264061|FG000|Overall Study|Adverse Event|2|||
128717835|NCT00445965|463264061|FG000|Overall Study|Physician Decision|1|||
128717836|NCT00445965|463264061|FG000|Overall Study|Enrolled but not treated|1|||
128717837|NCT00445965|463264061|FG000|Overall Study|Removed due to progressive disease|29|||
128895220|NCT00359021|463911664|FG001|Overall Study|Other|1|||
128895221|NCT00359021|463911663|FG000|Overall Study|Pregnancy|1|||
129022053|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
129022054|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
129022055|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
129022056|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
129022057|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
129022058|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
129022059|NCT01940341|464372549|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129022060|NCT01940341|464372550|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
129022061|NCT01940341|464372551|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129022062|NCT01940341|464372552|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129022063|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
129022064|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
129022065|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
129022066|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
129022067|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
129022068|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
129022069|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
129022070|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
129022071|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129022072|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129022073|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
129022074|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129022075|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
129022076|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
129022077|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
129022078|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
129022079|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129022080|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129022081|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
129022082|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129022083|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
129022084|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
129022085|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
129022086|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
129022087|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129022088|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129022089|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
129022090|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129022091|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129022092|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129022093|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129022094|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
129022095|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129022096|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129022097|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129022098|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
129022099|NCT01940341|464372549|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
129022100|NCT01940341|464372550|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
129022101|NCT01940341|464372551|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
129022102|NCT01940341|464372552|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
129022103|NCT01757392|464372555|FG000|Overall Study|Withdrawal by Subject|1|||
129022104|NCT01757392|464372555|FG000|Overall Study|Screen Fail|3|||
129022105|NCT00207090|464372560|FG000|Overall Study|Study drug toxicity|3|||
129022106|NCT00207090|464372560|FG000|Overall Study|Chest wall mass larger|1|||
129022107|NCT00207090|464372560|FG000|Overall Study|Disease progression/relapse|2|||
129022108|NCT00207090|464372560|FG000|Overall Study|Physician Decision|1|||
129022109|NCT00841698|464372563|FG000|First Intervention|Withdrawal by Subject|1|||
129022110|NCT00841698|464372564|FG001|First Intervention|Withdrawal by Subject|0|||
129022111|NCT00651820|464372575|FG000|Overall Study|Lost to Follow-up|2|||
129022112|NCT00773253|464372577|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
129022113|NCT00773253|464372578|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
129022114|NCT01878292|464372579|FG000|Randomized|Protocol Violation|1|||
128895222|NCT00359021|463911664|FG001|Overall Study|Pregnancy|0|||
128691550|NCT01555983|463169498|FG004|Overall Study|Withdrawal by Subject|1|||
128691551|NCT01555983|463169499|FG005|Overall Study|Withdrawal by Subject|1|||
128691552|NCT00385762|463170938|FG000|Overall Study|Adverse Event|1|||
128691553|NCT00385762|463170938|FG000|Overall Study|Lost to Follow-up|1|||
128691554|NCT02024529|463170945|FG000|Overall Study|Withdrawal by Subject|11|||
128691555|NCT02024529|463170946|FG001|Overall Study|Withdrawal by Subject|21|||
128691556|NCT02024529|463170945|FG000|Overall Study|Lost to Follow-up|2|||
128691557|NCT02024529|463170946|FG001|Overall Study|Lost to Follow-up|4|||
128895223|NCT01236573|463911665|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
128895224|NCT01236573|463911666|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
128895225|NCT01236573|463911667|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
128895226|NCT01236573|463911668|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
128895227|NCT01236573|463911669|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
128895228|NCT01236573|463911670|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129022115|NCT01878292|464372580|FG001|Randomized|Protocol Violation|0|||
129022116|NCT01878292|464372581|FG002|Randomized|Protocol Violation|0|||
129022117|NCT01878292|464372579|FG000|Randomized|Lost to Follow-up|1|||
129022118|NCT01878292|464372580|FG001|Randomized|Lost to Follow-up|0|||
129022119|NCT01878292|464372581|FG002|Randomized|Lost to Follow-up|0|||
129022120|NCT01878292|464372579|FG000|Randomized|Adverse Event|1|||
129022121|NCT01878292|464372580|FG001|Randomized|Adverse Event|0|||
129022122|NCT01878292|464372581|FG002|Randomized|Adverse Event|0|||
129022123|NCT01878292|464372579|FG000|Double-blind Treatment Period|Other Reasons|2|||
129022124|NCT01878292|464372580|FG001|Double-blind Treatment Period|Other Reasons|0|||
129022125|NCT01878292|464372581|FG002|Double-blind Treatment Period|Other Reasons|0|||
129022126|NCT01878292|464372579|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
129022127|NCT01878292|464372580|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
129022128|NCT01878292|464372581|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
129022129|NCT01878292|464372579|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
129022130|NCT01878292|464372580|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
129022131|NCT01878292|464372581|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
129022132|NCT01878292|464372579|FG000|Double-blind Treatment Period|Protocol Violation|3|||
129022133|NCT01878292|464372580|FG001|Double-blind Treatment Period|Protocol Violation|4|||
129022134|NCT01878292|464372581|FG002|Double-blind Treatment Period|Protocol Violation|2|||
129022135|NCT01878292|464372579|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
129022136|NCT01878292|464372580|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
129022137|NCT01878292|464372581|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
129022138|NCT01878292|464372579|FG000|Double-blind Treatment Period|Adverse Event|4|||
129022139|NCT01878292|464372580|FG001|Double-blind Treatment Period|Adverse Event|9|||
129022140|NCT01878292|464372581|FG002|Double-blind Treatment Period|Adverse Event|8|||
129022141|NCT01878292|464372579|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
129022142|NCT01878292|464372580|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
129022143|NCT01878292|464372581|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
129022144|NCT01249651|464372583|FG000|Overall Study|Withdrawal by Subject|4|||
129022145|NCT01249651|464372583|FG000|Overall Study|Adverse Event|1|||
129022146|NCT01249651|464372583|FG000|Overall Study|Protocol Violation|1|||
129022147|NCT01249651|464372583|FG000|Overall Study|Sponsor Decision|1|||
129022148|NCT02820350|464372584|FG000|Overall Study|Withdrawal by Subject|3|||
129022149|NCT02820350|464372584|FG000|Overall Study|Death|4|||
129022150|NCT03801707|464372587|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
129022151|NCT03873272|464372588|FG000|Overall Study|Withdrawal by Subject|2|||
129022152|NCT03873272|464372589|FG001|Overall Study|Withdrawal by Subject|0|||
129022153|NCT03873272|464372590|FG002|Overall Study|Withdrawal by Subject|1|||
129022154|NCT03873272|464372588|FG000|Overall Study|Death|0|||
129022155|NCT03873272|464372589|FG001|Overall Study|Death|2|||
129022156|NCT03873272|464372590|FG002|Overall Study|Death|1|||
129022157|NCT00787254|464372591|FG000|Overall Study|Adverse Event|24|||
129022158|NCT00787254|464372592|FG001|Overall Study|Adverse Event|23|||
129022159|NCT00787254|464372591|FG000|Overall Study|Protocol Violation|26|||
129022160|NCT00787254|464372592|FG001|Overall Study|Protocol Violation|23|||
129022161|NCT00787254|464372591|FG000|Overall Study|Withdrawal by Subject|16|||
129022162|NCT00787254|464372592|FG001|Overall Study|Withdrawal by Subject|11|||
129022163|NCT00787254|464372591|FG000|Overall Study|Lack of Efficacy|4|||
129022164|NCT00787254|464372592|FG001|Overall Study|Lack of Efficacy|15|||
129022165|NCT00787254|464372591|FG000|Overall Study|NSAIDs discontinuation|1|||
129022166|NCT00787254|464372592|FG001|Overall Study|NSAIDs discontinuation|2|||
129022167|NCT00787254|464372591|FG000|Overall Study|Institution closed|1|||
128764469|NCT00402337|463428335|FG001|Overall Study|Adverse Event|2|||
129022168|NCT00787254|464372592|FG001|Overall Study|Institution closed|0|||
129022169|NCT00787254|464372591|FG000|Overall Study|Physician Decision|4|||
129022170|NCT00787254|464372592|FG001|Overall Study|Physician Decision|8|||
128691558|NCT00354614|463170947|FG000|Overall Study|Lack of Efficacy|28|||
129022171|NCT04852978|464372597|FG000|Overall Study|Physician Decision|0|||
128691559|NCT01134731|463170948|FG000|Overall Study|Adverse Event|3|||
128764470|NCT00402337|463428336|FG002|Overall Study|Adverse Event|2|||
128764471|NCT00402337|463428337|FG003|Overall Study|Adverse Event|3|||
128764472|NCT00402337|463428338|FG004|Overall Study|Adverse Event|2|||
128764473|NCT00402337|463428334|FG000|Overall Study|Noncompliance|0|||
128764474|NCT00402337|463428335|FG001|Overall Study|Noncompliance|0|||
128764475|NCT00402337|463428336|FG002|Overall Study|Noncompliance|0|||
128764476|NCT00402337|463428337|FG003|Overall Study|Noncompliance|0|||
128764477|NCT00402337|463428338|FG004|Overall Study|Noncompliance|2|||
128764478|NCT00402337|463428334|FG000|Overall Study|Withdrawal by Subject|5|||
128764479|NCT00402337|463428335|FG001|Overall Study|Withdrawal by Subject|3|||
128764480|NCT00402337|463428336|FG002|Overall Study|Withdrawal by Subject|1|||
128764481|NCT00402337|463428337|FG003|Overall Study|Withdrawal by Subject|6|||
128764482|NCT00402337|463428338|FG004|Overall Study|Withdrawal by Subject|4|||
129022172|NCT04852978|464372598|FG001|Overall Study|Physician Decision|1|||
129022173|NCT04852978|464372599|FG002|Overall Study|Physician Decision|0|||
129022174|NCT04852978|464372600|FG003|Overall Study|Physician Decision|0|||
129022175|NCT04852978|464372601|FG004|Overall Study|Physician Decision|0|||
129022176|NCT04852978|464372602|FG005|Overall Study|Physician Decision|0|||
129022177|NCT04852978|464372603|FG006|Overall Study|Physician Decision|0|||
129022178|NCT04852978|464372604|FG007|Overall Study|Physician Decision|2|||
129022179|NCT04852978|464372605|FG008|Overall Study|Physician Decision|0|||
129022180|NCT04852978|464372597|FG000|Overall Study|Sponsor request|0|||
129022181|NCT04852978|464372598|FG001|Overall Study|Sponsor request|0|||
129022182|NCT04852978|464372599|FG002|Overall Study|Sponsor request|1|||
129022183|NCT04852978|464372600|FG003|Overall Study|Sponsor request|0|||
129022184|NCT04852978|464372601|FG004|Overall Study|Sponsor request|0|||
129022185|NCT04852978|464372602|FG005|Overall Study|Sponsor request|0|||
129022186|NCT04852978|464372603|FG006|Overall Study|Sponsor request|0|||
129022187|NCT04852978|464372604|FG007|Overall Study|Sponsor request|0|||
129022188|NCT04852978|464372605|FG008|Overall Study|Sponsor request|0|||
129022189|NCT04852978|464372597|FG000|Overall Study|Death|0|||
129022190|NCT04852978|464372598|FG001|Overall Study|Death|0|||
129022191|NCT04852978|464372599|FG002|Overall Study|Death|0|||
129022192|NCT04852978|464372600|FG003|Overall Study|Death|0|||
129022193|NCT04852978|464372601|FG004|Overall Study|Death|0|||
129022194|NCT04852978|464372602|FG005|Overall Study|Death|0|||
129022195|NCT04852978|464372603|FG006|Overall Study|Death|1|||
129022196|NCT04852978|464372604|FG007|Overall Study|Death|0|||
129022197|NCT04852978|464372605|FG008|Overall Study|Death|0|||
129022198|NCT04852978|464372597|FG000|Overall Study|Lost to Follow-up|3|||
129022199|NCT04852978|464372598|FG001|Overall Study|Lost to Follow-up|2|||
129022200|NCT04852978|464372599|FG002|Overall Study|Lost to Follow-up|2|||
129022201|NCT04852978|464372600|FG003|Overall Study|Lost to Follow-up|0|||
129022202|NCT04852978|464372601|FG004|Overall Study|Lost to Follow-up|2|||
129022203|NCT04852978|464372602|FG005|Overall Study|Lost to Follow-up|4|||
129022204|NCT04852978|464372603|FG006|Overall Study|Lost to Follow-up|1|||
129022205|NCT04852978|464372604|FG007|Overall Study|Lost to Follow-up|2|||
129022206|NCT04852978|464372605|FG008|Overall Study|Lost to Follow-up|2|||
129022207|NCT04852978|464372597|FG000|Overall Study|Withdrawal by Subject|4|||
129022208|NCT04852978|464372598|FG001|Overall Study|Withdrawal by Subject|2|||
129022209|NCT04852978|464372599|FG002|Overall Study|Withdrawal by Subject|2|||
129022210|NCT04852978|464372600|FG003|Overall Study|Withdrawal by Subject|1|||
129022211|NCT04852978|464372601|FG004|Overall Study|Withdrawal by Subject|5|||
129022212|NCT04852978|464372602|FG005|Overall Study|Withdrawal by Subject|3|||
129022213|NCT04852978|464372603|FG006|Overall Study|Withdrawal by Subject|2|||
129022214|NCT04852978|464372604|FG007|Overall Study|Withdrawal by Subject|2|||
129022215|NCT04852978|464372605|FG008|Overall Study|Withdrawal by Subject|1|||
129022216|NCT00859430|464372606|FG000|First Intervention|Withdrawal by Subject|0|||
129022217|NCT00859430|464372607|FG001|First Intervention|Withdrawal by Subject|1|||
129022218|NCT03635320|464374570|FG000|Overall Study|not implanted the device|1|||
129022219|NCT03635320|464374571|FG001|Overall Study|not implanted the device|2|||
129022220|NCT03635320|464374570|FG000|Overall Study|Withdrawal by Subject|11|||
129022221|NCT03635320|464374571|FG001|Overall Study|Withdrawal by Subject|6|||
129022222|NCT00835575|464374574|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
129022223|NCT00835575|464374575|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
129022224|NCT01609257|464374576|FG000|Overall Study|Lost to Follow-up|2|||
129022225|NCT01609257|464374577|FG001|Overall Study|Lost to Follow-up|1|||
129022226|NCT01609257|464374576|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
129022227|NCT01609257|464374577|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
129022228|NCT01609257|464374576|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
129022229|NCT01609257|464374577|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
129022230|NCT02125461|464374580|FG000|Overall Study|Withdrawal by Subject|30|||
129022231|NCT02125461|464374581|FG001|Overall Study|Withdrawal by Subject|16|||
129022232|NCT02125461|464374580|FG000|Overall Study|Lost to Follow-up|8|||
129022233|NCT02125461|464374581|FG001|Overall Study|Lost to Follow-up|3|||
129022234|NCT02125461|464374580|FG000|Overall Study|Death|260|||
129022235|NCT02125461|464374581|FG001|Overall Study|Death|149|||
129022236|NCT02125461|464374580|FG000|Overall Study|Missing Termination Reason|0|||
129022237|NCT02125461|464374581|FG001|Overall Study|Missing Termination Reason|1|||
128895229|NCT01236573|463911671|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
128895230|NCT01236573|463911672|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129022238|NCT01158118|464374585|FG000|Overall Study|Screen failure|1|||
129022239|NCT01158118|464374586|FG001|Overall Study|Screen failure|0|||
129022240|NCT01158118|464374585|FG000|Overall Study|Donor match was a screen failure|0|||
129022241|NCT01158118|464374586|FG001|Overall Study|Donor match was a screen failure|1|||
129022242|NCT01158118|464374585|FG000|Overall Study|Suffered stroke prior to transplant|0|||
129022243|NCT01158118|464374586|FG001|Overall Study|Suffered stroke prior to transplant|1|||
129022244|NCT01158118|464374585|FG000|Overall Study|Death|0|||
129022245|NCT01158118|464374586|FG001|Overall Study|Death|1|||
129022246|NCT04994535|464374587|FG000|Overall Study|Lost to Follow-up|7|||
129022247|NCT04994535|464374588|FG001|Overall Study|Lost to Follow-up|7|||
129022248|NCT04994535|464374587|FG000|Overall Study|Withdrawal by Subject|10|||
129022249|NCT04994535|464374588|FG001|Overall Study|Withdrawal by Subject|7|||
129022250|NCT04994535|464374587|FG000|Overall Study|Other|1|||
129022251|NCT04994535|464374588|FG001|Overall Study|Other|1|||
129022252|NCT01015287|464374589|FG000|Overall Study|Death|21|||
129022253|NCT01015287|464374590|FG001|Overall Study|Death|16|||
129022254|NCT01015287|464374589|FG000|Overall Study|Adverse Event|1|||
129022255|NCT01015287|464374590|FG001|Overall Study|Adverse Event|0|||
129022256|NCT01015287|464374589|FG000|Overall Study|Sponsor Decision|3|||
129022257|NCT01015287|464374590|FG001|Overall Study|Sponsor Decision|7|||
129022258|NCT01015287|464374589|FG000|Overall Study|Physician Decision|19|||
129022259|NCT01015287|464374590|FG001|Overall Study|Physician Decision|21|||
129022260|NCT01015287|464374589|FG000|Overall Study|Withdrawal by Subject|14|||
129022261|NCT01015287|464374590|FG001|Overall Study|Withdrawal by Subject|19|||
129022262|NCT01015287|464374589|FG000|Overall Study|Entry Criteria not Met|11|||
129022263|NCT01015287|464374590|FG001|Overall Study|Entry Criteria not Met|14|||
129022264|NCT01015287|464374589|FG000|Overall Study|Lost to Follow-up|2|||
129022265|NCT01015287|464374590|FG001|Overall Study|Lost to Follow-up|1|||
129022266|NCT01015287|464374589|FG000|Overall Study|Protocol Violation|1|||
129022267|NCT01015287|464374590|FG001|Overall Study|Protocol Violation|1|||
129022268|NCT00469898|464374591|FG000|Overall Study|Adverse Event|7|||
129022269|NCT00469898|464374591|FG000|Overall Study|Withdrawal by Subject|4|||
129022270|NCT00469898|464374591|FG000|Overall Study|Death|4|||
129022271|NCT00469898|464374591|FG000|Overall Study|Disease progression|9|||
129022272|NCT00469898|464374591|FG000|Overall Study|Decreased performance status|1|||
129022273|NCT01370317|464374592|FG000|Overall Study|Participant withdrew consent|1|||
129022274|NCT01370317|464374593|FG001|Overall Study|Participant withdrew consent|0|||
129022275|NCT01370317|464374592|FG000|Overall Study|Protocol deviation|0|||
129022276|NCT01370317|464374593|FG001|Overall Study|Protocol deviation|1|||
129022277|NCT00113386|464374600|FG000|Overall Study|Withdrawal by Subject|1|||
129022278|NCT00113386|464374601|FG001|Overall Study|Withdrawal by Subject|0|||
129022279|NCT00113386|464374600|FG000|Overall Study|Physician Decision|0|||
129022280|NCT00113386|464374601|FG001|Overall Study|Physician Decision|1|||
129022281|NCT00113386|464374600|FG000|Overall Study|Toxicity|3|||
129022282|NCT00113386|464374601|FG001|Overall Study|Toxicity|0|||
129022283|NCT00113386|464374600|FG000|Overall Study|Ineligible|1|||
129022284|NCT00113386|464374601|FG001|Overall Study|Ineligible|2|||
129022285|NCT00113386|464374600|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
129022286|NCT00113386|464374601|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
129022287|NCT00834340|464374602|FG000|Washout|Adverse Event|1|||
129022288|NCT00834340|464374603|FG001|Washout|Adverse Event|0|||
129022289|NCT00834340|464374602|FG000|Washout|Withdrawal by Subject|1|||
129022290|NCT00834340|464374603|FG001|Washout|Withdrawal by Subject|0|||
129022291|NCT02849457|464374606|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
129022292|NCT02849457|464374607|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
129022293|NCT02849457|464374608|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
129022294|NCT02849457|464374609|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
129022295|NCT03673670|464374612|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
129022296|NCT03673670|464374613|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129022297|NCT03673670|464374614|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129022298|NCT03673670|464374615|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129022299|NCT03673670|464374616|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129022300|NCT03673670|464374617|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129022301|NCT03673670|464374612|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
129022302|NCT03673670|464374613|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
129022303|NCT03673670|464374614|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
129022304|NCT03673670|464374615|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
129022305|NCT03673670|464374616|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
129022306|NCT03673670|464374617|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
129022307|NCT03673670|464374612|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
129022308|NCT03673670|464374613|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
129111653|NCT02735980|464703204|FG000|Overall Study|Death|5|||
129111654|NCT02735980|464703205|FG001|Overall Study|Death|4|||
129111655|NCT02735980|464703206|FG002|Overall Study|Death|0|||
129111656|NCT02735980|464703204|FG000|Overall Study|Physician Decision|3|||
129111657|NCT02735980|464703205|FG001|Overall Study|Physician Decision|1|||
129111658|NCT02735980|464703206|FG002|Overall Study|Physician Decision|0|||
129111659|NCT02735980|464703204|FG000|Overall Study|Screen failure|1|||
129111660|NCT02735980|464703205|FG001|Overall Study|Screen failure|0|||
129111661|NCT02735980|464703206|FG002|Overall Study|Screen failure|0|||
129111662|NCT02735980|464703204|FG000|Overall Study|Withdrawal by Subject|1|||
129111663|NCT02735980|464703205|FG001|Overall Study|Withdrawal by Subject|2|||
129111664|NCT02735980|464703206|FG002|Overall Study|Withdrawal by Subject|0|||
129111665|NCT00509899|464703207|FG000|Overall Study|Progressive disease|1|||
129111666|NCT00509899|464703208|FG001|Overall Study|Progressive disease|3|||
129111667|NCT00509899|464703209|FG002|Overall Study|Progressive disease|5|||
129111668|NCT00509899|464703210|FG003|Overall Study|Progressive disease|1|||
129111669|NCT00509899|464703211|FG004|Overall Study|Progressive disease|0|||
129111670|NCT00509899|464703212|FG005|Overall Study|Progressive disease|1|||
129111671|NCT00509899|464703213|FG006|Overall Study|Progressive disease|0|||
129111672|NCT00509899|464703214|FG007|Overall Study|Progressive disease|0|||
129111673|NCT00509899|464703207|FG000|Overall Study|Unacceptable Toxicity|1|||
129111674|NCT00509899|464703208|FG001|Overall Study|Unacceptable Toxicity|0|||
129111675|NCT00509899|464703209|FG002|Overall Study|Unacceptable Toxicity|0|||
129111676|NCT00509899|464703210|FG003|Overall Study|Unacceptable Toxicity|2|||
129111677|NCT00509899|464703211|FG004|Overall Study|Unacceptable Toxicity|0|||
129111678|NCT00509899|464703212|FG005|Overall Study|Unacceptable Toxicity|0|||
129111679|NCT00509899|464703213|FG006|Overall Study|Unacceptable Toxicity|0|||
129111680|NCT00509899|464703214|FG007|Overall Study|Unacceptable Toxicity|0|||
129111681|NCT00509899|464703207|FG000|Overall Study|Withdrawal by Subject|6|||
129111682|NCT00509899|464703208|FG001|Overall Study|Withdrawal by Subject|2|||
129111683|NCT00509899|464703209|FG002|Overall Study|Withdrawal by Subject|3|||
129111684|NCT00509899|464703210|FG003|Overall Study|Withdrawal by Subject|0|||
129111685|NCT00509899|464703211|FG004|Overall Study|Withdrawal by Subject|3|||
129111686|NCT00509899|464703212|FG005|Overall Study|Withdrawal by Subject|2|||
129111687|NCT00509899|464703213|FG006|Overall Study|Withdrawal by Subject|0|||
129111688|NCT00509899|464703214|FG007|Overall Study|Withdrawal by Subject|0|||
129111689|NCT00509899|464703207|FG000|Overall Study|Physician Decision|4|||
129111690|NCT00509899|464703208|FG001|Overall Study|Physician Decision|2|||
129111691|NCT00509899|464703209|FG002|Overall Study|Physician Decision|7|||
129111692|NCT00509899|464703210|FG003|Overall Study|Physician Decision|0|||
129111693|NCT00509899|464703211|FG004|Overall Study|Physician Decision|1|||
129111694|NCT00509899|464703212|FG005|Overall Study|Physician Decision|4|||
129111695|NCT00509899|464703213|FG006|Overall Study|Physician Decision|0|||
129111696|NCT00509899|464703214|FG007|Overall Study|Physician Decision|0|||
129111697|NCT00509899|464703207|FG000|Overall Study|Intercurrent Illness|1|||
129111698|NCT00509899|464703208|FG001|Overall Study|Intercurrent Illness|0|||
129111699|NCT00509899|464703209|FG002|Overall Study|Intercurrent Illness|0|||
129111700|NCT00509899|464703210|FG003|Overall Study|Intercurrent Illness|1|||
129111701|NCT00509899|464703211|FG004|Overall Study|Intercurrent Illness|0|||
129111702|NCT00509899|464703212|FG005|Overall Study|Intercurrent Illness|1|||
129111703|NCT00509899|464703213|FG006|Overall Study|Intercurrent Illness|0|||
129111704|NCT00509899|464703214|FG007|Overall Study|Intercurrent Illness|0|||
129111705|NCT00509899|464703207|FG000|Overall Study|Death|2|||
129111706|NCT00509899|464703208|FG001|Overall Study|Death|2|||
129111707|NCT00509899|464703209|FG002|Overall Study|Death|3|||
129111708|NCT00509899|464703210|FG003|Overall Study|Death|0|||
129111709|NCT00509899|464703211|FG004|Overall Study|Death|1|||
129111710|NCT00509899|464703212|FG005|Overall Study|Death|1|||
129111711|NCT00509899|464703213|FG006|Overall Study|Death|1|||
129111712|NCT00509899|464703214|FG007|Overall Study|Death|1|||
129111713|NCT00509899|464703207|FG000|Overall Study|Lack of Efficacy|1|||
129111714|NCT00509899|464703208|FG001|Overall Study|Lack of Efficacy|0|||
129111715|NCT00509899|464703209|FG002|Overall Study|Lack of Efficacy|2|||
128691560|NCT01134731|463170949|FG001|Overall Study|Adverse Event|2|||
129111716|NCT00509899|464703210|FG003|Overall Study|Lack of Efficacy|0|||
129111717|NCT00509899|464703211|FG004|Overall Study|Lack of Efficacy|0|||
129111718|NCT00509899|464703212|FG005|Overall Study|Lack of Efficacy|1|||
129111719|NCT00509899|464703213|FG006|Overall Study|Lack of Efficacy|0|||
129111720|NCT00509899|464703214|FG007|Overall Study|Lack of Efficacy|0|||
129111721|NCT03713684|464703215|FG000|Overall Study|Adverse Event|1|||
129111722|NCT03713684|464703216|FG001|Overall Study|Adverse Event|3|||
129111723|NCT03713684|464703217|FG002|Overall Study|Adverse Event|1|||
129111724|NCT03713684|464703218|FG003|Overall Study|Adverse Event|0|||
129111725|NCT03713684|464703215|FG000|Overall Study|Poor compliance to protocol|2|||
129111726|NCT03713684|464703216|FG001|Overall Study|Poor compliance to protocol|1|||
129111727|NCT03713684|464703217|FG002|Overall Study|Poor compliance to protocol|0|||
129111728|NCT03713684|464703218|FG003|Overall Study|Poor compliance to protocol|1|||
129111729|NCT03713684|464703215|FG000|Overall Study|Withdrawal by Subject|14|||
129111730|NCT03713684|464703216|FG001|Overall Study|Withdrawal by Subject|6|||
129111731|NCT03713684|464703217|FG002|Overall Study|Withdrawal by Subject|14|||
129111732|NCT03713684|464703218|FG003|Overall Study|Withdrawal by Subject|16|||
129111733|NCT03713684|464703215|FG000|Overall Study|Other than specified|69|||
129111734|NCT03713684|464703216|FG001|Overall Study|Other than specified|77|||
129111735|NCT03713684|464703217|FG002|Overall Study|Other than specified|73|||
129111736|NCT03713684|464703218|FG003|Overall Study|Other than specified|70|||
129111737|NCT02185417|464703219|FG000|Overall Study|Death|448|||
129111738|NCT02185417|464703220|FG001|Overall Study|Death|446|||
129111739|NCT02185417|464703221|FG002|Overall Study|Death|0|||
129111740|NCT02185417|464703219|FG000|Overall Study|Withdrawal by Subject|7|||
129111741|NCT02185417|464703220|FG001|Overall Study|Withdrawal by Subject|12|||
129111742|NCT02185417|464703221|FG002|Overall Study|Withdrawal by Subject|0|||
129111743|NCT02595502|464703222|FG000|Period 1|Adverse Event|0|||
129111744|NCT02595502|464703223|FG001|Period 1|Adverse Event|1|||
129111745|NCT02595502|464703222|FG000|Period 1|Withdrawal by Subject|1|||
129111746|NCT02595502|464703223|FG001|Period 1|Withdrawal by Subject|0|||
129111747|NCT02595502|464703222|FG000|Period 1|Lost to Follow-up|0|||
129111748|NCT02595502|464703223|FG001|Period 1|Lost to Follow-up|1|||
129111749|NCT02595502|464703222|FG000|Period 2|Adverse Event|1|||
129111750|NCT02595502|464703223|FG001|Period 2|Adverse Event|1|||
129111751|NCT02595502|464703222|FG000|Period 2|Received incorrect lens at Period 1|0|||
129111752|NCT02595502|464703223|FG001|Period 2|Received incorrect lens at Period 1|1|||
129111753|NCT02595502|464703222|FG000|Period 3|Protocol Violation|0|||
129111754|NCT02595502|464703223|FG001|Period 3|Protocol Violation|1|||
129111755|NCT02595502|464703222|FG000|Period 3|Lost to Follow-up|1|||
129111756|NCT02595502|464703223|FG001|Period 3|Lost to Follow-up|0|||
129111757|NCT02595502|464703222|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
129111758|NCT02595502|464703223|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
129111759|NCT00974311|464703224|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
129111760|NCT00974311|464703225|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
129111761|NCT00974311|464703224|FG000|DB Phase (up to 24 Months)|Death|561|||
129111762|NCT00974311|464703225|FG001|DB Phase (up to 24 Months)|Death|298|||
129111763|NCT00974311|464703224|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
129111764|NCT00974311|464703225|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
129111765|NCT00974311|464703224|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
129111766|NCT00974311|464703225|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
129111767|NCT00974311|464703224|FG000|DB Phase (up to 24 Months)|Other|1|||
129111768|NCT00974311|464703225|FG001|DB Phase (up to 24 Months)|Other|0|||
129111769|NCT00974311|464703224|FG000|OLE Phase (up to 77 Months)|Death|14|||
129111770|NCT00974311|464703225|FG001|OLE Phase (up to 77 Months)|Death|21|||
129111771|NCT00974311|464703224|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
129111772|NCT00974311|464703225|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
129111773|NCT00974311|464703224|FG000|OLE Phase (up to 77 Months)|Other|15|||
129111774|NCT00974311|464703225|FG001|OLE Phase (up to 77 Months)|Other|2|||
129111775|NCT00974311|464703224|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
129111776|NCT00974311|464703225|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
129111777|NCT05556148|464703226|FG000|Overall Study|Early Termination|29|||
129111778|NCT05556148|464703226|FG000|Overall Study|Baseline Tasks Expired|4|||
129111779|NCT05556148|464703226|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
129111780|NCT05556148|464703226|FG000|Overall Study|No Longer Wished to Participate|1|||
129111781|NCT05556148|464703226|FG000|Overall Study|Bacterial Conjunctivitis|1|||
129111782|NCT00458003|464703227|FG000|Overall Study|Non protocol spinal anesthesia|1|||
129111783|NCT00458003|464703228|FG001|Overall Study|Non protocol spinal anesthesia|1|||
129111784|NCT00809445|464703229|FG000|1 Month Follow-up|Lost contact|1|||
129111785|NCT00809445|464703230|FG001|1 Month Follow-up|Lost contact|2|||
129111786|NCT00809445|464703231|FG002|1 Month Follow-up|Lost contact|1|||
129111787|NCT00809445|464703229|FG000|1 Month Follow-up|Withdrew consent|1|||
129111788|NCT00809445|464703230|FG001|1 Month Follow-up|Withdrew consent|1|||
129111789|NCT00809445|464703231|FG002|1 Month Follow-up|Withdrew consent|1|||
128691561|NCT01134731|463170950|FG002|Overall Study|Adverse Event|1|||
128895231|NCT01236573|463911673|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
128895232|NCT01236573|463911674|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
128895233|NCT01236573|463911675|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
128895234|NCT01236573|463911665|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895235|NCT01236573|463911666|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129111790|NCT00809445|464703229|FG000|1 Month Follow-up|Death|0|||
129111791|NCT00809445|464703230|FG001|1 Month Follow-up|Death|1|||
129111792|NCT00809445|464703231|FG002|1 Month Follow-up|Death|1|||
129111793|NCT00809445|464703229|FG000|1 Month Follow-up|Incarcerated|0|||
129111794|NCT00809445|464703230|FG001|1 Month Follow-up|Incarcerated|0|||
129111795|NCT00809445|464703231|FG002|1 Month Follow-up|Incarcerated|1|||
129111796|NCT00809445|464703229|FG000|6 Month Follow-up|Lost contact|16|||
129111797|NCT00809445|464703230|FG001|6 Month Follow-up|Lost contact|14|||
129111798|NCT00809445|464703231|FG002|6 Month Follow-up|Lost contact|14|||
129111799|NCT00809445|464703229|FG000|6 Month Follow-up|Death|2|||
129111800|NCT00809445|464703230|FG001|6 Month Follow-up|Death|1|||
129111801|NCT00809445|464703231|FG002|6 Month Follow-up|Death|1|||
129111802|NCT00809445|464703229|FG000|6 Month Follow-up|Incarcerated|6|||
129111803|NCT00809445|464703230|FG001|6 Month Follow-up|Incarcerated|8|||
129111804|NCT00809445|464703231|FG002|6 Month Follow-up|Incarcerated|8|||
129111805|NCT00809445|464703229|FG000|6 Month Follow-up|Withdrew consent|0|||
129111806|NCT00809445|464703230|FG001|6 Month Follow-up|Withdrew consent|0|||
129111807|NCT00809445|464703231|FG002|6 Month Follow-up|Withdrew consent|1|||
129111808|NCT02048722|464703232|FG000|2 Cycles of Treatment|Adverse Event|2|||
129111809|NCT02048722|464703232|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
129111810|NCT02048722|464703232|FG000|2 Cycles of Treatment|Progressive Disease|2|||
129111811|NCT02048722|464703232|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
129111812|NCT02048722|464703232|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
129111813|NCT02048722|464703232|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
129111814|NCT01272908|464703235|FG000|Initial Treatment Period|Adverse Event|1|||
129111815|NCT01272908|464703235|FG000|Initial Treatment Period|Lack of Efficacy|5|||
129111816|NCT01272908|464703235|FG000|Initial Treatment Period|Protocol Violation|1|||
129111817|NCT01272908|464703235|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
129111818|NCT01272908|464703235|FG000|Re-Treatment Period|Adverse Event|2|||
129111819|NCT01272908|464703235|FG000|Re-Treatment Period|Lack of Efficacy|3|||
129111820|NCT01272908|464703235|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
129111821|NCT03489343|464703236|FG000|Overall Study|Documented progressive disease|1|||
129111822|NCT03489343|464703237|FG001|Overall Study|Documented progressive disease|0|||
129111823|NCT03489343|464703238|FG002|Overall Study|Documented progressive disease|3|||
129111824|NCT03489343|464703239|FG003|Overall Study|Documented progressive disease|1|||
129111825|NCT03489343|464703240|FG004|Overall Study|Documented progressive disease|3|||
129111826|NCT03489343|464703241|FG005|Overall Study|Documented progressive disease|5|||
129111827|NCT03489343|464703242|FG006|Overall Study|Documented progressive disease|4|||
129111828|NCT03489343|464703236|FG000|Overall Study|Adverse Event|0|||
129111829|NCT03489343|464703237|FG001|Overall Study|Adverse Event|1|||
129111830|NCT03489343|464703238|FG002|Overall Study|Adverse Event|0|||
129111831|NCT03489343|464703239|FG003|Overall Study|Adverse Event|0|||
129111832|NCT03489343|464703240|FG004|Overall Study|Adverse Event|0|||
129111833|NCT03489343|464703241|FG005|Overall Study|Adverse Event|1|||
129111834|NCT03489343|464703242|FG006|Overall Study|Adverse Event|0|||
129111835|NCT03489343|464703236|FG000|Overall Study|Withdrawal by Subject|0|||
129111836|NCT03489343|464703237|FG001|Overall Study|Withdrawal by Subject|0|||
129111837|NCT03489343|464703238|FG002|Overall Study|Withdrawal by Subject|0|||
129111838|NCT03489343|464703239|FG003|Overall Study|Withdrawal by Subject|1|||
129111839|NCT03489343|464703240|FG004|Overall Study|Withdrawal by Subject|0|||
129111840|NCT03489343|464703241|FG005|Overall Study|Withdrawal by Subject|1|||
129111841|NCT03489343|464703242|FG006|Overall Study|Withdrawal by Subject|1|||
129111842|NCT03489343|464703236|FG000|Overall Study|Clinical progression|0|||
129111843|NCT03489343|464703237|FG001|Overall Study|Clinical progression|0|||
129111844|NCT03489343|464703238|FG002|Overall Study|Clinical progression|0|||
129111845|NCT03489343|464703239|FG003|Overall Study|Clinical progression|1|||
129111846|NCT03489343|464703240|FG004|Overall Study|Clinical progression|0|||
129111847|NCT03489343|464703241|FG005|Overall Study|Clinical progression|0|||
129111848|NCT03489343|464703242|FG006|Overall Study|Clinical progression|1|||
129111849|NCT01158261|464703243|FG000|Overall Study|Lost to Follow-up|9|||
129111850|NCT01158261|464703243|FG000|Overall Study|Death|7|||
129111851|NCT01158261|464703243|FG000|Overall Study|Withdrawal by Subject|1|||
129111852|NCT03143101|464703244|FG000|Overall Study|Withdrawal by Subject|0|||
129111853|NCT03143101|464703245|FG001|Overall Study|Withdrawal by Subject|1|||
129111854|NCT03143101|464703246|FG002|Overall Study|Withdrawal by Subject|0|||
129111855|NCT03143101|464703244|FG000|Overall Study|Lost to Follow-up|2|||
129111856|NCT03143101|464703245|FG001|Overall Study|Lost to Follow-up|2|||
129111857|NCT03143101|464703246|FG002|Overall Study|Lost to Follow-up|0|||
129111858|NCT01630135|464703248|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
129111859|NCT01630135|464703249|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
129111860|NCT05227118|464703252|FG000|Overall Study|Adverse Event|0|||
129111861|NCT05227118|464703253|FG001|Overall Study|Adverse Event|0|||
129111862|NCT05227118|464703254|FG002|Overall Study|Adverse Event|1|||
129111863|NCT05227118|464703255|FG003|Overall Study|Adverse Event|0|||
129111864|NCT05227118|464703252|FG000|Overall Study|Withdrawal by Subject|0|||
129111865|NCT05227118|464703253|FG001|Overall Study|Withdrawal by Subject|0|||
129111866|NCT05227118|464703254|FG002|Overall Study|Withdrawal by Subject|2|||
129111867|NCT05227118|464703255|FG003|Overall Study|Withdrawal by Subject|0|||
129111868|NCT03727841|464703261|FG000|Overall Study|Physician Decision|3|||
128691562|NCT01134731|463170948|FG000|Overall Study|Physician Decision|2|||
128895236|NCT01236573|463911667|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129111869|NCT03727841|464703262|FG001|Overall Study|Physician Decision|1|||
129111870|NCT01601496|464703263|FG000|Overall Study|Physician Decision|1|||
129111871|NCT01601496|464703263|FG000|Overall Study|Withdrawal by Subject|1|||
129111872|NCT01601496|464703263|FG000|Overall Study|Lost to Follow-up|6|||
129111873|NCT01601496|464703263|FG000|Overall Study|Death|4|||
129111874|NCT01601496|464703263|FG000|Overall Study|Other: patient refusal to continue|3|||
129111875|NCT03243305|464703264|FG000|Overall Study|Lost to Follow-up|250|||
129022309|NCT03673670|464374614|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
129022310|NCT03673670|464374615|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
129022311|NCT03673670|464374616|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
129022312|NCT03673670|464374617|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
129022313|NCT03673670|464374612|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129022314|NCT03673670|464374613|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129022315|NCT03673670|464374614|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129022316|NCT03673670|464374615|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129022317|NCT03673670|464374616|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129022318|NCT03673670|464374617|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
129022319|NCT03673670|464374612|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
129022320|NCT03673670|464374613|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
129022321|NCT03673670|464374614|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
129022322|NCT03673670|464374615|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
129022323|NCT03673670|464374616|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
129022324|NCT03673670|464374617|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
129022325|NCT03673670|464374612|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129022326|NCT03673670|464374613|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129022327|NCT03673670|464374614|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129022328|NCT03673670|464374615|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129022329|NCT03673670|464374616|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
129022330|NCT03673670|464374617|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129022331|NCT03673670|464374612|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
129022332|NCT03673670|464374613|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
129022333|NCT03673670|464374614|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
129022334|NCT03673670|464374615|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
129022335|NCT03673670|464374616|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
129022336|NCT03673670|464374617|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
129022337|NCT04238754|464374620|FG000|Washout - 1 Week|Lost to Follow-up|1|||
129022338|NCT04238754|464374621|FG001|Washout - 1 Week|Lost to Follow-up|0|||
129022339|NCT03733444|464374626|FG000|Overall Study|Adverse Event|8|||
129022340|NCT03733444|464374627|FG001|Overall Study|Adverse Event|10|||
129022341|NCT03733444|464374628|FG002|Overall Study|Adverse Event|5|||
129022342|NCT03733444|464374626|FG000|Overall Study|Death|20|||
129022343|NCT03733444|464374627|FG001|Overall Study|Death|19|||
129022344|NCT03733444|464374628|FG002|Overall Study|Death|11|||
129022345|NCT03733444|464374626|FG000|Overall Study|Lost to Follow-up|3|||
129022346|NCT03733444|464374627|FG001|Overall Study|Lost to Follow-up|0|||
129022347|NCT03733444|464374628|FG002|Overall Study|Lost to Follow-up|1|||
129022348|NCT03733444|464374626|FG000|Overall Study|Lack of Efficacy|0|||
129022349|NCT03733444|464374627|FG001|Overall Study|Lack of Efficacy|1|||
129022350|NCT03733444|464374628|FG002|Overall Study|Lack of Efficacy|1|||
129022351|NCT03733444|464374626|FG000|Overall Study|Physician Decision|2|||
129022352|NCT03733444|464374627|FG001|Overall Study|Physician Decision|1|||
129022353|NCT03733444|464374628|FG002|Overall Study|Physician Decision|0|||
129022354|NCT03733444|464374626|FG000|Overall Study|Protocol Violation|2|||
129022355|NCT03733444|464374627|FG001|Overall Study|Protocol Violation|1|||
129022356|NCT03733444|464374628|FG002|Overall Study|Protocol Violation|0|||
129022357|NCT03733444|464374626|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
129022358|NCT03733444|464374627|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
129022359|NCT03733444|464374628|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
129022360|NCT03733444|464374626|FG000|Overall Study|Study Terminated by Sponsor|203|||
129022361|NCT03733444|464374627|FG001|Overall Study|Study Terminated by Sponsor|209|||
129022362|NCT03733444|464374628|FG002|Overall Study|Study Terminated by Sponsor|221|||
129022363|NCT03733444|464374626|FG000|Overall Study|Withdrawal by Subject|19|||
129022364|NCT03733444|464374627|FG001|Overall Study|Withdrawal by Subject|18|||
129022365|NCT03733444|464374628|FG002|Overall Study|Withdrawal by Subject|16|||
129022366|NCT03733444|464374626|FG000|Overall Study|Miscellaneous|1|||
129022367|NCT03733444|464374627|FG001|Overall Study|Miscellaneous|0|||
129022368|NCT03733444|464374628|FG002|Overall Study|Miscellaneous|1|||
129022369|NCT03733444|464374626|FG000|Overall Study|Not Treated|1|||
129022370|NCT03733444|464374627|FG001|Overall Study|Not Treated|2|||
129022371|NCT03733444|464374628|FG002|Overall Study|Not Treated|1|||
129022372|NCT00556322|464374629|FG000|Overall Study|Insufficient therapeutic response|158|||
129022373|NCT00556322|464374630|FG001|Overall Study|Insufficient therapeutic response|168|||
129022374|NCT00556322|464374629|FG000|Overall Study|Adverse Event|7|||
129022375|NCT00556322|464374630|FG001|Overall Study|Adverse Event|4|||
129022376|NCT00556322|464374629|FG000|Overall Study|Other|4|||
129022377|NCT00556322|464374630|FG001|Overall Study|Other|1|||
129022378|NCT00556322|464374629|FG000|Overall Study|Lost to Follow-up|5|||
129022379|NCT00556322|464374630|FG001|Overall Study|Lost to Follow-up|3|||
129022380|NCT00556322|464374629|FG000|Overall Study|Withdrawal by Subject|19|||
129022381|NCT00556322|464374630|FG001|Overall Study|Withdrawal by Subject|7|||
129022382|NCT00556322|464374629|FG000|Overall Study|Protocol Violation|5|||
129022383|NCT00556322|464374630|FG001|Overall Study|Protocol Violation|1|||
129111876|NCT03243305|464703264|FG000|Overall Study|Withdrawal by Subject|170|||
129111877|NCT03243305|464703264|FG000|Overall Study|Pregnancy|104|||
129111878|NCT03243305|464703264|FG000|Overall Study|Non-Compliance with Study Drug|38|||
129111879|NCT03243305|464703264|FG000|Overall Study|Adverse Event|23|||
129111880|NCT03243305|464703264|FG000|Overall Study|No sexually active|26|||
129111881|NCT03243305|464703264|FG000|Overall Study|Physician Decision|22|||
129111882|NCT03243305|464703264|FG000|Overall Study|Protocol Violation|22|||
129111883|NCT03243305|464703264|FG000|Overall Study|Study method no longer primary method|12|||
129111884|NCT03243305|464703264|FG000|Overall Study|Study Terminated by Sponsor|1|||
129111885|NCT03243305|464703264|FG000|Overall Study|Early terminations|267|||
129111886|NCT02689804|464703265|FG000|Overall Study|Withdrawal by Subject|2|||
129111887|NCT02689804|464703266|FG001|Overall Study|Withdrawal by Subject|0|||
129111888|NCT01166750|464703274|FG000|Overall Study|Lost to Follow-up|1|||
129111889|NCT01166750|464703275|FG001|Overall Study|Lost to Follow-up|0|||
129111890|NCT01585246|464703276|FG000|Overall Study|Lost to Follow-up|0|||
129111891|NCT01585246|464703277|FG001|Overall Study|Lost to Follow-up|0|||
129111892|NCT01585246|464703278|FG002|Overall Study|Lost to Follow-up|2|||
129111893|NCT01585246|464703279|FG003|Overall Study|Lost to Follow-up|1|||
129111894|NCT01585246|464703280|FG004|Overall Study|Lost to Follow-up|0|||
129111895|NCT01585246|464703276|FG000|Overall Study|Protocol Violation|0|||
129111896|NCT01585246|464703277|FG001|Overall Study|Protocol Violation|0|||
129111897|NCT01585246|464703278|FG002|Overall Study|Protocol Violation|0|||
129111898|NCT01585246|464703279|FG003|Overall Study|Protocol Violation|0|||
129111899|NCT01585246|464703280|FG004|Overall Study|Protocol Violation|1|||
129111900|NCT01585246|464703276|FG000|Overall Study|Withdrawal by Subject|0|||
129111901|NCT01585246|464703277|FG001|Overall Study|Withdrawal by Subject|0|||
129111902|NCT01585246|464703278|FG002|Overall Study|Withdrawal by Subject|1|||
129111903|NCT01585246|464703279|FG003|Overall Study|Withdrawal by Subject|2|||
129111904|NCT01585246|464703280|FG004|Overall Study|Withdrawal by Subject|1|||
129111905|NCT01585246|464703276|FG000|Overall Study|Other|0|||
129111906|NCT01585246|464703277|FG001|Overall Study|Other|1|||
129111907|NCT01585246|464703278|FG002|Overall Study|Other|1|||
129111908|NCT01585246|464703279|FG003|Overall Study|Other|1|||
129111909|NCT01585246|464703280|FG004|Overall Study|Other|0|||
129111910|NCT04396626|464703281|FG000|Overall Study|Premature termination of study|975|||
129111911|NCT02417753|464703282|FG000|Overall Study|Death|1|||
129111912|NCT02998151|464703289|FG000|Overall Study|Withdrawal by Subject|3|||
129111913|NCT02998151|464703289|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
129111914|NCT02998151|464703289|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
129111915|NCT02155985|464703290|FG000|Overall Study|Withdrawal by Subject|0|||
129111916|NCT02155985|464703291|FG001|Overall Study|Withdrawal by Subject|0|||
129111917|NCT02155985|464703292|FG002|Overall Study|Withdrawal by Subject|1|||
129111918|NCT02155985|464703290|FG000|Overall Study|Lost to Follow-up|1|||
129111919|NCT02155985|464703291|FG001|Overall Study|Lost to Follow-up|0|||
129111920|NCT02155985|464703292|FG002|Overall Study|Lost to Follow-up|0|||
129111921|NCT02573259|464703293|FG000|Overall Study|Death|1|||
129111922|NCT02573259|464703294|FG001|Overall Study|Death|6|||
129111923|NCT02573259|464703295|FG002|Overall Study|Death|5|||
129111924|NCT02573259|464703296|FG003|Overall Study|Death|6|||
129111925|NCT02573259|464703297|FG004|Overall Study|Death|9|||
129111926|NCT02573259|464703298|FG005|Overall Study|Death|32|||
129111927|NCT02573259|464703299|FG006|Overall Study|Death|21|||
129111928|NCT02573259|464703293|FG000|Overall Study|Lost to Follow-up|0|||
129111929|NCT02573259|464703294|FG001|Overall Study|Lost to Follow-up|0|||
129111930|NCT02573259|464703295|FG002|Overall Study|Lost to Follow-up|0|||
129111931|NCT02573259|464703296|FG003|Overall Study|Lost to Follow-up|0|||
129111932|NCT02573259|464703297|FG004|Overall Study|Lost to Follow-up|0|||
129111933|NCT02573259|464703298|FG005|Overall Study|Lost to Follow-up|2|||
129111934|NCT02573259|464703299|FG006|Overall Study|Lost to Follow-up|1|||
129111935|NCT02573259|464703293|FG000|Overall Study|Participant refused further follow-up|0|||
129111936|NCT02573259|464703294|FG001|Overall Study|Participant refused further follow-up|2|||
129111937|NCT02573259|464703295|FG002|Overall Study|Participant refused further follow-up|1|||
129111938|NCT02573259|464703296|FG003|Overall Study|Participant refused further follow-up|0|||
129111939|NCT02573259|464703297|FG004|Overall Study|Participant refused further follow-up|3|||
129111940|NCT02573259|464703298|FG005|Overall Study|Participant refused further follow-up|20|||
129111941|NCT02573259|464703299|FG006|Overall Study|Participant refused further follow-up|7|||
129111942|NCT02573259|464703293|FG000|Overall Study|Other|0|||
129111943|NCT02573259|464703294|FG001|Overall Study|Other|0|||
129111944|NCT02573259|464703295|FG002|Overall Study|Other|0|||
129111945|NCT02573259|464703296|FG003|Overall Study|Other|0|||
129111946|NCT02573259|464703297|FG004|Overall Study|Other|1|||
129111947|NCT02573259|464703298|FG005|Overall Study|Other|4|||
129111948|NCT02573259|464703299|FG006|Overall Study|Other|5|||
129111949|NCT01817075|464703305|FG000|Overall Study|Adverse Event|7|||
129111950|NCT01817075|464703306|FG001|Overall Study|Adverse Event|5|||
129111951|NCT01817075|464703305|FG000|Overall Study|Physician Decision|9|||
129111952|NCT01817075|464703306|FG001|Overall Study|Physician Decision|12|||
129111953|NCT01817075|464703305|FG000|Overall Study|Withdrawal by Subject|31|||
129111954|NCT01817075|464703306|FG001|Overall Study|Withdrawal by Subject|15|||
129111955|NCT01817075|464703305|FG000|Overall Study|Received Sorafenib after enrollment|0|||
129111956|NCT01817075|464703306|FG001|Overall Study|Received Sorafenib after enrollment|1|||
129111957|NCT01817075|464703305|FG000|Overall Study|Ineligible|0|||
129111958|NCT01817075|464703306|FG001|Overall Study|Ineligible|2|||
129111959|NCT05212168|464703307|FG000|Overall Study|Lost to Follow-up|0|||
129111960|NCT05212168|464703308|FG001|Overall Study|Lost to Follow-up|3|||
129111961|NCT05212168|464703307|FG000|Overall Study|Study terminated by sponsor|30|||
129111962|NCT05212168|464703308|FG001|Overall Study|Study terminated by sponsor|27|||
129111963|NCT05212168|464703307|FG000|Overall Study|Other|4|||
129111964|NCT05212168|464703308|FG001|Overall Study|Other|7|||
129111965|NCT01325350|464705568|FG000|Overall Study|Adverse Event|3|||
129111966|NCT01325350|464705569|FG001|Overall Study|Adverse Event|3|||
129111967|NCT01325350|464705570|FG002|Overall Study|Adverse Event|3|||
129111968|NCT01325350|464705571|FG003|Overall Study|Adverse Event|1|||
129111969|NCT01325350|464705572|FG004|Overall Study|Adverse Event|2|||
129111970|NCT01325350|464705568|FG000|Overall Study|Pregnancy|0|||
129111971|NCT01325350|464705569|FG001|Overall Study|Pregnancy|0|||
129111972|NCT01325350|464705570|FG002|Overall Study|Pregnancy|1|||
129111973|NCT01325350|464705571|FG003|Overall Study|Pregnancy|0|||
129111974|NCT01325350|464705572|FG004|Overall Study|Pregnancy|1|||
129111975|NCT01325350|464705568|FG000|Overall Study|Lost to Follow-up|1|||
129111976|NCT01325350|464705569|FG001|Overall Study|Lost to Follow-up|0|||
129111977|NCT01325350|464705570|FG002|Overall Study|Lost to Follow-up|5|||
129111978|NCT01325350|464705571|FG003|Overall Study|Lost to Follow-up|1|||
129111979|NCT01325350|464705572|FG004|Overall Study|Lost to Follow-up|5|||
129111980|NCT01325350|464705568|FG000|Overall Study|Personal Reasons|2|||
129111981|NCT01325350|464705569|FG001|Overall Study|Personal Reasons|1|||
129111982|NCT01325350|464705570|FG002|Overall Study|Personal Reasons|6|||
129111983|NCT01325350|464705571|FG003|Overall Study|Personal Reasons|5|||
129111984|NCT01325350|464705572|FG004|Overall Study|Personal Reasons|3|||
129111985|NCT01325350|464705568|FG000|Overall Study|Protocol Violation|0|||
129111986|NCT01325350|464705569|FG001|Overall Study|Protocol Violation|0|||
129111987|NCT01325350|464705570|FG002|Overall Study|Protocol Violation|0|||
129111988|NCT01325350|464705571|FG003|Overall Study|Protocol Violation|1|||
129111989|NCT01325350|464705572|FG004|Overall Study|Protocol Violation|0|||
129111990|NCT01325350|464705568|FG000|Overall Study|Withdrawal by Subject|0|||
129111991|NCT01325350|464705569|FG001|Overall Study|Withdrawal by Subject|0|||
129111992|NCT01325350|464705570|FG002|Overall Study|Withdrawal by Subject|1|||
129111993|NCT01325350|464705571|FG003|Overall Study|Withdrawal by Subject|1|||
129111994|NCT01325350|464705572|FG004|Overall Study|Withdrawal by Subject|0|||
129111995|NCT01325350|464705568|FG000|Overall Study|Did Not Receive Treatment|0|||
129111996|NCT01325350|464705569|FG001|Overall Study|Did Not Receive Treatment|1|||
129111997|NCT01325350|464705570|FG002|Overall Study|Did Not Receive Treatment|1|||
129111998|NCT01325350|464705571|FG003|Overall Study|Did Not Receive Treatment|0|||
129111999|NCT01325350|464705572|FG004|Overall Study|Did Not Receive Treatment|1|||
129112000|NCT00956839|464705573|FG000|Overall Study|Lost to Follow-up|3|||
129112001|NCT00956839|464705574|FG001|Overall Study|Lost to Follow-up|0|||
129112002|NCT00956839|464705575|FG002|Overall Study|Lost to Follow-up|3|||
129112003|NCT00619827|464705576|FG000|Overall Study|Adverse Event|1|||
129112004|NCT00619827|464705577|FG001|Overall Study|Adverse Event|2|||
129112005|NCT00619827|464705576|FG000|Overall Study|Withdrawal by Subject|2|||
129112006|NCT00619827|464705577|FG001|Overall Study|Withdrawal by Subject|2|||
129112007|NCT01063855|464705578|FG000|Overall Study|Adverse Event|4|||
129112008|NCT01063855|464705579|FG001|Overall Study|Adverse Event|4|||
129112009|NCT01063855|464705578|FG000|Overall Study|Death|0|||
129112010|NCT01063855|464705579|FG001|Overall Study|Death|1|||
129112011|NCT01063855|464705578|FG000|Overall Study|Lost to Follow-up|8|||
129112012|NCT01063855|464705579|FG001|Overall Study|Lost to Follow-up|4|||
128691563|NCT01134731|463170949|FG001|Overall Study|Physician Decision|2|||
128691564|NCT01134731|463170950|FG002|Overall Study|Physician Decision|2|||
128691565|NCT01134731|463170948|FG000|Overall Study|Lack of Efficacy|0|||
128691566|NCT01134731|463170949|FG001|Overall Study|Lack of Efficacy|0|||
129112013|NCT01063855|464705578|FG000|Overall Study|Pregnancy|1|||
129112014|NCT01063855|464705579|FG001|Overall Study|Pregnancy|0|||
129112015|NCT01063855|464705578|FG000|Overall Study|Lack of Efficacy|0|||
129112016|NCT01063855|464705579|FG001|Overall Study|Lack of Efficacy|1|||
129112017|NCT01063855|464705578|FG000|Overall Study|Withdrawal by Subject|11|||
129112018|NCT01063855|464705579|FG001|Overall Study|Withdrawal by Subject|8|||
128691567|NCT01134731|463170950|FG002|Overall Study|Lack of Efficacy|1|||
128691568|NCT01134731|463170948|FG000|Overall Study|Withdrawal by Subject|3|||
129112019|NCT01063855|464705578|FG000|Overall Study|Reason not specified|13|||
129112020|NCT01063855|464705579|FG001|Overall Study|Reason not specified|11|||
129112021|NCT01854697|464705587|FG000|Overall Study|Adverse Event|1|||
129112022|NCT01854697|464705588|FG001|Overall Study|Adverse Event|0|||
128691569|NCT01134731|463170949|FG001|Overall Study|Withdrawal by Subject|3|||
128691570|NCT01134731|463170950|FG002|Overall Study|Withdrawal by Subject|1|||
129112023|NCT01854697|464705589|FG002|Overall Study|Adverse Event|0|||
129112024|NCT01854697|464705590|FG003|Overall Study|Adverse Event|0|||
129112025|NCT01854697|464705591|FG004|Overall Study|Adverse Event|1|||
129022384|NCT00556322|464374629|FG000|Overall Study|Ongoing at data cutoff|3|||
129022385|NCT00556322|464374630|FG001|Overall Study|Ongoing at data cutoff|5|||
129022386|NCT00556322|464374629|FG000|Overall Study|Death|20|||
129022387|NCT00556322|464374630|FG001|Overall Study|Death|14|||
129022388|NCT01788423|464374631|FG000|Overall Study|See Comments in Completed (above)|0|||
129022389|NCT01788423|464374632|FG001|Overall Study|See Comments in Completed (above)|4|||
129022390|NCT01788423|464374633|FG002|Overall Study|See Comments in Completed (above)|5|||
129022391|NCT03637764|464374634|FG000|Overall Study|Adverse Event|2|||
129022392|NCT03637764|464374635|FG001|Overall Study|Adverse Event|0|||
129022393|NCT03637764|464374636|FG002|Overall Study|Adverse Event|0|||
129022394|NCT03637764|464374637|FG003|Overall Study|Adverse Event|1|||
129022395|NCT03637764|464374634|FG000|Overall Study|Progressive Disease|23|||
129022396|NCT03637764|464374635|FG001|Overall Study|Progressive Disease|23|||
129022397|NCT03637764|464374636|FG002|Overall Study|Progressive Disease|18|||
129022398|NCT03637764|464374637|FG003|Overall Study|Progressive Disease|31|||
129022399|NCT03637764|464374634|FG000|Overall Study|Withdrawal by Subject|1|||
129022400|NCT03637764|464374635|FG001|Overall Study|Withdrawal by Subject|3|||
129022401|NCT03637764|464374636|FG002|Overall Study|Withdrawal by Subject|0|||
129022402|NCT03637764|464374637|FG003|Overall Study|Withdrawal by Subject|1|||
129022403|NCT02760927|464374642|FG000|Overall Study|Tube Slippage from Device|1|||
129022404|NCT02105272|464374643|FG000|Overall Study|Adverse Event|1|||
129022405|NCT02105272|464374644|FG001|Overall Study|Adverse Event|2|||
129022406|NCT02105272|464374643|FG000|Overall Study|Physician Decision|0|||
129022407|NCT02105272|464374644|FG001|Overall Study|Physician Decision|1|||
129022408|NCT02105272|464374643|FG000|Overall Study|Protocol Violation|2|||
129022409|NCT02105272|464374644|FG001|Overall Study|Protocol Violation|0|||
129022410|NCT02105272|464374643|FG000|Overall Study|Withdrawal by Subject|2|||
129022411|NCT02105272|464374644|FG001|Overall Study|Withdrawal by Subject|0|||
129022412|NCT03190915|464374646|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
129022413|NCT03190915|464374646|FG000|Overall Study|Progressive Disease|3|||
129022414|NCT01911676|464374647|FG000|Period 1 of Study|Withdrawal by Subject|4|||
129022415|NCT01911676|464374648|FG001|Period 1 of Study|Withdrawal by Subject|2|||
129022416|NCT01911676|464374649|FG002|Period 1 of Study|Withdrawal by Subject|1|||
129022417|NCT01911676|464374650|FG003|Period 1 of Study|Withdrawal by Subject|2|||
129022418|NCT01911676|464374647|FG000|Period 1 of Study|Physician Decision|2|||
129022419|NCT01911676|464374648|FG001|Period 1 of Study|Physician Decision|0|||
129022420|NCT01911676|464374649|FG002|Period 1 of Study|Physician Decision|0|||
129022421|NCT01911676|464374650|FG003|Period 1 of Study|Physician Decision|1|||
129022422|NCT01911676|464374647|FG000|Period 2 of Study|Physician Decision|2|||
129022423|NCT01911676|464374648|FG001|Period 2 of Study|Physician Decision|0|||
129022424|NCT01911676|464374649|FG002|Period 2 of Study|Physician Decision|0|||
129112026|NCT01854697|464705587|FG000|Overall Study|Lost to Follow-up|4|||
129112027|NCT01854697|464705588|FG001|Overall Study|Lost to Follow-up|1|||
129112028|NCT01854697|464705589|FG002|Overall Study|Lost to Follow-up|1|||
129112029|NCT01854697|464705590|FG003|Overall Study|Lost to Follow-up|2|||
129112030|NCT01854697|464705591|FG004|Overall Study|Lost to Follow-up|0|||
129112031|NCT01854697|464705587|FG000|Overall Study|To enter another AbbVie study|1|||
129112032|NCT01854697|464705588|FG001|Overall Study|To enter another AbbVie study|0|||
129112033|NCT01854697|464705589|FG002|Overall Study|To enter another AbbVie study|0|||
129112034|NCT01854697|464705590|FG003|Overall Study|To enter another AbbVie study|0|||
129112035|NCT01854697|464705591|FG004|Overall Study|To enter another AbbVie study|1|||
129112036|NCT01854697|464705587|FG000|Overall Study|Withdrew Consent|0|||
129112037|NCT01854697|464705588|FG001|Overall Study|Withdrew Consent|1|||
129112038|NCT01854697|464705589|FG002|Overall Study|Withdrew Consent|0|||
129112039|NCT01854697|464705590|FG003|Overall Study|Withdrew Consent|1|||
129112040|NCT01854697|464705591|FG004|Overall Study|Withdrew Consent|0|||
129112041|NCT01854697|464705587|FG000|Overall Study|Other|0|||
129112042|NCT01854697|464705588|FG001|Overall Study|Other|1|||
129022425|NCT01911676|464374650|FG003|Period 2 of Study|Physician Decision|1|||
129022426|NCT01911676|464374647|FG000|Period 2 of Study|Lost to Follow-up|0|||
129112043|NCT01854697|464705589|FG002|Overall Study|Other|1|||
128691571|NCT01134731|463170948|FG000|Overall Study|Lost to Follow-up|5|||
129022427|NCT01911676|464374648|FG001|Period 2 of Study|Lost to Follow-up|0|||
129022428|NCT01911676|464374649|FG002|Period 2 of Study|Lost to Follow-up|0|||
129112044|NCT01854697|464705590|FG003|Overall Study|Other|0|||
129112045|NCT01854697|464705591|FG004|Overall Study|Other|0|||
129112046|NCT00115778|464705595|FG000|Overall Study|Withdrawal by Subject|0|||
129112047|NCT00115778|464705596|FG001|Overall Study|Withdrawal by Subject|1|||
129022429|NCT01911676|464374650|FG003|Period 2 of Study|Lost to Follow-up|1|||
129022430|NCT01566721|464374651|FG000|Treatment Period|Withdrawal by Subject|35|||
129022431|NCT01566721|464374652|FG001|Treatment Period|Withdrawal by Subject|9|||
129022432|NCT01566721|464374651|FG000|Treatment Period|Disease Progression/Recurrence|37|||
129022433|NCT01566721|464374652|FG001|Treatment Period|Disease Progression/Recurrence|13|||
129022434|NCT01566721|464374651|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
129022435|NCT01566721|464374652|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
129022436|NCT01566721|464374651|FG000|Treatment Period|Other|13|||
129022437|NCT01566721|464374652|FG001|Treatment Period|Other|2|||
128895237|NCT01236573|463911668|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895238|NCT01236573|463911669|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895239|NCT01236573|463911670|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895240|NCT01236573|463911671|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895241|NCT01236573|463911672|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895242|NCT01236573|463911673|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
128895243|NCT01236573|463911674|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895244|NCT01236573|463911675|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
128895245|NCT01236573|463911665|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
128895246|NCT01236573|463911666|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
128895247|NCT01236573|463911667|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129022438|NCT01566721|464374651|FG000|Treatment Period|Lack of Compliance|5|||
129022439|NCT01566721|464374652|FG001|Treatment Period|Lack of Compliance|1|||
129022440|NCT01566721|464374651|FG000|Treatment Period|Adverse Event|100|||
129022441|NCT01566721|464374652|FG001|Treatment Period|Adverse Event|30|||
129022442|NCT01566721|464374651|FG000|Treatment Period|Pregnancy|1|||
128691572|NCT01134731|463170949|FG001|Overall Study|Lost to Follow-up|4|||
128691573|NCT01134731|463170950|FG002|Overall Study|Lost to Follow-up|3|||
128895248|NCT01236573|463911668|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
128895249|NCT01236573|463911669|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
128895250|NCT01236573|463911670|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129022443|NCT01566721|464374652|FG001|Treatment Period|Pregnancy|0|||
129022444|NCT01566721|464374651|FG000|Safety Follow-up|Physician Decision|6|||
129022445|NCT01566721|464374652|FG001|Safety Follow-up|Physician Decision|4|||
128691574|NCT02124161|463170951|FG000|Overall Study|Other unspecified|0|||
128691575|NCT02124161|463170952|FG001|Overall Study|Other unspecified|1|||
128691576|NCT02124161|463170951|FG000|Overall Study|Death|1|||
128691577|NCT02124161|463170952|FG001|Overall Study|Death|0|||
128691578|NCT02124161|463170951|FG000|Overall Study|Protocol Violation|2|||
128895251|NCT01236573|463911671|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129022446|NCT01566721|464374651|FG000|Safety Follow-up|Lost to Follow-up|101|||
129022447|NCT01566721|464374652|FG001|Safety Follow-up|Lost to Follow-up|48|||
129022448|NCT01566721|464374651|FG000|Safety Follow-up|Withdrawal by Subject|155|||
129022449|NCT01566721|464374652|FG001|Safety Follow-up|Withdrawal by Subject|49|||
129022450|NCT01566721|464374651|FG000|Safety Follow-up|Death|28|||
129022451|NCT01566721|464374652|FG001|Safety Follow-up|Death|4|||
129022452|NCT01566721|464374651|FG000|Safety Follow-up|Non-compliance|7|||
129022453|NCT01566721|464374652|FG001|Safety Follow-up|Non-compliance|3|||
129022454|NCT01566721|464374651|FG000|Safety Follow-up|Protocol Violation|7|||
129022455|NCT01566721|464374652|FG001|Safety Follow-up|Protocol Violation|0|||
129022456|NCT01566721|464374651|FG000|Safety Follow-up|Site closure|2|||
129022457|NCT01566721|464374652|FG001|Safety Follow-up|Site closure|3|||
129022458|NCT01566721|464374651|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
129022459|NCT01566721|464374652|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
129022460|NCT01566721|464374651|FG000|Safety Follow-up|Missing|7|||
129022461|NCT01566721|464374652|FG001|Safety Follow-up|Missing|2|||
129022462|NCT01566721|464374651|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
129022463|NCT01566721|464374652|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
129022464|NCT01566721|464374651|FG000|Safety Follow-up|Sponsor decision|1|||
129022465|NCT01566721|464374652|FG001|Safety Follow-up|Sponsor decision|0|||
129022466|NCT01566721|464374651|FG000|Safety Follow-up|Adverse Event|8|||
129022467|NCT01566721|464374652|FG001|Safety Follow-up|Adverse Event|4|||
129022468|NCT01302548|464374657|FG000|Overall Study|Lost to Follow-up|2|||
129022469|NCT01302548|464374658|FG001|Overall Study|Lost to Follow-up|1|||
129022470|NCT01237054|464374659|FG000|Overall Study|imaging 10C0096|1|||
129022471|NCT02619682|464374660|FG000|Overall Study|Withdrawal by Subject|3|||
129022472|NCT02619682|464374660|FG000|Overall Study|Lack of Efficacy|8|||
129022473|NCT02619682|464374660|FG000|Overall Study|new secondary cancer|1|||
129022474|NCT02619682|464374660|FG000|Overall Study|post surgery complications|2|||
129022475|NCT00268203|464374663|FG000|Overall Study|Lost to Follow-up|92|||
129022476|NCT00268203|464374663|FG000|Overall Study|Withdrawal by Subject|9|||
129022477|NCT00268203|464374663|FG000|Overall Study|Received Other NHL Therapy|7|||
129022478|NCT00268203|464374663|FG000|Overall Study|Progressive Disease|359|||
129022479|NCT00268203|464374663|FG000|Overall Study|Death|84|||
129022480|NCT00268203|464374663|FG000|Overall Study|Reason Not Specified|34|||
129022481|NCT00268203|464374663|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
129022482|NCT00730691|464374670|FG000|Overall Study|Adverse Event|4|||
129022483|NCT00730691|464374671|FG001|Overall Study|Adverse Event|8|||
129022484|NCT00730691|464374672|FG002|Overall Study|Adverse Event|11|||
129022485|NCT00730691|464374673|FG003|Overall Study|Adverse Event|11|||
129022486|NCT00730691|464374674|FG004|Overall Study|Adverse Event|23|||
129022487|NCT00730691|464374670|FG000|Overall Study|Lack of Efficacy|4|||
129022488|NCT00730691|464374671|FG001|Overall Study|Lack of Efficacy|4|||
128691579|NCT02124161|463170952|FG001|Overall Study|Protocol Violation|1|||
129022489|NCT00730691|464374672|FG002|Overall Study|Lack of Efficacy|2|||
129022490|NCT00730691|464374673|FG003|Overall Study|Lack of Efficacy|1|||
128691580|NCT02124161|463170951|FG000|Overall Study|Withdrawal by Subject|1|||
128764483|NCT00402337|463428334|FG000|Overall Study|Lost to Follow-up|0|||
128764484|NCT00402337|463428335|FG001|Overall Study|Lost to Follow-up|0|||
128764485|NCT00402337|463428336|FG002|Overall Study|Lost to Follow-up|1|||
128764486|NCT00402337|463428337|FG003|Overall Study|Lost to Follow-up|2|||
128764487|NCT00402337|463428338|FG004|Overall Study|Lost to Follow-up|0|||
128764488|NCT00402337|463428334|FG000|Overall Study|Physician Decision|0|||
128764489|NCT00402337|463428335|FG001|Overall Study|Physician Decision|0|||
128764490|NCT00402337|463428336|FG002|Overall Study|Physician Decision|0|||
128764491|NCT00402337|463428337|FG003|Overall Study|Physician Decision|1|||
128764492|NCT00402337|463428338|FG004|Overall Study|Physician Decision|0|||
128764493|NCT00402337|463428334|FG000|Overall Study|Other Reason|0|||
128764494|NCT00402337|463428335|FG001|Overall Study|Other Reason|1|||
128764495|NCT00402337|463428336|FG002|Overall Study|Other Reason|0|||
128764496|NCT00402337|463428337|FG003|Overall Study|Other Reason|0|||
128764497|NCT00402337|463428338|FG004|Overall Study|Other Reason|0|||
128764498|NCT02178566|463428339|FG000|Overall Study|patient did not complete due to noncompliance|0|||
128764499|NCT02178566|463428340|FG001|Overall Study|patient did not complete due to noncompliance|1|||
128764500|NCT02658630|463428345|FG000|Overall Study|Withdrawal by Subject|4|||
128764501|NCT03565068|463428347|FG000|Overall Study|Protocol Violation|0|||
128764502|NCT03565068|463428348|FG001|Overall Study|Protocol Violation|0|||
128764503|NCT03565068|463428349|FG002|Overall Study|Protocol Violation|0|||
128764504|NCT03565068|463428350|FG003|Overall Study|Protocol Violation|0|||
128764505|NCT03565068|463428351|FG004|Overall Study|Protocol Violation|1|||
128764506|NCT03565068|463428352|FG005|Overall Study|Protocol Violation|0|||
128764507|NCT03565068|463428353|FG006|Overall Study|Protocol Violation|0|||
128764508|NCT03565068|463428354|FG007|Overall Study|Protocol Violation|1|||
128764509|NCT03565068|463428355|FG008|Overall Study|Protocol Violation|0|||
128764510|NCT03565068|463428347|FG000|Overall Study|Sponsor decision|0|||
128764511|NCT03565068|463428348|FG001|Overall Study|Sponsor decision|0|||
128764512|NCT03565068|463428349|FG002|Overall Study|Sponsor decision|0|||
128764513|NCT03565068|463428350|FG003|Overall Study|Sponsor decision|0|||
128764514|NCT03565068|463428351|FG004|Overall Study|Sponsor decision|1|||
128764515|NCT03565068|463428352|FG005|Overall Study|Sponsor decision|1|||
128764516|NCT03565068|463428353|FG006|Overall Study|Sponsor decision|0|||
128764517|NCT03565068|463428354|FG007|Overall Study|Sponsor decision|0|||
128764518|NCT03565068|463428355|FG008|Overall Study|Sponsor decision|0|||
128764519|NCT03565068|463428347|FG000|Overall Study|Withdrawal by Subject|0|||
128764520|NCT03565068|463428348|FG001|Overall Study|Withdrawal by Subject|0|||
128764521|NCT03565068|463428349|FG002|Overall Study|Withdrawal by Subject|1|||
128764522|NCT03565068|463428350|FG003|Overall Study|Withdrawal by Subject|0|||
128691581|NCT02124161|463170952|FG001|Overall Study|Withdrawal by Subject|2|||
128691582|NCT02124161|463170951|FG000|Overall Study|Adverse Event|2|||
128691583|NCT02124161|463170952|FG001|Overall Study|Adverse Event|0|||
128691584|NCT02124161|463170951|FG000|Overall Study|Does not meet entrance criteria|2|||
128691585|NCT02124161|463170952|FG001|Overall Study|Does not meet entrance criteria|3|||
128691586|NCT02124161|463170951|FG000|Overall Study|No longer meets eligibility criteria|5|||
128691587|NCT02124161|463170952|FG001|Overall Study|No longer meets eligibility criteria|4|||
128691588|NCT02124161|463170951|FG000|Overall Study|Lost to Follow-up|3|||
128691589|NCT02124161|463170952|FG001|Overall Study|Lost to Follow-up|4|||
128691590|NCT02517866|463170953|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
128691591|NCT02517866|463170954|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
128691592|NCT02517866|463170955|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
128691593|NCT02517866|463170953|FG000|Overall Study|Significant Protocol Deviation|4|||
128691594|NCT02517866|463170954|FG001|Overall Study|Significant Protocol Deviation|1|||
128764523|NCT03565068|463428351|FG004|Overall Study|Withdrawal by Subject|2|||
128764524|NCT03565068|463428352|FG005|Overall Study|Withdrawal by Subject|0|||
128764525|NCT03565068|463428353|FG006|Overall Study|Withdrawal by Subject|1|||
128764526|NCT03565068|463428354|FG007|Overall Study|Withdrawal by Subject|5|||
128764527|NCT03565068|463428355|FG008|Overall Study|Withdrawal by Subject|1|||
128764528|NCT03565068|463428347|FG000|Overall Study|Physician Decision|0|||
128764529|NCT03565068|463428348|FG001|Overall Study|Physician Decision|0|||
128764530|NCT03565068|463428349|FG002|Overall Study|Physician Decision|0|||
128764531|NCT03565068|463428350|FG003|Overall Study|Physician Decision|0|||
128764532|NCT03565068|463428351|FG004|Overall Study|Physician Decision|0|||
128764533|NCT03565068|463428352|FG005|Overall Study|Physician Decision|0|||
128764534|NCT03565068|463428353|FG006|Overall Study|Physician Decision|0|||
128691595|NCT02517866|463170955|FG002|Overall Study|Significant Protocol Deviation|0|||
128764535|NCT03565068|463428354|FG007|Overall Study|Physician Decision|1|||
128764536|NCT03565068|463428355|FG008|Overall Study|Physician Decision|0|||
128764537|NCT03565068|463428347|FG000|Overall Study|Lost to Follow-up|0|||
128764538|NCT03565068|463428348|FG001|Overall Study|Lost to Follow-up|0|||
128691596|NCT02517866|463170953|FG000|Overall Study|Lost to Follow-up|1|||
128691597|NCT02517866|463170954|FG001|Overall Study|Lost to Follow-up|0|||
128691598|NCT02517866|463170955|FG002|Overall Study|Lost to Follow-up|0|||
128764539|NCT03565068|463428349|FG002|Overall Study|Lost to Follow-up|0|||
128764540|NCT03565068|463428350|FG003|Overall Study|Lost to Follow-up|0|||
128764541|NCT03565068|463428351|FG004|Overall Study|Lost to Follow-up|0|||
128895252|NCT01236573|463911672|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
128895253|NCT01236573|463911673|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
128895254|NCT01236573|463911674|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
128895255|NCT01236573|463911675|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
128895256|NCT02161575|463911682|FG000|Overall Study|Protocol Violation|8|||
128895257|NCT02161575|463911682|FG000|Overall Study|Lack of Efficacy|1|||
128895258|NCT02161575|463911682|FG000|Overall Study|Adverse Event|2|||
128895259|NCT01835015|463911683|FG000|Overall Study|Adverse Event|0|||
128895260|NCT01835015|463911684|FG001|Overall Study|Adverse Event|0|||
128895261|NCT01835015|463911685|FG002|Overall Study|Adverse Event|1|||
128895262|NCT01835015|463911686|FG003|Overall Study|Adverse Event|0|||
128895263|NCT01835015|463911687|FG004|Overall Study|Adverse Event|0|||
128895264|NCT04109222|463911692|FG000|Overall Study|Adverse Event|1|||
128895265|NCT04109222|463911693|FG001|Overall Study|Adverse Event|0|||
128895266|NCT04109222|463911694|FG002|Overall Study|Adverse Event|0|||
128895267|NCT04569032|463911695|FG000|Overall Study|Death|10|||
128895268|NCT04569032|463911696|FG001|Overall Study|Death|13|||
128895269|NCT04569032|463911695|FG000|Overall Study|Withdrawal by Subject|2|||
128895270|NCT04569032|463911696|FG001|Overall Study|Withdrawal by Subject|0|||
128895271|NCT04569032|463911695|FG000|Overall Study|Lost to Follow-up|0|||
128895272|NCT04569032|463911696|FG001|Overall Study|Lost to Follow-up|1|||
128895273|NCT04569032|463911695|FG000|Overall Study|In long term follow up|22|||
129112048|NCT00528424|464705599|FG000|Overall Study|Lost to Follow-up|13|||
129112049|NCT00528424|464705599|FG000|Overall Study|Withdrew consent|2|||
129112050|NCT00528424|464705599|FG000|Overall Study|Administrative reason|2|||
129112051|NCT00528424|464705599|FG000|Overall Study|Other|12|||
129112052|NCT00483652|464705600|FG000|Double-blind Treatment Period|Protocol Violation|2|||
129112053|NCT00483652|464705601|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129112054|NCT00483652|464705600|FG000|Double-blind Treatment Period|Adverse Event|3|||
129112055|NCT00483652|464705601|FG001|Double-blind Treatment Period|Adverse Event|4|||
129112056|NCT00483652|464705600|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
129112057|NCT00483652|464705601|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
129112058|NCT00483652|464705600|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
129112059|NCT00483652|464705601|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
129112060|NCT00468585|464705602|FG000|Overall Study|Patient not treated|1|||
129112061|NCT00468585|464705603|FG001|Overall Study|Patient not treated|0|||
129112062|NCT00468585|464705604|FG002|Overall Study|Patient not treated|1|||
129112063|NCT00468585|464705605|FG003|Overall Study|Patient not treated|0|||
129112064|NCT00468585|464705602|FG000|Overall Study|Patient found to be ineligible|0|||
129112065|NCT00468585|464705603|FG001|Overall Study|Patient found to be ineligible|0|||
129112066|NCT00468585|464705604|FG002|Overall Study|Patient found to be ineligible|1|||
129112067|NCT00468585|464705605|FG003|Overall Study|Patient found to be ineligible|0|||
129112068|NCT00468585|464705602|FG000|Overall Study|Adverse Event|0|||
129112069|NCT00468585|464705603|FG001|Overall Study|Adverse Event|0|||
129112070|NCT00468585|464705604|FG002|Overall Study|Adverse Event|1|||
129112071|NCT00468585|464705605|FG003|Overall Study|Adverse Event|0|||
129112072|NCT00468585|464705602|FG000|Overall Study|Withdrawal by Subject|0|||
129112073|NCT00468585|464705603|FG001|Overall Study|Withdrawal by Subject|0|||
129112074|NCT00468585|464705604|FG002|Overall Study|Withdrawal by Subject|2|||
129112075|NCT00468585|464705605|FG003|Overall Study|Withdrawal by Subject|1|||
129112076|NCT02154139|464705606|FG000|Overall Study|Injection not administered|2|||
129112077|NCT02154139|464705606|FG000|Overall Study|Other|2|||
129112078|NCT02154139|464705606|FG000|Overall Study|Investigator transferred|3|||
129112079|NCT02087774|464705607|FG000|Overall Study|Were absent day of data collection|8|||
129112080|NCT02087774|464705608|FG001|Overall Study|Were absent day of data collection|20|||
129112081|NCT02157519|464705616|FG000|Overall Study|Death|3|||
129112082|NCT02157519|464705617|FG001|Overall Study|Death|1|||
129112083|NCT02157519|464705616|FG000|Overall Study|Withdrawal by Subject|7|||
129112084|NCT02157519|464705617|FG001|Overall Study|Withdrawal by Subject|0|||
129112085|NCT02157519|464705616|FG000|Overall Study|Lost to Follow-up|1|||
129112086|NCT02157519|464705617|FG001|Overall Study|Lost to Follow-up|0|||
129112087|NCT01656395|464705618|FG000|Overall Study|Adverse Event|1|||
129112088|NCT01656395|464705619|FG001|Overall Study|Adverse Event|14|||
129112089|NCT01656395|464705620|FG002|Overall Study|Adverse Event|5|||
128764542|NCT03565068|463428352|FG005|Overall Study|Lost to Follow-up|0|||
128764543|NCT03565068|463428353|FG006|Overall Study|Lost to Follow-up|0|||
128895274|NCT04569032|463911696|FG001|Overall Study|In long term follow up|34|||
128895275|NCT00701090|463911698|FG000|Overall Study|Adverse Event|11|||
128895276|NCT00701090|463911699|FG001|Overall Study|Adverse Event|2|||
129112090|NCT01656395|464705621|FG003|Overall Study|Adverse Event|4|||
129112091|NCT01656395|464705622|FG004|Overall Study|Adverse Event|5|||
129112092|NCT01656395|464705623|FG005|Overall Study|Adverse Event|7|||
129112093|NCT01656395|464705624|FG006|Overall Study|Adverse Event|0|||
128764544|NCT03565068|463428354|FG007|Overall Study|Lost to Follow-up|1|||
128764545|NCT03565068|463428355|FG008|Overall Study|Lost to Follow-up|0|||
128895277|NCT00701090|463911698|FG000|Overall Study|Death|0|||
128895278|NCT00701090|463911699|FG001|Overall Study|Death|1|||
128895279|NCT00701090|463911698|FG000|Overall Study|Lack of Efficacy|5|||
128895280|NCT00701090|463911699|FG001|Overall Study|Lack of Efficacy|4|||
128895281|NCT00701090|463911698|FG000|Overall Study|Lost to Follow-up|9|||
128895282|NCT00701090|463911699|FG001|Overall Study|Lost to Follow-up|9|||
128691599|NCT02517866|463170953|FG000|Overall Study|Voluntary Withdrawal|2|||
128691600|NCT02517866|463170954|FG001|Overall Study|Voluntary Withdrawal|2|||
128895283|NCT00701090|463911698|FG000|Overall Study|Physician Decision|3|||
128895284|NCT00701090|463911699|FG001|Overall Study|Physician Decision|4|||
128895285|NCT00701090|463911698|FG000|Overall Study|Protocol Violation|2|||
128895286|NCT00701090|463911699|FG001|Overall Study|Protocol Violation|3|||
128895287|NCT00701090|463911698|FG000|Overall Study|Withdrawal by Subject|11|||
128895288|NCT00701090|463911699|FG001|Overall Study|Withdrawal by Subject|16|||
128895289|NCT00701090|463911698|FG000|Overall Study|Other|7|||
128895290|NCT00701090|463911699|FG001|Overall Study|Other|12|||
128895291|NCT04534491|463911706|FG000|Overall Study|Not completed end-of-study interview|24|||
128895292|NCT04534491|463911706|FG000|Overall Study|Non-users|70|||
128895293|NCT04534491|463911706|FG000|Overall Study|Non-verifiable users|58|||
128895294|NCT00736034|463911707|FG000|Overall Study|Adverse Event|2|||
128691601|NCT02517866|463170955|FG002|Overall Study|Voluntary Withdrawal|0|||
128691602|NCT02517866|463170953|FG000|Overall Study|Investigator Decision|2|||
128691603|NCT02517866|463170954|FG001|Overall Study|Investigator Decision|1|||
128691604|NCT02517866|463170955|FG002|Overall Study|Investigator Decision|0|||
128691605|NCT02517866|463170953|FG000|Overall Study|Reason not specified|2|||
128691606|NCT02517866|463170954|FG001|Overall Study|Reason not specified|0|||
128691607|NCT02517866|463170955|FG002|Overall Study|Reason not specified|0|||
128691608|NCT01147640|463170956|FG000|Overall Study|Adverse Event|2|||
128691609|NCT01147640|463170957|FG001|Overall Study|Adverse Event|0|||
128691610|NCT01147640|463170956|FG000|Overall Study|Physician Decision|1|||
128691611|NCT01147640|463170957|FG001|Overall Study|Physician Decision|0|||
128691612|NCT01147640|463170956|FG000|Overall Study|Withdrawal by Subject|1|||
128691613|NCT01147640|463170957|FG001|Overall Study|Withdrawal by Subject|0|||
128691614|NCT01147640|463170956|FG000|Overall Study|Lost to Follow-up|0|||
128691615|NCT01147640|463170957|FG001|Overall Study|Lost to Follow-up|1|||
128691616|NCT01147640|463170956|FG000|Overall Study|Didn't meet eligibility criteria|1|||
128691617|NCT01147640|463170957|FG001|Overall Study|Didn't meet eligibility criteria|0|||
128691618|NCT05095454|463170959|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
128691619|NCT05095454|463170960|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
128691620|NCT03342963|463170961|FG000|Overall Study|Adverse Event|1|||
128691621|NCT03342963|463170962|FG001|Overall Study|Adverse Event|2|||
128691622|NCT03342963|463170963|FG002|Overall Study|Adverse Event|0|||
128691623|NCT03342963|463170964|FG003|Overall Study|Adverse Event|0|||
128691624|NCT03342963|463170961|FG000|Overall Study|Withdrawal by Subject|1|||
128691625|NCT03342963|463170962|FG001|Overall Study|Withdrawal by Subject|0|||
128691626|NCT03342963|463170963|FG002|Overall Study|Withdrawal by Subject|0|||
128691627|NCT03342963|463170964|FG003|Overall Study|Withdrawal by Subject|0|||
128691628|NCT03643575|463170965|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
128691629|NCT03643575|463170966|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
128691630|NCT03643575|463170967|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
128691631|NCT03643575|463170968|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
128691632|NCT03643575|463170969|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
128895295|NCT02566577|463911708|FG000|Overall Study|Withdrawal by Subject|1|||
128895296|NCT02566577|463911709|FG001|Overall Study|Withdrawal by Subject|1|||
128895297|NCT02566577|463911708|FG000|Overall Study|Equipment failure|1|||
128895298|NCT02566577|463911709|FG001|Overall Study|Equipment failure|1|||
128895299|NCT02566577|463911708|FG000|Overall Study|Physical limitation|1|||
128895300|NCT02566577|463911709|FG001|Overall Study|Physical limitation|0|||
128895301|NCT00073528|463911718|FG000|Overall Study|Death|488|||
128895302|NCT00073528|463911719|FG001|Overall Study|Death|473|||
128895303|NCT00073528|463911718|FG000|Overall Study|Lost to Follow-up|52|||
129022491|NCT00730691|464374674|FG004|Overall Study|Lack of Efficacy|1|||
129022492|NCT00730691|464374670|FG000|Overall Study|Non-compliance with Study Drug|6|||
128691633|NCT03643575|463170970|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
128691634|NCT03643575|463170965|FG000|Washout: 7 Days|Adverse Event|1|||
128691635|NCT03643575|463170966|FG001|Washout: 7 Days|Adverse Event|0|||
128691636|NCT03643575|463170967|FG002|Washout: 7 Days|Adverse Event|0|||
128691637|NCT03643575|463170968|FG003|Washout: 7 Days|Adverse Event|0|||
128691638|NCT03643575|463170969|FG004|Washout: 7 Days|Adverse Event|0|||
128691639|NCT03643575|463170970|FG005|Washout: 7 Days|Adverse Event|0|||
128691640|NCT03643575|463170965|FG000|Washout: 7 Days|Non compliance check in|0|||
128691641|NCT03643575|463170966|FG001|Washout: 7 Days|Non compliance check in|1|||
128895304|NCT00073528|463911719|FG001|Overall Study|Lost to Follow-up|45|||
128895305|NCT00073528|463911718|FG000|Overall Study|Withdrawal by Subject|50|||
128895306|NCT00073528|463911719|FG001|Overall Study|Withdrawal by Subject|45|||
128895307|NCT00073528|463911718|FG000|Overall Study|Study terminated by Sponsor|10|||
128895308|NCT00073528|463911719|FG001|Overall Study|Study terminated by Sponsor|29|||
128895309|NCT00073528|463911718|FG000|Overall Study|Other|18|||
128691642|NCT03643575|463170967|FG002|Washout: 7 Days|Non compliance check in|0|||
128691643|NCT03643575|463170968|FG003|Washout: 7 Days|Non compliance check in|0|||
128691644|NCT03643575|463170969|FG004|Washout: 7 Days|Non compliance check in|0|||
128895310|NCT00073528|463911719|FG001|Overall Study|Other|19|||
128895311|NCT00073528|463911718|FG000|Overall Study|Other|9|||
128895312|NCT00073528|463911719|FG001|Overall Study|Other|12|||
128895313|NCT00073528|463911718|FG000|Overall Study|Protocol Violation|3|||
128895314|NCT00073528|463911719|FG001|Overall Study|Protocol Violation|5|||
128691645|NCT03643575|463170970|FG005|Washout: 7 Days|Non compliance check in|0|||
128691646|NCT01189604|463170971|FG000|Overall Study|Impossible to visit|0|||
128895315|NCT03086057|463911720|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
128895316|NCT03086057|463911721|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
128895317|NCT03086057|463911722|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
128895318|NCT03086057|463911723|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
128895319|NCT03086057|463911720|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
128895320|NCT03086057|463911721|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
128895321|NCT03086057|463911722|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
128895322|NCT03086057|463911723|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
128895323|NCT03086057|463911720|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
128895324|NCT03086057|463911721|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
128895325|NCT03086057|463911722|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
128895326|NCT03086057|463911723|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
128691647|NCT01189604|463170972|FG001|Overall Study|Impossible to visit|0|||
128691648|NCT01189604|463170973|FG002|Overall Study|Impossible to visit|0|||
128691649|NCT01189604|463170974|FG003|Overall Study|Impossible to visit|0|||
128691650|NCT01189604|463170975|FG004|Overall Study|Impossible to visit|0|||
128691651|NCT01189604|463170976|FG005|Overall Study|Impossible to visit|1|||
128691652|NCT01189604|463170977|FG006|Overall Study|Impossible to visit|0|||
128691653|NCT01189604|463170971|FG000|Overall Study|Adverse Event|0|||
128691654|NCT01189604|463170972|FG001|Overall Study|Adverse Event|1|||
128764546|NCT01436201|463428357|FG000|Overall Study|Adverse Event|2|||
128895327|NCT03086057|463911720|FG000|Stage 1: PrEP Uptake|Death|1|||
128895328|NCT03086057|463911721|FG001|Stage 1: PrEP Uptake|Death|0|||
128895329|NCT03086057|463911722|FG002|Stage 1: PrEP Uptake|Death|0|||
128895330|NCT03086057|463911723|FG003|Stage 1: PrEP Uptake|Death|0|||
128895331|NCT03086057|463911720|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
128895332|NCT03086057|463911721|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
128895333|NCT03086057|463911722|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
128895334|NCT03086057|463911723|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
128895335|NCT03086057|463911720|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
128895336|NCT03086057|463911721|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
128895337|NCT03086057|463911722|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
128895338|NCT03086057|463911723|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
128895339|NCT03086057|463911720|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
128895340|NCT03086057|463911721|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
128895341|NCT03086057|463911722|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
128895342|NCT03086057|463911723|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
128895343|NCT04305275|463911726|FG000|Overall Study|Adverse Event|4|||
128895344|NCT04305275|463911727|FG001|Overall Study|Adverse Event|0|||
128895345|NCT04305275|463911726|FG000|Overall Study|Lost to Follow-up|1|||
128895346|NCT04305275|463911727|FG001|Overall Study|Lost to Follow-up|1|||
128895347|NCT04305275|463911726|FG000|Overall Study|Withdrawal by Participant|8|||
128895348|NCT04305275|463911727|FG001|Overall Study|Withdrawal by Participant|1|||
128895349|NCT01708291|463911738|FG000|Overall Study|fighting|2|||
128895350|NCT01708291|463911739|FG001|Overall Study|fighting|1|||
128895351|NCT01536951|463911740|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895352|NCT01536951|463911741|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895353|NCT01536951|463911742|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
128895354|NCT01536951|463911743|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895355|NCT01536951|463911744|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895356|NCT01536951|463911745|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895357|NCT01536951|463911746|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895358|NCT01536951|463911747|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895359|NCT01536951|463911748|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
128895360|NCT01536951|463911740|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
128895361|NCT01536951|463911741|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
128895362|NCT01536951|463911742|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
128895363|NCT01536951|463911743|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
128895364|NCT01536951|463911744|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
128895365|NCT01536951|463911745|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
128895366|NCT01536951|463911746|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
128691655|NCT01189604|463170973|FG002|Overall Study|Adverse Event|0|||
128691656|NCT01189604|463170974|FG003|Overall Study|Adverse Event|0|||
128691657|NCT01189604|463170975|FG004|Overall Study|Adverse Event|2|||
129112094|NCT01656395|464705625|FG007|Overall Study|Adverse Event|0|||
129112095|NCT01656395|464705618|FG000|Overall Study|Lack of Efficacy|1|||
129112096|NCT01656395|464705619|FG001|Overall Study|Lack of Efficacy|8|||
129112097|NCT01656395|464705620|FG002|Overall Study|Lack of Efficacy|6|||
129112098|NCT01656395|464705621|FG003|Overall Study|Lack of Efficacy|1|||
129112099|NCT01656395|464705622|FG004|Overall Study|Lack of Efficacy|1|||
129112100|NCT01656395|464705623|FG005|Overall Study|Lack of Efficacy|6|||
129112101|NCT01656395|464705624|FG006|Overall Study|Lack of Efficacy|0|||
129112102|NCT01656395|464705625|FG007|Overall Study|Lack of Efficacy|0|||
129112103|NCT01656395|464705618|FG000|Overall Study|Lost to Follow-up|1|||
129112104|NCT01656395|464705619|FG001|Overall Study|Lost to Follow-up|0|||
129112105|NCT01656395|464705620|FG002|Overall Study|Lost to Follow-up|0|||
129112106|NCT01656395|464705621|FG003|Overall Study|Lost to Follow-up|0|||
128691658|NCT01189604|463170976|FG005|Overall Study|Adverse Event|0|||
128691659|NCT01189604|463170977|FG006|Overall Study|Adverse Event|1|||
128691660|NCT01189604|463170971|FG000|Overall Study|Withdrawal by Subject|1|||
128691661|NCT01189604|463170972|FG001|Overall Study|Withdrawal by Subject|0|||
128691662|NCT01189604|463170973|FG002|Overall Study|Withdrawal by Subject|0|||
128691663|NCT01189604|463170974|FG003|Overall Study|Withdrawal by Subject|0|||
128691664|NCT01189604|463170975|FG004|Overall Study|Withdrawal by Subject|0|||
128691665|NCT01189604|463170976|FG005|Overall Study|Withdrawal by Subject|0|||
128691666|NCT01189604|463170977|FG006|Overall Study|Withdrawal by Subject|0|||
128691667|NCT00986830|463170980|FG000|Overall Study|Death|1|||
128691668|NCT00986830|463170980|FG000|Overall Study|Lost to Follow-up|1|||
128691669|NCT00986830|463170980|FG000|Overall Study|Lack of Efficacy|1|||
128691670|NCT00986830|463170980|FG000|Overall Study|Unable to access sinus with device|5|||
128691671|NCT01332331|463170982|FG000|Overall Study|Lost to Follow-up|0|||
128691672|NCT01332331|463170983|FG001|Overall Study|Lost to Follow-up|1|||
128691673|NCT01332331|463170982|FG000|Overall Study|Adverse Event|1|||
128691674|NCT01332331|463170983|FG001|Overall Study|Adverse Event|1|||
128691675|NCT01332331|463170982|FG000|Overall Study|Physician Decision|1|||
128691676|NCT01332331|463170983|FG001|Overall Study|Physician Decision|0|||
128691677|NCT00538291|463170984|FG000|Overall Study|Adverse Event|2|||
128691678|NCT00538291|463170984|FG000|Overall Study|Withdrawal by Subject|1|||
128691679|NCT00591344|463170985|FG000|Overall Study|Transportation issues|1|||
128691680|NCT00591344|463170986|FG001|Overall Study|Transportation issues|0|||
128691681|NCT00591344|463170985|FG000|Overall Study|Moved out of state|1|||
128691682|NCT00591344|463170986|FG001|Overall Study|Moved out of state|0|||
128691683|NCT00591344|463170985|FG000|Overall Study|Medical complications|1|||
128691684|NCT00591344|463170986|FG001|Overall Study|Medical complications|3|||
128691685|NCT00591344|463170985|FG000|Overall Study|Underwent DBS|2|||
128691686|NCT00591344|463170986|FG001|Overall Study|Underwent DBS|2|||
128691687|NCT00591344|463170985|FG000|Overall Study|Death|0|||
128691688|NCT00591344|463170986|FG001|Overall Study|Death|1|||
128691689|NCT00591344|463170985|FG000|Overall Study|Lost to Follow-up|0|||
128691690|NCT00591344|463170986|FG001|Overall Study|Lost to Follow-up|1|||
128691691|NCT00591344|463170985|FG000|Overall Study|Did not want to come off medication|0|||
128691692|NCT00591344|463170986|FG001|Overall Study|Did not want to come off medication|1|||
128691693|NCT04041375|463170993|FG000|Intervention Phase|Withdrawal by Subject|2|||
128691694|NCT04041375|463170994|FG001|Intervention Phase|Withdrawal by Subject|2|||
128691695|NCT04041375|463170993|FG000|Follow-up Phase|Death|2|||
128691696|NCT04041375|463170994|FG001|Follow-up Phase|Death|0|||
128691697|NCT04041375|463170993|FG000|Follow-up Phase|Lost to Follow-up|2|||
128691698|NCT04041375|463170994|FG001|Follow-up Phase|Lost to Follow-up|1|||
128691699|NCT04041375|463170993|FG000|Follow-up Phase|Too ill|3|||
128691700|NCT04041375|463170994|FG001|Follow-up Phase|Too ill|0|||
128691701|NCT04674644|463171000|FG000|Overall Study|with missing data|37|||
128691702|NCT03277690|463171004|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
128691703|NCT03277690|463171005|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
128691704|NCT03277690|463171004|FG000|Dose Titration and Maintenance|Physician Decision|1|||
128691705|NCT03277690|463171005|FG001|Dose Titration and Maintenance|Physician Decision|0|||
128691706|NCT03277690|463171004|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
128691707|NCT03277690|463171005|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
128691708|NCT03277690|463171004|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
129112107|NCT01656395|464705622|FG004|Overall Study|Lost to Follow-up|0|||
129112108|NCT01656395|464705623|FG005|Overall Study|Lost to Follow-up|0|||
128691709|NCT03277690|463171005|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
128691710|NCT03277690|463171004|FG000|Dose Titration and Maintenance|Adverse Event|15|||
128691711|NCT03277690|463171005|FG001|Dose Titration and Maintenance|Adverse Event|0|||
128691712|NCT03277690|463171004|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
128691713|NCT03277690|463171005|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
128691714|NCT03277690|463171004|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
128691715|NCT03277690|463171005|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
128691716|NCT00747812|463171006|FG000|Overall Study|Research Site Staff Relocation|5|||
129112109|NCT01656395|464705624|FG006|Overall Study|Lost to Follow-up|0|||
129112110|NCT01656395|464705625|FG007|Overall Study|Lost to Follow-up|0|||
129112111|NCT01656395|464705618|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128764547|NCT01436201|463428357|FG000|Overall Study|Withdrawal by Subject|1|||
128764548|NCT01436201|463428357|FG000|Overall Study|Protocol Violation|1|||
128764549|NCT00263328|463428358|FG000|Overall Study|Death|0|||
128764550|NCT00263328|463428359|FG001|Overall Study|Death|0|||
128764551|NCT00263328|463428360|FG002|Overall Study|Death|1|||
128764552|NCT00263328|463428358|FG000|Overall Study|Lost to Follow-up|1|||
128764553|NCT00263328|463428359|FG001|Overall Study|Lost to Follow-up|1|||
128691717|NCT00747812|463171007|FG001|Overall Study|Research Site Staff Relocation|3|||
128691718|NCT01708161|463171008|FG000|Overall Study|Adverse Event|1|||
128691719|NCT01708161|463171009|FG001|Overall Study|Adverse Event|3|||
128691720|NCT01708161|463171010|FG002|Overall Study|Adverse Event|4|||
128691721|NCT01708161|463171011|FG003|Overall Study|Adverse Event|2|||
128691722|NCT01708161|463171012|FG004|Overall Study|Adverse Event|3|||
128691723|NCT01708161|463171013|FG005|Overall Study|Adverse Event|0|||
128691724|NCT01708161|463171008|FG000|Overall Study|Death|0|||
128691725|NCT01708161|463171009|FG001|Overall Study|Death|0|||
128691726|NCT01708161|463171010|FG002|Overall Study|Death|0|||
128691727|NCT01708161|463171011|FG003|Overall Study|Death|1|||
128764554|NCT00263328|463428360|FG002|Overall Study|Lost to Follow-up|0|||
128764555|NCT00263328|463428358|FG000|Overall Study|Withdrawal by Subject|3|||
128764556|NCT00263328|463428359|FG001|Overall Study|Withdrawal by Subject|0|||
128764557|NCT00263328|463428360|FG002|Overall Study|Withdrawal by Subject|1|||
128764558|NCT00263328|463428358|FG000|Overall Study|Other|3|||
128764559|NCT00263328|463428359|FG001|Overall Study|Other|0|||
128764560|NCT00263328|463428360|FG002|Overall Study|Other|1|||
128764561|NCT00263328|463428358|FG000|Overall Study|Adverse Event|1|||
128895367|NCT01536951|463911747|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
128895368|NCT01536951|463911748|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
128895369|NCT01843972|463911749|FG000|Overall Study|Withdrawal by Subject|0|||
128895370|NCT01843972|463911750|FG001|Overall Study|Withdrawal by Subject|0|||
128895371|NCT01843972|463911751|FG002|Overall Study|Withdrawal by Subject|0|||
128895372|NCT01843972|463911752|FG003|Overall Study|Withdrawal by Subject|0|||
128895373|NCT01843972|463911753|FG004|Overall Study|Withdrawal by Subject|1|||
128895374|NCT01843972|463911754|FG005|Overall Study|Withdrawal by Subject|0|||
128895375|NCT01843972|463911755|FG006|Overall Study|Withdrawal by Subject|0|||
128895376|NCT01843972|463911756|FG007|Overall Study|Withdrawal by Subject|0|||
128895377|NCT01843972|463911757|FG008|Overall Study|Withdrawal by Subject|0|||
128895378|NCT01843972|463911758|FG009|Overall Study|Withdrawal by Subject|0|||
128764562|NCT00263328|463428359|FG001|Overall Study|Adverse Event|1|||
128764563|NCT00263328|463428360|FG002|Overall Study|Adverse Event|4|||
128764564|NCT01301274|463428364|FG000|Overall Study|Physician Decision|2|||
128895379|NCT00932425|463911759|FG000|Overall Study|Lost to Follow-up|0|||
128895380|NCT00932425|463911760|FG001|Overall Study|Lost to Follow-up|1|||
128895381|NCT00932425|463911759|FG000|Overall Study|Withdrawal by Subject|0|||
128895382|NCT00932425|463911760|FG001|Overall Study|Withdrawal by Subject|1|||
128895383|NCT00382018|463911761|FG000|Overall Study|Progression|0|||
128895384|NCT00382018|463911762|FG001|Overall Study|Progression|136|||
128895385|NCT00382018|463911763|FG002|Overall Study|Progression|51|||
128895386|NCT00382018|463911764|FG003|Overall Study|Progression|43|||
128895387|NCT00382018|463911761|FG000|Overall Study|Death|0|||
128895388|NCT00382018|463911762|FG001|Overall Study|Death|9|||
128895389|NCT00382018|463911763|FG002|Overall Study|Death|7|||
129022493|NCT00730691|464374671|FG001|Overall Study|Non-compliance with Study Drug|1|||
129022494|NCT00730691|464374672|FG002|Overall Study|Non-compliance with Study Drug|6|||
128691728|NCT01708161|463171012|FG004|Overall Study|Death|0|||
128691729|NCT01708161|463171013|FG005|Overall Study|Death|1|||
128691730|NCT01708161|463171008|FG000|Overall Study|Withdrawal by Subject|0|||
128691731|NCT01708161|463171009|FG001|Overall Study|Withdrawal by Subject|1|||
128895390|NCT00382018|463911764|FG003|Overall Study|Death|11|||
128895391|NCT00382018|463911761|FG000|Overall Study|Withdrawal by Subject|0|||
128895392|NCT00382018|463911762|FG001|Overall Study|Withdrawal by Subject|4|||
128895393|NCT00382018|463911763|FG002|Overall Study|Withdrawal by Subject|3|||
129022495|NCT00730691|464374673|FG003|Overall Study|Non-compliance with Study Drug|3|||
129022496|NCT00730691|464374674|FG004|Overall Study|Non-compliance with Study Drug|3|||
129022497|NCT00730691|464374670|FG000|Overall Study|Protocol Deviations|3|||
128691732|NCT01708161|463171010|FG002|Overall Study|Withdrawal by Subject|1|||
128691733|NCT01708161|463171011|FG003|Overall Study|Withdrawal by Subject|0|||
128691734|NCT01708161|463171012|FG004|Overall Study|Withdrawal by Subject|0|||
128691735|NCT01708161|463171013|FG005|Overall Study|Withdrawal by Subject|0|||
128764565|NCT01301274|463428365|FG001|Overall Study|Physician Decision|1|||
128895394|NCT00382018|463911764|FG003|Overall Study|Withdrawal by Subject|4|||
129022498|NCT00730691|464374671|FG001|Overall Study|Protocol Deviations|5|||
129022499|NCT00730691|464374672|FG002|Overall Study|Protocol Deviations|3|||
128691736|NCT01708161|463171008|FG000|Overall Study|Administrative problems|0|||
128691737|NCT01708161|463171009|FG001|Overall Study|Administrative problems|1|||
128691738|NCT01708161|463171010|FG002|Overall Study|Administrative problems|0|||
128764566|NCT04512066|463428366|FG000|Double-blind Treatment Period|Adverse Event|6|||
128764567|NCT04512066|463428367|FG001|Double-blind Treatment Period|Adverse Event|4|||
128895395|NCT00382018|463911761|FG000|Overall Study|Other, not protocol specified|0|||
128895396|NCT00382018|463911762|FG001|Overall Study|Other, not protocol specified|16|||
128895397|NCT00382018|463911763|FG002|Overall Study|Other, not protocol specified|3|||
128895398|NCT00382018|463911764|FG003|Overall Study|Other, not protocol specified|1|||
128895399|NCT03805750|463911765|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
128895400|NCT03805750|463911766|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
128895401|NCT00789880|463911767|FG000|Overall Study|Adverse Event|0|||
128895402|NCT00789880|463911768|FG001|Overall Study|Adverse Event|0|||
128895403|NCT00789880|463911769|FG002|Overall Study|Adverse Event|0|||
128895404|NCT00789880|463911770|FG003|Overall Study|Adverse Event|0|||
128895405|NCT00789880|463911771|FG004|Overall Study|Adverse Event|1|||
128895406|NCT00789880|463911772|FG005|Overall Study|Adverse Event|0|||
128895407|NCT00789880|463911767|FG000|Overall Study|Protocol Violation|0|||
128895408|NCT00789880|463911768|FG001|Overall Study|Protocol Violation|1|||
128895409|NCT00789880|463911769|FG002|Overall Study|Protocol Violation|0|||
128895410|NCT00789880|463911770|FG003|Overall Study|Protocol Violation|1|||
128895411|NCT00789880|463911771|FG004|Overall Study|Protocol Violation|0|||
128895412|NCT00789880|463911772|FG005|Overall Study|Protocol Violation|0|||
128895413|NCT00789880|463911767|FG000|Overall Study|Withdrawal by Subject|1|||
128895414|NCT00789880|463911768|FG001|Overall Study|Withdrawal by Subject|0|||
128895415|NCT00789880|463911769|FG002|Overall Study|Withdrawal by Subject|0|||
128895416|NCT00789880|463911770|FG003|Overall Study|Withdrawal by Subject|0|||
128895417|NCT00789880|463911771|FG004|Overall Study|Withdrawal by Subject|2|||
128895418|NCT00789880|463911772|FG005|Overall Study|Withdrawal by Subject|0|||
128895419|NCT01977820|463911776|FG000|Overall Study|Sponsor terminated the study|1|||
128895420|NCT01977820|463911777|FG001|Overall Study|Sponsor terminated the study|1|||
128895421|NCT00493220|463911778|FG000|Third Intervention|Withdrawal by Subject|1|||
128895422|NCT00493220|463911779|FG001|Third Intervention|Withdrawal by Subject|0|||
128895423|NCT00493220|463911780|FG002|Third Intervention|Withdrawal by Subject|0|||
128895424|NCT00493220|463911781|FG003|Third Intervention|Withdrawal by Subject|0|||
128895425|NCT00493220|463911782|FG004|Third Intervention|Withdrawal by Subject|0|||
128895426|NCT00493220|463911783|FG005|Third Intervention|Withdrawal by Subject|0|||
128895427|NCT02568475|463911784|FG000|Overall Study|Lost to Follow-up|40|||
128895428|NCT02568475|463911785|FG001|Overall Study|Lost to Follow-up|39|||
128895429|NCT02568475|463911784|FG000|Overall Study|Withdrawal by Subject|2|||
128895430|NCT02568475|463911785|FG001|Overall Study|Withdrawal by Subject|0|||
128895431|NCT02568475|463911784|FG000|Overall Study|Discharged home|4|||
128895432|NCT02568475|463911785|FG001|Overall Study|Discharged home|4|||
128895433|NCT02568475|463911784|FG000|Overall Study|Short-term: Discharge location unknown|4|||
128895434|NCT02568475|463911785|FG001|Overall Study|Short-term: Discharge location unknown|0|||
128895435|NCT02568475|463911784|FG000|Overall Study|Transferred to another facility|1|||
128895436|NCT02568475|463911785|FG001|Overall Study|Transferred to another facility|0|||
128895437|NCT02625233|463911786|FG000|Overall Study|Adverse Event|2|||
128895438|NCT02625233|463911787|FG001|Overall Study|Adverse Event|0|||
128895439|NCT01704287|463913247|FG000|Initial Treatment Period|Death|139|||
128895440|NCT01704287|463913248|FG001|Initial Treatment Period|Death|129|||
128895441|NCT01704287|463913249|FG002|Initial Treatment Period|Death|71|||
128895442|NCT01704287|463913250|FG003|Initial Treatment Period|Death|0|||
128895443|NCT01704287|463913251|FG004|Initial Treatment Period|Death|0|||
128895444|NCT01704287|463913247|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
129112112|NCT01656395|464705619|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129112113|NCT01656395|464705620|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129112114|NCT01656395|464705621|FG003|Overall Study|Non-Compliance with Study Drug|0|||
129112115|NCT01656395|464705622|FG004|Overall Study|Non-Compliance with Study Drug|1|||
129112116|NCT01656395|464705623|FG005|Overall Study|Non-Compliance with Study Drug|1|||
129112117|NCT01656395|464705624|FG006|Overall Study|Non-Compliance with Study Drug|0|||
129112118|NCT01656395|464705625|FG007|Overall Study|Non-Compliance with Study Drug|0|||
129112119|NCT01656395|464705618|FG000|Overall Study|Other|0|||
129112120|NCT01656395|464705619|FG001|Overall Study|Other|0|||
128895445|NCT01704287|463913248|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
128895446|NCT01704287|463913249|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
128895447|NCT01704287|463913250|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
128895448|NCT01704287|463913251|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
128895449|NCT01704287|463913247|FG000|Initial Treatment Period|Lost to Follow-up|5|||
128895450|NCT01704287|463913248|FG001|Initial Treatment Period|Lost to Follow-up|3|||
128895451|NCT01704287|463913249|FG002|Initial Treatment Period|Lost to Follow-up|0|||
129112121|NCT01656395|464705620|FG002|Overall Study|Other|1|||
128691739|NCT01708161|463171011|FG003|Overall Study|Administrative problems|0|||
128691740|NCT01708161|463171012|FG004|Overall Study|Administrative problems|0|||
128691741|NCT01708161|463171013|FG005|Overall Study|Administrative problems|0|||
128691742|NCT01708161|463171008|FG000|Overall Study|Disease progression|3|||
128691743|NCT01708161|463171009|FG001|Overall Study|Disease progression|5|||
128691744|NCT01708161|463171010|FG002|Overall Study|Disease progression|5|||
128691745|NCT01708161|463171011|FG003|Overall Study|Disease progression|13|||
129112122|NCT01656395|464705621|FG003|Overall Study|Other|0|||
129112123|NCT01656395|464705622|FG004|Overall Study|Other|0|||
128691746|NCT01708161|463171012|FG004|Overall Study|Disease progression|3|||
128895452|NCT01704287|463913250|FG003|Initial Treatment Period|Lost to Follow-up|0|||
128895453|NCT01704287|463913251|FG004|Initial Treatment Period|Lost to Follow-up|0|||
128895454|NCT01704287|463913247|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
128895455|NCT01704287|463913248|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
128895456|NCT01704287|463913249|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
128895457|NCT01704287|463913250|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
128895458|NCT01704287|463913251|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
128895459|NCT01704287|463913247|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
128895460|NCT01704287|463913248|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
128895461|NCT01704287|463913249|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
128895462|NCT01704287|463913250|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
128895463|NCT01704287|463913251|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
128895464|NCT01704287|463913247|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
128895465|NCT01704287|463913248|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
128895466|NCT01704287|463913249|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
128895467|NCT01704287|463913250|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
128895468|NCT01704287|463913251|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
128895469|NCT01704287|463913247|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
128895470|NCT01704287|463913248|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
128895471|NCT01704287|463913249|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
128895472|NCT01704287|463913250|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
128895473|NCT01704287|463913251|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
128895474|NCT04024228|463913252|FG000|Overall Study|Adverse Event|1|||
128895475|NCT04024228|463913253|FG001|Overall Study|Adverse Event|0|||
128895476|NCT04024228|463913252|FG000|Overall Study|Protocol Deviation|0|||
128895477|NCT04024228|463913253|FG001|Overall Study|Protocol Deviation|2|||
128895478|NCT04024228|463913252|FG000|Overall Study|Withdrawal by Subject|3|||
128895479|NCT04024228|463913253|FG001|Overall Study|Withdrawal by Subject|4|||
128895480|NCT04490395|463913254|FG000|Overall Study|Lost to Follow-up|0|||
128895481|NCT04490395|463913255|FG001|Overall Study|Lost to Follow-up|1|||
128895482|NCT00938717|463913256|FG000|Overall Study|Adverse Event|10|||
128895483|NCT00938717|463913257|FG001|Overall Study|Adverse Event|41|||
128895484|NCT00938717|463913256|FG000|Overall Study|Protocol Violation|11|||
128895485|NCT00938717|463913257|FG001|Overall Study|Protocol Violation|8|||
128895486|NCT00938717|463913256|FG000|Overall Study|Withdrawal by Subject|26|||
128895487|NCT00938717|463913257|FG001|Overall Study|Withdrawal by Subject|24|||
128895488|NCT00938717|463913256|FG000|Overall Study|Lost to Follow-up|13|||
128895489|NCT00938717|463913257|FG001|Overall Study|Lost to Follow-up|18|||
128895490|NCT00938717|463913256|FG000|Overall Study|Lack of Efficacy|33|||
128895491|NCT00938717|463913257|FG001|Overall Study|Lack of Efficacy|15|||
128895492|NCT00938717|463913256|FG000|Overall Study|Other reason|5|||
128895493|NCT00938717|463913257|FG001|Overall Study|Other reason|2|||
128895494|NCT01462435|463913260|FG000|Overall Study|Lack of Efficacy|1|||
128895495|NCT01462435|463913261|FG001|Overall Study|Lack of Efficacy|0|||
128895496|NCT01462435|463913262|FG002|Overall Study|Lack of Efficacy|0|||
128895497|NCT01462435|463913263|FG003|Overall Study|Lack of Efficacy|3|||
128895498|NCT01462435|463913260|FG000|Overall Study|Physician Decision|0|||
128895499|NCT01462435|463913261|FG001|Overall Study|Physician Decision|0|||
128895500|NCT01462435|463913262|FG002|Overall Study|Physician Decision|1|||
128895501|NCT01462435|463913263|FG003|Overall Study|Physician Decision|0|||
128895502|NCT01462435|463913260|FG000|Overall Study|Withdrawal by Subject|0|||
128895503|NCT01462435|463913261|FG001|Overall Study|Withdrawal by Subject|0|||
128895504|NCT01462435|463913262|FG002|Overall Study|Withdrawal by Subject|0|||
128895505|NCT01462435|463913263|FG003|Overall Study|Withdrawal by Subject|1|||
128895506|NCT01462435|463913260|FG000|Overall Study|Lost to Follow-up|0|||
128895507|NCT01462435|463913261|FG001|Overall Study|Lost to Follow-up|0|||
129022500|NCT00730691|464374673|FG003|Overall Study|Protocol Deviations|7|||
129022501|NCT00730691|464374674|FG004|Overall Study|Protocol Deviations|5|||
129022502|NCT00730691|464374670|FG000|Overall Study|Withdrawal of Consent|7|||
129022503|NCT00730691|464374671|FG001|Overall Study|Withdrawal of Consent|9|||
129022504|NCT00730691|464374672|FG002|Overall Study|Withdrawal of Consent|3|||
129022505|NCT00730691|464374673|FG003|Overall Study|Withdrawal of Consent|6|||
129022506|NCT00730691|464374674|FG004|Overall Study|Withdrawal of Consent|3|||
128895508|NCT01462435|463913262|FG002|Overall Study|Lost to Follow-up|0|||
128895509|NCT01462435|463913263|FG003|Overall Study|Lost to Follow-up|1|||
128895510|NCT05092919|463913264|FG000|Overall Study|Lost to Follow-up|7|||
128895511|NCT05092919|463913264|FG000|Overall Study|Withdrawal by Subject|2|||
128895512|NCT01942148|463913266|FG000|Overall Study|Adverse Event|4|||
128895513|NCT01942148|463913266|FG000|Overall Study|Lack of Efficacy|2|||
128895514|NCT01942148|463913266|FG000|Overall Study|Physician Decision|11|||
128895515|NCT01942148|463913266|FG000|Overall Study|Protocol Violation|1|||
128895516|NCT01942148|463913266|FG000|Overall Study|Withdrawal by Subject|8|||
129022507|NCT00730691|464374670|FG000|Overall Study|Lost to Follow-up|11|||
129022508|NCT00730691|464374671|FG001|Overall Study|Lost to Follow-up|8|||
128895517|NCT01942148|463913266|FG000|Overall Study|Use of the prohibition medicine|1|||
128895518|NCT02163187|463913267|FG000|Overall Study|Device removed|1|||
128895519|NCT02163187|463913268|FG001|Overall Study|Device removed|0|||
128895520|NCT02163187|463913267|FG000|Overall Study|Progressive disease|1|||
128895521|NCT02163187|463913268|FG001|Overall Study|Progressive disease|0|||
128895522|NCT00257725|463913270|FG000|Overall Study|Adverse Event|3|||
128895523|NCT01858532|463913271|FG000|Overall Study|Adverse Event|58|||
128895524|NCT01858532|463913272|FG001|Overall Study|Adverse Event|50|||
128895525|NCT01858532|463913273|FG002|Overall Study|Adverse Event|23|||
128895526|NCT01858532|463913274|FG003|Overall Study|Adverse Event|28|||
128895527|NCT01858532|463913271|FG000|Overall Study|Withdrew consent|71|||
128895528|NCT01858532|463913272|FG001|Overall Study|Withdrew consent|93|||
128895529|NCT01858532|463913273|FG002|Overall Study|Withdrew consent|46|||
128895530|NCT01858532|463913274|FG003|Overall Study|Withdrew consent|27|||
128895531|NCT01858532|463913271|FG000|Overall Study|Lost to Follow-up|17|||
128895532|NCT01858532|463913272|FG001|Overall Study|Lost to Follow-up|26|||
128895533|NCT01858532|463913273|FG002|Overall Study|Lost to Follow-up|11|||
128895534|NCT01858532|463913274|FG003|Overall Study|Lost to Follow-up|14|||
128895535|NCT01858532|463913271|FG000|Overall Study|Deterioration of medical status|3|||
128895536|NCT01858532|463913272|FG001|Overall Study|Deterioration of medical status|4|||
128895537|NCT01858532|463913273|FG002|Overall Study|Deterioration of medical status|3|||
128895538|NCT01858532|463913274|FG003|Overall Study|Deterioration of medical status|7|||
128895539|NCT01858532|463913271|FG000|Overall Study|Investigator request|3|||
128895540|NCT01858532|463913272|FG001|Overall Study|Investigator request|4|||
128895541|NCT01858532|463913273|FG002|Overall Study|Investigator request|2|||
128895542|NCT01858532|463913274|FG003|Overall Study|Investigator request|6|||
128895543|NCT01858532|463913271|FG000|Overall Study|Other, not specified|29|||
128895544|NCT01858532|463913272|FG001|Overall Study|Other, not specified|15|||
128895545|NCT01858532|463913273|FG002|Overall Study|Other, not specified|13|||
128895546|NCT01858532|463913274|FG003|Overall Study|Other, not specified|11|||
128895547|NCT00514514|463913275|FG000|Pre-phase|Death|10|||
128895548|NCT00514514|463913276|FG001|Pre-phase|Death|0|||
129112124|NCT01656395|464705623|FG005|Overall Study|Other|1|||
129112125|NCT01656395|464705624|FG006|Overall Study|Other|0|||
129112126|NCT01656395|464705625|FG007|Overall Study|Other|0|||
129112127|NCT01656395|464705618|FG000|Overall Study|Physician Decision|2|||
129112128|NCT01656395|464705619|FG001|Overall Study|Physician Decision|3|||
129112129|NCT01656395|464705620|FG002|Overall Study|Physician Decision|3|||
129112130|NCT01656395|464705621|FG003|Overall Study|Physician Decision|2|||
129112131|NCT01656395|464705622|FG004|Overall Study|Physician Decision|3|||
129112132|NCT01656395|464705623|FG005|Overall Study|Physician Decision|3|||
129112133|NCT01656395|464705624|FG006|Overall Study|Physician Decision|0|||
129112134|NCT01656395|464705625|FG007|Overall Study|Physician Decision|0|||
129112135|NCT01656395|464705618|FG000|Overall Study|Pregnancy|0|||
129112136|NCT01656395|464705619|FG001|Overall Study|Pregnancy|0|||
129112137|NCT01656395|464705620|FG002|Overall Study|Pregnancy|1|||
129112138|NCT01656395|464705621|FG003|Overall Study|Pregnancy|0|||
129112139|NCT01656395|464705622|FG004|Overall Study|Pregnancy|0|||
129112140|NCT01656395|464705623|FG005|Overall Study|Pregnancy|0|||
129112141|NCT01656395|464705624|FG006|Overall Study|Pregnancy|0|||
129112142|NCT01656395|464705625|FG007|Overall Study|Pregnancy|0|||
129112143|NCT01656395|464705618|FG000|Overall Study|Progressive Disease|0|||
129112144|NCT01656395|464705619|FG001|Overall Study|Progressive Disease|0|||
129112145|NCT01656395|464705620|FG002|Overall Study|Progressive Disease|0|||
129112146|NCT01656395|464705621|FG003|Overall Study|Progressive Disease|0|||
129112147|NCT01656395|464705622|FG004|Overall Study|Progressive Disease|0|||
128764568|NCT04512066|463428368|FG002|Double-blind Treatment Period|Adverse Event|5|||
128895549|NCT00514514|463913277|FG002|Pre-phase|Death|0|||
128895550|NCT00514514|463913275|FG000|Pre-phase|administrative problems|2|||
128895551|NCT00514514|463913276|FG001|Pre-phase|administrative problems|0|||
128895552|NCT00514514|463913277|FG002|Pre-phase|administrative problems|0|||
128895553|NCT00514514|463913275|FG000|Pre-phase|Protocol Violation|6|||
128895554|NCT00514514|463913276|FG001|Pre-phase|Protocol Violation|0|||
128895555|NCT00514514|463913277|FG002|Pre-phase|Protocol Violation|0|||
128895556|NCT00514514|463913275|FG000|Pre-phase|condition no longer requires study drug|7|||
128895557|NCT00514514|463913276|FG001|Pre-phase|condition no longer requires study drug|0|||
128764569|NCT04512066|463428369|FG003|Double-blind Treatment Period|Adverse Event|1|||
128895558|NCT00514514|463913277|FG002|Pre-phase|condition no longer requires study drug|0|||
128895559|NCT00514514|463913275|FG000|Pre-phase|abnormal test procedure results|15|||
128895560|NCT00514514|463913276|FG001|Pre-phase|abnormal test procedure results|0|||
128895561|NCT00514514|463913277|FG002|Pre-phase|abnormal test procedure results|0|||
128895562|NCT00514514|463913275|FG000|Pre-phase|Lost to Follow-up|2|||
128895563|NCT00514514|463913276|FG001|Pre-phase|Lost to Follow-up|0|||
128895564|NCT00514514|463913277|FG002|Pre-phase|Lost to Follow-up|0|||
128895565|NCT00514514|463913275|FG000|Pre-phase|abnormal lab values|23|||
128895566|NCT00514514|463913276|FG001|Pre-phase|abnormal lab values|0|||
129112148|NCT01656395|464705623|FG005|Overall Study|Progressive Disease|1|||
129112149|NCT01656395|464705624|FG006|Overall Study|Progressive Disease|0|||
129112150|NCT01656395|464705625|FG007|Overall Study|Progressive Disease|0|||
129112151|NCT01656395|464705618|FG000|Overall Study|Protocol Violation|6|||
128895567|NCT00514514|463913277|FG002|Pre-phase|abnormal lab values|0|||
128895568|NCT00514514|463913275|FG000|Pre-phase|Lack of Efficacy|35|||
128895569|NCT00514514|463913276|FG001|Pre-phase|Lack of Efficacy|0|||
128895570|NCT00514514|463913277|FG002|Pre-phase|Lack of Efficacy|0|||
128895571|NCT00514514|463913275|FG000|Pre-phase|Adverse Event|137|||
128895572|NCT00514514|463913276|FG001|Pre-phase|Adverse Event|0|||
128895573|NCT00514514|463913277|FG002|Pre-phase|Adverse Event|0|||
128895574|NCT00514514|463913275|FG000|Pre-phase|Withdrawal by Subject|66|||
128895575|NCT00514514|463913276|FG001|Pre-phase|Withdrawal by Subject|0|||
128895576|NCT00514514|463913277|FG002|Pre-phase|Withdrawal by Subject|0|||
128895577|NCT00514514|463913275|FG000|Randomized - 9 Month|Death|3|||
128895578|NCT00514514|463913276|FG001|Randomized - 9 Month|Death|2|||
128895579|NCT00514514|463913277|FG002|Randomized - 9 Month|Death|2|||
128895580|NCT00514514|463913275|FG000|Randomized - 9 Month|Administrative problems|1|||
128895581|NCT00514514|463913276|FG001|Randomized - 9 Month|Administrative problems|1|||
128895582|NCT00514514|463913277|FG002|Randomized - 9 Month|Administrative problems|2|||
128895583|NCT00514514|463913275|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
128895584|NCT00514514|463913276|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
128895585|NCT00514514|463913277|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
128895586|NCT00514514|463913275|FG000|Randomized - 9 Month|Protocol Violation|1|||
128895587|NCT00514514|463913276|FG001|Randomized - 9 Month|Protocol Violation|1|||
128895588|NCT00514514|463913277|FG002|Randomized - 9 Month|Protocol Violation|0|||
128895589|NCT00514514|463913275|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
128895590|NCT00514514|463913276|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
128895591|NCT00514514|463913277|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
128895592|NCT00514514|463913275|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
128895593|NCT00514514|463913276|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
128895594|NCT00514514|463913277|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
128895595|NCT00514514|463913275|FG000|Randomized - 9 Month|Adverse Event|25|||
128895596|NCT00514514|463913276|FG001|Randomized - 9 Month|Adverse Event|44|||
128895597|NCT00514514|463913277|FG002|Randomized - 9 Month|Adverse Event|27|||
128895598|NCT00514514|463913275|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
128895599|NCT00514514|463913276|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
128895600|NCT00514514|463913277|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
128895601|NCT00514514|463913275|FG000|Extension - 4 Years|Lost to Follow-up|12|||
128895602|NCT00514514|463913276|FG001|Extension - 4 Years|Lost to Follow-up|10|||
128895603|NCT00514514|463913277|FG002|Extension - 4 Years|Lost to Follow-up|9|||
128895604|NCT00514514|463913275|FG000|Extension - 4 Years|Administrative problems|3|||
129022509|NCT00730691|464374672|FG002|Overall Study|Lost to Follow-up|13|||
129022510|NCT00730691|464374673|FG003|Overall Study|Lost to Follow-up|15|||
129022511|NCT00730691|464374674|FG004|Overall Study|Lost to Follow-up|13|||
129022512|NCT00730691|464374670|FG000|Overall Study|Other|1|||
129022513|NCT00730691|464374671|FG001|Overall Study|Other|1|||
129022514|NCT00730691|464374672|FG002|Overall Study|Other|1|||
129022515|NCT00730691|464374673|FG003|Overall Study|Other|2|||
129022516|NCT00730691|464374674|FG004|Overall Study|Other|2|||
129022517|NCT02178787|464374675|FG000|Overall Study|Lost to Follow-up|1|||
129022518|NCT02178787|464374676|FG001|Overall Study|Lost to Follow-up|0|||
129022519|NCT02178787|464374675|FG000|Overall Study|Withdrawal by Subject|0|||
129022520|NCT02178787|464374676|FG001|Overall Study|Withdrawal by Subject|2|||
129022521|NCT02178787|464374675|FG000|Overall Study|No TCD window|3|||
129022522|NCT02178787|464374676|FG001|Overall Study|No TCD window|7|||
129022523|NCT02178787|464374675|FG000|Overall Study|Physician Decision|1|||
129022524|NCT02178787|464374676|FG001|Overall Study|Physician Decision|0|||
129022525|NCT02554890|464374677|FG000|Double-blind|Adverse Event|45|||
129022526|NCT02554890|464374678|FG001|Double-blind|Adverse Event|51|||
129022527|NCT02554890|464374677|FG000|Double-blind|Death|6|||
129022528|NCT02554890|464374678|FG001|Double-blind|Death|4|||
128895605|NCT00514514|463913276|FG001|Extension - 4 Years|Administrative problems|1|||
128895606|NCT00514514|463913277|FG002|Extension - 4 Years|Administrative problems|1|||
128895607|NCT00514514|463913275|FG000|Extension - 4 Years|Death|8|||
128895608|NCT00514514|463913276|FG001|Extension - 4 Years|Death|3|||
128895609|NCT00514514|463913277|FG002|Extension - 4 Years|Death|6|||
128895610|NCT00514514|463913275|FG000|Extension - 4 Years|Adverse Event|9|||
128895611|NCT00514514|463913276|FG001|Extension - 4 Years|Adverse Event|6|||
128895612|NCT00514514|463913277|FG002|Extension - 4 Years|Adverse Event|3|||
128895613|NCT03785925|463913279|FG000|Overall Study|Withdrawal by Subject|15|||
129022529|NCT02554890|464374677|FG000|Double-blind|Protocol Violation|1|||
129022530|NCT02554890|464374678|FG001|Double-blind|Protocol Violation|1|||
129022531|NCT02554890|464374677|FG000|Double-blind|Physician Decision|4|||
129022532|NCT02554890|464374678|FG001|Double-blind|Physician Decision|3|||
129022533|NCT02554890|464374677|FG000|Double-blind|Subject/Guardian decision|21|||
129022534|NCT02554890|464374678|FG001|Double-blind|Subject/Guardian decision|16|||
129022535|NCT02554890|464374677|FG000|Double-blind|Lost to Follow-up|7|||
129022536|NCT02554890|464374678|FG001|Double-blind|Lost to Follow-up|5|||
129022537|NCT02554890|464374677|FG000|Double-blind|Technical problems|1|||
129022538|NCT02554890|464374678|FG001|Double-blind|Technical problems|0|||
129022539|NCT02554890|464374677|FG000|Double-blind|Withdrawal by Subject|5|||
129022540|NCT02554890|464374678|FG001|Double-blind|Withdrawal by Subject|6|||
128895614|NCT03785925|463913279|FG000|Overall Study|Lost to Follow-up|1|||
128895615|NCT01848288|463913282|FG000|Overall Study|Death|1|||
128895616|NCT01848288|463913282|FG000|Overall Study|Protocol Violation|1|||
128895617|NCT01848288|463913282|FG000|Overall Study|Withdrawal by Subject|1|||
128895618|NCT03794583|463913287|FG000|Overall Study|Death|8|||
128895619|NCT03794583|463913287|FG000|Overall Study|Study Terminated by Sponsor|24|||
128895620|NCT03794583|463913287|FG000|Overall Study|Withdrawal by Subject|9|||
128895621|NCT00003895|463913288|FG000|Overall Study|Adverse Event|4|||
128895622|NCT00003895|463913289|FG001|Overall Study|Adverse Event|0|||
128895623|NCT00003895|463913288|FG000|Overall Study|Lack of Efficacy|1|||
128895624|NCT00003895|463913289|FG001|Overall Study|Lack of Efficacy|1|||
128895625|NCT00003895|463913288|FG000|Overall Study|Patient Vacation|2|||
128895626|NCT00003895|463913289|FG001|Overall Study|Patient Vacation|0|||
128895627|NCT00003895|463913288|FG000|Overall Study|Withdrawal by Subject|0|||
128895628|NCT00003895|463913289|FG001|Overall Study|Withdrawal by Subject|3|||
128895629|NCT00806195|463913292|FG000|Overall Study|Death|6|||
128895630|NCT00806195|463913293|FG001|Overall Study|Death|0|||
128895631|NCT00806195|463913294|FG002|Overall Study|Death|1|||
128895632|NCT00806195|463913295|FG003|Overall Study|Death|0|||
128895633|NCT00806195|463913292|FG000|Overall Study|Adverse Event|25|||
128895634|NCT00806195|463913293|FG001|Overall Study|Adverse Event|5|||
128895635|NCT00806195|463913294|FG002|Overall Study|Adverse Event|11|||
128895636|NCT00806195|463913295|FG003|Overall Study|Adverse Event|2|||
128895637|NCT00806195|463913292|FG000|Overall Study|Withdrawal by Subject|119|||
128895638|NCT00806195|463913293|FG001|Overall Study|Withdrawal by Subject|31|||
128895639|NCT00806195|463913294|FG002|Overall Study|Withdrawal by Subject|76|||
128895640|NCT00806195|463913295|FG003|Overall Study|Withdrawal by Subject|35|||
128895641|NCT00806195|463913292|FG000|Overall Study|Lost to Follow-up|217|||
128895642|NCT00806195|463913293|FG001|Overall Study|Lost to Follow-up|66|||
128895643|NCT00806195|463913294|FG002|Overall Study|Lost to Follow-up|90|||
128895644|NCT00806195|463913295|FG003|Overall Study|Lost to Follow-up|34|||
128895645|NCT00806195|463913292|FG000|Overall Study|Inappropriate Enrollment|0|||
128895646|NCT00806195|463913293|FG001|Overall Study|Inappropriate Enrollment|1|||
128895647|NCT00806195|463913294|FG002|Overall Study|Inappropriate Enrollment|0|||
128895648|NCT00806195|463913295|FG003|Overall Study|Inappropriate Enrollment|0|||
128895649|NCT00806195|463913292|FG000|Overall Study|Administrative Reason|113|||
128895650|NCT00806195|463913293|FG001|Overall Study|Administrative Reason|35|||
128895651|NCT00806195|463913294|FG002|Overall Study|Administrative Reason|66|||
128895652|NCT00806195|463913295|FG003|Overall Study|Administrative Reason|26|||
128895653|NCT00806195|463913292|FG000|Overall Study|Protocol Violation|34|||
128895654|NCT00806195|463913293|FG001|Overall Study|Protocol Violation|24|||
128895655|NCT00806195|463913294|FG002|Overall Study|Protocol Violation|26|||
128895656|NCT00806195|463913295|FG003|Overall Study|Protocol Violation|9|||
128895657|NCT02490475|463913296|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
128895658|NCT02490475|463913297|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
129022541|NCT02554890|464374677|FG000|Double-blind|Noncompliance with study treatment|6|||
129022542|NCT02554890|464374678|FG001|Double-blind|Noncompliance with study treatment|5|||
129022543|NCT02554890|464374677|FG000|Open-label|Adverse Event|0|||
129022544|NCT02554890|464374678|FG001|Open-label|Adverse Event|30|||
129022545|NCT02554890|464374677|FG000|Open-label|Death|0|||
129022546|NCT02554890|464374678|FG001|Open-label|Death|1|||
129022547|NCT02554890|464374677|FG000|Open-label|Physician Decision|0|||
129022548|NCT02554890|464374678|FG001|Open-label|Physician Decision|1|||
129022549|NCT02554890|464374677|FG000|Open-label|Subject/Guardian decision|0|||
129022550|NCT02554890|464374678|FG001|Open-label|Subject/Guardian decision|11|||
129022551|NCT02554890|464374677|FG000|Open-label|Lost to Follow-up|0|||
129022552|NCT02554890|464374678|FG001|Open-label|Lost to Follow-up|7|||
129022553|NCT02554890|464374677|FG000|Open-label|Technical problems|0|||
129022554|NCT02554890|464374678|FG001|Open-label|Technical problems|1|||
129022555|NCT02554890|464374677|FG000|Open-label|Withdrawal by Subject|0|||
128895659|NCT02490475|463913298|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
128895660|NCT02490475|463913299|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
128895661|NCT02490475|463913296|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
128895662|NCT02490475|463913297|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
128895663|NCT02490475|463913298|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
128895664|NCT02490475|463913299|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
128895665|NCT02490475|463913296|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
128895666|NCT02490475|463913297|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
128895667|NCT02490475|463913298|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
128895668|NCT02490475|463913299|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
129022556|NCT02554890|464374678|FG001|Open-label|Withdrawal by Subject|1|||
129022557|NCT03649477|464374679|FG000|Overall Study|Adverse Event|2|||
129022558|NCT03649477|464374680|FG001|Overall Study|Adverse Event|0|||
129022559|NCT03649477|464374681|FG002|Overall Study|Adverse Event|0|||
129022560|NCT02430480|464374684|FG000|Overall Study|Death|1|||
129022561|NCT02430480|464374684|FG000|Overall Study|Anesthesia concerns|1|||
129022562|NCT02430480|464374684|FG000|Overall Study|Progressed on treatment|1|||
129022563|NCT01097577|464374685|FG000|Overall Study|Adverse Event|0|||
128895669|NCT02490475|463913296|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
128895670|NCT02490475|463913297|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
128895671|NCT02490475|463913298|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
128895672|NCT02490475|463913299|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
128895673|NCT02490475|463913296|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
128895674|NCT02490475|463913297|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
128895675|NCT02490475|463913298|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
128895676|NCT02490475|463913299|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
128895677|NCT02490475|463913296|FG000|Period 2: Extension Phase|Refused Treatment|0|||
128895678|NCT02490475|463913297|FG001|Period 2: Extension Phase|Refused Treatment|0|||
128895679|NCT02490475|463913298|FG002|Period 2: Extension Phase|Refused Treatment|0|||
128895680|NCT02490475|463913299|FG003|Period 2: Extension Phase|Refused Treatment|1|||
128895681|NCT02490475|463913296|FG000|Period 2: Extension Phase|Adverse Event|0|||
128895682|NCT02490475|463913297|FG001|Period 2: Extension Phase|Adverse Event|0|||
128895683|NCT02490475|463913298|FG002|Period 2: Extension Phase|Adverse Event|1|||
128895684|NCT02490475|463913299|FG003|Period 2: Extension Phase|Adverse Event|0|||
128895685|NCT00139776|463913300|FG000|Period I|Did not enter Period II|575|||
128895686|NCT00139776|463913301|FG001|Period I|Did not enter Period II|0|||
128895687|NCT00139776|463913302|FG002|Period I|Did not enter Period II|0|||
128895688|NCT00139776|463913303|FG003|Period I|Did not enter Period II|0|||
128895689|NCT00139776|463913300|FG000|Period II|Not Randomized into Period III|0|||
128895690|NCT00139776|463913301|FG001|Period II|Not Randomized into Period III|322|||
128895691|NCT00139776|463913302|FG002|Period II|Not Randomized into Period III|0|||
128895692|NCT00139776|463913303|FG003|Period II|Not Randomized into Period III|0|||
128895693|NCT00139776|463913300|FG000|Period III|Adverse Event|0|||
128895694|NCT00139776|463913301|FG001|Period III|Adverse Event|0|||
128895695|NCT00139776|463913302|FG002|Period III|Adverse Event|22|||
128895696|NCT00139776|463913303|FG003|Period III|Adverse Event|23|||
128895697|NCT00139776|463913300|FG000|Period III|Other|0|||
128895698|NCT00139776|463913301|FG001|Period III|Other|0|||
128895699|NCT00139776|463913302|FG002|Period III|Other|23|||
128895700|NCT00139776|463913303|FG003|Period III|Other|34|||
128895701|NCT00139776|463913300|FG000|Period III|Lack of Efficacy|0|||
128895702|NCT00139776|463913301|FG001|Period III|Lack of Efficacy|0|||
128895703|NCT00139776|463913302|FG002|Period III|Lack of Efficacy|10|||
128895704|NCT00139776|463913303|FG003|Period III|Lack of Efficacy|24|||
128895705|NCT00139776|463913300|FG000|Period III|Lost to Follow-up|0|||
128895706|NCT00139776|463913301|FG001|Period III|Lost to Follow-up|0|||
128895707|NCT00139776|463913302|FG002|Period III|Lost to Follow-up|5|||
128895708|NCT00139776|463913303|FG003|Period III|Lost to Follow-up|4|||
128895709|NCT00139776|463913300|FG000|Period III|Withdrawal by Subject|0|||
128764570|NCT04512066|463428370|FG004|Double-blind Treatment Period|Adverse Event|0|||
128764571|NCT04512066|463428371|FG005|Double-blind Treatment Period|Adverse Event|0|||
128895710|NCT00139776|463913301|FG001|Period III|Withdrawal by Subject|0|||
128895711|NCT00139776|463913302|FG002|Period III|Withdrawal by Subject|16|||
128895712|NCT00139776|463913303|FG003|Period III|Withdrawal by Subject|21|||
128895713|NCT04912245|463913306|FG000|Overall Study|Withdrawal by Subject|21|||
128895714|NCT04912245|463913307|FG001|Overall Study|Withdrawal by Subject|4|||
128895715|NCT04912245|463913306|FG000|Overall Study|Lost to Follow-up|5|||
128895716|NCT04912245|463913307|FG001|Overall Study|Lost to Follow-up|11|||
128895717|NCT01134614|463913308|FG000|Overall Study|Still on treatment as of March 2013|21|||
128895718|NCT01134614|463913309|FG001|Overall Study|Still on treatment as of March 2013|13|||
128895719|NCT01134614|463913308|FG000|Overall Study|Progressive disease|60|||
128895720|NCT01134614|463913309|FG001|Overall Study|Progressive disease|54|||
128895721|NCT01134614|463913308|FG000|Overall Study|Adverse Event|26|||
128895722|NCT01134614|463913309|FG001|Overall Study|Adverse Event|39|||
128895723|NCT01134614|463913308|FG000|Overall Study|Death|5|||
128895724|NCT01134614|463913309|FG001|Overall Study|Death|8|||
128895725|NCT01134614|463913308|FG000|Overall Study|Withdrawal by Subject|3|||
128895726|NCT01134614|463913309|FG001|Overall Study|Withdrawal by Subject|2|||
128895727|NCT01134614|463913308|FG000|Overall Study|Alternative therapy|2|||
128895728|NCT01134614|463913309|FG001|Overall Study|Alternative therapy|0|||
128895729|NCT01134614|463913308|FG000|Overall Study|Complicating disease|2|||
128895730|NCT01134614|463913309|FG001|Overall Study|Complicating disease|1|||
129022564|NCT01097577|464374686|FG001|Overall Study|Adverse Event|1|||
128895731|NCT01134614|463913308|FG000|Overall Study|Physician's decision|0|||
128895732|NCT01134614|463913309|FG001|Overall Study|Physician's decision|1|||
128895733|NCT01134614|463913308|FG000|Overall Study|Never started treatment|4|||
128895734|NCT01134614|463913309|FG001|Overall Study|Never started treatment|1|||
128895735|NCT01134614|463913308|FG000|Overall Study|Pt received tx not allowed on study|0|||
128895736|NCT01134614|463913309|FG001|Overall Study|Pt received tx not allowed on study|1|||
128895737|NCT01134614|463913308|FG000|Overall Study|Symptomatic deterioration|0|||
128895738|NCT01134614|463913309|FG001|Overall Study|Symptomatic deterioration|1|||
128895739|NCT01134614|463913308|FG000|Overall Study|Patient in hospice care|0|||
128895740|NCT01134614|463913309|FG001|Overall Study|Patient in hospice care|1|||
128895741|NCT02752035|463913310|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
128691747|NCT01708161|463171013|FG005|Overall Study|Disease progression|0|||
128691748|NCT02019277|463171014|FG000|Overall Study|Withdrawal by Subject|3|||
128691749|NCT02019277|463171014|FG000|Overall Study|Death|7|||
128691750|NCT02019277|463171014|FG000|Overall Study|Did no Cooperate|1|||
128691751|NCT02019277|463171014|FG000|Overall Study|Adverse Event|1|||
128691752|NCT02633501|463171016|FG000|Overall Study|Adverse Event|0|||
128691753|NCT02633501|463171017|FG001|Overall Study|Adverse Event|0|||
128691754|NCT02633501|463171018|FG002|Overall Study|Adverse Event|1|||
128691755|NCT02633501|463171019|FG003|Overall Study|Adverse Event|0|||
128691756|NCT02633501|463171020|FG004|Overall Study|Adverse Event|1|||
128691757|NCT02633501|463171021|FG005|Overall Study|Adverse Event|1|||
128691758|NCT02633501|463171016|FG000|Overall Study|Withdrawal by Subject|2|||
128691759|NCT02633501|463171017|FG001|Overall Study|Withdrawal by Subject|1|||
128691760|NCT02633501|463171018|FG002|Overall Study|Withdrawal by Subject|2|||
128691761|NCT02633501|463171019|FG003|Overall Study|Withdrawal by Subject|2|||
128691762|NCT02633501|463171020|FG004|Overall Study|Withdrawal by Subject|1|||
128691763|NCT02633501|463171021|FG005|Overall Study|Withdrawal by Subject|3|||
128691764|NCT02633501|463171016|FG000|Overall Study|Various other reasons|0|||
128691765|NCT02633501|463171017|FG001|Overall Study|Various other reasons|2|||
128691766|NCT02633501|463171018|FG002|Overall Study|Various other reasons|4|||
128691767|NCT02633501|463171019|FG003|Overall Study|Various other reasons|1|||
128691768|NCT02633501|463171020|FG004|Overall Study|Various other reasons|7|||
128691769|NCT02633501|463171021|FG005|Overall Study|Various other reasons|11|||
128691770|NCT02633501|463171016|FG000|Overall Study|Lost to Follow-up|0|||
128691771|NCT02633501|463171017|FG001|Overall Study|Lost to Follow-up|0|||
128691772|NCT02633501|463171018|FG002|Overall Study|Lost to Follow-up|0|||
128691773|NCT02633501|463171019|FG003|Overall Study|Lost to Follow-up|1|||
128691774|NCT02633501|463171020|FG004|Overall Study|Lost to Follow-up|2|||
128691775|NCT02633501|463171021|FG005|Overall Study|Lost to Follow-up|0|||
128691776|NCT01262573|463171022|FG000|Overall Study|Withdrawal by Subject|0|||
128691777|NCT01262573|463171023|FG001|Overall Study|Withdrawal by Subject|1|||
128691778|NCT03800173|463171030|FG000|Overall Study|Lost to Follow-up|0|||
128691779|NCT03800173|463171031|FG001|Overall Study|Lost to Follow-up|0|||
128691780|NCT03800173|463171032|FG002|Overall Study|Lost to Follow-up|0|||
128691781|NCT03800173|463171033|FG003|Overall Study|Lost to Follow-up|0|||
128691782|NCT03800173|463171034|FG004|Overall Study|Lost to Follow-up|1|||
128691783|NCT00936611|463171035|FG000|Overall Study|Progressive Disease|3|||
128691784|NCT00936611|463171035|FG000|Overall Study|New Systemic Therapy|22|||
128691785|NCT00936611|463171035|FG000|Overall Study|Lost to Follow-up|1|||
128691786|NCT00936611|463171035|FG000|Overall Study|Withdrawal by Subject|2|||
128691787|NCT00936611|463171035|FG000|Overall Study|Still on Follow-up|1|||
128691788|NCT00936611|463171035|FG000|Overall Study|Still on Active Therapy|7|||
128691789|NCT00936611|463171035|FG000|Overall Study|Ineligible for Study Drug|3|||
128691790|NCT02507973|463171036|FG000|Overall Study|Adverse Event|1|||
128691791|NCT00910273|463171042|FG000|Overall Study|Lack of Efficacy|6|||
128691792|NCT00910273|463171043|FG001|Overall Study|Lack of Efficacy|9|||
128691793|NCT00910273|463171042|FG000|Overall Study|Adverse Event|1|||
128691794|NCT00910273|463171043|FG001|Overall Study|Adverse Event|1|||
128691795|NCT00910273|463171042|FG000|Overall Study|Withdrawal by Subject|1|||
128691796|NCT00910273|463171043|FG001|Overall Study|Withdrawal by Subject|0|||
129022565|NCT00316186|464374694|FG000|Overall Study|Adverse Event|6|||
129022566|NCT00316186|464374694|FG000|Overall Study|Disease Progression|4|||
129022567|NCT00316186|464374694|FG000|Overall Study|Lost to Follow-up|1|||
129022568|NCT00316186|464374694|FG000|Overall Study|Other|1|||
129022569|NCT04493684|464374697|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
129022570|NCT04493684|464374698|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022571|NCT04493684|464374699|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
129022572|NCT04493684|464374700|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022573|NCT04493684|464374701|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022574|NCT04493684|464374702|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
129022575|NCT04493684|464374703|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022576|NCT04493684|464374704|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022577|NCT04493684|464374705|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022578|NCT04493684|464374706|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022579|NCT04493684|464374707|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022580|NCT04493684|464374708|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022581|NCT04493684|464374709|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022582|NCT04493684|464374710|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022583|NCT04493684|464374711|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
128691797|NCT00910273|463171042|FG000|Overall Study|Discontinuation of study by sponsor|8|||
128691798|NCT00910273|463171043|FG001|Overall Study|Discontinuation of study by sponsor|2|||
128691799|NCT00910273|463171042|FG000|Overall Study|Protocol Violation|1|||
128691800|NCT00910273|463171043|FG001|Overall Study|Protocol Violation|0|||
128691801|NCT00910273|463171042|FG000|Overall Study|Lost to Follow-up|1|||
128895742|NCT02752035|463913311|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
128895743|NCT02752035|463913312|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
128895744|NCT02752035|463913313|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
128895745|NCT02752035|463913310|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
128895746|NCT02752035|463913311|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
128895747|NCT02752035|463913312|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
128895748|NCT02752035|463913313|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
128895749|NCT02752035|463913310|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
128895750|NCT02752035|463913311|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
128895751|NCT02752035|463913312|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
128895752|NCT02752035|463913313|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
128895753|NCT02752035|463913310|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
128895754|NCT02752035|463913311|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
128895755|NCT02752035|463913312|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
128895756|NCT02752035|463913313|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
128895757|NCT02752035|463913310|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
128895758|NCT02752035|463913311|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
128895759|NCT02752035|463913312|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
128895760|NCT02752035|463913313|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
128895761|NCT02752035|463913310|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
128895762|NCT02752035|463913311|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
128895763|NCT02752035|463913312|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
128895764|NCT02752035|463913313|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
128895765|NCT02752035|463913310|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
128895766|NCT02752035|463913311|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
128895767|NCT02752035|463913312|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
128895768|NCT02752035|463913313|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
128895769|NCT02752035|463913310|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
128895770|NCT02752035|463913311|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
128895771|NCT02752035|463913312|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
128895772|NCT02752035|463913313|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
128895773|NCT02752035|463913310|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
128895774|NCT02752035|463913311|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
128895775|NCT02752035|463913312|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
128895776|NCT02752035|463913313|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
128895777|NCT02752035|463913310|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
128895778|NCT02752035|463913311|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
128895779|NCT02752035|463913312|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
128895780|NCT02752035|463913313|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
128895781|NCT02752035|463913310|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
128895782|NCT02752035|463913311|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
128895783|NCT02752035|463913312|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
128895784|NCT02752035|463913313|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
128895785|NCT02752035|463913310|FG000|Randomization: Approximately 3 Years|Death|0|||
128895786|NCT02752035|463913311|FG001|Randomization: Approximately 3 Years|Death|25|||
128895787|NCT02752035|463913312|FG002|Randomization: Approximately 3 Years|Death|13|||
128895788|NCT02752035|463913313|FG003|Randomization: Approximately 3 Years|Death|4|||
128895789|NCT02752035|463913310|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
128895790|NCT02752035|463913311|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
128895791|NCT02752035|463913312|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
128895792|NCT02752035|463913313|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
128895793|NCT02752035|463913310|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
128895794|NCT02752035|463913311|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
128895795|NCT02752035|463913312|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
128895796|NCT02752035|463913313|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
128895797|NCT02752035|463913310|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
128895798|NCT02752035|463913311|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
128895799|NCT02752035|463913312|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
128895800|NCT02752035|463913313|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
128895801|NCT02752035|463913310|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
128895802|NCT02752035|463913311|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
128895803|NCT02752035|463913312|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
128895804|NCT02752035|463913313|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
128895805|NCT02752035|463913310|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
128895806|NCT02752035|463913311|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
128895807|NCT02752035|463913312|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
129022584|NCT04493684|464374712|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022585|NCT04493684|464374713|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129022586|NCT04493684|464374697|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
129022587|NCT04493684|464374698|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022588|NCT04493684|464374699|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022589|NCT04493684|464374700|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022590|NCT04493684|464374701|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022591|NCT04493684|464374702|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022592|NCT04493684|464374703|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022593|NCT04493684|464374704|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022594|NCT04493684|464374705|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022595|NCT04493684|464374706|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022596|NCT04493684|464374707|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022597|NCT04493684|464374708|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022598|NCT04493684|464374709|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022599|NCT04493684|464374710|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022600|NCT04493684|464374711|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022601|NCT04493684|464374712|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022602|NCT04493684|464374713|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129022603|NCT04493684|464374697|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022604|NCT04493684|464374698|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022605|NCT04493684|464374699|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022606|NCT04493684|464374700|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022607|NCT04493684|464374701|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022608|NCT04493684|464374702|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022609|NCT04493684|464374703|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
129022610|NCT04493684|464374704|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022611|NCT04493684|464374705|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
128691802|NCT00910273|463171043|FG001|Overall Study|Lost to Follow-up|1|||
128691803|NCT01011738|463171044|FG000|Overall Study|Death|12|||
128691804|NCT01011738|463171045|FG001|Overall Study|Death|3|||
128691805|NCT01011738|463171046|FG002|Overall Study|Death|0|||
128691806|NCT01011738|463171044|FG000|Overall Study|Unknown reasons|312|||
128691807|NCT01011738|463171045|FG001|Overall Study|Unknown reasons|291|||
128691808|NCT01011738|463171046|FG002|Overall Study|Unknown reasons|17|||
128691809|NCT00543543|463171047|FG000|Base Study|Adverse Event|1|||
128691810|NCT00543543|463171048|FG001|Base Study|Adverse Event|11|||
128691811|NCT00543543|463171049|FG002|Base Study|Adverse Event|0|||
128691812|NCT00543543|463171050|FG003|Base Study|Adverse Event|5|||
128895808|NCT02752035|463913313|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
128895809|NCT01519934|463913318|FG000|Overall Study|Lost to Follow-up|3|||
128895810|NCT01368536|463913321|FG000|Overall Study|Adverse Event|5|||
128895811|NCT01368536|463913322|FG001|Overall Study|Adverse Event|6|||
128895812|NCT01368536|463913323|FG002|Overall Study|Adverse Event|8|||
128895813|NCT01368536|463913321|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128895814|NCT01368536|463913322|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128895815|NCT01368536|463913323|FG002|Overall Study|Abnormal laboratory value(s)|2|||
128895816|NCT01368536|463913321|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128895817|NCT01368536|463913322|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128895818|NCT01368536|463913323|FG002|Overall Study|Abnormal test procedure result(s)|1|||
128895819|NCT01368536|463913321|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
128895820|NCT01368536|463913322|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128895821|NCT01368536|463913323|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
128895822|NCT01368536|463913321|FG000|Overall Study|No longer required study medication|0|||
128895823|NCT01368536|463913322|FG001|Overall Study|No longer required study medication|0|||
128895824|NCT01368536|463913323|FG002|Overall Study|No longer required study medication|1|||
128895825|NCT01368536|463913321|FG000|Overall Study|Withdrawal by Subject|2|||
128895826|NCT01368536|463913322|FG001|Overall Study|Withdrawal by Subject|5|||
128895827|NCT01368536|463913323|FG002|Overall Study|Withdrawal by Subject|4|||
128895828|NCT01368536|463913321|FG000|Overall Study|Lost to Follow-up|3|||
128895829|NCT01368536|463913322|FG001|Overall Study|Lost to Follow-up|3|||
128895830|NCT01368536|463913323|FG002|Overall Study|Lost to Follow-up|5|||
128895831|NCT01368536|463913321|FG000|Overall Study|Administrative problems|34|||
128895832|NCT01368536|463913322|FG001|Overall Study|Administrative problems|39|||
128691813|NCT00543543|463171047|FG000|Base Study|Lost to Follow-up|12|||
128691814|NCT00543543|463171048|FG001|Base Study|Lost to Follow-up|749|||
128691815|NCT00543543|463171049|FG002|Base Study|Lost to Follow-up|9|||
128691816|NCT00543543|463171050|FG003|Base Study|Lost to Follow-up|701|||
128691817|NCT00543543|463171047|FG000|Base Study|Physician Decision|0|||
128895833|NCT01368536|463913323|FG002|Overall Study|Administrative problems|35|||
128895834|NCT01368536|463913321|FG000|Overall Study|Protocol deviation|0|||
128895835|NCT01368536|463913322|FG001|Overall Study|Protocol deviation|3|||
128895836|NCT01368536|463913323|FG002|Overall Study|Protocol deviation|1|||
128895837|NCT02164929|463913324|FG000|Overall Study|Converted to open procedure|1|||
128895838|NCT02164929|463913325|FG001|Overall Study|Converted to open procedure|0|||
128895839|NCT02164929|463913326|FG002|Overall Study|Converted to open procedure|0|||
128895840|NCT02164929|463913327|FG003|Overall Study|Converted to open procedure|2|||
128895841|NCT02164929|463913324|FG000|Overall Study|Failed regional block|0|||
128895842|NCT02164929|463913325|FG001|Overall Study|Failed regional block|0|||
128895843|NCT02164929|463913326|FG002|Overall Study|Failed regional block|1|||
128895844|NCT02164929|463913327|FG003|Overall Study|Failed regional block|0|||
128895845|NCT03023059|463913329|FG000|Overall Study|Withdrawal by Subject|5|||
128895846|NCT00596947|463913334|FG000|Overall Study|study halted due to low enrollment|5|||
128895847|NCT00596947|463913335|FG001|Overall Study|study halted due to low enrollment|3|||
128895848|NCT00596947|463913334|FG000|Overall Study|Lost to Follow-up|1|||
128895849|NCT00596947|463913335|FG001|Overall Study|Lost to Follow-up|0|||
128895850|NCT00496730|463913336|FG000|Overall Study|Lost to Follow-up|4|||
128895851|NCT00496730|463913337|FG001|Overall Study|Lost to Follow-up|3|||
128895852|NCT00496730|463913336|FG000|Overall Study|Withdrawal by Subject|2|||
128895853|NCT00496730|463913337|FG001|Overall Study|Withdrawal by Subject|2|||
128895854|NCT00113074|463913339|FG000|Overall Study|Lost to Follow-up|10|||
128895855|NCT00113074|463913340|FG001|Overall Study|Lost to Follow-up|10|||
128895856|NCT00113074|463913341|FG002|Overall Study|Lost to Follow-up|14|||
128895857|NCT02114268|463913342|FG000|Overall Study|Lost to Follow-up|4|||
128895858|NCT02114268|463913343|FG001|Overall Study|Lost to Follow-up|1|||
128895859|NCT02114268|463913344|FG002|Overall Study|Lost to Follow-up|1|||
128895860|NCT02114268|463913345|FG003|Overall Study|Lost to Follow-up|0|||
128895861|NCT02114268|463913346|FG004|Overall Study|Lost to Follow-up|0|||
128895862|NCT02114268|463913347|FG005|Overall Study|Lost to Follow-up|2|||
128895863|NCT02114268|463913342|FG000|Overall Study|Withdrawal by Subject|1|||
128895864|NCT02114268|463913343|FG001|Overall Study|Withdrawal by Subject|0|||
128895865|NCT02114268|463913344|FG002|Overall Study|Withdrawal by Subject|0|||
128895866|NCT02114268|463913345|FG003|Overall Study|Withdrawal by Subject|0|||
128895867|NCT02114268|463913346|FG004|Overall Study|Withdrawal by Subject|0|||
128895868|NCT02114268|463913347|FG005|Overall Study|Withdrawal by Subject|1|||
128895869|NCT02114268|463913342|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
128895870|NCT02114268|463913343|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
128895871|NCT02114268|463913344|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
128895872|NCT02114268|463913345|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
128895873|NCT02114268|463913346|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
128895874|NCT02114268|463913347|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
128895875|NCT03962738|463913348|FG000|Overall Study|Protocol Deviation|3|||
128895876|NCT03962738|463913349|FG001|Overall Study|Protocol Deviation|0|||
128895877|NCT03962738|463913350|FG002|Overall Study|Protocol Deviation|1|||
128895878|NCT03962738|463913351|FG003|Overall Study|Protocol Deviation|1|||
128895879|NCT03962738|463913348|FG000|Overall Study|Withdrawal by Subject|4|||
128895880|NCT03962738|463913349|FG001|Overall Study|Withdrawal by Subject|0|||
128895881|NCT03962738|463913350|FG002|Overall Study|Withdrawal by Subject|0|||
128895882|NCT03962738|463913351|FG003|Overall Study|Withdrawal by Subject|0|||
128895883|NCT03962738|463913348|FG000|Overall Study|Lost to Follow-up|0|||
128895884|NCT03962738|463913349|FG001|Overall Study|Lost to Follow-up|0|||
128895885|NCT03962738|463913350|FG002|Overall Study|Lost to Follow-up|1|||
128895886|NCT03962738|463913351|FG003|Overall Study|Lost to Follow-up|0|||
128895887|NCT00509067|463913352|FG000|Overall Study|Lost to Follow-up|1|||
128895888|NCT00509067|463913353|FG001|Overall Study|Lost to Follow-up|1|||
128895889|NCT00509067|463913352|FG000|Overall Study|Adverse Event|3|||
128895890|NCT00509067|463913353|FG001|Overall Study|Adverse Event|1|||
128895891|NCT00509067|463913352|FG000|Overall Study|Protocol Violation|0|||
128895892|NCT00509067|463913353|FG001|Overall Study|Protocol Violation|3|||
128895893|NCT00131469|463913354|FG000|Overall Study|Withdrawal by Subject|3|||
128895894|NCT00131469|463913355|FG001|Overall Study|Withdrawal by Subject|4|||
128895895|NCT00131469|463913354|FG000|Overall Study|Protocol Violation|3|||
128895896|NCT00131469|463913355|FG001|Overall Study|Protocol Violation|1|||
128895897|NCT00131469|463913354|FG000|Overall Study|Death|0|||
128895898|NCT00131469|463913355|FG001|Overall Study|Death|1|||
128895899|NCT00131469|463913354|FG000|Overall Study|Lost to Follow-up|0|||
128895900|NCT00131469|463913355|FG001|Overall Study|Lost to Follow-up|1|||
128895901|NCT00131469|463913354|FG000|Overall Study|scan not analyzable|3|||
128895902|NCT00131469|463913355|FG001|Overall Study|scan not analyzable|6|||
128895903|NCT00574288|463913356|FG000|Overall Study|Adverse Event|2|||
128895904|NCT00574288|463913357|FG001|Overall Study|Adverse Event|0|||
128895905|NCT00574288|463913358|FG002|Overall Study|Adverse Event|0|||
128895906|NCT00574288|463913359|FG003|Overall Study|Adverse Event|0|||
128895907|NCT00574288|463913360|FG004|Overall Study|Adverse Event|1|||
128895908|NCT00574288|463913361|FG005|Overall Study|Adverse Event|0|||
128895909|NCT00574288|463913362|FG006|Overall Study|Adverse Event|0|||
128895910|NCT00574288|463913356|FG000|Overall Study|Death|0|||
128895911|NCT00574288|463913357|FG001|Overall Study|Death|0|||
128895912|NCT00574288|463913358|FG002|Overall Study|Death|0|||
128895913|NCT00574288|463913359|FG003|Overall Study|Death|0|||
128895914|NCT00574288|463913360|FG004|Overall Study|Death|0|||
128895915|NCT00574288|463913361|FG005|Overall Study|Death|25|||
128895916|NCT00574288|463913362|FG006|Overall Study|Death|21|||
128895917|NCT00574288|463913356|FG000|Overall Study|Lost to Follow-up|0|||
128895918|NCT00574288|463913357|FG001|Overall Study|Lost to Follow-up|0|||
128895919|NCT00574288|463913358|FG002|Overall Study|Lost to Follow-up|0|||
128895920|NCT00574288|463913359|FG003|Overall Study|Lost to Follow-up|0|||
128895921|NCT00574288|463913360|FG004|Overall Study|Lost to Follow-up|0|||
128895922|NCT00574288|463913361|FG005|Overall Study|Lost to Follow-up|1|||
128895923|NCT00574288|463913362|FG006|Overall Study|Lost to Follow-up|2|||
128895924|NCT00574288|463913356|FG000|Overall Study|Study Terminated By Sponsor|0|||
128895925|NCT00574288|463913357|FG001|Overall Study|Study Terminated By Sponsor|0|||
128895926|NCT00574288|463913358|FG002|Overall Study|Study Terminated By Sponsor|0|||
128895927|NCT00574288|463913359|FG003|Overall Study|Study Terminated By Sponsor|0|||
128895928|NCT00574288|463913360|FG004|Overall Study|Study Terminated By Sponsor|0|||
128895929|NCT00574288|463913361|FG005|Overall Study|Study Terminated By Sponsor|0|||
128895930|NCT00574288|463913362|FG006|Overall Study|Study Terminated By Sponsor|5|||
128895931|NCT00574288|463913356|FG000|Overall Study|Progressive Disease|17|||
128895932|NCT00574288|463913357|FG001|Overall Study|Progressive Disease|2|||
128895933|NCT00574288|463913358|FG002|Overall Study|Progressive Disease|3|||
129112152|NCT01656395|464705619|FG001|Overall Study|Protocol Violation|6|||
129112153|NCT01656395|464705620|FG002|Overall Study|Protocol Violation|9|||
129112154|NCT01656395|464705621|FG003|Overall Study|Protocol Violation|2|||
129112155|NCT01656395|464705622|FG004|Overall Study|Protocol Violation|4|||
129112156|NCT01656395|464705623|FG005|Overall Study|Protocol Violation|10|||
129112157|NCT01656395|464705624|FG006|Overall Study|Protocol Violation|0|||
129112158|NCT01656395|464705625|FG007|Overall Study|Protocol Violation|0|||
129112159|NCT01656395|464705618|FG000|Overall Study|Screen Failure|2|||
129112160|NCT01656395|464705619|FG001|Overall Study|Screen Failure|1|||
129112161|NCT01656395|464705620|FG002|Overall Study|Screen Failure|7|||
129112162|NCT01656395|464705621|FG003|Overall Study|Screen Failure|1|||
129112163|NCT01656395|464705622|FG004|Overall Study|Screen Failure|0|||
129112164|NCT01656395|464705623|FG005|Overall Study|Screen Failure|8|||
129112165|NCT01656395|464705624|FG006|Overall Study|Screen Failure|0|||
129112166|NCT01656395|464705625|FG007|Overall Study|Screen Failure|0|||
129112167|NCT01656395|464705618|FG000|Overall Study|Withdrawal by Subject|3|||
129112168|NCT01656395|464705619|FG001|Overall Study|Withdrawal by Subject|1|||
129112169|NCT01656395|464705620|FG002|Overall Study|Withdrawal by Subject|4|||
129112170|NCT01656395|464705621|FG003|Overall Study|Withdrawal by Subject|2|||
129112171|NCT01656395|464705622|FG004|Overall Study|Withdrawal by Subject|0|||
129112172|NCT01656395|464705623|FG005|Overall Study|Withdrawal by Subject|3|||
129112173|NCT01656395|464705624|FG006|Overall Study|Withdrawal by Subject|0|||
129112174|NCT01656395|464705625|FG007|Overall Study|Withdrawal by Subject|0|||
129112175|NCT03075267|464705626|FG000|Overall Study|Protocol Violation|1|||
129112176|NCT03075267|464705627|FG001|Overall Study|Protocol Violation|0|||
129112177|NCT03075267|464705628|FG002|Overall Study|Protocol Violation|0|||
129112178|NCT00676403|464705629|FG000|Overall Study|Adverse Event|1|||
129112179|NCT00676403|464705630|FG001|Overall Study|Adverse Event|2|||
129112180|NCT00676403|464705631|FG002|Overall Study|Adverse Event|0|||
129112181|NCT00676403|464705632|FG003|Overall Study|Adverse Event|5|||
129112182|NCT00676403|464705633|FG004|Overall Study|Adverse Event|1|||
129112183|NCT00676403|464705634|FG005|Overall Study|Adverse Event|2|||
129112184|NCT00676403|464705629|FG000|Overall Study|Lost to Follow-up|0|||
129112185|NCT00676403|464705630|FG001|Overall Study|Lost to Follow-up|0|||
129112186|NCT00676403|464705631|FG002|Overall Study|Lost to Follow-up|0|||
129112187|NCT00676403|464705632|FG003|Overall Study|Lost to Follow-up|0|||
129112188|NCT00676403|464705633|FG004|Overall Study|Lost to Follow-up|0|||
129112189|NCT00676403|464705634|FG005|Overall Study|Lost to Follow-up|1|||
129112190|NCT00676403|464705629|FG000|Overall Study|Reason Unspecified|1|||
129112191|NCT00676403|464705630|FG001|Overall Study|Reason Unspecified|0|||
129112192|NCT00676403|464705631|FG002|Overall Study|Reason Unspecified|1|||
129112193|NCT00676403|464705632|FG003|Overall Study|Reason Unspecified|0|||
129112194|NCT00676403|464705633|FG004|Overall Study|Reason Unspecified|0|||
129112195|NCT00676403|464705634|FG005|Overall Study|Reason Unspecified|1|||
129112196|NCT00676403|464705629|FG000|Overall Study|Withdrawal by Subject|0|||
128895934|NCT00574288|463913359|FG003|Overall Study|Progressive Disease|2|||
129112197|NCT00676403|464705630|FG001|Overall Study|Withdrawal by Subject|0|||
129112198|NCT00676403|464705631|FG002|Overall Study|Withdrawal by Subject|0|||
129112199|NCT00676403|464705632|FG003|Overall Study|Withdrawal by Subject|0|||
129112200|NCT00676403|464705633|FG004|Overall Study|Withdrawal by Subject|0|||
128895935|NCT00574288|463913360|FG004|Overall Study|Progressive Disease|1|||
128895936|NCT00574288|463913361|FG005|Overall Study|Progressive Disease|0|||
128895937|NCT00574288|463913362|FG006|Overall Study|Progressive Disease|0|||
128895938|NCT00574288|463913356|FG000|Overall Study|Other|1|||
128895939|NCT00574288|463913357|FG001|Overall Study|Other|1|||
129112201|NCT00676403|464705634|FG005|Overall Study|Withdrawal by Subject|1|||
129112202|NCT01746862|464705638|FG000|Overall Study|Withdrawal by Subject|1|||
129112203|NCT01746862|464705639|FG001|Overall Study|Withdrawal by Subject|1|||
128895940|NCT00574288|463913358|FG002|Overall Study|Other|0|||
128895941|NCT00574288|463913359|FG003|Overall Study|Other|0|||
128895942|NCT00574288|463913360|FG004|Overall Study|Other|0|||
128895943|NCT00574288|463913361|FG005|Overall Study|Other|0|||
128895944|NCT00574288|463913362|FG006|Overall Study|Other|0|||
128895945|NCT02361944|463913366|FG000|Overall Study|surgery cancellation|0|||
128895946|NCT02361944|463913367|FG001|Overall Study|surgery cancellation|1|||
128895947|NCT03654976|463913368|FG000|Overall Study|Withdrawal by Subject|12|||
128895948|NCT03654976|463913369|FG001|Overall Study|Withdrawal by Subject|11|||
128895949|NCT03654976|463913368|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
128895950|NCT03654976|463913369|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
128895951|NCT03654976|463913368|FG000|Overall Study|Adverse Event|5|||
128895952|NCT03654976|463913369|FG001|Overall Study|Adverse Event|0|||
128895953|NCT03654976|463913368|FG000|Overall Study|Lost to Follow-up|2|||
128895954|NCT03654976|463913369|FG001|Overall Study|Lost to Follow-up|0|||
128895955|NCT03654976|463913368|FG000|Overall Study|Lack of Efficacy|0|||
128895956|NCT03654976|463913369|FG001|Overall Study|Lack of Efficacy|1|||
128895957|NCT00117598|463913370|FG000|Prior to Treatment Cross Over|Death|40|||
128895958|NCT00117598|463913371|FG001|Prior to Treatment Cross Over|Death|41|||
128895959|NCT00117598|463913372|FG002|Prior to Treatment Cross Over|Death|37|||
128895960|NCT00117598|463913373|FG003|Prior to Treatment Cross Over|Death|0|||
128895961|NCT00117598|463913374|FG004|Prior to Treatment Cross Over|Death|0|||
128895962|NCT00117598|463913370|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
128895963|NCT00117598|463913371|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
128895964|NCT00117598|463913372|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
128895965|NCT00117598|463913373|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
128895966|NCT00117598|463913374|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
128895967|NCT00117598|463913370|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
128895968|NCT00117598|463913371|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
128895969|NCT00117598|463913372|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
128895970|NCT00117598|463913373|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
128895971|NCT00117598|463913374|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
128895972|NCT00117598|463913370|FG000|Prior to Treatment Cross Over|Other|15|||
128895973|NCT00117598|463913371|FG001|Prior to Treatment Cross Over|Other|9|||
128895974|NCT00117598|463913372|FG002|Prior to Treatment Cross Over|Other|9|||
128895975|NCT00117598|463913373|FG003|Prior to Treatment Cross Over|Other|0|||
128895976|NCT00117598|463913374|FG004|Prior to Treatment Cross Over|Other|0|||
128895977|NCT00117598|463913370|FG000|After Treament Cross Over|Death|0|||
128895978|NCT00117598|463913371|FG001|After Treament Cross Over|Death|0|||
128895979|NCT00117598|463913372|FG002|After Treament Cross Over|Death|0|||
128895980|NCT00117598|463913373|FG003|After Treament Cross Over|Death|1|||
128895981|NCT00117598|463913374|FG004|After Treament Cross Over|Death|2|||
128895982|NCT00117598|463913370|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
128895983|NCT00117598|463913371|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
128895984|NCT00117598|463913372|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
128895985|NCT00117598|463913373|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
128895986|NCT00117598|463913374|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
128895987|NCT00117598|463913370|FG000|After Treament Cross Over|Other|0|||
128895988|NCT00117598|463913371|FG001|After Treament Cross Over|Other|0|||
128895989|NCT00117598|463913372|FG002|After Treament Cross Over|Other|0|||
128895990|NCT00117598|463913373|FG003|After Treament Cross Over|Other|1|||
128895991|NCT00117598|463913374|FG004|After Treament Cross Over|Other|2|||
128895992|NCT03098836|463913375|FG000|Overall Study|Adverse Event|1|||
128895993|NCT03098836|463913376|FG001|Overall Study|Adverse Event|3|||
128895994|NCT03098836|463913375|FG000|Overall Study|Lack of Efficacy|30|||
128895995|NCT03098836|463913376|FG001|Overall Study|Lack of Efficacy|15|||
128895996|NCT03098836|463913375|FG000|Overall Study|Physician Decision|2|||
128895997|NCT03098836|463913376|FG001|Overall Study|Physician Decision|1|||
128895998|NCT03098836|463913375|FG000|Overall Study|Withdrawal by Subject|3|||
128895999|NCT03098836|463913376|FG001|Overall Study|Withdrawal by Subject|2|||
128896000|NCT04688775|463913379|FG000|Placebo-controlled Period|Randomized, not treated|1|||
128896001|NCT04688775|463913380|FG001|Placebo-controlled Period|Randomized, not treated|1|||
128896002|NCT04688775|463913381|FG002|Placebo-controlled Period|Randomized, not treated|0|||
128896003|NCT04688775|463913382|FG003|Placebo-controlled Period|Randomized, not treated|0|||
128896004|NCT04688775|463913379|FG000|Placebo-controlled Period|Adverse Event|2|||
128896005|NCT04688775|463913380|FG001|Placebo-controlled Period|Adverse Event|0|||
128896006|NCT04688775|463913381|FG002|Placebo-controlled Period|Adverse Event|0|||
128896007|NCT04688775|463913382|FG003|Placebo-controlled Period|Adverse Event|0|||
128896008|NCT04688775|463913379|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
128896009|NCT04688775|463913380|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
128896010|NCT04688775|463913381|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
128896011|NCT04688775|463913382|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
128896012|NCT04688775|463913379|FG000|Placebo-controlled Period|Protocol Violation|0|||
128896013|NCT04688775|463913380|FG001|Placebo-controlled Period|Protocol Violation|1|||
128896014|NCT04688775|463913381|FG002|Placebo-controlled Period|Protocol Violation|0|||
128896015|NCT04688775|463913382|FG003|Placebo-controlled Period|Protocol Violation|0|||
128896016|NCT04688775|463913379|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
128896017|NCT04688775|463913380|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
128896018|NCT04688775|463913381|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
128896019|NCT04688775|463913382|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
128896020|NCT04688775|463913379|FG000|Placebo-controlled Period|Other reasons|0|||
128896021|NCT04688775|463913380|FG001|Placebo-controlled Period|Other reasons|1|||
128896022|NCT04688775|463913381|FG002|Placebo-controlled Period|Other reasons|0|||
128896023|NCT04688775|463913382|FG003|Placebo-controlled Period|Other reasons|0|||
128896024|NCT04688775|463913379|FG000|Delayed Start Period|Adverse Event|0|||
128896025|NCT04688775|463913380|FG001|Delayed Start Period|Adverse Event|0|||
128896026|NCT04688775|463913381|FG002|Delayed Start Period|Adverse Event|1|||
128896027|NCT04688775|463913382|FG003|Delayed Start Period|Adverse Event|0|||
128896028|NCT04688775|463913379|FG000|Delayed Start Period|Lack of Efficacy|0|||
128896029|NCT04688775|463913380|FG001|Delayed Start Period|Lack of Efficacy|0|||
128896030|NCT04688775|463913381|FG002|Delayed Start Period|Lack of Efficacy|0|||
128896031|NCT04688775|463913382|FG003|Delayed Start Period|Lack of Efficacy|3|||
128896032|NCT04688775|463913379|FG000|Delayed Start Period|Withdrawal by Subject|0|||
128896033|NCT04688775|463913380|FG001|Delayed Start Period|Withdrawal by Subject|0|||
128896034|NCT04688775|463913381|FG002|Delayed Start Period|Withdrawal by Subject|2|||
128896035|NCT04688775|463913382|FG003|Delayed Start Period|Withdrawal by Subject|4|||
128896036|NCT04688775|463913379|FG000|Delayed Start Period|Lost to Follow-up|0|||
128896037|NCT04688775|463913380|FG001|Delayed Start Period|Lost to Follow-up|0|||
128896038|NCT04688775|463913381|FG002|Delayed Start Period|Lost to Follow-up|2|||
128896039|NCT04688775|463913382|FG003|Delayed Start Period|Lost to Follow-up|1|||
128896040|NCT04688775|463913379|FG000|Delayed Start Period|other reasons|0|||
128896041|NCT04688775|463913380|FG001|Delayed Start Period|other reasons|0|||
128896042|NCT04688775|463913381|FG002|Delayed Start Period|other reasons|1|||
128896043|NCT04688775|463913382|FG003|Delayed Start Period|other reasons|0|||
128896044|NCT01770912|463913383|FG000|Overall Study|Lost to Follow-up|2|||
128896045|NCT01770912|463913384|FG001|Overall Study|Lost to Follow-up|0|||
128896046|NCT01817751|463913389|FG000|Overall Study|Physician Decision|1|||
128896047|NCT02811549|463913390|FG000|Overall Study|Lost to Follow-up|1|||
128896048|NCT02811549|463913390|FG000|Overall Study|Withdrawal by Subject|3|||
128896049|NCT02811549|463913390|FG000|Overall Study|Subject screen failed|4|||
128896050|NCT02811549|463913390|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
128896051|NCT03472924|463913392|FG000|Overall Study|Adverse Event|1|||
128896052|NCT03472924|463913393|FG001|Overall Study|Adverse Event|0|||
128896053|NCT00427349|463913395|FG000|Overall Study|Lack of Efficacy|23|||
128896054|NCT00427349|463913395|FG000|Overall Study|Adverse Event|14|||
128896055|NCT00427349|463913395|FG000|Overall Study|Death|1|||
128896056|NCT00427349|463913395|FG000|Overall Study|Withdrawal by Subject|3|||
128896057|NCT00427349|463913395|FG000|Overall Study|Alternative therapy|1|||
128896058|NCT00427349|463913395|FG000|Overall Study|Other|2|||
128896059|NCT00427349|463913395|FG000|Overall Study|Ineligible|1|||
128896060|NCT00427349|463913395|FG000|Overall Study|Never started therapy|1|||
128896061|NCT03697720|463914817|FG000|Overall Study|Lost to Follow-up|7|||
128896062|NCT03496012|463914822|FG000|Overall Study|Withdrawal by Subject|2|||
128896063|NCT03496012|463914823|FG001|Overall Study|Withdrawal by Subject|0|||
128896064|NCT03496012|463914824|FG002|Overall Study|Withdrawal by Subject|2|||
128896065|NCT03496012|463914822|FG000|Overall Study|Adverse Event|0|||
128896066|NCT03496012|463914823|FG001|Overall Study|Adverse Event|0|||
128896067|NCT03496012|463914824|FG002|Overall Study|Adverse Event|1|||
128896068|NCT03496012|463914822|FG000|Overall Study|Reason Not Specified|2|||
128896069|NCT03496012|463914823|FG001|Overall Study|Reason Not Specified|0|||
128896070|NCT03496012|463914824|FG002|Overall Study|Reason Not Specified|1|||
128896071|NCT00937937|463914825|FG000|Overall Study|Adverse Event|6|||
128896072|NCT00937937|463914825|FG000|Overall Study|Withdrawal by Subject|2|||
128896073|NCT00937937|463914825|FG000|Overall Study|Progression/relapse|61|||
128896074|NCT00937937|463914825|FG000|Overall Study|Death|1|||
128896075|NCT00937937|463914825|FG000|Overall Study|Other|2|||
128896076|NCT02248259|463914826|FG000|Treatment Period 1|Adverse Event|0|||
128896077|NCT02248259|463914827|FG001|Treatment Period 1|Adverse Event|0|||
128896078|NCT02248259|463914828|FG002|Treatment Period 1|Adverse Event|1|||
128896079|NCT02248259|463914829|FG003|Treatment Period 1|Adverse Event|0|||
128896080|NCT01543152|463914830|FG000|Overall Study|Withdrawal by Subject|0|||
128896081|NCT01543152|463914831|FG001|Overall Study|Withdrawal by Subject|2|||
128896082|NCT01543152|463914832|FG002|Overall Study|Withdrawal by Subject|0|||
128896083|NCT01543152|463914833|FG003|Overall Study|Withdrawal by Subject|0|||
128896084|NCT01543152|463914834|FG004|Overall Study|Withdrawal by Subject|0|||
128896085|NCT02932410|463914835|FG000|Overall Study|Death|7|||
128896086|NCT02932410|463914836|FG001|Overall Study|Death|6|||
128896087|NCT02932410|463914837|FG002|Overall Study|Death|0|||
128896088|NCT02932410|463914838|FG003|Overall Study|Death|0|||
128896089|NCT02932410|463914835|FG000|Overall Study|Lost to Follow-up|1|||
128896090|NCT02932410|463914836|FG001|Overall Study|Lost to Follow-up|2|||
128896091|NCT02932410|463914837|FG002|Overall Study|Lost to Follow-up|0|||
128896092|NCT02932410|463914838|FG003|Overall Study|Lost to Follow-up|0|||
128896093|NCT02932410|463914835|FG000|Overall Study|Parent/Subjects decision|6|||
128896094|NCT02932410|463914836|FG001|Overall Study|Parent/Subjects decision|6|||
128896095|NCT02932410|463914837|FG002|Overall Study|Parent/Subjects decision|1|||
128896096|NCT02932410|463914838|FG003|Overall Study|Parent/Subjects decision|0|||
128896097|NCT02932410|463914835|FG000|Overall Study|Physician Decision|0|||
128896098|NCT02932410|463914836|FG001|Overall Study|Physician Decision|1|||
128896099|NCT02932410|463914837|FG002|Overall Study|Physician Decision|0|||
128896100|NCT02932410|463914838|FG003|Overall Study|Physician Decision|0|||
128896101|NCT02573870|463914839|FG000|Overall Study|Adverse Event|0|||
128896102|NCT02573870|463914840|FG001|Overall Study|Adverse Event|2|||
128896103|NCT02573870|463914839|FG000|Overall Study|Lack of Efficacy|0|||
128896104|NCT02573870|463914840|FG001|Overall Study|Lack of Efficacy|1|||
128896105|NCT02573870|463914839|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
128896106|NCT02573870|463914840|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
128896107|NCT02573870|463914839|FG000|Overall Study|Lost to Follow-up|0|||
128896108|NCT02573870|463914840|FG001|Overall Study|Lost to Follow-up|1|||
128896109|NCT02573870|463914839|FG000|Overall Study|Other: Fail to Meet Visit|0|||
128896110|NCT02573870|463914840|FG001|Overall Study|Other: Fail to Meet Visit|2|||
128896111|NCT01007032|463914850|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
128896112|NCT01007032|463914851|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
128896113|NCT01007032|463914852|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
128896114|NCT01007032|463914853|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
128896115|NCT01007032|463914850|FG000|Overall Study|Withdrawal by Subject|0|||
128896116|NCT01007032|463914851|FG001|Overall Study|Withdrawal by Subject|0|||
128896117|NCT01007032|463914852|FG002|Overall Study|Withdrawal by Subject|0|||
128896118|NCT01007032|463914853|FG003|Overall Study|Withdrawal by Subject|1|||
128896119|NCT00677820|463914854|FG000|Overall Study|Lost to Follow-up|1|||
128896120|NCT00677820|463914855|FG001|Overall Study|Lost to Follow-up|0|||
128896121|NCT01101438|463914859|FG000|Overall Study|Withdrawal by Subject|8|||
128896122|NCT01101438|463914860|FG001|Overall Study|Withdrawal by Subject|9|||
128896123|NCT00290290|463914883|FG000|Overall Study|Death|3|||
128896124|NCT00290290|463914884|FG001|Overall Study|Death|4|||
128896125|NCT00290290|463914883|FG000|Overall Study|Withdrawal by Subject|2|||
128896126|NCT00290290|463914884|FG001|Overall Study|Withdrawal by Subject|2|||
128896127|NCT00290290|463914883|FG000|Overall Study|Underwent clean surgical procedure|13|||
128896128|NCT00290290|463914884|FG001|Overall Study|Underwent clean surgical procedure|12|||
128896129|NCT00549939|463914887|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
128896130|NCT00549939|463914888|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
128896131|NCT00549939|463914889|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
128896132|NCT00549939|463914887|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
129022612|NCT04493684|464374706|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022613|NCT04493684|464374707|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022614|NCT04493684|464374708|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022615|NCT04493684|464374709|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
128691818|NCT00543543|463171048|FG001|Base Study|Physician Decision|4|||
128691819|NCT00543543|463171049|FG002|Base Study|Physician Decision|0|||
128691820|NCT00543543|463171050|FG003|Base Study|Physician Decision|7|||
128691821|NCT00543543|463171047|FG000|Base Study|Protocol Violation|0|||
128691822|NCT00543543|463171048|FG001|Base Study|Protocol Violation|6|||
128896133|NCT00549939|463914888|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
128896134|NCT00549939|463914889|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
129022616|NCT04493684|464374710|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022617|NCT04493684|464374711|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022618|NCT04493684|464374712|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022619|NCT04493684|464374713|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129022620|NCT04493684|464374697|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
129022621|NCT04493684|464374698|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022622|NCT04493684|464374699|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022623|NCT04493684|464374700|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022624|NCT04493684|464374701|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022625|NCT04493684|464374702|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022626|NCT04493684|464374703|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022627|NCT04493684|464374704|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
128691823|NCT00543543|463171049|FG002|Base Study|Protocol Violation|0|||
128691824|NCT00543543|463171050|FG003|Base Study|Protocol Violation|6|||
128691825|NCT00543543|463171047|FG000|Base Study|Withdrawal by Subject|7|||
128896135|NCT00549939|463914887|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
128896136|NCT00549939|463914888|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
129112204|NCT01746862|464705638|FG000|Overall Study|Protocol Violation|1|||
128896137|NCT00549939|463914889|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
128896138|NCT00549939|463914887|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
128896139|NCT00549939|463914888|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
128896140|NCT00549939|463914889|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
128896141|NCT00549939|463914887|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
128896142|NCT00549939|463914888|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
128896143|NCT00549939|463914889|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
128896144|NCT00549939|463914887|FG000|40-week Open Label Treatment Period|Other|0|||
128896145|NCT00549939|463914888|FG001|40-week Open Label Treatment Period|Other|1|||
128896146|NCT00549939|463914889|FG002|40-week Open Label Treatment Period|Other|4|||
128896147|NCT03677596|463914890|FG000|Overall Study|Adverse Event|0|||
128896148|NCT03677596|463914891|FG001|Overall Study|Adverse Event|1|||
129112205|NCT01746862|464705639|FG001|Overall Study|Protocol Violation|0|||
129112206|NCT01746862|464705638|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
129112207|NCT01746862|464705639|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
129112208|NCT01746862|464705638|FG000|Overall Study|Entered puberty during the study|1|||
129112209|NCT01746862|464705639|FG001|Overall Study|Entered puberty during the study|0|||
129112210|NCT04742673|464705640|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
129112211|NCT04742673|464705641|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
129112212|NCT06058390|464705643|FG000|Overall Study|Lost to Follow-up|0|||
129112213|NCT06058390|464705644|FG001|Overall Study|Lost to Follow-up|0|||
129112214|NCT06058390|464705645|FG002|Overall Study|Lost to Follow-up|2|||
129112215|NCT06058390|464705646|FG003|Overall Study|Lost to Follow-up|1|||
129112216|NCT06058390|464705643|FG000|Overall Study|Physician Decision|0|||
129112217|NCT06058390|464705644|FG001|Overall Study|Physician Decision|0|||
129112218|NCT06058390|464705645|FG002|Overall Study|Physician Decision|0|||
129112219|NCT06058390|464705646|FG003|Overall Study|Physician Decision|1|||
129112220|NCT06058390|464705643|FG000|Overall Study|Participants did not receive any study intervention|0|||
129112221|NCT06058390|464705644|FG001|Overall Study|Participants did not receive any study intervention|0|||
129112222|NCT06058390|464705645|FG002|Overall Study|Participants did not receive any study intervention|0|||
129112223|NCT06058390|464705646|FG003|Overall Study|Participants did not receive any study intervention|1|||
129112224|NCT03361306|464705647|FG000|Overall Study|Death|6|||
129112225|NCT04073303|464705648|FG000|Overall Study|Adverse Event|0|||
129112226|NCT04073303|464705649|FG001|Overall Study|Adverse Event|2|||
129112227|NCT04073303|464705648|FG000|Overall Study|Withdrawal by Subject|16|||
129112228|NCT04073303|464705649|FG001|Overall Study|Withdrawal by Subject|36|||
129112229|NCT04073303|464705648|FG000|Overall Study|Lost to Follow-up|6|||
129112230|NCT04073303|464705649|FG001|Overall Study|Lost to Follow-up|1|||
129112231|NCT04073303|464705648|FG000|Overall Study|Protocol Deviation|0|||
129112232|NCT04073303|464705649|FG001|Overall Study|Protocol Deviation|4|||
129112233|NCT04073303|464705648|FG000|Overall Study|Other|1|||
129112234|NCT04073303|464705649|FG001|Overall Study|Other|1|||
129112235|NCT04144322|464705652|FG000|Overall Study|Lack of Efficacy|2|||
129112236|NCT04144322|464705653|FG001|Overall Study|Lack of Efficacy|2|||
129112237|NCT02131064|464705662|FG000|Overall Study|Death|5|||
129112238|NCT02131064|464705663|FG001|Overall Study|Death|6|||
129112239|NCT02131064|464705662|FG000|Overall Study|Lost to Follow-up|4|||
129112240|NCT02131064|464705663|FG001|Overall Study|Lost to Follow-up|8|||
129112241|NCT02131064|464705662|FG000|Overall Study|Withdrawal by Subject|14|||
129112242|NCT02131064|464705663|FG001|Overall Study|Withdrawal by Subject|18|||
129112243|NCT02131064|464705662|FG000|Overall Study|Other|2|||
129112244|NCT02131064|464705663|FG001|Overall Study|Other|2|||
129112245|NCT03589807|464705664|FG000|Overall Study|Lost to Follow-up|0|||
128896149|NCT03677596|463914890|FG000|Overall Study|Death|10|||
128896150|NCT03677596|463914891|FG001|Overall Study|Death|6|||
128896151|NCT03677596|463914890|FG000|Overall Study|Lost to Follow-up|0|||
128896152|NCT03677596|463914891|FG001|Overall Study|Lost to Follow-up|1|||
129022628|NCT04493684|464374705|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022629|NCT04493684|464374706|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022630|NCT04493684|464374707|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022631|NCT04493684|464374708|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022632|NCT04493684|464374709|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022633|NCT04493684|464374710|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022634|NCT04493684|464374711|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022635|NCT04493684|464374712|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129112246|NCT03589807|464705665|FG001|Overall Study|Lost to Follow-up|2|||
129112247|NCT03589807|464705666|FG002|Overall Study|Lost to Follow-up|2|||
129112248|NCT03589807|464705667|FG003|Overall Study|Lost to Follow-up|3|||
129022636|NCT04493684|464374713|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129022637|NCT04493684|464374697|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129112249|NCT03589807|464705668|FG004|Overall Study|Lost to Follow-up|1|||
129112250|NCT03589807|464705669|FG005|Overall Study|Lost to Follow-up|1|||
129112251|NCT03589807|464705664|FG000|Overall Study|Withdrawal by Subject|0|||
129112252|NCT03589807|464705665|FG001|Overall Study|Withdrawal by Subject|5|||
129112253|NCT03589807|464705666|FG002|Overall Study|Withdrawal by Subject|0|||
129112254|NCT03589807|464705667|FG003|Overall Study|Withdrawal by Subject|0|||
128896153|NCT03677596|463914890|FG000|Overall Study|Progressive Disease|8|||
128896154|NCT03677596|463914891|FG001|Overall Study|Progressive Disease|8|||
128896155|NCT03677596|463914890|FG000|Overall Study|Withdrawal by Subject|3|||
128896156|NCT03677596|463914891|FG001|Overall Study|Withdrawal by Subject|0|||
128896157|NCT03677596|463914890|FG000|Overall Study|Disease Relapse|2|||
128896158|NCT03677596|463914891|FG001|Overall Study|Disease Relapse|2|||
128896159|NCT03677596|463914890|FG000|Overall Study|Other|0|||
128896160|NCT03677596|463914891|FG001|Overall Study|Other|1|||
128896161|NCT05197049|463914894|FG000|Overall Study|Death|0|||
128896162|NCT05197049|463914895|FG001|Overall Study|Death|1|||
128896163|NCT05197049|463914896|FG002|Overall Study|Death|0|||
128896164|NCT05197049|463914894|FG000|Overall Study|Lost to Follow-up|3|||
128896165|NCT05197049|463914895|FG001|Overall Study|Lost to Follow-up|1|||
128896166|NCT05197049|463914896|FG002|Overall Study|Lost to Follow-up|0|||
128896167|NCT05197049|463914894|FG000|Overall Study|Withdrawal by Subject|15|||
128896168|NCT05197049|463914895|FG001|Overall Study|Withdrawal by Subject|3|||
128896169|NCT05197049|463914896|FG002|Overall Study|Withdrawal by Subject|1|||
128896170|NCT05197049|463914894|FG000|Overall Study|GCP non-compliance|1|||
128896171|NCT05197049|463914895|FG001|Overall Study|GCP non-compliance|2|||
128896172|NCT05197049|463914896|FG002|Overall Study|GCP non-compliance|0|||
128896173|NCT01161043|463914899|FG000|Overall Study|Withdrawal by Subject|3|||
128896174|NCT00971178|463914906|FG000|Overall Study|Lost to Follow-up|2|||
128896175|NCT00971178|463914907|FG001|Overall Study|Lost to Follow-up|2|||
128896176|NCT00971178|463914908|FG002|Overall Study|Lost to Follow-up|2|||
128896177|NCT00424749|463914909|FG000|Overall Study|Withdrawal by Subject|1|||
128896178|NCT02577406|463914910|FG000|Randomized Period|Death|1|||
128896179|NCT02577406|463914911|FG001|Randomized Period|Death|0|||
128896180|NCT02577406|463914910|FG000|Randomized Period|Other reasons|0|||
128896181|NCT02577406|463914911|FG001|Randomized Period|Other reasons|20|||
128896182|NCT02577406|463914910|FG000|Treatment Period|Death|38|||
128896183|NCT02577406|463914911|FG001|Treatment Period|Death|23|||
128896184|NCT02577406|463914910|FG000|Treatment Period|Adverse Event|17|||
128896185|NCT02577406|463914911|FG001|Treatment Period|Adverse Event|12|||
128896186|NCT02577406|463914910|FG000|Treatment Period|Progressive Disease|53|||
128896187|NCT02577406|463914911|FG001|Treatment Period|Progressive Disease|37|||
128896188|NCT02577406|463914910|FG000|Treatment Period|Withdrawal by Subject|10|||
128896189|NCT02577406|463914911|FG001|Treatment Period|Withdrawal by Subject|24|||
128896190|NCT02577406|463914910|FG000|Treatment Period|Lost to Follow-up|0|||
128896191|NCT02577406|463914911|FG001|Treatment Period|Lost to Follow-up|1|||
128896192|NCT02577406|463914910|FG000|Treatment Period|Transition to commercially available treatment|1|||
128896193|NCT02577406|463914911|FG001|Treatment Period|Transition to commercially available treatment|1|||
128896194|NCT02577406|463914910|FG000|Treatment Period|Physician Decision|1|||
128896195|NCT02577406|463914911|FG001|Treatment Period|Physician Decision|0|||
128896196|NCT02577406|463914910|FG000|Treatment Period|Disease Relapse|28|||
128896197|NCT02577406|463914911|FG001|Treatment Period|Disease Relapse|1|||
128896198|NCT02577406|463914910|FG000|Treatment Period|Protocol Violation|0|||
128896199|NCT02577406|463914911|FG001|Treatment Period|Protocol Violation|1|||
128896200|NCT02577406|463914910|FG000|Treatment Period|Other Reasons|3|||
128896201|NCT02577406|463914911|FG001|Treatment Period|Other Reasons|39|||
128896202|NCT02577406|463914910|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
128896203|NCT02577406|463914911|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
128896204|NCT02138617|463914912|FG000|Overall Study|Death|1|||
128896205|NCT02138617|463914913|FG001|Overall Study|Death|2|||
128896206|NCT02138617|463914914|FG002|Overall Study|Death|2|||
128896207|NCT02138617|463914912|FG000|Overall Study|Adverse Event|8|||
128896208|NCT02138617|463914913|FG001|Overall Study|Adverse Event|5|||
128896209|NCT02138617|463914914|FG002|Overall Study|Adverse Event|2|||
128896210|NCT02138617|463914912|FG000|Overall Study|Disease Progression|20|||
128896211|NCT02138617|463914913|FG001|Overall Study|Disease Progression|13|||
128896212|NCT02138617|463914914|FG002|Overall Study|Disease Progression|4|||
128896213|NCT02138617|463914912|FG000|Overall Study|Withdrawal by Subject|7|||
128896214|NCT02138617|463914913|FG001|Overall Study|Withdrawal by Subject|10|||
128896215|NCT02138617|463914914|FG002|Overall Study|Withdrawal by Subject|2|||
128896216|NCT02138617|463914912|FG000|Overall Study|other complicating disease|0|||
128896217|NCT02138617|463914913|FG001|Overall Study|other complicating disease|2|||
128691826|NCT00543543|463171048|FG001|Base Study|Withdrawal by Subject|482|||
128691827|NCT00543543|463171049|FG002|Base Study|Withdrawal by Subject|5|||
128896218|NCT02138617|463914914|FG002|Overall Study|other complicating disease|0|||
128896219|NCT02138617|463914912|FG000|Overall Study|Protocol Violation|1|||
128896220|NCT02138617|463914913|FG001|Overall Study|Protocol Violation|0|||
128896221|NCT02138617|463914914|FG002|Overall Study|Protocol Violation|0|||
128896222|NCT02138617|463914912|FG000|Overall Study|Physician Decision|7|||
128896223|NCT02138617|463914913|FG001|Overall Study|Physician Decision|6|||
128896224|NCT02138617|463914914|FG002|Overall Study|Physician Decision|0|||
128896225|NCT02138617|463914912|FG000|Overall Study|financial reason|0|||
128896226|NCT02138617|463914913|FG001|Overall Study|financial reason|1|||
128896227|NCT02138617|463914914|FG002|Overall Study|financial reason|0|||
128896228|NCT02138617|463914912|FG000|Overall Study|other therapy|3|||
128896229|NCT02138617|463914913|FG001|Overall Study|other therapy|4|||
128896230|NCT02138617|463914914|FG002|Overall Study|other therapy|0|||
128896231|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
128896232|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
128896233|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896234|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896235|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896236|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
128896237|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
128896238|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896239|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896240|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896241|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896242|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896243|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896244|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
128896245|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896246|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896247|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896248|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896249|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896250|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
128896251|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
128896252|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896253|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896254|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896255|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896256|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896257|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896258|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
128896259|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
128896260|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896261|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896262|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896263|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896264|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896265|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
128896266|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896267|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896268|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896269|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896270|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128691828|NCT00543543|463171050|FG003|Base Study|Withdrawal by Subject|503|||
128691829|NCT00543543|463171047|FG000|Extension Study|Adverse Event|0|||
128896271|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129022638|NCT04493684|464374698|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022639|NCT04493684|464374699|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022640|NCT04493684|464374700|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022641|NCT04493684|464374701|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022642|NCT04493684|464374702|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
129022643|NCT04493684|464374703|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022644|NCT04493684|464374704|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022645|NCT04493684|464374705|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022646|NCT04493684|464374706|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022647|NCT04493684|464374707|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022648|NCT04493684|464374708|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022649|NCT04493684|464374709|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022650|NCT04493684|464374710|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022651|NCT04493684|464374711|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022652|NCT04493684|464374712|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022653|NCT04493684|464374713|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129022654|NCT04493684|464374697|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022655|NCT04493684|464374698|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022656|NCT04493684|464374699|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022657|NCT04493684|464374700|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022658|NCT04493684|464374701|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
128896272|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
128896273|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896274|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896275|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896276|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896277|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896278|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
128896279|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
128896280|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896281|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896282|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896283|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896284|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896285|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896286|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
128896287|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896288|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896289|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896290|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896291|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896292|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896293|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
128896294|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896295|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896296|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896297|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896298|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896299|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896300|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
128896301|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
128896302|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
128896303|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
128896304|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896305|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896306|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
128896307|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
128896308|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896309|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896310|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896311|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896312|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896313|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896314|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
128896315|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896316|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
128896317|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896318|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896319|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896320|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
128896321|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896322|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896323|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896324|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896325|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896326|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896327|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896328|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
128896329|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
129022659|NCT04493684|464374702|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022660|NCT04493684|464374703|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022661|NCT04493684|464374704|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022662|NCT04493684|464374705|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022663|NCT04493684|464374706|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022664|NCT04493684|464374707|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
128896330|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129022665|NCT04493684|464374708|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
128896331|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896332|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896333|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896334|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
128896335|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896336|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896337|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896338|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896339|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896340|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896341|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896342|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
128896343|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896344|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896345|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896346|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
128896347|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
128896348|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896349|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896350|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
128896351|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
128896352|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896353|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896354|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896355|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896356|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
128896357|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896358|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896359|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896360|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896361|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896362|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896363|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896364|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
128896365|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
128896366|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896367|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896368|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896369|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896370|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
128896371|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896372|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896373|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896374|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896375|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896376|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896377|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896378|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896379|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
128896380|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896381|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896382|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896383|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896384|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
128896385|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896386|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896387|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896388|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
128691830|NCT00543543|463171048|FG001|Extension Study|Adverse Event|0|||
128691831|NCT00543543|463171049|FG002|Extension Study|Adverse Event|0|||
128691832|NCT00543543|463171050|FG003|Extension Study|Adverse Event|5|||
129022666|NCT04493684|464374709|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022667|NCT04493684|464374710|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022668|NCT04493684|464374711|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
128691833|NCT00543543|463171047|FG000|Extension Study|Lost to Follow-up|0|||
128896389|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896390|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896391|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896392|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896393|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896394|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896395|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896396|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896397|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896398|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
128896399|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896400|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896401|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896402|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896403|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896404|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896405|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896406|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
128896407|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
128896408|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896409|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896410|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896411|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896412|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
128896413|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896414|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896415|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896416|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896417|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896418|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896419|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896420|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
128896421|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896422|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896423|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896424|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896425|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896426|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
128896427|NCT04033445|463914915|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896428|NCT04033445|463914916|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896429|NCT04033445|463914917|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896430|NCT04033445|463914918|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896431|NCT04033445|463914919|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896432|NCT04033445|463914920|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896433|NCT04033445|463914921|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896434|NCT04033445|463914922|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
128896435|NCT04033445|463914923|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896436|NCT04033445|463914924|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896437|NCT04033445|463914925|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896438|NCT04033445|463914926|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896439|NCT04033445|463914927|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129022669|NCT04493684|464374712|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022670|NCT04493684|464374713|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129022671|NCT04493684|464374697|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022672|NCT04493684|464374698|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022673|NCT04493684|464374699|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022674|NCT04493684|464374700|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022675|NCT04493684|464374701|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022676|NCT04493684|464374702|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022677|NCT04493684|464374703|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022678|NCT04493684|464374704|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022679|NCT04493684|464374705|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022680|NCT04493684|464374706|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
128896440|NCT04033445|463914928|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
128896441|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896442|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896443|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896444|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896445|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896446|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896447|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896448|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896449|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
128896450|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
128896451|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
128896452|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
128896453|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
128896454|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
128896455|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896456|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896457|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896458|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896459|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896460|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896461|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896462|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896463|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
128896464|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
128896465|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
128896466|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
128896467|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
128896468|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
128896469|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896470|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896471|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896472|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896473|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896474|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896475|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896476|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896477|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896478|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896479|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
128896480|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
128896481|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
128896482|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
128896483|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896484|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129022681|NCT04493684|464374707|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022682|NCT04493684|464374708|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022683|NCT04493684|464374709|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022684|NCT04493684|464374710|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022685|NCT04493684|464374711|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022686|NCT04493684|464374712|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
129022687|NCT04493684|464374713|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129022688|NCT04493684|464374697|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022689|NCT04493684|464374698|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022690|NCT04493684|464374699|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022691|NCT04493684|464374700|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022692|NCT04493684|464374701|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022693|NCT04493684|464374702|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022694|NCT04493684|464374703|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022695|NCT04493684|464374704|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022696|NCT04493684|464374705|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022697|NCT04493684|464374706|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022698|NCT04493684|464374707|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022699|NCT04493684|464374708|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129112255|NCT03589807|464705668|FG004|Overall Study|Withdrawal by Subject|0|||
129112256|NCT03589807|464705669|FG005|Overall Study|Withdrawal by Subject|0|||
128896485|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896486|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896487|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896488|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896489|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896490|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896491|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896492|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
128896493|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
128896494|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
128896495|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
128896496|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
128896497|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896498|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896499|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896500|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896501|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896502|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896503|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896504|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896505|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
128896506|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
128896507|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
128896508|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
128896509|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
129022700|NCT04493684|464374709|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022701|NCT04493684|464374710|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022702|NCT04493684|464374711|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022703|NCT04493684|464374712|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
129022704|NCT04493684|464374713|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129022705|NCT01963728|464374714|FG000|Overall Study|Study terminated early|0|||
129022706|NCT01963728|464374715|FG001|Overall Study|Study terminated early|1|||
129022707|NCT05152576|464374718|FG000|Overall Study|Lost to Follow-up|3|||
129022708|NCT05152576|464374719|FG001|Overall Study|Lost to Follow-up|0|||
129022709|NCT05152576|464374720|FG002|Overall Study|Lost to Follow-up|0|||
129022710|NCT05152576|464374721|FG003|Overall Study|Lost to Follow-up|1|||
129022711|NCT05152576|464374718|FG000|Overall Study|Withdrawal by Subject|0|||
129022712|NCT05152576|464374719|FG001|Overall Study|Withdrawal by Subject|1|||
129022713|NCT05152576|464374720|FG002|Overall Study|Withdrawal by Subject|0|||
129022714|NCT05152576|464374721|FG003|Overall Study|Withdrawal by Subject|1|||
129022715|NCT05152576|464374718|FG000|Overall Study|Other|2|||
129022716|NCT05152576|464374719|FG001|Overall Study|Other|0|||
129022717|NCT05152576|464374720|FG002|Overall Study|Other|0|||
129022718|NCT05152576|464374721|FG003|Overall Study|Other|0|||
129022719|NCT02057835|464376821|FG000|Overall Study|Withdrawal by Subject|0|||
129022720|NCT02057835|464376822|FG001|Overall Study|Withdrawal by Subject|2|||
129022721|NCT02057835|464376823|FG002|Overall Study|Withdrawal by Subject|0|||
129022722|NCT02057835|464376824|FG003|Overall Study|Withdrawal by Subject|0|||
129022723|NCT02057835|464376825|FG004|Overall Study|Withdrawal by Subject|0|||
129022724|NCT02057835|464376826|FG005|Overall Study|Withdrawal by Subject|0|||
129022725|NCT02057835|464376827|FG006|Overall Study|Withdrawal by Subject|0|||
129022726|NCT02057835|464376828|FG007|Overall Study|Withdrawal by Subject|0|||
129022727|NCT02057835|464376829|FG008|Overall Study|Withdrawal by Subject|0|||
129022728|NCT02057835|464376830|FG009|Overall Study|Withdrawal by Subject|0|||
129022729|NCT04278560|464376831|FG000|Overall Study|Adverse Event|1|||
129022730|NCT04278560|464376832|FG001|Overall Study|Adverse Event|2|||
129022731|NCT04278560|464376831|FG000|Overall Study|Withdrawal by Subject|0|||
129022732|NCT04278560|464376832|FG001|Overall Study|Withdrawal by Subject|1|||
129022733|NCT02832063|464376833|FG000|Overall Study|Adverse Event|2|||
129022734|NCT02832063|464376834|FG001|Overall Study|Adverse Event|1|||
129022735|NCT02832063|464376833|FG000|Overall Study|Physician Decision|5|||
129022736|NCT02832063|464376834|FG001|Overall Study|Physician Decision|7|||
129022737|NCT02832063|464376833|FG000|Overall Study|Lost to Follow-up|15|||
129022738|NCT02832063|464376834|FG001|Overall Study|Lost to Follow-up|8|||
129022739|NCT02832063|464376833|FG000|Overall Study|Withdrawal by Subject|10|||
129022740|NCT02832063|464376834|FG001|Overall Study|Withdrawal by Subject|21|||
129022741|NCT02832063|464376833|FG000|Overall Study|Other|2|||
129022742|NCT02832063|464376834|FG001|Overall Study|Other|1|||
128691834|NCT00543543|463171048|FG001|Extension Study|Lost to Follow-up|0|||
128896510|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
128896511|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896512|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896513|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896514|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896515|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896516|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896517|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896518|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896519|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896520|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896521|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896522|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896523|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
128896524|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
128896525|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896526|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896527|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896528|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896529|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896530|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896531|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896532|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896533|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
128896534|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
128896535|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
128896536|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
128896537|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
128896538|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
128896539|NCT04033445|463914915|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896540|NCT04033445|463914916|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896541|NCT04033445|463914917|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896542|NCT04033445|463914918|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896543|NCT04033445|463914919|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896544|NCT04033445|463914920|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896545|NCT04033445|463914921|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896546|NCT04033445|463914922|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896547|NCT04033445|463914923|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896548|NCT04033445|463914924|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
128896549|NCT04033445|463914925|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896550|NCT04033445|463914926|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
128896551|NCT04033445|463914927|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
128896552|NCT04033445|463914928|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
128896553|NCT04754802|463914934|FG000|Overall Study|Lost to Follow-up|0|||
128896554|NCT04754802|463914935|FG001|Overall Study|Lost to Follow-up|2|||
128896555|NCT04754802|463914934|FG000|Overall Study|Withdrawal by Subject|2|||
128896556|NCT04754802|463914935|FG001|Overall Study|Withdrawal by Subject|0|||
128896557|NCT04451161|463914936|FG000|Overall Study|Lost to Follow-up|28|||
128896558|NCT04451161|463914937|FG001|Overall Study|Lost to Follow-up|37|||
128896559|NCT04451161|463914938|FG002|Overall Study|Lost to Follow-up|22|||
128896560|NCT04451161|463914939|FG003|Overall Study|Lost to Follow-up|13|||
128896561|NCT04451161|463914940|FG004|Overall Study|Lost to Follow-up|11|||
128896562|NCT04451161|463914941|FG005|Overall Study|Lost to Follow-up|14|||
128896563|NCT04451161|463914936|FG000|Overall Study|Withdrawal by Subject|3|||
128896564|NCT04451161|463914937|FG001|Overall Study|Withdrawal by Subject|0|||
128896565|NCT04451161|463914938|FG002|Overall Study|Withdrawal by Subject|0|||
128896566|NCT04451161|463914939|FG003|Overall Study|Withdrawal by Subject|0|||
128896567|NCT04451161|463914940|FG004|Overall Study|Withdrawal by Subject|2|||
128896568|NCT04451161|463914941|FG005|Overall Study|Withdrawal by Subject|4|||
128896569|NCT05525689|463914942|FG000|Overall Study|Lost to Follow-up|1|||
128896570|NCT05525689|463914943|FG001|Overall Study|Lost to Follow-up|0|||
128896571|NCT01671111|463914944|FG000|Overall Study|Adverse Event|2|||
128896572|NCT01671111|463914944|FG000|Overall Study|Lack of Efficacy|1|||
128896573|NCT01671111|463914944|FG000|Overall Study|Withdrawal by Subject|2|||
128896574|NCT01671111|463914944|FG000|Overall Study|Physician Decision|1|||
128896575|NCT01671111|463914944|FG000|Overall Study|Other|24|||
128896576|NCT03680911|463914945|FG000|At Home Treatment|Study Termination|3|||
128896577|NCT03680911|463914946|FG001|At Home Treatment|Study Termination|0|||
128896578|NCT03680911|463914945|FG000|At Home Treatment|Lost to Follow-up|0|||
128896579|NCT03680911|463914946|FG001|At Home Treatment|Lost to Follow-up|1|||
128896580|NCT03680911|463914945|FG000|At Home Treatment|Withdrawal by Subject|0|||
128896581|NCT03680911|463914946|FG001|At Home Treatment|Withdrawal by Subject|2|||
128896582|NCT03680911|463914945|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
128896583|NCT03680911|463914946|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
128896584|NCT00898443|463914951|FG000|Overall Study|Withdrawal by Subject|1|||
128896585|NCT00898443|463914952|FG001|Overall Study|Withdrawal by Subject|0|||
128896586|NCT04695392|463914953|FG000|Overall Study|Withdrawn by parent/guardian|0|||
128896587|NCT04695392|463914954|FG001|Overall Study|Withdrawn by parent/guardian|1|||
128896588|NCT04695392|463914953|FG000|Overall Study|Withdrawn by physician|0|||
128896589|NCT04695392|463914954|FG001|Overall Study|Withdrawn by physician|1|||
128896590|NCT05082376|463914957|FG000|Overall Study|Lost to Follow-up|2|||
128896591|NCT04425720|463914965|FG000|Overall Study|Withdrawal by Subject|0|||
128896592|NCT04425720|463914966|FG001|Overall Study|Withdrawal by Subject|20|||
128896593|NCT00290186|463914967|FG000|Overall Study|Adverse Event|1|||
128896594|NCT00290186|463914968|FG001|Overall Study|Adverse Event|1|||
128896595|NCT00290186|463914967|FG000|Overall Study|Lost to Follow-up|3|||
128896596|NCT00290186|463914968|FG001|Overall Study|Lost to Follow-up|2|||
128896597|NCT00290186|463914967|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
128896598|NCT00290186|463914968|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
128896599|NCT00290186|463914967|FG000|Overall Study|Withdrawal by Subject|0|||
128896600|NCT00290186|463914968|FG001|Overall Study|Withdrawal by Subject|1|||
128896601|NCT00445224|463914969|FG000|Specific Exercises|Withdrawal by Subject|3|||
128896602|NCT00445224|463914970|FG001|Specific Exercises|Withdrawal by Subject|3|||
128896603|NCT00445224|463914969|FG000|Specific Exercises|Withdrawal by Subject|1|||
128896604|NCT00445224|463914970|FG001|Specific Exercises|Withdrawal by Subject|0|||
128896605|NCT04085523|463914975|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
128896606|NCT04085523|463914976|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
128896607|NCT04085523|463914977|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
128896608|NCT04085523|463914978|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
128896609|NCT04085523|463914979|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
128896610|NCT04085523|463914980|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
128691835|NCT00543543|463171049|FG002|Extension Study|Lost to Follow-up|0|||
128896611|NCT01877915|463914983|FG000|Overall Study|Lost to Follow-up|10|||
128896612|NCT01877915|463914984|FG001|Overall Study|Lost to Follow-up|9|||
128896613|NCT01877915|463914983|FG000|Overall Study|Withdrawal by Subject|42|||
128896614|NCT01877915|463914984|FG001|Overall Study|Withdrawal by Subject|55|||
128896615|NCT01877915|463914983|FG000|Overall Study|Other|2|||
128896616|NCT01877915|463914984|FG001|Overall Study|Other|4|||
128896617|NCT03520959|463914985|FG000|Overall Study|Study terminated by Sponsor|0|||
128896618|NCT03520959|463914986|FG001|Overall Study|Study terminated by Sponsor|1|||
128896619|NCT01449461|463914987|FG000|Overall Study|Adverse Event|0|||
128896620|NCT01449461|463914988|FG001|Overall Study|Adverse Event|3|||
128896621|NCT01449461|463914989|FG002|Overall Study|Adverse Event|2|||
128896622|NCT01449461|463914990|FG003|Overall Study|Adverse Event|3|||
128896623|NCT01449461|463914991|FG004|Overall Study|Adverse Event|4|||
128896624|NCT01449461|463914992|FG005|Overall Study|Adverse Event|4|||
128896625|NCT01449461|463914987|FG000|Overall Study|Death|0|||
128896626|NCT01449461|463914988|FG001|Overall Study|Death|2|||
128896627|NCT01449461|463914989|FG002|Overall Study|Death|0|||
128896628|NCT01449461|463914990|FG003|Overall Study|Death|0|||
128896629|NCT01449461|463914991|FG004|Overall Study|Death|7|||
128896630|NCT01449461|463914992|FG005|Overall Study|Death|1|||
128896631|NCT01449461|463914987|FG000|Overall Study|Physician Decision|0|||
128896632|NCT01449461|463914988|FG001|Overall Study|Physician Decision|1|||
128896633|NCT01449461|463914989|FG002|Overall Study|Physician Decision|0|||
128896634|NCT01449461|463914990|FG003|Overall Study|Physician Decision|4|||
128896635|NCT01449461|463914991|FG004|Overall Study|Physician Decision|1|||
128896636|NCT01449461|463914992|FG005|Overall Study|Physician Decision|0|||
128896637|NCT01449461|463914987|FG000|Overall Study|Documented Progressive Disease|4|||
128896638|NCT01449461|463914988|FG001|Overall Study|Documented Progressive Disease|7|||
128896639|NCT01449461|463914989|FG002|Overall Study|Documented Progressive Disease|14|||
128896640|NCT01449461|463914990|FG003|Overall Study|Documented Progressive Disease|15|||
128896641|NCT01449461|463914991|FG004|Overall Study|Documented Progressive Disease|24|||
128896642|NCT01449461|463914992|FG005|Overall Study|Documented Progressive Disease|5|||
128896643|NCT01449461|463914987|FG000|Overall Study|Clinical Progressive Disease|2|||
128896644|NCT01449461|463914988|FG001|Overall Study|Clinical Progressive Disease|2|||
128896645|NCT01449461|463914989|FG002|Overall Study|Clinical Progressive Disease|0|||
129112257|NCT03589807|464705664|FG000|Overall Study|Protocol Violation|0|||
128896646|NCT01449461|463914990|FG003|Overall Study|Clinical Progressive Disease|3|||
128896647|NCT01449461|463914991|FG004|Overall Study|Clinical Progressive Disease|4|||
129112258|NCT03589807|464705665|FG001|Overall Study|Protocol Violation|0|||
129112259|NCT03589807|464705666|FG002|Overall Study|Protocol Violation|0|||
128896648|NCT01449461|463914992|FG005|Overall Study|Clinical Progressive Disease|2|||
129112260|NCT03589807|464705667|FG003|Overall Study|Protocol Violation|1|||
128896649|NCT01449461|463914987|FG000|Overall Study|Protocol Violation|0|||
128896650|NCT01449461|463914988|FG001|Overall Study|Protocol Violation|0|||
128691836|NCT00543543|463171050|FG003|Extension Study|Lost to Follow-up|77|||
128896651|NCT01449461|463914989|FG002|Overall Study|Protocol Violation|0|||
128896652|NCT01449461|463914990|FG003|Overall Study|Protocol Violation|1|||
128896653|NCT01449461|463914991|FG004|Overall Study|Protocol Violation|0|||
128896654|NCT01449461|463914992|FG005|Overall Study|Protocol Violation|0|||
128896655|NCT01449461|463914987|FG000|Overall Study|Site Terminated by Sponsor|0|||
128896656|NCT01449461|463914988|FG001|Overall Study|Site Terminated by Sponsor|1|||
128896657|NCT01449461|463914989|FG002|Overall Study|Site Terminated by Sponsor|2|||
128896658|NCT01449461|463914990|FG003|Overall Study|Site Terminated by Sponsor|3|||
128896659|NCT01449461|463914991|FG004|Overall Study|Site Terminated by Sponsor|4|||
128896660|NCT01449461|463914992|FG005|Overall Study|Site Terminated by Sponsor|1|||
128896661|NCT01449461|463914987|FG000|Overall Study|Withdrawal by Subject|0|||
128896662|NCT01449461|463914988|FG001|Overall Study|Withdrawal by Subject|1|||
128896663|NCT01449461|463914989|FG002|Overall Study|Withdrawal by Subject|0|||
128896664|NCT01449461|463914990|FG003|Overall Study|Withdrawal by Subject|0|||
128896665|NCT01449461|463914991|FG004|Overall Study|Withdrawal by Subject|2|||
128896666|NCT01449461|463914992|FG005|Overall Study|Withdrawal by Subject|1|||
128896667|NCT01449461|463914987|FG000|Overall Study|Reason not Specified|0|||
129022743|NCT03733730|464376835|FG000|Overall Study|Lost to Follow-up|1|||
129022744|NCT03733730|464376836|FG001|Overall Study|Lost to Follow-up|32|||
129022745|NCT03733730|464376835|FG000|Overall Study|Other|1|||
129022746|NCT03733730|464376836|FG001|Overall Study|Other|0|||
129022747|NCT03733730|464376835|FG000|Overall Study|Adverse Event|0|||
129022748|NCT03733730|464376836|FG001|Overall Study|Adverse Event|4|||
128896668|NCT01449461|463914988|FG001|Overall Study|Reason not Specified|1|||
128896669|NCT01449461|463914989|FG002|Overall Study|Reason not Specified|0|||
128896670|NCT01449461|463914990|FG003|Overall Study|Reason not Specified|3|||
128896671|NCT01449461|463914991|FG004|Overall Study|Reason not Specified|2|||
128896672|NCT01449461|463914992|FG005|Overall Study|Reason not Specified|1|||
128896673|NCT01357577|463914993|FG000|Overall Study|Lost to Follow-up|20|||
128896674|NCT01357577|463914994|FG001|Overall Study|Lost to Follow-up|16|||
128896675|NCT01357577|463914993|FG000|Overall Study|Withdrawal by Subject|16|||
128896676|NCT01357577|463914994|FG001|Overall Study|Withdrawal by Subject|8|||
128896677|NCT01357577|463914993|FG000|Overall Study|look at data in database?|1|||
129022749|NCT03733730|464376835|FG000|Overall Study|Death|0|||
129022750|NCT03733730|464376836|FG001|Overall Study|Death|5|||
129022751|NCT03733730|464376835|FG000|Overall Study|Withdrawal by Subject|0|||
129022752|NCT03733730|464376836|FG001|Overall Study|Withdrawal by Subject|8|||
129022753|NCT01531894|464376841|FG000|Overall Study|Physician Decision|8|||
129022754|NCT01531894|464376841|FG000|Overall Study|Death|1|||
129022755|NCT03086460|464376842|FG000|Study Participants|Lost to Follow-up|2|||
129022756|NCT03086460|464376842|FG000|Study Participants|Protocol Violation|1|||
129022757|NCT03086460|464376842|FG000|Study Participants|Withdrawal by Subject|6|||
129022758|NCT03086460|464376842|FG000|Treatment A|Lost to Follow-up|1|||
129022759|NCT03086460|464376842|FG000|Treatment A|Protocol Violation|1|||
129022760|NCT03086460|464376842|FG000|Treatment A|Withdrawal by Subject|2|||
129022761|NCT03086460|464376842|FG000|Treatment C|Withdrawal by Subject|2|||
129022762|NCT03086460|464376842|FG000|Treatment E|Lost to Follow-up|1|||
129022763|NCT03086460|464376842|FG000|Treatment E|Withdrawal by Subject|3|||
129022764|NCT01440803|464376843|FG000|Overall Study|Met study stopping rule|2|||
129022765|NCT01440803|464376844|FG001|Overall Study|Met study stopping rule|1|||
129022766|NCT01440803|464376843|FG000|Overall Study|Lost to Follow-up|0|||
129022767|NCT01440803|464376844|FG001|Overall Study|Lost to Follow-up|2|||
129022768|NCT01440803|464376843|FG000|Overall Study|Withdrawal by Subject|0|||
129022769|NCT01440803|464376844|FG001|Overall Study|Withdrawal by Subject|1|||
129022770|NCT03502811|464376845|FG000|Overall Study|Death|157|||
129022771|NCT03502811|464376845|FG000|Overall Study|Withdrawal by Subject|105|||
129022772|NCT03502811|464376845|FG000|Overall Study|Lost to Follow-up|26|||
129022773|NCT03502811|464376845|FG000|Overall Study|No Visits (Missed)|31|||
129022774|NCT01735994|464376846|FG000|Overall Study|Withdrawal by Subject|6|||
129022775|NCT01735994|464376847|FG001|Overall Study|Withdrawal by Subject|4|||
129022776|NCT01735994|464376846|FG000|Overall Study|Injury|2|||
129022777|NCT01735994|464376847|FG001|Overall Study|Injury|0|||
129022778|NCT01735994|464376846|FG000|Overall Study|Kicked off team|5|||
128896678|NCT01357577|463914994|FG001|Overall Study|look at data in database?|2|||
128896679|NCT02322125|463916182|FG000|Overall Study|Withdrawal by Subject|2|||
128896680|NCT00449670|463916184|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
128896681|NCT00449670|463916185|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
128896682|NCT00449670|463916184|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
128896683|NCT00449670|463916185|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
129022779|NCT01735994|464376847|FG001|Overall Study|Kicked off team|0|||
129022780|NCT01735994|464376846|FG000|Overall Study|Lost to Follow-up|50|||
129022781|NCT01735994|464376847|FG001|Overall Study|Lost to Follow-up|62|||
129022782|NCT00604162|464376848|FG000|Overall Study|Physician Decision|3|||
129022783|NCT00604162|464376848|FG000|Overall Study|Withdrawal by Subject|1|||
129022784|NCT02241551|464376849|FG000|Overall Study|Adverse Event|1|||
128896684|NCT00449670|463916184|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
128896685|NCT00449670|463916185|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
128896686|NCT00449670|463916184|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
128896687|NCT00449670|463916185|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
128896688|NCT00449670|463916184|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
128896689|NCT00449670|463916185|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
128896690|NCT00449670|463916184|FG000|Booster Phase (Study no.109873)|Other|0|||
128896691|NCT00449670|463916185|FG001|Booster Phase (Study no.109873)|Other|2|||
128896692|NCT04183790|463916186|FG000|Overall Study|Participants did not rollover to Part B|12|||
128896693|NCT04183790|463916187|FG001|Overall Study|Participants did not rollover to Part B|0|||
128896694|NCT04183790|463916186|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
128896695|NCT04183790|463916187|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
128896696|NCT04183790|463916186|FG000|Overall Study|Commercial drug is available for participant|6|||
128896697|NCT04183790|463916187|FG001|Overall Study|Commercial drug is available for participant|0|||
128896698|NCT04183790|463916186|FG000|Overall Study|Adverse Event|1|||
128896699|NCT04183790|463916187|FG001|Overall Study|Adverse Event|0|||
128896700|NCT04183790|463916186|FG000|Overall Study|Not enrolled in 107 study|0|||
128896701|NCT04183790|463916187|FG001|Overall Study|Not enrolled in 107 study|2|||
128896702|NCT01439282|463916188|FG000|Overall Study|Adverse Event|5|||
128896703|NCT01439282|463916189|FG001|Overall Study|Adverse Event|0|||
128896704|NCT01439282|463916188|FG000|Overall Study|Withdrawal by Subject|2|||
128896705|NCT01439282|463916189|FG001|Overall Study|Withdrawal by Subject|0|||
128896706|NCT01439282|463916188|FG000|Overall Study|Other|1|||
128896707|NCT01439282|463916189|FG001|Overall Study|Other|1|||
128896708|NCT02232802|463916190|FG000|Period 1|Sponsor request|1|||
128896709|NCT02232802|463916191|FG001|Period 1|Sponsor request|0|||
128896710|NCT02232802|463916190|FG000|Period 1|Adverse Event|1|||
128896711|NCT02232802|463916191|FG001|Period 1|Adverse Event|1|||
128896712|NCT01502709|463916194|FG000|Overall Study|Lost to Follow-up|4|||
128896713|NCT01502709|463916195|FG001|Overall Study|Lost to Follow-up|0|||
128896714|NCT04096274|463916196|FG000|Phase I|Lost to Follow-up|5|||
128896715|NCT04096274|463916197|FG001|Phase I|Lost to Follow-up|5|||
128896716|NCT04096274|463916196|FG000|Phase II|Lost to Follow-up|11|||
128896717|NCT04096274|463916197|FG001|Phase II|Lost to Follow-up|11|||
128896718|NCT03197493|463916199|FG000|Overall Study|Withdrawal by Subject|5|||
128896719|NCT02807480|463916200|FG000|Overall Study|Withdrawal by Subject|14|||
128896720|NCT02807480|463916201|FG001|Overall Study|Withdrawal by Subject|10|||
128896721|NCT02369848|463916202|FG000|Overall Study|Death|1|||
128896722|NCT02369848|463916202|FG000|Overall Study|Withdrawal by Subject|2|||
128896723|NCT02369848|463916202|FG000|Overall Study|Lost to Follow-up|1|||
128896724|NCT03281668|463916204|FG000|Overall Study|Physician Decision|1|||
128896725|NCT03281668|463916204|FG000|Overall Study|scheduling conflict, family circumstance|2|||
128896726|NCT03281668|463916204|FG000|Overall Study|Withdrawal by Subject|4|||
128896727|NCT03281668|463916204|FG000|Overall Study|Lost to Follow-up|1|||
128896728|NCT00762892|463916206|FG000|Overall Study|Lost to Follow-up|2|||
128896729|NCT00762892|463916207|FG001|Overall Study|Lost to Follow-up|5|||
128896730|NCT00762892|463916206|FG000|Overall Study|Withdrawal by Subject|0|||
128896731|NCT00762892|463916207|FG001|Overall Study|Withdrawal by Subject|1|||
128896732|NCT00762892|463916206|FG000|Overall Study|Death|1|||
128896733|NCT00762892|463916207|FG001|Overall Study|Death|0|||
128896734|NCT00762892|463916206|FG000|Overall Study|Pregnancy|1|||
128896735|NCT00762892|463916207|FG001|Overall Study|Pregnancy|0|||
128896736|NCT00762892|463916206|FG000|Overall Study|Incarceration|1|||
128896737|NCT00762892|463916207|FG001|Overall Study|Incarceration|0|||
129022785|NCT02241551|464376850|FG001|Overall Study|Adverse Event|0|||
128896738|NCT01841749|463916208|FG000|Overall Study|Protocol Violation|1|||
128896739|NCT05807464|463916214|FG000|Overall Study|Adverse Event|1|||
128896740|NCT04702737|463916221|FG000|Overall Study|Decision by Sponsor|1|||
128896741|NCT04702737|463916221|FG000|Overall Study|Withdrawal of Consent from Study|3|||
128896742|NCT04702737|463916221|FG000|Overall Study|Lost to Follow-up|1|||
128896743|NCT04702737|463916221|FG000|Overall Study|Death|35|||
128896744|NCT00698997|463916222|FG000|Overall Study|Lost to Follow-up|3|||
128896745|NCT00698997|463916223|FG001|Overall Study|Lost to Follow-up|0|||
128896746|NCT00698997|463916222|FG000|Overall Study|Withdrawal by Subject|7|||
128896747|NCT00698997|463916223|FG001|Overall Study|Withdrawal by Subject|27|||
128896748|NCT01436084|463916224|FG000|Overall Study|Disease Progression|2|||
128896749|NCT01436084|463916224|FG000|Overall Study|Withdrawal by Subject|1|||
128896750|NCT01436084|463916224|FG000|Overall Study|Early Closure of Study|1|||
128896751|NCT00262522|463916227|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
128896752|NCT00262522|463916228|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
128896753|NCT00262522|463916229|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
128896754|NCT00262522|463916230|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
128896755|NCT00262522|463916227|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
128896756|NCT00262522|463916228|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
128896757|NCT00262522|463916229|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
128896758|NCT00262522|463916230|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
129022786|NCT00392665|464376852|FG000|Overall Study|Death|16|||
128896759|NCT00262522|463916227|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
128896760|NCT00262522|463916228|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
128896761|NCT00262522|463916229|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
128896762|NCT00262522|463916230|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
128896763|NCT00262522|463916227|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
128896764|NCT00262522|463916228|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
128896765|NCT00262522|463916229|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
128896766|NCT00262522|463916230|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
128896767|NCT00262522|463916227|FG000|Study Start Through 8 Weeks|Death|1|||
128896768|NCT00262522|463916228|FG001|Study Start Through 8 Weeks|Death|0|||
128896769|NCT00262522|463916229|FG002|Study Start Through 8 Weeks|Death|0|||
128896770|NCT00262522|463916230|FG003|Study Start Through 8 Weeks|Death|0|||
128896771|NCT00262522|463916227|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
128896772|NCT00262522|463916228|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
128896773|NCT00262522|463916229|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
128896774|NCT00262522|463916230|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
128896775|NCT00262522|463916227|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
128896776|NCT00262522|463916228|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
128896777|NCT00262522|463916229|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
128896778|NCT00262522|463916230|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
128896779|NCT00262522|463916227|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
128896780|NCT00262522|463916228|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
128896781|NCT00262522|463916229|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
128896782|NCT00262522|463916230|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
128896783|NCT00262522|463916227|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
128896784|NCT00262522|463916228|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
128896785|NCT00262522|463916229|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
128896786|NCT00262522|463916230|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
128896787|NCT00262522|463916227|FG000|Study Start Through 48 Weeks|Death|2|||
128896788|NCT00262522|463916228|FG001|Study Start Through 48 Weeks|Death|0|||
128896789|NCT00262522|463916229|FG002|Study Start Through 48 Weeks|Death|1|||
128896790|NCT00262522|463916230|FG003|Study Start Through 48 Weeks|Death|0|||
128896791|NCT00262522|463916227|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
128896792|NCT00262522|463916228|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
128896793|NCT00262522|463916229|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
128896794|NCT00262522|463916230|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
128896795|NCT00262522|463916227|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
128896796|NCT00262522|463916228|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
128896797|NCT00262522|463916229|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
128896798|NCT00262522|463916230|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
128896799|NCT00262522|463916227|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
128896800|NCT00262522|463916228|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
128896801|NCT00262522|463916229|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
128896802|NCT00262522|463916230|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
128896803|NCT00262522|463916227|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
128896804|NCT00262522|463916228|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
128896805|NCT00262522|463916229|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
128896806|NCT00262522|463916230|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
128896807|NCT00262522|463916227|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
128896808|NCT00262522|463916228|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
128896809|NCT00262522|463916229|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
128896810|NCT00262522|463916230|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
128896811|NCT00262522|463916227|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
128896812|NCT00262522|463916228|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
128896813|NCT00262522|463916229|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
128896814|NCT00262522|463916230|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
128896815|NCT00262522|463916227|FG000|Study Start Through 96 Weeks|Death|2|||
128896816|NCT00262522|463916228|FG001|Study Start Through 96 Weeks|Death|0|||
128896817|NCT00262522|463916229|FG002|Study Start Through 96 Weeks|Death|2|||
128896818|NCT00262522|463916230|FG003|Study Start Through 96 Weeks|Death|0|||
128896819|NCT00262522|463916227|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
128896820|NCT00262522|463916228|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
128896821|NCT00262522|463916229|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
128896822|NCT00262522|463916230|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
128896823|NCT00262522|463916227|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
128896824|NCT00262522|463916228|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
128896825|NCT00262522|463916229|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
128896826|NCT00262522|463916230|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
128896827|NCT04814823|463916231|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
128896828|NCT03740165|463916232|FG000|Overall Study|Death|232|||
128896829|NCT03740165|463916233|FG001|Overall Study|Death|242|||
128896830|NCT03740165|463916234|FG002|Overall Study|Death|229|||
128896831|NCT03740165|463916232|FG000|Overall Study|Lost to Follow-up|0|||
128896832|NCT03740165|463916233|FG001|Overall Study|Lost to Follow-up|0|||
128896833|NCT03740165|463916234|FG002|Overall Study|Lost to Follow-up|1|||
128896834|NCT03740165|463916232|FG000|Overall Study|Withdrawal by Subject|7|||
128896835|NCT03740165|463916233|FG001|Overall Study|Withdrawal by Subject|4|||
128896836|NCT03740165|463916234|FG002|Overall Study|Withdrawal by Subject|3|||
128896837|NCT03740165|463916232|FG000|Overall Study|Ongoing in Study|216|||
128896838|NCT03740165|463916233|FG001|Overall Study|Ongoing in Study|212|||
128896839|NCT03740165|463916234|FG002|Overall Study|Ongoing in Study|221|||
128896840|NCT05318937|463916237|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128896841|NCT05318937|463916238|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128896842|NCT05318937|463916237|FG000|Overall Study|Lost to Follow-up|0|||
128896843|NCT05318937|463916238|FG001|Overall Study|Lost to Follow-up|1|||
128896844|NCT05318937|463916237|FG000|Overall Study|Withdrawal by Subject|0|||
128896845|NCT05318937|463916238|FG001|Overall Study|Withdrawal by Subject|2|||
128896846|NCT05318937|463916237|FG000|Overall Study|Protocol Violation|0|||
128896847|NCT05318937|463916238|FG001|Overall Study|Protocol Violation|1|||
128896848|NCT05678257|463916246|FG000|Overall Study|Withdrawal by Subject|2|||
128896849|NCT05678257|463916247|FG001|Overall Study|Withdrawal by Subject|0|||
128896850|NCT05678257|463916248|FG002|Overall Study|Withdrawal by Subject|5|||
128896851|NCT05678257|463916246|FG000|Overall Study|Physician Decision|1|||
128896852|NCT05678257|463916247|FG001|Overall Study|Physician Decision|0|||
128896853|NCT05678257|463916248|FG002|Overall Study|Physician Decision|1|||
128896854|NCT05678257|463916246|FG000|Overall Study|Adverse Event|1|||
128896855|NCT05678257|463916247|FG001|Overall Study|Adverse Event|3|||
128896856|NCT05678257|463916248|FG002|Overall Study|Adverse Event|1|||
128896857|NCT05678257|463916246|FG000|Overall Study|Progressive disease|11|||
128896858|NCT05678257|463916247|FG001|Overall Study|Progressive disease|18|||
129112261|NCT03589807|464705668|FG004|Overall Study|Protocol Violation|0|||
129112262|NCT03589807|464705669|FG005|Overall Study|Protocol Violation|0|||
129112263|NCT03589807|464705664|FG000|Overall Study|Enrolled but treatment not administered|0|||
129112264|NCT03589807|464705665|FG001|Overall Study|Enrolled but treatment not administered|0|||
129112265|NCT03589807|464705666|FG002|Overall Study|Enrolled but treatment not administered|0|||
129112266|NCT03589807|464705667|FG003|Overall Study|Enrolled but treatment not administered|0|||
129112267|NCT03589807|464705668|FG004|Overall Study|Enrolled but treatment not administered|1|||
129112268|NCT03589807|464705669|FG005|Overall Study|Enrolled but treatment not administered|0|||
129112269|NCT00810069|464705670|FG000|Lead-in Period I|Adverse Event|43|||
129112270|NCT00810069|464705671|FG001|Lead-in Period I|Adverse Event|0|||
129112271|NCT00810069|464705672|FG002|Lead-in Period I|Adverse Event|0|||
129112272|NCT00810069|464705670|FG000|Lead-in Period I|Lack of Efficacy|1|||
129112273|NCT00810069|464705671|FG001|Lead-in Period I|Lack of Efficacy|0|||
129112274|NCT00810069|464705672|FG002|Lead-in Period I|Lack of Efficacy|0|||
129112275|NCT00810069|464705670|FG000|Lead-in Period I|Lost to Follow-up|19|||
129112276|NCT00810069|464705671|FG001|Lead-in Period I|Lost to Follow-up|0|||
129112277|NCT00810069|464705672|FG002|Lead-in Period I|Lost to Follow-up|0|||
129112278|NCT00810069|464705670|FG000|Lead-in Period I|Physician Decision|1|||
129112279|NCT00810069|464705671|FG001|Lead-in Period I|Physician Decision|0|||
129112280|NCT00810069|464705672|FG002|Lead-in Period I|Physician Decision|0|||
129112281|NCT00810069|464705670|FG000|Lead-in Period I|Protocol Violation|1|||
129112282|NCT00810069|464705671|FG001|Lead-in Period I|Protocol Violation|0|||
129112283|NCT00810069|464705672|FG002|Lead-in Period I|Protocol Violation|0|||
129112284|NCT00810069|464705670|FG000|Lead-in Period I|Withdrawal by Subject|46|||
129112285|NCT00810069|464705671|FG001|Lead-in Period I|Withdrawal by Subject|0|||
129112286|NCT00810069|464705672|FG002|Lead-in Period I|Withdrawal by Subject|0|||
129112287|NCT00810069|464705670|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
129112288|NCT00810069|464705671|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
129112289|NCT00810069|464705672|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
129112290|NCT00810069|464705670|FG000|Lead-in Period I|Randomization criteria not met|158|||
129112291|NCT00810069|464705671|FG001|Lead-in Period I|Randomization criteria not met|0|||
129112292|NCT00810069|464705672|FG002|Lead-in Period I|Randomization criteria not met|0|||
129112293|NCT00810069|464705670|FG000|Double-Blind Period II|Adverse Event|0|||
129112294|NCT00810069|464705671|FG001|Double-Blind Period II|Adverse Event|9|||
128896859|NCT05678257|463916248|FG002|Overall Study|Progressive disease|7|||
128896860|NCT05678257|463916246|FG000|Overall Study|No longer clinically benefitting|2|||
128896861|NCT05678257|463916247|FG001|Overall Study|No longer clinically benefitting|1|||
129112295|NCT00810069|464705672|FG002|Double-Blind Period II|Adverse Event|8|||
129112296|NCT00810069|464705670|FG000|Double-Blind Period II|Lack of Efficacy|0|||
129112297|NCT00810069|464705671|FG001|Double-Blind Period II|Lack of Efficacy|7|||
128896862|NCT05678257|463916248|FG002|Overall Study|No longer clinically benefitting|0|||
128896863|NCT05678257|463916246|FG000|Overall Study|Sponsor decision|5|||
128896864|NCT05678257|463916247|FG001|Overall Study|Sponsor decision|9|||
128896865|NCT05678257|463916248|FG002|Overall Study|Sponsor decision|8|||
128896866|NCT05678257|463916246|FG000|Overall Study|Protocol Violation|0|||
128896867|NCT05678257|463916247|FG001|Overall Study|Protocol Violation|0|||
128896868|NCT05678257|463916248|FG002|Overall Study|Protocol Violation|1|||
128896869|NCT05678257|463916246|FG000|Overall Study|Patient non-compliance|0|||
128896870|NCT05678257|463916247|FG001|Overall Study|Patient non-compliance|0|||
128896871|NCT05678257|463916248|FG002|Overall Study|Patient non-compliance|3|||
128896872|NCT02046096|463916249|FG000|Overall Study|Death|28|||
128896873|NCT02046096|463916250|FG001|Overall Study|Death|45|||
128896874|NCT02046096|463916249|FG000|Overall Study|Lost to Follow-up|9|||
128896875|NCT02046096|463916250|FG001|Overall Study|Lost to Follow-up|20|||
128896876|NCT02046096|463916249|FG000|Overall Study|Withdrawal by Subject|5|||
128896877|NCT02046096|463916250|FG001|Overall Study|Withdrawal by Subject|17|||
128896878|NCT02046096|463916249|FG000|Overall Study|Other endpoint|2|||
128896879|NCT02046096|463916250|FG001|Overall Study|Other endpoint|19|||
128896880|NCT05314517|463916251|FG000|Double-blind Period|Adverse Event|4|||
128896881|NCT05314517|463916252|FG001|Double-blind Period|Adverse Event|0|||
128896882|NCT05314517|463916253|FG002|Double-blind Period|Adverse Event|0|||
128896883|NCT05314517|463916254|FG003|Double-blind Period|Adverse Event|0|||
128896884|NCT05314517|463916251|FG000|Double-blind Period|Noncompliance|0|||
128896885|NCT05314517|463916252|FG001|Double-blind Period|Noncompliance|1|||
128896886|NCT05314517|463916253|FG002|Double-blind Period|Noncompliance|0|||
128896887|NCT05314517|463916254|FG003|Double-blind Period|Noncompliance|0|||
128896888|NCT05314517|463916251|FG000|Double-blind Period|Randomized, not treated|1|||
128896889|NCT05314517|463916252|FG001|Double-blind Period|Randomized, not treated|0|||
128896890|NCT05314517|463916253|FG002|Double-blind Period|Randomized, not treated|0|||
128896891|NCT05314517|463916254|FG003|Double-blind Period|Randomized, not treated|0|||
128896892|NCT05314517|463916251|FG000|Open-label Extension|Adverse Event|0|||
128896893|NCT05314517|463916252|FG001|Open-label Extension|Adverse Event|0|||
128896894|NCT05314517|463916253|FG002|Open-label Extension|Adverse Event|1|||
128896895|NCT05314517|463916254|FG003|Open-label Extension|Adverse Event|2|||
128896896|NCT05314517|463916251|FG000|Open-label Extension|Investigator decision|0|||
128896897|NCT05314517|463916252|FG001|Open-label Extension|Investigator decision|0|||
128896898|NCT05314517|463916253|FG002|Open-label Extension|Investigator decision|1|||
128896899|NCT05314517|463916254|FG003|Open-label Extension|Investigator decision|0|||
128896900|NCT05314517|463916251|FG000|Open-label Extension|Lost to Follow-up|0|||
128896901|NCT05314517|463916252|FG001|Open-label Extension|Lost to Follow-up|0|||
128896902|NCT05314517|463916253|FG002|Open-label Extension|Lost to Follow-up|0|||
128896903|NCT05314517|463916254|FG003|Open-label Extension|Lost to Follow-up|1|||
128896904|NCT05314517|463916251|FG000|Open-label Extension|Withdrawal by Subject|0|||
128896905|NCT05314517|463916252|FG001|Open-label Extension|Withdrawal by Subject|0|||
128896906|NCT05314517|463916253|FG002|Open-label Extension|Withdrawal by Subject|1|||
128896907|NCT05314517|463916254|FG003|Open-label Extension|Withdrawal by Subject|2|||
128896908|NCT05314517|463916251|FG000|Open-label Extension|Use of prohibited medication|0|||
128896909|NCT05314517|463916252|FG001|Open-label Extension|Use of prohibited medication|0|||
128896910|NCT05314517|463916253|FG002|Open-label Extension|Use of prohibited medication|1|||
128896911|NCT05314517|463916254|FG003|Open-label Extension|Use of prohibited medication|0|||
128896912|NCT05314517|463916251|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
128896913|NCT05314517|463916252|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
128896914|NCT05314517|463916253|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
128896915|NCT05314517|463916254|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
128896916|NCT04969276|463916255|FG000|Overall Study|Protocol Deviation|0|||
128896917|NCT04969276|463916256|FG001|Overall Study|Protocol Deviation|1|||
128896918|NCT04969276|463916257|FG002|Overall Study|Protocol Deviation|0|||
128896919|NCT04969276|463916255|FG000|Overall Study|Withdrawal by Subject|1|||
128896920|NCT04969276|463916256|FG001|Overall Study|Withdrawal by Subject|10|||
128896921|NCT04969276|463916257|FG002|Overall Study|Withdrawal by Subject|0|||
128896922|NCT04969276|463916255|FG000|Overall Study|Lost to Follow-up|0|||
128896923|NCT04969276|463916256|FG001|Overall Study|Lost to Follow-up|1|||
128896924|NCT04969276|463916257|FG002|Overall Study|Lost to Follow-up|0|||
128896925|NCT04655144|463916261|FG000|Overall Study|Consumed THC|1|||
128896926|NCT04655144|463916262|FG001|Overall Study|Consumed THC|0|||
128896927|NCT04655144|463916261|FG000|Overall Study|Unilateral embolization|0|||
129022787|NCT00392665|464376853|FG001|Overall Study|Death|14|||
129022788|NCT00392665|464376852|FG000|Overall Study|Lost to Follow-up|1|||
129022789|NCT00392665|464376853|FG001|Overall Study|Lost to Follow-up|1|||
129022790|NCT04408794|464376854|FG000|Overall Study|Adverse Event|43|||
129022791|NCT04408794|464376854|FG000|Overall Study|Infrequent study drug usage|43|||
128764572|NCT04512066|463428366|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
128896928|NCT04655144|463916262|FG001|Overall Study|Unilateral embolization|1|||
128896929|NCT04490018|463916263|FG000|Overall Study|Protocol Violation|0|||
128896930|NCT04490018|463916264|FG001|Overall Study|Protocol Violation|2|||
128896931|NCT04490018|463916265|FG002|Overall Study|Protocol Violation|1|||
128896932|NCT04490018|463916263|FG000|Overall Study|Lost to Follow-up|2|||
128896933|NCT04490018|463916264|FG001|Overall Study|Lost to Follow-up|2|||
129022792|NCT04408794|464376854|FG000|Overall Study|Lack of Efficacy|61|||
129022793|NCT04408794|464376854|FG000|Overall Study|Lost to Follow-up|33|||
129022794|NCT04408794|464376854|FG000|Overall Study|Non-compliance|6|||
129022795|NCT04408794|464376854|FG000|Overall Study|Physician Decision|1|||
128691837|NCT00543543|463171047|FG000|Extension Study|Physician Decision|0|||
128691838|NCT00543543|463171048|FG001|Extension Study|Physician Decision|0|||
128691839|NCT00543543|463171049|FG002|Extension Study|Physician Decision|0|||
129022796|NCT04408794|464376854|FG000|Overall Study|Pregnancy|6|||
129022797|NCT04408794|464376854|FG000|Overall Study|Protocol Deviation|9|||
129022798|NCT04408794|464376854|FG000|Overall Study|Sheehan-STS Result|1|||
128691840|NCT00543543|463171050|FG003|Extension Study|Physician Decision|7|||
128691841|NCT00543543|463171047|FG000|Extension Study|Pregnancy|0|||
128691842|NCT00543543|463171048|FG001|Extension Study|Pregnancy|0|||
128691843|NCT00543543|463171049|FG002|Extension Study|Pregnancy|0|||
128691844|NCT00543543|463171050|FG003|Extension Study|Pregnancy|6|||
128691845|NCT00543543|463171047|FG000|Extension Study|Protocol Violation|0|||
128691846|NCT00543543|463171048|FG001|Extension Study|Protocol Violation|0|||
128691847|NCT00543543|463171049|FG002|Extension Study|Protocol Violation|0|||
128691848|NCT00543543|463171050|FG003|Extension Study|Protocol Violation|11|||
128691849|NCT00543543|463171047|FG000|Extension Study|Withdrawal by Subject|0|||
128691850|NCT00543543|463171048|FG001|Extension Study|Withdrawal by Subject|0|||
128691851|NCT00543543|463171049|FG002|Extension Study|Withdrawal by Subject|0|||
128691852|NCT00543543|463171050|FG003|Extension Study|Withdrawal by Subject|120|||
128691853|NCT01163266|463171051|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
128691854|NCT01163266|463171052|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
128691855|NCT01163266|463171053|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
128691856|NCT01163266|463171051|FG000|Overall Study|Lack of Efficacy|1|||
128691857|NCT01163266|463171052|FG001|Overall Study|Lack of Efficacy|3|||
128691858|NCT01163266|463171053|FG002|Overall Study|Lack of Efficacy|1|||
128691859|NCT01163266|463171051|FG000|Overall Study|Noncompliance with Study Drug|0|||
128691860|NCT01163266|463171052|FG001|Overall Study|Noncompliance with Study Drug|2|||
128691861|NCT01163266|463171053|FG002|Overall Study|Noncompliance with Study Drug|0|||
128691862|NCT01163266|463171051|FG000|Overall Study|Protocol Deviations|2|||
128691863|NCT01163266|463171052|FG001|Overall Study|Protocol Deviations|2|||
128691864|NCT01163266|463171053|FG002|Overall Study|Protocol Deviations|5|||
128691865|NCT01163266|463171051|FG000|Overall Study|Withdrawal of Consent|5|||
128691866|NCT01163266|463171052|FG001|Overall Study|Withdrawal of Consent|7|||
128691867|NCT01163266|463171053|FG002|Overall Study|Withdrawal of Consent|3|||
128691868|NCT01163266|463171051|FG000|Overall Study|Lost to Follow-up|7|||
128691869|NCT01163266|463171052|FG001|Overall Study|Lost to Follow-up|7|||
128691870|NCT01163266|463171053|FG002|Overall Study|Lost to Follow-up|10|||
128691871|NCT01163266|463171051|FG000|Overall Study|Other|1|||
128691872|NCT01163266|463171052|FG001|Overall Study|Other|1|||
128691873|NCT01163266|463171053|FG002|Overall Study|Other|2|||
128691874|NCT02586064|463171054|FG000|Overall Study|Other Obligations|6|||
128691875|NCT02586064|463171055|FG001|Overall Study|Other Obligations|6|||
128691876|NCT02586064|463171054|FG000|Overall Study|Other|3|||
128691877|NCT02586064|463171055|FG001|Overall Study|Other|7|||
128691878|NCT02586064|463171054|FG000|Overall Study|Never Started|3|||
128691879|NCT02586064|463171055|FG001|Overall Study|Never Started|3|||
128691880|NCT02586064|463171054|FG000|Overall Study|Lost Interest|1|||
128691881|NCT02586064|463171055|FG001|Overall Study|Lost Interest|4|||
128691882|NCT02586064|463171054|FG000|Overall Study|Miscellaneous Life Issues|0|||
128691883|NCT02586064|463171055|FG001|Overall Study|Miscellaneous Life Issues|5|||
128691884|NCT02586064|463171054|FG000|Overall Study|Infrequent Attendance|2|||
128691885|NCT02586064|463171055|FG001|Overall Study|Infrequent Attendance|1|||
128691886|NCT02586064|463171054|FG000|Overall Study|Timed Out|2|||
128691887|NCT02586064|463171055|FG001|Overall Study|Timed Out|0|||
128691888|NCT02586064|463171054|FG000|Overall Study|AUD relapse|0|||
128691889|NCT02586064|463171055|FG001|Overall Study|AUD relapse|2|||
128691890|NCT02586064|463171054|FG000|Overall Study|Legal Issue|1|||
128691891|NCT02586064|463171055|FG001|Overall Study|Legal Issue|0|||
128691892|NCT00968864|463171057|FG000|Overall Study|Protocol exception/ not evaluable|1|||
128691893|NCT00484094|463171058|FG000|Overall Study|Discontinued|39|||
128691894|NCT00484094|463171058|FG000|Overall Study|Other|3|||
128691895|NCT00586625|463171059|FG000|Overall Study|Adverse Event|6|||
128691896|NCT00586625|463171060|FG001|Overall Study|Adverse Event|6|||
128691897|NCT00586625|463171059|FG000|Overall Study|Protocol Violation|3|||
128691898|NCT00586625|463171060|FG001|Overall Study|Protocol Violation|0|||
128691899|NCT00586625|463171059|FG000|Overall Study|Withdrawal by Subject|32|||
128691900|NCT00586625|463171060|FG001|Overall Study|Withdrawal by Subject|10|||
128691901|NCT00586625|463171059|FG000|Overall Study|Subject non-compliance|0|||
128691902|NCT00586625|463171060|FG001|Overall Study|Subject non-compliance|1|||
128691903|NCT00586625|463171059|FG000|Overall Study|Subject unable to return for visit|2|||
128691904|NCT00586625|463171060|FG001|Overall Study|Subject unable to return for visit|0|||
128691905|NCT00165984|463171061|FG000|Overall Study|Death|15|||
128691906|NCT01414608|463171062|FG000|Overall Study|Ineligible|5|||
128691907|NCT01414608|463171063|FG001|Overall Study|Ineligible|2|||
129022799|NCT04408794|464376854|FG000|Overall Study|Withdrawal by Subject|57|||
129022800|NCT04408794|464376854|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
129022801|NCT04408794|464376854|FG000|Overall Study|Never Treated Migraine|5|||
129022802|NCT02294786|464376859|FG000|Overall Study|Withdrawal by Subject|0|||
128691908|NCT03945266|463171064|FG000|Overall Study|Withdrawal by Subject|1|||
128691909|NCT03945266|463171065|FG001|Overall Study|Withdrawal by Subject|0|||
128691910|NCT03945266|463171064|FG000|Overall Study|Miscarriage|0|||
128691911|NCT03945266|463171065|FG001|Overall Study|Miscarriage|2|||
128691912|NCT03945266|463171064|FG000|Overall Study|Lost to Follow-up|1|||
128691913|NCT03945266|463171065|FG001|Overall Study|Lost to Follow-up|0|||
128691914|NCT04176705|463171068|FG000|Overall Study|Withdrawal by Subject|4|||
128691915|NCT04176705|463171069|FG001|Overall Study|Withdrawal by Subject|4|||
128691916|NCT04176705|463171068|FG000|Overall Study|Death|1|||
128691917|NCT04176705|463171069|FG001|Overall Study|Death|1|||
128691918|NCT04176705|463171068|FG000|Overall Study|Lost to Follow-up|3|||
128691919|NCT04176705|463171069|FG001|Overall Study|Lost to Follow-up|3|||
128691920|NCT02423772|463171070|FG000|Overall Study|Lost to Follow-up|3|||
128691921|NCT02423772|463171071|FG001|Overall Study|Lost to Follow-up|3|||
128691922|NCT02423772|463171070|FG000|Overall Study|Did not begin intervention|2|||
128691923|NCT02423772|463171071|FG001|Overall Study|Did not begin intervention|5|||
128691924|NCT01193842|463171075|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129022803|NCT02294786|464376860|FG001|Overall Study|Withdrawal by Subject|1|||
129022804|NCT02294786|464376859|FG000|Overall Study|Physician Decision|6|||
129022805|NCT02294786|464376860|FG001|Overall Study|Physician Decision|7|||
129022806|NCT02294786|464376859|FG000|Overall Study|Lost to Follow-up|1|||
129022807|NCT02294786|464376860|FG001|Overall Study|Lost to Follow-up|2|||
129022808|NCT02294786|464376859|FG000|Overall Study|Protocol Violation|1|||
129022809|NCT02294786|464376860|FG001|Overall Study|Protocol Violation|0|||
129022810|NCT02294786|464376859|FG000|Overall Study|Adverse Event|1|||
129022811|NCT02294786|464376860|FG001|Overall Study|Adverse Event|1|||
129022812|NCT02294786|464376859|FG000|Overall Study|Death|2|||
129022813|NCT02294786|464376860|FG001|Overall Study|Death|3|||
129022814|NCT01778010|464376861|FG000|Overall Study|Withdrawal by Subject|2|||
129022815|NCT01778010|464376861|FG000|Overall Study|abnormal ECG before meds|1|||
129022816|NCT01778010|464376861|FG000|Overall Study|Arrested|1|||
129022817|NCT01778010|464376861|FG000|Overall Study|rash while on placebo|1|||
129022818|NCT01518972|464376862|FG000|Overall Study|Lost to Follow-up|2|||
129022819|NCT01518972|464376863|FG001|Overall Study|Lost to Follow-up|1|||
129022820|NCT01518972|464376862|FG000|Overall Study|Withdrawal by Subject|1|||
129022821|NCT01518972|464376863|FG001|Overall Study|Withdrawal by Subject|0|||
129022822|NCT01518972|464376862|FG000|Overall Study|Moved from area|1|||
129022823|NCT01518972|464376863|FG001|Overall Study|Moved from area|0|||
129022824|NCT01518972|464376862|FG000|Overall Study|Transportation problems|1|||
129022825|NCT01518972|464376863|FG001|Overall Study|Transportation problems|0|||
129022826|NCT01518972|464376862|FG000|Overall Study|Exclusionary medical condition|1|||
129022827|NCT01518972|464376863|FG001|Overall Study|Exclusionary medical condition|0|||
129022828|NCT01518972|464376862|FG000|Overall Study|Missed safety visits|0|||
129022829|NCT01518972|464376863|FG001|Overall Study|Missed safety visits|1|||
129022830|NCT01518972|464376862|FG000|Overall Study|Exclusionary medication|0|||
129022831|NCT01518972|464376863|FG001|Overall Study|Exclusionary medication|1|||
129022832|NCT01518972|464376862|FG000|Overall Study|Declined medication starting on day 12|0|||
129022833|NCT01518972|464376863|FG001|Overall Study|Declined medication starting on day 12|1|||
129022834|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
129022835|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
129022836|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
129022837|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
129022838|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
129022839|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
129022840|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
129022841|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
129022842|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
129022843|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
129022844|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
129022845|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
129022846|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
129022847|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
129022848|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
129022849|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
129022850|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
129022851|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
129022852|NCT01667679|464376864|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
129022853|NCT01667679|464376865|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
129022854|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
128691925|NCT01193842|463171076|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
128691926|NCT01193842|463171077|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
128691927|NCT01193842|463171078|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
128691928|NCT01193842|463171079|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
128691929|NCT01193842|463171075|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
128896934|NCT04490018|463916265|FG002|Overall Study|Lost to Follow-up|0|||
128896935|NCT04490018|463916263|FG000|Overall Study|Withdrawal by Subject|2|||
128896936|NCT04490018|463916264|FG001|Overall Study|Withdrawal by Subject|1|||
128896937|NCT04490018|463916265|FG002|Overall Study|Withdrawal by Subject|0|||
128896938|NCT04490018|463916263|FG000|Overall Study|Withdrawal by parent/guardian|2|||
128896939|NCT04490018|463916264|FG001|Overall Study|Withdrawal by parent/guardian|3|||
128896940|NCT04490018|463916265|FG002|Overall Study|Withdrawal by parent/guardian|0|||
128896941|NCT00943579|463916267|FG000|Overall Study|Adverse Event|4|||
128896942|NCT00943579|463916268|FG001|Overall Study|Adverse Event|3|||
128896943|NCT00943579|463916267|FG000|Overall Study|Lack of Efficacy|2|||
128896944|NCT00943579|463916268|FG001|Overall Study|Lack of Efficacy|2|||
128896945|NCT00282295|463916269|FG000|Overall Study|Adverse Event|0|||
128896946|NCT00282295|463916270|FG001|Overall Study|Adverse Event|1|||
128896947|NCT00282295|463916271|FG002|Overall Study|Adverse Event|0|||
128896948|NCT00282295|463916269|FG000|Overall Study|Serious Adverse Events|0|||
128896949|NCT00282295|463916270|FG001|Overall Study|Serious Adverse Events|0|||
128896950|NCT00282295|463916271|FG002|Overall Study|Serious Adverse Events|1|||
128896951|NCT00282295|463916269|FG000|Overall Study|Protocol Violation|0|||
128896952|NCT00282295|463916270|FG001|Overall Study|Protocol Violation|2|||
128896953|NCT00282295|463916271|FG002|Overall Study|Protocol Violation|1|||
128896954|NCT00282295|463916269|FG000|Overall Study|Withdrawal by Subject|2|||
128896955|NCT00282295|463916270|FG001|Overall Study|Withdrawal by Subject|6|||
128896956|NCT00282295|463916271|FG002|Overall Study|Withdrawal by Subject|4|||
128896957|NCT00282295|463916269|FG000|Overall Study|Lost to Follow-up|1|||
128896958|NCT00282295|463916270|FG001|Overall Study|Lost to Follow-up|7|||
128896959|NCT00282295|463916271|FG002|Overall Study|Lost to Follow-up|2|||
128896960|NCT00282295|463916269|FG000|Overall Study|Other|0|||
128896961|NCT00282295|463916270|FG001|Overall Study|Other|1|||
128896962|NCT00282295|463916271|FG002|Overall Study|Other|0|||
128896963|NCT03337542|463916272|FG000|Overall Study|Withdrew Consent|17|||
128896964|NCT03337542|463916272|FG000|Overall Study|Allergic Adverse Event|1|||
128896965|NCT03337542|463916272|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
128896966|NCT03337542|463916272|FG000|Overall Study|Lost to Follow-up|1|||
128896967|NCT03337542|463916272|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
128896968|NCT00121108|463916273|FG000|Overall Study|Lost to Follow-up|10|||
128896969|NCT00121108|463916274|FG001|Overall Study|Lost to Follow-up|22|||
128896970|NCT00121108|463916273|FG000|Overall Study|Withdrawal by Subject|106|||
128896971|NCT00121108|463916274|FG001|Overall Study|Withdrawal by Subject|195|||
128896972|NCT00121108|463916273|FG000|Overall Study|Death|5|||
128896973|NCT00121108|463916274|FG001|Overall Study|Death|8|||
128896974|NCT01380379|463916275|FG000|Overall Study|Pregnancy|1|||
128896975|NCT03977974|463916278|FG000|Period 2|Adverse Event|0|||
128896976|NCT03977974|463916279|FG001|Period 2|Adverse Event|0|||
128896977|NCT03977974|463916280|FG002|Period 2|Adverse Event|0|||
129022855|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
129022856|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
129022857|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
129022858|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
129022859|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
129022860|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
129022861|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
129022862|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
129022863|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
129022864|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
129022865|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
129022866|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
129022867|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
129022868|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
129022869|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
129022870|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
129022871|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
129022872|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
129022873|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
129022874|NCT01667679|464376864|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
129022875|NCT01667679|464376865|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
129022876|NCT02159183|464376866|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
128896978|NCT03977974|463916281|FG003|Period 2|Adverse Event|0|||
128896979|NCT03977974|463916282|FG004|Period 2|Adverse Event|1|||
128896980|NCT03977974|463916283|FG005|Period 2|Adverse Event|0|||
128896981|NCT03977974|463916284|FG006|Period 2|Adverse Event|0|||
128896982|NCT03977974|463916285|FG007|Period 2|Adverse Event|0|||
128896983|NCT03977974|463916286|FG008|Period 2|Adverse Event|0|||
128896984|NCT03977974|463916287|FG009|Period 2|Adverse Event|0|||
128896985|NCT03977974|463916288|FG010|Period 2|Adverse Event|0|||
129112298|NCT00810069|464705672|FG002|Double-Blind Period II|Lack of Efficacy|12|||
128896986|NCT03977974|463916289|FG011|Period 2|Adverse Event|0|||
128896987|NCT03977974|463916290|FG012|Period 2|Adverse Event|0|||
128896988|NCT01251653|463917379|FG000|Overall Study|Progressive Disease|1|||
128896989|NCT01251653|463917380|FG001|Overall Study|Progressive Disease|7|||
128896990|NCT01251653|463917381|FG002|Overall Study|Progressive Disease|16|||
128896991|NCT01251653|463917382|FG003|Overall Study|Progressive Disease|4|||
128896992|NCT01251653|463917383|FG004|Overall Study|Progressive Disease|0|||
128896993|NCT01251653|463917384|FG005|Overall Study|Progressive Disease|17|||
128896994|NCT01251653|463917385|FG006|Overall Study|Progressive Disease|14|||
128896995|NCT01251653|463917386|FG007|Overall Study|Progressive Disease|7|||
128896996|NCT01251653|463917387|FG008|Overall Study|Progressive Disease|5|||
128896997|NCT01251653|463917379|FG000|Overall Study|Dose-limiting toxicity|0|||
128896998|NCT01251653|463917380|FG001|Overall Study|Dose-limiting toxicity|1|||
128896999|NCT01251653|463917381|FG002|Overall Study|Dose-limiting toxicity|1|||
128897000|NCT01251653|463917382|FG003|Overall Study|Dose-limiting toxicity|1|||
128897001|NCT01251653|463917383|FG004|Overall Study|Dose-limiting toxicity|0|||
128897002|NCT01251653|463917384|FG005|Overall Study|Dose-limiting toxicity|0|||
128897003|NCT01251653|463917385|FG006|Overall Study|Dose-limiting toxicity|2|||
128897004|NCT01251653|463917386|FG007|Overall Study|Dose-limiting toxicity|0|||
128897005|NCT01251653|463917387|FG008|Overall Study|Dose-limiting toxicity|0|||
128897006|NCT01251653|463917379|FG000|Overall Study|Adverse Event|1|||
128897007|NCT01251653|463917380|FG001|Overall Study|Adverse Event|0|||
128897008|NCT01251653|463917381|FG002|Overall Study|Adverse Event|2|||
128897009|NCT01251653|463917382|FG003|Overall Study|Adverse Event|1|||
128897010|NCT01251653|463917383|FG004|Overall Study|Adverse Event|1|||
128897011|NCT01251653|463917384|FG005|Overall Study|Adverse Event|0|||
128897012|NCT01251653|463917385|FG006|Overall Study|Adverse Event|2|||
128897013|NCT01251653|463917386|FG007|Overall Study|Adverse Event|2|||
128897014|NCT01251653|463917387|FG008|Overall Study|Adverse Event|1|||
128897015|NCT01251653|463917379|FG000|Overall Study|Withdrawal by Subject|1|||
128897016|NCT01251653|463917380|FG001|Overall Study|Withdrawal by Subject|0|||
128897017|NCT01251653|463917381|FG002|Overall Study|Withdrawal by Subject|1|||
128897018|NCT01251653|463917382|FG003|Overall Study|Withdrawal by Subject|0|||
128897019|NCT01251653|463917383|FG004|Overall Study|Withdrawal by Subject|1|||
128897020|NCT01251653|463917384|FG005|Overall Study|Withdrawal by Subject|1|||
128897021|NCT01251653|463917385|FG006|Overall Study|Withdrawal by Subject|0|||
128897022|NCT01251653|463917386|FG007|Overall Study|Withdrawal by Subject|1|||
128897023|NCT01251653|463917387|FG008|Overall Study|Withdrawal by Subject|0|||
128897024|NCT01251653|463917379|FG000|Overall Study|Other reason not mentioned above|0|||
128897025|NCT01251653|463917380|FG001|Overall Study|Other reason not mentioned above|0|||
128897026|NCT01251653|463917381|FG002|Overall Study|Other reason not mentioned above|0|||
128897027|NCT01251653|463917382|FG003|Overall Study|Other reason not mentioned above|0|||
128897028|NCT01251653|463917383|FG004|Overall Study|Other reason not mentioned above|0|||
128897029|NCT01251653|463917384|FG005|Overall Study|Other reason not mentioned above|0|||
128897030|NCT01251653|463917385|FG006|Overall Study|Other reason not mentioned above|0|||
128897031|NCT01251653|463917386|FG007|Overall Study|Other reason not mentioned above|2|||
128897032|NCT01251653|463917387|FG008|Overall Study|Other reason not mentioned above|0|||
128897033|NCT00885703|463917393|FG000|Overall Study|Death|9|||
128897034|NCT00885703|463917394|FG001|Overall Study|Death|7|||
128897035|NCT00885703|463917395|FG002|Overall Study|Death|8|||
128897036|NCT00885703|463917396|FG003|Overall Study|Death|7|||
128897037|NCT00885703|463917397|FG004|Overall Study|Death|7|||
128897038|NCT00885703|463917398|FG005|Overall Study|Death|8|||
128897039|NCT00885703|463917399|FG006|Overall Study|Death|4|||
128897040|NCT00885703|463917393|FG000|Overall Study|Lost to Follow-up|0|||
129112299|NCT00810069|464705670|FG000|Double-Blind Period II|Lost to Follow-up|0|||
129112300|NCT00810069|464705671|FG001|Double-Blind Period II|Lost to Follow-up|9|||
129112301|NCT00810069|464705672|FG002|Double-Blind Period II|Lost to Follow-up|9|||
129112302|NCT00810069|464705670|FG000|Double-Blind Period II|Physician Decision|0|||
129112303|NCT00810069|464705671|FG001|Double-Blind Period II|Physician Decision|0|||
128897041|NCT00885703|463917394|FG001|Overall Study|Lost to Follow-up|0|||
128897042|NCT00885703|463917395|FG002|Overall Study|Lost to Follow-up|1|||
128897043|NCT00885703|463917396|FG003|Overall Study|Lost to Follow-up|0|||
128897044|NCT00885703|463917397|FG004|Overall Study|Lost to Follow-up|0|||
128897045|NCT00885703|463917398|FG005|Overall Study|Lost to Follow-up|1|||
128897046|NCT00885703|463917399|FG006|Overall Study|Lost to Follow-up|0|||
128897047|NCT00885703|463917393|FG000|Overall Study|Withdrawal by Subject|0|||
128897048|NCT00885703|463917394|FG001|Overall Study|Withdrawal by Subject|0|||
128897049|NCT00885703|463917395|FG002|Overall Study|Withdrawal by Subject|0|||
128897050|NCT00885703|463917396|FG003|Overall Study|Withdrawal by Subject|1|||
128897051|NCT00885703|463917397|FG004|Overall Study|Withdrawal by Subject|3|||
128897052|NCT00885703|463917398|FG005|Overall Study|Withdrawal by Subject|1|||
128897053|NCT00885703|463917399|FG006|Overall Study|Withdrawal by Subject|1|||
128897054|NCT00885703|463917393|FG000|Overall Study|Ineligible (no CM)|1|||
128897055|NCT00885703|463917394|FG001|Overall Study|Ineligible (no CM)|3|||
128897056|NCT00885703|463917395|FG002|Overall Study|Ineligible (no CM)|2|||
128897057|NCT00885703|463917396|FG003|Overall Study|Ineligible (no CM)|1|||
128897058|NCT00885703|463917397|FG004|Overall Study|Ineligible (no CM)|2|||
128897059|NCT00885703|463917398|FG005|Overall Study|Ineligible (no CM)|3|||
128897060|NCT00885703|463917399|FG006|Overall Study|Ineligible (no CM)|1|||
128897061|NCT01183143|463917400|FG000|Overall Study|Protocol Violation|115|||
128897062|NCT01183143|463917400|FG000|Overall Study|Withdrawal by Subject|19|||
128897063|NCT01183143|463917400|FG000|Overall Study|Subject Questionnaires not returned|5|||
128897064|NCT01183143|463917400|FG000|Overall Study|Subjects enrolled, but not treated|11|||
128897065|NCT01490450|463917403|FG000|Period 1|Lack of Efficacy|2|||
128897066|NCT01490450|463917404|FG001|Period 1|Lack of Efficacy|0|||
128897067|NCT01490450|463917405|FG002|Period 1|Lack of Efficacy|3|||
128897068|NCT01490450|463917406|FG003|Period 1|Lack of Efficacy|0|||
128897069|NCT01490450|463917403|FG000|Period 1|Adverse Event|0|||
128897070|NCT01490450|463917404|FG001|Period 1|Adverse Event|0|||
128897071|NCT01490450|463917405|FG002|Period 1|Adverse Event|0|||
128897072|NCT01490450|463917406|FG003|Period 1|Adverse Event|5|||
128897073|NCT01490450|463917403|FG000|Period 1|Request to discontinue treatment|1|||
128897074|NCT01490450|463917404|FG001|Period 1|Request to discontinue treatment|0|||
128897075|NCT01490450|463917405|FG002|Period 1|Request to discontinue treatment|0|||
128897076|NCT01490450|463917406|FG003|Period 1|Request to discontinue treatment|0|||
128897077|NCT01490450|463917403|FG000|Period 1|Withdrawal by Subject|0|||
128897078|NCT01490450|463917404|FG001|Period 1|Withdrawal by Subject|0|||
128897079|NCT01490450|463917405|FG002|Period 1|Withdrawal by Subject|0|||
128897080|NCT01490450|463917406|FG003|Period 1|Withdrawal by Subject|3|||
128897081|NCT01490450|463917403|FG000|Period 1|No longer met study criteria|0|||
128897082|NCT01490450|463917404|FG001|Period 1|No longer met study criteria|1|||
128897083|NCT01490450|463917405|FG002|Period 1|No longer met study criteria|1|||
128897084|NCT01490450|463917406|FG003|Period 1|No longer met study criteria|0|||
128897085|NCT01490450|463917403|FG000|Period 2|Lack of Efficacy|0|||
128897086|NCT01490450|463917404|FG001|Period 2|Lack of Efficacy|0|||
128897087|NCT01490450|463917405|FG002|Period 2|Lack of Efficacy|0|||
128897088|NCT01490450|463917406|FG003|Period 2|Lack of Efficacy|1|||
128897089|NCT01490450|463917403|FG000|Period 2|Adverse Event|1|||
128897090|NCT01490450|463917404|FG001|Period 2|Adverse Event|1|||
128897091|NCT01490450|463917405|FG002|Period 2|Adverse Event|0|||
128897092|NCT01490450|463917406|FG003|Period 2|Adverse Event|1|||
128897093|NCT01490450|463917403|FG000|Period 2|Withdrawal by Subject|1|||
128897094|NCT01490450|463917404|FG001|Period 2|Withdrawal by Subject|0|||
128897095|NCT01490450|463917405|FG002|Period 2|Withdrawal by Subject|0|||
128897096|NCT01490450|463917406|FG003|Period 2|Withdrawal by Subject|0|||
128897097|NCT01490450|463917403|FG000|Period 2|Lost to Follow-up|0|||
128897098|NCT01490450|463917404|FG001|Period 2|Lost to Follow-up|0|||
128897099|NCT01490450|463917405|FG002|Period 2|Lost to Follow-up|0|||
128897100|NCT01490450|463917406|FG003|Period 2|Lost to Follow-up|2|||
128897101|NCT00636675|463917407|FG000|Overall Study|Lost to Follow-up|121|||
128897102|NCT00636675|463917408|FG001|Overall Study|Lost to Follow-up|31|||
128897103|NCT00636675|463917407|FG000|Overall Study|Withdrawal by Subject|19|||
128897104|NCT00636675|463917408|FG001|Overall Study|Withdrawal by Subject|10|||
128897105|NCT02865018|463917414|FG000|Overall Study|Withdrawal by Subject|1|||
128897106|NCT02636582|463917418|FG000|Overall Study|Surgical Pathology|1|||
128897107|NCT02636582|463917419|FG001|Overall Study|Surgical Pathology|0|||
128897108|NCT05500274|463917420|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
128897109|NCT05500274|463917421|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
129112304|NCT00810069|464705672|FG002|Double-Blind Period II|Physician Decision|1|||
129112305|NCT00810069|464705670|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
129112306|NCT00810069|464705671|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
129112307|NCT00810069|464705672|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
129112308|NCT00810069|464705670|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
128897110|NCT05500274|463917420|FG000|Overall Study|Lost to Follow-up|76|||
128897111|NCT05500274|463917421|FG001|Overall Study|Lost to Follow-up|51|||
128897112|NCT01555151|463917422|FG000|Overall Study|Withdrawal by Subject|6|||
128897113|NCT01555151|463917423|FG001|Overall Study|Withdrawal by Subject|2|||
128897114|NCT01555151|463917424|FG002|Overall Study|Withdrawal by Subject|0|||
128897115|NCT01555151|463917425|FG003|Overall Study|Withdrawal by Subject|2|||
128897116|NCT01555151|463917422|FG000|Overall Study|Administrative|3|||
128897117|NCT01555151|463917423|FG001|Overall Study|Administrative|1|||
128897118|NCT01555151|463917424|FG002|Overall Study|Administrative|2|||
128897119|NCT01555151|463917425|FG003|Overall Study|Administrative|0|||
128897120|NCT01555151|463917422|FG000|Overall Study|Protocol Violation|3|||
128897121|NCT01555151|463917423|FG001|Overall Study|Protocol Violation|3|||
128897122|NCT01555151|463917424|FG002|Overall Study|Protocol Violation|3|||
128897123|NCT01555151|463917425|FG003|Overall Study|Protocol Violation|5|||
128897124|NCT01555151|463917422|FG000|Overall Study|Adverse Event|1|||
128897125|NCT01555151|463917423|FG001|Overall Study|Adverse Event|2|||
128897126|NCT01555151|463917424|FG002|Overall Study|Adverse Event|1|||
128897127|NCT01555151|463917425|FG003|Overall Study|Adverse Event|2|||
128897128|NCT01555151|463917422|FG000|Overall Study|Lost to Follow-up|0|||
128897129|NCT01555151|463917423|FG001|Overall Study|Lost to Follow-up|0|||
128897130|NCT01555151|463917424|FG002|Overall Study|Lost to Follow-up|0|||
128897131|NCT01555151|463917425|FG003|Overall Study|Lost to Follow-up|1|||
129022877|NCT02159183|464376867|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
129022878|NCT02159183|464376866|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
129022879|NCT02159183|464376867|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
129022880|NCT02159183|464376866|FG000|Analysis After the 36 Months Follow-up|Death|0|||
129022881|NCT02159183|464376867|FG001|Analysis After the 36 Months Follow-up|Death|1|||
128897132|NCT03596866|463917426|FG000|Overall Study|Site terminated by Sponsor|64|||
128897133|NCT03596866|463917427|FG001|Overall Study|Site terminated by Sponsor|65|||
128897134|NCT03596866|463917426|FG000|Overall Study|Death|37|||
128897135|NCT03596866|463917427|FG001|Overall Study|Death|24|||
128897136|NCT03596866|463917426|FG000|Overall Study|Withdrawal by Subject|4|||
128897137|NCT03596866|463917427|FG001|Overall Study|Withdrawal by Subject|6|||
128897138|NCT03596866|463917426|FG000|Overall Study|Missing|0|||
129022882|NCT02159183|464376866|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
129022883|NCT02159183|464376867|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
128897139|NCT03596866|463917427|FG001|Overall Study|Missing|6|||
128897140|NCT03596866|463917426|FG000|Overall Study|Lost to Follow-up|2|||
128897141|NCT03596866|463917427|FG001|Overall Study|Lost to Follow-up|3|||
128897142|NCT03596866|463917426|FG000|Overall Study|Protocol Violation|1|||
128897143|NCT03596866|463917427|FG001|Overall Study|Protocol Violation|0|||
128897144|NCT03596866|463917426|FG000|Overall Study|Reason Not Specified|14|||
128897145|NCT03596866|463917427|FG001|Overall Study|Reason Not Specified|13|||
128897146|NCT02576444|463917428|FG000|Overall Study|Death|1|||
128897147|NCT02576444|463917429|FG001|Overall Study|Death|1|||
128897148|NCT02576444|463917430|FG002|Overall Study|Death|0|||
128897149|NCT02576444|463917431|FG003|Overall Study|Death|0|||
128897150|NCT02576444|463917428|FG000|Overall Study|Withdrawal by Subject|0|||
128897151|NCT02576444|463917429|FG001|Overall Study|Withdrawal by Subject|0|||
128897152|NCT02576444|463917430|FG002|Overall Study|Withdrawal by Subject|2|||
129022884|NCT02159183|464376866|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
128897153|NCT02576444|463917431|FG003|Overall Study|Withdrawal by Subject|0|||
128897154|NCT02576444|463917428|FG000|Overall Study|Adverse Event|0|||
128897155|NCT02576444|463917429|FG001|Overall Study|Adverse Event|0|||
128897156|NCT02576444|463917430|FG002|Overall Study|Adverse Event|1|||
128897157|NCT02576444|463917431|FG003|Overall Study|Adverse Event|0|||
128897158|NCT02576444|463917428|FG000|Overall Study|Physician Decision|0|||
129022885|NCT02159183|464376867|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
129022886|NCT01294917|464376871|FG000|Overall Study|Relocation|5|||
129022887|NCT01294917|464376871|FG000|Overall Study|Inconvenience|1|||
129022888|NCT02519348|464376872|FG000|Overall Study|Death|31|||
129022889|NCT02519348|464376873|FG001|Overall Study|Death|74|||
129022890|NCT02519348|464376874|FG002|Overall Study|Death|47|||
129022891|NCT02519348|464376875|FG003|Overall Study|Death|54|||
129022892|NCT02519348|464376876|FG004|Overall Study|Death|63|||
129022893|NCT02519348|464376877|FG005|Overall Study|Death|18|||
129022894|NCT02519348|464376878|FG006|Overall Study|Death|2|||
129022895|NCT02519348|464376879|FG007|Overall Study|Death|5|||
129022896|NCT02519348|464376880|FG008|Overall Study|Death|5|||
129022897|NCT02519348|464376872|FG000|Overall Study|Withdrawal by Subject|4|||
129022898|NCT02519348|464376873|FG001|Overall Study|Withdrawal by Subject|7|||
129022899|NCT02519348|464376874|FG002|Overall Study|Withdrawal by Subject|4|||
129022900|NCT02519348|464376875|FG003|Overall Study|Withdrawal by Subject|3|||
129022901|NCT02519348|464376876|FG004|Overall Study|Withdrawal by Subject|3|||
129022902|NCT02519348|464376877|FG005|Overall Study|Withdrawal by Subject|2|||
129022903|NCT02519348|464376878|FG006|Overall Study|Withdrawal by Subject|0|||
129022904|NCT02519348|464376879|FG007|Overall Study|Withdrawal by Subject|0|||
129022905|NCT02519348|464376880|FG008|Overall Study|Withdrawal by Subject|1|||
129022906|NCT02519348|464376872|FG000|Overall Study|Lost to Follow-up|0|||
129022907|NCT02519348|464376873|FG001|Overall Study|Lost to Follow-up|0|||
129022908|NCT02519348|464376874|FG002|Overall Study|Lost to Follow-up|1|||
129022909|NCT02519348|464376875|FG003|Overall Study|Lost to Follow-up|0|||
129022910|NCT02519348|464376876|FG004|Overall Study|Lost to Follow-up|2|||
129022911|NCT02519348|464376877|FG005|Overall Study|Lost to Follow-up|1|||
129022912|NCT02519348|464376878|FG006|Overall Study|Lost to Follow-up|1|||
129022913|NCT02519348|464376879|FG007|Overall Study|Lost to Follow-up|0|||
129022914|NCT02519348|464376880|FG008|Overall Study|Lost to Follow-up|0|||
129022915|NCT02519348|464376872|FG000|Overall Study|Other|0|||
129022916|NCT02519348|464376873|FG001|Overall Study|Other|3|||
129022917|NCT02519348|464376874|FG002|Overall Study|Other|0|||
129022918|NCT02519348|464376875|FG003|Overall Study|Other|0|||
129022919|NCT02519348|464376876|FG004|Overall Study|Other|1|||
129022920|NCT02519348|464376877|FG005|Overall Study|Other|0|||
128897159|NCT02576444|463917429|FG001|Overall Study|Physician Decision|0|||
129022921|NCT02519348|464376878|FG006|Overall Study|Other|0|||
129022922|NCT02519348|464376879|FG007|Overall Study|Other|0|||
129022923|NCT02519348|464376880|FG008|Overall Study|Other|0|||
129022924|NCT02519348|464376872|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
129022925|NCT02519348|464376873|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
129022926|NCT02519348|464376874|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
128897160|NCT02576444|463917430|FG002|Overall Study|Physician Decision|1|||
128897161|NCT02576444|463917431|FG003|Overall Study|Physician Decision|0|||
128897162|NCT00829179|463917435|FG000|Overall Study|Withdrawal by Subject|1|||
128897163|NCT03000179|463917436|FG000|Overall Study|Lost to Follow-up|2|||
128897164|NCT02343159|463917439|FG000|Overall Study|Early Study Termination|16|||
128897165|NCT02343159|463917440|FG001|Overall Study|Early Study Termination|19|||
128897166|NCT02343159|463917441|FG002|Overall Study|Early Study Termination|23|||
128897167|NCT02343159|463917439|FG000|Overall Study|Physician Decision|2|||
128897168|NCT02343159|463917440|FG001|Overall Study|Physician Decision|0|||
128897169|NCT02343159|463917441|FG002|Overall Study|Physician Decision|1|||
128897170|NCT02343159|463917439|FG000|Overall Study|Withdrawal by Subject|3|||
128897171|NCT02343159|463917440|FG001|Overall Study|Withdrawal by Subject|0|||
128897172|NCT02343159|463917441|FG002|Overall Study|Withdrawal by Subject|2|||
128897173|NCT02343159|463917439|FG000|Overall Study|Lost to Follow-up|0|||
128897174|NCT02343159|463917440|FG001|Overall Study|Lost to Follow-up|2|||
128897175|NCT02343159|463917441|FG002|Overall Study|Lost to Follow-up|2|||
128897176|NCT02343159|463917439|FG000|Overall Study|Adverse Event|4|||
128897177|NCT02343159|463917440|FG001|Overall Study|Adverse Event|4|||
128897178|NCT02343159|463917441|FG002|Overall Study|Adverse Event|2|||
128897179|NCT02343159|463917439|FG000|Overall Study|Sponsor Decision|0|||
128897180|NCT02343159|463917440|FG001|Overall Study|Sponsor Decision|1|||
128897181|NCT02343159|463917441|FG002|Overall Study|Sponsor Decision|0|||
128897182|NCT02343159|463917439|FG000|Overall Study|Enrollment Error|1|||
128897183|NCT02343159|463917440|FG001|Overall Study|Enrollment Error|0|||
128897184|NCT02343159|463917441|FG002|Overall Study|Enrollment Error|0|||
128897185|NCT01075412|463917445|FG000|Overall Study|Withdrawal by Subject|0|||
128897186|NCT01075412|463917446|FG001|Overall Study|Withdrawal by Subject|1|||
128897187|NCT00865904|463917449|FG000|Overall Study|Randomized but not Treated|2|||
128897188|NCT00865904|463917450|FG001|Overall Study|Randomized but not Treated|0|||
128897189|NCT00865904|463917451|FG002|Overall Study|Randomized but not Treated|0|||
128897190|NCT00865904|463917452|FG003|Overall Study|Randomized but not Treated|1|||
128897191|NCT00865904|463917453|FG004|Overall Study|Randomized but not Treated|1|||
128897192|NCT03625687|463917454|FG000|Overall Study|Death|1|||
128897193|NCT00711425|463917459|FG000|Overall Study|Protocol Violation|1|||
128897194|NCT00711425|463917459|FG000|Overall Study|Death|2|||
128897195|NCT00711425|463917459|FG000|Overall Study|Lost to Follow-up|1|||
128897196|NCT04607148|463917460|FG000|Overall Study|Withdrawal by Subject|0|||
128897197|NCT04607148|463917461|FG001|Overall Study|Withdrawal by Subject|4|||
128897198|NCT04607148|463917462|FG002|Overall Study|Withdrawal by Subject|2|||
128897199|NCT04607148|463917463|FG003|Overall Study|Withdrawal by Subject|8|||
128897200|NCT04607148|463917460|FG000|Overall Study|Study Terminated by Sponsor|14|||
128897201|NCT04607148|463917461|FG001|Overall Study|Study Terminated by Sponsor|59|||
128897202|NCT04607148|463917462|FG002|Overall Study|Study Terminated by Sponsor|9|||
128897203|NCT04607148|463917463|FG003|Overall Study|Study Terminated by Sponsor|39|||
128897204|NCT04607148|463917460|FG000|Overall Study|Sponsor Decision|0|||
128897205|NCT04607148|463917461|FG001|Overall Study|Sponsor Decision|0|||
128897206|NCT04607148|463917462|FG002|Overall Study|Sponsor Decision|1|||
128897207|NCT04607148|463917463|FG003|Overall Study|Sponsor Decision|0|||
128897208|NCT04607148|463917460|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128691930|NCT01193842|463171076|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
128691931|NCT01193842|463171077|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
128691932|NCT01193842|463171078|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
128691933|NCT01193842|463171079|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
128691934|NCT01193842|463171075|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
128897209|NCT04607148|463917461|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128897210|NCT04607148|463917462|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128897211|NCT04607148|463917463|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128897212|NCT04607148|463917460|FG000|Overall Study|Lost to Follow-up|0|||
128897213|NCT04607148|463917461|FG001|Overall Study|Lost to Follow-up|2|||
128897214|NCT04607148|463917462|FG002|Overall Study|Lost to Follow-up|0|||
129022927|NCT02519348|464376875|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
129022928|NCT02519348|464376876|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
129022929|NCT02519348|464376877|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
129022930|NCT02519348|464376878|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
129022931|NCT02519348|464376879|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
129022932|NCT02519348|464376880|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
129022933|NCT01444378|464376881|FG000|Overall Study|Lost to Follow-up|1|||
128897215|NCT04607148|463917463|FG003|Overall Study|Lost to Follow-up|0|||
128897216|NCT04607148|463917460|FG000|Overall Study|Death|0|||
128897217|NCT04607148|463917461|FG001|Overall Study|Death|3|||
128897218|NCT04607148|463917462|FG002|Overall Study|Death|0|||
128897219|NCT04607148|463917463|FG003|Overall Study|Death|1|||
128691935|NCT01193842|463171076|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
128897220|NCT04607148|463917460|FG000|Overall Study|Adverse Event|0|||
128897221|NCT04607148|463917461|FG001|Overall Study|Adverse Event|1|||
128897222|NCT04607148|463917462|FG002|Overall Study|Adverse Event|0|||
128897223|NCT04607148|463917463|FG003|Overall Study|Adverse Event|0|||
128897224|NCT00916149|463917464|FG000|Overall Study|Lost to Follow-up|3|||
128897225|NCT00916149|463917465|FG001|Overall Study|Lost to Follow-up|2|||
128897226|NCT00916149|463917466|FG002|Overall Study|Lost to Follow-up|0|||
128897227|NCT00916149|463917464|FG000|Overall Study|Unable to place scalp EEG leads|1|||
128897228|NCT00916149|463917465|FG001|Overall Study|Unable to place scalp EEG leads|0|||
128897229|NCT00916149|463917466|FG002|Overall Study|Unable to place scalp EEG leads|0|||
128897230|NCT00589420|463917467|FG000|Overall Study|screen failure|1|||
128897231|NCT00912028|463917468|FG000|Overall Study|Lost to Follow-up|2|||
128897232|NCT00912028|463917469|FG001|Overall Study|Lost to Follow-up|3|||
128897233|NCT00912028|463917470|FG002|Overall Study|Lost to Follow-up|0|||
128897234|NCT00912028|463917471|FG003|Overall Study|Lost to Follow-up|1|||
128897235|NCT00912028|463917472|FG004|Overall Study|Lost to Follow-up|3|||
128897236|NCT00912028|463917468|FG000|Overall Study|Withdrawal by Subject|3|||
128897237|NCT00912028|463917469|FG001|Overall Study|Withdrawal by Subject|0|||
128897238|NCT00912028|463917470|FG002|Overall Study|Withdrawal by Subject|0|||
128897239|NCT00912028|463917471|FG003|Overall Study|Withdrawal by Subject|0|||
128897240|NCT00912028|463917472|FG004|Overall Study|Withdrawal by Subject|0|||
128897241|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
128897242|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
128897243|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
128897244|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
128897245|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
128897246|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
128897247|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
128897248|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
128897249|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
128897250|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
128897251|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
128897252|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
128897253|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
128897254|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
128897255|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
128897256|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
128897257|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
128897258|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
129112309|NCT00810069|464705671|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
129112310|NCT00810069|464705672|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
129112311|NCT00810069|464705670|FG000|Double-Blind Period II|Clinical relapse|0|||
129112312|NCT00810069|464705671|FG001|Double-Blind Period II|Clinical relapse|3|||
128764573|NCT04512066|463428367|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
129112313|NCT00810069|464705672|FG002|Double-Blind Period II|Clinical relapse|0|||
129112314|NCT00810069|464705670|FG000|Double-Blind Period II|Protocol Violation|0|||
128691936|NCT01193842|463171077|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
128691937|NCT01193842|463171078|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
128691938|NCT01193842|463171079|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
128691939|NCT01193842|463171075|FG000|Phase II: Randomized Groups|Death|0|||
128691940|NCT01193842|463171076|FG001|Phase II: Randomized Groups|Death|0|||
129112315|NCT00810069|464705671|FG001|Double-Blind Period II|Protocol Violation|7|||
129112316|NCT00810069|464705672|FG002|Double-Blind Period II|Protocol Violation|6|||
129112317|NCT02899065|464705678|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
129112318|NCT02899065|464705679|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
129112319|NCT02899065|464705678|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
129112320|NCT02899065|464705679|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
129112321|NCT02899065|464705678|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
129112322|NCT02899065|464705679|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
129112323|NCT00971867|464705680|FG000|Overall Study|Adverse Event|4|||
129112324|NCT00971867|464705680|FG000|Overall Study|Participant Withdrew Consent|1|||
129112325|NCT00971867|464705680|FG000|Overall Study|Disease Progression|6|||
129112326|NCT04767373|464705681|FG000|Overall Study|Death|6|||
129112327|NCT04767373|464705682|FG001|Overall Study|Death|3|||
129112328|NCT04767373|464705681|FG000|Overall Study|Lost to Follow-up|67|||
129112329|NCT04767373|464705682|FG001|Overall Study|Lost to Follow-up|35|||
129112330|NCT04767373|464705681|FG000|Overall Study|Physician Decision|15|||
128691941|NCT01193842|463171077|FG002|Phase II: Randomized Groups|Death|0|||
129215239|NCT01588522|465089466|FG002|Overall Study|Did not initiate chemotherapy|0|||
128691942|NCT01193842|463171078|FG003|Phase II: Randomized Groups|Death|1|||
128897259|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
128897260|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
128897261|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
128897262|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
128897263|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
128691943|NCT01193842|463171079|FG004|Phase II: Randomized Groups|Death|1|||
128897264|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
128897265|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Death|2|||
128897266|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Death|1|||
128897267|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Death|0|||
128897268|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Death|0|||
128897269|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
128897270|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
128897271|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
128897272|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
128897273|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
128897274|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
128897275|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
128897276|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
128897277|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
128897278|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
128897279|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
128897280|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
128897281|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
128897282|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
128897283|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
128897284|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
128897285|NCT01940471|463917473|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
128897286|NCT01940471|463917474|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
128897287|NCT01940471|463917475|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
128897288|NCT01940471|463917476|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
128897289|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
128897290|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
128897291|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
128897292|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
128897293|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
128897294|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
128897295|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
128897296|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
128897297|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
128897298|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
128897299|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
128897300|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
128897301|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
128897302|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
128897303|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
128897304|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
128897305|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
128897306|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
128897307|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
128897308|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
128897309|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
128897310|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
128897311|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
128897312|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
128897313|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
128897314|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129022934|NCT01444378|464376881|FG000|Overall Study|Withdrawal by Subject|1|||
129022935|NCT01444378|464376881|FG000|Overall Study|Death|3|||
129022936|NCT01444378|464376881|FG000|Overall Study|Administrative Closure Of The Study|2|||
129022937|NCT01444378|464376881|FG000|Overall Study|Missed Visits|10|||
129022938|NCT00927069|464376882|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
129022939|NCT00927069|464376883|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
129022940|NCT00927069|464376884|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
129022941|NCT00927069|464376885|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
129022942|NCT00927069|464376882|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
129022943|NCT00927069|464376883|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
129022944|NCT00927069|464376884|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
129022945|NCT00927069|464376885|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
129022946|NCT00927069|464376882|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
129112331|NCT04767373|464705682|FG001|Overall Study|Physician Decision|4|||
129112332|NCT04767373|464705681|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128897315|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
128897316|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
128897317|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
128897318|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
128897319|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
128897320|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
128897321|NCT01940471|463917473|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
128897322|NCT01940471|463917474|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
128897323|NCT01940471|463917475|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
128897324|NCT01940471|463917476|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
128897325|NCT01846624|463917481|FG000|Overall Study|Died during induction, no midostaurin|1|||
128897326|NCT03574753|463917482|FG000|Overall Study|Adverse Event|3|||
128897327|NCT03574753|463917482|FG000|Overall Study|Progression/relapse|19|||
128897328|NCT03574753|463917482|FG000|Overall Study|Death|1|||
128897329|NCT01744665|463917485|FG000|Monitoring Phase|Adverse Event|4|||
128897330|NCT01744665|463917485|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
128897331|NCT01744665|463917485|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
128897332|NCT01744665|463917485|FG000|Monitoring Phase|Withdrawal by Subject|5|||
128897333|NCT01744665|463917485|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
128897334|NCT01744665|463917485|FG000|Consolidation Phase|Adverse Event|2|||
128897335|NCT01744665|463917485|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
128897336|NCT01744665|463917485|FG000|Consolidation Phase|Withdrawal by Subject|4|||
128897337|NCT01744665|463917485|FG000|Consolidation Phase|Administrative problems|9|||
128897338|NCT01744665|463917485|FG000|Re-initiation Phase|Administrative problems|10|||
128897339|NCT01744665|463917485|FG000|Re-initiation Phase|Adverse Event|1|||
128897340|NCT01744665|463917485|FG000|Re-initiation Phase|No longer required treatment|1|||
128897341|NCT01744665|463917485|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
128897342|NCT03184077|463917486|FG000|Overall Study|Lost to Follow-up|21|||
128897343|NCT03184077|463917487|FG001|Overall Study|Lost to Follow-up|21|||
128897344|NCT03159091|463917492|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
128897345|NCT03159091|463917493|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
128897346|NCT03159091|463917492|FG000|Overall Study|Patient has taken no dose of study drug|0|||
128897347|NCT03159091|463917493|FG001|Overall Study|Patient has taken no dose of study drug|1|||
128897348|NCT03462719|463917494|FG000|Overall Study|Withdrawal by Subject|4|||
128897349|NCT03462719|463917495|FG001|Overall Study|Withdrawal by Subject|3|||
128897350|NCT03462719|463917494|FG000|Overall Study|Ongoing|87|||
128897351|NCT03462719|463917495|FG001|Overall Study|Ongoing|72|||
128897352|NCT02044133|463917496|FG000|Overall Study|Lost to Follow-up|1|||
128897353|NCT02044133|463917497|FG001|Overall Study|Lost to Follow-up|1|||
128897354|NCT02044133|463917496|FG000|Overall Study|Death|1|||
128897355|NCT02044133|463917497|FG001|Overall Study|Death|0|||
128897356|NCT02044133|463917496|FG000|Overall Study|Release|3|||
128897357|NCT02044133|463917497|FG001|Overall Study|Release|4|||
128897358|NCT02044133|463917496|FG000|Overall Study|Transfer|1|||
128897359|NCT02044133|463917497|FG001|Overall Study|Transfer|0|||
128897360|NCT02044133|463917496|FG000|Overall Study|refusal of blood sampling|0|||
128897361|NCT02044133|463917497|FG001|Overall Study|refusal of blood sampling|1|||
128897362|NCT01401842|463917501|FG000|Overall Study|Withdrawal by Subject|3|||
128897363|NCT01401842|463917502|FG001|Overall Study|Withdrawal by Subject|2|||
128897364|NCT01401842|463917501|FG000|Overall Study|academic reason|4|||
128897365|NCT01401842|463917502|FG001|Overall Study|academic reason|1|||
128897366|NCT01401842|463917501|FG000|Overall Study|changed companies|20|||
128897367|NCT01401842|463917502|FG001|Overall Study|changed companies|34|||
128897368|NCT01401842|463917501|FG000|Overall Study|discharged from US Army|3|||
128897369|NCT01401842|463917502|FG001|Overall Study|discharged from US Army|4|||
128897370|NCT01401842|463917501|FG000|Overall Study|invalid follow-up strength data|1|||
128897371|NCT01401842|463917502|FG001|Overall Study|invalid follow-up strength data|4|||
129112333|NCT04767373|464705682|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129112334|NCT04767373|464705681|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
129112335|NCT04767373|464705682|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
129112336|NCT04767373|464705681|FG000|Overall Study|Other|1|||
129112337|NCT04767373|464705682|FG001|Overall Study|Other|2|||
129112338|NCT02983045|464705684|FG000|Overall Study|Withdrawal by Subject|0|||
129112339|NCT02983045|464705685|FG001|Overall Study|Withdrawal by Subject|1|||
129112340|NCT02983045|464705686|FG002|Overall Study|Withdrawal by Subject|0|||
128897372|NCT01401842|463917501|FG000|Overall Study|on profile|9|||
128897373|NCT01401842|463917502|FG001|Overall Study|on profile|5|||
128897374|NCT01401842|463917501|FG000|Overall Study|other/unknown|28|||
128897375|NCT01401842|463917502|FG001|Overall Study|other/unknown|17|||
128897376|NCT06156215|463917509|FG000|Overall Study|Withdrawal by Subject|2|||
128897377|NCT06156215|463917510|FG001|Overall Study|Withdrawal by Subject|4|||
128897378|NCT06156215|463917511|FG002|Overall Study|Withdrawal by Subject|4|||
128897379|NCT06156215|463917512|FG003|Overall Study|Withdrawal by Subject|0|||
129112341|NCT02983045|464705687|FG003|Overall Study|Withdrawal by Subject|5|||
129112342|NCT02983045|464705688|FG004|Overall Study|Withdrawal by Subject|0|||
128897380|NCT06156215|463917513|FG004|Overall Study|Withdrawal by Subject|2|||
128897381|NCT06156215|463917514|FG005|Overall Study|Withdrawal by Subject|2|||
128897382|NCT06156215|463917509|FG000|Overall Study|Left ED without completing study|9|||
128897383|NCT06156215|463917510|FG001|Overall Study|Left ED without completing study|3|||
128897384|NCT06156215|463917511|FG002|Overall Study|Left ED without completing study|9|||
128897385|NCT06156215|463917512|FG003|Overall Study|Left ED without completing study|0|||
128897386|NCT06156215|463917513|FG004|Overall Study|Left ED without completing study|8|||
128897387|NCT06156215|463917514|FG005|Overall Study|Left ED without completing study|16|||
128897388|NCT06156215|463917509|FG000|Overall Study|Physician Decision|1|||
128897389|NCT06156215|463917510|FG001|Overall Study|Physician Decision|0|||
128897390|NCT06156215|463917511|FG002|Overall Study|Physician Decision|0|||
128897391|NCT06156215|463917512|FG003|Overall Study|Physician Decision|0|||
128897392|NCT06156215|463917513|FG004|Overall Study|Physician Decision|0|||
128897393|NCT06156215|463917514|FG005|Overall Study|Physician Decision|0|||
128897394|NCT06156215|463917509|FG000|Overall Study|Became or found ineligible|2|||
128897395|NCT06156215|463917510|FG001|Overall Study|Became or found ineligible|0|||
128897396|NCT06156215|463917511|FG002|Overall Study|Became or found ineligible|2|||
128897397|NCT06156215|463917512|FG003|Overall Study|Became or found ineligible|0|||
128897398|NCT06156215|463917513|FG004|Overall Study|Became or found ineligible|1|||
128897399|NCT06156215|463917514|FG005|Overall Study|Became or found ineligible|2|||
128897400|NCT00766038|463919049|FG000|Overall Study|Lost to Follow-up|15|||
128897401|NCT00766038|463919050|FG001|Overall Study|Lost to Follow-up|14|||
128897402|NCT00847145|463919055|FG000|Overall Study|AE or Death|0|||
128897403|NCT00847145|463919056|FG001|Overall Study|AE or Death|1|||
128897404|NCT00847145|463919057|FG002|Overall Study|AE or Death|1|||
128897405|NCT00847145|463919058|FG003|Overall Study|AE or Death|0|||
128897406|NCT00847145|463919059|FG004|Overall Study|AE or Death|0|||
128897407|NCT00847145|463919060|FG005|Overall Study|AE or Death|0|||
128897408|NCT00847145|463919061|FG006|Overall Study|AE or Death|0|||
128897409|NCT00847145|463919062|FG007|Overall Study|AE or Death|0|||
128897410|NCT00847145|463919055|FG000|Overall Study|Withdrawal by Subject|3|||
128897411|NCT00847145|463919056|FG001|Overall Study|Withdrawal by Subject|4|||
128897412|NCT00847145|463919057|FG002|Overall Study|Withdrawal by Subject|6|||
128897413|NCT00847145|463919058|FG003|Overall Study|Withdrawal by Subject|1|||
128897414|NCT00847145|463919059|FG004|Overall Study|Withdrawal by Subject|0|||
128897415|NCT00847145|463919060|FG005|Overall Study|Withdrawal by Subject|0|||
128897416|NCT00847145|463919061|FG006|Overall Study|Withdrawal by Subject|1|||
128897417|NCT00847145|463919062|FG007|Overall Study|Withdrawal by Subject|1|||
128897418|NCT00847145|463919055|FG000|Overall Study|Lost to Follow-up|3|||
128897419|NCT00847145|463919056|FG001|Overall Study|Lost to Follow-up|1|||
128897420|NCT00847145|463919057|FG002|Overall Study|Lost to Follow-up|1|||
128897421|NCT00847145|463919058|FG003|Overall Study|Lost to Follow-up|0|||
128897422|NCT00847145|463919059|FG004|Overall Study|Lost to Follow-up|4|||
128897423|NCT00847145|463919060|FG005|Overall Study|Lost to Follow-up|4|||
128897424|NCT00847145|463919061|FG006|Overall Study|Lost to Follow-up|8|||
128897425|NCT00847145|463919062|FG007|Overall Study|Lost to Follow-up|2|||
128897426|NCT00847145|463919055|FG000|Overall Study|Inappropriate enrollment|0|||
128897427|NCT00847145|463919056|FG001|Overall Study|Inappropriate enrollment|0|||
128897428|NCT00847145|463919057|FG002|Overall Study|Inappropriate enrollment|0|||
128897429|NCT00847145|463919058|FG003|Overall Study|Inappropriate enrollment|0|||
128897430|NCT00847145|463919059|FG004|Overall Study|Inappropriate enrollment|1|||
128897431|NCT00847145|463919060|FG005|Overall Study|Inappropriate enrollment|0|||
129022947|NCT00927069|464376883|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
129022948|NCT00927069|464376884|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
129022949|NCT00927069|464376885|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
129022950|NCT00927069|464376882|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
129022951|NCT00927069|464376883|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
129022952|NCT00927069|464376884|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
129022953|NCT00927069|464376885|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
129022954|NCT00927069|464376882|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
129022955|NCT00927069|464376883|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
128897432|NCT00847145|463919061|FG006|Overall Study|Inappropriate enrollment|0|||
128897433|NCT00847145|463919062|FG007|Overall Study|Inappropriate enrollment|0|||
128897434|NCT00847145|463919055|FG000|Overall Study|Protocol Violation|0|||
128897435|NCT00847145|463919056|FG001|Overall Study|Protocol Violation|0|||
128897436|NCT00847145|463919057|FG002|Overall Study|Protocol Violation|3|||
128897437|NCT00847145|463919058|FG003|Overall Study|Protocol Violation|0|||
128897438|NCT00847145|463919059|FG004|Overall Study|Protocol Violation|1|||
129022956|NCT00927069|464376884|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
128897439|NCT00847145|463919060|FG005|Overall Study|Protocol Violation|0|||
128897440|NCT00847145|463919061|FG006|Overall Study|Protocol Violation|0|||
128897441|NCT00847145|463919062|FG007|Overall Study|Protocol Violation|1|||
128897442|NCT02833974|463919063|FG000|Overall Study|Lost to Follow-up|1|||
128897443|NCT02833974|463919064|FG001|Overall Study|Lost to Follow-up|0|||
128897444|NCT02833974|463919063|FG000|Overall Study|Adverse Event|0|||
128897445|NCT02833974|463919064|FG001|Overall Study|Adverse Event|3|||
128897446|NCT04419610|463919065|FG000|Overall Study|Withdrawal by Subject|3|||
128897447|NCT04419610|463919066|FG001|Overall Study|Withdrawal by Subject|1|||
128897448|NCT04419610|463919065|FG000|Overall Study|Adverse Event|1|||
128897449|NCT04419610|463919066|FG001|Overall Study|Adverse Event|0|||
128897450|NCT04419610|463919065|FG000|Overall Study|discharged early|1|||
128897451|NCT04419610|463919066|FG001|Overall Study|discharged early|1|||
128897452|NCT01524198|463919067|FG000|Overall Study|Protocol Violation|8|||
128897453|NCT01524198|463919068|FG001|Overall Study|Protocol Violation|6|||
128897454|NCT01524198|463919067|FG000|Overall Study|Withdrawal by Subject|15|||
128897455|NCT01524198|463919068|FG001|Overall Study|Withdrawal by Subject|10|||
128897456|NCT00307151|463919070|FG000|Overall Study|Death|4|||
128897457|NCT00307151|463919071|FG001|Overall Study|Death|3|||
128897458|NCT00307151|463919072|FG002|Overall Study|Death|10|||
128897459|NCT00307151|463919073|FG003|Overall Study|Death|3|||
128897460|NCT00307151|463919070|FG000|Overall Study|Severe debilitation, unable to continue|1|||
128897461|NCT00307151|463919071|FG001|Overall Study|Severe debilitation, unable to continue|0|||
128897462|NCT00307151|463919072|FG002|Overall Study|Severe debilitation, unable to continue|0|||
128897463|NCT00307151|463919073|FG003|Overall Study|Severe debilitation, unable to continue|0|||
128897464|NCT00307151|463919070|FG000|Overall Study|Subject unable to get to clinic|1|||
128897465|NCT00307151|463919071|FG001|Overall Study|Subject unable to get to clinic|0|||
128897466|NCT00307151|463919072|FG002|Overall Study|Subject unable to get to clinic|6|||
128897467|NCT00307151|463919073|FG003|Overall Study|Subject unable to get to clinic|2|||
128897468|NCT00307151|463919070|FG000|Overall Study|Withdrew consent|0|||
128897469|NCT00307151|463919071|FG001|Overall Study|Withdrew consent|1|||
128897470|NCT00307151|463919072|FG002|Overall Study|Withdrew consent|1|||
128897471|NCT00307151|463919073|FG003|Overall Study|Withdrew consent|3|||
128897472|NCT00307151|463919070|FG000|Overall Study|Not willing to adhere to study reqs|2|||
128897473|NCT00307151|463919071|FG001|Overall Study|Not willing to adhere to study reqs|0|||
128897474|NCT00307151|463919072|FG002|Overall Study|Not willing to adhere to study reqs|2|||
128897475|NCT00307151|463919073|FG003|Overall Study|Not willing to adhere to study reqs|2|||
128897476|NCT00307151|463919070|FG000|Overall Study|Clinic unable to contact subject|3|||
128897477|NCT00307151|463919071|FG001|Overall Study|Clinic unable to contact subject|3|||
128897478|NCT00307151|463919072|FG002|Overall Study|Clinic unable to contact subject|1|||
128897479|NCT00307151|463919073|FG003|Overall Study|Clinic unable to contact subject|1|||
128897480|NCT00516048|463919078|FG000|Overall Study|Death|0|||
128897481|NCT00516048|463919079|FG001|Overall Study|Death|0|||
128897482|NCT00516048|463919080|FG002|Overall Study|Death|1|||
128897483|NCT00516048|463919078|FG000|Overall Study|Subject Decision|0|||
128897484|NCT00516048|463919079|FG001|Overall Study|Subject Decision|2|||
128897485|NCT00516048|463919080|FG002|Overall Study|Subject Decision|0|||
128897486|NCT00054704|463919083|FG000|Overall Study|Lack of Efficacy|2|||
128897487|NCT00054704|463919084|FG001|Overall Study|Lack of Efficacy|3|||
128897488|NCT00054704|463919083|FG000|Overall Study|Adverse Event|3|||
128897489|NCT00054704|463919084|FG001|Overall Study|Adverse Event|1|||
128897490|NCT00054704|463919083|FG000|Overall Study|Lost to Follow-up|0|||
128897491|NCT00054704|463919084|FG001|Overall Study|Lost to Follow-up|1|||
128897492|NCT00362414|463919085|FG000|Overall Study|Death|2|||
128897493|NCT00362414|463919085|FG000|Overall Study|Adverse Event|1|||
128897494|NCT02053168|463919086|FG000|Overall Study|Withdrawal by Subject|1|||
128897495|NCT02053168|463919086|FG000|Overall Study|Physician Decision|1|||
128897496|NCT02053168|463919086|FG000|Overall Study|Lost to Follow-up|1|||
128897497|NCT00096785|463919087|FG000|Overall Study|Lost to Follow-up|1|||
128897498|NCT00096785|463919088|FG001|Overall Study|Lost to Follow-up|0|||
128897499|NCT00096785|463919087|FG000|Overall Study|Withdrawal by Subject|0|||
128897500|NCT00096785|463919088|FG001|Overall Study|Withdrawal by Subject|1|||
128897501|NCT00096785|463919087|FG000|Overall Study|Relocated|1|||
128897502|NCT00096785|463919088|FG001|Overall Study|Relocated|0|||
128897503|NCT04053868|463919089|FG000|Overall Study|Withdrawal by Subject|1|||
128897504|NCT04053868|463919090|FG001|Overall Study|Withdrawal by Subject|0|||
128897505|NCT00833053|463919093|FG000|Overall Study|Adverse Event|4|||
128897506|NCT00833053|463919094|FG001|Overall Study|Adverse Event|0|||
128897507|NCT00833053|463919093|FG000|Overall Study|Treatment Failure|3|||
128897508|NCT00833053|463919094|FG001|Overall Study|Treatment Failure|1|||
128897509|NCT00833053|463919093|FG000|Overall Study|Withdrawal by Subject|0|||
128897510|NCT00833053|463919094|FG001|Overall Study|Withdrawal by Subject|1|||
128897511|NCT00833053|463919093|FG000|Overall Study|Protocol Violation|2|||
128897512|NCT00833053|463919094|FG001|Overall Study|Protocol Violation|1|||
128897513|NCT02187471|463919097|FG000|Overall Study|Protocol Violation|4|||
128897514|NCT02187471|463919098|FG001|Overall Study|Protocol Violation|5|||
128897515|NCT02187471|463919099|FG002|Overall Study|Protocol Violation|4|||
128897516|NCT02187471|463919100|FG003|Overall Study|Protocol Violation|4|||
128897517|NCT02187471|463919097|FG000|Overall Study|Missing|0|||
128897518|NCT02187471|463919098|FG001|Overall Study|Missing|0|||
128897519|NCT02187471|463919099|FG002|Overall Study|Missing|0|||
128897520|NCT02187471|463919100|FG003|Overall Study|Missing|1|||
128897521|NCT02187471|463919097|FG000|Overall Study|Lack of Efficacy|18|||
128897522|NCT02187471|463919098|FG001|Overall Study|Lack of Efficacy|9|||
128897523|NCT02187471|463919099|FG002|Overall Study|Lack of Efficacy|13|||
128897524|NCT02187471|463919100|FG003|Overall Study|Lack of Efficacy|11|||
128897525|NCT02187471|463919097|FG000|Overall Study|Adverse Event|24|||
128897526|NCT02187471|463919098|FG001|Overall Study|Adverse Event|34|||
128897527|NCT02187471|463919099|FG002|Overall Study|Adverse Event|44|||
128897528|NCT02187471|463919100|FG003|Overall Study|Adverse Event|36|||
128897529|NCT02187471|463919097|FG000|Overall Study|Withdrawal by Subject|23|||
128897530|NCT02187471|463919098|FG001|Overall Study|Withdrawal by Subject|29|||
128897531|NCT02187471|463919099|FG002|Overall Study|Withdrawal by Subject|22|||
128897532|NCT02187471|463919100|FG003|Overall Study|Withdrawal by Subject|24|||
128897533|NCT02187471|463919097|FG000|Overall Study|Other|7|||
128897534|NCT02187471|463919098|FG001|Overall Study|Other|5|||
128897535|NCT02187471|463919099|FG002|Overall Study|Other|3|||
128897536|NCT02187471|463919100|FG003|Overall Study|Other|4|||
128897537|NCT02236520|463919101|FG000|Overall Study|Physician Decision|0|||
128897538|NCT02236520|463919102|FG001|Overall Study|Physician Decision|5|||
128897539|NCT02236520|463919103|FG002|Overall Study|Physician Decision|0|||
128897540|NCT02236520|463919104|FG003|Overall Study|Physician Decision|0|||
128897541|NCT02236520|463919101|FG000|Overall Study|Withdrawal by Subject|1|||
128897542|NCT02236520|463919102|FG001|Overall Study|Withdrawal by Subject|0|||
128897543|NCT02236520|463919103|FG002|Overall Study|Withdrawal by Subject|0|||
128897544|NCT02236520|463919104|FG003|Overall Study|Withdrawal by Subject|1|||
128897545|NCT02236520|463919101|FG000|Overall Study|Pregnancy|1|||
128897546|NCT02236520|463919102|FG001|Overall Study|Pregnancy|0|||
128897547|NCT02236520|463919103|FG002|Overall Study|Pregnancy|0|||
128897548|NCT02236520|463919104|FG003|Overall Study|Pregnancy|0|||
128897549|NCT01785160|463919105|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
128897550|NCT01785160|463919105|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
128897551|NCT00957528|463919106|FG000|Overall Study|Protocol Violation|0|||
128897552|NCT00957528|463919107|FG001|Overall Study|Protocol Violation|1|||
128897553|NCT00957528|463919108|FG002|Overall Study|Protocol Violation|0|||
128897554|NCT00957528|463919106|FG000|Overall Study|Withdrawal by Subject|0|||
128897555|NCT00957528|463919107|FG001|Overall Study|Withdrawal by Subject|0|||
128897556|NCT00957528|463919108|FG002|Overall Study|Withdrawal by Subject|1|||
128897557|NCT02081534|463919109|FG000|Overall Study|Adverse Event|5|||
128897558|NCT02081534|463919110|FG001|Overall Study|Adverse Event|4|||
128897559|NCT02081534|463919111|FG002|Overall Study|Adverse Event|3|||
128897560|NCT02081534|463919112|FG003|Overall Study|Adverse Event|10|||
128897561|NCT02081534|463919113|FG004|Overall Study|Adverse Event|2|||
128897562|NCT02081534|463919114|FG005|Overall Study|Adverse Event|8|||
128897563|NCT02081534|463919115|FG006|Overall Study|Adverse Event|2|||
128897564|NCT02081534|463919109|FG000|Overall Study|Withdrawal by Subject|0|||
128897565|NCT02081534|463919110|FG001|Overall Study|Withdrawal by Subject|1|||
128897566|NCT02081534|463919111|FG002|Overall Study|Withdrawal by Subject|1|||
128897567|NCT02081534|463919112|FG003|Overall Study|Withdrawal by Subject|1|||
128897568|NCT02081534|463919113|FG004|Overall Study|Withdrawal by Subject|1|||
128897569|NCT02081534|463919114|FG005|Overall Study|Withdrawal by Subject|0|||
128897570|NCT02081534|463919115|FG006|Overall Study|Withdrawal by Subject|1|||
128897571|NCT02081534|463919109|FG000|Overall Study|Protocol Violation|0|||
128897572|NCT02081534|463919110|FG001|Overall Study|Protocol Violation|3|||
128897573|NCT02081534|463919111|FG002|Overall Study|Protocol Violation|0|||
128897574|NCT02081534|463919112|FG003|Overall Study|Protocol Violation|0|||
128897575|NCT02081534|463919113|FG004|Overall Study|Protocol Violation|0|||
128897576|NCT02081534|463919114|FG005|Overall Study|Protocol Violation|0|||
128897577|NCT02081534|463919115|FG006|Overall Study|Protocol Violation|1|||
128897578|NCT02081534|463919109|FG000|Overall Study|Lost to Follow-up|0|||
128897579|NCT02081534|463919110|FG001|Overall Study|Lost to Follow-up|0|||
128897580|NCT02081534|463919111|FG002|Overall Study|Lost to Follow-up|0|||
129112343|NCT02983045|464705689|FG005|Overall Study|Withdrawal by Subject|72|||
129112344|NCT02983045|464705690|FG006|Overall Study|Withdrawal by Subject|0|||
129112345|NCT02983045|464705691|FG007|Overall Study|Withdrawal by Subject|0|||
129112346|NCT02983045|464705692|FG008|Overall Study|Withdrawal by Subject|0|||
128691944|NCT01193842|463171075|FG000|Phase II: Randomized Groups|Adverse Event|0|||
128691945|NCT01193842|463171076|FG001|Phase II: Randomized Groups|Adverse Event|0|||
128691946|NCT01193842|463171077|FG002|Phase II: Randomized Groups|Adverse Event|0|||
128691947|NCT01193842|463171078|FG003|Phase II: Randomized Groups|Adverse Event|5|||
128897581|NCT02081534|463919112|FG003|Overall Study|Lost to Follow-up|2|||
128897582|NCT02081534|463919113|FG004|Overall Study|Lost to Follow-up|1|||
128897583|NCT02081534|463919114|FG005|Overall Study|Lost to Follow-up|1|||
129112347|NCT02983045|464705693|FG009|Overall Study|Withdrawal by Subject|2|||
128691948|NCT01193842|463171079|FG004|Phase II: Randomized Groups|Adverse Event|3|||
128691949|NCT01193842|463171075|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
128897584|NCT02081534|463919115|FG006|Overall Study|Lost to Follow-up|0|||
128897585|NCT02234479|463919116|FG000|Overall Study|Withdrawal by Subject|1|||
128897586|NCT02234479|463919117|FG001|Overall Study|Withdrawal by Subject|3|||
128897587|NCT02318667|463919118|FG000|Overall Study|Adverse Event|1|||
128897588|NCT02318667|463919118|FG000|Overall Study|Lack of Efficacy|6|||
128897589|NCT02318667|463919118|FG000|Overall Study|Protocol Violation|2|||
128897590|NCT00003535|463919119|FG000|Overall Study|Not evaluable|5|||
128897591|NCT02289742|463919120|FG000|First Wear Period|Adverse event prior to treatment|0|||
128691950|NCT01193842|463171076|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
128897592|NCT02289742|463919121|FG001|First Wear Period|Adverse event prior to treatment|1|||
128897593|NCT02289742|463919122|FG002|First Wear Period|Adverse event prior to treatment|0|||
128897594|NCT02289742|463919123|FG003|First Wear Period|Adverse event prior to treatment|0|||
128897595|NCT02289742|463919120|FG000|First Wear Period|Adverse Event|0|||
128897596|NCT02289742|463919121|FG001|First Wear Period|Adverse Event|0|||
128897597|NCT02289742|463919122|FG002|First Wear Period|Adverse Event|1|||
128897598|NCT02289742|463919123|FG003|First Wear Period|Adverse Event|0|||
128897599|NCT02289742|463919120|FG000|First Wear Period|Other prior to treatment|0|||
128897600|NCT02289742|463919121|FG001|First Wear Period|Other prior to treatment|0|||
128897601|NCT02289742|463919122|FG002|First Wear Period|Other prior to treatment|0|||
128897602|NCT02289742|463919123|FG003|First Wear Period|Other prior to treatment|1|||
128897603|NCT02289742|463919120|FG000|Third Wear Period|Adverse Event|0|||
128897604|NCT02289742|463919121|FG001|Third Wear Period|Adverse Event|1|||
128897605|NCT02289742|463919122|FG002|Third Wear Period|Adverse Event|0|||
128897606|NCT02289742|463919123|FG003|Third Wear Period|Adverse Event|0|||
128897607|NCT02289742|463919120|FG000|Third Wear Period|Reason not given|0|||
128897608|NCT02289742|463919121|FG001|Third Wear Period|Reason not given|0|||
128897609|NCT02289742|463919122|FG002|Third Wear Period|Reason not given|0|||
128897610|NCT02289742|463919123|FG003|Third Wear Period|Reason not given|1|||
128897611|NCT02181816|463919124|FG000|Overall Study|Case Report Forms Uncollected|38|||
128897612|NCT02181816|463919124|FG000|Overall Study|Protocol Deviation|21|||
128897613|NCT01365039|463919125|FG000|Overall Study|Study related symptoms and complaints|1|||
128897614|NCT01365039|463919126|FG001|Overall Study|Study related symptoms and complaints|0|||
128897615|NCT03807349|463919129|FG000|Overall Study|Early Study Termination|9|||
128897616|NCT00294060|463919130|FG000|Overall Study|Death|225|||
128897617|NCT00294060|463919130|FG000|Overall Study|Other|59|||
128897618|NCT00294060|463919130|FG000|Overall Study|Lost to Follow-up|55|||
128897619|NCT00294060|463919130|FG000|Overall Study|Withdrawal by Subject|11|||
128897620|NCT00294060|463919130|FG000|Overall Study|Physician Decision|797|||
128897621|NCT00294060|463919130|FG000|Overall Study|Medical condition|3|||
128897622|NCT00294060|463919130|FG000|Overall Study|Device explanted/not replaced|23|||
128897623|NCT01360554|463919131|FG000|Overall Study|Death|359|||
128897624|NCT01360554|463919132|FG001|Overall Study|Death|371|||
128897625|NCT01360554|463919131|FG000|Overall Study|Lost to Follow-up|4|||
128897626|NCT01360554|463919132|FG001|Overall Study|Lost to Follow-up|4|||
128897627|NCT01360554|463919131|FG000|Overall Study|Withdrawal by Subject|23|||
128897628|NCT01360554|463919132|FG001|Overall Study|Withdrawal by Subject|24|||
128897629|NCT01360554|463919131|FG000|Overall Study|Study terminated by sponsor|49|||
128897630|NCT01360554|463919132|FG001|Overall Study|Study terminated by sponsor|37|||
128897631|NCT01360554|463919131|FG000|Overall Study|Other, not specified|1|||
128897632|NCT01360554|463919132|FG001|Overall Study|Other, not specified|0|||
128897633|NCT01360554|463919131|FG000|Overall Study|Randomized but not treated.|3|||
128897634|NCT01360554|463919132|FG001|Overall Study|Randomized but not treated.|3|||
128897635|NCT00187096|463919134|FG000|Overall Study|unacceptable toxicity|0|||
128897636|NCT00187096|463919135|FG001|Overall Study|unacceptable toxicity|0|||
128897637|NCT00187096|463919136|FG002|Overall Study|unacceptable toxicity|1|||
128897638|NCT00253643|463919141|FG000|Overall Study|Withdrawal by Subject|0|||
128897639|NCT00253643|463919142|FG001|Overall Study|Withdrawal by Subject|0|||
128897640|NCT00253643|463919143|FG002|Overall Study|Withdrawal by Subject|1|||
128897641|NCT00253643|463919144|FG003|Overall Study|Withdrawal by Subject|1|||
128897642|NCT00253643|463919141|FG000|Overall Study|Non-Compliance|0|||
128897643|NCT00253643|463919142|FG001|Overall Study|Non-Compliance|0|||
128897644|NCT00253643|463919143|FG002|Overall Study|Non-Compliance|0|||
128897645|NCT00253643|463919144|FG003|Overall Study|Non-Compliance|2|||
128897646|NCT00383084|463919145|FG000|Overall Study|Withdrawal by Subject|12|||
128897647|NCT00383084|463919146|FG001|Overall Study|Withdrawal by Subject|10|||
128897648|NCT02113436|463919147|FG000|Period 1: 8 Weeks|Adverse Event|1|||
128897649|NCT02113436|463919148|FG001|Period 1: 8 Weeks|Adverse Event|0|||
128897650|NCT02113436|463919149|FG002|Period 1: 8 Weeks|Adverse Event|0|||
128897651|NCT02113436|463919150|FG003|Period 1: 8 Weeks|Adverse Event|0|||
128897652|NCT02113436|463919147|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
128897653|NCT02113436|463919148|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
128897654|NCT02113436|463919149|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
128897655|NCT02113436|463919150|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
128897656|NCT02113436|463919147|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
128897657|NCT02113436|463919148|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
128897658|NCT02113436|463919149|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
128897659|NCT02113436|463919150|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
128897660|NCT02113436|463919147|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
128897661|NCT02113436|463919148|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
128897662|NCT02113436|463919149|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
128897663|NCT02113436|463919150|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
128897664|NCT02113436|463919147|FG000|Period 2: 16 Weeks|Adverse Event|0|||
128897665|NCT02113436|463919148|FG001|Period 2: 16 Weeks|Adverse Event|0|||
128897666|NCT02113436|463919149|FG002|Period 2: 16 Weeks|Adverse Event|4|||
128897667|NCT02113436|463919150|FG003|Period 2: 16 Weeks|Adverse Event|5|||
128897668|NCT02113436|463919147|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
128897669|NCT02113436|463919148|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
128897670|NCT02113436|463919149|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
128897671|NCT02113436|463919150|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
128897672|NCT02113436|463919147|FG000|Period 2: 16 Weeks|Physician Decision|0|||
128897673|NCT02113436|463919148|FG001|Period 2: 16 Weeks|Physician Decision|0|||
128897674|NCT02113436|463919149|FG002|Period 2: 16 Weeks|Physician Decision|2|||
128897675|NCT02113436|463919150|FG003|Period 2: 16 Weeks|Physician Decision|0|||
128897676|NCT02113436|463919147|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
128897677|NCT02113436|463919148|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
128897678|NCT02113436|463919149|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
128897679|NCT02113436|463919150|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
128897680|NCT02159729|463919151|FG000|Overall Study|Adverse Event|0|||
128897681|NCT02159729|463919152|FG001|Overall Study|Adverse Event|1|||
128897682|NCT02159729|463919151|FG000|Overall Study|Subject's Request|13|||
128897683|NCT02159729|463919152|FG001|Overall Study|Subject's Request|10|||
128897684|NCT02159729|463919151|FG000|Overall Study|Lost to Follow-up|24|||
128897685|NCT02159729|463919152|FG001|Overall Study|Lost to Follow-up|9|||
128897686|NCT02159729|463919151|FG000|Overall Study|Non compliance|2|||
128897687|NCT02159729|463919152|FG001|Overall Study|Non compliance|0|||
128897688|NCT02159729|463919151|FG000|Overall Study|Other Unspecified|3|||
128897689|NCT02159729|463919152|FG001|Overall Study|Other Unspecified|1|||
128897690|NCT01263483|463919153|FG000|Overall Study|Adverse Event|4|||
128897691|NCT01263483|463919154|FG001|Overall Study|Adverse Event|0|||
128897692|NCT01263483|463919155|FG002|Overall Study|Adverse Event|3|||
128897693|NCT01263483|463919153|FG000|Overall Study|Withdrawal by Subject|1|||
128897694|NCT01263483|463919154|FG001|Overall Study|Withdrawal by Subject|0|||
128897695|NCT01263483|463919155|FG002|Overall Study|Withdrawal by Subject|0|||
128897696|NCT01263483|463919153|FG000|Overall Study|Lack of Efficacy|2|||
128897697|NCT01263483|463919154|FG001|Overall Study|Lack of Efficacy|0|||
128897698|NCT01263483|463919155|FG002|Overall Study|Lack of Efficacy|0|||
128897699|NCT01263483|463919153|FG000|Overall Study|Protocol Violation|0|||
128897700|NCT01263483|463919154|FG001|Overall Study|Protocol Violation|1|||
128897701|NCT01263483|463919155|FG002|Overall Study|Protocol Violation|1|||
128897702|NCT01263483|463919153|FG000|Overall Study|Participant Unavailability|0|||
128897703|NCT01263483|463919154|FG001|Overall Study|Participant Unavailability|1|||
128897704|NCT01263483|463919155|FG002|Overall Study|Participant Unavailability|1|||
128897705|NCT00326209|463919156|FG000|Overall Study|Adverse Event|28|||
128897706|NCT00326209|463919156|FG000|Overall Study|Withdrawal by Subject|22|||
128897707|NCT00326209|463919156|FG000|Overall Study|Lack of Efficacy|31|||
128897708|NCT00326209|463919156|FG000|Overall Study|Lost to Follow-up|18|||
128897709|NCT00326209|463919156|FG000|Overall Study|Participant non-compliant|6|||
128897710|NCT00326209|463919156|FG000|Overall Study|Sponsor closed study|173|||
128897711|NCT00326209|463919156|FG000|Overall Study|Prohibited medication use|1|||
128897712|NCT00326209|463919156|FG000|Overall Study|Violation of entry criteria|1|||
128897713|NCT00326209|463919156|FG000|Overall Study|Withdrawn in error|1|||
128897714|NCT00326209|463919156|FG000|Overall Study|Pregnancy|1|||
128897715|NCT00714285|463919157|FG000|Overall Study|Lost to Follow-up|0|||
128897716|NCT00714285|463919158|FG001|Overall Study|Lost to Follow-up|2|||
128897717|NCT00714285|463919159|FG002|Overall Study|Lost to Follow-up|0|||
128897718|NCT00714285|463919160|FG003|Overall Study|Lost to Follow-up|1|||
128897719|NCT00714285|463919157|FG000|Overall Study|Migrated/moved from study area|0|||
128897720|NCT00714285|463919158|FG001|Overall Study|Migrated/moved from study area|1|||
128897721|NCT00714285|463919159|FG002|Overall Study|Migrated/moved from study area|0|||
128897722|NCT00714285|463919160|FG003|Overall Study|Migrated/moved from study area|0|||
128897723|NCT01372384|463919161|FG000|Overall Study|Progression of disease|3|||
128897724|NCT01131676|463919166|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
128897725|NCT01131676|463919167|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
128897726|NCT01131676|463919168|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
128897727|NCT01131676|463919166|FG000|Discontinuation From Treatment|Not treated|4|||
128897728|NCT01131676|463919167|FG001|Discontinuation From Treatment|Not treated|2|||
128897729|NCT01131676|463919168|FG002|Discontinuation From Treatment|Not treated|2|||
128897730|NCT01131676|463919166|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
128897731|NCT01131676|463919167|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
129022957|NCT00927069|464376885|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
129022958|NCT02911792|464376886|FG000|Overall Study|Lost to Follow-up|3|||
129022959|NCT02911792|464376887|FG001|Overall Study|Lost to Follow-up|3|||
129022960|NCT02911792|464376888|FG002|Overall Study|Lost to Follow-up|3|||
128897732|NCT01131676|463919168|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
128897733|NCT01131676|463919166|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
128897734|NCT01131676|463919167|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
129022961|NCT02911792|464376889|FG003|Overall Study|Lost to Follow-up|3|||
128897735|NCT01131676|463919168|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
128897736|NCT01131676|463919166|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
129022962|NCT01244620|464376892|FG000|Overall Study|Study terminated|4|||
128897737|NCT01131676|463919167|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
128897738|NCT01131676|463919168|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
128897739|NCT01131676|463919166|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
128897740|NCT01131676|463919167|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
128897741|NCT01131676|463919168|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
128897742|NCT01131676|463919166|FG000|Discontinuation From Treatment|Other than those specified|162|||
128897743|NCT01131676|463919167|FG001|Discontinuation From Treatment|Other than those specified|142|||
128897744|NCT01131676|463919168|FG002|Discontinuation From Treatment|Other than those specified|125|||
128897745|NCT01131676|463919166|FG000|Discontinuation From Treatment|Adverse Event|303|||
128897746|NCT01131676|463919167|FG001|Discontinuation From Treatment|Adverse Event|267|||
128897747|NCT01131676|463919168|FG002|Discontinuation From Treatment|Adverse Event|273|||
128897748|NCT01131676|463919166|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
128897749|NCT01131676|463919167|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
128897750|NCT01131676|463919168|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
128897751|NCT01131676|463919166|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
128897752|NCT01131676|463919167|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
128897753|NCT01131676|463919168|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
128897754|NCT01131676|463919166|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
128897755|NCT01131676|463919167|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
128897756|NCT01131676|463919168|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
128897757|NCT01131676|463919166|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
128897758|NCT01131676|463919167|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
128897759|NCT01131676|463919168|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
128897760|NCT01131676|463919166|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
128897761|NCT01131676|463919167|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
128897762|NCT01131676|463919168|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
128897763|NCT01131676|463919166|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
128897764|NCT01131676|463919167|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
128897765|NCT01131676|463919168|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
128897766|NCT01816061|463919171|FG000|Overall Study|Lost to Follow-up|13|||
128897767|NCT01816061|463919172|FG001|Overall Study|Lost to Follow-up|24|||
128897768|NCT01961349|463919173|FG000|Overall Study|Withdrawal by Subject|1|||
128897769|NCT01961349|463919174|FG001|Overall Study|Withdrawal by Subject|4|||
128897770|NCT01961349|463919175|FG002|Overall Study|Withdrawal by Subject|0|||
128897771|NCT01961349|463919173|FG000|Overall Study|Adverse Event|0|||
128897772|NCT01961349|463919174|FG001|Overall Study|Adverse Event|0|||
128897773|NCT01961349|463919175|FG002|Overall Study|Adverse Event|1|||
128897774|NCT01961349|463919173|FG000|Overall Study|registration error, personal reason etc|2|||
128897775|NCT01961349|463919174|FG001|Overall Study|registration error, personal reason etc|2|||
128897776|NCT01961349|463919175|FG002|Overall Study|registration error, personal reason etc|1|||
128897777|NCT01299376|463919176|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
128897778|NCT01299376|463919177|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
128897779|NCT01299376|463919176|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
128897780|NCT01299376|463919177|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
128897781|NCT01299376|463919176|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
128897782|NCT01299376|463919177|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
128897783|NCT01299376|463919176|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
128897784|NCT01299376|463919177|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
128897785|NCT01299376|463919176|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
128897786|NCT01299376|463919177|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
128897787|NCT01299376|463919176|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
128897788|NCT01299376|463919177|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
128897789|NCT01299376|463919176|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
128897790|NCT01299376|463919177|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
128897791|NCT01299376|463919176|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
128897792|NCT01299376|463919177|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
128897793|NCT01299376|463919176|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
128897794|NCT01299376|463919177|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
128897795|NCT01299376|463919176|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
129022963|NCT01244620|464376893|FG001|Overall Study|Study terminated|4|||
129022964|NCT01244620|464376894|FG002|Overall Study|Study terminated|4|||
128691951|NCT01193842|463171077|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
128691952|NCT01193842|463171078|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
129022965|NCT01244620|464376895|FG003|Overall Study|Study terminated|4|||
128897796|NCT01299376|463919177|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
128897797|NCT01299376|463919176|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
128897798|NCT01299376|463919177|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
128897799|NCT04315181|463919178|FG000|Overall Study|Non-responsive to drug conditions.|1|||
128897800|NCT05879107|463919181|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
128897801|NCT05879107|463919182|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
128897802|NCT05879107|463919181|FG000|Overall Study|Migrated / moved from the study area|1|||
128897803|NCT05879107|463919182|FG001|Overall Study|Migrated / moved from the study area|1|||
128897804|NCT05879107|463919181|FG000|Overall Study|Lost to Follow-up|8|||
128897805|NCT05879107|463919182|FG001|Overall Study|Lost to Follow-up|13|||
128897806|NCT05879107|463919181|FG000|Overall Study|Death|0|||
128897807|NCT05879107|463919182|FG001|Overall Study|Death|2|||
128897808|NCT05879107|463919181|FG000|Overall Study|Other|0|||
128897809|NCT05879107|463919182|FG001|Overall Study|Other|3|||
128897810|NCT00843518|463919183|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
128897811|NCT00843518|463919184|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
128897812|NCT00843518|463919183|FG000|Period 2 (Double-blind Treatment)|Death|0|||
128897813|NCT00843518|463919184|FG001|Period 2 (Double-blind Treatment)|Death|1|||
128897814|NCT00843518|463919183|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
128897815|NCT00843518|463919184|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
128897816|NCT00843518|463919183|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
128897817|NCT00843518|463919184|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
128897818|NCT00843518|463919183|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
128897819|NCT00843518|463919184|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
128897820|NCT00843518|463919183|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
128897821|NCT00843518|463919184|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
128897822|NCT00843518|463919183|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
128897823|NCT00843518|463919184|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
128897824|NCT00827606|463919187|FG000|Overall Study|Protocol Violation|4|||
128897825|NCT00827606|463919188|FG001|Overall Study|Protocol Violation|3|||
128897826|NCT00827606|463919187|FG000|Overall Study|Lost to Follow-up|3|||
128897827|NCT00827606|463919188|FG001|Overall Study|Lost to Follow-up|1|||
128897828|NCT00827606|463919187|FG000|Overall Study|Withdrawal by Subject|7|||
129112348|NCT02983045|464705684|FG000|Overall Study|Lost to Follow-up|0|||
129112349|NCT02983045|464705685|FG001|Overall Study|Lost to Follow-up|0|||
129112350|NCT02983045|464705686|FG002|Overall Study|Lost to Follow-up|0|||
129112351|NCT02983045|464705687|FG003|Overall Study|Lost to Follow-up|0|||
129112352|NCT02983045|464705688|FG004|Overall Study|Lost to Follow-up|0|||
128897829|NCT00827606|463919188|FG001|Overall Study|Withdrawal by Subject|6|||
129112353|NCT02983045|464705689|FG005|Overall Study|Lost to Follow-up|10|||
129112354|NCT02983045|464705690|FG006|Overall Study|Lost to Follow-up|0|||
129112355|NCT02983045|464705691|FG007|Overall Study|Lost to Follow-up|0|||
129112356|NCT02983045|464705692|FG008|Overall Study|Lost to Follow-up|0|||
129112357|NCT02983045|464705693|FG009|Overall Study|Lost to Follow-up|0|||
129112358|NCT00593918|464705694|FG000|Overall Study|Withdrawal by Subject|5|||
129112359|NCT00593918|464705695|FG001|Overall Study|Withdrawal by Subject|24|||
129112360|NCT02658669|464705696|FG000|Overall Study|Lost to Follow-up|7|||
129112361|NCT02658669|464705697|FG001|Overall Study|Lost to Follow-up|5|||
129112362|NCT03421379|464705699|FG000|Period 1|Withdrawal by Subject|0|||
129112363|NCT03421379|464705700|FG001|Period 1|Withdrawal by Subject|1|||
129112364|NCT03421379|464705699|FG000|Period 1|Physician Decision|1|||
129112365|NCT03421379|464705700|FG001|Period 1|Physician Decision|1|||
129112366|NCT03421379|464705699|FG000|Period 1|Did not receive treatment|1|||
129112367|NCT03421379|464705700|FG001|Period 1|Did not receive treatment|2|||
129112368|NCT02782741|464705701|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
129112369|NCT02782741|464705702|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
129112370|NCT02782741|464705703|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
129112371|NCT02782741|464705701|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
128691953|NCT01193842|463171079|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
128691954|NCT01193842|463171075|FG000|Phase II: Randomized Groups|Ineligible|0|||
128897830|NCT00827606|463919187|FG000|Overall Study|Pregnancy|0|||
128897831|NCT00827606|463919188|FG001|Overall Study|Pregnancy|1|||
129112372|NCT02782741|464705702|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
128897832|NCT00827606|463919187|FG000|Overall Study|Other|5|||
128897833|NCT00827606|463919188|FG001|Overall Study|Other|13|||
128897834|NCT00827606|463919187|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
128897835|NCT00827606|463919188|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
128897836|NCT00827606|463919187|FG000|Overall Study|Adverse Event|4|||
129112373|NCT02782741|464705703|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
129112374|NCT02782741|464705701|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
129112375|NCT02782741|464705702|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
129112376|NCT02782741|464705703|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
129112377|NCT02782741|464705701|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
128897837|NCT00827606|463919188|FG001|Overall Study|Adverse Event|2|||
128897838|NCT04037748|463919193|FG000|Treatment Period 1|Withdrawal by Subject|3|||
128897839|NCT04037748|463919194|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128897840|NCT04037748|463919193|FG000|Treatment Period 1|Adverse Event|1|||
128897841|NCT04037748|463919194|FG001|Treatment Period 1|Adverse Event|1|||
128897842|NCT04037748|463919193|FG000|Treatment Period 1|Protocol Violation|4|||
128897843|NCT04037748|463919194|FG001|Treatment Period 1|Protocol Violation|5|||
128897844|NCT04037748|463919193|FG000|Treatment Period 2|Adverse Event|0|||
128897845|NCT04037748|463919194|FG001|Treatment Period 2|Adverse Event|1|||
128897846|NCT04037748|463919193|FG000|Treatment Period 2|Protocol Violation|2|||
128897847|NCT04037748|463919194|FG001|Treatment Period 2|Protocol Violation|0|||
128897848|NCT04544475|463919199|FG000|Overall Study|Withdrawal by Subject|1|||
128897849|NCT04544475|463919200|FG001|Overall Study|Withdrawal by Subject|3|||
128897850|NCT01378858|463919201|FG000|Overall Study|Withdrawal by Subject|4|||
128897851|NCT01378858|463919202|FG001|Overall Study|Withdrawal by Subject|4|||
128897852|NCT00942175|463919203|FG000|Overall Study|Adverse Event|2|||
128897853|NCT00942175|463919204|FG001|Overall Study|Adverse Event|1|||
128897854|NCT00942175|463919205|FG002|Overall Study|Adverse Event|0|||
128897855|NCT00942175|463919206|FG003|Overall Study|Adverse Event|0|||
128897856|NCT00942175|463919203|FG000|Overall Study|Protocol Violation|0|||
128897857|NCT00942175|463919204|FG001|Overall Study|Protocol Violation|1|||
128897858|NCT00942175|463919205|FG002|Overall Study|Protocol Violation|2|||
128897859|NCT00942175|463919206|FG003|Overall Study|Protocol Violation|0|||
128897860|NCT00942175|463919203|FG000|Overall Study|Pregnancy|0|||
128897861|NCT00942175|463919204|FG001|Overall Study|Pregnancy|0|||
128897862|NCT00942175|463919205|FG002|Overall Study|Pregnancy|0|||
128897863|NCT00942175|463919206|FG003|Overall Study|Pregnancy|1|||
128897864|NCT00942175|463919203|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
128897865|NCT00942175|463919204|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
128897866|NCT00942175|463919205|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
128897867|NCT00942175|463919206|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
128897868|NCT00942175|463919203|FG000|Overall Study|Low Platelet Count|0|||
128897869|NCT00942175|463919204|FG001|Overall Study|Low Platelet Count|2|||
128897870|NCT00942175|463919205|FG002|Overall Study|Low Platelet Count|0|||
128897871|NCT00942175|463919206|FG003|Overall Study|Low Platelet Count|0|||
128897872|NCT02664272|463919207|FG000|Overall Study|Fluoroscopic images not made available|2|||
128897873|NCT03073980|463919208|FG000|Overall Study|Lost to Follow-up|10|||
128897874|NCT03073980|463919209|FG001|Overall Study|Lost to Follow-up|2|||
128897875|NCT03073980|463919210|FG002|Overall Study|Lost to Follow-up|9|||
128897876|NCT03073980|463919208|FG000|Overall Study|No post-procedure data|0|||
128897877|NCT03073980|463919209|FG001|Overall Study|No post-procedure data|0|||
128897878|NCT03073980|463919210|FG002|Overall Study|No post-procedure data|2|||
128897879|NCT00545064|463919211|FG000|Overall Study|Lost to Follow-up|3|||
128897880|NCT00545064|463919211|FG000|Overall Study|Withdrawal by Subject|2|||
128897881|NCT00545064|463919211|FG000|Overall Study|did not complete course of treatment|1|||
128897882|NCT00545064|463919211|FG000|Overall Study|cancel all appointments, no rebooking|1|||
128897883|NCT00545064|463919211|FG000|Overall Study|inclement weather|1|||
128897884|NCT00501007|463919212|FG000|Overall Study|Inclusion criteria not met.|29|||
128897885|NCT00501007|463919213|FG001|Overall Study|Inclusion criteria not met.|25|||
128897886|NCT00258674|463919216|FG000|Overall Study|Death|32|||
128897887|NCT00258674|463919217|FG001|Overall Study|Death|53|||
128897888|NCT00258674|463919218|FG002|Overall Study|Death|34|||
128897889|NCT03715153|463919219|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
128897890|NCT03715153|463919220|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
128897891|NCT03715153|463919219|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
128897892|NCT03715153|463919220|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
128897893|NCT03715153|463919219|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
128897894|NCT03715153|463919220|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
129022966|NCT02321098|464376897|FG000|12 Weeks Treament|Lost to Follow-up|1|||
129022967|NCT02321098|464376898|FG001|12 Weeks Treament|Lost to Follow-up|1|||
129022968|NCT02321098|464376899|FG002|12 Weeks Treament|Lost to Follow-up|0|||
129022969|NCT02321098|464376897|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
129022970|NCT02321098|464376898|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
129022971|NCT02321098|464376899|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
129022972|NCT02321098|464376897|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
129022973|NCT02321098|464376898|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
129022974|NCT02321098|464376899|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
129022975|NCT02321098|464376897|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
129022976|NCT02321098|464376898|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
129022977|NCT02321098|464376899|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
129022978|NCT01663233|464376900|FG000|Overall Study|Withdrawal by Subject|3|||
129022979|NCT01663233|464376901|FG001|Overall Study|Withdrawal by Subject|2|||
128897895|NCT03715153|463919219|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
128897896|NCT03715153|463919220|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
128897897|NCT03715153|463919219|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
128897898|NCT03715153|463919220|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
128897899|NCT03715153|463919219|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
128897900|NCT03715153|463919220|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
128897901|NCT01358760|463919225|FG000|Overall Study|Adverse Event|3|||
128897902|NCT01358760|463919226|FG001|Overall Study|Adverse Event|4|||
128897903|NCT01358760|463919227|FG002|Overall Study|Adverse Event|3|||
128897904|NCT01358760|463919225|FG000|Overall Study|Lost to Follow-up|1|||
128897905|NCT01358760|463919226|FG001|Overall Study|Lost to Follow-up|1|||
128897906|NCT01358760|463919227|FG002|Overall Study|Lost to Follow-up|3|||
128897907|NCT01358760|463919225|FG000|Overall Study|Withdrawal by Subject|5|||
128897908|NCT01358760|463919226|FG001|Overall Study|Withdrawal by Subject|3|||
128897909|NCT01358760|463919227|FG002|Overall Study|Withdrawal by Subject|2|||
128897910|NCT01358760|463919225|FG000|Overall Study|Physician Decision|1|||
128897911|NCT01358760|463919226|FG001|Overall Study|Physician Decision|0|||
128897912|NCT01358760|463919227|FG002|Overall Study|Physician Decision|1|||
128897913|NCT01358760|463919225|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
128897914|NCT01358760|463919226|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
128897915|NCT01358760|463919227|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
128897916|NCT01538628|463919228|FG000|Overall Study|Withdrawal by Subject|1|||
128897917|NCT01538628|463919229|FG001|Overall Study|Withdrawal by Subject|1|||
128897918|NCT01538628|463919228|FG000|Overall Study|Lost to Follow-up|0|||
128897919|NCT01538628|463919229|FG001|Overall Study|Lost to Follow-up|1|||
128897920|NCT00736255|463920958|FG000|Overall Study|Adverse Event|1|||
128897921|NCT00736255|463920959|FG001|Overall Study|Adverse Event|0|||
128897922|NCT00736255|463920958|FG000|Overall Study|Physician Decision|1|||
128897923|NCT00736255|463920959|FG001|Overall Study|Physician Decision|0|||
128897924|NCT00736255|463920958|FG000|Overall Study|Non-compliance|1|||
128897925|NCT00736255|463920959|FG001|Overall Study|Non-compliance|1|||
128897926|NCT02966509|463920965|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
128897927|NCT02966509|463920966|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
128897928|NCT02966509|463920965|FG000|Baseline Satisfaction Survey|Death|0|||
128897929|NCT02966509|463920966|FG001|Baseline Satisfaction Survey|Death|1|||
128897930|NCT02966509|463920965|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
128897931|NCT02966509|463920966|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
128897932|NCT02966509|463920965|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
128897933|NCT02966509|463920966|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
128897934|NCT02966509|463920965|FG000|6 Month Satisfaction Decision Survey|Death|22|||
128897935|NCT02966509|463920966|FG001|6 Month Satisfaction Decision Survey|Death|25|||
128897936|NCT02966509|463920965|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
128897937|NCT02966509|463920966|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
128897938|NCT02966509|463920965|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
128897939|NCT02966509|463920966|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
128897940|NCT02966509|463920965|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
128897941|NCT02966509|463920966|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
128897942|NCT02966509|463920965|FG000|6 Month Satisfaction Survey|Death|36|||
128897943|NCT02966509|463920966|FG001|6 Month Satisfaction Survey|Death|33|||
128897944|NCT02966509|463920965|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
128897945|NCT02966509|463920966|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
128897946|NCT02966509|463920965|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
128897947|NCT02966509|463920966|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
128897948|NCT02966509|463920965|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
128897949|NCT02966509|463920966|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
128897950|NCT02966509|463920965|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
128897951|NCT02966509|463920966|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
128897952|NCT02966509|463920965|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
128897953|NCT02966509|463920966|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
128897954|NCT01717287|463920967|FG000|Overall Study|Lost to Follow-up|0|||
128897955|NCT01717287|463920968|FG001|Overall Study|Lost to Follow-up|2|||
128897956|NCT01717287|463920967|FG000|Overall Study|Protocol Violation|0|||
128897957|NCT01717287|463920968|FG001|Overall Study|Protocol Violation|1|||
128897958|NCT00404820|463920969|FG000|Overall Study|Adverse Event|4|||
128897959|NCT00404820|463920970|FG001|Overall Study|Adverse Event|16|||
128897960|NCT00404820|463920969|FG000|Overall Study|Withdrawal by Subject|5|||
128897961|NCT00404820|463920970|FG001|Overall Study|Withdrawal by Subject|3|||
128897962|NCT00404820|463920969|FG000|Overall Study|Lost to Follow-up|7|||
128897963|NCT00404820|463920970|FG001|Overall Study|Lost to Follow-up|3|||
128897964|NCT00404820|463920969|FG000|Overall Study|Administrative problems|2|||
128897965|NCT00404820|463920970|FG001|Overall Study|Administrative problems|0|||
128897966|NCT00404820|463920969|FG000|Overall Study|Death|1|||
128897967|NCT00404820|463920970|FG001|Overall Study|Death|0|||
128897968|NCT00404820|463920969|FG000|Overall Study|Other|0|||
128897969|NCT00404820|463920970|FG001|Overall Study|Other|2|||
128897970|NCT01469182|463920975|FG000|Overall Study|Adverse Event|21|||
128897971|NCT01469182|463920976|FG001|Overall Study|Adverse Event|3|||
128897972|NCT01469182|463920975|FG000|Overall Study|Lost to Follow-up|3|||
128897973|NCT01469182|463920976|FG001|Overall Study|Lost to Follow-up|0|||
128897974|NCT01469182|463920975|FG000|Overall Study|Withdrawal by Subject|4|||
128897975|NCT01469182|463920976|FG001|Overall Study|Withdrawal by Subject|1|||
128897976|NCT01469182|463920975|FG000|Overall Study|Protocol Violation|4|||
128897977|NCT01469182|463920976|FG001|Overall Study|Protocol Violation|2|||
128897978|NCT01469182|463920975|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
128897979|NCT01469182|463920976|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
128897980|NCT02687542|463920977|FG000|Overall Study|Medication error without associated AEs|0|||
128897981|NCT02687542|463920978|FG001|Overall Study|Medication error without associated AEs|0|||
128897982|NCT02687542|463920979|FG002|Overall Study|Medication error without associated AEs|0|||
128897983|NCT02687542|463920980|FG003|Overall Study|Medication error without associated AEs|0|||
128897984|NCT02687542|463920981|FG004|Overall Study|Medication error without associated AEs|1|||
128897985|NCT02687542|463920977|FG000|Overall Study|Lost to Follow-up|0|||
128897986|NCT02687542|463920978|FG001|Overall Study|Lost to Follow-up|0|||
128897987|NCT02687542|463920979|FG002|Overall Study|Lost to Follow-up|0|||
128897988|NCT02687542|463920980|FG003|Overall Study|Lost to Follow-up|0|||
128897989|NCT02687542|463920981|FG004|Overall Study|Lost to Follow-up|1|||
128897990|NCT02687542|463920977|FG000|Overall Study|Protocol Violation|0|||
128897991|NCT02687542|463920978|FG001|Overall Study|Protocol Violation|1|||
128897992|NCT02687542|463920979|FG002|Overall Study|Protocol Violation|0|||
128897993|NCT02687542|463920980|FG003|Overall Study|Protocol Violation|0|||
128897994|NCT02687542|463920981|FG004|Overall Study|Protocol Violation|0|||
128897995|NCT02687542|463920977|FG000|Overall Study|Other|5|||
128897996|NCT02687542|463920978|FG001|Overall Study|Other|9|||
128897997|NCT02687542|463920979|FG002|Overall Study|Other|10|||
128897998|NCT02687542|463920980|FG003|Overall Study|Other|6|||
128897999|NCT02687542|463920981|FG004|Overall Study|Other|5|||
128898000|NCT02687542|463920977|FG000|Overall Study|Adverse Event|3|||
128898001|NCT02687542|463920978|FG001|Overall Study|Adverse Event|1|||
128898002|NCT02687542|463920979|FG002|Overall Study|Adverse Event|3|||
128898003|NCT02687542|463920980|FG003|Overall Study|Adverse Event|2|||
128898004|NCT02687542|463920981|FG004|Overall Study|Adverse Event|9|||
128898005|NCT02687542|463920977|FG000|Overall Study|Withdrawal by Subject|0|||
128898006|NCT02687542|463920978|FG001|Overall Study|Withdrawal by Subject|1|||
128898007|NCT02687542|463920979|FG002|Overall Study|Withdrawal by Subject|1|||
128898008|NCT02687542|463920980|FG003|Overall Study|Withdrawal by Subject|2|||
128898009|NCT02687542|463920981|FG004|Overall Study|Withdrawal by Subject|4|||
128898010|NCT01838616|463920984|FG000|Titration Period|Adverse Event|18|||
128898011|NCT01838616|463920985|FG001|Titration Period|Adverse Event|48|||
128898012|NCT01838616|463920984|FG000|Titration Period|Lack of Efficacy|5|||
128898013|NCT01838616|463920985|FG001|Titration Period|Lack of Efficacy|12|||
128764574|NCT04512066|463428368|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
128764575|NCT04512066|463428369|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
128764576|NCT04512066|463428370|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
128764577|NCT04512066|463428371|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
128764578|NCT04512066|463428366|FG000|Double-blind Treatment Period|Physician Decision|1|||
128764579|NCT04512066|463428367|FG001|Double-blind Treatment Period|Physician Decision|0|||
128764580|NCT04512066|463428368|FG002|Double-blind Treatment Period|Physician Decision|1|||
128764581|NCT04512066|463428369|FG003|Double-blind Treatment Period|Physician Decision|0|||
128764582|NCT04512066|463428370|FG004|Double-blind Treatment Period|Physician Decision|0|||
128764583|NCT04512066|463428371|FG005|Double-blind Treatment Period|Physician Decision|0|||
128764584|NCT04512066|463428366|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
128764585|NCT04512066|463428367|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
128764586|NCT04512066|463428368|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
128764587|NCT04512066|463428369|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
128764588|NCT04512066|463428370|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
128764589|NCT04512066|463428371|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
128898014|NCT01838616|463920984|FG000|Titration Period|Withdrawal by Subject|5|||
128898015|NCT01838616|463920985|FG001|Titration Period|Withdrawal by Subject|5|||
128898016|NCT01838616|463920984|FG000|Titration Period|Technical problems|1|||
128898017|NCT01838616|463920985|FG001|Titration Period|Technical problems|0|||
128898018|NCT01838616|463920984|FG000|Titration Period|Other|1|||
128898019|NCT01838616|463920985|FG001|Titration Period|Other|0|||
128898020|NCT01838616|463920984|FG000|Titration Period|Protocol Violation|0|||
128898021|NCT01838616|463920985|FG001|Titration Period|Protocol Violation|1|||
128898022|NCT01838616|463920984|FG000|Continuation Period|Lack of Efficacy|3|||
129022980|NCT01663233|464376900|FG000|Overall Study|Protocol Deviation|1|||
129022981|NCT01663233|464376901|FG001|Overall Study|Protocol Deviation|4|||
129022982|NCT01663233|464376900|FG000|Overall Study|Lost to Follow-up|0|||
129022983|NCT01663233|464376901|FG001|Overall Study|Lost to Follow-up|1|||
129022984|NCT02558491|464376902|FG000|First Invention|Withdrawal by Subject|3|||
129022985|NCT02558491|464376903|FG001|First Invention|Withdrawal by Subject|1|||
129022986|NCT02558491|464376902|FG000|First Invention|Data collection issues|1|||
129022987|NCT02558491|464376903|FG001|First Invention|Data collection issues|0|||
129022988|NCT02558491|464376902|FG000|First Invention|Stopping criteria|0|||
128898023|NCT01838616|463920985|FG001|Continuation Period|Lack of Efficacy|5|||
128898024|NCT01838616|463920984|FG000|Continuation Period|Adverse Event|8|||
128898025|NCT01838616|463920985|FG001|Continuation Period|Adverse Event|4|||
128898026|NCT01838616|463920984|FG000|Continuation Period|Protocol Violation|2|||
128898027|NCT01838616|463920985|FG001|Continuation Period|Protocol Violation|0|||
128898028|NCT01838616|463920984|FG000|Continuation Period|Lost to Follow-up|1|||
128898029|NCT01838616|463920985|FG001|Continuation Period|Lost to Follow-up|0|||
128898030|NCT01838616|463920984|FG000|Continuation Period|Withdrawal by Subject|0|||
128898031|NCT01838616|463920985|FG001|Continuation Period|Withdrawal by Subject|4|||
128898032|NCT01838616|463920984|FG000|Continuation Period|Technical problems|0|||
128898033|NCT01838616|463920985|FG001|Continuation Period|Technical problems|1|||
128898034|NCT01838616|463920984|FG000|Pick-up Arm|Lack of Efficacy|4|||
128898035|NCT01838616|463920985|FG001|Pick-up Arm|Lack of Efficacy|0|||
128898036|NCT01838616|463920984|FG000|Pick-up Arm|Adverse Event|9|||
128898037|NCT01838616|463920985|FG001|Pick-up Arm|Adverse Event|0|||
128898038|NCT01838616|463920984|FG000|Pick-up Arm|Withdrawal by Subject|1|||
128898039|NCT01838616|463920985|FG001|Pick-up Arm|Withdrawal by Subject|0|||
128898040|NCT01838616|463920984|FG000|Pick-up Arm|Technical problems|1|||
128898041|NCT01838616|463920985|FG001|Pick-up Arm|Technical problems|0|||
128898042|NCT01566773|463920986|FG000|Overall Study|Protocol specified criteria|4|||
128898043|NCT01566773|463920986|FG000|Overall Study|Protocol Violation|4|||
128898044|NCT01566773|463920986|FG000|Overall Study|Withdrawal by Subject|9|||
128898045|NCT01566773|463920986|FG000|Overall Study|Administrative reason|1|||
128898046|NCT01566773|463920986|FG000|Overall Study|Adverse Event|10|||
128898047|NCT01566773|463920986|FG000|Overall Study|Physician Decision|2|||
128898048|NCT01033734|463920987|FG000|Overall Study|Withdrawal by Subject|1|||
128898049|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
128898050|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
128898051|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
128898052|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
128898053|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
128898054|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
128898055|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
128898056|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
128898057|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
128898058|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
128898059|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
128898060|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
128898061|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
128898062|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
128898063|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
128898064|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
128898065|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
128898066|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
128898067|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
128898068|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
128898069|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
128898070|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
128898071|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
128898072|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
128898073|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
128898074|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
128898075|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
128898076|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
128898077|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
128898078|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
128898079|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
128898080|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
129022989|NCT02558491|464376903|FG001|First Invention|Stopping criteria|1|||
129112378|NCT02782741|464705702|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
128898081|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
128898082|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
128898083|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
128898084|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
129022990|NCT02558491|464376902|FG000|First Invention|Changed parameters during trial|1|||
129022991|NCT02558491|464376903|FG001|First Invention|Changed parameters during trial|0|||
129022992|NCT02558491|464376902|FG000|Second Intervention|Withdrawal by Subject|1|||
129022993|NCT02558491|464376903|FG001|Second Intervention|Withdrawal by Subject|0|||
129022994|NCT02558491|464376902|FG000|Second Intervention|Stopping Criteria|1|||
129022995|NCT02558491|464376903|FG001|Second Intervention|Stopping Criteria|0|||
129022996|NCT00834431|464376906|FG000|First Intervention|Adverse Event|0|||
129022997|NCT00834431|464376907|FG001|First Intervention|Adverse Event|1|||
128898085|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
128898086|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
128898087|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
128898088|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
128898089|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
128898090|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
128898091|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
128898092|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
128898093|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
128898094|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
128898095|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
128898096|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
128898097|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
128898098|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
128898099|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
128898100|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
128898101|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
128898102|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
128898103|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
128898104|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
128898105|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
128898106|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
128898107|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
128898108|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
128898109|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
128898110|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
128898111|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
128898112|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
128898113|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
128898114|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
128898115|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
128898116|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
128898117|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
128898118|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
128898119|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
128898120|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
128898121|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
128898122|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
128898123|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
128898124|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
128898125|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
128898126|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
128898127|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
128898128|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
128898129|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
128898130|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
128898131|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
128898132|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
128898133|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
128898134|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
128898135|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
128898136|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
128898137|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
128898138|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
128898139|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
128898140|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
128898141|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
128898142|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
128898143|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
128898144|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
128898145|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
128898146|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
128898147|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
128898148|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
128898149|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
128898150|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
128898151|NCT00111800|463920988|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
128898152|NCT00111800|463920989|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
128898153|NCT00111800|463920990|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
128898154|NCT00111800|463920991|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
128898155|NCT00111800|463920992|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
128898156|NCT00111800|463920993|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
128898157|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
128898158|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
128898159|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
128898160|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
128898161|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
128898162|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
128898163|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
128898164|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
128898165|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
128898166|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
128898167|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
128898168|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
128898169|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
128898170|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
128898171|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
128898172|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
128898173|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
128898174|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
128898175|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
128898176|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
128898177|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
128898178|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
128898179|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
128898180|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
128898181|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129112379|NCT02782741|464705703|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
129112380|NCT02782741|464705701|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
129112381|NCT02782741|464705702|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
129112382|NCT02782741|464705703|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
129112383|NCT04157088|464705704|FG000|Overall Study|Study terminated by sponsor|23|||
129112384|NCT04157088|464705704|FG000|Overall Study|Withdrawal by Subject|4|||
129112385|NCT04157088|464705704|FG000|Overall Study|Lost to Follow-up|2|||
129112386|NCT04157088|464705704|FG000|Overall Study|Death|1|||
129112387|NCT00196105|464705707|FG000|Overall Study|Lost to Follow-up|4|||
128898182|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
128898183|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
128898184|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129112388|NCT00196105|464705708|FG001|Overall Study|Lost to Follow-up|5|||
129112389|NCT00196105|464705709|FG002|Overall Study|Lost to Follow-up|7|||
129112390|NCT04863872|464705710|FG000|Overall Study|Withdrawal by Subject|4|||
129112391|NCT04863872|464705711|FG001|Overall Study|Withdrawal by Subject|15|||
128898185|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
128898186|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
128898187|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
128898188|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
128898189|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
128898190|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
129112392|NCT04863872|464705710|FG000|Overall Study|Death|5|||
129112393|NCT04863872|464705711|FG001|Overall Study|Death|2|||
129112394|NCT04863872|464705710|FG000|Overall Study|Lost to Follow-up|2|||
129112395|NCT04863872|464705711|FG001|Overall Study|Lost to Follow-up|1|||
129112396|NCT04058028|464705712|FG000|Overall Study|Withdrawal of Consent from Study|12|||
129112397|NCT04058028|464705713|FG001|Overall Study|Withdrawal of Consent from Study|8|||
129112398|NCT04058028|464705714|FG002|Overall Study|Withdrawal of Consent from Study|6|||
128898191|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
128898192|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
128898193|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
128898194|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
128898195|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
128898196|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
128898197|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
128898198|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
128898199|NCT00111800|463920988|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
128898200|NCT00111800|463920989|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
128898201|NCT00111800|463920990|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
128898202|NCT00111800|463920991|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
128898203|NCT00111800|463920992|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
128898204|NCT00111800|463920993|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
128898205|NCT01549275|463920994|FG000|Overall Study|Lost to Follow-up|1|||
128898206|NCT01549275|463920995|FG001|Overall Study|Lost to Follow-up|0|||
128898207|NCT01111851|463920998|FG000|Overall Study|All planned PET scans were not obtained.|2|||
128898208|NCT01111851|463920999|FG001|Overall Study|All planned PET scans were not obtained.|0|||
128898209|NCT01471015|463921001|FG000|Overall Study|Death|0|||
128898210|NCT01471015|463921002|FG001|Overall Study|Death|1|||
128898211|NCT01471015|463921003|FG002|Overall Study|Death|1|||
128898212|NCT01843842|463921004|FG000|Overall Study|Do not meet inclusion criteria|1|||
128898213|NCT01843842|463921005|FG001|Overall Study|Do not meet inclusion criteria|1|||
128898214|NCT02953340|463921006|FG000|Overall Study|Death|0|||
128898215|NCT02953340|463921007|FG001|Overall Study|Death|1|||
128898216|NCT02953340|463921006|FG000|Overall Study|Investigator Decision|3|||
128898217|NCT02953340|463921007|FG001|Overall Study|Investigator Decision|3|||
128898218|NCT02953340|463921006|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
128898219|NCT02953340|463921007|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
128898220|NCT02953340|463921006|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
128898221|NCT02953340|463921007|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
128898222|NCT02953340|463921006|FG000|Overall Study|Withdrawal by Subject|9|||
128898223|NCT02953340|463921007|FG001|Overall Study|Withdrawal by Subject|9|||
128898224|NCT02953340|463921006|FG000|Overall Study|Sponsor decision|0|||
128898225|NCT02953340|463921007|FG001|Overall Study|Sponsor decision|2|||
128898226|NCT02953340|463921006|FG000|Overall Study|Lost to Follow-up|3|||
128898227|NCT02953340|463921007|FG001|Overall Study|Lost to Follow-up|2|||
128898228|NCT02953340|463921006|FG000|Overall Study|Reason not specified|2|||
128898229|NCT02953340|463921007|FG001|Overall Study|Reason not specified|2|||
128898230|NCT01376778|463921008|FG000|Overall Study|Lost to Follow-up|3|||
128898231|NCT01376778|463921009|FG001|Overall Study|Lost to Follow-up|2|||
128898232|NCT00928889|463921010|FG000|Overall Study|Lost to Follow-up|3|||
128898233|NCT00928889|463921011|FG001|Overall Study|Lost to Follow-up|1|||
128898234|NCT00928889|463921010|FG000|Overall Study|Protocol Violation|0|||
128898235|NCT00928889|463921011|FG001|Overall Study|Protocol Violation|1|||
128898236|NCT00928889|463921010|FG000|Overall Study|Adverse Event|1|||
128898237|NCT00928889|463921011|FG001|Overall Study|Adverse Event|0|||
128898238|NCT00928889|463921010|FG000|Overall Study|Other|1|||
128898239|NCT00928889|463921011|FG001|Overall Study|Other|0|||
128898240|NCT04712110|463921012|FG000|Overall Study|Lost to Follow-up|0|||
128898241|NCT04712110|463921013|FG001|Overall Study|Lost to Follow-up|1|||
128898242|NCT04712110|463921012|FG000|Overall Study|Withdrawal by Subject|0|||
128898243|NCT04712110|463921013|FG001|Overall Study|Withdrawal by Subject|4|||
128898244|NCT04712110|463921012|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
128898245|NCT04712110|463921013|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
128898246|NCT01517893|463921014|FG000|Overall Study|Withdrawal by Subject|3|||
128898247|NCT01517893|463921015|FG001|Overall Study|Withdrawal by Subject|0|||
128898248|NCT01431274|463921019|FG000|Overall Study|Adverse Event|51|||
128898249|NCT01431274|463921020|FG001|Overall Study|Adverse Event|37|||
128898250|NCT01431274|463921021|FG002|Overall Study|Adverse Event|43|||
128898251|NCT01431274|463921022|FG003|Overall Study|Adverse Event|30|||
128898252|NCT01431274|463921023|FG004|Overall Study|Adverse Event|37|||
128898253|NCT01431274|463921019|FG000|Overall Study|Consent withdrawn not due to AE|29|||
128898254|NCT01431274|463921020|FG001|Overall Study|Consent withdrawn not due to AE|20|||
128898255|NCT01431274|463921021|FG002|Overall Study|Consent withdrawn not due to AE|17|||
128898256|NCT01431274|463921022|FG003|Overall Study|Consent withdrawn not due to AE|20|||
128898257|NCT01431274|463921023|FG004|Overall Study|Consent withdrawn not due to AE|11|||
129112399|NCT04058028|464705715|FG003|Overall Study|Withdrawal of Consent from Study|7|||
128898258|NCT01431274|463921019|FG000|Overall Study|Non compliant with protocol|5|||
128898259|NCT01431274|463921020|FG001|Overall Study|Non compliant with protocol|8|||
128898260|NCT01431274|463921021|FG002|Overall Study|Non compliant with protocol|4|||
128898261|NCT01431274|463921022|FG003|Overall Study|Non compliant with protocol|4|||
128898262|NCT01431274|463921023|FG004|Overall Study|Non compliant with protocol|4|||
128898263|NCT01431274|463921019|FG000|Overall Study|Lost to Follow-up|6|||
128898264|NCT01431274|463921020|FG001|Overall Study|Lost to Follow-up|7|||
128898265|NCT01431274|463921021|FG002|Overall Study|Lost to Follow-up|1|||
128898266|NCT01431274|463921022|FG003|Overall Study|Lost to Follow-up|4|||
128898267|NCT01431274|463921023|FG004|Overall Study|Lost to Follow-up|0|||
128898268|NCT01431274|463921019|FG000|Overall Study|Other reason not stated above|6|||
128898269|NCT01431274|463921020|FG001|Overall Study|Other reason not stated above|5|||
128898270|NCT01431274|463921021|FG002|Overall Study|Other reason not stated above|7|||
128898271|NCT01431274|463921022|FG003|Overall Study|Other reason not stated above|2|||
128898272|NCT01431274|463921023|FG004|Overall Study|Other reason not stated above|4|||
128898273|NCT02973087|463921024|FG000|Overall Study|Withdrawal by Subject|2|||
128898274|NCT02973087|463921025|FG001|Overall Study|Withdrawal by Subject|1|||
128898275|NCT02973087|463921024|FG000|Overall Study|Adverse Event|1|||
128898276|NCT02973087|463921025|FG001|Overall Study|Adverse Event|0|||
128898277|NCT02973087|463921024|FG000|Overall Study|other|1|||
128898278|NCT02973087|463921025|FG001|Overall Study|other|1|||
128898279|NCT01506960|463921026|FG000|Overall Study|Did not meet angiographic criteria|47|||
128898280|NCT00450723|463921028|FG000|Overall Study|Physician Decision|5|||
128898281|NCT04143009|463921029|FG000|Pilot Trial|Lost to Follow-up|0|||
128898282|NCT04143009|463921030|FG001|Pilot Trial|Lost to Follow-up|1|||
128898283|NCT04143009|463921031|FG002|Pilot Trial|Lost to Follow-up|1|||
128898284|NCT05003622|463921032|FG000|Overall Study|Progressive disease|2|||
128898285|NCT05003622|463921032|FG000|Overall Study|Withdrawal by Subject|1|||
128898286|NCT01045798|463921038|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
128898287|NCT01045798|463921039|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
128898288|NCT01045798|463921038|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
128898289|NCT01045798|463921039|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
128898290|NCT01045798|463921038|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
128898291|NCT01045798|463921039|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
128898292|NCT01045798|463921038|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
128898293|NCT01045798|463921039|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
128898294|NCT05264740|463921044|FG000|Baseline|Withdrawal by Subject|0|||
128898295|NCT05264740|463921045|FG001|Baseline|Withdrawal by Subject|1|||
128898296|NCT05264740|463921044|FG000|Follow Up 1|Lost to Follow-up|1|||
129112400|NCT04058028|464705712|FG000|Overall Study|Decision by Sponsor|13|||
129112401|NCT04058028|464705713|FG001|Overall Study|Decision by Sponsor|4|||
129112402|NCT04058028|464705714|FG002|Overall Study|Decision by Sponsor|1|||
129112403|NCT04058028|464705715|FG003|Overall Study|Decision by Sponsor|35|||
129112404|NCT04058028|464705712|FG000|Overall Study|Lost to Follow-up|1|||
129112405|NCT04058028|464705713|FG001|Overall Study|Lost to Follow-up|1|||
129112406|NCT04058028|464705714|FG002|Overall Study|Lost to Follow-up|1|||
129112407|NCT04058028|464705715|FG003|Overall Study|Lost to Follow-up|0|||
129112408|NCT04058028|464705712|FG000|Overall Study|Death|0|||
129112409|NCT04058028|464705713|FG001|Overall Study|Death|1|||
129112410|NCT04058028|464705714|FG002|Overall Study|Death|0|||
129112411|NCT04058028|464705715|FG003|Overall Study|Death|0|||
129112412|NCT03771963|464705716|FG000|Overall Study|Lost to Follow-up|22|||
129112413|NCT03771963|464705716|FG000|Overall Study|Withdrawal of Consent|10|||
129112414|NCT00485069|464705717|FG000|Overall Study|Adverse Event|10|||
129112415|NCT00485069|464705718|FG001|Overall Study|Adverse Event|4|||
129112416|NCT00485069|464705717|FG000|Overall Study|Lack of Efficacy|2|||
129112417|NCT00485069|464705718|FG001|Overall Study|Lack of Efficacy|1|||
129112418|NCT00485069|464705717|FG000|Overall Study|Protocol Violation|0|||
128691955|NCT01193842|463171076|FG001|Phase II: Randomized Groups|Ineligible|0|||
128691956|NCT01193842|463171077|FG002|Phase II: Randomized Groups|Ineligible|0|||
128691957|NCT01193842|463171078|FG003|Phase II: Randomized Groups|Ineligible|0|||
128691958|NCT01193842|463171079|FG004|Phase II: Randomized Groups|Ineligible|1|||
128691959|NCT01193842|463171075|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
128898297|NCT05264740|463921045|FG001|Follow Up 1|Lost to Follow-up|1|||
128898298|NCT05264740|463921044|FG000|Follow Up 1|Withdrawal by Subject|0|||
128898299|NCT05264740|463921045|FG001|Follow Up 1|Withdrawal by Subject|1|||
128898300|NCT05264740|463921044|FG000|Follow Up 2|Lost to Follow-up|1|||
128898301|NCT05264740|463921045|FG001|Follow Up 2|Lost to Follow-up|4|||
128898302|NCT05264740|463921044|FG000|Follow Up 3|Lost to Follow-up|7|||
128898303|NCT05264740|463921045|FG001|Follow Up 3|Lost to Follow-up|4|||
129112419|NCT00485069|464705718|FG001|Overall Study|Protocol Violation|1|||
128691960|NCT01193842|463171076|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
128898304|NCT00597753|463921048|FG000|Overall Study|Adverse Event|6|||
128898305|NCT00597753|463921049|FG001|Overall Study|Adverse Event|2|||
128898306|NCT00597753|463921048|FG000|Overall Study|Death|55|||
128898307|NCT00597753|463921049|FG001|Overall Study|Death|29|||
129112420|NCT00485069|464705717|FG000|Overall Study|Withdrawal by Subject|6|||
129112421|NCT00485069|464705718|FG001|Overall Study|Withdrawal by Subject|6|||
129112422|NCT03014206|464705719|FG000|Overall Study|Registration Violation|12|||
129112423|NCT00992017|464705721|FG000|Overall Study|Lost to Follow-up|2|||
129112424|NCT00992017|464705721|FG000|Overall Study|Withdrawal by Subject|2|||
128898308|NCT00597753|463921048|FG000|Overall Study|Lack of Efficacy|2|||
128898309|NCT00597753|463921049|FG001|Overall Study|Lack of Efficacy|0|||
128898310|NCT00597753|463921048|FG000|Overall Study|Lost to Follow-up|10|||
128898311|NCT00597753|463921049|FG001|Overall Study|Lost to Follow-up|3|||
128898312|NCT00597753|463921048|FG000|Overall Study|Physician Decision|5|||
128898313|NCT00597753|463921049|FG001|Overall Study|Physician Decision|1|||
128898314|NCT00597753|463921048|FG000|Overall Study|Pregnancy|1|||
128898315|NCT00597753|463921049|FG001|Overall Study|Pregnancy|0|||
128898316|NCT00597753|463921048|FG000|Overall Study|Withdrawal by Subject|35|||
128898317|NCT00597753|463921049|FG001|Overall Study|Withdrawal by Subject|12|||
128898318|NCT00597753|463921048|FG000|Overall Study|Discontinued Dialysis|0|||
128898319|NCT00597753|463921049|FG001|Overall Study|Discontinued Dialysis|1|||
128898320|NCT00597753|463921048|FG000|Overall Study|Never dosed|2|||
128898321|NCT00597753|463921049|FG001|Overall Study|Never dosed|0|||
128898322|NCT00597753|463921048|FG000|Overall Study|Noncompliance|2|||
128898323|NCT00597753|463921049|FG001|Overall Study|Noncompliance|1|||
128898324|NCT00597753|463921048|FG000|Overall Study|Relocation|17|||
128898325|NCT00597753|463921049|FG001|Overall Study|Relocation|6|||
128898326|NCT00597753|463921048|FG000|Overall Study|Renal transplant|10|||
128898327|NCT00597753|463921049|FG001|Overall Study|Renal transplant|3|||
128898328|NCT00597753|463921048|FG000|Overall Study|Site closed by sponsor|19|||
128898329|NCT00597753|463921049|FG001|Overall Study|Site closed by sponsor|7|||
129022998|NCT00834431|464376906|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129022999|NCT00834431|464376907|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129023000|NCT05630885|464376911|FG000|Study Completion|Took prohibited medications|2|||
129023001|NCT05630885|464376912|FG001|Study Completion|Took prohibited medications|0|||
129023002|NCT05630885|464376911|FG000|Study Completion|Non-compliance with study drug|1|||
129023003|NCT05630885|464376912|FG001|Study Completion|Non-compliance with study drug|0|||
129023004|NCT05630885|464376911|FG000|Study Completion|Adverse Event|1|||
129023005|NCT05630885|464376912|FG001|Study Completion|Adverse Event|0|||
129023006|NCT05630885|464376911|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
128764590|NCT04512066|463428366|FG000|Extension Period|Adverse Event|0|||
128898330|NCT00597753|463921048|FG000|Overall Study|Site elected to close|2|||
128898331|NCT00597753|463921049|FG001|Overall Study|Site elected to close|4|||
128898332|NCT03451851|463921050|FG000|PCP: Week 0 -16|Adverse Event|1|||
128898333|NCT03451851|463921051|FG001|PCP: Week 0 -16|Adverse Event|0|||
128898334|NCT03451851|463921052|FG002|PCP: Week 0 -16|Adverse Event|0|||
128898335|NCT03451851|463921053|FG003|PCP: Week 0 -16|Adverse Event|0|||
128898336|NCT03451851|463921054|FG004|PCP: Week 0 -16|Adverse Event|0|||
128898337|NCT03451851|463921055|FG005|PCP: Week 0 -16|Adverse Event|0|||
128898338|NCT03451851|463921056|FG006|PCP: Week 0 -16|Adverse Event|1|||
128898339|NCT03451851|463921057|FG007|PCP: Week 0 -16|Adverse Event|0|||
128898340|NCT03451851|463921050|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
128898341|NCT03451851|463921051|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
128898342|NCT03451851|463921052|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
128898343|NCT03451851|463921053|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
128898344|NCT03451851|463921054|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
128898345|NCT03451851|463921055|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
128898346|NCT03451851|463921056|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
128898347|NCT03451851|463921057|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
128898348|NCT03451851|463921050|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
128898349|NCT03451851|463921051|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
128764591|NCT04512066|463428367|FG001|Extension Period|Adverse Event|1|||
128898350|NCT03451851|463921052|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
128898351|NCT03451851|463921053|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
128898352|NCT03451851|463921054|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
128898353|NCT03451851|463921055|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
128898354|NCT03451851|463921056|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129023007|NCT05630885|464376912|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
129023008|NCT05630885|464376911|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
129023009|NCT05630885|464376912|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
129023010|NCT06539676|464376913|FG000|Overall Study|Early study termination|1|||
129023011|NCT06539676|464376914|FG001|Overall Study|Early study termination|0|||
129023012|NCT06539676|464376915|FG002|Overall Study|Early study termination|6|||
129023013|NCT02645409|464376916|FG000|Overall Study|Withdrawal by Subject|3|||
129023014|NCT02645409|464376917|FG001|Overall Study|Withdrawal by Subject|0|||
129023015|NCT02645409|464376916|FG000|Overall Study|Physician Decision|1|||
129023016|NCT02645409|464376917|FG001|Overall Study|Physician Decision|0|||
128898355|NCT03451851|463921057|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129023017|NCT03419403|464376918|FG000|Overall Study|Withdrawal by Subject|5|||
128898356|NCT03451851|463921050|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
128898357|NCT03451851|463921051|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
128898358|NCT03451851|463921052|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
128898359|NCT03451851|463921053|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
128898360|NCT03451851|463921054|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
128898361|NCT03451851|463921055|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
128898362|NCT03451851|463921056|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
128898363|NCT03451851|463921057|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
128898364|NCT03451851|463921050|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
128898365|NCT03451851|463921051|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
128898366|NCT03451851|463921052|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
128898367|NCT03451851|463921053|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
128898368|NCT03451851|463921054|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
128898369|NCT03451851|463921055|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
128898370|NCT03451851|463921056|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
128898371|NCT03451851|463921057|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
128898372|NCT03451851|463921050|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128898373|NCT03451851|463921051|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128898374|NCT03451851|463921052|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128898375|NCT03451851|463921053|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128898376|NCT03451851|463921054|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
128898377|NCT03451851|463921055|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128898378|NCT03451851|463921056|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128898379|NCT03451851|463921057|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
128898380|NCT05885737|463921058|FG000|DB Period|Adverse Event|4|||
128898381|NCT05885737|463921059|FG001|DB Period|Adverse Event|4|||
128898382|NCT05885737|463921058|FG000|DB Period|Lost to Follow-up|0|||
128898383|NCT05885737|463921059|FG001|DB Period|Lost to Follow-up|1|||
128898384|NCT05885737|463921058|FG000|DB Period|Physician Decision|2|||
128898385|NCT05885737|463921059|FG001|DB Period|Physician Decision|0|||
128898386|NCT05885737|463921058|FG000|DB Period|Withdrawal by Subject|12|||
128898387|NCT05885737|463921059|FG001|DB Period|Withdrawal by Subject|6|||
128898388|NCT05885737|463921058|FG000|DB Period|Other: Unspecified|2|||
128898389|NCT05885737|463921059|FG001|DB Period|Other: Unspecified|2|||
128898390|NCT05885737|463921058|FG000|OLE Period|Adverse Event|3|||
128898391|NCT05885737|463921059|FG001|OLE Period|Adverse Event|2|||
128898392|NCT05885737|463921058|FG000|OLE Period|Physician Decision|1|||
128898393|NCT05885737|463921059|FG001|OLE Period|Physician Decision|0|||
128898394|NCT05885737|463921058|FG000|OLE Period|Withdrawal by Subject|5|||
128898395|NCT05885737|463921059|FG001|OLE Period|Withdrawal by Subject|5|||
128898396|NCT05885737|463921058|FG000|OLE Period|Other: Unspecified|2|||
128898397|NCT05885737|463921059|FG001|OLE Period|Other: Unspecified|1|||
128898398|NCT01444742|463922200|FG000|Overall Study|Death|1|||
128898399|NCT02535715|463922201|FG000|Overall Study|Withdrawal by Subject|0|||
128898400|NCT02535715|463922202|FG001|Overall Study|Withdrawal by Subject|0|||
128898401|NCT02535715|463922203|FG002|Overall Study|Withdrawal by Subject|1|||
128898402|NCT00909181|463922204|FG000|Overall Study|Lost to Follow-up|39|||
128898403|NCT00909181|463922205|FG001|Overall Study|Lost to Follow-up|18|||
128898404|NCT00909181|463922206|FG002|Overall Study|Lost to Follow-up|33|||
128898405|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
128898406|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
128898407|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
128898408|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
128898409|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
128898410|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
128898411|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
128898412|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
128898413|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
128898414|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
128898415|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
128898416|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
128898417|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
128898418|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
128898419|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
128898420|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
128898421|NCT00094770|463922207|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
128898422|NCT00094770|463922208|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
128898423|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
128898424|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
128898425|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
128898426|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
128898427|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
128898428|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
128898429|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
128898430|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
128898431|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
128898432|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
128898433|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
128898434|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
128898435|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
128898436|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
128898437|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
128898438|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
128898439|NCT00094770|463922207|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
128898440|NCT00094770|463922208|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
128898441|NCT00914927|463922210|FG000|Overall Study|Adverse Event|0|||
128898442|NCT00914927|463922211|FG001|Overall Study|Adverse Event|0|||
128898443|NCT00914927|463922212|FG002|Overall Study|Adverse Event|0|||
128898444|NCT00914927|463922213|FG003|Overall Study|Adverse Event|0|||
128898445|NCT00914927|463922214|FG004|Overall Study|Adverse Event|1|||
128898446|NCT00914927|463922215|FG005|Overall Study|Adverse Event|0|||
128898447|NCT00914927|463922216|FG006|Overall Study|Adverse Event|0|||
128898448|NCT00914927|463922210|FG000|Overall Study|Withdrawal by Subject|0|||
128898449|NCT00914927|463922211|FG001|Overall Study|Withdrawal by Subject|1|||
128898450|NCT00914927|463922212|FG002|Overall Study|Withdrawal by Subject|0|||
128898451|NCT00914927|463922213|FG003|Overall Study|Withdrawal by Subject|1|||
128898452|NCT00914927|463922214|FG004|Overall Study|Withdrawal by Subject|0|||
128898453|NCT00914927|463922215|FG005|Overall Study|Withdrawal by Subject|0|||
128898454|NCT00914927|463922216|FG006|Overall Study|Withdrawal by Subject|0|||
128898455|NCT00914927|463922210|FG000|Overall Study|Lost to Follow-up|0|||
128898456|NCT00914927|463922211|FG001|Overall Study|Lost to Follow-up|0|||
128898457|NCT00914927|463922212|FG002|Overall Study|Lost to Follow-up|0|||
128898458|NCT00914927|463922213|FG003|Overall Study|Lost to Follow-up|1|||
128898459|NCT00914927|463922214|FG004|Overall Study|Lost to Follow-up|0|||
128898460|NCT00914927|463922215|FG005|Overall Study|Lost to Follow-up|0|||
128898461|NCT00914927|463922216|FG006|Overall Study|Lost to Follow-up|0|||
128898462|NCT00914927|463922210|FG000|Overall Study|Administrative/Other|2|||
128898463|NCT00914927|463922211|FG001|Overall Study|Administrative/Other|1|||
128898464|NCT00914927|463922212|FG002|Overall Study|Administrative/Other|0|||
128898465|NCT00914927|463922213|FG003|Overall Study|Administrative/Other|0|||
128898466|NCT00914927|463922214|FG004|Overall Study|Administrative/Other|1|||
128898467|NCT00914927|463922215|FG005|Overall Study|Administrative/Other|0|||
128898468|NCT00914927|463922216|FG006|Overall Study|Administrative/Other|0|||
128898469|NCT04773106|463922217|FG000|Overall Study|Withdrawal by Subject|3|||
128898470|NCT04773106|463922217|FG000|Overall Study|Death|1|||
128898471|NCT02969187|463922218|FG000|Overall Study|Physician Decision|12|||
128898472|NCT02969187|463922219|FG001|Overall Study|Physician Decision|13|||
128898473|NCT01486927|463922220|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
128898474|NCT01486927|463922220|FG000|Overall Study|Physician Decision|1|||
128898475|NCT01486927|463922220|FG000|Overall Study|50 Exposure days not reached|2|||
128898476|NCT01486927|463922220|FG000|Overall Study|Withdrawal by Subject|8|||
128898477|NCT01486927|463922220|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
128898478|NCT00365456|463922221|FG000|Trial Period I (12 Months)|Adverse Event|84|||
128898479|NCT00365456|463922222|FG001|Trial Period I (12 Months)|Adverse Event|0|||
128898480|NCT00365456|463922221|FG000|Trial Period I (12 Months)|Non-compliance|3|||
128898481|NCT00365456|463922222|FG001|Trial Period I (12 Months)|Non-compliance|0|||
128898482|NCT00365456|463922221|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
128898483|NCT00365456|463922222|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
128898484|NCT00365456|463922221|FG000|Trial Period I (12 Months)|Other|11|||
128898485|NCT00365456|463922222|FG001|Trial Period I (12 Months)|Other|0|||
129023018|NCT03419403|464376919|FG001|Overall Study|Withdrawal by Subject|2|||
129023019|NCT03419403|464376920|FG002|Overall Study|Withdrawal by Subject|5|||
129023020|NCT03419403|464376921|FG003|Overall Study|Withdrawal by Subject|1|||
128691961|NCT01193842|463171077|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
128691962|NCT01193842|463171078|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
128898486|NCT00365456|463922221|FG000|Trial Period II (12 Months)|Adverse Event|0|||
128898487|NCT00365456|463922222|FG001|Trial Period II (12 Months)|Adverse Event|6|||
128898488|NCT00365456|463922221|FG000|Trial Period II (12 Months)|Non-compliance|0|||
128898489|NCT00365456|463922222|FG001|Trial Period II (12 Months)|Non-compliance|2|||
128898490|NCT00365456|463922221|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
128898491|NCT00365456|463922222|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
128898492|NCT00365456|463922221|FG000|Trial Period II (12 Months)|Other|0|||
128691963|NCT01193842|463171079|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
128691964|NCT03698331|463171080|FG000|Overall Study|Adverse Event|2|||
128898493|NCT00365456|463922222|FG001|Trial Period II (12 Months)|Other|1|||
128898494|NCT00365456|463922221|FG000|Trial Period III (12 Months)|Adverse Event|13|||
128898495|NCT00365456|463922222|FG001|Trial Period III (12 Months)|Adverse Event|3|||
128898496|NCT00365456|463922221|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
128898497|NCT00365456|463922222|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
128898498|NCT00365456|463922221|FG000|Trial Period III (12 Months)|Other|1|||
128898499|NCT00365456|463922222|FG001|Trial Period III (12 Months)|Other|1|||
128898500|NCT03668600|463922223|FG000|Overall Study|Study Terminated by the Sponsor|157|||
128898501|NCT03668600|463922223|FG000|Overall Study|Protocol Violation|1|||
128898502|NCT03668600|463922223|FG000|Overall Study|Pregnancy|1|||
128898503|NCT03668600|463922223|FG000|Overall Study|Lost to Follow-up|7|||
128898504|NCT03668600|463922223|FG000|Overall Study|Withdrawal by Subject|56|||
128898505|NCT03668600|463922223|FG000|Overall Study|Lack of Efficacy|7|||
128898506|NCT03668600|463922223|FG000|Overall Study|Adverse Event|1|||
128898507|NCT01476475|463922225|FG000|Overall Study|Adverse Event|6|||
128898508|NCT01476475|463922226|FG001|Overall Study|Adverse Event|0|||
128898509|NCT01476475|463922225|FG000|Overall Study|Poor compliance to protocol|1|||
128898510|NCT01476475|463922226|FG001|Overall Study|Poor compliance to protocol|1|||
128898511|NCT01476475|463922225|FG000|Overall Study|Other reasons|4|||
128898512|NCT01476475|463922226|FG001|Overall Study|Other reasons|2|||
128898513|NCT01278745|463922227|FG000|Overall Study|Death|2|||
128898514|NCT01278745|463922228|FG001|Overall Study|Death|5|||
128898515|NCT01278745|463922229|FG002|Overall Study|Death|7|||
128898516|NCT01278745|463922230|FG003|Overall Study|Death|0|||
128898517|NCT01278745|463922227|FG000|Overall Study|Physician Decision|1|||
128898518|NCT01278745|463922228|FG001|Overall Study|Physician Decision|0|||
128898519|NCT01278745|463922229|FG002|Overall Study|Physician Decision|0|||
128898520|NCT01278745|463922230|FG003|Overall Study|Physician Decision|9|||
128898521|NCT01278745|463922227|FG000|Overall Study|Withdrawal by Subject|1|||
128898522|NCT01278745|463922228|FG001|Overall Study|Withdrawal by Subject|1|||
128898523|NCT01278745|463922229|FG002|Overall Study|Withdrawal by Subject|5|||
128898524|NCT01278745|463922230|FG003|Overall Study|Withdrawal by Subject|1|||
128898525|NCT01278745|463922227|FG000|Overall Study|Sponsor Decision|1|||
128898526|NCT01278745|463922228|FG001|Overall Study|Sponsor Decision|0|||
128898527|NCT01278745|463922229|FG002|Overall Study|Sponsor Decision|62|||
128898528|NCT01278745|463922230|FG003|Overall Study|Sponsor Decision|6|||
128898529|NCT01278745|463922227|FG000|Overall Study|Ineligible|0|||
128898530|NCT01278745|463922228|FG001|Overall Study|Ineligible|0|||
128898531|NCT01278745|463922229|FG002|Overall Study|Ineligible|42|||
128898532|NCT01278745|463922230|FG003|Overall Study|Ineligible|61|||
128898533|NCT01278745|463922227|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
128898534|NCT01278745|463922228|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
128898535|NCT01278745|463922229|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
128898536|NCT01278745|463922230|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
128898537|NCT02700412|463922233|FG000|Overall Study|Adverse Event|6|||
128898538|NCT02700412|463922233|FG000|Overall Study|Death|1|||
128898539|NCT02700412|463922233|FG000|Overall Study|Lack of Efficacy|19|||
128898540|NCT02700412|463922233|FG000|Overall Study|Protocol Violation|5|||
128898541|NCT02700412|463922233|FG000|Overall Study|Withdrawal by Subject|2|||
128898542|NCT03374189|463922239|FG000|Overall Study|Lost to Follow-up|1|||
128898543|NCT03374189|463922240|FG001|Overall Study|Lost to Follow-up|0|||
128898544|NCT01197521|463922241|FG000|Overall Study|Not reported|24|||
128898545|NCT01197521|463922242|FG001|Overall Study|Not reported|25|||
128898546|NCT01197521|463922243|FG002|Overall Study|Not reported|21|||
128898547|NCT01197521|463922241|FG000|Overall Study|Enrolment in long term extension|42|||
128898548|NCT01197521|463922242|FG001|Overall Study|Enrolment in long term extension|36|||
128898549|NCT01197521|463922243|FG002|Overall Study|Enrolment in long term extension|87|||
128898550|NCT01197521|463922241|FG000|Overall Study|Severe non-compliance to protocol|1|||
129023021|NCT03419403|464376918|FG000|Overall Study|Progressive disease (per protocol)|0|||
129023022|NCT03419403|464376919|FG001|Overall Study|Progressive disease (per protocol)|2|||
129023023|NCT03419403|464376920|FG002|Overall Study|Progressive disease (per protocol)|2|||
129023024|NCT03419403|464376921|FG003|Overall Study|Progressive disease (per protocol)|0|||
129023025|NCT03419403|464376918|FG000|Overall Study|Other, not specified|6|||
129023026|NCT03419403|464376919|FG001|Overall Study|Other, not specified|4|||
129023027|NCT03419403|464376920|FG002|Overall Study|Other, not specified|5|||
129023028|NCT03419403|464376921|FG003|Overall Study|Other, not specified|1|||
129023029|NCT03419403|464376918|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
129023030|NCT03419403|464376919|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
129023031|NCT03419403|464376920|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
128898551|NCT01197521|463922242|FG001|Overall Study|Severe non-compliance to protocol|3|||
129023032|NCT03419403|464376921|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
128898552|NCT01197521|463922243|FG002|Overall Study|Severe non-compliance to protocol|3|||
128898553|NCT01197521|463922241|FG000|Overall Study|Lack of therapeutic response|2|||
128898554|NCT01197521|463922242|FG001|Overall Study|Lack of therapeutic response|3|||
128898555|NCT01197521|463922243|FG002|Overall Study|Lack of therapeutic response|4|||
128898556|NCT01197521|463922241|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
128898557|NCT01197521|463922242|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
128898558|NCT01197521|463922243|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
128898559|NCT01197521|463922241|FG000|Overall Study|Lost to Follow-up|3|||
128898560|NCT01197521|463922242|FG001|Overall Study|Lost to Follow-up|2|||
128898561|NCT01197521|463922243|FG002|Overall Study|Lost to Follow-up|2|||
128898562|NCT01197521|463922241|FG000|Overall Study|Adverse Event|25|||
128898563|NCT01197521|463922242|FG001|Overall Study|Adverse Event|28|||
128898564|NCT01197521|463922243|FG002|Overall Study|Adverse Event|24|||
128898565|NCT01309659|463922244|FG000|Overall Study|Protocol Violation|0|||
128898566|NCT01309659|463922245|FG001|Overall Study|Protocol Violation|1|||
128898567|NCT03462576|463922246|FG000|Overall Study|Protocol Violation|5|||
128898568|NCT03462576|463922247|FG001|Overall Study|Protocol Violation|11|||
128898569|NCT03462576|463922248|FG002|Overall Study|Protocol Violation|7|||
128898570|NCT03462576|463922246|FG000|Overall Study|Device Malfunction|0|||
128898571|NCT03462576|463922247|FG001|Overall Study|Device Malfunction|0|||
128898572|NCT03462576|463922248|FG002|Overall Study|Device Malfunction|1|||
128898573|NCT02285777|463922252|FG000|Overall Study|Withdrawal by Subject|1|||
128898574|NCT02285777|463922253|FG001|Overall Study|Withdrawal by Subject|1|||
128898575|NCT02285777|463922252|FG000|Overall Study|Lost to Follow-up|4|||
128898576|NCT02285777|463922253|FG001|Overall Study|Lost to Follow-up|2|||
128898577|NCT03962101|463922257|FG000|Overall Study|Adverse Event|1|||
128898578|NCT03962101|463922257|FG000|Overall Study|Physician Decision|2|||
128898579|NCT03962101|463922257|FG000|Overall Study|Not related to medical events|1|||
128898580|NCT00271596|463922264|FG000|Overall Study|Protocol Violation|1|||
128898581|NCT00271596|463922265|FG001|Overall Study|Protocol Violation|0|||
128898582|NCT00271596|463922264|FG000|Overall Study|Withdrawal by Subject|0|||
128898583|NCT00271596|463922265|FG001|Overall Study|Withdrawal by Subject|1|||
128898584|NCT01069172|463922266|FG000|Overall Study|Withdrawal by Subject|1|||
128898585|NCT01069172|463922267|FG001|Overall Study|Withdrawal by Subject|0|||
128898586|NCT03901079|463922270|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
128898587|NCT00578136|463922271|FG000|Overall Study|Not given intervention|1|||
128898588|NCT00578136|463922272|FG001|Overall Study|Not given intervention|1|||
128898589|NCT02047253|463922273|FG000|Overall Study|Lost to Follow-up|8|||
128898590|NCT01987960|463922275|FG000|Period 1|Adverse Event|24|||
128898591|NCT01987960|463922276|FG001|Period 1|Adverse Event|0|||
128898592|NCT01987960|463922277|FG002|Period 1|Adverse Event|0|||
128898593|NCT01987960|463922278|FG003|Period 1|Adverse Event|0|||
128898594|NCT01987960|463922275|FG000|Period 1|Lack of Efficacy|4|||
128898595|NCT01987960|463922276|FG001|Period 1|Lack of Efficacy|0|||
128898596|NCT01987960|463922277|FG002|Period 1|Lack of Efficacy|0|||
128898597|NCT01987960|463922278|FG003|Period 1|Lack of Efficacy|0|||
128898598|NCT01987960|463922275|FG000|Period 1|Non-compliance with IMP|6|||
128898599|NCT01987960|463922276|FG001|Period 1|Non-compliance with IMP|0|||
128898600|NCT01987960|463922277|FG002|Period 1|Non-compliance with IMP|0|||
128898601|NCT01987960|463922278|FG003|Period 1|Non-compliance with IMP|0|||
128898602|NCT01987960|463922275|FG000|Period 1|Protocol Violation|12|||
128898603|NCT01987960|463922276|FG001|Period 1|Protocol Violation|0|||
128898604|NCT01987960|463922277|FG002|Period 1|Protocol Violation|0|||
128898605|NCT01987960|463922278|FG003|Period 1|Protocol Violation|0|||
128898606|NCT01987960|463922275|FG000|Period 1|Withdrawal by Subject|21|||
128898607|NCT01987960|463922276|FG001|Period 1|Withdrawal by Subject|0|||
128898608|NCT01987960|463922277|FG002|Period 1|Withdrawal by Subject|0|||
128898609|NCT01987960|463922278|FG003|Period 1|Withdrawal by Subject|0|||
128898610|NCT01987960|463922275|FG000|Period 1|Lost to Follow-up|40|||
128898611|NCT01987960|463922276|FG001|Period 1|Lost to Follow-up|0|||
128898612|NCT01987960|463922277|FG002|Period 1|Lost to Follow-up|0|||
128898613|NCT01987960|463922278|FG003|Period 1|Lost to Follow-up|0|||
128898614|NCT01987960|463922275|FG000|Period 1|administrative or other reason|75|||
128898615|NCT01987960|463922276|FG001|Period 1|administrative or other reason|0|||
128898616|NCT01987960|463922277|FG002|Period 1|administrative or other reason|0|||
128898617|NCT01987960|463922278|FG003|Period 1|administrative or other reason|0|||
128898618|NCT01987960|463922275|FG000|Period 1|Withdrawal of consent before treatment|4|||
128898619|NCT01987960|463922276|FG001|Period 1|Withdrawal of consent before treatment|0|||
128898620|NCT01987960|463922277|FG002|Period 1|Withdrawal of consent before treatment|0|||
128898621|NCT01987960|463922278|FG003|Period 1|Withdrawal of consent before treatment|0|||
128898622|NCT01987960|463922275|FG000|Period 2|Adverse Event|0|||
128898623|NCT01987960|463922276|FG001|Period 2|Adverse Event|0|||
128898624|NCT01987960|463922277|FG002|Period 2|Adverse Event|1|||
128898625|NCT01987960|463922278|FG003|Period 2|Adverse Event|0|||
128898626|NCT01987960|463922275|FG000|Period 2|Withdrawal by Subject|0|||
128898627|NCT01987960|463922276|FG001|Period 2|Withdrawal by Subject|0|||
128898628|NCT01987960|463922277|FG002|Period 2|Withdrawal by Subject|1|||
128898629|NCT01987960|463922278|FG003|Period 2|Withdrawal by Subject|0|||
128898630|NCT01987960|463922275|FG000|Period 2|Administrative or other reason|0|||
128898631|NCT01987960|463922276|FG001|Period 2|Administrative or other reason|5|||
128898632|NCT01987960|463922277|FG002|Period 2|Administrative or other reason|7|||
128898633|NCT01987960|463922278|FG003|Period 2|Administrative or other reason|0|||
128898634|NCT01987960|463922275|FG000|Period 3|Adverse Event|0|||
128898635|NCT01987960|463922276|FG001|Period 3|Adverse Event|0|||
128898636|NCT01987960|463922277|FG002|Period 3|Adverse Event|0|||
128898637|NCT01987960|463922278|FG003|Period 3|Adverse Event|7|||
128898638|NCT01987960|463922275|FG000|Period 3|Non-compliance with IMP|0|||
128898639|NCT01987960|463922276|FG001|Period 3|Non-compliance with IMP|0|||
128898640|NCT01987960|463922277|FG002|Period 3|Non-compliance with IMP|0|||
128898641|NCT01987960|463922278|FG003|Period 3|Non-compliance with IMP|1|||
128898642|NCT01987960|463922275|FG000|Period 3|Protocol Violation|0|||
128898643|NCT01987960|463922276|FG001|Period 3|Protocol Violation|0|||
128898644|NCT01987960|463922277|FG002|Period 3|Protocol Violation|0|||
128898645|NCT01987960|463922278|FG003|Period 3|Protocol Violation|6|||
128898646|NCT01987960|463922275|FG000|Period 3|Withdrawal by Subject|0|||
128898647|NCT01987960|463922276|FG001|Period 3|Withdrawal by Subject|0|||
128898648|NCT01987960|463922277|FG002|Period 3|Withdrawal by Subject|0|||
128898649|NCT01987960|463922278|FG003|Period 3|Withdrawal by Subject|9|||
128898650|NCT01987960|463922275|FG000|Period 3|Lost to Follow-up|0|||
128898651|NCT01987960|463922276|FG001|Period 3|Lost to Follow-up|0|||
128898652|NCT01987960|463922277|FG002|Period 3|Lost to Follow-up|0|||
128898653|NCT01987960|463922278|FG003|Period 3|Lost to Follow-up|5|||
128898654|NCT01987960|463922275|FG000|Period 3|Administrative or other reason|0|||
128898655|NCT01987960|463922276|FG001|Period 3|Administrative or other reason|0|||
128898656|NCT01987960|463922277|FG002|Period 3|Administrative or other reason|0|||
128898657|NCT01987960|463922278|FG003|Period 3|Administrative or other reason|43|||
128898658|NCT00932360|463922279|FG000|Washout (One Week)|Withdrawal by Subject|0|||
128898659|NCT00932360|463922280|FG001|Washout (One Week)|Withdrawal by Subject|0|||
128898660|NCT00932360|463922281|FG002|Washout (One Week)|Withdrawal by Subject|0|||
128898661|NCT00932360|463922282|FG003|Washout (One Week)|Withdrawal by Subject|0|||
128898662|NCT00932360|463922283|FG004|Washout (One Week)|Withdrawal by Subject|2|||
128898663|NCT00932360|463922284|FG005|Washout (One Week)|Withdrawal by Subject|0|||
128898664|NCT01357655|463922291|FG000|Overall Study|Administrative Reason by Sponsor|45|||
128898665|NCT01357655|463922292|FG001|Overall Study|Administrative Reason by Sponsor|0|||
128898666|NCT01357655|463922291|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
128898667|NCT01357655|463922292|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128898668|NCT01357655|463922291|FG000|Overall Study|Disease Progression|1|||
128898669|NCT01357655|463922292|FG001|Overall Study|Disease Progression|0|||
128898670|NCT01357655|463922291|FG000|Overall Study|Lost to Follow-up|2|||
128898671|NCT01357655|463922292|FG001|Overall Study|Lost to Follow-up|0|||
128898672|NCT01357655|463922291|FG000|Overall Study|Maximum Clinical Benefit|2|||
128898673|NCT01357655|463922292|FG001|Overall Study|Maximum Clinical Benefit|0|||
128898674|NCT01357655|463922291|FG000|Overall Study|Reason Unspecified|1|||
128898675|NCT01357655|463922292|FG001|Overall Study|Reason Unspecified|0|||
128898676|NCT01357655|463922291|FG000|Overall Study|Study Drug Toxicity|11|||
128898677|NCT01357655|463922292|FG001|Overall Study|Study Drug Toxicity|0|||
128898678|NCT01357655|463922291|FG000|Overall Study|Subject Withdrew Consent|1|||
128898679|NCT01357655|463922292|FG001|Overall Study|Subject Withdrew Consent|0|||
128898680|NCT00609986|463922293|FG000|Overall Study|Did not receive transplant or treatment|8|||
128898681|NCT00609986|463922294|FG001|Overall Study|Did not receive transplant or treatment|3|||
128898682|NCT04722042|463922296|FG000|Overall Study|Withdrawal by Subject|2|||
128898683|NCT04722042|463922297|FG001|Overall Study|Withdrawal by Subject|1|||
128898684|NCT04722042|463922298|FG002|Overall Study|Withdrawal by Subject|0|||
128898685|NCT02090413|463922301|FG000|Overall Study|Adverse Event|11|||
128898686|NCT02090413|463922302|FG001|Overall Study|Adverse Event|15|||
128898687|NCT02090413|463922303|FG002|Overall Study|Adverse Event|20|||
128898688|NCT02090413|463922301|FG000|Overall Study|Flushing event|2|||
128898689|NCT02090413|463922302|FG001|Overall Study|Flushing event|0|||
128898690|NCT02090413|463922303|FG002|Overall Study|Flushing event|1|||
128898691|NCT02090413|463922301|FG000|Overall Study|Withdrawal by Subject|2|||
128898692|NCT02090413|463922302|FG001|Overall Study|Withdrawal by Subject|2|||
128898693|NCT02090413|463922303|FG002|Overall Study|Withdrawal by Subject|2|||
128898694|NCT02090413|463922301|FG000|Overall Study|Investigator Decision|1|||
128898695|NCT02090413|463922302|FG001|Overall Study|Investigator Decision|1|||
128898696|NCT02090413|463922303|FG002|Overall Study|Investigator Decision|0|||
128898697|NCT02090413|463922301|FG000|Overall Study|Other|2|||
128898698|NCT02090413|463922302|FG001|Overall Study|Other|1|||
128898699|NCT02090413|463922303|FG002|Overall Study|Other|0|||
128898700|NCT02090413|463922301|FG000|Overall Study|Lost to Follow-up|1|||
128898701|NCT02090413|463922302|FG001|Overall Study|Lost to Follow-up|1|||
128898702|NCT02090413|463922303|FG002|Overall Study|Lost to Follow-up|0|||
128898703|NCT02321930|463922309|FG000|Overall Study|Lost to Follow-up|1|||
128898704|NCT05321069|463922310|FG000|Overall Study|Adverse Event|52|||
128898705|NCT05321069|463922311|FG001|Overall Study|Adverse Event|52|||
128898706|NCT05321069|463922312|FG002|Overall Study|Adverse Event|64|||
128898707|NCT05321069|463922310|FG000|Overall Study|Protocol Violation|1|||
128898708|NCT05321069|463922311|FG001|Overall Study|Protocol Violation|1|||
128898709|NCT05321069|463922312|FG002|Overall Study|Protocol Violation|0|||
128898710|NCT05321069|463922310|FG000|Overall Study|Withdrawal by Subject|23|||
128898711|NCT05321069|463922311|FG001|Overall Study|Withdrawal by Subject|18|||
128898712|NCT05321069|463922312|FG002|Overall Study|Withdrawal by Subject|12|||
128898713|NCT05321069|463922310|FG000|Overall Study|Lost to Follow-up|1|||
128898714|NCT05321069|463922311|FG001|Overall Study|Lost to Follow-up|0|||
128898715|NCT05321069|463922312|FG002|Overall Study|Lost to Follow-up|1|||
128898716|NCT05321069|463922310|FG000|Overall Study|No reason stated by the participants|23|||
128898717|NCT05321069|463922311|FG001|Overall Study|No reason stated by the participants|22|||
128898718|NCT05321069|463922312|FG002|Overall Study|No reason stated by the participants|16|||
128898719|NCT05321069|463922310|FG000|Overall Study|Lack of Efficacy|1|||
128898720|NCT05321069|463922311|FG001|Overall Study|Lack of Efficacy|1|||
128898721|NCT05321069|463922312|FG002|Overall Study|Lack of Efficacy|0|||
128898722|NCT01293968|463922313|FG000|Overall Study|non-cooperation|3|||
128898723|NCT01293968|463922314|FG001|Overall Study|non-cooperation|3|||
128898724|NCT01484977|463922315|FG000|Overall Study|Adverse Event|8|||
128898725|NCT01484977|463922315|FG000|Overall Study|Lack of Efficacy|4|||
128898726|NCT01484977|463922315|FG000|Overall Study|Protocol Violation|6|||
128898727|NCT01484977|463922315|FG000|Overall Study|Lost to Follow-up|1|||
128898728|NCT01484977|463922315|FG000|Overall Study|Withdrawal by Subject|4|||
128898729|NCT01484977|463922315|FG000|Overall Study|Subject Protocol Non-compliant|1|||
128898730|NCT01484977|463922315|FG000|Overall Study|Moving Overseas|1|||
128898731|NCT01484977|463922315|FG000|Overall Study|Low White Blood Cell Count|1|||
128898732|NCT01484977|463922315|FG000|Overall Study|Lack of Compliance|1|||
128898733|NCT00853749|463922316|FG000|Overall Study|Lost to Follow-up|0|||
128898734|NCT00853749|463922317|FG001|Overall Study|Lost to Follow-up|1|||
128898735|NCT04857996|463922318|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
128898736|NCT04857996|463922319|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
128898737|NCT04857996|463922318|FG000|Overall Study|Lost to Follow-up|1|||
128898738|NCT04857996|463922319|FG001|Overall Study|Lost to Follow-up|3|||
128898739|NCT04857996|463922318|FG000|Overall Study|Site Closure|1|||
128898740|NCT04857996|463922319|FG001|Overall Study|Site Closure|0|||
128898741|NCT04857996|463922318|FG000|Overall Study|Withdrawal by Subject|1|||
128898742|NCT04857996|463922319|FG001|Overall Study|Withdrawal by Subject|0|||
128898743|NCT02269787|463922320|FG000|Overall Study|Lost to Follow-up|20|||
128898744|NCT02269787|463922321|FG001|Overall Study|Lost to Follow-up|6|||
128898745|NCT02269787|463922320|FG000|Overall Study|Death|2|||
128898746|NCT02269787|463922321|FG001|Overall Study|Death|3|||
128898747|NCT02269787|463922320|FG000|Overall Study|Incapacitated|0|||
128898748|NCT02269787|463922321|FG001|Overall Study|Incapacitated|1|||
128898749|NCT00798135|463922322|FG000|Overall Study|Disease progression, relapse|11|||
128898750|NCT00798135|463922322|FG000|Overall Study|Disease progression, refractory|1|||
128898751|NCT00798135|463922322|FG000|Overall Study|Physician Decision|1|||
128898752|NCT00687440|463922323|FG000|Overall Study|Adverse Event|3|||
128898753|NCT00687440|463922323|FG000|Overall Study|Lost to Follow-up|3|||
128898754|NCT00687440|463922323|FG000|Overall Study|Lack of Efficacy|2|||
128898755|NCT00687440|463922323|FG000|Overall Study|Death|2|||
128898756|NCT00687440|463922323|FG000|Overall Study|Other|1|||
128898757|NCT00687440|463922323|FG000|Overall Study|Missing|1|||
128898758|NCT02228720|463922324|FG000|Open Label - Day 30|Lost to Follow-up|1|||
128898759|NCT01392677|463922329|FG000|Overall Study|Adverse Event|3|||
128898760|NCT01392677|463922330|FG001|Overall Study|Adverse Event|1|||
128898761|NCT01392677|463922329|FG000|Overall Study|Withdrawal by Subject|0|||
128898762|NCT01392677|463922330|FG001|Overall Study|Withdrawal by Subject|2|||
128898763|NCT01392677|463922329|FG000|Overall Study|Incorrect enrollment|2|||
128898764|NCT01392677|463922330|FG001|Overall Study|Incorrect enrollment|3|||
128898765|NCT01392677|463922329|FG000|Overall Study|Other reason|3|||
128898766|NCT01392677|463922330|FG001|Overall Study|Other reason|2|||
128898767|NCT03996876|463922331|FG000|Overall Study|Incomplete Data|2|||
128898768|NCT03996876|463922332|FG001|Overall Study|Incomplete Data|4|||
128898769|NCT03080883|463922337|FG000|Overall Study|Withdrawal by Subject|11|||
128898770|NCT03080883|463922338|FG001|Overall Study|Withdrawal by Subject|15|||
128898771|NCT03080883|463922337|FG000|Overall Study|Adverse Event|22|||
128898772|NCT03080883|463922338|FG001|Overall Study|Adverse Event|22|||
128898773|NCT03080883|463922337|FG000|Overall Study|Alternative Therapy|0|||
128898774|NCT03080883|463922338|FG001|Overall Study|Alternative Therapy|3|||
128898775|NCT03080883|463922337|FG000|Overall Study|Other Complicating Disease|9|||
128898776|NCT03080883|463922338|FG001|Overall Study|Other Complicating Disease|5|||
128898777|NCT03080883|463922337|FG000|Overall Study|Death|21|||
128898778|NCT03080883|463922338|FG001|Overall Study|Death|16|||
128898779|NCT03080883|463922337|FG000|Overall Study|Physician Decision|2|||
128898780|NCT03080883|463922338|FG001|Overall Study|Physician Decision|2|||
128898781|NCT03080883|463922337|FG000|Overall Study|Disease Progression|2|||
128898782|NCT03080883|463922338|FG001|Overall Study|Disease Progression|8|||
128898783|NCT03080883|463922337|FG000|Overall Study|Lost to Follow-up|1|||
128898784|NCT03080883|463922338|FG001|Overall Study|Lost to Follow-up|1|||
128898785|NCT04179734|463923545|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
128898786|NCT04179734|463923546|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
128898787|NCT04179734|463923545|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
128898788|NCT04179734|463923546|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
128898789|NCT01761292|463923548|FG000|Part 1|Adverse Event|1|||
128898790|NCT01761292|463923548|FG000|Part 1|not receiving treatment in Part 1|1|||
128898791|NCT01761292|463923548|FG000|Extension 1|Withdrawal by Subject|1|||
128898792|NCT00840086|463923549|FG000|Overall Study|Adverse Event|1|||
128898793|NCT00840086|463923549|FG000|Overall Study|Protocol Violation|2|||
128898794|NCT00840086|463923549|FG000|Overall Study|Lost to Follow-up|1|||
128898795|NCT03332498|463923550|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
128898796|NCT03332498|463923551|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
128898797|NCT03332498|463923552|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
128898798|NCT04036708|463923553|FG000|Overall Study|Lost to Follow-up|14|||
128898799|NCT04036708|463923554|FG001|Overall Study|Lost to Follow-up|4|||
128898800|NCT04036708|463923555|FG002|Overall Study|Lost to Follow-up|14|||
128898801|NCT04036708|463923556|FG003|Overall Study|Lost to Follow-up|4|||
128898802|NCT02349048|463923560|FG000|Overall Study|Withdrawal by Subject|4|||
128898803|NCT02349048|463923561|FG001|Overall Study|Withdrawal by Subject|0|||
128898804|NCT02349048|463923560|FG000|Overall Study|Lost to Follow-up|1|||
128898805|NCT02349048|463923561|FG001|Overall Study|Lost to Follow-up|0|||
129023033|NCT02089685|464376924|FG000|Overall Study|Adverse Event|1|||
129023034|NCT02089685|464376925|FG001|Overall Study|Adverse Event|0|||
129023035|NCT02089685|464376926|FG002|Overall Study|Adverse Event|0|||
129023036|NCT02089685|464376927|FG003|Overall Study|Adverse Event|0|||
129023037|NCT02089685|464376928|FG004|Overall Study|Adverse Event|1|||
128898806|NCT01349465|463923564|FG000|Overall Study|Adverse Event|1|||
128898807|NCT01349465|463923565|FG001|Overall Study|Adverse Event|0|||
128898808|NCT01349465|463923564|FG000|Overall Study|Death|3|||
128898809|NCT01349465|463923565|FG001|Overall Study|Death|0|||
128898810|NCT01349465|463923564|FG000|Overall Study|Lost to Follow-up|10|||
128898811|NCT01349465|463923565|FG001|Overall Study|Lost to Follow-up|1|||
128898812|NCT01349465|463923564|FG000|Overall Study|Withdrawal by Subject|4|||
128898813|NCT01349465|463923565|FG001|Overall Study|Withdrawal by Subject|2|||
128898814|NCT01349465|463923564|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
128898815|NCT01349465|463923565|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
128898816|NCT01648790|463923566|FG000|Treatment 3|Withdrawal by Subject|0|||
128898817|NCT01648790|463923567|FG001|Treatment 3|Withdrawal by Subject|0|||
129023038|NCT02089685|464376929|FG005|Overall Study|Adverse Event|0|||
129023039|NCT02089685|464376924|FG000|Overall Study|Clinical Progression|4|||
129023040|NCT02089685|464376925|FG001|Overall Study|Clinical Progression|0|||
128898818|NCT01648790|463923568|FG002|Treatment 3|Withdrawal by Subject|0|||
128898819|NCT01648790|463923569|FG003|Treatment 3|Withdrawal by Subject|1|||
128898820|NCT01648790|463923570|FG004|Treatment 3|Withdrawal by Subject|0|||
128898821|NCT01265615|463923575|FG000|Overall Study|Protocol Violation|2|||
128898822|NCT01265615|463923576|FG001|Overall Study|Protocol Violation|2|||
128898823|NCT01265615|463923577|FG002|Overall Study|Protocol Violation|4|||
128898824|NCT01265615|463923578|FG003|Overall Study|Protocol Violation|3|||
128898825|NCT03370120|463923583|FG000|Overall Study|Adverse event, non-fatal|24|||
128898826|NCT03370120|463923583|FG000|Overall Study|Withdrawal by Subject|6|||
128898827|NCT03370120|463923583|FG000|Overall Study|Lost to Follow-up|1|||
128898828|NCT03370120|463923583|FG000|Overall Study|Lack of Efficacy|37|||
128898829|NCT03370120|463923583|FG000|Overall Study|Per sponsor's instructions|1|||
128898830|NCT03370120|463923583|FG000|Overall Study|Study was terminated by parent company UCB|2|||
128898831|NCT03370120|463923583|FG000|Overall Study|The study was ended by the promoter|3|||
128898832|NCT03370120|463923583|FG000|Overall Study|Discontinuation of drug development|3|||
128898833|NCT03370120|463923583|FG000|Overall Study|End of project|2|||
128898834|NCT03370120|463923583|FG000|Overall Study|Premature study closure|2|||
128898835|NCT03370120|463923583|FG000|Overall Study|Premature program termination|1|||
128898836|NCT03370120|463923583|FG000|Overall Study|Premature study termination|7|||
128898837|NCT03370120|463923583|FG000|Overall Study|Trial terminated by sponsor|2|||
128898838|NCT03370120|463923583|FG000|Overall Study|Trial discontinued by sponsor|2|||
128898839|NCT03370120|463923583|FG000|Overall Study|Study ended|15|||
128898840|NCT03370120|463923583|FG000|Overall Study|Clinical trial has been cancelled|1|||
128898841|NCT03370120|463923583|FG000|Overall Study|End of study per sponsor decision|2|||
128898842|NCT03370120|463923583|FG000|Overall Study|Promoter's decision|2|||
129023041|NCT02089685|464376926|FG002|Overall Study|Clinical Progression|0|||
129023042|NCT02089685|464376927|FG003|Overall Study|Clinical Progression|5|||
128691965|NCT03698331|463171081|FG001|Overall Study|Adverse Event|3|||
128691966|NCT03698331|463171080|FG000|Overall Study|Withdrawal by Subject|1|||
128691967|NCT03698331|463171081|FG001|Overall Study|Withdrawal by Subject|1|||
128691968|NCT03698331|463171080|FG000|Overall Study|Lost to Follow-up|0|||
128691969|NCT03698331|463171081|FG001|Overall Study|Lost to Follow-up|2|||
128691970|NCT03698331|463171080|FG000|Overall Study|Non-compliance with study drug|1|||
128691971|NCT03698331|463171081|FG001|Overall Study|Non-compliance with study drug|0|||
128691972|NCT02130024|463171083|FG000|Overall Study|Adverse Event|10|||
128764592|NCT04512066|463428368|FG002|Extension Period|Adverse Event|4|||
128898843|NCT03370120|463923583|FG000|Overall Study|The trial has been suspended|3|||
128898844|NCT03370120|463923583|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
128898845|NCT03370120|463923583|FG000|Overall Study|Early termination by order of sponsor|2|||
128898846|NCT03370120|463923583|FG000|Overall Study|Discontinuation of the study|5|||
129023043|NCT02089685|464376928|FG004|Overall Study|Clinical Progression|1|||
129023044|NCT02089685|464376929|FG005|Overall Study|Clinical Progression|2|||
129023045|NCT02089685|464376924|FG000|Overall Study|Excluded Medication|1|||
129023046|NCT02089685|464376925|FG001|Overall Study|Excluded Medication|0|||
129023047|NCT02089685|464376926|FG002|Overall Study|Excluded Medication|0|||
129023048|NCT02089685|464376927|FG003|Overall Study|Excluded Medication|11|||
129023049|NCT02089685|464376928|FG004|Overall Study|Excluded Medication|2|||
128898847|NCT03370120|463923583|FG000|Overall Study|End of clinical trial discontinuation|1|||
128898848|NCT03370120|463923583|FG000|Overall Study|Because the clinical trial ended halfway|4|||
128898849|NCT03370120|463923583|FG000|Overall Study|Development discontinued|5|||
128898850|NCT03370120|463923583|FG000|Overall Study|Padsenovil program closed|3|||
128898851|NCT03370120|463923583|FG000|Overall Study|End of project|2|||
128898852|NCT03370120|463923583|FG000|Overall Study|Termination of project|1|||
128898853|NCT03370120|463923583|FG000|Overall Study|The study was interrupted by sponsor|4|||
128898854|NCT03370120|463923583|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
128898855|NCT03370120|463923583|FG000|Overall Study|End of sponsor decision|1|||
128898856|NCT03370120|463923583|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
128898857|NCT03370120|463923583|FG000|Overall Study|Early termination of studies|5|||
128898858|NCT03370120|463923583|FG000|Overall Study|This study is ended early|1|||
128898859|NCT03370120|463923583|FG000|Overall Study|End of padsevonil program|2|||
128898860|NCT03370120|463923583|FG000|Overall Study|Decision of sponsor|6|||
128898861|NCT03370120|463923583|FG000|Overall Study|Asked by the sponsor|3|||
128898862|NCT03370120|463923583|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
128898863|NCT03370120|463923583|FG000|Overall Study|PI decision poor compliance from participant|1|||
128898864|NCT03370120|463923583|FG000|Overall Study|Promoter ended the study|3|||
128898865|NCT03370120|463923583|FG000|Overall Study|Premature study close by sponsor's decision|4|||
128898866|NCT03370120|463923583|FG000|Overall Study|Study terminated by sponsor|33|||
128898867|NCT03370120|463923583|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
128898868|NCT03370120|463923583|FG000|Overall Study|Sponsor decision to terminate study|63|||
128898869|NCT03370120|463923583|FG000|Overall Study|Program closure|3|||
128898870|NCT03370120|463923583|FG000|Overall Study|Study ended prematurely|1|||
128898871|NCT03370120|463923583|FG000|Overall Study|Study stopped by sponsor|2|||
128898872|NCT03370120|463923583|FG000|Overall Study|Program termination|55|||
128898873|NCT03370120|463923583|FG000|Overall Study|Sponsor decision|62|||
128898874|NCT03370120|463923583|FG000|Overall Study|Sponsor study closure|10|||
128898875|NCT00454857|463923585|FG000|Overall Study|Withdrawal by Subject|15|||
128898876|NCT00454857|463923585|FG000|Overall Study|Lost to Follow-up|16|||
128898877|NCT00454857|463923585|FG000|Overall Study|Noncompliance|6|||
128898878|NCT00454857|463923585|FG000|Overall Study|Death|5|||
128898879|NCT00454857|463923585|FG000|Overall Study|Other|11|||
128898880|NCT00454857|463923585|FG000|Overall Study|Reason unknown|1|||
128898881|NCT04206020|463923586|FG000|Overall Study|Adverse Event|1|||
128898882|NCT04206020|463923587|FG001|Overall Study|Adverse Event|4|||
128898883|NCT04206020|463923586|FG000|Overall Study|Protocol Violation|2|||
128898884|NCT04206020|463923587|FG001|Overall Study|Protocol Violation|0|||
128898885|NCT04206020|463923586|FG000|Overall Study|Withdrawal by Subject|2|||
128898886|NCT04206020|463923587|FG001|Overall Study|Withdrawal by Subject|0|||
128898887|NCT04206020|463923586|FG000|Overall Study|Lost to Follow-up|2|||
128898888|NCT04206020|463923587|FG001|Overall Study|Lost to Follow-up|0|||
128898889|NCT04206020|463923586|FG000|Overall Study|Pregnancy|0|||
128898890|NCT04206020|463923587|FG001|Overall Study|Pregnancy|1|||
128898891|NCT04206020|463923586|FG000|Overall Study|Unable to attend visits|1|||
128898892|NCT04206020|463923587|FG001|Overall Study|Unable to attend visits|2|||
128898893|NCT00632099|463923588|FG000|Overall Study|Lost to Follow-up|3|||
128898894|NCT00632099|463923589|FG001|Overall Study|Lost to Follow-up|3|||
128898895|NCT02375724|463923590|FG000|Overall Study|Lack of Efficacy|1|||
128898896|NCT02375724|463923591|FG001|Overall Study|Lack of Efficacy|1|||
128898897|NCT02375724|463923590|FG000|Overall Study|Withdrawal by Subject|1|||
128898898|NCT02375724|463923591|FG001|Overall Study|Withdrawal by Subject|1|||
128898899|NCT02375724|463923590|FG000|Overall Study|Lost to Follow-up|1|||
128898900|NCT02375724|463923591|FG001|Overall Study|Lost to Follow-up|0|||
128898901|NCT02375724|463923590|FG000|Overall Study|Protocol Violation|1|||
128898902|NCT02375724|463923591|FG001|Overall Study|Protocol Violation|0|||
128898903|NCT02375724|463923590|FG000|Overall Study|Adverse Event|2|||
128898904|NCT02375724|463923591|FG001|Overall Study|Adverse Event|4|||
128898905|NCT00552175|463923594|FG000|Overall Study|Lack of Efficacy|2|||
128898906|NCT00552175|463923595|FG001|Overall Study|Lack of Efficacy|0|||
128898907|NCT00552175|463923596|FG002|Overall Study|Lack of Efficacy|1|||
128898908|NCT00552175|463923594|FG000|Overall Study|Adverse Event|9|||
128898909|NCT00552175|463923595|FG001|Overall Study|Adverse Event|9|||
128898910|NCT00552175|463923596|FG002|Overall Study|Adverse Event|10|||
128898911|NCT00552175|463923594|FG000|Overall Study|Withdrawal by Subject|2|||
128898912|NCT00552175|463923595|FG001|Overall Study|Withdrawal by Subject|2|||
128898913|NCT00552175|463923596|FG002|Overall Study|Withdrawal by Subject|1|||
128898914|NCT00552175|463923594|FG000|Overall Study|Lost to Follow-up|0|||
128898915|NCT00552175|463923595|FG001|Overall Study|Lost to Follow-up|0|||
128898916|NCT00552175|463923596|FG002|Overall Study|Lost to Follow-up|1|||
128898917|NCT00552175|463923594|FG000|Overall Study|Entry Criteria Not Met|1|||
128898918|NCT00552175|463923595|FG001|Overall Study|Entry Criteria Not Met|1|||
128898919|NCT00552175|463923596|FG002|Overall Study|Entry Criteria Not Met|0|||
128898920|NCT00552175|463923594|FG000|Overall Study|Reason Not Specified|3|||
128898921|NCT00552175|463923595|FG001|Overall Study|Reason Not Specified|1|||
128898922|NCT00552175|463923596|FG002|Overall Study|Reason Not Specified|1|||
128898923|NCT01543828|463923598|FG000|Treatment 2|Lost to Follow-up|1|||
128898924|NCT01543828|463923599|FG001|Treatment 2|Lost to Follow-up|0|||
128898925|NCT04206605|463923600|FG000|Overall Study|Adverse Event|0|||
128898926|NCT04206605|463923601|FG001|Overall Study|Adverse Event|1|||
128898927|NCT04206605|463923600|FG000|Overall Study|Withdrawal by Subject|1|||
128898928|NCT04206605|463923601|FG001|Overall Study|Withdrawal by Subject|0|||
128898929|NCT02285998|463923602|FG000|Overall Study|Adverse Event|9|||
128898930|NCT02285998|463923603|FG001|Overall Study|Adverse Event|8|||
128898931|NCT02285998|463923602|FG000|Overall Study|Physician Decision|1|||
128898932|NCT02285998|463923603|FG001|Overall Study|Physician Decision|2|||
128898933|NCT02285998|463923602|FG000|Overall Study|Lost to Follow-up|176|||
128898934|NCT02285998|463923603|FG001|Overall Study|Lost to Follow-up|172|||
128898935|NCT02285998|463923602|FG000|Overall Study|Withdrawal by Subject|53|||
128898936|NCT02285998|463923603|FG001|Overall Study|Withdrawal by Subject|61|||
128898937|NCT02285998|463923602|FG000|Overall Study|Other Reasons|7|||
128898938|NCT02285998|463923603|FG001|Overall Study|Other Reasons|10|||
128898939|NCT04995055|463923606|FG000|Period 1|COVID-19 Related|1|||
128898940|NCT04995055|463923607|FG001|Period 1|COVID-19 Related|0|||
128898941|NCT04995055|463923606|FG000|Period 1|Withdrawal by Subject|0|||
128898942|NCT04995055|463923607|FG001|Period 1|Withdrawal by Subject|1|||
128898943|NCT04995055|463923606|FG000|Period 1|Subject discontinued due to timing|4|||
128898944|NCT04995055|463923607|FG001|Period 1|Subject discontinued due to timing|4|||
128898945|NCT01066585|463923613|FG000|Overall Study|Protocol Violation|1|||
128898946|NCT01066585|463923614|FG001|Overall Study|Protocol Violation|0|||
128898947|NCT01066585|463923613|FG000|Overall Study|Withdrawal by Subject|0|||
128898948|NCT01066585|463923614|FG001|Overall Study|Withdrawal by Subject|3|||
128898949|NCT00884273|463923617|FG000|Overall Study|Adverse Event|0|||
128898950|NCT00884273|463923618|FG001|Overall Study|Adverse Event|2|||
128898951|NCT00884273|463923617|FG000|Overall Study|Protocol Violation|1|||
128898952|NCT00884273|463923618|FG001|Overall Study|Protocol Violation|3|||
128898953|NCT00884273|463923617|FG000|Overall Study|Practical reasons|1|||
128898954|NCT00884273|463923618|FG001|Overall Study|Practical reasons|0|||
128898955|NCT00078325|463923621|FG000|Overall Study|Adverse Event|15|||
128898956|NCT00078325|463923622|FG001|Overall Study|Adverse Event|10|||
128898957|NCT00078325|463923623|FG002|Overall Study|Adverse Event|5|||
128898958|NCT00078325|463923621|FG000|Overall Study|Protocol Violation|2|||
128898959|NCT00078325|463923622|FG001|Overall Study|Protocol Violation|2|||
128898960|NCT00078325|463923623|FG002|Overall Study|Protocol Violation|0|||
128898961|NCT00078325|463923621|FG000|Overall Study|Withdrawal by Subject|1|||
128898962|NCT00078325|463923622|FG001|Overall Study|Withdrawal by Subject|5|||
128898963|NCT00078325|463923623|FG002|Overall Study|Withdrawal by Subject|3|||
128898964|NCT00078325|463923621|FG000|Overall Study|Lost to Follow-up|0|||
128898965|NCT00078325|463923622|FG001|Overall Study|Lost to Follow-up|1|||
128898966|NCT00078325|463923623|FG002|Overall Study|Lost to Follow-up|1|||
128898967|NCT00078325|463923621|FG000|Overall Study|Physician Decision|2|||
128898968|NCT00078325|463923622|FG001|Overall Study|Physician Decision|0|||
128898969|NCT00078325|463923623|FG002|Overall Study|Physician Decision|1|||
128898970|NCT00078325|463923621|FG000|Overall Study|Miscellaneous|1|||
128898971|NCT00078325|463923622|FG001|Overall Study|Miscellaneous|1|||
128898972|NCT00078325|463923623|FG002|Overall Study|Miscellaneous|1|||
128898973|NCT04126083|463923624|FG000|Overall Study|Withdrawal by Subject|1|||
128898974|NCT03710486|463923625|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
128898975|NCT03710486|463923626|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
128898976|NCT03710486|463923625|FG000|Overall Study|Missing|0|||
128898977|NCT03710486|463923626|FG001|Overall Study|Missing|2|||
128898978|NCT01279850|463923627|FG000|Overall Study|Protocol Violation|50|||
128898979|NCT01279850|463923627|FG000|Overall Study|No Drug Administration Information|7|||
128898980|NCT01279850|463923627|FG000|Overall Study|No Visit After Treatment|34|||
128898981|NCT01131520|463923628|FG000|Overall Study|Computer problem|1|||
128898982|NCT01131520|463923629|FG001|Overall Study|Computer problem|0|||
128898983|NCT01131520|463923628|FG000|Overall Study|Counselor not available|0|||
128898984|NCT01131520|463923629|FG001|Overall Study|Counselor not available|3|||
128898985|NCT01131520|463923628|FG000|Overall Study|Subject changed history after enrollment|0|||
128898986|NCT01131520|463923629|FG001|Overall Study|Subject changed history after enrollment|1|||
128898987|NCT02536313|463923630|FG000|Overall Study|Lack of Efficacy|0|||
129023050|NCT02089685|464376929|FG005|Overall Study|Excluded Medication|1|||
129023051|NCT02089685|464376924|FG000|Overall Study|Progressive disease|13|||
128898988|NCT02536313|463923631|FG001|Overall Study|Lack of Efficacy|1|||
128898989|NCT02437864|463923641|FG000|Overall Study|Protocol Violation|4|||
128898990|NCT02437864|463923642|FG001|Overall Study|Protocol Violation|0|||
129023052|NCT02089685|464376925|FG001|Overall Study|Progressive disease|10|||
129023053|NCT02089685|464376926|FG002|Overall Study|Progressive disease|3|||
128898991|NCT01892163|463923643|FG000|Overall Study|Death|1|||
128898992|NCT01892163|463923644|FG001|Overall Study|Death|1|||
128898993|NCT01892163|463923643|FG000|Overall Study|Lost to Follow-up|1|||
128898994|NCT01892163|463923644|FG001|Overall Study|Lost to Follow-up|0|||
128898995|NCT03302975|463923645|FG000|Overall Study|Lost to Follow-up|4|||
128898996|NCT01924182|463923646|FG000|Overall Study|Withdrawal by Subject|1|||
129023054|NCT02089685|464376927|FG003|Overall Study|Progressive disease|51|||
128898997|NCT01924182|463923647|FG001|Overall Study|Withdrawal by Subject|0|||
128898998|NCT00993265|463923649|FG000|Overall Study|Adverse Event|1|||
128898999|NCT00993265|463923650|FG001|Overall Study|Adverse Event|0|||
128899000|NCT00993265|463923649|FG000|Overall Study|Changed dose of concomitant drug|2|||
128899001|NCT00993265|463923650|FG001|Overall Study|Changed dose of concomitant drug|0|||
128899002|NCT00993265|463923649|FG000|Overall Study|Non-compliant with study medication|1|||
128899003|NCT00993265|463923650|FG001|Overall Study|Non-compliant with study medication|0|||
128899004|NCT00807742|463923651|FG000|Overall Study|Death|9|||
128899005|NCT00807742|463923652|FG001|Overall Study|Death|2|||
128899006|NCT00807742|463923651|FG000|Overall Study|Withdrawal by Subject|2|||
128899007|NCT00807742|463923652|FG001|Overall Study|Withdrawal by Subject|1|||
128899008|NCT00807742|463923651|FG000|Overall Study|Lost to Follow-up|35|||
128899009|NCT00807742|463923652|FG001|Overall Study|Lost to Follow-up|51|||
128899010|NCT00492752|463923653|FG000|Double Blind Treatment|Death|13|||
128899011|NCT00492752|463923654|FG001|Double Blind Treatment|Death|0|||
128899012|NCT00492752|463923655|FG002|Double Blind Treatment|Death|2|||
128899013|NCT00492752|463923656|FG003|Double Blind Treatment|Death|0|||
128899014|NCT00492752|463923653|FG000|Double Blind Treatment|Adverse Event|1|||
128899015|NCT00492752|463923654|FG001|Double Blind Treatment|Adverse Event|0|||
128899016|NCT00492752|463923655|FG002|Double Blind Treatment|Adverse Event|0|||
128899017|NCT00492752|463923656|FG003|Double Blind Treatment|Adverse Event|0|||
128899018|NCT00492752|463923653|FG000|Double Blind Treatment|Protocol Violation|0|||
128899019|NCT00492752|463923654|FG001|Double Blind Treatment|Protocol Violation|0|||
128899020|NCT00492752|463923655|FG002|Double Blind Treatment|Protocol Violation|1|||
128899021|NCT00492752|463923656|FG003|Double Blind Treatment|Protocol Violation|0|||
128899022|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
128899023|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
128899024|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
128899025|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
128899026|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
128899027|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
128899028|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
128899029|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
128899030|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
128899031|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
128899032|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
128899033|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
128899034|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
128899035|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
128899036|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
128899037|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
128899038|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
128899039|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
128899040|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
128899041|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
128899042|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
128899043|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
128899044|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
128899045|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
128899046|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
128899047|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
128899048|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
128899049|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
128899050|NCT00492752|463923653|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
128899051|NCT00492752|463923654|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
128899052|NCT00492752|463923655|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
128899053|NCT00492752|463923656|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
128899054|NCT00219284|463923657|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
128899055|NCT00219284|463923658|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
128899056|NCT00219284|463923657|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
128899057|NCT00219284|463923658|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
128899058|NCT00219284|463923657|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
128899059|NCT00219284|463923658|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
128899060|NCT00219284|463923657|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
128899061|NCT00219284|463923658|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
128899062|NCT00219284|463923657|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
128899063|NCT00219284|463923658|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
128899064|NCT00219284|463923657|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
128899065|NCT00219284|463923658|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
128899066|NCT00219284|463923657|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
128899067|NCT00219284|463923658|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
128899068|NCT00219284|463923657|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
128899069|NCT00219284|463923658|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
128899070|NCT00219284|463923657|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
128899071|NCT00219284|463923658|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
128899072|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
128899073|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
128899074|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
128899075|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
129023055|NCT02089685|464376928|FG004|Overall Study|Progressive disease|17|||
129023056|NCT02089685|464376929|FG005|Overall Study|Progressive disease|12|||
129023057|NCT02089685|464376924|FG000|Overall Study|Follow up ended by sponsor|2|||
129023058|NCT02089685|464376925|FG001|Overall Study|Follow up ended by sponsor|2|||
129023059|NCT02089685|464376926|FG002|Overall Study|Follow up ended by sponsor|0|||
129023060|NCT02089685|464376927|FG003|Overall Study|Follow up ended by sponsor|70|||
129023061|NCT02089685|464376928|FG004|Overall Study|Follow up ended by sponsor|26|||
129023062|NCT02089685|464376929|FG005|Overall Study|Follow up ended by sponsor|26|||
129023063|NCT02089685|464376924|FG000|Overall Study|Withdrawal by Subject|0|||
129023064|NCT02089685|464376925|FG001|Overall Study|Withdrawal by Subject|2|||
128899076|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
128899077|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
128899078|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
129023065|NCT02089685|464376926|FG002|Overall Study|Withdrawal by Subject|0|||
129023066|NCT02089685|464376927|FG003|Overall Study|Withdrawal by Subject|8|||
129023067|NCT02089685|464376928|FG004|Overall Study|Withdrawal by Subject|1|||
129023068|NCT02089685|464376929|FG005|Overall Study|Withdrawal by Subject|1|||
128899079|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
128899080|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to death|4|||
128899081|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to death|3|||
128899082|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
128899083|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
128899084|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
128899085|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
128899086|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
128899087|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
128899088|NCT02258451|463923659|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
128899089|NCT02258451|463923660|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
128899090|NCT02258451|463923659|FG000|Overall Study|Other reason|1|||
128899091|NCT02258451|463923660|FG001|Overall Study|Other reason|1|||
128899092|NCT02258451|463923659|FG000|Overall Study|Never treated|2|||
128899093|NCT02258451|463923660|FG001|Overall Study|Never treated|3|||
128899094|NCT04360551|463925264|FG000|Overall Study|Withdrawal by Subject|1|||
128899095|NCT04360551|463925265|FG001|Overall Study|Withdrawal by Subject|0|||
129023069|NCT02089685|464376924|FG000|Overall Study|Status not recorded|1|||
129023070|NCT02089685|464376925|FG001|Overall Study|Status not recorded|0|||
129023071|NCT02089685|464376926|FG002|Overall Study|Status not recorded|0|||
129023072|NCT02089685|464376927|FG003|Overall Study|Status not recorded|0|||
129023073|NCT02089685|464376928|FG004|Overall Study|Status not recorded|1|||
129023074|NCT02089685|464376929|FG005|Overall Study|Status not recorded|0|||
129023075|NCT02089685|464376924|FG000|Overall Study|Death|0|||
129023076|NCT02089685|464376925|FG001|Overall Study|Death|0|||
129023077|NCT02089685|464376926|FG002|Overall Study|Death|0|||
129023078|NCT02089685|464376927|FG003|Overall Study|Death|7|||
129023079|NCT02089685|464376928|FG004|Overall Study|Death|2|||
129112425|NCT00992017|464705721|FG000|Overall Study|Unable to get to clinic|5|||
129112426|NCT00992017|464705721|FG000|Overall Study|Not adhere to study requirements|1|||
129112427|NCT02864407|464705722|FG000|Overall Study|Protocol Violation|3|||
129112428|NCT02864407|464705722|FG000|Overall Study|Lost to Follow-up|115|||
128691973|NCT02130024|463171084|FG001|Overall Study|Adverse Event|11|||
128691974|NCT02130024|463171083|FG000|Overall Study|Death|2|||
128691975|NCT02130024|463171084|FG001|Overall Study|Death|2|||
128691976|NCT02130024|463171083|FG000|Overall Study|Lost to Follow-up|1|||
129023080|NCT02089685|464376929|FG005|Overall Study|Death|5|||
129023081|NCT02089685|464376924|FG000|Overall Study|Lost to Follow-up|0|||
129023082|NCT02089685|464376925|FG001|Overall Study|Lost to Follow-up|0|||
129023083|NCT02089685|464376926|FG002|Overall Study|Lost to Follow-up|0|||
128691977|NCT02130024|463171084|FG001|Overall Study|Lost to Follow-up|1|||
128691978|NCT02130024|463171083|FG000|Overall Study|Physician Decision|1|||
128899096|NCT00388973|463925266|FG000|Overall Study|Adverse Event|16|||
128899097|NCT00388973|463925267|FG001|Overall Study|Adverse Event|6|||
128899098|NCT00388973|463925266|FG000|Overall Study|Lack of Efficacy|1|||
128899099|NCT00388973|463925267|FG001|Overall Study|Lack of Efficacy|12|||
128899100|NCT00388973|463925266|FG000|Overall Study|Protocol Violation|3|||
128899101|NCT00388973|463925267|FG001|Overall Study|Protocol Violation|0|||
128899102|NCT00388973|463925266|FG000|Overall Study|Withdrawal by Subject|14|||
128899103|NCT00388973|463925267|FG001|Overall Study|Withdrawal by Subject|17|||
128899104|NCT00388973|463925266|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
128899105|NCT00388973|463925267|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
128899106|NCT00388973|463925266|FG000|Overall Study|Did not complete 61 days of treatment|5|||
128899107|NCT00388973|463925267|FG001|Overall Study|Did not complete 61 days of treatment|4|||
128899108|NCT00388973|463925266|FG000|Overall Study|Left region|0|||
128899109|NCT00388973|463925267|FG001|Overall Study|Left region|1|||
128899110|NCT00388973|463925266|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
128899111|NCT00388973|463925267|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
128899112|NCT00346073|463925276|FG000|Overall Study|Serious Adverse Event|2|||
128899113|NCT00346073|463925277|FG001|Overall Study|Serious Adverse Event|0|||
128899114|NCT00346073|463925276|FG000|Overall Study|Lost to Follow-up|39|||
128899115|NCT00346073|463925277|FG001|Overall Study|Lost to Follow-up|24|||
128899116|NCT03703882|463925282|FG000|Overall Study|Adverse Event|1|||
128899117|NCT03703882|463925283|FG001|Overall Study|Adverse Event|0|||
128899118|NCT03703882|463925282|FG000|Overall Study|Lost to Follow-up|0|||
128899119|NCT03703882|463925283|FG001|Overall Study|Lost to Follow-up|2|||
128899120|NCT03703882|463925282|FG000|Overall Study|Non-compliance with study drug|0|||
128899121|NCT03703882|463925283|FG001|Overall Study|Non-compliance with study drug|1|||
128899122|NCT03703882|463925282|FG000|Overall Study|Physician Decision|0|||
128899123|NCT03703882|463925283|FG001|Overall Study|Physician Decision|1|||
128899124|NCT03703882|463925282|FG000|Overall Study|Progressive disease|1|||
128899125|NCT03703882|463925283|FG001|Overall Study|Progressive disease|0|||
128899126|NCT03703882|463925282|FG000|Overall Study|Withdrawal by parent/guardian|1|||
128899127|NCT03703882|463925283|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128899128|NCT03703882|463925282|FG000|Overall Study|Starting another treatment|0|||
128899129|NCT03703882|463925283|FG001|Overall Study|Starting another treatment|1|||
128899130|NCT03703882|463925282|FG000|Overall Study|noncompliance with study procedures|0|||
128899131|NCT03703882|463925283|FG001|Overall Study|noncompliance with study procedures|1|||
128899132|NCT01617460|463925284|FG000|Overall Study|Adverse Event|10|||
128899133|NCT01617460|463925284|FG000|Overall Study|Physician Decision|16|||
128899134|NCT01617460|463925284|FG000|Overall Study|Protocol Violation|5|||
128899135|NCT01617460|463925284|FG000|Overall Study|Withdrawal by Subject|9|||
128899136|NCT00075023|463925288|FG000|Pilot Study|Physician Decision|1|||
128899137|NCT00075023|463925289|FG001|Pilot Study|Physician Decision|2|||
128899138|NCT00075023|463925288|FG000|Pilot Study|Withdrawal by Subject|1|||
128899139|NCT00075023|463925289|FG001|Pilot Study|Withdrawal by Subject|0|||
128899140|NCT03670953|463925290|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
128899141|NCT03670953|463925291|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
128899142|NCT03670953|463925292|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
128899143|NCT03670953|463925293|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
128899144|NCT03670953|463925290|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
128899145|NCT03670953|463925291|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
128899146|NCT03670953|463925292|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
128899147|NCT03670953|463925293|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
128899148|NCT03670953|463925290|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
128899149|NCT03670953|463925291|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
128899150|NCT03670953|463925292|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
128899151|NCT03670953|463925293|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
128899152|NCT03670953|463925290|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
128899153|NCT03670953|463925291|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
128899154|NCT03670953|463925292|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
129023084|NCT02089685|464376927|FG003|Overall Study|Lost to Follow-up|1|||
129023085|NCT02089685|464376928|FG004|Overall Study|Lost to Follow-up|0|||
129023086|NCT02089685|464376929|FG005|Overall Study|Lost to Follow-up|0|||
129023087|NCT02089685|464376924|FG000|Overall Study|Physician Decision|0|||
129023088|NCT02089685|464376925|FG001|Overall Study|Physician Decision|0|||
129023089|NCT02089685|464376926|FG002|Overall Study|Physician Decision|0|||
129023090|NCT02089685|464376927|FG003|Overall Study|Physician Decision|0|||
128899155|NCT03670953|463925293|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
128899156|NCT03670953|463925290|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
128899157|NCT03670953|463925291|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
128899158|NCT03670953|463925292|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
128899159|NCT03670953|463925293|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
129023091|NCT02089685|464376928|FG004|Overall Study|Physician Decision|0|||
128899160|NCT03670953|463925290|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
128899161|NCT03670953|463925291|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
129023092|NCT02089685|464376929|FG005|Overall Study|Physician Decision|4|||
128899162|NCT03670953|463925292|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
128899163|NCT03670953|463925293|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
128899164|NCT03670953|463925290|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
128899165|NCT03670953|463925291|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
128899166|NCT03670953|463925292|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
128899167|NCT03670953|463925293|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
128899168|NCT03670953|463925290|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
128899169|NCT03670953|463925291|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
128899170|NCT03670953|463925292|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
128899171|NCT03670953|463925293|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
128899172|NCT03670953|463925290|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
128899173|NCT03670953|463925291|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
128899174|NCT03670953|463925292|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
128899175|NCT03670953|463925293|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
128899176|NCT03670953|463925290|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
128899177|NCT03670953|463925291|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
128899178|NCT03670953|463925292|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
128899179|NCT03670953|463925293|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
128899180|NCT03670953|463925290|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
128899181|NCT03670953|463925291|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
128899182|NCT03670953|463925292|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
128899183|NCT03670953|463925293|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
128899184|NCT03670953|463925290|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
128899185|NCT03670953|463925291|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
128899186|NCT03670953|463925292|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
128899187|NCT03670953|463925293|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
128899188|NCT03670953|463925290|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
128899189|NCT03670953|463925291|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
128899190|NCT03670953|463925292|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
128899191|NCT03670953|463925293|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
128899192|NCT03670953|463925290|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
128899193|NCT03670953|463925291|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
128899194|NCT03670953|463925292|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
128899195|NCT03670953|463925293|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
128899196|NCT03670953|463925290|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
128899197|NCT03670953|463925291|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
128899198|NCT03670953|463925292|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
128899199|NCT03670953|463925293|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
129023093|NCT02089685|464376924|FG000|Overall Study|Screen failure|1|||
129023094|NCT02089685|464376925|FG001|Overall Study|Screen failure|0|||
129023095|NCT02089685|464376926|FG002|Overall Study|Screen failure|0|||
129023096|NCT02089685|464376927|FG003|Overall Study|Screen failure|0|||
129023097|NCT02089685|464376928|FG004|Overall Study|Screen failure|0|||
129023098|NCT02089685|464376929|FG005|Overall Study|Screen failure|0|||
129023099|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Adverse Event|11|||
129023100|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Adverse Event|23|||
129023101|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Adverse Event|29|||
129023102|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Adverse Event|2|||
129023103|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Adverse Event|8|||
129023104|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
129023105|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
129023106|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
129023107|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
129023108|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
129023109|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
129023110|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
129023111|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
129023112|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
129023113|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
129023114|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
129023115|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
129023116|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
129023117|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
129023118|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
129023119|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129023120|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
129023121|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129023122|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129023123|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129023124|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
129023125|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
128899200|NCT03670953|463925290|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
128899201|NCT03670953|463925291|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
128899202|NCT03670953|463925292|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
128899203|NCT03670953|463925293|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
128899204|NCT03670953|463925290|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
128899205|NCT03670953|463925291|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
129112429|NCT02864407|464705722|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
128899206|NCT03670953|463925292|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
128899207|NCT03670953|463925293|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
129112430|NCT02864407|464705722|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
129112431|NCT02864407|464705722|FG000|Overall Study|Consent prior to the contract date|1|||
129112432|NCT04577794|464705730|FG000|Overall Study|Adverse Event|1|||
129112433|NCT04577794|464705731|FG001|Overall Study|Adverse Event|1|||
129112434|NCT02849080|464705732|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
129112435|NCT02849080|464705733|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
129112436|NCT02849080|464705734|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
129112437|NCT02849080|464705735|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
129112438|NCT02849080|464705732|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
129112439|NCT02849080|464705733|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
129112440|NCT02849080|464705734|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
129112441|NCT02849080|464705735|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
129112442|NCT02849080|464705732|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
129112443|NCT02849080|464705733|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
129112444|NCT02849080|464705734|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
129112445|NCT02849080|464705735|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
129112446|NCT02849080|464705732|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
129112447|NCT02849080|464705733|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
129112448|NCT02849080|464705734|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
129112449|NCT02849080|464705735|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
129112450|NCT02849080|464705732|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
129112451|NCT02849080|464705733|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
129112452|NCT02849080|464705734|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
129112453|NCT02849080|464705735|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
129112454|NCT02849080|464705732|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
129112455|NCT02849080|464705733|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
129112456|NCT02849080|464705734|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
129112457|NCT02849080|464705735|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
129112458|NCT01819727|464705736|FG000|Overall Study|Adverse Event|8|||
129112459|NCT01819727|464705737|FG001|Overall Study|Adverse Event|9|||
129112460|NCT01819727|464705736|FG000|Overall Study|Death|1|||
129112461|NCT01819727|464705737|FG001|Overall Study|Death|0|||
129112462|NCT01819727|464705736|FG000|Overall Study|Lost to Follow-up|1|||
129112463|NCT01819727|464705737|FG001|Overall Study|Lost to Follow-up|1|||
129112464|NCT01819727|464705736|FG000|Overall Study|Physician Decision|3|||
129112465|NCT01819727|464705737|FG001|Overall Study|Physician Decision|2|||
129112466|NCT01819727|464705736|FG000|Overall Study|Pregnancy|1|||
129112467|NCT01819727|464705737|FG001|Overall Study|Pregnancy|0|||
129112468|NCT01819727|464705736|FG000|Overall Study|Protocol Violation|0|||
129112469|NCT01819727|464705737|FG001|Overall Study|Protocol Violation|2|||
129112470|NCT01819727|464705736|FG000|Overall Study|Study Terminated by Sponsor|0|||
129112471|NCT01819727|464705737|FG001|Overall Study|Study Terminated by Sponsor|1|||
129112472|NCT01819727|464705736|FG000|Overall Study|Withdrawal by Subject|6|||
129112473|NCT01819727|464705737|FG001|Overall Study|Withdrawal by Subject|11|||
129112474|NCT01819727|464705736|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
129112475|NCT01819727|464705737|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
129112476|NCT01819727|464705736|FG000|Overall Study|Quit due to lack of health benifits|0|||
129112477|NCT01819727|464705737|FG001|Overall Study|Quit due to lack of health benifits|1|||
128899208|NCT03670953|463925290|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
128899209|NCT03670953|463925291|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
128899210|NCT03670953|463925292|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
129112478|NCT03839394|464705741|FG000|Overall Study|Lost to Follow-up|6|||
129112479|NCT03839394|464705742|FG001|Overall Study|Lost to Follow-up|8|||
129112480|NCT03839394|464705741|FG000|Overall Study|Withdrawal by Subject|0|||
129112481|NCT03839394|464705742|FG001|Overall Study|Withdrawal by Subject|2|||
129112482|NCT01367249|464705743|FG000|Overall Study|Withdrawal by Subject|6|||
129112483|NCT01367249|464705744|FG001|Overall Study|Withdrawal by Subject|6|||
129112484|NCT01367249|464705743|FG000|Overall Study|Other|3|||
129112485|NCT01367249|464705744|FG001|Overall Study|Other|10|||
129112486|NCT02358031|464707274|FG000|Overall Study|Death|253|||
129112487|NCT02358031|464707275|FG001|Overall Study|Death|237|||
129112488|NCT02358031|464707276|FG002|Overall Study|Death|266|||
129112489|NCT02358031|464707274|FG000|Overall Study|Lost to Follow-up|1|||
129112490|NCT02358031|464707275|FG001|Overall Study|Lost to Follow-up|1|||
128899211|NCT03670953|463925293|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
128899212|NCT04342871|463925294|FG000|Overall Study|Death|4|||
128899213|NCT04342871|463925294|FG000|Overall Study|Clinical deterioration/illness progression|2|||
128899214|NCT04342871|463925294|FG000|Overall Study|Did not complete baseline assessments|5|||
128899215|NCT04342871|463925294|FG000|Overall Study|Lost to Follow-up|13|||
128899216|NCT00666458|463925296|FG000|Overall Study|Adverse Event|8|||
128899217|NCT00666458|463925297|FG001|Overall Study|Adverse Event|7|||
128899218|NCT00666458|463925296|FG000|Overall Study|Withdrawal by Subject|5|||
128899219|NCT00666458|463925297|FG001|Overall Study|Withdrawal by Subject|4|||
128899220|NCT00666458|463925296|FG000|Overall Study|Lost to Follow-up|0|||
128899221|NCT00666458|463925297|FG001|Overall Study|Lost to Follow-up|3|||
128899222|NCT00666458|463925296|FG000|Overall Study|Administrative reason by sponsor|1|||
129023126|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
129023127|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
129023128|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
129023129|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
129023130|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
129023131|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
129023132|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
128899223|NCT00666458|463925297|FG001|Overall Study|Administrative reason by sponsor|1|||
128899224|NCT00666458|463925296|FG000|Overall Study|Incorrect enrollment|7|||
128899225|NCT00666458|463925297|FG001|Overall Study|Incorrect enrollment|1|||
128899226|NCT00666458|463925296|FG000|Overall Study|Study specific discontinuation criteria|14|||
128899227|NCT00666458|463925297|FG001|Overall Study|Study specific discontinuation criteria|7|||
128899228|NCT00666458|463925296|FG000|Overall Study|Severe non-compliance to the protocol|1|||
128899229|NCT00666458|463925297|FG001|Overall Study|Severe non-compliance to the protocol|1|||
128899230|NCT00666458|463925296|FG000|Overall Study|Safety reasons|1|||
128899231|NCT00666458|463925297|FG001|Overall Study|Safety reasons|0|||
129023133|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
129023134|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Move|0|||
129023135|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Move|1|||
129023136|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Move|0|||
129023137|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Move|0|||
129023138|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Move|0|||
129023139|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129023140|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129023141|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129023142|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129023143|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
129023144|NCT00318461|464376932|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
129023145|NCT00318461|464376933|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
129023146|NCT00318461|464376934|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
129023147|NCT00318461|464376935|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
129023148|NCT00318461|464376936|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
129023149|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Work commitment|0|||
129023150|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Work commitment|0|||
129023151|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Work commitment|0|||
129023152|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Work commitment|0|||
129023153|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Work commitment|1|||
129023154|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Investigator decision|0|||
129023155|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Investigator decision|0|||
129023156|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Investigator decision|0|||
129023157|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Investigator decision|0|||
129023158|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Investigator decision|1|||
129023159|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Lack of time|1|||
129112491|NCT02358031|464707276|FG002|Overall Study|Lost to Follow-up|0|||
129112492|NCT02358031|464707274|FG000|Overall Study|Withdrawal by Subject|19|||
129112493|NCT02358031|464707275|FG001|Overall Study|Withdrawal by Subject|14|||
129112494|NCT02358031|464707276|FG002|Overall Study|Withdrawal by Subject|18|||
129112495|NCT02358031|464707274|FG000|Overall Study|Sponsor Decision|26|||
129112496|NCT02358031|464707275|FG001|Overall Study|Sponsor Decision|28|||
129112497|NCT02358031|464707276|FG002|Overall Study|Sponsor Decision|16|||
128899232|NCT00666458|463925296|FG000|Overall Study|Medical history of anemia|1|||
129023160|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Lack of time|0|||
129023161|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Lack of time|0|||
129023162|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Lack of time|0|||
129023163|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Lack of time|0|||
129023164|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129112498|NCT05664581|464707277|FG000|Overall Study|Withdrawal by Subject|2|||
129112499|NCT03101150|464707278|FG000|Overall Study|Lost to Follow-up|2|||
128899233|NCT00666458|463925297|FG001|Overall Study|Medical history of anemia|0|||
128899234|NCT02222207|463925298|FG000|Overall Study|Death|1|||
128691979|NCT02130024|463171084|FG001|Overall Study|Physician Decision|3|||
128691980|NCT02130024|463171083|FG000|Overall Study|Protocol Deviation|4|||
128691981|NCT02130024|463171084|FG001|Overall Study|Protocol Deviation|0|||
128691982|NCT02130024|463171083|FG000|Overall Study|Site Administration Problems|1|||
128691983|NCT02130024|463171084|FG001|Overall Study|Site Administration Problems|0|||
128899235|NCT02222207|463925298|FG000|Overall Study|Other reasons|2|||
128899236|NCT02222207|463925298|FG000|Overall Study|Adverse Event|1|||
128899237|NCT02982954|463925299|FG000|Overall Study|Death|55|||
128899238|NCT02982954|463925300|FG001|Overall Study|Death|29|||
128899239|NCT02982954|463925301|FG002|Overall Study|Death|15|||
128899240|NCT02982954|463925302|FG003|Overall Study|Death|20|||
128899241|NCT02982954|463925299|FG000|Overall Study|Lost to Follow-up|2|||
128899242|NCT02982954|463925300|FG001|Overall Study|Lost to Follow-up|1|||
128899243|NCT02982954|463925301|FG002|Overall Study|Lost to Follow-up|0|||
128899244|NCT02982954|463925302|FG003|Overall Study|Lost to Follow-up|0|||
128899245|NCT02982954|463925299|FG000|Overall Study|Participant withdrew consent|7|||
128899246|NCT02982954|463925300|FG001|Overall Study|Participant withdrew consent|5|||
128899247|NCT02982954|463925301|FG002|Overall Study|Participant withdrew consent|1|||
128899248|NCT02982954|463925302|FG003|Overall Study|Participant withdrew consent|1|||
128899249|NCT02982954|463925299|FG000|Overall Study|Other reasons|42|||
128899250|NCT02982954|463925300|FG001|Overall Study|Other reasons|17|||
128899251|NCT02982954|463925301|FG002|Overall Study|Other reasons|12|||
128899252|NCT02982954|463925302|FG003|Overall Study|Other reasons|3|||
128899253|NCT02982954|463925299|FG000|Overall Study|Premature site closure|0|||
128899254|NCT02982954|463925300|FG001|Overall Study|Premature site closure|0|||
128899255|NCT02982954|463925301|FG002|Overall Study|Premature site closure|0|||
128899256|NCT02982954|463925302|FG003|Overall Study|Premature site closure|1|||
128899257|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
128899258|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
128899259|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
128899260|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
128899261|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
128899262|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
128899263|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Death|2|||
128899264|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Death|0|||
128899265|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
128899266|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
128899267|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
128899268|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
128899269|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
128899270|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
128899271|NCT02603120|463925303|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
128899272|NCT02603120|463925304|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
128899273|NCT02603120|463925303|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
128899274|NCT02603120|463925304|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
128899275|NCT02603120|463925303|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
128899276|NCT02603120|463925304|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
128899277|NCT02603120|463925303|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
128899278|NCT02603120|463925304|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
128899279|NCT02603120|463925303|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
128899280|NCT02603120|463925304|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
128899281|NCT02603120|463925303|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
128899282|NCT02603120|463925304|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
128899283|NCT02603120|463925303|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
128899284|NCT02603120|463925304|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
128899285|NCT00176605|463925307|FG000|Overall Study|Withdrawal by Subject|2|||
128899286|NCT01321710|463925308|FG000|Overall Study|Lost to Follow-up|4|||
128899287|NCT01321710|463925309|FG001|Overall Study|Lost to Follow-up|5|||
128899288|NCT01321710|463925310|FG002|Overall Study|Lost to Follow-up|0|||
129023165|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129023166|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129023167|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129023168|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
129023169|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
129023170|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
128691984|NCT02130024|463171083|FG000|Overall Study|Subject Withdrew Consent|6|||
128691985|NCT02130024|463171084|FG001|Overall Study|Subject Withdrew Consent|14|||
128899289|NCT01227187|463925311|FG000|Overall Study|Physician Decision|0|||
128899290|NCT01227187|463925312|FG001|Overall Study|Physician Decision|0|||
128899291|NCT01227187|463925313|FG002|Overall Study|Physician Decision|0|||
128899292|NCT01227187|463925314|FG003|Overall Study|Physician Decision|1|||
128899293|NCT03577730|463925316|FG000|Overall Study|Physician Decision|3|||
128899294|NCT03577730|463925317|FG001|Overall Study|Physician Decision|1|||
128899295|NCT03577730|463925316|FG000|Overall Study|Did not receive allocated intervention|1|||
128899296|NCT03577730|463925317|FG001|Overall Study|Did not receive allocated intervention|0|||
128899297|NCT01911442|463925318|FG000|Overall Study|Adverse Event|2|||
128899298|NCT01911442|463925319|FG001|Overall Study|Adverse Event|2|||
128899299|NCT01911442|463925320|FG002|Overall Study|Adverse Event|4|||
128899300|NCT01911442|463925318|FG000|Overall Study|Lack of Efficacy|1|||
128899301|NCT01911442|463925319|FG001|Overall Study|Lack of Efficacy|1|||
128899302|NCT01911442|463925320|FG002|Overall Study|Lack of Efficacy|1|||
128899303|NCT01911442|463925318|FG000|Overall Study|Lost to Follow-up|2|||
128899304|NCT01911442|463925319|FG001|Overall Study|Lost to Follow-up|0|||
128899305|NCT01911442|463925320|FG002|Overall Study|Lost to Follow-up|1|||
128899306|NCT01911442|463925318|FG000|Overall Study|Withdrawal by Subject|1|||
128899307|NCT01911442|463925319|FG001|Overall Study|Withdrawal by Subject|0|||
128899308|NCT01911442|463925320|FG002|Overall Study|Withdrawal by Subject|6|||
128899309|NCT01911442|463925318|FG000|Overall Study|Mother's Work Schedule|0|||
128899310|NCT01911442|463925319|FG001|Overall Study|Mother's Work Schedule|1|||
128899311|NCT01911442|463925320|FG002|Overall Study|Mother's Work Schedule|0|||
128899312|NCT00122681|463925324|FG000|Overall Study|Adverse Event|20|||
128899313|NCT00122681|463925325|FG001|Overall Study|Adverse Event|16|||
128899314|NCT00122681|463925324|FG000|Overall Study|Lost to Follow-up|1080|||
128899315|NCT00122681|463925325|FG001|Overall Study|Lost to Follow-up|1097|||
128899316|NCT00122681|463925324|FG000|Overall Study|Protocol Violation|7|||
129112500|NCT03101150|464707279|FG001|Overall Study|Lost to Follow-up|4|||
129112501|NCT03101150|464707278|FG000|Overall Study|Miscarriage|3|||
129112502|NCT03101150|464707279|FG001|Overall Study|Miscarriage|6|||
129112503|NCT00611806|464707280|FG000|Overall Study|Withdrawal by Subject|8|||
129112504|NCT00611806|464707281|FG001|Overall Study|Withdrawal by Subject|2|||
129112505|NCT00611806|464707280|FG000|Overall Study|Adverse Event|2|||
129112506|NCT00611806|464707281|FG001|Overall Study|Adverse Event|1|||
129112507|NCT00611806|464707280|FG000|Overall Study|Lost to Follow-up|6|||
129112508|NCT00611806|464707281|FG001|Overall Study|Lost to Follow-up|0|||
129112509|NCT00715559|464707282|FG000|Overall Study|medication not tolerated - nausea|1|||
129112510|NCT02787304|464707283|FG000|Overall Study|Adverse Event|9|||
129112511|NCT02787304|464707284|FG001|Overall Study|Adverse Event|3|||
129112512|NCT02787304|464707285|FG002|Overall Study|Adverse Event|8|||
129112513|NCT02787304|464707286|FG003|Overall Study|Adverse Event|1|||
129112514|NCT02787304|464707283|FG000|Overall Study|Withdrawal by Subject|1|||
129112515|NCT02787304|464707284|FG001|Overall Study|Withdrawal by Subject|4|||
129112516|NCT02787304|464707285|FG002|Overall Study|Withdrawal by Subject|0|||
129112517|NCT02787304|464707286|FG003|Overall Study|Withdrawal by Subject|0|||
129112518|NCT02787304|464707283|FG000|Overall Study|Lost to Follow-up|1|||
129112519|NCT02787304|464707284|FG001|Overall Study|Lost to Follow-up|0|||
129112520|NCT02787304|464707285|FG002|Overall Study|Lost to Follow-up|0|||
129112521|NCT02787304|464707286|FG003|Overall Study|Lost to Follow-up|1|||
129112522|NCT02787304|464707283|FG000|Overall Study|Noncompliance with study drug|0|||
129112523|NCT02787304|464707284|FG001|Overall Study|Noncompliance with study drug|0|||
129112524|NCT02787304|464707285|FG002|Overall Study|Noncompliance with study drug|1|||
129112525|NCT02787304|464707286|FG003|Overall Study|Noncompliance with study drug|0|||
129112526|NCT02787304|464707283|FG000|Overall Study|Physician Decision|0|||
129112527|NCT02787304|464707284|FG001|Overall Study|Physician Decision|0|||
129112528|NCT02787304|464707285|FG002|Overall Study|Physician Decision|1|||
129112529|NCT02787304|464707286|FG003|Overall Study|Physician Decision|0|||
129112530|NCT02787304|464707283|FG000|Overall Study|Study terminated by sponsor|25|||
129112531|NCT02787304|464707284|FG001|Overall Study|Study terminated by sponsor|31|||
129112532|NCT02787304|464707285|FG002|Overall Study|Study terminated by sponsor|31|||
129112533|NCT02787304|464707286|FG003|Overall Study|Study terminated by sponsor|32|||
129112534|NCT01051921|464707287|FG000|Overall Study|Physician Decision|9|||
129112535|NCT01051921|464707287|FG000|Overall Study|Adverse Event|8|||
129112536|NCT01051921|464707287|FG000|Overall Study|Withdrawal by Subject|7|||
128764593|NCT04512066|463428369|FG003|Extension Period|Adverse Event|3|||
128899317|NCT00122681|463925325|FG001|Overall Study|Protocol Violation|10|||
128899318|NCT00122681|463925324|FG000|Overall Study|Withdrawal by Subject|257|||
129112537|NCT01051921|464707287|FG000|Overall Study|Lost to Follow-up|4|||
128764594|NCT04512066|463428370|FG004|Extension Period|Adverse Event|1|||
128764595|NCT04512066|463428371|FG005|Extension Period|Adverse Event|3|||
129112538|NCT01051921|464707287|FG000|Overall Study|virological failure|1|||
128899319|NCT00122681|463925325|FG001|Overall Study|Withdrawal by Subject|251|||
128899320|NCT00122681|463925324|FG000|Overall Study|Personal reasons|150|||
128899321|NCT00122681|463925325|FG001|Overall Study|Personal reasons|147|||
128899322|NCT03200366|463925328|FG000|Patient Navigation Intervention Given|Death|0|||
128899323|NCT03200366|463925329|FG001|Patient Navigation Intervention Given|Death|2|||
128899324|NCT03200366|463925330|FG002|Patient Navigation Intervention Given|Death|0|||
129112539|NCT01051921|464707287|FG000|Overall Study|patient moved|1|||
129112540|NCT00379834|464707290|FG000|Overall Study|Time constraints|2|||
129112541|NCT01001429|464707291|FG000|Overall Study|surgery cancelled|0|||
129112542|NCT01001429|464707292|FG001|Overall Study|surgery cancelled|1|||
129112543|NCT01053741|464707297|FG000|2nd Study Intervention|Physician Decision|0|||
129112544|NCT01053741|464707298|FG001|2nd Study Intervention|Physician Decision|1|||
128691986|NCT05274165|463171085|FG000|Overall Study|Withdrawal by Subject|3|||
128691987|NCT05274165|463171086|FG001|Overall Study|Withdrawal by Subject|3|||
128691988|NCT03360747|463171089|FG000|Overall Study|Voluntary Withdrawal|1|||
128691989|NCT03672643|463171090|FG000|Overall Study|Adverse Event|3|||
128691990|NCT03672643|463171090|FG000|Overall Study|Death|2|||
128691991|NCT03672643|463171090|FG000|Overall Study|Withdrawal by Subject|1|||
128691992|NCT03672643|463171090|FG000|Overall Study|Progressive disease|11|||
128691993|NCT03672643|463171090|FG000|Overall Study|Global deterioration of health status|1|||
128691994|NCT03672643|463171090|FG000|Overall Study|Refused further treatment|7|||
128691995|NCT03672643|463171090|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
128691996|NCT00108433|463172761|FG000|Overall Study|Lack of Efficacy|1|||
128691997|NCT00108433|463172762|FG001|Overall Study|Lack of Efficacy|2|||
128691998|NCT00108433|463172761|FG000|Overall Study|Death|3|||
128691999|NCT00108433|463172762|FG001|Overall Study|Death|0|||
128692000|NCT00108433|463172761|FG000|Overall Study|Adverse Event|3|||
128692001|NCT00108433|463172762|FG001|Overall Study|Adverse Event|1|||
128692002|NCT00108433|463172761|FG000|Overall Study|Other|14|||
128692003|NCT00108433|463172762|FG001|Overall Study|Other|14|||
128692004|NCT04806503|463172766|FG000|Overall Study|Lost to Follow-up|0|||
128692005|NCT04806503|463172767|FG001|Overall Study|Lost to Follow-up|0|||
128692006|NCT04806503|463172768|FG002|Overall Study|Lost to Follow-up|1|||
128692007|NCT04806503|463172769|FG003|Overall Study|Lost to Follow-up|0|||
128692008|NCT04806503|463172770|FG004|Overall Study|Lost to Follow-up|0|||
128692009|NCT04806503|463172766|FG000|Overall Study|Withdrawal by Subject|1|||
128692010|NCT04806503|463172767|FG001|Overall Study|Withdrawal by Subject|0|||
128692011|NCT04806503|463172768|FG002|Overall Study|Withdrawal by Subject|1|||
128692012|NCT04806503|463172769|FG003|Overall Study|Withdrawal by Subject|1|||
128692013|NCT04806503|463172770|FG004|Overall Study|Withdrawal by Subject|1|||
128692014|NCT04806503|463172766|FG000|Overall Study|Adverse Event|1|||
128692015|NCT04806503|463172767|FG001|Overall Study|Adverse Event|1|||
128692016|NCT04806503|463172768|FG002|Overall Study|Adverse Event|0|||
128692017|NCT04806503|463172769|FG003|Overall Study|Adverse Event|1|||
128692018|NCT04806503|463172770|FG004|Overall Study|Adverse Event|0|||
128692019|NCT03589469|463172771|FG000|Overall Study|Withdrawal by Subject|8|||
128692020|NCT03589469|463172771|FG000|Overall Study|Physician Decision|20|||
128692021|NCT03589469|463172771|FG000|Overall Study|Death|97|||
128692022|NCT03589469|463172771|FG000|Overall Study|Lost to Follow-up|8|||
128692023|NCT03589469|463172771|FG000|Overall Study|Miscellaneous|1|||
128692024|NCT04195906|463172773|FG000|Part 1|Adverse Event|3|||
128692025|NCT04195906|463172774|FG001|Part 1|Adverse Event|7|||
128692026|NCT04195906|463172773|FG000|Part 1|Withdrawal by Subject|0|||
128692027|NCT04195906|463172774|FG001|Part 1|Withdrawal by Subject|1|||
128692028|NCT04195906|463172773|FG000|Part 2|Adverse Event|1|||
128692029|NCT04195906|463172774|FG001|Part 2|Adverse Event|1|||
128692030|NCT04195906|463172773|FG000|Part 2|Withdrawal by Subject|0|||
128692031|NCT04195906|463172774|FG001|Part 2|Withdrawal by Subject|3|||
128692032|NCT04195906|463172773|FG000|Part 2|Other|1|||
128692033|NCT04195906|463172774|FG001|Part 2|Other|3|||
129023171|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
129023172|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
128692034|NCT02008318|463172775|FG000|Overall Study|Adverse Event|4|||
128692035|NCT02008318|463172776|FG001|Overall Study|Adverse Event|0|||
128692036|NCT02008318|463172775|FG000|Overall Study|Physician Decision|2|||
128692037|NCT02008318|463172776|FG001|Overall Study|Physician Decision|0|||
128692038|NCT02008318|463172775|FG000|Overall Study|Progressive Disease|2|||
128692039|NCT02008318|463172776|FG001|Overall Study|Progressive Disease|0|||
128692040|NCT02008318|463172775|FG000|Overall Study|Protocol Violation|1|||
128692041|NCT02008318|463172776|FG001|Overall Study|Protocol Violation|1|||
128692042|NCT02008318|463172775|FG000|Overall Study|Withdrawal by Subject|3|||
128692043|NCT02008318|463172776|FG001|Overall Study|Withdrawal by Subject|0|||
128692044|NCT00371826|463172783|FG000|Core Phase (12 Months)|Adverse Event|15|||
128692045|NCT00371826|463172784|FG001|Core Phase (12 Months)|Adverse Event|4|||
128692046|NCT00371826|463172785|FG002|Core Phase (12 Months)|Adverse Event|9|||
128692047|NCT00371826|463172783|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
128692048|NCT00371826|463172784|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
128692049|NCT00371826|463172785|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
128692050|NCT00371826|463172783|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
128692051|NCT00371826|463172784|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
128692052|NCT00371826|463172785|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
128692053|NCT00371826|463172783|FG000|Core Phase (12 Months)|Protocol Violation|1|||
128692054|NCT00371826|463172784|FG001|Core Phase (12 Months)|Protocol Violation|0|||
128692055|NCT00371826|463172785|FG002|Core Phase (12 Months)|Protocol Violation|1|||
128692056|NCT00371826|463172783|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
128692057|NCT00371826|463172784|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
128692058|NCT00371826|463172785|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
129023173|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
128692059|NCT00371826|463172783|FG000|Core Phase (12 Months)|Administrative problems|1|||
128899325|NCT03200366|463925328|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
128899326|NCT03200366|463925329|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
128899327|NCT03200366|463925330|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
128899328|NCT03200366|463925328|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
128899329|NCT03200366|463925329|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
129112545|NCT02619617|464707314|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
129112546|NCT02619617|464707315|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
129112547|NCT02619617|464707314|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
129112548|NCT02619617|464707315|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
129112549|NCT02515630|464707316|FG000|Overall Study|Withdrawal by Subject|5|||
129112550|NCT02515630|464707316|FG000|Overall Study|Adverse Event|4|||
129112551|NCT02515630|464707316|FG000|Overall Study|Physician Decision|4|||
129112552|NCT02515630|464707316|FG000|Overall Study|Death|2|||
129112553|NCT02515630|464707316|FG000|Overall Study|Disease Progression|1|||
129112554|NCT00230048|464707325|FG000|Overall Study|Lost to Follow-up|13|||
129112555|NCT00230048|464707326|FG001|Overall Study|Lost to Follow-up|18|||
129112556|NCT01566604|464707327|FG000|Overall Study|Patient's inability to use the device|1|||
129112557|NCT01566604|464707328|FG001|Overall Study|Patient's inability to use the device|0|||
129112558|NCT01566604|464707327|FG000|Overall Study|Administrative problems|1|||
129112559|NCT01566604|464707328|FG001|Overall Study|Administrative problems|0|||
129112560|NCT01566604|464707327|FG000|Overall Study|Lack of Efficacy|1|||
129112561|NCT01566604|464707328|FG001|Overall Study|Lack of Efficacy|2|||
129112562|NCT01566604|464707327|FG000|Overall Study|Protocol deviation|2|||
129112563|NCT01566604|464707328|FG001|Overall Study|Protocol deviation|0|||
129112564|NCT01566604|464707327|FG000|Overall Study|Abnormal laboratory value|2|||
129112565|NCT01566604|464707328|FG001|Overall Study|Abnormal laboratory value|0|||
129112566|NCT01566604|464707327|FG000|Overall Study|Death|4|||
129112567|NCT01566604|464707328|FG001|Overall Study|Death|1|||
129112568|NCT01566604|464707327|FG000|Overall Study|Adverse Event|4|||
129112569|NCT01566604|464707328|FG001|Overall Study|Adverse Event|2|||
129112570|NCT01566604|464707327|FG000|Overall Study|Withdrawal by Subject|9|||
129112571|NCT01566604|464707328|FG001|Overall Study|Withdrawal by Subject|6|||
129112572|NCT03225170|464707329|FG000|Overall Study|Lost to Follow-up|4|||
129112573|NCT03225170|464707330|FG001|Overall Study|Lost to Follow-up|4|||
129112574|NCT03225170|464707331|FG002|Overall Study|Lost to Follow-up|0|||
129112575|NCT03225170|464707329|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
129112576|NCT03225170|464707330|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
129112577|NCT03225170|464707331|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
129112578|NCT00661089|464707338|FG000|Overall Study|1 subject withdrawal|0|||
129112579|NCT00661089|464707339|FG001|Overall Study|1 subject withdrawal|1|||
129112580|NCT00661089|464707338|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
129112581|NCT00661089|464707339|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
129112582|NCT00274742|464707340|FG000|Overall Study|Adverse Event|0|||
129112583|NCT00274742|464707341|FG001|Overall Study|Adverse Event|4|||
129112584|NCT00274742|464707342|FG002|Overall Study|Adverse Event|1|||
129112585|NCT00274742|464707343|FG003|Overall Study|Adverse Event|4|||
129112586|NCT00274742|464707344|FG004|Overall Study|Adverse Event|12|||
129112587|NCT00274742|464707345|FG005|Overall Study|Adverse Event|3|||
129112588|NCT00274742|464707340|FG000|Overall Study|Lost to Follow-up|0|||
129112589|NCT00274742|464707341|FG001|Overall Study|Lost to Follow-up|0|||
129112590|NCT00274742|464707342|FG002|Overall Study|Lost to Follow-up|0|||
129112591|NCT00274742|464707343|FG003|Overall Study|Lost to Follow-up|0|||
129112592|NCT00274742|464707344|FG004|Overall Study|Lost to Follow-up|1|||
129112593|NCT00274742|464707345|FG005|Overall Study|Lost to Follow-up|0|||
129112594|NCT00274742|464707340|FG000|Overall Study|End of Study|0|||
129112595|NCT00274742|464707341|FG001|Overall Study|End of Study|0|||
129112596|NCT00274742|464707342|FG002|Overall Study|End of Study|0|||
129112597|NCT00274742|464707343|FG003|Overall Study|End of Study|1|||
129112598|NCT00274742|464707344|FG004|Overall Study|End of Study|0|||
129112599|NCT00274742|464707345|FG005|Overall Study|End of Study|0|||
129112600|NCT00274742|464707340|FG000|Overall Study|Disease Progression|0|||
129112601|NCT00274742|464707341|FG001|Overall Study|Disease Progression|1|||
128692060|NCT00371826|463172784|FG001|Core Phase (12 Months)|Administrative problems|0|||
128692061|NCT00371826|463172785|FG002|Core Phase (12 Months)|Administrative problems|8|||
128692062|NCT00371826|463172783|FG000|Core Phase (12 Months)|Graft Loss|0|||
128692063|NCT00371826|463172784|FG001|Core Phase (12 Months)|Graft Loss|1|||
129112602|NCT00274742|464707342|FG002|Overall Study|Disease Progression|1|||
129112603|NCT00274742|464707343|FG003|Overall Study|Disease Progression|0|||
129112604|NCT00274742|464707344|FG004|Overall Study|Disease Progression|1|||
129112605|NCT00274742|464707345|FG005|Overall Study|Disease Progression|0|||
129112606|NCT00274742|464707340|FG000|Overall Study|Other|0|||
128692064|NCT00371826|463172785|FG002|Core Phase (12 Months)|Graft Loss|0|||
128692065|NCT00371826|463172783|FG000|Extension Phase (24 Months)|Adverse Event|4|||
129112607|NCT00274742|464707341|FG001|Overall Study|Other|3|||
129112608|NCT00274742|464707342|FG002|Overall Study|Other|0|||
129215240|NCT01588522|465089467|FG003|Overall Study|Did not initiate chemotherapy|0|||
128692066|NCT00371826|463172784|FG001|Extension Phase (24 Months)|Adverse Event|5|||
128692067|NCT00371826|463172785|FG002|Extension Phase (24 Months)|Adverse Event|0|||
128692068|NCT00371826|463172783|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
128692069|NCT00371826|463172784|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
128692070|NCT00371826|463172785|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
128692071|NCT00371826|463172783|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
128692072|NCT00371826|463172784|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
128692073|NCT00371826|463172785|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
128692074|NCT00371826|463172783|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
128692075|NCT00371826|463172784|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
128692076|NCT00371826|463172785|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
128692077|NCT00371826|463172783|FG000|Extension Phase (24 Months)|Administrative problems|0|||
128692078|NCT00371826|463172784|FG001|Extension Phase (24 Months)|Administrative problems|0|||
128692079|NCT00371826|463172785|FG002|Extension Phase (24 Months)|Administrative problems|2|||
128692080|NCT00231842|463172786|FG000|Overall Study|Withdrawal by Subject|3|||
128692081|NCT00231842|463172786|FG000|Overall Study|Did not complete the last 3 cycle|8|||
128692082|NCT00573183|463172787|FG000|Overall Study|Lost to Follow-up|52|||
128692083|NCT00573183|463172788|FG001|Overall Study|Lost to Follow-up|50|||
128692084|NCT00573183|463172787|FG000|Overall Study|Withdrawal by Subject|8|||
128692085|NCT00573183|463172788|FG001|Overall Study|Withdrawal by Subject|2|||
128692086|NCT00573183|463172787|FG000|Overall Study|Death|0|||
128692087|NCT00573183|463172788|FG001|Overall Study|Death|1|||
128692088|NCT00573183|463172787|FG000|Overall Study|Adverse Event|2|||
128692089|NCT00573183|463172788|FG001|Overall Study|Adverse Event|0|||
128692090|NCT00573183|463172787|FG000|Overall Study|Incarceration|5|||
128692091|NCT00573183|463172788|FG001|Overall Study|Incarceration|8|||
128692092|NCT00573183|463172787|FG000|Overall Study|Other|5|||
128692093|NCT00573183|463172788|FG001|Overall Study|Other|2|||
128692094|NCT02422303|463172791|FG000|Overall Study|Lost to Follow-up|1|||
128692095|NCT02422303|463172792|FG001|Overall Study|Lost to Follow-up|1|||
128692096|NCT00428792|463172793|FG000|Overall Study|Lack of Efficacy|1|||
128692097|NCT00428792|463172794|FG001|Overall Study|Lack of Efficacy|3|||
128692098|NCT00428792|463172793|FG000|Overall Study|Lost to Follow-up|0|||
128692099|NCT00428792|463172794|FG001|Overall Study|Lost to Follow-up|1|||
128692100|NCT00639678|463172795|FG000|Overall Study|Withdrawal by Subject|3|||
128692101|NCT00639678|463172796|FG001|Overall Study|Withdrawal by Subject|0|||
128692102|NCT00639678|463172797|FG002|Overall Study|Withdrawal by Subject|4|||
128692103|NCT00639678|463172798|FG003|Overall Study|Withdrawal by Subject|0|||
128692104|NCT00639678|463172795|FG000|Overall Study|Lost to Follow-up|1|||
128692105|NCT00639678|463172796|FG001|Overall Study|Lost to Follow-up|0|||
128692106|NCT00639678|463172797|FG002|Overall Study|Lost to Follow-up|6|||
128692107|NCT00639678|463172798|FG003|Overall Study|Lost to Follow-up|0|||
128692108|NCT00639678|463172795|FG000|Overall Study|Adverse Event|0|||
128692109|NCT00639678|463172796|FG001|Overall Study|Adverse Event|1|||
128692110|NCT00639678|463172797|FG002|Overall Study|Adverse Event|0|||
128692111|NCT00639678|463172798|FG003|Overall Study|Adverse Event|0|||
128692112|NCT00639678|463172795|FG000|Overall Study|Lack of Compliance|0|||
128692113|NCT00639678|463172796|FG001|Overall Study|Lack of Compliance|0|||
128692114|NCT00639678|463172797|FG002|Overall Study|Lack of Compliance|1|||
128692115|NCT00639678|463172798|FG003|Overall Study|Lack of Compliance|0|||
128692116|NCT01926015|463172799|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128692117|NCT01926015|463172800|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128692118|NCT01926015|463172799|FG000|Overall Study|Randomized not treated|2|||
128692119|NCT01926015|463172800|FG001|Overall Study|Randomized not treated|0|||
128692120|NCT01364649|463172801|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
128692121|NCT01364649|463172802|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
128692122|NCT01364649|463172801|FG000|Overall Study|Lack of Efficacy|6|||
128692123|NCT01364649|463172802|FG001|Overall Study|Lack of Efficacy|0|||
128692124|NCT01364649|463172801|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
128692125|NCT01364649|463172802|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
128692126|NCT01364649|463172801|FG000|Overall Study|Protocol Deviations|4|||
128692127|NCT01364649|463172802|FG001|Overall Study|Protocol Deviations|8|||
128764596|NCT04512066|463428366|FG000|Extension Period|Death|0|||
128764597|NCT04512066|463428367|FG001|Extension Period|Death|0|||
128692128|NCT01364649|463172801|FG000|Overall Study|Withdrawal of Consent|9|||
128692129|NCT01364649|463172802|FG001|Overall Study|Withdrawal of Consent|7|||
128692130|NCT01364649|463172801|FG000|Overall Study|Lost to Follow-up|12|||
128692131|NCT01364649|463172802|FG001|Overall Study|Lost to Follow-up|13|||
128692132|NCT01364649|463172801|FG000|Overall Study|Other|4|||
128692133|NCT01364649|463172802|FG001|Overall Study|Other|1|||
128692134|NCT03270644|463172814|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
128692135|NCT03270644|463172814|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
128692136|NCT00902668|463172818|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
128692137|NCT00615108|463172819|FG000|Overall Study|Adverse Event|122|||
128692138|NCT00615108|463172819|FG000|Overall Study|Other|370|||
128692139|NCT00615108|463172819|FG000|Overall Study|Lost to Follow-up|15|||
128692140|NCT01914757|463172820|FG000|Overall Study|Severe non-compliance to protocol|3|||
128692141|NCT01914757|463172821|FG001|Overall Study|Severe non-compliance to protocol|1|||
128692142|NCT01914757|463172822|FG002|Overall Study|Severe non-compliance to protocol|2|||
128692143|NCT01914757|463172820|FG000|Overall Study|Lost to Follow-up|5|||
128692144|NCT01914757|463172821|FG001|Overall Study|Lost to Follow-up|8|||
128692145|NCT01914757|463172822|FG002|Overall Study|Lost to Follow-up|6|||
128692146|NCT01914757|463172820|FG000|Overall Study|Withdrawal by Subject|15|||
128692147|NCT01914757|463172821|FG001|Overall Study|Withdrawal by Subject|27|||
128692148|NCT01914757|463172822|FG002|Overall Study|Withdrawal by Subject|19|||
128692149|NCT01914757|463172820|FG000|Overall Study|Death|2|||
128692150|NCT01914757|463172821|FG001|Overall Study|Death|2|||
128692151|NCT01914757|463172822|FG002|Overall Study|Death|1|||
128692152|NCT01914757|463172820|FG000|Overall Study|Adverse Event|4|||
128692153|NCT01914757|463172821|FG001|Overall Study|Adverse Event|3|||
128692154|NCT01914757|463172822|FG002|Overall Study|Adverse Event|4|||
128692155|NCT01914757|463172820|FG000|Overall Study|Study specific withdrawal criteria|0|||
128692156|NCT01914757|463172821|FG001|Overall Study|Study specific withdrawal criteria|1|||
128692157|NCT01914757|463172822|FG002|Overall Study|Study specific withdrawal criteria|0|||
128692158|NCT01914757|463172820|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
128692159|NCT01914757|463172821|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128692160|NCT01914757|463172822|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
128692161|NCT01914757|463172820|FG000|Overall Study|Other reasons|5|||
128692162|NCT01914757|463172821|FG001|Overall Study|Other reasons|9|||
128692163|NCT01914757|463172822|FG002|Overall Study|Other reasons|4|||
128692164|NCT01426438|463172829|FG000|Overall Study|Lost to Follow-up|1|||
128692165|NCT01426438|463172830|FG001|Overall Study|Lost to Follow-up|3|||
128692166|NCT01426438|463172829|FG000|Overall Study|Off study Treatment|9|||
128692167|NCT01426438|463172830|FG001|Overall Study|Off study Treatment|3|||
128692168|NCT01426438|463172829|FG000|Overall Study|Poor scan quality|3|||
128692169|NCT01426438|463172830|FG001|Overall Study|Poor scan quality|2|||
128692170|NCT01426438|463172829|FG000|Overall Study|Missed Scan|2|||
128692171|NCT01426438|463172830|FG001|Overall Study|Missed Scan|2|||
128692172|NCT02833350|463172831|FG000|Overall Study|Adverse Event|0|||
128692173|NCT02833350|463172832|FG001|Overall Study|Adverse Event|3|||
128692174|NCT02833350|463172833|FG002|Overall Study|Adverse Event|4|||
128692175|NCT02833350|463172834|FG003|Overall Study|Adverse Event|4|||
128692176|NCT02833350|463172835|FG004|Overall Study|Adverse Event|1|||
128692177|NCT02833350|463172836|FG005|Overall Study|Adverse Event|0|||
128692178|NCT02833350|463172837|FG006|Overall Study|Adverse Event|1|||
128692179|NCT02833350|463172831|FG000|Overall Study|Death|0|||
128692180|NCT02833350|463172832|FG001|Overall Study|Death|0|||
128692181|NCT02833350|463172833|FG002|Overall Study|Death|1|||
128692182|NCT02833350|463172834|FG003|Overall Study|Death|0|||
128692183|NCT02833350|463172835|FG004|Overall Study|Death|0|||
128692184|NCT02833350|463172836|FG005|Overall Study|Death|0|||
128692185|NCT02833350|463172837|FG006|Overall Study|Death|0|||
128692186|NCT02833350|463172831|FG000|Overall Study|Lack of Efficacy|0|||
128692187|NCT02833350|463172832|FG001|Overall Study|Lack of Efficacy|2|||
128692188|NCT02833350|463172833|FG002|Overall Study|Lack of Efficacy|1|||
128692189|NCT02833350|463172834|FG003|Overall Study|Lack of Efficacy|4|||
128692190|NCT02833350|463172835|FG004|Overall Study|Lack of Efficacy|0|||
128692191|NCT02833350|463172836|FG005|Overall Study|Lack of Efficacy|1|||
128692192|NCT02833350|463172837|FG006|Overall Study|Lack of Efficacy|1|||
128692193|NCT02833350|463172831|FG000|Overall Study|Lost to Follow-up|0|||
128692194|NCT02833350|463172832|FG001|Overall Study|Lost to Follow-up|1|||
128692195|NCT02833350|463172833|FG002|Overall Study|Lost to Follow-up|0|||
128692196|NCT02833350|463172834|FG003|Overall Study|Lost to Follow-up|0|||
128692197|NCT02833350|463172835|FG004|Overall Study|Lost to Follow-up|0|||
128764598|NCT04512066|463428368|FG002|Extension Period|Death|0|||
128899330|NCT03200366|463925330|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
128899331|NCT03200366|463925328|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
128899332|NCT03200366|463925329|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
128899333|NCT03200366|463925330|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
128899334|NCT03200366|463925328|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
129112609|NCT00274742|464707343|FG003|Overall Study|Other|0|||
128764599|NCT04512066|463428369|FG003|Extension Period|Death|0|||
128764600|NCT04512066|463428370|FG004|Extension Period|Death|0|||
128692198|NCT02833350|463172836|FG005|Overall Study|Lost to Follow-up|0|||
128692199|NCT02833350|463172837|FG006|Overall Study|Lost to Follow-up|1|||
128692200|NCT02833350|463172831|FG000|Overall Study|Withdrawal by Subject|3|||
128692201|NCT02833350|463172832|FG001|Overall Study|Withdrawal by Subject|3|||
128692202|NCT02833350|463172833|FG002|Overall Study|Withdrawal by Subject|2|||
128692203|NCT02833350|463172834|FG003|Overall Study|Withdrawal by Subject|0|||
128692204|NCT02833350|463172835|FG004|Overall Study|Withdrawal by Subject|2|||
128692205|NCT02833350|463172836|FG005|Overall Study|Withdrawal by Subject|0|||
128692206|NCT02833350|463172837|FG006|Overall Study|Withdrawal by Subject|2|||
128692207|NCT01031706|463172840|FG000|Overall Study|Adverse Event|1|||
128692208|NCT01031706|463172841|FG001|Overall Study|Adverse Event|0|||
129023174|NCT00318461|464376932|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129023175|NCT00318461|464376933|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129023176|NCT00318461|464376934|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129023177|NCT00318461|464376935|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129023178|NCT00318461|464376936|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
129112610|NCT00274742|464707344|FG004|Overall Study|Other|2|||
129112611|NCT00274742|464707345|FG005|Overall Study|Other|0|||
129112612|NCT01529606|464707349|FG000|Overall Study|Lost to Follow-up|21|||
129112613|NCT01529606|464707350|FG001|Overall Study|Lost to Follow-up|18|||
129112614|NCT01900444|464707354|FG000|Overall Study|Protocol Violation|2|||
129112615|NCT01900444|464707354|FG000|Overall Study|Lost to Follow-up|1|||
129112616|NCT00072384|464707357|FG000|Overall Study|Physician Decision|1|||
129112617|NCT00072384|464707357|FG000|Overall Study|Ineligible|8|||
129112618|NCT01825200|464707358|FG000|Overall Study|Lost to Follow-up|5|||
129112619|NCT01825200|464707359|FG001|Overall Study|Lost to Follow-up|6|||
129112620|NCT01825200|464707358|FG000|Overall Study|Withdrawal by Subject|0|||
129112621|NCT01825200|464707359|FG001|Overall Study|Withdrawal by Subject|1|||
129112622|NCT00490035|464707360|FG000|Overall Study|AE, non-serious non-fatal|3|||
129112623|NCT00490035|464707361|FG001|Overall Study|AE, non-serious non-fatal|4|||
129112624|NCT00490035|464707362|FG002|Overall Study|AE, non-serious non-fatal|4|||
129112625|NCT00490035|464707363|FG003|Overall Study|AE, non-serious non-fatal|5|||
129112626|NCT00490035|464707360|FG000|Overall Study|Lost to Follow-up|2|||
129112627|NCT00490035|464707361|FG001|Overall Study|Lost to Follow-up|0|||
129112628|NCT00490035|464707362|FG002|Overall Study|Lost to Follow-up|1|||
129112629|NCT00490035|464707363|FG003|Overall Study|Lost to Follow-up|0|||
129112630|NCT00490035|464707360|FG000|Overall Study|Withdrawal by Subject|2|||
129112631|NCT00490035|464707361|FG001|Overall Study|Withdrawal by Subject|1|||
129112632|NCT00490035|464707362|FG002|Overall Study|Withdrawal by Subject|1|||
129112633|NCT00490035|464707363|FG003|Overall Study|Withdrawal by Subject|0|||
128692209|NCT01031706|463172840|FG000|Overall Study|Withdrawal by Subject|1|||
128899335|NCT03200366|463925329|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
128899336|NCT03200366|463925330|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
128899337|NCT03200366|463925328|FG000|6 Month Post-Baseline Interview|Death|1|||
128899338|NCT03200366|463925329|FG001|6 Month Post-Baseline Interview|Death|1|||
128899339|NCT03200366|463925330|FG002|6 Month Post-Baseline Interview|Death|1|||
128899340|NCT03200366|463925328|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
128899341|NCT03200366|463925329|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
128899342|NCT03200366|463925330|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
128899343|NCT03200366|463925328|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
128899344|NCT03200366|463925329|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
128899345|NCT03200366|463925330|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
128899346|NCT03200366|463925328|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
128899347|NCT03200366|463925329|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
128899348|NCT03200366|463925330|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
128899349|NCT03200366|463925328|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
129023179|NCT00318461|464376932|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129023180|NCT00318461|464376933|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
129023181|NCT00318461|464376934|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129023182|NCT00318461|464376935|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129023183|NCT00318461|464376936|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129023184|NCT00318461|464376932|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
129023185|NCT00318461|464376933|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
129023186|NCT00318461|464376934|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
129023187|NCT00318461|464376935|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
129023188|NCT00318461|464376936|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
129023189|NCT00318461|464376932|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
129023190|NCT00318461|464376933|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
129023191|NCT00318461|464376934|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
129023192|NCT00318461|464376935|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
129023193|NCT00318461|464376936|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
129023194|NCT00318461|464376932|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
129023195|NCT00318461|464376933|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
129023196|NCT00318461|464376934|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
129112634|NCT00490035|464707360|FG000|Overall Study|Other reason|0|||
129112635|NCT00490035|464707361|FG001|Overall Study|Other reason|1|||
129112636|NCT00490035|464707362|FG002|Overall Study|Other reason|3|||
129112637|NCT00490035|464707363|FG003|Overall Study|Other reason|1|||
129112638|NCT00490035|464707360|FG000|Overall Study|AE, serious fatal|1|||
129112639|NCT00490035|464707361|FG001|Overall Study|AE, serious fatal|0|||
129112640|NCT00490035|464707362|FG002|Overall Study|AE, serious fatal|0|||
129112641|NCT00490035|464707363|FG003|Overall Study|AE, serious fatal|0|||
129112642|NCT00490035|464707360|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
129112643|NCT00490035|464707361|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
129112644|NCT00490035|464707362|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
129112645|NCT00490035|464707363|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
129112646|NCT00490035|464707360|FG000|Overall Study|AE of unknown type|0|||
129112647|NCT00490035|464707361|FG001|Overall Study|AE of unknown type|0|||
129112648|NCT00490035|464707362|FG002|Overall Study|AE of unknown type|2|||
129112649|NCT00490035|464707363|FG003|Overall Study|AE of unknown type|0|||
129112650|NCT00731822|464707364|FG000|Overall Study|Adverse Event|2|||
129112651|NCT00731822|464707365|FG001|Overall Study|Adverse Event|1|||
129112652|NCT00731822|464707364|FG000|Overall Study|Protocol Violation|1|||
129112653|NCT00731822|464707365|FG001|Overall Study|Protocol Violation|0|||
129112654|NCT00731822|464707364|FG000|Overall Study|Lost to Follow-up|1|||
129112655|NCT00731822|464707365|FG001|Overall Study|Lost to Follow-up|0|||
129112656|NCT05209880|464707375|FG000|1-Month Follow-up|Spoke with Doctor|5|||
129112657|NCT05209880|464707376|FG001|1-Month Follow-up|Spoke with Doctor|5|||
129112658|NCT05209880|464707375|FG000|1-Month Follow-up|Lost to Follow-up|7|||
129112659|NCT05209880|464707376|FG001|1-Month Follow-up|Lost to Follow-up|9|||
129112660|NCT05209880|464707375|FG000|1-Month Follow-up|Discontinued|0|||
129112661|NCT05209880|464707376|FG001|1-Month Follow-up|Discontinued|1|||
129112662|NCT05209880|464707375|FG000|3-Month Follow-up|Spoke with Doctor|17|||
129112663|NCT05209880|464707376|FG001|3-Month Follow-up|Spoke with Doctor|7|||
129112664|NCT05209880|464707375|FG000|3-Month Follow-up|Lost to Follow-up|8|||
129112665|NCT05209880|464707376|FG001|3-Month Follow-up|Lost to Follow-up|10|||
129112666|NCT05209880|464707375|FG000|3-Month Follow-up|Discontinued|1|||
129112667|NCT05209880|464707376|FG001|3-Month Follow-up|Discontinued|3|||
129112668|NCT05209880|464707375|FG000|6-Month Follow-up|Spoke with Doctor|25|||
129112669|NCT05209880|464707376|FG001|6-Month Follow-up|Spoke with Doctor|14|||
129112670|NCT05209880|464707375|FG000|6-Month Follow-up|Lost to Follow-up|9|||
129112671|NCT05209880|464707376|FG001|6-Month Follow-up|Lost to Follow-up|14|||
129112672|NCT05209880|464707375|FG000|6-Month Follow-up|Discontinued|1|||
129112673|NCT05209880|464707376|FG001|6-Month Follow-up|Discontinued|3|||
129112674|NCT04817332|464707377|FG000|Overall Study|Lost to Follow-up|3|||
129112675|NCT04817332|464707378|FG001|Overall Study|Lost to Follow-up|3|||
129112676|NCT04817332|464707377|FG000|Overall Study|Protocol Violation|2|||
129112677|NCT04817332|464707378|FG001|Overall Study|Protocol Violation|0|||
129112678|NCT04795466|464707384|FG000|Overall Study|Adverse Event|3|||
129112679|NCT04795466|464707385|FG001|Overall Study|Adverse Event|1|||
129112680|NCT04795466|464707384|FG000|Overall Study|Physician Decision|1|||
129112681|NCT04795466|464707385|FG001|Overall Study|Physician Decision|0|||
129112682|NCT04795466|464707384|FG000|Overall Study|Withdrawal by Subject|2|||
129112683|NCT04795466|464707385|FG001|Overall Study|Withdrawal by Subject|1|||
129112684|NCT05635045|464707386|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
129112685|NCT05635045|464707387|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
129112686|NCT05635045|464707388|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
129112687|NCT05635045|464707389|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
129112688|NCT02421419|464707395|FG000|Overall Study|Physician Decision|0|||
129112689|NCT02421419|464707396|FG001|Overall Study|Physician Decision|0|||
129112690|NCT02421419|464707397|FG002|Overall Study|Physician Decision|1|||
129112691|NCT05502302|464707401|FG000|Overall Study|Lost to Follow-up|6|||
129112692|NCT05502302|464707401|FG000|Overall Study|Death|2|||
129112693|NCT01628848|464707405|FG000|Overall Study|Adverse Event|9|||
129112694|NCT01628848|464707406|FG001|Overall Study|Adverse Event|7|||
129112695|NCT01628848|464707405|FG000|Overall Study|Lack of Efficacy|0|||
129112696|NCT01628848|464707406|FG001|Overall Study|Lack of Efficacy|4|||
129112697|NCT01628848|464707405|FG000|Overall Study|Withdrawal by Subject|0|||
129112698|NCT01628848|464707406|FG001|Overall Study|Withdrawal by Subject|2|||
129112699|NCT01628848|464707405|FG000|Overall Study|Physician Decision|3|||
129112700|NCT01628848|464707406|FG001|Overall Study|Physician Decision|1|||
129112701|NCT00003471|464707407|FG000|Overall Study|Not evaluable|4|||
128764601|NCT04512066|463428371|FG005|Extension Period|Death|1|||
128899350|NCT03200366|463925329|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
128899351|NCT03200366|463925330|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
129112702|NCT02104895|464707408|FG000|Overall Study|Withdrawal by Subject|0|||
128899352|NCT03200366|463925328|FG000|9 Month Post-Baseline Interview|Death|1|||
129112703|NCT02104895|464707409|FG001|Overall Study|Withdrawal by Subject|14|||
129112704|NCT03311945|464707411|FG000|Overall Study|Adverse Event|2|||
129112705|NCT03311945|464707411|FG000|Overall Study|Lack of Efficacy|1|||
129112706|NCT01619878|464707412|FG000|6 Week Follow-up Phase|Adverse Event|1|||
129112707|NCT01619878|464707412|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
129112708|NCT01619878|464707412|FG000|Follow-up at 12 Months of Age|Death|2|||
129112709|NCT02895295|464707415|FG000|Overall Study|Survey Non-response|71|||
129112710|NCT02895295|464707416|FG001|Overall Study|Survey Non-response|94|||
129112711|NCT02895295|464707417|FG002|Overall Study|Survey Non-response|92|||
128692210|NCT01031706|463172841|FG001|Overall Study|Withdrawal by Subject|1|||
128692211|NCT01500031|463172842|FG000|Overall Study|Death|1|||
128692212|NCT01500031|463172842|FG000|Overall Study|Withdrawal by Subject|4|||
128692213|NCT01904058|463172847|FG000|Overall Study|Adverse Event|2|||
128692214|NCT01904058|463172848|FG001|Overall Study|Adverse Event|0|||
128692215|NCT01904058|463172849|FG002|Overall Study|Adverse Event|0|||
128692216|NCT01904058|463172850|FG003|Overall Study|Adverse Event|0|||
128692217|NCT01904058|463172847|FG000|Overall Study|Withdrawal by Subject|1|||
128692218|NCT01904058|463172848|FG001|Overall Study|Withdrawal by Subject|0|||
128692219|NCT01904058|463172849|FG002|Overall Study|Withdrawal by Subject|1|||
128692220|NCT01904058|463172850|FG003|Overall Study|Withdrawal by Subject|0|||
128692221|NCT01904058|463172847|FG000|Overall Study|Pregnancy|0|||
128692222|NCT01904058|463172848|FG001|Overall Study|Pregnancy|0|||
128692223|NCT01904058|463172849|FG002|Overall Study|Pregnancy|0|||
128692224|NCT01904058|463172850|FG003|Overall Study|Pregnancy|1|||
128692225|NCT03096483|463172851|FG000|Overall Study|Withdrawal by site|1|||
128692226|NCT00199875|463172857|FG000|Overall Study|Withdrawal by Subject|0|||
128692227|NCT00199875|463172858|FG001|Overall Study|Withdrawal by Subject|0|||
128692228|NCT00199875|463172859|FG002|Overall Study|Withdrawal by Subject|0|||
128899353|NCT03200366|463925329|FG001|9 Month Post-Baseline Interview|Death|1|||
128899354|NCT03200366|463925330|FG002|9 Month Post-Baseline Interview|Death|1|||
128899355|NCT03200366|463925328|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
128899356|NCT03200366|463925329|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
128899357|NCT03200366|463925330|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
128692229|NCT00199875|463172860|FG003|Overall Study|Withdrawal by Subject|0|||
128692230|NCT00199875|463172861|FG004|Overall Study|Withdrawal by Subject|1|||
128692231|NCT01024231|463172862|FG000|Overall Study|Other Reasons|1|||
128692232|NCT01024231|463172863|FG001|Overall Study|Other Reasons|2|||
128692233|NCT01024231|463172864|FG002|Overall Study|Other Reasons|0|||
128692234|NCT01024231|463172865|FG003|Overall Study|Other Reasons|0|||
128692235|NCT01024231|463172866|FG004|Overall Study|Other Reasons|2|||
128692236|NCT01024231|463172867|FG005|Overall Study|Other Reasons|0|||
128692237|NCT01024231|463172868|FG006|Overall Study|Other Reasons|1|||
128692238|NCT01024231|463172862|FG000|Overall Study|Maximum Clinical Benefit|1|||
128692239|NCT01024231|463172863|FG001|Overall Study|Maximum Clinical Benefit|2|||
128692240|NCT01024231|463172864|FG002|Overall Study|Maximum Clinical Benefit|0|||
128692241|NCT01024231|463172865|FG003|Overall Study|Maximum Clinical Benefit|1|||
128692242|NCT01024231|463172866|FG004|Overall Study|Maximum Clinical Benefit|1|||
128692243|NCT01024231|463172867|FG005|Overall Study|Maximum Clinical Benefit|0|||
128692244|NCT01024231|463172868|FG006|Overall Study|Maximum Clinical Benefit|0|||
128692245|NCT01024231|463172862|FG000|Overall Study|Disease Progression|3|||
128692246|NCT01024231|463172863|FG001|Overall Study|Disease Progression|1|||
128692247|NCT01024231|463172864|FG002|Overall Study|Disease Progression|3|||
128692248|NCT01024231|463172865|FG003|Overall Study|Disease Progression|0|||
128692249|NCT01024231|463172866|FG004|Overall Study|Disease Progression|4|||
128692250|NCT01024231|463172867|FG005|Overall Study|Disease Progression|11|||
128692251|NCT01024231|463172868|FG006|Overall Study|Disease Progression|6|||
128692252|NCT01024231|463172862|FG000|Overall Study|AE unrelated to Study Drug|0|||
128692253|NCT01024231|463172863|FG001|Overall Study|AE unrelated to Study Drug|1|||
128692254|NCT01024231|463172864|FG002|Overall Study|AE unrelated to Study Drug|0|||
128692255|NCT01024231|463172865|FG003|Overall Study|AE unrelated to Study Drug|0|||
128692256|NCT01024231|463172866|FG004|Overall Study|AE unrelated to Study Drug|0|||
128692257|NCT01024231|463172867|FG005|Overall Study|AE unrelated to Study Drug|0|||
128692258|NCT01024231|463172868|FG006|Overall Study|AE unrelated to Study Drug|0|||
128692259|NCT01024231|463172862|FG000|Overall Study|No longer meets criteria|0|||
128692260|NCT01024231|463172863|FG001|Overall Study|No longer meets criteria|0|||
128692261|NCT01024231|463172864|FG002|Overall Study|No longer meets criteria|0|||
128692262|NCT01024231|463172865|FG003|Overall Study|No longer meets criteria|0|||
128692263|NCT01024231|463172866|FG004|Overall Study|No longer meets criteria|1|||
128692264|NCT01024231|463172867|FG005|Overall Study|No longer meets criteria|0|||
128692265|NCT01024231|463172868|FG006|Overall Study|No longer meets criteria|1|||
128899358|NCT03200366|463925328|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
128899359|NCT03200366|463925329|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
128899360|NCT03200366|463925330|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
128899361|NCT03200366|463925328|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
128899362|NCT03200366|463925329|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
128899363|NCT03200366|463925330|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
128692266|NCT01024231|463172862|FG000|Overall Study|Study Drug Toxicity|1|||
128692267|NCT01024231|463172863|FG001|Overall Study|Study Drug Toxicity|6|||
128692268|NCT01024231|463172864|FG002|Overall Study|Study Drug Toxicity|6|||
128692269|NCT01024231|463172865|FG003|Overall Study|Study Drug Toxicity|4|||
128692270|NCT01024231|463172866|FG004|Overall Study|Study Drug Toxicity|2|||
128692271|NCT01024231|463172867|FG005|Overall Study|Study Drug Toxicity|0|||
128692272|NCT01024231|463172868|FG006|Overall Study|Study Drug Toxicity|7|||
128692273|NCT01024231|463172862|FG000|Overall Study|Death|6|||
128692274|NCT01024231|463172863|FG001|Overall Study|Death|2|||
128692275|NCT01024231|463172864|FG002|Overall Study|Death|1|||
128692276|NCT01024231|463172865|FG003|Overall Study|Death|0|||
128899364|NCT02018822|463925331|FG000|Overall Study|filling replaced by crown|0|||
128899365|NCT02018822|463925332|FG001|Overall Study|filling replaced by crown|1|||
128899366|NCT02018822|463925333|FG002|Overall Study|filling replaced by crown|0|||
129112712|NCT04821830|464707418|FG000|Overall Study|Withdrawal by Subject|1|||
129112713|NCT04821830|464707419|FG001|Overall Study|Withdrawal by Subject|0|||
128899367|NCT02018822|463925331|FG000|Overall Study|Physician Decision|0|||
129023197|NCT00318461|464376935|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
129023198|NCT00318461|464376936|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
129023199|NCT00318461|464376932|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
129023200|NCT00318461|464376933|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
129023201|NCT00318461|464376934|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
129023202|NCT00318461|464376935|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
129023203|NCT00318461|464376936|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
129023204|NCT01929863|464376943|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
129023205|NCT01929863|464376944|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
129023206|NCT01929863|464376943|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
129023207|NCT01929863|464376944|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
129023208|NCT01929863|464376943|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
129023209|NCT01929863|464376944|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
129023210|NCT02911701|464376945|FG000|Overall Study|Withdrawal by Subject|2|||
129023211|NCT02911701|464376946|FG001|Overall Study|Withdrawal by Subject|4|||
129023212|NCT02911701|464376945|FG000|Overall Study|Adverse Event|1|||
129023213|NCT02911701|464376946|FG001|Overall Study|Adverse Event|0|||
129023214|NCT00830024|464376947|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129023215|NCT00830024|464376948|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129023216|NCT00429416|464376949|FG000|Overall Study|Death|1|||
129023217|NCT01983969|464376950|FG000|Overall Study|Disease Progression|0|||
129023218|NCT01983969|464376951|FG001|Overall Study|Disease Progression|1|||
129023219|NCT01983969|464376952|FG002|Overall Study|Disease Progression|0|||
129023220|NCT00436163|464376953|FG000|Overall Study|Lost to Follow-up|2|||
129023221|NCT00436163|464376953|FG000|Overall Study|Adverse Event|1|||
129023222|NCT02530905|464376954|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
129023223|NCT02530905|464376955|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
129023224|NCT02530905|464376956|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
129023225|NCT00950989|464376958|FG000|Overall Study|Death|0|||
129023226|NCT00950989|464376959|FG001|Overall Study|Death|0|||
129023227|NCT00950989|464376960|FG002|Overall Study|Death|1|||
129023228|NCT00950989|464376961|FG003|Overall Study|Death|0|||
129023229|NCT00950989|464376958|FG000|Overall Study|Administrative Decision|0|||
129023230|NCT00950989|464376959|FG001|Overall Study|Administrative Decision|1|||
129023231|NCT00950989|464376960|FG002|Overall Study|Administrative Decision|0|||
129023232|NCT00950989|464376961|FG003|Overall Study|Administrative Decision|0|||
129023233|NCT00950989|464376958|FG000|Overall Study|Disease Progression|0|||
129023234|NCT00950989|464376959|FG001|Overall Study|Disease Progression|0|||
129023235|NCT00950989|464376960|FG002|Overall Study|Disease Progression|1|||
129023236|NCT00950989|464376961|FG003|Overall Study|Disease Progression|0|||
129023237|NCT00950989|464376958|FG000|Overall Study|Withdrawal by Subject|2|||
129023238|NCT00950989|464376959|FG001|Overall Study|Withdrawal by Subject|1|||
129023239|NCT00950989|464376960|FG002|Overall Study|Withdrawal by Subject|0|||
129023240|NCT00950989|464376961|FG003|Overall Study|Withdrawal by Subject|0|||
129023241|NCT00950989|464376958|FG000|Overall Study|Adverse Event|2|||
129023242|NCT00950989|464376959|FG001|Overall Study|Adverse Event|1|||
129023243|NCT00950989|464376960|FG002|Overall Study|Adverse Event|1|||
129023244|NCT00950989|464376961|FG003|Overall Study|Adverse Event|0|||
129023245|NCT01841554|464376962|FG000|Overall Study|Death|7|||
129023246|NCT01841554|464376962|FG000|Overall Study|No Implantation|1|||
129023247|NCT01841554|464376962|FG000|Overall Study|Discontinued Follow Up|5|||
129023248|NCT01841554|464376962|FG000|Overall Study|Study exit due to secondary intervention|6|||
129023249|NCT03804983|464376966|FG000|Overall Study|Adverse Event|0|||
129023250|NCT03804983|464376967|FG001|Overall Study|Adverse Event|1|||
129023251|NCT03804983|464376966|FG000|Overall Study|Family Obligation|1|||
129023252|NCT03804983|464376967|FG001|Overall Study|Family Obligation|0|||
129023253|NCT03600376|464376968|FG000|Overall Study|Adverse Event|1|||
129023254|NCT03600376|464376969|FG001|Overall Study|Adverse Event|1|||
129023255|NCT03600376|464376968|FG000|Overall Study|Transferred to other facility|1|||
129023256|NCT03600376|464376969|FG001|Overall Study|Transferred to other facility|0|||
129023257|NCT03600376|464376968|FG000|Overall Study|Investigator Decision|0|||
129023258|NCT03600376|464376969|FG001|Overall Study|Investigator Decision|4|||
129023259|NCT03600376|464376968|FG000|Overall Study|Determined to be ineligible for study|0|||
129023260|NCT03600376|464376969|FG001|Overall Study|Determined to be ineligible for study|1|||
128899368|NCT02018822|463925332|FG001|Overall Study|Physician Decision|1|||
128899369|NCT02018822|463925333|FG002|Overall Study|Physician Decision|1|||
129023261|NCT02152163|464376970|FG000|Overall Study|Physician Decision|12|||
129023262|NCT02152163|464376971|FG001|Overall Study|Physician Decision|13|||
129023263|NCT00796562|464376972|FG000|Overall Study|Death|49|||
129112714|NCT00960804|464707420|FG000|Overall Study|Adverse Event|1|||
129112715|NCT00960804|464707421|FG001|Overall Study|Adverse Event|0|||
129112716|NCT00960804|464707422|FG002|Overall Study|Adverse Event|0|||
129112717|NCT00960804|464707420|FG000|Overall Study|Withdrawal by Subject|1|||
129112718|NCT00960804|464707421|FG001|Overall Study|Withdrawal by Subject|0|||
129112719|NCT00960804|464707422|FG002|Overall Study|Withdrawal by Subject|0|||
129112720|NCT00960804|464707420|FG000|Overall Study|Study terminated by the sponsor|5|||
129112721|NCT00960804|464707421|FG001|Overall Study|Study terminated by the sponsor|4|||
129112722|NCT00960804|464707422|FG002|Overall Study|Study terminated by the sponsor|10|||
129112723|NCT00490919|464707423|FG000|Open-label Run-in Period|Adverse Event|239|||
129112724|NCT00490919|464707424|FG001|Open-label Run-in Period|Adverse Event|0|||
129112725|NCT00490919|464707425|FG002|Open-label Run-in Period|Adverse Event|0|||
129112726|NCT00490919|464707423|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
129112727|NCT00490919|464707424|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
129112728|NCT00490919|464707425|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
129112729|NCT00490919|464707423|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
129112730|NCT00490919|464707424|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
129112731|NCT00490919|464707425|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
129112732|NCT00490919|464707423|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
129112733|NCT00490919|464707424|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
129112734|NCT00490919|464707425|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
129112735|NCT00490919|464707423|FG000|Open-label Run-in Period|Administrative|40|||
129112736|NCT00490919|464707424|FG001|Open-label Run-in Period|Administrative|0|||
129112737|NCT00490919|464707425|FG002|Open-label Run-in Period|Administrative|0|||
129112738|NCT00490919|464707423|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
129112739|NCT00490919|464707424|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
129112740|NCT00490919|464707425|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
129112741|NCT00490919|464707423|FG000|Double-blind Phase|Adverse Event|0|||
129112742|NCT00490919|464707424|FG001|Double-blind Phase|Adverse Event|40|||
129112743|NCT00490919|464707425|FG002|Double-blind Phase|Adverse Event|20|||
129112744|NCT00490919|464707423|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129112745|NCT00490919|464707424|FG001|Double-blind Phase|Withdrawal by Subject|10|||
129112746|NCT00490919|464707425|FG002|Double-blind Phase|Withdrawal by Subject|11|||
129112747|NCT00490919|464707423|FG000|Double-blind Phase|Lost to Follow-up|0|||
129112748|NCT00490919|464707424|FG001|Double-blind Phase|Lost to Follow-up|8|||
129112749|NCT00490919|464707425|FG002|Double-blind Phase|Lost to Follow-up|11|||
129112750|NCT00490919|464707423|FG000|Double-blind Phase|Lack of Efficacy|0|||
129112751|NCT00490919|464707424|FG001|Double-blind Phase|Lack of Efficacy|22|||
129112752|NCT00490919|464707425|FG002|Double-blind Phase|Lack of Efficacy|36|||
129112753|NCT00490919|464707423|FG000|Double-blind Phase|Administrative|0|||
129112754|NCT00490919|464707424|FG001|Double-blind Phase|Administrative|6|||
129112755|NCT00490919|464707425|FG002|Double-blind Phase|Administrative|6|||
129112756|NCT03163446|464709537|FG000|Overall Study|Unable to return for Day 180 visit|2|||
129112757|NCT03163446|464709538|FG001|Overall Study|Unable to return for Day 180 visit|0|||
129112758|NCT03163446|464709537|FG000|Overall Study|Withdrawal by Subject|2|||
129112759|NCT03163446|464709538|FG001|Overall Study|Withdrawal by Subject|6|||
129112760|NCT03163446|464709537|FG000|Overall Study|Death|16|||
129112761|NCT03163446|464709538|FG001|Overall Study|Death|5|||
129112762|NCT03163446|464709537|FG000|Overall Study|Lost to Follow-up|6|||
129112763|NCT03163446|464709538|FG001|Overall Study|Lost to Follow-up|5|||
129112764|NCT03163446|464709537|FG000|Overall Study|Physician Decision|1|||
129112765|NCT03163446|464709538|FG001|Overall Study|Physician Decision|1|||
129112766|NCT03163446|464709537|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
129112767|NCT03163446|464709538|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
129112768|NCT01317641|464709539|FG000|Overall Study|Not treated|0|||
129112769|NCT01317641|464709540|FG001|Overall Study|Not treated|0|||
129112770|NCT01317641|464709541|FG002|Overall Study|Not treated|0|||
129112771|NCT01317641|464709542|FG003|Overall Study|Not treated|0|||
129112772|NCT01317641|464709543|FG004|Overall Study|Not treated|0|||
129112773|NCT01317641|464709544|FG005|Overall Study|Not treated|0|||
129112774|NCT01317641|464709545|FG006|Overall Study|Not treated|0|||
129112775|NCT01317641|464709546|FG007|Overall Study|Not treated|1|||
129112776|NCT01317641|464709547|FG008|Overall Study|Not treated|1|||
129112777|NCT01317641|464709539|FG000|Overall Study|Adverse Event|0|||
129112778|NCT01317641|464709540|FG001|Overall Study|Adverse Event|1|||
129112779|NCT01317641|464709541|FG002|Overall Study|Adverse Event|0|||
129112780|NCT01317641|464709542|FG003|Overall Study|Adverse Event|1|||
129112781|NCT01317641|464709543|FG004|Overall Study|Adverse Event|0|||
129112782|NCT01317641|464709544|FG005|Overall Study|Adverse Event|0|||
129112783|NCT01317641|464709545|FG006|Overall Study|Adverse Event|2|||
129112784|NCT01317641|464709546|FG007|Overall Study|Adverse Event|1|||
129112785|NCT01317641|464709547|FG008|Overall Study|Adverse Event|0|||
129112786|NCT01317641|464709539|FG000|Overall Study|Protocol Violation|1|||
129112787|NCT01317641|464709540|FG001|Overall Study|Protocol Violation|0|||
129112788|NCT01317641|464709541|FG002|Overall Study|Protocol Violation|0|||
129112789|NCT01317641|464709542|FG003|Overall Study|Protocol Violation|0|||
129112790|NCT01317641|464709543|FG004|Overall Study|Protocol Violation|0|||
128692277|NCT01024231|463172866|FG004|Overall Study|Death|4|||
128692278|NCT01024231|463172867|FG005|Overall Study|Death|3|||
128692279|NCT01024231|463172868|FG006|Overall Study|Death|5|||
128692280|NCT01024231|463172862|FG000|Overall Study|Lost to Follow-up|0|||
128692281|NCT01024231|463172863|FG001|Overall Study|Lost to Follow-up|0|||
128692282|NCT01024231|463172864|FG002|Overall Study|Lost to Follow-up|0|||
128692283|NCT01024231|463172865|FG003|Overall Study|Lost to Follow-up|0|||
128692284|NCT01024231|463172866|FG004|Overall Study|Lost to Follow-up|0|||
128692285|NCT01024231|463172867|FG005|Overall Study|Lost to Follow-up|0|||
128692286|NCT01024231|463172868|FG006|Overall Study|Lost to Follow-up|1|||
128692287|NCT01024231|463172862|FG000|Overall Study|Withdrew Consent|0|||
128692288|NCT01024231|463172863|FG001|Overall Study|Withdrew Consent|1|||
128692289|NCT01024231|463172864|FG002|Overall Study|Withdrew Consent|0|||
128692290|NCT01024231|463172865|FG003|Overall Study|Withdrew Consent|0|||
128692291|NCT01024231|463172866|FG004|Overall Study|Withdrew Consent|0|||
128692292|NCT01024231|463172867|FG005|Overall Study|Withdrew Consent|0|||
128692293|NCT01024231|463172868|FG006|Overall Study|Withdrew Consent|0|||
128692294|NCT01024231|463172862|FG000|Overall Study|Continuing on Treatment|0|||
128692295|NCT01024231|463172863|FG001|Overall Study|Continuing on Treatment|0|||
128692296|NCT01024231|463172864|FG002|Overall Study|Continuing on Treatment|0|||
128692297|NCT01024231|463172865|FG003|Overall Study|Continuing on Treatment|0|||
128692298|NCT01024231|463172866|FG004|Overall Study|Continuing on Treatment|3|||
128692299|NCT01024231|463172867|FG005|Overall Study|Continuing on Treatment|2|||
128692300|NCT01024231|463172868|FG006|Overall Study|Continuing on Treatment|0|||
128692301|NCT01013350|463172869|FG000|Overall Study|Lost to Follow-up|15|||
128692302|NCT01013350|463172870|FG001|Overall Study|Lost to Follow-up|95|||
128692303|NCT01013350|463172869|FG000|Overall Study|Adverse Event|0|||
128692304|NCT01013350|463172870|FG001|Overall Study|Adverse Event|1|||
128692305|NCT01013350|463172869|FG000|Overall Study|Physician Decision|4|||
128692306|NCT01013350|463172870|FG001|Overall Study|Physician Decision|20|||
128692307|NCT01013350|463172869|FG000|Overall Study|Withdrawal by Subject|15|||
128692308|NCT01013350|463172870|FG001|Overall Study|Withdrawal by Subject|38|||
128692309|NCT01013350|463172869|FG000|Overall Study|Death|3|||
128692310|NCT01013350|463172870|FG001|Overall Study|Death|5|||
128899370|NCT02018822|463925331|FG000|Overall Study|Lost to Follow-up|6|||
128899371|NCT02018822|463925332|FG001|Overall Study|Lost to Follow-up|6|||
128899372|NCT02018822|463925333|FG002|Overall Study|Lost to Follow-up|5|||
128899373|NCT03201458|463925334|FG000|Overall Study|No longer eligible|2|||
128899374|NCT03201458|463925335|FG001|Overall Study|No longer eligible|5|||
128899375|NCT03201458|463925334|FG000|Overall Study|Health event before starting|1|||
128899376|NCT03201458|463925335|FG001|Overall Study|Health event before starting|0|||
128899377|NCT03201458|463925334|FG000|Overall Study|Physician Decision|1|||
128899378|NCT03201458|463925335|FG001|Overall Study|Physician Decision|0|||
128899379|NCT00715026|463925338|FG000|Overall Study|Withdrawal by Subject|5|||
128899380|NCT00715026|463925338|FG000|Overall Study|Lost to Follow-up|3|||
128899381|NCT00715026|463925338|FG000|Overall Study|Protocol Violation|1|||
128899382|NCT00715026|463925338|FG000|Overall Study|Surgery done on non-study consented hip|1|||
128899383|NCT00750737|463925339|FG000|Overall Study|Withdrawal by Subject|3|||
128899384|NCT00750737|463925340|FG001|Overall Study|Withdrawal by Subject|3|||
128899385|NCT04707157|463925342|FG000|Overall Study|Adverse Event|12|||
128899386|NCT04707157|463925343|FG001|Overall Study|Adverse Event|3|||
128899387|NCT04707157|463925342|FG000|Overall Study|Lost to Follow-up|2|||
128899388|NCT04707157|463925343|FG001|Overall Study|Lost to Follow-up|0|||
128899389|NCT04707157|463925342|FG000|Overall Study|Sponsor's decision|1|||
128899390|NCT04707157|463925343|FG001|Overall Study|Sponsor's decision|0|||
128899391|NCT04707157|463925342|FG000|Overall Study|Physician Decision|8|||
128899392|NCT04707157|463925343|FG001|Overall Study|Physician Decision|5|||
128899393|NCT04707157|463925342|FG000|Overall Study|Protocol Deviation|1|||
128899394|NCT04707157|463925343|FG001|Overall Study|Protocol Deviation|0|||
128899395|NCT04707157|463925342|FG000|Overall Study|Withdrawal by Subject|1|||
128899396|NCT04707157|463925343|FG001|Overall Study|Withdrawal by Subject|1|||
128899397|NCT01389752|463925346|FG000|Study Period 1|Sponsor decision|0|||
128692311|NCT01013350|463172869|FG000|Overall Study|Participant entered interventional study|0|||
128692312|NCT01013350|463172870|FG001|Overall Study|Participant entered interventional study|8|||
128899398|NCT01389752|463925347|FG001|Study Period 1|Sponsor decision|2|||
128692313|NCT01013350|463172869|FG000|Overall Study|Other|1|||
128692314|NCT01013350|463172870|FG001|Overall Study|Other|25|||
128692315|NCT01672736|463172872|FG000|Overall Study|Available drug expired on 31 May 16|3|||
128692316|NCT02081183|463172873|FG000|Overall Study|Lost to Follow-up|0|||
128692317|NCT02081183|463172874|FG001|Overall Study|Lost to Follow-up|1|||
128692318|NCT02081183|463172873|FG000|Overall Study|Protocol Violation|1|||
128899399|NCT01389752|463925346|FG000|Study Period 2|Sponsor decision|1|||
129112791|NCT01317641|464709544|FG005|Overall Study|Protocol Violation|0|||
128692319|NCT02081183|463172874|FG001|Overall Study|Protocol Violation|0|||
128692320|NCT02081183|463172873|FG000|Overall Study|Other|3|||
128692321|NCT02081183|463172874|FG001|Overall Study|Other|3|||
128899400|NCT01389752|463925347|FG001|Study Period 2|Sponsor decision|0|||
128899401|NCT03975920|463925353|FG000|Overall Study|Lost to Follow-up|1|||
128692322|NCT03841448|463172875|FG000|Double-blind Treatment (DBT) Period|Death|1|||
129112792|NCT01317641|464709545|FG006|Overall Study|Protocol Violation|0|||
128692323|NCT03841448|463172876|FG001|Double-blind Treatment (DBT) Period|Death|1|||
128692324|NCT03841448|463172877|FG002|Double-blind Treatment (DBT) Period|Death|0|||
128692325|NCT03841448|463172878|FG003|Double-blind Treatment (DBT) Period|Death|0|||
128692326|NCT03841448|463172875|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
128692327|NCT03841448|463172876|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
128692328|NCT03841448|463172877|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
128692329|NCT03841448|463172878|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
128692330|NCT03841448|463172875|FG000|Open-Label Extension (OLE) Period|Death|0|||
128692331|NCT03841448|463172876|FG001|Open-Label Extension (OLE) Period|Death|0|||
128692332|NCT03841448|463172877|FG002|Open-Label Extension (OLE) Period|Death|0|||
128692333|NCT03841448|463172878|FG003|Open-Label Extension (OLE) Period|Death|1|||
128692334|NCT03841448|463172875|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
128692335|NCT03841448|463172876|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
128692336|NCT03841448|463172877|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
128692337|NCT03841448|463172878|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
128692338|NCT03841448|463172875|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
128692339|NCT03841448|463172876|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
128692340|NCT03841448|463172877|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
128692341|NCT03841448|463172878|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
128692342|NCT03841448|463172875|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
128692343|NCT03841448|463172876|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
128692344|NCT03841448|463172877|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
128692345|NCT03841448|463172878|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
128692346|NCT03181893|463172879|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692347|NCT03181893|463172880|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
128692348|NCT03181893|463172881|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692349|NCT03181893|463172882|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692350|NCT03181893|463172883|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692351|NCT03181893|463172884|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692352|NCT03181893|463172885|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692353|NCT03181893|463172886|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692354|NCT03181893|463172887|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692355|NCT03181893|463172888|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692356|NCT03181893|463172889|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
128692357|NCT03181893|463172879|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
128692358|NCT03181893|463172880|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
128692359|NCT03181893|463172881|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692360|NCT03181893|463172882|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692361|NCT03181893|463172883|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692362|NCT03181893|463172884|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692363|NCT03181893|463172885|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692364|NCT03181893|463172886|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692365|NCT03181893|463172887|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692366|NCT03181893|463172888|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692367|NCT03181893|463172889|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
128692368|NCT03181893|463172879|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692369|NCT03181893|463172880|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692370|NCT03181893|463172881|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692371|NCT03181893|463172882|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692372|NCT03181893|463172883|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692373|NCT03181893|463172884|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692374|NCT03181893|463172885|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692375|NCT03181893|463172886|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
128692376|NCT03181893|463172887|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
128692377|NCT03181893|463172888|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692378|NCT03181893|463172889|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
128692379|NCT03181893|463172879|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692380|NCT03181893|463172880|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692381|NCT03181893|463172881|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692382|NCT03181893|463172882|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692383|NCT03181893|463172883|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129112793|NCT01317641|464709546|FG007|Overall Study|Protocol Violation|0|||
129112794|NCT01317641|464709547|FG008|Overall Study|Protocol Violation|0|||
129112795|NCT01317641|464709539|FG000|Overall Study|Disease progression|0|||
129112796|NCT01317641|464709540|FG001|Overall Study|Disease progression|0|||
128692384|NCT03181893|463172884|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129112797|NCT01317641|464709541|FG002|Overall Study|Disease progression|0|||
129112798|NCT01317641|464709542|FG003|Overall Study|Disease progression|0|||
128692385|NCT03181893|463172885|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692386|NCT03181893|463172886|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692387|NCT03181893|463172887|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692388|NCT03181893|463172888|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
128692389|NCT03181893|463172889|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
128692390|NCT03181893|463172879|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692391|NCT03181893|463172880|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692392|NCT03181893|463172881|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692393|NCT03181893|463172882|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692394|NCT03181893|463172883|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692395|NCT03181893|463172884|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692396|NCT03181893|463172885|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692397|NCT03181893|463172886|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692398|NCT03181893|463172887|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692399|NCT03181893|463172888|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
128692400|NCT03181893|463172889|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
128692401|NCT04128371|463172890|FG000|Overall Study|Lack of Efficacy|1|||
128692402|NCT01346969|463172891|FG000|Overall Study|Withdrawal by Subject|0|||
128692403|NCT01346969|463172892|FG001|Overall Study|Withdrawal by Subject|0|||
128692404|NCT01346969|463172893|FG002|Overall Study|Withdrawal by Subject|1|||
128692405|NCT01346969|463172894|FG003|Overall Study|Withdrawal by Subject|0|||
128692406|NCT01346969|463172891|FG000|Overall Study|Lost to Follow-up|1|||
128692407|NCT01346969|463172892|FG001|Overall Study|Lost to Follow-up|0|||
128692408|NCT01346969|463172893|FG002|Overall Study|Lost to Follow-up|2|||
128692409|NCT01346969|463172894|FG003|Overall Study|Lost to Follow-up|0|||
128692410|NCT01346969|463172891|FG000|Overall Study|Physician Decision|0|||
128692411|NCT01346969|463172892|FG001|Overall Study|Physician Decision|0|||
128692412|NCT01346969|463172893|FG002|Overall Study|Physician Decision|0|||
128692413|NCT01346969|463172894|FG003|Overall Study|Physician Decision|1|||
128692414|NCT01346969|463172891|FG000|Overall Study|Randomized but not treated|1|||
128692415|NCT01346969|463172892|FG001|Overall Study|Randomized but not treated|0|||
128692416|NCT01346969|463172893|FG002|Overall Study|Randomized but not treated|0|||
128692417|NCT01346969|463172894|FG003|Overall Study|Randomized but not treated|0|||
128692418|NCT04815031|463172895|FG000|Overall Study|No adverse event information (missing information)|33|||
128692419|NCT01736124|463172899|FG000|Post-intervention Assessment|Death|2|||
128692420|NCT01736124|463172900|FG001|Post-intervention Assessment|Death|2|||
128692421|NCT01736124|463172899|FG000|Post-intervention Assessment|lost computer access|1|||
128692422|NCT01736124|463172900|FG001|Post-intervention Assessment|lost computer access|1|||
128692423|NCT01736124|463172899|FG000|Post-intervention Assessment|Moved away|3|||
128692424|NCT01736124|463172900|FG001|Post-intervention Assessment|Moved away|1|||
128692425|NCT01736124|463172899|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
128692426|NCT01736124|463172900|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
128692427|NCT01736124|463172899|FG000|Post-intervention Assessment|Illness|3|||
128692428|NCT01736124|463172900|FG001|Post-intervention Assessment|Illness|2|||
128692429|NCT01736124|463172899|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
128692430|NCT01736124|463172900|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
128692431|NCT01736124|463172899|FG000|Post-intervention Assessment|Temporarily away|3|||
128692432|NCT01736124|463172900|FG001|Post-intervention Assessment|Temporarily away|1|||
128899402|NCT03975920|463925354|FG001|Overall Study|Lost to Follow-up|2|||
128899403|NCT03975920|463925353|FG000|Overall Study|Protocol Violation|1|||
128899404|NCT03975920|463925354|FG001|Overall Study|Protocol Violation|1|||
128899405|NCT03975920|463925353|FG000|Overall Study|Did not complete survey|2|||
129112799|NCT01317641|464709543|FG004|Overall Study|Disease progression|0|||
129112800|NCT01317641|464709544|FG005|Overall Study|Disease progression|0|||
129112801|NCT01317641|464709545|FG006|Overall Study|Disease progression|0|||
129112802|NCT01317641|464709546|FG007|Overall Study|Disease progression|3|||
129112803|NCT01317641|464709547|FG008|Overall Study|Disease progression|4|||
128899406|NCT03975920|463925354|FG001|Overall Study|Did not complete survey|1|||
129112804|NCT01317641|464709539|FG000|Overall Study|Withdrawal by Subject|0|||
129112805|NCT01317641|464709540|FG001|Overall Study|Withdrawal by Subject|0|||
128692433|NCT01736124|463172899|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
128692434|NCT01736124|463172900|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
128692435|NCT01736124|463172899|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
128692436|NCT01736124|463172900|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
128692437|NCT01736124|463172899|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
128692438|NCT01736124|463172900|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
128692439|NCT01736124|463172899|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
128692440|NCT01736124|463172900|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
128692441|NCT01736124|463172899|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
128764602|NCT04512066|463428366|FG000|Extension Period|Lack of Efficacy|0|||
128899407|NCT04251910|463925355|FG000|Overall Study|Covid 19 lockdown|0|||
129112806|NCT01317641|464709541|FG002|Overall Study|Withdrawal by Subject|0|||
128899408|NCT04251910|463925356|FG001|Overall Study|Covid 19 lockdown|5|||
128899409|NCT04251910|463925357|FG002|Overall Study|Covid 19 lockdown|0|||
128899410|NCT04251910|463925358|FG003|Overall Study|Covid 19 lockdown|4|||
128899411|NCT04251910|463925359|FG004|Overall Study|Covid 19 lockdown|0|||
128899412|NCT04251910|463925360|FG005|Overall Study|Covid 19 lockdown|0|||
128899413|NCT04251910|463925355|FG000|Overall Study|Assisted living facility was closed|0|||
128899414|NCT04251910|463925356|FG001|Overall Study|Assisted living facility was closed|0|||
128899415|NCT04251910|463925357|FG002|Overall Study|Assisted living facility was closed|0|||
128899416|NCT04251910|463925358|FG003|Overall Study|Assisted living facility was closed|0|||
128899417|NCT04251910|463925359|FG004|Overall Study|Assisted living facility was closed|1|||
128899418|NCT04251910|463925360|FG005|Overall Study|Assisted living facility was closed|0|||
128899419|NCT00804570|463925363|FG000|Overall Study|Adverse Event|14|||
128899420|NCT00804570|463925364|FG001|Overall Study|Adverse Event|7|||
128899421|NCT00804570|463925363|FG000|Overall Study|Lack of Efficacy|0|||
128899422|NCT00804570|463925364|FG001|Overall Study|Lack of Efficacy|1|||
128899423|NCT00804570|463925363|FG000|Overall Study|Lost to Follow-up|18|||
128899424|NCT00804570|463925364|FG001|Overall Study|Lost to Follow-up|21|||
128899425|NCT00804570|463925363|FG000|Overall Study|Entry criteria not met|5|||
128899426|NCT00804570|463925364|FG001|Overall Study|Entry criteria not met|5|||
128899427|NCT00804570|463925363|FG000|Overall Study|Protocol Violation|12|||
128899428|NCT00804570|463925364|FG001|Overall Study|Protocol Violation|16|||
128899429|NCT00804570|463925363|FG000|Overall Study|Physician Decision|1|||
128899430|NCT00804570|463925364|FG001|Overall Study|Physician Decision|2|||
128899431|NCT00804570|463925363|FG000|Overall Study|Sponsor decision|1|||
128899432|NCT00804570|463925364|FG001|Overall Study|Sponsor decision|4|||
128899433|NCT00804570|463925363|FG000|Overall Study|Withdrawal by Subject|21|||
128899434|NCT00804570|463925364|FG001|Overall Study|Withdrawal by Subject|38|||
128899435|NCT00290342|463925365|FG000|Overall Study|Other|0|||
128899436|NCT00290342|463925366|FG001|Overall Study|Other|1|||
129112807|NCT01317641|464709542|FG003|Overall Study|Withdrawal by Subject|0|||
129112808|NCT01317641|464709543|FG004|Overall Study|Withdrawal by Subject|0|||
128899437|NCT00290342|463925365|FG000|Overall Study|Withdrawal by Subject|6|||
128899438|NCT00290342|463925366|FG001|Overall Study|Withdrawal by Subject|4|||
128899439|NCT00290342|463925365|FG000|Overall Study|Lost to Follow-up|1|||
128899440|NCT00290342|463925366|FG001|Overall Study|Lost to Follow-up|0|||
128899441|NCT01056510|463925369|FG000|Overall Study|Dropout Before Start of Treatment|1|||
129112809|NCT01317641|464709544|FG005|Overall Study|Withdrawal by Subject|0|||
128899442|NCT01056510|463925370|FG001|Overall Study|Dropout Before Start of Treatment|1|||
128899443|NCT01056510|463925369|FG000|Overall Study|Withdrawal by Subject|4|||
128899444|NCT01056510|463925370|FG001|Overall Study|Withdrawal by Subject|2|||
128899445|NCT01056510|463925369|FG000|Overall Study|Death|29|||
128899446|NCT01056510|463925370|FG001|Overall Study|Death|34|||
128899447|NCT01056510|463925369|FG000|Overall Study|Noncompliance|1|||
128899448|NCT01056510|463925370|FG001|Overall Study|Noncompliance|3|||
128899449|NCT01056510|463925369|FG000|Overall Study|Physician Decision|4|||
128899450|NCT01056510|463925370|FG001|Overall Study|Physician Decision|5|||
128899451|NCT01056510|463925369|FG000|Overall Study|Lost to Follow-up|5|||
128899452|NCT01056510|463925370|FG001|Overall Study|Lost to Follow-up|6|||
128899453|NCT01056510|463925369|FG000|Overall Study|Other|10|||
128899454|NCT01056510|463925370|FG001|Overall Study|Other|12|||
128899455|NCT01056510|463925369|FG000|Overall Study|Missing|0|||
128899456|NCT01056510|463925370|FG001|Overall Study|Missing|1|||
128899457|NCT00243386|463925371|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
128899458|NCT00243386|463925372|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
128899459|NCT00243386|463925373|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
128899460|NCT00243386|463925371|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
128899461|NCT00243386|463925372|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
128899462|NCT00243386|463925373|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
128899463|NCT00243386|463925371|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
128899464|NCT00243386|463925372|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
128899465|NCT00243386|463925373|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
128899466|NCT00243386|463925371|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
128899467|NCT00243386|463925372|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
128899468|NCT00243386|463925373|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
128899469|NCT00243386|463925371|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
128899470|NCT00243386|463925372|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
128899471|NCT00243386|463925373|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
128899472|NCT00243386|463925371|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
128899473|NCT00243386|463925372|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
128899474|NCT00243386|463925373|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
129112810|NCT01317641|464709545|FG006|Overall Study|Withdrawal by Subject|1|||
129112811|NCT01317641|464709546|FG007|Overall Study|Withdrawal by Subject|0|||
129112812|NCT01317641|464709547|FG008|Overall Study|Withdrawal by Subject|0|||
129112813|NCT01228591|464709548|FG000|Baseline|Lack of Efficacy|1|||
129112814|NCT01228591|464709549|FG001|Baseline|Lack of Efficacy|2|||
128899475|NCT00243386|463925371|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
128899476|NCT00243386|463925372|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
128899477|NCT00243386|463925373|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
128899478|NCT00243386|463925371|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
128899479|NCT00243386|463925372|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
128899480|NCT00243386|463925373|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
128899481|NCT00133991|463925374|FG000|Overall Study|Death|4|||
128899482|NCT03002155|463925375|FG000|Overall Study|Lost to Follow-up|1|||
128899483|NCT03002155|463925376|FG001|Overall Study|Lost to Follow-up|2|||
128899484|NCT03002155|463925375|FG000|Overall Study|Withdrawal by Subject|1|||
128899485|NCT03002155|463925376|FG001|Overall Study|Withdrawal by Subject|0|||
128899486|NCT03002155|463925375|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
128899487|NCT03002155|463925376|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
128899488|NCT00978029|463925377|FG000|Overall Study|Adverse Event|1|||
128899489|NCT00978029|463925378|FG001|Overall Study|Adverse Event|2|||
128899490|NCT00978029|463925379|FG002|Overall Study|Adverse Event|5|||
128899491|NCT00978029|463925377|FG000|Overall Study|Withdrawal by Subject|0|||
128899492|NCT00978029|463925378|FG001|Overall Study|Withdrawal by Subject|0|||
128899493|NCT00978029|463925379|FG002|Overall Study|Withdrawal by Subject|1|||
128899494|NCT00978029|463925377|FG000|Overall Study|Protocol Violation|0|||
128899495|NCT00978029|463925378|FG001|Overall Study|Protocol Violation|1|||
128899496|NCT00978029|463925379|FG002|Overall Study|Protocol Violation|0|||
128899497|NCT00545298|463925380|FG000|Overall Study|Issues with Standard of Care|2|||
128899498|NCT00545298|463925381|FG001|Overall Study|Issues with Standard of Care|0|||
128899499|NCT00545298|463925382|FG002|Overall Study|Issues with Standard of Care|1|||
128899500|NCT01820364|463925386|FG000|Part I: LGX818|Death|1|||
128899501|NCT01820364|463925387|FG001|Part I: LGX818|Death|0|||
128899502|NCT01820364|463925386|FG000|Part I: LGX818|Administrative Problems|3|||
128899503|NCT01820364|463925387|FG001|Part I: LGX818|Administrative Problems|0|||
128899504|NCT01820364|463925386|FG000|Part I: LGX818|Adverse Event|6|||
128899505|NCT01820364|463925387|FG001|Part I: LGX818|Adverse Event|0|||
128899506|NCT01820364|463925386|FG000|Part I: LGX818|Disease Progression|4|||
128899507|NCT01820364|463925387|FG001|Part I: LGX818|Disease Progression|0|||
128899508|NCT01820364|463925386|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
128899509|NCT01820364|463925387|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
128899510|NCT01793142|463925390|FG000|Overall Study|Randomized not treated|7|||
128899511|NCT03451084|463925396|FG000|Overall Study|Withdrawal by Subject|2|||
128899512|NCT03451084|463925397|FG001|Overall Study|Withdrawal by Subject|1|||
128899513|NCT03451084|463925398|FG002|Overall Study|Withdrawal by Subject|2|||
128899514|NCT03451084|463925399|FG003|Overall Study|Withdrawal by Subject|1|||
128899515|NCT03451084|463925396|FG000|Overall Study|Disease recurrence|0|||
128899516|NCT03451084|463925397|FG001|Overall Study|Disease recurrence|2|||
128899517|NCT03451084|463925398|FG002|Overall Study|Disease recurrence|0|||
128899518|NCT03451084|463925399|FG003|Overall Study|Disease recurrence|0|||
128899519|NCT03451084|463925396|FG000|Overall Study|Lack of Efficacy|0|||
128899520|NCT03451084|463925397|FG001|Overall Study|Lack of Efficacy|3|||
128899521|NCT03451084|463925398|FG002|Overall Study|Lack of Efficacy|0|||
128899522|NCT03451084|463925399|FG003|Overall Study|Lack of Efficacy|1|||
128899523|NCT03451084|463925396|FG000|Overall Study|Death|1|||
128899524|NCT03451084|463925397|FG001|Overall Study|Death|0|||
128899525|NCT03451084|463925398|FG002|Overall Study|Death|2|||
128899526|NCT03451084|463925399|FG003|Overall Study|Death|0|||
128899527|NCT03451084|463925396|FG000|Overall Study|Physician Decision|0|||
128899528|NCT03451084|463925397|FG001|Overall Study|Physician Decision|0|||
128899529|NCT03451084|463925398|FG002|Overall Study|Physician Decision|2|||
128899530|NCT03451084|463925399|FG003|Overall Study|Physician Decision|2|||
128899531|NCT03451084|463925396|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
128899532|NCT03451084|463925397|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
128899533|NCT03451084|463925398|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
129023264|NCT00424047|464376973|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
129023265|NCT00424047|464376974|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
129023266|NCT00424047|464376973|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
128899534|NCT03451084|463925399|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
128899535|NCT03418129|463925402|FG000|Overall Study|Lost to Follow-up|11|||
128899536|NCT03418129|463925403|FG001|Overall Study|Lost to Follow-up|20|||
128899537|NCT03418129|463925404|FG002|Overall Study|Lost to Follow-up|15|||
128899538|NCT03418129|463925402|FG000|Overall Study|Withdrawal by Subject|3|||
129023267|NCT00424047|464376974|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
128899539|NCT03418129|463925403|FG001|Overall Study|Withdrawal by Subject|6|||
129023268|NCT00424047|464376973|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
129023269|NCT00424047|464376974|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
129023270|NCT00424047|464376973|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
128899540|NCT03418129|463925404|FG002|Overall Study|Withdrawal by Subject|4|||
128764603|NCT04512066|463428367|FG001|Extension Period|Lack of Efficacy|4|||
128899541|NCT01553188|463925407|FG000|Overall Study|Patient choice|1|||
128899542|NCT01553188|463925408|FG001|Overall Study|Patient choice|0|||
128899543|NCT01553188|463925409|FG002|Overall Study|Patient choice|0|||
128899544|NCT01553188|463925410|FG003|Overall Study|Patient choice|0|||
128899545|NCT01553188|463925407|FG000|Overall Study|Intercurrent illness and adverse event|0|||
128899546|NCT01553188|463925408|FG001|Overall Study|Intercurrent illness and adverse event|1|||
128899547|NCT01553188|463925409|FG002|Overall Study|Intercurrent illness and adverse event|2|||
128899548|NCT01553188|463925410|FG003|Overall Study|Intercurrent illness and adverse event|0|||
128899549|NCT04744207|463925414|FG000|Treatment|Withdrawal by Subject|2|||
128899550|NCT04744207|463925415|FG001|Treatment|Withdrawal by Subject|0|||
128764604|NCT04512066|463428368|FG002|Extension Period|Lack of Efficacy|4|||
128764605|NCT04512066|463428369|FG003|Extension Period|Lack of Efficacy|1|||
128764606|NCT04512066|463428370|FG004|Extension Period|Lack of Efficacy|3|||
128764607|NCT04512066|463428371|FG005|Extension Period|Lack of Efficacy|3|||
128764608|NCT04512066|463428366|FG000|Extension Period|Lost to Follow-up|0|||
128764609|NCT04512066|463428367|FG001|Extension Period|Lost to Follow-up|1|||
128764610|NCT04512066|463428368|FG002|Extension Period|Lost to Follow-up|5|||
128764611|NCT04512066|463428369|FG003|Extension Period|Lost to Follow-up|2|||
128899551|NCT04744207|463925414|FG000|Treatment|Adverse Event|1|||
129023271|NCT00424047|464376974|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
129023272|NCT00424047|464376973|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
129023273|NCT00424047|464376974|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
129023274|NCT00424047|464376973|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
129023275|NCT00424047|464376974|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
129023276|NCT00424047|464376973|FG000|On Study at Time of Unblinding|Adverse Event|22|||
129023277|NCT00424047|464376974|FG001|On Study at Time of Unblinding|Adverse Event|12|||
129023278|NCT00424047|464376973|FG000|On Study at Time of Unblinding|Progression of disease|92|||
129023279|NCT00424047|464376974|FG001|On Study at Time of Unblinding|Progression of disease|128|||
129023280|NCT00424047|464376973|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
129023281|NCT00424047|464376974|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
129023282|NCT00424047|464376973|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
129023283|NCT00424047|464376974|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
129023284|NCT00424047|464376973|FG000|On Study at Time of Unblinding|Death|11|||
129023285|NCT00424047|464376974|FG001|On Study at Time of Unblinding|Death|11|||
129023286|NCT00424047|464376973|FG000|On Study at Time of Unblinding|Other|5|||
129023287|NCT00424047|464376974|FG001|On Study at Time of Unblinding|Other|4|||
129023288|NCT00424047|464376973|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
129023289|NCT00424047|464376974|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
129023290|NCT00424047|464376973|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
129023291|NCT00424047|464376974|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
129023292|NCT00424047|464376973|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
129023293|NCT00424047|464376974|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
129023294|NCT00424047|464376973|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
129023295|NCT00424047|464376974|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
129023296|NCT00424047|464376973|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
129023297|NCT00424047|464376974|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
129023298|NCT00312897|464376977|FG000|Overall Study|Adverse Event|1|||
129023299|NCT00312897|464376978|FG001|Overall Study|Adverse Event|0|||
129023300|NCT00312897|464376977|FG000|Overall Study|Lost to Follow-up|2|||
129023301|NCT00312897|464376978|FG001|Overall Study|Lost to Follow-up|0|||
129023302|NCT00312897|464376977|FG000|Overall Study|Physician Decision|1|||
129023303|NCT00312897|464376978|FG001|Overall Study|Physician Decision|0|||
129023304|NCT00312897|464376977|FG000|Overall Study|Withdrawal by Subject|1|||
129023305|NCT00312897|464376978|FG001|Overall Study|Withdrawal by Subject|3|||
129023306|NCT00312897|464376977|FG000|Overall Study|Pregnancy|1|||
129023307|NCT00312897|464376978|FG001|Overall Study|Pregnancy|0|||
129023308|NCT00312897|464376977|FG000|Overall Study|discontinued prior to getting treatment|0|||
129023309|NCT00312897|464376978|FG001|Overall Study|discontinued prior to getting treatment|3|||
129023310|NCT03100344|464376979|FG000|Overall Study|Adverse Event|0|||
129023311|NCT03100344|464376980|FG001|Overall Study|Adverse Event|3|||
129023312|NCT03100344|464376981|FG002|Overall Study|Adverse Event|2|||
129023313|NCT03100344|464376982|FG003|Overall Study|Adverse Event|3|||
129023314|NCT03100344|464376979|FG000|Overall Study|Lack of Efficacy|2|||
129023315|NCT03100344|464376980|FG001|Overall Study|Lack of Efficacy|0|||
129023316|NCT03100344|464376981|FG002|Overall Study|Lack of Efficacy|0|||
129023317|NCT03100344|464376982|FG003|Overall Study|Lack of Efficacy|0|||
129023318|NCT03100344|464376979|FG000|Overall Study|Protocol Violation|1|||
129023319|NCT03100344|464376980|FG001|Overall Study|Protocol Violation|0|||
129023320|NCT03100344|464376981|FG002|Overall Study|Protocol Violation|0|||
129023321|NCT03100344|464376982|FG003|Overall Study|Protocol Violation|0|||
128899552|NCT04744207|463925415|FG001|Treatment|Adverse Event|2|||
128899553|NCT01147744|463925423|FG000|Overall Study|Protocol Violation|1|||
128899554|NCT01147744|463925424|FG001|Overall Study|Protocol Violation|0|||
128692442|NCT01736124|463172900|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
128692443|NCT01736124|463172899|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
128692444|NCT01736124|463172900|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
128692445|NCT01736124|463172899|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
128692446|NCT01736124|463172900|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
128692447|NCT01736124|463172899|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
128692448|NCT01736124|463172900|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
128692449|NCT01736124|463172899|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
128692450|NCT01736124|463172900|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
128692451|NCT03553927|463172901|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
128692452|NCT03553927|463172902|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
128692453|NCT03553927|463172901|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
128692454|NCT03553927|463172902|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
128692455|NCT01759511|463172904|FG000|Overall Study|Adverse Event|4|||
128692456|NCT01759511|463172904|FG000|Overall Study|Death|2|||
128692457|NCT01759511|463172904|FG000|Overall Study|Lack of Efficacy|2|||
128692458|NCT01759511|463172904|FG000|Overall Study|Physician Decision|1|||
128692459|NCT01759511|463172904|FG000|Overall Study|Progressive Disease|5|||
128692460|NCT01759511|463172904|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
128692461|NCT01759511|463172904|FG000|Overall Study|Study Terminated by Sponsor|13|||
128692462|NCT01759511|463172904|FG000|Overall Study|Withdrawal by Subject|3|||
128692463|NCT05736224|463172905|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
128692464|NCT02557295|463172906|FG000|Overall Study|Withdrawal by Subject|9|||
128692465|NCT02557295|463172907|FG001|Overall Study|Withdrawal by Subject|2|||
128692466|NCT02557295|463172908|FG002|Overall Study|Withdrawal by Subject|4|||
128692467|NCT02557295|463172909|FG003|Overall Study|Withdrawal by Subject|0|||
128692468|NCT02557295|463172910|FG004|Overall Study|Withdrawal by Subject|0|||
128692469|NCT02557295|463172911|FG005|Overall Study|Withdrawal by Subject|0|||
128692470|NCT02557295|463172912|FG006|Overall Study|Withdrawal by Subject|15|||
128692471|NCT02557295|463172913|FG007|Overall Study|Withdrawal by Subject|1|||
128692472|NCT02557295|463172914|FG008|Overall Study|Withdrawal by Subject|3|||
128692473|NCT02557295|463172906|FG000|Overall Study|Disease Progression|0|||
128692474|NCT02557295|463172907|FG001|Overall Study|Disease Progression|0|||
128692475|NCT02557295|463172908|FG002|Overall Study|Disease Progression|0|||
128692476|NCT02557295|463172909|FG003|Overall Study|Disease Progression|0|||
128692477|NCT02557295|463172910|FG004|Overall Study|Disease Progression|0|||
128692478|NCT02557295|463172911|FG005|Overall Study|Disease Progression|0|||
128692479|NCT02557295|463172912|FG006|Overall Study|Disease Progression|1|||
128899555|NCT01147744|463925425|FG002|Overall Study|Protocol Violation|1|||
128899556|NCT01147744|463925426|FG003|Overall Study|Protocol Violation|0|||
128899557|NCT01147744|463925427|FG004|Overall Study|Protocol Violation|1|||
128899558|NCT01147744|463925428|FG005|Overall Study|Protocol Violation|3|||
128899559|NCT01147744|463925429|FG006|Overall Study|Protocol Violation|1|||
128899560|NCT01147744|463925423|FG000|Overall Study|Physician Decision|0|||
128899561|NCT01147744|463925424|FG001|Overall Study|Physician Decision|1|||
128899562|NCT01147744|463925425|FG002|Overall Study|Physician Decision|1|||
128899563|NCT01147744|463925426|FG003|Overall Study|Physician Decision|0|||
128692480|NCT02557295|463172913|FG007|Overall Study|Disease Progression|0|||
128692481|NCT02557295|463172914|FG008|Overall Study|Disease Progression|0|||
128692482|NCT02557295|463172906|FG000|Overall Study|Lack of Efficacy|24|||
128692483|NCT02557295|463172907|FG001|Overall Study|Lack of Efficacy|1|||
128692484|NCT02557295|463172908|FG002|Overall Study|Lack of Efficacy|3|||
128692485|NCT02557295|463172909|FG003|Overall Study|Lack of Efficacy|0|||
128692486|NCT02557295|463172910|FG004|Overall Study|Lack of Efficacy|0|||
128692487|NCT02557295|463172911|FG005|Overall Study|Lack of Efficacy|0|||
128692488|NCT02557295|463172912|FG006|Overall Study|Lack of Efficacy|12|||
128692489|NCT02557295|463172913|FG007|Overall Study|Lack of Efficacy|1|||
128692490|NCT02557295|463172914|FG008|Overall Study|Lack of Efficacy|0|||
128692491|NCT02557295|463172906|FG000|Overall Study|Adverse Event|16|||
129112815|NCT01921517|464709550|FG000|Overall Study|Lost to Follow-up|5|||
129112816|NCT01921517|464709551|FG001|Overall Study|Lost to Follow-up|0|||
128692492|NCT02557295|463172907|FG001|Overall Study|Adverse Event|2|||
128692493|NCT02557295|463172908|FG002|Overall Study|Adverse Event|3|||
128692494|NCT02557295|463172909|FG003|Overall Study|Adverse Event|0|||
128692495|NCT02557295|463172910|FG004|Overall Study|Adverse Event|0|||
128692496|NCT02557295|463172911|FG005|Overall Study|Adverse Event|0|||
128692497|NCT02557295|463172912|FG006|Overall Study|Adverse Event|2|||
128692498|NCT02557295|463172913|FG007|Overall Study|Adverse Event|1|||
128692499|NCT02557295|463172914|FG008|Overall Study|Adverse Event|1|||
128692500|NCT02557295|463172906|FG000|Overall Study|Lost to Follow-up|4|||
128692501|NCT02557295|463172907|FG001|Overall Study|Lost to Follow-up|0|||
129112817|NCT01921517|464709550|FG000|Overall Study|Newly diagnosed health concern|2|||
128692502|NCT02557295|463172908|FG002|Overall Study|Lost to Follow-up|0|||
128899564|NCT01147744|463925427|FG004|Overall Study|Physician Decision|0|||
128899565|NCT01147744|463925428|FG005|Overall Study|Physician Decision|0|||
128899566|NCT01147744|463925429|FG006|Overall Study|Physician Decision|1|||
128899567|NCT01147744|463925423|FG000|Overall Study|Lack of Efficacy|11|||
128692503|NCT02557295|463172909|FG003|Overall Study|Lost to Follow-up|0|||
128692504|NCT02557295|463172910|FG004|Overall Study|Lost to Follow-up|0|||
128692505|NCT02557295|463172911|FG005|Overall Study|Lost to Follow-up|0|||
128692506|NCT02557295|463172912|FG006|Overall Study|Lost to Follow-up|9|||
128692507|NCT02557295|463172913|FG007|Overall Study|Lost to Follow-up|0|||
128692508|NCT02557295|463172914|FG008|Overall Study|Lost to Follow-up|0|||
128692509|NCT02557295|463172906|FG000|Overall Study|Study Close|54|||
128692510|NCT02557295|463172907|FG001|Overall Study|Study Close|3|||
128692511|NCT02557295|463172908|FG002|Overall Study|Study Close|5|||
128692512|NCT02557295|463172909|FG003|Overall Study|Study Close|3|||
128692513|NCT02557295|463172910|FG004|Overall Study|Study Close|0|||
128692514|NCT02557295|463172911|FG005|Overall Study|Study Close|0|||
128692515|NCT02557295|463172912|FG006|Overall Study|Study Close|37|||
128692516|NCT02557295|463172913|FG007|Overall Study|Study Close|3|||
128692517|NCT02557295|463172914|FG008|Overall Study|Study Close|19|||
128692518|NCT02557295|463172906|FG000|Overall Study|except for study close|4|||
128692519|NCT02557295|463172907|FG001|Overall Study|except for study close|0|||
128899568|NCT01147744|463925424|FG001|Overall Study|Lack of Efficacy|11|||
128899569|NCT01147744|463925425|FG002|Overall Study|Lack of Efficacy|9|||
128899570|NCT01147744|463925426|FG003|Overall Study|Lack of Efficacy|11|||
128899571|NCT01147744|463925427|FG004|Overall Study|Lack of Efficacy|13|||
128899572|NCT01147744|463925428|FG005|Overall Study|Lack of Efficacy|8|||
128899573|NCT01147744|463925429|FG006|Overall Study|Lack of Efficacy|7|||
128899574|NCT01147744|463925423|FG000|Overall Study|Adverse Event|1|||
128899575|NCT01147744|463925424|FG001|Overall Study|Adverse Event|2|||
128899576|NCT01147744|463925425|FG002|Overall Study|Adverse Event|3|||
128899577|NCT01147744|463925426|FG003|Overall Study|Adverse Event|0|||
128899578|NCT01147744|463925427|FG004|Overall Study|Adverse Event|2|||
128899579|NCT01147744|463925428|FG005|Overall Study|Adverse Event|1|||
128899580|NCT01147744|463925429|FG006|Overall Study|Adverse Event|2|||
128899581|NCT01147744|463925423|FG000|Overall Study|Withdrawal by Subject|8|||
128899582|NCT01147744|463925424|FG001|Overall Study|Withdrawal by Subject|4|||
128899583|NCT01147744|463925425|FG002|Overall Study|Withdrawal by Subject|2|||
128899584|NCT01147744|463925426|FG003|Overall Study|Withdrawal by Subject|2|||
128899585|NCT01147744|463925427|FG004|Overall Study|Withdrawal by Subject|2|||
128899586|NCT01147744|463925428|FG005|Overall Study|Withdrawal by Subject|5|||
128899587|NCT01147744|463925429|FG006|Overall Study|Withdrawal by Subject|2|||
128899588|NCT01147744|463925423|FG000|Overall Study|Lost to Follow-up|0|||
128899589|NCT01147744|463925424|FG001|Overall Study|Lost to Follow-up|1|||
128899590|NCT01147744|463925425|FG002|Overall Study|Lost to Follow-up|0|||
129023322|NCT03100344|464376979|FG000|Overall Study|Withdrawal by Subject|10|||
129023323|NCT03100344|464376980|FG001|Overall Study|Withdrawal by Subject|7|||
129023324|NCT03100344|464376981|FG002|Overall Study|Withdrawal by Subject|4|||
129023325|NCT03100344|464376982|FG003|Overall Study|Withdrawal by Subject|8|||
129023326|NCT03100344|464376979|FG000|Overall Study|Lost to Follow-up|1|||
129023327|NCT03100344|464376980|FG001|Overall Study|Lost to Follow-up|1|||
129023328|NCT03100344|464376981|FG002|Overall Study|Lost to Follow-up|1|||
129023329|NCT03100344|464376982|FG003|Overall Study|Lost to Follow-up|1|||
129023330|NCT01010503|464376983|FG000|Overall Study|Adverse Event|1|||
129023331|NCT01010503|464376983|FG000|Overall Study|Death|1|||
129023332|NCT04633564|464376984|FG000|Period 1|Adverse Event|28|||
129023333|NCT04633564|464376985|FG001|Period 1|Adverse Event|19|||
129023334|NCT04633564|464376984|FG000|Period 1|Death|8|||
129023335|NCT04633564|464376985|FG001|Period 1|Death|7|||
129023336|NCT04633564|464376984|FG000|Period 1|Lost to Follow-up|3|||
129023337|NCT04633564|464376985|FG001|Period 1|Lost to Follow-up|5|||
129023338|NCT04633564|464376984|FG000|Period 1|Physician Decision|4|||
129023339|NCT04633564|464376985|FG001|Period 1|Physician Decision|12|||
129023340|NCT04633564|464376984|FG000|Period 1|Protocol Violation|0|||
129023341|NCT04633564|464376985|FG001|Period 1|Protocol Violation|1|||
129023342|NCT04633564|464376984|FG000|Period 1|Withdrawal by Subject|10|||
129023343|NCT04633564|464376985|FG001|Period 1|Withdrawal by Subject|8|||
129023344|NCT04633564|464376984|FG000|Period 1|Progressive disease|47|||
129023345|NCT04633564|464376985|FG001|Period 1|Progressive disease|51|||
129023346|NCT04633564|464376984|FG000|Period 1|Terminated by Sponsor|8|||
129023347|NCT04633564|464376985|FG001|Period 1|Terminated by Sponsor|6|||
129023348|NCT04633564|464376984|FG000|Period 2|Adverse Event|3|||
129023349|NCT04633564|464376985|FG001|Period 2|Adverse Event|4|||
129023350|NCT04633564|464376984|FG000|Period 2|Death|0|||
129023351|NCT04633564|464376985|FG001|Period 2|Death|2|||
129023352|NCT04633564|464376984|FG000|Period 2|Lost to Follow-up|0|||
129023353|NCT04633564|464376985|FG001|Period 2|Lost to Follow-up|1|||
129023354|NCT04633564|464376984|FG000|Period 2|Physician Decision|2|||
129023355|NCT04633564|464376985|FG001|Period 2|Physician Decision|4|||
128692520|NCT02557295|463172908|FG002|Overall Study|except for study close|0|||
128692521|NCT02557295|463172909|FG003|Overall Study|except for study close|0|||
128692522|NCT02557295|463172910|FG004|Overall Study|except for study close|0|||
128692523|NCT02557295|463172911|FG005|Overall Study|except for study close|0|||
128899591|NCT01147744|463925426|FG003|Overall Study|Lost to Follow-up|0|||
128899592|NCT01147744|463925427|FG004|Overall Study|Lost to Follow-up|0|||
128899593|NCT01147744|463925428|FG005|Overall Study|Lost to Follow-up|0|||
129023356|NCT04633564|464376984|FG000|Period 2|Withdrawal by Subject|5|||
128692524|NCT02557295|463172912|FG006|Overall Study|except for study close|5|||
128692525|NCT02557295|463172913|FG007|Overall Study|except for study close|1|||
128692526|NCT02557295|463172914|FG008|Overall Study|except for study close|0|||
128692527|NCT03673046|463174125|FG000|Overall Study|Adverse Event|1|||
128692528|NCT03673046|463174126|FG001|Overall Study|Adverse Event|1|||
128692529|NCT03673046|463174125|FG000|Overall Study|Withdrawal by Subject|8|||
128692530|NCT03673046|463174126|FG001|Overall Study|Withdrawal by Subject|2|||
128692531|NCT03817879|463174127|FG000|Overall Study|Drop out|5|||
128692532|NCT03817879|463174128|FG001|Overall Study|Drop out|12|||
128692533|NCT03817879|463174127|FG000|Overall Study|Withdrawal by Subject|0|||
128692534|NCT03817879|463174128|FG001|Overall Study|Withdrawal by Subject|1|||
128692535|NCT01896050|463174129|FG000|Overall Study|Adverse Event|37|||
128692536|NCT01896050|463174130|FG001|Overall Study|Adverse Event|2|||
128764612|NCT04512066|463428370|FG004|Extension Period|Lost to Follow-up|3|||
128764613|NCT04512066|463428371|FG005|Extension Period|Lost to Follow-up|2|||
128764614|NCT04512066|463428366|FG000|Extension Period|Non-compliance with study drug|0|||
128764615|NCT04512066|463428367|FG001|Extension Period|Non-compliance with study drug|1|||
128764616|NCT04512066|463428368|FG002|Extension Period|Non-compliance with study drug|0|||
128764617|NCT04512066|463428369|FG003|Extension Period|Non-compliance with study drug|0|||
128764618|NCT04512066|463428370|FG004|Extension Period|Non-compliance with study drug|0|||
128764619|NCT04512066|463428371|FG005|Extension Period|Non-compliance with study drug|1|||
128764620|NCT04512066|463428366|FG000|Extension Period|Other|0|||
128764621|NCT04512066|463428367|FG001|Extension Period|Other|2|||
128764622|NCT04512066|463428368|FG002|Extension Period|Other|0|||
128764623|NCT04512066|463428369|FG003|Extension Period|Other|0|||
128764624|NCT04512066|463428370|FG004|Extension Period|Other|0|||
128764625|NCT04512066|463428371|FG005|Extension Period|Other|0|||
128764626|NCT04512066|463428366|FG000|Extension Period|Physician Decision|0|||
128764627|NCT04512066|463428367|FG001|Extension Period|Physician Decision|2|||
128764628|NCT04512066|463428368|FG002|Extension Period|Physician Decision|0|||
128764629|NCT04512066|463428369|FG003|Extension Period|Physician Decision|1|||
128764630|NCT04512066|463428370|FG004|Extension Period|Physician Decision|1|||
128764631|NCT04512066|463428371|FG005|Extension Period|Physician Decision|0|||
128764632|NCT04512066|463428366|FG000|Extension Period|Withdrawal by Subject|0|||
128764633|NCT04512066|463428367|FG001|Extension Period|Withdrawal by Subject|3|||
128764634|NCT04512066|463428368|FG002|Extension Period|Withdrawal by Subject|7|||
128764635|NCT04512066|463428369|FG003|Extension Period|Withdrawal by Subject|11|||
128764636|NCT04512066|463428370|FG004|Extension Period|Withdrawal by Subject|8|||
128764637|NCT04512066|463428371|FG005|Extension Period|Withdrawal by Subject|4|||
128764638|NCT03520400|463428372|FG000|Overall Study|Physician Decision|15|||
128764639|NCT03520400|463428373|FG001|Overall Study|Physician Decision|7|||
128692537|NCT01896050|463174129|FG000|Overall Study|Death|1|||
128692538|NCT01896050|463174130|FG001|Overall Study|Death|0|||
128764640|NCT01654601|463428379|FG000|1st Administration|Withdrawal by Subject|2|||
128764641|NCT01654601|463428380|FG001|1st Administration|Withdrawal by Subject|0|||
128764642|NCT01654601|463428379|FG000|1st Administration|Protocol Violation|0|||
128764643|NCT01654601|463428380|FG001|1st Administration|Protocol Violation|2|||
128764644|NCT01654601|463428379|FG000|2nd Administration|Adverse Event|1|||
129023357|NCT04633564|464376985|FG001|Period 2|Withdrawal by Subject|1|||
129023358|NCT04633564|464376984|FG000|Period 2|Progressive Disease|74|||
129023359|NCT04633564|464376985|FG001|Period 2|Progressive Disease|82|||
129023360|NCT04633564|464376984|FG000|Period 2|Terminated by Sponsor|9|||
129023361|NCT04633564|464376985|FG001|Period 2|Terminated by Sponsor|3|||
129023362|NCT03043872|464376991|FG000|Overall Study|Withdrawal by Subject|6|||
129023363|NCT03043872|464376992|FG001|Overall Study|Withdrawal by Subject|6|||
129023364|NCT03043872|464376993|FG002|Overall Study|Withdrawal by Subject|15|||
129023365|NCT03043872|464376991|FG000|Overall Study|Lost to Follow-up|2|||
129023366|NCT03043872|464376992|FG001|Overall Study|Lost to Follow-up|1|||
129023367|NCT03043872|464376993|FG002|Overall Study|Lost to Follow-up|1|||
129023368|NCT03043872|464376991|FG000|Overall Study|Death|270|||
129023369|NCT03043872|464376992|FG001|Overall Study|Death|269|||
129023370|NCT03043872|464376993|FG002|Overall Study|Death|296|||
129023371|NCT01154231|464376994|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
129023372|NCT01154231|464376994|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
129023373|NCT04115293|464378268|FG000|Overall Study|Adverse Event|0|||
129023374|NCT04115293|464378269|FG001|Overall Study|Adverse Event|2|||
129023375|NCT04115293|464378268|FG000|Overall Study|Withdrawal by Subject|2|||
129023376|NCT04115293|464378269|FG001|Overall Study|Withdrawal by Subject|1|||
129023377|NCT04115293|464378268|FG000|Overall Study|Physician Decision|1|||
129023378|NCT04115293|464378269|FG001|Overall Study|Physician Decision|0|||
129023379|NCT04115293|464378268|FG000|Overall Study|Death|1|||
129023380|NCT04115293|464378269|FG001|Overall Study|Death|1|||
129023381|NCT00001703|464378270|FG000|Overall Study|progressed disease|2|||
129023382|NCT00001703|464378270|FG000|Overall Study|No evidence of disease|1|||
129023383|NCT00001703|464378270|FG000|Overall Study|recurrent disease|2|||
129023384|NCT03447353|464378278|FG000|Overall Study|Failure at Screening Visit|2|||
129023385|NCT03447353|464378278|FG000|Overall Study|Lost to Follow-up|4|||
128692539|NCT00392015|463174131|FG000|Overall Study|Lost to Follow-up|2|||
128692540|NCT00392015|463174132|FG001|Overall Study|Lost to Follow-up|0|||
128692541|NCT00392015|463174133|FG002|Overall Study|Lost to Follow-up|2|||
128899594|NCT01147744|463925429|FG006|Overall Study|Lost to Follow-up|0|||
128899595|NCT01147744|463925423|FG000|Overall Study|Sponsor decision to amend protocol|7|||
128899596|NCT01147744|463925424|FG001|Overall Study|Sponsor decision to amend protocol|4|||
128899597|NCT01147744|463925425|FG002|Overall Study|Sponsor decision to amend protocol|2|||
128899598|NCT01147744|463925426|FG003|Overall Study|Sponsor decision to amend protocol|5|||
128899599|NCT01147744|463925427|FG004|Overall Study|Sponsor decision to amend protocol|7|||
128899600|NCT01147744|463925428|FG005|Overall Study|Sponsor decision to amend protocol|2|||
128899601|NCT01147744|463925429|FG006|Overall Study|Sponsor decision to amend protocol|6|||
128899602|NCT01147744|463925423|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128899603|NCT01147744|463925424|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
128899604|NCT01147744|463925425|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
128899605|NCT01147744|463925426|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
128899606|NCT01147744|463925427|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
128899607|NCT01147744|463925428|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128899608|NCT01147744|463925429|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
128899609|NCT05419128|463925431|FG000|Overall Study|Withdrawal by Subject|1|||
128899610|NCT05419128|463925432|FG001|Overall Study|Withdrawal by Subject|1|||
128899611|NCT05419128|463925433|FG002|Overall Study|Withdrawal by Subject|0|||
128899612|NCT05419128|463925434|FG003|Overall Study|Withdrawal by Subject|1|||
128899613|NCT05419128|463925435|FG004|Overall Study|Withdrawal by Subject|1|||
128899614|NCT05419128|463925436|FG005|Overall Study|Withdrawal by Subject|0|||
128899615|NCT05419128|463925431|FG000|Overall Study|Lost to Follow-up|0|||
128899616|NCT05419128|463925432|FG001|Overall Study|Lost to Follow-up|0|||
128899617|NCT05419128|463925433|FG002|Overall Study|Lost to Follow-up|1|||
128899618|NCT05419128|463925434|FG003|Overall Study|Lost to Follow-up|0|||
128899619|NCT05419128|463925435|FG004|Overall Study|Lost to Follow-up|0|||
128899620|NCT05419128|463925436|FG005|Overall Study|Lost to Follow-up|1|||
128899621|NCT03834519|463925437|FG000|Overall Study|Lost to Follow-up|2|||
128899622|NCT03834519|463925438|FG001|Overall Study|Lost to Follow-up|1|||
128899623|NCT03834519|463925437|FG000|Overall Study|Withdrawal by Subject|5|||
128899624|NCT03834519|463925438|FG001|Overall Study|Withdrawal by Subject|8|||
128899625|NCT03834519|463925437|FG000|Overall Study|Death|368|||
128899626|NCT03834519|463925438|FG001|Overall Study|Death|174|||
128899627|NCT03834519|463925437|FG000|Overall Study|Physician Decision|5|||
128899628|NCT03834519|463925438|FG001|Overall Study|Physician Decision|1|||
128899629|NCT03834519|463925437|FG000|Overall Study|Sponsor decision|149|||
128899630|NCT03834519|463925438|FG001|Overall Study|Sponsor decision|80|||
128899631|NCT04066491|463925439|FG000|Overall Study|Randomized, not treated|0|||
128899632|NCT04066491|463925440|FG001|Overall Study|Randomized, not treated|0|||
128899633|NCT04066491|463925441|FG002|Overall Study|Randomized, not treated|2|||
128899634|NCT04506086|463925442|FG000|Overall Study|Withdrawal by Subject|2|||
128899635|NCT00517751|463925443|FG000|Overall Study|Death|3|||
128899636|NCT00517751|463925443|FG000|Overall Study|Withdrawal by Subject|37|||
128899637|NCT00517751|463925443|FG000|Overall Study|Lost to Follow-up|4|||
128899638|NCT00517751|463925443|FG000|Overall Study|patient not over due|6|||
128899639|NCT00517751|463925443|FG000|Overall Study|Patient not due for visit|76|||
128899640|NCT00517751|463925443|FG000|Overall Study|Missing|3|||
128899641|NCT00495820|463925444|FG000|Overall Study|Adverse Event|1|||
128899642|NCT00495820|463925445|FG001|Overall Study|Adverse Event|1|||
128899643|NCT00820950|463925446|FG000|Overall Study|Scheduling Conflict|0|||
128899644|NCT00820950|463925447|FG001|Overall Study|Scheduling Conflict|0|||
129112818|NCT01921517|464709551|FG001|Overall Study|Newly diagnosed health concern|0|||
129112819|NCT01921517|464709550|FG000|Overall Study|Physician Decision|0|||
129112820|NCT01921517|464709551|FG001|Overall Study|Physician Decision|2|||
129112821|NCT01921517|464709550|FG000|Overall Study|Withdrawal by Subject|7|||
129112822|NCT01921517|464709551|FG001|Overall Study|Withdrawal by Subject|3|||
129112823|NCT01921517|464709550|FG000|Overall Study|Subject missed final imaging|1|||
129112824|NCT01921517|464709551|FG001|Overall Study|Subject missed final imaging|4|||
129112825|NCT03110354|464709557|FG000|Overall Study|Death|1|||
129112826|NCT03110354|464709558|FG001|Overall Study|Death|0|||
129112827|NCT03110354|464709559|FG002|Overall Study|Death|0|||
128692542|NCT00392015|463174134|FG003|Overall Study|Lost to Follow-up|1|||
128899645|NCT00820950|463925448|FG002|Overall Study|Scheduling Conflict|0|||
128899646|NCT00820950|463925449|FG003|Overall Study|Scheduling Conflict|0|||
128899647|NCT00820950|463925450|FG004|Overall Study|Scheduling Conflict|0|||
128899648|NCT00820950|463925451|FG005|Overall Study|Scheduling Conflict|0|||
128899649|NCT00820950|463925452|FG006|Overall Study|Scheduling Conflict|1|||
128899650|NCT00820950|463925453|FG007|Overall Study|Scheduling Conflict|1|||
128899651|NCT00820950|463925454|FG008|Overall Study|Scheduling Conflict|0|||
128899652|NCT00820950|463925455|FG009|Overall Study|Scheduling Conflict|0|||
128899653|NCT00820950|463925446|FG000|Overall Study|Protocol Violation|1|||
128899654|NCT00820950|463925447|FG001|Overall Study|Protocol Violation|1|||
128899655|NCT00820950|463925448|FG002|Overall Study|Protocol Violation|0|||
128899656|NCT00820950|463925449|FG003|Overall Study|Protocol Violation|0|||
128692543|NCT00392015|463174135|FG004|Overall Study|Lost to Follow-up|1|||
128899657|NCT00820950|463925450|FG004|Overall Study|Protocol Violation|0|||
128899658|NCT00820950|463925451|FG005|Overall Study|Protocol Violation|0|||
128899659|NCT00820950|463925452|FG006|Overall Study|Protocol Violation|0|||
128899660|NCT00820950|463925453|FG007|Overall Study|Protocol Violation|0|||
128899661|NCT00820950|463925454|FG008|Overall Study|Protocol Violation|0|||
128899662|NCT00820950|463925455|FG009|Overall Study|Protocol Violation|0|||
128899663|NCT03416153|463925456|FG000|Overall Study|Physician Decision|1|||
128899664|NCT03416153|463925457|FG001|Overall Study|Physician Decision|1|||
129112828|NCT03110354|464709560|FG003|Overall Study|Death|1|||
129112829|NCT03110354|464709561|FG004|Overall Study|Death|0|||
129112830|NCT03110354|464709557|FG000|Overall Study|Start of new therapy|0|||
129112831|NCT03110354|464709558|FG001|Overall Study|Start of new therapy|0|||
129112832|NCT03110354|464709559|FG002|Overall Study|Start of new therapy|0|||
129112833|NCT03110354|464709560|FG003|Overall Study|Start of new therapy|0|||
129112834|NCT03110354|464709561|FG004|Overall Study|Start of new therapy|1|||
129112835|NCT03110354|464709557|FG000|Overall Study|Failure to achieve response|2|||
129112836|NCT03110354|464709558|FG001|Overall Study|Failure to achieve response|3|||
129112837|NCT03110354|464709559|FG002|Overall Study|Failure to achieve response|0|||
129112838|NCT03110354|464709560|FG003|Overall Study|Failure to achieve response|2|||
129112839|NCT03110354|464709561|FG004|Overall Study|Failure to achieve response|1|||
129112840|NCT03110354|464709557|FG000|Overall Study|Progressive disease|1|||
129112841|NCT03110354|464709558|FG001|Overall Study|Progressive disease|1|||
129112842|NCT03110354|464709559|FG002|Overall Study|Progressive disease|3|||
129112843|NCT03110354|464709560|FG003|Overall Study|Progressive disease|4|||
129112844|NCT03110354|464709561|FG004|Overall Study|Progressive disease|2|||
129112845|NCT03110354|464709557|FG000|Overall Study|Adverse Event|0|||
129112846|NCT03110354|464709558|FG001|Overall Study|Adverse Event|0|||
129112847|NCT03110354|464709559|FG002|Overall Study|Adverse Event|0|||
129112848|NCT03110354|464709560|FG003|Overall Study|Adverse Event|2|||
129112849|NCT03110354|464709561|FG004|Overall Study|Adverse Event|2|||
129112850|NCT03110354|464709557|FG000|Overall Study|Other|0|||
129112851|NCT03110354|464709558|FG001|Overall Study|Other|0|||
129112852|NCT03110354|464709559|FG002|Overall Study|Other|0|||
129112853|NCT03110354|464709560|FG003|Overall Study|Other|1|||
129112854|NCT03110354|464709561|FG004|Overall Study|Other|1|||
129112855|NCT00116688|464709566|FG000|Overall Study|Protocol deviation|1|||
129112856|NCT00116688|464709567|FG001|Overall Study|Protocol deviation|0|||
129112857|NCT00116688|464709566|FG000|Overall Study|Noncompliance|3|||
129112858|NCT00116688|464709567|FG001|Overall Study|Noncompliance|1|||
129112859|NCT00116688|464709566|FG000|Overall Study|Adverse Event|11|||
129112860|NCT00116688|464709567|FG001|Overall Study|Adverse Event|0|||
129112861|NCT00116688|464709566|FG000|Overall Study|Withdrawal by Subject|26|||
129112862|NCT00116688|464709567|FG001|Overall Study|Withdrawal by Subject|2|||
129112863|NCT00116688|464709566|FG000|Overall Study|Requirement for alternative therapy|11|||
129112864|NCT00116688|464709567|FG001|Overall Study|Requirement for alternative therapy|1|||
129112865|NCT00116688|464709566|FG000|Overall Study|Physician Decision|7|||
129112866|NCT00116688|464709567|FG001|Overall Study|Physician Decision|0|||
129112867|NCT00116688|464709566|FG000|Overall Study|Lost to Follow-up|3|||
129112868|NCT00116688|464709567|FG001|Overall Study|Lost to Follow-up|0|||
129112869|NCT00116688|464709566|FG000|Overall Study|Death|15|||
129112870|NCT00116688|464709567|FG001|Overall Study|Death|0|||
129112871|NCT00116688|464709566|FG000|Overall Study|Protocol-specified criteria|3|||
129112872|NCT00116688|464709567|FG001|Overall Study|Protocol-specified criteria|0|||
129112873|NCT00116688|464709566|FG000|Overall Study|Pregnancy|1|||
129112874|NCT00116688|464709567|FG001|Overall Study|Pregnancy|0|||
129112875|NCT00116688|464709566|FG000|Overall Study|Other|11|||
129112876|NCT00116688|464709567|FG001|Overall Study|Other|0|||
129112877|NCT01775670|464709572|FG000|Overall Study|Lost to Follow-up|1|||
129112878|NCT01775670|464709573|FG001|Overall Study|Lost to Follow-up|1|||
129112879|NCT01298700|464709575|FG000|Overall Study|Adverse Event|50|||
129112880|NCT01298700|464709576|FG001|Overall Study|Adverse Event|51|||
128692544|NCT00392015|463174136|FG005|Overall Study|Lost to Follow-up|0|||
128692545|NCT00392015|463174131|FG000|Overall Study|Withdrawal by Subject|0|||
128899665|NCT03416153|463925456|FG000|Overall Study|Withdrawal by Subject|1|||
128899666|NCT03416153|463925457|FG001|Overall Study|Withdrawal by Subject|0|||
128899667|NCT01429584|463927148|FG000|Overall Study|Withdrawal by Subject|1|||
129112881|NCT01298700|464709575|FG000|Overall Study|Lack of Efficacy|9|||
129112882|NCT01298700|464709576|FG001|Overall Study|Lack of Efficacy|14|||
129112883|NCT01298700|464709575|FG000|Overall Study|Lost to Follow-up|5|||
129112884|NCT01298700|464709576|FG001|Overall Study|Lost to Follow-up|2|||
129112885|NCT01298700|464709575|FG000|Overall Study|Withdrawal by Subject|12|||
129112886|NCT01298700|464709576|FG001|Overall Study|Withdrawal by Subject|9|||
129112887|NCT01298700|464709575|FG000|Overall Study|Protocol Violation|6|||
129112888|NCT01298700|464709576|FG001|Overall Study|Protocol Violation|4|||
129112889|NCT01298700|464709575|FG000|Overall Study|Other Miscellaneous Reasons|16|||
129112890|NCT01298700|464709576|FG001|Overall Study|Other Miscellaneous Reasons|15|||
129112891|NCT01298700|464709575|FG000|Overall Study|Did not Receive Study Drug|3|||
129112892|NCT01298700|464709576|FG001|Overall Study|Did not Receive Study Drug|5|||
129112893|NCT04006145|464709579|FG000|Overall Study|Lost to Follow-up|0|||
129112894|NCT04006145|464709580|FG001|Overall Study|Lost to Follow-up|1|||
129112895|NCT04006145|464709579|FG000|Overall Study|Other|1|||
129112896|NCT04006145|464709580|FG001|Overall Study|Other|2|||
129112897|NCT00010257|464709583|FG000|Overall Study|Withdrawal by Subject|1|||
129112898|NCT00010257|464709584|FG001|Overall Study|Withdrawal by Subject|0|||
129112899|NCT00643760|464709587|FG000|Overall Study|Adverse Event|11|||
129112900|NCT00643760|464709588|FG001|Overall Study|Adverse Event|5|||
129112901|NCT00643760|464709589|FG002|Overall Study|Adverse Event|12|||
129112902|NCT00643760|464709590|FG003|Overall Study|Adverse Event|21|||
129112903|NCT00643760|464709591|FG004|Overall Study|Adverse Event|6|||
129112904|NCT00643760|464709587|FG000|Overall Study|Lack of Efficacy|3|||
129112905|NCT00643760|464709588|FG001|Overall Study|Lack of Efficacy|1|||
128899668|NCT01429584|463927149|FG001|Overall Study|Withdrawal by Subject|0|||
128899669|NCT01429584|463927148|FG000|Overall Study|Protocol Violation|0|||
128899670|NCT01429584|463927149|FG001|Overall Study|Protocol Violation|1|||
128899671|NCT02463409|463927155|FG000|Overall Study|Withdrawal by Subject|1|||
128899672|NCT02463409|463927155|FG000|Overall Study|Screen failure|1|||
128899673|NCT02819635|463927156|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
128899674|NCT02819635|463927157|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
128899675|NCT02819635|463927158|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
129112906|NCT00643760|464709589|FG002|Overall Study|Lack of Efficacy|0|||
129112907|NCT00643760|464709590|FG003|Overall Study|Lack of Efficacy|4|||
129112908|NCT00643760|464709591|FG004|Overall Study|Lack of Efficacy|3|||
129112909|NCT00643760|464709587|FG000|Overall Study|Protocol Violation|7|||
129112910|NCT00643760|464709588|FG001|Overall Study|Protocol Violation|6|||
129112911|NCT00643760|464709589|FG002|Overall Study|Protocol Violation|4|||
129112912|NCT00643760|464709590|FG003|Overall Study|Protocol Violation|4|||
129112913|NCT00643760|464709591|FG004|Overall Study|Protocol Violation|6|||
129112914|NCT00643760|464709587|FG000|Overall Study|Lost to Follow-up|6|||
129112915|NCT00643760|464709588|FG001|Overall Study|Lost to Follow-up|2|||
129112916|NCT00643760|464709589|FG002|Overall Study|Lost to Follow-up|1|||
129112917|NCT00643760|464709590|FG003|Overall Study|Lost to Follow-up|3|||
129112918|NCT00643760|464709591|FG004|Overall Study|Lost to Follow-up|3|||
129112919|NCT00643760|464709587|FG000|Overall Study|Investigator Discretion|0|||
129112920|NCT00643760|464709588|FG001|Overall Study|Investigator Discretion|0|||
129112921|NCT00643760|464709589|FG002|Overall Study|Investigator Discretion|0|||
129112922|NCT00643760|464709590|FG003|Overall Study|Investigator Discretion|2|||
129112923|NCT00643760|464709591|FG004|Overall Study|Investigator Discretion|0|||
129112924|NCT00643760|464709587|FG000|Overall Study|Withdrawal by Subject|3|||
129112925|NCT00643760|464709588|FG001|Overall Study|Withdrawal by Subject|1|||
129112926|NCT00643760|464709589|FG002|Overall Study|Withdrawal by Subject|2|||
129112927|NCT00643760|464709590|FG003|Overall Study|Withdrawal by Subject|4|||
129112928|NCT00643760|464709591|FG004|Overall Study|Withdrawal by Subject|1|||
129112929|NCT02063672|464709592|FG000|Overall Study|Ongoing Follow-up|27|||
129112930|NCT02063672|464709593|FG001|Overall Study|Ongoing Follow-up|14|||
129112931|NCT02063672|464709592|FG000|Overall Study|Death|5|||
129112932|NCT02063672|464709593|FG001|Overall Study|Death|3|||
129112933|NCT02063672|464709592|FG000|Overall Study|Lost to Follow-up|1|||
129112934|NCT02063672|464709593|FG001|Overall Study|Lost to Follow-up|3|||
129112935|NCT02063672|464709592|FG000|Overall Study|Withdrawal by Subject|2|||
129112936|NCT02063672|464709593|FG001|Overall Study|Withdrawal by Subject|2|||
129112937|NCT00104052|464709597|FG000|Overall Study|Adverse Event|1|||
129112938|NCT00104052|464709597|FG000|Overall Study|Lack of Efficacy|26|||
129112939|NCT00104052|464709597|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
129112940|NCT02498678|464709598|FG000|Overall Study|interference from the surgical team|0|||
129112941|NCT02498678|464709599|FG001|Overall Study|interference from the surgical team|2|||
129112942|NCT00239720|464709604|FG000|Overall Study|Adverse Event|1|||
129112943|NCT00239720|464709605|FG001|Overall Study|Adverse Event|0|||
129112944|NCT00239720|464709604|FG000|Overall Study|Lost to Follow-up|0|||
129112945|NCT00239720|464709605|FG001|Overall Study|Lost to Follow-up|1|||
129112946|NCT01484951|464709606|FG000|Overall Study|Adverse Event|3|||
129112947|NCT01484951|464709606|FG000|Overall Study|Personal Reasons|1|||
128692546|NCT00392015|463174132|FG001|Overall Study|Withdrawal by Subject|0|||
128692547|NCT00392015|463174133|FG002|Overall Study|Withdrawal by Subject|2|||
129112948|NCT01484951|464709606|FG000|Overall Study|Non-Compliance|1|||
128692548|NCT00392015|463174134|FG003|Overall Study|Withdrawal by Subject|0|||
128692549|NCT00392015|463174135|FG004|Overall Study|Withdrawal by Subject|0|||
128899676|NCT02819635|463927159|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
128899677|NCT02819635|463927160|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
129112949|NCT01249417|464709607|FG000|Randomised Population|Study treatment not received|0|||
129112950|NCT01249417|464709608|FG001|Randomised Population|Study treatment not received|0|||
129112951|NCT01249417|464709609|FG002|Randomised Population|Study treatment not received|2|||
129112952|NCT01249417|464709607|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
129112953|NCT01249417|464709608|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
129112954|NCT01249417|464709609|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
129112955|NCT01249417|464709607|FG000|Treatment Phase - ITT Population|Other|0|||
129112956|NCT01249417|464709608|FG001|Treatment Phase - ITT Population|Other|0|||
129112957|NCT01249417|464709609|FG002|Treatment Phase - ITT Population|Other|1|||
128692550|NCT00392015|463174136|FG005|Overall Study|Withdrawal by Subject|0|||
128692551|NCT00392015|463174131|FG000|Overall Study|Adverse Event|0|||
128692552|NCT00392015|463174132|FG001|Overall Study|Adverse Event|0|||
128692553|NCT00392015|463174133|FG002|Overall Study|Adverse Event|0|||
128692554|NCT00392015|463174134|FG003|Overall Study|Adverse Event|0|||
128692555|NCT00392015|463174135|FG004|Overall Study|Adverse Event|1|||
128692556|NCT00392015|463174136|FG005|Overall Study|Adverse Event|0|||
128692557|NCT00392015|463174131|FG000|Overall Study|Previous trial recipient|0|||
128692558|NCT00392015|463174132|FG001|Overall Study|Previous trial recipient|0|||
128692559|NCT00392015|463174133|FG002|Overall Study|Previous trial recipient|0|||
128692560|NCT00392015|463174134|FG003|Overall Study|Previous trial recipient|0|||
128692561|NCT00392015|463174135|FG004|Overall Study|Previous trial recipient|1|||
128692562|NCT00392015|463174136|FG005|Overall Study|Previous trial recipient|0|||
128692563|NCT03693300|463174137|FG000|Overall Study|Withdrawal by Subject|6|||
128692564|NCT03693300|463174138|FG001|Overall Study|Withdrawal by Subject|0|||
128692565|NCT03693300|463174137|FG000|Overall Study|Death|50|||
128692566|NCT03693300|463174138|FG001|Overall Study|Death|2|||
128692567|NCT03693300|463174137|FG000|Overall Study|Lost to Follow-up|2|||
128692568|NCT03693300|463174138|FG001|Overall Study|Lost to Follow-up|0|||
128692569|NCT02206048|463174139|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
128692570|NCT02925923|463174140|FG000|Overall Study|blood samples hemolyzed|0|||
128692571|NCT02925923|463174141|FG001|Overall Study|blood samples hemolyzed|2|||
128692572|NCT00866788|463174142|FG000|Overall Study|Adverse Event|0|||
128692573|NCT00866788|463174143|FG001|Overall Study|Adverse Event|2|||
128692574|NCT00866788|463174144|FG002|Overall Study|Adverse Event|0|||
128692575|NCT00866788|463174145|FG003|Overall Study|Adverse Event|1|||
128692576|NCT00866788|463174142|FG000|Overall Study|Lost to Follow-up|1|||
128692577|NCT00866788|463174143|FG001|Overall Study|Lost to Follow-up|1|||
128692578|NCT00866788|463174144|FG002|Overall Study|Lost to Follow-up|0|||
128692579|NCT00866788|463174145|FG003|Overall Study|Lost to Follow-up|2|||
128692580|NCT00866788|463174142|FG000|Overall Study|Withdrawal by Subject|2|||
128692581|NCT00866788|463174143|FG001|Overall Study|Withdrawal by Subject|1|||
128692582|NCT00866788|463174144|FG002|Overall Study|Withdrawal by Subject|0|||
128692583|NCT00866788|463174145|FG003|Overall Study|Withdrawal by Subject|1|||
128692584|NCT00866788|463174142|FG000|Overall Study|Pregnancy|0|||
128692585|NCT00866788|463174143|FG001|Overall Study|Pregnancy|1|||
128692586|NCT00866788|463174144|FG002|Overall Study|Pregnancy|0|||
128692587|NCT00866788|463174145|FG003|Overall Study|Pregnancy|0|||
128692588|NCT00866788|463174142|FG000|Overall Study|Disease progression|3|||
128692589|NCT00866788|463174143|FG001|Overall Study|Disease progression|1|||
128692590|NCT00866788|463174144|FG002|Overall Study|Disease progression|1|||
128692591|NCT00866788|463174145|FG003|Overall Study|Disease progression|0|||
128692592|NCT00866788|463174142|FG000|Overall Study|Physician Decision|0|||
128692593|NCT00866788|463174143|FG001|Overall Study|Physician Decision|0|||
128692594|NCT00866788|463174144|FG002|Overall Study|Physician Decision|1|||
128692595|NCT00866788|463174145|FG003|Overall Study|Physician Decision|1|||
128692596|NCT02742441|463174146|FG000|Overall Study|Lost to Follow-up|4|||
128692597|NCT02742441|463174147|FG001|Overall Study|Lost to Follow-up|4|||
128692598|NCT02742441|463174146|FG000|Overall Study|Withdrawal by Subject|2|||
128692599|NCT02742441|463174147|FG001|Overall Study|Withdrawal by Subject|2|||
128692600|NCT02742441|463174146|FG000|Overall Study|Adverse Event|0|||
128692601|NCT02742441|463174147|FG001|Overall Study|Adverse Event|2|||
128692602|NCT02202837|463174150|FG000|Overall Study|Enbrel treatment discontinued|36|||
128692603|NCT02202837|463174151|FG001|Overall Study|Enbrel treatment discontinued|4|||
128764645|NCT01654601|463428380|FG001|2nd Administration|Adverse Event|0|||
128764646|NCT01654601|463428379|FG000|2nd Administration|Protocol Violation|0|||
128764647|NCT01654601|463428380|FG001|2nd Administration|Protocol Violation|1|||
128764648|NCT00369681|463430250|FG000|Overall Study|Death|1|||
128764649|NCT02991482|463430251|FG000|Overall Study|Disease progression|56|||
128764650|NCT02991482|463430252|FG001|Overall Study|Disease progression|47|||
128899678|NCT02819635|463927161|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
128692604|NCT02202837|463174150|FG000|Overall Study|Other|10|||
128692605|NCT02202837|463174151|FG001|Overall Study|Other|0|||
128692606|NCT02202837|463174150|FG000|Overall Study|Lost to Follow-up|7|||
128692607|NCT02202837|463174151|FG001|Overall Study|Lost to Follow-up|1|||
128692608|NCT00313300|463174152|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
128692609|NCT00313300|463174153|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
128692610|NCT00313300|463174154|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
128692611|NCT00313300|463174155|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
128692612|NCT00313300|463174156|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
128692613|NCT00313300|463174152|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
128692614|NCT00313300|463174153|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
128764651|NCT02991482|463430251|FG000|Overall Study|Death|4|||
128764652|NCT02991482|463430252|FG001|Overall Study|Death|4|||
128899679|NCT02819635|463927162|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
128692615|NCT00313300|463174154|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
128692616|NCT00313300|463174155|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
128764653|NCT02991482|463430251|FG000|Overall Study|Adverse Event|1|||
129112958|NCT01249417|464709607|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
129112959|NCT01249417|464709608|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
129112960|NCT01249417|464709609|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
129112961|NCT01249417|464709607|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
129112962|NCT01249417|464709608|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
129112963|NCT01249417|464709609|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
129112964|NCT01249417|464709607|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
129112965|NCT01249417|464709608|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
129112966|NCT01249417|464709609|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
129112967|NCT00917124|464709610|FG000|Overall Study|Protocol Violation|4|||
129112968|NCT00917124|464709611|FG001|Overall Study|Protocol Violation|6|||
129112969|NCT00126594|464709613|FG000|Overall Study|Ineligible|2|||
129112970|NCT00126594|464709614|FG001|Overall Study|Ineligible|0|||
129112971|NCT00126594|464709613|FG000|Overall Study|Withdrawal by Subject|0|||
129112972|NCT00126594|464709614|FG001|Overall Study|Withdrawal by Subject|4|||
129112973|NCT00126594|464709613|FG000|Overall Study|Physician Decision|1|||
129112974|NCT00126594|464709614|FG001|Overall Study|Physician Decision|3|||
129112975|NCT00126594|464709613|FG000|Overall Study|Adverse Event|7|||
129112976|NCT00126594|464709614|FG001|Overall Study|Adverse Event|5|||
129112977|NCT00126594|464709613|FG000|Overall Study|Non-compliance|0|||
129112978|NCT00126594|464709614|FG001|Overall Study|Non-compliance|1|||
129112979|NCT00126594|464709613|FG000|Overall Study|Disease Progression|29|||
129112980|NCT00126594|464709614|FG001|Overall Study|Disease Progression|24|||
129112981|NCT03769649|464709615|FG000|Overall Study|Lost to Follow-up|4|||
129112982|NCT01290718|464709618|FG000|Overall Study|Early termination of the study|4|||
129112983|NCT00473655|464709619|FG000|Overall Study|Lost to Follow-up|9|||
129112984|NCT00473655|464709620|FG001|Overall Study|Lost to Follow-up|5|||
129112985|NCT00473655|464709621|FG002|Overall Study|Lost to Follow-up|8|||
129112986|NCT00243919|464709622|FG000|Overall Study|Death|3|||
129112987|NCT00243919|464709623|FG001|Overall Study|Death|4|||
129112988|NCT00243919|464709624|FG002|Overall Study|Death|6|||
129112989|NCT00243919|464709622|FG000|Overall Study|Withdrawal by Subject|6|||
129112990|NCT00243919|464709623|FG001|Overall Study|Withdrawal by Subject|6|||
129112991|NCT00243919|464709624|FG002|Overall Study|Withdrawal by Subject|2|||
129112992|NCT00243919|464709622|FG000|Overall Study|Lost to Follow-up|6|||
129112993|NCT00243919|464709623|FG001|Overall Study|Lost to Follow-up|7|||
129112994|NCT00243919|464709624|FG002|Overall Study|Lost to Follow-up|3|||
129112995|NCT00243919|464709622|FG000|Overall Study|Administrative Error|1|||
129112996|NCT00243919|464709623|FG001|Overall Study|Administrative Error|0|||
129112997|NCT00243919|464709624|FG002|Overall Study|Administrative Error|0|||
129112998|NCT00243919|464709622|FG000|Overall Study|Physician Decision|1|||
129112999|NCT00243919|464709623|FG001|Overall Study|Physician Decision|1|||
129113000|NCT00243919|464709624|FG002|Overall Study|Physician Decision|0|||
129113001|NCT01268267|464709625|FG000|Overall Study|Protocol Violation|1|||
129113002|NCT04176939|464709626|FG000|Overall Study|Withdrawal by Subject|5|||
129113003|NCT04176939|464709626|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
129113004|NCT04176939|464709626|FG000|Overall Study|Lost to Follow-up|2|||
129113005|NCT04176939|464709626|FG000|Overall Study|Unspecified reason|4|||
129113006|NCT04176939|464709626|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
129113007|NCT04919317|464709633|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
129113008|NCT04919317|464709634|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
129113009|NCT04919317|464709633|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
129113010|NCT04919317|464709634|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
129113011|NCT02869789|464709635|FG000|Overall Study|Disease progression|184|||
129113012|NCT02869789|464709636|FG001|Overall Study|Disease progression|109|||
129113013|NCT02869789|464709637|FG002|Overall Study|Disease progression|260|||
129113014|NCT02869789|464709638|FG003|Overall Study|Disease progression|19|||
129113015|NCT02869789|464709635|FG000|Overall Study|Study drug toxicity|90|||
129113016|NCT02869789|464709636|FG001|Overall Study|Study drug toxicity|32|||
129113017|NCT02869789|464709637|FG002|Overall Study|Study drug toxicity|55|||
129113018|NCT02869789|464709638|FG003|Overall Study|Study drug toxicity|14|||
129113019|NCT02869789|464709635|FG000|Overall Study|Death|7|||
129113020|NCT02869789|464709636|FG001|Overall Study|Death|3|||
129113021|NCT02869789|464709637|FG002|Overall Study|Death|5|||
129113022|NCT02869789|464709638|FG003|Overall Study|Death|1|||
129113023|NCT02869789|464709635|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
129113024|NCT02869789|464709636|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
129113025|NCT02869789|464709637|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
129113026|NCT02869789|464709638|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
129113027|NCT02869789|464709635|FG000|Overall Study|Participant request to discontinue study treatment|10|||
129113028|NCT02869789|464709636|FG001|Overall Study|Participant request to discontinue study treatment|5|||
129113029|NCT02869789|464709637|FG002|Overall Study|Participant request to discontinue study treatment|5|||
129113030|NCT02869789|464709638|FG003|Overall Study|Participant request to discontinue study treatment|3|||
129113031|NCT02869789|464709635|FG000|Overall Study|Withdrawal by Subject|5|||
129113032|NCT02869789|464709636|FG001|Overall Study|Withdrawal by Subject|2|||
128899680|NCT02819635|463927163|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
128899681|NCT02819635|463927164|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
128899682|NCT02819635|463927165|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
128899683|NCT02819635|463927166|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
128899684|NCT02819635|463927167|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
128899685|NCT02819635|463927156|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899686|NCT02819635|463927157|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899687|NCT02819635|463927158|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899688|NCT02819635|463927159|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899689|NCT02819635|463927160|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
128899690|NCT02819635|463927161|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
128899691|NCT02819635|463927162|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
128899692|NCT02819635|463927163|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899693|NCT02819635|463927164|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899694|NCT02819635|463927165|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899695|NCT02819635|463927166|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899696|NCT02819635|463927167|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
128899697|NCT02819635|463927156|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129023386|NCT03447353|464378278|FG000|Overall Study|Scheduling Conflicts|3|||
129023387|NCT03447353|464378278|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
129023388|NCT02642653|464378281|FG000|Overall Study|Adverse Event|2|||
129023389|NCT02642653|464378282|FG001|Overall Study|Adverse Event|0|||
129023390|NCT02267187|464378283|FG000|Overall Study|Physician Decision|2|||
129023391|NCT02267187|464378283|FG000|Overall Study|Screen fail|3|||
128692617|NCT00313300|463174156|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
128692618|NCT00313300|463174152|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
128692619|NCT00313300|463174153|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
129023392|NCT02222818|464378289|FG000|Period 1|Eligibility criteria not met|0|||
129023393|NCT02222818|464378290|FG001|Period 1|Eligibility criteria not met|3|||
129023394|NCT01660243|464378291|FG000|Overall Study|Adverse Event|1|||
129023395|NCT01660243|464378292|FG001|Overall Study|Adverse Event|0|||
129023396|NCT01660243|464378293|FG002|Overall Study|Adverse Event|1|||
129023397|NCT01660243|464378294|FG003|Overall Study|Adverse Event|0|||
129023398|NCT01660243|464378291|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
129023399|NCT01660243|464378292|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
129023400|NCT01660243|464378293|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
129023401|NCT01660243|464378294|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
129023402|NCT01660243|464378291|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
129023403|NCT01660243|464378292|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
129023404|NCT01660243|464378293|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
129023405|NCT01660243|464378294|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
129023406|NCT01660243|464378291|FG000|Overall Study|Randomization error|0|||
129023407|NCT01660243|464378292|FG001|Overall Study|Randomization error|0|||
129023408|NCT01660243|464378293|FG002|Overall Study|Randomization error|0|||
129023409|NCT01660243|464378294|FG003|Overall Study|Randomization error|1|||
129023410|NCT03025087|464378295|FG000|Overall Study|Physician Decision|3|||
129023411|NCT03025087|464378296|FG001|Overall Study|Physician Decision|3|||
129023412|NCT03025087|464378297|FG002|Overall Study|Physician Decision|0|||
129023413|NCT03025087|464378298|FG003|Overall Study|Physician Decision|0|||
129023414|NCT03025087|464378299|FG004|Overall Study|Physician Decision|0|||
129023415|NCT03025087|464378295|FG000|Overall Study|Withdrawal by Subject|1|||
129023416|NCT03025087|464378296|FG001|Overall Study|Withdrawal by Subject|1|||
129023417|NCT03025087|464378297|FG002|Overall Study|Withdrawal by Subject|0|||
129023418|NCT03025087|464378298|FG003|Overall Study|Withdrawal by Subject|0|||
129023419|NCT03025087|464378299|FG004|Overall Study|Withdrawal by Subject|0|||
129023420|NCT03025087|464378295|FG000|Overall Study|Unable to complete MRI|2|||
129023421|NCT03025087|464378296|FG001|Overall Study|Unable to complete MRI|2|||
129023422|NCT03025087|464378297|FG002|Overall Study|Unable to complete MRI|0|||
129023423|NCT03025087|464378298|FG003|Overall Study|Unable to complete MRI|0|||
129023424|NCT03025087|464378299|FG004|Overall Study|Unable to complete MRI|0|||
129023425|NCT00712959|464378306|FG000|Overall Study|Protocol Violation|3|||
129023426|NCT00712959|464378307|FG001|Overall Study|Protocol Violation|1|||
129023427|NCT00712959|464378306|FG000|Overall Study|Lost to Follow-up|13|||
128692620|NCT00313300|463174154|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
129023428|NCT00712959|464378307|FG001|Overall Study|Lost to Follow-up|2|||
129023429|NCT00712959|464378306|FG000|Overall Study|Withdrawal by Subject|3|||
129023430|NCT00712959|464378307|FG001|Overall Study|Withdrawal by Subject|0|||
129023431|NCT00508651|464378308|FG000|Overall Study|Lost to Follow-up|3|||
129023432|NCT00508651|464378309|FG001|Overall Study|Lost to Follow-up|1|||
128692621|NCT00313300|463174155|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
128899698|NCT02819635|463927157|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899699|NCT02819635|463927158|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899700|NCT02819635|463927159|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899701|NCT02819635|463927160|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899702|NCT02819635|463927161|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
128899703|NCT02819635|463927162|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
128899704|NCT02819635|463927163|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899705|NCT02819635|463927164|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899706|NCT02819635|463927165|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899707|NCT02819635|463927166|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899708|NCT02819635|463927167|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
128899709|NCT02819635|463927156|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899710|NCT02819635|463927157|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899711|NCT02819635|463927158|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899712|NCT02819635|463927159|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899713|NCT02819635|463927160|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899714|NCT02819635|463927161|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899715|NCT02819635|463927162|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
128899716|NCT02819635|463927163|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899717|NCT02819635|463927164|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899718|NCT02819635|463927165|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899719|NCT02819635|463927166|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899720|NCT02819635|463927167|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
128899721|NCT02819635|463927156|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
128899722|NCT02819635|463927157|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
128899723|NCT02819635|463927158|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
128899724|NCT02819635|463927159|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
128899725|NCT02819635|463927160|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
128899726|NCT02819635|463927161|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
128899727|NCT02819635|463927162|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
128899728|NCT02819635|463927163|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
128899729|NCT02819635|463927164|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
128899730|NCT02819635|463927165|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
128899731|NCT02819635|463927166|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
128899732|NCT02819635|463927167|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
128899733|NCT02819635|463927156|FG000|Substudy 2, Part 2|Adverse Event|0|||
128899734|NCT02819635|463927157|FG001|Substudy 2, Part 2|Adverse Event|0|||
128899735|NCT02819635|463927158|FG002|Substudy 2, Part 2|Adverse Event|0|||
128899736|NCT02819635|463927159|FG003|Substudy 2, Part 2|Adverse Event|0|||
129113033|NCT02869789|464709637|FG002|Overall Study|Withdrawal by Subject|7|||
129113034|NCT02869789|464709638|FG003|Overall Study|Withdrawal by Subject|2|||
128899737|NCT02819635|463927160|FG004|Substudy 2, Part 2|Adverse Event|0|||
128899738|NCT02819635|463927161|FG005|Substudy 2, Part 2|Adverse Event|4|||
128899739|NCT02819635|463927162|FG006|Substudy 2, Part 2|Adverse Event|0|||
128899740|NCT02819635|463927163|FG007|Substudy 2, Part 2|Adverse Event|0|||
128899741|NCT02819635|463927164|FG008|Substudy 2, Part 2|Adverse Event|0|||
128899742|NCT02819635|463927165|FG009|Substudy 2, Part 2|Adverse Event|0|||
128899743|NCT02819635|463927166|FG010|Substudy 2, Part 2|Adverse Event|0|||
128899744|NCT02819635|463927167|FG011|Substudy 2, Part 2|Adverse Event|0|||
128899745|NCT02819635|463927156|FG000|Substudy 2, Part 2|Withdrew consent|0|||
128899746|NCT02819635|463927157|FG001|Substudy 2, Part 2|Withdrew consent|0|||
129023433|NCT00508651|464378308|FG000|Overall Study|Withdrawal by Subject|1|||
129023434|NCT00508651|464378309|FG001|Overall Study|Withdrawal by Subject|1|||
129023435|NCT01376037|464378319|FG000|Overall Study|Lost to Follow-up|0|||
129023436|NCT01376037|464378320|FG001|Overall Study|Lost to Follow-up|2|||
129023437|NCT02328040|464378322|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
129023438|NCT02328040|464378323|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
129023439|NCT03121586|464378328|FG000|Overall Study|Study terminated by sponsor|0|||
129023440|NCT03121586|464378329|FG001|Overall Study|Study terminated by sponsor|0|||
129023441|NCT03121586|464378330|FG002|Overall Study|Study terminated by sponsor|99|||
129023442|NCT03121586|464378328|FG000|Overall Study|Withdrawal by Subject|37|||
129023443|NCT03121586|464378329|FG001|Overall Study|Withdrawal by Subject|14|||
129023444|NCT03121586|464378330|FG002|Overall Study|Withdrawal by Subject|9|||
129023445|NCT03121586|464378328|FG000|Overall Study|Not further specified|6|||
129113035|NCT02869789|464709635|FG000|Overall Study|Lost to Follow-up|0|||
129113036|NCT02869789|464709636|FG001|Overall Study|Lost to Follow-up|0|||
128692622|NCT00313300|463174156|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
128692623|NCT00313300|463174152|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
128692624|NCT00313300|463174153|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
128692625|NCT00313300|463174154|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
128692626|NCT00313300|463174155|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
128692627|NCT00313300|463174156|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
128692628|NCT00313300|463174152|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
128899747|NCT02819635|463927158|FG002|Substudy 2, Part 2|Withdrew consent|0|||
128899748|NCT02819635|463927159|FG003|Substudy 2, Part 2|Withdrew consent|0|||
128899749|NCT02819635|463927160|FG004|Substudy 2, Part 2|Withdrew consent|0|||
128899750|NCT02819635|463927161|FG005|Substudy 2, Part 2|Withdrew consent|3|||
128899751|NCT02819635|463927162|FG006|Substudy 2, Part 2|Withdrew consent|1|||
128899752|NCT02819635|463927163|FG007|Substudy 2, Part 2|Withdrew consent|0|||
128899753|NCT02819635|463927164|FG008|Substudy 2, Part 2|Withdrew consent|0|||
128899754|NCT02819635|463927165|FG009|Substudy 2, Part 2|Withdrew consent|0|||
128899755|NCT02819635|463927166|FG010|Substudy 2, Part 2|Withdrew consent|0|||
128899756|NCT02819635|463927167|FG011|Substudy 2, Part 2|Withdrew consent|0|||
128899757|NCT02819635|463927156|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
128899758|NCT02819635|463927157|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
128899759|NCT02819635|463927158|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
128899760|NCT02819635|463927159|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
128899761|NCT02819635|463927160|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
128899762|NCT02819635|463927161|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
128899763|NCT02819635|463927162|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
128899764|NCT02819635|463927163|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
128899765|NCT02819635|463927164|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
128899766|NCT02819635|463927165|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
128899767|NCT02819635|463927166|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
128899768|NCT02819635|463927167|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
128899769|NCT02819635|463927156|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899770|NCT02819635|463927157|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899771|NCT02819635|463927158|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899772|NCT02819635|463927159|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899773|NCT02819635|463927160|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899774|NCT02819635|463927161|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899775|NCT02819635|463927162|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
128899776|NCT02819635|463927163|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899777|NCT02819635|463927164|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899778|NCT02819635|463927165|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899779|NCT02819635|463927166|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899780|NCT02819635|463927167|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
128899781|NCT02819635|463927156|FG000|Substudy 2, Part 2|Other, not specified|0|||
128899782|NCT02819635|463927157|FG001|Substudy 2, Part 2|Other, not specified|0|||
128899783|NCT02819635|463927158|FG002|Substudy 2, Part 2|Other, not specified|0|||
128899784|NCT02819635|463927159|FG003|Substudy 2, Part 2|Other, not specified|0|||
128899785|NCT02819635|463927160|FG004|Substudy 2, Part 2|Other, not specified|0|||
128899786|NCT02819635|463927161|FG005|Substudy 2, Part 2|Other, not specified|4|||
128899787|NCT02819635|463927162|FG006|Substudy 2, Part 2|Other, not specified|8|||
128899788|NCT02819635|463927163|FG007|Substudy 2, Part 2|Other, not specified|0|||
128899789|NCT02819635|463927164|FG008|Substudy 2, Part 2|Other, not specified|0|||
128899790|NCT02819635|463927165|FG009|Substudy 2, Part 2|Other, not specified|0|||
128899791|NCT02819635|463927166|FG010|Substudy 2, Part 2|Other, not specified|0|||
128899792|NCT02819635|463927167|FG011|Substudy 2, Part 2|Other, not specified|0|||
128899793|NCT02819635|463927156|FG000|Substudy 3|Adverse Event|0|||
128899794|NCT02819635|463927157|FG001|Substudy 3|Adverse Event|0|||
128899795|NCT02819635|463927158|FG002|Substudy 3|Adverse Event|0|||
128899796|NCT02819635|463927159|FG003|Substudy 3|Adverse Event|0|||
128899797|NCT02819635|463927160|FG004|Substudy 3|Adverse Event|0|||
128899798|NCT02819635|463927161|FG005|Substudy 3|Adverse Event|0|||
128899799|NCT02819635|463927162|FG006|Substudy 3|Adverse Event|0|||
128899800|NCT02819635|463927163|FG007|Substudy 3|Adverse Event|0|||
128899801|NCT02819635|463927164|FG008|Substudy 3|Adverse Event|32|||
128899802|NCT02819635|463927165|FG009|Substudy 3|Adverse Event|3|||
128899803|NCT02819635|463927166|FG010|Substudy 3|Adverse Event|12|||
128899804|NCT02819635|463927167|FG011|Substudy 3|Adverse Event|18|||
128899805|NCT02819635|463927156|FG000|Substudy 3|Withdrew consent|0|||
128899806|NCT02819635|463927157|FG001|Substudy 3|Withdrew consent|0|||
128899807|NCT02819635|463927158|FG002|Substudy 3|Withdrew consent|0|||
128899808|NCT02819635|463927159|FG003|Substudy 3|Withdrew consent|0|||
128899809|NCT02819635|463927160|FG004|Substudy 3|Withdrew consent|0|||
128899810|NCT02819635|463927161|FG005|Substudy 3|Withdrew consent|0|||
128899811|NCT02819635|463927162|FG006|Substudy 3|Withdrew consent|0|||
128899812|NCT02819635|463927163|FG007|Substudy 3|Withdrew consent|0|||
128692629|NCT00313300|463174153|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
128899813|NCT02819635|463927164|FG008|Substudy 3|Withdrew consent|11|||
128899814|NCT02819635|463927165|FG009|Substudy 3|Withdrew consent|1|||
128899815|NCT02819635|463927166|FG010|Substudy 3|Withdrew consent|4|||
128764654|NCT02991482|463430252|FG001|Overall Study|Adverse Event|6|||
128899816|NCT02819635|463927167|FG011|Substudy 3|Withdrew consent|9|||
128899817|NCT02819635|463927156|FG000|Substudy 3|Lost to Follow-up|0|||
128899818|NCT02819635|463927157|FG001|Substudy 3|Lost to Follow-up|0|||
128899819|NCT02819635|463927158|FG002|Substudy 3|Lost to Follow-up|0|||
128899820|NCT02819635|463927159|FG003|Substudy 3|Lost to Follow-up|0|||
128899821|NCT02819635|463927160|FG004|Substudy 3|Lost to Follow-up|0|||
128899822|NCT02819635|463927161|FG005|Substudy 3|Lost to Follow-up|0|||
128899823|NCT02819635|463927162|FG006|Substudy 3|Lost to Follow-up|0|||
129113037|NCT02869789|464709637|FG002|Overall Study|Lost to Follow-up|2|||
129113038|NCT02869789|464709638|FG003|Overall Study|Lost to Follow-up|0|||
129113039|NCT02869789|464709635|FG000|Overall Study|Maximum clinical benefit|5|||
129113040|NCT02869789|464709636|FG001|Overall Study|Maximum clinical benefit|2|||
129113041|NCT02869789|464709637|FG002|Overall Study|Maximum clinical benefit|1|||
129113042|NCT02869789|464709638|FG003|Overall Study|Maximum clinical benefit|0|||
129113043|NCT02869789|464709635|FG000|Overall Study|Poor/Non-compliance|0|||
129113044|NCT02869789|464709636|FG001|Overall Study|Poor/Non-compliance|2|||
129113045|NCT02869789|464709637|FG002|Overall Study|Poor/Non-compliance|1|||
129113046|NCT02869789|464709638|FG003|Overall Study|Poor/Non-compliance|0|||
129113047|NCT02869789|464709635|FG000|Overall Study|Participant no longer meets study criteria|0|||
129113048|NCT02869789|464709636|FG001|Overall Study|Participant no longer meets study criteria|1|||
128899824|NCT02819635|463927163|FG007|Substudy 3|Lost to Follow-up|0|||
129113049|NCT02869789|464709637|FG002|Overall Study|Participant no longer meets study criteria|1|||
129113050|NCT02869789|464709638|FG003|Overall Study|Participant no longer meets study criteria|0|||
129113051|NCT02869789|464709635|FG000|Overall Study|Administrative reason by sponsor|0|||
129113052|NCT02869789|464709636|FG001|Overall Study|Administrative reason by sponsor|0|||
129113053|NCT02869789|464709637|FG002|Overall Study|Administrative reason by sponsor|1|||
129113054|NCT02869789|464709638|FG003|Overall Study|Administrative reason by sponsor|0|||
129113055|NCT02869789|464709635|FG000|Overall Study|Other reasons|4|||
129113056|NCT02869789|464709636|FG001|Overall Study|Other reasons|8|||
129113057|NCT02869789|464709637|FG002|Overall Study|Other reasons|6|||
129113058|NCT02869789|464709638|FG003|Overall Study|Other reasons|0|||
129113059|NCT02127658|464709653|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
129113060|NCT02127658|464709654|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
129113061|NCT02127658|464709653|FG000|Overall Study|Withdrawal by Subject|0|||
129113062|NCT02127658|464709654|FG001|Overall Study|Withdrawal by Subject|2|||
129113063|NCT02127658|464709653|FG000|Overall Study|Physician Decision|0|||
129113064|NCT02127658|464709654|FG001|Overall Study|Physician Decision|1|||
129113065|NCT01443858|464709655|FG000|Overall Study|Withdrawal by Subject|9|||
129113066|NCT01443858|464709656|FG001|Overall Study|Withdrawal by Subject|8|||
129113067|NCT01443858|464709657|FG002|Overall Study|Withdrawal by Subject|5|||
129113068|NCT01443858|464709655|FG000|Overall Study|Lack of Efficacy|1|||
129113069|NCT01443858|464709656|FG001|Overall Study|Lack of Efficacy|0|||
129113070|NCT01443858|464709657|FG002|Overall Study|Lack of Efficacy|0|||
129113071|NCT01443858|464709655|FG000|Overall Study|Lost to Follow-up|5|||
129113072|NCT01443858|464709656|FG001|Overall Study|Lost to Follow-up|5|||
129113073|NCT01443858|464709657|FG002|Overall Study|Lost to Follow-up|2|||
129113074|NCT01867008|464709658|FG000|Overall Study|Withdrawal by Subject|1|||
129113075|NCT01534273|464709659|FG000|Period 1|Physician Decision|0|||
129113076|NCT01534273|464709660|FG001|Period 1|Physician Decision|0|||
129113077|NCT01534273|464709661|FG002|Period 1|Physician Decision|0|||
129113078|NCT01534273|464709662|FG003|Period 1|Physician Decision|1|||
129113079|NCT01534273|464709663|FG004|Period 1|Physician Decision|0|||
129113080|NCT01534273|464709664|FG005|Period 1|Physician Decision|0|||
129113081|NCT01534273|464709665|FG006|Period 1|Physician Decision|0|||
129113082|NCT03586050|464709666|FG000|Overall Study|Death|3|||
129113083|NCT03586050|464709666|FG000|Overall Study|Withdrawal by Subject|2|||
129113084|NCT01435759|464709668|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
129113085|NCT01435759|464709669|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
129113086|NCT01435759|464709670|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
129113087|NCT01435759|464709671|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
129113088|NCT01435759|464709672|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
128899825|NCT02819635|463927164|FG008|Substudy 3|Lost to Follow-up|1|||
128899826|NCT02819635|463927165|FG009|Substudy 3|Lost to Follow-up|0|||
128899827|NCT02819635|463927166|FG010|Substudy 3|Lost to Follow-up|1|||
128899828|NCT02819635|463927167|FG011|Substudy 3|Lost to Follow-up|1|||
129113089|NCT01435759|464709673|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
129113090|NCT01435759|464709668|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
129113091|NCT01435759|464709669|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
129113092|NCT01435759|464709670|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
129113093|NCT01435759|464709671|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
129113094|NCT01435759|464709672|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
129113095|NCT01435759|464709673|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
129113096|NCT01435759|464709668|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
129113097|NCT01435759|464709669|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129113098|NCT01435759|464709670|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129113099|NCT01435759|464709671|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129113100|NCT01435759|464709672|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129113101|NCT01435759|464709673|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129113102|NCT01435759|464709668|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
129113103|NCT01435759|464709669|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129113104|NCT01435759|464709670|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129113105|NCT01435759|464709671|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129113106|NCT01435759|464709672|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129113107|NCT01435759|464709673|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129113108|NCT01435759|464709668|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
129113109|NCT01435759|464709669|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113110|NCT01435759|464709670|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113111|NCT01435759|464709671|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113112|NCT01435759|464709672|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113113|NCT01435759|464709673|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113114|NCT01435759|464709668|FG000|Antidepressant Lead-in Phase|Other|119|||
129113115|NCT01435759|464709669|FG001|Antidepressant Lead-in Phase|Other|0|||
129113116|NCT01435759|464709670|FG002|Antidepressant Lead-in Phase|Other|0|||
128899829|NCT02819635|463927156|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899830|NCT02819635|463927157|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899831|NCT02819635|463927158|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899832|NCT02819635|463927159|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899833|NCT02819635|463927160|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
129023446|NCT03121586|464378329|FG001|Overall Study|Not further specified|11|||
129023447|NCT03121586|464378330|FG002|Overall Study|Not further specified|10|||
129023448|NCT03121586|464378328|FG000|Overall Study|Adverse Event|16|||
129023449|NCT03121586|464378329|FG001|Overall Study|Adverse Event|5|||
129023450|NCT03121586|464378330|FG002|Overall Study|Adverse Event|6|||
129023451|NCT03121586|464378328|FG000|Overall Study|Protocol Violation|0|||
129023452|NCT03121586|464378329|FG001|Overall Study|Protocol Violation|5|||
129023453|NCT03121586|464378330|FG002|Overall Study|Protocol Violation|0|||
129023454|NCT03121586|464378328|FG000|Overall Study|Lack of Efficacy|3|||
129023455|NCT03121586|464378329|FG001|Overall Study|Lack of Efficacy|3|||
129023456|NCT03121586|464378330|FG002|Overall Study|Lack of Efficacy|1|||
129023457|NCT03121586|464378328|FG000|Overall Study|Physician Decision|2|||
129023458|NCT03121586|464378329|FG001|Overall Study|Physician Decision|2|||
129023459|NCT03121586|464378330|FG002|Overall Study|Physician Decision|0|||
129023460|NCT03121586|464378328|FG000|Overall Study|Noncompliance with study drug|5|||
129023461|NCT03121586|464378329|FG001|Overall Study|Noncompliance with study drug|3|||
129023462|NCT03121586|464378330|FG002|Overall Study|Noncompliance with study drug|5|||
129023463|NCT03121586|464378328|FG000|Overall Study|Lost to Follow-up|4|||
129023464|NCT03121586|464378329|FG001|Overall Study|Lost to Follow-up|2|||
129023465|NCT03121586|464378330|FG002|Overall Study|Lost to Follow-up|0|||
129023466|NCT03121586|464378328|FG000|Overall Study|Death|2|||
129023467|NCT03121586|464378329|FG001|Overall Study|Death|0|||
129023468|NCT03121586|464378330|FG002|Overall Study|Death|0|||
129023469|NCT06381102|464378331|FG000|Washout 5 Days|Withdrawal by Subject|0|||
129023470|NCT06381102|464378332|FG001|Washout 5 Days|Withdrawal by Subject|2|||
129023471|NCT01987765|464378334|FG000|Overall Study|Protocol Violation|65|||
129023472|NCT01987765|464378334|FG000|Overall Study|Lost to Follow-up|37|||
129023473|NCT01528696|464378335|FG000|Overall Study|See detailed description|18|||
129023474|NCT01528696|464378336|FG001|Overall Study|See detailed description|19|||
129023475|NCT03600805|464378337|FG000|Overall Study|Adverse Event|2|||
129023476|NCT03600805|464378338|FG001|Overall Study|Adverse Event|1|||
129023477|NCT03600805|464378339|FG002|Overall Study|Adverse Event|1|||
129023478|NCT03600805|464378340|FG003|Overall Study|Adverse Event|7|||
129023479|NCT03600805|464378337|FG000|Overall Study|Lack of Efficacy|2|||
129023480|NCT03600805|464378338|FG001|Overall Study|Lack of Efficacy|1|||
129023481|NCT03600805|464378339|FG002|Overall Study|Lack of Efficacy|0|||
129023482|NCT03600805|464378340|FG003|Overall Study|Lack of Efficacy|0|||
129023483|NCT03600805|464378337|FG000|Overall Study|Withdrawal by Subject|1|||
129113117|NCT01435759|464709671|FG003|Antidepressant Lead-in Phase|Other|0|||
129113118|NCT01435759|464709672|FG004|Antidepressant Lead-in Phase|Other|0|||
129113119|NCT01435759|464709673|FG005|Antidepressant Lead-in Phase|Other|0|||
129023484|NCT03600805|464378338|FG001|Overall Study|Withdrawal by Subject|0|||
129023485|NCT03600805|464378339|FG002|Overall Study|Withdrawal by Subject|0|||
129023486|NCT03600805|464378340|FG003|Overall Study|Withdrawal by Subject|1|||
129023487|NCT03600805|464378337|FG000|Overall Study|Other unspecified|14|||
129023488|NCT03600805|464378338|FG001|Overall Study|Other unspecified|6|||
129023489|NCT03600805|464378339|FG002|Overall Study|Other unspecified|7|||
129023490|NCT03600805|464378340|FG003|Overall Study|Other unspecified|11|||
129023491|NCT06195579|464378341|FG000|Overall Study|Withdrawal by Subject|1|||
129023492|NCT02545283|464378342|FG000|Overall Study|Lost to Follow-up|2|||
129023493|NCT02545283|464378343|FG001|Overall Study|Lost to Follow-up|4|||
129023494|NCT02545283|464378342|FG000|Overall Study|Withdrawal by Subject|5|||
128899834|NCT02819635|463927161|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899835|NCT02819635|463927162|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899836|NCT02819635|463927163|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899837|NCT02819635|463927164|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899838|NCT02819635|463927165|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899839|NCT02819635|463927166|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
128899840|NCT02819635|463927167|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
128899841|NCT02819635|463927156|FG000|Substudy 3|Other, not specified|0|||
128899842|NCT02819635|463927157|FG001|Substudy 3|Other, not specified|0|||
128899843|NCT02819635|463927158|FG002|Substudy 3|Other, not specified|0|||
128899844|NCT02819635|463927159|FG003|Substudy 3|Other, not specified|0|||
128899845|NCT02819635|463927160|FG004|Substudy 3|Other, not specified|0|||
128899846|NCT02819635|463927161|FG005|Substudy 3|Other, not specified|0|||
128899847|NCT02819635|463927162|FG006|Substudy 3|Other, not specified|0|||
128899848|NCT02819635|463927163|FG007|Substudy 3|Other, not specified|0|||
128899849|NCT02819635|463927164|FG008|Substudy 3|Other, not specified|202|||
128899850|NCT02819635|463927165|FG009|Substudy 3|Other, not specified|5|||
128899851|NCT02819635|463927166|FG010|Substudy 3|Other, not specified|89|||
128899852|NCT02819635|463927167|FG011|Substudy 3|Other, not specified|39|||
128899853|NCT03179891|463927169|FG000|First Intervention|Withdrawal by Subject|1|||
128899854|NCT03179891|463927170|FG001|First Intervention|Withdrawal by Subject|1|||
128899855|NCT03179891|463927169|FG000|First Intervention|Unspecified reason|1|||
128899856|NCT03179891|463927170|FG001|First Intervention|Unspecified reason|0|||
128899857|NCT03179891|463927169|FG000|First Intervention|Protocol Violation|0|||
128899858|NCT03179891|463927170|FG001|First Intervention|Protocol Violation|1|||
128899859|NCT04416555|463927171|FG000|Overall Study|Withdrawal by Subject|0|||
128899860|NCT04416555|463927172|FG001|Overall Study|Withdrawal by Subject|3|||
128899861|NCT02004262|463927183|FG000|Overall Study|Death|67|||
128899862|NCT02004262|463927184|FG001|Overall Study|Death|64|||
128899863|NCT02004262|463927185|FG002|Overall Study|Death|66|||
128899864|NCT02004262|463927186|FG003|Overall Study|Death|28|||
128899865|NCT02004262|463927187|FG004|Overall Study|Death|29|||
128899866|NCT02004262|463927188|FG005|Overall Study|Death|22|||
128899867|NCT02004262|463927183|FG000|Overall Study|Withdrawal by Subject|1|||
128899868|NCT02004262|463927184|FG001|Overall Study|Withdrawal by Subject|0|||
128899869|NCT02004262|463927185|FG002|Overall Study|Withdrawal by Subject|4|||
128899870|NCT02004262|463927186|FG003|Overall Study|Withdrawal by Subject|0|||
129023495|NCT02545283|464378343|FG001|Overall Study|Withdrawal by Subject|9|||
129113120|NCT01435759|464709668|FG000|Double-blind Phase|Adverse Event|7|||
129113121|NCT01435759|464709669|FG001|Double-blind Phase|Adverse Event|0|||
129023496|NCT02545283|464378342|FG000|Overall Study|Death|109|||
129023497|NCT02545283|464378343|FG001|Overall Study|Death|211|||
129023498|NCT02545283|464378342|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
129023499|NCT02545283|464378343|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
129023500|NCT02545283|464378342|FG000|Overall Study|Study Terminated By Sponsor|33|||
129023501|NCT02545283|464378343|FG001|Overall Study|Study Terminated By Sponsor|71|||
129023502|NCT01205035|464378355|FG000|Overall Study|Withdrawal by Subject|1|||
129023503|NCT01205035|464378356|FG001|Overall Study|Withdrawal by Subject|0|||
129023504|NCT01205035|464378355|FG000|Overall Study|Physician Decision|1|||
129023505|NCT01205035|464378356|FG001|Overall Study|Physician Decision|0|||
129023506|NCT00488774|464378357|FG000|Overall Study|Withdrawal of consent|2|||
129023507|NCT00488774|464378358|FG001|Overall Study|Withdrawal of consent|2|||
129023508|NCT00488774|464378359|FG002|Overall Study|Withdrawal of consent|2|||
129023509|NCT00488774|464378360|FG003|Overall Study|Withdrawal of consent|0|||
129023510|NCT00488774|464378357|FG000|Overall Study|Other|6|||
129023511|NCT00488774|464378358|FG001|Overall Study|Other|3|||
129023512|NCT00488774|464378359|FG002|Overall Study|Other|2|||
129023513|NCT00488774|464378360|FG003|Overall Study|Other|2|||
129023514|NCT00488774|464378357|FG000|Overall Study|Lost to Follow-up|0|||
129023515|NCT00488774|464378358|FG001|Overall Study|Lost to Follow-up|0|||
129023516|NCT00488774|464378359|FG002|Overall Study|Lost to Follow-up|1|||
129023517|NCT00488774|464378360|FG003|Overall Study|Lost to Follow-up|1|||
129023518|NCT03128723|464378363|FG000|Overall Study|Withdrawal by Subject|2|||
129023519|NCT00673660|464378364|FG000|Overall Study|Lost to Follow-up|107|||
128899871|NCT02004262|463927187|FG004|Overall Study|Withdrawal by Subject|1|||
128899872|NCT02004262|463927188|FG005|Overall Study|Withdrawal by Subject|3|||
128899873|NCT02004262|463927183|FG000|Overall Study|Lost to Follow-up|1|||
128899874|NCT02004262|463927184|FG001|Overall Study|Lost to Follow-up|1|||
128899875|NCT02004262|463927185|FG002|Overall Study|Lost to Follow-up|0|||
128899876|NCT02004262|463927186|FG003|Overall Study|Lost to Follow-up|0|||
128899877|NCT02004262|463927187|FG004|Overall Study|Lost to Follow-up|0|||
128899878|NCT02004262|463927188|FG005|Overall Study|Lost to Follow-up|0|||
128899879|NCT02004262|463927183|FG000|Overall Study|Study Terminated by Sponsor|4|||
129023520|NCT00245063|464378365|FG000|Overall Study|Adverse Event|6|||
129023521|NCT00245063|464378366|FG001|Overall Study|Adverse Event|5|||
129023522|NCT00245063|464378365|FG000|Overall Study|Death|1|||
129023523|NCT00245063|464378366|FG001|Overall Study|Death|0|||
129113122|NCT01435759|464709670|FG002|Double-blind Phase|Adverse Event|1|||
128692630|NCT00313300|463174154|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
128692631|NCT00313300|463174155|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
128692632|NCT00313300|463174156|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
128692633|NCT00313300|463174152|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
128692634|NCT00313300|463174153|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
128899880|NCT02004262|463927184|FG001|Overall Study|Study Terminated by Sponsor|3|||
128899881|NCT02004262|463927185|FG002|Overall Study|Study Terminated by Sponsor|2|||
128899882|NCT02004262|463927186|FG003|Overall Study|Study Terminated by Sponsor|1|||
128899883|NCT02004262|463927187|FG004|Overall Study|Study Terminated by Sponsor|1|||
128899884|NCT02004262|463927188|FG005|Overall Study|Study Terminated by Sponsor|5|||
128899885|NCT01923285|463927189|FG000|Overall Study|Withdrawal by Subject|7|||
128899886|NCT01923285|463927190|FG001|Overall Study|Withdrawal by Subject|6|||
128899887|NCT01617070|463927194|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
128899888|NCT00808236|463927195|FG000|Overall Study|Was not resuscitated|50|||
128899889|NCT00808236|463927196|FG001|Overall Study|Was not resuscitated|56|||
128692635|NCT00313300|463174154|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
128692636|NCT00313300|463174155|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
128692637|NCT00313300|463174156|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
128692638|NCT00313300|463174152|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
128692639|NCT00313300|463174153|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
128692640|NCT00313300|463174154|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
128692641|NCT00313300|463174155|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
128692642|NCT00313300|463174156|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
128692643|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
128692644|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
128692645|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
128692646|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
128692647|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
128692648|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
128692649|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
128692650|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
128692651|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
128692652|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
128692653|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
128692654|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
128692655|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
128692656|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
128692657|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
128692658|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
128692659|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
128692660|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
128692661|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
128692662|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
128692663|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
128692664|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
128692665|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
128692666|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
128692667|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
128692668|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
128692669|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
128899890|NCT00808236|463927195|FG000|Overall Study|Pre-defined exclusion|13|||
128899891|NCT00808236|463927196|FG001|Overall Study|Pre-defined exclusion|3|||
129023524|NCT05099380|464378367|FG000|Overall Study|Subject enrolled in error|1|||
129023525|NCT05099380|464378368|FG001|Overall Study|Subject enrolled in error|0|||
129023526|NCT05099380|464378367|FG000|Overall Study|Study Procedure|1|||
128692670|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
128692671|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
128692672|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
128692673|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
128692674|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
128692675|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
128692676|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
128692677|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
128692678|NCT00313300|463174152|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
128692679|NCT00313300|463174153|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
128692680|NCT00313300|463174154|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
128692681|NCT00313300|463174155|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
129023527|NCT05099380|464378368|FG001|Overall Study|Study Procedure|0|||
129113123|NCT01435759|464709671|FG003|Double-blind Phase|Adverse Event|1|||
129113124|NCT01435759|464709672|FG004|Double-blind Phase|Adverse Event|1|||
128692682|NCT00313300|463174156|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
128899892|NCT00808236|463927195|FG000|Overall Study|Lost to Follow-up|1|||
128899893|NCT00808236|463927196|FG001|Overall Study|Lost to Follow-up|1|||
128899894|NCT00808236|463927195|FG000|Overall Study|Physician Decision|0|||
128899895|NCT00808236|463927196|FG001|Overall Study|Physician Decision|1|||
128899896|NCT00808236|463927195|FG000|Overall Study|Death|18|||
128899897|NCT00808236|463927196|FG001|Overall Study|Death|30|||
128899898|NCT02230384|463927197|FG000|Phase 1|Lost to Follow-up|1|||
128899899|NCT02230384|463927198|FG001|Phase 1|Lost to Follow-up|0|||
128899900|NCT02230384|463927197|FG000|Phase 1|Physician Decision|0|||
128899901|NCT02230384|463927198|FG001|Phase 1|Physician Decision|1|||
128899902|NCT02230384|463927197|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
128899903|NCT02230384|463927198|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
128899904|NCT02230384|463927197|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
128899905|NCT02230384|463927198|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
128899906|NCT02230384|463927197|FG000|Phase 2 - Switch|Adverse Event|2|||
128899907|NCT02230384|463927198|FG001|Phase 2 - Switch|Adverse Event|0|||
128899908|NCT00777101|463927199|FG000|Overall Study|Death|48|||
128899909|NCT00777101|463927200|FG001|Overall Study|Death|43|||
128899910|NCT00777101|463927199|FG000|Overall Study|Withdrawal by Subject|11|||
128899911|NCT00777101|463927200|FG001|Overall Study|Withdrawal by Subject|6|||
128899912|NCT00777101|463927199|FG000|Overall Study|Lost to Follow-up|2|||
128899913|NCT00777101|463927200|FG001|Overall Study|Lost to Follow-up|1|||
128899914|NCT00777101|463927199|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
128899915|NCT00777101|463927200|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
128899916|NCT00777101|463927199|FG000|Overall Study|Failed to Return|0|||
128899917|NCT00777101|463927200|FG001|Overall Study|Failed to Return|1|||
128899918|NCT00961220|463927201|FG000|Overall Study|Adverse Event|3|||
128899919|NCT00961220|463927201|FG000|Overall Study|Lack of Efficacy|1|||
128899920|NCT00961220|463927201|FG000|Overall Study|No IV access for O6BG|1|||
128899921|NCT00961220|463927201|FG000|Overall Study|O6BG no longer supplied|1|||
128692683|NCT00313300|463174152|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
128692684|NCT00313300|463174153|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
128692685|NCT00313300|463174154|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
128899922|NCT00961220|463927201|FG000|Overall Study|Complete Response prior to 12 courses|1|||
128899923|NCT05376215|463927202|FG000|Overall Study|Withdrawal by Subject|2|||
129023528|NCT05099380|464378367|FG000|Overall Study|Protocol Violation|1|||
129023529|NCT05099380|464378368|FG001|Overall Study|Protocol Violation|0|||
129023530|NCT05099380|464378367|FG000|Overall Study|Adverse Event|1|||
129023531|NCT05099380|464378368|FG001|Overall Study|Adverse Event|1|||
129023532|NCT05099380|464378367|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
129023533|NCT05099380|464378368|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
129023534|NCT00835263|464378369|FG000|Second Intervention|Adverse Event|1|||
129023535|NCT00835263|464378370|FG001|Second Intervention|Adverse Event|0|||
129023536|NCT03249454|464378371|FG000|Overall Study|Withdrawal by Subject|0|||
129023537|NCT03249454|464378372|FG001|Overall Study|Withdrawal by Subject|0|||
129023538|NCT03249454|464378373|FG002|Overall Study|Withdrawal by Subject|0|||
129023539|NCT03249454|464378374|FG003|Overall Study|Withdrawal by Subject|0|||
129023540|NCT03249454|464378375|FG004|Overall Study|Withdrawal by Subject|0|||
129023541|NCT03249454|464378376|FG005|Overall Study|Withdrawal by Subject|0|||
129023542|NCT03249454|464378377|FG006|Overall Study|Withdrawal by Subject|0|||
129023543|NCT03249454|464378378|FG007|Overall Study|Withdrawal by Subject|0|||
129023544|NCT03249454|464378379|FG008|Overall Study|Withdrawal by Subject|0|||
129023545|NCT03249454|464378380|FG009|Overall Study|Withdrawal by Subject|1|||
129023546|NCT03249454|464378381|FG010|Overall Study|Withdrawal by Subject|1|||
129023547|NCT01913405|464378382|FG000|Overall Study|Withdrawal by Subject|1|||
129023548|NCT01913405|464378382|FG000|Overall Study|Adverse Event|1|||
129023549|NCT01020474|464378385|FG000|Overall Study|Adverse Event|4|||
129023550|NCT01020474|464378386|FG001|Overall Study|Adverse Event|4|||
129023551|NCT01020474|464378385|FG000|Overall Study|Protocol Violation|0|||
129023552|NCT01020474|464378386|FG001|Overall Study|Protocol Violation|2|||
129023553|NCT01020474|464378385|FG000|Overall Study|Withdrawal by Subject|5|||
128899924|NCT05376215|463927203|FG001|Overall Study|Withdrawal by Subject|1|||
128899925|NCT05376215|463927202|FG000|Overall Study|Lost to Follow-up|0|||
129023554|NCT01020474|464378386|FG001|Overall Study|Withdrawal by Subject|7|||
129023555|NCT01020474|464378385|FG000|Overall Study|Other Reasons|1|||
129023556|NCT01020474|464378386|FG001|Overall Study|Other Reasons|1|||
129023557|NCT01020474|464378385|FG000|Overall Study|Insufficient Clinical Response|0|||
129023558|NCT01020474|464378386|FG001|Overall Study|Insufficient Clinical Response|3|||
129023559|NCT03199963|464378389|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
128899926|NCT05376215|463927203|FG001|Overall Study|Lost to Follow-up|1|||
128899927|NCT01301950|463927212|FG000|Overall Study|Surgery was cancelled by patient|0|||
128899928|NCT01301950|463927213|FG001|Overall Study|Surgery was cancelled by patient|1|||
128899929|NCT00825162|463927218|FG000|Overall Study|Withdrawal by Subject|11|||
128692686|NCT00313300|463174155|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
128692687|NCT00313300|463174156|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
128692688|NCT00313300|463174152|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
128899930|NCT00825162|463927219|FG001|Overall Study|Withdrawal by Subject|13|||
128899931|NCT00825162|463927220|FG002|Overall Study|Withdrawal by Subject|3|||
128899932|NCT00825162|463927218|FG000|Overall Study|Lost to Follow-up|9|||
128899933|NCT00825162|463927219|FG001|Overall Study|Lost to Follow-up|6|||
128899934|NCT00825162|463927220|FG002|Overall Study|Lost to Follow-up|3|||
128899935|NCT00825162|463927218|FG000|Overall Study|Physician Decision|2|||
128899936|NCT00825162|463927219|FG001|Overall Study|Physician Decision|0|||
128899937|NCT00825162|463927220|FG002|Overall Study|Physician Decision|0|||
128899938|NCT00825162|463927218|FG000|Overall Study|Move away from the study area|1|||
128899939|NCT00825162|463927219|FG001|Overall Study|Move away from the study area|0|||
128899940|NCT00825162|463927220|FG002|Overall Study|Move away from the study area|0|||
128899941|NCT00825162|463927218|FG000|Overall Study|Unable to attend the study visit|5|||
128899942|NCT00825162|463927219|FG001|Overall Study|Unable to attend the study visit|2|||
128899943|NCT00825162|463927220|FG002|Overall Study|Unable to attend the study visit|0|||
128899944|NCT00964743|463927224|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
128899945|NCT00781911|463927225|FG000|Overall Study|Adverse Event|4|||
128899946|NCT00781911|463927226|FG001|Overall Study|Adverse Event|4|||
128899947|NCT00781911|463927225|FG000|Overall Study|Withdrawal by Subject|1|||
128899948|NCT00781911|463927226|FG001|Overall Study|Withdrawal by Subject|2|||
128899949|NCT00781911|463927225|FG000|Overall Study|Physician Decision|0|||
128899950|NCT00781911|463927226|FG001|Overall Study|Physician Decision|2|||
128899951|NCT00781911|463927225|FG000|Overall Study|Sponsor Decision|1|||
128899952|NCT00781911|463927226|FG001|Overall Study|Sponsor Decision|0|||
128899953|NCT03317795|463927229|FG000|Overall Study|IUD Expulsion|1|||
128899954|NCT03317795|463927230|FG001|Overall Study|IUD Expulsion|0|||
128899955|NCT03317795|463927229|FG000|Overall Study|Lost to Follow-up|1|||
128899956|NCT03317795|463927230|FG001|Overall Study|Lost to Follow-up|3|||
128899957|NCT03317795|463927229|FG000|Overall Study|Treatment change|0|||
128899958|NCT03317795|463927230|FG001|Overall Study|Treatment change|3|||
128899959|NCT03317795|463927229|FG000|Overall Study|Intolerance of medication|0|||
128899960|NCT03317795|463927230|FG001|Overall Study|Intolerance of medication|1|||
128899961|NCT01549002|463927231|FG000|Overall Study|Excessive pain|0|||
128899962|NCT01549002|463927232|FG001|Overall Study|Excessive pain|2|||
128899963|NCT01549002|463927231|FG000|Overall Study|Moderate sedation required|0|||
128899964|NCT01549002|463927232|FG001|Overall Study|Moderate sedation required|2|||
128899965|NCT02424253|463927235|FG000|Overall Study|Other, unspecified|1|||
128899966|NCT02424253|463927236|FG001|Overall Study|Other, unspecified|0|||
128899967|NCT02424253|463927235|FG000|Overall Study|Compliance problems|1|||
128899968|NCT02424253|463927236|FG001|Overall Study|Compliance problems|0|||
128899969|NCT02424253|463927235|FG000|Overall Study|Physician Decision|2|||
128899970|NCT02424253|463927236|FG001|Overall Study|Physician Decision|0|||
128899971|NCT02424253|463927235|FG000|Overall Study|Lack of Efficacy|0|||
128899972|NCT02424253|463927236|FG001|Overall Study|Lack of Efficacy|7|||
128899973|NCT02424253|463927235|FG000|Overall Study|Adverse Event|2|||
128899974|NCT02424253|463927236|FG001|Overall Study|Adverse Event|0|||
128899975|NCT02424253|463927235|FG000|Overall Study|Consent withdrawn by subject|4|||
128899976|NCT02424253|463927236|FG001|Overall Study|Consent withdrawn by subject|1|||
128899977|NCT02424253|463927235|FG000|Overall Study|Lost to Follow-up|1|||
128899978|NCT02424253|463927236|FG001|Overall Study|Lost to Follow-up|1|||
128899979|NCT02290873|463927239|FG000|Overall Study|Withdrawal by Subject|0|||
128899980|NCT02290873|463927240|FG001|Overall Study|Withdrawal by Subject|1|||
128899981|NCT02290873|463927241|FG002|Overall Study|Withdrawal by Subject|1|||
128899982|NCT02290873|463927239|FG000|Overall Study|Nellcor device error|1|||
128899983|NCT02290873|463927240|FG001|Overall Study|Nellcor device error|0|||
128899984|NCT02290873|463927241|FG002|Overall Study|Nellcor device error|0|||
128899985|NCT02290873|463927239|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
128899986|NCT02290873|463927240|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
128899987|NCT02290873|463927241|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
128899988|NCT02290873|463927239|FG000|Overall Study|Protocol Violation|0|||
128899989|NCT02290873|463927240|FG001|Overall Study|Protocol Violation|0|||
128899990|NCT02290873|463927241|FG002|Overall Study|Protocol Violation|1|||
128899991|NCT01378104|463927242|FG000|Overall Study|Adverse Event|8|||
128899992|NCT01378104|463927243|FG001|Overall Study|Adverse Event|8|||
128899993|NCT01378104|463927242|FG000|Overall Study|Lack of Efficacy|7|||
128899994|NCT01378104|463927243|FG001|Overall Study|Lack of Efficacy|5|||
128899995|NCT01378104|463927242|FG000|Overall Study|Withdrawal by Subject|12|||
128899996|NCT01378104|463927243|FG001|Overall Study|Withdrawal by Subject|13|||
128899997|NCT01473563|463927244|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
128899998|NCT01519765|463927245|FG000|Overall Study|Adverse Event|0|||
128899999|NCT01519765|463927246|FG001|Overall Study|Adverse Event|1|||
128900000|NCT01519765|463927245|FG000|Overall Study|Lack of Efficacy|2|||
128900001|NCT01519765|463927246|FG001|Overall Study|Lack of Efficacy|0|||
128900002|NCT01519765|463927245|FG000|Overall Study|Protocol Violation|1|||
128900003|NCT01519765|463927246|FG001|Overall Study|Protocol Violation|0|||
128692689|NCT00313300|463174153|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
128692690|NCT00313300|463174154|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
128692691|NCT00313300|463174155|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
128692692|NCT00313300|463174156|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
128692693|NCT00313300|463174152|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
128692694|NCT00313300|463174153|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
128692695|NCT00313300|463174154|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
128692696|NCT00313300|463174155|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
128692697|NCT00313300|463174156|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
128692698|NCT00313300|463174152|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
128692699|NCT00313300|463174153|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
128692700|NCT00313300|463174154|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
128692701|NCT00313300|463174155|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
128692702|NCT00313300|463174156|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
128692703|NCT00313300|463174152|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
128692704|NCT00313300|463174153|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
128692705|NCT00313300|463174154|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
128692706|NCT00313300|463174155|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
128692707|NCT00313300|463174156|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
128692708|NCT00313300|463174152|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
128692709|NCT00313300|463174153|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
128692710|NCT00313300|463174154|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
128692711|NCT00313300|463174155|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
128692712|NCT00313300|463174156|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
128692713|NCT02336373|463174157|FG000|Overall Study|Protocol closed early|4|||
128692714|NCT02336373|463174157|FG000|Overall Study|Physician Decision|14|||
128692715|NCT00850343|463174158|FG000|Overall Study|Withdrawal by Subject|11|||
128692716|NCT00850343|463174159|FG001|Overall Study|Withdrawal by Subject|0|||
128692717|NCT00850343|463174160|FG002|Overall Study|Withdrawal by Subject|3|||
128692718|NCT00850343|463174161|FG003|Overall Study|Withdrawal by Subject|2|||
128692719|NCT00850343|463174158|FG000|Overall Study|Adverse Event|15|||
128692720|NCT00850343|463174159|FG001|Overall Study|Adverse Event|2|||
128692721|NCT00850343|463174160|FG002|Overall Study|Adverse Event|6|||
129113125|NCT01435759|464709673|FG005|Double-blind Phase|Adverse Event|3|||
129113126|NCT01435759|464709668|FG000|Double-blind Phase|Protocol Violation|2|||
129113127|NCT01435759|464709669|FG001|Double-blind Phase|Protocol Violation|0|||
129113128|NCT01435759|464709670|FG002|Double-blind Phase|Protocol Violation|1|||
129113129|NCT01435759|464709671|FG003|Double-blind Phase|Protocol Violation|2|||
129113130|NCT01435759|464709672|FG004|Double-blind Phase|Protocol Violation|0|||
129113131|NCT01435759|464709673|FG005|Double-blind Phase|Protocol Violation|1|||
129113132|NCT01435759|464709668|FG000|Double-blind Phase|Withdrawal by Subject|17|||
129113133|NCT01435759|464709669|FG001|Double-blind Phase|Withdrawal by Subject|4|||
129113134|NCT01435759|464709670|FG002|Double-blind Phase|Withdrawal by Subject|3|||
129113135|NCT01435759|464709671|FG003|Double-blind Phase|Withdrawal by Subject|4|||
129113136|NCT01435759|464709672|FG004|Double-blind Phase|Withdrawal by Subject|2|||
129113137|NCT01435759|464709673|FG005|Double-blind Phase|Withdrawal by Subject|2|||
129113138|NCT01435759|464709668|FG000|Double-blind Phase|Lost to Follow-up|31|||
129113139|NCT01435759|464709669|FG001|Double-blind Phase|Lost to Follow-up|1|||
129113140|NCT01435759|464709670|FG002|Double-blind Phase|Lost to Follow-up|2|||
129113141|NCT01435759|464709671|FG003|Double-blind Phase|Lost to Follow-up|0|||
129113142|NCT01435759|464709672|FG004|Double-blind Phase|Lost to Follow-up|3|||
129113143|NCT01435759|464709673|FG005|Double-blind Phase|Lost to Follow-up|3|||
129113144|NCT01435759|464709668|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
129113145|NCT01435759|464709669|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113146|NCT01435759|464709670|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113147|NCT01435759|464709671|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113148|NCT01435759|464709672|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
129113149|NCT01435759|464709673|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129113150|NCT01435759|464709668|FG000|Double-blind Phase|Other|8|||
129113151|NCT01435759|464709669|FG001|Double-blind Phase|Other|2|||
129113152|NCT01435759|464709670|FG002|Double-blind Phase|Other|0|||
129113153|NCT01435759|464709671|FG003|Double-blind Phase|Other|2|||
129113154|NCT01435759|464709672|FG004|Double-blind Phase|Other|0|||
128692722|NCT00850343|463174161|FG003|Overall Study|Adverse Event|6|||
128692723|NCT00850343|463174158|FG000|Overall Study|Pregnancy|0|||
128692724|NCT00850343|463174159|FG001|Overall Study|Pregnancy|0|||
128692725|NCT00850343|463174160|FG002|Overall Study|Pregnancy|0|||
129113155|NCT01435759|464709673|FG005|Double-blind Phase|Other|0|||
129113156|NCT01211145|464709674|FG000|Overall Study|Reason not specified|3|||
129113157|NCT01211145|464709675|FG001|Overall Study|Reason not specified|2|||
129113158|NCT01211145|464709676|FG002|Overall Study|Reason not specified|2|||
129113159|NCT01211145|464709677|FG003|Overall Study|Reason not specified|1|||
128692726|NCT00850343|463174161|FG003|Overall Study|Pregnancy|1|||
128692727|NCT00850343|463174158|FG000|Overall Study|Lack of Efficacy|17|||
128692728|NCT00850343|463174159|FG001|Overall Study|Lack of Efficacy|0|||
128692729|NCT00850343|463174160|FG002|Overall Study|Lack of Efficacy|3|||
128692730|NCT00850343|463174161|FG003|Overall Study|Lack of Efficacy|2|||
128692731|NCT00850343|463174158|FG000|Overall Study|Non-compliance with Study Procedures|1|||
128692732|NCT00850343|463174159|FG001|Overall Study|Non-compliance with Study Procedures|0|||
128692733|NCT00850343|463174160|FG002|Overall Study|Non-compliance with Study Procedures|1|||
128692734|NCT00850343|463174161|FG003|Overall Study|Non-compliance with Study Procedures|1|||
128692735|NCT00850343|463174158|FG000|Overall Study|Physician Decision|2|||
128692736|NCT00850343|463174159|FG001|Overall Study|Physician Decision|1|||
128692737|NCT00850343|463174160|FG002|Overall Study|Physician Decision|1|||
128692738|NCT00850343|463174161|FG003|Overall Study|Physician Decision|1|||
128692739|NCT02764333|463174164|FG000|Overall Study|Ineligible|1|||
128692740|NCT01788046|463174172|FG000|Overall Study|Withdrawal by Subject|12|||
128692741|NCT01788046|463174173|FG001|Overall Study|Withdrawal by Subject|12|||
128692742|NCT01788046|463174172|FG000|Overall Study|Lost to Follow-up|12|||
128692743|NCT01788046|463174173|FG001|Overall Study|Lost to Follow-up|19|||
128692744|NCT01788046|463174172|FG000|Overall Study|Death|7|||
128692745|NCT01788046|463174173|FG001|Overall Study|Death|5|||
128692746|NCT01788046|463174172|FG000|Overall Study|Protocol Specified Criteria|25|||
128692747|NCT01788046|463174173|FG001|Overall Study|Protocol Specified Criteria|1|||
128692748|NCT01856907|463174174|FG000|Overall Study|Pregnancy|0|||
128692749|NCT01856907|463174175|FG001|Overall Study|Pregnancy|1|||
128692750|NCT01856907|463174176|FG002|Overall Study|Pregnancy|0|||
128692751|NCT01856907|463174174|FG000|Overall Study|Pregnancy|0|||
128692752|NCT01856907|463174175|FG001|Overall Study|Pregnancy|1|||
128692753|NCT01856907|463174176|FG002|Overall Study|Pregnancy|0|||
128692754|NCT01856907|463174174|FG000|Overall Study|Withdrawal by Subject|0|||
128692755|NCT01856907|463174175|FG001|Overall Study|Withdrawal by Subject|1|||
128692756|NCT01856907|463174176|FG002|Overall Study|Withdrawal by Subject|0|||
128692757|NCT01604408|463174179|FG000|Treatment Period 1|Protocol Violation|0|||
128692758|NCT01604408|463174180|FG001|Treatment Period 1|Protocol Violation|1|||
128692759|NCT01604408|463174179|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128692760|NCT01604408|463174180|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128692761|NCT01604408|463174179|FG000|Treatment Period 2|Protocol Violation|1|||
128692762|NCT01604408|463174180|FG001|Treatment Period 2|Protocol Violation|0|||
128692763|NCT01604408|463174179|FG000|Treatment Period 2|Adverse Event|0|||
128692764|NCT01604408|463174180|FG001|Treatment Period 2|Adverse Event|1|||
128692765|NCT01604408|463174179|FG000|Treatment Period 3|Protocol Violation|1|||
128692766|NCT01604408|463174180|FG001|Treatment Period 3|Protocol Violation|1|||
128692767|NCT01604408|463174179|FG000|Treatment Period 3|Adverse Event|0|||
128692768|NCT01604408|463174180|FG001|Treatment Period 3|Adverse Event|3|||
128692769|NCT01604408|463174179|FG000|Treatment Period 3|Withdrawal by Subject|3|||
128692770|NCT01604408|463174180|FG001|Treatment Period 3|Withdrawal by Subject|1|||
128692771|NCT01604408|463174179|FG000|Treatment Period 3|Sponsor Decision|1|||
128900004|NCT01519765|463927245|FG000|Overall Study|Withdrawal by Subject|0|||
128900005|NCT01519765|463927246|FG001|Overall Study|Withdrawal by Subject|1|||
128900006|NCT03610724|463927247|FG000|Overall Study|Death|17|||
128900007|NCT03610724|463927247|FG000|Overall Study|Lost to Follow-up|1|||
128900008|NCT03610724|463927247|FG000|Overall Study|Physician Decision|1|||
128900009|NCT03610724|463927247|FG000|Overall Study|Died prior to infusion|1|||
128900010|NCT02354222|463927248|FG000|Overall Study|Adverse Event|0|||
128900011|NCT02354222|463927249|FG001|Overall Study|Adverse Event|3|||
128900012|NCT02354222|463927248|FG000|Overall Study|Physician Decision|1|||
128900013|NCT02354222|463927249|FG001|Overall Study|Physician Decision|1|||
128900014|NCT02354222|463927248|FG000|Overall Study|Pregnancy|1|||
128900015|NCT02354222|463927249|FG001|Overall Study|Pregnancy|0|||
128900016|NCT02354222|463927248|FG000|Overall Study|Withdrawal by Subject|2|||
128900017|NCT02354222|463927249|FG001|Overall Study|Withdrawal by Subject|3|||
128900018|NCT02354222|463927248|FG000|Overall Study|Conflict with the stopping criteria|0|||
128900019|NCT02354222|463927249|FG001|Overall Study|Conflict with the stopping criteria|4|||
129023560|NCT03199963|464378390|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
129023561|NCT03199963|464378389|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
129023562|NCT03199963|464378390|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
128692772|NCT01604408|463174180|FG001|Treatment Period 3|Sponsor Decision|0|||
128692773|NCT01604408|463174179|FG000|Treatment Period 4|Death|1|||
128692774|NCT01604408|463174180|FG001|Treatment Period 4|Death|0|||
128692775|NCT01604408|463174179|FG000|Treatment Period 4|Withdrawal by Subject|2|||
128692776|NCT01604408|463174180|FG001|Treatment Period 4|Withdrawal by Subject|1|||
128692777|NCT01604408|463174179|FG000|Treatment Period 4|Adverse Event|0|||
128692778|NCT01604408|463174180|FG001|Treatment Period 4|Adverse Event|1|||
128692779|NCT01604408|463174179|FG000|Treatment Period 5|Adverse Event|4|||
128692780|NCT01604408|463174180|FG001|Treatment Period 5|Adverse Event|0|||
128692781|NCT01604408|463174179|FG000|Treatment Period 6|Lost to Follow-up|0|||
128900020|NCT00786565|463927250|FG000|Enrollment Prior to Surgery|Site Closed|3|||
128900021|NCT00786565|463927250|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
128900022|NCT00786565|463927250|FG000|Post Surgery|Abnormal macular pucker|1|||
128692782|NCT01604408|463174180|FG001|Treatment Period 6|Lost to Follow-up|1|||
128692783|NCT01604408|463174179|FG000|Treatment Period 6|Adverse Event|2|||
128692784|NCT01604408|463174180|FG001|Treatment Period 6|Adverse Event|0|||
128692785|NCT01604408|463174179|FG000|Treatment Period 6|Sponsor decision|0|||
128692786|NCT01604408|463174180|FG001|Treatment Period 6|Sponsor decision|1|||
128692787|NCT01604408|463174179|FG000|Observation Period|Adverse Event|1|||
128692788|NCT01604408|463174180|FG001|Observation Period|Adverse Event|1|||
128692789|NCT01604408|463174179|FG000|Observation Period|Withdrawal by Subject|0|||
128692790|NCT01604408|463174180|FG001|Observation Period|Withdrawal by Subject|2|||
128692791|NCT00917501|463174181|FG000|Overall Study|Lost to Follow-up|4|||
128692792|NCT00917501|463174182|FG001|Overall Study|Lost to Follow-up|1|||
128692793|NCT00917501|463174181|FG000|Overall Study|Withdrawal by Subject|3|||
128692794|NCT00917501|463174182|FG001|Overall Study|Withdrawal by Subject|1|||
128692795|NCT00917501|463174181|FG000|Overall Study|Lack of Efficacy|1|||
128692796|NCT00917501|463174182|FG001|Overall Study|Lack of Efficacy|2|||
128692797|NCT00917501|463174181|FG000|Overall Study|trouble swollowing capsules|0|||
128692798|NCT00917501|463174182|FG001|Overall Study|trouble swollowing capsules|1|||
128692799|NCT03626168|463174183|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
128692800|NCT03626168|463174184|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
128692801|NCT03626168|463174183|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
128692802|NCT03626168|463174184|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
128692803|NCT03626168|463174183|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
128692804|NCT03626168|463174184|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
128692805|NCT00808483|463174185|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
128692806|NCT00808483|463174186|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
128764655|NCT02991482|463430251|FG000|Overall Study|Patient decision|1|||
128900023|NCT00786565|463927250|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
128900024|NCT01342484|463927255|FG000|Overall Study|Other Reasons|1|||
128900025|NCT01342484|463927256|FG001|Overall Study|Other Reasons|0|||
128900026|NCT01342484|463927257|FG002|Overall Study|Other Reasons|0|||
128900027|NCT01342484|463927255|FG000|Overall Study|Protocol Violation|0|||
128900028|NCT01342484|463927256|FG001|Overall Study|Protocol Violation|0|||
128900029|NCT01342484|463927257|FG002|Overall Study|Protocol Violation|1|||
128900030|NCT01342484|463927255|FG000|Overall Study|Withdrawal by Subject|1|||
128900031|NCT01342484|463927256|FG001|Overall Study|Withdrawal by Subject|0|||
128900032|NCT01342484|463927257|FG002|Overall Study|Withdrawal by Subject|0|||
128900033|NCT01840579|463927260|FG000|Overall Study|Status not recorded|0|||
128900034|NCT01840579|463927261|FG001|Overall Study|Status not recorded|0|||
128900035|NCT01840579|463927262|FG002|Overall Study|Status not recorded|2|||
128692807|NCT00808483|463174185|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
128692808|NCT00808483|463174186|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
128900036|NCT01840579|463927263|FG003|Overall Study|Status not recorded|3|||
128900037|NCT01840579|463927264|FG004|Overall Study|Status not recorded|4|||
129023563|NCT03199963|464378389|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
129023564|NCT03199963|464378390|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
129023565|NCT03199963|464378389|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
129023566|NCT03199963|464378390|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
129023567|NCT03199963|464378389|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
129023568|NCT03199963|464378390|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
129023569|NCT03199963|464378389|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
129023570|NCT03199963|464378390|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
129023571|NCT00466167|464378391|FG000|Overall Study|Adverse Event|8|||
129023572|NCT00466167|464378392|FG001|Overall Study|Adverse Event|8|||
129023573|NCT00466167|464378393|FG002|Overall Study|Adverse Event|7|||
129023574|NCT00466167|464378391|FG000|Overall Study|Lack of Efficacy|2|||
129023575|NCT00466167|464378392|FG001|Overall Study|Lack of Efficacy|0|||
129023576|NCT00466167|464378393|FG002|Overall Study|Lack of Efficacy|3|||
129023577|NCT00466167|464378391|FG000|Overall Study|Protocol Violation|1|||
129023578|NCT00466167|464378392|FG001|Overall Study|Protocol Violation|1|||
129023579|NCT00466167|464378393|FG002|Overall Study|Protocol Violation|2|||
129023580|NCT00466167|464378391|FG000|Overall Study|Lost to Follow-up|3|||
129023581|NCT00466167|464378392|FG001|Overall Study|Lost to Follow-up|2|||
129023582|NCT00466167|464378393|FG002|Overall Study|Lost to Follow-up|2|||
129023583|NCT00466167|464378391|FG000|Overall Study|Withdrawal by Subject|4|||
129023584|NCT00466167|464378392|FG001|Overall Study|Withdrawal by Subject|1|||
129023585|NCT00466167|464378393|FG002|Overall Study|Withdrawal by Subject|6|||
129023586|NCT00466167|464378391|FG000|Overall Study|patient did not meet inclusion criteria|1|||
129023587|NCT00466167|464378392|FG001|Overall Study|patient did not meet inclusion criteria|0|||
128692809|NCT00808483|463174185|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
128764656|NCT02991482|463430252|FG001|Overall Study|Patient decision|1|||
128764657|NCT02991482|463430251|FG000|Overall Study|Physician Decision|0|||
128900038|NCT01840579|463927265|FG005|Overall Study|Status not recorded|3|||
128900039|NCT01840579|463927266|FG006|Overall Study|Status not recorded|0|||
128900040|NCT01840579|463927267|FG007|Overall Study|Status not recorded|3|||
128900041|NCT01840579|463927268|FG008|Overall Study|Status not recorded|3|||
128900042|NCT01840579|463927269|FG009|Overall Study|Status not recorded|3|||
128900043|NCT01840579|463927260|FG000|Overall Study|Progressive disease|3|||
128900044|NCT01840579|463927261|FG001|Overall Study|Progressive disease|5|||
128900045|NCT01840579|463927262|FG002|Overall Study|Progressive disease|0|||
128900046|NCT01840579|463927263|FG003|Overall Study|Progressive disease|0|||
128900047|NCT01840579|463927264|FG004|Overall Study|Progressive disease|0|||
128900048|NCT01840579|463927265|FG005|Overall Study|Progressive disease|0|||
128900049|NCT01840579|463927266|FG006|Overall Study|Progressive disease|0|||
128900050|NCT01840579|463927267|FG007|Overall Study|Progressive disease|0|||
128900051|NCT01840579|463927268|FG008|Overall Study|Progressive disease|0|||
128900052|NCT01840579|463927269|FG009|Overall Study|Progressive disease|0|||
128900053|NCT01840579|463927260|FG000|Overall Study|Ongoing in study|0|||
128900054|NCT01840579|463927261|FG001|Overall Study|Ongoing in study|1|||
128900055|NCT01840579|463927262|FG002|Overall Study|Ongoing in study|0|||
128900056|NCT01840579|463927263|FG003|Overall Study|Ongoing in study|0|||
128900057|NCT01840579|463927264|FG004|Overall Study|Ongoing in study|0|||
128900058|NCT01840579|463927265|FG005|Overall Study|Ongoing in study|0|||
128900059|NCT01840579|463927266|FG006|Overall Study|Ongoing in study|0|||
128900060|NCT01840579|463927267|FG007|Overall Study|Ongoing in study|0|||
128900061|NCT01840579|463927268|FG008|Overall Study|Ongoing in study|0|||
128900062|NCT01840579|463927269|FG009|Overall Study|Ongoing in study|0|||
128900063|NCT01840579|463927260|FG000|Overall Study|Death|0|||
128900064|NCT01840579|463927261|FG001|Overall Study|Death|0|||
128900065|NCT01840579|463927262|FG002|Overall Study|Death|0|||
129023588|NCT00466167|464378393|FG002|Overall Study|patient did not meet inclusion criteria|1|||
129023589|NCT00466167|464378391|FG000|Overall Study|Not treated|1|||
129023590|NCT00466167|464378392|FG001|Overall Study|Not treated|0|||
129023591|NCT00466167|464378393|FG002|Overall Study|Not treated|0|||
129023592|NCT01370733|464378403|FG000|Overall Study|Withdrawal by Subject|8|||
129023593|NCT01370733|464378404|FG001|Overall Study|Withdrawal by Subject|8|||
129023594|NCT01370733|464378403|FG000|Overall Study|Lost to Follow-up|3|||
129023595|NCT01370733|464378404|FG001|Overall Study|Lost to Follow-up|0|||
129023596|NCT01370733|464378403|FG000|Overall Study|Adverse Event|2|||
129023597|NCT01370733|464378404|FG001|Overall Study|Adverse Event|4|||
129023598|NCT01370733|464378403|FG000|Overall Study|Lack of Efficacy|3|||
129023599|NCT01370733|464378404|FG001|Overall Study|Lack of Efficacy|5|||
129023600|NCT01370733|464378403|FG000|Overall Study|Physician Decision|0|||
129023601|NCT01370733|464378404|FG001|Overall Study|Physician Decision|2|||
129023602|NCT01370733|464378403|FG000|Overall Study|Protocol Violation|1|||
129023603|NCT01370733|464378404|FG001|Overall Study|Protocol Violation|3|||
129023604|NCT00323882|464378405|FG000|Overall Study|Adverse Event|2|||
129023605|NCT00323882|464378406|FG001|Overall Study|Adverse Event|1|||
129023606|NCT00323882|464378407|FG002|Overall Study|Adverse Event|1|||
129023607|NCT00323882|464378408|FG003|Overall Study|Adverse Event|1|||
129023608|NCT00323882|464378409|FG004|Overall Study|Adverse Event|3|||
129023609|NCT00323882|464378405|FG000|Overall Study|Disease Progression|6|||
129023610|NCT00323882|464378406|FG001|Overall Study|Disease Progression|4|||
129023611|NCT00323882|464378407|FG002|Overall Study|Disease Progression|10|||
129023612|NCT00323882|464378408|FG003|Overall Study|Disease Progression|5|||
129023613|NCT00323882|464378409|FG004|Overall Study|Disease Progression|22|||
129023614|NCT00323882|464378405|FG000|Overall Study|Death|0|||
129023615|NCT00323882|464378406|FG001|Overall Study|Death|1|||
129023616|NCT00323882|464378407|FG002|Overall Study|Death|1|||
129023617|NCT00323882|464378408|FG003|Overall Study|Death|0|||
129023618|NCT00323882|464378409|FG004|Overall Study|Death|5|||
129023619|NCT00323882|464378405|FG000|Overall Study|Lost to Follow-up|0|||
129023620|NCT00323882|464378406|FG001|Overall Study|Lost to Follow-up|0|||
129023621|NCT00323882|464378407|FG002|Overall Study|Lost to Follow-up|1|||
129023622|NCT00323882|464378408|FG003|Overall Study|Lost to Follow-up|0|||
129023623|NCT00323882|464378409|FG004|Overall Study|Lost to Follow-up|1|||
129023624|NCT00323882|464378405|FG000|Overall Study|Other|0|||
129023625|NCT00323882|464378406|FG001|Overall Study|Other|0|||
129023626|NCT00323882|464378407|FG002|Overall Study|Other|0|||
129023627|NCT00323882|464378408|FG003|Overall Study|Other|1|||
129023628|NCT00323882|464378409|FG004|Overall Study|Other|1|||
128900066|NCT01840579|463927263|FG003|Overall Study|Death|0|||
128900067|NCT01840579|463927264|FG004|Overall Study|Death|0|||
128900068|NCT01840579|463927265|FG005|Overall Study|Death|1|||
128900069|NCT01840579|463927266|FG006|Overall Study|Death|0|||
129023629|NCT01794845|464378410|FG000|Overall Study|Withdrawal by Subject|1|||
129023630|NCT06647173|464378411|FG000|Overall Study|Lost to Follow-up|24|||
129023631|NCT06999265|464378412|FG000|Overall Study|Lost to Follow-up|1|||
128900070|NCT01840579|463927267|FG007|Overall Study|Death|0|||
128900071|NCT01840579|463927268|FG008|Overall Study|Death|0|||
128900072|NCT01840579|463927269|FG009|Overall Study|Death|0|||
128900073|NCT01840579|463927260|FG000|Overall Study|Adverse Event|0|||
128900074|NCT01840579|463927261|FG001|Overall Study|Adverse Event|1|||
129023632|NCT06999265|464378413|FG001|Overall Study|Lost to Follow-up|1|||
129023633|NCT04025229|464379818|FG000|Overall Study|Adverse Event|1|||
129023634|NCT04025229|464379819|FG001|Overall Study|Adverse Event|0|||
128692810|NCT00808483|463174186|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
128692811|NCT04553679|463174187|FG000|Overall Study|Withdrawal by Subject|2|||
128692812|NCT04553679|463174188|FG001|Overall Study|Withdrawal by Subject|0|||
128692813|NCT04553679|463174187|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
128692814|NCT04553679|463174188|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
128692815|NCT02357979|463174189|FG000|Overall Study|Lost to Follow-up|5|||
128692816|NCT02357979|463174190|FG001|Overall Study|Lost to Follow-up|5|||
128692817|NCT03945214|463174191|FG000|Overall Study|Lost to Follow-up|3|||
128900075|NCT01840579|463927262|FG002|Overall Study|Adverse Event|0|||
128900076|NCT01840579|463927263|FG003|Overall Study|Adverse Event|0|||
128900077|NCT01840579|463927264|FG004|Overall Study|Adverse Event|0|||
128900078|NCT01840579|463927265|FG005|Overall Study|Adverse Event|0|||
128900079|NCT01840579|463927266|FG006|Overall Study|Adverse Event|0|||
128900080|NCT01840579|463927267|FG007|Overall Study|Adverse Event|0|||
128900081|NCT01840579|463927268|FG008|Overall Study|Adverse Event|0|||
128900082|NCT01840579|463927269|FG009|Overall Study|Adverse Event|0|||
128900083|NCT01840579|463927260|FG000|Overall Study|Follow-up ended by Sponsor|0|||
128900084|NCT01840579|463927261|FG001|Overall Study|Follow-up ended by Sponsor|0|||
128900085|NCT01840579|463927262|FG002|Overall Study|Follow-up ended by Sponsor|0|||
128900086|NCT01840579|463927263|FG003|Overall Study|Follow-up ended by Sponsor|0|||
128900087|NCT01840579|463927264|FG004|Overall Study|Follow-up ended by Sponsor|0|||
128900088|NCT01840579|463927265|FG005|Overall Study|Follow-up ended by Sponsor|0|||
128900089|NCT01840579|463927266|FG006|Overall Study|Follow-up ended by Sponsor|2|||
128900090|NCT01840579|463927267|FG007|Overall Study|Follow-up ended by Sponsor|0|||
128900091|NCT01840579|463927268|FG008|Overall Study|Follow-up ended by Sponsor|0|||
128900092|NCT01840579|463927269|FG009|Overall Study|Follow-up ended by Sponsor|0|||
128900093|NCT05248295|463927274|FG000|Overall Study|found ineligible|4|||
128900094|NCT05248295|463927275|FG001|Overall Study|found ineligible|1|||
128900095|NCT05248295|463927274|FG000|Overall Study|Withdrawal by Subject|0|||
128900096|NCT05248295|463927275|FG001|Overall Study|Withdrawal by Subject|1|||
128900097|NCT05248295|463927274|FG000|Overall Study|Data loss: audio recording error|1|||
128900098|NCT05248295|463927275|FG001|Overall Study|Data loss: audio recording error|1|||
128900099|NCT03021499|463927278|FG000|Overall Study|Adverse Event|1|||
128900100|NCT03021499|463927279|FG001|Overall Study|Adverse Event|0|||
128900101|NCT03021499|463927278|FG000|Overall Study|Death|1|||
128900102|NCT03021499|463927279|FG001|Overall Study|Death|5|||
128900103|NCT03021499|463927278|FG000|Overall Study|Lack of Efficacy|0|||
128900104|NCT03021499|463927279|FG001|Overall Study|Lack of Efficacy|1|||
128900105|NCT03021499|463927278|FG000|Overall Study|Lost to Follow-up|1|||
128900106|NCT03021499|463927279|FG001|Overall Study|Lost to Follow-up|3|||
128900107|NCT03021499|463927278|FG000|Overall Study|Physician Decision|2|||
128900108|NCT03021499|463927279|FG001|Overall Study|Physician Decision|3|||
128900109|NCT03021499|463927278|FG000|Overall Study|Pregnancy|1|||
128900110|NCT03021499|463927279|FG001|Overall Study|Pregnancy|0|||
128900111|NCT03021499|463927278|FG000|Overall Study|Withdrawal by Subject|7|||
128900112|NCT03021499|463927279|FG001|Overall Study|Withdrawal by Subject|14|||
128900113|NCT03021499|463927278|FG000|Overall Study|Prohibited medication required|1|||
128900114|NCT03021499|463927279|FG001|Overall Study|Prohibited medication required|0|||
128900115|NCT03021499|463927278|FG000|Overall Study|Protocol non-compliance|1|||
128900116|NCT03021499|463927279|FG001|Overall Study|Protocol non-compliance|1|||
128900117|NCT03021499|463927278|FG000|Overall Study|None of the above|0|||
128900118|NCT03021499|463927279|FG001|Overall Study|None of the above|4|||
128900119|NCT03021499|463927278|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
128900120|NCT03021499|463927279|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
128900121|NCT01210690|463927280|FG000|Overall Study|Adverse Event|7|||
128900122|NCT01210690|463927280|FG000|Overall Study|Lack of Efficacy|12|||
128900123|NCT01210690|463927280|FG000|Overall Study|Lost to Follow-up|3|||
128900124|NCT01210690|463927280|FG000|Overall Study|Disease Remission|1|||
128900125|NCT01210690|463927280|FG000|Overall Study|Withdrawal by Subject|1|||
128692818|NCT03945214|463174192|FG001|Overall Study|Lost to Follow-up|4|||
128764658|NCT02991482|463430252|FG001|Overall Study|Physician Decision|6|||
128900126|NCT01210690|463927280|FG000|Overall Study|Patient refused to swallow|1|||
128900127|NCT01210690|463927280|FG000|Overall Study|Patient could not take glucose|1|||
128900128|NCT00470054|463927281|FG000|Overall Study|Ineligible|1|||
128900129|NCT04869345|463927288|FG000|Overall Study|Lost to Follow-up|8|||
128900130|NCT04869345|463927289|FG001|Overall Study|Lost to Follow-up|3|||
128900131|NCT00528021|463927293|FG000|Overall Study|Lack of Efficacy|17|||
128900132|NCT00528021|463927294|FG001|Overall Study|Lack of Efficacy|13|||
128900133|NCT00528021|463927295|FG002|Overall Study|Lack of Efficacy|7|||
128900134|NCT00528021|463927296|FG003|Overall Study|Lack of Efficacy|9|||
128900135|NCT04050982|463927297|FG000|Overall Study|Did not meet eligibility criteria|0|||
128900136|NCT04050982|463927298|FG001|Overall Study|Did not meet eligibility criteria|1|||
128900137|NCT04050982|463927299|FG002|Overall Study|Did not meet eligibility criteria|0|||
128900138|NCT04050982|463927297|FG000|Overall Study|Withdrawal by Subject|1|||
128692819|NCT03945214|463174193|FG002|Overall Study|Lost to Follow-up|7|||
128900139|NCT04050982|463927298|FG001|Overall Study|Withdrawal by Subject|0|||
128900140|NCT04050982|463927299|FG002|Overall Study|Withdrawal by Subject|0|||
128900141|NCT04050982|463927297|FG000|Overall Study|Unable to enroll on platform|1|||
128900142|NCT04050982|463927298|FG001|Overall Study|Unable to enroll on platform|0|||
128900143|NCT04050982|463927299|FG002|Overall Study|Unable to enroll on platform|0|||
128900144|NCT05054114|463927300|FG000|Overall Study|Protocol Violation|13|||
128900145|NCT05054114|463927301|FG001|Overall Study|Protocol Violation|1|||
128900146|NCT05054114|463927300|FG000|Overall Study|Pregnancy|0|||
128900147|NCT05054114|463927301|FG001|Overall Study|Pregnancy|1|||
128900148|NCT01423851|463927305|FG000|Whole Study|Disease progression|2|||
128900149|NCT01423851|463927306|FG001|Whole Study|Disease progression|1|||
128900150|NCT01423851|463927307|FG002|Whole Study|Disease progression|1|||
128900151|NCT01423851|463927308|FG003|Whole Study|Disease progression|4|||
128900152|NCT01423851|463927309|FG004|Whole Study|Disease progression|1|||
128900153|NCT01423851|463927310|FG005|Whole Study|Disease progression|3|||
128900154|NCT01423851|463927311|FG006|Whole Study|Disease progression|1|||
128900155|NCT01423851|463927312|FG007|Whole Study|Disease progression|4|||
128900156|NCT01423851|463927313|FG008|Whole Study|Disease progression|0|||
128900157|NCT01423851|463927314|FG009|Whole Study|Disease progression|2|||
128900158|NCT01423851|463927315|FG010|Whole Study|Disease progression|10|||
128900159|NCT01423851|463927305|FG000|Whole Study|Physician Decision|0|||
128900160|NCT01423851|463927306|FG001|Whole Study|Physician Decision|1|||
128900161|NCT01423851|463927307|FG002|Whole Study|Physician Decision|2|||
128900162|NCT01423851|463927308|FG003|Whole Study|Physician Decision|0|||
128900163|NCT01423851|463927309|FG004|Whole Study|Physician Decision|2|||
128900164|NCT01423851|463927310|FG005|Whole Study|Physician Decision|0|||
128900165|NCT01423851|463927311|FG006|Whole Study|Physician Decision|2|||
128900166|NCT01423851|463927312|FG007|Whole Study|Physician Decision|1|||
128900167|NCT01423851|463927313|FG008|Whole Study|Physician Decision|3|||
128900168|NCT01423851|463927314|FG009|Whole Study|Physician Decision|4|||
128900169|NCT01423851|463927315|FG010|Whole Study|Physician Decision|12|||
128900170|NCT01423851|463927305|FG000|Whole Study|Withdrawal by Subject|1|||
128900171|NCT01423851|463927306|FG001|Whole Study|Withdrawal by Subject|1|||
128900172|NCT01423851|463927307|FG002|Whole Study|Withdrawal by Subject|0|||
128900173|NCT01423851|463927308|FG003|Whole Study|Withdrawal by Subject|0|||
128900174|NCT01423851|463927309|FG004|Whole Study|Withdrawal by Subject|0|||
128900175|NCT01423851|463927310|FG005|Whole Study|Withdrawal by Subject|0|||
128900176|NCT01423851|463927311|FG006|Whole Study|Withdrawal by Subject|0|||
128900177|NCT01423851|463927312|FG007|Whole Study|Withdrawal by Subject|0|||
128900178|NCT01423851|463927313|FG008|Whole Study|Withdrawal by Subject|2|||
128900179|NCT01423851|463927314|FG009|Whole Study|Withdrawal by Subject|0|||
128900180|NCT01423851|463927315|FG010|Whole Study|Withdrawal by Subject|4|||
128900181|NCT01423851|463927305|FG000|Whole Study|Adverse Event|0|||
128900182|NCT01423851|463927306|FG001|Whole Study|Adverse Event|0|||
128900183|NCT01423851|463927307|FG002|Whole Study|Adverse Event|0|||
128900184|NCT01423851|463927308|FG003|Whole Study|Adverse Event|2|||
128900185|NCT01423851|463927309|FG004|Whole Study|Adverse Event|0|||
128900186|NCT01423851|463927310|FG005|Whole Study|Adverse Event|0|||
128900187|NCT01423851|463927311|FG006|Whole Study|Adverse Event|0|||
128900188|NCT01423851|463927312|FG007|Whole Study|Adverse Event|3|||
128900189|NCT01423851|463927313|FG008|Whole Study|Adverse Event|3|||
128900190|NCT01423851|463927314|FG009|Whole Study|Adverse Event|2|||
128900191|NCT01423851|463927315|FG010|Whole Study|Adverse Event|3|||
128900192|NCT00457015|463929416|FG000|Overall Study|Left study site against medical advice|0|||
128900193|NCT00457015|463929417|FG001|Overall Study|Left study site against medical advice|1|||
128900194|NCT00747643|463929418|FG000|Overall Study|Withdrawal by Subject|36|||
129023635|NCT04025229|464379818|FG000|Overall Study|Withdrawal by Subject|0|||
129023636|NCT04025229|464379819|FG001|Overall Study|Withdrawal by Subject|2|||
129023637|NCT04025229|464379818|FG000|Overall Study|Death|0|||
129023638|NCT04025229|464379819|FG001|Overall Study|Death|1|||
129023639|NCT04025229|464379818|FG000|Overall Study|Physician Decision|0|||
129023640|NCT04025229|464379819|FG001|Overall Study|Physician Decision|1|||
129023641|NCT02571907|464379820|FG000|Overall Study|Death|4|||
129215241|NCT01588522|465089468|FG004|Overall Study|Did not initiate chemotherapy|1|||
128764659|NCT02991482|463430251|FG000|Overall Study|Clinical deterioration|1|||
128764660|NCT02991482|463430252|FG001|Overall Study|Clinical deterioration|0|||
128900195|NCT00747643|463929419|FG001|Overall Study|Withdrawal by Subject|27|||
128900196|NCT00750698|463929420|FG000|Overall Study|Withdrawal by Subject|1|||
128900197|NCT00750698|463929421|FG001|Overall Study|Withdrawal by Subject|0|||
128900198|NCT00750698|463929420|FG000|Overall Study|Progressive disease|5|||
128900199|NCT00750698|463929421|FG001|Overall Study|Progressive disease|2|||
128900200|NCT02263079|463929422|FG000|Overall Study|Physician Decision|1|||
128900201|NCT02263079|463929423|FG001|Overall Study|Physician Decision|0|||
128900202|NCT02263079|463929424|FG002|Overall Study|Physician Decision|0|||
128900203|NCT02263079|463929422|FG000|Overall Study|Withdrawal by Subject|2|||
128900204|NCT02263079|463929423|FG001|Overall Study|Withdrawal by Subject|8|||
128900205|NCT02263079|463929424|FG002|Overall Study|Withdrawal by Subject|0|||
128900206|NCT03557281|463929425|FG000|Overall Study|Investigator discretion|0|||
128900207|NCT03557281|463929426|FG001|Overall Study|Investigator discretion|0|||
128900208|NCT03557281|463929427|FG002|Overall Study|Investigator discretion|1|||
128900209|NCT03557281|463929428|FG003|Overall Study|Investigator discretion|0|||
129023642|NCT02571907|464379820|FG000|Overall Study|Lost to Follow-up|3|||
128900210|NCT03557281|463929429|FG004|Overall Study|Investigator discretion|0|||
128900211|NCT03557281|463929425|FG000|Overall Study|Withdrawal by Subject|0|||
128900212|NCT03557281|463929426|FG001|Overall Study|Withdrawal by Subject|1|||
128900213|NCT03557281|463929427|FG002|Overall Study|Withdrawal by Subject|1|||
128900214|NCT03557281|463929428|FG003|Overall Study|Withdrawal by Subject|1|||
128900215|NCT03557281|463929429|FG004|Overall Study|Withdrawal by Subject|2|||
128900216|NCT03557281|463929425|FG000|Overall Study|Randomized, but did not receive treatment|0|||
128900217|NCT03557281|463929426|FG001|Overall Study|Randomized, but did not receive treatment|0|||
128900218|NCT03557281|463929427|FG002|Overall Study|Randomized, but did not receive treatment|0|||
128900219|NCT03557281|463929428|FG003|Overall Study|Randomized, but did not receive treatment|0|||
129113160|NCT01211145|464709674|FG000|Overall Study|Lost to Follow-up|3|||
129113161|NCT01211145|464709675|FG001|Overall Study|Lost to Follow-up|2|||
129113162|NCT01211145|464709676|FG002|Overall Study|Lost to Follow-up|1|||
129113163|NCT01211145|464709677|FG003|Overall Study|Lost to Follow-up|2|||
129113164|NCT01211145|464709674|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129113165|NCT01211145|464709675|FG001|Overall Study|Study-specific withdrawal criteria|0|||
128692820|NCT03945214|463174194|FG003|Overall Study|Lost to Follow-up|4|||
129113166|NCT01211145|464709676|FG002|Overall Study|Study-specific withdrawal criteria|0|||
129113167|NCT01211145|464709677|FG003|Overall Study|Study-specific withdrawal criteria|0|||
129113168|NCT01211145|464709674|FG000|Overall Study|Severe noncompliance to protocol|1|||
129113169|NCT01211145|464709675|FG001|Overall Study|Severe noncompliance to protocol|0|||
129113170|NCT01211145|464709676|FG002|Overall Study|Severe noncompliance to protocol|0|||
129113171|NCT01211145|464709677|FG003|Overall Study|Severe noncompliance to protocol|0|||
129113172|NCT01211145|464709674|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
129113173|NCT01211145|464709675|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
129113174|NCT01211145|464709676|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
129113175|NCT01211145|464709677|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
129113176|NCT01211145|464709674|FG000|Overall Study|Patient decision|2|||
129113177|NCT01211145|464709675|FG001|Overall Study|Patient decision|1|||
129113178|NCT01211145|464709676|FG002|Overall Study|Patient decision|0|||
129113179|NCT01211145|464709677|FG003|Overall Study|Patient decision|2|||
129113180|NCT00570401|464709678|FG000|Overall Study|Adverse Event|2|||
129113181|NCT02849587|464709679|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
129113182|NCT02849587|464709680|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
129113183|NCT02849587|464709681|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
129113184|NCT02849587|464709679|FG000|Overall Study|Withdrawal by Subject|0|||
129113185|NCT02849587|464709680|FG001|Overall Study|Withdrawal by Subject|1|||
129113186|NCT02849587|464709681|FG002|Overall Study|Withdrawal by Subject|0|||
129113187|NCT00385918|464709686|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
129113188|NCT00385918|464709687|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
129113189|NCT00385918|464709688|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
129113190|NCT00385918|464709686|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
129113191|NCT00385918|464709687|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
129113192|NCT00385918|464709688|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
128692821|NCT00850070|463174195|FG000|Overall Study|Lack of Efficacy|1|||
128692822|NCT00850070|463174196|FG001|Overall Study|Lack of Efficacy|1|||
128692823|NCT00850070|463174195|FG000|Overall Study|Adverse Event|2|||
128692824|NCT00850070|463174196|FG001|Overall Study|Adverse Event|0|||
128692825|NCT00074984|463174199|FG000|Overall Study|Death|1|||
128692826|NCT00074984|463174200|FG001|Overall Study|Death|2|||
128692827|NCT00074984|463174199|FG000|Overall Study|Withdrawal by Subject|2|||
128692828|NCT00074984|463174200|FG001|Overall Study|Withdrawal by Subject|3|||
128692829|NCT00074984|463174199|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
128692830|NCT00074984|463174200|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
128692831|NCT01522248|463174201|FG000|Overall Study|Lost to Follow-up|1|||
128692832|NCT01522248|463174202|FG001|Overall Study|Lost to Follow-up|0|||
128692833|NCT00694707|463174207|FG000|Overall Study|Did Not Receive Treatment|0|||
128692834|NCT00694707|463174208|FG001|Overall Study|Did Not Receive Treatment|0|||
128692835|NCT00694707|463174209|FG002|Overall Study|Did Not Receive Treatment|1|||
128692836|NCT00694707|463174210|FG003|Overall Study|Did Not Receive Treatment|1|||
129113193|NCT00385918|464709686|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
128692837|NCT00694707|463174211|FG004|Overall Study|Did Not Receive Treatment|1|||
128692838|NCT00694707|463174207|FG000|Overall Study|Adverse Event|22|||
129113194|NCT00385918|464709687|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
129113195|NCT00385918|464709688|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
129113196|NCT00385918|464709686|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
128692839|NCT00694707|463174208|FG001|Overall Study|Adverse Event|14|||
128692840|NCT00694707|463174209|FG002|Overall Study|Adverse Event|8|||
128692841|NCT00694707|463174210|FG003|Overall Study|Adverse Event|12|||
128900220|NCT03557281|463929429|FG004|Overall Study|Randomized, but did not receive treatment|1|||
128900221|NCT00402649|463929430|FG000|Overall Study|Lost to Follow-up|1|||
128900222|NCT00402649|463929430|FG000|Overall Study|Withdrawal by Subject|1|||
128900223|NCT01199042|463929433|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
128900224|NCT01199042|463929433|FG000|At Home (3 Months)|Lost to Follow-up|1|||
128900225|NCT01999465|463929434|FG000|Overall Study|Lost to Follow-up|0|||
128900226|NCT01999465|463929435|FG001|Overall Study|Lost to Follow-up|2|||
128900227|NCT01999465|463929434|FG000|Overall Study|Protocol Violation|0|||
128900228|NCT01999465|463929435|FG001|Overall Study|Protocol Violation|1|||
128900229|NCT02554019|463929439|FG000|Overall Study|Withdrawal by Subject|1|||
128900230|NCT02554019|463929440|FG001|Overall Study|Withdrawal by Subject|0|||
128900231|NCT02554019|463929441|FG002|Overall Study|Withdrawal by Subject|2|||
128900232|NCT02554019|463929439|FG000|Overall Study|Adverse Event|1|||
128900233|NCT02554019|463929440|FG001|Overall Study|Adverse Event|0|||
128900234|NCT02554019|463929441|FG002|Overall Study|Adverse Event|0|||
128900235|NCT00916357|463929442|FG000|Period 1|Withdrawal by Subject|1|||
128900236|NCT00916357|463929443|FG001|Period 1|Withdrawal by Subject|0|||
128900237|NCT00916357|463929444|FG002|Period 1|Withdrawal by Subject|0|||
128900238|NCT00916357|463929445|FG003|Period 1|Withdrawal by Subject|0|||
128900239|NCT00916357|463929446|FG004|Period 1|Withdrawal by Subject|0|||
128900240|NCT00916357|463929447|FG005|Period 1|Withdrawal by Subject|0|||
128900241|NCT00916357|463929442|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
128900242|NCT00916357|463929443|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
128900243|NCT00916357|463929444|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
128900244|NCT00916357|463929445|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
128900245|NCT00916357|463929446|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
128900246|NCT00916357|463929447|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
128900247|NCT01308008|463929448|FG000|4 Weeks|Illness, disinterest, time|9|||
128900248|NCT01308008|463929449|FG001|4 Weeks|Illness, disinterest, time|2|||
128900249|NCT01417195|463929450|FG000|Overall Study|Stimulation failure|1|||
128900250|NCT01417195|463929451|FG001|Overall Study|Stimulation failure|0|||
128900251|NCT01417195|463929450|FG000|Overall Study|No embryos for transfer|0|||
128900252|NCT01417195|463929451|FG001|Overall Study|No embryos for transfer|1|||
128900253|NCT01417195|463929450|FG000|Overall Study|No transfer due to risk of OHSS|1|||
128900254|NCT01417195|463929451|FG001|Overall Study|No transfer due to risk of OHSS|0|||
128900255|NCT01417195|463929450|FG000|Overall Study|No transfer due to elevated progesterone|1|||
128900256|NCT01417195|463929451|FG001|Overall Study|No transfer due to elevated progesterone|0|||
128900257|NCT03357731|463929452|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
128900258|NCT03357731|463929453|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
128900259|NCT03357731|463929454|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
128900260|NCT03357731|463929455|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
128900261|NCT03357731|463929456|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
128900262|NCT03357731|463929457|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
128900263|NCT03357731|463929452|FG000|Overall Study|Acute bradycardia and hypotension|0|||
128900264|NCT03357731|463929453|FG001|Overall Study|Acute bradycardia and hypotension|0|||
128900265|NCT03357731|463929454|FG002|Overall Study|Acute bradycardia and hypotension|0|||
128900266|NCT03357731|463929455|FG003|Overall Study|Acute bradycardia and hypotension|1|||
128900267|NCT03357731|463929456|FG004|Overall Study|Acute bradycardia and hypotension|0|||
128900268|NCT03357731|463929457|FG005|Overall Study|Acute bradycardia and hypotension|0|||
128900269|NCT03357731|463929452|FG000|Overall Study|Adverse Event|0|||
128900270|NCT03357731|463929453|FG001|Overall Study|Adverse Event|0|||
128900271|NCT03357731|463929454|FG002|Overall Study|Adverse Event|0|||
128900272|NCT03357731|463929455|FG003|Overall Study|Adverse Event|0|||
128900273|NCT03357731|463929456|FG004|Overall Study|Adverse Event|0|||
128900274|NCT03357731|463929457|FG005|Overall Study|Adverse Event|1|||
128900275|NCT03357731|463929452|FG000|Overall Study|Hypotension|0|||
128900276|NCT03357731|463929453|FG001|Overall Study|Hypotension|0|||
128900277|NCT03357731|463929454|FG002|Overall Study|Hypotension|1|||
128900278|NCT03357731|463929455|FG003|Overall Study|Hypotension|1|||
128900279|NCT03357731|463929456|FG004|Overall Study|Hypotension|0|||
128900280|NCT03357731|463929457|FG005|Overall Study|Hypotension|0|||
129023643|NCT02571907|464379820|FG000|Overall Study|Withdrawal by Subject|3|||
129023644|NCT02286739|464379825|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
129023645|NCT02286739|464379826|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
129023646|NCT02286739|464379825|FG000|Overall Study|No Verasense type documented|0|||
128900281|NCT03357731|463929452|FG000|Overall Study|Lost to Follow-up|0|||
128900282|NCT03357731|463929453|FG001|Overall Study|Lost to Follow-up|0|||
128900283|NCT03357731|463929454|FG002|Overall Study|Lost to Follow-up|0|||
129023647|NCT02286739|464379826|FG001|Overall Study|No Verasense type documented|23|||
129023648|NCT02286739|464379825|FG000|Overall Study|Adverse Event|1|||
129023649|NCT02286739|464379826|FG001|Overall Study|Adverse Event|2|||
129023650|NCT02286739|464379825|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
128900284|NCT03357731|463929455|FG003|Overall Study|Lost to Follow-up|1|||
128900285|NCT03357731|463929456|FG004|Overall Study|Lost to Follow-up|0|||
128900286|NCT03357731|463929457|FG005|Overall Study|Lost to Follow-up|0|||
128900287|NCT00772954|463929458|FG000|Overall Study|Adverse Event|0|||
128900288|NCT00772954|463929459|FG001|Overall Study|Adverse Event|0|||
128900289|NCT00772954|463929460|FG002|Overall Study|Adverse Event|1|||
128900290|NCT01773109|463929461|FG000|Overall Study|Symptomatic Progression|2|||
128900291|NCT01773109|463929461|FG000|Overall Study|Death|1|||
128900292|NCT01239342|463929462|FG000|Overall Study|Adverse Event|1|||
128900293|NCT01239342|463929463|FG001|Overall Study|Adverse Event|0|||
128900294|NCT01239342|463929462|FG000|Overall Study|Withdrawal by Subject|1|||
128900295|NCT01239342|463929463|FG001|Overall Study|Withdrawal by Subject|5|||
128900296|NCT01239342|463929462|FG000|Overall Study|Reason Unknown|1|||
128900297|NCT01239342|463929463|FG001|Overall Study|Reason Unknown|1|||
128900298|NCT02495844|463929464|FG000|Overall Study|Lack of Efficacy|1|||
128900299|NCT02495844|463929465|FG001|Overall Study|Lack of Efficacy|2|||
128900300|NCT02495844|463929464|FG000|Overall Study|AE, non-fatal|0|||
128900301|NCT02495844|463929465|FG001|Overall Study|AE, non-fatal|1|||
128900302|NCT02495844|463929464|FG000|Overall Study|Hepatitis Positivity|0|||
128900303|NCT02495844|463929465|FG001|Overall Study|Hepatitis Positivity|1|||
128900304|NCT02325219|463929468|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
128900305|NCT02325219|463929469|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
128900306|NCT02325219|463929470|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
129113197|NCT00385918|464709687|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
129113198|NCT00385918|464709688|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
129113199|NCT00385918|464709686|FG000|Intervention Phase After Randomization|Physician Decision|1|||
129113200|NCT00385918|464709687|FG001|Intervention Phase After Randomization|Physician Decision|0|||
129113201|NCT00385918|464709688|FG002|Intervention Phase After Randomization|Physician Decision|0|||
129113202|NCT00385918|464709686|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
129113203|NCT00385918|464709687|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
129113204|NCT00385918|464709688|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
129113205|NCT01676701|464709689|FG000|Overall Study|Protocol Violation|1|||
129113206|NCT01676701|464709690|FG001|Overall Study|Protocol Violation|0|||
129113207|NCT01676701|464709689|FG000|Overall Study|Sponsor Decision|3|||
129113208|NCT01676701|464709690|FG001|Overall Study|Sponsor Decision|4|||
129113209|NCT00549549|464709700|FG000|Overall Study|Adverse Event|5|||
129113210|NCT00549549|464709701|FG001|Overall Study|Adverse Event|3|||
129113211|NCT00549549|464709702|FG002|Overall Study|Adverse Event|1|||
129113212|NCT00549549|464709703|FG003|Overall Study|Adverse Event|9|||
129113213|NCT00549549|464709700|FG000|Overall Study|Lack of Efficacy|9|||
129113214|NCT00549549|464709701|FG001|Overall Study|Lack of Efficacy|6|||
129113215|NCT00549549|464709702|FG002|Overall Study|Lack of Efficacy|4|||
129113216|NCT00549549|464709703|FG003|Overall Study|Lack of Efficacy|2|||
129113217|NCT00549549|464709700|FG000|Overall Study|Lost to Follow-up|1|||
129113218|NCT00549549|464709701|FG001|Overall Study|Lost to Follow-up|0|||
129113219|NCT00549549|464709702|FG002|Overall Study|Lost to Follow-up|1|||
129113220|NCT00549549|464709703|FG003|Overall Study|Lost to Follow-up|2|||
129113221|NCT00549549|464709700|FG000|Overall Study|Withdrawal by Subject|0|||
129113222|NCT00549549|464709701|FG001|Overall Study|Withdrawal by Subject|4|||
129113223|NCT00549549|464709702|FG002|Overall Study|Withdrawal by Subject|1|||
129113224|NCT00549549|464709703|FG003|Overall Study|Withdrawal by Subject|0|||
129113225|NCT00549549|464709700|FG000|Overall Study|Other|9|||
129113226|NCT00549549|464709701|FG001|Overall Study|Other|9|||
129113227|NCT00549549|464709702|FG002|Overall Study|Other|9|||
129113228|NCT00549549|464709703|FG003|Overall Study|Other|11|||
129113229|NCT00549549|464709700|FG000|Overall Study|Randomized but not treated|0|||
129113230|NCT00549549|464709701|FG001|Overall Study|Randomized but not treated|0|||
129113231|NCT00549549|464709702|FG002|Overall Study|Randomized but not treated|1|||
129113232|NCT00549549|464709703|FG003|Overall Study|Randomized but not treated|1|||
129113233|NCT02227784|464709704|FG000|Double-Blind Phase|Adverse Event|3|||
129113234|NCT02227784|464709705|FG001|Double-Blind Phase|Adverse Event|2|||
129113235|NCT02227784|464709706|FG002|Double-Blind Phase|Adverse Event|1|||
129113236|NCT02227784|464709707|FG003|Double-Blind Phase|Adverse Event|3|||
129113237|NCT02227784|464709708|FG004|Double-Blind Phase|Adverse Event|0|||
129113238|NCT02227784|464709704|FG000|Double-Blind Phase|Physician Decision|1|||
129113239|NCT02227784|464709705|FG001|Double-Blind Phase|Physician Decision|0|||
128900307|NCT02325219|463929471|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
128900308|NCT02325219|463929472|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
128900309|NCT02325219|463929468|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
128900310|NCT02325219|463929469|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
128900311|NCT02325219|463929470|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128900312|NCT02325219|463929471|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129113240|NCT02227784|464709706|FG002|Double-Blind Phase|Physician Decision|0|||
129113241|NCT02227784|464709707|FG003|Double-Blind Phase|Physician Decision|1|||
129113242|NCT02227784|464709708|FG004|Double-Blind Phase|Physician Decision|0|||
129113243|NCT02227784|464709704|FG000|Double-Blind Phase|Protocol Violation|0|||
129113244|NCT02227784|464709705|FG001|Double-Blind Phase|Protocol Violation|0|||
129113245|NCT02227784|464709706|FG002|Double-Blind Phase|Protocol Violation|1|||
129113246|NCT02227784|464709707|FG003|Double-Blind Phase|Protocol Violation|1|||
129113247|NCT02227784|464709708|FG004|Double-Blind Phase|Protocol Violation|0|||
129113248|NCT02227784|464709704|FG000|Double-Blind Phase|Sponsor Decision|34|||
129113249|NCT02227784|464709705|FG001|Double-Blind Phase|Sponsor Decision|15|||
129113250|NCT02227784|464709706|FG002|Double-Blind Phase|Sponsor Decision|14|||
129113251|NCT02227784|464709707|FG003|Double-Blind Phase|Sponsor Decision|32|||
129113252|NCT02227784|464709708|FG004|Double-Blind Phase|Sponsor Decision|0|||
129113253|NCT02227784|464709704|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129113254|NCT02227784|464709705|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
129113255|NCT02227784|464709706|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
129113256|NCT02227784|464709707|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
129113257|NCT02227784|464709708|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129113258|NCT02227784|464709704|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129113259|NCT02227784|464709705|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129113260|NCT02227784|464709706|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129113261|NCT02227784|464709707|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129113262|NCT02227784|464709708|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
128900313|NCT02325219|463929472|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128900314|NCT02325219|463929468|FG000|Controlled Period (Week 0 - 16)|Other|0|||
128900315|NCT02325219|463929469|FG001|Controlled Period (Week 0 - 16)|Other|0|||
128900316|NCT02325219|463929470|FG002|Controlled Period (Week 0 - 16)|Other|1|||
128900317|NCT02325219|463929471|FG003|Controlled Period (Week 0 - 16)|Other|0|||
128900318|NCT02325219|463929472|FG004|Controlled Period (Week 0 - 16)|Other|0|||
128900319|NCT02325219|463929468|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
128900320|NCT02325219|463929469|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
128900321|NCT02325219|463929470|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
128900322|NCT02325219|463929471|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
128900323|NCT02325219|463929472|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
128900324|NCT02325219|463929468|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
128900325|NCT02325219|463929469|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
128900326|NCT02325219|463929470|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
128900327|NCT02325219|463929471|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
128900328|NCT02325219|463929472|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
128900329|NCT02325219|463929468|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
128900330|NCT02325219|463929469|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
128900331|NCT02325219|463929470|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
128900332|NCT02325219|463929471|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
128900333|NCT02325219|463929472|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
128900334|NCT02918864|463929473|FG000|Overall Study|Withdrawal by Subject|1|||
128900335|NCT02918864|463929474|FG001|Overall Study|Withdrawal by Subject|1|||
128900336|NCT02918864|463929473|FG000|Overall Study|Lost to Follow-up|3|||
128900337|NCT02918864|463929474|FG001|Overall Study|Lost to Follow-up|2|||
128900338|NCT04766021|463929475|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
128900339|NCT04766021|463929475|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
128900340|NCT02634151|463929479|FG000|Overall Study|Withdrawal by Subject|1|||
128900341|NCT02634151|463929480|FG001|Overall Study|Withdrawal by Subject|0|||
128900342|NCT02634151|463929479|FG000|Overall Study|Non-Compliance|0|||
128900343|NCT02634151|463929480|FG001|Overall Study|Non-Compliance|1|||
128900344|NCT02634151|463929479|FG000|Overall Study|Other|0|||
128900345|NCT02634151|463929480|FG001|Overall Study|Other|1|||
128900346|NCT02347098|463929481|FG000|Overall Study|Death|1|||
128900347|NCT02347098|463929482|FG001|Overall Study|Death|0|||
128900348|NCT02347098|463929481|FG000|Overall Study|Withdrawal by Subject|1|||
128900349|NCT02347098|463929482|FG001|Overall Study|Withdrawal by Subject|0|||
128900350|NCT02347098|463929481|FG000|Overall Study|Lost to Follow-up|2|||
128900351|NCT02347098|463929482|FG001|Overall Study|Lost to Follow-up|2|||
128900352|NCT02347098|463929481|FG000|Overall Study|Refuse Follow-up Visit|1|||
128900353|NCT02347098|463929482|FG001|Overall Study|Refuse Follow-up Visit|5|||
128900354|NCT02347098|463929481|FG000|Overall Study|no visit due to illness|2|||
128900355|NCT02347098|463929482|FG001|Overall Study|no visit due to illness|1|||
128900356|NCT02187172|463929483|FG000|Overall Study|Lost to Follow-up|1|||
128900357|NCT02187172|463929484|FG001|Overall Study|Lost to Follow-up|2|||
128900358|NCT02187172|463929483|FG000|Overall Study|Lack of Efficacy|1|||
128900359|NCT02187172|463929484|FG001|Overall Study|Lack of Efficacy|2|||
129113263|NCT02227784|464709704|FG000|Open-Label Extension Phase (OLE)|Death|0|||
129113264|NCT02227784|464709705|FG001|Open-Label Extension Phase (OLE)|Death|0|||
128900360|NCT02187172|463929483|FG000|Overall Study|Adverse Event|0|||
128900361|NCT02187172|463929484|FG001|Overall Study|Adverse Event|1|||
128900362|NCT02187172|463929483|FG000|Overall Study|Physician Decision|1|||
128900363|NCT02187172|463929484|FG001|Overall Study|Physician Decision|1|||
128900364|NCT04640272|463929485|FG000|Overall Study|Subject moved out of area|1|||
128900365|NCT00880399|463929486|FG000|Overall Study|Adverse Event|4|||
128900366|NCT00880399|463929487|FG001|Overall Study|Adverse Event|6|||
128900367|NCT00880399|463929488|FG002|Overall Study|Adverse Event|5|||
128900368|NCT00880399|463929486|FG000|Overall Study|Lack of Efficacy|1|||
128900369|NCT00880399|463929487|FG001|Overall Study|Lack of Efficacy|4|||
128900370|NCT00880399|463929488|FG002|Overall Study|Lack of Efficacy|2|||
129113265|NCT02227784|464709706|FG002|Open-Label Extension Phase (OLE)|Death|0|||
128900371|NCT00880399|463929486|FG000|Overall Study|Protocol Violation|4|||
128900372|NCT00880399|463929487|FG001|Overall Study|Protocol Violation|4|||
128900373|NCT00880399|463929488|FG002|Overall Study|Protocol Violation|6|||
128900374|NCT00880399|463929486|FG000|Overall Study|Study closed/terminated|3|||
128900375|NCT00880399|463929487|FG001|Overall Study|Study closed/terminated|7|||
128900376|NCT00880399|463929488|FG002|Overall Study|Study closed/terminated|4|||
128900377|NCT00880399|463929486|FG000|Overall Study|Lost to Follow-up|8|||
128900378|NCT00880399|463929487|FG001|Overall Study|Lost to Follow-up|5|||
128900379|NCT00880399|463929488|FG002|Overall Study|Lost to Follow-up|3|||
128900380|NCT00880399|463929486|FG000|Overall Study|Physician Decision|5|||
128900381|NCT00880399|463929487|FG001|Overall Study|Physician Decision|0|||
128900382|NCT00880399|463929488|FG002|Overall Study|Physician Decision|3|||
129113266|NCT02227784|464709707|FG003|Open-Label Extension Phase (OLE)|Death|0|||
129113267|NCT02227784|464709708|FG004|Open-Label Extension Phase (OLE)|Death|1|||
129113268|NCT02227784|464709704|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129113269|NCT02227784|464709705|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129113270|NCT02227784|464709706|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129113271|NCT02227784|464709707|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129113272|NCT02227784|464709708|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
129113273|NCT02227784|464709704|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129113274|NCT02227784|464709705|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129113275|NCT02227784|464709706|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129113276|NCT02227784|464709707|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129113277|NCT02227784|464709708|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
129113278|NCT02155699|464709709|FG000|Overall Study|Withdrawal by Subject|0|||
129113279|NCT02155699|464709710|FG001|Overall Study|Withdrawal by Subject|3|||
129113280|NCT02155699|464709711|FG002|Overall Study|Withdrawal by Subject|6|||
129113281|NCT02155699|464709712|FG003|Overall Study|Withdrawal by Subject|1|||
129113282|NCT02155699|464709709|FG000|Overall Study|Lost to Follow-up|0|||
129113283|NCT02155699|464709710|FG001|Overall Study|Lost to Follow-up|0|||
129113284|NCT02155699|464709711|FG002|Overall Study|Lost to Follow-up|0|||
129113285|NCT02155699|464709712|FG003|Overall Study|Lost to Follow-up|3|||
129113286|NCT02155699|464709709|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
129113287|NCT02155699|464709710|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
129113288|NCT02155699|464709711|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
129113289|NCT02155699|464709712|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
129113290|NCT00248651|464709717|FG000|Overall Study|Withdrawal by Subject|28|||
129113291|NCT00248651|464709718|FG001|Overall Study|Withdrawal by Subject|40|||
129113292|NCT00248651|464709719|FG002|Overall Study|Withdrawal by Subject|32|||
129113293|NCT02688933|464709720|FG000|Overall Study|Adverse Event|3|||
129113294|NCT02688933|464709721|FG001|Overall Study|Adverse Event|1|||
129113295|NCT02688933|464709720|FG000|Overall Study|Lack of Efficacy|2|||
129113296|NCT02688933|464709721|FG001|Overall Study|Lack of Efficacy|2|||
129113297|NCT02688933|464709720|FG000|Overall Study|Poor compliance to protocol|7|||
129113298|NCT02688933|464709721|FG001|Overall Study|Poor compliance to protocol|4|||
129113299|NCT02688933|464709720|FG000|Overall Study|Hypoglycemia|2|||
129113300|NCT02688933|464709721|FG001|Overall Study|Hypoglycemia|0|||
129113301|NCT02688933|464709720|FG000|Overall Study|Other than Specified|14|||
129113302|NCT02688933|464709721|FG001|Overall Study|Other than Specified|25|||
129113303|NCT02688933|464709720|FG000|Overall Study|Lost to Follow-up|1|||
129113304|NCT02688933|464709721|FG001|Overall Study|Lost to Follow-up|5|||
129113305|NCT01275144|464709722|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
129113306|NCT01275144|464709723|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
129113307|NCT00828113|464709724|FG000|Overall Study|Withdrawal by Subject|27|||
129113308|NCT00828113|464709725|FG001|Overall Study|Withdrawal by Subject|26|||
129113309|NCT00828113|464709724|FG000|Overall Study|Lost to Follow-up|3|||
129113310|NCT00828113|464709725|FG001|Overall Study|Lost to Follow-up|5|||
129113311|NCT01365130|464709726|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
129113312|NCT05607576|464709728|FG000|Overall Study|immediate sensor error|2|||
128900383|NCT00880399|463929486|FG000|Overall Study|Withdrawal by Subject|6|||
128900384|NCT00880399|463929487|FG001|Overall Study|Withdrawal by Subject|3|||
128900385|NCT00880399|463929488|FG002|Overall Study|Withdrawal by Subject|3|||
128900386|NCT04353284|463929493|FG000|Overall Study|Adverse Event|1|||
128900387|NCT04353284|463929494|FG001|Overall Study|Adverse Event|1|||
129113313|NCT05607576|464709728|FG000|Overall Study|Physician Decision|2|||
129113314|NCT00810199|464709729|FG000|Overall Study|Adverse Event|24|||
129113315|NCT00810199|464709730|FG001|Overall Study|Adverse Event|26|||
129113316|NCT00810199|464709729|FG000|Overall Study|Death|4|||
129113317|NCT00810199|464709730|FG001|Overall Study|Death|6|||
129113318|NCT00810199|464709729|FG000|Overall Study|Withdrew consent|9|||
129113319|NCT00810199|464709730|FG001|Overall Study|Withdrew consent|12|||
129113320|NCT00810199|464709729|FG000|Overall Study|Insufficient therapeutic response|5|||
128900388|NCT04353284|463929493|FG000|Overall Study|Lost to Follow-up|1|||
128900389|NCT04353284|463929494|FG001|Overall Study|Lost to Follow-up|0|||
128900390|NCT01438489|463929505|FG000|Overall Study|Lost to Follow-up|4|||
128900391|NCT01438489|463929506|FG001|Overall Study|Lost to Follow-up|2|||
128900392|NCT01438489|463929507|FG002|Overall Study|Lost to Follow-up|2|||
128900393|NCT01438489|463929505|FG000|Overall Study|Withdrawal by Subject|11|||
128900394|NCT01438489|463929506|FG001|Overall Study|Withdrawal by Subject|3|||
128900395|NCT01438489|463929507|FG002|Overall Study|Withdrawal by Subject|8|||
128900396|NCT01438489|463929505|FG000|Overall Study|Death|0|||
128900397|NCT01438489|463929506|FG001|Overall Study|Death|0|||
128900398|NCT01438489|463929507|FG002|Overall Study|Death|1|||
128900399|NCT01438489|463929505|FG000|Overall Study|Sponsor decision|4|||
128900400|NCT01438489|463929506|FG001|Overall Study|Sponsor decision|1|||
128900401|NCT01438489|463929507|FG002|Overall Study|Sponsor decision|4|||
128900402|NCT01438489|463929505|FG000|Overall Study|Subject choice/Subject moved|2|||
128900403|NCT01438489|463929506|FG001|Overall Study|Subject choice/Subject moved|1|||
128900404|NCT01438489|463929507|FG002|Overall Study|Subject choice/Subject moved|1|||
128900405|NCT01438489|463929505|FG000|Overall Study|Investigator decision|0|||
128900406|NCT01438489|463929506|FG001|Overall Study|Investigator decision|1|||
128900407|NCT01438489|463929507|FG002|Overall Study|Investigator decision|0|||
128900408|NCT01438489|463929505|FG000|Overall Study|AE/SAEs|2|||
128900409|NCT01438489|463929506|FG001|Overall Study|AE/SAEs|1|||
128900410|NCT01438489|463929507|FG002|Overall Study|AE/SAEs|1|||
128900411|NCT01438489|463929505|FG000|Overall Study|Received prohibited medication|1|||
128900412|NCT01438489|463929506|FG001|Overall Study|Received prohibited medication|0|||
128900413|NCT01438489|463929507|FG002|Overall Study|Received prohibited medication|0|||
128900414|NCT01438489|463929505|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
128900415|NCT01438489|463929506|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
128900416|NCT01438489|463929507|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
128900417|NCT01438489|463929505|FG000|Overall Study|Inadequate venous access|0|||
128900418|NCT01438489|463929506|FG001|Overall Study|Inadequate venous access|2|||
128900419|NCT01438489|463929507|FG002|Overall Study|Inadequate venous access|0|||
128900420|NCT00766532|463929508|FG000|Overall Study|Protocol Violation|2|||
128900421|NCT00751400|463929511|FG000|Overall Study|Lost to Follow-up|10|||
128900422|NCT00573430|463929512|FG000|Overall Study|Incorrect enrollment of randomization|0|||
128900423|NCT00573430|463929513|FG001|Overall Study|Incorrect enrollment of randomization|4|||
128900424|NCT00573430|463929514|FG002|Overall Study|Incorrect enrollment of randomization|3|||
128900425|NCT00573430|463929512|FG000|Overall Study|Adverse Event|0|||
128900426|NCT00573430|463929513|FG001|Overall Study|Adverse Event|0|||
128900427|NCT00573430|463929514|FG002|Overall Study|Adverse Event|2|||
128900428|NCT00573430|463929512|FG000|Overall Study|Withdrawal by Subject|1|||
128900429|NCT00573430|463929513|FG001|Overall Study|Withdrawal by Subject|0|||
128900430|NCT00573430|463929514|FG002|Overall Study|Withdrawal by Subject|1|||
128900431|NCT00573430|463929512|FG000|Overall Study|Protocol Violation|0|||
128900432|NCT00573430|463929513|FG001|Overall Study|Protocol Violation|1|||
128900433|NCT00573430|463929514|FG002|Overall Study|Protocol Violation|1|||
128900434|NCT00573430|463929512|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128900435|NCT00573430|463929513|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128900436|NCT00573430|463929514|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
128900437|NCT02037295|463929516|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
128900438|NCT02037295|463929517|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
128900439|NCT02037295|463929518|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
128900440|NCT02037295|463929519|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
128900441|NCT00441974|463929523|FG000|Overall Study|Adverse Event|6|||
128900442|NCT00441974|463929523|FG000|Overall Study|Consent Withdrawn|35|||
128900443|NCT00441974|463929523|FG000|Overall Study|Lost to Follow-up|80|||
128900444|NCT00441974|463929523|FG000|Overall Study|Protocol Violation|7|||
129023651|NCT02286739|464379826|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
129023652|NCT00834717|464379827|FG000|First Intervention|Adverse Event|1|||
129023653|NCT00834717|464379828|FG001|First Intervention|Adverse Event|0|||
128900445|NCT01148537|463929526|FG000|Overall Study|Withdrawal by Subject|1|||
128900446|NCT01148537|463929527|FG001|Overall Study|Withdrawal by Subject|0|||
128900447|NCT01148537|463929528|FG002|Overall Study|Withdrawal by Subject|2|||
128900448|NCT01148537|463929526|FG000|Overall Study|Adverse Event|2|||
129023654|NCT00834717|464379827|FG000|First Intervention|Withdrawal by Subject|0|||
129023655|NCT00834717|464379828|FG001|First Intervention|Withdrawal by Subject|1|||
129023656|NCT02255149|464379831|FG000|Overall Study|Lost to Follow-up|2|||
129023657|NCT02255149|464379831|FG000|Overall Study|Withdrawal by Subject|1|||
129023658|NCT02255149|464379831|FG000|Overall Study|Withdrawal by PI|1|||
128900449|NCT01148537|463929527|FG001|Overall Study|Adverse Event|0|||
128900450|NCT01148537|463929528|FG002|Overall Study|Adverse Event|1|||
128900451|NCT02770547|463929529|FG000|Overall Study|Patient non-compliant|1|||
128900452|NCT02770547|463929530|FG001|Overall Study|Patient non-compliant|0|||
128900453|NCT02770547|463929529|FG000|Overall Study|Adverse Event|0|||
128900454|NCT02770547|463929530|FG001|Overall Study|Adverse Event|1|||
129023659|NCT02255149|464379831|FG000|Overall Study|Implant Failure|1|||
129023660|NCT05710718|464379837|FG000|Overall Study|Withdrawal by Subject|5|||
128900455|NCT01324232|463929531|FG000|Overall Study|Protocol Violation|0|||
128900456|NCT01324232|463929532|FG001|Overall Study|Protocol Violation|0|||
128900457|NCT01324232|463929533|FG002|Overall Study|Protocol Violation|0|||
128900458|NCT01324232|463929534|FG003|Overall Study|Protocol Violation|2|||
128900459|NCT01324232|463929531|FG000|Overall Study|Missing|0|||
128900460|NCT01324232|463929532|FG001|Overall Study|Missing|0|||
128900461|NCT01324232|463929533|FG002|Overall Study|Missing|1|||
128900462|NCT01324232|463929534|FG003|Overall Study|Missing|0|||
128900463|NCT01324232|463929531|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
128900464|NCT01324232|463929532|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
128900465|NCT01324232|463929533|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
128900466|NCT01324232|463929534|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
128900467|NCT01324232|463929531|FG000|Overall Study|Lack of Efficacy|2|||
128692842|NCT00694707|463174211|FG004|Overall Study|Adverse Event|13|||
128900468|NCT01324232|463929532|FG001|Overall Study|Lack of Efficacy|1|||
128900469|NCT01324232|463929533|FG002|Overall Study|Lack of Efficacy|2|||
128900470|NCT01324232|463929534|FG003|Overall Study|Lack of Efficacy|2|||
128900471|NCT01324232|463929531|FG000|Overall Study|Participant Refused Medication|0|||
128900472|NCT01324232|463929532|FG001|Overall Study|Participant Refused Medication|1|||
128900473|NCT01324232|463929533|FG002|Overall Study|Participant Refused Medication|0|||
128900474|NCT01324232|463929534|FG003|Overall Study|Participant Refused Medication|0|||
128900475|NCT01324232|463929531|FG000|Overall Study|Intercurrent illness|0|||
128900476|NCT01324232|463929532|FG001|Overall Study|Intercurrent illness|0|||
128900477|NCT01324232|463929533|FG002|Overall Study|Intercurrent illness|0|||
128900478|NCT01324232|463929534|FG003|Overall Study|Intercurrent illness|1|||
128900479|NCT01324232|463929531|FG000|Overall Study|Adverse Event|2|||
128900480|NCT01324232|463929532|FG001|Overall Study|Adverse Event|5|||
128900481|NCT01324232|463929533|FG002|Overall Study|Adverse Event|6|||
129023661|NCT05710718|464379838|FG001|Overall Study|Withdrawal by Subject|1|||
129023662|NCT05710718|464379837|FG000|Overall Study|Lost to Follow-up|0|||
129023663|NCT05710718|464379838|FG001|Overall Study|Lost to Follow-up|1|||
129023664|NCT05710718|464379837|FG000|Overall Study|Death|0|||
129023665|NCT05710718|464379838|FG001|Overall Study|Death|1|||
129023666|NCT01319383|464379839|FG000|Overall Study|No ex vivo or in vivo response|4|||
129023667|NCT01319383|464379840|FG001|Overall Study|No ex vivo or in vivo response|0|||
129023668|NCT01319383|464379839|FG000|Overall Study|Physician Decision|3|||
129023669|NCT01319383|464379840|FG001|Overall Study|Physician Decision|0|||
129023670|NCT01319383|464379839|FG000|Overall Study|Lack of Efficacy|5|||
129023671|NCT01319383|464379840|FG001|Overall Study|Lack of Efficacy|9|||
129023672|NCT01319383|464379839|FG000|Overall Study|No in vivo response to interval doses|0|||
129023673|NCT01319383|464379840|FG001|Overall Study|No in vivo response to interval doses|1|||
129023674|NCT00446966|464379849|FG000|Overall Study|Lost to Follow-up|10|||
129023675|NCT00446966|464379850|FG001|Overall Study|Lost to Follow-up|7|||
129023676|NCT00443651|464379853|FG000|Overall Study|Death|1|||
129023677|NCT00443651|464379854|FG001|Overall Study|Death|5|||
129023678|NCT00443651|464379853|FG000|Overall Study|Adverse Event|5|||
129023679|NCT00443651|464379854|FG001|Overall Study|Adverse Event|6|||
129023680|NCT00443651|464379853|FG000|Overall Study|Lost to Follow-up|18|||
129023681|NCT00443651|464379854|FG001|Overall Study|Lost to Follow-up|12|||
129023682|NCT00443651|464379853|FG000|Overall Study|Patient's/Guardian's Decision|58|||
129023683|NCT00443651|464379854|FG001|Overall Study|Patient's/Guardian's Decision|30|||
129023684|NCT00443651|464379853|FG000|Overall Study|Physician Decision|13|||
129023685|NCT00443651|464379854|FG001|Overall Study|Physician Decision|4|||
129023686|NCT00443651|464379853|FG000|Overall Study|Pregnancy|0|||
129023687|NCT00443651|464379854|FG001|Overall Study|Pregnancy|1|||
129023688|NCT00859521|464379855|FG000|Washout|Withdrawal by Subject|0|||
129023689|NCT00859521|464379856|FG001|Washout|Withdrawal by Subject|1|||
129023690|NCT01547286|464379864|FG000|Overall Study|Did not meet all eligibility criteria|1|||
129023691|NCT01547286|464379864|FG000|Overall Study|Physician Decision|1|||
129023692|NCT03415308|464379867|FG000|Overall Study|Lost to Follow-up|0|||
129023693|NCT03415308|464379868|FG001|Overall Study|Lost to Follow-up|0|||
129023694|NCT03415308|464379869|FG002|Overall Study|Lost to Follow-up|1|||
129023695|NCT03415308|464379867|FG000|Overall Study|Scheduling Conflicts|0|||
129023696|NCT03415308|464379868|FG001|Overall Study|Scheduling Conflicts|0|||
129023697|NCT03415308|464379869|FG002|Overall Study|Scheduling Conflicts|7|||
129023698|NCT01471353|464379870|FG000|Overall Study|remain on study|3|||
129023699|NCT00836472|464379871|FG000|Washout|Adverse Event|1|||
128900482|NCT01324232|463929534|FG003|Overall Study|Adverse Event|6|||
129023700|NCT00836472|464379872|FG001|Washout|Adverse Event|2|||
129023701|NCT00836472|464379871|FG000|Washout|Withdrawal by Subject|1|||
129023702|NCT00836472|464379872|FG001|Washout|Withdrawal by Subject|1|||
129023703|NCT01695239|464379873|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
129023704|NCT01695239|464379874|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
129023705|NCT01695239|464379875|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
129023706|NCT01695239|464379876|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
129023707|NCT01695239|464379877|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129023708|NCT01695239|464379878|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
128900483|NCT01324232|463929531|FG000|Overall Study|Withdrawal by Subject|0|||
128900484|NCT01324232|463929532|FG001|Overall Study|Withdrawal by Subject|3|||
128900485|NCT01324232|463929533|FG002|Overall Study|Withdrawal by Subject|4|||
128900486|NCT01324232|463929534|FG003|Overall Study|Withdrawal by Subject|0|||
128900487|NCT01324232|463929531|FG000|Overall Study|Lost to Follow-up|1|||
128900488|NCT01324232|463929532|FG001|Overall Study|Lost to Follow-up|0|||
128900489|NCT01324232|463929533|FG002|Overall Study|Lost to Follow-up|0|||
128900490|NCT01324232|463929534|FG003|Overall Study|Lost to Follow-up|0|||
128900491|NCT00661531|463929535|FG000|Overall Study|Withdrawal by Subject|3|||
128900492|NCT03134599|463929537|FG000|Week 1|Lost to Follow-up|0|||
128900493|NCT03134599|463929538|FG001|Week 1|Lost to Follow-up|0|||
128900494|NCT03134599|463929539|FG002|Week 1|Lost to Follow-up|0|||
128900495|NCT03134599|463929540|FG003|Week 1|Lost to Follow-up|0|||
128900496|NCT03134599|463929541|FG004|Week 1|Lost to Follow-up|1|||
128900497|NCT03134599|463929542|FG005|Week 1|Lost to Follow-up|0|||
128900498|NCT03134599|463929537|FG000|Week 2|Lost to Follow-up|1|||
128900499|NCT03134599|463929538|FG001|Week 2|Lost to Follow-up|0|||
128900500|NCT03134599|463929539|FG002|Week 2|Lost to Follow-up|0|||
128900501|NCT03134599|463929540|FG003|Week 2|Lost to Follow-up|1|||
128900502|NCT03134599|463929541|FG004|Week 2|Lost to Follow-up|1|||
128900503|NCT03134599|463929542|FG005|Week 2|Lost to Follow-up|0|||
128900504|NCT03134599|463929537|FG000|Week 3|Lost to Follow-up|0|||
128900505|NCT03134599|463929538|FG001|Week 3|Lost to Follow-up|0|||
128900506|NCT03134599|463929539|FG002|Week 3|Lost to Follow-up|0|||
128900507|NCT03134599|463929540|FG003|Week 3|Lost to Follow-up|1|||
128900508|NCT03134599|463929541|FG004|Week 3|Lost to Follow-up|0|||
128900509|NCT03134599|463929542|FG005|Week 3|Lost to Follow-up|1|||
128900510|NCT00393887|463929543|FG000|Overall Study|Physician Decision|5|||
128900511|NCT00393887|463929544|FG001|Overall Study|Physician Decision|0|||
128900512|NCT00393887|463929543|FG000|Overall Study|Lost to Follow-up|11|||
128900513|NCT00393887|463929544|FG001|Overall Study|Lost to Follow-up|9|||
128900514|NCT04962022|463929547|FG000|Period 1|Withdrawal by Subject|1|||
128900515|NCT04962022|463929548|FG001|Period 1|Withdrawal by Subject|0|||
128900516|NCT01146873|463929551|FG000|Overall Study|Transfer out|0|||
128900517|NCT01146873|463929552|FG001|Overall Study|Transfer out|6|||
128900518|NCT01967628|463929553|FG000|Overall Study|Withdrawal by Subject|2|||
128900519|NCT01967628|463929554|FG001|Overall Study|Withdrawal by Subject|0|||
128900520|NCT01967628|463929553|FG000|Overall Study|Unable to complete bronchoscopy|4|||
128900521|NCT01967628|463929554|FG001|Overall Study|Unable to complete bronchoscopy|6|||
128900522|NCT01967628|463929553|FG000|Overall Study|Lost to Follow-up|1|||
128900523|NCT01967628|463929554|FG001|Overall Study|Lost to Follow-up|0|||
128900524|NCT01967628|463929553|FG000|Overall Study|Low protein concentration in sample|20|||
128900525|NCT01967628|463929554|FG001|Overall Study|Low protein concentration in sample|25|||
128900526|NCT01356407|463929555|FG000|Overall Study|Lost to Follow-up|2|||
128900527|NCT01356407|463929556|FG001|Overall Study|Lost to Follow-up|0|||
128900528|NCT01356407|463929555|FG000|Overall Study|Patient Withdrew Consent|2|||
128900529|NCT01356407|463929556|FG001|Overall Study|Patient Withdrew Consent|1|||
128900530|NCT01356407|463929555|FG000|Overall Study|Could not afford IMP administration|0|||
128900531|NCT01356407|463929556|FG001|Overall Study|Could not afford IMP administration|1|||
128900532|NCT01356407|463929555|FG000|Overall Study|Not complete Endoscopy|2|||
128900533|NCT01356407|463929556|FG001|Overall Study|Not complete Endoscopy|2|||
128900534|NCT02055820|463929559|FG000|Phase I: Dose-Finding|Death|1|||
128900535|NCT02055820|463929560|FG001|Phase I: Dose-Finding|Death|0|||
128900536|NCT02055820|463929561|FG002|Phase I: Dose-Finding|Death|1|||
128900537|NCT02055820|463929562|FG003|Phase I: Dose-Finding|Death|2|||
128900538|NCT02055820|463929563|FG004|Phase I: Dose-Finding|Death|0|||
128900539|NCT02055820|463929564|FG005|Phase I: Dose-Finding|Death|1|||
128900540|NCT02055820|463929565|FG006|Phase I: Dose-Finding|Death|1|||
129023709|NCT01695239|464379879|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129023710|NCT01695239|464379880|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129023711|NCT01695239|464379881|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129023712|NCT01695239|464379882|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129023713|NCT01695239|464379883|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129023714|NCT01695239|464379884|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
128900541|NCT02055820|463929566|FG007|Phase I: Dose-Finding|Death|0|||
128900542|NCT02055820|463929567|FG008|Phase I: Dose-Finding|Death|0|||
128900543|NCT02055820|463929568|FG009|Phase I: Dose-Finding|Death|0|||
128900544|NCT02055820|463929559|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900545|NCT02055820|463929560|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900546|NCT02055820|463929561|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129023715|NCT01695239|464379885|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129023716|NCT01695239|464379886|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
128900547|NCT02055820|463929562|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900548|NCT02055820|463929563|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900549|NCT02055820|463929564|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
128900550|NCT02055820|463929565|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900551|NCT02055820|463929566|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900552|NCT02055820|463929567|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900553|NCT02055820|463929568|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
128900554|NCT02055820|463929559|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900555|NCT02055820|463929560|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900556|NCT02055820|463929561|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900557|NCT02055820|463929562|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
128900558|NCT02055820|463929563|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900559|NCT02055820|463929564|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900560|NCT02055820|463929565|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
128900561|NCT02055820|463929566|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900562|NCT02055820|463929567|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900563|NCT02055820|463929568|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
128900564|NCT02055820|463929559|FG000|Phase II: Expansion|Death|0|||
128900565|NCT02055820|463929560|FG001|Phase II: Expansion|Death|0|||
128900566|NCT02055820|463929561|FG002|Phase II: Expansion|Death|0|||
128900567|NCT02055820|463929562|FG003|Phase II: Expansion|Death|0|||
128900568|NCT02055820|463929563|FG004|Phase II: Expansion|Death|33|||
128900569|NCT02055820|463929564|FG005|Phase II: Expansion|Death|0|||
128900570|NCT02055820|463929565|FG006|Phase II: Expansion|Death|0|||
128900571|NCT02055820|463929566|FG007|Phase II: Expansion|Death|0|||
128900572|NCT02055820|463929567|FG008|Phase II: Expansion|Death|0|||
128900573|NCT02055820|463929568|FG009|Phase II: Expansion|Death|0|||
128900574|NCT02055820|463929559|FG000|Phase II: Expansion|Lost to Follow-up|0|||
128900575|NCT02055820|463929560|FG001|Phase II: Expansion|Lost to Follow-up|0|||
128900576|NCT02055820|463929561|FG002|Phase II: Expansion|Lost to Follow-up|0|||
128900577|NCT02055820|463929562|FG003|Phase II: Expansion|Lost to Follow-up|0|||
128900578|NCT02055820|463929563|FG004|Phase II: Expansion|Lost to Follow-up|4|||
128900579|NCT02055820|463929564|FG005|Phase II: Expansion|Lost to Follow-up|0|||
128900580|NCT02055820|463929565|FG006|Phase II: Expansion|Lost to Follow-up|0|||
128900581|NCT02055820|463929566|FG007|Phase II: Expansion|Lost to Follow-up|0|||
128900582|NCT02055820|463929567|FG008|Phase II: Expansion|Lost to Follow-up|0|||
128900583|NCT02055820|463929568|FG009|Phase II: Expansion|Lost to Follow-up|0|||
128900584|NCT02055820|463929559|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
128900585|NCT02055820|463929560|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
128900586|NCT02055820|463929561|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
128900587|NCT02055820|463929562|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
128900588|NCT02055820|463929563|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
128692843|NCT00694707|463174207|FG000|Overall Study|Insufficient Therapeutic Response|33|||
128692844|NCT00694707|463174208|FG001|Overall Study|Insufficient Therapeutic Response|18|||
128692845|NCT00694707|463174209|FG002|Overall Study|Insufficient Therapeutic Response|17|||
128692846|NCT00694707|463174210|FG003|Overall Study|Insufficient Therapeutic Response|15|||
128692847|NCT00694707|463174211|FG004|Overall Study|Insufficient Therapeutic Response|10|||
128900589|NCT02055820|463929564|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
128900590|NCT02055820|463929565|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
128900591|NCT02055820|463929566|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
128900592|NCT02055820|463929567|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
129023717|NCT01695239|464379873|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
129023718|NCT01695239|464379874|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
129023719|NCT01695239|464379875|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
129023720|NCT01695239|464379876|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
129023721|NCT01695239|464379877|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023722|NCT01695239|464379878|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023723|NCT01695239|464379879|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023724|NCT01695239|464379880|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023725|NCT01695239|464379881|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023726|NCT01695239|464379882|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023727|NCT01695239|464379883|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023728|NCT01695239|464379884|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023729|NCT01695239|464379885|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023730|NCT01695239|464379886|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129023731|NCT01695239|464379873|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
129023732|NCT01695239|464379874|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023733|NCT01695239|464379875|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
129023734|NCT01695239|464379876|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023735|NCT01695239|464379877|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
128900593|NCT02055820|463929568|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
128900594|NCT01157364|463929569|FG000|Overall Study|Other Reasons|1|||
128900595|NCT01157364|463929570|FG001|Overall Study|Other Reasons|1|||
128900596|NCT01157364|463929571|FG002|Overall Study|Other Reasons|2|||
129023736|NCT01695239|464379878|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
128900597|NCT01157364|463929572|FG003|Overall Study|Other Reasons|1|||
128900598|NCT01157364|463929573|FG004|Overall Study|Other Reasons|0|||
128900599|NCT01157364|463929574|FG005|Overall Study|Other Reasons|0|||
128900600|NCT01157364|463929569|FG000|Overall Study|Personal Reasons|0|||
129113321|NCT00810199|464709730|FG001|Overall Study|Insufficient therapeutic response|14|||
129113322|NCT00810199|464709729|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
129113323|NCT00810199|464709730|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
129113324|NCT00810199|464709729|FG000|Overall Study|Administrative/Other|5|||
129113325|NCT00810199|464709730|FG001|Overall Study|Administrative/Other|6|||
129113326|NCT00810199|464709729|FG000|Overall Study|Protocol Violation|2|||
129113327|NCT00810199|464709730|FG001|Overall Study|Protocol Violation|6|||
129113328|NCT00810199|464709729|FG000|Overall Study|Failure to return|1|||
129113329|NCT00810199|464709730|FG001|Overall Study|Failure to return|4|||
129113330|NCT00810199|464709729|FG000|Overall Study|Did not receive study drug|2|||
129113331|NCT00810199|464709730|FG001|Overall Study|Did not receive study drug|1|||
129113332|NCT01091246|464709731|FG000|Overall Study|Lost to Follow-up|23|||
129113333|NCT01091246|464709732|FG001|Overall Study|Lost to Follow-up|11|||
129113334|NCT01091246|464709733|FG002|Overall Study|Lost to Follow-up|7|||
129113335|NCT01091246|464709731|FG000|Overall Study|Adverse Event|1|||
129113336|NCT01091246|464709732|FG001|Overall Study|Adverse Event|0|||
129113337|NCT01091246|464709733|FG002|Overall Study|Adverse Event|1|||
129113338|NCT01091246|464709731|FG000|Overall Study|Withdrawal by Subject|9|||
129113339|NCT01091246|464709732|FG001|Overall Study|Withdrawal by Subject|5|||
129113340|NCT01091246|464709733|FG002|Overall Study|Withdrawal by Subject|4|||
129113341|NCT01091246|464709731|FG000|Overall Study|Subject not dosed|2|||
129113342|NCT01091246|464709732|FG001|Overall Study|Subject not dosed|0|||
129113343|NCT01091246|464709733|FG002|Overall Study|Subject not dosed|1|||
129113344|NCT01107925|464709734|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
129113345|NCT01107925|464709735|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
129113346|NCT01107925|464709736|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
129113347|NCT01107925|464709737|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
128692848|NCT00694707|463174207|FG000|Overall Study|Protocol Violation|1|||
128692849|NCT00694707|463174208|FG001|Overall Study|Protocol Violation|2|||
128692850|NCT00694707|463174209|FG002|Overall Study|Protocol Violation|1|||
128692851|NCT00694707|463174210|FG003|Overall Study|Protocol Violation|3|||
128692852|NCT00694707|463174211|FG004|Overall Study|Protocol Violation|1|||
129023737|NCT01695239|464379879|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023738|NCT01695239|464379880|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023739|NCT01695239|464379881|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023740|NCT01695239|464379882|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023741|NCT01695239|464379883|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023742|NCT01695239|464379884|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023743|NCT01695239|464379885|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023744|NCT01695239|464379886|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129023745|NCT01695239|464379873|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
129023746|NCT01695239|464379874|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
129023747|NCT01695239|464379875|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
129023748|NCT01695239|464379876|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023749|NCT01695239|464379877|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023750|NCT01695239|464379878|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023751|NCT01695239|464379879|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023752|NCT01695239|464379880|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023753|NCT01695239|464379881|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023754|NCT01695239|464379882|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023755|NCT01695239|464379883|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023756|NCT01695239|464379884|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023757|NCT01695239|464379885|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023758|NCT01695239|464379886|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129023759|NCT01695239|464379873|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
129023760|NCT01695239|464379874|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023761|NCT01695239|464379875|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
129023762|NCT01695239|464379876|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023763|NCT01695239|464379877|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023764|NCT01695239|464379878|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023765|NCT01695239|464379879|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023766|NCT01695239|464379880|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023767|NCT01695239|464379881|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023768|NCT01695239|464379882|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023769|NCT01695239|464379883|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129113348|NCT01107925|464709738|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
129113349|NCT01107925|464709739|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
128900601|NCT01157364|463929570|FG001|Overall Study|Personal Reasons|2|||
129113350|NCT01107925|464709734|FG000|Period 2|Withdrawal by Subject|0|||
129113351|NCT01107925|464709735|FG001|Period 2|Withdrawal by Subject|1|||
128900602|NCT01157364|463929571|FG002|Overall Study|Personal Reasons|0|||
128900603|NCT01157364|463929572|FG003|Overall Study|Personal Reasons|0|||
128900604|NCT01157364|463929573|FG004|Overall Study|Personal Reasons|1|||
128900605|NCT01157364|463929574|FG005|Overall Study|Personal Reasons|1|||
128900606|NCT01157364|463929569|FG000|Overall Study|Lost to Follow-up|1|||
128900607|NCT01157364|463929570|FG001|Overall Study|Lost to Follow-up|0|||
128900608|NCT01157364|463929571|FG002|Overall Study|Lost to Follow-up|1|||
128900609|NCT01157364|463929572|FG003|Overall Study|Lost to Follow-up|0|||
128900610|NCT01157364|463929573|FG004|Overall Study|Lost to Follow-up|0|||
128900611|NCT01157364|463929574|FG005|Overall Study|Lost to Follow-up|0|||
129023770|NCT01695239|464379884|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023771|NCT01695239|464379885|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023772|NCT01695239|464379886|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129023773|NCT01695239|464379873|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129023774|NCT01695239|464379874|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023775|NCT01695239|464379875|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129023776|NCT01695239|464379876|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023777|NCT01695239|464379877|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023778|NCT01695239|464379878|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023779|NCT01695239|464379879|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023780|NCT01695239|464379880|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023781|NCT01695239|464379881|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023782|NCT01695239|464379882|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023783|NCT01695239|464379883|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023784|NCT01695239|464379884|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023785|NCT01695239|464379885|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023786|NCT01695239|464379886|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129023787|NCT01695239|464379873|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
129023788|NCT01695239|464379874|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023789|NCT01695239|464379875|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023790|NCT01695239|464379876|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023791|NCT01695239|464379877|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023792|NCT01695239|464379878|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023793|NCT01695239|464379879|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023794|NCT01695239|464379880|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023795|NCT01695239|464379881|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023796|NCT01695239|464379882|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023797|NCT01695239|464379883|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023798|NCT01695239|464379884|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023799|NCT01695239|464379885|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023800|NCT01695239|464379886|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129023801|NCT01695239|464379873|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023802|NCT01695239|464379874|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023803|NCT01695239|464379875|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023804|NCT01695239|464379876|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023805|NCT01695239|464379877|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023806|NCT01695239|464379878|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023807|NCT01695239|464379879|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023808|NCT01695239|464379880|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
129023809|NCT01695239|464379881|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023810|NCT01695239|464379882|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023811|NCT01695239|464379883|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023812|NCT01695239|464379884|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023813|NCT01695239|464379885|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023814|NCT01695239|464379886|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129023815|NCT01695239|464379873|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023816|NCT01695239|464379874|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023817|NCT01695239|464379875|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023818|NCT01695239|464379876|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023819|NCT01695239|464379877|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023820|NCT01695239|464379878|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023821|NCT01695239|464379879|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023822|NCT01695239|464379880|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
129023823|NCT01695239|464379881|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023824|NCT01695239|464379882|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023825|NCT01695239|464379883|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
128900612|NCT01157364|463929569|FG000|Overall Study|Lack of Efficacy|0|||
128692853|NCT00694707|463174207|FG000|Overall Study|Withdrawal of Consent|14|||
128692854|NCT00694707|463174208|FG001|Overall Study|Withdrawal of Consent|18|||
128692855|NCT00694707|463174209|FG002|Overall Study|Withdrawal of Consent|22|||
128692856|NCT00694707|463174210|FG003|Overall Study|Withdrawal of Consent|16|||
128692857|NCT00694707|463174211|FG004|Overall Study|Withdrawal of Consent|15|||
128692858|NCT00694707|463174207|FG000|Overall Study|Lost to Follow-up|0|||
128692859|NCT00694707|463174208|FG001|Overall Study|Lost to Follow-up|1|||
128692860|NCT00694707|463174209|FG002|Overall Study|Lost to Follow-up|2|||
128692861|NCT00694707|463174210|FG003|Overall Study|Lost to Follow-up|0|||
128692862|NCT00694707|463174211|FG004|Overall Study|Lost to Follow-up|0|||
128692863|NCT00694707|463174207|FG000|Overall Study|Jeopardizing Parole Status|1|||
128692864|NCT00694707|463174208|FG001|Overall Study|Jeopardizing Parole Status|0|||
128692865|NCT00694707|463174209|FG002|Overall Study|Jeopardizing Parole Status|0|||
128692866|NCT00694707|463174210|FG003|Overall Study|Jeopardizing Parole Status|0|||
128692867|NCT00694707|463174211|FG004|Overall Study|Jeopardizing Parole Status|0|||
128692868|NCT00694707|463174207|FG000|Overall Study|Death in the Family|1|||
128692869|NCT00694707|463174208|FG001|Overall Study|Death in the Family|0|||
128692870|NCT00694707|463174209|FG002|Overall Study|Death in the Family|0|||
128692871|NCT00694707|463174210|FG003|Overall Study|Death in the Family|0|||
129023826|NCT01695239|464379884|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023827|NCT01695239|464379885|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023828|NCT01695239|464379886|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129023829|NCT01695239|464379873|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023830|NCT01695239|464379874|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023831|NCT01695239|464379875|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023832|NCT01695239|464379876|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023833|NCT01695239|464379877|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023834|NCT01695239|464379878|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023835|NCT01695239|464379879|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023836|NCT01695239|464379880|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
129023837|NCT01695239|464379881|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023838|NCT01695239|464379882|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023839|NCT01695239|464379883|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023840|NCT01695239|464379884|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023841|NCT01695239|464379885|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023842|NCT01695239|464379886|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129023843|NCT01695239|464379873|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023844|NCT01695239|464379874|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023845|NCT01695239|464379875|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023846|NCT01695239|464379876|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023847|NCT01695239|464379877|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023848|NCT01695239|464379878|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023849|NCT01695239|464379879|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023850|NCT01695239|464379880|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023851|NCT01695239|464379881|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
129023852|NCT01695239|464379882|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
129023853|NCT01695239|464379883|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023854|NCT01695239|464379884|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023855|NCT01695239|464379885|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023856|NCT01695239|464379886|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129023857|NCT01695239|464379873|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
129023858|NCT01695239|464379874|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
129023859|NCT01695239|464379875|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
129023860|NCT01695239|464379876|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
129023861|NCT01695239|464379877|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
129023862|NCT01695239|464379878|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
129023863|NCT01695239|464379879|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
129023864|NCT01695239|464379880|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
129023865|NCT01695239|464379881|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
129023866|NCT01695239|464379882|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
129023867|NCT01695239|464379883|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
129023868|NCT01695239|464379884|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
129023869|NCT01695239|464379885|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
129023870|NCT01695239|464379886|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
128692872|NCT00694707|463174211|FG004|Overall Study|Death in the Family|0|||
128692873|NCT00694707|463174207|FG000|Overall Study|Arrest by Police|0|||
128692874|NCT00694707|463174208|FG001|Overall Study|Arrest by Police|1|||
128692875|NCT00694707|463174209|FG002|Overall Study|Arrest by Police|0|||
129113352|NCT01107925|464709736|FG002|Period 2|Withdrawal by Subject|0|||
129113353|NCT01107925|464709737|FG003|Period 2|Withdrawal by Subject|0|||
129113354|NCT01107925|464709738|FG004|Period 2|Withdrawal by Subject|0|||
129113355|NCT01107925|464709739|FG005|Period 2|Withdrawal by Subject|1|||
129113356|NCT04877990|464709740|FG000|Treatment|Other reasons|3|||
129113357|NCT04877990|464709741|FG001|Treatment|Other reasons|1|||
129113358|NCT04877990|464709740|FG000|Treatment|Administrative reasons by sponsor|17|||
129113359|NCT04877990|464709741|FG001|Treatment|Administrative reasons by sponsor|33|||
129113360|NCT04877990|464709740|FG000|Treatment|Withdrawal by Subject|2|||
129113361|NCT04877990|464709741|FG001|Treatment|Withdrawal by Subject|6|||
129113362|NCT04877990|464709740|FG000|Treatment|Adverse Event|2|||
129113363|NCT04877990|464709741|FG001|Treatment|Adverse Event|1|||
129113364|NCT01121263|464709742|FG000|Overall Study|Death|3|||
129113365|NCT01121263|464709743|FG001|Overall Study|Death|2|||
129113366|NCT01121263|464709742|FG000|Overall Study|Lost to Follow-up|22|||
129113367|NCT01121263|464709743|FG001|Overall Study|Lost to Follow-up|12|||
129113368|NCT01121263|464709742|FG000|Overall Study|Withdrawal by Subject|0|||
129113369|NCT01121263|464709743|FG001|Overall Study|Withdrawal by Subject|1|||
129113370|NCT02007720|464709744|FG000|Overall Study|Withdrawal by Subject|9|||
128900613|NCT01157364|463929570|FG001|Overall Study|Lack of Efficacy|0|||
128900614|NCT01157364|463929571|FG002|Overall Study|Lack of Efficacy|0|||
128900615|NCT01157364|463929572|FG003|Overall Study|Lack of Efficacy|1|||
128900616|NCT01157364|463929573|FG004|Overall Study|Lack of Efficacy|0|||
128900617|NCT01157364|463929574|FG005|Overall Study|Lack of Efficacy|0|||
128900618|NCT01157364|463929569|FG000|Overall Study|Adverse Event|0|||
128900619|NCT01157364|463929570|FG001|Overall Study|Adverse Event|1|||
128900620|NCT01157364|463929571|FG002|Overall Study|Adverse Event|1|||
128900621|NCT01157364|463929572|FG003|Overall Study|Adverse Event|0|||
128900622|NCT01157364|463929573|FG004|Overall Study|Adverse Event|1|||
128900623|NCT01157364|463929574|FG005|Overall Study|Adverse Event|0|||
128900624|NCT00841568|463929587|FG000|Overall Study|Adverse Event|1|||
128900625|NCT00841568|463929587|FG000|Overall Study|Death|1|||
128900626|NCT00841568|463929587|FG000|Overall Study|Withdrawal by Subject|2|||
128900627|NCT00841568|463929587|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
128900628|NCT01087775|463929588|FG000|Overall Study|failed inclusion criteria|2|||
128900629|NCT05289570|463929592|FG000|Overall Study|Physician Decision|1|||
128900630|NCT00733954|463929597|FG000|Overall Study|Lost to Follow-up|5|||
128900631|NCT00733954|463929598|FG001|Overall Study|Lost to Follow-up|2|||
128900632|NCT00733954|463929597|FG000|Overall Study|Protocol Violation|1|||
128900633|NCT00733954|463929598|FG001|Overall Study|Protocol Violation|0|||
128900634|NCT00733954|463929597|FG000|Overall Study|Withdrawal by Subject|2|||
129023871|NCT01695239|464379873|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023872|NCT01695239|464379874|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023873|NCT01695239|464379875|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023874|NCT01695239|464379876|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023875|NCT01695239|464379877|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023876|NCT01695239|464379878|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023877|NCT01695239|464379879|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023878|NCT01695239|464379880|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023879|NCT01695239|464379881|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
129023880|NCT01695239|464379882|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
129023881|NCT01695239|464379883|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023882|NCT01695239|464379884|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023883|NCT01695239|464379885|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023884|NCT01695239|464379886|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129023885|NCT01695239|464379873|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
129023886|NCT01695239|464379874|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
129023887|NCT01695239|464379875|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
129023888|NCT01695239|464379876|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
129023889|NCT01695239|464379877|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
129023890|NCT01695239|464379878|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
129023891|NCT01695239|464379879|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
129023892|NCT01695239|464379880|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
129023893|NCT01695239|464379881|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
129023894|NCT01695239|464379882|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
129023895|NCT01695239|464379883|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
129023896|NCT01695239|464379884|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
129023897|NCT01695239|464379885|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
129113371|NCT02007720|464709745|FG001|Overall Study|Withdrawal by Subject|11|||
129113372|NCT02007720|464709744|FG000|Overall Study|study terminated by sponsor|58|||
129113373|NCT02007720|464709745|FG001|Overall Study|study terminated by sponsor|54|||
129113374|NCT02007720|464709744|FG000|Overall Study|technical problem|4|||
129113375|NCT02007720|464709745|FG001|Overall Study|technical problem|2|||
129113376|NCT02007720|464709744|FG000|Overall Study|patient followd less than 165 days|11|||
129113377|NCT02007720|464709745|FG001|Overall Study|patient followd less than 165 days|5|||
129113378|NCT03810456|464709746|FG000|Treatment|Urgent Family Matters|3|||
129113379|NCT03810456|464709747|FG001|Treatment|Urgent Family Matters|0|||
129113380|NCT03810456|464709748|FG002|Treatment|Urgent Family Matters|0|||
129113381|NCT03810456|464709746|FG000|Treatment|Scheduling Conflicts|0|||
129113382|NCT03810456|464709747|FG001|Treatment|Scheduling Conflicts|11|||
129113383|NCT03810456|464709748|FG002|Treatment|Scheduling Conflicts|0|||
129113384|NCT03810456|464709746|FG000|Treatment|No Longer Interested|0|||
129113385|NCT03810456|464709747|FG001|Treatment|No Longer Interested|12|||
129113386|NCT03810456|464709748|FG002|Treatment|No Longer Interested|0|||
129113387|NCT03810456|464709746|FG000|Treatment|Transportation Issues|0|||
129113388|NCT03810456|464709747|FG001|Treatment|Transportation Issues|1|||
129113389|NCT03810456|464709748|FG002|Treatment|Transportation Issues|0|||
129113390|NCT03810456|464709746|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
129113391|NCT03810456|464709747|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
129113392|NCT03810456|464709748|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
129113393|NCT03810456|464709746|FG000|1 Month Follow-Up|Relocated to Different State|1|||
129113394|NCT03810456|464709747|FG001|1 Month Follow-Up|Relocated to Different State|0|||
129113395|NCT03810456|464709748|FG002|1 Month Follow-Up|Relocated to Different State|1|||
129113396|NCT03810456|464709746|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
129113397|NCT03810456|464709747|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
129113398|NCT03810456|464709748|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
129113399|NCT03810456|464709746|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
129113400|NCT03810456|464709747|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
129113401|NCT03810456|464709748|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
129113402|NCT03810456|464709746|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
129113403|NCT03810456|464709747|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
129113404|NCT03810456|464709748|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
129113405|NCT03810456|464709746|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
129113406|NCT03810456|464709747|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
129113407|NCT03810456|464709748|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
129113408|NCT03810456|464709746|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
129113409|NCT03810456|464709747|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
129113410|NCT03810456|464709748|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
129113411|NCT01386606|464711454|FG000|Overall Study|Adverse Event|0|||
129113412|NCT01386606|464711455|FG001|Overall Study|Adverse Event|1|||
129113413|NCT01386606|464711456|FG002|Overall Study|Adverse Event|0|||
129113414|NCT01386606|464711457|FG003|Overall Study|Adverse Event|0|||
129113415|NCT01386606|464711454|FG000|Overall Study|Withdrawal by Subject|0|||
129113416|NCT01386606|464711455|FG001|Overall Study|Withdrawal by Subject|1|||
129113417|NCT01386606|464711456|FG002|Overall Study|Withdrawal by Subject|1|||
129113418|NCT01386606|464711457|FG003|Overall Study|Withdrawal by Subject|0|||
129113419|NCT01386606|464711454|FG000|Overall Study|Protocol Violation|1|||
129113420|NCT01386606|464711455|FG001|Overall Study|Protocol Violation|0|||
129113421|NCT01386606|464711456|FG002|Overall Study|Protocol Violation|1|||
129113422|NCT01386606|464711457|FG003|Overall Study|Protocol Violation|1|||
129113423|NCT01386606|464711454|FG000|Overall Study|Lost to Follow-up|2|||
128692876|NCT00694707|463174210|FG003|Overall Study|Arrest by Police|0|||
128900635|NCT00733954|463929598|FG001|Overall Study|Withdrawal by Subject|0|||
128900636|NCT02663453|463929599|FG000|Overall Study|Death|4|||
128900637|NCT02663453|463929600|FG001|Overall Study|Death|4|||
128900638|NCT02663453|463929599|FG000|Overall Study|Withdrawal by Subject|1|||
128900639|NCT02663453|463929600|FG001|Overall Study|Withdrawal by Subject|0|||
128900640|NCT00980200|463930537|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
128900641|NCT00980200|463930538|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
128900642|NCT00980200|463930539|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
128900643|NCT00980200|463930540|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
128900644|NCT00980200|463930541|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
128900645|NCT00980200|463930537|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
128692877|NCT00694707|463174211|FG004|Overall Study|Arrest by Police|0|||
128692878|NCT00694707|463174207|FG000|Overall Study|Administrative Reasons|0|||
128900646|NCT00980200|463930538|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
129113424|NCT01386606|464711455|FG001|Overall Study|Lost to Follow-up|0|||
129113425|NCT01386606|464711456|FG002|Overall Study|Lost to Follow-up|0|||
129113426|NCT01386606|464711457|FG003|Overall Study|Lost to Follow-up|0|||
129113427|NCT01386606|464711454|FG000|Overall Study|Subject incarcerated|0|||
129113428|NCT01386606|464711455|FG001|Overall Study|Subject incarcerated|1|||
129113429|NCT01386606|464711456|FG002|Overall Study|Subject incarcerated|0|||
129113430|NCT01386606|464711457|FG003|Overall Study|Subject incarcerated|0|||
128692879|NCT00694707|463174208|FG001|Overall Study|Administrative Reasons|1|||
128692880|NCT00694707|463174209|FG002|Overall Study|Administrative Reasons|0|||
128692881|NCT00694707|463174210|FG003|Overall Study|Administrative Reasons|2|||
129113431|NCT01386606|464711454|FG000|Overall Study|Unable to draw PK|1|||
129113432|NCT01386606|464711455|FG001|Overall Study|Unable to draw PK|0|||
129113433|NCT01386606|464711456|FG002|Overall Study|Unable to draw PK|0|||
129113434|NCT01386606|464711457|FG003|Overall Study|Unable to draw PK|0|||
128900647|NCT00980200|463930539|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
128900648|NCT00980200|463930540|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
128900649|NCT00980200|463930541|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
129023898|NCT01695239|464379886|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
129023899|NCT01695239|464379873|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023900|NCT01695239|464379874|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023901|NCT01695239|464379875|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023902|NCT01695239|464379876|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023903|NCT01695239|464379877|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023904|NCT01695239|464379878|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023905|NCT01695239|464379879|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023906|NCT01695239|464379880|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023907|NCT01695239|464379881|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
129023908|NCT01695239|464379882|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
129023909|NCT01695239|464379883|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023910|NCT01695239|464379884|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023911|NCT01695239|464379885|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023912|NCT01695239|464379886|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129023913|NCT01695239|464379873|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023914|NCT01695239|464379874|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023915|NCT01695239|464379875|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023916|NCT01695239|464379876|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023917|NCT01695239|464379877|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023918|NCT01695239|464379878|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023919|NCT01695239|464379879|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023920|NCT01695239|464379880|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023921|NCT01695239|464379881|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
129023922|NCT01695239|464379882|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
129023923|NCT01695239|464379883|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023924|NCT01695239|464379884|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023925|NCT01695239|464379885|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023926|NCT01695239|464379886|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129023927|NCT01695239|464379873|FG000|Extension Long-Term Extension Periods|Death|0|||
129023928|NCT01695239|464379874|FG001|Extension Long-Term Extension Periods|Death|0|||
129023929|NCT01695239|464379875|FG002|Extension Long-Term Extension Periods|Death|0|||
129023930|NCT01695239|464379876|FG003|Extension Long-Term Extension Periods|Death|0|||
129023931|NCT01695239|464379877|FG004|Extension Long-Term Extension Periods|Death|0|||
129023932|NCT01695239|464379878|FG005|Extension Long-Term Extension Periods|Death|0|||
129023933|NCT01695239|464379879|FG006|Extension Long-Term Extension Periods|Death|0|||
129023934|NCT01695239|464379880|FG007|Extension Long-Term Extension Periods|Death|0|||
129023935|NCT01695239|464379881|FG008|Extension Long-Term Extension Periods|Death|1|||
129023936|NCT01695239|464379882|FG009|Extension Long-Term Extension Periods|Death|0|||
129023937|NCT01695239|464379883|FG010|Extension Long-Term Extension Periods|Death|0|||
129023938|NCT01695239|464379884|FG011|Extension Long-Term Extension Periods|Death|0|||
129023939|NCT01695239|464379885|FG012|Extension Long-Term Extension Periods|Death|0|||
129023940|NCT01695239|464379886|FG013|Extension Long-Term Extension Periods|Death|0|||
129023941|NCT01695239|464379873|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023942|NCT01695239|464379874|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023943|NCT01695239|464379875|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023944|NCT01695239|464379876|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023945|NCT01695239|464379877|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023946|NCT01695239|464379878|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023947|NCT01695239|464379879|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023948|NCT01695239|464379880|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023949|NCT01695239|464379881|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023950|NCT01695239|464379882|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023951|NCT01695239|464379883|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129023952|NCT01695239|464379884|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
129023953|NCT01695239|464379885|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
129023954|NCT01695239|464379886|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
129023955|NCT01695239|464379873|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023956|NCT01695239|464379874|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023957|NCT01695239|464379875|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023958|NCT01695239|464379876|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023959|NCT01695239|464379877|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023960|NCT01695239|464379878|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023961|NCT01695239|464379879|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128692882|NCT00694707|463174211|FG004|Overall Study|Administrative Reasons|0|||
128900650|NCT01611974|463930547|FG000|Overall Study|Death|10|||
128900651|NCT01611974|463930548|FG001|Overall Study|Death|12|||
128900652|NCT01611974|463930549|FG002|Overall Study|Death|10|||
128900653|NCT01611974|463930547|FG000|Overall Study|Lost to Follow-up|0|||
128900654|NCT01611974|463930548|FG001|Overall Study|Lost to Follow-up|1|||
128900655|NCT01611974|463930549|FG002|Overall Study|Lost to Follow-up|0|||
128900656|NCT01611974|463930547|FG000|Overall Study|Physician Decision|5|||
128900657|NCT01611974|463930548|FG001|Overall Study|Physician Decision|1|||
128900658|NCT01611974|463930549|FG002|Overall Study|Physician Decision|2|||
128900659|NCT01611974|463930547|FG000|Overall Study|Withdrawal by Subject|0|||
128900660|NCT01611974|463930548|FG001|Overall Study|Withdrawal by Subject|1|||
128900661|NCT01611974|463930549|FG002|Overall Study|Withdrawal by Subject|4|||
128900662|NCT02257372|463930555|FG000|Overall Study|Adverse Event|3|||
128900663|NCT02257372|463930556|FG001|Overall Study|Adverse Event|7|||
128900664|NCT02257372|463930555|FG000|Overall Study|Lack of Efficacy|2|||
128900665|NCT02257372|463930556|FG001|Overall Study|Lack of Efficacy|1|||
128900666|NCT02257372|463930555|FG000|Overall Study|Protocol Violation|1|||
128900667|NCT02257372|463930556|FG001|Overall Study|Protocol Violation|1|||
128900668|NCT02257372|463930555|FG000|Overall Study|Lost to Follow-up|0|||
128900669|NCT02257372|463930556|FG001|Overall Study|Lost to Follow-up|1|||
128900670|NCT02257372|463930555|FG000|Overall Study|Withdrew consent|1|||
128900671|NCT02257372|463930556|FG001|Overall Study|Withdrew consent|0|||
128900672|NCT00789529|463930557|FG000|Overall Study|Withdrawal by Subject|0|||
128900673|NCT00789529|463930558|FG001|Overall Study|Withdrawal by Subject|1|||
128900674|NCT00789529|463930557|FG000|Overall Study|Other Reason|1|||
128900675|NCT00789529|463930558|FG001|Overall Study|Other Reason|0|||
128900676|NCT01849874|463930560|FG000|Overall Study|Death|89|||
128900677|NCT01849874|463930561|FG001|Overall Study|Death|42|||
128900678|NCT01849874|463930560|FG000|Overall Study|Withdrawal by Subject|17|||
128900679|NCT01849874|463930561|FG001|Overall Study|Withdrawal by Subject|16|||
128900680|NCT01849874|463930560|FG000|Overall Study|Lost to Follow-up|3|||
128900681|NCT01849874|463930561|FG001|Overall Study|Lost to Follow-up|2|||
128900682|NCT01849874|463930560|FG000|Overall Study|Study Termination By Sponsor|93|||
128900683|NCT01849874|463930561|FG001|Overall Study|Study Termination By Sponsor|48|||
128900684|NCT01849874|463930560|FG000|Overall Study|Completed as per protocol amendment 6|3|||
128900685|NCT01849874|463930561|FG001|Overall Study|Completed as per protocol amendment 6|0|||
128900686|NCT01849874|463930560|FG000|Overall Study|Physician Decision|7|||
128900687|NCT01849874|463930561|FG001|Overall Study|Physician Decision|1|||
128900688|NCT01849874|463930560|FG000|Overall Study|Other|16|||
128900689|NCT01849874|463930561|FG001|Overall Study|Other|4|||
128900690|NCT01230242|463930574|FG000|Overall Study|Physician Decision|2|||
128900691|NCT01230242|463930574|FG000|Overall Study|Withdrawal by Subject|1|||
128900692|NCT04329702|463930575|FG000|Overall Study|illness|3|||
128900693|NCT04329702|463930576|FG001|Overall Study|illness|4|||
128900694|NCT04329702|463930577|FG002|Overall Study|illness|0|||
128900695|NCT04329702|463930575|FG000|Overall Study|Lost to Follow-up|0|||
128900696|NCT04329702|463930576|FG001|Overall Study|Lost to Follow-up|0|||
128900697|NCT04329702|463930577|FG002|Overall Study|Lost to Follow-up|2|||
128900698|NCT04329702|463930575|FG000|Overall Study|Death|0|||
128900699|NCT04329702|463930576|FG001|Overall Study|Death|2|||
128900700|NCT04329702|463930577|FG002|Overall Study|Death|0|||
128900701|NCT01140451|463930581|FG000|Overall Study|Withdrawal by Subject|26|||
128900702|NCT01140451|463930582|FG001|Overall Study|Withdrawal by Subject|33|||
128900703|NCT01140451|463930581|FG000|Overall Study|Adverse Event|2|||
128900704|NCT01140451|463930582|FG001|Overall Study|Adverse Event|6|||
128900705|NCT01140451|463930581|FG000|Overall Study|Physician Decision|5|||
128900706|NCT01140451|463930582|FG001|Overall Study|Physician Decision|3|||
128900707|NCT01140451|463930581|FG000|Overall Study|Lost to Follow-up|2|||
128692883|NCT00694707|463174207|FG000|Overall Study|Notification of Past Head Injury|0|||
128692884|NCT00694707|463174208|FG001|Overall Study|Notification of Past Head Injury|0|||
128900708|NCT01140451|463930582|FG001|Overall Study|Lost to Follow-up|0|||
128900709|NCT01140451|463930581|FG000|Overall Study|Participants Planning Pregnancy|3|||
128900710|NCT01140451|463930582|FG001|Overall Study|Participants Planning Pregnancy|0|||
128900711|NCT02614859|463930584|FG000|Overall Study|Physician Decision|0|||
128900712|NCT02614859|463930585|FG001|Overall Study|Physician Decision|1|||
128900713|NCT04081363|463930589|FG000|Overall Study|Withdrawal by Subject|1|||
128692885|NCT00694707|463174209|FG002|Overall Study|Notification of Past Head Injury|0|||
128692886|NCT00694707|463174210|FG003|Overall Study|Notification of Past Head Injury|1|||
128900714|NCT04081363|463930590|FG001|Overall Study|Withdrawal by Subject|0|||
128900715|NCT02370615|463930600|FG000|Overall Study|Adverse Event|1|||
128900716|NCT02370615|463930601|FG001|Overall Study|Adverse Event|0|||
128900717|NCT01136655|463930605|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
128900718|NCT01136655|463930605|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
128900719|NCT01136655|463930605|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
128900720|NCT01136655|463930605|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
128900721|NCT02287623|463930606|FG000|Overall Study|Protocol Violation|0|||
128900722|NCT02287623|463930607|FG001|Overall Study|Protocol Violation|1|||
128692887|NCT00694707|463174211|FG004|Overall Study|Notification of Past Head Injury|0|||
128692888|NCT02046733|463174216|FG000|Overall Study|never initiated 'treatment visits'|6|||
128692889|NCT02046733|463174217|FG001|Overall Study|never initiated 'treatment visits'|0|||
128692890|NCT00395733|463174218|FG000|Period 2|Withdrawal by Subject|1|||
128692891|NCT00395733|463174219|FG001|Period 2|Withdrawal by Subject|2|||
128692892|NCT00395733|463174218|FG000|Period 2|Protocol Violation|0|||
128692893|NCT00395733|463174219|FG001|Period 2|Protocol Violation|1|||
128692894|NCT00395733|463174218|FG000|Period 2|Adverse Event|0|||
128692895|NCT00395733|463174219|FG001|Period 2|Adverse Event|2|||
128692896|NCT00395733|463174218|FG000|Period 2|Technical problems|1|||
128692897|NCT00395733|463174219|FG001|Period 2|Technical problems|0|||
128692898|NCT01710046|463174223|FG000|Overall Study|Lost to Follow-up|1|||
128692899|NCT01710046|463174224|FG001|Overall Study|Lost to Follow-up|0|||
128692900|NCT03896165|463174225|FG000|Overall Study|Withdrawal by Subject|2|||
128900723|NCT02700997|463930608|FG000|Overall Study|Did not undergo CT imaging|1|||
128900724|NCT02700997|463930608|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
128692901|NCT00397215|463174235|FG000|Month 0 (Day 0)|Adverse Event|0|||
128692902|NCT00397215|463174236|FG001|Month 0 (Day 0)|Adverse Event|1|||
128692903|NCT00397215|463174237|FG002|Month 0 (Day 0)|Adverse Event|0|||
128692904|NCT00397215|463174238|FG003|Month 0 (Day 0)|Adverse Event|0|||
128692905|NCT00397215|463174235|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
128692906|NCT00397215|463174236|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
128692907|NCT00397215|463174237|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
128692908|NCT00397215|463174238|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
128692909|NCT00397215|463174235|FG000|Month 0 (Day 0)|Other|4|||
128900725|NCT00432042|463930609|FG000|Overall Study|Protocol Violation|2|||
128900726|NCT00432042|463930610|FG001|Overall Study|Protocol Violation|0|||
128900727|NCT00432042|463930611|FG002|Overall Study|Protocol Violation|0|||
128900728|NCT00432042|463930609|FG000|Overall Study|Withdrawal by Subject|0|||
128900729|NCT00432042|463930610|FG001|Overall Study|Withdrawal by Subject|0|||
128900730|NCT00432042|463930611|FG002|Overall Study|Withdrawal by Subject|2|||
128900731|NCT00432042|463930609|FG000|Overall Study|Lost to Follow-up|5|||
128900732|NCT00432042|463930610|FG001|Overall Study|Lost to Follow-up|1|||
128900733|NCT00432042|463930611|FG002|Overall Study|Lost to Follow-up|0|||
128900734|NCT01585272|463930612|FG000|Overall Study|Adverse Event|22|||
128900735|NCT01585272|463930612|FG000|Overall Study|Protocol Violation|7|||
128900736|NCT01585272|463930612|FG000|Overall Study|Withdrawal by Subject|10|||
128900737|NCT00645593|463930613|FG000|Overall Study|Later found to be ineligible|1|||
128900738|NCT00645593|463930614|FG001|Overall Study|Later found to be ineligible|0|||
128900739|NCT03765138|463930619|FG000|Overall Study|Lost to Follow-up|1|||
128900740|NCT02577146|463930620|FG000|Overall Study|Lost to Follow-up|8|||
128900741|NCT02577146|463930620|FG000|Overall Study|Physician Decision|3|||
128900742|NCT02577146|463930620|FG000|Overall Study|Screen Failure|17|||
128900743|NCT01970501|463930621|FG000|Overall Study|Discontinuation of study by sponsor|16|||
128900744|NCT01970501|463930622|FG001|Overall Study|Discontinuation of study by sponsor|14|||
128900745|NCT01970501|463930621|FG000|Overall Study|Withdrawal by Subject|6|||
128900746|NCT01970501|463930622|FG001|Overall Study|Withdrawal by Subject|7|||
128900747|NCT01970501|463930621|FG000|Overall Study|Adverse Event|2|||
128900748|NCT01970501|463930622|FG001|Overall Study|Adverse Event|4|||
128900749|NCT01970501|463930621|FG000|Overall Study|Death|1|||
128900750|NCT01970501|463930622|FG001|Overall Study|Death|3|||
128900751|NCT01970501|463930621|FG000|Overall Study|Physician Decision|2|||
128900752|NCT01970501|463930622|FG001|Overall Study|Physician Decision|0|||
128900753|NCT03803059|463930624|FG000|Overall Study|Protocol Violation|2|||
128900754|NCT03803059|463930624|FG000|Overall Study|Lost to Follow-up|1|||
128900755|NCT04013529|463930627|FG000|Overall Study|Withdrawal by Subject|1|||
128900756|NCT04013529|463930628|FG001|Overall Study|Withdrawal by Subject|1|||
128900757|NCT03116698|463930629|FG000|Overall Study|Adverse Event|1|||
128900758|NCT03116698|463930630|FG001|Overall Study|Adverse Event|1|||
128900759|NCT03116698|463930631|FG002|Overall Study|Adverse Event|1|||
128900760|NCT03116698|463930632|FG003|Overall Study|Adverse Event|0|||
128900761|NCT03116698|463930629|FG000|Overall Study|Withdrawal by Subject|1|||
128900762|NCT03116698|463930630|FG001|Overall Study|Withdrawal by Subject|4|||
128692910|NCT00397215|463174236|FG001|Month 0 (Day 0)|Other|1|||
128692911|NCT00397215|463174237|FG002|Month 0 (Day 0)|Other|3|||
128692912|NCT00397215|463174238|FG003|Month 0 (Day 0)|Other|3|||
128692913|NCT00397215|463174235|FG000|Month 6 (Day 180)|Adverse Event|0|||
128764661|NCT02991482|463430251|FG000|Overall Study|Patient feeling too unwell|1|||
128764662|NCT02991482|463430252|FG001|Overall Study|Patient feeling too unwell|0|||
128692914|NCT00397215|463174236|FG001|Month 6 (Day 180)|Adverse Event|3|||
128900763|NCT03116698|463930631|FG002|Overall Study|Withdrawal by Subject|5|||
128900764|NCT03116698|463930632|FG003|Overall Study|Withdrawal by Subject|2|||
128900765|NCT03116698|463930629|FG000|Overall Study|Lost to Follow-up|2|||
128900766|NCT03116698|463930630|FG001|Overall Study|Lost to Follow-up|0|||
128900767|NCT03116698|463930631|FG002|Overall Study|Lost to Follow-up|0|||
128900768|NCT03116698|463930632|FG003|Overall Study|Lost to Follow-up|0|||
128900769|NCT03116698|463930629|FG000|Overall Study|Physician Decision|1|||
128692915|NCT00397215|463174237|FG002|Month 6 (Day 180)|Adverse Event|2|||
128900770|NCT03116698|463930630|FG001|Overall Study|Physician Decision|1|||
128900771|NCT03116698|463930631|FG002|Overall Study|Physician Decision|0|||
128900772|NCT03116698|463930632|FG003|Overall Study|Physician Decision|0|||
128900773|NCT03116698|463930629|FG000|Overall Study|Protocol Violation|1|||
128900774|NCT03116698|463930630|FG001|Overall Study|Protocol Violation|0|||
128900775|NCT03116698|463930631|FG002|Overall Study|Protocol Violation|0|||
128900776|NCT03116698|463930632|FG003|Overall Study|Protocol Violation|0|||
128900777|NCT03116698|463930629|FG000|Overall Study|Death|0|||
128900778|NCT03116698|463930630|FG001|Overall Study|Death|0|||
128900779|NCT03116698|463930631|FG002|Overall Study|Death|2|||
128900780|NCT03116698|463930632|FG003|Overall Study|Death|0|||
128900781|NCT00788372|463930633|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
128900782|NCT00788372|463930633|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
128900783|NCT00788372|463930633|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
128900784|NCT00788372|463930633|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
128900785|NCT00788372|463930633|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
128900786|NCT00788372|463930633|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
128900787|NCT00788372|463930633|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
128900788|NCT02116777|463930636|FG000|Overall Study|Adverse Event|0|||
128900789|NCT02116777|463930637|FG001|Overall Study|Adverse Event|0|||
128900790|NCT02116777|463930638|FG002|Overall Study|Adverse Event|0|||
128900791|NCT02116777|463930639|FG003|Overall Study|Adverse Event|0|||
128900792|NCT02116777|463930640|FG004|Overall Study|Adverse Event|2|||
128900793|NCT02116777|463930641|FG005|Overall Study|Adverse Event|2|||
128900794|NCT02116777|463930642|FG006|Overall Study|Adverse Event|0|||
128900795|NCT02116777|463930636|FG000|Overall Study|Death|0|||
128900796|NCT02116777|463930637|FG001|Overall Study|Death|0|||
128900797|NCT02116777|463930638|FG002|Overall Study|Death|0|||
128900798|NCT02116777|463930639|FG003|Overall Study|Death|1|||
128900799|NCT02116777|463930640|FG004|Overall Study|Death|0|||
128900800|NCT02116777|463930641|FG005|Overall Study|Death|0|||
128900801|NCT02116777|463930642|FG006|Overall Study|Death|0|||
128900802|NCT02116777|463930636|FG000|Overall Study|Lack of Efficacy|3|||
128900803|NCT02116777|463930637|FG001|Overall Study|Lack of Efficacy|3|||
128900804|NCT02116777|463930638|FG002|Overall Study|Lack of Efficacy|3|||
128900805|NCT02116777|463930639|FG003|Overall Study|Lack of Efficacy|8|||
128900806|NCT02116777|463930640|FG004|Overall Study|Lack of Efficacy|4|||
128900807|NCT02116777|463930641|FG005|Overall Study|Lack of Efficacy|1|||
128900808|NCT02116777|463930642|FG006|Overall Study|Lack of Efficacy|9|||
128900809|NCT02116777|463930636|FG000|Overall Study|Physician Decision|0|||
128900810|NCT02116777|463930637|FG001|Overall Study|Physician Decision|0|||
128900811|NCT02116777|463930638|FG002|Overall Study|Physician Decision|0|||
128900812|NCT02116777|463930639|FG003|Overall Study|Physician Decision|2|||
128900813|NCT02116777|463930640|FG004|Overall Study|Physician Decision|0|||
128900814|NCT02116777|463930641|FG005|Overall Study|Physician Decision|0|||
128900815|NCT02116777|463930642|FG006|Overall Study|Physician Decision|0|||
128900816|NCT02116777|463930636|FG000|Overall Study|Protocol Violation|0|||
128900817|NCT02116777|463930637|FG001|Overall Study|Protocol Violation|0|||
128900818|NCT02116777|463930638|FG002|Overall Study|Protocol Violation|0|||
129023962|NCT01695239|464379880|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023963|NCT01695239|464379881|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023964|NCT01695239|464379882|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128692916|NCT00397215|463174238|FG003|Month 6 (Day 180)|Adverse Event|0|||
128692917|NCT00397215|463174235|FG000|Month 6 (Day 180)|Other|2|||
128692918|NCT00397215|463174236|FG001|Month 6 (Day 180)|Other|0|||
129023965|NCT01695239|464379883|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023966|NCT01695239|464379884|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129023967|NCT01695239|464379885|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
129023968|NCT01695239|464379886|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
128692919|NCT00397215|463174237|FG002|Month 6 (Day 180)|Other|3|||
128692920|NCT00397215|463174238|FG003|Month 6 (Day 180)|Other|0|||
128692921|NCT02128932|463174239|FG000|Overall Study|Withdrawal by Subject|11|||
128692922|NCT02128932|463174240|FG001|Overall Study|Withdrawal by Subject|7|||
128692923|NCT02128932|463174241|FG002|Overall Study|Withdrawal by Subject|8|||
128692924|NCT02128932|463174239|FG000|Overall Study|Death|2|||
128692925|NCT02128932|463174240|FG001|Overall Study|Death|0|||
128692926|NCT02128932|463174241|FG002|Overall Study|Death|2|||
128692927|NCT02128932|463174239|FG000|Overall Study|Lost to Follow-up|2|||
128764663|NCT02991482|463430251|FG000|Overall Study|Worsening of performance status|0|||
128764664|NCT02991482|463430252|FG001|Overall Study|Worsening of performance status|1|||
128900819|NCT02116777|463930639|FG003|Overall Study|Protocol Violation|1|||
128900820|NCT02116777|463930640|FG004|Overall Study|Protocol Violation|0|||
128900821|NCT02116777|463930641|FG005|Overall Study|Protocol Violation|0|||
128692928|NCT02128932|463174240|FG001|Overall Study|Lost to Follow-up|1|||
128900822|NCT02116777|463930642|FG006|Overall Study|Protocol Violation|0|||
128900823|NCT02116777|463930636|FG000|Overall Study|Withdrawal by Subject|0|||
128900824|NCT02116777|463930637|FG001|Overall Study|Withdrawal by Subject|0|||
128900825|NCT02116777|463930638|FG002|Overall Study|Withdrawal by Subject|0|||
128900826|NCT02116777|463930639|FG003|Overall Study|Withdrawal by Subject|1|||
128900827|NCT02116777|463930640|FG004|Overall Study|Withdrawal by Subject|0|||
128692929|NCT02128932|463174241|FG002|Overall Study|Lost to Follow-up|1|||
128692930|NCT02128932|463174239|FG000|Overall Study|No reason for withdrawal|12|||
128692931|NCT02128932|463174240|FG001|Overall Study|No reason for withdrawal|11|||
128692932|NCT02128932|463174241|FG002|Overall Study|No reason for withdrawal|7|||
128692933|NCT01361568|463174242|FG000|Overall Study|Adverse Event|0|||
128692934|NCT01361568|463174243|FG001|Overall Study|Adverse Event|0|||
128692935|NCT01361568|463174244|FG002|Overall Study|Adverse Event|0|||
128692936|NCT01361568|463174245|FG003|Overall Study|Adverse Event|0|||
128692937|NCT01361568|463174246|FG004|Overall Study|Adverse Event|1|||
128692938|NCT01361568|463174247|FG005|Overall Study|Adverse Event|0|||
128692939|NCT01361568|463174242|FG000|Overall Study|Physician Decision|0|||
128692940|NCT01361568|463174243|FG001|Overall Study|Physician Decision|0|||
128692941|NCT01361568|463174244|FG002|Overall Study|Physician Decision|0|||
128692942|NCT01361568|463174245|FG003|Overall Study|Physician Decision|0|||
128692943|NCT01361568|463174246|FG004|Overall Study|Physician Decision|0|||
128692944|NCT01361568|463174247|FG005|Overall Study|Physician Decision|1|||
128692945|NCT01361568|463174242|FG000|Overall Study|Withdrawal by Subject|2|||
128692946|NCT01361568|463174243|FG001|Overall Study|Withdrawal by Subject|1|||
128692947|NCT01361568|463174244|FG002|Overall Study|Withdrawal by Subject|0|||
128692948|NCT01361568|463174245|FG003|Overall Study|Withdrawal by Subject|0|||
128692949|NCT01361568|463174246|FG004|Overall Study|Withdrawal by Subject|0|||
128692950|NCT01361568|463174247|FG005|Overall Study|Withdrawal by Subject|1|||
128692951|NCT00657358|463174252|FG000|Overall Study|Lack of Efficacy|6|||
128692952|NCT02959983|463174253|FG000|Overall Study|Protocol Violation|0|||
128692953|NCT02959983|463174254|FG001|Overall Study|Protocol Violation|1|||
128692954|NCT02959983|463174253|FG000|Overall Study|Lack of Efficacy|0|||
128692955|NCT02959983|463174254|FG001|Overall Study|Lack of Efficacy|1|||
128692956|NCT02959983|463174253|FG000|Overall Study|Lost to Follow-up|12|||
128692957|NCT02959983|463174254|FG001|Overall Study|Lost to Follow-up|9|||
128692958|NCT02959983|463174253|FG000|Overall Study|Other|1|||
128692959|NCT02959983|463174254|FG001|Overall Study|Other|1|||
128692960|NCT02959983|463174253|FG000|Overall Study|Physician Decision|1|||
128692961|NCT02959983|463174254|FG001|Overall Study|Physician Decision|0|||
128692962|NCT02959983|463174253|FG000|Overall Study|Adverse Event|5|||
128692963|NCT02959983|463174254|FG001|Overall Study|Adverse Event|1|||
128692964|NCT02959983|463174253|FG000|Overall Study|Withdrawal by Subject|7|||
128692965|NCT02959983|463174254|FG001|Overall Study|Withdrawal by Subject|12|||
128692966|NCT02728596|463174255|FG000|Overall Study|Refusal unrelated to adverse event|3|||
128692967|NCT02728596|463174256|FG001|Overall Study|Refusal unrelated to adverse event|6|||
128692968|NCT02728596|463174257|FG002|Overall Study|Refusal unrelated to adverse event|7|||
128692969|NCT02728596|463174258|FG003|Overall Study|Refusal unrelated to adverse event|7|||
128692970|NCT02728596|463174255|FG000|Overall Study|Death|44|||
128692971|NCT02728596|463174256|FG001|Overall Study|Death|42|||
128692972|NCT02728596|463174257|FG002|Overall Study|Death|123|||
128692973|NCT02728596|463174258|FG003|Overall Study|Death|68|||
128692974|NCT04032652|463174265|FG000|Overall Study|The study was terminated and the PI has|1|||
128692975|NCT04032652|463174266|FG001|Overall Study|The study was terminated and the PI has|1|||
128692976|NCT02180724|463176112|FG000|Overall Study|Death|26|||
128692977|NCT02180724|463176113|FG001|Overall Study|Death|1|||
128692978|NCT02180724|463176112|FG000|Overall Study|Lost to Follow-up|3|||
128692979|NCT02180724|463176113|FG001|Overall Study|Lost to Follow-up|1|||
128692980|NCT02180724|463176112|FG000|Overall Study|Withdrawal by Subject|4|||
128692981|NCT02180724|463176113|FG001|Overall Study|Withdrawal by Subject|2|||
128692982|NCT02180724|463176112|FG000|Overall Study|PI Decision|5|||
128692983|NCT02180724|463176113|FG001|Overall Study|PI Decision|2|||
128692984|NCT02180724|463176112|FG000|Overall Study|Study terminated by sponsor|54|||
128692985|NCT02180724|463176113|FG001|Overall Study|Study terminated by sponsor|8|||
128692986|NCT01824342|463176122|FG000|Overall Study|Withdrawal by Subject|0|||
128692987|NCT01824342|463176123|FG001|Overall Study|Withdrawal by Subject|3|||
128764665|NCT02991482|463430251|FG000|Overall Study|Death prior to study drug initiation|1|||
128900828|NCT02116777|463930641|FG005|Overall Study|Withdrawal by Subject|0|||
128900829|NCT02116777|463930642|FG006|Overall Study|Withdrawal by Subject|0|||
128900830|NCT04218201|463932512|FG000|Overall Study|Death|0|||
128900831|NCT04218201|463932513|FG001|Overall Study|Death|0|||
128900832|NCT04218201|463932514|FG002|Overall Study|Death|2|||
128900833|NCT04218201|463932515|FG003|Overall Study|Death|0|||
128900834|NCT04218201|463932512|FG000|Overall Study|Unable to contact participant|4|||
129023969|NCT01695239|464379873|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
129215242|NCT01588522|465089469|FG005|Overall Study|Did not initiate chemotherapy|0|||
128692988|NCT01824342|463176122|FG000|Overall Study|Adverse Event|1|||
128692989|NCT01824342|463176123|FG001|Overall Study|Adverse Event|1|||
128692990|NCT01824342|463176122|FG000|Overall Study|Disease Progression|1|||
128692991|NCT01824342|463176123|FG001|Overall Study|Disease Progression|1|||
128692992|NCT01824342|463176122|FG000|Overall Study|Physician Decision|5|||
128692993|NCT01824342|463176123|FG001|Overall Study|Physician Decision|0|||
128692994|NCT01824342|463176122|FG000|Overall Study|Death|2|||
128692995|NCT01824342|463176123|FG001|Overall Study|Death|0|||
128692996|NCT02281773|463176128|FG000|Overall Study|Adverse Event|6|||
128692997|NCT02281773|463176129|FG001|Overall Study|Adverse Event|1|||
128900835|NCT04218201|463932513|FG001|Overall Study|Unable to contact participant|0|||
128900836|NCT04218201|463932514|FG002|Overall Study|Unable to contact participant|3|||
128900837|NCT04218201|463932515|FG003|Overall Study|Unable to contact participant|0|||
128900838|NCT04218201|463932512|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
128900839|NCT04218201|463932513|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
129113435|NCT01386606|464711454|FG000|Overall Study|T levels too high|0|||
129113436|NCT01386606|464711455|FG001|Overall Study|T levels too high|1|||
129113437|NCT01386606|464711456|FG002|Overall Study|T levels too high|1|||
129113438|NCT01386606|464711457|FG003|Overall Study|T levels too high|0|||
129113439|NCT04980014|464711458|FG000|Overall Study|Participants who are Duplicated|1|||
129113440|NCT04980014|464711458|FG000|Overall Study|Follow-up Failure|13|||
129113441|NCT04980014|464711458|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
129113442|NCT04980014|464711458|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
129113443|NCT04980014|464711458|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
129113444|NCT01241279|464711459|FG000|Overall Study|Lost to Follow-up|0|||
129113445|NCT01241279|464711460|FG001|Overall Study|Lost to Follow-up|1|||
129113446|NCT00301834|464711461|FG000|Overall Study|Death|1|||
129113447|NCT01145482|464711462|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129113448|NCT01145482|464711463|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129113449|NCT01405560|464711466|FG000|Overall Study|Physician Decision|1|||
129113450|NCT01699750|464711468|FG000|Overall Study|Withdrew Consent|0|||
129113451|NCT01699750|464711469|FG001|Overall Study|Withdrew Consent|1|||
129113452|NCT01699750|464711468|FG000|Overall Study|Other|0|||
129113453|NCT01699750|464711469|FG001|Overall Study|Other|2|||
129113454|NCT02119299|464711470|FG000|Overall Study|Withdrawal by Subject|7|||
129113455|NCT02119299|464711470|FG000|Overall Study|Lack of Efficacy|1|||
129113456|NCT02119299|464711470|FG000|Overall Study|Pregnancy|1|||
129113457|NCT02452047|464711471|FG000|Overall Study|Adverse Event|0|||
129113458|NCT02452047|464711472|FG001|Overall Study|Adverse Event|1|||
129113459|NCT02452047|464711473|FG002|Overall Study|Adverse Event|1|||
129113460|NCT02452047|464711471|FG000|Overall Study|Death|1|||
129113461|NCT02452047|464711472|FG001|Overall Study|Death|3|||
129113462|NCT02452047|464711473|FG002|Overall Study|Death|1|||
129113463|NCT02452047|464711471|FG000|Overall Study|Physician Decision|1|||
129113464|NCT02452047|464711472|FG001|Overall Study|Physician Decision|0|||
129113465|NCT02452047|464711473|FG002|Overall Study|Physician Decision|0|||
129113466|NCT02452047|464711471|FG000|Overall Study|Lost to Follow-up|1|||
129113467|NCT02452047|464711472|FG001|Overall Study|Lost to Follow-up|1|||
129113468|NCT02452047|464711473|FG002|Overall Study|Lost to Follow-up|0|||
129113469|NCT02452047|464711471|FG000|Overall Study|Withdrawal by Subject|1|||
129113470|NCT02452047|464711472|FG001|Overall Study|Withdrawal by Subject|0|||
129113471|NCT02452047|464711473|FG002|Overall Study|Withdrawal by Subject|0|||
129113472|NCT02026141|464711475|FG000|Overall Study|Protocol Violation|0|||
129113473|NCT02026141|464711476|FG001|Overall Study|Protocol Violation|1|||
129113474|NCT02219685|464711477|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
129113475|NCT02219685|464711478|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
129113476|NCT02219685|464711477|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
129113477|NCT02219685|464711478|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
129113478|NCT04202497|464711479|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
129113479|NCT04202497|464711480|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
129113480|NCT04202497|464711481|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
129113481|NCT04202497|464711482|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
129113482|NCT02115607|464711489|FG000|Overall Study|Withdrawal by Subject|1|||
129113483|NCT00102596|464711493|FG000|Part A|Screen failures|6|||
129113484|NCT00102596|464711494|FG001|Part A|Screen failures|0|||
129113485|NCT00102596|464711493|FG000|Part A|Adverse Event|1|||
129113486|NCT00102596|464711494|FG001|Part A|Adverse Event|0|||
129113487|NCT00069264|464711496|FG000|Overall Study|Adverse Event|3|||
129113488|NCT00069264|464711496|FG000|Overall Study|Progressive Disease|23|||
129113489|NCT00069264|464711496|FG000|Overall Study|Withdrawal by Subject|3|||
129113490|NCT00069264|464711496|FG000|Overall Study|Discon Therapy|3|||
128900840|NCT04218201|463932514|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
128900841|NCT04218201|463932515|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
128900842|NCT04218201|463932512|FG000|Overall Study|Withdrawal by Subject|2|||
129113491|NCT05547386|464711497|FG000|Overall Study|Withdrawal by Subject|7|||
129113492|NCT04622969|464711498|FG000|Overall Study|Withdrawal by Subject|2|||
129113493|NCT04622969|464711499|FG001|Overall Study|Withdrawal by Subject|3|||
128900843|NCT04218201|463932513|FG001|Overall Study|Withdrawal by Subject|0|||
128900844|NCT04218201|463932514|FG002|Overall Study|Withdrawal by Subject|0|||
128900845|NCT04218201|463932515|FG003|Overall Study|Withdrawal by Subject|0|||
129113494|NCT04467515|464711500|FG000|Overall Study|Lost to Follow-up|1|||
129113495|NCT04467515|464711501|FG001|Overall Study|Lost to Follow-up|0|||
129113496|NCT04467515|464711502|FG002|Overall Study|Lost to Follow-up|0|||
129113497|NCT04467515|464711500|FG000|Overall Study|Withdrawal by Subject|1|||
128764666|NCT02991482|463430252|FG001|Overall Study|Death prior to study drug initiation|0|||
128900846|NCT04218201|463932512|FG000|Overall Study|PCP plans to leave practice|0|||
128900847|NCT04218201|463932513|FG001|Overall Study|PCP plans to leave practice|8|||
128900848|NCT04218201|463932514|FG002|Overall Study|PCP plans to leave practice|0|||
128900849|NCT04218201|463932515|FG003|Overall Study|PCP plans to leave practice|5|||
128900850|NCT04218201|463932512|FG000|Overall Study|Reduced panel|0|||
128900851|NCT04218201|463932513|FG001|Overall Study|Reduced panel|0|||
128900852|NCT04218201|463932514|FG002|Overall Study|Reduced panel|0|||
128900853|NCT04218201|463932515|FG003|Overall Study|Reduced panel|1|||
128900854|NCT04218201|463932512|FG000|Overall Study|No longer interested in participating|0|||
128900855|NCT04218201|463932513|FG001|Overall Study|No longer interested in participating|1|||
128900856|NCT04218201|463932514|FG002|Overall Study|No longer interested in participating|0|||
128900857|NCT04218201|463932515|FG003|Overall Study|No longer interested in participating|0|||
128900858|NCT03723707|463932522|FG000|Overall Study|Death|32|||
128900859|NCT03723707|463932523|FG001|Overall Study|Death|32|||
128900860|NCT03723707|463932522|FG000|Overall Study|Admitted to long term care|12|||
128900861|NCT03723707|463932523|FG001|Overall Study|Admitted to long term care|12|||
128900862|NCT03723707|463932522|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
128900863|NCT03723707|463932523|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
128900864|NCT03723707|463932522|FG000|Overall Study|Lost to Follow-up|40|||
128900865|NCT03723707|463932523|FG001|Overall Study|Lost to Follow-up|22|||
128900866|NCT03723707|463932522|FG000|Overall Study|Discontinued after study closure|24|||
128900867|NCT03723707|463932523|FG001|Overall Study|Discontinued after study closure|12|||
128900868|NCT05121480|463932524|FG000|Overall Study|Lack of Efficacy|2|||
128900869|NCT05121480|463932525|FG001|Overall Study|Lack of Efficacy|2|||
128900870|NCT05121480|463932526|FG002|Overall Study|Lack of Efficacy|1|||
128900871|NCT05121480|463932527|FG003|Overall Study|Lack of Efficacy|4|||
128900872|NCT05121480|463932528|FG004|Overall Study|Lack of Efficacy|0|||
128900873|NCT05121480|463932529|FG005|Overall Study|Lack of Efficacy|1|||
128900874|NCT05121480|463932530|FG006|Overall Study|Lack of Efficacy|0|||
128900875|NCT05121480|463932531|FG007|Overall Study|Lack of Efficacy|2|||
128900876|NCT05121480|463932524|FG000|Overall Study|Treatment Failure|0|||
128900877|NCT05121480|463932525|FG001|Overall Study|Treatment Failure|2|||
128900878|NCT05121480|463932526|FG002|Overall Study|Treatment Failure|0|||
128900879|NCT05121480|463932527|FG003|Overall Study|Treatment Failure|1|||
128900880|NCT05121480|463932528|FG004|Overall Study|Treatment Failure|0|||
128900881|NCT05121480|463932529|FG005|Overall Study|Treatment Failure|0|||
128900882|NCT05121480|463932530|FG006|Overall Study|Treatment Failure|0|||
128900883|NCT05121480|463932531|FG007|Overall Study|Treatment Failure|0|||
128900884|NCT05121480|463932524|FG000|Overall Study|Adverse Event|0|||
128900885|NCT05121480|463932525|FG001|Overall Study|Adverse Event|1|||
128900886|NCT05121480|463932526|FG002|Overall Study|Adverse Event|0|||
128900887|NCT05121480|463932527|FG003|Overall Study|Adverse Event|5|||
128900888|NCT05121480|463932528|FG004|Overall Study|Adverse Event|3|||
128900889|NCT05121480|463932529|FG005|Overall Study|Adverse Event|2|||
129023970|NCT01695239|464379874|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023971|NCT01695239|464379875|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023972|NCT01695239|464379876|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023973|NCT01695239|464379877|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023974|NCT01695239|464379878|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023975|NCT01695239|464379879|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023976|NCT01695239|464379880|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023977|NCT01695239|464379881|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023978|NCT01695239|464379882|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023979|NCT01695239|464379883|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023980|NCT01695239|464379884|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023981|NCT01695239|464379885|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
129023982|NCT01695239|464379886|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
129023983|NCT01695239|464379873|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023984|NCT01695239|464379874|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023985|NCT01695239|464379875|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023986|NCT01695239|464379876|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023987|NCT01695239|464379877|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023988|NCT01695239|464379878|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128764667|NCT02991482|463430251|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
128900890|NCT05121480|463932530|FG006|Overall Study|Adverse Event|0|||
128900891|NCT05121480|463932531|FG007|Overall Study|Adverse Event|4|||
128900892|NCT05121480|463932524|FG000|Overall Study|Withdrawal by Subject|4|||
129023989|NCT01695239|464379879|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023990|NCT01695239|464379880|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128900893|NCT05121480|463932525|FG001|Overall Study|Withdrawal by Subject|9|||
128900894|NCT05121480|463932526|FG002|Overall Study|Withdrawal by Subject|1|||
128900895|NCT05121480|463932527|FG003|Overall Study|Withdrawal by Subject|8|||
128900896|NCT05121480|463932528|FG004|Overall Study|Withdrawal by Subject|0|||
128900897|NCT05121480|463932529|FG005|Overall Study|Withdrawal by Subject|9|||
128900898|NCT05121480|463932530|FG006|Overall Study|Withdrawal by Subject|0|||
128900899|NCT05121480|463932531|FG007|Overall Study|Withdrawal by Subject|4|||
128900900|NCT05121480|463932524|FG000|Overall Study|Non-compliance with the protocol|0|||
128900901|NCT05121480|463932525|FG001|Overall Study|Non-compliance with the protocol|0|||
128900902|NCT05121480|463932526|FG002|Overall Study|Non-compliance with the protocol|0|||
128900903|NCT05121480|463932527|FG003|Overall Study|Non-compliance with the protocol|0|||
128900904|NCT05121480|463932528|FG004|Overall Study|Non-compliance with the protocol|1|||
128900905|NCT05121480|463932529|FG005|Overall Study|Non-compliance with the protocol|6|||
128900906|NCT05121480|463932530|FG006|Overall Study|Non-compliance with the protocol|0|||
128900907|NCT05121480|463932531|FG007|Overall Study|Non-compliance with the protocol|1|||
128900908|NCT05121480|463932524|FG000|Overall Study|Lost to Follow-up|0|||
128900909|NCT05121480|463932525|FG001|Overall Study|Lost to Follow-up|4|||
128900910|NCT05121480|463932526|FG002|Overall Study|Lost to Follow-up|1|||
128900911|NCT05121480|463932527|FG003|Overall Study|Lost to Follow-up|3|||
128900912|NCT05121480|463932528|FG004|Overall Study|Lost to Follow-up|1|||
128900913|NCT05121480|463932529|FG005|Overall Study|Lost to Follow-up|1|||
128900914|NCT05121480|463932530|FG006|Overall Study|Lost to Follow-up|1|||
128900915|NCT05121480|463932531|FG007|Overall Study|Lost to Follow-up|4|||
128900916|NCT05121480|463932524|FG000|Overall Study|Physician Decision|0|||
128900917|NCT05121480|463932525|FG001|Overall Study|Physician Decision|0|||
128900918|NCT05121480|463932526|FG002|Overall Study|Physician Decision|0|||
128900919|NCT05121480|463932527|FG003|Overall Study|Physician Decision|0|||
128900920|NCT05121480|463932528|FG004|Overall Study|Physician Decision|0|||
128900921|NCT05121480|463932529|FG005|Overall Study|Physician Decision|1|||
128900922|NCT05121480|463932530|FG006|Overall Study|Physician Decision|0|||
128900923|NCT05121480|463932531|FG007|Overall Study|Physician Decision|1|||
128900924|NCT05121480|463932524|FG000|Overall Study|Other Reason|0|||
128900925|NCT05121480|463932525|FG001|Overall Study|Other Reason|0|||
128900926|NCT05121480|463932526|FG002|Overall Study|Other Reason|0|||
128900927|NCT05121480|463932527|FG003|Overall Study|Other Reason|0|||
128900928|NCT05121480|463932528|FG004|Overall Study|Other Reason|0|||
128900929|NCT05121480|463932529|FG005|Overall Study|Other Reason|1|||
128900930|NCT05121480|463932530|FG006|Overall Study|Other Reason|1|||
128900931|NCT05121480|463932531|FG007|Overall Study|Other Reason|1|||
128900932|NCT02356562|463932534|FG000|Overall Study|Withdrawal by Subject|0|||
128900933|NCT02356562|463932535|FG001|Overall Study|Withdrawal by Subject|1|||
128900934|NCT02356562|463932534|FG000|Overall Study|Re-entered treatment in a previous study|1|||
128900935|NCT02356562|463932535|FG001|Overall Study|Re-entered treatment in a previous study|0|||
128900936|NCT02356562|463932534|FG000|Overall Study|site closure|1|||
128900937|NCT02356562|463932535|FG001|Overall Study|site closure|0|||
128900938|NCT00412750|463932537|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129023991|NCT01695239|464379881|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023992|NCT01695239|464379882|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023993|NCT01695239|464379883|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023994|NCT01695239|464379884|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023995|NCT01695239|464379885|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129023996|NCT01695239|464379886|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
129023997|NCT05239195|464379888|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
129023998|NCT05239195|464379889|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
129023999|NCT03552484|464379890|FG000|Overall Study|Death|6|||
129024000|NCT03552484|464379891|FG001|Overall Study|Death|4|||
129024001|NCT03552484|464379890|FG000|Overall Study|Lost to Follow-up|0|||
129024002|NCT03552484|464379891|FG001|Overall Study|Lost to Follow-up|16|||
129024003|NCT02663349|464379896|FG000|Overall Study|Withdrawal by Subject|6|||
129024004|NCT01204294|464379898|FG000|Overall Study|Adverse Event|2|||
129024005|NCT01204294|464379899|FG001|Overall Study|Adverse Event|6|||
129113498|NCT04467515|464711501|FG001|Overall Study|Withdrawal by Subject|0|||
128692998|NCT02281773|463176130|FG002|Overall Study|Adverse Event|4|||
128692999|NCT02281773|463176131|FG003|Overall Study|Adverse Event|8|||
128900939|NCT00412750|463932538|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128900940|NCT00412750|463932539|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128900941|NCT00412750|463932537|FG000|Overall Study|Administrative problems|21|||
128900942|NCT00412750|463932538|FG001|Overall Study|Administrative problems|17|||
128900943|NCT00412750|463932539|FG002|Overall Study|Administrative problems|14|||
128900944|NCT00412750|463932537|FG000|Overall Study|Adverse Event|8|||
128900945|NCT00412750|463932538|FG001|Overall Study|Adverse Event|3|||
128900946|NCT00412750|463932539|FG002|Overall Study|Adverse Event|3|||
128900947|NCT00412750|463932537|FG000|Overall Study|Lost to Follow-up|1|||
128900948|NCT00412750|463932538|FG001|Overall Study|Lost to Follow-up|0|||
128900949|NCT00412750|463932539|FG002|Overall Study|Lost to Follow-up|1|||
128900950|NCT00412750|463932537|FG000|Overall Study|Withdrawal by Subject|0|||
128900951|NCT00412750|463932538|FG001|Overall Study|Withdrawal by Subject|1|||
128900952|NCT00412750|463932539|FG002|Overall Study|Withdrawal by Subject|2|||
128900953|NCT00412750|463932537|FG000|Overall Study|Lack of Efficacy|0|||
128693000|NCT02281773|463176132|FG004|Overall Study|Adverse Event|9|||
128693001|NCT02281773|463176128|FG000|Overall Study|Protocol Violation|1|||
128693002|NCT02281773|463176129|FG001|Overall Study|Protocol Violation|0|||
128693003|NCT02281773|463176130|FG002|Overall Study|Protocol Violation|0|||
128693004|NCT02281773|463176131|FG003|Overall Study|Protocol Violation|2|||
128693005|NCT02281773|463176132|FG004|Overall Study|Protocol Violation|2|||
128693006|NCT02281773|463176128|FG000|Overall Study|Lost to Follow-up|2|||
128693007|NCT02281773|463176129|FG001|Overall Study|Lost to Follow-up|2|||
128693008|NCT02281773|463176130|FG002|Overall Study|Lost to Follow-up|6|||
128693009|NCT02281773|463176131|FG003|Overall Study|Lost to Follow-up|2|||
128693010|NCT02281773|463176132|FG004|Overall Study|Lost to Follow-up|10|||
128693011|NCT02281773|463176128|FG000|Overall Study|Withdrawal by Subject|2|||
128693012|NCT02281773|463176129|FG001|Overall Study|Withdrawal by Subject|8|||
128693013|NCT02281773|463176130|FG002|Overall Study|Withdrawal by Subject|6|||
128693014|NCT02281773|463176131|FG003|Overall Study|Withdrawal by Subject|6|||
128693015|NCT02281773|463176132|FG004|Overall Study|Withdrawal by Subject|8|||
128693016|NCT02281773|463176128|FG000|Overall Study|Other Reason|0|||
128693017|NCT02281773|463176129|FG001|Overall Study|Other Reason|4|||
128693018|NCT02281773|463176130|FG002|Overall Study|Other Reason|2|||
128693019|NCT02281773|463176131|FG003|Overall Study|Other Reason|3|||
128693020|NCT02281773|463176132|FG004|Overall Study|Other Reason|1|||
128693021|NCT02104752|463176133|FG000|Overall Study|Withdrawal by Subject|1|||
128693022|NCT02104752|463176134|FG001|Overall Study|Withdrawal by Subject|0|||
128693023|NCT02104752|463176133|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
128693024|NCT02104752|463176134|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
128693025|NCT05439941|463176135|FG000|Overall Study|Lack of Efficacy|8|||
128693026|NCT05439941|463176136|FG001|Overall Study|Lack of Efficacy|5|||
128693027|NCT05439941|463176137|FG002|Overall Study|Lack of Efficacy|3|||
128900954|NCT00412750|463932538|FG001|Overall Study|Lack of Efficacy|0|||
128900955|NCT00412750|463932539|FG002|Overall Study|Lack of Efficacy|3|||
128900956|NCT02830880|463932552|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
128900957|NCT02830880|463932552|FG000|Overall Study|Death|1|||
128900958|NCT02830880|463932552|FG000|Overall Study|Physician Decision|1|||
128900959|NCT03551509|463932553|FG000|Overall Study|Lost to Follow-up|0|||
128900960|NCT03551509|463932554|FG001|Overall Study|Lost to Follow-up|1|||
128900961|NCT03551509|463932555|FG002|Overall Study|Lost to Follow-up|0|||
128900962|NCT01040351|463932556|FG000|Overall Study|poor ovarian response|1|||
128693028|NCT05439941|463176135|FG000|Overall Study|Treatment Failure|0|||
128693029|NCT05439941|463176136|FG001|Overall Study|Treatment Failure|1|||
128693030|NCT05439941|463176137|FG002|Overall Study|Treatment Failure|0|||
128693031|NCT05439941|463176135|FG000|Overall Study|Adverse Event|1|||
128900963|NCT01040351|463932557|FG001|Overall Study|poor ovarian response|2|||
128900964|NCT01230307|463932558|FG000|Overall Study|LVAD Placement|0|||
128900965|NCT01230307|463932559|FG001|Overall Study|LVAD Placement|2|||
128900966|NCT00530894|463932563|FG000|Overall Study|Death|84|||
128900967|NCT00530894|463932564|FG001|Overall Study|Death|89|||
128900968|NCT00530894|463932565|FG002|Overall Study|Death|55|||
128900969|NCT00530894|463932566|FG003|Overall Study|Death|89|||
128900970|NCT00530894|463932563|FG000|Overall Study|Lost to Follow-up|1|||
129024006|NCT01204294|464379900|FG002|Overall Study|Adverse Event|0|||
129024007|NCT01204294|464379901|FG003|Overall Study|Adverse Event|7|||
129024008|NCT01204294|464379902|FG004|Overall Study|Adverse Event|1|||
129024009|NCT01204294|464379903|FG005|Overall Study|Adverse Event|4|||
129024010|NCT01204294|464379904|FG006|Overall Study|Adverse Event|0|||
129024011|NCT01204294|464379898|FG000|Overall Study|Protocol Violation|1|||
129024012|NCT01204294|464379899|FG001|Overall Study|Protocol Violation|0|||
129024013|NCT01204294|464379900|FG002|Overall Study|Protocol Violation|2|||
129024014|NCT01204294|464379901|FG003|Overall Study|Protocol Violation|1|||
129024015|NCT01204294|464379902|FG004|Overall Study|Protocol Violation|0|||
129024016|NCT01204294|464379903|FG005|Overall Study|Protocol Violation|0|||
129024017|NCT01204294|464379904|FG006|Overall Study|Protocol Violation|0|||
128693032|NCT05439941|463176136|FG001|Overall Study|Adverse Event|3|||
128693033|NCT05439941|463176137|FG002|Overall Study|Adverse Event|0|||
128693034|NCT05439941|463176135|FG000|Overall Study|Adverse Event - Parent Study|1|||
128693035|NCT05439941|463176136|FG001|Overall Study|Adverse Event - Parent Study|0|||
128693036|NCT05439941|463176137|FG002|Overall Study|Adverse Event - Parent Study|0|||
128693037|NCT05439941|463176135|FG000|Overall Study|Pregnancy|1|||
128900971|NCT00530894|463932564|FG001|Overall Study|Lost to Follow-up|3|||
128900972|NCT00530894|463932565|FG002|Overall Study|Lost to Follow-up|0|||
128900973|NCT00530894|463932566|FG003|Overall Study|Lost to Follow-up|0|||
128693038|NCT05439941|463176136|FG001|Overall Study|Pregnancy|0|||
128693039|NCT05439941|463176137|FG002|Overall Study|Pregnancy|0|||
128693040|NCT05439941|463176135|FG000|Overall Study|Withdrawal by Subject|9|||
128900974|NCT00530894|463932563|FG000|Overall Study|Withdrawal by Subject|1|||
128900975|NCT00530894|463932564|FG001|Overall Study|Withdrawal by Subject|23|||
129024018|NCT01204294|464379898|FG000|Overall Study|Withdrawal by Subject|0|||
129024019|NCT01204294|464379899|FG001|Overall Study|Withdrawal by Subject|2|||
129024020|NCT01204294|464379900|FG002|Overall Study|Withdrawal by Subject|2|||
129024021|NCT01204294|464379901|FG003|Overall Study|Withdrawal by Subject|1|||
128900976|NCT00530894|463932565|FG002|Overall Study|Withdrawal by Subject|0|||
128900977|NCT00530894|463932566|FG003|Overall Study|Withdrawal by Subject|5|||
128900978|NCT00530894|463932563|FG000|Overall Study|Alive and censored prior to 1 year|2|||
128900979|NCT00530894|463932564|FG001|Overall Study|Alive and censored prior to 1 year|0|||
128900980|NCT00530894|463932565|FG002|Overall Study|Alive and censored prior to 1 year|0|||
128900981|NCT00530894|463932566|FG003|Overall Study|Alive and censored prior to 1 year|0|||
128900982|NCT02256540|463932567|FG000|Overall Study|Withdrawal by Subject|0|||
128900983|NCT02256540|463932568|FG001|Overall Study|Withdrawal by Subject|1|||
128900984|NCT02256540|463932569|FG002|Overall Study|Withdrawal by Subject|1|||
128900985|NCT02256540|463932567|FG000|Overall Study|Back pain preventing exercise|0|||
128900986|NCT02256540|463932568|FG001|Overall Study|Back pain preventing exercise|0|||
128900987|NCT02256540|463932569|FG002|Overall Study|Back pain preventing exercise|1|||
128900988|NCT03719690|463932578|FG000|Overall Study|Withdrawal by Subject|5|||
128900989|NCT03719690|463932579|FG001|Overall Study|Withdrawal by Subject|10|||
128900990|NCT03719690|463932578|FG000|Overall Study|Death|40|||
128900991|NCT03719690|463932579|FG001|Overall Study|Death|149|||
128900992|NCT03719690|463932578|FG000|Overall Study|Miscellaneous|12|||
128900993|NCT03719690|463932579|FG001|Overall Study|Miscellaneous|56|||
128900994|NCT03719690|463932578|FG000|Overall Study|Lost to Follow-up|2|||
128900995|NCT03719690|463932579|FG001|Overall Study|Lost to Follow-up|18|||
128900996|NCT03719690|463932578|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
128900997|NCT03719690|463932579|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
128900998|NCT01918007|463932580|FG000|Overall Study|Baseline oximetry not acceptable|11|||
128900999|NCT01918007|463932581|FG001|Overall Study|Baseline oximetry not acceptable|7|||
128901000|NCT01918007|463932580|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
128901001|NCT01918007|463932581|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
128901002|NCT01918007|463932580|FG000|Overall Study|Lost to Follow-up|4|||
128901003|NCT01918007|463932581|FG001|Overall Study|Lost to Follow-up|7|||
128901004|NCT00960661|463932584|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
128901005|NCT00960661|463932585|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
128901006|NCT00960661|463932586|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
128901007|NCT00960661|463932584|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
128901008|NCT00960661|463932585|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
128901009|NCT00960661|463932586|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
128901010|NCT00960661|463932584|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
128901011|NCT00960661|463932585|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
128901012|NCT00960661|463932586|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
128901013|NCT00960661|463932584|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
128901014|NCT00960661|463932585|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
128901015|NCT00960661|463932586|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
128901016|NCT00960661|463932584|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
128901017|NCT00960661|463932585|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
128901018|NCT00960661|463932586|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
128901019|NCT00960661|463932584|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
128901020|NCT00960661|463932585|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
128901021|NCT00960661|463932586|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
128901022|NCT00960661|463932584|FG000|Interventional Phase|Adverse Event|0|||
128901023|NCT00960661|463932585|FG001|Interventional Phase|Adverse Event|17|||
128901024|NCT00960661|463932586|FG002|Interventional Phase|Adverse Event|8|||
128901025|NCT00960661|463932584|FG000|Interventional Phase|Death|0|||
128901026|NCT00960661|463932585|FG001|Interventional Phase|Death|1|||
128901027|NCT00960661|463932586|FG002|Interventional Phase|Death|0|||
128901028|NCT00960661|463932584|FG000|Interventional Phase|Lost to Follow-up|0|||
128901029|NCT00960661|463932585|FG001|Interventional Phase|Lost to Follow-up|0|||
128901030|NCT00960661|463932586|FG002|Interventional Phase|Lost to Follow-up|2|||
128901031|NCT00960661|463932584|FG000|Interventional Phase|entry criteria not met|0|||
128901032|NCT00960661|463932585|FG001|Interventional Phase|entry criteria not met|3|||
128901033|NCT00960661|463932586|FG002|Interventional Phase|entry criteria not met|0|||
128901034|NCT00960661|463932584|FG000|Interventional Phase|Protocol Violation|0|||
128901035|NCT00960661|463932585|FG001|Interventional Phase|Protocol Violation|7|||
128901036|NCT00960661|463932586|FG002|Interventional Phase|Protocol Violation|2|||
128901037|NCT00960661|463932584|FG000|Interventional Phase|Withdrawal by Subject|0|||
129024022|NCT01204294|464379902|FG004|Overall Study|Withdrawal by Subject|1|||
128901038|NCT00960661|463932585|FG001|Interventional Phase|Withdrawal by Subject|18|||
128901039|NCT00960661|463932586|FG002|Interventional Phase|Withdrawal by Subject|29|||
128901040|NCT00960661|463932584|FG000|Interventional Phase|Physician Decision|0|||
129024023|NCT01204294|464379903|FG005|Overall Study|Withdrawal by Subject|1|||
128901041|NCT00960661|463932585|FG001|Interventional Phase|Physician Decision|3|||
128901042|NCT00960661|463932586|FG002|Interventional Phase|Physician Decision|5|||
128901043|NCT00960661|463932584|FG000|Interventional Phase|sponsor decision|0|||
129024024|NCT01204294|464379904|FG006|Overall Study|Withdrawal by Subject|2|||
128901044|NCT00960661|463932585|FG001|Interventional Phase|sponsor decision|1|||
128901045|NCT00960661|463932586|FG002|Interventional Phase|sponsor decision|0|||
128901046|NCT00960661|463932584|FG000|Interventional Phase|Lack of Efficacy|0|||
128901047|NCT00960661|463932585|FG001|Interventional Phase|Lack of Efficacy|2|||
128901048|NCT00960661|463932586|FG002|Interventional Phase|Lack of Efficacy|0|||
128901049|NCT02699892|463932587|FG000|Overall Study|Other|36|||
128901050|NCT00530270|463932599|FG000|Overall Study|Protocol Violation|1|||
128901051|NCT00530270|463932600|FG001|Overall Study|Protocol Violation|0|||
128901052|NCT01399788|463932606|FG000|First Intervention Period|Adverse Event|1|||
128901053|NCT01399788|463932607|FG001|First Intervention Period|Adverse Event|0|||
128901054|NCT02919436|463932608|FG000|Overall Study|Did not undergo surgery|16|||
128901055|NCT02919436|463932609|FG001|Overall Study|Did not undergo surgery|20|||
128901056|NCT02919436|463932608|FG000|Overall Study|Enrolled before trial registration|44|||
128901057|NCT02919436|463932609|FG001|Overall Study|Enrolled before trial registration|33|||
128901058|NCT03699007|463932611|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
128901059|NCT03699007|463932612|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
128901060|NCT03699007|463932611|FG000|6-month Follow Up|Lost to Follow-up|2|||
128901061|NCT03699007|463932612|FG001|6-month Follow Up|Lost to Follow-up|3|||
128901062|NCT04718974|463932615|FG000|Overall Study|Death|0|||
128901063|NCT04718974|463932616|FG001|Overall Study|Death|2|||
128901064|NCT04718974|463932615|FG000|Overall Study|Lost to Follow-up|10|||
128901065|NCT04718974|463932616|FG001|Overall Study|Lost to Follow-up|20|||
128901066|NCT04718974|463932615|FG000|Overall Study|Transferred out|2|||
128901067|NCT04718974|463932616|FG001|Overall Study|Transferred out|4|||
128901068|NCT03259074|463932617|FG000|Overall Study|Adverse Event|9|||
128901069|NCT03259074|463932618|FG001|Overall Study|Adverse Event|12|||
128901070|NCT03259074|463932619|FG002|Overall Study|Adverse Event|8|||
128901071|NCT03259074|463932617|FG000|Overall Study|Death|1|||
128901072|NCT03259074|463932618|FG001|Overall Study|Death|1|||
128901073|NCT03259074|463932619|FG002|Overall Study|Death|3|||
128901074|NCT03259074|463932617|FG000|Overall Study|Lost to Follow-up|2|||
128901075|NCT03259074|463932618|FG001|Overall Study|Lost to Follow-up|4|||
128901076|NCT03259074|463932619|FG002|Overall Study|Lost to Follow-up|3|||
128901077|NCT03259074|463932617|FG000|Overall Study|New Therapy For Study Indication|1|||
128901078|NCT03259074|463932618|FG001|Overall Study|New Therapy For Study Indication|2|||
128901079|NCT03259074|463932619|FG002|Overall Study|New Therapy For Study Indication|2|||
128901080|NCT03259074|463932617|FG000|Overall Study|Physician Decision|4|||
128901081|NCT03259074|463932618|FG001|Overall Study|Physician Decision|12|||
128901082|NCT03259074|463932619|FG002|Overall Study|Physician Decision|10|||
128901083|NCT03259074|463932617|FG000|Overall Study|Pregnancy|1|||
128901084|NCT03259074|463932618|FG001|Overall Study|Pregnancy|1|||
128901085|NCT03259074|463932619|FG002|Overall Study|Pregnancy|0|||
128901086|NCT03259074|463932617|FG000|Overall Study|Progressive Disease|1|||
128901087|NCT03259074|463932618|FG001|Overall Study|Progressive Disease|0|||
128901088|NCT03259074|463932619|FG002|Overall Study|Progressive Disease|0|||
128901089|NCT03259074|463932617|FG000|Overall Study|Protocol Deviation|1|||
128901090|NCT03259074|463932618|FG001|Overall Study|Protocol Deviation|1|||
128901091|NCT03259074|463932619|FG002|Overall Study|Protocol Deviation|3|||
128901092|NCT03259074|463932617|FG000|Overall Study|Subject/Guardian Decision|13|||
128901093|NCT03259074|463932618|FG001|Overall Study|Subject/Guardian Decision|16|||
128901094|NCT03259074|463932619|FG002|Overall Study|Subject/Guardian Decision|14|||
128901095|NCT01780662|463932620|FG000|Overall Study|Adverse Event|1|||
128901096|NCT01780662|463932621|FG001|Overall Study|Adverse Event|0|||
128901097|NCT01780662|463932622|FG002|Overall Study|Adverse Event|2|||
128901098|NCT01780662|463932620|FG000|Overall Study|Physician Decision|0|||
128901099|NCT01780662|463932621|FG001|Overall Study|Physician Decision|5|||
128901100|NCT01780662|463932622|FG002|Overall Study|Physician Decision|7|||
128901101|NCT01780662|463932620|FG000|Overall Study|Protocol Violation|0|||
128901102|NCT01780662|463932621|FG001|Overall Study|Protocol Violation|1|||
128901103|NCT01780662|463932622|FG002|Overall Study|Protocol Violation|0|||
128901104|NCT01780662|463932620|FG000|Overall Study|Ineligible|0|||
128901105|NCT01780662|463932621|FG001|Overall Study|Ineligible|0|||
128901106|NCT01780662|463932622|FG002|Overall Study|Ineligible|1|||
128901107|NCT00053417|463932623|FG000|Overall Study|Adverse Event|1|||
128901108|NCT00053417|463932624|FG001|Overall Study|Adverse Event|0|||
128901109|NCT00053417|463932625|FG002|Overall Study|Adverse Event|1|||
128901110|NCT00053417|463932626|FG003|Overall Study|Adverse Event|5|||
128901111|NCT00053417|463932623|FG000|Overall Study|Non-Compliance|0|||
128901112|NCT00053417|463932624|FG001|Overall Study|Non-Compliance|0|||
128901113|NCT00053417|463932625|FG002|Overall Study|Non-Compliance|0|||
128901114|NCT00053417|463932626|FG003|Overall Study|Non-Compliance|1|||
128901115|NCT00053417|463932623|FG000|Overall Study|Withdrawal by Subject|0|||
128901116|NCT00053417|463932624|FG001|Overall Study|Withdrawal by Subject|1|||
128901117|NCT00053417|463932625|FG002|Overall Study|Withdrawal by Subject|0|||
128901118|NCT00053417|463932626|FG003|Overall Study|Withdrawal by Subject|0|||
128901119|NCT00053417|463932623|FG000|Overall Study|Lost to Follow-up|1|||
128901120|NCT00053417|463932624|FG001|Overall Study|Lost to Follow-up|1|||
128901121|NCT00053417|463932625|FG002|Overall Study|Lost to Follow-up|0|||
128901122|NCT00053417|463932626|FG003|Overall Study|Lost to Follow-up|0|||
128693041|NCT05439941|463176136|FG001|Overall Study|Withdrawal by Subject|6|||
128693042|NCT05439941|463176137|FG002|Overall Study|Withdrawal by Subject|10|||
128693043|NCT05439941|463176135|FG000|Overall Study|Non-Compliance|1|||
128693044|NCT05439941|463176136|FG001|Overall Study|Non-Compliance|1|||
128901123|NCT00183274|463932627|FG000|Phase 1: Open-Label|Adverse Event|31|||
128901124|NCT00183274|463932628|FG001|Phase 1: Open-Label|Adverse Event|0|||
128901125|NCT00183274|463932629|FG002|Phase 1: Open-Label|Adverse Event|0|||
128901126|NCT00183274|463932630|FG003|Phase 1: Open-Label|Adverse Event|0|||
128901127|NCT00183274|463932631|FG004|Phase 1: Open-Label|Adverse Event|0|||
128901128|NCT00183274|463932632|FG005|Phase 1: Open-Label|Adverse Event|0|||
128901129|NCT00183274|463932627|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
128901130|NCT00183274|463932628|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
128901131|NCT00183274|463932629|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
128901132|NCT00183274|463932630|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
128901133|NCT00183274|463932631|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
128901134|NCT00183274|463932632|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
128901135|NCT00183274|463932627|FG000|Phase 1: Open-Label|Protocol Violation|11|||
129113499|NCT04467515|464711502|FG002|Overall Study|Withdrawal by Subject|1|||
129113500|NCT04467515|464711500|FG000|Overall Study|Progressive Disease|0|||
129113501|NCT04467515|464711501|FG001|Overall Study|Progressive Disease|1|||
129113502|NCT04467515|464711502|FG002|Overall Study|Progressive Disease|3|||
129113503|NCT04467515|464711500|FG000|Overall Study|Death|0|||
129113504|NCT04467515|464711501|FG001|Overall Study|Death|1|||
129113505|NCT04467515|464711502|FG002|Overall Study|Death|0|||
129113506|NCT05616013|464711505|FG000|Overall Study|Adverse Event|6|||
129113507|NCT05616013|464711506|FG001|Overall Study|Adverse Event|12|||
129113508|NCT05616013|464711507|FG002|Overall Study|Adverse Event|8|||
129113509|NCT05616013|464711508|FG003|Overall Study|Adverse Event|4|||
129113510|NCT05616013|464711509|FG004|Overall Study|Adverse Event|6|||
128901136|NCT00183274|463932628|FG001|Phase 1: Open-Label|Protocol Violation|0|||
128901137|NCT00183274|463932629|FG002|Phase 1: Open-Label|Protocol Violation|0|||
128901138|NCT00183274|463932630|FG003|Phase 1: Open-Label|Protocol Violation|0|||
128901139|NCT00183274|463932631|FG004|Phase 1: Open-Label|Protocol Violation|0|||
128901140|NCT00183274|463932632|FG005|Phase 1: Open-Label|Protocol Violation|0|||
128901141|NCT00183274|463932627|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
128901142|NCT00183274|463932628|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
128901143|NCT00183274|463932629|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
128901144|NCT00183274|463932630|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
128901145|NCT00183274|463932631|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
128901146|NCT00183274|463932632|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
128901147|NCT00183274|463932627|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
128901148|NCT00183274|463932628|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
128901149|NCT00183274|463932629|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
128901150|NCT00183274|463932630|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
128901151|NCT00183274|463932631|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
129113511|NCT05616013|464711510|FG005|Overall Study|Adverse Event|8|||
129113512|NCT05616013|464711511|FG006|Overall Study|Adverse Event|3|||
129113513|NCT05616013|464711512|FG007|Overall Study|Adverse Event|6|||
129113514|NCT05616013|464711513|FG008|Overall Study|Adverse Event|1|||
129113515|NCT05616013|464711505|FG000|Overall Study|Lost to Follow-up|5|||
128693045|NCT05439941|463176137|FG002|Overall Study|Non-Compliance|1|||
128693046|NCT05439941|463176135|FG000|Overall Study|Lost to Follow-up|2|||
128693047|NCT05439941|463176136|FG001|Overall Study|Lost to Follow-up|2|||
128693048|NCT05439941|463176137|FG002|Overall Study|Lost to Follow-up|0|||
128693049|NCT05439941|463176135|FG000|Overall Study|Physician Decision|1|||
128693050|NCT05439941|463176136|FG001|Overall Study|Physician Decision|0|||
128693051|NCT05439941|463176137|FG002|Overall Study|Physician Decision|0|||
128693052|NCT05439941|463176135|FG000|Overall Study|Trial Termination by Sponsor|78|||
128693053|NCT05439941|463176136|FG001|Overall Study|Trial Termination by Sponsor|83|||
128693054|NCT05439941|463176137|FG002|Overall Study|Trial Termination by Sponsor|65|||
128693055|NCT05439941|463176135|FG000|Overall Study|Other than Reasons Listed|2|||
128693056|NCT05439941|463176136|FG001|Overall Study|Other than Reasons Listed|1|||
128693057|NCT05439941|463176137|FG002|Overall Study|Other than Reasons Listed|0|||
128693058|NCT01313858|463176138|FG000|Overall Study|Premature Treatment Termination|251|||
129113516|NCT05616013|464711506|FG001|Overall Study|Lost to Follow-up|4|||
129113517|NCT05616013|464711507|FG002|Overall Study|Lost to Follow-up|3|||
129113518|NCT05616013|464711508|FG003|Overall Study|Lost to Follow-up|2|||
129113519|NCT05616013|464711509|FG004|Overall Study|Lost to Follow-up|0|||
129113520|NCT05616013|464711510|FG005|Overall Study|Lost to Follow-up|5|||
128693059|NCT01313858|463176139|FG001|Overall Study|Premature Treatment Termination|219|||
128693060|NCT01313858|463176140|FG002|Overall Study|Premature Treatment Termination|191|||
128901152|NCT00183274|463932632|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
129113521|NCT05616013|464711511|FG006|Overall Study|Lost to Follow-up|2|||
128901153|NCT00183274|463932627|FG000|Phase 1: Open-Label|Other|9|||
129113522|NCT05616013|464711512|FG007|Overall Study|Lost to Follow-up|1|||
128901154|NCT00183274|463932628|FG001|Phase 1: Open-Label|Other|0|||
128901155|NCT00183274|463932629|FG002|Phase 1: Open-Label|Other|0|||
129113523|NCT05616013|464711513|FG008|Overall Study|Lost to Follow-up|2|||
128901156|NCT00183274|463932630|FG003|Phase 1: Open-Label|Other|0|||
128901157|NCT00183274|463932631|FG004|Phase 1: Open-Label|Other|0|||
128901158|NCT00183274|463932632|FG005|Phase 1: Open-Label|Other|0|||
128901159|NCT00183274|463932627|FG000|Phase 2: Double-Blind|Relapsed|0|||
128901160|NCT00183274|463932628|FG001|Phase 2: Double-Blind|Relapsed|8|||
128901161|NCT00183274|463932629|FG002|Phase 2: Double-Blind|Relapsed|29|||
128901162|NCT00183274|463932630|FG003|Phase 2: Double-Blind|Relapsed|0|||
128901163|NCT00183274|463932631|FG004|Phase 2: Double-Blind|Relapsed|0|||
128901164|NCT00183274|463932632|FG005|Phase 2: Double-Blind|Relapsed|0|||
128901165|NCT00183274|463932627|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
129113524|NCT05616013|464711505|FG000|Overall Study|Non-compliance with study requirements|2|||
129113525|NCT05616013|464711506|FG001|Overall Study|Non-compliance with study requirements|2|||
128901166|NCT00183274|463932628|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
128901167|NCT00183274|463932629|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
128901168|NCT00183274|463932630|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
128901169|NCT00183274|463932631|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
128901170|NCT00183274|463932632|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
128901171|NCT00183274|463932627|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
129113526|NCT05616013|464711507|FG002|Overall Study|Non-compliance with study requirements|2|||
129113527|NCT05616013|464711508|FG003|Overall Study|Non-compliance with study requirements|3|||
129113528|NCT05616013|464711509|FG004|Overall Study|Non-compliance with study requirements|0|||
129113529|NCT05616013|464711510|FG005|Overall Study|Non-compliance with study requirements|2|||
129113530|NCT05616013|464711511|FG006|Overall Study|Non-compliance with study requirements|1|||
129113531|NCT05616013|464711512|FG007|Overall Study|Non-compliance with study requirements|1|||
129113532|NCT05616013|464711513|FG008|Overall Study|Non-compliance with study requirements|4|||
129113533|NCT05616013|464711505|FG000|Overall Study|Withdrawal by Subject|11|||
129113534|NCT05616013|464711506|FG001|Overall Study|Withdrawal by Subject|9|||
129113535|NCT05616013|464711507|FG002|Overall Study|Withdrawal by Subject|8|||
129113536|NCT05616013|464711508|FG003|Overall Study|Withdrawal by Subject|6|||
129113537|NCT05616013|464711509|FG004|Overall Study|Withdrawal by Subject|3|||
129113538|NCT05616013|464711510|FG005|Overall Study|Withdrawal by Subject|4|||
129113539|NCT05616013|464711511|FG006|Overall Study|Withdrawal by Subject|6|||
129113540|NCT05616013|464711512|FG007|Overall Study|Withdrawal by Subject|5|||
129113541|NCT05616013|464711513|FG008|Overall Study|Withdrawal by Subject|4|||
129113542|NCT05616013|464711505|FG000|Overall Study|Physician Decision|0|||
129113543|NCT05616013|464711506|FG001|Overall Study|Physician Decision|0|||
129113544|NCT05616013|464711507|FG002|Overall Study|Physician Decision|1|||
129113545|NCT05616013|464711508|FG003|Overall Study|Physician Decision|0|||
129113546|NCT05616013|464711509|FG004|Overall Study|Physician Decision|0|||
129113547|NCT05616013|464711510|FG005|Overall Study|Physician Decision|1|||
129113548|NCT05616013|464711511|FG006|Overall Study|Physician Decision|3|||
129113549|NCT05616013|464711512|FG007|Overall Study|Physician Decision|0|||
129113550|NCT05616013|464711513|FG008|Overall Study|Physician Decision|0|||
129113551|NCT05616013|464711505|FG000|Overall Study|Protocol Violation|0|||
129113552|NCT05616013|464711506|FG001|Overall Study|Protocol Violation|0|||
129113553|NCT05616013|464711507|FG002|Overall Study|Protocol Violation|0|||
129113554|NCT05616013|464711508|FG003|Overall Study|Protocol Violation|0|||
129113555|NCT05616013|464711509|FG004|Overall Study|Protocol Violation|0|||
129113556|NCT05616013|464711510|FG005|Overall Study|Protocol Violation|0|||
129113557|NCT05616013|464711511|FG006|Overall Study|Protocol Violation|1|||
129113558|NCT05616013|464711512|FG007|Overall Study|Protocol Violation|0|||
129113559|NCT05616013|464711513|FG008|Overall Study|Protocol Violation|2|||
128693061|NCT01313858|463176138|FG000|Overall Study|Lost to Follow-up|35|||
128693062|NCT01313858|463176139|FG001|Overall Study|Lost to Follow-up|51|||
128693063|NCT01313858|463176140|FG002|Overall Study|Lost to Follow-up|47|||
128693064|NCT02899299|463176141|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
128693065|NCT02899299|463176142|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
128693066|NCT02899299|463176141|FG000|Pre-treatment|Participant withdrew consent|1|||
128693067|NCT02899299|463176142|FG001|Pre-treatment|Participant withdrew consent|11|||
128693068|NCT02899299|463176141|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
128693069|NCT02899299|463176142|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
128693070|NCT02899299|463176141|FG000|Pre-treatment|Not reported|0|||
128693071|NCT02899299|463176142|FG001|Pre-treatment|Not reported|1|||
128693072|NCT02899299|463176141|FG000|Treatment|Disease Progression|182|||
128693073|NCT02899299|463176142|FG001|Treatment|Disease Progression|43|||
128693074|NCT02899299|463176141|FG000|Treatment|Study Drug Toxicity|60|||
128901172|NCT00183274|463932628|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
128901173|NCT00183274|463932629|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
128901174|NCT00183274|463932630|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
128901175|NCT00183274|463932631|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
128901176|NCT00183274|463932632|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
129113560|NCT05616013|464711505|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
129113561|NCT05616013|464711506|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113562|NCT05616013|464711507|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113563|NCT05616013|464711508|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113564|NCT05616013|464711509|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113565|NCT05616013|464711510|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113566|NCT05616013|464711511|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113567|NCT05616013|464711512|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113568|NCT05616013|464711513|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
129113569|NCT05616013|464711505|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
129113570|NCT05616013|464711506|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113571|NCT05616013|464711507|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113572|NCT05616013|464711508|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113573|NCT05616013|464711509|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113574|NCT05616013|464711510|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113575|NCT05616013|464711511|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113576|NCT05616013|464711512|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113577|NCT05616013|464711513|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129113578|NCT05616013|464711505|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
128693075|NCT02899299|463176142|FG001|Treatment|Study Drug Toxicity|24|||
128693076|NCT02899299|463176141|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
128901177|NCT00183274|463932627|FG000|Phase 3: Double-Blind|Relapsed|0|||
128901178|NCT00183274|463932628|FG001|Phase 3: Double-Blind|Relapsed|0|||
128901179|NCT00183274|463932629|FG002|Phase 3: Double-Blind|Relapsed|0|||
128901180|NCT00183274|463932630|FG003|Phase 3: Double-Blind|Relapsed|1|||
128901181|NCT00183274|463932631|FG004|Phase 3: Double-Blind|Relapsed|11|||
128901182|NCT00183274|463932632|FG005|Phase 3: Double-Blind|Relapsed|2|||
128901183|NCT02409290|463932635|FG000|Overall Study|Protocol Violation|3|||
128901184|NCT02409290|463932636|FG001|Overall Study|Protocol Violation|6|||
128901185|NCT02409290|463932637|FG002|Overall Study|Protocol Violation|9|||
128901186|NCT02409290|463932638|FG003|Overall Study|Protocol Violation|4|||
128901187|NCT02409290|463932635|FG000|Overall Study|No positive culture/no baseline sample|3|||
128901188|NCT02409290|463932636|FG001|Overall Study|No positive culture/no baseline sample|9|||
128901189|NCT02409290|463932637|FG002|Overall Study|No positive culture/no baseline sample|6|||
128901190|NCT02409290|463932638|FG003|Overall Study|No positive culture/no baseline sample|5|||
128901191|NCT02409290|463932635|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
128901192|NCT02409290|463932636|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
128901193|NCT02409290|463932637|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
128901194|NCT02409290|463932638|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
128901195|NCT00708500|463932639|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
128901196|NCT00708500|463932640|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
128901197|NCT00708500|463932641|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
128901198|NCT00708500|463932639|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
128901199|NCT00708500|463932640|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
128901200|NCT00708500|463932641|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
128901201|NCT00708500|463932639|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
128901202|NCT00708500|463932640|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
128901203|NCT00708500|463932641|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
128901204|NCT00708500|463932639|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
128901205|NCT00708500|463932640|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
128901206|NCT00708500|463932641|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
128901207|NCT00708500|463932639|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
128901208|NCT00708500|463932640|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
128901209|NCT00708500|463932641|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
128901210|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
128901211|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
128901212|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
128901213|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
128901214|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
128901215|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
128901216|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
128901217|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
128901218|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
129113579|NCT05616013|464711506|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129113580|NCT05616013|464711507|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129215243|NCT02017405|465089472|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
128901219|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
128901220|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
128693077|NCT02899299|463176142|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
128693078|NCT02899299|463176141|FG000|Treatment|Participant request to discontinue Study treatment|4|||
128693079|NCT02899299|463176142|FG001|Treatment|Participant request to discontinue Study treatment|10|||
128693080|NCT02899299|463176141|FG000|Treatment|Participant withdrew consent|6|||
128693081|NCT02899299|463176142|FG001|Treatment|Participant withdrew consent|3|||
128693082|NCT02899299|463176141|FG000|Treatment|Lost to Follow-up|0|||
128693083|NCT02899299|463176142|FG001|Treatment|Lost to Follow-up|2|||
128693084|NCT02899299|463176141|FG000|Treatment|Maximum Clinical Benefit|11|||
128693085|NCT02899299|463176142|FG001|Treatment|Maximum Clinical Benefit|2|||
128693086|NCT02899299|463176141|FG000|Treatment|Poor/Non-compliance|1|||
128693087|NCT02899299|463176142|FG001|Treatment|Poor/Non-compliance|0|||
128693088|NCT02899299|463176141|FG000|Treatment|Participant no longer meets Study criteria|4|||
128693089|NCT02899299|463176142|FG001|Treatment|Participant no longer meets Study criteria|0|||
128693090|NCT02899299|463176141|FG000|Treatment|Administrative reason by Sponsor|2|||
128693091|NCT02899299|463176142|FG001|Treatment|Administrative reason by Sponsor|0|||
128693092|NCT02899299|463176141|FG000|Treatment|Other reasons|12|||
128693093|NCT02899299|463176142|FG001|Treatment|Other reasons|2|||
128693094|NCT02899299|463176141|FG000|Treatment|Not reported|7|||
128693095|NCT02899299|463176142|FG001|Treatment|Not reported|0|||
128693096|NCT02468232|463176153|FG000|Core Part of Study|Adverse Event|0|||
128693097|NCT02468232|463176154|FG001|Core Part of Study|Adverse Event|1|||
128693098|NCT02468232|463176155|FG002|Core Part of Study|Adverse Event|0|||
128693099|NCT02468232|463176156|FG003|Core Part of Study|Adverse Event|0|||
128693100|NCT02468232|463176153|FG000|Core Part of Study|Death|20|||
128693101|NCT02468232|463176154|FG001|Core Part of Study|Death|17|||
128693102|NCT02468232|463176155|FG002|Core Part of Study|Death|0|||
128901221|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
128901222|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
128901223|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
128901224|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
128901225|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
128901226|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
128901227|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
128901228|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
128901229|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
128901230|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
128901231|NCT00708500|463932639|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
129024025|NCT01204294|464379898|FG000|Overall Study|Lack of Efficacy|0|||
129024026|NCT01204294|464379899|FG001|Overall Study|Lack of Efficacy|0|||
129024027|NCT01204294|464379900|FG002|Overall Study|Lack of Efficacy|0|||
129024028|NCT01204294|464379901|FG003|Overall Study|Lack of Efficacy|2|||
129024029|NCT01204294|464379902|FG004|Overall Study|Lack of Efficacy|0|||
129024030|NCT01204294|464379903|FG005|Overall Study|Lack of Efficacy|0|||
129024031|NCT01204294|464379904|FG006|Overall Study|Lack of Efficacy|0|||
129024032|NCT01204294|464379898|FG000|Overall Study|Other (house moving)|0|||
129024033|NCT01204294|464379899|FG001|Overall Study|Other (house moving)|0|||
129024034|NCT01204294|464379900|FG002|Overall Study|Other (house moving)|1|||
129024035|NCT01204294|464379901|FG003|Overall Study|Other (house moving)|0|||
129024036|NCT01204294|464379902|FG004|Overall Study|Other (house moving)|0|||
129024037|NCT01204294|464379903|FG005|Overall Study|Other (house moving)|0|||
129024038|NCT01204294|464379904|FG006|Overall Study|Other (house moving)|0|||
129024039|NCT04590027|464379905|FG000|Overall Study|Lost to Follow-up|17|||
129024040|NCT04590027|464379906|FG001|Overall Study|Lost to Follow-up|14|||
129024041|NCT04590027|464379905|FG000|Overall Study|Protocol Violation|0|||
129024042|NCT04590027|464379906|FG001|Overall Study|Protocol Violation|3|||
129024043|NCT02682238|464379907|FG000|Overall Study|Lost to Follow-up|0|||
129024044|NCT02682238|464379908|FG001|Overall Study|Lost to Follow-up|2|||
129024045|NCT02682238|464379907|FG000|Overall Study|Withdrawal by Subject|1|||
129024046|NCT02682238|464379908|FG001|Overall Study|Withdrawal by Subject|0|||
129024047|NCT02682238|464379907|FG000|Overall Study|Adverse Event|1|||
129024048|NCT02682238|464379908|FG001|Overall Study|Adverse Event|0|||
128693103|NCT02468232|463176156|FG003|Core Part of Study|Death|0|||
128693104|NCT02468232|463176153|FG000|Core Part of Study|Technical Problems|1|||
128693105|NCT02468232|463176154|FG001|Core Part of Study|Technical Problems|1|||
128693106|NCT02468232|463176155|FG002|Core Part of Study|Technical Problems|0|||
128693107|NCT02468232|463176156|FG003|Core Part of Study|Technical Problems|0|||
128693108|NCT02468232|463176153|FG000|OLE Part of Study|Adverse Event|0|||
129024049|NCT02682238|464379907|FG000|Overall Study|Non-compliance with Study Drug|1|||
129024050|NCT02682238|464379908|FG001|Overall Study|Non-compliance with Study Drug|0|||
129024051|NCT02682238|464379907|FG000|Overall Study|Non-compliance with Protocol|0|||
129024052|NCT02682238|464379908|FG001|Overall Study|Non-compliance with Protocol|2|||
129024053|NCT00075478|464379909|FG000|Overall Study|not eligible|1|||
128693109|NCT02468232|463176154|FG001|OLE Part of Study|Adverse Event|0|||
128693110|NCT02468232|463176155|FG002|OLE Part of Study|Adverse Event|4|||
128693111|NCT02468232|463176156|FG003|OLE Part of Study|Adverse Event|5|||
128693112|NCT02468232|463176153|FG000|OLE Part of Study|Death|0|||
128693113|NCT02468232|463176154|FG001|OLE Part of Study|Death|0|||
128693114|NCT02468232|463176155|FG002|OLE Part of Study|Death|4|||
128693115|NCT02468232|463176156|FG003|OLE Part of Study|Death|2|||
128693116|NCT02468232|463176153|FG000|OLE Part of Study|Physician Decision|0|||
128693117|NCT02468232|463176154|FG001|OLE Part of Study|Physician Decision|0|||
128693118|NCT02468232|463176155|FG002|OLE Part of Study|Physician Decision|4|||
128693119|NCT02468232|463176156|FG003|OLE Part of Study|Physician Decision|0|||
128693120|NCT02468232|463176153|FG000|OLE Part of Study|Subject/Guardian decision|0|||
128693121|NCT02468232|463176154|FG001|OLE Part of Study|Subject/Guardian decision|0|||
128693122|NCT02468232|463176155|FG002|OLE Part of Study|Subject/Guardian decision|2|||
128693123|NCT02468232|463176156|FG003|OLE Part of Study|Subject/Guardian decision|5|||
128693124|NCT00506662|463176157|FG000|Overall Study|Adverse Event|0|||
128693125|NCT00506662|463176158|FG001|Overall Study|Adverse Event|2|||
128693126|NCT00506662|463176157|FG000|Overall Study|Lack of Efficacy|1|||
128693127|NCT00506662|463176158|FG001|Overall Study|Lack of Efficacy|0|||
128693128|NCT00506662|463176157|FG000|Overall Study|Protocol Violation|2|||
128693129|NCT00506662|463176158|FG001|Overall Study|Protocol Violation|4|||
128693130|NCT00506662|463176157|FG000|Overall Study|Trial terminated|10|||
128693131|NCT00506662|463176158|FG001|Overall Study|Trial terminated|16|||
128693132|NCT00506662|463176157|FG000|Overall Study|Not recorded|4|||
128693133|NCT00506662|463176158|FG001|Overall Study|Not recorded|6|||
128693134|NCT00246753|463176159|FG000|Overall Study|Withdrawal by Subject|2|||
128693135|NCT00246753|463176159|FG000|Overall Study|Physician Decision|2|||
128693136|NCT00246753|463176159|FG000|Overall Study|Adverse Event|2|||
128693137|NCT00246753|463176159|FG000|Overall Study|Unacceptable toxicity|2|||
128693138|NCT00617851|463176163|FG000|Overall Study|Death|0|||
128693139|NCT00617851|463176164|FG001|Overall Study|Death|0|||
128693140|NCT00617851|463176165|FG002|Overall Study|Death|0|||
128693141|NCT00617851|463176166|FG003|Overall Study|Death|1|||
128693142|NCT00617851|463176163|FG000|Overall Study|Withdrawal by Subject|14|||
128693143|NCT00617851|463176164|FG001|Overall Study|Withdrawal by Subject|7|||
128693144|NCT00617851|463176165|FG002|Overall Study|Withdrawal by Subject|12|||
128693145|NCT00617851|463176166|FG003|Overall Study|Withdrawal by Subject|4|||
128693146|NCT00617851|463176163|FG000|Overall Study|Lost to Follow-up|27|||
128693147|NCT00617851|463176164|FG001|Overall Study|Lost to Follow-up|29|||
128693148|NCT00617851|463176165|FG002|Overall Study|Lost to Follow-up|31|||
128693149|NCT00617851|463176166|FG003|Overall Study|Lost to Follow-up|19|||
128693150|NCT00617851|463176163|FG000|Overall Study|Inappropriate Enrollment|5|||
128693151|NCT00617851|463176164|FG001|Overall Study|Inappropriate Enrollment|4|||
128693152|NCT00617851|463176165|FG002|Overall Study|Inappropriate Enrollment|1|||
128693153|NCT00617851|463176166|FG003|Overall Study|Inappropriate Enrollment|1|||
128693154|NCT00617851|463176163|FG000|Overall Study|Unable to classify|1|||
128693155|NCT00617851|463176164|FG001|Overall Study|Unable to classify|0|||
128693156|NCT00617851|463176165|FG002|Overall Study|Unable to classify|1|||
128693157|NCT00617851|463176166|FG003|Overall Study|Unable to classify|0|||
128693158|NCT01200524|463176167|FG000|Overall Study|Withdrawal by Subject|1|||
128693159|NCT01200524|463176168|FG001|Overall Study|Withdrawal by Subject|1|||
128693160|NCT01200524|463176169|FG002|Overall Study|Withdrawal by Subject|3|||
128693161|NCT01200524|463176167|FG000|Overall Study|Adverse Event|1|||
128693162|NCT01200524|463176168|FG001|Overall Study|Adverse Event|0|||
128693163|NCT01200524|463176169|FG002|Overall Study|Adverse Event|0|||
128693164|NCT01200524|463176167|FG000|Overall Study|Non availability of study nurse|0|||
128693165|NCT01200524|463176168|FG001|Overall Study|Non availability of study nurse|0|||
128693166|NCT01200524|463176169|FG002|Overall Study|Non availability of study nurse|1|||
128693167|NCT01303861|463176180|FG000|Overall Study|Lost to Follow-up|34|||
128764668|NCT02991482|463430252|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
128764669|NCT02396537|463430253|FG000|Overall Study|Protocol Violation|0|||
128764670|NCT02396537|463430254|FG001|Overall Study|Protocol Violation|1|||
128764671|NCT02312856|463430255|FG000|Overall Study|Death|1|||
129132897|NCT00827242|464778559|FG001|Overall Study|Adverse Event Excluding Death|1|||
128693168|NCT01303861|463176181|FG001|Overall Study|Lost to Follow-up|14|||
128693169|NCT01303861|463176182|FG002|Overall Study|Lost to Follow-up|27|||
128693170|NCT01303861|463176183|FG003|Overall Study|Lost to Follow-up|31|||
128693171|NCT01303861|463176180|FG000|Overall Study|Lack of Efficacy|3|||
128693172|NCT01303861|463176181|FG001|Overall Study|Lack of Efficacy|2|||
128693173|NCT01303861|463176182|FG002|Overall Study|Lack of Efficacy|1|||
128693174|NCT01303861|463176183|FG003|Overall Study|Lack of Efficacy|0|||
128693175|NCT01303861|463176180|FG000|Overall Study|Withdrawal by Subject|16|||
128693176|NCT01303861|463176181|FG001|Overall Study|Withdrawal by Subject|8|||
128693177|NCT01303861|463176182|FG002|Overall Study|Withdrawal by Subject|8|||
128693178|NCT01303861|463176183|FG003|Overall Study|Withdrawal by Subject|23|||
128693179|NCT01303861|463176180|FG000|Overall Study|Adverse Event|4|||
128693180|NCT01303861|463176181|FG001|Overall Study|Adverse Event|1|||
128693181|NCT01303861|463176182|FG002|Overall Study|Adverse Event|0|||
128693182|NCT01303861|463176183|FG003|Overall Study|Adverse Event|5|||
128693183|NCT01303861|463176180|FG000|Overall Study|Pregnancy|1|||
128764672|NCT02312856|463430255|FG000|Overall Study|Lost to Follow-up|3|||
128693184|NCT01303861|463176181|FG001|Overall Study|Pregnancy|0|||
128693185|NCT01303861|463176182|FG002|Overall Study|Pregnancy|0|||
128693186|NCT01303861|463176183|FG003|Overall Study|Pregnancy|0|||
128693187|NCT02476201|463176186|FG000|Overall Study|Unable to program MPP|9|||
128693188|NCT02476201|463176186|FG000|Overall Study|Study echo not performed|5|||
128693189|NCT02476201|463176186|FG000|Overall Study|Adverse Event|4|||
128693190|NCT02476201|463176186|FG000|Overall Study|Death|2|||
128693191|NCT02476201|463176186|FG000|Overall Study|Lost to Follow-up|2|||
128693192|NCT02476201|463176186|FG000|Overall Study|MPP programmed to OFF|2|||
128693193|NCT02476201|463176186|FG000|Overall Study|Withdrawal by Subject|1|||
128693194|NCT02476201|463176186|FG000|Overall Study|Unsuccessful implant|1|||
128693195|NCT02248701|463176195|FG000|Overall Study|Withdrawal by Subject|2|||
128693196|NCT02248701|463176196|FG001|Overall Study|Withdrawal by Subject|1|||
128693197|NCT02248701|463176195|FG000|Overall Study|Physician Decision|0|||
128693198|NCT02248701|463176196|FG001|Overall Study|Physician Decision|1|||
128693199|NCT02248701|463176195|FG000|Overall Study|Adverse Event|1|||
128693200|NCT02248701|463176196|FG001|Overall Study|Adverse Event|0|||
128693201|NCT02248701|463176195|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
128693202|NCT02248701|463176196|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
128693203|NCT05047770|463176197|FG000|Overall Study|Withdrawal by Subject|15|||
128693204|NCT05047770|463176198|FG001|Overall Study|Withdrawal by Subject|10|||
128693205|NCT05047770|463176199|FG002|Overall Study|Withdrawal by Subject|6|||
128693206|NCT05047770|463176200|FG003|Overall Study|Withdrawal by Subject|12|||
128693207|NCT05047770|463176197|FG000|Overall Study|Lost to Follow-up|7|||
128693208|NCT05047770|463176198|FG001|Overall Study|Lost to Follow-up|5|||
128693209|NCT05047770|463176199|FG002|Overall Study|Lost to Follow-up|12|||
128693210|NCT05047770|463176200|FG003|Overall Study|Lost to Follow-up|13|||
128693211|NCT05047770|463176197|FG000|Overall Study|Other|1|||
128901232|NCT00708500|463932640|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
128901233|NCT00708500|463932641|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
128901234|NCT00708500|463932639|FG000|FOLLOWUP|Adverse Event|0|||
128901235|NCT00708500|463932640|FG001|FOLLOWUP|Adverse Event|1|||
128901236|NCT00708500|463932641|FG002|FOLLOWUP|Adverse Event|0|||
128901237|NCT00708500|463932639|FG000|FOLLOWUP|Lost to Follow-up|1|||
128901238|NCT00708500|463932640|FG001|FOLLOWUP|Lost to Follow-up|6|||
128693212|NCT05047770|463176198|FG001|Overall Study|Other|0|||
128693213|NCT05047770|463176199|FG002|Overall Study|Other|1|||
128693214|NCT05047770|463176200|FG003|Overall Study|Other|0|||
128693215|NCT04289623|463176201|FG000|Wave 1 Emails|Email was not delivered|268|||
128693216|NCT04289623|463176202|FG001|Wave 1 Emails|Email was not delivered|257|||
128693217|NCT04289623|463176203|FG002|Wave 1 Emails|Email was not delivered|0|||
129024054|NCT00075478|464379910|FG001|Overall Study|not eligible|0|||
129024055|NCT00075478|464379909|FG000|Overall Study|Physician Decision|0|||
129024056|NCT00075478|464379910|FG001|Overall Study|Physician Decision|1|||
129024057|NCT02075463|464379912|FG000|Overall Study|Adverse Event|3|||
129024058|NCT02075463|464379912|FG000|Overall Study|Par. reached stopping criteria|4|||
129024059|NCT02075463|464379912|FG000|Overall Study|Withdrawal by Subject|1|||
129024060|NCT01383486|464379914|FG000|Overall Study|Lost to Follow-up|10|||
129024061|NCT01383486|464379914|FG000|Overall Study|Incomplete information for analysis|2|||
129024062|NCT01383486|464379914|FG000|Overall Study|Did not take any product|6|||
129024063|NCT01839279|464379916|FG000|Overall Study|Adverse Event|4|||
129024064|NCT01839279|464379917|FG001|Overall Study|Adverse Event|1|||
129024065|NCT01839279|464379918|FG002|Overall Study|Adverse Event|1|||
129024066|NCT01839279|464379916|FG000|Overall Study|Withdrawal by Subject|4|||
129024067|NCT01839279|464379917|FG001|Overall Study|Withdrawal by Subject|1|||
129024068|NCT01839279|464379918|FG002|Overall Study|Withdrawal by Subject|1|||
129024069|NCT01839279|464379916|FG000|Overall Study|Classified as 'Other'|5|||
129024070|NCT01839279|464379917|FG001|Overall Study|Classified as 'Other'|0|||
129024071|NCT01839279|464379918|FG002|Overall Study|Classified as 'Other'|0|||
129024072|NCT03276754|464379919|FG000|Overall Study|Withdrawal of informed consent|4|||
129024073|NCT03276754|464379919|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
129024074|NCT03276754|464379919|FG000|Overall Study|Lost to Follow-up|27|||
129024075|NCT03276754|464379919|FG000|Overall Study|No data reported at Month 24|31|||
129024076|NCT03276754|464379919|FG000|Overall Study|Death|39|||
128693218|NCT04289623|463176204|FG003|Wave 1 Emails|Email was not delivered|0|||
129024077|NCT03437265|464379920|FG000|Overall Study|Protocol Violation|6|||
129024078|NCT00316277|464379922|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
129024079|NCT00316277|464379923|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
128693219|NCT04289623|463176205|FG004|Wave 1 Emails|Email was not delivered|0|||
128693220|NCT04289623|463176206|FG005|Wave 1 Emails|Email was not delivered|0|||
128693221|NCT01772160|463176210|FG000|Overall Study|Death|3|||
128693222|NCT01772160|463176210|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
128764673|NCT03505476|463430259|FG000|Overall Study|Physician Decision|18|||
128693223|NCT01772160|463176210|FG000|Overall Study|Consent withdrawal|3|||
128901239|NCT00708500|463932641|FG002|FOLLOWUP|Lost to Follow-up|4|||
129024080|NCT00316277|464379922|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
129024081|NCT00316277|464379923|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
129024082|NCT00316277|464379922|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
128693224|NCT01772160|463176210|FG000|Overall Study|Migrated / moved from the study area|4|||
128693225|NCT01772160|463176210|FG000|Overall Study|Lost to Follow-up|30|||
128901240|NCT00708500|463932639|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
128901241|NCT00708500|463932640|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
128901242|NCT00708500|463932641|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
128901243|NCT00708500|463932639|FG000|FOLLOWUP|Subject withdrew consent|31|||
128901244|NCT00708500|463932640|FG001|FOLLOWUP|Subject withdrew consent|4|||
128901245|NCT00708500|463932641|FG002|FOLLOWUP|Subject withdrew consent|5|||
128901246|NCT00708500|463932639|FG000|FOLLOWUP|Non-compliance with protocol|5|||
128901247|NCT00708500|463932640|FG001|FOLLOWUP|Non-compliance with protocol|0|||
128901248|NCT00708500|463932641|FG002|FOLLOWUP|Non-compliance with protocol|1|||
128901249|NCT00618410|463932646|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
128901250|NCT00618410|463932647|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
128901251|NCT00705783|463932653|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
128901252|NCT00705783|463932654|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
128901253|NCT00705783|463932655|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
128901254|NCT00705783|463932653|FG000|Conversion Phase|Lost to Follow-up|13|||
128901255|NCT00705783|463932654|FG001|Conversion Phase|Lost to Follow-up|0|||
128901256|NCT00705783|463932655|FG002|Conversion Phase|Lost to Follow-up|0|||
128901257|NCT00705783|463932653|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
128901258|NCT00705783|463932654|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
128901259|NCT00705783|463932655|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
128901260|NCT00705783|463932653|FG000|Conversion Phase|Withdrawn by Investigator|4|||
128901261|NCT00705783|463932654|FG001|Conversion Phase|Withdrawn by Investigator|0|||
128901262|NCT00705783|463932655|FG002|Conversion Phase|Withdrawn by Investigator|0|||
128901263|NCT00705783|463932653|FG000|Conversion Phase|Withdrew Consent|24|||
128901264|NCT00705783|463932654|FG001|Conversion Phase|Withdrew Consent|0|||
128901265|NCT00705783|463932655|FG002|Conversion Phase|Withdrew Consent|0|||
128901266|NCT00705783|463932653|FG000|Conversion Phase|Protocol Deviation|2|||
128901267|NCT00705783|463932654|FG001|Conversion Phase|Protocol Deviation|0|||
128901268|NCT00705783|463932655|FG002|Conversion Phase|Protocol Deviation|0|||
128901269|NCT00705783|463932653|FG000|Conversion Phase|Adverse Event|11|||
128901270|NCT00705783|463932654|FG001|Conversion Phase|Adverse Event|0|||
128901271|NCT00705783|463932655|FG002|Conversion Phase|Adverse Event|0|||
128901272|NCT00705783|463932653|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
128901273|NCT00705783|463932654|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
128901274|NCT00705783|463932655|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
128901275|NCT00705783|463932653|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
128901276|NCT00705783|463932654|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
128901277|NCT00705783|463932655|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
128901278|NCT00705783|463932653|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
128901279|NCT00705783|463932654|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
128901280|NCT00705783|463932655|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
128901281|NCT00705783|463932653|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
128901282|NCT00705783|463932654|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
128901283|NCT00705783|463932655|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
129024083|NCT00316277|464379923|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
129024084|NCT00316277|464379922|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
129024085|NCT00316277|464379923|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
129024086|NCT00316277|464379922|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
129024087|NCT00316277|464379923|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
129024088|NCT00848536|464379926|FG000|Overall Study|Adverse Event|2|||
129024089|NCT00848536|464379927|FG001|Overall Study|Adverse Event|2|||
129024090|NCT00848536|464379926|FG000|Overall Study|Withdrawal by Subject|0|||
129024091|NCT00848536|464379927|FG001|Overall Study|Withdrawal by Subject|1|||
129024092|NCT00848536|464379926|FG000|Overall Study|Protocol Violation|0|||
129024093|NCT00848536|464379927|FG001|Overall Study|Protocol Violation|1|||
129024094|NCT00848536|464379926|FG000|Overall Study|Noncompliance|1|||
129024095|NCT00848536|464379927|FG001|Overall Study|Noncompliance|0|||
129024096|NCT00848536|464379926|FG000|Overall Study|Inadequate Control of IOP|1|||
129024097|NCT00848536|464379927|FG001|Overall Study|Inadequate Control of IOP|1|||
129024098|NCT00848536|464379926|FG000|Overall Study|Patient Moved|0|||
129024099|NCT00848536|464379927|FG001|Overall Study|Patient Moved|2|||
129024100|NCT03669861|464379928|FG000|Overall Study|Disease Flare|5|||
129024101|NCT03669861|464379928|FG000|Overall Study|Lack of Efficacy|2|||
129024102|NCT01604941|464379933|FG000|Overall Study|Adverse Event|1|||
129024103|NCT01604941|464379934|FG001|Overall Study|Adverse Event|2|||
129024104|NCT01604941|464379935|FG002|Overall Study|Adverse Event|0|||
129024105|NCT01604941|464379936|FG003|Overall Study|Adverse Event|0|||
128693226|NCT01772160|463176210|FG000|Overall Study|Other|5|||
128901284|NCT00705783|463932653|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
128901285|NCT00705783|463932654|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
128901286|NCT00705783|463932655|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
128901287|NCT00705783|463932653|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
129113581|NCT05616013|464711508|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129113582|NCT05616013|464711509|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129113583|NCT05616013|464711510|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129113584|NCT05616013|464711511|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129113585|NCT05616013|464711512|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129113586|NCT05616013|464711513|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129113587|NCT05616013|464711505|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113588|NCT05616013|464711506|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
129113589|NCT05616013|464711507|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113590|NCT05616013|464711508|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113591|NCT05616013|464711509|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113592|NCT05616013|464711510|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113593|NCT05616013|464711511|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113594|NCT05616013|464711512|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113595|NCT05616013|464711513|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129113596|NCT05616013|464711505|FG000|Overall Study|Participant Decision, Time Constraints|0|||
129113597|NCT05616013|464711506|FG001|Overall Study|Participant Decision, Time Constraints|1|||
129113598|NCT05616013|464711507|FG002|Overall Study|Participant Decision, Time Constraints|0|||
129113599|NCT05616013|464711508|FG003|Overall Study|Participant Decision, Time Constraints|0|||
129113600|NCT05616013|464711509|FG004|Overall Study|Participant Decision, Time Constraints|0|||
129113601|NCT05616013|464711510|FG005|Overall Study|Participant Decision, Time Constraints|0|||
129113602|NCT05616013|464711511|FG006|Overall Study|Participant Decision, Time Constraints|0|||
129113603|NCT05616013|464711512|FG007|Overall Study|Participant Decision, Time Constraints|0|||
129113604|NCT05616013|464711513|FG008|Overall Study|Participant Decision, Time Constraints|0|||
129113605|NCT05616013|464711505|FG000|Overall Study|Prohibited Concomitant Medication|0|||
129113606|NCT05616013|464711506|FG001|Overall Study|Prohibited Concomitant Medication|0|||
129113607|NCT05616013|464711507|FG002|Overall Study|Prohibited Concomitant Medication|1|||
129113608|NCT05616013|464711508|FG003|Overall Study|Prohibited Concomitant Medication|0|||
129113609|NCT05616013|464711509|FG004|Overall Study|Prohibited Concomitant Medication|0|||
129113610|NCT05616013|464711510|FG005|Overall Study|Prohibited Concomitant Medication|0|||
129113611|NCT05616013|464711511|FG006|Overall Study|Prohibited Concomitant Medication|0|||
129113612|NCT05616013|464711512|FG007|Overall Study|Prohibited Concomitant Medication|0|||
129113613|NCT05616013|464711513|FG008|Overall Study|Prohibited Concomitant Medication|0|||
129113614|NCT05616013|464711505|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
129113615|NCT05616013|464711506|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
129113616|NCT05616013|464711507|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
129113617|NCT05616013|464711508|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
129113618|NCT05616013|464711509|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
129113619|NCT05616013|464711510|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
129113620|NCT05616013|464711511|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
128693227|NCT01268150|463176218|FG000|Treatment Phase|Progression of disease|18|||
128693228|NCT01268150|463176218|FG000|Treatment Phase|Adverse Event|3|||
128693229|NCT01268150|463176218|FG000|Treatment Phase|Withdrawal by Subject|3|||
129024106|NCT01604941|464379937|FG004|Overall Study|Adverse Event|1|||
129024107|NCT01604941|464379938|FG005|Overall Study|Adverse Event|5|||
129024108|NCT01604941|464379933|FG000|Overall Study|Non-compliance|1|||
129024109|NCT01604941|464379934|FG001|Overall Study|Non-compliance|0|||
129024110|NCT01604941|464379935|FG002|Overall Study|Non-compliance|0|||
129024111|NCT01604941|464379936|FG003|Overall Study|Non-compliance|0|||
129024112|NCT01604941|464379937|FG004|Overall Study|Non-compliance|0|||
129024113|NCT01604941|464379938|FG005|Overall Study|Non-compliance|0|||
129024114|NCT01604941|464379933|FG000|Overall Study|Participant Decision|0|||
129024115|NCT01604941|464379934|FG001|Overall Study|Participant Decision|0|||
129024116|NCT01604941|464379935|FG002|Overall Study|Participant Decision|0|||
129024117|NCT01604941|464379936|FG003|Overall Study|Participant Decision|0|||
129024118|NCT01604941|464379937|FG004|Overall Study|Participant Decision|0|||
129024119|NCT01604941|464379938|FG005|Overall Study|Participant Decision|2|||
129024120|NCT01604941|464379933|FG000|Overall Study|Early Study Termination|9|||
129024121|NCT01604941|464379934|FG001|Overall Study|Early Study Termination|2|||
129024122|NCT01604941|464379935|FG002|Overall Study|Early Study Termination|3|||
129024123|NCT01604941|464379936|FG003|Overall Study|Early Study Termination|3|||
129024124|NCT01604941|464379937|FG004|Overall Study|Early Study Termination|0|||
129024125|NCT01604941|464379938|FG005|Overall Study|Early Study Termination|0|||
129024126|NCT05479058|464379939|FG000|Overall Study|Withdrawal by Subject|1|||
129024127|NCT05479058|464379940|FG001|Overall Study|Withdrawal by Subject|1|||
129024128|NCT05479058|464379939|FG000|Overall Study|Study terminated by sponsor|10|||
129024129|NCT05479058|464379940|FG001|Overall Study|Study terminated by sponsor|10|||
129113621|NCT05616013|464711512|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
129113622|NCT05616013|464711513|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
129113623|NCT05616013|464711505|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128764674|NCT03505476|463430259|FG000|Overall Study|Device Malfunctioned|101|||
128764675|NCT03505476|463430259|FG000|Overall Study|Data Corrupt|6|||
129024130|NCT04078022|464379945|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
129024131|NCT04078022|464379946|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
129024132|NCT01895335|464379947|FG000|Overall Study|Adverse Event|106|||
129024133|NCT01895335|464379947|FG000|Overall Study|Lack of Efficacy|53|||
129024134|NCT01895335|464379947|FG000|Overall Study|Poor Compliance to Protocol|11|||
129024135|NCT01895335|464379947|FG000|Overall Study|Included But Not treated|1|||
129024136|NCT01895335|464379947|FG000|Overall Study|Other than Specified Above|44|||
129024137|NCT00463684|464379948|FG000|Overall Study|Withdrawal by Subject|1|||
129024138|NCT00463684|464379948|FG000|Overall Study|Lost to Follow-up|3|||
129024139|NCT00115063|464379949|FG000|Overall Study|Lost to Follow-up|98|||
129024140|NCT00115063|464379950|FG001|Overall Study|Lost to Follow-up|104|||
129024141|NCT00115063|464379949|FG000|Overall Study|Death|1|||
129024142|NCT00115063|464379950|FG001|Overall Study|Death|0|||
129024143|NCT00191815|464379951|FG000|Overall Study|Adverse Event|2|||
129024144|NCT00191815|464379951|FG000|Overall Study|Disease progression or relapse|24|||
129024145|NCT00191815|464379951|FG000|Overall Study|Death|2|||
129024146|NCT00191815|464379951|FG000|Overall Study|Protocol Violation|3|||
129024147|NCT00191815|464379951|FG000|Overall Study|Physician Decision|2|||
129024148|NCT00191815|464379951|FG000|Overall Study|Withdrawal by Subject|7|||
129024149|NCT03808376|464379952|FG000|Overall Study|Withdrawal by Subject|10|||
129024150|NCT03644550|464379953|FG000|Overall Study|Withdrawal by Subject|3|||
129024151|NCT03644550|464379953|FG000|Overall Study|Progressive disease|15|||
129024152|NCT01075282|464379954|FG000|Overall Study|Withdrawal by Subject|11|||
129024153|NCT01075282|464379955|FG001|Overall Study|Withdrawal by Subject|7|||
129024154|NCT01075282|464379956|FG002|Overall Study|Withdrawal by Subject|11|||
129024155|NCT01075282|464379954|FG000|Overall Study|Adverse Event|9|||
129024156|NCT01075282|464379955|FG001|Overall Study|Adverse Event|8|||
129024157|NCT01075282|464379956|FG002|Overall Study|Adverse Event|5|||
129024158|NCT01075282|464379954|FG000|Overall Study|Entry Criteria Not Met|3|||
129024159|NCT01075282|464379955|FG001|Overall Study|Entry Criteria Not Met|2|||
129024160|NCT01075282|464379956|FG002|Overall Study|Entry Criteria Not Met|0|||
129024161|NCT01075282|464379954|FG000|Overall Study|Lost to Follow-up|3|||
129024162|NCT01075282|464379955|FG001|Overall Study|Lost to Follow-up|3|||
129024163|NCT01075282|464379956|FG002|Overall Study|Lost to Follow-up|3|||
129024164|NCT01075282|464379954|FG000|Overall Study|Physician Decision|3|||
129024165|NCT01075282|464379955|FG001|Overall Study|Physician Decision|3|||
129024166|NCT01075282|464379956|FG002|Overall Study|Physician Decision|3|||
129024167|NCT01075282|464379954|FG000|Overall Study|Lack of Efficacy|1|||
129024168|NCT01075282|464379955|FG001|Overall Study|Lack of Efficacy|1|||
129024169|NCT01075282|464379956|FG002|Overall Study|Lack of Efficacy|0|||
129024170|NCT01075282|464379954|FG000|Overall Study|Treatment Non-compliance|1|||
129024171|NCT01075282|464379955|FG001|Overall Study|Treatment Non-compliance|2|||
129024172|NCT01075282|464379956|FG002|Overall Study|Treatment Non-compliance|2|||
129024173|NCT01075282|464379954|FG000|Overall Study|Protocol Violation|0|||
129024174|NCT01075282|464379955|FG001|Overall Study|Protocol Violation|2|||
129024175|NCT01075282|464379956|FG002|Overall Study|Protocol Violation|1|||
129024176|NCT01075282|464379954|FG000|Overall Study|Death|0|||
129024177|NCT01075282|464379955|FG001|Overall Study|Death|1|||
129024178|NCT01075282|464379956|FG002|Overall Study|Death|2|||
129024179|NCT00003470|464379957|FG000|Overall Study|Not evaluable|6|||
129024180|NCT03503318|464379958|FG000|Overall Study|Death|1|||
129024181|NCT03503318|464379959|FG001|Overall Study|Death|0|||
129024182|NCT03503318|464379960|FG002|Overall Study|Death|4|||
129024183|NCT03503318|464379958|FG000|Overall Study|Adverse Event|3|||
129024184|NCT03503318|464379959|FG001|Overall Study|Adverse Event|4|||
129024185|NCT03503318|464379960|FG002|Overall Study|Adverse Event|2|||
129024186|NCT03503318|464379958|FG000|Overall Study|Withdrawal by Subject|12|||
129024187|NCT03503318|464379959|FG001|Overall Study|Withdrawal by Subject|17|||
129024188|NCT03503318|464379960|FG002|Overall Study|Withdrawal by Subject|16|||
129024189|NCT03503318|464379958|FG000|Overall Study|Protocol Violation|5|||
129024190|NCT03503318|464379959|FG001|Overall Study|Protocol Violation|0|||
129024191|NCT03503318|464379960|FG002|Overall Study|Protocol Violation|3|||
129024192|NCT03503318|464379958|FG000|Overall Study|Lost to Follow-up|17|||
129024193|NCT03503318|464379959|FG001|Overall Study|Lost to Follow-up|15|||
129024194|NCT03503318|464379960|FG002|Overall Study|Lost to Follow-up|12|||
129024195|NCT03503318|464379958|FG000|Overall Study|Other than specified|1|||
129024196|NCT03503318|464379959|FG001|Overall Study|Other than specified|3|||
129024197|NCT03503318|464379960|FG002|Overall Study|Other than specified|3|||
129132898|NCT00827242|464778558|FG000|Overall Study|Entry Criteria Not Met|4|||
129024198|NCT02139826|464379963|FG000|Overall Study|Adverse Event|1|||
129024199|NCT01456221|464379965|FG000|Overall Study|Withdrawal by Subject|56|||
129024200|NCT01456221|464379966|FG001|Overall Study|Withdrawal by Subject|49|||
129024201|NCT01456221|464379965|FG000|Overall Study|Lost to Follow-up|1|||
128693230|NCT01268150|463176218|FG000|Treatment Phase|Other|4|||
128693231|NCT01268150|463176218|FG000|Extension Phase|Adverse Event|3|||
128693232|NCT01268150|463176218|FG000|Extension Phase|Disease progression|18|||
128693233|NCT01268150|463176218|FG000|Extension Phase|Other|6|||
128693234|NCT03725852|463176219|FG000|Overall Study|Death|1|||
128693235|NCT03725852|463176220|FG001|Overall Study|Death|0|||
128693236|NCT03725852|463176219|FG000|Overall Study|Withdrawal by Subject|1|||
128693237|NCT03725852|463176220|FG001|Overall Study|Withdrawal by Subject|0|||
128693238|NCT03725852|463176219|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
128693239|NCT03725852|463176220|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
128693240|NCT04738734|463176222|FG000|Overall Study|Withdrawal by Subject|2|||
128693241|NCT04738734|463176223|FG001|Overall Study|Withdrawal by Subject|4|||
128693242|NCT04738734|463176222|FG000|Overall Study|Lost to Follow-up|5|||
128693243|NCT04738734|463176223|FG001|Overall Study|Lost to Follow-up|2|||
128693244|NCT04738734|463176222|FG000|Overall Study|Physician Decision|0|||
128693245|NCT04738734|463176223|FG001|Overall Study|Physician Decision|1|||
128693246|NCT04738734|463176222|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
128693247|NCT04738734|463176223|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
128693248|NCT02435147|463176226|FG000|Overall Study|non-evaluable DXA scan|11|||
128693249|NCT02853344|463176229|FG000|Overall Study|Lost to Follow-up|1|||
128693250|NCT02853344|463176230|FG001|Overall Study|Lost to Follow-up|1|||
128693251|NCT02853344|463176229|FG000|Overall Study|Withdrawal by Subject|2|||
128693252|NCT02853344|463176230|FG001|Overall Study|Withdrawal by Subject|4|||
128693253|NCT02853344|463176229|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
128693254|NCT02853344|463176230|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
128693255|NCT02853344|463176229|FG000|Overall Study|Death|70|||
128693256|NCT02853344|463176230|FG001|Overall Study|Death|112|||
128693257|NCT02913612|463176231|FG000|Overall Study|Lost to Follow-up|6|||
128693258|NCT02913612|463176232|FG001|Overall Study|Lost to Follow-up|5|||
128693259|NCT02913612|463176233|FG002|Overall Study|Lost to Follow-up|2|||
128693260|NCT02913612|463176234|FG003|Overall Study|Lost to Follow-up|0|||
128693261|NCT02913612|463176231|FG000|Overall Study|Physician Decision|1|||
128693262|NCT02913612|463176232|FG001|Overall Study|Physician Decision|4|||
128693263|NCT02913612|463176233|FG002|Overall Study|Physician Decision|1|||
128693264|NCT02913612|463176234|FG003|Overall Study|Physician Decision|0|||
128693265|NCT02913612|463176231|FG000|Overall Study|Withdrawal by Subject|2|||
128901288|NCT00705783|463932654|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
128901289|NCT00705783|463932655|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129113624|NCT05616013|464711506|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129113625|NCT05616013|464711507|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129113626|NCT05616013|464711508|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
128693266|NCT02913612|463176232|FG001|Overall Study|Withdrawal by Subject|4|||
128693267|NCT02913612|463176233|FG002|Overall Study|Withdrawal by Subject|0|||
128693268|NCT02913612|463176234|FG003|Overall Study|Withdrawal by Subject|0|||
128693269|NCT02913612|463176231|FG000|Overall Study|Hemangioma resolved|1|||
128901290|NCT00705783|463932653|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
129024202|NCT01456221|464379966|FG001|Overall Study|Lost to Follow-up|4|||
129024203|NCT01456221|464379965|FG000|Overall Study|Received medication|3|||
129024204|NCT01456221|464379966|FG001|Overall Study|Received medication|2|||
129024205|NCT01456221|464379965|FG000|Overall Study|Incomplete data|4|||
129024206|NCT01456221|464379966|FG001|Overall Study|Incomplete data|2|||
129024207|NCT01473953|464379969|FG000|Overall Study|Other|1|||
129024208|NCT01473953|464379970|FG001|Overall Study|Other|0|||
129024209|NCT01473953|464379971|FG002|Overall Study|Other|0|||
129024210|NCT01473953|464379972|FG003|Overall Study|Other|0|||
129024211|NCT01473953|464379973|FG004|Overall Study|Other|0|||
129024212|NCT01494532|464379974|FG000|Overall Study|Adverse Event|4|||
129024213|NCT01494532|464379975|FG001|Overall Study|Adverse Event|1|||
129024214|NCT01494532|464379976|FG002|Overall Study|Adverse Event|8|||
129024215|NCT01494532|464379977|FG003|Overall Study|Adverse Event|6|||
129024216|NCT01494532|464379978|FG004|Overall Study|Adverse Event|5|||
129024217|NCT01494532|464379979|FG005|Overall Study|Adverse Event|0|||
128693270|NCT02913612|463176232|FG001|Overall Study|Hemangioma resolved|0|||
128693271|NCT02913612|463176233|FG002|Overall Study|Hemangioma resolved|0|||
128901291|NCT00705783|463932654|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
129024218|NCT01494532|464379974|FG000|Overall Study|Lack of Efficacy|0|||
129024219|NCT01494532|464379975|FG001|Overall Study|Lack of Efficacy|0|||
129024220|NCT01494532|464379976|FG002|Overall Study|Lack of Efficacy|0|||
129024221|NCT01494532|464379977|FG003|Overall Study|Lack of Efficacy|0|||
129024222|NCT01494532|464379978|FG004|Overall Study|Lack of Efficacy|2|||
128693272|NCT02913612|463176234|FG003|Overall Study|Hemangioma resolved|0|||
128693273|NCT02913612|463176231|FG000|Overall Study|Local IRB decision|1|||
128693274|NCT02913612|463176232|FG001|Overall Study|Local IRB decision|0|||
128693275|NCT02913612|463176233|FG002|Overall Study|Local IRB decision|0|||
128901292|NCT00705783|463932655|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
129024223|NCT01494532|464379979|FG005|Overall Study|Lack of Efficacy|0|||
128693276|NCT02913612|463176234|FG003|Overall Study|Local IRB decision|0|||
128693277|NCT02913612|463176231|FG000|Overall Study|Study drug non-compliance|1|||
128693278|NCT02913612|463176232|FG001|Overall Study|Study drug non-compliance|1|||
128693279|NCT02913612|463176233|FG002|Overall Study|Study drug non-compliance|0|||
128693280|NCT02913612|463176234|FG003|Overall Study|Study drug non-compliance|0|||
128693281|NCT02913612|463176231|FG000|Overall Study|Insurance issues|0|||
128693282|NCT02913612|463176232|FG001|Overall Study|Insurance issues|1|||
128693283|NCT02913612|463176233|FG002|Overall Study|Insurance issues|0|||
128693284|NCT02913612|463176234|FG003|Overall Study|Insurance issues|0|||
128693285|NCT02913612|463176231|FG000|Overall Study|Needed to treat second hemangioma|0|||
128693286|NCT02913612|463176232|FG001|Overall Study|Needed to treat second hemangioma|1|||
128693287|NCT02913612|463176233|FG002|Overall Study|Needed to treat second hemangioma|0|||
128693288|NCT02913612|463176234|FG003|Overall Study|Needed to treat second hemangioma|0|||
128693289|NCT02913612|463176231|FG000|Overall Study|Study completion criteria not met|0|||
128693290|NCT02913612|463176232|FG001|Overall Study|Study completion criteria not met|1|||
128693291|NCT02913612|463176233|FG002|Overall Study|Study completion criteria not met|0|||
128693292|NCT02913612|463176234|FG003|Overall Study|Study completion criteria not met|0|||
128693293|NCT02913612|463176231|FG000|Overall Study|Ineligible|0|||
128693294|NCT02913612|463176232|FG001|Overall Study|Ineligible|1|||
128693295|NCT02913612|463176233|FG002|Overall Study|Ineligible|0|||
128693296|NCT02913612|463176234|FG003|Overall Study|Ineligible|0|||
128693297|NCT00973674|463176235|FG000|Overall Study|Protocol Violation|2|||
128693298|NCT00973674|463176236|FG001|Overall Study|Protocol Violation|0|||
128693299|NCT00116428|463176237|FG000|Overall Study|Withdrawal by Subject|2|||
128693300|NCT00116428|463176238|FG001|Overall Study|Withdrawal by Subject|5|||
128693301|NCT00116428|463176237|FG000|Overall Study|Did not meet inclusion criteria|1|||
128693302|NCT00116428|463176238|FG001|Overall Study|Did not meet inclusion criteria|0|||
128693303|NCT03452228|463176239|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
128693304|NCT03452228|463176240|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
128693305|NCT03452228|463176241|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
128693306|NCT03452228|463176239|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
128693307|NCT03452228|463176240|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
128693308|NCT03452228|463176241|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128693309|NCT03452228|463176239|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
128693310|NCT03452228|463176240|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
128693311|NCT03452228|463176241|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
128693312|NCT03452228|463176239|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128693313|NCT03452228|463176240|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128693314|NCT03452228|463176241|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
128693315|NCT00669396|463176242|FG000|Overall Study|Lost to Follow-up|10|||
128693316|NCT00669396|463176243|FG001|Overall Study|Lost to Follow-up|12|||
128693317|NCT00474760|463176246|FG000|Overall Study|Death|0|||
128693318|NCT00474760|463176247|FG001|Overall Study|Death|0|||
128693319|NCT00474760|463176248|FG002|Overall Study|Death|0|||
128693320|NCT00474760|463176249|FG003|Overall Study|Death|0|||
128693321|NCT00474760|463176250|FG004|Overall Study|Death|2|||
128693322|NCT00474760|463176251|FG005|Overall Study|Death|0|||
128693323|NCT00474760|463176252|FG006|Overall Study|Death|0|||
128693324|NCT00474760|463176246|FG000|Overall Study|Adverse Event|0|||
128693325|NCT00474760|463176247|FG001|Overall Study|Adverse Event|0|||
128693326|NCT00474760|463176248|FG002|Overall Study|Adverse Event|0|||
128693327|NCT00474760|463176249|FG003|Overall Study|Adverse Event|0|||
128693328|NCT00474760|463176250|FG004|Overall Study|Adverse Event|1|||
128693329|NCT00474760|463176251|FG005|Overall Study|Adverse Event|7|||
128693330|NCT00474760|463176252|FG006|Overall Study|Adverse Event|0|||
128693331|NCT00474760|463176246|FG000|Overall Study|Laboratory abnormality|0|||
128693332|NCT00474760|463176247|FG001|Overall Study|Laboratory abnormality|0|||
128693333|NCT00474760|463176248|FG002|Overall Study|Laboratory abnormality|0|||
128693334|NCT00474760|463176249|FG003|Overall Study|Laboratory abnormality|0|||
128693335|NCT00474760|463176250|FG004|Overall Study|Laboratory abnormality|0|||
128693336|NCT00474760|463176251|FG005|Overall Study|Laboratory abnormality|1|||
128693337|NCT00474760|463176252|FG006|Overall Study|Laboratory abnormality|0|||
128693338|NCT00474760|463176246|FG000|Overall Study|Withdrawal by Subject|0|||
128693339|NCT00474760|463176247|FG001|Overall Study|Withdrawal by Subject|0|||
128693340|NCT00474760|463176248|FG002|Overall Study|Withdrawal by Subject|0|||
128693341|NCT00474760|463176249|FG003|Overall Study|Withdrawal by Subject|1|||
128693342|NCT00474760|463176250|FG004|Overall Study|Withdrawal by Subject|0|||
128693343|NCT00474760|463176251|FG005|Overall Study|Withdrawal by Subject|1|||
128693344|NCT00474760|463176252|FG006|Overall Study|Withdrawal by Subject|1|||
128693345|NCT00474760|463176246|FG000|Overall Study|Other|0|||
128693346|NCT00474760|463176247|FG001|Overall Study|Other|1|||
128693347|NCT00474760|463176248|FG002|Overall Study|Other|0|||
128693348|NCT00474760|463176249|FG003|Overall Study|Other|0|||
128693349|NCT00474760|463176250|FG004|Overall Study|Other|1|||
128693350|NCT00474760|463176251|FG005|Overall Study|Other|0|||
128901293|NCT00705783|463932653|FG000|Oral Stabilization Phase|Adverse Event|14|||
128901294|NCT00705783|463932654|FG001|Oral Stabilization Phase|Adverse Event|0|||
128901295|NCT00705783|463932655|FG002|Oral Stabilization Phase|Adverse Event|0|||
128901296|NCT00705783|463932653|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
128901297|NCT00705783|463932654|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
128901298|NCT00705783|463932655|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
128901299|NCT00705783|463932653|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
128901300|NCT00705783|463932654|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
128901301|NCT00705783|463932655|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
128901302|NCT00705783|463932653|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
128901303|NCT00705783|463932654|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
128901304|NCT00705783|463932655|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
128901305|NCT00705783|463932653|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
128901306|NCT00705783|463932654|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
128901307|NCT00705783|463932655|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
128901308|NCT00705783|463932653|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
128901309|NCT00705783|463932654|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
128901310|NCT00705783|463932655|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
128901311|NCT00705783|463932653|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
128901312|NCT00705783|463932654|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
128901313|NCT00705783|463932655|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
128901314|NCT00705783|463932653|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
128901315|NCT00705783|463932654|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
128901316|NCT00705783|463932655|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
128901317|NCT00705783|463932653|FG000|Depot Stabilization Phase|Adverse Event|17|||
128901318|NCT00705783|463932654|FG001|Depot Stabilization Phase|Adverse Event|0|||
128901319|NCT00705783|463932655|FG002|Depot Stabilization Phase|Adverse Event|0|||
128901320|NCT00705783|463932653|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
128901321|NCT00705783|463932654|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
128901322|NCT00705783|463932655|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
128901323|NCT00705783|463932653|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
128901324|NCT00705783|463932654|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
128901325|NCT00705783|463932655|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
128901326|NCT00705783|463932653|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
128901327|NCT00705783|463932654|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
128901328|NCT00705783|463932655|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
128901329|NCT00705783|463932653|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
128901330|NCT00705783|463932654|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
128901331|NCT00705783|463932655|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
128901332|NCT00705783|463932653|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
128901333|NCT00705783|463932654|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
129024224|NCT01494532|464379974|FG000|Overall Study|Protocol deviation|2|||
129024225|NCT01494532|464379975|FG001|Overall Study|Protocol deviation|1|||
129024226|NCT01494532|464379976|FG002|Overall Study|Protocol deviation|3|||
129024227|NCT01494532|464379977|FG003|Overall Study|Protocol deviation|2|||
129024228|NCT01494532|464379978|FG004|Overall Study|Protocol deviation|3|||
129024229|NCT01494532|464379979|FG005|Overall Study|Protocol deviation|0|||
129024230|NCT01494532|464379974|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129024231|NCT01494532|464379975|FG001|Overall Study|Protocol-defined stopping criteria|0|||
129024232|NCT01494532|464379976|FG002|Overall Study|Protocol-defined stopping criteria|1|||
129024233|NCT01494532|464379977|FG003|Overall Study|Protocol-defined stopping criteria|0|||
129024234|NCT01494532|464379978|FG004|Overall Study|Protocol-defined stopping criteria|0|||
129024235|NCT01494532|464379979|FG005|Overall Study|Protocol-defined stopping criteria|0|||
129024236|NCT01494532|464379974|FG000|Overall Study|Lost to Follow-up|1|||
129024237|NCT01494532|464379975|FG001|Overall Study|Lost to Follow-up|0|||
129024238|NCT01494532|464379976|FG002|Overall Study|Lost to Follow-up|0|||
129024239|NCT01494532|464379977|FG003|Overall Study|Lost to Follow-up|2|||
129024240|NCT01494532|464379978|FG004|Overall Study|Lost to Follow-up|0|||
129024241|NCT01494532|464379979|FG005|Overall Study|Lost to Follow-up|0|||
129024242|NCT01494532|464379974|FG000|Overall Study|Physician Decision|0|||
129024243|NCT01494532|464379975|FG001|Overall Study|Physician Decision|1|||
129024244|NCT01494532|464379976|FG002|Overall Study|Physician Decision|1|||
129024245|NCT01494532|464379977|FG003|Overall Study|Physician Decision|2|||
129024246|NCT01494532|464379978|FG004|Overall Study|Physician Decision|0|||
129024247|NCT01494532|464379979|FG005|Overall Study|Physician Decision|0|||
129024248|NCT01494532|464379974|FG000|Overall Study|Withdrawal by Subject|3|||
128693351|NCT00474760|463176252|FG006|Overall Study|Other|0|||
128693352|NCT00474760|463176246|FG000|Overall Study|Progressive disease|3|||
128693353|NCT00474760|463176247|FG001|Overall Study|Progressive disease|2|||
128901334|NCT00705783|463932655|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
128901335|NCT00705783|463932653|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
128901336|NCT00705783|463932654|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
128901337|NCT00705783|463932655|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
128901338|NCT00705783|463932653|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
128901339|NCT00705783|463932654|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
128901340|NCT00705783|463932655|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
128901341|NCT00705783|463932653|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
128901342|NCT00705783|463932654|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
128901343|NCT00705783|463932655|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
128901344|NCT00705783|463932653|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
128901345|NCT00705783|463932654|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
128901346|NCT00705783|463932655|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
128901347|NCT00705783|463932653|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
128901348|NCT00705783|463932654|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
128901349|NCT00705783|463932655|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
128901350|NCT00705783|463932653|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
128901351|NCT00705783|463932654|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
128901352|NCT00705783|463932655|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
129024249|NCT01494532|464379975|FG001|Overall Study|Withdrawal by Subject|1|||
129024250|NCT01494532|464379976|FG002|Overall Study|Withdrawal by Subject|4|||
128693354|NCT00474760|463176248|FG002|Overall Study|Progressive disease|3|||
128693355|NCT00474760|463176249|FG003|Overall Study|Progressive disease|2|||
128693356|NCT00474760|463176250|FG004|Overall Study|Progressive disease|8|||
128693357|NCT00474760|463176251|FG005|Overall Study|Progressive disease|20|||
128693358|NCT00474760|463176252|FG006|Overall Study|Progressive disease|7|||
128693359|NCT00474760|463176246|FG000|Overall Study|Terminated by sponsor|0|||
128693360|NCT00474760|463176247|FG001|Overall Study|Terminated by sponsor|0|||
128693361|NCT00474760|463176248|FG002|Overall Study|Terminated by sponsor|0|||
128693362|NCT00474760|463176249|FG003|Overall Study|Terminated by sponsor|0|||
128693363|NCT00474760|463176250|FG004|Overall Study|Terminated by sponsor|0|||
128693364|NCT00474760|463176251|FG005|Overall Study|Terminated by sponsor|0|||
129024251|NCT01494532|464379977|FG003|Overall Study|Withdrawal by Subject|3|||
129024252|NCT01494532|464379978|FG004|Overall Study|Withdrawal by Subject|2|||
129024253|NCT01494532|464379979|FG005|Overall Study|Withdrawal by Subject|0|||
129024254|NCT00772603|464381218|FG000|Overall Study|Withdrawal by Subject|11|||
129024255|NCT00772603|464381219|FG001|Overall Study|Withdrawal by Subject|10|||
129024256|NCT00772603|464381220|FG002|Overall Study|Withdrawal by Subject|6|||
129024257|NCT00772603|464381218|FG000|Overall Study|Adverse Event|37|||
129024258|NCT00772603|464381219|FG001|Overall Study|Adverse Event|18|||
129024259|NCT00772603|464381220|FG002|Overall Study|Adverse Event|10|||
129024260|NCT00772603|464381218|FG000|Overall Study|Subject Non-compliance|1|||
129024261|NCT00772603|464381219|FG001|Overall Study|Subject Non-compliance|6|||
129024262|NCT00772603|464381220|FG002|Overall Study|Subject Non-compliance|4|||
129024263|NCT00772603|464381218|FG000|Overall Study|Protocol Violation|0|||
129024264|NCT00772603|464381219|FG001|Overall Study|Protocol Violation|1|||
129024265|NCT00772603|464381220|FG002|Overall Study|Protocol Violation|1|||
129024266|NCT00772603|464381218|FG000|Overall Study|Lost to Follow-up|1|||
129024267|NCT00772603|464381219|FG001|Overall Study|Lost to Follow-up|5|||
129024268|NCT00772603|464381220|FG002|Overall Study|Lost to Follow-up|2|||
129024269|NCT00772603|464381218|FG000|Overall Study|Physician Decision|0|||
129024270|NCT00772603|464381219|FG001|Overall Study|Physician Decision|0|||
129024271|NCT00772603|464381220|FG002|Overall Study|Physician Decision|1|||
129024272|NCT00772603|464381218|FG000|Overall Study|Other|2|||
129024273|NCT00772603|464381219|FG001|Overall Study|Other|0|||
129024274|NCT00772603|464381220|FG002|Overall Study|Other|2|||
129024275|NCT01056484|464381223|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
129024276|NCT01056484|464381224|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
129024277|NCT01056484|464381223|FG000|Randomized Controlled Trial|Physician Decision|1|||
129024278|NCT01056484|464381224|FG001|Randomized Controlled Trial|Physician Decision|0|||
129024279|NCT01056484|464381223|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
129024280|NCT01056484|464381224|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
129024281|NCT01564394|464381227|FG000|Overall Study|Withdrawal by Subject|6|||
129024282|NCT01564394|464381228|FG001|Overall Study|Withdrawal by Subject|10|||
129024283|NCT02888756|464381229|FG000|Analytical Treatment Interruption|Physician Decision|10|||
129024284|NCT02888756|464381230|FG001|Analytical Treatment Interruption|Physician Decision|6|||
129024285|NCT02888756|464381231|FG002|Analytical Treatment Interruption|Physician Decision|5|||
129024286|NCT03246503|464381234|FG000|Overall Study|Lost to Follow-up|23|||
129024287|NCT03246503|464381234|FG000|Overall Study|Withdrawal by Subject|20|||
129024288|NCT03246503|464381234|FG000|Overall Study|Physician Decision|5|||
129040323|NCT00544817|464440116|FG000|No Treatment Interval|Lack of Efficacy|8|||
128693365|NCT00474760|463176252|FG006|Overall Study|Terminated by sponsor|2|||
128693366|NCT03386474|463176264|FG000|Overall Study|Death|1|||
128901353|NCT02182687|463932656|FG000|Overall Study|Withdrawal by Subject|4|||
129040324|NCT00544817|464440116|FG000|No Treatment Interval|Physician Decision|3|||
129040325|NCT00544817|464440116|FG000|No Treatment Interval|Adverse Event|1|||
128693367|NCT03386474|463176265|FG001|Overall Study|Death|0|||
128693368|NCT03386474|463176264|FG000|Overall Study|Adverse Event|0|||
128693369|NCT03386474|463176265|FG001|Overall Study|Adverse Event|1|||
128693370|NCT02282358|463176266|FG000|Overall Study|Nonevaluable|1|||
128693371|NCT02155881|463176267|FG000|Overall Study|Withdrawal by Subject|0|||
128693372|NCT02155881|463176268|FG001|Overall Study|Withdrawal by Subject|2|||
128693373|NCT02155881|463176267|FG000|Overall Study|Inappropriately randomized|2|||
128693374|NCT02155881|463176268|FG001|Overall Study|Inappropriately randomized|2|||
128693375|NCT04357782|463176269|FG000|Overall Study|Discharged from hospital|1|||
128693376|NCT04357782|463176270|FG001|Overall Study|Discharged from hospital|0|||
128693377|NCT04357782|463176269|FG000|Overall Study|Death|0|||
128693378|NCT04357782|463176270|FG001|Overall Study|Death|2|||
128693379|NCT01786148|463176271|FG000|Overall Study|Lost to Follow-up|21|||
128693380|NCT01786148|463176272|FG001|Overall Study|Lost to Follow-up|13|||
128693381|NCT01786148|463176271|FG000|Overall Study|Death|0|||
128693382|NCT01786148|463176272|FG001|Overall Study|Death|1|||
128693383|NCT01786148|463176271|FG000|Overall Study|Withdrawal by Subject|0|||
128693384|NCT01786148|463176272|FG001|Overall Study|Withdrawal by Subject|7|||
128693385|NCT01786148|463176271|FG000|Overall Study|Incarceration|1|||
128693386|NCT01786148|463176272|FG001|Overall Study|Incarceration|1|||
128693387|NCT03780543|463176274|FG000|Overall Study|Adverse Event|1|||
128693388|NCT03780543|463176275|FG001|Overall Study|Adverse Event|0|||
128693389|NCT03780543|463176276|FG002|Overall Study|Adverse Event|2|||
128693390|NCT03780543|463176274|FG000|Overall Study|Lost to Follow-up|2|||
128693391|NCT03780543|463176275|FG001|Overall Study|Lost to Follow-up|0|||
128693392|NCT03780543|463176276|FG002|Overall Study|Lost to Follow-up|1|||
128693393|NCT03780543|463176274|FG000|Overall Study|Study terminated by Sponsor|8|||
128693394|NCT03780543|463176275|FG001|Overall Study|Study terminated by Sponsor|7|||
128693395|NCT03780543|463176276|FG002|Overall Study|Study terminated by Sponsor|13|||
128693396|NCT03780543|463176274|FG000|Overall Study|Withdrawal by Subject|1|||
128693397|NCT03780543|463176275|FG001|Overall Study|Withdrawal by Subject|8|||
128693398|NCT03780543|463176276|FG002|Overall Study|Withdrawal by Subject|1|||
129024289|NCT03246503|464381234|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
129024290|NCT00736190|464381235|FG000|Overall Study|Pregnancy|1|||
129024291|NCT00736190|464381235|FG000|Overall Study|Withdrawal by Subject|1|||
129024292|NCT00736190|464381235|FG000|Overall Study|Adverse Event|1|||
129024293|NCT01492439|464381237|FG000|Overall Study|Withdrew from RTE|4|||
129024294|NCT01492439|464381238|FG001|Overall Study|Withdrew from RTE|9|||
129024295|NCT00716625|464381239|FG000|Overall Study|Safety was not Assessable|1|||
129024296|NCT02909907|464381240|FG000|Overall Study|Withdrawal by Subject|0|||
129024297|NCT02909907|464381241|FG001|Overall Study|Withdrawal by Subject|1|||
129024298|NCT00824291|464381242|FG000|Overall Study|Adverse Event|15|||
129024299|NCT00824291|464381243|FG001|Overall Study|Adverse Event|6|||
129024300|NCT00824291|464381242|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
129024301|NCT00824291|464381243|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
129024302|NCT00824291|464381242|FG000|Overall Study|Lost to Follow-up|11|||
129024303|NCT00824291|464381243|FG001|Overall Study|Lost to Follow-up|9|||
129024304|NCT00824291|464381242|FG000|Overall Study|Non-compliance|1|||
129024305|NCT00824291|464381243|FG001|Overall Study|Non-compliance|1|||
129024306|NCT00824291|464381242|FG000|Overall Study|Protocol Violation|4|||
129024307|NCT00824291|464381243|FG001|Overall Study|Protocol Violation|1|||
129024308|NCT00824291|464381242|FG000|Overall Study|Withdrawal by Subject|14|||
129024309|NCT00824291|464381243|FG001|Overall Study|Withdrawal by Subject|8|||
129024310|NCT00824291|464381242|FG000|Overall Study|Lack of Efficacy|7|||
129024311|NCT00824291|464381243|FG001|Overall Study|Lack of Efficacy|8|||
129024312|NCT00824291|464381242|FG000|Overall Study|Participant on prohibited medication|1|||
129024313|NCT00824291|464381243|FG001|Overall Study|Participant on prohibited medication|0|||
129024314|NCT00933686|464381244|FG000|Overall Study|Protocol Violation|0|||
129024315|NCT00933686|464381245|FG001|Overall Study|Protocol Violation|1|||
129024316|NCT00933686|464381244|FG000|Overall Study|Lost to Follow-up|2|||
128693399|NCT03780543|463176274|FG000|Overall Study|Noncompliance with study drug|1|||
128693400|NCT03780543|463176275|FG001|Overall Study|Noncompliance with study drug|0|||
128693401|NCT03780543|463176276|FG002|Overall Study|Noncompliance with study drug|0|||
128693402|NCT00066729|463176284|FG000|Overall Study|Lost to Follow-up|1|||
128693403|NCT00066729|463176284|FG000|Overall Study|Disease progression|1|||
129024317|NCT00933686|464381245|FG001|Overall Study|Lost to Follow-up|2|||
129024318|NCT00933686|464381244|FG000|Overall Study|Withdrawal by Subject|6|||
129024319|NCT00933686|464381245|FG001|Overall Study|Withdrawal by Subject|5|||
129024320|NCT00933686|464381244|FG000|Overall Study|Adverse Event|1|||
129024321|NCT00933686|464381245|FG001|Overall Study|Adverse Event|1|||
129024322|NCT00933686|464381244|FG000|Overall Study|Physician Decision|1|||
128693404|NCT01811225|463176285|FG000|Treatment Period 1|Adverse Event|2|||
128693405|NCT01811225|463176286|FG001|Treatment Period 1|Adverse Event|3|||
128693406|NCT01811225|463176285|FG000|Treatment Period 1|Lost to Follow-up|12|||
129024323|NCT00933686|464381245|FG001|Overall Study|Physician Decision|0|||
128693407|NCT01811225|463176286|FG001|Treatment Period 1|Lost to Follow-up|8|||
129024324|NCT00933686|464381244|FG000|Overall Study|Failure to show up at endpoint visits|0|||
128693408|NCT01811225|463176285|FG000|Treatment Period 1|transporation|1|||
128693409|NCT01811225|463176286|FG001|Treatment Period 1|transporation|0|||
128693410|NCT01811225|463176285|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
128693411|NCT01811225|463176286|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
128693412|NCT01811225|463176285|FG000|Treatment Period 2|Lost to Follow-up|1|||
128693413|NCT01811225|463176286|FG001|Treatment Period 2|Lost to Follow-up|2|||
128693414|NCT01811225|463176285|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
129024325|NCT00933686|464381245|FG001|Overall Study|Failure to show up at endpoint visits|2|||
129024326|NCT01648582|464381248|FG000|Overall Study|Adverse Event|6|||
129024327|NCT01648582|464381249|FG001|Overall Study|Adverse Event|11|||
129024328|NCT01648582|464381250|FG002|Overall Study|Adverse Event|2|||
129024329|NCT01648582|464381248|FG000|Overall Study|Lost to Follow-up|9|||
129024330|NCT01648582|464381249|FG001|Overall Study|Lost to Follow-up|6|||
129024331|NCT01648582|464381250|FG002|Overall Study|Lost to Follow-up|8|||
129024332|NCT01648582|464381248|FG000|Overall Study|Protocol Violation|1|||
129024333|NCT01648582|464381249|FG001|Overall Study|Protocol Violation|2|||
129024334|NCT01648582|464381250|FG002|Overall Study|Protocol Violation|1|||
129024335|NCT01648582|464381248|FG000|Overall Study|Withdrawal by Subject|15|||
129024336|NCT01648582|464381249|FG001|Overall Study|Withdrawal by Subject|17|||
129024337|NCT01648582|464381250|FG002|Overall Study|Withdrawal by Subject|17|||
129024338|NCT01648582|464381248|FG000|Overall Study|Physician Decision|0|||
129024339|NCT01648582|464381249|FG001|Overall Study|Physician Decision|1|||
129024340|NCT01648582|464381250|FG002|Overall Study|Physician Decision|3|||
129024341|NCT01648582|464381248|FG000|Overall Study|Death|1|||
129024342|NCT01648582|464381249|FG001|Overall Study|Death|0|||
129024343|NCT01648582|464381250|FG002|Overall Study|Death|0|||
129024344|NCT01648582|464381248|FG000|Overall Study|Sponsor Decision|0|||
129024345|NCT01648582|464381249|FG001|Overall Study|Sponsor Decision|1|||
129024346|NCT01648582|464381250|FG002|Overall Study|Sponsor Decision|1|||
129024347|NCT02699866|464381251|FG000|Overall Study|Withdrawal by Subject|3|||
129024348|NCT02699866|464381251|FG000|Overall Study|Physician Decision|2|||
129024349|NCT02699866|464381251|FG000|Overall Study|Adverse Event|3|||
129024350|NCT03987191|464381258|FG000|Overall Study|COVID-19 related research disruption|0|||
129024351|NCT03987191|464381259|FG001|Overall Study|COVID-19 related research disruption|2|||
129024352|NCT03261167|464381260|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
129024353|NCT03261167|464381261|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
129024354|NCT03261167|464381260|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
129024355|NCT03261167|464381261|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
129024356|NCT03261167|464381260|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
129024357|NCT03261167|464381261|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
129024358|NCT03261167|464381260|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
129024359|NCT03261167|464381261|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
129024360|NCT03261167|464381260|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
129024361|NCT03261167|464381261|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
129024362|NCT01572662|464381262|FG000|Overall Study|Withdrawal by Subject|1|||
129024363|NCT01572662|464381263|FG001|Overall Study|Withdrawal by Subject|0|||
129024364|NCT01572662|464381262|FG000|Overall Study|Physician Decision|0|||
129024365|NCT01572662|464381263|FG001|Overall Study|Physician Decision|1|||
129024366|NCT03364192|464381264|FG000|Overall Study|Ineligible|10|||
129024367|NCT03364192|464381264|FG000|Overall Study|Withdrawal by Subject|5|||
129024368|NCT03364192|464381264|FG000|Overall Study|Lost to Follow-up|1|||
129024369|NCT00918645|464381265|FG000|Overall Study|Withdrawal by Subject|1|||
129024370|NCT03446768|464381266|FG000|Overall Study|Withdrawal by Subject|0|||
129024371|NCT03446768|464381267|FG001|Overall Study|Withdrawal by Subject|1|||
129024372|NCT05133180|464381268|FG000|Overall Study|Withdrawal of consent|1|||
129024373|NCT05133180|464381269|FG001|Overall Study|Withdrawal of consent|1|||
129024374|NCT05133180|464381268|FG000|Overall Study|Lost to Follow-up|1|||
129024375|NCT05133180|464381269|FG001|Overall Study|Lost to Follow-up|1|||
129024376|NCT05133180|464381268|FG000|Overall Study|Documented disease progression|0|||
129024377|NCT05133180|464381269|FG001|Overall Study|Documented disease progression|1|||
129024378|NCT01535222|464381270|FG000|Overall Study|Inclusion/exclusion|0|||
129024379|NCT01535222|464381271|FG001|Overall Study|Inclusion/exclusion|0|||
129024380|NCT01535222|464381272|FG002|Overall Study|Inclusion/exclusion|1|||
129024381|NCT01535222|464381273|FG003|Overall Study|Inclusion/exclusion|0|||
129024382|NCT01535222|464381274|FG004|Overall Study|Inclusion/exclusion|0|||
129024383|NCT01535222|464381275|FG005|Overall Study|Inclusion/exclusion|0|||
129024384|NCT00935012|464381276|FG000|Overall Study|Death|19|||
129024385|NCT00935012|464381276|FG000|Overall Study|Withdrawal by Subject|3|||
129024386|NCT00935012|464381276|FG000|Overall Study|Other|5|||
129024387|NCT00935012|464381276|FG000|Overall Study|Adverse Event|2|||
129024388|NCT01442155|464381277|FG000|Overall Study|Complete remission|35|||
129024389|NCT01442155|464381277|FG000|Overall Study|Recurrence|26|||
129024390|NCT01442155|464381277|FG000|Overall Study|Adverse Event|2|||
129024391|NCT01442155|464381277|FG000|Overall Study|Lost to Follow-up|2|||
129024392|NCT00705666|464381278|FG000|Overall Study|No post-treatment questionnaire|279|||
128693415|NCT01811225|463176286|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
128901354|NCT02182687|463932657|FG001|Overall Study|Withdrawal by Subject|0|||
128901355|NCT02182687|463932656|FG000|Overall Study|Adverse Event|1|||
128901356|NCT02182687|463932657|FG001|Overall Study|Adverse Event|0|||
128901357|NCT02182687|463932656|FG000|Overall Study|Lost to Follow-up|0|||
128901358|NCT02182687|463932657|FG001|Overall Study|Lost to Follow-up|1|||
128901359|NCT02184195|463932660|FG000|Overall Study|Patient decision|5|||
128901360|NCT02184195|463932661|FG001|Overall Study|Patient decision|2|||
128901361|NCT02184195|463932660|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128901362|NCT02184195|463932661|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
128901363|NCT02184195|463932660|FG000|Overall Study|Death|67|||
128901364|NCT02184195|463932661|FG001|Overall Study|Death|44|||
128901365|NCT02184195|463932660|FG000|Overall Study|Lost to Follow-up|1|||
128901366|NCT02184195|463932661|FG001|Overall Study|Lost to Follow-up|5|||
128901367|NCT02184195|463932660|FG000|Overall Study|Other|0|||
128901368|NCT02184195|463932661|FG001|Overall Study|Other|3|||
128901369|NCT00939783|463932664|FG000|Overall Study|Death|6|||
128901370|NCT00939783|463932664|FG000|Overall Study|Adverse Event|39|||
128901371|NCT00939783|463932664|FG000|Overall Study|Study Terminated by Sponsor|498|||
128901372|NCT00939783|463932664|FG000|Overall Study|Withdrawal by Subject|78|||
128901373|NCT00939783|463932664|FG000|Overall Study|Other|16|||
128901374|NCT00939783|463932664|FG000|Overall Study|Lost to Follow-up|8|||
128901375|NCT00939783|463932664|FG000|Overall Study|Protocol Violation|3|||
128901376|NCT00939783|463932664|FG000|Overall Study|Enrolled but not treated|1|||
128901377|NCT02255409|463932671|FG000|Overall Study|Administrative Reason|3|||
128901378|NCT02255409|463932672|FG001|Overall Study|Administrative Reason|7|||
128901379|NCT02255409|463932671|FG000|Overall Study|Withdrawal by Subject|1|||
128901380|NCT02255409|463932672|FG001|Overall Study|Withdrawal by Subject|5|||
128901381|NCT02255409|463932671|FG000|Overall Study|Lost to Follow-up|10|||
128901382|NCT02255409|463932672|FG001|Overall Study|Lost to Follow-up|19|||
128901383|NCT01251367|463932673|FG000|Overall Study|Protocol Violation|1|||
128901384|NCT01251367|463932673|FG000|Overall Study|Lack of Efficacy|2|||
128901385|NCT01251367|463932673|FG000|Overall Study|Adverse Event|19|||
128901386|NCT01251367|463932673|FG000|Overall Study|Withdrawal by Subject|36|||
128901387|NCT01251367|463932673|FG000|Overall Study|Lost to Follow-up|5|||
128901388|NCT01251367|463932673|FG000|Overall Study|Subject Required Alternative Treatment|7|||
128901389|NCT01251367|463932673|FG000|Overall Study|No Study Drug Available|1|||
128901390|NCT01251367|463932673|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
128901391|NCT01251367|463932673|FG000|Overall Study|End of Study Visit Performed in Error|1|||
128901392|NCT02016820|463932676|FG000|Overall Study|Lost to Follow-up|2|||
128901393|NCT02016820|463932677|FG001|Overall Study|Lost to Follow-up|4|||
128901394|NCT01227044|463932678|FG000|Overall Study|Lost to Follow-up|5|||
128901395|NCT01227044|463932679|FG001|Overall Study|Lost to Follow-up|7|||
128901396|NCT01227044|463932678|FG000|Overall Study|Discontinued Intervention|1|||
129024393|NCT00705666|464381278|FG000|Overall Study|Withdrawal by Subject|21|||
129024394|NCT00705666|464381278|FG000|Overall Study|Physician Decision|7|||
129024395|NCT00705666|464381278|FG000|Overall Study|Lost to Follow-up|5|||
129024396|NCT00705666|464381278|FG000|Overall Study|Death|1|||
129024397|NCT00705666|464381278|FG000|Overall Study|Adverse Event|4|||
129024398|NCT00705666|464381278|FG000|Overall Study|Other|12|||
129024399|NCT00705666|464381278|FG000|Overall Study|Other|2|||
129024400|NCT00705666|464381278|FG000|Overall Study|Lack of data|3|||
129024401|NCT00705666|464381278|FG000|Overall Study|Untreated|5|||
129024402|NCT01590563|464381287|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
129024403|NCT03256695|464381288|FG000|Overall Study|Adverse Event|8|||
129024404|NCT03256695|464381288|FG000|Overall Study|Death|2|||
129024405|NCT03256695|464381288|FG000|Overall Study|Withdrawal by Subject|14|||
129024406|NCT03256695|464381288|FG000|Overall Study|Non-compliance with study drug|1|||
129024407|NCT03256695|464381288|FG000|Overall Study|Lost to Follow-up|3|||
129024408|NCT03256695|464381288|FG000|Overall Study|Lack of Efficacy|3|||
129024409|NCT03256695|464381288|FG000|Overall Study|Protocol Violation|5|||
129024410|NCT03256695|464381288|FG000|Overall Study|Other than specified|3|||
129024411|NCT03930732|464381289|FG000|Overall Study|Adverse Event|9|||
129024412|NCT03930732|464381290|FG001|Overall Study|Adverse Event|7|||
128901397|NCT01227044|463932679|FG001|Overall Study|Discontinued Intervention|2|||
128901398|NCT00583362|463932680|FG000|Overall Study|Adverse Event|44|||
128901399|NCT00583362|463932680|FG000|Overall Study|Lack of Efficacy|22|||
129024413|NCT03930732|464381289|FG000|Overall Study|Poor compliance to protocol|0|||
129113627|NCT05616013|464711509|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
128901400|NCT00583362|463932680|FG000|Overall Study|Lost to Follow-up|4|||
128901401|NCT00583362|463932680|FG000|Overall Study|Non-compliance with study drug|28|||
128901402|NCT00583362|463932680|FG000|Overall Study|Pregnancy|7|||
128901403|NCT00583362|463932680|FG000|Overall Study|Miscommunication of visit window|5|||
128901404|NCT00583362|463932680|FG000|Overall Study|Current site closed|7|||
129024414|NCT03930732|464381290|FG001|Overall Study|Poor compliance to protocol|1|||
129024415|NCT03930732|464381289|FG000|Overall Study|Withdrawal by Subject|23|||
129024416|NCT03930732|464381290|FG001|Overall Study|Withdrawal by Subject|11|||
129024417|NCT03930732|464381289|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
128901405|NCT00583362|463932680|FG000|Overall Study|Subject not dosed in LBSL99|1|||
128901406|NCT00583362|463932680|FG000|Overall Study|Subject moved out of the country/state|2|||
128901407|NCT00583362|463932680|FG000|Overall Study|Missed visits due to staff changes|1|||
128901408|NCT00583362|463932680|FG000|Overall Study|Misunderstanding of protocol|1|||
128901409|NCT00583362|463932680|FG000|Overall Study|Behavioral problems and non-compliance|1|||
128901410|NCT00583362|463932680|FG000|Overall Study|Sponsor request due to missed doses|1|||
128901411|NCT00583362|463932680|FG000|Overall Study|Physician Decision|19|||
128901412|NCT00583362|463932680|FG000|Overall Study|Protocol Violation|2|||
128901413|NCT00583362|463932680|FG000|Overall Study|Withdrawal by Subject|57|||
128901414|NCT00473343|463932681|FG000|Overall Study|Adverse Event|9|||
128901415|NCT00473343|463932681|FG000|Overall Study|Lost to Follow-up|8|||
128901416|NCT00473343|463932681|FG000|Overall Study|Treatment failure|27|||
128901417|NCT00473343|463932681|FG000|Overall Study|Withdrew consent|3|||
128901418|NCT00473343|463932681|FG000|Overall Study|Other un-specified reason|3|||
128901419|NCT04247061|463932682|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
128901420|NCT04247061|463932682|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
128901421|NCT04247061|463932682|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
128901422|NCT03099187|463932688|FG000|Double-blind Treatment|Adverse Event|19|||
128901423|NCT03099187|463932689|FG001|Double-blind Treatment|Adverse Event|1|||
128901424|NCT03099187|463932690|FG002|Double-blind Treatment|Adverse Event|0|||
128901425|NCT03099187|463932691|FG003|Double-blind Treatment|Adverse Event|0|||
128901426|NCT03099187|463932688|FG000|Double-blind Treatment|Death|1|||
128901427|NCT03099187|463932689|FG001|Double-blind Treatment|Death|3|||
128901428|NCT03099187|463932690|FG002|Double-blind Treatment|Death|0|||
128901429|NCT03099187|463932691|FG003|Double-blind Treatment|Death|0|||
128901430|NCT03099187|463932688|FG000|Double-blind Treatment|Lack of Efficacy|1|||
128901431|NCT03099187|463932689|FG001|Double-blind Treatment|Lack of Efficacy|0|||
128901432|NCT03099187|463932690|FG002|Double-blind Treatment|Lack of Efficacy|0|||
128901433|NCT03099187|463932691|FG003|Double-blind Treatment|Lack of Efficacy|0|||
128901434|NCT03099187|463932688|FG000|Double-blind Treatment|Physician Decision|2|||
128901435|NCT03099187|463932689|FG001|Double-blind Treatment|Physician Decision|1|||
128901436|NCT03099187|463932690|FG002|Double-blind Treatment|Physician Decision|0|||
128901437|NCT03099187|463932691|FG003|Double-blind Treatment|Physician Decision|0|||
128901438|NCT03099187|463932688|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
128901439|NCT03099187|463932689|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
128901440|NCT03099187|463932690|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
128901441|NCT03099187|463932691|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
128901442|NCT03099187|463932688|FG000|Double-blind Treatment|Lung transplantation|0|||
128901443|NCT03099187|463932689|FG001|Double-blind Treatment|Lung transplantation|1|||
128901444|NCT03099187|463932690|FG002|Double-blind Treatment|Lung transplantation|0|||
128901445|NCT03099187|463932691|FG003|Double-blind Treatment|Lung transplantation|0|||
128901446|NCT03099187|463932688|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
128901447|NCT03099187|463932689|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
128901448|NCT03099187|463932690|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
128901449|NCT03099187|463932691|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
128901450|NCT03099187|463932688|FG000|Double-blind Treatment|Disease progression|0|||
128901451|NCT03099187|463932689|FG001|Double-blind Treatment|Disease progression|1|||
128901452|NCT03099187|463932690|FG002|Double-blind Treatment|Disease progression|0|||
128901453|NCT03099187|463932691|FG003|Double-blind Treatment|Disease progression|0|||
128901454|NCT03099187|463932688|FG000|Double-blind Treatment|Randomization error|0|||
128901455|NCT03099187|463932689|FG001|Double-blind Treatment|Randomization error|2|||
128901456|NCT03099187|463932690|FG002|Double-blind Treatment|Randomization error|0|||
128901457|NCT03099187|463932691|FG003|Double-blind Treatment|Randomization error|0|||
128901458|NCT03099187|463932688|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
128901459|NCT03099187|463932689|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
128901460|NCT03099187|463932690|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
128901461|NCT03099187|463932691|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
128901462|NCT03099187|463932688|FG000|12-month Safety Follow-up|Adverse Event|0|||
128901463|NCT03099187|463932689|FG001|12-month Safety Follow-up|Adverse Event|0|||
128901464|NCT03099187|463932690|FG002|12-month Safety Follow-up|Adverse Event|5|||
128901465|NCT03099187|463932691|FG003|12-month Safety Follow-up|Adverse Event|12|||
128901466|NCT03099187|463932688|FG000|12-month Safety Follow-up|Death|0|||
128901467|NCT03099187|463932689|FG001|12-month Safety Follow-up|Death|0|||
128901468|NCT03099187|463932690|FG002|12-month Safety Follow-up|Death|7|||
128901469|NCT03099187|463932691|FG003|12-month Safety Follow-up|Death|9|||
128901470|NCT03099187|463932688|FG000|12-month Safety Follow-up|Lung transplantation|0|||
128901471|NCT03099187|463932689|FG001|12-month Safety Follow-up|Lung transplantation|0|||
128901472|NCT03099187|463932690|FG002|12-month Safety Follow-up|Lung transplantation|2|||
128901473|NCT03099187|463932691|FG003|12-month Safety Follow-up|Lung transplantation|1|||
128901474|NCT03099187|463932688|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
128901475|NCT03099187|463932689|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
128693416|NCT02158975|463176287|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
128693417|NCT03000569|463176288|FG000|Overall Study|Withdrawal by Subject|1|||
128693418|NCT03000569|463176289|FG001|Overall Study|Withdrawal by Subject|0|||
128693419|NCT04122534|463176290|FG000|Overall Study|Lost to Follow-up|4|||
128693420|NCT01254630|463176294|FG000|Overall Study|Adverse Event|36|||
128693421|NCT01254630|463176295|FG001|Overall Study|Adverse Event|15|||
128693422|NCT01254630|463176296|FG002|Overall Study|Adverse Event|40|||
128693423|NCT01254630|463176297|FG003|Overall Study|Adverse Event|8|||
128693424|NCT01254630|463176294|FG000|Overall Study|Death|461|||
128693425|NCT01254630|463176295|FG001|Overall Study|Death|151|||
128693426|NCT01254630|463176296|FG002|Overall Study|Death|478|||
128693427|NCT01254630|463176297|FG003|Overall Study|Death|139|||
128693428|NCT01254630|463176294|FG000|Overall Study|Lost to Follow-up|80|||
128693429|NCT01254630|463176295|FG001|Overall Study|Lost to Follow-up|26|||
128693430|NCT01254630|463176296|FG002|Overall Study|Lost to Follow-up|89|||
128693431|NCT01254630|463176297|FG003|Overall Study|Lost to Follow-up|32|||
128693432|NCT01254630|463176294|FG000|Overall Study|Physician Decision|24|||
128693433|NCT01254630|463176295|FG001|Overall Study|Physician Decision|8|||
128693434|NCT01254630|463176296|FG002|Overall Study|Physician Decision|16|||
128901476|NCT03099187|463932690|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
128693435|NCT01254630|463176297|FG003|Overall Study|Physician Decision|7|||
128693436|NCT01254630|463176294|FG000|Overall Study|Withdrawal by Subject|201|||
128693437|NCT01254630|463176295|FG001|Overall Study|Withdrawal by Subject|94|||
128693438|NCT01254630|463176296|FG002|Overall Study|Withdrawal by Subject|188|||
128693439|NCT01254630|463176297|FG003|Overall Study|Withdrawal by Subject|89|||
128693440|NCT01254630|463176294|FG000|Overall Study|Study terminated by sponsor|0|||
128693441|NCT01254630|463176295|FG001|Overall Study|Study terminated by sponsor|994|||
128693442|NCT01254630|463176296|FG002|Overall Study|Study terminated by sponsor|0|||
128693443|NCT01254630|463176297|FG003|Overall Study|Study terminated by sponsor|1010|||
128693444|NCT01254630|463176294|FG000|Overall Study|Status not recorded|0|||
128693445|NCT01254630|463176295|FG001|Overall Study|Status not recorded|0|||
128693446|NCT01254630|463176296|FG002|Overall Study|Status not recorded|1|||
128693447|NCT01254630|463176297|FG003|Overall Study|Status not recorded|0|||
128693448|NCT01863953|463177700|FG000|Overall Study|Adverse Event|0|||
128693449|NCT01863953|463177701|FG001|Overall Study|Adverse Event|0|||
128693450|NCT01863953|463177702|FG002|Overall Study|Adverse Event|1|||
128693451|NCT01626456|463177708|FG000|Overall Study|Withdrawal by Subject|21|||
128693452|NCT01626456|463177709|FG001|Overall Study|Withdrawal by Subject|46|||
128693453|NCT01626456|463177708|FG000|Overall Study|Adverse Event|2|||
128693454|NCT01626456|463177709|FG001|Overall Study|Adverse Event|27|||
128693455|NCT01626456|463177708|FG000|Overall Study|Lost to Follow-up|2|||
128693456|NCT01626456|463177709|FG001|Overall Study|Lost to Follow-up|27|||
128693457|NCT01626456|463177708|FG000|Overall Study|Lack of Efficacy|6|||
128693458|NCT01626456|463177709|FG001|Overall Study|Lack of Efficacy|7|||
128693459|NCT01626456|463177708|FG000|Overall Study|Physician Decision|1|||
128901477|NCT03099187|463932691|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
128901478|NCT03099187|463932688|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
128901479|NCT03099187|463932689|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
128901480|NCT03099187|463932690|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
128901481|NCT03099187|463932691|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
128901482|NCT03099187|463932688|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
128901483|NCT03099187|463932689|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
128901484|NCT03099187|463932690|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
128901485|NCT03099187|463932691|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
128901486|NCT03099187|463932688|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
128901487|NCT03099187|463932689|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
128901488|NCT03099187|463932690|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
128901489|NCT03099187|463932691|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
128901490|NCT01439555|463932692|FG000|Overall Study|Protocol Violation|1|||
128901491|NCT01246583|463932693|FG000|Overall Study|Lost to Follow-up|0|||
128901492|NCT01246583|463932694|FG001|Overall Study|Lost to Follow-up|0|||
128901493|NCT01246583|463932695|FG002|Overall Study|Lost to Follow-up|0|||
128901494|NCT01246583|463932696|FG003|Overall Study|Lost to Follow-up|1|||
128901495|NCT01246583|463932693|FG000|Overall Study|Protocol Violation|0|||
128901496|NCT01246583|463932694|FG001|Overall Study|Protocol Violation|0|||
128693460|NCT01626456|463177709|FG001|Overall Study|Physician Decision|4|||
128693461|NCT01626456|463177708|FG000|Overall Study|Protocol Violation|1|||
128693462|NCT01626456|463177709|FG001|Overall Study|Protocol Violation|1|||
128901497|NCT01246583|463932695|FG002|Overall Study|Protocol Violation|1|||
128693463|NCT01626456|463177708|FG000|Overall Study|Site Closure|2|||
128901498|NCT01246583|463932696|FG003|Overall Study|Protocol Violation|0|||
129215244|NCT02017405|465089473|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
128693464|NCT01626456|463177709|FG001|Overall Study|Site Closure|3|||
128693465|NCT01626456|463177708|FG000|Overall Study|Incarceration|0|||
128693466|NCT01626456|463177709|FG001|Overall Study|Incarceration|2|||
128693467|NCT04015336|463177710|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
128901499|NCT01246583|463932693|FG000|Overall Study|Withdrawal by Subject|1|||
128901500|NCT01246583|463932694|FG001|Overall Study|Withdrawal by Subject|0|||
128901501|NCT01246583|463932695|FG002|Overall Study|Withdrawal by Subject|0|||
128901502|NCT01246583|463932696|FG003|Overall Study|Withdrawal by Subject|0|||
128901503|NCT00102960|463932698|FG000|Overall Study|Death|23|||
128901504|NCT00102960|463932699|FG001|Overall Study|Death|11|||
128901505|NCT00102960|463932700|FG002|Overall Study|Death|11|||
128901506|NCT00102960|463932698|FG000|Overall Study|Lost to Follow-up|6|||
128901507|NCT00102960|463932699|FG001|Overall Study|Lost to Follow-up|12|||
128901508|NCT00102960|463932700|FG002|Overall Study|Lost to Follow-up|16|||
128901509|NCT00102960|463932698|FG000|Overall Study|Withdrawal by Subject|1|||
128901510|NCT00102960|463932699|FG001|Overall Study|Withdrawal by Subject|0|||
128901511|NCT00102960|463932700|FG002|Overall Study|Withdrawal by Subject|1|||
128977894|NCT00699582|464205245|FG001|Overall Study|Withdrawal by Subject|7|||
128977895|NCT00699582|464205246|FG002|Overall Study|Withdrawal by Subject|4|||
128977896|NCT00699582|464205244|FG000|Overall Study|Lack of Efficacy|1|||
128977897|NCT00699582|464205245|FG001|Overall Study|Lack of Efficacy|0|||
128977898|NCT00699582|464205246|FG002|Overall Study|Lack of Efficacy|1|||
128977899|NCT00699582|464205244|FG000|Overall Study|Progressive Disease|1|||
128977900|NCT00699582|464205245|FG001|Overall Study|Progressive Disease|0|||
128977901|NCT00699582|464205246|FG002|Overall Study|Progressive Disease|0|||
128977902|NCT00699582|464205244|FG000|Overall Study|Administrative/Other|4|||
128977903|NCT00699582|464205245|FG001|Overall Study|Administrative/Other|3|||
128977904|NCT00699582|464205246|FG002|Overall Study|Administrative/Other|0|||
128977905|NCT00699582|464205244|FG000|Overall Study|Randomized, Not Treated|2|||
128977906|NCT00699582|464205245|FG001|Overall Study|Randomized, Not Treated|1|||
128977907|NCT00699582|464205246|FG002|Overall Study|Randomized, Not Treated|0|||
128977908|NCT01646255|464205249|FG000|Overall Study|Adverse Event|7|||
128977909|NCT01646255|464205250|FG001|Overall Study|Adverse Event|8|||
128977910|NCT01646255|464205249|FG000|Overall Study|Lack of Efficacy|2|||
128977911|NCT01646255|464205250|FG001|Overall Study|Lack of Efficacy|0|||
128977912|NCT01646255|464205249|FG000|Overall Study|Withdrawal by Subject|10|||
128977913|NCT01646255|464205250|FG001|Overall Study|Withdrawal by Subject|6|||
128977914|NCT01646255|464205249|FG000|Overall Study|Compliance is not well|1|||
128977915|NCT01646255|464205250|FG001|Overall Study|Compliance is not well|0|||
128977916|NCT01646255|464205249|FG000|Overall Study|Inclusion Criteria Deviation|1|||
128977917|NCT01646255|464205250|FG001|Overall Study|Inclusion Criteria Deviation|0|||
128977918|NCT00266695|464205253|FG000|Overall Study|Adverse Event|1|||
128977919|NCT00266695|464205253|FG000|Overall Study|Death|9|||
128977920|NCT00266695|464205253|FG000|Overall Study|Physician Decision|1|||
128977921|NCT00266695|464205253|FG000|Overall Study|Lost to Follow-up|3|||
128977922|NCT00266695|464205253|FG000|Overall Study|Withdrawal by Subject|15|||
128977923|NCT02380703|464205254|FG000|Overall Study|Withdrawal by Subject|12|||
128977924|NCT02380703|464205255|FG001|Overall Study|Withdrawal by Subject|9|||
128977925|NCT02380703|464205254|FG000|Overall Study|Lost to Follow-up|12|||
128977926|NCT02380703|464205255|FG001|Overall Study|Lost to Follow-up|12|||
128977927|NCT02380703|464205254|FG000|Overall Study|Caregiver death|1|||
128977928|NCT02380703|464205255|FG001|Overall Study|Caregiver death|0|||
128977929|NCT02380703|464205254|FG000|Overall Study|Person with dementia (PWD) death|7|||
128977930|NCT02380703|464205255|FG001|Overall Study|Person with dementia (PWD) death|8|||
128977931|NCT02380703|464205254|FG000|Overall Study|Entered Long-term Care|4|||
128977932|NCT02380703|464205255|FG001|Overall Study|Entered Long-term Care|7|||
128977933|NCT03480841|464205256|FG000|Overall Study|Lost to Follow-up|2|||
128977934|NCT01362049|464205257|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
128977935|NCT01362049|464205258|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
128977936|NCT01362049|464205259|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
128977937|NCT01362049|464205260|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
128977938|NCT01362049|464205257|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
128977939|NCT01362049|464205258|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
128977940|NCT01362049|464205259|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
128977941|NCT01362049|464205260|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
128977942|NCT03607994|464205261|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
128977943|NCT03607994|464205262|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
128977944|NCT02417935|464205265|FG000|Treatment Period|Adverse Event|12|||
128977945|NCT02417935|464205266|FG001|Treatment Period|Adverse Event|10|||
128977946|NCT02417935|464205265|FG000|Treatment Period|Lost to Follow-up|1|||
128977947|NCT02417935|464205266|FG001|Treatment Period|Lost to Follow-up|0|||
128977948|NCT02417935|464205265|FG000|Treatment Period|Entry Criteria not met|0|||
128977949|NCT02417935|464205266|FG001|Treatment Period|Entry Criteria not met|1|||
128977950|NCT02417935|464205265|FG000|Treatment Period|Protocol Violation|2|||
128977951|NCT02417935|464205266|FG001|Treatment Period|Protocol Violation|1|||
128977952|NCT02417935|464205265|FG000|Treatment Period|Withdrawal by Subject|3|||
128977953|NCT02417935|464205266|FG001|Treatment Period|Withdrawal by Subject|3|||
128977954|NCT02417935|464205265|FG000|Treatment Period|Physician Decision|3|||
128977955|NCT02417935|464205266|FG001|Treatment Period|Physician Decision|1|||
128977956|NCT02850276|464205269|FG000|Overall Study|screen failure|43|||
128901512|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
128901513|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
128901514|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
128901515|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
128901516|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
128901517|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
128901518|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
128901519|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
128901520|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
128901521|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
128901522|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
128901523|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
128901524|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
128901525|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
128901526|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
128901527|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
128901528|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
128901529|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
128901530|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
128901531|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
128901532|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
128901533|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
128901534|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
128901535|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
128901536|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
128901537|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
128901538|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
128901539|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
128901540|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
128901541|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
128901542|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
128901543|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
128901544|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
128901545|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
128901546|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
128901547|NCT02831673|463934571|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
128901548|NCT02831673|463934572|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
128901549|NCT02831673|463934573|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
128901550|NCT02831673|463934574|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
128901551|NCT02831673|463934575|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
128901552|NCT02831673|463934571|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
128901553|NCT02831673|463934572|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
128901554|NCT02831673|463934573|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
128901555|NCT02831673|463934574|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
128901556|NCT02831673|463934575|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
128901557|NCT02831673|463934571|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
128901558|NCT02831673|463934572|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
128901559|NCT02831673|463934573|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
128901560|NCT02831673|463934574|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
128901561|NCT02831673|463934575|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
128901562|NCT02831673|463934571|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
128901563|NCT02831673|463934572|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
128901564|NCT02831673|463934573|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
128901565|NCT02831673|463934574|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
128901566|NCT02831673|463934575|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
128901567|NCT02831673|463934571|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
128901568|NCT02831673|463934572|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
128901569|NCT02831673|463934573|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
128901570|NCT02831673|463934574|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
128901571|NCT02831673|463934575|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
129024418|NCT03930732|464381290|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
129024419|NCT03930732|464381289|FG000|Overall Study|Other reason not related to COVID-19|5|||
129024420|NCT03930732|464381290|FG001|Overall Study|Other reason not related to COVID-19|8|||
129024421|NCT03406156|464381291|FG000|Overall Study|Death|9|||
129024422|NCT03406156|464381292|FG001|Overall Study|Death|3|||
128693468|NCT01868503|463177714|FG000|Overall Study|Withdrawal by Subject|1|||
128693469|NCT01868503|463177714|FG000|Overall Study|Protocol Violation|1|||
128693470|NCT03650556|463177715|FG000|Overall Study|Death|2|||
128693471|NCT03650556|463177715|FG000|Overall Study|Withdrawal by Subject|20|||
128693472|NCT03650556|463177715|FG000|Overall Study|Physician Decision|2|||
128693473|NCT03650556|463177715|FG000|Overall Study|Lost to Follow-up|8|||
128693474|NCT03650556|463177715|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
128693475|NCT03650556|463177715|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
128693476|NCT00697788|463177718|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
128693477|NCT00697788|463177719|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
128693478|NCT00697788|463177720|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
128693479|NCT00697788|463177721|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
128693480|NCT00697788|463177722|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
128693481|NCT00697788|463177723|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
128693482|NCT00697788|463177724|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
128693483|NCT00697788|463177725|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
128693484|NCT00697788|463177718|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
128693485|NCT00697788|463177719|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
128693486|NCT00697788|463177720|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
128693487|NCT00697788|463177721|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
128901572|NCT02831673|463934571|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
128901573|NCT02831673|463934572|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
128901574|NCT02831673|463934573|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
128901575|NCT02831673|463934574|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
128901576|NCT02831673|463934575|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
128901577|NCT02831673|463934571|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
128901578|NCT02831673|463934572|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
128901579|NCT02831673|463934573|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
128901580|NCT02831673|463934574|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
128901581|NCT02831673|463934575|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
128901582|NCT02831673|463934571|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
128901583|NCT02831673|463934572|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
128901584|NCT02831673|463934573|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
128901585|NCT02831673|463934574|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
128901586|NCT02831673|463934575|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
128901587|NCT02831673|463934571|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
128901588|NCT02831673|463934572|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
128901589|NCT02831673|463934573|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
128901590|NCT02831673|463934574|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
128901591|NCT02831673|463934575|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
128901592|NCT02831673|463934571|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
128901593|NCT02831673|463934572|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
128901594|NCT02831673|463934573|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
128901595|NCT02831673|463934574|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
128901596|NCT02831673|463934575|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
128693488|NCT00697788|463177722|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
128693489|NCT00697788|463177723|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
128693490|NCT00697788|463177724|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
128693491|NCT00697788|463177725|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
128693492|NCT00075218|463177733|FG000|Double-Blind Treatment|Adverse Event|23|||
128764676|NCT03505476|463430259|FG000|Overall Study|Device application insufficiant|3|||
128764677|NCT03075904|463430260|FG000|Overall Study|Physician Decision|3|||
128764678|NCT03075904|463430260|FG000|Overall Study|Need for Medication not Permitted|1|||
128764679|NCT00539643|463430261|FG000|Overall Study|Adverse Event|1|||
128764680|NCT00539643|463430262|FG001|Overall Study|Adverse Event|0|||
128901597|NCT02831673|463934571|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
128901598|NCT02831673|463934572|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
128901599|NCT02831673|463934573|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129024423|NCT03406156|464381291|FG000|Overall Study|Withdrawal by Subject|1|||
129024424|NCT03406156|464381292|FG001|Overall Study|Withdrawal by Subject|2|||
129024425|NCT03406156|464381291|FG000|Overall Study|COVID-19 infection|1|||
129024426|NCT03406156|464381292|FG001|Overall Study|COVID-19 infection|0|||
129024427|NCT03406156|464381291|FG000|Overall Study|Non-compliance with study procedures|1|||
129024428|NCT03406156|464381292|FG001|Overall Study|Non-compliance with study procedures|1|||
129024429|NCT03406156|464381291|FG000|Overall Study|Lost to Follow-up|0|||
129024430|NCT03406156|464381292|FG001|Overall Study|Lost to Follow-up|2|||
128693493|NCT00075218|463177734|FG001|Double-Blind Treatment|Adverse Event|4|||
128901600|NCT02831673|463934574|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
128901601|NCT02831673|463934575|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
128901602|NCT02831673|463934571|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
128901603|NCT02831673|463934572|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
128901604|NCT02831673|463934573|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
128901605|NCT02831673|463934574|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
128901606|NCT02831673|463934575|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
128901607|NCT02831673|463934571|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
128901608|NCT02831673|463934572|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
128901609|NCT02831673|463934573|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
128901610|NCT02831673|463934574|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
128901611|NCT02831673|463934575|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
128901612|NCT02646982|463934576|FG000|Overall Study|Adverse Event|1|||
128901613|NCT02646982|463934577|FG001|Overall Study|Adverse Event|1|||
128901614|NCT02646982|463934576|FG000|Overall Study|Withdrawal by Subject|2|||
129113628|NCT05616013|464711510|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129113629|NCT05616013|464711511|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129113630|NCT05616013|464711512|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129113631|NCT05616013|464711513|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129113632|NCT05616013|464711505|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113633|NCT05616013|464711506|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113634|NCT05616013|464711507|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113635|NCT05616013|464711508|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113636|NCT05616013|464711509|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113637|NCT05616013|464711510|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113638|NCT05616013|464711511|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
129113639|NCT05616013|464711512|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113640|NCT05616013|464711513|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129113641|NCT05616013|464711505|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128901615|NCT02646982|463934577|FG001|Overall Study|Withdrawal by Subject|1|||
128901616|NCT00713700|463934578|FG000|Overall Study|Lost to Follow-up|3|||
128901617|NCT00713700|463934578|FG000|Overall Study|Withdrawal by Subject|1|||
128901618|NCT03923426|463934580|FG000|Overall Study|Other|19|||
128901619|NCT03923426|463934580|FG000|Overall Study|Lost to Follow-up|16|||
128901620|NCT03923426|463934580|FG000|Overall Study|Death|107|||
128901621|NCT03923426|463934580|FG000|Overall Study|Incomplete response to question|13|||
128901622|NCT00769002|463934581|FG000|Overall Study|Study was not completed, no data|9|||
128901623|NCT00769002|463934582|FG001|Overall Study|Study was not completed, no data|9|||
128901624|NCT00847912|463934592|FG000|Overall Study|Protocol Violation|6|||
128901625|NCT00847912|463934593|FG001|Overall Study|Protocol Violation|7|||
128901626|NCT00847912|463934592|FG000|Overall Study|Withdrawal by Subject|3|||
128901627|NCT00847912|463934593|FG001|Overall Study|Withdrawal by Subject|6|||
128901628|NCT01732796|463934594|FG000|Overall Study|Adverse Event|16|||
128901629|NCT01732796|463934595|FG001|Overall Study|Adverse Event|16|||
128901630|NCT01732796|463934596|FG002|Overall Study|Adverse Event|4|||
128901631|NCT01732796|463934594|FG000|Overall Study|Lack of Efficacy|21|||
128901632|NCT01732796|463934595|FG001|Overall Study|Lack of Efficacy|18|||
128901633|NCT01732796|463934596|FG002|Overall Study|Lack of Efficacy|5|||
128901634|NCT01732796|463934594|FG000|Overall Study|Lost to Follow-up|2|||
128901635|NCT01732796|463934595|FG001|Overall Study|Lost to Follow-up|0|||
128901636|NCT01732796|463934596|FG002|Overall Study|Lost to Follow-up|0|||
128901637|NCT01732796|463934594|FG000|Overall Study|Withdrawal by Subject|6|||
128901638|NCT01732796|463934595|FG001|Overall Study|Withdrawal by Subject|8|||
128901639|NCT01732796|463934596|FG002|Overall Study|Withdrawal by Subject|2|||
128901640|NCT01732796|463934594|FG000|Overall Study|Other reason not defined above|1|||
128901641|NCT01732796|463934595|FG001|Overall Study|Other reason not defined above|0|||
128901642|NCT01732796|463934596|FG002|Overall Study|Other reason not defined above|2|||
128901643|NCT00838331|463934600|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
129024431|NCT03406156|464381291|FG000|Overall Study|Other, not specified|72|||
129024432|NCT03406156|464381292|FG001|Overall Study|Other, not specified|28|||
129024433|NCT03366792|464381295|FG000|Overall Study|Withdrawal by Subject|7|||
129024434|NCT03366792|464381295|FG000|Overall Study|Lost to Follow-up|2|||
129024435|NCT03366792|464381295|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
129024436|NCT03366792|464381295|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
129024437|NCT02450539|464381296|FG000|Overall Study|Withdrawal by Subject|12|||
129024438|NCT02450539|464381297|FG001|Overall Study|Withdrawal by Subject|6|||
129024439|NCT02450539|464381296|FG000|Overall Study|Lost to Follow-up|4|||
129024440|NCT02450539|464381297|FG001|Overall Study|Lost to Follow-up|1|||
129024441|NCT02699463|464381298|FG000|Overall Study|Lost to Follow-up|11|||
129113642|NCT05616013|464711506|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129113643|NCT05616013|464711507|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129113644|NCT05616013|464711508|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129113645|NCT05616013|464711509|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129113646|NCT05616013|464711510|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129113647|NCT05616013|464711511|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129113648|NCT05616013|464711512|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
128901644|NCT03972969|463934601|FG000|3-month Follow-up|Death|1|||
128901645|NCT03972969|463934602|FG001|3-month Follow-up|Death|1|||
128901646|NCT03972969|463934603|FG002|3-month Follow-up|Death|0|||
128901647|NCT03972969|463934601|FG000|6-month Follow-up|Death|1|||
128901648|NCT03972969|463934602|FG001|6-month Follow-up|Death|1|||
128901649|NCT03972969|463934603|FG002|6-month Follow-up|Death|1|||
128901650|NCT03972969|463934601|FG000|6-month Follow-up|Lost to Follow-up|2|||
128901651|NCT03972969|463934602|FG001|6-month Follow-up|Lost to Follow-up|2|||
128901652|NCT03972969|463934603|FG002|6-month Follow-up|Lost to Follow-up|2|||
128901653|NCT00264875|463934604|FG000|Overall Study|Adverse Event|6|||
128901654|NCT00264875|463934604|FG000|Overall Study|Lost to Follow-up|6|||
128901655|NCT00264875|463934604|FG000|Overall Study|Protocol Violation|11|||
128901656|NCT00264875|463934604|FG000|Overall Study|Withdrawal by Subject|7|||
129113649|NCT05616013|464711513|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
129113650|NCT05616013|464711505|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113651|NCT05616013|464711506|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113652|NCT05616013|464711507|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113653|NCT05616013|464711508|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113654|NCT05616013|464711509|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113655|NCT05616013|464711510|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113656|NCT05616013|464711511|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113657|NCT05616013|464711512|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
129113658|NCT05616013|464711513|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
129113659|NCT05116202|464711514|FG000|Overall Study|Study Terminated by Sponsor|21|||
129113660|NCT05116202|464711515|FG001|Overall Study|Study Terminated by Sponsor|38|||
129113661|NCT05116202|464711516|FG002|Overall Study|Study Terminated by Sponsor|17|||
129113662|NCT05116202|464711517|FG003|Overall Study|Study Terminated by Sponsor|18|||
129113663|NCT05116202|464711518|FG004|Overall Study|Study Terminated by Sponsor|0|||
129113664|NCT05116202|464711514|FG000|Overall Study|Withdrawal by Subject|0|||
129113665|NCT05116202|464711515|FG001|Overall Study|Withdrawal by Subject|1|||
129113666|NCT05116202|464711516|FG002|Overall Study|Withdrawal by Subject|1|||
129113667|NCT05116202|464711517|FG003|Overall Study|Withdrawal by Subject|1|||
129113668|NCT05116202|464711518|FG004|Overall Study|Withdrawal by Subject|1|||
129113669|NCT05116202|464711514|FG000|Overall Study|Lost to Follow-up|0|||
129113670|NCT05116202|464711515|FG001|Overall Study|Lost to Follow-up|0|||
129113671|NCT05116202|464711516|FG002|Overall Study|Lost to Follow-up|0|||
129113672|NCT05116202|464711517|FG003|Overall Study|Lost to Follow-up|0|||
129113673|NCT05116202|464711518|FG004|Overall Study|Lost to Follow-up|2|||
129113674|NCT05116202|464711514|FG000|Overall Study|Death|1|||
129113675|NCT05116202|464711515|FG001|Overall Study|Death|1|||
129113676|NCT05116202|464711516|FG002|Overall Study|Death|2|||
129113677|NCT05116202|464711517|FG003|Overall Study|Death|1|||
129113678|NCT05116202|464711518|FG004|Overall Study|Death|5|||
129113679|NCT03834506|464711519|FG000|Overall Study|Death|336|||
129113680|NCT03834506|464711520|FG001|Overall Study|Death|326|||
129113681|NCT03834506|464711519|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129113682|NCT03834506|464711520|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129113683|NCT03834506|464711519|FG000|Overall Study|Withdrawal by Subject|10|||
129113684|NCT03834506|464711520|FG001|Overall Study|Withdrawal by Subject|8|||
129113685|NCT03834506|464711519|FG000|Overall Study|Sponsor decision|165|||
129113686|NCT03834506|464711520|FG001|Overall Study|Sponsor decision|178|||
129113687|NCT03834506|464711519|FG000|Overall Study|Physician Decision|3|||
129113688|NCT03834506|464711520|FG001|Overall Study|Physician Decision|1|||
129113689|NCT03834506|464711519|FG000|Overall Study|Lost to Follow-up|0|||
129113690|NCT03834506|464711520|FG001|Overall Study|Lost to Follow-up|1|||
129113691|NCT05067972|464711521|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
129113692|NCT05067972|464711522|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
128693494|NCT00075218|463177735|FG002|Double-Blind Treatment|Adverse Event|0|||
128693495|NCT00075218|463177733|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
128693496|NCT00075218|463177734|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
128901657|NCT00732303|463934605|FG000|Overall Study|Study Terminated|2|||
128901658|NCT01074190|463934606|FG000|Overall Study|Emergency Cesarean Delivery|1|||
128901659|NCT01074190|463934607|FG001|Overall Study|Emergency Cesarean Delivery|2|||
129113693|NCT05067972|464711523|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
128901660|NCT01074190|463934608|FG002|Overall Study|Emergency Cesarean Delivery|1|||
128901661|NCT01074190|463934606|FG000|Overall Study|Protocol Violation|2|||
128901662|NCT01074190|463934607|FG001|Overall Study|Protocol Violation|1|||
129113694|NCT05067972|464711524|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
129113695|NCT05067972|464711525|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
129113696|NCT05067972|464711526|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
129113697|NCT05067972|464711527|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
128901663|NCT01074190|463934608|FG002|Overall Study|Protocol Violation|0|||
128901664|NCT01074190|463934606|FG000|Overall Study|Delivered in under 90 minutes|0|||
128901665|NCT01074190|463934607|FG001|Overall Study|Delivered in under 90 minutes|2|||
128901666|NCT01074190|463934608|FG002|Overall Study|Delivered in under 90 minutes|1|||
128901667|NCT01074190|463934606|FG000|Overall Study|Subject withdrew consent|1|||
128901668|NCT01074190|463934607|FG001|Overall Study|Subject withdrew consent|1|||
128901669|NCT01074190|463934608|FG002|Overall Study|Subject withdrew consent|1|||
128901670|NCT01500278|463934615|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
128901671|NCT01500278|463934616|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
129113698|NCT05067972|464711521|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
129113699|NCT05067972|464711522|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
128901672|NCT01500278|463934615|FG000|Week 0 - Week 12|Protocol Violation|10|||
128901673|NCT01500278|463934616|FG001|Week 0 - Week 12|Protocol Violation|16|||
128901674|NCT01500278|463934615|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
128901675|NCT01500278|463934616|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
128901676|NCT01500278|463934615|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
128901677|NCT01500278|463934616|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
128901678|NCT01500278|463934615|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
128901679|NCT01500278|463934616|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
129024442|NCT02699463|464381299|FG001|Overall Study|Lost to Follow-up|8|||
129024443|NCT02699463|464381298|FG000|Overall Study|Withdrawal by Subject|4|||
129024444|NCT02699463|464381299|FG001|Overall Study|Withdrawal by Subject|1|||
129024445|NCT00585286|464381302|FG000|Overall Study|Lost to Follow-up|1|||
129024446|NCT00918684|464381306|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
129024447|NCT00918684|464381306|FG000|Treatment Phase|Lack of Efficacy|6|||
129024448|NCT00918684|464381306|FG000|Treatment Phase|Lost to Follow-up|2|||
129024449|NCT00918684|464381306|FG000|Treatment Phase|Physician Decision|8|||
129024450|NCT00918684|464381306|FG000|Treatment Phase|Protocol Violation|1|||
129024451|NCT00918684|464381306|FG000|Treatment Phase|Withdrawal by Subject|8|||
129024452|NCT00909038|464381307|FG000|Overall Study|Protocol Violation|187|||
129024453|NCT00909038|464381307|FG000|Overall Study|Non-evaluable Subjects|230|||
129024454|NCT00484679|464381308|FG000|Overall Study|Withdrawal by Subject|3|||
129024455|NCT00402103|464381309|FG000|Overall Study|Adverse Event|60|||
129024456|NCT00402103|464381310|FG001|Overall Study|Adverse Event|7|||
129024457|NCT00402103|464381309|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129024458|NCT00402103|464381310|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129024459|NCT00402103|464381309|FG000|Overall Study|Condition no longer requires study drug|2|||
129024460|NCT00402103|464381310|FG001|Overall Study|Condition no longer requires study drug|0|||
129024461|NCT00402103|464381309|FG000|Overall Study|Protocol Deviation|8|||
129024462|NCT00402103|464381310|FG001|Overall Study|Protocol Deviation|0|||
129024463|NCT00402103|464381309|FG000|Overall Study|Patient withdrew consent|12|||
129024464|NCT00402103|464381310|FG001|Overall Study|Patient withdrew consent|1|||
129024465|NCT00402103|464381309|FG000|Overall Study|Lost to Follow-up|6|||
129024466|NCT00402103|464381310|FG001|Overall Study|Lost to Follow-up|3|||
129024467|NCT00402103|464381309|FG000|Overall Study|Administrative problems|2|||
129024468|NCT00402103|464381310|FG001|Overall Study|Administrative problems|0|||
129024469|NCT00835692|464381311|FG000|First Intervention|Withdrawal by Subject|1|||
129024470|NCT00835692|464381312|FG001|First Intervention|Withdrawal by Subject|0|||
129024471|NCT04345653|464381315|FG000|Overall Study|Withdrawal by Subject|2|||
129024472|NCT00418938|464381320|FG000|Overall Study|Reimbursement|1|||
129024473|NCT00418938|464381321|FG001|Overall Study|Reimbursement|0|||
129024474|NCT00418938|464381320|FG000|Overall Study|Administrative decision|3|||
129024475|NCT00418938|464381321|FG001|Overall Study|Administrative decision|3|||
129024476|NCT00418938|464381320|FG000|Overall Study|Withdrawal by Subject|16|||
129024477|NCT00418938|464381321|FG001|Overall Study|Withdrawal by Subject|15|||
129024478|NCT00418938|464381320|FG000|Overall Study|Lost to Follow-up|1|||
129024479|NCT00418938|464381321|FG001|Overall Study|Lost to Follow-up|3|||
129113700|NCT05067972|464711523|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
128901680|NCT01500278|463934615|FG000|Week 0 - Week 12|Patient decision|1|||
128901681|NCT01500278|463934616|FG001|Week 0 - Week 12|Patient decision|0|||
128901682|NCT01500278|463934615|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
128901683|NCT01500278|463934616|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
128901684|NCT01500278|463934615|FG000|Week 0 - Week 12|Investigator decision|1|||
129024480|NCT00418938|464381320|FG000|Overall Study|Adverse Event|1|||
129024481|NCT00418938|464381321|FG001|Overall Study|Adverse Event|1|||
129024482|NCT00418938|464381320|FG000|Overall Study|On-going|1|||
129024483|NCT00418938|464381321|FG001|Overall Study|On-going|1|||
128901685|NCT01500278|463934616|FG001|Week 0 - Week 12|Investigator decision|0|||
129024484|NCT00418938|464381320|FG000|Overall Study|Ineligibility Determined|1|||
128901686|NCT01500278|463934615|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
128901687|NCT01500278|463934616|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
129024485|NCT00418938|464381321|FG001|Overall Study|Ineligibility Determined|0|||
129024486|NCT01316055|464381329|FG000|Overall Study|Lost to Follow-up|1|||
129024487|NCT01316055|464381330|FG001|Overall Study|Lost to Follow-up|0|||
129024488|NCT01316055|464381331|FG002|Overall Study|Lost to Follow-up|0|||
129024489|NCT01348789|464381332|FG000|Overall Study|Protocol Violation|2|||
129024490|NCT01348789|464381332|FG000|Overall Study|Withdrawal by Subject|2|||
129024491|NCT01825798|464381339|FG000|Overall Study|Adverse Event|1|||
129024492|NCT01825798|464381340|FG001|Overall Study|Adverse Event|5|||
129024493|NCT01825798|464381339|FG000|Overall Study|Lost to Follow-up|1|||
129024494|NCT01825798|464381340|FG001|Overall Study|Lost to Follow-up|0|||
129024495|NCT00834873|464381341|FG000|First Intervention|Adverse Event|0|||
129024496|NCT00834873|464381342|FG001|First Intervention|Adverse Event|1|||
129024497|NCT02358538|464381345|FG000|Through Week 26|Adverse Event|0|||
129024498|NCT02358538|464381346|FG001|Through Week 26|Adverse Event|1|||
129024499|NCT02358538|464381347|FG002|Through Week 26|Adverse Event|1|||
129024500|NCT02358538|464381348|FG003|Through Week 26|Adverse Event|2|||
129024501|NCT02358538|464381345|FG000|Through Week 26|Lack of Efficacy|1|||
129024502|NCT02358538|464381346|FG001|Through Week 26|Lack of Efficacy|1|||
129024503|NCT02358538|464381347|FG002|Through Week 26|Lack of Efficacy|3|||
129024504|NCT02358538|464381348|FG003|Through Week 26|Lack of Efficacy|3|||
129024505|NCT02358538|464381345|FG000|Through Week 26|Withdrawal by Subject|1|||
129024506|NCT02358538|464381346|FG001|Through Week 26|Withdrawal by Subject|0|||
129024507|NCT02358538|464381347|FG002|Through Week 26|Withdrawal by Subject|0|||
129024508|NCT02358538|464381348|FG003|Through Week 26|Withdrawal by Subject|0|||
129024509|NCT02358538|464381345|FG000|Through Week 26|Non-Compliance|0|||
129024510|NCT02358538|464381346|FG001|Through Week 26|Non-Compliance|0|||
129024511|NCT02358538|464381347|FG002|Through Week 26|Non-Compliance|1|||
129024512|NCT02358538|464381348|FG003|Through Week 26|Non-Compliance|0|||
129024513|NCT02358538|464381345|FG000|Through Week 26|Family did not see benefit from IP|1|||
129024514|NCT02358538|464381346|FG001|Through Week 26|Family did not see benefit from IP|0|||
129024515|NCT02358538|464381347|FG002|Through Week 26|Family did not see benefit from IP|0|||
129024516|NCT02358538|464381348|FG003|Through Week 26|Family did not see benefit from IP|0|||
129024517|NCT02358538|464381345|FG000|52 Week Extension Period|Lack of Efficacy|0|||
129024518|NCT02358538|464381346|FG001|52 Week Extension Period|Lack of Efficacy|0|||
129024519|NCT02358538|464381347|FG002|52 Week Extension Period|Lack of Efficacy|2|||
129024520|NCT02358538|464381348|FG003|52 Week Extension Period|Lack of Efficacy|4|||
129024521|NCT04827394|464381352|FG000|Overall Study|Physician Decision|0|||
129024522|NCT04827394|464381353|FG001|Overall Study|Physician Decision|2|||
129024523|NCT03500094|464381354|FG000|Overall Study|Withdrawal by Subject|1|||
129024524|NCT03500094|464381354|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
129024525|NCT03500094|464381354|FG000|Overall Study|Lost to Follow-up|1|||
129024526|NCT01030133|464381355|FG000|Overall Study|failed to experience pain at level 7/10|2|||
129024527|NCT01030133|464381356|FG001|Overall Study|failed to experience pain at level 7/10|2|||
129024528|NCT03114891|464381361|FG000|First Treatment Round|Lost to Follow-up|0|||
129024529|NCT03114891|464381362|FG001|First Treatment Round|Lost to Follow-up|1|||
129024530|NCT03114891|464381363|FG002|First Treatment Round|Lost to Follow-up|1|||
129024531|NCT03114891|464381364|FG003|First Treatment Round|Lost to Follow-up|0|||
129024532|NCT03114891|464381361|FG000|First Treatment Round|Withdrawal by Subject|0|||
129024533|NCT03114891|464381362|FG001|First Treatment Round|Withdrawal by Subject|2|||
129024534|NCT03114891|464381363|FG002|First Treatment Round|Withdrawal by Subject|0|||
129024535|NCT03114891|464381364|FG003|First Treatment Round|Withdrawal by Subject|1|||
129024536|NCT03114891|464381361|FG000|3 Week Break|Lost to Follow-up|1|||
129024537|NCT03114891|464381362|FG001|3 Week Break|Lost to Follow-up|0|||
129024538|NCT03114891|464381363|FG002|3 Week Break|Lost to Follow-up|0|||
129024539|NCT03114891|464381364|FG003|3 Week Break|Lost to Follow-up|1|||
129024540|NCT03114891|464381361|FG000|3 Week Break|Withdrawal by Subject|0|||
129024541|NCT03114891|464381362|FG001|3 Week Break|Withdrawal by Subject|1|||
129024542|NCT03114891|464381363|FG002|3 Week Break|Withdrawal by Subject|0|||
129024543|NCT03114891|464381364|FG003|3 Week Break|Withdrawal by Subject|0|||
129024544|NCT03114891|464381361|FG000|Second Treatment Round|Lost to Follow-up|1|||
129024545|NCT03114891|464381362|FG001|Second Treatment Round|Lost to Follow-up|0|||
129024546|NCT03114891|464381363|FG002|Second Treatment Round|Lost to Follow-up|0|||
129024547|NCT03114891|464381364|FG003|Second Treatment Round|Lost to Follow-up|0|||
129024548|NCT03114891|464381361|FG000|Second Treatment Round|Physician Decision|1|||
129024549|NCT03114891|464381362|FG001|Second Treatment Round|Physician Decision|0|||
129024550|NCT03114891|464381363|FG002|Second Treatment Round|Physician Decision|0|||
129024551|NCT03114891|464381364|FG003|Second Treatment Round|Physician Decision|0|||
129024552|NCT02068794|464383068|FG000|Overall Study|Withdrawal by Subject|0|||
129024553|NCT02068794|464383069|FG001|Overall Study|Withdrawal by Subject|1|||
129024554|NCT02068794|464383070|FG002|Overall Study|Withdrawal by Subject|2|||
129024555|NCT02068794|464383068|FG000|Overall Study|Early Progression|1|||
129024556|NCT02068794|464383069|FG001|Overall Study|Early Progression|0|||
129024557|NCT02068794|464383070|FG002|Overall Study|Early Progression|1|||
129024558|NCT02068794|464383068|FG000|Overall Study|Ineligible|0|||
129113701|NCT05067972|464711524|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
129113702|NCT05067972|464711525|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
129113703|NCT05067972|464711526|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
129113704|NCT05067972|464711527|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
129113705|NCT05067972|464711521|FG000|Part 1: Treatment|Progressive Disease|3|||
129113706|NCT05067972|464711522|FG001|Part 1: Treatment|Progressive Disease|3|||
129113707|NCT05067972|464711523|FG002|Part 1: Treatment|Progressive Disease|4|||
129113708|NCT05067972|464711524|FG003|Part 1: Treatment|Progressive Disease|2|||
129113709|NCT05067972|464711525|FG004|Part 1: Treatment|Progressive Disease|3|||
129113710|NCT05067972|464711526|FG005|Part 1: Treatment|Progressive Disease|0|||
129113711|NCT05067972|464711527|FG006|Part 1: Treatment|Progressive Disease|2|||
129113712|NCT05067972|464711521|FG000|Part 1: Treatment|Physician Decision|0|||
129113713|NCT05067972|464711522|FG001|Part 1: Treatment|Physician Decision|0|||
129113714|NCT05067972|464711523|FG002|Part 1: Treatment|Physician Decision|0|||
129113715|NCT05067972|464711524|FG003|Part 1: Treatment|Physician Decision|1|||
129113716|NCT05067972|464711525|FG004|Part 1: Treatment|Physician Decision|0|||
129113717|NCT05067972|464711526|FG005|Part 1: Treatment|Physician Decision|0|||
128693497|NCT00075218|463177735|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
128693498|NCT00075218|463177733|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
128693499|NCT00075218|463177734|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
128901688|NCT01500278|463934615|FG000|Week 0 - Week 12|Sponsor decision|1|||
128901689|NCT01500278|463934616|FG001|Week 0 - Week 12|Sponsor decision|0|||
128901690|NCT01500278|463934615|FG000|Week 0 - Week 12|Personal reason|0|||
128901691|NCT01500278|463934616|FG001|Week 0 - Week 12|Personal reason|1|||
128901692|NCT01500278|463934615|FG000|Week 0 - Week 12|Other serious disease|0|||
128901693|NCT01500278|463934616|FG001|Week 0 - Week 12|Other serious disease|1|||
128901694|NCT01500278|463934615|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
128901695|NCT01500278|463934616|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
128901696|NCT01500278|463934615|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
128901697|NCT01500278|463934616|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
129113718|NCT05067972|464711527|FG006|Part 1: Treatment|Physician Decision|0|||
129113719|NCT05067972|464711521|FG000|Part 1: Treatment|Death|0|||
129113720|NCT05067972|464711522|FG001|Part 1: Treatment|Death|0|||
129113721|NCT05067972|464711523|FG002|Part 1: Treatment|Death|0|||
129113722|NCT05067972|464711524|FG003|Part 1: Treatment|Death|2|||
129113723|NCT05067972|464711525|FG004|Part 1: Treatment|Death|0|||
129113724|NCT05067972|464711526|FG005|Part 1: Treatment|Death|0|||
129113725|NCT05067972|464711527|FG006|Part 1: Treatment|Death|0|||
129113726|NCT05067972|464711521|FG000|Part 1: Treatment|Adverse Event|0|||
129113727|NCT05067972|464711522|FG001|Part 1: Treatment|Adverse Event|0|||
128693500|NCT00075218|463177735|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
128693501|NCT00075218|463177733|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
128693502|NCT00075218|463177734|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
128693503|NCT00075218|463177735|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
128693504|NCT00075218|463177733|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
128693505|NCT00075218|463177734|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
128693506|NCT00075218|463177735|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
128693507|NCT00075218|463177733|FG000|Double-Blind Treatment|No study medication taken|2|||
128693508|NCT00075218|463177734|FG001|Double-Blind Treatment|No study medication taken|0|||
128693509|NCT00075218|463177735|FG002|Double-Blind Treatment|No study medication taken|0|||
128693510|NCT00075218|463177733|FG000|Open-Label Treatment|Lack of Efficacy|0|||
128693511|NCT00075218|463177734|FG001|Open-Label Treatment|Lack of Efficacy|0|||
128693512|NCT00075218|463177735|FG002|Open-Label Treatment|Lack of Efficacy|174|||
128693513|NCT00075218|463177733|FG000|Open-Label Treatment|Adverse Event|0|||
128693514|NCT00075218|463177734|FG001|Open-Label Treatment|Adverse Event|0|||
128693515|NCT00075218|463177735|FG002|Open-Label Treatment|Adverse Event|51|||
128693516|NCT00075218|463177733|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
129113728|NCT05067972|464711523|FG002|Part 1: Treatment|Adverse Event|0|||
129113729|NCT05067972|464711524|FG003|Part 1: Treatment|Adverse Event|0|||
129113730|NCT05067972|464711525|FG004|Part 1: Treatment|Adverse Event|0|||
129113731|NCT05067972|464711526|FG005|Part 1: Treatment|Adverse Event|2|||
129113732|NCT05067972|464711527|FG006|Part 1: Treatment|Adverse Event|1|||
129113733|NCT05067972|464711521|FG000|Part 1: Follow-up|Adverse Event|0|||
129113734|NCT05067972|464711522|FG001|Part 1: Follow-up|Adverse Event|0|||
129113735|NCT05067972|464711523|FG002|Part 1: Follow-up|Adverse Event|0|||
128693517|NCT00075218|463177734|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
128693518|NCT00075218|463177735|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
128693519|NCT00075218|463177733|FG000|Open-Label Treatment|Decision of Sponsor|0|||
128901698|NCT01500278|463934615|FG000|Week 13 - Week 104|Protocol Violation|6|||
128693520|NCT00075218|463177734|FG001|Open-Label Treatment|Decision of Sponsor|0|||
128693521|NCT00075218|463177735|FG002|Open-Label Treatment|Decision of Sponsor|8|||
129113736|NCT05067972|464711524|FG003|Part 1: Follow-up|Adverse Event|0|||
129113737|NCT05067972|464711525|FG004|Part 1: Follow-up|Adverse Event|0|||
129113738|NCT05067972|464711526|FG005|Part 1: Follow-up|Adverse Event|1|||
129113739|NCT05067972|464711527|FG006|Part 1: Follow-up|Adverse Event|0|||
129113740|NCT05067972|464711521|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
129113741|NCT05067972|464711522|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
128693522|NCT00075218|463177733|FG000|Open-Label Treatment|Protocol Violation|0|||
128693523|NCT00075218|463177734|FG001|Open-Label Treatment|Protocol Violation|0|||
128693524|NCT00075218|463177735|FG002|Open-Label Treatment|Protocol Violation|1|||
128693525|NCT00075218|463177733|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
128693526|NCT00075218|463177734|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
128693527|NCT00075218|463177735|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
128693528|NCT03840174|463177736|FG000|Overall Study|Withdrawal by Subject|1|||
128693529|NCT03840174|463177737|FG001|Overall Study|Withdrawal by Subject|0|||
128693530|NCT03840174|463177738|FG002|Overall Study|Withdrawal by Subject|0|||
128693531|NCT03840174|463177739|FG003|Overall Study|Withdrawal by Subject|0|||
128693532|NCT00131508|463177740|FG000|Overall Study|Disease progression|0|||
128693533|NCT00131508|463177741|FG001|Overall Study|Disease progression|2|||
128693534|NCT00131508|463177740|FG000|Overall Study|Non-Compliance|2|||
128693535|NCT00131508|463177741|FG001|Overall Study|Non-Compliance|4|||
128693536|NCT00131508|463177740|FG000|Overall Study|Withdrawal by Subject|1|||
128693537|NCT00131508|463177741|FG001|Overall Study|Withdrawal by Subject|2|||
128693538|NCT00845858|463177743|FG000|Overall Study|Withdrawal by Subject|5|||
128693539|NCT00845858|463177744|FG001|Overall Study|Withdrawal by Subject|1|||
128693540|NCT00845858|463177745|FG002|Overall Study|Withdrawal by Subject|1|||
128693541|NCT00845858|463177743|FG000|Overall Study|Adverse Event|3|||
128693542|NCT00845858|463177744|FG001|Overall Study|Adverse Event|8|||
128693543|NCT00845858|463177745|FG002|Overall Study|Adverse Event|4|||
128693544|NCT00845858|463177743|FG000|Overall Study|Protocol Violation|0|||
128693545|NCT00845858|463177744|FG001|Overall Study|Protocol Violation|0|||
128693546|NCT00845858|463177745|FG002|Overall Study|Protocol Violation|1|||
128693547|NCT00845858|463177743|FG000|Overall Study|not eligible|0|||
128693548|NCT00845858|463177744|FG001|Overall Study|not eligible|3|||
128693549|NCT00845858|463177745|FG002|Overall Study|not eligible|2|||
128693550|NCT00880542|463177746|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
128693551|NCT00880542|463177746|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
128693552|NCT00880542|463177746|FG000|REP: Surgical Resection|progressive disease|1|||
128693553|NCT03758443|463177747|FG000|Induction Period|Adverse Event|2|||
128693554|NCT03758443|463177748|FG001|Induction Period|Adverse Event|4|||
128693555|NCT03758443|463177749|FG002|Induction Period|Adverse Event|2|||
128693556|NCT03758443|463177750|FG003|Induction Period|Adverse Event|3|||
128693557|NCT03758443|463177747|FG000|Induction Period|Physician Decision|1|||
128693558|NCT03758443|463177748|FG001|Induction Period|Physician Decision|1|||
128693559|NCT03758443|463177749|FG002|Induction Period|Physician Decision|3|||
128693560|NCT03758443|463177750|FG003|Induction Period|Physician Decision|0|||
129113742|NCT05067972|464711523|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
129113743|NCT05067972|464711524|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
129113744|NCT05067972|464711525|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
129113745|NCT05067972|464711526|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
129113746|NCT05067972|464711527|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
129113747|NCT05067972|464711521|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129113748|NCT05067972|464711522|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129113749|NCT05067972|464711523|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129113750|NCT05067972|464711524|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129113751|NCT05067972|464711525|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129113752|NCT05067972|464711526|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
129113753|NCT05067972|464711527|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129113754|NCT05067972|464711521|FG000|Part 1: Follow-up|Physician Decision|0|||
129113755|NCT05067972|464711522|FG001|Part 1: Follow-up|Physician Decision|0|||
129113756|NCT05067972|464711523|FG002|Part 1: Follow-up|Physician Decision|0|||
129113757|NCT05067972|464711524|FG003|Part 1: Follow-up|Physician Decision|1|||
129113758|NCT05067972|464711525|FG004|Part 1: Follow-up|Physician Decision|0|||
129113759|NCT05067972|464711526|FG005|Part 1: Follow-up|Physician Decision|0|||
129113760|NCT05067972|464711527|FG006|Part 1: Follow-up|Physician Decision|0|||
129113761|NCT05067972|464711521|FG000|Part 1: Follow-up|Death|1|||
129113762|NCT05067972|464711522|FG001|Part 1: Follow-up|Death|2|||
129113763|NCT05067972|464711523|FG002|Part 1: Follow-up|Death|1|||
129113764|NCT05067972|464711524|FG003|Part 1: Follow-up|Death|0|||
129113765|NCT05067972|464711525|FG004|Part 1: Follow-up|Death|1|||
129113766|NCT05067972|464711526|FG005|Part 1: Follow-up|Death|0|||
129113767|NCT05067972|464711527|FG006|Part 1: Follow-up|Death|1|||
129113768|NCT04391842|464711528|FG000|Overall Study|Withdrawal by Subject|2|||
128693561|NCT03758443|463177747|FG000|Induction Period|Protocol Violation|0|||
128693562|NCT03758443|463177748|FG001|Induction Period|Protocol Violation|0|||
128693563|NCT03758443|463177749|FG002|Induction Period|Protocol Violation|0|||
128693564|NCT03758443|463177750|FG003|Induction Period|Protocol Violation|1|||
128693565|NCT03758443|463177747|FG000|Induction Period|Withdrawal by Subject|3|||
128693566|NCT03758443|463177748|FG001|Induction Period|Withdrawal by Subject|2|||
128693567|NCT03758443|463177749|FG002|Induction Period|Withdrawal by Subject|2|||
128693568|NCT03758443|463177750|FG003|Induction Period|Withdrawal by Subject|4|||
128693569|NCT03758443|463177747|FG000|Extended Induction Period|Adverse Event|1|||
129113769|NCT02287038|464711529|FG000|Overall Study|Stopped attending appointments|3|||
128901699|NCT01500278|463934616|FG001|Week 13 - Week 104|Protocol Violation|6|||
128901700|NCT01500278|463934615|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
128901701|NCT01500278|463934616|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
128901702|NCT01500278|463934615|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
128901703|NCT01500278|463934616|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
128901704|NCT01500278|463934615|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
128901705|NCT01500278|463934616|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
128901706|NCT01500278|463934615|FG000|Week 13 - Week 104|Non/bad compliance|7|||
128901707|NCT01500278|463934616|FG001|Week 13 - Week 104|Non/bad compliance|5|||
128901708|NCT01500278|463934615|FG000|Week 13 - Week 104|Recurrent infections|1|||
128901709|NCT01500278|463934616|FG001|Week 13 - Week 104|Recurrent infections|0|||
129113770|NCT02287038|464711530|FG001|Overall Study|Stopped attending appointments|2|||
129113771|NCT02287038|464711529|FG000|Overall Study|Anxiety after starting medication|0|||
129113772|NCT02287038|464711530|FG001|Overall Study|Anxiety after starting medication|1|||
129113773|NCT02287038|464711529|FG000|Overall Study|Nausea after starting medication|1|||
129113774|NCT02287038|464711530|FG001|Overall Study|Nausea after starting medication|0|||
128693570|NCT03758443|463177748|FG001|Extended Induction Period|Adverse Event|1|||
129113775|NCT02287038|464711529|FG000|Overall Study|Abnormal ECG after starting medication|1|||
129113776|NCT02287038|464711530|FG001|Overall Study|Abnormal ECG after starting medication|0|||
129113777|NCT01676012|464711538|FG000|Overall Study|Adverse Event|2|||
129113778|NCT01676012|464711538|FG000|Overall Study|incomplete set of videos|1|||
129113779|NCT02667301|464711559|FG000|Overall Study|Adverse Event|1|||
129113780|NCT02667301|464711559|FG000|Overall Study|Lack of Efficacy|1|||
129113781|NCT02283658|464711560|FG000|Overall Study|Withdrawal by Subject|1|||
129113782|NCT03528551|464711562|FG000|Overall Study|Lost to Follow-up|0|||
129113783|NCT03528551|464711563|FG001|Overall Study|Lost to Follow-up|1|||
129113784|NCT03528551|464711564|FG002|Overall Study|Lost to Follow-up|0|||
129113785|NCT03528551|464711562|FG000|Overall Study|Transferred to other arm/group|2|||
129113786|NCT03528551|464711563|FG001|Overall Study|Transferred to other arm/group|3|||
129113787|NCT03528551|464711564|FG002|Overall Study|Transferred to other arm/group|0|||
129113788|NCT03528551|464711562|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129113789|NCT03528551|464711563|FG001|Overall Study|Withdrawal by parent/guardian|5|||
129113790|NCT03528551|464711564|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129113791|NCT03528551|464711562|FG000|Overall Study|Protocol Violation|0|||
129113792|NCT03528551|464711563|FG001|Overall Study|Protocol Violation|3|||
129113793|NCT03528551|464711564|FG002|Overall Study|Protocol Violation|0|||
129113794|NCT03528551|464711562|FG000|Overall Study|Withdrawal by Subject|0|||
129113795|NCT03528551|464711563|FG001|Overall Study|Withdrawal by Subject|7|||
129113796|NCT03528551|464711564|FG002|Overall Study|Withdrawal by Subject|0|||
129113797|NCT00846586|464711565|FG000|Overall Study|Adverse Event|20|||
129113798|NCT00846586|464711566|FG001|Overall Study|Adverse Event|10|||
129113799|NCT00846586|464711565|FG000|Overall Study|Subject withdrew consent|8|||
129113800|NCT00846586|464711566|FG001|Overall Study|Subject withdrew consent|10|||
129113801|NCT00846586|464711565|FG000|Overall Study|Administrative problems|5|||
129113802|NCT00846586|464711566|FG001|Overall Study|Administrative problems|4|||
129113803|NCT00846586|464711565|FG000|Overall Study|Death|2|||
129113804|NCT00846586|464711566|FG001|Overall Study|Death|0|||
129113805|NCT00846586|464711565|FG000|Overall Study|Protocol deviation|2|||
129113806|NCT00846586|464711566|FG001|Overall Study|Protocol deviation|6|||
129113807|NCT00846586|464711565|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129113808|NCT00846586|464711566|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129113809|NCT00846586|464711565|FG000|Overall Study|Lost to Follow-up|1|||
129113810|NCT00846586|464711566|FG001|Overall Study|Lost to Follow-up|4|||
129113811|NCT00846586|464711565|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129113812|NCT00846586|464711566|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129113813|NCT00689338|464711567|FG000|Overall Study|Death|65|||
128693571|NCT03758443|463177749|FG002|Extended Induction Period|Adverse Event|0|||
128693572|NCT03758443|463177750|FG003|Extended Induction Period|Adverse Event|1|||
128693573|NCT03758443|463177747|FG000|Extended Induction Period|Lost to Follow-up|1|||
128901710|NCT01500278|463934615|FG000|Week 13 - Week 104|False positive test|1|||
128901711|NCT01500278|463934616|FG001|Week 13 - Week 104|False positive test|2|||
129113814|NCT00689338|464711567|FG000|Overall Study|Adverse Event|13|||
129113815|NCT00689338|464711567|FG000|Overall Study|Insufficient Clinical Response|1|||
129113816|NCT00689338|464711567|FG000|Overall Study|Lack of Efficacy|6|||
129113817|NCT00689338|464711567|FG000|Overall Study|Other|8|||
129113818|NCT00689338|464711567|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
129113819|NCT00689338|464711567|FG000|Overall Study|Lost to Follow-up|5|||
129113820|NCT00689338|464711567|FG000|Overall Study|Withdrawal by Subject|3|||
129113821|NCT00689338|464711567|FG000|Overall Study|Protocol Violation|15|||
129113822|NCT01061606|464711568|FG000|Overall Study|Adverse Event|1|||
128901712|NCT01500278|463934615|FG000|Week 13 - Week 104|Sponsor request|4|||
128901713|NCT01500278|463934616|FG001|Week 13 - Week 104|Sponsor request|0|||
129113823|NCT01061606|464711568|FG000|Overall Study|Death|1|||
129113824|NCT01061606|464711568|FG000|Overall Study|Disease Progression|4|||
129113825|NCT01061606|464711568|FG000|Overall Study|alternative therapy|2|||
129113826|NCT00735007|464711569|FG000|Overall Study|Adverse Event|4|||
129113827|NCT00735007|464711569|FG000|Overall Study|Protocol Violation|1|||
129113828|NCT00715403|464711570|FG000|Overall Study|Progressive disease|0|||
129113829|NCT00715403|464711571|FG001|Overall Study|Progressive disease|1|||
129113830|NCT00715403|464711572|FG002|Overall Study|Progressive disease|3|||
129113831|NCT00715403|464711573|FG003|Overall Study|Progressive disease|9|||
129113832|NCT00715403|464711574|FG004|Overall Study|Progressive disease|5|||
129113833|NCT00715403|464711575|FG005|Overall Study|Progressive disease|14|||
129113834|NCT00715403|464711576|FG006|Overall Study|Progressive disease|1|||
129113835|NCT00715403|464711570|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
129113836|NCT00715403|464711571|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
129113837|NCT00715403|464711572|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
129113838|NCT00715403|464711573|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
129113839|NCT00715403|464711574|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
129113840|NCT00715403|464711575|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
129113841|NCT00715403|464711576|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
129113842|NCT00715403|464711570|FG000|Overall Study|Other Adverse Event than DLT|1|||
129113843|NCT00715403|464711571|FG001|Overall Study|Other Adverse Event than DLT|0|||
129113844|NCT00715403|464711572|FG002|Overall Study|Other Adverse Event than DLT|0|||
129113845|NCT00715403|464711573|FG003|Overall Study|Other Adverse Event than DLT|0|||
129113846|NCT00715403|464711574|FG004|Overall Study|Other Adverse Event than DLT|0|||
129113847|NCT00715403|464711575|FG005|Overall Study|Other Adverse Event than DLT|2|||
129113848|NCT00715403|464711576|FG006|Overall Study|Other Adverse Event than DLT|0|||
129113849|NCT00715403|464711570|FG000|Overall Study|Protocol Violation|0|||
129113850|NCT00715403|464711571|FG001|Overall Study|Protocol Violation|0|||
129113851|NCT00715403|464711572|FG002|Overall Study|Protocol Violation|0|||
129113852|NCT00715403|464711573|FG003|Overall Study|Protocol Violation|0|||
129113853|NCT00715403|464711574|FG004|Overall Study|Protocol Violation|0|||
129113854|NCT00715403|464711575|FG005|Overall Study|Protocol Violation|1|||
129113855|NCT00715403|464711576|FG006|Overall Study|Protocol Violation|0|||
129113856|NCT00715403|464711570|FG000|Overall Study|Other reason not defined above|0|||
129113857|NCT00715403|464711571|FG001|Overall Study|Other reason not defined above|0|||
129113858|NCT00715403|464711572|FG002|Overall Study|Other reason not defined above|1|||
129113859|NCT00715403|464711573|FG003|Overall Study|Other reason not defined above|0|||
129113860|NCT00715403|464711574|FG004|Overall Study|Other reason not defined above|1|||
129113861|NCT00715403|464711575|FG005|Overall Study|Other reason not defined above|1|||
129113862|NCT00715403|464711576|FG006|Overall Study|Other reason not defined above|0|||
129113863|NCT03644017|464711577|FG000|Overall Study|Access Abandonment|5|||
129113864|NCT03644017|464711577|FG000|Overall Study|Kidney Transplant|2|||
129113865|NCT02700048|464711578|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
129113866|NCT02700048|464711579|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
129113867|NCT02175225|464711580|FG000|Overall Study|Withdrawal by Subject|1|||
129113868|NCT02175225|464711581|FG001|Overall Study|Withdrawal by Subject|2|||
129113869|NCT02175225|464711580|FG000|Overall Study|Lost to Follow-up|6|||
129113870|NCT02175225|464711581|FG001|Overall Study|Lost to Follow-up|7|||
129113871|NCT02175225|464711580|FG000|Overall Study|Study drug not administered|1|||
129113872|NCT02175225|464711581|FG001|Overall Study|Study drug not administered|2|||
129113873|NCT02340000|464711584|FG000|Time Period 1|Withdrawal by Subject|6|||
129113874|NCT02340000|464711585|FG001|Time Period 1|Withdrawal by Subject|8|||
129113875|NCT02340000|464711584|FG000|Time Period 1|Lost to Follow-up|6|||
129113876|NCT02340000|464711585|FG001|Time Period 1|Lost to Follow-up|7|||
129113877|NCT02340000|464711584|FG000|Time Period 2|Withdrawal by Subject|9|||
129113878|NCT02340000|464711585|FG001|Time Period 2|Withdrawal by Subject|7|||
129113879|NCT02340000|464711584|FG000|Time Period 2|Lost to Follow-up|10|||
129113880|NCT02340000|464711585|FG001|Time Period 2|Lost to Follow-up|8|||
129113881|NCT02668640|464711590|FG000|Overall Study|Lost to Follow-up|13|||
129113882|NCT02668640|464711590|FG000|Overall Study|Other, not specified|1|||
129113883|NCT01883895|464711591|FG000|Overall Study|Lost to Follow-up|2|||
129113884|NCT00073918|464711592|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
129113885|NCT00073918|464711592|FG000|Overall Study|Rapid disease progression|2|||
129113886|NCT00073918|464711592|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
129113887|NCT00919633|464711595|FG000|Overall Study|Adverse Event|1|||
129113888|NCT00919633|464711596|FG001|Overall Study|Adverse Event|9|||
129113889|NCT00919633|464711597|FG002|Overall Study|Adverse Event|12|||
129113890|NCT00919633|464711598|FG003|Overall Study|Adverse Event|10|||
129113891|NCT00919633|464711595|FG000|Overall Study|Death|0|||
129113892|NCT00919633|464711596|FG001|Overall Study|Death|0|||
129113893|NCT00919633|464711597|FG002|Overall Study|Death|2|||
129113894|NCT00919633|464711598|FG003|Overall Study|Death|0|||
129113895|NCT00919633|464711595|FG000|Overall Study|Lack of Efficacy|17|||
129113896|NCT00919633|464711596|FG001|Overall Study|Lack of Efficacy|3|||
129113897|NCT00919633|464711597|FG002|Overall Study|Lack of Efficacy|2|||
129113898|NCT00919633|464711598|FG003|Overall Study|Lack of Efficacy|3|||
129113899|NCT00919633|464711595|FG000|Overall Study|Withdrawal by Subject|1|||
129113900|NCT00919633|464711596|FG001|Overall Study|Withdrawal by Subject|2|||
129113901|NCT00919633|464711597|FG002|Overall Study|Withdrawal by Subject|4|||
128901714|NCT01500278|463934615|FG000|Week 13 - Week 104|Withdrawn in error|1|||
128901715|NCT01500278|463934616|FG001|Week 13 - Week 104|Withdrawn in error|0|||
128901716|NCT01500278|463934615|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
128901717|NCT01500278|463934616|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
128901718|NCT01500278|463934615|FG000|Week 13 - Week 104|Protocol deviation|1|||
128901719|NCT01500278|463934616|FG001|Week 13 - Week 104|Protocol deviation|0|||
128901720|NCT01500278|463934615|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
128901721|NCT01500278|463934616|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
128901722|NCT01500278|463934615|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
128901723|NCT01500278|463934616|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
128901724|NCT01500278|463934615|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
128901725|NCT01500278|463934616|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
128901726|NCT01500278|463934615|FG000|Week 13 - Week 104|Relocation|0|||
128901727|NCT01500278|463934616|FG001|Week 13 - Week 104|Relocation|1|||
128901728|NCT01500278|463934615|FG000|Week 13 - Week 104|Sponsor decision|0|||
128901729|NCT01500278|463934616|FG001|Week 13 - Week 104|Sponsor decision|2|||
128901730|NCT01500278|463934615|FG000|Week 13 - Week 104|Medical monitor decision|0|||
128901731|NCT01500278|463934616|FG001|Week 13 - Week 104|Medical monitor decision|2|||
128901732|NCT01500278|463934615|FG000|Week 13 - Week 104|Personal reason|0|||
128901733|NCT01500278|463934616|FG001|Week 13 - Week 104|Personal reason|1|||
128901734|NCT01500278|463934615|FG000|Week 13 - Week 104|Not completed|0|||
128901735|NCT01500278|463934616|FG001|Week 13 - Week 104|Not completed|1|||
128901736|NCT01500278|463934615|FG000|Week 13 - Week 104|Death|2|||
128901737|NCT01500278|463934616|FG001|Week 13 - Week 104|Death|4|||
128901738|NCT01500278|463934615|FG000|Week 13 - Week 104|Adverse Event|54|||
128901739|NCT01500278|463934616|FG001|Week 13 - Week 104|Adverse Event|54|||
128901740|NCT01709435|463934620|FG000|Overall Study|Adverse Event|1|||
128901741|NCT01709435|463934621|FG001|Overall Study|Adverse Event|1|||
128901742|NCT01709435|463934622|FG002|Overall Study|Adverse Event|1|||
128901743|NCT01709435|463934623|FG003|Overall Study|Adverse Event|0|||
128901744|NCT01709435|463934624|FG004|Overall Study|Adverse Event|0|||
128764681|NCT00539643|463430261|FG000|Overall Study|Death|2|||
128901745|NCT01709435|463934625|FG005|Overall Study|Adverse Event|1|||
128901746|NCT01709435|463934620|FG000|Overall Study|Lack of Efficacy|5|||
128901747|NCT01709435|463934621|FG001|Overall Study|Lack of Efficacy|7|||
128901748|NCT01709435|463934622|FG002|Overall Study|Lack of Efficacy|2|||
128901749|NCT01709435|463934623|FG003|Overall Study|Lack of Efficacy|2|||
128901750|NCT01709435|463934624|FG004|Overall Study|Lack of Efficacy|6|||
128901751|NCT01709435|463934625|FG005|Overall Study|Lack of Efficacy|3|||
128901752|NCT01709435|463934620|FG000|Overall Study|Physician Decision|0|||
128901753|NCT01709435|463934621|FG001|Overall Study|Physician Decision|1|||
128901754|NCT01709435|463934622|FG002|Overall Study|Physician Decision|0|||
128901755|NCT01709435|463934623|FG003|Overall Study|Physician Decision|1|||
128901756|NCT01709435|463934624|FG004|Overall Study|Physician Decision|2|||
128901757|NCT01709435|463934625|FG005|Overall Study|Physician Decision|0|||
128901758|NCT01709435|463934620|FG000|Overall Study|Withdrawal by Subject|0|||
128901759|NCT01709435|463934621|FG001|Overall Study|Withdrawal by Subject|0|||
128901760|NCT01709435|463934622|FG002|Overall Study|Withdrawal by Subject|3|||
128901761|NCT01709435|463934623|FG003|Overall Study|Withdrawal by Subject|0|||
128901762|NCT01709435|463934624|FG004|Overall Study|Withdrawal by Subject|2|||
128901763|NCT01709435|463934625|FG005|Overall Study|Withdrawal by Subject|2|||
128901764|NCT01297270|463934629|FG000|Overall Study|Adverse Event|19|||
128901765|NCT01297270|463934630|FG001|Overall Study|Adverse Event|32|||
128901766|NCT01297270|463934631|FG002|Overall Study|Adverse Event|5|||
128901767|NCT01297270|463934629|FG000|Overall Study|Lack of Efficacy|15|||
128901768|NCT01297270|463934630|FG001|Overall Study|Lack of Efficacy|17|||
128901769|NCT01297270|463934631|FG002|Overall Study|Lack of Efficacy|15|||
128901770|NCT01297270|463934629|FG000|Overall Study|Lost to Follow-up|1|||
128901771|NCT01297270|463934630|FG001|Overall Study|Lost to Follow-up|2|||
128901772|NCT01297270|463934631|FG002|Overall Study|Lost to Follow-up|1|||
128901773|NCT01297270|463934629|FG000|Overall Study|Protocol Violation|0|||
128901774|NCT01297270|463934630|FG001|Overall Study|Protocol Violation|2|||
128901775|NCT01297270|463934631|FG002|Overall Study|Protocol Violation|0|||
128901776|NCT01297270|463934629|FG000|Overall Study|Withdrawal by Subject|7|||
128901777|NCT01297270|463934630|FG001|Overall Study|Withdrawal by Subject|15|||
128901778|NCT01297270|463934631|FG002|Overall Study|Withdrawal by Subject|7|||
129024559|NCT02068794|464383069|FG001|Overall Study|Ineligible|0|||
129024560|NCT02068794|464383070|FG002|Overall Study|Ineligible|1|||
128901779|NCT01297270|463934629|FG000|Overall Study|Other reason not defined above|3|||
129024561|NCT02316548|464383072|FG000|Overall Study|Protocol Violation|0|||
129024562|NCT02316548|464383073|FG001|Overall Study|Protocol Violation|1|||
129024563|NCT01958294|464383074|FG000|Overall Study|Clinical Circumstances|2|||
129024564|NCT02566850|464383076|FG000|Overall Study|Protocol Violation|1|||
129024565|NCT02635750|464383077|FG000|Part 1, Period 2|Adverse Event|1|||
128901780|NCT01297270|463934630|FG001|Overall Study|Other reason not defined above|3|||
128901781|NCT01297270|463934631|FG002|Overall Study|Other reason not defined above|1|||
128901782|NCT01297270|463934629|FG000|Overall Study|Not treated|0|||
129024566|NCT02635750|464383078|FG001|Part 1, Period 2|Adverse Event|0|||
128901783|NCT01297270|463934630|FG001|Overall Study|Not treated|1|||
128901784|NCT01297270|463934631|FG002|Overall Study|Not treated|0|||
128901785|NCT03882970|463934634|FG000|Overall Study|Adverse Event|5|||
128901786|NCT03882970|463934635|FG001|Overall Study|Adverse Event|7|||
128901787|NCT03882970|463934636|FG002|Overall Study|Adverse Event|3|||
128901788|NCT03882970|463934637|FG003|Overall Study|Adverse Event|1|||
128901789|NCT03882970|463934634|FG000|Overall Study|Death|1|||
128901790|NCT03882970|463934635|FG001|Overall Study|Death|2|||
128901791|NCT03882970|463934636|FG002|Overall Study|Death|1|||
128901792|NCT03882970|463934637|FG003|Overall Study|Death|1|||
128901793|NCT03882970|463934634|FG000|Overall Study|Lost to Follow-up|8|||
128901794|NCT03882970|463934635|FG001|Overall Study|Lost to Follow-up|9|||
128901795|NCT03882970|463934636|FG002|Overall Study|Lost to Follow-up|5|||
128901796|NCT03882970|463934637|FG003|Overall Study|Lost to Follow-up|5|||
128901797|NCT03882970|463934634|FG000|Overall Study|Physician Decision|0|||
128901798|NCT03882970|463934635|FG001|Overall Study|Physician Decision|2|||
128901799|NCT03882970|463934636|FG002|Overall Study|Physician Decision|2|||
128901800|NCT03882970|463934637|FG003|Overall Study|Physician Decision|2|||
128901801|NCT03882970|463934634|FG000|Overall Study|Protocol Violation|2|||
128901802|NCT03882970|463934635|FG001|Overall Study|Protocol Violation|0|||
128901803|NCT03882970|463934636|FG002|Overall Study|Protocol Violation|0|||
128901804|NCT03882970|463934637|FG003|Overall Study|Protocol Violation|0|||
128901805|NCT03882970|463934634|FG000|Overall Study|Withdrawal by Subject|8|||
128901806|NCT03882970|463934635|FG001|Overall Study|Withdrawal by Subject|17|||
128901807|NCT03882970|463934636|FG002|Overall Study|Withdrawal by Subject|7|||
128901808|NCT03882970|463934637|FG003|Overall Study|Withdrawal by Subject|22|||
128901809|NCT03882970|463934634|FG000|Overall Study|Personal Reason|2|||
128901810|NCT03882970|463934635|FG001|Overall Study|Personal Reason|3|||
128901811|NCT03882970|463934636|FG002|Overall Study|Personal Reason|1|||
128901812|NCT03882970|463934637|FG003|Overall Study|Personal Reason|3|||
128901813|NCT02863809|463934639|FG000|Overall Study|Adverse Event|8|||
128901814|NCT02863809|463934640|FG001|Overall Study|Adverse Event|8|||
128693574|NCT03758443|463177748|FG001|Extended Induction Period|Lost to Follow-up|0|||
128901815|NCT02863809|463934639|FG000|Overall Study|Withdrawal by Subject|0|||
128901816|NCT02863809|463934640|FG001|Overall Study|Withdrawal by Subject|1|||
128901817|NCT02863809|463934639|FG000|Overall Study|Lost to Follow-up|1|||
128901818|NCT02863809|463934640|FG001|Overall Study|Lost to Follow-up|1|||
128901819|NCT02863809|463934639|FG000|Overall Study|Death|1|||
128901820|NCT02863809|463934640|FG001|Overall Study|Death|0|||
128901821|NCT02830776|463934641|FG000|Overall Study|Lost to Follow-up|1|||
128901822|NCT03029143|463934642|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
128901823|NCT03029143|463934643|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
128901824|NCT03029143|463934644|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
128901825|NCT03029143|463934642|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
128901826|NCT03029143|463934643|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
128901827|NCT03029143|463934644|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
129024567|NCT02635750|464383079|FG002|Part 1, Period 2|Adverse Event|0|||
129024568|NCT00830258|464383082|FG000|First Intervention|Adverse Event|1|||
128693575|NCT03758443|463177749|FG002|Extended Induction Period|Lost to Follow-up|0|||
128693576|NCT03758443|463177750|FG003|Extended Induction Period|Lost to Follow-up|0|||
128693577|NCT03758443|463177747|FG000|Extended Induction Period|Physician Decision|2|||
129024569|NCT00830258|464383083|FG001|First Intervention|Adverse Event|0|||
128693578|NCT03758443|463177748|FG001|Extended Induction Period|Physician Decision|1|||
128693579|NCT03758443|463177749|FG002|Extended Induction Period|Physician Decision|2|||
128693580|NCT03758443|463177750|FG003|Extended Induction Period|Physician Decision|2|||
129024570|NCT00830258|464383082|FG000|Washout: 7 Days|Protocol Violation|1|||
129024571|NCT00830258|464383083|FG001|Washout: 7 Days|Protocol Violation|0|||
129024572|NCT00682461|464383087|FG000|Overall Study|Adverse Event|5|||
129024573|NCT00682461|464383088|FG001|Overall Study|Adverse Event|7|||
129024574|NCT00682461|464383087|FG000|Overall Study|Lost to Follow-up|8|||
129024575|NCT00682461|464383088|FG001|Overall Study|Lost to Follow-up|5|||
129024576|NCT00682461|464383087|FG000|Overall Study|Withdrawal by Subject|12|||
129024577|NCT00682461|464383088|FG001|Overall Study|Withdrawal by Subject|19|||
129024578|NCT04035187|464383092|FG000|Overall Study|Withdrawal by Subject|2|||
129024579|NCT04035187|464383093|FG001|Overall Study|Withdrawal by Subject|1|||
129024580|NCT04035187|464383094|FG002|Overall Study|Withdrawal by Subject|0|||
129024581|NCT04035187|464383095|FG003|Overall Study|Withdrawal by Subject|0|||
128901828|NCT03029143|463934642|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
128901829|NCT03029143|463934643|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
128901830|NCT03029143|463934644|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
128901831|NCT03029143|463934642|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
128901832|NCT03029143|463934643|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
128901833|NCT03029143|463934644|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
128901834|NCT03029143|463934642|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
128901835|NCT03029143|463934643|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
128901836|NCT03029143|463934644|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
128901837|NCT03029143|463934642|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
128901838|NCT03029143|463934643|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
128901839|NCT03029143|463934644|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
128901840|NCT03029143|463934642|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
128901841|NCT03029143|463934643|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
128901842|NCT03029143|463934644|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
128901843|NCT03029143|463934642|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128901844|NCT03029143|463934643|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
128901845|NCT03029143|463934644|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
128901846|NCT03029143|463934642|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
128901847|NCT03029143|463934643|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
128901848|NCT03029143|463934644|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
128901849|NCT03029143|463934642|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
128901850|NCT03029143|463934643|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
128901851|NCT03029143|463934644|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
128901852|NCT03029143|463934642|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
128901853|NCT03029143|463934643|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
128901854|NCT03029143|463934644|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
128901855|NCT00974675|463934645|FG000|Overall Study|Adverse Event|2|||
128901856|NCT00974675|463934646|FG001|Overall Study|Adverse Event|1|||
128901857|NCT00974675|463934647|FG002|Overall Study|Adverse Event|1|||
128901858|NCT00974675|463934648|FG003|Overall Study|Adverse Event|1|||
128901859|NCT00974675|463934645|FG000|Overall Study|Physician Decision|0|||
128901860|NCT00974675|463934646|FG001|Overall Study|Physician Decision|0|||
128901861|NCT00974675|463934647|FG002|Overall Study|Physician Decision|1|||
128901862|NCT00974675|463934648|FG003|Overall Study|Physician Decision|0|||
128901863|NCT00974675|463934645|FG000|Overall Study|Participant on holiday; unable to attend|0|||
128901864|NCT00974675|463934646|FG001|Overall Study|Participant on holiday; unable to attend|0|||
128901865|NCT00974675|463934647|FG002|Overall Study|Participant on holiday; unable to attend|0|||
128901866|NCT00974675|463934648|FG003|Overall Study|Participant on holiday; unable to attend|1|||
128901867|NCT02121262|463934651|FG000|Overall Study|Adverse Event|6|||
128901868|NCT02121262|463934652|FG001|Overall Study|Adverse Event|3|||
128901869|NCT02121262|463934651|FG000|Overall Study|Lack of Efficacy|3|||
128901870|NCT02121262|463934652|FG001|Overall Study|Lack of Efficacy|0|||
128901871|NCT02121262|463934651|FG000|Overall Study|Personal Reasons|19|||
128901872|NCT02121262|463934652|FG001|Overall Study|Personal Reasons|5|||
128901873|NCT02121262|463934651|FG000|Overall Study|Protocol Violation|1|||
128901874|NCT02121262|463934652|FG001|Overall Study|Protocol Violation|1|||
128901875|NCT02121262|463934651|FG000|Overall Study|Participant Dropped-out|0|||
128901876|NCT02121262|463934652|FG001|Overall Study|Participant Dropped-out|1|||
128901877|NCT02121262|463934651|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
128901878|NCT02121262|463934652|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
128901879|NCT02121262|463934651|FG000|Overall Study|Consent Withdrawn|1|||
128901880|NCT02121262|463934652|FG001|Overall Study|Consent Withdrawn|0|||
128901881|NCT02829138|463934653|FG000|Overall Study|Withdrawal by Subject|1|||
128901882|NCT02829138|463934654|FG001|Overall Study|Withdrawal by Subject|0|||
128901883|NCT01394627|463934655|FG000|First Intervention (1 Day)|poor intravenous access|0|||
128901884|NCT01394627|463934656|FG001|First Intervention (1 Day)|poor intravenous access|1|||
128901885|NCT01394627|463934655|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
128901886|NCT01394627|463934656|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
128901887|NCT01765920|463934662|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
128901888|NCT01765920|463934663|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
128901889|NCT01765920|463934662|FG000|Overall Study|Patient code disclosure|0|||
128901890|NCT01765920|463934663|FG001|Overall Study|Patient code disclosure|1|||
128901891|NCT01081249|463934664|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
128901892|NCT01081249|463934665|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
128901893|NCT02025907|463934666|FG000|Overall Study|Lack of Efficacy|1|||
128901894|NCT02025907|463934667|FG001|Overall Study|Lack of Efficacy|0|||
129113902|NCT00919633|464711598|FG003|Overall Study|Withdrawal by Subject|3|||
129113903|NCT00919633|464711595|FG000|Overall Study|Lost to Follow-up|3|||
129113904|NCT00919633|464711596|FG001|Overall Study|Lost to Follow-up|1|||
129113905|NCT00919633|464711597|FG002|Overall Study|Lost to Follow-up|0|||
129113906|NCT00919633|464711598|FG003|Overall Study|Lost to Follow-up|2|||
129113907|NCT00919633|464711595|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
129113908|NCT00919633|464711596|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
129113909|NCT00919633|464711597|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
129113910|NCT00919633|464711598|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
128764682|NCT00539643|463430262|FG001|Overall Study|Death|1|||
128901895|NCT02025907|463934666|FG000|Overall Study|Withdrawal by Subject|15|||
128901896|NCT02025907|463934667|FG001|Overall Study|Withdrawal by Subject|8|||
129113911|NCT00919633|464711595|FG000|Overall Study|Protocol Violation|0|||
128693581|NCT03758443|463177747|FG000|Extended Induction Period|Protocol Violation|0|||
128693582|NCT03758443|463177748|FG001|Extended Induction Period|Protocol Violation|0|||
128693583|NCT03758443|463177749|FG002|Extended Induction Period|Protocol Violation|0|||
128693584|NCT03758443|463177750|FG003|Extended Induction Period|Protocol Violation|1|||
128901897|NCT02025907|463934666|FG000|Overall Study|Protocol Violation|2|||
128901898|NCT02025907|463934667|FG001|Overall Study|Protocol Violation|0|||
128901899|NCT02025907|463934666|FG000|Overall Study|Physician Decision|2|||
128901900|NCT02025907|463934667|FG001|Overall Study|Physician Decision|0|||
128901901|NCT02025907|463934666|FG000|Overall Study|Lost to Follow-up|2|||
128901902|NCT02025907|463934667|FG001|Overall Study|Lost to Follow-up|2|||
128901903|NCT02025907|463934666|FG000|Overall Study|Adverse Event|3|||
128901904|NCT02025907|463934667|FG001|Overall Study|Adverse Event|1|||
128901905|NCT02025907|463934666|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
128901906|NCT02025907|463934667|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
128901907|NCT02411539|463934668|FG000|Overall Study|Lost to Follow-up|2|||
128901908|NCT02411539|463934669|FG001|Overall Study|Lost to Follow-up|0|||
128901909|NCT02411539|463934668|FG000|Overall Study|Confounding medical condition|0|||
128901910|NCT02411539|463934669|FG001|Overall Study|Confounding medical condition|1|||
128901911|NCT00282334|463934670|FG000|Overall Study|Withdrawal by Subject|8|||
128901912|NCT00282334|463934671|FG001|Overall Study|Withdrawal by Subject|5|||
128901913|NCT03681119|463934673|FG000|Overall Study|No specific reason|4|||
128901914|NCT03681119|463934674|FG001|Overall Study|No specific reason|0|||
128901915|NCT03681119|463934673|FG000|Overall Study|Sickness|2|||
128901916|NCT03681119|463934674|FG001|Overall Study|Sickness|0|||
128901917|NCT04041284|463934677|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
128901918|NCT04041284|463934678|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
128901919|NCT04041284|463934677|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
128901920|NCT04041284|463934678|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
128901921|NCT04041284|463934677|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
128901922|NCT04041284|463934678|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
128901923|NCT04041284|463934677|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
129024582|NCT04035187|464383092|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
129024583|NCT04035187|464383093|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
129024584|NCT04035187|464383094|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
129024585|NCT04035187|464383095|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
129024586|NCT01116739|464383096|FG000|Overall Study|Child had 2 years of HS|110|||
129024587|NCT01116739|464383097|FG001|Overall Study|Child had 2 years of HS|128|||
129024588|NCT01116739|464383096|FG000|Overall Study|Withdrawal by Subject|6|||
129024589|NCT01116739|464383097|FG001|Overall Study|Withdrawal by Subject|0|||
129024590|NCT01116739|464383096|FG000|Overall Study|child too young|2|||
129024591|NCT01116739|464383097|FG001|Overall Study|child too young|6|||
129024592|NCT01116739|464383096|FG000|Overall Study|child not enrolled in head start|10|||
129024593|NCT01116739|464383097|FG001|Overall Study|child not enrolled in head start|2|||
129024594|NCT01116739|464383096|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
129024595|NCT01116739|464383097|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
129024596|NCT05511935|464383098|FG000|Overall Study|Lost to Follow-up|9|||
129024597|NCT05511935|464383099|FG001|Overall Study|Lost to Follow-up|27|||
129024598|NCT05090839|464383102|FG000|Overall Study|Lost to Follow-up|2|||
129024599|NCT05090839|464383103|FG001|Overall Study|Lost to Follow-up|3|||
129024600|NCT05090839|464383104|FG002|Overall Study|Lost to Follow-up|1|||
129024601|NCT05090839|464383105|FG003|Overall Study|Lost to Follow-up|1|||
129024602|NCT03913377|464383106|FG000|Period 1|Test Article no longer available|0|||
129024603|NCT03913377|464383107|FG001|Period 1|Test Article no longer available|1|||
129024604|NCT03913377|464383108|FG002|Period 1|Test Article no longer available|0|||
129024605|NCT03913377|464383106|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
129024606|NCT03913377|464383107|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
129024607|NCT03913377|464383108|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
129024608|NCT03499353|464383109|FG000|Treatment|Adverse Event|3|||
129024609|NCT03499353|464383109|FG000|Treatment|Progressive Disease|10|||
129024610|NCT03499353|464383109|FG000|Treatment|Other|1|||
129024611|NCT03499353|464383109|FG000|Treatment|Withdrawal by Subject|2|||
129024612|NCT03499353|464383109|FG000|Long-Term Follow-up|Death|2|||
129024613|NCT03499353|464383109|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
129024614|NCT03499353|464383109|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
129024615|NCT01117623|464383110|FG000|Overall Study|Adverse Event|0|||
129024616|NCT01117623|464383111|FG001|Overall Study|Adverse Event|2|||
129024617|NCT01117623|464383112|FG002|Overall Study|Adverse Event|4|||
129024618|NCT01117623|464383113|FG003|Overall Study|Adverse Event|0|||
129024619|NCT01117623|464383114|FG004|Overall Study|Adverse Event|2|||
129024620|NCT01117623|464383115|FG005|Overall Study|Adverse Event|0|||
128693585|NCT03758443|463177747|FG000|Extended Induction Period|Withdrawal by Subject|8|||
128901924|NCT04041284|463934678|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
128901925|NCT04041284|463934677|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
128901926|NCT04041284|463934678|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
128901927|NCT04041284|463934677|FG000|DB Phase (12 Weeks)|Other than specified|1|||
128901928|NCT04041284|463934678|FG001|DB Phase (12 Weeks)|Other than specified|0|||
128901929|NCT04041284|463934677|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
128901930|NCT04041284|463934678|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
128901931|NCT04041284|463934677|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
128901932|NCT04041284|463934678|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
128901933|NCT04041284|463934677|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
128901934|NCT04041284|463934678|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
129113912|NCT00919633|464711596|FG001|Overall Study|Protocol Violation|0|||
128901935|NCT04041284|463934677|FG000|OL Phase (12 Weeks)|Other than specified|6|||
128901936|NCT04041284|463934678|FG001|OL Phase (12 Weeks)|Other than specified|2|||
128901937|NCT00563186|463934679|FG000|Overall Study|LOS<48 hours|97|||
128901938|NCT00563186|463934680|FG001|Overall Study|LOS<48 hours|74|||
128901939|NCT00563186|463934679|FG000|Overall Study|Incomplete data|1|||
128901940|NCT00563186|463934680|FG001|Overall Study|Incomplete data|1|||
128901941|NCT00879645|463934685|FG000|Overall Study|Adverse Event|1|||
128901942|NCT00879645|463934686|FG001|Overall Study|Adverse Event|0|||
128901943|NCT00879645|463934687|FG002|Overall Study|Adverse Event|0|||
128901944|NCT00879645|463934688|FG003|Overall Study|Adverse Event|0|||
128901945|NCT03631732|463934689|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
128901946|NCT03631732|463934690|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
128901947|NCT03631732|463934689|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
128901948|NCT03631732|463934690|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
128901949|NCT03631732|463934689|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
128901950|NCT03631732|463934690|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
128901951|NCT03631732|463934689|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
128901952|NCT03631732|463934690|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
128901953|NCT03631732|463934689|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
128901954|NCT03631732|463934690|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
128901955|NCT03631732|463934689|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
128901956|NCT03631732|463934690|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
128901957|NCT03631732|463934689|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
128901958|NCT03631732|463934690|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
128901959|NCT03631732|463934689|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
128901960|NCT03631732|463934690|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
128901961|NCT03631732|463934689|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
128901962|NCT03631732|463934690|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
128901963|NCT03631732|463934689|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
128901964|NCT03631732|463934690|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
129113913|NCT00919633|464711597|FG002|Overall Study|Protocol Violation|0|||
129113914|NCT00919633|464711598|FG003|Overall Study|Protocol Violation|1|||
129113915|NCT00919633|464711595|FG000|Overall Study|Physician Decision|0|||
129113916|NCT00919633|464711596|FG001|Overall Study|Physician Decision|0|||
129113917|NCT00919633|464711597|FG002|Overall Study|Physician Decision|0|||
129113918|NCT00919633|464711598|FG003|Overall Study|Physician Decision|1|||
129113919|NCT00919633|464711595|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
129113920|NCT00919633|464711596|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
129113921|NCT00919633|464711597|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
129113922|NCT00919633|464711598|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
129113923|NCT00919633|464711595|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
129113924|NCT00919633|464711596|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
129113925|NCT00919633|464711597|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
129113926|NCT00919633|464711598|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
129113927|NCT02481050|464713013|FG000|Overall Study|Adverse Event|1|||
129113928|NCT02481050|464713013|FG000|Overall Study|Disease Progression|47|||
129113929|NCT02481050|464713013|FG000|Overall Study|Withdrawal by Subject|7|||
129113930|NCT02481050|464713013|FG000|Overall Study|Other|3|||
129113931|NCT03246347|464713016|FG000|Overall Study|On Study|23|||
128901965|NCT00886600|463934691|FG000|Double-blind Monotherapy|Adverse Event|1|||
128901966|NCT00886600|463934692|FG001|Double-blind Monotherapy|Adverse Event|1|||
128901967|NCT00886600|463934693|FG002|Double-blind Monotherapy|Adverse Event|1|||
129113932|NCT02188160|464713017|FG000|Overall Study|Adverse Event|1|||
129113933|NCT02188160|464713018|FG001|Overall Study|Adverse Event|0|||
129113934|NCT02188160|464713017|FG000|Overall Study|Use of an excluded medication|0|||
129113935|NCT02188160|464713018|FG001|Overall Study|Use of an excluded medication|1|||
129113936|NCT04113694|464713019|FG000|Overall Study|Adverse Event|2|||
129113937|NCT04113694|464713019|FG000|Overall Study|Lost to Follow-up|2|||
129113938|NCT04113694|464713019|FG000|Overall Study|Withdrawal by Subject|6|||
129113939|NCT04113694|464713019|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
129113940|NCT01022203|464713026|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
128901968|NCT00886600|463934694|FG003|Double-blind Monotherapy|Adverse Event|1|||
128901969|NCT00886600|463934691|FG000|Double-blind Monotherapy|Protocol Violation|0|||
128901970|NCT00886600|463934692|FG001|Double-blind Monotherapy|Protocol Violation|0|||
128901971|NCT00886600|463934693|FG002|Double-blind Monotherapy|Protocol Violation|0|||
128901972|NCT00886600|463934694|FG003|Double-blind Monotherapy|Protocol Violation|1|||
128901973|NCT00886600|463934691|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
128901974|NCT00886600|463934692|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
128901975|NCT00886600|463934693|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
128901976|NCT00886600|463934694|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
129113941|NCT01022203|464713027|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
129113942|NCT01022203|464713026|FG000|Post Treatment Assessment|Physician Decision|2|||
129113943|NCT01022203|464713027|FG001|Post Treatment Assessment|Physician Decision|0|||
128901977|NCT00886600|463934691|FG000|Combination Therapy Period|Adverse Event|0|||
128901978|NCT00886600|463934692|FG001|Combination Therapy Period|Adverse Event|0|||
128901979|NCT00886600|463934693|FG002|Combination Therapy Period|Adverse Event|1|||
128901980|NCT00886600|463934694|FG003|Combination Therapy Period|Adverse Event|0|||
128901981|NCT00886600|463934691|FG000|Combination Therapy Period|Protocol Violation|0|||
128901982|NCT00886600|463934692|FG001|Combination Therapy Period|Protocol Violation|0|||
128901983|NCT00886600|463934693|FG002|Combination Therapy Period|Protocol Violation|1|||
128901984|NCT00886600|463934694|FG003|Combination Therapy Period|Protocol Violation|0|||
128901985|NCT01439204|463934695|FG000|Overall Study|Withdrawal by Subject|0|||
128901986|NCT01439204|463934696|FG001|Overall Study|Withdrawal by Subject|1|||
128901987|NCT01439204|463934695|FG000|Overall Study|Lost to Follow-up|0|||
128901988|NCT01439204|463934696|FG001|Overall Study|Lost to Follow-up|2|||
128901989|NCT01439204|463934695|FG000|Overall Study|No longer meets study criteria|1|||
128901990|NCT01439204|463934696|FG001|Overall Study|No longer meets study criteria|0|||
128901991|NCT01439204|463934695|FG000|Overall Study|poor/non-compliance|3|||
128901992|NCT01439204|463934696|FG001|Overall Study|poor/non-compliance|0|||
129113944|NCT01022203|464713026|FG000|Post Treatment Assessment|Adverse Event|0|||
129113945|NCT01022203|464713027|FG001|Post Treatment Assessment|Adverse Event|2|||
128901993|NCT04288154|463934697|FG000|Overall Study|Withdrawal by Subject|9|||
128901994|NCT04288154|463934698|FG001|Overall Study|Withdrawal by Subject|9|||
128901995|NCT03775421|463934701|FG000|Overall Study|Lost to Follow-up|2|||
128901996|NCT03775421|463934701|FG000|Overall Study|Withdrawal by Subject|10|||
128901997|NCT03775421|463934701|FG000|Overall Study|Physician Decision|3|||
128901998|NCT03775421|463934701|FG000|Overall Study|Death|1|||
128901999|NCT03775421|463934701|FG000|Overall Study|Study Terminated by Sponsor|94|||
128902000|NCT03917823|463934702|FG000|Overall Study|Lost to Follow-up|1|||
128902001|NCT03917823|463934703|FG001|Overall Study|Lost to Follow-up|1|||
128902002|NCT03917823|463934702|FG000|Overall Study|Withdrawal by Subject|0|||
128902003|NCT03917823|463934703|FG001|Overall Study|Withdrawal by Subject|1|||
128902004|NCT00135668|463934704|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
128902005|NCT00135668|463934705|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
128902006|NCT00135668|463934706|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
129113946|NCT01022203|464713026|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
129113947|NCT01022203|464713027|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
129113948|NCT03638128|464713030|FG000|Overall Study|Withdrawal by Subject|1|||
129113949|NCT03638128|464713031|FG001|Overall Study|Withdrawal by Subject|7|||
129113950|NCT03638128|464713032|FG002|Overall Study|Withdrawal by Subject|6|||
128902007|NCT00135668|463934707|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
128902008|NCT00455013|463934715|FG000|Short Term Period|Adverse Event|2|||
128902009|NCT00455013|463934716|FG001|Short Term Period|Adverse Event|5|||
128902010|NCT00455013|463934717|FG002|Short Term Period|Adverse Event|0|||
128902011|NCT00455013|463934715|FG000|Short Term Period|Withdrawal by Subject|0|||
128902012|NCT00455013|463934716|FG001|Short Term Period|Withdrawal by Subject|0|||
128902013|NCT00455013|463934717|FG002|Short Term Period|Withdrawal by Subject|1|||
128902014|NCT00455013|463934715|FG000|Short Term Period|Lack of Efficacy|4|||
128902015|NCT00455013|463934716|FG001|Short Term Period|Lack of Efficacy|0|||
128902016|NCT00455013|463934717|FG002|Short Term Period|Lack of Efficacy|0|||
128902017|NCT00455013|463934715|FG000|Short Term Period|Other|0|||
128902018|NCT00455013|463934716|FG001|Short Term Period|Other|0|||
129113951|NCT03638128|464713030|FG000|Overall Study|Sponsor Decision|15|||
129113952|NCT03638128|464713031|FG001|Overall Study|Sponsor Decision|12|||
128902019|NCT00455013|463934717|FG002|Short Term Period|Other|1|||
128902020|NCT00455013|463934715|FG000|Long Term Extension (LTE)|Adverse Event|0|||
128902021|NCT00455013|463934716|FG001|Long Term Extension (LTE)|Adverse Event|1|||
128902022|NCT00455013|463934717|FG002|Long Term Extension (LTE)|Adverse Event|1|||
128902023|NCT00455013|463934715|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
128902024|NCT00455013|463934716|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
128902025|NCT00455013|463934717|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
128902026|NCT00455013|463934715|FG000|Long Term Extension (LTE)|Death|1|||
128902027|NCT00455013|463934716|FG001|Long Term Extension (LTE)|Death|1|||
128902028|NCT00455013|463934717|FG002|Long Term Extension (LTE)|Death|0|||
129113953|NCT03638128|464713032|FG002|Overall Study|Sponsor Decision|19|||
128902029|NCT00455013|463934715|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
128902030|NCT00455013|463934716|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
128902031|NCT00455013|463934717|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
128902032|NCT00455013|463934715|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
128902033|NCT00455013|463934716|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
128902034|NCT00455013|463934717|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
128902035|NCT00455013|463934715|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
128902036|NCT00455013|463934716|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
128902037|NCT00455013|463934717|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
128902038|NCT00455013|463934715|FG000|Long Term Extension (LTE)|non-specified|0|||
128902039|NCT00455013|463934716|FG001|Long Term Extension (LTE)|non-specified|0|||
128902040|NCT00455013|463934717|FG002|Long Term Extension (LTE)|non-specified|1|||
128902041|NCT02739620|463934720|FG000|Overall Study|Lost to Follow-up|3|||
128902042|NCT02739620|463934721|FG001|Overall Study|Lost to Follow-up|1|||
128902043|NCT02739620|463934720|FG000|Overall Study|Adverse Event|0|||
128902044|NCT02739620|463934721|FG001|Overall Study|Adverse Event|1|||
128902045|NCT02873936|463934722|FG000|Overall Study|Withdrew Consent|4|||
128902046|NCT02873936|463934723|FG001|Overall Study|Withdrew Consent|11|||
128902047|NCT02873936|463934724|FG002|Overall Study|Withdrew Consent|20|||
128902048|NCT02873936|463934722|FG000|Overall Study|Investigator's Discretion|3|||
128902049|NCT02873936|463934723|FG001|Overall Study|Investigator's Discretion|5|||
128902050|NCT02873936|463934724|FG002|Overall Study|Investigator's Discretion|4|||
128902051|NCT02873936|463934722|FG000|Overall Study|Adverse Event|3|||
128902052|NCT02873936|463934723|FG001|Overall Study|Adverse Event|5|||
128902053|NCT02873936|463934724|FG002|Overall Study|Adverse Event|3|||
128902054|NCT02873936|463934722|FG000|Overall Study|Protocol Violation|0|||
128902055|NCT02873936|463934723|FG001|Overall Study|Protocol Violation|1|||
128902056|NCT02873936|463934724|FG002|Overall Study|Protocol Violation|3|||
128902057|NCT02873936|463934722|FG000|Overall Study|Lost to Follow-up|1|||
128902058|NCT02873936|463934723|FG001|Overall Study|Lost to Follow-up|1|||
128902059|NCT02873936|463934724|FG002|Overall Study|Lost to Follow-up|1|||
128693586|NCT03758443|463177748|FG001|Extended Induction Period|Withdrawal by Subject|1|||
128902060|NCT02873936|463934722|FG000|Overall Study|Non-compliance With Study Drug|1|||
128902061|NCT02873936|463934723|FG001|Overall Study|Non-compliance With Study Drug|0|||
128902062|NCT02873936|463934724|FG002|Overall Study|Non-compliance With Study Drug|1|||
128902063|NCT02873936|463934722|FG000|Overall Study|Randomized but not Dosed|1|||
128902064|NCT02873936|463934723|FG001|Overall Study|Randomized but not Dosed|0|||
128902065|NCT02873936|463934724|FG002|Overall Study|Randomized but not Dosed|0|||
128902066|NCT00754793|463934726|FG000|Overall Study|voluntary withdrawn from study|0|||
128902067|NCT00754793|463934727|FG001|Overall Study|voluntary withdrawn from study|1|||
128902068|NCT02943564|463934728|FG000|Overall Study|Miscellaneous Reasons|0|||
128902069|NCT02943564|463934729|FG001|Overall Study|Miscellaneous Reasons|0|||
128902070|NCT02943564|463934730|FG002|Overall Study|Miscellaneous Reasons|3|||
128902071|NCT02943564|463934728|FG000|Overall Study|Site terminated by sponsor|0|||
128902072|NCT02943564|463934729|FG001|Overall Study|Site terminated by sponsor|1|||
128902073|NCT02943564|463934730|FG002|Overall Study|Site terminated by sponsor|0|||
128902074|NCT02943564|463934728|FG000|Overall Study|Non-compliance with study drug|0|||
128902075|NCT02943564|463934729|FG001|Overall Study|Non-compliance with study drug|1|||
128902076|NCT02943564|463934730|FG002|Overall Study|Non-compliance with study drug|0|||
128902077|NCT02943564|463934728|FG000|Overall Study|Pregnancy|0|||
129024621|NCT01117623|464383116|FG006|Overall Study|Adverse Event|0|||
129024622|NCT01117623|464383117|FG007|Overall Study|Adverse Event|2|||
129024623|NCT01117623|464383110|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
129024624|NCT01117623|464383111|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
129024625|NCT01117623|464383112|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
129024626|NCT01117623|464383113|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
129024627|NCT01117623|464383114|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
129024628|NCT01117623|464383115|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
129024629|NCT01117623|464383116|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
129024630|NCT01117623|464383117|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
129024631|NCT01117623|464383110|FG000|Overall Study|Withdrawal by Subject|0|||
129024632|NCT01117623|464383111|FG001|Overall Study|Withdrawal by Subject|0|||
129024633|NCT01117623|464383112|FG002|Overall Study|Withdrawal by Subject|2|||
129024634|NCT01117623|464383113|FG003|Overall Study|Withdrawal by Subject|0|||
129024635|NCT01117623|464383114|FG004|Overall Study|Withdrawal by Subject|0|||
128693587|NCT03758443|463177749|FG002|Extended Induction Period|Withdrawal by Subject|7|||
128693588|NCT03758443|463177750|FG003|Extended Induction Period|Withdrawal by Subject|3|||
128902078|NCT02943564|463934729|FG001|Overall Study|Pregnancy|1|||
129024636|NCT01117623|464383115|FG005|Overall Study|Withdrawal by Subject|1|||
128902079|NCT02943564|463934730|FG002|Overall Study|Pregnancy|1|||
129024637|NCT01117623|464383116|FG006|Overall Study|Withdrawal by Subject|1|||
128902080|NCT02943564|463934728|FG000|Overall Study|Protocol Violation|2|||
128902081|NCT02943564|463934729|FG001|Overall Study|Protocol Violation|2|||
128902082|NCT02943564|463934730|FG002|Overall Study|Protocol Violation|2|||
128902083|NCT02943564|463934728|FG000|Overall Study|Lost to Follow-up|1|||
128902084|NCT02943564|463934729|FG001|Overall Study|Lost to Follow-up|0|||
128902085|NCT02943564|463934730|FG002|Overall Study|Lost to Follow-up|0|||
128902086|NCT02943564|463934728|FG000|Overall Study|Withdrawal by Subject|6|||
129113954|NCT03638128|464713030|FG000|Overall Study|Lost to Follow-up|0|||
129113955|NCT03638128|464713031|FG001|Overall Study|Lost to Follow-up|0|||
129113956|NCT03638128|464713032|FG002|Overall Study|Lost to Follow-up|1|||
129113957|NCT00329108|464713034|FG000|Overall Study|Adverse Event|2|||
129113958|NCT00329108|464713035|FG001|Overall Study|Adverse Event|2|||
129113959|NCT00329108|464713034|FG000|Overall Study|Lack of Efficacy|3|||
129113960|NCT00329108|464713035|FG001|Overall Study|Lack of Efficacy|3|||
129113961|NCT00329108|464713034|FG000|Overall Study|Withdrawal by Subject|0|||
129113962|NCT00329108|464713035|FG001|Overall Study|Withdrawal by Subject|2|||
129113963|NCT00329108|464713034|FG000|Overall Study|symptomatic deterioration|1|||
129113964|NCT00329108|464713035|FG001|Overall Study|symptomatic deterioration|1|||
129113965|NCT00329108|464713034|FG000|Overall Study|Subject no longer willing to participate|2|||
129113966|NCT00329108|464713035|FG001|Overall Study|Subject no longer willing to participate|2|||
129113967|NCT00329108|464713034|FG000|Overall Study|study terminated by sponsor|1|||
129113968|NCT00329108|464713035|FG001|Overall Study|study terminated by sponsor|0|||
129113969|NCT00329108|464713034|FG000|Overall Study|withdrew patient after SAE resolved|1|||
129113970|NCT00329108|464713035|FG001|Overall Study|withdrew patient after SAE resolved|0|||
129113971|NCT00329108|464713034|FG000|Overall Study|Protocol Violation|0|||
129113972|NCT00329108|464713035|FG001|Overall Study|Protocol Violation|2|||
129113973|NCT00903201|464713036|FG000|Overall Study|Adverse Event|1|||
129113974|NCT00903201|464713037|FG001|Overall Study|Adverse Event|4|||
129113975|NCT00903201|464713038|FG002|Overall Study|Adverse Event|0|||
129113976|NCT00903201|464713036|FG000|Overall Study|Protocol Violation|2|||
129113977|NCT00903201|464713037|FG001|Overall Study|Protocol Violation|1|||
129113978|NCT00903201|464713038|FG002|Overall Study|Protocol Violation|0|||
129113979|NCT00903201|464713036|FG000|Overall Study|Lost to Follow-up|0|||
129113980|NCT00903201|464713037|FG001|Overall Study|Lost to Follow-up|1|||
129113981|NCT00903201|464713038|FG002|Overall Study|Lost to Follow-up|0|||
129113982|NCT00903201|464713036|FG000|Overall Study|Physician Decision|1|||
129113983|NCT00903201|464713037|FG001|Overall Study|Physician Decision|0|||
129113984|NCT00903201|464713038|FG002|Overall Study|Physician Decision|1|||
129113985|NCT00903201|464713036|FG000|Overall Study|Withdrawal by Subject|1|||
129113986|NCT00903201|464713037|FG001|Overall Study|Withdrawal by Subject|0|||
129113987|NCT00903201|464713038|FG002|Overall Study|Withdrawal by Subject|1|||
129113988|NCT01094288|464713039|FG000|Overall Study|Adverse Event|0|||
129113989|NCT01094288|464713040|FG001|Overall Study|Adverse Event|3|||
129113990|NCT01094288|464713041|FG002|Overall Study|Adverse Event|1|||
129113991|NCT01094288|464713042|FG003|Overall Study|Adverse Event|1|||
129113992|NCT01094288|464713043|FG004|Overall Study|Adverse Event|0|||
129113993|NCT01094288|464713044|FG005|Overall Study|Adverse Event|0|||
129113994|NCT01094288|464713045|FG006|Overall Study|Adverse Event|0|||
129113995|NCT01094288|464713046|FG007|Overall Study|Adverse Event|0|||
129113996|NCT01094288|464713039|FG000|Overall Study|Withdrawal by Subject|0|||
129113997|NCT01094288|464713040|FG001|Overall Study|Withdrawal by Subject|1|||
129113998|NCT01094288|464713041|FG002|Overall Study|Withdrawal by Subject|2|||
129113999|NCT01094288|464713042|FG003|Overall Study|Withdrawal by Subject|0|||
129114000|NCT01094288|464713043|FG004|Overall Study|Withdrawal by Subject|0|||
129114001|NCT01094288|464713044|FG005|Overall Study|Withdrawal by Subject|0|||
129114002|NCT01094288|464713045|FG006|Overall Study|Withdrawal by Subject|0|||
129114003|NCT01094288|464713046|FG007|Overall Study|Withdrawal by Subject|2|||
129114004|NCT01094288|464713039|FG000|Overall Study|Initiation of Alternative Therapy|0|||
129114005|NCT01094288|464713040|FG001|Overall Study|Initiation of Alternative Therapy|0|||
129114006|NCT01094288|464713041|FG002|Overall Study|Initiation of Alternative Therapy|1|||
129114007|NCT01094288|464713042|FG003|Overall Study|Initiation of Alternative Therapy|0|||
129114008|NCT01094288|464713043|FG004|Overall Study|Initiation of Alternative Therapy|0|||
129114009|NCT01094288|464713044|FG005|Overall Study|Initiation of Alternative Therapy|0|||
129114010|NCT01094288|464713045|FG006|Overall Study|Initiation of Alternative Therapy|0|||
129114011|NCT01094288|464713046|FG007|Overall Study|Initiation of Alternative Therapy|0|||
129114012|NCT01094288|464713039|FG000|Overall Study|Reason not Specified|2|||
129114013|NCT01094288|464713040|FG001|Overall Study|Reason not Specified|3|||
129114014|NCT01094288|464713041|FG002|Overall Study|Reason not Specified|0|||
129114015|NCT01094288|464713042|FG003|Overall Study|Reason not Specified|1|||
129114016|NCT01094288|464713043|FG004|Overall Study|Reason not Specified|0|||
129114017|NCT01094288|464713044|FG005|Overall Study|Reason not Specified|0|||
129114018|NCT01094288|464713045|FG006|Overall Study|Reason not Specified|0|||
129114019|NCT01094288|464713046|FG007|Overall Study|Reason not Specified|0|||
129114020|NCT01094288|464713039|FG000|Overall Study|Ongoing Participants|0|||
129114021|NCT01094288|464713040|FG001|Overall Study|Ongoing Participants|3|||
129114022|NCT01094288|464713041|FG002|Overall Study|Ongoing Participants|0|||
129114023|NCT01094288|464713042|FG003|Overall Study|Ongoing Participants|0|||
129114024|NCT01094288|464713043|FG004|Overall Study|Ongoing Participants|0|||
129114025|NCT01094288|464713044|FG005|Overall Study|Ongoing Participants|0|||
129114026|NCT01094288|464713045|FG006|Overall Study|Ongoing Participants|0|||
129114027|NCT01094288|464713046|FG007|Overall Study|Ongoing Participants|0|||
129114028|NCT02611882|464713049|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
129114029|NCT02611882|464713050|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
128902087|NCT02943564|463934729|FG001|Overall Study|Withdrawal by Subject|5|||
129114030|NCT02611882|464713051|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
129114031|NCT01389232|464713052|FG000|Overall Study|Had scaffold removed|15|||
129114032|NCT01389232|464713052|FG000|Overall Study|Personal reasons|2|||
129114033|NCT01389232|464713052|FG000|Overall Study|Adverse Event|1|||
129114034|NCT01389232|464713052|FG000|Overall Study|Death|1|||
129114035|NCT01317940|464713053|FG000|Overall Study|Death|1|||
129114036|NCT01317940|464713054|FG001|Overall Study|Death|0|||
129114037|NCT01317940|464713055|FG002|Overall Study|Death|1|||
129114038|NCT01317940|464713056|FG003|Overall Study|Death|0|||
129114039|NCT01317940|464713057|FG004|Overall Study|Death|0|||
129114040|NCT01317940|464713058|FG005|Overall Study|Death|0|||
129114041|NCT01317940|464713053|FG000|Overall Study|Lost to Follow-up|0|||
129114042|NCT01317940|464713054|FG001|Overall Study|Lost to Follow-up|0|||
128902088|NCT02943564|463934730|FG002|Overall Study|Withdrawal by Subject|2|||
128902089|NCT02943564|463934728|FG000|Overall Study|Adverse Event|1|||
128902090|NCT02943564|463934729|FG001|Overall Study|Adverse Event|2|||
128902091|NCT02943564|463934730|FG002|Overall Study|Adverse Event|1|||
128902092|NCT02943564|463934728|FG000|Overall Study|Lack of Efficacy|0|||
128902093|NCT02943564|463934729|FG001|Overall Study|Lack of Efficacy|1|||
128902094|NCT02943564|463934730|FG002|Overall Study|Lack of Efficacy|0|||
128902095|NCT01073267|463934734|FG000|Overall Study|Disease Progression|3|||
128902096|NCT01225731|463934735|FG000|Part 1|Did not meet eligibility criteria|1|||
128902097|NCT01225731|463934736|FG001|Part 1|Did not meet eligibility criteria|0|||
128902098|NCT01225731|463934737|FG002|Part 1|Did not meet eligibility criteria|0|||
128902099|NCT01225731|463934738|FG003|Part 1|Did not meet eligibility criteria|0|||
128902100|NCT01225731|463934739|FG004|Part 1|Did not meet eligibility criteria|1|||
128902101|NCT01225731|463934740|FG005|Part 1|Did not meet eligibility criteria|0|||
128902102|NCT01225731|463934741|FG006|Part 1|Did not meet eligibility criteria|0|||
128902103|NCT01225731|463934742|FG007|Part 1|Did not meet eligibility criteria|0|||
128902104|NCT01225731|463934743|FG008|Part 1|Did not meet eligibility criteria|0|||
128902105|NCT01225731|463934744|FG009|Part 1|Did not meet eligibility criteria|0|||
128902106|NCT01225731|463934745|FG010|Part 1|Did not meet eligibility criteria|0|||
128902107|NCT01225731|463934746|FG011|Part 1|Did not meet eligibility criteria|0|||
128902108|NCT01225731|463934747|FG012|Part 1|Did not meet eligibility criteria|0|||
128902109|NCT01225731|463934735|FG000|Part 1|Adverse Event|1|||
128902110|NCT01225731|463934736|FG001|Part 1|Adverse Event|2|||
128902111|NCT01225731|463934737|FG002|Part 1|Adverse Event|1|||
128902112|NCT01225731|463934738|FG003|Part 1|Adverse Event|1|||
128902113|NCT01225731|463934739|FG004|Part 1|Adverse Event|1|||
128902114|NCT01225731|463934740|FG005|Part 1|Adverse Event|0|||
128902115|NCT01225731|463934741|FG006|Part 1|Adverse Event|0|||
128902116|NCT01225731|463934742|FG007|Part 1|Adverse Event|0|||
128902117|NCT01225731|463934743|FG008|Part 1|Adverse Event|0|||
128902118|NCT01225731|463934744|FG009|Part 1|Adverse Event|0|||
128902119|NCT01225731|463934745|FG010|Part 1|Adverse Event|0|||
128902120|NCT01225731|463934746|FG011|Part 1|Adverse Event|0|||
128902121|NCT01225731|463934747|FG012|Part 1|Adverse Event|0|||
128902122|NCT01225731|463934735|FG000|Part 1|Withdrawal by Subject|0|||
128902123|NCT01225731|463934736|FG001|Part 1|Withdrawal by Subject|3|||
128902124|NCT01225731|463934737|FG002|Part 1|Withdrawal by Subject|0|||
128902125|NCT01225731|463934738|FG003|Part 1|Withdrawal by Subject|0|||
128902126|NCT01225731|463934739|FG004|Part 1|Withdrawal by Subject|4|||
128902127|NCT01225731|463934740|FG005|Part 1|Withdrawal by Subject|0|||
128902128|NCT01225731|463934741|FG006|Part 1|Withdrawal by Subject|0|||
128902129|NCT01225731|463934742|FG007|Part 1|Withdrawal by Subject|0|||
128902130|NCT01225731|463934743|FG008|Part 1|Withdrawal by Subject|0|||
128902131|NCT01225731|463934744|FG009|Part 1|Withdrawal by Subject|0|||
128902132|NCT01225731|463934745|FG010|Part 1|Withdrawal by Subject|0|||
128902133|NCT01225731|463934746|FG011|Part 1|Withdrawal by Subject|0|||
128902134|NCT01225731|463934747|FG012|Part 1|Withdrawal by Subject|0|||
128902135|NCT01225731|463934735|FG000|Part 1|Protocol Violation|0|||
129114043|NCT01317940|464713055|FG002|Overall Study|Lost to Follow-up|1|||
129114044|NCT01317940|464713056|FG003|Overall Study|Lost to Follow-up|1|||
128902136|NCT01225731|463934736|FG001|Part 1|Protocol Violation|0|||
128902137|NCT01225731|463934737|FG002|Part 1|Protocol Violation|0|||
128902138|NCT01225731|463934738|FG003|Part 1|Protocol Violation|1|||
129114045|NCT01317940|464713057|FG004|Overall Study|Lost to Follow-up|1|||
128902139|NCT01225731|463934739|FG004|Part 1|Protocol Violation|0|||
128902140|NCT01225731|463934740|FG005|Part 1|Protocol Violation|0|||
128902141|NCT01225731|463934741|FG006|Part 1|Protocol Violation|0|||
128902142|NCT01225731|463934742|FG007|Part 1|Protocol Violation|0|||
128902143|NCT01225731|463934743|FG008|Part 1|Protocol Violation|0|||
128902144|NCT01225731|463934744|FG009|Part 1|Protocol Violation|0|||
128902145|NCT01225731|463934745|FG010|Part 1|Protocol Violation|0|||
129114046|NCT01317940|464713058|FG005|Overall Study|Lost to Follow-up|0|||
129114047|NCT01317940|464713053|FG000|Overall Study|Change in therapy plan|0|||
129114048|NCT01317940|464713054|FG001|Overall Study|Change in therapy plan|0|||
128902146|NCT01225731|463934746|FG011|Part 1|Protocol Violation|0|||
128902147|NCT01225731|463934747|FG012|Part 1|Protocol Violation|0|||
128902148|NCT01225731|463934735|FG000|Part 2|Protocol Violation|0|||
129114049|NCT01317940|464713055|FG002|Overall Study|Change in therapy plan|3|||
128693589|NCT03758443|463177747|FG000|Extended Induction Period|Miscellaneous|1|||
128902149|NCT01225731|463934736|FG001|Part 2|Protocol Violation|0|||
128902150|NCT01225731|463934737|FG002|Part 2|Protocol Violation|0|||
128902151|NCT01225731|463934738|FG003|Part 2|Protocol Violation|0|||
128902152|NCT01225731|463934739|FG004|Part 2|Protocol Violation|0|||
128902153|NCT01225731|463934740|FG005|Part 2|Protocol Violation|1|||
128902154|NCT01225731|463934741|FG006|Part 2|Protocol Violation|0|||
128902155|NCT01225731|463934742|FG007|Part 2|Protocol Violation|0|||
128902156|NCT01225731|463934743|FG008|Part 2|Protocol Violation|1|||
128902157|NCT01225731|463934744|FG009|Part 2|Protocol Violation|0|||
128902158|NCT01225731|463934745|FG010|Part 2|Protocol Violation|0|||
128902159|NCT01225731|463934746|FG011|Part 2|Protocol Violation|0|||
128902160|NCT01225731|463934747|FG012|Part 2|Protocol Violation|0|||
128902161|NCT01225731|463934735|FG000|Part 2|Adverse Event|0|||
128902162|NCT01225731|463934736|FG001|Part 2|Adverse Event|0|||
128902163|NCT01225731|463934737|FG002|Part 2|Adverse Event|0|||
128902164|NCT01225731|463934738|FG003|Part 2|Adverse Event|0|||
128902165|NCT01225731|463934739|FG004|Part 2|Adverse Event|0|||
128902166|NCT01225731|463934740|FG005|Part 2|Adverse Event|0|||
128902167|NCT01225731|463934741|FG006|Part 2|Adverse Event|4|||
128902168|NCT01225731|463934742|FG007|Part 2|Adverse Event|4|||
128902169|NCT01225731|463934743|FG008|Part 2|Adverse Event|2|||
128902170|NCT01225731|463934744|FG009|Part 2|Adverse Event|0|||
128902171|NCT01225731|463934745|FG010|Part 2|Adverse Event|0|||
128902172|NCT01225731|463934746|FG011|Part 2|Adverse Event|0|||
128902173|NCT01225731|463934747|FG012|Part 2|Adverse Event|0|||
128902174|NCT01225731|463934735|FG000|Part 2|Lack of Efficacy|0|||
128902175|NCT01225731|463934736|FG001|Part 2|Lack of Efficacy|0|||
128902176|NCT01225731|463934737|FG002|Part 2|Lack of Efficacy|0|||
128902177|NCT01225731|463934738|FG003|Part 2|Lack of Efficacy|0|||
128902178|NCT01225731|463934739|FG004|Part 2|Lack of Efficacy|0|||
128902179|NCT01225731|463934740|FG005|Part 2|Lack of Efficacy|1|||
128902180|NCT01225731|463934741|FG006|Part 2|Lack of Efficacy|0|||
129024638|NCT01117623|464383117|FG007|Overall Study|Withdrawal by Subject|1|||
129024639|NCT01117623|464383110|FG000|Overall Study|Non-compliance with study medication|0|||
129024640|NCT01117623|464383111|FG001|Overall Study|Non-compliance with study medication|0|||
129024641|NCT01117623|464383112|FG002|Overall Study|Non-compliance with study medication|0|||
129024642|NCT01117623|464383113|FG003|Overall Study|Non-compliance with study medication|0|||
129024643|NCT01117623|464383114|FG004|Overall Study|Non-compliance with study medication|0|||
128693590|NCT03758443|463177748|FG001|Extended Induction Period|Miscellaneous|0|||
128902181|NCT01225731|463934742|FG007|Part 2|Lack of Efficacy|12|||
128902182|NCT01225731|463934743|FG008|Part 2|Lack of Efficacy|3|||
129024644|NCT01117623|464383115|FG005|Overall Study|Non-compliance with study medication|0|||
129024645|NCT01117623|464383116|FG006|Overall Study|Non-compliance with study medication|0|||
129024646|NCT01117623|464383117|FG007|Overall Study|Non-compliance with study medication|1|||
129024647|NCT01117623|464383110|FG000|Overall Study|Invest. text: completed all planned txs|0|||
129024648|NCT01117623|464383111|FG001|Overall Study|Invest. text: completed all planned txs|0|||
129024649|NCT01117623|464383112|FG002|Overall Study|Invest. text: completed all planned txs|0|||
129024650|NCT01117623|464383113|FG003|Overall Study|Invest. text: completed all planned txs|0|||
129024651|NCT01117623|464383114|FG004|Overall Study|Invest. text: completed all planned txs|0|||
129024652|NCT01117623|464383115|FG005|Overall Study|Invest. text: completed all planned txs|1|||
129024653|NCT01117623|464383116|FG006|Overall Study|Invest. text: completed all planned txs|0|||
129024654|NCT01117623|464383117|FG007|Overall Study|Invest. text: completed all planned txs|0|||
129024655|NCT01896934|464383122|FG000|Overall Study|Adverse Event|1|||
129024656|NCT01896934|464383122|FG000|Overall Study|Withdrawal by Subject|1|||
129024657|NCT00395694|464383124|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
129024658|NCT00395694|464383125|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
129024659|NCT00395694|464383124|FG000|Continuation Phase|Adverse Event|1|||
129024660|NCT00395694|464383125|FG001|Continuation Phase|Adverse Event|0|||
129114050|NCT01317940|464713056|FG003|Overall Study|Change in therapy plan|0|||
129114051|NCT01317940|464713057|FG004|Overall Study|Change in therapy plan|0|||
128902183|NCT01225731|463934744|FG009|Part 2|Lack of Efficacy|0|||
128902184|NCT01225731|463934745|FG010|Part 2|Lack of Efficacy|0|||
128902185|NCT01225731|463934746|FG011|Part 2|Lack of Efficacy|0|||
128902186|NCT01225731|463934747|FG012|Part 2|Lack of Efficacy|0|||
128902187|NCT01225731|463934735|FG000|Part 2|Pregnancy|0|||
128902188|NCT01225731|463934736|FG001|Part 2|Pregnancy|0|||
128902189|NCT01225731|463934737|FG002|Part 2|Pregnancy|0|||
128902190|NCT01225731|463934738|FG003|Part 2|Pregnancy|0|||
128902191|NCT01225731|463934739|FG004|Part 2|Pregnancy|0|||
128902192|NCT01225731|463934740|FG005|Part 2|Pregnancy|0|||
128902193|NCT01225731|463934741|FG006|Part 2|Pregnancy|1|||
128902194|NCT01225731|463934742|FG007|Part 2|Pregnancy|0|||
128902195|NCT01225731|463934743|FG008|Part 2|Pregnancy|1|||
128902196|NCT01225731|463934744|FG009|Part 2|Pregnancy|0|||
128902197|NCT01225731|463934745|FG010|Part 2|Pregnancy|0|||
128902198|NCT01225731|463934746|FG011|Part 2|Pregnancy|0|||
128902199|NCT01225731|463934747|FG012|Part 2|Pregnancy|0|||
128902200|NCT01225731|463934735|FG000|Part 2|Lost to Follow-up|0|||
128902201|NCT01225731|463934736|FG001|Part 2|Lost to Follow-up|0|||
128902202|NCT01225731|463934737|FG002|Part 2|Lost to Follow-up|0|||
128902203|NCT01225731|463934738|FG003|Part 2|Lost to Follow-up|0|||
128902204|NCT01225731|463934739|FG004|Part 2|Lost to Follow-up|0|||
128902205|NCT01225731|463934740|FG005|Part 2|Lost to Follow-up|0|||
128902206|NCT01225731|463934741|FG006|Part 2|Lost to Follow-up|0|||
128902207|NCT01225731|463934742|FG007|Part 2|Lost to Follow-up|3|||
128902208|NCT01225731|463934743|FG008|Part 2|Lost to Follow-up|1|||
128902209|NCT01225731|463934744|FG009|Part 2|Lost to Follow-up|0|||
128902210|NCT01225731|463934745|FG010|Part 2|Lost to Follow-up|0|||
128902211|NCT01225731|463934746|FG011|Part 2|Lost to Follow-up|0|||
128902212|NCT01225731|463934747|FG012|Part 2|Lost to Follow-up|0|||
128902213|NCT01225731|463934735|FG000|Part 2|Physician Decision|0|||
128902214|NCT01225731|463934736|FG001|Part 2|Physician Decision|0|||
128902215|NCT01225731|463934737|FG002|Part 2|Physician Decision|0|||
128902216|NCT01225731|463934738|FG003|Part 2|Physician Decision|0|||
128902217|NCT01225731|463934739|FG004|Part 2|Physician Decision|0|||
128902218|NCT01225731|463934740|FG005|Part 2|Physician Decision|0|||
128902219|NCT01225731|463934741|FG006|Part 2|Physician Decision|0|||
128902220|NCT01225731|463934742|FG007|Part 2|Physician Decision|2|||
128902221|NCT01225731|463934743|FG008|Part 2|Physician Decision|2|||
128902222|NCT01225731|463934744|FG009|Part 2|Physician Decision|0|||
128902223|NCT01225731|463934745|FG010|Part 2|Physician Decision|0|||
128902224|NCT01225731|463934746|FG011|Part 2|Physician Decision|0|||
129114052|NCT01317940|464713058|FG005|Overall Study|Change in therapy plan|0|||
129114053|NCT02371616|464713060|FG000|Overall Study|Protocol Violation|2|||
129114054|NCT02371616|464713061|FG001|Overall Study|Protocol Violation|1|||
129114055|NCT02371616|464713060|FG000|Overall Study|Adverse Event|0|||
129114056|NCT02371616|464713061|FG001|Overall Study|Adverse Event|1|||
129114057|NCT02371616|464713060|FG000|Overall Study|Withdrawal of Consent|1|||
129114058|NCT02371616|464713061|FG001|Overall Study|Withdrawal of Consent|0|||
129114059|NCT02371616|464713060|FG000|Overall Study|Other (Not specified)|1|||
129114060|NCT02371616|464713061|FG001|Overall Study|Other (Not specified)|5|||
129114061|NCT00754741|464713062|FG000|Overall Study|Died or disenrolled|57|||
129114062|NCT00754741|464713063|FG001|Overall Study|Died or disenrolled|69|||
129114063|NCT00754741|464713064|FG002|Overall Study|Died or disenrolled|54|||
129114064|NCT04152200|464713066|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
129114065|NCT04152200|464713067|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
129114066|NCT00593814|464713068|FG000|Overall Study|Death|7|||
128693591|NCT03758443|463177749|FG002|Extended Induction Period|Miscellaneous|0|||
128693592|NCT03758443|463177750|FG003|Extended Induction Period|Miscellaneous|0|||
128693593|NCT03758443|463177747|FG000|Maintenance Period|Adverse Event|1|||
128693594|NCT03758443|463177748|FG001|Maintenance Period|Adverse Event|2|||
129114067|NCT00593814|464713069|FG001|Overall Study|Death|0|||
129114068|NCT00593814|464713068|FG000|Overall Study|Withdrawal by Subject|7|||
129114069|NCT00593814|464713069|FG001|Overall Study|Withdrawal by Subject|0|||
129114070|NCT00593814|464713068|FG000|Overall Study|Lost to Follow-up|7|||
128693595|NCT03758443|463177749|FG002|Maintenance Period|Adverse Event|0|||
129114071|NCT00593814|464713069|FG001|Overall Study|Lost to Follow-up|0|||
129114072|NCT00593814|464713068|FG000|Overall Study|Physician Decision|3|||
129114073|NCT00593814|464713069|FG001|Overall Study|Physician Decision|0|||
129114074|NCT02699996|464713070|FG000|Overall Study|Withdrawal by Subject|5|||
129114075|NCT02699996|464713071|FG001|Overall Study|Withdrawal by Subject|2|||
129114076|NCT04069715|464713072|FG000|Overall Study|Lost to Follow-up|1|||
129114077|NCT04069715|464713073|FG001|Overall Study|Lost to Follow-up|1|||
129114078|NCT04069715|464713072|FG000|Overall Study|Physician Decision|1|||
129114079|NCT04069715|464713073|FG001|Overall Study|Physician Decision|1|||
129114080|NCT04069715|464713072|FG000|Overall Study|Withdrawal by Subject|3|||
129114081|NCT04069715|464713073|FG001|Overall Study|Withdrawal by Subject|3|||
129114082|NCT03205150|464713074|FG000|Overall Study|Protocol deviation|1|||
129114083|NCT03205150|464713075|FG001|Overall Study|Protocol deviation|3|||
129114084|NCT03205150|464713076|FG002|Overall Study|Protocol deviation|0|||
129114085|NCT03205150|464713074|FG000|Overall Study|Patient/guardian decision|0|||
129114086|NCT03205150|464713075|FG001|Overall Study|Patient/guardian decision|3|||
129114087|NCT03205150|464713076|FG002|Overall Study|Patient/guardian decision|0|||
128902225|NCT01225731|463934747|FG012|Part 2|Physician Decision|0|||
128902226|NCT01225731|463934735|FG000|Part 2|Withdrawal by Subject|0|||
128902227|NCT01225731|463934736|FG001|Part 2|Withdrawal by Subject|0|||
128902228|NCT01225731|463934737|FG002|Part 2|Withdrawal by Subject|0|||
128693596|NCT03758443|463177750|FG003|Maintenance Period|Adverse Event|0|||
128693597|NCT03758443|463177747|FG000|Maintenance Period|Lost to Follow-up|0|||
128902229|NCT01225731|463934738|FG003|Part 2|Withdrawal by Subject|0|||
128902230|NCT01225731|463934739|FG004|Part 2|Withdrawal by Subject|0|||
128693598|NCT03758443|463177748|FG001|Maintenance Period|Lost to Follow-up|0|||
128693599|NCT03758443|463177749|FG002|Maintenance Period|Lost to Follow-up|0|||
128764683|NCT00539643|463430261|FG000|Overall Study|Physician Decision|3|||
129114088|NCT03205150|464713074|FG000|Overall Study|Adverse Event|1|||
129114089|NCT03205150|464713075|FG001|Overall Study|Adverse Event|1|||
129114090|NCT03205150|464713076|FG002|Overall Study|Adverse Event|1|||
128693600|NCT03758443|463177750|FG003|Maintenance Period|Lost to Follow-up|1|||
128902231|NCT01225731|463934740|FG005|Part 2|Withdrawal by Subject|1|||
128902232|NCT01225731|463934741|FG006|Part 2|Withdrawal by Subject|3|||
128693601|NCT03758443|463177747|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
128693602|NCT03758443|463177748|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
128693603|NCT03758443|463177749|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
128693604|NCT03758443|463177750|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
128693605|NCT03758443|463177747|FG000|Maintenance Period|Protocol Violation|0|||
128693606|NCT03758443|463177748|FG001|Maintenance Period|Protocol Violation|1|||
128693607|NCT03758443|463177749|FG002|Maintenance Period|Protocol Violation|0|||
128693608|NCT03758443|463177750|FG003|Maintenance Period|Protocol Violation|0|||
128693609|NCT03758443|463177747|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
128902233|NCT01225731|463934742|FG007|Part 2|Withdrawal by Subject|4|||
128902234|NCT01225731|463934743|FG008|Part 2|Withdrawal by Subject|1|||
129024661|NCT00395694|464383124|FG000|Continuation Phase|Lack of Efficacy|12|||
129024662|NCT00395694|464383125|FG001|Continuation Phase|Lack of Efficacy|11|||
129024663|NCT00395694|464383124|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
129024664|NCT00395694|464383125|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
129024665|NCT00395694|464383124|FG000|Continuation Phase|Poor Compliance|1|||
129024666|NCT00395694|464383125|FG001|Continuation Phase|Poor Compliance|0|||
129024667|NCT00395694|464383124|FG000|Continuation Phase|Withdrawal by Subject|0|||
129024668|NCT00395694|464383125|FG001|Continuation Phase|Withdrawal by Subject|2|||
129024669|NCT01959672|464383129|FG000|Overall Study|Death|1|||
129024670|NCT00840216|464383130|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129024671|NCT00840216|464383131|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129024672|NCT01058668|464383132|FG000|Double-blind Treatment Phase|Adverse Event|8|||
129024673|NCT01058668|464383133|FG001|Double-blind Treatment Phase|Adverse Event|15|||
129024674|NCT01058668|464383134|FG002|Double-blind Treatment Phase|Adverse Event|25|||
129024675|NCT01058668|464383132|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
129024676|NCT01058668|464383133|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
129024677|NCT01058668|464383134|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
129024678|NCT01058668|464383132|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
129024679|NCT01058668|464383133|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
129024680|NCT01058668|464383134|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
129024681|NCT01058668|464383132|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
129024682|NCT01058668|464383133|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
129024683|NCT01058668|464383134|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
129024684|NCT01058668|464383132|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129024685|NCT01058668|464383133|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
129024686|NCT01058668|464383134|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
129024687|NCT01058668|464383132|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
129024688|NCT01058668|464383133|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
129024689|NCT01058668|464383134|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
129024690|NCT03605342|464383141|FG000|Overall Study|Withdrawal by Subject|9|||
129024691|NCT03605342|464383142|FG001|Overall Study|Withdrawal by Subject|7|||
129024692|NCT03605342|464383141|FG000|Overall Study|Lost to Follow-up|1|||
129024693|NCT03605342|464383142|FG001|Overall Study|Lost to Follow-up|1|||
129024694|NCT00796328|464383143|FG000|Overall Study|experienced hypotension requiring tx|6|||
129024695|NCT02842853|464383146|FG000|Overall Study|Non-compliance with the protocol|3|||
129024696|NCT02842853|464383147|FG001|Overall Study|Non-compliance with the protocol|7|||
129024697|NCT02842853|464383148|FG002|Overall Study|Non-compliance with the protocol|2|||
129024698|NCT02842853|464383149|FG003|Overall Study|Non-compliance with the protocol|5|||
129024699|NCT02842853|464383146|FG000|Overall Study|Subject met exclusion criteria|0|||
129024700|NCT02842853|464383147|FG001|Overall Study|Subject met exclusion criteria|1|||
129024701|NCT02842853|464383148|FG002|Overall Study|Subject met exclusion criteria|0|||
129024702|NCT02842853|464383149|FG003|Overall Study|Subject met exclusion criteria|0|||
129024703|NCT02842853|464383146|FG000|Overall Study|Withdrawal by Subject|11|||
129024704|NCT02842853|464383147|FG001|Overall Study|Withdrawal by Subject|13|||
129024705|NCT02842853|464383148|FG002|Overall Study|Withdrawal by Subject|9|||
129024706|NCT02842853|464383149|FG003|Overall Study|Withdrawal by Subject|8|||
129024707|NCT02842853|464383146|FG000|Overall Study|Lost to Follow-up|9|||
129024708|NCT02842853|464383147|FG001|Overall Study|Lost to Follow-up|13|||
129024709|NCT02842853|464383148|FG002|Overall Study|Lost to Follow-up|10|||
129024710|NCT02842853|464383149|FG003|Overall Study|Lost to Follow-up|11|||
129024711|NCT04089553|464383150|FG000|Overall Study|Death|1|||
129024712|NCT04089553|464383151|FG001|Overall Study|Death|1|||
129024713|NCT04089553|464383150|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
129024714|NCT04089553|464383151|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
128902235|NCT01225731|463934744|FG009|Part 2|Withdrawal by Subject|0|||
129024715|NCT04089553|464383150|FG000|Overall Study|Withdrawal by Subject|3|||
129024716|NCT04089553|464383151|FG001|Overall Study|Withdrawal by Subject|3|||
129024717|NCT04089553|464383150|FG000|Overall Study|Physician Decision|1|||
129024718|NCT04089553|464383151|FG001|Overall Study|Physician Decision|0|||
129024719|NCT04089553|464383150|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
128693610|NCT03758443|463177748|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
128693611|NCT03758443|463177749|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
128693612|NCT03758443|463177750|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
128693613|NCT03758443|463177747|FG000|Maintenance Period|Withdrawal by Subject|1|||
128693614|NCT03758443|463177748|FG001|Maintenance Period|Withdrawal by Subject|0|||
128693615|NCT03758443|463177749|FG002|Maintenance Period|Withdrawal by Subject|1|||
128902236|NCT01225731|463934745|FG010|Part 2|Withdrawal by Subject|0|||
129024720|NCT04089553|464383151|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
129024721|NCT04089553|464383150|FG000|Overall Study|Other|1|||
129024722|NCT04089553|464383151|FG001|Overall Study|Other|0|||
129024723|NCT04089553|464383150|FG000|Overall Study|Adverse Event|1|||
129024724|NCT04089553|464383151|FG001|Overall Study|Adverse Event|1|||
129024725|NCT01403194|464383159|FG000|Overall Study|Screen Failure|2|||
129024726|NCT01403194|464383159|FG000|Overall Study|Lost to Follow-up|8|||
129024727|NCT00107991|464383164|FG000|Eligibility Assessment|Disease not severe enough|7|||
129024728|NCT00107991|464383164|FG000|Eligibility Assessment|Unwilling to participate|7|||
129024729|NCT00107991|464383164|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
129024730|NCT00107991|464383164|FG000|Eligibility Assessment|Abnormal labs|2|||
129024731|NCT00107991|464383164|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
129024732|NCT00107991|464383164|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
129024733|NCT00107991|464383164|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
129024734|NCT00107991|464383164|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
129024735|NCT00107991|464383164|FG000|12 Week Treatment Period|Adverse Event|1|||
129024736|NCT00107991|464383164|FG000|12 Week Treatment Period|Protocol Violation|1|||
129024737|NCT00107991|464383164|FG000|12 Week Treatment Period|Incarcerated|1|||
129024738|NCT00107991|464383164|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
129024739|NCT00506831|464383171|FG000|Overall Study|Death|1|||
129024740|NCT00506831|464383171|FG000|Overall Study|Withdrawal by Subject|1|||
129024741|NCT01808651|464383175|FG000|Study Period 1|Lost to Follow-up|1|||
129024742|NCT01808651|464383176|FG001|Study Period 1|Lost to Follow-up|3|||
129024743|NCT01808651|464383177|FG002|Study Period 1|Lost to Follow-up|0|||
129024744|NCT01808651|464383175|FG000|Study Period 1|Protocol Violation|1|||
129024745|NCT01808651|464383176|FG001|Study Period 1|Protocol Violation|0|||
129024746|NCT01808651|464383177|FG002|Study Period 1|Protocol Violation|1|||
129024747|NCT01808651|464383175|FG000|Study Period 1|Physician Decision|3|||
129024748|NCT01808651|464383176|FG001|Study Period 1|Physician Decision|2|||
129024749|NCT01808651|464383177|FG002|Study Period 1|Physician Decision|0|||
129024750|NCT01808651|464383175|FG000|Study Period 1|Lack of Efficacy|2|||
129024751|NCT01808651|464383176|FG001|Study Period 1|Lack of Efficacy|1|||
129024752|NCT01808651|464383177|FG002|Study Period 1|Lack of Efficacy|0|||
129024753|NCT01808651|464383175|FG000|Study Period 1|Adverse Event|10|||
129024754|NCT01808651|464383176|FG001|Study Period 1|Adverse Event|4|||
129024755|NCT01808651|464383177|FG002|Study Period 1|Adverse Event|1|||
129024756|NCT01808651|464383175|FG000|Study Period 1|Participant Decision|9|||
129024757|NCT01808651|464383176|FG001|Study Period 1|Participant Decision|7|||
129024758|NCT01808651|464383177|FG002|Study Period 1|Participant Decision|3|||
129024759|NCT02488239|464383178|FG000|Overall Study|Death|3|||
129024760|NCT02488239|464383178|FG000|Overall Study|Withdrawal by Subject|3|||
129024761|NCT02488239|464383178|FG000|Overall Study|Physician Decision|2|||
129024762|NCT02488239|464383178|FG000|Overall Study|Consent ineligible|1|||
129024763|NCT02488239|464383178|FG000|Overall Study|Did not undergo implant procedure|1|||
129024764|NCT03957551|464383181|FG000|Overall Study|Adverse Event|2|||
129024765|NCT03957551|464383182|FG001|Overall Study|Adverse Event|2|||
129024766|NCT03957551|464383183|FG002|Overall Study|Adverse Event|6|||
129024767|NCT03957551|464383181|FG000|Overall Study|Physician Decision|1|||
129024768|NCT03957551|464383182|FG001|Overall Study|Physician Decision|0|||
129024769|NCT03957551|464383183|FG002|Overall Study|Physician Decision|2|||
129024770|NCT03957551|464383181|FG000|Overall Study|Withdrawal by Subject|1|||
129024771|NCT03957551|464383182|FG001|Overall Study|Withdrawal by Subject|0|||
129024772|NCT03957551|464383183|FG002|Overall Study|Withdrawal by Subject|2|||
129024773|NCT03957551|464383181|FG000|Overall Study|Disease progression|1|||
129024774|NCT03957551|464383182|FG001|Overall Study|Disease progression|0|||
129024775|NCT03957551|464383183|FG002|Overall Study|Disease progression|8|||
129024776|NCT00608322|464383187|FG000|Overall Study|Death|2|||
129024777|NCT00608322|464383188|FG001|Overall Study|Death|1|||
129024778|NCT00834444|464383189|FG000|First Intervention|Adverse Event|1|||
129024779|NCT00834444|464383190|FG001|First Intervention|Adverse Event|0|||
129024780|NCT00834444|464383189|FG000|First Intervention|Intolerance to Venopuncture|0|||
129024781|NCT00834444|464383190|FG001|First Intervention|Intolerance to Venopuncture|1|||
129024782|NCT00834444|464383189|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129024783|NCT00834444|464383190|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129024784|NCT00834444|464383189|FG000|Second Intervention|Adverse Event|1|||
129024785|NCT00834444|464383190|FG001|Second Intervention|Adverse Event|0|||
129024786|NCT00606281|464383193|FG000|Overall Study|Adverse Event|11|||
129024787|NCT00606281|464383194|FG001|Overall Study|Adverse Event|12|||
129024788|NCT00606281|464383193|FG000|Overall Study|Death|1|||
129024789|NCT00606281|464383194|FG001|Overall Study|Death|0|||
129024790|NCT00606281|464383193|FG000|Overall Study|Lack of Efficacy|28|||
128693616|NCT03758443|463177750|FG003|Maintenance Period|Withdrawal by Subject|1|||
129114091|NCT03205150|464713074|FG000|Overall Study|Lost to Follow-up|0|||
129114092|NCT03205150|464713075|FG001|Overall Study|Lost to Follow-up|0|||
129114093|NCT03205150|464713076|FG002|Overall Study|Lost to Follow-up|1|||
129114094|NCT02723188|464713077|FG000|Overall Study|Withdrawal by Subject|1|||
129114095|NCT02723188|464713078|FG001|Overall Study|Withdrawal by Subject|0|||
129114096|NCT02723188|464713079|FG002|Overall Study|Withdrawal by Subject|0|||
129114097|NCT01095835|464713080|FG000|Overall Study|Adverse Event|8|||
129114098|NCT01095835|464713081|FG001|Overall Study|Adverse Event|6|||
129114099|NCT01095835|464713082|FG002|Overall Study|Adverse Event|6|||
129114100|NCT01095835|464713080|FG000|Overall Study|Lack of Efficacy|0|||
129114101|NCT01095835|464713081|FG001|Overall Study|Lack of Efficacy|1|||
129114102|NCT01095835|464713082|FG002|Overall Study|Lack of Efficacy|0|||
129114103|NCT01095835|464713080|FG000|Overall Study|Physician Decision|0|||
129114104|NCT01095835|464713081|FG001|Overall Study|Physician Decision|0|||
129114105|NCT01095835|464713082|FG002|Overall Study|Physician Decision|1|||
129114106|NCT01095835|464713080|FG000|Overall Study|Withdrawal by Subject|1|||
129114107|NCT01095835|464713081|FG001|Overall Study|Withdrawal by Subject|3|||
129114108|NCT01095835|464713082|FG002|Overall Study|Withdrawal by Subject|0|||
129114109|NCT01095835|464713080|FG000|Overall Study|Non study compliance|0|||
129114110|NCT01095835|464713081|FG001|Overall Study|Non study compliance|0|||
129114111|NCT01095835|464713082|FG002|Overall Study|Non study compliance|1|||
129114112|NCT01095835|464713080|FG000|Overall Study|Protocol Violation|1|||
129114113|NCT01095835|464713081|FG001|Overall Study|Protocol Violation|2|||
129114114|NCT01095835|464713082|FG002|Overall Study|Protocol Violation|0|||
129114115|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
129114116|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
129114117|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
129114118|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
129114119|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
129114120|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
129114121|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
129114122|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
129114123|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
129114124|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
129114125|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
129114126|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
129114127|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
129114128|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
129114129|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
129114130|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
129114131|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
129114132|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
128693617|NCT03758443|463177747|FG000|Maintenance Period|Miscellaneous|0|||
128693618|NCT03758443|463177748|FG001|Maintenance Period|Miscellaneous|0|||
128693619|NCT03758443|463177749|FG002|Maintenance Period|Miscellaneous|1|||
128902237|NCT01225731|463934746|FG011|Part 2|Withdrawal by Subject|0|||
128902238|NCT01225731|463934747|FG012|Part 2|Withdrawal by Subject|0|||
129114133|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
129114134|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
129114135|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
129114136|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
129114137|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
129114138|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
129114139|NCT01198002|464713085|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
129114140|NCT01198002|464713086|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
129114141|NCT01198002|464713087|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
129114142|NCT01198002|464713085|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
129114143|NCT01198002|464713086|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
129114144|NCT01198002|464713087|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
129114145|NCT01198002|464713085|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
129114146|NCT01198002|464713086|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
129114147|NCT01198002|464713087|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
129114148|NCT01198002|464713085|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
129114149|NCT01198002|464713086|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
129114150|NCT01198002|464713087|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
129114151|NCT01198002|464713085|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
129114152|NCT01198002|464713086|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
129114153|NCT01198002|464713087|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
129114154|NCT01198002|464713085|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
128693620|NCT03758443|463177750|FG003|Maintenance Period|Miscellaneous|0|||
128764684|NCT00539643|463430262|FG001|Overall Study|Physician Decision|1|||
128693621|NCT03080454|463177751|FG000|Baseline|Adverse Event|2|||
129114155|NCT01198002|464713086|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
129114156|NCT01198002|464713087|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
129114157|NCT01198002|464713085|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
129114158|NCT01198002|464713086|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
129114159|NCT01198002|464713087|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
129114160|NCT00789321|464713095|FG000|Overall Study|Adverse Event|0|||
129114161|NCT00789321|464713096|FG001|Overall Study|Adverse Event|1|||
129114162|NCT01965327|464713097|FG000|Overall Study|Physician Decision|2|||
129114163|NCT03652818|464713102|FG000|Overall Study|Adverse Event|1|||
129114164|NCT03652818|464713103|FG001|Overall Study|Adverse Event|0|||
129114165|NCT03652818|464713104|FG002|Overall Study|Adverse Event|0|||
129114166|NCT03652818|464713105|FG003|Overall Study|Adverse Event|0|||
129114167|NCT03652818|464713106|FG004|Overall Study|Adverse Event|0|||
129114168|NCT03652818|464713102|FG000|Overall Study|Physician Decision|1|||
129114169|NCT03652818|464713103|FG001|Overall Study|Physician Decision|0|||
129114170|NCT03652818|464713104|FG002|Overall Study|Physician Decision|0|||
129114171|NCT03652818|464713105|FG003|Overall Study|Physician Decision|0|||
129114172|NCT03652818|464713106|FG004|Overall Study|Physician Decision|0|||
129114173|NCT03652818|464713102|FG000|Overall Study|Lost to Follow-up|0|||
129114174|NCT03652818|464713103|FG001|Overall Study|Lost to Follow-up|1|||
129114175|NCT03652818|464713104|FG002|Overall Study|Lost to Follow-up|2|||
129114176|NCT03652818|464713105|FG003|Overall Study|Lost to Follow-up|1|||
129114177|NCT03652818|464713106|FG004|Overall Study|Lost to Follow-up|1|||
129114178|NCT03964207|464713107|FG000|First Treatment|Withdrawal by Subject|1|||
129114179|NCT03964207|464713108|FG001|First Treatment|Withdrawal by Subject|2|||
129114180|NCT03964207|464713107|FG000|First Treatment|Protocol Violation|1|||
129114181|NCT03964207|464713108|FG001|First Treatment|Protocol Violation|0|||
129114182|NCT03964207|464713107|FG000|First Treatment|Lost to Follow-up|1|||
129114183|NCT03964207|464713108|FG001|First Treatment|Lost to Follow-up|0|||
129114184|NCT03964207|464713107|FG000|Second Treatment|Lost to Follow-up|0|||
129114185|NCT03964207|464713108|FG001|Second Treatment|Lost to Follow-up|1|||
129114186|NCT03964207|464713107|FG000|Second Treatment|Adverse Event|1|||
129114187|NCT03964207|464713108|FG001|Second Treatment|Adverse Event|2|||
129114188|NCT01930539|464713113|FG000|Overall Study|Withdrawal by Subject|2|||
129114189|NCT01930539|464713114|FG001|Overall Study|Withdrawal by Subject|2|||
129114190|NCT00830219|464713115|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129114191|NCT00830219|464713116|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129114192|NCT01294423|464713117|FG000|Overall Study|Adverse Event|1|||
129114193|NCT01294423|464713118|FG001|Overall Study|Adverse Event|2|||
129114194|NCT01294423|464713119|FG002|Overall Study|Adverse Event|3|||
129114195|NCT01294423|464713117|FG000|Overall Study|Withdrawal by Subject|1|||
129114196|NCT01294423|464713118|FG001|Overall Study|Withdrawal by Subject|2|||
129114197|NCT01294423|464713119|FG002|Overall Study|Withdrawal by Subject|2|||
129114198|NCT01294423|464713117|FG000|Overall Study|subject no longer meets study criteria|2|||
129114199|NCT01294423|464713118|FG001|Overall Study|subject no longer meets study criteria|5|||
129114200|NCT01294423|464713119|FG002|Overall Study|subject no longer meets study criteria|2|||
129114201|NCT01294423|464713117|FG000|Overall Study|poor/non-compliance|1|||
128693622|NCT03080454|463177751|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
128693623|NCT03080454|463177751|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
128693624|NCT01436396|463177752|FG000|Overall Study|Protocol Violation|7|||
128693625|NCT01436396|463177753|FG001|Overall Study|Protocol Violation|5|||
128693626|NCT01436396|463177752|FG000|Overall Study|Adverse Event|1|||
128693627|NCT01436396|463177753|FG001|Overall Study|Adverse Event|2|||
128693628|NCT01436396|463177752|FG000|Overall Study|Withdrawal by Subject|19|||
128693629|NCT01436396|463177753|FG001|Overall Study|Withdrawal by Subject|29|||
128693630|NCT01436396|463177752|FG000|Overall Study|Serious adverse event|2|||
128693631|NCT01436396|463177753|FG001|Overall Study|Serious adverse event|3|||
128693632|NCT01436396|463177752|FG000|Overall Study|Lost to Follow-up|3|||
128693633|NCT01436396|463177753|FG001|Overall Study|Lost to Follow-up|3|||
128693634|NCT00216476|463177754|FG000|Overall Study|Withdrawal by Subject|59|||
128693635|NCT00216476|463177755|FG001|Overall Study|Withdrawal by Subject|72|||
128693636|NCT00216476|463177756|FG002|Overall Study|Withdrawal by Subject|9|||
129114202|NCT01294423|464713118|FG001|Overall Study|poor/non-compliance|0|||
128693637|NCT00216476|463177754|FG000|Overall Study|Lost to Follow-up|10|||
128693638|NCT00216476|463177755|FG001|Overall Study|Lost to Follow-up|9|||
128693639|NCT00216476|463177756|FG002|Overall Study|Lost to Follow-up|1|||
129114203|NCT01294423|464713119|FG002|Overall Study|poor/non-compliance|1|||
129114204|NCT01811732|464713122|FG000|Overall Study|Lost to Follow-up|24|||
129114205|NCT01811732|464713123|FG001|Overall Study|Lost to Follow-up|30|||
129114206|NCT01811732|464713122|FG000|Overall Study|Withdrawal by Subject|16|||
129114207|NCT01811732|464713123|FG001|Overall Study|Withdrawal by Subject|10|||
129114208|NCT01811732|464713122|FG000|Overall Study|Adverse Event|3|||
129114209|NCT01811732|464713123|FG001|Overall Study|Adverse Event|9|||
129114210|NCT01811732|464713122|FG000|Overall Study|Lack of Efficacy|3|||
128693640|NCT00216476|463177754|FG000|Overall Study|Adverse Event|6|||
128693641|NCT00216476|463177755|FG001|Overall Study|Adverse Event|10|||
128693642|NCT00216476|463177756|FG002|Overall Study|Adverse Event|1|||
128902239|NCT01225731|463934735|FG000|Part 3|Adverse Event|0|||
129114211|NCT01811732|464713123|FG001|Overall Study|Lack of Efficacy|1|||
129114212|NCT01811732|464713122|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
129114213|NCT01811732|464713123|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
129114214|NCT01811732|464713122|FG000|Overall Study|Physician Decision|2|||
129114215|NCT01811732|464713123|FG001|Overall Study|Physician Decision|0|||
129114216|NCT01811732|464713122|FG000|Overall Study|Death|1|||
129114217|NCT01811732|464713123|FG001|Overall Study|Death|1|||
129114218|NCT01811732|464713122|FG000|Overall Study|Insufficient venous access|0|||
129114219|NCT01811732|464713123|FG001|Overall Study|Insufficient venous access|1|||
129114220|NCT01811732|464713122|FG000|Overall Study|Protocol Violation|0|||
129114221|NCT01811732|464713123|FG001|Overall Study|Protocol Violation|1|||
129114222|NCT01811732|464713122|FG000|Overall Study|Subject incarcerated|1|||
129114223|NCT01811732|464713123|FG001|Overall Study|Subject incarcerated|2|||
128902240|NCT01225731|463934736|FG001|Part 3|Adverse Event|0|||
128902241|NCT01225731|463934737|FG002|Part 3|Adverse Event|0|||
128902242|NCT01225731|463934738|FG003|Part 3|Adverse Event|0|||
128902243|NCT01225731|463934739|FG004|Part 3|Adverse Event|0|||
128902244|NCT01225731|463934740|FG005|Part 3|Adverse Event|0|||
128902245|NCT01225731|463934741|FG006|Part 3|Adverse Event|0|||
128902246|NCT01225731|463934742|FG007|Part 3|Adverse Event|0|||
128902247|NCT01225731|463934743|FG008|Part 3|Adverse Event|0|||
128902248|NCT01225731|463934744|FG009|Part 3|Adverse Event|0|||
128902249|NCT01225731|463934745|FG010|Part 3|Adverse Event|1|||
128902250|NCT01225731|463934746|FG011|Part 3|Adverse Event|1|||
128902251|NCT01225731|463934747|FG012|Part 3|Adverse Event|0|||
129114224|NCT01811732|464713122|FG000|Overall Study|Admitted to another facility|1|||
129114225|NCT01811732|464713123|FG001|Overall Study|Admitted to another facility|0|||
129114226|NCT01811732|464713122|FG000|Overall Study|Correct study drug not available on site|1|||
129114227|NCT01811732|464713123|FG001|Overall Study|Correct study drug not available on site|0|||
129114228|NCT00288912|464713126|FG000|Overall Study|Developed exclusion criterion|4|||
129114229|NCT00288912|464713127|FG001|Overall Study|Developed exclusion criterion|6|||
129114230|NCT00288912|464713128|FG002|Overall Study|Developed exclusion criterion|7|||
129114231|NCT00288912|464713126|FG000|Overall Study|Lost to Follow-up|9|||
129114232|NCT00288912|464713127|FG001|Overall Study|Lost to Follow-up|6|||
129114233|NCT00288912|464713128|FG002|Overall Study|Lost to Follow-up|9|||
129114234|NCT00288912|464713126|FG000|Overall Study|Withdrawal by Subject|4|||
129114235|NCT00288912|464713127|FG001|Overall Study|Withdrawal by Subject|5|||
129114236|NCT00288912|464713128|FG002|Overall Study|Withdrawal by Subject|12|||
129114237|NCT01783743|464713133|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
129114238|NCT01783743|464713134|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
129114239|NCT01783743|464713133|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
129114240|NCT01783743|464713134|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
129114241|NCT01783743|464713133|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
129114242|NCT01783743|464713134|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
129114243|NCT01607593|464713135|FG000|Overall Study|Adverse Event|15|||
129114244|NCT01607593|464713135|FG000|Overall Study|Lack of Efficacy|16|||
129114245|NCT01607593|464713135|FG000|Overall Study|Lost to Follow-up|25|||
129114246|NCT01607593|464713135|FG000|Overall Study|Continuation|33|||
129114247|NCT01607593|464713135|FG000|Overall Study|Other|4|||
129114248|NCT02771275|464713136|FG000|Overall Study|Reoperation|3|||
129114249|NCT02771275|464713136|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
129114250|NCT00728494|464713149|FG000|Overall Study|Adverse Event|7|||
129114251|NCT00728494|464713150|FG001|Overall Study|Adverse Event|0|||
129114252|NCT00728494|464713149|FG000|Overall Study|Withdrawal by Subject|0|||
129114253|NCT00728494|464713150|FG001|Overall Study|Withdrawal by Subject|2|||
129114254|NCT00728494|464713149|FG000|Overall Study|Lack of Efficacy|2|||
129114255|NCT00728494|464713150|FG001|Overall Study|Lack of Efficacy|4|||
129114256|NCT00728494|464713149|FG000|Overall Study|No data available|0|||
129114257|NCT00728494|464713150|FG001|Overall Study|No data available|1|||
129114258|NCT03439137|464713151|FG000|Overall Study|Adverse Event|16|||
129114259|NCT03439137|464713152|FG001|Overall Study|Adverse Event|12|||
129114260|NCT03439137|464713151|FG000|Overall Study|Physician Decision|0|||
128693643|NCT00216476|463177754|FG000|Overall Study|Lack of Efficacy|4|||
128902252|NCT01225731|463934735|FG000|Part 3|Lost to Follow-up|0|||
128902253|NCT01225731|463934736|FG001|Part 3|Lost to Follow-up|0|||
128902254|NCT01225731|463934737|FG002|Part 3|Lost to Follow-up|0|||
129114261|NCT03439137|464713152|FG001|Overall Study|Physician Decision|5|||
129114262|NCT03439137|464713151|FG000|Overall Study|Withdrawal by Subject|14|||
129114263|NCT03439137|464713152|FG001|Overall Study|Withdrawal by Subject|4|||
129114264|NCT03439137|464713151|FG000|Overall Study|Conducting rescue therapy|2|||
129114265|NCT03439137|464713152|FG001|Overall Study|Conducting rescue therapy|1|||
129114266|NCT03439137|464713151|FG000|Overall Study|Difficult to control Hb|10|||
129114267|NCT03439137|464713152|FG001|Overall Study|Difficult to control Hb|2|||
129114268|NCT03439137|464713151|FG000|Overall Study|Initiation of a renal transplant|0|||
128902255|NCT01225731|463934738|FG003|Part 3|Lost to Follow-up|0|||
128902256|NCT01225731|463934739|FG004|Part 3|Lost to Follow-up|0|||
128902257|NCT01225731|463934740|FG005|Part 3|Lost to Follow-up|0|||
129114269|NCT03439137|464713152|FG001|Overall Study|Initiation of a renal transplant|2|||
129114270|NCT05081388|464713153|FG000|Overall Study|Adverse Event|1|||
129114271|NCT05081388|464713154|FG001|Overall Study|Adverse Event|0|||
129114272|NCT05081388|464713155|FG002|Overall Study|Adverse Event|0|||
129114273|NCT05081388|464713156|FG003|Overall Study|Adverse Event|0|||
129114274|NCT05081388|464713157|FG004|Overall Study|Adverse Event|0|||
129114275|NCT05081388|464713153|FG000|Overall Study|Lost to Follow-up|0|||
129114276|NCT05081388|464713154|FG001|Overall Study|Lost to Follow-up|1|||
129114277|NCT05081388|464713155|FG002|Overall Study|Lost to Follow-up|0|||
129114278|NCT05081388|464713156|FG003|Overall Study|Lost to Follow-up|0|||
129114279|NCT05081388|464713157|FG004|Overall Study|Lost to Follow-up|0|||
129114280|NCT05081388|464713153|FG000|Overall Study|Subject decision|0|||
129114281|NCT05081388|464713154|FG001|Overall Study|Subject decision|0|||
129114282|NCT05081388|464713155|FG002|Overall Study|Subject decision|0|||
129114283|NCT05081388|464713156|FG003|Overall Study|Subject decision|1|||
129114284|NCT05081388|464713157|FG004|Overall Study|Subject decision|0|||
129114285|NCT02059239|464713158|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
129114286|NCT02059239|464713159|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
129114287|NCT02059239|464713158|FG000|Overall Study|Physician Decision|1|||
129114288|NCT02059239|464713159|FG001|Overall Study|Physician Decision|0|||
129114289|NCT01789047|464713160|FG000|Overall Study|Adverse Event|3|||
129114290|NCT01789047|464713161|FG001|Overall Study|Adverse Event|2|||
129114291|NCT01789047|464713160|FG000|Overall Study|Withdrawal by Subject|1|||
129114292|NCT01789047|464713161|FG001|Overall Study|Withdrawal by Subject|2|||
129114293|NCT04194814|464713162|FG000|Overall Study|Physician Decision|3|||
129114294|NCT04194814|464713163|FG001|Overall Study|Physician Decision|0|||
129114295|NCT04194814|464713162|FG000|Overall Study|Withdrawal by Subject|0|||
129114296|NCT04194814|464713163|FG001|Overall Study|Withdrawal by Subject|2|||
129114297|NCT01868646|464715084|FG000|Overall Study|Do not meet inclusion criteria|3|||
129114298|NCT01868646|464715085|FG001|Overall Study|Do not meet inclusion criteria|5|||
129114299|NCT03191799|464715090|FG000|Overall Study|Withdrawal by Subject|4|||
129114300|NCT03191799|464715090|FG000|Overall Study|Physician Decision|2|||
129114301|NCT03191799|464715090|FG000|Overall Study|Lost to Follow-up|1|||
129114302|NCT03191799|464715090|FG000|Overall Study|Death|2|||
129114303|NCT00748241|464715097|FG000|Overall Study|Implant failure|1|||
129114304|NCT00748241|464715097|FG000|Overall Study|Lost to Follow-up|5|||
129114305|NCT00748241|464715097|FG000|Overall Study|Death|2|||
129114306|NCT01240382|464715098|FG000|Overall Study|Adverse Event|2|||
129114307|NCT01240382|464715099|FG001|Overall Study|Adverse Event|1|||
129114308|NCT01240382|464715098|FG000|Overall Study|Lack of Efficacy|0|||
129114309|NCT01240382|464715099|FG001|Overall Study|Lack of Efficacy|2|||
129114310|NCT01240382|464715098|FG000|Overall Study|Fear of adverse events|0|||
129114311|NCT01240382|464715099|FG001|Overall Study|Fear of adverse events|1|||
129114312|NCT02456727|464715107|FG000|Overall Study|Lost to Follow-up|63|||
129114313|NCT02456727|464715108|FG001|Overall Study|Lost to Follow-up|65|||
129114314|NCT02456727|464715107|FG000|Overall Study|Death|2|||
129114315|NCT02456727|464715108|FG001|Overall Study|Death|1|||
129114316|NCT02456727|464715107|FG000|Overall Study|Withdrawal by Subject|1|||
129114317|NCT02456727|464715108|FG001|Overall Study|Withdrawal by Subject|10|||
129114318|NCT02456727|464715107|FG000|Overall Study|Never Initiated Treatment|43|||
129114319|NCT02456727|464715108|FG001|Overall Study|Never Initiated Treatment|30|||
129114320|NCT02643693|464715109|FG000|Overall Study|Physician Decision|0|||
129114321|NCT02643693|464715110|FG001|Overall Study|Physician Decision|1|||
129114322|NCT02643693|464715111|FG002|Overall Study|Physician Decision|0|||
129114323|NCT02643693|464715112|FG003|Overall Study|Physician Decision|0|||
128902258|NCT01225731|463934741|FG006|Part 3|Lost to Follow-up|0|||
128902259|NCT01225731|463934742|FG007|Part 3|Lost to Follow-up|0|||
128902260|NCT01225731|463934743|FG008|Part 3|Lost to Follow-up|0|||
128902261|NCT01225731|463934744|FG009|Part 3|Lost to Follow-up|0|||
128902262|NCT01225731|463934745|FG010|Part 3|Lost to Follow-up|1|||
128902263|NCT01225731|463934746|FG011|Part 3|Lost to Follow-up|2|||
129114324|NCT02643693|464715113|FG004|Overall Study|Physician Decision|0|||
129114325|NCT02643693|464715114|FG005|Overall Study|Physician Decision|0|||
129114326|NCT02643693|464715109|FG000|Overall Study|Withdrawal by Subject|0|||
128902264|NCT01225731|463934747|FG012|Part 3|Lost to Follow-up|1|||
128902265|NCT01225731|463934735|FG000|Part 3|Physician Decision|0|||
128902266|NCT01225731|463934736|FG001|Part 3|Physician Decision|0|||
129114327|NCT02643693|464715110|FG001|Overall Study|Withdrawal by Subject|1|||
129114328|NCT02643693|464715111|FG002|Overall Study|Withdrawal by Subject|0|||
129114329|NCT02643693|464715112|FG003|Overall Study|Withdrawal by Subject|0|||
129114330|NCT02643693|464715113|FG004|Overall Study|Withdrawal by Subject|0|||
129114331|NCT02643693|464715114|FG005|Overall Study|Withdrawal by Subject|0|||
129114332|NCT02643693|464715109|FG000|Overall Study|Protocol Adherence Issues|2|||
129114333|NCT02643693|464715110|FG001|Overall Study|Protocol Adherence Issues|0|||
128902267|NCT01225731|463934737|FG002|Part 3|Physician Decision|0|||
128693644|NCT00216476|463177755|FG001|Overall Study|Lack of Efficacy|3|||
128902268|NCT01225731|463934738|FG003|Part 3|Physician Decision|0|||
129114334|NCT02643693|464715111|FG002|Overall Study|Protocol Adherence Issues|1|||
129114335|NCT02643693|464715112|FG003|Overall Study|Protocol Adherence Issues|0|||
129114336|NCT02643693|464715113|FG004|Overall Study|Protocol Adherence Issues|0|||
129114337|NCT02643693|464715114|FG005|Overall Study|Protocol Adherence Issues|1|||
129114338|NCT00888654|464715115|FG000|Overall Study|Problems swallowing oral meds.|1|||
129114339|NCT00888654|464715115|FG000|Overall Study|Not enough oral meds before surgery|3|||
129114340|NCT00888654|464715115|FG000|Overall Study|Surgery aborted|2|||
129114341|NCT00888654|464715115|FG000|Overall Study|Withdrawal by Subject|1|||
129114342|NCT00888654|464715115|FG000|Overall Study|Inelig. due to contraindication of med|1|||
129114343|NCT00888654|464715115|FG000|Overall Study|Change in surg date|1|||
129114344|NCT00888654|464715115|FG000|Overall Study|Stopped meds due to headaches|1|||
129114345|NCT02974868|464715118|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
129114346|NCT02974868|464715119|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
129114347|NCT02974868|464715120|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
129114348|NCT02974868|464715121|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
129114349|NCT02974868|464715118|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
129114350|NCT02974868|464715119|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
129114351|NCT02974868|464715120|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
129114352|NCT02974868|464715121|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
129114353|NCT02974868|464715118|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
129114354|NCT02974868|464715119|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
129114355|NCT02974868|464715120|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
129114356|NCT02974868|464715121|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
129114357|NCT02974868|464715118|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
129114358|NCT02974868|464715119|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
129114359|NCT02974868|464715120|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
129114360|NCT02974868|464715121|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
129114361|NCT00297648|464715124|FG000|Overall Study|Adverse Event|13|||
129114362|NCT00297648|464715124|FG000|Overall Study|Lack of Efficacy|18|||
129114363|NCT00297648|464715124|FG000|Overall Study|Lost to Follow-up|1|||
129114364|NCT00297648|464715124|FG000|Overall Study|Withdrawal by Subject|3|||
129114365|NCT00297648|464715124|FG000|Overall Study|Other: Incompliance|1|||
129114366|NCT03575702|464715125|FG000|Overall Study|Withdrawal by Subject|1|||
129114367|NCT03575702|464715126|FG001|Overall Study|Withdrawal by Subject|1|||
129114368|NCT03575702|464715125|FG000|Overall Study|Lost to Follow-up|1|||
129114369|NCT03575702|464715126|FG001|Overall Study|Lost to Follow-up|2|||
129114370|NCT03575702|464715125|FG000|Overall Study|Protocol Violation|0|||
129114371|NCT03575702|464715126|FG001|Overall Study|Protocol Violation|1|||
129114372|NCT03575702|464715125|FG000|Overall Study|Patient non compliance|4|||
129114373|NCT03575702|464715126|FG001|Overall Study|Patient non compliance|0|||
129114374|NCT03903172|464715127|FG000|Overall Study|screen fail|4|||
129114375|NCT03903172|464715128|FG001|Overall Study|screen fail|1|||
129114376|NCT01545388|464715129|FG000|Overall Study|Adverse Event|2|||
129114377|NCT01545388|464715130|FG001|Overall Study|Adverse Event|4|||
129114378|NCT01545388|464715131|FG002|Overall Study|Adverse Event|1|||
129114379|NCT01545388|464715129|FG000|Overall Study|Lack of Efficacy|3|||
129114380|NCT01545388|464715130|FG001|Overall Study|Lack of Efficacy|2|||
129114381|NCT01545388|464715131|FG002|Overall Study|Lack of Efficacy|5|||
129114382|NCT01545388|464715129|FG000|Overall Study|Participant moved or relocated|1|||
129114383|NCT01545388|464715130|FG001|Overall Study|Participant moved or relocated|0|||
129114384|NCT01545388|464715131|FG002|Overall Study|Participant moved or relocated|0|||
129114385|NCT01545388|464715129|FG000|Overall Study|Withdrawal by Subject|1|||
129114386|NCT01545388|464715130|FG001|Overall Study|Withdrawal by Subject|4|||
129114387|NCT01545388|464715131|FG002|Overall Study|Withdrawal by Subject|2|||
129114388|NCT01545388|464715129|FG000|Overall Study|Other|1|||
129114389|NCT01545388|464715130|FG001|Overall Study|Other|1|||
129114390|NCT01545388|464715131|FG002|Overall Study|Other|0|||
129114391|NCT01255163|464715132|FG000|Overall Study|Withdrawal by Subject|1|||
129114392|NCT01255163|464715133|FG001|Overall Study|Withdrawal by Subject|0|||
129114393|NCT01255163|464715132|FG000|Overall Study|Lost to Follow-up|2|||
129114394|NCT01255163|464715133|FG001|Overall Study|Lost to Follow-up|0|||
129114395|NCT01255163|464715132|FG000|Overall Study|Adverse Event|0|||
129114396|NCT01255163|464715133|FG001|Overall Study|Adverse Event|2|||
129114397|NCT01255163|464715132|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
129114398|NCT01255163|464715133|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
129114399|NCT02495389|464715134|FG000|Overall Study|Withdrawal by Subject|40|||
129114400|NCT01802385|464715138|FG000|Overall Study|Death|106|||
129114401|NCT01802385|464715139|FG001|Overall Study|Death|120|||
129114402|NCT03834493|464715140|FG000|Overall Study|Participants Ongoing|311|||
129114403|NCT03834493|464715141|FG001|Overall Study|Participants Ongoing|324|||
129114404|NCT03834493|464715140|FG000|Overall Study|Withdrawal by Subject|20|||
129114405|NCT03834493|464715141|FG001|Overall Study|Withdrawal by Subject|17|||
129114406|NCT03834493|464715140|FG000|Overall Study|Physician Decision|1|||
129114407|NCT03834493|464715141|FG001|Overall Study|Physician Decision|0|||
129114408|NCT03834493|464715140|FG000|Overall Study|Death|289|||
129114409|NCT03834493|464715141|FG001|Overall Study|Death|282|||
129114410|NCT05559905|464715142|FG000|Overall Study|Withdrawal by Subject|1|||
129114411|NCT05559905|464715143|FG001|Overall Study|Withdrawal by Subject|0|||
129114412|NCT05559905|464715144|FG002|Overall Study|Withdrawal by Subject|0|||
129114413|NCT05559905|464715142|FG000|Overall Study|Not Reported|1|||
129114414|NCT05559905|464715143|FG001|Overall Study|Not Reported|0|||
129114415|NCT05559905|464715144|FG002|Overall Study|Not Reported|0|||
129114416|NCT04003103|464715145|FG000|Overall Study|Death|1|||
129114417|NCT04003103|464715146|FG001|Overall Study|Death|0|||
129114418|NCT04003103|464715147|FG002|Overall Study|Death|0|||
129114419|NCT04003103|464715145|FG000|Overall Study|Lost to Follow-up|4|||
129114420|NCT04003103|464715146|FG001|Overall Study|Lost to Follow-up|3|||
129114421|NCT04003103|464715147|FG002|Overall Study|Lost to Follow-up|2|||
129114422|NCT04003103|464715145|FG000|Overall Study|Withdrawal by Subject|10|||
129114423|NCT04003103|464715146|FG001|Overall Study|Withdrawal by Subject|1|||
129114424|NCT04003103|464715147|FG002|Overall Study|Withdrawal by Subject|1|||
129114425|NCT04003103|464715145|FG000|Overall Study|Status not recorded|0|||
129114426|NCT04003103|464715146|FG001|Overall Study|Status not recorded|2|||
129114427|NCT04003103|464715147|FG002|Overall Study|Status not recorded|0|||
129114428|NCT02277028|464715148|FG000|Overall Study|Lost to Follow-up|1|||
129114429|NCT02277028|464715149|FG001|Overall Study|Lost to Follow-up|0|||
129114430|NCT02277028|464715148|FG000|Overall Study|Withdrawal by Subject|0|||
129114431|NCT02277028|464715149|FG001|Overall Study|Withdrawal by Subject|1|||
129114432|NCT05002972|464715150|FG000|Overall Study|Withdrawal by Subject|2|||
129114433|NCT02053493|464715153|FG000|Overall Study|Withdrawal by Subject|1|||
129114434|NCT02053493|464715154|FG001|Overall Study|Withdrawal by Subject|1|||
129114435|NCT04613518|464715157|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
129114436|NCT04613518|464715158|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
129114437|NCT04613518|464715159|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
129114438|NCT04613518|464715157|FG000|Double-Blind Treatment Period|Adverse Event|2|||
129114439|NCT04613518|464715158|FG001|Double-Blind Treatment Period|Adverse Event|0|||
129114440|NCT04613518|464715159|FG002|Double-Blind Treatment Period|Adverse Event|1|||
129114441|NCT04613518|464715157|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
129114442|NCT04613518|464715158|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
129114443|NCT04613518|464715159|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
129114444|NCT04613518|464715157|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
129114445|NCT04613518|464715158|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
129114446|NCT04613518|464715159|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
129114447|NCT04613518|464715157|FG000|Double-Blind Treatment Period|Other Reasons|2|||
129114448|NCT04613518|464715158|FG001|Double-Blind Treatment Period|Other Reasons|0|||
129114449|NCT04613518|464715159|FG002|Double-Blind Treatment Period|Other Reasons|0|||
129114450|NCT04613518|464715157|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
129114451|NCT04613518|464715158|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
129114452|NCT04613518|464715159|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129114453|NCT04613518|464715157|FG000|Open-Label Treatment Period|Adverse Event|1|||
129114454|NCT04613518|464715158|FG001|Open-Label Treatment Period|Adverse Event|0|||
129114455|NCT04613518|464715159|FG002|Open-Label Treatment Period|Adverse Event|3|||
129114456|NCT04613518|464715157|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
129114457|NCT04613518|464715158|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
129114458|NCT04613518|464715159|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
129114459|NCT04613518|464715157|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
129114460|NCT04613518|464715158|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
129114461|NCT04613518|464715159|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
129114462|NCT04613518|464715157|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
129114463|NCT04613518|464715158|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
129114464|NCT04613518|464715159|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
129114465|NCT04613518|464715157|FG000|Open-Label Treatment Period|Other reasons|1|||
129114466|NCT04613518|464715158|FG001|Open-Label Treatment Period|Other reasons|0|||
129114467|NCT04613518|464715159|FG002|Open-Label Treatment Period|Other reasons|0|||
129114468|NCT01619865|464715160|FG000|Overall Study|Adverse Event|1|||
129114469|NCT01619865|464715160|FG000|Overall Study|Death|2|||
129114470|NCT01619865|464715160|FG000|Overall Study|subject not able to comply|1|||
129114471|NCT01494818|464715161|FG000|Overall Study|Relocation|1|||
129114472|NCT01494818|464715162|FG001|Overall Study|Relocation|2|||
129114473|NCT01494818|464715161|FG000|Overall Study|Lost to Follow-up|1|||
129114474|NCT01494818|464715162|FG001|Overall Study|Lost to Follow-up|0|||
129114475|NCT00791999|464715163|FG000|Overall Study|Protocol planed withdrawal|14|||
129114476|NCT00791999|464715164|FG001|Overall Study|Protocol planed withdrawal|11|||
129114477|NCT00791999|464715165|FG002|Overall Study|Protocol planed withdrawal|11|||
129114478|NCT00791999|464715166|FG003|Overall Study|Protocol planed withdrawal|45|||
129114479|NCT00791999|464715163|FG000|Overall Study|Withdrawal by Subject|0|||
129114480|NCT00791999|464715164|FG001|Overall Study|Withdrawal by Subject|1|||
129114481|NCT00791999|464715165|FG002|Overall Study|Withdrawal by Subject|0|||
128693645|NCT00216476|463177756|FG002|Overall Study|Lack of Efficacy|0|||
128902269|NCT01225731|463934739|FG004|Part 3|Physician Decision|0|||
128902270|NCT01225731|463934740|FG005|Part 3|Physician Decision|0|||
129024791|NCT00606281|464383194|FG001|Overall Study|Lack of Efficacy|35|||
129024792|NCT00606281|464383193|FG000|Overall Study|Physician Decision|0|||
129024793|NCT00606281|464383194|FG001|Overall Study|Physician Decision|1|||
129024794|NCT00606281|464383193|FG000|Overall Study|Protocol Violation|3|||
129024795|NCT00606281|464383194|FG001|Overall Study|Protocol Violation|3|||
129024796|NCT00606281|464383193|FG000|Overall Study|Withdrawal by Subject|11|||
129024797|NCT00606281|464383194|FG001|Overall Study|Withdrawal by Subject|13|||
129024798|NCT00606281|464383193|FG000|Overall Study|Progression to depressive phase|1|||
129024799|NCT00606281|464383194|FG001|Overall Study|Progression to depressive phase|1|||
129024800|NCT00606281|464383193|FG000|Overall Study|Change of residence or other commitments|1|||
129024801|NCT00606281|464383194|FG001|Overall Study|Change of residence or other commitments|1|||
129024802|NCT02294981|464383195|FG000|Overall Study|Lost to Follow-up|1|||
129024803|NCT00829712|464383196|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129024804|NCT00829712|464383197|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129024805|NCT00263588|464383198|FG000|Overall Study|Death|54|||
129024806|NCT00263588|464383199|FG001|Overall Study|Death|90|||
129024807|NCT00263588|464383198|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
129024808|NCT00263588|464383199|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
129024809|NCT00263588|464383198|FG000|Overall Study|Lost to Follow-up|7|||
129024810|NCT00263588|464383199|FG001|Overall Study|Lost to Follow-up|10|||
129024811|NCT00263588|464383198|FG000|Overall Study|Withdrawal by Subject|3|||
129024812|NCT00263588|464383199|FG001|Overall Study|Withdrawal by Subject|4|||
129024813|NCT00263588|464383198|FG000|Overall Study|Protocol Violation|0|||
129024814|NCT00263588|464383199|FG001|Overall Study|Protocol Violation|1|||
129024815|NCT00263588|464383198|FG000|Overall Study|Investigator decision|7|||
129024816|NCT00263588|464383199|FG001|Overall Study|Investigator decision|15|||
129024817|NCT00263588|464383198|FG000|Overall Study|Sponsor terminated study|0|||
129024818|NCT00263588|464383199|FG001|Overall Study|Sponsor terminated study|1|||
129024819|NCT02622386|464383200|FG000|First Assignment|Withdrawal by Subject|3|||
129024820|NCT02622386|464383201|FG001|First Assignment|Withdrawal by Subject|2|||
129024821|NCT02622386|464383200|FG000|Washout|Withdrawal by Subject|4|||
129024822|NCT02622386|464383201|FG001|Washout|Withdrawal by Subject|4|||
129024823|NCT02622386|464383200|FG000|Second Assignment|Withdrawal by Subject|0|||
129024824|NCT02622386|464383201|FG001|Second Assignment|Withdrawal by Subject|2|||
129024825|NCT00700739|464383202|FG000|Overall Study|Lost to Follow-up|4|||
129024826|NCT00700739|464383203|FG001|Overall Study|Lost to Follow-up|4|||
129024827|NCT02336074|464383204|FG000|Overall Study|Adverse Event|0|||
129024828|NCT02336074|464383205|FG001|Overall Study|Adverse Event|2|||
129024829|NCT02679729|464383206|FG000|Overall Study|Lost to Follow-up|0|||
129024830|NCT02679729|464383207|FG001|Overall Study|Lost to Follow-up|1|||
129024831|NCT02679729|464383208|FG002|Overall Study|Lost to Follow-up|0|||
129024832|NCT02679729|464383209|FG003|Overall Study|Lost to Follow-up|0|||
129024833|NCT02679729|464383210|FG004|Overall Study|Lost to Follow-up|1|||
129024834|NCT02679729|464383211|FG005|Overall Study|Lost to Follow-up|0|||
129024835|NCT02679729|464383212|FG006|Overall Study|Lost to Follow-up|0|||
129024836|NCT02679729|464383213|FG007|Overall Study|Lost to Follow-up|0|||
129024837|NCT02679729|464383214|FG008|Overall Study|Lost to Follow-up|0|||
129024838|NCT02679729|464383206|FG000|Overall Study|Participant decision|0|||
129024839|NCT02679729|464383207|FG001|Overall Study|Participant decision|1|||
129024840|NCT02679729|464383208|FG002|Overall Study|Participant decision|0|||
129024841|NCT02679729|464383209|FG003|Overall Study|Participant decision|0|||
129024842|NCT02679729|464383210|FG004|Overall Study|Participant decision|0|||
129024843|NCT02679729|464383211|FG005|Overall Study|Participant decision|0|||
129024844|NCT02679729|464383212|FG006|Overall Study|Participant decision|1|||
129024845|NCT02679729|464383213|FG007|Overall Study|Participant decision|0|||
129024846|NCT02679729|464383214|FG008|Overall Study|Participant decision|0|||
129024847|NCT03488108|464383221|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
129024848|NCT03488108|464383222|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129024849|NCT03488108|464383221|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
129024850|NCT03488108|464383222|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
129024851|NCT03602339|464383227|FG000|Overall Study|Withdrawal by Subject|9|||
129024852|NCT03602339|464383227|FG000|Overall Study|Physician Decision|2|||
129024853|NCT03602339|464383227|FG000|Overall Study|Other reason|4|||
128902271|NCT01225731|463934741|FG006|Part 3|Physician Decision|0|||
128902272|NCT01225731|463934742|FG007|Part 3|Physician Decision|0|||
129024854|NCT00477594|464383230|FG000|Year 1 and Year 2|Adverse Event|4|||
129024855|NCT00477594|464383231|FG001|Year 1 and Year 2|Adverse Event|2|||
129024856|NCT00477594|464383230|FG000|Year 1 and Year 2|Physician Decision|2|||
129024857|NCT00477594|464383231|FG001|Year 1 and Year 2|Physician Decision|1|||
129024858|NCT00477594|464383230|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
129024859|NCT00477594|464383231|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
129024860|NCT00477594|464383230|FG000|Year 1 and Year 2|Other|1|||
129024861|NCT00477594|464383231|FG001|Year 1 and Year 2|Other|0|||
129024862|NCT00477594|464383230|FG000|Year 3|Adverse Event|1|||
129024863|NCT00477594|464383231|FG001|Year 3|Adverse Event|0|||
129114482|NCT00791999|464715166|FG003|Overall Study|Withdrawal by Subject|2|||
129114483|NCT00791999|464715163|FG000|Overall Study|Protocol Violation|3|||
129114484|NCT00791999|464715164|FG001|Overall Study|Protocol Violation|0|||
129114485|NCT00791999|464715165|FG002|Overall Study|Protocol Violation|1|||
129114486|NCT00791999|464715166|FG003|Overall Study|Protocol Violation|0|||
129114487|NCT00791999|464715163|FG000|Overall Study|Adverse Event|3|||
129114488|NCT00791999|464715164|FG001|Overall Study|Adverse Event|3|||
129114489|NCT00791999|464715165|FG002|Overall Study|Adverse Event|7|||
129114490|NCT00791999|464715166|FG003|Overall Study|Adverse Event|3|||
129114491|NCT00791999|464715163|FG000|Overall Study|Lack of Efficacy|0|||
129114492|NCT00791999|464715164|FG001|Overall Study|Lack of Efficacy|1|||
129114493|NCT00791999|464715165|FG002|Overall Study|Lack of Efficacy|0|||
129114494|NCT00791999|464715166|FG003|Overall Study|Lack of Efficacy|2|||
129114495|NCT00791999|464715163|FG000|Overall Study|Reason other than those above|1|||
129114496|NCT00791999|464715164|FG001|Overall Study|Reason other than those above|0|||
129114497|NCT00791999|464715165|FG002|Overall Study|Reason other than those above|1|||
129114498|NCT00791999|464715166|FG003|Overall Study|Reason other than those above|0|||
129114499|NCT01077323|464715167|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
129114500|NCT01077323|464715168|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
129114501|NCT01077323|464715169|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
129114502|NCT01077323|464715167|FG000|Overall Study|Dispensing of drug in baseline period|0|||
129114503|NCT01077323|464715168|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
129114504|NCT01077323|464715169|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
129114505|NCT01077323|464715167|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
129114506|NCT01077323|464715168|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
129114507|NCT01077323|464715169|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
129114508|NCT00617357|464715170|FG000|Overall Study|Lost to Follow-up|7|||
129114509|NCT00617357|464715170|FG000|Overall Study|Death|5|||
129114510|NCT00617357|464715170|FG000|Overall Study|insurance concerns|2|||
129114511|NCT00617357|464715170|FG000|Overall Study|Withdrawal by Subject|1|||
129114512|NCT00617357|464715170|FG000|Overall Study|Physician Decision|1|||
129114513|NCT00427908|464715171|FG000|Primary Phase|Lost to Follow-up|4|||
129114514|NCT00427908|464715172|FG001|Primary Phase|Lost to Follow-up|0|||
129114515|NCT00427908|464715173|FG002|Primary Phase|Lost to Follow-up|2|||
129114516|NCT00427908|464715174|FG003|Primary Phase|Lost to Follow-up|0|||
129114517|NCT00427908|464715171|FG000|Primary Phase|Withdrawal by Subject|1|||
129114518|NCT00427908|464715172|FG001|Primary Phase|Withdrawal by Subject|2|||
129114519|NCT00427908|464715173|FG002|Primary Phase|Withdrawal by Subject|1|||
129114520|NCT00427908|464715174|FG003|Primary Phase|Withdrawal by Subject|0|||
129114521|NCT00427908|464715171|FG000|Primary Phase|Adverse Event|0|||
129114522|NCT00427908|464715172|FG001|Primary Phase|Adverse Event|1|||
129114523|NCT00427908|464715173|FG002|Primary Phase|Adverse Event|0|||
129114524|NCT00427908|464715174|FG003|Primary Phase|Adverse Event|0|||
129114525|NCT01710020|464715175|FG000|Period 1|Protocol Violation|1|||
129114526|NCT02153918|464715176|FG000|Overall Study|Refused further treatment|1|||
129114527|NCT01764841|464715177|FG000|Overall Study|Logistical Difficulties|0|||
129114528|NCT01764841|464715178|FG001|Overall Study|Logistical Difficulties|1|||
129114529|NCT01764841|464715179|FG002|Overall Study|Logistical Difficulties|0|||
129114530|NCT01764841|464715180|FG003|Overall Study|Logistical Difficulties|0|||
129114531|NCT01764841|464715177|FG000|Overall Study|Death|3|||
129114532|NCT01764841|464715178|FG001|Overall Study|Death|0|||
129114533|NCT01764841|464715179|FG002|Overall Study|Death|1|||
129114534|NCT01764841|464715180|FG003|Overall Study|Death|4|||
129114535|NCT01764841|464715177|FG000|Overall Study|No Follow Up|1|||
129114536|NCT01764841|464715178|FG001|Overall Study|No Follow Up|0|||
129114537|NCT01764841|464715179|FG002|Overall Study|No Follow Up|1|||
129114538|NCT01764841|464715180|FG003|Overall Study|No Follow Up|0|||
129114539|NCT01764841|464715177|FG000|Overall Study|Protocol Violation|0|||
129114540|NCT01764841|464715178|FG001|Overall Study|Protocol Violation|1|||
129114541|NCT01764841|464715179|FG002|Overall Study|Protocol Violation|0|||
129114542|NCT01764841|464715180|FG003|Overall Study|Protocol Violation|0|||
129114543|NCT01764841|464715177|FG000|Overall Study|Withdrawal by Subject|16|||
129114544|NCT01764841|464715178|FG001|Overall Study|Withdrawal by Subject|24|||
129114545|NCT01764841|464715179|FG002|Overall Study|Withdrawal by Subject|11|||
129114546|NCT01764841|464715180|FG003|Overall Study|Withdrawal by Subject|15|||
129114547|NCT01764841|464715177|FG000|Overall Study|Lost to Follow-up|3|||
129114548|NCT01764841|464715178|FG001|Overall Study|Lost to Follow-up|0|||
129114549|NCT01764841|464715179|FG002|Overall Study|Lost to Follow-up|1|||
129114550|NCT01764841|464715180|FG003|Overall Study|Lost to Follow-up|0|||
129114551|NCT02616783|464715181|FG000|Overall Study|Randomized but Not Treated|1|||
129114552|NCT02616783|464715182|FG001|Overall Study|Randomized but Not Treated|0|||
129114553|NCT02616783|464715181|FG000|Overall Study|Adverse Event|1|||
129114554|NCT02616783|464715182|FG001|Overall Study|Adverse Event|0|||
129114555|NCT02616783|464715181|FG000|Overall Study|Death|1|||
129114556|NCT02616783|464715182|FG001|Overall Study|Death|0|||
129114557|NCT02616783|464715181|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129114558|NCT02616783|464715182|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128693646|NCT00216476|463177754|FG000|Overall Study|Death|2|||
128693647|NCT00216476|463177755|FG001|Overall Study|Death|0|||
128693648|NCT00216476|463177756|FG002|Overall Study|Death|0|||
128693649|NCT00216476|463177754|FG000|Overall Study|Pregnancy|0|||
128693650|NCT00216476|463177755|FG001|Overall Study|Pregnancy|1|||
128693651|NCT00216476|463177756|FG002|Overall Study|Pregnancy|1|||
128693652|NCT00216476|463177754|FG000|Overall Study|Other|0|||
128693653|NCT00216476|463177755|FG001|Overall Study|Other|0|||
128693654|NCT00216476|463177756|FG002|Overall Study|Other|1|||
128693655|NCT00216476|463177754|FG000|Overall Study|Refuses Injection|11|||
128693656|NCT00216476|463177755|FG001|Overall Study|Refuses Injection|0|||
128693657|NCT00216476|463177756|FG002|Overall Study|Refuses Injection|0|||
128693658|NCT00216476|463177754|FG000|Overall Study|No Further Need for Treatment|3|||
128693659|NCT00216476|463177755|FG001|Overall Study|No Further Need for Treatment|4|||
128693660|NCT00216476|463177756|FG002|Overall Study|No Further Need for Treatment|1|||
128693661|NCT00216476|463177754|FG000|Overall Study|Non-compliance|0|||
128693662|NCT00216476|463177755|FG001|Overall Study|Non-compliance|4|||
128693663|NCT00216476|463177756|FG002|Overall Study|Non-compliance|1|||
128693664|NCT00216476|463177754|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
128693665|NCT00216476|463177755|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
128693666|NCT00216476|463177756|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
128693667|NCT00216476|463177754|FG000|Overall Study|Administrative Reasons|1|||
128693668|NCT00216476|463177755|FG001|Overall Study|Administrative Reasons|1|||
128693669|NCT00216476|463177756|FG002|Overall Study|Administrative Reasons|0|||
128693670|NCT00216476|463177754|FG000|Overall Study|Protocol Deviation|5|||
128693671|NCT00216476|463177755|FG001|Overall Study|Protocol Deviation|1|||
128693672|NCT00216476|463177756|FG002|Overall Study|Protocol Deviation|0|||
128693673|NCT00216476|463177754|FG000|Overall Study|Patient Moved|2|||
128693674|NCT00216476|463177755|FG001|Overall Study|Patient Moved|2|||
128693675|NCT00216476|463177756|FG002|Overall Study|Patient Moved|0|||
128693676|NCT02191137|463177757|FG000|Treatment|Death|4|||
128693677|NCT02191137|463177757|FG000|Treatment|Withdrawal by Subject|3|||
128693678|NCT02191137|463177757|FG000|Treatment|Adverse Event|2|||
128902273|NCT01225731|463934743|FG008|Part 3|Physician Decision|0|||
128693679|NCT02191137|463177757|FG000|Treatment|Other|1|||
128693680|NCT02191137|463177757|FG000|Follow-up|Lost to Follow-up|2|||
128693681|NCT02191137|463177757|FG000|Follow-up|Ongoing/unknown|2|||
128693682|NCT02191137|463177757|FG000|Follow-up|Adverse Event|1|||
128693683|NCT00696800|463177758|FG000|Overall Study|Adverse Event|16|||
128693684|NCT00696800|463177759|FG001|Overall Study|Adverse Event|3|||
128693685|NCT00696800|463177758|FG000|Overall Study|Insufficient compliance with medication|2|||
128902274|NCT01225731|463934744|FG009|Part 3|Physician Decision|0|||
128902275|NCT01225731|463934745|FG010|Part 3|Physician Decision|0|||
128902276|NCT01225731|463934746|FG011|Part 3|Physician Decision|1|||
128902277|NCT01225731|463934747|FG012|Part 3|Physician Decision|2|||
128902278|NCT01225731|463934735|FG000|Part 3|Withdrawal by Subject|0|||
129215245|NCT02017405|465089474|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
129024864|NCT00477594|464383230|FG000|Year 3|Withdrawal by Subject|1|||
128693686|NCT00696800|463177759|FG001|Overall Study|Insufficient compliance with medication|1|||
128693687|NCT00696800|463177758|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
129215246|NCT02017405|465089475|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
129024865|NCT00477594|464383231|FG001|Year 3|Withdrawal by Subject|0|||
129024866|NCT00477594|464383230|FG000|Follow-up Period|Withdrawal by Subject|2|||
129024867|NCT00477594|464383231|FG001|Follow-up Period|Withdrawal by Subject|1|||
129024868|NCT00477594|464383230|FG000|Follow-up Period|Other|1|||
129024869|NCT00477594|464383231|FG001|Follow-up Period|Other|0|||
129024870|NCT02875392|464385481|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
129024871|NCT02875392|464385482|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
129024872|NCT03599193|464385483|FG000|Overall Study|Adverse Event|0|||
129024873|NCT03599193|464385484|FG001|Overall Study|Adverse Event|2|||
129024874|NCT03599193|464385483|FG000|Overall Study|Withdrawal by Subject|1|||
129024875|NCT03599193|464385484|FG001|Overall Study|Withdrawal by Subject|0|||
129024876|NCT03599193|464385483|FG000|Overall Study|Protocol Violation|1|||
129024877|NCT03599193|464385484|FG001|Overall Study|Protocol Violation|0|||
129024878|NCT03599193|464385483|FG000|Overall Study|Lost to Follow-up|0|||
129024879|NCT03599193|464385484|FG001|Overall Study|Lost to Follow-up|1|||
129024880|NCT00835705|464385485|FG000|First Intervention|Difficulty with vein|1|||
129215247|NCT02017405|465089476|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
128693688|NCT00696800|463177759|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
128693689|NCT00696800|463177758|FG000|Overall Study|Insufficient ovarian response|4|||
128693690|NCT00696800|463177759|FG001|Overall Study|Insufficient ovarian response|1|||
128693691|NCT00696800|463177758|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
128693692|NCT00696800|463177759|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
128693693|NCT00696800|463177758|FG000|Overall Study|Too high ovarian response|6|||
128902279|NCT01225731|463934736|FG001|Part 3|Withdrawal by Subject|0|||
129024881|NCT00835705|464385486|FG001|First Intervention|Difficulty with vein|0|||
128693694|NCT00696800|463177759|FG001|Overall Study|Too high ovarian response|1|||
128693695|NCT00696800|463177758|FG000|Overall Study|No/too few/bad quality oocytes|4|||
128693696|NCT00696800|463177759|FG001|Overall Study|No/too few/bad quality oocytes|3|||
128693697|NCT00696800|463177758|FG000|Overall Study|No/abnormal fertilization|11|||
128693698|NCT00696800|463177759|FG001|Overall Study|No/abnormal fertilization|13|||
128693699|NCT00696800|463177758|FG000|Overall Study|No/too few/bad quality embryos|24|||
128693700|NCT00696800|463177759|FG001|Overall Study|No/too few/bad quality embryos|18|||
128693701|NCT00696800|463177758|FG000|Overall Study|Other Reasons|5|||
128693702|NCT00696800|463177759|FG001|Overall Study|Other Reasons|3|||
128693703|NCT00696800|463177758|FG000|Overall Study|Not treated|1|||
128693704|NCT00696800|463177759|FG001|Overall Study|Not treated|2|||
128693705|NCT00071396|463177765|FG000|Overall Study|Withdrawal by Subject|1|||
128693706|NCT00071396|463177765|FG000|Overall Study|Physician Decision|2|||
128693707|NCT02713204|463177766|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
128693708|NCT02713204|463177767|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
128693709|NCT02713204|463177768|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
128693710|NCT02713204|463177769|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
128693711|NCT02713204|463177770|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
128693712|NCT02713204|463177771|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
128693713|NCT02713204|463177772|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
128693714|NCT02713204|463177773|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
128693715|NCT02713204|463177766|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128693716|NCT02713204|463177767|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128693717|NCT02713204|463177768|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
128693718|NCT02713204|463177769|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128693719|NCT02713204|463177770|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128693720|NCT02713204|463177771|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128693721|NCT02713204|463177772|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128693722|NCT02713204|463177773|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128693723|NCT02713204|463177766|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128693724|NCT02713204|463177767|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
128693725|NCT02713204|463177768|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128693726|NCT02713204|463177769|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128693727|NCT02713204|463177770|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128693728|NCT02713204|463177771|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128693729|NCT02713204|463177772|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128693730|NCT02713204|463177773|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128693731|NCT02713204|463177766|FG000|From Week 12 up to Week 36|Adverse Event|1|||
128693732|NCT02713204|463177767|FG001|From Week 12 up to Week 36|Adverse Event|0|||
128693733|NCT02713204|463177768|FG002|From Week 12 up to Week 36|Adverse Event|0|||
129114559|NCT02616783|464715181|FG000|Overall Study|Protocol Violation|1|||
129114560|NCT02616783|464715182|FG001|Overall Study|Protocol Violation|1|||
129114561|NCT02616783|464715181|FG000|Overall Study|Withdrew Consent|1|||
129114562|NCT02616783|464715182|FG001|Overall Study|Withdrew Consent|1|||
129114563|NCT04344301|464715183|FG000|Overall Study|Withdrawal by Subject|1|||
129114564|NCT04344301|464715184|FG001|Overall Study|Withdrawal by Subject|0|||
129114565|NCT04344301|464715183|FG000|Overall Study|Death|0|||
129114566|NCT04344301|464715184|FG001|Overall Study|Death|1|||
129114567|NCT05214118|464715187|FG000|Overall Study|Lost to Follow-up|0|||
129114568|NCT05214118|464715188|FG001|Overall Study|Lost to Follow-up|2|||
129114569|NCT05214118|464715187|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
128693734|NCT02713204|463177769|FG003|From Week 12 up to Week 36|Adverse Event|1|||
128693735|NCT02713204|463177770|FG004|From Week 12 up to Week 36|Adverse Event|1|||
128693736|NCT02713204|463177771|FG005|From Week 12 up to Week 36|Adverse Event|0|||
128693737|NCT02713204|463177772|FG006|From Week 12 up to Week 36|Adverse Event|2|||
128693738|NCT02713204|463177773|FG007|From Week 12 up to Week 36|Adverse Event|1|||
128693739|NCT02713204|463177766|FG000|From Week 12 up to Week 36|Death|0|||
128693740|NCT02713204|463177767|FG001|From Week 12 up to Week 36|Death|0|||
128693741|NCT02713204|463177768|FG002|From Week 12 up to Week 36|Death|0|||
128693742|NCT02713204|463177769|FG003|From Week 12 up to Week 36|Death|1|||
128693743|NCT02713204|463177770|FG004|From Week 12 up to Week 36|Death|0|||
128693744|NCT02713204|463177771|FG005|From Week 12 up to Week 36|Death|1|||
129114570|NCT05214118|464715188|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
128693745|NCT02713204|463177772|FG006|From Week 12 up to Week 36|Death|0|||
128693746|NCT02713204|463177773|FG007|From Week 12 up to Week 36|Death|3|||
128693747|NCT02713204|463177766|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
128693748|NCT02713204|463177767|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
128693749|NCT02713204|463177768|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
128693750|NCT02713204|463177769|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
128693751|NCT02713204|463177770|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
128693752|NCT02713204|463177771|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
128693753|NCT02713204|463177772|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
129114571|NCT05214118|464715187|FG000|Overall Study|moved|1|||
129114572|NCT05214118|464715188|FG001|Overall Study|moved|0|||
129215248|NCT02017405|465089477|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
129215249|NCT02017405|465089472|FG000|Open-label Phase|Adverse Event|1|||
129215250|NCT02017405|465089473|FG001|Open-label Phase|Adverse Event|1|||
129215251|NCT02017405|465089474|FG002|Open-label Phase|Adverse Event|0|||
129215252|NCT02017405|465089475|FG003|Open-label Phase|Adverse Event|0|||
129215253|NCT02017405|465089476|FG004|Open-label Phase|Adverse Event|0|||
129215254|NCT02017405|465089477|FG005|Open-label Phase|Adverse Event|0|||
129215255|NCT04730804|465089482|FG000|Overall Study|Physician Decision|0|||
129215256|NCT04730804|465089483|FG001|Overall Study|Physician Decision|0|||
129215257|NCT04730804|465089484|FG002|Overall Study|Physician Decision|0|||
129215258|NCT04730804|465089485|FG003|Overall Study|Physician Decision|0|||
129215259|NCT04730804|465089486|FG004|Overall Study|Physician Decision|0|||
129215260|NCT04730804|465089487|FG005|Overall Study|Physician Decision|1|||
129215261|NCT04730804|465089482|FG000|Overall Study|Withdrawal by Subject|0|||
129215262|NCT04730804|465089483|FG001|Overall Study|Withdrawal by Subject|0|||
129215263|NCT04730804|465089484|FG002|Overall Study|Withdrawal by Subject|0|||
129215264|NCT04730804|465089485|FG003|Overall Study|Withdrawal by Subject|0|||
129215265|NCT04730804|465089486|FG004|Overall Study|Withdrawal by Subject|1|||
129215266|NCT04730804|465089487|FG005|Overall Study|Withdrawal by Subject|2|||
129215267|NCT00554216|465091116|FG000|Overall Study|Lost to Follow-up|92|||
129215268|NCT00554216|465091117|FG001|Overall Study|Lost to Follow-up|31|||
129215269|NCT00554216|465091118|FG002|Overall Study|Lost to Follow-up|63|||
129215270|NCT00554216|465091116|FG000|Overall Study|Adverse Event|16|||
129215271|NCT00554216|465091117|FG001|Overall Study|Adverse Event|16|||
129215272|NCT00554216|465091118|FG002|Overall Study|Adverse Event|36|||
129215273|NCT00554216|465091116|FG000|Overall Study|Withdrawal by Subject|92|||
129215274|NCT00554216|465091117|FG001|Overall Study|Withdrawal by Subject|31|||
129215275|NCT00554216|465091118|FG002|Overall Study|Withdrawal by Subject|43|||
129215276|NCT00554216|465091116|FG000|Overall Study|Non compliance|10|||
129215277|NCT00554216|465091117|FG001|Overall Study|Non compliance|4|||
129215278|NCT00554216|465091118|FG002|Overall Study|Non compliance|5|||
129215279|NCT00554216|465091116|FG000|Overall Study|Pregnancy|2|||
129215280|NCT00554216|465091117|FG001|Overall Study|Pregnancy|1|||
129215281|NCT00554216|465091118|FG002|Overall Study|Pregnancy|14|||
129215282|NCT00554216|465091116|FG000|Overall Study|Restricted med|3|||
129215283|NCT00554216|465091117|FG001|Overall Study|Restricted med|1|||
129215284|NCT00554216|465091118|FG002|Overall Study|Restricted med|1|||
129215285|NCT00554216|465091116|FG000|Overall Study|Other|12|||
129215286|NCT00554216|465091117|FG001|Overall Study|Other|7|||
129215287|NCT00554216|465091118|FG002|Overall Study|Other|10|||
129215288|NCT00554216|465091116|FG000|Overall Study|Lack of Efficacy|15|||
129215289|NCT00554216|465091117|FG001|Overall Study|Lack of Efficacy|3|||
129215290|NCT00554216|465091118|FG002|Overall Study|Lack of Efficacy|0|||
129215291|NCT00463567|465091125|FG000|Overall Study|Adverse Event|29|||
129215292|NCT00463567|465091126|FG001|Overall Study|Adverse Event|26|||
128902280|NCT01225731|463934737|FG002|Part 3|Withdrawal by Subject|0|||
128902281|NCT01225731|463934738|FG003|Part 3|Withdrawal by Subject|0|||
128902282|NCT01225731|463934739|FG004|Part 3|Withdrawal by Subject|0|||
129024882|NCT00835705|464385485|FG000|Second Intervention|Difficulty with vein|1|||
129024883|NCT00835705|464385486|FG001|Second Intervention|Difficulty with vein|0|||
129024884|NCT01750294|464385487|FG000|Overall Study|Withdrawal by Subject|1|||
129024885|NCT01750294|464385487|FG000|Overall Study|Safety Endpoint|1|||
129024886|NCT00665925|464385488|FG000|Overall Study|Lack of Efficacy|10|||
129024887|NCT00665925|464385489|FG001|Overall Study|Lack of Efficacy|8|||
129024888|NCT00665925|464385490|FG002|Overall Study|Lack of Efficacy|9|||
129024889|NCT00665925|464385491|FG003|Overall Study|Lack of Efficacy|8|||
129024890|NCT00665925|464385488|FG000|Overall Study|Lost to Follow-up|1|||
129024891|NCT00665925|464385489|FG001|Overall Study|Lost to Follow-up|2|||
129024892|NCT00665925|464385490|FG002|Overall Study|Lost to Follow-up|2|||
129024893|NCT00665925|464385491|FG003|Overall Study|Lost to Follow-up|2|||
129024894|NCT00665925|464385488|FG000|Overall Study|Withdrawal by Subject|2|||
129024895|NCT00665925|464385489|FG001|Overall Study|Withdrawal by Subject|2|||
129024896|NCT00665925|464385490|FG002|Overall Study|Withdrawal by Subject|3|||
129024897|NCT00665925|464385491|FG003|Overall Study|Withdrawal by Subject|2|||
129024898|NCT00665925|464385488|FG000|Overall Study|Physician Decision|0|||
129024899|NCT00665925|464385489|FG001|Overall Study|Physician Decision|0|||
129024900|NCT00665925|464385490|FG002|Overall Study|Physician Decision|1|||
129215293|NCT00463567|465091127|FG002|Overall Study|Adverse Event|17|||
129215294|NCT00463567|465091128|FG003|Overall Study|Adverse Event|46|||
129215295|NCT00463567|465091129|FG004|Overall Study|Adverse Event|10|||
129215296|NCT00463567|465091130|FG005|Overall Study|Adverse Event|10|||
129215297|NCT00463567|465091131|FG006|Overall Study|Adverse Event|4|||
129215298|NCT00463567|465091125|FG000|Overall Study|Withdrawal by Subject|29|||
129215299|NCT00463567|465091126|FG001|Overall Study|Withdrawal by Subject|22|||
129215300|NCT00463567|465091127|FG002|Overall Study|Withdrawal by Subject|20|||
129215301|NCT00463567|465091128|FG003|Overall Study|Withdrawal by Subject|37|||
129215302|NCT00463567|465091129|FG004|Overall Study|Withdrawal by Subject|6|||
129215303|NCT00463567|465091130|FG005|Overall Study|Withdrawal by Subject|5|||
129215304|NCT00463567|465091131|FG006|Overall Study|Withdrawal by Subject|1|||
129215305|NCT00463567|465091125|FG000|Overall Study|Protocol Deviation|13|||
128764685|NCT00539643|463430261|FG000|Overall Study|Withdrawal by Subject|0|||
128902283|NCT01225731|463934740|FG005|Part 3|Withdrawal by Subject|0|||
128902284|NCT01225731|463934741|FG006|Part 3|Withdrawal by Subject|0|||
128902285|NCT01225731|463934742|FG007|Part 3|Withdrawal by Subject|0|||
128902286|NCT01225731|463934743|FG008|Part 3|Withdrawal by Subject|0|||
128902287|NCT01225731|463934744|FG009|Part 3|Withdrawal by Subject|0|||
128902288|NCT01225731|463934745|FG010|Part 3|Withdrawal by Subject|4|||
128902289|NCT01225731|463934746|FG011|Part 3|Withdrawal by Subject|6|||
128902290|NCT01225731|463934747|FG012|Part 3|Withdrawal by Subject|4|||
128902291|NCT00577642|463934748|FG000|Overall Study|Clinical Disease Progression|1|||
128902292|NCT00917150|463934753|FG000|Overall Study|Adverse Event|12|||
128902293|NCT00917150|463934754|FG001|Overall Study|Adverse Event|7|||
128902294|NCT00917150|463934755|FG002|Overall Study|Adverse Event|12|||
128902295|NCT00917150|463934756|FG003|Overall Study|Adverse Event|11|||
128902296|NCT00917150|463934753|FG000|Overall Study|Death|1|||
128902297|NCT00917150|463934754|FG001|Overall Study|Death|4|||
128902298|NCT00917150|463934755|FG002|Overall Study|Death|3|||
128902299|NCT00917150|463934756|FG003|Overall Study|Death|2|||
128902300|NCT00917150|463934753|FG000|Overall Study|Lost to Follow-up|1|||
128902301|NCT00917150|463934754|FG001|Overall Study|Lost to Follow-up|0|||
128902302|NCT00917150|463934755|FG002|Overall Study|Lost to Follow-up|4|||
128902303|NCT00917150|463934756|FG003|Overall Study|Lost to Follow-up|2|||
128902304|NCT00917150|463934753|FG000|Overall Study|Physician Decision|0|||
128902305|NCT00917150|463934754|FG001|Overall Study|Physician Decision|2|||
128902306|NCT00917150|463934755|FG002|Overall Study|Physician Decision|0|||
128902307|NCT00917150|463934756|FG003|Overall Study|Physician Decision|1|||
128902308|NCT00917150|463934753|FG000|Overall Study|Protocol Violation|5|||
129024901|NCT00665925|464385491|FG003|Overall Study|Physician Decision|2|||
129024902|NCT00665925|464385488|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
129024903|NCT00665925|464385489|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
129024904|NCT00665925|464385490|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
129024905|NCT00665925|464385491|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
129024906|NCT00665925|464385488|FG000|Overall Study|Adverse Event|1|||
129024907|NCT00665925|464385489|FG001|Overall Study|Adverse Event|5|||
129024908|NCT00665925|464385490|FG002|Overall Study|Adverse Event|10|||
129024909|NCT00665925|464385491|FG003|Overall Study|Adverse Event|5|||
129024910|NCT00665925|464385488|FG000|Overall Study|Enrolled by mistake|0|||
129024911|NCT00665925|464385489|FG001|Overall Study|Enrolled by mistake|0|||
129024912|NCT00665925|464385490|FG002|Overall Study|Enrolled by mistake|0|||
129024913|NCT00665925|464385491|FG003|Overall Study|Enrolled by mistake|1|||
129024914|NCT00665925|464385488|FG000|Overall Study|Due to exclusion criteria|1|||
129024915|NCT00665925|464385489|FG001|Overall Study|Due to exclusion criteria|0|||
129024916|NCT00665925|464385490|FG002|Overall Study|Due to exclusion criteria|0|||
129024917|NCT00665925|464385491|FG003|Overall Study|Due to exclusion criteria|0|||
129024918|NCT04372238|464385494|FG000|Overall Study|Duplicate|3|||
129024919|NCT04372238|464385495|FG001|Overall Study|Duplicate|3|||
129024920|NCT04372238|464385494|FG000|Overall Study|Did not consent for data linkage|6|||
129024921|NCT04372238|464385495|FG001|Overall Study|Did not consent for data linkage|10|||
129024922|NCT01592240|464385496|FG000|Overall Study|Adverse Event|1|||
129024923|NCT01592240|464385497|FG001|Overall Study|Adverse Event|0|||
129024924|NCT01592240|464385498|FG002|Overall Study|Adverse Event|0|||
129024925|NCT01592240|464385499|FG003|Overall Study|Adverse Event|1|||
129024926|NCT01592240|464385500|FG004|Overall Study|Adverse Event|1|||
129024927|NCT01592240|464385501|FG005|Overall Study|Adverse Event|0|||
129024928|NCT01592240|464385502|FG006|Overall Study|Adverse Event|0|||
129024929|NCT01592240|464385496|FG000|Overall Study|Death|0|||
129024930|NCT01592240|464385497|FG001|Overall Study|Death|1|||
129024931|NCT01592240|464385498|FG002|Overall Study|Death|0|||
129024932|NCT01592240|464385499|FG003|Overall Study|Death|0|||
129024933|NCT01592240|464385500|FG004|Overall Study|Death|0|||
129024934|NCT01592240|464385501|FG005|Overall Study|Death|0|||
129024935|NCT01592240|464385502|FG006|Overall Study|Death|0|||
129024936|NCT01592240|464385496|FG000|Overall Study|Lost to Follow-up|1|||
129024937|NCT01592240|464385497|FG001|Overall Study|Lost to Follow-up|3|||
129024938|NCT01592240|464385498|FG002|Overall Study|Lost to Follow-up|1|||
129024939|NCT01592240|464385499|FG003|Overall Study|Lost to Follow-up|0|||
129024940|NCT01592240|464385500|FG004|Overall Study|Lost to Follow-up|3|||
128902309|NCT00917150|463934754|FG001|Overall Study|Protocol Violation|5|||
128902310|NCT00917150|463934755|FG002|Overall Study|Protocol Violation|3|||
128902311|NCT00917150|463934756|FG003|Overall Study|Protocol Violation|5|||
128902312|NCT00917150|463934753|FG000|Overall Study|Withdrawal by Subject|15|||
128902313|NCT00917150|463934754|FG001|Overall Study|Withdrawal by Subject|16|||
128902314|NCT00917150|463934755|FG002|Overall Study|Withdrawal by Subject|18|||
128902315|NCT00917150|463934756|FG003|Overall Study|Withdrawal by Subject|11|||
128902316|NCT00917150|463934753|FG000|Overall Study|Other than specified|3|||
129024941|NCT01592240|464385501|FG005|Overall Study|Lost to Follow-up|2|||
129024942|NCT01592240|464385502|FG006|Overall Study|Lost to Follow-up|0|||
129024943|NCT01592240|464385496|FG000|Overall Study|Protocol Violation|0|||
128902317|NCT00917150|463934754|FG001|Overall Study|Other than specified|3|||
129024944|NCT01592240|464385497|FG001|Overall Study|Protocol Violation|0|||
128902318|NCT00917150|463934755|FG002|Overall Study|Other than specified|2|||
128902319|NCT00917150|463934756|FG003|Overall Study|Other than specified|2|||
128902320|NCT01624662|463934757|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
128902321|NCT01624662|463934758|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
129114573|NCT04010461|464715189|FG000|Overall Study|COVID based withdrawal|5|||
129114574|NCT04010461|464715189|FG000|Overall Study|Withdrawal by Subject|5|||
129114575|NCT04010461|464715189|FG000|Overall Study|Adverse Event|1|||
129114576|NCT04010461|464715189|FG000|Overall Study|No Motor Threshold obtainable|1|||
129114577|NCT04010461|464715189|FG000|Overall Study|Physician Decision|1|||
129114578|NCT03797898|464715190|FG000|Overall Study|Lost to Follow-up|60|||
129114579|NCT03797898|464715191|FG001|Overall Study|Lost to Follow-up|69|||
129114580|NCT03797898|464715190|FG000|Overall Study|Withdrawal by Subject|9|||
129114581|NCT03797898|464715191|FG001|Overall Study|Withdrawal by Subject|7|||
129114582|NCT03797898|464715190|FG000|Overall Study|Became ineligible|5|||
129114583|NCT03797898|464715191|FG001|Overall Study|Became ineligible|2|||
129114584|NCT00086190|464715192|FG000|Overall Study|Adverse Event|6|||
129114585|NCT00086190|464715193|FG001|Overall Study|Adverse Event|2|||
129114586|NCT00086190|464715194|FG002|Overall Study|Adverse Event|2|||
129114587|NCT00086190|464715192|FG000|Overall Study|Withdrawal by Subject|0|||
129114588|NCT00086190|464715193|FG001|Overall Study|Withdrawal by Subject|2|||
129114589|NCT00086190|464715194|FG002|Overall Study|Withdrawal by Subject|2|||
129114590|NCT00086190|464715192|FG000|Overall Study|Protocol Violation|1|||
129114591|NCT00086190|464715193|FG001|Overall Study|Protocol Violation|0|||
129114592|NCT00086190|464715194|FG002|Overall Study|Protocol Violation|0|||
129114593|NCT00086190|464715192|FG000|Overall Study|Moved|1|||
129114594|NCT00086190|464715193|FG001|Overall Study|Moved|0|||
129114595|NCT00086190|464715194|FG002|Overall Study|Moved|0|||
128902322|NCT01624662|463934759|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
128902323|NCT01624662|463934760|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
128902324|NCT01624662|463934757|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
128902325|NCT01624662|463934758|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
128902326|NCT01624662|463934759|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
128902327|NCT01624662|463934760|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
128902328|NCT01624662|463934757|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
128902329|NCT01624662|463934758|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
128902330|NCT01624662|463934759|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
128902331|NCT01624662|463934760|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
128902332|NCT01624662|463934757|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
128902333|NCT01624662|463934758|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
128902334|NCT01624662|463934759|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
128902335|NCT01624662|463934760|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
128902336|NCT01624662|463934757|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
128902337|NCT01624662|463934758|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
129114596|NCT00086190|464715192|FG000|Overall Study|Worsening depression|0|||
129114597|NCT00086190|464715193|FG001|Overall Study|Worsening depression|0|||
129114598|NCT00086190|464715194|FG002|Overall Study|Worsening depression|2|||
129114599|NCT03902613|464715198|FG000|Overall Study|Physician Decision|1|||
129114600|NCT02027025|464715199|FG000|Overall Study|Adverse Event|0|||
129114601|NCT02027025|464715200|FG001|Overall Study|Adverse Event|1|||
129114602|NCT02027025|464715201|FG002|Overall Study|Adverse Event|1|||
129114603|NCT02027025|464715199|FG000|Overall Study|Protocol Violation|1|||
129114604|NCT02027025|464715200|FG001|Overall Study|Protocol Violation|0|||
128764686|NCT00539643|463430262|FG001|Overall Study|Withdrawal by Subject|1|||
129114605|NCT02027025|464715201|FG002|Overall Study|Protocol Violation|0|||
129114606|NCT02027025|464715199|FG000|Overall Study|Lost to Follow-up|0|||
129114607|NCT02027025|464715200|FG001|Overall Study|Lost to Follow-up|2|||
129114608|NCT02027025|464715201|FG002|Overall Study|Lost to Follow-up|0|||
129114609|NCT02027025|464715199|FG000|Overall Study|Withdrawal by Subject|0|||
129114610|NCT02027025|464715200|FG001|Overall Study|Withdrawal by Subject|1|||
129114611|NCT02027025|464715201|FG002|Overall Study|Withdrawal by Subject|0|||
128764687|NCT04503096|463430267|FG000|Overall Study|Withdrawal by Subject|3|||
128902338|NCT01624662|463934759|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
129114612|NCT02027025|464715199|FG000|Overall Study|Sponsor's decision|0|||
129114613|NCT02027025|464715200|FG001|Overall Study|Sponsor's decision|1|||
128764688|NCT01480596|463430268|FG000|Overall Study|Adverse Event|3|||
128764689|NCT01480596|463430269|FG001|Overall Study|Adverse Event|0|||
128764690|NCT01480596|463430268|FG000|Overall Study|MG exacerbation or change in medication|2|||
129114614|NCT02027025|464715201|FG002|Overall Study|Sponsor's decision|0|||
129114615|NCT00732069|464715202|FG000|Washout After First Study Drug|Adverse Event|1|||
129114616|NCT00732069|464715203|FG001|Washout After First Study Drug|Adverse Event|0|||
129114617|NCT00732069|464715204|FG002|Washout After First Study Drug|Adverse Event|0|||
129114618|NCT00732069|464715205|FG003|Washout After First Study Drug|Adverse Event|0|||
128764691|NCT01480596|463430269|FG001|Overall Study|MG exacerbation or change in medication|2|||
128902339|NCT01624662|463934760|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
128902340|NCT01624662|463934757|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
128902341|NCT01624662|463934758|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
128902342|NCT01624662|463934759|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
128902343|NCT01624662|463934760|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
128902344|NCT01624662|463934757|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
128902345|NCT01624662|463934758|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
128902346|NCT01624662|463934759|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
128902347|NCT01624662|463934760|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
128902348|NCT01135498|463936326|FG000|Overall Study|Adverse Event|20|||
128902349|NCT01135498|463936326|FG000|Overall Study|Progressive disease|38|||
128902350|NCT01135498|463936326|FG000|Overall Study|Investigator judgement|25|||
128902351|NCT01135498|463936326|FG000|Overall Study|Withdrawal by Subject|4|||
128902352|NCT01135498|463936326|FG000|Overall Study|Death|1|||
128902353|NCT01135498|463936326|FG000|Overall Study|Ongoing at time of analysis|2|||
128902354|NCT02104583|463936327|FG000|Overall Study|New ICD or CRT-D implanted|2|||
128902355|NCT02104583|463936328|FG001|Overall Study|New ICD or CRT-D implanted|0|||
128902356|NCT02104583|463936329|FG002|Overall Study|New ICD or CRT-D implanted|1|||
128902357|NCT02104583|463936330|FG003|Overall Study|New ICD or CRT-D implanted|0|||
128902358|NCT02104583|463936331|FG004|Overall Study|New ICD or CRT-D implanted|0|||
128902359|NCT02104583|463936327|FG000|Overall Study|Death|2|||
128902360|NCT02104583|463936328|FG001|Overall Study|Death|1|||
128902361|NCT02104583|463936329|FG002|Overall Study|Death|3|||
128902362|NCT02104583|463936330|FG003|Overall Study|Death|3|||
128902363|NCT02104583|463936331|FG004|Overall Study|Death|5|||
128902364|NCT02104583|463936327|FG000|Overall Study|Subject required cardiac ablation|6|||
128902365|NCT02104583|463936328|FG001|Overall Study|Subject required cardiac ablation|4|||
128902366|NCT02104583|463936329|FG002|Overall Study|Subject required cardiac ablation|4|||
128902367|NCT02104583|463936330|FG003|Overall Study|Subject required cardiac ablation|5|||
128902368|NCT02104583|463936331|FG004|Overall Study|Subject required cardiac ablation|4|||
128902369|NCT02104583|463936327|FG000|Overall Study|Subject required prohibited medication|0|||
128902370|NCT02104583|463936328|FG001|Overall Study|Subject required prohibited medication|1|||
128902371|NCT02104583|463936329|FG002|Overall Study|Subject required prohibited medication|1|||
128902372|NCT02104583|463936330|FG003|Overall Study|Subject required prohibited medication|0|||
128902373|NCT02104583|463936331|FG004|Overall Study|Subject required prohibited medication|1|||
128902374|NCT02104583|463936327|FG000|Overall Study|Withdrew Consent|3|||
128902375|NCT02104583|463936328|FG001|Overall Study|Withdrew Consent|2|||
128902376|NCT02104583|463936329|FG002|Overall Study|Withdrew Consent|0|||
128902377|NCT02104583|463936330|FG003|Overall Study|Withdrew Consent|2|||
128693754|NCT02713204|463177773|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
128693755|NCT02713204|463177766|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
128693756|NCT02713204|463177767|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
128902378|NCT02104583|463936331|FG004|Overall Study|Withdrew Consent|1|||
128693757|NCT02713204|463177768|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
128902379|NCT02104583|463936327|FG000|Overall Study|Investigator's Discretion|1|||
128902380|NCT02104583|463936328|FG001|Overall Study|Investigator's Discretion|0|||
128902381|NCT02104583|463936329|FG002|Overall Study|Investigator's Discretion|0|||
129024945|NCT01592240|464385498|FG002|Overall Study|Protocol Violation|0|||
129024946|NCT01592240|464385499|FG003|Overall Study|Protocol Violation|0|||
129024947|NCT01592240|464385500|FG004|Overall Study|Protocol Violation|0|||
129024948|NCT01592240|464385501|FG005|Overall Study|Protocol Violation|1|||
129024949|NCT01592240|464385502|FG006|Overall Study|Protocol Violation|0|||
129024950|NCT01592240|464385496|FG000|Overall Study|Withdrawal by Subject|0|||
129024951|NCT01592240|464385497|FG001|Overall Study|Withdrawal by Subject|4|||
129024952|NCT01592240|464385498|FG002|Overall Study|Withdrawal by Subject|4|||
129024953|NCT01592240|464385499|FG003|Overall Study|Withdrawal by Subject|1|||
129024954|NCT01592240|464385500|FG004|Overall Study|Withdrawal by Subject|3|||
129024955|NCT01592240|464385501|FG005|Overall Study|Withdrawal by Subject|0|||
129024956|NCT01592240|464385502|FG006|Overall Study|Withdrawal by Subject|2|||
129024957|NCT01592240|464385496|FG000|Overall Study|Other|0|||
129024958|NCT01592240|464385497|FG001|Overall Study|Other|3|||
129024959|NCT01592240|464385498|FG002|Overall Study|Other|1|||
129024960|NCT01592240|464385499|FG003|Overall Study|Other|1|||
129024961|NCT01592240|464385500|FG004|Overall Study|Other|0|||
129024962|NCT01592240|464385501|FG005|Overall Study|Other|0|||
129024963|NCT01592240|464385502|FG006|Overall Study|Other|1|||
129024964|NCT01592240|464385496|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129024965|NCT01592240|464385497|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
129024966|NCT01592240|464385498|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
129024967|NCT01592240|464385499|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
129024968|NCT01592240|464385500|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
129024969|NCT01592240|464385501|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
129024970|NCT01592240|464385502|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
129024971|NCT02751424|464385506|FG000|Part 2|Adverse Event|0|||
128693758|NCT02713204|463177769|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
128693759|NCT02713204|463177770|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
128693760|NCT02713204|463177771|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
128693761|NCT02713204|463177772|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
128693762|NCT02713204|463177773|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
128693763|NCT04402060|463177774|FG000|Overall Study|Death|1|||
128693764|NCT04402060|463177775|FG001|Overall Study|Death|12|||
128693765|NCT04402060|463177776|FG002|Overall Study|Death|7|||
128693766|NCT04402060|463177774|FG000|Overall Study|Adverse Event|0|||
128693767|NCT04402060|463177775|FG001|Overall Study|Adverse Event|0|||
128693768|NCT04402060|463177776|FG002|Overall Study|Adverse Event|1|||
128693769|NCT04402060|463177774|FG000|Overall Study|Withdrawal by Subject|0|||
128693770|NCT04402060|463177775|FG001|Overall Study|Withdrawal by Subject|1|||
128693771|NCT04402060|463177776|FG002|Overall Study|Withdrawal by Subject|2|||
128693772|NCT04402060|463177774|FG000|Overall Study|Sponsor Request|0|||
128693773|NCT04402060|463177775|FG001|Overall Study|Sponsor Request|2|||
128693774|NCT04402060|463177776|FG002|Overall Study|Sponsor Request|0|||
128693775|NCT04402060|463177774|FG000|Overall Study|Physician Decision|0|||
128902382|NCT02104583|463936330|FG003|Overall Study|Investigator's Discretion|0|||
128902383|NCT02104583|463936331|FG004|Overall Study|Investigator's Discretion|0|||
128902384|NCT02104583|463936327|FG000|Overall Study|Protocol Violation|0|||
129024972|NCT02751424|464385507|FG001|Part 2|Adverse Event|0|||
128693776|NCT04402060|463177775|FG001|Overall Study|Physician Decision|0|||
128693777|NCT04402060|463177776|FG002|Overall Study|Physician Decision|1|||
128693778|NCT04402060|463177774|FG000|Overall Study|Other|0|||
128693779|NCT04402060|463177775|FG001|Overall Study|Other|1|||
128693780|NCT04402060|463177776|FG002|Overall Study|Other|0|||
128693781|NCT01297920|463177779|FG000|Overall Study|Adverse Event|42|||
128693782|NCT01297920|463177780|FG001|Overall Study|Adverse Event|10|||
128693783|NCT01297920|463177781|FG002|Overall Study|Adverse Event|38|||
128693784|NCT01297920|463177779|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
128693785|NCT01297920|463177780|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
128693786|NCT01297920|463177781|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
128693787|NCT01297920|463177779|FG000|Overall Study|Noncompliance|1|||
128693788|NCT01297920|463177780|FG001|Overall Study|Noncompliance|0|||
128693789|NCT01297920|463177781|FG002|Overall Study|Noncompliance|0|||
128902385|NCT02104583|463936328|FG001|Overall Study|Protocol Violation|0|||
129024973|NCT02751424|464385508|FG002|Part 2|Adverse Event|0|||
129024974|NCT02751424|464385509|FG003|Part 2|Adverse Event|0|||
129024975|NCT02751424|464385510|FG004|Part 2|Adverse Event|0|||
129024976|NCT02751424|464385511|FG005|Part 2|Adverse Event|0|||
129024977|NCT02751424|464385512|FG006|Part 2|Adverse Event|0|||
129024978|NCT02751424|464385513|FG007|Part 2|Adverse Event|5|||
129024979|NCT02751424|464385514|FG008|Part 2|Adverse Event|0|||
129024980|NCT03206749|464385515|FG000|Overall Study|Withdrawal of consent|5|||
129024981|NCT03206749|464385516|FG001|Overall Study|Withdrawal of consent|3|||
129024982|NCT03206749|464385517|FG002|Overall Study|Withdrawal of consent|6|||
129024983|NCT03206749|464385515|FG000|Overall Study|Lost to Follow-up|0|||
129024984|NCT03206749|464385516|FG001|Overall Study|Lost to Follow-up|0|||
129024985|NCT03206749|464385517|FG002|Overall Study|Lost to Follow-up|1|||
129024986|NCT02197416|464385518|FG000|Overall Study|Other reasons|0|||
129024987|NCT02197416|464385519|FG001|Overall Study|Other reasons|2|||
129024988|NCT02197416|464385520|FG002|Overall Study|Other reasons|5|||
129024989|NCT02197416|464385518|FG000|Overall Study|Withdrawal by Subject|0|||
129024990|NCT02197416|464385519|FG001|Overall Study|Withdrawal by Subject|2|||
129024991|NCT02197416|464385520|FG002|Overall Study|Withdrawal by Subject|1|||
129024992|NCT02197416|464385518|FG000|Overall Study|Protocol Violation|1|||
129024993|NCT02197416|464385519|FG001|Overall Study|Protocol Violation|0|||
129024994|NCT02197416|464385520|FG002|Overall Study|Protocol Violation|1|||
129024995|NCT02197416|464385518|FG000|Overall Study|Adverse Event|0|||
129024996|NCT02197416|464385519|FG001|Overall Study|Adverse Event|0|||
129024997|NCT02197416|464385520|FG002|Overall Study|Adverse Event|1|||
129024998|NCT02451696|464385521|FG000|Overall Study|Surgery postponed|1|||
129024999|NCT02451696|464385522|FG001|Overall Study|Surgery postponed|0|||
129025000|NCT05014828|464385524|FG000|Overall Study|Study Completed by Sponsor|16|||
129025001|NCT05014828|464385525|FG001|Overall Study|Study Completed by Sponsor|16|||
129025002|NCT05014828|464385526|FG002|Overall Study|Study Completed by Sponsor|3|||
129025003|NCT05014828|464385527|FG003|Overall Study|Study Completed by Sponsor|3|||
128693790|NCT01297920|463177779|FG000|Overall Study|Protocol Violation|1|||
128693791|NCT01297920|463177780|FG001|Overall Study|Protocol Violation|3|||
128693792|NCT01297920|463177781|FG002|Overall Study|Protocol Violation|0|||
128693793|NCT01297920|463177779|FG000|Overall Study|Inadequate Control of IOP|7|||
128693794|NCT01297920|463177780|FG001|Overall Study|Inadequate Control of IOP|9|||
128693795|NCT01297920|463177781|FG002|Overall Study|Inadequate Control of IOP|17|||
128693796|NCT01297920|463177779|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
128693797|NCT01297920|463177780|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
128693798|NCT01297920|463177781|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
129025004|NCT05014828|464385524|FG000|Overall Study|Death|11|||
129025005|NCT05014828|464385525|FG001|Overall Study|Death|6|||
128902386|NCT02104583|463936329|FG002|Overall Study|Protocol Violation|1|||
128902387|NCT02104583|463936330|FG003|Overall Study|Protocol Violation|0|||
128902388|NCT02104583|463936331|FG004|Overall Study|Protocol Violation|0|||
128902389|NCT02104583|463936327|FG000|Overall Study|Adverse Event|3|||
128902390|NCT02104583|463936328|FG001|Overall Study|Adverse Event|3|||
128902391|NCT02104583|463936329|FG002|Overall Study|Adverse Event|6|||
128902392|NCT02104583|463936330|FG003|Overall Study|Adverse Event|6|||
128902393|NCT02104583|463936331|FG004|Overall Study|Adverse Event|1|||
128902394|NCT02104583|463936327|FG000|Overall Study|Lost to Follow-up|1|||
128902395|NCT02104583|463936328|FG001|Overall Study|Lost to Follow-up|0|||
128902396|NCT02104583|463936329|FG002|Overall Study|Lost to Follow-up|0|||
128902397|NCT02104583|463936330|FG003|Overall Study|Lost to Follow-up|0|||
128902398|NCT02104583|463936331|FG004|Overall Study|Lost to Follow-up|0|||
128902399|NCT02104583|463936327|FG000|Overall Study|Randomized but Never Treated|0|||
128902400|NCT02104583|463936328|FG001|Overall Study|Randomized but Never Treated|0|||
128902401|NCT02104583|463936329|FG002|Overall Study|Randomized but Never Treated|0|||
128902402|NCT02104583|463936330|FG003|Overall Study|Randomized but Never Treated|1|||
128902403|NCT02104583|463936331|FG004|Overall Study|Randomized but Never Treated|0|||
129025006|NCT05014828|464385526|FG002|Overall Study|Death|0|||
129025007|NCT05014828|464385527|FG003|Overall Study|Death|0|||
129025008|NCT05014828|464385524|FG000|Overall Study|Lost to Follow-up|0|||
129025009|NCT05014828|464385525|FG001|Overall Study|Lost to Follow-up|0|||
129025010|NCT05014828|464385526|FG002|Overall Study|Lost to Follow-up|2|||
129025011|NCT05014828|464385527|FG003|Overall Study|Lost to Follow-up|0|||
129025012|NCT05014828|464385524|FG000|Overall Study|Miscellaneous.|0|||
129025013|NCT05014828|464385525|FG001|Overall Study|Miscellaneous.|1|||
129025014|NCT05014828|464385526|FG002|Overall Study|Miscellaneous.|0|||
129025015|NCT05014828|464385527|FG003|Overall Study|Miscellaneous.|0|||
129025016|NCT05523895|464385528|FG000|Overall Study|Adverse Event|2|||
129025017|NCT05523895|464385529|FG001|Overall Study|Adverse Event|1|||
129025018|NCT05523895|464385530|FG002|Overall Study|Adverse Event|1|||
129025019|NCT05523895|464385528|FG000|Overall Study|Lost to Follow-up|0|||
129025020|NCT05523895|464385529|FG001|Overall Study|Lost to Follow-up|1|||
129025021|NCT05523895|464385530|FG002|Overall Study|Lost to Follow-up|2|||
129025022|NCT05523895|464385528|FG000|Overall Study|Noncompliance with study drug|1|||
129025023|NCT05523895|464385529|FG001|Overall Study|Noncompliance with study drug|1|||
129025024|NCT05523895|464385530|FG002|Overall Study|Noncompliance with study drug|1|||
129025025|NCT05523895|464385528|FG000|Overall Study|Protocol Violation|0|||
129025026|NCT05523895|464385529|FG001|Overall Study|Protocol Violation|2|||
129025027|NCT05523895|464385530|FG002|Overall Study|Protocol Violation|0|||
129025028|NCT05523895|464385528|FG000|Overall Study|Withdrawal by Subject|1|||
129025029|NCT05523895|464385529|FG001|Overall Study|Withdrawal by Subject|3|||
129025030|NCT05523895|464385530|FG002|Overall Study|Withdrawal by Subject|1|||
129025031|NCT05523895|464385528|FG000|Overall Study|Not further specified|0|||
129025032|NCT05523895|464385529|FG001|Overall Study|Not further specified|3|||
129025033|NCT05523895|464385530|FG002|Overall Study|Not further specified|1|||
129025034|NCT03674892|464385531|FG000|Overall Study|Lack of Efficacy|5|||
129025035|NCT03674892|464385531|FG000|Overall Study|Lost to Follow-up|3|||
129025036|NCT03674892|464385531|FG000|Overall Study|Migraine|2|||
129025037|NCT03674892|464385531|FG000|Overall Study|Excessive Tearing|1|||
129025038|NCT03674892|464385531|FG000|Overall Study|Increased Eye Pain|1|||
129025039|NCT03674892|464385531|FG000|Overall Study|Increased Facial Pain|1|||
129025040|NCT03674892|464385531|FG000|Overall Study|Sinus Irritation|1|||
129025041|NCT03674892|464385531|FG000|Overall Study|Sinus Infection|1|||
129025042|NCT05041361|464385533|FG000|Overall Study|Lost to Follow-up|1|||
129025043|NCT05041361|464385534|FG001|Overall Study|Lost to Follow-up|3|||
129025044|NCT01642277|464385535|FG000|Overall Study|Adverse Event|10|||
129025045|NCT01642277|464385536|FG001|Overall Study|Adverse Event|0|||
129025046|NCT01642277|464385535|FG000|Overall Study|Physician Decision|2|||
129025047|NCT01642277|464385536|FG001|Overall Study|Physician Decision|0|||
129025048|NCT01642277|464385535|FG000|Overall Study|Protocol Violation|1|||
129025049|NCT01642277|464385536|FG001|Overall Study|Protocol Violation|0|||
129025050|NCT01642277|464385535|FG000|Overall Study|Withdrawal by Subject|11|||
129025051|NCT01642277|464385536|FG001|Overall Study|Withdrawal by Subject|0|||
129025052|NCT03779334|464385539|FG000|Overall Study|Withdrawal by Subject|3|||
128693799|NCT00331422|463177782|FG000|Overall Study|Did not receive entire study regimen|5|||
129025053|NCT03779334|464385540|FG001|Overall Study|Withdrawal by Subject|0|||
129025054|NCT03779334|464385541|FG002|Overall Study|Withdrawal by Subject|0|||
129025055|NCT03779334|464385539|FG000|Overall Study|Ongoing in Study|5|||
129025056|NCT03779334|464385540|FG001|Overall Study|Ongoing in Study|13|||
129114619|NCT00732069|464715206|FG004|Washout After First Study Drug|Adverse Event|0|||
128902404|NCT01351389|463936332|FG000|Overall Study|Withdrawal by Subject|7|||
128902405|NCT01351389|463936333|FG001|Overall Study|Withdrawal by Subject|0|||
129025057|NCT03779334|464385541|FG002|Overall Study|Ongoing in Study|5|||
129114620|NCT00732069|464715207|FG005|Washout After First Study Drug|Adverse Event|0|||
129025058|NCT01175135|464385542|FG000|Overall Study|Adverse Event|2|||
128902406|NCT01351389|463936332|FG000|Overall Study|did not complete intervention|23|||
128902407|NCT01351389|463936333|FG001|Overall Study|did not complete intervention|15|||
128693800|NCT02345226|463177783|FG000|Double-Blind Phase|Adverse Event|5|||
128693801|NCT02345226|463177784|FG001|Double-Blind Phase|Adverse Event|6|||
128693802|NCT02345226|463177783|FG000|Double-Blind Phase|Death|3|||
128693803|NCT02345226|463177784|FG001|Double-Blind Phase|Death|0|||
128693804|NCT02345226|463177783|FG000|Double-Blind Phase|Pregnancy|0|||
128693805|NCT02345226|463177784|FG001|Double-Blind Phase|Pregnancy|1|||
128693806|NCT02345226|463177783|FG000|Double-Blind Phase|Lack of Efficacy|1|||
128693807|NCT02345226|463177784|FG001|Double-Blind Phase|Lack of Efficacy|0|||
128693808|NCT02345226|463177783|FG000|Double-Blind Phase|Investigator's Discretion|4|||
128693809|NCT02345226|463177784|FG001|Double-Blind Phase|Investigator's Discretion|3|||
128693810|NCT02345226|463177783|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
128693811|NCT02345226|463177784|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
128693812|NCT02345226|463177783|FG000|Double-Blind Phase|Withdrew Consent|41|||
128693813|NCT02345226|463177784|FG001|Double-Blind Phase|Withdrew Consent|39|||
128693814|NCT02345226|463177783|FG000|Double-Blind Phase|Lost to Follow-up|12|||
128693815|NCT02345226|463177784|FG001|Double-Blind Phase|Lost to Follow-up|16|||
128693816|NCT02345226|463177783|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
128693817|NCT02345226|463177784|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
128693818|NCT02345226|463177783|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
128693819|NCT02345226|463177784|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
128693820|NCT00287365|463177785|FG000|Overall Study|sample not acquired|13|||
128693821|NCT02298023|463177788|FG000|Overall Study|Withdrawal by Subject|1|||
128693822|NCT02298023|463177789|FG001|Overall Study|Withdrawal by Subject|0|||
128693823|NCT02298023|463177790|FG002|Overall Study|Withdrawal by Subject|0|||
128693824|NCT02840721|463177791|FG000|Treatment Period|Adverse Event|1|||
128693825|NCT02840721|463177791|FG000|Follow-Up|Lack of Efficacy|1|||
128693826|NCT02840721|463177791|FG000|Follow-Up|Withdrawal by Subject|4|||
128693827|NCT02840721|463177791|FG000|Follow-Up|Withdrawal of Consent|2|||
128693828|NCT01967173|463177792|FG000|Overall Study|Lost to Follow-up|5|||
128693829|NCT01967173|463177793|FG001|Overall Study|Lost to Follow-up|3|||
128693830|NCT01967173|463177794|FG002|Overall Study|Lost to Follow-up|2|||
128693831|NCT01967173|463177795|FG003|Overall Study|Lost to Follow-up|4|||
128693832|NCT01967173|463177796|FG004|Overall Study|Lost to Follow-up|8|||
128693833|NCT01967173|463177797|FG005|Overall Study|Lost to Follow-up|12|||
128693834|NCT01967173|463177798|FG006|Overall Study|Lost to Follow-up|6|||
128693835|NCT01967173|463177799|FG007|Overall Study|Lost to Follow-up|8|||
128693836|NCT01967173|463177792|FG000|Overall Study|Physician Decision|2|||
128693837|NCT01967173|463177793|FG001|Overall Study|Physician Decision|0|||
128693838|NCT01967173|463177794|FG002|Overall Study|Physician Decision|2|||
128693839|NCT01967173|463177795|FG003|Overall Study|Physician Decision|1|||
128693840|NCT01967173|463177796|FG004|Overall Study|Physician Decision|1|||
128693841|NCT01967173|463177797|FG005|Overall Study|Physician Decision|1|||
128693842|NCT01967173|463177798|FG006|Overall Study|Physician Decision|1|||
128693843|NCT01967173|463177799|FG007|Overall Study|Physician Decision|0|||
128693844|NCT01967173|463177792|FG000|Overall Study|Lack of Efficacy|2|||
128693845|NCT01967173|463177793|FG001|Overall Study|Lack of Efficacy|0|||
128693846|NCT01967173|463177794|FG002|Overall Study|Lack of Efficacy|2|||
128693847|NCT01967173|463177795|FG003|Overall Study|Lack of Efficacy|2|||
128693848|NCT01967173|463177796|FG004|Overall Study|Lack of Efficacy|0|||
128693849|NCT01967173|463177797|FG005|Overall Study|Lack of Efficacy|1|||
128693850|NCT01967173|463177798|FG006|Overall Study|Lack of Efficacy|0|||
128693851|NCT01967173|463177799|FG007|Overall Study|Lack of Efficacy|2|||
128693852|NCT01967173|463177792|FG000|Overall Study|Pregnancy|0|||
128693853|NCT01967173|463177793|FG001|Overall Study|Pregnancy|0|||
128693854|NCT01967173|463177794|FG002|Overall Study|Pregnancy|0|||
128693855|NCT01967173|463177795|FG003|Overall Study|Pregnancy|0|||
128693856|NCT01967173|463177796|FG004|Overall Study|Pregnancy|0|||
128693857|NCT01967173|463177797|FG005|Overall Study|Pregnancy|0|||
128693858|NCT01967173|463177798|FG006|Overall Study|Pregnancy|1|||
128693859|NCT01967173|463177799|FG007|Overall Study|Pregnancy|1|||
128693860|NCT01967173|463177792|FG000|Overall Study|Adverse Event|0|||
128693861|NCT01967173|463177793|FG001|Overall Study|Adverse Event|0|||
128693862|NCT01967173|463177794|FG002|Overall Study|Adverse Event|0|||
128693863|NCT01967173|463177795|FG003|Overall Study|Adverse Event|0|||
128693864|NCT01967173|463177796|FG004|Overall Study|Adverse Event|0|||
128693865|NCT01967173|463177797|FG005|Overall Study|Adverse Event|0|||
128693866|NCT01967173|463177798|FG006|Overall Study|Adverse Event|0|||
128693867|NCT01967173|463177799|FG007|Overall Study|Adverse Event|1|||
128693868|NCT01967173|463177792|FG000|Overall Study|Withdrawal by Subject|15|||
128693869|NCT01967173|463177793|FG001|Overall Study|Withdrawal by Subject|14|||
128693870|NCT01967173|463177794|FG002|Overall Study|Withdrawal by Subject|10|||
128693871|NCT01967173|463177795|FG003|Overall Study|Withdrawal by Subject|7|||
128693872|NCT01967173|463177796|FG004|Overall Study|Withdrawal by Subject|8|||
128693873|NCT01967173|463177797|FG005|Overall Study|Withdrawal by Subject|9|||
128693874|NCT01967173|463177798|FG006|Overall Study|Withdrawal by Subject|10|||
128693875|NCT01967173|463177799|FG007|Overall Study|Withdrawal by Subject|12|||
128693876|NCT02020577|463177800|FG000|Overall Study|Progressive disease|3|||
128693877|NCT02020577|463177801|FG001|Overall Study|Progressive disease|38|||
128693878|NCT02020577|463177800|FG000|Overall Study|Other AE or clinical progression|0|||
128693879|NCT02020577|463177801|FG001|Overall Study|Other AE or clinical progression|15|||
128693880|NCT02020577|463177800|FG000|Overall Study|Withdrawal by Subject|0|||
128693881|NCT02020577|463177801|FG001|Overall Study|Withdrawal by Subject|1|||
128693882|NCT02020577|463177800|FG000|Overall Study|Other than stated above|0|||
128693883|NCT02020577|463177801|FG001|Overall Study|Other than stated above|1|||
128693884|NCT03113916|463177802|FG000|Overall Study|Withdrawal by Subject|9|||
128693885|NCT03113916|463177803|FG001|Overall Study|Withdrawal by Subject|7|||
128693886|NCT03113916|463177802|FG000|Overall Study|Pregnancy|1|||
128693887|NCT03113916|463177803|FG001|Overall Study|Pregnancy|3|||
128693888|NCT03113916|463177802|FG000|Overall Study|Lost to Follow-up|1|||
128693889|NCT03113916|463177803|FG001|Overall Study|Lost to Follow-up|2|||
128693890|NCT00241358|463177804|FG000|Overall Study|Determined to be not ineligible|0|||
128693891|NCT00241358|463177805|FG001|Overall Study|Determined to be not ineligible|1|||
128693892|NCT00241358|463177806|FG002|Overall Study|Determined to be not ineligible|1|||
128693893|NCT02663908|463177807|FG000|Overall Study|Withdrawal by Subject|8|||
129114621|NCT04460326|464715208|FG000|Completed at Least 4 Meals|Early discharge|5|||
129114622|NCT04460326|464715209|FG001|Completed at Least 4 Meals|Early discharge|5|||
129114623|NCT04460326|464715208|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
129114624|NCT04460326|464715209|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
129114625|NCT04460326|464715208|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
129114626|NCT04460326|464715209|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
129114627|NCT04460326|464715208|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
129114628|NCT04460326|464715209|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
129114629|NCT04460326|464715208|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
129114630|NCT04460326|464715209|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
129114631|NCT04460326|464715208|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
129114632|NCT04460326|464715209|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
129114633|NCT00577317|464715210|FG000|Overall Study|Study Terminated|0|||
129114634|NCT00577317|464715211|FG001|Overall Study|Study Terminated|2|||
129114635|NCT04794751|464715214|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
129114636|NCT04794751|464715215|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
129114637|NCT04794751|464715214|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
129114638|NCT04794751|464715215|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
129114639|NCT04794751|464715214|FG000|Period 1|Protocol Violation|0|||
129114640|NCT04794751|464715215|FG001|Period 1|Protocol Violation|2|||
129114641|NCT04794751|464715214|FG000|Period 1|Withdrawal by Subject|0|||
129114642|NCT04794751|464715215|FG001|Period 1|Withdrawal by Subject|1|||
129114643|NCT04794751|464715214|FG000|Period 2|Withdrawal by Subject|0|||
128693894|NCT02663908|463177808|FG001|Overall Study|Withdrawal by Subject|5|||
128693895|NCT02663908|463177807|FG000|Overall Study|Lost to Follow-up|1|||
128693896|NCT02663908|463177808|FG001|Overall Study|Lost to Follow-up|5|||
128693897|NCT02663908|463177807|FG000|Overall Study|Adverse Event|13|||
128693898|NCT02663908|463177808|FG001|Overall Study|Adverse Event|11|||
128693899|NCT02663908|463177807|FG000|Overall Study|Protocol Violation|1|||
128693900|NCT02663908|463177808|FG001|Overall Study|Protocol Violation|2|||
128693901|NCT02663908|463177807|FG000|Overall Study|Lack of therapeutic response|2|||
128693902|NCT02663908|463177808|FG001|Overall Study|Lack of therapeutic response|0|||
128693903|NCT02663908|463177807|FG000|Overall Study|COVID-19|1|||
128693904|NCT02663908|463177808|FG001|Overall Study|COVID-19|0|||
128693905|NCT02663908|463177807|FG000|Overall Study|Site closed|1|||
128693906|NCT02663908|463177808|FG001|Overall Study|Site closed|0|||
128693907|NCT02663908|463177807|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
128693908|NCT02663908|463177808|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
128693909|NCT02663908|463177807|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
128693910|NCT02663908|463177808|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
128693911|NCT02663908|463177807|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
128693912|NCT02663908|463177808|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
128693913|NCT02663908|463177807|FG000|Overall Study|Death|1|||
128693914|NCT02663908|463177808|FG001|Overall Study|Death|0|||
128693915|NCT02663908|463177807|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
128693916|NCT02663908|463177808|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
128693917|NCT02663908|463177807|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
128693918|NCT02663908|463177808|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
128693919|NCT03308786|463177809|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
128693920|NCT00761631|463177810|FG000|Overall Study|Parent/legal guardian request|8|||
128693921|NCT00761631|463177811|FG001|Overall Study|Parent/legal guardian request|3|||
128693922|NCT00761631|463177812|FG002|Overall Study|Parent/legal guardian request|8|||
128693923|NCT00761631|463177813|FG003|Overall Study|Parent/legal guardian request|0|||
128693924|NCT00761631|463177814|FG004|Overall Study|Parent/legal guardian request|5|||
128693925|NCT00761631|463177815|FG005|Overall Study|Parent/legal guardian request|0|||
128902408|NCT00283595|463936334|FG000|Overall Study|Withdrawal by Subject|1|||
128902409|NCT00283595|463936335|FG001|Overall Study|Withdrawal by Subject|2|||
128902410|NCT01263639|463936336|FG000|Overall Study|Lost to Follow-up|66|||
128902411|NCT01263639|463936337|FG001|Overall Study|Lost to Follow-up|70|||
128902412|NCT01263639|463936336|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
128902413|NCT01263639|463936337|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
128902414|NCT00607386|463936338|FG000|Overall Study|Physician Decision|1|||
128902415|NCT00440947|463936339|FG000|36-Week Induction Phase|Adverse Event|16|||
128902416|NCT00440947|463936340|FG001|36-Week Induction Phase|Adverse Event|0|||
128902417|NCT00440947|463936341|FG002|36-Week Induction Phase|Adverse Event|0|||
128902418|NCT00440947|463936342|FG003|36-Week Induction Phase|Adverse Event|0|||
128902419|NCT00440947|463936343|FG004|36-Week Induction Phase|Adverse Event|0|||
128902420|NCT00440947|463936339|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
128902421|NCT00440947|463936340|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
128902422|NCT00440947|463936341|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
128902423|NCT00440947|463936342|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
128902424|NCT00440947|463936343|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
128902425|NCT00440947|463936339|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
128902426|NCT00440947|463936340|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
128902427|NCT00440947|463936341|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
128902428|NCT00440947|463936342|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
128902429|NCT00440947|463936343|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
128902430|NCT00440947|463936339|FG000|36-Week Induction Phase|Non-compliance|10|||
128902431|NCT00440947|463936340|FG001|36-Week Induction Phase|Non-compliance|0|||
128902432|NCT00440947|463936341|FG002|36-Week Induction Phase|Non-compliance|0|||
128902433|NCT00440947|463936342|FG003|36-Week Induction Phase|Non-compliance|0|||
128902434|NCT00440947|463936343|FG004|36-Week Induction Phase|Non-compliance|0|||
128902435|NCT00440947|463936339|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
128902436|NCT00440947|463936340|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
128902437|NCT00440947|463936341|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
128902438|NCT00440947|463936342|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
128902439|NCT00440947|463936343|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
128902440|NCT00440947|463936339|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
128902441|NCT00440947|463936340|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
128902442|NCT00440947|463936341|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
128902443|NCT00440947|463936342|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
128902444|NCT00440947|463936343|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
128902445|NCT00440947|463936339|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
128902446|NCT00440947|463936340|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
129114644|NCT04794751|464715215|FG001|Period 2|Withdrawal by Subject|1|||
129114645|NCT04794751|464715214|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
129114646|NCT04794751|464715215|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
129114647|NCT04794751|464715214|FG000|Period 2|Protocol Violation|1|||
129114648|NCT04794751|464715215|FG001|Period 2|Protocol Violation|0|||
129114649|NCT03669588|464715216|FG000|Overall Study|Adverse Event|1|||
129114650|NCT03669588|464715217|FG001|Overall Study|Adverse Event|0|||
129215306|NCT00463567|465091126|FG001|Overall Study|Protocol Deviation|9|||
129215307|NCT00463567|465091127|FG002|Overall Study|Protocol Deviation|14|||
129215308|NCT00463567|465091128|FG003|Overall Study|Protocol Deviation|11|||
129215309|NCT00463567|465091129|FG004|Overall Study|Protocol Deviation|1|||
129215310|NCT00463567|465091130|FG005|Overall Study|Protocol Deviation|1|||
129215311|NCT00463567|465091131|FG006|Overall Study|Protocol Deviation|2|||
129215312|NCT00463567|465091125|FG000|Overall Study|Lost to Follow-up|12|||
129215313|NCT00463567|465091126|FG001|Overall Study|Lost to Follow-up|6|||
129215314|NCT00463567|465091127|FG002|Overall Study|Lost to Follow-up|13|||
129215315|NCT00463567|465091128|FG003|Overall Study|Lost to Follow-up|8|||
129215316|NCT00463567|465091129|FG004|Overall Study|Lost to Follow-up|1|||
128693926|NCT00761631|463177810|FG000|Overall Study|Lost to Follow-up|2|||
129114651|NCT03669588|464715216|FG000|Overall Study|Physician Decision|0|||
129114652|NCT03669588|464715217|FG001|Overall Study|Physician Decision|1|||
128902447|NCT00440947|463936341|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
128902448|NCT00440947|463936342|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
128902449|NCT00440947|463936343|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
129114653|NCT03669588|464715216|FG000|Overall Study|Protocol Violation|1|||
129114654|NCT03669588|464715217|FG001|Overall Study|Protocol Violation|0|||
129114655|NCT03669588|464715216|FG000|Overall Study|Sponsor Decision|1|||
129114656|NCT03669588|464715217|FG001|Overall Study|Sponsor Decision|1|||
129114657|NCT03669588|464715216|FG000|Overall Study|Withdrawal by Subject|1|||
129215317|NCT00463567|465091130|FG005|Overall Study|Lost to Follow-up|1|||
128902450|NCT00440947|463936339|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
128902451|NCT00440947|463936340|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
129114658|NCT03669588|464715217|FG001|Overall Study|Withdrawal by Subject|4|||
129215318|NCT00463567|465091131|FG006|Overall Study|Lost to Follow-up|1|||
128902452|NCT00440947|463936341|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
128902453|NCT00440947|463936342|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
128902454|NCT00440947|463936343|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
128902455|NCT00440947|463936339|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
128902456|NCT00440947|463936340|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
128902457|NCT00440947|463936341|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
128902458|NCT00440947|463936342|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
128902459|NCT00440947|463936343|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
128902460|NCT00440947|463936339|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
128902461|NCT00440947|463936340|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
128902462|NCT00440947|463936341|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
128902463|NCT00440947|463936342|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
128902464|NCT00440947|463936343|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
128902465|NCT00440947|463936339|FG000|36-Week Induction Phase|Incarceration|3|||
128902466|NCT00440947|463936340|FG001|36-Week Induction Phase|Incarceration|0|||
128902467|NCT00440947|463936341|FG002|36-Week Induction Phase|Incarceration|0|||
128902468|NCT00440947|463936342|FG003|36-Week Induction Phase|Incarceration|0|||
128902469|NCT00440947|463936343|FG004|36-Week Induction Phase|Incarceration|0|||
128902470|NCT00440947|463936339|FG000|36-Week Induction Phase|Pregnancy|1|||
128902471|NCT00440947|463936340|FG001|36-Week Induction Phase|Pregnancy|0|||
128902472|NCT00440947|463936341|FG002|36-Week Induction Phase|Pregnancy|0|||
128902473|NCT00440947|463936342|FG003|36-Week Induction Phase|Pregnancy|0|||
128902474|NCT00440947|463936343|FG004|36-Week Induction Phase|Pregnancy|0|||
128902475|NCT00440947|463936339|FG000|48-Week Randomization Phase|Adverse Event|0|||
128902476|NCT00440947|463936340|FG001|48-Week Randomization Phase|Adverse Event|2|||
129114659|NCT03669588|464715216|FG000|Overall Study|Rescue Therapy Needed|0|||
129114660|NCT03669588|464715217|FG001|Overall Study|Rescue Therapy Needed|1|||
129114661|NCT00369343|464715220|FG000|Double-blind Phase|Adverse Event|19|||
129114662|NCT00369343|464715221|FG001|Double-blind Phase|Adverse Event|4|||
129114663|NCT00369343|464715220|FG000|Double-blind Phase|Failed to return|2|||
129114664|NCT00369343|464715221|FG001|Double-blind Phase|Failed to return|0|||
129114665|NCT00369343|464715220|FG000|Double-blind Phase|Lost to Follow-up|9|||
129114666|NCT00369343|464715221|FG001|Double-blind Phase|Lost to Follow-up|2|||
129114667|NCT00369343|464715220|FG000|Double-blind Phase|Protocol Violation|2|||
129114668|NCT00369343|464715221|FG001|Double-blind Phase|Protocol Violation|0|||
129114669|NCT00369343|464715220|FG000|Double-blind Phase|Withdrawal by Subject|8|||
129114670|NCT00369343|464715221|FG001|Double-blind Phase|Withdrawal by Subject|6|||
129114671|NCT00369343|464715220|FG000|Double-blind Phase|Lack of Efficacy|0|||
129114672|NCT00369343|464715221|FG001|Double-blind Phase|Lack of Efficacy|4|||
129114673|NCT00369343|464715220|FG000|Double-blind Phase|Protocol deviation|4|||
129114674|NCT00369343|464715221|FG001|Double-blind Phase|Protocol deviation|0|||
129114675|NCT00369343|464715220|FG000|Open-label Phase|Adverse Event|19|||
129114676|NCT00369343|464715221|FG001|Open-label Phase|Adverse Event|7|||
129114677|NCT00369343|464715220|FG000|Open-label Phase|Failed to return|4|||
129114678|NCT00369343|464715221|FG001|Open-label Phase|Failed to return|0|||
128902477|NCT00440947|463936341|FG002|48-Week Randomization Phase|Adverse Event|5|||
129114679|NCT00369343|464715220|FG000|Open-label Phase|Physician Decision|2|||
129114680|NCT00369343|464715221|FG001|Open-label Phase|Physician Decision|0|||
129114681|NCT00369343|464715220|FG000|Open-label Phase|Lost to Follow-up|5|||
129114682|NCT00369343|464715221|FG001|Open-label Phase|Lost to Follow-up|3|||
129114683|NCT00369343|464715220|FG000|Open-label Phase|inadvertently reported study completers|3|||
129114684|NCT00369343|464715221|FG001|Open-label Phase|inadvertently reported study completers|2|||
129114685|NCT00369343|464715220|FG000|Open-label Phase|Protocol Violation|1|||
129114686|NCT00369343|464715221|FG001|Open-label Phase|Protocol Violation|3|||
129114687|NCT00369343|464715220|FG000|Open-label Phase|Withdrawal by Subject|15|||
129114688|NCT00369343|464715221|FG001|Open-label Phase|Withdrawal by Subject|6|||
129114689|NCT00369343|464715220|FG000|Open-label Phase|Lack of Efficacy|4|||
129114690|NCT00369343|464715221|FG001|Open-label Phase|Lack of Efficacy|3|||
129114691|NCT00369343|464715220|FG000|Open-label Phase|Lack of continuance tolerability|3|||
129114692|NCT00369343|464715221|FG001|Open-label Phase|Lack of continuance tolerability|4|||
129114693|NCT00369343|464715220|FG000|Open-label Phase|did not take study drug|1|||
129114694|NCT00369343|464715221|FG001|Open-label Phase|did not take study drug|2|||
128902478|NCT00440947|463936342|FG003|48-Week Randomization Phase|Adverse Event|0|||
128902479|NCT00440947|463936343|FG004|48-Week Randomization Phase|Adverse Event|0|||
129114695|NCT01100502|464715222|FG000|Overall Study|Withdrawal by Subject|18|||
128902480|NCT00440947|463936339|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
128902481|NCT00440947|463936340|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
129114696|NCT01100502|464715223|FG001|Overall Study|Withdrawal by Subject|25|||
129114697|NCT01100502|464715222|FG000|Overall Study|Lost to Follow-up|13|||
129114698|NCT01100502|464715223|FG001|Overall Study|Lost to Follow-up|28|||
129114699|NCT01100502|464715222|FG000|Overall Study|Site request to end participation in study|0|||
129114700|NCT01100502|464715223|FG001|Overall Study|Site request to end participation in study|1|||
129114701|NCT01100502|464715222|FG000|Overall Study|Death|45|||
128902482|NCT00440947|463936341|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
128902483|NCT00440947|463936342|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
129114702|NCT01100502|464715223|FG001|Overall Study|Death|40|||
129114703|NCT02322749|464715224|FG000|Period 2|Adverse Event|0|||
129114704|NCT02322749|464715225|FG001|Period 2|Adverse Event|0|||
129114705|NCT02322749|464715226|FG002|Period 2|Adverse Event|0|||
129114706|NCT02322749|464715227|FG003|Period 2|Adverse Event|1|||
129114707|NCT02322749|464715228|FG004|Period 2|Adverse Event|0|||
129114708|NCT02322749|464715229|FG005|Period 2|Adverse Event|0|||
129114709|NCT02322749|464715224|FG000|Period 2|Withdrawal by Subject|0|||
129114710|NCT02322749|464715225|FG001|Period 2|Withdrawal by Subject|0|||
129114711|NCT02322749|464715226|FG002|Period 2|Withdrawal by Subject|0|||
129114712|NCT02322749|464715227|FG003|Period 2|Withdrawal by Subject|1|||
129114713|NCT02322749|464715228|FG004|Period 2|Withdrawal by Subject|0|||
129114714|NCT02322749|464715229|FG005|Period 2|Withdrawal by Subject|0|||
129114715|NCT02322749|464715224|FG000|Period 3|Withdrawal by Subject|0|||
129114716|NCT02322749|464715225|FG001|Period 3|Withdrawal by Subject|0|||
129114717|NCT02322749|464715226|FG002|Period 3|Withdrawal by Subject|1|||
129114718|NCT02322749|464715227|FG003|Period 3|Withdrawal by Subject|0|||
129114719|NCT02322749|464715228|FG004|Period 3|Withdrawal by Subject|0|||
129114720|NCT02322749|464715229|FG005|Period 3|Withdrawal by Subject|0|||
129114721|NCT01190813|464715234|FG000|Overall Study|Lost to Follow-up|1|||
129114722|NCT01190813|464715235|FG001|Overall Study|Lost to Follow-up|2|||
129114723|NCT01190813|464715234|FG000|Overall Study|Withdrawal by Subject|2|||
129114724|NCT01190813|464715235|FG001|Overall Study|Withdrawal by Subject|1|||
128902484|NCT00440947|463936343|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
128902485|NCT00440947|463936339|FG000|48-Week Randomization Phase|Non-compliance|0|||
129114725|NCT01190813|464715234|FG000|Overall Study|Refused study treatment after randomized|1|||
129114726|NCT01190813|464715235|FG001|Overall Study|Refused study treatment after randomized|0|||
129114727|NCT01190813|464715234|FG000|Overall Study|Adverse Event|0|||
129114728|NCT01190813|464715235|FG001|Overall Study|Adverse Event|1|||
129114729|NCT05158140|464715242|FG000|Overall Study|Death|0|||
129114730|NCT05158140|464715243|FG001|Overall Study|Death|0|||
129114731|NCT05158140|464715244|FG002|Overall Study|Death|0|||
129114732|NCT05158140|464715245|FG003|Overall Study|Death|1|||
129114733|NCT05158140|464715242|FG000|Overall Study|Lost to Follow-up|3|||
129114734|NCT05158140|464715243|FG001|Overall Study|Lost to Follow-up|6|||
129114735|NCT05158140|464715244|FG002|Overall Study|Lost to Follow-up|4|||
129114736|NCT05158140|464715245|FG003|Overall Study|Lost to Follow-up|3|||
129114737|NCT05158140|464715242|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129114738|NCT05158140|464715243|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129114739|NCT05158140|464715244|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
129114740|NCT05158140|464715245|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129114741|NCT05158140|464715242|FG000|Overall Study|Withdrawal by Subject|3|||
129114742|NCT05158140|464715243|FG001|Overall Study|Withdrawal by Subject|7|||
129114743|NCT05158140|464715244|FG002|Overall Study|Withdrawal by Subject|3|||
129114744|NCT05158140|464715245|FG003|Overall Study|Withdrawal by Subject|7|||
129114745|NCT04414787|464715250|FG000|Overall Study|Patient Death|18|||
129114746|NCT04414787|464715251|FG001|Overall Study|Patient Death|18|||
129114747|NCT04414787|464715252|FG002|Overall Study|Patient Death|15|||
129114748|NCT04414787|464715253|FG003|Overall Study|Patient Death|15|||
129114749|NCT04414787|464715250|FG000|Overall Study|Patient Hospitalization|1|||
129114750|NCT04414787|464715251|FG001|Overall Study|Patient Hospitalization|1|||
129114751|NCT04414787|464715252|FG002|Overall Study|Patient Hospitalization|2|||
129114752|NCT04414787|464715253|FG003|Overall Study|Patient Hospitalization|2|||
129114753|NCT04414787|464715250|FG000|Overall Study|Lost to Follow-up|7|||
129114754|NCT04414787|464715251|FG001|Overall Study|Lost to Follow-up|7|||
129114755|NCT04414787|464715252|FG002|Overall Study|Lost to Follow-up|5|||
129114756|NCT04414787|464715253|FG003|Overall Study|Lost to Follow-up|5|||
129114757|NCT04414787|464715250|FG000|Overall Study|Residence in post-acute care facility|3|||
129114758|NCT04414787|464715251|FG001|Overall Study|Residence in post-acute care facility|3|||
129114759|NCT04414787|464715252|FG002|Overall Study|Residence in post-acute care facility|5|||
129114760|NCT04414787|464715253|FG003|Overall Study|Residence in post-acute care facility|5|||
129114761|NCT00807365|464715254|FG000|Overall Study|Study Terminated|5|||
129114762|NCT01526785|464715255|FG000|Overall Study|Study Terminated by Sponsor|8|||
129114763|NCT01526785|464715255|FG000|Overall Study|Death|2|||
129114764|NCT01526785|464715255|FG000|Overall Study|Physician Decision|1|||
129114765|NCT01526785|464715255|FG000|Overall Study|Withdrawal by Subject|2|||
129114766|NCT04350827|464715262|FG000|Overall Study|Lost to Follow-up|1|||
129114767|NCT04350827|464715263|FG001|Overall Study|Lost to Follow-up|2|||
129114768|NCT00916578|464716776|FG000|Overall Study|Physician Decision|2|||
129114769|NCT00916578|464716776|FG000|Overall Study|Withdrawal by Subject|3|||
129114770|NCT00916578|464716776|FG000|Overall Study|Insurance Denial|2|||
129114771|NCT00945243|464716781|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
129114772|NCT03256578|464716782|FG000|Overall Study|Excluded Post Randomization|66|||
129114773|NCT03256578|464716783|FG001|Overall Study|Excluded Post Randomization|56|||
129114774|NCT03028142|464716784|FG000|Overall Study|Adverse Event|1|||
129114775|NCT03028142|464716785|FG001|Overall Study|Adverse Event|1|||
129114776|NCT03028142|464716786|FG002|Overall Study|Adverse Event|0|||
128902486|NCT00440947|463936340|FG001|48-Week Randomization Phase|Non-compliance|3|||
128902487|NCT00440947|463936341|FG002|48-Week Randomization Phase|Non-compliance|4|||
128902488|NCT00440947|463936342|FG003|48-Week Randomization Phase|Non-compliance|0|||
128902489|NCT00440947|463936343|FG004|48-Week Randomization Phase|Non-compliance|0|||
128902490|NCT00440947|463936339|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
128902491|NCT00440947|463936340|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
128902492|NCT00440947|463936341|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
128902493|NCT00440947|463936342|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
128902494|NCT00440947|463936343|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
128902495|NCT00440947|463936339|FG000|48-Week Randomization Phase|Protocol Violation|0|||
128902496|NCT00440947|463936340|FG001|48-Week Randomization Phase|Protocol Violation|0|||
128902497|NCT00440947|463936341|FG002|48-Week Randomization Phase|Protocol Violation|1|||
128902498|NCT00440947|463936342|FG003|48-Week Randomization Phase|Protocol Violation|0|||
128902499|NCT00440947|463936343|FG004|48-Week Randomization Phase|Protocol Violation|0|||
128902500|NCT00440947|463936339|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
128902501|NCT00440947|463936340|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
128902502|NCT00440947|463936341|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
128902503|NCT00440947|463936342|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
128902504|NCT00440947|463936343|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
128902505|NCT00440947|463936339|FG000|48-Week Randomization Phase|Pregnancy|0|||
128902506|NCT00440947|463936340|FG001|48-Week Randomization Phase|Pregnancy|0|||
128902507|NCT00440947|463936341|FG002|48-Week Randomization Phase|Pregnancy|1|||
128902508|NCT00440947|463936342|FG003|48-Week Randomization Phase|Pregnancy|0|||
128902509|NCT00440947|463936343|FG004|48-Week Randomization Phase|Pregnancy|0|||
128902510|NCT00440947|463936339|FG000|48-Week Randomization Phase|Incarceration|0|||
128902511|NCT00440947|463936340|FG001|48-Week Randomization Phase|Incarceration|3|||
128902512|NCT00440947|463936341|FG002|48-Week Randomization Phase|Incarceration|0|||
128902513|NCT00440947|463936342|FG003|48-Week Randomization Phase|Incarceration|0|||
128902514|NCT00440947|463936343|FG004|48-Week Randomization Phase|Incarceration|0|||
128902515|NCT00440947|463936339|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
128902516|NCT00440947|463936340|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
128902517|NCT00440947|463936341|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
128902518|NCT00440947|463936342|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
128902519|NCT00440947|463936343|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
128902520|NCT00440947|463936339|FG000|48-Week Randomization Phase|Physician Decision|0|||
128902521|NCT00440947|463936340|FG001|48-Week Randomization Phase|Physician Decision|2|||
128902522|NCT00440947|463936341|FG002|48-Week Randomization Phase|Physician Decision|0|||
128902523|NCT00440947|463936342|FG003|48-Week Randomization Phase|Physician Decision|0|||
128902524|NCT00440947|463936343|FG004|48-Week Randomization Phase|Physician Decision|0|||
128902525|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
128902526|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
129025059|NCT01175135|464385543|FG001|Overall Study|Adverse Event|5|||
129025060|NCT01175135|464385544|FG002|Overall Study|Adverse Event|3|||
129025061|NCT01175135|464385545|FG003|Overall Study|Adverse Event|4|||
129025062|NCT01175135|464385542|FG000|Overall Study|Death|1|||
129025063|NCT01175135|464385543|FG001|Overall Study|Death|0|||
129025064|NCT01175135|464385544|FG002|Overall Study|Death|0|||
129025065|NCT01175135|464385545|FG003|Overall Study|Death|0|||
129025066|NCT01175135|464385542|FG000|Overall Study|Lack of Efficacy|4|||
129025067|NCT01175135|464385543|FG001|Overall Study|Lack of Efficacy|5|||
129025068|NCT01175135|464385544|FG002|Overall Study|Lack of Efficacy|0|||
129025069|NCT01175135|464385545|FG003|Overall Study|Lack of Efficacy|5|||
129025070|NCT01175135|464385542|FG000|Overall Study|Lost to Follow-up|1|||
129025071|NCT01175135|464385543|FG001|Overall Study|Lost to Follow-up|2|||
129025072|NCT01175135|464385544|FG002|Overall Study|Lost to Follow-up|0|||
129025073|NCT01175135|464385545|FG003|Overall Study|Lost to Follow-up|0|||
129025074|NCT01175135|464385542|FG000|Overall Study|Protocol Violation|1|||
129025075|NCT01175135|464385543|FG001|Overall Study|Protocol Violation|1|||
129025076|NCT01175135|464385544|FG002|Overall Study|Protocol Violation|0|||
129025077|NCT01175135|464385545|FG003|Overall Study|Protocol Violation|0|||
129025078|NCT01175135|464385542|FG000|Overall Study|Withdrawal by Subject|4|||
129025079|NCT01175135|464385543|FG001|Overall Study|Withdrawal by Subject|8|||
129025080|NCT01175135|464385544|FG002|Overall Study|Withdrawal by Subject|5|||
129025081|NCT01175135|464385545|FG003|Overall Study|Withdrawal by Subject|5|||
129114777|NCT03028142|464716787|FG003|Overall Study|Adverse Event|0|||
129114778|NCT03028142|464716788|FG004|Overall Study|Adverse Event|0|||
128693927|NCT00761631|463177811|FG001|Overall Study|Lost to Follow-up|4|||
128693928|NCT00761631|463177812|FG002|Overall Study|Lost to Follow-up|7|||
128902527|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
128902528|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
129025082|NCT01175135|464385542|FG000|Overall Study|Other|3|||
129025083|NCT01175135|464385543|FG001|Overall Study|Other|1|||
129025084|NCT01175135|464385544|FG002|Overall Study|Other|3|||
128902529|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
128902530|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
128902531|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
128902532|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
128902533|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
128902534|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
128902535|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
128902536|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
128902537|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
128902538|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
129025085|NCT01175135|464385545|FG003|Overall Study|Other|0|||
129025086|NCT01175135|464385542|FG000|Overall Study|Randomized But Not Treated|0|||
129025087|NCT01175135|464385543|FG001|Overall Study|Randomized But Not Treated|0|||
129025088|NCT01175135|464385544|FG002|Overall Study|Randomized But Not Treated|1|||
129025089|NCT01175135|464385545|FG003|Overall Study|Randomized But Not Treated|0|||
129025090|NCT04692155|464385549|FG000|Overall Study|Death|1|||
129025091|NCT02213263|464385554|FG000|Overall Study|Insufficient clinical response|4|||
129025092|NCT02213263|464385555|FG001|Overall Study|Insufficient clinical response|3|||
129025093|NCT02213263|464385554|FG000|Overall Study|Lost to Follow-up|0|||
129025094|NCT02213263|464385555|FG001|Overall Study|Lost to Follow-up|1|||
129025095|NCT02213263|464385554|FG000|Overall Study|No longer willing to participate|3|||
129025096|NCT02213263|464385555|FG001|Overall Study|No longer willing to participate|4|||
129025097|NCT02213263|464385554|FG000|Overall Study|Progressive disease|20|||
129025098|NCT02213263|464385555|FG001|Overall Study|Progressive disease|14|||
129025099|NCT02213263|464385554|FG000|Overall Study|Protocol Violation|0|||
129025100|NCT02213263|464385555|FG001|Overall Study|Protocol Violation|1|||
129025101|NCT02213263|464385554|FG000|Overall Study|Adverse Event|1|||
129025102|NCT02213263|464385555|FG001|Overall Study|Adverse Event|3|||
129025103|NCT05752721|464385556|FG000|Overall Study|Lost to Follow-up|22|||
129025104|NCT05752721|464385557|FG001|Overall Study|Lost to Follow-up|20|||
129025105|NCT05752721|464385556|FG000|Overall Study|Withdrawal by Subject|15|||
129025106|NCT05752721|464385557|FG001|Overall Study|Withdrawal by Subject|12|||
129025107|NCT01188681|464385558|FG000|Overall Study|bladder cancer|0|||
129025108|NCT01188681|464385559|FG001|Overall Study|bladder cancer|0|||
129025109|NCT01188681|464385560|FG002|Overall Study|bladder cancer|1|||
129025110|NCT01188681|464385561|FG003|Overall Study|bladder cancer|0|||
129025111|NCT01188681|464385558|FG000|Overall Study|Withdrawal by Subject|0|||
129025112|NCT01188681|464385559|FG001|Overall Study|Withdrawal by Subject|0|||
129025113|NCT01188681|464385560|FG002|Overall Study|Withdrawal by Subject|0|||
129025114|NCT01188681|464385561|FG003|Overall Study|Withdrawal by Subject|1|||
129025115|NCT02280863|464385562|FG000|Integrated Platform|Met stopping criteria|0|||
129025116|NCT02280863|464385563|FG001|Integrated Platform|Met stopping criteria|1|||
129025117|NCT03236311|464385564|FG000|Overall Study|Study terminated by sponsor|0|||
129025118|NCT03236311|464385565|FG001|Overall Study|Study terminated by sponsor|2|||
129025119|NCT03236311|464385564|FG000|Overall Study|Adverse Event|0|||
129025120|NCT03236311|464385565|FG001|Overall Study|Adverse Event|1|||
129025121|NCT00367133|464385570|FG000|2 Years|Death|20|||
129025122|NCT00367133|464385571|FG001|2 Years|Death|12|||
129025123|NCT00367133|464385572|FG002|2 Years|Death|12|||
129025124|NCT00367133|464385570|FG000|2 Years|Dropped|34|||
129025125|NCT00367133|464385571|FG001|2 Years|Dropped|19|||
129025126|NCT00367133|464385572|FG002|2 Years|Dropped|33|||
129025127|NCT00367133|464385570|FG000|2 Years|Missed visit|4|||
129025128|NCT00367133|464385571|FG001|2 Years|Missed visit|5|||
129025129|NCT00367133|464385572|FG002|2 Years|Missed visit|4|||
129025130|NCT00906399|464385573|FG000|Year 1|Randomized But Not Treated|0|||
129025131|NCT00906399|464385574|FG001|Year 1|Randomized But Not Treated|1|||
129025132|NCT00906399|464385575|FG002|Year 1|Randomized But Not Treated|3|||
129025133|NCT00906399|464385576|FG003|Year 1|Randomized But Not Treated|0|||
129025134|NCT00906399|464385577|FG004|Year 1|Randomized But Not Treated|0|||
129025135|NCT00906399|464385578|FG005|Year 1|Randomized But Not Treated|0|||
129025136|NCT00906399|464385579|FG006|Year 1|Randomized But Not Treated|0|||
129025137|NCT00906399|464385573|FG000|Year 1|Adverse Event|4|||
129025138|NCT00906399|464385574|FG001|Year 1|Adverse Event|22|||
129025139|NCT00906399|464385575|FG002|Year 1|Adverse Event|24|||
129025140|NCT00906399|464385576|FG003|Year 1|Adverse Event|0|||
129025141|NCT00906399|464385577|FG004|Year 1|Adverse Event|0|||
129025142|NCT00906399|464385578|FG005|Year 1|Adverse Event|0|||
129025143|NCT00906399|464385579|FG006|Year 1|Adverse Event|0|||
129025144|NCT00906399|464385573|FG000|Year 1|Lost to Follow-up|4|||
129025145|NCT00906399|464385574|FG001|Year 1|Lost to Follow-up|4|||
129025146|NCT00906399|464385575|FG002|Year 1|Lost to Follow-up|2|||
129025147|NCT00906399|464385576|FG003|Year 1|Lost to Follow-up|0|||
129025148|NCT00906399|464385577|FG004|Year 1|Lost to Follow-up|0|||
129025149|NCT00906399|464385578|FG005|Year 1|Lost to Follow-up|0|||
129025150|NCT00906399|464385579|FG006|Year 1|Lost to Follow-up|0|||
129025151|NCT00906399|464385573|FG000|Year 1|Withdrawal by Subject|30|||
129025152|NCT00906399|464385574|FG001|Year 1|Withdrawal by Subject|32|||
129025153|NCT00906399|464385575|FG002|Year 1|Withdrawal by Subject|36|||
128902539|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
128902540|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
128902541|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
128902542|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
128902543|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
128902544|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
128902545|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
128902546|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
128902547|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
128902548|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
128902549|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
128902550|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
128902551|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
128902552|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
128902553|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
128902554|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
128902555|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
128902556|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
128902557|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
128902558|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
128902559|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
128902560|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
128902561|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
128902562|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
128902563|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
128902564|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
128902565|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
128902566|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
128902567|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
129025154|NCT00906399|464385576|FG003|Year 1|Withdrawal by Subject|0|||
129025155|NCT00906399|464385577|FG004|Year 1|Withdrawal by Subject|0|||
129025156|NCT00906399|464385578|FG005|Year 1|Withdrawal by Subject|0|||
129025157|NCT00906399|464385579|FG006|Year 1|Withdrawal by Subject|0|||
129025158|NCT00906399|464385573|FG000|Year 1|Physician Decision|0|||
129025159|NCT00906399|464385574|FG001|Year 1|Physician Decision|1|||
129025160|NCT00906399|464385575|FG002|Year 1|Physician Decision|3|||
129025161|NCT00906399|464385576|FG003|Year 1|Physician Decision|0|||
129025162|NCT00906399|464385577|FG004|Year 1|Physician Decision|0|||
129025163|NCT00906399|464385578|FG005|Year 1|Physician Decision|0|||
129025164|NCT00906399|464385579|FG006|Year 1|Physician Decision|0|||
129025165|NCT00906399|464385573|FG000|Year 1|Death|2|||
129025166|NCT00906399|464385574|FG001|Year 1|Death|1|||
129025167|NCT00906399|464385575|FG002|Year 1|Death|1|||
129025168|NCT00906399|464385576|FG003|Year 1|Death|0|||
129025169|NCT00906399|464385577|FG004|Year 1|Death|0|||
129025170|NCT00906399|464385578|FG005|Year 1|Death|0|||
129025171|NCT00906399|464385579|FG006|Year 1|Death|0|||
129025172|NCT00906399|464385573|FG000|Year 1|Other|4|||
129025173|NCT00906399|464385574|FG001|Year 1|Other|2|||
129025174|NCT00906399|464385575|FG002|Year 1|Other|7|||
129025175|NCT00906399|464385576|FG003|Year 1|Other|0|||
129025176|NCT00906399|464385577|FG004|Year 1|Other|0|||
129025177|NCT00906399|464385578|FG005|Year 1|Other|0|||
129025178|NCT00906399|464385579|FG006|Year 1|Other|0|||
129025179|NCT00906399|464385573|FG000|Year 2|Adverse Event|0|||
129025180|NCT00906399|464385574|FG001|Year 2|Adverse Event|0|||
129025181|NCT00906399|464385575|FG002|Year 2|Adverse Event|0|||
129025182|NCT00906399|464385576|FG003|Year 2|Adverse Event|9|||
129025183|NCT00906399|464385577|FG004|Year 2|Adverse Event|8|||
129025184|NCT00906399|464385578|FG005|Year 2|Adverse Event|11|||
129025185|NCT00906399|464385579|FG006|Year 2|Adverse Event|6|||
129025186|NCT00906399|464385573|FG000|Year 2|Lost to Follow-up|0|||
129025187|NCT00906399|464385574|FG001|Year 2|Lost to Follow-up|0|||
129025188|NCT00906399|464385575|FG002|Year 2|Lost to Follow-up|0|||
129025189|NCT00906399|464385576|FG003|Year 2|Lost to Follow-up|1|||
128902568|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
129025190|NCT00906399|464385577|FG004|Year 2|Lost to Follow-up|4|||
129025191|NCT00906399|464385578|FG005|Year 2|Lost to Follow-up|2|||
129025192|NCT00906399|464385579|FG006|Year 2|Lost to Follow-up|4|||
129025193|NCT00906399|464385573|FG000|Year 2|Withdrawal by Subject|0|||
129025194|NCT00906399|464385574|FG001|Year 2|Withdrawal by Subject|0|||
129025195|NCT00906399|464385575|FG002|Year 2|Withdrawal by Subject|0|||
129025196|NCT00906399|464385576|FG003|Year 2|Withdrawal by Subject|17|||
129025197|NCT00906399|464385577|FG004|Year 2|Withdrawal by Subject|18|||
129025198|NCT00906399|464385578|FG005|Year 2|Withdrawal by Subject|27|||
129025199|NCT00906399|464385579|FG006|Year 2|Withdrawal by Subject|13|||
129025200|NCT00906399|464385573|FG000|Year 2|Physician Decision|0|||
129025201|NCT00906399|464385574|FG001|Year 2|Physician Decision|0|||
129025202|NCT00906399|464385575|FG002|Year 2|Physician Decision|0|||
128902569|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
128902570|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
128902571|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
128902572|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
128902573|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
128902574|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
128902575|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
128902576|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
128902577|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
128902578|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
128902579|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
128902580|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Other|0|||
128902581|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Other|0|||
128902582|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Other|0|||
128902583|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Other|1|||
128902584|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Other|0|||
128902585|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
128902586|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
128902587|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
128902588|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
128902589|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
128902590|NCT00440947|463936339|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
128902591|NCT00440947|463936340|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
128902592|NCT00440947|463936341|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
128902593|NCT00440947|463936342|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
128902594|NCT00440947|463936343|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
128902595|NCT02716987|463936344|FG000|Overall Study|Ligand synthesis failure|0|||
128902596|NCT02716987|463936345|FG001|Overall Study|Ligand synthesis failure|0|||
128902597|NCT02716987|463936346|FG002|Overall Study|Ligand synthesis failure|1|||
128902598|NCT02716987|463936347|FG003|Overall Study|Ligand synthesis failure|0|||
128902599|NCT02716987|463936348|FG004|Overall Study|Ligand synthesis failure|0|||
128902600|NCT02716987|463936349|FG005|Overall Study|Ligand synthesis failure|0|||
128902601|NCT02716987|463936344|FG000|Overall Study|Withdrawal by Subject|0|||
128902602|NCT02716987|463936345|FG001|Overall Study|Withdrawal by Subject|0|||
128902603|NCT02716987|463936346|FG002|Overall Study|Withdrawal by Subject|0|||
128902604|NCT02716987|463936347|FG003|Overall Study|Withdrawal by Subject|0|||
128902605|NCT02716987|463936348|FG004|Overall Study|Withdrawal by Subject|1|||
128902606|NCT02716987|463936349|FG005|Overall Study|Withdrawal by Subject|1|||
128902607|NCT03223428|463936350|FG000|Overall Study|No longer taking Xermelo|27|||
128902608|NCT03223428|463936350|FG000|Overall Study|Declined Consent|1|||
128902609|NCT03223428|463936350|FG000|Overall Study|Non-responders|56|||
128902610|NCT03223428|463936350|FG000|Overall Study|Withdrawal by Subject|14|||
128902611|NCT01834274|463936351|FG000|Overall Study|Study Termination|41|||
128902612|NCT01834274|463936352|FG001|Overall Study|Study Termination|38|||
128902613|NCT01834274|463936351|FG000|Overall Study|Withdrawal by Subject|1|||
128902614|NCT01834274|463936352|FG001|Overall Study|Withdrawal by Subject|1|||
128902615|NCT01834274|463936351|FG000|Overall Study|Lost to Follow-up|3|||
128902616|NCT01834274|463936352|FG001|Overall Study|Lost to Follow-up|1|||
128902617|NCT01834274|463936351|FG000|Overall Study|Other|2|||
129025203|NCT00906399|464385576|FG003|Year 2|Physician Decision|0|||
129025204|NCT00906399|464385577|FG004|Year 2|Physician Decision|2|||
129025205|NCT00906399|464385578|FG005|Year 2|Physician Decision|6|||
129025206|NCT00906399|464385579|FG006|Year 2|Physician Decision|3|||
129025207|NCT00906399|464385573|FG000|Year 2|Death|0|||
128764692|NCT02343003|463430270|FG000|Overall Study|Withdrawal by Subject|9|||
128764693|NCT02343003|463430271|FG001|Overall Study|Withdrawal by Subject|4|||
128764694|NCT02343003|463430270|FG000|Overall Study|Lost to Follow-up|5|||
128764695|NCT02343003|463430271|FG001|Overall Study|Lost to Follow-up|1|||
128764696|NCT02343003|463430270|FG000|Overall Study|Protocol Violation|1|||
129025208|NCT00906399|464385574|FG001|Year 2|Death|0|||
128764697|NCT02343003|463430271|FG001|Overall Study|Protocol Violation|0|||
128902618|NCT01834274|463936352|FG001|Overall Study|Other|1|||
128902619|NCT02980224|463936355|FG000|Overall Study|Adverse Event|4|||
128902620|NCT02980224|463936356|FG001|Overall Study|Adverse Event|1|||
128902621|NCT02980224|463936355|FG000|Overall Study|Withdrawal by Subject|0|||
128902622|NCT02980224|463936356|FG001|Overall Study|Withdrawal by Subject|2|||
128902623|NCT01087905|463936357|FG000|Overall Study|Lost to Follow-up|24|||
128902624|NCT01087905|463936358|FG001|Overall Study|Lost to Follow-up|28|||
128902625|NCT01087905|463936359|FG002|Overall Study|Lost to Follow-up|18|||
128902626|NCT01087905|463936360|FG003|Overall Study|Lost to Follow-up|31|||
128902627|NCT01087905|463936361|FG004|Overall Study|Lost to Follow-up|27|||
128902628|NCT01087905|463936362|FG005|Overall Study|Lost to Follow-up|25|||
129025209|NCT00906399|464385575|FG002|Year 2|Death|0|||
128764698|NCT02343003|463430270|FG000|Overall Study|Death|0|||
128764699|NCT02343003|463430271|FG001|Overall Study|Death|1|||
129114779|NCT03028142|464716789|FG005|Overall Study|Adverse Event|1|||
129114780|NCT03028142|464716784|FG000|Overall Study|Withdrawal by Subject|0|||
129114781|NCT03028142|464716785|FG001|Overall Study|Withdrawal by Subject|0|||
129114782|NCT03028142|464716786|FG002|Overall Study|Withdrawal by Subject|0|||
129114783|NCT03028142|464716787|FG003|Overall Study|Withdrawal by Subject|0|||
129114784|NCT03028142|464716788|FG004|Overall Study|Withdrawal by Subject|1|||
129114785|NCT03028142|464716789|FG005|Overall Study|Withdrawal by Subject|0|||
129114786|NCT02810418|464716790|FG000|Arm A Dose Escalation|Adverse Event|2|||
129114787|NCT02810418|464716791|FG001|Arm A Dose Escalation|Adverse Event|1|||
129114788|NCT02810418|464716792|FG002|Arm A Dose Escalation|Adverse Event|0|||
129114789|NCT02810418|464716793|FG003|Arm A Dose Escalation|Adverse Event|0|||
129114790|NCT02810418|464716794|FG004|Arm A Dose Escalation|Adverse Event|0|||
129114791|NCT02810418|464716795|FG005|Arm A Dose Escalation|Adverse Event|0|||
129114792|NCT02810418|464716796|FG006|Arm A Dose Escalation|Adverse Event|0|||
129114793|NCT02810418|464716790|FG000|Dose Expansion|Adverse Event|0|||
129114794|NCT02810418|464716791|FG001|Dose Expansion|Adverse Event|1|||
129114795|NCT02810418|464716792|FG002|Dose Expansion|Adverse Event|1|||
129114796|NCT02810418|464716793|FG003|Dose Expansion|Adverse Event|0|||
129114797|NCT02810418|464716794|FG004|Dose Expansion|Adverse Event|0|||
129114798|NCT02810418|464716795|FG005|Dose Expansion|Adverse Event|0|||
129114799|NCT02810418|464716796|FG006|Dose Expansion|Adverse Event|0|||
129114800|NCT02810418|464716790|FG000|Dose Expansion|Physician Decision|0|||
129114801|NCT02810418|464716791|FG001|Dose Expansion|Physician Decision|0|||
129114802|NCT02810418|464716792|FG002|Dose Expansion|Physician Decision|2|||
129114803|NCT02810418|464716793|FG003|Dose Expansion|Physician Decision|0|||
129114804|NCT02810418|464716794|FG004|Dose Expansion|Physician Decision|0|||
129114805|NCT02810418|464716795|FG005|Dose Expansion|Physician Decision|0|||
129114806|NCT02810418|464716796|FG006|Dose Expansion|Physician Decision|0|||
129114807|NCT02810418|464716790|FG000|Arm B Dose Escalation|Adverse Event|0|||
129114808|NCT02810418|464716791|FG001|Arm B Dose Escalation|Adverse Event|0|||
129114809|NCT02810418|464716792|FG002|Arm B Dose Escalation|Adverse Event|0|||
129114810|NCT02810418|464716793|FG003|Arm B Dose Escalation|Adverse Event|0|||
129114811|NCT02810418|464716794|FG004|Arm B Dose Escalation|Adverse Event|1|||
129114812|NCT02810418|464716795|FG005|Arm B Dose Escalation|Adverse Event|2|||
129114813|NCT02810418|464716796|FG006|Arm B Dose Escalation|Adverse Event|0|||
129114814|NCT01162343|464716800|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
129114815|NCT01162343|464716800|FG000|Overall Study|Refused psychiatrist assessment|12|||
129114816|NCT04635839|464716814|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
129114817|NCT04635839|464716815|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
129114818|NCT02737358|464716816|FG000|Overall Study|Withdrawal by Subject|7|||
129114819|NCT02737358|464716817|FG001|Overall Study|Withdrawal by Subject|12|||
129114820|NCT02737358|464716816|FG000|Overall Study|Lost to Follow-up|2|||
129114821|NCT02737358|464716817|FG001|Overall Study|Lost to Follow-up|3|||
129114822|NCT02870868|464716818|FG000|Overall Study|Withdrawal by Subject|2|||
129114823|NCT02870868|464716819|FG001|Overall Study|Withdrawal by Subject|1|||
129114824|NCT00744939|464716820|FG000|Overall Study|Withdrawal by Subject|9|||
129114825|NCT00744939|464716820|FG000|Overall Study|Protocol Violation|13|||
129114826|NCT00744939|464716820|FG000|Overall Study|Death|24|||
129114827|NCT00744939|464716820|FG000|Overall Study|distance|4|||
129114828|NCT00744939|464716820|FG000|Overall Study|Lost to Follow-up|12|||
129114829|NCT00744939|464716820|FG000|Overall Study|Medical history exclusionary|1|||
129114830|NCT00744939|464716820|FG000|Overall Study|Did not receive Magnevist|7|||
129114831|NCT00744939|464716820|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
129114832|NCT00744939|464716820|FG000|Overall Study|coma|1|||
128902629|NCT01087905|463936363|FG006|Overall Study|Lost to Follow-up|20|||
129114833|NCT00744939|464716820|FG000|Overall Study|incorrect race|1|||
129114834|NCT01674725|464716822|FG000|Overall Study|Adverse Event|1|||
129114835|NCT01674725|464716823|FG001|Overall Study|Adverse Event|0|||
129114836|NCT01674725|464716822|FG000|Overall Study|Did not receive study drug|1|||
129114837|NCT01674725|464716823|FG001|Overall Study|Did not receive study drug|0|||
128693929|NCT00761631|463177813|FG003|Overall Study|Lost to Follow-up|1|||
128693930|NCT00761631|463177814|FG004|Overall Study|Lost to Follow-up|6|||
128693931|NCT00761631|463177815|FG005|Overall Study|Lost to Follow-up|1|||
128693932|NCT00761631|463177810|FG000|Overall Study|Protocol Violation|2|||
129114838|NCT01674725|464716822|FG000|Overall Study|Withdrawal by Subject|1|||
129114839|NCT01674725|464716823|FG001|Overall Study|Withdrawal by Subject|0|||
129114840|NCT01674725|464716822|FG000|Overall Study|Lost to Follow-up|0|||
129114841|NCT01674725|464716823|FG001|Overall Study|Lost to Follow-up|1|||
128902630|NCT01087905|463936364|FG007|Overall Study|Lost to Follow-up|24|||
128902631|NCT01087905|463936357|FG000|Overall Study|Withdrawal by Subject|5|||
129114842|NCT02900352|464716824|FG000|Overall Study|Lost to Follow-up|28|||
129114843|NCT02900352|464716825|FG001|Overall Study|Lost to Follow-up|17|||
128693933|NCT00761631|463177811|FG001|Overall Study|Protocol Violation|0|||
128693934|NCT00761631|463177812|FG002|Overall Study|Protocol Violation|0|||
129114844|NCT03074695|464716826|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
129114845|NCT03074695|464716827|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
129114846|NCT03074695|464716826|FG000|Overall Study|Research staff not available|1|||
128902632|NCT01087905|463936358|FG001|Overall Study|Withdrawal by Subject|4|||
128902633|NCT01087905|463936359|FG002|Overall Study|Withdrawal by Subject|4|||
128902634|NCT01087905|463936360|FG003|Overall Study|Withdrawal by Subject|5|||
128902635|NCT01087905|463936361|FG004|Overall Study|Withdrawal by Subject|4|||
128902636|NCT01087905|463936362|FG005|Overall Study|Withdrawal by Subject|3|||
128902637|NCT01087905|463936363|FG006|Overall Study|Withdrawal by Subject|3|||
128902638|NCT01087905|463936364|FG007|Overall Study|Withdrawal by Subject|5|||
128902639|NCT02937818|463936365|FG000|Overall Study|Participants decision|2|||
128902640|NCT02937818|463936366|FG001|Overall Study|Participants decision|1|||
128902641|NCT02937818|463936367|FG002|Overall Study|Participants decision|1|||
128902642|NCT02937818|463936368|FG003|Overall Study|Participants decision|1|||
128902643|NCT02937818|463936365|FG000|Overall Study|Adverse Event|2|||
128902644|NCT02937818|463936366|FG001|Overall Study|Adverse Event|4|||
128902645|NCT02937818|463936367|FG002|Overall Study|Adverse Event|1|||
128902646|NCT02937818|463936368|FG003|Overall Study|Adverse Event|1|||
128902647|NCT02937818|463936365|FG000|Overall Study|Disease progression|17|||
128902648|NCT02937818|463936366|FG001|Overall Study|Disease progression|15|||
128902649|NCT02937818|463936367|FG002|Overall Study|Disease progression|7|||
128902650|NCT02937818|463936368|FG003|Overall Study|Disease progression|19|||
128902651|NCT02937818|463936365|FG000|Overall Study|Condition under investigation worsened|0|||
128902652|NCT02937818|463936366|FG001|Overall Study|Condition under investigation worsened|0|||
128902653|NCT02937818|463936367|FG002|Overall Study|Condition under investigation worsened|1|||
128902654|NCT02937818|463936368|FG003|Overall Study|Condition under investigation worsened|0|||
128902655|NCT05513625|463936369|FG000|Overall Study|Withdrawal by Subject|1|||
128902656|NCT01015768|463936370|FG000|Overall Study|Some subject data unuseable|4|||
128902657|NCT01015768|463936371|FG001|Overall Study|Some subject data unuseable|4|||
128902658|NCT03891264|463936372|FG000|Overall Study|Adverse Event|1|||
128902659|NCT03891264|463936372|FG000|Overall Study|Withdrawal by Subject|2|||
128902660|NCT03891264|463936372|FG000|Overall Study|Physician Decision|2|||
128902661|NCT01505634|463936377|FG000|Overall Study|Withdrawal by Subject|2|||
128902662|NCT01505634|463936378|FG001|Overall Study|Withdrawal by Subject|5|||
128902663|NCT01505634|463936379|FG002|Overall Study|Withdrawal by Subject|1|||
128902664|NCT01505634|463936377|FG000|Overall Study|Physician Decision|1|||
128902665|NCT01505634|463936378|FG001|Overall Study|Physician Decision|1|||
128902666|NCT01505634|463936379|FG002|Overall Study|Physician Decision|0|||
128902667|NCT01505634|463936377|FG000|Overall Study|Adverse Event|1|||
128902668|NCT01505634|463936378|FG001|Overall Study|Adverse Event|0|||
128902669|NCT01505634|463936379|FG002|Overall Study|Adverse Event|0|||
128902670|NCT01505634|463936377|FG000|Overall Study|Insufficient supply of drug at site|1|||
128902671|NCT01505634|463936378|FG001|Overall Study|Insufficient supply of drug at site|0|||
128902672|NCT01505634|463936379|FG002|Overall Study|Insufficient supply of drug at site|0|||
128902673|NCT01505634|463936377|FG000|Overall Study|Protocol Violation|2|||
128902674|NCT01505634|463936378|FG001|Overall Study|Protocol Violation|0|||
128902675|NCT01505634|463936379|FG002|Overall Study|Protocol Violation|0|||
128902676|NCT01505634|463936377|FG000|Overall Study|Lost to Follow-up|1|||
128902677|NCT01505634|463936378|FG001|Overall Study|Lost to Follow-up|4|||
128902678|NCT01505634|463936379|FG002|Overall Study|Lost to Follow-up|4|||
128902679|NCT01505634|463936377|FG000|Overall Study|Death|1|||
128902680|NCT01505634|463936378|FG001|Overall Study|Death|0|||
128693935|NCT00761631|463177813|FG003|Overall Study|Protocol Violation|1|||
128693936|NCT00761631|463177814|FG004|Overall Study|Protocol Violation|5|||
128693937|NCT00761631|463177815|FG005|Overall Study|Protocol Violation|1|||
128693938|NCT00761631|463177810|FG000|Overall Study|Randomized, not treated|1|||
128693939|NCT00761631|463177811|FG001|Overall Study|Randomized, not treated|0|||
128693940|NCT00761631|463177812|FG002|Overall Study|Randomized, not treated|0|||
128902681|NCT01505634|463936379|FG002|Overall Study|Death|0|||
128902682|NCT01505634|463936377|FG000|Overall Study|In a conflict zone|0|||
128902683|NCT01505634|463936378|FG001|Overall Study|In a conflict zone|0|||
128902684|NCT01505634|463936379|FG002|Overall Study|In a conflict zone|1|||
128902685|NCT02054897|463936380|FG000|Overall Study|Withdrawal by Subject|2|||
128902686|NCT02054897|463936381|FG001|Overall Study|Withdrawal by Subject|0|||
129025210|NCT00906399|464385576|FG003|Year 2|Death|1|||
129025211|NCT00906399|464385577|FG004|Year 2|Death|0|||
129025212|NCT00906399|464385578|FG005|Year 2|Death|0|||
129025213|NCT00906399|464385579|FG006|Year 2|Death|3|||
129025214|NCT00906399|464385573|FG000|Year 2|Other|0|||
129025215|NCT00906399|464385574|FG001|Year 2|Other|0|||
129025216|NCT00906399|464385575|FG002|Year 2|Other|0|||
129025217|NCT00906399|464385576|FG003|Year 2|Other|2|||
129025218|NCT00906399|464385577|FG004|Year 2|Other|3|||
129025219|NCT00906399|464385578|FG005|Year 2|Other|1|||
129025220|NCT00906399|464385579|FG006|Year 2|Other|0|||
128902687|NCT02054897|463936382|FG002|Overall Study|Withdrawal by Subject|2|||
128902688|NCT02054897|463936380|FG000|Overall Study|Missing follow-up information|3|||
128902689|NCT02054897|463936381|FG001|Overall Study|Missing follow-up information|5|||
129025221|NCT00858780|464385588|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
129025222|NCT00858780|464385589|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
129025223|NCT00858780|464385590|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
128902690|NCT02054897|463936382|FG002|Overall Study|Missing follow-up information|3|||
128902691|NCT02054897|463936380|FG000|Overall Study|Lost to Follow-up|4|||
128902692|NCT02054897|463936381|FG001|Overall Study|Lost to Follow-up|2|||
128902693|NCT02054897|463936382|FG002|Overall Study|Lost to Follow-up|7|||
129114847|NCT03074695|464716827|FG001|Overall Study|Research staff not available|2|||
129114848|NCT03074695|464716826|FG000|Overall Study|Did not receive neuraxial block|2|||
129114849|NCT03074695|464716827|FG001|Overall Study|Did not receive neuraxial block|2|||
129114850|NCT01774981|464716828|FG000|Overall Study|Adverse Event|0|||
129114851|NCT01774981|464716829|FG001|Overall Study|Adverse Event|0|||
129114852|NCT01774981|464716830|FG002|Overall Study|Adverse Event|0|||
129114853|NCT01774981|464716831|FG003|Overall Study|Adverse Event|0|||
129114854|NCT01774981|464716832|FG004|Overall Study|Adverse Event|0|||
129114855|NCT01774981|464716833|FG005|Overall Study|Adverse Event|1|||
129114856|NCT01774981|464716834|FG006|Overall Study|Adverse Event|0|||
129114857|NCT01774981|464716835|FG007|Overall Study|Adverse Event|0|||
129114858|NCT01774981|464716828|FG000|Overall Study|Withdrawal by Subject|0|||
129114859|NCT01774981|464716829|FG001|Overall Study|Withdrawal by Subject|0|||
129114860|NCT01774981|464716830|FG002|Overall Study|Withdrawal by Subject|0|||
129114861|NCT01774981|464716831|FG003|Overall Study|Withdrawal by Subject|0|||
129114862|NCT01774981|464716832|FG004|Overall Study|Withdrawal by Subject|0|||
129114863|NCT01774981|464716833|FG005|Overall Study|Withdrawal by Subject|0|||
129114864|NCT01774981|464716834|FG006|Overall Study|Withdrawal by Subject|0|||
129114865|NCT01774981|464716835|FG007|Overall Study|Withdrawal by Subject|1|||
129114866|NCT01774981|464716828|FG000|Overall Study|Death|0|||
129114867|NCT01774981|464716829|FG001|Overall Study|Death|0|||
129114868|NCT01774981|464716830|FG002|Overall Study|Death|0|||
129114869|NCT01774981|464716831|FG003|Overall Study|Death|0|||
129114870|NCT01774981|464716832|FG004|Overall Study|Death|1|||
129114871|NCT01774981|464716833|FG005|Overall Study|Death|0|||
128902694|NCT02054897|463936380|FG000|Overall Study|Randomized but not exposed|1|||
128902695|NCT02054897|463936381|FG001|Overall Study|Randomized but not exposed|0|||
128902696|NCT02054897|463936382|FG002|Overall Study|Randomized but not exposed|0|||
128902697|NCT00794157|463936383|FG000|Overall Study|Adverse Event|4|||
128902698|NCT00794157|463936384|FG001|Overall Study|Adverse Event|1|||
128902699|NCT00794157|463936385|FG002|Overall Study|Adverse Event|8|||
128902700|NCT00794157|463936383|FG000|Overall Study|Subject withdrew consent|2|||
128902701|NCT00794157|463936384|FG001|Overall Study|Subject withdrew consent|0|||
128902702|NCT00794157|463936385|FG002|Overall Study|Subject withdrew consent|3|||
128902703|NCT00794157|463936383|FG000|Overall Study|Lost to Follow-up|2|||
129114872|NCT01774981|464716834|FG006|Overall Study|Death|0|||
129114873|NCT01774981|464716835|FG007|Overall Study|Death|0|||
129114874|NCT00960193|464716836|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
129114875|NCT01239797|464716837|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
129114876|NCT01239797|464716838|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
129114877|NCT01239797|464716837|FG000|Randomized Participants|Participant withdrew consent|1|||
129114878|NCT01239797|464716838|FG001|Randomized Participants|Participant withdrew consent|7|||
129114879|NCT01239797|464716837|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
129114880|NCT01239797|464716838|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
129114881|NCT01239797|464716837|FG000|Treated Participants|Disease progression|185|||
129114882|NCT01239797|464716838|FG001|Treated Participants|Disease progression|185|||
128693941|NCT00761631|463177813|FG003|Overall Study|Randomized, not treated|0|||
128902704|NCT00794157|463936384|FG001|Overall Study|Lost to Follow-up|0|||
128902705|NCT00794157|463936385|FG002|Overall Study|Lost to Follow-up|1|||
128902706|NCT00794157|463936383|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128902707|NCT00794157|463936384|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128902708|NCT00794157|463936385|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
128902709|NCT00794157|463936383|FG000|Overall Study|Administrative problems|1|||
128902710|NCT00794157|463936384|FG001|Overall Study|Administrative problems|7|||
128902711|NCT00794157|463936385|FG002|Overall Study|Administrative problems|4|||
128902712|NCT00794157|463936383|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128902713|NCT00794157|463936384|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129114883|NCT01239797|464716837|FG000|Treated Participants|Study drug toxicity|39|||
128902714|NCT00794157|463936385|FG002|Overall Study|Abnormal test procedure result(s)|0|||
128902715|NCT00794157|463936383|FG000|Overall Study|Protocol deviation|0|||
128902716|NCT00794157|463936384|FG001|Overall Study|Protocol deviation|1|||
129114884|NCT01239797|464716838|FG001|Treated Participants|Study drug toxicity|45|||
129114885|NCT01239797|464716837|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
128902717|NCT00794157|463936385|FG002|Overall Study|Protocol deviation|1|||
128902718|NCT01692275|463936386|FG000|Overall Study|Lost to Follow-up|57|||
128902719|NCT01692275|463936387|FG001|Overall Study|Lost to Follow-up|48|||
128902720|NCT01692275|463936386|FG000|Overall Study|Withdrawal by Subject|9|||
128902721|NCT01692275|463936387|FG001|Overall Study|Withdrawal by Subject|11|||
128902722|NCT00361270|463936390|FG000|Overall Study|Death|0|||
129114886|NCT01239797|464716838|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
129114887|NCT01239797|464716837|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
128902723|NCT00361270|463936391|FG001|Overall Study|Death|0|||
128902724|NCT00361270|463936392|FG002|Overall Study|Death|0|||
128902725|NCT00361270|463936393|FG003|Overall Study|Death|2|||
128902726|NCT00361270|463936390|FG000|Overall Study|Lost to Follow-up|4|||
128902727|NCT00361270|463936391|FG001|Overall Study|Lost to Follow-up|1|||
128902728|NCT00361270|463936392|FG002|Overall Study|Lost to Follow-up|0|||
128902729|NCT00361270|463936393|FG003|Overall Study|Lost to Follow-up|0|||
128902730|NCT00361270|463936390|FG000|Overall Study|Physician Decision|0|||
128902731|NCT00361270|463936391|FG001|Overall Study|Physician Decision|0|||
128902732|NCT00361270|463936392|FG002|Overall Study|Physician Decision|1|||
128902733|NCT00361270|463936393|FG003|Overall Study|Physician Decision|0|||
128902734|NCT00361270|463936390|FG000|Overall Study|Protocol Violation|9|||
128902735|NCT00361270|463936391|FG001|Overall Study|Protocol Violation|4|||
128902736|NCT00361270|463936392|FG002|Overall Study|Protocol Violation|5|||
128902737|NCT00361270|463936393|FG003|Overall Study|Protocol Violation|4|||
128902738|NCT00361270|463936390|FG000|Overall Study|Withdrawal by Subject|6|||
128902739|NCT00361270|463936391|FG001|Overall Study|Withdrawal by Subject|6|||
128902740|NCT00361270|463936392|FG002|Overall Study|Withdrawal by Subject|3|||
128902741|NCT00361270|463936393|FG003|Overall Study|Withdrawal by Subject|7|||
128902742|NCT00361270|463936390|FG000|Overall Study|Afraid of Hypnosis|1|||
128902743|NCT00361270|463936391|FG001|Overall Study|Afraid of Hypnosis|2|||
128902744|NCT00361270|463936392|FG002|Overall Study|Afraid of Hypnosis|0|||
128902745|NCT00361270|463936393|FG003|Overall Study|Afraid of Hypnosis|0|||
128902746|NCT00361270|463936390|FG000|Overall Study|Problems with Transportation|4|||
128902747|NCT00361270|463936391|FG001|Overall Study|Problems with Transportation|0|||
128902748|NCT00361270|463936392|FG002|Overall Study|Problems with Transportation|0|||
129114888|NCT01239797|464716838|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
129114889|NCT01239797|464716837|FG000|Treated Participants|Administrative reason by sponsor|13|||
129114890|NCT01239797|464716838|FG001|Treated Participants|Administrative reason by sponsor|4|||
129114891|NCT01239797|464716837|FG000|Treated Participants|Other reasons|14|||
128902749|NCT00361270|463936393|FG003|Overall Study|Problems with Transportation|0|||
128902750|NCT00361270|463936390|FG000|Overall Study|Adverse Event|0|||
128902751|NCT00361270|463936391|FG001|Overall Study|Adverse Event|1|||
128902752|NCT00361270|463936392|FG002|Overall Study|Adverse Event|1|||
128902753|NCT00361270|463936393|FG003|Overall Study|Adverse Event|0|||
128902754|NCT00677014|463936395|FG000|Overall Study|Lost to Follow-up|20|||
128902755|NCT00677014|463936396|FG001|Overall Study|Lost to Follow-up|12|||
128902756|NCT00677014|463936397|FG002|Overall Study|Lost to Follow-up|24|||
128902757|NCT00677014|463936395|FG000|Overall Study|Death|6|||
128902758|NCT00677014|463936396|FG001|Overall Study|Death|15|||
128902759|NCT00677014|463936397|FG002|Overall Study|Death|7|||
128902760|NCT00677014|463936395|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
128902761|NCT00677014|463936396|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
128902762|NCT00677014|463936397|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
128902763|NCT00640328|463936398|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
128902764|NCT00640328|463936399|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
129114892|NCT01239797|464716838|FG001|Treated Participants|Other reasons|14|||
129114893|NCT01239797|464716837|FG000|Treated Participants|Participant withdrew consent|6|||
129114894|NCT01239797|464716838|FG001|Treated Participants|Participant withdrew consent|11|||
129114895|NCT01239797|464716837|FG000|Treated Participants|Death|1|||
128902765|NCT00640328|463936400|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
128902766|NCT00640328|463936401|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
128902767|NCT00640328|463936402|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
128902768|NCT00640328|463936403|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
128902769|NCT00640328|463936398|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
128902770|NCT00640328|463936399|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
128902771|NCT00640328|463936400|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
129114896|NCT01239797|464716838|FG001|Treated Participants|Death|1|||
129114897|NCT01239797|464716837|FG000|Treated Participants|Participant no longer meets study criteria|1|||
129114898|NCT01239797|464716838|FG001|Treated Participants|Participant no longer meets study criteria|1|||
128902772|NCT00640328|463936401|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
128902773|NCT00640328|463936402|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
128902774|NCT00640328|463936403|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
128902775|NCT00640328|463936398|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
128902776|NCT00640328|463936399|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
128902777|NCT00640328|463936400|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
129114899|NCT01239797|464716837|FG000|Treated Participants|Poor/non-compliance|0|||
129114900|NCT01239797|464716838|FG001|Treated Participants|Poor/non-compliance|1|||
128764700|NCT02343003|463430270|FG000|Overall Study|exclusion criteria met|1|||
129114901|NCT02631941|464716843|FG000|Overall Study|Physician Decision|0|||
128902778|NCT00640328|463936401|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
128902779|NCT00640328|463936402|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
128764701|NCT02343003|463430271|FG001|Overall Study|exclusion criteria met|1|||
128902780|NCT00640328|463936403|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
128902781|NCT00640328|463936398|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
128902782|NCT00640328|463936399|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
128902783|NCT00640328|463936400|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
128902784|NCT00640328|463936401|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
128902785|NCT00640328|463936402|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
128902786|NCT00640328|463936403|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
128902787|NCT02374099|463936404|FG000|Overall Study|Adverse Event|1|||
128902788|NCT02374099|463936405|FG001|Overall Study|Adverse Event|0|||
128902789|NCT02374099|463936404|FG000|Overall Study|Progressive Disease|35|||
128902790|NCT02374099|463936405|FG001|Overall Study|Progressive Disease|40|||
128902791|NCT02374099|463936404|FG000|Overall Study|Withdrawal by Subject|5|||
128902792|NCT02374099|463936405|FG001|Overall Study|Withdrawal by Subject|1|||
128902793|NCT02374099|463936404|FG000|Overall Study|Miscellaneous|2|||
128902794|NCT02374099|463936405|FG001|Overall Study|Miscellaneous|3|||
128902795|NCT02374099|463936404|FG000|Overall Study|Randomized, but not treated|2|||
128902796|NCT02374099|463936405|FG001|Overall Study|Randomized, but not treated|1|||
128902797|NCT02374099|463936404|FG000|Overall Study|Study Terminated by Sponsor|3|||
128902798|NCT02374099|463936405|FG001|Overall Study|Study Terminated by Sponsor|4|||
128902799|NCT01326546|463936406|FG000|Overall Study|Lost to Follow-up|8|||
128902800|NCT01326546|463936407|FG001|Overall Study|Lost to Follow-up|7|||
128902801|NCT01326546|463936406|FG000|Overall Study|Protocol Violation|3|||
128902802|NCT01326546|463936407|FG001|Overall Study|Protocol Violation|4|||
128902803|NCT01326546|463936406|FG000|Overall Study|Pregnancy|0|||
128902804|NCT01326546|463936407|FG001|Overall Study|Pregnancy|1|||
128902805|NCT01326546|463936406|FG000|Overall Study|Adverse Event|1|||
128902806|NCT01326546|463936407|FG001|Overall Study|Adverse Event|0|||
128902807|NCT01326546|463936406|FG000|Overall Study|Withdrawal by Subject|5|||
128902808|NCT01326546|463936407|FG001|Overall Study|Withdrawal by Subject|1|||
128902809|NCT01033825|463936408|FG000|Overall Study|Withdrawal by Subject|2|||
128902810|NCT01033825|463936409|FG001|Overall Study|Withdrawal by Subject|3|||
128902811|NCT01033825|463936410|FG002|Overall Study|Withdrawal by Subject|2|||
128902812|NCT01033825|463936411|FG003|Overall Study|Withdrawal by Subject|1|||
128902813|NCT01033825|463936412|FG004|Overall Study|Withdrawal by Subject|1|||
128902814|NCT01033825|463936413|FG005|Overall Study|Withdrawal by Subject|0|||
128902815|NCT01033825|463936414|FG006|Overall Study|Withdrawal by Subject|0|||
128902816|NCT01033825|463936408|FG000|Overall Study|Adverse Event|0|||
128902817|NCT01033825|463936409|FG001|Overall Study|Adverse Event|0|||
128902818|NCT01033825|463936410|FG002|Overall Study|Adverse Event|0|||
128902819|NCT01033825|463936411|FG003|Overall Study|Adverse Event|1|||
128902820|NCT01033825|463936412|FG004|Overall Study|Adverse Event|0|||
128902821|NCT01033825|463936413|FG005|Overall Study|Adverse Event|0|||
128902822|NCT01033825|463936414|FG006|Overall Study|Adverse Event|0|||
128902823|NCT01033825|463936408|FG000|Overall Study|Protocol Violation|1|||
128902824|NCT01033825|463936409|FG001|Overall Study|Protocol Violation|0|||
128902825|NCT01033825|463936410|FG002|Overall Study|Protocol Violation|0|||
128902826|NCT01033825|463936411|FG003|Overall Study|Protocol Violation|0|||
128902827|NCT01033825|463936412|FG004|Overall Study|Protocol Violation|0|||
128902828|NCT01033825|463936413|FG005|Overall Study|Protocol Violation|0|||
128902829|NCT01033825|463936414|FG006|Overall Study|Protocol Violation|0|||
128902830|NCT01033825|463936408|FG000|Overall Study|Other|0|||
128902831|NCT01033825|463936409|FG001|Overall Study|Other|0|||
128902832|NCT01033825|463936410|FG002|Overall Study|Other|0|||
128902833|NCT01033825|463936411|FG003|Overall Study|Other|0|||
128902834|NCT01033825|463936412|FG004|Overall Study|Other|1|||
128902835|NCT01033825|463936413|FG005|Overall Study|Other|0|||
128902836|NCT01033825|463936414|FG006|Overall Study|Other|0|||
128902837|NCT04294719|463936415|FG000|Overall Study|Withdrawal by Subject|1|||
128902838|NCT00081159|463936416|FG000|Overall Study|Withdrawal by Subject|0|||
129114902|NCT02631941|464716844|FG001|Overall Study|Physician Decision|1|||
129114903|NCT02631941|464716845|FG002|Overall Study|Physician Decision|0|||
128902839|NCT00081159|463936417|FG001|Overall Study|Withdrawal by Subject|3|||
128902840|NCT00081159|463936416|FG000|Overall Study|Myelosuppression prior to treatment|0|||
128902841|NCT00081159|463936417|FG001|Overall Study|Myelosuppression prior to treatment|1|||
128902842|NCT00081159|463936416|FG000|Overall Study|Lost to Follow-up|2|||
128902843|NCT00081159|463936417|FG001|Overall Study|Lost to Follow-up|1|||
128902844|NCT01714687|463936418|FG000|Overall Study|Withdrawal by Subject|1|||
129114904|NCT02631941|464716846|FG003|Overall Study|Physician Decision|0|||
129114905|NCT02631941|464716847|FG004|Overall Study|Physician Decision|0|||
128902845|NCT01714687|463936419|FG001|Overall Study|Withdrawal by Subject|0|||
128902846|NCT01714687|463936418|FG000|Overall Study|Lost to Follow-up|2|||
128902847|NCT01714687|463936419|FG001|Overall Study|Lost to Follow-up|4|||
128902848|NCT01553136|463936424|FG000|Overall Study|Adverse Event|3|||
128902849|NCT01553136|463936425|FG001|Overall Study|Adverse Event|2|||
128902850|NCT01553136|463936424|FG000|Overall Study|Withdrawal by Subject|2|||
128902851|NCT01553136|463936425|FG001|Overall Study|Withdrawal by Subject|3|||
128902852|NCT01553136|463936424|FG000|Overall Study|Lost to Follow-up|4|||
129114906|NCT02631941|464716848|FG005|Overall Study|Physician Decision|0|||
129114907|NCT02631941|464716849|FG006|Overall Study|Physician Decision|0|||
129114908|NCT02631941|464716850|FG007|Overall Study|Physician Decision|0|||
129114909|NCT02631941|464716851|FG008|Overall Study|Physician Decision|0|||
129114910|NCT02631941|464716852|FG009|Overall Study|Physician Decision|0|||
129114911|NCT02631941|464716843|FG000|Overall Study|Adverse Event|0|||
129114912|NCT02631941|464716844|FG001|Overall Study|Adverse Event|1|||
129114913|NCT02631941|464716845|FG002|Overall Study|Adverse Event|0|||
129114914|NCT02631941|464716846|FG003|Overall Study|Adverse Event|0|||
129114915|NCT02631941|464716847|FG004|Overall Study|Adverse Event|0|||
129114916|NCT02631941|464716848|FG005|Overall Study|Adverse Event|0|||
128764702|NCT02343003|463430270|FG000|Overall Study|terminated by sponsor|2|||
128764703|NCT02343003|463430271|FG001|Overall Study|terminated by sponsor|0|||
128764704|NCT02281760|463430273|FG000|Overall Study|Withdrawal by Subject|1|||
128764705|NCT01576367|463430278|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128764706|NCT01576367|463430278|FG000|Overall Study|Moved to commercial use after 6 months|1|||
128764707|NCT01453348|463430279|FG000|Overall Study|Death|0|||
128764708|NCT01453348|463430280|FG001|Overall Study|Death|0|||
128764709|NCT01453348|463430281|FG002|Overall Study|Death|1|||
128764710|NCT01453348|463430279|FG000|Overall Study|Withdrawal by Subject|0|||
128764711|NCT01453348|463430280|FG001|Overall Study|Withdrawal by Subject|1|||
128764712|NCT01453348|463430281|FG002|Overall Study|Withdrawal by Subject|0|||
128764713|NCT01453348|463430279|FG000|Overall Study|Protocol Violation|1|||
128764714|NCT01453348|463430280|FG001|Overall Study|Protocol Violation|0|||
128764715|NCT01453348|463430281|FG002|Overall Study|Protocol Violation|0|||
128764716|NCT04359771|463430286|FG000|Overall Study|Lack of Efficacy|2|||
128764717|NCT04359771|463430287|FG001|Overall Study|Lack of Efficacy|2|||
128764718|NCT03592277|463430288|FG000|Overall Study|Withdrawal by Subject|6|||
128764719|NCT03592277|463430289|FG001|Overall Study|Withdrawal by Subject|8|||
128764720|NCT00954733|463430290|FG000|Overall Study|blood gas machine did not work|1|||
128764721|NCT00622713|463430293|FG000|Overall Study|Adverse Event|35|||
128764722|NCT00622713|463430293|FG000|Overall Study|Administrative problems|4|||
128764723|NCT00622713|463430293|FG000|Overall Study|Withdrawal by Subject|11|||
128764724|NCT00622713|463430293|FG000|Overall Study|Lost to Follow-up|5|||
128764725|NCT00622713|463430293|FG000|Overall Study|Death|2|||
128764726|NCT00622713|463430293|FG000|Overall Study|Subject no longer required study drug|1|||
128764727|NCT00622713|463430293|FG000|Overall Study|Did not meet eligibility criteria|1|||
128764728|NCT01462162|463430296|FG000|Overall Study|Adverse Event|5|||
128764729|NCT01462162|463430296|FG000|Overall Study|Lack of Efficacy|4|||
128764730|NCT01462162|463430296|FG000|Overall Study|Abnormal laboratory parameters|1|||
128764731|NCT01462162|463430296|FG000|Overall Study|Other|2|||
128764732|NCT03485911|463430297|FG000|Part 1|Perceived lack of efficacy|1|||
128764733|NCT03485911|463430298|FG001|Part 1|Perceived lack of efficacy|1|||
128764734|NCT03485911|463430299|FG002|Part 1|Perceived lack of efficacy|2|||
128764735|NCT03485911|463430300|FG003|Part 1|Perceived lack of efficacy|0|||
128764736|NCT03485911|463430297|FG000|Part 1|Subject withdrew consent|0|||
128764737|NCT03485911|463430298|FG001|Part 1|Subject withdrew consent|1|||
128764738|NCT03485911|463430299|FG002|Part 1|Subject withdrew consent|0|||
128764739|NCT03485911|463430300|FG003|Part 1|Subject withdrew consent|1|||
128764740|NCT03485911|463430297|FG000|Part 1|Lab abnormalities/AEs|3|||
128764741|NCT03485911|463430298|FG001|Part 1|Lab abnormalities/AEs|1|||
128764742|NCT03485911|463430299|FG002|Part 1|Lab abnormalities/AEs|1|||
128764743|NCT03485911|463430300|FG003|Part 1|Lab abnormalities/AEs|0|||
128764744|NCT03485911|463430297|FG000|Part 1|Withdrew Consent prior to dosing|0|||
128764745|NCT03485911|463430298|FG001|Part 1|Withdrew Consent prior to dosing|0|||
128764746|NCT03485911|463430299|FG002|Part 1|Withdrew Consent prior to dosing|0|||
128764747|NCT03485911|463430300|FG003|Part 1|Withdrew Consent prior to dosing|1|||
128764748|NCT03485911|463430297|FG000|Part 1|Other NOS|0|||
128764749|NCT03485911|463430298|FG001|Part 1|Other NOS|0|||
128764750|NCT03485911|463430299|FG002|Part 1|Other NOS|0|||
129114917|NCT02631941|464716849|FG006|Overall Study|Adverse Event|0|||
128764751|NCT03485911|463430300|FG003|Part 1|Other NOS|1|||
128764752|NCT03485911|463430297|FG000|Part 2|Perceived lack of efficacy|5|||
128764753|NCT03485911|463430298|FG001|Part 2|Perceived lack of efficacy|3|||
128764754|NCT03485911|463430299|FG002|Part 2|Perceived lack of efficacy|0|||
128764755|NCT03485911|463430300|FG003|Part 2|Perceived lack of efficacy|2|||
128764756|NCT03485911|463430297|FG000|Part 2|Subject withdrew consent|1|||
128764757|NCT03485911|463430298|FG001|Part 2|Subject withdrew consent|0|||
129215319|NCT00463567|465091125|FG000|Overall Study|Administrative problems|5|||
129215320|NCT00463567|465091126|FG001|Overall Study|Administrative problems|3|||
128764758|NCT03485911|463430299|FG002|Part 2|Subject withdrew consent|2|||
128764759|NCT03485911|463430300|FG003|Part 2|Subject withdrew consent|1|||
128764760|NCT03485911|463430297|FG000|Part 2|Lab abnormalities/AEs|1|||
128764761|NCT03485911|463430298|FG001|Part 2|Lab abnormalities/AEs|2|||
128764762|NCT03485911|463430299|FG002|Part 2|Lab abnormalities/AEs|0|||
128764763|NCT03485911|463430300|FG003|Part 2|Lab abnormalities/AEs|0|||
128764764|NCT03485911|463430297|FG000|Part 2|Other NOS|0|||
129114918|NCT02631941|464716850|FG007|Overall Study|Adverse Event|0|||
129114919|NCT02631941|464716851|FG008|Overall Study|Adverse Event|0|||
129114920|NCT02631941|464716852|FG009|Overall Study|Adverse Event|0|||
129114921|NCT02631941|464716843|FG000|Overall Study|Withdrawal by Subject|0|||
129114922|NCT02631941|464716844|FG001|Overall Study|Withdrawal by Subject|0|||
129114923|NCT02631941|464716845|FG002|Overall Study|Withdrawal by Subject|0|||
129114924|NCT02631941|464716846|FG003|Overall Study|Withdrawal by Subject|0|||
129114925|NCT02631941|464716847|FG004|Overall Study|Withdrawal by Subject|1|||
129114926|NCT02631941|464716848|FG005|Overall Study|Withdrawal by Subject|0|||
129114927|NCT02631941|464716849|FG006|Overall Study|Withdrawal by Subject|0|||
129114928|NCT02631941|464716850|FG007|Overall Study|Withdrawal by Subject|1|||
129114929|NCT02631941|464716851|FG008|Overall Study|Withdrawal by Subject|0|||
129114930|NCT02631941|464716852|FG009|Overall Study|Withdrawal by Subject|0|||
129114931|NCT02631941|464716843|FG000|Overall Study|Lost to Follow-up|0|||
129114932|NCT02631941|464716844|FG001|Overall Study|Lost to Follow-up|0|||
129114933|NCT02631941|464716845|FG002|Overall Study|Lost to Follow-up|0|||
129114934|NCT02631941|464716846|FG003|Overall Study|Lost to Follow-up|0|||
129114935|NCT02631941|464716847|FG004|Overall Study|Lost to Follow-up|0|||
129114936|NCT02631941|464716848|FG005|Overall Study|Lost to Follow-up|0|||
129114937|NCT02631941|464716849|FG006|Overall Study|Lost to Follow-up|0|||
129114938|NCT02631941|464716850|FG007|Overall Study|Lost to Follow-up|0|||
129114939|NCT02631941|464716851|FG008|Overall Study|Lost to Follow-up|1|||
129114940|NCT02631941|464716852|FG009|Overall Study|Lost to Follow-up|0|||
129114941|NCT00492297|464716853|FG000|Treatment|Death|2|||
129114942|NCT00492297|464716853|FG000|Treatment|Study terminated by sponsor|3|||
129114943|NCT00492297|464716853|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
129114944|NCT00492297|464716853|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
128902853|NCT01553136|463936425|FG001|Overall Study|Lost to Follow-up|10|||
128902854|NCT01553136|463936424|FG000|Overall Study|Physician Decision|2|||
128902855|NCT01553136|463936425|FG001|Overall Study|Physician Decision|3|||
128902856|NCT01553136|463936424|FG000|Overall Study|Scheduling Difficulties|5|||
128902857|NCT01553136|463936425|FG001|Overall Study|Scheduling Difficulties|4|||
129114945|NCT00492297|464716853|FG000|Survival Only Follow-up|Death|46|||
129114946|NCT00492297|464716853|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
129114947|NCT00492297|464716853|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
129114948|NCT01408706|464716855|FG000|Overall Study|Physician Decision|1|||
129114949|NCT01408706|464716856|FG001|Overall Study|Physician Decision|0|||
129114950|NCT02204917|464716857|FG000|Overall Study|Protocol Violation|1|||
129114951|NCT03669549|464716858|FG000|Overall Study|Adverse Event|4|||
129114952|NCT03669549|464716858|FG000|Overall Study|Withdrawal by Subject|1|||
129114953|NCT03669549|464716858|FG000|Overall Study|Study terminated by the Sponsor|1|||
129114954|NCT00698815|464716859|FG000|Overall Study|Death|1|||
129114955|NCT00698815|464716860|FG001|Overall Study|Death|2|||
129114956|NCT00698815|464716861|FG002|Overall Study|Death|4|||
129114957|NCT00698815|464716859|FG000|Overall Study|Withdrawal by Subject|6|||
129114958|NCT00698815|464716860|FG001|Overall Study|Withdrawal by Subject|3|||
129114959|NCT00698815|464716861|FG002|Overall Study|Withdrawal by Subject|2|||
129114960|NCT00698815|464716859|FG000|Overall Study|MD discretion|2|||
129114961|NCT00698815|464716860|FG001|Overall Study|MD discretion|7|||
129114962|NCT00698815|464716861|FG002|Overall Study|MD discretion|2|||
129114963|NCT00698815|464716859|FG000|Overall Study|Did not receive protocol treatment|1|||
129114964|NCT00698815|464716860|FG001|Overall Study|Did not receive protocol treatment|2|||
129114965|NCT00698815|464716861|FG002|Overall Study|Did not receive protocol treatment|2|||
129114966|NCT01663402|464716862|FG000|Overall Study|Randomized but not treated|19|||
129114967|NCT01663402|464716863|FG001|Overall Study|Randomized but not treated|11|||
129114968|NCT01663402|464716862|FG000|Overall Study|Adverse Event|347|||
129114969|NCT01663402|464716863|FG001|Overall Study|Adverse Event|362|||
128902858|NCT01100437|463936426|FG000|Titration/Stabilization|Adverse Event|0|||
128902859|NCT01100437|463936427|FG001|Titration/Stabilization|Adverse Event|0|||
128902860|NCT01100437|463936428|FG002|Titration/Stabilization|Adverse Event|4|||
128902861|NCT01100437|463936426|FG000|Titration/Stabilization|Non-compliance|0|||
128902862|NCT01100437|463936427|FG001|Titration/Stabilization|Non-compliance|0|||
129114970|NCT01663402|464716862|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
129114971|NCT01663402|464716863|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
128902863|NCT01100437|463936428|FG002|Titration/Stabilization|Non-compliance|1|||
129114972|NCT01663402|464716862|FG000|Overall Study|Poor compliance to protocol|529|||
129114973|NCT01663402|464716863|FG001|Overall Study|Poor compliance to protocol|454|||
129114974|NCT01663402|464716862|FG000|Overall Study|Physician Decision|77|||
129114975|NCT01663402|464716863|FG001|Overall Study|Physician Decision|62|||
129114976|NCT01663402|464716862|FG000|Overall Study|Site terminated by sponsor|1|||
129114977|NCT01663402|464716863|FG001|Overall Study|Site terminated by sponsor|3|||
129114978|NCT01663402|464716862|FG000|Overall Study|Participant moved|139|||
129114979|NCT01663402|464716863|FG001|Overall Study|Participant moved|104|||
129114980|NCT01663402|464716862|FG000|Overall Study|Withdrawal by Subject|118|||
129114981|NCT01663402|464716863|FG001|Overall Study|Withdrawal by Subject|91|||
129114982|NCT01663402|464716862|FG000|Overall Study|Related to study drug administration|96|||
129114983|NCT01663402|464716863|FG001|Overall Study|Related to study drug administration|105|||
129114984|NCT01663402|464716862|FG000|Overall Study|Lost to Follow-up|17|||
129114985|NCT01663402|464716863|FG001|Overall Study|Lost to Follow-up|15|||
129114986|NCT01663402|464716862|FG000|Overall Study|Other than specified above|172|||
129114987|NCT01663402|464716863|FG001|Overall Study|Other than specified above|147|||
129114988|NCT03829462|464716875|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
129114989|NCT03829462|464716876|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
129114990|NCT03829462|464716875|FG000|Overall Study|No treatment due to progression disease|0|||
129114991|NCT03829462|464716876|FG001|Overall Study|No treatment due to progression disease|1|||
129114992|NCT02718911|464716878|FG000|Overall Study|Adverse Event|0|||
129114993|NCT02718911|464716879|FG001|Overall Study|Adverse Event|0|||
128902864|NCT01100437|463936426|FG000|Titration/Stabilization|Sponsor canceled study|0|||
128902865|NCT01100437|463936427|FG001|Titration/Stabilization|Sponsor canceled study|0|||
128902866|NCT01100437|463936428|FG002|Titration/Stabilization|Sponsor canceled study|1|||
128902867|NCT01100437|463936426|FG000|Maintenance|Withdrawal by Subject|0|||
128902868|NCT01100437|463936427|FG001|Maintenance|Withdrawal by Subject|0|||
128902869|NCT01100437|463936428|FG002|Maintenance|Withdrawal by Subject|1|||
128902870|NCT01100437|463936426|FG000|Maintenance|Sponsor termination of study|0|||
128902871|NCT01100437|463936427|FG001|Maintenance|Sponsor termination of study|0|||
128902872|NCT01100437|463936428|FG002|Maintenance|Sponsor termination of study|1|||
128902873|NCT00894556|463936431|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
129025224|NCT00858780|464385591|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
129025225|NCT00858780|464385592|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
129025226|NCT00858780|464385588|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129025227|NCT00858780|464385589|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129025228|NCT00858780|464385590|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
129025229|NCT00858780|464385591|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129025230|NCT00858780|464385592|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129025231|NCT00858780|464385588|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
129025232|NCT00858780|464385589|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
129025233|NCT00858780|464385590|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
129025234|NCT00858780|464385591|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
129025235|NCT00858780|464385592|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
129025236|NCT00858780|464385588|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129025237|NCT00858780|464385589|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
129025238|NCT00858780|464385590|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129025239|NCT00858780|464385591|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129025240|NCT00858780|464385592|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129025241|NCT00858780|464385588|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129025242|NCT00858780|464385589|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129025243|NCT00858780|464385590|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129025244|NCT00858780|464385591|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129025245|NCT00858780|464385592|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
129025246|NCT00858780|464385588|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
129025247|NCT00858780|464385589|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
129025248|NCT00858780|464385590|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
129025249|NCT00858780|464385591|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
129025250|NCT00858780|464385592|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
129025251|NCT00863330|464385593|FG000|Overall Study|study terminated early due to administra|6|||
129025252|NCT01297504|464385594|FG000|Overall Study|Invalid Consent|1|||
129025253|NCT01297504|464385594|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
129025254|NCT01297504|464385594|FG000|Overall Study|No Study Visits|4|||
129025255|NCT01297504|464385594|FG000|Overall Study|Death|3|||
129025256|NCT01297504|464385594|FG000|Overall Study|Lost to Follow-up|43|||
129025257|NCT01297504|464385594|FG000|Overall Study|Withdrawal by Subject|9|||
129025258|NCT01297504|464385594|FG000|Overall Study|Site Closure|3|||
129025259|NCT01297504|464385594|FG000|Overall Study|Protocol Violation|3|||
129025260|NCT02615249|464385595|FG000|Overall Study|Withdrawal by Subject|1|||
129025261|NCT00574847|464385596|FG000|Overall Study|Adverse Event|2|||
129025262|NCT00574847|464385597|FG001|Overall Study|Adverse Event|0|||
129025263|NCT00574847|464385596|FG000|Overall Study|Death|1|||
129025264|NCT00574847|464385597|FG001|Overall Study|Death|0|||
129025265|NCT00574847|464385596|FG000|Overall Study|Withdrawal by Subject|2|||
129025266|NCT00574847|464385597|FG001|Overall Study|Withdrawal by Subject|2|||
129025267|NCT00574847|464385596|FG000|Overall Study|Physician Decision|1|||
129114994|NCT02718911|464716880|FG002|Overall Study|Adverse Event|0|||
128902874|NCT00894556|463936432|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
128902875|NCT00894556|463936433|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
128902876|NCT00894556|463936434|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
129025268|NCT00574847|464385597|FG001|Overall Study|Physician Decision|0|||
129025269|NCT00574847|464385596|FG000|Overall Study|Did not receive medication (declined)|2|||
129025270|NCT00574847|464385597|FG001|Overall Study|Did not receive medication (declined)|5|||
129025271|NCT02055547|464385599|FG000|Overall Study|Protocol Violation|0|||
129025272|NCT02055547|464385600|FG001|Overall Study|Protocol Violation|0|||
129025273|NCT02055547|464385601|FG002|Overall Study|Protocol Violation|1|||
128902877|NCT00894556|463936431|FG000|Treatment Phase|Lost to Follow-up|2|||
128902878|NCT00894556|463936432|FG001|Treatment Phase|Lost to Follow-up|3|||
128902879|NCT00894556|463936433|FG002|Treatment Phase|Lost to Follow-up|1|||
128902880|NCT00894556|463936434|FG003|Treatment Phase|Lost to Follow-up|0|||
128902881|NCT00894556|463936431|FG000|Treatment Phase|Lack of Qualifying Event|2|||
128902882|NCT00894556|463936432|FG001|Treatment Phase|Lack of Qualifying Event|1|||
128902883|NCT00894556|463936433|FG002|Treatment Phase|Lack of Qualifying Event|0|||
128902884|NCT00894556|463936434|FG003|Treatment Phase|Lack of Qualifying Event|0|||
128902885|NCT01979536|463936437|FG000|Overall Study|Physician Decision|2|||
128902886|NCT01979536|463936438|FG001|Overall Study|Physician Decision|3|||
128902887|NCT01979536|463936437|FG000|Overall Study|Withdrawal by Subject|0|||
128902888|NCT01979536|463936438|FG001|Overall Study|Withdrawal by Subject|1|||
128902889|NCT01979536|463936437|FG000|Overall Study|Refusal|0|||
128902890|NCT01979536|463936438|FG001|Overall Study|Refusal|1|||
128902891|NCT01979536|463936437|FG000|Overall Study|Relapse|0|||
128902892|NCT01979536|463936438|FG001|Overall Study|Relapse|1|||
128902893|NCT01979536|463936437|FG000|Overall Study|Study terminated by Sponsor|0|||
128902894|NCT01979536|463936438|FG001|Overall Study|Study terminated by Sponsor|1|||
128902895|NCT01979536|463936437|FG000|Overall Study|Did not start treatment|0|||
128902896|NCT01979536|463936438|FG001|Overall Study|Did not start treatment|1|||
128902897|NCT03077685|463936439|FG000|Overall Study|Lost to Follow-up|0|||
128902898|NCT03077685|463936440|FG001|Overall Study|Lost to Follow-up|0|||
128902899|NCT03077685|463936441|FG002|Overall Study|Lost to Follow-up|0|||
128902900|NCT03077685|463936442|FG003|Overall Study|Lost to Follow-up|0|||
128902901|NCT03077685|463936443|FG004|Overall Study|Lost to Follow-up|1|||
128902902|NCT03077685|463936439|FG000|Overall Study|Death|0|||
128902903|NCT03077685|463936440|FG001|Overall Study|Death|0|||
128902904|NCT03077685|463936441|FG002|Overall Study|Death|1|||
128902905|NCT03077685|463936442|FG003|Overall Study|Death|1|||
128902906|NCT03077685|463936443|FG004|Overall Study|Death|3|||
128902907|NCT03077685|463936439|FG000|Overall Study|Withdrawal by Subject|0|||
128902908|NCT03077685|463936440|FG001|Overall Study|Withdrawal by Subject|0|||
128902909|NCT03077685|463936441|FG002|Overall Study|Withdrawal by Subject|0|||
128902910|NCT03077685|463936442|FG003|Overall Study|Withdrawal by Subject|2|||
128902911|NCT03077685|463936443|FG004|Overall Study|Withdrawal by Subject|1|||
128902912|NCT03077685|463936439|FG000|Overall Study|Physician Decision|0|||
128902913|NCT03077685|463936440|FG001|Overall Study|Physician Decision|0|||
128902914|NCT03077685|463936441|FG002|Overall Study|Physician Decision|1|||
128902915|NCT03077685|463936442|FG003|Overall Study|Physician Decision|0|||
128902916|NCT03077685|463936443|FG004|Overall Study|Physician Decision|3|||
128902917|NCT03077685|463936439|FG000|Overall Study|Disease Progression|1|||
128902918|NCT03077685|463936440|FG001|Overall Study|Disease Progression|0|||
128902919|NCT03077685|463936441|FG002|Overall Study|Disease Progression|0|||
128902920|NCT03077685|463936442|FG003|Overall Study|Disease Progression|2|||
128902921|NCT03077685|463936443|FG004|Overall Study|Disease Progression|1|||
128902922|NCT03077685|463936439|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
128902923|NCT03077685|463936440|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
128902924|NCT03077685|463936441|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
128902925|NCT03077685|463936442|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
128902926|NCT03077685|463936443|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
128902927|NCT03077685|463936439|FG000|Overall Study|Subject entered hospice care|0|||
128902928|NCT03077685|463936440|FG001|Overall Study|Subject entered hospice care|0|||
128902929|NCT03077685|463936441|FG002|Overall Study|Subject entered hospice care|0|||
128902930|NCT03077685|463936442|FG003|Overall Study|Subject entered hospice care|0|||
128902931|NCT03077685|463936443|FG004|Overall Study|Subject entered hospice care|1|||
128902932|NCT02595450|463936453|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
128902933|NCT02595450|463936453|FG000|Overall Study|Enrolled, but not treated|8|||
128902934|NCT04294901|463936455|FG000|Overall Study|Death|86|||
128902935|NCT04294901|463936456|FG001|Overall Study|Death|110|||
128902936|NCT04294901|463936455|FG000|Overall Study|Provider did not have historical control patients|581|||
128902937|NCT04294901|463936456|FG001|Overall Study|Provider did not have historical control patients|0|||
128902938|NCT04294901|463936455|FG000|Overall Study|Provider did not have intervention patients|0|||
129114995|NCT02718911|464716881|FG003|Overall Study|Adverse Event|0|||
128693942|NCT00761631|463177814|FG004|Overall Study|Randomized, not treated|0|||
128902939|NCT04294901|463936456|FG001|Overall Study|Provider did not have intervention patients|98|||
128902940|NCT01934556|463936459|FG000|Overall Study|Withdrawal by Subject|0|||
128693943|NCT00761631|463177815|FG005|Overall Study|Randomized, not treated|0|||
128902941|NCT01934556|463936460|FG001|Overall Study|Withdrawal by Subject|1|||
128902942|NCT01934556|463936461|FG002|Overall Study|Withdrawal by Subject|1|||
128902943|NCT01934556|463936459|FG000|Overall Study|Lost to Follow-up|4|||
128902944|NCT01934556|463936460|FG001|Overall Study|Lost to Follow-up|10|||
128902945|NCT01934556|463936461|FG002|Overall Study|Lost to Follow-up|7|||
128902946|NCT01934556|463936459|FG000|Overall Study|Death|1|||
128902947|NCT01934556|463936460|FG001|Overall Study|Death|5|||
128902948|NCT01934556|463936461|FG002|Overall Study|Death|2|||
128902949|NCT03770260|463937893|FG000|Overall Study|Disease progression|0|||
128902950|NCT03770260|463937894|FG001|Overall Study|Disease progression|1|||
129114996|NCT02718911|464716882|FG004|Overall Study|Adverse Event|0|||
128902951|NCT03770260|463937895|FG002|Overall Study|Disease progression|0|||
128902952|NCT03770260|463937896|FG003|Overall Study|Disease progression|0|||
128902953|NCT02484911|463937897|FG000|Overall Study|Withdrawal by Subject|2|||
128902954|NCT02484911|463937898|FG001|Overall Study|Withdrawal by Subject|1|||
128902955|NCT02484911|463937897|FG000|Overall Study|Protocol Violation|2|||
128902956|NCT02484911|463937898|FG001|Overall Study|Protocol Violation|1|||
128902957|NCT00075400|463937899|FG000|Overall Study|Ineligible: wrong primary|1|||
128902958|NCT00075400|463937899|FG000|Overall Study|Never treated|2|||
128902959|NCT00490568|463937900|FG000|Overall Study|Adverse Event|116|||
128902960|NCT00490568|463937900|FG000|Overall Study|Lost to Follow-up|13|||
128902961|NCT00490568|463937900|FG000|Overall Study|Protocol Violation|45|||
128902962|NCT00490568|463937900|FG000|Overall Study|Withdrawal by Subject|135|||
128902963|NCT00490568|463937900|FG000|Overall Study|Still in the study at termination|974|||
128902964|NCT00490568|463937900|FG000|Overall Study|Other|1|||
128902965|NCT00490568|463937900|FG000|Overall Study|Exclusion criteria met|1|||
128902966|NCT00490568|463937900|FG000|Overall Study|Caregiver related|20|||
128902967|NCT00490568|463937900|FG000|Overall Study|Abnormal ECG|25|||
128902968|NCT00490568|463937900|FG000|Overall Study|Participant refused follow-up|9|||
128902969|NCT00490568|463937900|FG000|Overall Study|Legal representative withdrew consent|1|||
128902970|NCT00490568|463937900|FG000|Overall Study|Disease progression|4|||
128902971|NCT00490568|463937900|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
128902972|NCT00490568|463937900|FG000|Overall Study|Investigator decision|3|||
128902973|NCT00490568|463937900|FG000|Overall Study|Non-Compliance|7|||
128902974|NCT00490568|463937900|FG000|Overall Study|Efficacy related|3|||
128902975|NCT00490568|463937900|FG000|Overall Study|Participant died|1|||
128902976|NCT00490568|463937900|FG000|Overall Study|Participant withdrawal due to surgery|1|||
128902977|NCT03451773|463937903|FG000|Overall Study|Death on study|1|||
128902978|NCT03451773|463937904|FG001|Overall Study|Death on study|5|||
128902979|NCT03451773|463937903|FG000|Overall Study|Death during follow-up period|0|||
128902980|NCT03451773|463937904|FG001|Overall Study|Death during follow-up period|1|||
128902981|NCT03468855|463937905|FG000|Overall Study|Adverse Event|2|||
128902982|NCT03468855|463937905|FG000|Overall Study|Lost to Follow-up|5|||
128902983|NCT03468855|463937905|FG000|Overall Study|Withdrawal by Subject|3|||
128902984|NCT03468855|463937905|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
128902985|NCT01908101|463937906|FG000|Overall Study|Physician Decision|1|||
128902986|NCT01908101|463937906|FG000|Overall Study|Withdrawal by Subject|1|||
128902987|NCT01908101|463937906|FG000|Overall Study|Incorrect Diagnosis|2|||
128902988|NCT01908101|463937906|FG000|Overall Study|Incorrect Starting Dose|1|||
128902989|NCT01908101|463937906|FG000|Overall Study|Did not complete the first cycle|4|||
128902990|NCT02135692|463937907|FG000|Overall Study|Adverse Event|3|||
129025274|NCT02055547|464385602|FG003|Overall Study|Protocol Violation|0|||
129025275|NCT02055547|464385603|FG004|Overall Study|Protocol Violation|0|||
129025276|NCT02055547|464385604|FG005|Overall Study|Protocol Violation|0|||
129025277|NCT02055547|464385605|FG006|Overall Study|Protocol Violation|1|||
129025278|NCT02055547|464385606|FG007|Overall Study|Protocol Violation|0|||
129025279|NCT02055547|464385607|FG008|Overall Study|Protocol Violation|0|||
129025280|NCT02055547|464385608|FG009|Overall Study|Protocol Violation|0|||
129025281|NCT02055547|464385609|FG010|Overall Study|Protocol Violation|0|||
129025282|NCT02055547|464385610|FG011|Overall Study|Protocol Violation|0|||
129025283|NCT02055547|464385611|FG012|Overall Study|Protocol Violation|0|||
129025284|NCT02055547|464385612|FG013|Overall Study|Protocol Violation|0|||
129025285|NCT02055547|464385613|FG014|Overall Study|Protocol Violation|0|||
129025286|NCT02055547|464385614|FG015|Overall Study|Protocol Violation|0|||
129025287|NCT02055547|464385615|FG016|Overall Study|Protocol Violation|0|||
129025288|NCT02055547|464385616|FG017|Overall Study|Protocol Violation|0|||
129025289|NCT02055547|464385617|FG018|Overall Study|Protocol Violation|0|||
129025290|NCT02055547|464385599|FG000|Overall Study|Physician Decision|0|||
129025291|NCT02055547|464385600|FG001|Overall Study|Physician Decision|1|||
129025292|NCT02055547|464385601|FG002|Overall Study|Physician Decision|1|||
129025293|NCT02055547|464385602|FG003|Overall Study|Physician Decision|0|||
129025294|NCT02055547|464385603|FG004|Overall Study|Physician Decision|1|||
129025295|NCT02055547|464385604|FG005|Overall Study|Physician Decision|0|||
129025296|NCT02055547|464385605|FG006|Overall Study|Physician Decision|0|||
129025297|NCT02055547|464385606|FG007|Overall Study|Physician Decision|0|||
129025298|NCT02055547|464385607|FG008|Overall Study|Physician Decision|0|||
129025299|NCT02055547|464385608|FG009|Overall Study|Physician Decision|1|||
129025300|NCT02055547|464385609|FG010|Overall Study|Physician Decision|1|||
129025301|NCT02055547|464385610|FG011|Overall Study|Physician Decision|0|||
129025302|NCT02055547|464385611|FG012|Overall Study|Physician Decision|0|||
128902991|NCT02135692|463937907|FG000|Overall Study|Lack of Efficacy|2|||
128902992|NCT02135692|463937907|FG000|Overall Study|Protocol Violation|2|||
128902993|NCT02135692|463937907|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
129025303|NCT02055547|464385612|FG013|Overall Study|Physician Decision|0|||
129025304|NCT02055547|464385613|FG014|Overall Study|Physician Decision|0|||
129025305|NCT02055547|464385614|FG015|Overall Study|Physician Decision|0|||
129025306|NCT02055547|464385615|FG016|Overall Study|Physician Decision|0|||
129025307|NCT02055547|464385616|FG017|Overall Study|Physician Decision|0|||
129025308|NCT02055547|464385617|FG018|Overall Study|Physician Decision|0|||
129025309|NCT02055547|464385599|FG000|Overall Study|Adverse Event|0|||
128902994|NCT02135692|463937907|FG000|Overall Study|Product commercially available|159|||
128902995|NCT02135692|463937907|FG000|Overall Study|Study closed/terminated|153|||
128902996|NCT02135692|463937907|FG000|Overall Study|Lost to Follow-up|4|||
128902997|NCT02135692|463937907|FG000|Overall Study|Withdrawal by Subject|15|||
128902998|NCT04429061|463937910|FG000|Overall Study|Lost to Follow-up|62|||
128693944|NCT00761631|463177810|FG000|Overall Study|Failed to return|1|||
128693945|NCT00761631|463177811|FG001|Overall Study|Failed to return|0|||
128902999|NCT04429061|463937911|FG001|Overall Study|Lost to Follow-up|87|||
128903000|NCT04429061|463937910|FG000|Overall Study|Withdrawal by Subject|3|||
128903001|NCT04429061|463937911|FG001|Overall Study|Withdrawal by Subject|4|||
128903002|NCT00879229|463937917|FG000|Overall Study|Study terminated by Sponsor|13|||
128903003|NCT00879229|463937918|FG001|Overall Study|Study terminated by Sponsor|12|||
128903004|NCT00879229|463937917|FG000|Overall Study|Death|4|||
128903005|NCT00879229|463937918|FG001|Overall Study|Death|2|||
128903006|NCT00879229|463937917|FG000|Overall Study|Adverse Event|2|||
128903007|NCT00879229|463937918|FG001|Overall Study|Adverse Event|0|||
128903008|NCT00879229|463937917|FG000|Overall Study|Withdrawal by Subject|1|||
128903009|NCT00879229|463937918|FG001|Overall Study|Withdrawal by Subject|0|||
128903010|NCT00879229|463937917|FG000|Overall Study|Clinical status did not improve|1|||
128903011|NCT00879229|463937918|FG001|Overall Study|Clinical status did not improve|0|||
128903012|NCT00879229|463937917|FG000|Overall Study|Other|1|||
128903013|NCT00879229|463937918|FG001|Overall Study|Other|0|||
128903014|NCT01097746|463937919|FG000|Overall Study|Adverse Event|4|||
128903015|NCT01097746|463937919|FG000|Overall Study|taken off study before any treatment given|1|||
128693946|NCT00761631|463177812|FG002|Overall Study|Failed to return|1|||
128903016|NCT00631371|463937926|FG000|Overall Study|Lost to Follow-up|24|||
128903017|NCT00631371|463937927|FG001|Overall Study|Lost to Follow-up|19|||
128903018|NCT00631371|463937926|FG000|Overall Study|Other reason|5|||
128903019|NCT00631371|463937927|FG001|Overall Study|Other reason|12|||
128903020|NCT00631371|463937926|FG000|Overall Study|subject request|38|||
128903021|NCT00631371|463937927|FG001|Overall Study|subject request|45|||
128903022|NCT00631371|463937926|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
128903023|NCT00631371|463937927|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
128903024|NCT00631371|463937926|FG000|Overall Study|Death|263|||
128903025|NCT00631371|463937927|FG001|Overall Study|Death|239|||
128903026|NCT00390546|463937928|FG000|Overall Study|Renal impairment|1|||
128903027|NCT00390546|463937929|FG001|Overall Study|Renal impairment|0|||
128903028|NCT00390546|463937928|FG000|Overall Study|Physician Decision|5|||
128903029|NCT00390546|463937929|FG001|Overall Study|Physician Decision|5|||
128903030|NCT00812214|463937935|FG000|Overall Study|Lost to Follow-up|3|||
128903031|NCT00812214|463937936|FG001|Overall Study|Lost to Follow-up|1|||
128903032|NCT02145741|463937937|FG000|Overall Study|Progressive disease|3|||
128903033|NCT02145741|463937938|FG001|Overall Study|Progressive disease|6|||
128903034|NCT02145741|463937939|FG002|Overall Study|Progressive disease|6|||
128903035|NCT02145741|463937937|FG000|Overall Study|quality issue with the administered drug|3|||
128903036|NCT02145741|463937938|FG001|Overall Study|quality issue with the administered drug|0|||
128903037|NCT02145741|463937939|FG002|Overall Study|quality issue with the administered drug|0|||
128903038|NCT00129766|463937941|FG000|Overall Study|Death|3|||
128903039|NCT00129766|463937942|FG001|Overall Study|Death|8|||
128903040|NCT00129766|463937941|FG000|Overall Study|Withdrawal of consent|31|||
128903041|NCT00129766|463937942|FG001|Overall Study|Withdrawal of consent|30|||
128903042|NCT00129766|463937941|FG000|Overall Study|Lost to Follow-up|26|||
129025310|NCT02055547|464385600|FG001|Overall Study|Adverse Event|0|||
129025311|NCT02055547|464385601|FG002|Overall Study|Adverse Event|0|||
129025312|NCT02055547|464385602|FG003|Overall Study|Adverse Event|0|||
129025313|NCT02055547|464385603|FG004|Overall Study|Adverse Event|0|||
129025314|NCT02055547|464385604|FG005|Overall Study|Adverse Event|0|||
128693947|NCT00761631|463177813|FG003|Overall Study|Failed to return|1|||
128693948|NCT00761631|463177814|FG004|Overall Study|Failed to return|5|||
128903043|NCT00129766|463937942|FG001|Overall Study|Lost to Follow-up|21|||
129025315|NCT02055547|464385605|FG006|Overall Study|Adverse Event|1|||
129025316|NCT02055547|464385606|FG007|Overall Study|Adverse Event|0|||
129025317|NCT02055547|464385607|FG008|Overall Study|Adverse Event|1|||
128903044|NCT04091087|463937944|FG000|Overall Study|Not treated|1|||
128903045|NCT04091087|463937945|FG001|Overall Study|Not treated|0|||
128903046|NCT04091087|463937944|FG000|Overall Study|Adverse Event|4|||
128903047|NCT04091087|463937945|FG001|Overall Study|Adverse Event|4|||
128903048|NCT04091087|463937944|FG000|Overall Study|Protocol Violation|0|||
128903049|NCT04091087|463937945|FG001|Overall Study|Protocol Violation|1|||
128903050|NCT04091087|463937944|FG000|Overall Study|Withdrawal by Subject|5|||
128903051|NCT04091087|463937945|FG001|Overall Study|Withdrawal by Subject|2|||
128903052|NCT05440539|463937946|FG000|Overall Study|Lost to Follow-up|4|||
129025318|NCT02055547|464385608|FG009|Overall Study|Adverse Event|0|||
129025319|NCT02055547|464385609|FG010|Overall Study|Adverse Event|0|||
128903053|NCT05440539|463937947|FG001|Overall Study|Lost to Follow-up|4|||
128903054|NCT05440539|463937946|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
128903055|NCT05440539|463937947|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
128903056|NCT03808077|463937948|FG000|Overall Study|Physician Decision|2|||
129025320|NCT02055547|464385610|FG011|Overall Study|Adverse Event|0|||
128903057|NCT03808077|463937949|FG001|Overall Study|Physician Decision|3|||
128903058|NCT03808077|463937948|FG000|Overall Study|Withdrawal by Subject|1|||
128903059|NCT03808077|463937949|FG001|Overall Study|Withdrawal by Subject|0|||
128903060|NCT03808077|463937948|FG000|Overall Study|Equipment Issues|2|||
128903061|NCT03808077|463937949|FG001|Overall Study|Equipment Issues|1|||
128903062|NCT04152161|463937950|FG000|Overall Study|Death|0|||
128903063|NCT04152161|463937951|FG001|Overall Study|Death|1|||
128903064|NCT04152161|463937950|FG000|Overall Study|Physician Decision|0|||
128903065|NCT04152161|463937951|FG001|Overall Study|Physician Decision|1|||
128903066|NCT04152161|463937950|FG000|Overall Study|Lost to Follow-up|9|||
128903067|NCT04152161|463937951|FG001|Overall Study|Lost to Follow-up|3|||
128903068|NCT04152161|463937950|FG000|Overall Study|Protocol Violation|1|||
128903069|NCT04152161|463937951|FG001|Overall Study|Protocol Violation|0|||
128903070|NCT04152161|463937950|FG000|Overall Study|Withdrawal by Subject|29|||
128903071|NCT04152161|463937951|FG001|Overall Study|Withdrawal by Subject|28|||
128903072|NCT04152161|463937950|FG000|Overall Study|Sponsor termination of study|750|||
128903073|NCT04152161|463937951|FG001|Overall Study|Sponsor termination of study|755|||
128903074|NCT04152161|463937950|FG000|Overall Study|Other|20|||
128903075|NCT04152161|463937951|FG001|Overall Study|Other|18|||
128903076|NCT03246958|463937952|FG000|Overall Study|Withdrawal by Subject|0|||
128903077|NCT03246958|463937953|FG001|Overall Study|Withdrawal by Subject|1|||
128903078|NCT03246958|463937954|FG002|Overall Study|Withdrawal by Subject|0|||
128903079|NCT03246958|463937955|FG003|Overall Study|Withdrawal by Subject|0|||
128903080|NCT03246958|463937956|FG004|Overall Study|Withdrawal by Subject|0|||
128903081|NCT03246958|463937957|FG005|Overall Study|Withdrawal by Subject|1|||
128903082|NCT03246958|463937958|FG006|Overall Study|Withdrawal by Subject|0|||
128903083|NCT03246958|463937952|FG000|Overall Study|Progression|13|||
128903084|NCT03246958|463937953|FG001|Overall Study|Progression|9|||
128903085|NCT03246958|463937954|FG002|Overall Study|Progression|3|||
128903086|NCT03246958|463937955|FG003|Overall Study|Progression|2|||
128903087|NCT03246958|463937956|FG004|Overall Study|Progression|1|||
128903088|NCT03246958|463937957|FG005|Overall Study|Progression|2|||
128903089|NCT03246958|463937958|FG006|Overall Study|Progression|1|||
128903090|NCT03246958|463937952|FG000|Overall Study|Adverse Event|2|||
128903091|NCT03246958|463937953|FG001|Overall Study|Adverse Event|2|||
128903092|NCT03246958|463937954|FG002|Overall Study|Adverse Event|0|||
128903093|NCT03246958|463937955|FG003|Overall Study|Adverse Event|1|||
129025321|NCT02055547|464385611|FG012|Overall Study|Adverse Event|0|||
129025322|NCT02055547|464385612|FG013|Overall Study|Adverse Event|0|||
129025323|NCT02055547|464385613|FG014|Overall Study|Adverse Event|0|||
129025324|NCT02055547|464385614|FG015|Overall Study|Adverse Event|0|||
129025325|NCT02055547|464385615|FG016|Overall Study|Adverse Event|0|||
129025326|NCT02055547|464385616|FG017|Overall Study|Adverse Event|0|||
129025327|NCT02055547|464385617|FG018|Overall Study|Adverse Event|0|||
129025328|NCT02055547|464385599|FG000|Overall Study|Withdrawal by Subject|0|||
129025329|NCT02055547|464385600|FG001|Overall Study|Withdrawal by Subject|0|||
129025330|NCT02055547|464385601|FG002|Overall Study|Withdrawal by Subject|0|||
129025331|NCT02055547|464385602|FG003|Overall Study|Withdrawal by Subject|0|||
129025332|NCT02055547|464385603|FG004|Overall Study|Withdrawal by Subject|0|||
129025333|NCT02055547|464385604|FG005|Overall Study|Withdrawal by Subject|1|||
129025334|NCT02055547|464385605|FG006|Overall Study|Withdrawal by Subject|0|||
129025335|NCT02055547|464385606|FG007|Overall Study|Withdrawal by Subject|0|||
129025336|NCT02055547|464385607|FG008|Overall Study|Withdrawal by Subject|1|||
129025337|NCT02055547|464385608|FG009|Overall Study|Withdrawal by Subject|0|||
129025338|NCT02055547|464385609|FG010|Overall Study|Withdrawal by Subject|0|||
129025339|NCT02055547|464385610|FG011|Overall Study|Withdrawal by Subject|0|||
129025340|NCT02055547|464385611|FG012|Overall Study|Withdrawal by Subject|0|||
129025341|NCT02055547|464385612|FG013|Overall Study|Withdrawal by Subject|1|||
129025342|NCT02055547|464385613|FG014|Overall Study|Withdrawal by Subject|0|||
129025343|NCT02055547|464385614|FG015|Overall Study|Withdrawal by Subject|1|||
129114997|NCT02718911|464716883|FG005|Overall Study|Adverse Event|0|||
128903094|NCT03246958|463937956|FG004|Overall Study|Adverse Event|1|||
129025344|NCT02055547|464385615|FG016|Overall Study|Withdrawal by Subject|0|||
129025345|NCT02055547|464385616|FG017|Overall Study|Withdrawal by Subject|0|||
129025346|NCT02055547|464385617|FG018|Overall Study|Withdrawal by Subject|0|||
129025347|NCT02055547|464385599|FG000|Overall Study|Lost to Follow-up|0|||
128693949|NCT00761631|463177815|FG005|Overall Study|Failed to return|2|||
128903095|NCT03246958|463937957|FG005|Overall Study|Adverse Event|0|||
128903096|NCT03246958|463937958|FG006|Overall Study|Adverse Event|2|||
128903097|NCT03246958|463937952|FG000|Overall Study|Death|0|||
128903098|NCT03246958|463937953|FG001|Overall Study|Death|1|||
128903099|NCT03246958|463937954|FG002|Overall Study|Death|0|||
128903100|NCT03246958|463937955|FG003|Overall Study|Death|0|||
128903101|NCT03246958|463937956|FG004|Overall Study|Death|0|||
128903102|NCT03246958|463937957|FG005|Overall Study|Death|0|||
128903103|NCT03246958|463937958|FG006|Overall Study|Death|0|||
128903104|NCT03246958|463937952|FG000|Overall Study|Physician Decision|0|||
128903105|NCT03246958|463937953|FG001|Overall Study|Physician Decision|0|||
128903106|NCT03246958|463937954|FG002|Overall Study|Physician Decision|0|||
129025348|NCT02055547|464385600|FG001|Overall Study|Lost to Follow-up|0|||
129114998|NCT02718911|464716884|FG006|Overall Study|Adverse Event|0|||
129114999|NCT02718911|464716885|FG007|Overall Study|Adverse Event|0|||
129115000|NCT02718911|464716886|FG008|Overall Study|Adverse Event|0|||
129115001|NCT02718911|464716887|FG009|Overall Study|Adverse Event|2|||
129115002|NCT02718911|464716878|FG000|Overall Study|Death|2|||
129115003|NCT02718911|464716879|FG001|Overall Study|Death|3|||
129115004|NCT02718911|464716880|FG002|Overall Study|Death|1|||
129115005|NCT02718911|464716881|FG003|Overall Study|Death|0|||
129115006|NCT02718911|464716882|FG004|Overall Study|Death|1|||
129115007|NCT02718911|464716883|FG005|Overall Study|Death|3|||
129115008|NCT02718911|464716884|FG006|Overall Study|Death|1|||
129115009|NCT02718911|464716885|FG007|Overall Study|Death|1|||
129115010|NCT02718911|464716886|FG008|Overall Study|Death|4|||
129115011|NCT02718911|464716887|FG009|Overall Study|Death|3|||
129115012|NCT02718911|464716878|FG000|Overall Study|Lost to Follow-up|0|||
129115013|NCT02718911|464716879|FG001|Overall Study|Lost to Follow-up|0|||
129115014|NCT02718911|464716880|FG002|Overall Study|Lost to Follow-up|0|||
129115015|NCT02718911|464716881|FG003|Overall Study|Lost to Follow-up|0|||
129115016|NCT02718911|464716882|FG004|Overall Study|Lost to Follow-up|0|||
129115017|NCT02718911|464716883|FG005|Overall Study|Lost to Follow-up|0|||
129115018|NCT02718911|464716884|FG006|Overall Study|Lost to Follow-up|0|||
129115019|NCT02718911|464716885|FG007|Overall Study|Lost to Follow-up|0|||
129115020|NCT02718911|464716886|FG008|Overall Study|Lost to Follow-up|1|||
129115021|NCT02718911|464716887|FG009|Overall Study|Lost to Follow-up|0|||
129115022|NCT02718911|464716878|FG000|Overall Study|Physician Decision|2|||
129115023|NCT02718911|464716879|FG001|Overall Study|Physician Decision|0|||
129115024|NCT02718911|464716880|FG002|Overall Study|Physician Decision|1|||
129115025|NCT02718911|464716881|FG003|Overall Study|Physician Decision|1|||
129115026|NCT02718911|464716882|FG004|Overall Study|Physician Decision|0|||
129115027|NCT02718911|464716883|FG005|Overall Study|Physician Decision|0|||
129115028|NCT02718911|464716884|FG006|Overall Study|Physician Decision|0|||
129115029|NCT02718911|464716885|FG007|Overall Study|Physician Decision|1|||
129115030|NCT02718911|464716886|FG008|Overall Study|Physician Decision|2|||
129115031|NCT02718911|464716887|FG009|Overall Study|Physician Decision|1|||
129115032|NCT02718911|464716878|FG000|Overall Study|Withdrawal by Subject|0|||
129115033|NCT02718911|464716879|FG001|Overall Study|Withdrawal by Subject|0|||
129115034|NCT02718911|464716880|FG002|Overall Study|Withdrawal by Subject|0|||
129115035|NCT02718911|464716881|FG003|Overall Study|Withdrawal by Subject|0|||
129115036|NCT02718911|464716882|FG004|Overall Study|Withdrawal by Subject|1|||
129115037|NCT02718911|464716883|FG005|Overall Study|Withdrawal by Subject|0|||
129115038|NCT02718911|464716884|FG006|Overall Study|Withdrawal by Subject|0|||
129115039|NCT02718911|464716885|FG007|Overall Study|Withdrawal by Subject|0|||
129115040|NCT02718911|464716886|FG008|Overall Study|Withdrawal by Subject|1|||
129115041|NCT02718911|464716887|FG009|Overall Study|Withdrawal by Subject|4|||
129115042|NCT02718911|464716878|FG000|Overall Study|Reason Not Collected|0|||
129115043|NCT02718911|464716879|FG001|Overall Study|Reason Not Collected|0|||
129115044|NCT02718911|464716880|FG002|Overall Study|Reason Not Collected|1|||
129115045|NCT02718911|464716881|FG003|Overall Study|Reason Not Collected|0|||
129115046|NCT02718911|464716882|FG004|Overall Study|Reason Not Collected|0|||
129115047|NCT02718911|464716883|FG005|Overall Study|Reason Not Collected|0|||
129115048|NCT02718911|464716884|FG006|Overall Study|Reason Not Collected|2|||
129115049|NCT02718911|464716885|FG007|Overall Study|Reason Not Collected|1|||
129115050|NCT02718911|464716886|FG008|Overall Study|Reason Not Collected|4|||
129115051|NCT02718911|464716887|FG009|Overall Study|Reason Not Collected|9|||
129115052|NCT01172873|464716891|FG000|Overall Study|Withdrawal by Subject|3|||
129115053|NCT01172873|464716892|FG001|Overall Study|Withdrawal by Subject|2|||
129115054|NCT00983372|464716893|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
129115055|NCT00983372|464716893|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
129115056|NCT00983372|464716893|FG000|Diltiazem ER Alone|Adverse Event|1|||
129115057|NCT05518539|464716896|FG000|Overall Study|Lost to Follow-up|6|||
129115058|NCT02984982|464716905|FG000|Overall Study|Adverse Event|2|||
129115059|NCT02984982|464716906|FG001|Overall Study|Adverse Event|5|||
129115060|NCT02984982|464716905|FG000|Overall Study|Poor Compliance to Protocol|4|||
129115061|NCT02984982|464716906|FG001|Overall Study|Poor Compliance to Protocol|4|||
129115062|NCT02984982|464716905|FG000|Overall Study|Withdrawal by Subject|2|||
129115063|NCT02984982|464716906|FG001|Overall Study|Withdrawal by Subject|0|||
129115064|NCT02984982|464716905|FG000|Overall Study|Randomized but not treated|0|||
129115065|NCT02984982|464716906|FG001|Overall Study|Randomized but not treated|1|||
129115066|NCT01747499|464716908|FG000|Overall Study|Steroid refractory aGvHD|1|||
129115067|NCT01747499|464716909|FG001|Overall Study|Steroid refractory aGvHD|0|||
129115068|NCT01747499|464716910|FG002|Overall Study|Steroid refractory aGvHD|0|||
129115069|NCT01747499|464716911|FG003|Overall Study|Steroid refractory aGvHD|1|||
129115070|NCT01747499|464716912|FG004|Overall Study|Steroid refractory aGvHD|4|||
129115071|NCT01747499|464716908|FG000|Overall Study|Physician Decision|0|||
129115072|NCT01747499|464716909|FG001|Overall Study|Physician Decision|1|||
129115073|NCT01747499|464716910|FG002|Overall Study|Physician Decision|0|||
129115074|NCT01747499|464716911|FG003|Overall Study|Physician Decision|0|||
129115075|NCT01747499|464716912|FG004|Overall Study|Physician Decision|2|||
129115076|NCT01747499|464716908|FG000|Overall Study|Death|0|||
129115077|NCT01747499|464716909|FG001|Overall Study|Death|0|||
129115078|NCT01747499|464716910|FG002|Overall Study|Death|0|||
129115079|NCT01747499|464716911|FG003|Overall Study|Death|1|||
129115080|NCT01747499|464716912|FG004|Overall Study|Death|1|||
129115081|NCT01747499|464716908|FG000|Overall Study|Withdrawal by Subject|0|||
129115082|NCT01747499|464716909|FG001|Overall Study|Withdrawal by Subject|0|||
128693950|NCT00761631|463177810|FG000|Overall Study|Physician Decision|1|||
128693951|NCT00761631|463177811|FG001|Overall Study|Physician Decision|0|||
128903107|NCT03246958|463937955|FG003|Overall Study|Physician Decision|1|||
128903108|NCT03246958|463937956|FG004|Overall Study|Physician Decision|0|||
128903109|NCT03246958|463937957|FG005|Overall Study|Physician Decision|0|||
128903110|NCT03246958|463937958|FG006|Overall Study|Physician Decision|0|||
128903111|NCT03246958|463937952|FG000|Overall Study|Never start treatment|1|||
128903112|NCT03246958|463937953|FG001|Overall Study|Never start treatment|0|||
128903113|NCT03246958|463937954|FG002|Overall Study|Never start treatment|0|||
128903114|NCT03246958|463937955|FG003|Overall Study|Never start treatment|0|||
128903115|NCT03246958|463937956|FG004|Overall Study|Never start treatment|0|||
128903116|NCT03246958|463937957|FG005|Overall Study|Never start treatment|0|||
128903117|NCT03246958|463937958|FG006|Overall Study|Never start treatment|0|||
128903118|NCT03246958|463937952|FG000|Overall Study|Over enrollment|0|||
128903119|NCT03246958|463937953|FG001|Overall Study|Over enrollment|2|||
128903120|NCT03246958|463937954|FG002|Overall Study|Over enrollment|0|||
128903121|NCT03246958|463937955|FG003|Overall Study|Over enrollment|0|||
128903122|NCT03246958|463937956|FG004|Overall Study|Over enrollment|0|||
128903123|NCT03246958|463937957|FG005|Overall Study|Over enrollment|0|||
128903124|NCT03246958|463937958|FG006|Overall Study|Over enrollment|0|||
128903125|NCT01379274|463937959|FG000|Overall Study|funding withdrawn|1|||
128903126|NCT03287219|463937960|FG000|Overall Study|Protocol Violation|0|||
128903127|NCT03287219|463937961|FG001|Overall Study|Protocol Violation|2|||
128903128|NCT00930761|463937962|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
128903129|NCT00930761|463937963|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
128903130|NCT00930761|463937962|FG000|Overall Study|less than 3 music therapy sessions|0|||
128903131|NCT00930761|463937963|FG001|Overall Study|less than 3 music therapy sessions|3|||
128903132|NCT00631020|463937964|FG000|Overall Study|Lost to Follow-up|7|||
128903133|NCT00631020|463937964|FG000|Overall Study|Incarcerated|1|||
129025349|NCT02055547|464385601|FG002|Overall Study|Lost to Follow-up|1|||
129025350|NCT02055547|464385602|FG003|Overall Study|Lost to Follow-up|0|||
129025351|NCT02055547|464385603|FG004|Overall Study|Lost to Follow-up|0|||
129025352|NCT02055547|464385604|FG005|Overall Study|Lost to Follow-up|0|||
129025353|NCT02055547|464385605|FG006|Overall Study|Lost to Follow-up|0|||
129025354|NCT02055547|464385606|FG007|Overall Study|Lost to Follow-up|0|||
129025355|NCT02055547|464385607|FG008|Overall Study|Lost to Follow-up|0|||
129025356|NCT02055547|464385608|FG009|Overall Study|Lost to Follow-up|0|||
129025357|NCT02055547|464385609|FG010|Overall Study|Lost to Follow-up|0|||
129025358|NCT02055547|464385610|FG011|Overall Study|Lost to Follow-up|0|||
129025359|NCT02055547|464385611|FG012|Overall Study|Lost to Follow-up|0|||
129025360|NCT02055547|464385612|FG013|Overall Study|Lost to Follow-up|0|||
129025361|NCT02055547|464385613|FG014|Overall Study|Lost to Follow-up|0|||
129025362|NCT02055547|464385614|FG015|Overall Study|Lost to Follow-up|0|||
129025363|NCT02055547|464385615|FG016|Overall Study|Lost to Follow-up|0|||
129025364|NCT02055547|464385616|FG017|Overall Study|Lost to Follow-up|0|||
129025365|NCT02055547|464385617|FG018|Overall Study|Lost to Follow-up|0|||
129025366|NCT05098743|464385618|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
129025367|NCT05098743|464385619|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
129025368|NCT05098743|464385618|FG000|Overall Study|Lost to Follow-up|1|||
129025369|NCT05098743|464385619|FG001|Overall Study|Lost to Follow-up|2|||
129025370|NCT02911025|464385628|FG000|Overall Study|Lost to Follow-up|3|||
129025371|NCT03719040|464385629|FG000|Overall Study|Withdrawal by Subject|177|||
129025372|NCT03719040|464385629|FG000|Overall Study|Lost to Follow-up|26|||
129025373|NCT02923349|464385631|FG000|Overall Study|Other|1|||
129025374|NCT02923349|464385632|FG001|Overall Study|Other|2|||
129115083|NCT01747499|464716910|FG002|Overall Study|Withdrawal by Subject|0|||
128693952|NCT00761631|463177812|FG002|Overall Study|Physician Decision|0|||
128693953|NCT00761631|463177813|FG003|Overall Study|Physician Decision|0|||
128693954|NCT00761631|463177814|FG004|Overall Study|Physician Decision|0|||
128903134|NCT03221751|463937965|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
129025375|NCT02923349|464385633|FG002|Overall Study|Other|4|||
129025376|NCT02923349|464385634|FG003|Overall Study|Other|1|||
129115084|NCT01747499|464716911|FG003|Overall Study|Withdrawal by Subject|0|||
128693955|NCT00761631|463177815|FG005|Overall Study|Physician Decision|0|||
128903135|NCT03221751|463937966|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
128903136|NCT03571646|463937967|FG000|Overall Study|Adverse Event|1|||
128903137|NCT03571646|463937968|FG001|Overall Study|Adverse Event|0|||
128903138|NCT03571646|463937967|FG000|Overall Study|Withdrawal by Subject|1|||
129025377|NCT02923349|464385635|FG004|Overall Study|Other|3|||
129025378|NCT02923349|464385636|FG005|Overall Study|Other|0|||
129025379|NCT02923349|464385637|FG006|Overall Study|Other|1|||
129115085|NCT01747499|464716912|FG004|Overall Study|Withdrawal by Subject|6|||
128903139|NCT03571646|463937968|FG001|Overall Study|Withdrawal by Subject|1|||
128903140|NCT03548935|463937969|FG000|Overall Study|Withdrawal by Subject|26|||
128903141|NCT03548935|463937970|FG001|Overall Study|Withdrawal by Subject|17|||
128903142|NCT03548935|463937969|FG000|Overall Study|Lost to Follow-up|39|||
128903143|NCT03548935|463937970|FG001|Overall Study|Lost to Follow-up|28|||
128903144|NCT03548935|463937969|FG000|Overall Study|Death|1|||
128903145|NCT03548935|463937970|FG001|Overall Study|Death|1|||
128903146|NCT04677959|463937971|FG000|Overall Study|Adverse Event|1|||
128903147|NCT04677959|463937972|FG001|Overall Study|Adverse Event|9|||
128903148|NCT04677959|463937971|FG000|Overall Study|Withdrawal by Subject|2|||
128903149|NCT04677959|463937972|FG001|Overall Study|Withdrawal by Subject|15|||
128903150|NCT04677959|463937971|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128903151|NCT04677959|463937972|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128903152|NCT04677959|463937971|FG000|Overall Study|Non-compliance with study drug|0|||
128903153|NCT04677959|463937972|FG001|Overall Study|Non-compliance with study drug|2|||
128903154|NCT04677959|463937971|FG000|Overall Study|Protocol deviation|0|||
128903155|NCT04677959|463937972|FG001|Overall Study|Protocol deviation|11|||
128903156|NCT04677959|463937971|FG000|Overall Study|Lost to Follow-up|9|||
128903157|NCT04677959|463937972|FG001|Overall Study|Lost to Follow-up|13|||
128903158|NCT04677959|463937971|FG000|Overall Study|Other than specified|0|||
128903159|NCT04677959|463937972|FG001|Overall Study|Other than specified|8|||
128903160|NCT00763815|463937973|FG000|Overall Study|Adverse Event|14|||
128903161|NCT00763815|463937974|FG001|Overall Study|Adverse Event|29|||
128903162|NCT00763815|463937973|FG000|Overall Study|Lack of Efficacy|10|||
128903163|NCT00763815|463937974|FG001|Overall Study|Lack of Efficacy|11|||
128903164|NCT00763815|463937973|FG000|Overall Study|Poor Compliance to Protocol|6|||
128903165|NCT00763815|463937974|FG001|Overall Study|Poor Compliance to Protocol|6|||
128903166|NCT00763815|463937973|FG000|Overall Study|Lost to Follow-up|2|||
128903167|NCT00763815|463937974|FG001|Overall Study|Lost to Follow-up|4|||
128903168|NCT00763815|463937973|FG000|Overall Study|Early Termination|1|||
128903169|NCT00763815|463937974|FG001|Overall Study|Early Termination|0|||
128903170|NCT00763815|463937973|FG000|Overall Study|Familial and Personal Reasons|9|||
128903171|NCT00763815|463937974|FG001|Overall Study|Familial and Personal Reasons|16|||
128903172|NCT00763815|463937973|FG000|Overall Study|Physician Decision|1|||
128903173|NCT00763815|463937974|FG001|Overall Study|Physician Decision|0|||
128903174|NCT00763815|463937973|FG000|Overall Study|Withdrawal by Subject|7|||
128903175|NCT00763815|463937974|FG001|Overall Study|Withdrawal by Subject|12|||
128903176|NCT00763815|463937973|FG000|Overall Study|Protocol Violation|2|||
128903177|NCT00763815|463937974|FG001|Overall Study|Protocol Violation|5|||
128903178|NCT00763815|463937973|FG000|Overall Study|Sponsor's Decision|0|||
128903179|NCT00763815|463937974|FG001|Overall Study|Sponsor's Decision|1|||
128903180|NCT01970995|463937975|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
128903181|NCT01970995|463937976|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
128903182|NCT01970995|463937977|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
128903183|NCT01970995|463937975|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
129115086|NCT01747499|464716908|FG000|Overall Study|Developed AML and death|0|||
129115087|NCT01747499|464716909|FG001|Overall Study|Developed AML and death|0|||
129115088|NCT01747499|464716910|FG002|Overall Study|Developed AML and death|0|||
129115089|NCT01747499|464716911|FG003|Overall Study|Developed AML and death|0|||
129115090|NCT01747499|464716912|FG004|Overall Study|Developed AML and death|1|||
129115091|NCT01747499|464716908|FG000|Overall Study|Determined not to be eligible|0|||
129115092|NCT01747499|464716909|FG001|Overall Study|Determined not to be eligible|0|||
129115093|NCT01747499|464716910|FG002|Overall Study|Determined not to be eligible|0|||
129115094|NCT01747499|464716911|FG003|Overall Study|Determined not to be eligible|0|||
129115095|NCT01747499|464716912|FG004|Overall Study|Determined not to be eligible|1|||
129115096|NCT01103323|464716913|FG000|Without/Before Drug Switch|Adverse Event|50|||
129115097|NCT01103323|464716914|FG001|Without/Before Drug Switch|Adverse Event|7|||
128903184|NCT01970995|463937976|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
129115098|NCT01103323|464716913|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
128693956|NCT00761631|463177810|FG000|Overall Study|Other|0|||
128693957|NCT00761631|463177811|FG001|Overall Study|Other|0|||
128693958|NCT00761631|463177812|FG002|Overall Study|Other|0|||
128693959|NCT00761631|463177813|FG003|Overall Study|Other|0|||
128693960|NCT00761631|463177814|FG004|Overall Study|Other|1|||
128693961|NCT00761631|463177815|FG005|Overall Study|Other|1|||
128693962|NCT01441180|463177816|FG000|Overall Study|Lost to Follow-up|1|||
128903185|NCT01970995|463937977|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
128903186|NCT01576549|463937978|FG000|Overall Study|Sponsor Decision|2|||
128903187|NCT00586495|463937979|FG000|Treatment Period|Adverse Event|11|||
128903188|NCT00586495|463937979|FG000|Treatment Period|Death|1|||
128903189|NCT00586495|463937979|FG000|Treatment Period|Protocol Violation|1|||
128903190|NCT00586495|463937979|FG000|Treatment Period|Withdrawal by Subject|1|||
128903191|NCT00586495|463937979|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
128903192|NCT00586495|463937979|FG000|Treatment Period|Switch to commercial drug|10|||
128903193|NCT00586495|463937979|FG000|Follow-up|Death|40|||
128903194|NCT00586495|463937979|FG000|Follow-up|Lost to Follow-up|1|||
129115099|NCT01103323|464716914|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
129115100|NCT01103323|464716913|FG000|Without/Before Drug Switch|Protocol Violation|2|||
129115101|NCT01103323|464716914|FG001|Without/Before Drug Switch|Protocol Violation|0|||
128903195|NCT00586495|463937979|FG000|Follow-up|Withdrawal by Subject|4|||
128903196|NCT00586495|463937979|FG000|Follow-up|Protocol driven decision point|37|||
128903197|NCT00586495|463937979|FG000|Follow-up|Switch to commercial drug|10|||
128903198|NCT01265797|463938001|FG000|Run-in Month|Withdrawal by Subject|0|||
128903199|NCT01265797|463938002|FG001|Run-in Month|Withdrawal by Subject|4|||
128903200|NCT01265797|463938001|FG000|Run-in Month|1st seizure during run-in month|0|||
128903201|NCT01265797|463938002|FG001|Run-in Month|1st seizure during run-in month|1|||
128903202|NCT01265797|463938001|FG000|Blinded Month|Lack of Efficacy|5|||
128903203|NCT01265797|463938002|FG001|Blinded Month|Lack of Efficacy|0|||
128903204|NCT01265797|463938001|FG000|Blinded Month|Lost to Follow-up|1|||
128903205|NCT01265797|463938002|FG001|Blinded Month|Lost to Follow-up|0|||
128903206|NCT01265797|463938001|FG000|Blinded Month|Protocol Violation|2|||
128903207|NCT01265797|463938002|FG001|Blinded Month|Protocol Violation|1|||
128903208|NCT01265797|463938001|FG000|Blinded Month|Adverse Event|2|||
128903209|NCT01265797|463938002|FG001|Blinded Month|Adverse Event|0|||
128903210|NCT01265797|463938001|FG000|Blinded Month|Diary data incomplete|0|||
128903211|NCT01265797|463938002|FG001|Blinded Month|Diary data incomplete|1|||
128903212|NCT01265797|463938001|FG000|Open Label Month|Lost to Follow-up|0|||
128903213|NCT01265797|463938002|FG001|Open Label Month|Lost to Follow-up|1|||
128903214|NCT02813694|463938003|FG000|Overall Study|Physician Decision|0|||
128903215|NCT02813694|463938004|FG001|Overall Study|Physician Decision|1|||
128903216|NCT02813694|463938003|FG000|Overall Study|Withdrawal by Subject|10|||
128903217|NCT02813694|463938004|FG001|Overall Study|Withdrawal by Subject|9|||
128903218|NCT02813694|463938003|FG000|Overall Study|Lost to Follow-up|1|||
128903219|NCT02813694|463938004|FG001|Overall Study|Lost to Follow-up|1|||
128903220|NCT02813694|463938003|FG000|Overall Study|Death|3|||
128903221|NCT02813694|463938004|FG001|Overall Study|Death|3|||
128903222|NCT02813694|463938003|FG000|Overall Study|Randomized- did not receive study drug|2|||
128903223|NCT02813694|463938004|FG001|Overall Study|Randomized- did not receive study drug|0|||
128903224|NCT02813694|463938003|FG000|Overall Study|Patient hospitalized|1|||
128903225|NCT02813694|463938004|FG001|Overall Study|Patient hospitalized|0|||
128903226|NCT00606320|463938007|FG000|Overall Study|Adverse Event|3|||
128903227|NCT00606320|463938007|FG000|Overall Study|Lack of Efficacy|5|||
128903228|NCT00606320|463938007|FG000|Overall Study|Physician Decision|7|||
128903229|NCT00606320|463938007|FG000|Overall Study|Protocol Violation|8|||
128903230|NCT00606320|463938007|FG000|Overall Study|Withdrawal by Subject|10|||
128903231|NCT00606320|463938007|FG000|Overall Study|Progression to depressive phase|4|||
128903232|NCT02595723|463938008|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
128903233|NCT02595723|463938009|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
128903234|NCT02595723|463938010|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
128903235|NCT02595723|463938008|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
128903236|NCT02595723|463938009|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
128903237|NCT02595723|463938010|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
128903238|NCT04839380|463938011|FG000|Overall Study|Withdrawal by Subject|2|||
128903239|NCT04839380|463938011|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
128903240|NCT01347554|463938012|FG000|Overall Study|Lack of Efficacy|7|||
128903241|NCT01347554|463938013|FG001|Overall Study|Lack of Efficacy|11|||
128903242|NCT00004259|463938015|FG000|Overall Study|Protocol Violation|1|||
128903243|NCT00004259|463938016|FG001|Overall Study|Protocol Violation|2|||
128903244|NCT00004259|463938017|FG002|Overall Study|Protocol Violation|0|||
128903245|NCT00004259|463938018|FG003|Overall Study|Protocol Violation|0|||
128903246|NCT00004259|463938015|FG000|Overall Study|Withdrawal by Subject|0|||
128903247|NCT00004259|463938016|FG001|Overall Study|Withdrawal by Subject|2|||
128903248|NCT00004259|463938017|FG002|Overall Study|Withdrawal by Subject|0|||
128903249|NCT00004259|463938018|FG003|Overall Study|Withdrawal by Subject|0|||
128903250|NCT00996944|463938019|FG000|Double-blind Treatment Period|Adverse Event|2|||
129115102|NCT01103323|464716913|FG000|Without/Before Drug Switch|Physician Decision|2|||
129115103|NCT01103323|464716914|FG001|Without/Before Drug Switch|Physician Decision|0|||
129115104|NCT01103323|464716913|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
128903251|NCT00996944|463938020|FG001|Double-blind Treatment Period|Adverse Event|1|||
129115105|NCT01103323|464716914|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
128693963|NCT01441180|463177817|FG001|Overall Study|Lost to Follow-up|1|||
128693964|NCT01441180|463177818|FG002|Overall Study|Lost to Follow-up|1|||
128903252|NCT00996944|463938019|FG000|Double-blind Treatment Period|Protocol Violation|1|||
128903253|NCT00996944|463938020|FG001|Double-blind Treatment Period|Protocol Violation|0|||
128903254|NCT00996944|463938019|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
128903255|NCT00996944|463938020|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
128903256|NCT00996944|463938019|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
128903257|NCT00996944|463938020|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
128903258|NCT00996944|463938019|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
128903259|NCT00996944|463938020|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
128693965|NCT01441180|463177816|FG000|Overall Study|Discontinued|0|||
128693966|NCT01441180|463177817|FG001|Overall Study|Discontinued|0|||
128693967|NCT01441180|463177818|FG002|Overall Study|Discontinued|2|||
128693968|NCT01402011|463177823|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
128693969|NCT01402011|463177824|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
128693970|NCT01402011|463177825|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
128693971|NCT01402011|463177823|FG000|Active Treatment Period|Withdrawal by Subject|1|||
128693972|NCT01402011|463177824|FG001|Active Treatment Period|Withdrawal by Subject|3|||
128693973|NCT01402011|463177825|FG002|Active Treatment Period|Withdrawal by Subject|0|||
128693974|NCT01402011|463177823|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
128693975|NCT01402011|463177824|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
128693976|NCT01402011|463177825|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
128693977|NCT02569671|463177827|FG000|Overall Study|Lost to Follow-up|2|||
128693978|NCT02569671|463177828|FG001|Overall Study|Lost to Follow-up|1|||
128693979|NCT02569671|463177827|FG000|Overall Study|Withdrawal by Subject|1|||
128693980|NCT02569671|463177828|FG001|Overall Study|Withdrawal by Subject|3|||
128693981|NCT02612129|463177829|FG000|Single Dose Treatment Period|Screening Failure|1|||
128693982|NCT02612129|463177830|FG001|Single Dose Treatment Period|Screening Failure|0|||
128693983|NCT02612129|463177831|FG002|Single Dose Treatment Period|Screening Failure|0|||
128693984|NCT02612129|463177829|FG000|Continuous Treatment Period|Early Escape|0|||
128693985|NCT02612129|463177830|FG001|Continuous Treatment Period|Early Escape|2|||
128693986|NCT02612129|463177831|FG002|Continuous Treatment Period|Early Escape|0|||
128693987|NCT02612129|463177829|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
128693988|NCT02612129|463177830|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
128693989|NCT02612129|463177831|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
128693990|NCT02612129|463177829|FG000|Continuous Treatment Period|Safety Reasons|0|||
128693991|NCT02612129|463177830|FG001|Continuous Treatment Period|Safety Reasons|3|||
128693992|NCT02612129|463177831|FG002|Continuous Treatment Period|Safety Reasons|0|||
128693993|NCT02612129|463177829|FG000|Continuous Treatment Period|Death|0|||
128693994|NCT02612129|463177830|FG001|Continuous Treatment Period|Death|1|||
128693995|NCT02612129|463177831|FG002|Continuous Treatment Period|Death|0|||
128693996|NCT02612129|463177829|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
128693997|NCT02612129|463177830|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
128693998|NCT02612129|463177831|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
128693999|NCT03487549|463177832|FG000|Overall Study|Protocol Violation|0|||
128694000|NCT03487549|463177833|FG001|Overall Study|Protocol Violation|1|||
128694001|NCT03487549|463177832|FG000|Overall Study|Lost to Follow-up|2|||
128694002|NCT03487549|463177833|FG001|Overall Study|Lost to Follow-up|1|||
128694003|NCT03487549|463177832|FG000|Overall Study|Withdrawal by Subject|2|||
128694004|NCT03487549|463177833|FG001|Overall Study|Withdrawal by Subject|0|||
128694005|NCT06238362|463177834|FG000|Overall Study|Insufficient total sleep time|1|||
128694006|NCT06238362|463177835|FG001|Overall Study|Insufficient total sleep time|0|||
128694007|NCT06238362|463177834|FG000|Overall Study|Inadequate signal quality|1|||
128694008|NCT06238362|463177835|FG001|Overall Study|Inadequate signal quality|0|||
128694009|NCT05136690|463177836|FG000|Period 1|Withdrawal by Subject|0|||
128694010|NCT05136690|463177837|FG001|Period 1|Withdrawal by Subject|1|||
128694011|NCT05136690|463177836|FG000|Period 2|Lost to Follow-up|0|||
129025380|NCT02923349|464385631|FG000|Overall Study|Withdrawal by Subject|2|||
129025381|NCT02923349|464385632|FG001|Overall Study|Withdrawal by Subject|2|||
129025382|NCT02923349|464385633|FG002|Overall Study|Withdrawal by Subject|8|||
129025383|NCT02923349|464385634|FG003|Overall Study|Withdrawal by Subject|10|||
129025384|NCT02923349|464385635|FG004|Overall Study|Withdrawal by Subject|12|||
128694012|NCT05136690|463177837|FG001|Period 2|Lost to Follow-up|3|||
128694013|NCT05136690|463177836|FG000|Period 2|Withdrawal by Subject|0|||
128694014|NCT05136690|463177837|FG001|Period 2|Withdrawal by Subject|1|||
128694015|NCT01543698|463180414|FG000|Phase 1b|Disease progression|2|||
128694016|NCT01543698|463180415|FG001|Phase 1b|Disease progression|4|||
128694017|NCT01543698|463180416|FG002|Phase 1b|Disease progression|3|||
128694018|NCT01543698|463180417|FG003|Phase 1b|Disease progression|2|||
128694019|NCT01543698|463180418|FG004|Phase 1b|Disease progression|10|||
129025385|NCT02923349|464385636|FG005|Overall Study|Withdrawal by Subject|3|||
129025386|NCT02923349|464385637|FG006|Overall Study|Withdrawal by Subject|0|||
129025387|NCT02923349|464385631|FG000|Overall Study|Physician Decision|0|||
128694020|NCT01543698|463180419|FG005|Phase 1b|Disease progression|6|||
128694021|NCT01543698|463180420|FG006|Phase 1b|Disease progression|5|||
129025388|NCT02923349|464385632|FG001|Overall Study|Physician Decision|0|||
129025389|NCT02923349|464385633|FG002|Overall Study|Physician Decision|0|||
129115106|NCT01103323|464716913|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
128694022|NCT01543698|463180421|FG007|Phase 1b|Disease progression|3|||
128694023|NCT01543698|463180422|FG008|Phase 1b|Disease progression|4|||
128694024|NCT01543698|463180423|FG009|Phase 1b|Disease progression|5|||
128694025|NCT01543698|463180424|FG010|Phase 1b|Disease progression|1|||
128903260|NCT00769184|463938021|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
128903261|NCT00769184|463938022|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
128903262|NCT00769184|463938021|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
128903263|NCT00769184|463938022|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
128903264|NCT00769184|463938021|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
128903265|NCT00769184|463938022|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
128903266|NCT00385255|463938023|FG000|Overall Study|Serious Adverse Event|1|||
128903267|NCT00385255|463938024|FG001|Overall Study|Serious Adverse Event|2|||
128903268|NCT00385255|463938023|FG000|Overall Study|Protocol Violation|0|||
128903269|NCT00385255|463938024|FG001|Overall Study|Protocol Violation|4|||
128903270|NCT00385255|463938023|FG000|Overall Study|Withdrawal by Subject|0|||
128903271|NCT00385255|463938024|FG001|Overall Study|Withdrawal by Subject|8|||
128903272|NCT00385255|463938023|FG000|Overall Study|Migrated/moved from study area|0|||
128903273|NCT00385255|463938024|FG001|Overall Study|Migrated/moved from study area|1|||
128903274|NCT00385255|463938023|FG000|Overall Study|Lost to Follow-up|20|||
128903275|NCT00385255|463938024|FG001|Overall Study|Lost to Follow-up|58|||
128903276|NCT02443883|463938025|FG000|Overall Study|Adverse Event|0|||
128903277|NCT02443883|463938026|FG001|Overall Study|Adverse Event|1|||
128903278|NCT02443883|463938027|FG002|Overall Study|Adverse Event|0|||
128903279|NCT02443883|463938028|FG003|Overall Study|Adverse Event|0|||
128903280|NCT02443883|463938025|FG000|Overall Study|Lost to Follow-up|3|||
128903281|NCT02443883|463938026|FG001|Overall Study|Lost to Follow-up|2|||
128903282|NCT02443883|463938027|FG002|Overall Study|Lost to Follow-up|1|||
128903283|NCT02443883|463938028|FG003|Overall Study|Lost to Follow-up|0|||
128903284|NCT02443883|463938025|FG000|Overall Study|Physician Decision|1|||
129115107|NCT01103323|464716914|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
129115108|NCT01103323|464716913|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
128903285|NCT02443883|463938026|FG001|Overall Study|Physician Decision|1|||
128903286|NCT02443883|463938027|FG002|Overall Study|Physician Decision|0|||
128903287|NCT02443883|463938028|FG003|Overall Study|Physician Decision|3|||
128903288|NCT02443883|463938025|FG000|Overall Study|Withdrawal by Subject|1|||
128903289|NCT02443883|463938026|FG001|Overall Study|Withdrawal by Subject|0|||
129115109|NCT01103323|464716914|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
129115110|NCT03160716|464716915|FG000|Overall Study|Lost to Follow-up|1|||
129115111|NCT00875810|464716919|FG000|Overall Study|Withdrawal by Subject|1|||
129115112|NCT00875810|464716919|FG000|Overall Study|Physician Decision|3|||
129115113|NCT00875810|464716919|FG000|Overall Study|Lost to Follow-up|39|||
129115114|NCT00875810|464716919|FG000|Overall Study|Patient enroled but not implanted|2|||
129115115|NCT00875810|464716919|FG000|Overall Study|Device explanted|1|||
129115116|NCT00780975|464716922|FG000|Overall Study|Progressive disease|3|||
129115117|NCT00780975|464716922|FG000|Overall Study|Toxicity|5|||
128903290|NCT02443883|463938027|FG002|Overall Study|Withdrawal by Subject|0|||
128903291|NCT02443883|463938028|FG003|Overall Study|Withdrawal by Subject|2|||
128903292|NCT02443883|463938025|FG000|Overall Study|Randomized, but never treated|1|||
128903293|NCT02443883|463938026|FG001|Overall Study|Randomized, but never treated|0|||
128903294|NCT02443883|463938027|FG002|Overall Study|Randomized, but never treated|0|||
129115118|NCT01939314|464716923|FG000|Overall Study|Withdrawal by Subject|3|||
129115119|NCT01939314|464716924|FG001|Overall Study|Withdrawal by Subject|1|||
129115120|NCT01939314|464716923|FG000|Overall Study|Protocol Violation|1|||
129115121|NCT01939314|464716924|FG001|Overall Study|Protocol Violation|0|||
129115122|NCT01939314|464716923|FG000|Overall Study|Pregnancy|0|||
129115123|NCT01939314|464716924|FG001|Overall Study|Pregnancy|1|||
129115124|NCT01939314|464716923|FG000|Overall Study|Lost to Follow-up|5|||
128903295|NCT02443883|463938028|FG003|Overall Study|Randomized, but never treated|0|||
128903296|NCT00205855|463938044|FG000|Overall Study|Only received temporary implants|16|||
129025390|NCT02923349|464385634|FG003|Overall Study|Physician Decision|1|||
129025391|NCT02923349|464385635|FG004|Overall Study|Physician Decision|1|||
129025392|NCT02923349|464385636|FG005|Overall Study|Physician Decision|0|||
129025393|NCT02923349|464385637|FG006|Overall Study|Physician Decision|2|||
129025394|NCT02923349|464385631|FG000|Overall Study|Lost to Follow-up|0|||
129025395|NCT02923349|464385632|FG001|Overall Study|Lost to Follow-up|0|||
129025396|NCT02923349|464385633|FG002|Overall Study|Lost to Follow-up|3|||
129115125|NCT01939314|464716924|FG001|Overall Study|Lost to Follow-up|6|||
128903297|NCT00205855|463938044|FG000|Overall Study|Withdrawal by Subject|5|||
128903298|NCT00506883|463938045|FG000|Overall Study|Lost to Follow-up|1|||
129115126|NCT00969228|464716928|FG000|Overall Study|Adverse Event|1|||
128694026|NCT01543698|463180425|FG011|Phase 1b|Disease progression|0|||
128694027|NCT01543698|463180426|FG012|Phase 1b|Disease progression|0|||
128903299|NCT00506883|463938046|FG001|Overall Study|Lost to Follow-up|1|||
128903300|NCT00506883|463938047|FG002|Overall Study|Lost to Follow-up|1|||
129025397|NCT02923349|464385634|FG003|Overall Study|Lost to Follow-up|0|||
128903301|NCT00506883|463938045|FG000|Overall Study|Withdrawal by Subject|1|||
129115127|NCT00969228|464716929|FG001|Overall Study|Adverse Event|0|||
129115128|NCT00969228|464716928|FG000|Overall Study|Withdrawal by Subject|4|||
129025398|NCT02923349|464385635|FG004|Overall Study|Lost to Follow-up|1|||
128694028|NCT01543698|463180427|FG013|Phase 1b|Disease progression|0|||
129115129|NCT00969228|464716929|FG001|Overall Study|Withdrawal by Subject|0|||
129115130|NCT00969228|464716928|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
129115131|NCT00969228|464716929|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
129115132|NCT02563899|464716930|FG000|Overall Study|Protocol Violation|1|||
129115133|NCT02563899|464716931|FG001|Overall Study|Protocol Violation|0|||
129115134|NCT02563899|464716932|FG002|Overall Study|Protocol Violation|0|||
128694029|NCT01543698|463180428|FG014|Phase 1b|Disease progression|0|||
128694030|NCT01543698|463180414|FG000|Phase 1b|Death|0|||
128694031|NCT01543698|463180415|FG001|Phase 1b|Death|0|||
128694032|NCT01543698|463180416|FG002|Phase 1b|Death|1|||
128694033|NCT01543698|463180417|FG003|Phase 1b|Death|1|||
128694034|NCT01543698|463180418|FG004|Phase 1b|Death|0|||
128694035|NCT01543698|463180419|FG005|Phase 1b|Death|0|||
128694036|NCT01543698|463180420|FG006|Phase 1b|Death|0|||
128694037|NCT01543698|463180421|FG007|Phase 1b|Death|0|||
128694038|NCT01543698|463180422|FG008|Phase 1b|Death|0|||
128694039|NCT01543698|463180423|FG009|Phase 1b|Death|0|||
128694040|NCT01543698|463180424|FG010|Phase 1b|Death|1|||
128903302|NCT00506883|463938046|FG001|Overall Study|Withdrawal by Subject|0|||
128903303|NCT00506883|463938047|FG002|Overall Study|Withdrawal by Subject|1|||
128903304|NCT00506883|463938045|FG000|Overall Study|Lack of Efficacy|0|||
128903305|NCT00506883|463938046|FG001|Overall Study|Lack of Efficacy|1|||
128903306|NCT00506883|463938047|FG002|Overall Study|Lack of Efficacy|1|||
128903307|NCT00506883|463938045|FG000|Overall Study|Other|5|||
128903308|NCT00506883|463938046|FG001|Overall Study|Other|1|||
128903309|NCT00506883|463938047|FG002|Overall Study|Other|1|||
128903310|NCT01445951|463938048|FG000|Overall Study|Adverse Event|16|||
128903311|NCT01445951|463938049|FG001|Overall Study|Adverse Event|9|||
128903312|NCT01445951|463938050|FG002|Overall Study|Adverse Event|0|||
128903313|NCT01445951|463938048|FG000|Overall Study|Protocol Violation|2|||
128903314|NCT01445951|463938049|FG001|Overall Study|Protocol Violation|2|||
128903315|NCT01445951|463938050|FG002|Overall Study|Protocol Violation|2|||
128903316|NCT01445951|463938048|FG000|Overall Study|Withdrawal by Subject|21|||
128903317|NCT01445951|463938049|FG001|Overall Study|Withdrawal by Subject|16|||
128903318|NCT01445951|463938050|FG002|Overall Study|Withdrawal by Subject|8|||
128903319|NCT01445951|463938048|FG000|Overall Study|Physician Decision|3|||
128903320|NCT01445951|463938049|FG001|Overall Study|Physician Decision|1|||
129115135|NCT02563899|464716933|FG003|Overall Study|Protocol Violation|0|||
129115136|NCT02563899|464716930|FG000|Overall Study|Withdrawal by Subject|0|||
129115137|NCT02563899|464716931|FG001|Overall Study|Withdrawal by Subject|0|||
129115138|NCT02563899|464716932|FG002|Overall Study|Withdrawal by Subject|1|||
129115139|NCT02563899|464716933|FG003|Overall Study|Withdrawal by Subject|0|||
129115140|NCT00794664|464716934|FG000|Treatment Period|Withdrawal by Subject|0|||
129115141|NCT00794664|464716935|FG001|Treatment Period|Withdrawal by Subject|2|||
129115142|NCT00794664|464716934|FG000|Treatment Period|Protocol non-compliance|0|||
129115143|NCT00794664|464716935|FG001|Treatment Period|Protocol non-compliance|1|||
128694041|NCT01543698|463180425|FG011|Phase 1b|Death|0|||
128694042|NCT01543698|463180426|FG012|Phase 1b|Death|0|||
128694043|NCT01543698|463180427|FG013|Phase 1b|Death|0|||
128694044|NCT01543698|463180428|FG014|Phase 1b|Death|0|||
128694045|NCT01543698|463180414|FG000|Phase 1b|Withdrawal by Subject|0|||
128694046|NCT01543698|463180415|FG001|Phase 1b|Withdrawal by Subject|1|||
128903321|NCT01445951|463938050|FG002|Overall Study|Physician Decision|0|||
128903322|NCT01445951|463938048|FG000|Overall Study|Lost to Follow-up|1|||
129025399|NCT02923349|464385636|FG005|Overall Study|Lost to Follow-up|1|||
129025400|NCT02923349|464385637|FG006|Overall Study|Lost to Follow-up|0|||
129025401|NCT02923349|464385631|FG000|Overall Study|Death|1|||
129025402|NCT02923349|464385632|FG001|Overall Study|Death|0|||
129025403|NCT02923349|464385633|FG002|Overall Study|Death|2|||
129025404|NCT02923349|464385634|FG003|Overall Study|Death|4|||
129025405|NCT02923349|464385635|FG004|Overall Study|Death|2|||
129025406|NCT02923349|464385636|FG005|Overall Study|Death|3|||
128694047|NCT01543698|463180416|FG002|Phase 1b|Withdrawal by Subject|0|||
128694048|NCT01543698|463180417|FG003|Phase 1b|Withdrawal by Subject|1|||
128903323|NCT01445951|463938049|FG001|Overall Study|Lost to Follow-up|2|||
128694049|NCT01543698|463180418|FG004|Phase 1b|Withdrawal by Subject|0|||
128694050|NCT01543698|463180419|FG005|Phase 1b|Withdrawal by Subject|0|||
128694051|NCT01543698|463180420|FG006|Phase 1b|Withdrawal by Subject|1|||
128694052|NCT01543698|463180421|FG007|Phase 1b|Withdrawal by Subject|0|||
128694053|NCT01543698|463180422|FG008|Phase 1b|Withdrawal by Subject|0|||
128694054|NCT01543698|463180423|FG009|Phase 1b|Withdrawal by Subject|0|||
128903324|NCT01445951|463938050|FG002|Overall Study|Lost to Follow-up|4|||
128694055|NCT01543698|463180424|FG010|Phase 1b|Withdrawal by Subject|0|||
128903325|NCT01445951|463938048|FG000|Overall Study|Pregnancy|0|||
128903326|NCT01445951|463938049|FG001|Overall Study|Pregnancy|1|||
128903327|NCT01445951|463938050|FG002|Overall Study|Pregnancy|4|||
129025407|NCT02923349|464385637|FG006|Overall Study|Death|0|||
128694056|NCT01543698|463180425|FG011|Phase 1b|Withdrawal by Subject|0|||
128694057|NCT01543698|463180426|FG012|Phase 1b|Withdrawal by Subject|0|||
128694058|NCT01543698|463180427|FG013|Phase 1b|Withdrawal by Subject|0|||
128694059|NCT01543698|463180428|FG014|Phase 1b|Withdrawal by Subject|0|||
128903328|NCT01445951|463938048|FG000|Overall Study|Death|0|||
129025408|NCT04063878|464385640|FG000|Overall Study|Withdrawal by Subject|2|||
129025409|NCT04063878|464385640|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
128694060|NCT01543698|463180414|FG000|Phase 1b|Adverse Event|1|||
128694061|NCT01543698|463180415|FG001|Phase 1b|Adverse Event|0|||
128694062|NCT01543698|463180416|FG002|Phase 1b|Adverse Event|0|||
128694063|NCT01543698|463180417|FG003|Phase 1b|Adverse Event|1|||
128694064|NCT01543698|463180418|FG004|Phase 1b|Adverse Event|2|||
128694065|NCT01543698|463180419|FG005|Phase 1b|Adverse Event|2|||
128694066|NCT01543698|463180420|FG006|Phase 1b|Adverse Event|0|||
129025410|NCT02751827|464385641|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
129025411|NCT02751827|464385642|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
129025412|NCT02751827|464385643|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
129025413|NCT01248728|464385644|FG000|Overall Study|Adverse Event|1|||
129025414|NCT01248728|464385645|FG001|Overall Study|Adverse Event|1|||
129025415|NCT01248728|464385644|FG000|Overall Study|Withdrawal by Subject|2|||
129025416|NCT01248728|464385645|FG001|Overall Study|Withdrawal by Subject|1|||
129025417|NCT01248728|464385644|FG000|Overall Study|Lack of Efficacy|1|||
129025418|NCT01248728|464385645|FG001|Overall Study|Lack of Efficacy|0|||
129025419|NCT00147498|464385646|FG000|Overall Study|Adverse Event|1|||
129025420|NCT00147498|464385647|FG001|Overall Study|Adverse Event|6|||
129025421|NCT00147498|464385648|FG002|Overall Study|Adverse Event|7|||
129025422|NCT00147498|464385649|FG003|Overall Study|Adverse Event|3|||
129025423|NCT00147498|464385646|FG000|Overall Study|Lack of Efficacy|1|||
129025424|NCT00147498|464385647|FG001|Overall Study|Lack of Efficacy|1|||
129025425|NCT00147498|464385648|FG002|Overall Study|Lack of Efficacy|1|||
129025426|NCT00147498|464385649|FG003|Overall Study|Lack of Efficacy|8|||
129025427|NCT00147498|464385646|FG000|Overall Study|Laboratory abnormality|0|||
129025428|NCT00147498|464385647|FG001|Overall Study|Laboratory abnormality|0|||
129025429|NCT00147498|464385648|FG002|Overall Study|Laboratory abnormality|2|||
129025430|NCT00147498|464385649|FG003|Overall Study|Laboratory abnormality|0|||
129025431|NCT00147498|464385646|FG000|Overall Study|Participant defaulted|0|||
129025432|NCT00147498|464385647|FG001|Overall Study|Participant defaulted|1|||
129025433|NCT00147498|464385648|FG002|Overall Study|Participant defaulted|4|||
129025434|NCT00147498|464385649|FG003|Overall Study|Participant defaulted|3|||
129025435|NCT00147498|464385646|FG000|Overall Study|Other|1|||
129025436|NCT00147498|464385647|FG001|Overall Study|Other|1|||
129025437|NCT00147498|464385648|FG002|Overall Study|Other|3|||
129025438|NCT00147498|464385649|FG003|Overall Study|Other|3|||
129025439|NCT01229150|464385652|FG000|Overall Study|Toxicity|2|||
129025440|NCT01229150|464385653|FG001|Overall Study|Toxicity|2|||
129025441|NCT01229150|464385654|FG002|Overall Study|Toxicity|0|||
129025442|NCT01229150|464385655|FG003|Overall Study|Toxicity|0|||
129025443|NCT00902538|464385656|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
129025444|NCT00902538|464385657|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129025445|NCT00902538|464385658|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129025446|NCT00902538|464385659|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129025447|NCT00902538|464385660|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129025448|NCT00902538|464385661|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129025449|NCT00902538|464385656|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
129025450|NCT00902538|464385657|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129025451|NCT00902538|464385658|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129025452|NCT00902538|464385659|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129025453|NCT00902538|464385660|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129025454|NCT00902538|464385661|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129025455|NCT00902538|464385656|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
129025456|NCT00902538|464385657|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129025457|NCT00902538|464385658|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129025458|NCT00902538|464385659|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129025459|NCT00902538|464385660|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129025460|NCT00902538|464385661|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129025461|NCT00902538|464385656|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
129025462|NCT00902538|464385657|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129115144|NCT00794664|464716934|FG000|Treatment Period|Other|0|||
129115145|NCT00794664|464716935|FG001|Treatment Period|Other|1|||
129025463|NCT00902538|464385658|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129025464|NCT00902538|464385659|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129025465|NCT00902538|464385660|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129025466|NCT00902538|464385661|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129115146|NCT00794664|464716934|FG000|Treatment Period|Adverse Event|1|||
129025467|NCT00902538|464385656|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
129025468|NCT00902538|464385657|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
128694067|NCT01543698|463180421|FG007|Phase 1b|Adverse Event|0|||
128694068|NCT01543698|463180422|FG008|Phase 1b|Adverse Event|1|||
128694069|NCT01543698|463180423|FG009|Phase 1b|Adverse Event|1|||
128694070|NCT01543698|463180424|FG010|Phase 1b|Adverse Event|2|||
128694071|NCT01543698|463180425|FG011|Phase 1b|Adverse Event|0|||
128694072|NCT01543698|463180426|FG012|Phase 1b|Adverse Event|0|||
128694073|NCT01543698|463180427|FG013|Phase 1b|Adverse Event|0|||
128694074|NCT01543698|463180428|FG014|Phase 1b|Adverse Event|0|||
129115147|NCT00794664|464716935|FG001|Treatment Period|Adverse Event|8|||
129115148|NCT00794664|464716934|FG000|Follow-up Period|Other|1|||
129115149|NCT00794664|464716935|FG001|Follow-up Period|Other|2|||
129115150|NCT00794664|464716934|FG000|Follow-up Period|Withdrawal by Subject|0|||
129115151|NCT00794664|464716935|FG001|Follow-up Period|Withdrawal by Subject|2|||
129115152|NCT00794664|464716934|FG000|Follow-up Period|Protocol non-compliance|0|||
129115153|NCT00794664|464716935|FG001|Follow-up Period|Protocol non-compliance|1|||
129115154|NCT01305564|464716938|FG000|Overall Study|Death|21|||
129115155|NCT01305564|464716938|FG000|Overall Study|Lost to Follow-up|12|||
129115156|NCT01305564|464716938|FG000|Overall Study|Withdrawal by Subject|1|||
129115157|NCT01305564|464716938|FG000|Overall Study|Physician Decision|3|||
129115158|NCT01655901|464719662|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129115159|NCT01655901|464719663|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129115160|NCT01655901|464719664|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129115161|NCT01655901|464719665|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
129115162|NCT01655901|464719666|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129115163|NCT01655901|464719667|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
129115164|NCT00922636|464719670|FG000|Overall Study|Adverse Event|3|||
129115165|NCT00922636|464719671|FG001|Overall Study|Adverse Event|3|||
129115166|NCT00922636|464719672|FG002|Overall Study|Adverse Event|2|||
128694075|NCT01543698|463180414|FG000|Phase 1b|Administrative problems|1|||
128694076|NCT01543698|463180415|FG001|Phase 1b|Administrative problems|0|||
128694077|NCT01543698|463180416|FG002|Phase 1b|Administrative problems|0|||
129115167|NCT00922636|464719673|FG003|Overall Study|Adverse Event|3|||
129115168|NCT00922636|464719674|FG004|Overall Study|Adverse Event|2|||
129115169|NCT00922636|464719670|FG000|Overall Study|Lack of Efficacy|1|||
129115170|NCT00922636|464719671|FG001|Overall Study|Lack of Efficacy|7|||
129115171|NCT00922636|464719672|FG002|Overall Study|Lack of Efficacy|3|||
129115172|NCT00922636|464719673|FG003|Overall Study|Lack of Efficacy|2|||
129115173|NCT00922636|464719674|FG004|Overall Study|Lack of Efficacy|4|||
129115174|NCT00922636|464719670|FG000|Overall Study|Sponsor Decision|0|||
129115175|NCT00922636|464719671|FG001|Overall Study|Sponsor Decision|0|||
129115176|NCT00922636|464719672|FG002|Overall Study|Sponsor Decision|2|||
129115177|NCT00922636|464719673|FG003|Overall Study|Sponsor Decision|0|||
129115178|NCT00922636|464719674|FG004|Overall Study|Sponsor Decision|0|||
129115179|NCT00922636|464719670|FG000|Overall Study|Withdrawal by Subject|0|||
129115180|NCT00922636|464719671|FG001|Overall Study|Withdrawal by Subject|0|||
129115181|NCT00922636|464719672|FG002|Overall Study|Withdrawal by Subject|5|||
129115182|NCT00922636|464719673|FG003|Overall Study|Withdrawal by Subject|2|||
129115183|NCT00922636|464719674|FG004|Overall Study|Withdrawal by Subject|4|||
129115184|NCT00922636|464719670|FG000|Overall Study|Protocol Violation|0|||
129115185|NCT00922636|464719671|FG001|Overall Study|Protocol Violation|0|||
129115186|NCT00922636|464719672|FG002|Overall Study|Protocol Violation|2|||
129115187|NCT00922636|464719673|FG003|Overall Study|Protocol Violation|2|||
129115188|NCT00922636|464719674|FG004|Overall Study|Protocol Violation|0|||
129115189|NCT00922636|464719670|FG000|Overall Study|Entry Criteria Not Met|0|||
129115190|NCT00922636|464719671|FG001|Overall Study|Entry Criteria Not Met|0|||
129115191|NCT00922636|464719672|FG002|Overall Study|Entry Criteria Not Met|1|||
129115192|NCT00922636|464719673|FG003|Overall Study|Entry Criteria Not Met|1|||
129115193|NCT00922636|464719674|FG004|Overall Study|Entry Criteria Not Met|0|||
129115194|NCT00922636|464719670|FG000|Overall Study|Parent/Caregiver Decision|2|||
129115195|NCT00922636|464719671|FG001|Overall Study|Parent/Caregiver Decision|4|||
129115196|NCT00922636|464719672|FG002|Overall Study|Parent/Caregiver Decision|3|||
129115197|NCT00922636|464719673|FG003|Overall Study|Parent/Caregiver Decision|5|||
129115198|NCT00922636|464719674|FG004|Overall Study|Parent/Caregiver Decision|2|||
129115199|NCT00922636|464719670|FG000|Overall Study|Lost to Follow-up|1|||
129115200|NCT00922636|464719671|FG001|Overall Study|Lost to Follow-up|2|||
128694078|NCT01543698|463180417|FG003|Phase 1b|Administrative problems|0|||
129115201|NCT00922636|464719672|FG002|Overall Study|Lost to Follow-up|2|||
129115202|NCT00922636|464719673|FG003|Overall Study|Lost to Follow-up|2|||
128694079|NCT01543698|463180418|FG004|Phase 1b|Administrative problems|1|||
129115203|NCT00922636|464719674|FG004|Overall Study|Lost to Follow-up|4|||
129115204|NCT04969289|464719675|FG000|Overall Study|Lost to Follow-up|13|||
129115205|NCT04969289|464719676|FG001|Overall Study|Lost to Follow-up|9|||
129115206|NCT00557466|464719677|FG000|Overall Study|Adverse Event|3|||
129115207|NCT00557466|464719678|FG001|Overall Study|Adverse Event|1|||
129115208|NCT00557466|464719679|FG002|Overall Study|Adverse Event|4|||
128694080|NCT01543698|463180419|FG005|Phase 1b|Administrative problems|0|||
128694081|NCT01543698|463180420|FG006|Phase 1b|Administrative problems|0|||
128694082|NCT01543698|463180421|FG007|Phase 1b|Administrative problems|1|||
128694083|NCT01543698|463180422|FG008|Phase 1b|Administrative problems|0|||
128694084|NCT01543698|463180423|FG009|Phase 1b|Administrative problems|0|||
128694085|NCT01543698|463180424|FG010|Phase 1b|Administrative problems|2|||
128694086|NCT01543698|463180425|FG011|Phase 1b|Administrative problems|0|||
129115209|NCT00557466|464719680|FG003|Overall Study|Adverse Event|1|||
129115210|NCT00557466|464719681|FG004|Overall Study|Adverse Event|2|||
129115211|NCT00557466|464719682|FG005|Overall Study|Adverse Event|4|||
129115212|NCT00557466|464719677|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129115213|NCT00557466|464719678|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129115214|NCT00557466|464719679|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129115215|NCT00557466|464719680|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129115216|NCT00557466|464719681|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129115217|NCT00557466|464719682|FG005|Overall Study|Abnormal laboratory value(s)|0|||
129115218|NCT00557466|464719677|FG000|Overall Study|Protocol deviation|0|||
129115219|NCT00557466|464719678|FG001|Overall Study|Protocol deviation|1|||
129115220|NCT00557466|464719679|FG002|Overall Study|Protocol deviation|0|||
129115221|NCT00557466|464719680|FG003|Overall Study|Protocol deviation|2|||
129115222|NCT00557466|464719681|FG004|Overall Study|Protocol deviation|0|||
129115223|NCT00557466|464719682|FG005|Overall Study|Protocol deviation|0|||
129115224|NCT00557466|464719677|FG000|Overall Study|Subject withdrew consent|0|||
129115225|NCT00557466|464719678|FG001|Overall Study|Subject withdrew consent|0|||
129115226|NCT00557466|464719679|FG002|Overall Study|Subject withdrew consent|0|||
129115227|NCT00557466|464719680|FG003|Overall Study|Subject withdrew consent|0|||
129115228|NCT00557466|464719681|FG004|Overall Study|Subject withdrew consent|1|||
129115229|NCT00557466|464719682|FG005|Overall Study|Subject withdrew consent|2|||
129115230|NCT00557466|464719677|FG000|Overall Study|Administrative problems|0|||
129115231|NCT00557466|464719678|FG001|Overall Study|Administrative problems|1|||
129115232|NCT00557466|464719679|FG002|Overall Study|Administrative problems|1|||
129115233|NCT00557466|464719680|FG003|Overall Study|Administrative problems|0|||
129115234|NCT00557466|464719681|FG004|Overall Study|Administrative problems|0|||
129115235|NCT00557466|464719682|FG005|Overall Study|Administrative problems|0|||
129115236|NCT00557466|464719677|FG000|Overall Study|Abnormal test procedure results|0|||
129115237|NCT00557466|464719678|FG001|Overall Study|Abnormal test procedure results|0|||
129115238|NCT00557466|464719679|FG002|Overall Study|Abnormal test procedure results|1|||
129115239|NCT00557466|464719680|FG003|Overall Study|Abnormal test procedure results|0|||
129115240|NCT00557466|464719681|FG004|Overall Study|Abnormal test procedure results|0|||
129115241|NCT00557466|464719682|FG005|Overall Study|Abnormal test procedure results|0|||
129115242|NCT00557466|464719677|FG000|Overall Study|Lost to Follow-up|0|||
129115243|NCT00557466|464719678|FG001|Overall Study|Lost to Follow-up|0|||
129115244|NCT00557466|464719679|FG002|Overall Study|Lost to Follow-up|0|||
129115245|NCT00557466|464719680|FG003|Overall Study|Lost to Follow-up|1|||
129115246|NCT00557466|464719681|FG004|Overall Study|Lost to Follow-up|0|||
129115247|NCT00557466|464719682|FG005|Overall Study|Lost to Follow-up|0|||
129115248|NCT01251952|464719685|FG000|Overall Study|Adverse Event|1|||
129115249|NCT00496769|464719686|FG000|Double Blind|>=1 reason assigned per patient|558|||
129115250|NCT00496769|464719687|FG001|Double Blind|>=1 reason assigned per patient|649|||
129115251|NCT00496769|464719688|FG002|Double Blind|>=1 reason assigned per patient|0|||
129115252|NCT00496769|464719686|FG000|Open Label|>=1 reason assigned per patient|0|||
129115253|NCT00496769|464719687|FG001|Open Label|>=1 reason assigned per patient|0|||
129115254|NCT00496769|464719688|FG002|Open Label|>=1 reason assigned per patient|1011|||
129115255|NCT02486692|464719689|FG000|Overall Study|did not login for randomization|4|||
129115256|NCT02486692|464719690|FG001|Overall Study|did not login for randomization|7|||
129115257|NCT02224625|464719693|FG000|Irritation|Adverse Event|6|||
129115258|NCT02224625|464719693|FG000|Sensitization|Adverse Event|55|||
129115259|NCT02812186|464719694|FG000|Period 1|Post randomization screen failure|5|||
129115260|NCT02812186|464719695|FG001|Period 1|Post randomization screen failure|9|||
129115261|NCT02812186|464719694|FG000|Period 1|nonevaluable data sets|6|||
129115262|NCT02812186|464719695|FG001|Period 1|nonevaluable data sets|6|||
129115263|NCT01307787|464719698|FG000|Overall Study|Withdrawal by Subject|2|||
129115264|NCT01307787|464719699|FG001|Overall Study|Withdrawal by Subject|0|||
129115265|NCT01573000|464719700|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
129115266|NCT01573000|464719701|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
129115267|NCT01573000|464719700|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
129115268|NCT01573000|464719701|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
129115269|NCT01573000|464719700|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
129115270|NCT01573000|464719701|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
128694087|NCT01543698|463180426|FG012|Phase 1b|Administrative problems|0|||
128694088|NCT01543698|463180427|FG013|Phase 1b|Administrative problems|0|||
128694089|NCT01543698|463180428|FG014|Phase 1b|Administrative problems|0|||
128694090|NCT01543698|463180414|FG000|Phase 1b|Protocol Violation|2|||
128694091|NCT01543698|463180415|FG001|Phase 1b|Protocol Violation|0|||
129115271|NCT01573000|464719700|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
129115272|NCT01573000|464719701|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
129115273|NCT01573000|464719700|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
129115274|NCT01573000|464719701|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
129115275|NCT01573000|464719700|FG000|Crossover Phase|Lack of Efficacy|0|||
129115276|NCT01573000|464719701|FG001|Crossover Phase|Lack of Efficacy|13|||
128694092|NCT01543698|463180416|FG002|Phase 1b|Protocol Violation|0|||
128903329|NCT01445951|463938049|FG001|Overall Study|Death|0|||
128903330|NCT01445951|463938050|FG002|Overall Study|Death|1|||
128903331|NCT01445951|463938048|FG000|Overall Study|Non-compliance with study drug|1|||
128903332|NCT01445951|463938049|FG001|Overall Study|Non-compliance with study drug|2|||
128903333|NCT01445951|463938050|FG002|Overall Study|Non-compliance with study drug|0|||
128903334|NCT01445951|463938048|FG000|Overall Study|Non-compliance with protocol|0|||
128903335|NCT01445951|463938049|FG001|Overall Study|Non-compliance with protocol|1|||
128903336|NCT01445951|463938050|FG002|Overall Study|Non-compliance with protocol|0|||
128903337|NCT01445951|463938048|FG000|Overall Study|Sponsor decision - subject travel|0|||
128903338|NCT01445951|463938049|FG001|Overall Study|Sponsor decision - subject travel|1|||
128903339|NCT01445951|463938050|FG002|Overall Study|Sponsor decision - subject travel|0|||
128903340|NCT01445951|463938048|FG000|Overall Study|Cough|0|||
128903341|NCT01445951|463938049|FG001|Overall Study|Cough|1|||
128903342|NCT01445951|463938050|FG002|Overall Study|Cough|0|||
128903343|NCT03921424|463938058|FG000|Overall Study|Lost to Follow-up|0|||
128903344|NCT03921424|463938059|FG001|Overall Study|Lost to Follow-up|1|||
128903345|NCT03921424|463938058|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
128903346|NCT03921424|463938059|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
128903347|NCT02581202|463938062|FG000|Overall Study|Lack of Efficacy|2|||
128903348|NCT02581202|463938062|FG000|Overall Study|Withdrawal by Subject|4|||
128903349|NCT02581202|463938062|FG000|Overall Study|Lost to Follow-up|5|||
128903350|NCT02581202|463938062|FG000|Overall Study|Pregnancy|3|||
128903351|NCT01806779|463938066|FG000|Overall Study|Physician Decision|2|||
128903352|NCT01806779|463938067|FG001|Overall Study|Physician Decision|0|||
128903353|NCT01806779|463938068|FG002|Overall Study|Physician Decision|1|||
128903354|NCT01806779|463938066|FG000|Overall Study|Lack of Efficacy|1|||
128903355|NCT01806779|463938067|FG001|Overall Study|Lack of Efficacy|1|||
128903356|NCT01806779|463938068|FG002|Overall Study|Lack of Efficacy|0|||
128903357|NCT01806779|463938066|FG000|Overall Study|Lost to Follow-up|19|||
128903358|NCT01806779|463938067|FG001|Overall Study|Lost to Follow-up|20|||
128903359|NCT01806779|463938068|FG002|Overall Study|Lost to Follow-up|0|||
128903360|NCT01806779|463938066|FG000|Overall Study|Withdrawal by Subject|20|||
128903361|NCT01806779|463938067|FG001|Overall Study|Withdrawal by Subject|23|||
129025469|NCT00902538|464385658|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129025470|NCT00902538|464385659|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129025471|NCT00902538|464385660|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129025472|NCT00902538|464385661|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129025473|NCT00902538|464385656|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
129025474|NCT00902538|464385657|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
129025475|NCT00902538|464385658|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
129025476|NCT00902538|464385659|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
129025477|NCT00902538|464385660|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
129025478|NCT00902538|464385661|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
129025479|NCT00902538|464385656|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
129025480|NCT00902538|464385657|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
129025481|NCT00902538|464385658|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
129025482|NCT00902538|464385659|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
129025483|NCT00902538|464385660|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
129025484|NCT00902538|464385661|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
129025485|NCT00902538|464385656|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
129025486|NCT00902538|464385657|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129025487|NCT00902538|464385658|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
129025488|NCT00902538|464385659|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129025489|NCT00902538|464385660|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129025490|NCT00902538|464385661|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129025491|NCT00902538|464385656|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
129025492|NCT00902538|464385657|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
129025493|NCT00902538|464385658|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
129025494|NCT00902538|464385659|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
129025495|NCT00902538|464385660|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
129025496|NCT00902538|464385661|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
129025497|NCT00902538|464385656|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
129025498|NCT00902538|464385657|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
129025499|NCT00902538|464385658|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
129025500|NCT00902538|464385659|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
129025501|NCT00902538|464385660|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
129025502|NCT00902538|464385661|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
128903362|NCT01806779|463938068|FG002|Overall Study|Withdrawal by Subject|22|||
128903363|NCT05038020|463938069|FG000|Overall Study|Early Termination|3|||
128903364|NCT05038020|463938070|FG001|Overall Study|Early Termination|0|||
128903365|NCT04649255|463939863|FG000|Overall Study|Death|9|||
128903366|NCT04649255|463939863|FG000|Overall Study|Withdrawal by Subject|1|||
128903367|NCT04129528|463939864|FG000|Overall Study|Adverse Event|1|||
128903368|NCT04129528|463939865|FG001|Overall Study|Adverse Event|0|||
128903369|NCT04129528|463939864|FG000|Overall Study|Physician Decision|1|||
128903370|NCT04129528|463939865|FG001|Overall Study|Physician Decision|1|||
129025503|NCT00902538|464385656|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
129025504|NCT00902538|464385657|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
129025505|NCT00902538|464385658|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
129025506|NCT00902538|464385659|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
129025507|NCT00902538|464385660|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
129025508|NCT00902538|464385661|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
129025509|NCT00902538|464385656|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
129025510|NCT00902538|464385657|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
129025511|NCT00902538|464385658|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
129025512|NCT00902538|464385659|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
129025513|NCT00902538|464385660|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
129025514|NCT00902538|464385661|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
129025515|NCT00902538|464385656|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129025516|NCT00902538|464385657|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
129025517|NCT00902538|464385658|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129025518|NCT00902538|464385659|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129025519|NCT00902538|464385660|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129025520|NCT00902538|464385661|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129025521|NCT00902538|464385656|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129025522|NCT00902538|464385657|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
129025523|NCT00902538|464385658|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129025524|NCT00902538|464385659|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129025525|NCT00902538|464385660|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129025526|NCT00902538|464385661|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129025527|NCT00902538|464385656|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
129025528|NCT00902538|464385657|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
129025529|NCT00902538|464385658|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
129025530|NCT00902538|464385659|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
129025531|NCT00902538|464385660|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
129025532|NCT00902538|464385661|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
129025533|NCT00902538|464385656|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129025534|NCT00902538|464385657|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129025535|NCT00902538|464385658|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129025536|NCT00902538|464385659|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
129025537|NCT00902538|464385660|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
129025538|NCT00902538|464385661|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129025539|NCT00902538|464385656|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129025540|NCT00902538|464385657|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129025541|NCT00902538|464385658|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129025542|NCT00902538|464385659|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
129025543|NCT00902538|464385660|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129025544|NCT00902538|464385661|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129025545|NCT03531827|464385662|FG000|Overall Study|Adverse Event|2|||
129025546|NCT03531827|464385663|FG001|Overall Study|Adverse Event|0|||
129025547|NCT03531827|464385662|FG000|Overall Study|Progressive disease|1|||
129025548|NCT03531827|464385663|FG001|Overall Study|Progressive disease|0|||
129025549|NCT03578809|464387533|FG000|Overall Study|Death|0|||
129025550|NCT03578809|464387534|FG001|Overall Study|Death|2|||
129025551|NCT03578809|464387535|FG002|Overall Study|Death|0|||
129025552|NCT03578809|464387536|FG003|Overall Study|Death|1|||
129025553|NCT03578809|464387533|FG000|Overall Study|Lost to Follow-up|0|||
129025554|NCT03578809|464387534|FG001|Overall Study|Lost to Follow-up|1|||
129025555|NCT03578809|464387535|FG002|Overall Study|Lost to Follow-up|0|||
129025556|NCT03578809|464387536|FG003|Overall Study|Lost to Follow-up|0|||
129025557|NCT03578809|464387533|FG000|Overall Study|Withdrawal by Subject|3|||
129025558|NCT03578809|464387534|FG001|Overall Study|Withdrawal by Subject|5|||
129025559|NCT03578809|464387535|FG002|Overall Study|Withdrawal by Subject|2|||
129025560|NCT03578809|464387536|FG003|Overall Study|Withdrawal by Subject|0|||
129025561|NCT03578809|464387533|FG000|Overall Study|Other|3|||
129025562|NCT03578809|464387534|FG001|Overall Study|Other|6|||
129025563|NCT03578809|464387535|FG002|Overall Study|Other|2|||
129025564|NCT03578809|464387536|FG003|Overall Study|Other|8|||
129025565|NCT01624233|464387539|FG000|Period 2 - Induction|Adverse Event|1|||
129025566|NCT01624233|464387539|FG000|Period 3 - Maintenance|Adverse Event|2|||
129025567|NCT01624233|464387539|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
129025568|NCT01624233|464387539|FG000|Period 3 - Maintenance|Physician Decision|2|||
128903371|NCT04129528|463939864|FG000|Overall Study|Withdrawal by Subject|1|||
128903372|NCT04129528|463939865|FG001|Overall Study|Withdrawal by Subject|1|||
129025569|NCT01624233|464387539|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
129025570|NCT01624233|464387539|FG000|Period 4 - Drug Free Period|Relapsed|61|||
129025571|NCT01624233|464387539|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
129025572|NCT01624233|464387539|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
129025573|NCT01624233|464387539|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
129025574|NCT01624233|464387539|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
129025575|NCT01624233|464387539|FG000|Period 6: Follow-up|Adverse Event|3|||
129025576|NCT01624233|464387539|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
129025577|NCT01624233|464387539|FG000|Period 6: Follow-up|Physician Decision|1|||
129025578|NCT01624233|464387539|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
129025579|NCT04241458|464387540|FG000|Overall Study|Withdrawal by Subject|0|||
129025580|NCT04241458|464387541|FG001|Overall Study|Withdrawal by Subject|0|||
129025581|NCT04241458|464387542|FG002|Overall Study|Withdrawal by Subject|0|||
129025582|NCT04241458|464387543|FG003|Overall Study|Withdrawal by Subject|0|||
129025583|NCT04241458|464387544|FG004|Overall Study|Withdrawal by Subject|1|||
129025584|NCT00334815|464387545|FG000|Overall Study|Adverse Event|3|||
129025585|NCT00334815|464387546|FG001|Overall Study|Adverse Event|2|||
129025586|NCT00334815|464387545|FG000|Overall Study|Death|0|||
129025587|NCT00334815|464387546|FG001|Overall Study|Death|2|||
129025588|NCT00334815|464387545|FG000|Overall Study|Progression|1|||
129025589|NCT00334815|464387546|FG001|Overall Study|Progression|0|||
129025590|NCT00334815|464387545|FG000|Overall Study|ineligible|1|||
129025591|NCT00334815|464387546|FG001|Overall Study|ineligible|1|||
129025592|NCT00334815|464387545|FG000|Overall Study|patient refused treatment|0|||
129025593|NCT00334815|464387546|FG001|Overall Study|patient refused treatment|1|||
129025594|NCT00334815|464387545|FG000|Overall Study|Physician Decision|2|||
129025595|NCT00334815|464387546|FG001|Overall Study|Physician Decision|4|||
129025596|NCT03325881|464387554|FG000|Overall Study|Protocol Violation|0|||
129025597|NCT03325881|464387555|FG001|Overall Study|Protocol Violation|1|||
129025598|NCT03325881|464387554|FG000|Overall Study|Withdrawal by Subject|0|||
129025599|NCT03325881|464387555|FG001|Overall Study|Withdrawal by Subject|2|||
129025600|NCT03325881|464387554|FG000|Overall Study|Lack of Efficacy|2|||
129025601|NCT03325881|464387555|FG001|Overall Study|Lack of Efficacy|0|||
129025602|NCT03325881|464387554|FG000|Overall Study|Not treated|1|||
129025603|NCT03325881|464387555|FG001|Overall Study|Not treated|0|||
129025604|NCT03676634|464387558|FG000|Overall Study|Red blood cell loss|1|||
129025605|NCT03676634|464387558|FG000|Overall Study|Out-of-limit pulse|2|||
129025606|NCT03131895|464387564|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
129025607|NCT03131895|464387565|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
129025608|NCT03131895|464387566|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
129025609|NCT03131895|464387567|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
129025610|NCT03131895|464387564|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129025611|NCT03131895|464387565|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
129025612|NCT03131895|464387566|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
129025613|NCT03131895|464387567|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
129025614|NCT03131895|464387564|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129025615|NCT03131895|464387565|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
129025616|NCT03131895|464387566|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129025617|NCT03131895|464387567|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
129025618|NCT03131895|464387564|FG000|Washout Period (at Least 5 Days)|Other|0|||
129025619|NCT03131895|464387565|FG001|Washout Period (at Least 5 Days)|Other|0|||
129025620|NCT03131895|464387566|FG002|Washout Period (at Least 5 Days)|Other|2|||
129025621|NCT03131895|464387567|FG003|Washout Period (at Least 5 Days)|Other|0|||
129025622|NCT03131895|464387564|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
129025623|NCT03131895|464387565|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
129025624|NCT03131895|464387566|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
128694093|NCT01543698|463180417|FG003|Phase 1b|Protocol Violation|0|||
128694094|NCT01543698|463180418|FG004|Phase 1b|Protocol Violation|0|||
128694095|NCT01543698|463180419|FG005|Phase 1b|Protocol Violation|0|||
128694096|NCT01543698|463180420|FG006|Phase 1b|Protocol Violation|0|||
128694097|NCT01543698|463180421|FG007|Phase 1b|Protocol Violation|0|||
128903373|NCT01652885|463939870|FG000|Overall Study|Adverse Event|1|||
129025625|NCT03131895|464387567|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
129025626|NCT03131895|464387564|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
129025627|NCT03131895|464387565|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
129025628|NCT03131895|464387566|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
129025629|NCT03131895|464387567|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
129025630|NCT00540423|464387568|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129025631|NCT00540423|464387569|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129025632|NCT00540423|464387570|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129115277|NCT01573000|464719700|FG000|Crossover Phase|Lost to Follow-up|0|||
128694098|NCT01543698|463180422|FG008|Phase 1b|Protocol Violation|0|||
128694099|NCT01543698|463180423|FG009|Phase 1b|Protocol Violation|0|||
129115278|NCT01573000|464719701|FG001|Crossover Phase|Lost to Follow-up|2|||
129115279|NCT01573000|464719700|FG000|Crossover Phase|Death|0|||
129115280|NCT01573000|464719701|FG001|Crossover Phase|Death|3|||
129115281|NCT01573000|464719700|FG000|Long-Term Follow-Up|Death|3|||
129115282|NCT01573000|464719701|FG001|Long-Term Follow-Up|Death|0|||
129115283|NCT01573000|464719700|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
129115284|NCT01573000|464719701|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
129115285|NCT03353792|464719702|FG000|Overall Study|Lost to Follow-up|1|||
129115286|NCT03353792|464719703|FG001|Overall Study|Lost to Follow-up|0|||
129115287|NCT03353792|464719702|FG000|Overall Study|Participant Unable to Manage Device|1|||
129115288|NCT03353792|464719703|FG001|Overall Study|Participant Unable to Manage Device|0|||
129115289|NCT03342001|464719709|FG000|Overall Study|Adverse Event|1|||
129115290|NCT03342001|464719709|FG000|Overall Study|Lost to Follow-up|1|||
129115291|NCT01433159|464719711|FG000|Overall Study|Adverse Event|1|||
129115292|NCT01433159|464719712|FG001|Overall Study|Adverse Event|0|||
129115293|NCT01433159|464719711|FG000|Overall Study|Physician Decision|1|||
129115294|NCT01433159|464719712|FG001|Overall Study|Physician Decision|0|||
129115295|NCT01433159|464719711|FG000|Overall Study|Protocol Violation|0|||
129115296|NCT01433159|464719712|FG001|Overall Study|Protocol Violation|1|||
129115297|NCT01100853|464719713|FG000|Overall Study|Lost to Follow-up|11|||
129115298|NCT01100853|464719714|FG001|Overall Study|Lost to Follow-up|6|||
129115299|NCT01100853|464719713|FG000|Overall Study|Received <4 study injections|10|||
129115300|NCT01100853|464719714|FG001|Overall Study|Received <4 study injections|13|||
129115301|NCT01100853|464719713|FG000|Overall Study|Withdrawal by Subject|6|||
129115302|NCT01100853|464719714|FG001|Overall Study|Withdrawal by Subject|4|||
129115303|NCT04161391|464719717|FG000|Overall Study|Adverse Event|0|||
129115304|NCT04161391|464719718|FG001|Overall Study|Adverse Event|1|||
129115305|NCT04161391|464719719|FG002|Overall Study|Adverse Event|0|||
129115306|NCT04161391|464719720|FG003|Overall Study|Adverse Event|1|||
129115307|NCT04161391|464719721|FG004|Overall Study|Adverse Event|0|||
129115308|NCT04161391|464719722|FG005|Overall Study|Adverse Event|0|||
129115309|NCT04161391|464719723|FG006|Overall Study|Adverse Event|0|||
129115310|NCT04161391|464719724|FG007|Overall Study|Adverse Event|3|||
129115311|NCT04161391|464719725|FG008|Overall Study|Adverse Event|0|||
129115312|NCT04161391|464719717|FG000|Overall Study|Death|0|||
129115313|NCT04161391|464719718|FG001|Overall Study|Death|0|||
129115314|NCT04161391|464719719|FG002|Overall Study|Death|0|||
129115315|NCT04161391|464719720|FG003|Overall Study|Death|0|||
129115316|NCT04161391|464719721|FG004|Overall Study|Death|0|||
129115317|NCT04161391|464719722|FG005|Overall Study|Death|0|||
129115318|NCT04161391|464719723|FG006|Overall Study|Death|0|||
129115319|NCT04161391|464719724|FG007|Overall Study|Death|1|||
129115320|NCT04161391|464719725|FG008|Overall Study|Death|0|||
129115321|NCT04161391|464719717|FG000|Overall Study|Physician Decision|0|||
129115322|NCT04161391|464719718|FG001|Overall Study|Physician Decision|0|||
129115323|NCT04161391|464719719|FG002|Overall Study|Physician Decision|1|||
129115324|NCT04161391|464719720|FG003|Overall Study|Physician Decision|2|||
129115325|NCT04161391|464719721|FG004|Overall Study|Physician Decision|0|||
129115326|NCT04161391|464719722|FG005|Overall Study|Physician Decision|0|||
129115327|NCT04161391|464719723|FG006|Overall Study|Physician Decision|2|||
129115328|NCT04161391|464719724|FG007|Overall Study|Physician Decision|0|||
129115329|NCT04161391|464719725|FG008|Overall Study|Physician Decision|0|||
129115330|NCT04161391|464719717|FG000|Overall Study|Progressive Disease|4|||
129115331|NCT04161391|464719718|FG001|Overall Study|Progressive Disease|3|||
129115332|NCT04161391|464719719|FG002|Overall Study|Progressive Disease|3|||
129115333|NCT04161391|464719720|FG003|Overall Study|Progressive Disease|5|||
129115334|NCT04161391|464719721|FG004|Overall Study|Progressive Disease|3|||
129115335|NCT04161391|464719722|FG005|Overall Study|Progressive Disease|3|||
129115336|NCT04161391|464719723|FG006|Overall Study|Progressive Disease|5|||
129115337|NCT04161391|464719724|FG007|Overall Study|Progressive Disease|2|||
129115338|NCT04161391|464719725|FG008|Overall Study|Progressive Disease|2|||
129115339|NCT02579629|464719728|FG000|Overall Study|Withdrawal by Subject|0|||
129115340|NCT02579629|464719729|FG001|Overall Study|Withdrawal by Subject|1|||
129115341|NCT02579629|464719730|FG002|Overall Study|Withdrawal by Subject|0|||
129115342|NCT02579629|464719728|FG000|Overall Study|Screen Failure|2|||
129115343|NCT02579629|464719729|FG001|Overall Study|Screen Failure|0|||
129115344|NCT02579629|464719730|FG002|Overall Study|Screen Failure|2|||
129115345|NCT01190891|464719731|FG000|Overall Study|Protocol Violation|1|||
129115346|NCT01190891|464719732|FG001|Overall Study|Protocol Violation|0|||
129115347|NCT01190891|464719731|FG000|Overall Study|Withdrawal by Subject|5|||
129115348|NCT01190891|464719732|FG001|Overall Study|Withdrawal by Subject|0|||
129115349|NCT00266708|464719733|FG000|Overall Study|No renal function|1|||
129115350|NCT00266708|464719734|FG001|Overall Study|No renal function|1|||
129115351|NCT00266708|464719733|FG000|Overall Study|Refused biopsy|3|||
129115352|NCT00266708|464719734|FG001|Overall Study|Refused biopsy|6|||
129115353|NCT00266708|464719733|FG000|Overall Study|Asthma|0|||
129115354|NCT00266708|464719734|FG001|Overall Study|Asthma|2|||
129115355|NCT01926028|464719735|FG000|Overall Study|Lost to Follow-up|7|||
129115356|NCT01926028|464719736|FG001|Overall Study|Lost to Follow-up|6|||
129115357|NCT01926028|464719737|FG002|Overall Study|Lost to Follow-up|0|||
129115358|NCT01926028|464719735|FG000|Overall Study|Physician Decision|1|||
129115359|NCT01926028|464719736|FG001|Overall Study|Physician Decision|5|||
129115360|NCT01926028|464719737|FG002|Overall Study|Physician Decision|0|||
129115361|NCT01926028|464719735|FG000|Overall Study|Withdrawal by Subject|9|||
129115362|NCT01926028|464719736|FG001|Overall Study|Withdrawal by Subject|9|||
129115363|NCT01926028|464719737|FG002|Overall Study|Withdrawal by Subject|2|||
129115364|NCT01926028|464719735|FG000|Overall Study|Non compliance or other reasons|4|||
129115365|NCT01926028|464719736|FG001|Overall Study|Non compliance or other reasons|2|||
129115366|NCT01926028|464719737|FG002|Overall Study|Non compliance or other reasons|0|||
129115367|NCT01130272|464719738|FG000|Overall Study|Adverse Event|2|||
129115368|NCT01130272|464719739|FG001|Overall Study|Adverse Event|5|||
129115369|NCT01130272|464719740|FG002|Overall Study|Adverse Event|6|||
129115370|NCT01130272|464719741|FG003|Overall Study|Adverse Event|22|||
129115371|NCT01130272|464719742|FG004|Overall Study|Adverse Event|7|||
129115372|NCT01130272|464719738|FG000|Overall Study|IVRS-confirmed constipation|0|||
129115373|NCT01130272|464719739|FG001|Overall Study|IVRS-confirmed constipation|1|||
129115374|NCT01130272|464719740|FG002|Overall Study|IVRS-confirmed constipation|1|||
129115375|NCT01130272|464719741|FG003|Overall Study|IVRS-confirmed constipation|2|||
129115376|NCT01130272|464719742|FG004|Overall Study|IVRS-confirmed constipation|0|||
129115377|NCT01130272|464719738|FG000|Overall Study|Rescue medications due to diarrhea|3|||
129115378|NCT01130272|464719739|FG001|Overall Study|Rescue medications due to diarrhea|5|||
129115379|NCT01130272|464719740|FG002|Overall Study|Rescue medications due to diarrhea|8|||
129115380|NCT01130272|464719741|FG003|Overall Study|Rescue medications due to diarrhea|8|||
129115381|NCT01130272|464719742|FG004|Overall Study|Rescue medications due to diarrhea|6|||
129115382|NCT01130272|464719738|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
129115383|NCT01130272|464719739|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
129115384|NCT01130272|464719740|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
129115385|NCT01130272|464719741|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
129115386|NCT01130272|464719742|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
129115387|NCT01130272|464719738|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129115388|NCT01130272|464719739|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129115389|NCT01130272|464719740|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129115390|NCT01130272|464719741|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
129115391|NCT01130272|464719742|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129115392|NCT01130272|464719738|FG000|Overall Study|Protocol Violation|0|||
129115393|NCT01130272|464719739|FG001|Overall Study|Protocol Violation|0|||
129115394|NCT01130272|464719740|FG002|Overall Study|Protocol Violation|3|||
129115395|NCT01130272|464719741|FG003|Overall Study|Protocol Violation|5|||
129115396|NCT01130272|464719742|FG004|Overall Study|Protocol Violation|5|||
129115397|NCT01130272|464719738|FG000|Overall Study|Lost to Follow-up|4|||
129115398|NCT01130272|464719739|FG001|Overall Study|Lost to Follow-up|3|||
129115399|NCT01130272|464719740|FG002|Overall Study|Lost to Follow-up|4|||
129115400|NCT01130272|464719741|FG003|Overall Study|Lost to Follow-up|7|||
129115401|NCT01130272|464719742|FG004|Overall Study|Lost to Follow-up|6|||
129115402|NCT01130272|464719738|FG000|Overall Study|Withdrawal by Subject|4|||
129115403|NCT01130272|464719739|FG001|Overall Study|Withdrawal by Subject|11|||
129115404|NCT01130272|464719740|FG002|Overall Study|Withdrawal by Subject|10|||
129115405|NCT01130272|464719741|FG003|Overall Study|Withdrawal by Subject|9|||
129115406|NCT01130272|464719742|FG004|Overall Study|Withdrawal by Subject|8|||
129115407|NCT01130272|464719738|FG000|Overall Study|Physician Decision|1|||
129115408|NCT01130272|464719739|FG001|Overall Study|Physician Decision|1|||
129115409|NCT01130272|464719740|FG002|Overall Study|Physician Decision|0|||
129115410|NCT01130272|464719741|FG003|Overall Study|Physician Decision|1|||
129115411|NCT01130272|464719742|FG004|Overall Study|Physician Decision|2|||
128903374|NCT01395394|463939871|FG000|Baseline Study Visit|Protocol Violation|1|||
128903375|NCT01395394|463939872|FG001|Baseline Study Visit|Protocol Violation|0|||
128903376|NCT01395394|463939873|FG002|Baseline Study Visit|Protocol Violation|0|||
128903377|NCT01964352|463939874|FG000|Overall Study|Adverse Event|13|||
128903378|NCT01964352|463939875|FG001|Overall Study|Adverse Event|3|||
128903379|NCT01964352|463939876|FG002|Overall Study|Adverse Event|4|||
128903380|NCT01964352|463939877|FG003|Overall Study|Adverse Event|3|||
128903381|NCT01964352|463939874|FG000|Overall Study|Lack of Efficacy|6|||
129115412|NCT01130272|464719738|FG000|Overall Study|Sponsor decision|6|||
129115413|NCT01130272|464719739|FG001|Overall Study|Sponsor decision|15|||
129115414|NCT01130272|464719740|FG002|Overall Study|Sponsor decision|16|||
128903382|NCT01964352|463939875|FG001|Overall Study|Lack of Efficacy|0|||
128903383|NCT01964352|463939876|FG002|Overall Study|Lack of Efficacy|0|||
128903384|NCT01964352|463939877|FG003|Overall Study|Lack of Efficacy|0|||
128903385|NCT01964352|463939874|FG000|Overall Study|Protocol Violation|2|||
129115415|NCT01130272|464719741|FG003|Overall Study|Sponsor decision|13|||
129115416|NCT01130272|464719742|FG004|Overall Study|Sponsor decision|16|||
129115417|NCT01130272|464719738|FG000|Overall Study|Study arm discontinued|38|||
129115418|NCT01130272|464719739|FG001|Overall Study|Study arm discontinued|0|||
129115419|NCT01130272|464719740|FG002|Overall Study|Study arm discontinued|0|||
129115420|NCT01130272|464719741|FG003|Overall Study|Study arm discontinued|0|||
128903386|NCT01964352|463939875|FG001|Overall Study|Protocol Violation|4|||
128903387|NCT01964352|463939876|FG002|Overall Study|Protocol Violation|0|||
128903388|NCT01964352|463939877|FG003|Overall Study|Protocol Violation|2|||
128903389|NCT01964352|463939874|FG000|Overall Study|Lost to Follow-up|1|||
128903390|NCT01964352|463939875|FG001|Overall Study|Lost to Follow-up|0|||
128903391|NCT01964352|463939876|FG002|Overall Study|Lost to Follow-up|0|||
128903392|NCT01964352|463939877|FG003|Overall Study|Lost to Follow-up|1|||
128903393|NCT01964352|463939874|FG000|Overall Study|Withdrawal by Subject|4|||
128903394|NCT01964352|463939875|FG001|Overall Study|Withdrawal by Subject|2|||
128903395|NCT01964352|463939876|FG002|Overall Study|Withdrawal by Subject|1|||
128903396|NCT01964352|463939877|FG003|Overall Study|Withdrawal by Subject|0|||
128903397|NCT01964352|463939874|FG000|Overall Study|Other than stated above|0|||
128903398|NCT01964352|463939875|FG001|Overall Study|Other than stated above|2|||
128903399|NCT01964352|463939876|FG002|Overall Study|Other than stated above|1|||
128903400|NCT01964352|463939877|FG003|Overall Study|Other than stated above|2|||
128903401|NCT00477165|463939881|FG000|Overall Study|Adverse Event|7|||
128903402|NCT00477165|463939882|FG001|Overall Study|Adverse Event|2|||
128903403|NCT00105443|463939883|FG000|Double-Blind Treatment|Adverse Event|1|||
128903404|NCT00105443|463939884|FG001|Double-Blind Treatment|Adverse Event|0|||
128903405|NCT00105443|463939885|FG002|Double-Blind Treatment|Adverse Event|0|||
128903406|NCT00105443|463939886|FG003|Double-Blind Treatment|Adverse Event|0|||
128903407|NCT00105443|463939883|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
128903408|NCT00105443|463939884|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
128903409|NCT00105443|463939885|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
128903410|NCT00105443|463939886|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
128903411|NCT00105443|463939883|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
128903412|NCT00105443|463939884|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
128903413|NCT00105443|463939885|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
128903414|NCT00105443|463939886|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
128903415|NCT00105443|463939883|FG000|Double-Blind Treatment|Physician Decision|1|||
128903416|NCT00105443|463939884|FG001|Double-Blind Treatment|Physician Decision|0|||
128903417|NCT00105443|463939885|FG002|Double-Blind Treatment|Physician Decision|2|||
128903418|NCT00105443|463939886|FG003|Double-Blind Treatment|Physician Decision|0|||
128903419|NCT00105443|463939883|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
128903420|NCT00105443|463939884|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
128903421|NCT00105443|463939885|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
128903422|NCT00105443|463939886|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
128903423|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
128903424|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
128903425|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
128903426|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
128903427|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
128903428|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
128903429|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
128903430|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
128903431|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
128903432|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
128903433|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
128903434|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
128903435|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
128903436|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
128903437|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
128903438|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
128903439|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
128903440|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
128903441|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
128903442|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
128903443|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
128903444|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
128903445|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
128903446|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
128903447|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
128903448|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
128903449|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
128903450|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
128903451|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
128903452|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
128903453|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
128903454|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
128903455|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
128903456|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
128903457|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
128903458|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
128903459|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
128903460|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
128903461|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
128903462|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
128903463|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
128903464|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
128903465|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
128903466|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
128903467|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
128903468|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
128903469|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
128903470|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
128903471|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
128903472|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
128903473|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
128903474|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
128903475|NCT00105443|463939883|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
128903476|NCT00105443|463939884|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
128903477|NCT00105443|463939885|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
128903478|NCT00105443|463939886|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
128764765|NCT03485911|463430298|FG001|Part 2|Other NOS|1|||
128903479|NCT01157078|463939887|FG000|Overall Study|Withdrawal by Subject|12|||
128903480|NCT01157078|463939888|FG001|Overall Study|Withdrawal by Subject|14|||
128903481|NCT01157078|463939887|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
128903482|NCT01157078|463939888|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128903483|NCT01157078|463939887|FG000|Overall Study|Adverse Event|6|||
128903484|NCT01157078|463939888|FG001|Overall Study|Adverse Event|6|||
128903485|NCT01157078|463939887|FG000|Overall Study|Severe non-compliance to protocol|2|||
128903486|NCT01157078|463939888|FG001|Overall Study|Severe non-compliance to protocol|4|||
128903487|NCT01157078|463939887|FG000|Overall Study|Condition under investigation worsened|0|||
128903488|NCT01157078|463939888|FG001|Overall Study|Condition under investigation worsened|1|||
128903489|NCT01157078|463939887|FG000|Overall Study|Lack of Efficacy|2|||
128903490|NCT01157078|463939888|FG001|Overall Study|Lack of Efficacy|0|||
128903491|NCT01157078|463939887|FG000|Overall Study|Study-specific withdrawal criteria|2|||
128903492|NCT01157078|463939888|FG001|Overall Study|Study-specific withdrawal criteria|2|||
128903493|NCT01157078|463939887|FG000|Overall Study|Lost to Follow-up|7|||
128903494|NCT01157078|463939888|FG001|Overall Study|Lost to Follow-up|5|||
128903495|NCT01157078|463939887|FG000|Overall Study|Other|2|||
128903496|NCT01157078|463939888|FG001|Overall Study|Other|4|||
128903497|NCT00513409|463939893|FG000|Overall Study|Adverse Event|0|||
128903498|NCT00513409|463939894|FG001|Overall Study|Adverse Event|1|||
128903499|NCT00513409|463939893|FG000|Overall Study|Withdrawal by Subject|0|||
128903500|NCT00513409|463939894|FG001|Overall Study|Withdrawal by Subject|2|||
128903501|NCT00513409|463939893|FG000|Overall Study|Lost to Follow-up|0|||
128903502|NCT00513409|463939894|FG001|Overall Study|Lost to Follow-up|1|||
128903503|NCT00513409|463939893|FG000|Overall Study|Physician Decision|1|||
128903504|NCT00513409|463939894|FG001|Overall Study|Physician Decision|0|||
128903505|NCT00513409|463939893|FG000|Overall Study|Visit 3 not done|1|||
128903506|NCT00513409|463939894|FG001|Overall Study|Visit 3 not done|2|||
128764766|NCT03485911|463430299|FG002|Part 2|Other NOS|0|||
128764767|NCT03485911|463430300|FG003|Part 2|Other NOS|0|||
128903507|NCT03189446|463939896|FG000|Overall Study|Adverse Event|2|||
128903508|NCT03189446|463939896|FG000|Overall Study|Withdrawal by Subject|2|||
128903509|NCT03189446|463939896|FG000|Overall Study|Physician Decision|1|||
128903510|NCT05634577|463939897|FG000|Overall Study|Lost to Follow-up|1|||
128903511|NCT05634577|463939897|FG000|Overall Study|Withdrawal by Subject|1|||
128903512|NCT01192022|463939898|FG000|Overall Study|Withdrawal of Consent|3|||
128903513|NCT01192022|463939899|FG001|Overall Study|Withdrawal of Consent|1|||
128903514|NCT01192022|463939900|FG002|Overall Study|Withdrawal of Consent|0|||
128903515|NCT01192022|463939901|FG003|Overall Study|Withdrawal of Consent|0|||
128903516|NCT01192022|463939902|FG004|Overall Study|Withdrawal of Consent|0|||
128903517|NCT01192022|463939898|FG000|Overall Study|Lost to Follow-up|4|||
128903518|NCT01192022|463939899|FG001|Overall Study|Lost to Follow-up|2|||
128903519|NCT01192022|463939900|FG002|Overall Study|Lost to Follow-up|1|||
128903520|NCT01192022|463939901|FG003|Overall Study|Lost to Follow-up|1|||
128903521|NCT01192022|463939902|FG004|Overall Study|Lost to Follow-up|0|||
128903522|NCT01192022|463939898|FG000|Overall Study|Adverse Event|1|||
128903523|NCT01192022|463939899|FG001|Overall Study|Adverse Event|0|||
128764768|NCT03485911|463430297|FG000|Part 2|Intercurrent illness/new medical condition|1|||
128903524|NCT01192022|463939900|FG002|Overall Study|Adverse Event|0|||
128903525|NCT01192022|463939901|FG003|Overall Study|Adverse Event|0|||
128903526|NCT01192022|463939902|FG004|Overall Study|Adverse Event|0|||
128903527|NCT01192022|463939898|FG000|Overall Study|Fatal Adverse Event|4|||
128903528|NCT01192022|463939899|FG001|Overall Study|Fatal Adverse Event|6|||
128903529|NCT01192022|463939900|FG002|Overall Study|Fatal Adverse Event|0|||
128903530|NCT01192022|463939901|FG003|Overall Study|Fatal Adverse Event|0|||
128903531|NCT01192022|463939902|FG004|Overall Study|Fatal Adverse Event|1|||
128903532|NCT01192022|463939898|FG000|Overall Study|Physician withdrew-patient hardship|1|||
128903533|NCT01192022|463939899|FG001|Overall Study|Physician withdrew-patient hardship|0|||
128903534|NCT01192022|463939900|FG002|Overall Study|Physician withdrew-patient hardship|0|||
128903535|NCT01192022|463939901|FG003|Overall Study|Physician withdrew-patient hardship|0|||
128903536|NCT01192022|463939902|FG004|Overall Study|Physician withdrew-patient hardship|0|||
128903537|NCT01192022|463939898|FG000|Overall Study|Patient too sick from chemotherapy|0|||
128694100|NCT01543698|463180424|FG010|Phase 1b|Protocol Violation|0|||
128694101|NCT01543698|463180425|FG011|Phase 1b|Protocol Violation|0|||
128694102|NCT01543698|463180426|FG012|Phase 1b|Protocol Violation|0|||
128694103|NCT01543698|463180427|FG013|Phase 1b|Protocol Violation|0|||
128694104|NCT01543698|463180428|FG014|Phase 1b|Protocol Violation|0|||
128694105|NCT01543698|463180414|FG000|Phase 2|Protocol Violation|0|||
128694106|NCT01543698|463180415|FG001|Phase 2|Protocol Violation|0|||
128694107|NCT01543698|463180416|FG002|Phase 2|Protocol Violation|0|||
128694108|NCT01543698|463180417|FG003|Phase 2|Protocol Violation|0|||
128694109|NCT01543698|463180418|FG004|Phase 2|Protocol Violation|0|||
128694110|NCT01543698|463180419|FG005|Phase 2|Protocol Violation|0|||
128694111|NCT01543698|463180420|FG006|Phase 2|Protocol Violation|0|||
128694112|NCT01543698|463180421|FG007|Phase 2|Protocol Violation|0|||
128694113|NCT01543698|463180422|FG008|Phase 2|Protocol Violation|0|||
128694114|NCT01543698|463180423|FG009|Phase 2|Protocol Violation|0|||
128694115|NCT01543698|463180424|FG010|Phase 2|Protocol Violation|0|||
128694116|NCT01543698|463180425|FG011|Phase 2|Protocol Violation|0|||
128694117|NCT01543698|463180426|FG012|Phase 2|Protocol Violation|1|||
128694118|NCT01543698|463180427|FG013|Phase 2|Protocol Violation|0|||
128694119|NCT01543698|463180428|FG014|Phase 2|Protocol Violation|0|||
128694120|NCT01543698|463180414|FG000|Phase 2|Disease progression|0|||
128694121|NCT01543698|463180415|FG001|Phase 2|Disease progression|0|||
128694122|NCT01543698|463180416|FG002|Phase 2|Disease progression|0|||
128694123|NCT01543698|463180417|FG003|Phase 2|Disease progression|0|||
128694124|NCT01543698|463180418|FG004|Phase 2|Disease progression|0|||
128694125|NCT01543698|463180419|FG005|Phase 2|Disease progression|0|||
128694126|NCT01543698|463180420|FG006|Phase 2|Disease progression|0|||
128694127|NCT01543698|463180421|FG007|Phase 2|Disease progression|0|||
128694128|NCT01543698|463180422|FG008|Phase 2|Disease progression|0|||
128694129|NCT01543698|463180423|FG009|Phase 2|Disease progression|0|||
128694130|NCT01543698|463180424|FG010|Phase 2|Disease progression|0|||
128694131|NCT01543698|463180425|FG011|Phase 2|Disease progression|10|||
128694132|NCT01543698|463180426|FG012|Phase 2|Disease progression|21|||
128694133|NCT01543698|463180427|FG013|Phase 2|Disease progression|30|||
128694134|NCT01543698|463180428|FG014|Phase 2|Disease progression|25|||
128694135|NCT01543698|463180414|FG000|Phase 2|Death|0|||
128694136|NCT01543698|463180415|FG001|Phase 2|Death|0|||
128694137|NCT01543698|463180416|FG002|Phase 2|Death|0|||
128694138|NCT01543698|463180417|FG003|Phase 2|Death|0|||
128694139|NCT01543698|463180418|FG004|Phase 2|Death|0|||
128694140|NCT01543698|463180419|FG005|Phase 2|Death|0|||
128694141|NCT01543698|463180420|FG006|Phase 2|Death|0|||
128694142|NCT01543698|463180421|FG007|Phase 2|Death|0|||
128903538|NCT01192022|463939899|FG001|Overall Study|Patient too sick from chemotherapy|1|||
128903539|NCT01192022|463939900|FG002|Overall Study|Patient too sick from chemotherapy|0|||
128903540|NCT01192022|463939901|FG003|Overall Study|Patient too sick from chemotherapy|0|||
128903541|NCT01192022|463939902|FG004|Overall Study|Patient too sick from chemotherapy|0|||
128903542|NCT01192022|463939898|FG000|Overall Study|Patient needed surgery|0|||
128903543|NCT01192022|463939899|FG001|Overall Study|Patient needed surgery|1|||
128903544|NCT01192022|463939900|FG002|Overall Study|Patient needed surgery|0|||
128903545|NCT01192022|463939901|FG003|Overall Study|Patient needed surgery|0|||
128903546|NCT01192022|463939902|FG004|Overall Study|Patient needed surgery|0|||
129025633|NCT00540423|464387568|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
128694143|NCT01543698|463180422|FG008|Phase 2|Death|0|||
128694144|NCT01543698|463180423|FG009|Phase 2|Death|0|||
128694145|NCT01543698|463180424|FG010|Phase 2|Death|0|||
128694146|NCT01543698|463180425|FG011|Phase 2|Death|0|||
128694147|NCT01543698|463180426|FG012|Phase 2|Death|1|||
128694148|NCT01543698|463180427|FG013|Phase 2|Death|1|||
128694149|NCT01543698|463180428|FG014|Phase 2|Death|1|||
128694150|NCT01543698|463180414|FG000|Phase 2|Administrative problems|0|||
128694151|NCT01543698|463180415|FG001|Phase 2|Administrative problems|0|||
128694152|NCT01543698|463180416|FG002|Phase 2|Administrative problems|0|||
128694153|NCT01543698|463180417|FG003|Phase 2|Administrative problems|0|||
128694154|NCT01543698|463180418|FG004|Phase 2|Administrative problems|0|||
128694155|NCT01543698|463180419|FG005|Phase 2|Administrative problems|0|||
128694156|NCT01543698|463180420|FG006|Phase 2|Administrative problems|0|||
128903547|NCT01192022|463939898|FG000|Overall Study|Parents did not allow all follow up|0|||
128903548|NCT01192022|463939899|FG001|Overall Study|Parents did not allow all follow up|0|||
128903549|NCT01192022|463939900|FG002|Overall Study|Parents did not allow all follow up|0|||
128903550|NCT01192022|463939901|FG003|Overall Study|Parents did not allow all follow up|1|||
128903551|NCT01192022|463939902|FG004|Overall Study|Parents did not allow all follow up|0|||
128903552|NCT04839978|463939903|FG000|Overall Study|Lost to Follow-up|135|||
128903553|NCT04839978|463939904|FG001|Overall Study|Lost to Follow-up|147|||
128903554|NCT03865706|463939905|FG000|Overall Study|Death|0|||
128903555|NCT03865706|463939906|FG001|Overall Study|Death|3|||
128903556|NCT03865706|463939907|FG002|Overall Study|Death|1|||
128903557|NCT00781456|463939908|FG000|Overall Study|Adverse Event|3|||
128903558|NCT00781456|463939909|FG001|Overall Study|Adverse Event|3|||
128903559|NCT00781456|463939908|FG000|Overall Study|Withdrawal by Subject|3|||
128903560|NCT00781456|463939909|FG001|Overall Study|Withdrawal by Subject|5|||
128903561|NCT00781456|463939908|FG000|Overall Study|Protocol Violation|4|||
128903562|NCT00781456|463939909|FG001|Overall Study|Protocol Violation|1|||
128903563|NCT00781456|463939908|FG000|Overall Study|Noncompliance With Protocol|1|||
128903564|NCT00781456|463939909|FG001|Overall Study|Noncompliance With Protocol|1|||
128903565|NCT00781456|463939908|FG000|Overall Study|Lost to Follow-up|10|||
128903566|NCT00781456|463939909|FG001|Overall Study|Lost to Follow-up|5|||
128903567|NCT00781456|463939908|FG000|Overall Study|Other Reason, Unknown|0|||
128903568|NCT00781456|463939909|FG001|Overall Study|Other Reason, Unknown|1|||
128903569|NCT01594853|463939910|FG000|Overall Study|Withdrawal by Subject|1|||
128903570|NCT01594853|463939911|FG001|Overall Study|Withdrawal by Subject|1|||
128903571|NCT01594853|463939910|FG000|Overall Study|Lost to Follow-up|1|||
128903572|NCT01594853|463939911|FG001|Overall Study|Lost to Follow-up|1|||
128903573|NCT01594853|463939910|FG000|Overall Study|noncompliance with exercise|0|||
128903574|NCT01594853|463939911|FG001|Overall Study|noncompliance with exercise|1|||
128903575|NCT04677712|463939913|FG000|Overall Study|Lost to Follow-up|0|||
128903576|NCT04677712|463939914|FG001|Overall Study|Lost to Follow-up|1|||
128903577|NCT04677712|463939915|FG002|Overall Study|Lost to Follow-up|0|||
128903578|NCT04677712|463939916|FG003|Overall Study|Lost to Follow-up|0|||
128903579|NCT04677712|463939917|FG004|Overall Study|Lost to Follow-up|0|||
128903580|NCT04677712|463939918|FG005|Overall Study|Lost to Follow-up|0|||
128903581|NCT00711100|463939919|FG000|Overall Study|Lack of Efficacy|5|||
128903582|NCT00711100|463939919|FG000|Overall Study|Withdrawal by Subject|8|||
128903583|NCT00783094|463939920|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
128903584|NCT00783094|463939921|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
128903585|NCT00783094|463939922|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
128903586|NCT00783094|463939920|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
128903587|NCT00783094|463939921|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
128903588|NCT00783094|463939922|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
128903589|NCT00783094|463939920|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
128903590|NCT00783094|463939921|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
128903591|NCT00783094|463939922|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
128903592|NCT00783094|463939920|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
128903593|NCT00783094|463939921|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
128903594|NCT00783094|463939922|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
128903595|NCT00783094|463939920|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
128903596|NCT00783094|463939921|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
128903597|NCT00783094|463939922|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
128903598|NCT00783094|463939920|FG000|Open-Label Extension Period|Adverse Event|12|||
128903599|NCT00783094|463939921|FG001|Open-Label Extension Period|Adverse Event|7|||
128903600|NCT00783094|463939922|FG002|Open-Label Extension Period|Adverse Event|16|||
128903601|NCT00783094|463939920|FG000|Open-Label Extension Period|Death|0|||
128903602|NCT00783094|463939921|FG001|Open-Label Extension Period|Death|0|||
129025634|NCT00540423|464387569|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
129025635|NCT00540423|464387570|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
129025636|NCT00216736|464387579|FG000|Overall Study|Lost to Follow-up|1|||
128903603|NCT00783094|463939922|FG002|Open-Label Extension Period|Death|1|||
128903604|NCT00783094|463939920|FG000|Open-Label Extension Period|Protocol Violation|4|||
128903605|NCT00783094|463939921|FG001|Open-Label Extension Period|Protocol Violation|5|||
128903606|NCT00783094|463939922|FG002|Open-Label Extension Period|Protocol Violation|7|||
128903607|NCT00783094|463939920|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
128903608|NCT00783094|463939921|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
128903609|NCT00783094|463939922|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
128903610|NCT00783094|463939920|FG000|Open-Label Extension Period|Physician Decision|4|||
128903611|NCT00783094|463939921|FG001|Open-Label Extension Period|Physician Decision|2|||
128903612|NCT00783094|463939922|FG002|Open-Label Extension Period|Physician Decision|3|||
129025637|NCT00216736|464387580|FG001|Overall Study|Lost to Follow-up|1|||
129025638|NCT02890992|464387581|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129025639|NCT02890992|464387582|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
129025640|NCT02890992|464387583|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
128903613|NCT00783094|463939920|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
128903614|NCT00783094|463939921|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
128903615|NCT00783094|463939922|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
128903616|NCT02513329|463939923|FG000|Overall Study|Lost to Follow-up|5|||
128903617|NCT02513329|463939924|FG001|Overall Study|Lost to Follow-up|2|||
128903618|NCT01294670|463939925|FG000|Overall Study|Not treated|1|||
128903619|NCT01294670|463939926|FG001|Overall Study|Not treated|0|||
128903620|NCT01294670|463939927|FG002|Overall Study|Not treated|0|||
128903621|NCT01294670|463939928|FG003|Overall Study|Not treated|0|||
128903622|NCT01294670|463939929|FG004|Overall Study|Not treated|0|||
128903623|NCT03703102|463939931|FG000|Overall Study|Adverse Event|4|||
128903624|NCT03703102|463939932|FG001|Overall Study|Adverse Event|3|||
128903625|NCT03703102|463939933|FG002|Overall Study|Adverse Event|7|||
128903626|NCT03703102|463939934|FG003|Overall Study|Adverse Event|3|||
128903627|NCT03703102|463939935|FG004|Overall Study|Adverse Event|13|||
128903628|NCT03703102|463939931|FG000|Overall Study|Lack of Efficacy|4|||
128903629|NCT03703102|463939932|FG001|Overall Study|Lack of Efficacy|0|||
128903630|NCT03703102|463939933|FG002|Overall Study|Lack of Efficacy|1|||
128903631|NCT03703102|463939934|FG003|Overall Study|Lack of Efficacy|4|||
128903632|NCT03703102|463939935|FG004|Overall Study|Lack of Efficacy|1|||
128903633|NCT03703102|463939931|FG000|Overall Study|Lost to Follow-up|0|||
128903634|NCT03703102|463939932|FG001|Overall Study|Lost to Follow-up|0|||
128903635|NCT03703102|463939933|FG002|Overall Study|Lost to Follow-up|1|||
128903636|NCT03703102|463939934|FG003|Overall Study|Lost to Follow-up|2|||
128903637|NCT03703102|463939935|FG004|Overall Study|Lost to Follow-up|2|||
128903638|NCT03703102|463939931|FG000|Overall Study|Physician Decision|2|||
128903639|NCT03703102|463939932|FG001|Overall Study|Physician Decision|2|||
128903640|NCT03703102|463939933|FG002|Overall Study|Physician Decision|2|||
128903641|NCT03703102|463939934|FG003|Overall Study|Physician Decision|2|||
128903642|NCT03703102|463939935|FG004|Overall Study|Physician Decision|4|||
128903643|NCT03703102|463939931|FG000|Overall Study|Withdrawal by Subject|7|||
128903644|NCT03703102|463939932|FG001|Overall Study|Withdrawal by Subject|5|||
128903645|NCT03703102|463939933|FG002|Overall Study|Withdrawal by Subject|5|||
128903646|NCT03703102|463939934|FG003|Overall Study|Withdrawal by Subject|5|||
128903647|NCT03703102|463939935|FG004|Overall Study|Withdrawal by Subject|9|||
128903648|NCT03703102|463939931|FG000|Overall Study|Ineligibility|0|||
128903649|NCT03703102|463939932|FG001|Overall Study|Ineligibility|0|||
128903650|NCT03703102|463939933|FG002|Overall Study|Ineligibility|1|||
128903651|NCT03703102|463939934|FG003|Overall Study|Ineligibility|0|||
128903652|NCT03703102|463939935|FG004|Overall Study|Ineligibility|0|||
128903653|NCT03703102|463939931|FG000|Overall Study|Protocol Deviation|4|||
128903654|NCT03703102|463939932|FG001|Overall Study|Protocol Deviation|4|||
128903655|NCT03703102|463939933|FG002|Overall Study|Protocol Deviation|3|||
128903656|NCT03703102|463939934|FG003|Overall Study|Protocol Deviation|0|||
128903657|NCT03703102|463939935|FG004|Overall Study|Protocol Deviation|0|||
128903658|NCT03703102|463939931|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128903659|NCT03703102|463939932|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128903660|NCT03703102|463939933|FG002|Overall Study|Non-Compliance with Study Drug|2|||
128903661|NCT03703102|463939934|FG003|Overall Study|Non-Compliance with Study Drug|1|||
128903662|NCT03703102|463939935|FG004|Overall Study|Non-Compliance with Study Drug|4|||
128903663|NCT00876187|463939936|FG000|Overall Study|Adverse Event|14|||
128903664|NCT00876187|463939937|FG001|Overall Study|Adverse Event|12|||
128903665|NCT00876187|463939938|FG002|Overall Study|Adverse Event|19|||
128903666|NCT00876187|463939939|FG003|Overall Study|Adverse Event|29|||
128903667|NCT00876187|463939940|FG004|Overall Study|Adverse Event|10|||
128903668|NCT00876187|463939936|FG000|Overall Study|Lack of Efficacy|59|||
128903669|NCT00876187|463939937|FG001|Overall Study|Lack of Efficacy|34|||
128903670|NCT00876187|463939938|FG002|Overall Study|Lack of Efficacy|45|||
128903671|NCT00876187|463939939|FG003|Overall Study|Lack of Efficacy|34|||
128903672|NCT00876187|463939940|FG004|Overall Study|Lack of Efficacy|59|||
128903673|NCT00876187|463939936|FG000|Overall Study|Lost to Follow-up|9|||
128903674|NCT00876187|463939937|FG001|Overall Study|Lost to Follow-up|10|||
128903675|NCT00876187|463939938|FG002|Overall Study|Lost to Follow-up|8|||
128903676|NCT00876187|463939939|FG003|Overall Study|Lost to Follow-up|8|||
128903677|NCT00876187|463939940|FG004|Overall Study|Lost to Follow-up|11|||
128903678|NCT00876187|463939936|FG000|Overall Study|Protocol Violation|6|||
128903679|NCT00876187|463939937|FG001|Overall Study|Protocol Violation|7|||
128903680|NCT00876187|463939938|FG002|Overall Study|Protocol Violation|7|||
128903681|NCT00876187|463939939|FG003|Overall Study|Protocol Violation|6|||
128903682|NCT00876187|463939940|FG004|Overall Study|Protocol Violation|3|||
128903683|NCT00876187|463939936|FG000|Overall Study|Withdrawal by Subject|16|||
128903684|NCT00876187|463939937|FG001|Overall Study|Withdrawal by Subject|26|||
128903685|NCT00876187|463939938|FG002|Overall Study|Withdrawal by Subject|32|||
128903686|NCT00876187|463939939|FG003|Overall Study|Withdrawal by Subject|38|||
128903687|NCT00876187|463939940|FG004|Overall Study|Withdrawal by Subject|37|||
128903688|NCT00876187|463939936|FG000|Overall Study|Entered extension study|101|||
128903689|NCT00876187|463939937|FG001|Overall Study|Entered extension study|120|||
128903690|NCT00876187|463939938|FG002|Overall Study|Entered extension study|156|||
128903691|NCT00876187|463939939|FG003|Overall Study|Entered extension study|151|||
128903692|NCT00876187|463939940|FG004|Overall Study|Entered extension study|144|||
128903693|NCT00876187|463939936|FG000|Overall Study|Randomized but not treated|3|||
128903694|NCT00876187|463939937|FG001|Overall Study|Randomized but not treated|1|||
128903695|NCT00876187|463939938|FG002|Overall Study|Randomized but not treated|3|||
128903696|NCT00876187|463939939|FG003|Overall Study|Randomized but not treated|2|||
128903697|NCT00876187|463939940|FG004|Overall Study|Randomized but not treated|3|||
128903698|NCT00876187|463939936|FG000|Overall Study|Other|2|||
128903699|NCT00876187|463939937|FG001|Overall Study|Other|5|||
128903700|NCT00876187|463939938|FG002|Overall Study|Other|9|||
128903701|NCT00876187|463939939|FG003|Overall Study|Other|7|||
128903702|NCT00876187|463939940|FG004|Overall Study|Other|4|||
128903703|NCT01650636|463939941|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
128903704|NCT01650636|463939942|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
128903705|NCT01650636|463939941|FG000|Washout up to 5 Months|Physician Decision|2|||
128903706|NCT01650636|463939942|FG001|Washout up to 5 Months|Physician Decision|2|||
128903707|NCT01650636|463939941|FG000|Washout up to 5 Months|Death|1|||
128903708|NCT01650636|463939942|FG001|Washout up to 5 Months|Death|0|||
128903709|NCT01650636|463939941|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
128903710|NCT01650636|463939942|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
128903711|NCT01650636|463939941|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
128903712|NCT01650636|463939942|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
128903713|NCT01650636|463939941|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
128903714|NCT01650636|463939942|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
128903715|NCT03363321|463939944|FG000|Overall Study|Withdrawal by Subject|0|||
128903716|NCT03363321|463939945|FG001|Overall Study|Withdrawal by Subject|1|||
128903717|NCT03363321|463939946|FG002|Overall Study|Withdrawal by Subject|0|||
128903718|NCT03363321|463939947|FG003|Overall Study|Withdrawal by Subject|1|||
128903719|NCT03363321|463939948|FG004|Overall Study|Withdrawal by Subject|0|||
128903720|NCT01577186|463939949|FG000|Overall Study|Adverse Event|23|||
128903721|NCT01577186|463939949|FG000|Overall Study|Death|1|||
128903722|NCT01577186|463939949|FG000|Overall Study|Lost to Follow-up|28|||
128903723|NCT01577186|463939949|FG000|Overall Study|Withdrawal by Subject|35|||
128903724|NCT01577186|463939949|FG000|Overall Study|Insufficient Response|18|||
128903725|NCT01577186|463939949|FG000|Overall Study|Ineligible to Continue|15|||
128903726|NCT01577186|463939949|FG000|Overall Study|Non-Compliant|8|||
128903727|NCT01577186|463939949|FG000|Overall Study|Other|2|||
128903728|NCT02915523|463939953|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
128903729|NCT02915523|463939954|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
128903730|NCT02915523|463939955|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
128903731|NCT02915523|463939956|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
128903732|NCT02915523|463939953|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
128903733|NCT02915523|463939954|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
128903734|NCT02915523|463939955|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
128903735|NCT02915523|463939956|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
128903736|NCT02915523|463939953|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
128903737|NCT02915523|463939954|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
128903738|NCT02915523|463939955|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
128903739|NCT02915523|463939956|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
128903740|NCT02915523|463939953|FG000|Expansion Phase (Phase 2)|Death|0|||
128903741|NCT02915523|463939954|FG001|Expansion Phase (Phase 2)|Death|0|||
128903742|NCT02915523|463939955|FG002|Expansion Phase (Phase 2)|Death|26|||
128903743|NCT02915523|463939956|FG003|Expansion Phase (Phase 2)|Death|53|||
128903744|NCT02915523|463939953|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
128903745|NCT02915523|463939954|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
128903746|NCT02915523|463939955|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
128903747|NCT02915523|463939956|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
128903748|NCT02915523|463939953|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
128903749|NCT02915523|463939954|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
128903750|NCT02915523|463939955|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
128903751|NCT02915523|463939956|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
128903752|NCT02915523|463939953|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
128903753|NCT02915523|463939954|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
128903754|NCT02915523|463939955|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
128903755|NCT02915523|463939956|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
128903756|NCT00957008|463939957|FG000|Overall Study|Withdrawal by Subject|13|||
128903757|NCT00957008|463939958|FG001|Overall Study|Withdrawal by Subject|10|||
128903758|NCT00957008|463939959|FG002|Overall Study|Withdrawal by Subject|12|||
128903759|NCT00957008|463939960|FG003|Overall Study|Withdrawal by Subject|16|||
128903760|NCT00957008|463939957|FG000|Overall Study|Lost to Follow-up|3|||
128903761|NCT00957008|463939958|FG001|Overall Study|Lost to Follow-up|1|||
128903762|NCT00957008|463939959|FG002|Overall Study|Lost to Follow-up|3|||
128903763|NCT00957008|463939960|FG003|Overall Study|Lost to Follow-up|4|||
128903764|NCT00957008|463939957|FG000|Overall Study|Physician Decision|1|||
128903765|NCT00957008|463939958|FG001|Overall Study|Physician Decision|0|||
128903766|NCT00957008|463939959|FG002|Overall Study|Physician Decision|1|||
128903767|NCT00957008|463939960|FG003|Overall Study|Physician Decision|1|||
128903768|NCT00957008|463939957|FG000|Overall Study|Relocated; Family conflict|4|||
128903769|NCT00957008|463939958|FG001|Overall Study|Relocated; Family conflict|1|||
128903770|NCT00957008|463939959|FG002|Overall Study|Relocated; Family conflict|1|||
128903771|NCT00957008|463939960|FG003|Overall Study|Relocated; Family conflict|3|||
128903772|NCT05630937|463939964|FG000|Overall Study|Study terminated by sponsor|1|||
128903773|NCT05630937|463939965|FG001|Overall Study|Study terminated by sponsor|1|||
128903774|NCT05630937|463939966|FG002|Overall Study|Study terminated by sponsor|8|||
128903775|NCT05630937|463939967|FG003|Overall Study|Study terminated by sponsor|0|||
128903776|NCT05630937|463939964|FG000|Overall Study|Lost to Follow-up|0|||
128903777|NCT05630937|463939965|FG001|Overall Study|Lost to Follow-up|0|||
128903778|NCT05630937|463939966|FG002|Overall Study|Lost to Follow-up|1|||
128903779|NCT05630937|463939967|FG003|Overall Study|Lost to Follow-up|0|||
128903780|NCT05630937|463939964|FG000|Overall Study|Enrolled but not treated|0|||
128903781|NCT05630937|463939965|FG001|Overall Study|Enrolled but not treated|0|||
128903782|NCT05630937|463939966|FG002|Overall Study|Enrolled but not treated|0|||
128903783|NCT05630937|463939967|FG003|Overall Study|Enrolled but not treated|1|||
128903784|NCT01604265|463939971|FG000|Overall Study|Adverse Event|1|||
128903785|NCT01604265|463939972|FG001|Overall Study|Adverse Event|0|||
128903786|NCT01604265|463939971|FG000|Overall Study|Withdrawal by Subject|1|||
128903787|NCT01604265|463939972|FG001|Overall Study|Withdrawal by Subject|0|||
128903788|NCT02706873|463939973|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
128903789|NCT02706873|463939974|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
128903790|NCT02706873|463939975|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
128903791|NCT02706873|463939976|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
128903792|NCT02706873|463939973|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
128903793|NCT02706873|463939974|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
128903794|NCT02706873|463939975|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
128903795|NCT02706873|463939976|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
128903796|NCT02706873|463939973|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
128903797|NCT02706873|463939974|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
128903798|NCT02706873|463939975|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
128903799|NCT02706873|463939976|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
128903800|NCT02706873|463939973|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
128903801|NCT02706873|463939974|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
128903802|NCT02706873|463939975|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
128903803|NCT02706873|463939976|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
128903804|NCT02706873|463939973|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
128903805|NCT02706873|463939974|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
128903806|NCT02706873|463939975|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
128903807|NCT02706873|463939976|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
128903808|NCT02706873|463939973|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
128903809|NCT02706873|463939974|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
128903810|NCT02706873|463939975|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
128903811|NCT02706873|463939976|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
128903812|NCT02706873|463939973|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
128903813|NCT02706873|463939974|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
128903814|NCT02706873|463939975|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
128903815|NCT02706873|463939976|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
128903816|NCT02706873|463939973|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
128903817|NCT02706873|463939974|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
128903818|NCT02706873|463939975|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
128903819|NCT02706873|463939976|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
128903820|NCT02706873|463939973|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
128903821|NCT02706873|463939974|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
128903822|NCT02706873|463939975|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
128903823|NCT02706873|463939976|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
128903824|NCT02706873|463939973|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
128903825|NCT02706873|463939974|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
128903826|NCT02706873|463939975|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
128903827|NCT02706873|463939976|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
128903828|NCT02706873|463939973|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
128903829|NCT02706873|463939974|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
128903830|NCT02706873|463939975|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
128903831|NCT02706873|463939976|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
128903832|NCT02706873|463939973|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
128903833|NCT02706873|463939974|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
129025641|NCT02890992|464387584|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129025642|NCT02890992|464387585|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
128903834|NCT02706873|463939975|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
128903835|NCT02706873|463939976|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
128903836|NCT02706873|463939973|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
128903837|NCT02706873|463939974|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
128903838|NCT02706873|463939975|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
128903839|NCT02706873|463939976|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
128903840|NCT00464334|463939982|FG000|Overall Study|Adverse Event|0|||
128903841|NCT00464334|463939983|FG001|Overall Study|Adverse Event|0|||
128903842|NCT00464334|463939984|FG002|Overall Study|Adverse Event|0|||
128903843|NCT00464334|463939985|FG003|Overall Study|Adverse Event|1|||
128903844|NCT00464334|463939986|FG004|Overall Study|Adverse Event|1|||
128903845|NCT00464334|463939987|FG005|Overall Study|Adverse Event|1|||
128903846|NCT00464334|463939988|FG006|Overall Study|Adverse Event|0|||
128903847|NCT00464334|463939989|FG007|Overall Study|Adverse Event|0|||
128903848|NCT00464334|463939990|FG008|Overall Study|Adverse Event|2|||
128903849|NCT00464334|463939991|FG009|Overall Study|Adverse Event|1|||
128903850|NCT00464334|463939992|FG010|Overall Study|Adverse Event|2|||
128903851|NCT00464334|463939982|FG000|Overall Study|Lack of Efficacy|0|||
128903852|NCT00464334|463939983|FG001|Overall Study|Lack of Efficacy|1|||
128903853|NCT00464334|463939984|FG002|Overall Study|Lack of Efficacy|0|||
128903854|NCT00464334|463939985|FG003|Overall Study|Lack of Efficacy|0|||
128903855|NCT00464334|463939986|FG004|Overall Study|Lack of Efficacy|0|||
128903856|NCT00464334|463939987|FG005|Overall Study|Lack of Efficacy|0|||
128903857|NCT00464334|463939988|FG006|Overall Study|Lack of Efficacy|0|||
128903858|NCT00464334|463939989|FG007|Overall Study|Lack of Efficacy|0|||
128903859|NCT00464334|463939990|FG008|Overall Study|Lack of Efficacy|0|||
128903860|NCT00464334|463939991|FG009|Overall Study|Lack of Efficacy|0|||
128903861|NCT00464334|463939992|FG010|Overall Study|Lack of Efficacy|0|||
128903862|NCT00464334|463939982|FG000|Overall Study|Lost to Follow-up|0|||
128903863|NCT00464334|463939983|FG001|Overall Study|Lost to Follow-up|0|||
128903864|NCT00464334|463939984|FG002|Overall Study|Lost to Follow-up|1|||
128903865|NCT00464334|463939985|FG003|Overall Study|Lost to Follow-up|0|||
128903866|NCT00464334|463939986|FG004|Overall Study|Lost to Follow-up|1|||
128903867|NCT00464334|463939987|FG005|Overall Study|Lost to Follow-up|0|||
128903868|NCT00464334|463939988|FG006|Overall Study|Lost to Follow-up|1|||
128903869|NCT00464334|463939989|FG007|Overall Study|Lost to Follow-up|0|||
128903870|NCT00464334|463939990|FG008|Overall Study|Lost to Follow-up|0|||
128903871|NCT00464334|463939991|FG009|Overall Study|Lost to Follow-up|0|||
128903872|NCT00464334|463939992|FG010|Overall Study|Lost to Follow-up|2|||
128903873|NCT00464334|463939982|FG000|Overall Study|Progressive Disease|0|||
128903874|NCT00464334|463939983|FG001|Overall Study|Progressive Disease|0|||
128903875|NCT00464334|463939984|FG002|Overall Study|Progressive Disease|0|||
128903876|NCT00464334|463939985|FG003|Overall Study|Progressive Disease|0|||
128903877|NCT00464334|463939986|FG004|Overall Study|Progressive Disease|0|||
128903878|NCT00464334|463939987|FG005|Overall Study|Progressive Disease|1|||
128903879|NCT00464334|463939988|FG006|Overall Study|Progressive Disease|0|||
128903880|NCT00464334|463939989|FG007|Overall Study|Progressive Disease|0|||
128903881|NCT00464334|463939990|FG008|Overall Study|Progressive Disease|1|||
128903882|NCT00464334|463939991|FG009|Overall Study|Progressive Disease|0|||
128903883|NCT00464334|463939992|FG010|Overall Study|Progressive Disease|0|||
128903884|NCT00464334|463939982|FG000|Overall Study|Study Terminated by Sponsor|0|||
128903885|NCT00464334|463939983|FG001|Overall Study|Study Terminated by Sponsor|0|||
128903886|NCT00464334|463939984|FG002|Overall Study|Study Terminated by Sponsor|0|||
128903887|NCT00464334|463939985|FG003|Overall Study|Study Terminated by Sponsor|1|||
128903888|NCT00464334|463939986|FG004|Overall Study|Study Terminated by Sponsor|0|||
128903889|NCT00464334|463939987|FG005|Overall Study|Study Terminated by Sponsor|0|||
128903890|NCT00464334|463939988|FG006|Overall Study|Study Terminated by Sponsor|0|||
128903891|NCT00464334|463939989|FG007|Overall Study|Study Terminated by Sponsor|0|||
128903892|NCT00464334|463939990|FG008|Overall Study|Study Terminated by Sponsor|0|||
128903893|NCT00464334|463939991|FG009|Overall Study|Study Terminated by Sponsor|0|||
128903894|NCT00464334|463939992|FG010|Overall Study|Study Terminated by Sponsor|0|||
128903895|NCT00464334|463939982|FG000|Overall Study|Withdrawal by Subject|1|||
128903896|NCT00464334|463939983|FG001|Overall Study|Withdrawal by Subject|7|||
128903897|NCT00464334|463939984|FG002|Overall Study|Withdrawal by Subject|4|||
128903898|NCT00464334|463939985|FG003|Overall Study|Withdrawal by Subject|2|||
128903899|NCT00464334|463939986|FG004|Overall Study|Withdrawal by Subject|2|||
128903900|NCT00464334|463939987|FG005|Overall Study|Withdrawal by Subject|2|||
128903901|NCT00464334|463939988|FG006|Overall Study|Withdrawal by Subject|2|||
128903902|NCT00464334|463939989|FG007|Overall Study|Withdrawal by Subject|1|||
128903903|NCT00464334|463939990|FG008|Overall Study|Withdrawal by Subject|3|||
128903904|NCT00464334|463939991|FG009|Overall Study|Withdrawal by Subject|0|||
128903905|NCT00464334|463939992|FG010|Overall Study|Withdrawal by Subject|0|||
128903906|NCT00794677|463939999|FG000|First Intervention|Withdrawal by Subject|2|||
128903907|NCT00794677|463940000|FG001|First Intervention|Withdrawal by Subject|0|||
128903908|NCT01422915|463940001|FG000|Overall Study|Adverse Event|1|||
128903909|NCT01152021|463940002|FG000|Overall Study|Adverse Event|4|||
128903910|NCT01152021|463940003|FG001|Overall Study|Adverse Event|4|||
128903911|NCT01152021|463940002|FG000|Overall Study|Study drug had expired|1|||
128903912|NCT01152021|463940003|FG001|Overall Study|Study drug had expired|0|||
128903913|NCT01152021|463940002|FG000|Overall Study|Physician Decision|1|||
128903914|NCT01152021|463940003|FG001|Overall Study|Physician Decision|1|||
128903915|NCT01152021|463940002|FG000|Overall Study|No access to study drug in Pharmacy|0|||
128903916|NCT01152021|463940003|FG001|Overall Study|No access to study drug in Pharmacy|1|||
128903917|NCT00889265|463940009|FG000|Overall Study|Adverse Event|1|||
128903918|NCT00889265|463940009|FG000|Overall Study|Lost to Follow-up|5|||
128903919|NCT00889265|463940009|FG000|Overall Study|Protocol Violation|1|||
128903920|NCT00531752|463940013|FG000|First Double-blind Intervention Period|Adverse Event|2|||
128903921|NCT00531752|463940014|FG001|First Double-blind Intervention Period|Adverse Event|0|||
128903922|NCT00531752|463940015|FG002|First Double-blind Intervention Period|Adverse Event|1|||
128903923|NCT00531752|463940016|FG003|First Double-blind Intervention Period|Adverse Event|1|||
128903924|NCT00531752|463940013|FG000|First Double-blind Intervention Period|Other|1|||
128903925|NCT00531752|463940014|FG001|First Double-blind Intervention Period|Other|4|||
128903926|NCT00531752|463940015|FG002|First Double-blind Intervention Period|Other|4|||
128903927|NCT00531752|463940016|FG003|First Double-blind Intervention Period|Other|0|||
128903928|NCT00531752|463940013|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
128903929|NCT00531752|463940014|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
128903930|NCT00531752|463940015|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
128903931|NCT00531752|463940016|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
128903932|NCT00531752|463940013|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
128903933|NCT00531752|463940014|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
128903934|NCT00531752|463940015|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
128903935|NCT00531752|463940016|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
128903936|NCT00531752|463940013|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
128903937|NCT00531752|463940014|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
128903938|NCT00531752|463940015|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
128903939|NCT00531752|463940016|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
128903940|NCT00531752|463940013|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
128903941|NCT00531752|463940014|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
128903942|NCT00531752|463940015|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
128903943|NCT00531752|463940016|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
128903944|NCT00531752|463940013|FG000|Second Double-blind Intervention Period|Other|1|||
128903945|NCT00531752|463940014|FG001|Second Double-blind Intervention Period|Other|1|||
128903946|NCT00531752|463940015|FG002|Second Double-blind Intervention Period|Other|0|||
128903947|NCT00531752|463940016|FG003|Second Double-blind Intervention Period|Other|0|||
128903948|NCT00531752|463940013|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
128903949|NCT00531752|463940014|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
128903950|NCT00531752|463940015|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
128903951|NCT00531752|463940016|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
128903952|NCT00531752|463940013|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
128903953|NCT00531752|463940014|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
128903954|NCT00531752|463940015|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
128903955|NCT00531752|463940016|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
128903956|NCT00401375|463940017|FG000|Overall Study|Protocol Violation|2|||
128903957|NCT00401375|463940018|FG001|Overall Study|Protocol Violation|2|||
128903958|NCT00401375|463940019|FG002|Overall Study|Protocol Violation|1|||
128903959|NCT00401375|463940017|FG000|Overall Study|Adverse Event|6|||
128903960|NCT00401375|463940018|FG001|Overall Study|Adverse Event|11|||
128903961|NCT00401375|463940019|FG002|Overall Study|Adverse Event|10|||
128903962|NCT00401375|463940017|FG000|Overall Study|Withdrawal by Subject|9|||
128903963|NCT00401375|463940018|FG001|Overall Study|Withdrawal by Subject|7|||
128903964|NCT00401375|463940019|FG002|Overall Study|Withdrawal by Subject|7|||
128903965|NCT00401375|463940017|FG000|Overall Study|Lost to Follow-up|0|||
128903966|NCT00401375|463940018|FG001|Overall Study|Lost to Follow-up|1|||
128903967|NCT00401375|463940019|FG002|Overall Study|Lost to Follow-up|1|||
128903968|NCT00401375|463940017|FG000|Overall Study|Other than specified|2|||
128903969|NCT00401375|463940018|FG001|Overall Study|Other than specified|1|||
128903970|NCT00401375|463940019|FG002|Overall Study|Other than specified|3|||
128903971|NCT00401375|463940017|FG000|Overall Study|Randomized but not treated|3|||
128903972|NCT00401375|463940018|FG001|Overall Study|Randomized but not treated|3|||
128903973|NCT00401375|463940019|FG002|Overall Study|Randomized but not treated|3|||
128903974|NCT00950664|463940020|FG000|First Intervention|Lost to Follow-up|1|||
128903975|NCT00950664|463940021|FG001|First Intervention|Lost to Follow-up|3|||
128903976|NCT00950664|463940020|FG000|First Intervention|Withdrawal by Subject|2|||
128903977|NCT00950664|463940021|FG001|First Intervention|Withdrawal by Subject|2|||
128903978|NCT02821715|463940022|FG000|Overall Study|Protocol Violation|1|||
128903979|NCT02821715|463940023|FG001|Overall Study|Protocol Violation|0|||
128903980|NCT02821715|463940024|FG002|Overall Study|Protocol Violation|0|||
129115421|NCT01130272|464719742|FG004|Overall Study|Study arm discontinued|0|||
128903981|NCT02821715|463940025|FG003|Overall Study|Protocol Violation|0|||
129115422|NCT01548404|464719743|FG000|Overall Study|Adverse Event|3|||
128903982|NCT02821715|463940026|FG004|Overall Study|Protocol Violation|0|||
129115423|NCT01548404|464719744|FG001|Overall Study|Adverse Event|1|||
128694157|NCT01543698|463180421|FG007|Phase 2|Administrative problems|0|||
128903983|NCT02821715|463940027|FG005|Overall Study|Protocol Violation|0|||
128903984|NCT03152019|463940028|FG000|Overall Study|Adverse Event|0|||
128903985|NCT03152019|463940029|FG001|Overall Study|Adverse Event|1|||
128903986|NCT00254501|463940035|FG000|Overall Study|Lost to Follow-up|1|||
128903987|NCT00254501|463940036|FG001|Overall Study|Lost to Follow-up|1|||
128903988|NCT00923130|463940037|FG000|Overall Study|Stopped treatment due to progression|17|||
128903989|NCT00923130|463940037|FG000|Overall Study|Death|1|||
128903990|NCT00923130|463940037|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
128903991|NCT00923130|463940037|FG000|Overall Study|Switched to alternative treatment|2|||
128903992|NCT00923130|463940037|FG000|Overall Study|Refused further treatment|2|||
128903993|NCT04682405|463941419|FG000|Overall Study|Adverse Event|0|||
128903994|NCT04682405|463941420|FG001|Overall Study|Adverse Event|1|||
128903995|NCT00522431|463941421|FG000|Overall Study|Adverse Event|5|||
128903996|NCT00522431|463941421|FG000|Overall Study|Protocol Violation|2|||
128903997|NCT00522431|463941421|FG000|Overall Study|Withdrawal by Subject|2|||
128903998|NCT00522431|463941421|FG000|Overall Study|Subject non-compliance|1|||
128903999|NCT00522431|463941421|FG000|Overall Study|Other/unknown|1|||
128904000|NCT01049035|463941424|FG000|Overall Study|Serious adverse event|0|||
128904001|NCT01049035|463941425|FG001|Overall Study|Serious adverse event|1|||
128904002|NCT01049035|463941426|FG002|Overall Study|Serious adverse event|1|||
128904003|NCT01049035|463941427|FG003|Overall Study|Serious adverse event|2|||
128904004|NCT01049035|463941428|FG004|Overall Study|Serious adverse event|0|||
128904005|NCT01049035|463941429|FG005|Overall Study|Serious adverse event|0|||
128904006|NCT01049035|463941430|FG006|Overall Study|Serious adverse event|0|||
128904007|NCT01049035|463941424|FG000|Overall Study|Other adverse event (AE)|0|||
128904008|NCT01049035|463941425|FG001|Overall Study|Other adverse event (AE)|0|||
128904009|NCT01049035|463941426|FG002|Overall Study|Other adverse event (AE)|0|||
128904010|NCT01049035|463941427|FG003|Overall Study|Other adverse event (AE)|1|||
128904011|NCT01049035|463941428|FG004|Overall Study|Other adverse event (AE)|0|||
128904012|NCT01049035|463941429|FG005|Overall Study|Other adverse event (AE)|0|||
128904013|NCT01049035|463941430|FG006|Overall Study|Other adverse event (AE)|0|||
128904014|NCT01049035|463941424|FG000|Overall Study|Non-compliance with the protocol|12|||
128904015|NCT01049035|463941425|FG001|Overall Study|Non-compliance with the protocol|6|||
128904016|NCT01049035|463941426|FG002|Overall Study|Non-compliance with the protocol|14|||
128904017|NCT01049035|463941427|FG003|Overall Study|Non-compliance with the protocol|5|||
128904018|NCT01049035|463941428|FG004|Overall Study|Non-compliance with the protocol|3|||
128904019|NCT01049035|463941429|FG005|Overall Study|Non-compliance with the protocol|4|||
128904020|NCT01049035|463941430|FG006|Overall Study|Non-compliance with the protocol|10|||
128904021|NCT01049035|463941424|FG000|Overall Study|Lost to Follow-up|5|||
128904022|NCT01049035|463941425|FG001|Overall Study|Lost to Follow-up|4|||
128904023|NCT01049035|463941426|FG002|Overall Study|Lost to Follow-up|4|||
128904024|NCT01049035|463941427|FG003|Overall Study|Lost to Follow-up|1|||
128904025|NCT01049035|463941428|FG004|Overall Study|Lost to Follow-up|0|||
128904026|NCT01049035|463941429|FG005|Overall Study|Lost to Follow-up|3|||
128904027|NCT01049035|463941430|FG006|Overall Study|Lost to Follow-up|3|||
128904028|NCT01049035|463941424|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
128904029|NCT01049035|463941425|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
128904030|NCT01049035|463941426|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
128904031|NCT01049035|463941427|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
128904032|NCT01049035|463941428|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
128904033|NCT01049035|463941429|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
128904034|NCT01049035|463941430|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
128904035|NCT02095535|463941431|FG000|Recruitment|Protocol Violation|2|||
128904036|NCT00623480|463941432|FG000|Overall Study|Lost to Follow-up|0|||
128904037|NCT00623480|463941433|FG001|Overall Study|Lost to Follow-up|1|||
128904038|NCT00623480|463941432|FG000|Overall Study|Withdrawal by Subject|2|||
128904039|NCT00623480|463941433|FG001|Overall Study|Withdrawal by Subject|4|||
128904040|NCT00623480|463941432|FG000|Overall Study|Lack of Efficacy|1|||
128904041|NCT00623480|463941433|FG001|Overall Study|Lack of Efficacy|0|||
128904042|NCT00623480|463941432|FG000|Overall Study|Non-compliant with study medication|4|||
128904043|NCT00623480|463941433|FG001|Overall Study|Non-compliant with study medication|0|||
128694158|NCT01543698|463180422|FG008|Phase 2|Administrative problems|0|||
128694159|NCT01543698|463180423|FG009|Phase 2|Administrative problems|0|||
128694160|NCT01543698|463180424|FG010|Phase 2|Administrative problems|0|||
128904044|NCT00623480|463941432|FG000|Overall Study|Protocol Violation|0|||
128904045|NCT00623480|463941433|FG001|Overall Study|Protocol Violation|1|||
128904046|NCT00623480|463941432|FG000|Overall Study|Site closed by sponsor|0|||
128904047|NCT00623480|463941433|FG001|Overall Study|Site closed by sponsor|1|||
128904048|NCT03709654|463941434|FG000|Overall Study|Lost to Follow-up|1|||
128904049|NCT03709654|463941435|FG001|Overall Study|Lost to Follow-up|1|||
128904050|NCT03709654|463941434|FG000|Overall Study|Withdrawal by Subject|1|||
128904051|NCT03709654|463941435|FG001|Overall Study|Withdrawal by Subject|1|||
128904052|NCT03709654|463941434|FG000|Overall Study|Adverse Event|1|||
128904053|NCT03709654|463941435|FG001|Overall Study|Adverse Event|0|||
128904054|NCT01902966|463941436|FG000|Overall Study|Death|1|||
128904055|NCT01902966|463941436|FG000|Overall Study|Physician Decision|1|||
128904056|NCT01902966|463941436|FG000|Overall Study|Withdrawal by Subject|1|||
128904057|NCT02631200|463941439|FG000|First Period|Death|1|||
128904058|NCT02631200|463941440|FG001|First Period|Death|2|||
128904059|NCT02631200|463941439|FG000|First Period|Patient ill-health|2|||
128904060|NCT02631200|463941440|FG001|First Period|Patient ill-health|4|||
128904061|NCT02631200|463941439|FG000|First Period|Withdrawal by Subject|4|||
128904062|NCT02631200|463941440|FG001|First Period|Withdrawal by Subject|1|||
128904063|NCT02631200|463941439|FG000|Deferred Period|Death|0|||
128904064|NCT02631200|463941440|FG001|Deferred Period|Death|1|||
128904065|NCT02631200|463941439|FG000|Deferred Period|Received kidney transplant|0|||
128904066|NCT02631200|463941440|FG001|Deferred Period|Received kidney transplant|1|||
128904067|NCT02631200|463941439|FG000|Deferred Period|Withdrawal by Subject|0|||
128904068|NCT02631200|463941440|FG001|Deferred Period|Withdrawal by Subject|2|||
128904069|NCT02631200|463941439|FG000|Deferred Period|Lost to Follow-up|0|||
128904070|NCT02631200|463941440|FG001|Deferred Period|Lost to Follow-up|1|||
128904071|NCT01081912|463941441|FG000|Conversion/Titration|Adverse Event|47|||
128904072|NCT01081912|463941442|FG001|Conversion/Titration|Adverse Event|0|||
128904073|NCT01081912|463941443|FG002|Conversion/Titration|Adverse Event|0|||
128904074|NCT01081912|463941441|FG000|Conversion/Titration|Lack of Efficacy|17|||
128904075|NCT01081912|463941442|FG001|Conversion/Titration|Lack of Efficacy|0|||
128904076|NCT01081912|463941443|FG002|Conversion/Titration|Lack of Efficacy|0|||
128904077|NCT01081912|463941441|FG000|Conversion/Titration|Lost to Follow-up|5|||
128904078|NCT01081912|463941442|FG001|Conversion/Titration|Lost to Follow-up|0|||
128904079|NCT01081912|463941443|FG002|Conversion/Titration|Lost to Follow-up|0|||
128904080|NCT01081912|463941441|FG000|Conversion/Titration|Physician Decision|2|||
128904081|NCT01081912|463941442|FG001|Conversion/Titration|Physician Decision|0|||
128904082|NCT01081912|463941443|FG002|Conversion/Titration|Physician Decision|0|||
128904083|NCT01081912|463941441|FG000|Conversion/Titration|Protocol Violation|67|||
128904084|NCT01081912|463941442|FG001|Conversion/Titration|Protocol Violation|0|||
128904085|NCT01081912|463941443|FG002|Conversion/Titration|Protocol Violation|0|||
128904086|NCT01081912|463941441|FG000|Conversion/Titration|Withdrawal by Subject|23|||
128904087|NCT01081912|463941442|FG001|Conversion/Titration|Withdrawal by Subject|0|||
128904088|NCT01081912|463941443|FG002|Conversion/Titration|Withdrawal by Subject|0|||
128904089|NCT01081912|463941441|FG000|Conversion/Titration|Non-Compliance|47|||
128904090|NCT01081912|463941442|FG001|Conversion/Titration|Non-Compliance|0|||
128904091|NCT01081912|463941443|FG002|Conversion/Titration|Non-Compliance|0|||
128904092|NCT01081912|463941441|FG000|Maintenance Treatment|Adverse Event|0|||
128904093|NCT01081912|463941442|FG001|Maintenance Treatment|Adverse Event|2|||
128904094|NCT01081912|463941443|FG002|Maintenance Treatment|Adverse Event|12|||
128904095|NCT01081912|463941441|FG000|Maintenance Treatment|Lack of Efficacy|0|||
128904096|NCT01081912|463941442|FG001|Maintenance Treatment|Lack of Efficacy|14|||
128904097|NCT01081912|463941443|FG002|Maintenance Treatment|Lack of Efficacy|64|||
128904098|NCT01081912|463941441|FG000|Maintenance Treatment|Lost to Follow-up|0|||
128904099|NCT01081912|463941442|FG001|Maintenance Treatment|Lost to Follow-up|1|||
128904100|NCT01081912|463941443|FG002|Maintenance Treatment|Lost to Follow-up|0|||
128904101|NCT01081912|463941441|FG000|Maintenance Treatment|Physician Decision|0|||
128764769|NCT03485911|463430298|FG001|Part 2|Intercurrent illness/new medical condition|0|||
128904102|NCT01081912|463941442|FG001|Maintenance Treatment|Physician Decision|0|||
128904103|NCT01081912|463941443|FG002|Maintenance Treatment|Physician Decision|1|||
128904104|NCT01081912|463941441|FG000|Maintenance Treatment|Protocol Violation|0|||
128904105|NCT01081912|463941442|FG001|Maintenance Treatment|Protocol Violation|1|||
128904106|NCT01081912|463941443|FG002|Maintenance Treatment|Protocol Violation|2|||
128904107|NCT01081912|463941441|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
128904108|NCT01081912|463941442|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
128904109|NCT01081912|463941443|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
128904110|NCT01081912|463941441|FG000|Maintenance Treatment|Non-Compliance|0|||
128904111|NCT01081912|463941442|FG001|Maintenance Treatment|Non-Compliance|4|||
128904112|NCT01081912|463941443|FG002|Maintenance Treatment|Non-Compliance|7|||
129025643|NCT02890992|464387586|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129025644|NCT02890992|464387587|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129025645|NCT02890992|464387588|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129025646|NCT02890992|464387581|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129025647|NCT02890992|464387582|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129025648|NCT02890992|464387583|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129025649|NCT02890992|464387584|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129115424|NCT01548404|464719743|FG000|Overall Study|Physician Decision|2|||
129115425|NCT01548404|464719744|FG001|Overall Study|Physician Decision|1|||
128904113|NCT01081912|463941441|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
128904114|NCT01081912|463941442|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
128904115|NCT01081912|463941443|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
128904116|NCT02083380|463941447|FG000|Overall Study|Lack of Efficacy|68|||
128904117|NCT02083380|463941448|FG001|Overall Study|Lack of Efficacy|79|||
128904118|NCT02083380|463941449|FG002|Overall Study|Lack of Efficacy|64|||
128904119|NCT02083380|463941447|FG000|Overall Study|Withdrawal by Subject|9|||
129025650|NCT02890992|464387585|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129025651|NCT02890992|464387586|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129025652|NCT02890992|464387587|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
129025653|NCT02890992|464387588|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
129025654|NCT02890992|464387581|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
129025655|NCT02890992|464387582|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
129025656|NCT02890992|464387583|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
129025657|NCT02890992|464387584|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
129025658|NCT02890992|464387585|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
129025659|NCT02890992|464387586|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
129025660|NCT02890992|464387587|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
129025661|NCT02890992|464387588|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
129025662|NCT00807495|464387589|FG000|Overall Study|Adverse Event|6|||
129025663|NCT00807495|464387590|FG001|Overall Study|Adverse Event|3|||
129025664|NCT00807495|464387591|FG002|Overall Study|Adverse Event|1|||
129025665|NCT00807495|464387592|FG003|Overall Study|Adverse Event|1|||
129025666|NCT00807495|464387593|FG004|Overall Study|Adverse Event|2|||
129025667|NCT00807495|464387589|FG000|Overall Study|Withdrawal by Patient|2|||
129025668|NCT00807495|464387590|FG001|Overall Study|Withdrawal by Patient|0|||
129025669|NCT00807495|464387591|FG002|Overall Study|Withdrawal by Patient|1|||
129025670|NCT00807495|464387592|FG003|Overall Study|Withdrawal by Patient|0|||
129025671|NCT00807495|464387593|FG004|Overall Study|Withdrawal by Patient|0|||
129025672|NCT00807495|464387589|FG000|Overall Study|Reason Not Specified|0|||
128904120|NCT02083380|463941448|FG001|Overall Study|Withdrawal by Subject|3|||
128904121|NCT02083380|463941449|FG002|Overall Study|Withdrawal by Subject|7|||
129025673|NCT00807495|464387590|FG001|Overall Study|Reason Not Specified|3|||
129025674|NCT00807495|464387591|FG002|Overall Study|Reason Not Specified|2|||
129025675|NCT00807495|464387592|FG003|Overall Study|Reason Not Specified|0|||
129025676|NCT00807495|464387593|FG004|Overall Study|Reason Not Specified|3|||
129025677|NCT01174186|464387597|FG000|Overall Study|Lost to Follow-up|0|||
129025678|NCT01174186|464387598|FG001|Overall Study|Lost to Follow-up|1|||
129025679|NCT01174186|464387597|FG000|Overall Study|Withdrawal by Subject|0|||
129025680|NCT01174186|464387598|FG001|Overall Study|Withdrawal by Subject|2|||
128904122|NCT02083380|463941447|FG000|Overall Study|Physician Decision|1|||
128904123|NCT02083380|463941448|FG001|Overall Study|Physician Decision|6|||
128904124|NCT02083380|463941449|FG002|Overall Study|Physician Decision|3|||
128904125|NCT02083380|463941447|FG000|Overall Study|Adverse Event|0|||
128904126|NCT02083380|463941448|FG001|Overall Study|Adverse Event|0|||
128904127|NCT02083380|463941449|FG002|Overall Study|Adverse Event|1|||
128904128|NCT02083380|463941447|FG000|Overall Study|Lost to Follow-up|5|||
128904129|NCT02083380|463941448|FG001|Overall Study|Lost to Follow-up|3|||
128904130|NCT02083380|463941449|FG002|Overall Study|Lost to Follow-up|3|||
128904131|NCT02083380|463941447|FG000|Overall Study|Other|8|||
128904132|NCT02083380|463941448|FG001|Overall Study|Other|4|||
128904133|NCT02083380|463941449|FG002|Overall Study|Other|6|||
128904134|NCT00001379|463941450|FG000|Initial Treatment|Disease progression|21|||
128904135|NCT00001379|463941451|FG001|Initial Treatment|Disease progression|3|||
128904136|NCT00001379|463941452|FG002|Initial Treatment|Disease progression|0|||
128904137|NCT00001379|463941453|FG003|Initial Treatment|Disease progression|0|||
129025681|NCT05274763|464387599|FG000|Overall Study|Lost to Follow-up|1|||
129025682|NCT00909753|464387601|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
129025683|NCT00909753|464387602|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
129025684|NCT00909753|464387601|FG000|Period: Second Intervention|Protocol Violation|1|||
128764770|NCT03485911|463430299|FG002|Part 2|Intercurrent illness/new medical condition|0|||
128764771|NCT03485911|463430300|FG003|Part 2|Intercurrent illness/new medical condition|0|||
128764772|NCT03485911|463430297|FG000|Part 2|Investigator judgement|1|||
128764773|NCT03485911|463430298|FG001|Part 2|Investigator judgement|0|||
128764774|NCT03485911|463430299|FG002|Part 2|Investigator judgement|0|||
128764775|NCT03485911|463430300|FG003|Part 2|Investigator judgement|0|||
128764776|NCT03485911|463430297|FG000|Part 3|Perceived lack of efficacy|2|||
128764777|NCT03485911|463430298|FG001|Part 3|Perceived lack of efficacy|2|||
128764778|NCT03485911|463430299|FG002|Part 3|Perceived lack of efficacy|2|||
129025685|NCT00909753|464387602|FG001|Period: Second Intervention|Protocol Violation|0|||
128764779|NCT03485911|463430300|FG003|Part 3|Perceived lack of efficacy|0|||
128764780|NCT03485911|463430297|FG000|Part 3|Subject withdrew consent|1|||
128764781|NCT03485911|463430298|FG001|Part 3|Subject withdrew consent|4|||
128764782|NCT03485911|463430299|FG002|Part 3|Subject withdrew consent|0|||
128764783|NCT03485911|463430300|FG003|Part 3|Subject withdrew consent|1|||
128904138|NCT00001379|463941450|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
128904139|NCT00001379|463941451|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
128904140|NCT00001379|463941452|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
128764784|NCT03485911|463430297|FG000|Part 3|Lab abnormalities/AEs|1|||
128904141|NCT00001379|463941453|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
128904142|NCT00001379|463941450|FG000|Initial Treatment|Received alternative treatment|2|||
128904143|NCT00001379|463941451|FG001|Initial Treatment|Received alternative treatment|1|||
128904144|NCT00001379|463941452|FG002|Initial Treatment|Received alternative treatment|0|||
128904145|NCT00001379|463941453|FG003|Initial Treatment|Received alternative treatment|0|||
128904146|NCT00001379|463941450|FG000|Initial Treatment|Refused further treatment|2|||
128904147|NCT00001379|463941451|FG001|Initial Treatment|Refused further treatment|0|||
128904148|NCT00001379|463941452|FG002|Initial Treatment|Refused further treatment|0|||
128904149|NCT00001379|463941453|FG003|Initial Treatment|Refused further treatment|0|||
128904150|NCT00001379|463941450|FG000|Initial Treatment|Did not receive protocol treatment|0|||
128904151|NCT00001379|463941451|FG001|Initial Treatment|Did not receive protocol treatment|0|||
128904152|NCT00001379|463941452|FG002|Initial Treatment|Did not receive protocol treatment|5|||
128764785|NCT03485911|463430298|FG001|Part 3|Lab abnormalities/AEs|1|||
128764786|NCT03485911|463430299|FG002|Part 3|Lab abnormalities/AEs|0|||
128764787|NCT03485911|463430300|FG003|Part 3|Lab abnormalities/AEs|2|||
128764788|NCT03485911|463430297|FG000|Part 3|Other NOS|1|||
128764789|NCT03485911|463430298|FG001|Part 3|Other NOS|1|||
128764790|NCT03485911|463430299|FG002|Part 3|Other NOS|0|||
128764791|NCT03485911|463430300|FG003|Part 3|Other NOS|0|||
128764792|NCT03485911|463430297|FG000|Part 3|Intercurrent illness/new medical condition|0|||
128904153|NCT00001379|463941453|FG003|Initial Treatment|Did not receive protocol treatment|0|||
128764793|NCT03485911|463430298|FG001|Part 3|Intercurrent illness/new medical condition|1|||
128764794|NCT03485911|463430299|FG002|Part 3|Intercurrent illness/new medical condition|1|||
128764795|NCT03485911|463430300|FG003|Part 3|Intercurrent illness/new medical condition|0|||
128764796|NCT03485911|463430297|FG000|Part 3|Sponsor discontinuation|1|||
128764797|NCT03485911|463430298|FG001|Part 3|Sponsor discontinuation|0|||
128764798|NCT03485911|463430299|FG002|Part 3|Sponsor discontinuation|0|||
128764799|NCT03485911|463430300|FG003|Part 3|Sponsor discontinuation|0|||
128764800|NCT03485911|463430297|FG000|Part 3|Berotralstat provided by alternative means|13|||
128764801|NCT03485911|463430298|FG001|Part 3|Berotralstat provided by alternative means|13|||
128764802|NCT03485911|463430299|FG002|Part 3|Berotralstat provided by alternative means|7|||
128764803|NCT03485911|463430300|FG003|Part 3|Berotralstat provided by alternative means|7|||
128764804|NCT01346514|463430301|FG000|Overall Study|Lost to Follow-up|19|||
128764805|NCT01346514|463430302|FG001|Overall Study|Lost to Follow-up|30|||
128764806|NCT01346514|463430301|FG000|Overall Study|Withdrawal by Subject|7|||
128764807|NCT01346514|463430302|FG001|Overall Study|Withdrawal by Subject|3|||
128764808|NCT01346514|463430301|FG000|Overall Study|Death|3|||
128764809|NCT01346514|463430302|FG001|Overall Study|Death|4|||
128764810|NCT00909480|463430303|FG000|Overall Study|Adverse Event|5|||
128764811|NCT00909480|463430304|FG001|Overall Study|Adverse Event|3|||
128764812|NCT00909480|463430303|FG000|Overall Study|Protocol Violation|6|||
128764813|NCT00909480|463430304|FG001|Overall Study|Protocol Violation|8|||
128764814|NCT00909480|463430303|FG000|Overall Study|Withdrawal criteria|9|||
128904154|NCT00001379|463941450|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
129025686|NCT00418145|464387605|FG000|Overall Study|study terminated|6|||
129025687|NCT03214588|464387606|FG000|Overall Study|Adverse Event|1|||
128694161|NCT01543698|463180425|FG011|Phase 2|Administrative problems|0|||
128694162|NCT01543698|463180426|FG012|Phase 2|Administrative problems|0|||
128694163|NCT01543698|463180427|FG013|Phase 2|Administrative problems|3|||
128694164|NCT01543698|463180428|FG014|Phase 2|Administrative problems|1|||
128694165|NCT01543698|463180414|FG000|Phase 2|Withdrawal by Subject|0|||
128694166|NCT01543698|463180415|FG001|Phase 2|Withdrawal by Subject|0|||
128694167|NCT01543698|463180416|FG002|Phase 2|Withdrawal by Subject|0|||
128694168|NCT01543698|463180417|FG003|Phase 2|Withdrawal by Subject|0|||
128694169|NCT01543698|463180418|FG004|Phase 2|Withdrawal by Subject|0|||
128694170|NCT01543698|463180419|FG005|Phase 2|Withdrawal by Subject|0|||
128694171|NCT01543698|463180420|FG006|Phase 2|Withdrawal by Subject|0|||
128694172|NCT01543698|463180421|FG007|Phase 2|Withdrawal by Subject|0|||
128694173|NCT01543698|463180422|FG008|Phase 2|Withdrawal by Subject|0|||
128694174|NCT01543698|463180423|FG009|Phase 2|Withdrawal by Subject|0|||
128694175|NCT01543698|463180424|FG010|Phase 2|Withdrawal by Subject|0|||
128694176|NCT01543698|463180425|FG011|Phase 2|Withdrawal by Subject|0|||
129025688|NCT03214588|464387607|FG001|Overall Study|Adverse Event|0|||
128694177|NCT01543698|463180426|FG012|Phase 2|Withdrawal by Subject|0|||
128694178|NCT01543698|463180427|FG013|Phase 2|Withdrawal by Subject|3|||
128694179|NCT01543698|463180428|FG014|Phase 2|Withdrawal by Subject|1|||
128694180|NCT01543698|463180414|FG000|Phase 2|Adverse Event|0|||
128764815|NCT00909480|463430304|FG001|Overall Study|Withdrawal criteria|11|||
128764816|NCT00909480|463430303|FG000|Overall Study|Unclassified|18|||
128764817|NCT00909480|463430304|FG001|Overall Study|Unclassified|19|||
128764818|NCT01215357|463430308|FG000|Overall Study|Withdrawal by Subject|3|||
128764819|NCT01215357|463430308|FG000|Overall Study|Protocol Violation|9|||
128764820|NCT03002038|463430315|FG000|Overall Study|Adverse Event|3|||
128694181|NCT01543698|463180415|FG001|Phase 2|Adverse Event|0|||
128764821|NCT03002038|463430316|FG001|Overall Study|Adverse Event|1|||
129025689|NCT03214588|464387608|FG002|Overall Study|Adverse Event|2|||
129025690|NCT03214588|464387606|FG000|Overall Study|Reason Not Specified|0|||
129025691|NCT03214588|464387607|FG001|Overall Study|Reason Not Specified|1|||
128904155|NCT00001379|463941451|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
128904156|NCT00001379|463941452|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
128904157|NCT00001379|463941453|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
128904158|NCT00001379|463941450|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
128904159|NCT00001379|463941451|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
128904160|NCT00001379|463941452|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
128904161|NCT00001379|463941453|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
128904162|NCT00001379|463941450|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
128904163|NCT00001379|463941451|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
128904164|NCT00001379|463941452|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
128904165|NCT00001379|463941453|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
128904166|NCT00001379|463941450|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
128904167|NCT00001379|463941451|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
128694182|NCT01543698|463180416|FG002|Phase 2|Adverse Event|0|||
128904168|NCT00001379|463941452|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
128904169|NCT00001379|463941453|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
128904170|NCT00001379|463941450|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
128904171|NCT00001379|463941451|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
128904172|NCT00001379|463941452|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
128904173|NCT00001379|463941453|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
128904174|NCT00405067|463941456|FG000|Overall Study|Adverse Event|4|||
128904175|NCT00405067|463941457|FG001|Overall Study|Adverse Event|9|||
128904176|NCT00405067|463941458|FG002|Overall Study|Adverse Event|4|||
128904177|NCT00405067|463941456|FG000|Overall Study|Lost to Follow-up|0|||
128904178|NCT00405067|463941457|FG001|Overall Study|Lost to Follow-up|0|||
128904179|NCT00405067|463941458|FG002|Overall Study|Lost to Follow-up|1|||
128904180|NCT01560780|463941459|FG000|Overall Study|Death|2|||
128904181|NCT01560780|463941460|FG001|Overall Study|Death|1|||
128904182|NCT01560780|463941459|FG000|Overall Study|Patient Preference|11|||
128904183|NCT01560780|463941460|FG001|Overall Study|Patient Preference|11|||
128904184|NCT01032915|463941461|FG000|Overall Study|Adverse Event|2|||
128904185|NCT01032915|463941462|FG001|Overall Study|Adverse Event|2|||
128904186|NCT01032915|463941463|FG002|Overall Study|Adverse Event|1|||
128904187|NCT01032915|463941464|FG003|Overall Study|Adverse Event|1|||
128904188|NCT01032915|463941461|FG000|Overall Study|Abnormal test procedure result|0|||
128904189|NCT01032915|463941462|FG001|Overall Study|Abnormal test procedure result|0|||
128904190|NCT01032915|463941463|FG002|Overall Study|Abnormal test procedure result|1|||
128904191|NCT01032915|463941464|FG003|Overall Study|Abnormal test procedure result|0|||
128904192|NCT01032915|463941461|FG000|Overall Study|Withdrawal by Subject|0|||
128904193|NCT01032915|463941462|FG001|Overall Study|Withdrawal by Subject|3|||
128904194|NCT01032915|463941463|FG002|Overall Study|Withdrawal by Subject|1|||
128904195|NCT01032915|463941464|FG003|Overall Study|Withdrawal by Subject|1|||
128904196|NCT01032915|463941461|FG000|Overall Study|Administrative reasons|5|||
128904197|NCT01032915|463941462|FG001|Overall Study|Administrative reasons|6|||
128904198|NCT01032915|463941463|FG002|Overall Study|Administrative reasons|4|||
128904199|NCT01032915|463941464|FG003|Overall Study|Administrative reasons|4|||
128904200|NCT01032915|463941461|FG000|Overall Study|Protocol Violation|1|||
128904201|NCT01032915|463941462|FG001|Overall Study|Protocol Violation|0|||
128904202|NCT01032915|463941463|FG002|Overall Study|Protocol Violation|0|||
128904203|NCT01032915|463941464|FG003|Overall Study|Protocol Violation|1|||
128904204|NCT00915681|463941465|FG000|Overall Study|Screening failures|46|||
128904205|NCT00811135|463941466|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
128904206|NCT00811135|463941466|FG000|Overall Study|Death|3|||
128904207|NCT00811135|463941466|FG000|Overall Study|Protocol Violation|2|||
128904208|NCT00811135|463941466|FG000|Overall Study|Violation of Selection Criteria|1|||
129025692|NCT03214588|464387608|FG002|Overall Study|Reason Not Specified|0|||
128904209|NCT00811135|463941466|FG000|Overall Study|Refused Treatment|1|||
128904210|NCT00811135|463941466|FG000|Overall Study|Withdrawal by Subject|3|||
128904211|NCT00811135|463941466|FG000|Overall Study|Administrative/Other Unspecified|11|||
128904212|NCT00811135|463941466|FG000|Overall Study|Ongoing|59|||
129025693|NCT03480763|464387613|FG000|Overall Study|Withdrawal by Subject|18|||
129025694|NCT03480763|464387614|FG001|Overall Study|Withdrawal by Subject|10|||
129025695|NCT03480763|464387613|FG000|Overall Study|Lost to Follow-up|4|||
129025696|NCT03480763|464387614|FG001|Overall Study|Lost to Follow-up|7|||
129025697|NCT03480763|464387613|FG000|Overall Study|non-study pneumococcal vaccine|1|||
129025698|NCT03480763|464387614|FG001|Overall Study|non-study pneumococcal vaccine|0|||
128694183|NCT01543698|463180417|FG003|Phase 2|Adverse Event|0|||
128904213|NCT01118351|463941467|FG000|Overall Study|Adverse Event|3|||
128904214|NCT01118351|463941467|FG000|Overall Study|Withdrawal by Subject|1|||
128904215|NCT00845728|463941479|FG000|Overall Study|Abnormal laboratory value (s)|2|||
128694184|NCT01543698|463180418|FG004|Phase 2|Adverse Event|0|||
128904216|NCT00845728|463941480|FG001|Overall Study|Abnormal laboratory value (s)|2|||
128904217|NCT00845728|463941479|FG000|Overall Study|Patient's inability to use the device|4|||
128904218|NCT00845728|463941480|FG001|Overall Study|Patient's inability to use the device|6|||
128904219|NCT00845728|463941479|FG000|Overall Study|Abnormal test procedure result (s)|7|||
128904220|NCT00845728|463941480|FG001|Overall Study|Abnormal test procedure result (s)|2|||
128904221|NCT00845728|463941479|FG000|Overall Study|Lost to Follow-up|22|||
128904222|NCT00845728|463941480|FG001|Overall Study|Lost to Follow-up|13|||
128904223|NCT00845728|463941479|FG000|Overall Study|Death|24|||
128904224|NCT00845728|463941480|FG001|Overall Study|Death|26|||
128904225|NCT00845728|463941479|FG000|Overall Study|Administrative Problems|34|||
128694185|NCT01543698|463180419|FG005|Phase 2|Adverse Event|0|||
128694186|NCT01543698|463180420|FG006|Phase 2|Adverse Event|0|||
128904226|NCT00845728|463941480|FG001|Overall Study|Administrative Problems|26|||
128904227|NCT00845728|463941479|FG000|Overall Study|Protocol Violation|36|||
128904228|NCT00845728|463941480|FG001|Overall Study|Protocol Violation|24|||
128904229|NCT00845728|463941479|FG000|Overall Study|Lack of Efficacy|51|||
128904230|NCT00845728|463941480|FG001|Overall Study|Lack of Efficacy|39|||
128904231|NCT00845728|463941479|FG000|Overall Study|Adverse Event|101|||
128904232|NCT00845728|463941480|FG001|Overall Study|Adverse Event|96|||
128904233|NCT00845728|463941479|FG000|Overall Study|Withdrawal by Subject|105|||
128904234|NCT00845728|463941480|FG001|Overall Study|Withdrawal by Subject|108|||
128904235|NCT04951037|463941483|FG000|Overall Study|Lost to Follow-up|16|||
128904236|NCT04951037|463941483|FG000|Overall Study|Withdrawal by Subject|5|||
128904237|NCT04951037|463941483|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
128904238|NCT02599961|463941487|FG000|Overall Study|Withdrawal by Subject|1|||
128904239|NCT02599961|463941487|FG000|Overall Study|Subject Non-Compliance|2|||
128904240|NCT02599961|463941487|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
128904241|NCT02599961|463941487|FG000|Overall Study|Other, Not Specified|3|||
128904242|NCT00143312|463941490|FG000|Overall Study|Death|11|||
128904243|NCT00143312|463941490|FG000|Overall Study|Adverse Event|2|||
128904244|NCT00143312|463941490|FG000|Overall Study|Lost to Follow-up|1|||
128904245|NCT00143312|463941490|FG000|Overall Study|Other|1|||
128904246|NCT00143312|463941490|FG000|Overall Study|Withdrawal by Subject|1|||
128904247|NCT01029366|463941491|FG000|Overall Study|Withdrawal by Subject|1|||
128904248|NCT01029366|463941492|FG001|Overall Study|Withdrawal by Subject|0|||
128904249|NCT01029366|463941491|FG000|Overall Study|Death|1|||
128904250|NCT01029366|463941492|FG001|Overall Study|Death|1|||
128904251|NCT01029366|463941491|FG000|Overall Study|disease progression|2|||
128904252|NCT01029366|463941492|FG001|Overall Study|disease progression|0|||
128904253|NCT01029366|463941491|FG000|Overall Study|manufacturing failure|0|||
128904254|NCT01029366|463941492|FG001|Overall Study|manufacturing failure|1|||
128904255|NCT00906087|463941498|FG000|Initial Washout|Withdrawal by Subject|1|||
128904256|NCT00906087|463941498|FG000|Initial Washout|Physician Decision|1|||
128904257|NCT00513500|463941512|FG000|Overall Study|Lost to Follow-up|35|||
128904258|NCT00513500|463941513|FG001|Overall Study|Lost to Follow-up|39|||
128904259|NCT00513500|463941512|FG000|Overall Study|Death|2|||
128904260|NCT00513500|463941513|FG001|Overall Study|Death|1|||
128904261|NCT00513500|463941512|FG000|Overall Study|Hospitalized|4|||
128904262|NCT00513500|463941513|FG001|Overall Study|Hospitalized|14|||
128904263|NCT00749996|463941516|FG000|Overall Study|Lost to Follow-up|7|||
128904264|NCT00749996|463941517|FG001|Overall Study|Lost to Follow-up|4|||
128904265|NCT00749996|463941516|FG000|Overall Study|Withdrawal by Subject|5|||
128904266|NCT00749996|463941517|FG001|Overall Study|Withdrawal by Subject|4|||
128904267|NCT00749996|463941516|FG000|Overall Study|Protocol Violation|2|||
128904268|NCT00749996|463941517|FG001|Overall Study|Protocol Violation|3|||
128904269|NCT00749996|463941516|FG000|Overall Study|Physician Decision|2|||
128904270|NCT00749996|463941517|FG001|Overall Study|Physician Decision|0|||
128904271|NCT00749996|463941516|FG000|Overall Study|Pregnancy|0|||
128904272|NCT00749996|463941517|FG001|Overall Study|Pregnancy|2|||
128904273|NCT00749996|463941516|FG000|Overall Study|Adverse Event|1|||
128904274|NCT00749996|463941517|FG001|Overall Study|Adverse Event|0|||
128904275|NCT00749996|463941516|FG000|Overall Study|Death|1|||
128904276|NCT00749996|463941517|FG001|Overall Study|Death|0|||
128904277|NCT00517829|463941518|FG000|Overall Study|Adverse Event|22|||
128904278|NCT00517829|463941519|FG001|Overall Study|Adverse Event|34|||
128904279|NCT00517829|463941518|FG000|Overall Study|Disease Progression|39|||
128904280|NCT00517829|463941519|FG001|Overall Study|Disease Progression|32|||
128904281|NCT00517829|463941518|FG000|Overall Study|Patient Request|6|||
128904282|NCT00517829|463941519|FG001|Overall Study|Patient Request|5|||
128904283|NCT00517829|463941518|FG000|Overall Study|Investigator Request|5|||
128904284|NCT00517829|463941519|FG001|Overall Study|Investigator Request|3|||
128904285|NCT00517829|463941518|FG000|Overall Study|Other|3|||
128904286|NCT00517829|463941519|FG001|Overall Study|Other|1|||
128904287|NCT00606086|463941520|FG000|Overall Study|Adverse Event|1|||
128694187|NCT01543698|463180421|FG007|Phase 2|Adverse Event|0|||
128904288|NCT00606086|463941521|FG001|Overall Study|Adverse Event|1|||
128904289|NCT00606086|463941520|FG000|Overall Study|Lost to Follow-up|4|||
128904290|NCT00606086|463941521|FG001|Overall Study|Lost to Follow-up|8|||
128904291|NCT00606086|463941520|FG000|Overall Study|Protocol Violation|1|||
128904292|NCT00606086|463941521|FG001|Overall Study|Protocol Violation|0|||
128904293|NCT00606086|463941520|FG000|Overall Study|Withdrawal by Subject|5|||
128904294|NCT00606086|463941521|FG001|Overall Study|Withdrawal by Subject|3|||
128904295|NCT00606086|463941520|FG000|Overall Study|Non-compliance|0|||
128904296|NCT00606086|463941521|FG001|Overall Study|Non-compliance|1|||
128904297|NCT00606086|463941520|FG000|Overall Study|Randomized, not treated|1|||
128904298|NCT00606086|463941521|FG001|Overall Study|Randomized, not treated|2|||
128904299|NCT00796315|463941528|FG000|Overall Study|Protocol Violation|0|||
128904300|NCT00796315|463941529|FG001|Overall Study|Protocol Violation|1|||
128904301|NCT00796315|463941530|FG002|Overall Study|Protocol Violation|0|||
128904302|NCT01627860|463941531|FG000|Overall Study|Adverse Event|9|||
128904303|NCT01627860|463941532|FG001|Overall Study|Adverse Event|4|||
128904304|NCT01627860|463941531|FG000|Overall Study|Withdrawal by Subject|2|||
128904305|NCT01627860|463941532|FG001|Overall Study|Withdrawal by Subject|1|||
128904306|NCT01627860|463941531|FG000|Overall Study|Seizure frequency doubled|0|||
128904307|NCT01627860|463941532|FG001|Overall Study|Seizure frequency doubled|1|||
128904308|NCT01627860|463941531|FG000|Overall Study|Protocol Violation|1|||
128904309|NCT01627860|463941532|FG001|Overall Study|Protocol Violation|0|||
128904310|NCT00689871|463941537|FG000|Overall Study|Lost to Follow-up|123|||
128904311|NCT00689871|463941538|FG001|Overall Study|Lost to Follow-up|13|||
128904312|NCT00689871|463941539|FG002|Overall Study|Lost to Follow-up|37|||
128904313|NCT00689871|463941540|FG003|Overall Study|Lost to Follow-up|1|||
128904314|NCT00689871|463941537|FG000|Overall Study|Explanted of All Study Devices|36|||
128904315|NCT00689871|463941538|FG001|Overall Study|Explanted of All Study Devices|25|||
128904316|NCT00689871|463941539|FG002|Overall Study|Explanted of All Study Devices|29|||
128904317|NCT00689871|463941540|FG003|Overall Study|Explanted of All Study Devices|3|||
128904318|NCT00689871|463941537|FG000|Overall Study|Withdrawal by Subject|13|||
128904319|NCT00689871|463941538|FG001|Overall Study|Withdrawal by Subject|3|||
128904320|NCT00689871|463941539|FG002|Overall Study|Withdrawal by Subject|4|||
128904321|NCT00689871|463941540|FG003|Overall Study|Withdrawal by Subject|1|||
128904322|NCT00689871|463941537|FG000|Overall Study|Death|1|||
128904323|NCT00689871|463941538|FG001|Overall Study|Death|10|||
128904324|NCT00689871|463941539|FG002|Overall Study|Death|2|||
128904325|NCT00689871|463941540|FG003|Overall Study|Death|2|||
128904326|NCT00689871|463941537|FG000|Overall Study|Physician Decision|2|||
128904327|NCT00689871|463941538|FG001|Overall Study|Physician Decision|1|||
128904328|NCT00689871|463941539|FG002|Overall Study|Physician Decision|1|||
128904329|NCT00689871|463941540|FG003|Overall Study|Physician Decision|0|||
128904330|NCT00159861|463941545|FG000|Core Study - 16 Weeks|Death|3|||
128904331|NCT00159861|463941546|FG001|Core Study - 16 Weeks|Death|0|||
128904332|NCT00159861|463941545|FG000|Core Study - 16 Weeks|Adverse Event|12|||
128904333|NCT00159861|463941546|FG001|Core Study - 16 Weeks|Adverse Event|6|||
128904334|NCT00159861|463941545|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
128904335|NCT00159861|463941546|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
128904336|NCT00159861|463941545|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
128904337|NCT00159861|463941546|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
128904338|NCT00159861|463941545|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
128904339|NCT00159861|463941546|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
128904340|NCT00159861|463941545|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
128904341|NCT00159861|463941546|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
128904342|NCT00159861|463941545|FG000|Extension Study - up to 3 Years|Death|24|||
128904343|NCT00159861|463941546|FG001|Extension Study - up to 3 Years|Death|28|||
128904344|NCT00159861|463941545|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
128904345|NCT00159861|463941546|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
128904346|NCT00159861|463941545|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
128904347|NCT00159861|463941546|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
128904348|NCT00159861|463941545|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
129025699|NCT03480763|464387613|FG000|Overall Study|oncological treatment|0|||
129025700|NCT03480763|464387614|FG001|Overall Study|oncological treatment|2|||
129025701|NCT03480763|464387613|FG000|Overall Study|pain with vaccination|1|||
129025702|NCT03480763|464387614|FG001|Overall Study|pain with vaccination|0|||
129025703|NCT01647828|464387615|FG000|Overall Study|Death|3|||
129025704|NCT01647828|464387616|FG001|Overall Study|Death|4|||
129025705|NCT01647828|464387617|FG002|Overall Study|Death|4|||
129025706|NCT01647828|464387618|FG003|Overall Study|Death|5|||
129025707|NCT01647828|464387619|FG004|Overall Study|Death|6|||
129025708|NCT01647828|464387620|FG005|Overall Study|Death|3|||
129025709|NCT01647828|464387621|FG006|Overall Study|Death|10|||
128904349|NCT00159861|463941546|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
128904350|NCT00159861|463941545|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
128904351|NCT00159861|463941546|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
128904352|NCT04489888|463941547|FG000|Overall Study|Death|75|||
128904353|NCT04489888|463941547|FG000|Overall Study|Sponsor Decision|26|||
128904354|NCT03349099|463941550|FG000|Overall Study|Physician Decision|3|||
128904355|NCT03349099|463941551|FG001|Overall Study|Physician Decision|4|||
128904356|NCT03349099|463941550|FG000|Overall Study|Stone migrated from the kidney|1|||
128904357|NCT03349099|463941551|FG001|Overall Study|Stone migrated from the kidney|0|||
128904358|NCT00278993|463941552|FG000|Overall Study|Adverse Event|24|||
128904359|NCT00278993|463941552|FG000|Overall Study|Withdrawal by Subject|5|||
128904360|NCT00278993|463941552|FG000|Overall Study|Progressive Disease|65|||
128904361|NCT00278993|463941552|FG000|Overall Study|Physician Decision|9|||
128904362|NCT00278993|463941552|FG000|Overall Study|Not Otherwise Specified|4|||
128904363|NCT04194528|463941558|FG000|Overall Study|Adverse Event|1|||
128904364|NCT00609791|463942924|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
128904365|NCT01394939|463942929|FG000|Overall Study|Adverse Event|1|||
128904366|NCT01394939|463942930|FG001|Overall Study|Adverse Event|3|||
128904367|NCT01394939|463942931|FG002|Overall Study|Adverse Event|0|||
128904368|NCT01394939|463942932|FG003|Overall Study|Adverse Event|2|||
128904369|NCT01394939|463942929|FG000|Overall Study|Death|0|||
128904370|NCT01394939|463942930|FG001|Overall Study|Death|2|||
128904371|NCT01394939|463942931|FG002|Overall Study|Death|0|||
128904372|NCT01394939|463942932|FG003|Overall Study|Death|0|||
128904373|NCT01394939|463942929|FG000|Overall Study|Physician Decision|0|||
128904374|NCT01394939|463942930|FG001|Overall Study|Physician Decision|1|||
128904375|NCT01394939|463942931|FG002|Overall Study|Physician Decision|0|||
128904376|NCT01394939|463942932|FG003|Overall Study|Physician Decision|0|||
128904377|NCT01394939|463942929|FG000|Overall Study|Withdrawal by Subject|0|||
128904378|NCT01394939|463942930|FG001|Overall Study|Withdrawal by Subject|2|||
128904379|NCT01394939|463942931|FG002|Overall Study|Withdrawal by Subject|0|||
129025710|NCT01647828|464387622|FG007|Overall Study|Death|60|||
129025711|NCT01647828|464387623|FG008|Overall Study|Death|71|||
129025712|NCT01647828|464387615|FG000|Overall Study|Withdrawal by Subject|2|||
129025713|NCT01647828|464387616|FG001|Overall Study|Withdrawal by Subject|0|||
129025714|NCT01647828|464387617|FG002|Overall Study|Withdrawal by Subject|0|||
129025715|NCT01647828|464387618|FG003|Overall Study|Withdrawal by Subject|1|||
129025716|NCT01647828|464387619|FG004|Overall Study|Withdrawal by Subject|0|||
129025717|NCT01647828|464387620|FG005|Overall Study|Withdrawal by Subject|0|||
129025718|NCT01647828|464387621|FG006|Overall Study|Withdrawal by Subject|1|||
129025719|NCT01647828|464387622|FG007|Overall Study|Withdrawal by Subject|0|||
129025720|NCT01647828|464387623|FG008|Overall Study|Withdrawal by Subject|2|||
129025721|NCT01647828|464387615|FG000|Overall Study|Study terminated by Sponsor|0|||
129025722|NCT01647828|464387616|FG001|Overall Study|Study terminated by Sponsor|0|||
129025723|NCT01647828|464387617|FG002|Overall Study|Study terminated by Sponsor|0|||
129025724|NCT01647828|464387618|FG003|Overall Study|Study terminated by Sponsor|0|||
129025725|NCT01647828|464387619|FG004|Overall Study|Study terminated by Sponsor|0|||
129025726|NCT01647828|464387620|FG005|Overall Study|Study terminated by Sponsor|0|||
129025727|NCT01647828|464387621|FG006|Overall Study|Study terminated by Sponsor|1|||
129025728|NCT01647828|464387622|FG007|Overall Study|Study terminated by Sponsor|26|||
129025729|NCT01647828|464387623|FG008|Overall Study|Study terminated by Sponsor|16|||
129025730|NCT01647828|464387615|FG000|Overall Study|Lost to Follow-up|0|||
129025731|NCT01647828|464387616|FG001|Overall Study|Lost to Follow-up|0|||
129025732|NCT01647828|464387617|FG002|Overall Study|Lost to Follow-up|0|||
129025733|NCT01647828|464387618|FG003|Overall Study|Lost to Follow-up|0|||
129025734|NCT01647828|464387619|FG004|Overall Study|Lost to Follow-up|0|||
129025735|NCT01647828|464387620|FG005|Overall Study|Lost to Follow-up|0|||
129025736|NCT01647828|464387621|FG006|Overall Study|Lost to Follow-up|0|||
129025737|NCT01647828|464387622|FG007|Overall Study|Lost to Follow-up|2|||
129025738|NCT01647828|464387623|FG008|Overall Study|Lost to Follow-up|0|||
129025739|NCT01906372|464387624|FG000|Overall Study|Withdrawal by Subject|2|||
129025740|NCT03629054|464387628|FG000|Period 2 (4 Days)|Not treated|0|||
129025741|NCT03629054|464387629|FG001|Period 2 (4 Days)|Not treated|1|||
129025742|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
129025743|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
129025744|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
129025745|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
129025746|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
129025747|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
129025748|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Death|9|||
129025749|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Death|7|||
129025750|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Death|14|||
129025751|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Death|7|||
129025752|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Death|0|||
129025753|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Death|0|||
129025754|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
129025755|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
129025756|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
129025757|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
129025758|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
129025759|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
129025760|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Other Event|49|||
129025761|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Other Event|52|||
129025762|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Other Event|41|||
128904380|NCT01394939|463942932|FG003|Overall Study|Withdrawal by Subject|2|||
128904381|NCT01394939|463942929|FG000|Overall Study|Others|0|||
128904382|NCT01394939|463942930|FG001|Overall Study|Others|2|||
128904383|NCT01394939|463942931|FG002|Overall Study|Others|0|||
128904384|NCT01394939|463942932|FG003|Overall Study|Others|3|||
128904385|NCT00150592|463942935|FG000|Overall Study|Adverse Event|4|||
128904386|NCT00150592|463942936|FG001|Overall Study|Adverse Event|1|||
128904387|NCT00150592|463942935|FG000|Overall Study|Protocol Violation|1|||
128904388|NCT00150592|463942936|FG001|Overall Study|Protocol Violation|0|||
128904389|NCT00150592|463942935|FG000|Overall Study|Withdrawal by Subject|1|||
128904390|NCT00150592|463942936|FG001|Overall Study|Withdrawal by Subject|2|||
128904391|NCT00150592|463942935|FG000|Overall Study|Non-compliance|1|||
128904392|NCT00150592|463942936|FG001|Overall Study|Non-compliance|0|||
128904393|NCT00874120|463942941|FG000|First Intervention|Adverse Event|0|||
128904394|NCT00874120|463942942|FG001|First Intervention|Adverse Event|1|||
128904395|NCT00874120|463942941|FG000|First Intervention|Withdrawal by Subject|2|||
128904396|NCT00874120|463942942|FG001|First Intervention|Withdrawal by Subject|0|||
128904397|NCT00874120|463942941|FG000|First Intervention|Lost to Follow-up|0|||
128904398|NCT00874120|463942942|FG001|First Intervention|Lost to Follow-up|1|||
128904399|NCT00874120|463942941|FG000|First Intervention|Protocol Violation|3|||
128904400|NCT00874120|463942942|FG001|First Intervention|Protocol Violation|0|||
128904401|NCT00874120|463942941|FG000|First Intervention|positive drug test|1|||
128904402|NCT00874120|463942942|FG001|First Intervention|positive drug test|0|||
128904403|NCT00874120|463942941|FG000|Second Intervention|Withdrawal by Subject|1|||
128904404|NCT00874120|463942942|FG001|Second Intervention|Withdrawal by Subject|0|||
128904405|NCT00874120|463942941|FG000|Second Intervention|Protocol Violation|1|||
128904406|NCT00874120|463942942|FG001|Second Intervention|Protocol Violation|0|||
128904407|NCT01823679|463942943|FG000|Overall Study|Death|1|||
128904408|NCT03776175|463942945|FG000|Treatment Period (42 Days)|Adverse Event|0|||
128904409|NCT03776175|463942946|FG001|Treatment Period (42 Days)|Adverse Event|1|||
128904410|NCT03776175|463942947|FG002|Treatment Period (42 Days)|Adverse Event|1|||
128904411|NCT03776175|463942948|FG003|Treatment Period (42 Days)|Adverse Event|0|||
128904412|NCT03776175|463942945|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
128904413|NCT03776175|463942946|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
128904414|NCT03776175|463942947|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
128904415|NCT03776175|463942948|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
128904416|NCT03776175|463942945|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
128904417|NCT03776175|463942946|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
128904418|NCT03776175|463942947|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
128904419|NCT03776175|463942948|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
128904420|NCT03776175|463942945|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
128904421|NCT03776175|463942946|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
128904422|NCT03776175|463942947|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
128904423|NCT03776175|463942948|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
128904424|NCT03776175|463942945|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
128904425|NCT03776175|463942946|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
128904426|NCT03776175|463942947|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
128904427|NCT03776175|463942948|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
128904428|NCT03776175|463942945|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
128904429|NCT03776175|463942946|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
128904430|NCT03776175|463942947|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
128904431|NCT03776175|463942948|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
128904432|NCT02412787|463942949|FG000|Overall Study|Withdrawal by Subject|9|||
128904433|NCT02412787|463942949|FG000|Overall Study|Participation Terminated by Investigator|1|||
129115426|NCT01548404|464719743|FG000|Overall Study|Inadequate response to study treatment|23|||
129115427|NCT01548404|464719744|FG001|Overall Study|Inadequate response to study treatment|7|||
129115428|NCT01548404|464719743|FG000|Overall Study|Lost to Follow-up|2|||
129115429|NCT01548404|464719744|FG001|Overall Study|Lost to Follow-up|0|||
129115430|NCT01548404|464719743|FG000|Overall Study|Withdrawal by Subject|0|||
129115431|NCT01548404|464719744|FG001|Overall Study|Withdrawal by Subject|3|||
129115432|NCT01548404|464719743|FG000|Overall Study|Other than specified above|0|||
129115433|NCT01548404|464719744|FG001|Overall Study|Other than specified above|2|||
129115434|NCT00737048|464719745|FG000|Overall Study|Physician Decision|0|||
129115435|NCT00737048|464719746|FG001|Overall Study|Physician Decision|0|||
128904434|NCT02412787|463942949|FG000|Overall Study|Site Terminated by Sponsor|21|||
128904435|NCT02412787|463942949|FG000|Overall Study|Technical Problems|1|||
128904436|NCT02412787|463942949|FG000|Overall Study|Reason Not Specified|1|||
128904437|NCT02311153|463942953|FG000|Overall Study|Lost to Follow-up|5|||
128904438|NCT02311153|463942954|FG001|Overall Study|Lost to Follow-up|7|||
129115436|NCT00737048|464719747|FG002|Overall Study|Physician Decision|1|||
129115437|NCT00737048|464719745|FG000|Overall Study|Adverse Event|0|||
129115438|NCT00737048|464719746|FG001|Overall Study|Adverse Event|1|||
128904439|NCT00414453|463942960|FG000|Overall Study|Abnormal lab work|16|||
128904440|NCT00290433|463942961|FG000|Overall Study|Disease Progression|13|||
128904441|NCT00290433|463942961|FG000|Overall Study|Adverse Event|14|||
128904442|NCT00290433|463942961|FG000|Overall Study|Withdrawal by Subject|1|||
128904443|NCT00290433|463942961|FG000|Overall Study|Non-Compliance|1|||
128904444|NCT00290433|463942961|FG000|Overall Study|Congestive Heart Failure|1|||
128904445|NCT00290433|463942961|FG000|Overall Study|Transplant in CR|5|||
128904446|NCT00290433|463942961|FG000|Overall Study|Unrelated Infection/Death|1|||
128904447|NCT03031301|463942963|FG000|Overall Study|Protocol Violation|4|||
128904448|NCT03031301|463942964|FG001|Overall Study|Protocol Violation|8|||
128904449|NCT03031301|463942963|FG000|Overall Study|Withdrawal by Subject|7|||
128904450|NCT03031301|463942964|FG001|Overall Study|Withdrawal by Subject|4|||
128904451|NCT03031301|463942963|FG000|Overall Study|Lost to Follow-up|4|||
128904452|NCT03031301|463942964|FG001|Overall Study|Lost to Follow-up|12|||
128904453|NCT03031301|463942963|FG000|Overall Study|Noncompliance|1|||
128904454|NCT03031301|463942964|FG001|Overall Study|Noncompliance|3|||
128904455|NCT03031301|463942963|FG000|Overall Study|Technical issue|1|||
128904456|NCT03031301|463942964|FG001|Overall Study|Technical issue|1|||
128904457|NCT03031301|463942963|FG000|Overall Study|Adverse Event|1|||
128904458|NCT03031301|463942964|FG001|Overall Study|Adverse Event|0|||
128904459|NCT02429414|463942965|FG000|Overall Study|Physician Decision|0|||
128904460|NCT02429414|463942966|FG001|Overall Study|Physician Decision|1|||
128904461|NCT03245450|463942967|FG000|Overall Study|Radiological disease progression|3|||
128904462|NCT03245450|463942968|FG001|Overall Study|Radiological disease progression|3|||
128904463|NCT03245450|463942969|FG002|Overall Study|Radiological disease progression|2|||
128904464|NCT03245450|463942970|FG003|Overall Study|Radiological disease progression|2|||
128904465|NCT03245450|463942971|FG004|Overall Study|Radiological disease progression|7|||
128904466|NCT03245450|463942972|FG005|Overall Study|Radiological disease progression|6|||
128904467|NCT03245450|463942973|FG006|Overall Study|Radiological disease progression|6|||
128904468|NCT03245450|463942967|FG000|Overall Study|Clinical disease progression|0|||
128904469|NCT03245450|463942968|FG001|Overall Study|Clinical disease progression|0|||
128904470|NCT03245450|463942969|FG002|Overall Study|Clinical disease progression|1|||
128904471|NCT03245450|463942970|FG003|Overall Study|Clinical disease progression|0|||
128904472|NCT03245450|463942971|FG004|Overall Study|Clinical disease progression|0|||
128904473|NCT03245450|463942972|FG005|Overall Study|Clinical disease progression|2|||
128904474|NCT03245450|463942973|FG006|Overall Study|Clinical disease progression|0|||
128904475|NCT03245450|463942967|FG000|Overall Study|Other|0|||
128904476|NCT03245450|463942968|FG001|Overall Study|Other|0|||
128904477|NCT03245450|463942969|FG002|Overall Study|Other|0|||
128904478|NCT03245450|463942970|FG003|Overall Study|Other|1|||
128904479|NCT03245450|463942971|FG004|Overall Study|Other|1|||
128904480|NCT03245450|463942972|FG005|Overall Study|Other|1|||
128904481|NCT03245450|463942973|FG006|Overall Study|Other|1|||
128904482|NCT03245450|463942967|FG000|Overall Study|Withdrawal by Subject|0|||
128904483|NCT03245450|463942968|FG001|Overall Study|Withdrawal by Subject|1|||
128904484|NCT03245450|463942969|FG002|Overall Study|Withdrawal by Subject|0|||
128904485|NCT03245450|463942970|FG003|Overall Study|Withdrawal by Subject|0|||
128904486|NCT03245450|463942971|FG004|Overall Study|Withdrawal by Subject|0|||
128904487|NCT03245450|463942972|FG005|Overall Study|Withdrawal by Subject|0|||
128904488|NCT03245450|463942973|FG006|Overall Study|Withdrawal by Subject|0|||
128904489|NCT03245450|463942967|FG000|Overall Study|Adverse Event|0|||
128904490|NCT03245450|463942968|FG001|Overall Study|Adverse Event|0|||
128904491|NCT03245450|463942969|FG002|Overall Study|Adverse Event|0|||
128904492|NCT03245450|463942970|FG003|Overall Study|Adverse Event|0|||
128904493|NCT03245450|463942971|FG004|Overall Study|Adverse Event|1|||
128904494|NCT03245450|463942972|FG005|Overall Study|Adverse Event|0|||
128904495|NCT03245450|463942973|FG006|Overall Study|Adverse Event|2|||
128904496|NCT01784861|463942978|FG000|Overall Study|Adverse Event|0|||
128904497|NCT01784861|463942979|FG001|Overall Study|Adverse Event|0|||
128904498|NCT01784861|463942980|FG002|Overall Study|Adverse Event|1|||
128904499|NCT01784861|463942981|FG003|Overall Study|Adverse Event|2|||
128904500|NCT01784861|463942982|FG004|Overall Study|Adverse Event|1|||
128904501|NCT01784861|463942983|FG005|Overall Study|Adverse Event|0|||
128904502|NCT01784861|463942978|FG000|Overall Study|Withdrawal by Subject|0|||
128904503|NCT01784861|463942979|FG001|Overall Study|Withdrawal by Subject|0|||
128904504|NCT01784861|463942980|FG002|Overall Study|Withdrawal by Subject|0|||
128904505|NCT01784861|463942981|FG003|Overall Study|Withdrawal by Subject|1|||
128904506|NCT01784861|463942982|FG004|Overall Study|Withdrawal by Subject|0|||
128904507|NCT01784861|463942983|FG005|Overall Study|Withdrawal by Subject|0|||
128904508|NCT01784861|463942978|FG000|Overall Study|Physician Decision|0|||
128904509|NCT01784861|463942979|FG001|Overall Study|Physician Decision|0|||
128904510|NCT01784861|463942980|FG002|Overall Study|Physician Decision|0|||
129115439|NCT00737048|464719747|FG002|Overall Study|Adverse Event|0|||
129115440|NCT00737048|464719745|FG000|Overall Study|Worsening of the symptoms|3|||
128904511|NCT01784861|463942981|FG003|Overall Study|Physician Decision|2|||
128904512|NCT01784861|463942982|FG004|Overall Study|Physician Decision|0|||
128904513|NCT01784861|463942983|FG005|Overall Study|Physician Decision|1|||
128904514|NCT03948178|463942986|FG000|Overall Study|Protocol Violation|1|||
128904515|NCT03948178|463942986|FG000|Overall Study|Lost to Follow-up|2|||
128904516|NCT03948178|463942986|FG000|Overall Study|Withdrawal by Subject|2|||
128904517|NCT03948178|463942986|FG000|Overall Study|Reason not known|2|||
128904518|NCT03948178|463942986|FG000|Overall Study|Personal reason|14|||
128904519|NCT03948178|463942986|FG000|Overall Study|Disease progression|30|||
128904520|NCT03948178|463942986|FG000|Overall Study|Adverse Event|12|||
128904521|NCT03948178|463942986|FG000|Overall Study|Sponsor terminated study|164|||
128904522|NCT02432235|463942987|FG000|Overall Study|Death|1|||
128904523|NCT02432235|463942988|FG001|Overall Study|Death|1|||
128904524|NCT02432235|463942989|FG002|Overall Study|Death|2|||
128904525|NCT02432235|463942990|FG003|Overall Study|Death|2|||
128904526|NCT02432235|463942991|FG004|Overall Study|Death|1|||
128904527|NCT02432235|463942992|FG005|Overall Study|Death|3|||
128904528|NCT02432235|463942993|FG006|Overall Study|Death|11|||
128904529|NCT02432235|463942994|FG007|Overall Study|Death|15|||
128904530|NCT02432235|463942995|FG008|Overall Study|Death|15|||
128904531|NCT02432235|463942996|FG009|Overall Study|Death|3|||
128904532|NCT02432235|463942997|FG010|Overall Study|Death|1|||
128904533|NCT02432235|463942998|FG011|Overall Study|Death|0|||
128904534|NCT02432235|463942987|FG000|Overall Study|Withdrawal by Subject|0|||
128904535|NCT02432235|463942988|FG001|Overall Study|Withdrawal by Subject|1|||
128904536|NCT02432235|463942989|FG002|Overall Study|Withdrawal by Subject|0|||
128904537|NCT02432235|463942990|FG003|Overall Study|Withdrawal by Subject|0|||
128904538|NCT02432235|463942991|FG004|Overall Study|Withdrawal by Subject|0|||
128904539|NCT02432235|463942992|FG005|Overall Study|Withdrawal by Subject|2|||
128904540|NCT02432235|463942993|FG006|Overall Study|Withdrawal by Subject|5|||
128904541|NCT02432235|463942994|FG007|Overall Study|Withdrawal by Subject|3|||
128904542|NCT02432235|463942995|FG008|Overall Study|Withdrawal by Subject|1|||
128904543|NCT02432235|463942996|FG009|Overall Study|Withdrawal by Subject|0|||
128904544|NCT02432235|463942997|FG010|Overall Study|Withdrawal by Subject|0|||
128904545|NCT02432235|463942998|FG011|Overall Study|Withdrawal by Subject|0|||
128904546|NCT02432235|463942987|FG000|Overall Study|Lost to Follow-up|0|||
128904547|NCT02432235|463942988|FG001|Overall Study|Lost to Follow-up|0|||
128904548|NCT02432235|463942989|FG002|Overall Study|Lost to Follow-up|0|||
128904549|NCT02432235|463942990|FG003|Overall Study|Lost to Follow-up|0|||
128904550|NCT02432235|463942991|FG004|Overall Study|Lost to Follow-up|0|||
128904551|NCT02432235|463942992|FG005|Overall Study|Lost to Follow-up|1|||
128904552|NCT02432235|463942993|FG006|Overall Study|Lost to Follow-up|0|||
128904553|NCT02432235|463942994|FG007|Overall Study|Lost to Follow-up|0|||
128904554|NCT02432235|463942995|FG008|Overall Study|Lost to Follow-up|1|||
128904555|NCT02432235|463942996|FG009|Overall Study|Lost to Follow-up|0|||
128904556|NCT02432235|463942997|FG010|Overall Study|Lost to Follow-up|0|||
128904557|NCT02432235|463942998|FG011|Overall Study|Lost to Follow-up|0|||
128904558|NCT02432235|463942987|FG000|Overall Study|Miscellaneous|0|||
128904559|NCT02432235|463942988|FG001|Overall Study|Miscellaneous|0|||
128904560|NCT02432235|463942989|FG002|Overall Study|Miscellaneous|0|||
128904561|NCT02432235|463942990|FG003|Overall Study|Miscellaneous|0|||
128904562|NCT02432235|463942991|FG004|Overall Study|Miscellaneous|1|||
128904563|NCT02432235|463942992|FG005|Overall Study|Miscellaneous|6|||
128904564|NCT02432235|463942993|FG006|Overall Study|Miscellaneous|2|||
128904565|NCT02432235|463942994|FG007|Overall Study|Miscellaneous|2|||
128904566|NCT02432235|463942995|FG008|Overall Study|Miscellaneous|4|||
128904567|NCT02432235|463942996|FG009|Overall Study|Miscellaneous|0|||
128904568|NCT02432235|463942997|FG010|Overall Study|Miscellaneous|0|||
128904569|NCT02432235|463942998|FG011|Overall Study|Miscellaneous|1|||
128904570|NCT01965262|463943011|FG000|Second Intervention (7 Days)|Discontinued|0|||
128904571|NCT01965262|463943012|FG001|Second Intervention (7 Days)|Discontinued|1|||
128904572|NCT01965262|463943011|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
128904573|NCT01965262|463943012|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
128904574|NCT01965262|463943011|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
128904575|NCT01965262|463943012|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
128904576|NCT02970292|463943013|FG000|Overall Study|Physician Decision|1|||
128904577|NCT02970292|463943014|FG001|Overall Study|Physician Decision|1|||
128904578|NCT02970292|463943013|FG000|Overall Study|Withdrawal by Subject|11|||
128904579|NCT02970292|463943014|FG001|Overall Study|Withdrawal by Subject|5|||
128694188|NCT01543698|463180422|FG008|Phase 2|Adverse Event|0|||
128904580|NCT02970292|463943013|FG000|Overall Study|Noncompliance with study drug|2|||
128904581|NCT02970292|463943014|FG001|Overall Study|Noncompliance with study drug|2|||
128694189|NCT01543698|463180423|FG009|Phase 2|Adverse Event|0|||
128904582|NCT02970292|463943013|FG000|Overall Study|Adverse Event|5|||
128904583|NCT02970292|463943014|FG001|Overall Study|Adverse Event|0|||
128904584|NCT02970292|463943013|FG000|Overall Study|Lack of Efficacy|1|||
128904585|NCT02970292|463943014|FG001|Overall Study|Lack of Efficacy|0|||
128694190|NCT01543698|463180424|FG010|Phase 2|Adverse Event|0|||
128694191|NCT01543698|463180425|FG011|Phase 2|Adverse Event|1|||
128694192|NCT01543698|463180426|FG012|Phase 2|Adverse Event|3|||
128904586|NCT02970292|463943013|FG000|Overall Study|Lost to Follow-up|1|||
128904587|NCT02970292|463943014|FG001|Overall Study|Lost to Follow-up|0|||
128904588|NCT02970292|463943013|FG000|Overall Study|Protocol Violation|2|||
128904589|NCT02970292|463943014|FG001|Overall Study|Protocol Violation|0|||
128904590|NCT02970292|463943013|FG000|Overall Study|Other|1|||
128904591|NCT02970292|463943014|FG001|Overall Study|Other|0|||
128904592|NCT03215771|463943019|FG000|Overall Study|Withdrawal by Subject|2|||
128904593|NCT03215771|463943019|FG000|Overall Study|Physician Decision|1|||
128904594|NCT02039375|463943020|FG000|Overall Study|Lost to Follow-up|2|||
128904595|NCT04770389|463943021|FG000|Overall Study|Adverse Event|1|||
128904596|NCT04770389|463943022|FG001|Overall Study|Adverse Event|2|||
128904597|NCT04770389|463943023|FG002|Overall Study|Adverse Event|0|||
128904598|NCT04770389|463943024|FG003|Overall Study|Adverse Event|1|||
128904599|NCT04770389|463943021|FG000|Overall Study|Withdrawal by Subject|0|||
128904600|NCT04770389|463943022|FG001|Overall Study|Withdrawal by Subject|2|||
128904601|NCT04770389|463943023|FG002|Overall Study|Withdrawal by Subject|1|||
128904602|NCT04770389|463943024|FG003|Overall Study|Withdrawal by Subject|0|||
128904603|NCT04770389|463943021|FG000|Overall Study|Failed attempt to draw blood|1|||
128904604|NCT04770389|463943022|FG001|Overall Study|Failed attempt to draw blood|0|||
128904605|NCT04770389|463943023|FG002|Overall Study|Failed attempt to draw blood|0|||
128904606|NCT04770389|463943024|FG003|Overall Study|Failed attempt to draw blood|0|||
128904607|NCT04770389|463943021|FG000|Overall Study|Left the country|0|||
128904608|NCT04770389|463943022|FG001|Overall Study|Left the country|0|||
128904609|NCT04770389|463943023|FG002|Overall Study|Left the country|1|||
128904610|NCT04770389|463943024|FG003|Overall Study|Left the country|2|||
128904611|NCT04770389|463943021|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
128904612|NCT04770389|463943022|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
128904613|NCT04770389|463943023|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
128904614|NCT04770389|463943024|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
128904615|NCT04770389|463943021|FG000|Overall Study|Lost to Follow-up|0|||
128904616|NCT04770389|463943022|FG001|Overall Study|Lost to Follow-up|0|||
128904617|NCT04770389|463943023|FG002|Overall Study|Lost to Follow-up|0|||
128904618|NCT04770389|463943024|FG003|Overall Study|Lost to Follow-up|1|||
128904619|NCT04770389|463943021|FG000|Overall Study|Moved away from study site|0|||
128904620|NCT04770389|463943022|FG001|Overall Study|Moved away from study site|1|||
128904621|NCT04770389|463943023|FG002|Overall Study|Moved away from study site|0|||
128904622|NCT04770389|463943024|FG003|Overall Study|Moved away from study site|0|||
128904623|NCT00542269|463943025|FG000|Overall Study|Adverse Event|10|||
128904624|NCT00542269|463943026|FG001|Overall Study|Adverse Event|4|||
128904625|NCT00542269|463943027|FG002|Overall Study|Adverse Event|5|||
128904626|NCT00542269|463943025|FG000|Overall Study|Protocol Violation|1|||
128904627|NCT00542269|463943026|FG001|Overall Study|Protocol Violation|1|||
128904628|NCT00542269|463943027|FG002|Overall Study|Protocol Violation|0|||
128904629|NCT00542269|463943025|FG000|Overall Study|Withdrawal by Subject|1|||
128904630|NCT00542269|463943026|FG001|Overall Study|Withdrawal by Subject|0|||
128904631|NCT00542269|463943027|FG002|Overall Study|Withdrawal by Subject|0|||
128904632|NCT00542269|463943025|FG000|Overall Study|Administrative problems|1|||
128904633|NCT00542269|463943026|FG001|Overall Study|Administrative problems|1|||
128904634|NCT00542269|463943027|FG002|Overall Study|Administrative problems|1|||
128904635|NCT03873714|463943028|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
128904636|NCT03028870|463943029|FG000|Overall Study|Adverse Event|7|||
128904637|NCT03028870|463943030|FG001|Overall Study|Adverse Event|4|||
128904638|NCT03028870|463943031|FG002|Overall Study|Adverse Event|3|||
128904639|NCT03028870|463943032|FG003|Overall Study|Adverse Event|3|||
128904640|NCT03028870|463943029|FG000|Overall Study|Withdrawal by Subject|1|||
128904641|NCT03028870|463943030|FG001|Overall Study|Withdrawal by Subject|1|||
128904642|NCT03028870|463943031|FG002|Overall Study|Withdrawal by Subject|1|||
128904643|NCT03028870|463943032|FG003|Overall Study|Withdrawal by Subject|2|||
128904644|NCT03028870|463943029|FG000|Overall Study|Lost to Follow-up|1|||
128904645|NCT03028870|463943030|FG001|Overall Study|Lost to Follow-up|0|||
128904646|NCT03028870|463943031|FG002|Overall Study|Lost to Follow-up|0|||
128904647|NCT03028870|463943032|FG003|Overall Study|Lost to Follow-up|0|||
128904648|NCT03028870|463943029|FG000|Overall Study|Lack of Efficacy|3|||
128904649|NCT03028870|463943030|FG001|Overall Study|Lack of Efficacy|0|||
128904650|NCT03028870|463943031|FG002|Overall Study|Lack of Efficacy|0|||
128904651|NCT03028870|463943032|FG003|Overall Study|Lack of Efficacy|0|||
128904652|NCT03028870|463943029|FG000|Overall Study|Administrative|5|||
128904653|NCT03028870|463943030|FG001|Overall Study|Administrative|5|||
128904654|NCT03028870|463943031|FG002|Overall Study|Administrative|12|||
128904655|NCT03028870|463943032|FG003|Overall Study|Administrative|4|||
129115441|NCT00737048|464719746|FG001|Overall Study|Worsening of the symptoms|5|||
128904656|NCT00708123|463943035|FG000|Period 1|Protocol Violation|0|||
128904657|NCT00708123|463943036|FG001|Period 1|Protocol Violation|1|||
128904658|NCT00708123|463943037|FG002|Period 1|Protocol Violation|0|||
128904659|NCT00708123|463943038|FG003|Period 1|Protocol Violation|1|||
128904660|NCT00708123|463943039|FG004|Period 1|Protocol Violation|0|||
128904661|NCT00708123|463943035|FG000|Period 1|Adverse Event|0|||
128904662|NCT00708123|463943036|FG001|Period 1|Adverse Event|0|||
128904663|NCT00708123|463943037|FG002|Period 1|Adverse Event|1|||
128904664|NCT00708123|463943038|FG003|Period 1|Adverse Event|0|||
128904665|NCT00708123|463943039|FG004|Period 1|Adverse Event|0|||
128904666|NCT00708123|463943035|FG000|Period 2|Protocol Violation|0|||
128904667|NCT00708123|463943036|FG001|Period 2|Protocol Violation|0|||
129115442|NCT00737048|464719747|FG002|Overall Study|Worsening of the symptoms|3|||
128904668|NCT00708123|463943037|FG002|Period 2|Protocol Violation|0|||
128904669|NCT00708123|463943038|FG003|Period 2|Protocol Violation|1|||
128904670|NCT00708123|463943039|FG004|Period 2|Protocol Violation|0|||
128904671|NCT00708123|463943035|FG000|Period 2|Other Reason|1|||
128904672|NCT00708123|463943036|FG001|Period 2|Other Reason|0|||
128904673|NCT00708123|463943037|FG002|Period 2|Other Reason|0|||
128904674|NCT00708123|463943038|FG003|Period 2|Other Reason|0|||
128904675|NCT00708123|463943039|FG004|Period 2|Other Reason|0|||
128904676|NCT00708123|463943035|FG000|Period 3|Lost to Follow-up|0|||
128904677|NCT00708123|463943036|FG001|Period 3|Lost to Follow-up|0|||
128904678|NCT00708123|463943037|FG002|Period 3|Lost to Follow-up|1|||
128904679|NCT00708123|463943038|FG003|Period 3|Lost to Follow-up|1|||
128904680|NCT00708123|463943039|FG004|Period 3|Lost to Follow-up|0|||
128904681|NCT00708123|463943035|FG000|Period 4|Protocol Violation|0|||
128904682|NCT00708123|463943036|FG001|Period 4|Protocol Violation|1|||
128904683|NCT00708123|463943037|FG002|Period 4|Protocol Violation|0|||
128904684|NCT00708123|463943038|FG003|Period 4|Protocol Violation|0|||
128904685|NCT00708123|463943039|FG004|Period 4|Protocol Violation|0|||
128904686|NCT00814892|463943040|FG000|Overall Study|Disease Progression|1|||
128904687|NCT00814892|463943040|FG000|Overall Study|Study Termination|1|||
128904688|NCT00845650|463943041|FG000|Overall Study|Withdrawal by Subject|0|||
128904689|NCT00845650|463943042|FG001|Overall Study|Withdrawal by Subject|0|||
128904690|NCT00845650|463943043|FG002|Overall Study|Withdrawal by Subject|0|||
128904691|NCT00845650|463943044|FG003|Overall Study|Withdrawal by Subject|0|||
128904692|NCT00845650|463943045|FG004|Overall Study|Withdrawal by Subject|2|||
128904693|NCT00845650|463943046|FG005|Overall Study|Withdrawal by Subject|0|||
128904694|NCT00845650|463943041|FG000|Overall Study|Lost to Follow-up|0|||
128904695|NCT00845650|463943042|FG001|Overall Study|Lost to Follow-up|0|||
128904696|NCT00845650|463943043|FG002|Overall Study|Lost to Follow-up|3|||
128904697|NCT00845650|463943044|FG003|Overall Study|Lost to Follow-up|1|||
128904698|NCT00845650|463943045|FG004|Overall Study|Lost to Follow-up|0|||
128904699|NCT00845650|463943046|FG005|Overall Study|Lost to Follow-up|1|||
128904700|NCT00845650|463943041|FG000|Overall Study|Sponsor hold on dosing|0|||
128904701|NCT00845650|463943042|FG001|Overall Study|Sponsor hold on dosing|0|||
128904702|NCT00845650|463943043|FG002|Overall Study|Sponsor hold on dosing|0|||
128904703|NCT00845650|463943044|FG003|Overall Study|Sponsor hold on dosing|0|||
128904704|NCT00845650|463943045|FG004|Overall Study|Sponsor hold on dosing|1|||
128904705|NCT00845650|463943046|FG005|Overall Study|Sponsor hold on dosing|1|||
128904706|NCT00845650|463943041|FG000|Overall Study|Unable to access IV line|1|||
128904707|NCT00845650|463943042|FG001|Overall Study|Unable to access IV line|0|||
128904708|NCT00845650|463943043|FG002|Overall Study|Unable to access IV line|0|||
128904709|NCT00845650|463943044|FG003|Overall Study|Unable to access IV line|0|||
128904710|NCT00845650|463943045|FG004|Overall Study|Unable to access IV line|0|||
128904711|NCT00845650|463943046|FG005|Overall Study|Unable to access IV line|0|||
128904712|NCT00250835|463943047|FG000|Overall Study|Withdrawal by Subject|1|||
128904713|NCT01187953|463943048|FG000|Overall Study|Death|11|||
128904714|NCT01187953|463943049|FG001|Overall Study|Death|13|||
128904715|NCT01187953|463943048|FG000|Overall Study|Adverse Event|1|||
128904716|NCT01187953|463943049|FG001|Overall Study|Adverse Event|2|||
128904717|NCT01187953|463943048|FG000|Overall Study|Lost to Follow-up|0|||
128904718|NCT01187953|463943049|FG001|Overall Study|Lost to Follow-up|3|||
128904719|NCT01187953|463943048|FG000|Overall Study|Withdrawal by Subject|3|||
128904720|NCT01187953|463943049|FG001|Overall Study|Withdrawal by Subject|3|||
128904721|NCT01430455|463943050|FG000|Overall Study|Withdrawal by Subject|1|||
128904722|NCT01430455|463943050|FG000|Overall Study|Switched to follow-up phase|1|||
128904723|NCT03829657|463943052|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
128694193|NCT01543698|463180427|FG013|Phase 2|Adverse Event|5|||
128694194|NCT01543698|463180428|FG014|Phase 2|Adverse Event|14|||
128694195|NCT00150709|463180429|FG000|Overall Study|Protocol Violation|7|||
128694196|NCT00150709|463180430|FG001|Overall Study|Protocol Violation|8|||
128694197|NCT00150709|463180431|FG002|Overall Study|Protocol Violation|3|||
128694198|NCT00150709|463180432|FG003|Overall Study|Protocol Violation|1|||
128694199|NCT00150709|463180429|FG000|Overall Study|Adverse Event|8|||
128694200|NCT00150709|463180430|FG001|Overall Study|Adverse Event|2|||
128904724|NCT03829657|463943053|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
128904725|NCT03829657|463943054|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
128904726|NCT03829657|463943055|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
128904727|NCT03829657|463943056|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
128904728|NCT03829657|463943052|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
128904729|NCT03829657|463943053|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
128904730|NCT03829657|463943054|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
128904731|NCT03829657|463943055|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
128694201|NCT00150709|463180431|FG002|Overall Study|Adverse Event|2|||
128764822|NCT03002038|463430315|FG000|Overall Study|Withdrawal by Subject|8|||
128904732|NCT03829657|463943056|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
128904733|NCT03829657|463943052|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
128904734|NCT03829657|463943053|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
128904735|NCT03829657|463943054|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
128694202|NCT00150709|463180432|FG003|Overall Study|Adverse Event|3|||
128904736|NCT03829657|463943055|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
128904737|NCT03829657|463943056|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
128904738|NCT03829657|463943052|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
128904739|NCT03829657|463943053|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
128904740|NCT03829657|463943054|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
128904741|NCT03829657|463943055|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
128904742|NCT03829657|463943056|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
128904743|NCT03829657|463943052|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
128904744|NCT03829657|463943053|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
128904745|NCT03829657|463943054|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
128904746|NCT03829657|463943055|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
128904747|NCT03829657|463943056|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
128904748|NCT03829657|463943052|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
128904749|NCT03829657|463943053|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
128904750|NCT03829657|463943054|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
128904751|NCT03829657|463943055|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
128904752|NCT03829657|463943056|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
128904753|NCT03829657|463943052|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
128904754|NCT03829657|463943053|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
128904755|NCT03829657|463943054|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
128904756|NCT03829657|463943055|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
128904757|NCT03829657|463943056|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
128904758|NCT03829657|463943052|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
128904759|NCT03829657|463943053|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
128904760|NCT03829657|463943054|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
128904761|NCT03829657|463943055|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
128904762|NCT03829657|463943056|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
128904763|NCT03829657|463943052|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
128904764|NCT03829657|463943053|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
128904765|NCT03829657|463943054|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
128904766|NCT03829657|463943055|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
128904767|NCT03829657|463943056|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
128904768|NCT03829657|463943052|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
128904769|NCT03829657|463943053|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
128904770|NCT03829657|463943054|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
128904771|NCT03829657|463943055|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
128904772|NCT03829657|463943056|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
128904773|NCT01014689|463943057|FG000|Overall Study|Lack of Efficacy|0|||
128904774|NCT01014689|463943058|FG001|Overall Study|Lack of Efficacy|1|||
129115443|NCT00641056|464719748|FG000|Overall Study|Adverse Event|12|||
129115444|NCT00641056|464719749|FG001|Overall Study|Adverse Event|2|||
129115445|NCT00641056|464719748|FG000|Overall Study|Lost to Follow-up|2|||
129115446|NCT00641056|464719749|FG001|Overall Study|Lost to Follow-up|1|||
129115447|NCT00641056|464719748|FG000|Overall Study|Physician Decision|3|||
129115448|NCT00641056|464719749|FG001|Overall Study|Physician Decision|1|||
129115449|NCT00641056|464719748|FG000|Overall Study|Protocol Violation|2|||
129115450|NCT00641056|464719749|FG001|Overall Study|Protocol Violation|0|||
129115451|NCT00641056|464719748|FG000|Overall Study|Entry Criteria Not Met|3|||
129115452|NCT00641056|464719749|FG001|Overall Study|Entry Criteria Not Met|0|||
129115453|NCT00641056|464719748|FG000|Overall Study|Subject Decision|6|||
129115454|NCT00641056|464719749|FG001|Overall Study|Subject Decision|19|||
129115455|NCT00641056|464719748|FG000|Overall Study|Sponsor Decision|1|||
129115456|NCT00641056|464719749|FG001|Overall Study|Sponsor Decision|2|||
129115457|NCT02351934|464719750|FG000|Allocation|POD weight<pre-op weight|3|||
129115458|NCT02351934|464719751|FG001|Allocation|POD weight<pre-op weight|0|||
129115459|NCT02351934|464719750|FG000|Allocation|Hypotension preventing administration|2|||
129115460|NCT02351934|464719751|FG001|Allocation|Hypotension preventing administration|0|||
129115461|NCT02351934|464719750|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
129115462|NCT02351934|464719751|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
129115463|NCT02351934|464719750|FG000|Follow-Up|POD weight<pre-op weight|3|||
129115464|NCT02351934|464719751|FG001|Follow-Up|POD weight<pre-op weight|0|||
129115465|NCT02351934|464719750|FG000|Follow-Up|Acute Kidney Injury|1|||
128904775|NCT01014689|463943057|FG000|Overall Study|Adverse Event|3|||
129115466|NCT02351934|464719751|FG001|Follow-Up|Acute Kidney Injury|0|||
129115467|NCT02351934|464719750|FG000|Follow-Up|Early dismissal|3|||
129115468|NCT02351934|464719751|FG001|Follow-Up|Early dismissal|0|||
129115469|NCT02351934|464719750|FG000|Follow-Up|Hypotension|3|||
129115470|NCT02351934|464719751|FG001|Follow-Up|Hypotension|0|||
128904776|NCT01014689|463943058|FG001|Overall Study|Adverse Event|0|||
128904777|NCT01014689|463943057|FG000|Overall Study|Withdrawal by Subject|5|||
128904778|NCT01014689|463943058|FG001|Overall Study|Withdrawal by Subject|4|||
128904779|NCT01014689|463943057|FG000|Overall Study|Protocol Violation|1|||
128904780|NCT01014689|463943058|FG001|Overall Study|Protocol Violation|1|||
128904781|NCT01014689|463943057|FG000|Overall Study|Lost to Follow-up|3|||
128904782|NCT01014689|463943058|FG001|Overall Study|Lost to Follow-up|7|||
128904783|NCT01014689|463943057|FG000|Overall Study|Pregnancy|1|||
128904784|NCT01014689|463943058|FG001|Overall Study|Pregnancy|0|||
128904785|NCT00333359|463943060|FG000|Overall Study|Adverse Event|29|||
128904786|NCT00333359|463943061|FG001|Overall Study|Adverse Event|35|||
128904787|NCT00333359|463943060|FG000|Overall Study|Withdrawal by Subject|19|||
128904788|NCT00333359|463943061|FG001|Overall Study|Withdrawal by Subject|37|||
128904789|NCT00333359|463943060|FG000|Overall Study|Physician Decision|2|||
128904790|NCT00333359|463943061|FG001|Overall Study|Physician Decision|2|||
128904791|NCT00333359|463943060|FG000|Overall Study|Protocol Non-compliance|2|||
128904792|NCT00333359|463943061|FG001|Overall Study|Protocol Non-compliance|8|||
128904793|NCT00333359|463943060|FG000|Overall Study|Lost to Follow-up|15|||
128904794|NCT00333359|463943061|FG001|Overall Study|Lost to Follow-up|25|||
128904795|NCT00333359|463943060|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
128904796|NCT00333359|463943061|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
128904797|NCT00333359|463943060|FG000|Overall Study|Treatment Failure|3|||
128904798|NCT00333359|463943061|FG001|Overall Study|Treatment Failure|8|||
128904799|NCT00333359|463943060|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
128904800|NCT00333359|463943061|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
128904801|NCT02867995|463943063|FG000|Overall Study|Withdrawal by Subject|0|||
128904802|NCT02867995|463943064|FG001|Overall Study|Withdrawal by Subject|1|||
128904803|NCT02867995|463943063|FG000|Overall Study|Lost to Follow-up|0|||
128904804|NCT02867995|463943064|FG001|Overall Study|Lost to Follow-up|2|||
128904805|NCT04099251|463946402|FG000|Pre-Treatment|Other reasons|1|||
128904806|NCT04099251|463946403|FG001|Pre-Treatment|Other reasons|0|||
128904807|NCT04099251|463946402|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
128904808|NCT04099251|463946403|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
128904809|NCT04099251|463946402|FG000|Blinded Treatment Phase|Other reasons|16|||
128904810|NCT04099251|463946403|FG001|Blinded Treatment Phase|Other reasons|7|||
128904811|NCT04099251|463946402|FG000|Blinded Treatment Phase|Disease recurrence|26|||
128904812|NCT04099251|463946403|FG001|Blinded Treatment Phase|Disease recurrence|41|||
128904813|NCT04099251|463946402|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
128904814|NCT04099251|463946403|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
128904815|NCT04099251|463946402|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
128904816|NCT04099251|463946403|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
128904817|NCT04099251|463946402|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
128904818|NCT04099251|463946403|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
128904819|NCT04099251|463946402|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
128904820|NCT04099251|463946403|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
128904821|NCT04099251|463946402|FG000|Blinded Treatment Phase|Death|6|||
128904822|NCT04099251|463946403|FG001|Blinded Treatment Phase|Death|2|||
128904823|NCT04099251|463946402|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
128904824|NCT04099251|463946403|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
128904825|NCT04099251|463946402|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
128904826|NCT04099251|463946403|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
128904827|NCT04099251|463946402|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
129115471|NCT02351934|464719750|FG000|Follow-Up|No documentation|2|||
129115472|NCT02351934|464719751|FG001|Follow-Up|No documentation|0|||
129115473|NCT02351934|464719750|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
129115474|NCT02351934|464719751|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
129115475|NCT02351934|464719750|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
129115476|NCT02351934|464719751|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
129115477|NCT00896493|464719752|FG000|Overall Study|Early disease relapse|3|||
129115478|NCT01739335|464719754|FG000|Overall Study|Lost to Follow-up|7|||
129115479|NCT01739335|464719755|FG001|Overall Study|Lost to Follow-up|4|||
129115480|NCT01739335|464719754|FG000|Overall Study|Ineligible patient randomized|0|||
129215321|NCT00463567|465091127|FG002|Overall Study|Administrative problems|6|||
128764823|NCT03002038|463430316|FG001|Overall Study|Withdrawal by Subject|4|||
128904828|NCT04099251|463946403|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
128904829|NCT04099251|463946402|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
128904830|NCT04099251|463946403|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
128904831|NCT04099251|463946402|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
128904832|NCT04099251|463946403|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
128904833|NCT04099251|463946402|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
129115481|NCT01739335|464719755|FG001|Overall Study|Ineligible patient randomized|1|||
129215322|NCT00463567|465091128|FG003|Overall Study|Administrative problems|9|||
129215323|NCT00463567|465091129|FG004|Overall Study|Administrative problems|3|||
128904834|NCT04099251|463946403|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
128904835|NCT04099251|463946402|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
128904836|NCT04099251|463946403|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
128904837|NCT04099251|463946402|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
128904838|NCT04099251|463946403|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
128904839|NCT04099251|463946402|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
128904840|NCT04099251|463946403|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
128904841|NCT05032157|463946404|FG000|Overall Study|Adverse Event|12|||
128904842|NCT05032157|463946405|FG001|Overall Study|Adverse Event|7|||
128904843|NCT05032157|463946404|FG000|Overall Study|Pregnancy|0|||
128904844|NCT05032157|463946405|FG001|Overall Study|Pregnancy|2|||
128904845|NCT05032157|463946404|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
128904846|NCT05032157|463946405|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
128904847|NCT05032157|463946404|FG000|Overall Study|Protocol Deviation|8|||
128904848|NCT05032157|463946405|FG001|Overall Study|Protocol Deviation|4|||
128904849|NCT05032157|463946404|FG000|Overall Study|Lost to Follow-up|1|||
128904850|NCT05032157|463946405|FG001|Overall Study|Lost to Follow-up|3|||
128904851|NCT05032157|463946404|FG000|Overall Study|Physician Decision|7|||
128904852|NCT05032157|463946405|FG001|Overall Study|Physician Decision|2|||
128904853|NCT05032157|463946404|FG000|Overall Study|Patient Decision|38|||
128904854|NCT05032157|463946405|FG001|Overall Study|Patient Decision|19|||
128904855|NCT03047980|463946406|FG000|Overall Study|Adverse Event|1|||
128904856|NCT02164981|463946407|FG000|Started|Withdrawal by Subject|2|||
128904857|NCT02164981|463946408|FG001|Started|Withdrawal by Subject|1|||
128904858|NCT02164981|463946409|FG002|Started|Withdrawal by Subject|0|||
128904859|NCT02164981|463946407|FG000|Started|Protocol Violation|2|||
128904860|NCT02164981|463946408|FG001|Started|Protocol Violation|0|||
128904861|NCT02164981|463946409|FG002|Started|Protocol Violation|0|||
128904862|NCT02164981|463946407|FG000|Started|Adverse Event|1|||
128904863|NCT02164981|463946408|FG001|Started|Adverse Event|2|||
128904864|NCT02164981|463946409|FG002|Started|Adverse Event|0|||
128904865|NCT02164981|463946407|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
128904866|NCT02164981|463946408|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
128904867|NCT02164981|463946409|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
128694203|NCT00150709|463180429|FG000|Overall Study|Lack of Efficacy|6|||
128904868|NCT02164981|463946407|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
128904869|NCT02164981|463946408|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
128904870|NCT02164981|463946409|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
128904871|NCT02164981|463946407|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
128904872|NCT02164981|463946408|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
128904873|NCT02164981|463946409|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
128904874|NCT02404103|463946410|FG000|Overall Study|Adverse Event|1|||
128904875|NCT02404103|463946411|FG001|Overall Study|Adverse Event|0|||
128904876|NCT02404103|463946410|FG000|Overall Study|Lost to Follow-up|3|||
128904877|NCT02404103|463946411|FG001|Overall Study|Lost to Follow-up|3|||
128904878|NCT01995071|463946412|FG000|Overall Study|Adverse Event|0|||
128904879|NCT01995071|463946413|FG001|Overall Study|Adverse Event|0|||
128904880|NCT01995071|463946414|FG002|Overall Study|Adverse Event|0|||
128904881|NCT01995071|463946415|FG003|Overall Study|Adverse Event|0|||
128904882|NCT01995071|463946416|FG004|Overall Study|Adverse Event|0|||
128904883|NCT01995071|463946417|FG005|Overall Study|Adverse Event|0|||
128904884|NCT01995071|463946418|FG006|Overall Study|Adverse Event|1|||
128904885|NCT01995071|463946419|FG007|Overall Study|Adverse Event|0|||
128904886|NCT01995071|463946420|FG008|Overall Study|Adverse Event|0|||
128904887|NCT01995071|463946421|FG009|Overall Study|Adverse Event|0|||
128904888|NCT01995071|463946422|FG010|Overall Study|Adverse Event|0|||
129025763|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Other Event|58|||
129025764|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Other Event|0|||
129025765|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Other Event|0|||
129025766|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
129025767|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
129025768|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
128694204|NCT00150709|463180430|FG001|Overall Study|Lack of Efficacy|11|||
129025769|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
128694205|NCT00150709|463180431|FG002|Overall Study|Lack of Efficacy|9|||
128694206|NCT00150709|463180432|FG003|Overall Study|Lack of Efficacy|0|||
128904889|NCT01995071|463946423|FG011|Overall Study|Adverse Event|0|||
128904890|NCT01995071|463946412|FG000|Overall Study|Moved|0|||
128904891|NCT01995071|463946413|FG001|Overall Study|Moved|0|||
128904892|NCT01995071|463946414|FG002|Overall Study|Moved|1|||
128904893|NCT01995071|463946415|FG003|Overall Study|Moved|0|||
128694207|NCT00150709|463180429|FG000|Overall Study|Withdrawal by Subject|7|||
128904894|NCT01995071|463946416|FG004|Overall Study|Moved|1|||
128904895|NCT01995071|463946417|FG005|Overall Study|Moved|0|||
128904896|NCT01995071|463946418|FG006|Overall Study|Moved|0|||
128904897|NCT01995071|463946419|FG007|Overall Study|Moved|0|||
128904898|NCT01995071|463946420|FG008|Overall Study|Moved|0|||
128904899|NCT01995071|463946421|FG009|Overall Study|Moved|0|||
128904900|NCT01995071|463946422|FG010|Overall Study|Moved|1|||
128904901|NCT01995071|463946423|FG011|Overall Study|Moved|0|||
128904902|NCT01995071|463946412|FG000|Overall Study|Lost to Follow-up|1|||
128904903|NCT01995071|463946413|FG001|Overall Study|Lost to Follow-up|0|||
128904904|NCT01995071|463946414|FG002|Overall Study|Lost to Follow-up|0|||
128904905|NCT01995071|463946415|FG003|Overall Study|Lost to Follow-up|0|||
128904906|NCT01995071|463946416|FG004|Overall Study|Lost to Follow-up|0|||
128904907|NCT01995071|463946417|FG005|Overall Study|Lost to Follow-up|0|||
128904908|NCT01995071|463946418|FG006|Overall Study|Lost to Follow-up|0|||
128904909|NCT01995071|463946419|FG007|Overall Study|Lost to Follow-up|1|||
128904910|NCT01995071|463946420|FG008|Overall Study|Lost to Follow-up|1|||
128904911|NCT01995071|463946421|FG009|Overall Study|Lost to Follow-up|0|||
128904912|NCT01995071|463946422|FG010|Overall Study|Lost to Follow-up|0|||
128904913|NCT01995071|463946423|FG011|Overall Study|Lost to Follow-up|0|||
128904914|NCT01995071|463946412|FG000|Overall Study|Incarcerated|0|||
128904915|NCT01995071|463946413|FG001|Overall Study|Incarcerated|0|||
128904916|NCT01995071|463946414|FG002|Overall Study|Incarcerated|0|||
128904917|NCT01995071|463946415|FG003|Overall Study|Incarcerated|0|||
129115482|NCT04040439|464719761|FG000|Overall Study|Invalid registration|11|||
128904918|NCT01995071|463946416|FG004|Overall Study|Incarcerated|0|||
128904919|NCT01995071|463946417|FG005|Overall Study|Incarcerated|0|||
128904920|NCT01995071|463946418|FG006|Overall Study|Incarcerated|0|||
128904921|NCT01995071|463946419|FG007|Overall Study|Incarcerated|1|||
129115483|NCT04040439|464719761|FG000|Overall Study|No IC* on publication of study results|2|||
129115484|NCT01309386|464719762|FG000|Overall Study|Other|2|||
129115485|NCT01309386|464719763|FG001|Overall Study|Other|0|||
129115486|NCT01309386|464719762|FG000|Overall Study|Withdrawal by Subject|2|||
129115487|NCT01309386|464719763|FG001|Overall Study|Withdrawal by Subject|0|||
129115488|NCT01309386|464719762|FG000|Overall Study|Progressive disease|9|||
129115489|NCT01309386|464719763|FG001|Overall Study|Progressive disease|11|||
129115490|NCT01309386|464719762|FG000|Overall Study|Physician Decision|1|||
128694208|NCT00150709|463180430|FG001|Overall Study|Withdrawal by Subject|10|||
128904922|NCT01995071|463946420|FG008|Overall Study|Incarcerated|0|||
128904923|NCT01995071|463946421|FG009|Overall Study|Incarcerated|0|||
128904924|NCT01995071|463946422|FG010|Overall Study|Incarcerated|0|||
128904925|NCT01995071|463946423|FG011|Overall Study|Incarcerated|0|||
128904926|NCT01783678|463946424|FG000|Overall Study|Randomized but Not Treated|0|||
128904927|NCT01783678|463946425|FG001|Overall Study|Randomized but Not Treated|0|||
128904928|NCT01783678|463946426|FG002|Overall Study|Randomized but Not Treated|0|||
128904929|NCT01783678|463946427|FG003|Overall Study|Randomized but Not Treated|1|||
128904930|NCT01783678|463946428|FG004|Overall Study|Randomized but Not Treated|0|||
128904931|NCT01783678|463946429|FG005|Overall Study|Randomized but Not Treated|0|||
128904932|NCT01783678|463946424|FG000|Overall Study|Lack of Efficacy|1|||
128904933|NCT01783678|463946425|FG001|Overall Study|Lack of Efficacy|13|||
128904934|NCT01783678|463946426|FG002|Overall Study|Lack of Efficacy|1|||
128904935|NCT01783678|463946427|FG003|Overall Study|Lack of Efficacy|3|||
128904936|NCT01783678|463946428|FG004|Overall Study|Lack of Efficacy|6|||
128904937|NCT01783678|463946429|FG005|Overall Study|Lack of Efficacy|5|||
128904938|NCT01783678|463946424|FG000|Overall Study|Lost to Follow-up|0|||
128904939|NCT01783678|463946425|FG001|Overall Study|Lost to Follow-up|4|||
128904940|NCT01783678|463946426|FG002|Overall Study|Lost to Follow-up|0|||
128904941|NCT01783678|463946427|FG003|Overall Study|Lost to Follow-up|2|||
128904942|NCT01783678|463946428|FG004|Overall Study|Lost to Follow-up|1|||
128904943|NCT01783678|463946429|FG005|Overall Study|Lost to Follow-up|0|||
128904944|NCT01783678|463946424|FG000|Overall Study|Withdrew Consent|1|||
128904945|NCT01783678|463946425|FG001|Overall Study|Withdrew Consent|1|||
128904946|NCT01783678|463946426|FG002|Overall Study|Withdrew Consent|0|||
128904947|NCT01783678|463946427|FG003|Overall Study|Withdrew Consent|2|||
128904948|NCT01783678|463946428|FG004|Overall Study|Withdrew Consent|0|||
128694209|NCT00150709|463180431|FG002|Overall Study|Withdrawal by Subject|5|||
128904949|NCT01783678|463946429|FG005|Overall Study|Withdrew Consent|0|||
128904950|NCT00328627|463946430|FG000|Overall Study|Hyperglycemic Rescue|41|||
128904951|NCT00328627|463946431|FG001|Overall Study|Hyperglycemic Rescue|18|||
129115491|NCT01309386|464719763|FG001|Overall Study|Physician Decision|1|||
128904952|NCT00328627|463946432|FG002|Overall Study|Hyperglycemic Rescue|16|||
129115492|NCT01309386|464719762|FG000|Overall Study|Lack of Efficacy|3|||
128904953|NCT00328627|463946433|FG003|Overall Study|Hyperglycemic Rescue|13|||
128904954|NCT00328627|463946434|FG004|Overall Study|Hyperglycemic Rescue|6|||
128904955|NCT00328627|463946435|FG005|Overall Study|Hyperglycemic Rescue|5|||
128904956|NCT00328627|463946436|FG006|Overall Study|Hyperglycemic Rescue|19|||
128904957|NCT00328627|463946437|FG007|Overall Study|Hyperglycemic Rescue|6|||
128904958|NCT00328627|463946438|FG008|Overall Study|Hyperglycemic Rescue|6|||
128904959|NCT00328627|463946439|FG009|Overall Study|Hyperglycemic Rescue|11|||
128904960|NCT00328627|463946440|FG010|Overall Study|Hyperglycemic Rescue|3|||
128904961|NCT00328627|463946441|FG011|Overall Study|Hyperglycemic Rescue|2|||
129115493|NCT01309386|464719763|FG001|Overall Study|Lack of Efficacy|1|||
128904962|NCT00328627|463946430|FG000|Overall Study|Adverse Event|3|||
128904963|NCT00328627|463946431|FG001|Overall Study|Adverse Event|1|||
129115494|NCT01309386|464719762|FG000|Overall Study|Adverse Event|5|||
128904964|NCT00328627|463946432|FG002|Overall Study|Adverse Event|2|||
128904965|NCT00328627|463946433|FG003|Overall Study|Adverse Event|3|||
128904966|NCT00328627|463946434|FG004|Overall Study|Adverse Event|1|||
128904967|NCT00328627|463946435|FG005|Overall Study|Adverse Event|2|||
128904968|NCT00328627|463946436|FG006|Overall Study|Adverse Event|1|||
128904969|NCT00328627|463946437|FG007|Overall Study|Adverse Event|2|||
128904970|NCT00328627|463946438|FG008|Overall Study|Adverse Event|0|||
128904971|NCT00328627|463946439|FG009|Overall Study|Adverse Event|7|||
128904972|NCT00328627|463946440|FG010|Overall Study|Adverse Event|5|||
128904973|NCT00328627|463946441|FG011|Overall Study|Adverse Event|4|||
128904974|NCT00328627|463946430|FG000|Overall Study|Protocol Violation|2|||
128904975|NCT00328627|463946431|FG001|Overall Study|Protocol Violation|2|||
128904976|NCT00328627|463946432|FG002|Overall Study|Protocol Violation|2|||
128904977|NCT00328627|463946433|FG003|Overall Study|Protocol Violation|8|||
128904978|NCT00328627|463946434|FG004|Overall Study|Protocol Violation|5|||
128904979|NCT00328627|463946435|FG005|Overall Study|Protocol Violation|5|||
128904980|NCT00328627|463946436|FG006|Overall Study|Protocol Violation|6|||
128904981|NCT00328627|463946437|FG007|Overall Study|Protocol Violation|2|||
128904982|NCT00328627|463946438|FG008|Overall Study|Protocol Violation|1|||
128904983|NCT00328627|463946439|FG009|Overall Study|Protocol Violation|4|||
128904984|NCT00328627|463946440|FG010|Overall Study|Protocol Violation|6|||
128904985|NCT00328627|463946441|FG011|Overall Study|Protocol Violation|2|||
128904986|NCT00328627|463946430|FG000|Overall Study|Lost to Follow-up|4|||
128904987|NCT00328627|463946431|FG001|Overall Study|Lost to Follow-up|2|||
128904988|NCT00328627|463946432|FG002|Overall Study|Lost to Follow-up|2|||
128904989|NCT00328627|463946433|FG003|Overall Study|Lost to Follow-up|4|||
128904990|NCT00328627|463946434|FG004|Overall Study|Lost to Follow-up|0|||
128904991|NCT00328627|463946435|FG005|Overall Study|Lost to Follow-up|2|||
128904992|NCT00328627|463946436|FG006|Overall Study|Lost to Follow-up|3|||
128904993|NCT00328627|463946437|FG007|Overall Study|Lost to Follow-up|0|||
128904994|NCT00328627|463946438|FG008|Overall Study|Lost to Follow-up|3|||
128904995|NCT00328627|463946439|FG009|Overall Study|Lost to Follow-up|2|||
128904996|NCT00328627|463946440|FG010|Overall Study|Lost to Follow-up|0|||
128904997|NCT00328627|463946441|FG011|Overall Study|Lost to Follow-up|1|||
128904998|NCT00328627|463946430|FG000|Overall Study|Withdrawal by Subject|5|||
128904999|NCT00328627|463946431|FG001|Overall Study|Withdrawal by Subject|4|||
128905000|NCT00328627|463946432|FG002|Overall Study|Withdrawal by Subject|5|||
128905001|NCT00328627|463946433|FG003|Overall Study|Withdrawal by Subject|6|||
128905002|NCT00328627|463946434|FG004|Overall Study|Withdrawal by Subject|2|||
128905003|NCT00328627|463946435|FG005|Overall Study|Withdrawal by Subject|5|||
128905004|NCT00328627|463946436|FG006|Overall Study|Withdrawal by Subject|4|||
128905005|NCT00328627|463946437|FG007|Overall Study|Withdrawal by Subject|4|||
128905006|NCT00328627|463946438|FG008|Overall Study|Withdrawal by Subject|4|||
128905007|NCT00328627|463946439|FG009|Overall Study|Withdrawal by Subject|5|||
128905008|NCT00328627|463946440|FG010|Overall Study|Withdrawal by Subject|2|||
128905009|NCT00328627|463946441|FG011|Overall Study|Withdrawal by Subject|7|||
128905010|NCT00328627|463946430|FG000|Overall Study|Pregnancy|0|||
128905011|NCT00328627|463946431|FG001|Overall Study|Pregnancy|1|||
128905012|NCT00328627|463946432|FG002|Overall Study|Pregnancy|0|||
128905013|NCT00328627|463946433|FG003|Overall Study|Pregnancy|0|||
128905014|NCT00328627|463946434|FG004|Overall Study|Pregnancy|0|||
128905015|NCT00328627|463946435|FG005|Overall Study|Pregnancy|0|||
128905016|NCT00328627|463946436|FG006|Overall Study|Pregnancy|0|||
128905017|NCT00328627|463946437|FG007|Overall Study|Pregnancy|0|||
128905018|NCT00328627|463946438|FG008|Overall Study|Pregnancy|0|||
128905019|NCT00328627|463946439|FG009|Overall Study|Pregnancy|0|||
128905020|NCT00328627|463946440|FG010|Overall Study|Pregnancy|0|||
128905021|NCT00328627|463946441|FG011|Overall Study|Pregnancy|0|||
128905022|NCT00328627|463946430|FG000|Overall Study|Physician Decision|4|||
128905023|NCT00328627|463946431|FG001|Overall Study|Physician Decision|3|||
128905024|NCT00328627|463946432|FG002|Overall Study|Physician Decision|1|||
129115495|NCT01309386|464719763|FG001|Overall Study|Adverse Event|8|||
129115496|NCT02062437|464719764|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
128905025|NCT00328627|463946433|FG003|Overall Study|Physician Decision|2|||
128905026|NCT00328627|463946434|FG004|Overall Study|Physician Decision|1|||
128905027|NCT00328627|463946435|FG005|Overall Study|Physician Decision|1|||
128905028|NCT00328627|463946436|FG006|Overall Study|Physician Decision|1|||
128905029|NCT00328627|463946437|FG007|Overall Study|Physician Decision|0|||
128905030|NCT00328627|463946438|FG008|Overall Study|Physician Decision|3|||
128905031|NCT00328627|463946439|FG009|Overall Study|Physician Decision|2|||
128905032|NCT00328627|463946440|FG010|Overall Study|Physician Decision|1|||
128905033|NCT00328627|463946441|FG011|Overall Study|Physician Decision|0|||
128905034|NCT00328627|463946430|FG000|Overall Study|Other|0|||
128905035|NCT00328627|463946431|FG001|Overall Study|Other|0|||
128905036|NCT00328627|463946432|FG002|Overall Study|Other|0|||
128905037|NCT00328627|463946433|FG003|Overall Study|Other|1|||
128905038|NCT00328627|463946434|FG004|Overall Study|Other|0|||
128905039|NCT00328627|463946435|FG005|Overall Study|Other|0|||
128905040|NCT00328627|463946436|FG006|Overall Study|Other|1|||
128905041|NCT00328627|463946437|FG007|Overall Study|Other|0|||
128905042|NCT00328627|463946438|FG008|Overall Study|Other|0|||
128905043|NCT00328627|463946439|FG009|Overall Study|Other|1|||
128905044|NCT00328627|463946440|FG010|Overall Study|Other|1|||
128905045|NCT00328627|463946441|FG011|Overall Study|Other|0|||
128905046|NCT03311711|463946442|FG000|Overall Study|Death|1|||
128905047|NCT03311711|463946443|FG001|Overall Study|Death|0|||
128905048|NCT03311711|463946444|FG002|Overall Study|Death|0|||
128905049|NCT03311711|463946445|FG003|Overall Study|Death|0|||
128905050|NCT03311711|463946446|FG004|Overall Study|Death|0|||
128905051|NCT03311711|463946447|FG005|Overall Study|Death|0|||
128905052|NCT03311711|463946448|FG006|Overall Study|Death|1|||
128905053|NCT03311711|463946449|FG007|Overall Study|Death|0|||
128905054|NCT03311711|463946450|FG008|Overall Study|Death|1|||
128905055|NCT03311711|463946451|FG009|Overall Study|Death|0|||
128905056|NCT03311711|463946442|FG000|Overall Study|Death of dyad partner|0|||
128905057|NCT03311711|463946443|FG001|Overall Study|Death of dyad partner|1|||
128905058|NCT03311711|463946444|FG002|Overall Study|Death of dyad partner|0|||
128905059|NCT03311711|463946445|FG003|Overall Study|Death of dyad partner|0|||
128905060|NCT03311711|463946446|FG004|Overall Study|Death of dyad partner|0|||
128905061|NCT03311711|463946447|FG005|Overall Study|Death of dyad partner|0|||
128905062|NCT03311711|463946448|FG006|Overall Study|Death of dyad partner|0|||
128905063|NCT03311711|463946449|FG007|Overall Study|Death of dyad partner|1|||
128905064|NCT03311711|463946450|FG008|Overall Study|Death of dyad partner|0|||
128905065|NCT03311711|463946451|FG009|Overall Study|Death of dyad partner|1|||
128905066|NCT03311711|463946442|FG000|Overall Study|Lost to Follow-up|2|||
128905067|NCT03311711|463946443|FG001|Overall Study|Lost to Follow-up|2|||
128905068|NCT03311711|463946444|FG002|Overall Study|Lost to Follow-up|0|||
128905069|NCT03311711|463946445|FG003|Overall Study|Lost to Follow-up|0|||
128905070|NCT03311711|463946446|FG004|Overall Study|Lost to Follow-up|0|||
128905071|NCT03311711|463946447|FG005|Overall Study|Lost to Follow-up|0|||
128905072|NCT03311711|463946448|FG006|Overall Study|Lost to Follow-up|1|||
128905073|NCT03311711|463946449|FG007|Overall Study|Lost to Follow-up|1|||
128905074|NCT03311711|463946450|FG008|Overall Study|Lost to Follow-up|0|||
128905075|NCT03311711|463946451|FG009|Overall Study|Lost to Follow-up|0|||
128905076|NCT03311711|463946442|FG000|Overall Study|Withdrawal by Subject|1|||
128905077|NCT03311711|463946443|FG001|Overall Study|Withdrawal by Subject|1|||
128905078|NCT03311711|463946444|FG002|Overall Study|Withdrawal by Subject|0|||
128905079|NCT03311711|463946445|FG003|Overall Study|Withdrawal by Subject|0|||
128905080|NCT03311711|463946446|FG004|Overall Study|Withdrawal by Subject|0|||
128905081|NCT03311711|463946447|FG005|Overall Study|Withdrawal by Subject|0|||
128905082|NCT03311711|463946448|FG006|Overall Study|Withdrawal by Subject|3|||
128905083|NCT03311711|463946449|FG007|Overall Study|Withdrawal by Subject|3|||
128905084|NCT03311711|463946450|FG008|Overall Study|Withdrawal by Subject|0|||
128905085|NCT03311711|463946451|FG009|Overall Study|Withdrawal by Subject|0|||
128905086|NCT01339559|463946453|FG000|Overall Study|Adverse Event|92|||
128905087|NCT01339559|463946453|FG000|Overall Study|Death|5|||
128905088|NCT01339559|463946453|FG000|Overall Study|Lack of Efficacy|164|||
128905089|NCT01339559|463946453|FG000|Overall Study|Lost to Follow-up|22|||
128905090|NCT01339559|463946453|FG000|Overall Study|Subject choice|89|||
128905091|NCT01339559|463946453|FG000|Overall Study|Protocol Violation|15|||
128905092|NCT01339559|463946453|FG000|Overall Study|Study closure at site|1|||
128905093|NCT01339559|463946453|FG000|Overall Study|Incarcerated|2|||
128905094|NCT01339559|463946453|FG000|Overall Study|Epilepsy surgery|1|||
128905095|NCT01339559|463946453|FG000|Overall Study|Pregnancy planned|2|||
128905096|NCT01339559|463946453|FG000|Overall Study|Left the country|1|||
128905097|NCT01339559|463946453|FG000|Overall Study|Investigator decision|2|||
128905098|NCT01339559|463946453|FG000|Overall Study|Patient didn't wish to continue|1|||
128905099|NCT01339559|463946453|FG000|Overall Study|PI decision|1|||
128905100|NCT01137773|463946454|FG000|Overall Study|Death|3|||
128905101|NCT01137773|463946455|FG001|Overall Study|Death|3|||
128905102|NCT01137773|463946454|FG000|Overall Study|Lost to Follow-up|6|||
128905103|NCT01137773|463946455|FG001|Overall Study|Lost to Follow-up|0|||
128905104|NCT03548051|463946456|FG000|Overall Study|Death|1|||
128905105|NCT03548051|463946457|FG001|Overall Study|Death|1|||
129025770|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
129025771|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
129025772|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
128905106|NCT03548051|463946456|FG000|Overall Study|Withdrawal by Subject|1|||
128905107|NCT03548051|463946457|FG001|Overall Study|Withdrawal by Subject|0|||
128905108|NCT03927105|463946458|FG000|Overall Study|Death|1|||
128905109|NCT03927105|463946458|FG000|Overall Study|In observation for potential re-treatment|2|||
128905110|NCT03927105|463946458|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
128905111|NCT01745146|463946462|FG000|Overall Study|Withdrawal by Subject|1|||
128905112|NCT01745146|463946463|FG001|Overall Study|Withdrawal by Subject|3|||
128905113|NCT01745146|463946462|FG000|Overall Study|Lost to Follow-up|2|||
128905114|NCT01745146|463946463|FG001|Overall Study|Lost to Follow-up|0|||
129025773|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
128905115|NCT05594173|463946464|FG000|Overall Study|Adverse Event|1|||
128905116|NCT05594173|463946464|FG000|Overall Study|COVID-19 Pandemic|2|||
128905117|NCT00647556|463946465|FG000|Overall Study|Adverse Event|0|||
129025774|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
128905118|NCT00647556|463946466|FG001|Overall Study|Adverse Event|1|||
128905119|NCT00647556|463946465|FG000|Overall Study|Lost to Follow-up|1|||
128905120|NCT00647556|463946466|FG001|Overall Study|Lost to Follow-up|0|||
128905121|NCT00647556|463946465|FG000|Overall Study|Protocol Violation|0|||
128905122|NCT00647556|463946466|FG001|Overall Study|Protocol Violation|1|||
128905123|NCT00647556|463946465|FG000|Overall Study|Withdrawal by Subject|1|||
128905124|NCT00647556|463946466|FG001|Overall Study|Withdrawal by Subject|0|||
128905125|NCT00647556|463946465|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
128905126|NCT00647556|463946466|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
128905127|NCT01877187|463946467|FG000|Overall Study|Death|2|||
128905128|NCT01877187|463946467|FG000|Overall Study|Withdrawal by Subject|4|||
128905129|NCT01877187|463946467|FG000|Overall Study|Lost to Follow-up|3|||
128905130|NCT01877187|463946467|FG000|Overall Study|Declining clinical status|11|||
128905131|NCT01877187|463946467|FG000|Overall Study|Liver transplant|2|||
128905132|NCT02559687|463946475|FG000|Overall Study|Death|112|||
128905133|NCT02559687|463946475|FG000|Overall Study|Sponsor Decision|5|||
128905134|NCT02559687|463946475|FG000|Overall Study|Withdrawal by Subject|4|||
128905135|NCT00382993|463946478|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
128905136|NCT00382993|463946479|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
128905137|NCT00382993|463946478|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
128905138|NCT00382993|463946479|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
128905139|NCT00382993|463946478|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
128905140|NCT00382993|463946479|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
128905141|NCT00382993|463946478|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
128905142|NCT00382993|463946479|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
128905143|NCT00382993|463946478|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
128905144|NCT00382993|463946479|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
128905145|NCT00382993|463946478|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
128905146|NCT00382993|463946479|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
128905147|NCT00382993|463946478|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
128905148|NCT00382993|463946479|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
128905149|NCT00382993|463946478|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
128905150|NCT00382993|463946479|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
129025775|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
129025776|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
128694210|NCT00150709|463180432|FG003|Overall Study|Withdrawal by Subject|0|||
128694211|NCT00150709|463180429|FG000|Overall Study|Lost to Follow-up|3|||
128694212|NCT00150709|463180430|FG001|Overall Study|Lost to Follow-up|2|||
128694213|NCT00150709|463180431|FG002|Overall Study|Lost to Follow-up|0|||
128694214|NCT00150709|463180432|FG003|Overall Study|Lost to Follow-up|0|||
128694215|NCT00150709|463180429|FG000|Overall Study|Sponsor decision|0|||
128694216|NCT00150709|463180430|FG001|Overall Study|Sponsor decision|0|||
128694217|NCT00150709|463180431|FG002|Overall Study|Sponsor decision|0|||
128694218|NCT00150709|463180432|FG003|Overall Study|Sponsor decision|1|||
128694219|NCT00150709|463180429|FG000|Overall Study|Site/Investigator discontinued the study|5|||
128764824|NCT03002038|463430315|FG000|Overall Study|Immigration to another region|0|||
129025777|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
129025778|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
129025779|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
129025780|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
129025781|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
129025782|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
129025783|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
129025784|NCT00205777|464387630|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
129025785|NCT00205777|464387631|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
129025786|NCT00205777|464387632|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
129025787|NCT00205777|464387633|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
129025788|NCT00205777|464387634|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
129025789|NCT00205777|464387635|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
129025790|NCT00205777|464387630|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
129025791|NCT00205777|464387631|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
129025792|NCT00205777|464387632|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
129025793|NCT00205777|464387633|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
129025794|NCT00205777|464387634|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
129025795|NCT00205777|464387635|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
129025796|NCT00205777|464387630|FG000|Completed Core Study, Entered SE I|Other Event|52|||
128905151|NCT00382993|463946478|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
128905152|NCT00382993|463946479|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
128694220|NCT00150709|463180430|FG001|Overall Study|Site/Investigator discontinued the study|5|||
128694221|NCT00150709|463180431|FG002|Overall Study|Site/Investigator discontinued the study|2|||
128905153|NCT00382993|463946478|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
128905154|NCT00382993|463946479|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
128905155|NCT02898259|463946480|FG000|Overall Study|Adverse Event|0|||
128905156|NCT02898259|463946481|FG001|Overall Study|Adverse Event|0|||
128905157|NCT02898259|463946482|FG002|Overall Study|Adverse Event|1|||
128905158|NCT02898259|463946483|FG003|Overall Study|Adverse Event|0|||
128905159|NCT02898259|463946484|FG004|Overall Study|Adverse Event|0|||
128905160|NCT02898259|463946480|FG000|Overall Study|Lack of Efficacy|1|||
128905161|NCT02898259|463946481|FG001|Overall Study|Lack of Efficacy|1|||
128905162|NCT02898259|463946482|FG002|Overall Study|Lack of Efficacy|3|||
128905163|NCT02898259|463946483|FG003|Overall Study|Lack of Efficacy|0|||
128905164|NCT02898259|463946484|FG004|Overall Study|Lack of Efficacy|0|||
128905165|NCT02898259|463946480|FG000|Overall Study|Lost to Follow-up|0|||
128905166|NCT02898259|463946481|FG001|Overall Study|Lost to Follow-up|0|||
128905167|NCT02898259|463946482|FG002|Overall Study|Lost to Follow-up|1|||
128905168|NCT02898259|463946483|FG003|Overall Study|Lost to Follow-up|0|||
128905169|NCT02898259|463946484|FG004|Overall Study|Lost to Follow-up|0|||
128905170|NCT02898259|463946480|FG000|Overall Study|Transformation before study began|0|||
128905171|NCT02898259|463946481|FG001|Overall Study|Transformation before study began|0|||
128905172|NCT02898259|463946482|FG002|Overall Study|Transformation before study began|0|||
128905173|NCT02898259|463946483|FG003|Overall Study|Transformation before study began|1|||
128905174|NCT02898259|463946484|FG004|Overall Study|Transformation before study began|0|||
128905175|NCT01046877|463946485|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
128905176|NCT01046877|463946485|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
128905177|NCT03016325|463946486|FG000|Treatment Period|Participant withdrew consent|0|||
128905178|NCT03016325|463946487|FG001|Treatment Period|Participant withdrew consent|1|||
128905179|NCT03016325|463946488|FG002|Treatment Period|Participant withdrew consent|0|||
128905180|NCT03016325|463946489|FG003|Treatment Period|Participant withdrew consent|0|||
128905181|NCT03016325|463946490|FG004|Treatment Period|Participant withdrew consent|0|||
128905182|NCT03016325|463946491|FG005|Treatment Period|Participant withdrew consent|0|||
128905183|NCT03016325|463946492|FG006|Treatment Period|Participant withdrew consent|0|||
129025797|NCT00205777|464387631|FG001|Completed Core Study, Entered SE I|Other Event|46|||
129025798|NCT00205777|464387632|FG002|Completed Core Study, Entered SE I|Other Event|47|||
129025799|NCT00205777|464387633|FG003|Completed Core Study, Entered SE I|Other Event|50|||
129025800|NCT00205777|464387634|FG004|Completed Core Study, Entered SE I|Other Event|0|||
129025801|NCT00205777|464387635|FG005|Completed Core Study, Entered SE I|Other Event|0|||
129025802|NCT00205777|464387630|FG000|Study Extension I|Adverse Event|57|||
129025803|NCT00205777|464387631|FG001|Study Extension I|Adverse Event|0|||
129025804|NCT00205777|464387632|FG002|Study Extension I|Adverse Event|0|||
129025805|NCT00205777|464387633|FG003|Study Extension I|Adverse Event|61|||
129025806|NCT00205777|464387634|FG004|Study Extension I|Adverse Event|58|||
129025807|NCT00205777|464387635|FG005|Study Extension I|Adverse Event|0|||
129025808|NCT00205777|464387630|FG000|Study Extension I|Death|5|||
129025809|NCT00205777|464387631|FG001|Study Extension I|Death|0|||
129025810|NCT00205777|464387632|FG002|Study Extension I|Death|0|||
129025811|NCT00205777|464387633|FG003|Study Extension I|Death|1|||
129025812|NCT00205777|464387634|FG004|Study Extension I|Death|2|||
129025813|NCT00205777|464387635|FG005|Study Extension I|Death|0|||
129025814|NCT00205777|464387630|FG000|Study Extension I|Withdrawal by Subject|99|||
129025815|NCT00205777|464387631|FG001|Study Extension I|Withdrawal by Subject|0|||
129025816|NCT00205777|464387632|FG002|Study Extension I|Withdrawal by Subject|0|||
129025817|NCT00205777|464387633|FG003|Study Extension I|Withdrawal by Subject|106|||
129025818|NCT00205777|464387634|FG004|Study Extension I|Withdrawal by Subject|89|||
129025819|NCT00205777|464387635|FG005|Study Extension I|Withdrawal by Subject|0|||
129025820|NCT00205777|464387630|FG000|Study Extension I|Protocol Violation|4|||
129025821|NCT00205777|464387631|FG001|Study Extension I|Protocol Violation|0|||
129025822|NCT00205777|464387632|FG002|Study Extension I|Protocol Violation|0|||
129025823|NCT00205777|464387633|FG003|Study Extension I|Protocol Violation|8|||
129025824|NCT00205777|464387634|FG004|Study Extension I|Protocol Violation|8|||
129025825|NCT00205777|464387635|FG005|Study Extension I|Protocol Violation|0|||
128905184|NCT03016325|463946493|FG007|Treatment Period|Participant withdrew consent|0|||
128905185|NCT03016325|463946486|FG000|Treatment Period|Death|0|||
128905186|NCT03016325|463946487|FG001|Treatment Period|Death|0|||
128905187|NCT03016325|463946488|FG002|Treatment Period|Death|0|||
128905188|NCT03016325|463946489|FG003|Treatment Period|Death|0|||
128905189|NCT03016325|463946490|FG004|Treatment Period|Death|2|||
128905190|NCT03016325|463946491|FG005|Treatment Period|Death|0|||
128905191|NCT03016325|463946492|FG006|Treatment Period|Death|0|||
129025826|NCT00205777|464387630|FG000|Study Extension I|Lack of Efficacy|0|||
129025827|NCT00205777|464387631|FG001|Study Extension I|Lack of Efficacy|0|||
129025828|NCT00205777|464387632|FG002|Study Extension I|Lack of Efficacy|0|||
129025829|NCT00205777|464387633|FG003|Study Extension I|Lack of Efficacy|1|||
129025830|NCT00205777|464387634|FG004|Study Extension I|Lack of Efficacy|2|||
129025831|NCT00205777|464387635|FG005|Study Extension I|Lack of Efficacy|0|||
129025832|NCT00205777|464387630|FG000|Study Extension I|Failed to return|15|||
129025833|NCT00205777|464387631|FG001|Study Extension I|Failed to return|0|||
129025834|NCT00205777|464387632|FG002|Study Extension I|Failed to return|0|||
128905192|NCT03016325|463946493|FG007|Treatment Period|Death|0|||
128905193|NCT03016325|463946486|FG000|Treatment Period|Participant refuses assessments|0|||
128905194|NCT03016325|463946487|FG001|Treatment Period|Participant refuses assessments|0|||
128905195|NCT03016325|463946488|FG002|Treatment Period|Participant refuses assessments|1|||
128905196|NCT03016325|463946489|FG003|Treatment Period|Participant refuses assessments|0|||
128905197|NCT03016325|463946490|FG004|Treatment Period|Participant refuses assessments|0|||
128905198|NCT03016325|463946491|FG005|Treatment Period|Participant refuses assessments|0|||
128905199|NCT03016325|463946492|FG006|Treatment Period|Participant refuses assessments|0|||
128905200|NCT03016325|463946493|FG007|Treatment Period|Participant refuses assessments|0|||
128905201|NCT03016325|463946486|FG000|32-Day Follow-Up Period|Death|2|||
128905202|NCT03016325|463946487|FG001|32-Day Follow-Up Period|Death|0|||
128905203|NCT03016325|463946488|FG002|32-Day Follow-Up Period|Death|5|||
128905204|NCT03016325|463946489|FG003|32-Day Follow-Up Period|Death|6|||
128905205|NCT03016325|463946490|FG004|32-Day Follow-Up Period|Death|3|||
128905206|NCT03016325|463946491|FG005|32-Day Follow-Up Period|Death|0|||
128905207|NCT03016325|463946492|FG006|32-Day Follow-Up Period|Death|0|||
128905208|NCT03016325|463946493|FG007|32-Day Follow-Up Period|Death|0|||
128905209|NCT03016325|463946486|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
128905210|NCT03016325|463946487|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
128905211|NCT03016325|463946488|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
128905212|NCT03016325|463946489|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
128905213|NCT03016325|463946490|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
128905214|NCT03016325|463946491|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
128905215|NCT03016325|463946492|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
128905216|NCT03016325|463946493|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
128905217|NCT03016325|463946486|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
128905218|NCT03016325|463946487|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
128905219|NCT03016325|463946488|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
128905220|NCT03016325|463946489|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
128905221|NCT03016325|463946490|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
128905222|NCT03016325|463946491|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
128905223|NCT03016325|463946492|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
128905224|NCT03016325|463946493|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
128905225|NCT03016325|463946486|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
128905226|NCT03016325|463946487|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
128905227|NCT03016325|463946488|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
128905228|NCT03016325|463946489|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
128905229|NCT03016325|463946490|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
128905230|NCT03016325|463946491|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
128905231|NCT03016325|463946492|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
128905232|NCT03016325|463946493|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
128905233|NCT03016325|463946486|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
128905234|NCT03016325|463946487|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
128905235|NCT03016325|463946488|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
128905236|NCT03016325|463946489|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
128905237|NCT03016325|463946490|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
128905238|NCT03016325|463946491|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
128905239|NCT03016325|463946492|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
128905240|NCT03016325|463946493|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
128905241|NCT03016325|463946486|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
128905242|NCT03016325|463946487|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
128905243|NCT03016325|463946488|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
128905244|NCT03016325|463946489|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
128905245|NCT03016325|463946490|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
128905246|NCT03016325|463946491|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
128905247|NCT03016325|463946492|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
128905248|NCT03016325|463946493|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129025835|NCT00205777|464387633|FG003|Study Extension I|Failed to return|17|||
129025836|NCT00205777|464387634|FG004|Study Extension I|Failed to return|13|||
129025837|NCT00205777|464387635|FG005|Study Extension I|Failed to return|0|||
129025838|NCT00205777|464387630|FG000|Study Extension I|Other Event|34|||
129025839|NCT00205777|464387631|FG001|Study Extension I|Other Event|0|||
129025840|NCT00205777|464387632|FG002|Study Extension I|Other Event|0|||
129025841|NCT00205777|464387633|FG003|Study Extension I|Other Event|34|||
129025842|NCT00205777|464387634|FG004|Study Extension I|Other Event|29|||
128905249|NCT03016325|463946486|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
128905250|NCT03016325|463946487|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
129025843|NCT00205777|464387635|FG005|Study Extension I|Other Event|0|||
129025844|NCT00205777|464387630|FG000|Study Extension I|Withdrawn as per protocol|0|||
129025845|NCT00205777|464387631|FG001|Study Extension I|Withdrawn as per protocol|0|||
129115497|NCT02062437|464719764|FG000|Overall Study|Patient not available for the 2y visit|18|||
129115498|NCT02062437|464719764|FG000|Overall Study|Death|2|||
129115499|NCT02062437|464719764|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
129115500|NCT00752089|464719765|FG000|Overall Study|Adverse Event|1|||
129115501|NCT00752089|464719765|FG000|Overall Study|Protocol Deviation|2|||
129115502|NCT00752089|464719765|FG000|Overall Study|Could not attend visit 9|1|||
129115503|NCT00752089|464719765|FG000|Overall Study|Not capable of wearing partial denture|1|||
129115504|NCT00752089|464719765|FG000|Overall Study|Cannot continue the study|1|||
129115505|NCT01324102|464719766|FG000|Overall Study|illness|1|||
129115506|NCT01324102|464719767|FG001|Overall Study|illness|6|||
129115507|NCT00386334|464719772|FG000|Double Blind Period|Adverse Event|9|||
129115508|NCT00386334|464719773|FG001|Double Blind Period|Adverse Event|14|||
129115509|NCT00386334|464719772|FG000|Double Blind Period|Protocol Violation|1|||
129115510|NCT00386334|464719773|FG001|Double Blind Period|Protocol Violation|1|||
129115511|NCT00386334|464719772|FG000|Double Blind Period|Withdrawal by Subject|9|||
129115512|NCT00386334|464719773|FG001|Double Blind Period|Withdrawal by Subject|13|||
129115513|NCT00386334|464719772|FG000|Double Blind Period|Lack of Efficacy|20|||
129115514|NCT00386334|464719773|FG001|Double Blind Period|Lack of Efficacy|11|||
129115515|NCT00386334|464719772|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
129115516|NCT00386334|464719773|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
129115517|NCT00386334|464719772|FG000|Double Blind Period|Other|3|||
129115518|NCT00386334|464719773|FG001|Double Blind Period|Other|3|||
129115519|NCT00386334|464719772|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
129115520|NCT00386334|464719773|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
129115521|NCT00902577|464719776|FG000|Overall Study|Withdrawal by Subject|6|||
129115522|NCT00902577|464719776|FG000|Overall Study|FMISO production failure|2|||
129115523|NCT00785356|464719779|FG000|Overall Study|Study prematurely terminated|8|||
129115524|NCT01232790|464719781|FG000|Randomization|Withdrawal by Subject|2|||
129115525|NCT01232790|464719782|FG001|Randomization|Withdrawal by Subject|0|||
129115526|NCT01232790|464719781|FG000|Randomization|Protocol Violation|0|||
129115527|NCT01232790|464719782|FG001|Randomization|Protocol Violation|1|||
129115528|NCT01232790|464719781|FG000|Randomization|Physician Decision|0|||
129115529|NCT01232790|464719782|FG001|Randomization|Physician Decision|1|||
129115530|NCT01232790|464719781|FG000|Initial Assessment|Withdrawal by Subject|0|||
129115531|NCT01232790|464719782|FG001|Initial Assessment|Withdrawal by Subject|1|||
129115532|NCT01232790|464719781|FG000|First Crossover|Withdrawal by Subject|1|||
129115533|NCT01232790|464719782|FG001|First Crossover|Withdrawal by Subject|0|||
129115534|NCT01232790|464719781|FG000|Second Crossover|Withdrawal by Subject|1|||
129115535|NCT01232790|464719782|FG001|Second Crossover|Withdrawal by Subject|2|||
129115536|NCT03238417|464719783|FG000|Overall|non-response|955|||
129115537|NCT03238417|464719784|FG001|Overall|non-response|1920|||
129115538|NCT03238417|464719783|FG000|Overall|partial completion|48|||
129115539|NCT03238417|464719784|FG001|Overall|partial completion|68|||
129115540|NCT03238417|464719783|FG000|Baseline|Partial completion|17|||
129115541|NCT03238417|464719784|FG001|Baseline|Partial completion|48|||
129025846|NCT00205777|464387632|FG002|Study Extension I|Withdrawn as per protocol|1070|||
129025847|NCT00205777|464387633|FG003|Study Extension I|Withdrawn as per protocol|0|||
129025848|NCT00205777|464387634|FG004|Study Extension I|Withdrawn as per protocol|0|||
129025849|NCT00205777|464387635|FG005|Study Extension I|Withdrawn as per protocol|0|||
129025850|NCT00205777|464387630|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
129025851|NCT00205777|464387631|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
129025852|NCT00205777|464387632|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
129025853|NCT00205777|464387633|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
129025854|NCT00205777|464387634|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
129025855|NCT00205777|464387635|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
129025856|NCT00205777|464387630|FG000|Study Extension II|Adverse Event|0|||
129025857|NCT00205777|464387631|FG001|Study Extension II|Adverse Event|0|||
129025858|NCT00205777|464387632|FG002|Study Extension II|Adverse Event|0|||
129025859|NCT00205777|464387633|FG003|Study Extension II|Adverse Event|14|||
129025860|NCT00205777|464387634|FG004|Study Extension II|Adverse Event|0|||
129025861|NCT00205777|464387635|FG005|Study Extension II|Adverse Event|30|||
129025862|NCT00205777|464387630|FG000|Study Extension II|Death|0|||
129025863|NCT00205777|464387631|FG001|Study Extension II|Death|0|||
129025864|NCT00205777|464387632|FG002|Study Extension II|Death|0|||
129025865|NCT00205777|464387633|FG003|Study Extension II|Death|2|||
129025866|NCT00205777|464387634|FG004|Study Extension II|Death|0|||
129115542|NCT03238417|464719783|FG000|Baseline|non-response|372|||
129115543|NCT03238417|464719784|FG001|Baseline|non-response|669|||
129115544|NCT03238417|464719783|FG000|12-month|non-response|296|||
129115545|NCT03238417|464719784|FG001|12-month|non-response|669|||
128764825|NCT03002038|463430316|FG001|Overall Study|Immigration to another region|2|||
129025867|NCT00205777|464387635|FG005|Study Extension II|Death|5|||
129025868|NCT00205777|464387630|FG000|Study Extension II|Withdrawal by Subject|0|||
129025869|NCT00205777|464387631|FG001|Study Extension II|Withdrawal by Subject|0|||
129115546|NCT03238417|464719783|FG000|12-month|partial completion|23|||
128905251|NCT03016325|463946488|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
128905252|NCT03016325|463946489|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
128905253|NCT03016325|463946490|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
128905254|NCT03016325|463946491|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
128905255|NCT03016325|463946492|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
128905256|NCT03016325|463946493|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
128905257|NCT03016325|463946486|FG000|182-Day Follow-Up Period|Death|3|||
128905258|NCT03016325|463946487|FG001|182-Day Follow-Up Period|Death|3|||
128905259|NCT03016325|463946488|FG002|182-Day Follow-Up Period|Death|11|||
128905260|NCT03016325|463946489|FG003|182-Day Follow-Up Period|Death|12|||
128905261|NCT03016325|463946490|FG004|182-Day Follow-Up Period|Death|9|||
128905262|NCT03016325|463946491|FG005|182-Day Follow-Up Period|Death|0|||
128905263|NCT03016325|463946492|FG006|182-Day Follow-Up Period|Death|0|||
128905264|NCT03016325|463946493|FG007|182-Day Follow-Up Period|Death|1|||
128905265|NCT03016325|463946486|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
128905266|NCT03016325|463946487|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
128905267|NCT03016325|463946488|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
128905268|NCT03016325|463946489|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
128905269|NCT03016325|463946490|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
128905270|NCT03016325|463946491|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
128905271|NCT03016325|463946492|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
128905272|NCT03016325|463946493|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
128905273|NCT03016325|463946486|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
128905274|NCT03016325|463946487|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
128905275|NCT03016325|463946488|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
128905276|NCT03016325|463946489|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
128905277|NCT03016325|463946490|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
128905278|NCT03016325|463946491|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
128905279|NCT03016325|463946492|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
128905280|NCT03016325|463946493|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
128905281|NCT03016325|463946486|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
128905282|NCT03016325|463946487|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
128905283|NCT03016325|463946488|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
128905284|NCT03016325|463946489|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
128905285|NCT03016325|463946490|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
128905286|NCT03016325|463946491|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
128905287|NCT03016325|463946492|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
128905288|NCT03016325|463946493|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
128905289|NCT03016325|463946486|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
128905290|NCT03016325|463946487|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
128905291|NCT03016325|463946488|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
128905292|NCT03016325|463946489|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
128905293|NCT03016325|463946490|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
128905294|NCT03016325|463946491|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
128905295|NCT03016325|463946492|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
128905296|NCT03016325|463946493|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
128905297|NCT03016325|463946486|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
128905298|NCT03016325|463946487|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
128905299|NCT03016325|463946488|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
128905300|NCT03016325|463946489|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
128905301|NCT03016325|463946490|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
128905302|NCT03016325|463946491|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
128905303|NCT03016325|463946492|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
128905304|NCT03016325|463946493|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
128905305|NCT03016325|463946486|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
128905306|NCT03016325|463946487|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
128905307|NCT03016325|463946488|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
128905308|NCT03016325|463946489|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
128905309|NCT03016325|463946490|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
128905310|NCT03016325|463946491|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
128905311|NCT03016325|463946492|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
128905312|NCT03016325|463946493|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129025870|NCT00205777|464387632|FG002|Study Extension II|Withdrawal by Subject|0|||
129025871|NCT00205777|464387633|FG003|Study Extension II|Withdrawal by Subject|35|||
129025872|NCT00205777|464387634|FG004|Study Extension II|Withdrawal by Subject|0|||
129025873|NCT00205777|464387635|FG005|Study Extension II|Withdrawal by Subject|59|||
129025874|NCT00205777|464387630|FG000|Study Extension II|Protocol Violation|0|||
128905313|NCT03016325|463946486|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
128905314|NCT03016325|463946487|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
128905315|NCT03016325|463946488|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
128905316|NCT03016325|463946489|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
128905317|NCT03016325|463946490|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
128905318|NCT03016325|463946491|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
128905319|NCT03016325|463946492|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
128905320|NCT03016325|463946493|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
128905321|NCT01902290|463946500|FG000|Overall Study|Withdrawal by Subject|19|||
128905322|NCT01902290|463946501|FG001|Overall Study|Withdrawal by Subject|27|||
128905323|NCT01902290|463946500|FG000|Overall Study|Lost to Follow-up|2|||
128905324|NCT01902290|463946501|FG001|Overall Study|Lost to Follow-up|2|||
128905325|NCT01902290|463946500|FG000|Overall Study|Death|1|||
128905326|NCT01902290|463946501|FG001|Overall Study|Death|0|||
128905327|NCT01902290|463946500|FG000|Overall Study|Sponsor Decision|26|||
128905328|NCT01902290|463946501|FG001|Overall Study|Sponsor Decision|24|||
128905329|NCT02250274|463946503|FG000|Overall Study|Insufficient blood draw amount|7|||
128905330|NCT02250274|463946504|FG001|Overall Study|Insufficient blood draw amount|6|||
128905331|NCT01277549|463946505|FG000|Overall Study|Failed to meet eligibility criteria|13|||
128905332|NCT01277549|463946506|FG001|Overall Study|Failed to meet eligibility criteria|9|||
128905333|NCT01277549|463946505|FG000|Overall Study|Withdrawal by Subject|1|||
128905334|NCT01277549|463946506|FG001|Overall Study|Withdrawal by Subject|3|||
128905335|NCT01277549|463946505|FG000|Overall Study|Protocol Violation|10|||
128905336|NCT01277549|463946506|FG001|Overall Study|Protocol Violation|1|||
128905337|NCT01277549|463946505|FG000|Overall Study|Physician Decision|2|||
128905338|NCT01277549|463946506|FG001|Overall Study|Physician Decision|1|||
128905339|NCT00446511|463946507|FG000|Overall Study|Adverse Event|7|||
128764826|NCT02904902|463430325|FG000|Overall Study|Withdrawal by Subject|1|||
128764827|NCT01216163|463430334|FG000|Overall Study|Withdrawal by Subject|1|||
128764828|NCT01216163|463430335|FG001|Overall Study|Withdrawal by Subject|1|||
128764829|NCT01216163|463430336|FG002|Overall Study|Withdrawal by Subject|0|||
128764830|NCT02914314|463430337|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
128764831|NCT02914314|463430338|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
129115547|NCT03238417|464719784|FG001|12-month|partial completion|37|||
129115548|NCT03238417|464719783|FG000|24-month|non-response|287|||
129115549|NCT03238417|464719784|FG001|24-month|non-response|594|||
129115550|NCT03238417|464719783|FG000|24-month|partial completion|8|||
129115551|NCT03238417|464719784|FG001|24-month|partial completion|31|||
129115552|NCT00083915|464719785|FG000|Overall Study|Death|6|||
129115553|NCT00083915|464719786|FG001|Overall Study|Death|3|||
129115554|NCT00083915|464719785|FG000|Overall Study|Physician Decision|11|||
129115555|NCT00083915|464719786|FG001|Overall Study|Physician Decision|6|||
129115556|NCT00083915|464719785|FG000|Overall Study|Withdrawal by Subject|8|||
129115557|NCT00083915|464719786|FG001|Overall Study|Withdrawal by Subject|3|||
129115558|NCT00083915|464719785|FG000|Overall Study|disease progression|18|||
129115559|NCT00083915|464719786|FG001|Overall Study|disease progression|23|||
129115560|NCT00083915|464719785|FG000|Overall Study|Failure to collect|3|||
129115561|NCT00083915|464719786|FG001|Overall Study|Failure to collect|0|||
129115562|NCT00083915|464719785|FG000|Overall Study|No response|3|||
129115563|NCT00083915|464719786|FG001|Overall Study|No response|1|||
129115564|NCT00083915|464719785|FG000|Overall Study|Insurance issues|1|||
129115565|NCT00083915|464719786|FG001|Overall Study|Insurance issues|1|||
129115566|NCT00853762|464719790|FG000|Overall Study|Premature Termination|16|||
129115567|NCT00853762|464719791|FG001|Overall Study|Premature Termination|15|||
129115568|NCT00853762|464719792|FG002|Overall Study|Premature Termination|14|||
129115569|NCT00853762|464719793|FG003|Overall Study|Premature Termination|21|||
129115570|NCT00853762|464719790|FG000|Overall Study|Protocol Violation|0|||
128905340|NCT00446511|463946508|FG001|Overall Study|Adverse Event|2|||
128905341|NCT00446511|463946509|FG002|Overall Study|Adverse Event|3|||
128905342|NCT00446511|463946510|FG003|Overall Study|Adverse Event|1|||
128905343|NCT00446511|463946507|FG000|Overall Study|Protocol Violation|0|||
128905344|NCT00446511|463946508|FG001|Overall Study|Protocol Violation|0|||
128905345|NCT00446511|463946509|FG002|Overall Study|Protocol Violation|0|||
128905346|NCT00446511|463946510|FG003|Overall Study|Protocol Violation|1|||
128905347|NCT00446511|463946507|FG000|Overall Study|Withdrawal by Subject|0|||
128905348|NCT00446511|463946508|FG001|Overall Study|Withdrawal by Subject|0|||
128905349|NCT00446511|463946509|FG002|Overall Study|Withdrawal by Subject|0|||
128905350|NCT00446511|463946510|FG003|Overall Study|Withdrawal by Subject|3|||
128905351|NCT00446511|463946507|FG000|Overall Study|Administrative Problems|3|||
129115571|NCT00853762|464719791|FG001|Overall Study|Protocol Violation|0|||
129115572|NCT00853762|464719792|FG002|Overall Study|Protocol Violation|0|||
129115573|NCT00853762|464719793|FG003|Overall Study|Protocol Violation|1|||
129115574|NCT00853762|464719790|FG000|Overall Study|Withdrawal by Subject|0|||
129115575|NCT00853762|464719791|FG001|Overall Study|Withdrawal by Subject|0|||
129115576|NCT00853762|464719792|FG002|Overall Study|Withdrawal by Subject|1|||
129115577|NCT00853762|464719793|FG003|Overall Study|Withdrawal by Subject|0|||
129115578|NCT00853762|464719790|FG000|Overall Study|Other|0|||
128905352|NCT00446511|463946508|FG001|Overall Study|Administrative Problems|0|||
128905353|NCT00446511|463946509|FG002|Overall Study|Administrative Problems|4|||
128905354|NCT00446511|463946510|FG003|Overall Study|Administrative Problems|1|||
128905355|NCT01618214|463946511|FG000|Overall Study|Adverse Event|3|||
128905356|NCT01618214|463946512|FG001|Overall Study|Adverse Event|1|||
128905357|NCT01618214|463946511|FG000|Overall Study|Lack of Efficacy|1|||
128905358|NCT01618214|463946512|FG001|Overall Study|Lack of Efficacy|1|||
128905359|NCT01618214|463946511|FG000|Overall Study|Protocol Violation|1|||
128905360|NCT01618214|463946512|FG001|Overall Study|Protocol Violation|4|||
128905361|NCT01618214|463946511|FG000|Overall Study|Withdrawal Criteria|1|||
128905362|NCT01618214|463946512|FG001|Overall Study|Withdrawal Criteria|2|||
128905363|NCT01618214|463946511|FG000|Overall Study|Unclassified|4|||
128905364|NCT01618214|463946512|FG001|Overall Study|Unclassified|5|||
128905365|NCT04486950|463946516|FG000|Overall Study|Lost to Follow-up|0|||
128905366|NCT04486950|463946517|FG001|Overall Study|Lost to Follow-up|0|||
128905367|NCT04486950|463946518|FG002|Overall Study|Lost to Follow-up|0|||
128905368|NCT04486950|463946519|FG003|Overall Study|Lost to Follow-up|0|||
128905369|NCT04486950|463946520|FG004|Overall Study|Lost to Follow-up|0|||
128905370|NCT04486950|463946521|FG005|Overall Study|Lost to Follow-up|1|||
128905371|NCT04486950|463946522|FG006|Overall Study|Lost to Follow-up|0|||
128905372|NCT00550680|463946527|FG000|Overall Study|Administrative Reasons|1|||
128905373|NCT00550680|463946527|FG000|Overall Study|Adverse Event|5|||
128905374|NCT00550680|463946527|FG000|Overall Study|Death|3|||
128905375|NCT00550680|463946527|FG000|Overall Study|Early Improvement|1|||
128905376|NCT00550680|463946527|FG000|Overall Study|Lost to Follow-up|3|||
128905377|NCT00550680|463946527|FG000|Overall Study|Lack of Efficacy|1|||
128905378|NCT00550680|463946527|FG000|Overall Study|Other|10|||
128905379|NCT00550680|463946527|FG000|Overall Study|Protocol Violation|7|||
128905380|NCT00550680|463946527|FG000|Overall Study|Refused Treatment|19|||
128905381|NCT00550680|463946527|FG000|Overall Study|Screen Failure|6|||
128905382|NCT01119248|463946528|FG000|Overall Study|Physician Decision|5|||
128905383|NCT00562354|463946529|FG000|Overall Study|Physician Decision|0|||
128905384|NCT00562354|463946530|FG001|Overall Study|Physician Decision|1|||
128905385|NCT00562354|463946529|FG000|Overall Study|Lost to Follow-up|0|||
128905386|NCT00562354|463946530|FG001|Overall Study|Lost to Follow-up|1|||
128905387|NCT00317109|463946531|FG000|Overall Study|Withdrawal by Subject|2|||
128905388|NCT00317109|463946532|FG001|Overall Study|Withdrawal by Subject|0|||
128905389|NCT00317109|463946531|FG000|Overall Study|Migated/moved from study area|1|||
128905390|NCT00317109|463946532|FG001|Overall Study|Migated/moved from study area|0|||
128905391|NCT03693625|463946534|FG000|Overall Study|Adverse Event|2|||
128905392|NCT03693625|463946535|FG001|Overall Study|Adverse Event|0|||
128905393|NCT03693625|463946534|FG000|Overall Study|Study Terminated By Sponsor|20|||
128905394|NCT03693625|463946535|FG001|Overall Study|Study Terminated By Sponsor|7|||
128905395|NCT03693625|463946534|FG000|Overall Study|Withdrawal by Subject|1|||
128905396|NCT03693625|463946535|FG001|Overall Study|Withdrawal by Subject|1|||
128905397|NCT01508702|463946536|FG000|Overall Study|Adverse Event|7|||
128905398|NCT01508702|463946537|FG001|Overall Study|Adverse Event|3|||
128905399|NCT01508702|463946536|FG000|Overall Study|Gout flare|2|||
128905400|NCT01508702|463946537|FG001|Overall Study|Gout flare|0|||
128905401|NCT01508702|463946536|FG000|Overall Study|Protocol Violation|2|||
128905402|NCT01508702|463946537|FG001|Overall Study|Protocol Violation|1|||
128905403|NCT01508702|463946536|FG000|Overall Study|Lost to Follow-up|1|||
128905404|NCT01508702|463946537|FG001|Overall Study|Lost to Follow-up|2|||
128694222|NCT00150709|463180432|FG003|Overall Study|Site/Investigator discontinued the study|0|||
128694223|NCT00150709|463180429|FG000|Overall Study|Decision of parent(s)|1|||
128694224|NCT00150709|463180430|FG001|Overall Study|Decision of parent(s)|2|||
128694225|NCT00150709|463180431|FG002|Overall Study|Decision of parent(s)|0|||
128694226|NCT00150709|463180432|FG003|Overall Study|Decision of parent(s)|0|||
128694227|NCT00150709|463180429|FG000|Overall Study|Decision of parent(s) and investigator|3|||
128694228|NCT00150709|463180430|FG001|Overall Study|Decision of parent(s) and investigator|0|||
128905405|NCT01508702|463946536|FG000|Overall Study|Withdrawal by Subject|11|||
128905406|NCT01508702|463946537|FG001|Overall Study|Withdrawal by Subject|7|||
128905407|NCT01883635|463946539|FG000|Overall Study|Withdrawal by Subject|4|||
128905408|NCT01883635|463946540|FG001|Overall Study|Withdrawal by Subject|0|||
128905409|NCT01464307|463946544|FG000|Main Period|Death|0|||
128905410|NCT01464307|463946545|FG001|Main Period|Death|1|||
128905411|NCT01464307|463946544|FG000|Main Period|Adverse Event|6|||
128905412|NCT01464307|463946545|FG001|Main Period|Adverse Event|1|||
128905413|NCT01464307|463946544|FG000|Main Period|Lack of Efficacy|2|||
128905414|NCT01464307|463946545|FG001|Main Period|Lack of Efficacy|0|||
128905415|NCT01464307|463946544|FG000|Main Period|Withdrawal by Subject|5|||
129115579|NCT00853762|464719791|FG001|Overall Study|Other|2|||
128905416|NCT01464307|463946545|FG001|Main Period|Withdrawal by Subject|2|||
128905417|NCT01464307|463946544|FG000|Main Period|Predefined discontinuation criteria|2|||
128905418|NCT01464307|463946545|FG001|Main Period|Predefined discontinuation criteria|1|||
128905419|NCT01464307|463946544|FG000|Open-Label Extension Period|Adverse Event|15|||
128905420|NCT01464307|463946545|FG001|Open-Label Extension Period|Adverse Event|0|||
128905421|NCT01464307|463946544|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
128905422|NCT01464307|463946545|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
128694229|NCT00150709|463180431|FG002|Overall Study|Decision of parent(s) and investigator|0|||
128694230|NCT00150709|463180432|FG003|Overall Study|Decision of parent(s) and investigator|0|||
128694231|NCT00150709|463180429|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
128694232|NCT00150709|463180430|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
128694233|NCT00150709|463180431|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
128694234|NCT00150709|463180432|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
128694235|NCT00150709|463180429|FG000|Overall Study|Investigator decision|1|||
128694236|NCT00150709|463180430|FG001|Overall Study|Investigator decision|0|||
128694237|NCT00150709|463180431|FG002|Overall Study|Investigator decision|0|||
128694238|NCT00150709|463180432|FG003|Overall Study|Investigator decision|1|||
128694239|NCT00150709|463180429|FG000|Overall Study|Subject relocated|2|||
128694240|NCT00150709|463180430|FG001|Overall Study|Subject relocated|2|||
128694241|NCT00150709|463180431|FG002|Overall Study|Subject relocated|1|||
128694242|NCT00150709|463180432|FG003|Overall Study|Subject relocated|0|||
128694243|NCT00150709|463180429|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
128905423|NCT01464307|463946544|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
128905424|NCT01464307|463946545|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
128905425|NCT01464307|463946544|FG000|Open-Label Extension Period|Death|1|||
128905426|NCT01464307|463946545|FG001|Open-Label Extension Period|Death|0|||
128905427|NCT01464307|463946544|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
128905428|NCT01464307|463946545|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
128905429|NCT01464307|463946544|FG000|Open-Label Extension Period|Non-compliance|9|||
128905430|NCT01464307|463946545|FG001|Open-Label Extension Period|Non-compliance|0|||
128905431|NCT01464307|463946544|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
128905432|NCT01464307|463946545|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
128905433|NCT00761514|463946548|FG000|Overall Study|Adverse Event|1|||
128905434|NCT00761514|463946548|FG000|Overall Study|Withdrawal by Subject|2|||
128905435|NCT00761514|463946548|FG000|Overall Study|Lost to Follow-up|1|||
128905436|NCT00761514|463946548|FG000|Overall Study|Health insurance didn't cover study drug|1|||
128905437|NCT00761514|463946548|FG000|Overall Study|Problem complying with study visit|1|||
128905438|NCT00761514|463946548|FG000|Overall Study|Unable to pay for medications|1|||
128905439|NCT02457637|463946549|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
128905440|NCT04942925|463946552|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
128905441|NCT04942925|463946553|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
128905442|NCT04942925|463946552|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
128905443|NCT04942925|463946553|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
128694244|NCT00150709|463180430|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
128694245|NCT00150709|463180431|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
128694246|NCT00150709|463180432|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
128694247|NCT00150709|463180429|FG000|Overall Study|Convenience|0|||
128694248|NCT00150709|463180430|FG001|Overall Study|Convenience|1|||
128694249|NCT00150709|463180431|FG002|Overall Study|Convenience|0|||
128694250|NCT00150709|463180432|FG003|Overall Study|Convenience|0|||
128694251|NCT00150709|463180429|FG000|Overall Study|Subject entered new drug study|0|||
128694252|NCT00150709|463180430|FG001|Overall Study|Subject entered new drug study|1|||
128694253|NCT00150709|463180431|FG002|Overall Study|Subject entered new drug study|0|||
128905444|NCT01273883|463946554|FG000|First Intervention|Adverse Event|2|||
128905445|NCT01273883|463946555|FG001|First Intervention|Adverse Event|1|||
128905446|NCT01273883|463946554|FG000|Second Intervention|Lost to Follow-up|1|||
128905447|NCT01273883|463946555|FG001|Second Intervention|Lost to Follow-up|1|||
128905448|NCT01273883|463946554|FG000|Second Intervention|Lack of Efficacy|1|||
128905449|NCT01273883|463946555|FG001|Second Intervention|Lack of Efficacy|0|||
128905450|NCT02124564|463946560|FG000|Treatment Period|Adverse Event|2|||
128905451|NCT02124564|463946560|FG000|Treatment Period|Lack of Efficacy|3|||
128905452|NCT02124564|463946560|FG000|Treatment Period|Withdrawal by Subject|2|||
129025875|NCT00205777|464387631|FG001|Study Extension II|Protocol Violation|0|||
129025876|NCT00205777|464387632|FG002|Study Extension II|Protocol Violation|0|||
129025877|NCT00205777|464387633|FG003|Study Extension II|Protocol Violation|1|||
129025878|NCT00205777|464387634|FG004|Study Extension II|Protocol Violation|0|||
129025879|NCT00205777|464387635|FG005|Study Extension II|Protocol Violation|10|||
129025880|NCT00205777|464387630|FG000|Study Extension II|Lack of Efficacy|0|||
129025881|NCT00205777|464387631|FG001|Study Extension II|Lack of Efficacy|0|||
129025882|NCT00205777|464387632|FG002|Study Extension II|Lack of Efficacy|0|||
129025883|NCT00205777|464387633|FG003|Study Extension II|Lack of Efficacy|0|||
129025884|NCT00205777|464387634|FG004|Study Extension II|Lack of Efficacy|0|||
129025885|NCT00205777|464387635|FG005|Study Extension II|Lack of Efficacy|1|||
129025886|NCT00205777|464387630|FG000|Study Extension II|Failed to return|0|||
129025887|NCT00205777|464387631|FG001|Study Extension II|Failed to return|0|||
129025888|NCT00205777|464387632|FG002|Study Extension II|Failed to return|0|||
129025889|NCT00205777|464387633|FG003|Study Extension II|Failed to return|14|||
129025890|NCT00205777|464387634|FG004|Study Extension II|Failed to return|0|||
129025891|NCT00205777|464387635|FG005|Study Extension II|Failed to return|26|||
129025892|NCT00205777|464387630|FG000|Study Extension II|Other Event|0|||
128905453|NCT03885089|463946561|FG000|Overall Study|No informed consent for publication of study results|2|||
128905454|NCT02043548|463946567|FG000|Overall Study|Lack of Efficacy|1|||
128905455|NCT02043548|463946568|FG001|Overall Study|Lack of Efficacy|0|||
128905456|NCT02043548|463946567|FG000|Overall Study|Adverse Event|0|||
128905457|NCT02043548|463946568|FG001|Overall Study|Adverse Event|1|||
128905458|NCT01425008|463946577|FG000|Dose Escalation Phase|Progressive Disease|2|||
128905459|NCT01425008|463946578|FG001|Dose Escalation Phase|Progressive Disease|3|||
128905460|NCT01425008|463946579|FG002|Dose Escalation Phase|Progressive Disease|2|||
128905461|NCT01425008|463946580|FG003|Dose Escalation Phase|Progressive Disease|3|||
128905462|NCT01425008|463946581|FG004|Dose Escalation Phase|Progressive Disease|5|||
128905463|NCT01425008|463946582|FG005|Dose Escalation Phase|Progressive Disease|4|||
128905464|NCT01425008|463946583|FG006|Dose Escalation Phase|Progressive Disease|0|||
128905465|NCT01425008|463946584|FG007|Dose Escalation Phase|Progressive Disease|2|||
128905466|NCT01425008|463946585|FG008|Dose Escalation Phase|Progressive Disease|6|||
128905467|NCT01425008|463946586|FG009|Dose Escalation Phase|Progressive Disease|2|||
128905468|NCT01425008|463946587|FG010|Dose Escalation Phase|Progressive Disease|0|||
128905469|NCT01425008|463946588|FG011|Dose Escalation Phase|Progressive Disease|0|||
128905470|NCT01425008|463946589|FG012|Dose Escalation Phase|Progressive Disease|0|||
128905471|NCT01425008|463946590|FG013|Dose Escalation Phase|Progressive Disease|0|||
128905472|NCT01425008|463946591|FG014|Dose Escalation Phase|Progressive Disease|0|||
128905473|NCT01425008|463946592|FG015|Dose Escalation Phase|Progressive Disease|0|||
128905474|NCT01425008|463946593|FG016|Dose Escalation Phase|Progressive Disease|0|||
128905475|NCT01425008|463946594|FG017|Dose Escalation Phase|Progressive Disease|0|||
128905476|NCT01425008|463946595|FG018|Dose Escalation Phase|Progressive Disease|0|||
128905477|NCT01425008|463946577|FG000|Dose Escalation Phase|Adverse Event|2|||
128905478|NCT01425008|463946578|FG001|Dose Escalation Phase|Adverse Event|0|||
129025893|NCT00205777|464387631|FG001|Study Extension II|Other Event|0|||
129025894|NCT00205777|464387632|FG002|Study Extension II|Other Event|0|||
129025895|NCT00205777|464387633|FG003|Study Extension II|Other Event|12|||
129025896|NCT00205777|464387634|FG004|Study Extension II|Other Event|0|||
129025897|NCT00205777|464387635|FG005|Study Extension II|Other Event|20|||
129025898|NCT00205777|464387630|FG000|Study Extension II|Enrolled but not treated|0|||
129025899|NCT00205777|464387631|FG001|Study Extension II|Enrolled but not treated|0|||
129025900|NCT00205777|464387632|FG002|Study Extension II|Enrolled but not treated|0|||
129025901|NCT00205777|464387633|FG003|Study Extension II|Enrolled but not treated|71|||
129025902|NCT00205777|464387634|FG004|Study Extension II|Enrolled but not treated|0|||
129025903|NCT00205777|464387635|FG005|Study Extension II|Enrolled but not treated|131|||
129025904|NCT00624286|464387642|FG000|Overall Study|Protocol Deviation|7|||
129025905|NCT00624286|464387643|FG001|Overall Study|Protocol Deviation|9|||
129025906|NCT00624286|464387642|FG000|Overall Study|Adverse Event|6|||
129025907|NCT00624286|464387643|FG001|Overall Study|Adverse Event|3|||
129025908|NCT00624286|464387642|FG000|Overall Study|Withdrawal by Subject|5|||
129025909|NCT00624286|464387643|FG001|Overall Study|Withdrawal by Subject|4|||
129025910|NCT00624286|464387642|FG000|Overall Study|Lost to Follow-up|3|||
129025911|NCT00624286|464387643|FG001|Overall Study|Lost to Follow-up|2|||
129025912|NCT00624286|464387642|FG000|Overall Study|Administrative problems|3|||
129025913|NCT00624286|464387643|FG001|Overall Study|Administrative problems|0|||
129025914|NCT00624286|464387642|FG000|Overall Study|Lack of Efficacy|1|||
129025915|NCT00624286|464387643|FG001|Overall Study|Lack of Efficacy|6|||
129025916|NCT00624286|464387642|FG000|Overall Study|Not stated|0|||
129025917|NCT00624286|464387643|FG001|Overall Study|Not stated|1|||
129025918|NCT00624286|464387642|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129025919|NCT00624286|464387643|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129025920|NCT00624286|464387642|FG000|Overall Study|Death|0|||
129025921|NCT00624286|464387643|FG001|Overall Study|Death|1|||
129025922|NCT00842309|464387648|FG000|Overall Study|Withdrawal by Subject|3|||
129025923|NCT00842309|464387649|FG001|Overall Study|Withdrawal by Subject|1|||
129025924|NCT03218787|464387650|FG000|Overall Study|Lost to Follow-up|12|||
129025925|NCT03218787|464387650|FG000|Overall Study|Withdrawal by Subject|72|||
129025926|NCT03218787|464387650|FG000|Overall Study|Physician Decision|11|||
129025927|NCT03218787|464387650|FG000|Overall Study|Death|111|||
129025928|NCT02264977|464387651|FG000|Overall Study|Death|3|||
129025929|NCT02264977|464387651|FG000|Overall Study|Physician Decision|1|||
129025930|NCT02264977|464387651|FG000|Overall Study|Refuse to return|1|||
129025931|NCT03573544|464387652|FG000|Overall Study|Adverse Event|0|||
129025932|NCT03573544|464387653|FG001|Overall Study|Adverse Event|0|||
129025933|NCT03573544|464387654|FG002|Overall Study|Adverse Event|0|||
129025934|NCT03573544|464387655|FG003|Overall Study|Adverse Event|3|||
129025935|NCT03573544|464387656|FG004|Overall Study|Adverse Event|1|||
129025936|NCT03573544|464387657|FG005|Overall Study|Adverse Event|0|||
129025937|NCT03573544|464387658|FG006|Overall Study|Adverse Event|2|||
129025938|NCT03573544|464387659|FG007|Overall Study|Adverse Event|0|||
129025939|NCT03573544|464387652|FG000|Overall Study|Physician Decision|0|||
129025940|NCT03573544|464387653|FG001|Overall Study|Physician Decision|0|||
129025941|NCT03573544|464387654|FG002|Overall Study|Physician Decision|0|||
129025942|NCT03573544|464387655|FG003|Overall Study|Physician Decision|0|||
129025943|NCT03573544|464387656|FG004|Overall Study|Physician Decision|0|||
129025944|NCT03573544|464387657|FG005|Overall Study|Physician Decision|0|||
128905479|NCT01425008|463946579|FG002|Dose Escalation Phase|Adverse Event|0|||
128905480|NCT01425008|463946580|FG003|Dose Escalation Phase|Adverse Event|0|||
128905481|NCT01425008|463946581|FG004|Dose Escalation Phase|Adverse Event|0|||
128905482|NCT01425008|463946582|FG005|Dose Escalation Phase|Adverse Event|2|||
128905483|NCT01425008|463946583|FG006|Dose Escalation Phase|Adverse Event|0|||
128905484|NCT01425008|463946584|FG007|Dose Escalation Phase|Adverse Event|0|||
128905485|NCT01425008|463946585|FG008|Dose Escalation Phase|Adverse Event|2|||
128905486|NCT01425008|463946586|FG009|Dose Escalation Phase|Adverse Event|0|||
128905487|NCT01425008|463946587|FG010|Dose Escalation Phase|Adverse Event|0|||
128905488|NCT01425008|463946588|FG011|Dose Escalation Phase|Adverse Event|0|||
128905489|NCT01425008|463946589|FG012|Dose Escalation Phase|Adverse Event|0|||
128905490|NCT01425008|463946590|FG013|Dose Escalation Phase|Adverse Event|0|||
128905491|NCT01425008|463946591|FG014|Dose Escalation Phase|Adverse Event|0|||
129115580|NCT00853762|464719792|FG002|Overall Study|Other|0|||
129115581|NCT00853762|464719793|FG003|Overall Study|Other|0|||
129115582|NCT00853762|464719790|FG000|Overall Study|Randomised but not Treated|0|||
129115583|NCT00853762|464719791|FG001|Overall Study|Randomised but not Treated|2|||
129115584|NCT00853762|464719792|FG002|Overall Study|Randomised but not Treated|2|||
129115585|NCT00853762|464719793|FG003|Overall Study|Randomised but not Treated|0|||
129115586|NCT02000921|464719796|FG000|Overall Study|Withdrawal by Subject|3|||
129115587|NCT02000921|464719797|FG001|Overall Study|Withdrawal by Subject|10|||
129115588|NCT02000921|464719798|FG002|Overall Study|Withdrawal by Subject|5|||
129115589|NCT02000921|464719796|FG000|Overall Study|Lost to Follow-up|2|||
129115590|NCT02000921|464719797|FG001|Overall Study|Lost to Follow-up|4|||
129115591|NCT02000921|464719798|FG002|Overall Study|Lost to Follow-up|5|||
129115592|NCT02000921|464719796|FG000|Overall Study|Physician Decision|0|||
129115593|NCT02000921|464719797|FG001|Overall Study|Physician Decision|2|||
129115594|NCT02000921|464719798|FG002|Overall Study|Physician Decision|0|||
129115595|NCT02051296|464719799|FG000|Overall Study|Lost to Follow-up|1|||
129115596|NCT02051296|464719800|FG001|Overall Study|Lost to Follow-up|2|||
129115597|NCT02051296|464719799|FG000|Overall Study|withdraw prior to treatment|7|||
129115598|NCT02051296|464719800|FG001|Overall Study|withdraw prior to treatment|7|||
129115599|NCT00106002|464719801|FG000|Overall Study|Did not take any study drug|1|||
129115600|NCT00106002|464719801|FG000|Overall Study|Ineligible after Registration|1|||
129115601|NCT01245101|464719804|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
129115602|NCT01245101|464719805|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
128764832|NCT02914314|463430339|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
128764833|NCT02914314|463430340|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
128764834|NCT02914314|463430337|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
128764835|NCT02914314|463430338|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
128764836|NCT02914314|463430339|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
128764837|NCT02914314|463430340|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
128764838|NCT02914314|463430337|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
129115603|NCT01245101|464719804|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
129115604|NCT01245101|464719805|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
129115605|NCT01245101|464719804|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
129115606|NCT01245101|464719805|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
129115607|NCT01225549|464719806|FG000|Period 4 - Washout|Disallowed medication|0|||
129115608|NCT01225549|464719807|FG001|Period 4 - Washout|Disallowed medication|1|||
129115609|NCT01225549|464719808|FG002|Period 4 - Washout|Disallowed medication|0|||
129115610|NCT01225549|464719809|FG003|Period 4 - Washout|Disallowed medication|0|||
129115611|NCT01225549|464719810|FG004|Period 4 - Washout|Disallowed medication|0|||
129115612|NCT01225549|464719811|FG005|Period 4 - Washout|Disallowed medication|0|||
129115613|NCT01225549|464719812|FG006|Period 4 - Washout|Disallowed medication|0|||
129115614|NCT01225549|464719813|FG007|Period 4 - Washout|Disallowed medication|0|||
129115615|NCT01225549|464719814|FG008|Period 4 - Washout|Disallowed medication|0|||
129115616|NCT01225549|464719815|FG009|Period 4 - Washout|Disallowed medication|0|||
129115617|NCT01225549|464719806|FG000|Period 6 - Washout|Disallowed medication|0|||
129115618|NCT01225549|464719807|FG001|Period 6 - Washout|Disallowed medication|0|||
129115619|NCT01225549|464719808|FG002|Period 6 - Washout|Disallowed medication|0|||
129115620|NCT01225549|464719809|FG003|Period 6 - Washout|Disallowed medication|1|||
129115621|NCT01225549|464719810|FG004|Period 6 - Washout|Disallowed medication|0|||
129115622|NCT01225549|464719811|FG005|Period 6 - Washout|Disallowed medication|0|||
129115623|NCT01225549|464719812|FG006|Period 6 - Washout|Disallowed medication|0|||
129115624|NCT01225549|464719813|FG007|Period 6 - Washout|Disallowed medication|0|||
129115625|NCT01225549|464719814|FG008|Period 6 - Washout|Disallowed medication|0|||
129115626|NCT01225549|464719815|FG009|Period 6 - Washout|Disallowed medication|0|||
128764839|NCT02914314|463430338|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
129115627|NCT04456686|464719816|FG000|Overall Study|Adverse Event|2|||
128764840|NCT02914314|463430339|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
129115628|NCT04456686|464719817|FG001|Overall Study|Adverse Event|1|||
128764841|NCT02914314|463430340|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
128905492|NCT01425008|463946592|FG015|Dose Escalation Phase|Adverse Event|0|||
128905493|NCT01425008|463946593|FG016|Dose Escalation Phase|Adverse Event|0|||
128905494|NCT01425008|463946594|FG017|Dose Escalation Phase|Adverse Event|0|||
128764842|NCT02914314|463430337|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
128764843|NCT02914314|463430338|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
128764844|NCT02914314|463430339|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
128764845|NCT02914314|463430340|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
128764846|NCT02914314|463430337|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
128764847|NCT02914314|463430338|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
128764848|NCT02914314|463430339|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
128764849|NCT02914314|463430340|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
128764850|NCT04146896|463430351|FG000|Overall Study|Adverse Event|5|||
128764851|NCT04146896|463430352|FG001|Overall Study|Adverse Event|8|||
128764852|NCT04146896|463430351|FG000|Overall Study|Lack of Efficacy|3|||
128764853|NCT04146896|463430352|FG001|Overall Study|Lack of Efficacy|2|||
128764854|NCT04146896|463430351|FG000|Overall Study|Lost to Follow-up|0|||
129025945|NCT03573544|464387658|FG006|Overall Study|Physician Decision|1|||
129025946|NCT03573544|464387659|FG007|Overall Study|Physician Decision|0|||
129025947|NCT03573544|464387652|FG000|Overall Study|Withdrawal by Subject|2|||
129025948|NCT03573544|464387653|FG001|Overall Study|Withdrawal by Subject|0|||
129025949|NCT03573544|464387654|FG002|Overall Study|Withdrawal by Subject|0|||
129025950|NCT03573544|464387655|FG003|Overall Study|Withdrawal by Subject|1|||
129025951|NCT03573544|464387656|FG004|Overall Study|Withdrawal by Subject|1|||
129025952|NCT03573544|464387657|FG005|Overall Study|Withdrawal by Subject|1|||
129025953|NCT03573544|464387658|FG006|Overall Study|Withdrawal by Subject|0|||
129025954|NCT03573544|464387659|FG007|Overall Study|Withdrawal by Subject|1|||
129025955|NCT03573544|464387652|FG000|Overall Study|Disease progression|3|||
129025956|NCT03573544|464387653|FG001|Overall Study|Disease progression|3|||
129025957|NCT03573544|464387654|FG002|Overall Study|Disease progression|6|||
129025958|NCT03573544|464387655|FG003|Overall Study|Disease progression|4|||
129025959|NCT03573544|464387656|FG004|Overall Study|Disease progression|5|||
129025960|NCT03573544|464387657|FG005|Overall Study|Disease progression|7|||
129025961|NCT03573544|464387658|FG006|Overall Study|Disease progression|6|||
129025962|NCT03573544|464387659|FG007|Overall Study|Disease progression|7|||
129025963|NCT01838681|464387660|FG000|Period A|Adverse Event|39|||
129025964|NCT01838681|464387661|FG001|Period A|Adverse Event|0|||
129025965|NCT01838681|464387662|FG002|Period A|Adverse Event|0|||
129025966|NCT01838681|464387663|FG003|Period A|Adverse Event|0|||
129025967|NCT01838681|464387660|FG000|Period A|Lack of Efficacy|21|||
129025968|NCT01838681|464387661|FG001|Period A|Lack of Efficacy|0|||
129025969|NCT01838681|464387662|FG002|Period A|Lack of Efficacy|0|||
129025970|NCT01838681|464387663|FG003|Period A|Lack of Efficacy|0|||
129025971|NCT01838681|464387660|FG000|Period A|Early response|148|||
129025972|NCT01838681|464387661|FG001|Period A|Early response|0|||
129025973|NCT01838681|464387662|FG002|Period A|Early response|0|||
129025974|NCT01838681|464387663|FG003|Period A|Early response|0|||
129025975|NCT01838681|464387660|FG000|Period A|Withdrawal by Subject|70|||
129025976|NCT01838681|464387661|FG001|Period A|Withdrawal by Subject|0|||
129025977|NCT01838681|464387662|FG002|Period A|Withdrawal by Subject|0|||
129025978|NCT01838681|464387663|FG003|Period A|Withdrawal by Subject|0|||
129025979|NCT01838681|464387660|FG000|Period A|Protocol Violation|16|||
129025980|NCT01838681|464387661|FG001|Period A|Protocol Violation|0|||
129025981|NCT01838681|464387662|FG002|Period A|Protocol Violation|0|||
129025982|NCT01838681|464387663|FG003|Period A|Protocol Violation|0|||
129025983|NCT01838681|464387660|FG000|Period A|Non-compliance with IMP|6|||
129025984|NCT01838681|464387661|FG001|Period A|Non-compliance with IMP|0|||
129025985|NCT01838681|464387662|FG002|Period A|Non-compliance with IMP|0|||
129025986|NCT01838681|464387663|FG003|Period A|Non-compliance with IMP|0|||
129025987|NCT01838681|464387660|FG000|Period A|Lost to Follow-up|4|||
129025988|NCT01838681|464387661|FG001|Period A|Lost to Follow-up|0|||
129025989|NCT01838681|464387662|FG002|Period A|Lost to Follow-up|0|||
129025990|NCT01838681|464387663|FG003|Period A|Lost to Follow-up|0|||
129025991|NCT01838681|464387660|FG000|Period A|Withdrawal before treatment|4|||
129025992|NCT01838681|464387661|FG001|Period A|Withdrawal before treatment|0|||
129025993|NCT01838681|464387662|FG002|Period A|Withdrawal before treatment|0|||
129025994|NCT01838681|464387663|FG003|Period A|Withdrawal before treatment|0|||
129025995|NCT01838681|464387660|FG000|Period A|Administrative or other reasons|17|||
129025996|NCT01838681|464387661|FG001|Period A|Administrative or other reasons|0|||
129025997|NCT01838681|464387662|FG002|Period A|Administrative or other reasons|0|||
129025998|NCT01838681|464387663|FG003|Period A|Administrative or other reasons|0|||
129025999|NCT01838681|464387660|FG000|Period B/A+|Adverse Event|0|||
129026000|NCT01838681|464387661|FG001|Period B/A+|Adverse Event|13|||
129026001|NCT01838681|464387662|FG002|Period B/A+|Adverse Event|27|||
129026002|NCT01838681|464387663|FG003|Period B/A+|Adverse Event|16|||
129026003|NCT01838681|464387660|FG000|Period B/A+|Lack of Efficacy|0|||
129026004|NCT01838681|464387661|FG001|Period B/A+|Lack of Efficacy|9|||
129026005|NCT01838681|464387662|FG002|Period B/A+|Lack of Efficacy|11|||
129026006|NCT01838681|464387663|FG003|Period B/A+|Lack of Efficacy|6|||
129026007|NCT01838681|464387660|FG000|Period B/A+|Withdrawal by Subject|0|||
129026008|NCT01838681|464387661|FG001|Period B/A+|Withdrawal by Subject|28|||
129026009|NCT01838681|464387662|FG002|Period B/A+|Withdrawal by Subject|35|||
129026010|NCT01838681|464387663|FG003|Period B/A+|Withdrawal by Subject|47|||
129115629|NCT04456686|464719816|FG000|Overall Study|Lack of Efficacy|3|||
129115630|NCT04456686|464719817|FG001|Overall Study|Lack of Efficacy|1|||
129115631|NCT04456686|464719816|FG000|Overall Study|Withdrew consent|3|||
129115632|NCT04456686|464719817|FG001|Overall Study|Withdrew consent|1|||
129115633|NCT04456686|464719816|FG000|Overall Study|Physician Decision|2|||
129115634|NCT04456686|464719817|FG001|Overall Study|Physician Decision|2|||
129115635|NCT04456686|464719816|FG000|Overall Study|Withdrawal by Subject|5|||
129115636|NCT04456686|464719817|FG001|Overall Study|Withdrawal by Subject|1|||
129115637|NCT04456686|464719816|FG000|Overall Study|Protocol Violation|0|||
129115638|NCT04456686|464719817|FG001|Overall Study|Protocol Violation|1|||
129115639|NCT00891813|464719821|FG000|Overall Study|Adverse Event|3|||
129115640|NCT00891813|464719821|FG000|Overall Study|Withdrawal by Subject|1|||
129115641|NCT00891813|464719821|FG000|Overall Study|Patient Noncompliance|6|||
129115642|NCT00891813|464719821|FG000|Overall Study|Protocol Violation|2|||
129115643|NCT00473083|464719826|FG000|Overall Study|Adverse Event|1|||
129115644|NCT00473083|464719827|FG001|Overall Study|Adverse Event|0|||
129115645|NCT00473083|464719828|FG002|Overall Study|Adverse Event|0|||
129115646|NCT02858401|464719829|FG000|Overall Study|Withdrew Consent|0|||
129115647|NCT02858401|464719830|FG001|Overall Study|Withdrew Consent|0|||
129115648|NCT02858401|464719831|FG002|Overall Study|Withdrew Consent|0|||
129115649|NCT02858401|464719832|FG003|Overall Study|Withdrew Consent|0|||
129115650|NCT02858401|464719833|FG004|Overall Study|Withdrew Consent|0|||
129115651|NCT02858401|464719834|FG005|Overall Study|Withdrew Consent|1|||
129115652|NCT02858401|464719835|FG006|Overall Study|Withdrew Consent|0|||
129115653|NCT02858401|464719829|FG000|Overall Study|Lost to Follow-up|0|||
129115654|NCT02858401|464719830|FG001|Overall Study|Lost to Follow-up|1|||
129115655|NCT02858401|464719831|FG002|Overall Study|Lost to Follow-up|0|||
129115656|NCT02858401|464719832|FG003|Overall Study|Lost to Follow-up|0|||
129115657|NCT02858401|464719833|FG004|Overall Study|Lost to Follow-up|0|||
129115658|NCT02858401|464719834|FG005|Overall Study|Lost to Follow-up|0|||
129115659|NCT02858401|464719835|FG006|Overall Study|Lost to Follow-up|0|||
129115660|NCT02915835|464719836|FG000|Overall Study|Physician Decision|1|||
129115661|NCT02915835|464719837|FG001|Overall Study|Physician Decision|0|||
129115662|NCT02915835|464719836|FG000|Overall Study|Withdrawal by Subject|0|||
128905495|NCT01425008|463946595|FG018|Dose Escalation Phase|Adverse Event|0|||
128905496|NCT01425008|463946577|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905497|NCT01425008|463946578|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129026011|NCT01838681|464387660|FG000|Period B/A+|Protocol Violation|0|||
129026012|NCT01838681|464387661|FG001|Period B/A+|Protocol Violation|1|||
129026013|NCT01838681|464387662|FG002|Period B/A+|Protocol Violation|4|||
129026014|NCT01838681|464387663|FG003|Period B/A+|Protocol Violation|6|||
129026015|NCT01838681|464387660|FG000|Period B/A+|Non-compliance with IMP|0|||
129026016|NCT01838681|464387661|FG001|Period B/A+|Non-compliance with IMP|2|||
129026017|NCT01838681|464387662|FG002|Period B/A+|Non-compliance with IMP|3|||
129026018|NCT01838681|464387663|FG003|Period B/A+|Non-compliance with IMP|3|||
129026019|NCT01838681|464387660|FG000|Period B/A+|Lost to Follow-up|0|||
129026020|NCT01838681|464387661|FG001|Period B/A+|Lost to Follow-up|2|||
129026021|NCT01838681|464387662|FG002|Period B/A+|Lost to Follow-up|5|||
129026022|NCT01838681|464387663|FG003|Period B/A+|Lost to Follow-up|11|||
129026023|NCT01838681|464387660|FG000|Period B/A+|Withdrawal before treatment|0|||
129026024|NCT01838681|464387661|FG001|Period B/A+|Withdrawal before treatment|1|||
129026025|NCT01838681|464387662|FG002|Period B/A+|Withdrawal before treatment|0|||
129026026|NCT01838681|464387663|FG003|Period B/A+|Withdrawal before treatment|0|||
129026027|NCT01838681|464387660|FG000|Period B/A+|Administrative or other reasons|0|||
129026028|NCT01838681|464387661|FG001|Period B/A+|Administrative or other reasons|6|||
129026029|NCT01838681|464387662|FG002|Period B/A+|Administrative or other reasons|10|||
129026030|NCT01838681|464387663|FG003|Period B/A+|Administrative or other reasons|28|||
129026031|NCT02011945|464387664|FG000|Overall Study|Participant requested to Discontinue|0|||
129026032|NCT02011945|464387665|FG001|Overall Study|Participant requested to Discontinue|1|||
129026033|NCT02011945|464387666|FG002|Overall Study|Participant requested to Discontinue|1|||
129026034|NCT02011945|464387664|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
129026035|NCT02011945|464387665|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
129026036|NCT02011945|464387666|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
129026037|NCT02011945|464387664|FG000|Overall Study|Study Drug Toxicity|0|||
129026038|NCT02011945|464387665|FG001|Overall Study|Study Drug Toxicity|0|||
129026039|NCT02011945|464387666|FG002|Overall Study|Study Drug Toxicity|1|||
129026040|NCT02011945|464387664|FG000|Overall Study|Treatment Failure|0|||
129026041|NCT02011945|464387665|FG001|Overall Study|Treatment Failure|7|||
129026042|NCT02011945|464387666|FG002|Overall Study|Treatment Failure|6|||
129026043|NCT02011945|464387664|FG000|Overall Study|No Longer Meets Study Criteria|1|||
129026044|NCT02011945|464387665|FG001|Overall Study|No Longer Meets Study Criteria|0|||
129026045|NCT02011945|464387666|FG002|Overall Study|No Longer Meets Study Criteria|0|||
129026046|NCT02011945|464387664|FG000|Overall Study|Proceeded to stem cell transplant|0|||
129026047|NCT02011945|464387665|FG001|Overall Study|Proceeded to stem cell transplant|0|||
129115663|NCT02915835|464719837|FG001|Overall Study|Withdrawal by Subject|1|||
129115664|NCT03722576|464719838|FG000|Overall Study|Withdrawal by Subject|3|||
129115665|NCT03722576|464719838|FG000|Overall Study|Adverse Event|2|||
128764855|NCT04146896|463430352|FG001|Overall Study|Lost to Follow-up|1|||
129026048|NCT02011945|464387666|FG002|Overall Study|Proceeded to stem cell transplant|1|||
129026049|NCT02011945|464387664|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
129026050|NCT02011945|464387665|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
129026051|NCT02011945|464387666|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
129026052|NCT00849797|464387667|FG000|First Intervention|bad veins|1|||
129026053|NCT00849797|464387668|FG001|First Intervention|bad veins|0|||
129026054|NCT00849797|464387667|FG000|First Intervention|Adverse Event|0|||
129026055|NCT00849797|464387668|FG001|First Intervention|Adverse Event|1|||
129026056|NCT00849797|464387667|FG000|Washout: One Week|Withdrawal by Subject|0|||
129026057|NCT00849797|464387668|FG001|Washout: One Week|Withdrawal by Subject|2|||
129026058|NCT00679081|464387669|FG000|Overall Study|Lost to Follow-up|1|||
129026059|NCT00725322|464387670|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
129026060|NCT00725322|464387671|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
129026061|NCT00725322|464387670|FG000|Washout (28 Days)|Protocol Violation|0|||
129026062|NCT00725322|464387671|FG001|Washout (28 Days)|Protocol Violation|1|||
129026063|NCT01279486|464387672|FG000|Overall Study|Lost to Follow-up|1|||
129026064|NCT04198363|464387675|FG000|Overall Study|Adverse Event|1|||
129026065|NCT04198363|464387676|FG001|Overall Study|Adverse Event|1|||
129026066|NCT04198363|464387675|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
129026067|NCT04198363|464387676|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
129026068|NCT04198363|464387675|FG000|Overall Study|Reason not Specified|1|||
129026069|NCT04198363|464387676|FG001|Overall Study|Reason not Specified|0|||
129026070|NCT03067987|464387679|FG000|Overall Study|Lost to Follow-up|7|||
129026071|NCT03067987|464387680|FG001|Overall Study|Lost to Follow-up|10|||
129026072|NCT03067987|464387679|FG000|Overall Study|Protocol Violation|1|||
129026073|NCT03067987|464387680|FG001|Overall Study|Protocol Violation|2|||
129026074|NCT03067987|464387679|FG000|Overall Study|Withdrawal by Subject|2|||
129026075|NCT03067987|464387680|FG001|Overall Study|Withdrawal by Subject|1|||
128764856|NCT04146896|463430351|FG000|Overall Study|Non-compliance|5|||
128764857|NCT04146896|463430352|FG001|Overall Study|Non-compliance|4|||
128764858|NCT04146896|463430351|FG000|Overall Study|Withdrawal by Subject|3|||
128764859|NCT04146896|463430352|FG001|Overall Study|Withdrawal by Subject|5|||
128764860|NCT04146896|463430351|FG000|Overall Study|Randomized in error|1|||
128764861|NCT04146896|463430352|FG001|Overall Study|Randomized in error|2|||
128764862|NCT02118337|463430353|FG000|Overall Study|Other|1|||
128764863|NCT02118337|463430354|FG001|Overall Study|Other|0|||
128764864|NCT02118337|463430355|FG002|Overall Study|Other|0|||
128764865|NCT02118337|463430356|FG003|Overall Study|Other|0|||
128764866|NCT02118337|463430357|FG004|Overall Study|Other|2|||
128764867|NCT02118337|463430358|FG005|Overall Study|Other|3|||
128764868|NCT02118337|463430359|FG006|Overall Study|Other|1|||
128764869|NCT02118337|463430360|FG007|Overall Study|Other|28|||
128764870|NCT02118337|463430361|FG008|Overall Study|Other|15|||
128764871|NCT02118337|463430353|FG000|Overall Study|Lost to Follow-up|0|||
128764872|NCT02118337|463430354|FG001|Overall Study|Lost to Follow-up|0|||
128764873|NCT02118337|463430355|FG002|Overall Study|Lost to Follow-up|0|||
128764874|NCT02118337|463430356|FG003|Overall Study|Lost to Follow-up|0|||
128764875|NCT02118337|463430357|FG004|Overall Study|Lost to Follow-up|0|||
128764876|NCT02118337|463430358|FG005|Overall Study|Lost to Follow-up|0|||
128764877|NCT02118337|463430359|FG006|Overall Study|Lost to Follow-up|0|||
128764878|NCT02118337|463430360|FG007|Overall Study|Lost to Follow-up|1|||
128764879|NCT02118337|463430361|FG008|Overall Study|Lost to Follow-up|0|||
128764880|NCT02118337|463430353|FG000|Overall Study|Withdrawal by Subject|1|||
128764881|NCT02118337|463430354|FG001|Overall Study|Withdrawal by Subject|3|||
128764882|NCT02118337|463430355|FG002|Overall Study|Withdrawal by Subject|2|||
128764883|NCT02118337|463430356|FG003|Overall Study|Withdrawal by Subject|1|||
128764884|NCT02118337|463430357|FG004|Overall Study|Withdrawal by Subject|2|||
128764885|NCT02118337|463430358|FG005|Overall Study|Withdrawal by Subject|2|||
128764886|NCT02118337|463430359|FG006|Overall Study|Withdrawal by Subject|1|||
128764887|NCT02118337|463430360|FG007|Overall Study|Withdrawal by Subject|4|||
128764888|NCT02118337|463430361|FG008|Overall Study|Withdrawal by Subject|2|||
129026076|NCT01404988|464387683|FG000|Overall Study|Death|2|||
129026077|NCT01404988|464387684|FG001|Overall Study|Death|0|||
129026078|NCT01404988|464387685|FG002|Overall Study|Death|2|||
128764889|NCT02118337|463430353|FG000|Overall Study|Death|2|||
128764890|NCT02118337|463430354|FG001|Overall Study|Death|2|||
128764891|NCT02118337|463430355|FG002|Overall Study|Death|1|||
128764892|NCT02118337|463430356|FG003|Overall Study|Death|2|||
129026079|NCT01404988|464387683|FG000|Overall Study|Adverse Event|1|||
129026080|NCT01404988|464387684|FG001|Overall Study|Adverse Event|0|||
129026081|NCT01404988|464387685|FG002|Overall Study|Adverse Event|0|||
129026082|NCT01404988|464387683|FG000|Overall Study|Withdrawal by Subject|2|||
128764893|NCT02118337|463430357|FG004|Overall Study|Death|5|||
128905498|NCT01425008|463946579|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129026083|NCT01404988|464387684|FG001|Overall Study|Withdrawal by Subject|2|||
128764894|NCT02118337|463430358|FG005|Overall Study|Death|1|||
128764895|NCT02118337|463430359|FG006|Overall Study|Death|2|||
128764896|NCT02118337|463430360|FG007|Overall Study|Death|9|||
128764897|NCT02118337|463430361|FG008|Overall Study|Death|4|||
129115666|NCT03722576|464719838|FG000|Overall Study|Physician Decision|1|||
129115667|NCT03722576|464719838|FG000|Overall Study|Lost to Follow-up|1|||
129115668|NCT02513550|464719841|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
129115669|NCT02513550|464719842|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
129115670|NCT02513550|464719843|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
129115671|NCT02513550|464719844|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
129115672|NCT02513550|464719845|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
129115673|NCT02513550|464719846|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
129115674|NCT02513550|464719841|FG000|Double Blind Treatment Period|Adverse Event|5|||
129115675|NCT02513550|464719842|FG001|Double Blind Treatment Period|Adverse Event|13|||
129115676|NCT02513550|464719843|FG002|Double Blind Treatment Period|Adverse Event|17|||
129115677|NCT02513550|464719844|FG003|Double Blind Treatment Period|Adverse Event|0|||
129115678|NCT02513550|464719845|FG004|Double Blind Treatment Period|Adverse Event|1|||
129115679|NCT02513550|464719846|FG005|Double Blind Treatment Period|Adverse Event|0|||
129115680|NCT02513550|464719841|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
129115681|NCT02513550|464719842|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
129115682|NCT02513550|464719843|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
129115683|NCT02513550|464719844|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
129115684|NCT02513550|464719845|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
129115685|NCT02513550|464719846|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
129115686|NCT02513550|464719841|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
129115687|NCT02513550|464719842|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
129115688|NCT02513550|464719843|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
129115689|NCT02513550|464719844|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
129115690|NCT02513550|464719845|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
129115691|NCT02513550|464719846|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
129115692|NCT02513550|464719841|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129115693|NCT02513550|464719842|FG001|Double Blind Treatment Period|Protocol Violation|1|||
129115694|NCT02513550|464719843|FG002|Double Blind Treatment Period|Protocol Violation|4|||
129115695|NCT02513550|464719844|FG003|Double Blind Treatment Period|Protocol Violation|0|||
129115696|NCT02513550|464719845|FG004|Double Blind Treatment Period|Protocol Violation|0|||
129115697|NCT02513550|464719846|FG005|Double Blind Treatment Period|Protocol Violation|0|||
129115698|NCT02513550|464719841|FG000|Double Blind Treatment Period|Physician Decision|2|||
129115699|NCT02513550|464719842|FG001|Double Blind Treatment Period|Physician Decision|0|||
129115700|NCT02513550|464719843|FG002|Double Blind Treatment Period|Physician Decision|4|||
129115701|NCT02513550|464719844|FG003|Double Blind Treatment Period|Physician Decision|0|||
129115702|NCT02513550|464719845|FG004|Double Blind Treatment Period|Physician Decision|0|||
129115703|NCT02513550|464719846|FG005|Double Blind Treatment Period|Physician Decision|0|||
129115704|NCT02513550|464719841|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
129115705|NCT02513550|464719842|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
129115706|NCT02513550|464719843|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
129115707|NCT02513550|464719844|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
129115708|NCT02513550|464719845|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
129115709|NCT02513550|464719846|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
129115710|NCT02513550|464719841|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129115711|NCT02513550|464719842|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129115712|NCT02513550|464719843|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
129115713|NCT02513550|464719844|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129115714|NCT02513550|464719845|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129115715|NCT02513550|464719846|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129115716|NCT02513550|464719841|FG000|Double Blind Treatment Period|Due to personal business|2|||
129115717|NCT02513550|464719842|FG001|Double Blind Treatment Period|Due to personal business|0|||
129115718|NCT02513550|464719843|FG002|Double Blind Treatment Period|Due to personal business|1|||
129115719|NCT02513550|464719844|FG003|Double Blind Treatment Period|Due to personal business|0|||
129115720|NCT02513550|464719845|FG004|Double Blind Treatment Period|Due to personal business|0|||
129115721|NCT02513550|464719846|FG005|Double Blind Treatment Period|Due to personal business|0|||
129115722|NCT02513550|464719841|FG000|Double Blind Treatment Period|Death|1|||
129115723|NCT02513550|464719842|FG001|Double Blind Treatment Period|Death|0|||
129115724|NCT02513550|464719843|FG002|Double Blind Treatment Period|Death|2|||
129115725|NCT02513550|464719844|FG003|Double Blind Treatment Period|Death|0|||
129115726|NCT02513550|464719845|FG004|Double Blind Treatment Period|Death|0|||
129115727|NCT02513550|464719846|FG005|Double Blind Treatment Period|Death|0|||
129115728|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
129115729|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
129115730|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
129115731|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129115732|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129115733|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
128694254|NCT00150709|463180432|FG003|Overall Study|Subject entered new drug study|0|||
128694255|NCT00150709|463180429|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
128694256|NCT00150709|463180430|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
128694257|NCT00150709|463180431|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
128694258|NCT00150709|463180432|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
128694259|NCT00150709|463180429|FG000|Overall Study|Lack of ease of swallowing|0|||
128694260|NCT00150709|463180430|FG001|Overall Study|Lack of ease of swallowing|1|||
128694261|NCT00150709|463180431|FG002|Overall Study|Lack of ease of swallowing|0|||
128694262|NCT00150709|463180432|FG003|Overall Study|Lack of ease of swallowing|0|||
128694263|NCT02975336|463180433|FG000|DBPC (52 Weeks)|Adverse Event|16|||
128694264|NCT02975336|463180434|FG001|DBPC (52 Weeks)|Adverse Event|17|||
128694265|NCT02975336|463180435|FG002|DBPC (52 Weeks)|Adverse Event|13|||
128694266|NCT02975336|463180436|FG003|DBPC (52 Weeks)|Adverse Event|18|||
128694267|NCT02975336|463180437|FG004|DBPC (52 Weeks)|Adverse Event|0|||
128694268|NCT02975336|463180438|FG005|DBPC (52 Weeks)|Adverse Event|0|||
128694269|NCT02975336|463180439|FG006|DBPC (52 Weeks)|Adverse Event|0|||
128694270|NCT02975336|463180440|FG007|DBPC (52 Weeks)|Adverse Event|0|||
128694271|NCT02975336|463180433|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
128694272|NCT02975336|463180434|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
128694273|NCT02975336|463180435|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
128694274|NCT02975336|463180436|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
128694275|NCT02975336|463180437|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
128694276|NCT02975336|463180438|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
128694277|NCT02975336|463180439|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
128694278|NCT02975336|463180440|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
128694279|NCT02975336|463180433|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
128694280|NCT02975336|463180434|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
128694281|NCT02975336|463180435|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
128694282|NCT02975336|463180436|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
128694283|NCT02975336|463180437|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
128694284|NCT02975336|463180438|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
128694285|NCT02975336|463180439|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
128694286|NCT02975336|463180440|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
128694287|NCT02975336|463180433|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
128694288|NCT02975336|463180434|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
128694289|NCT02975336|463180435|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
128694290|NCT02975336|463180436|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
128694291|NCT02975336|463180437|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
128694292|NCT02975336|463180438|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
128694293|NCT02975336|463180439|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
128694294|NCT02975336|463180440|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
128694295|NCT02975336|463180433|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
128694296|NCT02975336|463180434|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
128694297|NCT02975336|463180435|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
128694298|NCT02975336|463180436|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
128694299|NCT02975336|463180437|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129026084|NCT01404988|464387685|FG002|Overall Study|Withdrawal by Subject|0|||
129026085|NCT01404988|464387683|FG000|Overall Study|Lost to Follow-up|1|||
129026086|NCT01404988|464387684|FG001|Overall Study|Lost to Follow-up|2|||
129026087|NCT01404988|464387685|FG002|Overall Study|Lost to Follow-up|1|||
129026088|NCT00829764|464387686|FG000|First Intervention|Adverse Event|1|||
129026089|NCT00829764|464387687|FG001|First Intervention|Adverse Event|0|||
129026090|NCT00829764|464387686|FG000|First Intervention|Withdrawal by Subject|1|||
129026091|NCT00829764|464387687|FG001|First Intervention|Withdrawal by Subject|1|||
129026092|NCT04594252|464387688|FG000|Overall Study|Adverse Event|0|||
129026093|NCT04594252|464387689|FG001|Overall Study|Adverse Event|2|||
129026094|NCT01952691|464389874|FG000|Overall Study|Lost to Follow-up|2|||
129026095|NCT00199901|464389875|FG000|Overall Study|Protocol Violation|2|||
129026096|NCT00199901|464389876|FG001|Overall Study|Protocol Violation|0|||
129026097|NCT00199901|464389875|FG000|Overall Study|Withdrawal by Subject|1|||
129026098|NCT00199901|464389876|FG001|Overall Study|Withdrawal by Subject|0|||
129026099|NCT00199901|464389875|FG000|Overall Study|Progressive Disease|24|||
129026100|NCT00199901|464389876|FG001|Overall Study|Progressive Disease|24|||
129026101|NCT05776901|464389879|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
129026102|NCT02997176|464389882|FG000|Overall Study|Adverse Event|0|||
129026103|NCT02997176|464389883|FG001|Overall Study|Adverse Event|0|||
129026104|NCT02997176|464389884|FG002|Overall Study|Adverse Event|0|||
129026105|NCT02997176|464389885|FG003|Overall Study|Adverse Event|8|||
129026106|NCT02997176|464389882|FG000|Overall Study|Progressive Disease|1|||
128694300|NCT02975336|463180438|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
128694301|NCT02975336|463180439|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
128694302|NCT02975336|463180440|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
128694303|NCT02975336|463180433|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
128694304|NCT02975336|463180434|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
128694305|NCT02975336|463180435|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
129026107|NCT02997176|464389883|FG001|Overall Study|Progressive Disease|0|||
129026108|NCT02997176|464389884|FG002|Overall Study|Progressive Disease|1|||
129215324|NCT00463567|465091130|FG005|Overall Study|Administrative problems|2|||
128694306|NCT02975336|463180436|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
128694307|NCT02975336|463180437|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
128694308|NCT02975336|463180438|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
128694309|NCT02975336|463180439|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
128694310|NCT02975336|463180440|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
128694311|NCT02975336|463180433|FG000|LTE (104 Weeks)|Adverse Event|0|||
128694312|NCT02975336|463180434|FG001|LTE (104 Weeks)|Adverse Event|0|||
129026109|NCT02997176|464389885|FG003|Overall Study|Progressive Disease|1|||
129026110|NCT02997176|464389882|FG000|Overall Study|Death|0|||
129026111|NCT02997176|464389883|FG001|Overall Study|Death|0|||
129026112|NCT02997176|464389884|FG002|Overall Study|Death|1|||
129026113|NCT02997176|464389885|FG003|Overall Study|Death|1|||
129026114|NCT02997176|464389882|FG000|Overall Study|Withdrawal by Subject|0|||
129026115|NCT02997176|464389883|FG001|Overall Study|Withdrawal by Subject|2|||
129026116|NCT02997176|464389884|FG002|Overall Study|Withdrawal by Subject|0|||
129026117|NCT02997176|464389885|FG003|Overall Study|Withdrawal by Subject|1|||
129026118|NCT00373256|464389886|FG000|Overall Study|Adverse Event (AE)|1|||
129026119|NCT00373256|464389887|FG001|Overall Study|Adverse Event (AE)|5|||
129026120|NCT00373256|464389886|FG000|Overall Study|Lost to Follow-up|2|||
129026121|NCT00373256|464389887|FG001|Overall Study|Lost to Follow-up|1|||
129026122|NCT00373256|464389886|FG000|Overall Study|Death|9|||
129026123|NCT00373256|464389887|FG001|Overall Study|Death|8|||
129026124|NCT00373256|464389886|FG000|Overall Study|Objective Progression or Relapse|111|||
129026125|NCT00373256|464389887|FG001|Overall Study|Objective Progression or Relapse|104|||
129026126|NCT00373256|464389886|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
129026127|NCT00373256|464389887|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
129026128|NCT00373256|464389886|FG000|Overall Study|Other|73|||
129026129|NCT00373256|464389887|FG001|Overall Study|Other|107|||
129026130|NCT00373256|464389886|FG000|Overall Study|Protocol Violation|0|||
129026131|NCT00373256|464389887|FG001|Overall Study|Protocol Violation|2|||
129026132|NCT00373256|464389886|FG000|Overall Study|Study Terminated by Sponsor|41|||
129026133|NCT00373256|464389887|FG001|Overall Study|Study Terminated by Sponsor|13|||
129026134|NCT06144424|464389888|FG000|Overall Study|Withdrawal by Subject|2|||
129026135|NCT06144424|464389889|FG001|Overall Study|Withdrawal by Subject|0|||
129026136|NCT06144424|464389888|FG000|Overall Study|Incarceration|1|||
129026137|NCT06144424|464389889|FG001|Overall Study|Incarceration|0|||
129026138|NCT02727192|464389890|FG000|Overall Study|Lost to Follow-up|1|||
129026139|NCT02727192|464389891|FG001|Overall Study|Lost to Follow-up|0|||
129026140|NCT02727192|464389892|FG002|Overall Study|Lost to Follow-up|0|||
129026141|NCT00928057|464389893|FG000|Overall Study|Adverse Event|1|||
129026142|NCT00928057|464389894|FG001|Overall Study|Adverse Event|2|||
129026143|NCT00928057|464389893|FG000|Overall Study|Withdrawal by Subject|1|||
129026144|NCT00928057|464389894|FG001|Overall Study|Withdrawal by Subject|0|||
129026145|NCT00928057|464389893|FG000|Overall Study|Lost to Follow-up|0|||
129026146|NCT00928057|464389894|FG001|Overall Study|Lost to Follow-up|1|||
129026147|NCT00928057|464389893|FG000|Overall Study|Protocol Violation|0|||
129026148|NCT00928057|464389894|FG001|Overall Study|Protocol Violation|1|||
129026149|NCT05497557|464389901|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
129026150|NCT05497557|464389902|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
129026151|NCT05497557|464389903|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
129026152|NCT02752074|464389906|FG000|Overall Study|Lost to Follow-up|1|||
129026153|NCT02752074|464389907|FG001|Overall Study|Lost to Follow-up|4|||
129026154|NCT02752074|464389906|FG000|Overall Study|Death|146|||
129026155|NCT02752074|464389907|FG001|Overall Study|Death|129|||
129026156|NCT02752074|464389906|FG000|Overall Study|Withdrawal by Subject|9|||
129026157|NCT02752074|464389907|FG001|Overall Study|Withdrawal by Subject|10|||
129026158|NCT02392195|464389910|FG000|Overall Study|Lost to Follow-up|4|||
129026159|NCT02392195|464389910|FG000|Overall Study|Withdrawal by Subject|4|||
129026160|NCT00545792|464389913|FG000|Overall Study|Withdrawal by Subject|1|||
129026161|NCT03679598|464389915|FG000|Overall Study|Adverse Event|2|||
129026162|NCT03679598|464389916|FG001|Overall Study|Adverse Event|0|||
129026163|NCT01380782|464389921|FG000|Overall Study|Adverse Event|0|||
129026164|NCT01380782|464389922|FG001|Overall Study|Adverse Event|1|||
129026165|NCT01380782|464389923|FG002|Overall Study|Adverse Event|0|||
129026166|NCT01380782|464389924|FG003|Overall Study|Adverse Event|0|||
129026167|NCT01380782|464389921|FG000|Overall Study|Death|1|||
129026168|NCT01380782|464389922|FG001|Overall Study|Death|0|||
129026169|NCT01380782|464389923|FG002|Overall Study|Death|0|||
129026170|NCT01380782|464389924|FG003|Overall Study|Death|0|||
129026171|NCT01380782|464389921|FG000|Overall Study|Lack of Efficacy|10|||
129026172|NCT01380782|464389922|FG001|Overall Study|Lack of Efficacy|9|||
129026173|NCT01380782|464389923|FG002|Overall Study|Lack of Efficacy|10|||
129026174|NCT01380782|464389924|FG003|Overall Study|Lack of Efficacy|3|||
129026175|NCT01380782|464389921|FG000|Overall Study|Physician Decision|1|||
129026176|NCT01380782|464389922|FG001|Overall Study|Physician Decision|0|||
129026177|NCT01380782|464389923|FG002|Overall Study|Physician Decision|0|||
129026178|NCT01380782|464389924|FG003|Overall Study|Physician Decision|0|||
129215325|NCT00463567|465091131|FG006|Overall Study|Administrative problems|2|||
129026179|NCT01380782|464389921|FG000|Overall Study|Withdrawal by Subject|0|||
129026180|NCT01380782|464389922|FG001|Overall Study|Withdrawal by Subject|0|||
129026181|NCT01380782|464389923|FG002|Overall Study|Withdrawal by Subject|1|||
129026182|NCT01380782|464389924|FG003|Overall Study|Withdrawal by Subject|1|||
129026183|NCT05387408|464389927|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
129026184|NCT03428750|464389928|FG000|Overall Study|Withdrawal by Subject|11|||
129026185|NCT03428750|464389929|FG001|Overall Study|Withdrawal by Subject|10|||
129026186|NCT03428750|464389928|FG000|Overall Study|Lost to Follow-up|3|||
129026187|NCT03428750|464389929|FG001|Overall Study|Lost to Follow-up|9|||
129026188|NCT03428750|464389928|FG000|Overall Study|Adverse Event|9|||
129026189|NCT03428750|464389929|FG001|Overall Study|Adverse Event|1|||
129026190|NCT03428750|464389928|FG000|Overall Study|Protocol Violation|1|||
129026191|NCT03428750|464389929|FG001|Overall Study|Protocol Violation|0|||
129026192|NCT03428750|464389928|FG000|Overall Study|Administrative|0|||
129026193|NCT03428750|464389929|FG001|Overall Study|Administrative|1|||
129026194|NCT01919112|464389930|FG000|Secondary Analysis-day 30|Death|1|||
129026195|NCT01919112|464389931|FG001|Secondary Analysis-day 30|Death|1|||
129026196|NCT01919112|464389932|FG002|Secondary Analysis-day 30|Death|1|||
129026197|NCT01919112|464389930|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
129026198|NCT01919112|464389931|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
129026199|NCT01919112|464389932|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
129026200|NCT02554877|464389933|FG000|Overall Study|Adverse Event|2|||
129026201|NCT02554877|464389934|FG001|Overall Study|Adverse Event|0|||
129026202|NCT02554877|464389935|FG002|Overall Study|Adverse Event|0|||
129026203|NCT02554877|464389936|FG003|Overall Study|Adverse Event|1|||
129026204|NCT02554877|464389933|FG000|Overall Study|Lost to Follow-up|1|||
129026205|NCT02554877|464389934|FG001|Overall Study|Lost to Follow-up|1|||
129026206|NCT02554877|464389935|FG002|Overall Study|Lost to Follow-up|1|||
129026207|NCT02554877|464389936|FG003|Overall Study|Lost to Follow-up|2|||
129026208|NCT02554877|464389933|FG000|Overall Study|Did not meet entrance criteria|0|||
129026209|NCT02554877|464389934|FG001|Overall Study|Did not meet entrance criteria|0|||
129026210|NCT02554877|464389935|FG002|Overall Study|Did not meet entrance criteria|1|||
129026211|NCT02554877|464389936|FG003|Overall Study|Did not meet entrance criteria|0|||
129026212|NCT02554877|464389933|FG000|Overall Study|No longer met eligibility criteria|1|||
129026213|NCT02554877|464389934|FG001|Overall Study|No longer met eligibility criteria|0|||
129026214|NCT02554877|464389935|FG002|Overall Study|No longer met eligibility criteria|1|||
129026215|NCT02554877|464389936|FG003|Overall Study|No longer met eligibility criteria|1|||
129026216|NCT02554877|464389933|FG000|Overall Study|Protocol Violation|3|||
129026217|NCT02554877|464389934|FG001|Overall Study|Protocol Violation|1|||
129026218|NCT02554877|464389935|FG002|Overall Study|Protocol Violation|1|||
129026219|NCT02554877|464389936|FG003|Overall Study|Protocol Violation|0|||
129026220|NCT02554877|464389933|FG000|Overall Study|Other|1|||
129026221|NCT02554877|464389934|FG001|Overall Study|Other|3|||
129026222|NCT02554877|464389935|FG002|Overall Study|Other|0|||
129026223|NCT02554877|464389936|FG003|Overall Study|Other|3|||
129026224|NCT02554877|464389933|FG000|Overall Study|Insufficient clinical response|4|||
129026225|NCT02554877|464389934|FG001|Overall Study|Insufficient clinical response|0|||
129026226|NCT02554877|464389935|FG002|Overall Study|Insufficient clinical response|0|||
129026227|NCT02554877|464389936|FG003|Overall Study|Insufficient clinical response|0|||
129026228|NCT02554877|464389933|FG000|Overall Study|No longer willing to participate|0|||
129026229|NCT02554877|464389934|FG001|Overall Study|No longer willing to participate|2|||
129026230|NCT02554877|464389935|FG002|Overall Study|No longer willing to participate|2|||
129026231|NCT02554877|464389936|FG003|Overall Study|No longer willing to participate|0|||
129026232|NCT04474405|464389937|FG000|Overall Study|Withdrawal by Subject|0|||
129026233|NCT04474405|464389938|FG001|Overall Study|Withdrawal by Subject|0|||
129026234|NCT04474405|464389939|FG002|Overall Study|Withdrawal by Subject|1|||
129026235|NCT04474405|464389940|FG003|Overall Study|Withdrawal by Subject|0|||
129026236|NCT04474405|464389941|FG004|Overall Study|Withdrawal by Subject|1|||
129026237|NCT04474405|464389942|FG005|Overall Study|Withdrawal by Subject|0|||
129026238|NCT04474405|464389937|FG000|Overall Study|Other|0|||
129026239|NCT04474405|464389938|FG001|Overall Study|Other|0|||
129026240|NCT04474405|464389939|FG002|Overall Study|Other|0|||
129026241|NCT04474405|464389940|FG003|Overall Study|Other|0|||
129026242|NCT04474405|464389941|FG004|Overall Study|Other|3|||
129026243|NCT04474405|464389942|FG005|Overall Study|Other|0|||
129026244|NCT00274651|464389943|FG000|Overall Study|Adverse Event|6|||
129026245|NCT00274651|464389944|FG001|Overall Study|Adverse Event|3|||
129026246|NCT00274651|464389943|FG000|Overall Study|Lack of Efficacy|13|||
129026247|NCT00274651|464389944|FG001|Overall Study|Lack of Efficacy|6|||
129026248|NCT00274651|464389943|FG000|Overall Study|Death|1|||
129026249|NCT00274651|464389944|FG001|Overall Study|Death|3|||
129026250|NCT00274651|464389943|FG000|Overall Study|Withdrawal by Subject|0|||
129026251|NCT00274651|464389944|FG001|Overall Study|Withdrawal by Subject|1|||
129026252|NCT00274651|464389943|FG000|Overall Study|Physician Decision|8|||
129026253|NCT00274651|464389944|FG001|Overall Study|Physician Decision|7|||
129026254|NCT00635648|464389945|FG000|Overall Study|Adverse Event|12|||
129026255|NCT00635648|464389945|FG000|Overall Study|Withdrawal by Subject|9|||
128694313|NCT02975336|463180435|FG002|LTE (104 Weeks)|Adverse Event|0|||
128694314|NCT02975336|463180436|FG003|LTE (104 Weeks)|Adverse Event|0|||
129026256|NCT00635648|464389945|FG000|Overall Study|Physician Decision|4|||
129026257|NCT00635648|464389945|FG000|Overall Study|Rapid progression of baseline disease|4|||
129026258|NCT00635648|464389945|FG000|Overall Study|Use of other antifungal agent needed|1|||
129026259|NCT00635648|464389945|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
129026260|NCT00635648|464389945|FG000|Overall Study|Noncompliance with protocol|1|||
129026261|NCT00635648|464389945|FG000|Overall Study|Other reason|2|||
129026262|NCT04547192|464389946|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
129026263|NCT04547192|464389947|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
129026264|NCT04547192|464389948|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
129026265|NCT04547192|464389949|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
129026266|NCT04547192|464389946|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
129026267|NCT04547192|464389947|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
129026268|NCT04547192|464389948|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
129026269|NCT04547192|464389949|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
129026270|NCT04547192|464389946|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
129026271|NCT04547192|464389947|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
129026272|NCT04547192|464389948|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
129026273|NCT04547192|464389949|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
129026274|NCT04547192|464389946|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
129026275|NCT04547192|464389947|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
129026276|NCT04547192|464389948|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
129026277|NCT04547192|464389949|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
129026278|NCT04547192|464389946|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
129026279|NCT04547192|464389947|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
129026280|NCT04547192|464389948|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
129026281|NCT04547192|464389949|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
129026282|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
129026283|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
129026284|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
129026285|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
129026286|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
129026287|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
129026288|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
129026289|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
129026290|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
129026291|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
129026292|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
129026293|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
129026294|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
129026295|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
129026296|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
129026297|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
129026298|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
129026299|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
129026300|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
129026301|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
129026302|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
129026303|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
129026304|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
129026305|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
129026306|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
129026307|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
129026308|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
129026309|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
129026310|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
129026311|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
129026312|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
129026313|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
129026314|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
129026315|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
129026316|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
129026317|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
129026318|NCT04194801|464389950|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
129026319|NCT04194801|464389951|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
129026320|NCT04194801|464389952|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
128694315|NCT02975336|463180437|FG004|LTE (104 Weeks)|Adverse Event|7|||
129026321|NCT04194801|464389950|FG000|Part Ib/II End of Study|Death|2|||
129026322|NCT04194801|464389951|FG001|Part Ib/II End of Study|Death|3|||
129026323|NCT04194801|464389952|FG002|Part Ib/II End of Study|Death|3|||
129026324|NCT04194801|464389950|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
129026325|NCT04194801|464389951|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
129026326|NCT04194801|464389952|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
129026327|NCT04194801|464389950|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
129026328|NCT04194801|464389951|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
129026329|NCT04194801|464389952|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
129026330|NCT04194801|464389950|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
129026331|NCT04194801|464389951|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
129026332|NCT04194801|464389952|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
129026333|NCT04194801|464389950|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
129026334|NCT04194801|464389951|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
129026335|NCT04194801|464389952|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
129026336|NCT01923740|464389953|FG000|Overall Study|Lost to Follow-up|4|||
129026337|NCT01923740|464389954|FG001|Overall Study|Lost to Follow-up|9|||
129026338|NCT01923740|464389953|FG000|Overall Study|Withdrawal by Subject|2|||
129026339|NCT01923740|464389954|FG001|Overall Study|Withdrawal by Subject|0|||
129026340|NCT04723693|464389955|FG000|Overall Study|Withdrawal by Subject|2|||
129026341|NCT01410227|464389956|FG000|Overall Study|Adverse Event|1|||
129026342|NCT01410227|464389957|FG001|Overall Study|Adverse Event|0|||
129026343|NCT01410227|464389958|FG002|Overall Study|Adverse Event|0|||
129026344|NCT01410227|464389959|FG003|Overall Study|Adverse Event|0|||
129026345|NCT01410227|464389956|FG000|Overall Study|Withdrawal by Subject|3|||
129026346|NCT01410227|464389957|FG001|Overall Study|Withdrawal by Subject|0|||
129026347|NCT01410227|464389958|FG002|Overall Study|Withdrawal by Subject|1|||
129026348|NCT01410227|464389959|FG003|Overall Study|Withdrawal by Subject|0|||
129026349|NCT01410227|464389956|FG000|Overall Study|Pregnancy|0|||
129026350|NCT01410227|464389957|FG001|Overall Study|Pregnancy|0|||
129026351|NCT01410227|464389958|FG002|Overall Study|Pregnancy|0|||
129026352|NCT01410227|464389959|FG003|Overall Study|Pregnancy|1|||
129026353|NCT01410227|464389956|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
129026354|NCT01410227|464389957|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
129026355|NCT01410227|464389958|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
129026356|NCT01410227|464389959|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
129026357|NCT03497130|464389960|FG000|Overall Study|Lost to Follow-up|1|||
129026358|NCT03497130|464389961|FG001|Overall Study|Lost to Follow-up|1|||
129026359|NCT04002648|464389962|FG000|Overall Study|Lost to Follow-up|2|||
129026360|NCT04002648|464389963|FG001|Overall Study|Lost to Follow-up|0|||
129026361|NCT00669162|464389966|FG000|Overall Study|Withdrawal by Subject|1|||
129026362|NCT02412852|464389967|FG000|Overall Study|Withdrawal by Subject|0|||
129026363|NCT02412852|464389968|FG001|Overall Study|Withdrawal by Subject|1|||
129026364|NCT02412852|464389969|FG002|Overall Study|Withdrawal by Subject|0|||
129026365|NCT02412852|464389970|FG003|Overall Study|Withdrawal by Subject|0|||
129026366|NCT02412852|464389967|FG000|Overall Study|Physician Decision|0|||
129026367|NCT02412852|464389968|FG001|Overall Study|Physician Decision|0|||
129026368|NCT02412852|464389969|FG002|Overall Study|Physician Decision|0|||
129026369|NCT02412852|464389970|FG003|Overall Study|Physician Decision|1|||
129026370|NCT01051349|464389971|FG000|Overall Study|Adverse Event|88|||
129026371|NCT01051349|464389971|FG000|Overall Study|Consent Withdrawn|54|||
129026372|NCT01051349|464389971|FG000|Overall Study|Investigator Decision|6|||
129026373|NCT01051349|464389971|FG000|Overall Study|Lost to Follow-up|6|||
129026374|NCT01051349|464389971|FG000|Overall Study|Subject non-compliance|7|||
129026375|NCT01051349|464389971|FG000|Overall Study|Reason not Specified|12|||
129026376|NCT00841542|464389972|FG000|Period 1|Adverse Event|1|||
129026377|NCT00841542|464389973|FG001|Period 1|Adverse Event|0|||
129026378|NCT00472212|464389974|FG000|Overall Study|Lost to Follow-up|6|||
129026379|NCT00472212|464389975|FG001|Overall Study|Lost to Follow-up|4|||
129026380|NCT02462837|464389976|FG000|Overall Study|pt developed hives|1|||
129026381|NCT02462837|464389977|FG001|Overall Study|pt developed hives|0|||
129026382|NCT02462837|464389976|FG000|Overall Study|Withdrawal by Subject|1|||
129026383|NCT02462837|464389977|FG001|Overall Study|Withdrawal by Subject|0|||
129026384|NCT00841659|464389979|FG000|Washout: 2 Weeks|Protocol Violation|1|||
129026385|NCT00841659|464389980|FG001|Washout: 2 Weeks|Protocol Violation|0|||
129026386|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Refused|1|||
129026387|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Refused|3|||
129026388|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Medical|0|||
129026389|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Medical|1|||
129026390|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
129026391|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
129026392|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
129026393|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
129026394|NCT02054715|464389981|FG000|Baseline/Follow-up 1|No Reason|0|||
129026395|NCT02054715|464389982|FG001|Baseline/Follow-up 1|No Reason|1|||
129026396|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
129026397|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
129115734|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
129115735|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
129115736|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
129115737|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
129115738|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
129115739|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
129115740|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
129115741|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
129115742|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
129115743|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129115744|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129115745|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129115746|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
129115747|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
129115748|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
129115749|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
129115750|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
129115751|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
129115752|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
129115753|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
129115754|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
129115755|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
129115756|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
129115757|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
129115758|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Death|0|||
129115759|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Death|0|||
129115760|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Death|1|||
129115761|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Death|0|||
129115762|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Death|0|||
129115763|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Death|0|||
129115764|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
129115765|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
129115766|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
129115767|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
129115768|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
129115769|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
129115770|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129115771|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129115772|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
129115773|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129115774|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129115775|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129115776|NCT02513550|464719841|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
129115777|NCT02513550|464719842|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
129115778|NCT02513550|464719843|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
129115779|NCT02513550|464719844|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
129115780|NCT02513550|464719845|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
129115781|NCT02513550|464719846|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
129115782|NCT00192114|464719850|FG000|Overall Study|Objective Tumor Progression|19|||
129115783|NCT00192114|464719850|FG000|Overall Study|Adverse Event|2|||
129115784|NCT00192114|464719850|FG000|Overall Study|Clinical Progression|2|||
129115785|NCT00192114|464719850|FG000|Overall Study|Death|1|||
129115786|NCT00113607|464719851|FG000|Overall Study|Adverse Event|40|||
129115787|NCT00113607|464719852|FG001|Overall Study|Adverse Event|71|||
129115788|NCT00113607|464719851|FG000|Overall Study|Death|8|||
129115789|NCT00113607|464719852|FG001|Overall Study|Death|8|||
129115790|NCT00113607|464719851|FG000|Overall Study|Withdrawal by Subject|50|||
129115791|NCT00113607|464719852|FG001|Overall Study|Withdrawal by Subject|58|||
129115792|NCT00113607|464719851|FG000|Overall Study|Lost to Follow-up|0|||
129115793|NCT00113607|464719852|FG001|Overall Study|Lost to Follow-up|2|||
128694316|NCT02975336|463180438|FG005|LTE (104 Weeks)|Adverse Event|4|||
128694317|NCT02975336|463180439|FG006|LTE (104 Weeks)|Adverse Event|2|||
129115794|NCT00113607|464719851|FG000|Overall Study|Disease Progression|180|||
128694318|NCT02975336|463180440|FG007|LTE (104 Weeks)|Adverse Event|0|||
129115795|NCT00113607|464719852|FG001|Overall Study|Disease Progression|142|||
128694319|NCT02975336|463180433|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
128694320|NCT02975336|463180434|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
128694321|NCT02975336|463180435|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
128694322|NCT02975336|463180436|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
128694323|NCT02975336|463180437|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
129115796|NCT00113607|464719851|FG000|Overall Study|Complete Response (Confirmed)|14|||
129115797|NCT00113607|464719852|FG001|Overall Study|Complete Response (Confirmed)|24|||
129115798|NCT00113607|464719851|FG000|Overall Study|Other|43|||
129115799|NCT00113607|464719852|FG001|Overall Study|Other|32|||
129115800|NCT01222104|464719853|FG000|Overall Study|Lost to Follow-up|37|||
129115801|NCT01222104|464719853|FG000|Overall Study|Death|10|||
129115802|NCT01418339|464719855|FG000|Overall Study|Adverse Event|5|||
129115803|NCT01418339|464719856|FG001|Overall Study|Adverse Event|2|||
129115804|NCT01418339|464719855|FG000|Overall Study|Subject Withdrew Consent|1|||
129115805|NCT01418339|464719856|FG001|Overall Study|Subject Withdrew Consent|2|||
129115806|NCT01418339|464719855|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
129115807|NCT01418339|464719856|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
129115808|NCT03885908|464719857|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
129115809|NCT03885908|464719858|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
129115810|NCT03885908|464719857|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
129115811|NCT03885908|464719858|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
129115812|NCT03885908|464719857|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
129115813|NCT03885908|464719858|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
129115814|NCT03885908|464719857|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
129115815|NCT03885908|464719858|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
129115816|NCT00909844|464719859|FG000|Overall Study|Adverse Event|1|||
129115817|NCT00909844|464719859|FG000|Overall Study|Withdrawal by Subject|1|||
129115818|NCT00909844|464719859|FG000|Overall Study|Lost to Follow-up|2|||
129115819|NCT00706004|464719860|FG000|Overall Study|Did not meet eligibility criteria|2|||
129115820|NCT01064479|464719861|FG000|Overall Study|Death|10|||
129115821|NCT01064479|464719862|FG001|Overall Study|Death|11|||
128905499|NCT01425008|463946580|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905500|NCT01425008|463946581|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
128905501|NCT01425008|463946582|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129115822|NCT01064479|464719861|FG000|Overall Study|Withdrawal by Subject|2|||
129115823|NCT01064479|464719862|FG001|Overall Study|Withdrawal by Subject|2|||
129115824|NCT01064479|464719861|FG000|Overall Study|Disease progression|1|||
129115825|NCT01064479|464719862|FG001|Overall Study|Disease progression|1|||
129115826|NCT01064479|464719861|FG000|Overall Study|Toxicity|1|||
129115827|NCT01064479|464719862|FG001|Overall Study|Toxicity|1|||
129115828|NCT01064479|464719861|FG000|Overall Study|Other|1|||
129115829|NCT01064479|464719862|FG001|Overall Study|Other|2|||
129115830|NCT00749398|464719863|FG000|Overall Study|Lack of Efficacy|7|||
129115831|NCT00749398|464719863|FG000|Overall Study|Adverse Event|4|||
129115832|NCT00749398|464719863|FG000|Overall Study|Serious adverse event|11|||
129115833|NCT00749398|464719863|FG000|Overall Study|Withdrawal by Subject|17|||
129115834|NCT00749398|464719863|FG000|Overall Study|Lost to Follow-up|11|||
129115835|NCT00749398|464719863|FG000|Overall Study|Reason not specified|2|||
129115836|NCT00749398|464719863|FG000|Overall Study|Unknown reason|1|||
129115837|NCT03093181|464719868|FG000|Overall Study|Withdrawal by Subject|2|||
129115838|NCT03093181|464719869|FG001|Overall Study|Withdrawal by Subject|1|||
129115839|NCT03093181|464719870|FG002|Overall Study|Withdrawal by Subject|2|||
129115840|NCT03093181|464719868|FG000|Overall Study|Other (Not specified)|1|||
129115841|NCT03093181|464719869|FG001|Overall Study|Other (Not specified)|0|||
129115842|NCT03093181|464719870|FG002|Overall Study|Other (Not specified)|0|||
129115843|NCT03093181|464719868|FG000|Overall Study|Adverse Event|0|||
129115844|NCT03093181|464719869|FG001|Overall Study|Adverse Event|1|||
129115845|NCT03093181|464719870|FG002|Overall Study|Adverse Event|0|||
129115846|NCT03093181|464719868|FG000|Overall Study|Other (Protocol violation)|0|||
129115847|NCT03093181|464719869|FG001|Overall Study|Other (Protocol violation)|0|||
129115848|NCT03093181|464719870|FG002|Overall Study|Other (Protocol violation)|1|||
129115849|NCT04210986|464719871|FG000|Overall Study|Lost to Follow-up|5|||
129115850|NCT04210986|464719872|FG001|Overall Study|Lost to Follow-up|2|||
129115851|NCT04210986|464719871|FG000|Overall Study|Withdrawal by Subject|3|||
129115852|NCT04210986|464719872|FG001|Overall Study|Withdrawal by Subject|1|||
128764898|NCT04296890|463430362|FG000|Overall Study|Withdrawal by Subject|1|||
128905502|NCT01425008|463946583|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
129115853|NCT04210986|464719871|FG000|Overall Study|Protocol Violation|1|||
129115854|NCT04210986|464719872|FG001|Overall Study|Protocol Violation|1|||
129115855|NCT04210986|464719871|FG000|Overall Study|Physician Decision|0|||
129115856|NCT04210986|464719872|FG001|Overall Study|Physician Decision|1|||
129115857|NCT01076543|464719873|FG000|Overall Study|Withdrawal by Subject|2|||
128764899|NCT04296890|463430362|FG000|Overall Study|Death|62|||
128905503|NCT01425008|463946584|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
129115858|NCT01076543|464719874|FG001|Overall Study|Withdrawal by Subject|0|||
128905504|NCT01425008|463946585|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
129115859|NCT01076543|464719875|FG002|Overall Study|Withdrawal by Subject|0|||
129115860|NCT01076543|464719876|FG003|Overall Study|Withdrawal by Subject|0|||
129215326|NCT00463567|465091125|FG000|Overall Study|Lack of Efficacy|4|||
129115861|NCT01076543|464719877|FG004|Overall Study|Withdrawal by Subject|0|||
129115862|NCT01076543|464719878|FG005|Overall Study|Withdrawal by Subject|0|||
129115863|NCT05222880|464719879|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129026398|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Ineligible|3|||
129026399|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Ineligible|0|||
129026400|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Hospitalization|1|||
129026401|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Hospitalization|0|||
129026402|NCT02054715|464389981|FG000|Baseline/Follow-up 1|Changed Mind|1|||
129026403|NCT02054715|464389982|FG001|Baseline/Follow-up 1|Changed Mind|0|||
129026404|NCT02054715|464389981|FG000|Follow-up 2|Lost to Followup|3|||
129026405|NCT02054715|464389982|FG001|Follow-up 2|Lost to Followup|1|||
129026406|NCT02054715|464389981|FG000|Follow-up 2|Refused|3|||
129026407|NCT02054715|464389982|FG001|Follow-up 2|Refused|2|||
129026408|NCT02054715|464389981|FG000|Follow-up 2|Followup Not Completed|3|||
129026409|NCT02054715|464389982|FG001|Follow-up 2|Followup Not Completed|4|||
129026410|NCT02054715|464389981|FG000|Follow-up 2|Ineligible|4|||
129026411|NCT02054715|464389982|FG001|Follow-up 2|Ineligible|5|||
129026412|NCT02054715|464389981|FG000|Follow-up 2|Death|3|||
129026413|NCT02054715|464389982|FG001|Follow-up 2|Death|3|||
129026414|NCT02054715|464389981|FG000|Follow-up 2|Hospitalization|0|||
129026415|NCT02054715|464389982|FG001|Follow-up 2|Hospitalization|2|||
129026416|NCT02054715|464389981|FG000|Follow-up 2|Changed MD/Facility|0|||
129026417|NCT02054715|464389982|FG001|Follow-up 2|Changed MD/Facility|1|||
129026418|NCT02054715|464389981|FG000|Follow-up 2|Changed Mind|0|||
129026419|NCT02054715|464389982|FG001|Follow-up 2|Changed Mind|1|||
129026420|NCT02054715|464389981|FG000|Follow-up 2|No Reason|2|||
129026421|NCT02054715|464389982|FG001|Follow-up 2|No Reason|0|||
129026422|NCT02054715|464389981|FG000|Follow-up 2|Treatment Change or Delay|1|||
129026423|NCT02054715|464389982|FG001|Follow-up 2|Treatment Change or Delay|0|||
129026424|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
129026425|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
129026426|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
129026427|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
129026428|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
129026429|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
129026430|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
129026431|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
129026432|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
129026433|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
129026434|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
129026435|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
129026436|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
129026437|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
129026438|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
129026439|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
129026440|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
129026441|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
129026442|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
129026443|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
129026444|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
129026445|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
129026446|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
129026447|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
129026448|NCT00073307|464389990|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
129026449|NCT00073307|464389991|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
129026450|NCT00073307|464389992|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
129026451|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
129026452|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
129026453|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
129026454|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
129026455|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
129026456|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
129026457|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
129026458|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
129115864|NCT05222880|464719879|FG000|Overall Study|Withdrew Consent during Study|1|||
129026459|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
129115865|NCT05222880|464719879|FG000|Overall Study|COVID-19 Related|1|||
129026460|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
129026461|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
129115866|NCT01814007|464719893|FG000|Overall Study|Withdrawal by Subject|1|||
129115867|NCT02357459|464721551|FG000|Overall Study|Adverse Event|0|||
129115868|NCT02357459|464721552|FG001|Overall Study|Adverse Event|1|||
129115869|NCT02357459|464721553|FG002|Overall Study|Adverse Event|1|||
129115870|NCT02357459|464721551|FG000|Overall Study|Withdrawal by Subject|5|||
129115871|NCT02357459|464721552|FG001|Overall Study|Withdrawal by Subject|3|||
129115872|NCT02357459|464721553|FG002|Overall Study|Withdrawal by Subject|3|||
129115873|NCT02357459|464721551|FG000|Overall Study|Physician Decision|0|||
129115874|NCT02357459|464721552|FG001|Overall Study|Physician Decision|2|||
129115875|NCT02357459|464721553|FG002|Overall Study|Physician Decision|0|||
129026462|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
129026463|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
129026464|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
129026465|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
129026466|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
129026467|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
129026468|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
129026469|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
129026470|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
129026471|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
129026472|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
129026473|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
129026474|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
129026475|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
129026476|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
129026477|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
129026478|NCT00073307|464389990|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
129026479|NCT00073307|464389991|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
129026480|NCT00073307|464389992|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
129026481|NCT01438060|464389993|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
129026482|NCT01438060|464389994|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
129026483|NCT01438060|464389993|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
129026484|NCT01438060|464389994|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
129026485|NCT01438060|464389993|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
129026486|NCT01438060|464389994|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
129026487|NCT01438060|464389993|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
129026488|NCT01438060|464389994|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
129026489|NCT01438060|464389993|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
129026490|NCT01438060|464389994|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
129026491|NCT01438060|464389993|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
129026492|NCT01438060|464389994|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
129026493|NCT01438060|464389993|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
129026494|NCT01438060|464389994|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
129026495|NCT01438060|464389993|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
129026496|NCT01438060|464389994|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
129026497|NCT01438060|464389993|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
129026498|NCT01438060|464389994|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
129026499|NCT01438060|464389993|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
129026500|NCT01438060|464389994|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
129026501|NCT01438060|464389993|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
129026502|NCT01438060|464389994|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
129026503|NCT01438060|464389993|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
129026504|NCT01438060|464389994|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
129026505|NCT01438060|464389993|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
129026506|NCT01438060|464389994|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
129026507|NCT01438060|464389993|FG000|On Study Beyond Week 140|Adverse Event|0|||
129026508|NCT01438060|464389994|FG001|On Study Beyond Week 140|Adverse Event|2|||
129026509|NCT01438060|464389993|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
129026510|NCT01438060|464389994|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
129026511|NCT01438060|464389993|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
129026512|NCT01438060|464389994|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
129026513|NCT01438060|464389993|FG000|On Study Beyond Week 140|Death|0|||
129026514|NCT01438060|464389994|FG001|On Study Beyond Week 140|Death|1|||
129026515|NCT01438060|464389993|FG000|On Study Beyond Week 140|Other Reason|0|||
129026516|NCT01438060|464389994|FG001|On Study Beyond Week 140|Other Reason|3|||
129026517|NCT01442376|464389996|FG000|Overall Study|Adverse Event|0|||
129115876|NCT02357459|464721551|FG000|Overall Study|Protocol Violation|1|||
129115877|NCT02357459|464721552|FG001|Overall Study|Protocol Violation|1|||
129115878|NCT02357459|464721553|FG002|Overall Study|Protocol Violation|0|||
129115879|NCT02357459|464721551|FG000|Overall Study|Lost to Follow-up|1|||
129115880|NCT02357459|464721552|FG001|Overall Study|Lost to Follow-up|3|||
129115881|NCT02357459|464721553|FG002|Overall Study|Lost to Follow-up|0|||
129115882|NCT02357459|464721551|FG000|Overall Study|Lack of Efficacy|7|||
129115883|NCT02357459|464721552|FG001|Overall Study|Lack of Efficacy|4|||
129115884|NCT02357459|464721553|FG002|Overall Study|Lack of Efficacy|4|||
129115885|NCT02357459|464721551|FG000|Overall Study|Patient Relocated|2|||
129115886|NCT02357459|464721552|FG001|Overall Study|Patient Relocated|0|||
128694324|NCT02975336|463180438|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
128694325|NCT02975336|463180439|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
128694326|NCT02975336|463180440|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
128694327|NCT02975336|463180433|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
129115887|NCT02357459|464721553|FG002|Overall Study|Patient Relocated|0|||
129115888|NCT02357459|464721551|FG000|Overall Study|Instruction from PCP|1|||
129115889|NCT02357459|464721552|FG001|Overall Study|Instruction from PCP|0|||
129115890|NCT02357459|464721553|FG002|Overall Study|Instruction from PCP|0|||
129115891|NCT02357459|464721551|FG000|Overall Study|Incarceration|0|||
129115892|NCT02357459|464721552|FG001|Overall Study|Incarceration|0|||
129115893|NCT02357459|464721553|FG002|Overall Study|Incarceration|1|||
129115894|NCT02357459|464721551|FG000|Overall Study|Pre-planned Knee surgery|0|||
129115895|NCT02357459|464721552|FG001|Overall Study|Pre-planned Knee surgery|0|||
129115896|NCT02357459|464721553|FG002|Overall Study|Pre-planned Knee surgery|2|||
129115897|NCT02357459|464721551|FG000|Overall Study|Job Commitments|0|||
129115898|NCT02357459|464721552|FG001|Overall Study|Job Commitments|0|||
129115899|NCT02357459|464721553|FG002|Overall Study|Job Commitments|1|||
129115900|NCT01548599|464721554|FG000|Overall Study|Lost to Follow-up|0|||
129115901|NCT01548599|464721555|FG001|Overall Study|Lost to Follow-up|1|||
129115902|NCT01548599|464721554|FG000|Overall Study|Withdrawal by Subject|4|||
129115903|NCT01548599|464721555|FG001|Overall Study|Withdrawal by Subject|0|||
129115904|NCT01548599|464721554|FG000|Overall Study|Death|2|||
129115905|NCT01548599|464721555|FG001|Overall Study|Death|1|||
129115906|NCT05630196|464721556|FG000|Overall Study|Adverse Event|2|||
129115907|NCT05630196|464721557|FG001|Overall Study|Adverse Event|1|||
129115908|NCT05630196|464721556|FG000|Overall Study|Lost to Follow-up|1|||
129115909|NCT05630196|464721557|FG001|Overall Study|Lost to Follow-up|1|||
129115910|NCT05630196|464721556|FG000|Overall Study|Protocol Violation|2|||
129115911|NCT05630196|464721557|FG001|Overall Study|Protocol Violation|3|||
129115912|NCT05630196|464721556|FG000|Overall Study|Physician Decision|1|||
129115913|NCT05630196|464721557|FG001|Overall Study|Physician Decision|0|||
129115914|NCT05630196|464721556|FG000|Overall Study|Withdrawal by Subject|3|||
129115915|NCT05630196|464721557|FG001|Overall Study|Withdrawal by Subject|4|||
129115916|NCT00352118|464721559|FG000|Overall Study|Physician Decision|4|||
129115917|NCT02990000|464721560|FG000|Overall Study|Failed to provide data beyond baseline|36|||
129115918|NCT02990000|464721561|FG001|Overall Study|Failed to provide data beyond baseline|34|||
129115919|NCT02308046|464721562|FG000|Overall Study|Negative yeast culture at Baseline|32|||
129115920|NCT02308046|464721563|FG001|Overall Study|Negative yeast culture at Baseline|33|||
129115921|NCT02308046|464721562|FG000|Overall Study|Positive for STD at Baseline|1|||
129115922|NCT02308046|464721563|FG001|Overall Study|Positive for STD at Baseline|2|||
129115923|NCT02308046|464721562|FG000|Overall Study|Lost to Follow-up|1|||
129115924|NCT02308046|464721563|FG001|Overall Study|Lost to Follow-up|3|||
129115925|NCT00883181|464721564|FG000|Overall Study|Hematological Adverse Event|26|||
129115926|NCT00883181|464721564|FG000|Overall Study|Non-hematological Adverse Event|55|||
129115927|NCT00883181|464721564|FG000|Overall Study|Disease Progression|94|||
129115928|NCT00883181|464721564|FG000|Overall Study|Administrative Reason|24|||
129115929|NCT00883181|464721564|FG000|Overall Study|Withdrawal by Subject|4|||
129115930|NCT00883181|464721564|FG000|Overall Study|Death|31|||
129115931|NCT00883181|464721564|FG000|Overall Study|Other|38|||
129115932|NCT00883181|464721564|FG000|Overall Study|Protocol Deviation|3|||
129115933|NCT00883181|464721564|FG000|Overall Study|Noncompliance|3|||
129115934|NCT01587885|464721567|FG000|Treatment Period 1|Failure to Return|0|||
129115935|NCT01587885|464721568|FG001|Treatment Period 1|Failure to Return|1|||
129115936|NCT01587885|464721567|FG000|Treatment Period 1|Protocol Violation|0|||
129115937|NCT01587885|464721568|FG001|Treatment Period 1|Protocol Violation|2|||
128694328|NCT02975336|463180434|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
129115938|NCT00001566|464721573|FG000|Overall Study|patients' choice to discontinue protocol|3|||
129115939|NCT00001566|464721573|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
129115940|NCT00001566|464721573|FG000|Overall Study|Death|13|||
128694329|NCT02975336|463180435|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
128694330|NCT02975336|463180436|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
129115941|NCT00001566|464721573|FG000|Overall Study|Lost to Follow-up|1|||
129115942|NCT00001566|464721573|FG000|Overall Study|unable to complete initial apheresis|1|||
129115943|NCT02914834|464721574|FG000|Overall Study|Study halted due to COVID|1|||
129115944|NCT02914834|464721575|FG001|Overall Study|Study halted due to COVID|1|||
129115945|NCT02914834|464721574|FG000|Overall Study|1 subject withdrew|0|||
128694331|NCT02975336|463180437|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
128694332|NCT02975336|463180438|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
129115946|NCT02914834|464721575|FG001|Overall Study|1 subject withdrew|1|||
129115947|NCT00975416|464721578|FG000|Overall Study|early discharge from tx|3|||
129115948|NCT00975416|464721579|FG001|Overall Study|early discharge from tx|5|||
129115949|NCT01249131|464721584|FG000|Washout Period of 10 Days|Adverse Event|0|||
129115950|NCT01249131|464721585|FG001|Washout Period of 10 Days|Adverse Event|0|||
129115951|NCT01249131|464721586|FG002|Washout Period of 10 Days|Adverse Event|0|||
129115952|NCT01249131|464721587|FG003|Washout Period of 10 Days|Adverse Event|0|||
129115953|NCT01249131|464721588|FG004|Washout Period of 10 Days|Adverse Event|1|||
129115954|NCT01249131|464721589|FG005|Washout Period of 10 Days|Adverse Event|0|||
129115955|NCT02378662|464721590|FG000|Overall Study|Early Discontinuation|2|||
129115956|NCT02378662|464721591|FG001|Overall Study|Early Discontinuation|0|||
128694333|NCT02975336|463180439|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
128694334|NCT02975336|463180440|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
128694335|NCT02975336|463180433|FG000|LTE (104 Weeks)|Other|0|||
128694336|NCT02975336|463180434|FG001|LTE (104 Weeks)|Other|0|||
128694337|NCT02975336|463180435|FG002|LTE (104 Weeks)|Other|0|||
128694338|NCT02975336|463180436|FG003|LTE (104 Weeks)|Other|0|||
128694339|NCT02975336|463180437|FG004|LTE (104 Weeks)|Other|55|||
128694340|NCT02975336|463180438|FG005|LTE (104 Weeks)|Other|63|||
129026518|NCT01442376|464389997|FG001|Overall Study|Adverse Event|3|||
129026519|NCT01442376|464389998|FG002|Overall Study|Adverse Event|2|||
129026520|NCT01442376|464389996|FG000|Overall Study|Death|0|||
129026521|NCT01442376|464389997|FG001|Overall Study|Death|1|||
129026522|NCT01442376|464389998|FG002|Overall Study|Death|1|||
129026523|NCT01442376|464389996|FG000|Overall Study|Withdrawal of consent|0|||
129026524|NCT01442376|464389997|FG001|Overall Study|Withdrawal of consent|0|||
129026525|NCT01442376|464389998|FG002|Overall Study|Withdrawal of consent|1|||
129026526|NCT01442376|464389996|FG000|Overall Study|Patients not treated|2|||
129026527|NCT01442376|464389997|FG001|Overall Study|Patients not treated|3|||
129026528|NCT01442376|464389998|FG002|Overall Study|Patients not treated|1|||
129026529|NCT01442376|464389996|FG000|Overall Study|Not eligible for subsequent cycles|1|||
129026530|NCT01442376|464389997|FG001|Overall Study|Not eligible for subsequent cycles|2|||
129026531|NCT01442376|464389998|FG002|Overall Study|Not eligible for subsequent cycles|0|||
129026532|NCT03499873|464389999|FG000|Overall Study|Withdrawal by Subject|4|||
129026533|NCT03499873|464390000|FG001|Overall Study|Withdrawal by Subject|6|||
129026534|NCT03499873|464390001|FG002|Overall Study|Withdrawal by Subject|1|||
129026535|NCT03499873|464389999|FG000|Overall Study|Subjects condition worsened|0|||
129026536|NCT03499873|464390000|FG001|Overall Study|Subjects condition worsened|3|||
129026537|NCT03499873|464390001|FG002|Overall Study|Subjects condition worsened|11|||
129026538|NCT03499873|464389999|FG000|Overall Study|Adverse Event|8|||
129026539|NCT03499873|464390000|FG001|Overall Study|Adverse Event|3|||
129026540|NCT03499873|464390001|FG002|Overall Study|Adverse Event|6|||
129026541|NCT03499873|464389999|FG000|Overall Study|Physician Decision|1|||
129026542|NCT03499873|464390000|FG001|Overall Study|Physician Decision|0|||
129026543|NCT03499873|464390001|FG002|Overall Study|Physician Decision|0|||
129026544|NCT03499873|464389999|FG000|Overall Study|Administrative reasons|0|||
129026545|NCT03499873|464390000|FG001|Overall Study|Administrative reasons|1|||
129026546|NCT03499873|464390001|FG002|Overall Study|Administrative reasons|0|||
129026547|NCT03499873|464389999|FG000|Overall Study|Concomitant therapy|5|||
129026548|NCT03499873|464390000|FG001|Overall Study|Concomitant therapy|4|||
129026549|NCT03499873|464390001|FG002|Overall Study|Concomitant therapy|7|||
129026550|NCT03499873|464389999|FG000|Overall Study|Miscellaneous|1|||
129026551|NCT03499873|464390000|FG001|Overall Study|Miscellaneous|2|||
129026552|NCT03499873|464390001|FG002|Overall Study|Miscellaneous|2|||
129026553|NCT03499873|464389999|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
129026554|NCT03499873|464390000|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
129026555|NCT03499873|464390001|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
129026556|NCT01964950|464390002|FG000|Overall Study|Protocol Violation|25|||
129026557|NCT04404725|464390003|FG000|First Intervention|Withdrawal by Subject|0|||
129026558|NCT04404725|464390004|FG001|First Intervention|Withdrawal by Subject|2|||
129026559|NCT04404725|464390003|FG000|Second Intervention|Adverse Event|1|||
129026560|NCT04404725|464390004|FG001|Second Intervention|Adverse Event|1|||
129026561|NCT04404725|464390003|FG000|Second Intervention|Withdrawal by Subject|0|||
129026562|NCT04404725|464390004|FG001|Second Intervention|Withdrawal by Subject|1|||
129026563|NCT01075516|464390005|FG000|Overall Study|Death|5|||
129026564|NCT01075516|464390006|FG001|Overall Study|Death|9|||
129026565|NCT01075516|464390005|FG000|Overall Study|Lost to Follow-up|10|||
129026566|NCT01075516|464390006|FG001|Overall Study|Lost to Follow-up|2|||
129026567|NCT01075516|464390005|FG000|Overall Study|Withdrawal by Subject|3|||
129026568|NCT01075516|464390006|FG001|Overall Study|Withdrawal by Subject|5|||
129115957|NCT01774591|464721592|FG000|Overall Study|Physician Decision|1|||
129115958|NCT01774591|464721593|FG001|Overall Study|Physician Decision|1|||
128694341|NCT02975336|463180439|FG006|LTE (104 Weeks)|Other|76|||
128694342|NCT02975336|463180440|FG007|LTE (104 Weeks)|Other|72|||
129026569|NCT02252016|464390009|FG000|Overall Study|Lost to Follow-up|2|||
129026570|NCT02252016|464390010|FG001|Overall Study|Lost to Follow-up|1|||
129026571|NCT02252016|464390009|FG000|Overall Study|Physician Decision|1|||
129026572|NCT02252016|464390010|FG001|Overall Study|Physician Decision|0|||
129026573|NCT02252016|464390009|FG000|Overall Study|Withdrawal by Subject|0|||
129026574|NCT02252016|464390010|FG001|Overall Study|Withdrawal by Subject|2|||
129026575|NCT04631562|464390015|FG000|Overall Study|Withdrawal by Subject|0|||
129026576|NCT04631562|464390016|FG001|Overall Study|Withdrawal by Subject|0|||
129026577|NCT04631562|464390017|FG002|Overall Study|Withdrawal by Subject|0|||
129026578|NCT04631562|464390018|FG003|Overall Study|Withdrawal by Subject|0|||
129026579|NCT04631562|464390019|FG004|Overall Study|Withdrawal by Subject|0|||
129026580|NCT04631562|464390020|FG005|Overall Study|Withdrawal by Subject|0|||
129026581|NCT04631562|464390021|FG006|Overall Study|Withdrawal by Subject|0|||
129026582|NCT04631562|464390022|FG007|Overall Study|Withdrawal by Subject|1|||
129026583|NCT04631562|464390023|FG008|Overall Study|Withdrawal by Subject|0|||
129026584|NCT04631562|464390015|FG000|Overall Study|Other|0|||
129026585|NCT04631562|464390016|FG001|Overall Study|Other|0|||
129026586|NCT04631562|464390017|FG002|Overall Study|Other|0|||
129026587|NCT04631562|464390018|FG003|Overall Study|Other|0|||
129026588|NCT04631562|464390019|FG004|Overall Study|Other|0|||
129026589|NCT04631562|464390020|FG005|Overall Study|Other|0|||
129026590|NCT04631562|464390021|FG006|Overall Study|Other|0|||
129026591|NCT04631562|464390022|FG007|Overall Study|Other|0|||
129026592|NCT04631562|464390023|FG008|Overall Study|Other|1|||
129026593|NCT04631562|464390015|FG000|Overall Study|Lost to Follow-up|0|||
129026594|NCT04631562|464390016|FG001|Overall Study|Lost to Follow-up|0|||
129026595|NCT04631562|464390017|FG002|Overall Study|Lost to Follow-up|0|||
129026596|NCT04631562|464390018|FG003|Overall Study|Lost to Follow-up|1|||
129026597|NCT04631562|464390019|FG004|Overall Study|Lost to Follow-up|0|||
129026598|NCT04631562|464390020|FG005|Overall Study|Lost to Follow-up|0|||
129026599|NCT04631562|464390021|FG006|Overall Study|Lost to Follow-up|0|||
129026600|NCT04631562|464390022|FG007|Overall Study|Lost to Follow-up|0|||
129026601|NCT04631562|464390023|FG008|Overall Study|Lost to Follow-up|0|||
129026602|NCT04631562|464390015|FG000|Overall Study|Adverse Event|0|||
129026603|NCT04631562|464390016|FG001|Overall Study|Adverse Event|0|||
129026604|NCT04631562|464390017|FG002|Overall Study|Adverse Event|0|||
129026605|NCT04631562|464390018|FG003|Overall Study|Adverse Event|0|||
129026606|NCT04631562|464390019|FG004|Overall Study|Adverse Event|0|||
129026607|NCT04631562|464390020|FG005|Overall Study|Adverse Event|0|||
129026608|NCT04631562|464390021|FG006|Overall Study|Adverse Event|1|||
129026609|NCT04631562|464390022|FG007|Overall Study|Adverse Event|0|||
129026610|NCT04631562|464390023|FG008|Overall Study|Adverse Event|0|||
129026611|NCT01190865|464390035|FG000|Overall Study|Withdrawal by Subject|1|||
129026612|NCT01190865|464390035|FG000|Overall Study|Non-compliance|2|||
129026613|NCT02436200|464390037|FG000|Overall Study|Significant outlier|1|||
129026614|NCT02471807|464390043|FG000|Overall Study|Death|14|||
129026615|NCT02471807|464390043|FG000|Overall Study|Withdrawal by Subject|2|||
129026616|NCT02471807|464390043|FG000|Overall Study|Explant|5|||
129026617|NCT02471807|464390043|FG000|Overall Study|Lost to Follow-up|1|||
129026618|NCT00957021|464390044|FG000|Overall Study|Death|5|||
129026619|NCT00957021|464390044|FG000|Overall Study|Lost to Follow-up|8|||
129026620|NCT00957021|464390044|FG000|Overall Study|Withdrawal by Subject|34|||
129026621|NCT00957021|464390044|FG000|Overall Study|No 2 yr ROM data|35|||
129026622|NCT00957021|464390044|FG000|Overall Study|Revised study component by 2 yr visit|8|||
129026623|NCT00957021|464390044|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
129026624|NCT00957021|464390044|FG000|Overall Study|Surgery Cancelled|9|||
129026625|NCT00957021|464390044|FG000|Overall Study|Termination due to language issue|2|||
129026626|NCT01483820|464390059|FG000|Overall Study|Lack of Efficacy|6|||
129026627|NCT01483820|464390059|FG000|Overall Study|Adverse Event|1|||
129026628|NCT01483820|464390059|FG000|Overall Study|Death|1|||
129026629|NCT00867360|464390060|FG000|Overall Study|Withdrawal by Subject|1|||
129026630|NCT00867360|464390061|FG001|Overall Study|Withdrawal by Subject|0|||
129026631|NCT00867360|464390060|FG000|Overall Study|Physician Decision|0|||
129026632|NCT00867360|464390061|FG001|Overall Study|Physician Decision|1|||
129026633|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
129026634|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
129026635|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
129026636|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
129026637|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
129026638|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026639|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026640|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026641|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026642|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
129215327|NCT00463567|465091126|FG001|Overall Study|Lack of Efficacy|9|||
129026643|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026644|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026645|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026646|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026647|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026648|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026649|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026650|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
129115959|NCT01774591|464721592|FG000|Overall Study|Withdrawal by Subject|0|||
129115960|NCT01774591|464721593|FG001|Overall Study|Withdrawal by Subject|1|||
129115961|NCT01774591|464721592|FG000|Overall Study|Adverse Event|0|||
128905505|NCT01425008|463946586|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905506|NCT01425008|463946587|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905507|NCT01425008|463946588|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905508|NCT01425008|463946589|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905509|NCT01425008|463946590|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905510|NCT01425008|463946591|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905511|NCT01425008|463946592|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905512|NCT01425008|463946593|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905513|NCT01425008|463946594|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905514|NCT01425008|463946595|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128905515|NCT01425008|463946577|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
128905516|NCT01425008|463946578|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
128905517|NCT01425008|463946579|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
128905518|NCT01425008|463946580|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
128905519|NCT01425008|463946581|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
128905520|NCT01425008|463946582|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
128905521|NCT01425008|463946583|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
128905522|NCT01425008|463946584|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
128905523|NCT01425008|463946585|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
128905524|NCT01425008|463946586|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
128905525|NCT01425008|463946587|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
128905526|NCT01425008|463946588|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
128905527|NCT01425008|463946589|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
128905528|NCT01425008|463946590|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
128905529|NCT01425008|463946591|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
128905530|NCT01425008|463946592|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
128905531|NCT01425008|463946593|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
128905532|NCT01425008|463946594|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
128905533|NCT01425008|463946595|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
128905534|NCT01425008|463946577|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905535|NCT01425008|463946578|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905536|NCT01425008|463946579|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
128905537|NCT01425008|463946580|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905538|NCT01425008|463946581|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905539|NCT01425008|463946582|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905540|NCT01425008|463946583|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905541|NCT01425008|463946584|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905542|NCT01425008|463946585|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
128905543|NCT01425008|463946586|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
128905544|NCT01425008|463946587|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905545|NCT01425008|463946588|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905546|NCT01425008|463946589|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905547|NCT01425008|463946590|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905548|NCT01425008|463946591|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905549|NCT01425008|463946592|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905550|NCT01425008|463946593|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905551|NCT01425008|463946594|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
128905552|NCT01425008|463946595|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
129026651|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026652|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026653|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026654|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026655|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026656|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026657|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
129026658|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
129115962|NCT01774591|464721593|FG001|Overall Study|Adverse Event|2|||
129115963|NCT01701245|464721594|FG000|Overall Study|Protocol Violation|1|||
128764900|NCT04296890|463430362|FG000|Overall Study|Lost to Follow-up|3|||
128764901|NCT04296890|463430362|FG000|Overall Study|Other than specified|2|||
128905553|NCT01425008|463946577|FG000|Dose Escalation Phase|Other|0|||
128905554|NCT01425008|463946578|FG001|Dose Escalation Phase|Other|0|||
128905555|NCT01425008|463946579|FG002|Dose Escalation Phase|Other|0|||
128905556|NCT01425008|463946580|FG003|Dose Escalation Phase|Other|0|||
128905557|NCT01425008|463946581|FG004|Dose Escalation Phase|Other|0|||
128905558|NCT01425008|463946582|FG005|Dose Escalation Phase|Other|0|||
128905559|NCT01425008|463946583|FG006|Dose Escalation Phase|Other|0|||
129115964|NCT01701245|464721595|FG001|Overall Study|Protocol Violation|3|||
128905560|NCT01425008|463946584|FG007|Dose Escalation Phase|Other|0|||
128905561|NCT01425008|463946585|FG008|Dose Escalation Phase|Other|1|||
128905562|NCT01425008|463946586|FG009|Dose Escalation Phase|Other|0|||
128905563|NCT01425008|463946587|FG010|Dose Escalation Phase|Other|0|||
128905564|NCT01425008|463946588|FG011|Dose Escalation Phase|Other|0|||
128905565|NCT01425008|463946589|FG012|Dose Escalation Phase|Other|0|||
128905566|NCT01425008|463946590|FG013|Dose Escalation Phase|Other|0|||
128905567|NCT01425008|463946591|FG014|Dose Escalation Phase|Other|0|||
128905568|NCT01425008|463946592|FG015|Dose Escalation Phase|Other|0|||
128905569|NCT01425008|463946593|FG016|Dose Escalation Phase|Other|0|||
128905570|NCT01425008|463946594|FG017|Dose Escalation Phase|Other|0|||
128905571|NCT01425008|463946595|FG018|Dose Escalation Phase|Other|0|||
128905572|NCT01425008|463946577|FG000|Dose Expansion Phase|Progressive Disease|0|||
128905573|NCT01425008|463946578|FG001|Dose Expansion Phase|Progressive Disease|0|||
128905574|NCT01425008|463946579|FG002|Dose Expansion Phase|Progressive Disease|0|||
128905575|NCT01425008|463946580|FG003|Dose Expansion Phase|Progressive Disease|0|||
128905576|NCT01425008|463946581|FG004|Dose Expansion Phase|Progressive Disease|0|||
128905577|NCT01425008|463946582|FG005|Dose Expansion Phase|Progressive Disease|0|||
128905578|NCT01425008|463946583|FG006|Dose Expansion Phase|Progressive Disease|0|||
128905579|NCT01425008|463946584|FG007|Dose Expansion Phase|Progressive Disease|0|||
128905580|NCT01425008|463946585|FG008|Dose Expansion Phase|Progressive Disease|0|||
128905581|NCT01425008|463946586|FG009|Dose Expansion Phase|Progressive Disease|0|||
128905582|NCT01425008|463946587|FG010|Dose Expansion Phase|Progressive Disease|10|||
128905583|NCT01425008|463946588|FG011|Dose Expansion Phase|Progressive Disease|4|||
128905584|NCT01425008|463946589|FG012|Dose Expansion Phase|Progressive Disease|12|||
128905585|NCT01425008|463946590|FG013|Dose Expansion Phase|Progressive Disease|1|||
128905586|NCT01425008|463946591|FG014|Dose Expansion Phase|Progressive Disease|5|||
128905587|NCT01425008|463946592|FG015|Dose Expansion Phase|Progressive Disease|8|||
128905588|NCT01425008|463946593|FG016|Dose Expansion Phase|Progressive Disease|9|||
128905589|NCT01425008|463946594|FG017|Dose Expansion Phase|Progressive Disease|2|||
128905590|NCT01425008|463946595|FG018|Dose Expansion Phase|Progressive Disease|10|||
128905591|NCT01425008|463946577|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
128905592|NCT01425008|463946578|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
128905593|NCT01425008|463946579|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
128905594|NCT01425008|463946580|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
128905595|NCT01425008|463946581|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
128905596|NCT01425008|463946582|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
128905597|NCT01425008|463946583|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
129026659|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026660|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
129026661|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026662|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026663|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026664|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026665|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026666|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026667|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026668|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026669|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026670|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026671|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026672|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026673|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026674|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026675|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026676|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026677|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026678|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026679|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026680|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026681|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
128764902|NCT05400746|463430363|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
128764903|NCT05400746|463430364|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
128905598|NCT01425008|463946584|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
128905599|NCT01425008|463946585|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
128905600|NCT01425008|463946586|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
128905601|NCT01425008|463946587|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
128905602|NCT01425008|463946588|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
128905603|NCT01425008|463946589|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
128905604|NCT01425008|463946590|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
129026682|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026683|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129026684|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
128905605|NCT01425008|463946591|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
128905606|NCT01425008|463946592|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
128905607|NCT01425008|463946593|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
128905608|NCT01425008|463946594|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
128905609|NCT01425008|463946595|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
128905610|NCT01425008|463946577|FG000|Dose Expansion Phase|Other|0|||
128905611|NCT01425008|463946578|FG001|Dose Expansion Phase|Other|0|||
128905612|NCT01425008|463946579|FG002|Dose Expansion Phase|Other|0|||
128905613|NCT01425008|463946580|FG003|Dose Expansion Phase|Other|0|||
128905614|NCT01425008|463946581|FG004|Dose Expansion Phase|Other|0|||
128905615|NCT01425008|463946582|FG005|Dose Expansion Phase|Other|0|||
128905616|NCT01425008|463946583|FG006|Dose Expansion Phase|Other|0|||
128905617|NCT01425008|463946584|FG007|Dose Expansion Phase|Other|0|||
128905618|NCT01425008|463946585|FG008|Dose Expansion Phase|Other|0|||
128905619|NCT01425008|463946586|FG009|Dose Expansion Phase|Other|0|||
128905620|NCT01425008|463946587|FG010|Dose Expansion Phase|Other|0|||
128905621|NCT01425008|463946588|FG011|Dose Expansion Phase|Other|0|||
128905622|NCT01425008|463946589|FG012|Dose Expansion Phase|Other|1|||
128905623|NCT01425008|463946590|FG013|Dose Expansion Phase|Other|0|||
128905624|NCT01425008|463946591|FG014|Dose Expansion Phase|Other|0|||
128905625|NCT01425008|463946592|FG015|Dose Expansion Phase|Other|0|||
128905626|NCT01425008|463946593|FG016|Dose Expansion Phase|Other|2|||
128905627|NCT01425008|463946594|FG017|Dose Expansion Phase|Other|0|||
128905628|NCT01425008|463946595|FG018|Dose Expansion Phase|Other|4|||
129026685|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026686|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
129026687|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026688|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026689|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026690|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026691|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026692|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026693|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026694|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026695|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026696|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026697|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026698|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026699|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026700|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026701|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026702|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026703|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026704|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026705|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026706|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026707|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026708|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026709|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026710|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129026711|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
129026712|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026713|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
129026714|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
129026715|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
129026716|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026717|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026718|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026719|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026720|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026721|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026722|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026723|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026724|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026725|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026726|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026727|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026728|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026729|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026730|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026731|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026732|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026733|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129115965|NCT01701245|464721594|FG000|Overall Study|Did not complete the open label period|11|||
129115966|NCT01701245|464721595|FG001|Overall Study|Did not complete the open label period|12|||
129115967|NCT01159574|464721596|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
129115968|NCT01159574|464721596|FG000|Treatment Phase|Adverse Event|3|||
129115969|NCT01159574|464721596|FG000|Treatment Phase|Death|6|||
129115970|NCT01159574|464721596|FG000|Treatment Phase|Physician Decision|2|||
129115971|NCT01159574|464721596|FG000|Treatment Phase|Withdrawal by Subject|7|||
129115972|NCT01159574|464721596|FG000|Treatment Phase|still on treatment|2|||
129115973|NCT01159574|464721596|FG000|Follow Up Phase|Lost to Follow-up|2|||
129115974|NCT01159574|464721596|FG000|Follow Up Phase|still being followed for overall surviva|18|||
129115975|NCT03555149|464721601|FG000|Overall Study|Death|18|||
129115976|NCT03555149|464721602|FG001|Overall Study|Death|15|||
129115977|NCT03555149|464721603|FG002|Overall Study|Death|15|||
129115978|NCT03555149|464721604|FG003|Overall Study|Death|4|||
129115979|NCT03555149|464721605|FG004|Overall Study|Death|4|||
129115980|NCT03555149|464721606|FG005|Overall Study|Death|11|||
129115981|NCT03555149|464721607|FG006|Overall Study|Death|12|||
129115982|NCT03555149|464721608|FG007|Overall Study|Death|1|||
129115983|NCT03555149|464721601|FG000|Overall Study|Lost to Follow-up|1|||
129115984|NCT03555149|464721602|FG001|Overall Study|Lost to Follow-up|0|||
129115985|NCT03555149|464721603|FG002|Overall Study|Lost to Follow-up|0|||
129115986|NCT03555149|464721604|FG003|Overall Study|Lost to Follow-up|0|||
129115987|NCT03555149|464721605|FG004|Overall Study|Lost to Follow-up|0|||
129115988|NCT03555149|464721606|FG005|Overall Study|Lost to Follow-up|1|||
129115989|NCT03555149|464721607|FG006|Overall Study|Lost to Follow-up|0|||
129115990|NCT03555149|464721608|FG007|Overall Study|Lost to Follow-up|0|||
129115991|NCT03555149|464721601|FG000|Overall Study|Physician Decision|1|||
129115992|NCT03555149|464721602|FG001|Overall Study|Physician Decision|0|||
129115993|NCT03555149|464721603|FG002|Overall Study|Physician Decision|0|||
129115994|NCT03555149|464721604|FG003|Overall Study|Physician Decision|0|||
129115995|NCT03555149|464721605|FG004|Overall Study|Physician Decision|0|||
129115996|NCT03555149|464721606|FG005|Overall Study|Physician Decision|0|||
129115997|NCT03555149|464721607|FG006|Overall Study|Physician Decision|0|||
129115998|NCT03555149|464721608|FG007|Overall Study|Physician Decision|0|||
129115999|NCT03555149|464721601|FG000|Overall Study|Study Terminated By Sponsor|1|||
129116000|NCT03555149|464721602|FG001|Overall Study|Study Terminated By Sponsor|0|||
129116001|NCT03555149|464721603|FG002|Overall Study|Study Terminated By Sponsor|0|||
129116002|NCT03555149|464721604|FG003|Overall Study|Study Terminated By Sponsor|0|||
129116003|NCT03555149|464721605|FG004|Overall Study|Study Terminated By Sponsor|0|||
128905629|NCT01425008|463946577|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905630|NCT01425008|463946578|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905631|NCT01425008|463946579|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905632|NCT01425008|463946580|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905633|NCT01425008|463946581|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905634|NCT01425008|463946582|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905635|NCT01425008|463946583|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
129026734|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026735|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026736|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129026737|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
129026738|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
129026739|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
129026740|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
129026741|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
129026742|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026743|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026744|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026745|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026746|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026747|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026748|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026749|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026750|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026751|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129116004|NCT03555149|464721606|FG005|Overall Study|Study Terminated By Sponsor|2|||
129116005|NCT03555149|464721607|FG006|Overall Study|Study Terminated By Sponsor|3|||
129116006|NCT03555149|464721608|FG007|Overall Study|Study Terminated By Sponsor|1|||
129116007|NCT03555149|464721601|FG000|Overall Study|Withdrawal by Subject|3|||
129116008|NCT03555149|464721602|FG001|Overall Study|Withdrawal by Subject|0|||
129116009|NCT03555149|464721603|FG002|Overall Study|Withdrawal by Subject|0|||
129116010|NCT03555149|464721604|FG003|Overall Study|Withdrawal by Subject|2|||
129116011|NCT03555149|464721605|FG004|Overall Study|Withdrawal by Subject|0|||
129116012|NCT03555149|464721606|FG005|Overall Study|Withdrawal by Subject|1|||
128694343|NCT01816074|463180442|FG000|Phase 1|Time commitment issues|0|||
128905636|NCT01425008|463946584|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905637|NCT01425008|463946585|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905638|NCT01425008|463946586|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905639|NCT01425008|463946587|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
128905640|NCT01425008|463946588|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
128905641|NCT01425008|463946589|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905642|NCT01425008|463946590|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905643|NCT01425008|463946591|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905644|NCT01425008|463946592|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
128905645|NCT01425008|463946593|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
128905646|NCT01425008|463946594|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
128905647|NCT01425008|463946595|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
128905648|NCT01425008|463946577|FG000|Dose Expansion Phase|Adverse Event|0|||
128905649|NCT01425008|463946578|FG001|Dose Expansion Phase|Adverse Event|0|||
128905650|NCT01425008|463946579|FG002|Dose Expansion Phase|Adverse Event|0|||
128905651|NCT01425008|463946580|FG003|Dose Expansion Phase|Adverse Event|0|||
128905652|NCT01425008|463946581|FG004|Dose Expansion Phase|Adverse Event|0|||
128905653|NCT01425008|463946582|FG005|Dose Expansion Phase|Adverse Event|0|||
128905654|NCT01425008|463946583|FG006|Dose Expansion Phase|Adverse Event|0|||
128905655|NCT01425008|463946584|FG007|Dose Expansion Phase|Adverse Event|0|||
128905656|NCT01425008|463946585|FG008|Dose Expansion Phase|Adverse Event|0|||
128905657|NCT01425008|463946586|FG009|Dose Expansion Phase|Adverse Event|0|||
128905658|NCT01425008|463946587|FG010|Dose Expansion Phase|Adverse Event|2|||
128905659|NCT01425008|463946588|FG011|Dose Expansion Phase|Adverse Event|3|||
128905660|NCT01425008|463946589|FG012|Dose Expansion Phase|Adverse Event|3|||
128905661|NCT01425008|463946590|FG013|Dose Expansion Phase|Adverse Event|0|||
128905662|NCT01425008|463946591|FG014|Dose Expansion Phase|Adverse Event|1|||
128905663|NCT01425008|463946592|FG015|Dose Expansion Phase|Adverse Event|1|||
128905664|NCT01425008|463946593|FG016|Dose Expansion Phase|Adverse Event|5|||
128905665|NCT01425008|463946594|FG017|Dose Expansion Phase|Adverse Event|0|||
128905666|NCT01425008|463946595|FG018|Dose Expansion Phase|Adverse Event|3|||
128905667|NCT01425008|463946577|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
128905668|NCT01425008|463946578|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
128905669|NCT01425008|463946579|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
128905670|NCT01425008|463946580|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
128905671|NCT01425008|463946581|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
128905672|NCT01425008|463946582|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
128905673|NCT01425008|463946583|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
128905674|NCT01425008|463946584|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
128905675|NCT01425008|463946585|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
128905676|NCT01425008|463946586|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
128905677|NCT01425008|463946587|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
128905678|NCT01425008|463946588|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
128905679|NCT01425008|463946589|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
128905680|NCT01425008|463946590|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
128905681|NCT01425008|463946591|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
128905682|NCT01425008|463946592|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
128905683|NCT01425008|463946593|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
128905684|NCT01425008|463946594|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
128905685|NCT01425008|463946595|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
128694344|NCT01816074|463180443|FG001|Phase 1|Time commitment issues|0|||
128694345|NCT01816074|463180444|FG002|Phase 1|Time commitment issues|1|||
128905686|NCT01425008|463946577|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905687|NCT01425008|463946578|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905688|NCT01425008|463946579|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905689|NCT01425008|463946580|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905690|NCT01425008|463946581|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905691|NCT01425008|463946582|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905692|NCT01425008|463946583|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905693|NCT01425008|463946584|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905694|NCT01425008|463946585|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905695|NCT01425008|463946586|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905696|NCT01425008|463946587|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905697|NCT01425008|463946588|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905698|NCT01425008|463946589|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905699|NCT01425008|463946590|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905700|NCT01425008|463946591|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905701|NCT01425008|463946592|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905702|NCT01425008|463946593|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905703|NCT01425008|463946594|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128905704|NCT01425008|463946595|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
128694346|NCT01816074|463180445|FG003|Phase 1|Time commitment issues|0|||
129026752|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026753|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026754|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026755|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026756|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026757|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026758|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026759|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026760|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026761|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026762|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129026763|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|moved|0|||
129026764|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|moved|1|||
129026765|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|moved|1|||
129026766|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|moved|0|||
129026767|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|moved|0|||
129026768|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|moved|0|||
129026769|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|moved|0|||
129026770|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|moved|0|||
129026771|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|moved|0|||
129026772|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|moved|0|||
129026773|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|moved|0|||
129026774|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|moved|0|||
129026775|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|moved|0|||
129026776|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|moved|0|||
129026777|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|moved|0|||
129026778|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|moved|0|||
129026779|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|moved|0|||
129026780|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|moved|0|||
129026781|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|moved|0|||
129026782|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|moved|0|||
129026783|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|moved|0|||
129026784|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|moved|0|||
129026785|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|moved|0|||
129026786|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|moved|0|||
129026787|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|moved|0|||
129026788|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|moved|0|||
129026789|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026790|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026791|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026792|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
129026793|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026794|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026795|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026796|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026797|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026798|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026799|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026800|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026801|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026802|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026803|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026804|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026805|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026806|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026807|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026808|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026809|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026810|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026811|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026812|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
128694347|NCT01816074|463180442|FG000|Phase 2|Time commitment Issues|0|||
128694348|NCT01816074|463180443|FG001|Phase 2|Time commitment Issues|2|||
128694349|NCT01816074|463180444|FG002|Phase 2|Time commitment Issues|0|||
128694350|NCT01816074|463180445|FG003|Phase 2|Time commitment Issues|0|||
128694351|NCT01816074|463180442|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
128905705|NCT00805480|463946598|FG000|Overall Study|Withdrawal by Subject|13|||
128905706|NCT00805480|463946599|FG001|Overall Study|Withdrawal by Subject|5|||
128905707|NCT00805480|463946600|FG002|Overall Study|Withdrawal by Subject|11|||
128905708|NCT00805480|463946601|FG003|Overall Study|Withdrawal by Subject|5|||
128905709|NCT00805480|463946598|FG000|Overall Study|Lost to Follow-up|1|||
128905710|NCT00805480|463946599|FG001|Overall Study|Lost to Follow-up|2|||
128905711|NCT00805480|463946600|FG002|Overall Study|Lost to Follow-up|0|||
128905712|NCT00805480|463946601|FG003|Overall Study|Lost to Follow-up|0|||
128905713|NCT00805480|463946598|FG000|Overall Study|Adverse Event|0|||
128905714|NCT00805480|463946599|FG001|Overall Study|Adverse Event|0|||
128905715|NCT00805480|463946600|FG002|Overall Study|Adverse Event|1|||
128905716|NCT00805480|463946601|FG003|Overall Study|Adverse Event|0|||
128905717|NCT00562588|463946602|FG000|Overall Study|Adverse Event|40|||
128905718|NCT00562588|463946603|FG001|Overall Study|Adverse Event|58|||
128905719|NCT00562588|463946602|FG000|Overall Study|Protocol Violation|30|||
128905720|NCT00562588|463946603|FG001|Overall Study|Protocol Violation|26|||
128905721|NCT00562588|463946602|FG000|Overall Study|Lost to Follow-up|12|||
128905722|NCT00562588|463946603|FG001|Overall Study|Lost to Follow-up|4|||
128905723|NCT00562588|463946602|FG000|Overall Study|Withdrawal by Subject|10|||
128905724|NCT00562588|463946603|FG001|Overall Study|Withdrawal by Subject|9|||
128905725|NCT00562588|463946602|FG000|Overall Study|Other|0|||
128905726|NCT00562588|463946603|FG001|Overall Study|Other|2|||
128905727|NCT03315871|463946607|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
128905728|NCT03315871|463946608|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
128905729|NCT03315871|463946609|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
128905730|NCT03315871|463946607|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
129026813|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026814|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129026815|NCT00112437|464390065|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026816|NCT00112437|464390066|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026817|NCT00112437|464390067|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
128905731|NCT03315871|463946608|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
128905732|NCT03315871|463946609|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
128905733|NCT03315871|463946607|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
128905734|NCT03315871|463946608|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
128905735|NCT03315871|463946609|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
128905736|NCT03315871|463946607|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
128977957|NCT02850276|464205269|FG000|Overall Study|Withdrawal by Subject|14|||
128977958|NCT02850276|464205269|FG000|Overall Study|Physician Decision|2|||
128977959|NCT02850276|464205269|FG000|Overall Study|Lost to Follow-up|2|||
128977960|NCT01454531|464205272|FG000|Overall Study|Adverse Event|14|||
128977961|NCT01454531|464205272|FG000|Overall Study|Withdrawal by Subject|5|||
128977962|NCT01454531|464205272|FG000|Overall Study|Lost to Follow-up|1|||
128977963|NCT01454531|464205272|FG000|Overall Study|Physician Decision|1|||
128977964|NCT01454531|464205272|FG000|Overall Study|Delay in IMP administration|1|||
128977965|NCT01454531|464205272|FG000|Overall Study|Other|1|||
128977966|NCT02504424|464205277|FG000|Overall Study|Withdrawal by Subject|2|||
128977967|NCT00440232|464205278|FG000|Overall Study|Lost to Follow-up|1|||
128977968|NCT00440232|464205279|FG001|Overall Study|Lost to Follow-up|1|||
128977969|NCT00440232|464205278|FG000|Overall Study|Unable to treat within allowed time|0|||
128977970|NCT00440232|464205279|FG001|Overall Study|Unable to treat within allowed time|1|||
128977971|NCT00440232|464205278|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
128977972|NCT00440232|464205279|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
128977973|NCT00819052|464205280|FG000|Overall Study|Adverse Event|0|||
128977974|NCT00819052|464205281|FG001|Overall Study|Adverse Event|5|||
128977975|NCT00819052|464205280|FG000|Overall Study|Protocol Violation|1|||
128977976|NCT00819052|464205281|FG001|Overall Study|Protocol Violation|2|||
128977977|NCT00819052|464205280|FG000|Overall Study|Lost to Follow-up|1|||
128977978|NCT00819052|464205281|FG001|Overall Study|Lost to Follow-up|2|||
128977979|NCT00819052|464205280|FG000|Overall Study|Withdrawal by Subject|1|||
128977980|NCT00819052|464205281|FG001|Overall Study|Withdrawal by Subject|2|||
128977981|NCT00819052|464205280|FG000|Overall Study|Lack of Efficacy|1|||
128977982|NCT00819052|464205281|FG001|Overall Study|Lack of Efficacy|1|||
128977983|NCT00819052|464205280|FG000|Overall Study|Pregnancy|1|||
128977984|NCT00819052|464205281|FG001|Overall Study|Pregnancy|2|||
128977985|NCT00819052|464205280|FG000|Overall Study|Death or events leading to death|1|||
128977986|NCT00819052|464205281|FG001|Overall Study|Death or events leading to death|0|||
128977987|NCT00426842|464205282|FG000|Overall Study|Lost to Follow-up|1|||
128977988|NCT00362297|464205283|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
128977989|NCT00362297|464205284|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
128977990|NCT01277666|464205289|FG000|Overall Study|Adverse Event|26|||
128977991|NCT01277666|464205290|FG001|Overall Study|Adverse Event|25|||
128977992|NCT01277666|464205291|FG002|Overall Study|Adverse Event|20|||
128977993|NCT01277666|464205289|FG000|Overall Study|Lack of Efficacy|8|||
128905737|NCT03315871|463946608|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
128905738|NCT03315871|463946609|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
128905739|NCT03315871|463946607|FG000|PROSTVAC + CV301|Progressive disease|0|||
128905740|NCT03315871|463946608|FG001|PROSTVAC + CV301|Progressive disease|0|||
128905741|NCT03315871|463946609|FG002|PROSTVAC + CV301|Progressive disease|1|||
128905742|NCT03315871|463946607|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
128905743|NCT03315871|463946608|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
128905744|NCT03315871|463946609|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
128905745|NCT00880893|463948537|FG000|Overall Study|Protocol Violation|13|||
128905746|NCT00880893|463948538|FG001|Overall Study|Protocol Violation|1|||
128905747|NCT00880893|463948537|FG000|Overall Study|Withdrawal by Subject|15|||
128905748|NCT00880893|463948538|FG001|Overall Study|Withdrawal by Subject|11|||
128905749|NCT00880893|463948537|FG000|Overall Study|Lost to Follow-up|76|||
128905750|NCT00880893|463948538|FG001|Overall Study|Lost to Follow-up|33|||
128905751|NCT00880893|463948537|FG000|Overall Study|Serious adverse event|3|||
128905752|NCT00880893|463948538|FG001|Overall Study|Serious adverse event|0|||
128905753|NCT01623271|463948543|FG000|Overall Study|Withdrawal by Subject|2|||
128905754|NCT00488982|463948548|FG000|Course 1|Physician Decision|0|||
128905755|NCT00488982|463948549|FG001|Course 1|Physician Decision|2|||
128905756|NCT00488982|463948550|FG002|Course 1|Physician Decision|4|||
128905757|NCT00488982|463948548|FG000|Course 1|Withdrawal by Subject|0|||
128905758|NCT00488982|463948549|FG001|Course 1|Withdrawal by Subject|8|||
128905759|NCT00488982|463948550|FG002|Course 1|Withdrawal by Subject|2|||
128905760|NCT00488982|463948548|FG000|Course 1|nonprotocol therapy|0|||
128905761|NCT00488982|463948549|FG001|Course 1|nonprotocol therapy|2|||
128905762|NCT00488982|463948550|FG002|Course 1|nonprotocol therapy|2|||
128905763|NCT00488982|463948548|FG000|Course 1|Adverse Event|0|||
128905764|NCT00488982|463948549|FG001|Course 1|Adverse Event|0|||
128905765|NCT00488982|463948550|FG002|Course 1|Adverse Event|6|||
128905766|NCT03548558|463948551|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
128905767|NCT03548558|463948552|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
128905768|NCT03548558|463948553|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
128905769|NCT03548558|463948554|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
128905770|NCT03548558|463948555|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
128905771|NCT03548558|463948556|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
128905772|NCT03548558|463948557|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
128905773|NCT03548558|463948551|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
128905774|NCT03548558|463948552|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
128905775|NCT03548558|463948553|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
128905776|NCT03548558|463948554|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
128905777|NCT03548558|463948555|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
128905778|NCT03548558|463948556|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
128905779|NCT03548558|463948557|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
128905780|NCT03548558|463948551|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
128905781|NCT03548558|463948552|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
128905782|NCT03548558|463948553|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
128905783|NCT03548558|463948554|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
128905784|NCT03548558|463948555|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
128905785|NCT03548558|463948556|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
128905786|NCT03548558|463948557|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
128905787|NCT03548558|463948551|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
128905788|NCT03548558|463948552|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
128905789|NCT03548558|463948553|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
128905790|NCT03548558|463948554|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
128905791|NCT03548558|463948555|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
128905792|NCT03548558|463948556|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
128905793|NCT03548558|463948557|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
128905794|NCT03548558|463948551|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
128905795|NCT03548558|463948552|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
128905796|NCT03548558|463948553|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
128905797|NCT03548558|463948554|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
128905798|NCT03548558|463948555|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
128905799|NCT03548558|463948556|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
128905800|NCT03548558|463948557|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
128905801|NCT03548558|463948551|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
128905802|NCT03548558|463948552|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
128905803|NCT03548558|463948553|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
128905804|NCT03548558|463948554|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
128977994|NCT01277666|464205290|FG001|Overall Study|Lack of Efficacy|20|||
128905805|NCT03548558|463948555|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
128905806|NCT03548558|463948556|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
128905807|NCT03548558|463948557|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
128905808|NCT03273166|463948565|FG000|Overall Study|Withdrawn prior to Completion|31|||
128905809|NCT02669017|463948566|FG000|Overall Study|Death|1|||
128905810|NCT02669017|463948567|FG001|Overall Study|Death|2|||
128905811|NCT02669017|463948568|FG002|Overall Study|Death|2|||
128905812|NCT02669017|463948569|FG003|Overall Study|Death|3|||
128905813|NCT02669017|463948570|FG004|Overall Study|Death|8|||
128905814|NCT02669017|463948571|FG005|Overall Study|Death|18|||
128905815|NCT02669017|463948572|FG006|Overall Study|Death|10|||
128905816|NCT02669017|463948573|FG007|Overall Study|Death|47|||
128905817|NCT02669017|463948574|FG008|Overall Study|Death|20|||
128905818|NCT02669017|463948566|FG000|Overall Study|Withdrawal by Subject|0|||
128905819|NCT02669017|463948567|FG001|Overall Study|Withdrawal by Subject|0|||
128905820|NCT02669017|463948568|FG002|Overall Study|Withdrawal by Subject|0|||
128905821|NCT02669017|463948569|FG003|Overall Study|Withdrawal by Subject|1|||
128905822|NCT02669017|463948570|FG004|Overall Study|Withdrawal by Subject|2|||
128905823|NCT02669017|463948571|FG005|Overall Study|Withdrawal by Subject|0|||
128905824|NCT02669017|463948572|FG006|Overall Study|Withdrawal by Subject|0|||
128905825|NCT02669017|463948573|FG007|Overall Study|Withdrawal by Subject|2|||
128905826|NCT02669017|463948574|FG008|Overall Study|Withdrawal by Subject|2|||
128905827|NCT02669017|463948566|FG000|Overall Study|Lost to Follow-up|0|||
128905828|NCT02669017|463948567|FG001|Overall Study|Lost to Follow-up|0|||
128905829|NCT02669017|463948568|FG002|Overall Study|Lost to Follow-up|0|||
128905830|NCT02669017|463948569|FG003|Overall Study|Lost to Follow-up|0|||
128905831|NCT02669017|463948570|FG004|Overall Study|Lost to Follow-up|0|||
128905832|NCT02669017|463948571|FG005|Overall Study|Lost to Follow-up|0|||
128905833|NCT02669017|463948572|FG006|Overall Study|Lost to Follow-up|0|||
128905834|NCT02669017|463948573|FG007|Overall Study|Lost to Follow-up|0|||
128905835|NCT02669017|463948574|FG008|Overall Study|Lost to Follow-up|1|||
128905836|NCT02669017|463948566|FG000|Overall Study|Miscellaneous|0|||
128905837|NCT02669017|463948567|FG001|Overall Study|Miscellaneous|0|||
128905838|NCT02669017|463948568|FG002|Overall Study|Miscellaneous|0|||
128905839|NCT02669017|463948569|FG003|Overall Study|Miscellaneous|0|||
128905840|NCT02669017|463948570|FG004|Overall Study|Miscellaneous|2|||
128905841|NCT02669017|463948571|FG005|Overall Study|Miscellaneous|1|||
128905842|NCT02669017|463948572|FG006|Overall Study|Miscellaneous|1|||
128905843|NCT02669017|463948573|FG007|Overall Study|Miscellaneous|13|||
128905844|NCT02669017|463948574|FG008|Overall Study|Miscellaneous|2|||
128905845|NCT01289015|463948575|FG000|Overall Study|Protocol Violation|12|||
128905846|NCT01289015|463948576|FG001|Overall Study|Protocol Violation|9|||
128905847|NCT01289015|463948575|FG000|Overall Study|Adverse Event|3|||
128905848|NCT01289015|463948576|FG001|Overall Study|Adverse Event|0|||
128905849|NCT01289015|463948575|FG000|Overall Study|Lost to Follow-up|33|||
128905850|NCT01289015|463948576|FG001|Overall Study|Lost to Follow-up|17|||
128905851|NCT01289015|463948575|FG000|Overall Study|Withdrawal by Subject|17|||
128905852|NCT01289015|463948576|FG001|Overall Study|Withdrawal by Subject|8|||
128905853|NCT01289015|463948575|FG000|Overall Study|Disease progression|1|||
128905854|NCT01289015|463948576|FG001|Overall Study|Disease progression|0|||
129116013|NCT03555149|464721607|FG006|Overall Study|Withdrawal by Subject|0|||
128905855|NCT01289015|463948575|FG000|Overall Study|Negative baseline culture and others|33|||
128905856|NCT01289015|463948576|FG001|Overall Study|Negative baseline culture and others|20|||
129026818|NCT00112437|464390068|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026819|NCT00112437|464390069|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
129026820|NCT00112437|464390070|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026821|NCT00112437|464390071|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026822|NCT00112437|464390072|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026823|NCT00112437|464390073|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026824|NCT00112437|464390074|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026825|NCT00112437|464390075|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026826|NCT00112437|464390076|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026827|NCT00112437|464390077|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026828|NCT00112437|464390078|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026829|NCT00112437|464390079|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026830|NCT00112437|464390080|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026831|NCT00112437|464390081|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026832|NCT00112437|464390082|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129116014|NCT03555149|464721608|FG007|Overall Study|Withdrawal by Subject|0|||
128905857|NCT03509350|463948582|FG000|Overall Study|Withdrawal by Subject|0|||
128905858|NCT03509350|463948583|FG001|Overall Study|Withdrawal by Subject|2|||
128905859|NCT01425203|463948586|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
128905860|NCT01425203|463948587|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
128905861|NCT01425203|463948588|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
128905862|NCT01425203|463948586|FG000|Treatment Phase|Failure at futility timepoint|8|||
128905863|NCT01425203|463948587|FG001|Treatment Phase|Failure at futility timepoint|27|||
128905864|NCT01425203|463948588|FG002|Treatment Phase|Failure at futility timepoint|0|||
128905865|NCT01425203|463948586|FG000|Treatment Phase|Other virologic failure criteria|5|||
128905866|NCT01425203|463948587|FG001|Treatment Phase|Other virologic failure criteria|3|||
128905867|NCT01425203|463948588|FG002|Treatment Phase|Other virologic failure criteria|0|||
128905868|NCT01425203|463948586|FG000|Treatment Phase|Unidentified reasons|11|||
128905869|NCT01425203|463948587|FG001|Treatment Phase|Unidentified reasons|5|||
128905870|NCT01425203|463948588|FG002|Treatment Phase|Unidentified reasons|0|||
128905871|NCT01425203|463948586|FG000|Treatment Phase|Did not receive treatment|0|||
128905872|NCT01425203|463948587|FG001|Treatment Phase|Did not receive treatment|1|||
128905873|NCT01425203|463948588|FG002|Treatment Phase|Did not receive treatment|0|||
128905874|NCT01425203|463948586|FG000|Crossover Phase|Failure at futility timepoint|0|||
128905875|NCT01425203|463948587|FG001|Crossover Phase|Failure at futility timepoint|0|||
128905876|NCT01425203|463948588|FG002|Crossover Phase|Failure at futility timepoint|3|||
128905877|NCT01425203|463948586|FG000|Crossover Phase|Other virologic failure criteria|0|||
128905878|NCT01425203|463948587|FG001|Crossover Phase|Other virologic failure criteria|0|||
128905879|NCT01425203|463948588|FG002|Crossover Phase|Other virologic failure criteria|3|||
128905880|NCT00535132|463948589|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
128905881|NCT00535132|463948590|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
128905882|NCT00535132|463948589|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
128905883|NCT00535132|463948590|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
128905884|NCT02590588|463948591|FG000|Overall Study|Adverse Event|1|||
128905885|NCT01827670|463948596|FG000|Overall Study|Withdrawal of Consent|3|||
128905886|NCT01827670|463948597|FG001|Overall Study|Withdrawal of Consent|2|||
128905887|NCT01827670|463948596|FG000|Overall Study|Lost to Follow-up|0|||
128905888|NCT01827670|463948597|FG001|Overall Study|Lost to Follow-up|1|||
129116015|NCT02666222|464721610|FG000|Overall Study|Death|2|||
128694352|NCT01816074|463180443|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
128694353|NCT01816074|463180444|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
128694354|NCT01816074|463180445|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
128694355|NCT01816074|463180442|FG000|Phase 2|Physician Decision|0|||
128694356|NCT01816074|463180443|FG001|Phase 2|Physician Decision|0|||
128694357|NCT01816074|463180444|FG002|Phase 2|Physician Decision|0|||
128694358|NCT01816074|463180445|FG003|Phase 2|Physician Decision|1|||
128694359|NCT01816074|463180442|FG000|Phase 2|Withdrawal by Subject|1|||
128694360|NCT01816074|463180443|FG001|Phase 2|Withdrawal by Subject|0|||
129116016|NCT01474486|464721612|FG000|Overall Study|Death|2|||
129116017|NCT01474486|464721612|FG000|Overall Study|Withdrawal by Subject|4|||
129116018|NCT01474486|464721612|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
129116019|NCT03504917|464721616|FG000|Blinded Treatment Period|Protocol Violation|1|||
129116020|NCT03504917|464721617|FG001|Blinded Treatment Period|Protocol Violation|0|||
129116021|NCT03504917|464721616|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
129116022|NCT03504917|464721617|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
129116023|NCT03504917|464721616|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
129116024|NCT03504917|464721617|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
129116025|NCT03504917|464721616|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
129116026|NCT03504917|464721617|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
129116027|NCT03504917|464721616|FG000|Blinded Treatment Period|Adverse Event|4|||
129116028|NCT03504917|464721617|FG001|Blinded Treatment Period|Adverse Event|4|||
128694361|NCT01816074|463180444|FG002|Phase 2|Withdrawal by Subject|0|||
128694362|NCT01816074|463180445|FG003|Phase 2|Withdrawal by Subject|0|||
128694363|NCT00691301|463180446|FG000|Overall Study|Adverse Event|10|||
128694364|NCT00691301|463180446|FG000|Overall Study|Death|2|||
128694365|NCT00691301|463180446|FG000|Overall Study|Lack of Efficacy|32|||
128694366|NCT00691301|463180446|FG000|Overall Study|Withdrawal by Subject|4|||
128694367|NCT00691301|463180446|FG000|Overall Study|Concurrent illness|2|||
128694368|NCT00691301|463180446|FG000|Overall Study|other reason|3|||
128694369|NCT00691301|463180446|FG000|Overall Study|Did not initiate study treatment|1|||
128694370|NCT01823146|463180447|FG000|Overall Study|Withdrawal by Subject|0|||
128694371|NCT01823146|463180448|FG001|Overall Study|Withdrawal by Subject|1|||
128694372|NCT01823146|463180447|FG000|Overall Study|Lost to Follow-up|2|||
128694373|NCT01823146|463180448|FG001|Overall Study|Lost to Follow-up|1|||
128694374|NCT00463580|463180449|FG000|Overall Study|Lost to Follow-up|1|||
128694375|NCT00463580|463180450|FG001|Overall Study|Lost to Follow-up|0|||
129116029|NCT03504917|464721616|FG000|Blinded Treatment Period|Physician Decision|1|||
129116030|NCT03504917|464721617|FG001|Blinded Treatment Period|Physician Decision|0|||
128694376|NCT00463580|463180449|FG000|Overall Study|Schedule conflict|2|||
128694377|NCT00463580|463180450|FG001|Overall Study|Schedule conflict|0|||
128694378|NCT00463580|463180449|FG000|Overall Study|Medical/psychiatric complications|0|||
128905889|NCT02941627|463948598|FG000|Overall Study|Death|1|||
128905890|NCT02941627|463948598|FG000|Overall Study|Surgical failure|1|||
128905891|NCT02941627|463948598|FG000|Overall Study|cholesteatoma prevented implantation|1|||
128905892|NCT03594227|463948599|FG000|Overall Study|Adverse Event|2|||
128694379|NCT00463580|463180450|FG001|Overall Study|Medical/psychiatric complications|2|||
128694380|NCT03917459|463180451|FG000|Overall Study|Adverse Event|1|||
128694381|NCT03917459|463180452|FG001|Overall Study|Adverse Event|0|||
128694382|NCT03917459|463180451|FG000|Overall Study|Withdrawal by Subject|0|||
128694383|NCT03917459|463180452|FG001|Overall Study|Withdrawal by Subject|1|||
128694384|NCT00491764|463180453|FG000|Overall Study|Adverse Event|1|||
128694385|NCT00491764|463180454|FG001|Overall Study|Adverse Event|2|||
128694386|NCT00491764|463180455|FG002|Overall Study|Adverse Event|4|||
128694387|NCT00491764|463180456|FG003|Overall Study|Adverse Event|4|||
128694388|NCT00491764|463180457|FG004|Overall Study|Adverse Event|0|||
128694389|NCT00491764|463180458|FG005|Overall Study|Adverse Event|1|||
128694390|NCT00491764|463180453|FG000|Overall Study|Lost to Follow-up|0|||
128694391|NCT00491764|463180454|FG001|Overall Study|Lost to Follow-up|1|||
128694392|NCT00491764|463180455|FG002|Overall Study|Lost to Follow-up|0|||
128694393|NCT00491764|463180456|FG003|Overall Study|Lost to Follow-up|1|||
128694394|NCT00491764|463180457|FG004|Overall Study|Lost to Follow-up|0|||
128694395|NCT00491764|463180458|FG005|Overall Study|Lost to Follow-up|3|||
128694396|NCT00491764|463180453|FG000|Overall Study|Withdrawal by Subject|2|||
128694397|NCT00491764|463180454|FG001|Overall Study|Withdrawal by Subject|3|||
128694398|NCT00491764|463180455|FG002|Overall Study|Withdrawal by Subject|1|||
128694399|NCT00491764|463180456|FG003|Overall Study|Withdrawal by Subject|2|||
128694400|NCT00491764|463180457|FG004|Overall Study|Withdrawal by Subject|2|||
128694401|NCT00491764|463180458|FG005|Overall Study|Withdrawal by Subject|4|||
128694402|NCT00491764|463180453|FG000|Overall Study|Non Compliance with the Protocol|1|||
128694403|NCT00491764|463180454|FG001|Overall Study|Non Compliance with the Protocol|0|||
129116031|NCT03504917|464721616|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
129116032|NCT03504917|464721617|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
129116033|NCT03504917|464721616|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
129116034|NCT03504917|464721617|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
129116035|NCT03504917|464721616|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
129116036|NCT03504917|464721617|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
129116037|NCT03504917|464721616|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
129116038|NCT03504917|464721617|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
129116039|NCT03504917|464721616|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
129116040|NCT03504917|464721617|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
129116041|NCT03504917|464721616|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
129116042|NCT03504917|464721617|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
129116043|NCT03504917|464721616|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
129116044|NCT03504917|464721617|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
129116045|NCT03504917|464721616|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
129116046|NCT03504917|464721617|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
129116047|NCT03504917|464721616|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
129116048|NCT03504917|464721617|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
129116049|NCT03504917|464721616|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
129116050|NCT03504917|464721617|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
129116051|NCT04219189|464721618|FG000|Overall Study|Withdrawal by Subject|1|||
129215328|NCT00463567|465091127|FG002|Overall Study|Lack of Efficacy|9|||
128694404|NCT00491764|463180455|FG002|Overall Study|Non Compliance with the Protocol|0|||
128694405|NCT00491764|463180456|FG003|Overall Study|Non Compliance with the Protocol|0|||
128694406|NCT00491764|463180457|FG004|Overall Study|Non Compliance with the Protocol|0|||
128694407|NCT00491764|463180458|FG005|Overall Study|Non Compliance with the Protocol|0|||
128694408|NCT00491764|463180453|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
128694409|NCT00491764|463180454|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
128694410|NCT00491764|463180455|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
128694411|NCT00491764|463180456|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
128694412|NCT00491764|463180457|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
128694413|NCT00491764|463180458|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
128694414|NCT00491764|463180453|FG000|Overall Study|Administrative|1|||
128694415|NCT00491764|463180454|FG001|Overall Study|Administrative|0|||
128694416|NCT00491764|463180455|FG002|Overall Study|Administrative|2|||
128694417|NCT00491764|463180456|FG003|Overall Study|Administrative|1|||
128694418|NCT00491764|463180457|FG004|Overall Study|Administrative|0|||
128694419|NCT00491764|463180458|FG005|Overall Study|Administrative|0|||
128905893|NCT03594227|463948600|FG001|Overall Study|Adverse Event|1|||
128694420|NCT05224141|463180460|FG000|Overall Study|Ongoing|75|||
128694421|NCT05224141|463180461|FG001|Overall Study|Ongoing|88|||
128694422|NCT05224141|463180460|FG000|Overall Study|Withdrawal by Subject|2|||
128694423|NCT05224141|463180461|FG001|Overall Study|Withdrawal by Subject|4|||
128694424|NCT05224141|463180460|FG000|Overall Study|Death|153|||
128694425|NCT05224141|463180461|FG001|Overall Study|Death|138|||
128694426|NCT03469934|463180465|FG000|Overall Study|Withdrawal by Subject|0|||
128694427|NCT03469934|463180466|FG001|Overall Study|Withdrawal by Subject|1|||
128694428|NCT04889222|463180470|FG000|Overall Study|Did not meet eligibility criteria|8|||
128694429|NCT04889222|463180470|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
128694430|NCT04889222|463180470|FG000|Overall Study|Did not proceed due to time constraints|5|||
128694431|NCT01180647|463180471|FG000|Overall Study|Lost to Follow-up|5|||
128694432|NCT01180647|463180472|FG001|Overall Study|Lost to Follow-up|6|||
128694433|NCT02639546|463180477|FG000|Overall Study|Death|2|||
128694434|NCT02639546|463180478|FG001|Overall Study|Death|2|||
128694435|NCT02639546|463180479|FG002|Overall Study|Death|1|||
128694436|NCT02639546|463180480|FG003|Overall Study|Death|2|||
128694437|NCT02639546|463180481|FG004|Overall Study|Death|2|||
128694438|NCT02639546|463180482|FG005|Overall Study|Death|2|||
128694439|NCT02639546|463180483|FG006|Overall Study|Death|0|||
128694440|NCT02639546|463180484|FG007|Overall Study|Death|0|||
128694441|NCT02639546|463180477|FG000|Overall Study|Lost to Follow-up|0|||
128694442|NCT02639546|463180478|FG001|Overall Study|Lost to Follow-up|0|||
128694443|NCT02639546|463180479|FG002|Overall Study|Lost to Follow-up|1|||
128694444|NCT02639546|463180480|FG003|Overall Study|Lost to Follow-up|0|||
128694445|NCT02639546|463180481|FG004|Overall Study|Lost to Follow-up|1|||
128694446|NCT02639546|463180482|FG005|Overall Study|Lost to Follow-up|1|||
128694447|NCT02639546|463180483|FG006|Overall Study|Lost to Follow-up|0|||
128694448|NCT02639546|463180484|FG007|Overall Study|Lost to Follow-up|1|||
128694449|NCT02639546|463180477|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
128694450|NCT02639546|463180478|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
128694451|NCT02639546|463180479|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
128694452|NCT02639546|463180480|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
128694453|NCT02639546|463180481|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
128694454|NCT02639546|463180482|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
128694455|NCT02639546|463180483|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
128694456|NCT02639546|463180484|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
128694457|NCT02639546|463180477|FG000|Overall Study|Study Terminated By Sponsor|0|||
128694458|NCT02639546|463180478|FG001|Overall Study|Study Terminated By Sponsor|2|||
128694459|NCT02639546|463180479|FG002|Overall Study|Study Terminated By Sponsor|3|||
128694460|NCT02639546|463180480|FG003|Overall Study|Study Terminated By Sponsor|4|||
128694461|NCT02639546|463180481|FG004|Overall Study|Study Terminated By Sponsor|4|||
128694462|NCT02639546|463180482|FG005|Overall Study|Study Terminated By Sponsor|3|||
128694463|NCT02639546|463180483|FG006|Overall Study|Study Terminated By Sponsor|3|||
128694464|NCT02639546|463180484|FG007|Overall Study|Study Terminated By Sponsor|9|||
128694465|NCT02639546|463180477|FG000|Overall Study|Withdrawal by Subject|2|||
128905894|NCT03594227|463948601|FG002|Overall Study|Adverse Event|0|||
128905895|NCT03594227|463948602|FG003|Overall Study|Adverse Event|2|||
128905896|NCT03594227|463948599|FG000|Overall Study|Lost to Follow-up|1|||
128905897|NCT03594227|463948600|FG001|Overall Study|Lost to Follow-up|1|||
128905898|NCT03594227|463948601|FG002|Overall Study|Lost to Follow-up|1|||
128694466|NCT02639546|463180478|FG001|Overall Study|Withdrawal by Subject|2|||
128694467|NCT02639546|463180479|FG002|Overall Study|Withdrawal by Subject|1|||
128694468|NCT02639546|463180480|FG003|Overall Study|Withdrawal by Subject|0|||
128694469|NCT02639546|463180481|FG004|Overall Study|Withdrawal by Subject|0|||
128694470|NCT02639546|463180482|FG005|Overall Study|Withdrawal by Subject|1|||
128694471|NCT02639546|463180483|FG006|Overall Study|Withdrawal by Subject|2|||
128905899|NCT03594227|463948602|FG003|Overall Study|Lost to Follow-up|0|||
128905900|NCT03594227|463948599|FG000|Overall Study|Withdrawal by Subject|1|||
128905901|NCT03594227|463948600|FG001|Overall Study|Withdrawal by Subject|1|||
129026833|NCT00112437|464390083|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026834|NCT00112437|464390084|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026835|NCT00112437|464390085|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026836|NCT00112437|464390086|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026837|NCT00112437|464390087|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026838|NCT00112437|464390088|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026839|NCT00112437|464390089|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026840|NCT00112437|464390090|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129026841|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
129026842|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
128694472|NCT02639546|463180484|FG007|Overall Study|Withdrawal by Subject|1|||
128694473|NCT00113087|463180485|FG000|Overall Study|Death or Transplant|14|||
128905902|NCT03594227|463948601|FG002|Overall Study|Withdrawal by Subject|1|||
128905903|NCT03594227|463948602|FG003|Overall Study|Withdrawal by Subject|1|||
128905904|NCT03594227|463948599|FG000|Overall Study|Pregnancy|0|||
128905905|NCT03594227|463948600|FG001|Overall Study|Pregnancy|1|||
128905906|NCT03594227|463948601|FG002|Overall Study|Pregnancy|0|||
128694474|NCT00113087|463180486|FG001|Overall Study|Death or Transplant|16|||
128694475|NCT00113087|463180485|FG000|Overall Study|Family or MD withdrew subject|10|||
128694476|NCT00113087|463180486|FG001|Overall Study|Family or MD withdrew subject|5|||
128694477|NCT00386607|463180487|FG000|Core|Adverse Event|40|||
128694478|NCT00386607|463180488|FG001|Core|Adverse Event|0|||
128905907|NCT03594227|463948602|FG003|Overall Study|Pregnancy|0|||
128905908|NCT03594227|463948599|FG000|Overall Study|Sponsor Decision|0|||
128905909|NCT03594227|463948600|FG001|Overall Study|Sponsor Decision|0|||
128905910|NCT03594227|463948601|FG002|Overall Study|Sponsor Decision|0|||
128905911|NCT03594227|463948602|FG003|Overall Study|Sponsor Decision|1|||
128905912|NCT03594227|463948599|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
128905913|NCT03594227|463948600|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
128905914|NCT03594227|463948601|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
128905915|NCT03594227|463948602|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
128905916|NCT00790907|463948603|FG000|Overall Study|Adverse Event|9|||
128905917|NCT00790907|463948604|FG001|Overall Study|Adverse Event|7|||
128905918|NCT00790907|463948605|FG002|Overall Study|Adverse Event|6|||
128905919|NCT00790907|463948603|FG000|Overall Study|Physician Decision|304|||
128905920|NCT00790907|463948604|FG001|Overall Study|Physician Decision|271|||
128905921|NCT00790907|463948605|FG002|Overall Study|Physician Decision|255|||
128905922|NCT00790907|463948603|FG000|Overall Study|Withdrawal by Subject|1|||
128905923|NCT00790907|463948604|FG001|Overall Study|Withdrawal by Subject|7|||
128905924|NCT00790907|463948605|FG002|Overall Study|Withdrawal by Subject|5|||
128905925|NCT00790907|463948603|FG000|Overall Study|Bleeding Event|11|||
128905926|NCT00790907|463948604|FG001|Overall Study|Bleeding Event|16|||
128905927|NCT00790907|463948605|FG002|Overall Study|Bleeding Event|21|||
128905928|NCT00790907|463948603|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
128905929|NCT00790907|463948604|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
128905930|NCT00790907|463948605|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
128905931|NCT00790907|463948603|FG000|Overall Study|Qualifying Condition Not Present|29|||
128905932|NCT00790907|463948604|FG001|Overall Study|Qualifying Condition Not Present|14|||
128905933|NCT00790907|463948605|FG002|Overall Study|Qualifying Condition Not Present|16|||
128905934|NCT00790907|463948603|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
128905935|NCT00790907|463948604|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
128905936|NCT00790907|463948605|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
128905937|NCT00790907|463948603|FG000|Overall Study|Did Not Receive Study Drug|10|||
128905938|NCT00790907|463948604|FG001|Overall Study|Did Not Receive Study Drug|0|||
129116052|NCT04219189|464721619|FG001|Overall Study|Withdrawal by Subject|2|||
128694479|NCT00386607|463180487|FG000|Core|Abnormal laboratory value(s)|3|||
128694480|NCT00386607|463180488|FG001|Core|Abnormal laboratory value(s)|0|||
128694481|NCT00386607|463180487|FG000|Core|Unsatisfactory therapeutic effect|23|||
128694482|NCT00386607|463180488|FG001|Core|Unsatisfactory therapeutic effect|0|||
128694483|NCT00386607|463180487|FG000|Core|Condition no longer requires study drug|4|||
128694484|NCT00386607|463180488|FG001|Core|Condition no longer requires study drug|0|||
128694485|NCT00386607|463180487|FG000|Core|Patient withdrew consent|15|||
128694486|NCT00386607|463180488|FG001|Core|Patient withdrew consent|0|||
128694487|NCT00386607|463180487|FG000|Core|Lost to Follow-up|23|||
129116053|NCT04219189|464721618|FG000|Overall Study|Protocol Violation|0|||
129116054|NCT04219189|464721619|FG001|Overall Study|Protocol Violation|1|||
128694488|NCT00386607|463180488|FG001|Core|Lost to Follow-up|0|||
128694489|NCT00386607|463180487|FG000|Core|Administrative problems|1|||
128694490|NCT00386607|463180488|FG001|Core|Administrative problems|0|||
128694491|NCT00386607|463180487|FG000|Core|Protocol Deviation|6|||
129116055|NCT04219189|464721618|FG000|Overall Study|Lost to Follow-up|0|||
129116056|NCT04219189|464721619|FG001|Overall Study|Lost to Follow-up|1|||
129116057|NCT04219189|464721618|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
129116058|NCT04219189|464721619|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
129116059|NCT03101020|464721620|FG000|Overall Study|Lack of time to participate|1|||
129116060|NCT03101020|464721621|FG001|Overall Study|Lack of time to participate|0|||
129116061|NCT03101020|464721620|FG000|Overall Study|Ran over by a car|0|||
129116062|NCT03101020|464721621|FG001|Overall Study|Ran over by a car|1|||
128694492|NCT00386607|463180488|FG001|Core|Protocol Deviation|0|||
128694493|NCT00386607|463180487|FG000|Extension|Adverse Event|0|||
128694494|NCT00386607|463180488|FG001|Extension|Adverse Event|6|||
128694495|NCT00386607|463180487|FG000|Extension|Abnormal laboratory value(s)|0|||
128694496|NCT00386607|463180488|FG001|Extension|Abnormal laboratory value(s)|1|||
128694497|NCT00386607|463180487|FG000|Extension|Administrative problems|0|||
128694498|NCT00386607|463180488|FG001|Extension|Administrative problems|1|||
128694499|NCT00386607|463180487|FG000|Extension|Lost to Follow-up|0|||
128694500|NCT00386607|463180488|FG001|Extension|Lost to Follow-up|3|||
128694501|NCT00386607|463180487|FG000|Extension|Patient withdrew consent|0|||
128694502|NCT00386607|463180488|FG001|Extension|Patient withdrew consent|5|||
128905939|NCT00790907|463948605|FG002|Overall Study|Did Not Receive Study Drug|0|||
128905940|NCT01888640|463948606|FG000|Overall Study|Lost to Follow-up|1|||
128905941|NCT01888640|463948607|FG001|Overall Study|Lost to Follow-up|2|||
128905942|NCT01888640|463948608|FG002|Overall Study|Lost to Follow-up|0|||
128694503|NCT00386607|463180487|FG000|Extension|Unsatisfactory therapeutic effect|0|||
128694504|NCT00386607|463180488|FG001|Extension|Unsatisfactory therapeutic effect|1|||
128694505|NCT04251273|463180489|FG000|Overall Study|Lost to Follow-up|331|||
128905943|NCT01888640|463948606|FG000|Overall Study|Withdrawal by Subject|15|||
128905944|NCT01888640|463948607|FG001|Overall Study|Withdrawal by Subject|11|||
128764904|NCT05400746|463430365|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
128694506|NCT04251273|463180490|FG001|Overall Study|Lost to Follow-up|290|||
128694507|NCT00810693|463180491|FG000|Treatment Period|Adverse Event|8|||
128694508|NCT00810693|463180492|FG001|Treatment Period|Adverse Event|1|||
128694509|NCT00810693|463180493|FG002|Treatment Period|Adverse Event|7|||
128694510|NCT00810693|463180491|FG000|Treatment Period|Death|0|||
128694511|NCT00810693|463180492|FG001|Treatment Period|Death|1|||
128694512|NCT00810693|463180493|FG002|Treatment Period|Death|2|||
128694513|NCT00810693|463180491|FG000|Treatment Period|Lack of Efficacy|0|||
128694514|NCT00810693|463180492|FG001|Treatment Period|Lack of Efficacy|0|||
128694515|NCT00810693|463180493|FG002|Treatment Period|Lack of Efficacy|1|||
128694516|NCT00810693|463180491|FG000|Treatment Period|Lost to Follow-up|1|||
128694517|NCT00810693|463180492|FG001|Treatment Period|Lost to Follow-up|0|||
129116063|NCT03101020|464721620|FG000|Overall Study|Withdrawal by Subject|0|||
129116064|NCT03101020|464721621|FG001|Overall Study|Withdrawal by Subject|2|||
129116065|NCT05817669|464721622|FG000|Overall Study|Prohibited medication used|1|||
129116066|NCT05817669|464721623|FG001|Overall Study|Prohibited medication used|2|||
129116067|NCT05817669|464721622|FG000|Overall Study|Adverse Event|1|||
129116068|NCT05817669|464721623|FG001|Overall Study|Adverse Event|0|||
129116069|NCT05817669|464721622|FG000|Overall Study|Withdrawal by Subject|1|||
129116070|NCT05817669|464721623|FG001|Overall Study|Withdrawal by Subject|2|||
129116071|NCT04233879|464721624|FG000|Overall Study|Death|2|||
129116072|NCT04233879|464721625|FG001|Overall Study|Death|0|||
129116073|NCT04233879|464721624|FG000|Overall Study|Lost to Follow-up|3|||
128764905|NCT03300570|463430371|FG000|Overall Study|Adverse Event|0|||
128764906|NCT03300570|463430372|FG001|Overall Study|Adverse Event|1|||
128694518|NCT00810693|463180493|FG002|Treatment Period|Lost to Follow-up|0|||
128694519|NCT00810693|463180491|FG000|Treatment Period|Non-compliance|1|||
128694520|NCT00810693|463180492|FG001|Treatment Period|Non-compliance|0|||
128694521|NCT00810693|463180493|FG002|Treatment Period|Non-compliance|0|||
128694522|NCT00810693|463180491|FG000|Treatment Period|Protocol Violation|1|||
128694523|NCT00810693|463180492|FG001|Treatment Period|Protocol Violation|2|||
128694524|NCT00810693|463180493|FG002|Treatment Period|Protocol Violation|2|||
128694525|NCT00810693|463180491|FG000|Treatment Period|Withdrawal by Subject|6|||
128694526|NCT00810693|463180492|FG001|Treatment Period|Withdrawal by Subject|2|||
128694527|NCT00810693|463180493|FG002|Treatment Period|Withdrawal by Subject|3|||
128694528|NCT00810693|463180491|FG000|Treatment Period|Not treated|0|||
128694529|NCT00810693|463180492|FG001|Treatment Period|Not treated|1|||
128694530|NCT00810693|463180493|FG002|Treatment Period|Not treated|1|||
128694531|NCT00810693|463180491|FG000|Follow-up Period (FUP)|Adverse Event|3|||
128694532|NCT00810693|463180492|FG001|Follow-up Period (FUP)|Adverse Event|1|||
128694533|NCT00810693|463180493|FG002|Follow-up Period (FUP)|Adverse Event|1|||
128694534|NCT00810693|463180491|FG000|Follow-up Period (FUP)|Death|2|||
128694535|NCT00810693|463180492|FG001|Follow-up Period (FUP)|Death|0|||
128694536|NCT00810693|463180493|FG002|Follow-up Period (FUP)|Death|1|||
128694537|NCT00810693|463180491|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
128694538|NCT00810693|463180492|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
128694539|NCT00810693|463180493|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
129116074|NCT04233879|464721625|FG001|Overall Study|Lost to Follow-up|8|||
129116075|NCT04233879|464721624|FG000|Overall Study|Physician Decision|4|||
129116076|NCT04233879|464721625|FG001|Overall Study|Physician Decision|4|||
128764907|NCT03300570|463430371|FG000|Overall Study|Withdrawal by Subject|1|||
128764908|NCT03300570|463430372|FG001|Overall Study|Withdrawal by Subject|0|||
128764909|NCT03300570|463430371|FG000|Overall Study|Inadequate bowel prep|1|||
128764910|NCT03300570|463430372|FG001|Overall Study|Inadequate bowel prep|0|||
128764911|NCT03188120|463430373|FG000|Overall Study|Adverse Event|4|||
128764912|NCT03188120|463430373|FG000|Overall Study|Insufficient Effectiveness|8|||
128764913|NCT03188120|463430373|FG000|Overall Study|Improved|12|||
128764914|NCT03188120|463430373|FG000|Overall Study|Lost to Follow-up|7|||
128764915|NCT03188120|463430373|FG000|Overall Study|Other than specified|3|||
129116077|NCT04233879|464721624|FG000|Overall Study|Withdrawal by Subject|7|||
128694540|NCT00810693|463180491|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
128694541|NCT00810693|463180492|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
128694542|NCT00810693|463180493|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
129116078|NCT04233879|464721625|FG001|Overall Study|Withdrawal by Subject|10|||
129116079|NCT04233879|464721624|FG000|Overall Study|Other|281|||
128764916|NCT03188120|463430373|FG000|Overall Study|No visit after the first visit|13|||
128764917|NCT01235403|463430375|FG000|Overall Study|Adverse Event|14|||
128764918|NCT01235403|463430375|FG000|Overall Study|Lost to Follow-up|2|||
128694543|NCT00810693|463180491|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
128694544|NCT00810693|463180492|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
128694545|NCT00810693|463180493|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
128694546|NCT03212690|463180494|FG000|Overall Study|Protocol Violation|1|||
128694547|NCT00633750|463180495|FG000|Overall Study|Adverse Event|2|||
128694548|NCT00633750|463180495|FG000|Overall Study|Withdrawal by Subject|3|||
128764919|NCT01235403|463430375|FG000|Overall Study|Withdrawal by Subject|4|||
129116080|NCT04233879|464721625|FG001|Overall Study|Other|279|||
128694549|NCT02215096|463180498|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
128694550|NCT02215096|463180499|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
128694551|NCT02215096|463180500|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
128694552|NCT02215096|463180501|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
128694553|NCT02215096|463180502|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
128694554|NCT02215096|463180498|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
128694555|NCT02215096|463180499|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
128694556|NCT02215096|463180500|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
128694557|NCT02215096|463180501|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
128694558|NCT02215096|463180502|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
128694559|NCT02215096|463180498|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
128694560|NCT02215096|463180499|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
128905945|NCT01888640|463948608|FG002|Overall Study|Withdrawal by Subject|4|||
128905946|NCT01888640|463948606|FG000|Overall Study|Minimum dose not met|10|||
128694561|NCT02215096|463180500|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
128905947|NCT01888640|463948607|FG001|Overall Study|Minimum dose not met|16|||
129026843|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
129026844|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
129026845|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
129026846|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
129026847|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
129026848|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
129026849|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
129026850|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
129026851|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
129026852|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
129026853|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
129026854|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
129026855|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
129026856|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
129026857|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
129026858|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
129026859|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
129026860|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
129026861|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
129026862|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
129026863|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
129026864|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
129026865|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
129026866|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
129026867|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026868|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026869|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026870|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026871|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026872|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
129026873|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
129026874|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026875|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026876|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
129026877|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026878|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026879|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026880|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026881|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026882|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026883|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026884|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026885|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026886|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026887|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026888|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026889|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026890|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026891|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026892|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129026893|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026894|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026895|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026896|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026897|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026898|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129116081|NCT03585270|464721628|FG000|Overall Study|Withdrawal by Subject|2|||
129116082|NCT03585270|464721629|FG001|Overall Study|Withdrawal by Subject|6|||
129116083|NCT03585270|464721628|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
129116084|NCT03585270|464721629|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
129116085|NCT03585270|464721628|FG000|Overall Study|Adverse Event|5|||
129116086|NCT03585270|464721629|FG001|Overall Study|Adverse Event|2|||
129116087|NCT03585270|464721628|FG000|Overall Study|Lost to Follow-up|1|||
129116088|NCT03585270|464721629|FG001|Overall Study|Lost to Follow-up|4|||
129116089|NCT03585270|464721628|FG000|Overall Study|Death|5|||
128694562|NCT02215096|463180501|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
128694563|NCT02215096|463180502|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
128694564|NCT02215096|463180498|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
128694565|NCT02215096|463180499|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
128694566|NCT02215096|463180500|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
128694567|NCT02215096|463180501|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
128694568|NCT02215096|463180502|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
128694569|NCT03307785|463180506|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
128694570|NCT03307785|463180507|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
128694571|NCT03307785|463180508|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
128694572|NCT03307785|463180509|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
128694573|NCT03307785|463180510|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
128694574|NCT03307785|463180511|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
128694575|NCT03307785|463180512|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
128694576|NCT03307785|463180513|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
128694577|NCT03307785|463180514|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
128694578|NCT03307785|463180515|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
128694579|NCT03307785|463180516|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
128694580|NCT03307785|463180506|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
128694581|NCT03307785|463180507|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
128694582|NCT03307785|463180508|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694583|NCT03307785|463180509|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694584|NCT03307785|463180510|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694585|NCT03307785|463180511|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694586|NCT03307785|463180512|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694587|NCT03307785|463180513|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694588|NCT03307785|463180514|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694589|NCT03307785|463180515|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694590|NCT03307785|463180516|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
128694591|NCT03307785|463180506|FG000|Part A: Up to 28.5 Months|Death|4|||
128694592|NCT03307785|463180507|FG001|Part A: Up to 28.5 Months|Death|4|||
128694593|NCT03307785|463180508|FG002|Part A: Up to 28.5 Months|Death|0|||
128694594|NCT03307785|463180509|FG003|Part A: Up to 28.5 Months|Death|0|||
128694595|NCT03307785|463180510|FG004|Part A: Up to 28.5 Months|Death|0|||
128694596|NCT03307785|463180511|FG005|Part A: Up to 28.5 Months|Death|0|||
128694597|NCT03307785|463180512|FG006|Part A: Up to 28.5 Months|Death|0|||
128694598|NCT03307785|463180513|FG007|Part A: Up to 28.5 Months|Death|0|||
128694599|NCT03307785|463180514|FG008|Part A: Up to 28.5 Months|Death|0|||
128694600|NCT03307785|463180515|FG009|Part A: Up to 28.5 Months|Death|0|||
128694601|NCT03307785|463180516|FG010|Part A: Up to 28.5 Months|Death|0|||
128694602|NCT03307785|463180506|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
128905948|NCT01888640|463948608|FG002|Overall Study|Minimum dose not met|0|||
129116090|NCT03585270|464721629|FG001|Overall Study|Death|3|||
129116091|NCT03585270|464721628|FG000|Overall Study|Other reasons|2|||
129116092|NCT03585270|464721629|FG001|Overall Study|Other reasons|2|||
129116093|NCT03292016|464721630|FG000|Second Washout|Adverse Event|0|||
129116094|NCT03292016|464721631|FG001|Second Washout|Adverse Event|1|||
129116095|NCT03292016|464721632|FG002|Second Washout|Adverse Event|0|||
129116096|NCT03292016|464721633|FG003|Second Washout|Adverse Event|0|||
129116097|NCT03292016|464721634|FG004|Second Washout|Adverse Event|0|||
129116098|NCT03292016|464721635|FG005|Second Washout|Adverse Event|0|||
129116099|NCT03786380|464721636|FG000|Overall Study|Adverse Event|1|||
129116100|NCT03786380|464721637|FG001|Overall Study|Adverse Event|0|||
129116101|NCT03786380|464721638|FG002|Overall Study|Adverse Event|0|||
129116102|NCT03786380|464721639|FG003|Overall Study|Adverse Event|3|||
128694603|NCT03307785|463180507|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
128694604|NCT03307785|463180508|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
128694605|NCT03307785|463180509|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
129116103|NCT03786380|464721640|FG004|Overall Study|Adverse Event|1|||
128694606|NCT03307785|463180510|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
128694607|NCT03307785|463180511|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
128694608|NCT03307785|463180512|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
129116104|NCT03786380|464721636|FG000|Overall Study|Lack of Efficacy|0|||
129116105|NCT03786380|464721637|FG001|Overall Study|Lack of Efficacy|0|||
129116106|NCT03786380|464721638|FG002|Overall Study|Lack of Efficacy|0|||
128694609|NCT03307785|463180513|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
128694610|NCT03307785|463180514|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
128694611|NCT03307785|463180515|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
128694612|NCT03307785|463180516|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
128694613|NCT03307785|463180506|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
129116107|NCT03786380|464721639|FG003|Overall Study|Lack of Efficacy|0|||
129116108|NCT03786380|464721640|FG004|Overall Study|Lack of Efficacy|1|||
129116109|NCT03786380|464721636|FG000|Overall Study|Withdrawal by Subject|1|||
129116110|NCT03786380|464721637|FG001|Overall Study|Withdrawal by Subject|2|||
129116111|NCT03786380|464721638|FG002|Overall Study|Withdrawal by Subject|2|||
129116112|NCT03786380|464721639|FG003|Overall Study|Withdrawal by Subject|1|||
129116113|NCT03786380|464721640|FG004|Overall Study|Withdrawal by Subject|2|||
129116114|NCT03786380|464721636|FG000|Overall Study|Lost to Follow-up|3|||
129116115|NCT03786380|464721637|FG001|Overall Study|Lost to Follow-up|0|||
129116116|NCT03786380|464721638|FG002|Overall Study|Lost to Follow-up|1|||
129116117|NCT03786380|464721639|FG003|Overall Study|Lost to Follow-up|2|||
129116118|NCT03786380|464721640|FG004|Overall Study|Lost to Follow-up|0|||
129116119|NCT03786380|464721636|FG000|Overall Study|Physician Decision|0|||
129116120|NCT03786380|464721637|FG001|Overall Study|Physician Decision|0|||
129116121|NCT03786380|464721638|FG002|Overall Study|Physician Decision|1|||
129116122|NCT03786380|464721639|FG003|Overall Study|Physician Decision|0|||
129116123|NCT03786380|464721640|FG004|Overall Study|Physician Decision|0|||
129116124|NCT03786380|464721636|FG000|Overall Study|Study Terminated by the Sponsor|30|||
129116125|NCT03786380|464721637|FG001|Overall Study|Study Terminated by the Sponsor|20|||
129116126|NCT03786380|464721638|FG002|Overall Study|Study Terminated by the Sponsor|50|||
129116127|NCT03786380|464721639|FG003|Overall Study|Study Terminated by the Sponsor|57|||
129116128|NCT03786380|464721640|FG004|Overall Study|Study Terminated by the Sponsor|23|||
129116129|NCT03786380|464721636|FG000|Overall Study|Reason Not Specified|0|||
129116130|NCT03786380|464721637|FG001|Overall Study|Reason Not Specified|0|||
129116131|NCT03786380|464721638|FG002|Overall Study|Reason Not Specified|0|||
129116132|NCT03786380|464721639|FG003|Overall Study|Reason Not Specified|0|||
129116133|NCT03786380|464721640|FG004|Overall Study|Reason Not Specified|1|||
129116134|NCT01664091|464721643|FG000|Overall Study|Death|1|||
129116135|NCT01664091|464721643|FG000|Overall Study|Disease Progression|2|||
129116136|NCT01664091|464721643|FG000|Overall Study|Lost to Follow-up|2|||
129116137|NCT01664091|464721643|FG000|Overall Study|Withdrawal by Subject|1|||
129116138|NCT01038687|464721646|FG000|Overall Study|Adverse Event|0|||
129116139|NCT01038687|464721647|FG001|Overall Study|Adverse Event|2|||
129116140|NCT01038687|464721648|FG002|Overall Study|Adverse Event|1|||
129116141|NCT00338741|464721650|FG000|Overall Study|Lost to Follow-up|2|||
129116142|NCT00338741|464721651|FG001|Overall Study|Lost to Follow-up|0|||
129116143|NCT01218802|464721652|FG000|Overall Study|Lost to Follow-up|5|||
129116144|NCT01218802|464721653|FG001|Overall Study|Lost to Follow-up|6|||
129116145|NCT01218802|464721652|FG000|Overall Study|Withdrawal by Subject|3|||
129116146|NCT01218802|464721653|FG001|Overall Study|Withdrawal by Subject|10|||
129116147|NCT01218802|464721652|FG000|Overall Study|Adverse Event|0|||
129116148|NCT01218802|464721653|FG001|Overall Study|Adverse Event|2|||
129116149|NCT01218802|464721652|FG000|Overall Study|Incarcerated|2|||
129116150|NCT01218802|464721653|FG001|Overall Study|Incarcerated|0|||
129116151|NCT01791985|464721654|FG000|Overall Study|Adverse Event|7|||
129116152|NCT01791985|464721654|FG000|Overall Study|Withdrawal by Subject|1|||
129116153|NCT00372424|464721655|FG000|Overall Study|Adverse Event|2|||
129116154|NCT00372424|464721655|FG000|Overall Study|Withdrawal by Subject|1|||
129116155|NCT00372424|464721655|FG000|Overall Study|Death|1|||
129116156|NCT00372424|464721655|FG000|Overall Study|Objective Progression or Relapse|14|||
129116157|NCT00372424|464721655|FG000|Overall Study|Other|7|||
129116158|NCT00372424|464721655|FG000|Overall Study|Enrolled, Not Treated|1|||
129116159|NCT00072410|464721656|FG000|Overall Study|Progressive disease|0|||
128694614|NCT03307785|463180507|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694615|NCT03307785|463180508|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
128905949|NCT01888640|463948606|FG000|Overall Study|Given wrong unit (placebo)|1|||
129116160|NCT00072410|464721657|FG001|Overall Study|Progressive disease|3|||
129116161|NCT02314728|464721666|FG000|Overall Study|Protocol Violation|1|||
129116162|NCT02314728|464721667|FG001|Overall Study|Protocol Violation|0|||
129116163|NCT02314728|464721666|FG000|Overall Study|Lost to Follow-up|0|||
129116164|NCT02314728|464721667|FG001|Overall Study|Lost to Follow-up|1|||
129116165|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
129116166|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129116167|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129116168|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129116169|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129116170|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129116171|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129116172|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
129116173|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129116174|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
128694616|NCT03307785|463180509|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694617|NCT03307785|463180510|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694618|NCT03307785|463180511|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694619|NCT03307785|463180512|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694620|NCT03307785|463180513|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694621|NCT03307785|463180514|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694622|NCT03307785|463180515|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694623|NCT03307785|463180516|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
128694624|NCT03307785|463180506|FG000|Part B: Up to Approx. 66 Months|Death|0|||
128694625|NCT03307785|463180507|FG001|Part B: Up to Approx. 66 Months|Death|0|||
128694626|NCT03307785|463180508|FG002|Part B: Up to Approx. 66 Months|Death|7|||
128694627|NCT03307785|463180509|FG003|Part B: Up to Approx. 66 Months|Death|0|||
128694628|NCT03307785|463180510|FG004|Part B: Up to Approx. 66 Months|Death|0|||
128694629|NCT03307785|463180511|FG005|Part B: Up to Approx. 66 Months|Death|0|||
128694630|NCT03307785|463180512|FG006|Part B: Up to Approx. 66 Months|Death|0|||
128694631|NCT03307785|463180513|FG007|Part B: Up to Approx. 66 Months|Death|0|||
128694632|NCT03307785|463180514|FG008|Part B: Up to Approx. 66 Months|Death|0|||
128694633|NCT03307785|463180515|FG009|Part B: Up to Approx. 66 Months|Death|0|||
128694634|NCT03307785|463180516|FG010|Part B: Up to Approx. 66 Months|Death|0|||
128694635|NCT03307785|463180506|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128764920|NCT01235403|463430375|FG000|Overall Study|Lack of Efficacy|2|||
128977995|NCT01277666|464205291|FG002|Overall Study|Lack of Efficacy|12|||
128977996|NCT01277666|464205289|FG000|Overall Study|Protocol Violation|2|||
128977997|NCT01277666|464205290|FG001|Overall Study|Protocol Violation|3|||
128977998|NCT01277666|464205291|FG002|Overall Study|Protocol Violation|2|||
128977999|NCT01277666|464205289|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
128978000|NCT01277666|464205290|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
128978001|NCT01277666|464205291|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
128978002|NCT01277666|464205289|FG000|Overall Study|Lost to Follow-up|1|||
128978003|NCT01277666|464205290|FG001|Overall Study|Lost to Follow-up|1|||
128978004|NCT01277666|464205291|FG002|Overall Study|Lost to Follow-up|2|||
128978005|NCT01277666|464205289|FG000|Overall Study|Withdrawal by Subject|7|||
128978006|NCT01277666|464205290|FG001|Overall Study|Withdrawal by Subject|8|||
128978007|NCT01277666|464205291|FG002|Overall Study|Withdrawal by Subject|6|||
128978008|NCT01277666|464205289|FG000|Overall Study|Death|0|||
128978009|NCT01277666|464205290|FG001|Overall Study|Death|0|||
128978010|NCT01277666|464205291|FG002|Overall Study|Death|1|||
128978011|NCT01747655|464205292|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
128978012|NCT01747655|464205293|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
128978013|NCT01747655|464205292|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
128978014|NCT01747655|464205293|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
128978015|NCT01747655|464205292|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
128978016|NCT01747655|464205293|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
128978017|NCT00982111|464205294|FG000|Overall Study|Adverse Event|1|||
128978018|NCT00982111|464205295|FG001|Overall Study|Adverse Event|1|||
128978019|NCT00982111|464205294|FG000|Overall Study|Progressive Disease|46|||
128978020|NCT00982111|464205295|FG001|Overall Study|Progressive Disease|39|||
128978021|NCT00982111|464205294|FG000|Overall Study|Lost to Follow-up|9|||
128978022|NCT00982111|464205295|FG001|Overall Study|Lost to Follow-up|6|||
128978023|NCT00982111|464205294|FG000|Overall Study|New Anti-Cancer Therapy|5|||
128978024|NCT00982111|464205295|FG001|Overall Study|New Anti-Cancer Therapy|5|||
128978025|NCT00982111|464205294|FG000|Overall Study|Medical Decision|1|||
128978026|NCT00982111|464205295|FG001|Overall Study|Medical Decision|0|||
128978027|NCT00982111|464205294|FG000|Overall Study|Withdrawal by Subject|17|||
128978028|NCT00982111|464205295|FG001|Overall Study|Withdrawal by Subject|19|||
128978029|NCT00982111|464205294|FG000|Overall Study|Global Study End|0|||
128978030|NCT00982111|464205295|FG001|Overall Study|Global Study End|1|||
128978031|NCT00982111|464205294|FG000|Overall Study|Sponsor's Decision|0|||
128978032|NCT00982111|464205295|FG001|Overall Study|Sponsor's Decision|1|||
128978033|NCT01070381|464205296|FG000|Period 2, 1 Week of Wear|Handling|0|||
128978034|NCT01070381|464205297|FG001|Period 2, 1 Week of Wear|Handling|1|||
128978035|NCT01070381|464205296|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
128978036|NCT01070381|464205297|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
128978037|NCT03512028|464205299|FG000|Overall Study|Withdrawal by Subject|2|||
128978038|NCT03512028|464205300|FG001|Overall Study|Withdrawal by Subject|0|||
128978039|NCT03512028|464205299|FG000|Overall Study|Protocol Violation|2|||
128978040|NCT03512028|464205300|FG001|Overall Study|Protocol Violation|0|||
128978041|NCT01259388|464205301|FG000|Overall Study|Adverse Event|3|||
128978042|NCT01259388|464205302|FG001|Overall Study|Adverse Event|0|||
128978043|NCT01259388|464205301|FG000|Overall Study|Withdrawal by Subject|1|||
128978044|NCT01259388|464205302|FG001|Overall Study|Withdrawal by Subject|1|||
128978045|NCT01259388|464205301|FG000|Overall Study|Physician Decision|1|||
128978046|NCT01259388|464205302|FG001|Overall Study|Physician Decision|0|||
128694636|NCT03307785|463180507|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694637|NCT03307785|463180508|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
128694638|NCT03307785|463180509|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694639|NCT03307785|463180510|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694640|NCT03307785|463180511|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694641|NCT03307785|463180512|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694642|NCT03307785|463180513|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694643|NCT03307785|463180514|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694644|NCT03307785|463180515|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694645|NCT03307785|463180516|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
128694646|NCT03307785|463180506|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694647|NCT03307785|463180507|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694648|NCT03307785|463180508|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
128694649|NCT03307785|463180509|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694650|NCT03307785|463180510|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694651|NCT03307785|463180511|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694652|NCT03307785|463180512|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694653|NCT03307785|463180513|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694654|NCT03307785|463180514|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128905950|NCT01888640|463948607|FG001|Overall Study|Given wrong unit (placebo)|0|||
129116175|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129116176|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129116177|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129116178|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129116179|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129116180|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
129116181|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129116182|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129116183|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129116184|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129116185|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129116186|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129116187|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129116188|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
129116189|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129116190|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129116191|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129116192|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129116193|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129116194|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129116195|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
129116196|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129116197|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129116198|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129116199|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129116200|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129116201|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129116202|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
129116203|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129116204|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129116205|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129116206|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129116207|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129116208|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129116209|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129116210|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
129116211|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129116212|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
128694655|NCT03307785|463180515|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694656|NCT03307785|463180516|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
128694657|NCT03307785|463180506|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694658|NCT03307785|463180507|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128905951|NCT01888640|463948608|FG002|Overall Study|Given wrong unit (placebo)|0|||
128694659|NCT03307785|463180508|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
128694660|NCT03307785|463180509|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694661|NCT03307785|463180510|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694662|NCT03307785|463180511|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694663|NCT03307785|463180512|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694664|NCT03307785|463180513|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694665|NCT03307785|463180514|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128905952|NCT01888640|463948606|FG000|Overall Study|Excluded for prior TENS|0|||
128905953|NCT01888640|463948607|FG001|Overall Study|Excluded for prior TENS|1|||
128905954|NCT01888640|463948608|FG002|Overall Study|Excluded for prior TENS|0|||
128905955|NCT01888640|463948606|FG000|Overall Study|Researcher Termination of Participant|0|||
128905956|NCT01888640|463948607|FG001|Overall Study|Researcher Termination of Participant|1|||
128905957|NCT01888640|463948608|FG002|Overall Study|Researcher Termination of Participant|1|||
128905958|NCT00109707|463948613|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
128905959|NCT00109707|463948614|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
128694666|NCT03307785|463180515|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694667|NCT03307785|463180516|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
128694668|NCT03307785|463180506|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694669|NCT03307785|463180507|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694670|NCT03307785|463180508|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694671|NCT03307785|463180509|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
128694672|NCT03307785|463180510|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
128694673|NCT03307785|463180511|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694674|NCT03307785|463180512|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694675|NCT03307785|463180513|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694676|NCT03307785|463180514|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694677|NCT03307785|463180515|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694678|NCT03307785|463180516|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
128694679|NCT03307785|463180506|FG000|Part C: Up to Approx. 60 Months|Death|0|||
128694680|NCT03307785|463180507|FG001|Part C: Up to Approx. 60 Months|Death|0|||
128694681|NCT03307785|463180508|FG002|Part C: Up to Approx. 60 Months|Death|0|||
128905960|NCT00109707|463948615|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
128905961|NCT00109707|463948613|FG000|Overall Study|Abnormal laboratory values|1|||
128905962|NCT00109707|463948614|FG001|Overall Study|Abnormal laboratory values|0|||
128905963|NCT00109707|463948615|FG002|Overall Study|Abnormal laboratory values|0|||
128905964|NCT00109707|463948613|FG000|Overall Study|Administrative problems|2|||
128905965|NCT00109707|463948614|FG001|Overall Study|Administrative problems|0|||
128694682|NCT03307785|463180509|FG003|Part C: Up to Approx. 60 Months|Death|2|||
128694683|NCT03307785|463180510|FG004|Part C: Up to Approx. 60 Months|Death|5|||
128905966|NCT00109707|463948615|FG002|Overall Study|Administrative problems|1|||
128905967|NCT00109707|463948613|FG000|Overall Study|Adverse Event|10|||
128905968|NCT00109707|463948614|FG001|Overall Study|Adverse Event|2|||
128905969|NCT00109707|463948615|FG002|Overall Study|Adverse Event|3|||
128905970|NCT00109707|463948613|FG000|Overall Study|Death|4|||
128905971|NCT00109707|463948614|FG001|Overall Study|Death|0|||
128905972|NCT00109707|463948615|FG002|Overall Study|Death|0|||
128905973|NCT00109707|463948613|FG000|Overall Study|Disease progression|12|||
128905974|NCT00109707|463948614|FG001|Overall Study|Disease progression|4|||
128905975|NCT00109707|463948615|FG002|Overall Study|Disease progression|3|||
128905976|NCT00109707|463948613|FG000|Overall Study|Lost to Follow-up|3|||
128905977|NCT00109707|463948614|FG001|Overall Study|Lost to Follow-up|0|||
128905978|NCT00109707|463948615|FG002|Overall Study|Lost to Follow-up|0|||
129026899|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026900|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129116213|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129116214|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
128694684|NCT03307785|463180511|FG005|Part C: Up to Approx. 60 Months|Death|0|||
129026901|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
129026902|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026903|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026904|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026905|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026906|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129116215|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129215329|NCT00463567|465091128|FG003|Overall Study|Lack of Efficacy|17|||
128694685|NCT03307785|463180512|FG006|Part C: Up to Approx. 60 Months|Death|0|||
128694686|NCT03307785|463180513|FG007|Part C: Up to Approx. 60 Months|Death|0|||
128905979|NCT00109707|463948613|FG000|Overall Study|Protocol Violation|1|||
128905980|NCT00109707|463948614|FG001|Overall Study|Protocol Violation|0|||
129026907|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026908|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
128905981|NCT00109707|463948615|FG002|Overall Study|Protocol Violation|0|||
128905982|NCT00109707|463948613|FG000|Overall Study|Patient withdrew consent|6|||
128905983|NCT00109707|463948614|FG001|Overall Study|Patient withdrew consent|1|||
128694687|NCT03307785|463180514|FG008|Part C: Up to Approx. 60 Months|Death|0|||
128694688|NCT03307785|463180515|FG009|Part C: Up to Approx. 60 Months|Death|0|||
128694689|NCT03307785|463180516|FG010|Part C: Up to Approx. 60 Months|Death|0|||
128694690|NCT03307785|463180506|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694691|NCT03307785|463180507|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694692|NCT03307785|463180508|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694693|NCT03307785|463180509|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
128694694|NCT03307785|463180510|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694695|NCT03307785|463180511|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694696|NCT03307785|463180512|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128905984|NCT00109707|463948615|FG002|Overall Study|Patient withdrew consent|0|||
128905985|NCT02199080|463948619|FG000|Overall Study|Protocol Violation|12|||
128905986|NCT03436862|463948624|FG000|Overall Study|Adverse Event|4|||
128905987|NCT03436862|463948624|FG000|Overall Study|Progressive Disease|2|||
128905988|NCT02228590|463948626|FG000|Overall Study|Withdrawal by Subject|1|||
128905989|NCT00391222|463948627|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
128905990|NCT00391222|463948628|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
128905991|NCT00391222|463948629|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
128905992|NCT00391222|463948630|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
128905993|NCT00391222|463948627|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
128694697|NCT03307785|463180513|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694698|NCT03307785|463180514|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694699|NCT03307785|463180515|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694700|NCT03307785|463180516|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
128694701|NCT03307785|463180506|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694702|NCT03307785|463180507|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128764921|NCT01235403|463430375|FG000|Overall Study|Other reasons for premature termination|4|||
128764922|NCT02978443|463430376|FG000|Overall Study|Withdrawal by Subject|1|||
128764923|NCT02978443|463430376|FG000|Overall Study|Adverse Event|3|||
128764924|NCT02978443|463430376|FG000|Overall Study|Disease Progression on study|6|||
128764925|NCT02978443|463430376|FG000|Overall Study|Death|1|||
128764926|NCT02978443|463430376|FG000|Overall Study|Physician Decision|1|||
128764927|NCT02978443|463430376|FG000|Overall Study|Switch to alternative therapy|1|||
128764928|NCT02978443|463430376|FG000|Overall Study|Refused further treatment|1|||
128764929|NCT02296190|463430377|FG000|Overall Study|Lost to Follow-up|0|||
128764930|NCT02296190|463430378|FG001|Overall Study|Lost to Follow-up|0|||
128764931|NCT02296190|463430379|FG002|Overall Study|Lost to Follow-up|0|||
128764932|NCT02296190|463430380|FG003|Overall Study|Lost to Follow-up|0|||
128764933|NCT02296190|463430381|FG004|Overall Study|Lost to Follow-up|1|||
128764934|NCT02296190|463430382|FG005|Overall Study|Lost to Follow-up|0|||
128764935|NCT02296190|463430377|FG000|Overall Study|Failure to induce PSVT|6|||
128905994|NCT00391222|463948628|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
128905995|NCT00391222|463948629|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
128905996|NCT00391222|463948630|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
129026909|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026910|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026911|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026912|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026913|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026914|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026915|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026916|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026917|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026918|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129026919|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026920|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026921|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
128694703|NCT03307785|463180508|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694704|NCT03307785|463180509|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694705|NCT03307785|463180510|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
128694706|NCT03307785|463180511|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694707|NCT03307785|463180512|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128764936|NCT02296190|463430378|FG001|Overall Study|Failure to induce PSVT|10|||
128764937|NCT02296190|463430379|FG002|Overall Study|Failure to induce PSVT|5|||
128905997|NCT00391222|463948627|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
129026922|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026923|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
128905998|NCT00391222|463948628|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
128905999|NCT00391222|463948629|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
128906000|NCT00391222|463948630|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
128906001|NCT00391222|463948627|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
128906002|NCT00391222|463948628|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
128906003|NCT00391222|463948629|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
128906004|NCT00391222|463948630|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
128906005|NCT00391222|463948627|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
128906006|NCT00391222|463948628|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
128906007|NCT00391222|463948629|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
128764938|NCT02296190|463430380|FG003|Overall Study|Failure to induce PSVT|13|||
128764939|NCT02296190|463430381|FG004|Overall Study|Failure to induce PSVT|8|||
128906008|NCT00391222|463948630|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
128906009|NCT00391222|463948627|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
128906010|NCT00391222|463948628|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
129026924|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
128764940|NCT02296190|463430382|FG005|Overall Study|Failure to induce PSVT|0|||
128764941|NCT02296190|463430377|FG000|Overall Study|Physician Decision|1|||
128764942|NCT02296190|463430378|FG001|Overall Study|Physician Decision|1|||
129026925|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026926|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
128694708|NCT03307785|463180513|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694709|NCT03307785|463180514|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694710|NCT03307785|463180515|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694711|NCT03307785|463180516|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
128694712|NCT03307785|463180506|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694713|NCT03307785|463180507|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694714|NCT03307785|463180508|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694715|NCT03307785|463180509|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694716|NCT03307785|463180510|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694717|NCT03307785|463180511|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
128694718|NCT03307785|463180512|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694719|NCT03307785|463180513|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694720|NCT03307785|463180514|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694721|NCT03307785|463180515|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694722|NCT03307785|463180516|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
128694723|NCT03307785|463180506|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
129026927|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
129026928|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026929|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026930|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026931|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026932|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026933|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026934|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026935|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026936|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026937|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026938|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026939|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026940|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026941|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026942|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026943|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026944|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
129026945|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026946|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026947|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026948|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026949|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
128694724|NCT03307785|463180507|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
128694725|NCT03307785|463180508|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
128694726|NCT03307785|463180509|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
128694727|NCT03307785|463180510|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
128764943|NCT02296190|463430379|FG002|Overall Study|Physician Decision|0|||
128764944|NCT02296190|463430380|FG003|Overall Study|Physician Decision|1|||
129026950|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
129026951|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
129026952|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
128694728|NCT03307785|463180511|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
128694729|NCT03307785|463180512|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
128694730|NCT03307785|463180513|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
128694731|NCT03307785|463180514|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
128694732|NCT03307785|463180515|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
128694733|NCT03307785|463180516|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
128694734|NCT03307785|463180506|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694735|NCT03307785|463180507|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694736|NCT03307785|463180508|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694737|NCT03307785|463180509|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694738|NCT03307785|463180510|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694739|NCT03307785|463180511|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
129116216|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129116217|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
129116218|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129116219|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129116220|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129116221|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129116222|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129116223|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129116224|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129116225|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
129116226|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129116227|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129116228|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129116229|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129116230|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129116231|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129116232|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
129116233|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129116234|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129116235|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129116236|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129116237|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129116238|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129116239|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
129116240|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129116241|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129116242|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129116243|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129116244|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129116245|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129116246|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
129116247|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129116248|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129116249|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129116250|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129116251|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129116252|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129116253|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129116254|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
129116255|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129116256|NCT01791595|464721668|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129116257|NCT01791595|464721669|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129116258|NCT01791595|464721670|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129116259|NCT01791595|464721671|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
128694740|NCT03307785|463180512|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694741|NCT03307785|463180513|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694742|NCT03307785|463180514|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694743|NCT03307785|463180515|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694744|NCT03307785|463180516|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
128694745|NCT03307785|463180506|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694746|NCT03307785|463180507|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129116260|NCT01791595|464721672|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129132899|NCT00827242|464778559|FG001|Overall Study|Entry Criteria Not Met|1|||
128694747|NCT03307785|463180508|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694748|NCT03307785|463180509|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694749|NCT03307785|463180510|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694750|NCT03307785|463180511|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
128694751|NCT03307785|463180512|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694752|NCT03307785|463180513|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694753|NCT03307785|463180514|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129026953|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
129026954|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
129026955|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026956|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026957|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026958|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026959|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026960|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026961|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026962|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026963|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026964|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026965|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026966|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026967|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026968|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026969|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026970|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129026971|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026972|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026973|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026974|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026975|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026976|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026977|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026978|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026979|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026980|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
129026981|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026982|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026983|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026984|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026985|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026986|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026987|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026988|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026989|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026990|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026991|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026992|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026993|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026994|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026995|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026996|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129026997|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
129026998|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
129026999|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027000|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027001|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
128694754|NCT03307785|463180515|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694755|NCT03307785|463180516|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
128694756|NCT03307785|463180506|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694757|NCT03307785|463180507|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694758|NCT03307785|463180508|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128906011|NCT00391222|463948629|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
129027002|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
129132900|NCT00827242|464778558|FG000|Overall Study|Physician Decision|2|||
129116261|NCT01791595|464721673|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
129116262|NCT01791595|464721674|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129116263|NCT01791595|464721668|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129116264|NCT01791595|464721669|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129116265|NCT01791595|464721670|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129116266|NCT01791595|464721671|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129116267|NCT01791595|464721672|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129116268|NCT01791595|464721673|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129116269|NCT01791595|464721674|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
129116270|NCT01791595|464721668|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129116271|NCT01791595|464721669|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129116272|NCT01791595|464721670|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129116273|NCT01791595|464721671|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129116274|NCT01791595|464721672|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129116275|NCT01791595|464721673|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129116276|NCT01791595|464721674|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
129116277|NCT01791595|464721668|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129116278|NCT01791595|464721669|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129116279|NCT01791595|464721670|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129116280|NCT01791595|464721671|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129116281|NCT01791595|464721672|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129116282|NCT01791595|464721673|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129116283|NCT01791595|464721674|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
128764945|NCT02296190|463430381|FG004|Overall Study|Physician Decision|2|||
128764946|NCT02296190|463430382|FG005|Overall Study|Physician Decision|0|||
128764947|NCT02296190|463430377|FG000|Overall Study|Withdrawal by Subject|0|||
128764948|NCT02296190|463430378|FG001|Overall Study|Withdrawal by Subject|1|||
128764949|NCT02296190|463430379|FG002|Overall Study|Withdrawal by Subject|0|||
128764950|NCT02296190|463430380|FG003|Overall Study|Withdrawal by Subject|0|||
128764951|NCT02296190|463430381|FG004|Overall Study|Withdrawal by Subject|0|||
128764952|NCT02296190|463430382|FG005|Overall Study|Withdrawal by Subject|0|||
128764953|NCT02296190|463430377|FG000|Overall Study|PSVT < 5 minutes|5|||
128764954|NCT02296190|463430378|FG001|Overall Study|PSVT < 5 minutes|6|||
128764955|NCT02296190|463430379|FG002|Overall Study|PSVT < 5 minutes|6|||
128764956|NCT02296190|463430380|FG003|Overall Study|PSVT < 5 minutes|6|||
128764957|NCT02296190|463430381|FG004|Overall Study|PSVT < 5 minutes|5|||
129116284|NCT01791595|464721668|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129116285|NCT01791595|464721669|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129116286|NCT01791595|464721670|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129116287|NCT01791595|464721671|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129116288|NCT01791595|464721672|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129116289|NCT01791595|464721673|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129116290|NCT01791595|464721674|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
129116291|NCT03118934|464721675|FG000|Overall Study|Adverse Event|0|||
129116292|NCT03118934|464721676|FG001|Overall Study|Adverse Event|0|||
129116293|NCT03118934|464721677|FG002|Overall Study|Adverse Event|0|||
129116294|NCT03118934|464721678|FG003|Overall Study|Adverse Event|0|||
129116295|NCT03118934|464721679|FG004|Overall Study|Adverse Event|0|||
129116296|NCT03118934|464721680|FG005|Overall Study|Adverse Event|1|||
129116297|NCT03118934|464721675|FG000|Overall Study|Physician Decision|0|||
129116298|NCT03118934|464721676|FG001|Overall Study|Physician Decision|0|||
129116299|NCT03118934|464721677|FG002|Overall Study|Physician Decision|0|||
129116300|NCT03118934|464721678|FG003|Overall Study|Physician Decision|0|||
129116301|NCT03118934|464721679|FG004|Overall Study|Physician Decision|0|||
129116302|NCT03118934|464721680|FG005|Overall Study|Physician Decision|1|||
129116303|NCT03118934|464721675|FG000|Overall Study|Discontinued prior to exposure|0|||
129116304|NCT03118934|464721676|FG001|Overall Study|Discontinued prior to exposure|1|||
129116305|NCT03118934|464721677|FG002|Overall Study|Discontinued prior to exposure|1|||
129116306|NCT03118934|464721678|FG003|Overall Study|Discontinued prior to exposure|1|||
129116307|NCT03118934|464721679|FG004|Overall Study|Discontinued prior to exposure|2|||
129116308|NCT03118934|464721680|FG005|Overall Study|Discontinued prior to exposure|0|||
129116309|NCT01614470|464721681|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
129116310|NCT01614470|464721682|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129116311|NCT01614470|464721683|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128764958|NCT02296190|463430382|FG005|Overall Study|PSVT < 5 minutes|0|||
128764959|NCT02296190|463430377|FG000|Overall Study|Patient was given Propofol|0|||
128764960|NCT02296190|463430378|FG001|Overall Study|Patient was given Propofol|1|||
128906012|NCT00391222|463948630|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
129116312|NCT01614470|464721681|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
129116313|NCT01614470|464721682|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
128694759|NCT03307785|463180509|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694760|NCT03307785|463180510|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694761|NCT03307785|463180511|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
128694762|NCT03307785|463180512|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694763|NCT03307785|463180513|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694764|NCT03307785|463180514|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694765|NCT03307785|463180515|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694766|NCT03307785|463180516|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
128694767|NCT03307785|463180506|FG000|Part E: Up to 4.4 Months|Death|0|||
128694768|NCT03307785|463180507|FG001|Part E: Up to 4.4 Months|Death|0|||
128694769|NCT03307785|463180508|FG002|Part E: Up to 4.4 Months|Death|0|||
128694770|NCT03307785|463180509|FG003|Part E: Up to 4.4 Months|Death|0|||
128694771|NCT03307785|463180510|FG004|Part E: Up to 4.4 Months|Death|0|||
128694772|NCT03307785|463180511|FG005|Part E: Up to 4.4 Months|Death|0|||
128694773|NCT03307785|463180512|FG006|Part E: Up to 4.4 Months|Death|1|||
128694774|NCT03307785|463180513|FG007|Part E: Up to 4.4 Months|Death|0|||
128694775|NCT03307785|463180514|FG008|Part E: Up to 4.4 Months|Death|0|||
128694776|NCT03307785|463180515|FG009|Part E: Up to 4.4 Months|Death|0|||
128694777|NCT03307785|463180516|FG010|Part E: Up to 4.4 Months|Death|0|||
128694778|NCT03307785|463180506|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
128694779|NCT03307785|463180507|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
128694780|NCT03307785|463180508|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
128694781|NCT03307785|463180509|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
128694782|NCT03307785|463180510|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
128694783|NCT03307785|463180511|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
128694784|NCT03307785|463180512|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
128694785|NCT03307785|463180513|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
128694786|NCT03307785|463180514|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
128694787|NCT03307785|463180515|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
128694788|NCT03307785|463180516|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
128694789|NCT03307785|463180506|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
128694790|NCT03307785|463180507|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
128694791|NCT03307785|463180508|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
128694792|NCT03307785|463180509|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
128694793|NCT03307785|463180510|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
128694794|NCT03307785|463180511|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
128694795|NCT03307785|463180512|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
128694796|NCT03307785|463180513|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
128694797|NCT03307785|463180514|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
128694798|NCT03307785|463180515|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
128694799|NCT03307785|463180516|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
128694800|NCT03666624|463180521|FG000|Overall Study|participant grieving over recent death of parent|1|||
128694801|NCT03666624|463180522|FG001|Overall Study|participant grieving over recent death of parent|0|||
128694802|NCT03021304|463180523|FG000|Overall Study|Lack of Efficacy|1|||
128694803|NCT00569270|463180525|FG000|Period: First Intervention|Protocol Violation|0|||
128694804|NCT00569270|463180526|FG001|Period: First Intervention|Protocol Violation|1|||
128694805|NCT00492531|463180527|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
128694806|NCT00492531|463180528|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
128694807|NCT03822182|463180529|FG000|Overall Study|Protocol Violation|0|||
128694808|NCT03822182|463180530|FG001|Overall Study|Protocol Violation|1|||
128694809|NCT03822182|463180531|FG002|Overall Study|Protocol Violation|1|||
128694810|NCT00810355|463180532|FG000|Overall Study|Lost to Follow-up|13|||
128694811|NCT00810355|463180533|FG001|Overall Study|Lost to Follow-up|17|||
128694812|NCT00810355|463180534|FG002|Overall Study|Lost to Follow-up|11|||
128694813|NCT00810355|463180532|FG000|Overall Study|Withdrawal by Subject|1|||
128694814|NCT00810355|463180533|FG001|Overall Study|Withdrawal by Subject|0|||
128694815|NCT00810355|463180534|FG002|Overall Study|Withdrawal by Subject|0|||
128694816|NCT00423514|463180536|FG000|Overall Study|Ineligible|1|||
128694817|NCT00423514|463180537|FG001|Overall Study|Ineligible|0|||
128694818|NCT03685123|463180538|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
128906013|NCT00391222|463948627|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
128906014|NCT00391222|463948628|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
128906015|NCT00391222|463948629|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
128906016|NCT00391222|463948630|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
128694819|NCT03685123|463180539|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
128694820|NCT03685123|463180540|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
128694821|NCT03685123|463180538|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
128694822|NCT03685123|463180539|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
128694823|NCT03685123|463180540|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
128694824|NCT03685123|463180538|FG000|Weight Loss Phase|Lost to Follow-up|1|||
128694825|NCT03685123|463180539|FG001|Weight Loss Phase|Lost to Follow-up|0|||
128694826|NCT03685123|463180540|FG002|Weight Loss Phase|Lost to Follow-up|0|||
128694827|NCT03685123|463180538|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
128694828|NCT03685123|463180539|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
128694829|NCT03685123|463180540|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
128694830|NCT03685123|463180538|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
128694831|NCT03685123|463180539|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
128694832|NCT03685123|463180540|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
128694833|NCT03685123|463180538|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
128694834|NCT03685123|463180539|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
128694835|NCT03685123|463180540|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
128694836|NCT00400764|463180541|FG000|Phase Ib|Adverse Event|1|||
128694837|NCT00400764|463180542|FG001|Phase Ib|Adverse Event|0|||
128694838|NCT00400764|463180543|FG002|Phase Ib|Adverse Event|0|||
128694839|NCT00400764|463180544|FG003|Phase Ib|Adverse Event|0|||
128694840|NCT00400764|463180545|FG004|Phase Ib|Adverse Event|0|||
128694841|NCT00400764|463180541|FG000|Phase Ib|Death|1|||
128694842|NCT00400764|463180542|FG001|Phase Ib|Death|0|||
128694843|NCT00400764|463180543|FG002|Phase Ib|Death|0|||
128694844|NCT00400764|463180544|FG003|Phase Ib|Death|0|||
128694845|NCT00400764|463180545|FG004|Phase Ib|Death|0|||
128694846|NCT00400764|463180541|FG000|Phase Ib|Disease Progression|4|||
128694847|NCT00400764|463180542|FG001|Phase Ib|Disease Progression|4|||
128694848|NCT00400764|463180543|FG002|Phase Ib|Disease Progression|0|||
128694849|NCT00400764|463180544|FG003|Phase Ib|Disease Progression|0|||
128694850|NCT00400764|463180545|FG004|Phase Ib|Disease Progression|0|||
128906017|NCT00391222|463948627|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
128906018|NCT00391222|463948628|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
128906019|NCT00391222|463948629|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
128906020|NCT00391222|463948630|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
128906021|NCT00391222|463948627|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
128906022|NCT00391222|463948628|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
128906023|NCT00391222|463948629|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
128906024|NCT00391222|463948630|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
128906025|NCT00391222|463948627|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
128906026|NCT00391222|463948628|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
128906027|NCT00391222|463948629|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
128906028|NCT00391222|463948630|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
128906029|NCT00391222|463948627|FG000|Period III (Double-Blind Treatment)|Other|6|||
128906030|NCT00391222|463948628|FG001|Period III (Double-Blind Treatment)|Other|1|||
128906031|NCT00391222|463948629|FG002|Period III (Double-Blind Treatment)|Other|6|||
128906032|NCT00391222|463948630|FG003|Period III (Double-Blind Treatment)|Other|0|||
128906033|NCT01097863|463948631|FG000|Overall Study|Discomfort|1|||
128906034|NCT01097863|463948632|FG001|Overall Study|Discomfort|0|||
128906035|NCT01097863|463948633|FG002|Overall Study|Discomfort|1|||
128906036|NCT01097863|463948631|FG000|Overall Study|Did not return for final visit|0|||
128906037|NCT01097863|463948632|FG001|Overall Study|Did not return for final visit|0|||
128906038|NCT01097863|463948633|FG002|Overall Study|Did not return for final visit|1|||
128906039|NCT00574275|463948634|FG000|Overall Study|Randomized but not treated|2|||
128906040|NCT00574275|463948635|FG001|Overall Study|Randomized but not treated|3|||
128906041|NCT00574275|463948634|FG000|Overall Study|Adverse Event|32|||
128906042|NCT00574275|463948635|FG001|Overall Study|Adverse Event|76|||
128906043|NCT00574275|463948634|FG000|Overall Study|Disease progression|160|||
128906044|NCT00574275|463948635|FG001|Overall Study|Disease progression|146|||
128906045|NCT00574275|463948634|FG000|Overall Study|Lost to Follow-up|2|||
128906046|NCT00574275|463948635|FG001|Overall Study|Lost to Follow-up|1|||
128906047|NCT00574275|463948634|FG000|Overall Study|Study stopped based on DMC decision|62|||
128906048|NCT00574275|463948635|FG001|Overall Study|Study stopped based on DMC decision|23|||
128906049|NCT00574275|463948634|FG000|Overall Study|Withdrawal by Subject|15|||
128906050|NCT00574275|463948635|FG001|Overall Study|Withdrawal by Subject|17|||
128906051|NCT00574275|463948634|FG000|Overall Study|Error calculating tumor measurement|1|||
128906052|NCT00574275|463948635|FG001|Overall Study|Error calculating tumor measurement|0|||
128906053|NCT00574275|463948634|FG000|Overall Study|Physician Decision|1|||
128906054|NCT00574275|463948635|FG001|Overall Study|Physician Decision|1|||
129027003|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027004|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027005|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
128694851|NCT00400764|463180541|FG000|Phase II|Death|0|||
128694852|NCT00400764|463180542|FG001|Phase II|Death|0|||
128764961|NCT02296190|463430379|FG002|Overall Study|Patient was given Propofol|0|||
128906055|NCT00574275|463948634|FG000|Overall Study|Protocol Violation|0|||
128906056|NCT00574275|463948635|FG001|Overall Study|Protocol Violation|1|||
128906057|NCT00574275|463948634|FG000|Overall Study|Patient and Investigator decision|0|||
128694853|NCT00400764|463180543|FG002|Phase II|Death|1|||
128694854|NCT00400764|463180544|FG003|Phase II|Death|2|||
128694855|NCT00400764|463180545|FG004|Phase II|Death|0|||
128694856|NCT00400764|463180541|FG000|Phase II|Lost to Follow-up|0|||
128906058|NCT00574275|463948635|FG001|Overall Study|Patient and Investigator decision|1|||
128906059|NCT00574275|463948634|FG000|Overall Study|Insurance change|0|||
128906060|NCT00574275|463948635|FG001|Overall Study|Insurance change|1|||
128906061|NCT00574275|463948634|FG000|Overall Study|Operation for curative intent|0|||
128906062|NCT00574275|463948635|FG001|Overall Study|Operation for curative intent|1|||
128906063|NCT02703311|463948637|FG000|Overall Study|Death|5|||
128906064|NCT02703311|463948637|FG000|Overall Study|Withdrawal by Subject|3|||
128906065|NCT00960843|463948638|FG000|Overall Study|Lost to Follow-up|2|||
128906066|NCT00960843|463948639|FG001|Overall Study|Lost to Follow-up|0|||
128906067|NCT00960843|463948638|FG000|Overall Study|Protocol Violation|0|||
128906068|NCT00960843|463948639|FG001|Overall Study|Protocol Violation|4|||
128906069|NCT00960843|463948638|FG000|Overall Study|Repeated needle dislodgment|0|||
128906070|NCT00960843|463948639|FG001|Overall Study|Repeated needle dislodgment|1|||
128906071|NCT00652366|463948640|FG000|Overall Study|Adverse Event|8|||
128906072|NCT00652366|463948641|FG001|Overall Study|Adverse Event|4|||
128906073|NCT00652366|463948642|FG002|Overall Study|Adverse Event|7|||
128906074|NCT00652366|463948643|FG003|Overall Study|Adverse Event|17|||
128906075|NCT00652366|463948644|FG004|Overall Study|Adverse Event|13|||
128906076|NCT00652366|463948640|FG000|Overall Study|Death|5|||
128906077|NCT00652366|463948641|FG001|Overall Study|Death|4|||
128906078|NCT00652366|463948642|FG002|Overall Study|Death|1|||
128906079|NCT00652366|463948643|FG003|Overall Study|Death|8|||
128906080|NCT00652366|463948644|FG004|Overall Study|Death|5|||
128906081|NCT00652366|463948640|FG000|Overall Study|Lack of Efficacy|84|||
128906082|NCT00652366|463948641|FG001|Overall Study|Lack of Efficacy|58|||
128906083|NCT00652366|463948642|FG002|Overall Study|Lack of Efficacy|53|||
128906084|NCT00652366|463948643|FG003|Overall Study|Lack of Efficacy|133|||
128906085|NCT00652366|463948644|FG004|Overall Study|Lack of Efficacy|13|||
128906086|NCT00652366|463948640|FG000|Overall Study|Violation of Selection Criteria|0|||
128906087|NCT00652366|463948641|FG001|Overall Study|Violation of Selection Criteria|0|||
128906088|NCT00652366|463948642|FG002|Overall Study|Violation of Selection Criteria|1|||
128906089|NCT00652366|463948643|FG003|Overall Study|Violation of Selection Criteria|0|||
128906090|NCT00652366|463948644|FG004|Overall Study|Violation of Selection Criteria|0|||
128906091|NCT00652366|463948640|FG000|Overall Study|Protocol Violation|1|||
128906092|NCT00652366|463948641|FG001|Overall Study|Protocol Violation|0|||
128906093|NCT00652366|463948642|FG002|Overall Study|Protocol Violation|0|||
128906094|NCT00652366|463948643|FG003|Overall Study|Protocol Violation|0|||
128906095|NCT00652366|463948644|FG004|Overall Study|Protocol Violation|0|||
128906096|NCT00652366|463948640|FG000|Overall Study|Refused treatment|3|||
128906097|NCT00652366|463948641|FG001|Overall Study|Refused treatment|7|||
128906098|NCT00652366|463948642|FG002|Overall Study|Refused treatment|6|||
128906099|NCT00652366|463948643|FG003|Overall Study|Refused treatment|17|||
128906100|NCT00652366|463948644|FG004|Overall Study|Refused treatment|5|||
128906101|NCT00652366|463948640|FG000|Overall Study|Other|5|||
128906102|NCT00652366|463948641|FG001|Overall Study|Other|2|||
128906103|NCT00652366|463948642|FG002|Overall Study|Other|3|||
129027006|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
129027007|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027008|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027009|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027010|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027011|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027012|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
129116314|NCT01614470|464721683|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
129116315|NCT03217591|464721684|FG000|Overall Study|Adverse Event|1|||
129116316|NCT03217591|464721685|FG001|Overall Study|Adverse Event|2|||
129116317|NCT03217591|464721686|FG002|Overall Study|Adverse Event|6|||
129116318|NCT03217591|464721684|FG000|Overall Study|Withdrawal by Subject|0|||
129116319|NCT03217591|464721685|FG001|Overall Study|Withdrawal by Subject|1|||
128906104|NCT00652366|463948643|FG003|Overall Study|Other|4|||
128906105|NCT00652366|463948644|FG004|Overall Study|Other|0|||
128906106|NCT02069899|463948649|FG000|Overall Study|Adverse Event|6|||
128906107|NCT02069899|463948650|FG001|Overall Study|Adverse Event|0|||
128906108|NCT02069899|463948651|FG002|Overall Study|Adverse Event|1|||
129027013|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
129116320|NCT03217591|464721686|FG002|Overall Study|Withdrawal by Subject|3|||
129116321|NCT03217591|464721684|FG000|Overall Study|Lost to Follow-up|1|||
129027014|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
128694857|NCT00400764|463180542|FG001|Phase II|Lost to Follow-up|0|||
128906109|NCT02069899|463948649|FG000|Overall Study|Withdrawal by Participant|2|||
128906110|NCT02069899|463948650|FG001|Overall Study|Withdrawal by Participant|0|||
128906111|NCT02069899|463948651|FG002|Overall Study|Withdrawal by Participant|0|||
128906112|NCT02069899|463948649|FG000|Overall Study|Lost to Follow-up|1|||
128906113|NCT02069899|463948650|FG001|Overall Study|Lost to Follow-up|0|||
128906114|NCT02069899|463948651|FG002|Overall Study|Lost to Follow-up|1|||
128906115|NCT02069899|463948649|FG000|Overall Study|Other|4|||
129116322|NCT03217591|464721685|FG001|Overall Study|Lost to Follow-up|0|||
129116323|NCT03217591|464721686|FG002|Overall Study|Lost to Follow-up|0|||
128906116|NCT02069899|463948650|FG001|Overall Study|Other|0|||
128906117|NCT02069899|463948651|FG002|Overall Study|Other|0|||
128906118|NCT02069899|463948649|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
128906119|NCT02069899|463948650|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
128906120|NCT02069899|463948651|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
128906121|NCT02069899|463948649|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
128906122|NCT02069899|463948650|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
128906123|NCT02069899|463948651|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
128906124|NCT00490451|463948654|FG000|Overall Study|Adverse Event|3|||
128906125|NCT00490451|463948655|FG001|Overall Study|Adverse Event|3|||
128906126|NCT00490451|463948654|FG000|Overall Study|Death|3|||
129116324|NCT03217591|464721684|FG000|Overall Study|Protocol Violation|1|||
129116325|NCT03217591|464721685|FG001|Overall Study|Protocol Violation|0|||
129116326|NCT03217591|464721686|FG002|Overall Study|Protocol Violation|1|||
129116327|NCT00249834|464721687|FG000|Overall Study|Ovarian stimulation failed|1|||
129116328|NCT00249834|464721688|FG001|Overall Study|Ovarian stimulation failed|0|||
129116329|NCT00249834|464721689|FG002|Overall Study|Ovarian stimulation failed|0|||
129116330|NCT00249834|464721690|FG003|Overall Study|Ovarian stimulation failed|0|||
129116331|NCT00249834|464721691|FG004|Overall Study|Ovarian stimulation failed|0|||
129116332|NCT00249834|464721692|FG005|Overall Study|Ovarian stimulation failed|0|||
129116333|NCT00249834|464721693|FG006|Overall Study|Ovarian stimulation failed|0|||
129116334|NCT00249834|464721694|FG007|Overall Study|Ovarian stimulation failed|0|||
129116335|NCT00249834|464721687|FG000|Overall Study|Failure of down-regulation|0|||
129116336|NCT00249834|464721688|FG001|Overall Study|Failure of down-regulation|0|||
129116337|NCT00249834|464721689|FG002|Overall Study|Failure of down-regulation|0|||
129116338|NCT00249834|464721690|FG003|Overall Study|Failure of down-regulation|0|||
129116339|NCT00249834|464721691|FG004|Overall Study|Failure of down-regulation|0|||
129116340|NCT00249834|464721692|FG005|Overall Study|Failure of down-regulation|0|||
129116341|NCT00249834|464721693|FG006|Overall Study|Failure of down-regulation|1|||
129116342|NCT00249834|464721694|FG007|Overall Study|Failure of down-regulation|0|||
129116343|NCT00249834|464721687|FG000|Overall Study|Protocol Violation|0|||
129116344|NCT00249834|464721688|FG001|Overall Study|Protocol Violation|19|||
129116345|NCT00249834|464721689|FG002|Overall Study|Protocol Violation|14|||
129116346|NCT00249834|464721690|FG003|Overall Study|Protocol Violation|8|||
129116347|NCT00249834|464721691|FG004|Overall Study|Protocol Violation|5|||
129116348|NCT00249834|464721692|FG005|Overall Study|Protocol Violation|2|||
129116349|NCT00249834|464721693|FG006|Overall Study|Protocol Violation|0|||
129116350|NCT00249834|464721694|FG007|Overall Study|Protocol Violation|0|||
129116351|NCT02895347|464721696|FG000|Overall Study|Withdrawal by Subject|3|||
129116352|NCT02895347|464721697|FG001|Overall Study|Withdrawal by Subject|1|||
128694858|NCT00400764|463180543|FG002|Phase II|Lost to Follow-up|1|||
128906127|NCT00490451|463948655|FG001|Overall Study|Death|1|||
128906128|NCT00490451|463948654|FG000|Overall Study|Withdrawal by Subject|2|||
128906129|NCT00490451|463948655|FG001|Overall Study|Withdrawal by Subject|0|||
128906130|NCT00490451|463948654|FG000|Overall Study|Investigator Decision|1|||
128906131|NCT00490451|463948655|FG001|Overall Study|Investigator Decision|0|||
128906132|NCT00490451|463948654|FG000|Overall Study|Protocol Violation|1|||
128906133|NCT00490451|463948655|FG001|Overall Study|Protocol Violation|0|||
129027015|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027016|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027017|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027018|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027019|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027020|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027021|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027022|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
129027023|NCT00112437|464390065|FG000|Year 2 (12-Month Extension)|Moved|0|||
129027024|NCT00112437|464390066|FG001|Year 2 (12-Month Extension)|Moved|0|||
129027025|NCT00112437|464390067|FG002|Year 2 (12-Month Extension)|Moved|0|||
129027026|NCT00112437|464390068|FG003|Year 2 (12-Month Extension)|Moved|0|||
129027027|NCT00112437|464390069|FG004|Year 2 (12-Month Extension)|Moved|0|||
129027028|NCT00112437|464390070|FG005|Year 2 (12-Month Extension)|Moved|0|||
129027029|NCT00112437|464390071|FG006|Year 2 (12-Month Extension)|Moved|0|||
129027030|NCT00112437|464390072|FG007|Year 2 (12-Month Extension)|Moved|0|||
129027031|NCT00112437|464390073|FG008|Year 2 (12-Month Extension)|Moved|0|||
129027032|NCT00112437|464390074|FG009|Year 2 (12-Month Extension)|Moved|1|||
129027033|NCT00112437|464390075|FG010|Year 2 (12-Month Extension)|Moved|0|||
129027034|NCT00112437|464390076|FG011|Year 2 (12-Month Extension)|Moved|0|||
129027035|NCT00112437|464390077|FG012|Year 2 (12-Month Extension)|Moved|0|||
129027036|NCT00112437|464390078|FG013|Year 2 (12-Month Extension)|Moved|0|||
129116353|NCT01204671|464721701|FG000|Overall Study|Adverse Event|4|||
129116354|NCT01204671|464721702|FG001|Overall Study|Adverse Event|3|||
129116355|NCT01204671|464721703|FG002|Overall Study|Adverse Event|3|||
129116356|NCT01204671|464721704|FG003|Overall Study|Adverse Event|3|||
128906134|NCT00490451|463948654|FG000|Overall Study|Progressive Disease|53|||
128906135|NCT00490451|463948655|FG001|Overall Study|Progressive Disease|34|||
128906136|NCT01181011|463948656|FG000|Overall Study|Adverse Event|2|||
128906137|NCT01181011|463948656|FG000|Overall Study|Lost to Follow-up|1|||
128906138|NCT00137111|463948657|FG000|Total Therapy|Death|35|||
128906139|NCT00137111|463948658|FG001|Total Therapy|Death|0|||
128906140|NCT00137111|463948659|FG002|Total Therapy|Death|0|||
128906141|NCT00137111|463948660|FG003|Total Therapy|Death|0|||
128906142|NCT00137111|463948657|FG000|Total Therapy|Non Compliance|5|||
128906143|NCT00137111|463948658|FG001|Total Therapy|Non Compliance|0|||
128906144|NCT00137111|463948659|FG002|Total Therapy|Non Compliance|0|||
128694859|NCT00400764|463180544|FG003|Phase II|Lost to Follow-up|0|||
128694860|NCT00400764|463180545|FG004|Phase II|Lost to Follow-up|0|||
128694861|NCT00400764|463180541|FG000|Phase II|Physician Decision|0|||
128694862|NCT00400764|463180542|FG001|Phase II|Physician Decision|0|||
128694863|NCT00400764|463180543|FG002|Phase II|Physician Decision|1|||
128694864|NCT00400764|463180544|FG003|Phase II|Physician Decision|1|||
128694865|NCT00400764|463180545|FG004|Phase II|Physician Decision|0|||
128694866|NCT00400764|463180541|FG000|Phase II|Sponsor's decision to terminate|0|||
128694867|NCT00400764|463180542|FG001|Phase II|Sponsor's decision to terminate|0|||
128694868|NCT00400764|463180543|FG002|Phase II|Sponsor's decision to terminate|18|||
128694869|NCT00400764|463180544|FG003|Phase II|Sponsor's decision to terminate|22|||
128694870|NCT00400764|463180545|FG004|Phase II|Sponsor's decision to terminate|11|||
128694871|NCT00400764|463180541|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
128694872|NCT00400764|463180542|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
128694873|NCT00400764|463180543|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
128694874|NCT00400764|463180544|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
128906145|NCT00137111|463948660|FG003|Total Therapy|Non Compliance|0|||
128906146|NCT04703075|463948661|FG000|Overall Study|Adverse Event|11|||
128906147|NCT04703075|463948662|FG001|Overall Study|Adverse Event|7|||
128906148|NCT04703075|463948661|FG000|Overall Study|Lost to Follow-up|6|||
128906149|NCT04703075|463948662|FG001|Overall Study|Lost to Follow-up|12|||
128906150|NCT04703075|463948661|FG000|Overall Study|Physician Decision|3|||
129116357|NCT01204671|464721705|FG004|Overall Study|Adverse Event|1|||
129116358|NCT01204671|464721701|FG000|Overall Study|Withdrawal by Subject|2|||
128694875|NCT00400764|463180545|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
128694876|NCT00400764|463180541|FG000|Phase II|Withdrawal by Subject|0|||
128694877|NCT00400764|463180542|FG001|Phase II|Withdrawal by Subject|0|||
128694878|NCT00400764|463180543|FG002|Phase II|Withdrawal by Subject|1|||
128694879|NCT00400764|463180544|FG003|Phase II|Withdrawal by Subject|1|||
128694880|NCT00400764|463180545|FG004|Phase II|Withdrawal by Subject|0|||
128694881|NCT02628938|463180546|FG000|Overall Study|Did not attend the follow up recall|2|||
128694882|NCT02628938|463180547|FG001|Overall Study|Did not attend the follow up recall|2|||
128694883|NCT02628938|463180548|FG002|Overall Study|Did not attend the follow up recall|1|||
128694884|NCT02628938|463180546|FG000|Overall Study|Failure to comply with the instructions|3|||
128694885|NCT02628938|463180547|FG001|Overall Study|Failure to comply with the instructions|0|||
128694886|NCT02628938|463180548|FG002|Overall Study|Failure to comply with the instructions|3|||
128694887|NCT00843856|463180551|FG000|Overall Study|Lost to Follow-up|1|||
128694888|NCT00843856|463180552|FG001|Overall Study|Lost to Follow-up|2|||
128694889|NCT01758523|463180553|FG000|Overall Study|Adverse Event|2|||
128694890|NCT01758523|463180554|FG001|Overall Study|Adverse Event|1|||
128694891|NCT01758523|463180553|FG000|Overall Study|Lack of Efficacy|4|||
128694892|NCT01758523|463180554|FG001|Overall Study|Lack of Efficacy|2|||
128694893|NCT01758523|463180553|FG000|Overall Study|Lost to Follow-up|3|||
128694894|NCT01758523|463180554|FG001|Overall Study|Lost to Follow-up|4|||
128694895|NCT01758523|463180553|FG000|Overall Study|Withdrawal by Subject|12|||
128694896|NCT01758523|463180554|FG001|Overall Study|Withdrawal by Subject|7|||
128694897|NCT01893203|463180555|FG000|Overall Study|Withdrawal by Subject|1|||
128694898|NCT00621959|463180556|FG000|Overall Study|Adverse Event|4|||
129116359|NCT01204671|464721702|FG001|Overall Study|Withdrawal by Subject|3|||
129116360|NCT01204671|464721703|FG002|Overall Study|Withdrawal by Subject|4|||
129116361|NCT01204671|464721704|FG003|Overall Study|Withdrawal by Subject|5|||
128694899|NCT00621959|463180557|FG001|Overall Study|Adverse Event|2|||
128906151|NCT04703075|463948662|FG001|Overall Study|Physician Decision|0|||
128906152|NCT04703075|463948661|FG000|Overall Study|Moved|0|||
128694900|NCT00621959|463180556|FG000|Overall Study|Lack of Efficacy|1|||
128694901|NCT00621959|463180557|FG001|Overall Study|Lack of Efficacy|1|||
128694902|NCT00621959|463180556|FG000|Overall Study|Lost to Follow-up|0|||
128694903|NCT00621959|463180557|FG001|Overall Study|Lost to Follow-up|2|||
128694904|NCT00621959|463180556|FG000|Overall Study|Withdrawal by Subject|1|||
128694905|NCT00621959|463180557|FG001|Overall Study|Withdrawal by Subject|1|||
128694906|NCT00621959|463180556|FG000|Overall Study|Other|1|||
128906153|NCT04703075|463948662|FG001|Overall Study|Moved|2|||
128906154|NCT04703075|463948661|FG000|Overall Study|Index INH Resistant|0|||
128694907|NCT00621959|463180557|FG001|Overall Study|Other|3|||
128906155|NCT04703075|463948662|FG001|Overall Study|Index INH Resistant|1|||
128906156|NCT04703075|463948661|FG000|Overall Study|Lack of Efficacy|6|||
128906157|NCT04703075|463948662|FG001|Overall Study|Lack of Efficacy|18|||
129116362|NCT01204671|464721705|FG004|Overall Study|Withdrawal by Subject|3|||
128694908|NCT00590135|463180558|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
128694909|NCT04729621|463180559|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
128694910|NCT04729621|463180560|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
128694911|NCT04729621|463180561|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
128694912|NCT04729621|463180562|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
128694913|NCT04729621|463180563|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
128694914|NCT04729621|463180559|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
128694915|NCT04729621|463180560|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
128694916|NCT04729621|463180561|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
128694917|NCT04729621|463180562|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
128694918|NCT04729621|463180563|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
128694919|NCT04729621|463180559|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
128694920|NCT04729621|463180560|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
128694921|NCT04729621|463180561|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
128906158|NCT01967550|463948663|FG000|Overall Study|Withdrawal by Subject|1|||
128906159|NCT01967550|463948664|FG001|Overall Study|Withdrawal by Subject|0|||
128906160|NCT01967550|463948663|FG000|Overall Study|Adverse Event|2|||
129027037|NCT00112437|464390079|FG014|Year 2 (12-Month Extension)|Moved|0|||
129027038|NCT00112437|464390080|FG015|Year 2 (12-Month Extension)|Moved|0|||
128694922|NCT04729621|463180562|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
128694923|NCT04729621|463180563|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
128694924|NCT04729621|463180559|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
128694925|NCT04729621|463180560|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
128694926|NCT04729621|463180561|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
128694927|NCT04729621|463180562|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
128694928|NCT04729621|463180563|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
128694929|NCT04729621|463180559|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
128694930|NCT04729621|463180560|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
128694931|NCT04729621|463180561|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
128694932|NCT04729621|463180562|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
128694933|NCT04729621|463180563|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
128694934|NCT04729621|463180559|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
128694935|NCT04729621|463180560|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
128694936|NCT04729621|463180561|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
128694937|NCT04729621|463180562|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
128694938|NCT04729621|463180563|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
128694939|NCT03439657|463180564|FG000|Overall Study|Adverse Event|2|||
128694940|NCT03439657|463180565|FG001|Overall Study|Adverse Event|3|||
128694941|NCT03439657|463180564|FG000|Overall Study|Lost to Follow-up|1|||
128694942|NCT03439657|463180565|FG001|Overall Study|Lost to Follow-up|0|||
128694943|NCT03439657|463180564|FG000|Overall Study|Protocol Violation|1|||
128694944|NCT03439657|463180565|FG001|Overall Study|Protocol Violation|1|||
128694945|NCT03439657|463180564|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
128694946|NCT03439657|463180565|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
128694947|NCT00370071|463180569|FG000|Overall Study|Withdrawal by Subject|2|||
128694948|NCT01999868|463180571|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
128906161|NCT01967550|463948664|FG001|Overall Study|Adverse Event|0|||
129027039|NCT00112437|464390081|FG016|Year 2 (12-Month Extension)|Moved|0|||
129027040|NCT00112437|464390082|FG017|Year 2 (12-Month Extension)|Moved|0|||
129027041|NCT00112437|464390083|FG018|Year 2 (12-Month Extension)|Moved|0|||
129027042|NCT00112437|464390084|FG019|Year 2 (12-Month Extension)|Moved|0|||
129027043|NCT00112437|464390085|FG020|Year 2 (12-Month Extension)|Moved|0|||
129027044|NCT00112437|464390086|FG021|Year 2 (12-Month Extension)|Moved|0|||
129027045|NCT00112437|464390087|FG022|Year 2 (12-Month Extension)|Moved|0|||
129027046|NCT00112437|464390088|FG023|Year 2 (12-Month Extension)|Moved|0|||
129027047|NCT00112437|464390089|FG024|Year 2 (12-Month Extension)|Moved|0|||
129027048|NCT00112437|464390090|FG025|Year 2 (12-Month Extension)|Moved|0|||
129027049|NCT00112437|464390065|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
129027050|NCT00112437|464390066|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
129027051|NCT00112437|464390067|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
129027052|NCT00112437|464390068|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
129027053|NCT00112437|464390069|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
129027054|NCT00112437|464390070|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
128694949|NCT01999868|463180572|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
128906162|NCT01967550|463948663|FG000|Overall Study|Protocol Violation|2|||
129027055|NCT00112437|464390071|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
129027056|NCT00112437|464390072|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
129027057|NCT00112437|464390073|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
129027058|NCT00112437|464390074|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
129027059|NCT00112437|464390075|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
128694950|NCT01999868|463180573|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
128694951|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
128694952|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
128694953|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
128694954|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
128694955|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
128694956|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
128694957|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
128694958|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
128694959|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
128694960|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
128694961|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
128694962|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
128694963|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
128694964|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
128694965|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
128694966|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
128694967|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
128694968|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
128694969|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
128694970|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
128694971|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
128694972|NCT01999868|463180571|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
128694973|NCT01999868|463180572|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
128694974|NCT01999868|463180573|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
128694975|NCT01999868|463180571|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
128694976|NCT01999868|463180572|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
129116363|NCT01204671|464721701|FG000|Overall Study|Lost to Follow-up|7|||
129116364|NCT01204671|464721702|FG001|Overall Study|Lost to Follow-up|8|||
128694977|NCT01999868|463180573|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
128694978|NCT01999868|463180571|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
128694979|NCT01999868|463180572|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
128694980|NCT01999868|463180573|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
128694981|NCT01999868|463180571|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
128694982|NCT01999868|463180572|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
128694983|NCT01999868|463180573|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
128694984|NCT01999868|463180571|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
128694985|NCT01999868|463180572|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
128694986|NCT01999868|463180573|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
128694987|NCT01999868|463180571|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
128694988|NCT01999868|463180572|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
129116365|NCT01204671|464721703|FG002|Overall Study|Lost to Follow-up|6|||
129116366|NCT01204671|464721704|FG003|Overall Study|Lost to Follow-up|4|||
129116367|NCT01204671|464721705|FG004|Overall Study|Lost to Follow-up|0|||
129116368|NCT01204671|464721701|FG000|Overall Study|Unknown Completion Status|1|||
129116369|NCT01204671|464721702|FG001|Overall Study|Unknown Completion Status|1|||
129116370|NCT01204671|464721703|FG002|Overall Study|Unknown Completion Status|0|||
129116371|NCT01204671|464721704|FG003|Overall Study|Unknown Completion Status|0|||
129116372|NCT01204671|464721705|FG004|Overall Study|Unknown Completion Status|0|||
129116373|NCT01204671|464721701|FG000|Overall Study|Physician Decision|0|||
129116374|NCT01204671|464721702|FG001|Overall Study|Physician Decision|0|||
129116375|NCT01204671|464721703|FG002|Overall Study|Physician Decision|0|||
129116376|NCT01204671|464721704|FG003|Overall Study|Physician Decision|1|||
129116377|NCT01204671|464721705|FG004|Overall Study|Physician Decision|0|||
129116378|NCT00492726|464721710|FG000|Overall Study|Adverse Event|10|||
129116379|NCT00492726|464721711|FG001|Overall Study|Adverse Event|6|||
129116380|NCT00492726|464721710|FG000|Overall Study|Death|7|||
128694989|NCT01999868|463180573|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
128694990|NCT01999868|463180571|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
128694991|NCT01999868|463180572|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
128694992|NCT01999868|463180573|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
128694993|NCT00289016|463180578|FG000|Overall Study|Disease Progression|29|||
129116381|NCT00492726|464721711|FG001|Overall Study|Death|2|||
129116382|NCT00492726|464721710|FG000|Overall Study|Lack of Efficacy|0|||
129116383|NCT00492726|464721711|FG001|Overall Study|Lack of Efficacy|2|||
129116384|NCT00492726|464721710|FG000|Overall Study|Lost to Follow-up|27|||
129116385|NCT00492726|464721711|FG001|Overall Study|Lost to Follow-up|19|||
128694994|NCT00289016|463180578|FG000|Overall Study|Death|2|||
128694995|NCT00289016|463180578|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
128694996|NCT00289016|463180578|FG000|Overall Study|Withdrawal by Subject|2|||
128694997|NCT00289016|463180578|FG000|Overall Study|Adverse Event|1|||
128694998|NCT00289016|463180578|FG000|Overall Study|Other|1|||
128694999|NCT00319501|463180579|FG000|Double-blind Period|Withdrawal by Subject|0|||
128695000|NCT00319501|463180580|FG001|Double-blind Period|Withdrawal by Subject|3|||
128695001|NCT00319501|463180579|FG000|Double-blind Period|Sponsor Request|1|||
128695002|NCT00319501|463180580|FG001|Double-blind Period|Sponsor Request|0|||
128695003|NCT00319501|463180579|FG000|Double-blind Period|Did not receive treatment|42|||
128695004|NCT00319501|463180580|FG001|Double-blind Period|Did not receive treatment|29|||
128695005|NCT00319501|463180579|FG000|Open-label Period|Adverse Event|5|||
128695006|NCT00319501|463180580|FG001|Open-label Period|Adverse Event|0|||
128695007|NCT00319501|463180579|FG000|Open-label Period|Protocol Violation|6|||
128695008|NCT00319501|463180580|FG001|Open-label Period|Protocol Violation|0|||
128695009|NCT00319501|463180579|FG000|Open-label Period|Withdrawal by Subject|38|||
128695010|NCT00319501|463180580|FG001|Open-label Period|Withdrawal by Subject|0|||
128695011|NCT00319501|463180579|FG000|Open-label Period|Principal Investigator decision|6|||
128695012|NCT00319501|463180580|FG001|Open-label Period|Principal Investigator decision|0|||
128695013|NCT00319501|463180579|FG000|Open-label Period|Sponsor request|12|||
128695014|NCT00319501|463180580|FG001|Open-label Period|Sponsor request|0|||
128695015|NCT00319501|463180579|FG000|Open-label Period|Lost to Follow-up|5|||
128695016|NCT00319501|463180580|FG001|Open-label Period|Lost to Follow-up|0|||
128695017|NCT00319501|463180579|FG000|Open-label Period|Did not receive treatment|33|||
128695018|NCT00319501|463180580|FG001|Open-label Period|Did not receive treatment|0|||
128695019|NCT00319501|463180579|FG000|Open-label Period|Other|11|||
128695020|NCT00319501|463180580|FG001|Open-label Period|Other|0|||
128695021|NCT00319501|463180579|FG000|Open-label Extension Period|Adverse Event|2|||
128695022|NCT00319501|463180580|FG001|Open-label Extension Period|Adverse Event|0|||
128695023|NCT00319501|463180579|FG000|Open-label Extension Period|Did not receive treatment|18|||
128695024|NCT00319501|463180580|FG001|Open-label Extension Period|Did not receive treatment|0|||
128695025|NCT00319501|463180579|FG000|Open-label Extension Period|Other|1|||
128695026|NCT00319501|463180580|FG001|Open-label Extension Period|Other|0|||
128695027|NCT00319501|463180579|FG000|Open-label Extension Period|Principal investigator decision|2|||
128695028|NCT00319501|463180580|FG001|Open-label Extension Period|Principal investigator decision|0|||
129027060|NCT00112437|464390076|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
129027061|NCT00112437|464390077|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
129027062|NCT00112437|464390078|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
129027063|NCT00112437|464390079|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
129027064|NCT00112437|464390080|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
129027065|NCT00112437|464390081|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
129027066|NCT00112437|464390082|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
129027067|NCT00112437|464390083|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
129027068|NCT00112437|464390084|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
129027069|NCT00112437|464390085|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
129027070|NCT00112437|464390086|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
129027071|NCT00112437|464390087|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
129027072|NCT00112437|464390088|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
129027073|NCT00112437|464390089|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
129027074|NCT00112437|464390090|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
129027075|NCT00112437|464390065|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027076|NCT00112437|464390066|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027077|NCT00112437|464390067|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027078|NCT00112437|464390068|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027079|NCT00112437|464390069|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027080|NCT00112437|464390070|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027081|NCT00112437|464390071|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027082|NCT00112437|464390072|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027083|NCT00112437|464390073|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027084|NCT00112437|464390074|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027085|NCT00112437|464390075|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027086|NCT00112437|464390076|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
129027087|NCT00112437|464390077|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027088|NCT00112437|464390078|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
129027089|NCT00112437|464390079|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027090|NCT00112437|464390080|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
129027091|NCT00112437|464390081|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129116386|NCT00492726|464721710|FG000|Overall Study|Physician Decision|0|||
129116387|NCT00492726|464721711|FG001|Overall Study|Physician Decision|1|||
128695029|NCT00319501|463180579|FG000|Open-label Extension Period|Sponsor request|26|||
128695030|NCT00319501|463180580|FG001|Open-label Extension Period|Sponsor request|0|||
128695031|NCT00319501|463180579|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
128695032|NCT00319501|463180580|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
128695033|NCT02764697|463180587|FG000|Overall Study|Lack of Efficacy|3|||
128695034|NCT00302107|463180588|FG000|Overall Study|Lost to Follow-up|6|||
128695035|NCT00302107|463180589|FG001|Overall Study|Lost to Follow-up|5|||
128695036|NCT00302107|463180588|FG000|Overall Study|Protocol Violation|1|||
128695037|NCT00302107|463180589|FG001|Overall Study|Protocol Violation|0|||
128695038|NCT00302107|463180588|FG000|Overall Study|Relocation|0|||
128695039|NCT00302107|463180589|FG001|Overall Study|Relocation|1|||
128695040|NCT00302107|463180588|FG000|Overall Study|Withdrawal by Subject|0|||
128695041|NCT00302107|463180589|FG001|Overall Study|Withdrawal by Subject|3|||
128695042|NCT00302107|463180588|FG000|Overall Study|Adverse Event|1|||
128695043|NCT00302107|463180589|FG001|Overall Study|Adverse Event|0|||
128695044|NCT01790932|463180590|FG000|Overall Study|Disease Progression|41|||
128695045|NCT01790932|463180590|FG000|Overall Study|Adverse Event|7|||
128695046|NCT01790932|463180590|FG000|Overall Study|Physician Decision|1|||
128695047|NCT01790932|463180590|FG000|Overall Study|Withdrawal by Subject|1|||
128695048|NCT04223973|463180591|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
128695049|NCT04223973|463180592|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
128695050|NCT04223973|463180591|FG000|Overall Study|Adverse Event|4|||
128695051|NCT04223973|463180592|FG001|Overall Study|Adverse Event|0|||
128695052|NCT04223973|463180591|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
128695053|NCT04223973|463180592|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
128695054|NCT04223973|463180591|FG000|Overall Study|Physician Decision|1|||
128695055|NCT04223973|463180592|FG001|Overall Study|Physician Decision|1|||
128695056|NCT04223973|463180591|FG000|Overall Study|Withdrawal by Subject|0|||
128695057|NCT04223973|463180592|FG001|Overall Study|Withdrawal by Subject|1|||
128695058|NCT01757535|463180598|FG000|Overall Study|Disease Relapse|151|||
128695059|NCT01757535|463180599|FG001|Overall Study|Disease Relapse|181|||
128695060|NCT01757535|463180598|FG000|Overall Study|Other Reasons|28|||
128695061|NCT01757535|463180599|FG001|Overall Study|Other Reasons|27|||
128695062|NCT01757535|463180598|FG000|Overall Study|Adverse Event|31|||
128695063|NCT01757535|463180599|FG001|Overall Study|Adverse Event|11|||
128695064|NCT01757535|463180598|FG000|Overall Study|Withdrew Consent|19|||
128695065|NCT01757535|463180599|FG001|Overall Study|Withdrew Consent|13|||
128695066|NCT01757535|463180598|FG000|Overall Study|Physician Decision|7|||
128695067|NCT01757535|463180599|FG001|Overall Study|Physician Decision|0|||
128695068|NCT01757535|463180598|FG000|Overall Study|Death|2|||
128695069|NCT01757535|463180599|FG001|Overall Study|Death|2|||
128695070|NCT00531934|463182035|FG000|Overall Study|Adverse Event|4|||
128695071|NCT00531934|463182036|FG001|Overall Study|Adverse Event|8|||
128695072|NCT00531934|463182035|FG000|Overall Study|Progression|52|||
128695073|NCT00531934|463182036|FG001|Overall Study|Progression|42|||
128695074|NCT00531934|463182035|FG000|Overall Study|Death|7|||
128695075|NCT00531934|463182036|FG001|Overall Study|Death|10|||
128695076|NCT00531934|463182035|FG000|Overall Study|Withdrawal by Subject|1|||
128695077|NCT00531934|463182036|FG001|Overall Study|Withdrawal by Subject|1|||
128695078|NCT00531934|463182035|FG000|Overall Study|Other|2|||
128695079|NCT00531934|463182036|FG001|Overall Study|Other|2|||
128695080|NCT00217620|463182041|FG000|Overall Study|Adverse Event|2|||
128695081|NCT00217620|463182041|FG000|Overall Study|Progression|31|||
128695082|NCT00217620|463182041|FG000|Overall Study|Not Protocol Specified|4|||
128906163|NCT01967550|463948664|FG001|Overall Study|Protocol Violation|1|||
128906164|NCT01967550|463948663|FG000|Overall Study|Non Compliance|0|||
128906165|NCT01967550|463948664|FG001|Overall Study|Non Compliance|1|||
128906166|NCT02500121|463948672|FG000|Overall Study|Lost to Follow-up|0|||
128906167|NCT02500121|463948673|FG001|Overall Study|Lost to Follow-up|1|||
128906168|NCT02500121|463948672|FG000|Overall Study|Withdrawal by Subject|1|||
128906169|NCT02500121|463948673|FG001|Overall Study|Withdrawal by Subject|1|||
128906170|NCT02500121|463948672|FG000|Overall Study|Death|26|||
128906171|NCT02500121|463948673|FG001|Overall Study|Death|24|||
128906172|NCT00852995|463948674|FG000|Overall Study|Adverse Event|1|||
128695083|NCT00217620|463182041|FG000|Overall Study|Ineligible|13|||
128695084|NCT00217620|463182041|FG000|Overall Study|Never received treatment|1|||
128695085|NCT00825682|463182047|FG000|Overall Study|personal reasons/ inconvenience|13|||
128695086|NCT00825682|463182048|FG001|Overall Study|personal reasons/ inconvenience|5|||
128695087|NCT01897454|463182049|FG000|Overall Study|Withdrawal by Subject|1|||
128695088|NCT01392443|463182056|FG000|Overall Study|Disease progression|30|||
128906173|NCT00852995|463948675|FG001|Overall Study|Adverse Event|0|||
128695089|NCT01392443|463182056|FG000|Overall Study|Adverse Event|24|||
128695090|NCT01392443|463182056|FG000|Overall Study|Death|7|||
128695091|NCT01392443|463182056|FG000|Overall Study|Withdrawal by Subject|5|||
128695092|NCT01392443|463182056|FG000|Overall Study|Lost to Follow-up|1|||
128695093|NCT01392443|463182056|FG000|Overall Study|Protocol Violation|1|||
128695094|NCT01977794|463182057|FG000|Overall Study|Adverse Event|2|||
128695095|NCT01977794|463182058|FG001|Overall Study|Adverse Event|2|||
128695096|NCT01977794|463182057|FG000|Overall Study|Lost to Follow-up|2|||
128695097|NCT01977794|463182058|FG001|Overall Study|Lost to Follow-up|1|||
128695098|NCT01977794|463182057|FG000|Overall Study|Protocol Violation|1|||
128906174|NCT00852995|463948676|FG002|Overall Study|Adverse Event|4|||
128906175|NCT00852995|463948677|FG003|Overall Study|Adverse Event|0|||
128906176|NCT00852995|463948678|FG004|Overall Study|Adverse Event|0|||
128695099|NCT01977794|463182058|FG001|Overall Study|Protocol Violation|0|||
128695100|NCT01977794|463182057|FG000|Overall Study|Death|1|||
128695101|NCT01977794|463182058|FG001|Overall Study|Death|1|||
128695102|NCT01977794|463182057|FG000|Overall Study|Withdrew consent|2|||
128695103|NCT01977794|463182058|FG001|Overall Study|Withdrew consent|1|||
128695104|NCT01977794|463182057|FG000|Overall Study|Other|0|||
128695105|NCT01977794|463182058|FG001|Overall Study|Other|1|||
128695106|NCT00533897|463182063|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
128695107|NCT00533897|463182064|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
128695108|NCT00533897|463182065|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
128695109|NCT00533897|463182066|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
128695110|NCT00533897|463182067|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
128695111|NCT00533897|463182068|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
128695112|NCT00533897|463182069|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
128695113|NCT00533897|463182070|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
128695114|NCT00533897|463182063|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
128695115|NCT00533897|463182064|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
128695116|NCT00533897|463182065|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
128695117|NCT00533897|463182066|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
128695118|NCT00533897|463182067|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
128695119|NCT00533897|463182068|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
128695120|NCT00533897|463182069|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
128695121|NCT00533897|463182070|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
128695122|NCT00533897|463182063|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
128695123|NCT00533897|463182064|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
128695124|NCT00533897|463182065|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
128695125|NCT00533897|463182066|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
128695126|NCT00533897|463182067|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
128695127|NCT00533897|463182068|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
128695128|NCT00533897|463182069|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
128695129|NCT00533897|463182070|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
128695130|NCT00533897|463182063|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
128695131|NCT00533897|463182064|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
128906177|NCT00852995|463948674|FG000|Overall Study|Lost to Follow-up|0|||
128906178|NCT00852995|463948675|FG001|Overall Study|Lost to Follow-up|1|||
128906179|NCT00852995|463948676|FG002|Overall Study|Lost to Follow-up|1|||
129027092|NCT00112437|464390082|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027093|NCT00112437|464390083|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
128695132|NCT00533897|463182065|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
128695133|NCT00533897|463182066|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
128695134|NCT00533897|463182067|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
128695135|NCT00533897|463182068|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
128695136|NCT00533897|463182069|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
128695137|NCT00533897|463182070|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
128695138|NCT00533897|463182063|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
128695139|NCT00533897|463182064|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
128695140|NCT00533897|463182065|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
128695141|NCT00533897|463182066|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
128695142|NCT00533897|463182067|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
128695143|NCT00533897|463182068|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
128695144|NCT00533897|463182069|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
128695145|NCT00533897|463182070|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
128764962|NCT02296190|463430380|FG003|Overall Study|Patient was given Propofol|1|||
129027094|NCT00112437|464390084|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027095|NCT00112437|464390085|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027096|NCT00112437|464390086|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027097|NCT00112437|464390087|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027098|NCT00112437|464390088|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027099|NCT00112437|464390089|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027100|NCT00112437|464390090|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129027101|NCT00112437|464390065|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027102|NCT00112437|464390066|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
128695146|NCT00533897|463182063|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
128695147|NCT00533897|463182064|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
128695148|NCT00533897|463182065|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
128695149|NCT00533897|463182066|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
128695150|NCT00533897|463182067|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
128764963|NCT02296190|463430381|FG004|Overall Study|Patient was given Propofol|0|||
128906180|NCT00852995|463948677|FG003|Overall Study|Lost to Follow-up|0|||
129027103|NCT00112437|464390067|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027104|NCT00112437|464390068|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027105|NCT00112437|464390069|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
128695151|NCT00533897|463182068|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
128695152|NCT00533897|463182069|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
128695153|NCT00533897|463182070|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
128695154|NCT00533897|463182063|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
128695155|NCT00533897|463182064|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
128906181|NCT00852995|463948678|FG004|Overall Study|Lost to Follow-up|0|||
128906182|NCT00852995|463948674|FG000|Overall Study|Withdrawal by Subject|4|||
128906183|NCT00852995|463948675|FG001|Overall Study|Withdrawal by Subject|0|||
128906184|NCT00852995|463948676|FG002|Overall Study|Withdrawal by Subject|0|||
128906185|NCT00852995|463948677|FG003|Overall Study|Withdrawal by Subject|1|||
128906186|NCT00852995|463948678|FG004|Overall Study|Withdrawal by Subject|2|||
128906187|NCT00852995|463948674|FG000|Overall Study|Non-Compliance|0|||
128906188|NCT00852995|463948675|FG001|Overall Study|Non-Compliance|0|||
128906189|NCT00852995|463948676|FG002|Overall Study|Non-Compliance|0|||
128906190|NCT00852995|463948677|FG003|Overall Study|Non-Compliance|2|||
128906191|NCT00852995|463948678|FG004|Overall Study|Non-Compliance|0|||
128906192|NCT00852995|463948674|FG000|Overall Study|Progressive Disease|1|||
128906193|NCT00852995|463948675|FG001|Overall Study|Progressive Disease|0|||
128906194|NCT00852995|463948676|FG002|Overall Study|Progressive Disease|0|||
128906195|NCT00852995|463948677|FG003|Overall Study|Progressive Disease|2|||
128906196|NCT00852995|463948678|FG004|Overall Study|Progressive Disease|1|||
128906197|NCT00852995|463948674|FG000|Overall Study|Physician Decision|1|||
128906198|NCT00852995|463948675|FG001|Overall Study|Physician Decision|0|||
128906199|NCT00852995|463948676|FG002|Overall Study|Physician Decision|0|||
128906200|NCT00852995|463948677|FG003|Overall Study|Physician Decision|0|||
128906201|NCT00852995|463948678|FG004|Overall Study|Physician Decision|0|||
128906202|NCT00852995|463948674|FG000|Overall Study|Protocol Violation|0|||
128906203|NCT00852995|463948675|FG001|Overall Study|Protocol Violation|0|||
128906204|NCT00852995|463948676|FG002|Overall Study|Protocol Violation|0|||
128695156|NCT00533897|463182065|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
128695157|NCT00533897|463182066|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
128695158|NCT00533897|463182067|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
128695159|NCT00533897|463182068|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
128695160|NCT00533897|463182069|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
128695161|NCT00533897|463182070|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
128695162|NCT00533897|463182063|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
128695163|NCT00533897|463182064|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
128695164|NCT00533897|463182065|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
128695165|NCT00533897|463182066|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
128695166|NCT00533897|463182067|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
128695167|NCT00533897|463182068|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
128695168|NCT00533897|463182069|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
128695169|NCT00533897|463182070|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
128695170|NCT00533897|463182063|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
128695171|NCT00533897|463182064|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
128695172|NCT00533897|463182065|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
128695173|NCT00533897|463182066|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
128906205|NCT00852995|463948677|FG003|Overall Study|Protocol Violation|0|||
128906206|NCT00852995|463948678|FG004|Overall Study|Protocol Violation|1|||
128906207|NCT00852995|463948674|FG000|Overall Study|Moved Out of Area|1|||
128906208|NCT00852995|463948675|FG001|Overall Study|Moved Out of Area|0|||
128906209|NCT00852995|463948676|FG002|Overall Study|Moved Out of Area|0|||
128906210|NCT00852995|463948677|FG003|Overall Study|Moved Out of Area|0|||
128906211|NCT00852995|463948678|FG004|Overall Study|Moved Out of Area|0|||
128906212|NCT01836783|463948680|FG000|Overall Study|Withdrawal by Subject|0|||
128906213|NCT01836783|463948681|FG001|Overall Study|Withdrawal by Subject|2|||
128906214|NCT04518462|463948685|FG000|Overall Study|Withdrawal by Subject|0|||
128906215|NCT04518462|463948686|FG001|Overall Study|Withdrawal by Subject|0|||
128906216|NCT04518462|463948687|FG002|Overall Study|Withdrawal by Subject|1|||
128906217|NCT04518462|463948685|FG000|Overall Study|Physician Decision|1|||
128906218|NCT04518462|463948686|FG001|Overall Study|Physician Decision|1|||
128906219|NCT04518462|463948687|FG002|Overall Study|Physician Decision|0|||
128906220|NCT04418076|463948691|FG000|Overall Study|Death|1|||
128906221|NCT04418076|463948692|FG001|Overall Study|Death|0|||
128906222|NCT04418076|463948693|FG002|Overall Study|Death|0|||
128906223|NCT04418076|463948694|FG003|Overall Study|Death|0|||
128695174|NCT00533897|463182067|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
128906224|NCT04418076|463948691|FG000|Overall Study|Lost to Follow-up|2|||
128906225|NCT04418076|463948692|FG001|Overall Study|Lost to Follow-up|5|||
128906226|NCT04418076|463948693|FG002|Overall Study|Lost to Follow-up|1|||
128906227|NCT04418076|463948694|FG003|Overall Study|Lost to Follow-up|2|||
128906228|NCT04418076|463948691|FG000|Overall Study|Withdrawal by Subject|1|||
128906229|NCT04418076|463948692|FG001|Overall Study|Withdrawal by Subject|0|||
129132901|NCT00827242|464778559|FG001|Overall Study|Physician Decision|0|||
129027106|NCT00112437|464390070|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027107|NCT00112437|464390071|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027108|NCT00112437|464390072|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027109|NCT00112437|464390073|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
128764964|NCT02296190|463430382|FG005|Overall Study|Patient was given Propofol|0|||
128764965|NCT02296190|463430377|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
128764966|NCT02296190|463430378|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
128764967|NCT02296190|463430379|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
128764968|NCT02296190|463430380|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
128764969|NCT02296190|463430381|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
128764970|NCT02296190|463430382|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
128764971|NCT02296190|463430377|FG000|Overall Study|Blood pressure <100 after sedation|0|||
128764972|NCT02296190|463430378|FG001|Overall Study|Blood pressure <100 after sedation|0|||
128764973|NCT02296190|463430379|FG002|Overall Study|Blood pressure <100 after sedation|0|||
128764974|NCT02296190|463430380|FG003|Overall Study|Blood pressure <100 after sedation|1|||
128764975|NCT02296190|463430381|FG004|Overall Study|Blood pressure <100 after sedation|0|||
128764976|NCT02296190|463430382|FG005|Overall Study|Blood pressure <100 after sedation|0|||
128764977|NCT02296190|463430377|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
128764978|NCT02296190|463430378|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
128764979|NCT02296190|463430379|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
128764980|NCT02296190|463430380|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
128764981|NCT02296190|463430381|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
128764982|NCT02296190|463430382|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
128764983|NCT02296190|463430377|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
128764984|NCT02296190|463430378|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
128764985|NCT02296190|463430379|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
128764986|NCT02296190|463430380|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
128764987|NCT02296190|463430381|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
128764988|NCT02296190|463430382|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
128764989|NCT02296190|463430377|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
128764990|NCT02296190|463430378|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
128764991|NCT02296190|463430379|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
128764992|NCT02296190|463430380|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
128764993|NCT02296190|463430381|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
128764994|NCT02296190|463430382|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
128764995|NCT02296190|463430377|FG000|Overall Study|Lab result not available in time|1|||
128764996|NCT02296190|463430378|FG001|Overall Study|Lab result not available in time|0|||
128764997|NCT02296190|463430379|FG002|Overall Study|Lab result not available in time|0|||
128764998|NCT02296190|463430380|FG003|Overall Study|Lab result not available in time|0|||
128764999|NCT02296190|463430381|FG004|Overall Study|Lab result not available in time|0|||
128765000|NCT02296190|463430382|FG005|Overall Study|Lab result not available in time|0|||
128765001|NCT00717314|463430383|FG000|Overall Study|Adverse Event|3|||
128765002|NCT00717314|463430384|FG001|Overall Study|Adverse Event|2|||
128765003|NCT00717314|463430383|FG000|Overall Study|Protocol Violation|1|||
128765004|NCT00717314|463430384|FG001|Overall Study|Protocol Violation|0|||
128765005|NCT00717314|463430383|FG000|Overall Study|Lost to Follow-up|1|||
128765006|NCT00717314|463430384|FG001|Overall Study|Lost to Follow-up|5|||
128765007|NCT00717314|463430383|FG000|Overall Study|Withdrawal by Subject|1|||
128765008|NCT00717314|463430384|FG001|Overall Study|Withdrawal by Subject|3|||
128765009|NCT00117156|463430385|FG000|Overall Study|Adverse Event|9|||
128765010|NCT00117156|463430385|FG000|Overall Study|Physician Decision|1|||
128765011|NCT00117156|463430385|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
128765012|NCT01521884|463430388|FG000|Overall Study|Non Responders|10|||
128765013|NCT01521884|463430388|FG000|Overall Study|Adverse Event|5|||
128765014|NCT01521884|463430388|FG000|Overall Study|Pregnancy|1|||
128765015|NCT01521884|463430388|FG000|Overall Study|Withdrawal by Subject|1|||
128765016|NCT01521884|463430388|FG000|Overall Study|Physician Decision|2|||
128765017|NCT01521884|463430388|FG000|Overall Study|Protocol Violation|3|||
128765018|NCT01521884|463430388|FG000|Overall Study|Participant non-eligible|1|||
128765019|NCT01521884|463430388|FG000|Overall Study|Lost to Follow-up|4|||
128765020|NCT02821819|463430389|FG000|Overall Study|Protocol Violation|1|||
128765021|NCT00085202|463430390|FG000|Overall Study|Still on therapy|2|||
129027110|NCT00112437|464390074|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027111|NCT00112437|464390075|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027112|NCT00112437|464390076|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027113|NCT00112437|464390077|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
128765022|NCT00085202|463430391|FG001|Overall Study|Still on therapy|0|||
128765023|NCT00085202|463430390|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
128765024|NCT00085202|463430391|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
128765025|NCT00085202|463430390|FG000|Overall Study|Excessive toxicity|6|||
128765026|NCT00085202|463430391|FG001|Overall Study|Excessive toxicity|5|||
128765027|NCT00085202|463430390|FG000|Overall Study|Non-specified|3|||
129027114|NCT00112437|464390078|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
128906230|NCT04418076|463948693|FG002|Overall Study|Withdrawal by Subject|1|||
128906231|NCT04418076|463948694|FG003|Overall Study|Withdrawal by Subject|1|||
128906232|NCT04418076|463948691|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
128906233|NCT04418076|463948692|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
128906234|NCT04418076|463948693|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
128906235|NCT04418076|463948694|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
129116388|NCT00492726|464721710|FG000|Overall Study|Withdrawal by Subject|6|||
129116389|NCT00492726|464721711|FG001|Overall Study|Withdrawal by Subject|3|||
129116390|NCT00492726|464721710|FG000|Overall Study|Non compliant with study medication|0|||
129116391|NCT00492726|464721711|FG001|Overall Study|Non compliant with study medication|3|||
129116392|NCT04386902|464721712|FG000|Overall Study|Withdrawal by Subject|5|||
129116393|NCT04386902|464721712|FG000|Overall Study|Technical problems in the recording|5|||
129116394|NCT02404545|464721713|FG000|Overall Study|Sponsor Termination|6|||
129116395|NCT02404545|464721714|FG001|Overall Study|Sponsor Termination|6|||
129116396|NCT01712516|464723176|FG000|Overall Study|Technical problems|0|||
129116397|NCT01712516|464723177|FG001|Overall Study|Technical problems|0|||
129116398|NCT01712516|464723178|FG002|Overall Study|Technical problems|0|||
129116399|NCT01712516|464723179|FG003|Overall Study|Technical problems|2|||
129116400|NCT01712516|464723176|FG000|Overall Study|Lost to Follow-up|0|||
129116401|NCT01712516|464723177|FG001|Overall Study|Lost to Follow-up|0|||
129116402|NCT01712516|464723178|FG002|Overall Study|Lost to Follow-up|2|||
129116403|NCT01712516|464723179|FG003|Overall Study|Lost to Follow-up|1|||
129116404|NCT01712516|464723176|FG000|Overall Study|Death|0|||
129116405|NCT01712516|464723177|FG001|Overall Study|Death|1|||
129116406|NCT01712516|464723178|FG002|Overall Study|Death|0|||
129116407|NCT01712516|464723179|FG003|Overall Study|Death|0|||
129116408|NCT01712516|464723176|FG000|Overall Study|Protocol deviation|1|||
129116409|NCT01712516|464723177|FG001|Overall Study|Protocol deviation|0|||
129116410|NCT01712516|464723178|FG002|Overall Study|Protocol deviation|1|||
129116411|NCT01712516|464723179|FG003|Overall Study|Protocol deviation|0|||
129116412|NCT01712516|464723176|FG000|Overall Study|Physician Decision|2|||
129116413|NCT01712516|464723177|FG001|Overall Study|Physician Decision|0|||
129116414|NCT01712516|464723178|FG002|Overall Study|Physician Decision|0|||
129116415|NCT01712516|464723179|FG003|Overall Study|Physician Decision|1|||
129116416|NCT01712516|464723176|FG000|Overall Study|Withdrawal by Subject|3|||
129116417|NCT01712516|464723177|FG001|Overall Study|Withdrawal by Subject|9|||
129116418|NCT01712516|464723178|FG002|Overall Study|Withdrawal by Subject|3|||
128695175|NCT00533897|463182068|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
128695176|NCT00533897|463182069|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
128695177|NCT00533897|463182070|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
128695178|NCT00533897|463182063|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
128695179|NCT00533897|463182064|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
128695180|NCT00533897|463182065|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
128695181|NCT00533897|463182066|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
128695182|NCT00533897|463182067|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
128695183|NCT00533897|463182068|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
128695184|NCT00533897|463182069|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
128695185|NCT00533897|463182070|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
128695186|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
128695187|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
128695188|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
128695189|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
128695190|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
128695191|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
128695192|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
128695193|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
128695194|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Death|0|||
128695195|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Death|0|||
128695196|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Death|0|||
128695197|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Death|0|||
128906236|NCT01471782|463948695|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
129116419|NCT01712516|464723179|FG003|Overall Study|Withdrawal by Subject|9|||
129116420|NCT01181167|464723180|FG000|Overall Study|Adverse Event|11|||
129116421|NCT01181167|464723181|FG001|Overall Study|Adverse Event|21|||
129116422|NCT01181167|464723180|FG000|Overall Study|Lost to Follow-up|1|||
129116423|NCT01181167|464723181|FG001|Overall Study|Lost to Follow-up|0|||
129116424|NCT01181167|464723180|FG000|Overall Study|Physician Decision|2|||
128695198|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Death|0|||
128695199|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Death|0|||
129116425|NCT01181167|464723181|FG001|Overall Study|Physician Decision|3|||
129116426|NCT01181167|464723180|FG000|Overall Study|Protocol Violation|3|||
129116427|NCT01181167|464723181|FG001|Overall Study|Protocol Violation|0|||
129116428|NCT01181167|464723180|FG000|Overall Study|Withdrawal by Subject|6|||
128695200|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Death|1|||
128695201|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Death|3|||
128695202|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
128695203|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
128695204|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
128695205|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
128695206|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
128695207|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
128695208|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
128695209|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
128695210|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
128695211|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
128695212|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
128695213|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
128906237|NCT01471782|463948696|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
128695214|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
128906238|NCT01471782|463948697|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
129116429|NCT01181167|464723181|FG001|Overall Study|Withdrawal by Subject|8|||
129116430|NCT00161213|464723182|FG000|Overall Study|Withdrawal by Subject|1|||
129116431|NCT00161213|464723182|FG000|Overall Study|Evaluable for toxicity but not response|1|||
129116432|NCT03103503|464723183|FG000|Overall Study|Death|64|||
129116433|NCT03103503|464723183|FG000|Overall Study|Physician Decision|57|||
129116434|NCT03103503|464723183|FG000|Overall Study|Withdrawal by Subject|10|||
129116435|NCT03103503|464723183|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
129116436|NCT03103503|464723183|FG000|Overall Study|Lost to Follow-up|3|||
129116437|NCT03103503|464723183|FG000|Overall Study|Study Closure|757|||
129116438|NCT02683109|464723185|FG000|Overall Study|Adverse Event|1|||
129116439|NCT02683109|464723186|FG001|Overall Study|Adverse Event|0|||
129116440|NCT00183430|464723187|FG000|Overall Study|Adverse Event|1|||
129116441|NCT00183430|464723188|FG001|Overall Study|Adverse Event|0|||
129116442|NCT00183430|464723187|FG000|Overall Study|Lost to Follow-up|3|||
129116443|NCT00183430|464723188|FG001|Overall Study|Lost to Follow-up|0|||
129116444|NCT00183430|464723187|FG000|Overall Study|did not meet inclusion criteria|1|||
129116445|NCT00183430|464723188|FG001|Overall Study|did not meet inclusion criteria|0|||
129116446|NCT00183430|464723187|FG000|Overall Study|Withdrawal by Subject|1|||
129116447|NCT00183430|464723188|FG001|Overall Study|Withdrawal by Subject|0|||
129116448|NCT00719901|464723191|FG000|Overall Study|Adverse Event|5|||
129116449|NCT00719901|464723191|FG000|Overall Study|Withdrawal by Subject|1|||
129116450|NCT00719901|464723191|FG000|Overall Study|Alternate Treatment|1|||
129116451|NCT00719901|464723191|FG000|Overall Study|Disease Progression|3|||
129116452|NCT00719901|464723191|FG000|Overall Study|Availability of Study Drug|1|||
129116453|NCT01122173|464723192|FG000|Overall Study|Lost to Follow-up|3|||
129116454|NCT01122173|464723192|FG000|Overall Study|Withdrawal by Subject|3|||
129116455|NCT01122173|464723192|FG000|Overall Study|Left study for other reasons|3|||
129116456|NCT01184872|464723193|FG000|Overall Study|Adverse Event|3|||
129116457|NCT01184872|464723194|FG001|Overall Study|Adverse Event|4|||
129116458|NCT01184872|464723193|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129116459|NCT01184872|464723194|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129116460|NCT01184872|464723193|FG000|Overall Study|Withdrawal by Subject|2|||
129116461|NCT01184872|464723194|FG001|Overall Study|Withdrawal by Subject|0|||
129116462|NCT01184872|464723193|FG000|Overall Study|Lost to Follow-up|0|||
129116463|NCT01184872|464723194|FG001|Overall Study|Lost to Follow-up|1|||
129116464|NCT01184872|464723193|FG000|Overall Study|Administrative problems|1|||
128695215|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
128695216|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
128695217|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
128695218|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Adverse Event|0|||
128695219|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Adverse Event|0|||
128695220|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Adverse Event|0|||
128906239|NCT01471782|463948698|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
128906240|NCT01471782|463948699|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
128906241|NCT01471782|463948700|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
129116465|NCT01184872|464723194|FG001|Overall Study|Administrative problems|1|||
129116466|NCT01184872|464723193|FG000|Overall Study|Protocol deviation|1|||
129116467|NCT01184872|464723194|FG001|Overall Study|Protocol deviation|0|||
128695221|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Adverse Event|0|||
128765028|NCT00085202|463430391|FG001|Overall Study|Non-specified|5|||
128906242|NCT01471782|463948695|FG000|Overall Study|Lack of Efficacy|1|||
129116468|NCT03863353|464723198|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
129116469|NCT03863353|464723199|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
129116470|NCT01299584|464723200|FG000|Overall Study|Protocol Violation|9|||
129116471|NCT02747927|464723201|FG000|Overall Study|Adverse Event|5|||
129116472|NCT02747927|464723202|FG001|Overall Study|Adverse Event|14|||
129116473|NCT02747927|464723201|FG000|Overall Study|Lost to Follow-up|22|||
129116474|NCT02747927|464723202|FG001|Overall Study|Lost to Follow-up|43|||
129116475|NCT02747927|464723201|FG000|Overall Study|Pregnancy|34|||
129116476|NCT02747927|464723202|FG001|Overall Study|Pregnancy|66|||
129116477|NCT02747927|464723201|FG000|Overall Study|Protocol Violation|2|||
129116478|NCT02747927|464723202|FG001|Overall Study|Protocol Violation|4|||
129116479|NCT02747927|464723201|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
129116480|NCT02747927|464723202|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
129116481|NCT02747927|464723201|FG000|Overall Study|Reason not Specified|11|||
129116482|NCT02747927|464723202|FG001|Overall Study|Reason not Specified|27|||
129116483|NCT03810183|464723205|FG000|Overall Study|Study terminated by Sponsor|2|||
129116484|NCT03810183|464723206|FG001|Overall Study|Study terminated by Sponsor|1|||
129116485|NCT00323063|464723208|FG000|Overall Study|Adverse Event|1|||
129116486|NCT00323063|464723209|FG001|Overall Study|Adverse Event|0|||
129116487|NCT00323063|464723208|FG000|Overall Study|brain mets discovered prior to treatment|1|||
129116488|NCT00323063|464723209|FG001|Overall Study|brain mets discovered prior to treatment|0|||
129116489|NCT00423046|464723210|FG000|Overall Study|Other|340|||
129116490|NCT00423046|464723211|FG001|Overall Study|Other|345|||
129116491|NCT01909804|464723214|FG000|Overall Study|Randomized but Never Treated|0|||
129116492|NCT01909804|464723215|FG001|Overall Study|Randomized but Never Treated|0|||
129116493|NCT01909804|464723216|FG002|Overall Study|Randomized but Never Treated|0|||
129116494|NCT01909804|464723217|FG003|Overall Study|Randomized but Never Treated|0|||
129116495|NCT01909804|464723218|FG004|Overall Study|Randomized but Never Treated|0|||
128906243|NCT01471782|463948696|FG001|Overall Study|Lack of Efficacy|2|||
128906244|NCT01471782|463948697|FG002|Overall Study|Lack of Efficacy|1|||
128906245|NCT01471782|463948698|FG003|Overall Study|Lack of Efficacy|1|||
128906246|NCT01471782|463948699|FG004|Overall Study|Lack of Efficacy|5|||
128906247|NCT01471782|463948700|FG005|Overall Study|Lack of Efficacy|18|||
128906248|NCT01471782|463948695|FG000|Overall Study|Adverse Event|1|||
128906249|NCT01471782|463948696|FG001|Overall Study|Adverse Event|1|||
128906250|NCT01471782|463948697|FG002|Overall Study|Adverse Event|2|||
128906251|NCT01471782|463948698|FG003|Overall Study|Adverse Event|2|||
128906252|NCT01471782|463948699|FG004|Overall Study|Adverse Event|3|||
128906253|NCT01471782|463948700|FG005|Overall Study|Adverse Event|1|||
129116496|NCT01909804|464723219|FG005|Overall Study|Randomized but Never Treated|0|||
129116497|NCT01909804|464723220|FG006|Overall Study|Randomized but Never Treated|1|||
129116498|NCT01909804|464723221|FG007|Overall Study|Randomized but Never Treated|0|||
128695222|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Adverse Event|0|||
128695223|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Adverse Event|0|||
128695224|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Adverse Event|2|||
128695225|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Adverse Event|5|||
128695226|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Pregnancy|0|||
128695227|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Pregnancy|0|||
128695228|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Pregnancy|0|||
128695229|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Pregnancy|0|||
128695230|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Pregnancy|0|||
128695231|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Pregnancy|0|||
128695232|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Pregnancy|0|||
128695233|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Pregnancy|2|||
128695234|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
128695235|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
128695236|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
128695237|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
128695238|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
128695239|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
128695240|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
128695241|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
128695242|NCT00533897|463182063|FG000|Long Term Extension (LTE)|Other|0|||
128695243|NCT00533897|463182064|FG001|Long Term Extension (LTE)|Other|0|||
128695244|NCT00533897|463182065|FG002|Long Term Extension (LTE)|Other|0|||
128695245|NCT00533897|463182066|FG003|Long Term Extension (LTE)|Other|0|||
128695246|NCT00533897|463182067|FG004|Long Term Extension (LTE)|Other|0|||
128695247|NCT00533897|463182068|FG005|Long Term Extension (LTE)|Other|0|||
128906254|NCT01471782|463948695|FG000|Overall Study|Other|0|||
129116499|NCT01909804|464723222|FG008|Overall Study|Randomized but Never Treated|0|||
129116500|NCT01909804|464723223|FG009|Overall Study|Randomized but Never Treated|0|||
129116501|NCT01909804|464723224|FG010|Overall Study|Randomized but Never Treated|0|||
129116502|NCT01909804|464723225|FG011|Overall Study|Randomized but Never Treated|1|||
129116503|NCT01909804|464723214|FG000|Overall Study|Death|0|||
128695248|NCT00533897|463182069|FG006|Long Term Extension (LTE)|Other|1|||
128695249|NCT00533897|463182070|FG007|Long Term Extension (LTE)|Other|6|||
128695250|NCT02110238|463182071|FG000|12 Week Pivotal Phase|Adverse Event|3|||
128695251|NCT02110238|463182072|FG001|12 Week Pivotal Phase|Adverse Event|0|||
128695252|NCT02110238|463182071|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
128906255|NCT01471782|463948696|FG001|Overall Study|Other|0|||
128906256|NCT01471782|463948697|FG002|Overall Study|Other|1|||
128906257|NCT01471782|463948698|FG003|Overall Study|Other|1|||
128695253|NCT02110238|463182072|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
128695254|NCT02110238|463182071|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
128695255|NCT02110238|463182072|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
128695256|NCT02110238|463182071|FG000|12 Week Pivotal Phase|Physician Decision|0|||
128695257|NCT02110238|463182072|FG001|12 Week Pivotal Phase|Physician Decision|2|||
128695258|NCT02110238|463182071|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
128695259|NCT02110238|463182072|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
128695260|NCT02110238|463182071|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
128695261|NCT02110238|463182072|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
128695262|NCT02110238|463182071|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
128695263|NCT02110238|463182072|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
128695264|NCT02110238|463182071|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
128695265|NCT02110238|463182072|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
128695266|NCT02110238|463182071|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
128695267|NCT02110238|463182072|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
128695268|NCT02110238|463182071|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
128695269|NCT02110238|463182072|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
128695270|NCT02110238|463182071|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
128695271|NCT02110238|463182072|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
128695272|NCT03228433|463182077|FG000|Overall Study|Lost to Follow-up|1|||
128695273|NCT03228433|463182078|FG001|Overall Study|Lost to Follow-up|0|||
128695274|NCT03228433|463182079|FG002|Overall Study|Lost to Follow-up|0|||
128695275|NCT03228433|463182080|FG003|Overall Study|Lost to Follow-up|0|||
128695276|NCT03228433|463182081|FG004|Overall Study|Lost to Follow-up|0|||
128695277|NCT03228433|463182082|FG005|Overall Study|Lost to Follow-up|0|||
128906258|NCT01471782|463948699|FG004|Overall Study|Other|6|||
129027115|NCT00112437|464390079|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027116|NCT00112437|464390080|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
129027117|NCT00112437|464390081|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027118|NCT00112437|464390082|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027119|NCT00112437|464390083|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027120|NCT00112437|464390084|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027121|NCT00112437|464390085|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027122|NCT00112437|464390086|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027123|NCT00112437|464390087|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027124|NCT00112437|464390088|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027125|NCT00112437|464390089|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027126|NCT00112437|464390090|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129027127|NCT00112437|464390065|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027128|NCT00112437|464390066|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027129|NCT00112437|464390067|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027130|NCT00112437|464390068|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027131|NCT00112437|464390069|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027132|NCT00112437|464390070|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027133|NCT00112437|464390071|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027134|NCT00112437|464390072|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027135|NCT00112437|464390073|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027136|NCT00112437|464390074|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027137|NCT00112437|464390075|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027138|NCT00112437|464390076|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027139|NCT00112437|464390077|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027140|NCT00112437|464390078|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027141|NCT00112437|464390079|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027142|NCT00112437|464390080|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
129027143|NCT00112437|464390081|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027144|NCT00112437|464390082|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027145|NCT00112437|464390083|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027146|NCT00112437|464390084|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027147|NCT00112437|464390085|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027148|NCT00112437|464390086|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027149|NCT00112437|464390087|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027150|NCT00112437|464390088|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027151|NCT00112437|464390089|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027152|NCT00112437|464390090|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
129027153|NCT00112437|464390065|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027154|NCT00112437|464390066|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027155|NCT00112437|464390067|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027156|NCT00112437|464390068|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129116504|NCT01909804|464723215|FG001|Overall Study|Death|0|||
129027157|NCT00112437|464390069|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129116505|NCT01909804|464723216|FG002|Overall Study|Death|0|||
129116506|NCT01909804|464723217|FG003|Overall Study|Death|0|||
129116507|NCT01909804|464723218|FG004|Overall Study|Death|0|||
129116508|NCT01909804|464723219|FG005|Overall Study|Death|0|||
129116509|NCT01909804|464723220|FG006|Overall Study|Death|0|||
129116510|NCT01909804|464723221|FG007|Overall Study|Death|0|||
129116511|NCT01909804|464723222|FG008|Overall Study|Death|0|||
129116512|NCT01909804|464723223|FG009|Overall Study|Death|0|||
129116513|NCT01909804|464723224|FG010|Overall Study|Death|1|||
129116514|NCT01909804|464723225|FG011|Overall Study|Death|0|||
129116515|NCT01909804|464723214|FG000|Overall Study|Lack of Efficacy|4|||
129116516|NCT01909804|464723215|FG001|Overall Study|Lack of Efficacy|1|||
129116517|NCT01909804|464723216|FG002|Overall Study|Lack of Efficacy|0|||
129116518|NCT01909804|464723217|FG003|Overall Study|Lack of Efficacy|0|||
129116519|NCT01909804|464723218|FG004|Overall Study|Lack of Efficacy|7|||
129116520|NCT01909804|464723219|FG005|Overall Study|Lack of Efficacy|3|||
129116521|NCT01909804|464723220|FG006|Overall Study|Lack of Efficacy|1|||
129116522|NCT01909804|464723221|FG007|Overall Study|Lack of Efficacy|1|||
129116523|NCT01909804|464723222|FG008|Overall Study|Lack of Efficacy|0|||
129116524|NCT01909804|464723223|FG009|Overall Study|Lack of Efficacy|1|||
129116525|NCT01909804|464723224|FG010|Overall Study|Lack of Efficacy|0|||
129116526|NCT01909804|464723225|FG011|Overall Study|Lack of Efficacy|1|||
129116527|NCT01909804|464723214|FG000|Overall Study|Withdrew Consent|0|||
129116528|NCT01909804|464723215|FG001|Overall Study|Withdrew Consent|0|||
129116529|NCT01909804|464723216|FG002|Overall Study|Withdrew Consent|0|||
129116530|NCT01909804|464723217|FG003|Overall Study|Withdrew Consent|0|||
129116531|NCT01909804|464723218|FG004|Overall Study|Withdrew Consent|1|||
129116532|NCT01909804|464723219|FG005|Overall Study|Withdrew Consent|1|||
128695278|NCT03228433|463182077|FG000|Overall Study|Positive alcohol test|0|||
128695279|NCT03228433|463182078|FG001|Overall Study|Positive alcohol test|0|||
128695280|NCT03228433|463182079|FG002|Overall Study|Positive alcohol test|0|||
129116533|NCT01909804|464723220|FG006|Overall Study|Withdrew Consent|0|||
129116534|NCT01909804|464723221|FG007|Overall Study|Withdrew Consent|0|||
129116535|NCT01909804|464723222|FG008|Overall Study|Withdrew Consent|0|||
129116536|NCT01909804|464723223|FG009|Overall Study|Withdrew Consent|0|||
129116537|NCT01909804|464723224|FG010|Overall Study|Withdrew Consent|0|||
129116538|NCT01909804|464723225|FG011|Overall Study|Withdrew Consent|0|||
129116539|NCT01909804|464723214|FG000|Overall Study|Protocol Violation|0|||
129116540|NCT01909804|464723215|FG001|Overall Study|Protocol Violation|0|||
128695281|NCT03228433|463182080|FG003|Overall Study|Positive alcohol test|1|||
128695282|NCT03228433|463182081|FG004|Overall Study|Positive alcohol test|0|||
128695283|NCT03228433|463182082|FG005|Overall Study|Positive alcohol test|0|||
128695284|NCT01030536|463182083|FG000|Overall Study|Withdrawal by Subject|0|||
128695285|NCT01030536|463182084|FG001|Overall Study|Withdrawal by Subject|0|||
128695286|NCT01030536|463182085|FG002|Overall Study|Withdrawal by Subject|1|||
128695287|NCT01030536|463182086|FG003|Overall Study|Withdrawal by Subject|0|||
128695288|NCT01030536|463182087|FG004|Overall Study|Withdrawal by Subject|0|||
128695289|NCT01030536|463182083|FG000|Overall Study|undefined|1|||
128695290|NCT01030536|463182084|FG001|Overall Study|undefined|0|||
128695291|NCT01030536|463182085|FG002|Overall Study|undefined|1|||
128695292|NCT01030536|463182086|FG003|Overall Study|undefined|1|||
128695293|NCT01030536|463182087|FG004|Overall Study|undefined|0|||
128695294|NCT01030536|463182083|FG000|Overall Study|Adverse Event|0|||
128695295|NCT01030536|463182084|FG001|Overall Study|Adverse Event|3|||
128695296|NCT01030536|463182085|FG002|Overall Study|Adverse Event|1|||
128695297|NCT01030536|463182086|FG003|Overall Study|Adverse Event|0|||
128695298|NCT01030536|463182087|FG004|Overall Study|Adverse Event|1|||
128695299|NCT01030536|463182083|FG000|Overall Study|Progressive disease|6|||
128695300|NCT01030536|463182084|FG001|Overall Study|Progressive disease|2|||
128695301|NCT01030536|463182085|FG002|Overall Study|Progressive disease|3|||
128695302|NCT01030536|463182086|FG003|Overall Study|Progressive disease|2|||
128695303|NCT01030536|463182087|FG004|Overall Study|Progressive disease|0|||
128695304|NCT01030536|463182083|FG000|Overall Study|Death|0|||
128695305|NCT01030536|463182084|FG001|Overall Study|Death|1|||
128695306|NCT01030536|463182085|FG002|Overall Study|Death|0|||
128695307|NCT01030536|463182086|FG003|Overall Study|Death|0|||
128695308|NCT01030536|463182087|FG004|Overall Study|Death|0|||
128695309|NCT01419626|463182092|FG000|Overall Study|Protocol Violation|3|||
128695310|NCT01419626|463182093|FG001|Overall Study|Protocol Violation|2|||
128695311|NCT01419626|463182094|FG002|Overall Study|Protocol Violation|2|||
128695312|NCT01419626|463182092|FG000|Overall Study|Withdrawal by Subject|1|||
128695313|NCT01419626|463182093|FG001|Overall Study|Withdrawal by Subject|0|||
128695314|NCT01419626|463182094|FG002|Overall Study|Withdrawal by Subject|0|||
129116541|NCT01909804|464723216|FG002|Overall Study|Protocol Violation|0|||
129116542|NCT01909804|464723217|FG003|Overall Study|Protocol Violation|0|||
129116543|NCT01909804|464723218|FG004|Overall Study|Protocol Violation|0|||
129116544|NCT01909804|464723219|FG005|Overall Study|Protocol Violation|0|||
129116545|NCT01909804|464723220|FG006|Overall Study|Protocol Violation|0|||
129116546|NCT01909804|464723221|FG007|Overall Study|Protocol Violation|0|||
129116547|NCT01909804|464723222|FG008|Overall Study|Protocol Violation|0|||
129116548|NCT01909804|464723223|FG009|Overall Study|Protocol Violation|0|||
129116549|NCT01909804|464723224|FG010|Overall Study|Protocol Violation|0|||
129116550|NCT01909804|464723225|FG011|Overall Study|Protocol Violation|1|||
129116551|NCT00830128|464723226|FG000|Overall Study|Adverse Event|5|||
129116552|NCT00830128|464723226|FG000|Overall Study|Lack of Efficacy|7|||
129116553|NCT00830128|464723226|FG000|Overall Study|Protocol Violation|1|||
129116554|NCT00830128|464723226|FG000|Overall Study|Withdrawal by Subject|2|||
129116555|NCT00830128|464723226|FG000|Overall Study|Family obligation|1|||
129116556|NCT00830128|464723226|FG000|Overall Study|Relocation|1|||
129116557|NCT00830128|464723226|FG000|Overall Study|Work obligation|1|||
129116558|NCT00830128|464723226|FG000|Overall Study|Operating a vehicle|1|||
128695315|NCT01419626|463182092|FG000|Overall Study|Lost to Follow-up|0|||
129116559|NCT02144701|464723231|FG000|Overall Study|development of relapse, GVHD or death|9|||
129116560|NCT02144701|464723232|FG001|Overall Study|development of relapse, GVHD or death|3|||
129116561|NCT03327324|464723234|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116562|NCT03327324|464723235|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
128695316|NCT01419626|463182093|FG001|Overall Study|Lost to Follow-up|1|||
128695317|NCT01419626|463182094|FG002|Overall Study|Lost to Follow-up|1|||
128695318|NCT01365052|463182095|FG000|Overall Study|Adverse Event|4|||
128695319|NCT01365052|463182096|FG001|Overall Study|Adverse Event|4|||
128695320|NCT01146912|463182097|FG000|Overall Study|Already received influenza vaccination|817|||
128695321|NCT01146912|463182098|FG001|Overall Study|Already received influenza vaccination|822|||
128695322|NCT01146912|463182099|FG002|Overall Study|Already received influenza vaccination|13|||
128695323|NCT01146912|463182100|FG003|Overall Study|Already received influenza vaccination|15|||
128695324|NCT01146912|463182101|FG004|Overall Study|Already received influenza vaccination|41|||
128695325|NCT01146912|463182102|FG005|Overall Study|Already received influenza vaccination|61|||
128695326|NCT01146912|463182103|FG006|Overall Study|Already received influenza vaccination|56|||
128695327|NCT01146912|463182104|FG007|Overall Study|Already received influenza vaccination|0|||
128695328|NCT01146912|463182097|FG000|Overall Study|< 14 weeks gestational age|0|||
128695329|NCT01146912|463182098|FG001|Overall Study|< 14 weeks gestational age|0|||
128695330|NCT01146912|463182099|FG002|Overall Study|< 14 weeks gestational age|3|||
128695331|NCT01146912|463182100|FG003|Overall Study|< 14 weeks gestational age|2|||
128695332|NCT01146912|463182101|FG004|Overall Study|< 14 weeks gestational age|0|||
128695333|NCT01146912|463182102|FG005|Overall Study|< 14 weeks gestational age|0|||
128695334|NCT01146912|463182103|FG006|Overall Study|< 14 weeks gestational age|0|||
128695335|NCT01146912|463182104|FG007|Overall Study|< 14 weeks gestational age|0|||
128695336|NCT01146912|463182097|FG000|Overall Study|Duplicate patient|0|||
128695337|NCT01146912|463182098|FG001|Overall Study|Duplicate patient|0|||
128695338|NCT01146912|463182099|FG002|Overall Study|Duplicate patient|1|||
128695339|NCT01146912|463182100|FG003|Overall Study|Duplicate patient|0|||
128695340|NCT01146912|463182101|FG004|Overall Study|Duplicate patient|0|||
128695341|NCT01146912|463182102|FG005|Overall Study|Duplicate patient|0|||
128695342|NCT01146912|463182103|FG006|Overall Study|Duplicate patient|0|||
128695343|NCT01146912|463182104|FG007|Overall Study|Duplicate patient|0|||
128695344|NCT01145625|463182107|FG000|Overall Study|Lost to Follow-up|8|||
128695345|NCT01145625|463182108|FG001|Overall Study|Lost to Follow-up|9|||
128695346|NCT01145625|463182107|FG000|Overall Study|Adverse Event|6|||
128695347|NCT01145625|463182108|FG001|Overall Study|Adverse Event|4|||
128695348|NCT01145625|463182107|FG000|Overall Study|Protocol Violation|3|||
128695349|NCT01145625|463182108|FG001|Overall Study|Protocol Violation|1|||
128695350|NCT01145625|463182107|FG000|Overall Study|Withdrawal by Subject|7|||
128695351|NCT01145625|463182108|FG001|Overall Study|Withdrawal by Subject|16|||
128695352|NCT01145625|463182107|FG000|Overall Study|Pregnancy|0|||
128695353|NCT01145625|463182108|FG001|Overall Study|Pregnancy|1|||
128695354|NCT02202980|463182111|FG000|Overall Study|Lack of Efficacy|1|||
128695355|NCT02202980|463182112|FG001|Overall Study|Lack of Efficacy|0|||
128695356|NCT02202980|463182113|FG002|Overall Study|Lack of Efficacy|7|||
128695357|NCT02202980|463182114|FG003|Overall Study|Lack of Efficacy|0|||
128695358|NCT02202980|463182115|FG004|Overall Study|Lack of Efficacy|3|||
128695359|NCT02202980|463182116|FG005|Overall Study|Lack of Efficacy|1|||
128695360|NCT02202980|463182117|FG006|Overall Study|Lack of Efficacy|11|||
128695361|NCT02202980|463182118|FG007|Overall Study|Lack of Efficacy|2|||
128695362|NCT02202980|463182119|FG008|Overall Study|Lack of Efficacy|2|||
128695363|NCT02202980|463182120|FG009|Overall Study|Lack of Efficacy|0|||
128695364|NCT02202980|463182121|FG010|Overall Study|Lack of Efficacy|0|||
128695365|NCT02202980|463182122|FG011|Overall Study|Lack of Efficacy|3|||
129116563|NCT03327324|464723236|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116564|NCT03327324|464723237|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
129116565|NCT03327324|464723238|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128695366|NCT02202980|463182123|FG012|Overall Study|Lack of Efficacy|10|||
128695367|NCT02202980|463182124|FG013|Overall Study|Lack of Efficacy|0|||
128695368|NCT02202980|463182111|FG000|Overall Study|Protocol Violation|0|||
128695369|NCT02202980|463182112|FG001|Overall Study|Protocol Violation|0|||
128695370|NCT02202980|463182113|FG002|Overall Study|Protocol Violation|0|||
128695371|NCT02202980|463182114|FG003|Overall Study|Protocol Violation|3|||
128695372|NCT02202980|463182115|FG004|Overall Study|Protocol Violation|3|||
128695373|NCT02202980|463182116|FG005|Overall Study|Protocol Violation|0|||
128695374|NCT02202980|463182117|FG006|Overall Study|Protocol Violation|0|||
129116566|NCT03327324|464723239|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
129116567|NCT03327324|464723234|FG000|Baseline (Month 0-Month 3)|Refused|0|||
129116568|NCT03327324|464723235|FG001|Baseline (Month 0-Month 3)|Refused|0|||
129116569|NCT03327324|464723236|FG002|Baseline (Month 0-Month 3)|Refused|0|||
129116570|NCT03327324|464723237|FG003|Baseline (Month 0-Month 3)|Refused|0|||
129116571|NCT03327324|464723238|FG004|Baseline (Month 0-Month 3)|Refused|1|||
129116572|NCT03327324|464723239|FG005|Baseline (Month 0-Month 3)|Refused|0|||
129116573|NCT03327324|464723234|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
128695375|NCT02202980|463182118|FG007|Overall Study|Protocol Violation|0|||
128695376|NCT02202980|463182119|FG008|Overall Study|Protocol Violation|0|||
128695377|NCT02202980|463182120|FG009|Overall Study|Protocol Violation|0|||
128695378|NCT02202980|463182121|FG010|Overall Study|Protocol Violation|0|||
128695379|NCT02202980|463182122|FG011|Overall Study|Protocol Violation|0|||
128695380|NCT02202980|463182123|FG012|Overall Study|Protocol Violation|0|||
128695381|NCT02202980|463182124|FG013|Overall Study|Protocol Violation|0|||
128695382|NCT02202980|463182111|FG000|Overall Study|Lost to Follow-up|0|||
128695383|NCT02202980|463182112|FG001|Overall Study|Lost to Follow-up|1|||
128695384|NCT02202980|463182113|FG002|Overall Study|Lost to Follow-up|1|||
128695385|NCT02202980|463182114|FG003|Overall Study|Lost to Follow-up|1|||
128695386|NCT02202980|463182115|FG004|Overall Study|Lost to Follow-up|0|||
128695387|NCT02202980|463182116|FG005|Overall Study|Lost to Follow-up|0|||
128695388|NCT02202980|463182117|FG006|Overall Study|Lost to Follow-up|0|||
128695389|NCT02202980|463182118|FG007|Overall Study|Lost to Follow-up|1|||
128695390|NCT02202980|463182119|FG008|Overall Study|Lost to Follow-up|1|||
128695391|NCT02202980|463182120|FG009|Overall Study|Lost to Follow-up|0|||
128695392|NCT02202980|463182121|FG010|Overall Study|Lost to Follow-up|0|||
128695393|NCT02202980|463182122|FG011|Overall Study|Lost to Follow-up|0|||
128695394|NCT02202980|463182123|FG012|Overall Study|Lost to Follow-up|1|||
128695395|NCT02202980|463182124|FG013|Overall Study|Lost to Follow-up|0|||
128695396|NCT02202980|463182111|FG000|Overall Study|Withdrew Consent|0|||
128695397|NCT02202980|463182112|FG001|Overall Study|Withdrew Consent|1|||
128695398|NCT02202980|463182113|FG002|Overall Study|Withdrew Consent|2|||
128695399|NCT02202980|463182114|FG003|Overall Study|Withdrew Consent|0|||
128695400|NCT02202980|463182115|FG004|Overall Study|Withdrew Consent|0|||
128695401|NCT02202980|463182116|FG005|Overall Study|Withdrew Consent|0|||
128695402|NCT02202980|463182117|FG006|Overall Study|Withdrew Consent|0|||
128695403|NCT02202980|463182118|FG007|Overall Study|Withdrew Consent|0|||
128695404|NCT02202980|463182119|FG008|Overall Study|Withdrew Consent|1|||
128695405|NCT02202980|463182120|FG009|Overall Study|Withdrew Consent|0|||
128695406|NCT02202980|463182121|FG010|Overall Study|Withdrew Consent|0|||
128695407|NCT02202980|463182122|FG011|Overall Study|Withdrew Consent|0|||
128695408|NCT02202980|463182123|FG012|Overall Study|Withdrew Consent|0|||
128695409|NCT02202980|463182124|FG013|Overall Study|Withdrew Consent|0|||
128695410|NCT01781975|463182139|FG000|Overall Study|Death|1|||
128695411|NCT01781975|463182140|FG001|Overall Study|Death|0|||
128695412|NCT01781975|463182139|FG000|Overall Study|Withdrawal by Subject|1|||
128695413|NCT01781975|463182140|FG001|Overall Study|Withdrawal by Subject|1|||
128695414|NCT02404220|463182142|FG000|Overall Study|Adverse Event|0|||
128695415|NCT02404220|463182143|FG001|Overall Study|Adverse Event|0|||
128695416|NCT02404220|463182144|FG002|Overall Study|Adverse Event|1|||
128695417|NCT02404220|463182145|FG003|Overall Study|Adverse Event|0|||
128695418|NCT02404220|463182142|FG000|Overall Study|Death|5|||
128695419|NCT02404220|463182143|FG001|Overall Study|Death|5|||
128695420|NCT02404220|463182144|FG002|Overall Study|Death|3|||
128695421|NCT02404220|463182145|FG003|Overall Study|Death|8|||
128695422|NCT02404220|463182142|FG000|Overall Study|Progressive Disease|0|||
128695423|NCT02404220|463182143|FG001|Overall Study|Progressive Disease|0|||
128695424|NCT02404220|463182144|FG002|Overall Study|Progressive Disease|1|||
128695425|NCT02404220|463182145|FG003|Overall Study|Progressive Disease|1|||
128695426|NCT02404220|463182142|FG000|Overall Study|Study Terminated by Sponsor|0|||
128695427|NCT02404220|463182143|FG001|Overall Study|Study Terminated by Sponsor|0|||
128695428|NCT02404220|463182144|FG002|Overall Study|Study Terminated by Sponsor|2|||
128695429|NCT02404220|463182145|FG003|Overall Study|Study Terminated by Sponsor|1|||
128695430|NCT02404220|463182142|FG000|Overall Study|Withdrawal by Subject|0|||
128695431|NCT02404220|463182143|FG001|Overall Study|Withdrawal by Subject|1|||
128695432|NCT02404220|463182144|FG002|Overall Study|Withdrawal by Subject|0|||
128695433|NCT02404220|463182145|FG003|Overall Study|Withdrawal by Subject|0|||
128695434|NCT02404220|463182142|FG000|Overall Study|Enrolled but Never Treated|0|||
128695435|NCT02404220|463182143|FG001|Overall Study|Enrolled but Never Treated|2|||
128695436|NCT02404220|463182144|FG002|Overall Study|Enrolled but Never Treated|0|||
128695437|NCT02404220|463182145|FG003|Overall Study|Enrolled but Never Treated|0|||
128695438|NCT01622231|463182146|FG000|Overall Study|Physician Decision|1|||
128695439|NCT01622231|463182146|FG000|Overall Study|Withdrawal by Subject|1|||
128695440|NCT01609231|463182147|FG000|Overall Study|Adverse Event|1|||
128695441|NCT01609231|463182148|FG001|Overall Study|Adverse Event|3|||
128695442|NCT01609231|463182147|FG000|Overall Study|Physician Decision|1|||
128695443|NCT01609231|463182148|FG001|Overall Study|Physician Decision|0|||
128695444|NCT01609231|463182147|FG000|Overall Study|Withdrawal by Subject|1|||
128695445|NCT01609231|463182148|FG001|Overall Study|Withdrawal by Subject|0|||
129116574|NCT03327324|464723235|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
129116575|NCT03327324|464723236|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129116576|NCT03327324|464723237|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129116577|NCT03327324|464723238|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129116578|NCT03327324|464723239|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129116579|NCT03327324|464723234|FG000|Baseline (Month 0-Month 3)|Death|0|||
129116580|NCT03327324|464723235|FG001|Baseline (Month 0-Month 3)|Death|0|||
129116581|NCT03327324|464723236|FG002|Baseline (Month 0-Month 3)|Death|0|||
129116582|NCT03327324|464723237|FG003|Baseline (Month 0-Month 3)|Death|0|||
129116583|NCT03327324|464723238|FG004|Baseline (Month 0-Month 3)|Death|1|||
129116584|NCT03327324|464723239|FG005|Baseline (Month 0-Month 3)|Death|0|||
129116585|NCT03327324|464723234|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116586|NCT03327324|464723235|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116587|NCT03327324|464723236|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116588|NCT03327324|464723237|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116589|NCT03327324|464723238|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116590|NCT03327324|464723239|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
129116591|NCT03327324|464723234|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116592|NCT03327324|464723235|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116593|NCT03327324|464723236|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
129116594|NCT03327324|464723237|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116595|NCT03327324|464723238|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116596|NCT03327324|464723239|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116597|NCT03327324|464723234|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
129116598|NCT03327324|464723235|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
129116599|NCT03327324|464723236|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
129116600|NCT03327324|464723237|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
129116601|NCT03327324|464723238|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
129116602|NCT03327324|464723239|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
129116603|NCT03327324|464723234|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
129116604|NCT03327324|464723235|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129116605|NCT03327324|464723236|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
128695446|NCT02846324|463182152|FG000|Overall Study|Other|1|||
128695447|NCT02846324|463182153|FG001|Overall Study|Other|0|||
128695448|NCT02846324|463182154|FG002|Overall Study|Other|0|||
128695449|NCT02846324|463182155|FG003|Overall Study|Other|0|||
128695450|NCT02846324|463182152|FG000|Overall Study|Withdrawal by Subject|1|||
128695451|NCT02846324|463182153|FG001|Overall Study|Withdrawal by Subject|0|||
128695452|NCT02846324|463182154|FG002|Overall Study|Withdrawal by Subject|4|||
128695453|NCT02846324|463182155|FG003|Overall Study|Withdrawal by Subject|0|||
128695454|NCT01927627|463182157|FG000|Overall Study|Adverse Event|3|||
128695455|NCT01927627|463182157|FG000|Overall Study|Lack of Efficacy|1|||
128695456|NCT01927627|463182157|FG000|Overall Study|Financial Concerns|1|||
128695457|NCT00467857|463182158|FG000|Overall Study|Adverse Event|1|||
128695458|NCT00467857|463182159|FG001|Overall Study|Adverse Event|0|||
128695459|NCT00467857|463182158|FG000|Overall Study|Withdrew consent|2|||
128695460|NCT00467857|463182159|FG001|Overall Study|Withdrew consent|0|||
128695461|NCT00467857|463182158|FG000|Overall Study|Death|0|||
128695462|NCT00467857|463182159|FG001|Overall Study|Death|1|||
128695463|NCT00467857|463182158|FG000|Overall Study|Discharged from court service|0|||
128695464|NCT00467857|463182159|FG001|Overall Study|Discharged from court service|1|||
128695465|NCT00467857|463182158|FG000|Overall Study|Emergency care required|0|||
128695466|NCT00467857|463182159|FG001|Overall Study|Emergency care required|1|||
128695467|NCT00467857|463182158|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
128695468|NCT00467857|463182159|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
128695469|NCT00467857|463182158|FG000|Overall Study|Discontinuation reason missing|0|||
128695470|NCT00467857|463182159|FG001|Overall Study|Discontinuation reason missing|3|||
128695471|NCT03208127|463182162|FG000|Overall Study|Death|1|||
128695472|NCT00579098|463182163|FG000|Overall Study|Lost to Follow-up|2|||
128695473|NCT00579098|463182164|FG001|Overall Study|Lost to Follow-up|0|||
128695474|NCT00579098|463182163|FG000|Overall Study|Adverse Event|2|||
128695475|NCT00579098|463182164|FG001|Overall Study|Adverse Event|3|||
128695476|NCT00579098|463182163|FG000|Overall Study|Withdrawal by Subject|2|||
128695477|NCT00579098|463182164|FG001|Overall Study|Withdrawal by Subject|3|||
128695478|NCT00579098|463182163|FG000|Overall Study|AF returned after ablation|3|||
128695479|NCT00579098|463182164|FG001|Overall Study|AF returned after ablation|2|||
129116606|NCT03327324|464723237|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129116607|NCT03327324|464723238|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129116608|NCT03327324|464723239|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
128695480|NCT00338104|463182171|FG000|Overall Study|Protocol Violation|2|||
128695481|NCT00338104|463182172|FG001|Overall Study|Protocol Violation|1|||
128695482|NCT00338104|463182173|FG002|Overall Study|Protocol Violation|3|||
128695483|NCT00003487|463182174|FG000|Overall Study|Not evaluable|2|||
128695484|NCT03855228|463182176|FG000|Overall Study|Adverse Event|2|||
128695485|NCT03855228|463182177|FG001|Overall Study|Adverse Event|4|||
128695486|NCT03855228|463182178|FG002|Overall Study|Adverse Event|4|||
128695487|NCT03855228|463182179|FG003|Overall Study|Adverse Event|8|||
128695488|NCT03855228|463182176|FG000|Overall Study|Treatment Failure|1|||
128695489|NCT03855228|463182177|FG001|Overall Study|Treatment Failure|2|||
128695490|NCT03855228|463182178|FG002|Overall Study|Treatment Failure|1|||
128695491|NCT03855228|463182179|FG003|Overall Study|Treatment Failure|8|||
128695492|NCT03855228|463182176|FG000|Overall Study|Lost to Follow-up|0|||
128695493|NCT03855228|463182177|FG001|Overall Study|Lost to Follow-up|0|||
128695494|NCT03855228|463182178|FG002|Overall Study|Lost to Follow-up|0|||
128695495|NCT03855228|463182179|FG003|Overall Study|Lost to Follow-up|1|||
128695496|NCT03855228|463182176|FG000|Overall Study|Protocol Violation|0|||
128695497|NCT03855228|463182177|FG001|Overall Study|Protocol Violation|1|||
128695498|NCT03855228|463182178|FG002|Overall Study|Protocol Violation|2|||
128695499|NCT03855228|463182179|FG003|Overall Study|Protocol Violation|1|||
128695500|NCT03855228|463182176|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
128695501|NCT03855228|463182177|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
128695502|NCT03855228|463182178|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
128695503|NCT03855228|463182179|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
128695504|NCT05147428|463182184|FG000|Overall Study|Removed prior to mailing|289|||
128695505|NCT05147428|463182185|FG001|Overall Study|Removed prior to mailing|306|||
128695506|NCT05147428|463182186|FG002|Overall Study|Removed prior to mailing|270|||
128695507|NCT05147428|463182184|FG000|Overall Study|Died or disenrolled during blackout period|239|||
128695508|NCT05147428|463182185|FG001|Overall Study|Died or disenrolled during blackout period|278|||
128695509|NCT05147428|463182186|FG002|Overall Study|Died or disenrolled during blackout period|273|||
128695510|NCT00717093|463183531|FG000|Overall Study|Adverse Event|19|||
128695511|NCT00717093|463183532|FG001|Overall Study|Adverse Event|9|||
128695512|NCT00717093|463183531|FG000|Overall Study|Lack of Efficacy|3|||
128695513|NCT00717093|463183532|FG001|Overall Study|Lack of Efficacy|13|||
128695514|NCT00717093|463183531|FG000|Overall Study|Lost to Follow-up|9|||
128695515|NCT00717093|463183532|FG001|Overall Study|Lost to Follow-up|6|||
128695516|NCT00717093|463183531|FG000|Overall Study|Withdrawal by Subject|12|||
128695517|NCT00717093|463183532|FG001|Overall Study|Withdrawal by Subject|19|||
128695518|NCT00717093|463183531|FG000|Overall Study|Other|0|||
128695519|NCT00717093|463183532|FG001|Overall Study|Other|1|||
128695520|NCT00717093|463183531|FG000|Overall Study|Randomized but not treated|1|||
128765029|NCT00085202|463430390|FG000|Overall Study|Withdrawal by Subject|2|||
128765030|NCT00085202|463430391|FG001|Overall Study|Withdrawal by Subject|1|||
128765031|NCT00085202|463430390|FG000|Overall Study|Physician Decision|4|||
128765032|NCT00085202|463430391|FG001|Overall Study|Physician Decision|1|||
128765033|NCT00085202|463430390|FG000|Overall Study|Progressive disease|1|||
128765034|NCT00085202|463430391|FG001|Overall Study|Progressive disease|11|||
128765035|NCT03238300|463430395|FG000|Baseline (Before Intervention)|Physician Decision|0|||
128765036|NCT03238300|463430396|FG001|Baseline (Before Intervention)|Physician Decision|1|||
128765037|NCT03238300|463430395|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
128765038|NCT03238300|463430396|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
128765039|NCT03238300|463430395|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
128765040|NCT03238300|463430396|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
128765041|NCT03238300|463430395|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
128765042|NCT03238300|463430396|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
128765043|NCT01435655|463430401|FG000|Overall Study|Death|2|||
128765044|NCT01435655|463430401|FG000|Overall Study|Other|1|||
128765045|NCT00110890|463430403|FG000|Overall Study|Adverse Event|30|||
128765046|NCT00110890|463430404|FG001|Overall Study|Adverse Event|7|||
128765047|NCT00110890|463430403|FG000|Overall Study|Death|16|||
128765048|NCT00110890|463430404|FG001|Overall Study|Death|9|||
128695521|NCT00717093|463183532|FG001|Overall Study|Randomized but not treated|0|||
128695522|NCT01644565|463183535|FG000|Overall Study|Undisclosed Medical History|1|||
128765049|NCT00110890|463430403|FG000|Overall Study|Lost to Follow-up|3|||
128765050|NCT00110890|463430404|FG001|Overall Study|Lost to Follow-up|1|||
128765051|NCT00110890|463430403|FG000|Overall Study|Physician Decision|4|||
128695523|NCT01644565|463183536|FG001|Overall Study|Undisclosed Medical History|0|||
128695524|NCT01644565|463183537|FG002|Overall Study|Undisclosed Medical History|0|||
128695525|NCT01644565|463183538|FG003|Overall Study|Undisclosed Medical History|0|||
128765052|NCT00110890|463430404|FG001|Overall Study|Physician Decision|5|||
129116609|NCT03327324|464723234|FG000|Intervention (Month 3-Month 6)|Death|1|||
128695526|NCT01644565|463183539|FG004|Overall Study|Undisclosed Medical History|0|||
128695527|NCT01644565|463183540|FG005|Overall Study|Undisclosed Medical History|0|||
128695528|NCT01644565|463183541|FG006|Overall Study|Undisclosed Medical History|0|||
128695529|NCT01644565|463183542|FG007|Overall Study|Undisclosed Medical History|0|||
128695530|NCT01644565|463183543|FG008|Overall Study|Undisclosed Medical History|0|||
128695531|NCT01644565|463183535|FG000|Overall Study|Lost to Follow-up|0|||
128695532|NCT01644565|463183536|FG001|Overall Study|Lost to Follow-up|0|||
128695533|NCT01644565|463183537|FG002|Overall Study|Lost to Follow-up|0|||
128695534|NCT01644565|463183538|FG003|Overall Study|Lost to Follow-up|1|||
128695535|NCT01644565|463183539|FG004|Overall Study|Lost to Follow-up|0|||
128695536|NCT01644565|463183540|FG005|Overall Study|Lost to Follow-up|0|||
128695537|NCT01644565|463183541|FG006|Overall Study|Lost to Follow-up|0|||
128695538|NCT01644565|463183542|FG007|Overall Study|Lost to Follow-up|2|||
128695539|NCT01644565|463183543|FG008|Overall Study|Lost to Follow-up|0|||
128695540|NCT01644565|463183535|FG000|Overall Study|Family emergency|0|||
128695541|NCT01644565|463183536|FG001|Overall Study|Family emergency|0|||
128695542|NCT01644565|463183537|FG002|Overall Study|Family emergency|0|||
128695543|NCT01644565|463183538|FG003|Overall Study|Family emergency|0|||
128695544|NCT01644565|463183539|FG004|Overall Study|Family emergency|1|||
128695545|NCT01644565|463183540|FG005|Overall Study|Family emergency|0|||
128695546|NCT01644565|463183541|FG006|Overall Study|Family emergency|0|||
128695547|NCT01644565|463183542|FG007|Overall Study|Family emergency|0|||
128695548|NCT01644565|463183543|FG008|Overall Study|Family emergency|0|||
128695549|NCT01644565|463183535|FG000|Overall Study|Relocation|0|||
128695550|NCT01644565|463183536|FG001|Overall Study|Relocation|0|||
128695551|NCT01644565|463183537|FG002|Overall Study|Relocation|0|||
128695552|NCT01644565|463183538|FG003|Overall Study|Relocation|0|||
128695553|NCT01644565|463183539|FG004|Overall Study|Relocation|0|||
128695554|NCT01644565|463183540|FG005|Overall Study|Relocation|0|||
128695555|NCT01644565|463183541|FG006|Overall Study|Relocation|0|||
128695556|NCT01644565|463183542|FG007|Overall Study|Relocation|0|||
128695557|NCT01644565|463183543|FG008|Overall Study|Relocation|1|||
128695558|NCT01550289|463183544|FG000|Overall Study|Protocol Violation|1|||
128695559|NCT01550289|463183545|FG001|Overall Study|Protocol Violation|0|||
128695560|NCT01550289|463183544|FG000|Overall Study|Lost to Follow-up|1|||
128695561|NCT01550289|463183545|FG001|Overall Study|Lost to Follow-up|1|||
128695562|NCT01550289|463183544|FG000|Overall Study|Withdrawal by Subject|11|||
128695563|NCT01550289|463183545|FG001|Overall Study|Withdrawal by Subject|3|||
128695564|NCT00094172|463183546|FG000|Overall Study|Adverse Event|0|||
128695565|NCT00094172|463183547|FG001|Overall Study|Adverse Event|1|||
128695566|NCT00094172|463183546|FG000|Overall Study|Lost to Follow-up|2|||
128695567|NCT00094172|463183547|FG001|Overall Study|Lost to Follow-up|0|||
128695568|NCT00094172|463183546|FG000|Overall Study|Protocol Violation|0|||
128695569|NCT00094172|463183547|FG001|Overall Study|Protocol Violation|1|||
128695570|NCT00094172|463183546|FG000|Overall Study|Withdrawal by Subject|10|||
128695571|NCT00094172|463183547|FG001|Overall Study|Withdrawal by Subject|5|||
128695572|NCT00094172|463183546|FG000|Overall Study|Primary endpoint met.|1|||
128695573|NCT00094172|463183547|FG001|Overall Study|Primary endpoint met.|0|||
128695574|NCT00094172|463183546|FG000|Overall Study|Started other MS therapy due to disease|1|||
128695575|NCT00094172|463183547|FG001|Overall Study|Started other MS therapy due to disease|0|||
128695576|NCT00827502|463183548|FG000|Overall Study|randomized but not treated|11|||
128695577|NCT00827502|463183548|FG000|Overall Study|Adverse Event|1|||
128695578|NCT00827502|463183548|FG000|Overall Study|Lost to Follow-up|4|||
128695579|NCT00827502|463183548|FG000|Overall Study|Withdrawal by Subject|5|||
128695580|NCT02478632|463183549|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
128695581|NCT02478632|463183550|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
128695582|NCT02478632|463183549|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
128695583|NCT02478632|463183550|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
128695584|NCT02478632|463183549|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
128695585|NCT02478632|463183550|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
128695586|NCT02130570|463183553|FG000|Overall Study|Death|3|||
128695587|NCT02130570|463183554|FG001|Overall Study|Death|5|||
129027158|NCT00112437|464390070|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027159|NCT00112437|464390071|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027160|NCT00112437|464390072|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027161|NCT00112437|464390073|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
128695588|NCT02130570|463183553|FG000|Overall Study|Withdrawal by Subject|6|||
128765053|NCT00110890|463430403|FG000|Overall Study|Withdrawal by Subject|17|||
128695589|NCT02130570|463183554|FG001|Overall Study|Withdrawal by Subject|3|||
128765054|NCT00110890|463430404|FG001|Overall Study|Withdrawal by Subject|5|||
128695590|NCT02130570|463183553|FG000|Overall Study|Part of practice that discontinued study|0|||
128695591|NCT02130570|463183554|FG001|Overall Study|Part of practice that discontinued study|5|||
128695592|NCT01696695|463183555|FG000|Overall Study|Disease progression|373|||
128695593|NCT01696695|463183555|FG000|Overall Study|Death|29|||
128695594|NCT01696695|463183555|FG000|Overall Study|Adverse Event|74|||
128695595|NCT01696695|463183555|FG000|Overall Study|Withdrawal by Subject|92|||
128695596|NCT01696695|463183555|FG000|Overall Study|Lost to Follow-up|48|||
128695597|NCT01696695|463183555|FG000|Overall Study|Other|74|||
128695598|NCT01696695|463183555|FG000|Overall Study|Major Protocol Violation|192|||
128695599|NCT02589405|463183561|FG000|Overall Study|Adverse Event|3|||
129027162|NCT00112437|464390074|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027163|NCT00112437|464390075|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027164|NCT00112437|464390076|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
129027165|NCT00112437|464390077|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027166|NCT00112437|464390078|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027167|NCT00112437|464390079|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
129027168|NCT00112437|464390080|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027169|NCT00112437|464390081|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027170|NCT00112437|464390082|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027171|NCT00112437|464390083|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027172|NCT00112437|464390084|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027173|NCT00112437|464390085|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027174|NCT00112437|464390086|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027175|NCT00112437|464390087|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027176|NCT00112437|464390088|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027177|NCT00112437|464390089|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027178|NCT00112437|464390090|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129027179|NCT00112437|464390065|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027180|NCT00112437|464390066|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027181|NCT00112437|464390067|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027182|NCT00112437|464390068|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027183|NCT00112437|464390069|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027184|NCT00112437|464390070|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027185|NCT00112437|464390071|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027186|NCT00112437|464390072|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027187|NCT00112437|464390073|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
128695600|NCT02589405|463183561|FG000|Overall Study|Withdrawal by Subject|1|||
128695601|NCT02905149|463183562|FG000|Overall Study|Lost to Follow-up|2|||
128695602|NCT02905149|463183563|FG001|Overall Study|Lost to Follow-up|0|||
128695603|NCT02329080|463183564|FG000|Overall Study|Adverse Event|1|||
128695604|NCT02329080|463183564|FG000|Overall Study|Death|4|||
128695605|NCT02329080|463183564|FG000|Overall Study|Lack of Efficacy|22|||
129027188|NCT00112437|464390074|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027189|NCT00112437|464390075|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
129027190|NCT00112437|464390076|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
129027191|NCT00112437|464390077|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027192|NCT00112437|464390078|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027193|NCT00112437|464390079|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027194|NCT00112437|464390080|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027195|NCT00112437|464390081|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027196|NCT00112437|464390082|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
128695606|NCT02329080|463183564|FG000|Overall Study|Lost to Follow-up|1|||
128695607|NCT02329080|463183564|FG000|Overall Study|Physician Decision|2|||
128695608|NCT02329080|463183564|FG000|Overall Study|Partial response|4|||
128695609|NCT02329080|463183564|FG000|Overall Study|Complete response|4|||
128695610|NCT03082261|463183573|FG000|Overall Study|Death|4|||
128695611|NCT03082261|463183573|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
128695612|NCT03082261|463183573|FG000|Overall Study|Insurance denial|1|||
128695613|NCT03082261|463183573|FG000|Overall Study|Peripheral lead added|1|||
128695614|NCT03082261|463183573|FG000|Overall Study|Withdrawal by Subject|40|||
128695615|NCT03082261|463183573|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
128695616|NCT03082261|463183573|FG000|Overall Study|Subject implanted with device other than study device|1|||
128695617|NCT03082261|463183573|FG000|Overall Study|Lost to Follow-up|14|||
128695618|NCT03082261|463183573|FG000|Overall Study|Subject moved to a different state|1|||
128695619|NCT03082261|463183573|FG000|Overall Study|Subject non-compliance|2|||
128695620|NCT03082261|463183573|FG000|Overall Study|Subject participation terminated by investigator|9|||
128695621|NCT03082261|463183573|FG000|Overall Study|Subject participation terminated by sponsor|4|||
128695622|NCT03082261|463183573|FG000|Overall Study|System explant|19|||
128695623|NCT03082261|463183573|FG000|Overall Study|Unable to place lead(s)|2|||
128695624|NCT03082261|463183573|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
128695625|NCT01032174|463183578|FG000|Overall Study|Adverse Event|0|||
128695626|NCT01032174|463183579|FG001|Overall Study|Adverse Event|1|||
128695627|NCT00702689|463183580|FG000|Overall Study|Withdrawal by Subject|4|||
128695628|NCT00702689|463183580|FG000|Overall Study|Recurrent malignancy|1|||
128695629|NCT00702689|463183580|FG000|Overall Study|Adverse Event|1|||
128695630|NCT01281137|463183583|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
128695631|NCT01281137|463183584|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
128695632|NCT01281137|463183583|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
129132902|NCT00827242|464778558|FG000|Overall Study|Death|1|||
129116610|NCT03327324|464723235|FG001|Intervention (Month 3-Month 6)|Death|0|||
129116611|NCT03327324|464723236|FG002|Intervention (Month 3-Month 6)|Death|1|||
129116612|NCT03327324|464723237|FG003|Intervention (Month 3-Month 6)|Death|1|||
129116613|NCT03327324|464723238|FG004|Intervention (Month 3-Month 6)|Death|1|||
129116614|NCT03327324|464723239|FG005|Intervention (Month 3-Month 6)|Death|0|||
129116615|NCT03327324|464723234|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116616|NCT03327324|464723235|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116617|NCT03327324|464723236|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116618|NCT03327324|464723237|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116619|NCT03327324|464723238|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116620|NCT03327324|464723239|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
129116621|NCT03327324|464723234|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
129116622|NCT03327324|464723235|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116623|NCT03327324|464723236|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116624|NCT03327324|464723237|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116625|NCT03327324|464723238|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
128695633|NCT01281137|463183584|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
128695634|NCT01281137|463183583|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
128695635|NCT01281137|463183584|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
128695636|NCT01281137|463183583|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
128695637|NCT01281137|463183584|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
128695638|NCT01281137|463183583|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
128695639|NCT01281137|463183584|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
128695640|NCT02761733|463183587|FG000|Overall Study|Death|3|||
128695641|NCT02761733|463183588|FG001|Overall Study|Death|5|||
128695642|NCT02761733|463183589|FG002|Overall Study|Death|1|||
128695643|NCT02761733|463183590|FG003|Overall Study|Death|1|||
128695644|NCT02761733|463183587|FG000|Overall Study|Lost to Follow-up|6|||
128695645|NCT02761733|463183588|FG001|Overall Study|Lost to Follow-up|7|||
128695646|NCT02761733|463183589|FG002|Overall Study|Lost to Follow-up|0|||
128695647|NCT02761733|463183590|FG003|Overall Study|Lost to Follow-up|3|||
128695648|NCT02761733|463183587|FG000|Overall Study|Physician Decision|4|||
128695649|NCT02761733|463183588|FG001|Overall Study|Physician Decision|0|||
128695650|NCT02761733|463183589|FG002|Overall Study|Physician Decision|0|||
128695651|NCT02761733|463183590|FG003|Overall Study|Physician Decision|0|||
128695652|NCT02761733|463183587|FG000|Overall Study|Withdrawal by Subject|2|||
128695653|NCT02761733|463183588|FG001|Overall Study|Withdrawal by Subject|0|||
128695654|NCT02761733|463183589|FG002|Overall Study|Withdrawal by Subject|0|||
128695655|NCT02761733|463183590|FG003|Overall Study|Withdrawal by Subject|0|||
128695656|NCT02761733|463183587|FG000|Overall Study|Discharged from Study Site|10|||
128695657|NCT02761733|463183588|FG001|Overall Study|Discharged from Study Site|9|||
128695658|NCT02761733|463183589|FG002|Overall Study|Discharged from Study Site|25|||
128695659|NCT02761733|463183590|FG003|Overall Study|Discharged from Study Site|11|||
128695660|NCT02761733|463183587|FG000|Overall Study|Cognitive Impairment|5|||
128695661|NCT02761733|463183588|FG001|Overall Study|Cognitive Impairment|0|||
128695662|NCT02761733|463183589|FG002|Overall Study|Cognitive Impairment|1|||
128695663|NCT02761733|463183590|FG003|Overall Study|Cognitive Impairment|0|||
128695664|NCT01986907|463183593|FG000|Overall Study|Adverse Event|11|||
128695665|NCT01986907|463183593|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
128695666|NCT01986907|463183593|FG000|Overall Study|Protocol Violation|4|||
128695667|NCT01986907|463183593|FG000|Overall Study|Withdrawal by Subject|76|||
128695668|NCT01986907|463183593|FG000|Overall Study|Lost to Follow-up|38|||
128695669|NCT01986907|463183593|FG000|Overall Study|Death|9|||
128695670|NCT04295772|463183596|FG000|Overall Study|Protocol Violation|1|||
128906259|NCT01471782|463948700|FG005|Overall Study|Other|5|||
128906260|NCT01471782|463948695|FG000|Overall Study|Change of Chemotherapy|1|||
128906261|NCT01471782|463948696|FG001|Overall Study|Change of Chemotherapy|1|||
128906262|NCT01471782|463948697|FG002|Overall Study|Change of Chemotherapy|0|||
128906263|NCT01471782|463948698|FG003|Overall Study|Change of Chemotherapy|0|||
128906264|NCT01471782|463948699|FG004|Overall Study|Change of Chemotherapy|1|||
128906265|NCT01471782|463948700|FG005|Overall Study|Change of Chemotherapy|4|||
128906266|NCT01471782|463948695|FG000|Overall Study|Disease Relapse|0|||
128906267|NCT01471782|463948696|FG001|Overall Study|Disease Relapse|0|||
128906268|NCT01471782|463948697|FG002|Overall Study|Disease Relapse|0|||
128906269|NCT01471782|463948698|FG003|Overall Study|Disease Relapse|1|||
128906270|NCT01471782|463948699|FG004|Overall Study|Disease Relapse|2|||
128906271|NCT01471782|463948700|FG005|Overall Study|Disease Relapse|1|||
128906272|NCT01471782|463948695|FG000|Overall Study|Physician Decision|0|||
129027197|NCT00112437|464390083|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027198|NCT00112437|464390084|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027199|NCT00112437|464390085|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027200|NCT00112437|464390086|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027201|NCT00112437|464390087|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027202|NCT00112437|464390088|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027203|NCT00112437|464390089|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027204|NCT00112437|464390090|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129027205|NCT00112437|464390065|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027206|NCT00112437|464390066|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027207|NCT00112437|464390067|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027208|NCT00112437|464390068|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027209|NCT00112437|464390069|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027210|NCT00112437|464390070|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027211|NCT00112437|464390071|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027212|NCT00112437|464390072|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027213|NCT00112437|464390073|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027214|NCT00112437|464390074|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027215|NCT00112437|464390075|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027216|NCT00112437|464390076|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027217|NCT00112437|464390077|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027218|NCT00112437|464390078|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027219|NCT00112437|464390079|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027220|NCT00112437|464390080|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027221|NCT00112437|464390081|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027222|NCT00112437|464390082|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027223|NCT00112437|464390083|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027224|NCT00112437|464390084|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027225|NCT00112437|464390085|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
129027226|NCT00112437|464390086|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
129027227|NCT00112437|464390087|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027228|NCT00112437|464390088|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027229|NCT00112437|464390089|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027230|NCT00112437|464390090|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129027231|NCT00112437|464390065|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027232|NCT00112437|464390066|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027233|NCT00112437|464390067|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027234|NCT00112437|464390068|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027235|NCT00112437|464390069|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027236|NCT00112437|464390070|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
128695671|NCT04295772|463183597|FG001|Overall Study|Protocol Violation|0|||
128695672|NCT04295772|463183596|FG000|Overall Study|Ongoing for safety monitoring|14|||
128695673|NCT04295772|463183597|FG001|Overall Study|Ongoing for safety monitoring|1|||
128695674|NCT04295772|463183596|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
128695675|NCT04295772|463183597|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
128695676|NCT03576495|463183614|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
128695677|NCT03576495|463183615|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
128695678|NCT04203797|463183617|FG000|Overall Study|Adverse Event|1|||
128695679|NCT04203797|463183618|FG001|Overall Study|Adverse Event|0|||
128695680|NCT04203797|463183617|FG000|Overall Study|Did not complete End of Study follow-up|1|||
128695681|NCT04203797|463183618|FG001|Overall Study|Did not complete End of Study follow-up|0|||
128695682|NCT02121522|463183620|FG000|Overall Study|Adverse Event|1|||
128695683|NCT00516074|463183621|FG000|Overall Study|Adverse Event|0|||
128695684|NCT00516074|463183622|FG001|Overall Study|Adverse Event|1|||
128695685|NCT00516074|463183621|FG000|Overall Study|Subject Decision|4|||
128695686|NCT00516074|463183622|FG001|Overall Study|Subject Decision|2|||
128695687|NCT00516074|463183621|FG000|Overall Study|Loss of Glucose Control|2|||
128695688|NCT00516074|463183622|FG001|Overall Study|Loss of Glucose Control|0|||
128695689|NCT03540030|463183623|FG000|Overall Study|Withdrawal by Subject|2|||
128695690|NCT03540030|463183624|FG001|Overall Study|Withdrawal by Subject|1|||
129027237|NCT00112437|464390071|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
128695691|NCT03540030|463183623|FG000|Overall Study|screen fail|7|||
128695692|NCT03540030|463183624|FG001|Overall Study|screen fail|1|||
128695693|NCT03540030|463183623|FG000|Overall Study|never had surgery after signing consent|9|||
128695694|NCT03540030|463183624|FG001|Overall Study|never had surgery after signing consent|1|||
128906273|NCT01471782|463948696|FG001|Overall Study|Physician Decision|0|||
128906274|NCT01471782|463948697|FG002|Overall Study|Physician Decision|0|||
128906275|NCT01471782|463948698|FG003|Overall Study|Physician Decision|0|||
128906276|NCT01471782|463948699|FG004|Overall Study|Physician Decision|3|||
128906277|NCT01471782|463948700|FG005|Overall Study|Physician Decision|8|||
128906278|NCT01471782|463948695|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128906279|NCT01471782|463948696|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128906280|NCT01471782|463948697|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128906281|NCT01471782|463948698|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128906282|NCT01471782|463948699|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
128906283|NCT01471782|463948700|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
128906284|NCT01471782|463948695|FG000|Overall Study|Death|0|||
128695695|NCT00447005|463183626|FG000|Overall Study|Adverse Event|1|||
128695696|NCT00447005|463183626|FG000|Overall Study|Lack of Efficacy|11|||
128695697|NCT02130297|463183637|FG000|Overall Study|Lost to Follow-up|4|||
128695698|NCT00913380|463183649|FG000|Clinical Outcomes|Lost to Follow-up|6|||
128695699|NCT00913380|463183650|FG001|Clinical Outcomes|Lost to Follow-up|6|||
128695700|NCT00806351|463183651|FG000|Overall Study|Death|5|||
128695701|NCT00806351|463183652|FG001|Overall Study|Death|4|||
128695702|NCT00508755|463183658|FG000|Overall Study|Withdrawal by Subject|1|||
128695703|NCT02004522|463183664|FG000|Overall Study|Adverse Event|55|||
128695704|NCT02004522|463183665|FG001|Overall Study|Adverse Event|6|||
128695705|NCT02004522|463183664|FG000|Overall Study|Withdrawal by Subject|13|||
128695706|NCT02004522|463183665|FG001|Overall Study|Withdrawal by Subject|7|||
128695707|NCT02004522|463183664|FG000|Overall Study|Death|12|||
128695708|NCT02004522|463183665|FG001|Overall Study|Death|3|||
128695709|NCT02004522|463183664|FG000|Overall Study|Physician Decision|3|||
128695710|NCT02004522|463183665|FG001|Overall Study|Physician Decision|4|||
128695711|NCT02004522|463183664|FG000|Overall Study|Protocol Violation|1|||
128695712|NCT02004522|463183665|FG001|Overall Study|Protocol Violation|0|||
128695713|NCT02004522|463183664|FG000|Overall Study|Other is reason listed by PI|4|||
128695714|NCT02004522|463183665|FG001|Overall Study|Other is reason listed by PI|1|||
128695715|NCT02004522|463183664|FG000|Overall Study|Never Dosed|2|||
128695716|NCT02004522|463183665|FG001|Overall Study|Never Dosed|4|||
128695717|NCT02004522|463183664|FG000|Overall Study|Disease Progression|35|||
128695718|NCT02004522|463183665|FG001|Overall Study|Disease Progression|31|||
128695719|NCT02004522|463183664|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
128695720|NCT02004522|463183665|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
128695721|NCT01787331|463183666|FG000|Overall Study|Physician Decision|1|||
128695722|NCT01787331|463183666|FG000|Overall Study|Withdrawal by Subject|1|||
128695723|NCT00667875|463183669|FG000|Overall Study|Adverse Event|0|||
128695724|NCT00667875|463183670|FG001|Overall Study|Adverse Event|2|||
128695725|NCT00667875|463183671|FG002|Overall Study|Adverse Event|6|||
128695726|NCT00667875|463183669|FG000|Overall Study|Withdrawal by Subject|10|||
128695727|NCT00667875|463183670|FG001|Overall Study|Withdrawal by Subject|9|||
128695728|NCT00667875|463183671|FG002|Overall Study|Withdrawal by Subject|7|||
128695729|NCT00450255|463183672|FG000|Overall Study|Prior RFA ablation of liver|1|||
128695730|NCT01696071|463183673|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
128695731|NCT01696071|463183674|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
128695732|NCT00142298|463183677|FG000|Overall Study|Adverse Event|10|||
128695733|NCT00142298|463183678|FG001|Overall Study|Adverse Event|10|||
128695734|NCT00142298|463183679|FG002|Overall Study|Adverse Event|1|||
128695735|NCT00142298|463183680|FG003|Overall Study|Adverse Event|5|||
128695736|NCT00142298|463183681|FG004|Overall Study|Adverse Event|2|||
128695737|NCT00142298|463183682|FG005|Overall Study|Adverse Event|2|||
128695738|NCT00142298|463183683|FG006|Overall Study|Adverse Event|0|||
128695739|NCT00142298|463183684|FG007|Overall Study|Adverse Event|0|||
128695740|NCT00142298|463183685|FG008|Overall Study|Adverse Event|0|||
128695741|NCT00142298|463183686|FG009|Overall Study|Adverse Event|0|||
128695742|NCT00142298|463183677|FG000|Overall Study|Clinical disease progression|1|||
128695743|NCT00142298|463183678|FG001|Overall Study|Clinical disease progression|0|||
128695744|NCT00142298|463183679|FG002|Overall Study|Clinical disease progression|0|||
128695745|NCT00142298|463183680|FG003|Overall Study|Clinical disease progression|0|||
128695746|NCT00142298|463183681|FG004|Overall Study|Clinical disease progression|0|||
128695747|NCT00142298|463183682|FG005|Overall Study|Clinical disease progression|0|||
128695748|NCT00142298|463183683|FG006|Overall Study|Clinical disease progression|0|||
128695749|NCT00142298|463183684|FG007|Overall Study|Clinical disease progression|0|||
128695750|NCT00142298|463183685|FG008|Overall Study|Clinical disease progression|0|||
128695751|NCT00142298|463183686|FG009|Overall Study|Clinical disease progression|0|||
128695752|NCT00142298|463183677|FG000|Overall Study|Death|1|||
128695753|NCT00142298|463183678|FG001|Overall Study|Death|1|||
128906285|NCT01471782|463948696|FG001|Overall Study|Death|0|||
128906286|NCT01471782|463948697|FG002|Overall Study|Death|0|||
128906287|NCT01471782|463948698|FG003|Overall Study|Death|0|||
128906288|NCT01471782|463948699|FG004|Overall Study|Death|0|||
128695754|NCT00142298|463183679|FG002|Overall Study|Death|1|||
128695755|NCT00142298|463183680|FG003|Overall Study|Death|0|||
128695756|NCT00142298|463183681|FG004|Overall Study|Death|0|||
129116626|NCT03327324|464723239|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129116627|NCT03327324|464723234|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
129116628|NCT03327324|464723235|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
129116629|NCT03327324|464723236|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129116630|NCT03327324|464723237|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129116631|NCT03327324|464723238|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129116632|NCT03327324|464723239|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129116633|NCT03327324|464723234|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
129116634|NCT03327324|464723235|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
129116635|NCT03327324|464723236|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
129116636|NCT03327324|464723237|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
129116637|NCT03327324|464723238|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
129116638|NCT03327324|464723239|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
129116639|NCT03327324|464723234|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116640|NCT03327324|464723235|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116641|NCT03327324|464723236|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116642|NCT03327324|464723237|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
129116643|NCT03327324|464723238|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
129116644|NCT03327324|464723239|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129116645|NCT03327324|464723234|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
129116646|NCT03327324|464723235|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129116647|NCT03327324|464723236|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129116648|NCT03327324|464723237|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129116649|NCT03327324|464723238|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129116650|NCT03327324|464723239|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129116651|NCT03327324|464723234|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
129116652|NCT03327324|464723235|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129116653|NCT03327324|464723236|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129116654|NCT03327324|464723237|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129116655|NCT03327324|464723238|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129116656|NCT03327324|464723239|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
128695757|NCT00142298|463183682|FG005|Overall Study|Death|6|||
128695758|NCT00142298|463183683|FG006|Overall Study|Death|0|||
128695759|NCT00142298|463183684|FG007|Overall Study|Death|0|||
129116657|NCT04249427|464723240|FG000|Overall Study|Adverse Event|3|||
129116658|NCT04249427|464723241|FG001|Overall Study|Adverse Event|1|||
129116659|NCT04249427|464723240|FG000|Overall Study|Lack of Efficacy|0|||
129116660|NCT04249427|464723241|FG001|Overall Study|Lack of Efficacy|1|||
129116661|NCT04249427|464723240|FG000|Overall Study|Withdrawal by Subject|1|||
129116662|NCT04249427|464723241|FG001|Overall Study|Withdrawal by Subject|2|||
129116663|NCT01673178|464723242|FG000|Overall Study|Lost to Follow-up|0|||
129116664|NCT01673178|464723243|FG001|Overall Study|Lost to Follow-up|1|||
129116665|NCT01673178|464723244|FG002|Overall Study|Lost to Follow-up|0|||
129116666|NCT01673178|464723245|FG003|Overall Study|Lost to Follow-up|0|||
129116667|NCT01673178|464723246|FG004|Overall Study|Lost to Follow-up|0|||
129116668|NCT01673178|464723242|FG000|Overall Study|Withdrawal by Subject|0|||
129116669|NCT01673178|464723243|FG001|Overall Study|Withdrawal by Subject|0|||
129116670|NCT01673178|464723244|FG002|Overall Study|Withdrawal by Subject|1|||
129116671|NCT01673178|464723245|FG003|Overall Study|Withdrawal by Subject|4|||
129116672|NCT01673178|464723246|FG004|Overall Study|Withdrawal by Subject|2|||
129116673|NCT01673178|464723242|FG000|Overall Study|Protocol Violation|1|||
129116674|NCT01673178|464723243|FG001|Overall Study|Protocol Violation|1|||
129116675|NCT01673178|464723244|FG002|Overall Study|Protocol Violation|0|||
129116676|NCT01673178|464723245|FG003|Overall Study|Protocol Violation|1|||
129116677|NCT01673178|464723246|FG004|Overall Study|Protocol Violation|0|||
129116678|NCT01673178|464723242|FG000|Overall Study|Adverse Event|1|||
129116679|NCT01673178|464723243|FG001|Overall Study|Adverse Event|0|||
128695760|NCT00142298|463183685|FG008|Overall Study|Death|0|||
128695761|NCT00142298|463183686|FG009|Overall Study|Death|0|||
129116680|NCT01673178|464723244|FG002|Overall Study|Adverse Event|0|||
129116681|NCT01673178|464723245|FG003|Overall Study|Adverse Event|2|||
128695762|NCT00142298|463183677|FG000|Overall Study|Lack of Efficacy|44|||
128695763|NCT00142298|463183678|FG001|Overall Study|Lack of Efficacy|62|||
128695764|NCT00142298|463183679|FG002|Overall Study|Lack of Efficacy|9|||
129116682|NCT01673178|464723246|FG004|Overall Study|Adverse Event|0|||
129116683|NCT01673178|464723242|FG000|Overall Study|Other|1|||
129116684|NCT01673178|464723243|FG001|Overall Study|Other|0|||
128695765|NCT00142298|463183680|FG003|Overall Study|Lack of Efficacy|12|||
128695766|NCT00142298|463183681|FG004|Overall Study|Lack of Efficacy|1|||
128695767|NCT00142298|463183682|FG005|Overall Study|Lack of Efficacy|0|||
128695768|NCT00142298|463183683|FG006|Overall Study|Lack of Efficacy|0|||
128695769|NCT00142298|463183684|FG007|Overall Study|Lack of Efficacy|1|||
128695770|NCT00142298|463183685|FG008|Overall Study|Lack of Efficacy|0|||
128695771|NCT00142298|463183686|FG009|Overall Study|Lack of Efficacy|0|||
128695772|NCT00142298|463183677|FG000|Overall Study|Non-compliance|15|||
128695773|NCT00142298|463183678|FG001|Overall Study|Non-compliance|13|||
128695774|NCT00142298|463183679|FG002|Overall Study|Non-compliance|0|||
128695775|NCT00142298|463183680|FG003|Overall Study|Non-compliance|6|||
128695776|NCT00142298|463183681|FG004|Overall Study|Non-compliance|1|||
128695777|NCT00142298|463183682|FG005|Overall Study|Non-compliance|0|||
128695778|NCT00142298|463183683|FG006|Overall Study|Non-compliance|0|||
128695779|NCT00142298|463183684|FG007|Overall Study|Non-compliance|3|||
128695780|NCT00142298|463183685|FG008|Overall Study|Non-compliance|3|||
128695781|NCT00142298|463183686|FG009|Overall Study|Non-compliance|0|||
128695782|NCT00142298|463183677|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
128695783|NCT00142298|463183678|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
128695784|NCT00142298|463183679|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
128695785|NCT00142298|463183680|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
128695786|NCT00142298|463183681|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
128695787|NCT00142298|463183682|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
128695788|NCT00142298|463183683|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
128695789|NCT00142298|463183684|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
128695790|NCT00142298|463183685|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
128695791|NCT00142298|463183686|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
128695792|NCT00142298|463183677|FG000|Overall Study|Pregnancy|4|||
128695793|NCT00142298|463183678|FG001|Overall Study|Pregnancy|4|||
128695794|NCT00142298|463183679|FG002|Overall Study|Pregnancy|2|||
128695795|NCT00142298|463183680|FG003|Overall Study|Pregnancy|3|||
128695796|NCT00142298|463183681|FG004|Overall Study|Pregnancy|0|||
128695797|NCT00142298|463183682|FG005|Overall Study|Pregnancy|0|||
128695798|NCT00142298|463183683|FG006|Overall Study|Pregnancy|0|||
128695799|NCT00142298|463183684|FG007|Overall Study|Pregnancy|0|||
128695800|NCT00142298|463183685|FG008|Overall Study|Pregnancy|1|||
128695801|NCT00142298|463183686|FG009|Overall Study|Pregnancy|0|||
128695802|NCT00142298|463183677|FG000|Overall Study|Virologic breakthrough|19|||
128695803|NCT00142298|463183678|FG001|Overall Study|Virologic breakthrough|23|||
128695804|NCT00142298|463183679|FG002|Overall Study|Virologic breakthrough|9|||
128695805|NCT00142298|463183680|FG003|Overall Study|Virologic breakthrough|7|||
128695806|NCT00142298|463183681|FG004|Overall Study|Virologic breakthrough|2|||
128695807|NCT00142298|463183682|FG005|Overall Study|Virologic breakthrough|3|||
128695808|NCT00142298|463183683|FG006|Overall Study|Virologic breakthrough|3|||
128695809|NCT00142298|463183684|FG007|Overall Study|Virologic breakthrough|0|||
128695810|NCT00142298|463183685|FG008|Overall Study|Virologic breakthrough|0|||
128695811|NCT00142298|463183686|FG009|Overall Study|Virologic breakthrough|0|||
128695812|NCT00142298|463183677|FG000|Overall Study|Other- not specified|0|||
128695813|NCT00142298|463183678|FG001|Overall Study|Other- not specified|3|||
128695814|NCT00142298|463183679|FG002|Overall Study|Other- not specified|0|||
128695815|NCT00142298|463183680|FG003|Overall Study|Other- not specified|1|||
128695816|NCT00142298|463183681|FG004|Overall Study|Other- not specified|0|||
128695817|NCT00142298|463183682|FG005|Overall Study|Other- not specified|0|||
128695818|NCT00142298|463183683|FG006|Overall Study|Other- not specified|0|||
129027238|NCT00112437|464390072|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027239|NCT00112437|464390073|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027240|NCT00112437|464390074|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027241|NCT00112437|464390075|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027242|NCT00112437|464390076|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027243|NCT00112437|464390077|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027244|NCT00112437|464390078|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027245|NCT00112437|464390079|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027246|NCT00112437|464390080|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027247|NCT00112437|464390081|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027248|NCT00112437|464390082|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027249|NCT00112437|464390083|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027250|NCT00112437|464390084|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027251|NCT00112437|464390085|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
129027252|NCT00112437|464390086|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129116685|NCT01673178|464723244|FG002|Overall Study|Other|2|||
128695819|NCT00142298|463183684|FG007|Overall Study|Other- not specified|0|||
128695820|NCT00142298|463183685|FG008|Overall Study|Other- not specified|0|||
128695821|NCT00142298|463183686|FG009|Overall Study|Other- not specified|0|||
128695822|NCT00142298|463183677|FG000|Overall Study|Lost to Follow-up|0|||
128695823|NCT00142298|463183678|FG001|Overall Study|Lost to Follow-up|0|||
129116686|NCT01673178|464723245|FG003|Overall Study|Other|1|||
128695824|NCT00142298|463183679|FG002|Overall Study|Lost to Follow-up|0|||
128695825|NCT00142298|463183680|FG003|Overall Study|Lost to Follow-up|0|||
128695826|NCT00142298|463183681|FG004|Overall Study|Lost to Follow-up|0|||
128695827|NCT00142298|463183682|FG005|Overall Study|Lost to Follow-up|0|||
128695828|NCT00142298|463183683|FG006|Overall Study|Lost to Follow-up|2|||
128695829|NCT00142298|463183684|FG007|Overall Study|Lost to Follow-up|0|||
128695830|NCT00142298|463183685|FG008|Overall Study|Lost to Follow-up|0|||
128695831|NCT00142298|463183686|FG009|Overall Study|Lost to Follow-up|0|||
128695832|NCT00142298|463183677|FG000|Overall Study|Treatment Failure|0|||
128695833|NCT00142298|463183678|FG001|Overall Study|Treatment Failure|0|||
128695834|NCT00142298|463183679|FG002|Overall Study|Treatment Failure|0|||
128695835|NCT00142298|463183680|FG003|Overall Study|Treatment Failure|0|||
128695836|NCT00142298|463183681|FG004|Overall Study|Treatment Failure|0|||
128695837|NCT00142298|463183682|FG005|Overall Study|Treatment Failure|2|||
128695838|NCT00142298|463183683|FG006|Overall Study|Treatment Failure|2|||
128695839|NCT00142298|463183684|FG007|Overall Study|Treatment Failure|0|||
128695840|NCT00142298|463183685|FG008|Overall Study|Treatment Failure|0|||
128695841|NCT00142298|463183686|FG009|Overall Study|Treatment Failure|0|||
128695842|NCT00300274|463183687|FG000|Overall Study|Withdrawal by Subject|12|||
128695843|NCT00300274|463183688|FG001|Overall Study|Withdrawal by Subject|3|||
128695844|NCT00300274|463183689|FG002|Overall Study|Withdrawal by Subject|14|||
128695845|NCT00300274|463183687|FG000|Overall Study|Lost to Follow-up|3|||
128695846|NCT00300274|463183688|FG001|Overall Study|Lost to Follow-up|4|||
128695847|NCT00300274|463183689|FG002|Overall Study|Lost to Follow-up|5|||
128695848|NCT00300274|463183687|FG000|Overall Study|Death|31|||
128695849|NCT00300274|463183688|FG001|Overall Study|Death|20|||
128695850|NCT00300274|463183689|FG002|Overall Study|Death|25|||
128695851|NCT00300274|463183687|FG000|Overall Study|Re-transplant|0|||
128695852|NCT00300274|463183688|FG001|Overall Study|Re-transplant|0|||
128695853|NCT00300274|463183689|FG002|Overall Study|Re-transplant|1|||
128695854|NCT03730012|463183690|FG000|Overall Study|Adverse Event|0|||
128695855|NCT03730012|463183691|FG001|Overall Study|Adverse Event|1|||
128695856|NCT03730012|463183690|FG000|Overall Study|Lack of Efficacy|1|||
128695857|NCT03730012|463183691|FG001|Overall Study|Lack of Efficacy|5|||
128695858|NCT03730012|463183690|FG000|Overall Study|Withdrawal by Subject|0|||
128695859|NCT03730012|463183691|FG001|Overall Study|Withdrawal by Subject|1|||
128695860|NCT03730012|463183690|FG000|Overall Study|Miscellaneous|2|||
128695861|NCT03730012|463183691|FG001|Overall Study|Miscellaneous|1|||
128695862|NCT04680052|463185227|FG000|Overall Study|Ongoing|244|||
128695863|NCT04680052|463185228|FG001|Overall Study|Ongoing|229|||
128695864|NCT04680052|463185229|FG002|Overall Study|Ongoing|39|||
128695865|NCT04680052|463185230|FG003|Overall Study|Ongoing|46|||
128695866|NCT04680052|463185227|FG000|Overall Study|Death|15|||
128695867|NCT04680052|463185228|FG001|Overall Study|Death|22|||
128695868|NCT04680052|463185229|FG002|Overall Study|Death|7|||
128695869|NCT04680052|463185230|FG003|Overall Study|Death|1|||
128695870|NCT04680052|463185227|FG000|Overall Study|Lost to Follow-up|3|||
128695871|NCT04680052|463185228|FG001|Overall Study|Lost to Follow-up|2|||
128695872|NCT04680052|463185229|FG002|Overall Study|Lost to Follow-up|0|||
128695873|NCT04680052|463185230|FG003|Overall Study|Lost to Follow-up|1|||
128695874|NCT04680052|463185227|FG000|Overall Study|Withdrawal by Subject|11|||
128695875|NCT04680052|463185228|FG001|Overall Study|Withdrawal by Subject|19|||
128695876|NCT04680052|463185229|FG002|Overall Study|Withdrawal by Subject|7|||
128695877|NCT04680052|463185230|FG003|Overall Study|Withdrawal by Subject|5|||
128695878|NCT04680052|463185227|FG000|Overall Study|Missing|0|||
128695879|NCT04680052|463185228|FG001|Overall Study|Missing|1|||
128695880|NCT04680052|463185229|FG002|Overall Study|Missing|0|||
128695881|NCT04680052|463185230|FG003|Overall Study|Missing|0|||
128695882|NCT04680052|463185227|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
128695883|NCT04680052|463185228|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
128695884|NCT04680052|463185229|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
128695885|NCT04680052|463185230|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
129116687|NCT01673178|464723246|FG004|Overall Study|Other|0|||
129116688|NCT03177148|464723247|FG000|Overall Study|Lost to Follow-up|50|||
129116689|NCT03177148|464723248|FG001|Overall Study|Lost to Follow-up|1|||
128695886|NCT04680052|463185227|FG000|Overall Study|Physician Decision|0|||
128695887|NCT04680052|463185228|FG001|Overall Study|Physician Decision|1|||
128695888|NCT04680052|463185229|FG002|Overall Study|Physician Decision|0|||
128695889|NCT04680052|463185230|FG003|Overall Study|Physician Decision|0|||
128695890|NCT03320057|463185231|FG000|Overall Study|Lost to Follow-up|4|||
129116690|NCT03177148|464723247|FG000|Overall Study|Death|1|||
129116691|NCT03177148|464723248|FG001|Overall Study|Death|0|||
128695891|NCT03320057|463185232|FG001|Overall Study|Lost to Follow-up|17|||
128695892|NCT03320057|463185231|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
129116692|NCT02848664|464723251|FG000|Overall Study|Withdrawal by Subject|2|||
128695893|NCT03320057|463185232|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
128695894|NCT01367002|463185233|FG000|Overall Study|Withdrawal by Subject|1|||
128695895|NCT01367002|463185234|FG001|Overall Study|Withdrawal by Subject|0|||
128695896|NCT01367002|463185233|FG000|Overall Study|Physician Decision|0|||
128695897|NCT01367002|463185234|FG001|Overall Study|Physician Decision|2|||
128695898|NCT06956170|463185235|FG000|Overall Study|Death|2|||
128695899|NCT06956170|463185236|FG001|Overall Study|Death|1|||
128695900|NCT06956170|463185235|FG000|Overall Study|Withdrawal by Subject|1|||
128695901|NCT06956170|463185236|FG001|Overall Study|Withdrawal by Subject|0|||
128695902|NCT06956170|463185235|FG000|Overall Study|Ongoing|7|||
128695903|NCT06956170|463185236|FG001|Overall Study|Ongoing|10|||
128695904|NCT01516437|463185237|FG000|Overall Study|Reason not specified|0|||
128695905|NCT01516437|463185238|FG001|Overall Study|Reason not specified|0|||
128695906|NCT01516437|463185239|FG002|Overall Study|Reason not specified|1|||
128695907|NCT01516437|463185240|FG003|Overall Study|Reason not specified|1|||
128695908|NCT00316719|463185243|FG000|Overall Study|Adverse Event|0|||
128695909|NCT00316719|463185244|FG001|Overall Study|Adverse Event|6|||
128695910|NCT00316719|463185243|FG000|Overall Study|Consent withdrawn|2|||
128695911|NCT00316719|463185244|FG001|Overall Study|Consent withdrawn|0|||
128695912|NCT02468674|463185247|FG000|Overall Study|Adverse Event|0|||
128695913|NCT02468674|463185248|FG001|Overall Study|Adverse Event|0|||
128695914|NCT02468674|463185249|FG002|Overall Study|Adverse Event|0|||
128695915|NCT02468674|463185250|FG003|Overall Study|Adverse Event|1|||
128695916|NCT02468674|463185251|FG004|Overall Study|Adverse Event|0|||
128695917|NCT02468674|463185252|FG005|Overall Study|Adverse Event|1|||
128695918|NCT02468674|463185253|FG006|Overall Study|Adverse Event|0|||
128695919|NCT02468674|463185254|FG007|Overall Study|Adverse Event|0|||
128695920|NCT02468674|463185255|FG008|Overall Study|Adverse Event|0|||
128695921|NCT02468674|463185247|FG000|Overall Study|Lost to Follow-up|1|||
128695922|NCT02468674|463185248|FG001|Overall Study|Lost to Follow-up|0|||
128695923|NCT02468674|463185249|FG002|Overall Study|Lost to Follow-up|0|||
128695924|NCT02468674|463185250|FG003|Overall Study|Lost to Follow-up|0|||
128695925|NCT02468674|463185251|FG004|Overall Study|Lost to Follow-up|0|||
128695926|NCT02468674|463185252|FG005|Overall Study|Lost to Follow-up|0|||
128695927|NCT02468674|463185253|FG006|Overall Study|Lost to Follow-up|0|||
128695928|NCT02468674|463185254|FG007|Overall Study|Lost to Follow-up|1|||
128695929|NCT02468674|463185255|FG008|Overall Study|Lost to Follow-up|1|||
128695930|NCT02468674|463185247|FG000|Overall Study|Physician Decision|0|||
128695931|NCT02468674|463185248|FG001|Overall Study|Physician Decision|0|||
128695932|NCT02468674|463185249|FG002|Overall Study|Physician Decision|0|||
128695933|NCT02468674|463185250|FG003|Overall Study|Physician Decision|0|||
128695934|NCT02468674|463185251|FG004|Overall Study|Physician Decision|0|||
128695935|NCT02468674|463185252|FG005|Overall Study|Physician Decision|0|||
128695936|NCT02468674|463185253|FG006|Overall Study|Physician Decision|1|||
128695937|NCT02468674|463185254|FG007|Overall Study|Physician Decision|0|||
128695938|NCT02468674|463185255|FG008|Overall Study|Physician Decision|0|||
128695939|NCT02468674|463185247|FG000|Overall Study|Patient/Guardian Decision|0|||
128695940|NCT02468674|463185248|FG001|Overall Study|Patient/Guardian Decision|0|||
128695941|NCT02468674|463185249|FG002|Overall Study|Patient/Guardian Decision|0|||
128695942|NCT02468674|463185250|FG003|Overall Study|Patient/Guardian Decision|0|||
128695943|NCT02468674|463185251|FG004|Overall Study|Patient/Guardian Decision|1|||
128695944|NCT02468674|463185252|FG005|Overall Study|Patient/Guardian Decision|0|||
128695945|NCT02468674|463185253|FG006|Overall Study|Patient/Guardian Decision|0|||
128695946|NCT02468674|463185254|FG007|Overall Study|Patient/Guardian Decision|2|||
128695947|NCT02468674|463185255|FG008|Overall Study|Patient/Guardian Decision|1|||
128695948|NCT02468674|463185247|FG000|Overall Study|Protocol Deviation|0|||
128695949|NCT02468674|463185248|FG001|Overall Study|Protocol Deviation|0|||
128695950|NCT02468674|463185249|FG002|Overall Study|Protocol Deviation|0|||
128695951|NCT02468674|463185250|FG003|Overall Study|Protocol Deviation|0|||
128695952|NCT02468674|463185251|FG004|Overall Study|Protocol Deviation|0|||
128695953|NCT02468674|463185252|FG005|Overall Study|Protocol Deviation|0|||
128695954|NCT02468674|463185253|FG006|Overall Study|Protocol Deviation|0|||
128695955|NCT02468674|463185254|FG007|Overall Study|Protocol Deviation|1|||
128695956|NCT02468674|463185255|FG008|Overall Study|Protocol Deviation|1|||
128695957|NCT03689530|463185261|FG000|Overall Study|Withdrawal by Subject|53|||
128695958|NCT03689530|463185262|FG001|Overall Study|Withdrawal by Subject|16|||
128695959|NCT01546207|463185265|FG000|Overall Study|Death|1|||
128695960|NCT00713323|463185266|FG000|Overall Study|Adverse Event|75|||
128695961|NCT00713323|463185266|FG000|Overall Study|Withdrawal by Subject|15|||
128695962|NCT00713323|463185266|FG000|Overall Study|Lost to Follow-up|11|||
128695963|NCT00713323|463185266|FG000|Overall Study|Lack of Efficacy|36|||
128695964|NCT00713323|463185266|FG000|Overall Study|Low creatine clearance at screening|1|||
128695965|NCT00713323|463185266|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
128695966|NCT00713323|463185266|FG000|Overall Study|Surgery cured allodynic pain|1|||
128695967|NCT00713323|463185266|FG000|Overall Study|Pain free|1|||
128695968|NCT00713323|463185266|FG000|Overall Study|Non-compliance|1|||
128695969|NCT00713323|463185266|FG000|Overall Study|Pain resolved|1|||
128695970|NCT00713323|463185266|FG000|Overall Study|Subject travelling to USA|1|||
128695971|NCT00713323|463185266|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
128695972|NCT00713323|463185266|FG000|Overall Study|Treatment that may interact with Sativex|1|||
128695973|NCT01826604|463185268|FG000|Overall Study|Lost to Follow-up|8|||
128695974|NCT01826604|463185269|FG001|Overall Study|Lost to Follow-up|9|||
128695975|NCT00491075|463185270|FG000|Overall Study|Withdrawal by Subject|1|||
128695976|NCT00491075|463185270|FG000|Overall Study|Physician Decision|1|||
128695977|NCT03019185|463185271|FG000|Overall Study|Lost to Follow-up|3|||
128695978|NCT03019185|463185272|FG001|Overall Study|Lost to Follow-up|0|||
128695979|NCT03019185|463185273|FG002|Overall Study|Lost to Follow-up|2|||
128695980|NCT03019185|463185271|FG000|Overall Study|Withdrawal by Subject|1|||
128695981|NCT03019185|463185272|FG001|Overall Study|Withdrawal by Subject|1|||
128695982|NCT03019185|463185273|FG002|Overall Study|Withdrawal by Subject|0|||
128695983|NCT03019185|463185271|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
128695984|NCT03019185|463185272|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
128695985|NCT03019185|463185273|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
128695986|NCT03019185|463185271|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
128695987|NCT03019185|463185272|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
128695988|NCT03019185|463185273|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
128695989|NCT03355365|463185276|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
128695990|NCT03355365|463185277|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
128695991|NCT03355365|463185276|FG000|Year 1, First Intervention|Protocol Violation|1|||
128695992|NCT03355365|463185277|FG001|Year 1, First Intervention|Protocol Violation|0|||
128695993|NCT03355365|463185276|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
128695994|NCT03355365|463185277|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
128695995|NCT03355365|463185276|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
128695996|NCT03355365|463185277|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
128695997|NCT03355365|463185276|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
128695998|NCT03355365|463185277|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
128695999|NCT03355365|463185276|FG000|Year 2, Crossover Intervention|severe COVID|0|||
128696000|NCT03355365|463185277|FG001|Year 2, Crossover Intervention|severe COVID|1|||
128696001|NCT03355365|463185276|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
128696002|NCT03355365|463185277|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
128696003|NCT04622306|463185278|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
128696004|NCT04622306|463185279|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
128696005|NCT04622306|463185280|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
128696006|NCT04622306|463185281|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
128696007|NCT04622306|463185282|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
128696008|NCT04622306|463185283|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
128696009|NCT04622306|463185278|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
128696010|NCT04622306|463185279|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
128696011|NCT04622306|463185280|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
128696012|NCT04622306|463185281|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
128696013|NCT04622306|463185282|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
128696014|NCT04622306|463185283|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
128696015|NCT00736944|463185284|FG000|Induction|Death|1|||
128696016|NCT00736944|463185284|FG000|Definitive Treatment|Physician Decision|1|||
128696017|NCT05350410|463185285|FG000|Overall Study|Withdrawal by Subject|1|||
128696018|NCT01601132|463185286|FG000|Overall Study|Patient withdrew consent|1|||
128696019|NCT01601132|463185286|FG000|Overall Study|Protocol deviation|1|||
128696020|NCT00142935|463185287|FG000|Overall Study|Other reason|1|||
128696021|NCT00142935|463185288|FG001|Overall Study|Other reason|1|||
128696022|NCT00142935|463185289|FG002|Overall Study|Other reason|1|||
128696023|NCT00142935|463185287|FG000|Overall Study|Lost to Follow-up|2|||
128696024|NCT00142935|463185288|FG001|Overall Study|Lost to Follow-up|5|||
128696025|NCT00142935|463185289|FG002|Overall Study|Lost to Follow-up|5|||
128696026|NCT00142935|463185287|FG000|Overall Study|Death|0|||
128696027|NCT00142935|463185288|FG001|Overall Study|Death|2|||
128696028|NCT00142935|463185289|FG002|Overall Study|Death|1|||
128696029|NCT01330030|463185295|FG000|Overall Study|Lost to Follow-up|16|||
128696030|NCT01330030|463185296|FG001|Overall Study|Lost to Follow-up|17|||
128696031|NCT02980783|463185297|FG000|Overall Study|Lost to Follow-up|1|||
128696032|NCT04545060|463185299|FG000|Overall Study|Adverse Event|0|||
128696033|NCT04545060|463185300|FG001|Overall Study|Adverse Event|1|||
128696034|NCT04545060|463185299|FG000|Overall Study|Death|0|||
128696035|NCT04545060|463185300|FG001|Overall Study|Death|5|||
129027253|NCT00112437|464390087|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027254|NCT00112437|464390088|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027255|NCT00112437|464390089|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129027256|NCT00112437|464390090|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
128696036|NCT04545060|463185299|FG000|Overall Study|Lost to Follow-up|10|||
128696037|NCT04545060|463185300|FG001|Overall Study|Lost to Follow-up|13|||
128696038|NCT04545060|463185299|FG000|Overall Study|Physician Decision|3|||
128696039|NCT04545060|463185300|FG001|Overall Study|Physician Decision|0|||
128696040|NCT04545060|463185299|FG000|Overall Study|Withdrawal by Subject|17|||
128696041|NCT04545060|463185300|FG001|Overall Study|Withdrawal by Subject|22|||
128696042|NCT00619177|463185303|FG000|Overall Study|Adverse Event|18|||
129116693|NCT02848664|464723251|FG000|Overall Study|Adverse Event|1|||
129116694|NCT02848664|464723251|FG000|Overall Study|no assistance for device training|1|||
129116695|NCT01419314|464723253|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
129116696|NCT01419314|464723254|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
129116697|NCT01419314|464723253|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
129116698|NCT01419314|464723254|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
129116699|NCT01419314|464723253|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
129116700|NCT01419314|464723254|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
129116701|NCT00402727|464723257|FG000|Overall Study|Adverse Event|10|||
129116702|NCT00402727|464723258|FG001|Overall Study|Adverse Event|6|||
129116703|NCT00402727|464723257|FG000|Overall Study|Death|1|||
129116704|NCT00402727|464723258|FG001|Overall Study|Death|0|||
129116705|NCT00402727|464723257|FG000|Overall Study|Lack of Efficacy|1|||
129116706|NCT00402727|464723258|FG001|Overall Study|Lack of Efficacy|3|||
129116707|NCT00402727|464723257|FG000|Overall Study|Lost to Follow-up|24|||
129116708|NCT00402727|464723258|FG001|Overall Study|Lost to Follow-up|11|||
129116709|NCT00402727|464723257|FG000|Overall Study|Physician Decision|1|||
128696043|NCT00619177|463185303|FG000|Overall Study|Lost to Follow-up|2|||
128696044|NCT00619177|463185303|FG000|Overall Study|Lack of Efficacy|1|||
128696045|NCT00619177|463185303|FG000|Overall Study|Missing termination information|481|||
128696046|NCT00619177|463185303|FG000|Overall Study|Not specified reasons|6|||
129116710|NCT00402727|464723258|FG001|Overall Study|Physician Decision|1|||
129116711|NCT00402727|464723257|FG000|Overall Study|Protocol Violation|0|||
129116712|NCT00402727|464723258|FG001|Overall Study|Protocol Violation|4|||
129116713|NCT00402727|464723257|FG000|Overall Study|Withdrawal by Subject|3|||
129116714|NCT00402727|464723258|FG001|Overall Study|Withdrawal by Subject|7|||
128696047|NCT02805972|463185307|FG000|Washout Period|Lost to Follow-up|3|||
128696048|NCT02805972|463185308|FG001|Washout Period|Lost to Follow-up|0|||
128696049|NCT01206166|463185310|FG000|Overall Study|No evaluable data|2|||
128696050|NCT01206166|463185311|FG001|Overall Study|No evaluable data|3|||
128696051|NCT02716805|463185312|FG000|Overall Study|Progressive disease|2|||
128696052|NCT02716805|463185313|FG001|Overall Study|Progressive disease|0|||
128696053|NCT02716805|463185314|FG002|Overall Study|Progressive disease|0|||
128696054|NCT02716805|463185315|FG003|Overall Study|Progressive disease|0|||
128696055|NCT02635776|463185319|FG000|Overall Study|Physician Decision|1|||
128696056|NCT02635776|463185320|FG001|Overall Study|Physician Decision|0|||
128696057|NCT02635776|463185319|FG000|Overall Study|Adverse Event|51|||
128696058|NCT02635776|463185320|FG001|Overall Study|Adverse Event|3|||
128696059|NCT02635776|463185319|FG000|Overall Study|Withdrawal by Subject|41|||
128696060|NCT02635776|463185320|FG001|Overall Study|Withdrawal by Subject|7|||
128696061|NCT02635776|463185319|FG000|Overall Study|Lost to Follow-up|4|||
128696062|NCT02635776|463185320|FG001|Overall Study|Lost to Follow-up|0|||
128696063|NCT02635776|463185319|FG000|Overall Study|Other reasons|5|||
128696064|NCT02635776|463185320|FG001|Overall Study|Other reasons|1|||
128696065|NCT00239590|463185321|FG000|Randomized|Lost to Follow-up|0|||
128696066|NCT00239590|463185322|FG001|Randomized|Lost to Follow-up|1|||
128696067|NCT00239590|463185321|FG000|Randomized|Withdrawal by Subject|0|||
128696068|NCT00239590|463185322|FG001|Randomized|Withdrawal by Subject|1|||
128696069|NCT00239590|463185321|FG000|Completed Study Protocol|Adverse Event|1|||
128696070|NCT00239590|463185322|FG001|Completed Study Protocol|Adverse Event|1|||
128696071|NCT00239590|463185321|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
128696072|NCT00239590|463185322|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
128696073|NCT02362269|463185325|FG000|Overall Study|Moved|1|||
128696074|NCT02362269|463185326|FG001|Overall Study|Moved|0|||
128696075|NCT02362269|463185325|FG000|Overall Study|Lost to Follow-up|0|||
128696076|NCT02362269|463185326|FG001|Overall Study|Lost to Follow-up|6|||
128696077|NCT01903031|463185327|FG000|Overall Study|Not Able to Attend Clinic|1|||
128696078|NCT01903031|463185328|FG001|Overall Study|Not Able to Attend Clinic|1|||
128696079|NCT01903031|463185329|FG002|Overall Study|Not Able to Attend Clinic|0|||
128696080|NCT01903031|463185327|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
128696081|NCT01903031|463185328|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
128696082|NCT01903031|463185329|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
128696083|NCT01903031|463185327|FG000|Overall Study|Adverse Event|0|||
128696084|NCT01903031|463185328|FG001|Overall Study|Adverse Event|1|||
128696085|NCT01903031|463185329|FG002|Overall Study|Adverse Event|0|||
129116715|NCT00402727|464723257|FG000|Overall Study|supply problems|2|||
129116716|NCT00402727|464723258|FG001|Overall Study|supply problems|1|||
129116717|NCT00402727|464723257|FG000|Overall Study|non-compliance|0|||
129116718|NCT00402727|464723258|FG001|Overall Study|non-compliance|1|||
129116719|NCT03188055|464723259|FG000|Overall Study|Unavailable for training|0|||
129116720|NCT03188055|464723260|FG001|Overall Study|Unavailable for training|0|||
128696086|NCT01903031|463185327|FG000|Overall Study|Withdrawal by Subject|0|||
129116721|NCT03188055|464723261|FG002|Overall Study|Unavailable for training|19|||
128696087|NCT01903031|463185328|FG001|Overall Study|Withdrawal by Subject|1|||
128696088|NCT01903031|463185329|FG002|Overall Study|Withdrawal by Subject|1|||
128696089|NCT01903031|463185327|FG000|Overall Study|Protocol Violation|0|||
129116722|NCT03188055|464723262|FG003|Overall Study|Unavailable for training|0|||
129116723|NCT03188055|464723263|FG004|Overall Study|Unavailable for training|0|||
129116724|NCT03188055|464723264|FG005|Overall Study|Unavailable for training|0|||
129116725|NCT03188055|464723259|FG000|Overall Study|Lost to Follow-up|0|||
129116726|NCT03188055|464723260|FG001|Overall Study|Lost to Follow-up|18|||
129116727|NCT03188055|464723261|FG002|Overall Study|Lost to Follow-up|0|||
129116728|NCT03188055|464723262|FG003|Overall Study|Lost to Follow-up|11|||
129116729|NCT03188055|464723263|FG004|Overall Study|Lost to Follow-up|0|||
129116730|NCT03188055|464723264|FG005|Overall Study|Lost to Follow-up|0|||
129116731|NCT03188055|464723259|FG000|Overall Study|Withdrawal by Subject|0|||
129116732|NCT03188055|464723260|FG001|Overall Study|Withdrawal by Subject|1|||
129116733|NCT03188055|464723261|FG002|Overall Study|Withdrawal by Subject|0|||
129116734|NCT03188055|464723262|FG003|Overall Study|Withdrawal by Subject|1|||
129116735|NCT03188055|464723263|FG004|Overall Study|Withdrawal by Subject|0|||
129116736|NCT03188055|464723264|FG005|Overall Study|Withdrawal by Subject|0|||
129116737|NCT01405898|464723265|FG000|Overall Study|Withdrawal by Subject|2|||
129116738|NCT01405898|464723266|FG001|Overall Study|Withdrawal by Subject|2|||
129116739|NCT00887484|464723279|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
129116740|NCT00887484|464723279|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
129116741|NCT00887484|464723279|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
129116742|NCT03044314|464723280|FG000|Overall Study|Physician Decision|2|||
129116743|NCT03044314|464723280|FG000|Overall Study|Withdrawal by Subject|1|||
129116744|NCT03044314|464723280|FG000|Overall Study|Connector tubing not available|1|||
129116745|NCT00264147|464723281|FG000|Treatment I Period|Adverse Event|3|||
129116746|NCT00264147|464723282|FG001|Treatment I Period|Adverse Event|6|||
129116747|NCT00264147|464723283|FG002|Treatment I Period|Adverse Event|3|||
129116748|NCT00264147|464723284|FG003|Treatment I Period|Adverse Event|5|||
129116749|NCT00264147|464723285|FG004|Treatment I Period|Adverse Event|7|||
129116750|NCT00264147|464723286|FG005|Treatment I Period|Adverse Event|0|||
129116751|NCT00264147|464723281|FG000|Treatment I Period|Laboratory Adverse Event|0|||
129116752|NCT00264147|464723282|FG001|Treatment I Period|Laboratory Adverse Event|0|||
129116753|NCT00264147|464723283|FG002|Treatment I Period|Laboratory Adverse Event|0|||
129116754|NCT00264147|464723284|FG003|Treatment I Period|Laboratory Adverse Event|1|||
129116755|NCT00264147|464723285|FG004|Treatment I Period|Laboratory Adverse Event|0|||
129116756|NCT00264147|464723286|FG005|Treatment I Period|Laboratory Adverse Event|0|||
129116757|NCT00264147|464723281|FG000|Treatment I Period|Lack of Efficacy|6|||
129116758|NCT00264147|464723282|FG001|Treatment I Period|Lack of Efficacy|2|||
129116759|NCT00264147|464723283|FG002|Treatment I Period|Lack of Efficacy|8|||
129116760|NCT00264147|464723284|FG003|Treatment I Period|Lack of Efficacy|0|||
129116761|NCT00264147|464723285|FG004|Treatment I Period|Lack of Efficacy|1|||
129116762|NCT00264147|464723286|FG005|Treatment I Period|Lack of Efficacy|0|||
128765055|NCT00110890|463430403|FG000|Overall Study|Protocol Deviation|1|||
128765056|NCT00110890|463430404|FG001|Overall Study|Protocol Deviation|0|||
128765057|NCT00110890|463430403|FG000|Overall Study|Noncompliance|10|||
128765058|NCT00110890|463430404|FG001|Overall Study|Noncompliance|0|||
128765059|NCT00110890|463430403|FG000|Overall Study|Kidney Transplant|16|||
128765060|NCT00110890|463430404|FG001|Overall Study|Kidney Transplant|12|||
128765061|NCT00110890|463430403|FG000|Overall Study|Invest. Product Commercially Available|217|||
128765062|NCT00110890|463430404|FG001|Overall Study|Invest. Product Commercially Available|110|||
128765063|NCT00110890|463430403|FG000|Overall Study|Other|34|||
128765064|NCT00110890|463430404|FG001|Overall Study|Other|23|||
128765065|NCT00110890|463430403|FG000|Overall Study|Ineligibility determined|3|||
128765066|NCT00110890|463430404|FG001|Overall Study|Ineligibility determined|0|||
128765067|NCT00110890|463430403|FG000|Overall Study|Requirement for alternative therapy|0|||
129116763|NCT00264147|464723281|FG000|Treatment I Period|Lost to Follow-up|1|||
129116764|NCT00264147|464723282|FG001|Treatment I Period|Lost to Follow-up|0|||
129116765|NCT00264147|464723283|FG002|Treatment I Period|Lost to Follow-up|0|||
129116766|NCT00264147|464723284|FG003|Treatment I Period|Lost to Follow-up|1|||
129116767|NCT00264147|464723285|FG004|Treatment I Period|Lost to Follow-up|1|||
129116768|NCT00264147|464723286|FG005|Treatment I Period|Lost to Follow-up|0|||
129116769|NCT00264147|464723281|FG000|Treatment I Period|Protocol Violation|2|||
129116770|NCT00264147|464723282|FG001|Treatment I Period|Protocol Violation|2|||
128906289|NCT01471782|463948700|FG005|Overall Study|Death|1|||
128906290|NCT01314716|463948701|FG000|Double-Blind Phase|Randomized but not treated|1|||
129116771|NCT00264147|464723283|FG002|Treatment I Period|Protocol Violation|0|||
129116772|NCT00264147|464723284|FG003|Treatment I Period|Protocol Violation|0|||
129116773|NCT00264147|464723285|FG004|Treatment I Period|Protocol Violation|0|||
129116774|NCT00264147|464723286|FG005|Treatment I Period|Protocol Violation|0|||
129116775|NCT00264147|464723281|FG000|Treatment I Period|Withdrawal by Subject|2|||
129116776|NCT00264147|464723282|FG001|Treatment I Period|Withdrawal by Subject|0|||
129116777|NCT00264147|464723283|FG002|Treatment I Period|Withdrawal by Subject|0|||
128765068|NCT00110890|463430404|FG001|Overall Study|Requirement for alternative therapy|1|||
128765069|NCT00110890|463430403|FG000|Overall Study|Disease progression|0|||
128765070|NCT00110890|463430404|FG001|Overall Study|Disease progression|1|||
129116778|NCT00264147|464723284|FG003|Treatment I Period|Withdrawal by Subject|2|||
129116779|NCT00264147|464723285|FG004|Treatment I Period|Withdrawal by Subject|2|||
129116780|NCT00264147|464723286|FG005|Treatment I Period|Withdrawal by Subject|0|||
129027257|NCT00112437|464390065|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027258|NCT00112437|464390066|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027259|NCT00112437|464390067|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027260|NCT00112437|464390068|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027261|NCT00112437|464390069|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027262|NCT00112437|464390070|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027263|NCT00112437|464390071|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129116781|NCT00264147|464723281|FG000|Treatment I Period|Patient out of town for an extended time|0|||
129116782|NCT00264147|464723282|FG001|Treatment I Period|Patient out of town for an extended time|1|||
129116783|NCT00264147|464723283|FG002|Treatment I Period|Patient out of town for an extended time|0|||
129116784|NCT00264147|464723284|FG003|Treatment I Period|Patient out of town for an extended time|0|||
129116785|NCT00264147|464723285|FG004|Treatment I Period|Patient out of town for an extended time|0|||
129116786|NCT00264147|464723286|FG005|Treatment I Period|Patient out of town for an extended time|0|||
129116787|NCT00264147|464723281|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129116788|NCT00264147|464723282|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
128696090|NCT01903031|463185328|FG001|Overall Study|Protocol Violation|0|||
128696091|NCT01903031|463185329|FG002|Overall Study|Protocol Violation|2|||
128696092|NCT01903031|463185327|FG000|Overall Study|Lost to Follow-up|0|||
128696093|NCT01903031|463185328|FG001|Overall Study|Lost to Follow-up|0|||
128696094|NCT01903031|463185329|FG002|Overall Study|Lost to Follow-up|1|||
128696095|NCT01903031|463185327|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
128696096|NCT01903031|463185328|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
128696097|NCT01903031|463185329|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
128696098|NCT01484275|463185330|FG000|Overall Study|Study terminated by sponsor|28|||
128696099|NCT01484275|463185331|FG001|Overall Study|Study terminated by sponsor|32|||
128696100|NCT01484275|463185330|FG000|Overall Study|Other|10|||
128696101|NCT01484275|463185331|FG001|Overall Study|Other|0|||
128696102|NCT01484275|463185330|FG000|Overall Study|Death|3|||
128696103|NCT01484275|463185331|FG001|Overall Study|Death|4|||
128696104|NCT01484275|463185330|FG000|Overall Study|Withdrawal by Subject|1|||
128696105|NCT01484275|463185331|FG001|Overall Study|Withdrawal by Subject|5|||
128696106|NCT01484275|463185330|FG000|Overall Study|Lost to Follow-up|1|||
128696107|NCT01484275|463185331|FG001|Overall Study|Lost to Follow-up|1|||
128696108|NCT04154930|463185332|FG000|Overall Study|Withdrawal by Subject|15|||
129116789|NCT00264147|464723283|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
129116790|NCT00264147|464723284|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
128696109|NCT04154930|463185333|FG001|Overall Study|Withdrawal by Subject|6|||
128696110|NCT04154930|463185332|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
128696111|NCT04154930|463185333|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
128696112|NCT04154930|463185332|FG000|Overall Study|Lost to Follow-up|14|||
128696113|NCT04154930|463185333|FG001|Overall Study|Lost to Follow-up|6|||
128696114|NCT04154930|463185332|FG000|Overall Study|Other|6|||
128696115|NCT04154930|463185333|FG001|Overall Study|Other|0|||
128696116|NCT00347360|463185336|FG000|Overall Study|Adverse Event|1|||
128696117|NCT00347360|463185337|FG001|Overall Study|Adverse Event|2|||
128696118|NCT00347360|463185338|FG002|Overall Study|Adverse Event|0|||
128696119|NCT00347360|463185339|FG003|Overall Study|Adverse Event|4|||
128696120|NCT00347360|463185340|FG004|Overall Study|Adverse Event|1|||
128696121|NCT00347360|463185341|FG005|Overall Study|Adverse Event|2|||
128696122|NCT00347360|463185342|FG006|Overall Study|Adverse Event|2|||
128696123|NCT00347360|463185343|FG007|Overall Study|Adverse Event|0|||
128696124|NCT00347360|463185344|FG008|Overall Study|Adverse Event|2|||
128696125|NCT00347360|463185345|FG009|Overall Study|Adverse Event|3|||
128696126|NCT00347360|463185346|FG010|Overall Study|Adverse Event|3|||
128696127|NCT00347360|463185347|FG011|Overall Study|Adverse Event|1|||
128696128|NCT00347360|463185348|FG012|Overall Study|Adverse Event|3|||
128696129|NCT00347360|463185349|FG013|Overall Study|Adverse Event|2|||
128696130|NCT00347360|463185350|FG014|Overall Study|Adverse Event|2|||
128906291|NCT01314716|463948702|FG001|Double-Blind Phase|Randomized but not treated|1|||
129027264|NCT00112437|464390072|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027265|NCT00112437|464390073|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027266|NCT00112437|464390074|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027267|NCT00112437|464390075|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027268|NCT00112437|464390076|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027269|NCT00112437|464390077|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027270|NCT00112437|464390078|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027271|NCT00112437|464390079|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027272|NCT00112437|464390080|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
128696131|NCT00347360|463185336|FG000|Overall Study|Lost to Follow-up|0|||
128696132|NCT00347360|463185337|FG001|Overall Study|Lost to Follow-up|0|||
128696133|NCT00347360|463185338|FG002|Overall Study|Lost to Follow-up|0|||
128696134|NCT00347360|463185339|FG003|Overall Study|Lost to Follow-up|2|||
128696135|NCT00347360|463185340|FG004|Overall Study|Lost to Follow-up|1|||
128696136|NCT00347360|463185341|FG005|Overall Study|Lost to Follow-up|1|||
129027273|NCT00112437|464390081|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027274|NCT00112437|464390082|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027275|NCT00112437|464390083|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027276|NCT00112437|464390084|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027277|NCT00112437|464390085|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027278|NCT00112437|464390086|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
129027279|NCT00112437|464390087|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027280|NCT00112437|464390088|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129027281|NCT00112437|464390089|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129116791|NCT00264147|464723285|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129116792|NCT00264147|464723286|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129116793|NCT00264147|464723281|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
129116794|NCT00264147|464723282|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
129116795|NCT00264147|464723283|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
129116796|NCT00264147|464723284|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
129116797|NCT00264147|464723285|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
129116798|NCT00264147|464723286|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
129116799|NCT00264147|464723281|FG000|Treatment II Period|Adverse Event|0|||
129116800|NCT00264147|464723282|FG001|Treatment II Period|Adverse Event|0|||
128696137|NCT00347360|463185342|FG006|Overall Study|Lost to Follow-up|0|||
128696138|NCT00347360|463185343|FG007|Overall Study|Lost to Follow-up|1|||
128696139|NCT00347360|463185344|FG008|Overall Study|Lost to Follow-up|1|||
128696140|NCT00347360|463185345|FG009|Overall Study|Lost to Follow-up|2|||
128696141|NCT00347360|463185346|FG010|Overall Study|Lost to Follow-up|0|||
128696142|NCT00347360|463185347|FG011|Overall Study|Lost to Follow-up|0|||
128696143|NCT00347360|463185348|FG012|Overall Study|Lost to Follow-up|1|||
128696144|NCT00347360|463185349|FG013|Overall Study|Lost to Follow-up|0|||
128696145|NCT00347360|463185350|FG014|Overall Study|Lost to Follow-up|0|||
128696146|NCT00347360|463185336|FG000|Overall Study|Protocol Violation|2|||
128696147|NCT00347360|463185337|FG001|Overall Study|Protocol Violation|3|||
128696148|NCT00347360|463185338|FG002|Overall Study|Protocol Violation|1|||
128696149|NCT00347360|463185339|FG003|Overall Study|Protocol Violation|2|||
128696150|NCT00347360|463185340|FG004|Overall Study|Protocol Violation|1|||
128696151|NCT00347360|463185341|FG005|Overall Study|Protocol Violation|2|||
128696152|NCT00347360|463185342|FG006|Overall Study|Protocol Violation|0|||
128696153|NCT00347360|463185343|FG007|Overall Study|Protocol Violation|0|||
128696154|NCT00347360|463185344|FG008|Overall Study|Protocol Violation|1|||
128696155|NCT00347360|463185345|FG009|Overall Study|Protocol Violation|2|||
128696156|NCT00347360|463185346|FG010|Overall Study|Protocol Violation|0|||
128696157|NCT00347360|463185347|FG011|Overall Study|Protocol Violation|0|||
128696158|NCT00347360|463185348|FG012|Overall Study|Protocol Violation|0|||
128696159|NCT00347360|463185349|FG013|Overall Study|Protocol Violation|1|||
128696160|NCT00347360|463185350|FG014|Overall Study|Protocol Violation|0|||
128696161|NCT00347360|463185336|FG000|Overall Study|Withdrawal by Subject|0|||
128696162|NCT00347360|463185337|FG001|Overall Study|Withdrawal by Subject|1|||
128696163|NCT00347360|463185338|FG002|Overall Study|Withdrawal by Subject|2|||
128696164|NCT00347360|463185339|FG003|Overall Study|Withdrawal by Subject|4|||
128696165|NCT00347360|463185340|FG004|Overall Study|Withdrawal by Subject|1|||
128696166|NCT00347360|463185341|FG005|Overall Study|Withdrawal by Subject|2|||
128696167|NCT00347360|463185342|FG006|Overall Study|Withdrawal by Subject|1|||
128696168|NCT00347360|463185343|FG007|Overall Study|Withdrawal by Subject|1|||
128696169|NCT00347360|463185344|FG008|Overall Study|Withdrawal by Subject|1|||
128696170|NCT00347360|463185345|FG009|Overall Study|Withdrawal by Subject|1|||
128696171|NCT00347360|463185346|FG010|Overall Study|Withdrawal by Subject|0|||
128696172|NCT00347360|463185347|FG011|Overall Study|Withdrawal by Subject|3|||
128696173|NCT00347360|463185348|FG012|Overall Study|Withdrawal by Subject|4|||
128696174|NCT00347360|463185349|FG013|Overall Study|Withdrawal by Subject|2|||
128696175|NCT00347360|463185350|FG014|Overall Study|Withdrawal by Subject|1|||
128696176|NCT00347360|463185336|FG000|Overall Study|Lack of Efficacy|1|||
128696177|NCT00347360|463185337|FG001|Overall Study|Lack of Efficacy|1|||
128696178|NCT00347360|463185338|FG002|Overall Study|Lack of Efficacy|3|||
128696179|NCT00347360|463185339|FG003|Overall Study|Lack of Efficacy|1|||
128696180|NCT00347360|463185340|FG004|Overall Study|Lack of Efficacy|0|||
128696181|NCT00347360|463185341|FG005|Overall Study|Lack of Efficacy|1|||
128696182|NCT00347360|463185342|FG006|Overall Study|Lack of Efficacy|0|||
128696183|NCT00347360|463185343|FG007|Overall Study|Lack of Efficacy|1|||
128696184|NCT00347360|463185344|FG008|Overall Study|Lack of Efficacy|1|||
128696185|NCT00347360|463185345|FG009|Overall Study|Lack of Efficacy|0|||
128765071|NCT00110890|463430403|FG000|Overall Study|Parathyroidectomy|0|||
128765072|NCT00110890|463430404|FG001|Overall Study|Parathyroidectomy|1|||
129027282|NCT00112437|464390090|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129116801|NCT00264147|464723283|FG002|Treatment II Period|Adverse Event|0|||
128696186|NCT00347360|463185346|FG010|Overall Study|Lack of Efficacy|0|||
128696187|NCT00347360|463185347|FG011|Overall Study|Lack of Efficacy|0|||
128696188|NCT00347360|463185348|FG012|Overall Study|Lack of Efficacy|0|||
128696189|NCT00347360|463185349|FG013|Overall Study|Lack of Efficacy|0|||
129116802|NCT00264147|464723284|FG003|Treatment II Period|Adverse Event|0|||
129116803|NCT00264147|464723285|FG004|Treatment II Period|Adverse Event|9|||
129116804|NCT00264147|464723286|FG005|Treatment II Period|Adverse Event|9|||
129116805|NCT00264147|464723281|FG000|Treatment II Period|Laboratory Adverse Event|0|||
129116806|NCT00264147|464723282|FG001|Treatment II Period|Laboratory Adverse Event|0|||
129116807|NCT00264147|464723283|FG002|Treatment II Period|Laboratory Adverse Event|0|||
129116808|NCT00264147|464723284|FG003|Treatment II Period|Laboratory Adverse Event|0|||
129116809|NCT00264147|464723285|FG004|Treatment II Period|Laboratory Adverse Event|0|||
129116810|NCT00264147|464723286|FG005|Treatment II Period|Laboratory Adverse Event|1|||
129116811|NCT00264147|464723281|FG000|Treatment II Period|Lack of Efficacy|0|||
129116812|NCT00264147|464723282|FG001|Treatment II Period|Lack of Efficacy|0|||
129116813|NCT00264147|464723283|FG002|Treatment II Period|Lack of Efficacy|0|||
129116814|NCT00264147|464723284|FG003|Treatment II Period|Lack of Efficacy|0|||
129116815|NCT00264147|464723285|FG004|Treatment II Period|Lack of Efficacy|20|||
129116816|NCT00264147|464723286|FG005|Treatment II Period|Lack of Efficacy|19|||
129116817|NCT00264147|464723281|FG000|Treatment II Period|Lost to Follow-up|0|||
129116818|NCT00264147|464723282|FG001|Treatment II Period|Lost to Follow-up|0|||
129116819|NCT00264147|464723283|FG002|Treatment II Period|Lost to Follow-up|0|||
129116820|NCT00264147|464723284|FG003|Treatment II Period|Lost to Follow-up|0|||
129116821|NCT00264147|464723285|FG004|Treatment II Period|Lost to Follow-up|1|||
129116822|NCT00264147|464723286|FG005|Treatment II Period|Lost to Follow-up|1|||
129116823|NCT00264147|464723281|FG000|Treatment II Period|Withdrawal by Subject|0|||
129116824|NCT00264147|464723282|FG001|Treatment II Period|Withdrawal by Subject|0|||
129116825|NCT00264147|464723283|FG002|Treatment II Period|Withdrawal by Subject|0|||
129116826|NCT00264147|464723284|FG003|Treatment II Period|Withdrawal by Subject|0|||
129116827|NCT00264147|464723285|FG004|Treatment II Period|Withdrawal by Subject|3|||
129116828|NCT00264147|464723286|FG005|Treatment II Period|Withdrawal by Subject|2|||
128696190|NCT00347360|463185350|FG014|Overall Study|Lack of Efficacy|0|||
128696191|NCT00347360|463185336|FG000|Overall Study|Reason not listed/blank|1|||
128696192|NCT00347360|463185337|FG001|Overall Study|Reason not listed/blank|0|||
128696193|NCT00347360|463185338|FG002|Overall Study|Reason not listed/blank|0|||
128696194|NCT00347360|463185339|FG003|Overall Study|Reason not listed/blank|0|||
128696195|NCT00347360|463185340|FG004|Overall Study|Reason not listed/blank|0|||
128696196|NCT00347360|463185341|FG005|Overall Study|Reason not listed/blank|0|||
128696197|NCT00347360|463185342|FG006|Overall Study|Reason not listed/blank|1|||
128696198|NCT00347360|463185343|FG007|Overall Study|Reason not listed/blank|0|||
128696199|NCT00347360|463185344|FG008|Overall Study|Reason not listed/blank|0|||
128696200|NCT00347360|463185345|FG009|Overall Study|Reason not listed/blank|0|||
128696201|NCT00347360|463185346|FG010|Overall Study|Reason not listed/blank|0|||
128696202|NCT00347360|463185347|FG011|Overall Study|Reason not listed/blank|0|||
128696203|NCT00347360|463185348|FG012|Overall Study|Reason not listed/blank|0|||
128696204|NCT00347360|463185349|FG013|Overall Study|Reason not listed/blank|1|||
128696205|NCT00347360|463185350|FG014|Overall Study|Reason not listed/blank|0|||
128696206|NCT00347360|463185336|FG000|Overall Study|Per sponsors instruction|0|||
128696207|NCT00347360|463185337|FG001|Overall Study|Per sponsors instruction|1|||
128696208|NCT00347360|463185338|FG002|Overall Study|Per sponsors instruction|0|||
128696209|NCT00347360|463185339|FG003|Overall Study|Per sponsors instruction|0|||
128696210|NCT00347360|463185340|FG004|Overall Study|Per sponsors instruction|0|||
128696211|NCT00347360|463185341|FG005|Overall Study|Per sponsors instruction|0|||
128696212|NCT00347360|463185342|FG006|Overall Study|Per sponsors instruction|0|||
128696213|NCT00347360|463185343|FG007|Overall Study|Per sponsors instruction|0|||
128696214|NCT00347360|463185344|FG008|Overall Study|Per sponsors instruction|0|||
128696215|NCT00347360|463185345|FG009|Overall Study|Per sponsors instruction|0|||
128696216|NCT00347360|463185346|FG010|Overall Study|Per sponsors instruction|0|||
128696217|NCT00347360|463185347|FG011|Overall Study|Per sponsors instruction|0|||
128696218|NCT00347360|463185348|FG012|Overall Study|Per sponsors instruction|0|||
128696219|NCT00347360|463185349|FG013|Overall Study|Per sponsors instruction|0|||
128696220|NCT00347360|463185350|FG014|Overall Study|Per sponsors instruction|0|||
128696221|NCT00347360|463185336|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
128696222|NCT00347360|463185337|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
128696223|NCT00347360|463185338|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
128696224|NCT00347360|463185339|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
128696225|NCT00347360|463185340|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
128696226|NCT00347360|463185341|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
128696227|NCT00347360|463185342|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
128696228|NCT00347360|463185343|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
128696229|NCT00347360|463185344|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
129116829|NCT00264147|464723281|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
129116830|NCT00264147|464723282|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
129116831|NCT00264147|464723283|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
129116832|NCT00264147|464723284|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
129116833|NCT00264147|464723285|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
129116834|NCT00264147|464723286|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
128696230|NCT00347360|463185345|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
128696231|NCT00347360|463185346|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
128696232|NCT00347360|463185347|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
128696233|NCT00347360|463185348|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
128696234|NCT00347360|463185349|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
128696235|NCT00347360|463185350|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
128696236|NCT00347360|463185336|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
128696237|NCT00347360|463185337|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
128696238|NCT00347360|463185338|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
128696239|NCT00347360|463185339|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
128696240|NCT00347360|463185340|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
128696241|NCT00347360|463185341|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
128696242|NCT00347360|463185342|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
128696243|NCT00347360|463185343|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
128696244|NCT00347360|463185344|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
128696245|NCT00347360|463185345|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
128696246|NCT00347360|463185346|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
128696247|NCT00347360|463185347|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
128696248|NCT00347360|463185348|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
128696249|NCT00347360|463185349|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
128696250|NCT00347360|463185350|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
128696251|NCT00347360|463185336|FG000|Overall Study|Abnormal lab values|0|||
128696252|NCT00347360|463185337|FG001|Overall Study|Abnormal lab values|0|||
128696253|NCT00347360|463185338|FG002|Overall Study|Abnormal lab values|0|||
128696254|NCT00347360|463185339|FG003|Overall Study|Abnormal lab values|0|||
128696255|NCT00347360|463185340|FG004|Overall Study|Abnormal lab values|0|||
128696256|NCT00347360|463185341|FG005|Overall Study|Abnormal lab values|0|||
128696257|NCT00347360|463185342|FG006|Overall Study|Abnormal lab values|1|||
128696258|NCT00347360|463185343|FG007|Overall Study|Abnormal lab values|0|||
128696259|NCT00347360|463185344|FG008|Overall Study|Abnormal lab values|0|||
128696260|NCT00347360|463185345|FG009|Overall Study|Abnormal lab values|0|||
128696261|NCT00347360|463185346|FG010|Overall Study|Abnormal lab values|0|||
128696262|NCT00347360|463185347|FG011|Overall Study|Abnormal lab values|0|||
128696263|NCT00347360|463185348|FG012|Overall Study|Abnormal lab values|0|||
128696264|NCT00347360|463185349|FG013|Overall Study|Abnormal lab values|0|||
128696265|NCT00347360|463185350|FG014|Overall Study|Abnormal lab values|0|||
128696266|NCT00347360|463185336|FG000|Overall Study|PI recommended early withdrawal|0|||
128696267|NCT00347360|463185337|FG001|Overall Study|PI recommended early withdrawal|0|||
128696268|NCT00347360|463185338|FG002|Overall Study|PI recommended early withdrawal|0|||
128696269|NCT00347360|463185339|FG003|Overall Study|PI recommended early withdrawal|0|||
128696270|NCT00347360|463185340|FG004|Overall Study|PI recommended early withdrawal|0|||
128696271|NCT00347360|463185341|FG005|Overall Study|PI recommended early withdrawal|0|||
128696272|NCT00347360|463185342|FG006|Overall Study|PI recommended early withdrawal|0|||
128696273|NCT00347360|463185343|FG007|Overall Study|PI recommended early withdrawal|0|||
128696274|NCT00347360|463185344|FG008|Overall Study|PI recommended early withdrawal|0|||
128696275|NCT00347360|463185345|FG009|Overall Study|PI recommended early withdrawal|1|||
128696276|NCT00347360|463185346|FG010|Overall Study|PI recommended early withdrawal|0|||
128696277|NCT00347360|463185347|FG011|Overall Study|PI recommended early withdrawal|0|||
128696278|NCT00347360|463185348|FG012|Overall Study|PI recommended early withdrawal|0|||
128696279|NCT00347360|463185349|FG013|Overall Study|PI recommended early withdrawal|0|||
128696280|NCT00347360|463185350|FG014|Overall Study|PI recommended early withdrawal|0|||
128696281|NCT00347360|463185336|FG000|Overall Study|Did not meet criteria before ABPM|0|||
128696282|NCT00347360|463185337|FG001|Overall Study|Did not meet criteria before ABPM|0|||
128696283|NCT00347360|463185338|FG002|Overall Study|Did not meet criteria before ABPM|0|||
128696284|NCT00347360|463185339|FG003|Overall Study|Did not meet criteria before ABPM|0|||
128696285|NCT00347360|463185340|FG004|Overall Study|Did not meet criteria before ABPM|0|||
128696286|NCT00347360|463185341|FG005|Overall Study|Did not meet criteria before ABPM|0|||
128696287|NCT00347360|463185342|FG006|Overall Study|Did not meet criteria before ABPM|0|||
128696288|NCT00347360|463185343|FG007|Overall Study|Did not meet criteria before ABPM|0|||
128696289|NCT00347360|463185344|FG008|Overall Study|Did not meet criteria before ABPM|0|||
128696290|NCT00347360|463185345|FG009|Overall Study|Did not meet criteria before ABPM|0|||
128696291|NCT00347360|463185346|FG010|Overall Study|Did not meet criteria before ABPM|1|||
128696292|NCT00347360|463185347|FG011|Overall Study|Did not meet criteria before ABPM|0|||
128696293|NCT00347360|463185348|FG012|Overall Study|Did not meet criteria before ABPM|0|||
128696294|NCT00347360|463185349|FG013|Overall Study|Did not meet criteria before ABPM|0|||
128696295|NCT00347360|463185350|FG014|Overall Study|Did not meet criteria before ABPM|0|||
128696296|NCT00347360|463185336|FG000|Overall Study|Randomized in error|0|||
128696297|NCT00347360|463185337|FG001|Overall Study|Randomized in error|0|||
128696298|NCT00347360|463185338|FG002|Overall Study|Randomized in error|0|||
128696299|NCT00347360|463185339|FG003|Overall Study|Randomized in error|0|||
128765073|NCT00110890|463430403|FG000|Overall Study|Did not enter follow-up phase|10|||
128696300|NCT00347360|463185340|FG004|Overall Study|Randomized in error|0|||
128696301|NCT00347360|463185341|FG005|Overall Study|Randomized in error|0|||
128696302|NCT00347360|463185342|FG006|Overall Study|Randomized in error|0|||
128696303|NCT00347360|463185343|FG007|Overall Study|Randomized in error|0|||
128696304|NCT00347360|463185344|FG008|Overall Study|Randomized in error|0|||
128696305|NCT00347360|463185345|FG009|Overall Study|Randomized in error|0|||
128696306|NCT00347360|463185346|FG010|Overall Study|Randomized in error|0|||
128696307|NCT00347360|463185347|FG011|Overall Study|Randomized in error|1|||
128696308|NCT00347360|463185348|FG012|Overall Study|Randomized in error|0|||
128696309|NCT00347360|463185349|FG013|Overall Study|Randomized in error|0|||
128696310|NCT00347360|463185350|FG014|Overall Study|Randomized in error|0|||
128696311|NCT00347360|463185336|FG000|Overall Study|Failed inclusion criteria #4|0|||
128696312|NCT00347360|463185337|FG001|Overall Study|Failed inclusion criteria #4|0|||
128696313|NCT00347360|463185338|FG002|Overall Study|Failed inclusion criteria #4|0|||
128696314|NCT00347360|463185339|FG003|Overall Study|Failed inclusion criteria #4|0|||
128696315|NCT00347360|463185340|FG004|Overall Study|Failed inclusion criteria #4|0|||
128696316|NCT00347360|463185341|FG005|Overall Study|Failed inclusion criteria #4|0|||
128696317|NCT00347360|463185342|FG006|Overall Study|Failed inclusion criteria #4|0|||
128696318|NCT00347360|463185343|FG007|Overall Study|Failed inclusion criteria #4|0|||
128696319|NCT00347360|463185344|FG008|Overall Study|Failed inclusion criteria #4|0|||
128696320|NCT00347360|463185345|FG009|Overall Study|Failed inclusion criteria #4|0|||
128696321|NCT00347360|463185346|FG010|Overall Study|Failed inclusion criteria #4|0|||
129027283|NCT00112437|464390065|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027284|NCT00112437|464390066|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027285|NCT00112437|464390067|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027286|NCT00112437|464390068|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027287|NCT00112437|464390069|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027288|NCT00112437|464390070|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027289|NCT00112437|464390071|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027290|NCT00112437|464390072|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027291|NCT00112437|464390073|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027292|NCT00112437|464390074|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027293|NCT00112437|464390075|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027294|NCT00112437|464390076|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027295|NCT00112437|464390077|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027296|NCT00112437|464390078|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027297|NCT00112437|464390079|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027298|NCT00112437|464390080|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027299|NCT00112437|464390081|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027300|NCT00112437|464390082|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027301|NCT00112437|464390083|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027302|NCT00112437|464390084|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027303|NCT00112437|464390085|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027304|NCT00112437|464390086|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
129027305|NCT00112437|464390087|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027306|NCT00112437|464390088|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027307|NCT00112437|464390089|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027308|NCT00112437|464390090|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
129027309|NCT00112437|464390065|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027310|NCT00112437|464390066|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027311|NCT00112437|464390067|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027312|NCT00112437|464390068|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027313|NCT00112437|464390069|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027314|NCT00112437|464390070|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027315|NCT00112437|464390071|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027316|NCT00112437|464390072|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027317|NCT00112437|464390073|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027318|NCT00112437|464390074|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027319|NCT00112437|464390075|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027320|NCT00112437|464390076|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027321|NCT00112437|464390077|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027322|NCT00112437|464390078|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
128696322|NCT00347360|463185347|FG011|Overall Study|Failed inclusion criteria #4|1|||
128696323|NCT00347360|463185348|FG012|Overall Study|Failed inclusion criteria #4|0|||
128696324|NCT00347360|463185349|FG013|Overall Study|Failed inclusion criteria #4|0|||
128696325|NCT00347360|463185350|FG014|Overall Study|Failed inclusion criteria #4|0|||
128906292|NCT01314716|463948701|FG000|Double-Blind Phase|Adverse Event|10|||
129027323|NCT00112437|464390079|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027324|NCT00112437|464390080|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
128696326|NCT00347360|463185336|FG000|Overall Study|Prolonged duration between visits|0|||
128765074|NCT00110890|463430404|FG001|Overall Study|Did not enter follow-up phase|4|||
128765075|NCT01975220|463430405|FG000|Test Period 1|Not treated|0|||
128765076|NCT01975220|463430406|FG001|Test Period 1|Not treated|1|||
128765077|NCT01975220|463430407|FG002|Test Period 1|Not treated|0|||
128765078|NCT01975220|463430408|FG003|Test Period 1|Not treated|0|||
128765079|NCT01975220|463430409|FG004|Test Period 1|Not treated|0|||
128765080|NCT01975220|463430410|FG005|Test Period 1|Not treated|0|||
128765081|NCT02839343|463430411|FG000|Overall Study|Withdrawal by Subject|3|||
128765082|NCT02839343|463430412|FG001|Overall Study|Withdrawal by Subject|1|||
128765083|NCT02839343|463430411|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
128765084|NCT02839343|463430412|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
128765085|NCT02839343|463430411|FG000|Overall Study|Adverse Event|1|||
128765086|NCT02839343|463430412|FG001|Overall Study|Adverse Event|0|||
128765087|NCT00445679|463430413|FG000|Overall Study|Adverse Event|22|||
128765088|NCT00445679|463430414|FG001|Overall Study|Adverse Event|12|||
128765089|NCT00445679|463430415|FG002|Overall Study|Adverse Event|30|||
128765090|NCT00445679|463430416|FG003|Overall Study|Adverse Event|19|||
128765091|NCT00445679|463430413|FG000|Overall Study|Failed to return|1|||
128765092|NCT00445679|463430414|FG001|Overall Study|Failed to return|3|||
128765093|NCT00445679|463430415|FG002|Overall Study|Failed to return|2|||
128765094|NCT00445679|463430416|FG003|Overall Study|Failed to return|2|||
128765095|NCT00445679|463430413|FG000|Overall Study|Physician Decision|0|||
128765096|NCT00445679|463430414|FG001|Overall Study|Physician Decision|0|||
128765097|NCT00445679|463430415|FG002|Overall Study|Physician Decision|1|||
128765098|NCT00445679|463430416|FG003|Overall Study|Physician Decision|0|||
128765099|NCT00445679|463430413|FG000|Overall Study|Lost to Follow-up|10|||
128765100|NCT00445679|463430414|FG001|Overall Study|Lost to Follow-up|6|||
128765101|NCT00445679|463430415|FG002|Overall Study|Lost to Follow-up|6|||
128906293|NCT01314716|463948702|FG001|Double-Blind Phase|Adverse Event|4|||
128696327|NCT00347360|463185337|FG001|Overall Study|Prolonged duration between visits|0|||
129027325|NCT00112437|464390081|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
128696328|NCT00347360|463185338|FG002|Overall Study|Prolonged duration between visits|0|||
128696329|NCT00347360|463185339|FG003|Overall Study|Prolonged duration between visits|0|||
128696330|NCT00347360|463185340|FG004|Overall Study|Prolonged duration between visits|0|||
128696331|NCT00347360|463185341|FG005|Overall Study|Prolonged duration between visits|0|||
128696332|NCT00347360|463185342|FG006|Overall Study|Prolonged duration between visits|0|||
128696333|NCT00347360|463185343|FG007|Overall Study|Prolonged duration between visits|0|||
128696334|NCT00347360|463185344|FG008|Overall Study|Prolonged duration between visits|0|||
129027326|NCT00112437|464390082|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027327|NCT00112437|464390083|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027328|NCT00112437|464390084|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027329|NCT00112437|464390085|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
129027330|NCT00112437|464390086|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
129027331|NCT00112437|464390087|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027332|NCT00112437|464390088|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027333|NCT00112437|464390089|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027334|NCT00112437|464390090|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129027335|NCT00112437|464390065|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027336|NCT00112437|464390066|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027337|NCT00112437|464390067|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027338|NCT00112437|464390068|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027339|NCT00112437|464390069|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027340|NCT00112437|464390070|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027341|NCT00112437|464390071|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027342|NCT00112437|464390072|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027343|NCT00112437|464390073|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027344|NCT00112437|464390074|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027345|NCT00112437|464390075|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027346|NCT00112437|464390076|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027347|NCT00112437|464390077|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027348|NCT00112437|464390078|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129116835|NCT01316224|464723287|FG000|Overall Study|Protocol Violation|3|||
128696335|NCT00347360|463185345|FG009|Overall Study|Prolonged duration between visits|0|||
128696336|NCT00347360|463185346|FG010|Overall Study|Prolonged duration between visits|0|||
128765102|NCT00445679|463430416|FG003|Overall Study|Lost to Follow-up|5|||
128765103|NCT00445679|463430413|FG000|Overall Study|Compliance|3|||
128765104|NCT00445679|463430414|FG001|Overall Study|Compliance|2|||
128765105|NCT00445679|463430415|FG002|Overall Study|Compliance|1|||
129027349|NCT00112437|464390079|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027350|NCT00112437|464390080|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027351|NCT00112437|464390081|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027352|NCT00112437|464390082|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
128765106|NCT00445679|463430416|FG003|Overall Study|Compliance|2|||
128765107|NCT00445679|463430413|FG000|Overall Study|Withdrawal of Informed Consent|0|||
128696337|NCT00347360|463185347|FG011|Overall Study|Prolonged duration between visits|0|||
128696338|NCT00347360|463185348|FG012|Overall Study|Prolonged duration between visits|1|||
128696339|NCT00347360|463185349|FG013|Overall Study|Prolonged duration between visits|0|||
128696340|NCT00347360|463185350|FG014|Overall Study|Prolonged duration between visits|0|||
128696341|NCT00347360|463185336|FG000|Overall Study|Subject left town, ran out of study drug|0|||
128696342|NCT00347360|463185337|FG001|Overall Study|Subject left town, ran out of study drug|0|||
128696343|NCT00347360|463185338|FG002|Overall Study|Subject left town, ran out of study drug|0|||
128696344|NCT00347360|463185339|FG003|Overall Study|Subject left town, ran out of study drug|0|||
128696345|NCT00347360|463185340|FG004|Overall Study|Subject left town, ran out of study drug|0|||
128696346|NCT00347360|463185341|FG005|Overall Study|Subject left town, ran out of study drug|0|||
128696347|NCT00347360|463185342|FG006|Overall Study|Subject left town, ran out of study drug|0|||
128696348|NCT00347360|463185343|FG007|Overall Study|Subject left town, ran out of study drug|0|||
128696349|NCT00347360|463185344|FG008|Overall Study|Subject left town, ran out of study drug|0|||
128696350|NCT00347360|463185345|FG009|Overall Study|Subject left town, ran out of study drug|0|||
128696351|NCT00347360|463185346|FG010|Overall Study|Subject left town, ran out of study drug|0|||
128906294|NCT01314716|463948701|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
128906295|NCT01314716|463948702|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
128906296|NCT01314716|463948701|FG000|Double-Blind Phase|Lost to Follow-up|0|||
128906297|NCT01314716|463948702|FG001|Double-Blind Phase|Lost to Follow-up|1|||
128696352|NCT00347360|463185347|FG011|Overall Study|Subject left town, ran out of study drug|0|||
128696353|NCT00347360|463185348|FG012|Overall Study|Subject left town, ran out of study drug|0|||
128696354|NCT00347360|463185349|FG013|Overall Study|Subject left town, ran out of study drug|1|||
128696355|NCT00347360|463185350|FG014|Overall Study|Subject left town, ran out of study drug|0|||
128696356|NCT00347360|463185336|FG000|Overall Study|Subject refuse to sign updated consent|0|||
128696357|NCT00347360|463185337|FG001|Overall Study|Subject refuse to sign updated consent|0|||
128696358|NCT00347360|463185338|FG002|Overall Study|Subject refuse to sign updated consent|0|||
128696359|NCT00347360|463185339|FG003|Overall Study|Subject refuse to sign updated consent|0|||
128696360|NCT00347360|463185340|FG004|Overall Study|Subject refuse to sign updated consent|0|||
128696361|NCT00347360|463185341|FG005|Overall Study|Subject refuse to sign updated consent|0|||
128906298|NCT01314716|463948701|FG000|Double-Blind Phase|Sponsor request|1|||
128906299|NCT01314716|463948702|FG001|Double-Blind Phase|Sponsor request|2|||
128906300|NCT01314716|463948701|FG000|Double-Blind Phase|Physician Decision|0|||
128906301|NCT01314716|463948702|FG001|Double-Blind Phase|Physician Decision|1|||
128906302|NCT01314716|463948701|FG000|Open-Label Phase|Adverse Event|4|||
128906303|NCT01314716|463948702|FG001|Open-Label Phase|Adverse Event|6|||
128906304|NCT01314716|463948701|FG000|Open-Label Phase|Withdrawal by Subject|1|||
128906305|NCT01314716|463948702|FG001|Open-Label Phase|Withdrawal by Subject|2|||
128906306|NCT01314716|463948701|FG000|Open-Label Phase|Physician Decision|5|||
128906307|NCT01314716|463948702|FG001|Open-Label Phase|Physician Decision|4|||
129027353|NCT00112437|464390083|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027354|NCT00112437|464390084|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027355|NCT00112437|464390085|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027356|NCT00112437|464390086|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027357|NCT00112437|464390087|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
129027358|NCT00112437|464390088|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
129027359|NCT00112437|464390089|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129027360|NCT00112437|464390090|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
129027361|NCT00112437|464390065|FG000|Years 6-10 (60-Month Extension)|Death|0|||
129027362|NCT00112437|464390066|FG001|Years 6-10 (60-Month Extension)|Death|0|||
129027363|NCT00112437|464390067|FG002|Years 6-10 (60-Month Extension)|Death|0|||
129027364|NCT00112437|464390068|FG003|Years 6-10 (60-Month Extension)|Death|0|||
129027365|NCT00112437|464390069|FG004|Years 6-10 (60-Month Extension)|Death|0|||
129027366|NCT00112437|464390070|FG005|Years 6-10 (60-Month Extension)|Death|0|||
129027367|NCT00112437|464390071|FG006|Years 6-10 (60-Month Extension)|Death|0|||
129027368|NCT00112437|464390072|FG007|Years 6-10 (60-Month Extension)|Death|0|||
129027369|NCT00112437|464390073|FG008|Years 6-10 (60-Month Extension)|Death|0|||
129027370|NCT00112437|464390074|FG009|Years 6-10 (60-Month Extension)|Death|0|||
129027371|NCT00112437|464390075|FG010|Years 6-10 (60-Month Extension)|Death|0|||
129027372|NCT00112437|464390076|FG011|Years 6-10 (60-Month Extension)|Death|0|||
129027373|NCT00112437|464390077|FG012|Years 6-10 (60-Month Extension)|Death|0|||
129027374|NCT00112437|464390078|FG013|Years 6-10 (60-Month Extension)|Death|0|||
129027375|NCT00112437|464390079|FG014|Years 6-10 (60-Month Extension)|Death|0|||
129027376|NCT00112437|464390080|FG015|Years 6-10 (60-Month Extension)|Death|0|||
128906308|NCT00112905|463950384|FG000|Overall Study|Adverse Event|4|||
128906309|NCT00112905|463950384|FG000|Overall Study|Death|1|||
129027377|NCT00112437|464390081|FG016|Years 6-10 (60-Month Extension)|Death|0|||
129027378|NCT00112437|464390082|FG017|Years 6-10 (60-Month Extension)|Death|0|||
129027379|NCT00112437|464390083|FG018|Years 6-10 (60-Month Extension)|Death|0|||
129027380|NCT00112437|464390084|FG019|Years 6-10 (60-Month Extension)|Death|0|||
129027381|NCT00112437|464390085|FG020|Years 6-10 (60-Month Extension)|Death|0|||
129027382|NCT00112437|464390086|FG021|Years 6-10 (60-Month Extension)|Death|0|||
129027383|NCT00112437|464390087|FG022|Years 6-10 (60-Month Extension)|Death|0|||
128765108|NCT00445679|463430414|FG001|Overall Study|Withdrawal of Informed Consent|0|||
128765109|NCT00445679|463430415|FG002|Overall Study|Withdrawal of Informed Consent|1|||
129116836|NCT01316224|464723287|FG000|Overall Study|Adverse Event|3|||
128765110|NCT00445679|463430416|FG003|Overall Study|Withdrawal of Informed Consent|0|||
128765111|NCT00445679|463430413|FG000|Overall Study|Protocol Violation|2|||
128765112|NCT00445679|463430414|FG001|Overall Study|Protocol Violation|3|||
128765113|NCT00445679|463430415|FG002|Overall Study|Protocol Violation|3|||
128765114|NCT00445679|463430416|FG003|Overall Study|Protocol Violation|1|||
128765115|NCT00445679|463430413|FG000|Overall Study|Withdrawal by Subject|8|||
128765116|NCT00445679|463430414|FG001|Overall Study|Withdrawal by Subject|14|||
128765117|NCT00445679|463430415|FG002|Overall Study|Withdrawal by Subject|20|||
128765118|NCT00445679|463430416|FG003|Overall Study|Withdrawal by Subject|18|||
128765119|NCT00445679|463430413|FG000|Overall Study|Lack of Efficacy|2|||
128765120|NCT00445679|463430414|FG001|Overall Study|Lack of Efficacy|6|||
128765121|NCT00445679|463430415|FG002|Overall Study|Lack of Efficacy|2|||
128765122|NCT00445679|463430416|FG003|Overall Study|Lack of Efficacy|0|||
128765123|NCT03535337|463430419|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
128765124|NCT03535337|463430420|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
128765125|NCT03535337|463430421|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
128765126|NCT03535337|463430422|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
128765127|NCT03535337|463430423|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
128765128|NCT03535337|463430424|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
128765129|NCT03535337|463430425|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
128765130|NCT03535337|463430426|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
128765131|NCT03535337|463430427|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
128765132|NCT03535337|463430428|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
128765133|NCT02272725|463430429|FG000|Overall Study|equipment malfunction|2|||
128765134|NCT02272725|463430430|FG001|Overall Study|equipment malfunction|0|||
128765135|NCT02202434|463432047|FG000|Overall Study|Death|70|||
128765136|NCT02202434|463432048|FG001|Overall Study|Death|39|||
128765137|NCT02202434|463432049|FG002|Overall Study|Death|13|||
128765138|NCT02202434|463432050|FG003|Overall Study|Death|27|||
128765139|NCT02202434|463432047|FG000|Overall Study|Lost to Follow-up|1|||
128765140|NCT02202434|463432048|FG001|Overall Study|Lost to Follow-up|1|||
128765141|NCT02202434|463432049|FG002|Overall Study|Lost to Follow-up|1|||
128765142|NCT02202434|463432050|FG003|Overall Study|Lost to Follow-up|0|||
128765143|NCT02202434|463432047|FG000|Overall Study|Physician Decision|2|||
128765144|NCT02202434|463432048|FG001|Overall Study|Physician Decision|3|||
128765145|NCT02202434|463432049|FG002|Overall Study|Physician Decision|0|||
128765146|NCT02202434|463432050|FG003|Overall Study|Physician Decision|0|||
128765147|NCT02202434|463432047|FG000|Overall Study|Withdrawal by Subject|13|||
128765148|NCT02202434|463432048|FG001|Overall Study|Withdrawal by Subject|14|||
128765149|NCT02202434|463432049|FG002|Overall Study|Withdrawal by Subject|1|||
128765150|NCT02202434|463432050|FG003|Overall Study|Withdrawal by Subject|4|||
128765151|NCT02202434|463432047|FG000|Overall Study|Completed Study|1|||
128765152|NCT02202434|463432048|FG001|Overall Study|Completed Study|0|||
128765153|NCT02202434|463432049|FG002|Overall Study|Completed Study|0|||
128765154|NCT02202434|463432050|FG003|Overall Study|Completed Study|0|||
128765155|NCT02202434|463432047|FG000|Overall Study|Visit Missed|21|||
128765156|NCT02202434|463432048|FG001|Overall Study|Visit Missed|12|||
129116837|NCT01316224|464723287|FG000|Overall Study|Lack of Efficacy|1|||
129116838|NCT01316224|464723287|FG000|Overall Study|Withdrawal by Subject|1|||
129116839|NCT01316224|464723287|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
129116840|NCT01316224|464723287|FG000|Overall Study|Other|1|||
129116841|NCT03234465|464723288|FG000|Overall Study|Adverse Event|4|||
129116842|NCT03234465|464723289|FG001|Overall Study|Adverse Event|2|||
129116843|NCT03234465|464723288|FG000|Overall Study|Death|0|||
129116844|NCT03234465|464723289|FG001|Overall Study|Death|1|||
129116845|NCT03234465|464723288|FG000|Overall Study|Lost to Follow-up|1|||
129116846|NCT03234465|464723289|FG001|Overall Study|Lost to Follow-up|1|||
129116847|NCT03234465|464723288|FG000|Overall Study|Withdrawal by Subject|12|||
128765157|NCT02202434|463432049|FG002|Overall Study|Visit Missed|0|||
128765158|NCT02202434|463432050|FG003|Overall Study|Visit Missed|5|||
128765159|NCT02202434|463432047|FG000|Overall Study|Other|1|||
128765160|NCT02202434|463432048|FG001|Overall Study|Other|0|||
128765161|NCT02202434|463432049|FG002|Overall Study|Other|0|||
128765162|NCT02202434|463432050|FG003|Overall Study|Other|1|||
128765163|NCT03528174|463432054|FG000|Overall Study|Adverse Event|1|||
129116848|NCT03234465|464723289|FG001|Overall Study|Withdrawal by Subject|27|||
129116849|NCT03234465|464723288|FG000|Overall Study|Symptomatic deterioration|0|||
128765164|NCT03528174|463432054|FG000|Overall Study|sensors dislodged|1|||
128765165|NCT00979602|463432055|FG000|Overall Study|Serious Adverse Event|5|||
128765166|NCT00979602|463432056|FG001|Overall Study|Serious Adverse Event|3|||
128765167|NCT00979602|463432055|FG000|Overall Study|Protocol Violation|3|||
128765168|NCT00979602|463432056|FG001|Overall Study|Protocol Violation|0|||
128765169|NCT00979602|463432055|FG000|Overall Study|Withdrawal by Subject|31|||
128765170|NCT00979602|463432056|FG001|Overall Study|Withdrawal by Subject|25|||
129116850|NCT03234465|464723289|FG001|Overall Study|Symptomatic deterioration|1|||
129116851|NCT03234465|464723288|FG000|Overall Study|Non-compliance|2|||
128906310|NCT00112905|463950384|FG000|Overall Study|Ineligibility|5|||
128906311|NCT00112905|463950384|FG000|Overall Study|Alternative treatment|1|||
128906312|NCT00112905|463950384|FG000|Overall Study|performance status was deteiorating|1|||
128906313|NCT02600507|463950385|FG000|Overall Study|Adverse Event|3|||
128906314|NCT02600507|463950386|FG001|Overall Study|Adverse Event|15|||
128906315|NCT02600507|463950387|FG002|Overall Study|Adverse Event|5|||
128906316|NCT02600507|463950385|FG000|Overall Study|Lack of Efficacy|3|||
128906317|NCT02600507|463950386|FG001|Overall Study|Lack of Efficacy|8|||
128906318|NCT02600507|463950387|FG002|Overall Study|Lack of Efficacy|5|||
128906319|NCT02600507|463950385|FG000|Overall Study|Lost to Follow-up|3|||
128906320|NCT02600507|463950386|FG001|Overall Study|Lost to Follow-up|5|||
128906321|NCT02600507|463950387|FG002|Overall Study|Lost to Follow-up|2|||
128906322|NCT02600507|463950385|FG000|Overall Study|Protocol Violation|12|||
128906323|NCT02600507|463950386|FG001|Overall Study|Protocol Violation|4|||
128906324|NCT02600507|463950387|FG002|Overall Study|Protocol Violation|4|||
128906325|NCT02600507|463950385|FG000|Overall Study|Physician Decision|1|||
128906326|NCT02600507|463950386|FG001|Overall Study|Physician Decision|0|||
128906327|NCT02600507|463950387|FG002|Overall Study|Physician Decision|1|||
128906328|NCT02600507|463950385|FG000|Overall Study|Withdrawal by Subject|7|||
128906329|NCT02600507|463950386|FG001|Overall Study|Withdrawal by Subject|11|||
128906330|NCT02600507|463950387|FG002|Overall Study|Withdrawal by Subject|7|||
128906331|NCT02600507|463950385|FG000|Overall Study|Other|0|||
128906332|NCT02600507|463950386|FG001|Overall Study|Other|1|||
128906333|NCT02600507|463950387|FG002|Overall Study|Other|1|||
128906334|NCT00621504|463950393|FG000|Overall Study|Adverse Event|1|||
128906335|NCT00621504|463950394|FG001|Overall Study|Adverse Event|3|||
128906336|NCT00621504|463950393|FG000|Overall Study|At the request of sponsor/investigator|1|||
128906337|NCT00621504|463950394|FG001|Overall Study|At the request of sponsor/investigator|0|||
128906338|NCT00621504|463950393|FG000|Overall Study|Withdrew consent|9|||
128906339|NCT00621504|463950394|FG001|Overall Study|Withdrew consent|6|||
128906340|NCT00621504|463950393|FG000|Overall Study|Lost to Follow-up|8|||
128906341|NCT00621504|463950394|FG001|Overall Study|Lost to Follow-up|10|||
128906342|NCT00621504|463950393|FG000|Overall Study|Other|1|||
128906343|NCT00621504|463950394|FG001|Overall Study|Other|0|||
128906344|NCT00621504|463950393|FG000|Overall Study|Death|6|||
128906345|NCT00621504|463950394|FG001|Overall Study|Death|6|||
128906346|NCT00605085|463950395|FG000|Overall Study|Withdrawal by Subject|8|||
128906347|NCT00605085|463950396|FG001|Overall Study|Withdrawal by Subject|5|||
128906348|NCT00605085|463950395|FG000|Overall Study|Adverse Event|9|||
128906349|NCT00605085|463950396|FG001|Overall Study|Adverse Event|5|||
128906350|NCT00605085|463950395|FG000|Overall Study|Pregnancy|2|||
128906351|NCT00605085|463950396|FG001|Overall Study|Pregnancy|0|||
128906352|NCT00605085|463950395|FG000|Overall Study|Protocol Violation|3|||
128906353|NCT00605085|463950396|FG001|Overall Study|Protocol Violation|2|||
128906354|NCT00605085|463950395|FG000|Overall Study|Lost to Follow-up|10|||
128906355|NCT00605085|463950396|FG001|Overall Study|Lost to Follow-up|5|||
128906356|NCT00605085|463950395|FG000|Overall Study|administrative reasons|18|||
128906357|NCT00605085|463950396|FG001|Overall Study|administrative reasons|8|||
128906358|NCT03257267|463950401|FG000|Overall Study|Adverse Event|17|||
128906359|NCT03257267|463950402|FG001|Overall Study|Adverse Event|7|||
128906360|NCT03257267|463950401|FG000|Overall Study|Death|96|||
128906361|NCT03257267|463950402|FG001|Overall Study|Death|98|||
128906362|NCT03257267|463950401|FG000|Overall Study|Lost to Follow-up|2|||
128906363|NCT03257267|463950402|FG001|Overall Study|Lost to Follow-up|2|||
128906364|NCT03257267|463950401|FG000|Overall Study|Non-compliance with Study Drug|0|||
128906365|NCT03257267|463950402|FG001|Overall Study|Non-compliance with Study Drug|2|||
128906366|NCT03257267|463950401|FG000|Overall Study|Participant Decision|35|||
128906367|NCT03257267|463950402|FG001|Overall Study|Participant Decision|43|||
128906368|NCT03257267|463950401|FG000|Overall Study|Sponsor Decision|1|||
128906369|NCT03257267|463950402|FG001|Overall Study|Sponsor Decision|0|||
128906370|NCT03257267|463950401|FG000|Overall Study|Physician Decision|1|||
128906371|NCT03257267|463950402|FG001|Overall Study|Physician Decision|3|||
128906372|NCT03257267|463950401|FG000|Overall Study|Disease Progression|109|||
128906373|NCT03257267|463950402|FG001|Overall Study|Disease Progression|121|||
128906374|NCT03257267|463950401|FG000|Overall Study|Withdrawal by Subject|8|||
128906375|NCT03257267|463950402|FG001|Overall Study|Withdrawal by Subject|26|||
128906376|NCT03257267|463950401|FG000|Overall Study|Other|0|||
128906377|NCT03257267|463950402|FG001|Overall Study|Other|2|||
128906378|NCT01979523|463950403|FG000|Overall Study|Withdrawal by Subject|1|||
128906379|NCT01979523|463950404|FG001|Overall Study|Withdrawal by Subject|0|||
128906380|NCT00706134|463950405|FG000|Overall Study|Adverse Event|8|||
128906381|NCT00706134|463950406|FG001|Overall Study|Adverse Event|7|||
128906382|NCT00706134|463950407|FG002|Overall Study|Adverse Event|2|||
128906383|NCT00706134|463950408|FG003|Overall Study|Adverse Event|3|||
128906384|NCT00706134|463950405|FG000|Overall Study|Lost to Follow-up|0|||
128906385|NCT00706134|463950406|FG001|Overall Study|Lost to Follow-up|1|||
128906386|NCT00706134|463950407|FG002|Overall Study|Lost to Follow-up|0|||
128906387|NCT00706134|463950408|FG003|Overall Study|Lost to Follow-up|0|||
128906388|NCT00706134|463950405|FG000|Overall Study|Protocol Violation|0|||
128906389|NCT00706134|463950406|FG001|Overall Study|Protocol Violation|6|||
128906390|NCT00706134|463950407|FG002|Overall Study|Protocol Violation|0|||
128906391|NCT00706134|463950408|FG003|Overall Study|Protocol Violation|3|||
128906392|NCT00706134|463950405|FG000|Overall Study|Withdrawal by Subject|1|||
128906393|NCT00706134|463950406|FG001|Overall Study|Withdrawal by Subject|2|||
128906394|NCT00706134|463950407|FG002|Overall Study|Withdrawal by Subject|1|||
128906395|NCT00706134|463950408|FG003|Overall Study|Withdrawal by Subject|0|||
128906396|NCT00706134|463950405|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
128906397|NCT00706134|463950406|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
128906398|NCT00706134|463950407|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
128906399|NCT00706134|463950408|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
128906400|NCT00706134|463950405|FG000|Overall Study|Did not meet study criteria|2|||
128906401|NCT00706134|463950406|FG001|Overall Study|Did not meet study criteria|0|||
128906402|NCT00706134|463950407|FG002|Overall Study|Did not meet study criteria|0|||
128906403|NCT00706134|463950408|FG003|Overall Study|Did not meet study criteria|0|||
128906404|NCT01982292|463950409|FG000|Overall Study|Adverse Event|2|||
128906405|NCT01982292|463950410|FG001|Overall Study|Adverse Event|0|||
128906406|NCT01982292|463950409|FG000|Overall Study|Death|1|||
128906407|NCT01982292|463950410|FG001|Overall Study|Death|0|||
128906408|NCT01982292|463950409|FG000|Overall Study|Lost to Follow-up|2|||
128906409|NCT01982292|463950410|FG001|Overall Study|Lost to Follow-up|0|||
128906410|NCT01982292|463950409|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
128906411|NCT01982292|463950410|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
128906412|NCT01982292|463950409|FG000|Overall Study|Protocol Deviation|1|||
128906413|NCT01982292|463950410|FG001|Overall Study|Protocol Deviation|0|||
128906414|NCT01982292|463950409|FG000|Overall Study|Patient/Guardian Decision|3|||
128906415|NCT01982292|463950410|FG001|Overall Study|Patient/Guardian Decision|1|||
128906416|NCT01982292|463950409|FG000|Overall Study|Technical Problems|2|||
128906417|NCT01982292|463950410|FG001|Overall Study|Technical Problems|0|||
128906418|NCT00746252|463950413|FG000|Overall Study|weight gain >7.5 %|1|||
128906419|NCT00746252|463950414|FG001|Overall Study|weight gain >7.5 %|2|||
128906420|NCT00082888|463950415|FG000|Overall Study|Ineligible|1|||
128906421|NCT00082888|463950416|FG001|Overall Study|Ineligible|0|||
128906422|NCT00082888|463950417|FG002|Overall Study|Ineligible|0|||
128906423|NCT01659320|463950419|FG000|Overall Study|Withdrawal by Subject|2|||
128906424|NCT01659320|463950419|FG000|Overall Study|Physician Decision|1|||
128906425|NCT01870401|463950420|FG000|Overall Study|Death|48|||
128906426|NCT01870401|463950421|FG001|Overall Study|Death|24|||
128906427|NCT01870401|463950420|FG000|Overall Study|Withdrawal by Subject|39|||
129116852|NCT03234465|464723289|FG001|Overall Study|Non-compliance|0|||
129116853|NCT03234465|464723288|FG000|Overall Study|Other|14|||
129116854|NCT03234465|464723289|FG001|Overall Study|Other|8|||
129116855|NCT03106077|464723290|FG000|Overall Study|Screen Failure|94|||
129116856|NCT03106077|464723291|FG001|Overall Study|Screen Failure|0|||
129116857|NCT00449163|464723292|FG000|Overall Study|Physician Decision|3|||
129116858|NCT00606307|464723295|FG000|Overall Study|Adverse Event|2|||
129116859|NCT00606307|464723295|FG000|Overall Study|Withdrawal by Subject|2|||
128906428|NCT01870401|463950421|FG001|Overall Study|Withdrawal by Subject|26|||
129116860|NCT00606307|464723295|FG000|Overall Study|Disease progression|6|||
129116861|NCT00606307|464723295|FG000|Overall Study|QTc prolongation|1|||
129116862|NCT01274533|464723296|FG000|Overall Study|Withdrawal by Subject|1|||
129116863|NCT01274533|464723296|FG000|Overall Study|Non-compliance|1|||
129116864|NCT01274533|464723296|FG000|Overall Study|Disease progression|2|||
129116865|NCT02008526|464723306|FG000|Overall Study|Death|0|||
129116866|NCT02008526|464723307|FG001|Overall Study|Death|2|||
129116867|NCT02008526|464723308|FG002|Overall Study|Death|1|||
129116868|NCT02008526|464723306|FG000|Overall Study|Withdrawal by Subject|3|||
129116869|NCT02008526|464723307|FG001|Overall Study|Withdrawal by Subject|3|||
129116870|NCT02008526|464723308|FG002|Overall Study|Withdrawal by Subject|2|||
129116871|NCT02008526|464723306|FG000|Overall Study|Lost to Follow-up|5|||
128906429|NCT01870401|463950420|FG000|Overall Study|Lost to Follow-up|19|||
129116872|NCT02008526|464723307|FG001|Overall Study|Lost to Follow-up|9|||
129116873|NCT02008526|464723308|FG002|Overall Study|Lost to Follow-up|6|||
128906430|NCT01870401|463950421|FG001|Overall Study|Lost to Follow-up|14|||
128906431|NCT01870401|463950420|FG000|Overall Study|Other|9|||
129116874|NCT01118052|464723309|FG000|Overall Study|Never treated|2|||
128906432|NCT01870401|463950421|FG001|Overall Study|Other|7|||
128906433|NCT01870401|463950420|FG000|Overall Study|On-going in the Study|35|||
128906434|NCT01870401|463950421|FG001|Overall Study|On-going in the Study|25|||
129116875|NCT02949947|464723310|FG000|Overall Study|Non Compliance|0|||
129116876|NCT02949947|464723311|FG001|Overall Study|Non Compliance|1|||
129116877|NCT02949947|464723310|FG000|Overall Study|Insurance change|1|||
129116878|NCT02949947|464723311|FG001|Overall Study|Insurance change|0|||
129116879|NCT00828711|464723313|FG000|Overall Study|Lost to Follow-up|1|||
129116880|NCT00828711|464723314|FG001|Overall Study|Lost to Follow-up|0|||
128906435|NCT02684981|463950422|FG000|Overall Study|Permanently discontinued the treatment|157|||
128906436|NCT02684981|463950423|FG001|Overall Study|Permanently discontinued the treatment|161|||
128906437|NCT02684981|463950424|FG002|Overall Study|Permanently discontinued the treatment|110|||
129116881|NCT00828711|464723315|FG002|Overall Study|Lost to Follow-up|0|||
129116882|NCT01618968|464723316|FG000|Overall Study|Adverse Event|1|||
128696362|NCT00347360|463185342|FG006|Overall Study|Subject refuse to sign updated consent|0|||
129116883|NCT01618968|464723317|FG001|Overall Study|Adverse Event|0|||
129116884|NCT01618968|464723318|FG002|Overall Study|Adverse Event|0|||
129116885|NCT01618968|464723319|FG003|Overall Study|Adverse Event|0|||
128696363|NCT00347360|463185343|FG007|Overall Study|Subject refuse to sign updated consent|0|||
128696364|NCT00347360|463185344|FG008|Overall Study|Subject refuse to sign updated consent|0|||
128696365|NCT00347360|463185345|FG009|Overall Study|Subject refuse to sign updated consent|0|||
128696366|NCT00347360|463185346|FG010|Overall Study|Subject refuse to sign updated consent|0|||
128696367|NCT00347360|463185347|FG011|Overall Study|Subject refuse to sign updated consent|0|||
128696368|NCT00347360|463185348|FG012|Overall Study|Subject refuse to sign updated consent|0|||
128696369|NCT00347360|463185349|FG013|Overall Study|Subject refuse to sign updated consent|0|||
128696370|NCT00347360|463185350|FG014|Overall Study|Subject refuse to sign updated consent|1|||
128696371|NCT00347360|463185336|FG000|Overall Study|Visits conflicted with new job|0|||
128696372|NCT00347360|463185337|FG001|Overall Study|Visits conflicted with new job|0|||
128696373|NCT00347360|463185338|FG002|Overall Study|Visits conflicted with new job|0|||
128696374|NCT00347360|463185339|FG003|Overall Study|Visits conflicted with new job|0|||
128696375|NCT00347360|463185340|FG004|Overall Study|Visits conflicted with new job|0|||
128696376|NCT00347360|463185341|FG005|Overall Study|Visits conflicted with new job|0|||
128696377|NCT00347360|463185342|FG006|Overall Study|Visits conflicted with new job|1|||
128696378|NCT00347360|463185343|FG007|Overall Study|Visits conflicted with new job|0|||
128696379|NCT00347360|463185344|FG008|Overall Study|Visits conflicted with new job|0|||
128696380|NCT00347360|463185345|FG009|Overall Study|Visits conflicted with new job|0|||
128696381|NCT00347360|463185346|FG010|Overall Study|Visits conflicted with new job|0|||
128696382|NCT00347360|463185347|FG011|Overall Study|Visits conflicted with new job|0|||
128696383|NCT00347360|463185348|FG012|Overall Study|Visits conflicted with new job|0|||
128696384|NCT00347360|463185349|FG013|Overall Study|Visits conflicted with new job|0|||
128696385|NCT00347360|463185350|FG014|Overall Study|Visits conflicted with new job|0|||
128696386|NCT01449539|463185351|FG000|Overall Study|Withdrawal by Subject|3|||
128696387|NCT01449539|463185351|FG000|Overall Study|Toxicity not study related|1|||
128696388|NCT02187744|463185354|FG000|Study|Participant refused further follow-up|1|||
128696389|NCT02187744|463185355|FG001|Study|Participant refused further follow-up|0|||
128696390|NCT02187744|463185354|FG000|Study|Other|2|||
128696391|NCT02187744|463185355|FG001|Study|Other|1|||
128696392|NCT02187744|463185354|FG000|Study|Lost to Follow-up|0|||
128696393|NCT02187744|463185355|FG001|Study|Lost to Follow-up|2|||
128696394|NCT02187744|463185354|FG000|Study|Related adverse event, not serious|0|||
128696395|NCT02187744|463185355|FG001|Study|Related adverse event, not serious|2|||
128696396|NCT02187744|463185354|FG000|Study|Death|1|||
128696397|NCT02187744|463185355|FG001|Study|Death|0|||
128696398|NCT02187744|463185354|FG000|Study|Related adverse event, serious non-fatal|0|||
128696399|NCT02187744|463185355|FG001|Study|Related adverse event, serious non-fatal|1|||
128696400|NCT02187744|463185354|FG000|Treatment|Death|1|||
128696401|NCT02187744|463185355|FG001|Treatment|Death|0|||
128696402|NCT02187744|463185354|FG000|Treatment|Related adverse event, serious non-fatal|0|||
128696403|NCT02187744|463185355|FG001|Treatment|Related adverse event, serious non-fatal|1|||
128696404|NCT02187744|463185354|FG000|Treatment|Related adverse event, not serious|0|||
128696405|NCT02187744|463185355|FG001|Treatment|Related adverse event, not serious|2|||
128696406|NCT02187744|463185354|FG000|Treatment|Lost to Follow-up|0|||
128696407|NCT02187744|463185355|FG001|Treatment|Lost to Follow-up|1|||
128696408|NCT02187744|463185354|FG000|Treatment|Other|2|||
128696409|NCT02187744|463185355|FG001|Treatment|Other|0|||
128696410|NCT02187744|463185354|FG000|Treatment|Participant refused continued treatment|1|||
128696411|NCT02187744|463185355|FG001|Treatment|Participant refused continued treatment|1|||
128696412|NCT01972568|463185356|FG000|Overall Study|Other events|3|||
128696413|NCT01972568|463185357|FG001|Overall Study|Other events|0|||
128696414|NCT01972568|463185358|FG002|Overall Study|Other events|0|||
128696415|NCT01972568|463185356|FG000|Overall Study|Lack of Efficacy|0|||
128696416|NCT01972568|463185357|FG001|Overall Study|Lack of Efficacy|1|||
128696417|NCT01972568|463185358|FG002|Overall Study|Lack of Efficacy|2|||
128696418|NCT01972568|463185356|FG000|Overall Study|Protocol Violation|1|||
128696419|NCT01972568|463185357|FG001|Overall Study|Protocol Violation|2|||
128696420|NCT01972568|463185358|FG002|Overall Study|Protocol Violation|2|||
128696421|NCT01972568|463185356|FG000|Overall Study|Withdrawal by Subject|6|||
128696422|NCT01972568|463185357|FG001|Overall Study|Withdrawal by Subject|3|||
128696423|NCT01972568|463185358|FG002|Overall Study|Withdrawal by Subject|7|||
128696424|NCT01972568|463185356|FG000|Overall Study|Lost to Follow-up|1|||
128906438|NCT02684981|463950422|FG000|Overall Study|Other|83|||
129116886|NCT01618968|464723316|FG000|Overall Study|Death|0|||
128696425|NCT01972568|463185357|FG001|Overall Study|Lost to Follow-up|0|||
128696426|NCT01972568|463185358|FG002|Overall Study|Lost to Follow-up|0|||
128696427|NCT01972568|463185356|FG000|Overall Study|Adverse Event|5|||
128696428|NCT01972568|463185357|FG001|Overall Study|Adverse Event|6|||
128696429|NCT01972568|463185358|FG002|Overall Study|Adverse Event|5|||
128696430|NCT02572401|463185359|FG000|Overall Study|Lost to Follow-up|5|||
128696431|NCT02572401|463185360|FG001|Overall Study|Lost to Follow-up|8|||
129116887|NCT01618968|464723317|FG001|Overall Study|Death|0|||
128906439|NCT02684981|463950423|FG001|Overall Study|Other|49|||
128906440|NCT02684981|463950424|FG002|Overall Study|Other|17|||
128906441|NCT04623242|463950425|FG000|Overall Study|Withdrawal by Subject|7|||
128906442|NCT04623242|463950426|FG001|Overall Study|Withdrawal by Subject|12|||
128906443|NCT04623242|463950427|FG002|Overall Study|Withdrawal by Subject|5|||
128906444|NCT04623242|463950428|FG003|Overall Study|Withdrawal by Subject|7|||
128906445|NCT04623242|463950429|FG004|Overall Study|Withdrawal by Subject|0|||
128906446|NCT04623242|463950425|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
128906447|NCT04623242|463950426|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
128906448|NCT04623242|463950427|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
128906449|NCT04623242|463950428|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
128906450|NCT04623242|463950429|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
128906451|NCT04623242|463950425|FG000|Overall Study|Subject unblinded to mutation status|0|||
128906452|NCT04623242|463950426|FG001|Overall Study|Subject unblinded to mutation status|0|||
128906453|NCT04623242|463950427|FG002|Overall Study|Subject unblinded to mutation status|0|||
128906454|NCT04623242|463950428|FG003|Overall Study|Subject unblinded to mutation status|13|||
128906455|NCT04623242|463950429|FG004|Overall Study|Subject unblinded to mutation status|0|||
128906456|NCT00820898|463950430|FG000|Overall Study|Inelgible - wrong primary site|1|||
128906457|NCT00493870|463950433|FG000|Overall Study|Lost to Follow-up|12|||
128906458|NCT00493870|463950434|FG001|Overall Study|Lost to Follow-up|15|||
128906459|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
128906460|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
128906461|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
128906462|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
128906463|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
128906464|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
128906465|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
128906466|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
128906467|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
128906468|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
128906469|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
128906470|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
128906471|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
128906472|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
128906473|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
128906474|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
128906475|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
128906476|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
128906477|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
128906478|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
128906479|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
128906480|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
128906481|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
128906482|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
128906483|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
128906484|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
128906485|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
128906486|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
128906487|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
128906488|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
128906489|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
128906490|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
128906491|NCT03605680|463950435|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
128906492|NCT03605680|463950436|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
128906493|NCT03605680|463950437|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
128906494|NCT03605680|463950438|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
128906495|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
128906496|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
128906497|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
128906498|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
128906499|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
128906500|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
128906501|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
128906502|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
128906503|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128906504|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128906505|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128906506|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
128906507|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
128906508|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
128906509|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
128906510|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
128906511|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
128906512|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
128906513|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
128906514|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
128906515|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
128906516|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
128906517|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
128906518|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
128906519|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
128906520|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
128906521|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
128906522|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
128906523|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
128906524|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
128906525|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
128906526|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
128906527|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
128906528|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
128906529|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
128906530|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
128906531|NCT03605680|463950435|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
128906532|NCT03605680|463950436|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
128906533|NCT03605680|463950437|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
128906534|NCT03605680|463950438|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
128906535|NCT01652287|463950439|FG000|Overall Study|Withdrawal by Subject|2|||
128906536|NCT01652287|463950440|FG001|Overall Study|Withdrawal by Subject|0|||
128906537|NCT00527605|463950441|FG000|Overall Study|Adverse Event|3|||
128906538|NCT00527605|463950442|FG001|Overall Study|Adverse Event|0|||
128906539|NCT00527605|463950441|FG000|Overall Study|Withdrawal by Subject|3|||
128906540|NCT00527605|463950442|FG001|Overall Study|Withdrawal by Subject|7|||
128906541|NCT00527605|463950441|FG000|Overall Study|Lost to Follow-up|6|||
128906542|NCT00527605|463950442|FG001|Overall Study|Lost to Follow-up|2|||
128906543|NCT00527605|463950441|FG000|Overall Study|Protocol Violation|1|||
128906544|NCT00527605|463950442|FG001|Overall Study|Protocol Violation|2|||
128906545|NCT00763139|463950443|FG000|Overall Study|Adverse Event|4|||
128906546|NCT00763139|463950444|FG001|Overall Study|Adverse Event|2|||
128906547|NCT00763139|463950443|FG000|Overall Study|Withdrawal by Subject|0|||
128906548|NCT00763139|463950444|FG001|Overall Study|Withdrawal by Subject|1|||
128906549|NCT00763139|463950443|FG000|Overall Study|med change not allowed by protocol|1|||
128906550|NCT00763139|463950444|FG001|Overall Study|med change not allowed by protocol|0|||
128906551|NCT01592760|463950445|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
128906552|NCT01592760|463950446|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
128906553|NCT01592760|463950447|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
128906554|NCT04312009|463950448|FG000|Overall Study|Withdrawal by Subject|2|||
128906555|NCT04312009|463950449|FG001|Overall Study|Withdrawal by Subject|1|||
129027384|NCT00112437|464390088|FG023|Years 6-10 (60-Month Extension)|Death|2|||
129027385|NCT00112437|464390089|FG024|Years 6-10 (60-Month Extension)|Death|0|||
129027386|NCT00112437|464390090|FG025|Years 6-10 (60-Month Extension)|Death|0|||
129027387|NCT00112437|464390065|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027388|NCT00112437|464390066|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027389|NCT00112437|464390067|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027390|NCT00112437|464390068|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027391|NCT00112437|464390069|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027392|NCT00112437|464390070|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027393|NCT00112437|464390071|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
128906556|NCT00179309|463950455|FG000|Treatment|Toxicity|2|||
128906557|NCT00179309|463950456|FG001|Treatment|Toxicity|3|||
128906558|NCT00179309|463950455|FG000|Treatment|Withdrawal by Subject|1|||
129027394|NCT00112437|464390072|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
128696432|NCT02572401|463185361|FG002|Overall Study|Lost to Follow-up|9|||
128906559|NCT00179309|463950456|FG001|Treatment|Withdrawal by Subject|2|||
128906560|NCT00179309|463950455|FG000|Treatment|Allergy|1|||
128906561|NCT00179309|463950456|FG001|Treatment|Allergy|0|||
128906562|NCT01709149|463950463|FG000|Open-label Lead-in Phase|Adverse Event|109|||
128906563|NCT01709149|463950464|FG001|Open-label Lead-in Phase|Adverse Event|0|||
128906564|NCT01709149|463950465|FG002|Open-label Lead-in Phase|Adverse Event|0|||
128906565|NCT01709149|463950463|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
128906566|NCT01709149|463950464|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
128906567|NCT01709149|463950465|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
128906568|NCT01709149|463950463|FG000|Open-label Lead-in Phase|Death|1|||
128765171|NCT00979602|463432055|FG000|Overall Study|Lost to Follow-up|100|||
128906569|NCT01709149|463950464|FG001|Open-label Lead-in Phase|Death|0|||
128906570|NCT01709149|463950465|FG002|Open-label Lead-in Phase|Death|0|||
128906571|NCT01709149|463950463|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
128906572|NCT01709149|463950464|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
128906573|NCT01709149|463950465|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
128906574|NCT01709149|463950463|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
128906575|NCT01709149|463950464|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
128906576|NCT01709149|463950465|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
128906577|NCT01709149|463950463|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
128906578|NCT01709149|463950464|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
128906579|NCT01709149|463950465|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
128906580|NCT01709149|463950463|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
128906581|NCT01709149|463950464|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
128906582|NCT01709149|463950465|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
128906583|NCT01709149|463950463|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
128906584|NCT01709149|463950464|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
128906585|NCT01709149|463950465|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
128906586|NCT01709149|463950463|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
128906587|NCT01709149|463950464|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
128906588|NCT01709149|463950465|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
128906589|NCT01709149|463950463|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
128906590|NCT01709149|463950464|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
128906591|NCT01709149|463950465|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
128906592|NCT02797808|463950466|FG000|Overall Study|Withdrawal by Subject|1|||
128906593|NCT02797808|463950467|FG001|Overall Study|Withdrawal by Subject|1|||
128906594|NCT02797808|463950466|FG000|Overall Study|Physician Decision|6|||
128906595|NCT02797808|463950467|FG001|Overall Study|Physician Decision|2|||
128906596|NCT02192827|463950468|FG000|Overall Study|Lost to Follow-up|25|||
128906597|NCT02192827|463950469|FG001|Overall Study|Lost to Follow-up|27|||
128906598|NCT02192827|463950468|FG000|Overall Study|Given additional steroids with admission|13|||
128906599|NCT02192827|463950469|FG001|Overall Study|Given additional steroids with admission|11|||
128906600|NCT01780831|463950472|FG000|Overall Study|Withdrawal by Subject|0|||
128906601|NCT01780831|463950473|FG001|Overall Study|Withdrawal by Subject|0|||
128906602|NCT01780831|463950474|FG002|Overall Study|Withdrawal by Subject|4|||
128906603|NCT01780831|463950475|FG003|Overall Study|Withdrawal by Subject|0|||
128906604|NCT01780831|463950472|FG000|Overall Study|Lost to Follow-up|0|||
128906605|NCT01780831|463950473|FG001|Overall Study|Lost to Follow-up|0|||
128906606|NCT01780831|463950474|FG002|Overall Study|Lost to Follow-up|0|||
128906607|NCT01780831|463950475|FG003|Overall Study|Lost to Follow-up|1|||
128906608|NCT00267748|463950479|FG000|Non-randomized Period|Progressive disease|10|||
128906609|NCT00267748|463950480|FG001|Non-randomized Period|Progressive disease|0|||
128906610|NCT00267748|463950481|FG002|Non-randomized Period|Progressive disease|0|||
128906611|NCT00267748|463950479|FG000|Non-randomized Period|Adverse Event|8|||
128906612|NCT00267748|463950480|FG001|Non-randomized Period|Adverse Event|0|||
128906613|NCT00267748|463950481|FG002|Non-randomized Period|Adverse Event|0|||
128906614|NCT00267748|463950479|FG000|Non-randomized Period|Death|1|||
128906615|NCT00267748|463950480|FG001|Non-randomized Period|Death|0|||
128906616|NCT00267748|463950481|FG002|Non-randomized Period|Death|0|||
128906617|NCT00267748|463950479|FG000|Non-randomized Period|Participant not willing to participate|1|||
128906618|NCT00267748|463950480|FG001|Non-randomized Period|Participant not willing to participate|0|||
128906619|NCT00267748|463950481|FG002|Non-randomized Period|Participant not willing to participate|0|||
128906620|NCT00267748|463950479|FG000|Non-randomized Period|Other|3|||
129027395|NCT00112437|464390073|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027396|NCT00112437|464390074|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027397|NCT00112437|464390075|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027398|NCT00112437|464390076|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
128906621|NCT00267748|463950480|FG001|Non-randomized Period|Other|0|||
128906622|NCT00267748|463950481|FG002|Non-randomized Period|Other|0|||
128906623|NCT00267748|463950479|FG000|Randomized Period|Death|0|||
128906624|NCT00267748|463950480|FG001|Randomized Period|Death|2|||
128906625|NCT00267748|463950481|FG002|Randomized Period|Death|3|||
128765172|NCT00979602|463432056|FG001|Overall Study|Lost to Follow-up|96|||
128906626|NCT00267748|463950479|FG000|Randomized Period|Adverse Event|0|||
128906627|NCT00267748|463950480|FG001|Randomized Period|Adverse Event|23|||
128906628|NCT00267748|463950481|FG002|Randomized Period|Adverse Event|25|||
128906629|NCT00267748|463950479|FG000|Randomized Period|Global deterioration of health status|0|||
128906630|NCT00267748|463950480|FG001|Randomized Period|Global deterioration of health status|6|||
128906631|NCT00267748|463950481|FG002|Randomized Period|Global deterioration of health status|7|||
128906632|NCT00267748|463950479|FG000|Randomized Period|Lost to Follow-up|0|||
128906633|NCT00267748|463950480|FG001|Randomized Period|Lost to Follow-up|1|||
128906634|NCT00267748|463950481|FG002|Randomized Period|Lost to Follow-up|0|||
128906635|NCT00267748|463950479|FG000|Randomized Period|Objective progression or relapse|0|||
128906636|NCT00267748|463950480|FG001|Randomized Period|Objective progression or relapse|77|||
128906637|NCT00267748|463950481|FG002|Randomized Period|Objective progression or relapse|86|||
128906638|NCT00267748|463950479|FG000|Randomized Period|Withdrawal by Subject|0|||
128906639|NCT00267748|463950480|FG001|Randomized Period|Withdrawal by Subject|9|||
128906640|NCT00267748|463950481|FG002|Randomized Period|Withdrawal by Subject|2|||
128906641|NCT00267748|463950479|FG000|Randomized Period|Other|0|||
128906642|NCT00267748|463950480|FG001|Randomized Period|Other|9|||
128906643|NCT00267748|463950481|FG002|Randomized Period|Other|6|||
128906644|NCT00267748|463950479|FG000|Randomized Period|randomized but not treated|0|||
128906645|NCT00267748|463950480|FG001|Randomized Period|randomized but not treated|0|||
128906646|NCT00267748|463950481|FG002|Randomized Period|randomized but not treated|3|||
128906647|NCT01294800|463950482|FG000|Overall Study|Adverse Event|7|||
128906648|NCT01294800|463950483|FG001|Overall Study|Adverse Event|6|||
128906649|NCT01294800|463950484|FG002|Overall Study|Adverse Event|12|||
128906650|NCT01294800|463950485|FG003|Overall Study|Adverse Event|5|||
128906651|NCT01294800|463950482|FG000|Overall Study|Subject Withdrew Consent|2|||
128906652|NCT01294800|463950483|FG001|Overall Study|Subject Withdrew Consent|2|||
128906653|NCT01294800|463950484|FG002|Overall Study|Subject Withdrew Consent|2|||
128906654|NCT01294800|463950485|FG003|Overall Study|Subject Withdrew Consent|11|||
128906655|NCT01294800|463950482|FG000|Overall Study|Lost to Follow-up|0|||
128906656|NCT01294800|463950483|FG001|Overall Study|Lost to Follow-up|0|||
128906657|NCT01294800|463950484|FG002|Overall Study|Lost to Follow-up|1|||
128906658|NCT01294800|463950485|FG003|Overall Study|Lost to Follow-up|0|||
128906659|NCT01294800|463950482|FG000|Overall Study|Non-compliance With Protocol|0|||
128906660|NCT01294800|463950483|FG001|Overall Study|Non-compliance With Protocol|1|||
128906661|NCT01294800|463950484|FG002|Overall Study|Non-compliance With Protocol|1|||
128906662|NCT01294800|463950485|FG003|Overall Study|Non-compliance With Protocol|0|||
128906663|NCT01294800|463950482|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
128906664|NCT01294800|463950483|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
128906665|NCT01294800|463950484|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
128696433|NCT02572401|463185362|FG003|Overall Study|Lost to Follow-up|9|||
128696434|NCT02572401|463185359|FG000|Overall Study|Death|0|||
128906666|NCT01294800|463950485|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
128906667|NCT05098041|463950487|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
128906668|NCT00797732|463950494|FG000|Overall Study|Withdrawal by Subject|3|||
128906669|NCT00797732|463950495|FG001|Overall Study|Withdrawal by Subject|3|||
128906670|NCT00797732|463950496|FG002|Overall Study|Withdrawal by Subject|0|||
128906671|NCT00797732|463950494|FG000|Overall Study|Lost to Follow-up|1|||
128906672|NCT00797732|463950495|FG001|Overall Study|Lost to Follow-up|0|||
128906673|NCT00797732|463950496|FG002|Overall Study|Lost to Follow-up|0|||
128906674|NCT00797732|463950494|FG000|Overall Study|Death|1|||
128906675|NCT00797732|463950495|FG001|Overall Study|Death|0|||
129027399|NCT00112437|464390077|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027400|NCT00112437|464390078|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027401|NCT00112437|464390079|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027402|NCT00112437|464390080|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027403|NCT00112437|464390081|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027404|NCT00112437|464390082|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027405|NCT00112437|464390083|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027406|NCT00112437|464390084|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027407|NCT00112437|464390085|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027408|NCT00112437|464390086|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027409|NCT00112437|464390087|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027410|NCT00112437|464390088|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027411|NCT00112437|464390089|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129027412|NCT00112437|464390090|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
129027413|NCT00112437|464390065|FG000|Years 6-10 (60-Month Extension)|Other|0|||
129027414|NCT00112437|464390066|FG001|Years 6-10 (60-Month Extension)|Other|0|||
129027415|NCT00112437|464390067|FG002|Years 6-10 (60-Month Extension)|Other|0|||
128696435|NCT02572401|463185360|FG001|Overall Study|Death|0|||
129027416|NCT00112437|464390068|FG003|Years 6-10 (60-Month Extension)|Other|0|||
129027417|NCT00112437|464390069|FG004|Years 6-10 (60-Month Extension)|Other|0|||
129027418|NCT00112437|464390070|FG005|Years 6-10 (60-Month Extension)|Other|0|||
128696436|NCT02572401|463185361|FG002|Overall Study|Death|0|||
128906676|NCT00797732|463950496|FG002|Overall Study|Death|0|||
128906677|NCT00797732|463950494|FG000|Overall Study|Not meet inclusion criteria|0|||
128906678|NCT00797732|463950495|FG001|Overall Study|Not meet inclusion criteria|0|||
128906679|NCT00797732|463950496|FG002|Overall Study|Not meet inclusion criteria|7|||
128906680|NCT00797732|463950494|FG000|Overall Study|Excluded due to time constraints|0|||
128906681|NCT00797732|463950495|FG001|Overall Study|Excluded due to time constraints|0|||
128906682|NCT00797732|463950496|FG002|Overall Study|Excluded due to time constraints|24|||
128906683|NCT00797732|463950494|FG000|Overall Study|Refused to Participate|0|||
128906684|NCT00797732|463950495|FG001|Overall Study|Refused to Participate|0|||
128906685|NCT00797732|463950496|FG002|Overall Study|Refused to Participate|123|||
128906686|NCT00401752|463950497|FG000|Overall Study|Adverse Event|2|||
128906687|NCT00401752|463950498|FG001|Overall Study|Adverse Event|5|||
128906688|NCT00401752|463950497|FG000|Overall Study|Withdrawal by Subject|2|||
128906689|NCT00401752|463950498|FG001|Overall Study|Withdrawal by Subject|6|||
128906690|NCT00401752|463950497|FG000|Overall Study|Lost to Follow-up|1|||
128906691|NCT00401752|463950498|FG001|Overall Study|Lost to Follow-up|4|||
128906692|NCT00401752|463950497|FG000|Overall Study|Development of any exclusion criteria|4|||
128906693|NCT00401752|463950498|FG001|Overall Study|Development of any exclusion criteria|2|||
128906694|NCT00401752|463950497|FG000|Overall Study|Physician Decision|1|||
128906695|NCT00401752|463950498|FG001|Overall Study|Physician Decision|1|||
128906696|NCT02275338|463950499|FG000|Overall Study|Adverse Event|15|||
128906697|NCT02275338|463950499|FG000|Overall Study|Lack of Efficacy|3|||
128906698|NCT02275338|463950499|FG000|Overall Study|Withdrawal by Subject|4|||
128906699|NCT02275338|463950499|FG000|Overall Study|Disease progression (death)|1|||
128906700|NCT02275338|463950499|FG000|Overall Study|Ineligible to start Phase 2|4|||
128906701|NCT02275338|463950499|FG000|Overall Study|Reason not specified|5|||
128906702|NCT02275338|463950499|FG000|Overall Study|Does not meet entry criteria|1|||
128906703|NCT01857869|463950502|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
128906704|NCT01857869|463950503|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
128906705|NCT01857869|463950504|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
128906706|NCT01857869|463950505|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
128906707|NCT01857869|463950506|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
128906708|NCT01857869|463950507|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
128906709|NCT01857869|463950508|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
128906710|NCT01857869|463950509|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
128906711|NCT01857869|463950510|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
128906712|NCT01857869|463950511|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
128906713|NCT01857869|463950502|FG000|Primary/Challenge Phase|Pregnancy|1|||
128906714|NCT01857869|463950503|FG001|Primary/Challenge Phase|Pregnancy|0|||
128906715|NCT01857869|463950504|FG002|Primary/Challenge Phase|Pregnancy|0|||
128906716|NCT01857869|463950505|FG003|Primary/Challenge Phase|Pregnancy|0|||
128906717|NCT01857869|463950506|FG004|Primary/Challenge Phase|Pregnancy|0|||
128906718|NCT01857869|463950507|FG005|Primary/Challenge Phase|Pregnancy|0|||
128906719|NCT01857869|463950508|FG006|Primary/Challenge Phase|Pregnancy|0|||
128906720|NCT01857869|463950509|FG007|Primary/Challenge Phase|Pregnancy|0|||
128906721|NCT01857869|463950510|FG008|Primary/Challenge Phase|Pregnancy|0|||
128906722|NCT01857869|463950511|FG009|Primary/Challenge Phase|Pregnancy|0|||
128906723|NCT01857869|463950502|FG000|Primary/Challenge Phase|Protocol Violation|1|||
128906724|NCT01857869|463950503|FG001|Primary/Challenge Phase|Protocol Violation|0|||
128906725|NCT01857869|463950504|FG002|Primary/Challenge Phase|Protocol Violation|0|||
128906726|NCT01857869|463950505|FG003|Primary/Challenge Phase|Protocol Violation|0|||
128906727|NCT01857869|463950506|FG004|Primary/Challenge Phase|Protocol Violation|0|||
128906728|NCT01857869|463950507|FG005|Primary/Challenge Phase|Protocol Violation|0|||
128906729|NCT01857869|463950508|FG006|Primary/Challenge Phase|Protocol Violation|0|||
128906730|NCT01857869|463950509|FG007|Primary/Challenge Phase|Protocol Violation|0|||
128906731|NCT01857869|463950510|FG008|Primary/Challenge Phase|Protocol Violation|0|||
129116888|NCT01618968|464723318|FG002|Overall Study|Death|0|||
129116889|NCT01618968|464723319|FG003|Overall Study|Death|1|||
129116890|NCT02230891|464723320|FG000|Baseline|Did not meet inclusion|0|||
129116891|NCT02230891|464723321|FG001|Baseline|Did not meet inclusion|1|||
128906732|NCT01857869|463950511|FG009|Primary/Challenge Phase|Protocol Violation|0|||
128906733|NCT01857869|463950502|FG000|Primary/Challenge Phase|Other|1|||
128906734|NCT01857869|463950503|FG001|Primary/Challenge Phase|Other|1|||
128906735|NCT01857869|463950504|FG002|Primary/Challenge Phase|Other|0|||
128906736|NCT01857869|463950505|FG003|Primary/Challenge Phase|Other|0|||
128906737|NCT01857869|463950506|FG004|Primary/Challenge Phase|Other|0|||
128906738|NCT01857869|463950507|FG005|Primary/Challenge Phase|Other|0|||
128906739|NCT01857869|463950508|FG006|Primary/Challenge Phase|Other|0|||
128906740|NCT01857869|463950509|FG007|Primary/Challenge Phase|Other|0|||
128906741|NCT01857869|463950510|FG008|Primary/Challenge Phase|Other|0|||
128906742|NCT01857869|463950511|FG009|Primary/Challenge Phase|Other|0|||
128765173|NCT00979602|463432055|FG000|Overall Study|Migrated/moved from study area|3|||
128906743|NCT01857869|463950502|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906744|NCT01857869|463950503|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906745|NCT01857869|463950504|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906746|NCT01857869|463950505|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
129116892|NCT02230891|464723322|FG002|Baseline|Did not meet inclusion|1|||
129116893|NCT02230891|464723320|FG000|2 Week|Withdrawal by Subject|2|||
128696437|NCT02572401|463185362|FG003|Overall Study|Death|1|||
129116894|NCT02230891|464723321|FG001|2 Week|Withdrawal by Subject|2|||
129116895|NCT02230891|464723322|FG002|2 Week|Withdrawal by Subject|0|||
129116896|NCT02230891|464723320|FG000|2 Week|Consent withdrawn|1|||
129116897|NCT02230891|464723321|FG001|2 Week|Consent withdrawn|0|||
129116898|NCT02230891|464723322|FG002|2 Week|Consent withdrawn|0|||
129116899|NCT02230891|464723320|FG000|6 Month|Withdrawal by Subject|1|||
129116900|NCT02230891|464723321|FG001|6 Month|Withdrawal by Subject|1|||
129116901|NCT02230891|464723322|FG002|6 Month|Withdrawal by Subject|1|||
129116902|NCT02230891|464723320|FG000|6 Month|Physician Decision|0|||
129116903|NCT02230891|464723321|FG001|6 Month|Physician Decision|2|||
129116904|NCT02230891|464723322|FG002|6 Month|Physician Decision|0|||
129116905|NCT02230891|464723320|FG000|12 Month|Death|1|||
129116906|NCT02230891|464723321|FG001|12 Month|Death|0|||
129116907|NCT02230891|464723322|FG002|12 Month|Death|0|||
129116908|NCT02230891|464723320|FG000|12 Month|Lost to Follow-up|0|||
129116909|NCT02230891|464723321|FG001|12 Month|Lost to Follow-up|1|||
129116910|NCT02230891|464723322|FG002|12 Month|Lost to Follow-up|0|||
129116911|NCT02230891|464723320|FG000|12 Month|Withdrawal by Subject|0|||
129116912|NCT02230891|464723321|FG001|12 Month|Withdrawal by Subject|2|||
129116913|NCT02230891|464723322|FG002|12 Month|Withdrawal by Subject|0|||
129116914|NCT02230891|464723320|FG000|18 Month End of Study|Death|0|||
129116915|NCT02230891|464723321|FG001|18 Month End of Study|Death|0|||
129116916|NCT02230891|464723322|FG002|18 Month End of Study|Death|1|||
129116917|NCT02230891|464723320|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
129116918|NCT02230891|464723321|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
129116919|NCT02230891|464723322|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
129116920|NCT02370511|464723325|FG000|Overall Study|Death|10|||
129116921|NCT02370511|464723326|FG001|Overall Study|Death|7|||
129116922|NCT02370511|464723327|FG002|Overall Study|Death|1|||
129116923|NCT02370511|464723325|FG000|Overall Study|Withdrawal by Subject|2|||
129116924|NCT02370511|464723326|FG001|Overall Study|Withdrawal by Subject|0|||
129116925|NCT02370511|464723327|FG002|Overall Study|Withdrawal by Subject|0|||
129116926|NCT02370511|464723325|FG000|Overall Study|Lost to Follow-up|0|||
129116927|NCT02370511|464723326|FG001|Overall Study|Lost to Follow-up|4|||
129116928|NCT02370511|464723327|FG002|Overall Study|Lost to Follow-up|0|||
129116929|NCT03882918|464723335|FG000|Overall Study|Study terminated by sponsor|98|||
129116930|NCT03882918|464723335|FG000|Overall Study|Protocol Violation|1|||
129116931|NCT03882918|464723335|FG000|Overall Study|Other|9|||
129116932|NCT03882918|464723335|FG000|Overall Study|Lack of Efficacy|14|||
129116933|NCT03882918|464723335|FG000|Overall Study|Adverse Event|13|||
129116934|NCT03882918|464723335|FG000|Overall Study|Withdrawal by Subject|5|||
129116935|NCT02100124|464723341|FG000|Overall Study|Lost to Follow-up|5|||
129116936|NCT02100124|464723342|FG001|Overall Study|Lost to Follow-up|11|||
129116937|NCT02100124|464723343|FG002|Overall Study|Lost to Follow-up|3|||
129116938|NCT02100124|464723341|FG000|Overall Study|Withdrawal by Subject|1|||
129116939|NCT02100124|464723342|FG001|Overall Study|Withdrawal by Subject|0|||
129116940|NCT02100124|464723343|FG002|Overall Study|Withdrawal by Subject|0|||
129116941|NCT00870727|464725230|FG000|Overall Study|Lost to Follow-up|0|||
129116942|NCT00870727|464725231|FG001|Overall Study|Lost to Follow-up|1|||
129116943|NCT00870727|464725230|FG000|Overall Study|Lack of Efficacy|1|||
129116944|NCT00870727|464725231|FG001|Overall Study|Lack of Efficacy|3|||
129116945|NCT00870727|464725230|FG000|Overall Study|Adverse Event|0|||
129116946|NCT00870727|464725231|FG001|Overall Study|Adverse Event|1|||
129116947|NCT01384877|464725235|FG000|Treatment 2|Lost to Follow-up|2|||
129116948|NCT01384877|464725236|FG001|Treatment 2|Lost to Follow-up|2|||
129116949|NCT03630393|464725237|FG000|Overall Study|Death|1|||
129116950|NCT03630393|464725238|FG001|Overall Study|Death|0|||
129116951|NCT00408499|464725239|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
128696438|NCT00306189|463185363|FG000|Overall Study|Physician Decision|0|||
128696439|NCT00306189|463185364|FG001|Overall Study|Physician Decision|0|||
129116952|NCT00408499|464725240|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
129116953|NCT00408499|464725241|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
129116954|NCT00408499|464725242|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
129116955|NCT00408499|464725243|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
129116956|NCT00408499|464725239|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
128696440|NCT00306189|463185365|FG002|Overall Study|Physician Decision|0|||
129116957|NCT00408499|464725240|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
129116958|NCT00408499|464725241|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
129116959|NCT00408499|464725242|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
129116960|NCT00408499|464725243|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
129116961|NCT00408499|464725239|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
129116962|NCT00408499|464725240|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
129116963|NCT00408499|464725241|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
129116964|NCT00408499|464725242|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
129116965|NCT00408499|464725243|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
129116966|NCT00408499|464725239|FG000|Phase II- MTD Expansion|Adverse Event|0|||
129116967|NCT00408499|464725240|FG001|Phase II- MTD Expansion|Adverse Event|0|||
128696441|NCT00306189|463185366|FG003|Overall Study|Physician Decision|1|||
128696442|NCT00306189|463185363|FG000|Overall Study|Adverse Event|3|||
128906747|NCT01857869|463950506|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906748|NCT01857869|463950507|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906749|NCT01857869|463950508|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906750|NCT01857869|463950509|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906751|NCT01857869|463950510|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906752|NCT01857869|463950511|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
128906753|NCT01857869|463950502|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906754|NCT01857869|463950503|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906755|NCT01857869|463950504|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906756|NCT01857869|463950505|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
128906757|NCT01857869|463950506|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906758|NCT01857869|463950507|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906759|NCT01857869|463950508|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906760|NCT01857869|463950509|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906761|NCT01857869|463950510|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906762|NCT01857869|463950511|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
128906763|NCT04607733|463950517|FG000|Overall Study|Lost to Follow-up|1|||
128906764|NCT04607733|463950518|FG001|Overall Study|Lost to Follow-up|0|||
128906765|NCT04607733|463950519|FG002|Overall Study|Lost to Follow-up|0|||
128906766|NCT04607733|463950520|FG003|Overall Study|Lost to Follow-up|1|||
128906767|NCT04607733|463950521|FG004|Overall Study|Lost to Follow-up|1|||
128906768|NCT04607733|463950522|FG005|Overall Study|Lost to Follow-up|0|||
128906769|NCT04607733|463950517|FG000|Overall Study|Withdrawal by Subject|0|||
128906770|NCT04607733|463950518|FG001|Overall Study|Withdrawal by Subject|0|||
128906771|NCT04607733|463950519|FG002|Overall Study|Withdrawal by Subject|0|||
128906772|NCT04607733|463950520|FG003|Overall Study|Withdrawal by Subject|0|||
128906773|NCT04607733|463950521|FG004|Overall Study|Withdrawal by Subject|1|||
128906774|NCT04607733|463950522|FG005|Overall Study|Withdrawal by Subject|0|||
128906775|NCT00835237|463950550|FG000|Overall Study|Lost to Follow-up|4|||
128906776|NCT00835237|463950551|FG001|Overall Study|Lost to Follow-up|0|||
128906777|NCT00835237|463950550|FG000|Overall Study|Withdrawal by Subject|2|||
128906778|NCT00835237|463950551|FG001|Overall Study|Withdrawal by Subject|0|||
128906779|NCT01265550|463950552|FG000|Pre Randomization|Withdrawal by Subject|0|||
128906780|NCT01265550|463950553|FG001|Pre Randomization|Withdrawal by Subject|0|||
128906781|NCT01265550|463950554|FG002|Pre Randomization|Withdrawal by Subject|0|||
128906782|NCT01265550|463950555|FG003|Pre Randomization|Withdrawal by Subject|70|||
128906783|NCT01265550|463950552|FG000|Pre Randomization|Technical Exclusions|0|||
128906784|NCT01265550|463950553|FG001|Pre Randomization|Technical Exclusions|0|||
128906785|NCT01265550|463950554|FG002|Pre Randomization|Technical Exclusions|0|||
128906786|NCT01265550|463950555|FG003|Pre Randomization|Technical Exclusions|54|||
128906787|NCT01265550|463950552|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
128906788|NCT01265550|463950553|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
128906789|NCT01265550|463950554|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
128906790|NCT01265550|463950555|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
128906791|NCT01265550|463950552|FG000|Pre Randomization|Non-GERD organic disorders|0|||
129027419|NCT00112437|464390071|FG006|Years 6-10 (60-Month Extension)|Other|0|||
129027420|NCT00112437|464390072|FG007|Years 6-10 (60-Month Extension)|Other|0|||
129027421|NCT00112437|464390073|FG008|Years 6-10 (60-Month Extension)|Other|0|||
129027422|NCT00112437|464390074|FG009|Years 6-10 (60-Month Extension)|Other|0|||
129027423|NCT00112437|464390075|FG010|Years 6-10 (60-Month Extension)|Other|0|||
129027424|NCT00112437|464390076|FG011|Years 6-10 (60-Month Extension)|Other|0|||
129027425|NCT00112437|464390077|FG012|Years 6-10 (60-Month Extension)|Other|0|||
129027426|NCT00112437|464390078|FG013|Years 6-10 (60-Month Extension)|Other|0|||
129027427|NCT00112437|464390079|FG014|Years 6-10 (60-Month Extension)|Other|0|||
129027428|NCT00112437|464390080|FG015|Years 6-10 (60-Month Extension)|Other|0|||
129027429|NCT00112437|464390081|FG016|Years 6-10 (60-Month Extension)|Other|0|||
129027430|NCT00112437|464390082|FG017|Years 6-10 (60-Month Extension)|Other|0|||
129027431|NCT00112437|464390083|FG018|Years 6-10 (60-Month Extension)|Other|0|||
129027432|NCT00112437|464390084|FG019|Years 6-10 (60-Month Extension)|Other|0|||
129027433|NCT00112437|464390085|FG020|Years 6-10 (60-Month Extension)|Other|0|||
129027434|NCT00112437|464390086|FG021|Years 6-10 (60-Month Extension)|Other|0|||
129027435|NCT00112437|464390087|FG022|Years 6-10 (60-Month Extension)|Other|0|||
129027436|NCT00112437|464390088|FG023|Years 6-10 (60-Month Extension)|Other|0|||
129027437|NCT00112437|464390089|FG024|Years 6-10 (60-Month Extension)|Other|1|||
129027438|NCT00112437|464390090|FG025|Years 6-10 (60-Month Extension)|Other|0|||
129027439|NCT00112437|464390065|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027440|NCT00112437|464390066|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027441|NCT00112437|464390067|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027442|NCT00112437|464390068|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
128906792|NCT01265550|463950553|FG001|Pre Randomization|Non-GERD organic disorders|0|||
128906793|NCT01265550|463950554|FG002|Pre Randomization|Non-GERD organic disorders|0|||
128906794|NCT01265550|463950555|FG003|Pre Randomization|Non-GERD organic disorders|23|||
128906795|NCT01265550|463950552|FG000|Pre Randomization|Functional heartburn|0|||
128906796|NCT01265550|463950553|FG001|Pre Randomization|Functional heartburn|0|||
128906797|NCT01265550|463950554|FG002|Pre Randomization|Functional heartburn|0|||
128906798|NCT01265550|463950555|FG003|Pre Randomization|Functional heartburn|99|||
128906799|NCT00623428|463950558|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
128906800|NCT00623428|463950559|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
128906801|NCT00623428|463950558|FG000|Treatment Period|Death|0|||
128906802|NCT00623428|463950559|FG001|Treatment Period|Death|1|||
128906803|NCT00623428|463950558|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
128906804|NCT00623428|463950559|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
128906805|NCT00623428|463950558|FG000|Treatment Period|Insufficient therapeutic response|0|||
128906806|NCT00623428|463950559|FG001|Treatment Period|Insufficient therapeutic response|2|||
128906807|NCT00623428|463950558|FG000|Treatment Period|Other|0|||
128906808|NCT00623428|463950559|FG001|Treatment Period|Other|1|||
128906809|NCT00623428|463950558|FG000|Treatment Period|Withdrawal by Subject|0|||
128906810|NCT00623428|463950559|FG001|Treatment Period|Withdrawal by Subject|1|||
128906811|NCT00623428|463950558|FG000|Follow-up Period|Relapse post-treatment|11|||
128906812|NCT00623428|463950559|FG001|Follow-up Period|Relapse post-treatment|3|||
128906813|NCT00623428|463950558|FG000|Follow-up Period|Failure to return|10|||
128906814|NCT00623428|463950559|FG001|Follow-up Period|Failure to return|2|||
128906815|NCT00623428|463950558|FG000|Follow-up Period|Patient withdrew consent|5|||
128906816|NCT00623428|463950559|FG001|Follow-up Period|Patient withdrew consent|4|||
128906817|NCT00623428|463950558|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
128906818|NCT00623428|463950559|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
128906819|NCT00623428|463950558|FG000|Follow-up Period|Did not cooperate|0|||
128906820|NCT00623428|463950559|FG001|Follow-up Period|Did not cooperate|3|||
128906821|NCT00623428|463950558|FG000|Follow-up Period|Reason not specified|1|||
128906822|NCT00623428|463950559|FG001|Follow-up Period|Reason not specified|1|||
128906823|NCT00623428|463950558|FG000|Follow-up Period|Death|0|||
128906824|NCT00623428|463950559|FG001|Follow-up Period|Death|1|||
128906825|NCT01929408|463950562|FG000|Overall Study|received HCT as initial treatment|8|||
128906826|NCT02788747|463950563|FG000|Overall Study|Adverse Event|1|||
128906827|NCT02788747|463950564|FG001|Overall Study|Adverse Event|0|||
128906828|NCT02788747|463950565|FG002|Overall Study|Adverse Event|0|||
129027443|NCT00112437|464390069|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027444|NCT00112437|464390070|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027445|NCT00112437|464390071|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027446|NCT00112437|464390072|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027447|NCT00112437|464390073|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027448|NCT00112437|464390074|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129116968|NCT00408499|464725241|FG002|Phase II- MTD Expansion|Adverse Event|0|||
129116969|NCT00408499|464725242|FG003|Phase II- MTD Expansion|Adverse Event|0|||
129116970|NCT00408499|464725243|FG004|Phase II- MTD Expansion|Adverse Event|9|||
129116971|NCT00408499|464725239|FG000|Phase II- MTD Expansion|Death|0|||
129116972|NCT00408499|464725240|FG001|Phase II- MTD Expansion|Death|0|||
129116973|NCT00408499|464725241|FG002|Phase II- MTD Expansion|Death|0|||
129116974|NCT00408499|464725242|FG003|Phase II- MTD Expansion|Death|0|||
129116975|NCT00408499|464725243|FG004|Phase II- MTD Expansion|Death|2|||
129116976|NCT00408499|464725239|FG000|Phase II- MTD Expansion|Physician Decision|0|||
129116977|NCT00408499|464725240|FG001|Phase II- MTD Expansion|Physician Decision|0|||
129116978|NCT00408499|464725241|FG002|Phase II- MTD Expansion|Physician Decision|0|||
129116979|NCT00408499|464725242|FG003|Phase II- MTD Expansion|Physician Decision|0|||
129116980|NCT00408499|464725243|FG004|Phase II- MTD Expansion|Physician Decision|1|||
129116981|NCT00408499|464725239|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129116982|NCT00408499|464725240|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129116983|NCT00408499|464725241|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129116984|NCT00408499|464725242|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129116985|NCT00408499|464725243|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
128765174|NCT00979602|463432056|FG001|Overall Study|Migrated/moved from study area|6|||
128906829|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
129027449|NCT00112437|464390075|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
128906830|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
128906831|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
128906832|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
129116986|NCT00408499|464725239|FG000|Phase II- MTD Expansion|treatment delay|0|||
128906833|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
129116987|NCT00408499|464725240|FG001|Phase II- MTD Expansion|treatment delay|0|||
129116988|NCT00408499|464725241|FG002|Phase II- MTD Expansion|treatment delay|0|||
128765175|NCT00979602|463432055|FG000|Overall Study|Others|3|||
128906834|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
128906835|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
129116989|NCT00408499|464725242|FG003|Phase II- MTD Expansion|treatment delay|0|||
129116990|NCT00408499|464725243|FG004|Phase II- MTD Expansion|treatment delay|3|||
129116991|NCT01586195|464725244|FG000|Overall Study|Death|11|||
129116992|NCT01586195|464725244|FG000|Overall Study|Withdrawal of Consent|5|||
129116993|NCT01586195|464725244|FG000|Overall Study|Started new anti-melanoma therapy|1|||
129116994|NCT01586195|464725244|FG000|Overall Study|Reason not specified|9|||
129116995|NCT00997334|464725247|FG000|Overall Study|still on therapy|12|||
129116996|NCT00997334|464725247|FG000|Overall Study|Adverse Event|3|||
129116997|NCT00997334|464725247|FG000|Overall Study|Patient non-compliance|1|||
129116998|NCT00997334|464725247|FG000|Overall Study|Withdrawal by Subject|3|||
129116999|NCT00997334|464725247|FG000|Overall Study|Death|2|||
129117000|NCT00997334|464725247|FG000|Overall Study|Urgent Palliative Care|2|||
129117001|NCT00997334|464725247|FG000|Overall Study|No lesion amenable|1|||
129117002|NCT00997334|464725247|FG000|Overall Study|Ineligible|1|||
129117003|NCT01248455|464725255|FG000|Overall Study|switched to alternate treatment|1|||
129117004|NCT00426270|464725256|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
129117005|NCT00426270|464725256|FG000|Overall Study|Adverse Event|5|||
129117006|NCT01117870|464725258|FG000|Overall Study|Inability to place needle|1|||
128765176|NCT00979602|463432056|FG001|Overall Study|Others|3|||
128765177|NCT01719237|463432057|FG000|Overall Study|Physician Decision|0|||
128765178|NCT01719237|463432058|FG001|Overall Study|Physician Decision|1|||
128765179|NCT02712398|463432059|FG000|Overall Study|Withdrawal by Subject|6|||
128765180|NCT02712398|463432059|FG000|Overall Study|Lost to Follow-up|6|||
128765181|NCT02712398|463432059|FG000|Overall Study|Sponsor Decision|1|||
128765182|NCT02712398|463432059|FG000|Overall Study|Physician Decision|1|||
128765183|NCT02712398|463432059|FG000|Overall Study|Death|2|||
128765184|NCT02712398|463432059|FG000|Overall Study|Re-operation|21|||
128765185|NCT04772053|463432066|FG000|Overall Study|Physician Decision|2|||
128765186|NCT04772053|463432066|FG000|Overall Study|Withdrawal by Subject|3|||
128765187|NCT04772053|463432066|FG000|Overall Study|Study Terminated by Sponsor|1|||
128765188|NCT04599101|463432067|FG000|Overall Study|Lost to Follow-up|5|||
128765189|NCT04599101|463432068|FG001|Overall Study|Lost to Follow-up|5|||
128765190|NCT00098254|463432071|FG000|Overall Study|Adverse Event|2|||
128765191|NCT00098254|463432071|FG000|Overall Study|Death|1|||
128765192|NCT04631705|463432077|FG000|Overall Study|Withdrawal by Subject|0|||
128765193|NCT04631705|463432078|FG001|Overall Study|Withdrawal by Subject|0|||
128765194|NCT04631705|463432079|FG002|Overall Study|Withdrawal by Subject|0|||
128765195|NCT04631705|463432080|FG003|Overall Study|Withdrawal by Subject|0|||
128765196|NCT04631705|463432081|FG004|Overall Study|Withdrawal by Subject|0|||
128765197|NCT04631705|463432082|FG005|Overall Study|Withdrawal by Subject|0|||
128765198|NCT04631705|463432083|FG006|Overall Study|Withdrawal by Subject|1|||
128906836|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
128906837|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
128906838|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
128906839|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
128906840|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
128906841|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
128906842|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
128906843|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
129117007|NCT01117870|464725259|FG001|Overall Study|Inability to place needle|0|||
129117008|NCT00958074|464725260|FG000|Overall Study|Withdrawal by Subject|0|||
129117009|NCT00958074|464725261|FG001|Overall Study|Withdrawal by Subject|1|||
129117010|NCT03102762|464725262|FG000|Overall Study|Lost to Follow-up|1|||
129117011|NCT03102762|464725263|FG001|Overall Study|Lost to Follow-up|0|||
129117012|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
129117013|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129117014|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129117015|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129117016|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129117017|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
129117018|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129117019|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129117020|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129117021|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129117022|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
128765199|NCT04631705|463432084|FG007|Overall Study|Withdrawal by Subject|0|||
128765200|NCT04631705|463432085|FG008|Overall Study|Withdrawal by Subject|0|||
128765201|NCT02130284|463432086|FG000|Overall Study|Withdrawal by Subject|3|||
128765202|NCT02130284|463432086|FG000|Overall Study|Subject Withdrew Consent|1|||
128765203|NCT02130284|463432086|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
128765204|NCT02130284|463432086|FG000|Overall Study|Subject was screened as backup for study|3|||
128765205|NCT02130284|463432086|FG000|Overall Study|Screen Failure|1|||
128765206|NCT00661661|463432087|FG000|Overall Study|Adverse Event|99|||
128906844|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
128906845|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
128906846|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
128906847|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
128906848|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
128906849|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
128906850|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
128906851|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
128906852|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
128906853|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
128906854|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
128906855|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
128906856|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
128906857|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
128906858|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
128906859|NCT00784654|463950566|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
128906860|NCT00784654|463950567|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
128906861|NCT00784654|463950568|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
128906862|NCT00784654|463950566|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
128906863|NCT00784654|463950567|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
128906864|NCT00784654|463950568|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
128906865|NCT00784654|463950566|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
128906866|NCT00784654|463950567|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
128906867|NCT00784654|463950568|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
128906868|NCT00784654|463950566|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128906869|NCT00784654|463950567|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
128906870|NCT00784654|463950568|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
128906871|NCT00784654|463950566|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
128906872|NCT00784654|463950567|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
128906873|NCT00784654|463950568|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
128906874|NCT00784654|463950566|FG000|Randomized Withdrawal Period|Adverse Event|0|||
128906875|NCT00784654|463950567|FG001|Randomized Withdrawal Period|Adverse Event|1|||
128906876|NCT00784654|463950568|FG002|Randomized Withdrawal Period|Adverse Event|1|||
128906877|NCT00784654|463950566|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
128906878|NCT00784654|463950567|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
128906879|NCT00784654|463950568|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
128906880|NCT00784654|463950566|FG000|Randomized Withdrawal Period|Family reasons|0|||
128906881|NCT00784654|463950567|FG001|Randomized Withdrawal Period|Family reasons|0|||
128906882|NCT00784654|463950568|FG002|Randomized Withdrawal Period|Family reasons|1|||
128906883|NCT00262873|463950569|FG000|Overall Study|Adverse Event|3|||
128906884|NCT00262873|463950569|FG000|Overall Study|Withdrawal by Subject|5|||
128906885|NCT00844753|463950570|FG000|Overall Study|Lack of Efficacy|1|||
129117023|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129117024|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129117025|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129117026|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129117027|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
129117028|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129117029|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129117030|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129117031|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129117032|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
129117033|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129117034|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129117035|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129117036|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129117037|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
129117038|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129117039|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129117040|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129117041|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129117042|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
129117043|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129132903|NCT00827242|464778559|FG001|Overall Study|Death|0|||
128906886|NCT00844753|463950571|FG001|Overall Study|Lack of Efficacy|0|||
128906887|NCT00844753|463950572|FG002|Overall Study|Lack of Efficacy|2|||
128906888|NCT00844753|463950573|FG003|Overall Study|Lack of Efficacy|2|||
128906889|NCT00844753|463950570|FG000|Overall Study|Adverse Event|3|||
128906890|NCT00844753|463950571|FG001|Overall Study|Adverse Event|2|||
128906891|NCT00844753|463950572|FG002|Overall Study|Adverse Event|5|||
128906892|NCT00844753|463950573|FG003|Overall Study|Adverse Event|5|||
128906893|NCT00844753|463950570|FG000|Overall Study|Lost to Follow-up|1|||
128906894|NCT00844753|463950571|FG001|Overall Study|Lost to Follow-up|1|||
128906895|NCT00844753|463950572|FG002|Overall Study|Lost to Follow-up|0|||
128906896|NCT00844753|463950573|FG003|Overall Study|Lost to Follow-up|1|||
128906897|NCT00844753|463950570|FG000|Overall Study|could not swallow medication|2|||
128906898|NCT00844753|463950571|FG001|Overall Study|could not swallow medication|0|||
128906899|NCT00844753|463950572|FG002|Overall Study|could not swallow medication|0|||
128906900|NCT00844753|463950573|FG003|Overall Study|could not swallow medication|0|||
128906901|NCT00844753|463950570|FG000|Overall Study|Withdrawal by Subject|1|||
128906902|NCT00844753|463950571|FG001|Overall Study|Withdrawal by Subject|0|||
128906903|NCT00844753|463950572|FG002|Overall Study|Withdrawal by Subject|0|||
128906904|NCT00844753|463950573|FG003|Overall Study|Withdrawal by Subject|3|||
128906905|NCT02425826|463950574|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
128906906|NCT02425826|463950575|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
128906907|NCT02425826|463950576|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
128906908|NCT02425826|463950574|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
128906909|NCT02425826|463950575|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
128906910|NCT02425826|463950576|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
128906911|NCT02425826|463950574|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
128906912|NCT02425826|463950575|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
128906913|NCT02425826|463950576|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
128906914|NCT02425826|463950574|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
128906915|NCT02425826|463950575|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
128906916|NCT02425826|463950576|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
128906917|NCT02425826|463950574|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
128906918|NCT02425826|463950575|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
128906919|NCT02425826|463950576|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
128906920|NCT02425826|463950574|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
128906921|NCT02425826|463950575|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
128906922|NCT02425826|463950576|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
128906923|NCT02425826|463950574|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
128906924|NCT02425826|463950575|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
128906925|NCT02425826|463950576|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
128906926|NCT02425826|463950574|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
128906927|NCT02425826|463950575|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
128906928|NCT02425826|463950576|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
128906929|NCT02425826|463950574|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
128906930|NCT02425826|463950575|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
128906931|NCT02425826|463950576|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
129027450|NCT00112437|464390076|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027451|NCT00112437|464390077|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027452|NCT00112437|464390078|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027453|NCT00112437|464390079|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027454|NCT00112437|464390080|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027455|NCT00112437|464390081|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
128696443|NCT00306189|463185364|FG001|Overall Study|Adverse Event|3|||
128696444|NCT00306189|463185365|FG002|Overall Study|Adverse Event|2|||
128696445|NCT00306189|463185366|FG003|Overall Study|Adverse Event|2|||
128696446|NCT00306189|463185363|FG000|Overall Study|Withdrawal by Subject|4|||
128696447|NCT00306189|463185364|FG001|Overall Study|Withdrawal by Subject|2|||
128696448|NCT00306189|463185365|FG002|Overall Study|Withdrawal by Subject|8|||
128906932|NCT02425826|463950574|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
128906933|NCT02425826|463950575|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
128906934|NCT02425826|463950576|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
128906935|NCT01452152|463950577|FG000|Overall Study|Study termination by sponsor|5|||
128906936|NCT01452152|463950578|FG001|Overall Study|Study termination by sponsor|0|||
128906937|NCT01452152|463950579|FG002|Overall Study|Study termination by sponsor|4|||
128696449|NCT00306189|463185366|FG003|Overall Study|Withdrawal by Subject|1|||
128696450|NCT00306189|463185363|FG000|Overall Study|Ineligibility determined|1|||
128906938|NCT04311502|463951981|FG000|Overall Study|Death|1|||
128906939|NCT04311502|463951982|FG001|Overall Study|Death|1|||
128906940|NCT04311502|463951983|FG002|Overall Study|Death|1|||
128906941|NCT04311502|463951981|FG000|Overall Study|Lost to Follow-up|2|||
128906942|NCT04311502|463951982|FG001|Overall Study|Lost to Follow-up|3|||
128906943|NCT04311502|463951983|FG002|Overall Study|Lost to Follow-up|0|||
128906944|NCT04311502|463951981|FG000|Overall Study|Participant is in prison|1|||
128906945|NCT04311502|463951982|FG001|Overall Study|Participant is in prison|0|||
128906946|NCT04311502|463951983|FG002|Overall Study|Participant is in prison|0|||
128906947|NCT04311502|463951981|FG000|Overall Study|Participant moved out of country|1|||
128906948|NCT04311502|463951982|FG001|Overall Study|Participant moved out of country|0|||
128906949|NCT04311502|463951983|FG002|Overall Study|Participant moved out of country|0|||
128906950|NCT04311502|463951981|FG000|Overall Study|Withdrawal by Subject|2|||
128906951|NCT04311502|463951982|FG001|Overall Study|Withdrawal by Subject|0|||
128906952|NCT04311502|463951983|FG002|Overall Study|Withdrawal by Subject|0|||
128906953|NCT04311502|463951981|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
129117044|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129117045|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129117046|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129117047|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
129117048|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129117049|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129117050|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129117051|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129117052|NCT02709746|464725264|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
129117053|NCT02709746|464725265|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129117054|NCT02709746|464725266|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129117055|NCT02709746|464725267|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129117056|NCT02709746|464725268|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129117057|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
129117058|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
129117059|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
129117060|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
129117061|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
129117062|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
129117063|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
129117064|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
129117065|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
129117066|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
129117067|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
129117068|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
129117069|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
129117070|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
129117071|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
129117072|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
129117073|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
129117074|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
129117075|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
129117076|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
129117077|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
129117078|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
129117079|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
129117080|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
129117081|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
129117082|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
129117083|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
129117084|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
129117085|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
129117086|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
128765207|NCT00661661|463432088|FG001|Overall Study|Adverse Event|24|||
128765208|NCT00661661|463432087|FG000|Overall Study|Lack of Efficacy|3|||
128906954|NCT04311502|463951982|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
129117087|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
128906955|NCT04311502|463951983|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
128906956|NCT03040999|463951984|FG000|Overall Study|Lost to Follow-up|2|||
128906957|NCT03040999|463951985|FG001|Overall Study|Lost to Follow-up|2|||
128906958|NCT03040999|463951984|FG000|Overall Study|Withdrawal by Subject|12|||
128906959|NCT03040999|463951985|FG001|Overall Study|Withdrawal by Subject|13|||
128906960|NCT03040999|463951984|FG000|Overall Study|Death|155|||
128765209|NCT00661661|463432088|FG001|Overall Study|Lack of Efficacy|2|||
129117088|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
129117089|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
129117090|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
129117091|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
129117092|NCT02709746|464725264|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
129117093|NCT02709746|464725265|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
129117094|NCT02709746|464725266|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
129117095|NCT02709746|464725267|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
129117096|NCT02709746|464725268|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
129117097|NCT03322293|464725274|FG000|Overall Study|Lost to Follow-up|0|||
129117098|NCT03322293|464725275|FG001|Overall Study|Lost to Follow-up|0|||
129117099|NCT03322293|464725276|FG002|Overall Study|Lost to Follow-up|1|||
129117100|NCT01178294|464725277|FG000|Overall Study|Adverse Event|4|||
129117101|NCT01178294|464725277|FG000|Overall Study|Lost to Follow-up|2|||
129117102|NCT01178294|464725277|FG000|Overall Study|Lack of Efficacy|1|||
129117103|NCT01178294|464725277|FG000|Overall Study|Death|1|||
129117104|NCT01178294|464725277|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
129117105|NCT01178294|464725277|FG000|Overall Study|Subject status is terminal|1|||
129117106|NCT01178294|464725277|FG000|Overall Study|Completion status could not be verified|1|||
129117107|NCT02089347|464725278|FG000|Overall Study|Protocol Violation|1|||
129117108|NCT02089347|464725279|FG001|Overall Study|Protocol Violation|0|||
129117109|NCT00551369|464725280|FG000|Overall Study|Protocol Violation|5|||
129117110|NCT00551369|464725280|FG000|Overall Study|Withdrawal by Subject|1|||
129117111|NCT00551369|464725280|FG000|Overall Study|Not treated per protocol and re|1|||
129117112|NCT03426345|464725281|FG000|Overall Study|Adverse Event|4|||
129117113|NCT03426345|464725282|FG001|Overall Study|Adverse Event|4|||
129117114|NCT03426345|464725281|FG000|Overall Study|Lack of Efficacy|1|||
129117115|NCT03426345|464725282|FG001|Overall Study|Lack of Efficacy|0|||
129117116|NCT03426345|464725281|FG000|Overall Study|Withdrawal by Subject|5|||
129117117|NCT03426345|464725282|FG001|Overall Study|Withdrawal by Subject|6|||
129117118|NCT03426345|464725281|FG000|Overall Study|Lost to Follow-up|3|||
129117119|NCT03426345|464725282|FG001|Overall Study|Lost to Follow-up|1|||
129117120|NCT03426345|464725281|FG000|Overall Study|Protocol Deviation|3|||
129117121|NCT03426345|464725282|FG001|Overall Study|Protocol Deviation|4|||
129117122|NCT03426345|464725281|FG000|Overall Study|Reason Not Specified|1|||
129117123|NCT03426345|464725282|FG001|Overall Study|Reason Not Specified|2|||
129117124|NCT03426345|464725281|FG000|Overall Study|Missing Completion Status|1|||
129117125|NCT03426345|464725282|FG001|Overall Study|Missing Completion Status|0|||
129117126|NCT02446691|464725283|FG000|Overall Study|Withdrawal by Subject|2|||
129117127|NCT02446691|464725283|FG000|Overall Study|Lost to Follow-up|8|||
129117128|NCT02446691|464725283|FG000|Overall Study|Protocol Violation|1|||
129117129|NCT02497469|464725284|FG000|Overall Study|Randomized but not Treated|0|||
129117130|NCT02497469|464725285|FG001|Overall Study|Randomized but not Treated|2|||
129117131|NCT02497469|464725284|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
129117132|NCT02497469|464725285|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
129117133|NCT02497469|464725284|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
129117134|NCT02497469|464725285|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
129117135|NCT02497469|464725284|FG000|Overall Study|Significant Protocol Deviation|4|||
129117136|NCT02497469|464725285|FG001|Overall Study|Significant Protocol Deviation|5|||
129117137|NCT02497469|464725284|FG000|Overall Study|Lost to Follow-up|14|||
129117138|NCT02497469|464725285|FG001|Overall Study|Lost to Follow-up|4|||
129117139|NCT02497469|464725284|FG000|Overall Study|Voluntary Withdrawal|39|||
129117140|NCT02497469|464725285|FG001|Overall Study|Voluntary Withdrawal|41|||
129117141|NCT02497469|464725284|FG000|Overall Study|Pregnancy|1|||
129117142|NCT02497469|464725285|FG001|Overall Study|Pregnancy|1|||
129117143|NCT02497469|464725284|FG000|Overall Study|Lack of Efficacy|86|||
129117144|NCT02497469|464725285|FG001|Overall Study|Lack of Efficacy|40|||
129117145|NCT02497469|464725284|FG000|Overall Study|Reason not Specified|6|||
129117146|NCT02497469|464725285|FG001|Overall Study|Reason not Specified|6|||
129117147|NCT02674516|464725287|FG000|Overall Study|Lost to Follow-up|3|||
129117148|NCT02674516|464725288|FG001|Overall Study|Lost to Follow-up|0|||
129117149|NCT02674516|464725287|FG000|Overall Study|Protocol Violation|0|||
129117150|NCT02674516|464725288|FG001|Overall Study|Protocol Violation|4|||
128696451|NCT00306189|463185364|FG001|Overall Study|Ineligibility determined|1|||
129117151|NCT02674516|464725287|FG000|Overall Study|Knowledge of study hypothesis|1|||
129117152|NCT02674516|464725288|FG001|Overall Study|Knowledge of study hypothesis|0|||
128696452|NCT00306189|463185365|FG002|Overall Study|Ineligibility determined|1|||
129117153|NCT01026493|464725289|FG000|Overall Study|Protocol Violation|0|||
129117154|NCT01026493|464725290|FG001|Overall Study|Protocol Violation|1|||
129117155|NCT01026493|464725291|FG002|Overall Study|Protocol Violation|0|||
129117156|NCT01026493|464725292|FG003|Overall Study|Protocol Violation|0|||
129117157|NCT01026493|464725293|FG004|Overall Study|Protocol Violation|2|||
129117158|NCT01026493|464725294|FG005|Overall Study|Protocol Violation|3|||
129117159|NCT01026493|464725295|FG006|Overall Study|Protocol Violation|4|||
129117160|NCT01026493|464725296|FG007|Overall Study|Protocol Violation|1|||
129117161|NCT02662569|464725298|FG000|Overall Study|Withdrawal by Subject|6|||
128906961|NCT03040999|463951985|FG001|Overall Study|Death|171|||
128906962|NCT03040999|463951984|FG000|Overall Study|Physician Decision|0|||
128906963|NCT03040999|463951985|FG001|Overall Study|Physician Decision|3|||
128906964|NCT03657043|463951986|FG000|Overall Study|Withdrawal by Subject|1|||
128906965|NCT03657043|463951987|FG001|Overall Study|Withdrawal by Subject|1|||
128906966|NCT03657043|463951988|FG002|Overall Study|Withdrawal by Subject|0|||
128906967|NCT03657043|463951989|FG003|Overall Study|Withdrawal by Subject|0|||
128906968|NCT03657043|463951990|FG004|Overall Study|Withdrawal by Subject|4|||
128906969|NCT03657043|463951986|FG000|Overall Study|Study closure by Sponsor|0|||
128906970|NCT03657043|463951987|FG001|Overall Study|Study closure by Sponsor|2|||
129117162|NCT02662569|464725299|FG001|Overall Study|Withdrawal by Subject|1|||
129117163|NCT02662569|464725300|FG002|Overall Study|Withdrawal by Subject|6|||
129117164|NCT02662569|464725301|FG003|Overall Study|Withdrawal by Subject|4|||
129117165|NCT02662569|464725298|FG000|Overall Study|Lost to Follow-up|1|||
129117166|NCT02662569|464725299|FG001|Overall Study|Lost to Follow-up|0|||
129117167|NCT02662569|464725300|FG002|Overall Study|Lost to Follow-up|0|||
129117168|NCT02662569|464725301|FG003|Overall Study|Lost to Follow-up|0|||
129117169|NCT04076917|464725302|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
129117170|NCT04076917|464725302|FG000|Overall Study|Study closure|13|||
129117171|NCT04076917|464725302|FG000|Overall Study|Physician Decision|3|||
129117172|NCT04076917|464725302|FG000|Overall Study|Death|1|||
129117173|NCT04076917|464725302|FG000|Overall Study|Lost to Follow-up|1|||
129117174|NCT04076917|464725302|FG000|Overall Study|Withdrawal by Subject|1|||
129117175|NCT04076917|464725302|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
129117176|NCT00630916|464725306|FG000|Overall Study|Death|110|||
129117177|NCT00630916|464725306|FG000|Overall Study|Explant|8|||
129117178|NCT00630916|464725306|FG000|Overall Study|Lost to Follow-up|5|||
129117179|NCT00630916|464725306|FG000|Overall Study|Withdrawal by Subject|30|||
129117180|NCT00630916|464725306|FG000|Overall Study|Protocol Violation|7|||
129117181|NCT00630916|464725306|FG000|Overall Study|Physician Decision|47|||
129117182|NCT00630916|464725306|FG000|Overall Study|Lack of Efficacy|3|||
129117183|NCT05412134|464725313|FG000|Overall Study|Lost to Follow-up|2|||
129117184|NCT05412134|464725314|FG001|Overall Study|Lost to Follow-up|0|||
129117185|NCT03167242|464725315|FG000|Overall Study|Patient/Guardian Decision|0|||
129117186|NCT03167242|464725316|FG001|Overall Study|Patient/Guardian Decision|1|||
129117187|NCT03167242|464725317|FG002|Overall Study|Patient/Guardian Decision|2|||
129117188|NCT03167242|464725318|FG003|Overall Study|Patient/Guardian Decision|1|||
129117189|NCT03167242|464725319|FG004|Overall Study|Patient/Guardian Decision|1|||
129117190|NCT03167242|464725320|FG005|Overall Study|Patient/Guardian Decision|1|||
128906971|NCT03657043|463951988|FG002|Overall Study|Study closure by Sponsor|0|||
129027456|NCT00112437|464390082|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027457|NCT00112437|464390083|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027458|NCT00112437|464390084|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027459|NCT00112437|464390085|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027460|NCT00112437|464390086|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027461|NCT00112437|464390087|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027462|NCT00112437|464390088|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
129027463|NCT00112437|464390089|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027464|NCT00112437|464390090|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129027465|NCT00112437|464390065|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027466|NCT00112437|464390066|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027467|NCT00112437|464390067|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027468|NCT00112437|464390068|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027469|NCT00112437|464390069|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027470|NCT00112437|464390070|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027471|NCT00112437|464390071|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027472|NCT00112437|464390072|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027473|NCT00112437|464390073|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027474|NCT00112437|464390074|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027475|NCT00112437|464390075|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027476|NCT00112437|464390076|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027477|NCT00112437|464390077|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027478|NCT00112437|464390078|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129117191|NCT03167242|464725321|FG006|Overall Study|Patient/Guardian Decision|0|||
129117192|NCT03167242|464725322|FG007|Overall Study|Patient/Guardian Decision|0|||
129117193|NCT03167242|464725323|FG008|Overall Study|Patient/Guardian Decision|0|||
129117194|NCT03167242|464725324|FG009|Overall Study|Patient/Guardian Decision|0|||
129117195|NCT03167242|464725325|FG010|Overall Study|Patient/Guardian Decision|1|||
129117196|NCT03167242|464725326|FG011|Overall Study|Patient/Guardian Decision|0|||
128906972|NCT03657043|463951989|FG003|Overall Study|Study closure by Sponsor|0|||
128906973|NCT03657043|463951990|FG004|Overall Study|Study closure by Sponsor|17|||
129117197|NCT03167242|464725315|FG000|Overall Study|Lost to Follow-up|0|||
129117198|NCT03167242|464725316|FG001|Overall Study|Lost to Follow-up|0|||
128696453|NCT00306189|463185366|FG003|Overall Study|Ineligibility determined|1|||
128906974|NCT03657043|463951986|FG000|Overall Study|Lost to Follow-up|0|||
128906975|NCT03657043|463951987|FG001|Overall Study|Lost to Follow-up|0|||
128906976|NCT03657043|463951988|FG002|Overall Study|Lost to Follow-up|0|||
128906977|NCT03657043|463951989|FG003|Overall Study|Lost to Follow-up|0|||
128906978|NCT03657043|463951990|FG004|Overall Study|Lost to Follow-up|4|||
128906979|NCT03657043|463951986|FG000|Overall Study|Death|6|||
128906980|NCT03657043|463951987|FG001|Overall Study|Death|5|||
128906981|NCT03657043|463951988|FG002|Overall Study|Death|0|||
128906982|NCT03657043|463951989|FG003|Overall Study|Death|0|||
128906983|NCT03657043|463951990|FG004|Overall Study|Death|53|||
128906984|NCT03657043|463951986|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
128906985|NCT03657043|463951987|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
128906986|NCT03657043|463951988|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
128906987|NCT03657043|463951989|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
128696454|NCT00306189|463185363|FG000|Overall Study|Other|1|||
128696455|NCT00306189|463185364|FG001|Overall Study|Other|0|||
128906988|NCT03657043|463951990|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
128906989|NCT03657043|463951986|FG000|Overall Study|Adverse Event|0|||
128906990|NCT03657043|463951987|FG001|Overall Study|Adverse Event|0|||
128906991|NCT03657043|463951988|FG002|Overall Study|Adverse Event|0|||
128906992|NCT03657043|463951989|FG003|Overall Study|Adverse Event|0|||
128906993|NCT03657043|463951990|FG004|Overall Study|Adverse Event|2|||
128906994|NCT03657043|463951986|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
128906995|NCT03657043|463951987|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
128906996|NCT03657043|463951988|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
128906997|NCT03657043|463951989|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
128906998|NCT03657043|463951990|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
128906999|NCT03657043|463951986|FG000|Overall Study|Withdrawal - declined follow-up|0|||
128907000|NCT03657043|463951987|FG001|Overall Study|Withdrawal - declined follow-up|0|||
128907001|NCT03657043|463951988|FG002|Overall Study|Withdrawal - declined follow-up|0|||
128907002|NCT03657043|463951989|FG003|Overall Study|Withdrawal - declined follow-up|0|||
128907003|NCT03657043|463951990|FG004|Overall Study|Withdrawal - declined follow-up|1|||
128907004|NCT02627495|463951993|FG000|Overall Study|Withdrawal by Subject|4|||
128907005|NCT01736579|463951994|FG000|Overall Study|Termination of Study by Sponsor|2|||
128907006|NCT01736579|463951995|FG001|Overall Study|Termination of Study by Sponsor|2|||
128907007|NCT02543528|463952003|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
128907008|NCT02543528|463952004|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
128907009|NCT02543528|463952005|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
128907010|NCT02543528|463952006|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
128907011|NCT02543528|463952007|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
128907012|NCT02543528|463952003|FG000|Adaptation Period|Lens Handling Difficultes|0|||
128907013|NCT02543528|463952004|FG001|Adaptation Period|Lens Handling Difficultes|0|||
129027479|NCT00112437|464390079|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027480|NCT00112437|464390080|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027481|NCT00112437|464390081|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027482|NCT00112437|464390082|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027483|NCT00112437|464390083|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027484|NCT00112437|464390084|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027485|NCT00112437|464390085|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027486|NCT00112437|464390086|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027487|NCT00112437|464390087|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
129027488|NCT00112437|464390088|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
129027489|NCT00112437|464390089|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129027490|NCT00112437|464390090|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
129027491|NCT03541252|464390091|FG000|Overall Study|Withdrawal by Subject|1|||
129027492|NCT00227370|464390092|FG000|Overall Study|Withdrawal by Subject|1|||
129027493|NCT00227370|464390093|FG001|Overall Study|Withdrawal by Subject|2|||
129027494|NCT00227370|464390092|FG000|Overall Study|Death|3|||
129027495|NCT00227370|464390093|FG001|Overall Study|Death|4|||
129027496|NCT00227370|464390092|FG000|Overall Study|Adverse Event|6|||
129027497|NCT00227370|464390093|FG001|Overall Study|Adverse Event|11|||
129027498|NCT00227370|464390092|FG000|Overall Study|Physician Decision|9|||
129027499|NCT00227370|464390093|FG001|Overall Study|Physician Decision|6|||
129027500|NCT00227370|464390092|FG000|Overall Study|Other reasons|2|||
129027501|NCT00227370|464390093|FG001|Overall Study|Other reasons|1|||
129027502|NCT03846193|464390094|FG000|Overall Study|Physician Decision|0|||
129027503|NCT03846193|464390095|FG001|Overall Study|Physician Decision|0|||
129027504|NCT03846193|464390096|FG002|Overall Study|Physician Decision|1|||
128696456|NCT00306189|463185365|FG002|Overall Study|Other|0|||
128907014|NCT02543528|463952005|FG002|Adaptation Period|Lens Handling Difficultes|0|||
129027505|NCT03846193|464390097|FG003|Overall Study|Physician Decision|0|||
129027506|NCT03846193|464390098|FG004|Overall Study|Physician Decision|0|||
129027507|NCT03846193|464390094|FG000|Overall Study|Lost to Follow-up|0|||
128907015|NCT02543528|463952006|FG003|Adaptation Period|Lens Handling Difficultes|0|||
128907016|NCT02543528|463952007|FG004|Adaptation Period|Lens Handling Difficultes|8|||
128907017|NCT02543528|463952003|FG000|Adaptation Period|Lost to Follow-up|0|||
128696457|NCT00306189|463185366|FG003|Overall Study|Other|0|||
128907018|NCT02543528|463952004|FG001|Adaptation Period|Lost to Follow-up|0|||
128907019|NCT02543528|463952005|FG002|Adaptation Period|Lost to Follow-up|0|||
128907020|NCT02543528|463952006|FG003|Adaptation Period|Lost to Follow-up|0|||
128907021|NCT02543528|463952007|FG004|Adaptation Period|Lost to Follow-up|14|||
128907022|NCT02543528|463952003|FG000|Adaptation Period|Adverse Event|0|||
128907023|NCT02543528|463952004|FG001|Adaptation Period|Adverse Event|0|||
128907024|NCT02543528|463952005|FG002|Adaptation Period|Adverse Event|0|||
128907025|NCT02543528|463952006|FG003|Adaptation Period|Adverse Event|0|||
128907026|NCT02543528|463952007|FG004|Adaptation Period|Adverse Event|2|||
128907027|NCT02543528|463952003|FG000|Extended Wear Period|Adverse Event|17|||
128907028|NCT02543528|463952004|FG001|Extended Wear Period|Adverse Event|11|||
128907029|NCT02543528|463952005|FG002|Extended Wear Period|Adverse Event|16|||
128907030|NCT02543528|463952006|FG003|Extended Wear Period|Adverse Event|3|||
128907031|NCT02543528|463952007|FG004|Extended Wear Period|Adverse Event|0|||
128907032|NCT02543528|463952003|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
128907033|NCT02543528|463952004|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
128907034|NCT02543528|463952005|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
128907035|NCT02543528|463952006|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
128907036|NCT02543528|463952007|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
128907037|NCT02543528|463952003|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
128907038|NCT02543528|463952004|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
128907039|NCT02543528|463952005|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
128907040|NCT02543528|463952006|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
128907041|NCT02543528|463952007|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
128907042|NCT02543528|463952003|FG000|Extended Wear Period|Lost to Follow-up|0|||
128907043|NCT02543528|463952004|FG001|Extended Wear Period|Lost to Follow-up|1|||
128907044|NCT02543528|463952005|FG002|Extended Wear Period|Lost to Follow-up|2|||
128907045|NCT02543528|463952006|FG003|Extended Wear Period|Lost to Follow-up|1|||
128907046|NCT02543528|463952007|FG004|Extended Wear Period|Lost to Follow-up|0|||
128907047|NCT02543528|463952003|FG000|Extended Wear Period|Withdrawal by Subject|10|||
128907048|NCT02543528|463952004|FG001|Extended Wear Period|Withdrawal by Subject|9|||
128907049|NCT02543528|463952005|FG002|Extended Wear Period|Withdrawal by Subject|4|||
128907050|NCT02543528|463952006|FG003|Extended Wear Period|Withdrawal by Subject|5|||
128907051|NCT02543528|463952007|FG004|Extended Wear Period|Withdrawal by Subject|0|||
128907052|NCT02049944|463952008|FG000|Overall Study|Protocol Violation|2|||
128907053|NCT01408147|463952009|FG000|Overall Study|Withdrawal by Subject|0|||
128696458|NCT00945893|463185367|FG000|Overall Study|Lost to Follow-up|2|||
128696459|NCT00945893|463185368|FG001|Overall Study|Lost to Follow-up|8|||
129027508|NCT03846193|464390095|FG001|Overall Study|Lost to Follow-up|0|||
129027509|NCT03846193|464390096|FG002|Overall Study|Lost to Follow-up|0|||
129027510|NCT03846193|464390097|FG003|Overall Study|Lost to Follow-up|0|||
129027511|NCT03846193|464390098|FG004|Overall Study|Lost to Follow-up|1|||
129027512|NCT03846193|464390094|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129027513|NCT03846193|464390095|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129027514|NCT03846193|464390096|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129027515|NCT03846193|464390097|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
129027516|NCT03846193|464390098|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129027517|NCT02588339|464390100|FG000|Overall Study|Withdrawal by Subject|1|||
129027518|NCT02588339|464390100|FG000|Overall Study|GVHD Progression prior to treatment|2|||
129027519|NCT00660660|464391676|FG000|Overall Study|Adverse Event|1|||
129027520|NCT00660660|464391677|FG001|Overall Study|Adverse Event|0|||
129027521|NCT00660660|464391676|FG000|Overall Study|Lost to Follow-up|0|||
129027522|NCT00660660|464391677|FG001|Overall Study|Lost to Follow-up|6|||
129027523|NCT00660660|464391676|FG000|Overall Study|Lack of Efficacy|0|||
129027524|NCT00660660|464391677|FG001|Overall Study|Lack of Efficacy|2|||
129027525|NCT00660660|464391676|FG000|Overall Study|Withdrawal by Subject|3|||
129027526|NCT00660660|464391677|FG001|Overall Study|Withdrawal by Subject|0|||
129027527|NCT00660660|464391676|FG000|Overall Study|Incorrect enrollment and other|0|||
129027528|NCT00660660|464391677|FG001|Overall Study|Incorrect enrollment and other|1|||
129027529|NCT00660660|464391676|FG000|Overall Study|New medication after randomization|1|||
129027530|NCT00660660|464391677|FG001|Overall Study|New medication after randomization|0|||
129027531|NCT01701063|464391682|FG000|Overall Study|Lost to Follow-up|0|||
129117199|NCT03167242|464725317|FG002|Overall Study|Lost to Follow-up|1|||
129117200|NCT03167242|464725318|FG003|Overall Study|Lost to Follow-up|0|||
128696460|NCT00945893|463185367|FG000|Overall Study|Withdrawal of consent|1|||
128907054|NCT01408147|463952010|FG001|Overall Study|Withdrawal by Subject|1|||
128907055|NCT01765673|463952011|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
128907056|NCT01042600|463952012|FG000|Overall Study|Ineligible|1|||
129027532|NCT01701063|464391683|FG001|Overall Study|Lost to Follow-up|1|||
129117201|NCT03167242|464725319|FG004|Overall Study|Lost to Follow-up|0|||
128907057|NCT01042600|463952013|FG001|Overall Study|Ineligible|0|||
128907058|NCT04541004|463952014|FG000|Overall Study|Adverse Event|2|||
128907059|NCT05048719|463952015|FG000|Overall Study|Withdrawal by Subject|2|||
128907060|NCT05048719|463952016|FG001|Overall Study|Withdrawal by Subject|1|||
128907061|NCT05048719|463952017|FG002|Overall Study|Withdrawal by Subject|3|||
128907062|NCT05048719|463952018|FG003|Overall Study|Withdrawal by Subject|1|||
129117202|NCT03167242|464725320|FG005|Overall Study|Lost to Follow-up|1|||
129117203|NCT03167242|464725321|FG006|Overall Study|Lost to Follow-up|2|||
129117204|NCT03167242|464725322|FG007|Overall Study|Lost to Follow-up|1|||
129117205|NCT03167242|464725323|FG008|Overall Study|Lost to Follow-up|0|||
129117206|NCT03167242|464725324|FG009|Overall Study|Lost to Follow-up|0|||
129117207|NCT03167242|464725325|FG010|Overall Study|Lost to Follow-up|1|||
129117208|NCT03167242|464725326|FG011|Overall Study|Lost to Follow-up|1|||
129117209|NCT03167242|464725315|FG000|Overall Study|Reason not provided|0|||
128907063|NCT05048719|463952019|FG004|Overall Study|Withdrawal by Subject|0|||
128907064|NCT05048719|463952020|FG005|Overall Study|Withdrawal by Subject|2|||
128907065|NCT05048719|463952021|FG006|Overall Study|Withdrawal by Subject|1|||
128907066|NCT05048719|463952022|FG007|Overall Study|Withdrawal by Subject|1|||
128907067|NCT05048719|463952023|FG008|Overall Study|Withdrawal by Subject|0|||
128907068|NCT05048719|463952015|FG000|Overall Study|Death|1|||
128907069|NCT05048719|463952016|FG001|Overall Study|Death|0|||
128907070|NCT05048719|463952017|FG002|Overall Study|Death|0|||
128907071|NCT05048719|463952018|FG003|Overall Study|Death|0|||
128907072|NCT05048719|463952019|FG004|Overall Study|Death|0|||
128907073|NCT05048719|463952020|FG005|Overall Study|Death|0|||
128907074|NCT05048719|463952021|FG006|Overall Study|Death|0|||
129027533|NCT01701063|464391684|FG002|Overall Study|Lost to Follow-up|0|||
129027534|NCT01701063|464391682|FG000|Overall Study|Withdrawal by Subject|0|||
129027535|NCT01701063|464391683|FG001|Overall Study|Withdrawal by Subject|0|||
129027536|NCT01701063|464391684|FG002|Overall Study|Withdrawal by Subject|1|||
129027537|NCT01701063|464391682|FG000|Overall Study|Other|0|||
128907075|NCT05048719|463952022|FG007|Overall Study|Death|0|||
128907076|NCT05048719|463952023|FG008|Overall Study|Death|0|||
129027538|NCT01701063|464391683|FG001|Overall Study|Other|0|||
129027539|NCT01701063|464391684|FG002|Overall Study|Other|1|||
129027540|NCT02043132|464391685|FG000|Overall Study|Lost to Follow-up|1|||
129027541|NCT02043132|464391686|FG001|Overall Study|Lost to Follow-up|1|||
129027542|NCT02043132|464391685|FG000|Overall Study|screen failures|4|||
129027543|NCT02043132|464391686|FG001|Overall Study|screen failures|8|||
129027544|NCT03827395|464391687|FG000|Overall Study|Lost to Follow-up|1|||
129027545|NCT03827395|464391688|FG001|Overall Study|Lost to Follow-up|0|||
129027546|NCT03827395|464391687|FG000|Overall Study|Protocol Violation|1|||
129027547|NCT03827395|464391688|FG001|Overall Study|Protocol Violation|0|||
129027548|NCT03827395|464391687|FG000|Overall Study|Became ineligible after enrollment|1|||
129027549|NCT03827395|464391688|FG001|Overall Study|Became ineligible after enrollment|2|||
129027550|NCT00294047|464391689|FG000|Month 48|Adverse Event|28|||
129027551|NCT00294047|464391690|FG001|Month 48|Adverse Event|13|||
129027552|NCT00294047|464391689|FG000|Month 48|Protocol Violation|4|||
129027553|NCT00294047|464391690|FG001|Month 48|Protocol Violation|4|||
129027554|NCT00294047|464391689|FG000|Month 48|Withdrawal by Subject|111|||
129027555|NCT00294047|464391690|FG001|Month 48|Withdrawal by Subject|115|||
129027556|NCT00294047|464391689|FG000|Month 48|Lost to Follow-up|272|||
129027557|NCT00294047|464391690|FG001|Month 48|Lost to Follow-up|287|||
129027558|NCT00294047|464391689|FG000|Month 48|Other|10|||
129027559|NCT00294047|464391690|FG001|Month 48|Other|14|||
129027560|NCT00294047|464391689|FG000|Month 84|Adverse Event|4|||
129027561|NCT00294047|464391690|FG001|Month 84|Adverse Event|2|||
129027562|NCT00294047|464391689|FG000|Month 84|Protocol Violation|1|||
129027563|NCT00294047|464391690|FG001|Month 84|Protocol Violation|1|||
129027564|NCT00294047|464391689|FG000|Month 84|Withdrawal by Subject|33|||
129027565|NCT00294047|464391690|FG001|Month 84|Withdrawal by Subject|31|||
129027566|NCT00294047|464391689|FG000|Month 84|Lost to Follow-up|187|||
129027567|NCT00294047|464391690|FG001|Month 84|Lost to Follow-up|190|||
129027568|NCT00294047|464391689|FG000|Month 84|Absent Cervix|2|||
129027569|NCT00294047|464391690|FG001|Month 84|Absent Cervix|0|||
129027570|NCT00294047|464391689|FG000|Month 84|Work related reasons|4|||
129027571|NCT00294047|464391690|FG001|Month 84|Work related reasons|2|||
129027572|NCT00294047|464391689|FG000|Month 84|Center closed, subject did not transfer|1|||
129027573|NCT00294047|464391690|FG001|Month 84|Center closed, subject did not transfer|0|||
129027574|NCT00294047|464391689|FG000|Month 84|Family problems|2|||
129027575|NCT00294047|464391690|FG001|Month 84|Family problems|2|||
129117210|NCT03167242|464725316|FG001|Overall Study|Reason not provided|0|||
129027576|NCT00294047|464391689|FG000|Month 84|Lack of time|3|||
129027577|NCT00294047|464391690|FG001|Month 84|Lack of time|1|||
129117211|NCT03167242|464725317|FG002|Overall Study|Reason not provided|0|||
129117212|NCT03167242|464725318|FG003|Overall Study|Reason not provided|0|||
128907077|NCT05048719|463952015|FG000|Overall Study|Adverse Event|0|||
128907078|NCT05048719|463952016|FG001|Overall Study|Adverse Event|1|||
128907079|NCT05048719|463952017|FG002|Overall Study|Adverse Event|2|||
128907080|NCT05048719|463952018|FG003|Overall Study|Adverse Event|0|||
129027578|NCT00294047|464391689|FG000|Month 84|Personal reason|2|||
129027579|NCT00294047|464391690|FG001|Month 84|Personal reason|4|||
129117213|NCT03167242|464725319|FG004|Overall Study|Reason not provided|0|||
129117214|NCT03167242|464725320|FG005|Overall Study|Reason not provided|0|||
129117215|NCT03167242|464725321|FG006|Overall Study|Reason not provided|0|||
129117216|NCT03167242|464725322|FG007|Overall Study|Reason not provided|0|||
129117217|NCT03167242|464725323|FG008|Overall Study|Reason not provided|1|||
129117218|NCT03167242|464725324|FG009|Overall Study|Reason not provided|0|||
129117219|NCT03167242|464725325|FG010|Overall Study|Reason not provided|0|||
129117220|NCT03167242|464725326|FG011|Overall Study|Reason not provided|0|||
129117221|NCT05401565|464725331|FG000|Overall Study|Lost to Follow-up|1|||
129117222|NCT05401565|464725332|FG001|Overall Study|Lost to Follow-up|0|||
129117223|NCT05401565|464725331|FG000|Overall Study|Adverse Event|2|||
129117224|NCT05401565|464725332|FG001|Overall Study|Adverse Event|0|||
129117225|NCT00726609|464725335|FG000|Overall Study|Adverse Event|10|||
129117226|NCT00726609|464725335|FG000|Overall Study|Withdrawal by Subject|2|||
129117227|NCT00726609|464725335|FG000|Overall Study|Lack of Efficacy|25|||
129117228|NCT00726609|464725335|FG000|Overall Study|Other|16|||
129117229|NCT00726609|464725335|FG000|Overall Study|Missing|42|||
129117230|NCT00726609|464725335|FG000|Overall Study|Other|3|||
129117231|NCT03080935|464725345|FG000|Overall Study|Death|34|||
129117232|NCT03080935|464725346|FG001|Overall Study|Death|50|||
129117233|NCT03080935|464725345|FG000|Overall Study|Lost to Follow-up|5|||
129117234|NCT03080935|464725346|FG001|Overall Study|Lost to Follow-up|4|||
129117235|NCT03080935|464725345|FG000|Overall Study|Withdrawal by Subject|11|||
129117236|NCT03080935|464725346|FG001|Overall Study|Withdrawal by Subject|15|||
129117237|NCT02175121|464725347|FG000|Overall Study|Lack of Efficacy|1|||
129117238|NCT02175121|464725348|FG001|Overall Study|Lack of Efficacy|0|||
129117239|NCT02175121|464725349|FG002|Overall Study|Lack of Efficacy|0|||
129117240|NCT02175121|464725350|FG003|Overall Study|Lack of Efficacy|0|||
129117241|NCT02175121|464725351|FG004|Overall Study|Lack of Efficacy|0|||
129117242|NCT02175121|464725347|FG000|Overall Study|Lost to Follow-up|0|||
129117243|NCT02175121|464725348|FG001|Overall Study|Lost to Follow-up|1|||
129117244|NCT02175121|464725349|FG002|Overall Study|Lost to Follow-up|0|||
129117245|NCT02175121|464725350|FG003|Overall Study|Lost to Follow-up|1|||
129117246|NCT02175121|464725351|FG004|Overall Study|Lost to Follow-up|0|||
129117247|NCT02175121|464725347|FG000|Overall Study|Personal emergency|0|||
129117248|NCT02175121|464725348|FG001|Overall Study|Personal emergency|0|||
129117249|NCT02175121|464725349|FG002|Overall Study|Personal emergency|0|||
129117250|NCT02175121|464725350|FG003|Overall Study|Personal emergency|0|||
129117251|NCT02175121|464725351|FG004|Overall Study|Personal emergency|1|||
129117252|NCT02175121|464725347|FG000|Overall Study|Schedule conflict|0|||
129117253|NCT02175121|464725348|FG001|Overall Study|Schedule conflict|0|||
129117254|NCT02175121|464725349|FG002|Overall Study|Schedule conflict|1|||
129117255|NCT02175121|464725350|FG003|Overall Study|Schedule conflict|0|||
129117256|NCT02175121|464725351|FG004|Overall Study|Schedule conflict|0|||
129117257|NCT02175121|464725347|FG000|Overall Study|Time issues|0|||
129117258|NCT02175121|464725348|FG001|Overall Study|Time issues|0|||
129117259|NCT02175121|464725349|FG002|Overall Study|Time issues|1|||
129117260|NCT02175121|464725350|FG003|Overall Study|Time issues|0|||
129117261|NCT02175121|464725351|FG004|Overall Study|Time issues|0|||
129117262|NCT03329885|464725352|FG000|Overall Study|Sponsor discontinued the study early|0|||
129117263|NCT03329885|464725353|FG001|Overall Study|Sponsor discontinued the study early|0|||
129117264|NCT03329885|464725354|FG002|Overall Study|Sponsor discontinued the study early|0|||
129117265|NCT03329885|464725355|FG003|Overall Study|Sponsor discontinued the study early|0|||
129117266|NCT03329885|464725356|FG004|Overall Study|Sponsor discontinued the study early|0|||
129117267|NCT03329885|464725357|FG005|Overall Study|Sponsor discontinued the study early|0|||
129117268|NCT03329885|464725358|FG006|Overall Study|Sponsor discontinued the study early|1|||
129117269|NCT03329885|464725359|FG007|Overall Study|Sponsor discontinued the study early|1|||
129117270|NCT03329885|464725360|FG008|Overall Study|Sponsor discontinued the study early|0|||
129117271|NCT00269152|464725367|FG000|Overall Study|Adverse Event|9|||
129117272|NCT00269152|464725368|FG001|Overall Study|Adverse Event|3|||
129117273|NCT00269152|464725367|FG000|Overall Study|Withdrawal by Subject|7|||
129117274|NCT00269152|464725368|FG001|Overall Study|Withdrawal by Subject|3|||
129117275|NCT00269152|464725367|FG000|Overall Study|Physician Decision|2|||
129117276|NCT00269152|464725368|FG001|Overall Study|Physician Decision|3|||
129117277|NCT00269152|464725367|FG000|Overall Study|Protocol Violation|0|||
129117278|NCT00269152|464725368|FG001|Overall Study|Protocol Violation|1|||
129117279|NCT03886272|464725369|FG000|Period 1|Withdrawal by Subject|0|||
129117280|NCT03886272|464725370|FG001|Period 1|Withdrawal by Subject|0|||
129117281|NCT03886272|464725371|FG002|Period 1|Withdrawal by Subject|0|||
129117282|NCT03886272|464725372|FG003|Period 1|Withdrawal by Subject|0|||
129117283|NCT03886272|464725373|FG004|Period 1|Withdrawal by Subject|0|||
129117284|NCT03886272|464725374|FG005|Period 1|Withdrawal by Subject|1|||
129117285|NCT03886272|464725375|FG006|Period 1|Withdrawal by Subject|0|||
129117286|NCT02557399|464725376|FG000|Overall Study|Adverse Event|6|||
129117287|NCT02557399|464725377|FG001|Overall Study|Adverse Event|5|||
129117288|NCT02557399|464725376|FG000|Overall Study|Protocol Violation|0|||
129117289|NCT02557399|464725377|FG001|Overall Study|Protocol Violation|1|||
129117290|NCT02557399|464725376|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129117291|NCT02557399|464725377|FG001|Overall Study|Protocol-defined stopping criteria|1|||
128907081|NCT05048719|463952019|FG004|Overall Study|Adverse Event|1|||
128907082|NCT05048719|463952020|FG005|Overall Study|Adverse Event|0|||
128907083|NCT05048719|463952021|FG006|Overall Study|Adverse Event|0|||
128907084|NCT05048719|463952022|FG007|Overall Study|Adverse Event|0|||
128907085|NCT05048719|463952023|FG008|Overall Study|Adverse Event|0|||
129027580|NCT00294047|464391689|FG000|Month 84|Subject does not want male physician|1|||
129027581|NCT00294047|464391690|FG001|Month 84|Subject does not want male physician|0|||
129027582|NCT00294047|464391689|FG000|Month 84|Transport reimbursement delayed|0|||
129027583|NCT00294047|464391690|FG001|Month 84|Transport reimbursement delayed|1|||
129027584|NCT00294047|464391689|FG000|Month 84|Unable to reach study site|1|||
129027585|NCT00294047|464391690|FG001|Month 84|Unable to reach study site|0|||
129027586|NCT00294047|464391689|FG000|Month 84|Under investigation locally|1|||
129027587|NCT00294047|464391690|FG001|Month 84|Under investigation locally|0|||
129027588|NCT00294047|464391689|FG000|Month 84|Visit missed|0|||
129027589|NCT00294047|464391690|FG001|Month 84|Visit missed|1|||
129027590|NCT00294047|464391689|FG000|Month 84|No consent for Month 84 Follow-up|731|||
129027591|NCT00294047|464391690|FG001|Month 84|No consent for Month 84 Follow-up|754|||
129027592|NCT02157974|464391691|FG000|Overall Study|Withdrawal by Subject|0|||
129027593|NCT02157974|464391692|FG001|Overall Study|Withdrawal by Subject|1|||
129027594|NCT02157974|464391693|FG002|Overall Study|Withdrawal by Subject|0|||
129027595|NCT02157974|464391694|FG003|Overall Study|Withdrawal by Subject|0|||
129027596|NCT02157974|464391695|FG004|Overall Study|Withdrawal by Subject|0|||
129027597|NCT02157974|464391691|FG000|Overall Study|Screen Failure|0|||
129027598|NCT02157974|464391692|FG001|Overall Study|Screen Failure|1|||
129027599|NCT02157974|464391693|FG002|Overall Study|Screen Failure|0|||
129027600|NCT02157974|464391694|FG003|Overall Study|Screen Failure|0|||
129027601|NCT02157974|464391695|FG004|Overall Study|Screen Failure|0|||
129027602|NCT02157974|464391691|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129027603|NCT02157974|464391692|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
129027604|NCT02157974|464391693|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129027605|NCT02157974|464391694|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129027606|NCT02157974|464391695|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129027607|NCT01484912|464391699|FG000|Overall Study|Withdrawal by Subject|1|||
129027608|NCT01484912|464391700|FG001|Overall Study|Withdrawal by Subject|0|||
129027609|NCT01484912|464391699|FG000|Overall Study|Physician Decision|0|||
129027610|NCT01484912|464391700|FG001|Overall Study|Physician Decision|1|||
129027611|NCT03158727|464391701|FG000|Overall Study|Withdrawal by Subject|2|||
129027612|NCT03158727|464391702|FG001|Overall Study|Withdrawal by Subject|6|||
129027613|NCT03158727|464391701|FG000|Overall Study|Death|11|||
129027614|NCT03158727|464391702|FG001|Overall Study|Death|12|||
129027615|NCT03158727|464391701|FG000|Overall Study|Lost to Follow-up|1|||
129027616|NCT03158727|464391702|FG001|Overall Study|Lost to Follow-up|0|||
129027617|NCT03158727|464391701|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
129027618|NCT03158727|464391702|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
129027619|NCT03158727|464391701|FG000|Overall Study|Visit 11 not done by mistake|0|||
129027620|NCT03158727|464391702|FG001|Overall Study|Visit 11 not done by mistake|1|||
128696461|NCT00945893|463185368|FG001|Overall Study|Withdrawal of consent|2|||
128907086|NCT05048719|463952015|FG000|Overall Study|Lost to Follow-up|0|||
129027621|NCT03158727|464391701|FG000|Overall Study|Enrolled, not treated|1|||
129027622|NCT03158727|464391702|FG001|Overall Study|Enrolled, not treated|0|||
129027623|NCT00985439|464391703|FG000|Overall Study|Adverse Event|0|||
129027624|NCT00985439|464391704|FG001|Overall Study|Adverse Event|0|||
129027625|NCT00985439|464391705|FG002|Overall Study|Adverse Event|1|||
129027626|NCT00985439|464391706|FG003|Overall Study|Adverse Event|0|||
129027627|NCT00924638|464391713|FG000|Overall Study|Death|3|||
129027628|NCT00924638|464391714|FG001|Overall Study|Death|2|||
129027629|NCT00924638|464391713|FG000|Overall Study|Lost to Follow-up|1|||
129027630|NCT00924638|464391714|FG001|Overall Study|Lost to Follow-up|1|||
129027631|NCT00924638|464391713|FG000|Overall Study|Withdrawal by Subject|5|||
129027632|NCT00924638|464391714|FG001|Overall Study|Withdrawal by Subject|7|||
129027633|NCT00924638|464391713|FG000|Overall Study|Physician Decision|3|||
129027634|NCT00924638|464391714|FG001|Overall Study|Physician Decision|3|||
129027635|NCT00847535|464391715|FG000|Overall Study|Withdrawal by Subject|2|||
129027636|NCT00847535|464391716|FG001|Overall Study|Withdrawal by Subject|1|||
129027637|NCT00847535|464391717|FG002|Overall Study|Withdrawal by Subject|1|||
129027638|NCT00847535|464391715|FG000|Overall Study|Lost to Follow-up|0|||
129027639|NCT00847535|464391716|FG001|Overall Study|Lost to Follow-up|1|||
129027640|NCT00847535|464391717|FG002|Overall Study|Lost to Follow-up|0|||
129027641|NCT01252953|464391718|FG000|Overall Study|Withdrawal by Subject|16|||
129027642|NCT01252953|464391719|FG001|Overall Study|Withdrawal by Subject|17|||
129027643|NCT01252953|464391718|FG000|Overall Study|Lost to Follow-up|22|||
129027644|NCT01252953|464391719|FG001|Overall Study|Lost to Follow-up|21|||
129027645|NCT00958724|464391723|FG000|Overall Study|Disease Progression|6|||
129027646|NCT05604014|464391741|FG000|Overall Study|Lost to Follow-up|13|||
128907087|NCT05048719|463952016|FG001|Overall Study|Lost to Follow-up|0|||
128907088|NCT05048719|463952017|FG002|Overall Study|Lost to Follow-up|1|||
129117292|NCT02557399|464725376|FG000|Overall Study|Withdrawal by Subject|1|||
129117293|NCT02557399|464725377|FG001|Overall Study|Withdrawal by Subject|1|||
129117294|NCT00931632|464725378|FG000|Overall Study|Withdrawal by Subject|2|||
129117295|NCT00931632|464725379|FG001|Overall Study|Withdrawal by Subject|3|||
129117296|NCT00931632|464725378|FG000|Overall Study|Adverse Event|19|||
129117297|NCT00931632|464725379|FG001|Overall Study|Adverse Event|15|||
129117298|NCT01687218|464725383|FG000|Overall Study|Withdrawal by Subject|2|||
129117299|NCT01687218|464725384|FG001|Overall Study|Withdrawal by Subject|3|||
129117300|NCT01687218|464725385|FG002|Overall Study|Withdrawal by Subject|0|||
129117301|NCT01687218|464725386|FG003|Overall Study|Withdrawal by Subject|1|||
129117302|NCT01687218|464725387|FG004|Overall Study|Withdrawal by Subject|1|||
129117303|NCT01687218|464725388|FG005|Overall Study|Withdrawal by Subject|0|||
129117304|NCT01687218|464725383|FG000|Overall Study|Relocated, no follow-up planned|1|||
129117305|NCT01687218|464725384|FG001|Overall Study|Relocated, no follow-up planned|0|||
129117306|NCT01687218|464725385|FG002|Overall Study|Relocated, no follow-up planned|1|||
129117307|NCT01687218|464725386|FG003|Overall Study|Relocated, no follow-up planned|1|||
129117308|NCT01687218|464725387|FG004|Overall Study|Relocated, no follow-up planned|0|||
129117309|NCT01687218|464725388|FG005|Overall Study|Relocated, no follow-up planned|0|||
129117310|NCT03139552|464725393|FG000|Overall Study|unable to attend tasting due to schedule|3|||
129117311|NCT03368807|464725402|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
129117312|NCT03368807|464725402|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
129117313|NCT03368807|464725402|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
129117314|NCT03368807|464725402|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
129117315|NCT01973218|464725403|FG000|Overall Study|Adverse Event|1|||
129117316|NCT01973218|464725404|FG001|Overall Study|Adverse Event|0|||
129117317|NCT01973218|464725403|FG000|Overall Study|Withdrawal by Subject|1|||
129117318|NCT01973218|464725404|FG001|Overall Study|Withdrawal by Subject|0|||
129117319|NCT02247466|464725405|FG000|Overall Study|Procedure changed to open surgery|0|||
129117320|NCT02247466|464725406|FG001|Overall Study|Procedure changed to open surgery|3|||
129117321|NCT02033759|464725407|FG000|Overall Study|Withdrawal by Subject|2|||
129117322|NCT02033759|464725408|FG001|Overall Study|Withdrawal by Subject|1|||
129117323|NCT02033759|464725407|FG000|Overall Study|Protocol Violation|1|||
129117324|NCT02033759|464725408|FG001|Overall Study|Protocol Violation|1|||
129117325|NCT04356937|464725411|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
129117326|NCT04356937|464725412|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
129117327|NCT03533751|464725413|FG000|Overall Study|Withdrawal by Subject|12|||
129117328|NCT03533751|464725414|FG001|Overall Study|Withdrawal by Subject|6|||
129117329|NCT03533751|464725415|FG002|Overall Study|Withdrawal by Subject|11|||
129117330|NCT03533751|464725416|FG003|Overall Study|Withdrawal by Subject|9|||
129117331|NCT03533751|464725417|FG004|Overall Study|Withdrawal by Subject|10|||
129117332|NCT03533751|464725413|FG000|Overall Study|Adverse Event|4|||
129117333|NCT03533751|464725414|FG001|Overall Study|Adverse Event|7|||
129117334|NCT03533751|464725415|FG002|Overall Study|Adverse Event|2|||
129117335|NCT03533751|464725416|FG003|Overall Study|Adverse Event|4|||
129117336|NCT03533751|464725417|FG004|Overall Study|Adverse Event|5|||
129117337|NCT03533751|464725413|FG000|Overall Study|Physician Decision|0|||
129117338|NCT03533751|464725414|FG001|Overall Study|Physician Decision|2|||
129117339|NCT03533751|464725415|FG002|Overall Study|Physician Decision|1|||
129117340|NCT03533751|464725416|FG003|Overall Study|Physician Decision|2|||
129117341|NCT03533751|464725417|FG004|Overall Study|Physician Decision|1|||
129117342|NCT03533751|464725413|FG000|Overall Study|Sponsor Decision|0|||
129117343|NCT03533751|464725414|FG001|Overall Study|Sponsor Decision|0|||
129117344|NCT03533751|464725415|FG002|Overall Study|Sponsor Decision|1|||
129117345|NCT03533751|464725416|FG003|Overall Study|Sponsor Decision|1|||
129117346|NCT03533751|464725417|FG004|Overall Study|Sponsor Decision|0|||
129117347|NCT03533751|464725413|FG000|Overall Study|Lost to Follow-up|3|||
129117348|NCT03533751|464725414|FG001|Overall Study|Lost to Follow-up|7|||
129117349|NCT03533751|464725415|FG002|Overall Study|Lost to Follow-up|6|||
129117350|NCT03533751|464725416|FG003|Overall Study|Lost to Follow-up|4|||
129117351|NCT03533751|464725417|FG004|Overall Study|Lost to Follow-up|3|||
129117352|NCT03533751|464725413|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
129117353|NCT03533751|464725414|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
129117354|NCT03533751|464725415|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
129117355|NCT03533751|464725416|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
129117356|NCT03533751|464725417|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
129117357|NCT03533751|464725413|FG000|Overall Study|Other|0|||
129117358|NCT03533751|464725414|FG001|Overall Study|Other|2|||
129117359|NCT03533751|464725415|FG002|Overall Study|Other|1|||
129117360|NCT03533751|464725416|FG003|Overall Study|Other|0|||
129117361|NCT03533751|464725417|FG004|Overall Study|Other|3|||
129117362|NCT05117060|464725418|FG000|Overall Study|Adverse Event|3|||
129117363|NCT05117060|464725419|FG001|Overall Study|Adverse Event|5|||
129117364|NCT05117060|464725420|FG002|Overall Study|Adverse Event|6|||
129117365|NCT05117060|464725421|FG003|Overall Study|Adverse Event|1|||
129117366|NCT05117060|464725418|FG000|Overall Study|Lost to Follow-up|0|||
129117367|NCT05117060|464725419|FG001|Overall Study|Lost to Follow-up|0|||
129117368|NCT05117060|464725420|FG002|Overall Study|Lost to Follow-up|0|||
129117369|NCT05117060|464725421|FG003|Overall Study|Lost to Follow-up|1|||
129117370|NCT05117060|464725418|FG000|Overall Study|Lack of Efficacy|4|||
129117371|NCT05117060|464725419|FG001|Overall Study|Lack of Efficacy|5|||
129117372|NCT05117060|464725420|FG002|Overall Study|Lack of Efficacy|2|||
129117373|NCT05117060|464725421|FG003|Overall Study|Lack of Efficacy|6|||
129117374|NCT05117060|464725418|FG000|Overall Study|Withdrawal by Subject|8|||
129117375|NCT05117060|464725419|FG001|Overall Study|Withdrawal by Subject|5|||
129117376|NCT05117060|464725420|FG002|Overall Study|Withdrawal by Subject|5|||
129117377|NCT05117060|464725421|FG003|Overall Study|Withdrawal by Subject|6|||
129117378|NCT05117060|464725418|FG000|Overall Study|Other|2|||
129117379|NCT05117060|464725419|FG001|Overall Study|Other|1|||
129117380|NCT05117060|464725420|FG002|Overall Study|Other|3|||
129117381|NCT05117060|464725421|FG003|Overall Study|Other|1|||
129117382|NCT01419535|464725422|FG000|Overall Study|could not maintain iv line|1|||
129117383|NCT01419535|464725423|FG001|Overall Study|could not maintain iv line|1|||
129117384|NCT01419535|464725422|FG000|Overall Study|Withdrawal by Subject|0|||
129117385|NCT01419535|464725423|FG001|Overall Study|Withdrawal by Subject|1|||
129117386|NCT00720278|464727341|FG000|Overall Study|Adverse Event|5|||
129117387|NCT00720278|464727342|FG001|Overall Study|Adverse Event|3|||
129117388|NCT00720278|464727343|FG002|Overall Study|Adverse Event|4|||
129117389|NCT00720278|464727341|FG000|Overall Study|Withdrawal by Subject|0|||
129117390|NCT00720278|464727342|FG001|Overall Study|Withdrawal by Subject|1|||
129117391|NCT00720278|464727343|FG002|Overall Study|Withdrawal by Subject|0|||
129117392|NCT00720278|464727341|FG000|Overall Study|Lost to Follow-up|0|||
129117393|NCT00720278|464727342|FG001|Overall Study|Lost to Follow-up|0|||
129117394|NCT00720278|464727343|FG002|Overall Study|Lost to Follow-up|1|||
129117395|NCT00720278|464727341|FG000|Overall Study|Non-compliance|1|||
129117396|NCT00720278|464727342|FG001|Overall Study|Non-compliance|0|||
129117397|NCT00720278|464727343|FG002|Overall Study|Non-compliance|0|||
129117398|NCT00720278|464727341|FG000|Overall Study|eligibility criteria violation|1|||
129117399|NCT00720278|464727342|FG001|Overall Study|eligibility criteria violation|0|||
129117400|NCT00720278|464727343|FG002|Overall Study|eligibility criteria violation|1|||
129117401|NCT00368251|464727344|FG000|Overall Study|SAE, non-fatal|1|||
129117402|NCT00368251|464727345|FG001|Overall Study|SAE, non-fatal|0|||
129117403|NCT00368251|464727346|FG002|Overall Study|SAE, non-fatal|0|||
129117404|NCT00368251|464727344|FG000|Overall Study|AE, non-serious non-fatal|0|||
129117405|NCT00368251|464727345|FG001|Overall Study|AE, non-serious non-fatal|0|||
129117406|NCT00368251|464727346|FG002|Overall Study|AE, non-serious non-fatal|1|||
129117407|NCT03312738|464727348|FG000|Overall Study|Progressive disease|58|||
129117408|NCT03312738|464727349|FG001|Overall Study|Progressive disease|67|||
129117409|NCT03312738|464727348|FG000|Overall Study|Patient/guardian decision|13|||
129117410|NCT03312738|464727349|FG001|Overall Study|Patient/guardian decision|5|||
129117411|NCT03312738|464727348|FG000|Overall Study|Adverse Event|5|||
129117412|NCT03312738|464727349|FG001|Overall Study|Adverse Event|3|||
129117413|NCT03312738|464727348|FG000|Overall Study|Protocol deviation|2|||
129117414|NCT03312738|464727349|FG001|Overall Study|Protocol deviation|0|||
129117415|NCT03312738|464727348|FG000|Overall Study|Technical problems|0|||
129117416|NCT03312738|464727349|FG001|Overall Study|Technical problems|1|||
129117417|NCT03312738|464727348|FG000|Overall Study|Physician Decision|2|||
129117418|NCT03312738|464727349|FG001|Overall Study|Physician Decision|3|||
129117419|NCT02466399|464727356|FG000|Overall Study|Adverse Event|1|||
129117420|NCT02466399|464727357|FG001|Overall Study|Adverse Event|0|||
129117421|NCT02466399|464727356|FG000|Overall Study|Early exit due to family emergency|1|||
129117422|NCT02466399|464727357|FG001|Overall Study|Early exit due to family emergency|0|||
129117423|NCT00607893|464727358|FG000|Overall Study|Lost to Follow-up|4|||
129117424|NCT00607893|464727359|FG001|Overall Study|Lost to Follow-up|0|||
129117425|NCT00607893|464727358|FG000|Overall Study|withdrew due to loss of interest|0|||
129117426|NCT00607893|464727359|FG001|Overall Study|withdrew due to loss of interest|1|||
129117427|NCT00607893|464727358|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
128696462|NCT01187433|463185369|FG000|Overall Study|Protocol Violation|6|||
128696463|NCT01187433|463185370|FG001|Overall Study|Protocol Violation|2|||
128696464|NCT01187433|463185369|FG000|Overall Study|Withdrawal by Subject|5|||
129117428|NCT00607893|464727359|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
129117429|NCT00607893|464727358|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
128696465|NCT01187433|463185370|FG001|Overall Study|Withdrawal by Subject|2|||
128696466|NCT00437983|463185372|FG000|Overall Study|Adverse Event|6|||
128696467|NCT00437983|463185373|FG001|Overall Study|Adverse Event|6|||
129117430|NCT00607893|464727359|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
129117431|NCT00607893|464727358|FG000|Overall Study|Declined to be treated|1|||
129117432|NCT00607893|464727359|FG001|Overall Study|Declined to be treated|0|||
128696468|NCT00437983|463185372|FG000|Overall Study|Protocol Violation|2|||
129117433|NCT00607893|464727358|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
129117434|NCT00607893|464727359|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
128696469|NCT00437983|463185373|FG001|Overall Study|Protocol Violation|1|||
128696470|NCT00437983|463185372|FG000|Overall Study|Withdrawal by Subject|5|||
129117435|NCT02669849|464727362|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129117436|NCT02669849|464727363|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129117437|NCT02669849|464727364|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
129117438|NCT02669849|464727362|FG000|Overall Study|Lost to Follow-up|1|||
129117439|NCT02669849|464727363|FG001|Overall Study|Lost to Follow-up|0|||
129117440|NCT02669849|464727364|FG002|Overall Study|Lost to Follow-up|3|||
129117441|NCT02669849|464727362|FG000|Overall Study|Death|1|||
129117442|NCT02669849|464727363|FG001|Overall Study|Death|1|||
129117443|NCT02669849|464727364|FG002|Overall Study|Death|2|||
129117444|NCT02669849|464727362|FG000|Overall Study|Study terminated by sponsor|16|||
129117445|NCT02669849|464727363|FG001|Overall Study|Study terminated by sponsor|1|||
129117446|NCT02669849|464727364|FG002|Overall Study|Study terminated by sponsor|14|||
129117447|NCT02669849|464727362|FG000|Overall Study|Other|0|||
129117448|NCT02669849|464727363|FG001|Overall Study|Other|0|||
129117449|NCT02669849|464727364|FG002|Overall Study|Other|2|||
129117450|NCT03408899|464727365|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
129117451|NCT00606008|464727366|FG000|Overall Study|Adverse Event|1|||
129117452|NCT00606008|464727366|FG000|Overall Study|Withdrawal by Subject|4|||
129117453|NCT04745351|464727367|FG000|Overall Study|Death|51|||
129117454|NCT04745351|464727368|FG001|Overall Study|Death|25|||
129117455|NCT04745351|464727367|FG000|Overall Study|Lost to Follow-up|9|||
129117456|NCT04745351|464727368|FG001|Overall Study|Lost to Follow-up|3|||
129117457|NCT04745351|464727367|FG000|Overall Study|Randomized but Never Treated|3|||
129117458|NCT04745351|464727368|FG001|Overall Study|Randomized but Never Treated|3|||
129117459|NCT04745351|464727367|FG000|Overall Study|Adverse Event|4|||
129117460|NCT04745351|464727368|FG001|Overall Study|Adverse Event|0|||
129117461|NCT04745351|464727367|FG000|Overall Study|Withdrew Consent|1|||
129117462|NCT04745351|464727368|FG001|Overall Study|Withdrew Consent|2|||
129117463|NCT04745351|464727367|FG000|Overall Study|Investigator's Discretion|2|||
129117464|NCT04745351|464727368|FG001|Overall Study|Investigator's Discretion|0|||
129117465|NCT04745351|464727367|FG000|Overall Study|Protocol Violation|1|||
129117466|NCT04745351|464727368|FG001|Overall Study|Protocol Violation|0|||
129117467|NCT01863771|464727374|FG000|Induction Phase|Adverse Event|9|||
129117468|NCT01863771|464727375|FG001|Induction Phase|Adverse Event|0|||
129117469|NCT01863771|464727376|FG002|Induction Phase|Adverse Event|0|||
129117470|NCT01863771|464727377|FG003|Induction Phase|Adverse Event|0|||
129117471|NCT01863771|464727374|FG000|Induction Phase|Lack of Efficacy|10|||
129117472|NCT01863771|464727375|FG001|Induction Phase|Lack of Efficacy|0|||
129117473|NCT01863771|464727376|FG002|Induction Phase|Lack of Efficacy|0|||
129117474|NCT01863771|464727377|FG003|Induction Phase|Lack of Efficacy|0|||
129117475|NCT01863771|464727374|FG000|Induction Phase|Withdrawal by Subject|2|||
129117476|NCT01863771|464727375|FG001|Induction Phase|Withdrawal by Subject|0|||
129117477|NCT01863771|464727376|FG002|Induction Phase|Withdrawal by Subject|0|||
129117478|NCT01863771|464727377|FG003|Induction Phase|Withdrawal by Subject|0|||
129117479|NCT01863771|464727374|FG000|Maintenance Phase|Adverse Event|0|||
129117480|NCT01863771|464727375|FG001|Maintenance Phase|Adverse Event|0|||
129117481|NCT01863771|464727376|FG002|Maintenance Phase|Adverse Event|1|||
129117482|NCT01863771|464727377|FG003|Maintenance Phase|Adverse Event|1|||
129117483|NCT01863771|464727374|FG000|Maintenance Phase|Lack of Efficacy|0|||
129117484|NCT01863771|464727375|FG001|Maintenance Phase|Lack of Efficacy|3|||
129117485|NCT01863771|464727376|FG002|Maintenance Phase|Lack of Efficacy|7|||
129117486|NCT01863771|464727377|FG003|Maintenance Phase|Lack of Efficacy|38|||
129117487|NCT01863771|464727374|FG000|Maintenance Phase|Physician Decision|0|||
129117488|NCT01863771|464727375|FG001|Maintenance Phase|Physician Decision|0|||
129117489|NCT01863771|464727376|FG002|Maintenance Phase|Physician Decision|2|||
129117490|NCT01863771|464727377|FG003|Maintenance Phase|Physician Decision|1|||
129117491|NCT01863771|464727374|FG000|Maintenance Phase|Pregnancy|0|||
129117492|NCT01863771|464727375|FG001|Maintenance Phase|Pregnancy|1|||
129117493|NCT01863771|464727376|FG002|Maintenance Phase|Pregnancy|0|||
129117494|NCT01863771|464727377|FG003|Maintenance Phase|Pregnancy|0|||
129117495|NCT01863771|464727374|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129117496|NCT01863771|464727375|FG001|Maintenance Phase|Withdrawal by Subject|1|||
129117497|NCT01863771|464727376|FG002|Maintenance Phase|Withdrawal by Subject|2|||
129117498|NCT01863771|464727377|FG003|Maintenance Phase|Withdrawal by Subject|3|||
129117499|NCT02014272|464727378|FG000|Intervention Period 1|Withdrawal by Subject|1|||
129117500|NCT02014272|464727379|FG001|Intervention Period 1|Withdrawal by Subject|0|||
129117501|NCT02014272|464727378|FG000|Intervention Period 1|Adverse Event|0|||
129117502|NCT02014272|464727379|FG001|Intervention Period 1|Adverse Event|1|||
129117503|NCT03499795|464727380|FG000|Overall Study|Adverse Event|1|||
129117504|NCT03499795|464727380|FG000|Overall Study|Lost to Follow-up|1|||
129117505|NCT03636256|464727381|FG000|Overall Study|Lost to Follow-up|3|||
129117506|NCT03636256|464727382|FG001|Overall Study|Lost to Follow-up|0|||
129117507|NCT03636256|464727383|FG002|Overall Study|Lost to Follow-up|2|||
129117508|NCT03636256|464727384|FG003|Overall Study|Lost to Follow-up|1|||
129117509|NCT03636256|464727385|FG004|Overall Study|Lost to Follow-up|0|||
129117510|NCT03636256|464727386|FG005|Overall Study|Lost to Follow-up|4|||
129117511|NCT03636256|464727387|FG006|Overall Study|Lost to Follow-up|2|||
129117512|NCT03636256|464727388|FG007|Overall Study|Lost to Follow-up|0|||
129117513|NCT03636256|464727389|FG008|Overall Study|Lost to Follow-up|4|||
129117514|NCT03636256|464727381|FG000|Overall Study|Withdrawal by Subject|0|||
129117515|NCT03636256|464727382|FG001|Overall Study|Withdrawal by Subject|0|||
129117516|NCT03636256|464727383|FG002|Overall Study|Withdrawal by Subject|0|||
129117517|NCT03636256|464727384|FG003|Overall Study|Withdrawal by Subject|0|||
129117518|NCT03636256|464727385|FG004|Overall Study|Withdrawal by Subject|0|||
128907089|NCT05048719|463952018|FG003|Overall Study|Lost to Follow-up|3|||
128907090|NCT05048719|463952019|FG004|Overall Study|Lost to Follow-up|1|||
128907091|NCT05048719|463952020|FG005|Overall Study|Lost to Follow-up|1|||
128907092|NCT05048719|463952021|FG006|Overall Study|Lost to Follow-up|1|||
128907093|NCT05048719|463952022|FG007|Overall Study|Lost to Follow-up|1|||
128907094|NCT05048719|463952023|FG008|Overall Study|Lost to Follow-up|0|||
129117519|NCT03636256|464727386|FG005|Overall Study|Withdrawal by Subject|0|||
129117520|NCT03636256|464727387|FG006|Overall Study|Withdrawal by Subject|0|||
128907095|NCT05048719|463952015|FG000|Overall Study|Physician Decision|0|||
128907096|NCT05048719|463952016|FG001|Overall Study|Physician Decision|0|||
128907097|NCT05048719|463952017|FG002|Overall Study|Physician Decision|0|||
128907098|NCT05048719|463952018|FG003|Overall Study|Physician Decision|0|||
128907099|NCT05048719|463952019|FG004|Overall Study|Physician Decision|0|||
128907100|NCT05048719|463952020|FG005|Overall Study|Physician Decision|0|||
128907101|NCT05048719|463952021|FG006|Overall Study|Physician Decision|0|||
129117521|NCT03636256|464727388|FG007|Overall Study|Withdrawal by Subject|0|||
129117522|NCT03636256|464727389|FG008|Overall Study|Withdrawal by Subject|1|||
129117523|NCT01218308|464727392|FG000|Overall Study|Adverse Event|1|||
129117524|NCT01218308|464727393|FG001|Overall Study|Adverse Event|2|||
129117525|NCT01218308|464727392|FG000|Overall Study|Protocol Violation|0|||
129117526|NCT01218308|464727393|FG001|Overall Study|Protocol Violation|2|||
129117527|NCT01218308|464727392|FG000|Overall Study|Withdrawal by Subject|61|||
129117528|NCT01218308|464727393|FG001|Overall Study|Withdrawal by Subject|64|||
129117529|NCT01218308|464727392|FG000|Overall Study|Lost to Follow-up|27|||
129117530|NCT01218308|464727393|FG001|Overall Study|Lost to Follow-up|31|||
129117531|NCT01218308|464727392|FG000|Overall Study|Other|14|||
129117532|NCT01218308|464727393|FG001|Overall Study|Other|21|||
129117533|NCT00547339|464727396|FG000|Overall Study|Physician Decision|0|||
129117534|NCT00547339|464727397|FG001|Overall Study|Physician Decision|0|||
129117535|NCT00547339|464727398|FG002|Overall Study|Physician Decision|1|||
129117536|NCT00547339|464727399|FG003|Overall Study|Physician Decision|0|||
129117537|NCT01516216|464727400|FG000|Overall Study|Adverse Event|2|||
128907102|NCT05048719|463952022|FG007|Overall Study|Physician Decision|1|||
128907103|NCT05048719|463952023|FG008|Overall Study|Physician Decision|1|||
128907104|NCT05048719|463952015|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
128907105|NCT05048719|463952016|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
128907106|NCT05048719|463952017|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
128907107|NCT05048719|463952018|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
128907108|NCT05048719|463952019|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129117538|NCT01516216|464727401|FG001|Overall Study|Adverse Event|4|||
129117539|NCT01516216|464727400|FG000|Overall Study|Disease Progression|38|||
129117540|NCT01516216|464727401|FG001|Overall Study|Disease Progression|34|||
129117541|NCT01516216|464727400|FG000|Overall Study|Withdrawal by Subject|9|||
129117542|NCT01516216|464727401|FG001|Overall Study|Withdrawal by Subject|11|||
129117543|NCT01516216|464727400|FG000|Overall Study|Potentially Curative Resection|6|||
129117544|NCT01516216|464727401|FG001|Overall Study|Potentially Curative Resection|12|||
129117545|NCT01516216|464727400|FG000|Overall Study|Nonadherence|2|||
129117546|NCT01516216|464727401|FG001|Overall Study|Nonadherence|3|||
129117547|NCT01516216|464727400|FG000|Overall Study|Physician Decision|6|||
129117548|NCT01516216|464727401|FG001|Overall Study|Physician Decision|3|||
129117549|NCT01516216|464727400|FG000|Overall Study|Prolonged Treatment Delay|5|||
129117550|NCT01516216|464727401|FG001|Overall Study|Prolonged Treatment Delay|1|||
129117551|NCT01516216|464727400|FG000|Overall Study|Intercurrent Illness|1|||
128907109|NCT05048719|463952020|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129117552|NCT01516216|464727401|FG001|Overall Study|Intercurrent Illness|0|||
129117553|NCT01516216|464727400|FG000|Overall Study|Death|1|||
129117554|NCT01516216|464727401|FG001|Overall Study|Death|1|||
129117555|NCT02783066|464727402|FG000|Overall Study|Withdrawal by Subject|13|||
129117556|NCT05379920|464727411|FG000|Overall Study|Lost to Follow-up|0|||
129117557|NCT05379920|464727412|FG001|Overall Study|Lost to Follow-up|5|||
129117558|NCT05379920|464727413|FG002|Overall Study|Lost to Follow-up|0|||
128907110|NCT05048719|463952021|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
128907111|NCT05048719|463952022|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
128907112|NCT05048719|463952023|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
128978047|NCT02743494|464205305|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
129117559|NCT05379920|464727414|FG003|Overall Study|Lost to Follow-up|0|||
129117560|NCT03176771|464727415|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
129117561|NCT03176771|464727416|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
129117562|NCT03176771|464727417|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
129117563|NCT03176771|464727418|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
129117564|NCT03176771|464727419|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
128907113|NCT05048719|463952015|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907114|NCT05048719|463952016|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
128907115|NCT05048719|463952017|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907116|NCT05048719|463952018|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907117|NCT05048719|463952019|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907118|NCT05048719|463952020|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907119|NCT05048719|463952021|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907120|NCT05048719|463952022|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907121|NCT05048719|463952023|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
128907122|NCT05048719|463952015|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907123|NCT05048719|463952016|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
128907124|NCT05048719|463952017|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907125|NCT05048719|463952018|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907126|NCT05048719|463952019|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907127|NCT05048719|463952020|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907128|NCT05048719|463952021|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907129|NCT05048719|463952022|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907130|NCT05048719|463952023|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
128907131|NCT05048719|463952015|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907132|NCT05048719|463952016|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907133|NCT05048719|463952017|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907134|NCT05048719|463952018|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
128907135|NCT05048719|463952019|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907136|NCT05048719|463952020|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907137|NCT05048719|463952021|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907138|NCT05048719|463952022|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907139|NCT05048719|463952023|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
128907140|NCT05048719|463952015|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907141|NCT05048719|463952016|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907142|NCT05048719|463952017|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907143|NCT05048719|463952018|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907144|NCT05048719|463952019|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907145|NCT05048719|463952020|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
128907146|NCT05048719|463952021|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907147|NCT05048719|463952022|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907148|NCT05048719|463952023|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
128907149|NCT02229552|463952025|FG000|Baseline|Withdrawal by Subject|6|||
128907150|NCT02229552|463952025|FG000|1-year Follow up|Withdrawal by Subject|7|||
128907151|NCT02229552|463952025|FG000|1-year Follow up|Lost to Follow-up|18|||
128907152|NCT02229552|463952025|FG000|2-Year Follow up|Withdrawal by Subject|9|||
128907153|NCT02229552|463952025|FG000|2-Year Follow up|Lost to Follow-up|17|||
128907154|NCT04872101|463952026|FG000|Overall Study|Withdrawal by Subject|10|||
128907155|NCT04872101|463952027|FG001|Overall Study|Withdrawal by Subject|16|||
128907156|NCT04872101|463952026|FG000|Overall Study|Lack of Efficacy|6|||
128907157|NCT04872101|463952027|FG001|Overall Study|Lack of Efficacy|14|||
128907158|NCT04872101|463952026|FG000|Overall Study|Adverse Event|1|||
128907159|NCT04872101|463952027|FG001|Overall Study|Adverse Event|6|||
128907160|NCT04872101|463952026|FG000|Overall Study|Lost to Follow-up|2|||
128907161|NCT04872101|463952027|FG001|Overall Study|Lost to Follow-up|1|||
128907162|NCT04872101|463952026|FG000|Overall Study|Pregnancy|2|||
128907163|NCT04872101|463952027|FG001|Overall Study|Pregnancy|0|||
128907164|NCT04872101|463952026|FG000|Overall Study|Prohibited Medication|1|||
128907165|NCT04872101|463952027|FG001|Overall Study|Prohibited Medication|0|||
128907166|NCT04872101|463952026|FG000|Overall Study|Not dosed|1|||
128907167|NCT04872101|463952027|FG001|Overall Study|Not dosed|0|||
128907168|NCT00971945|463952028|FG000|Overall Study|Progressive Disease|3|||
128907169|NCT00971945|463952028|FG000|Overall Study|Change in treatment policy|1|||
128907170|NCT00971945|463952028|FG000|Overall Study|Other reasons|2|||
128907171|NCT03354663|463952029|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
128907172|NCT03354663|463952029|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
128907173|NCT03354663|463952029|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
128907174|NCT03354663|463952029|FG000|Completed 30-day Visit|Missed Visit|1|||
129132904|NCT00827242|464778558|FG000|Overall Study|Lack of Efficacy|1|||
128696471|NCT00437983|463185373|FG001|Overall Study|Withdrawal by Subject|6|||
128696472|NCT00672646|463185376|FG000|Overall Study|Lost to Follow-up|0|||
128696473|NCT00672646|463185377|FG001|Overall Study|Lost to Follow-up|1|||
128696474|NCT00672646|463185378|FG002|Overall Study|Lost to Follow-up|2|||
128696475|NCT00672646|463185376|FG000|Overall Study|Withdrawal by Subject|0|||
128696476|NCT00672646|463185377|FG001|Overall Study|Withdrawal by Subject|0|||
128696477|NCT00672646|463185378|FG002|Overall Study|Withdrawal by Subject|1|||
128696478|NCT00242216|463185379|FG000|Overall Study|Lost to Follow-up|12|||
128696479|NCT00242216|463185380|FG001|Overall Study|Lost to Follow-up|17|||
128696480|NCT00242216|463185379|FG000|Overall Study|Death|4|||
128696481|NCT00242216|463185380|FG001|Overall Study|Death|2|||
128696482|NCT00242216|463185379|FG000|Overall Study|Lack of Efficacy|1|||
128696483|NCT00242216|463185380|FG001|Overall Study|Lack of Efficacy|2|||
128696484|NCT00242216|463185379|FG000|Overall Study|no medicaiton dispensed|1|||
128696485|NCT00242216|463185380|FG001|Overall Study|no medicaiton dispensed|1|||
128696486|NCT00678080|463185381|FG000|Overall Study|Physician Decision|2|||
128907175|NCT03691974|463952030|FG000|Overall Study|Physician Decision|1|||
128907176|NCT03691974|463952031|FG001|Overall Study|Physician Decision|0|||
128907177|NCT03691974|463952030|FG000|Overall Study|Adverse Event|1|||
128907178|NCT03691974|463952031|FG001|Overall Study|Adverse Event|0|||
128907179|NCT03691974|463952030|FG000|Overall Study|Withdrawal by Subject|11|||
128907180|NCT03691974|463952031|FG001|Overall Study|Withdrawal by Subject|9|||
128907181|NCT03691974|463952030|FG000|Overall Study|Protocol Violation|1|||
128907182|NCT03691974|463952031|FG001|Overall Study|Protocol Violation|0|||
128907183|NCT03691974|463952030|FG000|Overall Study|Lost to Follow-up|8|||
128907184|NCT03691974|463952031|FG001|Overall Study|Lost to Follow-up|7|||
128907185|NCT02239939|463952032|FG000|Overall Study|Adverse Event|1|||
128907186|NCT02239939|463952033|FG001|Overall Study|Adverse Event|0|||
128907187|NCT02239939|463952032|FG000|Overall Study|Withdrawal by Subject|1|||
128907188|NCT02239939|463952033|FG001|Overall Study|Withdrawal by Subject|1|||
128907189|NCT02239939|463952032|FG000|Overall Study|Lost to Follow-up|0|||
128907190|NCT02239939|463952033|FG001|Overall Study|Lost to Follow-up|1|||
128907191|NCT03325673|463952042|FG000|Overall Study|Adverse Event|4|||
128907192|NCT03325673|463952043|FG001|Overall Study|Adverse Event|0|||
128907193|NCT01514682|463952044|FG000|Overall Study|Withdrawal by Subject|2|||
128907194|NCT01514682|463952045|FG001|Overall Study|Withdrawal by Subject|3|||
128907195|NCT01514682|463952044|FG000|Overall Study|Physician Decision|4|||
128907196|NCT01514682|463952045|FG001|Overall Study|Physician Decision|3|||
128907197|NCT00590590|463952046|FG000|Overall Study|Lack of Efficacy|1|||
128907198|NCT00590590|463952047|FG001|Overall Study|Lack of Efficacy|2|||
128907199|NCT00590590|463952048|FG002|Overall Study|Lack of Efficacy|0|||
128907200|NCT00590590|463952046|FG000|Overall Study|Adverse Event|1|||
128907201|NCT00590590|463952047|FG001|Overall Study|Adverse Event|0|||
128907202|NCT00590590|463952048|FG002|Overall Study|Adverse Event|0|||
128907203|NCT00590590|463952046|FG000|Overall Study|Protocol Violation|0|||
128907204|NCT00590590|463952047|FG001|Overall Study|Protocol Violation|0|||
128907205|NCT00590590|463952048|FG002|Overall Study|Protocol Violation|2|||
128907206|NCT00590590|463952046|FG000|Overall Study|Lost to Follow-up|4|||
128907207|NCT00590590|463952047|FG001|Overall Study|Lost to Follow-up|1|||
128907208|NCT00590590|463952048|FG002|Overall Study|Lost to Follow-up|2|||
128907209|NCT00590590|463952046|FG000|Overall Study|Withdrawal by Subject|0|||
128907210|NCT00590590|463952047|FG001|Overall Study|Withdrawal by Subject|1|||
128907211|NCT00590590|463952048|FG002|Overall Study|Withdrawal by Subject|1|||
128907212|NCT00590590|463952046|FG000|Overall Study|Did not complete due to study closure|1|||
128907213|NCT00590590|463952047|FG001|Overall Study|Did not complete due to study closure|1|||
128907214|NCT00590590|463952048|FG002|Overall Study|Did not complete due to study closure|1|||
128907215|NCT00590590|463952046|FG000|Overall Study|Did not complete study|0|||
128907216|NCT00590590|463952047|FG001|Overall Study|Did not complete study|1|||
128907217|NCT00590590|463952048|FG002|Overall Study|Did not complete study|0|||
128907218|NCT02105454|463952051|FG000|Overall Study|Withdrawal by Subject|1|||
128907219|NCT00272038|463952052|FG000|Overall Study|withdrew before they received 2 cycles|7|||
128907220|NCT02721355|463952053|FG000|Overall Study|Lost to Follow-up|6|||
128907221|NCT02721355|463952054|FG001|Overall Study|Lost to Follow-up|1|||
128907222|NCT00356278|463952055|FG000|Overall Study|Withdrawal by Subject|25|||
128907223|NCT00356278|463952056|FG001|Overall Study|Withdrawal by Subject|15|||
128696487|NCT00678080|463185382|FG001|Overall Study|Physician Decision|0|||
128907224|NCT00356278|463952057|FG002|Overall Study|Withdrawal by Subject|19|||
128907225|NCT00883337|463952058|FG000|Core Treatment Period|Adverse Event|9|||
128907226|NCT00883337|463952059|FG001|Core Treatment Period|Adverse Event|12|||
128696488|NCT00678080|463185381|FG000|Overall Study|Lost to Follow-up|1|||
128907227|NCT00883337|463952060|FG002|Core Treatment Period|Adverse Event|22|||
128907228|NCT00883337|463952058|FG000|Core Treatment Period|Lack of Efficacy|7|||
128907229|NCT00883337|463952059|FG001|Core Treatment Period|Lack of Efficacy|4|||
128907230|NCT00883337|463952060|FG002|Core Treatment Period|Lack of Efficacy|2|||
128696489|NCT00678080|463185382|FG001|Overall Study|Lost to Follow-up|0|||
128696490|NCT00678080|463185381|FG000|Overall Study|Withdrawal by Subject|0|||
128696491|NCT00678080|463185382|FG001|Overall Study|Withdrawal by Subject|1|||
128696492|NCT04439201|463185383|FG000|Overall Study|Ineligible|2|||
128907231|NCT00883337|463952058|FG000|Core Treatment Period|Lost to Follow-up|1|||
128907232|NCT00883337|463952059|FG001|Core Treatment Period|Lost to Follow-up|1|||
128907233|NCT00883337|463952060|FG002|Core Treatment Period|Lost to Follow-up|0|||
128907234|NCT00883337|463952058|FG000|Core Treatment Period|Withdrawal by Subject|2|||
128907235|NCT00883337|463952059|FG001|Core Treatment Period|Withdrawal by Subject|2|||
128907236|NCT00883337|463952060|FG002|Core Treatment Period|Withdrawal by Subject|6|||
128907237|NCT00883337|463952058|FG000|Core Treatment Period|Wish to be pregnant|1|||
128907238|NCT00883337|463952059|FG001|Core Treatment Period|Wish to be pregnant|2|||
128907239|NCT00883337|463952060|FG002|Core Treatment Period|Wish to be pregnant|1|||
128907240|NCT00883337|463952058|FG000|Core Treatment Period|Poor compliance to protocol|0|||
128907241|NCT00883337|463952059|FG001|Core Treatment Period|Poor compliance to protocol|0|||
128907242|NCT00883337|463952060|FG002|Core Treatment Period|Poor compliance to protocol|1|||
128907243|NCT00883337|463952058|FG000|Core Treatment Period|Other than above|0|||
128907244|NCT00883337|463952059|FG001|Core Treatment Period|Other than above|1|||
128907245|NCT00883337|463952060|FG002|Core Treatment Period|Other than above|1|||
128907246|NCT00883337|463952058|FG000|Extension Treatment Period|Adverse Event|8|||
128907247|NCT00883337|463952059|FG001|Extension Treatment Period|Adverse Event|5|||
128907248|NCT00883337|463952060|FG002|Extension Treatment Period|Adverse Event|5|||
128907249|NCT00883337|463952058|FG000|Extension Treatment Period|Lack of Efficacy|8|||
128907250|NCT00883337|463952059|FG001|Extension Treatment Period|Lack of Efficacy|8|||
128907251|NCT00883337|463952060|FG002|Extension Treatment Period|Lack of Efficacy|8|||
128907252|NCT00883337|463952058|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
128907253|NCT00883337|463952059|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
128907254|NCT00883337|463952060|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
128907255|NCT00883337|463952058|FG000|Extension Treatment Period|Lost to Follow-up|1|||
128907256|NCT00883337|463952059|FG001|Extension Treatment Period|Lost to Follow-up|0|||
128907257|NCT00883337|463952060|FG002|Extension Treatment Period|Lost to Follow-up|0|||
128907258|NCT00883337|463952058|FG000|Extension Treatment Period|Other than above|10|||
128907259|NCT00883337|463952059|FG001|Extension Treatment Period|Other than above|9|||
128907260|NCT00883337|463952060|FG002|Extension Treatment Period|Other than above|5|||
128907261|NCT01678144|463952069|FG000|Stage 1: MAR Classic|Adverse Event|1|||
128907262|NCT02363686|463952070|FG000|Overall Study|Withdrawal by Subject|22|||
128907263|NCT02363686|463952070|FG000|Overall Study|incomplete FEES examinations|13|||
128907264|NCT01485627|463952073|FG000|Overall Study|Patient withdrew|6|||
128907265|NCT01485627|463952074|FG001|Overall Study|Patient withdrew|5|||
128907266|NCT01485627|463952073|FG000|Overall Study|Patient died|3|||
128907267|NCT01485627|463952074|FG001|Overall Study|Patient died|1|||
128907268|NCT01485627|463952073|FG000|Overall Study|Patient lost to followup|0|||
128907269|NCT01485627|463952074|FG001|Overall Study|Patient lost to followup|1|||
128907270|NCT01485627|463952073|FG000|Overall Study|Caregiver withdrew|3|||
128907271|NCT01485627|463952074|FG001|Overall Study|Caregiver withdrew|3|||
128907272|NCT01485627|463952073|FG000|Overall Study|Caregiver lost to follow up|11|||
128907273|NCT01485627|463952074|FG001|Overall Study|Caregiver lost to follow up|12|||
128907274|NCT01485627|463952073|FG000|Overall Study|Caregiver died|1|||
128907275|NCT01485627|463952074|FG001|Overall Study|Caregiver died|0|||
128907276|NCT01485627|463952073|FG000|Overall Study|caregiver was not bereaved|42|||
128907277|NCT01485627|463952074|FG001|Overall Study|caregiver was not bereaved|35|||
128907278|NCT02264990|463952079|FG000|Overall Study|Death|255|||
128907279|NCT02264990|463952080|FG001|Overall Study|Death|250|||
128907280|NCT02264990|463952079|FG000|Overall Study|Withdrawal by Subject|4|||
128907281|NCT02264990|463952080|FG001|Overall Study|Withdrawal by Subject|5|||
128907282|NCT02264990|463952079|FG000|Overall Study|Lost to Follow-up|1|||
128907283|NCT02264990|463952080|FG001|Overall Study|Lost to Follow-up|3|||
128907284|NCT02264990|463952079|FG000|Overall Study|Other|0|||
128907285|NCT02264990|463952080|FG001|Overall Study|Other|1|||
128907286|NCT01662895|463952083|FG000|Overall Study|Lost to Follow-up|0|||
128907287|NCT01662895|463952084|FG001|Overall Study|Lost to Follow-up|1|||
128907288|NCT01895322|463952087|FG000|Overall Study|Adverse Event|1|||
128907289|NCT01895322|463952087|FG000|Overall Study|Withdrawal by Subject|2|||
128907290|NCT01895322|463952087|FG000|Overall Study|Protocol Violation|10|||
128907291|NCT03603496|463952100|FG000|Overall Study|Death|19|||
128907292|NCT03603496|463952101|FG001|Overall Study|Death|24|||
128907293|NCT03603496|463952100|FG000|Overall Study|Lost to Follow-up|141|||
128907294|NCT03603496|463952101|FG001|Overall Study|Lost to Follow-up|141|||
128907295|NCT03603496|463952100|FG000|Overall Study|Withdrawal by Subject|26|||
129027647|NCT02121184|464391742|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
128696493|NCT04439201|463185383|FG000|Overall Study|Never start protocol therapy|1|||
128696494|NCT04439201|463185383|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
128907296|NCT03603496|463952101|FG001|Overall Study|Withdrawal by Subject|20|||
128907297|NCT00774345|463952102|FG000|Pre-treatment|Other reasons|2|||
128907298|NCT00774345|463952103|FG001|Pre-treatment|Other reasons|0|||
128907299|NCT00774345|463952102|FG000|Treatment|Adverse Event|61|||
128765210|NCT00661661|463432087|FG000|Overall Study|Lost to Follow-up|0|||
128907300|NCT00774345|463952103|FG001|Treatment|Adverse Event|15|||
128907301|NCT00774345|463952102|FG000|Treatment|Progressive Disease without histologic transformation|51|||
128907302|NCT00774345|463952103|FG001|Treatment|Progressive Disease without histologic transformation|111|||
128907303|NCT00774345|463952102|FG000|Treatment|Progressive Disease with histologic transformation|4|||
128907304|NCT00774345|463952103|FG001|Treatment|Progressive Disease with histologic transformation|2|||
128907305|NCT00774345|463952102|FG000|Treatment|Withdrawal by Subject|5|||
128907306|NCT00774345|463952103|FG001|Treatment|Withdrawal by Subject|2|||
128907307|NCT00774345|463952102|FG000|Treatment|Lost to Follow-up|1|||
128907308|NCT00774345|463952103|FG001|Treatment|Lost to Follow-up|1|||
128907309|NCT00774345|463952102|FG000|Treatment|Death|4|||
128907310|NCT00774345|463952103|FG001|Treatment|Death|0|||
128907311|NCT00774345|463952102|FG000|Treatment|Other Reasons|32|||
128907312|NCT00774345|463952103|FG001|Treatment|Other Reasons|26|||
128907313|NCT00075504|463952104|FG000|Overall Study|Withdrawal by Subject|9|||
128907314|NCT00075504|463952105|FG001|Overall Study|Withdrawal by Subject|7|||
128907315|NCT01692301|463952107|FG000|Overall Study|Adverse Event|15|||
128907316|NCT01692301|463952108|FG001|Overall Study|Adverse Event|12|||
128907317|NCT01692301|463952107|FG000|Overall Study|Death|1|||
129027648|NCT02121184|464391743|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
129027649|NCT02121184|464391742|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
129027650|NCT02121184|464391743|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
129027651|NCT02121184|464391742|FG000|Overall Study|Emergency cesarean section required|0|||
129027652|NCT02121184|464391743|FG001|Overall Study|Emergency cesarean section required|2|||
129027653|NCT02121184|464391742|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
129027654|NCT02121184|464391743|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
129027655|NCT00840203|464391747|FG000|First Intervention|Protocol Violation|1|||
129027656|NCT00840203|464391748|FG001|First Intervention|Protocol Violation|1|||
129027657|NCT00840203|464391747|FG000|Washout|Protocol Violation|1|||
129027658|NCT00840203|464391748|FG001|Washout|Protocol Violation|0|||
129027659|NCT05562011|464391749|FG000|Overall Study|Withdrawal by Subject|3|||
129027660|NCT05562011|464391749|FG000|Overall Study|Lost to Follow-up|1|||
129027661|NCT05562011|464391749|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
129027662|NCT05562011|464391749|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
129027663|NCT05562011|464391749|FG000|Overall Study|Device malfunction|13|||
129027664|NCT04411680|464391754|FG000|Treatment Period|Adverse Event|3|||
129027665|NCT04411680|464391755|FG001|Treatment Period|Adverse Event|0|||
129027666|NCT04411680|464391754|FG000|Treatment Period|Discharged from hospital|18|||
129027667|NCT04411680|464391755|FG001|Treatment Period|Discharged from hospital|7|||
129027668|NCT04411680|464391754|FG000|Treatment Period|Missed 1 or more doses|8|||
129027669|NCT04411680|464391755|FG001|Treatment Period|Missed 1 or more doses|0|||
129027670|NCT04411680|464391754|FG000|Treatment Period|Transferred to another hospital|0|||
129027671|NCT04411680|464391755|FG001|Treatment Period|Transferred to another hospital|1|||
129027672|NCT04411680|464391754|FG000|Follow up Period|Withdrawal by Subject|2|||
129027673|NCT04411680|464391755|FG001|Follow up Period|Withdrawal by Subject|0|||
129027674|NCT04411680|464391754|FG000|Follow up Period|Lost to Follow-up|5|||
129027675|NCT04411680|464391755|FG001|Follow up Period|Lost to Follow-up|6|||
129027676|NCT04411680|464391754|FG000|Follow up Period|Death|11|||
129027677|NCT04411680|464391755|FG001|Follow up Period|Death|8|||
129027678|NCT00748566|464391756|FG000|Overall Study|Adverse Event|49|||
129027679|NCT00748566|464391756|FG000|Overall Study|Death|1|||
129027680|NCT00748566|464391756|FG000|Overall Study|Lack of Efficacy|12|||
129027681|NCT00748566|464391756|FG000|Overall Study|Lost to Follow-up|1|||
129027682|NCT00748566|464391756|FG000|Overall Study|Protocol Violation|13|||
129027683|NCT00748566|464391756|FG000|Overall Study|Withdrawal by Subject|22|||
129027684|NCT00748566|464391756|FG000|Overall Study|Study terminated by sponsor|5|||
129027685|NCT00748566|464391756|FG000|Overall Study|Other|9|||
129117565|NCT03176771|464727415|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129117566|NCT03176771|464727416|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
129027686|NCT04025021|464391757|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
129027687|NCT04025021|464391758|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
129027688|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
129027689|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
129027690|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
129027691|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
129027692|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
129027693|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
129027694|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
129027695|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
129027696|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
129027697|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
129132905|NCT00827242|464778559|FG001|Overall Study|Lack of Efficacy|0|||
128907318|NCT01692301|463952108|FG001|Overall Study|Death|2|||
128907319|NCT01692301|463952107|FG000|Overall Study|Lack of Efficacy|0|||
128907320|NCT01692301|463952108|FG001|Overall Study|Lack of Efficacy|5|||
128907321|NCT01692301|463952107|FG000|Overall Study|Non-compliance with study treatment|1|||
128907322|NCT01692301|463952108|FG001|Overall Study|Non-compliance with study treatment|2|||
128907323|NCT01692301|463952107|FG000|Overall Study|Protocol deviation|9|||
128907324|NCT01692301|463952108|FG001|Overall Study|Protocol deviation|2|||
128907325|NCT01692301|463952107|FG000|Overall Study|Patient/guardian decision|16|||
128907326|NCT01692301|463952108|FG001|Overall Study|Patient/guardian decision|15|||
128907327|NCT01692301|463952107|FG000|Overall Study|Technical problems|0|||
128907328|NCT01692301|463952108|FG001|Overall Study|Technical problems|1|||
128907329|NCT01692301|463952107|FG000|Overall Study|Physician Decision|2|||
128907330|NCT01692301|463952108|FG001|Overall Study|Physician Decision|2|||
128907331|NCT01692301|463952107|FG000|Overall Study|Lost to Follow-up|1|||
129117567|NCT03176771|464727417|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129117568|NCT03176771|464727418|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129117569|NCT03176771|464727419|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129117570|NCT03176771|464727415|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
129117571|NCT03176771|464727416|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
128907332|NCT01692301|463952108|FG001|Overall Study|Lost to Follow-up|1|||
128907333|NCT01142726|463952109|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
128907334|NCT01142726|463952110|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
128907335|NCT01142726|463952111|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
128907336|NCT01142726|463952109|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
128907337|NCT01142726|463952110|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
128907338|NCT01142726|463952111|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
128907339|NCT01142726|463952109|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
128907340|NCT01142726|463952110|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
128907341|NCT01142726|463952111|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
128907342|NCT01142726|463952109|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
128907343|NCT01142726|463952110|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
128907344|NCT01142726|463952111|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
128907345|NCT01142726|463952109|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
128907346|NCT01142726|463952110|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
128907347|NCT01142726|463952111|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
128907348|NCT01142726|463952109|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
128907349|NCT01142726|463952110|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
128907350|NCT01142726|463952111|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
128907351|NCT01142726|463952109|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
128907352|NCT01142726|463952110|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
128907353|NCT01142726|463952111|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
128907354|NCT01142726|463952109|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
128907355|NCT01142726|463952110|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
128907356|NCT01142726|463952111|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
129117572|NCT03176771|464727417|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
129117573|NCT03176771|464727418|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
129117574|NCT03176771|464727419|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
129117575|NCT03176771|464727415|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129117576|NCT03176771|464727416|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129117577|NCT03176771|464727417|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
129117578|NCT03176771|464727418|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129117579|NCT03176771|464727419|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129117580|NCT03176771|464727415|FG000|Double-Blind Extension Period|Adverse Event|0|||
129117581|NCT03176771|464727416|FG001|Double-Blind Extension Period|Adverse Event|0|||
129117582|NCT03176771|464727417|FG002|Double-Blind Extension Period|Adverse Event|0|||
129117583|NCT03176771|464727418|FG003|Double-Blind Extension Period|Adverse Event|15|||
129117584|NCT03176771|464727419|FG004|Double-Blind Extension Period|Adverse Event|18|||
128907357|NCT01142726|463952109|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
128907358|NCT01142726|463952110|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
128907359|NCT01142726|463952111|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
128907360|NCT01142726|463952109|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
128907361|NCT01142726|463952110|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
128907362|NCT01142726|463952111|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
128907363|NCT01142726|463952109|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
128907364|NCT01142726|463952110|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
128907365|NCT01142726|463952111|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
128907366|NCT01142726|463952109|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
128907367|NCT01142726|463952110|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
128907368|NCT01142726|463952111|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
128907369|NCT01142726|463952109|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
128907370|NCT01142726|463952110|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
128907371|NCT01142726|463952111|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
128907372|NCT01142726|463952109|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
128907373|NCT01142726|463952110|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
128907374|NCT01142726|463952111|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
128907375|NCT01142726|463952109|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
128907376|NCT01142726|463952110|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
128907377|NCT01142726|463952111|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
128907378|NCT01142726|463952109|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
128907379|NCT01142726|463952110|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
128907380|NCT01142726|463952111|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
128907381|NCT01568593|463952112|FG000|Overall Study|Lack of Efficacy|4|||
128907382|NCT01568593|463952113|FG001|Overall Study|Lack of Efficacy|1|||
128907383|NCT01568593|463952112|FG000|Overall Study|Adverse Event|3|||
128907384|NCT01568593|463952113|FG001|Overall Study|Adverse Event|2|||
128907385|NCT02109484|463952114|FG000|Overall Study|Lost to Follow-up|0|||
128907386|NCT02109484|463952115|FG001|Overall Study|Lost to Follow-up|0|||
128907387|NCT02109484|463952116|FG002|Overall Study|Lost to Follow-up|0|||
128907388|NCT02109484|463952117|FG003|Overall Study|Lost to Follow-up|1|||
128907389|NCT02109484|463952118|FG004|Overall Study|Lost to Follow-up|1|||
128907390|NCT02109484|463952119|FG005|Overall Study|Lost to Follow-up|0|||
128907391|NCT02109484|463952120|FG006|Overall Study|Lost to Follow-up|1|||
128907392|NCT02109484|463952121|FG007|Overall Study|Lost to Follow-up|0|||
128907393|NCT02109484|463952114|FG000|Overall Study|Withdrawal by Subject|0|||
128907394|NCT02109484|463952115|FG001|Overall Study|Withdrawal by Subject|0|||
128907395|NCT02109484|463952116|FG002|Overall Study|Withdrawal by Subject|0|||
128907396|NCT02109484|463952117|FG003|Overall Study|Withdrawal by Subject|0|||
128907397|NCT02109484|463952118|FG004|Overall Study|Withdrawal by Subject|1|||
128907398|NCT02109484|463952119|FG005|Overall Study|Withdrawal by Subject|1|||
128907399|NCT02109484|463952120|FG006|Overall Study|Withdrawal by Subject|1|||
128907400|NCT02109484|463952121|FG007|Overall Study|Withdrawal by Subject|0|||
128907401|NCT02109484|463952114|FG000|Overall Study|Physician Decision|0|||
128907402|NCT02109484|463952115|FG001|Overall Study|Physician Decision|0|||
128907403|NCT02109484|463952116|FG002|Overall Study|Physician Decision|0|||
128907404|NCT02109484|463952117|FG003|Overall Study|Physician Decision|0|||
128907405|NCT02109484|463952118|FG004|Overall Study|Physician Decision|2|||
128907406|NCT02109484|463952119|FG005|Overall Study|Physician Decision|0|||
128907407|NCT02109484|463952120|FG006|Overall Study|Physician Decision|0|||
128907408|NCT02109484|463952121|FG007|Overall Study|Physician Decision|0|||
128907409|NCT02109484|463952114|FG000|Overall Study|Death|0|||
128907410|NCT02109484|463952115|FG001|Overall Study|Death|0|||
128907411|NCT02109484|463952116|FG002|Overall Study|Death|0|||
128907412|NCT02109484|463952117|FG003|Overall Study|Death|0|||
128907413|NCT02109484|463952118|FG004|Overall Study|Death|0|||
128907414|NCT02109484|463952119|FG005|Overall Study|Death|0|||
128907415|NCT02109484|463952120|FG006|Overall Study|Death|0|||
128907416|NCT02109484|463952121|FG007|Overall Study|Death|2|||
128907417|NCT02109484|463952114|FG000|Overall Study|Moved away from study area|0|||
128907418|NCT02109484|463952115|FG001|Overall Study|Moved away from study area|0|||
128907419|NCT02109484|463952116|FG002|Overall Study|Moved away from study area|0|||
128907420|NCT02109484|463952117|FG003|Overall Study|Moved away from study area|0|||
128907421|NCT02109484|463952118|FG004|Overall Study|Moved away from study area|0|||
128907422|NCT02109484|463952119|FG005|Overall Study|Moved away from study area|0|||
128907423|NCT02109484|463952120|FG006|Overall Study|Moved away from study area|1|||
128907424|NCT02109484|463952121|FG007|Overall Study|Moved away from study area|1|||
128907425|NCT02111993|463952126|FG000|Overall Study|Physician Decision|5|||
128907426|NCT02111993|463952127|FG001|Overall Study|Physician Decision|4|||
128907427|NCT00293579|463952128|FG000|Overall Study|Withdrawal by Subject|1|||
128907428|NCT01180660|463952135|FG000|Overall Study|Changed to open surgery|1|||
128907429|NCT01180660|463952136|FG001|Overall Study|Changed to open surgery|0|||
128907430|NCT04042103|463952138|FG000|Overall Study|Lost to Follow-up|1|||
128907431|NCT04042103|463952138|FG000|Overall Study|Withdrawal by Subject|1|||
128907432|NCT03124563|463952139|FG000|Overall Study|Lost to Follow-up|1|||
128907433|NCT03124563|463952140|FG001|Overall Study|Lost to Follow-up|1|||
128907434|NCT03124563|463952139|FG000|Overall Study|Withdrawal by Subject|1|||
128907435|NCT03124563|463952140|FG001|Overall Study|Withdrawal by Subject|1|||
128907436|NCT02068547|463953436|FG000|Overall Study|Lost to Follow-up|3|||
128907437|NCT02068547|463953437|FG001|Overall Study|Lost to Follow-up|3|||
128907438|NCT02068547|463953436|FG000|Overall Study|Physician Decision|1|||
128907439|NCT02068547|463953437|FG001|Overall Study|Physician Decision|0|||
128907440|NCT01391000|463953438|FG000|Overall Study|Lost to Follow-up|2|||
128907441|NCT01391000|463953439|FG001|Overall Study|Lost to Follow-up|0|||
128907442|NCT00817531|463953440|FG000|Overall Study|Adverse Event|1|||
128907443|NCT00817531|463953440|FG000|Overall Study|Lack of Efficacy|1|||
128907444|NCT00132132|463953444|FG000|Overall Study|Lost to Follow-up|7|||
128907445|NCT00132132|463953445|FG001|Overall Study|Lost to Follow-up|2|||
128696495|NCT04439201|463185383|FG000|Overall Study|Mutation status not confirmed|4|||
128696496|NCT04439201|463185383|FG000|Overall Study|Adverse Event|1|||
128696497|NCT04439201|463185383|FG000|Overall Study|Death|7|||
129117585|NCT03176771|464727415|FG000|Double-Blind Extension Period|Death|0|||
129117586|NCT03176771|464727416|FG001|Double-Blind Extension Period|Death|0|||
128907446|NCT03468309|463953450|FG000|Overall Study|Lost to Follow-up|4|||
128907447|NCT03468309|463953450|FG000|Overall Study|Withdrawal by Subject|2|||
128907448|NCT01496885|463953454|FG000|Overall Study|Lost to Follow-up|13|||
128907449|NCT01496885|463953454|FG000|Overall Study|Withdrawal by Subject|7|||
128907450|NCT01496885|463953454|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
128907451|NCT01496885|463953454|FG000|Overall Study|Death|1|||
128907452|NCT03446885|463953455|FG000|Overall Study|Lost to Follow-up|1|||
128907453|NCT03446885|463953456|FG001|Overall Study|Lost to Follow-up|0|||
128907454|NCT03446885|463953455|FG000|Overall Study|Did not complete entire visit|1|||
128907455|NCT03446885|463953456|FG001|Overall Study|Did not complete entire visit|0|||
128907456|NCT00252057|463953463|FG000|Overall Study|Withdrawal by Subject|2|||
128907457|NCT00252057|463953464|FG001|Overall Study|Withdrawal by Subject|5|||
128907458|NCT00252057|463953463|FG000|Overall Study|Death|1|||
128907459|NCT00252057|463953464|FG001|Overall Study|Death|2|||
128907460|NCT00252057|463953463|FG000|Overall Study|Participant previously enrolled|0|||
128907461|NCT00252057|463953464|FG001|Overall Study|Participant previously enrolled|1|||
128907462|NCT01098071|463953471|FG000|Overall Study|Surgery (adenoidectomy)|2|||
128907463|NCT01098071|463953471|FG000|Overall Study|Lost to Follow-up|13|||
128907464|NCT00143455|463953473|FG000|Cohort 1|Adverse Event|8|||
128907465|NCT00143455|463953474|FG001|Cohort 1|Adverse Event|4|||
128907466|NCT00143455|463953475|FG002|Cohort 1|Adverse Event|0|||
128907467|NCT00143455|463953476|FG003|Cohort 1|Adverse Event|0|||
128907468|NCT00143455|463953473|FG000|Cohort 1|Death|5|||
128907469|NCT00143455|463953474|FG001|Cohort 1|Death|2|||
128907470|NCT00143455|463953475|FG002|Cohort 1|Death|0|||
128907471|NCT00143455|463953476|FG003|Cohort 1|Death|0|||
128907472|NCT00143455|463953473|FG000|Cohort 1|Progressive Disease|0|||
128907473|NCT00143455|463953474|FG001|Cohort 1|Progressive Disease|6|||
128907474|NCT00143455|463953475|FG002|Cohort 1|Progressive Disease|0|||
128907475|NCT00143455|463953476|FG003|Cohort 1|Progressive Disease|0|||
128907476|NCT00143455|463953473|FG000|Cohort 1|Withdrawal by Subject|1|||
128907477|NCT00143455|463953474|FG001|Cohort 1|Withdrawal by Subject|4|||
128907478|NCT00143455|463953475|FG002|Cohort 1|Withdrawal by Subject|0|||
128907479|NCT00143455|463953476|FG003|Cohort 1|Withdrawal by Subject|0|||
129117587|NCT03176771|464727417|FG002|Double-Blind Extension Period|Death|0|||
129117588|NCT03176771|464727418|FG003|Double-Blind Extension Period|Death|3|||
129117589|NCT03176771|464727419|FG004|Double-Blind Extension Period|Death|4|||
129117590|NCT03176771|464727415|FG000|Double-Blind Extension Period|Physician Decision|0|||
129117591|NCT03176771|464727416|FG001|Double-Blind Extension Period|Physician Decision|0|||
129117592|NCT03176771|464727417|FG002|Double-Blind Extension Period|Physician Decision|0|||
129117593|NCT03176771|464727418|FG003|Double-Blind Extension Period|Physician Decision|3|||
129117594|NCT03176771|464727419|FG004|Double-Blind Extension Period|Physician Decision|1|||
129117595|NCT03176771|464727415|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
128696498|NCT04439201|463185383|FG000|Overall Study|Withdrawal by Subject|2|||
128696499|NCT04439201|463185383|FG000|Overall Study|Disease progression|20|||
128696500|NCT04439201|463185383|FG000|Overall Study|Alternative therapy|1|||
128696501|NCT04439201|463185383|FG000|Overall Study|Physician Decision|1|||
128696502|NCT02400333|463186790|FG000|Overall Study|Withdrawal by Subject|0|||
128696503|NCT02400333|463186791|FG001|Overall Study|Withdrawal by Subject|1|||
128696504|NCT02400333|463186792|FG002|Overall Study|Withdrawal by Subject|0|||
128696505|NCT02400333|463186793|FG003|Overall Study|Withdrawal by Subject|1|||
128907480|NCT00143455|463953473|FG000|Cohort 1|Randomized But Not Treated|0|||
128907481|NCT00143455|463953474|FG001|Cohort 1|Randomized But Not Treated|1|||
128907482|NCT00143455|463953475|FG002|Cohort 1|Randomized But Not Treated|0|||
128907483|NCT00143455|463953476|FG003|Cohort 1|Randomized But Not Treated|0|||
128907484|NCT00143455|463953473|FG000|Cohort 2|Adverse Event|0|||
128907485|NCT00143455|463953474|FG001|Cohort 2|Adverse Event|0|||
128907486|NCT00143455|463953475|FG002|Cohort 2|Adverse Event|42|||
128907487|NCT00143455|463953476|FG003|Cohort 2|Adverse Event|30|||
128907488|NCT00143455|463953473|FG000|Cohort 2|No Longer Required Study Treatment|0|||
128907489|NCT00143455|463953474|FG001|Cohort 2|No Longer Required Study Treatment|0|||
128907490|NCT00143455|463953475|FG002|Cohort 2|No Longer Required Study Treatment|1|||
128907491|NCT00143455|463953476|FG003|Cohort 2|No Longer Required Study Treatment|0|||
128907492|NCT00143455|463953473|FG000|Cohort 2|Protocol Violation|0|||
128907493|NCT00143455|463953474|FG001|Cohort 2|Protocol Violation|0|||
128907494|NCT00143455|463953475|FG002|Cohort 2|Protocol Violation|1|||
128907495|NCT00143455|463953476|FG003|Cohort 2|Protocol Violation|1|||
128907496|NCT00143455|463953473|FG000|Cohort 2|Lost to Follow-up|0|||
128696506|NCT02400333|463186790|FG000|Overall Study|Protocol Violation|1|||
128696507|NCT02400333|463186791|FG001|Overall Study|Protocol Violation|0|||
128907497|NCT00143455|463953474|FG001|Cohort 2|Lost to Follow-up|0|||
128907498|NCT00143455|463953475|FG002|Cohort 2|Lost to Follow-up|1|||
128907499|NCT00143455|463953476|FG003|Cohort 2|Lost to Follow-up|4|||
128907500|NCT00143455|463953473|FG000|Cohort 2|Death|0|||
128907501|NCT00143455|463953474|FG001|Cohort 2|Death|0|||
128907502|NCT00143455|463953475|FG002|Cohort 2|Death|20|||
128907503|NCT00143455|463953476|FG003|Cohort 2|Death|12|||
128907504|NCT00143455|463953473|FG000|Cohort 2|Progressive Disease|0|||
128907505|NCT00143455|463953474|FG001|Cohort 2|Progressive Disease|0|||
128907506|NCT00143455|463953475|FG002|Cohort 2|Progressive Disease|20|||
128907507|NCT00143455|463953476|FG003|Cohort 2|Progressive Disease|27|||
128907508|NCT00143455|463953473|FG000|Cohort 2|Withdrawal by Subject|0|||
128907509|NCT00143455|463953474|FG001|Cohort 2|Withdrawal by Subject|0|||
128907510|NCT00143455|463953475|FG002|Cohort 2|Withdrawal by Subject|13|||
128907511|NCT00143455|463953476|FG003|Cohort 2|Withdrawal by Subject|12|||
128907512|NCT00143455|463953473|FG000|Cohort 2|Other|0|||
128907513|NCT00143455|463953474|FG001|Cohort 2|Other|0|||
128907514|NCT00143455|463953475|FG002|Cohort 2|Other|7|||
128907515|NCT00143455|463953476|FG003|Cohort 2|Other|6|||
128907516|NCT00143455|463953473|FG000|Cohort 2|Randomized But Not Treated|0|||
128907517|NCT00143455|463953474|FG001|Cohort 2|Randomized But Not Treated|0|||
128907518|NCT00143455|463953475|FG002|Cohort 2|Randomized But Not Treated|1|||
128907519|NCT00143455|463953476|FG003|Cohort 2|Randomized But Not Treated|1|||
128907520|NCT03713944|463953477|FG000|Study Treatment|Patient non-compliance|1|||
128907521|NCT03713944|463953477|FG000|Study Treatment|Alternative Cancer Therapy|3|||
128907522|NCT03713944|463953477|FG000|Study Treatment|Disease Progression|18|||
128907523|NCT03713944|463953477|FG000|Study Treatment|AE/Side Effects/Complications|2|||
128907524|NCT03713944|463953477|FG000|Study Treatment|Death|2|||
128907525|NCT03713944|463953477|FG000|Study Treatment|Withdrawal by Subject|1|||
128907526|NCT03713944|463953477|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
128907527|NCT03713944|463953477|FG000|Study Treatment|Symptomatic Deterioration|2|||
128907528|NCT03713944|463953477|FG000|Follow up|Withdrawal by Subject|2|||
128907529|NCT03713944|463953477|FG000|Follow up|Death|11|||
128907530|NCT03713944|463953477|FG000|Follow up|Study Terminated|3|||
128907531|NCT00419380|463953480|FG000|Overall Study|Lack of Efficacy|1|||
128907532|NCT00419380|463953481|FG001|Overall Study|Lack of Efficacy|7|||
128907533|NCT00419380|463953480|FG000|Overall Study|Physician Decision|0|||
128907534|NCT00419380|463953481|FG001|Overall Study|Physician Decision|1|||
128907535|NCT00419380|463953480|FG000|Overall Study|Lost to Follow-up|0|||
128907536|NCT00419380|463953481|FG001|Overall Study|Lost to Follow-up|1|||
128907537|NCT00419380|463953480|FG000|Overall Study|Withdrawal by Subject|0|||
128907538|NCT00419380|463953481|FG001|Overall Study|Withdrawal by Subject|1|||
129117596|NCT03176771|464727416|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
129117597|NCT03176771|464727417|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
129117598|NCT03176771|464727418|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
129117599|NCT03176771|464727419|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
129117600|NCT03530293|464727420|FG000|Pre-randomization|Adverse Event|12|||
129117601|NCT03530293|464727421|FG001|Pre-randomization|Adverse Event|0|||
128765211|NCT00661661|463432088|FG001|Overall Study|Lost to Follow-up|1|||
129117602|NCT03530293|464727422|FG002|Pre-randomization|Adverse Event|0|||
129117603|NCT03530293|464727420|FG000|Pre-randomization|Protocol Violation|2|||
129117604|NCT03530293|464727421|FG001|Pre-randomization|Protocol Violation|0|||
129117605|NCT03530293|464727422|FG002|Pre-randomization|Protocol Violation|0|||
129117606|NCT03530293|464727420|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
129117607|NCT03530293|464727421|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
129117608|NCT03530293|464727422|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
129117609|NCT03530293|464727420|FG000|Pre-randomization|Withdrawal by Subject|5|||
129117610|NCT03530293|464727421|FG001|Pre-randomization|Withdrawal by Subject|0|||
128765212|NCT00661661|463432087|FG000|Overall Study|Withdrawal by Subject|15|||
128765213|NCT00661661|463432088|FG001|Overall Study|Withdrawal by Subject|5|||
128765214|NCT00661661|463432087|FG000|Overall Study|Other|22|||
128765215|NCT00661661|463432088|FG001|Overall Study|Other|7|||
128765216|NCT00661661|463432087|FG000|Overall Study|Not assigned treatment|1|||
128907539|NCT03127384|463953484|FG000|Overall Study|Lost to Follow-up|4|||
128907540|NCT03127384|463953484|FG000|Overall Study|Subject request|2|||
128907541|NCT01026831|463953486|FG000|Overall Study|Adverse Event|4|||
128907542|NCT01026831|463953487|FG001|Overall Study|Adverse Event|3|||
128907543|NCT01026831|463953486|FG000|Overall Study|Lost to Follow-up|2|||
128907544|NCT01026831|463953487|FG001|Overall Study|Lost to Follow-up|0|||
128907545|NCT01026831|463953486|FG000|Overall Study|Physician Decision|1|||
128907546|NCT01026831|463953487|FG001|Overall Study|Physician Decision|1|||
128907547|NCT01026831|463953486|FG000|Overall Study|Protocol Violation|0|||
128907548|NCT01026831|463953487|FG001|Overall Study|Protocol Violation|2|||
128907549|NCT01026831|463953486|FG000|Overall Study|Withdrawal by Subject|7|||
128907550|NCT01026831|463953487|FG001|Overall Study|Withdrawal by Subject|5|||
128907551|NCT04417894|463953488|FG000|Overall Study|Lost to Follow-up|3|||
128907552|NCT04417894|463953489|FG001|Overall Study|Lost to Follow-up|0|||
128907553|NCT04417894|463953488|FG000|Overall Study|Withdrawal by Subject|7|||
128765217|NCT00661661|463432088|FG001|Overall Study|Not assigned treatment|0|||
128907554|NCT04417894|463953489|FG001|Overall Study|Withdrawal by Subject|6|||
128907555|NCT04417894|463953488|FG000|Overall Study|Lack of Efficacy|3|||
128907556|NCT04417894|463953489|FG001|Overall Study|Lack of Efficacy|1|||
128907557|NCT03861559|463953490|FG000|Overall Study|Adverse Event|0|||
128907558|NCT03861559|463953491|FG001|Overall Study|Adverse Event|2|||
128907559|NCT03861559|463953490|FG000|Overall Study|Treatment failure|0|||
128907560|NCT03861559|463953491|FG001|Overall Study|Treatment failure|2|||
128907561|NCT03861559|463953490|FG000|Overall Study|Noncompliance|1|||
128907562|NCT03861559|463953491|FG001|Overall Study|Noncompliance|1|||
128907563|NCT03861559|463953490|FG000|Overall Study|Did not meet eligibility requirements|1|||
128907564|NCT03861559|463953491|FG001|Overall Study|Did not meet eligibility requirements|0|||
128907565|NCT03652662|463953492|FG000|Overall Study|Withdrawal by Subject|2|||
128907566|NCT03652662|463953493|FG001|Overall Study|Withdrawal by Subject|1|||
128907567|NCT03652662|463953492|FG000|Overall Study|Lost to Follow-up|1|||
128907568|NCT03652662|463953493|FG001|Overall Study|Lost to Follow-up|0|||
128907569|NCT00487539|463953494|FG000|Overall Study|Adverse Event|3|||
128907570|NCT00487539|463953495|FG001|Overall Study|Adverse Event|2|||
128907571|NCT00487539|463953496|FG002|Overall Study|Adverse Event|1|||
128907572|NCT00487539|463953497|FG003|Overall Study|Adverse Event|1|||
128907573|NCT00487539|463953494|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128907574|NCT00487539|463953495|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128907575|NCT00487539|463953496|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
128907576|NCT00487539|463953497|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
128907577|NCT00487539|463953494|FG000|Overall Study|Other|3|||
128907578|NCT00487539|463953495|FG001|Overall Study|Other|1|||
128907579|NCT00487539|463953496|FG002|Overall Study|Other|2|||
128907580|NCT00487539|463953497|FG003|Overall Study|Other|2|||
128907581|NCT03440814|463953498|FG000|Overall Study|Adverse Event|2|||
128907582|NCT03440814|463953499|FG001|Overall Study|Adverse Event|1|||
128907583|NCT03440814|463953498|FG000|Overall Study|Lost to Follow-up|2|||
128907584|NCT03440814|463953499|FG001|Overall Study|Lost to Follow-up|0|||
128907585|NCT03440814|463953498|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
128907586|NCT03440814|463953499|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
128907587|NCT00879697|463953500|FG000|Overall Study|Physician Decision|2|||
128907588|NCT00879697|463953501|FG001|Overall Study|Physician Decision|2|||
128907589|NCT02751502|463953502|FG000|Overall Study|Lack of funding|4|||
128907590|NCT00088374|463953503|FG000|Overall Study|patient did not receive any 17AAG|1|||
128907591|NCT00088374|463953503|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
128907592|NCT02678390|463953504|FG000|AE (1 Day)|Withdrawal by Subject|0|||
128907593|NCT02678390|463953505|FG001|AE (1 Day)|Withdrawal by Subject|1|||
128907594|NCT00498173|463953506|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
128907595|NCT00498173|463953507|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
128907596|NCT00498173|463953508|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
128907597|NCT01110200|463953509|FG000|Overall Study|Adverse Event|28|||
128907598|NCT01110200|463953510|FG001|Overall Study|Adverse Event|28|||
128907599|NCT01110200|463953509|FG000|Overall Study|Withdrawal by Subject|25|||
128907600|NCT01110200|463953510|FG001|Overall Study|Withdrawal by Subject|32|||
128907601|NCT01110200|463953509|FG000|Overall Study|Lack of Efficacy|16|||
128907602|NCT01110200|463953510|FG001|Overall Study|Lack of Efficacy|25|||
128907603|NCT01110200|463953509|FG000|Overall Study|Protocol Violation|14|||
128907604|NCT01110200|463953510|FG001|Overall Study|Protocol Violation|12|||
128907605|NCT01110200|463953509|FG000|Overall Study|Physician Decision|13|||
128907606|NCT01110200|463953510|FG001|Overall Study|Physician Decision|17|||
129027698|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
129027699|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
129027700|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
129027701|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
129027702|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
129027703|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
129027704|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
129027705|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
129027706|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
129027707|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
129027708|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
129027709|NCT02227238|464391759|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
129027710|NCT02227238|464391760|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
129027711|NCT02227238|464391761|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
129027712|NCT02227238|464391759|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
129027713|NCT02227238|464391760|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
129027714|NCT02227238|464391761|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
129027715|NCT02227238|464391759|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
129027716|NCT02227238|464391760|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
129027717|NCT02227238|464391761|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
129027718|NCT02227238|464391759|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
129027719|NCT02227238|464391760|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
128907607|NCT01110200|463953509|FG000|Overall Study|Lost to Follow-up|10|||
128907608|NCT01110200|463953510|FG001|Overall Study|Lost to Follow-up|7|||
128907609|NCT00903175|463953511|FG000|Period 1 - First Line|Adverse Event|36|||
128907610|NCT00903175|463953512|FG001|Period 1 - First Line|Adverse Event|50|||
128907611|NCT00903175|463953511|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
128907612|NCT00903175|463953512|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
128907613|NCT00903175|463953511|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
128907614|NCT00903175|463953512|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
128907615|NCT00903175|463953511|FG000|Period 1 - First Line|Protocol Violation|3|||
128907616|NCT00903175|463953512|FG001|Period 1 - First Line|Protocol Violation|3|||
128907617|NCT00903175|463953511|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
128907618|NCT00903175|463953512|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
128907619|NCT00903175|463953511|FG000|Period 1 - First Line|Administrative problems|12|||
128907620|NCT00903175|463953512|FG001|Period 1 - First Line|Administrative problems|13|||
128907621|NCT00903175|463953511|FG000|Period 1 - First Line|Death|17|||
128907622|NCT00903175|463953512|FG001|Period 1 - First Line|Death|10|||
128907623|NCT00903175|463953511|FG000|Period 2 - Second Line|Missing|1|||
128907624|NCT00903175|463953512|FG001|Period 2 - Second Line|Missing|0|||
128907625|NCT00903175|463953511|FG000|Period 2 - Second Line|Adverse Event|16|||
128907626|NCT00903175|463953512|FG001|Period 2 - Second Line|Adverse Event|20|||
128907627|NCT00903175|463953511|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
128907628|NCT00903175|463953512|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
128907629|NCT00903175|463953511|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
128907630|NCT00903175|463953512|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
128907631|NCT00903175|463953511|FG000|Period 2 - Second Line|Administrative problems|19|||
128907632|NCT00903175|463953512|FG001|Period 2 - Second Line|Administrative problems|9|||
128907633|NCT00903175|463953511|FG000|Period 2 - Second Line|Death|5|||
128907634|NCT00903175|463953512|FG001|Period 2 - Second Line|Death|2|||
128907635|NCT01687712|463953513|FG000|Cycle 1|Not Biochemically Pregnant|386|||
128907636|NCT01687712|463953514|FG001|Cycle 1|Not Biochemically Pregnant|348|||
128907637|NCT01687712|463953513|FG000|Cycle 1|Early Pregnancy Loss|43|||
128907638|NCT01687712|463953514|FG001|Cycle 1|Early Pregnancy Loss|60|||
128907639|NCT01687712|463953513|FG000|Cycle 1|Ectopic Pregnancy|5|||
128907640|NCT01687712|463953514|FG001|Cycle 1|Ectopic Pregnancy|5|||
128907641|NCT01687712|463953513|FG000|Cycle 1|Heterotropic Pregnancy|1|||
128907642|NCT01687712|463953514|FG001|Cycle 1|Heterotropic Pregnancy|0|||
128907643|NCT01687712|463953513|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
128907644|NCT01687712|463953514|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
128907645|NCT01687712|463953513|FG000|Cycle 1|Abortion|3|||
128907646|NCT01687712|463953514|FG001|Cycle 1|Abortion|0|||
128907647|NCT01687712|463953513|FG000|Cycle 1|Intrauterine Fetal Death|0|||
128907648|NCT01687712|463953514|FG001|Cycle 1|Intrauterine Fetal Death|1|||
128907649|NCT01687712|463953513|FG000|Cycle 1|Lost to Follow-up|1|||
128907650|NCT01687712|463953514|FG001|Cycle 1|Lost to Follow-up|1|||
128907651|NCT01687712|463953513|FG000|Cycle 2|Not Biochemically Pregnant|74|||
128907652|NCT01687712|463953514|FG001|Cycle 2|Not Biochemically Pregnant|77|||
128907653|NCT01687712|463953513|FG000|Cycle 2|Early Pregnancy Loss|18|||
128907654|NCT01687712|463953514|FG001|Cycle 2|Early Pregnancy Loss|16|||
128907655|NCT01687712|463953513|FG000|Cycle 2|Ectopic Pregnancy|0|||
128907656|NCT01687712|463953514|FG001|Cycle 2|Ectopic Pregnancy|1|||
128907657|NCT01687712|463953513|FG000|Cycle 2|Still Birth|1|||
128907658|NCT01687712|463953514|FG001|Cycle 2|Still Birth|0|||
128907659|NCT01687712|463953513|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
128907660|NCT01687712|463953514|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
128907661|NCT01687712|463953513|FG000|Cycle 3|Not Biochemically Pregnant|21|||
128907662|NCT01687712|463953514|FG001|Cycle 3|Not Biochemically Pregnant|22|||
128907663|NCT01687712|463953513|FG000|Cycle 3|Early Pregnancy Loss|1|||
128907664|NCT01687712|463953514|FG001|Cycle 3|Early Pregnancy Loss|2|||
128907665|NCT01687712|463953513|FG000|Cycle 3|Ectopic Pregnancy|1|||
128907666|NCT01687712|463953514|FG001|Cycle 3|Ectopic Pregnancy|0|||
128907667|NCT01687712|463953513|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
128907668|NCT01687712|463953514|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
129027720|NCT02227238|464391761|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
129027721|NCT02227238|464391759|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
129027722|NCT02227238|464391760|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
129027723|NCT02227238|464391761|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
129027724|NCT02227238|464391759|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
129027725|NCT02227238|464391760|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
129027726|NCT02227238|464391761|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
129132906|NCT02609633|464778564|FG000|Overall Study|Consent Withdrawn|0|||
128907669|NCT03074474|463953519|FG000|Overall Study|Lost to Follow-up|10|||
128907670|NCT03074474|463953519|FG000|Overall Study|Withdrawal by Subject|10|||
128907671|NCT03074474|463953519|FG000|Overall Study|Death|4|||
128907672|NCT03074474|463953519|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
128907673|NCT00371865|463953522|FG000|Overall Study|Lack of Efficacy|0|||
128907674|NCT00371865|463953523|FG001|Overall Study|Lack of Efficacy|2|||
128907675|NCT00371865|463953522|FG000|Overall Study|Protocol Violation|3|||
128907676|NCT00371865|463953523|FG001|Overall Study|Protocol Violation|2|||
128907677|NCT00371865|463953522|FG000|Overall Study|Withdrawal by Subject|12|||
128907678|NCT00371865|463953523|FG001|Overall Study|Withdrawal by Subject|10|||
128907679|NCT01632566|463953525|FG000|Overall Study|Withdrawal by Subject|0|||
128907680|NCT01632566|463953526|FG001|Overall Study|Withdrawal by Subject|1|||
128907681|NCT01632566|463953527|FG002|Overall Study|Withdrawal by Subject|0|||
128907682|NCT01632566|463953528|FG003|Overall Study|Withdrawal by Subject|0|||
128907683|NCT01632566|463953529|FG004|Overall Study|Withdrawal by Subject|0|||
128907684|NCT01632566|463953525|FG000|Overall Study|Sponsor Decision|0|||
128907685|NCT01632566|463953526|FG001|Overall Study|Sponsor Decision|2|||
128907686|NCT01632566|463953527|FG002|Overall Study|Sponsor Decision|9|||
128907687|NCT01632566|463953528|FG003|Overall Study|Sponsor Decision|2|||
128907688|NCT01632566|463953529|FG004|Overall Study|Sponsor Decision|2|||
128907689|NCT01318109|463953530|FG000|Overall Study|Adverse Event|0|||
128907690|NCT01318109|463953531|FG001|Overall Study|Adverse Event|2|||
128907691|NCT01318109|463953532|FG002|Overall Study|Adverse Event|0|||
128907692|NCT01318109|463953530|FG000|Overall Study|Withdrawal by Subject|1|||
128907693|NCT01318109|463953531|FG001|Overall Study|Withdrawal by Subject|0|||
128907694|NCT01318109|463953532|FG002|Overall Study|Withdrawal by Subject|0|||
128907695|NCT01318109|463953530|FG000|Overall Study|Schedule Conflict|0|||
128907696|NCT01318109|463953531|FG001|Overall Study|Schedule Conflict|1|||
128907697|NCT01318109|463953532|FG002|Overall Study|Schedule Conflict|0|||
128907698|NCT01328951|463953533|FG000|Overall Study|Disease Progression|17|||
128907699|NCT01328951|463953534|FG001|Overall Study|Disease Progression|14|||
128907700|NCT01328951|463953533|FG000|Overall Study|Adverse Event|2|||
128907701|NCT01328951|463953534|FG001|Overall Study|Adverse Event|0|||
128907702|NCT01328951|463953533|FG000|Overall Study|Death|243|||
128907703|NCT01328951|463953534|FG001|Overall Study|Death|258|||
128907704|NCT01328951|463953533|FG000|Overall Study|Lost to Follow-up|6|||
128907705|NCT01328951|463953534|FG001|Overall Study|Lost to Follow-up|7|||
128907706|NCT01328951|463953533|FG000|Overall Study|Withdrawal by Subject|6|||
128907707|NCT01328951|463953534|FG001|Overall Study|Withdrawal by Subject|6|||
128907708|NCT01328951|463953533|FG000|Overall Study|Study Closed by the Sponsor|36|||
128907709|NCT01328951|463953534|FG001|Overall Study|Study Closed by the Sponsor|31|||
128907710|NCT01328951|463953533|FG000|Overall Study|Other|11|||
128907711|NCT01328951|463953534|FG001|Overall Study|Other|6|||
128907712|NCT01003210|463953538|FG000|Overall Study|Lost to Follow-up|1|||
128907713|NCT01003210|463953539|FG001|Overall Study|Lost to Follow-up|3|||
128907714|NCT00271817|463953540|FG000|Part 1|Adverse Event|68|||
128907715|NCT00271817|463953541|FG001|Part 1|Adverse Event|25|||
128907716|NCT00271817|463953542|FG002|Part 1|Adverse Event|156|||
128907717|NCT00271817|463953540|FG000|Part 1|Lost to Follow-up|6|||
128907718|NCT00271817|463953541|FG001|Part 1|Lost to Follow-up|8|||
128907719|NCT00271817|463953542|FG002|Part 1|Lost to Follow-up|24|||
128907720|NCT00271817|463953540|FG000|Part 1|Protocol Violation|5|||
128907721|NCT00271817|463953541|FG001|Part 1|Protocol Violation|4|||
128907722|NCT00271817|463953542|FG002|Part 1|Protocol Violation|7|||
128907723|NCT00271817|463953540|FG000|Part 1|Patient Moved|3|||
128907724|NCT00271817|463953541|FG001|Part 1|Patient Moved|1|||
128907725|NCT00271817|463953542|FG002|Part 1|Patient Moved|5|||
128907726|NCT00271817|463953540|FG000|Part 1|Withdrawal by Subject|23|||
128907727|NCT00271817|463953541|FG001|Part 1|Withdrawal by Subject|17|||
128907728|NCT00271817|463953542|FG002|Part 1|Withdrawal by Subject|45|||
128907729|NCT00271817|463953540|FG000|Part 1|LDL < 50 mg/dL|1|||
128907730|NCT00271817|463953541|FG001|Part 1|LDL < 50 mg/dL|4|||
128907731|NCT00271817|463953542|FG002|Part 1|LDL < 50 mg/dL|48|||
128907732|NCT00271817|463953540|FG000|Part 2|Adverse Event|0|||
128907733|NCT00271817|463953541|FG001|Part 2|Adverse Event|17|||
128907734|NCT00271817|463953542|FG002|Part 2|Adverse Event|33|||
128907735|NCT00271817|463953540|FG000|Part 2|Lack of Efficacy|0|||
128907736|NCT00271817|463953541|FG001|Part 2|Lack of Efficacy|1|||
128907737|NCT00271817|463953542|FG002|Part 2|Lack of Efficacy|6|||
128907738|NCT00271817|463953540|FG000|Part 2|Lost to Follow-up|0|||
129117611|NCT03530293|464727422|FG002|Pre-randomization|Withdrawal by Subject|0|||
128907739|NCT00271817|463953541|FG001|Part 2|Lost to Follow-up|6|||
128907740|NCT00271817|463953542|FG002|Part 2|Lost to Follow-up|18|||
128907741|NCT00271817|463953540|FG000|Part 2|Protocol Violation|0|||
128907742|NCT00271817|463953541|FG001|Part 2|Protocol Violation|3|||
128907743|NCT00271817|463953542|FG002|Part 2|Protocol Violation|5|||
128907744|NCT00271817|463953540|FG000|Part 2|Patient Moved|0|||
128907745|NCT00271817|463953541|FG001|Part 2|Patient Moved|0|||
128907746|NCT00271817|463953542|FG002|Part 2|Patient Moved|5|||
128907747|NCT00271817|463953540|FG000|Part 2|Withdrawal by Subject|0|||
128907748|NCT00271817|463953541|FG001|Part 2|Withdrawal by Subject|2|||
128907749|NCT00271817|463953542|FG002|Part 2|Withdrawal by Subject|13|||
128907750|NCT00271817|463953540|FG000|Part 2|LDL < 50 mg/dL|0|||
128907751|NCT00271817|463953541|FG001|Part 2|LDL < 50 mg/dL|3|||
128907752|NCT00271817|463953542|FG002|Part 2|LDL < 50 mg/dL|4|||
128907753|NCT04153188|463953545|FG000|Overall Study|Lost to Follow-up|1|||
128907754|NCT04153188|463953546|FG001|Overall Study|Lost to Follow-up|1|||
128907755|NCT04153188|463953545|FG000|Overall Study|Withdrawal by Subject|2|||
128907756|NCT04153188|463953546|FG001|Overall Study|Withdrawal by Subject|0|||
128907757|NCT04153188|463953545|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
128907758|NCT04153188|463953546|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
128907759|NCT00264238|463953548|FG000|Overall Study|Protocol Violation|1|||
128907760|NCT00700271|463953549|FG000|Overall Study|Adverse Event|4|||
128907761|NCT00700271|463953550|FG001|Overall Study|Adverse Event|6|||
128907762|NCT00700271|463953549|FG000|Overall Study|Protocol Violation|1|||
128907763|NCT00700271|463953550|FG001|Overall Study|Protocol Violation|0|||
128907764|NCT00700271|463953549|FG000|Overall Study|Administrative Reasons|1|||
128907765|NCT00700271|463953550|FG001|Overall Study|Administrative Reasons|0|||
128907766|NCT00700271|463953549|FG000|Overall Study|Withdrawal by Subject|6|||
128907767|NCT00700271|463953550|FG001|Overall Study|Withdrawal by Subject|4|||
128907768|NCT00700271|463953549|FG000|Overall Study|Lost to Follow-up|2|||
128907769|NCT00700271|463953550|FG001|Overall Study|Lost to Follow-up|2|||
128907770|NCT00861744|463953551|FG000|Overall Study|Adverse Event|0|||
128907771|NCT00861744|463953552|FG001|Overall Study|Adverse Event|0|||
128907772|NCT00861744|463953553|FG002|Overall Study|Adverse Event|0|||
128907773|NCT00861744|463953554|FG003|Overall Study|Adverse Event|1|||
128907774|NCT00861744|463953551|FG000|Overall Study|Lost to Follow-up|7|||
128907775|NCT00861744|463953552|FG001|Overall Study|Lost to Follow-up|19|||
128907776|NCT00861744|463953553|FG002|Overall Study|Lost to Follow-up|17|||
128907777|NCT00861744|463953554|FG003|Overall Study|Lost to Follow-up|12|||
128907778|NCT00861744|463953551|FG000|Overall Study|Withdrawal by Subject|10|||
128907779|NCT00861744|463953552|FG001|Overall Study|Withdrawal by Subject|6|||
128907780|NCT00861744|463953553|FG002|Overall Study|Withdrawal by Subject|6|||
128907781|NCT00861744|463953554|FG003|Overall Study|Withdrawal by Subject|19|||
128907782|NCT00861744|463953551|FG000|Overall Study|Protocol Violation|0|||
128907783|NCT00861744|463953552|FG001|Overall Study|Protocol Violation|1|||
128907784|NCT00861744|463953553|FG002|Overall Study|Protocol Violation|0|||
128907785|NCT00861744|463953554|FG003|Overall Study|Protocol Violation|0|||
128907786|NCT00861744|463953551|FG000|Overall Study|Migration from study area|0|||
128907787|NCT00861744|463953552|FG001|Overall Study|Migration from study area|3|||
128907788|NCT00861744|463953553|FG002|Overall Study|Migration from study area|1|||
128907789|NCT00861744|463953554|FG003|Overall Study|Migration from study area|0|||
128907790|NCT00861744|463953551|FG000|Overall Study|Blood draws|0|||
128907791|NCT00861744|463953552|FG001|Overall Study|Blood draws|0|||
128907792|NCT00861744|463953553|FG002|Overall Study|Blood draws|0|||
128907793|NCT00861744|463953554|FG003|Overall Study|Blood draws|1|||
128907794|NCT05107765|463953555|FG000|Overall Study|Lost to Follow-up|4|||
128907795|NCT05107765|463953556|FG001|Overall Study|Lost to Follow-up|1|||
128907796|NCT05107765|463953555|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
128907797|NCT05107765|463953556|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
128907798|NCT05107765|463953555|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
128907799|NCT05107765|463953556|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
128907800|NCT01411085|463953559|FG000|Overall Study|Physician Decision|1|||
128907801|NCT01411085|463953559|FG000|Overall Study|Protocol Violation|1|||
128907802|NCT01411085|463953559|FG000|Overall Study|Adverse Event|1|||
128907803|NCT03809611|463953560|FG000|Overall Study|Withdrawal by Subject|1|||
129027727|NCT02227238|464391759|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
129027728|NCT02227238|464391760|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
128696508|NCT02400333|463186792|FG002|Overall Study|Protocol Violation|2|||
128696509|NCT02400333|463186793|FG003|Overall Study|Protocol Violation|1|||
128696510|NCT02280304|463186795|FG000|Overall Study|Lost to Follow-up|7|||
128696511|NCT02280304|463186796|FG001|Overall Study|Lost to Follow-up|8|||
128696512|NCT01890473|463186800|FG000|Overall Study|Lost to Follow-up|1|||
128696513|NCT01890473|463186801|FG001|Overall Study|Lost to Follow-up|0|||
128696514|NCT01890473|463186800|FG000|Overall Study|Poor/non-compliance|1|||
128696515|NCT01890473|463186801|FG001|Overall Study|Poor/non-compliance|0|||
128696516|NCT00934089|463186802|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
128696517|NCT00934089|463186803|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
128696518|NCT00934089|463186802|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
128696519|NCT00934089|463186803|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
128696520|NCT00003473|463186804|FG000|Overall Study|Three patients were not evaluable.|3|||
128696521|NCT01947582|463186812|FG000|Overall Study|Withdrawal by Subject|1|||
128696522|NCT01603355|463186813|FG000|Overall Study|Lack of Efficacy|2|||
128907804|NCT03809611|463953561|FG001|Overall Study|Withdrawal by Subject|1|||
128907805|NCT02193074|463953562|FG000|Overall Study|Withdrawal by Subject|1|||
128907806|NCT02193074|463953563|FG001|Overall Study|Withdrawal by Subject|2|||
128907807|NCT02193074|463953562|FG000|Overall Study|Adverse Event|16|||
128907808|NCT02193074|463953563|FG001|Overall Study|Adverse Event|13|||
128907809|NCT01534533|463953564|FG000|Overall Study|Lost to Follow-up|3|||
128696523|NCT00864721|463186817|FG000|Overall Study|Patient request|11|||
128907810|NCT01534533|463953565|FG001|Overall Study|Lost to Follow-up|0|||
128907811|NCT01534533|463953566|FG002|Overall Study|Lost to Follow-up|4|||
128907812|NCT01534533|463953567|FG003|Overall Study|Lost to Follow-up|3|||
128907813|NCT01534533|463953564|FG000|Overall Study|Withdrawal by Subject|5|||
128907814|NCT01534533|463953565|FG001|Overall Study|Withdrawal by Subject|3|||
128907815|NCT01534533|463953566|FG002|Overall Study|Withdrawal by Subject|4|||
128907816|NCT01534533|463953567|FG003|Overall Study|Withdrawal by Subject|1|||
128907817|NCT03368170|463955030|FG000|Overall Study|Adverse Event|2|||
128907818|NCT03368170|463955031|FG001|Overall Study|Adverse Event|1|||
128907819|NCT01662440|463955036|FG000|Overall Study|Adverse Event|1|||
128907820|NCT01662440|463955037|FG001|Overall Study|Adverse Event|0|||
128907821|NCT01662440|463955038|FG002|Overall Study|Adverse Event|0|||
128907822|NCT01662440|463955039|FG003|Overall Study|Adverse Event|1|||
128765218|NCT01893827|463432089|FG000|Overall Study|Lost to Follow-up|19|||
128765219|NCT01893827|463432090|FG001|Overall Study|Lost to Follow-up|26|||
128765220|NCT04182880|463432093|FG000|Overall Study|Pregnancy|1|||
128765221|NCT04182880|463432094|FG001|Overall Study|Pregnancy|0|||
128765222|NCT03389477|463432095|FG000|Step 1|Withdrawal by Subject|1|||
128765223|NCT03389477|463432096|FG001|Step 1|Withdrawal by Subject|0|||
128907823|NCT01662440|463955036|FG000|Overall Study|Death|0|||
128907824|NCT01662440|463955037|FG001|Overall Study|Death|1|||
128907825|NCT01662440|463955038|FG002|Overall Study|Death|0|||
128696524|NCT00864721|463186817|FG000|Overall Study|Hospitalized|1|||
128696525|NCT00864721|463186817|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
128696526|NCT00864721|463186817|FG000|Overall Study|Adverse Event|21|||
128696527|NCT01705730|463186818|FG000|Overall Study|Lack of Efficacy|1|||
128696528|NCT01705730|463186818|FG000|Overall Study|Adverse Event|3|||
128696529|NCT01705730|463186818|FG000|Overall Study|Lost to Follow-up|1|||
128696530|NCT01705730|463186818|FG000|Overall Study|Reason not Specified|4|||
128696531|NCT01773733|463186819|FG000|Overall Study|Adverse Event|3286|||
128696532|NCT01773733|463186820|FG001|Overall Study|Adverse Event|540|||
128696533|NCT01773733|463186819|FG000|Overall Study|Pregnancy|28|||
128696534|NCT01773733|463186820|FG001|Overall Study|Pregnancy|0|||
128696535|NCT01773733|463186819|FG000|Overall Study|Other different categories of not compl|55415|||
128696536|NCT01773733|463186820|FG001|Overall Study|Other different categories of not compl|7781|||
128696537|NCT00705289|463186821|FG000|Overall Study|Subject or treating physician's choice|131|||
128696538|NCT02601027|463186822|FG000|Registration to Surgery|Withdrawal by Subject|20|||
128696539|NCT02601027|463186823|FG001|Registration to Surgery|Withdrawal by Subject|10|||
128696540|NCT02609828|463186824|FG000|Overall Study|Adverse Event|8|||
128696541|NCT02609828|463186825|FG001|Overall Study|Adverse Event|1|||
128696542|NCT02609828|463186826|FG002|Overall Study|Adverse Event|0|||
128696543|NCT02609828|463186827|FG003|Overall Study|Adverse Event|6|||
128696544|NCT02609828|463186824|FG000|Overall Study|Death|15|||
128696545|NCT02609828|463186825|FG001|Overall Study|Death|1|||
128696546|NCT02609828|463186826|FG002|Overall Study|Death|1|||
128696547|NCT02609828|463186827|FG003|Overall Study|Death|19|||
128696548|NCT02609828|463186824|FG000|Overall Study|Insufficient clinical response|2|||
128696549|NCT02609828|463186825|FG001|Overall Study|Insufficient clinical response|1|||
128696550|NCT02609828|463186826|FG002|Overall Study|Insufficient clinical response|0|||
128696551|NCT02609828|463186827|FG003|Overall Study|Insufficient clinical response|0|||
128696552|NCT02609828|463186824|FG000|Overall Study|Lost to Follow-up|0|||
128696553|NCT02609828|463186825|FG001|Overall Study|Lost to Follow-up|0|||
128696554|NCT02609828|463186826|FG002|Overall Study|Lost to Follow-up|0|||
128696555|NCT02609828|463186827|FG003|Overall Study|Lost to Follow-up|1|||
128696556|NCT02609828|463186824|FG000|Overall Study|Protocol Violation|2|||
128696557|NCT02609828|463186825|FG001|Overall Study|Protocol Violation|0|||
128696558|NCT02609828|463186826|FG002|Overall Study|Protocol Violation|0|||
128696559|NCT02609828|463186827|FG003|Overall Study|Protocol Violation|1|||
128696560|NCT02609828|463186824|FG000|Overall Study|Withdrawal by Subject|12|||
128696561|NCT02609828|463186825|FG001|Overall Study|Withdrawal by Subject|1|||
128696562|NCT02609828|463186826|FG002|Overall Study|Withdrawal by Subject|0|||
128696563|NCT02609828|463186827|FG003|Overall Study|Withdrawal by Subject|10|||
128696564|NCT02609828|463186824|FG000|Overall Study|Other|3|||
128696565|NCT02609828|463186825|FG001|Overall Study|Other|0|||
128696566|NCT02609828|463186826|FG002|Overall Study|Other|0|||
128696567|NCT02609828|463186827|FG003|Overall Study|Other|6|||
128696568|NCT02609828|463186824|FG000|Overall Study|Randomized but not treated|1|||
128696569|NCT02609828|463186825|FG001|Overall Study|Randomized but not treated|0|||
128696570|NCT02609828|463186826|FG002|Overall Study|Randomized but not treated|0|||
128696571|NCT02609828|463186827|FG003|Overall Study|Randomized but not treated|0|||
128907826|NCT01662440|463955039|FG003|Overall Study|Death|0|||
128907827|NCT01662440|463955036|FG000|Overall Study|Lost to Follow-up|2|||
128696572|NCT01952145|463186828|FG000|Overall Study|Protocol Violation|2|||
128696573|NCT01952145|463186829|FG001|Overall Study|Protocol Violation|1|||
128696574|NCT01952145|463186828|FG000|Overall Study|Death|0|||
128696575|NCT01952145|463186829|FG001|Overall Study|Death|1|||
128696576|NCT01952145|463186828|FG000|Overall Study|Adverse Event|9|||
128696577|NCT01952145|463186829|FG001|Overall Study|Adverse Event|0|||
128696578|NCT01952145|463186828|FG000|Overall Study|Withdrawal Criteria|16|||
128696579|NCT01952145|463186829|FG001|Overall Study|Withdrawal Criteria|11|||
128907828|NCT01662440|463955037|FG001|Overall Study|Lost to Follow-up|2|||
128765224|NCT03389477|463432095|FG000|Step 2|Withdrawal by Subject|1|||
128765225|NCT03389477|463432096|FG001|Step 2|Withdrawal by Subject|2|||
128907829|NCT01662440|463955038|FG002|Overall Study|Lost to Follow-up|4|||
128907830|NCT01662440|463955039|FG003|Overall Study|Lost to Follow-up|1|||
128907831|NCT01662440|463955036|FG000|Overall Study|Subject moved to another country.|0|||
128907832|NCT01662440|463955037|FG001|Overall Study|Subject moved to another country.|1|||
128907833|NCT01662440|463955038|FG002|Overall Study|Subject moved to another country.|0|||
128907834|NCT01662440|463955039|FG003|Overall Study|Subject moved to another country.|0|||
128907835|NCT01662440|463955036|FG000|Overall Study|Protocol Violation|1|||
128907836|NCT01662440|463955037|FG001|Overall Study|Protocol Violation|0|||
128907837|NCT01662440|463955038|FG002|Overall Study|Protocol Violation|0|||
128907838|NCT01662440|463955039|FG003|Overall Study|Protocol Violation|0|||
128907839|NCT01662440|463955036|FG000|Overall Study|Withdrawal by Subject|5|||
128907840|NCT01662440|463955037|FG001|Overall Study|Withdrawal by Subject|2|||
128907841|NCT01662440|463955038|FG002|Overall Study|Withdrawal by Subject|2|||
128907842|NCT01662440|463955039|FG003|Overall Study|Withdrawal by Subject|2|||
128907843|NCT01661140|463955040|FG000|Open-Label Period|Adverse Event|44|||
128907844|NCT01661140|463955041|FG001|Open-Label Period|Adverse Event|0|||
128907845|NCT01661140|463955042|FG002|Open-Label Period|Adverse Event|0|||
128907846|NCT01661140|463955040|FG000|Open-Label Period|Protocol Violation|3|||
128907847|NCT01661140|463955041|FG001|Open-Label Period|Protocol Violation|0|||
128907848|NCT01661140|463955042|FG002|Open-Label Period|Protocol Violation|0|||
128907849|NCT01661140|463955040|FG000|Open-Label Period|Withdrawal by Subject|5|||
128907850|NCT01661140|463955041|FG001|Open-Label Period|Withdrawal by Subject|0|||
128907851|NCT01661140|463955042|FG002|Open-Label Period|Withdrawal by Subject|0|||
128907852|NCT01661140|463955040|FG000|Open-Label Period|Investigator Decision|3|||
128907853|NCT01661140|463955041|FG001|Open-Label Period|Investigator Decision|0|||
128907854|NCT01661140|463955042|FG002|Open-Label Period|Investigator Decision|0|||
128907855|NCT01661140|463955040|FG000|Open-Label Period|Death|1|||
128907856|NCT01661140|463955041|FG001|Open-Label Period|Death|0|||
128907857|NCT01661140|463955042|FG002|Open-Label Period|Death|0|||
128907858|NCT01661140|463955040|FG000|Open-Label Period|Administrative/Other|1|||
128907859|NCT01661140|463955041|FG001|Open-Label Period|Administrative/Other|0|||
128907860|NCT01661140|463955042|FG002|Open-Label Period|Administrative/Other|0|||
128907861|NCT01661140|463955040|FG000|Open-Label Period|Sponsor termination|16|||
128907862|NCT01661140|463955041|FG001|Open-Label Period|Sponsor termination|0|||
128907863|NCT01661140|463955042|FG002|Open-Label Period|Sponsor termination|0|||
128907864|NCT01661140|463955040|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
128907865|NCT01661140|463955041|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
128907866|NCT01661140|463955042|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
128907867|NCT01661140|463955040|FG000|Open-Label Period|Lost to Follow-up|2|||
128907868|NCT01661140|463955041|FG001|Open-Label Period|Lost to Follow-up|0|||
128907869|NCT01661140|463955042|FG002|Open-Label Period|Lost to Follow-up|0|||
128907870|NCT01661140|463955040|FG000|Double-Blind Period|Refused Treatment|0|||
128907871|NCT01661140|463955041|FG001|Double-Blind Period|Refused Treatment|0|||
128907872|NCT01661140|463955042|FG002|Double-Blind Period|Refused Treatment|1|||
128907873|NCT01661140|463955040|FG000|Double-Blind Period|Adverse Event|0|||
128907874|NCT01661140|463955041|FG001|Double-Blind Period|Adverse Event|16|||
128907875|NCT01661140|463955042|FG002|Double-Blind Period|Adverse Event|18|||
128907876|NCT01661140|463955040|FG000|Double-Blind Period|Protocol Violation|0|||
128907877|NCT01661140|463955041|FG001|Double-Blind Period|Protocol Violation|2|||
128907878|NCT01661140|463955042|FG002|Double-Blind Period|Protocol Violation|3|||
128907879|NCT01661140|463955040|FG000|Double-Blind Period|Withdrawal by Subject|0|||
128907880|NCT01661140|463955041|FG001|Double-Blind Period|Withdrawal by Subject|1|||
128907881|NCT01661140|463955042|FG002|Double-Blind Period|Withdrawal by Subject|3|||
128907882|NCT01661140|463955040|FG000|Double-Blind Period|Investigator's Decision|0|||
128907883|NCT01661140|463955041|FG001|Double-Blind Period|Investigator's Decision|1|||
128696580|NCT01952145|463186828|FG000|Overall Study|Unclassified|1|||
128696581|NCT01952145|463186829|FG001|Overall Study|Unclassified|1|||
128907884|NCT01661140|463955042|FG002|Double-Blind Period|Investigator's Decision|2|||
128907885|NCT01661140|463955040|FG000|Double-Blind Period|Sponsor Termination|0|||
128907886|NCT01661140|463955041|FG001|Double-Blind Period|Sponsor Termination|14|||
128907887|NCT01661140|463955042|FG002|Double-Blind Period|Sponsor Termination|17|||
128907888|NCT01661140|463955040|FG000|Double-Blind Period|Administrative/Other|0|||
128907889|NCT01661140|463955041|FG001|Double-Blind Period|Administrative/Other|7|||
128907890|NCT01661140|463955042|FG002|Double-Blind Period|Administrative/Other|6|||
128907891|NCT02787850|463955045|FG000|Overall Study|Withdrawal by Subject|0|||
128907892|NCT02787850|463955046|FG001|Overall Study|Withdrawal by Subject|1|||
128907893|NCT00494091|463955049|FG000|Overall Study|Death|5|||
128696582|NCT03758066|463186830|FG000|Overall Study|Lost to Follow-up|14|||
128696583|NCT04138810|463186834|FG000|Overall Study|Withdrawal by Subject|0|||
128696584|NCT04138810|463186835|FG001|Overall Study|Withdrawal by Subject|1|||
128907894|NCT00494091|463955050|FG001|Overall Study|Death|54|||
128907895|NCT00494091|463955049|FG000|Overall Study|Lost to Follow-up|0|||
128907896|NCT00494091|463955050|FG001|Overall Study|Lost to Follow-up|4|||
128907897|NCT00494091|463955049|FG000|Overall Study|Other|1|||
128907898|NCT00494091|463955050|FG001|Overall Study|Other|11|||
128907899|NCT00494091|463955049|FG000|Overall Study|Withdrawal by Subject|0|||
128907900|NCT00494091|463955050|FG001|Overall Study|Withdrawal by Subject|7|||
128907901|NCT02921971|463955051|FG000|Overall Study|Adverse Event|1|||
128765226|NCT03389477|463432095|FG000|Step 2|Disease progression|1|||
128696585|NCT04138810|463186834|FG000|Overall Study|Subject cancelled surgery|1|||
128696586|NCT04138810|463186835|FG001|Overall Study|Subject cancelled surgery|0|||
128696587|NCT00762385|463186838|FG000|First Intervention|Lens Issue|1|||
128696588|NCT00762385|463186839|FG001|First Intervention|Lens Issue|1|||
128696589|NCT00762385|463186838|FG000|First Intervention|Lost to Follow-up|0|||
128907902|NCT02921971|463955052|FG001|Overall Study|Adverse Event|2|||
128907903|NCT02921971|463955051|FG000|Overall Study|Lack of Efficacy|3|||
128907904|NCT02921971|463955052|FG001|Overall Study|Lack of Efficacy|1|||
128907905|NCT02921971|463955051|FG000|Overall Study|Other than specified above|2|||
128907906|NCT02921971|463955052|FG001|Overall Study|Other than specified above|1|||
128907907|NCT00452699|463955053|FG000|Overall Study|Adverse Event|10|||
128907908|NCT00452699|463955054|FG001|Overall Study|Adverse Event|3|||
128907909|NCT00452699|463955053|FG000|Overall Study|Lack of Efficacy|6|||
128907910|NCT00452699|463955054|FG001|Overall Study|Lack of Efficacy|4|||
128907911|NCT00452699|463955053|FG000|Overall Study|Lost to Follow-up|6|||
128907912|NCT00452699|463955054|FG001|Overall Study|Lost to Follow-up|9|||
128907913|NCT00452699|463955053|FG000|Overall Study|Protocol Violation|21|||
128907914|NCT00452699|463955054|FG001|Overall Study|Protocol Violation|25|||
128907915|NCT00452699|463955053|FG000|Overall Study|Withdrawal by Subject|26|||
128907916|NCT00452699|463955054|FG001|Overall Study|Withdrawal by Subject|25|||
128907917|NCT00452699|463955053|FG000|Overall Study|Other|12|||
128907918|NCT00452699|463955054|FG001|Overall Study|Other|7|||
128907919|NCT00326898|463955055|FG000|Overall Study|Disease progression|52|||
128907920|NCT00326898|463955056|FG001|Overall Study|Disease progression|54|||
128907921|NCT00326898|463955057|FG002|Overall Study|Disease progression|102|||
128907922|NCT00326898|463955055|FG000|Overall Study|Adverse Event|124|||
128907923|NCT00326898|463955056|FG001|Overall Study|Adverse Event|128|||
128907924|NCT00326898|463955057|FG002|Overall Study|Adverse Event|33|||
128907925|NCT00326898|463955055|FG000|Overall Study|Death|2|||
128907926|NCT00326898|463955056|FG001|Overall Study|Death|0|||
128696590|NCT00762385|463186839|FG001|First Intervention|Lost to Follow-up|2|||
128696591|NCT00762385|463186838|FG000|First Intervention|Ineligible|1|||
128696592|NCT00762385|463186839|FG001|First Intervention|Ineligible|0|||
128765227|NCT03389477|463432096|FG001|Step 2|Disease progression|0|||
129027729|NCT02227238|464391761|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
129027730|NCT03966911|464391763|FG000|Overall Study|Adverse Event|1|||
129027731|NCT03966911|464391764|FG001|Overall Study|Adverse Event|1|||
128907927|NCT00326898|463955057|FG002|Overall Study|Death|0|||
128907928|NCT00326898|463955055|FG000|Overall Study|Withdrawal by Subject|134|||
128907929|NCT00326898|463955056|FG001|Overall Study|Withdrawal by Subject|128|||
128907930|NCT00326898|463955057|FG002|Overall Study|Withdrawal by Subject|32|||
128907931|NCT00326898|463955055|FG000|Overall Study|Alternative therapy|1|||
128907932|NCT00326898|463955056|FG001|Overall Study|Alternative therapy|0|||
128907933|NCT00326898|463955057|FG002|Overall Study|Alternative therapy|0|||
129027732|NCT03966911|464391763|FG000|Overall Study|Withdrawal by Subject|8|||
129027733|NCT03966911|464391764|FG001|Overall Study|Withdrawal by Subject|2|||
128765228|NCT03389477|463432095|FG000|Step 2|Death|0|||
128907934|NCT00326898|463955055|FG000|Overall Study|Other complicating disease|5|||
128907935|NCT00326898|463955056|FG001|Overall Study|Other complicating disease|5|||
128907936|NCT00326898|463955057|FG002|Overall Study|Other complicating disease|4|||
128907937|NCT00326898|463955055|FG000|Overall Study|Other/Missing/Unknown|33|||
128907938|NCT00326898|463955056|FG001|Overall Study|Other/Missing/Unknown|28|||
128907939|NCT00326898|463955057|FG002|Overall Study|Other/Missing/Unknown|32|||
128907940|NCT03847987|463955058|FG000|Overall Study|Lost to Follow-up|1|||
128907941|NCT03847987|463955059|FG001|Overall Study|Lost to Follow-up|0|||
128907942|NCT03847987|463955058|FG000|Overall Study|Adverse Event|2|||
128907943|NCT03847987|463955059|FG001|Overall Study|Adverse Event|0|||
128907944|NCT01637142|463955070|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
128907945|NCT02111564|463955071|FG000|Overall Study|Death|109|||
128907946|NCT02111564|463955072|FG001|Overall Study|Death|120|||
128907947|NCT02111564|463955071|FG000|Overall Study|Lost to Follow-up|2|||
128907948|NCT02111564|463955072|FG001|Overall Study|Lost to Follow-up|3|||
128907949|NCT02111564|463955071|FG000|Overall Study|Withdrawal by Subject|20|||
129027734|NCT03966911|464391763|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
128907950|NCT02111564|463955072|FG001|Overall Study|Withdrawal by Subject|20|||
128907951|NCT00687362|463955073|FG000|Overall Study|Protocol Violation|2|||
128907952|NCT00687362|463955073|FG000|Overall Study|Withdrawal by Subject|1|||
129027735|NCT03966911|464391764|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
128696593|NCT00762385|463186838|FG000|First Intervention|Protocol Violation|0|||
128696594|NCT00762385|463186839|FG001|First Intervention|Protocol Violation|1|||
128696595|NCT00762385|463186838|FG000|Second Intervention|Protocol Violation|3|||
128907953|NCT02354703|463955074|FG000|Overall Study|Withdrawal by Subject|1|||
128907954|NCT02354703|463955075|FG001|Overall Study|Withdrawal by Subject|1|||
128907955|NCT02354703|463955076|FG002|Overall Study|Withdrawal by Subject|1|||
128907956|NCT02354703|463955077|FG003|Overall Study|Withdrawal by Subject|1|||
128907957|NCT02354703|463955074|FG000|Overall Study|Lost to Follow-up|2|||
128907958|NCT02354703|463955075|FG001|Overall Study|Lost to Follow-up|7|||
128765229|NCT03389477|463432096|FG001|Step 2|Death|1|||
129027736|NCT01986647|464391765|FG000|Overall Study|Lost to Follow-up|4|||
129117612|NCT03530293|464727420|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
128907959|NCT02354703|463955076|FG002|Overall Study|Lost to Follow-up|9|||
128907960|NCT02354703|463955077|FG003|Overall Study|Lost to Follow-up|2|||
128907961|NCT02354703|463955074|FG000|Overall Study|Adverse Event|0|||
128907962|NCT02354703|463955075|FG001|Overall Study|Adverse Event|0|||
128907963|NCT02354703|463955076|FG002|Overall Study|Adverse Event|1|||
128907964|NCT02354703|463955077|FG003|Overall Study|Adverse Event|0|||
128907965|NCT01415752|463955088|FG000|Induction (Step 1)|Ineligible|4|||
128907966|NCT01415752|463955089|FG001|Induction (Step 1)|Ineligible|3|||
128907967|NCT01415752|463955090|FG002|Induction (Step 1)|Ineligible|4|||
128907968|NCT01415752|463955091|FG003|Induction (Step 1)|Ineligible|4|||
128907969|NCT01415752|463955088|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
128907970|NCT01415752|463955089|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
128907971|NCT01415752|463955090|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
129117613|NCT03530293|464727421|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
129117614|NCT03530293|464727422|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
129117615|NCT03530293|464727420|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
129117616|NCT03530293|464727421|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
129117617|NCT03530293|464727422|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
129117618|NCT03530293|464727420|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
129117619|NCT03530293|464727421|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
129117620|NCT03530293|464727422|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
129117621|NCT03530293|464727420|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
128907972|NCT01415752|463955091|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
129117622|NCT03530293|464727421|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
129117623|NCT03530293|464727422|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
129117624|NCT03530293|464727420|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
129117625|NCT03530293|464727421|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
129117626|NCT03530293|464727422|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
129117627|NCT02732639|464727424|FG000|Overall Study|Lost to Follow-up|1|||
129117628|NCT02265510|464727427|FG000|Overall Study|Withdrawal by Subject|1|||
128907973|NCT01415752|463955088|FG000|Maintenance (Step 2)|Adverse Event|3|||
128907974|NCT01415752|463955089|FG001|Maintenance (Step 2)|Adverse Event|4|||
128907975|NCT01415752|463955090|FG002|Maintenance (Step 2)|Adverse Event|9|||
128907976|NCT01415752|463955091|FG003|Maintenance (Step 2)|Adverse Event|6|||
128907977|NCT01415752|463955088|FG000|Maintenance (Step 2)|Death|1|||
128907978|NCT01415752|463955089|FG001|Maintenance (Step 2)|Death|1|||
128907979|NCT01415752|463955090|FG002|Maintenance (Step 2)|Death|2|||
129117629|NCT02265510|464727428|FG001|Overall Study|Withdrawal by Subject|1|||
129117630|NCT02265510|464727429|FG002|Overall Study|Withdrawal by Subject|2|||
129117631|NCT02265510|464727430|FG003|Overall Study|Withdrawal by Subject|1|||
129117632|NCT02265510|464727431|FG004|Overall Study|Withdrawal by Subject|0|||
129117633|NCT02265510|464727432|FG005|Overall Study|Withdrawal by Subject|2|||
129117634|NCT02265510|464727433|FG006|Overall Study|Withdrawal by Subject|0|||
129117635|NCT02265510|464727434|FG007|Overall Study|Withdrawal by Subject|2|||
129117636|NCT02265510|464727435|FG008|Overall Study|Withdrawal by Subject|0|||
129117637|NCT02265510|464727436|FG009|Overall Study|Withdrawal by Subject|0|||
129117638|NCT02265510|464727437|FG010|Overall Study|Withdrawal by Subject|0|||
129117639|NCT02265510|464727438|FG011|Overall Study|Withdrawal by Subject|0|||
129117640|NCT02265510|464727439|FG012|Overall Study|Withdrawal by Subject|1|||
128696596|NCT00762385|463186839|FG001|Second Intervention|Protocol Violation|3|||
128696597|NCT01540838|463186840|FG000|Overall Study|Open nasogastric tube|9|||
128696598|NCT01540838|463186841|FG001|Overall Study|Open nasogastric tube|7|||
128696599|NCT01540838|463186840|FG000|Overall Study|Treatment doses missing|8|||
128696600|NCT01540838|463186841|FG001|Overall Study|Treatment doses missing|12|||
128696601|NCT01540838|463186840|FG000|Overall Study|Additional antibiotic treatment|1|||
128907980|NCT01415752|463955091|FG003|Maintenance (Step 2)|Death|0|||
128907981|NCT01415752|463955088|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
128907982|NCT01415752|463955089|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
128907983|NCT01415752|463955090|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
128907984|NCT01415752|463955091|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
128907985|NCT01415752|463955088|FG000|Maintenance (Step 2)|Alternative therapy|0|||
128907986|NCT01415752|463955089|FG001|Maintenance (Step 2)|Alternative therapy|1|||
128907987|NCT01415752|463955090|FG002|Maintenance (Step 2)|Alternative therapy|0|||
128907988|NCT01415752|463955091|FG003|Maintenance (Step 2)|Alternative therapy|0|||
128907989|NCT01415752|463955088|FG000|Maintenance (Step 2)|Other reasons|3|||
128907990|NCT01415752|463955089|FG001|Maintenance (Step 2)|Other reasons|6|||
128907991|NCT01415752|463955090|FG002|Maintenance (Step 2)|Other reasons|4|||
128907992|NCT01415752|463955091|FG003|Maintenance (Step 2)|Other reasons|6|||
128907993|NCT01415752|463955088|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
128907994|NCT01415752|463955089|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
128907995|NCT01415752|463955090|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
129117641|NCT02265510|464727440|FG013|Overall Study|Withdrawal by Subject|0|||
129117642|NCT02265510|464727427|FG000|Overall Study|Disease Progression|0|||
129117643|NCT02265510|464727428|FG001|Overall Study|Disease Progression|1|||
129117644|NCT02265510|464727429|FG002|Overall Study|Disease Progression|2|||
129117645|NCT02265510|464727430|FG003|Overall Study|Disease Progression|1|||
129117646|NCT02265510|464727431|FG004|Overall Study|Disease Progression|1|||
129117647|NCT02265510|464727432|FG005|Overall Study|Disease Progression|0|||
129117648|NCT02265510|464727433|FG006|Overall Study|Disease Progression|0|||
128696602|NCT01540838|463186841|FG001|Overall Study|Additional antibiotic treatment|2|||
128696603|NCT01540838|463186840|FG000|Overall Study|Died before treatment initiation|1|||
128696604|NCT01540838|463186841|FG001|Overall Study|Died before treatment initiation|1|||
128696605|NCT01540838|463186840|FG000|Overall Study|Not BM. Other treatment|3|||
128696606|NCT01540838|463186841|FG001|Overall Study|Not BM. Other treatment|1|||
128907996|NCT01415752|463955091|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
128907997|NCT01415752|463955088|FG000|Maintenance (Step 2)|ineligible|1|||
128907998|NCT01415752|463955089|FG001|Maintenance (Step 2)|ineligible|1|||
128907999|NCT01415752|463955090|FG002|Maintenance (Step 2)|ineligible|1|||
128908000|NCT01415752|463955091|FG003|Maintenance (Step 2)|ineligible|0|||
128908001|NCT01415752|463955088|FG000|Maintenance (Step 2)|Missing|4|||
128908002|NCT01415752|463955089|FG001|Maintenance (Step 2)|Missing|1|||
128908003|NCT01415752|463955090|FG002|Maintenance (Step 2)|Missing|4|||
128908004|NCT01415752|463955091|FG003|Maintenance (Step 2)|Missing|3|||
128908005|NCT01903837|463955093|FG000|Part A|Withdrawal by Subject|4|||
128908006|NCT01903837|463955094|FG001|Part A|Withdrawal by Subject|9|||
128908007|NCT01903837|463955095|FG002|Part A|Withdrawal by Subject|8|||
128908008|NCT01903837|463955096|FG003|Part A|Withdrawal by Subject|5|||
128908009|NCT01903837|463955093|FG000|Part A|Adverse Event|3|||
128908010|NCT01903837|463955094|FG001|Part A|Adverse Event|6|||
128908011|NCT01903837|463955095|FG002|Part A|Adverse Event|9|||
128908012|NCT01903837|463955096|FG003|Part A|Adverse Event|6|||
128908013|NCT01903837|463955093|FG000|Part A|Lost to Follow-up|9|||
128908014|NCT01903837|463955094|FG001|Part A|Lost to Follow-up|7|||
128908015|NCT01903837|463955095|FG002|Part A|Lost to Follow-up|7|||
128908016|NCT01903837|463955096|FG003|Part A|Lost to Follow-up|2|||
128908017|NCT01903837|463955093|FG000|Part A|Non-compliance with study drug|1|||
128908018|NCT01903837|463955094|FG001|Part A|Non-compliance with study drug|4|||
128908019|NCT01903837|463955095|FG002|Part A|Non-compliance with study drug|4|||
129027737|NCT01986647|464391766|FG001|Overall Study|Lost to Follow-up|1|||
129027738|NCT01986647|464391767|FG002|Overall Study|Lost to Follow-up|4|||
129027739|NCT01986647|464391768|FG003|Overall Study|Lost to Follow-up|4|||
129027740|NCT01986647|464391765|FG000|Overall Study|Withdrawal by Subject|1|||
129027741|NCT01986647|464391766|FG001|Overall Study|Withdrawal by Subject|3|||
129027742|NCT01986647|464391767|FG002|Overall Study|Withdrawal by Subject|2|||
129027743|NCT01986647|464391768|FG003|Overall Study|Withdrawal by Subject|3|||
129027744|NCT01986647|464391765|FG000|Overall Study|Health|5|||
129027745|NCT01986647|464391766|FG001|Overall Study|Health|3|||
129027746|NCT01986647|464391767|FG002|Overall Study|Health|6|||
129027747|NCT01986647|464391768|FG003|Overall Study|Health|4|||
129027748|NCT00868998|464391770|FG000|Overall Study|Screen Failure|1|||
129027749|NCT00868998|464391770|FG000|Overall Study|Withdrawal by Subject|1|||
129027750|NCT00868998|464391770|FG000|Overall Study|Progression of disease|2|||
129027751|NCT00868998|464391770|FG000|Overall Study|Death|1|||
129027752|NCT02905435|464391771|FG000|Overall Study|Death|2|||
129027753|NCT02905435|464391771|FG000|Overall Study|Physician Decision|1|||
129027754|NCT02905435|464391771|FG000|Overall Study|Lost to Follow-up|4|||
129027755|NCT03498560|464391775|FG000|Overall Study|Found Ineligible|2|||
129027756|NCT03498560|464391775|FG000|Overall Study|Withdrawal by Subject|14|||
129027757|NCT03498560|464391775|FG000|Overall Study|Lost to Follow-up|4|||
129027758|NCT03498560|464391775|FG000|Overall Study|Death|1|||
129027759|NCT01507662|464391776|FG000|Overall Study|Death|26|||
129027760|NCT01507662|464391777|FG001|Overall Study|Death|18|||
129027761|NCT01507662|464391776|FG000|Overall Study|Withdrawal by Subject|290|||
129027762|NCT01507662|464391777|FG001|Overall Study|Withdrawal by Subject|287|||
129027763|NCT01507662|464391776|FG000|Overall Study|Lost to Follow-up|498|||
129027764|NCT01507662|464391777|FG001|Overall Study|Lost to Follow-up|523|||
129027765|NCT01507662|464391776|FG000|Overall Study|Proxy interview done|2|||
129117649|NCT02265510|464727434|FG007|Overall Study|Disease Progression|0|||
128908020|NCT01903837|463955096|FG003|Part A|Non-compliance with study drug|0|||
128908021|NCT01903837|463955093|FG000|Part A|Physician Decision|1|||
128908022|NCT01903837|463955094|FG001|Part A|Physician Decision|1|||
129027766|NCT01507662|464391777|FG001|Overall Study|Proxy interview done|3|||
128908023|NCT01903837|463955095|FG002|Part A|Physician Decision|0|||
128908024|NCT01903837|463955096|FG003|Part A|Physician Decision|0|||
128908025|NCT01903837|463955093|FG000|Part A|Protocol Violation|1|||
129027767|NCT01004510|464391782|FG000|Overall Study|Adverse Event|1|||
129027768|NCT01960296|464391785|FG000|Overall Study|Postponed surgery|1|||
129027769|NCT01960296|464391786|FG001|Overall Study|Postponed surgery|0|||
129027770|NCT01960296|464391785|FG000|Overall Study|Received different procedure|1|||
129027771|NCT01960296|464391786|FG001|Overall Study|Received different procedure|3|||
129027772|NCT02003391|464391787|FG000|Overall Study|Withdrawal by Subject|2|||
128696607|NCT04891978|463186842|FG000|Baseline|Protocol Violation|2|||
128696608|NCT04891978|463186843|FG001|Baseline|Protocol Violation|1|||
128696609|NCT04891978|463186844|FG002|Baseline|Protocol Violation|0|||
129117650|NCT02265510|464727435|FG008|Overall Study|Disease Progression|0|||
129117651|NCT02265510|464727436|FG009|Overall Study|Disease Progression|0|||
129117652|NCT02265510|464727437|FG010|Overall Study|Disease Progression|0|||
129117653|NCT02265510|464727438|FG011|Overall Study|Disease Progression|0|||
129117654|NCT02265510|464727439|FG012|Overall Study|Disease Progression|0|||
129117655|NCT02265510|464727440|FG013|Overall Study|Disease Progression|0|||
129117656|NCT02265510|464727427|FG000|Overall Study|Death|2|||
129117657|NCT02265510|464727428|FG001|Overall Study|Death|0|||
129117658|NCT02265510|464727429|FG002|Overall Study|Death|2|||
129117659|NCT02265510|464727430|FG003|Overall Study|Death|2|||
129117660|NCT02265510|464727431|FG004|Overall Study|Death|1|||
129117661|NCT02265510|464727432|FG005|Overall Study|Death|3|||
129117662|NCT02265510|464727433|FG006|Overall Study|Death|2|||
129117663|NCT02265510|464727434|FG007|Overall Study|Death|1|||
129117664|NCT02265510|464727435|FG008|Overall Study|Death|3|||
129117665|NCT02265510|464727436|FG009|Overall Study|Death|3|||
129117666|NCT02265510|464727437|FG010|Overall Study|Death|4|||
129117667|NCT02265510|464727438|FG011|Overall Study|Death|12|||
129117668|NCT02265510|464727439|FG012|Overall Study|Death|7|||
129117669|NCT02265510|464727440|FG013|Overall Study|Death|6|||
129117670|NCT02265510|464727427|FG000|Overall Study|Lost to Follow-up|0|||
129117671|NCT02265510|464727428|FG001|Overall Study|Lost to Follow-up|0|||
129117672|NCT02265510|464727429|FG002|Overall Study|Lost to Follow-up|0|||
129117673|NCT02265510|464727430|FG003|Overall Study|Lost to Follow-up|0|||
129117674|NCT02265510|464727431|FG004|Overall Study|Lost to Follow-up|1|||
129117675|NCT02265510|464727432|FG005|Overall Study|Lost to Follow-up|0|||
129117676|NCT02265510|464727433|FG006|Overall Study|Lost to Follow-up|0|||
129117677|NCT02265510|464727434|FG007|Overall Study|Lost to Follow-up|0|||
129117678|NCT02265510|464727435|FG008|Overall Study|Lost to Follow-up|0|||
129117679|NCT02265510|464727436|FG009|Overall Study|Lost to Follow-up|2|||
129117680|NCT02265510|464727437|FG010|Overall Study|Lost to Follow-up|0|||
129117681|NCT02265510|464727438|FG011|Overall Study|Lost to Follow-up|0|||
129117682|NCT02265510|464727439|FG012|Overall Study|Lost to Follow-up|0|||
129117683|NCT02265510|464727440|FG013|Overall Study|Lost to Follow-up|2|||
129117684|NCT02265510|464727427|FG000|Overall Study|Other|0|||
129117685|NCT02265510|464727428|FG001|Overall Study|Other|1|||
129117686|NCT02265510|464727429|FG002|Overall Study|Other|0|||
129117687|NCT02265510|464727430|FG003|Overall Study|Other|0|||
129117688|NCT02265510|464727431|FG004|Overall Study|Other|0|||
129117689|NCT02265510|464727432|FG005|Overall Study|Other|0|||
129117690|NCT02265510|464727433|FG006|Overall Study|Other|0|||
129117691|NCT02265510|464727434|FG007|Overall Study|Other|0|||
129117692|NCT02265510|464727435|FG008|Overall Study|Other|0|||
129117693|NCT02265510|464727436|FG009|Overall Study|Other|0|||
129117694|NCT02265510|464727437|FG010|Overall Study|Other|0|||
129117695|NCT02265510|464727438|FG011|Overall Study|Other|0|||
129117696|NCT02265510|464727439|FG012|Overall Study|Other|0|||
129117697|NCT02265510|464727440|FG013|Overall Study|Other|0|||
129117698|NCT02265510|464727427|FG000|Overall Study|Study Terminated by Sponsor|0|||
129117699|NCT02265510|464727428|FG001|Overall Study|Study Terminated by Sponsor|0|||
129117700|NCT02265510|464727429|FG002|Overall Study|Study Terminated by Sponsor|0|||
129117701|NCT02265510|464727430|FG003|Overall Study|Study Terminated by Sponsor|0|||
129117702|NCT02265510|464727431|FG004|Overall Study|Study Terminated by Sponsor|0|||
129117703|NCT02265510|464727432|FG005|Overall Study|Study Terminated by Sponsor|1|||
129117704|NCT02265510|464727433|FG006|Overall Study|Study Terminated by Sponsor|1|||
129117705|NCT02265510|464727434|FG007|Overall Study|Study Terminated by Sponsor|1|||
129117706|NCT02265510|464727435|FG008|Overall Study|Study Terminated by Sponsor|1|||
129117707|NCT02265510|464727436|FG009|Overall Study|Study Terminated by Sponsor|2|||
129117708|NCT02265510|464727437|FG010|Overall Study|Study Terminated by Sponsor|1|||
129117709|NCT02265510|464727438|FG011|Overall Study|Study Terminated by Sponsor|4|||
129117710|NCT02265510|464727439|FG012|Overall Study|Study Terminated by Sponsor|1|||
129117711|NCT02265510|464727440|FG013|Overall Study|Study Terminated by Sponsor|2|||
129117712|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
129117713|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
129117714|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
129117715|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
129117716|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
129117717|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
129117718|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
128696610|NCT04891978|463186842|FG000|Baseline|Missing AIRQ|1|||
128696611|NCT04891978|463186843|FG001|Baseline|Missing AIRQ|0|||
129117719|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
129117720|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
129117721|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
129117722|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
129117723|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
129117724|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
128908026|NCT01903837|463955094|FG001|Part A|Protocol Violation|1|||
128908027|NCT01903837|463955095|FG002|Part A|Protocol Violation|0|||
128908028|NCT01903837|463955096|FG003|Part A|Protocol Violation|0|||
128908029|NCT01903837|463955093|FG000|Part B|Lost to Follow-up|0|||
128908030|NCT01903837|463955094|FG001|Part B|Lost to Follow-up|3|||
128908031|NCT01903837|463955095|FG002|Part B|Lost to Follow-up|3|||
128908032|NCT01903837|463955096|FG003|Part B|Lost to Follow-up|4|||
128908033|NCT01903837|463955093|FG000|Part B|Withdrawal by Subject|1|||
128908034|NCT01903837|463955094|FG001|Part B|Withdrawal by Subject|2|||
128908035|NCT01903837|463955095|FG002|Part B|Withdrawal by Subject|0|||
128908036|NCT01903837|463955096|FG003|Part B|Withdrawal by Subject|3|||
128908037|NCT01903837|463955093|FG000|Part B|Adverse Event|3|||
128908038|NCT01903837|463955094|FG001|Part B|Adverse Event|0|||
128908039|NCT01903837|463955095|FG002|Part B|Adverse Event|2|||
128908040|NCT01903837|463955096|FG003|Part B|Adverse Event|0|||
128908041|NCT01903837|463955093|FG000|Part B|Non-compliance with study drug|2|||
128908042|NCT01903837|463955094|FG001|Part B|Non-compliance with study drug|0|||
128908043|NCT01903837|463955095|FG002|Part B|Non-compliance with study drug|0|||
128908044|NCT01903837|463955096|FG003|Part B|Non-compliance with study drug|1|||
128908045|NCT01903837|463955093|FG000|Part B|Incarceration|2|||
128908046|NCT01903837|463955094|FG001|Part B|Incarceration|0|||
128908047|NCT01903837|463955095|FG002|Part B|Incarceration|0|||
128908048|NCT01903837|463955096|FG003|Part B|Incarceration|1|||
128908049|NCT01903837|463955093|FG000|Part B|Physician Decision|1|||
128908050|NCT01903837|463955094|FG001|Part B|Physician Decision|0|||
128908051|NCT01903837|463955095|FG002|Part B|Physician Decision|0|||
128908052|NCT01903837|463955096|FG003|Part B|Physician Decision|2|||
128908053|NCT01903837|463955093|FG000|Part B|Lack of Efficacy|0|||
128908054|NCT01903837|463955094|FG001|Part B|Lack of Efficacy|1|||
128908055|NCT01903837|463955095|FG002|Part B|Lack of Efficacy|0|||
128908056|NCT01903837|463955096|FG003|Part B|Lack of Efficacy|0|||
128908057|NCT00705939|463955098|FG000|Overall Study|Protocol Violation|0|||
128908058|NCT00705939|463955099|FG001|Overall Study|Protocol Violation|0|||
128696612|NCT04891978|463186844|FG002|Baseline|Missing AIRQ|0|||
128696613|NCT04891978|463186842|FG000|Baseline|Did not attend a baseline visit|0|||
128696614|NCT04891978|463186843|FG001|Baseline|Did not attend a baseline visit|0|||
128696615|NCT04891978|463186844|FG002|Baseline|Did not attend a baseline visit|9|||
128696616|NCT03641339|463186845|FG000|Overall Study|Physician Decision|1|||
128696617|NCT03641339|463186846|FG001|Overall Study|Physician Decision|0|||
128696618|NCT03641339|463186847|FG002|Overall Study|Physician Decision|0|||
128696619|NCT03641339|463186848|FG003|Overall Study|Physician Decision|0|||
128696620|NCT03641339|463186849|FG004|Overall Study|Physician Decision|0|||
128696621|NCT03641339|463186850|FG005|Overall Study|Physician Decision|0|||
128696622|NCT03641339|463186845|FG000|Overall Study|Withdrawal by Subject|0|||
128696623|NCT03641339|463186846|FG001|Overall Study|Withdrawal by Subject|2|||
128696624|NCT03641339|463186847|FG002|Overall Study|Withdrawal by Subject|0|||
128696625|NCT03641339|463186848|FG003|Overall Study|Withdrawal by Subject|2|||
128696626|NCT03641339|463186849|FG004|Overall Study|Withdrawal by Subject|0|||
128696627|NCT03641339|463186850|FG005|Overall Study|Withdrawal by Subject|1|||
128696628|NCT05338216|463186851|FG000|Overall Study|Withdrawal by Subject|1|||
128696629|NCT05338216|463186852|FG001|Overall Study|Withdrawal by Subject|1|||
128696630|NCT00413244|463186855|FG000|Overall Study|Withdrawal by Subject|10|||
128696631|NCT00413244|463186856|FG001|Overall Study|Withdrawal by Subject|1|||
128696632|NCT00446251|463186857|FG000|Overall Study|On-study Transplants|2|||
128696633|NCT00446251|463186857|FG000|Overall Study|Rituximab Infusion Reaction|2|||
128696634|NCT00446251|463186857|FG000|Overall Study|Lost to Follow-up|1|||
128696635|NCT02264639|463186859|FG000|Overall Study|Death (after completing single-dose phase)|1|||
128696636|NCT02264639|463186860|FG001|Overall Study|Death (after completing single-dose phase)|0|||
128696637|NCT02264639|463186861|FG002|Overall Study|Death (after completing single-dose phase)|0|||
128696638|NCT02264639|463186862|FG003|Overall Study|Death (after completing single-dose phase)|0|||
128696639|NCT02264639|463186863|FG004|Overall Study|Death (after completing single-dose phase)|0|||
128696640|NCT02264639|463186859|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
128696641|NCT02264639|463186860|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
128696642|NCT02264639|463186861|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
128696643|NCT02264639|463186862|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
128696644|NCT02264639|463186863|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
128696645|NCT02264639|463186859|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
128696646|NCT02264639|463186860|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
128696647|NCT02264639|463186861|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
128696648|NCT02264639|463186862|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
128696649|NCT02264639|463186863|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
128696650|NCT02264639|463186859|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
128696651|NCT02264639|463186860|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
128908059|NCT00705939|463955100|FG002|Overall Study|Protocol Violation|1|||
128908060|NCT00705939|463955098|FG000|Overall Study|Withdrawal by Subject|0|||
128908061|NCT00705939|463955099|FG001|Overall Study|Withdrawal by Subject|1|||
128908062|NCT00705939|463955100|FG002|Overall Study|Withdrawal by Subject|3|||
128908063|NCT00705939|463955098|FG000|Overall Study|Physician Decision|0|||
128908064|NCT00705939|463955099|FG001|Overall Study|Physician Decision|1|||
128908065|NCT00705939|463955100|FG002|Overall Study|Physician Decision|0|||
128908066|NCT05048342|463955101|FG000|Overall Study|Adverse Event|1|||
128908067|NCT05048342|463955101|FG000|Overall Study|Subject decision|2|||
128908068|NCT01441063|463955102|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
128908069|NCT01441063|463955102|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
128908070|NCT04372927|463955106|FG000|Overall Study|Death|1|||
128908071|NCT01665807|463955107|FG000|Overall Study|Withdrawal by Subject|2|||
128908072|NCT01665807|463955108|FG001|Overall Study|Withdrawal by Subject|0|||
128908073|NCT01665807|463955109|FG002|Overall Study|Withdrawal by Subject|1|||
128908074|NCT02728830|463955110|FG000|Overall Study|Exclusionary Surgery|9|||
128908075|NCT02728830|463955110|FG000|Overall Study|Exclusionary Pathology|6|||
128908076|NCT02728830|463955110|FG000|Overall Study|Physician Decision|3|||
128908077|NCT02728830|463955110|FG000|Overall Study|Withdrawal by Subject|2|||
128908078|NCT02728830|463955110|FG000|Overall Study|Lost to Follow-up|1|||
128908079|NCT02728830|463955110|FG000|Overall Study|Exclusionary Lab Values|1|||
128908080|NCT02728830|463955110|FG000|Overall Study|Contraindicated Illness|1|||
128908081|NCT02728830|463955110|FG000|Overall Study|Language Barrier|1|||
128908082|NCT01081795|463955111|FG000|Overall Study|Adverse Event|18|||
128908083|NCT01081795|463955112|FG001|Overall Study|Adverse Event|23|||
128908084|NCT01081795|463955113|FG002|Overall Study|Adverse Event|6|||
128908085|NCT01081795|463955111|FG000|Overall Study|Lack of Efficacy|7|||
128908086|NCT01081795|463955112|FG001|Overall Study|Lack of Efficacy|5|||
128908087|NCT01081795|463955113|FG002|Overall Study|Lack of Efficacy|19|||
128908088|NCT01081795|463955111|FG000|Overall Study|Subject's schedule|1|||
128908089|NCT01081795|463955112|FG001|Overall Study|Subject's schedule|1|||
128908090|NCT01081795|463955113|FG002|Overall Study|Subject's schedule|2|||
128908091|NCT01081795|463955111|FG000|Overall Study|Revocation of informed consent|2|||
128908092|NCT01081795|463955112|FG001|Overall Study|Revocation of informed consent|0|||
128908093|NCT01081795|463955113|FG002|Overall Study|Revocation of informed consent|0|||
128908094|NCT01081795|463955111|FG000|Overall Study|Ineligible for participation|1|||
128908095|NCT01081795|463955112|FG001|Overall Study|Ineligible for participation|0|||
128908096|NCT01081795|463955113|FG002|Overall Study|Ineligible for participation|0|||
128908097|NCT01081795|463955111|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
128908098|NCT01081795|463955112|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
128908099|NCT01081795|463955113|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
128908100|NCT01081795|463955111|FG000|Overall Study|Using drug with restricted days of use|2|||
128908101|NCT01081795|463955112|FG001|Overall Study|Using drug with restricted days of use|3|||
128908102|NCT01081795|463955113|FG002|Overall Study|Using drug with restricted days of use|2|||
128908103|NCT01081795|463955111|FG000|Overall Study|Other|1|||
128908104|NCT01081795|463955112|FG001|Overall Study|Other|2|||
128908105|NCT01081795|463955113|FG002|Overall Study|Other|0|||
128908106|NCT00661271|463955114|FG000|Overall Study|Lost to Follow-up|28|||
128908107|NCT00661271|463955115|FG001|Overall Study|Lost to Follow-up|25|||
128908108|NCT01707693|463955117|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
128908109|NCT01707693|463955118|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
128908110|NCT01707693|463955117|FG000|Overall Study Allocation|Protocol Violation|4|||
128908111|NCT01707693|463955118|FG001|Overall Study Allocation|Protocol Violation|3|||
128908112|NCT01707693|463955117|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
128908113|NCT01707693|463955118|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
128908114|NCT01707693|463955117|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
128908115|NCT01707693|463955118|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
128908116|NCT01325428|463955119|FG000|Part A|Progressive disease according to RECIST|9|||
128908117|NCT01325428|463955119|FG000|Part A|Clinical signs, symptoms of progression|2|||
128908118|NCT01325428|463955119|FG000|Part A|Other adverse event|1|||
128908119|NCT01325428|463955119|FG000|Part A|Refused continue taking trial medication|2|||
128908120|NCT01325428|463955119|FG000|Part A|Other reason not defined above|2|||
128908121|NCT01325428|463955119|FG000|Part B|Refused continue taking trial medication|2|||
128908122|NCT01325428|463955119|FG000|Part B|Other reason not defined above|1|||
128908123|NCT03847610|463955120|FG000|Overall Study|Withdrawal by Subject|1|||
128908124|NCT03099707|463955121|FG000|Overall Study|Withdrawal by Subject|0|||
128908125|NCT03099707|463955122|FG001|Overall Study|Withdrawal by Subject|3|||
128908126|NCT03099707|463955121|FG000|Overall Study|Lost to Follow-up|0|||
128908127|NCT03099707|463955122|FG001|Overall Study|Lost to Follow-up|1|||
128908128|NCT01445769|463955123|FG000|Overall Study|Consent Withdrawn|2|||
128908129|NCT01445769|463955123|FG000|Overall Study|Disease Progression|1|||
128908130|NCT01445769|463955123|FG000|Overall Study|Lost to Follow-up|5|||
128908131|NCT00343889|463955146|FG000|Overall Study|Lost to Follow-up|2|||
128908132|NCT00343889|463955147|FG001|Overall Study|Lost to Follow-up|0|||
128908133|NCT00343889|463955146|FG000|Overall Study|Withdrawal by Subject|0|||
128908134|NCT00343889|463955147|FG001|Overall Study|Withdrawal by Subject|1|||
128908135|NCT00343889|463955146|FG000|Overall Study|Protocol Violation|1|||
128908136|NCT00343889|463955147|FG001|Overall Study|Protocol Violation|0|||
129117725|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
128908137|NCT01294579|463955148|FG000|Overall Study|Disease progression|12|||
128908138|NCT01294579|463955148|FG000|Overall Study|Adverse Event|11|||
128908139|NCT01294579|463955148|FG000|Overall Study|Study closed/terminated|3|||
128908140|NCT01294579|463955148|FG000|Overall Study|Lost to Follow-up|1|||
128908141|NCT01294579|463955148|FG000|Overall Study|Physician Decision|3|||
128908142|NCT01294579|463955148|FG000|Overall Study|Withdrawal by Subject|5|||
128908143|NCT01967537|463955151|FG000|Overall Study|Withdrawal by Subject|52|||
128908144|NCT01967537|463955151|FG000|Overall Study|Refuse treatment|2|||
128908145|NCT01967537|463955151|FG000|Overall Study|Lost to Follow-up|6|||
128908146|NCT01079182|463955152|FG000|Overall Study|Lost to Follow-up|1634|||
128908147|NCT01079182|463955152|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
128908148|NCT01079182|463955152|FG000|Overall Study|Lack of Efficacy|514|||
128908149|NCT01079182|463955152|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
128908150|NCT01079182|463955152|FG000|Overall Study|Reasons not Evaluated|271|||
128908151|NCT05130463|463955153|FG000|Overall Study|Unspecified reasons|2|||
128908152|NCT05130463|463955153|FG000|Overall Study|off-label indication dose|435|||
128908153|NCT03461757|463955154|FG000|Overall Study|Adverse Event|1|||
128908154|NCT03461757|463955155|FG001|Overall Study|Adverse Event|0|||
128908155|NCT03461757|463955154|FG000|Overall Study|Lost to Follow-up|13|||
128908156|NCT03461757|463955155|FG001|Overall Study|Lost to Follow-up|7|||
128908157|NCT03461757|463955154|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
128908158|NCT03461757|463955155|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
128908159|NCT03461757|463955154|FG000|Overall Study|Non-compliance with study treatment|0|||
128908160|NCT03461757|463955155|FG001|Overall Study|Non-compliance with study treatment|1|||
128908161|NCT03461757|463955154|FG000|Overall Study|Pregnancy|2|||
128908162|NCT03461757|463955155|FG001|Overall Study|Pregnancy|0|||
128908163|NCT03461757|463955154|FG000|Overall Study|Protocol Violation|1|||
128908164|NCT03461757|463955155|FG001|Overall Study|Protocol Violation|1|||
128908165|NCT03461757|463955154|FG000|Overall Study|Withdrawal by Subject|7|||
128908166|NCT03461757|463955155|FG001|Overall Study|Withdrawal by Subject|7|||
128908167|NCT03461757|463955154|FG000|Overall Study|Other Reasons|1|||
128908168|NCT03461757|463955155|FG001|Overall Study|Other Reasons|4|||
128908169|NCT03499028|463955161|FG000|Overall Study|Lost to Follow-up|12|||
128908170|NCT03499028|463955162|FG001|Overall Study|Lost to Follow-up|9|||
128908171|NCT03499028|463955161|FG000|Overall Study|Withdrawal by Subject|5|||
128908172|NCT03499028|463955162|FG001|Overall Study|Withdrawal by Subject|8|||
128908173|NCT03499028|463955161|FG000|Overall Study|Unplanned SNF discharge|5|||
128908174|NCT03499028|463955162|FG001|Overall Study|Unplanned SNF discharge|8|||
128908175|NCT03595553|463955163|FG000|Overall Study|Withdrawal by Subject|20|||
128908176|NCT03595553|463955164|FG001|Overall Study|Withdrawal by Subject|8|||
128908177|NCT03595553|463955163|FG000|Overall Study|Physician Decision|3|||
128908178|NCT03595553|463955164|FG001|Overall Study|Physician Decision|2|||
128908179|NCT03595553|463955163|FG000|Overall Study|Adverse Event|2|||
128908180|NCT03595553|463955164|FG001|Overall Study|Adverse Event|5|||
128908181|NCT03595553|463955163|FG000|Overall Study|Death|24|||
128908182|NCT03595553|463955164|FG001|Overall Study|Death|22|||
128908183|NCT03595553|463955163|FG000|Overall Study|Lost to Follow-up|6|||
128908184|NCT03595553|463955164|FG001|Overall Study|Lost to Follow-up|7|||
128908185|NCT03595553|463955163|FG000|Overall Study|Other as indicated in CSR|3|||
128908186|NCT03595553|463955164|FG001|Overall Study|Other as indicated in CSR|3|||
128908187|NCT03595553|463955163|FG000|Overall Study|Sponsor Decision|0|||
128908188|NCT03595553|463955164|FG001|Overall Study|Sponsor Decision|1|||
128908189|NCT01437397|463955165|FG000|Overall Study|Lost to Follow-up|9|||
128908190|NCT01437397|463955166|FG001|Overall Study|Lost to Follow-up|4|||
128908191|NCT01437397|463955167|FG002|Overall Study|Lost to Follow-up|2|||
128908192|NCT01437397|463955168|FG003|Overall Study|Lost to Follow-up|4|||
128908193|NCT01437397|463955169|FG004|Overall Study|Lost to Follow-up|5|||
128908194|NCT01437397|463955165|FG000|Overall Study|Withdrawal by Subject|11|||
128908195|NCT01437397|463955166|FG001|Overall Study|Withdrawal by Subject|12|||
128908196|NCT01437397|463955167|FG002|Overall Study|Withdrawal by Subject|24|||
128908197|NCT01437397|463955168|FG003|Overall Study|Withdrawal by Subject|11|||
128908198|NCT01437397|463955169|FG004|Overall Study|Withdrawal by Subject|22|||
128908199|NCT01437397|463955165|FG000|Overall Study|Protocol Violation|10|||
128908200|NCT01437397|463955166|FG001|Overall Study|Protocol Violation|12|||
128908201|NCT01437397|463955167|FG002|Overall Study|Protocol Violation|13|||
128908202|NCT01437397|463955168|FG003|Overall Study|Protocol Violation|21|||
128908203|NCT01437397|463955169|FG004|Overall Study|Protocol Violation|19|||
128908204|NCT01437397|463955165|FG000|Overall Study|Lack of Efficacy|5|||
128908205|NCT01437397|463955166|FG001|Overall Study|Lack of Efficacy|4|||
129117726|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
128908206|NCT01437397|463955167|FG002|Overall Study|Lack of Efficacy|8|||
129117727|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
128908207|NCT01437397|463955168|FG003|Overall Study|Lack of Efficacy|10|||
128908208|NCT01437397|463955169|FG004|Overall Study|Lack of Efficacy|20|||
128908209|NCT01437397|463955165|FG000|Overall Study|Adverse Event|21|||
128908210|NCT01437397|463955166|FG001|Overall Study|Adverse Event|22|||
128908211|NCT01437397|463955167|FG002|Overall Study|Adverse Event|16|||
128908212|NCT01437397|463955168|FG003|Overall Study|Adverse Event|14|||
128908213|NCT01437397|463955169|FG004|Overall Study|Adverse Event|21|||
128908214|NCT01437397|463955165|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
128908215|NCT01437397|463955166|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
128908216|NCT01437397|463955167|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
128908217|NCT01437397|463955168|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
128908218|NCT01437397|463955169|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
128908219|NCT01035905|463955170|FG000|Overall Study|Lack of Efficacy|1|||
128908220|NCT01035905|463955171|FG001|Overall Study|Lack of Efficacy|1|||
128908221|NCT02508194|463955172|FG000|Overall Study|Death|5|||
128908222|NCT02508194|463955173|FG001|Overall Study|Death|3|||
128908223|NCT02508194|463955172|FG000|Overall Study|Lost to Follow-up|25|||
128908224|NCT02508194|463955173|FG001|Overall Study|Lost to Follow-up|18|||
128908225|NCT02508194|463955172|FG000|Overall Study|Withdrawal by Subject|20|||
128908226|NCT02508194|463955173|FG001|Overall Study|Withdrawal by Subject|18|||
128908227|NCT02508194|463955172|FG000|Overall Study|Error in Randomization|1|||
128908228|NCT02508194|463955173|FG001|Overall Study|Error in Randomization|3|||
128908229|NCT02508194|463955172|FG000|Overall Study|Principal Investigator Decision|1|||
128908230|NCT02508194|463955173|FG001|Overall Study|Principal Investigator Decision|2|||
128908231|NCT02158091|463955179|FG000|Overall Study|DLT|2|||
128908232|NCT02158091|463955180|FG001|Overall Study|DLT|1|||
128908233|NCT02158091|463955181|FG002|Overall Study|DLT|0|||
128908234|NCT03977467|463955182|FG000|Overall Study|Disease Progression|1|||
128908235|NCT03977467|463955183|FG001|Overall Study|Disease Progression|1|||
129027773|NCT02003391|464391788|FG001|Overall Study|Withdrawal by Subject|1|||
129027774|NCT02003391|464391787|FG000|Overall Study|Protocol Violation|0|||
129027775|NCT02003391|464391788|FG001|Overall Study|Protocol Violation|1|||
129027776|NCT02003391|464391787|FG000|Overall Study|Adverse Event|1|||
129027777|NCT02003391|464391788|FG001|Overall Study|Adverse Event|0|||
129027778|NCT02272803|464391789|FG000|Overall Study|Disease progression|16|||
129027779|NCT02272803|464391790|FG001|Overall Study|Disease progression|8|||
129027780|NCT02272803|464391789|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
129027781|NCT02272803|464391790|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
129027782|NCT02272803|464391789|FG000|Overall Study|Study drug toxicity|4|||
129027783|NCT02272803|464391790|FG001|Overall Study|Study drug toxicity|9|||
129027784|NCT02272803|464391789|FG000|Overall Study|Participant request to discontinue study treatment|3|||
129027785|NCT02272803|464391790|FG001|Overall Study|Participant request to discontinue study treatment|7|||
129027786|NCT02272803|464391789|FG000|Overall Study|Maximum clinical benefit|4|||
129027787|NCT02272803|464391790|FG001|Overall Study|Maximum clinical benefit|2|||
129027788|NCT02272803|464391789|FG000|Overall Study|Poor/non-compliance|2|||
129027789|NCT02272803|464391790|FG001|Overall Study|Poor/non-compliance|2|||
129027790|NCT02272803|464391789|FG000|Overall Study|Withdrawal by Subject|2|||
129027791|NCT02272803|464391790|FG001|Overall Study|Withdrawal by Subject|1|||
129027792|NCT02272803|464391789|FG000|Overall Study|Death|0|||
129027793|NCT02272803|464391790|FG001|Overall Study|Death|1|||
129027794|NCT02272803|464391789|FG000|Overall Study|Other reasons|1|||
129027795|NCT02272803|464391790|FG001|Overall Study|Other reasons|3|||
129027796|NCT02272803|464391789|FG000|Overall Study|Administrative reason by sponsor|5|||
129027797|NCT02272803|464391790|FG001|Overall Study|Administrative reason by sponsor|4|||
129027798|NCT01566435|464391794|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
129027799|NCT03684928|464391795|FG000|First Intervention|Lost to Follow-up|0|||
129027800|NCT03684928|464391796|FG001|First Intervention|Lost to Follow-up|1|||
129027801|NCT03684928|464391795|FG000|First Intervention|Withdrawal by Subject|0|||
129027802|NCT03684928|464391796|FG001|First Intervention|Withdrawal by Subject|2|||
129027803|NCT03684928|464391795|FG000|Second Intervention|Soft Tissue Injury|1|||
129027804|NCT03684928|464391796|FG001|Second Intervention|Soft Tissue Injury|0|||
129027805|NCT03733145|464391800|FG000|Overall Study|screenfail|3|||
129027806|NCT03733145|464391801|FG001|Overall Study|screenfail|3|||
129027807|NCT03733145|464391802|FG002|Overall Study|screenfail|2|||
129027808|NCT02302716|464392747|FG000|Overall Study|Adverse Event|1|||
129027809|NCT02302716|464392748|FG001|Overall Study|Adverse Event|1|||
129027810|NCT02302716|464392747|FG000|Overall Study|Death|0|||
129027811|NCT02302716|464392748|FG001|Overall Study|Death|1|||
129027812|NCT02302716|464392747|FG000|Overall Study|Lack of Efficacy|0|||
129027813|NCT02302716|464392748|FG001|Overall Study|Lack of Efficacy|1|||
129027814|NCT02302716|464392747|FG000|Overall Study|Lost to Follow-up|2|||
129027815|NCT02302716|464392748|FG001|Overall Study|Lost to Follow-up|4|||
129027816|NCT02302716|464392747|FG000|Overall Study|Physician Decision|3|||
129027817|NCT02302716|464392748|FG001|Overall Study|Physician Decision|4|||
129027818|NCT02302716|464392747|FG000|Overall Study|Withdrawal by Subject|13|||
129027819|NCT02302716|464392748|FG001|Overall Study|Withdrawal by Subject|7|||
129027820|NCT02302716|464392747|FG000|Overall Study|Protocol Violation|0|||
128908236|NCT03977467|463955184|FG002|Overall Study|Disease Progression|30|||
129027821|NCT02302716|464392748|FG001|Overall Study|Protocol Violation|1|||
129027822|NCT00557245|464392752|FG000|Overall Study|Lost to Follow-up|7|||
129027823|NCT00557245|464392753|FG001|Overall Study|Lost to Follow-up|8|||
129027824|NCT00557245|464392754|FG002|Overall Study|Lost to Follow-up|10|||
128908237|NCT03977467|463955185|FG003|Overall Study|Disease Progression|0|||
128908238|NCT03977467|463955182|FG000|Overall Study|Adverse Event|0|||
128908239|NCT03977467|463955183|FG001|Overall Study|Adverse Event|1|||
128908240|NCT03977467|463955184|FG002|Overall Study|Adverse Event|0|||
128908241|NCT03977467|463955185|FG003|Overall Study|Adverse Event|0|||
128908242|NCT03977467|463955182|FG000|Overall Study|Death|0|||
128908243|NCT03977467|463955183|FG001|Overall Study|Death|0|||
128908244|NCT03977467|463955184|FG002|Overall Study|Death|3|||
128908245|NCT03977467|463955185|FG003|Overall Study|Death|0|||
128908246|NCT03977467|463955182|FG000|Overall Study|Lack of Efficacy|0|||
128908247|NCT03977467|463955183|FG001|Overall Study|Lack of Efficacy|0|||
128908248|NCT03977467|463955184|FG002|Overall Study|Lack of Efficacy|1|||
128908249|NCT03977467|463955185|FG003|Overall Study|Lack of Efficacy|0|||
128908250|NCT03977467|463955182|FG000|Overall Study|Withdrawal by Subject|2|||
128908251|NCT03977467|463955183|FG001|Overall Study|Withdrawal by Subject|1|||
128908252|NCT03977467|463955184|FG002|Overall Study|Withdrawal by Subject|4|||
128908253|NCT03977467|463955185|FG003|Overall Study|Withdrawal by Subject|0|||
128908254|NCT03977467|463955182|FG000|Overall Study|Study Terminated|1|||
128908255|NCT03977467|463955183|FG001|Overall Study|Study Terminated|0|||
128908256|NCT03977467|463955184|FG002|Overall Study|Study Terminated|0|||
128908257|NCT03977467|463955185|FG003|Overall Study|Study Terminated|1|||
128908258|NCT05913232|463955186|FG000|Overall Study|Adverse Event|0|||
128908259|NCT05913232|463955187|FG001|Overall Study|Adverse Event|2|||
128908260|NCT05913232|463955188|FG002|Overall Study|Adverse Event|1|||
128908261|NCT05913232|463955189|FG003|Overall Study|Adverse Event|1|||
128908262|NCT02926950|463955190|FG000|Overall Study|Adverse Event|4|||
128908263|NCT02926950|463955191|FG001|Overall Study|Adverse Event|6|||
128908264|NCT02926950|463955190|FG000|Overall Study|At the participant's own request|21|||
128908265|NCT02926950|463955191|FG001|Overall Study|At the participant's own request|25|||
128908266|NCT02926950|463955190|FG000|Overall Study|Reason not Specified|17|||
128908267|NCT02926950|463955191|FG001|Overall Study|Reason not Specified|9|||
128908268|NCT02926950|463955190|FG000|Overall Study|Lost to Follow-up|7|||
128908269|NCT02926950|463955191|FG001|Overall Study|Lost to Follow-up|8|||
128908270|NCT04341948|463955192|FG000|Overall Study|Adverse Event|0|||
128908271|NCT04341948|463955193|FG001|Overall Study|Adverse Event|1|||
128908272|NCT04341948|463955192|FG000|Overall Study|Lost to Follow-up|6|||
128908273|NCT04341948|463955193|FG001|Overall Study|Lost to Follow-up|1|||
128908274|NCT04341948|463955192|FG000|Overall Study|Physician Decision|1|||
128908275|NCT04341948|463955193|FG001|Overall Study|Physician Decision|2|||
128908276|NCT04341948|463955192|FG000|Overall Study|Withdrawal by Participant|6|||
128908277|NCT04341948|463955193|FG001|Overall Study|Withdrawal by Participant|3|||
128908278|NCT04341948|463955192|FG000|Overall Study|Lack of compliance by Participant|1|||
128908279|NCT04341948|463955193|FG001|Overall Study|Lack of compliance by Participant|0|||
128908280|NCT01761266|463956758|FG000|Overall Study|Death|415|||
128908281|NCT01761266|463956759|FG001|Overall Study|Death|402|||
128908282|NCT01761266|463956758|FG000|Overall Study|Lost to Follow-up|8|||
128908283|NCT01761266|463956759|FG001|Overall Study|Lost to Follow-up|12|||
128908284|NCT01761266|463956758|FG000|Overall Study|Withdrawal by Subject|14|||
128908285|NCT01761266|463956759|FG001|Overall Study|Withdrawal by Subject|10|||
128908286|NCT01761266|463956758|FG000|Overall Study|Sponsor Decision|41|||
128908287|NCT01761266|463956759|FG001|Overall Study|Sponsor Decision|52|||
128908288|NCT01284114|463956760|FG000|Overall Study|viral infection|1|||
128908289|NCT01284114|463956760|FG000|Overall Study|From the results of ALLTITUDE study|1|||
128908290|NCT01284114|463956760|FG000|Overall Study|Symptomatic hypotension|1|||
128908291|NCT01284114|463956760|FG000|Overall Study|dizziness|1|||
128908292|NCT03445000|463956761|FG000|Overall Study|Disease progression|8|||
128908293|NCT03445000|463956761|FG000|Overall Study|Adverse Event|3|||
128908294|NCT03445000|463956761|FG000|Overall Study|Death|2|||
128908295|NCT03445000|463956761|FG000|Overall Study|Physician Decision|1|||
128908296|NCT03409744|463956762|FG000|Overall Study|Death|2|||
128717850|NCT05104567|463264067|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
128717851|NCT05104567|463264068|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
128717852|NCT05104567|463264062|FG000|Overall Study|Progressive disease|3|||
128717853|NCT05104567|463264063|FG001|Overall Study|Progressive disease|13|||
128717854|NCT05104567|463264064|FG002|Overall Study|Progressive disease|13|||
128717855|NCT05104567|463264065|FG003|Overall Study|Progressive disease|17|||
128717856|NCT05104567|463264066|FG004|Overall Study|Progressive disease|17|||
128717857|NCT05104567|463264067|FG005|Overall Study|Progressive disease|28|||
128717858|NCT05104567|463264068|FG006|Overall Study|Progressive disease|24|||
128717859|NCT05104567|463264062|FG000|Overall Study|Withdrawal by Subject|1|||
128717860|NCT05104567|463264063|FG001|Overall Study|Withdrawal by Subject|1|||
128717861|NCT05104567|463264064|FG002|Overall Study|Withdrawal by Subject|2|||
128717862|NCT05104567|463264065|FG003|Overall Study|Withdrawal by Subject|0|||
128717863|NCT05104567|463264066|FG004|Overall Study|Withdrawal by Subject|0|||
128717864|NCT05104567|463264067|FG005|Overall Study|Withdrawal by Subject|0|||
128717865|NCT05104567|463264068|FG006|Overall Study|Withdrawal by Subject|0|||
128717866|NCT05104567|463264062|FG000|Overall Study|Other|1|||
128717867|NCT05104567|463264063|FG001|Overall Study|Other|1|||
128717868|NCT05104567|463264064|FG002|Overall Study|Other|1|||
128717869|NCT05104567|463264065|FG003|Overall Study|Other|0|||
128717870|NCT05104567|463264066|FG004|Overall Study|Other|0|||
128717871|NCT05104567|463264067|FG005|Overall Study|Other|0|||
128908297|NCT03409744|463956762|FG000|Overall Study|Physician Decision|5|||
128908298|NCT03409744|463956762|FG000|Overall Study|Pregnancy|1|||
128908299|NCT03409744|463956762|FG000|Overall Study|Lost to Follow-up|1|||
128908300|NCT03409744|463956762|FG000|Overall Study|Protocol Violation|1|||
128908301|NCT00264004|463956763|FG000|Overall Study|Adverse Event|2|||
128908302|NCT00264004|463956764|FG001|Overall Study|Adverse Event|3|||
128908303|NCT00264004|463956765|FG002|Overall Study|Adverse Event|6|||
128908304|NCT00264004|463956766|FG003|Overall Study|Adverse Event|4|||
128908305|NCT00264004|463956763|FG000|Overall Study|Withdrawal by Subject|0|||
128908306|NCT00264004|463956764|FG001|Overall Study|Withdrawal by Subject|1|||
128908307|NCT00264004|463956765|FG002|Overall Study|Withdrawal by Subject|2|||
128908308|NCT00264004|463956766|FG003|Overall Study|Withdrawal by Subject|2|||
128908309|NCT00264004|463956763|FG000|Overall Study|Other|2|||
128908310|NCT00264004|463956764|FG001|Overall Study|Other|2|||
128908311|NCT00264004|463956765|FG002|Overall Study|Other|0|||
128908312|NCT00264004|463956766|FG003|Overall Study|Other|3|||
128908313|NCT00264004|463956763|FG000|Overall Study|Development study specific disc. crit.|1|||
128908314|NCT00264004|463956764|FG001|Overall Study|Development study specific disc. crit.|0|||
128908315|NCT00264004|463956765|FG002|Overall Study|Development study specific disc. crit.|1|||
128908316|NCT00264004|463956766|FG003|Overall Study|Development study specific disc. crit.|0|||
128908317|NCT00264004|463956763|FG000|Overall Study|Cond. under inv. worsened|9|||
128908318|NCT00264004|463956764|FG001|Overall Study|Cond. under inv. worsened|5|||
128908319|NCT00264004|463956765|FG002|Overall Study|Cond. under inv. worsened|3|||
128908320|NCT00264004|463956766|FG003|Overall Study|Cond. under inv. worsened|4|||
128908321|NCT00264004|463956763|FG000|Overall Study|Not treated|3|||
128908322|NCT00264004|463956764|FG001|Overall Study|Not treated|0|||
128908323|NCT00264004|463956765|FG002|Overall Study|Not treated|2|||
128908324|NCT00264004|463956766|FG003|Overall Study|Not treated|2|||
128908325|NCT00691483|463956767|FG000|Overall Study|Adverse Event|14|||
128908326|NCT00691483|463956768|FG001|Overall Study|Adverse Event|6|||
128908327|NCT00691483|463956767|FG000|Overall Study|Lost to Follow-up|17|||
128908328|NCT00691483|463956768|FG001|Overall Study|Lost to Follow-up|10|||
128908329|NCT00691483|463956767|FG000|Overall Study|Withdrawal by Subject|24|||
128908330|NCT00691483|463956768|FG001|Overall Study|Withdrawal by Subject|7|||
128908331|NCT00691483|463956767|FG000|Overall Study|Other known cause|6|||
128908332|NCT00691483|463956768|FG001|Overall Study|Other known cause|1|||
128908333|NCT00691483|463956767|FG000|Overall Study|Randomized by not treated|7|||
128908334|NCT00691483|463956768|FG001|Overall Study|Randomized by not treated|1|||
128908335|NCT00049673|463956770|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
128908336|NCT00049673|463956771|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
128908337|NCT02475681|463956772|FG000|Overall Study|Death|16|||
128908338|NCT02475681|463956773|FG001|Overall Study|Death|6|||
128908339|NCT02475681|463956774|FG002|Overall Study|Death|9|||
128908340|NCT02475681|463956772|FG000|Overall Study|Physician Decision|0|||
128908341|NCT02475681|463956773|FG001|Overall Study|Physician Decision|3|||
128908342|NCT02475681|463956774|FG002|Overall Study|Physician Decision|1|||
128908343|NCT02475681|463956772|FG000|Overall Study|Withdrawal by Subject|12|||
128908344|NCT02475681|463956773|FG001|Overall Study|Withdrawal by Subject|6|||
128908345|NCT02475681|463956774|FG002|Overall Study|Withdrawal by Subject|9|||
128908346|NCT02475681|463956772|FG000|Overall Study|Lost to Follow-up|2|||
128908347|NCT02475681|463956773|FG001|Overall Study|Lost to Follow-up|1|||
128908348|NCT02475681|463956774|FG002|Overall Study|Lost to Follow-up|3|||
128908349|NCT02475681|463956772|FG000|Overall Study|Ongoing in Study|0|||
128908350|NCT02475681|463956773|FG001|Overall Study|Ongoing in Study|163|||
128908351|NCT02475681|463956774|FG002|Overall Study|Ongoing in Study|157|||
128908352|NCT02475681|463956772|FG000|Overall Study|Reasons other than above listed|2|||
128908353|NCT02475681|463956773|FG001|Overall Study|Reasons other than above listed|0|||
128908354|NCT02475681|463956774|FG002|Overall Study|Reasons other than above listed|0|||
128908355|NCT01535729|463956775|FG000|Overall Study|Withdrawal by Subject|2|||
128908356|NCT01535729|463956775|FG000|Overall Study|Disease progression|230|||
129027825|NCT00557245|464392752|FG000|Overall Study|Ineligible|5|||
129027826|NCT00557245|464392753|FG001|Overall Study|Ineligible|4|||
129027827|NCT00557245|464392754|FG002|Overall Study|Ineligible|2|||
128908357|NCT01535729|463956775|FG000|Overall Study|Discontinued treatment|25|||
128908358|NCT01535729|463956775|FG000|Overall Study|Lost to Follow-up|8|||
128908359|NCT01535729|463956775|FG000|Overall Study|Death|52|||
128908360|NCT01535729|463956775|FG000|Overall Study|Other|19|||
129027828|NCT00798603|464392757|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
129027829|NCT00798603|464392757|FG000|Overall Study|Withdrawal by Subject|10|||
128908361|NCT01535729|463956775|FG000|Overall Study|Did not sign informed consent|1|||
128908362|NCT01535729|463956775|FG000|Overall Study|No previous chemotherapy|33|||
128908363|NCT01535729|463956775|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
128908364|NCT01535729|463956775|FG000|Overall Study|Protocol Violation|11|||
128908365|NCT01535729|463956775|FG000|Overall Study|Screening failure|1|||
128908366|NCT01535729|463956775|FG000|Overall Study|Not treated|9|||
128908367|NCT01535729|463956775|FG000|Overall Study|No participant record available|5|||
128908368|NCT01262365|463956776|FG000|Overall Study|Lack of Efficacy|35|||
128908369|NCT01262365|463956777|FG001|Overall Study|Lack of Efficacy|30|||
128908370|NCT01262365|463956778|FG002|Overall Study|Lack of Efficacy|47|||
128908371|NCT01262365|463956776|FG000|Overall Study|Protocol Violation|3|||
129117728|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
129117729|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
128908372|NCT01262365|463956777|FG001|Overall Study|Protocol Violation|1|||
128908373|NCT01262365|463956778|FG002|Overall Study|Protocol Violation|1|||
128908374|NCT01262365|463956776|FG000|Overall Study|Lost to Follow-up|3|||
129117730|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
129117731|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
129117732|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
129117733|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
129117734|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
129117735|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
129117736|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
129117737|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
129117738|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
129117739|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
129117740|NCT01668797|464727441|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
129117741|NCT01668797|464727442|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
128908375|NCT01262365|463956777|FG001|Overall Study|Lost to Follow-up|7|||
128908376|NCT01262365|463956778|FG002|Overall Study|Lost to Follow-up|6|||
128908377|NCT01262365|463956776|FG000|Overall Study|Withdrawal by Subject|17|||
128908378|NCT01262365|463956777|FG001|Overall Study|Withdrawal by Subject|22|||
128908379|NCT01262365|463956778|FG002|Overall Study|Withdrawal by Subject|22|||
128908380|NCT01262365|463956776|FG000|Overall Study|Death|1|||
128908381|NCT01262365|463956777|FG001|Overall Study|Death|2|||
128908382|NCT01262365|463956778|FG002|Overall Study|Death|1|||
128908383|NCT01262365|463956776|FG000|Overall Study|Adverse Event|26|||
128908384|NCT01262365|463956777|FG001|Overall Study|Adverse Event|16|||
128908385|NCT01262365|463956778|FG002|Overall Study|Adverse Event|11|||
128908386|NCT01262365|463956776|FG000|Overall Study|sponsor decision|1|||
128908387|NCT01262365|463956777|FG001|Overall Study|sponsor decision|1|||
128908388|NCT01262365|463956778|FG002|Overall Study|sponsor decision|0|||
128908389|NCT01262365|463956776|FG000|Overall Study|Randomization error|1|||
129117742|NCT01668797|464727443|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
129117743|NCT01668797|464727444|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
129117744|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
129117745|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
129117746|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
129117747|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
129117748|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
129117749|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
129117750|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
129117751|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
128908390|NCT01262365|463956777|FG001|Overall Study|Randomization error|0|||
128908391|NCT01262365|463956778|FG002|Overall Study|Randomization error|2|||
128908392|NCT01262365|463956776|FG000|Overall Study|Non-compliance|1|||
128908393|NCT01262365|463956777|FG001|Overall Study|Non-compliance|0|||
128908394|NCT01262365|463956778|FG002|Overall Study|Non-compliance|2|||
128908395|NCT01262365|463956776|FG000|Overall Study|Suspected pregnancy|1|||
128908396|NCT01262365|463956777|FG001|Overall Study|Suspected pregnancy|0|||
128908397|NCT01262365|463956778|FG002|Overall Study|Suspected pregnancy|0|||
128908398|NCT01262365|463956776|FG000|Overall Study|Patient pregnant|1|||
128908399|NCT01262365|463956777|FG001|Overall Study|Patient pregnant|0|||
128908400|NCT01262365|463956778|FG002|Overall Study|Patient pregnant|1|||
128908401|NCT01262365|463956776|FG000|Overall Study|Toxicity related to study drug|0|||
128908402|NCT01262365|463956777|FG001|Overall Study|Toxicity related to study drug|1|||
128908403|NCT01262365|463956778|FG002|Overall Study|Toxicity related to study drug|0|||
128908404|NCT01262365|463956776|FG000|Overall Study|Cannot tolerate the protocol|0|||
128908405|NCT01262365|463956777|FG001|Overall Study|Cannot tolerate the protocol|1|||
128908406|NCT01262365|463956778|FG002|Overall Study|Cannot tolerate the protocol|0|||
128908407|NCT01262365|463956776|FG000|Overall Study|Patient unavailable|0|||
128908408|NCT01262365|463956777|FG001|Overall Study|Patient unavailable|0|||
129117752|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
129132907|NCT02609633|464778565|FG001|Overall Study|Consent Withdrawn|1|||
128908409|NCT01262365|463956778|FG002|Overall Study|Patient unavailable|1|||
128908410|NCT02322710|463956779|FG000|Overall Study|No efficacy assessment post-baseline|0|||
128908411|NCT02322710|463956780|FG001|Overall Study|No efficacy assessment post-baseline|1|||
128908412|NCT02322710|463956779|FG000|Overall Study|Protocol Violation|20|||
128908413|NCT02322710|463956780|FG001|Overall Study|Protocol Violation|25|||
128908414|NCT04161131|463956781|FG000|Overall Study|Ineligible|2|||
128908415|NCT04161131|463956781|FG000|Overall Study|Lost to Follow-up|4|||
128908416|NCT03733392|463956782|FG000|Overall Study|Withdrawal by Subject|11|||
128908417|NCT03733392|463956783|FG001|Overall Study|Withdrawal by Subject|1|||
128908418|NCT03733392|463956782|FG000|Overall Study|Death|1|||
128908419|NCT03733392|463956783|FG001|Overall Study|Death|0|||
128908420|NCT03733392|463956782|FG000|Overall Study|Lost to Follow-up|5|||
128908421|NCT03733392|463956783|FG001|Overall Study|Lost to Follow-up|0|||
128908422|NCT03733392|463956782|FG000|Overall Study|Protocol Violation|0|||
128908423|NCT03733392|463956783|FG001|Overall Study|Protocol Violation|1|||
128908424|NCT03733392|463956782|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
128908425|NCT03733392|463956783|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
128908426|NCT03733392|463956782|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
128908427|NCT03733392|463956783|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
128908428|NCT03733392|463956782|FG000|Overall Study|Patient Non-Compliance|2|||
128908429|NCT03733392|463956783|FG001|Overall Study|Patient Non-Compliance|1|||
128908430|NCT03733392|463956782|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
128908431|NCT03733392|463956783|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
128908432|NCT03733392|463956782|FG000|Overall Study|Withdrawal prior to procedure|5|||
128908433|NCT03733392|463956783|FG001|Overall Study|Withdrawal prior to procedure|2|||
128908434|NCT02615990|463956786|FG000|Overall Study|study terminated|1|||
128908435|NCT02615990|463956787|FG001|Overall Study|study terminated|1|||
128908436|NCT01363986|463956788|FG000|Overall Study|Disease progression|1|||
128908437|NCT00130832|463956789|FG000|Overall Study|Adverse Event|1|||
128908438|NCT00130832|463956790|FG001|Overall Study|Adverse Event|1|||
128908439|NCT00130832|463956789|FG000|Overall Study|Lost to Follow-up|1|||
128908440|NCT00130832|463956790|FG001|Overall Study|Lost to Follow-up|2|||
128908441|NCT00130832|463956789|FG000|Overall Study|Protocol Violation|6|||
128908442|NCT00130832|463956790|FG001|Overall Study|Protocol Violation|8|||
128908443|NCT00130832|463956789|FG000|Overall Study|Withdrawal by Subject|6|||
128908444|NCT00130832|463956790|FG001|Overall Study|Withdrawal by Subject|1|||
128908445|NCT00130832|463956789|FG000|Overall Study|Moved|2|||
128908446|NCT00130832|463956790|FG001|Overall Study|Moved|2|||
128908447|NCT00130832|463956789|FG000|Overall Study|Other|0|||
128908448|NCT00130832|463956790|FG001|Overall Study|Other|3|||
128908449|NCT03905863|463956791|FG000|Overall Study|Adverse Event|2|||
128908450|NCT03905863|463956792|FG001|Overall Study|Adverse Event|4|||
128908451|NCT03905863|463956791|FG000|Overall Study|Withdrawal by Subject|2|||
128908452|NCT03905863|463956792|FG001|Overall Study|Withdrawal by Subject|2|||
128908453|NCT03905863|463956791|FG000|Overall Study|Physician Decision|0|||
128908454|NCT03905863|463956792|FG001|Overall Study|Physician Decision|3|||
128908455|NCT03905863|463956791|FG000|Overall Study|Lost to Follow-up|1|||
128908456|NCT03905863|463956792|FG001|Overall Study|Lost to Follow-up|0|||
128908457|NCT03905863|463956791|FG000|Overall Study|Protocol Violation|0|||
128908458|NCT03905863|463956792|FG001|Overall Study|Protocol Violation|2|||
128908459|NCT03905863|463956791|FG000|Overall Study|Death|0|||
128908460|NCT03905863|463956792|FG001|Overall Study|Death|1|||
128908461|NCT02944448|463956794|FG000|Overall Study|Adverse Event|37|||
128908462|NCT02944448|463956795|FG001|Overall Study|Adverse Event|6|||
128908463|NCT02944448|463956794|FG000|Overall Study|Lack of Efficacy|8|||
128908464|NCT02944448|463956795|FG001|Overall Study|Lack of Efficacy|5|||
128908465|NCT02944448|463956794|FG000|Overall Study|Lost to Follow-up|3|||
128908466|NCT02944448|463956795|FG001|Overall Study|Lost to Follow-up|1|||
128908467|NCT02944448|463956794|FG000|Overall Study|Protocol Violation|25|||
128908468|NCT02944448|463956795|FG001|Overall Study|Protocol Violation|7|||
128908469|NCT02944448|463956794|FG000|Overall Study|Withdrawal by Subject|14|||
128908470|NCT02944448|463956795|FG001|Overall Study|Withdrawal by Subject|4|||
128908471|NCT02944448|463956794|FG000|Overall Study|Sponsor did not supply drug in time|0|||
128908472|NCT02944448|463956795|FG001|Overall Study|Sponsor did not supply drug in time|1|||
129027830|NCT00798603|464392757|FG000|Overall Study|Adverse Event|22|||
129027831|NCT00798603|464392757|FG000|Overall Study|Physician Decision|1|||
129027832|NCT00798603|464392757|FG000|Overall Study|Lack of insurance coverage|1|||
129027833|NCT02316223|464392760|FG000|Overall Study|Lack of Efficacy|0|||
129027834|NCT02316223|464392761|FG001|Overall Study|Lack of Efficacy|1|||
129027835|NCT02316223|464392762|FG002|Overall Study|Lack of Efficacy|1|||
129027836|NCT02316223|464392760|FG000|Overall Study|Lost to Follow-up|27|||
129027837|NCT02316223|464392761|FG001|Overall Study|Lost to Follow-up|34|||
129027838|NCT02316223|464392762|FG002|Overall Study|Lost to Follow-up|36|||
128908473|NCT02944448|463956794|FG000|Overall Study|Noncompliant with dosing|1|||
128908474|NCT02944448|463956795|FG001|Overall Study|Noncompliant with dosing|0|||
128908475|NCT02944448|463956794|FG000|Overall Study|Abnormal laboratory values|1|||
128908476|NCT02944448|463956795|FG001|Overall Study|Abnormal laboratory values|0|||
129027839|NCT02316223|464392760|FG000|Overall Study|COPD Diagnosis|3|||
128908477|NCT00925015|463956798|FG000|Overall Study|Adverse Event|1|||
128908478|NCT00925015|463956799|FG001|Overall Study|Adverse Event|2|||
128908479|NCT00925015|463956800|FG002|Overall Study|Adverse Event|1|||
128908480|NCT00925015|463956798|FG000|Overall Study|Physician Decision|0|||
128908481|NCT00925015|463956799|FG001|Overall Study|Physician Decision|1|||
128908482|NCT00925015|463956800|FG002|Overall Study|Physician Decision|0|||
128908483|NCT00925015|463956798|FG000|Overall Study|Progressive Disease|7|||
129027840|NCT02316223|464392761|FG001|Overall Study|COPD Diagnosis|2|||
129027841|NCT02316223|464392762|FG002|Overall Study|COPD Diagnosis|3|||
128908484|NCT00925015|463956799|FG001|Overall Study|Progressive Disease|3|||
128908485|NCT00925015|463956800|FG002|Overall Study|Progressive Disease|4|||
128908486|NCT00925015|463956798|FG000|Overall Study|Withdrawal by Subject|0|||
128908487|NCT00925015|463956799|FG001|Overall Study|Withdrawal by Subject|0|||
128908488|NCT00925015|463956800|FG002|Overall Study|Withdrawal by Subject|1|||
128908489|NCT05499559|463956805|FG000|Overall Study|Lost to Follow-up|467|||
128908490|NCT04681170|463956806|FG000|Stratified Enrolment & run-in|Death|1|||
128908491|NCT04681170|463956807|FG001|Stratified Enrolment & run-in|Death|0|||
128908492|NCT04681170|463956806|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
128908493|NCT04681170|463956807|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
128908494|NCT04681170|463956806|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
128908495|NCT04681170|463956807|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
128908496|NCT04681170|463956806|FG000|Open Label Efficacy Phase|Adverse Event|0|||
128908497|NCT04681170|463956807|FG001|Open Label Efficacy Phase|Adverse Event|2|||
128908498|NCT04681170|463956806|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
128908499|NCT04681170|463956807|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
128908500|NCT04681170|463956806|FG000|Open Label Safety Phase|AEs and none compliance|0|||
128908501|NCT04681170|463956807|FG001|Open Label Safety Phase|AEs and none compliance|1|||
128908502|NCT04986202|463956808|FG000|Overall Study|Death|10|||
128908503|NCT04986202|463956809|FG001|Overall Study|Death|3|||
128908504|NCT04986202|463956810|FG002|Overall Study|Death|10|||
128908505|NCT04986202|463956808|FG000|Overall Study|Physician Decision|3|||
129027842|NCT02316223|464392760|FG000|Overall Study|Reside outside study area|1|||
129027843|NCT02316223|464392761|FG001|Overall Study|Reside outside study area|1|||
129027844|NCT02316223|464392762|FG002|Overall Study|Reside outside study area|1|||
129027845|NCT02316223|464392760|FG000|Overall Study|No asthma|2|||
129027846|NCT02316223|464392761|FG001|Overall Study|No asthma|0|||
129027847|NCT02316223|464392762|FG002|Overall Study|No asthma|0|||
129027848|NCT02316223|464392760|FG000|Overall Study|Discontinued by PI|11|||
129027849|NCT02316223|464392761|FG001|Overall Study|Discontinued by PI|19|||
129027850|NCT02316223|464392762|FG002|Overall Study|Discontinued by PI|3|||
129027851|NCT00529763|464392764|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
128908506|NCT04986202|463956809|FG001|Overall Study|Physician Decision|1|||
128908507|NCT04986202|463956810|FG002|Overall Study|Physician Decision|2|||
128908508|NCT04986202|463956808|FG000|Overall Study|Withdrawal by Subject|4|||
128908509|NCT04986202|463956809|FG001|Overall Study|Withdrawal by Subject|2|||
128908510|NCT04986202|463956810|FG002|Overall Study|Withdrawal by Subject|4|||
128908511|NCT02468648|463956811|FG000|Overall Study|Death|1|||
128908512|NCT02118792|463956812|FG000|Overall Study|Withdrawal by Subject|6|||
128908513|NCT02118792|463956813|FG001|Overall Study|Withdrawal by Subject|3|||
128908514|NCT02118792|463956812|FG000|Overall Study|Lost to Follow-up|4|||
128908515|NCT02118792|463956813|FG001|Overall Study|Lost to Follow-up|4|||
128908516|NCT02118792|463956812|FG000|Overall Study|Adverse Event|5|||
128908517|NCT02118792|463956813|FG001|Overall Study|Adverse Event|4|||
128908518|NCT02118792|463956812|FG000|Overall Study|Withdrawal by parent/guardian|14|||
128908519|NCT02118792|463956813|FG001|Overall Study|Withdrawal by parent/guardian|20|||
129027852|NCT00529763|464392765|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
129027853|NCT00529763|464392766|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129027854|NCT00529763|464392764|FG000|Overall Study|Death|1|||
129027855|NCT00529763|464392765|FG001|Overall Study|Death|1|||
128908520|NCT02118792|463956812|FG000|Overall Study|Other|1|||
128908521|NCT02118792|463956813|FG001|Overall Study|Other|6|||
128908522|NCT02118792|463956812|FG000|Overall Study|Randomised but not treated|1|||
128908523|NCT02118792|463956813|FG001|Overall Study|Randomised but not treated|0|||
128908524|NCT05131204|463956814|FG000|Overall Study|Sponsor request|2|||
129027856|NCT00529763|464392766|FG002|Overall Study|Death|1|||
129027857|NCT00529763|464392764|FG000|Overall Study|Disease Progression|10|||
129027858|NCT00529763|464392765|FG001|Overall Study|Disease Progression|16|||
128908525|NCT05131204|463956815|FG001|Overall Study|Sponsor request|1|||
129027859|NCT00529763|464392766|FG002|Overall Study|Disease Progression|11|||
129027860|NCT00529763|464392764|FG000|Overall Study|Lost to Follow-up|1|||
128696652|NCT02264639|463186861|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
128908526|NCT02787863|463956816|FG000|Overall Study|Death|1|||
128908527|NCT02787863|463956817|FG001|Overall Study|Death|0|||
129027861|NCT00529763|464392765|FG001|Overall Study|Lost to Follow-up|2|||
128908528|NCT02787863|463956818|FG002|Overall Study|Death|1|||
128908529|NCT02787863|463956819|FG003|Overall Study|Death|0|||
128908530|NCT02787863|463956820|FG004|Overall Study|Death|0|||
128908531|NCT02787863|463956821|FG005|Overall Study|Death|0|||
128908532|NCT02787863|463956822|FG006|Overall Study|Death|0|||
128908533|NCT02787863|463956823|FG007|Overall Study|Death|0|||
128908534|NCT02787863|463956816|FG000|Overall Study|Withdrawal by Subject|0|||
128908535|NCT02787863|463956817|FG001|Overall Study|Withdrawal by Subject|1|||
128908536|NCT02787863|463956818|FG002|Overall Study|Withdrawal by Subject|1|||
128908537|NCT02787863|463956819|FG003|Overall Study|Withdrawal by Subject|0|||
128908538|NCT02787863|463956820|FG004|Overall Study|Withdrawal by Subject|0|||
129027862|NCT00529763|464392766|FG002|Overall Study|Lost to Follow-up|3|||
129027863|NCT00529763|464392764|FG000|Overall Study|Stem Cell Transplant|0|||
128908539|NCT02787863|463956821|FG005|Overall Study|Withdrawal by Subject|0|||
128908540|NCT02787863|463956822|FG006|Overall Study|Withdrawal by Subject|0|||
128908541|NCT02787863|463956823|FG007|Overall Study|Withdrawal by Subject|0|||
128908542|NCT01368835|463956824|FG000|Overall Study|Inclusion criteria/photography quality|22|||
128908543|NCT01368835|463956824|FG000|Overall Study|Lost to Follow-up|11|||
128908544|NCT03118297|463956825|FG000|Overall Study|Lost to Follow-up|0|||
128908545|NCT03118297|463956826|FG001|Overall Study|Lost to Follow-up|2|||
128908546|NCT02754726|463956827|FG000|Overall Study|Progressive Disease by RECIST|13|||
128908547|NCT02754726|463956827|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
128908548|NCT02754726|463956827|FG000|Overall Study|Clinical Disease Progression|5|||
128908549|NCT02754726|463956827|FG000|Overall Study|Adverse Event|3|||
128908550|NCT02754726|463956827|FG000|Overall Study|Withdrawal by Subject|1|||
128908551|NCT02754726|463956827|FG000|Overall Study|Tolerability|1|||
128908552|NCT01885000|463956828|FG000|Overall Study|Adverse Event|1|||
128908553|NCT01885000|463956829|FG001|Overall Study|Adverse Event|0|||
128908554|NCT01885000|463956828|FG000|Overall Study|Withdrawal by Subject|1|||
128908555|NCT01885000|463956829|FG001|Overall Study|Withdrawal by Subject|1|||
128908556|NCT01885000|463956828|FG000|Overall Study|Protocol Violation|0|||
128908557|NCT01885000|463956829|FG001|Overall Study|Protocol Violation|1|||
128908558|NCT03124784|463956830|FG000|Overall Study|Adverse Event|1|||
128908559|NCT03124784|463956830|FG000|Overall Study|Computer/Equip Malfunction|1|||
128908560|NCT02462473|463956834|FG000|Overall Study|Death|1|||
128908561|NCT02462473|463956834|FG000|Overall Study|Other|3|||
128908562|NCT00430508|463956835|FG000|Overall Study|Adverse Event|2|||
128908563|NCT00430508|463956836|FG001|Overall Study|Adverse Event|3|||
128908564|NCT00430508|463956837|FG002|Overall Study|Adverse Event|5|||
128908565|NCT00430508|463956838|FG003|Overall Study|Adverse Event|3|||
128908566|NCT00430508|463956835|FG000|Overall Study|Withdrawal by Subject|0|||
128908567|NCT00430508|463956836|FG001|Overall Study|Withdrawal by Subject|1|||
128908568|NCT00430508|463956837|FG002|Overall Study|Withdrawal by Subject|1|||
128908569|NCT00430508|463956838|FG003|Overall Study|Withdrawal by Subject|1|||
128908570|NCT00430508|463956835|FG000|Overall Study|responder at visit 4|0|||
128908571|NCT00430508|463956836|FG001|Overall Study|responder at visit 4|0|||
128908572|NCT00430508|463956837|FG002|Overall Study|responder at visit 4|2|||
128908573|NCT00430508|463956838|FG003|Overall Study|responder at visit 4|0|||
128908574|NCT00430508|463956835|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
128908575|NCT00430508|463956836|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
128908576|NCT00430508|463956837|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
128908577|NCT00430508|463956838|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
128908578|NCT00430508|463956835|FG000|Overall Study|Other|1|||
128908579|NCT00430508|463956836|FG001|Overall Study|Other|1|||
128908580|NCT00430508|463956837|FG002|Overall Study|Other|3|||
128908581|NCT00430508|463956838|FG003|Overall Study|Other|0|||
128908582|NCT04673786|463956844|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
128908583|NCT04673786|463956845|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
128908584|NCT04673786|463956846|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
128908585|NCT04673786|463956844|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
128908586|NCT04673786|463956845|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
128908587|NCT04673786|463956846|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
128908588|NCT04673786|463956844|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
128908589|NCT04673786|463956845|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
128908590|NCT04673786|463956846|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
128908591|NCT04673786|463956844|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
128908592|NCT04673786|463956845|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
128908593|NCT04673786|463956846|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
128908594|NCT04673786|463956844|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
128908595|NCT04673786|463956845|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
128908596|NCT04673786|463956846|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
128908597|NCT04673786|463956844|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
129027864|NCT00529763|464392765|FG001|Overall Study|Stem Cell Transplant|3|||
128908598|NCT04673786|463956845|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
129027865|NCT00529763|464392766|FG002|Overall Study|Stem Cell Transplant|1|||
129027866|NCT00529763|464392764|FG000|Overall Study|Study Drug Toxicity|3|||
129027867|NCT00529763|464392765|FG001|Overall Study|Study Drug Toxicity|6|||
129027868|NCT00529763|464392766|FG002|Overall Study|Study Drug Toxicity|4|||
128908599|NCT04673786|463956846|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
128908600|NCT03298022|463956847|FG000|Overall Study|Lack of Efficacy|4|||
128908601|NCT03298022|463956847|FG000|Overall Study|Withdrawal by Subject|7|||
128908602|NCT03298022|463956847|FG000|Overall Study|Adverse Event|1|||
128908603|NCT03298022|463956847|FG000|Overall Study|disease relapse|1|||
129132908|NCT02609633|464778564|FG000|Overall Study|Protocol Deviation|1|||
128908604|NCT01422239|463956850|FG000|Overall Study|Lost to Follow-up|4|||
128908605|NCT01422239|463956851|FG001|Overall Study|Lost to Follow-up|3|||
128908606|NCT01400451|463956852|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
128908607|NCT01400451|463956853|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
128908608|NCT01400451|463956854|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
128765230|NCT03389477|463432095|FG000|Step 2|Poor performance status and nutrition|0|||
128765231|NCT03389477|463432096|FG001|Step 2|Poor performance status and nutrition|1|||
128765232|NCT03389477|463432095|FG000|Step 3|Withdrawal after 3 cycles|0|||
128765233|NCT03389477|463432096|FG001|Step 3|Withdrawal after 3 cycles|1|||
128765234|NCT03389477|463432095|FG000|Step 3|Still receiving active treatment|4|||
128765235|NCT03389477|463432096|FG001|Step 3|Still receiving active treatment|0|||
128765236|NCT03389477|463432095|FG000|Step 3|Progressive disease after 2 cycles|1|||
128765237|NCT03389477|463432096|FG001|Step 3|Progressive disease after 2 cycles|0|||
128765238|NCT03403426|463432099|FG000|Overall Study|Death|1|||
128765239|NCT03403426|463432099|FG000|Overall Study|Lost to Follow-up|2|||
128765240|NCT00909428|463432100|FG000|Overall Study|Lost to Follow-up|13|||
128765241|NCT00909428|463432101|FG001|Overall Study|Lost to Follow-up|10|||
128765242|NCT00909428|463432102|FG002|Overall Study|Lost to Follow-up|9|||
128765243|NCT03021668|463432103|FG000|Overall Study|Physician Decision|0|||
128765244|NCT03021668|463432104|FG001|Overall Study|Physician Decision|1|||
128765245|NCT01122381|463432105|FG000|Overall Study|study terminated early|0|||
128765246|NCT01122381|463432106|FG001|Overall Study|study terminated early|1|||
128765247|NCT02217280|463432107|FG000|Overall Study|Withdrawal by Subject|2|||
128765248|NCT02217280|463432107|FG000|Overall Study|Post-consent sceen fail|2|||
128765249|NCT00116844|463432110|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
128908609|NCT01400451|463956852|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
128908610|NCT01400451|463956853|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
128908611|NCT01400451|463956854|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
128908612|NCT01400451|463956852|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
128908613|NCT01400451|463956853|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
128908614|NCT01400451|463956854|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
128908615|NCT01400451|463956852|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
128908616|NCT01400451|463956853|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
128908617|NCT01400451|463956854|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
128908618|NCT01400451|463956852|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
128908619|NCT01400451|463956853|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
128908620|NCT01400451|463956854|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
128908621|NCT00720109|463956859|FG000|Induction Period|Did not meet eligibility criteria|3|||
128908622|NCT00720109|463956860|FG001|Induction Period|Did not meet eligibility criteria|0|||
128908623|NCT00720109|463956861|FG002|Induction Period|Did not meet eligibility criteria|0|||
128908624|NCT00720109|463956859|FG000|Induction Period|Bone Marrow Transplant|2|||
128908625|NCT00720109|463956860|FG001|Induction Period|Bone Marrow Transplant|0|||
128908626|NCT00720109|463956861|FG002|Induction Period|Bone Marrow Transplant|0|||
128908627|NCT00720109|463956859|FG000|Induction Period|Physician Decision|1|||
128908628|NCT00720109|463956860|FG001|Induction Period|Physician Decision|0|||
128908629|NCT00720109|463956861|FG002|Induction Period|Physician Decision|0|||
128908630|NCT00720109|463956859|FG000|Risk Stratification Period|Adverse Event|0|||
128908631|NCT00720109|463956860|FG001|Risk Stratification Period|Adverse Event|1|||
128908632|NCT00720109|463956861|FG002|Risk Stratification Period|Adverse Event|0|||
128908633|NCT00720109|463956859|FG000|Risk Stratification Period|Physician Decision|0|||
128908634|NCT00720109|463956860|FG001|Risk Stratification Period|Physician Decision|2|||
128908635|NCT00720109|463956861|FG002|Risk Stratification Period|Physician Decision|1|||
128908636|NCT00720109|463956859|FG000|Risk Stratification Period|Bone marrow transplant|0|||
128908637|NCT00720109|463956860|FG001|Risk Stratification Period|Bone marrow transplant|9|||
128908638|NCT00720109|463956861|FG002|Risk Stratification Period|Bone marrow transplant|7|||
128908639|NCT00720109|463956859|FG000|Risk Stratification Period|Disease progression or relapse|0|||
128908640|NCT00720109|463956860|FG001|Risk Stratification Period|Disease progression or relapse|2|||
128908641|NCT00720109|463956861|FG002|Risk Stratification Period|Disease progression or relapse|0|||
128908642|NCT00720109|463956859|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
128908643|NCT00720109|463956860|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
128908644|NCT00720109|463956861|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
128908645|NCT00903929|463956864|FG000|Overall Study|Withdrawal by Subject|0|||
128908646|NCT00903929|463956865|FG001|Overall Study|Withdrawal by Subject|0|||
128908647|NCT00903929|463956866|FG002|Overall Study|Withdrawal by Subject|1|||
128908648|NCT00903929|463956867|FG003|Overall Study|Withdrawal by Subject|2|||
128908649|NCT00903929|463956864|FG000|Overall Study|Adverse Event|0|||
128908650|NCT00903929|463956865|FG001|Overall Study|Adverse Event|0|||
128908651|NCT00903929|463956866|FG002|Overall Study|Adverse Event|0|||
128908652|NCT00903929|463956867|FG003|Overall Study|Adverse Event|1|||
129117753|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
128765250|NCT00116844|463432111|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
128765251|NCT00116844|463432110|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
128765252|NCT00116844|463432111|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
128908653|NCT00512798|463956868|FG000|Overall Study|Death|0|||
128908654|NCT00512798|463956869|FG001|Overall Study|Death|3|||
128908655|NCT00512798|463956868|FG000|Overall Study|Adverse Event|2|||
128908656|NCT00512798|463956869|FG001|Overall Study|Adverse Event|4|||
128908657|NCT00512798|463956868|FG000|Overall Study|Progression of disease|14|||
128908658|NCT00512798|463956869|FG001|Overall Study|Progression of disease|20|||
128908659|NCT00512798|463956868|FG000|Overall Study|Withdrawal by Subject|3|||
128908660|NCT00512798|463956869|FG001|Overall Study|Withdrawal by Subject|0|||
128908661|NCT01627899|463956872|FG000|Overall Study|Study terminated early by sponsor.|5|||
128908662|NCT04158648|463956880|FG000|Overall Study|Ongoing in the Study|69|||
128908663|NCT04158648|463956880|FG000|Overall Study|Withdrawal by Subject|4|||
128908664|NCT04209855|463956881|FG000|Overall Study|Death|161|||
128908665|NCT04209855|463956882|FG001|Overall Study|Death|177|||
128908666|NCT04209855|463956881|FG000|Overall Study|PI Discretion|1|||
128908667|NCT04209855|463956882|FG001|Overall Study|PI Discretion|1|||
128908668|NCT04209855|463956881|FG000|Overall Study|Lost to Follow-up|5|||
128908669|NCT04209855|463956882|FG001|Overall Study|Lost to Follow-up|2|||
128908670|NCT04209855|463956881|FG000|Overall Study|Withdrew consent|10|||
128908671|NCT04209855|463956882|FG001|Overall Study|Withdrew consent|24|||
128908672|NCT04209855|463956881|FG000|Overall Study|Sponsor decision|44|||
128908673|NCT04209855|463956882|FG001|Overall Study|Sponsor decision|18|||
128908674|NCT04209855|463956881|FG000|Overall Study|Other than specified|6|||
128908675|NCT04209855|463956882|FG001|Overall Study|Other than specified|4|||
128908676|NCT01250379|463956885|FG000|Overall Study|Death|141|||
128908677|NCT01250379|463956886|FG001|Overall Study|Death|148|||
128908678|NCT01250379|463956885|FG000|Overall Study|Withdrawal by Subject|32|||
128908679|NCT01250379|463956886|FG001|Overall Study|Withdrawal by Subject|20|||
128908680|NCT01250379|463956885|FG000|Overall Study|Physician Decision|11|||
128908681|NCT01250379|463956886|FG001|Overall Study|Physician Decision|3|||
128908682|NCT01250379|463956885|FG000|Overall Study|Protocol Violation|2|||
128908683|NCT01250379|463956886|FG001|Overall Study|Protocol Violation|8|||
128908684|NCT01250379|463956885|FG000|Overall Study|Lost to Follow-up|9|||
128908685|NCT01250379|463956886|FG001|Overall Study|Lost to Follow-up|6|||
128908686|NCT01250379|463956885|FG000|Overall Study|Adverse Event|5|||
128908687|NCT01250379|463956886|FG001|Overall Study|Adverse Event|4|||
128908688|NCT01250379|463956885|FG000|Overall Study|Other|0|||
128908689|NCT01250379|463956886|FG001|Overall Study|Other|4|||
128908690|NCT01250379|463956885|FG000|Overall Study|Participant noncompliance|2|||
128908691|NCT01250379|463956886|FG001|Overall Study|Participant noncompliance|0|||
128908692|NCT05902364|463956887|FG000|Overall Study|Adverse Event|1|||
128908693|NCT05902364|463956888|FG001|Overall Study|Adverse Event|0|||
128908694|NCT01984268|463956890|FG000|Overall Study|Study Terminated|15|||
128908695|NCT04899232|463956891|FG000|Screening Period|Physician Decision|1|||
128908696|NCT04899232|463956892|FG001|Screening Period|Physician Decision|0|||
128908697|NCT04899232|463956893|FG002|Screening Period|Physician Decision|0|||
128908698|NCT04899232|463956891|FG000|Screening Period|Withdrawal by Subject|1|||
128908699|NCT04899232|463956892|FG001|Screening Period|Withdrawal by Subject|0|||
128908700|NCT04899232|463956893|FG002|Screening Period|Withdrawal by Subject|0|||
128908701|NCT04899232|463956891|FG000|Screening Period|Participant discharged before receiving intervention|3|||
128908702|NCT04899232|463956892|FG001|Screening Period|Participant discharged before receiving intervention|0|||
128908703|NCT04899232|463956893|FG002|Screening Period|Participant discharged before receiving intervention|0|||
128908704|NCT03110224|463956894|FG000|Overall Study|Death|3|||
128908705|NCT03110224|463956894|FG000|Overall Study|Lost to Follow-up|132|||
128908706|NCT03110224|463956894|FG000|Overall Study|Physician Decision|2|||
128908707|NCT03110224|463956894|FG000|Overall Study|Site Closed by Physician|35|||
128908708|NCT03110224|463956894|FG000|Overall Study|Site Closed by Sponsor|202|||
128908709|NCT03110224|463956894|FG000|Overall Study|Withdrawal by Subject|9|||
128908710|NCT04818593|463956895|FG000|Overall Study|Low Oocyte Yield|8|||
128908711|NCT04818593|463956896|FG001|Overall Study|Low Oocyte Yield|8|||
128908712|NCT04818593|463956895|FG000|Overall Study|Not ICSI Insemination|7|||
128908713|NCT04818593|463956896|FG001|Overall Study|Not ICSI Insemination|7|||
128908714|NCT04818593|463956895|FG000|Overall Study|Poor Sperm Quality|2|||
128908715|NCT04818593|463956896|FG001|Overall Study|Poor Sperm Quality|2|||
129117754|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
129117755|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
129117756|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
129132909|NCT02609633|464778565|FG001|Overall Study|Protocol Deviation|0|||
128908716|NCT04818593|463956895|FG000|Overall Study|Withdrawal by Subject|2|||
128908717|NCT04818593|463956896|FG001|Overall Study|Withdrawal by Subject|2|||
128908718|NCT04818593|463956895|FG000|Overall Study|Conversion to IUI due to low response|1|||
128908719|NCT04818593|463956896|FG001|Overall Study|Conversion to IUI due to low response|1|||
128908720|NCT01564862|463956897|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
128908721|NCT01564862|463956898|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
128908722|NCT01564862|463956899|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
128908723|NCT01564862|463956897|FG000|Overall Study|Major Protocol Deviation|3|||
128908724|NCT01564862|463956898|FG001|Overall Study|Major Protocol Deviation|3|||
128908725|NCT01564862|463956899|FG002|Overall Study|Major Protocol Deviation|4|||
128717872|NCT05104567|463264068|FG006|Overall Study|Other|0|||
129117757|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
129117758|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
129117759|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
129117760|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
129117761|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
129117762|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
128696653|NCT02264639|463186862|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
128908726|NCT01564862|463956897|FG000|Overall Study|Lost to Follow-up|10|||
128908727|NCT01564862|463956898|FG001|Overall Study|Lost to Follow-up|8|||
128908728|NCT01564862|463956899|FG002|Overall Study|Lost to Follow-up|6|||
128908729|NCT01564862|463956897|FG000|Overall Study|Voluntary Withdrawal|9|||
128908730|NCT01564862|463956898|FG001|Overall Study|Voluntary Withdrawal|6|||
128908731|NCT01564862|463956899|FG002|Overall Study|Voluntary Withdrawal|8|||
128908732|NCT01564862|463956897|FG000|Overall Study|Lack of Efficacy|1|||
128908733|NCT01564862|463956898|FG001|Overall Study|Lack of Efficacy|5|||
128908734|NCT01564862|463956899|FG002|Overall Study|Lack of Efficacy|6|||
128908735|NCT01564862|463956897|FG000|Overall Study|Other reason(s)|1|||
128908736|NCT01564862|463956898|FG001|Overall Study|Other reason(s)|0|||
128908737|NCT01564862|463956899|FG002|Overall Study|Other reason(s)|0|||
128908738|NCT02028455|463956900|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
128908739|NCT02028455|463956901|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
128908740|NCT02028455|463956902|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
128908741|NCT02028455|463956903|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
128908742|NCT02028455|463956904|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
128908743|NCT02028455|463956905|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
128908744|NCT02028455|463956906|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
128908745|NCT02028455|463956907|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
128908746|NCT02028455|463956900|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
128908747|NCT02028455|463956901|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
128908748|NCT02028455|463956902|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
128908749|NCT02028455|463956903|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
128908750|NCT02028455|463956904|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
128908751|NCT02028455|463956905|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
128908752|NCT02028455|463956906|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
128908753|NCT02028455|463956907|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
128908754|NCT02028455|463956900|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
128908755|NCT02028455|463956901|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
128908756|NCT02028455|463956902|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
128908757|NCT02028455|463956903|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
128908758|NCT02028455|463956904|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
128908759|NCT02028455|463956905|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
128908760|NCT02028455|463956906|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
128908761|NCT02028455|463956907|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
128908762|NCT02028455|463956900|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
128908763|NCT02028455|463956901|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
128908764|NCT02028455|463956902|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
128908765|NCT02028455|463956903|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
128908766|NCT02028455|463956904|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
128908767|NCT02028455|463956905|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
128908768|NCT02028455|463956906|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
128908769|NCT02028455|463956907|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
128908770|NCT02396589|463956908|FG000|Intervention|Lost to Follow-up|1|||
128908771|NCT02396589|463956909|FG001|Intervention|Lost to Follow-up|0|||
128908772|NCT02396589|463956908|FG000|6 Month Follow-up|change in health status|0|||
129117763|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
128696654|NCT02264639|463186863|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
128696655|NCT00753766|463186864|FG000|Overall Study|Physician Decision|1|||
128696656|NCT00753766|463186865|FG001|Overall Study|Physician Decision|0|||
128696657|NCT00839852|463186866|FG000|Overall Study|Adverse Event|10|||
128696658|NCT00839852|463186866|FG000|Overall Study|Insufficient Therapeutic Response|3|||
128908773|NCT02396589|463956909|FG001|6 Month Follow-up|change in health status|1|||
129117764|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
129117765|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
128696659|NCT00839852|463186866|FG000|Overall Study|Protocol Violation|9|||
128696660|NCT00839852|463186866|FG000|Overall Study|Withdrawal of Consent|16|||
128908774|NCT02396589|463956908|FG000|9 Month Follow-up|Death|0|||
128908775|NCT02396589|463956909|FG001|9 Month Follow-up|Death|1|||
128908776|NCT02396589|463956908|FG000|12 Month Follow up|Lost to Follow-up|0|||
128908777|NCT02396589|463956909|FG001|12 Month Follow up|Lost to Follow-up|2|||
128908778|NCT02740478|463958110|FG000|Overall Study|Withdrawal by Subject|1|||
128908779|NCT04316585|463958111|FG000|Overall Study|Adverse Event|2|||
128908780|NCT04316585|463958112|FG001|Overall Study|Adverse Event|1|||
128908781|NCT04316585|463958111|FG000|Overall Study|Lost to Follow-up|1|||
128908782|NCT04316585|463958112|FG001|Overall Study|Lost to Follow-up|0|||
128908783|NCT04316585|463958111|FG000|Overall Study|Withdrawal by Subject|2|||
128908784|NCT04316585|463958112|FG001|Overall Study|Withdrawal by Subject|3|||
128908785|NCT04316585|463958111|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
128908786|NCT04316585|463958112|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
128908787|NCT04316585|463958111|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
128908788|NCT04316585|463958112|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
128908789|NCT01777152|463958117|FG000|Overall Study|Withdrawal by Subject|22|||
128908790|NCT01777152|463958118|FG001|Overall Study|Withdrawal by Subject|16|||
128908791|NCT01777152|463958117|FG000|Overall Study|Lost to Follow-up|3|||
128908792|NCT01777152|463958118|FG001|Overall Study|Lost to Follow-up|5|||
128908793|NCT01777152|463958117|FG000|Overall Study|Death|68|||
128908794|NCT01777152|463958118|FG001|Overall Study|Death|89|||
128908795|NCT01777152|463958117|FG000|Overall Study|Not eligible, no study drug received|1|||
128908796|NCT01777152|463958118|FG001|Overall Study|Not eligible, no study drug received|0|||
128908797|NCT01777152|463958117|FG000|Overall Study|Change of diagnosis|1|||
128908798|NCT01777152|463958118|FG001|Overall Study|Change of diagnosis|0|||
128908799|NCT02792842|463958121|FG000|Overall Study|Adverse Event|4|||
128908800|NCT02792842|463958122|FG001|Overall Study|Adverse Event|2|||
128908801|NCT02792842|463958123|FG002|Overall Study|Adverse Event|3|||
128908802|NCT02792842|463958121|FG000|Overall Study|Withdrawal by Subject|0|||
128908803|NCT02792842|463958122|FG001|Overall Study|Withdrawal by Subject|1|||
128908804|NCT02792842|463958123|FG002|Overall Study|Withdrawal by Subject|2|||
128908805|NCT02792842|463958121|FG000|Overall Study|Lost to Follow-up|0|||
128908806|NCT02792842|463958122|FG001|Overall Study|Lost to Follow-up|0|||
128908807|NCT02792842|463958123|FG002|Overall Study|Lost to Follow-up|1|||
128908808|NCT02792842|463958121|FG000|Overall Study|Schedule delay|0|||
128908809|NCT02792842|463958122|FG001|Overall Study|Schedule delay|1|||
128908810|NCT02792842|463958123|FG002|Overall Study|Schedule delay|1|||
128908811|NCT02469090|463958124|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
128908812|NCT02469090|463958125|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
128908813|NCT02469090|463958126|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
128908814|NCT02469090|463958124|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
128908815|NCT02469090|463958125|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
128908816|NCT02469090|463958126|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
128908817|NCT02469090|463958124|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
128908818|NCT02469090|463958125|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
128908819|NCT02469090|463958126|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
128908820|NCT02469090|463958124|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
128908821|NCT02469090|463958125|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
128908822|NCT02469090|463958126|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
128908823|NCT02469090|463958124|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
128908824|NCT02469090|463958125|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
128908825|NCT02469090|463958126|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
128908826|NCT02469090|463958124|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
128908827|NCT02469090|463958125|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
128908828|NCT02469090|463958126|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
128908829|NCT02469090|463958124|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
128908830|NCT02469090|463958125|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
128908831|NCT02469090|463958126|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
128908832|NCT02469090|463958124|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
128908833|NCT02469090|463958125|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
128908834|NCT02469090|463958126|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
128908835|NCT01391507|463958131|FG000|Overall Study|Death|0|||
128908836|NCT01391507|463958132|FG001|Overall Study|Death|0|||
128908837|NCT01391507|463958133|FG002|Overall Study|Death|0|||
128908838|NCT01391507|463958134|FG003|Overall Study|Death|1|||
128908839|NCT01391507|463958131|FG000|Overall Study|Adverse Event|1|||
128908840|NCT01391507|463958132|FG001|Overall Study|Adverse Event|1|||
128908841|NCT01391507|463958133|FG002|Overall Study|Adverse Event|2|||
128908842|NCT01391507|463958134|FG003|Overall Study|Adverse Event|2|||
128908843|NCT01391507|463958131|FG000|Overall Study|Withdrawal by Subject|1|||
128908844|NCT01391507|463958132|FG001|Overall Study|Withdrawal by Subject|2|||
128908845|NCT01391507|463958133|FG002|Overall Study|Withdrawal by Subject|1|||
128908846|NCT01391507|463958134|FG003|Overall Study|Withdrawal by Subject|1|||
128908847|NCT01391507|463958131|FG000|Overall Study|Lack of Efficacy|0|||
129117766|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
129117767|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
129117768|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
129117769|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
129117770|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
129117771|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
129117772|NCT01668797|464727441|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
129117773|NCT01668797|464727442|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
129117774|NCT01668797|464727443|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
129117775|NCT01668797|464727444|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
129117776|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
129117777|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
129117778|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
129117779|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
129117780|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
129117781|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
129117782|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
129117783|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
129117784|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
129117785|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
129117786|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
129117787|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
129117788|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
129117789|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
129117790|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
129117791|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
129117792|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
129117793|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
129117794|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
129117795|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
129117796|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
129117797|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
129117798|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
129117799|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
129117800|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
129117801|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
129117802|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
129117803|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
129117804|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
129117805|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
129117806|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
129117807|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
129117808|NCT01668797|464727441|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
129117809|NCT01668797|464727442|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
129117810|NCT01668797|464727443|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
129117811|NCT01668797|464727444|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
129117812|NCT01004614|464727445|FG000|Washout|Withdrawal by Subject|0|||
129117813|NCT01004614|464727446|FG001|Washout|Withdrawal by Subject|1|||
129117814|NCT01004614|464727447|FG002|Washout|Withdrawal by Subject|0|||
129117815|NCT01004614|464727448|FG003|Washout|Withdrawal by Subject|0|||
129117816|NCT02530385|464727449|FG000|Overall Study|Withdrawal by Subject|0|||
129117817|NCT02530385|464727450|FG001|Overall Study|Withdrawal by Subject|1|||
129117818|NCT01569022|464727452|FG000|First Intervention|Lost to Follow-up|2|||
129117819|NCT01569022|464727453|FG001|First Intervention|Lost to Follow-up|1|||
129117820|NCT01569022|464727452|FG000|Second Intervention|Lost to Follow-up|2|||
129117821|NCT01569022|464727453|FG001|Second Intervention|Lost to Follow-up|2|||
129117822|NCT02111083|464727458|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
128696661|NCT00839852|463186866|FG000|Overall Study|Lost to Follow-up|7|||
128696662|NCT00839852|463186866|FG000|Overall Study|Lack of Compliance While in Jail|1|||
128696663|NCT00839852|463186866|FG000|Overall Study|Pregnancy|1|||
128696664|NCT00494299|463186867|FG000|Overall Study|Adverse Event|93|||
128696665|NCT00494299|463186868|FG001|Overall Study|Adverse Event|13|||
128908848|NCT01391507|463958132|FG001|Overall Study|Lack of Efficacy|0|||
128696666|NCT00494299|463186867|FG000|Overall Study|Lost to Follow-up|1|||
128908849|NCT01391507|463958133|FG002|Overall Study|Lack of Efficacy|0|||
128908850|NCT01391507|463958134|FG003|Overall Study|Lack of Efficacy|1|||
128908851|NCT01391507|463958131|FG000|Overall Study|Protocol Violation|2|||
128908852|NCT01391507|463958132|FG001|Overall Study|Protocol Violation|1|||
128908853|NCT01391507|463958133|FG002|Overall Study|Protocol Violation|1|||
128908854|NCT01391507|463958134|FG003|Overall Study|Protocol Violation|2|||
128908855|NCT02926209|463958142|FG000|Study Cohort|Poor Bowel Preparation|1|||
128908856|NCT02926209|463958143|FG001|Study Cohort|Poor Bowel Preparation|0|||
128908857|NCT00493038|463958144|FG000|Treatment|Adverse Event|8|||
128908858|NCT00493038|463958145|FG001|Treatment|Adverse Event|4|||
128908859|NCT00493038|463958144|FG000|Treatment|Lost to Follow-up|5|||
128908860|NCT00493038|463958145|FG001|Treatment|Lost to Follow-up|3|||
128908861|NCT00493038|463958144|FG000|Treatment|Withdrawal by Subject|11|||
128908862|NCT00493038|463958145|FG001|Treatment|Withdrawal by Subject|12|||
128908863|NCT00493038|463958144|FG000|Treatment|Other|0|||
128908864|NCT00493038|463958145|FG001|Treatment|Other|1|||
128908865|NCT00493038|463958144|FG000|Follow-up|Lost to Follow-up|1|||
128908866|NCT00493038|463958145|FG001|Follow-up|Lost to Follow-up|0|||
128908867|NCT03345472|463958146|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
128908868|NCT03345472|463958146|FG000|Implant to 3 Months|Physician Decision|1|||
128908869|NCT03345472|463958146|FG000|Implant to 3 Months|Adverse Event|1|||
128908870|NCT03345472|463958146|FG000|3 Months to 12 Months|Physician Decision|3|||
128908871|NCT03345472|463958146|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
128908872|NCT03345472|463958146|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
128908873|NCT03345472|463958146|FG000|3 Months to 12 Months|Adverse Event|1|||
128908874|NCT03345472|463958146|FG000|3 Months to 12 Months|Death|1|||
128908875|NCT01926782|463958147|FG000|Overall Study|Participant moved|2|||
128908876|NCT01926782|463958148|FG001|Overall Study|Participant moved|0|||
128908877|NCT01926782|463958149|FG002|Overall Study|Participant moved|1|||
128908878|NCT01926782|463958150|FG003|Overall Study|Participant moved|1|||
128908879|NCT01926782|463958151|FG004|Overall Study|Participant moved|0|||
128908880|NCT01926782|463958152|FG005|Overall Study|Participant moved|3|||
128908881|NCT01926782|463958147|FG000|Overall Study|Physician Decision|0|||
128908882|NCT01926782|463958148|FG001|Overall Study|Physician Decision|2|||
128908883|NCT01926782|463958149|FG002|Overall Study|Physician Decision|1|||
128908884|NCT01926782|463958150|FG003|Overall Study|Physician Decision|1|||
128908885|NCT01926782|463958151|FG004|Overall Study|Physician Decision|0|||
128908886|NCT01926782|463958152|FG005|Overall Study|Physician Decision|0|||
128908887|NCT01926782|463958147|FG000|Overall Study|Other than specified|2|||
128908888|NCT01926782|463958148|FG001|Overall Study|Other than specified|3|||
128908889|NCT01926782|463958149|FG002|Overall Study|Other than specified|5|||
128908890|NCT01926782|463958150|FG003|Overall Study|Other than specified|12|||
128908891|NCT01926782|463958151|FG004|Overall Study|Other than specified|4|||
128908892|NCT01926782|463958152|FG005|Overall Study|Other than specified|11|||
128908893|NCT01926782|463958147|FG000|Overall Study|Adverse Event|13|||
128908894|NCT01926782|463958148|FG001|Overall Study|Adverse Event|4|||
128908895|NCT01926782|463958149|FG002|Overall Study|Adverse Event|17|||
128908896|NCT01926782|463958150|FG003|Overall Study|Adverse Event|4|||
128908897|NCT01926782|463958151|FG004|Overall Study|Adverse Event|3|||
128908898|NCT01926782|463958152|FG005|Overall Study|Adverse Event|14|||
128908899|NCT01926782|463958147|FG000|Overall Study|Poor compliance to protocol|5|||
128908900|NCT01926782|463958148|FG001|Overall Study|Poor compliance to protocol|3|||
128908901|NCT01926782|463958149|FG002|Overall Study|Poor compliance to protocol|8|||
128908902|NCT01926782|463958150|FG003|Overall Study|Poor compliance to protocol|0|||
128908903|NCT01926782|463958151|FG004|Overall Study|Poor compliance to protocol|1|||
128908904|NCT01926782|463958152|FG005|Overall Study|Poor compliance to protocol|6|||
128908905|NCT01926782|463958147|FG000|Overall Study|Randomized and not treated|0|||
128908906|NCT01926782|463958148|FG001|Overall Study|Randomized and not treated|0|||
128908907|NCT01926782|463958149|FG002|Overall Study|Randomized and not treated|0|||
129027869|NCT00529763|464392764|FG000|Overall Study|Participant Withdrew Consent|2|||
129027870|NCT00529763|464392765|FG001|Overall Study|Participant Withdrew Consent|3|||
129027871|NCT00529763|464392766|FG002|Overall Study|Participant Withdrew Consent|4|||
129027872|NCT00529763|464392764|FG000|Overall Study|Other reasons|2|||
129027873|NCT00529763|464392765|FG001|Overall Study|Other reasons|0|||
128908908|NCT01926782|463958150|FG003|Overall Study|Randomized and not treated|1|||
128908909|NCT01926782|463958151|FG004|Overall Study|Randomized and not treated|0|||
128908910|NCT01926782|463958152|FG005|Overall Study|Randomized and not treated|0|||
128908911|NCT01926782|463958147|FG000|Overall Study|Withdrawal by Subject|6|||
128908912|NCT01926782|463958148|FG001|Overall Study|Withdrawal by Subject|1|||
129027874|NCT00529763|464392766|FG002|Overall Study|Other reasons|2|||
128908913|NCT01926782|463958149|FG002|Overall Study|Withdrawal by Subject|8|||
128908914|NCT01926782|463958150|FG003|Overall Study|Withdrawal by Subject|1|||
128908915|NCT01926782|463958151|FG004|Overall Study|Withdrawal by Subject|0|||
128908916|NCT01926782|463958152|FG005|Overall Study|Withdrawal by Subject|5|||
128908917|NCT01926782|463958147|FG000|Overall Study|Related to study drug administration|0|||
128908918|NCT01926782|463958148|FG001|Overall Study|Related to study drug administration|0|||
128908919|NCT01926782|463958149|FG002|Overall Study|Related to study drug administration|0|||
129027875|NCT00529763|464392764|FG000|Overall Study|Participant request to discontinue treatment|1|||
128908920|NCT01926782|463958150|FG003|Overall Study|Related to study drug administration|0|||
128908921|NCT01926782|463958151|FG004|Overall Study|Related to study drug administration|0|||
128908922|NCT01926782|463958152|FG005|Overall Study|Related to study drug administration|2|||
128908923|NCT01847885|463958155|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
128908924|NCT01847885|463958156|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
128908925|NCT01847885|463958157|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
128908926|NCT01847885|463958155|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
128908927|NCT01847885|463958156|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
128908928|NCT01847885|463958157|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
128908929|NCT01847885|463958155|FG000|Initial Enrollment (Consented)|Screen failure|39|||
128908930|NCT01847885|463958156|FG001|Initial Enrollment (Consented)|Screen failure|0|||
128908931|NCT01847885|463958157|FG002|Initial Enrollment (Consented)|Screen failure|0|||
128908932|NCT01847885|463958155|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
128908933|NCT01847885|463958156|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
128908934|NCT01847885|463958157|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
128908935|NCT01847885|463958155|FG000|Randomization|Protocol Violation|0|||
128908936|NCT01847885|463958156|FG001|Randomization|Protocol Violation|1|||
128908937|NCT01847885|463958157|FG002|Randomization|Protocol Violation|0|||
128908938|NCT01847885|463958155|FG000|Randomization|Withdrawal by Subject|0|||
128908939|NCT01847885|463958156|FG001|Randomization|Withdrawal by Subject|0|||
128908940|NCT01847885|463958157|FG002|Randomization|Withdrawal by Subject|2|||
128908941|NCT01847885|463958155|FG000|Randomization|Screen Failure|0|||
128908942|NCT01847885|463958156|FG001|Randomization|Screen Failure|3|||
128908943|NCT01847885|463958157|FG002|Randomization|Screen Failure|0|||
128908944|NCT01276236|463958158|FG000|Overall Study|Lack of Efficacy|2|||
128908945|NCT01276236|463958158|FG000|Overall Study|Withdrawal by Subject|4|||
128908946|NCT00044512|463958159|FG000|Follow Up|Lost to Follow-up|2|||
128908947|NCT00357500|463958177|FG000|Overall Study|Adverse Event|3|||
128908948|NCT00357500|463958177|FG000|Overall Study|Withdrawal by Subject|5|||
128908949|NCT00357500|463958177|FG000|Overall Study|Progressive Disease|65|||
128908950|NCT00357500|463958177|FG000|Overall Study|Not Started Protocol Therapy|4|||
128908951|NCT02695628|463958178|FG000|Overall Study|Withdrawal by Subject|1|||
128908952|NCT00516737|463958182|FG000|Overall Study|Lost to Follow-up|2|||
128908953|NCT00516737|463958183|FG001|Overall Study|Lost to Follow-up|0|||
128908954|NCT00516737|463958182|FG000|Overall Study|Physician Decision|0|||
128908955|NCT00516737|463958183|FG001|Overall Study|Physician Decision|1|||
128908956|NCT00516737|463958182|FG000|Overall Study|Withdrawal by Subject|0|||
128908957|NCT00516737|463958183|FG001|Overall Study|Withdrawal by Subject|1|||
128908958|NCT00516737|463958182|FG000|Overall Study|Lack of Qualifying Event|9|||
128908959|NCT00516737|463958183|FG001|Overall Study|Lack of Qualifying Event|6|||
128908960|NCT01844895|463958184|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
128908961|NCT01844895|463958184|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
128908962|NCT01844895|463958184|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
128908963|NCT01844895|463958184|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
128908964|NCT01844895|463958184|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
128908965|NCT01844895|463958184|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
128908966|NCT01844895|463958184|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
128908967|NCT00511355|463958186|FG000|Overall Study|Adverse Event|4|||
128908968|NCT00511355|463958187|FG001|Overall Study|Adverse Event|4|||
128908969|NCT00511355|463958186|FG000|Overall Study|Pregnancy Wish|1|||
128908970|NCT00511355|463958187|FG001|Overall Study|Pregnancy Wish|0|||
129027876|NCT00529763|464392765|FG001|Overall Study|Participant request to discontinue treatment|1|||
128696667|NCT00494299|463186868|FG001|Overall Study|Lost to Follow-up|0|||
128696668|NCT00494299|463186867|FG000|Overall Study|Physician Decision|0|||
128696669|NCT00494299|463186868|FG001|Overall Study|Physician Decision|2|||
128696670|NCT00494299|463186867|FG000|Overall Study|Protocol Violation|1|||
128696671|NCT00494299|463186868|FG001|Overall Study|Protocol Violation|2|||
128696672|NCT00494299|463186867|FG000|Overall Study|Withdrawal by Subject|8|||
128696673|NCT00494299|463186868|FG001|Overall Study|Withdrawal by Subject|3|||
128696674|NCT00494299|463186867|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
128696675|NCT00494299|463186868|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
128908971|NCT00511355|463958186|FG000|Overall Study|Lost to Follow-up|2|||
128908972|NCT00511355|463958187|FG001|Overall Study|Lost to Follow-up|1|||
128908973|NCT00511355|463958186|FG000|Overall Study|Other Reason|0|||
128908974|NCT00511355|463958187|FG001|Overall Study|Other Reason|1|||
128908975|NCT00511355|463958186|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
128908976|NCT00511355|463958187|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
128908977|NCT00511355|463958186|FG000|Overall Study|Withdrawal of informed consent|0|||
128908978|NCT00511355|463958187|FG001|Overall Study|Withdrawal of informed consent|1|||
128908979|NCT00511355|463958186|FG000|Overall Study|Other reason pre-treatment|0|||
128908980|NCT00511355|463958187|FG001|Overall Study|Other reason pre-treatment|1|||
128908981|NCT00454805|463958190|FG000|Overall Study|Withdrawal by Subject|9|||
128908982|NCT00454805|463958191|FG001|Overall Study|Withdrawal by Subject|2|||
129117823|NCT02111083|464727459|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
129117824|NCT00116142|464727460|FG000|Overall Study|Adverse Event|8|||
129117825|NCT00116142|464727461|FG001|Overall Study|Adverse Event|7|||
129117826|NCT00116142|464727460|FG000|Overall Study|Protocol Violation|2|||
129117827|NCT00116142|464727461|FG001|Overall Study|Protocol Violation|1|||
129117828|NCT00116142|464727460|FG000|Overall Study|Withdrawal by Subject|5|||
129117829|NCT00116142|464727461|FG001|Overall Study|Withdrawal by Subject|5|||
129117830|NCT00116142|464727460|FG000|Overall Study|Physician Decision|3|||
129117831|NCT00116142|464727461|FG001|Overall Study|Physician Decision|1|||
129117832|NCT00116142|464727460|FG000|Overall Study|Delayed Radiation Therapy|1|||
129117833|NCT00116142|464727461|FG001|Overall Study|Delayed Radiation Therapy|0|||
129117834|NCT00116142|464727460|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
129117835|NCT00116142|464727461|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
129117836|NCT00116142|464727460|FG000|Overall Study|Patient stopped due to depression|0|||
129117837|NCT00116142|464727461|FG001|Overall Study|Patient stopped due to depression|1|||
129117838|NCT00116142|464727460|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
129117839|NCT00116142|464727461|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
129117840|NCT00116142|464727460|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
129117841|NCT00116142|464727461|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
129117842|NCT00116142|464727460|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
129117843|NCT00116142|464727461|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
129117844|NCT00433836|464727462|FG000|Overall Study|Adverse Event|7|||
129117845|NCT00433836|464727463|FG001|Overall Study|Adverse Event|0|||
129117846|NCT00433836|464727462|FG000|Overall Study|Lost to Follow-up|3|||
129117847|NCT00433836|464727463|FG001|Overall Study|Lost to Follow-up|0|||
129117848|NCT00433836|464727462|FG000|Overall Study|Withdrawal by Subject|2|||
129117849|NCT00433836|464727463|FG001|Overall Study|Withdrawal by Subject|1|||
129117850|NCT00433836|464727462|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129117851|NCT00433836|464727463|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129117852|NCT00433836|464727462|FG000|Overall Study|Protocol Violation|0|||
129117853|NCT00433836|464727463|FG001|Overall Study|Protocol Violation|2|||
129117854|NCT00433836|464727462|FG000|Overall Study|Condition no longer requires study drug|0|||
129117855|NCT00433836|464727463|FG001|Overall Study|Condition no longer requires study drug|1|||
128908983|NCT00454805|463958190|FG000|Overall Study|Death|0|||
128908984|NCT00454805|463958191|FG001|Overall Study|Death|2|||
128908985|NCT00454805|463958190|FG000|Overall Study|Disease progression|16|||
128908986|NCT00454805|463958191|FG001|Overall Study|Disease progression|19|||
128908987|NCT00454805|463958190|FG000|Overall Study|In order to begin radiotherapy|1|||
128908988|NCT00454805|463958191|FG001|Overall Study|In order to begin radiotherapy|0|||
128908989|NCT01358864|463958209|FG000|Overall Study|Adverse Event|0|||
128908990|NCT01358864|463958210|FG001|Overall Study|Adverse Event|6|||
128908991|NCT01358864|463958211|FG002|Overall Study|Adverse Event|9|||
128908992|NCT01358864|463958212|FG003|Overall Study|Adverse Event|0|||
128908993|NCT01358864|463958213|FG004|Overall Study|Adverse Event|4|||
128908994|NCT01358864|463958214|FG005|Overall Study|Adverse Event|8|||
128908995|NCT01358864|463958215|FG006|Overall Study|Adverse Event|12|||
128908996|NCT01358864|463958216|FG007|Overall Study|Adverse Event|7|||
129117856|NCT00433836|464727462|FG000|Overall Study|Abnormal laboratory values|0|||
129117857|NCT00433836|464727463|FG001|Overall Study|Abnormal laboratory values|1|||
129117858|NCT00644059|464727464|FG000|Overall Study|Lost to Follow-up|37|||
129117859|NCT00644059|464727465|FG001|Overall Study|Lost to Follow-up|34|||
129117860|NCT00644059|464727466|FG002|Overall Study|Lost to Follow-up|16|||
129117861|NCT00644059|464727464|FG000|Overall Study|Withdrawal by Subject|52|||
129117862|NCT00644059|464727465|FG001|Overall Study|Withdrawal by Subject|60|||
129117863|NCT00644059|464727466|FG002|Overall Study|Withdrawal by Subject|30|||
129117864|NCT00644059|464727464|FG000|Overall Study|Adverse Event|8|||
129117865|NCT00644059|464727465|FG001|Overall Study|Adverse Event|5|||
129117866|NCT00644059|464727466|FG002|Overall Study|Adverse Event|1|||
129117867|NCT00644059|464727464|FG000|Overall Study|Inappropriate Enrollment|1|||
129117868|NCT00644059|464727465|FG001|Overall Study|Inappropriate Enrollment|3|||
129117869|NCT00644059|464727466|FG002|Overall Study|Inappropriate Enrollment|0|||
129117870|NCT00644059|464727464|FG000|Overall Study|Protocol Deviation/violation|20|||
128908997|NCT01358864|463958209|FG000|Overall Study|Lack of Efficacy|26|||
128908998|NCT01358864|463958210|FG001|Overall Study|Lack of Efficacy|3|||
128908999|NCT01358864|463958211|FG002|Overall Study|Lack of Efficacy|4|||
129117871|NCT00644059|464727465|FG001|Overall Study|Protocol Deviation/violation|19|||
129117872|NCT00644059|464727466|FG002|Overall Study|Protocol Deviation/violation|15|||
129117873|NCT00644059|464727464|FG000|Overall Study|Unable to classify|6|||
129117874|NCT00644059|464727465|FG001|Overall Study|Unable to classify|2|||
129117875|NCT00644059|464727466|FG002|Overall Study|Unable to classify|3|||
128909000|NCT01358864|463958212|FG003|Overall Study|Lack of Efficacy|19|||
128909001|NCT01358864|463958213|FG004|Overall Study|Lack of Efficacy|7|||
129117876|NCT02133508|464727467|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
129117877|NCT02133508|464727467|FG000|Overall Study|Death|12|||
129117878|NCT02133508|464727467|FG000|Overall Study|Lost to Follow-up|2|||
129215330|NCT00463567|465091129|FG004|Overall Study|Lack of Efficacy|1|||
128909002|NCT01358864|463958214|FG005|Overall Study|Lack of Efficacy|4|||
128909003|NCT01358864|463958215|FG006|Overall Study|Lack of Efficacy|49|||
128909004|NCT01358864|463958216|FG007|Overall Study|Lack of Efficacy|44|||
128909005|NCT01358864|463958209|FG000|Overall Study|Lost to Follow-up|0|||
128909006|NCT01358864|463958210|FG001|Overall Study|Lost to Follow-up|0|||
128909007|NCT01358864|463958211|FG002|Overall Study|Lost to Follow-up|1|||
128696676|NCT00494299|463186867|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
128696677|NCT00494299|463186868|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
128696678|NCT00494299|463186867|FG000|Overall Study|Site Closed by Sponsor|6|||
128696679|NCT00494299|463186868|FG001|Overall Study|Site Closed by Sponsor|0|||
128696680|NCT00494299|463186867|FG000|Overall Study|Protocol Driven Decision Point|11|||
128696681|NCT00494299|463186868|FG001|Overall Study|Protocol Driven Decision Point|22|||
128909008|NCT01358864|463958212|FG003|Overall Study|Lost to Follow-up|0|||
128909009|NCT01358864|463958213|FG004|Overall Study|Lost to Follow-up|0|||
128909010|NCT01358864|463958214|FG005|Overall Study|Lost to Follow-up|0|||
128909011|NCT01358864|463958215|FG006|Overall Study|Lost to Follow-up|0|||
128909012|NCT01358864|463958216|FG007|Overall Study|Lost to Follow-up|1|||
128909013|NCT01358864|463958209|FG000|Overall Study|Withdrawal by Subject|3|||
128909014|NCT01358864|463958210|FG001|Overall Study|Withdrawal by Subject|4|||
128909015|NCT01358864|463958211|FG002|Overall Study|Withdrawal by Subject|2|||
128909016|NCT01358864|463958212|FG003|Overall Study|Withdrawal by Subject|0|||
128909017|NCT01358864|463958213|FG004|Overall Study|Withdrawal by Subject|0|||
128909018|NCT01358864|463958214|FG005|Overall Study|Withdrawal by Subject|1|||
128909019|NCT01358864|463958215|FG006|Overall Study|Withdrawal by Subject|1|||
128909020|NCT01358864|463958216|FG007|Overall Study|Withdrawal by Subject|3|||
128909021|NCT01358864|463958209|FG000|Overall Study|Other reason not defined above|2|||
128909022|NCT01358864|463958210|FG001|Overall Study|Other reason not defined above|0|||
128909023|NCT01358864|463958211|FG002|Overall Study|Other reason not defined above|0|||
128909024|NCT01358864|463958212|FG003|Overall Study|Other reason not defined above|0|||
128909025|NCT01358864|463958213|FG004|Overall Study|Other reason not defined above|0|||
128909026|NCT01358864|463958214|FG005|Overall Study|Other reason not defined above|0|||
128909027|NCT01358864|463958215|FG006|Overall Study|Other reason not defined above|2|||
128909028|NCT01358864|463958216|FG007|Overall Study|Other reason not defined above|0|||
128909029|NCT01358864|463958209|FG000|Overall Study|Not treated|0|||
128909030|NCT01358864|463958210|FG001|Overall Study|Not treated|0|||
128909031|NCT01358864|463958211|FG002|Overall Study|Not treated|0|||
128909032|NCT01358864|463958212|FG003|Overall Study|Not treated|0|||
128909033|NCT01358864|463958213|FG004|Overall Study|Not treated|0|||
128909034|NCT01358864|463958214|FG005|Overall Study|Not treated|0|||
128909035|NCT01358864|463958215|FG006|Overall Study|Not treated|1|||
128909036|NCT01358864|463958216|FG007|Overall Study|Not treated|0|||
128909037|NCT00644787|463958219|FG000|Period 1: Titration Phase|Adverse Event|11|||
128909038|NCT00644787|463958220|FG001|Period 1: Titration Phase|Adverse Event|0|||
128909039|NCT00644787|463958221|FG002|Period 1: Titration Phase|Adverse Event|0|||
128909040|NCT00644787|463958219|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
128909041|NCT00644787|463958220|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
128909042|NCT00644787|463958221|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
128909043|NCT00644787|463958219|FG000|Period 1: Titration Phase|Physician Decision|1|||
128909044|NCT00644787|463958220|FG001|Period 1: Titration Phase|Physician Decision|0|||
128909045|NCT00644787|463958221|FG002|Period 1: Titration Phase|Physician Decision|0|||
128909046|NCT00644787|463958219|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
128909047|NCT00644787|463958220|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
128909048|NCT00644787|463958221|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
128909049|NCT00644787|463958219|FG000|Period 1: Titration Phase|Worsening of complications|1|||
128909050|NCT00644787|463958220|FG001|Period 1: Titration Phase|Worsening of complications|0|||
128909051|NCT00644787|463958221|FG002|Period 1: Titration Phase|Worsening of complications|0|||
128909052|NCT00644787|463958219|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
128909053|NCT00644787|463958220|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
128909054|NCT00644787|463958221|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
128909055|NCT00644787|463958219|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
128909056|NCT00644787|463958220|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
128909057|NCT00644787|463958221|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
128909058|NCT00644787|463958219|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
128909059|NCT00644787|463958220|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
128909060|NCT00644787|463958221|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
128909061|NCT00644787|463958219|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
128909062|NCT00644787|463958220|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
128909063|NCT00644787|463958221|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
128696682|NCT00932126|463186871|FG000|Overall Study|Adverse Event|0|||
128909064|NCT00644787|463958219|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
128909065|NCT00644787|463958220|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
129215331|NCT00463567|465091130|FG005|Overall Study|Lack of Efficacy|0|||
128696683|NCT00932126|463186872|FG001|Overall Study|Adverse Event|0|||
128909066|NCT00644787|463958221|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
128909067|NCT00644787|463958219|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
128909068|NCT00644787|463958220|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
128909069|NCT00644787|463958221|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
128909070|NCT00644787|463958219|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
128909071|NCT00644787|463958220|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
128909072|NCT00644787|463958221|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
128909073|NCT01489527|463958222|FG000|Overall Study|Pregnancy|9|||
128909074|NCT01489527|463958223|FG001|Overall Study|Pregnancy|14|||
128909075|NCT01489527|463958222|FG000|Overall Study|Participant moved|6|||
128909076|NCT01489527|463958223|FG001|Overall Study|Participant moved|7|||
128909077|NCT01489527|463958222|FG000|Overall Study|Withdrawal by Subject|0|||
128909078|NCT01489527|463958223|FG001|Overall Study|Withdrawal by Subject|4|||
128909079|NCT01489527|463958222|FG000|Overall Study|Lost to Follow-up|5|||
128909080|NCT01489527|463958223|FG001|Overall Study|Lost to Follow-up|1|||
128909081|NCT01489527|463958222|FG000|Overall Study|Procedures|1|||
128909082|NCT01489527|463958223|FG001|Overall Study|Procedures|0|||
128909083|NCT01489527|463958222|FG000|Overall Study|Not compliant|1|||
128909084|NCT01489527|463958223|FG001|Overall Study|Not compliant|0|||
128909085|NCT00936208|463958225|FG000|Overall Study|Protocol Violation|37|||
128909086|NCT00936208|463958226|FG001|Overall Study|Protocol Violation|22|||
128909087|NCT01344876|463958229|FG000|Overall Study|Adverse Event|0|||
128909088|NCT01344876|463958230|FG001|Overall Study|Adverse Event|0|||
128909089|NCT01344876|463958231|FG002|Overall Study|Adverse Event|0|||
128909090|NCT01344876|463958232|FG003|Overall Study|Adverse Event|0|||
128909091|NCT01344876|463958233|FG004|Overall Study|Adverse Event|1|||
128909092|NCT01344876|463958229|FG000|Overall Study|Withdrawal by Subject|0|||
128909093|NCT01344876|463958230|FG001|Overall Study|Withdrawal by Subject|0|||
128909094|NCT01344876|463958231|FG002|Overall Study|Withdrawal by Subject|1|||
128909095|NCT01344876|463958232|FG003|Overall Study|Withdrawal by Subject|0|||
128909096|NCT01344876|463958233|FG004|Overall Study|Withdrawal by Subject|0|||
128909097|NCT01344876|463958229|FG000|Overall Study|Definite progression of primary disease|1|||
128909098|NCT01344876|463958230|FG001|Overall Study|Definite progression of primary disease|0|||
128909099|NCT01344876|463958231|FG002|Overall Study|Definite progression of primary disease|0|||
128909100|NCT01344876|463958232|FG003|Overall Study|Definite progression of primary disease|3|||
128909101|NCT01344876|463958233|FG004|Overall Study|Definite progression of primary disease|0|||
128909102|NCT04428424|463958234|FG000|Overall Study|Does not meet entrance criteria|132|||
128909103|NCT04428424|463958234|FG000|Overall Study|Lost to Follow-up|115|||
128909104|NCT05036083|463958238|FG000|Overall Study|Physician Decision|1|||
128909105|NCT05036083|463958238|FG000|Overall Study|Withdrawal by Subject|1|||
128909106|NCT05036083|463958238|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
128909107|NCT05036083|463958238|FG000|Overall Study|IV not sustainable|1|||
128909108|NCT04622046|463958239|FG000|Intervention Period|Adverse Event|1|||
128909109|NCT04622046|463958239|FG000|Intervention Period|Withdrawal by Subject|2|||
128909110|NCT04622046|463958239|FG000|Extension Period|Ongoing in the Extension Period|21|||
128909111|NCT04705051|463960319|FG000|Overall Study|Enrolled but not treated|1|||
128909112|NCT04705051|463960319|FG000|Overall Study|Study terminated by sponsor|23|||
128909113|NCT02968810|463960320|FG000|Overall Study|Lost to Follow-up|1|||
128909114|NCT02968810|463960321|FG001|Overall Study|Lost to Follow-up|0|||
128909115|NCT02968810|463960320|FG000|Overall Study|Physician Decision|1|||
128909116|NCT02968810|463960321|FG001|Overall Study|Physician Decision|0|||
128909117|NCT02968810|463960320|FG000|Overall Study|Withdrawal by Subject|1|||
128909118|NCT02968810|463960321|FG001|Overall Study|Withdrawal by Subject|3|||
128909119|NCT02968810|463960320|FG000|Overall Study|Disease Progression|0|||
128909120|NCT02968810|463960321|FG001|Overall Study|Disease Progression|1|||
128909121|NCT00699348|463960322|FG000|Overall Study|Death|6|||
128909122|NCT00699348|463960322|FG000|Overall Study|Adverse Event|15|||
128909123|NCT00699348|463960322|FG000|Overall Study|Withdrawal by Subject|11|||
128909124|NCT00699348|463960322|FG000|Overall Study|Protocol Violation|10|||
128909125|NCT00699348|463960322|FG000|Overall Study|Lack of Efficacy|8|||
128909126|NCT00699348|463960322|FG000|Overall Study|Failure to return|1|||
128909127|NCT00699348|463960322|FG000|Overall Study|Blood transfusion|24|||
128909128|NCT00699348|463960322|FG000|Overall Study|Renal transplantation|10|||
128909129|NCT00699348|463960322|FG000|Overall Study|Other|5|||
128909130|NCT03269344|463960323|FG000|Overall Study|Protocol Violation|4|||
128909131|NCT03269344|463960324|FG001|Overall Study|Protocol Violation|3|||
128909132|NCT02597855|463960325|FG000|Overall Study|Lost to Follow-up|2|||
128909133|NCT02597855|463960326|FG001|Overall Study|Lost to Follow-up|1|||
128909134|NCT03704194|463960334|FG000|Overall Study|Withdrawal by Subject|0|||
128909135|NCT03704194|463960335|FG001|Overall Study|Withdrawal by Subject|1|||
128909136|NCT00223496|463960338|FG000|Overall Study|screen failure|9|||
128909137|NCT00223496|463960338|FG000|Overall Study|Lost to Follow-up|4|||
128909138|NCT00223496|463960338|FG000|Overall Study|Lack of Efficacy|6|||
128909139|NCT00223496|463960338|FG000|Overall Study|Withdrawal by Subject|1|||
129117879|NCT00472420|464727474|FG000|Induction Treatment Period|Physician Decision|9|||
128909140|NCT00223496|463960338|FG000|Overall Study|Physician Decision|2|||
128909141|NCT00559507|463960339|FG000|Overall Study|Not treated, patient ineligible|3|||
128909142|NCT02889796|463960340|FG000|Overall Study|Withdrew Consent|18|||
128909143|NCT02889796|463960341|FG001|Overall Study|Withdrew Consent|29|||
128909144|NCT02889796|463960342|FG002|Overall Study|Withdrew Consent|20|||
128909145|NCT02889796|463960343|FG003|Overall Study|Withdrew Consent|1|||
128909146|NCT02889796|463960344|FG004|Overall Study|Withdrew Consent|2|||
128909147|NCT02889796|463960345|FG005|Overall Study|Withdrew Consent|35|||
128909148|NCT02889796|463960340|FG000|Overall Study|Investigator's Discretion|10|||
128909149|NCT02889796|463960341|FG001|Overall Study|Investigator's Discretion|9|||
128909150|NCT02889796|463960342|FG002|Overall Study|Investigator's Discretion|10|||
128909151|NCT02889796|463960343|FG003|Overall Study|Investigator's Discretion|3|||
128909152|NCT02889796|463960344|FG004|Overall Study|Investigator's Discretion|0|||
128909153|NCT02889796|463960345|FG005|Overall Study|Investigator's Discretion|15|||
128909154|NCT02889796|463960340|FG000|Overall Study|Adverse Event|17|||
128909155|NCT02889796|463960341|FG001|Overall Study|Adverse Event|8|||
128909156|NCT02889796|463960342|FG002|Overall Study|Adverse Event|8|||
128909157|NCT02889796|463960343|FG003|Overall Study|Adverse Event|4|||
128909158|NCT02889796|463960344|FG004|Overall Study|Adverse Event|1|||
128909159|NCT02889796|463960345|FG005|Overall Study|Adverse Event|7|||
128909160|NCT02889796|463960340|FG000|Overall Study|Lost to Follow-up|5|||
128909161|NCT02889796|463960341|FG001|Overall Study|Lost to Follow-up|7|||
128909162|NCT02889796|463960342|FG002|Overall Study|Lost to Follow-up|2|||
128909163|NCT02889796|463960343|FG003|Overall Study|Lost to Follow-up|0|||
128909164|NCT02889796|463960344|FG004|Overall Study|Lost to Follow-up|2|||
128909165|NCT02889796|463960345|FG005|Overall Study|Lost to Follow-up|6|||
128909166|NCT02889796|463960340|FG000|Overall Study|Protocol Violation|0|||
128909167|NCT02889796|463960341|FG001|Overall Study|Protocol Violation|1|||
128909168|NCT02889796|463960342|FG002|Overall Study|Protocol Violation|3|||
128909169|NCT02889796|463960343|FG003|Overall Study|Protocol Violation|0|||
128909170|NCT02889796|463960344|FG004|Overall Study|Protocol Violation|0|||
128909171|NCT02889796|463960345|FG005|Overall Study|Protocol Violation|4|||
128909172|NCT02889796|463960340|FG000|Overall Study|Non-compliance With Study Drug|0|||
128909173|NCT02889796|463960341|FG001|Overall Study|Non-compliance With Study Drug|2|||
128909174|NCT02889796|463960342|FG002|Overall Study|Non-compliance With Study Drug|0|||
128909175|NCT02889796|463960343|FG003|Overall Study|Non-compliance With Study Drug|0|||
128909176|NCT02889796|463960344|FG004|Overall Study|Non-compliance With Study Drug|1|||
128909177|NCT02889796|463960345|FG005|Overall Study|Non-compliance With Study Drug|2|||
128909178|NCT02889796|463960340|FG000|Overall Study|Death|1|||
128909179|NCT02889796|463960341|FG001|Overall Study|Death|1|||
128909180|NCT02889796|463960342|FG002|Overall Study|Death|0|||
128909181|NCT02889796|463960343|FG003|Overall Study|Death|1|||
128909182|NCT02889796|463960344|FG004|Overall Study|Death|0|||
128909183|NCT02889796|463960345|FG005|Overall Study|Death|1|||
128909184|NCT02889796|463960340|FG000|Overall Study|Pregnancy|0|||
128909185|NCT02889796|463960341|FG001|Overall Study|Pregnancy|1|||
128909186|NCT02889796|463960342|FG002|Overall Study|Pregnancy|1|||
128909187|NCT02889796|463960343|FG003|Overall Study|Pregnancy|0|||
128909188|NCT02889796|463960344|FG004|Overall Study|Pregnancy|0|||
128909189|NCT02889796|463960345|FG005|Overall Study|Pregnancy|0|||
128909190|NCT02889796|463960340|FG000|Overall Study|Randomized but not Dosed|2|||
128909191|NCT02889796|463960341|FG001|Overall Study|Randomized but not Dosed|0|||
128909192|NCT02889796|463960342|FG002|Overall Study|Randomized but not Dosed|0|||
128909193|NCT02889796|463960343|FG003|Overall Study|Randomized but not Dosed|0|||
128909194|NCT02889796|463960344|FG004|Overall Study|Randomized but not Dosed|0|||
128909195|NCT02889796|463960345|FG005|Overall Study|Randomized but not Dosed|2|||
128909196|NCT01407926|463960351|FG000|Overall Study|Lost to Follow-up|55|||
128909197|NCT02814565|463960352|FG000|Overall Study|Lack of Efficacy|0|||
128909198|NCT02814565|463960353|FG001|Overall Study|Lack of Efficacy|1|||
128909199|NCT02814565|463960352|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
128909200|NCT02814565|463960353|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
128909201|NCT04656652|463960354|FG000|Overall Study|Lost to Follow-up|2|||
128909202|NCT04656652|463960355|FG001|Overall Study|Lost to Follow-up|2|||
128909203|NCT04656652|463960354|FG000|Overall Study|Death|213|||
128909204|NCT04656652|463960355|FG001|Overall Study|Death|212|||
128909205|NCT04656652|463960354|FG000|Overall Study|Other|1|||
128909206|NCT04656652|463960355|FG001|Overall Study|Other|0|||
128909207|NCT04656652|463960354|FG000|Overall Study|Withdrawal by Subject|15|||
128909208|NCT04656652|463960355|FG001|Overall Study|Withdrawal by Subject|29|||
128909209|NCT01414257|463960358|FG000|Overall Study|No Visit After First Day of Treatment|12|||
128909210|NCT01414257|463960358|FG000|Overall Study|Protocol Violation|10|||
128909211|NCT02479802|463960359|FG000|Overall Study|Lost to Follow-up|1|||
128909212|NCT02479802|463960359|FG000|Overall Study|Adverse Event|1|||
128909213|NCT01882907|463960360|FG000|Overall Study|Adverse Event|3|||
128909214|NCT01882907|463960361|FG001|Overall Study|Adverse Event|1|||
128909215|NCT01882907|463960360|FG000|Overall Study|Lack of Efficacy|0|||
128909216|NCT01882907|463960361|FG001|Overall Study|Lack of Efficacy|3|||
128909217|NCT01882907|463960360|FG000|Overall Study|Lost to Follow-up|1|||
128909218|NCT01882907|463960361|FG001|Overall Study|Lost to Follow-up|4|||
128909219|NCT01882907|463960360|FG000|Overall Study|Protocol Violation|10|||
128909220|NCT01882907|463960361|FG001|Overall Study|Protocol Violation|14|||
128909221|NCT01882907|463960360|FG000|Overall Study|Withdrawal by Subject|0|||
128909222|NCT01882907|463960361|FG001|Overall Study|Withdrawal by Subject|6|||
128765253|NCT00116844|463432110|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
128765254|NCT00116844|463432111|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
128765255|NCT00116844|463432110|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
128765256|NCT00116844|463432111|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
128765257|NCT00116844|463432110|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
128765258|NCT00116844|463432111|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
128765259|NCT00116844|463432110|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
128765260|NCT00116844|463432111|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
128765261|NCT00116844|463432110|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
128765262|NCT00116844|463432111|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
128765263|NCT00116844|463432110|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
128765264|NCT00116844|463432111|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
128765265|NCT00116844|463432110|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
128765266|NCT00116844|463432111|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
128765267|NCT01933880|463432112|FG000|Overall Study|Withdrawal by Subject|5|||
128765268|NCT01933880|463432113|FG001|Overall Study|Withdrawal by Subject|0|||
128765269|NCT01933880|463432112|FG000|Overall Study|Lack of Efficacy|1|||
128765270|NCT01933880|463432113|FG001|Overall Study|Lack of Efficacy|0|||
128765271|NCT01933880|463432112|FG000|Overall Study|Concomitant medication Interference|0|||
128765272|NCT01933880|463432113|FG001|Overall Study|Concomitant medication Interference|1|||
128765273|NCT01933880|463432112|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
128765274|NCT01933880|463432113|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
128765275|NCT01933880|463432112|FG000|Overall Study|Other|4|||
128765276|NCT01933880|463432113|FG001|Overall Study|Other|0|||
128765277|NCT01933880|463432112|FG000|Overall Study|Protocol Violation|1|||
128765278|NCT01933880|463432113|FG001|Overall Study|Protocol Violation|0|||
128765279|NCT02395133|463432114|FG000|Overall Study|Adverse Event|4|||
128765280|NCT02395133|463432115|FG001|Overall Study|Adverse Event|1|||
128765281|NCT02395133|463432116|FG002|Overall Study|Adverse Event|3|||
128765282|NCT02395133|463432117|FG003|Overall Study|Adverse Event|0|||
128765283|NCT02395133|463432114|FG000|Overall Study|Lack of Efficacy|1|||
128765284|NCT02395133|463432115|FG001|Overall Study|Lack of Efficacy|0|||
128909223|NCT01978093|463960362|FG000|Overall Study|Death|1|||
128909224|NCT01978093|463960363|FG001|Overall Study|Death|0|||
128909225|NCT01978093|463960362|FG000|Overall Study|Adverse Event|0|||
128696684|NCT00932126|463186873|FG002|Overall Study|Adverse Event|0|||
128696685|NCT00932126|463186874|FG003|Overall Study|Adverse Event|0|||
128696686|NCT00932126|463186875|FG004|Overall Study|Adverse Event|0|||
128696687|NCT00932126|463186876|FG005|Overall Study|Adverse Event|0|||
128696688|NCT00932126|463186877|FG006|Overall Study|Adverse Event|1|||
128696689|NCT00932126|463186878|FG007|Overall Study|Adverse Event|2|||
128696690|NCT00932126|463186871|FG000|Overall Study|Protocol Violation|0|||
128696691|NCT00932126|463186872|FG001|Overall Study|Protocol Violation|0|||
128696692|NCT00932126|463186873|FG002|Overall Study|Protocol Violation|0|||
128696693|NCT00932126|463186874|FG003|Overall Study|Protocol Violation|0|||
128696694|NCT00932126|463186875|FG004|Overall Study|Protocol Violation|1|||
128696695|NCT00932126|463186876|FG005|Overall Study|Protocol Violation|0|||
128696696|NCT00932126|463186877|FG006|Overall Study|Protocol Violation|0|||
128696697|NCT00932126|463186878|FG007|Overall Study|Protocol Violation|0|||
128696698|NCT00932126|463186871|FG000|Overall Study|Withdrawal by Subject|0|||
128696699|NCT00932126|463186872|FG001|Overall Study|Withdrawal by Subject|0|||
128696700|NCT00932126|463186873|FG002|Overall Study|Withdrawal by Subject|1|||
128696701|NCT00932126|463186874|FG003|Overall Study|Withdrawal by Subject|0|||
128696702|NCT00932126|463186875|FG004|Overall Study|Withdrawal by Subject|0|||
128696703|NCT00932126|463186876|FG005|Overall Study|Withdrawal by Subject|0|||
128696704|NCT00932126|463186877|FG006|Overall Study|Withdrawal by Subject|0|||
128696705|NCT00932126|463186878|FG007|Overall Study|Withdrawal by Subject|1|||
128696706|NCT00932126|463186871|FG000|Overall Study|Objective progression or relapse|3|||
128696707|NCT00932126|463186872|FG001|Overall Study|Objective progression or relapse|3|||
128696708|NCT00932126|463186873|FG002|Overall Study|Objective progression or relapse|2|||
128696709|NCT00932126|463186874|FG003|Overall Study|Objective progression or relapse|3|||
128696710|NCT00932126|463186875|FG004|Overall Study|Objective progression or relapse|3|||
128696711|NCT00932126|463186876|FG005|Overall Study|Objective progression or relapse|3|||
128696712|NCT00932126|463186877|FG006|Overall Study|Objective progression or relapse|3|||
128696713|NCT00932126|463186878|FG007|Overall Study|Objective progression or relapse|5|||
128696714|NCT00932126|463186871|FG000|Overall Study|Other|0|||
128696715|NCT00932126|463186872|FG001|Overall Study|Other|0|||
128765285|NCT02395133|463432116|FG002|Overall Study|Lack of Efficacy|1|||
128765286|NCT02395133|463432117|FG003|Overall Study|Lack of Efficacy|1|||
128909226|NCT01978093|463960363|FG001|Overall Study|Adverse Event|5|||
128909227|NCT01978093|463960362|FG000|Overall Study|Protocol Violation|8|||
128909228|NCT01978093|463960363|FG001|Overall Study|Protocol Violation|2|||
128909229|NCT01978093|463960362|FG000|Overall Study|Withdrawal by Subject|29|||
128909230|NCT01978093|463960363|FG001|Overall Study|Withdrawal by Subject|25|||
128909231|NCT01978093|463960362|FG000|Overall Study|Lost to Follow-up|11|||
128909232|NCT01978093|463960363|FG001|Overall Study|Lost to Follow-up|15|||
128909233|NCT01978093|463960362|FG000|Overall Study|Migrated/moved from study area|11|||
128909234|NCT01978093|463960363|FG001|Overall Study|Migrated/moved from study area|13|||
128909235|NCT01978093|463960362|FG000|Overall Study|Loss of kaiser coverage|4|||
128909236|NCT01978093|463960363|FG001|Overall Study|Loss of kaiser coverage|10|||
128909237|NCT01978093|463960362|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
128909238|NCT01978093|463960363|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
128909239|NCT01978093|463960362|FG000|Overall Study|Mother lost custody of child|0|||
128909240|NCT01978093|463960363|FG001|Overall Study|Mother lost custody of child|1|||
128909241|NCT01978093|463960362|FG000|Overall Study|Child was in care of grandmother|0|||
128909242|NCT01978093|463960363|FG001|Overall Study|Child was in care of grandmother|1|||
128909243|NCT01978093|463960362|FG000|Overall Study|N/A for vaccine administration|0|||
128909244|NCT01978093|463960363|FG001|Overall Study|N/A for vaccine administration|1|||
128909245|NCT01604512|463960367|FG000|Overall Study|Withdrawal by Subject|3|||
128909246|NCT01604512|463960367|FG000|Overall Study|Not treated|4|||
128909247|NCT01100944|463960371|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
128909248|NCT01100944|463960372|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
128909249|NCT01100944|463960373|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
128909250|NCT01100944|463960371|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
128909251|NCT01100944|463960372|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
128909252|NCT01100944|463960373|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
128909253|NCT01100944|463960371|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
128909254|NCT01100944|463960372|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
128909255|NCT01100944|463960373|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
128909256|NCT01100944|463960371|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
128909257|NCT01100944|463960372|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
128909258|NCT01100944|463960373|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
128909259|NCT00577993|463960376|FG000|Overall Study|Adverse Event|1|||
128909260|NCT00577993|463960377|FG001|Overall Study|Adverse Event|0|||
128909261|NCT00577993|463960378|FG002|Overall Study|Adverse Event|0|||
128909262|NCT00577993|463960376|FG000|Overall Study|Death|0|||
128909263|NCT00577993|463960377|FG001|Overall Study|Death|1|||
128909264|NCT00577993|463960378|FG002|Overall Study|Death|1|||
128909265|NCT00577993|463960376|FG000|Overall Study|Lack of Efficacy|0|||
128909266|NCT00577993|463960377|FG001|Overall Study|Lack of Efficacy|1|||
128909267|NCT00577993|463960378|FG002|Overall Study|Lack of Efficacy|0|||
128909268|NCT00577993|463960376|FG000|Overall Study|Protocol Violation|2|||
128909269|NCT00577993|463960377|FG001|Overall Study|Protocol Violation|3|||
128909270|NCT00577993|463960378|FG002|Overall Study|Protocol Violation|0|||
128909271|NCT00577993|463960376|FG000|Overall Study|Withdrawal by Subject|1|||
128909272|NCT00577993|463960377|FG001|Overall Study|Withdrawal by Subject|0|||
128909273|NCT00577993|463960378|FG002|Overall Study|Withdrawal by Subject|2|||
128909274|NCT00577993|463960376|FG000|Overall Study|Conversion|2|||
128909275|NCT00577993|463960377|FG001|Overall Study|Conversion|5|||
128909276|NCT00577993|463960378|FG002|Overall Study|Conversion|0|||
128909277|NCT00577993|463960376|FG000|Overall Study|Uninsured|1|||
128909278|NCT00577993|463960377|FG001|Overall Study|Uninsured|0|||
128909279|NCT00577993|463960378|FG002|Overall Study|Uninsured|0|||
128909280|NCT00070941|463960381|FG000|Overall Study|Adverse Event|10|||
128909281|NCT00070941|463960382|FG001|Overall Study|Adverse Event|8|||
128909282|NCT00070941|463960383|FG002|Overall Study|Adverse Event|4|||
128909283|NCT00094055|463960384|FG000|Overall Study|Adverse Event|11|||
128909284|NCT00094055|463960384|FG000|Overall Study|Death|4|||
128909285|NCT00094055|463960384|FG000|Overall Study|Lack of Efficacy|17|||
128909286|NCT00094055|463960384|FG000|Overall Study|Lost to Follow-up|2|||
128909287|NCT00094055|463960384|FG000|Overall Study|progressive disease|2|||
128909288|NCT00094055|463960384|FG000|Overall Study|clinical progression|1|||
128909289|NCT00094055|463960384|FG000|Overall Study|roll-over to another study|14|||
128909290|NCT00094055|463960384|FG000|Overall Study|Withdrawal by Subject|9|||
129027877|NCT00529763|464392766|FG002|Overall Study|Participant request to discontinue treatment|3|||
129027878|NCT03669250|464392767|FG000|Overall Study|Adverse Event|0|||
128909291|NCT00411554|463960388|FG000|Overall Study|Adverse Event|2|||
129027879|NCT03669250|464392768|FG001|Overall Study|Adverse Event|0|||
129027880|NCT03669250|464392769|FG002|Overall Study|Adverse Event|0|||
128909292|NCT00411554|463960389|FG001|Overall Study|Adverse Event|4|||
128909293|NCT00411554|463960388|FG000|Overall Study|Lack of Efficacy|2|||
128909294|NCT00411554|463960389|FG001|Overall Study|Lack of Efficacy|5|||
128909295|NCT00411554|463960388|FG000|Overall Study|Withdrawal by Subject|3|||
128909296|NCT00411554|463960389|FG001|Overall Study|Withdrawal by Subject|0|||
128909297|NCT00411554|463960388|FG000|Overall Study|Patient Moved|1|||
128909298|NCT00411554|463960389|FG001|Overall Study|Patient Moved|0|||
128909299|NCT00699907|463960390|FG000|Overall Study|Withdrawal by Subject|2|||
129027881|NCT03669250|464392770|FG003|Overall Study|Adverse Event|0|||
128909300|NCT00699907|463960391|FG001|Overall Study|Withdrawal by Subject|1|||
128909301|NCT00699907|463960392|FG002|Overall Study|Withdrawal by Subject|0|||
128909302|NCT00699907|463960390|FG000|Overall Study|No usable sample|0|||
128909303|NCT00699907|463960391|FG001|Overall Study|No usable sample|9|||
128909304|NCT00699907|463960392|FG002|Overall Study|No usable sample|8|||
128909305|NCT02161211|463960393|FG000|Overall Study|Lost to Follow-up|21|||
128909306|NCT02161211|463960394|FG001|Overall Study|Lost to Follow-up|27|||
128909307|NCT02161211|463960395|FG002|Overall Study|Lost to Follow-up|21|||
128909308|NCT02161211|463960393|FG000|Overall Study|Dropped|12|||
128909309|NCT02161211|463960394|FG001|Overall Study|Dropped|5|||
128909310|NCT02161211|463960395|FG002|Overall Study|Dropped|9|||
128909311|NCT03728309|463960396|FG000|Overall Study|Randomized but not Treated|0|||
128909312|NCT03728309|463960397|FG001|Overall Study|Randomized but not Treated|1|||
128909313|NCT03728309|463960396|FG000|Overall Study|Adverse Event|0|||
128909314|NCT03728309|463960397|FG001|Overall Study|Adverse Event|1|||
128909315|NCT03728309|463960396|FG000|Overall Study|Withdrawal by Subject|2|||
128909316|NCT03728309|463960397|FG001|Overall Study|Withdrawal by Subject|8|||
128909317|NCT03728309|463960396|FG000|Overall Study|Lost to Follow-up|9|||
128909318|NCT03728309|463960397|FG001|Overall Study|Lost to Follow-up|10|||
128909319|NCT03728309|463960396|FG000|Overall Study|Protocol Deviation|0|||
128909320|NCT03728309|463960397|FG001|Overall Study|Protocol Deviation|1|||
128909321|NCT03728309|463960396|FG000|Overall Study|Due to COVID|1|||
128909322|NCT03728309|463960397|FG001|Overall Study|Due to COVID|3|||
128909323|NCT00953758|463960400|FG000|Overall Study|Death|2|||
128909324|NCT00953758|463960401|FG001|Overall Study|Death|0|||
128909325|NCT00953758|463960402|FG002|Overall Study|Death|1|||
128909326|NCT00953758|463960403|FG003|Overall Study|Death|1|||
128909327|NCT00953758|463960404|FG004|Overall Study|Death|1|||
128909328|NCT00953758|463960405|FG005|Overall Study|Death|1|||
128909329|NCT00953758|463960406|FG006|Overall Study|Death|1|||
128909330|NCT00953758|463960407|FG007|Overall Study|Death|3|||
128909331|NCT00953758|463960408|FG008|Overall Study|Death|1|||
128909332|NCT00953758|463960409|FG009|Overall Study|Death|0|||
128909333|NCT00953758|463960400|FG000|Overall Study|Participant refused further follow-up|0|||
128909334|NCT00953758|463960401|FG001|Overall Study|Participant refused further follow-up|0|||
128909335|NCT00953758|463960402|FG002|Overall Study|Participant refused further follow-up|1|||
128909336|NCT00953758|463960403|FG003|Overall Study|Participant refused further follow-up|0|||
128909337|NCT00953758|463960404|FG004|Overall Study|Participant refused further follow-up|3|||
128909338|NCT00953758|463960405|FG005|Overall Study|Participant refused further follow-up|0|||
128909339|NCT00953758|463960406|FG006|Overall Study|Participant refused further follow-up|0|||
128909340|NCT00953758|463960407|FG007|Overall Study|Participant refused further follow-up|0|||
128909341|NCT00953758|463960408|FG008|Overall Study|Participant refused further follow-up|1|||
128909342|NCT00953758|463960409|FG009|Overall Study|Participant refused further follow-up|0|||
128909343|NCT00953758|463960400|FG000|Overall Study|Lost to Follow-up|0|||
128909344|NCT00953758|463960401|FG001|Overall Study|Lost to Follow-up|0|||
128909345|NCT00953758|463960402|FG002|Overall Study|Lost to Follow-up|0|||
128909346|NCT00953758|463960403|FG003|Overall Study|Lost to Follow-up|1|||
128909347|NCT00953758|463960404|FG004|Overall Study|Lost to Follow-up|0|||
128909348|NCT00953758|463960405|FG005|Overall Study|Lost to Follow-up|0|||
128909349|NCT00953758|463960406|FG006|Overall Study|Lost to Follow-up|0|||
128909350|NCT00953758|463960407|FG007|Overall Study|Lost to Follow-up|1|||
128909351|NCT00953758|463960408|FG008|Overall Study|Lost to Follow-up|0|||
128909352|NCT00953758|463960409|FG009|Overall Study|Lost to Follow-up|1|||
128909353|NCT00953758|463960400|FG000|Overall Study|Physician Decision|0|||
128909354|NCT00953758|463960401|FG001|Overall Study|Physician Decision|0|||
128909355|NCT00953758|463960402|FG002|Overall Study|Physician Decision|0|||
128909356|NCT00953758|463960403|FG003|Overall Study|Physician Decision|0|||
129027882|NCT03669250|464392771|FG004|Overall Study|Adverse Event|1|||
129027883|NCT03669250|464392772|FG005|Overall Study|Adverse Event|0|||
128696716|NCT00932126|463186873|FG002|Overall Study|Other|0|||
128909357|NCT00953758|463960404|FG004|Overall Study|Physician Decision|1|||
129027884|NCT03669250|464392767|FG000|Overall Study|Withdrawal by Subject|0|||
128909358|NCT00953758|463960405|FG005|Overall Study|Physician Decision|0|||
128909359|NCT00953758|463960406|FG006|Overall Study|Physician Decision|0|||
128909360|NCT00953758|463960407|FG007|Overall Study|Physician Decision|0|||
128909361|NCT00953758|463960408|FG008|Overall Study|Physician Decision|0|||
129027885|NCT03669250|464392768|FG001|Overall Study|Withdrawal by Subject|1|||
128909362|NCT00953758|463960409|FG009|Overall Study|Physician Decision|0|||
128909363|NCT00953758|463960400|FG000|Overall Study|Disease progression|0|||
128909364|NCT00953758|463960401|FG001|Overall Study|Disease progression|0|||
129027886|NCT03669250|464392769|FG002|Overall Study|Withdrawal by Subject|0|||
129027887|NCT03669250|464392770|FG003|Overall Study|Withdrawal by Subject|1|||
128696717|NCT00932126|463186874|FG003|Overall Study|Other|0|||
128909365|NCT00953758|463960402|FG002|Overall Study|Disease progression|0|||
128909366|NCT00953758|463960403|FG003|Overall Study|Disease progression|0|||
128909367|NCT00953758|463960404|FG004|Overall Study|Disease progression|1|||
128909368|NCT00953758|463960405|FG005|Overall Study|Disease progression|0|||
128909369|NCT00953758|463960406|FG006|Overall Study|Disease progression|0|||
128909370|NCT00953758|463960407|FG007|Overall Study|Disease progression|0|||
128909371|NCT00953758|463960408|FG008|Overall Study|Disease progression|0|||
128909372|NCT00953758|463960409|FG009|Overall Study|Disease progression|0|||
128909373|NCT00953758|463960400|FG000|Overall Study|Participant went for transplant|0|||
128909374|NCT00953758|463960401|FG001|Overall Study|Participant went for transplant|0|||
128909375|NCT00953758|463960402|FG002|Overall Study|Participant went for transplant|0|||
128909376|NCT00953758|463960403|FG003|Overall Study|Participant went for transplant|0|||
128909377|NCT00953758|463960404|FG004|Overall Study|Participant went for transplant|0|||
128909378|NCT00953758|463960405|FG005|Overall Study|Participant went for transplant|0|||
128696718|NCT00932126|463186875|FG004|Overall Study|Other|1|||
128696719|NCT00932126|463186876|FG005|Overall Study|Other|0|||
128696720|NCT00932126|463186877|FG006|Overall Study|Other|1|||
128696721|NCT00932126|463186878|FG007|Overall Study|Other|2|||
128696722|NCT00066365|463186879|FG000|Overall Study|Adverse Event|1|||
128696723|NCT00066365|463186880|FG001|Overall Study|Adverse Event|0|||
128696724|NCT00066365|463186879|FG000|Overall Study|Lack of Efficacy|15|||
128696725|NCT00066365|463186880|FG001|Overall Study|Lack of Efficacy|12|||
128696726|NCT00066365|463186879|FG000|Overall Study|Physician Decision|1|||
128696727|NCT00066365|463186880|FG001|Overall Study|Physician Decision|0|||
128696728|NCT00066365|463186879|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
128696729|NCT00066365|463186880|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
128696730|NCT00066365|463186879|FG000|Overall Study|Ineligible|4|||
128696731|NCT00066365|463186880|FG001|Overall Study|Ineligible|2|||
128696732|NCT00788073|463186882|FG000|STX209 Then Placebo|Adverse Event|1|||
128696733|NCT00788073|463186883|FG001|STX209 Then Placebo|Adverse Event|0|||
128765287|NCT02395133|463432114|FG000|Overall Study|Protocol Violation|1|||
128909379|NCT00953758|463960406|FG006|Overall Study|Participant went for transplant|0|||
128909380|NCT00953758|463960407|FG007|Overall Study|Participant went for transplant|0|||
128765288|NCT02395133|463432115|FG001|Overall Study|Protocol Violation|1|||
128765289|NCT02395133|463432116|FG002|Overall Study|Protocol Violation|0|||
128765290|NCT02395133|463432117|FG003|Overall Study|Protocol Violation|3|||
128765291|NCT02395133|463432114|FG000|Overall Study|Lost to Follow-up|0|||
128765292|NCT02395133|463432115|FG001|Overall Study|Lost to Follow-up|1|||
128765293|NCT02395133|463432116|FG002|Overall Study|Lost to Follow-up|1|||
128765294|NCT02395133|463432117|FG003|Overall Study|Lost to Follow-up|0|||
128765295|NCT02395133|463432114|FG000|Overall Study|Pregnancy|0|||
128765296|NCT02395133|463432115|FG001|Overall Study|Pregnancy|0|||
128765297|NCT02395133|463432116|FG002|Overall Study|Pregnancy|3|||
128765298|NCT02395133|463432117|FG003|Overall Study|Pregnancy|0|||
128765299|NCT02395133|463432114|FG000|Overall Study|Consent withdrawn with no reason given|1|||
128765300|NCT02395133|463432115|FG001|Overall Study|Consent withdrawn with no reason given|3|||
128765301|NCT02395133|463432116|FG002|Overall Study|Consent withdrawn with no reason given|0|||
128765302|NCT02395133|463432117|FG003|Overall Study|Consent withdrawn with no reason given|2|||
128765303|NCT02395133|463432114|FG000|Overall Study|Consent withdrawn with personal reason|0|||
128765304|NCT02395133|463432115|FG001|Overall Study|Consent withdrawn with personal reason|1|||
128765305|NCT02395133|463432116|FG002|Overall Study|Consent withdrawn with personal reason|0|||
128765306|NCT02395133|463432117|FG003|Overall Study|Consent withdrawn with personal reason|3|||
128765307|NCT02395133|463432114|FG000|Overall Study|Sponsor decision|2|||
128765308|NCT02395133|463432115|FG001|Overall Study|Sponsor decision|0|||
128765309|NCT02395133|463432116|FG002|Overall Study|Sponsor decision|0|||
128765310|NCT02395133|463432117|FG003|Overall Study|Sponsor decision|1|||
128765311|NCT02395133|463432114|FG000|Overall Study|Other than specified above|5|||
128909381|NCT00953758|463960408|FG008|Overall Study|Participant went for transplant|1|||
129117880|NCT00472420|464727474|FG000|Induction Treatment Period|Adverse Event|3|||
129117881|NCT00472420|464727474|FG000|Induction Treatment Period|Non-compliance|1|||
129117882|NCT00472420|464727474|FG000|Induction Treatment Period|Death|3|||
129117883|NCT00472420|464727474|FG000|Follow-up Period|Death|5|||
129117884|NCT00472420|464727474|FG000|Follow-up Period|Physician Decision|9|||
129117885|NCT00472420|464727474|FG000|Follow-up Period|Lost to Follow-up|2|||
129117886|NCT00472420|464727474|FG000|Follow-up Period|Protocol Violation|1|||
129117887|NCT01787552|464727480|FG000|Overall Study|Withdrawal by Subject|2|||
129117888|NCT01787552|464727481|FG001|Overall Study|Withdrawal by Subject|0|||
129117889|NCT01787552|464727482|FG002|Overall Study|Withdrawal by Subject|0|||
129117890|NCT01787552|464727483|FG003|Overall Study|Withdrawal by Subject|4|||
129117891|NCT01787552|464727480|FG000|Overall Study|Physician Decision|2|||
128696734|NCT00788073|463186882|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
128765312|NCT02395133|463432115|FG001|Overall Study|Other than specified above|2|||
128765313|NCT02395133|463432116|FG002|Overall Study|Other than specified above|2|||
128765314|NCT02395133|463432117|FG003|Overall Study|Other than specified above|4|||
128909382|NCT00953758|463960409|FG009|Overall Study|Participant went for transplant|0|||
128909383|NCT01536860|463960410|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
128696735|NCT00788073|463186883|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
128696736|NCT00788073|463186882|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
128696737|NCT00788073|463186883|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
128765315|NCT00962247|463432118|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
128696738|NCT00788073|463186882|FG000|STX209 Then Placebo|unable to return due to travel|0|||
128696739|NCT00788073|463186883|FG001|STX209 Then Placebo|unable to return due to travel|1|||
129027888|NCT03669250|464392771|FG004|Overall Study|Withdrawal by Subject|0|||
129027889|NCT03669250|464392772|FG005|Overall Study|Withdrawal by Subject|0|||
129027890|NCT00828321|464392773|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
129027891|NCT00828321|464392774|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
129027892|NCT00828321|464392773|FG000|Second Intervention|Protocol Violation|0|||
129027893|NCT00828321|464392774|FG001|Second Intervention|Protocol Violation|1|||
129027894|NCT02034513|464392775|FG000|Overall Study|Adverse Event|11|||
129027895|NCT02034513|464392776|FG001|Overall Study|Adverse Event|10|||
129027896|NCT02034513|464392775|FG000|Overall Study|Lack of Efficacy|0|||
129027897|NCT02034513|464392776|FG001|Overall Study|Lack of Efficacy|1|||
129027898|NCT02034513|464392775|FG000|Overall Study|Lost to Follow-up|6|||
129027899|NCT02034513|464392776|FG001|Overall Study|Lost to Follow-up|7|||
129027900|NCT02034513|464392775|FG000|Overall Study|Pregnancy|0|||
129027901|NCT02034513|464392776|FG001|Overall Study|Pregnancy|3|||
129027902|NCT02034513|464392775|FG000|Overall Study|Protocol Violation|7|||
129027903|NCT02034513|464392776|FG001|Overall Study|Protocol Violation|10|||
129027904|NCT02034513|464392775|FG000|Overall Study|Withdrawal by Subject|25|||
129027905|NCT02034513|464392776|FG001|Overall Study|Withdrawal by Subject|25|||
129027906|NCT02034513|464392775|FG000|Overall Study|Unclassified|0|||
129027907|NCT02034513|464392776|FG001|Overall Study|Unclassified|1|||
129027908|NCT03119662|464392779|FG000|Overall Study|Withdrawal by Subject|0|||
129027909|NCT03119662|464392780|FG001|Overall Study|Withdrawal by Subject|1|||
129027910|NCT04523480|464392781|FG000|Overall Study|Lost to Follow-up|30|||
129027911|NCT04523480|464392782|FG001|Overall Study|Lost to Follow-up|35|||
129027912|NCT04523480|464392783|FG002|Overall Study|Lost to Follow-up|0|||
128909384|NCT01536860|463960411|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
128909385|NCT01536860|463960412|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
128909386|NCT01164722|463960413|FG000|Overall Study|Adverse Event|0|||
128909387|NCT01164722|463960414|FG001|Overall Study|Adverse Event|1|||
128909388|NCT01164722|463960413|FG000|Overall Study|Withdrawal by Subject|3|||
128909389|NCT01164722|463960414|FG001|Overall Study|Withdrawal by Subject|4|||
128909390|NCT01164722|463960413|FG000|Overall Study|Lost to Follow-up|3|||
128909391|NCT01164722|463960414|FG001|Overall Study|Lost to Follow-up|6|||
128909392|NCT01164722|463960413|FG000|Overall Study|met protocol criteria for non-treatment|11|||
128909393|NCT01164722|463960414|FG001|Overall Study|met protocol criteria for non-treatment|1|||
128909394|NCT01164722|463960413|FG000|Overall Study|enrolled on other study, concomitant med|1|||
128909395|NCT01164722|463960414|FG001|Overall Study|enrolled on other study, concomitant med|3|||
128909396|NCT00999908|463960415|FG000|Treatment Period 1|Subject withdrew consent|2|||
128909397|NCT00999908|463960416|FG001|Treatment Period 1|Subject withdrew consent|0|||
128909398|NCT00999908|463960417|FG002|Treatment Period 1|Subject withdrew consent|0|||
128909399|NCT00999908|463960415|FG000|Treatment Period 2|Protocol Violation|1|||
128909400|NCT00999908|463960416|FG001|Treatment Period 2|Protocol Violation|0|||
128909401|NCT00999908|463960417|FG002|Treatment Period 2|Protocol Violation|0|||
128909402|NCT02682901|463960422|FG000|Overall Study|Adverse Event|10|||
128909403|NCT02682901|463960423|FG001|Overall Study|Adverse Event|3|||
128909404|NCT02682901|463960422|FG000|Overall Study|Lack of Efficacy|0|||
128909405|NCT02682901|463960423|FG001|Overall Study|Lack of Efficacy|1|||
128909406|NCT03870555|463960424|FG000|Period 3 (2 Days)|Adverse Event|1|||
128909407|NCT03870555|463960425|FG001|Period 3 (2 Days)|Adverse Event|0|||
128909408|NCT03870555|463960426|FG002|Period 3 (2 Days)|Adverse Event|0|||
128909409|NCT03694925|463960427|FG000|Overall Study|Inadequate laboratory testing|0|||
128909410|NCT03694925|463960428|FG001|Overall Study|Inadequate laboratory testing|3|||
128909411|NCT03694925|463960429|FG002|Overall Study|Inadequate laboratory testing|0|||
128909412|NCT03167073|463960435|FG000|Overall Study|Stillbirth|1|||
128909413|NCT03167073|463960436|FG001|Overall Study|Stillbirth|0|||
128909414|NCT02799069|463960437|FG000|Overall Study|Adverse Event|0|||
128909415|NCT02799069|463960438|FG001|Overall Study|Adverse Event|2|||
129027913|NCT00081653|464392789|FG000|Overall Study|Adverse Event|23|||
128696740|NCT00788073|463186882|FG000|Placebo Then STX209|Adverse Event|2|||
128696741|NCT00788073|463186883|FG001|Placebo Then STX209|Adverse Event|0|||
128696742|NCT00788073|463186882|FG000|Placebo Then STX209|Protocol Violation|0|||
128696743|NCT00788073|463186883|FG001|Placebo Then STX209|Protocol Violation|1|||
128909416|NCT02799069|463960439|FG002|Overall Study|Adverse Event|2|||
128909417|NCT02799069|463960437|FG000|Overall Study|Lack of Efficacy|2|||
129027914|NCT00081653|464392790|FG001|Overall Study|Adverse Event|17|||
128696744|NCT03608254|463186884|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
128717873|NCT00733746|463264069|FG000|Overall Study|Ineligible|5|||
128909418|NCT02799069|463960438|FG001|Overall Study|Lack of Efficacy|0|||
128909419|NCT02799069|463960439|FG002|Overall Study|Lack of Efficacy|0|||
128909420|NCT02799069|463960437|FG000|Overall Study|Lost to Follow-up|1|||
128909421|NCT02799069|463960438|FG001|Overall Study|Lost to Follow-up|1|||
128909422|NCT02799069|463960439|FG002|Overall Study|Lost to Follow-up|0|||
129027915|NCT00081653|464392789|FG000|Overall Study|Lost to Follow-up|2|||
129027916|NCT00081653|464392790|FG001|Overall Study|Lost to Follow-up|4|||
128909423|NCT02799069|463960437|FG000|Overall Study|Withdrawal by Subject|4|||
128909424|NCT02799069|463960438|FG001|Overall Study|Withdrawal by Subject|4|||
128909425|NCT02799069|463960439|FG002|Overall Study|Withdrawal by Subject|3|||
129027917|NCT00081653|464392789|FG000|Overall Study|Refused Treatment|18|||
128909426|NCT02799069|463960437|FG000|Overall Study|Protocol Violation|1|||
128909427|NCT02799069|463960438|FG001|Overall Study|Protocol Violation|0|||
128909428|NCT02799069|463960439|FG002|Overall Study|Protocol Violation|2|||
128909429|NCT02573155|463960440|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
128909430|NCT02573155|463960441|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
128909431|NCT02573155|463960440|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
128909432|NCT02573155|463960441|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
128909433|NCT02573155|463960440|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
128909434|NCT02573155|463960441|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
128909435|NCT02573155|463960440|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
128909436|NCT02573155|463960441|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
128909437|NCT02573155|463960440|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
128909438|NCT02573155|463960441|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
128909439|NCT02573155|463960440|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
128909440|NCT02573155|463960441|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
128909441|NCT02573155|463960440|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
128909442|NCT02573155|463960441|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
128909443|NCT02573155|463960440|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
128909444|NCT02573155|463960441|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
128909445|NCT01681433|463960442|FG000|Overall Study|Lack of Efficacy|23|||
128909446|NCT01681433|463960443|FG001|Overall Study|Lack of Efficacy|23|||
128909447|NCT01681433|463960442|FG000|Overall Study|Withdrawal by Subject|5|||
128909448|NCT01681433|463960443|FG001|Overall Study|Withdrawal by Subject|5|||
128909449|NCT01681433|463960442|FG000|Overall Study|Protocol Violation|2|||
128909450|NCT01681433|463960443|FG001|Overall Study|Protocol Violation|0|||
128909451|NCT01681433|463960442|FG000|Overall Study|Adverse Event|2|||
128765316|NCT00962247|463432118|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
128765317|NCT03474549|463432119|FG000|Overall Study|Death|31|||
128765318|NCT03474549|463432119|FG000|Overall Study|Lost to Follow-up|4|||
128765319|NCT03474549|463432119|FG000|Overall Study|Withdrawal by Subject|2|||
128765320|NCT00738101|463432124|FG000|Overall Study|Physician Decision|5|||
128765321|NCT00738101|463432124|FG000|Overall Study|Death|1|||
128765322|NCT00738101|463432124|FG000|Overall Study|Repeat enrollment|1|||
128765323|NCT00709059|463432131|FG000|Overall Study|Lost to Follow-up|34|||
128765324|NCT00709059|463432131|FG000|Overall Study|Withdrawal by Subject|19|||
128765325|NCT00709059|463432131|FG000|Overall Study|Physician Decision|7|||
128765326|NCT00709059|463432131|FG000|Overall Study|Disease complication|3|||
128765327|NCT00709059|463432131|FG000|Overall Study|Side effects|20|||
128765328|NCT00709059|463432131|FG000|Overall Study|Serious side effects|11|||
128765329|NCT01786330|463432132|FG000|Overall Study|Withdrawal by Subject|0|||
128765330|NCT01786330|463432133|FG001|Overall Study|Withdrawal by Subject|1|||
128765331|NCT01786330|463432132|FG000|Overall Study|Lost to Follow-up|0|||
128765332|NCT01786330|463432133|FG001|Overall Study|Lost to Follow-up|1|||
128765333|NCT01786330|463432132|FG000|Overall Study|Excluded intraoperatively|0|||
128765334|NCT01786330|463432133|FG001|Overall Study|Excluded intraoperatively|1|||
128765335|NCT01786330|463432132|FG000|Overall Study|Protocol Violation|1|||
128765336|NCT01786330|463432133|FG001|Overall Study|Protocol Violation|0|||
128909452|NCT01681433|463960443|FG001|Overall Study|Adverse Event|4|||
128909453|NCT01681433|463960442|FG000|Overall Study|Lost to Follow-up|0|||
128909454|NCT01681433|463960443|FG001|Overall Study|Lost to Follow-up|1|||
128909455|NCT02301403|463960444|FG000|Overall Study|Withdrawal by Subject|28|||
128909456|NCT02301403|463960445|FG001|Overall Study|Withdrawal by Subject|41|||
129117892|NCT01787552|464727481|FG001|Overall Study|Physician Decision|2|||
129117893|NCT01787552|464727482|FG002|Overall Study|Physician Decision|1|||
129117894|NCT01787552|464727483|FG003|Overall Study|Physician Decision|2|||
129117895|NCT01787552|464727480|FG000|Overall Study|Death|0|||
129117896|NCT01787552|464727481|FG001|Overall Study|Death|0|||
128909457|NCT03064841|463960446|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
128909458|NCT03064841|463960446|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
128909459|NCT03064841|463960446|FG000|Overall Study|Screen failure|2|||
128909460|NCT03434977|463960447|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
128909461|NCT03434977|463960448|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
128909462|NCT00217087|463960449|FG000|Overall Study|decided to have esophagectomy|1|||
128909463|NCT00217087|463960450|FG001|Overall Study|decided to have esophagectomy|2|||
128909464|NCT00217087|463960449|FG000|Overall Study|completed less than 12 months return|10|||
128909465|NCT00217087|463960450|FG001|Overall Study|completed less than 12 months return|18|||
128909466|NCT03920670|463960451|FG000|Overall Study|Protocol Violation|2|||
128909467|NCT03920670|463960452|FG001|Overall Study|Protocol Violation|2|||
128909468|NCT03920670|463960451|FG000|Overall Study|Adverse Event|1|||
129117897|NCT01787552|464727482|FG002|Overall Study|Death|0|||
128765337|NCT02969525|463432138|FG000|Double-Blind Period|Adverse Event|0|||
128765338|NCT02969525|463432139|FG001|Double-Blind Period|Adverse Event|0|||
128765339|NCT02969525|463432140|FG002|Double-Blind Period|Adverse Event|1|||
128765340|NCT02969525|463432141|FG003|Double-Blind Period|Adverse Event|1|||
128909469|NCT03920670|463960452|FG001|Overall Study|Adverse Event|0|||
128909470|NCT03208231|463960458|FG000|Overall Study|Death|1|||
128909471|NCT03208231|463960459|FG001|Overall Study|Death|2|||
128909472|NCT03208231|463960458|FG000|Overall Study|Moved and unable to get to clinic|1|||
128909473|NCT03208231|463960459|FG001|Overall Study|Moved and unable to get to clinic|0|||
128909474|NCT03208231|463960458|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
128909475|NCT03208231|463960459|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
128909476|NCT04347239|463960473|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
128909477|NCT04347239|463960474|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
128909478|NCT04347239|463960475|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
128909479|NCT04347239|463960473|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
128909480|NCT04347239|463960474|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
128909481|NCT04347239|463960475|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
128909482|NCT04770779|463960476|FG000|Overall Study|Randomized, never treated|0|||
128909483|NCT04770779|463960477|FG001|Overall Study|Randomized, never treated|1|||
128909484|NCT04770779|463960476|FG000|Overall Study|Adverse Event|9|||
128909485|NCT04770779|463960477|FG001|Overall Study|Adverse Event|1|||
128909486|NCT04770779|463960476|FG000|Overall Study|Withdrawal by Subject|7|||
128909487|NCT04770779|463960477|FG001|Overall Study|Withdrawal by Subject|1|||
128909488|NCT04770779|463960476|FG000|Overall Study|Pregnancy|0|||
128909489|NCT04770779|463960477|FG001|Overall Study|Pregnancy|1|||
128909490|NCT02289950|463960479|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
128909491|NCT02289950|463960480|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
128909492|NCT02289950|463960479|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
128909493|NCT02289950|463960480|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
128909494|NCT02289950|463960479|FG000|Overall Study|Lost to Follow-up|1|||
128909495|NCT02289950|463960480|FG001|Overall Study|Lost to Follow-up|0|||
128909496|NCT02289950|463960479|FG000|Overall Study|Physician Decision|9|||
128909497|NCT02289950|463960480|FG001|Overall Study|Physician Decision|3|||
128909498|NCT02289950|463960479|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
128909499|NCT02289950|463960480|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
128909500|NCT02289950|463960479|FG000|Overall Study|Withdrawal by Subject|1|||
128909501|NCT02289950|463960480|FG001|Overall Study|Withdrawal by Subject|3|||
128909502|NCT02289950|463960479|FG000|Overall Study|Test article held for greater than 28 days|0|||
128909503|NCT02289950|463960480|FG001|Overall Study|Test article held for greater than 28 days|1|||
128909504|NCT02289950|463960479|FG000|Overall Study|Adverse Event|11|||
128909505|NCT02289950|463960480|FG001|Overall Study|Adverse Event|3|||
128909506|NCT02289950|463960479|FG000|Overall Study|Death|1|||
128909507|NCT02289950|463960480|FG001|Overall Study|Death|1|||
128909508|NCT02289950|463960479|FG000|Overall Study|Other|5|||
128909509|NCT02289950|463960480|FG001|Overall Study|Other|2|||
128909510|NCT02289950|463960479|FG000|Overall Study|Not Treated|2|||
128909511|NCT02289950|463960480|FG001|Overall Study|Not Treated|1|||
128909512|NCT02270242|463960481|FG000|Overall Study|Withdrawal by Subject|18|||
128909513|NCT02270242|463960482|FG001|Overall Study|Withdrawal by Subject|25|||
128909514|NCT02270242|463960481|FG000|Overall Study|Lost to Follow-up|41|||
128909515|NCT02270242|463960482|FG001|Overall Study|Lost to Follow-up|27|||
128909516|NCT02270242|463960481|FG000|Overall Study|Physician Decision|0|||
128909517|NCT02270242|463960482|FG001|Overall Study|Physician Decision|1|||
129027918|NCT00081653|464392790|FG001|Overall Study|Refused Treatment|14|||
129027919|NCT00081653|464392789|FG000|Overall Study|Low bone mineral density|1|||
129027920|NCT00081653|464392790|FG001|Overall Study|Low bone mineral density|0|||
129027921|NCT00081653|464392789|FG000|Overall Study|Bone loss|2|||
129027922|NCT00081653|464392790|FG001|Overall Study|Bone loss|0|||
129027923|NCT00081653|464392789|FG000|Overall Study|Participant leaving country|1|||
129027924|NCT00081653|464392790|FG001|Overall Study|Participant leaving country|0|||
129027925|NCT00081653|464392789|FG000|Overall Study|Loss of bone mass|0|||
129027926|NCT00081653|464392790|FG001|Overall Study|Loss of bone mass|2|||
129027927|NCT02694536|464392798|FG000|Overall Study|Progressive Disease|40|||
129027928|NCT02694536|464392798|FG000|Overall Study|Lost to Follow-up|1|||
129027929|NCT02694536|464392798|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
129027930|NCT02694536|464392798|FG000|Overall Study|Withdrawal by Subject|8|||
129027931|NCT02694536|464392798|FG000|Overall Study|Death|8|||
128909518|NCT02321436|463960483|FG000|Overall Study|Withdrawal by Subject|1|||
128909519|NCT02321436|463960484|FG001|Overall Study|Withdrawal by Subject|0|||
128909520|NCT02321436|463960483|FG000|Overall Study|Lost to Follow-up|0|||
128909521|NCT02321436|463960484|FG001|Overall Study|Lost to Follow-up|1|||
128909522|NCT03355300|463960485|FG000|Overall Study|Physician Decision|0|||
128909523|NCT03355300|463960486|FG001|Overall Study|Physician Decision|1|||
128909524|NCT03355300|463960485|FG000|Overall Study|Lack of Efficacy|2|||
128909525|NCT03355300|463960486|FG001|Overall Study|Lack of Efficacy|1|||
128909526|NCT03355300|463960485|FG000|Overall Study|Other reason|1|||
129027932|NCT02694536|464392798|FG000|Overall Study|Other|22|||
129027933|NCT01911429|464392801|FG000|Overall Study|Adverse Event|5|||
128909527|NCT03355300|463960486|FG001|Overall Study|Other reason|0|||
128909528|NCT03048422|463960487|FG000|Overall Study|Death|1|||
128909529|NCT03048422|463960488|FG001|Overall Study|Death|0|||
128909530|NCT03048422|463960489|FG002|Overall Study|Death|0|||
128909531|NCT03048422|463960487|FG000|Overall Study|Lost to Follow-up|5|||
128909532|NCT03048422|463960488|FG001|Overall Study|Lost to Follow-up|0|||
128909533|NCT03048422|463960489|FG002|Overall Study|Lost to Follow-up|1|||
128909534|NCT03048422|463960487|FG000|Overall Study|Withdrawal by Subject|5|||
128909535|NCT03048422|463960488|FG001|Overall Study|Withdrawal by Subject|7|||
128909536|NCT03048422|463960489|FG002|Overall Study|Withdrawal by Subject|4|||
128909537|NCT03048422|463960487|FG000|Overall Study|Moved|3|||
128909538|NCT03048422|463960488|FG001|Overall Study|Moved|2|||
128909539|NCT03048422|463960489|FG002|Overall Study|Moved|2|||
128909540|NCT03048422|463960487|FG000|Overall Study|Noncompliant with Study Requirements|2|||
128909541|NCT03048422|463960488|FG001|Overall Study|Noncompliant with Study Requirements|1|||
128909542|NCT03048422|463960489|FG002|Overall Study|Noncompliant with Study Requirements|2|||
128909543|NCT03048422|463960487|FG000|Overall Study|Not Able to Get to Clinic|1|||
128909544|NCT03048422|463960488|FG001|Overall Study|Not Able to Get to Clinic|0|||
128909545|NCT03048422|463960489|FG002|Overall Study|Not Able to Get to Clinic|0|||
128909546|NCT01844986|463960490|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
128909547|NCT01844986|463960491|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
128909548|NCT01844986|463960490|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
128909549|NCT01844986|463960491|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
128909550|NCT01844986|463960490|FG000|Overall Study (Global Cohort)|Death|55|||
128909551|NCT01844986|463960491|FG001|Overall Study (Global Cohort)|Death|26|||
128909552|NCT01844986|463960490|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
128909553|NCT01844986|463960491|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
128909554|NCT01844986|463960490|FG000|Overall Study (China Cohort)|Death|10|||
128909555|NCT01844986|463960491|FG001|Overall Study (China Cohort)|Death|6|||
128909556|NCT04137887|463962719|FG000|Overall Study|Death|102|||
128909557|NCT04137887|463962720|FG001|Overall Study|Death|92|||
128909558|NCT04137887|463962719|FG000|Overall Study|Withdrawal by Subject|2|||
128909559|NCT04137887|463962720|FG001|Overall Study|Withdrawal by Subject|3|||
128909560|NCT04137887|463962719|FG000|Overall Study|Randomized but not treated|0|||
128909561|NCT04137887|463962720|FG001|Overall Study|Randomized but not treated|1|||
128909562|NCT01790503|463962723|FG000|Overall Study|Adverse Event|1|||
128909563|NCT01790503|463962724|FG001|Overall Study|Adverse Event|0|||
128909564|NCT01790503|463962725|FG002|Overall Study|Adverse Event|0|||
128909565|NCT01790503|463962726|FG003|Overall Study|Adverse Event|0|||
128909566|NCT01790503|463962727|FG004|Overall Study|Adverse Event|0|||
128909567|NCT01790503|463962728|FG005|Overall Study|Adverse Event|2|||
128909568|NCT01790503|463962729|FG006|Overall Study|Adverse Event|0|||
128909569|NCT01790503|463962730|FG007|Overall Study|Adverse Event|0|||
128909570|NCT01790503|463962731|FG008|Overall Study|Adverse Event|2|||
128909571|NCT01790503|463962732|FG009|Overall Study|Adverse Event|4|||
128909572|NCT01790503|463962733|FG010|Overall Study|Adverse Event|7|||
128909573|NCT01790503|463962723|FG000|Overall Study|Withdrawal by Subject|0|||
128909574|NCT01790503|463962724|FG001|Overall Study|Withdrawal by Subject|0|||
128909575|NCT01790503|463962725|FG002|Overall Study|Withdrawal by Subject|1|||
128909576|NCT01790503|463962726|FG003|Overall Study|Withdrawal by Subject|1|||
128909577|NCT01790503|463962727|FG004|Overall Study|Withdrawal by Subject|1|||
129117898|NCT01787552|464727483|FG003|Overall Study|Death|1|||
129117899|NCT01787552|464727480|FG000|Overall Study|Adverse Event|2|||
128909578|NCT01790503|463962728|FG005|Overall Study|Withdrawal by Subject|2|||
128909579|NCT01790503|463962729|FG006|Overall Study|Withdrawal by Subject|1|||
128909580|NCT01790503|463962730|FG007|Overall Study|Withdrawal by Subject|0|||
128909581|NCT01790503|463962731|FG008|Overall Study|Withdrawal by Subject|0|||
128909582|NCT01790503|463962732|FG009|Overall Study|Withdrawal by Subject|0|||
128909583|NCT01790503|463962733|FG010|Overall Study|Withdrawal by Subject|1|||
128909584|NCT01790503|463962723|FG000|Overall Study|Disease progression|2|||
128909585|NCT01790503|463962724|FG001|Overall Study|Disease progression|1|||
128909586|NCT01790503|463962725|FG002|Overall Study|Disease progression|0|||
128909587|NCT01790503|463962726|FG003|Overall Study|Disease progression|1|||
128909588|NCT01790503|463962727|FG004|Overall Study|Disease progression|2|||
128909589|NCT01790503|463962728|FG005|Overall Study|Disease progression|1|||
129117900|NCT01787552|464727481|FG001|Overall Study|Adverse Event|5|||
128909590|NCT01790503|463962729|FG006|Overall Study|Disease progression|0|||
128909591|NCT01790503|463962730|FG007|Overall Study|Disease progression|1|||
128909592|NCT01790503|463962731|FG008|Overall Study|Disease progression|0|||
128909593|NCT01790503|463962732|FG009|Overall Study|Disease progression|17|||
128909594|NCT01790503|463962733|FG010|Overall Study|Disease progression|7|||
128909595|NCT01790503|463962723|FG000|Overall Study|Protocol Violation|0|||
128909596|NCT01790503|463962724|FG001|Overall Study|Protocol Violation|0|||
128909597|NCT01790503|463962725|FG002|Overall Study|Protocol Violation|0|||
128909598|NCT01790503|463962726|FG003|Overall Study|Protocol Violation|0|||
128909599|NCT01790503|463962727|FG004|Overall Study|Protocol Violation|0|||
128909600|NCT01790503|463962728|FG005|Overall Study|Protocol Violation|0|||
129117901|NCT01787552|464727482|FG002|Overall Study|Adverse Event|2|||
128909601|NCT01790503|463962729|FG006|Overall Study|Protocol Violation|0|||
128909602|NCT01790503|463962730|FG007|Overall Study|Protocol Violation|0|||
128909603|NCT01790503|463962731|FG008|Overall Study|Protocol Violation|0|||
128909604|NCT01790503|463962732|FG009|Overall Study|Protocol Violation|1|||
128909605|NCT01790503|463962733|FG010|Overall Study|Protocol Violation|0|||
128909606|NCT01790503|463962723|FG000|Overall Study|Physician Decision|0|||
128909607|NCT01790503|463962724|FG001|Overall Study|Physician Decision|0|||
128909608|NCT01790503|463962725|FG002|Overall Study|Physician Decision|0|||
128909609|NCT01790503|463962726|FG003|Overall Study|Physician Decision|0|||
128909610|NCT01790503|463962727|FG004|Overall Study|Physician Decision|0|||
128909611|NCT01790503|463962728|FG005|Overall Study|Physician Decision|0|||
128909612|NCT01790503|463962729|FG006|Overall Study|Physician Decision|0|||
128909613|NCT01790503|463962730|FG007|Overall Study|Physician Decision|0|||
128909614|NCT01790503|463962731|FG008|Overall Study|Physician Decision|0|||
129117902|NCT01787552|464727483|FG003|Overall Study|Adverse Event|16|||
128696745|NCT03608254|463186884|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
128696746|NCT00660673|463186885|FG000|Overall Study|Adverse Event|84|||
128696747|NCT00660673|463186885|FG000|Overall Study|Lack of Efficacy|7|||
128696748|NCT00660673|463186885|FG000|Overall Study|Withdrawal by Subject|22|||
128696749|NCT00660673|463186885|FG000|Overall Study|Administrative|2|||
128696750|NCT00660673|463186885|FG000|Overall Study|Protocol Violation|2|||
128696751|NCT05213481|463186887|FG000|Overall Study|Adverse Event|3|||
128696752|NCT05213481|463186887|FG000|Overall Study|Lost to Follow-up|1|||
128696753|NCT02058693|463186894|FG000|Phase 1|Withdrawal by Subject|3|||
128696754|NCT02058693|463186895|FG001|Phase 1|Withdrawal by Subject|2|||
128696755|NCT02058693|463186894|FG000|Phase 1|Adverse Event|0|||
128696756|NCT02058693|463186895|FG001|Phase 1|Adverse Event|1|||
128696757|NCT02058693|463186894|FG000|Phase 1|Lack of Efficacy|1|||
128696758|NCT02058693|463186895|FG001|Phase 1|Lack of Efficacy|0|||
128696759|NCT02058693|463186894|FG000|Phase 1|Physician Decision|1|||
128696760|NCT02058693|463186895|FG001|Phase 1|Physician Decision|1|||
128696761|NCT02058693|463186894|FG000|Phase 2|Withdrawal by Subject|0|||
128696762|NCT02058693|463186895|FG001|Phase 2|Withdrawal by Subject|2|||
128696763|NCT00722800|463186896|FG000|Overall Study|Withdrawal by Subject|1|||
128696764|NCT00722800|463186897|FG001|Overall Study|Withdrawal by Subject|0|||
128696765|NCT00722800|463186896|FG000|Overall Study|Physician Decision|1|||
128696766|NCT00722800|463186897|FG001|Overall Study|Physician Decision|0|||
128696767|NCT02059408|463186904|FG000|Overall Study|Did not get tested|0|||
128696768|NCT02059408|463186905|FG001|Overall Study|Did not get tested|330|||
128696769|NCT02059408|463186906|FG002|Overall Study|Did not get tested|358|||
128696770|NCT01681472|463186908|FG000|Overall Study|Adverse Event|0|||
128696771|NCT01681472|463186909|FG001|Overall Study|Adverse Event|1|||
128696772|NCT01681472|463186910|FG002|Overall Study|Adverse Event|0|||
128696773|NCT01681472|463186911|FG003|Overall Study|Adverse Event|0|||
128696774|NCT03128047|463186921|FG000|Overall Study|Withdrawal by Subject|1|||
128696775|NCT04805541|463188876|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
128696776|NCT00283400|463188877|FG000|Overall Study|Withdrawal by Subject|1|||
128696777|NCT00283400|463188878|FG001|Overall Study|Withdrawal by Subject|1|||
128696778|NCT00283400|463188879|FG002|Overall Study|Withdrawal by Subject|0|||
128696779|NCT00283400|463188880|FG003|Overall Study|Withdrawal by Subject|0|||
128696780|NCT00283400|463188877|FG000|Overall Study|Death|1|||
128696781|NCT00283400|463188878|FG001|Overall Study|Death|0|||
128696782|NCT00283400|463188879|FG002|Overall Study|Death|1|||
128696783|NCT00283400|463188880|FG003|Overall Study|Death|0|||
128696784|NCT01034631|463188882|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
128696785|NCT01034631|463188883|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
128696786|NCT01034631|463188884|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
128696787|NCT01034631|463188882|FG000|Phase II|Not Evaluable per protocol|0|||
128696788|NCT01034631|463188883|FG001|Phase II|Not Evaluable per protocol|0|||
128696789|NCT01034631|463188884|FG002|Phase II|Not Evaluable per protocol|2|||
128696790|NCT01034631|463188882|FG000|Phase II|Determined Ineligible per protocol|0|||
128765341|NCT02969525|463432142|FG004|Double-Blind Period|Adverse Event|0|||
129117903|NCT01787552|464727480|FG000|Overall Study|Study terminated by Sponsor|0|||
129117904|NCT01787552|464727481|FG001|Overall Study|Study terminated by Sponsor|0|||
128696791|NCT01034631|463188883|FG001|Phase II|Determined Ineligible per protocol|1|||
128696792|NCT01034631|463188884|FG002|Phase II|Determined Ineligible per protocol|0|||
128696793|NCT01560403|463188885|FG000|Overall Study|Lost to Follow-up|0|||
128696794|NCT01560403|463188886|FG001|Overall Study|Lost to Follow-up|1|||
128696795|NCT03166735|463188887|FG000|Overall Study|Not Treated|1|||
128696796|NCT03166735|463188888|FG001|Overall Study|Not Treated|0|||
128696797|NCT03166735|463188889|FG002|Overall Study|Not Treated|0|||
128696798|NCT03166735|463188890|FG003|Overall Study|Not Treated|0|||
128696799|NCT03166735|463188891|FG004|Overall Study|Not Treated|0|||
128696800|NCT03166735|463188887|FG000|Overall Study|follow-up not completed as planned|0|||
128696801|NCT03166735|463188888|FG001|Overall Study|follow-up not completed as planned|1|||
128696802|NCT03166735|463188889|FG002|Overall Study|follow-up not completed as planned|1|||
128909615|NCT01790503|463962732|FG009|Overall Study|Physician Decision|1|||
128909616|NCT01790503|463962733|FG010|Overall Study|Physician Decision|1|||
128909617|NCT01790503|463962723|FG000|Overall Study|Death|0|||
128909618|NCT01790503|463962724|FG001|Overall Study|Death|0|||
128909619|NCT01790503|463962725|FG002|Overall Study|Death|0|||
128909620|NCT01790503|463962726|FG003|Overall Study|Death|0|||
128909621|NCT01790503|463962727|FG004|Overall Study|Death|0|||
128909622|NCT01790503|463962728|FG005|Overall Study|Death|0|||
128909623|NCT01790503|463962729|FG006|Overall Study|Death|0|||
128909624|NCT01790503|463962730|FG007|Overall Study|Death|0|||
128909625|NCT01790503|463962731|FG008|Overall Study|Death|0|||
128909626|NCT01790503|463962732|FG009|Overall Study|Death|1|||
128909627|NCT01790503|463962733|FG010|Overall Study|Death|0|||
128909628|NCT01790503|463962723|FG000|Overall Study|Non Compliance|0|||
128909629|NCT01790503|463962724|FG001|Overall Study|Non Compliance|0|||
128909630|NCT01790503|463962725|FG002|Overall Study|Non Compliance|0|||
128909631|NCT01790503|463962726|FG003|Overall Study|Non Compliance|0|||
128909632|NCT01790503|463962727|FG004|Overall Study|Non Compliance|1|||
128909633|NCT01790503|463962728|FG005|Overall Study|Non Compliance|0|||
128909634|NCT01790503|463962729|FG006|Overall Study|Non Compliance|0|||
128909635|NCT01790503|463962730|FG007|Overall Study|Non Compliance|0|||
128909636|NCT01790503|463962731|FG008|Overall Study|Non Compliance|0|||
128909637|NCT01790503|463962732|FG009|Overall Study|Non Compliance|0|||
128909638|NCT01790503|463962733|FG010|Overall Study|Non Compliance|0|||
128909639|NCT01790503|463962723|FG000|Overall Study|Other|0|||
128909640|NCT01790503|463962724|FG001|Overall Study|Other|0|||
128909641|NCT01790503|463962725|FG002|Overall Study|Other|0|||
128909642|NCT01790503|463962726|FG003|Overall Study|Other|0|||
128909643|NCT01790503|463962727|FG004|Overall Study|Other|1|||
128909644|NCT01790503|463962728|FG005|Overall Study|Other|0|||
128909645|NCT01790503|463962729|FG006|Overall Study|Other|0|||
128909646|NCT01790503|463962730|FG007|Overall Study|Other|0|||
128909647|NCT01790503|463962731|FG008|Overall Study|Other|1|||
128909648|NCT01790503|463962732|FG009|Overall Study|Other|2|||
128909649|NCT01790503|463962733|FG010|Overall Study|Other|0|||
128909650|NCT00984204|463962745|FG000|Overall Study|Death|1|||
128909651|NCT00984204|463962745|FG000|Overall Study|Lost to Follow-up|4|||
128909652|NCT00984204|463962745|FG000|Overall Study|Lack of Efficacy|10|||
128909653|NCT01449708|463962747|FG000|Overall Study|Protocol Violation|0|||
128909654|NCT01449708|463962748|FG001|Overall Study|Protocol Violation|1|||
128909655|NCT01449708|463962747|FG000|Overall Study|surgical complication|1|||
128909656|NCT01449708|463962748|FG001|Overall Study|surgical complication|2|||
128909657|NCT01449708|463962747|FG000|Overall Study|respiratory failure|1|||
128909658|NCT01449708|463962748|FG001|Overall Study|respiratory failure|0|||
128909659|NCT05702515|463962749|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
128909660|NCT01784965|463962750|FG000|Overall Study|Withdrawal by Subject|6|||
128909661|NCT01784965|463962751|FG001|Overall Study|Withdrawal by Subject|3|||
128909662|NCT01784965|463962750|FG000|Overall Study|Adverse Event|0|||
128909663|NCT01784965|463962751|FG001|Overall Study|Adverse Event|8|||
128909664|NCT03757988|463962752|FG000|Overall Study|Withdrawal by Subject|1|||
128909665|NCT01491178|463962755|FG000|Overall Study|Adverse Event|1016|||
128909666|NCT01491178|463962755|FG000|Overall Study|Improvement of NVAF|210|||
128909667|NCT01491178|463962755|FG000|Overall Study|To conduct invasive treatment|59|||
128696803|NCT03166735|463188890|FG003|Overall Study|follow-up not completed as planned|0|||
128717874|NCT02447081|463264070|FG000|Overall Study|Death|161|||
128909668|NCT01491178|463962755|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
128909669|NCT01491178|463962755|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
128909670|NCT01491178|463962755|FG000|Overall Study|To take a contraindication|20|||
128909671|NCT01491178|463962755|FG000|Overall Study|Other than specified above|657|||
128909672|NCT05689047|463962756|FG000|Overall Study|Lost to Follow-up|0|||
128909673|NCT05689047|463962757|FG001|Overall Study|Lost to Follow-up|1|||
128909674|NCT05689047|463962756|FG000|Overall Study|Protocol Deviation|1|||
128909675|NCT05689047|463962757|FG001|Overall Study|Protocol Deviation|0|||
128909676|NCT03286842|463962759|FG000|Overall Study|Patients rolled over to another study|80|||
128909677|NCT03178487|463962760|FG000|Period 1|Adverse Event|1|||
128909678|NCT03178487|463962761|FG001|Period 1|Adverse Event|2|||
129027934|NCT01911429|464392802|FG001|Overall Study|Adverse Event|3|||
129027935|NCT01911429|464392803|FG002|Overall Study|Adverse Event|9|||
129027936|NCT01911429|464392801|FG000|Overall Study|Lack of Efficacy|1|||
129027937|NCT01911429|464392802|FG001|Overall Study|Lack of Efficacy|2|||
129027938|NCT01911429|464392803|FG002|Overall Study|Lack of Efficacy|4|||
129027939|NCT01911429|464392801|FG000|Overall Study|Lost to Follow-up|0|||
129027940|NCT01911429|464392802|FG001|Overall Study|Lost to Follow-up|0|||
129027941|NCT01911429|464392803|FG002|Overall Study|Lost to Follow-up|1|||
129027942|NCT01911429|464392801|FG000|Overall Study|Protocol Violation|0|||
129027943|NCT01911429|464392802|FG001|Overall Study|Protocol Violation|0|||
129027944|NCT01911429|464392803|FG002|Overall Study|Protocol Violation|1|||
129027945|NCT01911429|464392801|FG000|Overall Study|Withdrawal by Subject|5|||
128909679|NCT03178487|463962760|FG000|Period 1|Withdrawal by Subject|2|||
128909680|NCT03178487|463962761|FG001|Period 1|Withdrawal by Subject|1|||
128909681|NCT03178487|463962760|FG000|Period 1|Lost to Follow-up|1|||
128909682|NCT03178487|463962761|FG001|Period 1|Lost to Follow-up|0|||
128909683|NCT03178487|463962760|FG000|Period 1|Other|0|||
128909684|NCT03178487|463962761|FG001|Period 1|Other|1|||
128909685|NCT03178487|463962760|FG000|Period 2|Adverse Event|4|||
128909686|NCT03178487|463962761|FG001|Period 2|Adverse Event|4|||
128909687|NCT03178487|463962760|FG000|Period 2|Withdrawal by Subject|6|||
128909688|NCT03178487|463962761|FG001|Period 2|Withdrawal by Subject|6|||
128909689|NCT03178487|463962760|FG000|Period 2|Lost to Follow-up|2|||
128909690|NCT03178487|463962761|FG001|Period 2|Lost to Follow-up|2|||
128909691|NCT03178487|463962760|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
128909692|NCT03178487|463962761|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
128909693|NCT03178487|463962760|FG000|Period 2|Other|8|||
128909694|NCT03178487|463962761|FG001|Period 2|Other|7|||
128909695|NCT01453855|463962762|FG000|Overall Study|Adverse Event|3|||
128909696|NCT01453855|463962763|FG001|Overall Study|Adverse Event|4|||
128909697|NCT01453855|463962762|FG000|Overall Study|Lost to Follow-up|2|||
128909698|NCT01453855|463962763|FG001|Overall Study|Lost to Follow-up|1|||
128909699|NCT01453855|463962762|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
128909700|NCT01453855|463962763|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
128909701|NCT01453855|463962762|FG000|Overall Study|Noncompliance|1|||
128909702|NCT01453855|463962763|FG001|Overall Study|Noncompliance|0|||
128909703|NCT01453855|463962762|FG000|Overall Study|Inadequate Control of IOP|1|||
128909704|NCT01453855|463962763|FG001|Overall Study|Inadequate Control of IOP|5|||
128909705|NCT01453855|463962762|FG000|Overall Study|Other|0|||
128909706|NCT01453855|463962763|FG001|Overall Study|Other|1|||
128909707|NCT01562548|463962766|FG000|Overall Study|Lost to Follow-up|0|||
128909708|NCT01562548|463962767|FG001|Overall Study|Lost to Follow-up|0|||
128909709|NCT01562548|463962768|FG002|Overall Study|Lost to Follow-up|1|||
128909710|NCT01562548|463962769|FG003|Overall Study|Lost to Follow-up|0|||
128909711|NCT01496066|463962770|FG000|Overall Study|Lost to Follow-up|8|||
128909712|NCT01496066|463962771|FG001|Overall Study|Lost to Follow-up|5|||
128909713|NCT01496066|463962770|FG000|Overall Study|Explant|3|||
128909714|NCT01496066|463962771|FG001|Overall Study|Explant|0|||
128909715|NCT01496066|463962770|FG000|Overall Study|Death|1|||
128909716|NCT01496066|463962771|FG001|Overall Study|Death|4|||
128909717|NCT03237065|463962772|FG000|Overall Study|Adverse Event|0|||
128909718|NCT03237065|463962773|FG001|Overall Study|Adverse Event|2|||
128909719|NCT03237065|463962772|FG000|Overall Study|Protocol Violation|0|||
128909720|NCT03237065|463962773|FG001|Overall Study|Protocol Violation|1|||
128909721|NCT03237065|463962772|FG000|Overall Study|Withdrawal by Subject|3|||
128909722|NCT03237065|463962773|FG001|Overall Study|Withdrawal by Subject|0|||
128909723|NCT03237065|463962772|FG000|Overall Study|Lost to Follow-up|1|||
128909724|NCT03237065|463962773|FG001|Overall Study|Lost to Follow-up|0|||
128909725|NCT03237065|463962772|FG000|Overall Study|Unable to obtain venous access|0|||
128909726|NCT03237065|463962773|FG001|Overall Study|Unable to obtain venous access|1|||
128909727|NCT00209339|463962774|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
128909728|NCT00209339|463962774|FG000|At 12 Months Follow-up|Death|1|||
128909729|NCT00209339|463962774|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
128909730|NCT00209339|463962774|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
128696804|NCT03166735|463188891|FG004|Overall Study|follow-up not completed as planned|1|||
128696805|NCT03166735|463188887|FG000|Overall Study|Withdrawal by Subject|0|||
128696806|NCT03166735|463188888|FG001|Overall Study|Withdrawal by Subject|0|||
128696807|NCT03166735|463188889|FG002|Overall Study|Withdrawal by Subject|1|||
128696808|NCT03166735|463188890|FG003|Overall Study|Withdrawal by Subject|1|||
128696809|NCT03166735|463188891|FG004|Overall Study|Withdrawal by Subject|2|||
128909731|NCT00209339|463962774|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
128909732|NCT00209339|463962774|FG000|At 24 Months Follow-up|Death|1|||
128909733|NCT00209339|463962774|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
128909734|NCT00209339|463962774|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
128909735|NCT00209339|463962774|FG000|At 4 Years Follow-up|Death|1|||
128909736|NCT00209339|463962774|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
128909737|NCT00209339|463962774|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
128909738|NCT00209339|463962774|FG000|At 5 Years Follow-up|Death|1|||
128909739|NCT01764633|463962775|FG000|Overall Study|Withdrawal by Subject|105|||
128909740|NCT01764633|463962776|FG001|Overall Study|Withdrawal by Subject|88|||
128909741|NCT01764633|463962775|FG000|Overall Study|Lost to Follow-up|13|||
128909742|NCT01764633|463962776|FG001|Overall Study|Lost to Follow-up|5|||
128909743|NCT00704964|463962777|FG000|Overall Study|Not completed on time|328|||
128909744|NCT04418765|463962778|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
128909745|NCT04418765|463962779|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
128909746|NCT04418765|463962780|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
129117905|NCT01787552|464727482|FG002|Overall Study|Study terminated by Sponsor|1|||
129117906|NCT01787552|464727483|FG003|Overall Study|Study terminated by Sponsor|3|||
128696810|NCT03166735|463188887|FG000|Overall Study|Lost to Follow-up|0|||
128696811|NCT03166735|463188888|FG001|Overall Study|Lost to Follow-up|2|||
128696812|NCT03166735|463188889|FG002|Overall Study|Lost to Follow-up|1|||
128909747|NCT04418765|463962778|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
128909748|NCT04418765|463962779|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
128909749|NCT04418765|463962780|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
129117907|NCT01787552|464727480|FG000|Overall Study|Progressive Disease|2|||
129117908|NCT01787552|464727481|FG001|Overall Study|Progressive Disease|2|||
129117909|NCT01787552|464727482|FG002|Overall Study|Progressive Disease|1|||
129117910|NCT01787552|464727483|FG003|Overall Study|Progressive Disease|1|||
129117911|NCT02295644|464727484|FG000|Overall Study|Did not meet inclusion criterion|0|||
129117912|NCT02295644|464727485|FG001|Overall Study|Did not meet inclusion criterion|0|||
129117913|NCT02295644|464727486|FG002|Overall Study|Did not meet inclusion criterion|1|||
129117914|NCT02295644|464727487|FG003|Overall Study|Did not meet inclusion criterion|2|||
129117915|NCT04079790|464727489|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
129117916|NCT04079790|464727490|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
129117917|NCT04079790|464727491|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
129117918|NCT04079790|464727492|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
129117919|NCT04079790|464727489|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
129117920|NCT04079790|464727490|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
129117921|NCT04079790|464727491|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
129117922|NCT04079790|464727492|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
129117923|NCT04079790|464727489|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
129117924|NCT04079790|464727490|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
129117925|NCT04079790|464727491|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
129117926|NCT04079790|464727492|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
129117927|NCT00324155|464727493|FG000|Enrolled and Randomized|No longer met study criteria|3|||
129117928|NCT00324155|464727494|FG001|Enrolled and Randomized|No longer met study criteria|0|||
129117929|NCT00324155|464727493|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
129117930|NCT00324155|464727494|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
129117931|NCT00324155|464727493|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
129117932|NCT00324155|464727494|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
129117933|NCT00324155|464727493|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
129117934|NCT00324155|464727494|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
129117935|NCT00324155|464727493|FG000|Received Treatment in Induction Phase|Death|8|||
129117936|NCT00324155|464727494|FG001|Received Treatment in Induction Phase|Death|15|||
129117937|NCT00324155|464727493|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
129117938|NCT00324155|464727494|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
129117939|NCT00324155|464727493|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
129117940|NCT00324155|464727494|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
129117941|NCT00324155|464727493|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
129117942|NCT00324155|464727494|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
129117943|NCT00324155|464727493|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
129117944|NCT00324155|464727494|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
129117945|NCT00324155|464727493|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
129117946|NCT00324155|464727494|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
129117947|NCT00324155|464727493|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
129117948|NCT00324155|464727494|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
129117949|NCT00324155|464727493|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
129117950|NCT00324155|464727494|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
129117951|NCT00324155|464727493|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
129117952|NCT00324155|464727494|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
129117953|NCT00324155|464727493|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
129117954|NCT00324155|464727494|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
129117955|NCT00324155|464727493|FG000|Follow-up Phase|On-going participants still on drug|11|||
129117956|NCT00324155|464727494|FG001|Follow-up Phase|On-going participants still on drug|6|||
129117957|NCT00390689|464727495|FG000|Overall Study|Adverse Event|2|||
129117958|NCT00390689|464727496|FG001|Overall Study|Adverse Event|5|||
129117959|NCT00390689|464727497|FG002|Overall Study|Adverse Event|2|||
129117960|NCT00390689|464727495|FG000|Overall Study|Lack of Efficacy|0|||
129117961|NCT00390689|464727496|FG001|Overall Study|Lack of Efficacy|0|||
129117962|NCT00390689|464727497|FG002|Overall Study|Lack of Efficacy|1|||
129117963|NCT00390689|464727495|FG000|Overall Study|Protocol Violation|1|||
129117964|NCT00390689|464727496|FG001|Overall Study|Protocol Violation|0|||
129117965|NCT00390689|464727497|FG002|Overall Study|Protocol Violation|0|||
128909750|NCT04418765|463962778|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
129117966|NCT00390689|464727495|FG000|Overall Study|Investigator's judgement|2|||
129117967|NCT00390689|464727496|FG001|Overall Study|Investigator's judgement|0|||
129117968|NCT00390689|464727497|FG002|Overall Study|Investigator's judgement|0|||
129117969|NCT01253161|464727498|FG000|Overall Study|Adverse Event|1|||
129117970|NCT01924533|464727500|FG000|Overall Study|Death|181|||
129117971|NCT01924533|464727501|FG001|Overall Study|Death|200|||
129117972|NCT01924533|464727500|FG000|Overall Study|Lost to Follow-up|0|||
129117973|NCT01924533|464727501|FG001|Overall Study|Lost to Follow-up|1|||
129117974|NCT01924533|464727500|FG000|Overall Study|Withdrawal by Subject|7|||
128909751|NCT04418765|463962779|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
128909752|NCT04418765|463962780|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
128909753|NCT04418765|463962778|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
128909754|NCT04418765|463962779|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
128909755|NCT04418765|463962780|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
128909756|NCT04418765|463962778|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
128909757|NCT04418765|463962779|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
128909758|NCT04418765|463962780|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
128909759|NCT04418765|463962778|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
128909760|NCT04418765|463962779|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
128909761|NCT04418765|463962780|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
128909762|NCT04418765|463962778|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
128909763|NCT04418765|463962779|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
128909764|NCT04418765|463962780|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
128909765|NCT04418765|463962778|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
128909766|NCT04418765|463962779|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
128909767|NCT04418765|463962780|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
128909768|NCT04418765|463962778|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
128909769|NCT04418765|463962779|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
128909770|NCT04418765|463962780|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
128909771|NCT04418765|463962778|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
128909772|NCT04418765|463962779|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
128909773|NCT04418765|463962780|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
128909774|NCT04418765|463962778|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
128909775|NCT04418765|463962779|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
128909776|NCT04418765|463962780|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
128909777|NCT04418765|463962778|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
128909778|NCT04418765|463962779|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
128909779|NCT04418765|463962780|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
129117975|NCT01924533|464727501|FG001|Overall Study|Withdrawal by Subject|3|||
129117976|NCT01924533|464727500|FG000|Overall Study|Other Eligibility criteria|1|||
129117977|NCT01924533|464727501|FG001|Overall Study|Other Eligibility criteria|1|||
129117978|NCT03307174|464727503|FG000|Overall Study|Unplanned ICU Administrion|5|||
129117979|NCT03307174|464727504|FG001|Overall Study|Unplanned ICU Administrion|3|||
129117980|NCT03307174|464727503|FG000|Overall Study|Aborted Surgery|1|||
129117981|NCT03307174|464727504|FG001|Overall Study|Aborted Surgery|2|||
129117982|NCT03307174|464727503|FG000|Overall Study|Hypotension|6|||
129117983|NCT03307174|464727504|FG001|Overall Study|Hypotension|0|||
129117984|NCT03307174|464727503|FG000|Overall Study|Nonfunctional epidural|1|||
129117985|NCT03307174|464727504|FG001|Overall Study|Nonfunctional epidural|1|||
129117986|NCT03307174|464727503|FG000|Overall Study|Planned epidural removal|1|||
129117987|NCT03307174|464727504|FG001|Overall Study|Planned epidural removal|0|||
129117988|NCT03307174|464727503|FG000|Overall Study|Intrathecal catheter placement|0|||
129117989|NCT03307174|464727504|FG001|Overall Study|Intrathecal catheter placement|1|||
129117990|NCT04275336|464727505|FG000|Overall Study|First venipuncture failed|4|||
129117991|NCT04275336|464727506|FG001|Overall Study|First venipuncture failed|6|||
129117992|NCT04275336|464727507|FG002|Overall Study|First venipuncture failed|5|||
129117993|NCT04275336|464727505|FG000|Overall Study|Unscheduled venipuncture|9|||
129117994|NCT04275336|464727506|FG001|Overall Study|Unscheduled venipuncture|13|||
129117995|NCT04275336|464727507|FG002|Overall Study|Unscheduled venipuncture|7|||
129117996|NCT04275336|464727505|FG000|Overall Study|Failed specimen of saliva|4|||
129117997|NCT04275336|464727506|FG001|Overall Study|Failed specimen of saliva|3|||
129117998|NCT04275336|464727507|FG002|Overall Study|Failed specimen of saliva|4|||
129117999|NCT03055936|464727508|FG000|Overall Study|Adverse Event|0|||
129118000|NCT03055936|464727509|FG001|Overall Study|Adverse Event|1|||
129118001|NCT03055936|464727510|FG002|Overall Study|Adverse Event|1|||
129118002|NCT03055936|464727511|FG003|Overall Study|Adverse Event|1|||
129118003|NCT03055936|464727508|FG000|Overall Study|Personal reason|2|||
129118004|NCT03055936|464727509|FG001|Overall Study|Personal reason|0|||
129118005|NCT03055936|464727510|FG002|Overall Study|Personal reason|1|||
129118006|NCT03055936|464727511|FG003|Overall Study|Personal reason|0|||
129118007|NCT00721799|464727526|FG000|Overall Study|Withdrawal by Subject|7|||
129118008|NCT00721799|464727526|FG000|Overall Study|withdraw by subject after scan 1|1|||
129118009|NCT03141359|464727527|FG000|Overall Study|Death|32|||
129118010|NCT03141359|464727527|FG000|Overall Study|Still On Study (in follow up)|29|||
129118011|NCT01081626|464727528|FG000|Overall Study|Dosing error|1|||
129118012|NCT01081626|464727529|FG001|Overall Study|Dosing error|1|||
129118013|NCT01081626|464727528|FG000|Overall Study|Missing Estradiol|25|||
129118014|NCT01081626|464727529|FG001|Overall Study|Missing Estradiol|28|||
129118015|NCT01081626|464727528|FG000|Overall Study|Low antral follicle count|1|||
128909780|NCT04418765|463962778|FG000|Extension Period (48 Weeks)|Other than specified|0|||
128909781|NCT04418765|463962779|FG001|Extension Period (48 Weeks)|Other than specified|5|||
128909782|NCT04418765|463962780|FG002|Extension Period (48 Weeks)|Other than specified|2|||
128909783|NCT01121393|463962781|FG000|Overall Study|Progressive disease|201|||
128909784|NCT01121393|463962782|FG001|Overall Study|Progressive disease|20|||
128909785|NCT01121393|463962781|FG000|Overall Study|Other Adverse events|24|||
128909786|NCT01121393|463962782|FG001|Overall Study|Other Adverse events|45|||
128909787|NCT01121393|463962781|FG000|Overall Study|Non-compliant with protocol|0|||
128909788|NCT01121393|463962782|FG001|Overall Study|Non-compliant with protocol|3|||
128909789|NCT01121393|463962781|FG000|Overall Study|Lost to Follow-up|1|||
128909790|NCT01121393|463962782|FG001|Overall Study|Lost to Follow-up|0|||
128909791|NCT01121393|463962781|FG000|Overall Study|Refused cont. medication|7|||
128909792|NCT01121393|463962782|FG001|Overall Study|Refused cont. medication|7|||
128909793|NCT01121393|463962781|FG000|Overall Study|Not treated|3|||
128909794|NCT01121393|463962782|FG001|Overall Study|Not treated|9|||
128909795|NCT01121393|463962781|FG000|Overall Study|Other than listed|6|||
128909796|NCT01121393|463962782|FG001|Overall Study|Other than listed|0|||
128909797|NCT02574637|463962784|FG000|Double-blind Period|Adverse Event|1|||
128909798|NCT02574637|463962785|FG001|Double-blind Period|Adverse Event|0|||
128909799|NCT02574637|463962786|FG002|Double-blind Period|Adverse Event|0|||
128909800|NCT02574637|463962787|FG003|Double-blind Period|Adverse Event|0|||
128909801|NCT02574637|463962788|FG004|Double-blind Period|Adverse Event|0|||
128909802|NCT02574637|463962789|FG005|Double-blind Period|Adverse Event|0|||
128909803|NCT02574637|463962790|FG006|Double-blind Period|Adverse Event|0|||
128909804|NCT02574637|463962791|FG007|Double-blind Period|Adverse Event|0|||
128909805|NCT02574637|463962792|FG008|Double-blind Period|Adverse Event|0|||
128909806|NCT02574637|463962793|FG009|Double-blind Period|Adverse Event|0|||
128909807|NCT02574637|463962784|FG000|Double-blind Period|Lack of Efficacy|0|||
128909808|NCT02574637|463962785|FG001|Double-blind Period|Lack of Efficacy|0|||
128909809|NCT02574637|463962786|FG002|Double-blind Period|Lack of Efficacy|2|||
128909810|NCT02574637|463962787|FG003|Double-blind Period|Lack of Efficacy|0|||
128909811|NCT02574637|463962788|FG004|Double-blind Period|Lack of Efficacy|0|||
128909812|NCT02574637|463962789|FG005|Double-blind Period|Lack of Efficacy|0|||
128909813|NCT02574637|463962790|FG006|Double-blind Period|Lack of Efficacy|0|||
128909814|NCT02574637|463962791|FG007|Double-blind Period|Lack of Efficacy|0|||
128909815|NCT02574637|463962792|FG008|Double-blind Period|Lack of Efficacy|0|||
128909816|NCT02574637|463962793|FG009|Double-blind Period|Lack of Efficacy|0|||
128909817|NCT02574637|463962784|FG000|Double-blind Period|Protocol Deviation|1|||
128909818|NCT02574637|463962785|FG001|Double-blind Period|Protocol Deviation|0|||
128909819|NCT02574637|463962786|FG002|Double-blind Period|Protocol Deviation|0|||
128909820|NCT02574637|463962787|FG003|Double-blind Period|Protocol Deviation|0|||
128909821|NCT02574637|463962788|FG004|Double-blind Period|Protocol Deviation|0|||
128909822|NCT02574637|463962789|FG005|Double-blind Period|Protocol Deviation|0|||
128909823|NCT02574637|463962790|FG006|Double-blind Period|Protocol Deviation|0|||
128909824|NCT02574637|463962791|FG007|Double-blind Period|Protocol Deviation|0|||
128909825|NCT02574637|463962792|FG008|Double-blind Period|Protocol Deviation|0|||
128909826|NCT02574637|463962793|FG009|Double-blind Period|Protocol Deviation|0|||
128909827|NCT02574637|463962784|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
128909828|NCT02574637|463962785|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
128909829|NCT02574637|463962786|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
128909830|NCT02574637|463962787|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
128909831|NCT02574637|463962788|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
128909832|NCT02574637|463962789|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
128909833|NCT02574637|463962790|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
128909834|NCT02574637|463962791|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
128909835|NCT02574637|463962792|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
129027946|NCT01911429|464392802|FG001|Overall Study|Withdrawal by Subject|5|||
129027947|NCT01911429|464392803|FG002|Overall Study|Withdrawal by Subject|4|||
129027948|NCT01911429|464392801|FG000|Overall Study|Accidental randomization|0|||
129027949|NCT01911429|464392802|FG001|Overall Study|Accidental randomization|0|||
129027950|NCT01911429|464392803|FG002|Overall Study|Accidental randomization|1|||
129027951|NCT01911429|464392801|FG000|Overall Study|subject left study|1|||
129027952|NCT01911429|464392802|FG001|Overall Study|subject left study|0|||
129027953|NCT01911429|464392803|FG002|Overall Study|subject left study|0|||
129027954|NCT01168856|464392817|FG000|Overall Study|Lost to Follow-up|4|||
129027955|NCT01168856|464392818|FG001|Overall Study|Lost to Follow-up|34|||
129027956|NCT01168856|464392817|FG000|Overall Study|Withdrawal by Subject|6|||
128909836|NCT02574637|463962793|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
128909837|NCT02574637|463962784|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
128909838|NCT02574637|463962785|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
128909839|NCT02574637|463962786|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
128909840|NCT02574637|463962787|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
128909841|NCT02574637|463962788|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
128909842|NCT02574637|463962789|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
128909843|NCT02574637|463962790|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
128909844|NCT02574637|463962791|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
128909845|NCT02574637|463962792|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
128909846|NCT02574637|463962793|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
128909847|NCT02574637|463962784|FG000|Double-blind Period|Reason Not Specified|0|||
128909848|NCT02574637|463962785|FG001|Double-blind Period|Reason Not Specified|0|||
128909849|NCT02574637|463962786|FG002|Double-blind Period|Reason Not Specified|0|||
128909850|NCT02574637|463962787|FG003|Double-blind Period|Reason Not Specified|1|||
128909851|NCT02574637|463962788|FG004|Double-blind Period|Reason Not Specified|0|||
128909852|NCT02574637|463962789|FG005|Double-blind Period|Reason Not Specified|0|||
128909853|NCT02574637|463962790|FG006|Double-blind Period|Reason Not Specified|0|||
128909854|NCT02574637|463962791|FG007|Double-blind Period|Reason Not Specified|0|||
128909855|NCT02574637|463962792|FG008|Double-blind Period|Reason Not Specified|0|||
128909856|NCT02574637|463962793|FG009|Double-blind Period|Reason Not Specified|0|||
128909857|NCT02574637|463962784|FG000|Open-label (OL) Period|Adverse Event|0|||
128909858|NCT02574637|463962785|FG001|Open-label (OL) Period|Adverse Event|0|||
128909859|NCT02574637|463962786|FG002|Open-label (OL) Period|Adverse Event|0|||
128909860|NCT02574637|463962787|FG003|Open-label (OL) Period|Adverse Event|0|||
128909861|NCT02574637|463962788|FG004|Open-label (OL) Period|Adverse Event|0|||
128909862|NCT02574637|463962789|FG005|Open-label (OL) Period|Adverse Event|0|||
128909863|NCT02574637|463962790|FG006|Open-label (OL) Period|Adverse Event|0|||
128909864|NCT02574637|463962791|FG007|Open-label (OL) Period|Adverse Event|0|||
128909865|NCT02574637|463962792|FG008|Open-label (OL) Period|Adverse Event|1|||
128909866|NCT02574637|463962793|FG009|Open-label (OL) Period|Adverse Event|0|||
128909867|NCT02574637|463962784|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
128909868|NCT02574637|463962785|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
128909869|NCT02574637|463962786|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
128909870|NCT02574637|463962787|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
128909871|NCT02574637|463962788|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
128909872|NCT02574637|463962789|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
128909873|NCT02574637|463962790|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
128909874|NCT02574637|463962791|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
128909875|NCT02574637|463962792|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
128909876|NCT02574637|463962793|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
128909877|NCT02574637|463962784|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
128909878|NCT02574637|463962785|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
128909879|NCT02574637|463962786|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
128909880|NCT02574637|463962787|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
128909881|NCT02574637|463962788|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
128909882|NCT02574637|463962789|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
128909883|NCT02574637|463962790|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
128909884|NCT02574637|463962791|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
128909885|NCT02574637|463962792|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
128909886|NCT02574637|463962793|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
128909887|NCT04016311|463962795|FG000|Overall Study|Withdrawal by Subject|1|||
128909888|NCT04016311|463962796|FG001|Overall Study|Withdrawal by Subject|0|||
128909889|NCT04029519|463962798|FG000|Overall Study|Protocol Violation|1|||
128909890|NCT04029519|463962798|FG000|Overall Study|Withdrawal by Subject|3|||
128909891|NCT04029519|463962798|FG000|Overall Study|Lost to Follow-up|1|||
128909892|NCT02064387|463962799|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909893|NCT02064387|463962800|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909894|NCT02064387|463962801|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909895|NCT02064387|463962802|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909896|NCT02064387|463962803|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909897|NCT02064387|463962804|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909898|NCT02064387|463962805|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909899|NCT02064387|463962806|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
128909900|NCT02064387|463962807|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909901|NCT02064387|463962808|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
128909902|NCT02064387|463962809|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909903|NCT02064387|463962810|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
128909904|NCT02064387|463962799|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909905|NCT02064387|463962800|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909906|NCT02064387|463962801|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129027957|NCT01168856|464392818|FG001|Overall Study|Withdrawal by Subject|8|||
129027958|NCT01168856|464392817|FG000|Overall Study|Physician Decision|2|||
128909907|NCT02064387|463962802|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909908|NCT02064387|463962803|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909909|NCT02064387|463962804|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909910|NCT02064387|463962805|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909911|NCT02064387|463962806|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
128909912|NCT02064387|463962807|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909913|NCT02064387|463962808|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129118016|NCT01081626|464727529|FG001|Overall Study|Low antral follicle count|0|||
129118017|NCT01081626|464727528|FG000|Overall Study|Overstimulation|0|||
129118018|NCT01081626|464727529|FG001|Overall Study|Overstimulation|1|||
129118019|NCT01081626|464727528|FG000|Overall Study|Lost to Follow-up|0|||
129118020|NCT01081626|464727529|FG001|Overall Study|Lost to Follow-up|1|||
129118021|NCT01081626|464727528|FG000|Overall Study|Other|33|||
129118022|NCT01081626|464727529|FG001|Overall Study|Other|30|||
129118023|NCT04158219|464727530|FG000|Overall Study|Lost to Follow-up|1|||
129118024|NCT02074514|464727531|FG000|Overall Study|Lack of Efficacy|3|||
129118025|NCT02074514|464727532|FG001|Overall Study|Lack of Efficacy|2|||
129118026|NCT02074514|464727531|FG000|Overall Study|Lost to Follow-up|0|||
129118027|NCT02074514|464727532|FG001|Overall Study|Lost to Follow-up|1|||
129118028|NCT02074514|464727531|FG000|Overall Study|Withdrew Consent|0|||
129118029|NCT02074514|464727532|FG001|Overall Study|Withdrew Consent|1|||
129118030|NCT02873689|464728873|FG000|Overall Study|Lack of Efficacy|1|||
129118031|NCT02873689|464728874|FG001|Overall Study|Lack of Efficacy|0|||
129118032|NCT02873689|464728873|FG000|Overall Study|Withdrawal by Subject|2|||
129118033|NCT02873689|464728874|FG001|Overall Study|Withdrawal by Subject|2|||
129118034|NCT02873689|464728873|FG000|Overall Study|Protocol Violation|1|||
129118035|NCT02873689|464728874|FG001|Overall Study|Protocol Violation|0|||
129118036|NCT02873689|464728873|FG000|Overall Study|Adverse Event|2|||
129118037|NCT02873689|464728874|FG001|Overall Study|Adverse Event|2|||
129118038|NCT02873689|464728873|FG000|Overall Study|Randomized but not Treated|1|||
129118039|NCT02873689|464728874|FG001|Overall Study|Randomized but not Treated|1|||
129118040|NCT00350545|464728875|FG000|Overall Study|Withdrawal by Subject|2|||
129118041|NCT01458587|464728888|FG000|Overall Study|Withdrawal by Subject|1|||
128696813|NCT03166735|463188890|FG003|Overall Study|Lost to Follow-up|0|||
128696814|NCT03166735|463188891|FG004|Overall Study|Lost to Follow-up|1|||
128696815|NCT03372096|463188895|FG000|Overall Study|Study Closed|8|||
128696816|NCT00040365|463188896|FG000|Overall Study|Death|1|||
128696817|NCT00040365|463188896|FG000|Overall Study|Progressive disease|7|||
128696818|NCT00040365|463188896|FG000|Overall Study|Lost to Follow-up|3|||
129118042|NCT01458587|464728889|FG001|Overall Study|Withdrawal by Subject|0|||
129118043|NCT01603602|464728890|FG000|Overall Study|Adverse Event|1|||
129118044|NCT01603602|464728891|FG001|Overall Study|Adverse Event|0|||
129118045|NCT01603602|464728892|FG002|Overall Study|Adverse Event|0|||
129118046|NCT01603602|464728890|FG000|Overall Study|Personal Reasons|1|||
129118047|NCT01603602|464728891|FG001|Overall Study|Personal Reasons|0|||
129118048|NCT01603602|464728892|FG002|Overall Study|Personal Reasons|1|||
129118049|NCT04748718|464728895|FG000|Overall Study|Lost to Follow-up|50|||
129118050|NCT01065818|464728896|FG000|Overall Study|Withdrawal by Subject|1|||
129118051|NCT01065818|464728896|FG000|Overall Study|Not a candidate for surgery|1|||
129118052|NCT01450813|464728897|FG000|Overall Study|Physician Decision|1|||
129118053|NCT01450813|464728898|FG001|Overall Study|Physician Decision|1|||
129118054|NCT01450813|464728899|FG002|Overall Study|Physician Decision|0|||
129118055|NCT01450813|464728900|FG003|Overall Study|Physician Decision|3|||
129118056|NCT01935089|464728902|FG000|Overall Study|Adverse Event|2|||
129118057|NCT01935089|464728902|FG000|Overall Study|Withdrawal by Subject|1|||
129118058|NCT02337491|464728906|FG000|Overall Study|Death|1|||
129118059|NCT02337491|464728907|FG001|Overall Study|Death|1|||
129118060|NCT02337491|464728906|FG000|Overall Study|Adverse Event|0|||
129118061|NCT02337491|464728907|FG001|Overall Study|Adverse Event|1|||
129118062|NCT02337491|464728906|FG000|Overall Study|Withdrawal by Subject|3|||
129118063|NCT02337491|464728907|FG001|Overall Study|Withdrawal by Subject|0|||
129118064|NCT02337491|464728906|FG000|Overall Study|Progressive Disease|44|||
129118065|NCT02337491|464728907|FG001|Overall Study|Progressive Disease|28|||
129118066|NCT02337491|464728906|FG000|Overall Study|On Treatment|2|||
129118067|NCT02337491|464728907|FG001|Overall Study|On Treatment|0|||
129118068|NCT00723229|464728908|FG000|First Intervention|Lost to Follow-up|7|||
129118069|NCT00723229|464728909|FG001|First Intervention|Lost to Follow-up|3|||
129118070|NCT01483118|464728914|FG000|Overall Study|Lost to Follow-up|12|||
129118071|NCT01483118|464728915|FG001|Overall Study|Lost to Follow-up|16|||
129118072|NCT01079780|464728917|FG000|Overall Study|Disease progression|43|||
129118073|NCT01079780|464728918|FG001|Overall Study|Disease progression|7|||
129118074|NCT01079780|464728919|FG002|Overall Study|Disease progression|31|||
128696819|NCT00541931|463188897|FG000|Overall Study|Adverse Event|1|||
128696820|NCT00541931|463188898|FG001|Overall Study|Adverse Event|0|||
129118075|NCT01079780|464728917|FG000|Overall Study|Adverse Event|13|||
129118076|NCT01079780|464728918|FG001|Overall Study|Adverse Event|5|||
129118077|NCT01079780|464728919|FG002|Overall Study|Adverse Event|7|||
129118078|NCT01079780|464728917|FG000|Overall Study|Death|2|||
128696821|NCT00541931|463188897|FG000|Overall Study|Lost to Follow-up|3|||
128696822|NCT00541931|463188898|FG001|Overall Study|Lost to Follow-up|3|||
129118079|NCT01079780|464728918|FG001|Overall Study|Death|0|||
129118080|NCT01079780|464728919|FG002|Overall Study|Death|2|||
129118081|NCT01079780|464728917|FG000|Overall Study|Withdrawal by Subject|6|||
129118082|NCT01079780|464728918|FG001|Overall Study|Withdrawal by Subject|4|||
129118083|NCT01079780|464728919|FG002|Overall Study|Withdrawal by Subject|4|||
129118084|NCT01079780|464728917|FG000|Overall Study|Alternative therapy|2|||
129118085|NCT01079780|464728918|FG001|Overall Study|Alternative therapy|0|||
128909914|NCT02064387|463962809|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909915|NCT02064387|463962810|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
128909916|NCT02064387|463962799|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128696823|NCT00541931|463188897|FG000|Overall Study|Withdrawal by Subject|1|||
128696824|NCT00541931|463188898|FG001|Overall Study|Withdrawal by Subject|0|||
128909917|NCT02064387|463962800|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128696825|NCT00541931|463188897|FG000|Overall Study|Transportation Issue|0|||
128696826|NCT00541931|463188898|FG001|Overall Study|Transportation Issue|1|||
128696827|NCT00680017|463188899|FG000|Overall Study|Adverse Event|13|||
128909918|NCT02064387|463962801|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909919|NCT02064387|463962802|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909920|NCT02064387|463962803|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909921|NCT02064387|463962804|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909922|NCT02064387|463962805|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909923|NCT02064387|463962806|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909924|NCT02064387|463962807|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
128909925|NCT02064387|463962808|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129027959|NCT01168856|464392818|FG001|Overall Study|Physician Decision|1|||
129027960|NCT01168856|464392817|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
129027961|NCT01168856|464392818|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
129027962|NCT01168856|464392817|FG000|Overall Study|Participant received anti-HCV treatment|1|||
129027963|NCT01168856|464392818|FG001|Overall Study|Participant received anti-HCV treatment|0|||
129027964|NCT01168856|464392817|FG000|Overall Study|Death|0|||
129027965|NCT01168856|464392818|FG001|Overall Study|Death|2|||
129027966|NCT01168856|464392817|FG000|Overall Study|Other|1|||
129027967|NCT01168856|464392818|FG001|Overall Study|Other|291|||
129027968|NCT01168856|464392817|FG000|Overall Study|Protocol Violation|4|||
129027969|NCT01168856|464392818|FG001|Overall Study|Protocol Violation|6|||
129027970|NCT04567329|464392823|FG000|Overall Study|Withdrawal by Subject|5|||
129027971|NCT04567329|464392824|FG001|Overall Study|Withdrawal by Subject|6|||
129027972|NCT04567329|464392823|FG000|Overall Study|Protocol Violation|2|||
129027973|NCT04567329|464392824|FG001|Overall Study|Protocol Violation|3|||
129027974|NCT04567329|464392823|FG000|Overall Study|Discontinued|2|||
129027975|NCT04567329|464392824|FG001|Overall Study|Discontinued|2|||
129027976|NCT04567329|464392823|FG000|Overall Study|Lost to Follow-up|0|||
129027977|NCT04567329|464392824|FG001|Overall Study|Lost to Follow-up|1|||
129027978|NCT04567329|464392823|FG000|Overall Study|Lack of Efficacy|0|||
129027979|NCT04567329|464392824|FG001|Overall Study|Lack of Efficacy|1|||
129027980|NCT00674128|464392826|FG000|Overall Study|Withdrawal by Subject|25|||
129027981|NCT00674128|464392827|FG001|Overall Study|Withdrawal by Subject|23|||
129027982|NCT00829452|464392831|FG000|First Intervention|Withdrawal by Subject|0|||
129027983|NCT00829452|464392832|FG001|First Intervention|Withdrawal by Subject|1|||
129027984|NCT00829452|464392831|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
129027985|NCT00829452|464392832|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
129027986|NCT00829452|464392831|FG000|Second Intervention|Physician Decision|0|||
129027987|NCT00829452|464392832|FG001|Second Intervention|Physician Decision|1|||
129027988|NCT01559363|464392850|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
129027989|NCT01559363|464392851|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
129027990|NCT01559363|464392852|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
129027991|NCT01559363|464392853|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
129027992|NCT01559363|464392854|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
129027993|NCT01559363|464392855|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
129027994|NCT01559363|464392850|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
129027995|NCT01559363|464392851|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
129027996|NCT01559363|464392852|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
129027997|NCT01559363|464392853|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
129027998|NCT01559363|464392854|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
129027999|NCT01559363|464392855|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
129028000|NCT01559363|464392850|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
129028001|NCT01559363|464392851|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
129028002|NCT01559363|464392852|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129028003|NCT01559363|464392853|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129028004|NCT01559363|464392854|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129028005|NCT01559363|464392855|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129028006|NCT01559363|464392850|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
129028007|NCT01559363|464392851|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
129028008|NCT01559363|464392852|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
129028009|NCT01559363|464392853|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
128696828|NCT00680017|463188900|FG001|Overall Study|Adverse Event|7|||
129028010|NCT01559363|464392854|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
129028011|NCT01559363|464392855|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
128696829|NCT00680017|463188899|FG000|Overall Study|Withdrawal by Subject|2|||
128696830|NCT00680017|463188900|FG001|Overall Study|Withdrawal by Subject|5|||
128696831|NCT00680017|463188899|FG000|Overall Study|Lost to Follow-up|2|||
128696832|NCT00680017|463188900|FG001|Overall Study|Lost to Follow-up|0|||
128696833|NCT02555683|463188901|FG000|Overall Study|Physician Decision|1|||
128696834|NCT02555683|463188902|FG001|Overall Study|Physician Decision|0|||
128696835|NCT02555683|463188903|FG002|Overall Study|Physician Decision|2|||
128696836|NCT02555683|463188901|FG000|Overall Study|Lost to Follow-up|2|||
128696837|NCT02555683|463188902|FG001|Overall Study|Lost to Follow-up|1|||
128696838|NCT02555683|463188903|FG002|Overall Study|Lost to Follow-up|2|||
128696839|NCT02555683|463188901|FG000|Overall Study|Technical Problems|1|||
128696840|NCT02555683|463188902|FG001|Overall Study|Technical Problems|1|||
128696841|NCT02555683|463188903|FG002|Overall Study|Technical Problems|0|||
128696842|NCT02555683|463188901|FG000|Overall Study|Protocol deviation|0|||
128696843|NCT02555683|463188902|FG001|Overall Study|Protocol deviation|1|||
128696844|NCT02555683|463188903|FG002|Overall Study|Protocol deviation|0|||
128696845|NCT02555683|463188901|FG000|Overall Study|Lack of Efficacy|2|||
128696846|NCT02555683|463188902|FG001|Overall Study|Lack of Efficacy|0|||
128696847|NCT02555683|463188903|FG002|Overall Study|Lack of Efficacy|0|||
128909926|NCT02064387|463962809|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909927|NCT02064387|463962810|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
128909928|NCT02064387|463962799|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
128909929|NCT02064387|463962800|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
128909930|NCT02064387|463962801|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
128909931|NCT02064387|463962802|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
128909932|NCT02064387|463962803|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
128909933|NCT02064387|463962804|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
128909934|NCT02064387|463962805|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
128909935|NCT02064387|463962806|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
128909936|NCT02064387|463962807|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
128909937|NCT02064387|463962808|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
128909938|NCT02064387|463962809|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
128909939|NCT02064387|463962810|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
128909940|NCT02064387|463962799|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909941|NCT02064387|463962800|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909942|NCT02064387|463962801|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909943|NCT02064387|463962802|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909944|NCT02064387|463962803|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909945|NCT02064387|463962804|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909946|NCT02064387|463962805|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909947|NCT02064387|463962806|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909948|NCT02064387|463962807|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909949|NCT02064387|463962808|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129118086|NCT01079780|464728919|FG002|Overall Study|Alternative therapy|2|||
129118087|NCT01079780|464728917|FG000|Overall Study|Physician Decision|1|||
129118088|NCT01079780|464728918|FG001|Overall Study|Physician Decision|0|||
129118089|NCT01079780|464728919|FG002|Overall Study|Physician Decision|1|||
129118090|NCT01079780|464728917|FG000|Overall Study|Error made in lesion measurement|1|||
129118091|NCT01079780|464728918|FG001|Overall Study|Error made in lesion measurement|0|||
129118092|NCT01079780|464728919|FG002|Overall Study|Error made in lesion measurement|0|||
129118093|NCT01079780|464728917|FG000|Overall Study|Patient had surgery|1|||
129118094|NCT01079780|464728918|FG001|Overall Study|Patient had surgery|0|||
129118095|NCT01079780|464728919|FG002|Overall Study|Patient had surgery|0|||
129118096|NCT01079780|464728917|FG000|Overall Study|Treatment cycle delay|0|||
129118097|NCT01079780|464728918|FG001|Overall Study|Treatment cycle delay|0|||
129118098|NCT01079780|464728919|FG002|Overall Study|Treatment cycle delay|1|||
129118099|NCT01079780|464728917|FG000|Overall Study|Never started treatment|1|||
129118100|NCT01079780|464728918|FG001|Overall Study|Never started treatment|0|||
129118101|NCT01079780|464728919|FG002|Overall Study|Never started treatment|2|||
129118102|NCT03435055|464728920|FG000|Screening|Physician Decision|2|||
129118103|NCT03435055|464728920|FG000|Received Intervention|Did not complete nitrous administration|3|||
128696848|NCT02555683|463188901|FG000|Overall Study|Death|0|||
128696849|NCT02555683|463188902|FG001|Overall Study|Death|1|||
128696850|NCT02555683|463188903|FG002|Overall Study|Death|2|||
128696851|NCT02555683|463188901|FG000|Overall Study|Adverse Event|1|||
128696852|NCT02555683|463188902|FG001|Overall Study|Adverse Event|0|||
128696853|NCT02555683|463188903|FG002|Overall Study|Adverse Event|1|||
128717875|NCT02447081|463264070|FG000|Overall Study|Lost to Follow-up|36|||
128717876|NCT02447081|463264070|FG000|Overall Study|Visit not completed|17|||
128717877|NCT02447081|463264070|FG000|Overall Study|unsuccessful implant procedure|10|||
129118104|NCT03712280|464728921|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
129118105|NCT03712280|464728922|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
129118106|NCT03712280|464728923|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
129215332|NCT00463567|465091131|FG006|Overall Study|Lack of Efficacy|1|||
129215333|NCT00463567|465091125|FG000|Overall Study|Abnormal lab value(s)|1|||
129215334|NCT00463567|465091126|FG001|Overall Study|Abnormal lab value(s)|1|||
129215335|NCT00463567|465091127|FG002|Overall Study|Abnormal lab value(s)|2|||
129215336|NCT00463567|465091128|FG003|Overall Study|Abnormal lab value(s)|1|||
129215337|NCT00463567|465091129|FG004|Overall Study|Abnormal lab value(s)|1|||
129215338|NCT00463567|465091130|FG005|Overall Study|Abnormal lab value(s)|0|||
129215339|NCT00463567|465091131|FG006|Overall Study|Abnormal lab value(s)|0|||
129215340|NCT00463567|465091125|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129215341|NCT00463567|465091126|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129215342|NCT00463567|465091127|FG002|Overall Study|Abnormal test procedure result(s)|6|||
129215343|NCT00463567|465091128|FG003|Overall Study|Abnormal test procedure result(s)|2|||
129215344|NCT00463567|465091129|FG004|Overall Study|Abnormal test procedure result(s)|0|||
129215345|NCT00463567|465091130|FG005|Overall Study|Abnormal test procedure result(s)|2|||
129215346|NCT00463567|465091131|FG006|Overall Study|Abnormal test procedure result(s)|0|||
129215347|NCT00463567|465091125|FG000|Overall Study|Death|1|||
129215348|NCT00463567|465091126|FG001|Overall Study|Death|0|||
129215349|NCT00463567|465091127|FG002|Overall Study|Death|2|||
129215350|NCT00463567|465091128|FG003|Overall Study|Death|0|||
129215351|NCT00463567|465091129|FG004|Overall Study|Death|0|||
129215352|NCT00463567|465091130|FG005|Overall Study|Death|0|||
129215353|NCT00463567|465091131|FG006|Overall Study|Death|0|||
129215354|NCT01524796|465091133|FG000|Overall Study|Adverse Event|13|||
129215355|NCT01524796|465091133|FG000|Overall Study|Lack of Efficacy|3|||
129215356|NCT01524796|465091133|FG000|Overall Study|Lost to Follow-up|1|||
129215357|NCT01524796|465091133|FG000|Overall Study|The price|1|||
129215358|NCT01524796|465091133|FG000|Overall Study|Withdrawal by Subject|4|||
129215359|NCT01524796|465091133|FG000|Overall Study|Move|1|||
129215360|NCT01524796|465091133|FG000|Overall Study|Deterioration of pains|1|||
129215361|NCT01524796|465091133|FG000|Overall Study|Gall stone surgery|1|||
129215362|NCT01524796|465091133|FG000|Overall Study|Nervous about confidentiality|1|||
129215363|NCT01524796|465091133|FG000|Overall Study|Switch to carbamazapine|1|||
129215364|NCT01524796|465091133|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
129215365|NCT00956007|465091136|FG000|Overall Study|Protocol Violation|27|||
129215366|NCT00956007|465091137|FG001|Overall Study|Protocol Violation|23|||
129215367|NCT03774576|465091138|FG000|Period 2|Adverse Event|1|||
129215368|NCT00927953|465091139|FG000|Overall Study|Death|2|||
129215369|NCT00927953|465091140|FG001|Overall Study|Death|1|||
129215370|NCT02900378|465091141|FG000|Randomization (Visit 2)|Adverse Event|14|||
129215371|NCT02900378|465091142|FG001|Randomization (Visit 2)|Adverse Event|11|||
129215372|NCT02900378|465091141|FG000|Randomization (Visit 2)|Death|1|||
129215373|NCT02900378|465091142|FG001|Randomization (Visit 2)|Death|4|||
129215374|NCT02900378|465091141|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
129215375|NCT02900378|465091142|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
129215376|NCT02900378|465091141|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
129215377|NCT02900378|465091142|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
129215378|NCT02900378|465091141|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
129215379|NCT02900378|465091142|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
129215380|NCT02900378|465091141|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
129215381|NCT02900378|465091142|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
128696854|NCT02555683|463188901|FG000|Overall Study|Subject/guardian decision|12|||
128696855|NCT02555683|463188902|FG001|Overall Study|Subject/guardian decision|12|||
128696856|NCT02555683|463188903|FG002|Overall Study|Subject/guardian decision|22|||
128696857|NCT02555683|463188901|FG000|Overall Study|Death post Treatment/safety period|0|||
128696858|NCT02555683|463188902|FG001|Overall Study|Death post Treatment/safety period|1|||
128909950|NCT02064387|463962809|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
129028012|NCT01559363|464392850|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
128909951|NCT02064387|463962810|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
128909952|NCT02706730|463962811|FG000|Overall Study|Adverse Event|3|||
128909953|NCT02706730|463962811|FG000|Overall Study|Lack of Efficacy|5|||
128909954|NCT02706730|463962811|FG000|Overall Study|Withdrawal by Subject|11|||
128909955|NCT02706730|463962811|FG000|Overall Study|Study Terminated by Sponsor|11|||
128909956|NCT02706730|463962811|FG000|Overall Study|Subject chose not to receive injection|3|||
129028013|NCT01559363|464392851|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
129028014|NCT01559363|464392852|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129028015|NCT01559363|464392853|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129215382|NCT02900378|465091141|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
129215383|NCT02900378|465091142|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
129215384|NCT01249261|465091156|FG000|Overall Study|Withdrawal by Subject|1|||
129215385|NCT01249261|465091157|FG001|Overall Study|Withdrawal by Subject|0|||
129215386|NCT00482053|465091161|FG000|Inter-treatment Period|Disease progression|1|||
129215387|NCT01967940|465091163|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
129215388|NCT01967940|465091164|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
129215389|NCT01967940|465091165|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
129215390|NCT01967940|465091166|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
128909957|NCT02499029|463962812|FG000|Overall Study|Lost to Follow-up|2|||
128909958|NCT02499029|463962813|FG001|Overall Study|Lost to Follow-up|2|||
128909959|NCT02499029|463962812|FG000|Overall Study|Physician Decision|2|||
128909960|NCT02499029|463962813|FG001|Overall Study|Physician Decision|1|||
128909961|NCT02499029|463962812|FG000|Overall Study|Death|1|||
128909962|NCT02499029|463962813|FG001|Overall Study|Death|0|||
128909963|NCT01999582|463962814|FG000|Overall Study|Withdrawal by Subject|0|||
128909964|NCT01999582|463962815|FG001|Overall Study|Withdrawal by Subject|0|||
128909965|NCT01999582|463962816|FG002|Overall Study|Withdrawal by Subject|0|||
128909966|NCT01999582|463962817|FG003|Overall Study|Withdrawal by Subject|1|||
128909967|NCT01999582|463962818|FG004|Overall Study|Withdrawal by Subject|0|||
128909968|NCT01999582|463962819|FG005|Overall Study|Withdrawal by Subject|0|||
128909969|NCT01999582|463962814|FG000|Overall Study|Adverse Event|0|||
128909970|NCT01999582|463962815|FG001|Overall Study|Adverse Event|0|||
128909971|NCT01999582|463962816|FG002|Overall Study|Adverse Event|3|||
128909972|NCT01999582|463962817|FG003|Overall Study|Adverse Event|0|||
128909973|NCT01999582|463962818|FG004|Overall Study|Adverse Event|1|||
128909974|NCT01999582|463962819|FG005|Overall Study|Adverse Event|0|||
128909975|NCT01999582|463962814|FG000|Overall Study|Other Reasons|1|||
128909976|NCT01999582|463962815|FG001|Overall Study|Other Reasons|0|||
128909977|NCT01999582|463962816|FG002|Overall Study|Other Reasons|3|||
128909978|NCT01999582|463962817|FG003|Overall Study|Other Reasons|1|||
128909979|NCT01999582|463962818|FG004|Overall Study|Other Reasons|1|||
128909980|NCT01999582|463962819|FG005|Overall Study|Other Reasons|2|||
128909981|NCT01999582|463962814|FG000|Overall Study|Protocol Violation|1|||
128909982|NCT01999582|463962815|FG001|Overall Study|Protocol Violation|0|||
128909983|NCT01999582|463962816|FG002|Overall Study|Protocol Violation|0|||
128909984|NCT01999582|463962817|FG003|Overall Study|Protocol Violation|0|||
128909985|NCT01999582|463962818|FG004|Overall Study|Protocol Violation|0|||
128909986|NCT01999582|463962819|FG005|Overall Study|Protocol Violation|1|||
128909987|NCT01999582|463962814|FG000|Overall Study|Lack of Efficacy|1|||
128909988|NCT01999582|463962815|FG001|Overall Study|Lack of Efficacy|3|||
128909989|NCT01999582|463962816|FG002|Overall Study|Lack of Efficacy|0|||
128909990|NCT01999582|463962817|FG003|Overall Study|Lack of Efficacy|1|||
128909991|NCT01999582|463962818|FG004|Overall Study|Lack of Efficacy|0|||
128909992|NCT01999582|463962819|FG005|Overall Study|Lack of Efficacy|0|||
128909993|NCT03889639|463962822|FG000|Overall Study|Withdrawal by Subject|0|||
128909994|NCT03889639|463962823|FG001|Overall Study|Withdrawal by Subject|0|||
128909995|NCT03889639|463962824|FG002|Overall Study|Withdrawal by Subject|0|||
128909996|NCT03889639|463962825|FG003|Overall Study|Withdrawal by Subject|0|||
128909997|NCT03889639|463962826|FG004|Overall Study|Withdrawal by Subject|0|||
128909998|NCT03889639|463962827|FG005|Overall Study|Withdrawal by Subject|0|||
128909999|NCT03889639|463962828|FG006|Overall Study|Withdrawal by Subject|0|||
128910000|NCT03889639|463962829|FG007|Overall Study|Withdrawal by Subject|1|||
128910001|NCT01703858|463962830|FG000|Overall Study|Withdrawal by Subject|0|||
128910002|NCT01703858|463962831|FG001|Overall Study|Withdrawal by Subject|1|||
128910003|NCT01703858|463962832|FG002|Overall Study|Withdrawal by Subject|0|||
128910004|NCT00927095|463962833|FG000|Overall Study|Adverse Event|3|||
128910005|NCT00927095|463962834|FG001|Overall Study|Adverse Event|1|||
128910006|NCT00927095|463962835|FG002|Overall Study|Adverse Event|0|||
128910007|NCT00927095|463962833|FG000|Overall Study|Withdrawal by Subject|2|||
128910008|NCT00927095|463962834|FG001|Overall Study|Withdrawal by Subject|1|||
128910009|NCT00927095|463962835|FG002|Overall Study|Withdrawal by Subject|1|||
128910010|NCT00927095|463962833|FG000|Overall Study|Physician Decision|1|||
128910011|NCT00927095|463962834|FG001|Overall Study|Physician Decision|2|||
128910012|NCT00927095|463962835|FG002|Overall Study|Physician Decision|1|||
128910013|NCT01290692|463962836|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
128910014|NCT02556255|463962837|FG000|Overall Study|Lost to Follow-up|4|||
128910015|NCT00993031|463962841|FG000|Overall Study|Death|0|||
128910016|NCT00993031|463962842|FG001|Overall Study|Death|1|||
128910017|NCT00993031|463962841|FG000|Overall Study|Physician Decision|0|||
128910018|NCT00993031|463962842|FG001|Overall Study|Physician Decision|2|||
128910019|NCT00993031|463962841|FG000|Overall Study|Withdrawal by Subject|3|||
128910020|NCT00993031|463962842|FG001|Overall Study|Withdrawal by Subject|3|||
128910021|NCT00993031|463962841|FG000|Overall Study|Lost to Follow-up|19|||
128696859|NCT02555683|463188903|FG002|Overall Study|Death post Treatment/safety period|0|||
128910022|NCT00993031|463962842|FG001|Overall Study|Lost to Follow-up|13|||
128910023|NCT03115151|463962843|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
128910024|NCT03115151|463962844|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
128910025|NCT03115151|463962843|FG000|Overall Study|Epidural catheter removal|1|||
128910026|NCT03115151|463962844|FG001|Overall Study|Epidural catheter removal|0|||
128910027|NCT03115151|463962843|FG000|Overall Study|Withdrawal by Subject|0|||
128910028|NCT03115151|463962844|FG001|Overall Study|Withdrawal by Subject|1|||
129028016|NCT01559363|464392854|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
128910029|NCT03115151|463962843|FG000|Overall Study|Intervention not received according to the protocol.|1|||
128910030|NCT03115151|463962844|FG001|Overall Study|Intervention not received according to the protocol.|1|||
128696860|NCT05074667|463188904|FG000|Overall Study|Death|1|||
128910031|NCT03115151|463962843|FG000|Overall Study|Physician Decision|1|||
128910032|NCT03115151|463962844|FG001|Overall Study|Physician Decision|0|||
128910033|NCT03115151|463962843|FG000|Overall Study|Randomization not applied|1|||
128910034|NCT03115151|463962844|FG001|Overall Study|Randomization not applied|1|||
128910035|NCT01543087|463962850|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
128910036|NCT01543087|463962851|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
128910037|NCT01543087|463962852|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
128910038|NCT01543087|463962853|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
128910039|NCT01543087|463962854|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
128910040|NCT01543087|463962855|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
128910041|NCT01543087|463962850|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
128910042|NCT01543087|463962851|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
129118107|NCT03712280|464728924|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
129118108|NCT03712280|464728921|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
129118109|NCT03712280|464728922|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
129118110|NCT03712280|464728923|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
129118111|NCT03712280|464728924|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
129118112|NCT03712280|464728921|FG000|Overall Study|Adverse Event|0|||
129118113|NCT03712280|464728922|FG001|Overall Study|Adverse Event|0|||
129118114|NCT03712280|464728923|FG002|Overall Study|Adverse Event|1|||
129118115|NCT03712280|464728924|FG003|Overall Study|Adverse Event|0|||
129118116|NCT04494646|464728930|FG000|Overall Study|Adverse Event|0|||
129118117|NCT04494646|464728931|FG001|Overall Study|Adverse Event|1|||
129118118|NCT04494646|464728930|FG000|Overall Study|Withdrawal by Subject|0|||
129118119|NCT04494646|464728931|FG001|Overall Study|Withdrawal by Subject|1|||
129118120|NCT02785939|464728932|FG000|Overall Study|Progression|25|||
129118121|NCT02785939|464728933|FG001|Overall Study|Progression|8|||
129118122|NCT02785939|464728932|FG000|Overall Study|Adverse Event|3|||
129118123|NCT02785939|464728933|FG001|Overall Study|Adverse Event|1|||
129118124|NCT02785939|464728932|FG000|Overall Study|Death|1|||
129118125|NCT02785939|464728933|FG001|Overall Study|Death|0|||
129118126|NCT02785939|464728932|FG000|Overall Study|Refusal|1|||
129118127|NCT02785939|464728933|FG001|Overall Study|Refusal|0|||
129118128|NCT02785939|464728932|FG000|Overall Study|Deteriorating health|1|||
129118129|NCT02785939|464728933|FG001|Overall Study|Deteriorating health|0|||
129118130|NCT02785939|464728932|FG000|Overall Study|Not protocol specified|0|||
129118131|NCT02785939|464728933|FG001|Overall Study|Not protocol specified|1|||
129118132|NCT02147626|464728934|FG000|Overall Study|Lost to Follow-up|4|||
129118133|NCT02147626|464728935|FG001|Overall Study|Lost to Follow-up|4|||
129118134|NCT02147626|464728934|FG000|Overall Study|Pregnancy|1|||
129118135|NCT02147626|464728935|FG001|Overall Study|Pregnancy|2|||
129118136|NCT02147626|464728934|FG000|Overall Study|Withdrawal by Subject|0|||
129118137|NCT02147626|464728935|FG001|Overall Study|Withdrawal by Subject|1|||
129118138|NCT01704261|464728936|FG000|Overall Study|Withdrawal by Subject|12|||
129118139|NCT01704261|464728937|FG001|Overall Study|Withdrawal by Subject|15|||
129118140|NCT01704261|464728936|FG000|Overall Study|Lost to Follow-up|1|||
129118141|NCT01704261|464728937|FG001|Overall Study|Lost to Follow-up|0|||
129118142|NCT00846053|464728940|FG000|Overall Study|Physician Decision|3|||
129118143|NCT00846053|464728941|FG001|Overall Study|Physician Decision|0|||
129118144|NCT00467519|464728943|FG000|Overall Study|Protocol Violation|8|||
129118145|NCT00467519|464728944|FG001|Overall Study|Protocol Violation|4|||
129118146|NCT00467519|464728943|FG000|Overall Study|Lost to Follow-up|2|||
129118147|NCT00467519|464728944|FG001|Overall Study|Lost to Follow-up|9|||
129118148|NCT00467519|464728943|FG000|Overall Study|Withdrawal by Subject|4|||
129118149|NCT00467519|464728944|FG001|Overall Study|Withdrawal by Subject|10|||
129118150|NCT03372798|464728950|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
129118151|NCT03372798|464728951|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
129118152|NCT03372798|464728950|FG000|Overall Study|Failure of imaging probe|0|||
129118153|NCT03372798|464728951|FG001|Overall Study|Failure of imaging probe|1|||
129118154|NCT00843492|464728966|FG000|Overall Study|Adverse Event|0|||
129118155|NCT00843492|464728967|FG001|Overall Study|Adverse Event|3|||
129118156|NCT00843492|464728966|FG000|Overall Study|Lost to Follow-up|4|||
129118157|NCT00843492|464728967|FG001|Overall Study|Lost to Follow-up|4|||
129118158|NCT00843492|464728966|FG000|Overall Study|Withdrawal by Subject|0|||
129118159|NCT00843492|464728967|FG001|Overall Study|Withdrawal by Subject|4|||
129118160|NCT00843492|464728966|FG000|Overall Study|Immobilization Stopped|1|||
129118161|NCT00843492|464728967|FG001|Overall Study|Immobilization Stopped|0|||
129118162|NCT00843492|464728966|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
129118163|NCT00843492|464728967|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
129118164|NCT00843492|464728966|FG000|Overall Study|Orthopedic Surgery|0|||
129118165|NCT00843492|464728967|FG001|Overall Study|Orthopedic Surgery|2|||
129118166|NCT00843492|464728966|FG000|Overall Study|Visit Not Performed|1|||
128910043|NCT01543087|463962852|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
128910044|NCT01543087|463962853|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
129118167|NCT00843492|464728967|FG001|Overall Study|Visit Not Performed|0|||
129118168|NCT00843492|464728966|FG000|Overall Study|Deep-vein Thrombosis|1|||
128910045|NCT01543087|463962854|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
128910046|NCT01543087|463962855|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
128910047|NCT01543087|463962850|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
128910048|NCT01543087|463962851|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
128910049|NCT01543087|463962852|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
128910050|NCT01543087|463962853|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
128910051|NCT01543087|463962854|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
128910052|NCT01543087|463962855|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
128910053|NCT01543087|463962850|FG000|Stage 1 (48 Months)|Other than specified|5|||
128910054|NCT01543087|463962851|FG001|Stage 1 (48 Months)|Other than specified|0|||
128910055|NCT01543087|463962852|FG002|Stage 1 (48 Months)|Other than specified|9|||
128910056|NCT01543087|463962853|FG003|Stage 1 (48 Months)|Other than specified|0|||
128910057|NCT01543087|463962854|FG004|Stage 1 (48 Months)|Other than specified|0|||
128910058|NCT01543087|463962855|FG005|Stage 1 (48 Months)|Other than specified|0|||
128910059|NCT01543087|463962850|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
128910060|NCT01543087|463962851|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
128910061|NCT01543087|463962852|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
128910062|NCT01543087|463962853|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
128910063|NCT01543087|463962854|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
128910064|NCT01543087|463962855|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
128910065|NCT01543087|463962850|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
128910066|NCT01543087|463962851|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
128910067|NCT01543087|463962852|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
128910068|NCT01543087|463962853|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
128910069|NCT01543087|463962854|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
128910070|NCT01543087|463962855|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
128910071|NCT01543087|463962850|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
128910072|NCT01543087|463962851|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
128910073|NCT01543087|463962852|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
128910074|NCT01543087|463962853|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
128910075|NCT01543087|463962854|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
128910076|NCT01543087|463962855|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
128910077|NCT00706030|463962856|FG000|Overall Study|Disease Progression|4|||
128910078|NCT00706030|463962857|FG001|Overall Study|Disease Progression|6|||
128910079|NCT00706030|463962858|FG002|Overall Study|Disease Progression|46|||
128910080|NCT00706030|463962859|FG003|Overall Study|Disease Progression|12|||
128910081|NCT00706030|463962856|FG000|Overall Study|Adverse Event|1|||
128910082|NCT00706030|463962857|FG001|Overall Study|Adverse Event|0|||
128910083|NCT00706030|463962858|FG002|Overall Study|Adverse Event|4|||
128910084|NCT00706030|463962859|FG003|Overall Study|Adverse Event|2|||
128910085|NCT00706030|463962856|FG000|Overall Study|Withdrawal by Subject|1|||
128910086|NCT00706030|463962857|FG001|Overall Study|Withdrawal by Subject|0|||
128910087|NCT00706030|463962858|FG002|Overall Study|Withdrawal by Subject|2|||
128910088|NCT00706030|463962859|FG003|Overall Study|Withdrawal by Subject|0|||
128910089|NCT00706030|463962856|FG000|Overall Study|Physician Decision|0|||
128910090|NCT00706030|463962857|FG001|Overall Study|Physician Decision|0|||
128910091|NCT00706030|463962858|FG002|Overall Study|Physician Decision|2|||
128910092|NCT00706030|463962859|FG003|Overall Study|Physician Decision|0|||
128910093|NCT00706030|463962856|FG000|Overall Study|Not recorded|0|||
128910094|NCT00706030|463962857|FG001|Overall Study|Not recorded|0|||
128910095|NCT00706030|463962858|FG002|Overall Study|Not recorded|2|||
128910096|NCT00706030|463962859|FG003|Overall Study|Not recorded|0|||
128910097|NCT00706030|463962856|FG000|Overall Study|Protocol Violation|0|||
128910098|NCT00706030|463962857|FG001|Overall Study|Protocol Violation|0|||
128910099|NCT00706030|463962858|FG002|Overall Study|Protocol Violation|1|||
128910100|NCT00706030|463962859|FG003|Overall Study|Protocol Violation|1|||
128910101|NCT00706030|463962856|FG000|Overall Study|Failed to return|0|||
128910102|NCT00706030|463962857|FG001|Overall Study|Failed to return|0|||
128910103|NCT00706030|463962858|FG002|Overall Study|Failed to return|1|||
128910104|NCT00706030|463962859|FG003|Overall Study|Failed to return|0|||
128910105|NCT00706030|463962856|FG000|Overall Study|Symptomatic Deterioration|0|||
128910106|NCT00706030|463962857|FG001|Overall Study|Symptomatic Deterioration|0|||
128910107|NCT00706030|463962858|FG002|Overall Study|Symptomatic Deterioration|1|||
128910108|NCT00706030|463962859|FG003|Overall Study|Symptomatic Deterioration|0|||
128910109|NCT00706030|463962856|FG000|Overall Study|No treatment received|0|||
128910110|NCT00706030|463962857|FG001|Overall Study|No treatment received|0|||
128910111|NCT00706030|463962858|FG002|Overall Study|No treatment received|0|||
128910112|NCT00706030|463962859|FG003|Overall Study|No treatment received|1|||
128910113|NCT00706030|463962856|FG000|Overall Study|Death|0|||
128910114|NCT00706030|463962857|FG001|Overall Study|Death|0|||
128910115|NCT00706030|463962858|FG002|Overall Study|Death|1|||
128910116|NCT00706030|463962859|FG003|Overall Study|Death|0|||
128910117|NCT05779072|463962861|FG000|Overall Study|Lost to Follow-up|0|||
128910118|NCT05779072|463962862|FG001|Overall Study|Lost to Follow-up|1|||
128910119|NCT05779072|463962861|FG000|Overall Study|Withdrawal by Subject|1|||
129215391|NCT01967940|465091163|FG000|Part 2|Adverse Event|0|||
129215392|NCT01967940|465091164|FG001|Part 2|Adverse Event|0|||
129215393|NCT01967940|465091165|FG002|Part 2|Adverse Event|0|||
129215394|NCT01967940|465091166|FG003|Part 2|Adverse Event|1|||
129215395|NCT01967940|465091163|FG000|Part 2|Unknown Reason|0|||
129215396|NCT01967940|465091164|FG001|Part 2|Unknown Reason|0|||
129215397|NCT01967940|465091165|FG002|Part 2|Unknown Reason|0|||
129215398|NCT01967940|465091166|FG003|Part 2|Unknown Reason|1|||
129215399|NCT01663103|465091167|FG000|Overall Study|Withdrawal by Subject|1|||
129215400|NCT01663103|465091168|FG001|Overall Study|Withdrawal by Subject|2|||
129215401|NCT01663103|465091167|FG000|Overall Study|Adverse Event|1|||
129215402|NCT01663103|465091168|FG001|Overall Study|Adverse Event|0|||
129215403|NCT01663103|465091167|FG000|Overall Study|dog bite|1|||
129215404|NCT01663103|465091168|FG001|Overall Study|dog bite|0|||
129215405|NCT03113487|465091173|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
129215406|NCT03777982|465091174|FG000|Overall Study|Physician Decision|0|||
129215407|NCT03777982|465091175|FG001|Overall Study|Physician Decision|1|||
129215408|NCT00391586|465091179|FG000|Overall Study|Progressive disease|13|||
129215409|NCT00391586|465091179|FG000|Overall Study|Adverse Event|5|||
129215410|NCT00391586|465091179|FG000|Overall Study|Physician Decision|2|||
129215411|NCT00391586|465091179|FG000|Overall Study|Death|4|||
129215412|NCT00904982|465091180|FG000|Overall Study|Withdrawal by Subject|2|||
129215413|NCT00904982|465091181|FG001|Overall Study|Withdrawal by Subject|0|||
129215414|NCT00904982|465091182|FG002|Overall Study|Withdrawal by Subject|0|||
129215415|NCT00904982|465091183|FG003|Overall Study|Withdrawal by Subject|0|||
129215416|NCT02072668|465091184|FG000|Second Intervention|Lost to Follow-up|1|||
129215417|NCT02072668|465091185|FG001|Second Intervention|Lost to Follow-up|0|||
129215418|NCT00771758|465091190|FG000|Overall Study|Adverse Event|2|||
129215419|NCT00771758|465091191|FG001|Overall Study|Adverse Event|8|||
129215420|NCT00771758|465091192|FG002|Overall Study|Adverse Event|1|||
129215421|NCT00771758|465091190|FG000|Overall Study|Lack of Efficacy|0|||
129215422|NCT00771758|465091191|FG001|Overall Study|Lack of Efficacy|2|||
129215423|NCT00771758|465091192|FG002|Overall Study|Lack of Efficacy|1|||
129215424|NCT00771758|465091190|FG000|Overall Study|Lost to Follow-up|1|||
128696861|NCT05074667|463188904|FG000|Overall Study|Withdrawal by Subject|4|||
128696862|NCT05074667|463188904|FG000|Overall Study|Lost to Follow-up|10|||
128910120|NCT05779072|463962862|FG001|Overall Study|Withdrawal by Subject|5|||
128910121|NCT00730639|463962868|FG000|Overall Study|Adverse Event|3|||
128910122|NCT00730639|463962869|FG001|Overall Study|Adverse Event|0|||
128910123|NCT00730639|463962870|FG002|Overall Study|Adverse Event|9|||
128910124|NCT00730639|463962871|FG003|Overall Study|Adverse Event|8|||
128910125|NCT00730639|463962872|FG004|Overall Study|Adverse Event|23|||
128910126|NCT00730639|463962868|FG000|Overall Study|Complete Response|0|||
128910127|NCT00730639|463962869|FG001|Overall Study|Complete Response|0|||
128910128|NCT00730639|463962870|FG002|Overall Study|Complete Response|2|||
128910129|NCT00730639|463962871|FG003|Overall Study|Complete Response|2|||
128910130|NCT00730639|463962872|FG004|Overall Study|Complete Response|1|||
128910131|NCT00730639|463962868|FG000|Overall Study|Completed Maximum Cycles|0|||
128910132|NCT00730639|463962869|FG001|Overall Study|Completed Maximum Cycles|0|||
128910133|NCT00730639|463962870|FG002|Overall Study|Completed Maximum Cycles|11|||
128910134|NCT00730639|463962871|FG003|Overall Study|Completed Maximum Cycles|3|||
128910135|NCT00730639|463962872|FG004|Overall Study|Completed Maximum Cycles|6|||
128910136|NCT00730639|463962868|FG000|Overall Study|Death|0|||
128910137|NCT00730639|463962869|FG001|Overall Study|Death|0|||
128910138|NCT00730639|463962870|FG002|Overall Study|Death|0|||
128910139|NCT00730639|463962871|FG003|Overall Study|Death|0|||
128910140|NCT00730639|463962872|FG004|Overall Study|Death|2|||
128910141|NCT00730639|463962868|FG000|Overall Study|Disease Progression|12|||
128910142|NCT00730639|463962869|FG001|Overall Study|Disease Progression|13|||
128910143|NCT00730639|463962870|FG002|Overall Study|Disease Progression|48|||
128910144|NCT00730639|463962871|FG003|Overall Study|Disease Progression|32|||
128910145|NCT00730639|463962872|FG004|Overall Study|Disease Progression|88|||
128910146|NCT00730639|463962868|FG000|Overall Study|non-specified|0|||
128910147|NCT00730639|463962869|FG001|Overall Study|non-specified|0|||
128910148|NCT00730639|463962870|FG002|Overall Study|non-specified|4|||
128910149|NCT00730639|463962871|FG003|Overall Study|non-specified|2|||
128910150|NCT00730639|463962872|FG004|Overall Study|non-specified|3|||
128910151|NCT00730639|463962868|FG000|Overall Study|Protocol Violation|0|||
129028017|NCT01559363|464392855|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129028018|NCT01559363|464392850|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
129215425|NCT00771758|465091191|FG001|Overall Study|Lost to Follow-up|0|||
129215426|NCT00771758|465091192|FG002|Overall Study|Lost to Follow-up|0|||
129215427|NCT00771758|465091190|FG000|Overall Study|Protocol Violation|1|||
129215428|NCT00771758|465091191|FG001|Overall Study|Protocol Violation|0|||
129215429|NCT00771758|465091192|FG002|Overall Study|Protocol Violation|0|||
129215430|NCT00771758|465091190|FG000|Overall Study|Withdrawal by Subject|1|||
129215431|NCT00771758|465091191|FG001|Overall Study|Withdrawal by Subject|0|||
129215432|NCT00771758|465091192|FG002|Overall Study|Withdrawal by Subject|0|||
129215433|NCT00771758|465091190|FG000|Overall Study|Other|3|||
129215434|NCT00771758|465091191|FG001|Overall Study|Other|2|||
128696863|NCT01086033|463188908|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
128696864|NCT01086033|463188908|FG000|Overall Study|Lost to Follow-up|86|||
128696865|NCT01086033|463188908|FG000|Overall Study|Adverse Event|42|||
128696866|NCT01086033|463188908|FG000|Overall Study|Withdrawal by Subject|41|||
128696867|NCT01086033|463188908|FG000|Overall Study|Other|14|||
128910152|NCT00730639|463962869|FG001|Overall Study|Protocol Violation|0|||
128910153|NCT00730639|463962870|FG002|Overall Study|Protocol Violation|1|||
128910154|NCT00730639|463962871|FG003|Overall Study|Protocol Violation|0|||
128910155|NCT00730639|463962872|FG004|Overall Study|Protocol Violation|0|||
128910156|NCT00730639|463962868|FG000|Overall Study|Withdrawal by Subject|0|||
128910157|NCT00730639|463962869|FG001|Overall Study|Withdrawal by Subject|0|||
128910158|NCT00730639|463962870|FG002|Overall Study|Withdrawal by Subject|6|||
128910159|NCT00730639|463962871|FG003|Overall Study|Withdrawal by Subject|3|||
128910160|NCT00730639|463962872|FG004|Overall Study|Withdrawal by Subject|4|||
128910161|NCT00730639|463962868|FG000|Overall Study|Treatment on-going|2|||
128910162|NCT00730639|463962869|FG001|Overall Study|Treatment on-going|5|||
128910163|NCT00730639|463962870|FG002|Overall Study|Treatment on-going|5|||
128910164|NCT00730639|463962871|FG003|Overall Study|Treatment on-going|4|||
128910165|NCT00730639|463962872|FG004|Overall Study|Treatment on-going|4|||
128910166|NCT02665286|463962873|FG000|Overall Study|Lost to Follow-up|3|||
128910167|NCT02665286|463962874|FG001|Overall Study|Lost to Follow-up|2|||
128910168|NCT02665286|463962875|FG002|Overall Study|Lost to Follow-up|1|||
128910169|NCT04820309|463962883|FG000|Overall Study|Adverse Event|96|||
128910170|NCT04820309|463962883|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
128910171|NCT04820309|463962883|FG000|Overall Study|Consent Withdrawn|93|||
128910172|NCT04820309|463962883|FG000|Overall Study|failure to adhere to protocol|32|||
128910173|NCT04820309|463962883|FG000|Overall Study|alcohol or drug use|6|||
128910174|NCT04820309|463962883|FG000|Overall Study|Lost to Follow-up|46|||
128910175|NCT04820309|463962883|FG000|Overall Study|Death|2|||
128910176|NCT04820309|463962883|FG000|Overall Study|Pregnancy|1|||
128910177|NCT04820309|463962883|FG000|Overall Study|Other reasons|12|||
128910178|NCT03692052|463962884|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
128910179|NCT03692052|463962884|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
128910180|NCT03692052|463962884|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
128910181|NCT03692052|463962884|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
128910182|NCT05600309|463962887|FG000|Overall Study|Death|41|||
128910183|NCT05600309|463962888|FG001|Overall Study|Death|38|||
128910184|NCT05600309|463962887|FG000|Overall Study|Sponsor Decision|9|||
128910185|NCT05600309|463962888|FG001|Overall Study|Sponsor Decision|6|||
128910186|NCT00980538|463962893|FG000|Overall Study|Lost to Follow-up|20|||
128910187|NCT00980538|463962893|FG000|Overall Study|Sponsor's Decision|4|||
128910188|NCT00980538|463962893|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
128910189|NCT00980538|463962893|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
128910190|NCT00980538|463962893|FG000|Overall Study|Switch to Commercially Available Medication|25|||
128910191|NCT00980538|463962893|FG000|Overall Study|Participant Non-Compliant|9|||
128910192|NCT00980538|463962893|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
128910193|NCT00980538|463962893|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
128910194|NCT00980538|463962893|FG000|Overall Study|Other|60|||
128910195|NCT00980538|463962893|FG000|Overall Study|Other|1|||
128910196|NCT02482129|463962894|FG000|Overall Study|Adverse Event-prior to treatment|0|||
128910197|NCT02482129|463962895|FG001|Overall Study|Adverse Event-prior to treatment|1|||
128910198|NCT02482129|463962894|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
128910199|NCT02482129|463962895|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
128910200|NCT02482129|463962894|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
128910201|NCT02482129|463962895|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
128910202|NCT02482129|463962894|FG000|Overall Study|Criteria not met-prior to treatment|1|||
128910203|NCT02482129|463962895|FG001|Overall Study|Criteria not met-prior to treatment|0|||
128910204|NCT02482129|463962894|FG000|Overall Study|Adverse Event|1|||
128910205|NCT02482129|463962895|FG001|Overall Study|Adverse Event|0|||
128910206|NCT02482129|463962894|FG000|Overall Study|Withdrawal by Subject|2|||
128696868|NCT01086033|463188908|FG000|Overall Study|Other|13|||
128696869|NCT01086033|463188908|FG000|Overall Study|AE and Withdrew Consent|5|||
128765342|NCT02969525|463432143|FG005|Double-Blind Period|Adverse Event|0|||
128765343|NCT02969525|463432144|FG006|Double-Blind Period|Adverse Event|0|||
128910207|NCT02482129|463962895|FG001|Overall Study|Withdrawal by Subject|0|||
128910208|NCT02482129|463962894|FG000|Overall Study|Criteria not met|1|||
128910209|NCT02482129|463962895|FG001|Overall Study|Criteria not met|0|||
128910210|NCT03505021|463962896|FG000|Overall Study|Protocol Violation|1|||
128910211|NCT03505021|463962897|FG001|Overall Study|Protocol Violation|0|||
129028019|NCT01559363|464392851|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
128696870|NCT01086033|463188908|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
128696871|NCT01086033|463188908|FG000|Overall Study|Withdrew consent and Other Reason|4|||
128910212|NCT03505021|463962896|FG000|Overall Study|Death|9|||
128910213|NCT03505021|463962897|FG001|Overall Study|Death|8|||
128910214|NCT03505021|463962896|FG000|Overall Study|Consent withdrawn by subject|6|||
128910215|NCT03505021|463962897|FG001|Overall Study|Consent withdrawn by subject|1|||
128910216|NCT03505021|463962896|FG000|Overall Study|Lost to Follow-up|5|||
128910217|NCT03505021|463962897|FG001|Overall Study|Lost to Follow-up|3|||
128910218|NCT03505021|463962896|FG000|Overall Study|Adverse Event|26|||
128910219|NCT03505021|463962897|FG001|Overall Study|Adverse Event|9|||
128910220|NCT03505021|463962896|FG000|Overall Study|Disease progression|33|||
128910221|NCT03505021|463962897|FG001|Overall Study|Disease progression|17|||
128910222|NCT03505021|463962896|FG000|Overall Study|Other|11|||
128910223|NCT03505021|463962897|FG001|Overall Study|Other|5|||
128910224|NCT03505021|463962896|FG000|Overall Study|Personal reason|21|||
128910225|NCT03505021|463962897|FG001|Overall Study|Personal reason|12|||
128910226|NCT03406897|463964716|FG000|Overall Study|Lost to Follow-up|1|||
129028020|NCT01559363|464392852|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
129028021|NCT01559363|464392853|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
129028022|NCT01559363|464392854|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
129028023|NCT01559363|464392855|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
129028024|NCT01559363|464392850|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129028025|NCT01559363|464392851|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129028026|NCT01559363|464392852|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129028027|NCT01559363|464392853|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
129028028|NCT01559363|464392854|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129028029|NCT01559363|464392855|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129028030|NCT02705716|464392856|FG000|Overall Study|Adverse Event|0|||
129028031|NCT02705716|464392857|FG001|Overall Study|Adverse Event|1|||
129028032|NCT02705716|464392856|FG000|Overall Study|Protocol Violation|3|||
129028033|NCT02705716|464392857|FG001|Overall Study|Protocol Violation|0|||
129028034|NCT02705716|464392856|FG000|Overall Study|Withdrawal of Consent|1|||
129028035|NCT02705716|464392857|FG001|Overall Study|Withdrawal of Consent|1|||
129028036|NCT00562718|464392859|FG000|Overall Study|Death|1|||
129028037|NCT00562718|464392859|FG000|Overall Study|Withdrawal by Subject|3|||
129028038|NCT00562718|464392859|FG000|Overall Study|Adverse Event|4|||
129028039|NCT00562718|464392859|FG000|Overall Study|Lack of Efficacy|2|||
129028040|NCT00562718|464392859|FG000|Overall Study|not stated|1|||
129028041|NCT01868243|464392860|FG000|Overall Study|Death|0|||
129028042|NCT01868243|464392861|FG001|Overall Study|Death|1|||
129028043|NCT01395017|464392862|FG000|Overall Study|Lost to Follow-up|1|||
129028044|NCT01395017|464392863|FG001|Overall Study|Lost to Follow-up|0|||
129028045|NCT01395017|464392862|FG000|Overall Study|Adverse Event|26|||
129028046|NCT01395017|464392863|FG001|Overall Study|Adverse Event|12|||
129028047|NCT01395017|464392862|FG000|Overall Study|Physician Decision|11|||
129028048|NCT01395017|464392863|FG001|Overall Study|Physician Decision|15|||
129028049|NCT01395017|464392862|FG000|Overall Study|Withdrawal by Subject|14|||
129028050|NCT01395017|464392863|FG001|Overall Study|Withdrawal by Subject|8|||
129028051|NCT01395017|464392862|FG000|Overall Study|Protocol deviation|1|||
129028052|NCT01395017|464392863|FG001|Overall Study|Protocol deviation|2|||
129028053|NCT01395017|464392862|FG000|Overall Study|Death|4|||
129028054|NCT01395017|464392863|FG001|Overall Study|Death|3|||
129028055|NCT01395017|464392862|FG000|Overall Study|Disease progression|42|||
129028056|NCT01395017|464392863|FG001|Overall Study|Disease progression|58|||
129028057|NCT01395017|464392862|FG000|Overall Study|Sponsor discontinued study|1|||
129028058|NCT01395017|464392863|FG001|Overall Study|Sponsor discontinued study|4|||
129028059|NCT00999687|464392867|FG000|First Intervention|Withdrawal by Subject|1|||
129028060|NCT00999687|464392867|FG000|Second Intervention|Withdrawal by Subject|2|||
129028061|NCT00999687|464392867|FG000|Second Intervention|Lack of Efficacy|1|||
128910227|NCT03406897|463964717|FG001|Overall Study|Lost to Follow-up|2|||
129028062|NCT00474188|464392868|FG000|Overall Study|Withdrawal by Subject|1|||
129028063|NCT00474188|464392868|FG000|Overall Study|Study discontinued by sponsor|5|||
129028064|NCT03961204|464392871|FG000|Overall Study|Withdrawal by Subject|2|||
129028065|NCT03961204|464392871|FG000|Overall Study|Lost to Follow-up|3|||
129028066|NCT03961204|464392871|FG000|Overall Study|Other|1|||
129028067|NCT03961204|464392871|FG000|Overall Study|Missing|1|||
129028068|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Subject request|8|||
129028069|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Subject request|11|||
129028070|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
129028071|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
129028072|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
129028073|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
129028074|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
129028075|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
129028076|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
129028077|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
129028078|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
129028079|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
129028080|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Death|1|||
129028081|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Death|0|||
129028082|NCT00521586|464394470|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
128696872|NCT01086033|463188908|FG000|Overall Study|AE and Lack of Efficacy|4|||
128910228|NCT03406897|463964716|FG000|Overall Study|Withdrawal by Subject|4|||
128910229|NCT03406897|463964717|FG001|Overall Study|Withdrawal by Subject|4|||
128910230|NCT03406897|463964716|FG000|Overall Study|Physician Decision|0|||
128910231|NCT03406897|463964717|FG001|Overall Study|Physician Decision|1|||
128910232|NCT03087955|463964718|FG000|Overall Study|Death|4|||
128910233|NCT03087955|463964719|FG001|Overall Study|Death|0|||
128910234|NCT03087955|463964718|FG000|Overall Study|Lack of Efficacy|2|||
128910235|NCT03087955|463964719|FG001|Overall Study|Lack of Efficacy|0|||
128910236|NCT03087955|463964718|FG000|Overall Study|Lost to Follow-up|1|||
128910237|NCT03087955|463964719|FG001|Overall Study|Lost to Follow-up|0|||
128910238|NCT02392429|463964720|FG000|Screening|Screen failure|15|||
128910239|NCT02392429|463964720|FG000|Enrolled Participants|Ineligible due to disease|3|||
128910240|NCT02392429|463964720|FG000|Enrolled Participants|Withdrawal by Subject|4|||
128910241|NCT02392429|463964720|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
128910242|NCT02392429|463964720|FG000|Evaluable|Death|5|||
128910243|NCT02392429|463964720|FG000|Evaluable|Withdrawal by Subject|1|||
128910244|NCT02392429|463964720|FG000|Evaluable|Adverse Event|1|||
128910245|NCT02392429|463964720|FG000|Evaluable|remission bone marrow biopsy|3|||
128910246|NCT03266016|463964724|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
128910247|NCT03266016|463964725|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
128910248|NCT03266016|463964726|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
128910249|NCT03266016|463964727|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
128910250|NCT03266016|463964724|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
128910251|NCT03266016|463964725|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
128910252|NCT03266016|463964726|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
128910253|NCT03266016|463964727|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
128910254|NCT00482014|463964728|FG000|Overall Study|Withdrawal by Subject|1|||
128910255|NCT00482014|463964729|FG001|Overall Study|Withdrawal by Subject|2|||
128910256|NCT00482014|463964730|FG002|Overall Study|Withdrawal by Subject|3|||
128910257|NCT00482014|463964731|FG003|Overall Study|Withdrawal by Subject|4|||
128910258|NCT00482014|463964728|FG000|Overall Study|Adverse Event|3|||
128910259|NCT00482014|463964729|FG001|Overall Study|Adverse Event|0|||
128910260|NCT00482014|463964730|FG002|Overall Study|Adverse Event|2|||
128910261|NCT00482014|463964731|FG003|Overall Study|Adverse Event|8|||
128910262|NCT00482014|463964728|FG000|Overall Study|Death|1|||
128910263|NCT00482014|463964729|FG001|Overall Study|Death|2|||
128910264|NCT00482014|463964730|FG002|Overall Study|Death|1|||
128910265|NCT00482014|463964731|FG003|Overall Study|Death|4|||
128910266|NCT00482014|463964728|FG000|Overall Study|Lack of Efficacy|1|||
128910267|NCT00482014|463964729|FG001|Overall Study|Lack of Efficacy|0|||
128910268|NCT00482014|463964730|FG002|Overall Study|Lack of Efficacy|4|||
128910269|NCT00482014|463964731|FG003|Overall Study|Lack of Efficacy|6|||
128910270|NCT00482014|463964728|FG000|Overall Study|Sponsor Decision|1|||
128910271|NCT00482014|463964729|FG001|Overall Study|Sponsor Decision|2|||
128910272|NCT00482014|463964730|FG002|Overall Study|Sponsor Decision|1|||
128910273|NCT00482014|463964731|FG003|Overall Study|Sponsor Decision|1|||
128910274|NCT03686397|463964732|FG000|Overall Study|Lack of Efficacy|3|||
128910275|NCT03686397|463964733|FG001|Overall Study|Lack of Efficacy|5|||
128910276|NCT03686397|463964732|FG000|Overall Study|Adverse Event|0|||
128910277|NCT03686397|463964733|FG001|Overall Study|Adverse Event|1|||
128910278|NCT03686397|463964732|FG000|Overall Study|Protocol Violation|0|||
128910279|NCT03686397|463964733|FG001|Overall Study|Protocol Violation|1|||
128910280|NCT03686397|463964732|FG000|Overall Study|Withdrawal by Subject|0|||
128910281|NCT03686397|463964733|FG001|Overall Study|Withdrawal by Subject|1|||
128910282|NCT03686397|463964732|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
128910283|NCT03686397|463964733|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
128910284|NCT01241708|463964734|FG000|Overall Study|Withdrawal by Subject|6|||
129028083|NCT00521586|464394471|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
129028084|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
129028085|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
129028086|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
129028087|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
129028088|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
128910285|NCT01241708|463964734|FG000|Overall Study|Screen Failure|6|||
128910286|NCT01241708|463964734|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
128910287|NCT01241708|463964734|FG000|Overall Study|Lost to Follow-up|5|||
129028089|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
128910288|NCT04183335|463964735|FG000|Overall Study|Adverse Event|1|||
128910289|NCT04183335|463964736|FG001|Overall Study|Adverse Event|0|||
128910290|NCT04183335|463964735|FG000|Overall Study|Withdrawal by Subject|12|||
128910291|NCT04183335|463964736|FG001|Overall Study|Withdrawal by Subject|3|||
128910292|NCT02605642|463964737|FG000|Overall Study|Other|11|||
128910293|NCT02605642|463964738|FG001|Overall Study|Other|1|||
128910294|NCT02605642|463964737|FG000|Overall Study|Participant non-compliance|2|||
128910295|NCT02605642|463964738|FG001|Overall Study|Participant non-compliance|4|||
128910296|NCT02605642|463964737|FG000|Overall Study|Physician Decision|10|||
128696873|NCT01086033|463188908|FG000|Overall Study|Death|1|||
128696874|NCT01086033|463188908|FG000|Overall Study|AE and Lost to Follow-up|1|||
128696875|NCT01086033|463188908|FG000|Overall Study|AE and Other Reason|1|||
128910297|NCT02605642|463964738|FG001|Overall Study|Physician Decision|0|||
128910298|NCT02605642|463964737|FG000|Overall Study|Lost to Follow-up|12|||
128910299|NCT02605642|463964738|FG001|Overall Study|Lost to Follow-up|1|||
128910300|NCT02605642|463964737|FG000|Overall Study|Adverse Event|14|||
128910301|NCT02605642|463964738|FG001|Overall Study|Adverse Event|2|||
128910302|NCT02605642|463964737|FG000|Overall Study|Withdrawal by Subject|23|||
128910303|NCT02605642|463964738|FG001|Overall Study|Withdrawal by Subject|2|||
128910304|NCT02605642|463964737|FG000|Overall Study|Lack of response|24|||
128910305|NCT02605642|463964738|FG001|Overall Study|Lack of response|11|||
128910306|NCT01268293|463964743|FG000|Overall Study|Disease progression|7|||
128910307|NCT01268293|463964743|FG000|Overall Study|Adverse Event|1|||
128910308|NCT01268293|463964743|FG000|Overall Study|Subject choice|1|||
128910309|NCT01396005|463964748|FG000|Overall Study|Withdrawal by Subject|0|||
128910310|NCT01396005|463964749|FG001|Overall Study|Withdrawal by Subject|1|||
128910311|NCT01396005|463964748|FG000|Overall Study|Non-compliance with protocol|0|||
128910312|NCT01396005|463964749|FG001|Overall Study|Non-compliance with protocol|1|||
128910313|NCT00424827|463964750|FG000|Overall Study|Adverse Event|1|||
128910314|NCT03806127|463964751|FG000|Overall Study|Withdrawal by Subject|4|||
128910315|NCT03806127|463964752|FG001|Overall Study|Withdrawal by Subject|5|||
128910316|NCT03806127|463964751|FG000|Overall Study|Protocol Violation|3|||
128910317|NCT03806127|463964752|FG001|Overall Study|Protocol Violation|1|||
128910318|NCT03806127|463964751|FG000|Overall Study|Adverse Event|3|||
128910319|NCT03806127|463964752|FG001|Overall Study|Adverse Event|0|||
128910320|NCT03806127|463964751|FG000|Overall Study|Unable to Complete Procedures|0|||
128910321|NCT03806127|463964752|FG001|Overall Study|Unable to Complete Procedures|1|||
128910322|NCT03806127|463964751|FG000|Overall Study|Pregnancy|0|||
128910323|NCT03806127|463964752|FG001|Overall Study|Pregnancy|1|||
128910324|NCT03806127|463964751|FG000|Overall Study|Lost to Follow-up|5|||
128910325|NCT03806127|463964752|FG001|Overall Study|Lost to Follow-up|1|||
128910326|NCT03806127|463964751|FG000|Overall Study|Physician Decision|1|||
128910327|NCT03806127|463964752|FG001|Overall Study|Physician Decision|1|||
128910328|NCT03806127|463964751|FG000|Overall Study|Could Not Come Due to Covid|1|||
128910329|NCT03806127|463964752|FG001|Overall Study|Could Not Come Due to Covid|0|||
128910330|NCT03806127|463964751|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
128910331|NCT03806127|463964752|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
128910332|NCT03806127|463964751|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
128910333|NCT03806127|463964752|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
128910334|NCT03806127|463964751|FG000|Overall Study|Covid 19 Restrictions|2|||
128910335|NCT03806127|463964752|FG001|Overall Study|Covid 19 Restrictions|0|||
128910336|NCT03806127|463964751|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
128910337|NCT03806127|463964752|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
128910338|NCT03806127|463964751|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
128910339|NCT03806127|463964752|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
128910340|NCT01467492|463964755|FG000|Overall Study|Withdrawal by Subject|6|||
128910341|NCT01467492|463964756|FG001|Overall Study|Withdrawal by Subject|4|||
128910342|NCT01467492|463964755|FG000|Overall Study|Study Terminated by Sponsor|6|||
128910343|NCT01467492|463964756|FG001|Overall Study|Study Terminated by Sponsor|4|||
128910344|NCT01467492|463964755|FG000|Overall Study|Adverse Event|4|||
128910345|NCT01467492|463964756|FG001|Overall Study|Adverse Event|3|||
128910346|NCT01467492|463964755|FG000|Overall Study|Lost to Follow-up|3|||
128910347|NCT01467492|463964756|FG001|Overall Study|Lost to Follow-up|2|||
128910348|NCT01467492|463964755|FG000|Overall Study|Undefined|2|||
128910349|NCT01467492|463964756|FG001|Overall Study|Undefined|0|||
128910350|NCT01467492|463964755|FG000|Overall Study|Enrolled But Not Treated|1|||
128910351|NCT01467492|463964756|FG001|Overall Study|Enrolled But Not Treated|0|||
128910352|NCT03823391|463964758|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
128910353|NCT03823391|463964759|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
128696876|NCT01086033|463188908|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
128696877|NCT05154578|463188910|FG000|Overall Study|Withdrawal by Subject|2|||
128696878|NCT05154578|463188911|FG001|Overall Study|Withdrawal by Subject|3|||
128910354|NCT03823391|463964758|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
128910355|NCT03823391|463964759|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
128910356|NCT02450487|463964760|FG000|Overall Study|Lost to Follow-up|3|||
129118169|NCT00843492|464728967|FG001|Overall Study|Deep-vein Thrombosis|0|||
128910357|NCT01790048|463964761|FG000|Overall Study|Incorrect Age|9|||
128910358|NCT01790048|463964762|FG001|Overall Study|Incorrect Age|14|||
128910359|NCT01790048|463964761|FG000|Overall Study|data entry error|0|||
128910360|NCT01790048|463964762|FG001|Overall Study|data entry error|1|||
128910361|NCT01790048|463964761|FG000|Overall Study|Other|0|||
128910362|NCT01790048|463964762|FG001|Overall Study|Other|2|||
128696879|NCT05154578|463188912|FG002|Overall Study|Withdrawal by Subject|2|||
128696880|NCT05154578|463188913|FG003|Overall Study|Withdrawal by Subject|4|||
128910363|NCT01790048|463964761|FG000|Overall Study|SAM at Enrollment|2|||
128910364|NCT01790048|463964762|FG001|Overall Study|SAM at Enrollment|0|||
128910365|NCT01790048|463964761|FG000|Overall Study|Measurement error|1|||
128910366|NCT01790048|463964762|FG001|Overall Study|Measurement error|0|||
128910367|NCT00159432|463964763|FG000|Overall Study|Adverse Event|1|||
128910368|NCT00159432|463964763|FG000|Overall Study|Death|1|||
128910369|NCT00159432|463964763|FG000|Overall Study|Lack of Efficacy|8|||
128910370|NCT03132636|463964764|FG000|Overall Study|Adverse Event|1|||
128910371|NCT03132636|463964765|FG001|Overall Study|Adverse Event|2|||
128910372|NCT03132636|463964764|FG000|Overall Study|Death|4|||
128910373|NCT03132636|463964765|FG001|Overall Study|Death|7|||
128910374|NCT03132636|463964764|FG000|Overall Study|Lost to Follow-up|3|||
128910375|NCT03132636|463964765|FG001|Overall Study|Lost to Follow-up|2|||
128910376|NCT03132636|463964764|FG000|Overall Study|Non compliance with protocol by participant|1|||
128910377|NCT03132636|463964765|FG001|Overall Study|Non compliance with protocol by participant|1|||
128910378|NCT03132636|463964764|FG000|Overall Study|Subject decision|1|||
128910379|NCT03132636|463964765|FG001|Overall Study|Subject decision|9|||
128910380|NCT03132636|463964764|FG000|Overall Study|Sponsor decision|0|||
128910381|NCT03132636|463964765|FG001|Overall Study|Sponsor decision|1|||
128910382|NCT03132636|463964764|FG000|Overall Study|Physician Decision|1|||
128910383|NCT03132636|463964765|FG001|Overall Study|Physician Decision|0|||
128910384|NCT03132636|463964764|FG000|Overall Study|Progressive disease|33|||
128910385|NCT03132636|463964765|FG001|Overall Study|Progressive disease|36|||
128910386|NCT03132636|463964764|FG000|Overall Study|Withdrawal of consent|2|||
128910387|NCT03132636|463964765|FG001|Overall Study|Withdrawal of consent|5|||
128910388|NCT03132636|463964764|FG000|Overall Study|Did not re-consent|1|||
128910389|NCT03132636|463964765|FG001|Overall Study|Did not re-consent|0|||
128910390|NCT03132636|463964764|FG000|Overall Study|Lost insurance coverage|1|||
128910391|NCT03132636|463964765|FG001|Overall Study|Lost insurance coverage|0|||
128910392|NCT03132636|463964764|FG000|Overall Study|Related to radiological outcomes|0|||
128910393|NCT03132636|463964765|FG001|Overall Study|Related to radiological outcomes|1|||
128910394|NCT03132636|463964764|FG000|Overall Study|Unable to come to site for continued visits|0|||
128910395|NCT03132636|463964765|FG001|Overall Study|Unable to come to site for continued visits|1|||
128910396|NCT04537208|463964770|FG000|Overall Study|Adverse Event|0|||
128910397|NCT04537208|463964771|FG001|Overall Study|Adverse Event|0|||
128910398|NCT04537208|463964772|FG002|Overall Study|Adverse Event|0|||
128910399|NCT04537208|463964773|FG003|Overall Study|Adverse Event|0|||
128910400|NCT04537208|463964774|FG004|Overall Study|Adverse Event|0|||
128910401|NCT04537208|463964775|FG005|Overall Study|Adverse Event|0|||
128910402|NCT04537208|463964776|FG006|Overall Study|Adverse Event|0|||
128910403|NCT04537208|463964777|FG007|Overall Study|Adverse Event|0|||
128910404|NCT04537208|463964778|FG008|Overall Study|Adverse Event|1|||
128910405|NCT04537208|463964779|FG009|Overall Study|Adverse Event|0|||
128910406|NCT04537208|463964780|FG010|Overall Study|Adverse Event|0|||
128910407|NCT04537208|463964770|FG000|Overall Study|Protocol deviation|0|||
128910408|NCT04537208|463964771|FG001|Overall Study|Protocol deviation|0|||
128910409|NCT04537208|463964772|FG002|Overall Study|Protocol deviation|2|||
128910410|NCT04537208|463964773|FG003|Overall Study|Protocol deviation|0|||
128910411|NCT04537208|463964774|FG004|Overall Study|Protocol deviation|0|||
129028090|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
129028091|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
129028092|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
129028093|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
128910412|NCT04537208|463964775|FG005|Overall Study|Protocol deviation|2|||
128910413|NCT04537208|463964776|FG006|Overall Study|Protocol deviation|4|||
128910414|NCT04537208|463964777|FG007|Overall Study|Protocol deviation|0|||
128910415|NCT04537208|463964778|FG008|Overall Study|Protocol deviation|1|||
129028094|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
129028095|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
129028096|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
129028097|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
129028098|NCT00521586|464394470|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
129028099|NCT00521586|464394471|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
129028100|NCT00521586|464394470|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
129118170|NCT01677741|464728968|FG000|Overall Study|Death|0|||
129118171|NCT01677741|464728969|FG001|Overall Study|Death|0|||
128910416|NCT04537208|463964779|FG009|Overall Study|Protocol deviation|0|||
129118172|NCT01677741|464728970|FG002|Overall Study|Death|0|||
129118173|NCT01677741|464728971|FG003|Overall Study|Death|1|||
128910417|NCT04537208|463964780|FG010|Overall Study|Protocol deviation|2|||
128910418|NCT04537208|463964770|FG000|Overall Study|Withdrawal by Subject|4|||
128910419|NCT04537208|463964771|FG001|Overall Study|Withdrawal by Subject|2|||
128910420|NCT04537208|463964772|FG002|Overall Study|Withdrawal by Subject|1|||
128910421|NCT04537208|463964773|FG003|Overall Study|Withdrawal by Subject|3|||
128910422|NCT04537208|463964774|FG004|Overall Study|Withdrawal by Subject|5|||
128910423|NCT04537208|463964775|FG005|Overall Study|Withdrawal by Subject|1|||
129118174|NCT01677741|464728972|FG004|Overall Study|Death|0|||
128910424|NCT04537208|463964776|FG006|Overall Study|Withdrawal by Subject|6|||
128910425|NCT04537208|463964777|FG007|Overall Study|Withdrawal by Subject|1|||
128910426|NCT04537208|463964778|FG008|Overall Study|Withdrawal by Subject|7|||
128910427|NCT04537208|463964779|FG009|Overall Study|Withdrawal by Subject|2|||
128910428|NCT04537208|463964780|FG010|Overall Study|Withdrawal by Subject|4|||
128910429|NCT04537208|463964770|FG000|Overall Study|Lost to Follow-up|4|||
128910430|NCT04537208|463964771|FG001|Overall Study|Lost to Follow-up|1|||
128910431|NCT04537208|463964772|FG002|Overall Study|Lost to Follow-up|3|||
128910432|NCT04537208|463964773|FG003|Overall Study|Lost to Follow-up|4|||
128910433|NCT04537208|463964774|FG004|Overall Study|Lost to Follow-up|3|||
128910434|NCT04537208|463964775|FG005|Overall Study|Lost to Follow-up|2|||
128910435|NCT04537208|463964776|FG006|Overall Study|Lost to Follow-up|3|||
128910436|NCT04537208|463964777|FG007|Overall Study|Lost to Follow-up|2|||
128910437|NCT04537208|463964778|FG008|Overall Study|Lost to Follow-up|7|||
128910438|NCT04537208|463964779|FG009|Overall Study|Lost to Follow-up|2|||
128910439|NCT04537208|463964780|FG010|Overall Study|Lost to Follow-up|2|||
128910440|NCT05030311|463964781|FG000|Overall Study|Technical problems|0|||
128910441|NCT05030311|463964782|FG001|Overall Study|Technical problems|1|||
128910442|NCT05030311|463964781|FG000|Overall Study|Withdrawal by Subject|31|||
128910443|NCT05030311|463964782|FG001|Overall Study|Withdrawal by Subject|17|||
128910444|NCT05030311|463964781|FG000|Overall Study|Adverse Event|13|||
128910445|NCT05030311|463964782|FG001|Overall Study|Adverse Event|5|||
128910446|NCT05030311|463964781|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
128910447|NCT05030311|463964782|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
128910448|NCT05030311|463964781|FG000|Overall Study|Physician Decision|5|||
128910449|NCT05030311|463964782|FG001|Overall Study|Physician Decision|2|||
128910450|NCT05030311|463964781|FG000|Overall Study|Lost to Follow-up|5|||
128910451|NCT05030311|463964782|FG001|Overall Study|Lost to Follow-up|1|||
128910452|NCT05030311|463964781|FG000|Overall Study|Protocol Violation|4|||
128910453|NCT05030311|463964782|FG001|Overall Study|Protocol Violation|4|||
128910454|NCT03042468|463964784|FG000|Overall Study|Death|0|||
128910455|NCT03042468|463964785|FG001|Overall Study|Death|1|||
128910456|NCT03042468|463964786|FG002|Overall Study|Death|1|||
128910457|NCT03042468|463964787|FG003|Overall Study|Death|0|||
128910458|NCT03042468|463964788|FG004|Overall Study|Death|0|||
128910459|NCT03042468|463964789|FG005|Overall Study|Death|0|||
128910460|NCT03042468|463964784|FG000|Overall Study|Withdrawal by Subject|0|||
128910461|NCT03042468|463964785|FG001|Overall Study|Withdrawal by Subject|0|||
128910462|NCT03042468|463964786|FG002|Overall Study|Withdrawal by Subject|0|||
128910463|NCT03042468|463964787|FG003|Overall Study|Withdrawal by Subject|0|||
128910464|NCT03042468|463964788|FG004|Overall Study|Withdrawal by Subject|0|||
128910465|NCT03042468|463964789|FG005|Overall Study|Withdrawal by Subject|1|||
128910466|NCT03042468|463964784|FG000|Overall Study|Lost to Follow-up|0|||
128910467|NCT03042468|463964785|FG001|Overall Study|Lost to Follow-up|0|||
128910468|NCT03042468|463964786|FG002|Overall Study|Lost to Follow-up|0|||
128910469|NCT03042468|463964787|FG003|Overall Study|Lost to Follow-up|0|||
128910470|NCT03042468|463964788|FG004|Overall Study|Lost to Follow-up|1|||
128910471|NCT03042468|463964789|FG005|Overall Study|Lost to Follow-up|1|||
128910472|NCT00253630|463964790|FG000|Overall Study|ineligible|2|||
128910473|NCT00429858|463964791|FG000|Overall Study|Withdrawal by Subject|1|||
128910474|NCT00429858|463964791|FG000|Overall Study|Study Termination|1|||
128910475|NCT01587079|463964792|FG000|Overall Study|Protocol-specified criteria|9|||
128910476|NCT01587079|463964792|FG000|Overall Study|Protocol Violation|5|||
128910477|NCT01587079|463964792|FG000|Overall Study|Lost to Follow-up|2|||
128910478|NCT01587079|463964792|FG000|Overall Study|Physician Decision|2|||
128910479|NCT01587079|463964792|FG000|Overall Study|Withdrawal by Subject|7|||
128910480|NCT01587079|463964792|FG000|Overall Study|Adverse Event|14|||
128910481|NCT01239160|463964794|FG000|Overall Study|Lost to Follow-up|3|||
128910482|NCT01239160|463964795|FG001|Overall Study|Lost to Follow-up|5|||
128910483|NCT01239160|463964796|FG002|Overall Study|Lost to Follow-up|0|||
128910484|NCT01239160|463964794|FG000|Overall Study|Withdrawal by Subject|17|||
128910485|NCT01239160|463964795|FG001|Overall Study|Withdrawal by Subject|6|||
128910486|NCT01239160|463964796|FG002|Overall Study|Withdrawal by Subject|2|||
128910487|NCT01239160|463964794|FG000|Overall Study|Physician Decision|5|||
129118175|NCT01677741|464728973|FG005|Overall Study|Death|1|||
129118176|NCT01677741|464728974|FG006|Overall Study|Death|0|||
129118177|NCT01677741|464728975|FG007|Overall Study|Death|0|||
129118178|NCT01677741|464728968|FG000|Overall Study|Withdrawal by Subject|2|||
129118179|NCT01677741|464728969|FG001|Overall Study|Withdrawal by Subject|7|||
129118180|NCT01677741|464728970|FG002|Overall Study|Withdrawal by Subject|5|||
128910488|NCT01239160|463964795|FG001|Overall Study|Physician Decision|7|||
129118181|NCT01677741|464728971|FG003|Overall Study|Withdrawal by Subject|4|||
128910489|NCT01239160|463964796|FG002|Overall Study|Physician Decision|2|||
128910490|NCT01239160|463964794|FG000|Overall Study|Early Termination Due to Study Closure|0|||
128910491|NCT01239160|463964795|FG001|Overall Study|Early Termination Due to Study Closure|1|||
128910492|NCT01239160|463964796|FG002|Overall Study|Early Termination Due to Study Closure|6|||
128910493|NCT02268058|463964797|FG000|Overall Study|Protocol Violation|1|||
128910494|NCT02268058|463964798|FG001|Overall Study|Protocol Violation|0|||
129118182|NCT01677741|464728972|FG004|Overall Study|Withdrawal by Subject|11|||
128910495|NCT02268058|463964799|FG002|Overall Study|Protocol Violation|0|||
128910496|NCT02268058|463964800|FG003|Overall Study|Protocol Violation|0|||
128910497|NCT04781816|463964802|FG000|Overall Study|Adverse Event|0|||
128910498|NCT04781816|463964803|FG001|Overall Study|Adverse Event|1|||
128910499|NCT04781816|463964802|FG000|Overall Study|Withdrawal by Subject|1|||
128910500|NCT04781816|463964803|FG001|Overall Study|Withdrawal by Subject|1|||
128910501|NCT04781816|463964802|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
128910502|NCT04781816|463964803|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
128910503|NCT01789970|463964804|FG000|Open-label Titration Period|Adverse Event|68|||
128910504|NCT01789970|463964805|FG001|Open-label Titration Period|Adverse Event|0|||
128910505|NCT01789970|463964806|FG002|Open-label Titration Period|Adverse Event|0|||
128910506|NCT01789970|463964804|FG000|Open-label Titration Period|Lack of Efficacy|31|||
128910507|NCT01789970|463964805|FG001|Open-label Titration Period|Lack of Efficacy|0|||
128910508|NCT01789970|463964806|FG002|Open-label Titration Period|Lack of Efficacy|0|||
128910509|NCT01789970|463964804|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
128910510|NCT01789970|463964805|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
128910511|NCT01789970|463964806|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
128910512|NCT01789970|463964804|FG000|Open-label Titration Period|Protocol Violation|18|||
128910513|NCT01789970|463964805|FG001|Open-label Titration Period|Protocol Violation|0|||
128910514|NCT01789970|463964806|FG002|Open-label Titration Period|Protocol Violation|0|||
128910515|NCT01789970|463964804|FG000|Open-label Titration Period|Lost to Follow-up|5|||
128910516|NCT01789970|463964805|FG001|Open-label Titration Period|Lost to Follow-up|0|||
128910517|NCT01789970|463964806|FG002|Open-label Titration Period|Lost to Follow-up|0|||
128910518|NCT01789970|463964804|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
128910519|NCT01789970|463964805|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
128910520|NCT01789970|463964806|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
128910521|NCT01789970|463964804|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
128910522|NCT01789970|463964805|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
128910523|NCT01789970|463964806|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
128910524|NCT01789970|463964804|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
128910525|NCT01789970|463964805|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
128910526|NCT01789970|463964806|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
128910527|NCT01789970|463964804|FG000|Open-label Titration Period|Pregnancy|2|||
128910528|NCT01789970|463964805|FG001|Open-label Titration Period|Pregnancy|0|||
128910529|NCT01789970|463964806|FG002|Open-label Titration Period|Pregnancy|0|||
128910530|NCT01789970|463964804|FG000|Open-label Titration Period|Other|76|||
128910531|NCT01789970|463964805|FG001|Open-label Titration Period|Other|0|||
128910532|NCT01789970|463964806|FG002|Open-label Titration Period|Other|0|||
128910533|NCT01789970|463964804|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
128910534|NCT01789970|463964805|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
128910535|NCT01789970|463964806|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
128910536|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
128910537|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
128910538|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
128910539|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
128910540|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
128910541|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
128910542|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
128910543|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
128910544|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
128910545|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
128910546|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
128910547|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
128910548|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
128910549|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
128910550|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
128910551|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
128910552|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
128910553|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
128910554|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
128910555|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
128910556|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
128910557|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
128910558|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
128910559|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
128910560|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
128910561|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
128910562|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
128910563|NCT01789970|463964804|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
128910564|NCT01789970|463964805|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
128910565|NCT01789970|463964806|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
128910566|NCT02296242|463964811|FG000|Overall Study|Death|1|||
128910567|NCT02296242|463964812|FG001|Overall Study|Death|1|||
128910568|NCT02296242|463964813|FG002|Overall Study|Death|1|||
128910569|NCT02296242|463964814|FG003|Overall Study|Death|1|||
128910570|NCT02296242|463964815|FG004|Overall Study|Death|1|||
128910571|NCT02296242|463964811|FG000|Overall Study|Withdrawal by Subject|0|||
128910572|NCT02296242|463964812|FG001|Overall Study|Withdrawal by Subject|0|||
128910573|NCT02296242|463964813|FG002|Overall Study|Withdrawal by Subject|1|||
128910574|NCT02296242|463964814|FG003|Overall Study|Withdrawal by Subject|1|||
128910575|NCT02296242|463964815|FG004|Overall Study|Withdrawal by Subject|3|||
128910576|NCT02296242|463964811|FG000|Overall Study|Disease Progression|1|||
128910577|NCT02296242|463964812|FG001|Overall Study|Disease Progression|3|||
128910578|NCT02296242|463964813|FG002|Overall Study|Disease Progression|2|||
128910579|NCT02296242|463964814|FG003|Overall Study|Disease Progression|8|||
128910580|NCT02296242|463964815|FG004|Overall Study|Disease Progression|11|||
128910581|NCT02296242|463964811|FG000|Overall Study|Unacceptable Toxicity|0|||
128910582|NCT02296242|463964812|FG001|Overall Study|Unacceptable Toxicity|0|||
128910583|NCT02296242|463964813|FG002|Overall Study|Unacceptable Toxicity|0|||
128910584|NCT02296242|463964814|FG003|Overall Study|Unacceptable Toxicity|0|||
128910585|NCT02296242|463964815|FG004|Overall Study|Unacceptable Toxicity|1|||
128910586|NCT02296242|463964811|FG000|Overall Study|Patient Condition Changed|0|||
128910587|NCT02296242|463964812|FG001|Overall Study|Patient Condition Changed|0|||
128910588|NCT02296242|463964813|FG002|Overall Study|Patient Condition Changed|2|||
128910589|NCT02296242|463964814|FG003|Overall Study|Patient Condition Changed|0|||
128910590|NCT02296242|463964815|FG004|Overall Study|Patient Condition Changed|1|||
128910591|NCT02296242|463964811|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
128910592|NCT02296242|463964812|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
128910593|NCT02296242|463964813|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
128910594|NCT02296242|463964814|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
128910595|NCT02296242|463964815|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
128910596|NCT02296242|463964811|FG000|Overall Study|Lost to Follow-up|1|||
128910597|NCT02296242|463964812|FG001|Overall Study|Lost to Follow-up|0|||
128910598|NCT02296242|463964813|FG002|Overall Study|Lost to Follow-up|0|||
128910599|NCT02296242|463964814|FG003|Overall Study|Lost to Follow-up|0|||
128910600|NCT02296242|463964815|FG004|Overall Study|Lost to Follow-up|0|||
128910601|NCT02296242|463964811|FG000|Overall Study|Need for Hydroxyurea|2|||
128910602|NCT02296242|463964812|FG001|Overall Study|Need for Hydroxyurea|0|||
128910603|NCT02296242|463964813|FG002|Overall Study|Need for Hydroxyurea|0|||
128910604|NCT02296242|463964814|FG003|Overall Study|Need for Hydroxyurea|0|||
128910605|NCT02296242|463964815|FG004|Overall Study|Need for Hydroxyurea|0|||
128910606|NCT02296242|463964811|FG000|Overall Study|Screened for Other Protocol|0|||
128910607|NCT02296242|463964812|FG001|Overall Study|Screened for Other Protocol|1|||
128910608|NCT02296242|463964813|FG002|Overall Study|Screened for Other Protocol|0|||
128910609|NCT02296242|463964814|FG003|Overall Study|Screened for Other Protocol|0|||
128910610|NCT02296242|463964815|FG004|Overall Study|Screened for Other Protocol|0|||
128910611|NCT02296242|463964811|FG000|Overall Study|Physician Decision|0|||
128910612|NCT02296242|463964812|FG001|Overall Study|Physician Decision|1|||
128910613|NCT02296242|463964813|FG002|Overall Study|Physician Decision|0|||
128910614|NCT02296242|463964814|FG003|Overall Study|Physician Decision|1|||
128910615|NCT02296242|463964815|FG004|Overall Study|Physician Decision|0|||
128910616|NCT02296242|463964811|FG000|Overall Study|Alternative Treatment|0|||
128910617|NCT02296242|463964812|FG001|Overall Study|Alternative Treatment|0|||
128910618|NCT02296242|463964813|FG002|Overall Study|Alternative Treatment|0|||
128910619|NCT02296242|463964814|FG003|Overall Study|Alternative Treatment|1|||
128910620|NCT02296242|463964815|FG004|Overall Study|Alternative Treatment|0|||
128910621|NCT02296242|463964811|FG000|Overall Study|Adverse Event|0|||
128910622|NCT02296242|463964812|FG001|Overall Study|Adverse Event|0|||
128910623|NCT02296242|463964813|FG002|Overall Study|Adverse Event|0|||
128910624|NCT02296242|463964814|FG003|Overall Study|Adverse Event|1|||
128910625|NCT02296242|463964815|FG004|Overall Study|Adverse Event|0|||
128910626|NCT02296242|463964811|FG000|Overall Study|Lack of Efficacy|0|||
128910627|NCT02296242|463964812|FG001|Overall Study|Lack of Efficacy|0|||
128910628|NCT02296242|463964813|FG002|Overall Study|Lack of Efficacy|0|||
128910629|NCT02296242|463964814|FG003|Overall Study|Lack of Efficacy|0|||
128910630|NCT02296242|463964815|FG004|Overall Study|Lack of Efficacy|3|||
128910631|NCT02217566|463964816|FG000|Overall Study|Lost to Follow-up|2|||
128765344|NCT02969525|463432145|FG007|Double-Blind Period|Adverse Event|0|||
128910632|NCT02217566|463964816|FG000|Overall Study|Death|3|||
128910633|NCT02217566|463964816|FG000|Overall Study|Early study termination|6|||
128910634|NCT01639833|463964817|FG000|Overall Study|Death|4|||
128910635|NCT01639833|463964818|FG001|Overall Study|Death|2|||
128910636|NCT01639833|463964817|FG000|Overall Study|Withdrawal by Subject|2|||
128910637|NCT01639833|463964818|FG001|Overall Study|Withdrawal by Subject|2|||
128910638|NCT00608985|463964827|FG000|Overall Study|Adverse Event|2|||
128910639|NCT00608985|463964828|FG001|Overall Study|Adverse Event|7|||
128910640|NCT00608985|463964829|FG002|Overall Study|Adverse Event|4|||
128910641|NCT00608985|463964830|FG003|Overall Study|Adverse Event|6|||
128910642|NCT00608985|463964827|FG000|Overall Study|Administrative/Other|7|||
128910643|NCT00608985|463964828|FG001|Overall Study|Administrative/Other|4|||
128910644|NCT00608985|463964829|FG002|Overall Study|Administrative/Other|1|||
128910645|NCT00608985|463964830|FG003|Overall Study|Administrative/Other|2|||
128910646|NCT00608985|463964827|FG000|Overall Study|Withdrawal of Consent|5|||
128910647|NCT00608985|463964828|FG001|Overall Study|Withdrawal of Consent|1|||
128910648|NCT00608985|463964829|FG002|Overall Study|Withdrawal of Consent|1|||
128910649|NCT00608985|463964830|FG003|Overall Study|Withdrawal of Consent|1|||
128910650|NCT00608985|463964827|FG000|Overall Study|Lost to Follow-up|2|||
128910651|NCT00608985|463964828|FG001|Overall Study|Lost to Follow-up|1|||
128910652|NCT00608985|463964829|FG002|Overall Study|Lost to Follow-up|0|||
128910653|NCT00608985|463964830|FG003|Overall Study|Lost to Follow-up|0|||
128910654|NCT03033745|463964831|FG000|Overall Study|Protocol Violation|0|||
128910655|NCT03033745|463964832|FG001|Overall Study|Protocol Violation|0|||
128910656|NCT03033745|463964833|FG002|Overall Study|Protocol Violation|1|||
128910657|NCT03033745|463964831|FG000|Overall Study|Adverse Event|1|||
128910658|NCT03033745|463964832|FG001|Overall Study|Adverse Event|0|||
128910659|NCT03033745|463964833|FG002|Overall Study|Adverse Event|1|||
128910660|NCT03033745|463964831|FG000|Overall Study|Withdrawal by Subject|0|||
128910661|NCT03033745|463964832|FG001|Overall Study|Withdrawal by Subject|1|||
128910662|NCT03033745|463964833|FG002|Overall Study|Withdrawal by Subject|0|||
128910663|NCT02436876|463964844|FG000|Overall Study|Lost to Follow-up|0|||
128910664|NCT02436876|463964845|FG001|Overall Study|Lost to Follow-up|1|||
128910665|NCT02436876|463964846|FG002|Overall Study|Lost to Follow-up|1|||
128910666|NCT02436876|463964847|FG003|Overall Study|Lost to Follow-up|1|||
128910667|NCT02436876|463964844|FG000|Overall Study|Withdrawal by Subject|1|||
128910668|NCT02436876|463964845|FG001|Overall Study|Withdrawal by Subject|0|||
128910669|NCT02436876|463964846|FG002|Overall Study|Withdrawal by Subject|0|||
128910670|NCT02436876|463964847|FG003|Overall Study|Withdrawal by Subject|1|||
128910671|NCT02436876|463964844|FG000|Overall Study|Physician Decision|0|||
128910672|NCT02436876|463964845|FG001|Overall Study|Physician Decision|2|||
128910673|NCT02436876|463964846|FG002|Overall Study|Physician Decision|1|||
128910674|NCT02436876|463964847|FG003|Overall Study|Physician Decision|0|||
128910675|NCT02436876|463964844|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
128910676|NCT02436876|463964845|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
128910677|NCT02436876|463964846|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
128910678|NCT02436876|463964847|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
128910679|NCT03403205|463964848|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
128910680|NCT03403205|463964849|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
128910681|NCT03403205|463964850|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
128910682|NCT03403205|463964851|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
128910683|NCT03403205|463964852|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
128910684|NCT03403205|463964853|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
128910685|NCT03403205|463964848|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
128910686|NCT03403205|463964849|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128910687|NCT03403205|463964850|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
128910688|NCT03403205|463964851|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128910689|NCT03403205|463964852|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128910690|NCT03403205|463964853|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128910691|NCT03403205|463964848|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
128910692|NCT03403205|463964849|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
128910693|NCT03403205|463964850|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
128910694|NCT03403205|463964851|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
128910695|NCT03403205|463964852|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
128910696|NCT03403205|463964853|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
128910697|NCT03403205|463964848|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
128910698|NCT03403205|463964849|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
128910699|NCT03403205|463964850|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
128910700|NCT03403205|463964851|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
128910701|NCT03403205|463964852|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
129028101|NCT00521586|464394471|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
129028102|NCT00521586|464394470|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
129028103|NCT00521586|464394471|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
129028104|NCT00521586|464394470|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
129028105|NCT00521586|464394471|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
129028106|NCT03234907|464394472|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
128910702|NCT03403205|463964853|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
128910703|NCT03403205|463964848|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
128910704|NCT03403205|463964849|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
128696881|NCT05154578|463188914|FG004|Overall Study|Withdrawal by Subject|0|||
128696882|NCT05154578|463188910|FG000|Overall Study|Lost to Follow-up|0|||
128910705|NCT03403205|463964850|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
128910706|NCT03403205|463964851|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
128910707|NCT03403205|463964852|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
128910708|NCT03403205|463964853|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
128910709|NCT03403205|463964848|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
128910710|NCT03403205|463964849|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
128910711|NCT03403205|463964850|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
128910712|NCT03403205|463964851|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
128910713|NCT03403205|463964852|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
128910714|NCT03403205|463964853|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
128910715|NCT03403205|463964848|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
128910716|NCT03403205|463964849|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
128910717|NCT03403205|463964850|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
128910718|NCT03403205|463964851|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
128910719|NCT03403205|463964852|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
128910720|NCT03403205|463964853|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
128910721|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
128910722|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
128910723|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
128910724|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
128910725|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
128696883|NCT05154578|463188911|FG001|Overall Study|Lost to Follow-up|1|||
128696884|NCT05154578|463188912|FG002|Overall Study|Lost to Follow-up|0|||
128910726|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
128910727|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
128910728|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
128910729|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
128910730|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
128910731|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
128910732|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
128910733|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Death|1|||
128910734|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Death|0|||
128910735|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Death|0|||
128910736|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Death|0|||
128696885|NCT05154578|463188913|FG003|Overall Study|Lost to Follow-up|3|||
128696886|NCT05154578|463188914|FG004|Overall Study|Lost to Follow-up|0|||
128910737|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Death|0|||
128910738|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Death|0|||
128910739|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
128910740|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
128910741|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
128910742|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
128910743|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
128910744|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
128910745|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
128910746|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
128910747|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
128910748|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
128910749|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
128910750|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
128910751|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
128910752|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
128910753|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
128910754|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
128910755|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
128910756|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
128910757|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
128910758|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
128910759|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
128910760|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
128696887|NCT05154578|463188910|FG000|Overall Study|Adverse Event|0|||
128696888|NCT05154578|463188911|FG001|Overall Study|Adverse Event|0|||
128696889|NCT05154578|463188912|FG002|Overall Study|Adverse Event|0|||
128910761|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
128910762|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
128910763|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
128910764|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
128910765|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
128910766|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
128910767|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
128910768|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
128910769|NCT03403205|463964848|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
128910770|NCT03403205|463964849|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
128910771|NCT03403205|463964850|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
128910772|NCT03403205|463964851|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
128910773|NCT03403205|463964852|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
128910774|NCT03403205|463964853|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
128696890|NCT05154578|463188913|FG003|Overall Study|Adverse Event|1|||
128696891|NCT05154578|463188914|FG004|Overall Study|Adverse Event|0|||
128696892|NCT05154578|463188910|FG000|Overall Study|Relocated to another province|0|||
128696893|NCT05154578|463188911|FG001|Overall Study|Relocated to another province|0|||
128696894|NCT05154578|463188912|FG002|Overall Study|Relocated to another province|1|||
128696895|NCT05154578|463188913|FG003|Overall Study|Relocated to another province|0|||
128696896|NCT05154578|463188914|FG004|Overall Study|Relocated to another province|1|||
128696897|NCT05154578|463188910|FG000|Overall Study|Baby loss|0|||
128696898|NCT05154578|463188911|FG001|Overall Study|Baby loss|1|||
128696899|NCT05154578|463188912|FG002|Overall Study|Baby loss|0|||
128696900|NCT05154578|463188913|FG003|Overall Study|Baby loss|0|||
128696901|NCT05154578|463188914|FG004|Overall Study|Baby loss|0|||
128696902|NCT04572633|463188920|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
128696903|NCT02924571|463188921|FG000|Overall Study|Lost to Follow-up|1|||
128696904|NCT02924571|463188922|FG001|Overall Study|Lost to Follow-up|1|||
128696905|NCT02924571|463188923|FG002|Overall Study|Lost to Follow-up|0|||
128696906|NCT00434954|463188924|FG000|Overall Study|Adverse Event|17|||
128696907|NCT00434954|463188925|FG001|Overall Study|Adverse Event|2|||
128696908|NCT00434954|463188924|FG000|Overall Study|Entry criteria not met|14|||
128696909|NCT00434954|463188925|FG001|Overall Study|Entry criteria not met|16|||
128696910|NCT00434954|463188924|FG000|Overall Study|Lost to Follow-up|0|||
128696911|NCT00434954|463188925|FG001|Overall Study|Lost to Follow-up|1|||
128696912|NCT00434954|463188924|FG000|Overall Study|Physician Decision|6|||
128696913|NCT00434954|463188925|FG001|Overall Study|Physician Decision|3|||
128696914|NCT00434954|463188924|FG000|Overall Study|Protocol Violation|36|||
128696915|NCT00434954|463188925|FG001|Overall Study|Protocol Violation|27|||
128696916|NCT00434954|463188924|FG000|Overall Study|Sponsor decision|1|||
128696917|NCT00434954|463188925|FG001|Overall Study|Sponsor decision|0|||
128696918|NCT00434954|463188924|FG000|Overall Study|Subject decision|8|||
128696919|NCT00434954|463188925|FG001|Overall Study|Subject decision|22|||
128696920|NCT00894166|463188926|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
128696921|NCT00894166|463188927|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
128696922|NCT00894166|463188928|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
128696923|NCT00894166|463188929|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
128696924|NCT00894166|463188930|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
128696925|NCT00894166|463188931|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
128696926|NCT00894166|463188932|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
128696927|NCT00894166|463188933|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
128696928|NCT00894166|463188926|FG000|Overall Study|Death|0|||
128696929|NCT00894166|463188927|FG001|Overall Study|Death|0|||
128696930|NCT00894166|463188928|FG002|Overall Study|Death|0|||
128696931|NCT00894166|463188929|FG003|Overall Study|Death|1|||
128696932|NCT00894166|463188930|FG004|Overall Study|Death|0|||
128696933|NCT00894166|463188931|FG005|Overall Study|Death|0|||
128696934|NCT00894166|463188932|FG006|Overall Study|Death|0|||
128696935|NCT00894166|463188933|FG007|Overall Study|Death|0|||
128696936|NCT03750955|463188941|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
128696937|NCT03750955|463188942|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
128910775|NCT01834729|463964854|FG000|Overall Study|Did not return bowel diaries|0|||
128696938|NCT03750955|463188941|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
128696939|NCT03750955|463188942|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
128696940|NCT01180985|463188945|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
128696941|NCT01180985|463188946|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
128696942|NCT00129272|463188951|FG000|Overall Study|Lost to Follow-up|12|||
128696943|NCT00129272|463188952|FG001|Overall Study|Lost to Follow-up|11|||
128696944|NCT00129272|463188951|FG000|Overall Study|Withdrawal by Subject|5|||
128696945|NCT00129272|463188952|FG001|Overall Study|Withdrawal by Subject|11|||
128696946|NCT03345914|463188953|FG000|Overall Study|Transition to another study at week 16|80|||
128696947|NCT03345914|463188954|FG001|Overall Study|Transition to another study at week 16|86|||
128765345|NCT02969525|463432146|FG008|Double-Blind Period|Adverse Event|0|||
128910776|NCT01834729|463964855|FG001|Overall Study|Did not return bowel diaries|0|||
128910777|NCT01834729|463964856|FG002|Overall Study|Did not return bowel diaries|3|||
128910778|NCT01834729|463964857|FG003|Overall Study|Did not return bowel diaries|0|||
128910779|NCT01834729|463964854|FG000|Overall Study|Withdrawal by Subject|1|||
128910780|NCT01834729|463964855|FG001|Overall Study|Withdrawal by Subject|1|||
128910781|NCT01834729|463964856|FG002|Overall Study|Withdrawal by Subject|0|||
128910782|NCT01834729|463964857|FG003|Overall Study|Withdrawal by Subject|0|||
128910783|NCT01834729|463964854|FG000|Overall Study|Adverse Event|0|||
128910784|NCT01834729|463964855|FG001|Overall Study|Adverse Event|0|||
128910785|NCT01834729|463964856|FG002|Overall Study|Adverse Event|0|||
128910786|NCT01834729|463964857|FG003|Overall Study|Adverse Event|2|||
128910787|NCT02971670|463964858|FG000|Overall Study|Withdrawal by Subject|4|||
128910788|NCT02971670|463964859|FG001|Overall Study|Withdrawal by Subject|1|||
128910789|NCT02971670|463964860|FG002|Overall Study|Withdrawal by Subject|1|||
128910790|NCT02971670|463964861|FG003|Overall Study|Withdrawal by Subject|2|||
128910791|NCT00288080|463964862|FG000|Overall Study|Withdrawal by Subject|1|||
128910792|NCT00288080|463964863|FG001|Overall Study|Withdrawal by Subject|3|||
128910793|NCT00288080|463964862|FG000|Overall Study|Protocol Violation|25|||
128910794|NCT00288080|463964863|FG001|Overall Study|Protocol Violation|20|||
128910795|NCT02387580|463964867|FG000|Overall Study|Withdrawal by Subject|0|||
128910796|NCT02387580|463964868|FG001|Overall Study|Withdrawal by Subject|0|||
128910797|NCT02387580|463964869|FG002|Overall Study|Withdrawal by Subject|0|||
128910798|NCT02387580|463964870|FG003|Overall Study|Withdrawal by Subject|1|||
128910799|NCT02387580|463964871|FG004|Overall Study|Withdrawal by Subject|0|||
128910800|NCT02387580|463964872|FG005|Overall Study|Withdrawal by Subject|0|||
128910801|NCT06098729|463964875|FG000|Overall Study|Withdrawal by Subject|1|||
128910802|NCT03033875|463964881|FG000|Overall Study|Withdrawal by Subject|5|||
128910803|NCT03033875|463964882|FG001|Overall Study|Withdrawal by Subject|9|||
128910804|NCT03033875|463964883|FG002|Overall Study|Withdrawal by Subject|4|||
128910805|NCT03033875|463964881|FG000|Overall Study|Other|14|||
128910806|NCT03033875|463964882|FG001|Overall Study|Other|15|||
128910807|NCT03033875|463964883|FG002|Overall Study|Other|8|||
128910808|NCT01972074|463964886|FG000|Overall Study|Adverse Event|4|||
128910809|NCT01972074|463964887|FG001|Overall Study|Adverse Event|1|||
128910810|NCT01972074|463964888|FG002|Overall Study|Adverse Event|0|||
128910811|NCT01972074|463964886|FG000|Overall Study|Lack of Efficacy|1|||
128910812|NCT01972074|463964887|FG001|Overall Study|Lack of Efficacy|1|||
128910813|NCT01972074|463964888|FG002|Overall Study|Lack of Efficacy|0|||
128910814|NCT01972074|463964886|FG000|Overall Study|Lost to Follow-up|0|||
128910815|NCT01972074|463964887|FG001|Overall Study|Lost to Follow-up|1|||
128910816|NCT01972074|463964888|FG002|Overall Study|Lost to Follow-up|1|||
128910817|NCT01972074|463964886|FG000|Overall Study|Withdrawal by Subject|1|||
128910818|NCT01972074|463964887|FG001|Overall Study|Withdrawal by Subject|1|||
128910819|NCT01972074|463964888|FG002|Overall Study|Withdrawal by Subject|1|||
128910820|NCT01972074|463964886|FG000|Overall Study|Scanner Unavailable|0|||
128910821|NCT01972074|463964887|FG001|Overall Study|Scanner Unavailable|0|||
128910822|NCT01972074|463964888|FG002|Overall Study|Scanner Unavailable|1|||
128910823|NCT05574062|463964889|FG000|Pre Run-In|Screening failure|3|||
128910824|NCT05574062|463964890|FG001|Pre Run-In|Screening failure|0|||
129118183|NCT01677741|464728973|FG005|Overall Study|Withdrawal by Subject|20|||
129118184|NCT01677741|464728974|FG006|Overall Study|Withdrawal by Subject|4|||
129118185|NCT01677741|464728975|FG007|Overall Study|Withdrawal by Subject|2|||
129118186|NCT01677741|464728968|FG000|Overall Study|Enrolled in a rollover study|0|||
129118187|NCT01677741|464728969|FG001|Overall Study|Enrolled in a rollover study|3|||
129118188|NCT01677741|464728970|FG002|Overall Study|Enrolled in a rollover study|2|||
129118189|NCT01677741|464728971|FG003|Overall Study|Enrolled in a rollover study|1|||
129118190|NCT01677741|464728972|FG004|Overall Study|Enrolled in a rollover study|6|||
129118191|NCT01677741|464728973|FG005|Overall Study|Enrolled in a rollover study|6|||
129118192|NCT01677741|464728974|FG006|Overall Study|Enrolled in a rollover study|7|||
129118193|NCT01677741|464728975|FG007|Overall Study|Enrolled in a rollover study|0|||
129118194|NCT01677741|464728968|FG000|Overall Study|Progressive disease|1|||
129118195|NCT01677741|464728969|FG001|Overall Study|Progressive disease|0|||
129118196|NCT01677741|464728970|FG002|Overall Study|Progressive disease|1|||
129118197|NCT01677741|464728971|FG003|Overall Study|Progressive disease|0|||
129118198|NCT01677741|464728972|FG004|Overall Study|Progressive disease|0|||
128765346|NCT02969525|463432147|FG009|Double-Blind Period|Adverse Event|0|||
129118199|NCT01677741|464728973|FG005|Overall Study|Progressive disease|1|||
129215435|NCT00771758|465091192|FG002|Overall Study|Other|0|||
128910825|NCT05574062|463964891|FG002|Pre Run-In|Screening failure|0|||
128910826|NCT05574062|463964892|FG003|Pre Run-In|Screening failure|0|||
128910827|NCT05574062|463964893|FG004|Pre Run-In|Screening failure|0|||
128910828|NCT05574062|463964889|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
128910829|NCT05574062|463964890|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
128910830|NCT05574062|463964891|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
128910831|NCT05574062|463964892|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
128910832|NCT05574062|463964893|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
129118200|NCT01677741|464728974|FG006|Overall Study|Progressive disease|0|||
128910833|NCT05574062|463964889|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
128910834|NCT05574062|463964890|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
128910835|NCT05574062|463964891|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
128910836|NCT05574062|463964892|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
128910837|NCT05574062|463964893|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
128910838|NCT05574062|463964889|FG000|Continuation Phase Period 1|Physician Decision|1|||
128910839|NCT05574062|463964890|FG001|Continuation Phase Period 1|Physician Decision|0|||
128910840|NCT05574062|463964891|FG002|Continuation Phase Period 1|Physician Decision|0|||
128910841|NCT05574062|463964892|FG003|Continuation Phase Period 1|Physician Decision|0|||
128910842|NCT05574062|463964893|FG004|Continuation Phase Period 1|Physician Decision|0|||
128910843|NCT05574062|463964889|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
128910844|NCT05574062|463964890|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
128910845|NCT05574062|463964891|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
128910846|NCT05574062|463964892|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
128910847|NCT05574062|463964893|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
128910848|NCT05574062|463964889|FG000|Continuation Phase Period 1|Adverse Event|1|||
128910849|NCT05574062|463964890|FG001|Continuation Phase Period 1|Adverse Event|0|||
128910850|NCT05574062|463964891|FG002|Continuation Phase Period 1|Adverse Event|0|||
128910851|NCT05574062|463964892|FG003|Continuation Phase Period 1|Adverse Event|0|||
128910852|NCT05574062|463964893|FG004|Continuation Phase Period 1|Adverse Event|0|||
129118201|NCT01677741|464728975|FG007|Overall Study|Progressive disease|0|||
128910853|NCT05574062|463964889|FG000|Continuation Phase Period 1|Death|1|||
128910854|NCT05574062|463964890|FG001|Continuation Phase Period 1|Death|0|||
128910855|NCT05574062|463964891|FG002|Continuation Phase Period 1|Death|0|||
128910856|NCT05574062|463964892|FG003|Continuation Phase Period 1|Death|0|||
128910857|NCT05574062|463964893|FG004|Continuation Phase Period 1|Death|0|||
128910858|NCT05574062|463964889|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
128910859|NCT05574062|463964890|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
128910860|NCT05574062|463964891|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
128910861|NCT05574062|463964892|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
128910862|NCT05574062|463964893|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
128910863|NCT03864653|463964896|FG000|Overall Study|Withdrawal by Subject|1|||
128910864|NCT00546052|463964897|FG000|Overall Study|Adverse Event|47|||
128910865|NCT00546052|463964897|FG000|Overall Study|Lost to Follow-up|144|||
128910866|NCT00546052|463964897|FG000|Overall Study|Protocol Violation|9|||
128910867|NCT00546052|463964897|FG000|Overall Study|Withdrawal by Subject|20|||
128910868|NCT00546052|463964897|FG000|Overall Study|Non Compliance|7|||
128910869|NCT01928381|463964900|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
128910870|NCT01928381|463964901|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
128910871|NCT01928381|463964902|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
128910872|NCT01928381|463964903|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
128910873|NCT01928381|463964904|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
128910874|NCT01928381|463964905|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
128910875|NCT01928381|463964906|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
128910876|NCT01928381|463964900|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
128910877|NCT01928381|463964901|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
128910878|NCT01928381|463964902|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
128910879|NCT01928381|463964903|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
128910880|NCT01928381|463964904|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
128910881|NCT01928381|463964905|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
128910882|NCT01928381|463964906|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
128910883|NCT01928381|463964900|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
128910884|NCT01928381|463964901|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
128910885|NCT01928381|463964902|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
128910886|NCT01928381|463964903|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
128910887|NCT01928381|463964904|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
128910888|NCT01928381|463964905|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
128910889|NCT01928381|463964906|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
128910890|NCT01928381|463964900|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
128910891|NCT01928381|463964901|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
128910892|NCT01928381|463964902|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
128910893|NCT01928381|463964903|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
129118202|NCT00720499|464728976|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
129118203|NCT00720499|464728977|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
128910894|NCT01928381|463964904|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
128910895|NCT01928381|463964905|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
128910896|NCT01928381|463964906|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
128910897|NCT01928381|463964900|FG000|Part 1 - Pain Training|Protocol Violation|1|||
128910898|NCT01928381|463964901|FG001|Part 1 - Pain Training|Protocol Violation|0|||
128910899|NCT01928381|463964902|FG002|Part 1 - Pain Training|Protocol Violation|0|||
128910900|NCT01928381|463964903|FG003|Part 1 - Pain Training|Protocol Violation|0|||
128696948|NCT03345914|463188955|FG002|Overall Study|Transition to another study at week 16|78|||
128696949|NCT03345914|463188953|FG000|Overall Study|Transition to OLE during follow-up|37|||
128696950|NCT03345914|463188954|FG001|Overall Study|Transition to OLE during follow-up|33|||
128696951|NCT03345914|463188955|FG002|Overall Study|Transition to OLE during follow-up|39|||
128696952|NCT03345914|463188953|FG000|Overall Study|Physician Decision|0|||
128696953|NCT03345914|463188954|FG001|Overall Study|Physician Decision|1|||
128696954|NCT03345914|463188955|FG002|Overall Study|Physician Decision|1|||
128910901|NCT01928381|463964904|FG004|Part 1 - Pain Training|Protocol Violation|0|||
128910902|NCT01928381|463964905|FG005|Part 1 - Pain Training|Protocol Violation|0|||
128910903|NCT01928381|463964906|FG006|Part 1 - Pain Training|Protocol Violation|0|||
128910904|NCT01928381|463964900|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
128910905|NCT01928381|463964901|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
128910906|NCT01928381|463964902|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
128910907|NCT01928381|463964903|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
128910908|NCT01928381|463964904|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
128910909|NCT01928381|463964905|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
128910910|NCT01928381|463964906|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
128910911|NCT01928381|463964900|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
128910912|NCT01928381|463964901|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
128910913|NCT01928381|463964902|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
128910914|NCT01928381|463964903|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
128910915|NCT01928381|463964904|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
128910916|NCT01928381|463964905|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
128910917|NCT01928381|463964906|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
128910918|NCT01928381|463964900|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
128910919|NCT01928381|463964901|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
128910920|NCT01928381|463964902|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
128910921|NCT01928381|463964903|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
128910922|NCT01928381|463964904|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
128910923|NCT01928381|463964905|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
128910924|NCT01928381|463964906|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
128910925|NCT01928381|463964900|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
128910926|NCT01928381|463964901|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
128910927|NCT01928381|463964902|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
128910928|NCT01928381|463964903|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
128910929|NCT01928381|463964904|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
128910930|NCT01928381|463964905|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
128910931|NCT01928381|463964906|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
128910932|NCT01928381|463964900|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
129118204|NCT00720499|464728976|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
129118205|NCT00720499|464728977|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
129118206|NCT00720499|464728976|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
129118207|NCT00720499|464728977|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
129118208|NCT03641508|464728988|FG000|First Injection|Lost to Follow-up|2|||
129118209|NCT03641508|464728989|FG001|First Injection|Lost to Follow-up|0|||
129118210|NCT03642990|464728990|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
129118211|NCT03642990|464728990|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
129118212|NCT00855218|464728991|FG000|Overall Study|Adverse Event|43|||
129118213|NCT00855218|464728992|FG001|Overall Study|Adverse Event|27|||
129118214|NCT00855218|464728991|FG000|Overall Study|Withdrawal by Subject|10|||
129118215|NCT00855218|464728992|FG001|Overall Study|Withdrawal by Subject|6|||
129118216|NCT00855218|464728991|FG000|Overall Study|Physician Decision|18|||
129118217|NCT00855218|464728992|FG001|Overall Study|Physician Decision|11|||
129118218|NCT00855218|464728991|FG000|Overall Study|Lost to Follow-up|0|||
129118219|NCT00855218|464728992|FG001|Overall Study|Lost to Follow-up|1|||
129118220|NCT00855218|464728991|FG000|Overall Study|Protocol Violation|5|||
129118221|NCT00855218|464728992|FG001|Overall Study|Protocol Violation|9|||
129118222|NCT00855218|464728991|FG000|Overall Study|non-compliant with study drug|3|||
128696955|NCT03345914|463188953|FG000|Overall Study|Withdrawal by Subject|5|||
128765347|NCT02969525|463432148|FG010|Double-Blind Period|Adverse Event|0|||
128910933|NCT01928381|463964901|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
129118223|NCT00855218|464728992|FG001|Overall Study|non-compliant with study drug|1|||
129118224|NCT00855218|464728991|FG000|Overall Study|patient convenience|2|||
129118225|NCT00855218|464728992|FG001|Overall Study|patient convenience|0|||
129118226|NCT00855218|464728991|FG000|Overall Study|technical problems|2|||
129118227|NCT00855218|464728992|FG001|Overall Study|technical problems|1|||
129118228|NCT00855218|464728991|FG000|Overall Study|Still treated with study medication|0|||
128696956|NCT03345914|463188954|FG001|Overall Study|Withdrawal by Subject|1|||
129118229|NCT00855218|464728992|FG001|Overall Study|Still treated with study medication|1|||
128765348|NCT02969525|463432149|FG011|Double-Blind Period|Adverse Event|0|||
128765349|NCT02969525|463432138|FG000|Double-Blind Period|LOW EGFR|0|||
129215436|NCT03067077|465091193|FG000|Overall Study|Did not receive surgery|4|||
128765350|NCT02969525|463432139|FG001|Double-Blind Period|LOW EGFR|0|||
128765351|NCT02969525|463432140|FG002|Double-Blind Period|LOW EGFR|0|||
128765352|NCT02969525|463432141|FG003|Double-Blind Period|LOW EGFR|1|||
128765353|NCT02969525|463432142|FG004|Double-Blind Period|LOW EGFR|0|||
128765354|NCT02969525|463432143|FG005|Double-Blind Period|LOW EGFR|0|||
128765355|NCT02969525|463432144|FG006|Double-Blind Period|LOW EGFR|0|||
128765356|NCT02969525|463432145|FG007|Double-Blind Period|LOW EGFR|0|||
128765357|NCT02969525|463432146|FG008|Double-Blind Period|LOW EGFR|0|||
128765358|NCT02969525|463432147|FG009|Double-Blind Period|LOW EGFR|0|||
128765359|NCT02969525|463432148|FG010|Double-Blind Period|LOW EGFR|0|||
128765360|NCT02969525|463432149|FG011|Double-Blind Period|LOW EGFR|0|||
128765361|NCT02969525|463432138|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
128765362|NCT02969525|463432139|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765363|NCT02969525|463432140|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765364|NCT02969525|463432141|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
128910934|NCT01928381|463964902|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
128910935|NCT01928381|463964903|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
128910936|NCT01928381|463964904|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
128910937|NCT01928381|463964905|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
128910938|NCT01928381|463964906|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
129215437|NCT03067077|465091194|FG001|Overall Study|Did not receive surgery|5|||
129215438|NCT03067077|465091193|FG000|Overall Study|Lost to Follow-up|3|||
129215439|NCT03067077|465091194|FG001|Overall Study|Lost to Follow-up|2|||
129215440|NCT00935584|465091197|FG000|Overall Study|Withdrawal by Subject|9|||
129215441|NCT00935584|465091198|FG001|Overall Study|Withdrawal by Subject|0|||
129215442|NCT00935584|465091197|FG000|Overall Study|Death|3|||
129215443|NCT00935584|465091198|FG001|Overall Study|Death|0|||
129215444|NCT00935584|465091197|FG000|Overall Study|Lost to Follow-up|8|||
129215445|NCT00935584|465091198|FG001|Overall Study|Lost to Follow-up|0|||
129215446|NCT00935584|465091197|FG000|Overall Study|No show|9|||
129215447|NCT00935584|465091198|FG001|Overall Study|No show|0|||
129215448|NCT00935584|465091197|FG000|Overall Study|Relocated|3|||
129215449|NCT00935584|465091198|FG001|Overall Study|Relocated|0|||
129215450|NCT00935584|465091197|FG000|Overall Study|Patient changed provider|3|||
129215451|NCT00935584|465091198|FG001|Overall Study|Patient changed provider|0|||
129215452|NCT00935584|465091197|FG000|Overall Study|Provider dropped out of study|14|||
129215453|NCT00935584|465091198|FG001|Overall Study|Provider dropped out of study|4|||
129215454|NCT00687193|465091199|FG000|Overall Study|Adverse Event|0|||
128910939|NCT01928381|463964900|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
128910940|NCT01928381|463964901|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
128910941|NCT01928381|463964902|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
128910942|NCT01928381|463964903|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
128910943|NCT01928381|463964904|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
128910944|NCT01928381|463964905|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
128910945|NCT01928381|463964906|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
128910946|NCT01928381|463964900|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
128910947|NCT01928381|463964901|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
128910948|NCT01928381|463964902|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
128910949|NCT01928381|463964903|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
128910950|NCT01928381|463964904|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
129215455|NCT00687193|465091200|FG001|Overall Study|Adverse Event|1|||
129215456|NCT00687193|465091201|FG002|Overall Study|Adverse Event|2|||
128765365|NCT02969525|463432142|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765366|NCT02969525|463432143|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765367|NCT02969525|463432144|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765368|NCT02969525|463432145|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765369|NCT02969525|463432146|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765370|NCT02969525|463432147|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765371|NCT02969525|463432148|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128765372|NCT02969525|463432149|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
128910951|NCT01928381|463964905|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
128910952|NCT01928381|463964906|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
128910953|NCT01928381|463964900|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
128910954|NCT01928381|463964901|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
128910955|NCT01928381|463964902|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
129215457|NCT00687193|465091202|FG003|Overall Study|Adverse Event|3|||
129215458|NCT00687193|465091203|FG004|Overall Study|Adverse Event|0|||
129215459|NCT00687193|465091204|FG005|Overall Study|Adverse Event|2|||
129215460|NCT00687193|465091199|FG000|Overall Study|Lack of Efficacy|1|||
129215461|NCT00687193|465091200|FG001|Overall Study|Lack of Efficacy|1|||
129215462|NCT00687193|465091201|FG002|Overall Study|Lack of Efficacy|0|||
128696957|NCT03345914|463188955|FG002|Overall Study|Withdrawal by Subject|2|||
128696958|NCT03345914|463188953|FG000|Overall Study|Other|1|||
128696959|NCT03345914|463188954|FG001|Overall Study|Other|1|||
128696960|NCT03345914|463188955|FG002|Overall Study|Other|1|||
128696961|NCT03345914|463188953|FG000|Overall Study|Ongoing|0|||
128696962|NCT03345914|463188954|FG001|Overall Study|Ongoing|0|||
128696963|NCT03345914|463188955|FG002|Overall Study|Ongoing|1|||
128910956|NCT01928381|463964903|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
128910957|NCT01928381|463964904|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
128910958|NCT01928381|463964905|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
128910959|NCT01928381|463964906|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
128910960|NCT01928381|463964900|FG000|Washout First Intervention|Protocol Violation|0|||
128910961|NCT01928381|463964901|FG001|Washout First Intervention|Protocol Violation|0|||
128910962|NCT01928381|463964902|FG002|Washout First Intervention|Protocol Violation|0|||
128910963|NCT01928381|463964903|FG003|Washout First Intervention|Protocol Violation|0|||
128910964|NCT01928381|463964904|FG004|Washout First Intervention|Protocol Violation|1|||
128910965|NCT01928381|463964905|FG005|Washout First Intervention|Protocol Violation|0|||
128910966|NCT01928381|463964906|FG006|Washout First Intervention|Protocol Violation|0|||
128910967|NCT01928381|463964900|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
128910968|NCT01928381|463964901|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
128910969|NCT01928381|463964902|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
128910970|NCT01928381|463964903|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
128910971|NCT01928381|463964904|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
128910972|NCT01928381|463964905|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
128910973|NCT01928381|463964906|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
128910974|NCT01928381|463964900|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
128910975|NCT01928381|463964901|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
128910976|NCT01928381|463964902|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
128910977|NCT01928381|463964903|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
129028107|NCT03234907|464394473|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
129028108|NCT03234907|464394474|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129028109|NCT03234907|464394475|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129028110|NCT03234907|464394476|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129028111|NCT03234907|464394477|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129028112|NCT03234907|464394472|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
129028113|NCT03234907|464394473|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
129028114|NCT03234907|464394474|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129028115|NCT03234907|464394475|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129028116|NCT03234907|464394476|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129028117|NCT03234907|464394477|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129028118|NCT03234907|464394472|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
129028119|NCT03234907|464394473|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129028120|NCT03234907|464394474|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129028121|NCT03234907|464394475|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129028122|NCT03234907|464394476|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129028123|NCT03234907|464394477|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129028124|NCT03234907|464394472|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
129028125|NCT03234907|464394473|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
129028126|NCT03234907|464394474|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129028127|NCT03234907|464394475|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129028128|NCT03234907|464394476|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129028129|NCT03234907|464394477|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129028130|NCT03234907|464394472|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
129028131|NCT03234907|464394473|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
129028132|NCT03234907|464394474|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
129028133|NCT03234907|464394475|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
129028134|NCT03234907|464394476|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
129028135|NCT03234907|464394477|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
129028136|NCT03234907|464394472|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
129028137|NCT03234907|464394473|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
129028138|NCT03234907|464394474|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
129028139|NCT03234907|464394475|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
129028140|NCT03234907|464394476|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
129215463|NCT00687193|465091202|FG003|Overall Study|Lack of Efficacy|0|||
128696964|NCT01786668|463188960|FG000|Overall Study|Adverse Event|0|||
128696965|NCT01786668|463188961|FG001|Overall Study|Adverse Event|1|||
128696966|NCT01786668|463188962|FG002|Overall Study|Adverse Event|1|||
128910978|NCT01928381|463964904|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
128696967|NCT01786668|463188963|FG003|Overall Study|Adverse Event|2|||
128696968|NCT01786668|463188960|FG000|Overall Study|Withdrawal by Subject|0|||
128696969|NCT01786668|463188961|FG001|Overall Study|Withdrawal by Subject|0|||
128696970|NCT01786668|463188962|FG002|Overall Study|Withdrawal by Subject|3|||
128696971|NCT01786668|463188963|FG003|Overall Study|Withdrawal by Subject|1|||
128696972|NCT01786668|463188960|FG000|Overall Study|Pregnancy|0|||
128696973|NCT01786668|463188961|FG001|Overall Study|Pregnancy|0|||
128696974|NCT01786668|463188962|FG002|Overall Study|Pregnancy|0|||
128910979|NCT01928381|463964905|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
128910980|NCT01928381|463964906|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
128696975|NCT01786668|463188963|FG003|Overall Study|Pregnancy|1|||
128910981|NCT04441905|463966683|FG000|Overall Study|Lost to Follow-up|1|||
128910982|NCT04441905|463966684|FG001|Overall Study|Lost to Follow-up|0|||
128910983|NCT04441905|463966685|FG002|Overall Study|Lost to Follow-up|0|||
128910984|NCT04441905|463966686|FG003|Overall Study|Lost to Follow-up|0|||
128910985|NCT04441905|463966687|FG004|Overall Study|Lost to Follow-up|0|||
128910986|NCT04441905|463966688|FG005|Overall Study|Lost to Follow-up|0|||
128910987|NCT04441905|463966683|FG000|Overall Study|Enrolled but treatment not administered|0|||
128910988|NCT04441905|463966684|FG001|Overall Study|Enrolled but treatment not administered|1|||
128910989|NCT04441905|463966685|FG002|Overall Study|Enrolled but treatment not administered|0|||
128910990|NCT04441905|463966686|FG003|Overall Study|Enrolled but treatment not administered|0|||
128910991|NCT04441905|463966687|FG004|Overall Study|Enrolled but treatment not administered|0|||
128910992|NCT04441905|463966688|FG005|Overall Study|Enrolled but treatment not administered|0|||
128910993|NCT04441905|463966683|FG000|Overall Study|Became ineligible after enrollment|0|||
128910994|NCT04441905|463966684|FG001|Overall Study|Became ineligible after enrollment|0|||
128910995|NCT04441905|463966685|FG002|Overall Study|Became ineligible after enrollment|0|||
128910996|NCT04441905|463966686|FG003|Overall Study|Became ineligible after enrollment|0|||
128910997|NCT04441905|463966687|FG004|Overall Study|Became ineligible after enrollment|1|||
128910998|NCT04441905|463966688|FG005|Overall Study|Became ineligible after enrollment|0|||
128910999|NCT04770753|463966689|FG000|Overall Study|Randomized, never treated|1|||
128911000|NCT04770753|463966690|FG001|Overall Study|Randomized, never treated|1|||
128911001|NCT04770753|463966689|FG000|Overall Study|Withdrawal by Subject|3|||
128911002|NCT04770753|463966690|FG001|Overall Study|Withdrawal by Subject|1|||
128911003|NCT04770753|463966689|FG000|Overall Study|Adverse Event|2|||
128911004|NCT04770753|463966690|FG001|Overall Study|Adverse Event|0|||
128911005|NCT04770753|463966689|FG000|Overall Study|Pregnancy|1|||
128911006|NCT04770753|463966690|FG001|Overall Study|Pregnancy|0|||
128911007|NCT04770753|463966689|FG000|Overall Study|Other un-specified|1|||
128911008|NCT04770753|463966690|FG001|Overall Study|Other un-specified|0|||
128911009|NCT02775851|463966691|FG000|Overall Study|Adverse Event|1|||
128911010|NCT02775851|463966692|FG001|Overall Study|Adverse Event|10|||
128911011|NCT02775851|463966691|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
128911012|NCT02775851|463966692|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
128911013|NCT02775851|463966691|FG000|Overall Study|Progression/Relapse|0|||
128911014|NCT02775851|463966692|FG001|Overall Study|Progression/Relapse|4|||
128911015|NCT02775851|463966691|FG000|Overall Study|Other - Not Protocol Specified|0|||
128911016|NCT02775851|463966692|FG001|Overall Study|Other - Not Protocol Specified|7|||
128911017|NCT02775851|463966691|FG000|Overall Study|Withdrawal by Subject|1|||
128911018|NCT02775851|463966692|FG001|Overall Study|Withdrawal by Subject|0|||
129118230|NCT00855218|464728991|FG000|Overall Study|Untreatable disease progression|54|||
129118231|NCT00855218|464728992|FG001|Overall Study|Untreatable disease progression|67|||
129118232|NCT00855218|464728991|FG000|Overall Study|Second malignancy|0|||
129118233|NCT00855218|464728992|FG001|Overall Study|Second malignancy|1|||
129118234|NCT00855218|464728991|FG000|Overall Study|Progression measurement proven|7|||
129118235|NCT00855218|464728992|FG001|Overall Study|Progression measurement proven|15|||
129118236|NCT00855218|464728991|FG000|Overall Study|Clinical endpoint reached|10|||
129118237|NCT00855218|464728992|FG001|Overall Study|Clinical endpoint reached|13|||
129118238|NCT00764790|464728993|FG000|Overall Study|Protocol Violation|0|||
129118239|NCT00764790|464728994|FG001|Overall Study|Protocol Violation|0|||
129118240|NCT00764790|464728995|FG002|Overall Study|Protocol Violation|1|||
129118241|NCT00764790|464728993|FG000|Overall Study|Withdrawal by Subject|10|||
129118242|NCT00764790|464728994|FG001|Overall Study|Withdrawal by Subject|12|||
129118243|NCT00764790|464728995|FG002|Overall Study|Withdrawal by Subject|6|||
129118244|NCT00764790|464728993|FG000|Overall Study|Lost to Follow-up|28|||
129118245|NCT00764790|464728994|FG001|Overall Study|Lost to Follow-up|29|||
129118246|NCT00764790|464728995|FG002|Overall Study|Lost to Follow-up|23|||
129118247|NCT03191552|464728996|FG000|Overall Study|Lost to Follow-up|1|||
129118248|NCT03191552|464728997|FG001|Overall Study|Lost to Follow-up|0|||
129118249|NCT03191552|464728998|FG002|Overall Study|Lost to Follow-up|0|||
129118250|NCT03191552|464728996|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
128765373|NCT02969525|463432138|FG000|Dose-Blind Period|Adverse Event|0|||
128911019|NCT00598975|463966695|FG000|Overall Study|Adverse Event|1|||
128911020|NCT00598975|463966696|FG001|Overall Study|Adverse Event|1|||
128911021|NCT00598975|463966695|FG000|Overall Study|Brain metastases|1|||
128911022|NCT00598975|463966696|FG001|Overall Study|Brain metastases|0|||
128911023|NCT00598975|463966695|FG000|Overall Study|Withdrawal by Subject|1|||
128696976|NCT01786668|463188960|FG000|Overall Study|Lost to Follow-up|1|||
128696977|NCT01786668|463188961|FG001|Overall Study|Lost to Follow-up|0|||
128911024|NCT00598975|463966696|FG001|Overall Study|Withdrawal by Subject|1|||
128911025|NCT00598975|463966695|FG000|Overall Study|Withdrawal of consent|0|||
128911026|NCT00598975|463966696|FG001|Overall Study|Withdrawal of consent|1|||
128911027|NCT00598975|463966695|FG000|Overall Study|Disease progression|8|||
128911028|NCT00598975|463966696|FG001|Overall Study|Disease progression|3|||
128911029|NCT00598975|463966695|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
128911030|NCT00598975|463966696|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
128911031|NCT01178138|463966697|FG000|Overall Study|Lost to Follow-up|8|||
128911032|NCT01178138|463966697|FG000|Overall Study|Withdrawal by Subject|7|||
128911033|NCT01178138|463966697|FG000|Overall Study|Physician Decision|8|||
128911034|NCT01934140|463966701|FG000|Persistence Phase (Year 6-10)|Other|24|||
128911035|NCT01934140|463966702|FG001|Persistence Phase (Year 6-10)|Other|6|||
128911036|NCT01934140|463966701|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
128911037|NCT01934140|463966702|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
128911038|NCT01934140|463966701|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
128911039|NCT01934140|463966702|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
128911040|NCT01934140|463966701|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
128911041|NCT01934140|463966702|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
128911042|NCT01934140|463966701|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
128911043|NCT01934140|463966702|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
128911044|NCT01934140|463966701|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
128911045|NCT01934140|463966702|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
129118251|NCT03191552|464728997|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
129118252|NCT03191552|464728998|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
129118253|NCT01441973|464728999|FG000|Overall Study|Disease progression|8|||
129118254|NCT01441973|464729000|FG001|Overall Study|Disease progression|6|||
129118255|NCT01441973|464728999|FG000|Overall Study|Adverse event unrelated to study drug|3|||
129118256|NCT01441973|464729000|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129118257|NCT01441973|464728999|FG000|Overall Study|Participant request to discontinue|1|||
129118258|NCT01441973|464729000|FG001|Overall Study|Participant request to discontinue|1|||
129118259|NCT01441973|464728999|FG000|Overall Study|Poor compliance/noncompliance|0|||
129118260|NCT01441973|464729000|FG001|Overall Study|Poor compliance/noncompliance|1|||
129118261|NCT01441973|464728999|FG000|Overall Study|Administrative reason by sponsor|3|||
129118262|NCT01441973|464729000|FG001|Overall Study|Administrative reason by sponsor|5|||
129118263|NCT01441973|464728999|FG000|Overall Study|Participant withdrew consent|0|||
129118264|NCT01441973|464729000|FG001|Overall Study|Participant withdrew consent|1|||
129118265|NCT01149655|464729001|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
129118266|NCT01149655|464729002|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
129118267|NCT01149655|464729003|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
129118268|NCT01149655|464729004|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
129118269|NCT01149655|464729001|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
129118270|NCT01149655|464729002|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
129118271|NCT01149655|464729003|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
129118272|NCT01149655|464729004|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
129118273|NCT01149655|464729001|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
129118274|NCT01149655|464729002|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
129118275|NCT01149655|464729003|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
129118276|NCT01149655|464729004|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
129118277|NCT01149655|464729001|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
129118278|NCT01149655|464729002|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
129118279|NCT01149655|464729003|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
129118280|NCT01149655|464729004|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
129118281|NCT01149655|464729001|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
129118282|NCT01149655|464729002|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
129118283|NCT01149655|464729003|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
129118284|NCT01149655|464729004|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
129118285|NCT01149655|464729001|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
129118286|NCT01149655|464729002|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
129118287|NCT01149655|464729003|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
129118288|NCT01149655|464729004|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
129118289|NCT01149655|464729001|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
129118290|NCT01149655|464729002|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
129118291|NCT01149655|464729003|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
129118292|NCT01149655|464729004|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
128911046|NCT01934140|463966701|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
128696978|NCT01786668|463188962|FG002|Overall Study|Lost to Follow-up|1|||
128696979|NCT01786668|463188963|FG003|Overall Study|Lost to Follow-up|0|||
128911047|NCT01934140|463966702|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
128911048|NCT01934140|463966701|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
128911049|NCT01934140|463966702|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
128911050|NCT00618748|463966708|FG000|Overall Study|Adverse Event|4|||
128911051|NCT00618748|463966709|FG001|Overall Study|Adverse Event|3|||
128911052|NCT00618748|463966710|FG002|Overall Study|Adverse Event|8|||
128911053|NCT00618748|463966708|FG000|Overall Study|Physician Decision|3|||
128911054|NCT00618748|463966709|FG001|Overall Study|Physician Decision|1|||
128911055|NCT00618748|463966710|FG002|Overall Study|Physician Decision|1|||
128911056|NCT00618748|463966708|FG000|Overall Study|Withdrawal by Subject|4|||
128911057|NCT00618748|463966709|FG001|Overall Study|Withdrawal by Subject|1|||
128911058|NCT00618748|463966710|FG002|Overall Study|Withdrawal by Subject|5|||
128911059|NCT02595879|463966711|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
128911060|NCT02595879|463966712|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
128911061|NCT04294459|463966713|FG000|Overall Study|Adverse Event|0|||
128911062|NCT04294459|463966714|FG001|Overall Study|Adverse Event|1|||
128911063|NCT01534676|463966715|FG000|Overall Study|Study closed due to poor enrollment|2|||
128911064|NCT01534676|463966716|FG001|Overall Study|Study closed due to poor enrollment|1|||
128911065|NCT02908880|463966718|FG000|Overall Study|Lost to Follow-up|4|||
128911066|NCT02908880|463966718|FG000|Overall Study|Explantation of the device|1|||
128911067|NCT02908880|463966718|FG000|Overall Study|Withdrawal by Subject|17|||
128911068|NCT02908880|463966718|FG000|Overall Study|Death|5|||
128911069|NCT02421887|463966719|FG000|Overall Study|Lost to Follow-up|5|||
128911070|NCT02421887|463966720|FG001|Overall Study|Lost to Follow-up|0|||
128911071|NCT02421887|463966719|FG000|Overall Study|Withdrawal by Subject|8|||
128911072|NCT02421887|463966720|FG001|Overall Study|Withdrawal by Subject|5|||
128911073|NCT02421887|463966719|FG000|Overall Study|Physician Decision|2|||
128911074|NCT02421887|463966720|FG001|Overall Study|Physician Decision|4|||
128911075|NCT02421887|463966719|FG000|Overall Study|Adverse Event|2|||
128911076|NCT02421887|463966720|FG001|Overall Study|Adverse Event|0|||
128911077|NCT03946670|463966725|FG000|Overall Study|Progressive Disease|26|||
128911078|NCT03946670|463966726|FG001|Overall Study|Progressive Disease|23|||
128911079|NCT03946670|463966725|FG000|Overall Study|Adverse Event|7|||
128911080|NCT03946670|463966726|FG001|Overall Study|Adverse Event|9|||
128911081|NCT03946670|463966725|FG000|Overall Study|Death|5|||
129028141|NCT03234907|464394477|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
129028142|NCT03234907|464394472|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
129028143|NCT03234907|464394473|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
129028144|NCT03234907|464394474|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
129028145|NCT03234907|464394475|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
129028146|NCT03234907|464394476|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
129028147|NCT03234907|464394477|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
129028148|NCT00642993|464394478|FG000|Overall Study|Adverse Event|85|||
129028149|NCT00642993|464394479|FG001|Overall Study|Adverse Event|4|||
129028150|NCT00642993|464394478|FG000|Overall Study|Lost to Follow-up|8|||
129028151|NCT00642993|464394479|FG001|Overall Study|Lost to Follow-up|4|||
129028152|NCT00642993|464394478|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
129028153|NCT00642993|464394479|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
129028154|NCT00642993|464394478|FG000|Overall Study|Protocol Violation|1|||
129028155|NCT00642993|464394479|FG001|Overall Study|Protocol Violation|4|||
129028156|NCT00642993|464394478|FG000|Overall Study|Did not meet protocol eligibility|0|||
129028157|NCT00642993|464394479|FG001|Overall Study|Did not meet protocol eligibility|1|||
129028158|NCT00642993|464394478|FG000|Overall Study|Administrative|1|||
129028159|NCT00642993|464394479|FG001|Overall Study|Administrative|0|||
129028160|NCT02664415|464394480|FG000|Overall Study|Adverse Event|1|||
129028161|NCT02664415|464394481|FG001|Overall Study|Adverse Event|0|||
129028162|NCT02986139|464394485|FG000|Overall Study|Sponsor Decision|1|||
129028163|NCT02986139|464394486|FG001|Overall Study|Sponsor Decision|2|||
129028164|NCT02986139|464394485|FG000|Overall Study|Withdrawal by Subject|0|||
129028165|NCT02986139|464394486|FG001|Overall Study|Withdrawal by Subject|1|||
129028166|NCT02986139|464394485|FG000|Overall Study|Lost to Follow-up|0|||
129028167|NCT02986139|464394486|FG001|Overall Study|Lost to Follow-up|1|||
129118293|NCT01149655|464729001|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
129118294|NCT01149655|464729002|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
128911082|NCT03946670|463966726|FG001|Overall Study|Death|6|||
128911083|NCT03946670|463966725|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
128911084|NCT03946670|463966726|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
128911085|NCT03946670|463966725|FG000|Overall Study|Subject Decision|4|||
128911086|NCT03946670|463966726|FG001|Overall Study|Subject Decision|4|||
128911087|NCT03946670|463966725|FG000|Overall Study|Physician Decision|3|||
128911088|NCT03946670|463966726|FG001|Overall Study|Physician Decision|3|||
128911089|NCT03946670|463966725|FG000|Overall Study|New Therapy for Study Indication|1|||
129028168|NCT00414726|464394487|FG000|Overall Study|Withdrawal by Subject|0|||
129028169|NCT00414726|464394488|FG001|Overall Study|Withdrawal by Subject|1|||
129028170|NCT02107196|464394489|FG000|12-week Treatment Period|Adverse Event|6|||
128696980|NCT00493025|463188964|FG000|Overall Study|Physician Decision|19|||
128911090|NCT03946670|463966726|FG001|Overall Study|New Therapy for Study Indication|0|||
128911091|NCT03946670|463966725|FG000|Overall Study|Not treated|1|||
128911092|NCT03946670|463966726|FG001|Overall Study|Not treated|1|||
128911093|NCT03083886|463966727|FG000|Overall Study|Withdrawal by Subject|51|||
128911094|NCT03083886|463966728|FG001|Overall Study|Withdrawal by Subject|73|||
128911095|NCT03083886|463966729|FG002|Overall Study|Withdrawal by Subject|104|||
128911096|NCT03083886|463966727|FG000|Overall Study|Missing Baseline data|43|||
128911097|NCT03083886|463966728|FG001|Overall Study|Missing Baseline data|42|||
128911098|NCT03083886|463966729|FG002|Overall Study|Missing Baseline data|31|||
128911099|NCT03083886|463966727|FG000|Overall Study|Investigator terminated|1|||
128911100|NCT03083886|463966728|FG001|Overall Study|Investigator terminated|6|||
128911101|NCT03083886|463966729|FG002|Overall Study|Investigator terminated|3|||
128911102|NCT04161495|463966730|FG000|Overall Study|Withdrawal by Subject|3|||
128911103|NCT04161495|463966731|FG001|Overall Study|Withdrawal by Subject|0|||
128911104|NCT04161495|463966730|FG000|Overall Study|Protocol Violation|1|||
128911105|NCT04161495|463966731|FG001|Overall Study|Protocol Violation|0|||
128911106|NCT04161495|463966730|FG000|Overall Study|Prohibited concomitant medication|3|||
128911107|NCT04161495|463966731|FG001|Overall Study|Prohibited concomitant medication|0|||
128911108|NCT04161495|463966730|FG000|Overall Study|Adverse Event|1|||
128911109|NCT04161495|463966731|FG001|Overall Study|Adverse Event|0|||
128911110|NCT04161495|463966730|FG000|Overall Study|Other - Unspecified|1|||
128911111|NCT04161495|463966731|FG001|Overall Study|Other - Unspecified|0|||
128911112|NCT04161495|463966730|FG000|Overall Study|Death|0|||
128911113|NCT04161495|463966731|FG001|Overall Study|Death|1|||
128911114|NCT03655756|463966732|FG000|Overall Study|Death|1|||
128911115|NCT02062658|463966737|FG000|Overall Study|Withdrawal by Subject|1|||
128911116|NCT02062658|463966737|FG000|Overall Study|Lack of Efficacy|1|||
128911117|NCT02161562|463966738|FG000|Overall Study|Withdrawal by Subject|5|||
128911118|NCT02161562|463966739|FG001|Overall Study|Withdrawal by Subject|8|||
128911119|NCT02161562|463966738|FG000|Overall Study|Protocol Violation|9|||
128911120|NCT02161562|463966739|FG001|Overall Study|Protocol Violation|4|||
128911121|NCT02161562|463966738|FG000|Overall Study|Pregnancy|1|||
128911122|NCT02161562|463966739|FG001|Overall Study|Pregnancy|2|||
128911123|NCT02161562|463966738|FG000|Overall Study|Lost to Follow-up|3|||
128911124|NCT02161562|463966739|FG001|Overall Study|Lost to Follow-up|1|||
128911125|NCT02161562|463966738|FG000|Overall Study|Lack of Efficacy|4|||
128911126|NCT02161562|463966739|FG001|Overall Study|Lack of Efficacy|1|||
128911127|NCT02161562|463966738|FG000|Overall Study|Adverse Event|1|||
128911128|NCT02161562|463966739|FG001|Overall Study|Adverse Event|1|||
128911129|NCT02161562|463966738|FG000|Overall Study|Participant moved back to home country|1|||
128911130|NCT02161562|463966739|FG001|Overall Study|Participant moved back to home country|0|||
128911131|NCT02161562|463966738|FG000|Overall Study|Withdrew due to being out of the country|1|||
128911132|NCT02161562|463966739|FG001|Overall Study|Withdrew due to being out of the country|0|||
128911133|NCT02161562|463966738|FG000|Overall Study|Participant moved out of province|1|||
128911134|NCT02161562|463966739|FG001|Overall Study|Participant moved out of province|0|||
128911135|NCT02347176|463966742|FG000|Overall Study|Lost to Follow-up|2|||
128911136|NCT02347176|463966743|FG001|Overall Study|Lost to Follow-up|3|||
129028171|NCT02107196|464394490|FG001|12-week Treatment Period|Adverse Event|3|||
129028172|NCT02107196|464394489|FG000|12-week Treatment Period|Lack of Efficacy|2|||
129028173|NCT02107196|464394490|FG001|12-week Treatment Period|Lack of Efficacy|1|||
129028174|NCT02107196|464394489|FG000|12-week Treatment Period|Lost to Follow-up|3|||
129028175|NCT02107196|464394490|FG001|12-week Treatment Period|Lost to Follow-up|6|||
129028176|NCT02107196|464394489|FG000|12-week Treatment Period|Physician Decision|0|||
129028177|NCT02107196|464394490|FG001|12-week Treatment Period|Physician Decision|1|||
129028178|NCT02107196|464394489|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
129028179|NCT02107196|464394490|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
129028180|NCT02107196|464394489|FG000|12-week Treatment Period|Protocol Violation|7|||
129028181|NCT02107196|464394490|FG001|12-week Treatment Period|Protocol Violation|8|||
129028182|NCT02107196|464394489|FG000|12-week Treatment Period|Reason Missing|11|||
129028183|NCT02107196|464394490|FG001|12-week Treatment Period|Reason Missing|8|||
129028184|NCT02107196|464394489|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
129028185|NCT02107196|464394490|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
129028186|NCT02107196|464394489|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
129028187|NCT02107196|464394490|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129028188|NCT02107196|464394489|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
128696981|NCT03173313|463188967|FG000|Overall Study|Lost to Follow-up|2|||
128911137|NCT02347176|463966744|FG002|Overall Study|Lost to Follow-up|1|||
128911138|NCT02347176|463966745|FG003|Overall Study|Lost to Follow-up|1|||
128911139|NCT02347176|463966742|FG000|Overall Study|Withdrawal by Subject|9|||
128911140|NCT02347176|463966743|FG001|Overall Study|Withdrawal by Subject|5|||
129215464|NCT00687193|465091203|FG004|Overall Study|Lack of Efficacy|0|||
128911141|NCT02347176|463966744|FG002|Overall Study|Withdrawal by Subject|5|||
128911142|NCT02347176|463966745|FG003|Overall Study|Withdrawal by Subject|3|||
128911143|NCT02347176|463966742|FG000|Overall Study|Other|1|||
128911144|NCT02347176|463966743|FG001|Overall Study|Other|2|||
129215465|NCT00687193|465091204|FG005|Overall Study|Lack of Efficacy|2|||
129215466|NCT00687193|465091199|FG000|Overall Study|Protocol Violation|1|||
129215467|NCT00687193|465091200|FG001|Overall Study|Protocol Violation|2|||
129215468|NCT00687193|465091201|FG002|Overall Study|Protocol Violation|0|||
129215469|NCT00687193|465091202|FG003|Overall Study|Protocol Violation|1|||
129215470|NCT00687193|465091203|FG004|Overall Study|Protocol Violation|2|||
129215471|NCT00687193|465091204|FG005|Overall Study|Protocol Violation|0|||
129215472|NCT04986904|465091205|FG000|Overall Study|Lost to Follow-up|11|||
129215473|NCT04986904|465091205|FG000|Overall Study|Withdrawal by Subject|1|||
129215474|NCT03435211|465091206|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
129215475|NCT03863080|465091207|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
129215476|NCT03863080|465091208|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
129215477|NCT03863080|465091209|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
129215478|NCT03863080|465091210|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
129215479|NCT03863080|465091207|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
129215480|NCT03863080|465091208|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
129215481|NCT03863080|465091209|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
129215482|NCT03863080|465091210|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
129215483|NCT03863080|465091207|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
129215484|NCT03863080|465091208|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
129215485|NCT03863080|465091209|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
129215486|NCT03863080|465091210|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
129215487|NCT01342211|465091211|FG000|Overall Study|Lost to Follow-up|0|||
129215488|NCT01342211|465091212|FG001|Overall Study|Lost to Follow-up|0|||
129215489|NCT01342211|465091213|FG002|Overall Study|Lost to Follow-up|0|||
129215490|NCT01342211|465091214|FG003|Overall Study|Lost to Follow-up|1|||
129215491|NCT01342211|465091215|FG004|Overall Study|Lost to Follow-up|0|||
129215492|NCT01342211|465091211|FG000|Overall Study|Adverse Event|0|||
129215493|NCT01342211|465091212|FG001|Overall Study|Adverse Event|0|||
129215494|NCT01342211|465091213|FG002|Overall Study|Adverse Event|0|||
129215495|NCT01342211|465091214|FG003|Overall Study|Adverse Event|0|||
129215496|NCT01342211|465091215|FG004|Overall Study|Adverse Event|1|||
129215497|NCT01342211|465091211|FG000|Overall Study|Withdrawal by Subject|0|||
129215498|NCT01342211|465091212|FG001|Overall Study|Withdrawal by Subject|0|||
129215499|NCT01342211|465091213|FG002|Overall Study|Withdrawal by Subject|0|||
129215500|NCT01342211|465091214|FG003|Overall Study|Withdrawal by Subject|1|||
129215501|NCT01342211|465091215|FG004|Overall Study|Withdrawal by Subject|0|||
129215502|NCT01342211|465091211|FG000|Overall Study|Randomized, but not Treated|0|||
129215503|NCT01342211|465091212|FG001|Overall Study|Randomized, but not Treated|2|||
129215504|NCT01342211|465091213|FG002|Overall Study|Randomized, but not Treated|0|||
129215505|NCT01342211|465091214|FG003|Overall Study|Randomized, but not Treated|0|||
129215506|NCT01342211|465091215|FG004|Overall Study|Randomized, but not Treated|1|||
129215507|NCT01648751|465091233|FG000|Overall Study|Withdrawal by Subject|2|||
129215508|NCT01648751|465091234|FG001|Overall Study|Withdrawal by Subject|3|||
129215509|NCT05673876|465091237|FG000|Overall Study|Death|3|||
129215510|NCT05673876|465091238|FG001|Overall Study|Death|1|||
129215511|NCT05673876|465091237|FG000|Overall Study|Study Terminated by Sponsor|0|||
129215512|NCT05673876|465091238|FG001|Overall Study|Study Terminated by Sponsor|1|||
129215513|NCT05673876|465091237|FG000|Overall Study|Physician Decision|0|||
129215514|NCT05673876|465091238|FG001|Overall Study|Physician Decision|1|||
129215515|NCT03205423|465091241|FG000|Overall Study|Personal|1|||
129215516|NCT03205423|465091242|FG001|Overall Study|Personal|1|||
129215517|NCT03205423|465091241|FG000|Overall Study|Physician Decision|0|||
129215518|NCT03205423|465091242|FG001|Overall Study|Physician Decision|2|||
129215519|NCT02749422|465091245|FG000|Overall Study|Lost to Follow-up|0|||
129215520|NCT02749422|465091246|FG001|Overall Study|Lost to Follow-up|2|||
129215521|NCT02749422|465091245|FG000|Overall Study|Ineligible|0|||
129215522|NCT02749422|465091246|FG001|Overall Study|Ineligible|1|||
129215523|NCT05786651|465091249|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
129215524|NCT04390763|465091250|FG000|Safety run-in Part|Adverse Event|4|||
129215525|NCT04390763|465091251|FG001|Safety run-in Part|Adverse Event|0|||
129215526|NCT04390763|465091252|FG002|Safety run-in Part|Adverse Event|0|||
129215527|NCT04390763|465091253|FG003|Safety run-in Part|Adverse Event|0|||
129215528|NCT04390763|465091250|FG000|Safety run-in Part|Physician Decision|1|||
129215529|NCT04390763|465091251|FG001|Safety run-in Part|Physician Decision|0|||
129215530|NCT04390763|465091252|FG002|Safety run-in Part|Physician Decision|0|||
129215531|NCT04390763|465091253|FG003|Safety run-in Part|Physician Decision|0|||
129215532|NCT04390763|465091250|FG000|Safety run-in Part|Progressive Disease|6|||
129215533|NCT04390763|465091251|FG001|Safety run-in Part|Progressive Disease|0|||
129215534|NCT04390763|465091252|FG002|Safety run-in Part|Progressive Disease|0|||
129215535|NCT04390763|465091253|FG003|Safety run-in Part|Progressive Disease|0|||
129215536|NCT04390763|465091250|FG000|Randomized Part|Adverse Event|0|||
129215537|NCT04390763|465091251|FG001|Randomized Part|Adverse Event|11|||
129215538|NCT04390763|465091252|FG002|Randomized Part|Adverse Event|5|||
129215539|NCT04390763|465091253|FG003|Randomized Part|Adverse Event|5|||
129215540|NCT04390763|465091250|FG000|Randomized Part|Death|0|||
129215541|NCT04390763|465091251|FG001|Randomized Part|Death|3|||
129215542|NCT04390763|465091252|FG002|Randomized Part|Death|4|||
129215543|NCT04390763|465091253|FG003|Randomized Part|Death|2|||
129215544|NCT04390763|465091250|FG000|Randomized Part|Physician Decision|0|||
129215545|NCT04390763|465091251|FG001|Randomized Part|Physician Decision|2|||
129215546|NCT04390763|465091252|FG002|Randomized Part|Physician Decision|2|||
129215547|NCT04390763|465091253|FG003|Randomized Part|Physician Decision|9|||
129215548|NCT04390763|465091250|FG000|Randomized Part|Progressive Disease|0|||
129215549|NCT04390763|465091251|FG001|Randomized Part|Progressive Disease|24|||
129215550|NCT04390763|465091252|FG002|Randomized Part|Progressive Disease|31|||
129215551|NCT04390763|465091253|FG003|Randomized Part|Progressive Disease|23|||
129215552|NCT04390763|465091250|FG000|Randomized Part|Study terminated by sponsor|0|||
129215553|NCT04390763|465091251|FG001|Randomized Part|Study terminated by sponsor|1|||
129215554|NCT04390763|465091252|FG002|Randomized Part|Study terminated by sponsor|0|||
129215555|NCT04390763|465091253|FG003|Randomized Part|Study terminated by sponsor|0|||
129215556|NCT04390763|465091250|FG000|Randomized Part|Participant Decision|0|||
129215557|NCT04390763|465091251|FG001|Randomized Part|Participant Decision|5|||
129215558|NCT04390763|465091252|FG002|Randomized Part|Participant Decision|7|||
129215559|NCT04390763|465091253|FG003|Randomized Part|Participant Decision|6|||
129215560|NCT04390763|465091250|FG000|Randomized Part|Not treated|0|||
129215561|NCT04390763|465091251|FG001|Randomized Part|Not treated|4|||
129215562|NCT04390763|465091252|FG002|Randomized Part|Not treated|2|||
129215563|NCT04390763|465091253|FG003|Randomized Part|Not treated|7|||
129215564|NCT04949490|465091259|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129215565|NCT04949490|465091260|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129215566|NCT04949490|465091261|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129215567|NCT04949490|465091262|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
128911145|NCT02347176|463966744|FG002|Overall Study|Other|2|||
128911146|NCT02347176|463966745|FG003|Overall Study|Other|0|||
128911147|NCT01064167|463966749|FG000|Overall Study|Protocol Violation|14|||
128911148|NCT01064167|463966750|FG001|Overall Study|Protocol Violation|15|||
128911149|NCT00725075|463966751|FG000|Overall Study|Use of Excluded Medication|0|||
128911150|NCT00725075|463966752|FG001|Overall Study|Use of Excluded Medication|1|||
128911151|NCT00725075|463966753|FG002|Overall Study|Use of Excluded Medication|0|||
128911152|NCT00725075|463966751|FG000|Overall Study|Protocol Violation|0|||
128911153|NCT00725075|463966752|FG001|Overall Study|Protocol Violation|0|||
128911154|NCT00725075|463966753|FG002|Overall Study|Protocol Violation|1|||
128911155|NCT00725075|463966751|FG000|Overall Study|Lost to Follow-up|1|||
129118295|NCT01149655|464729003|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
129118296|NCT01149655|464729004|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
129118297|NCT01149655|464729001|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
129118298|NCT01149655|464729002|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
129118299|NCT01149655|464729003|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
129118300|NCT01149655|464729004|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
129118301|NCT01149655|464729001|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
129118302|NCT01149655|464729002|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
129118303|NCT01149655|464729003|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
129118304|NCT01149655|464729004|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
128911156|NCT00725075|463966752|FG001|Overall Study|Lost to Follow-up|0|||
128911157|NCT00725075|463966753|FG002|Overall Study|Lost to Follow-up|0|||
128911158|NCT00725075|463966751|FG000|Overall Study|Withdrawal by Subject|4|||
128911159|NCT00725075|463966752|FG001|Overall Study|Withdrawal by Subject|5|||
128911160|NCT00725075|463966753|FG002|Overall Study|Withdrawal by Subject|4|||
128911161|NCT00725075|463966751|FG000|Overall Study|Adverse Event|2|||
128911162|NCT00725075|463966752|FG001|Overall Study|Adverse Event|1|||
128911163|NCT00725075|463966753|FG002|Overall Study|Adverse Event|1|||
128911164|NCT00725075|463966751|FG000|Overall Study|Worsening of Disease|2|||
128911165|NCT00725075|463966752|FG001|Overall Study|Worsening of Disease|1|||
129215568|NCT04949490|465091263|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129215569|NCT04949490|465091264|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129215570|NCT04949490|465091259|FG000|Group A and Group B|Withdrawal by Subject|0|||
129215571|NCT04949490|465091260|FG001|Group A and Group B|Withdrawal by Subject|0|||
128911166|NCT00725075|463966753|FG002|Overall Study|Worsening of Disease|2|||
129215572|NCT04949490|465091261|FG002|Group A and Group B|Withdrawal by Subject|1|||
129215573|NCT04949490|465091262|FG003|Group A and Group B|Withdrawal by Subject|0|||
128696982|NCT03173313|463188968|FG001|Overall Study|Lost to Follow-up|3|||
128911167|NCT00725075|463966751|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
128911168|NCT00725075|463966752|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
128911169|NCT00725075|463966753|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
128911170|NCT00725075|463966751|FG000|Overall Study|Other|1|||
129215574|NCT04949490|465091263|FG004|Group A and Group B|Withdrawal by Subject|0|||
128911171|NCT00725075|463966752|FG001|Overall Study|Other|0|||
129215575|NCT04949490|465091264|FG005|Group A and Group B|Withdrawal by Subject|0|||
129215576|NCT04949490|465091259|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129118305|NCT01149655|464729001|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
129118306|NCT01149655|464729002|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
129118307|NCT01149655|464729003|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
129118308|NCT01149655|464729004|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
129118309|NCT01149655|464729001|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
129118310|NCT01149655|464729002|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
129118311|NCT01149655|464729003|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
129118312|NCT01149655|464729004|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
129118313|NCT01149655|464729001|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
129118314|NCT01149655|464729002|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
129118315|NCT01149655|464729003|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
129118316|NCT01149655|464729004|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
129118317|NCT01149655|464729001|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
129118318|NCT01149655|464729002|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
129118319|NCT01149655|464729003|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
129118320|NCT01149655|464729004|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
129118321|NCT01149655|464729001|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
129118322|NCT01149655|464729002|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
129118323|NCT01149655|464729003|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
129118324|NCT01149655|464729004|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
129118325|NCT01149655|464729001|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
129118326|NCT01149655|464729002|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
129118327|NCT01149655|464729003|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
129118328|NCT01149655|464729004|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
129118329|NCT05079321|464729005|FG000|Overall Study|Withdrawal by Subject|2|||
129118330|NCT05079321|464729006|FG001|Overall Study|Withdrawal by Subject|2|||
129118331|NCT05079321|464729005|FG000|Overall Study|Lost to Follow-up|0|||
129118332|NCT05079321|464729006|FG001|Overall Study|Lost to Follow-up|1|||
129118333|NCT02003144|464729007|FG000|Open Label Maintenance Phase|Other than specified|2|||
129118334|NCT02003144|464729008|FG001|Open Label Maintenance Phase|Other than specified|4|||
129118335|NCT02003144|464729007|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
129118336|NCT02003144|464729008|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
129118337|NCT02003144|464729007|FG000|Open Label Maintenance Phase|Pregnancy|0|||
129118338|NCT02003144|464729008|FG001|Open Label Maintenance Phase|Pregnancy|2|||
129118339|NCT02003144|464729007|FG000|Open Label Maintenance Phase|Physician Decision|1|||
129118340|NCT02003144|464729008|FG001|Open Label Maintenance Phase|Physician Decision|1|||
129118341|NCT02003144|464729007|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
129118342|NCT02003144|464729008|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
129118343|NCT02003144|464729007|FG000|Open Label Maintenance Phase|Adverse Event|2|||
129118344|NCT02003144|464729008|FG001|Open Label Maintenance Phase|Adverse Event|1|||
129118345|NCT05965752|464729009|FG000|Overall Study|Adverse Event|0|||
129118346|NCT05965752|464729010|FG001|Overall Study|Adverse Event|1|||
129118347|NCT05965752|464729011|FG002|Overall Study|Adverse Event|0|||
129118348|NCT05965752|464729012|FG003|Overall Study|Adverse Event|1|||
129118349|NCT05965752|464729013|FG004|Overall Study|Adverse Event|3|||
129118350|NCT05965752|464729009|FG000|Overall Study|Lost to Follow-up|2|||
128696983|NCT03173313|463188967|FG000|Overall Study|Withdrawal by Subject|0|||
128696984|NCT03173313|463188968|FG001|Overall Study|Withdrawal by Subject|1|||
128696985|NCT03173313|463188967|FG000|Overall Study|Death|5|||
128911172|NCT00725075|463966753|FG002|Overall Study|Other|0|||
128911173|NCT03984305|463966755|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
128911174|NCT03984305|463966756|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
128911175|NCT03984305|463966755|FG000|Overall Study|Withdrawal by Subject|3|||
128911176|NCT03984305|463966756|FG001|Overall Study|Withdrawal by Subject|3|||
128911177|NCT03984305|463966755|FG000|Overall Study|Lost to Follow-up|1|||
128911178|NCT03984305|463966756|FG001|Overall Study|Lost to Follow-up|0|||
128911179|NCT02340663|463966757|FG000|Overall Study|Lost to Follow-up|1|||
128911180|NCT02340663|463966758|FG001|Overall Study|Lost to Follow-up|0|||
128911181|NCT02340663|463966757|FG000|Overall Study|Protocol Violation|1|||
128911182|NCT02340663|463966758|FG001|Overall Study|Protocol Violation|0|||
128911183|NCT02340663|463966757|FG000|Overall Study|Withdrawal by Subject|3|||
128911184|NCT02340663|463966758|FG001|Overall Study|Withdrawal by Subject|1|||
128911185|NCT02979431|463966759|FG000|Overall Study|Parent/guardian withdrew consent|2|||
128911186|NCT02979431|463966760|FG001|Overall Study|Parent/guardian withdrew consent|1|||
129118351|NCT05965752|464729010|FG001|Overall Study|Lost to Follow-up|0|||
129118352|NCT05965752|464729011|FG002|Overall Study|Lost to Follow-up|1|||
129118353|NCT05965752|464729012|FG003|Overall Study|Lost to Follow-up|1|||
129118354|NCT05965752|464729013|FG004|Overall Study|Lost to Follow-up|1|||
129118355|NCT05965752|464729009|FG000|Overall Study|Withdrawal by Subject|2|||
128696986|NCT03173313|463188968|FG001|Overall Study|Death|0|||
128911187|NCT02979431|463966761|FG002|Overall Study|Parent/guardian withdrew consent|1|||
128911188|NCT02979431|463966762|FG003|Overall Study|Parent/guardian withdrew consent|1|||
128911189|NCT02979431|463966759|FG000|Overall Study|Randomized but received no study drug|1|||
128911190|NCT02979431|463966760|FG001|Overall Study|Randomized but received no study drug|1|||
128911191|NCT02979431|463966761|FG002|Overall Study|Randomized but received no study drug|0|||
128911192|NCT02979431|463966762|FG003|Overall Study|Randomized but received no study drug|0|||
128911193|NCT02979431|463966759|FG000|Overall Study|Adverse Event|0|||
128911194|NCT02979431|463966760|FG001|Overall Study|Adverse Event|0|||
128911195|NCT02979431|463966761|FG002|Overall Study|Adverse Event|1|||
128911196|NCT02979431|463966762|FG003|Overall Study|Adverse Event|0|||
128911197|NCT02979431|463966759|FG000|Overall Study|Subject left country after Day14|1|||
128911198|NCT02979431|463966760|FG001|Overall Study|Subject left country after Day14|0|||
128911199|NCT02979431|463966761|FG002|Overall Study|Subject left country after Day14|0|||
128911200|NCT02979431|463966762|FG003|Overall Study|Subject left country after Day14|0|||
128911201|NCT01656434|463966763|FG000|Overall Study|Adverse Event|199|||
128911202|NCT01656434|463966764|FG001|Overall Study|Adverse Event|63|||
128911203|NCT01656434|463966763|FG000|Overall Study|Enrollment terminated at trial site|2|||
128911204|NCT01656434|463966764|FG001|Overall Study|Enrollment terminated at trial site|0|||
128911205|NCT01656434|463966763|FG000|Overall Study|Lost to Follow-up|309|||
128911206|NCT01656434|463966764|FG001|Overall Study|Lost to Follow-up|76|||
128911207|NCT01656434|463966763|FG000|Overall Study|Site discontinued study participation|24|||
128911208|NCT01656434|463966764|FG001|Overall Study|Site discontinued study participation|9|||
128696987|NCT03173313|463188967|FG000|Overall Study|Physician Decision|1|||
128911209|NCT01656434|463966763|FG000|Overall Study|Screen failure|2|||
128911210|NCT01656434|463966764|FG001|Overall Study|Screen failure|0|||
128911211|NCT01656434|463966763|FG000|Overall Study|Protocol Violation|7|||
128911212|NCT01656434|463966764|FG001|Overall Study|Protocol Violation|0|||
128911213|NCT01656434|463966763|FG000|Overall Study|Pregnancy wish|18|||
128911214|NCT01656434|463966764|FG001|Overall Study|Pregnancy wish|6|||
128911215|NCT01656434|463966763|FG000|Overall Study|Pregnancy|45|||
128911216|NCT01656434|463966764|FG001|Overall Study|Pregnancy|10|||
128911217|NCT01656434|463966763|FG000|Overall Study|Physician Decision|7|||
128911218|NCT01656434|463966764|FG001|Overall Study|Physician Decision|2|||
128911219|NCT01656434|463966763|FG000|Overall Study|Non-compliance with study drug|48|||
128911220|NCT01656434|463966764|FG001|Overall Study|Non-compliance with study drug|9|||
128911221|NCT01656434|463966763|FG000|Overall Study|Study terminated by sponsor|1501|||
128911222|NCT01656434|463966764|FG001|Overall Study|Study terminated by sponsor|348|||
128911223|NCT01656434|463966763|FG000|Overall Study|Participant discontinued; drug related|13|||
128911224|NCT01656434|463966764|FG001|Overall Study|Participant discontinued; drug related|4|||
128911225|NCT01656434|463966763|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
128911226|NCT01656434|463966764|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
128911227|NCT01656434|463966763|FG000|Overall Study|Non-compliance with protocol|39|||
128911228|NCT01656434|463966764|FG001|Overall Study|Non-compliance with protocol|15|||
128911229|NCT01656434|463966763|FG000|Overall Study|Participant moved|40|||
128911230|NCT01656434|463966764|FG001|Overall Study|Participant moved|12|||
128911231|NCT01656434|463966763|FG000|Overall Study|Participant withdrew consent|28|||
128911232|NCT01656434|463966764|FG001|Overall Study|Participant withdrew consent|9|||
128911233|NCT01656434|463966763|FG000|Overall Study|Withdrawal by Subject|64|||
128911234|NCT01656434|463966764|FG001|Overall Study|Withdrawal by Subject|7|||
128911235|NCT00087646|463966765|FG000|Overall Study|Adverse Event|37|||
128911236|NCT00087646|463966766|FG001|Overall Study|Adverse Event|6|||
128911237|NCT00087646|463966767|FG002|Overall Study|Adverse Event|18|||
128911238|NCT00087646|463966768|FG003|Overall Study|Adverse Event|20|||
128911239|NCT00087646|463966765|FG000|Overall Study|Death|0|||
128911240|NCT00087646|463966766|FG001|Overall Study|Death|1|||
128911241|NCT00087646|463966767|FG002|Overall Study|Death|0|||
128911242|NCT00087646|463966768|FG003|Overall Study|Death|0|||
129028189|NCT02107196|464394490|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
129028190|NCT02107196|464394489|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
129028191|NCT02107196|464394490|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
129028192|NCT00516295|464394491|FG000|Overall Study|Lack of Efficacy|2|||
129028193|NCT00516295|464394492|FG001|Overall Study|Lack of Efficacy|0|||
129028194|NCT00516295|464394493|FG002|Overall Study|Lack of Efficacy|0|||
129028195|NCT00516295|464394491|FG000|Overall Study|Ineligible|1|||
129028196|NCT00516295|464394492|FG001|Overall Study|Ineligible|0|||
129028197|NCT00516295|464394493|FG002|Overall Study|Ineligible|0|||
129028198|NCT01630616|464394498|FG000|Overall Study|Adverse Event|0|||
129028199|NCT01630616|464394499|FG001|Overall Study|Adverse Event|0|||
129028200|NCT01630616|464394500|FG002|Overall Study|Adverse Event|0|||
128696988|NCT03173313|463188968|FG001|Overall Study|Physician Decision|0|||
129028201|NCT01630616|464394501|FG003|Overall Study|Adverse Event|1|||
129028202|NCT01630616|464394502|FG004|Overall Study|Adverse Event|0|||
128911243|NCT00087646|463966765|FG000|Overall Study|Withdrawal by Subject|6|||
128911244|NCT00087646|463966766|FG001|Overall Study|Withdrawal by Subject|1|||
128911245|NCT00087646|463966767|FG002|Overall Study|Withdrawal by Subject|2|||
128911246|NCT00087646|463966768|FG003|Overall Study|Withdrawal by Subject|2|||
128911247|NCT00087646|463966765|FG000|Overall Study|Insufficient therapeutic response|64|||
128911248|NCT00087646|463966766|FG001|Overall Study|Insufficient therapeutic response|24|||
128911249|NCT00087646|463966767|FG002|Overall Study|Insufficient therapeutic response|38|||
128911250|NCT00087646|463966768|FG003|Overall Study|Insufficient therapeutic response|51|||
128911251|NCT00087646|463966765|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
128911252|NCT00087646|463966766|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
128911253|NCT00087646|463966767|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
128911254|NCT00087646|463966768|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
128911255|NCT00087646|463966765|FG000|Overall Study|Failure to Return|5|||
128911256|NCT00087646|463966766|FG001|Overall Study|Failure to Return|2|||
128911257|NCT00087646|463966767|FG002|Overall Study|Failure to Return|2|||
128911258|NCT00087646|463966768|FG003|Overall Study|Failure to Return|3|||
128911259|NCT00087646|463966765|FG000|Overall Study|Administrative/Other|6|||
128911260|NCT00087646|463966766|FG001|Overall Study|Administrative/Other|1|||
128911261|NCT00087646|463966767|FG002|Overall Study|Administrative/Other|1|||
128911262|NCT00087646|463966768|FG003|Overall Study|Administrative/Other|2|||
128911263|NCT00087646|463966765|FG000|Overall Study|Other Protocol Violation|3|||
128911264|NCT00087646|463966766|FG001|Overall Study|Other Protocol Violation|1|||
128911265|NCT00087646|463966767|FG002|Overall Study|Other Protocol Violation|0|||
128911266|NCT00087646|463966768|FG003|Overall Study|Other Protocol Violation|0|||
128911267|NCT00087646|463966765|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
128911268|NCT00087646|463966766|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
128911269|NCT00087646|463966767|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
128911270|NCT00087646|463966768|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
128911271|NCT01235962|463966769|FG000|Overall Study|Withdrawal by Subject|20|||
128911272|NCT01235962|463966770|FG001|Overall Study|Withdrawal by Subject|19|||
128911273|NCT01235962|463966771|FG002|Overall Study|Withdrawal by Subject|62|||
128911274|NCT01235962|463966772|FG003|Overall Study|Withdrawal by Subject|49|||
128911275|NCT01235962|463966769|FG000|Overall Study|Lost to Follow-up|21|||
128911276|NCT01235962|463966770|FG001|Overall Study|Lost to Follow-up|16|||
128911277|NCT01235962|463966771|FG002|Overall Study|Lost to Follow-up|47|||
128911278|NCT01235962|463966772|FG003|Overall Study|Lost to Follow-up|32|||
128911279|NCT01235962|463966769|FG000|Overall Study|Physician Decision|5|||
128911280|NCT01235962|463966770|FG001|Overall Study|Physician Decision|0|||
128911281|NCT01235962|463966771|FG002|Overall Study|Physician Decision|9|||
128911282|NCT01235962|463966772|FG003|Overall Study|Physician Decision|5|||
128911283|NCT01580397|463966775|FG000|Overall Study|Lack of Efficacy|14|||
128911284|NCT02902120|463966777|FG000|Overall Study|Lack of Efficacy|1|||
128911285|NCT02004873|463966778|FG000|Overall Study|Implant unsuccessful|6|||
128911286|NCT02004873|463966778|FG000|Overall Study|Awaiting 6-month visit|390|||
128911287|NCT02004873|463966778|FG000|Overall Study|Missed 6-month visit|4|||
128911288|NCT02004873|463966778|FG000|Overall Study|Death|23|||
128911289|NCT02004873|463966778|FG000|Overall Study|Withdrawal by Subject|1|||
128911290|NCT01353703|463966779|FG000|Overall Study|Migrated/moved from study area|1|||
128911291|NCT01353703|463966780|FG001|Overall Study|Migrated/moved from study area|0|||
128911292|NCT04925752|463966798|FG000|Overall Study|Still on Study|1826|||
128911293|NCT04925752|463966799|FG001|Overall Study|Still on Study|926|||
128911294|NCT04925752|463966798|FG000|Overall Study|Withdrew Consent|128|||
128911295|NCT04925752|463966799|FG001|Overall Study|Withdrew Consent|59|||
129118356|NCT05965752|464729010|FG001|Overall Study|Withdrawal by Subject|2|||
129118357|NCT05965752|464729011|FG002|Overall Study|Withdrawal by Subject|1|||
129118358|NCT05965752|464729012|FG003|Overall Study|Withdrawal by Subject|5|||
129118359|NCT05965752|464729013|FG004|Overall Study|Withdrawal by Subject|0|||
129118360|NCT05965752|464729009|FG000|Overall Study|Disease Relapse|1|||
129118361|NCT05965752|464729010|FG001|Overall Study|Disease Relapse|0|||
129118362|NCT05965752|464729011|FG002|Overall Study|Disease Relapse|1|||
129118363|NCT05965752|464729012|FG003|Overall Study|Disease Relapse|0|||
129118364|NCT05965752|464729013|FG004|Overall Study|Disease Relapse|0|||
129118365|NCT05965752|464729009|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129118366|NCT05965752|464729010|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
129118367|NCT05965752|464729011|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
129118368|NCT05965752|464729012|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
129118369|NCT05965752|464729013|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
129118370|NCT05965752|464729009|FG000|Overall Study|Unable to Return for Study Visits|0|||
129118371|NCT05965752|464729010|FG001|Overall Study|Unable to Return for Study Visits|1|||
129118372|NCT05965752|464729011|FG002|Overall Study|Unable to Return for Study Visits|0|||
128696989|NCT03173313|463188967|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
128696990|NCT03173313|463188968|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
128696991|NCT03173313|463188967|FG000|Overall Study|Bone Fracture|1|||
128696992|NCT03173313|463188968|FG001|Overall Study|Bone Fracture|0|||
128911296|NCT04925752|463966798|FG000|Overall Study|Lost to Follow-up|73|||
128911297|NCT04925752|463966799|FG001|Overall Study|Lost to Follow-up|47|||
128911298|NCT04925752|463966798|FG000|Overall Study|Randomized but Never Treated|12|||
128911299|NCT04925752|463966799|FG001|Overall Study|Randomized but Never Treated|9|||
128911300|NCT04925752|463966798|FG000|Overall Study|Hiv-1 Infection|6|||
128911301|NCT04925752|463966799|FG001|Overall Study|Hiv-1 Infection|7|||
128911302|NCT04925752|463966798|FG000|Overall Study|Investigator's discretion|8|||
128911303|NCT04925752|463966799|FG001|Overall Study|Investigator's discretion|5|||
128911304|NCT04925752|463966798|FG000|Overall Study|Non-compliance with Study Drug|8|||
128911305|NCT04925752|463966799|FG001|Overall Study|Non-compliance with Study Drug|5|||
128911306|NCT04925752|463966798|FG000|Overall Study|Adverse Event|5|||
128911307|NCT04925752|463966799|FG001|Overall Study|Adverse Event|2|||
128911308|NCT04925752|463966798|FG000|Overall Study|Death|4|||
128911309|NCT04925752|463966799|FG001|Overall Study|Death|2|||
128911310|NCT04925752|463966798|FG000|Overall Study|Protocol Violation|1|||
128911311|NCT04925752|463966799|FG001|Overall Study|Protocol Violation|3|||
128696993|NCT01876420|463188969|FG000|Overall Study|Missed 30 day visit|1|||
128696994|NCT01065597|463188973|FG000|Overall Study|Adverse Event|1|||
128696995|NCT01042678|463188974|FG000|Overall Study|Physician Decision|1|||
128911312|NCT04925752|463966798|FG000|Overall Study|Withdrew Assent|1|||
128911313|NCT04925752|463966799|FG001|Overall Study|Withdrew Assent|0|||
128911314|NCT03467958|463966800|FG000|Overall Study|Adverse Event|20|||
128911315|NCT03467958|463966801|FG001|Overall Study|Adverse Event|32|||
128911316|NCT03467958|463966802|FG002|Overall Study|Adverse Event|5|||
128911317|NCT03467958|463966803|FG003|Overall Study|Adverse Event|3|||
128911318|NCT03467958|463966804|FG004|Overall Study|Adverse Event|3|||
128911319|NCT03467958|463966805|FG005|Overall Study|Adverse Event|3|||
128696996|NCT01042678|463188975|FG001|Overall Study|Physician Decision|0|||
128696997|NCT01042678|463188976|FG002|Overall Study|Physician Decision|0|||
128696998|NCT01042678|463188977|FG003|Overall Study|Physician Decision|0|||
128696999|NCT01042678|463188978|FG004|Overall Study|Physician Decision|0|||
128697000|NCT01042678|463188979|FG005|Overall Study|Physician Decision|0|||
128911320|NCT03467958|463966806|FG006|Overall Study|Adverse Event|6|||
128911321|NCT03467958|463966807|FG007|Overall Study|Adverse Event|5|||
128911322|NCT03467958|463966808|FG008|Overall Study|Adverse Event|0|||
128911323|NCT03467958|463966800|FG000|Overall Study|Lack of Efficacy|59|||
128911324|NCT03467958|463966801|FG001|Overall Study|Lack of Efficacy|120|||
129028203|NCT01630616|464394503|FG005|Overall Study|Adverse Event|0|||
129028204|NCT01630616|464394498|FG000|Overall Study|Withdrawal by Subject|0|||
129028205|NCT01630616|464394499|FG001|Overall Study|Withdrawal by Subject|0|||
129028206|NCT01630616|464394500|FG002|Overall Study|Withdrawal by Subject|0|||
129028207|NCT01630616|464394501|FG003|Overall Study|Withdrawal by Subject|2|||
129028208|NCT01630616|464394502|FG004|Overall Study|Withdrawal by Subject|0|||
129028209|NCT01630616|464394503|FG005|Overall Study|Withdrawal by Subject|0|||
129028210|NCT02218541|464394504|FG000|Overall Study|Lost to Follow-up|2|||
129028211|NCT02218541|464394505|FG001|Overall Study|Lost to Follow-up|1|||
129028212|NCT02218541|464394504|FG000|Overall Study|Implant Failure|4|||
129028213|NCT02218541|464394505|FG001|Overall Study|Implant Failure|1|||
129028214|NCT00691704|464394506|FG000|Induction Therapy|Disease Progression|1|||
129028215|NCT00691704|464394506|FG000|Induction Therapy|Active Hepatitis|1|||
129028216|NCT00691704|464394506|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
129028217|NCT00691704|464394506|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
129028218|NCT00691704|464394506|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
129028219|NCT01993186|464394508|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
129028220|NCT01993186|464394509|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
129028221|NCT01993186|464394508|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
129028222|NCT01993186|464394509|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
129028223|NCT01993186|464394508|FG000|Open-Label Extension Period|Other, Not Specified|0|||
129028224|NCT01993186|464394509|FG001|Open-Label Extension Period|Other, Not Specified|1|||
129028225|NCT01993186|464394508|FG000|Open-Label Extension Period|Adverse Event|1|||
129028226|NCT01993186|464394509|FG001|Open-Label Extension Period|Adverse Event|0|||
129028227|NCT01993186|464394508|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
129028228|NCT01993186|464394509|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
129028229|NCT01993186|464394508|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
129028230|NCT01993186|464394509|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
129028231|NCT01993186|464394508|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
129028232|NCT01993186|464394509|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
129028233|NCT04661202|464394510|FG000|Overall Study|Withdrawal by Subject|1|||
129028234|NCT04661202|464394511|FG001|Overall Study|Withdrawal by Subject|1|||
129028235|NCT04661202|464394510|FG000|Overall Study|Lack of Efficacy|2|||
129028236|NCT04661202|464394511|FG001|Overall Study|Lack of Efficacy|0|||
129028237|NCT02313558|464394513|FG000|Overall Study|Withdrawal by Subject|2|||
129028238|NCT02313558|464394514|FG001|Overall Study|Withdrawal by Subject|0|||
129028239|NCT02313558|464394513|FG000|Overall Study|Lost to Follow-up|4|||
129028240|NCT02313558|464394514|FG001|Overall Study|Lost to Follow-up|4|||
129028241|NCT04158687|464394515|FG000|Overall Study|Adverse Event|2|||
129028242|NCT04158687|464394516|FG001|Overall Study|Adverse Event|3|||
129028243|NCT04158687|464394517|FG002|Overall Study|Adverse Event|0|||
129028244|NCT04158687|464394518|FG003|Overall Study|Adverse Event|3|||
129028245|NCT04158687|464394515|FG000|Overall Study|Lost to Follow-up|5|||
129028246|NCT04158687|464394516|FG001|Overall Study|Lost to Follow-up|12|||
129028247|NCT04158687|464394517|FG002|Overall Study|Lost to Follow-up|4|||
128911325|NCT03467958|463966802|FG002|Overall Study|Lack of Efficacy|6|||
128911326|NCT03467958|463966803|FG003|Overall Study|Lack of Efficacy|9|||
128911327|NCT03467958|463966804|FG004|Overall Study|Lack of Efficacy|8|||
128911328|NCT03467958|463966805|FG005|Overall Study|Lack of Efficacy|9|||
128911329|NCT03467958|463966806|FG006|Overall Study|Lack of Efficacy|11|||
128911330|NCT03467958|463966807|FG007|Overall Study|Lack of Efficacy|9|||
128911331|NCT03467958|463966808|FG008|Overall Study|Lack of Efficacy|3|||
128911332|NCT03467958|463966800|FG000|Overall Study|Lost to Follow-up|1|||
128911333|NCT03467958|463966801|FG001|Overall Study|Lost to Follow-up|2|||
128911334|NCT03467958|463966802|FG002|Overall Study|Lost to Follow-up|1|||
128911335|NCT03467958|463966803|FG003|Overall Study|Lost to Follow-up|0|||
128911336|NCT03467958|463966804|FG004|Overall Study|Lost to Follow-up|4|||
128911337|NCT03467958|463966805|FG005|Overall Study|Lost to Follow-up|0|||
128911338|NCT03467958|463966806|FG006|Overall Study|Lost to Follow-up|0|||
128911339|NCT03467958|463966807|FG007|Overall Study|Lost to Follow-up|0|||
128911340|NCT03467958|463966808|FG008|Overall Study|Lost to Follow-up|0|||
128911341|NCT03467958|463966800|FG000|Overall Study|Other reasons|8|||
128911342|NCT03467958|463966801|FG001|Overall Study|Other reasons|14|||
128911343|NCT03467958|463966802|FG002|Overall Study|Other reasons|2|||
128911344|NCT03467958|463966803|FG003|Overall Study|Other reasons|1|||
128911345|NCT03467958|463966804|FG004|Overall Study|Other reasons|4|||
128911346|NCT03467958|463966805|FG005|Overall Study|Other reasons|0|||
128911347|NCT03467958|463966806|FG006|Overall Study|Other reasons|1|||
128911348|NCT03467958|463966807|FG007|Overall Study|Other reasons|0|||
128911349|NCT03467958|463966808|FG008|Overall Study|Other reasons|1|||
128911350|NCT03467958|463966800|FG000|Overall Study|Pregnancy|1|||
128911351|NCT03467958|463966801|FG001|Overall Study|Pregnancy|0|||
128911352|NCT03467958|463966802|FG002|Overall Study|Pregnancy|0|||
128911353|NCT03467958|463966803|FG003|Overall Study|Pregnancy|0|||
128911354|NCT03467958|463966804|FG004|Overall Study|Pregnancy|0|||
128911355|NCT03467958|463966805|FG005|Overall Study|Pregnancy|1|||
128911356|NCT03467958|463966806|FG006|Overall Study|Pregnancy|0|||
129118373|NCT05965752|464729012|FG003|Overall Study|Unable to Return for Study Visits|3|||
129118374|NCT05965752|464729013|FG004|Overall Study|Unable to Return for Study Visits|1|||
129118375|NCT05965752|464729009|FG000|Overall Study|Early Termination|0|||
129118376|NCT05965752|464729010|FG001|Overall Study|Early Termination|0|||
129118377|NCT05965752|464729011|FG002|Overall Study|Early Termination|1|||
129118378|NCT05965752|464729012|FG003|Overall Study|Early Termination|0|||
129118379|NCT05965752|464729013|FG004|Overall Study|Early Termination|0|||
129118380|NCT05965752|464729009|FG000|Overall Study|Reported Unwanted Symptoms|0|||
129118381|NCT05965752|464729010|FG001|Overall Study|Reported Unwanted Symptoms|0|||
129118382|NCT05965752|464729011|FG002|Overall Study|Reported Unwanted Symptoms|0|||
129118383|NCT05965752|464729012|FG003|Overall Study|Reported Unwanted Symptoms|0|||
129118384|NCT05965752|464729013|FG004|Overall Study|Reported Unwanted Symptoms|1|||
129118385|NCT05965752|464729009|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129118386|NCT05965752|464729010|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129118387|NCT05965752|464729011|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129118388|NCT05965752|464729012|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129118389|NCT05965752|464729013|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
129118390|NCT01324947|464729014|FG000|Overall Study|Adverse Event|7|||
129118391|NCT01324947|464729014|FG000|Overall Study|Death|10|||
129118392|NCT01324947|464729014|FG000|Overall Study|Other|3|||
129118393|NCT01324947|464729014|FG000|Overall Study|Progressive Disease|50|||
129118394|NCT01324947|464729014|FG000|Overall Study|Withdrawal by Subject|3|||
128911357|NCT03467958|463966807|FG007|Overall Study|Pregnancy|0|||
128911358|NCT03467958|463966808|FG008|Overall Study|Pregnancy|0|||
128911359|NCT03467958|463966800|FG000|Overall Study|Study terminated by sponsor|65|||
128911360|NCT03467958|463966801|FG001|Overall Study|Study terminated by sponsor|117|||
128911361|NCT03467958|463966802|FG002|Overall Study|Study terminated by sponsor|45|||
128911362|NCT03467958|463966803|FG003|Overall Study|Study terminated by sponsor|64|||
128911363|NCT03467958|463966804|FG004|Overall Study|Study terminated by sponsor|66|||
128911364|NCT03467958|463966805|FG005|Overall Study|Study terminated by sponsor|17|||
128911365|NCT03467958|463966806|FG006|Overall Study|Study terminated by sponsor|11|||
129118395|NCT01324947|464729014|FG000|Overall Study|1 discontinued before starting drug|1|||
128911366|NCT03467958|463966807|FG007|Overall Study|Study terminated by sponsor|5|||
129118396|NCT01274351|464729015|FG000|Overall Study|Lost to Follow-up|1|||
129118397|NCT01274351|464729015|FG000|Overall Study|patient not compliant with the protocol|1|||
129118398|NCT01274351|464729015|FG000|Overall Study|Pregnancy|1|||
129118399|NCT01274351|464729015|FG000|Overall Study|Death|2|||
128911367|NCT03467958|463966808|FG008|Overall Study|Study terminated by sponsor|5|||
128911368|NCT03467958|463966800|FG000|Overall Study|Withdrawal by Subject|25|||
128911369|NCT03467958|463966801|FG001|Overall Study|Withdrawal by Subject|44|||
129118400|NCT01274351|464729015|FG000|Overall Study|Withdrawal by Subject|3|||
128697001|NCT01416272|463188981|FG000|Overall Study|Unacceptable distance visual acuity|2|||
128911370|NCT03467958|463966802|FG002|Overall Study|Withdrawal by Subject|7|||
128911371|NCT03467958|463966803|FG003|Overall Study|Withdrawal by Subject|8|||
128911372|NCT03467958|463966804|FG004|Overall Study|Withdrawal by Subject|6|||
128911373|NCT03467958|463966805|FG005|Overall Study|Withdrawal by Subject|8|||
128911374|NCT03467958|463966806|FG006|Overall Study|Withdrawal by Subject|4|||
128911375|NCT03467958|463966807|FG007|Overall Study|Withdrawal by Subject|1|||
128911376|NCT03467958|463966808|FG008|Overall Study|Withdrawal by Subject|4|||
128911377|NCT02925156|463966810|FG000|Overall Study|Lost to Follow-up|27|||
128911378|NCT02925156|463966811|FG001|Overall Study|Lost to Follow-up|53|||
128911379|NCT02925156|463966812|FG002|Overall Study|Lost to Follow-up|51|||
128911380|NCT02925156|463966813|FG003|Overall Study|Lost to Follow-up|59|||
128911381|NCT02925156|463966814|FG004|Overall Study|Lost to Follow-up|89|||
128911382|NCT02925156|463966815|FG005|Overall Study|Lost to Follow-up|107|||
128911383|NCT02925156|463966816|FG006|Overall Study|Lost to Follow-up|34|||
128911384|NCT02925156|463966817|FG007|Overall Study|Lost to Follow-up|36|||
128911385|NCT02925156|463966818|FG008|Overall Study|Lost to Follow-up|73|||
128911386|NCT02925156|463966819|FG009|Overall Study|Lost to Follow-up|34|||
128911387|NCT00866307|463966820|FG000|Induction|Adverse Event|5|||
128911388|NCT00866307|463966821|FG001|Induction|Adverse Event|0|||
128911389|NCT00866307|463966822|FG002|Induction|Adverse Event|0|||
128911390|NCT00866307|463966820|FG000|Induction|Death|2|||
128911391|NCT00866307|463966821|FG001|Induction|Death|0|||
128911392|NCT00866307|463966822|FG002|Induction|Death|0|||
128911393|NCT00866307|463966820|FG000|Induction|Physician Decision|5|||
128911394|NCT00866307|463966821|FG001|Induction|Physician Decision|0|||
128911395|NCT00866307|463966822|FG002|Induction|Physician Decision|0|||
128911396|NCT00866307|463966820|FG000|Induction|Progressive Disease|1|||
128911397|NCT00866307|463966821|FG001|Induction|Progressive Disease|0|||
128911398|NCT00866307|463966822|FG002|Induction|Progressive Disease|0|||
128911399|NCT00866307|463966820|FG000|Induction|Identification of Patients with Day 29 M|3|||
128911400|NCT00866307|463966821|FG001|Induction|Identification of Patients with Day 29 M|0|||
128911401|NCT00866307|463966822|FG002|Induction|Identification of Patients with Day 29 M|0|||
128911402|NCT00866307|463966820|FG000|Induction|Inadequate cytognetic samples th|1|||
128911403|NCT00866307|463966821|FG001|Induction|Inadequate cytognetic samples th|0|||
128911404|NCT00866307|463966822|FG002|Induction|Inadequate cytognetic samples th|0|||
128911405|NCT00866307|463966820|FG000|Induction|Improper post-induction consent|2|||
128911406|NCT00866307|463966821|FG001|Induction|Improper post-induction consent|0|||
128911407|NCT00866307|463966822|FG002|Induction|Improper post-induction consent|0|||
128911408|NCT00866307|463966820|FG000|Induction|Study was closed at the time|1|||
128911409|NCT00866307|463966821|FG001|Induction|Study was closed at the time|0|||
128911410|NCT00866307|463966822|FG002|Induction|Study was closed at the time|0|||
128911411|NCT00866307|463966820|FG000|Consolidation/Maintenance|Adverse Event|0|||
128911412|NCT00866307|463966821|FG001|Consolidation/Maintenance|Adverse Event|0|||
128911413|NCT00866307|463966822|FG002|Consolidation/Maintenance|Adverse Event|8|||
128911414|NCT00866307|463966820|FG000|Consolidation/Maintenance|Death|0|||
128911415|NCT00866307|463966821|FG001|Consolidation/Maintenance|Death|0|||
128911416|NCT00866307|463966822|FG002|Consolidation/Maintenance|Death|1|||
128911417|NCT00866307|463966820|FG000|Consolidation/Maintenance|Physician Decision|0|||
128911418|NCT00866307|463966821|FG001|Consolidation/Maintenance|Physician Decision|3|||
128911419|NCT00866307|463966822|FG002|Consolidation/Maintenance|Physician Decision|2|||
128911420|NCT00866307|463966820|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
128911421|NCT00866307|463966821|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
128911422|NCT00866307|463966822|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
128911423|NCT00866307|463966820|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
128911424|NCT00866307|463966821|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
128911425|NCT00866307|463966822|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
128911426|NCT00866307|463966820|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
128911427|NCT00866307|463966821|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
128911428|NCT00866307|463966822|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
128911429|NCT00866307|463966820|FG000|Consolidation/Maintenance|Therapy error|0|||
128911430|NCT00866307|463966821|FG001|Consolidation/Maintenance|Therapy error|1|||
128911431|NCT00866307|463966822|FG002|Consolidation/Maintenance|Therapy error|0|||
128911432|NCT00866307|463966820|FG000|Consolidation/Maintenance|Non-compliance|0|||
128911433|NCT00866307|463966821|FG001|Consolidation/Maintenance|Non-compliance|0|||
128911434|NCT00866307|463966822|FG002|Consolidation/Maintenance|Non-compliance|1|||
128911435|NCT00866307|463966820|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
128911436|NCT00866307|463966821|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
128911437|NCT00866307|463966822|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
129028248|NCT04158687|464394518|FG003|Overall Study|Lost to Follow-up|5|||
129028249|NCT04158687|464394515|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
128911438|NCT02286947|463966825|FG000|Overall Study|Withdrawal by Subject|2|||
128911439|NCT01060059|463966828|FG000|Overall Study|Adverse Event|1|||
128911440|NCT01060059|463966829|FG001|Overall Study|Adverse Event|1|||
128911441|NCT01060059|463966828|FG000|Overall Study|Death|2|||
128911442|NCT01060059|463966829|FG001|Overall Study|Death|3|||
129028250|NCT04158687|464394516|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
128911443|NCT01060059|463966828|FG000|Overall Study|Lost to Follow-up|18|||
128911444|NCT01060059|463966829|FG001|Overall Study|Lost to Follow-up|34|||
129028251|NCT04158687|464394517|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
129118401|NCT01274351|464729015|FG000|Overall Study|Adverse Event|8|||
128911445|NCT01060059|463966828|FG000|Overall Study|entry criteria not met|4|||
128911446|NCT01060059|463966829|FG001|Overall Study|entry criteria not met|3|||
128911447|NCT01060059|463966828|FG000|Overall Study|Withdrawal by Subject|35|||
128911448|NCT01060059|463966829|FG001|Overall Study|Withdrawal by Subject|23|||
128911449|NCT01060059|463966828|FG000|Overall Study|lack of glycemic control|2|||
128911450|NCT01060059|463966829|FG001|Overall Study|lack of glycemic control|1|||
128911451|NCT01060059|463966828|FG000|Overall Study|lack of compliance|5|||
128911452|NCT01060059|463966829|FG001|Overall Study|lack of compliance|2|||
128911453|NCT01614093|463966830|FG000|Overall Study|Withdrawal by Subject|1|||
128911454|NCT00848354|463966831|FG000|Phase 1|Adverse Event|5|||
128911455|NCT00848354|463966832|FG001|Phase 1|Adverse Event|4|||
128911456|NCT00848354|463966831|FG000|Phase 1|Discontinuation of study by sponsor|2|||
128911457|NCT00848354|463966832|FG001|Phase 1|Discontinuation of study by sponsor|1|||
128911458|NCT00848354|463966831|FG000|Phase 1|Failed to return|0|||
128911459|NCT00848354|463966832|FG001|Phase 1|Failed to return|1|||
128911460|NCT00848354|463966831|FG000|Phase 1|Lost to Follow-up|1|||
128911461|NCT00848354|463966832|FG001|Phase 1|Lost to Follow-up|1|||
128911462|NCT00848354|463966831|FG000|Phase 1|Unspecified Reason|1|||
128911463|NCT00848354|463966832|FG001|Phase 1|Unspecified Reason|1|||
128911464|NCT00848354|463966831|FG000|Phase 1|Protocol Violation|1|||
128911465|NCT00848354|463966832|FG001|Phase 1|Protocol Violation|1|||
128911466|NCT00848354|463966831|FG000|Phase 1|Withdrawal by Subject|2|||
128911467|NCT00848354|463966832|FG001|Phase 1|Withdrawal by Subject|4|||
128911468|NCT00848354|463966831|FG000|Phase 1|Lack of Efficacy|0|||
128911469|NCT00848354|463966832|FG001|Phase 1|Lack of Efficacy|1|||
128911470|NCT00848354|463966831|FG000|Phase 2 Year 1|Adverse Event|7|||
128911471|NCT00848354|463966832|FG001|Phase 2 Year 1|Adverse Event|2|||
128911472|NCT00848354|463966831|FG000|Phase 2 Year 1|Death|1|||
128911473|NCT00848354|463966832|FG001|Phase 2 Year 1|Death|0|||
128911474|NCT00848354|463966831|FG000|Phase 2 Year 1|Failed to Return|1|||
128911475|NCT00848354|463966832|FG001|Phase 2 Year 1|Failed to Return|1|||
128911476|NCT00848354|463966831|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
128911477|NCT00848354|463966832|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
128911478|NCT00848354|463966831|FG000|Phase 2 Year 1|Unspecified Reason|3|||
128911479|NCT00848354|463966832|FG001|Phase 2 Year 1|Unspecified Reason|0|||
128911480|NCT00848354|463966831|FG000|Phase 2 Year 1|Protocol Violation|4|||
128911481|NCT00848354|463966832|FG001|Phase 2 Year 1|Protocol Violation|1|||
128911482|NCT00848354|463966831|FG000|Phase 2 Year 1|Subject Request|1|||
128911483|NCT00848354|463966832|FG001|Phase 2 Year 1|Subject Request|2|||
128911484|NCT00848354|463966831|FG000|Phase 2 Year 2|Adverse Event|12|||
128911485|NCT00848354|463966832|FG001|Phase 2 Year 2|Adverse Event|2|||
128911486|NCT00848354|463966831|FG000|Phase 2 Year 2|Death|2|||
128911487|NCT00848354|463966832|FG001|Phase 2 Year 2|Death|0|||
128911488|NCT00848354|463966831|FG000|Phase 2 Year 2|Failed to return|3|||
128911489|NCT00848354|463966832|FG001|Phase 2 Year 2|Failed to return|0|||
128911490|NCT00848354|463966831|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
128911491|NCT00848354|463966832|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
128911492|NCT00848354|463966831|FG000|Phase 2 Year 2|Unspecified Reason|1|||
128911493|NCT00848354|463966832|FG001|Phase 2 Year 2|Unspecified Reason|0|||
128911494|NCT00848354|463966831|FG000|Phase 2 Year 2|Protocol Violation|1|||
128911495|NCT00848354|463966832|FG001|Phase 2 Year 2|Protocol Violation|1|||
128911496|NCT00848354|463966831|FG000|Phase 2 Year 2|Subject Request|1|||
128911497|NCT00848354|463966832|FG001|Phase 2 Year 2|Subject Request|1|||
128911498|NCT00848354|463966831|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
128911499|NCT00848354|463966832|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
128911500|NCT01777581|463966833|FG000|Overall Study|Lost to Follow-up|1|||
128911501|NCT01777581|463966834|FG001|Overall Study|Lost to Follow-up|1|||
128911502|NCT01777581|463966833|FG000|Overall Study|Adverse Event|2|||
128911503|NCT01777581|463966834|FG001|Overall Study|Adverse Event|0|||
129118402|NCT01274351|464729015|FG000|Overall Study|progression of disease|3|||
129118403|NCT01274351|464729015|FG000|Overall Study|hospitalization|1|||
129118404|NCT01296412|464729019|FG000|Overall Study|Adverse Event|8|||
129118405|NCT01296412|464729020|FG001|Overall Study|Adverse Event|29|||
129118406|NCT01296412|464729019|FG000|Overall Study|Lack of Efficacy|1|||
129118407|NCT01296412|464729020|FG001|Overall Study|Lack of Efficacy|0|||
129118408|NCT01296412|464729019|FG000|Overall Study|Lost to Follow-up|10|||
129118409|NCT01296412|464729020|FG001|Overall Study|Lost to Follow-up|7|||
129118410|NCT01296412|464729019|FG000|Overall Study|Non-compliance with study drug|1|||
129118411|NCT01296412|464729020|FG001|Overall Study|Non-compliance with study drug|2|||
128911504|NCT01777581|463966833|FG000|Overall Study|Lack of Efficacy|0|||
128911505|NCT01777581|463966834|FG001|Overall Study|Lack of Efficacy|1|||
128911506|NCT04202679|463966837|FG000|Overall Study|Adverse Event|2|||
128911507|NCT04202679|463966838|FG001|Overall Study|Adverse Event|0|||
129118412|NCT01296412|464729019|FG000|Overall Study|Other reason not specified|20|||
128911508|NCT04202679|463966837|FG000|Overall Study|Poor compliance to protocol|1|||
128911509|NCT04202679|463966838|FG001|Overall Study|Poor compliance to protocol|0|||
128911510|NCT04202679|463966837|FG000|Overall Study|Withdrawal by Subject|23|||
128911511|NCT04202679|463966838|FG001|Overall Study|Withdrawal by Subject|6|||
129118413|NCT01296412|464729020|FG001|Overall Study|Other reason not specified|15|||
128911512|NCT03718143|463969156|FG000|Overall Study|Death|1|||
128911513|NCT03718143|463969157|FG001|Overall Study|Death|0|||
128911514|NCT03718143|463969158|FG002|Overall Study|Death|0|||
128911515|NCT03718143|463969156|FG000|Overall Study|Progression of Disease|1|||
128911516|NCT03718143|463969157|FG001|Overall Study|Progression of Disease|0|||
128911517|NCT03718143|463969158|FG002|Overall Study|Progression of Disease|0|||
128911518|NCT03718143|463969156|FG000|Overall Study|Withdrawal of Informed Consent|1|||
128911519|NCT03718143|463969157|FG001|Overall Study|Withdrawal of Informed Consent|2|||
128911520|NCT03718143|463969158|FG002|Overall Study|Withdrawal of Informed Consent|1|||
128911521|NCT05064059|463969159|FG000|Overall Study|Death|199|||
128911522|NCT05064059|463969160|FG001|Overall Study|Death|196|||
128911523|NCT05064059|463969159|FG000|Overall Study|Physician Decision|4|||
128911524|NCT05064059|463969160|FG001|Overall Study|Physician Decision|2|||
128911525|NCT05064059|463969159|FG000|Overall Study|Sponsor Decision|14|||
128911526|NCT05064059|463969160|FG001|Overall Study|Sponsor Decision|11|||
128911527|NCT05064059|463969159|FG000|Overall Study|Withdrawal by Subject|4|||
128911528|NCT05064059|463969160|FG001|Overall Study|Withdrawal by Subject|11|||
128911529|NCT00805740|463969161|FG000|Overall Study|Death|7|||
128911530|NCT00805740|463969162|FG001|Overall Study|Death|4|||
128911531|NCT00805740|463969161|FG000|Overall Study|Withdrawal by Subject|1|||
128911532|NCT00805740|463969162|FG001|Overall Study|Withdrawal by Subject|0|||
128911533|NCT00805740|463969161|FG000|Overall Study|Lost to Follow-up|1|||
128911534|NCT00805740|463969162|FG001|Overall Study|Lost to Follow-up|0|||
128911535|NCT00805740|463969161|FG000|Overall Study|Randomized, but not treated|2|||
128911536|NCT00805740|463969162|FG001|Overall Study|Randomized, but not treated|0|||
128911537|NCT00200850|463969167|FG000|Overall Study|relocation|1|||
128911538|NCT00200850|463969168|FG001|Overall Study|relocation|0|||
128911539|NCT00200850|463969169|FG002|Overall Study|relocation|1|||
128911540|NCT00200850|463969167|FG000|Overall Study|too busy|1|||
128765374|NCT02969525|463432139|FG001|Dose-Blind Period|Adverse Event|0|||
128765375|NCT02969525|463432140|FG002|Dose-Blind Period|Adverse Event|0|||
128765376|NCT02969525|463432141|FG003|Dose-Blind Period|Adverse Event|0|||
128765377|NCT02969525|463432142|FG004|Dose-Blind Period|Adverse Event|0|||
128911541|NCT00200850|463969168|FG001|Overall Study|too busy|0|||
129028252|NCT04158687|464394518|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
128765378|NCT02969525|463432143|FG005|Dose-Blind Period|Adverse Event|0|||
128765379|NCT02969525|463432144|FG006|Dose-Blind Period|Adverse Event|0|||
128765380|NCT02969525|463432145|FG007|Dose-Blind Period|Adverse Event|0|||
129028253|NCT04158687|464394515|FG000|Overall Study|Non-Compliance with Study Medication|2|||
129028254|NCT04158687|464394516|FG001|Overall Study|Non-Compliance with Study Medication|2|||
129028255|NCT04158687|464394517|FG002|Overall Study|Non-Compliance with Study Medication|3|||
129028256|NCT04158687|464394518|FG003|Overall Study|Non-Compliance with Study Medication|0|||
129028257|NCT04158687|464394515|FG000|Overall Study|Investigator Decision|0|||
129028258|NCT04158687|464394516|FG001|Overall Study|Investigator Decision|0|||
129028259|NCT04158687|464394517|FG002|Overall Study|Investigator Decision|2|||
129028260|NCT04158687|464394518|FG003|Overall Study|Investigator Decision|0|||
129028261|NCT04158687|464394515|FG000|Overall Study|Protocol Violation|0|||
129028262|NCT04158687|464394516|FG001|Overall Study|Protocol Violation|2|||
129028263|NCT04158687|464394517|FG002|Overall Study|Protocol Violation|1|||
129028264|NCT04158687|464394518|FG003|Overall Study|Protocol Violation|0|||
129028265|NCT04158687|464394515|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
129028266|NCT04158687|464394516|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
129028267|NCT04158687|464394517|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
129028268|NCT04158687|464394518|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
129028269|NCT04158687|464394515|FG000|Overall Study|Reason not Specified|3|||
129028270|NCT04158687|464394516|FG001|Overall Study|Reason not Specified|2|||
129028271|NCT04158687|464394517|FG002|Overall Study|Reason not Specified|4|||
129028272|NCT04158687|464394518|FG003|Overall Study|Reason not Specified|4|||
129028273|NCT04102345|464394519|FG000|Overall Study|Withdrawal by Subject|1|||
129028274|NCT04102345|464394520|FG001|Overall Study|Withdrawal by Subject|0|||
129028275|NCT00385736|464394521|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
129028276|NCT00385736|464394522|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
129028277|NCT00385736|464394523|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
129028278|NCT00385736|464394521|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
129028279|NCT00385736|464394522|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
128765381|NCT02969525|463432146|FG008|Dose-Blind Period|Adverse Event|0|||
128765382|NCT02969525|463432147|FG009|Dose-Blind Period|Adverse Event|1|||
128765383|NCT02969525|463432148|FG010|Dose-Blind Period|Adverse Event|1|||
128765384|NCT02969525|463432149|FG011|Dose-Blind Period|Adverse Event|1|||
128911542|NCT00200850|463969169|FG002|Overall Study|too busy|0|||
128911543|NCT00200850|463969167|FG000|Overall Study|Pregnancy|0|||
128911544|NCT00200850|463969168|FG001|Overall Study|Pregnancy|0|||
128911545|NCT00200850|463969169|FG002|Overall Study|Pregnancy|1|||
129028280|NCT00385736|464394523|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
129028281|NCT00385736|464394521|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
128911546|NCT00200850|463969167|FG000|Overall Study|Poor adherence|0|||
128911547|NCT00200850|463969168|FG001|Overall Study|Poor adherence|0|||
128911548|NCT00200850|463969169|FG002|Overall Study|Poor adherence|1|||
128911549|NCT00200850|463969167|FG000|Overall Study|optic neuritis|0|||
128911550|NCT00200850|463969168|FG001|Overall Study|optic neuritis|0|||
128911551|NCT00200850|463969169|FG002|Overall Study|optic neuritis|1|||
128911552|NCT00200850|463969167|FG000|Overall Study|Adverse Event|1|||
128911553|NCT00200850|463969168|FG001|Overall Study|Adverse Event|1|||
128911554|NCT00200850|463969169|FG002|Overall Study|Adverse Event|2|||
128911555|NCT05227690|463969175|FG000|Overall Study|Adverse Event|5|||
128911556|NCT05227690|463969176|FG001|Overall Study|Adverse Event|6|||
129028282|NCT00385736|464394522|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
129028283|NCT00385736|464394523|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
129028284|NCT00385736|464394521|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
129028285|NCT00385736|464394522|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
129028286|NCT00385736|464394523|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
129028287|NCT00385736|464394521|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
129028288|NCT00385736|464394522|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
129028289|NCT00385736|464394523|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
129028290|NCT00385736|464394521|FG000|Efficacy Analysis Set - Induction|Other|0|||
129028291|NCT00385736|464394522|FG001|Efficacy Analysis Set - Induction|Other|0|||
129028292|NCT00385736|464394523|FG002|Efficacy Analysis Set - Induction|Other|1|||
129028293|NCT00385736|464394521|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
129028294|NCT00385736|464394522|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
129028295|NCT00385736|464394523|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
129028296|NCT00385736|464394521|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
129028297|NCT00385736|464394522|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
129028298|NCT00385736|464394523|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
129028299|NCT00385736|464394521|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
129028300|NCT00385736|464394522|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
129028301|NCT00385736|464394523|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
129028302|NCT00385736|464394521|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
129028303|NCT00385736|464394522|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
129028304|NCT00385736|464394523|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
129028305|NCT00385736|464394521|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
129028306|NCT00385736|464394522|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
129028307|NCT00385736|464394523|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
129028308|NCT00385736|464394521|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
129028309|NCT00385736|464394522|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
129028310|NCT00385736|464394523|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
129028311|NCT00385736|464394521|FG000|Safety Analysis Set|Adverse Event|23|||
129028312|NCT00385736|464394522|FG001|Safety Analysis Set|Adverse Event|15|||
129028313|NCT00385736|464394523|FG002|Safety Analysis Set|Adverse Event|23|||
129028314|NCT00385736|464394521|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
129028315|NCT00385736|464394522|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
129028316|NCT00385736|464394523|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
129028317|NCT00385736|464394521|FG000|Safety Analysis Set|Lost to Follow-up|0|||
129028318|NCT00385736|464394522|FG001|Safety Analysis Set|Lost to Follow-up|2|||
129028319|NCT00385736|464394523|FG002|Safety Analysis Set|Lost to Follow-up|2|||
129028320|NCT00385736|464394521|FG000|Safety Analysis Set|Lack of Efficacy|38|||
129028321|NCT00385736|464394522|FG001|Safety Analysis Set|Lack of Efficacy|16|||
129028322|NCT00385736|464394523|FG002|Safety Analysis Set|Lack of Efficacy|31|||
129028323|NCT00385736|464394521|FG000|Safety Analysis Set|Protocol Violation|2|||
129028324|NCT00385736|464394522|FG001|Safety Analysis Set|Protocol Violation|1|||
129028325|NCT00385736|464394523|FG002|Safety Analysis Set|Protocol Violation|6|||
129028326|NCT00385736|464394521|FG000|Safety Analysis Set|Other|1|||
129028327|NCT00385736|464394522|FG001|Safety Analysis Set|Other|4|||
129028328|NCT00385736|464394523|FG002|Safety Analysis Set|Other|4|||
129028329|NCT01557751|464394524|FG000|Overall Study|Physician Decision|3|||
129028330|NCT00835666|464394525|FG000|Washout|Protocol Violation|1|||
129028331|NCT00835666|464394526|FG001|Washout|Protocol Violation|0|||
129028332|NCT00835666|464394525|FG000|Washout|Withdrawal by Subject|1|||
129028333|NCT00835666|464394526|FG001|Washout|Withdrawal by Subject|0|||
129028334|NCT03599362|464394527|FG000|Overall Study|Screen Failure|3|||
129028335|NCT03707587|464394528|FG000|Overall Study|Death|0|||
128911557|NCT05227690|463969177|FG002|Overall Study|Adverse Event|10|||
128911558|NCT05227690|463969175|FG000|Overall Study|Lack of Efficacy|2|||
128911559|NCT05227690|463969176|FG001|Overall Study|Lack of Efficacy|4|||
129028336|NCT03707587|464394529|FG001|Overall Study|Death|1|||
129028337|NCT01634139|464394531|FG000|Overall Study|Non compliant with protocol|1|||
129028338|NCT01634139|464394532|FG001|Overall Study|Non compliant with protocol|0|||
129028339|NCT01634139|464394533|FG002|Overall Study|Non compliant with protocol|0|||
129028340|NCT01634139|464394531|FG000|Overall Study|Consent withdrawn not due to AE|4|||
129028341|NCT01634139|464394532|FG001|Overall Study|Consent withdrawn not due to AE|3|||
129028342|NCT01634139|464394533|FG002|Overall Study|Consent withdrawn not due to AE|2|||
128911560|NCT05227690|463969177|FG002|Overall Study|Lack of Efficacy|1|||
129215577|NCT04949490|465091260|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129215578|NCT04949490|465091261|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129215579|NCT04949490|465091262|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129028343|NCT01634139|464394531|FG000|Overall Study|Other|4|||
129028344|NCT01634139|464394532|FG001|Overall Study|Other|0|||
129028345|NCT01634139|464394533|FG002|Overall Study|Other|3|||
129028346|NCT01634139|464394531|FG000|Overall Study|Lost to Follow-up|0|||
129028347|NCT01634139|464394532|FG001|Overall Study|Lost to Follow-up|2|||
129028348|NCT01634139|464394533|FG002|Overall Study|Lost to Follow-up|0|||
129028349|NCT01634139|464394531|FG000|Overall Study|Not treated|1|||
129028350|NCT01634139|464394532|FG001|Overall Study|Not treated|1|||
129028351|NCT01634139|464394533|FG002|Overall Study|Not treated|0|||
129028352|NCT00425308|464394541|FG000|Overall Study|Adverse Event|2|||
129028353|NCT00425308|464394542|FG001|Overall Study|Adverse Event|1|||
129028354|NCT00425308|464394541|FG000|Overall Study|Withdrawal by Subject|1|||
129028355|NCT00425308|464394542|FG001|Overall Study|Withdrawal by Subject|0|||
129028356|NCT00425308|464394541|FG000|Overall Study|Death|1|||
129028357|NCT00425308|464394542|FG001|Overall Study|Death|0|||
129028358|NCT04442503|464394545|FG000|Overall Study|Adverse Event|1|||
129028359|NCT04442503|464394546|FG001|Overall Study|Adverse Event|1|||
129028360|NCT04442503|464394545|FG000|Overall Study|Lost to Follow-up|8|||
129028361|NCT04442503|464394546|FG001|Overall Study|Lost to Follow-up|6|||
129028362|NCT04442503|464394545|FG000|Overall Study|Physician Decision|0|||
129028363|NCT04442503|464394546|FG001|Overall Study|Physician Decision|2|||
129028364|NCT04442503|464394545|FG000|Overall Study|Withdrawal by Subject|3|||
129028365|NCT04442503|464394546|FG001|Overall Study|Withdrawal by Subject|4|||
129028366|NCT04442503|464394545|FG000|Overall Study|Reason not Specified|0|||
129028367|NCT04442503|464394546|FG001|Overall Study|Reason not Specified|1|||
129028368|NCT04442503|464394545|FG000|Overall Study|Randomized but not Treated|3|||
129028369|NCT04442503|464394546|FG001|Overall Study|Randomized but not Treated|1|||
129028370|NCT01945580|464394547|FG000|Overall Study|Withdrawal by Subject|13|||
129028371|NCT01945580|464394548|FG001|Overall Study|Withdrawal by Subject|35|||
129028372|NCT01945580|464394547|FG000|Overall Study|Physician Decision|3|||
129028373|NCT01945580|464394548|FG001|Overall Study|Physician Decision|2|||
129028374|NCT01945580|464394547|FG000|Overall Study|Lost to Follow-up|26|||
129028375|NCT01945580|464394548|FG001|Overall Study|Lost to Follow-up|39|||
129028376|NCT01945580|464394547|FG000|Overall Study|Death|7|||
129028377|NCT01945580|464394548|FG001|Overall Study|Death|2|||
129028378|NCT01945580|464394547|FG000|Overall Study|Patient moved out of state|0|||
129028379|NCT01945580|464394548|FG001|Overall Study|Patient moved out of state|1|||
129028380|NCT01945580|464394547|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
129028381|NCT01945580|464394548|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
129028382|NCT01945580|464394547|FG000|Overall Study|Family illness - unable to return|0|||
129028383|NCT01945580|464394548|FG001|Overall Study|Family illness - unable to return|1|||
129028384|NCT01945580|464394547|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
129028385|NCT01945580|464394548|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
129028386|NCT01945580|464394547|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
129028387|NCT01945580|464394548|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
129028388|NCT01945580|464394547|FG000|Overall Study|Noncompliance with 36 month visit|1|||
129028389|NCT01945580|464394548|FG001|Overall Study|Noncompliance with 36 month visit|0|||
129028390|NCT01945580|464394547|FG000|Overall Study|The patient moved.|1|||
129028391|NCT01945580|464394548|FG001|Overall Study|The patient moved.|0|||
129028392|NCT01945580|464394547|FG000|Overall Study|No data available|0|||
129028393|NCT01945580|464394548|FG001|Overall Study|No data available|2|||
129028394|NCT02933060|464394549|FG000|Overall Study|Withdrawal by Subject|0|||
129028395|NCT02933060|464394550|FG001|Overall Study|Withdrawal by Subject|1|||
129028396|NCT05034874|464394553|FG000|Overall Study|Withdrawal by Subject|6|||
129028397|NCT05034874|464394554|FG001|Overall Study|Withdrawal by Subject|6|||
129028398|NCT05034874|464394553|FG000|Overall Study|Lost to Follow-up|18|||
129028399|NCT05034874|464394554|FG001|Overall Study|Lost to Follow-up|8|||
129028400|NCT05034874|464394553|FG000|Overall Study|Physician Decision|0|||
129028401|NCT05034874|464394554|FG001|Overall Study|Physician Decision|1|||
129028402|NCT05034874|464394553|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
129028403|NCT05034874|464394554|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
129028404|NCT00989950|464394555|FG000|Randomized Phase|Protocol Violation|1|||
129028405|NCT00989950|464394556|FG001|Randomized Phase|Protocol Violation|0|||
129028406|NCT00989950|464394557|FG002|Randomized Phase|Protocol Violation|0|||
129028407|NCT00989950|464394558|FG003|Randomized Phase|Protocol Violation|0|||
129028408|NCT00989950|464394555|FG000|Randomized Phase|Adverse Event|0|||
129028409|NCT00989950|464394556|FG001|Randomized Phase|Adverse Event|1|||
129028410|NCT00989950|464394557|FG002|Randomized Phase|Adverse Event|0|||
129028411|NCT00989950|464394558|FG003|Randomized Phase|Adverse Event|0|||
129028412|NCT00101439|464394559|FG000|Period 2|Withdrawal by Subject|0|||
128911561|NCT05227690|463969175|FG000|Overall Study|Physician Decision|6|||
128911562|NCT05227690|463969176|FG001|Overall Study|Physician Decision|0|||
128911563|NCT05227690|463969177|FG002|Overall Study|Physician Decision|4|||
128911564|NCT05227690|463969175|FG000|Overall Study|Withdrawal of consent|28|||
128911565|NCT05227690|463969176|FG001|Overall Study|Withdrawal of consent|27|||
128911566|NCT05227690|463969177|FG002|Overall Study|Withdrawal of consent|21|||
128911567|NCT05227690|463969175|FG000|Overall Study|Other, not specified|2|||
129118414|NCT01296412|464729019|FG000|Overall Study|Physician Decision|1|||
129118415|NCT01296412|464729020|FG001|Overall Study|Physician Decision|3|||
129118416|NCT01296412|464729019|FG000|Overall Study|Pregnancy|0|||
129118417|NCT01296412|464729020|FG001|Overall Study|Pregnancy|1|||
129118418|NCT01296412|464729019|FG000|Overall Study|Withdrawal by Subject|10|||
129118419|NCT01296412|464729020|FG001|Overall Study|Withdrawal by Subject|13|||
129118420|NCT02160626|464729021|FG000|Overall Study|Adverse Event|1|||
129118421|NCT02160626|464729022|FG001|Overall Study|Adverse Event|0|||
129118422|NCT02160626|464729023|FG002|Overall Study|Adverse Event|0|||
129118423|NCT02160626|464729021|FG000|Overall Study|Schedule not conducive to study visits|0|||
129118424|NCT02160626|464729022|FG001|Overall Study|Schedule not conducive to study visits|0|||
129118425|NCT02160626|464729023|FG002|Overall Study|Schedule not conducive to study visits|1|||
129118426|NCT02160626|464729021|FG000|Overall Study|Withdrawal by Subject|0|||
129118427|NCT02160626|464729022|FG001|Overall Study|Withdrawal by Subject|1|||
129118428|NCT02160626|464729023|FG002|Overall Study|Withdrawal by Subject|0|||
129118429|NCT04239924|464729024|FG000|Overall Study|Lost to Follow-up|2|||
129118430|NCT00434252|464731082|FG000|Overall Study|Lack of Efficacy|50|||
129118431|NCT00434252|464731083|FG001|Overall Study|Lack of Efficacy|100|||
129118432|NCT00434252|464731082|FG000|Overall Study|Adverse Event|6|||
129118433|NCT00434252|464731083|FG001|Overall Study|Adverse Event|13|||
129118434|NCT00434252|464731082|FG000|Overall Study|Death|1|||
129118435|NCT00434252|464731083|FG001|Overall Study|Death|2|||
129118436|NCT00434252|464731082|FG000|Overall Study|Lost to Follow-up|0|||
129118437|NCT00434252|464731083|FG001|Overall Study|Lost to Follow-up|1|||
129118438|NCT00434252|464731082|FG000|Overall Study|Physician Decision|4|||
129118439|NCT00434252|464731083|FG001|Overall Study|Physician Decision|8|||
129118440|NCT00434252|464731082|FG000|Overall Study|Withdrawal by Subject|3|||
129118441|NCT00434252|464731083|FG001|Overall Study|Withdrawal by Subject|7|||
129118442|NCT02997163|464731085|FG000|Overall Study|Adverse Event|1|||
129118443|NCT02997163|464731086|FG001|Overall Study|Adverse Event|0|||
129118444|NCT02997163|464731087|FG002|Overall Study|Adverse Event|0|||
129118445|NCT02997163|464731088|FG003|Overall Study|Adverse Event|1|||
129118446|NCT02337764|464731089|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
129118447|NCT02337764|464731089|FG000|Overall Study|Voluntary Withdrawal|12|||
129118448|NCT02337764|464731089|FG000|Overall Study|Lack of Efficacy|2|||
129118449|NCT01855958|464731104|FG000|Overall Study|Withdrawal by Subject|1|||
129118450|NCT01855958|464731105|FG001|Overall Study|Withdrawal by Subject|0|||
129118451|NCT00296244|464731106|FG000|Overall Study|Underwent retransplant|0|||
129118452|NCT00296244|464731107|FG001|Overall Study|Underwent retransplant|1|||
129118453|NCT00427934|464731108|FG000|Overall Study|Adverse Event|1|||
129118454|NCT00427934|464731109|FG001|Overall Study|Adverse Event|0|||
129118455|NCT00427934|464731110|FG002|Overall Study|Adverse Event|5|||
129118456|NCT00427934|464731111|FG003|Overall Study|Adverse Event|4|||
129118457|NCT00427934|464731108|FG000|Overall Study|Lack of Efficacy|0|||
129118458|NCT00427934|464731109|FG001|Overall Study|Lack of Efficacy|0|||
129118459|NCT00427934|464731110|FG002|Overall Study|Lack of Efficacy|5|||
129118460|NCT00427934|464731111|FG003|Overall Study|Lack of Efficacy|2|||
129118461|NCT00427934|464731108|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
129118462|NCT00427934|464731109|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
129118463|NCT00427934|464731110|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
129118464|NCT00427934|464731111|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
129118465|NCT00427934|464731108|FG000|Overall Study|Other|0|||
129118466|NCT00427934|464731109|FG001|Overall Study|Other|0|||
129118467|NCT00427934|464731110|FG002|Overall Study|Other|11|||
129118468|NCT00427934|464731111|FG003|Overall Study|Other|5|||
129118469|NCT00427934|464731108|FG000|Overall Study|Withdrawal by Subject|0|||
129118470|NCT00427934|464731109|FG001|Overall Study|Withdrawal by Subject|0|||
129118471|NCT00427934|464731110|FG002|Overall Study|Withdrawal by Subject|1|||
129118472|NCT00427934|464731111|FG003|Overall Study|Withdrawal by Subject|3|||
129118473|NCT00499122|464731112|FG000|Overall Study|Withdrawal by Subject|2|||
129118474|NCT04539275|464731113|FG000|Overall Study|Death|2|||
129118475|NCT04539275|464731114|FG001|Overall Study|Death|4|||
129118476|NCT04539275|464731113|FG000|Overall Study|Lost to Follow-up|1|||
129118477|NCT04539275|464731114|FG001|Overall Study|Lost to Follow-up|1|||
129118478|NCT04539275|464731113|FG000|Overall Study|Withdrawal by Subject|3|||
129118479|NCT04539275|464731114|FG001|Overall Study|Withdrawal by Subject|0|||
129118480|NCT00903968|464731115|FG000|Overall Study|Adverse Event|0|||
129118481|NCT00903968|464731116|FG001|Overall Study|Adverse Event|0|||
129118482|NCT00903968|464731117|FG002|Overall Study|Adverse Event|0|||
129118483|NCT00903968|464731118|FG003|Overall Study|Adverse Event|0|||
129118484|NCT00903968|464731119|FG004|Overall Study|Adverse Event|0|||
128911568|NCT05227690|463969176|FG001|Overall Study|Other, not specified|2|||
128911569|NCT05227690|463969177|FG002|Overall Study|Other, not specified|1|||
128911570|NCT02770326|463969180|FG000|Overall Study|Death|3|||
128911571|NCT02770326|463969180|FG000|Overall Study|Lost to Follow-up|1|||
128911572|NCT04033367|463969181|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
128911573|NCT04033367|463969182|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
129118485|NCT00903968|464731120|FG005|Overall Study|Adverse Event|0|||
129118486|NCT00903968|464731121|FG006|Overall Study|Adverse Event|1|||
129118487|NCT00903968|464731122|FG007|Overall Study|Adverse Event|8|||
129118488|NCT00903968|464731115|FG000|Overall Study|DLT|0|||
129118489|NCT00903968|464731116|FG001|Overall Study|DLT|0|||
129118490|NCT00903968|464731117|FG002|Overall Study|DLT|0|||
129118491|NCT00903968|464731118|FG003|Overall Study|DLT|0|||
129118492|NCT00903968|464731119|FG004|Overall Study|DLT|0|||
129118493|NCT00903968|464731120|FG005|Overall Study|DLT|0|||
129118494|NCT00903968|464731121|FG006|Overall Study|DLT|2|||
129118495|NCT00903968|464731122|FG007|Overall Study|DLT|0|||
129118496|NCT00903968|464731115|FG000|Overall Study|Withdrawal by Subject|1|||
129118497|NCT00903968|464731116|FG001|Overall Study|Withdrawal by Subject|0|||
129118498|NCT00903968|464731117|FG002|Overall Study|Withdrawal by Subject|1|||
129118499|NCT00903968|464731118|FG003|Overall Study|Withdrawal by Subject|0|||
129118500|NCT00903968|464731119|FG004|Overall Study|Withdrawal by Subject|1|||
129118501|NCT00903968|464731120|FG005|Overall Study|Withdrawal by Subject|1|||
129118502|NCT00903968|464731121|FG006|Overall Study|Withdrawal by Subject|0|||
129118503|NCT00903968|464731122|FG007|Overall Study|Withdrawal by Subject|4|||
129118504|NCT00903968|464731115|FG000|Overall Study|Non-Compliance|0|||
129118505|NCT00903968|464731116|FG001|Overall Study|Non-Compliance|0|||
129118506|NCT00903968|464731117|FG002|Overall Study|Non-Compliance|0|||
129118507|NCT00903968|464731118|FG003|Overall Study|Non-Compliance|0|||
129118508|NCT00903968|464731119|FG004|Overall Study|Non-Compliance|0|||
129118509|NCT00903968|464731120|FG005|Overall Study|Non-Compliance|1|||
129118510|NCT00903968|464731121|FG006|Overall Study|Non-Compliance|0|||
129118511|NCT00903968|464731122|FG007|Overall Study|Non-Compliance|0|||
129118512|NCT00903968|464731115|FG000|Overall Study|Physician Decision|0|||
129118513|NCT00903968|464731116|FG001|Overall Study|Physician Decision|0|||
129118514|NCT00903968|464731117|FG002|Overall Study|Physician Decision|0|||
129118515|NCT00903968|464731118|FG003|Overall Study|Physician Decision|0|||
129118516|NCT00903968|464731119|FG004|Overall Study|Physician Decision|0|||
129118517|NCT00903968|464731120|FG005|Overall Study|Physician Decision|1|||
129118518|NCT00903968|464731121|FG006|Overall Study|Physician Decision|0|||
129118519|NCT00903968|464731122|FG007|Overall Study|Physician Decision|0|||
129118520|NCT00903968|464731115|FG000|Overall Study|Progressive Disease|2|||
129118521|NCT00903968|464731116|FG001|Overall Study|Progressive Disease|3|||
129118522|NCT00903968|464731117|FG002|Overall Study|Progressive Disease|2|||
129118523|NCT00903968|464731118|FG003|Overall Study|Progressive Disease|3|||
129118524|NCT00903968|464731119|FG004|Overall Study|Progressive Disease|3|||
129118525|NCT00903968|464731120|FG005|Overall Study|Progressive Disease|3|||
129118526|NCT00903968|464731121|FG006|Overall Study|Progressive Disease|0|||
129118527|NCT00903968|464731122|FG007|Overall Study|Progressive Disease|18|||
129118528|NCT00903968|464731115|FG000|Overall Study|Lack of Efficacy|0|||
128911574|NCT04033367|463969181|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
128911575|NCT04033367|463969182|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
128911576|NCT04033367|463969181|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
128911577|NCT04033367|463969182|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
128911578|NCT04033367|463969181|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
128911579|NCT04033367|463969182|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
128911580|NCT02723201|463969183|FG000|Second Intervention Period|Protocol Violation|1|||
128911581|NCT02723201|463969184|FG001|Second Intervention Period|Protocol Violation|0|||
128911582|NCT02723201|463969185|FG002|Second Intervention Period|Protocol Violation|0|||
128911583|NCT02723201|463969183|FG000|Second Intervention Period|Adverse Event|1|||
129118529|NCT00903968|464731116|FG001|Overall Study|Lack of Efficacy|0|||
129118530|NCT00903968|464731117|FG002|Overall Study|Lack of Efficacy|0|||
129118531|NCT00903968|464731118|FG003|Overall Study|Lack of Efficacy|0|||
129118532|NCT00903968|464731119|FG004|Overall Study|Lack of Efficacy|0|||
129118533|NCT00903968|464731120|FG005|Overall Study|Lack of Efficacy|0|||
129118534|NCT00903968|464731121|FG006|Overall Study|Lack of Efficacy|0|||
129118535|NCT00903968|464731122|FG007|Overall Study|Lack of Efficacy|3|||
129118536|NCT01373164|464731127|FG000|Overall Study|Lost to Follow-up|0|||
128911584|NCT02723201|463969184|FG001|Second Intervention Period|Adverse Event|0|||
129118537|NCT01373164|464731128|FG001|Overall Study|Lost to Follow-up|0|||
129118538|NCT01373164|464731129|FG002|Overall Study|Lost to Follow-up|1|||
129118539|NCT01373164|464731130|FG003|Overall Study|Lost to Follow-up|2|||
129118540|NCT01373164|464731131|FG004|Overall Study|Lost to Follow-up|0|||
129118541|NCT01373164|464731127|FG000|Overall Study|Withdrawal by Subject|0|||
129118542|NCT01373164|464731128|FG001|Overall Study|Withdrawal by Subject|1|||
129118543|NCT01373164|464731129|FG002|Overall Study|Withdrawal by Subject|0|||
128911585|NCT02723201|463969185|FG002|Second Intervention Period|Adverse Event|0|||
129118544|NCT01373164|464731130|FG003|Overall Study|Withdrawal by Subject|10|||
129118545|NCT01373164|464731131|FG004|Overall Study|Withdrawal by Subject|2|||
128911586|NCT03472560|463969186|FG000|Overall Study|Subject transfer to continuation protocol|0|||
128911587|NCT03472560|463969187|FG001|Overall Study|Subject transfer to continuation protocol|1|||
128911588|NCT03472560|463969186|FG000|Overall Study|Withdrawal by Subject|4|||
128911589|NCT03472560|463969187|FG001|Overall Study|Withdrawal by Subject|0|||
128911590|NCT03472560|463969186|FG000|Overall Study|Progressive disease|24|||
128911591|NCT03472560|463969187|FG001|Overall Study|Progressive disease|8|||
128911592|NCT03472560|463969186|FG000|Overall Study|Physician Decision|1|||
128911593|NCT03472560|463969187|FG001|Overall Study|Physician Decision|0|||
128911594|NCT03472560|463969186|FG000|Overall Study|Death|7|||
128911595|NCT03472560|463969187|FG001|Overall Study|Death|4|||
128911596|NCT03472560|463969186|FG000|Overall Study|Adverse Event|5|||
128911597|NCT03472560|463969187|FG001|Overall Study|Adverse Event|3|||
128911598|NCT03472560|463969186|FG000|Overall Study|Global deterioration of health status|0|||
128911599|NCT03472560|463969187|FG001|Overall Study|Global deterioration of health status|4|||
128911600|NCT02634580|463969188|FG000|Double-blind Treatment Period|Subject Request|1|||
128911601|NCT02634580|463969189|FG001|Double-blind Treatment Period|Subject Request|0|||
128911602|NCT02634580|463969190|FG002|Double-blind Treatment Period|Subject Request|1|||
128911603|NCT02634580|463969191|FG003|Double-blind Treatment Period|Subject Request|1|||
128911604|NCT02634580|463969188|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
128911605|NCT02634580|463969189|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
128911606|NCT02634580|463969190|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
128911607|NCT02634580|463969191|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
128911608|NCT00491179|463969192|FG000|Overall Study|Adverse Event|5|||
128911609|NCT00491179|463969193|FG001|Overall Study|Adverse Event|1|||
129028413|NCT00101439|464394560|FG001|Period 2|Withdrawal by Subject|2|||
129028414|NCT01867658|464394562|FG000|Overall Study|Withdrawal by Subject|6|||
129028415|NCT01867658|464394562|FG000|Overall Study|Death|2|||
129028416|NCT01867658|464394562|FG000|Overall Study|Subject could not be contacted|1|||
129028417|NCT00840658|464394563|FG000|Overall Study|Death|2|||
129028418|NCT00840658|464394564|FG001|Overall Study|Death|2|||
129028419|NCT00840658|464394565|FG002|Overall Study|Death|3|||
129028420|NCT00840658|464394566|FG003|Overall Study|Death|3|||
129028421|NCT00840658|464394563|FG000|Overall Study|Lost to Follow-up|3|||
129028422|NCT00840658|464394564|FG001|Overall Study|Lost to Follow-up|1|||
129028423|NCT00840658|464394565|FG002|Overall Study|Lost to Follow-up|2|||
129028424|NCT00840658|464394566|FG003|Overall Study|Lost to Follow-up|1|||
129028425|NCT00474058|464394567|FG000|Overall Study|Adverse Event|11|||
129028426|NCT00474058|464394568|FG001|Overall Study|Adverse Event|6|||
129028427|NCT00474058|464394567|FG000|Overall Study|Lack of Efficacy|0|||
129028428|NCT00474058|464394568|FG001|Overall Study|Lack of Efficacy|4|||
129028429|NCT00474058|464394567|FG000|Overall Study|Withdrawal by Subject|11|||
129028430|NCT00474058|464394568|FG001|Overall Study|Withdrawal by Subject|7|||
129028431|NCT00474058|464394567|FG000|Overall Study|Other|2|||
129028432|NCT00474058|464394568|FG001|Overall Study|Other|0|||
129028433|NCT03101358|464394569|FG000|Overall Study|Non-compliance with study schedule|1|||
129028434|NCT03101358|464394570|FG001|Overall Study|Non-compliance with study schedule|0|||
129028435|NCT03101358|464394571|FG002|Overall Study|Non-compliance with study schedule|0|||
129028436|NCT03101358|464394572|FG003|Overall Study|Non-compliance with study schedule|1|||
129028437|NCT03101358|464394569|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
129028438|NCT03101358|464394570|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
129028439|NCT03101358|464394571|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
129028440|NCT03101358|464394572|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
129028441|NCT03101358|464394569|FG000|Overall Study|Physician Decision|1|||
129028442|NCT03101358|464394570|FG001|Overall Study|Physician Decision|0|||
129028443|NCT03101358|464394571|FG002|Overall Study|Physician Decision|0|||
129028444|NCT03101358|464394572|FG003|Overall Study|Physician Decision|3|||
129028445|NCT03101358|464394569|FG000|Overall Study|Adverse Event|0|||
129028446|NCT03101358|464394570|FG001|Overall Study|Adverse Event|0|||
129028447|NCT03101358|464394571|FG002|Overall Study|Adverse Event|1|||
129028448|NCT03101358|464394572|FG003|Overall Study|Adverse Event|0|||
129028449|NCT03101358|464394569|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
129028450|NCT03101358|464394570|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
129028451|NCT03101358|464394571|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
129028452|NCT03101358|464394572|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
129028453|NCT03101358|464394569|FG000|Overall Study|Lost to Follow-up|1|||
129028454|NCT03101358|464394570|FG001|Overall Study|Lost to Follow-up|0|||
128697002|NCT01416272|463188981|FG000|Overall Study|Lost to Follow-up|1|||
128911610|NCT00491179|463969192|FG000|Overall Study|Withdrawal by Subject|2|||
129028455|NCT03101358|464394571|FG002|Overall Study|Lost to Follow-up|0|||
129028456|NCT03101358|464394572|FG003|Overall Study|Lost to Follow-up|1|||
128911611|NCT00491179|463969193|FG001|Overall Study|Withdrawal by Subject|1|||
128911612|NCT04269395|463969195|FG000|Overall Study|Lost to Follow-up|1|||
129028457|NCT05616728|464394573|FG000|Overall Study|Lost to Follow-up|0|||
129028458|NCT05616728|464394574|FG001|Overall Study|Lost to Follow-up|0|||
128911613|NCT04269395|463969196|FG001|Overall Study|Lost to Follow-up|0|||
128911614|NCT04269395|463969195|FG000|Overall Study|Study terminated by Sponsor|13|||
128911615|NCT04269395|463969196|FG001|Overall Study|Study terminated by Sponsor|10|||
128911616|NCT01285908|463969197|FG000|Baseline Measurement|unable to insert catheter|1|||
128911617|NCT01285908|463969198|FG001|Baseline Measurement|unable to insert catheter|0|||
128911618|NCT01285908|463969199|FG002|Baseline Measurement|unable to insert catheter|0|||
128911619|NCT01285908|463969197|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
128911620|NCT01285908|463969198|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
128911621|NCT01285908|463969199|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
128911622|NCT01285908|463969197|FG000|Baseline Measurement|unable to tolerate procedure|1|||
128911623|NCT01285908|463969198|FG001|Baseline Measurement|unable to tolerate procedure|0|||
128911624|NCT01285908|463969199|FG002|Baseline Measurement|unable to tolerate procedure|0|||
128911625|NCT03529773|463969200|FG000|Overall Study|Adverse Event|0|||
128911626|NCT03529773|463969201|FG001|Overall Study|Adverse Event|0|||
128911627|NCT03529773|463969202|FG002|Overall Study|Adverse Event|0|||
128911628|NCT03529773|463969203|FG003|Overall Study|Adverse Event|0|||
128911629|NCT03529773|463969204|FG004|Overall Study|Adverse Event|0|||
129118546|NCT03736967|464731147|FG000|Overall Study|Withdrawal by Subject|26|||
129118547|NCT03736967|464731148|FG001|Overall Study|Withdrawal by Subject|25|||
129118548|NCT03736967|464731149|FG002|Overall Study|Withdrawal by Subject|23|||
129118549|NCT03736967|464731150|FG003|Overall Study|Withdrawal by Subject|26|||
129118550|NCT03736967|464731147|FG000|Overall Study|Lost to Follow-up|3|||
129118551|NCT03736967|464731148|FG001|Overall Study|Lost to Follow-up|2|||
129118552|NCT03736967|464731149|FG002|Overall Study|Lost to Follow-up|1|||
129118553|NCT03736967|464731150|FG003|Overall Study|Lost to Follow-up|1|||
129118554|NCT03736967|464731147|FG000|Overall Study|Physician Decision|1|||
129118555|NCT03736967|464731148|FG001|Overall Study|Physician Decision|0|||
129118556|NCT03736967|464731149|FG002|Overall Study|Physician Decision|0|||
129118557|NCT03736967|464731150|FG003|Overall Study|Physician Decision|1|||
129118558|NCT03736967|464731147|FG000|Overall Study|Adverse Event|0|||
129118559|NCT03736967|464731148|FG001|Overall Study|Adverse Event|1|||
129118560|NCT03736967|464731149|FG002|Overall Study|Adverse Event|0|||
129118561|NCT03736967|464731150|FG003|Overall Study|Adverse Event|1|||
129118562|NCT03736967|464731147|FG000|Overall Study|Death|0|||
129118563|NCT03736967|464731148|FG001|Overall Study|Death|0|||
129118564|NCT03736967|464731149|FG002|Overall Study|Death|0|||
129118565|NCT03736967|464731150|FG003|Overall Study|Death|1|||
129118566|NCT03736967|464731147|FG000|Overall Study|Randomized but never treated|1|||
129118567|NCT03736967|464731148|FG001|Overall Study|Randomized but never treated|0|||
129118568|NCT03736967|464731149|FG002|Overall Study|Randomized but never treated|0|||
129118569|NCT03736967|464731150|FG003|Overall Study|Randomized but never treated|0|||
129118570|NCT02419807|464731151|FG000|Overall Study|Withdrawal by Subject|4|||
129118571|NCT02419807|464731151|FG000|Overall Study|Physician Decision|1|||
129118572|NCT02419807|464731151|FG000|Overall Study|Protocol Violation|5|||
129118573|NCT01006629|464731152|FG000|Overall Study|Adverse Event|1|||
129118574|NCT01006629|464731152|FG000|Overall Study|Parent refused to continue participation|1|||
129118575|NCT01006629|464731152|FG000|Overall Study|Parent unable to perform site visit|4|||
129118576|NCT02932943|464731153|FG000|Overall Study|Lost to Follow-up|0|||
129118577|NCT02932943|464731154|FG001|Overall Study|Lost to Follow-up|2|||
129118578|NCT02932943|464731153|FG000|Overall Study|Adverse Event|2|||
129118579|NCT02932943|464731154|FG001|Overall Study|Adverse Event|2|||
129118580|NCT02932943|464731153|FG000|Overall Study|Withdrawal by Subject|3|||
129118581|NCT02932943|464731154|FG001|Overall Study|Withdrawal by Subject|3|||
129118582|NCT00095979|464731155|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
129118583|NCT01663623|464731158|FG000|Overall Study|Adverse Event|3|||
129118584|NCT01663623|464731159|FG001|Overall Study|Adverse Event|7|||
129118585|NCT01663623|464731158|FG000|Overall Study|Lack of Efficacy|5|||
129118586|NCT01663623|464731159|FG001|Overall Study|Lack of Efficacy|6|||
129118587|NCT01663623|464731158|FG000|Overall Study|Protocol Violation|0|||
129118588|NCT01663623|464731159|FG001|Overall Study|Protocol Violation|1|||
129118589|NCT01663623|464731158|FG000|Overall Study|Other-Study closed/terminated|1|||
128911630|NCT03529773|463969205|FG005|Overall Study|Adverse Event|0|||
128911631|NCT03529773|463969206|FG006|Overall Study|Adverse Event|0|||
129118590|NCT01663623|464731159|FG001|Overall Study|Other-Study closed/terminated|1|||
129118591|NCT01663623|464731158|FG000|Overall Study|Physician Decision|1|||
129118592|NCT01663623|464731159|FG001|Overall Study|Physician Decision|4|||
129118593|NCT01663623|464731158|FG000|Overall Study|Withdrawal by Subject|2|||
129118594|NCT01663623|464731159|FG001|Overall Study|Withdrawal by Subject|1|||
129118595|NCT02251275|464731160|FG000|Overall Study|Adverse Event|23|||
129222170|NCT03184870|465116023|FG007|Initial Treatment|Moved to crossover treatment|0|||
128911632|NCT03529773|463969207|FG007|Overall Study|Adverse Event|0|||
128911633|NCT03529773|463969208|FG008|Overall Study|Adverse Event|0|||
129118596|NCT02251275|464731161|FG001|Overall Study|Adverse Event|60|||
129118597|NCT02251275|464731162|FG002|Overall Study|Adverse Event|28|||
129118598|NCT02251275|464731163|FG003|Overall Study|Adverse Event|0|||
129118599|NCT02251275|464731164|FG004|Overall Study|Adverse Event|0|||
129118600|NCT02251275|464731160|FG000|Overall Study|Lost to Follow-up|5|||
129215580|NCT04949490|465091263|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129215581|NCT04949490|465091264|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
129215582|NCT04949490|465091259|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129215583|NCT04949490|465091260|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
128911634|NCT03529773|463969209|FG009|Overall Study|Adverse Event|0|||
128911635|NCT03529773|463969210|FG010|Overall Study|Adverse Event|0|||
128911636|NCT03529773|463969211|FG011|Overall Study|Adverse Event|0|||
128911637|NCT03529773|463969212|FG012|Overall Study|Adverse Event|0|||
128911638|NCT03529773|463969213|FG013|Overall Study|Adverse Event|0|||
128911639|NCT03529773|463969214|FG014|Overall Study|Adverse Event|0|||
129215584|NCT04949490|465091261|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129215585|NCT04949490|465091262|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129215586|NCT04949490|465091263|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
129215587|NCT04949490|465091264|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129215588|NCT04721977|465091265|FG000|Overall Study|Death|15|||
129215589|NCT04721977|465091265|FG000|Overall Study|Ongoing|51|||
129215590|NCT02864394|465091267|FG000|Overall Study|Death|184|||
129215591|NCT02864394|465091268|FG001|Overall Study|Death|189|||
129215592|NCT02864394|465091267|FG000|Overall Study|Lost to Follow-up|0|||
129215593|NCT02864394|465091268|FG001|Overall Study|Lost to Follow-up|2|||
129215594|NCT02864394|465091267|FG000|Overall Study|Sponsor Decision|26|||
129215595|NCT02864394|465091268|FG001|Overall Study|Sponsor Decision|11|||
129215596|NCT02864394|465091267|FG000|Overall Study|Withdrawal by Subject|3|||
129215597|NCT02864394|465091268|FG001|Overall Study|Withdrawal by Subject|10|||
129215598|NCT00777153|465092780|FG000|Overall Study|Lost to Follow-up|1|||
129215599|NCT00777153|465092781|FG001|Overall Study|Lost to Follow-up|1|||
129215600|NCT00777153|465092782|FG002|Overall Study|Lost to Follow-up|0|||
129215601|NCT00777153|465092780|FG000|Overall Study|Death|85|||
129215602|NCT00777153|465092781|FG001|Overall Study|Death|73|||
129215603|NCT00777153|465092782|FG002|Overall Study|Death|33|||
129215604|NCT00777153|465092780|FG000|Overall Study|Withdrawal by Subject|3|||
129215605|NCT00777153|465092781|FG001|Overall Study|Withdrawal by Subject|4|||
129215606|NCT00777153|465092782|FG002|Overall Study|Withdrawal by Subject|3|||
129215607|NCT00777153|465092780|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
129215608|NCT00777153|465092781|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
129215609|NCT00777153|465092782|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
129215610|NCT02079246|465092784|FG000|OLEX|Withdrawal before treatment|1|||
129215611|NCT02079246|465092785|FG001|OLEX|Withdrawal before treatment|0|||
129215612|NCT02079246|465092784|FG000|OLEX|Death|11|||
129215613|NCT02079246|465092785|FG001|OLEX|Death|0|||
129215614|NCT02079246|465092784|FG000|OLEX|Adverse Event|66|||
129215615|NCT02079246|465092785|FG001|OLEX|Adverse Event|0|||
129215616|NCT02079246|465092784|FG000|OLEX|Withdrawal by Subject|60|||
129215617|NCT02079246|465092785|FG001|OLEX|Withdrawal by Subject|0|||
129215618|NCT02079246|465092784|FG000|OLEX|Lost to Follow-up|6|||
129215619|NCT02079246|465092785|FG001|OLEX|Lost to Follow-up|0|||
129215620|NCT02079246|465092784|FG000|OLEX|Protocol Violation|6|||
129215621|NCT02079246|465092785|FG001|OLEX|Protocol Violation|0|||
129215622|NCT02079246|465092784|FG000|OLEX|Lack of Efficacy|3|||
129215623|NCT02079246|465092785|FG001|OLEX|Lack of Efficacy|0|||
128911640|NCT03529773|463969215|FG015|Overall Study|Adverse Event|0|||
128911641|NCT03529773|463969216|FG016|Overall Study|Adverse Event|0|||
128911642|NCT03529773|463969217|FG017|Overall Study|Adverse Event|0|||
128911643|NCT03529773|463969218|FG018|Overall Study|Adverse Event|0|||
128911644|NCT03529773|463969219|FG019|Overall Study|Adverse Event|0|||
128911645|NCT03529773|463969220|FG020|Overall Study|Adverse Event|0|||
129215624|NCT02079246|465092784|FG000|OLEX|Results of the lead-in studies|58|||
129215625|NCT02079246|465092785|FG001|OLEX|Results of the lead-in studies|0|||
129215626|NCT02079246|465092784|FG000|OLEX|Other: Disallowed medication|8|||
129215627|NCT02079246|465092785|FG001|OLEX|Other: Disallowed medication|0|||
128911646|NCT03529773|463969221|FG021|Overall Study|Adverse Event|0|||
128911647|NCT03529773|463969222|FG022|Overall Study|Adverse Event|0|||
128911648|NCT03529773|463969223|FG023|Overall Study|Adverse Event|0|||
129215628|NCT02079246|465092784|FG000|OLEX|Other: Insufficient compliance|2|||
128765385|NCT02969525|463432138|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
128911649|NCT03529773|463969224|FG024|Overall Study|Adverse Event|0|||
128911650|NCT03529773|463969225|FG025|Overall Study|Adverse Event|0|||
128911651|NCT03529773|463969226|FG026|Overall Study|Adverse Event|0|||
129215629|NCT02079246|465092785|FG001|OLEX|Other: Insufficient compliance|0|||
129215630|NCT02079246|465092784|FG000|OLEX|Other: Caregiver unavailable|3|||
129215631|NCT02079246|465092785|FG001|OLEX|Other: Caregiver unavailable|0|||
129215632|NCT02079246|465092784|FG000|OLEX|Other: Coordinator decision|1|||
129215633|NCT02079246|465092785|FG001|OLEX|Other: Coordinator decision|0|||
129215634|NCT02079246|465092784|FG000|OLEX|Other: Worsening of condition|1|||
129215635|NCT02079246|465092785|FG001|OLEX|Other: Worsening of condition|0|||
129215636|NCT02079246|465092784|FG000|OLEX|Other: Moved to nursing home|1|||
129215637|NCT02079246|465092785|FG001|OLEX|Other: Moved to nursing home|0|||
129215638|NCT02079246|465092784|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
128911652|NCT03529773|463969227|FG027|Overall Study|Adverse Event|0|||
128911653|NCT03529773|463969228|FG028|Overall Study|Adverse Event|0|||
128911654|NCT03529773|463969229|FG029|Overall Study|Adverse Event|0|||
128911655|NCT03529773|463969230|FG030|Overall Study|Adverse Event|1|||
128911656|NCT03529773|463969231|FG031|Overall Study|Adverse Event|0|||
128911657|NCT03529773|463969232|FG032|Overall Study|Adverse Event|0|||
128911658|NCT03529773|463969233|FG033|Overall Study|Adverse Event|0|||
128911659|NCT03529773|463969234|FG034|Overall Study|Adverse Event|0|||
128911660|NCT03529773|463969235|FG035|Overall Study|Adverse Event|1|||
128911661|NCT03529773|463969236|FG036|Overall Study|Adverse Event|0|||
128911662|NCT03529773|463969237|FG037|Overall Study|Adverse Event|0|||
128911663|NCT03529773|463969238|FG038|Overall Study|Adverse Event|1|||
128911664|NCT03529773|463969239|FG039|Overall Study|Adverse Event|1|||
128911665|NCT03529773|463969200|FG000|Overall Study|Death|0|||
128911666|NCT03529773|463969201|FG001|Overall Study|Death|0|||
128911667|NCT03529773|463969202|FG002|Overall Study|Death|0|||
128911668|NCT03529773|463969203|FG003|Overall Study|Death|0|||
128911669|NCT03529773|463969204|FG004|Overall Study|Death|0|||
128911670|NCT03529773|463969205|FG005|Overall Study|Death|0|||
128911671|NCT03529773|463969206|FG006|Overall Study|Death|0|||
128911672|NCT03529773|463969207|FG007|Overall Study|Death|0|||
128911673|NCT03529773|463969208|FG008|Overall Study|Death|0|||
128911674|NCT03529773|463969209|FG009|Overall Study|Death|0|||
128911675|NCT03529773|463969210|FG010|Overall Study|Death|0|||
128911676|NCT03529773|463969211|FG011|Overall Study|Death|0|||
128911677|NCT03529773|463969212|FG012|Overall Study|Death|1|||
128911678|NCT03529773|463969213|FG013|Overall Study|Death|0|||
128911679|NCT03529773|463969214|FG014|Overall Study|Death|0|||
128911680|NCT03529773|463969215|FG015|Overall Study|Death|0|||
128911681|NCT03529773|463969216|FG016|Overall Study|Death|0|||
128911682|NCT03529773|463969217|FG017|Overall Study|Death|0|||
128911683|NCT03529773|463969218|FG018|Overall Study|Death|0|||
128911684|NCT03529773|463969219|FG019|Overall Study|Death|1|||
128911685|NCT03529773|463969220|FG020|Overall Study|Death|0|||
128911686|NCT03529773|463969221|FG021|Overall Study|Death|0|||
128911687|NCT03529773|463969222|FG022|Overall Study|Death|1|||
128911688|NCT03529773|463969223|FG023|Overall Study|Death|0|||
128911689|NCT03529773|463969224|FG024|Overall Study|Death|0|||
128911690|NCT03529773|463969225|FG025|Overall Study|Death|0|||
128911691|NCT03529773|463969226|FG026|Overall Study|Death|0|||
128911692|NCT03529773|463969227|FG027|Overall Study|Death|0|||
128911693|NCT03529773|463969228|FG028|Overall Study|Death|0|||
128911694|NCT03529773|463969229|FG029|Overall Study|Death|0|||
128911695|NCT03529773|463969230|FG030|Overall Study|Death|0|||
128911696|NCT03529773|463969231|FG031|Overall Study|Death|0|||
128911697|NCT03529773|463969232|FG032|Overall Study|Death|0|||
128911698|NCT03529773|463969233|FG033|Overall Study|Death|1|||
128911699|NCT03529773|463969234|FG034|Overall Study|Death|1|||
128911700|NCT03529773|463969235|FG035|Overall Study|Death|0|||
128911701|NCT03529773|463969236|FG036|Overall Study|Death|1|||
128911702|NCT03529773|463969237|FG037|Overall Study|Death|0|||
128911703|NCT03529773|463969238|FG038|Overall Study|Death|0|||
128911704|NCT03529773|463969239|FG039|Overall Study|Death|0|||
128911705|NCT03529773|463969200|FG000|Overall Study|Lost to Follow-up|0|||
128911706|NCT03529773|463969201|FG001|Overall Study|Lost to Follow-up|0|||
128911707|NCT03529773|463969202|FG002|Overall Study|Lost to Follow-up|1|||
128911708|NCT03529773|463969203|FG003|Overall Study|Lost to Follow-up|0|||
128911709|NCT03529773|463969204|FG004|Overall Study|Lost to Follow-up|1|||
128911710|NCT03529773|463969205|FG005|Overall Study|Lost to Follow-up|1|||
128911711|NCT03529773|463969206|FG006|Overall Study|Lost to Follow-up|0|||
128911712|NCT03529773|463969207|FG007|Overall Study|Lost to Follow-up|0|||
128911713|NCT03529773|463969208|FG008|Overall Study|Lost to Follow-up|0|||
128911714|NCT03529773|463969209|FG009|Overall Study|Lost to Follow-up|0|||
128911715|NCT03529773|463969210|FG010|Overall Study|Lost to Follow-up|0|||
128911716|NCT03529773|463969211|FG011|Overall Study|Lost to Follow-up|0|||
128911717|NCT03529773|463969212|FG012|Overall Study|Lost to Follow-up|0|||
128911718|NCT03529773|463969213|FG013|Overall Study|Lost to Follow-up|1|||
128911719|NCT03529773|463969214|FG014|Overall Study|Lost to Follow-up|4|||
128911720|NCT03529773|463969215|FG015|Overall Study|Lost to Follow-up|1|||
128911721|NCT03529773|463969216|FG016|Overall Study|Lost to Follow-up|1|||
128911722|NCT03529773|463969217|FG017|Overall Study|Lost to Follow-up|0|||
128911723|NCT03529773|463969218|FG018|Overall Study|Lost to Follow-up|1|||
128911724|NCT03529773|463969219|FG019|Overall Study|Lost to Follow-up|1|||
128911725|NCT03529773|463969220|FG020|Overall Study|Lost to Follow-up|2|||
128911726|NCT03529773|463969221|FG021|Overall Study|Lost to Follow-up|4|||
128911727|NCT03529773|463969222|FG022|Overall Study|Lost to Follow-up|3|||
128911728|NCT03529773|463969223|FG023|Overall Study|Lost to Follow-up|4|||
128911729|NCT03529773|463969224|FG024|Overall Study|Lost to Follow-up|3|||
128911730|NCT03529773|463969225|FG025|Overall Study|Lost to Follow-up|5|||
128911731|NCT03529773|463969226|FG026|Overall Study|Lost to Follow-up|5|||
128911732|NCT03529773|463969227|FG027|Overall Study|Lost to Follow-up|0|||
128911733|NCT03529773|463969228|FG028|Overall Study|Lost to Follow-up|0|||
128911734|NCT03529773|463969229|FG029|Overall Study|Lost to Follow-up|0|||
128911735|NCT03529773|463969230|FG030|Overall Study|Lost to Follow-up|1|||
128911736|NCT03529773|463969231|FG031|Overall Study|Lost to Follow-up|0|||
128911737|NCT03529773|463969232|FG032|Overall Study|Lost to Follow-up|0|||
128911738|NCT03529773|463969233|FG033|Overall Study|Lost to Follow-up|1|||
128911739|NCT03529773|463969234|FG034|Overall Study|Lost to Follow-up|1|||
128911740|NCT03529773|463969235|FG035|Overall Study|Lost to Follow-up|0|||
128911741|NCT03529773|463969236|FG036|Overall Study|Lost to Follow-up|0|||
128911742|NCT03529773|463969237|FG037|Overall Study|Lost to Follow-up|3|||
128911743|NCT03529773|463969238|FG038|Overall Study|Lost to Follow-up|1|||
128911744|NCT03529773|463969239|FG039|Overall Study|Lost to Follow-up|1|||
128911745|NCT03529773|463969200|FG000|Overall Study|No longer meets eligibility criteria|0|||
128911746|NCT03529773|463969201|FG001|Overall Study|No longer meets eligibility criteria|0|||
128911747|NCT03529773|463969202|FG002|Overall Study|No longer meets eligibility criteria|0|||
128911748|NCT03529773|463969203|FG003|Overall Study|No longer meets eligibility criteria|0|||
128911749|NCT03529773|463969204|FG004|Overall Study|No longer meets eligibility criteria|0|||
128911750|NCT03529773|463969205|FG005|Overall Study|No longer meets eligibility criteria|0|||
128911751|NCT03529773|463969206|FG006|Overall Study|No longer meets eligibility criteria|0|||
128911752|NCT03529773|463969207|FG007|Overall Study|No longer meets eligibility criteria|0|||
128911753|NCT03529773|463969208|FG008|Overall Study|No longer meets eligibility criteria|0|||
128911754|NCT03529773|463969209|FG009|Overall Study|No longer meets eligibility criteria|0|||
128911755|NCT03529773|463969210|FG010|Overall Study|No longer meets eligibility criteria|0|||
128911756|NCT03529773|463969211|FG011|Overall Study|No longer meets eligibility criteria|0|||
128911757|NCT03529773|463969212|FG012|Overall Study|No longer meets eligibility criteria|0|||
128911758|NCT03529773|463969213|FG013|Overall Study|No longer meets eligibility criteria|0|||
128911759|NCT03529773|463969214|FG014|Overall Study|No longer meets eligibility criteria|0|||
128911760|NCT03529773|463969215|FG015|Overall Study|No longer meets eligibility criteria|0|||
128911761|NCT03529773|463969216|FG016|Overall Study|No longer meets eligibility criteria|0|||
128911762|NCT03529773|463969217|FG017|Overall Study|No longer meets eligibility criteria|0|||
128911763|NCT03529773|463969218|FG018|Overall Study|No longer meets eligibility criteria|0|||
128911764|NCT03529773|463969219|FG019|Overall Study|No longer meets eligibility criteria|0|||
128911765|NCT03529773|463969220|FG020|Overall Study|No longer meets eligibility criteria|0|||
128911766|NCT03529773|463969221|FG021|Overall Study|No longer meets eligibility criteria|0|||
128911767|NCT03529773|463969222|FG022|Overall Study|No longer meets eligibility criteria|1|||
128911768|NCT03529773|463969223|FG023|Overall Study|No longer meets eligibility criteria|0|||
128911769|NCT03529773|463969224|FG024|Overall Study|No longer meets eligibility criteria|0|||
128911770|NCT03529773|463969225|FG025|Overall Study|No longer meets eligibility criteria|0|||
128911771|NCT03529773|463969226|FG026|Overall Study|No longer meets eligibility criteria|0|||
128911772|NCT03529773|463969227|FG027|Overall Study|No longer meets eligibility criteria|0|||
128911773|NCT03529773|463969228|FG028|Overall Study|No longer meets eligibility criteria|0|||
128911774|NCT03529773|463969229|FG029|Overall Study|No longer meets eligibility criteria|0|||
128911775|NCT03529773|463969230|FG030|Overall Study|No longer meets eligibility criteria|0|||
128911776|NCT03529773|463969231|FG031|Overall Study|No longer meets eligibility criteria|0|||
128911777|NCT03529773|463969232|FG032|Overall Study|No longer meets eligibility criteria|0|||
128911778|NCT03529773|463969233|FG033|Overall Study|No longer meets eligibility criteria|0|||
128911779|NCT03529773|463969234|FG034|Overall Study|No longer meets eligibility criteria|0|||
128911780|NCT03529773|463969235|FG035|Overall Study|No longer meets eligibility criteria|0|||
129028459|NCT05616728|464394575|FG002|Overall Study|Lost to Follow-up|1|||
129028460|NCT05616728|464394573|FG000|Overall Study|Withdrawal by Subject|1|||
129028461|NCT05616728|464394574|FG001|Overall Study|Withdrawal by Subject|1|||
129028462|NCT05616728|464394575|FG002|Overall Study|Withdrawal by Subject|0|||
129028463|NCT05616728|464394573|FG000|Overall Study|Physician Decision|1|||
129028464|NCT05616728|464394574|FG001|Overall Study|Physician Decision|1|||
129028465|NCT05616728|464394575|FG002|Overall Study|Physician Decision|1|||
129028466|NCT05616728|464394573|FG000|Overall Study|Other|0|||
129028467|NCT05616728|464394574|FG001|Overall Study|Other|2|||
129028468|NCT05616728|464394575|FG002|Overall Study|Other|0|||
129028469|NCT01024855|464394578|FG000|Overall Study|Inclusion/exclusion criteria|1|||
129028470|NCT03306277|464394583|FG000|Overall Study|Death|1|||
129028471|NCT03306277|464394583|FG000|Overall Study|Adverse Event|1|||
129028472|NCT03306277|464394583|FG000|Overall Study|Withdrawal by Subject|1|||
129028473|NCT00881751|464394584|FG000|Overall Study|Physician Decision|0|||
129028474|NCT00881751|464394585|FG001|Overall Study|Physician Decision|1|||
129028475|NCT00881751|464394584|FG000|Overall Study|Adverse Event|0|||
129028476|NCT00881751|464394585|FG001|Overall Study|Adverse Event|2|||
129028477|NCT00881751|464394584|FG000|Overall Study|Withdrawal by Subject|0|||
129028478|NCT00881751|464394585|FG001|Overall Study|Withdrawal by Subject|2|||
129028479|NCT02385708|464394586|FG000|Overall Study|Withdrawal by Subject|0|||
129028480|NCT02385708|464394587|FG001|Overall Study|Withdrawal by Subject|2|||
129028481|NCT02385708|464394586|FG000|Overall Study|Withdrawn - surgery canceled|2|||
129028482|NCT02385708|464394587|FG001|Overall Study|Withdrawn - surgery canceled|5|||
129028483|NCT02385708|464394586|FG000|Overall Study|Investigator decision|5|||
129028484|NCT02385708|464394587|FG001|Overall Study|Investigator decision|7|||
128911781|NCT03529773|463969236|FG036|Overall Study|No longer meets eligibility criteria|0|||
128911782|NCT03529773|463969237|FG037|Overall Study|No longer meets eligibility criteria|0|||
128911783|NCT03529773|463969238|FG038|Overall Study|No longer meets eligibility criteria|1|||
128911784|NCT03529773|463969239|FG039|Overall Study|No longer meets eligibility criteria|0|||
128911785|NCT03529773|463969200|FG000|Overall Study|Other|0|||
128911786|NCT03529773|463969201|FG001|Overall Study|Other|0|||
128911787|NCT03529773|463969202|FG002|Overall Study|Other|0|||
128911788|NCT03529773|463969203|FG003|Overall Study|Other|0|||
128911789|NCT03529773|463969204|FG004|Overall Study|Other|0|||
128911790|NCT03529773|463969205|FG005|Overall Study|Other|0|||
128911791|NCT03529773|463969206|FG006|Overall Study|Other|0|||
128911792|NCT03529773|463969207|FG007|Overall Study|Other|0|||
128911793|NCT03529773|463969208|FG008|Overall Study|Other|0|||
128911794|NCT03529773|463969209|FG009|Overall Study|Other|0|||
128911795|NCT03529773|463969210|FG010|Overall Study|Other|0|||
128911796|NCT03529773|463969211|FG011|Overall Study|Other|0|||
128911797|NCT03529773|463969212|FG012|Overall Study|Other|1|||
128911798|NCT03529773|463969213|FG013|Overall Study|Other|0|||
128911799|NCT03529773|463969214|FG014|Overall Study|Other|2|||
128911800|NCT03529773|463969215|FG015|Overall Study|Other|0|||
128911801|NCT03529773|463969216|FG016|Overall Study|Other|0|||
128911802|NCT03529773|463969217|FG017|Overall Study|Other|3|||
128911803|NCT03529773|463969218|FG018|Overall Study|Other|0|||
128911804|NCT03529773|463969219|FG019|Overall Study|Other|0|||
128911805|NCT03529773|463969220|FG020|Overall Study|Other|1|||
128911806|NCT03529773|463969221|FG021|Overall Study|Other|0|||
128911807|NCT03529773|463969222|FG022|Overall Study|Other|1|||
128911808|NCT03529773|463969223|FG023|Overall Study|Other|0|||
128911809|NCT03529773|463969224|FG024|Overall Study|Other|3|||
128911810|NCT03529773|463969225|FG025|Overall Study|Other|2|||
128911811|NCT03529773|463969226|FG026|Overall Study|Other|2|||
128911812|NCT03529773|463969227|FG027|Overall Study|Other|0|||
128911813|NCT03529773|463969228|FG028|Overall Study|Other|0|||
128911814|NCT03529773|463969229|FG029|Overall Study|Other|0|||
128911815|NCT03529773|463969230|FG030|Overall Study|Other|0|||
128911816|NCT03529773|463969231|FG031|Overall Study|Other|0|||
128911817|NCT03529773|463969232|FG032|Overall Study|Other|0|||
128911818|NCT03529773|463969233|FG033|Overall Study|Other|0|||
128911819|NCT03529773|463969234|FG034|Overall Study|Other|1|||
128911820|NCT03529773|463969235|FG035|Overall Study|Other|1|||
128911821|NCT03529773|463969236|FG036|Overall Study|Other|0|||
128911822|NCT03529773|463969237|FG037|Overall Study|Other|0|||
128911823|NCT03529773|463969238|FG038|Overall Study|Other|0|||
128911824|NCT03529773|463969239|FG039|Overall Study|Other|0|||
128911825|NCT03529773|463969200|FG000|Overall Study|Physician Decision|0|||
128911826|NCT03529773|463969201|FG001|Overall Study|Physician Decision|0|||
128911827|NCT03529773|463969202|FG002|Overall Study|Physician Decision|0|||
128911828|NCT03529773|463969203|FG003|Overall Study|Physician Decision|0|||
128911829|NCT03529773|463969204|FG004|Overall Study|Physician Decision|0|||
129028485|NCT02385708|464394586|FG000|Overall Study|Protocol Violation|1|||
129028486|NCT02385708|464394587|FG001|Overall Study|Protocol Violation|1|||
129028487|NCT00672984|464394588|FG000|First Intervention|Adverse Event|5|||
129028488|NCT00672984|464394589|FG001|First Intervention|Adverse Event|0|||
129028489|NCT00672984|464394590|FG002|First Intervention|Adverse Event|0|||
129028490|NCT00672984|464394588|FG000|First Intervention|Withdrawal by Subject|1|||
129028491|NCT00672984|464394589|FG001|First Intervention|Withdrawal by Subject|2|||
129028492|NCT00672984|464394590|FG002|First Intervention|Withdrawal by Subject|2|||
129028493|NCT00672984|464394588|FG000|First Intervention|Sponsor decision|3|||
129028494|NCT00672984|464394589|FG001|First Intervention|Sponsor decision|0|||
129028495|NCT00672984|464394590|FG002|First Intervention|Sponsor decision|0|||
129028496|NCT00672984|464394588|FG000|Second Intervention|Non-compliance with facility policies|0|||
129028497|NCT00672984|464394589|FG001|Second Intervention|Non-compliance with facility policies|2|||
129028498|NCT00672984|464394590|FG002|Second Intervention|Non-compliance with facility policies|0|||
129028499|NCT00672984|464394588|FG000|Second Intervention|Withdrawal by Subject|0|||
129028500|NCT00672984|464394589|FG001|Second Intervention|Withdrawal by Subject|3|||
129028501|NCT00672984|464394590|FG002|Second Intervention|Withdrawal by Subject|0|||
128911830|NCT03529773|463969205|FG005|Overall Study|Physician Decision|0|||
128911831|NCT03529773|463969206|FG006|Overall Study|Physician Decision|0|||
128911832|NCT03529773|463969207|FG007|Overall Study|Physician Decision|0|||
129028502|NCT00672984|464394588|FG000|Second Intervention|Protocol Violation|0|||
129028503|NCT00672984|464394589|FG001|Second Intervention|Protocol Violation|1|||
129028504|NCT00672984|464394590|FG002|Second Intervention|Protocol Violation|1|||
129028505|NCT00672984|464394588|FG000|Third Intervention|Adverse Event|1|||
129028506|NCT00672984|464394589|FG001|Third Intervention|Adverse Event|0|||
128911833|NCT03529773|463969208|FG008|Overall Study|Physician Decision|0|||
128911834|NCT03529773|463969209|FG009|Overall Study|Physician Decision|0|||
128911835|NCT03529773|463969210|FG010|Overall Study|Physician Decision|0|||
128911836|NCT03529773|463969211|FG011|Overall Study|Physician Decision|0|||
128911837|NCT03529773|463969212|FG012|Overall Study|Physician Decision|0|||
128911838|NCT03529773|463969213|FG013|Overall Study|Physician Decision|0|||
128911839|NCT03529773|463969214|FG014|Overall Study|Physician Decision|0|||
128911840|NCT03529773|463969215|FG015|Overall Study|Physician Decision|0|||
129118601|NCT02251275|464731161|FG001|Overall Study|Lost to Follow-up|6|||
129118602|NCT02251275|464731162|FG002|Overall Study|Lost to Follow-up|4|||
129118603|NCT02251275|464731163|FG003|Overall Study|Lost to Follow-up|0|||
129118604|NCT02251275|464731164|FG004|Overall Study|Lost to Follow-up|0|||
129118605|NCT02251275|464731160|FG000|Overall Study|Physician Decision|19|||
129118606|NCT02251275|464731161|FG001|Overall Study|Physician Decision|30|||
128697003|NCT01416272|463188981|FG000|Overall Study|Study related complaints|1|||
128697004|NCT02319837|463188982|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
128697005|NCT02319837|463188983|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
128911841|NCT03529773|463969216|FG016|Overall Study|Physician Decision|0|||
128911842|NCT03529773|463969217|FG017|Overall Study|Physician Decision|0|||
128911843|NCT03529773|463969218|FG018|Overall Study|Physician Decision|0|||
128911844|NCT03529773|463969219|FG019|Overall Study|Physician Decision|1|||
128911845|NCT03529773|463969220|FG020|Overall Study|Physician Decision|1|||
128911846|NCT03529773|463969221|FG021|Overall Study|Physician Decision|0|||
128911847|NCT03529773|463969222|FG022|Overall Study|Physician Decision|0|||
128911848|NCT03529773|463969223|FG023|Overall Study|Physician Decision|0|||
128911849|NCT03529773|463969224|FG024|Overall Study|Physician Decision|0|||
128911850|NCT03529773|463969225|FG025|Overall Study|Physician Decision|0|||
128911851|NCT03529773|463969226|FG026|Overall Study|Physician Decision|0|||
128911852|NCT03529773|463969227|FG027|Overall Study|Physician Decision|0|||
128911853|NCT03529773|463969228|FG028|Overall Study|Physician Decision|0|||
128911854|NCT03529773|463969229|FG029|Overall Study|Physician Decision|0|||
128911855|NCT03529773|463969230|FG030|Overall Study|Physician Decision|0|||
128911856|NCT03529773|463969231|FG031|Overall Study|Physician Decision|0|||
128911857|NCT03529773|463969232|FG032|Overall Study|Physician Decision|0|||
128911858|NCT03529773|463969233|FG033|Overall Study|Physician Decision|0|||
128911859|NCT03529773|463969234|FG034|Overall Study|Physician Decision|0|||
128911860|NCT03529773|463969235|FG035|Overall Study|Physician Decision|0|||
128911861|NCT03529773|463969236|FG036|Overall Study|Physician Decision|0|||
128911862|NCT03529773|463969237|FG037|Overall Study|Physician Decision|0|||
128911863|NCT03529773|463969238|FG038|Overall Study|Physician Decision|0|||
128911864|NCT03529773|463969239|FG039|Overall Study|Physician Decision|0|||
128911865|NCT03529773|463969200|FG000|Overall Study|Protocol Violation|0|||
128911866|NCT03529773|463969201|FG001|Overall Study|Protocol Violation|0|||
128911867|NCT03529773|463969202|FG002|Overall Study|Protocol Violation|0|||
128911868|NCT03529773|463969203|FG003|Overall Study|Protocol Violation|0|||
128911869|NCT03529773|463969204|FG004|Overall Study|Protocol Violation|0|||
128911870|NCT03529773|463969205|FG005|Overall Study|Protocol Violation|0|||
128911871|NCT03529773|463969206|FG006|Overall Study|Protocol Violation|0|||
128911872|NCT03529773|463969207|FG007|Overall Study|Protocol Violation|0|||
128911873|NCT03529773|463969208|FG008|Overall Study|Protocol Violation|0|||
128911874|NCT03529773|463969209|FG009|Overall Study|Protocol Violation|0|||
128911875|NCT03529773|463969210|FG010|Overall Study|Protocol Violation|0|||
128911876|NCT03529773|463969211|FG011|Overall Study|Protocol Violation|0|||
128911877|NCT03529773|463969212|FG012|Overall Study|Protocol Violation|0|||
128911878|NCT03529773|463969213|FG013|Overall Study|Protocol Violation|0|||
128911879|NCT03529773|463969214|FG014|Overall Study|Protocol Violation|0|||
128911880|NCT03529773|463969215|FG015|Overall Study|Protocol Violation|0|||
128911881|NCT03529773|463969216|FG016|Overall Study|Protocol Violation|0|||
128911882|NCT03529773|463969217|FG017|Overall Study|Protocol Violation|0|||
128911883|NCT03529773|463969218|FG018|Overall Study|Protocol Violation|0|||
128911884|NCT03529773|463969219|FG019|Overall Study|Protocol Violation|0|||
128911885|NCT03529773|463969220|FG020|Overall Study|Protocol Violation|0|||
128911886|NCT03529773|463969221|FG021|Overall Study|Protocol Violation|0|||
128911887|NCT03529773|463969222|FG022|Overall Study|Protocol Violation|0|||
129118607|NCT02251275|464731162|FG002|Overall Study|Physician Decision|26|||
129118608|NCT02251275|464731163|FG003|Overall Study|Physician Decision|0|||
129118609|NCT02251275|464731164|FG004|Overall Study|Physician Decision|1|||
129118610|NCT02251275|464731160|FG000|Overall Study|Protocol Deviation|0|||
129118611|NCT02251275|464731161|FG001|Overall Study|Protocol Deviation|0|||
128697006|NCT02319837|463188984|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
128911888|NCT03529773|463969223|FG023|Overall Study|Protocol Violation|0|||
128911889|NCT03529773|463969224|FG024|Overall Study|Protocol Violation|0|||
128911890|NCT03529773|463969225|FG025|Overall Study|Protocol Violation|0|||
128911891|NCT03529773|463969226|FG026|Overall Study|Protocol Violation|0|||
128911892|NCT03529773|463969227|FG027|Overall Study|Protocol Violation|0|||
128911893|NCT03529773|463969228|FG028|Overall Study|Protocol Violation|0|||
128911894|NCT03529773|463969229|FG029|Overall Study|Protocol Violation|0|||
128911895|NCT03529773|463969230|FG030|Overall Study|Protocol Violation|1|||
128911896|NCT03529773|463969231|FG031|Overall Study|Protocol Violation|0|||
128911897|NCT03529773|463969232|FG032|Overall Study|Protocol Violation|0|||
128911898|NCT03529773|463969233|FG033|Overall Study|Protocol Violation|0|||
128911899|NCT03529773|463969234|FG034|Overall Study|Protocol Violation|0|||
128911900|NCT03529773|463969235|FG035|Overall Study|Protocol Violation|0|||
128911901|NCT03529773|463969236|FG036|Overall Study|Protocol Violation|0|||
128911902|NCT03529773|463969237|FG037|Overall Study|Protocol Violation|0|||
128911903|NCT03529773|463969238|FG038|Overall Study|Protocol Violation|0|||
128911904|NCT03529773|463969239|FG039|Overall Study|Protocol Violation|0|||
129118612|NCT02251275|464731162|FG002|Overall Study|Protocol Deviation|1|||
128911905|NCT03529773|463969200|FG000|Overall Study|Withdrawal by Subject|0|||
128911906|NCT03529773|463969201|FG001|Overall Study|Withdrawal by Subject|0|||
128911907|NCT03529773|463969202|FG002|Overall Study|Withdrawal by Subject|0|||
128911908|NCT03529773|463969203|FG003|Overall Study|Withdrawal by Subject|0|||
128911909|NCT03529773|463969204|FG004|Overall Study|Withdrawal by Subject|0|||
128911910|NCT03529773|463969205|FG005|Overall Study|Withdrawal by Subject|0|||
128911911|NCT03529773|463969206|FG006|Overall Study|Withdrawal by Subject|0|||
128911912|NCT03529773|463969207|FG007|Overall Study|Withdrawal by Subject|1|||
128911913|NCT03529773|463969208|FG008|Overall Study|Withdrawal by Subject|0|||
128911914|NCT03529773|463969209|FG009|Overall Study|Withdrawal by Subject|1|||
128911915|NCT03529773|463969210|FG010|Overall Study|Withdrawal by Subject|1|||
128911916|NCT03529773|463969211|FG011|Overall Study|Withdrawal by Subject|0|||
128911917|NCT03529773|463969212|FG012|Overall Study|Withdrawal by Subject|0|||
128911918|NCT03529773|463969213|FG013|Overall Study|Withdrawal by Subject|0|||
128911919|NCT03529773|463969214|FG014|Overall Study|Withdrawal by Subject|0|||
128911920|NCT03529773|463969215|FG015|Overall Study|Withdrawal by Subject|3|||
128911921|NCT03529773|463969216|FG016|Overall Study|Withdrawal by Subject|0|||
128911922|NCT03529773|463969217|FG017|Overall Study|Withdrawal by Subject|2|||
128911923|NCT03529773|463969218|FG018|Overall Study|Withdrawal by Subject|3|||
128911924|NCT03529773|463969219|FG019|Overall Study|Withdrawal by Subject|1|||
128911925|NCT03529773|463969220|FG020|Overall Study|Withdrawal by Subject|3|||
128911926|NCT03529773|463969221|FG021|Overall Study|Withdrawal by Subject|1|||
128911927|NCT03529773|463969222|FG022|Overall Study|Withdrawal by Subject|1|||
128911928|NCT03529773|463969223|FG023|Overall Study|Withdrawal by Subject|2|||
128911929|NCT03529773|463969224|FG024|Overall Study|Withdrawal by Subject|2|||
128911930|NCT03529773|463969225|FG025|Overall Study|Withdrawal by Subject|4|||
128911931|NCT03529773|463969226|FG026|Overall Study|Withdrawal by Subject|2|||
128911932|NCT03529773|463969227|FG027|Overall Study|Withdrawal by Subject|1|||
128911933|NCT03529773|463969228|FG028|Overall Study|Withdrawal by Subject|1|||
128911934|NCT03529773|463969229|FG029|Overall Study|Withdrawal by Subject|0|||
128911935|NCT03529773|463969230|FG030|Overall Study|Withdrawal by Subject|0|||
128911936|NCT03529773|463969231|FG031|Overall Study|Withdrawal by Subject|0|||
128911937|NCT03529773|463969232|FG032|Overall Study|Withdrawal by Subject|0|||
128911938|NCT03529773|463969233|FG033|Overall Study|Withdrawal by Subject|0|||
128911939|NCT03529773|463969234|FG034|Overall Study|Withdrawal by Subject|1|||
128911940|NCT03529773|463969235|FG035|Overall Study|Withdrawal by Subject|2|||
128911941|NCT03529773|463969236|FG036|Overall Study|Withdrawal by Subject|0|||
128911942|NCT03529773|463969237|FG037|Overall Study|Withdrawal by Subject|2|||
128911943|NCT03529773|463969238|FG038|Overall Study|Withdrawal by Subject|1|||
128911944|NCT03529773|463969239|FG039|Overall Study|Withdrawal by Subject|1|||
128911945|NCT03529773|463969200|FG000|Overall Study|Screen Failure|0|||
128911946|NCT03529773|463969201|FG001|Overall Study|Screen Failure|0|||
128911947|NCT03529773|463969202|FG002|Overall Study|Screen Failure|0|||
128911948|NCT03529773|463969203|FG003|Overall Study|Screen Failure|0|||
128911949|NCT03529773|463969204|FG004|Overall Study|Screen Failure|0|||
129118613|NCT02251275|464731163|FG003|Overall Study|Protocol Deviation|0|||
129118614|NCT02251275|464731164|FG004|Overall Study|Protocol Deviation|0|||
129118615|NCT02251275|464731160|FG000|Overall Study|Withdrawal by Subject|25|||
128911950|NCT03529773|463969205|FG005|Overall Study|Screen Failure|0|||
128911951|NCT03529773|463969206|FG006|Overall Study|Screen Failure|0|||
128911952|NCT03529773|463969207|FG007|Overall Study|Screen Failure|0|||
128911953|NCT03529773|463969208|FG008|Overall Study|Screen Failure|0|||
128911954|NCT03529773|463969209|FG009|Overall Study|Screen Failure|0|||
128911955|NCT03529773|463969210|FG010|Overall Study|Screen Failure|0|||
128911956|NCT03529773|463969211|FG011|Overall Study|Screen Failure|0|||
128911957|NCT03529773|463969212|FG012|Overall Study|Screen Failure|0|||
128911958|NCT03529773|463969213|FG013|Overall Study|Screen Failure|0|||
128911959|NCT03529773|463969214|FG014|Overall Study|Screen Failure|0|||
128911960|NCT03529773|463969215|FG015|Overall Study|Screen Failure|0|||
128911961|NCT03529773|463969216|FG016|Overall Study|Screen Failure|0|||
128911962|NCT03529773|463969217|FG017|Overall Study|Screen Failure|0|||
128911963|NCT03529773|463969218|FG018|Overall Study|Screen Failure|0|||
128911964|NCT03529773|463969219|FG019|Overall Study|Screen Failure|0|||
129118616|NCT02251275|464731161|FG001|Overall Study|Withdrawal by Subject|51|||
129118617|NCT02251275|464731162|FG002|Overall Study|Withdrawal by Subject|35|||
129118618|NCT02251275|464731163|FG003|Overall Study|Withdrawal by Subject|1|||
129118619|NCT02251275|464731164|FG004|Overall Study|Withdrawal by Subject|0|||
128911965|NCT03529773|463969220|FG020|Overall Study|Screen Failure|0|||
128911966|NCT03529773|463969221|FG021|Overall Study|Screen Failure|0|||
128911967|NCT03529773|463969222|FG022|Overall Study|Screen Failure|0|||
128911968|NCT03529773|463969223|FG023|Overall Study|Screen Failure|0|||
128911969|NCT03529773|463969224|FG024|Overall Study|Screen Failure|0|||
128911970|NCT03529773|463969225|FG025|Overall Study|Screen Failure|0|||
128911971|NCT03529773|463969226|FG026|Overall Study|Screen Failure|0|||
128911972|NCT03529773|463969227|FG027|Overall Study|Screen Failure|0|||
128911973|NCT03529773|463969228|FG028|Overall Study|Screen Failure|0|||
128911974|NCT03529773|463969229|FG029|Overall Study|Screen Failure|0|||
128911975|NCT03529773|463969230|FG030|Overall Study|Screen Failure|0|||
129028507|NCT00672984|464394590|FG002|Third Intervention|Adverse Event|1|||
129028508|NCT00645853|464394591|FG000|Overall Study|Adverse Event|18|||
128911976|NCT03529773|463969231|FG031|Overall Study|Screen Failure|0|||
128911977|NCT03529773|463969232|FG032|Overall Study|Screen Failure|0|||
128911978|NCT03529773|463969233|FG033|Overall Study|Screen Failure|0|||
128911979|NCT03529773|463969234|FG034|Overall Study|Screen Failure|0|||
128911980|NCT03529773|463969235|FG035|Overall Study|Screen Failure|0|||
128911981|NCT03529773|463969236|FG036|Overall Study|Screen Failure|1|||
128911982|NCT03529773|463969237|FG037|Overall Study|Screen Failure|1|||
128911983|NCT03529773|463969238|FG038|Overall Study|Screen Failure|0|||
128911984|NCT03529773|463969239|FG039|Overall Study|Screen Failure|1|||
128911985|NCT03529773|463969200|FG000|Overall Study|Randomized but not vaccinated|0|||
129028509|NCT00645853|464394592|FG001|Overall Study|Adverse Event|7|||
129028510|NCT00645853|464394591|FG000|Overall Study|AZ study closure in Hungary|60|||
129028511|NCT00645853|464394592|FG001|Overall Study|AZ study closure in Hungary|40|||
129028512|NCT00645853|464394591|FG000|Overall Study|Withdrawal by Subject|5|||
129028513|NCT00645853|464394592|FG001|Overall Study|Withdrawal by Subject|2|||
129028514|NCT00645853|464394591|FG000|Overall Study|Protocol Violation|0|||
129028515|NCT00645853|464394592|FG001|Overall Study|Protocol Violation|2|||
129028516|NCT00645853|464394591|FG000|Overall Study|Discontinuation criteria|2|||
129028517|NCT00645853|464394592|FG001|Overall Study|Discontinuation criteria|2|||
128911986|NCT03529773|463969201|FG001|Overall Study|Randomized but not vaccinated|0|||
128911987|NCT03529773|463969202|FG002|Overall Study|Randomized but not vaccinated|0|||
129028518|NCT00645853|464394591|FG000|Overall Study|recall of ICF, planned operation, death|7|||
129118620|NCT00856180|464731168|FG000|Overall Study|Adverse Event|4|||
129118621|NCT00856180|464731168|FG000|Overall Study|Progressive Disease|16|||
128911988|NCT03529773|463969203|FG003|Overall Study|Randomized but not vaccinated|0|||
129118622|NCT01302899|464731169|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
129118623|NCT01302899|464731170|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
129118624|NCT01302899|464731169|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
128911989|NCT03529773|463969204|FG004|Overall Study|Randomized but not vaccinated|0|||
128911990|NCT03529773|463969205|FG005|Overall Study|Randomized but not vaccinated|0|||
128911991|NCT03529773|463969206|FG006|Overall Study|Randomized but not vaccinated|0|||
128911992|NCT03529773|463969207|FG007|Overall Study|Randomized but not vaccinated|0|||
128911993|NCT03529773|463969208|FG008|Overall Study|Randomized but not vaccinated|0|||
128911994|NCT03529773|463969209|FG009|Overall Study|Randomized but not vaccinated|0|||
128911995|NCT03529773|463969210|FG010|Overall Study|Randomized but not vaccinated|0|||
128911996|NCT03529773|463969211|FG011|Overall Study|Randomized but not vaccinated|0|||
128911997|NCT03529773|463969212|FG012|Overall Study|Randomized but not vaccinated|0|||
129028519|NCT00645853|464394592|FG001|Overall Study|recall of ICF, planned operation, death|4|||
129118625|NCT01302899|464731170|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
129118626|NCT02834975|464731171|FG000|Overall Study|Physician Decision|2|||
129118627|NCT02834975|464731171|FG000|Overall Study|Adverse Event|1|||
129118628|NCT02834975|464731171|FG000|Overall Study|Withdrawal by Subject|1|||
129118629|NCT02834975|464731171|FG000|Overall Study|Lack of Efficacy|1|||
129118630|NCT03558516|464731172|FG000|Overall Study|Protocol Violation|2|||
129118631|NCT03558516|464731173|FG001|Overall Study|Protocol Violation|2|||
129118632|NCT00929669|464731174|FG000|Overall Study|elevated glucose levels|1|||
129118633|NCT00686972|464731176|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
129118634|NCT01462942|464731177|FG000|Overall Study|Adverse Event|7|||
129118635|NCT01462942|464731178|FG001|Overall Study|Adverse Event|12|||
129118636|NCT01462942|464731179|FG002|Overall Study|Adverse Event|10|||
129118637|NCT01462942|464731180|FG003|Overall Study|Adverse Event|11|||
129118638|NCT01462942|464731181|FG004|Overall Study|Adverse Event|11|||
129118639|NCT01462942|464731177|FG000|Overall Study|Other, including COPD exacerbation|3|||
129118640|NCT01462942|464731178|FG001|Overall Study|Other, including COPD exacerbation|5|||
129118641|NCT01462942|464731179|FG002|Overall Study|Other, including COPD exacerbation|2|||
129118642|NCT01462942|464731180|FG003|Overall Study|Other, including COPD exacerbation|8|||
129118643|NCT01462942|464731181|FG004|Overall Study|Other, including COPD exacerbation|5|||
129118644|NCT01462942|464731177|FG000|Overall Study|Withdrawal by Subject|14|||
129118645|NCT01462942|464731178|FG001|Overall Study|Withdrawal by Subject|10|||
129118646|NCT01462942|464731179|FG002|Overall Study|Withdrawal by Subject|14|||
129118647|NCT01462942|464731180|FG003|Overall Study|Withdrawal by Subject|16|||
129118648|NCT01462942|464731181|FG004|Overall Study|Withdrawal by Subject|19|||
129215639|NCT02079246|465092785|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
128911998|NCT03529773|463969213|FG013|Overall Study|Randomized but not vaccinated|0|||
128911999|NCT03529773|463969214|FG014|Overall Study|Randomized but not vaccinated|0|||
128912000|NCT03529773|463969215|FG015|Overall Study|Randomized but not vaccinated|0|||
129028520|NCT04060251|464394593|FG000|Overall Study|Study terminated due to low enrollment.|7|||
129028521|NCT04060251|464394594|FG001|Overall Study|Study terminated due to low enrollment.|5|||
129028522|NCT04060251|464394595|FG002|Overall Study|Study terminated due to low enrollment.|7|||
129028523|NCT04060251|464394593|FG000|Overall Study|Adverse Event|1|||
129028524|NCT04060251|464394594|FG001|Overall Study|Adverse Event|1|||
129028525|NCT04060251|464394595|FG002|Overall Study|Adverse Event|0|||
129028526|NCT00487435|464394596|FG000|Overall Study|Adverse Event|146|||
129028527|NCT00487435|464394596|FG000|Overall Study|Death|2|||
129028528|NCT00487435|464394596|FG000|Overall Study|Lack of Efficacy|33|||
129028529|NCT00487435|464394596|FG000|Overall Study|Lost to Follow-up|54|||
129028530|NCT00487435|464394596|FG000|Overall Study|Pregnancy|2|||
129028531|NCT00487435|464394596|FG000|Overall Study|Withdrawal by Subject|132|||
129028532|NCT00487435|464394596|FG000|Overall Study|Resolution Of Pain|1|||
129028533|NCT00487435|464394596|FG000|Overall Study|Study Medication Non-Compliant|32|||
129028534|NCT00487435|464394596|FG000|Overall Study|Other|83|||
129028535|NCT00985751|464394597|FG000|Overall Study|Adverse Event|0|||
129028536|NCT00985751|464394598|FG001|Overall Study|Adverse Event|0|||
129028537|NCT00985751|464394599|FG002|Overall Study|Adverse Event|0|||
129028538|NCT00985751|464394600|FG003|Overall Study|Adverse Event|0|||
129028539|NCT00985751|464394601|FG004|Overall Study|Adverse Event|1|||
129028540|NCT00858403|464394608|FG000|Overall Study|Withdrawal by Subject|1|||
129028541|NCT00858403|464394608|FG000|Overall Study|Death|3|||
129028542|NCT00858403|464394608|FG000|Overall Study|Disease Progression|1|||
129028543|NCT03867760|464394611|FG000|Overall Study|Lost to Follow-up|2|||
129028544|NCT03867760|464394612|FG001|Overall Study|Lost to Follow-up|3|||
129028545|NCT03867760|464394611|FG000|Overall Study|Withdrawal by Subject|1|||
129028546|NCT03867760|464394612|FG001|Overall Study|Withdrawal by Subject|2|||
129028547|NCT03867760|464394611|FG000|Overall Study|subject could not meet study logistics|3|||
129028548|NCT03867760|464394612|FG001|Overall Study|subject could not meet study logistics|3|||
129028549|NCT01018862|464394622|FG000|Overall Study|Adverse Event|2|||
129028550|NCT01018862|464394623|FG001|Overall Study|Adverse Event|0|||
129028551|NCT01018862|464394624|FG002|Overall Study|Adverse Event|6|||
129028552|NCT01018862|464394622|FG000|Overall Study|Lack of Efficacy|1|||
129028553|NCT01018862|464394623|FG001|Overall Study|Lack of Efficacy|0|||
129028554|NCT01018862|464394624|FG002|Overall Study|Lack of Efficacy|2|||
129028555|NCT01018862|464394622|FG000|Overall Study|Lost to Follow-up|3|||
129028556|NCT01018862|464394623|FG001|Overall Study|Lost to Follow-up|1|||
129028557|NCT01018862|464394624|FG002|Overall Study|Lost to Follow-up|0|||
129028558|NCT01018862|464394622|FG000|Overall Study|Protocol Violation|1|||
129028559|NCT01018862|464394623|FG001|Overall Study|Protocol Violation|3|||
129028560|NCT01018862|464394624|FG002|Overall Study|Protocol Violation|3|||
129028561|NCT01018862|464394622|FG000|Overall Study|Withdrawal by Subject|1|||
129028562|NCT01018862|464394623|FG001|Overall Study|Withdrawal by Subject|2|||
129028563|NCT01018862|464394624|FG002|Overall Study|Withdrawal by Subject|1|||
129028564|NCT01018862|464394622|FG000|Overall Study|administrative problems|5|||
129118649|NCT01462942|464731177|FG000|Overall Study|Lack of Efficacy|6|||
129118650|NCT01462942|464731178|FG001|Overall Study|Lack of Efficacy|0|||
129118651|NCT01462942|464731179|FG002|Overall Study|Lack of Efficacy|4|||
129118652|NCT01462942|464731180|FG003|Overall Study|Lack of Efficacy|5|||
129118653|NCT01462942|464731181|FG004|Overall Study|Lack of Efficacy|3|||
129118654|NCT01462942|464731177|FG000|Overall Study|Lost to Follow-up|0|||
129118655|NCT01462942|464731178|FG001|Overall Study|Lost to Follow-up|1|||
129118656|NCT01462942|464731179|FG002|Overall Study|Lost to Follow-up|1|||
128697007|NCT02319837|463188982|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
128697008|NCT02319837|463188983|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
128697009|NCT02319837|463188984|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
128697010|NCT02319837|463188982|FG000|Study Treatment Phase|Adverse Event|73|||
129028565|NCT01018862|464394623|FG001|Overall Study|administrative problems|4|||
129028566|NCT01018862|464394624|FG002|Overall Study|administrative problems|4|||
129028567|NCT01968031|464394625|FG000|Overall Study|Adverse Event|13|||
129028568|NCT01968031|464394626|FG001|Overall Study|Adverse Event|10|||
129028569|NCT01968031|464394627|FG002|Overall Study|Adverse Event|22|||
129028570|NCT01968031|464394625|FG000|Overall Study|Withdrawal by Subject|3|||
129028571|NCT01968031|464394626|FG001|Overall Study|Withdrawal by Subject|7|||
129028572|NCT01968031|464394627|FG002|Overall Study|Withdrawal by Subject|3|||
129028573|NCT01968031|464394625|FG000|Overall Study|Did not meet entry criteria|1|||
129028574|NCT01968031|464394626|FG001|Overall Study|Did not meet entry criteria|1|||
129028575|NCT01968031|464394627|FG002|Overall Study|Did not meet entry criteria|1|||
129028576|NCT01968031|464394625|FG000|Overall Study|Noncompliance|0|||
129028577|NCT01968031|464394626|FG001|Overall Study|Noncompliance|0|||
129028578|NCT01968031|464394627|FG002|Overall Study|Noncompliance|2|||
129028579|NCT01968031|464394625|FG000|Overall Study|Failed inclusion criteria|0|||
129028580|NCT01968031|464394626|FG001|Overall Study|Failed inclusion criteria|2|||
129028581|NCT01968031|464394627|FG002|Overall Study|Failed inclusion criteria|0|||
129028582|NCT01968031|464394625|FG000|Overall Study|Death|0|||
129028583|NCT01968031|464394626|FG001|Overall Study|Death|0|||
129028584|NCT01968031|464394627|FG002|Overall Study|Death|1|||
129028585|NCT01968031|464394625|FG000|Overall Study|Prohibited concomitant medication|1|||
129028586|NCT01968031|464394626|FG001|Overall Study|Prohibited concomitant medication|0|||
129118657|NCT01462942|464731180|FG003|Overall Study|Lost to Follow-up|1|||
129118658|NCT01462942|464731181|FG004|Overall Study|Lost to Follow-up|1|||
129118659|NCT01462942|464731177|FG000|Overall Study|Protocol Violation|4|||
129118660|NCT01462942|464731178|FG001|Overall Study|Protocol Violation|6|||
129118661|NCT01462942|464731179|FG002|Overall Study|Protocol Violation|9|||
128912001|NCT03529773|463969216|FG016|Overall Study|Randomized but not vaccinated|0|||
128912002|NCT03529773|463969217|FG017|Overall Study|Randomized but not vaccinated|1|||
128912003|NCT03529773|463969218|FG018|Overall Study|Randomized but not vaccinated|0|||
128912004|NCT03529773|463969219|FG019|Overall Study|Randomized but not vaccinated|0|||
128912005|NCT03529773|463969220|FG020|Overall Study|Randomized but not vaccinated|0|||
128912006|NCT03529773|463969221|FG021|Overall Study|Randomized but not vaccinated|0|||
128912007|NCT03529773|463969222|FG022|Overall Study|Randomized but not vaccinated|0|||
128912008|NCT03529773|463969223|FG023|Overall Study|Randomized but not vaccinated|0|||
128912009|NCT03529773|463969224|FG024|Overall Study|Randomized but not vaccinated|0|||
128912010|NCT03529773|463969225|FG025|Overall Study|Randomized but not vaccinated|0|||
128912011|NCT03529773|463969226|FG026|Overall Study|Randomized but not vaccinated|0|||
128912012|NCT03529773|463969227|FG027|Overall Study|Randomized but not vaccinated|1|||
128912013|NCT03529773|463969228|FG028|Overall Study|Randomized but not vaccinated|0|||
128912014|NCT03529773|463969229|FG029|Overall Study|Randomized but not vaccinated|0|||
128912015|NCT03529773|463969230|FG030|Overall Study|Randomized but not vaccinated|0|||
128912016|NCT03529773|463969231|FG031|Overall Study|Randomized but not vaccinated|0|||
128912017|NCT03529773|463969232|FG032|Overall Study|Randomized but not vaccinated|0|||
128912018|NCT03529773|463969233|FG033|Overall Study|Randomized but not vaccinated|0|||
128912019|NCT03529773|463969234|FG034|Overall Study|Randomized but not vaccinated|0|||
128912020|NCT03529773|463969235|FG035|Overall Study|Randomized but not vaccinated|0|||
128912021|NCT03529773|463969236|FG036|Overall Study|Randomized but not vaccinated|0|||
128912022|NCT03529773|463969237|FG037|Overall Study|Randomized but not vaccinated|0|||
128912023|NCT03529773|463969238|FG038|Overall Study|Randomized but not vaccinated|0|||
128912024|NCT03529773|463969239|FG039|Overall Study|Randomized but not vaccinated|0|||
128912025|NCT01537211|463969240|FG000|Overall Study|Lost to Follow-up|0|||
128912026|NCT01537211|463969241|FG001|Overall Study|Lost to Follow-up|1|||
128912027|NCT02475655|463969243|FG000|Overall Study|Lost to Follow-up|0|||
128912028|NCT02475655|463969244|FG001|Overall Study|Lost to Follow-up|1|||
128912029|NCT00643994|463969245|FG000|Overall Study|Death|24|||
128912030|NCT00643994|463969245|FG000|Overall Study|Lost to Follow-up|72|||
128912031|NCT00257010|463969264|FG000|Overall Study|Lack of Efficacy|11|||
128912032|NCT00257010|463969264|FG000|Overall Study|Lost to Follow-up|53|||
128912033|NCT00257010|463969264|FG000|Overall Study|Withdrawal by Subject|34|||
128912034|NCT00257010|463969264|FG000|Overall Study|Adverse Event|10|||
128912035|NCT00257010|463969264|FG000|Overall Study|various|11|||
128912036|NCT00257010|463969264|FG000|Overall Study|no headache reported|9|||
128912037|NCT00323557|463969265|FG000|Overall Study|Physician Decision|1|||
128912038|NCT00323557|463969266|FG001|Overall Study|Physician Decision|0|||
128912039|NCT00197054|463969267|FG000|Overall Study|Withdrawal by Subject|9|||
128912040|NCT00197054|463969268|FG001|Overall Study|Withdrawal by Subject|3|||
128912041|NCT00197054|463969269|FG002|Overall Study|Withdrawal by Subject|3|||
128912042|NCT00197054|463969267|FG000|Overall Study|Moved from area|7|||
128912043|NCT00197054|463969268|FG001|Overall Study|Moved from area|14|||
128912044|NCT00197054|463969269|FG002|Overall Study|Moved from area|9|||
128912045|NCT00197054|463969267|FG000|Overall Study|Lost to Follow-up|1|||
128912046|NCT00197054|463969268|FG001|Overall Study|Lost to Follow-up|4|||
128912047|NCT00197054|463969269|FG002|Overall Study|Lost to Follow-up|0|||
128912048|NCT02450578|463969272|FG000|Overall Study|ECG abnormality so not treated|1|||
128912049|NCT02450578|463969273|FG001|Overall Study|ECG abnormality so not treated|0|||
128912050|NCT02450578|463969274|FG002|Overall Study|ECG abnormality so not treated|0|||
128912051|NCT02450578|463969275|FG003|Overall Study|ECG abnormality so not treated|0|||
128912052|NCT00662792|463969276|FG000|Period 1|Personal Reasons|0|||
128912053|NCT00662792|463969277|FG001|Period 1|Personal Reasons|0|||
128912054|NCT00662792|463969278|FG002|Period 1|Personal Reasons|1|||
128912055|NCT00662792|463969279|FG003|Period 1|Personal Reasons|0|||
128912056|NCT00662792|463969276|FG000|Period 1|Refused continuing medication|0|||
128912057|NCT00662792|463969277|FG001|Period 1|Refused continuing medication|1|||
128912058|NCT00662792|463969278|FG002|Period 1|Refused continuing medication|1|||
128912059|NCT00662792|463969279|FG003|Period 1|Refused continuing medication|0|||
128912060|NCT00662792|463969276|FG000|Period 1|Lost to Follow-up|1|||
128912061|NCT00662792|463969277|FG001|Period 1|Lost to Follow-up|0|||
129118662|NCT01462942|464731180|FG003|Overall Study|Protocol Violation|9|||
129118663|NCT01462942|464731181|FG004|Overall Study|Protocol Violation|6|||
129118664|NCT01027845|464731182|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
128912062|NCT00662792|463969278|FG002|Period 1|Lost to Follow-up|0|||
128912063|NCT00662792|463969279|FG003|Period 1|Lost to Follow-up|0|||
128912064|NCT00662792|463969276|FG000|Period 1|Other adverse event (AE)|0|||
128912065|NCT00662792|463969277|FG001|Period 1|Other adverse event (AE)|2|||
128912066|NCT00662792|463969278|FG002|Period 1|Other adverse event (AE)|0|||
128912067|NCT00662792|463969279|FG003|Period 1|Other adverse event (AE)|0|||
128912068|NCT00662792|463969276|FG000|Period 1|Worsening of disease under study (AE)|1|||
128912069|NCT00662792|463969277|FG001|Period 1|Worsening of disease under study (AE)|3|||
128912070|NCT00662792|463969278|FG002|Period 1|Worsening of disease under study (AE)|2|||
129118665|NCT01027845|464731183|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
129118666|NCT01027845|464731184|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
129215640|NCT02079246|465092784|FG000|OLEX-MEM|Adverse Event|0|||
129028587|NCT01968031|464394627|FG002|Overall Study|Prohibited concomitant medication|0|||
129028588|NCT00840879|464394628|FG000|Second Intervention|Withdrawal by Subject|1|||
129028589|NCT00840879|464394629|FG001|Second Intervention|Withdrawal by Subject|0|||
129028590|NCT04236596|464394630|FG000|Overall Study|Withdrawal by Subject|1|||
129028591|NCT04236596|464394630|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
129028592|NCT04236596|464394630|FG000|Overall Study|Participants did not receive implant at all|4|||
129028593|NCT02957331|464394633|FG000|Overall Study|Protocol Violation|1|||
129028594|NCT02957331|464394634|FG001|Overall Study|Protocol Violation|0|||
129028595|NCT02583048|464396329|FG000|Overall Study|Withdrawal by Subject|0|||
129028596|NCT02583048|464396330|FG001|Overall Study|Withdrawal by Subject|1|||
129028597|NCT02583048|464396331|FG002|Overall Study|Withdrawal by Subject|0|||
129028598|NCT02583048|464396329|FG000|Overall Study|Failed to meet eligibility criterion|0|||
129028599|NCT02583048|464396330|FG001|Overall Study|Failed to meet eligibility criterion|0|||
129028600|NCT02583048|464396331|FG002|Overall Study|Failed to meet eligibility criterion|1|||
129028601|NCT01151280|464396337|FG000|Overall Study|Adverse Event|1|||
129028602|NCT01151280|464396337|FG000|Overall Study|Lack of Efficacy|3|||
129028603|NCT01243151|464396338|FG000|Overall Study|Adverse Event|0|||
129028604|NCT01243151|464396339|FG001|Overall Study|Adverse Event|1|||
129028605|NCT01243151|464396340|FG002|Overall Study|Adverse Event|0|||
129028606|NCT01243151|464396341|FG003|Overall Study|Adverse Event|0|||
129028607|NCT01243151|464396342|FG004|Overall Study|Adverse Event|0|||
129028608|NCT01243151|464396338|FG000|Overall Study|Protocol Violation|0|||
129028609|NCT01243151|464396339|FG001|Overall Study|Protocol Violation|0|||
129028610|NCT01243151|464396340|FG002|Overall Study|Protocol Violation|1|||
129028611|NCT01243151|464396341|FG003|Overall Study|Protocol Violation|0|||
129028612|NCT01243151|464396342|FG004|Overall Study|Protocol Violation|0|||
129028613|NCT01243151|464396338|FG000|Overall Study|Other|0|||
129028614|NCT01243151|464396339|FG001|Overall Study|Other|0|||
129028615|NCT01243151|464396340|FG002|Overall Study|Other|0|||
129028616|NCT01243151|464396341|FG003|Overall Study|Other|1|||
129028617|NCT01243151|464396342|FG004|Overall Study|Other|0|||
129028618|NCT01243151|464396338|FG000|Overall Study|Randomized but not treated|0|||
129028619|NCT01243151|464396339|FG001|Overall Study|Randomized but not treated|0|||
129028620|NCT01243151|464396340|FG002|Overall Study|Randomized but not treated|0|||
129028621|NCT01243151|464396341|FG003|Overall Study|Randomized but not treated|1|||
129028622|NCT01243151|464396342|FG004|Overall Study|Randomized but not treated|0|||
129028623|NCT02308241|464396345|FG000|Overall Study|Withdrawal by Subject|3|||
129028624|NCT04408924|464396346|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
129028625|NCT04408924|464396346|FG000|Overall Study|Lost to Follow-up|3|||
129028626|NCT04408924|464396346|FG000|Overall Study|Withdrawal by Subject|5|||
129028627|NCT04408924|464396346|FG000|Overall Study|Sponsor Decision|2|||
129028628|NCT02578641|464396347|FG000|Overall Study|Adverse Event|5|||
129028629|NCT02578641|464396348|FG001|Overall Study|Adverse Event|15|||
129028630|NCT02578641|464396347|FG000|Overall Study|Death|16|||
129118667|NCT01027845|464731185|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
129118668|NCT01027845|464731182|FG000|Primary Vaccination Phase|Adverse Event|1|||
129118669|NCT01027845|464731183|FG001|Primary Vaccination Phase|Adverse Event|0|||
128697011|NCT02319837|463188983|FG001|Study Treatment Phase|Adverse Event|36|||
128697012|NCT02319837|463188984|FG002|Study Treatment Phase|Adverse Event|63|||
128697013|NCT02319837|463188982|FG000|Study Treatment Phase|Development of castration resistance|0|||
128697014|NCT02319837|463188983|FG001|Study Treatment Phase|Development of castration resistance|2|||
128697015|NCT02319837|463188984|FG002|Study Treatment Phase|Development of castration resistance|0|||
128697016|NCT02319837|463188982|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
128697017|NCT02319837|463188983|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
128697018|NCT02319837|463188984|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
128697019|NCT02319837|463188982|FG000|Study Treatment Phase|Protocol Violation|2|||
128697020|NCT02319837|463188983|FG001|Study Treatment Phase|Protocol Violation|2|||
128697021|NCT02319837|463188984|FG002|Study Treatment Phase|Protocol Violation|1|||
128697022|NCT02319837|463188982|FG000|Study Treatment Phase|Lost to Follow-up|0|||
128697023|NCT02319837|463188983|FG001|Study Treatment Phase|Lost to Follow-up|1|||
128697024|NCT02319837|463188984|FG002|Study Treatment Phase|Lost to Follow-up|0|||
128697025|NCT02319837|463188982|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
128717878|NCT02113956|463264076|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
128765386|NCT02969525|463432139|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
129028631|NCT02578641|464396348|FG001|Overall Study|Death|8|||
129028632|NCT02578641|464396347|FG000|Overall Study|Lost to Follow-up|0|||
129028633|NCT02578641|464396348|FG001|Overall Study|Lost to Follow-up|1|||
129028634|NCT02578641|464396347|FG000|Overall Study|Withdrawal by Subject|14|||
129028635|NCT02578641|464396348|FG001|Overall Study|Withdrawal by Subject|7|||
129028636|NCT02578641|464396347|FG000|Overall Study|Progressive Disease|69|||
129028637|NCT02578641|464396348|FG001|Overall Study|Progressive Disease|21|||
129028638|NCT02578641|464396347|FG000|Overall Study|No Study Drug|2|||
129028639|NCT02578641|464396348|FG001|Overall Study|No Study Drug|0|||
129028640|NCT02578641|464396347|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
129118670|NCT01027845|464731184|FG002|Primary Vaccination Phase|Adverse Event|0|||
128912071|NCT00662792|463969279|FG003|Period 1|Worsening of disease under study (AE)|0|||
128912072|NCT00662792|463969276|FG000|Period 1|Not treated|0|||
128912073|NCT00662792|463969277|FG001|Period 1|Not treated|1|||
128912074|NCT00662792|463969278|FG002|Period 1|Not treated|0|||
128912075|NCT00662792|463969279|FG003|Period 1|Not treated|0|||
128912076|NCT00662792|463969276|FG000|Period 2|Worsening of disease under study|1|||
128912077|NCT00662792|463969277|FG001|Period 2|Worsening of disease under study|0|||
128912078|NCT00662792|463969278|FG002|Period 2|Worsening of disease under study|0|||
128697026|NCT02319837|463188983|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
128697027|NCT02319837|463188984|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
128697028|NCT02319837|463188982|FG000|Study Treatment Phase|Other|0|||
128912079|NCT00662792|463969279|FG003|Period 2|Worsening of disease under study|3|||
128912080|NCT00662792|463969276|FG000|Period 3|Refused continuing medication|1|||
128912081|NCT00662792|463969277|FG001|Period 3|Refused continuing medication|0|||
128912082|NCT00662792|463969278|FG002|Period 3|Refused continuing medication|1|||
128912083|NCT00662792|463969279|FG003|Period 3|Refused continuing medication|0|||
128912084|NCT00662792|463969276|FG000|Period 3|Other adverse event (AE)|0|||
128912085|NCT00662792|463969277|FG001|Period 3|Other adverse event (AE)|0|||
128912086|NCT00662792|463969278|FG002|Period 3|Other adverse event (AE)|1|||
128912087|NCT00662792|463969279|FG003|Period 3|Other adverse event (AE)|1|||
128912088|NCT00662792|463969276|FG000|Period 4|Refused continuing medication|0|||
128912089|NCT00662792|463969277|FG001|Period 4|Refused continuing medication|1|||
128912090|NCT00662792|463969278|FG002|Period 4|Refused continuing medication|0|||
128912091|NCT00662792|463969279|FG003|Period 4|Refused continuing medication|0|||
128912092|NCT00662792|463969276|FG000|Period 4|Other adverse event (AE)|1|||
128912093|NCT00662792|463969277|FG001|Period 4|Other adverse event (AE)|0|||
128912094|NCT00662792|463969278|FG002|Period 4|Other adverse event (AE)|0|||
128697029|NCT02319837|463188983|FG001|Study Treatment Phase|Other|1|||
128912095|NCT00662792|463969279|FG003|Period 4|Other adverse event (AE)|0|||
128912096|NCT00662792|463969276|FG000|Period 4|Worsening of disease under study (AE)|0|||
128697030|NCT02319837|463188984|FG002|Study Treatment Phase|Other|0|||
128697031|NCT02319837|463188982|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
128697032|NCT02319837|463188983|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
128697033|NCT02319837|463188984|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
128697034|NCT02319837|463188982|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
128697035|NCT02319837|463188983|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
128697036|NCT02319837|463188984|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
128765387|NCT02969525|463432140|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
128765388|NCT02969525|463432141|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
128912097|NCT00662792|463969277|FG001|Period 4|Worsening of disease under study (AE)|0|||
128912098|NCT00662792|463969278|FG002|Period 4|Worsening of disease under study (AE)|0|||
128912099|NCT00662792|463969279|FG003|Period 4|Worsening of disease under study (AE)|1|||
128912100|NCT01699087|463969281|FG000|Overall Study|Lost to Follow-up|7|||
128912101|NCT01699087|463969281|FG000|Overall Study|Screen failure (prior to treatment)|15|||
128912102|NCT01699087|463969281|FG000|Overall Study|Unable to make future visits|2|||
128912103|NCT03021642|463969284|FG000|Washout Period (21 Days)|Adverse Event|1|||
128912104|NCT03021642|463969285|FG001|Washout Period (21 Days)|Adverse Event|1|||
128912105|NCT00090545|463969286|FG000|Overall Study|Disease progression on study|21|||
128912106|NCT00090545|463969287|FG001|Overall Study|Disease progression on study|17|||
128912107|NCT00090545|463969286|FG000|Overall Study|Refused further treatment|1|||
128912108|NCT00090545|463969287|FG001|Overall Study|Refused further treatment|4|||
128912109|NCT00090545|463969286|FG000|Overall Study|Death|0|||
128912110|NCT00090545|463969287|FG001|Overall Study|Death|1|||
128912111|NCT00090545|463969286|FG000|Overall Study|Adverse Event|0|||
128912112|NCT00090545|463969287|FG001|Overall Study|Adverse Event|2|||
128912113|NCT00441545|463969288|FG000|First Intervention|Adverse Event|6|||
128912114|NCT00441545|463969289|FG001|First Intervention|Adverse Event|5|||
128912115|NCT00441545|463969288|FG000|First Intervention|Protocol Violation|2|||
128912116|NCT00441545|463969289|FG001|First Intervention|Protocol Violation|2|||
128912117|NCT00441545|463969288|FG000|First Intervention|Withdrawal by Subject|3|||
128912118|NCT00441545|463969289|FG001|First Intervention|Withdrawal by Subject|3|||
128912119|NCT00441545|463969288|FG000|First Intervention|Kidney transplant|1|||
128912120|NCT00441545|463969289|FG001|First Intervention|Kidney transplant|1|||
128912121|NCT00441545|463969288|FG000|First Intervention|Lack of Efficacy|2|||
129028641|NCT02578641|464396348|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
129028642|NCT02578641|464396347|FG000|Overall Study|Non-compliance with Study Schedule|1|||
129028643|NCT02578641|464396348|FG001|Overall Study|Non-compliance with Study Schedule|0|||
128912122|NCT00441545|463969289|FG001|First Intervention|Lack of Efficacy|0|||
128912123|NCT00441545|463969288|FG000|First Intervention|Subject exceeded safety criteria|0|||
128912124|NCT00441545|463969289|FG001|First Intervention|Subject exceeded safety criteria|1|||
128912125|NCT00441545|463969288|FG000|First Intervention|Subject met an exclusionary criteria|1|||
129028644|NCT02578641|464396347|FG000|Overall Study|Other|1|||
128912126|NCT00441545|463969289|FG001|First Intervention|Subject met an exclusionary criteria|0|||
128912127|NCT00441545|463969288|FG000|First Intervention|Extended hospitalization|1|||
128912128|NCT00441545|463969289|FG001|First Intervention|Extended hospitalization|0|||
128912129|NCT00441545|463969288|FG000|First Intervention|Site error|1|||
128912130|NCT00441545|463969289|FG001|First Intervention|Site error|0|||
128912131|NCT00441545|463969288|FG000|First Intervention|Sponsor's request|1|||
128912132|NCT00441545|463969289|FG001|First Intervention|Sponsor's request|0|||
128912133|NCT00441545|463969288|FG000|Second Intervention|Adverse Event|5|||
128912134|NCT00441545|463969289|FG001|Second Intervention|Adverse Event|2|||
128912135|NCT00441545|463969288|FG000|Second Intervention|Protocol Violation|4|||
128912136|NCT00441545|463969289|FG001|Second Intervention|Protocol Violation|1|||
128912137|NCT00441545|463969288|FG000|Second Intervention|Withdrawal by Subject|1|||
128912138|NCT00441545|463969289|FG001|Second Intervention|Withdrawal by Subject|1|||
128912139|NCT00441545|463969288|FG000|Second Intervention|Kidney Transplant|1|||
128912140|NCT00441545|463969289|FG001|Second Intervention|Kidney Transplant|1|||
128912141|NCT00441545|463969288|FG000|Second Intervention|Lack of Efficacy|0|||
128912142|NCT00441545|463969289|FG001|Second Intervention|Lack of Efficacy|1|||
128912143|NCT00441545|463969288|FG000|Second Intervention|Subject exceeded safety criteria|1|||
128912144|NCT00441545|463969289|FG001|Second Intervention|Subject exceeded safety criteria|0|||
128912145|NCT00441545|463969288|FG000|Second Intervention|Subject moved|0|||
128912146|NCT00441545|463969289|FG001|Second Intervention|Subject moved|1|||
128912147|NCT02474082|463969290|FG000|Overall Study|Adverse Event|2|||
128912148|NCT02474082|463969291|FG001|Overall Study|Adverse Event|32|||
128912149|NCT02474082|463969290|FG000|Overall Study|Withdrawal of informed consent|1|||
128912150|NCT02474082|463969291|FG001|Overall Study|Withdrawal of informed consent|11|||
128912151|NCT02474082|463969290|FG000|Overall Study|Lost to Follow-up|2|||
128912152|NCT02474082|463969291|FG001|Overall Study|Lost to Follow-up|2|||
128912153|NCT02474082|463969290|FG000|Overall Study|Dose tapering not achieved|0|||
128912154|NCT02474082|463969291|FG001|Overall Study|Dose tapering not achieved|4|||
128912155|NCT02474082|463969290|FG000|Overall Study|Participant/guardian decision|1|||
128912156|NCT02474082|463969291|FG001|Overall Study|Participant/guardian decision|2|||
128912157|NCT02474082|463969290|FG000|Overall Study|Non-compliance with study treatment|0|||
128912158|NCT02474082|463969291|FG001|Overall Study|Non-compliance with study treatment|2|||
128912159|NCT02474082|463969290|FG000|Overall Study|Protocol deviation|0|||
128912160|NCT02474082|463969291|FG001|Overall Study|Protocol deviation|1|||
128912161|NCT02809833|463969298|FG000|Overall Study|Death|3|||
128912162|NCT02809833|463969298|FG000|Overall Study|Intolerance|54|||
128912163|NCT02809833|463969298|FG000|Overall Study|Lack of Efficacy|89|||
128912164|NCT02809833|463969298|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
128912165|NCT02809833|463969298|FG000|Overall Study|Noncompliance|1|||
128912166|NCT02809833|463969298|FG000|Overall Study|Withdrawal by Subject|34|||
128912167|NCT02809833|463969298|FG000|Overall Study|Lost to Follow-up|35|||
128912168|NCT02809833|463969298|FG000|Overall Study|Adverse Event (AE)|24|||
128912169|NCT02809833|463969298|FG000|Overall Study|Other|5|||
128912170|NCT02809833|463969298|FG000|Overall Study|Missing Information|52|||
128912171|NCT00523991|463969299|FG000|Overall Study|Adverse Event|6|||
128912172|NCT00523991|463969300|FG001|Overall Study|Adverse Event|5|||
129118671|NCT01027845|464731185|FG003|Primary Vaccination Phase|Adverse Event|0|||
129118672|NCT01027845|464731182|FG000|Primary Vaccination Phase|Protocol Violation|1|||
129118673|NCT01027845|464731183|FG001|Primary Vaccination Phase|Protocol Violation|0|||
129118674|NCT01027845|464731184|FG002|Primary Vaccination Phase|Protocol Violation|0|||
129118675|NCT01027845|464731185|FG003|Primary Vaccination Phase|Protocol Violation|0|||
129118676|NCT01027845|464731182|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
129118677|NCT01027845|464731183|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
129118678|NCT01027845|464731184|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
129118679|NCT01027845|464731185|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
129118680|NCT01027845|464731182|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
129118681|NCT01027845|464731183|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129118682|NCT01027845|464731184|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
128912173|NCT00523991|463969299|FG000|Overall Study|Protocol Violation|1|||
128912174|NCT00523991|463969300|FG001|Overall Study|Protocol Violation|4|||
128912175|NCT00523991|463969299|FG000|Overall Study|Lost to Follow-up|4|||
128912176|NCT00523991|463969300|FG001|Overall Study|Lost to Follow-up|1|||
128912177|NCT00523991|463969299|FG000|Overall Study|Withdrawal by Subject|7|||
128912178|NCT00523991|463969300|FG001|Overall Study|Withdrawal by Subject|17|||
128912179|NCT00523991|463969299|FG000|Overall Study|Other reason (not specified)|3|||
128912180|NCT00523991|463969300|FG001|Overall Study|Other reason (not specified)|0|||
128912181|NCT00193063|463969301|FG000|Overall Study|Lack of Efficacy|3|||
128912182|NCT00193063|463969301|FG000|Overall Study|Adverse Event|1|||
128912183|NCT00744874|463969302|FG000|Overall Study|Lost to Follow-up|1|||
129118683|NCT01027845|464731185|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
129118684|NCT01027845|464731182|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
129118685|NCT01027845|464731183|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
129118686|NCT01027845|464731184|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
129215641|NCT02079246|465092785|FG001|OLEX-MEM|Adverse Event|6|||
128912184|NCT00744874|463969302|FG000|Overall Study|Withdrawal by Subject|1|||
128912185|NCT00744874|463969302|FG000|Overall Study|Study Device not available at procedure|1|||
128912186|NCT00744874|463969302|FG000|Overall Study|Unable to accomodate schedule|1|||
128912187|NCT01127165|463969303|FG000|Overall Study|Adverse Event|2|||
128912188|NCT01127165|463969304|FG001|Overall Study|Adverse Event|2|||
128912189|NCT01127165|463969303|FG000|Overall Study|Lack of Efficacy|10|||
128912190|NCT01127165|463969304|FG001|Overall Study|Lack of Efficacy|8|||
128912191|NCT01127165|463969303|FG000|Overall Study|Lost to Follow-up|3|||
128912192|NCT01127165|463969304|FG001|Overall Study|Lost to Follow-up|5|||
128697037|NCT02319837|463188982|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
128697038|NCT02319837|463188983|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
128697039|NCT02319837|463188984|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
128697040|NCT02319837|463188982|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
128697041|NCT02319837|463188983|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
128697042|NCT02319837|463188984|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
128697043|NCT02319837|463188982|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
128697044|NCT02319837|463188983|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
128697045|NCT02319837|463188984|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
128697046|NCT02319837|463188982|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
128697047|NCT02319837|463188983|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
128697048|NCT02319837|463188984|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
128912193|NCT01127165|463969303|FG000|Overall Study|Withdrawal by Subject|1|||
128912194|NCT01127165|463969304|FG001|Overall Study|Withdrawal by Subject|3|||
128912195|NCT01127165|463969303|FG000|Overall Study|Protocol Violation|0|||
128912196|NCT01127165|463969304|FG001|Overall Study|Protocol Violation|1|||
128912197|NCT00763321|463969305|FG000|Open-label Period|Adverse Event|24|||
128912198|NCT00763321|463969306|FG001|Open-label Period|Adverse Event|0|||
128912199|NCT00763321|463969307|FG002|Open-label Period|Adverse Event|0|||
128912200|NCT00763321|463969305|FG000|Open-label Period|Lost to Follow-up|14|||
128912201|NCT00763321|463969306|FG001|Open-label Period|Lost to Follow-up|0|||
128912202|NCT00763321|463969307|FG002|Open-label Period|Lost to Follow-up|0|||
128912203|NCT00763321|463969305|FG000|Open-label Period|Withdrawal by Subject|7|||
128912204|NCT00763321|463969306|FG001|Open-label Period|Withdrawal by Subject|0|||
128912205|NCT00763321|463969307|FG002|Open-label Period|Withdrawal by Subject|0|||
128912206|NCT00763321|463969305|FG000|Open-label Period|Subject noncompliant|7|||
128912207|NCT00763321|463969306|FG001|Open-label Period|Subject noncompliant|0|||
128912208|NCT00763321|463969307|FG002|Open-label Period|Subject noncompliant|0|||
128912209|NCT00763321|463969305|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
128912210|NCT00763321|463969306|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
128912211|NCT00763321|463969307|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
128912212|NCT00763321|463969305|FG000|Open-label Period|Lack of Efficacy|2|||
128912213|NCT00763321|463969306|FG001|Open-label Period|Lack of Efficacy|0|||
128912214|NCT00763321|463969307|FG002|Open-label Period|Lack of Efficacy|0|||
128912215|NCT00763321|463969305|FG000|Open-label Period|Other|4|||
128912216|NCT00763321|463969306|FG001|Open-label Period|Other|0|||
128912217|NCT00763321|463969307|FG002|Open-label Period|Other|0|||
128912218|NCT00763321|463969305|FG000|Double-blind Period|Lack of Efficacy|0|||
128912219|NCT00763321|463969306|FG001|Double-blind Period|Lack of Efficacy|9|||
128912220|NCT00763321|463969307|FG002|Double-blind Period|Lack of Efficacy|17|||
128912221|NCT00763321|463969305|FG000|Double-blind Period|Adverse Event|0|||
128912222|NCT00763321|463969306|FG001|Double-blind Period|Adverse Event|4|||
128912223|NCT00763321|463969307|FG002|Double-blind Period|Adverse Event|4|||
128912224|NCT00763321|463969305|FG000|Double-blind Period|Lost to Follow-up|0|||
128912225|NCT00763321|463969306|FG001|Double-blind Period|Lost to Follow-up|4|||
128912226|NCT00763321|463969307|FG002|Double-blind Period|Lost to Follow-up|2|||
128912227|NCT00763321|463969305|FG000|Double-blind Period|Withdrawal by Subject|0|||
128912228|NCT00763321|463969306|FG001|Double-blind Period|Withdrawal by Subject|2|||
128912229|NCT00763321|463969307|FG002|Double-blind Period|Withdrawal by Subject|3|||
128912230|NCT00763321|463969305|FG000|Double-blind Period|Other|0|||
129028645|NCT02578641|464396348|FG001|Overall Study|Other|10|||
128912231|NCT00763321|463969306|FG001|Double-blind Period|Other|2|||
128912232|NCT00763321|463969307|FG002|Double-blind Period|Other|3|||
128912233|NCT03175549|463969308|FG000|Overall Study|Lost to Follow-up|2|||
129028646|NCT02578641|464396347|FG000|Overall Study|Not treated|1|||
129028647|NCT02578641|464396348|FG001|Overall Study|Not treated|4|||
129028648|NCT00084864|464396351|FG000|Overall Study|Adverse Event|1|||
129028649|NCT00084864|464396352|FG001|Overall Study|Adverse Event|0|||
129028650|NCT00084864|464396353|FG002|Overall Study|Adverse Event|0|||
129028651|NCT00084864|464396354|FG003|Overall Study|Adverse Event|0|||
128912234|NCT03175549|463969309|FG001|Overall Study|Lost to Follow-up|2|||
128912235|NCT03175549|463969308|FG000|Overall Study|Medication non-compliance|2|||
128912236|NCT03175549|463969309|FG001|Overall Study|Medication non-compliance|2|||
129028652|NCT01741545|464396355|FG000|Treatment Period|Lack of Efficacy|0|||
128912237|NCT02435849|463969310|FG000|Overall Study|Death|23|||
128912238|NCT02435849|463969311|FG001|Overall Study|Death|0|||
128912239|NCT02435849|463969310|FG000|Overall Study|Lack of Efficacy|10|||
128912240|NCT02435849|463969311|FG001|Overall Study|Lack of Efficacy|0|||
128912241|NCT02435849|463969310|FG000|Overall Study|New therapy for study indication|8|||
128912242|NCT02435849|463969311|FG001|Overall Study|New therapy for study indication|0|||
128912243|NCT02435849|463969310|FG000|Overall Study|Subject/guardian decision|5|||
128912244|NCT02435849|463969311|FG001|Overall Study|Subject/guardian decision|1|||
128912245|NCT02435849|463969310|FG000|Overall Study|Lost to Follow-up|1|||
128912246|NCT02435849|463969311|FG001|Overall Study|Lost to Follow-up|0|||
128912247|NCT02435849|463969310|FG000|Overall Study|Physician Decision|1|||
128912248|NCT02435849|463969311|FG001|Overall Study|Physician Decision|0|||
128912249|NCT02486757|463969312|FG000|Overall Study|Lost to Follow-up|1|||
128912250|NCT01913483|463969318|FG000|Overall Study|Withdrawal by Subject|1|||
128912251|NCT01913483|463969319|FG001|Overall Study|Withdrawal by Subject|2|||
128912252|NCT01913483|463969318|FG000|Overall Study|Lost to Follow-up|6|||
128912253|NCT01913483|463969319|FG001|Overall Study|Lost to Follow-up|3|||
129028653|NCT01741545|464396356|FG001|Treatment Period|Lack of Efficacy|1|||
129028654|NCT01741545|464396355|FG000|Treatment Period|Adverse event, non-fatal|1|||
129028655|NCT01741545|464396356|FG001|Treatment Period|Adverse event, non-fatal|3|||
129028656|NCT01741545|464396355|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
129028657|NCT01741545|464396356|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
129028658|NCT01741545|464396355|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
129028659|NCT01741545|464396356|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
129028660|NCT01456962|464396357|FG000|Overall Study|Lost to Follow-up|2|||
129028661|NCT01456962|464396358|FG001|Overall Study|Lost to Follow-up|1|||
129028662|NCT01853176|464396359|FG000|Overall Study|Study terminated|4|||
129028663|NCT01853176|464396360|FG001|Overall Study|Study terminated|0|||
129028664|NCT00198133|464396361|FG000|Overall Study|Disease progression|2|||
129028665|NCT00198133|464396362|FG001|Overall Study|Disease progression|5|||
129028666|NCT00198133|464396361|FG000|Overall Study|Adverse Event|1|||
129028667|NCT00198133|464396362|FG001|Overall Study|Adverse Event|3|||
129028668|NCT00198133|464396361|FG000|Overall Study|Withdrawal by Subject|1|||
129028669|NCT00198133|464396362|FG001|Overall Study|Withdrawal by Subject|0|||
129028670|NCT00198133|464396361|FG000|Overall Study|Physician Decision|1|||
129028671|NCT00198133|464396362|FG001|Overall Study|Physician Decision|0|||
129028672|NCT01537887|464396368|FG000|Period 1|Physician Decision|0|||
129028673|NCT01537887|464396369|FG001|Period 1|Physician Decision|0|||
128697049|NCT02319837|463188982|FG000|Long-Term Follow-Up Phase|Death|33|||
128697050|NCT02319837|463188983|FG001|Long-Term Follow-Up Phase|Death|54|||
128697051|NCT02319837|463188984|FG002|Long-Term Follow-Up Phase|Death|42|||
128697052|NCT04545554|463188989|FG000|Overall Study|Withdrawal by Subject|0|||
128697053|NCT04545554|463188990|FG001|Overall Study|Withdrawal by Subject|0|||
128697054|NCT04545554|463188991|FG002|Overall Study|Withdrawal by Subject|0|||
128697055|NCT04545554|463188992|FG003|Overall Study|Withdrawal by Subject|1|||
128697056|NCT04545554|463188993|FG004|Overall Study|Withdrawal by Subject|0|||
128697057|NCT04545554|463188994|FG005|Overall Study|Withdrawal by Subject|0|||
128697058|NCT00415168|463188995|FG000|Overall Study|Death|26|||
128697059|NCT00415168|463188995|FG000|Overall Study|Lost to Follow-up|3|||
128697060|NCT00415168|463188995|FG000|Overall Study|Physician Decision|13|||
128697061|NCT00415168|463188995|FG000|Overall Study|Sponsor Decision|4|||
128697062|NCT00415168|463188995|FG000|Overall Study|Withdrawal by Subject|6|||
128697063|NCT02925117|463188998|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
128697064|NCT02925117|463188999|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
128697065|NCT02925117|463189000|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
128697066|NCT02925117|463189001|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
128697067|NCT02925117|463189002|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697068|NCT02925117|463189003|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697069|NCT02925117|463189004|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697070|NCT02925117|463189005|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697071|NCT02925117|463189006|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697072|NCT02925117|463189007|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697073|NCT02925117|463189008|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697074|NCT02925117|463189009|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
128697075|NCT02925117|463188998|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
128697076|NCT02925117|463188999|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
128697077|NCT02925117|463189000|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
128765389|NCT02969525|463432142|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
128912254|NCT01913483|463969318|FG000|Overall Study|Death|14|||
128912255|NCT01913483|463969319|FG001|Overall Study|Death|17|||
128912256|NCT00915343|463969320|FG000|Part B - Open Label Period|Treatment switch|0|||
128912257|NCT00915343|463969321|FG001|Part B - Open Label Period|Treatment switch|0|||
128912258|NCT00915343|463969322|FG002|Part B - Open Label Period|Treatment switch|1|||
128912259|NCT00915343|463969320|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
129028674|NCT01537887|464396370|FG002|Period 1|Physician Decision|0|||
129028675|NCT01537887|464396371|FG003|Period 1|Physician Decision|0|||
129028676|NCT01537887|464396372|FG004|Period 1|Physician Decision|1|||
128912260|NCT00915343|463969321|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
128912261|NCT00915343|463969322|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
128912262|NCT01920711|463969323|FG000|Overall Study|Death|347|||
128912263|NCT01920711|463969324|FG001|Overall Study|Death|356|||
128912264|NCT01920711|463969323|FG000|Overall Study|Lost to Follow-up|13|||
128912265|NCT01920711|463969324|FG001|Overall Study|Lost to Follow-up|14|||
128912266|NCT01920711|463969323|FG000|Overall Study|Withdrawal by Subject|4|||
128912267|NCT01920711|463969324|FG001|Overall Study|Withdrawal by Subject|3|||
128912268|NCT01145066|463969325|FG000|Overall Study|To resume NSAIDs|2|||
128912269|NCT01145066|463969326|FG001|Overall Study|To resume NSAIDs|2|||
128912270|NCT01145066|463969327|FG002|Overall Study|To resume NSAIDs|1|||
128912271|NCT01145066|463969325|FG000|Overall Study|Non-related surgery|0|||
128912272|NCT01145066|463969326|FG001|Overall Study|Non-related surgery|0|||
128912273|NCT01145066|463969327|FG002|Overall Study|Non-related surgery|1|||
128912274|NCT01145066|463969325|FG000|Overall Study|Withdrawal by Subject|0|||
128912275|NCT01145066|463969326|FG001|Overall Study|Withdrawal by Subject|0|||
128912276|NCT01145066|463969327|FG002|Overall Study|Withdrawal by Subject|2|||
128912277|NCT01145066|463969325|FG000|Overall Study|To start new med|1|||
128912278|NCT01145066|463969326|FG001|Overall Study|To start new med|0|||
128912279|NCT01145066|463969327|FG002|Overall Study|To start new med|0|||
128912280|NCT01145066|463969325|FG000|Overall Study|problems swallowing capsule|1|||
128912281|NCT01145066|463969326|FG001|Overall Study|problems swallowing capsule|0|||
128912282|NCT01145066|463969327|FG002|Overall Study|problems swallowing capsule|0|||
128912283|NCT01145066|463969325|FG000|Overall Study|Abdominal discomfort|0|||
128912284|NCT01145066|463969326|FG001|Overall Study|Abdominal discomfort|1|||
128912285|NCT01145066|463969327|FG002|Overall Study|Abdominal discomfort|0|||
128912286|NCT01145066|463969325|FG000|Overall Study|Low platelet count|0|||
128912287|NCT01145066|463969326|FG001|Overall Study|Low platelet count|1|||
128912288|NCT01145066|463969327|FG002|Overall Study|Low platelet count|0|||
128912289|NCT03687502|463969332|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
128912290|NCT03687502|463969332|FG000|Overall Study|Lumason not available|1|||
128912291|NCT01724528|463969336|FG000|Overall Study|Death|3|||
128912292|NCT01724528|463969337|FG001|Overall Study|Death|0|||
128912293|NCT01724528|463969336|FG000|Overall Study|Withdrawal by Subject|0|||
128912294|NCT01724528|463969337|FG001|Overall Study|Withdrawal by Subject|2|||
128912295|NCT01724528|463969336|FG000|Overall Study|Protocol Violation|0|||
128912296|NCT01724528|463969337|FG001|Overall Study|Protocol Violation|1|||
128912297|NCT01724528|463969336|FG000|Overall Study|Patient refused to attend last visit|1|||
128912298|NCT01724528|463969337|FG001|Overall Study|Patient refused to attend last visit|0|||
128912299|NCT01634555|463969341|FG000|Overall Study|Adverse Event|3|||
128912300|NCT01634555|463969341|FG000|Overall Study|Physician Decision|1|||
128912301|NCT06228586|463969342|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
128912302|NCT06228586|463969343|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
128912303|NCT01227902|463970750|FG000|Overall Study|Adverse Event|12|||
128912304|NCT01227902|463970751|FG001|Overall Study|Adverse Event|8|||
128912305|NCT01227902|463970752|FG002|Overall Study|Adverse Event|11|||
128912306|NCT01227902|463970753|FG003|Overall Study|Adverse Event|4|||
128912307|NCT01227902|463970750|FG000|Overall Study|Lack of Efficacy|1|||
128912308|NCT01227902|463970751|FG001|Overall Study|Lack of Efficacy|2|||
128912309|NCT01227902|463970752|FG002|Overall Study|Lack of Efficacy|2|||
128912310|NCT01227902|463970753|FG003|Overall Study|Lack of Efficacy|1|||
128912311|NCT01227902|463970750|FG000|Overall Study|Protocol Violation|1|||
128912312|NCT01227902|463970751|FG001|Overall Study|Protocol Violation|0|||
128912313|NCT01227902|463970752|FG002|Overall Study|Protocol Violation|0|||
129215642|NCT02079246|465092784|FG000|OLEX-MEM|Withdrawal by Subject|0|||
129215643|NCT02079246|465092785|FG001|OLEX-MEM|Withdrawal by Subject|7|||
129215644|NCT02079246|465092784|FG000|OLEX-MEM|Protocol Violation|0|||
129215645|NCT02079246|465092785|FG001|OLEX-MEM|Protocol Violation|2|||
129215646|NCT02079246|465092784|FG000|OLEX-MEM|Lost to Follow-up|0|||
129215647|NCT02079246|465092785|FG001|OLEX-MEM|Lost to Follow-up|1|||
128697078|NCT02925117|463189001|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128697079|NCT02925117|463189002|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128912314|NCT01227902|463970753|FG003|Overall Study|Protocol Violation|0|||
128912315|NCT01227902|463970750|FG000|Overall Study|Lost to Follow-up|0|||
128912316|NCT01227902|463970751|FG001|Overall Study|Lost to Follow-up|0|||
128912317|NCT01227902|463970752|FG002|Overall Study|Lost to Follow-up|1|||
128912318|NCT01227902|463970753|FG003|Overall Study|Lost to Follow-up|2|||
128912319|NCT01227902|463970750|FG000|Overall Study|Physician Decision|0|||
128912320|NCT01227902|463970751|FG001|Overall Study|Physician Decision|1|||
128912321|NCT01227902|463970752|FG002|Overall Study|Physician Decision|1|||
128912322|NCT01227902|463970753|FG003|Overall Study|Physician Decision|0|||
128912323|NCT01227902|463970750|FG000|Overall Study|Withdrawal by Subject|4|||
128912324|NCT01227902|463970751|FG001|Overall Study|Withdrawal by Subject|2|||
128912325|NCT01227902|463970752|FG002|Overall Study|Withdrawal by Subject|4|||
128912326|NCT01227902|463970753|FG003|Overall Study|Withdrawal by Subject|3|||
129215648|NCT02079246|465092784|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
129215649|NCT02079246|465092785|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
128912327|NCT01299766|463970757|FG000|Overall Study|Death|5|||
128912328|NCT01299766|463970758|FG001|Overall Study|Death|4|||
128912329|NCT01299766|463970757|FG000|Overall Study|Withdrawal by Subject|29|||
128912330|NCT01299766|463970758|FG001|Overall Study|Withdrawal by Subject|19|||
128912331|NCT00403260|463970759|FG000|Overall Study|Adverse Event|5|||
128912332|NCT00403260|463970760|FG001|Overall Study|Adverse Event|4|||
128912333|NCT00403260|463970759|FG000|Overall Study|Withdrawal by Subject|5|||
128912334|NCT00403260|463970760|FG001|Overall Study|Withdrawal by Subject|6|||
128912335|NCT00403260|463970759|FG000|Overall Study|Lost to Follow-up|49|||
128912336|NCT00403260|463970760|FG001|Overall Study|Lost to Follow-up|25|||
128912337|NCT00403260|463970759|FG000|Overall Study|Re-appearance of P. falciparum|34|||
128912338|NCT00403260|463970760|FG001|Overall Study|Re-appearance of P. falciparum|25|||
128912339|NCT00403260|463970759|FG000|Overall Study|P. vivax infection|26|||
128912340|NCT00403260|463970760|FG001|Overall Study|P. vivax infection|4|||
128912341|NCT00403260|463970759|FG000|Overall Study|Mixed infection with P. vivax|2|||
128912342|NCT00403260|463970760|FG001|Overall Study|Mixed infection with P. vivax|0|||
128912343|NCT00403260|463970759|FG000|Overall Study|Mixed infection with P. falciparum|1|||
128912344|NCT00403260|463970760|FG001|Overall Study|Mixed infection with P. falciparum|0|||
128912345|NCT00403260|463970759|FG000|Overall Study|P. vivax infection at screening|1|||
128912346|NCT00403260|463970760|FG001|Overall Study|P. vivax infection at screening|0|||
128912347|NCT00403260|463970759|FG000|Overall Study|P. ovale infection|1|||
128912348|NCT00403260|463970760|FG001|Overall Study|P. ovale infection|0|||
128912349|NCT00403260|463970759|FG000|Overall Study|Gametocyte re-appearance|1|||
128912350|NCT00403260|463970760|FG001|Overall Study|Gametocyte re-appearance|1|||
128912351|NCT00403260|463970759|FG000|Overall Study|Withdrawn from study accidentally|0|||
128912352|NCT00403260|463970760|FG001|Overall Study|Withdrawn from study accidentally|1|||
128912353|NCT01354028|463970761|FG000|Overall Study|Physician Decision|0|||
128912354|NCT01354028|463970762|FG001|Overall Study|Physician Decision|2|||
128912355|NCT01354028|463970761|FG000|Overall Study|Discharged before study start|2|||
128912356|NCT01354028|463970762|FG001|Overall Study|Discharged before study start|2|||
128912357|NCT01354028|463970761|FG000|Overall Study|No quiet alert state|0|||
128912358|NCT01354028|463970762|FG001|Overall Study|No quiet alert state|1|||
128912359|NCT00935883|463970765|FG000|Treatment Period|Physician Decision|1|||
128912360|NCT00935883|463970766|FG001|Treatment Period|Physician Decision|0|||
128912361|NCT00935883|463970765|FG000|Treatment Period|Withdrawal by Subject|0|||
128912362|NCT00935883|463970766|FG001|Treatment Period|Withdrawal by Subject|2|||
128912363|NCT02971202|463970769|FG000|Overall Study|Pregnancy|1|||
128912364|NCT02971202|463970770|FG001|Overall Study|Pregnancy|0|||
128912365|NCT02971202|463970771|FG002|Overall Study|Pregnancy|0|||
128912366|NCT02971202|463970769|FG000|Overall Study|screen fail after consent|1|||
128912367|NCT02971202|463970770|FG001|Overall Study|screen fail after consent|0|||
128912368|NCT02971202|463970771|FG002|Overall Study|screen fail after consent|1|||
128912369|NCT01946178|463970772|FG000|Overall Study|Pregnancy|1|||
128912370|NCT01946178|463970772|FG000|Overall Study|Lost to Follow-up|1|||
128912371|NCT01505894|463970773|FG000|Overall Study|Adverse Event|1|||
128912372|NCT01505894|463970774|FG001|Overall Study|Adverse Event|0|||
128912373|NCT01505894|463970775|FG002|Overall Study|Adverse Event|0|||
128912374|NCT01505894|463970776|FG003|Overall Study|Adverse Event|0|||
128912375|NCT01505894|463970777|FG004|Overall Study|Adverse Event|0|||
128912376|NCT01505894|463970778|FG005|Overall Study|Adverse Event|0|||
128912377|NCT01505894|463970779|FG006|Overall Study|Adverse Event|0|||
128912378|NCT01505894|463970780|FG007|Overall Study|Adverse Event|0|||
128912379|NCT01505894|463970781|FG008|Overall Study|Adverse Event|0|||
128912380|NCT01505894|463970773|FG000|Overall Study|Other than specified|0|||
128912381|NCT01505894|463970774|FG001|Overall Study|Other than specified|0|||
128912382|NCT01505894|463970775|FG002|Overall Study|Other than specified|0|||
128912383|NCT01505894|463970776|FG003|Overall Study|Other than specified|0|||
128912384|NCT01505894|463970777|FG004|Overall Study|Other than specified|1|||
128912385|NCT01505894|463970778|FG005|Overall Study|Other than specified|0|||
128912386|NCT01505894|463970779|FG006|Overall Study|Other than specified|0|||
128912387|NCT01505894|463970780|FG007|Overall Study|Other than specified|0|||
128912388|NCT01505894|463970781|FG008|Overall Study|Other than specified|0|||
128697080|NCT02925117|463189003|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128697081|NCT02925117|463189004|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128912389|NCT01622569|463970782|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
128912390|NCT01622569|463970783|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
128912391|NCT01622569|463970784|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
128912392|NCT01622569|463970785|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
128912393|NCT01622569|463970782|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
128912394|NCT01622569|463970783|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
128912395|NCT01622569|463970784|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
128912396|NCT01622569|463970785|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
128912397|NCT01622569|463970782|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
128697082|NCT02925117|463189005|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128912398|NCT01622569|463970783|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
128912399|NCT01622569|463970784|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
128912400|NCT01622569|463970785|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
128912401|NCT01622569|463970782|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
128912402|NCT01622569|463970783|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
128912403|NCT01622569|463970784|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
128912404|NCT01622569|463970785|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
128912405|NCT01622569|463970782|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
128912406|NCT01622569|463970783|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
128912407|NCT01622569|463970784|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
128912408|NCT01622569|463970785|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
128912409|NCT01622569|463970782|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
128912410|NCT01622569|463970783|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
128912411|NCT01622569|463970784|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
128912412|NCT01622569|463970785|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
128912413|NCT01622569|463970782|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
128912414|NCT01622569|463970783|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
128912415|NCT01622569|463970784|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
128912416|NCT01622569|463970785|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
128912417|NCT01622569|463970782|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
128912418|NCT01622569|463970783|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
128912419|NCT01622569|463970784|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
128912420|NCT01622569|463970785|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
128912421|NCT01001702|463970786|FG000|Overall Study|Lost to Follow-up|7|||
128912422|NCT01001702|463970786|FG000|Overall Study|Adverse Event|7|||
128912423|NCT01001702|463970786|FG000|Overall Study|Sponsor Discontinued Study|4|||
128912424|NCT01001702|463970786|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
128912425|NCT01001702|463970786|FG000|Overall Study|Investigator withdrew Subject|10|||
128912426|NCT01001702|463970786|FG000|Overall Study|Withdrawal by Subject|19|||
128912427|NCT01001702|463970786|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
128912428|NCT00584233|463970789|FG000|Overall Study|Withdrawal by Subject|5|||
128912429|NCT00584233|463970789|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
128912430|NCT02222714|463970790|FG000|Overall Study|Death|0|||
128912431|NCT02222714|463970791|FG001|Overall Study|Death|2|||
128912432|NCT02222714|463970792|FG002|Overall Study|Death|3|||
128912433|NCT02222714|463970793|FG003|Overall Study|Death|4|||
128912434|NCT02222714|463970794|FG004|Overall Study|Death|6|||
128912435|NCT02222714|463970790|FG000|Overall Study|Withdrawal by Subject|0|||
128912436|NCT02222714|463970791|FG001|Overall Study|Withdrawal by Subject|0|||
128912437|NCT02222714|463970792|FG002|Overall Study|Withdrawal by Subject|1|||
128912438|NCT02222714|463970793|FG003|Overall Study|Withdrawal by Subject|0|||
128912439|NCT02222714|463970794|FG004|Overall Study|Withdrawal by Subject|1|||
128912440|NCT01940484|463970795|FG000|Overall Study|Withdrawal by Subject|3|||
128912441|NCT01940484|463970795|FG000|Overall Study|Underwent transplantation|4|||
128912442|NCT01940484|463970795|FG000|Overall Study|Death|2|||
128912443|NCT01940484|463970795|FG000|Overall Study|Adverse Event|1|||
128912444|NCT01340209|463970796|FG000|Overall Study|Adverse Event|1|||
128912445|NCT01340209|463970797|FG001|Overall Study|Adverse Event|1|||
128912446|NCT01340209|463970798|FG002|Overall Study|Adverse Event|2|||
128912447|NCT01340209|463970796|FG000|Overall Study|Protocol Violation|1|||
128912448|NCT01340209|463970797|FG001|Overall Study|Protocol Violation|2|||
128912449|NCT01340209|463970798|FG002|Overall Study|Protocol Violation|1|||
128912450|NCT01340209|463970796|FG000|Overall Study|Withdrawal by Subject|0|||
128912451|NCT01340209|463970797|FG001|Overall Study|Withdrawal by Subject|0|||
128912452|NCT01340209|463970798|FG002|Overall Study|Withdrawal by Subject|1|||
128912453|NCT01340209|463970796|FG000|Overall Study|Other reason not defined above|3|||
128912454|NCT01340209|463970797|FG001|Overall Study|Other reason not defined above|5|||
128912455|NCT01340209|463970798|FG002|Overall Study|Other reason not defined above|4|||
128912456|NCT04142983|463970801|FG000|Overall Study|Lost to Follow-up|73|||
128912457|NCT04142983|463970801|FG000|Overall Study|Withdrawal by Subject|10|||
128912458|NCT04142983|463970801|FG000|Overall Study|Physician Decision|1|||
128912459|NCT04142983|463970801|FG000|Overall Study|Adverse Event|1|||
129028677|NCT01537887|464396373|FG005|Period 1|Physician Decision|1|||
129028678|NCT01537887|464396368|FG000|Period 1|Did not receive treatment|0|||
128912460|NCT04142983|463970801|FG000|Overall Study|No longer eligible|4|||
128912461|NCT04142983|463970801|FG000|Overall Study|Screen Failure|10|||
128912462|NCT02918019|463970807|FG000|Overall Study|Death|0|||
128912463|NCT02918019|463970808|FG001|Overall Study|Death|0|||
128912464|NCT02918019|463970809|FG002|Overall Study|Death|1|||
128912465|NCT02918019|463970810|FG003|Overall Study|Death|0|||
128912466|NCT02918019|463970807|FG000|Overall Study|Lost to Follow-up|1|||
129028679|NCT01537887|464396369|FG001|Period 1|Did not receive treatment|0|||
129028680|NCT01537887|464396370|FG002|Period 1|Did not receive treatment|1|||
129028681|NCT01537887|464396371|FG003|Period 1|Did not receive treatment|0|||
129028682|NCT01537887|464396372|FG004|Period 1|Did not receive treatment|0|||
128765390|NCT02969525|463432143|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
128765391|NCT02969525|463432144|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
128765392|NCT02969525|463432145|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
128765393|NCT02969525|463432146|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
128765394|NCT02969525|463432147|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
128765395|NCT02969525|463432148|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
128765396|NCT02969525|463432149|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
128765397|NCT02969525|463432138|FG000|Dose-Blind Period|Non-cooperating patient|0|||
128912467|NCT02918019|463970808|FG001|Overall Study|Lost to Follow-up|1|||
128912468|NCT02918019|463970809|FG002|Overall Study|Lost to Follow-up|0|||
128912469|NCT02918019|463970810|FG003|Overall Study|Lost to Follow-up|1|||
128912470|NCT02918019|463970807|FG000|Overall Study|Principal investigator request|0|||
128912471|NCT02918019|463970808|FG001|Overall Study|Principal investigator request|0|||
128912472|NCT02918019|463970809|FG002|Overall Study|Principal investigator request|0|||
128912473|NCT02918019|463970810|FG003|Overall Study|Principal investigator request|1|||
128912474|NCT02918019|463970807|FG000|Overall Study|Physician Decision|1|||
128912475|NCT02918019|463970808|FG001|Overall Study|Physician Decision|3|||
128912476|NCT02918019|463970809|FG002|Overall Study|Physician Decision|2|||
128912477|NCT02918019|463970810|FG003|Overall Study|Physician Decision|0|||
128912478|NCT02918019|463970807|FG000|Overall Study|Protocol deviation|1|||
128912479|NCT02918019|463970808|FG001|Overall Study|Protocol deviation|1|||
128765398|NCT02969525|463432139|FG001|Dose-Blind Period|Non-cooperating patient|0|||
128765399|NCT02969525|463432140|FG002|Dose-Blind Period|Non-cooperating patient|0|||
128912480|NCT02918019|463970809|FG002|Overall Study|Protocol deviation|0|||
128912481|NCT02918019|463970810|FG003|Overall Study|Protocol deviation|2|||
128912482|NCT02918019|463970807|FG000|Overall Study|Withdrawal by Subject|3|||
128912483|NCT02918019|463970808|FG001|Overall Study|Withdrawal by Subject|4|||
128912484|NCT02918019|463970809|FG002|Overall Study|Withdrawal by Subject|6|||
128912485|NCT02918019|463970810|FG003|Overall Study|Withdrawal by Subject|4|||
128765400|NCT02969525|463432141|FG003|Dose-Blind Period|Non-cooperating patient|0|||
128765401|NCT02969525|463432142|FG004|Dose-Blind Period|Non-cooperating patient|0|||
128765402|NCT02969525|463432143|FG005|Dose-Blind Period|Non-cooperating patient|0|||
128912486|NCT02918019|463970807|FG000|Overall Study|Adverse Event|0|||
128765403|NCT02969525|463432144|FG006|Dose-Blind Period|Non-cooperating patient|0|||
128765404|NCT02969525|463432145|FG007|Dose-Blind Period|Non-cooperating patient|0|||
128765405|NCT02969525|463432146|FG008|Dose-Blind Period|Non-cooperating patient|0|||
128765406|NCT02969525|463432147|FG009|Dose-Blind Period|Non-cooperating patient|0|||
128912487|NCT02918019|463970808|FG001|Overall Study|Adverse Event|1|||
128912488|NCT02918019|463970809|FG002|Overall Study|Adverse Event|0|||
128912489|NCT02918019|463970810|FG003|Overall Study|Adverse Event|1|||
128912490|NCT01212185|463970811|FG000|Overall Study|Protocol Violation|2|||
128912491|NCT01212185|463970812|FG001|Overall Study|Protocol Violation|1|||
128912492|NCT00094757|463970813|FG000|Overall Study|Adverse Event|11|||
128912493|NCT00094757|463970814|FG001|Overall Study|Adverse Event|9|||
129028683|NCT01537887|464396373|FG005|Period 1|Did not receive treatment|0|||
129028684|NCT01537887|464396368|FG000|Period 2|Withdrawal by Subject|0|||
128765407|NCT02969525|463432148|FG010|Dose-Blind Period|Non-cooperating patient|0|||
128765408|NCT02969525|463432149|FG011|Dose-Blind Period|Non-cooperating patient|1|||
128765409|NCT02969525|463432138|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765410|NCT02969525|463432139|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765411|NCT02969525|463432140|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765412|NCT02969525|463432141|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765413|NCT02969525|463432142|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765414|NCT02969525|463432143|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765415|NCT02969525|463432144|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765416|NCT02969525|463432145|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765417|NCT02969525|463432146|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765418|NCT02969525|463432147|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765419|NCT02969525|463432148|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
128765420|NCT02969525|463432149|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
128765421|NCT02172625|463432150|FG000|Overall Study|Adverse Event|0|||
128765422|NCT02172625|463432151|FG001|Overall Study|Adverse Event|1|||
129028685|NCT01537887|464396369|FG001|Period 2|Withdrawal by Subject|1|||
128765423|NCT02172625|463432150|FG000|Overall Study|Pregnancy|0|||
128765424|NCT02172625|463432151|FG001|Overall Study|Pregnancy|1|||
128765425|NCT02172625|463432150|FG000|Overall Study|car accident|0|||
128912494|NCT00094757|463970815|FG002|Overall Study|Adverse Event|6|||
128912495|NCT00094757|463970813|FG000|Overall Study|Lack of Efficacy|11|||
128912496|NCT00094757|463970814|FG001|Overall Study|Lack of Efficacy|15|||
128912497|NCT00094757|463970815|FG002|Overall Study|Lack of Efficacy|8|||
128912498|NCT00094757|463970813|FG000|Overall Study|Lost to Follow-up|3|||
128912499|NCT00094757|463970814|FG001|Overall Study|Lost to Follow-up|5|||
128912500|NCT00094757|463970815|FG002|Overall Study|Lost to Follow-up|6|||
129028686|NCT01537887|464396370|FG002|Period 2|Withdrawal by Subject|0|||
129028687|NCT01537887|464396371|FG003|Period 2|Withdrawal by Subject|0|||
128912501|NCT00094757|463970813|FG000|Overall Study|Patient Moved|2|||
128912502|NCT00094757|463970814|FG001|Overall Study|Patient Moved|1|||
128912503|NCT00094757|463970815|FG002|Overall Study|Patient Moved|1|||
128912504|NCT00094757|463970813|FG000|Overall Study|Protocol Violation|8|||
128912505|NCT00094757|463970814|FG001|Overall Study|Protocol Violation|5|||
128912506|NCT00094757|463970815|FG002|Overall Study|Protocol Violation|3|||
128912507|NCT00094757|463970813|FG000|Overall Study|Withdrawal by Subject|14|||
128697083|NCT02925117|463189006|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128912508|NCT00094757|463970814|FG001|Overall Study|Withdrawal by Subject|21|||
128912509|NCT00094757|463970815|FG002|Overall Study|Withdrawal by Subject|5|||
128912510|NCT00094757|463970813|FG000|Overall Study|Other|3|||
128912511|NCT00094757|463970814|FG001|Overall Study|Other|3|||
128912512|NCT00094757|463970815|FG002|Overall Study|Other|1|||
128912513|NCT00094757|463970813|FG000|Overall Study|Protocol specified discontinuation|1|||
128912514|NCT00094757|463970814|FG001|Overall Study|Protocol specified discontinuation|3|||
128912515|NCT00094757|463970815|FG002|Overall Study|Protocol specified discontinuation|0|||
128912516|NCT00756938|463970816|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
128912517|NCT00756938|463970817|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
128912518|NCT00756938|463970818|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
128912519|NCT00756938|463970819|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
128912520|NCT00756938|463970816|FG000|12-week Base Study|Protocol Violation|0|||
128912521|NCT00756938|463970817|FG001|12-week Base Study|Protocol Violation|0|||
128912522|NCT00756938|463970818|FG002|12-week Base Study|Protocol Violation|1|||
128912523|NCT00756938|463970819|FG003|12-week Base Study|Protocol Violation|0|||
128912524|NCT00756938|463970816|FG000|12-week Base Study|Lost to Follow-up|1|||
128912525|NCT00756938|463970817|FG001|12-week Base Study|Lost to Follow-up|0|||
128912526|NCT00756938|463970818|FG002|12-week Base Study|Lost to Follow-up|0|||
128912527|NCT00756938|463970819|FG003|12-week Base Study|Lost to Follow-up|0|||
128912528|NCT00756938|463970816|FG000|Optional Extension|Lack of Efficacy|0|||
128912529|NCT00756938|463970817|FG001|Optional Extension|Lack of Efficacy|0|||
128912530|NCT00756938|463970818|FG002|Optional Extension|Lack of Efficacy|0|||
128912531|NCT00756938|463970819|FG003|Optional Extension|Lack of Efficacy|1|||
128912532|NCT00756938|463970816|FG000|Optional Extension|End of Study|0|||
128912533|NCT00756938|463970817|FG001|Optional Extension|End of Study|0|||
128912534|NCT00756938|463970818|FG002|Optional Extension|End of Study|0|||
128912535|NCT00756938|463970819|FG003|Optional Extension|End of Study|11|||
128912536|NCT00756938|463970816|FG000|Optional Extension|Protocol-specific criteria met|0|||
129028688|NCT01537887|464396372|FG004|Period 2|Withdrawal by Subject|0|||
129028689|NCT01537887|464396373|FG005|Period 2|Withdrawal by Subject|0|||
129028690|NCT01537887|464396368|FG000|Period 3|Adverse Event|0|||
129028691|NCT01537887|464396369|FG001|Period 3|Adverse Event|0|||
129028692|NCT01537887|464396370|FG002|Period 3|Adverse Event|1|||
129028693|NCT01537887|464396371|FG003|Period 3|Adverse Event|0|||
129028694|NCT01537887|464396372|FG004|Period 3|Adverse Event|0|||
129028695|NCT01537887|464396373|FG005|Period 3|Adverse Event|0|||
129028696|NCT01537887|464396368|FG000|Period 3|Withdrawal by Subject|0|||
129028697|NCT01537887|464396369|FG001|Period 3|Withdrawal by Subject|1|||
129028698|NCT01537887|464396370|FG002|Period 3|Withdrawal by Subject|0|||
129028699|NCT01537887|464396371|FG003|Period 3|Withdrawal by Subject|0|||
129028700|NCT01537887|464396372|FG004|Period 3|Withdrawal by Subject|0|||
129028701|NCT01537887|464396373|FG005|Period 3|Withdrawal by Subject|0|||
129028702|NCT01370083|464396374|FG000|Overall Study|Lost to Follow-up|2|||
129028703|NCT01370083|464396375|FG001|Overall Study|Lost to Follow-up|0|||
129028704|NCT01370083|464396374|FG000|Overall Study|Adverse Event|0|||
129028705|NCT01370083|464396375|FG001|Overall Study|Adverse Event|1|||
129028706|NCT00731939|464396377|FG000|Overall Study|Adverse Event|6|||
129028707|NCT00731939|464396377|FG000|Overall Study|Lost to Follow-up|15|||
129028708|NCT00731939|464396377|FG000|Overall Study|Not implanted with study device|9|||
129028709|NCT00731939|464396377|FG000|Overall Study|Withdrawal by Subject|2|||
129028710|NCT00731939|464396377|FG000|Overall Study|Did not meet enrollment criteria|2|||
129028711|NCT02072096|464396378|FG000|Overall Study|Lack of Efficacy|18|||
129028712|NCT02072096|464396379|FG001|Overall Study|Lack of Efficacy|29|||
129028713|NCT02072096|464396378|FG000|Overall Study|Protocol Violation|7|||
129028714|NCT02072096|464396379|FG001|Overall Study|Protocol Violation|7|||
129028715|NCT02072096|464396378|FG000|Overall Study|Withdrawal by Subject|5|||
129118687|NCT01027845|464731185|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
128912537|NCT00756938|463970817|FG001|Optional Extension|Protocol-specific criteria met|0|||
128912538|NCT00756938|463970818|FG002|Optional Extension|Protocol-specific criteria met|0|||
128912539|NCT00756938|463970819|FG003|Optional Extension|Protocol-specific criteria met|9|||
128912540|NCT00756938|463970816|FG000|Optional Extension|Physician Decision|0|||
128912541|NCT00756938|463970817|FG001|Optional Extension|Physician Decision|0|||
129028716|NCT02072096|464396379|FG001|Overall Study|Withdrawal by Subject|7|||
129028717|NCT02072096|464396378|FG000|Overall Study|Adverse Event|5|||
129028718|NCT02072096|464396379|FG001|Overall Study|Adverse Event|2|||
129028719|NCT02072096|464396378|FG000|Overall Study|No Reason Provided|4|||
129028720|NCT02072096|464396379|FG001|Overall Study|No Reason Provided|2|||
129028721|NCT02072096|464396378|FG000|Overall Study|Death|2|||
129028722|NCT02072096|464396379|FG001|Overall Study|Death|0|||
129118688|NCT00368550|464731186|FG000|Overall Study|Adverse Event|7|||
129118689|NCT00368550|464731187|FG001|Overall Study|Adverse Event|4|||
129118690|NCT00368550|464731186|FG000|Overall Study|Lack of Efficacy|4|||
129118691|NCT00368550|464731187|FG001|Overall Study|Lack of Efficacy|9|||
129118692|NCT00368550|464731186|FG000|Overall Study|Withdrawal by Subject|17|||
129118693|NCT00368550|464731187|FG001|Overall Study|Withdrawal by Subject|10|||
129118694|NCT00486044|464731188|FG000|Overall Study|Withdrawal by Subject|2|||
129118695|NCT00486044|464731189|FG001|Overall Study|Withdrawal by Subject|1|||
129118696|NCT00486044|464731188|FG000|Overall Study|Adverse Event|0|||
129118697|NCT00486044|464731189|FG001|Overall Study|Adverse Event|1|||
129118698|NCT00486044|464731188|FG000|Overall Study|Lost to Follow-up|0|||
128912542|NCT00756938|463970818|FG002|Optional Extension|Physician Decision|0|||
128912543|NCT00756938|463970819|FG003|Optional Extension|Physician Decision|3|||
128912544|NCT00756938|463970816|FG000|Optional Extension|Lost to Follow-up|0|||
128912545|NCT00756938|463970817|FG001|Optional Extension|Lost to Follow-up|0|||
128912546|NCT00756938|463970818|FG002|Optional Extension|Lost to Follow-up|0|||
128912547|NCT00756938|463970819|FG003|Optional Extension|Lost to Follow-up|1|||
128912548|NCT00756938|463970816|FG000|Optional Extension|Protocol Violation|0|||
128912549|NCT00756938|463970817|FG001|Optional Extension|Protocol Violation|0|||
128912550|NCT00756938|463970818|FG002|Optional Extension|Protocol Violation|0|||
128912551|NCT00756938|463970819|FG003|Optional Extension|Protocol Violation|1|||
128912552|NCT00756938|463970816|FG000|Optional Extension|Withdrawal by Subject|0|||
128912553|NCT00756938|463970817|FG001|Optional Extension|Withdrawal by Subject|0|||
128912554|NCT00756938|463970818|FG002|Optional Extension|Withdrawal by Subject|0|||
128912555|NCT00756938|463970819|FG003|Optional Extension|Withdrawal by Subject|10|||
128912556|NCT00756938|463970816|FG000|Optional Extension|Adverse Event|0|||
128912557|NCT00756938|463970817|FG001|Optional Extension|Adverse Event|0|||
128912558|NCT00756938|463970818|FG002|Optional Extension|Adverse Event|0|||
128912559|NCT00756938|463970819|FG003|Optional Extension|Adverse Event|1|||
128912560|NCT04317274|463970820|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
128912561|NCT04317274|463970821|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
128912562|NCT04317274|463970822|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
128912563|NCT04317274|463970823|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
128912564|NCT00797823|463970825|FG000|First Period (Initial Randomization)|Physician Decision|1|||
128912565|NCT00797823|463970826|FG001|First Period (Initial Randomization)|Physician Decision|0|||
128912566|NCT00797823|463970827|FG002|First Period (Initial Randomization)|Physician Decision|0|||
128912567|NCT02568046|463970828|FG000|Overall Study|Adverse Event|0|||
128912568|NCT02568046|463970829|FG001|Overall Study|Adverse Event|1|||
128912569|NCT02568046|463970828|FG000|Overall Study|Death|2|||
128912570|NCT02568046|463970829|FG001|Overall Study|Death|0|||
128912571|NCT02568046|463970828|FG000|Overall Study|Progressive Disease|1|||
128912572|NCT02568046|463970829|FG001|Overall Study|Progressive Disease|0|||
128912573|NCT02568046|463970828|FG000|Overall Study|Withdrawal by Subject|2|||
128912574|NCT02568046|463970829|FG001|Overall Study|Withdrawal by Subject|1|||
128912575|NCT02568046|463970828|FG000|Overall Study|Other Events|0|||
128912576|NCT02568046|463970829|FG001|Overall Study|Other Events|1|||
128912577|NCT03403192|463970835|FG000|Overall Study|Lost to Follow-up|1|||
128912578|NCT03403192|463970836|FG001|Overall Study|Lost to Follow-up|2|||
128912579|NCT03403192|463970837|FG002|Overall Study|Lost to Follow-up|0|||
128912580|NCT03403192|463970838|FG003|Overall Study|Lost to Follow-up|0|||
128912581|NCT03403192|463970835|FG000|Overall Study|Unable to respond|0|||
128912582|NCT03403192|463970836|FG001|Overall Study|Unable to respond|1|||
128912583|NCT03403192|463970837|FG002|Overall Study|Unable to respond|0|||
128912584|NCT03403192|463970838|FG003|Overall Study|Unable to respond|0|||
128912585|NCT03403192|463970835|FG000|Overall Study|Incomplete|3|||
128912586|NCT03403192|463970836|FG001|Overall Study|Incomplete|1|||
128912587|NCT03403192|463970837|FG002|Overall Study|Incomplete|3|||
128912588|NCT03403192|463970838|FG003|Overall Study|Incomplete|6|||
128912589|NCT00379795|463970839|FG000|Overall Study|Death|31|||
128912590|NCT00379795|463970840|FG001|Overall Study|Death|8|||
129118699|NCT00486044|464731189|FG001|Overall Study|Lost to Follow-up|1|||
129118700|NCT01670292|464731193|FG000|Overall Study|Lost to Follow-up|14|||
129118701|NCT03154086|464731196|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
128912591|NCT00379795|463970841|FG002|Overall Study|Death|6|||
128912592|NCT00379795|463970842|FG003|Overall Study|Death|4|||
128912593|NCT00379795|463970843|FG004|Overall Study|Death|7|||
128912594|NCT00379795|463970839|FG000|Overall Study|Adverse Event|17|||
129118702|NCT03154086|464731197|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118703|NCT03154086|464731198|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118704|NCT03154086|464731199|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
128912595|NCT00379795|463970840|FG001|Overall Study|Adverse Event|3|||
128912596|NCT00379795|463970841|FG002|Overall Study|Adverse Event|3|||
128912597|NCT00379795|463970842|FG003|Overall Study|Adverse Event|1|||
128912598|NCT00379795|463970843|FG004|Overall Study|Adverse Event|4|||
128912599|NCT00379795|463970839|FG000|Overall Study|Lost to Follow-up|8|||
128912600|NCT00379795|463970840|FG001|Overall Study|Lost to Follow-up|1|||
128912601|NCT00379795|463970841|FG002|Overall Study|Lost to Follow-up|2|||
128912602|NCT00379795|463970842|FG003|Overall Study|Lost to Follow-up|1|||
128912603|NCT00379795|463970843|FG004|Overall Study|Lost to Follow-up|4|||
128912604|NCT00379795|463970839|FG000|Overall Study|Physician Decision|25|||
128912605|NCT00379795|463970840|FG001|Overall Study|Physician Decision|0|||
128912606|NCT00379795|463970841|FG002|Overall Study|Physician Decision|2|||
128912607|NCT00379795|463970842|FG003|Overall Study|Physician Decision|2|||
128912608|NCT00379795|463970843|FG004|Overall Study|Physician Decision|2|||
128912609|NCT00379795|463970839|FG000|Overall Study|Withdrawal by Subject|94|||
128912610|NCT00379795|463970840|FG001|Overall Study|Withdrawal by Subject|11|||
128912611|NCT00379795|463970841|FG002|Overall Study|Withdrawal by Subject|19|||
128912612|NCT00379795|463970842|FG003|Overall Study|Withdrawal by Subject|7|||
128912613|NCT00379795|463970843|FG004|Overall Study|Withdrawal by Subject|14|||
128912614|NCT00379795|463970839|FG000|Overall Study|Subject non-compliance|7|||
128912615|NCT00379795|463970840|FG001|Overall Study|Subject non-compliance|2|||
128912616|NCT00379795|463970841|FG002|Overall Study|Subject non-compliance|0|||
128912617|NCT00379795|463970842|FG003|Overall Study|Subject non-compliance|0|||
128912618|NCT00379795|463970843|FG004|Overall Study|Subject non-compliance|1|||
128912619|NCT00379795|463970839|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
128912620|NCT00379795|463970840|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
128912621|NCT00379795|463970841|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
128912622|NCT00379795|463970842|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
128912623|NCT00379795|463970843|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
128912624|NCT00379795|463970839|FG000|Overall Study|Subjects condition mandated intervention|34|||
128912625|NCT00379795|463970840|FG001|Overall Study|Subjects condition mandated intervention|9|||
128912626|NCT00379795|463970841|FG002|Overall Study|Subjects condition mandated intervention|7|||
128912627|NCT00379795|463970842|FG003|Overall Study|Subjects condition mandated intervention|5|||
128912628|NCT00379795|463970843|FG004|Overall Study|Subjects condition mandated intervention|7|||
128912629|NCT00379795|463970839|FG000|Overall Study|Sponsor's decision|257|||
128912630|NCT00379795|463970840|FG001|Overall Study|Sponsor's decision|17|||
128912631|NCT00379795|463970841|FG002|Overall Study|Sponsor's decision|54|||
128912632|NCT00379795|463970842|FG003|Overall Study|Sponsor's decision|47|||
128912633|NCT00379795|463970843|FG004|Overall Study|Sponsor's decision|10|||
128912634|NCT01017952|463970844|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
128912635|NCT01017952|463970845|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128912636|NCT01017952|463970846|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128912637|NCT01017952|463970847|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128912638|NCT01017952|463970848|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128912639|NCT01017952|463970844|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
128912640|NCT01017952|463970845|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
128912641|NCT01017952|463970846|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
128912642|NCT01017952|463970847|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
128912643|NCT01017952|463970848|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
128912644|NCT01017952|463970844|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
128912645|NCT01017952|463970845|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
128912646|NCT01017952|463970846|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
128912647|NCT01017952|463970847|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
128912648|NCT01017952|463970848|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
128912649|NCT01017952|463970844|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
128912650|NCT01017952|463970845|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
128912651|NCT01017952|463970846|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
128912652|NCT01017952|463970847|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
128697084|NCT02925117|463189007|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128912653|NCT01017952|463970848|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
128697085|NCT02925117|463189008|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128697086|NCT02925117|463189009|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
128912654|NCT01017952|463970844|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
128912655|NCT01017952|463970845|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
128912656|NCT01017952|463970846|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
129028723|NCT02072096|464396378|FG000|Overall Study|Physician Decision|0|||
129028724|NCT02072096|464396379|FG001|Overall Study|Physician Decision|1|||
129028725|NCT02072096|464396378|FG000|Overall Study|Study Terminated by Sponsor|43|||
129028726|NCT02072096|464396379|FG001|Overall Study|Study Terminated by Sponsor|30|||
129028727|NCT02072096|464396378|FG000|Overall Study|Lost to Follow-up|1|||
129028728|NCT02072096|464396379|FG001|Overall Study|Lost to Follow-up|0|||
129028729|NCT01266902|464396381|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
129028730|NCT01266902|464396382|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
129028731|NCT01266902|464396383|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
129028732|NCT01266902|464396381|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
128912657|NCT01017952|463970847|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
128912658|NCT01017952|463970848|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
128912659|NCT01017952|463970844|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
128912660|NCT01017952|463970845|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128912661|NCT01017952|463970846|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128912662|NCT01017952|463970847|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128912663|NCT01017952|463970848|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128912664|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
128912665|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
128912666|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
128912667|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
128912668|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
128912669|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
128912670|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
128912671|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
128912672|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
128912673|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
128912674|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
128912675|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
128912676|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
128912677|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
128912678|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
128912679|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
128912680|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
128912681|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
128912682|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
128912683|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
128912684|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
128912685|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
128912686|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
128912687|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
128912688|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
128912689|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
128912690|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
128912691|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
128912692|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
128912693|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
128912694|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128912695|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
128912696|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
128912697|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
128912698|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
128912699|NCT01017952|463970844|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
128912700|NCT01017952|463970845|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
128912701|NCT01017952|463970846|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
128912702|NCT01017952|463970847|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
128912703|NCT01017952|463970848|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
128912704|NCT04849780|463970849|FG000|Period 1|Covid-19 Related|1|||
128912705|NCT04849780|463970850|FG001|Period 1|Covid-19 Related|0|||
129028733|NCT01266902|464396382|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
129028734|NCT01266902|464396383|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
129028735|NCT01266902|464396381|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
129028736|NCT01266902|464396382|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
129028737|NCT01266902|464396383|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
129028738|NCT01266902|464396381|FG000|Period 1 (Main Study)|Adverse Event|3|||
129028739|NCT01266902|464396382|FG001|Period 1 (Main Study)|Adverse Event|11|||
129028740|NCT01266902|464396383|FG002|Period 1 (Main Study)|Adverse Event|0|||
129028741|NCT01266902|464396381|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
129028742|NCT01266902|464396382|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
129028743|NCT01266902|464396383|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
129028744|NCT01266902|464396381|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
129028745|NCT01266902|464396382|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
128765426|NCT02172625|463432151|FG001|Overall Study|car accident|1|||
128912706|NCT04849780|463970849|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
129028746|NCT01266902|464396383|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
129028747|NCT01266902|464396381|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
128697087|NCT02925117|463188998|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
128697088|NCT02925117|463188999|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
128697089|NCT02925117|463189000|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697090|NCT02925117|463189001|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697091|NCT02925117|463189002|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128912707|NCT04849780|463970850|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
128912708|NCT04849780|463970849|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
128912709|NCT04849780|463970850|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
128912710|NCT01298492|463970851|FG000|Overall Study|Death|2|||
128912711|NCT01298492|463970851|FG000|Overall Study|Insufficient Clinical Response|22|||
128912712|NCT01298492|463970851|FG000|Overall Study|Lost to Follow-up|12|||
128912713|NCT01298492|463970851|FG000|Overall Study|Withdrawal by Subject|47|||
128912714|NCT01298492|463970851|FG000|Overall Study|Other (Unspecified)|7|||
128912715|NCT01298492|463970851|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
128912716|NCT01298492|463970851|FG000|Overall Study|Protocol Violation|2|||
128912717|NCT01298492|463970851|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
128912718|NCT01298492|463970851|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
128912719|NCT00352105|463970852|FG000|Overall Study|Death|5|||
128912720|NCT00352105|463970852|FG000|Overall Study|Withdrawal by Subject|5|||
128912721|NCT00352105|463970852|FG000|Overall Study|Lack of Efficacy|9|||
128912722|NCT00352105|463970852|FG000|Overall Study|Adverse Event|19|||
128912723|NCT00352105|463970852|FG000|Overall Study|Protocol Violation|2|||
128912724|NCT01405053|463970853|FG000|Overall Study|Adverse Event|3|||
128912725|NCT01405053|463970854|FG001|Overall Study|Adverse Event|0|||
128912726|NCT01405053|463970853|FG000|Overall Study|Lost to Follow-up|0|||
128912727|NCT01405053|463970854|FG001|Overall Study|Lost to Follow-up|1|||
128912728|NCT01405053|463970853|FG000|Overall Study|Participant choice|2|||
128912729|NCT01405053|463970854|FG001|Overall Study|Participant choice|1|||
128912730|NCT01405053|463970853|FG000|Overall Study|Inadequate therapeutic effect|2|||
129118705|NCT03154086|464731200|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118706|NCT03154086|464731201|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118707|NCT03154086|464731202|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118708|NCT03154086|464731203|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118709|NCT03154086|464731204|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118710|NCT03154086|464731205|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118711|NCT03154086|464731206|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118712|NCT03154086|464731207|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118713|NCT03154086|464731208|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118714|NCT03154086|464731209|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118715|NCT03154086|464731210|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129118716|NCT03154086|464731196|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118717|NCT03154086|464731197|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
129118718|NCT03154086|464731198|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118719|NCT03154086|464731199|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118720|NCT03154086|464731200|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118721|NCT03154086|464731201|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118722|NCT03154086|464731202|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118723|NCT03154086|464731203|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118724|NCT03154086|464731204|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118725|NCT03154086|464731205|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118726|NCT03154086|464731206|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118727|NCT03154086|464731207|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118728|NCT03154086|464731208|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118729|NCT03154086|464731209|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118730|NCT03154086|464731210|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129118731|NCT03154086|464731196|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129118732|NCT03154086|464731197|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129118733|NCT03154086|464731198|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
129118734|NCT03154086|464731199|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128912731|NCT01405053|463970854|FG001|Overall Study|Inadequate therapeutic effect|1|||
129118735|NCT03154086|464731200|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128697092|NCT02925117|463189003|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697093|NCT02925117|463189004|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697094|NCT02925117|463189005|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128912732|NCT01405053|463970853|FG000|Overall Study|Withdrawal by Subject|3|||
128912733|NCT01405053|463970854|FG001|Overall Study|Withdrawal by Subject|4|||
128912734|NCT01405053|463970853|FG000|Overall Study|Other|0|||
128912735|NCT01405053|463970854|FG001|Overall Study|Other|1|||
128912736|NCT02551159|463970857|FG000|Overall Study|Death|352|||
128912737|NCT02551159|463970858|FG001|Overall Study|Death|174|||
128912738|NCT02551159|463970859|FG002|Overall Study|Death|161|||
128912739|NCT02551159|463970857|FG000|Overall Study|Withdrawal by Subject|8|||
128912740|NCT02551159|463970858|FG001|Overall Study|Withdrawal by Subject|5|||
128912741|NCT02551159|463970859|FG002|Overall Study|Withdrawal by Subject|16|||
128912742|NCT02551159|463970857|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
128912743|NCT02551159|463970858|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
128912744|NCT02551159|463970859|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
128912745|NCT02175680|463970860|FG000|Overall Study|non-compliance|1|||
128912746|NCT02175680|463970860|FG000|Overall Study|other non-medical reason|1|||
129215650|NCT03077412|465092786|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
128697095|NCT02925117|463189006|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697096|NCT02925117|463189007|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697097|NCT02925117|463189008|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697098|NCT02925117|463189009|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
128697099|NCT02925117|463188998|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
128697100|NCT02925117|463188999|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
128697101|NCT02925117|463189000|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
128697102|NCT02925117|463189001|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
128697103|NCT02925117|463189002|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
128697104|NCT02925117|463189003|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
128697105|NCT02925117|463189004|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
128697106|NCT02925117|463189005|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
128697107|NCT02925117|463189006|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
128697108|NCT02925117|463189007|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
128697109|NCT02925117|463189008|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
128697110|NCT02925117|463189009|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
128697111|NCT02925117|463188998|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697112|NCT02925117|463188999|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697113|NCT02925117|463189000|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697114|NCT02925117|463189001|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697115|NCT02925117|463189002|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697116|NCT02925117|463189003|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
128697117|NCT02925117|463189004|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697118|NCT02925117|463189005|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697119|NCT02925117|463189006|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697120|NCT02925117|463189007|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
128697121|NCT02925117|463189008|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
128697122|NCT02925117|463189009|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
128697123|NCT02925117|463188998|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
128697124|NCT02925117|463188999|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
128697125|NCT02925117|463189000|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
128697126|NCT02925117|463189001|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
128697127|NCT02925117|463189002|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
128697128|NCT02925117|463189003|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
128697129|NCT02925117|463189004|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
128697130|NCT02925117|463189005|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
128697131|NCT02925117|463189006|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
128697132|NCT02925117|463189007|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
128697133|NCT02925117|463189008|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
128697134|NCT02925117|463189009|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
128697135|NCT02925117|463188998|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
128697136|NCT02925117|463188999|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
128697137|NCT02925117|463189000|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
128697138|NCT02925117|463189001|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
128697139|NCT02925117|463189002|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
128697140|NCT02925117|463189003|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
128697141|NCT02925117|463189004|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
128697142|NCT02925117|463189005|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
128697143|NCT02925117|463189006|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
128697144|NCT02925117|463189007|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
128697145|NCT02925117|463189008|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
128697146|NCT02925117|463189009|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
128697147|NCT02925117|463188998|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
128697148|NCT02925117|463188999|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
128697149|NCT02925117|463189000|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
128697150|NCT02925117|463189001|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
128697151|NCT02925117|463189002|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
128697152|NCT02925117|463189003|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
128697153|NCT02925117|463189004|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
128697154|NCT02925117|463189005|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
128697155|NCT02925117|463189006|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
128697156|NCT02925117|463189007|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
128697157|NCT02925117|463189008|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
128697158|NCT02925117|463189009|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
128912747|NCT01665144|463970861|FG000|Core Part|Withdrawal by Subject|96|||
128912748|NCT01665144|463970862|FG001|Core Part|Withdrawal by Subject|77|||
128912749|NCT01665144|463970863|FG002|Core Part|Withdrawal by Subject|0|||
128912750|NCT01665144|463970861|FG000|Core Part|Adverse Event|45|||
128912751|NCT01665144|463970862|FG001|Core Part|Adverse Event|18|||
128912752|NCT01665144|463970863|FG002|Core Part|Adverse Event|0|||
128912753|NCT01665144|463970861|FG000|Core Part|Lack of Efficacy|16|||
128912754|NCT01665144|463970862|FG001|Core Part|Lack of Efficacy|11|||
128912755|NCT01665144|463970863|FG002|Core Part|Lack of Efficacy|0|||
128912756|NCT01665144|463970861|FG000|Core Part|Lost to Follow-up|9|||
128912757|NCT01665144|463970862|FG001|Core Part|Lost to Follow-up|8|||
128912758|NCT01665144|463970863|FG002|Core Part|Lost to Follow-up|0|||
128912759|NCT01665144|463970861|FG000|Core Part|Physician Decision|13|||
128912760|NCT01665144|463970862|FG001|Core Part|Physician Decision|1|||
128912761|NCT01665144|463970863|FG002|Core Part|Physician Decision|0|||
128912762|NCT01665144|463970861|FG000|Core Part|Progressive disease|8|||
128912763|NCT01665144|463970862|FG001|Core Part|Progressive disease|4|||
128912764|NCT01665144|463970863|FG002|Core Part|Progressive disease|0|||
128912765|NCT01665144|463970861|FG000|Core Part|Non-compliance with study treatment|5|||
128912766|NCT01665144|463970862|FG001|Core Part|Non-compliance with study treatment|0|||
128912767|NCT01665144|463970863|FG002|Core Part|Non-compliance with study treatment|0|||
128912768|NCT01665144|463970861|FG000|Core Part|Death|3|||
128912769|NCT01665144|463970862|FG001|Core Part|Death|1|||
128912770|NCT01665144|463970863|FG002|Core Part|Death|0|||
128912771|NCT01665144|463970861|FG000|Core Part|Protocol deviation|3|||
128912772|NCT01665144|463970862|FG001|Core Part|Protocol deviation|1|||
128912773|NCT01665144|463970863|FG002|Core Part|Protocol deviation|0|||
128912774|NCT01665144|463970861|FG000|Core Part|New therapy for study indication|2|||
128912775|NCT01665144|463970862|FG001|Core Part|New therapy for study indication|1|||
128912776|NCT01665144|463970863|FG002|Core Part|New therapy for study indication|0|||
128912777|NCT01665144|463970861|FG000|Core Part|Technical problems|2|||
128912778|NCT01665144|463970862|FG001|Core Part|Technical problems|0|||
128912779|NCT01665144|463970863|FG002|Core Part|Technical problems|0|||
128912780|NCT01665144|463970861|FG000|Extension Part|Patient/guardian decision|180|||
128912781|NCT01665144|463970862|FG001|Extension Part|Patient/guardian decision|0|||
128912782|NCT01665144|463970863|FG002|Extension Part|Patient/guardian decision|98|||
128912783|NCT01665144|463970861|FG000|Extension Part|Adverse Event|104|||
128912784|NCT01665144|463970862|FG001|Extension Part|Adverse Event|0|||
128912785|NCT01665144|463970863|FG002|Extension Part|Adverse Event|59|||
128912786|NCT01665144|463970861|FG000|Extension Part|Study closed early|42|||
128912787|NCT01665144|463970862|FG001|Extension Part|Study closed early|0|||
128912788|NCT01665144|463970863|FG002|Extension Part|Study closed early|19|||
128912789|NCT01665144|463970861|FG000|Extension Part|Progressive disease|36|||
128912790|NCT01665144|463970862|FG001|Extension Part|Progressive disease|0|||
128912791|NCT01665144|463970863|FG002|Extension Part|Progressive disease|14|||
128912792|NCT01665144|463970861|FG000|Extension Part|Lack of Efficacy|37|||
128912793|NCT01665144|463970862|FG001|Extension Part|Lack of Efficacy|0|||
128912794|NCT01665144|463970863|FG002|Extension Part|Lack of Efficacy|12|||
128912795|NCT01665144|463970861|FG000|Extension Part|Physician Decision|29|||
128912796|NCT01665144|463970862|FG001|Extension Part|Physician Decision|0|||
128912797|NCT01665144|463970863|FG002|Extension Part|Physician Decision|13|||
128912798|NCT01665144|463970861|FG000|Extension Part|Technical problems|20|||
128912799|NCT01665144|463970862|FG001|Extension Part|Technical problems|0|||
128912800|NCT01665144|463970863|FG002|Extension Part|Technical problems|8|||
128912801|NCT01665144|463970861|FG000|Extension Part|Death|20|||
128912802|NCT01665144|463970862|FG001|Extension Part|Death|0|||
128912803|NCT01665144|463970863|FG002|Extension Part|Death|4|||
128912804|NCT01665144|463970861|FG000|Extension Part|Missing|12|||
128912805|NCT01665144|463970862|FG001|Extension Part|Missing|0|||
128912806|NCT01665144|463970863|FG002|Extension Part|Missing|6|||
128912807|NCT01665144|463970861|FG000|Extension Part|Lost to Follow-up|9|||
128912808|NCT01665144|463970862|FG001|Extension Part|Lost to Follow-up|0|||
128912809|NCT01665144|463970863|FG002|Extension Part|Lost to Follow-up|5|||
128912810|NCT01665144|463970861|FG000|Extension Part|New therapy for study indication|3|||
128912811|NCT01665144|463970862|FG001|Extension Part|New therapy for study indication|0|||
128912812|NCT01665144|463970863|FG002|Extension Part|New therapy for study indication|2|||
128912813|NCT01665144|463970861|FG000|Extension Part|Protocol deviation|3|||
128912814|NCT01665144|463970862|FG001|Extension Part|Protocol deviation|0|||
128912815|NCT01665144|463970863|FG002|Extension Part|Protocol deviation|0|||
128912816|NCT02302963|463970864|FG000|Overall Study|Withdrawal by Subject|2|||
128912817|NCT02302963|463970865|FG001|Overall Study|Withdrawal by Subject|1|||
128912818|NCT02302963|463970864|FG000|Overall Study|Steroid injection|0|||
129028748|NCT01266902|464396382|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
128697159|NCT01387789|463189011|FG000|Overall Study|Adverse Event|5|||
128697160|NCT01387789|463189011|FG000|Overall Study|Lack of Efficacy|2|||
128697161|NCT01387789|463189011|FG000|Overall Study|Lost to Follow-up|1|||
128697162|NCT02993757|463189014|FG000|Overall Study|Non compliance with the protocol|155|||
128697163|NCT02993757|463189015|FG001|Overall Study|Non compliance with the protocol|170|||
128912819|NCT02302963|463970865|FG001|Overall Study|Steroid injection|1|||
128912820|NCT02302963|463970864|FG000|Overall Study|Physician Decision|1|||
128912821|NCT02302963|463970865|FG001|Overall Study|Physician Decision|0|||
128912822|NCT01816243|463970866|FG000|Overall Study|Adverse Event|6|||
128912823|NCT01816243|463970866|FG000|Overall Study|Lost to Follow-up|1|||
128912824|NCT01816243|463970866|FG000|Overall Study|Lack of Efficacy|1|||
128912825|NCT01816243|463970866|FG000|Overall Study|Not eligible for the study|1|||
128912826|NCT01816243|463970866|FG000|Overall Study|Amputation|3|||
128912827|NCT00911989|463970869|FG000|Overall Study|Adverse Event|1|||
128912828|NCT02937350|463970871|FG000|Overall Study|Withdrawal by Subject|0|||
128912829|NCT02937350|463970872|FG001|Overall Study|Withdrawal by Subject|1|||
128912830|NCT02937350|463970873|FG002|Overall Study|Withdrawal by Subject|0|||
128912831|NCT04811716|463970877|FG000|Overall Study|Withdrawal by Subject|2|||
128912832|NCT04811716|463970878|FG001|Overall Study|Withdrawal by Subject|0|||
128912833|NCT00429585|463970884|FG000|Overall Study|Death|1|||
128912834|NCT00429585|463970885|FG001|Overall Study|Death|0|||
128912835|NCT00429585|463970884|FG000|Overall Study|Lost to Follow-up|27|||
128912836|NCT00429585|463970885|FG001|Overall Study|Lost to Follow-up|20|||
128912837|NCT00429585|463970884|FG000|Overall Study|Physician Decision|2|||
128912838|NCT00429585|463970885|FG001|Overall Study|Physician Decision|0|||
128912839|NCT05280756|463972499|FG000|Overall Study|Lost to Follow-up|1|||
128912840|NCT05280756|463972500|FG001|Overall Study|Lost to Follow-up|1|||
128912841|NCT02527707|463972506|FG000|Overall Study|Adverse Event|1|||
128912842|NCT02527707|463972506|FG000|Overall Study|Adverse Event|1|||
128912843|NCT00930059|463972507|FG000|Overall Study|Death|1|||
128912844|NCT00930059|463972508|FG001|Overall Study|Death|0|||
128912845|NCT00930059|463972507|FG000|Overall Study|Did not meet entrance criteria|1|||
128912846|NCT00930059|463972508|FG001|Overall Study|Did not meet entrance criteria|1|||
128912847|NCT00930059|463972507|FG000|Overall Study|Withdrawal by Subject|3|||
128912848|NCT00930059|463972508|FG001|Overall Study|Withdrawal by Subject|4|||
128912849|NCT00930059|463972507|FG000|Overall Study|Other|1|||
128912850|NCT00930059|463972508|FG001|Overall Study|Other|0|||
128912851|NCT00930059|463972507|FG000|Overall Study|1 site terminated by sponsor|1|||
128912852|NCT00930059|463972508|FG001|Overall Study|1 site terminated by sponsor|1|||
128912853|NCT00930059|463972507|FG000|Overall Study|Adverse Event|1|||
128912854|NCT00930059|463972508|FG001|Overall Study|Adverse Event|6|||
128912855|NCT04002310|463972511|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
128912856|NCT04002310|463972512|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
128912857|NCT04002310|463972513|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
128912858|NCT04002310|463972514|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
128912859|NCT04002310|463972515|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
128912860|NCT00542997|463972516|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
128912861|NCT00542997|463972516|FG000|Wash in / Wash Out Period|Adverse Event|3|||
128912862|NCT00542997|463972516|FG000|Efficacy Period|Adverse Event|3|||
128912863|NCT03064763|463972522|FG000|Overall Study|Lost to Follow-up|1|||
128912864|NCT03064763|463972522|FG000|Overall Study|Death|8|||
128912865|NCT00808444|463972532|FG000|Overall Study|Withdrawal by Subject|1|||
128912866|NCT00808444|463972533|FG001|Overall Study|Withdrawal by Subject|0|||
128912867|NCT00808444|463972532|FG000|Overall Study|Lost to Follow-up|0|||
128912868|NCT00808444|463972533|FG001|Overall Study|Lost to Follow-up|1|||
128912869|NCT01461044|463972534|FG000|Overall Study|Death|58|||
128912870|NCT01461044|463972535|FG001|Overall Study|Death|35|||
128912871|NCT01461044|463972534|FG000|Overall Study|Lost to Follow-up|12|||
128912872|NCT01461044|463972535|FG001|Overall Study|Lost to Follow-up|5|||
128912873|NCT00716976|463972536|FG000|Overall Study|Adverse Event|2|||
128912874|NCT00716976|463972537|FG001|Overall Study|Adverse Event|0|||
128912875|NCT00716976|463972536|FG000|Overall Study|Death|1|||
128912876|NCT00716976|463972537|FG001|Overall Study|Death|0|||
128912877|NCT00716976|463972536|FG000|Overall Study|Physician Decision|2|||
128912878|NCT00716976|463972537|FG001|Overall Study|Physician Decision|2|||
128912879|NCT00716976|463972536|FG000|Overall Study|Withdrawal by Subject|5|||
128912880|NCT00716976|463972537|FG001|Overall Study|Withdrawal by Subject|1|||
128912881|NCT00716976|463972536|FG000|Overall Study|Premature discontinuation cisplatin|5|||
128912882|NCT00716976|463972537|FG001|Overall Study|Premature discontinuation cisplatin|4|||
128912883|NCT00716976|463972536|FG000|Overall Study|Radiation during protocol|1|||
128912884|NCT00716976|463972537|FG001|Overall Study|Radiation during protocol|0|||
128912885|NCT00716976|463972536|FG000|Overall Study|Ineligibles|4|||
128912886|NCT00716976|463972537|FG001|Overall Study|Ineligibles|2|||
128912887|NCT00122135|463972538|FG000|Overall Study|Withdrawal by Subject|3|||
128912888|NCT00122135|463972539|FG001|Overall Study|Withdrawal by Subject|0|||
128912889|NCT03068325|463972545|FG000|Overall Study|Lost to Follow-up|5|||
129118736|NCT03154086|464731201|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128697164|NCT02993757|463189014|FG000|Overall Study|Lost to Follow-up|1|||
128697165|NCT02993757|463189015|FG001|Overall Study|Lost to Follow-up|0|||
128697166|NCT02993757|463189014|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
128697167|NCT02993757|463189015|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
128697168|NCT00957580|463189018|FG000|Overall Study|Ongoing at data cut-off|0|||
128697169|NCT00957580|463189019|FG001|Overall Study|Ongoing at data cut-off|1|||
128697170|NCT00957580|463189020|FG002|Overall Study|Ongoing at data cut-off|0|||
128697171|NCT00957580|463189018|FG000|Overall Study|Enrolled but not treated|0|||
128697172|NCT00957580|463189019|FG001|Overall Study|Enrolled but not treated|1|||
128697173|NCT00957580|463189020|FG002|Overall Study|Enrolled but not treated|0|||
128697174|NCT01090492|463189021|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
128697175|NCT01090492|463189022|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
128697176|NCT01090492|463189023|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
128912890|NCT00975156|463972546|FG000|Overall Study|Protocol Violation|0|||
128912891|NCT00975156|463972547|FG001|Overall Study|Protocol Violation|1|||
128912892|NCT00454779|463972552|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
128912893|NCT00454779|463972553|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
128912894|NCT00454779|463972552|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
129118737|NCT03154086|464731202|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128697177|NCT01090492|463189024|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
128912895|NCT00454779|463972553|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
128912896|NCT00454779|463972552|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
128912897|NCT00454779|463972553|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
128912898|NCT00454779|463972552|FG000|First-line Treatment Phase|Protocol Violation|0|||
128912899|NCT00454779|463972553|FG001|First-line Treatment Phase|Protocol Violation|1|||
128912900|NCT00454779|463972552|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
128912901|NCT00454779|463972553|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
128912902|NCT00454779|463972552|FG000|First-line Treatment Phase|Ongoing|1|||
128912903|NCT00454779|463972553|FG001|First-line Treatment Phase|Ongoing|0|||
128912904|NCT00454779|463972552|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
128912905|NCT00454779|463972553|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
128912906|NCT00454779|463972552|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
128912907|NCT00454779|463972553|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
128912908|NCT00454779|463972552|FG000|Second-line Treatment Phase|Ongoing|0|||
128912909|NCT00454779|463972553|FG001|Second-line Treatment Phase|Ongoing|1|||
128912910|NCT05425563|463972554|FG000|Overall Study|Withdrawal by Subject|17|||
128912911|NCT00634569|463972557|FG000|Overall Study|Withdrawal by Subject|0|||
128912912|NCT00634569|463972558|FG001|Overall Study|Withdrawal by Subject|4|||
128912913|NCT00634569|463972557|FG000|Overall Study|Physician Decision|0|||
128912914|NCT00634569|463972558|FG001|Overall Study|Physician Decision|1|||
128912915|NCT01163786|463972559|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
128912916|NCT01163786|463972559|FG000|Treatment With Bortezomib|Adverse Event|2|||
128912917|NCT01163786|463972559|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
128912918|NCT03222349|463972560|FG000|Overall Study|Treatment B not done|5|||
128912919|NCT03222349|463972561|FG001|Overall Study|Treatment B not done|0|||
128912920|NCT03222349|463972560|FG000|Overall Study|Lost to Follow-up|1|||
128912921|NCT03222349|463972561|FG001|Overall Study|Lost to Follow-up|2|||
128912922|NCT03222349|463972560|FG000|Overall Study|Withdrawal by Subject|1|||
128912923|NCT03222349|463972561|FG001|Overall Study|Withdrawal by Subject|0|||
128912924|NCT03222349|463972560|FG000|Overall Study|Treatment A not done|0|||
128912925|NCT03222349|463972561|FG001|Overall Study|Treatment A not done|5|||
128912926|NCT03222349|463972560|FG000|Overall Study|Study terminated by sponsor|1|||
128912927|NCT03222349|463972561|FG001|Overall Study|Study terminated by sponsor|0|||
128912928|NCT01808612|463972568|FG000|Treatment Period|Adverse Event|8|||
128912929|NCT01808612|463972569|FG001|Treatment Period|Adverse Event|4|||
128912930|NCT01808612|463972570|FG002|Treatment Period|Adverse Event|3|||
128912931|NCT01808612|463972568|FG000|Treatment Period|Lost to Follow-up|2|||
128912932|NCT01808612|463972569|FG001|Treatment Period|Lost to Follow-up|2|||
128912933|NCT01808612|463972570|FG002|Treatment Period|Lost to Follow-up|1|||
128697178|NCT01090492|463189025|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
128697179|NCT01090492|463189026|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
128697180|NCT01090492|463189027|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
128697181|NCT01090492|463189028|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
128697182|NCT01090492|463189021|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
128697183|NCT01090492|463189022|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
128697184|NCT01090492|463189023|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
128697185|NCT01090492|463189024|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
128697186|NCT01090492|463189025|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
128697187|NCT01090492|463189026|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
128697188|NCT01090492|463189027|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
128697189|NCT01090492|463189028|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
128697190|NCT01090492|463189021|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697191|NCT01090492|463189022|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697192|NCT01090492|463189023|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
128912934|NCT01808612|463972568|FG000|Treatment Period|Protocol Violation|1|||
128912935|NCT01808612|463972569|FG001|Treatment Period|Protocol Violation|0|||
128912936|NCT01808612|463972570|FG002|Treatment Period|Protocol Violation|0|||
128912937|NCT01808612|463972568|FG000|Treatment Period|Withdrawal by Subject|1|||
128765427|NCT03445065|463432152|FG000|Overall Study|Withdrawal by Subject|3|||
128765428|NCT03445065|463432153|FG001|Overall Study|Withdrawal by Subject|6|||
128765429|NCT03445065|463432154|FG002|Overall Study|Withdrawal by Subject|2|||
128765430|NCT03445065|463432155|FG003|Overall Study|Withdrawal by Subject|2|||
128765431|NCT03445065|463432152|FG000|Overall Study|Other|4|||
128765432|NCT03445065|463432153|FG001|Overall Study|Other|3|||
128765433|NCT03445065|463432154|FG002|Overall Study|Other|3|||
128765434|NCT03445065|463432155|FG003|Overall Study|Other|1|||
128765435|NCT03315130|463432156|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
128765436|NCT03315130|463432157|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
128765437|NCT03315130|463432158|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
128765438|NCT03315130|463432159|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
128765439|NCT03315130|463432156|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
128765440|NCT03315130|463432157|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
128765441|NCT03315130|463432158|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
128765442|NCT03315130|463432159|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
128765443|NCT03315130|463432156|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
128765444|NCT03315130|463432157|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
128765445|NCT03315130|463432158|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
128765446|NCT03315130|463432159|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
128765447|NCT03315130|463432156|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
128765448|NCT03315130|463432157|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
128697193|NCT01090492|463189024|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697194|NCT01090492|463189025|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697195|NCT01090492|463189026|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697196|NCT01090492|463189027|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697197|NCT01090492|463189028|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697198|NCT01090492|463189021|FG000|First Intervention Period (4 Weeks)|Other|0|||
128697199|NCT01090492|463189022|FG001|First Intervention Period (4 Weeks)|Other|0|||
128697200|NCT01090492|463189023|FG002|First Intervention Period (4 Weeks)|Other|1|||
128697201|NCT01090492|463189024|FG003|First Intervention Period (4 Weeks)|Other|1|||
128697202|NCT01090492|463189025|FG004|First Intervention Period (4 Weeks)|Other|2|||
128697203|NCT01090492|463189026|FG005|First Intervention Period (4 Weeks)|Other|0|||
128765449|NCT03315130|463432158|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
128765450|NCT03315130|463432159|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
128765451|NCT03315130|463432156|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
128765452|NCT03315130|463432157|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
128765453|NCT03315130|463432158|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
128765454|NCT03315130|463432159|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
128765455|NCT03315130|463432156|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
128765456|NCT03315130|463432157|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
128765457|NCT03315130|463432158|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
128765458|NCT03315130|463432159|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
128765459|NCT00524030|463432160|FG000|Overall Study|Lack of Efficacy|10|||
128765460|NCT00524030|463432161|FG001|Overall Study|Lack of Efficacy|24|||
128765461|NCT00524030|463432160|FG000|Overall Study|Lost to Follow-up|0|||
128765462|NCT00524030|463432161|FG001|Overall Study|Lost to Follow-up|2|||
128765463|NCT00524030|463432160|FG000|Overall Study|Withdrawal by Subject|3|||
128765464|NCT00524030|463432161|FG001|Overall Study|Withdrawal by Subject|8|||
128765465|NCT00524030|463432160|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
128765466|NCT00524030|463432161|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
128765467|NCT00524030|463432160|FG000|Overall Study|Protocol Violation|0|||
128765468|NCT00524030|463432161|FG001|Overall Study|Protocol Violation|1|||
128765469|NCT00524030|463432160|FG000|Overall Study|Pregnancy|1|||
128765470|NCT00524030|463432161|FG001|Overall Study|Pregnancy|0|||
128765471|NCT00524030|463432160|FG000|Overall Study|Adverse Event|3|||
128765472|NCT00524030|463432161|FG001|Overall Study|Adverse Event|21|||
128765473|NCT00524030|463432160|FG000|Overall Study|Death|0|||
128765474|NCT00524030|463432161|FG001|Overall Study|Death|1|||
128765475|NCT02089230|463432169|FG000|Overall Study|Death|0|||
129215651|NCT03077412|465092787|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
128697204|NCT01090492|463189027|FG006|First Intervention Period (4 Weeks)|Other|0|||
128765476|NCT02089230|463432170|FG001|Overall Study|Death|0|||
128765477|NCT02089230|463432171|FG002|Overall Study|Death|2|||
128765478|NCT02089230|463432169|FG000|Overall Study|Seeking Alternative Therapy|0|||
128765479|NCT02089230|463432170|FG001|Overall Study|Seeking Alternative Therapy|0|||
128765480|NCT02089230|463432171|FG002|Overall Study|Seeking Alternative Therapy|4|||
128765481|NCT02392611|463433831|FG000|Overall Study|Adverse Event|0|||
128765482|NCT02392611|463433832|FG001|Overall Study|Adverse Event|0|||
128765483|NCT02392611|463433833|FG002|Overall Study|Adverse Event|0|||
128697205|NCT01090492|463189028|FG007|First Intervention Period (4 Weeks)|Other|0|||
128765484|NCT02392611|463433834|FG003|Overall Study|Adverse Event|1|||
128697206|NCT01090492|463189021|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
128697207|NCT01090492|463189022|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
128697208|NCT01090492|463189023|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
128697209|NCT01090492|463189024|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
128697210|NCT01090492|463189025|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
128697211|NCT01090492|463189026|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
128697212|NCT01090492|463189027|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
128697213|NCT01090492|463189028|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
128697214|NCT01090492|463189021|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
128697215|NCT01090492|463189022|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
128697216|NCT01090492|463189023|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
128697217|NCT01090492|463189024|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
128697218|NCT01090492|463189025|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
128697219|NCT01090492|463189026|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
128697220|NCT01090492|463189027|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
128697221|NCT01090492|463189028|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
128697222|NCT01090492|463189021|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
128697223|NCT01090492|463189022|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
128697224|NCT01090492|463189023|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
128697225|NCT01090492|463189024|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
128697226|NCT01090492|463189025|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
128697227|NCT01090492|463189026|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
128697228|NCT01090492|463189027|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
128697229|NCT01090492|463189028|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
128697230|NCT01090492|463189021|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
128697231|NCT01090492|463189022|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
128697232|NCT01090492|463189023|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
128697233|NCT01090492|463189024|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
128697234|NCT01090492|463189025|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
128697235|NCT01090492|463189026|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
128697236|NCT01090492|463189027|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
128697237|NCT01090492|463189028|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
128697238|NCT01090492|463189021|FG000|Second Intervention Period (4 Weeks)|Other|0|||
128697239|NCT01090492|463189022|FG001|Second Intervention Period (4 Weeks)|Other|1|||
128697240|NCT01090492|463189023|FG002|Second Intervention Period (4 Weeks)|Other|1|||
128912938|NCT01808612|463972569|FG001|Treatment Period|Withdrawal by Subject|0|||
128912939|NCT01808612|463972570|FG002|Treatment Period|Withdrawal by Subject|4|||
128912940|NCT01808612|463972568|FG000|Treatment Period|Physician Decision|1|||
128912941|NCT01808612|463972569|FG001|Treatment Period|Physician Decision|0|||
128912942|NCT01808612|463972570|FG002|Treatment Period|Physician Decision|4|||
128912943|NCT01808612|463972568|FG000|Treatment Period|Sponsor Decision|1|||
128912944|NCT01808612|463972569|FG001|Treatment Period|Sponsor Decision|0|||
128912945|NCT01808612|463972570|FG002|Treatment Period|Sponsor Decision|0|||
128912946|NCT01808612|463972568|FG000|Treatment Period|Lack of Efficacy|1|||
128912947|NCT01808612|463972569|FG001|Treatment Period|Lack of Efficacy|1|||
128912948|NCT01808612|463972570|FG002|Treatment Period|Lack of Efficacy|2|||
128912949|NCT01808612|463972568|FG000|Discontinuation Period|Adverse Event|1|||
128912950|NCT01808612|463972569|FG001|Discontinuation Period|Adverse Event|0|||
128912951|NCT01808612|463972570|FG002|Discontinuation Period|Adverse Event|0|||
128912952|NCT01808612|463972568|FG000|Discontinuation Period|Physician Decision|1|||
128912953|NCT01808612|463972569|FG001|Discontinuation Period|Physician Decision|0|||
128912954|NCT01808612|463972570|FG002|Discontinuation Period|Physician Decision|0|||
128912955|NCT01808612|463972568|FG000|Discontinuation Period|Lost to Follow-up|0|||
128912956|NCT01808612|463972569|FG001|Discontinuation Period|Lost to Follow-up|1|||
128912957|NCT01808612|463972570|FG002|Discontinuation Period|Lost to Follow-up|0|||
128912958|NCT04823949|463972571|FG000|Overall Study|Withdrawal by Subject|0|||
128912959|NCT04823949|463972572|FG001|Overall Study|Withdrawal by Subject|4|||
128912960|NCT04823949|463972571|FG000|Overall Study|Physician Decision|0|||
128912961|NCT04823949|463972572|FG001|Overall Study|Physician Decision|1|||
128912962|NCT01700192|463972574|FG000|Overall Study|Adverse Event|73|||
128912963|NCT01700192|463972575|FG001|Overall Study|Adverse Event|18|||
128912964|NCT01700192|463972574|FG000|Overall Study|Lack of Efficacy|1|||
128912965|NCT01700192|463972575|FG001|Overall Study|Lack of Efficacy|0|||
128912966|NCT01700192|463972574|FG000|Overall Study|Lost to Follow-up|42|||
128697241|NCT01090492|463189024|FG003|Second Intervention Period (4 Weeks)|Other|0|||
128697242|NCT01090492|463189025|FG004|Second Intervention Period (4 Weeks)|Other|0|||
128912967|NCT01700192|463972575|FG001|Overall Study|Lost to Follow-up|29|||
128912968|NCT01700192|463972574|FG000|Overall Study|Noncompliance with study drug|0|||
128912969|NCT01700192|463972575|FG001|Overall Study|Noncompliance with study drug|5|||
128912970|NCT01700192|463972574|FG000|Overall Study|Physician Decision|2|||
128912971|NCT01700192|463972575|FG001|Overall Study|Physician Decision|3|||
128912972|NCT01700192|463972574|FG000|Overall Study|Pregnancy|1|||
128912973|NCT01700192|463972575|FG001|Overall Study|Pregnancy|4|||
128697243|NCT01090492|463189026|FG005|Second Intervention Period (4 Weeks)|Other|0|||
128697244|NCT01090492|463189027|FG006|Second Intervention Period (4 Weeks)|Other|0|||
128697245|NCT01090492|463189028|FG007|Second Intervention Period (4 Weeks)|Other|0|||
128697246|NCT01090492|463189021|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
128697247|NCT01090492|463189022|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
128912974|NCT01700192|463972574|FG000|Overall Study|Progressive disease|1|||
128912975|NCT01700192|463972575|FG001|Overall Study|Progressive disease|0|||
128912976|NCT01700192|463972574|FG000|Overall Study|Protocol Violation|3|||
128912977|NCT01700192|463972575|FG001|Overall Study|Protocol Violation|4|||
128912978|NCT01700192|463972574|FG000|Overall Study|Technical problems|0|||
128912979|NCT01700192|463972575|FG001|Overall Study|Technical problems|1|||
128912980|NCT01700192|463972574|FG000|Overall Study|Withdrawal by Subject|56|||
128912981|NCT01700192|463972575|FG001|Overall Study|Withdrawal by Subject|64|||
128912982|NCT01700192|463972574|FG000|Overall Study|Never received study drug|1|||
128912983|NCT01700192|463972575|FG001|Overall Study|Never received study drug|0|||
128912984|NCT02793232|463972576|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
128912985|NCT02793232|463972577|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
128912986|NCT02793232|463972578|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
128912987|NCT02793232|463972579|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
128912988|NCT02793232|463972580|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
128912989|NCT02793232|463972581|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
128912990|NCT02793232|463972582|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
128912991|NCT02793232|463972583|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
128912992|NCT02793232|463972584|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
128912993|NCT00993928|463972585|FG000|Overall Study|Withdrawal by Subject|4|||
128912994|NCT00993928|463972586|FG001|Overall Study|Withdrawal by Subject|7|||
128912995|NCT00993928|463972585|FG000|Overall Study|ineligible|1|||
128912996|NCT00993928|463972586|FG001|Overall Study|ineligible|0|||
128912997|NCT03979274|463972587|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128912998|NCT03979274|463972588|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128912999|NCT03551743|463972591|FG000|Overall Study|Adverse Event|1|||
128913000|NCT03551743|463972592|FG001|Overall Study|Adverse Event|0|||
128913001|NCT03551743|463972593|FG002|Overall Study|Adverse Event|0|||
128913002|NCT03551743|463972594|FG003|Overall Study|Adverse Event|0|||
128913003|NCT03551743|463972591|FG000|Overall Study|Withdrawal by Subject|1|||
128913004|NCT03551743|463972592|FG001|Overall Study|Withdrawal by Subject|0|||
128913005|NCT03551743|463972593|FG002|Overall Study|Withdrawal by Subject|0|||
128913006|NCT03551743|463972594|FG003|Overall Study|Withdrawal by Subject|0|||
128913007|NCT02319044|463972595|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
128913008|NCT02319044|463972596|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
128913009|NCT02319044|463972597|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
128913010|NCT02319044|463972595|FG000|Overall Study|Withdrawal by Subject|3|||
128913011|NCT02319044|463972596|FG001|Overall Study|Withdrawal by Subject|3|||
128913012|NCT02319044|463972597|FG002|Overall Study|Withdrawal by Subject|6|||
128913013|NCT02319044|463972595|FG000|Overall Study|Condition under investigation worsened|100|||
128913014|NCT02319044|463972596|FG001|Overall Study|Condition under investigation worsened|50|||
128913015|NCT02319044|463972597|FG002|Overall Study|Condition under investigation worsened|46|||
128913016|NCT02319044|463972595|FG000|Overall Study|Adverse Event|17|||
128913017|NCT02319044|463972596|FG001|Overall Study|Adverse Event|2|||
128913018|NCT02319044|463972597|FG002|Overall Study|Adverse Event|8|||
128913019|NCT02319044|463972595|FG000|Overall Study|Study specific discontinuation criteria|2|||
128913020|NCT02319044|463972596|FG001|Overall Study|Study specific discontinuation criteria|2|||
128913021|NCT02319044|463972597|FG002|Overall Study|Study specific discontinuation criteria|1|||
128913022|NCT02319044|463972595|FG000|Overall Study|Not treated|0|||
128913023|NCT02319044|463972596|FG001|Overall Study|Not treated|2|||
128697248|NCT01090492|463189023|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
128697249|NCT01090492|463189024|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
128697250|NCT01090492|463189025|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
128697251|NCT01090492|463189026|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
128697252|NCT01090492|463189027|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
128697253|NCT01090492|463189028|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
128697254|NCT01090492|463189021|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697255|NCT01090492|463189022|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697256|NCT01090492|463189023|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128913024|NCT02319044|463972597|FG002|Overall Study|Not treated|2|||
128765485|NCT02392611|463433835|FG004|Overall Study|Adverse Event|0|||
128913025|NCT02317562|463972598|FG000|Overall Study|Physician Decision|1|||
128913026|NCT02317562|463972598|FG000|Overall Study|early termination of the study|8|||
128913027|NCT02317562|463972598|FG000|Overall Study|Lack of Efficacy|4|||
128913028|NCT02317562|463972598|FG000|Overall Study|Withdrawal by Subject|1|||
128913029|NCT00626093|463972599|FG000|Overall Study|Lost to Follow-up|5|||
128913030|NCT00626093|463972599|FG000|Overall Study|Death|1|||
128913031|NCT00626093|463972599|FG000|Overall Study|Physician Decision|4|||
128913032|NCT00626093|463972599|FG000|Overall Study|Withdrawal by Subject|6|||
128913033|NCT00626093|463972599|FG000|Overall Study|Protocol Violation|1|||
128913034|NCT00626093|463972599|FG000|Overall Study|One of the required devices not implante|6|||
128913035|NCT03434379|463972600|FG000|Global Period|Lost to Follow-up|3|||
128913036|NCT03434379|463972601|FG001|Global Period|Lost to Follow-up|6|||
128913037|NCT03434379|463972602|FG002|Global Period|Lost to Follow-up|0|||
128913038|NCT03434379|463972603|FG003|Global Period|Lost to Follow-up|0|||
128913039|NCT03434379|463972600|FG000|Global Period|Death|115|||
128913040|NCT03434379|463972601|FG001|Global Period|Death|228|||
128913041|NCT03434379|463972602|FG002|Global Period|Death|0|||
128913042|NCT03434379|463972603|FG003|Global Period|Death|0|||
128913043|NCT03434379|463972600|FG000|Global Period|Withdrawal by Subject|20|||
128913044|NCT03434379|463972601|FG001|Global Period|Withdrawal by Subject|21|||
128913045|NCT03434379|463972602|FG002|Global Period|Withdrawal by Subject|0|||
128913046|NCT03434379|463972603|FG003|Global Period|Withdrawal by Subject|0|||
128913047|NCT03434379|463972600|FG000|Global Period|Reason Unspecified|0|||
128913048|NCT03434379|463972601|FG001|Global Period|Reason Unspecified|1|||
128913049|NCT03434379|463972602|FG002|Global Period|Reason Unspecified|0|||
128913050|NCT03434379|463972603|FG003|Global Period|Reason Unspecified|0|||
128913051|NCT03434379|463972600|FG000|Global Period|Study Ended by Sponsor|26|||
128913052|NCT03434379|463972601|FG001|Global Period|Study Ended by Sponsor|80|||
128913053|NCT03434379|463972602|FG002|Global Period|Study Ended by Sponsor|0|||
128913054|NCT03434379|463972603|FG003|Global Period|Study Ended by Sponsor|0|||
128913055|NCT03434379|463972600|FG000|Global Period|Physician Decision|1|||
128913056|NCT03434379|463972601|FG001|Global Period|Physician Decision|0|||
128913057|NCT03434379|463972602|FG002|Global Period|Physician Decision|0|||
128913058|NCT03434379|463972603|FG003|Global Period|Physician Decision|0|||
128913059|NCT03434379|463972600|FG000|China Extension Period|Lost to Follow-up|0|||
128913060|NCT03434379|463972601|FG001|China Extension Period|Lost to Follow-up|0|||
128913061|NCT03434379|463972602|FG002|China Extension Period|Lost to Follow-up|2|||
128913062|NCT03434379|463972603|FG003|China Extension Period|Lost to Follow-up|3|||
128913063|NCT03434379|463972600|FG000|China Extension Period|Death|0|||
128913064|NCT03434379|463972601|FG001|China Extension Period|Death|0|||
128913065|NCT03434379|463972602|FG002|China Extension Period|Death|46|||
128913066|NCT03434379|463972603|FG003|China Extension Period|Death|88|||
128913067|NCT03434379|463972600|FG000|China Extension Period|Withdrawal by Subject|0|||
128913068|NCT03434379|463972601|FG001|China Extension Period|Withdrawal by Subject|0|||
128913069|NCT03434379|463972602|FG002|China Extension Period|Withdrawal by Subject|8|||
128913070|NCT03434379|463972603|FG003|China Extension Period|Withdrawal by Subject|6|||
128913071|NCT03434379|463972600|FG000|China Extension Period|Study Ended by Sponsor|0|||
128913072|NCT03434379|463972601|FG001|China Extension Period|Study Ended by Sponsor|0|||
128913073|NCT03434379|463972602|FG002|China Extension Period|Study Ended by Sponsor|5|||
128913074|NCT03434379|463972603|FG003|China Extension Period|Study Ended by Sponsor|36|||
128913075|NCT04556617|463972610|FG000|Overall Study|progressive disease|0|||
128913076|NCT04556617|463972611|FG001|Overall Study|progressive disease|2|||
128913077|NCT04556617|463972612|FG002|Overall Study|progressive disease|2|||
128913078|NCT04556617|463972613|FG003|Overall Study|progressive disease|1|||
128913079|NCT04556617|463972614|FG004|Overall Study|progressive disease|1|||
128913080|NCT04556617|463972610|FG000|Overall Study|Physician Decision|0|||
128913081|NCT04556617|463972611|FG001|Overall Study|Physician Decision|0|||
128913082|NCT04556617|463972612|FG002|Overall Study|Physician Decision|2|||
128913083|NCT04556617|463972613|FG003|Overall Study|Physician Decision|0|||
128913084|NCT04556617|463972614|FG004|Overall Study|Physician Decision|0|||
128913085|NCT04556617|463972610|FG000|Overall Study|Adverse Event|0|||
128913086|NCT04556617|463972611|FG001|Overall Study|Adverse Event|0|||
128913087|NCT04556617|463972612|FG002|Overall Study|Adverse Event|2|||
128913088|NCT04556617|463972613|FG003|Overall Study|Adverse Event|3|||
128697257|NCT01090492|463189024|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697258|NCT01090492|463189025|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697259|NCT01090492|463189026|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697260|NCT01090492|463189027|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
128697261|NCT01090492|463189028|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
128697262|NCT03113071|463189029|FG000|Overall Study|Withdrawal by Subject|1|||
128697263|NCT03113071|463189030|FG001|Overall Study|Withdrawal by Subject|0|||
128697264|NCT01602120|463189031|FG000|Overall Study|Adverse Event|3|||
128697265|NCT01602120|463189032|FG001|Overall Study|Adverse Event|6|||
128913089|NCT04556617|463972614|FG004|Overall Study|Adverse Event|0|||
128913090|NCT04556617|463972610|FG000|Overall Study|Withdrawal by Subject|0|||
128913091|NCT04556617|463972611|FG001|Overall Study|Withdrawal by Subject|2|||
128697266|NCT01602120|463189033|FG002|Overall Study|Adverse Event|0|||
128913092|NCT04556617|463972612|FG002|Overall Study|Withdrawal by Subject|1|||
128913093|NCT04556617|463972613|FG003|Overall Study|Withdrawal by Subject|1|||
128913094|NCT04556617|463972614|FG004|Overall Study|Withdrawal by Subject|0|||
128913095|NCT04556617|463972610|FG000|Overall Study|PSA increase|0|||
128913096|NCT04556617|463972611|FG001|Overall Study|PSA increase|1|||
128913097|NCT04556617|463972612|FG002|Overall Study|PSA increase|0|||
128913098|NCT04556617|463972613|FG003|Overall Study|PSA increase|0|||
128913099|NCT04556617|463972614|FG004|Overall Study|PSA increase|0|||
128913100|NCT04556617|463972610|FG000|Overall Study|Sponsor study termination|1|||
128913101|NCT04556617|463972611|FG001|Overall Study|Sponsor study termination|0|||
128913102|NCT04556617|463972612|FG002|Overall Study|Sponsor study termination|0|||
128913103|NCT04556617|463972613|FG003|Overall Study|Sponsor study termination|0|||
128913104|NCT04556617|463972614|FG004|Overall Study|Sponsor study termination|0|||
128913105|NCT04949841|463972615|FG000|Overall Study|Adverse Event|7|||
128913106|NCT04949841|463972615|FG000|Overall Study|Death|1|||
128913107|NCT04949841|463972615|FG000|Overall Study|Withdrawal by Subject|52|||
128913108|NCT04949841|463972615|FG000|Overall Study|Pregnancy|4|||
128913109|NCT04949841|463972615|FG000|Overall Study|Lost to Follow-up|9|||
128913110|NCT04949841|463972615|FG000|Overall Study|Lack of Efficacy|55|||
128913111|NCT04949841|463972615|FG000|Overall Study|Various reasons|9|||
128913112|NCT03179436|463972616|FG000|Overall Study|Withdrawal by Subject|1|||
128913113|NCT03179436|463972617|FG001|Overall Study|Withdrawal by Subject|0|||
128913114|NCT03179436|463972618|FG002|Overall Study|Withdrawal by Subject|0|||
128913115|NCT03179436|463972619|FG003|Overall Study|Withdrawal by Subject|4|||
128913116|NCT03179436|463972620|FG004|Overall Study|Withdrawal by Subject|2|||
128913117|NCT03179436|463972621|FG005|Overall Study|Withdrawal by Subject|2|||
128913118|NCT03179436|463972622|FG006|Overall Study|Withdrawal by Subject|5|||
128913119|NCT03179436|463972623|FG007|Overall Study|Withdrawal by Subject|0|||
128913120|NCT03179436|463972624|FG008|Overall Study|Withdrawal by Subject|3|||
128913121|NCT03179436|463972625|FG009|Overall Study|Withdrawal by Subject|0|||
128913122|NCT03179436|463972626|FG010|Overall Study|Withdrawal by Subject|0|||
128913123|NCT03179436|463972627|FG011|Overall Study|Withdrawal by Subject|0|||
128913124|NCT03179436|463972616|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128913125|NCT03179436|463972617|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128913126|NCT03179436|463972618|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128913127|NCT03179436|463972619|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128913128|NCT03179436|463972620|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
128913129|NCT03179436|463972621|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
128913130|NCT03179436|463972622|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
128913131|NCT03179436|463972623|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
128913132|NCT03179436|463972624|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
128913133|NCT03179436|463972625|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
128913134|NCT03179436|463972626|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
128913135|NCT03179436|463972627|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
128913136|NCT03179436|463972616|FG000|Overall Study|Sponsor Decision|0|||
128913137|NCT03179436|463972617|FG001|Overall Study|Sponsor Decision|0|||
128913138|NCT03179436|463972618|FG002|Overall Study|Sponsor Decision|1|||
128913139|NCT03179436|463972619|FG003|Overall Study|Sponsor Decision|3|||
128913140|NCT03179436|463972620|FG004|Overall Study|Sponsor Decision|9|||
128913141|NCT03179436|463972621|FG005|Overall Study|Sponsor Decision|7|||
128913142|NCT03179436|463972622|FG006|Overall Study|Sponsor Decision|2|||
128913143|NCT03179436|463972623|FG007|Overall Study|Sponsor Decision|4|||
128913144|NCT03179436|463972624|FG008|Overall Study|Sponsor Decision|23|||
128913145|NCT03179436|463972625|FG009|Overall Study|Sponsor Decision|6|||
128913146|NCT03179436|463972626|FG010|Overall Study|Sponsor Decision|7|||
128913147|NCT03179436|463972627|FG011|Overall Study|Sponsor Decision|5|||
128913148|NCT03179436|463972616|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913149|NCT03179436|463972617|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
128913150|NCT03179436|463972618|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913151|NCT03179436|463972619|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913152|NCT03179436|463972620|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913153|NCT03179436|463972621|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
128913154|NCT03179436|463972622|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913155|NCT03179436|463972623|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913156|NCT03179436|463972624|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913157|NCT03179436|463972625|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913158|NCT03179436|463972626|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
129118738|NCT03154086|464731203|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129118739|NCT03154086|464731204|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128913159|NCT03179436|463972627|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
128913160|NCT03179436|463972616|FG000|Overall Study|Lost to Follow-up|1|||
128913161|NCT03179436|463972617|FG001|Overall Study|Lost to Follow-up|0|||
128913162|NCT03179436|463972618|FG002|Overall Study|Lost to Follow-up|0|||
128913163|NCT03179436|463972619|FG003|Overall Study|Lost to Follow-up|1|||
128913164|NCT03179436|463972620|FG004|Overall Study|Lost to Follow-up|0|||
128913165|NCT03179436|463972621|FG005|Overall Study|Lost to Follow-up|1|||
128913166|NCT03179436|463972622|FG006|Overall Study|Lost to Follow-up|0|||
128913167|NCT03179436|463972623|FG007|Overall Study|Lost to Follow-up|0|||
128913168|NCT03179436|463972624|FG008|Overall Study|Lost to Follow-up|1|||
128913169|NCT03179436|463972625|FG009|Overall Study|Lost to Follow-up|1|||
128913170|NCT03179436|463972626|FG010|Overall Study|Lost to Follow-up|0|||
128913171|NCT03179436|463972627|FG011|Overall Study|Lost to Follow-up|0|||
128765486|NCT02392611|463433836|FG005|Overall Study|Adverse Event|0|||
128913172|NCT03179436|463972616|FG000|Overall Study|Death|12|||
128913173|NCT03179436|463972617|FG001|Overall Study|Death|17|||
128913174|NCT03179436|463972618|FG002|Overall Study|Death|7|||
128913175|NCT03179436|463972619|FG003|Overall Study|Death|32|||
128913176|NCT03179436|463972620|FG004|Overall Study|Death|29|||
128913177|NCT03179436|463972621|FG005|Overall Study|Death|30|||
128913178|NCT03179436|463972622|FG006|Overall Study|Death|33|||
128913179|NCT03179436|463972623|FG007|Overall Study|Death|9|||
128913180|NCT03179436|463972624|FG008|Overall Study|Death|84|||
128913181|NCT03179436|463972625|FG009|Overall Study|Death|33|||
128913182|NCT03179436|463972626|FG010|Overall Study|Death|22|||
128913183|NCT03179436|463972627|FG011|Overall Study|Death|15|||
128913184|NCT05168267|463972628|FG000|Overall Study|Withdrawal by Subject|2|||
128913185|NCT05168267|463972629|FG001|Overall Study|Withdrawal by Subject|1|||
128913186|NCT05168267|463972628|FG000|Overall Study|Withdrawn by Therapist|1|||
128913187|NCT05168267|463972629|FG001|Overall Study|Withdrawn by Therapist|1|||
128913188|NCT05168267|463972628|FG000|Overall Study|Left Facility|1|||
128913189|NCT05168267|463972629|FG001|Overall Study|Left Facility|0|||
128913190|NCT05702736|463972630|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
128913191|NCT05702736|463972631|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
128913192|NCT05702736|463972630|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
128913193|NCT05702736|463972631|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
128913194|NCT01877083|463972634|FG000|Treatment Phase|Disease Progression|10|||
128913195|NCT01877083|463972634|FG000|Treatment Phase|Clinical Progression|1|||
128913196|NCT01877083|463972634|FG000|Treatment Phase|Adverse Event|6|||
128913197|NCT01877083|463972634|FG000|Treatment Phase|Withdrawal by Subject|2|||
128913198|NCT01877083|463972634|FG000|Treatment Phase|Lost to Follow-up|1|||
128913199|NCT01877083|463972634|FG000|Extension Phase|Disease Progression|3|||
128913200|NCT01877083|463972634|FG000|Extension Phase|Adverse Event|2|||
128913201|NCT00500682|463972635|FG000|Overall Study|Adverse Event|37|||
128913202|NCT00500682|463972636|FG001|Overall Study|Adverse Event|29|||
128913203|NCT00500682|463972635|FG000|Overall Study|Death|25|||
128913204|NCT00500682|463972636|FG001|Overall Study|Death|16|||
128913205|NCT00500682|463972635|FG000|Overall Study|Lost to Follow-up|11|||
128913206|NCT00500682|463972636|FG001|Overall Study|Lost to Follow-up|11|||
128913207|NCT00500682|463972635|FG000|Overall Study|Physician Decision|6|||
128913208|NCT00500682|463972636|FG001|Overall Study|Physician Decision|10|||
128913209|NCT00500682|463972635|FG000|Overall Study|Pregnancy|2|||
128913210|NCT00500682|463972636|FG001|Overall Study|Pregnancy|0|||
128913211|NCT00500682|463972635|FG000|Overall Study|Protocol Violation|1|||
128913212|NCT00500682|463972636|FG001|Overall Study|Protocol Violation|3|||
128913213|NCT00500682|463972635|FG000|Overall Study|Withdrawal by Subject|80|||
128913214|NCT00500682|463972636|FG001|Overall Study|Withdrawal by Subject|74|||
128913215|NCT00500682|463972635|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
128913216|NCT00500682|463972636|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
128913217|NCT01582308|463972637|FG000|Period 1|Withdrawal by Subject|0|||
128913218|NCT01582308|463972638|FG001|Period 1|Withdrawal by Subject|0|||
128913219|NCT01582308|463972639|FG002|Period 1|Withdrawal by Subject|0|||
128913220|NCT01582308|463972640|FG003|Period 1|Withdrawal by Subject|0|||
128913221|NCT01582308|463972641|FG004|Period 1|Withdrawal by Subject|0|||
128913222|NCT01582308|463972642|FG005|Period 1|Withdrawal by Subject|0|||
128913223|NCT01582308|463972643|FG006|Period 1|Withdrawal by Subject|1|||
128913224|NCT01582308|463972644|FG007|Period 1|Withdrawal by Subject|0|||
128913225|NCT01582308|463972645|FG008|Period 1|Withdrawal by Subject|0|||
128913226|NCT01582308|463972646|FG009|Period 1|Withdrawal by Subject|0|||
128913227|NCT01582308|463972637|FG000|10-day Washout Following Period 1|Physician Decision|0|||
128913228|NCT01582308|463972638|FG001|10-day Washout Following Period 1|Physician Decision|0|||
128913229|NCT01582308|463972639|FG002|10-day Washout Following Period 1|Physician Decision|0|||
128913230|NCT01582308|463972640|FG003|10-day Washout Following Period 1|Physician Decision|0|||
128913231|NCT01582308|463972641|FG004|10-day Washout Following Period 1|Physician Decision|1|||
128913232|NCT01582308|463972642|FG005|10-day Washout Following Period 1|Physician Decision|0|||
128913233|NCT01582308|463972643|FG006|10-day Washout Following Period 1|Physician Decision|0|||
128913234|NCT01582308|463972644|FG007|10-day Washout Following Period 1|Physician Decision|0|||
128913235|NCT01582308|463972645|FG008|10-day Washout Following Period 1|Physician Decision|0|||
128913236|NCT01582308|463972646|FG009|10-day Washout Following Period 1|Physician Decision|0|||
128913237|NCT01582308|463972637|FG000|Period 4|Physician Decision|1|||
128913238|NCT01582308|463972638|FG001|Period 4|Physician Decision|0|||
128913239|NCT01582308|463972639|FG002|Period 4|Physician Decision|0|||
128913240|NCT01582308|463972640|FG003|Period 4|Physician Decision|0|||
128913241|NCT01582308|463972641|FG004|Period 4|Physician Decision|0|||
128913242|NCT01582308|463972642|FG005|Period 4|Physician Decision|1|||
128913243|NCT01582308|463972643|FG006|Period 4|Physician Decision|0|||
128913244|NCT01582308|463972644|FG007|Period 4|Physician Decision|0|||
128913245|NCT01582308|463972645|FG008|Period 4|Physician Decision|0|||
128913246|NCT01582308|463972646|FG009|Period 4|Physician Decision|1|||
128913247|NCT01182428|463972649|FG000|Overall Study|Physician Decision|1|||
128913248|NCT01182428|463972650|FG001|Overall Study|Physician Decision|0|||
128913249|NCT01182428|463972649|FG000|Overall Study|Lost to Follow-up|9|||
128913250|NCT01182428|463972650|FG001|Overall Study|Lost to Follow-up|1|||
128913251|NCT01182428|463972649|FG000|Overall Study|Withdrawal by Subject|1|||
128913252|NCT01182428|463972650|FG001|Overall Study|Withdrawal by Subject|0|||
128913253|NCT00684957|463972651|FG000|Overall Study|Withdrawal by Subject|1|||
128913254|NCT00684957|463972652|FG001|Overall Study|Withdrawal by Subject|1|||
128913255|NCT00684957|463972651|FG000|Overall Study|Lost to Follow-up|1|||
128913256|NCT00684957|463972652|FG001|Overall Study|Lost to Follow-up|0|||
128913257|NCT04484285|463974164|FG000|Overall Study|Unable to operate stimulator|3|||
128913258|NCT04484285|463974165|FG001|Overall Study|Unable to operate stimulator|0|||
128913259|NCT00768898|463974166|FG000|Overall Study|Unrelated injury|1|||
128913260|NCT00768898|463974166|FG000|Overall Study|Headache|1|||
128913261|NCT02949128|463974167|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
128913262|NCT02949128|463974167|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
128913263|NCT02949128|463974167|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
128913264|NCT02949128|463974167|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
128913265|NCT02949128|463974167|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
128913266|NCT02949128|463974167|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
128913267|NCT02949128|463974167|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
128913268|NCT02949128|463974167|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
128913269|NCT02949128|463974167|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
128913270|NCT02949128|463974167|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
128913271|NCT03160560|463974170|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
128913272|NCT03160560|463974171|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
128913273|NCT03160560|463974172|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
128913274|NCT03160560|463974173|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
128913275|NCT03160560|463974170|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
128913276|NCT03160560|463974171|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
128913277|NCT03160560|463974172|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
128913278|NCT03160560|463974173|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
128913279|NCT00667576|463974174|FG000|Overall Study|Withdrawal by Subject|1|||
128913280|NCT00667576|463974175|FG001|Overall Study|Withdrawal by Subject|0|||
128913281|NCT00667576|463974176|FG002|Overall Study|Withdrawal by Subject|1|||
128913282|NCT00667576|463974177|FG003|Overall Study|Withdrawal by Subject|1|||
128913283|NCT00667576|463974178|FG004|Overall Study|Withdrawal by Subject|1|||
128913284|NCT00667576|463974174|FG000|Overall Study|Adverse Event|1|||
128913285|NCT00667576|463974175|FG001|Overall Study|Adverse Event|1|||
128913286|NCT00667576|463974176|FG002|Overall Study|Adverse Event|0|||
128913287|NCT00667576|463974177|FG003|Overall Study|Adverse Event|0|||
128913288|NCT00667576|463974178|FG004|Overall Study|Adverse Event|0|||
128913289|NCT00667576|463974174|FG000|Overall Study|Lost to Follow-up|0|||
128913290|NCT00667576|463974175|FG001|Overall Study|Lost to Follow-up|0|||
128913291|NCT00667576|463974176|FG002|Overall Study|Lost to Follow-up|1|||
128913292|NCT00667576|463974177|FG003|Overall Study|Lost to Follow-up|0|||
128913293|NCT00667576|463974178|FG004|Overall Study|Lost to Follow-up|0|||
128913294|NCT00667576|463974174|FG000|Overall Study|Protocol Violation|0|||
128913295|NCT00667576|463974175|FG001|Overall Study|Protocol Violation|0|||
128913296|NCT00667576|463974176|FG002|Overall Study|Protocol Violation|0|||
128913297|NCT00667576|463974177|FG003|Overall Study|Protocol Violation|1|||
128913298|NCT00667576|463974178|FG004|Overall Study|Protocol Violation|0|||
128913299|NCT00667576|463974174|FG000|Overall Study|Physician Decision|0|||
128913300|NCT00667576|463974175|FG001|Overall Study|Physician Decision|0|||
128913301|NCT00667576|463974176|FG002|Overall Study|Physician Decision|0|||
128913302|NCT00667576|463974177|FG003|Overall Study|Physician Decision|1|||
128913303|NCT00667576|463974178|FG004|Overall Study|Physician Decision|0|||
128913304|NCT00667576|463974174|FG000|Overall Study|Missed Visit|0|||
128913305|NCT00667576|463974175|FG001|Overall Study|Missed Visit|0|||
128913306|NCT00667576|463974176|FG002|Overall Study|Missed Visit|0|||
128913307|NCT00667576|463974177|FG003|Overall Study|Missed Visit|1|||
128913308|NCT00667576|463974178|FG004|Overall Study|Missed Visit|0|||
128913309|NCT01390389|463974179|FG000|Overall Study|Withdrawal by Subject|2|||
128913310|NCT01390389|463974180|FG001|Overall Study|Withdrawal by Subject|0|||
128913311|NCT01390389|463974179|FG000|Overall Study|Screen Fail|2|||
128913312|NCT01390389|463974180|FG001|Overall Study|Screen Fail|1|||
128913313|NCT02002975|463974183|FG000|Overall Study|Case Report Forms Uncollected|135|||
129118740|NCT03154086|464731205|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128913314|NCT02002975|463974183|FG000|Overall Study|Protocol Deviation|437|||
128913315|NCT01430442|463974184|FG000|Overall Study|Subject Withdrew Consent|3|||
128913316|NCT01430442|463974185|FG001|Overall Study|Subject Withdrew Consent|0|||
128913317|NCT01430442|463974186|FG002|Overall Study|Subject Withdrew Consent|1|||
129118741|NCT03154086|464731206|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129118742|NCT03154086|464731207|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
128913318|NCT01430442|463974187|FG003|Overall Study|Subject Withdrew Consent|0|||
128913319|NCT01430442|463974188|FG004|Overall Study|Subject Withdrew Consent|2|||
128913320|NCT01430442|463974189|FG005|Overall Study|Subject Withdrew Consent|1|||
128913321|NCT01430442|463974190|FG006|Overall Study|Subject Withdrew Consent|5|||
128913322|NCT01430442|463974191|FG007|Overall Study|Subject Withdrew Consent|2|||
128913323|NCT01430442|463974184|FG000|Overall Study|Lost to Follow-up|2|||
128913324|NCT01430442|463974185|FG001|Overall Study|Lost to Follow-up|0|||
128913325|NCT01430442|463974186|FG002|Overall Study|Lost to Follow-up|1|||
128913326|NCT01430442|463974187|FG003|Overall Study|Lost to Follow-up|2|||
128913327|NCT01430442|463974188|FG004|Overall Study|Lost to Follow-up|2|||
128913328|NCT01430442|463974189|FG005|Overall Study|Lost to Follow-up|1|||
128913329|NCT01430442|463974190|FG006|Overall Study|Lost to Follow-up|5|||
128913330|NCT01430442|463974191|FG007|Overall Study|Lost to Follow-up|1|||
128913331|NCT01430442|463974184|FG000|Overall Study|Pregnancy|1|||
128913332|NCT01430442|463974185|FG001|Overall Study|Pregnancy|0|||
128913333|NCT01430442|463974186|FG002|Overall Study|Pregnancy|0|||
128913334|NCT01430442|463974187|FG003|Overall Study|Pregnancy|0|||
128913335|NCT01430442|463974188|FG004|Overall Study|Pregnancy|0|||
128913336|NCT01430442|463974189|FG005|Overall Study|Pregnancy|1|||
128913337|NCT01430442|463974190|FG006|Overall Study|Pregnancy|0|||
128913338|NCT01430442|463974191|FG007|Overall Study|Pregnancy|0|||
128913339|NCT01430442|463974184|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
128913340|NCT01430442|463974185|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
128913341|NCT01430442|463974186|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
128913342|NCT01430442|463974187|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
128913343|NCT01430442|463974188|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
128913344|NCT01430442|463974189|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
128913345|NCT01430442|463974190|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
128913346|NCT01430442|463974191|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
128913347|NCT01641939|463974192|FG000|Overall Study|Death|90|||
128913348|NCT01641939|463974193|FG001|Overall Study|Death|187|||
128913349|NCT01641939|463974194|FG002|Overall Study|Death|61|||
128913350|NCT01641939|463974192|FG000|Overall Study|Lost to Follow-up|3|||
128913351|NCT01641939|463974193|FG001|Overall Study|Lost to Follow-up|2|||
128913352|NCT01641939|463974194|FG002|Overall Study|Lost to Follow-up|1|||
128913353|NCT01641939|463974192|FG000|Overall Study|Withdrawal by Subject|14|||
128913354|NCT01641939|463974193|FG001|Overall Study|Withdrawal by Subject|11|||
128913355|NCT01641939|463974194|FG002|Overall Study|Withdrawal by Subject|5|||
128913356|NCT01641939|463974192|FG000|Overall Study|Study Terminated by Sponsor|10|||
128913357|NCT01641939|463974193|FG001|Overall Study|Study Terminated by Sponsor|28|||
128913358|NCT01641939|463974194|FG002|Overall Study|Study Terminated by Sponsor|3|||
128913359|NCT00772629|463974195|FG000|Overall Study|Subject was not vaccinated|1|||
128913360|NCT00772629|463974196|FG001|Overall Study|Subject was not vaccinated|0|||
128913361|NCT05162066|463974200|FG000|Overall Study|Adverse Event|1|||
128913362|NCT05162066|463974201|FG001|Overall Study|Adverse Event|0|||
128913363|NCT05162066|463974202|FG002|Overall Study|Adverse Event|0|||
128913364|NCT05162066|463974200|FG000|Overall Study|Perceived lack of efficacy|1|||
128913365|NCT05162066|463974201|FG001|Overall Study|Perceived lack of efficacy|0|||
128913366|NCT05162066|463974202|FG002|Overall Study|Perceived lack of efficacy|0|||
128913367|NCT01072344|463974203|FG000|Overall Study|Relasped-reached end point|7|||
128913368|NCT01072344|463974204|FG001|Overall Study|Relasped-reached end point|12|||
128913369|NCT01072344|463974203|FG000|Overall Study|Protocol Violation|1|||
128913370|NCT01072344|463974204|FG001|Overall Study|Protocol Violation|2|||
128913371|NCT01072344|463974203|FG000|Overall Study|Lost to Follow-up|3|||
128913372|NCT01072344|463974204|FG001|Overall Study|Lost to Follow-up|4|||
128913373|NCT01871090|463974205|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
128913374|NCT01871090|463974206|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
128697267|NCT01602120|463189034|FG003|Overall Study|Adverse Event|2|||
128697268|NCT01602120|463189031|FG000|Overall Study|Death|0|||
128697269|NCT01602120|463189032|FG001|Overall Study|Death|4|||
128913375|NCT01871090|463974205|FG000|Overall Study|Interrogation not completed correctly|1|||
128913376|NCT01871090|463974206|FG001|Overall Study|Interrogation not completed correctly|0|||
128913377|NCT01871090|463974205|FG000|Overall Study|Subject Non-Compliance|0|||
128913378|NCT01871090|463974206|FG001|Overall Study|Subject Non-Compliance|1|||
128913379|NCT00168831|463974215|FG000|Overall Study|Adverse Event|36|||
128913380|NCT00168831|463974216|FG001|Overall Study|Adverse Event|47|||
128913381|NCT00168831|463974217|FG002|Overall Study|Adverse Event|74|||
128913382|NCT00168831|463974215|FG000|Overall Study|Lost to Follow-up|5|||
128913383|NCT00168831|463974216|FG001|Overall Study|Lost to Follow-up|6|||
128913384|NCT00168831|463974217|FG002|Overall Study|Lost to Follow-up|4|||
129028749|NCT01266902|464396383|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
129028750|NCT01266902|464396381|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
129028751|NCT01266902|464396382|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
129028752|NCT01266902|464396383|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
129028753|NCT01266902|464396381|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
129028754|NCT01266902|464396382|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
129028755|NCT01266902|464396383|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
128913385|NCT00168831|463974215|FG000|Overall Study|Withdrawal by Subject|7|||
128913386|NCT00168831|463974216|FG001|Overall Study|Withdrawal by Subject|14|||
128913387|NCT00168831|463974217|FG002|Overall Study|Withdrawal by Subject|19|||
128913388|NCT00168831|463974215|FG000|Overall Study|Protocol Violation|6|||
128913389|NCT00168831|463974216|FG001|Overall Study|Protocol Violation|11|||
128913390|NCT00168831|463974217|FG002|Overall Study|Protocol Violation|11|||
128913391|NCT00168831|463974215|FG000|Overall Study|Other|6|||
128913392|NCT00168831|463974216|FG001|Overall Study|Other|3|||
128913393|NCT00168831|463974217|FG002|Overall Study|Other|6|||
128913394|NCT02009878|463974221|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
128913395|NCT02009878|463974222|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
128913396|NCT02009878|463974223|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
128913397|NCT03106779|463974226|FG000|Overall Study|Lack of Efficacy|33|||
128913398|NCT03106779|463974227|FG001|Overall Study|Lack of Efficacy|24|||
128913399|NCT03106779|463974226|FG000|Overall Study|Adverse Event|8|||
128913400|NCT03106779|463974227|FG001|Overall Study|Adverse Event|16|||
128913401|NCT03106779|463974226|FG000|Overall Study|Physician Decision|10|||
128913402|NCT03106779|463974227|FG001|Overall Study|Physician Decision|6|||
128913403|NCT03106779|463974226|FG000|Overall Study|Patient/guardian decision|4|||
128913404|NCT03106779|463974227|FG001|Overall Study|Patient/guardian decision|3|||
128913405|NCT03106779|463974226|FG000|Overall Study|Progressive disease|1|||
128913406|NCT03106779|463974227|FG001|Overall Study|Progressive disease|3|||
128913407|NCT03106779|463974226|FG000|Overall Study|Lost to Follow-up|1|||
128913408|NCT03106779|463974227|FG001|Overall Study|Lost to Follow-up|2|||
128913409|NCT03106779|463974226|FG000|Overall Study|Death|1|||
128913410|NCT03106779|463974227|FG001|Overall Study|Death|0|||
128913411|NCT03106779|463974226|FG000|Overall Study|Protocol Violation|1|||
128913412|NCT03106779|463974227|FG001|Overall Study|Protocol Violation|0|||
128913413|NCT03106779|463974226|FG000|Overall Study|Not treated|1|||
128913414|NCT03106779|463974227|FG001|Overall Study|Not treated|0|||
128913415|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
128913416|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
128913417|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
128913418|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
128913419|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
128913420|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
128913421|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
128913422|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
128913423|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
128913424|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
129118743|NCT03154086|464731208|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129118744|NCT03154086|464731209|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129118745|NCT03154086|464731210|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129118746|NCT03154086|464731196|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
129118747|NCT03154086|464731197|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118748|NCT03154086|464731198|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118749|NCT03154086|464731199|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118750|NCT03154086|464731200|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118751|NCT03154086|464731201|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118752|NCT03154086|464731202|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118753|NCT03154086|464731203|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118754|NCT03154086|464731204|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118755|NCT03154086|464731205|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118756|NCT03154086|464731206|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118757|NCT03154086|464731207|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118758|NCT03154086|464731208|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118759|NCT03154086|464731209|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118760|NCT03154086|464731210|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129118761|NCT03154086|464731196|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118762|NCT03154086|464731197|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128913425|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
129118763|NCT03154086|464731198|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118764|NCT03154086|464731199|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118765|NCT03154086|464731200|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118766|NCT03154086|464731201|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128913426|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
128913427|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
128913428|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
128913429|NCT02288247|463974228|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
128913430|NCT02288247|463974229|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
128913431|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
128913432|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
128913433|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
128913434|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
128913435|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
128913436|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
128913437|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
128913438|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
128913439|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
128913440|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
128913441|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
128913442|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
128913443|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
128913444|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
128913445|NCT02288247|463974228|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
128913446|NCT02288247|463974229|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
128913447|NCT04093531|463974230|FG000|Overall Study|failed screening|4|||
128913448|NCT03634800|463974231|FG000|Overall Study|Adverse Event|1|||
128913449|NCT03634800|463974231|FG000|Overall Study|Disease Progression|4|||
128913450|NCT03634800|463974231|FG000|Overall Study|Withdrawal by Subject|1|||
128697270|NCT01602120|463189033|FG002|Overall Study|Death|0|||
128697271|NCT01602120|463189034|FG003|Overall Study|Death|0|||
128697272|NCT01602120|463189031|FG000|Overall Study|Lost to Follow-up|0|||
128697273|NCT01602120|463189032|FG001|Overall Study|Lost to Follow-up|1|||
128697274|NCT01602120|463189033|FG002|Overall Study|Lost to Follow-up|0|||
128697275|NCT01602120|463189034|FG003|Overall Study|Lost to Follow-up|1|||
128697276|NCT01602120|463189031|FG000|Overall Study|Protocol Violation|1|||
128697277|NCT01602120|463189032|FG001|Overall Study|Protocol Violation|1|||
128697278|NCT01602120|463189033|FG002|Overall Study|Protocol Violation|0|||
128697279|NCT01602120|463189034|FG003|Overall Study|Protocol Violation|0|||
128697280|NCT01602120|463189031|FG000|Overall Study|Non-compliance|0|||
128697281|NCT01602120|463189032|FG001|Overall Study|Non-compliance|3|||
128697282|NCT01602120|463189033|FG002|Overall Study|Non-compliance|0|||
128697283|NCT01602120|463189034|FG003|Overall Study|Non-compliance|1|||
128697284|NCT01602120|463189031|FG000|Overall Study|Withdrawal by Subject|8|||
128913451|NCT00343512|463974234|FG000|Overall Study|Withdrawal by Subject|2|||
128913452|NCT00684515|463974237|FG000|Overall Study|Adverse Event|3|||
128913453|NCT00684515|463974238|FG001|Overall Study|Adverse Event|3|||
128913454|NCT00684515|463974239|FG002|Overall Study|Adverse Event|1|||
128913455|NCT00684515|463974237|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
128913456|NCT00684515|463974238|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
128913457|NCT00684515|463974239|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
128913458|NCT04428411|463974240|FG000|Overall Study|Lost to Follow-up|114|||
128913459|NCT00272987|463974241|FG000|Overall Study|Adverse Event|1|||
128913460|NCT00272987|463974242|FG001|Overall Study|Adverse Event|0|||
128913461|NCT00272987|463974243|FG002|Overall Study|Adverse Event|0|||
128913462|NCT00272987|463974241|FG000|Overall Study|Lost to Follow-up|3|||
128913463|NCT00272987|463974242|FG001|Overall Study|Lost to Follow-up|1|||
128913464|NCT00272987|463974243|FG002|Overall Study|Lost to Follow-up|1|||
128913465|NCT00272987|463974241|FG000|Overall Study|Withdrawal by Subject|1|||
128913466|NCT00272987|463974242|FG001|Overall Study|Withdrawal by Subject|0|||
128913467|NCT00272987|463974243|FG002|Overall Study|Withdrawal by Subject|3|||
128913468|NCT00272987|463974241|FG000|Overall Study|Sponsor Terminated study|0|||
128913469|NCT00272987|463974242|FG001|Overall Study|Sponsor Terminated study|1|||
128913470|NCT00272987|463974243|FG002|Overall Study|Sponsor Terminated study|1|||
128913471|NCT00272987|463974241|FG000|Overall Study|Disease progression|1|||
128913472|NCT00272987|463974242|FG001|Overall Study|Disease progression|1|||
128913473|NCT00272987|463974243|FG002|Overall Study|Disease progression|2|||
128913474|NCT00272987|463974241|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
128913475|NCT00272987|463974242|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
128913476|NCT00272987|463974243|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
128913477|NCT00272987|463974241|FG000|Overall Study|Death|1|||
129215652|NCT03077412|465092788|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
128697285|NCT01602120|463189032|FG001|Overall Study|Withdrawal by Subject|17|||
128697286|NCT01602120|463189033|FG002|Overall Study|Withdrawal by Subject|0|||
128697287|NCT01602120|463189034|FG003|Overall Study|Withdrawal by Subject|3|||
128697288|NCT01602120|463189031|FG000|Overall Study|Study Terminated by Sponsor|12|||
128697289|NCT01602120|463189032|FG001|Overall Study|Study Terminated by Sponsor|24|||
128913478|NCT00272987|463974242|FG001|Overall Study|Death|0|||
128913479|NCT00272987|463974243|FG002|Overall Study|Death|0|||
128913480|NCT03543410|463974248|FG000|Overall Study|Adverse Event|10|||
128913481|NCT03543410|463974249|FG001|Overall Study|Adverse Event|8|||
128913482|NCT03543410|463974250|FG002|Overall Study|Adverse Event|2|||
128913483|NCT03543410|463974248|FG000|Overall Study|Lack of Efficacy|0|||
128697290|NCT01602120|463189033|FG002|Overall Study|Study Terminated by Sponsor|17|||
128697291|NCT01602120|463189034|FG003|Overall Study|Study Terminated by Sponsor|44|||
128913484|NCT03543410|463974249|FG001|Overall Study|Lack of Efficacy|1|||
128913485|NCT03543410|463974250|FG002|Overall Study|Lack of Efficacy|0|||
128913486|NCT03543410|463974248|FG000|Overall Study|Lost to Follow-up|0|||
128913487|NCT03543410|463974249|FG001|Overall Study|Lost to Follow-up|1|||
128913488|NCT03543410|463974250|FG002|Overall Study|Lost to Follow-up|0|||
128913489|NCT03543410|463974248|FG000|Overall Study|Withdrawal by Subject|5|||
128913490|NCT03543410|463974249|FG001|Overall Study|Withdrawal by Subject|2|||
128913491|NCT03543410|463974250|FG002|Overall Study|Withdrawal by Subject|8|||
128913492|NCT03543410|463974248|FG000|Overall Study|Protocol Violation|0|||
128913493|NCT03543410|463974249|FG001|Overall Study|Protocol Violation|1|||
128913494|NCT03543410|463974250|FG002|Overall Study|Protocol Violation|0|||
128913495|NCT03543410|463974248|FG000|Overall Study|Due to COVID-19|4|||
128913496|NCT03543410|463974249|FG001|Overall Study|Due to COVID-19|0|||
128913497|NCT03543410|463974250|FG002|Overall Study|Due to COVID-19|2|||
128913498|NCT03543410|463974248|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
128913499|NCT03543410|463974249|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
128913500|NCT03543410|463974250|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
128913501|NCT03543410|463974248|FG000|Overall Study|Not Due to COVID-19|2|||
128913502|NCT03543410|463974249|FG001|Overall Study|Not Due to COVID-19|0|||
128913503|NCT03543410|463974250|FG002|Overall Study|Not Due to COVID-19|1|||
128913504|NCT02883244|463974251|FG000|Overall Study|Lost to Follow-up|0|||
128913505|NCT02883244|463974252|FG001|Overall Study|Lost to Follow-up|1|||
128913506|NCT02435914|463974253|FG000|Overall Study|Ocular Adverse Event|1|||
128913507|NCT02435914|463974254|FG001|Overall Study|Ocular Adverse Event|0|||
128913508|NCT02435914|463974255|FG002|Overall Study|Ocular Adverse Event|0|||
128913509|NCT02435914|463974256|FG003|Overall Study|Ocular Adverse Event|0|||
128913510|NCT02435914|463974253|FG000|Overall Study|Withdrawal by Subject|0|||
128913511|NCT02435914|463974254|FG001|Overall Study|Withdrawal by Subject|1|||
128913512|NCT02435914|463974255|FG002|Overall Study|Withdrawal by Subject|0|||
128913513|NCT02435914|463974256|FG003|Overall Study|Withdrawal by Subject|0|||
128913514|NCT02435914|463974253|FG000|Overall Study|Other Miscellaneous Reason|0|||
128913515|NCT02435914|463974254|FG001|Overall Study|Other Miscellaneous Reason|0|||
128913516|NCT02435914|463974255|FG002|Overall Study|Other Miscellaneous Reason|1|||
128913517|NCT02435914|463974256|FG003|Overall Study|Other Miscellaneous Reason|0|||
128913518|NCT00880256|463974259|FG000|Overall Study|Lost to Follow-up|28|||
128913519|NCT00268242|463974264|FG000|Overall Study|Death|1|||
128913520|NCT04871711|463974265|FG000|Overall Study|Withdrawal by Subject|11|||
128913521|NCT04871711|463974266|FG001|Overall Study|Withdrawal by Subject|5|||
128913522|NCT04871711|463974265|FG000|Overall Study|Lack of Efficacy|5|||
128913523|NCT04871711|463974266|FG001|Overall Study|Lack of Efficacy|7|||
128913524|NCT04871711|463974265|FG000|Overall Study|Adverse Event|2|||
128913525|NCT04871711|463974266|FG001|Overall Study|Adverse Event|6|||
128913526|NCT04871711|463974265|FG000|Overall Study|Various reasons|2|||
128913527|NCT04871711|463974266|FG001|Overall Study|Various reasons|1|||
128913528|NCT04871711|463974265|FG000|Overall Study|Lost to Follow-up|0|||
128913529|NCT04871711|463974266|FG001|Overall Study|Lost to Follow-up|2|||
128913530|NCT00603915|463974272|FG000|Overall Study|Physician Decision|1|||
128913531|NCT03891901|463974273|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
128913532|NCT03891901|463974274|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128913533|NCT03891901|463974275|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128913534|NCT03891901|463974276|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128913535|NCT03891901|463974277|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128913536|NCT03891901|463974278|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128913537|NCT03891901|463974279|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128913538|NCT03891901|463974280|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128913539|NCT03891901|463974281|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
128697292|NCT01602120|463189031|FG000|Overall Study|Physician Decision|2|||
128697293|NCT01602120|463189032|FG001|Overall Study|Physician Decision|3|||
128697294|NCT01602120|463189033|FG002|Overall Study|Physician Decision|0|||
128697295|NCT01602120|463189034|FG003|Overall Study|Physician Decision|0|||
128913540|NCT03891901|463974273|FG000|Overall Study|Adverse Event|2|||
128913541|NCT03891901|463974274|FG001|Overall Study|Adverse Event|2|||
128913542|NCT03891901|463974275|FG002|Overall Study|Adverse Event|0|||
128913543|NCT03891901|463974276|FG003|Overall Study|Adverse Event|0|||
128913544|NCT03891901|463974277|FG004|Overall Study|Adverse Event|0|||
128913545|NCT03891901|463974278|FG005|Overall Study|Adverse Event|0|||
128913546|NCT03891901|463974279|FG006|Overall Study|Adverse Event|0|||
128913547|NCT03891901|463974280|FG007|Overall Study|Adverse Event|0|||
128697296|NCT01602120|463189031|FG000|Overall Study|Unspecified Reason|3|||
128697297|NCT01602120|463189032|FG001|Overall Study|Unspecified Reason|1|||
128697298|NCT01602120|463189033|FG002|Overall Study|Unspecified Reason|0|||
128913548|NCT03891901|463974281|FG008|Overall Study|Adverse Event|0|||
128913549|NCT03891901|463974273|FG000|Overall Study|Poor venous access|1|||
128913550|NCT03891901|463974274|FG001|Overall Study|Poor venous access|0|||
128913551|NCT03891901|463974275|FG002|Overall Study|Poor venous access|0|||
128913552|NCT03891901|463974276|FG003|Overall Study|Poor venous access|0|||
128913553|NCT03891901|463974277|FG004|Overall Study|Poor venous access|0|||
128913554|NCT03891901|463974278|FG005|Overall Study|Poor venous access|0|||
128913555|NCT03891901|463974279|FG006|Overall Study|Poor venous access|0|||
128913556|NCT03891901|463974280|FG007|Overall Study|Poor venous access|0|||
128913557|NCT03891901|463974281|FG008|Overall Study|Poor venous access|0|||
128913558|NCT03891901|463974273|FG000|Overall Study|Withdrawal by Subject|0|||
128913559|NCT03891901|463974274|FG001|Overall Study|Withdrawal by Subject|2|||
128913560|NCT03891901|463974275|FG002|Overall Study|Withdrawal by Subject|0|||
128913561|NCT03891901|463974276|FG003|Overall Study|Withdrawal by Subject|0|||
128913562|NCT03891901|463974277|FG004|Overall Study|Withdrawal by Subject|0|||
128913563|NCT03891901|463974278|FG005|Overall Study|Withdrawal by Subject|0|||
128913564|NCT03891901|463974279|FG006|Overall Study|Withdrawal by Subject|0|||
128913565|NCT03891901|463974280|FG007|Overall Study|Withdrawal by Subject|0|||
128913566|NCT03891901|463974281|FG008|Overall Study|Withdrawal by Subject|0|||
128913567|NCT02026063|463974285|FG000|Overall Study|Physician Decision|0|||
128913568|NCT02026063|463974286|FG001|Overall Study|Physician Decision|10|||
128913569|NCT02026063|463974285|FG000|Overall Study|Noncompliance with Study Drug|1|||
128913570|NCT02026063|463974286|FG001|Overall Study|Noncompliance with Study Drug|1|||
128913571|NCT02026063|463974285|FG000|Overall Study|Withdrawal of Consent|1|||
128913572|NCT02026063|463974286|FG001|Overall Study|Withdrawal of Consent|6|||
128913573|NCT02026063|463974285|FG000|Overall Study|Adverse Event|5|||
128913574|NCT02026063|463974286|FG001|Overall Study|Adverse Event|20|||
128913575|NCT02026063|463974285|FG000|Overall Study|Lack of Efficacy|0|||
128913576|NCT02026063|463974286|FG001|Overall Study|Lack of Efficacy|4|||
128913577|NCT02026063|463974285|FG000|Overall Study|Lost to Follow-up|0|||
128913578|NCT02026063|463974286|FG001|Overall Study|Lost to Follow-up|1|||
128913579|NCT02026063|463974285|FG000|Overall Study|Reason not Specified|2|||
128913580|NCT02026063|463974286|FG001|Overall Study|Reason not Specified|7|||
128913581|NCT02154087|463974287|FG000|Overall Study|Study Termination|1|||
128913582|NCT01116544|463974289|FG000|Overall Study|Protocol Violation|1|||
128913583|NCT01116544|463974290|FG001|Overall Study|Protocol Violation|0|||
128913584|NCT01116544|463974289|FG000|Overall Study|Withdrawal by Subject|1|||
128913585|NCT01116544|463974290|FG001|Overall Study|Withdrawal by Subject|1|||
128913586|NCT00486278|463974291|FG000|Overall Study|Adverse Event|5|||
128913587|NCT00486278|463974291|FG000|Overall Study|Withdrawal by Subject|2|||
128913588|NCT00486278|463974291|FG000|Overall Study|Physician Decision|2|||
128913589|NCT02183519|463974292|FG000|Overall Study|computer error|3|||
128913590|NCT02183519|463974293|FG001|Overall Study|computer error|0|||
128913591|NCT02183519|463974292|FG000|Overall Study|Did not respond to cough inducter|0|||
128913592|NCT02183519|463974293|FG001|Overall Study|Did not respond to cough inducter|3|||
128913593|NCT00803179|463974296|FG000|Overall Study|Lost to Follow-up|3|||
128913594|NCT02419508|463974297|FG000|Overall Study|Adverse Event|9|||
128913595|NCT02419508|463974298|FG001|Overall Study|Adverse Event|3|||
128913596|NCT02419508|463974297|FG000|Overall Study|Withdrawal by Subject|1|||
128913597|NCT02419508|463974298|FG001|Overall Study|Withdrawal by Subject|0|||
128913598|NCT02419508|463974297|FG000|Overall Study|Other - Reason not specified|0|||
128913599|NCT02419508|463974298|FG001|Overall Study|Other - Reason not specified|1|||
128913600|NCT03110900|463974299|FG000|Overall Study|Sponsor withdrew|1|||
128913601|NCT03110900|463974300|FG001|Overall Study|Sponsor withdrew|1|||
128913602|NCT02320487|463974313|FG000|Overall Study|Reason not Specified|1|||
129118767|NCT03154086|464731202|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118768|NCT03154086|464731203|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118769|NCT03154086|464731204|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
129118770|NCT03154086|464731205|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118771|NCT03154086|464731206|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118772|NCT03154086|464731207|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118773|NCT03154086|464731208|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118774|NCT03154086|464731209|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129118775|NCT03154086|464731210|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
128913603|NCT02320487|463974313|FG000|Overall Study|Physician Decision|5|||
128913604|NCT02320487|463974313|FG000|Overall Study|Withdrawal by Subject|1|||
128913605|NCT02320487|463974313|FG000|Overall Study|Death|3|||
128913606|NCT02320487|463974313|FG000|Overall Study|Adverse Event|11|||
128913607|NCT00772668|463974314|FG000|Overall Study|Physician Decision|3|||
128913608|NCT04439175|463976415|FG000|Overall Study|Never started treatment|4|||
128913609|NCT04439175|463976415|FG000|Overall Study|Ineligible|5|||
128913610|NCT04439175|463976415|FG000|Overall Study|Adverse Event|6|||
128913611|NCT04439175|463976415|FG000|Overall Study|Death|4|||
128913612|NCT04439175|463976415|FG000|Overall Study|Disease progression|44|||
128913613|NCT04439175|463976415|FG000|Overall Study|Withdrawal by Subject|4|||
128913614|NCT04439175|463976415|FG000|Overall Study|Alternative Therapy|1|||
128913615|NCT04439175|463976415|FG000|Overall Study|Other|2|||
128913616|NCT02363478|463976416|FG000|Overall Study|Lost to Follow-up|4|||
128913617|NCT02363478|463976416|FG000|Overall Study|Adverse Event|4|||
128913618|NCT02554929|463976417|FG000|Overall Study|Lost to Follow-up|4|||
128913619|NCT02554929|463976418|FG001|Overall Study|Lost to Follow-up|4|||
128913620|NCT02554929|463976417|FG000|Overall Study|Withdrawal by Subject|2|||
128913621|NCT02554929|463976418|FG001|Overall Study|Withdrawal by Subject|8|||
128913622|NCT00546364|463976419|FG000|Overall Study|Disease progression|5|||
128913623|NCT00546364|463976420|FG001|Overall Study|Disease progression|11|||
128913624|NCT00546364|463976421|FG002|Overall Study|Disease progression|8|||
128913625|NCT00546364|463976419|FG000|Overall Study|Completed and off treatment|1|||
128913626|NCT00546364|463976420|FG001|Overall Study|Completed and off treatment|0|||
128913627|NCT00546364|463976421|FG002|Overall Study|Completed and off treatment|2|||
128913628|NCT00546364|463976419|FG000|Overall Study|Administrative reason by sponsor|1|||
128913629|NCT00546364|463976420|FG001|Overall Study|Administrative reason by sponsor|0|||
128913630|NCT00546364|463976421|FG002|Overall Study|Administrative reason by sponsor|0|||
128913631|NCT00546364|463976419|FG000|Overall Study|Poor compliance/noncompliance|0|||
128913632|NCT00546364|463976420|FG001|Overall Study|Poor compliance/noncompliance|0|||
128913633|NCT00546364|463976421|FG002|Overall Study|Poor compliance/noncompliance|1|||
128913634|NCT00546364|463976419|FG000|Overall Study|No longer meets study criteria|1|||
128913635|NCT00546364|463976420|FG001|Overall Study|No longer meets study criteria|1|||
128913636|NCT00546364|463976421|FG002|Overall Study|No longer meets study criteria|0|||
128913637|NCT00546364|463976419|FG000|Overall Study|Withdrawal by Subject|5|||
128913638|NCT00546364|463976420|FG001|Overall Study|Withdrawal by Subject|6|||
128913639|NCT00546364|463976421|FG002|Overall Study|Withdrawal by Subject|3|||
128913640|NCT00546364|463976419|FG000|Overall Study|Prior taxotere|1|||
128913641|NCT00546364|463976420|FG001|Overall Study|Prior taxotere|0|||
128913642|NCT00546364|463976421|FG002|Overall Study|Prior taxotere|0|||
128913643|NCT00546364|463976419|FG000|Overall Study|Mixed response|1|||
128913644|NCT00546364|463976420|FG001|Overall Study|Mixed response|0|||
128913645|NCT00546364|463976421|FG002|Overall Study|Mixed response|0|||
128913646|NCT00546364|463976419|FG000|Overall Study|Palliative treatment|1|||
128913647|NCT00546364|463976420|FG001|Overall Study|Palliative treatment|0|||
128913648|NCT00546364|463976421|FG002|Overall Study|Palliative treatment|1|||
128913649|NCT00546364|463976419|FG000|Overall Study|Target lesions resected|1|||
128913650|NCT00546364|463976420|FG001|Overall Study|Target lesions resected|0|||
128913651|NCT00546364|463976421|FG002|Overall Study|Target lesions resected|0|||
128913652|NCT00546364|463976419|FG000|Overall Study|Physician Decision|0|||
128913653|NCT00546364|463976420|FG001|Overall Study|Physician Decision|0|||
128913654|NCT00546364|463976421|FG002|Overall Study|Physician Decision|1|||
128913655|NCT00546364|463976419|FG000|Overall Study|Sponsor decision|0|||
128913656|NCT00546364|463976420|FG001|Overall Study|Sponsor decision|0|||
128913657|NCT00546364|463976421|FG002|Overall Study|Sponsor decision|1|||
128913658|NCT03593915|463976423|FG000|Overall Study|Adverse Event|0|||
128913659|NCT03593915|463976424|FG001|Overall Study|Adverse Event|0|||
128913660|NCT03593915|463976425|FG002|Overall Study|Adverse Event|0|||
128913661|NCT03593915|463976426|FG003|Overall Study|Adverse Event|1|||
128913662|NCT03593915|463976427|FG004|Overall Study|Adverse Event|0|||
128913663|NCT03593915|463976428|FG005|Overall Study|Adverse Event|0|||
128913664|NCT03593915|463976423|FG000|Overall Study|Physician Decision|0|||
128913665|NCT03593915|463976424|FG001|Overall Study|Physician Decision|0|||
128913666|NCT03593915|463976425|FG002|Overall Study|Physician Decision|0|||
128913667|NCT03593915|463976426|FG003|Overall Study|Physician Decision|0|||
129028756|NCT01266902|464396381|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
128697299|NCT01602120|463189034|FG003|Overall Study|Unspecified Reason|2|||
128697300|NCT01999179|463189044|FG000|Overall Study|Adverse Event|1|||
128697301|NCT01999179|463189044|FG000|Overall Study|Lost to Follow-up|1|||
128697302|NCT01999179|463189044|FG000|Overall Study|Change in Therapy|3|||
128697303|NCT01999179|463189044|FG000|Overall Study|New catheter|2|||
128697304|NCT03128411|463189048|FG000|Treatment Phase|Adverse Event|21|||
128697305|NCT03128411|463189048|FG000|Treatment Phase|Physician Decision|1|||
128697306|NCT03128411|463189048|FG000|Treatment Phase|Other|2|||
128697307|NCT03128411|463189048|FG000|Long Term Follow-up Phase|Death|2|||
128697308|NCT00660699|463189049|FG000|Overall Study|Withdrawal by Subject|2|||
128697309|NCT02900976|463189054|FG000|Overall Study|Adverse Event|0|||
128913668|NCT03593915|463976427|FG004|Overall Study|Physician Decision|0|||
128913669|NCT03593915|463976428|FG005|Overall Study|Physician Decision|1|||
128913670|NCT02894840|463976429|FG000|Overall Study|Lost to Follow-up|1|||
128913671|NCT02894840|463976430|FG001|Overall Study|Lost to Follow-up|0|||
128913672|NCT02894840|463976431|FG002|Overall Study|Lost to Follow-up|3|||
128913673|NCT02894840|463976432|FG003|Overall Study|Lost to Follow-up|0|||
128913674|NCT00167245|463976434|FG000|Overall Study|Lost to Follow-up|20|||
128913675|NCT00167245|463976435|FG001|Overall Study|Lost to Follow-up|31|||
128913676|NCT00167245|463976434|FG000|Overall Study|Withdrawal by Subject|5|||
128913677|NCT00167245|463976435|FG001|Overall Study|Withdrawal by Subject|8|||
128913678|NCT00167245|463976434|FG000|Overall Study|Incarcerated|3|||
128913679|NCT00167245|463976435|FG001|Overall Study|Incarcerated|2|||
128697310|NCT02900976|463189055|FG001|Overall Study|Adverse Event|1|||
128913680|NCT00167245|463976434|FG000|Overall Study|Drowsy|1|||
128913681|NCT00167245|463976435|FG001|Overall Study|Drowsy|0|||
128913682|NCT02415712|463976439|FG000|Overall Study|Protocol Violation|16|||
128697311|NCT02900976|463189054|FG000|Overall Study|Physician Decision|0|||
128697312|NCT02900976|463189055|FG001|Overall Study|Physician Decision|2|||
128913683|NCT01668654|463976440|FG000|Overall Study|Study Closed/Terminated|3|||
128913684|NCT01668654|463976440|FG000|Overall Study|Withdrawal by Subject|1|||
128913685|NCT04557384|463976441|FG000|Overall Study|Study Terminated by Sponsor|1|||
128913686|NCT04557384|463976441|FG000|Overall Study|Death|1|||
128913687|NCT02397473|463976443|FG000|Treatment Phase|Adverse Event|1|||
128913688|NCT02397473|463976444|FG001|Treatment Phase|Adverse Event|2|||
128913689|NCT02397473|463976443|FG000|Treatment Phase|Lack of Efficacy|8|||
128913690|NCT02397473|463976444|FG001|Treatment Phase|Lack of Efficacy|1|||
128913691|NCT02397473|463976443|FG000|Treatment Phase|Lost to Follow-up|1|||
128913692|NCT02397473|463976444|FG001|Treatment Phase|Lost to Follow-up|0|||
128913693|NCT02397473|463976443|FG000|Treatment Phase|Withdrawal by Subject|2|||
128913694|NCT02397473|463976444|FG001|Treatment Phase|Withdrawal by Subject|1|||
128913695|NCT02397473|463976443|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
128913696|NCT02397473|463976444|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
128913697|NCT02397473|463976443|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
128913698|NCT02397473|463976444|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
128913699|NCT02397473|463976443|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
128913700|NCT02397473|463976444|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
128913701|NCT02397473|463976443|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
128913702|NCT02397473|463976444|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
128913703|NCT02397473|463976443|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
128913704|NCT02397473|463976444|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
128913705|NCT02658448|463976447|FG000|Overall Study|Lost to Follow-up|1|||
128913706|NCT04652804|463976448|FG000|Overall Study|Ineligible post randomization|1|||
128913707|NCT04652804|463976449|FG001|Overall Study|Ineligible post randomization|0|||
128913708|NCT04652804|463976450|FG002|Overall Study|Ineligible post randomization|1|||
128913709|NCT04652804|463976451|FG003|Overall Study|Ineligible post randomization|0|||
128913710|NCT04652804|463976452|FG004|Overall Study|Ineligible post randomization|1|||
128913711|NCT04652804|463976453|FG005|Overall Study|Ineligible post randomization|1|||
128913712|NCT04652804|463976448|FG000|Overall Study|Missing SVR lab results|2|||
128913713|NCT04652804|463976449|FG001|Overall Study|Missing SVR lab results|0|||
128913714|NCT04652804|463976450|FG002|Overall Study|Missing SVR lab results|0|||
128913715|NCT04652804|463976451|FG003|Overall Study|Missing SVR lab results|0|||
128913716|NCT04652804|463976452|FG004|Overall Study|Missing SVR lab results|0|||
128913717|NCT04652804|463976453|FG005|Overall Study|Missing SVR lab results|0|||
128913718|NCT00364689|463976457|FG000|Overall Study|Lost to Follow-up|1|||
128913719|NCT00191451|463976463|FG000|Overall Study|Withdrawal by Subject|2|||
128913720|NCT00191451|463976464|FG001|Overall Study|Withdrawal by Subject|3|||
128913721|NCT00191451|463976465|FG002|Overall Study|Withdrawal by Subject|5|||
128913722|NCT00191451|463976463|FG000|Overall Study|Physician Decision|2|||
128913723|NCT00191451|463976464|FG001|Overall Study|Physician Decision|9|||
128913724|NCT00191451|463976465|FG002|Overall Study|Physician Decision|6|||
128913725|NCT00191451|463976463|FG000|Overall Study|Sponsor Decision|1|||
128913726|NCT00191451|463976464|FG001|Overall Study|Sponsor Decision|0|||
128913727|NCT00191451|463976465|FG002|Overall Study|Sponsor Decision|0|||
128913728|NCT00191451|463976463|FG000|Overall Study|Ineligible|0|||
128913729|NCT00191451|463976464|FG001|Overall Study|Ineligible|1|||
128913730|NCT00191451|463976465|FG002|Overall Study|Ineligible|0|||
128913731|NCT00191451|463976463|FG000|Overall Study|Reason Not Specified|2|||
128913732|NCT00191451|463976464|FG001|Overall Study|Reason Not Specified|1|||
128913733|NCT00191451|463976465|FG002|Overall Study|Reason Not Specified|3|||
128913734|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
128913735|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
128913736|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
128913737|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
128913738|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
128913739|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
129118776|NCT03154086|464731196|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118777|NCT03154086|464731197|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118778|NCT03154086|464731198|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118779|NCT03154086|464731199|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118780|NCT03154086|464731200|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
128697313|NCT02900976|463189054|FG000|Overall Study|Progressive disease|0|||
128697314|NCT02900976|463189055|FG001|Overall Study|Progressive disease|6|||
128913740|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
128913741|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
128913742|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
128697315|NCT01752985|463189056|FG000|Treatment Period|Subject request to discontinue treatment|1|||
128913743|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
128765487|NCT02392611|463433837|FG006|Overall Study|Adverse Event|0|||
129118781|NCT03154086|464731201|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118782|NCT03154086|464731202|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118783|NCT03154086|464731203|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
129118784|NCT03154086|464731204|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118785|NCT03154086|464731205|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118786|NCT03154086|464731206|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118787|NCT03154086|464731207|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118788|NCT03154086|464731208|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118789|NCT03154086|464731209|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118790|NCT03154086|464731210|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129118791|NCT03154086|464731196|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
129118792|NCT03154086|464731197|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
129118793|NCT03154086|464731198|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
129118794|NCT03154086|464731199|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
129118795|NCT03154086|464731200|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
129118796|NCT03154086|464731201|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
129118797|NCT03154086|464731202|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
129118798|NCT03154086|464731203|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
129118799|NCT03154086|464731204|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
129118800|NCT03154086|464731205|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
129118801|NCT03154086|464731206|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
129118802|NCT03154086|464731207|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
129118803|NCT03154086|464731208|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
129118804|NCT03154086|464731209|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
129118805|NCT03154086|464731210|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
129118806|NCT01603277|464731211|FG000|Overall Study|Adverse Event|1|||
129118807|NCT01603277|464731212|FG001|Overall Study|Adverse Event|2|||
129118808|NCT01603277|464731211|FG000|Overall Study|Physician Decision|0|||
129118809|NCT01603277|464731212|FG001|Overall Study|Physician Decision|1|||
129118810|NCT01603277|464731211|FG000|Overall Study|Protocol Violation|6|||
129118811|NCT01603277|464731212|FG001|Overall Study|Protocol Violation|10|||
129118812|NCT01603277|464731211|FG000|Overall Study|Withdrawal by Subject|5|||
129118813|NCT01603277|464731212|FG001|Overall Study|Withdrawal by Subject|4|||
129118814|NCT01603277|464731211|FG000|Overall Study|Non-Compliance|2|||
129118815|NCT01603277|464731212|FG001|Overall Study|Non-Compliance|1|||
129118816|NCT04465422|464731217|FG000|Overall Study|Lost to Follow-up|0|||
129118817|NCT04465422|464731218|FG001|Overall Study|Lost to Follow-up|2|||
129118818|NCT00572832|464731221|FG000|Overall Study|Lost to Follow-up|0|||
129118819|NCT00572832|464731222|FG001|Overall Study|Lost to Follow-up|11|||
129118820|NCT00572832|464731221|FG000|Overall Study|Pregnancy|0|||
129118821|NCT00572832|464731222|FG001|Overall Study|Pregnancy|1|||
129118822|NCT02722967|464731226|FG000|Overall Study|Adverse Event|1|||
129118823|NCT02722967|464731227|FG001|Overall Study|Adverse Event|0|||
129118824|NCT02722967|464731228|FG002|Overall Study|Adverse Event|0|||
129118825|NCT02722967|464731226|FG000|Overall Study|Lost to Follow-up|0|||
129118826|NCT02722967|464731227|FG001|Overall Study|Lost to Follow-up|1|||
129118827|NCT02722967|464731228|FG002|Overall Study|Lost to Follow-up|0|||
129118828|NCT02722967|464731226|FG000|Overall Study|Non-compliance with patch wearing|2|||
129118829|NCT02722967|464731227|FG001|Overall Study|Non-compliance with patch wearing|1|||
129118830|NCT02722967|464731228|FG002|Overall Study|Non-compliance with patch wearing|1|||
129118831|NCT02722967|464731226|FG000|Overall Study|Withdrawal by Subject|1|||
129118832|NCT02722967|464731227|FG001|Overall Study|Withdrawal by Subject|0|||
129118833|NCT02722967|464731228|FG002|Overall Study|Withdrawal by Subject|1|||
128913744|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
128913745|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
128913746|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
128913747|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
128913748|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
128913749|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
128913750|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
128913751|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
128913752|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
128913753|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
129118834|NCT02722967|464731226|FG000|Overall Study|Physician Decision|1|||
129118835|NCT02722967|464731227|FG001|Overall Study|Physician Decision|0|||
129118836|NCT02722967|464731228|FG002|Overall Study|Physician Decision|0|||
129118837|NCT02722967|464731226|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
129118838|NCT02722967|464731227|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
129118839|NCT02722967|464731228|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
129118840|NCT02391337|464731229|FG000|6 Months Follow-up|Death|5|||
129118841|NCT02391337|464731230|FG001|6 Months Follow-up|Death|4|||
129118842|NCT02391337|464731229|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
129118843|NCT02391337|464731230|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
128913754|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
128913755|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
128913756|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
128913757|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
128913758|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Death|2|||
129118844|NCT02391337|464731229|FG000|12 Months Follow-up|Death|2|||
129118845|NCT02391337|464731230|FG001|12 Months Follow-up|Death|0|||
129118846|NCT02391337|464731229|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
129118847|NCT02391337|464731230|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
129118848|NCT02391337|464731229|FG000|12 Months Follow-up|Lost to Follow-up|0|||
129118849|NCT02391337|464731230|FG001|12 Months Follow-up|Lost to Follow-up|2|||
129118850|NCT00111761|464731231|FG000|Part 1|Physician Decision|0|||
129118851|NCT00111761|464731232|FG001|Part 1|Physician Decision|1|||
129118852|NCT00111761|464731231|FG000|Part 1|Death|0|||
129118853|NCT00111761|464731232|FG001|Part 1|Death|2|||
129118854|NCT00111761|464731231|FG000|Part 1|Other|0|||
129118855|NCT00111761|464731232|FG001|Part 1|Other|1|||
129118856|NCT00111761|464731231|FG000|Part 1|Withdrawal by Subject|0|||
129118857|NCT00111761|464731232|FG001|Part 1|Withdrawal by Subject|1|||
129118858|NCT00111761|464731231|FG000|Part 2|Adverse Event|1|||
129118859|NCT00111761|464731232|FG001|Part 2|Adverse Event|0|||
129118860|NCT00111761|464731231|FG000|Part 2|Physician Decision|1|||
128913759|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Death|1|||
128913760|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Death|2|||
128913761|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Graft loss|0|||
128913762|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Graft loss|2|||
128913763|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Graft loss|0|||
128913764|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
128913765|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
128913766|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
129118861|NCT00111761|464731232|FG001|Part 2|Physician Decision|0|||
129118862|NCT00111761|464731231|FG000|Part 2|Death|1|||
129118863|NCT00111761|464731232|FG001|Part 2|Death|0|||
129118864|NCT00111761|464731231|FG000|Part 2|Disease progression|3|||
128913767|NCT01114529|463976469|FG000|Completed Study Medication at Month 24|Missing|2|||
128913768|NCT01114529|463976470|FG001|Completed Study Medication at Month 24|Missing|0|||
128913769|NCT01114529|463976471|FG002|Completed Study Medication at Month 24|Missing|0|||
128913770|NCT01114529|463976469|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
128913771|NCT01114529|463976470|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
128913772|NCT01114529|463976471|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
128913773|NCT01114529|463976469|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
128913774|NCT01114529|463976470|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
128913775|NCT01114529|463976471|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
128913776|NCT01114529|463976469|FG000|Completed Study Phase at Month 24|Death|8|||
128913777|NCT01114529|463976470|FG001|Completed Study Phase at Month 24|Death|5|||
128913778|NCT01114529|463976471|FG002|Completed Study Phase at Month 24|Death|4|||
128913779|NCT01114529|463976469|FG000|Completed Study Phase at Month 24|Other|2|||
128913780|NCT01114529|463976470|FG001|Completed Study Phase at Month 24|Other|0|||
128913781|NCT01114529|463976471|FG002|Completed Study Phase at Month 24|Other|0|||
128913782|NCT01114529|463976469|FG000|Completed Study Phase at Month 24|Missing|2|||
128913783|NCT01114529|463976470|FG001|Completed Study Phase at Month 24|Missing|0|||
128913784|NCT01114529|463976471|FG002|Completed Study Phase at Month 24|Missing|0|||
128913785|NCT00132730|463976474|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
128913786|NCT00132730|463976475|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
128913787|NCT00132730|463976476|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
128913788|NCT00132730|463976477|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
128913789|NCT00132730|463976478|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
128913790|NCT00132730|463976479|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
128913791|NCT00132730|463976474|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
128913792|NCT00132730|463976475|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
128913793|NCT00132730|463976476|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
128913794|NCT00132730|463976477|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
128913795|NCT00132730|463976478|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
128913796|NCT00132730|463976479|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
128913797|NCT00132730|463976474|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
129118865|NCT00111761|464731232|FG001|Part 2|Disease progression|0|||
129118866|NCT00111761|464731231|FG000|Part 2|Protocol-specified criteria|1|||
129118867|NCT00111761|464731232|FG001|Part 2|Protocol-specified criteria|0|||
129118868|NCT00111761|464731231|FG000|Part 2|Other|1|||
129215653|NCT03077412|465092786|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
129118869|NCT00111761|464731232|FG001|Part 2|Other|0|||
129118870|NCT00746551|464731235|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
128913798|NCT00132730|463976475|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
128913799|NCT00132730|463976476|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
128913800|NCT00132730|463976477|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
128913801|NCT00132730|463976478|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
128913802|NCT00132730|463976479|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
128913803|NCT00132730|463976474|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
128913804|NCT00132730|463976475|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
128913805|NCT00132730|463976476|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
128913806|NCT00132730|463976477|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
128913807|NCT00132730|463976478|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
128913808|NCT00132730|463976479|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
128913809|NCT00132730|463976474|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
128913810|NCT00132730|463976475|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
128913811|NCT00132730|463976476|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
128913812|NCT00132730|463976477|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
128913813|NCT00132730|463976478|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
128913814|NCT00132730|463976479|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
128913815|NCT00132730|463976474|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
128913816|NCT00132730|463976475|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
128913817|NCT00132730|463976476|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
128913818|NCT00132730|463976477|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
128913819|NCT00132730|463976478|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
128913820|NCT00132730|463976479|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
128913821|NCT00132730|463976474|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
128913822|NCT00132730|463976475|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
128913823|NCT00132730|463976476|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
128913824|NCT00132730|463976477|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
128913825|NCT00132730|463976478|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
128913826|NCT00132730|463976479|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
128913827|NCT00132730|463976474|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
128913828|NCT00132730|463976475|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
128913829|NCT00132730|463976476|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
128913830|NCT00132730|463976477|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
128913831|NCT00132730|463976478|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
129028757|NCT01266902|464396382|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
128765488|NCT02392611|463433838|FG007|Overall Study|Adverse Event|0|||
128765489|NCT02392611|463433839|FG008|Overall Study|Adverse Event|0|||
128765490|NCT02392611|463433831|FG000|Overall Study|Progressive disease|0|||
128765491|NCT02392611|463433832|FG001|Overall Study|Progressive disease|0|||
128765492|NCT02392611|463433833|FG002|Overall Study|Progressive disease|0|||
128765493|NCT02392611|463433834|FG003|Overall Study|Progressive disease|2|||
129028758|NCT01266902|464396383|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
129028759|NCT00387153|464396384|FG000|Overall Study|Adverse Event|1|||
129028760|NCT00387153|464396384|FG000|Overall Study|Disease Progression|3|||
129028761|NCT00387153|464396384|FG000|Overall Study|Lack of Response|4|||
129028762|NCT02426918|464396391|FG000|Overall Study|Adverse Event|2|||
129028763|NCT02426918|464396392|FG001|Overall Study|Adverse Event|2|||
129028764|NCT02426918|464396393|FG002|Overall Study|Adverse Event|0|||
129028765|NCT02426918|464396391|FG000|Overall Study|Physician Decision|1|||
129028766|NCT02426918|464396392|FG001|Overall Study|Physician Decision|1|||
128765494|NCT02392611|463433835|FG004|Overall Study|Progressive disease|1|||
128765495|NCT02392611|463433836|FG005|Overall Study|Progressive disease|0|||
128765496|NCT02392611|463433837|FG006|Overall Study|Progressive disease|0|||
128765497|NCT02392611|463433838|FG007|Overall Study|Progressive disease|0|||
128765498|NCT02392611|463433839|FG008|Overall Study|Progressive disease|0|||
128765499|NCT02392611|463433831|FG000|Overall Study|Death|1|||
129028767|NCT02426918|464396393|FG002|Overall Study|Physician Decision|1|||
129028768|NCT02426918|464396391|FG000|Overall Study|Withdrawal by Subject|5|||
129028769|NCT02426918|464396392|FG001|Overall Study|Withdrawal by Subject|5|||
129028770|NCT02426918|464396393|FG002|Overall Study|Withdrawal by Subject|4|||
129028771|NCT02426918|464396391|FG000|Overall Study|Other|9|||
129028772|NCT02426918|464396392|FG001|Overall Study|Other|11|||
128765500|NCT02392611|463433832|FG001|Overall Study|Death|0|||
128765501|NCT02392611|463433833|FG002|Overall Study|Death|0|||
128765502|NCT02392611|463433834|FG003|Overall Study|Death|0|||
129028773|NCT02426918|464396393|FG002|Overall Study|Other|9|||
128765503|NCT02392611|463433835|FG004|Overall Study|Death|0|||
129028774|NCT02845336|464396394|FG000|Overall Study|Lost to Follow-up|3|||
128765504|NCT02392611|463433836|FG005|Overall Study|Death|1|||
128765505|NCT02392611|463433837|FG006|Overall Study|Death|0|||
128765506|NCT02392611|463433838|FG007|Overall Study|Death|0|||
128913832|NCT00132730|463976479|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
128913833|NCT00132730|463976474|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
128913834|NCT00132730|463976475|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
128913835|NCT00132730|463976476|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
128913836|NCT00132730|463976477|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
128913837|NCT00132730|463976478|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
128913838|NCT00132730|463976479|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
128913839|NCT00132730|463976474|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
128913840|NCT00132730|463976475|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
128913841|NCT00132730|463976476|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
128913842|NCT00132730|463976477|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
128913843|NCT00132730|463976478|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
128913844|NCT00132730|463976479|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
128913845|NCT00132730|463976474|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
128913846|NCT00132730|463976475|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
128913847|NCT00132730|463976476|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
128913848|NCT00132730|463976477|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
128913849|NCT00132730|463976478|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
128913850|NCT00132730|463976479|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
128913851|NCT00132730|463976474|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
128913852|NCT00132730|463976475|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
128913853|NCT00132730|463976476|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
128913854|NCT00132730|463976477|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
128913855|NCT00132730|463976478|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
128913856|NCT00132730|463976479|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
128913857|NCT01554579|463976480|FG000|Overall Study|Adverse Event|6|||
128913858|NCT01554579|463976481|FG001|Overall Study|Adverse Event|25|||
128913859|NCT01554579|463976480|FG000|Overall Study|Lack of Efficacy|2|||
128913860|NCT01554579|463976481|FG001|Overall Study|Lack of Efficacy|1|||
128913861|NCT01554579|463976480|FG000|Overall Study|Withdrawal by Subject|2|||
128913862|NCT01554579|463976481|FG001|Overall Study|Withdrawal by Subject|1|||
128913863|NCT01192347|463976482|FG000|Overall Study|Death|3|||
128913864|NCT01192347|463976482|FG000|Overall Study|Lost to Follow-up|3|||
128913865|NCT01192347|463976482|FG000|Overall Study|Withdrawal by Subject|1|||
128913866|NCT01192347|463976482|FG000|Overall Study|Adverse Event|1|||
128913867|NCT01192347|463976482|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
128913868|NCT01192347|463976482|FG000|Overall Study|Patient seen in different hospital|1|||
128913869|NCT01192347|463976482|FG000|Overall Study|Patient not visiting hospital regularly|1|||
128913870|NCT01192347|463976482|FG000|Overall Study|Patient did not show up for visits|1|||
128913871|NCT02623335|463976483|FG000|Overall Study|Death|8|||
129028775|NCT02845336|464396395|FG001|Overall Study|Lost to Follow-up|1|||
129028776|NCT02845336|464396394|FG000|Overall Study|Inability to get medication|2|||
129028777|NCT02845336|464396395|FG001|Overall Study|Inability to get medication|0|||
129028778|NCT01496118|464396396|FG000|Overall Study|Disease progression|3|||
129028779|NCT01496118|464396397|FG001|Overall Study|Disease progression|2|||
129028780|NCT01496118|464396398|FG002|Overall Study|Disease progression|3|||
129028781|NCT01496118|464396399|FG003|Overall Study|Disease progression|1|||
128697316|NCT01752985|463189057|FG001|Treatment Period|Subject request to discontinue treatment|0|||
128697317|NCT01752985|463189058|FG002|Treatment Period|Subject request to discontinue treatment|1|||
128697318|NCT01752985|463189056|FG000|Treatment Period|Subject no longer meets study criteria|0|||
128697319|NCT01752985|463189057|FG001|Treatment Period|Subject no longer meets study criteria|1|||
128697320|NCT01752985|463189058|FG002|Treatment Period|Subject no longer meets study criteria|1|||
128697321|NCT01752985|463189056|FG000|Treatment Period|Adverse Event|2|||
128697322|NCT01752985|463189057|FG001|Treatment Period|Adverse Event|1|||
128697323|NCT01752985|463189058|FG002|Treatment Period|Adverse Event|2|||
128697324|NCT01752985|463189056|FG000|Treatment Period|Withdrawal by Subject|1|||
128697325|NCT01752985|463189057|FG001|Treatment Period|Withdrawal by Subject|1|||
128697326|NCT01752985|463189058|FG002|Treatment Period|Withdrawal by Subject|0|||
128697327|NCT01752985|463189056|FG000|Treatment Period|Lost to Follow-up|0|||
128697328|NCT01752985|463189057|FG001|Treatment Period|Lost to Follow-up|0|||
128697329|NCT01752985|463189058|FG002|Treatment Period|Lost to Follow-up|1|||
128697330|NCT06934993|463189059|FG000|Overall Study|Withdrawal by Subject|29|||
128697331|NCT06934993|463189059|FG000|Overall Study|elevated postoperative creatinine level|11|||
128697332|NCT06934993|463189059|FG000|Overall Study|Death|3|||
128913872|NCT02623335|463976484|FG001|Overall Study|Death|7|||
128913873|NCT02623335|463976483|FG000|Overall Study|Lost to Follow-up|15|||
128913874|NCT02623335|463976484|FG001|Overall Study|Lost to Follow-up|23|||
128913875|NCT02623335|463976483|FG000|Overall Study|Withdrawal by Subject|2|||
128913876|NCT02623335|463976484|FG001|Overall Study|Withdrawal by Subject|5|||
129028782|NCT01496118|464396400|FG004|Overall Study|Disease progression|2|||
128913877|NCT02623335|463976483|FG000|Overall Study|Protocol Violation|2|||
128913878|NCT02623335|463976484|FG001|Overall Study|Protocol Violation|1|||
128913879|NCT03739528|463976485|FG000|Overall Study|Not treated|8|||
128913880|NCT03739528|463976486|FG001|Overall Study|Not treated|12|||
128913881|NCT03739528|463976485|FG000|Overall Study|Treatment and study discontinued|6|||
128913882|NCT03739528|463976486|FG001|Overall Study|Treatment and study discontinued|2|||
128913883|NCT03739528|463976485|FG000|Overall Study|Treatment discontinued + study completed|1|||
128913884|NCT03739528|463976486|FG001|Overall Study|Treatment discontinued + study completed|3|||
128913885|NCT01046695|463976487|FG000|Overall Study|Subject had a pacemaker|0|||
128913886|NCT01046695|463976488|FG001|Overall Study|Subject had a pacemaker|1|||
128913887|NCT01046695|463976487|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
128913888|NCT01046695|463976488|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
128913889|NCT03072160|463976489|FG000|Overall Study|Adverse Event|3|||
128913890|NCT03072160|463976490|FG001|Overall Study|Adverse Event|1|||
128913891|NCT03072160|463976489|FG000|Overall Study|Refused further treatment|6|||
128913892|NCT03072160|463976490|FG001|Overall Study|Refused further treatment|1|||
128913893|NCT03072160|463976489|FG000|Overall Study|Physician Decision|1|||
128913894|NCT03072160|463976490|FG001|Overall Study|Physician Decision|0|||
128913895|NCT03072160|463976489|FG000|Overall Study|Disease progression on study|1|||
128913896|NCT03072160|463976490|FG001|Overall Study|Disease progression on study|1|||
128913897|NCT03072160|463976489|FG000|Overall Study|No contact|0|||
128913898|NCT03072160|463976490|FG001|Overall Study|No contact|1|||
128913899|NCT01463098|463976491|FG000|Part A (11 Days)|Participant Choice|2|||
128913900|NCT01463098|463976492|FG001|Part A (11 Days)|Participant Choice|0|||
128913901|NCT01463098|463976493|FG002|Part A (11 Days)|Participant Choice|0|||
128913902|NCT01463098|463976494|FG003|Part A (11 Days)|Participant Choice|0|||
128913903|NCT01463098|463976495|FG004|Part A (11 Days)|Participant Choice|0|||
128913904|NCT01463098|463976496|FG005|Part A (11 Days)|Participant Choice|0|||
128913905|NCT01463098|463976497|FG006|Part A (11 Days)|Participant Choice|0|||
128913906|NCT01463098|463976498|FG007|Part A (11 Days)|Participant Choice|0|||
128913907|NCT01463098|463976499|FG008|Part A (11 Days)|Participant Choice|1|||
128913908|NCT01463098|463976500|FG009|Part A (11 Days)|Participant Choice|0|||
128913909|NCT01463098|463976501|FG010|Part A (11 Days)|Participant Choice|0|||
128913910|NCT01463098|463976502|FG011|Part A (11 Days)|Participant Choice|0|||
128913911|NCT01463098|463976503|FG012|Part A (11 Days)|Participant Choice|0|||
128913912|NCT01463098|463976504|FG013|Part A (11 Days)|Participant Choice|0|||
128913913|NCT01463098|463976491|FG000|Part A (11 Days)|Lost to Follow-up|0|||
128913914|NCT01463098|463976492|FG001|Part A (11 Days)|Lost to Follow-up|0|||
128913915|NCT01463098|463976493|FG002|Part A (11 Days)|Lost to Follow-up|0|||
128913916|NCT01463098|463976494|FG003|Part A (11 Days)|Lost to Follow-up|0|||
128913917|NCT01463098|463976495|FG004|Part A (11 Days)|Lost to Follow-up|1|||
128913918|NCT01463098|463976496|FG005|Part A (11 Days)|Lost to Follow-up|0|||
128913919|NCT01463098|463976497|FG006|Part A (11 Days)|Lost to Follow-up|0|||
128913920|NCT01463098|463976498|FG007|Part A (11 Days)|Lost to Follow-up|0|||
128913921|NCT01463098|463976499|FG008|Part A (11 Days)|Lost to Follow-up|0|||
128913922|NCT01463098|463976500|FG009|Part A (11 Days)|Lost to Follow-up|0|||
128913923|NCT01463098|463976501|FG010|Part A (11 Days)|Lost to Follow-up|0|||
128913924|NCT01463098|463976502|FG011|Part A (11 Days)|Lost to Follow-up|0|||
128913925|NCT01463098|463976503|FG012|Part A (11 Days)|Lost to Follow-up|0|||
128913926|NCT01463098|463976504|FG013|Part A (11 Days)|Lost to Follow-up|0|||
128913927|NCT01463098|463976491|FG000|Part B (11 Days)|Participant Choice|0|||
128913928|NCT01463098|463976492|FG001|Part B (11 Days)|Participant Choice|0|||
128913929|NCT01463098|463976493|FG002|Part B (11 Days)|Participant Choice|0|||
128913930|NCT01463098|463976494|FG003|Part B (11 Days)|Participant Choice|0|||
128913931|NCT01463098|463976495|FG004|Part B (11 Days)|Participant Choice|0|||
128913932|NCT01463098|463976496|FG005|Part B (11 Days)|Participant Choice|0|||
128913933|NCT01463098|463976497|FG006|Part B (11 Days)|Participant Choice|0|||
128913934|NCT01463098|463976498|FG007|Part B (11 Days)|Participant Choice|0|||
128913935|NCT01463098|463976499|FG008|Part B (11 Days)|Participant Choice|0|||
128913936|NCT01463098|463976500|FG009|Part B (11 Days)|Participant Choice|0|||
129215654|NCT03077412|465092787|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
128765507|NCT02392611|463433839|FG008|Overall Study|Death|0|||
128765508|NCT02392611|463433831|FG000|Overall Study|Withdrawal by Subject|0|||
128765509|NCT02392611|463433832|FG001|Overall Study|Withdrawal by Subject|0|||
128765510|NCT02392611|463433833|FG002|Overall Study|Withdrawal by Subject|0|||
128765511|NCT02392611|463433834|FG003|Overall Study|Withdrawal by Subject|1|||
128765512|NCT02392611|463433835|FG004|Overall Study|Withdrawal by Subject|0|||
128765513|NCT02392611|463433836|FG005|Overall Study|Withdrawal by Subject|0|||
128765514|NCT02392611|463433837|FG006|Overall Study|Withdrawal by Subject|0|||
128765515|NCT02392611|463433838|FG007|Overall Study|Withdrawal by Subject|0|||
128913937|NCT01463098|463976501|FG010|Part B (11 Days)|Participant Choice|0|||
128913938|NCT01463098|463976502|FG011|Part B (11 Days)|Participant Choice|1|||
128913939|NCT01463098|463976503|FG012|Part B (11 Days)|Participant Choice|0|||
128913940|NCT01463098|463976504|FG013|Part B (11 Days)|Participant Choice|0|||
129028783|NCT01496118|464396401|FG005|Overall Study|Disease progression|2|||
128913941|NCT00939692|463976509|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
128913942|NCT00939692|463976510|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
128913943|NCT00939692|463976509|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
128913944|NCT00939692|463976510|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
128913945|NCT01528787|463976511|FG000|Overall Study|Withdrawal by Subject|0|||
128913946|NCT01528787|463976512|FG001|Overall Study|Withdrawal by Subject|0|||
128765516|NCT02392611|463433839|FG008|Overall Study|Withdrawal by Subject|0|||
128913947|NCT01528787|463976513|FG002|Overall Study|Withdrawal by Subject|0|||
128913948|NCT01528787|463976514|FG003|Overall Study|Withdrawal by Subject|1|||
128913949|NCT01528787|463976511|FG000|Overall Study|Family Emergency|0|||
128913950|NCT01528787|463976512|FG001|Overall Study|Family Emergency|0|||
128913951|NCT01528787|463976513|FG002|Overall Study|Family Emergency|1|||
128913952|NCT01528787|463976514|FG003|Overall Study|Family Emergency|0|||
128913953|NCT03433781|463976520|FG000|Overall Study|Progression of Disease|1|||
128913954|NCT03433781|463976521|FG001|Overall Study|Progression of Disease|0|||
128913955|NCT03433781|463976522|FG002|Overall Study|Progression of Disease|0|||
128765517|NCT02392611|463433831|FG000|Overall Study|Lost to Follow-up|0|||
128765518|NCT02392611|463433832|FG001|Overall Study|Lost to Follow-up|0|||
128765519|NCT02392611|463433833|FG002|Overall Study|Lost to Follow-up|0|||
128765520|NCT02392611|463433834|FG003|Overall Study|Lost to Follow-up|0|||
128765521|NCT02392611|463433835|FG004|Overall Study|Lost to Follow-up|0|||
128765522|NCT02392611|463433836|FG005|Overall Study|Lost to Follow-up|0|||
128765523|NCT02392611|463433837|FG006|Overall Study|Lost to Follow-up|1|||
128765524|NCT02392611|463433838|FG007|Overall Study|Lost to Follow-up|0|||
128765525|NCT02392611|463433839|FG008|Overall Study|Lost to Follow-up|0|||
128765526|NCT02392611|463433831|FG000|Overall Study|Enrolled, not treated|0|||
128765527|NCT02392611|463433832|FG001|Overall Study|Enrolled, not treated|0|||
128765528|NCT02392611|463433833|FG002|Overall Study|Enrolled, not treated|0|||
128765529|NCT02392611|463433834|FG003|Overall Study|Enrolled, not treated|2|||
128765530|NCT02392611|463433835|FG004|Overall Study|Enrolled, not treated|0|||
128765531|NCT02392611|463433836|FG005|Overall Study|Enrolled, not treated|0|||
128765532|NCT02392611|463433837|FG006|Overall Study|Enrolled, not treated|0|||
128765533|NCT02392611|463433838|FG007|Overall Study|Enrolled, not treated|0|||
128765534|NCT02392611|463433839|FG008|Overall Study|Enrolled, not treated|0|||
128765535|NCT03585296|463433855|FG000|Overall Study|Adverse Event|1|||
128765536|NCT03585296|463433855|FG000|Overall Study|Lost to Follow-up|2|||
128765537|NCT03585296|463433855|FG000|Overall Study|Withdrawal by Subject|2|||
128765538|NCT00462670|463433856|FG000|Overall Study|Adverse Event|3|||
128765539|NCT00462670|463433857|FG001|Overall Study|Adverse Event|5|||
128765540|NCT00462670|463433856|FG000|Overall Study|Lack of Efficacy|1|||
128765541|NCT00462670|463433857|FG001|Overall Study|Lack of Efficacy|0|||
128765542|NCT00462670|463433856|FG000|Overall Study|Protocol Violation|1|||
128765543|NCT00462670|463433857|FG001|Overall Study|Protocol Violation|0|||
128765544|NCT00462670|463433856|FG000|Overall Study|Resolution of signs and symptoms|0|||
128765545|NCT00462670|463433857|FG001|Overall Study|Resolution of signs and symptoms|2|||
128765546|NCT02110732|463433858|FG000|Overall Study|Physician Decision|5|||
128765547|NCT02110732|463433859|FG001|Overall Study|Physician Decision|2|||
128765548|NCT02110732|463433858|FG000|Overall Study|Lost to Follow-up|1|||
128765549|NCT02110732|463433859|FG001|Overall Study|Lost to Follow-up|1|||
128765550|NCT00633932|463433861|FG000|Overall Study|Adverse Event|1|||
128765551|NCT00633932|463433862|FG001|Overall Study|Adverse Event|3|||
128765552|NCT00633932|463433863|FG002|Overall Study|Adverse Event|4|||
128765553|NCT00633932|463433861|FG000|Overall Study|Withdrawal by Subject|3|||
128765554|NCT00633932|463433862|FG001|Overall Study|Withdrawal by Subject|9|||
128765555|NCT00633932|463433863|FG002|Overall Study|Withdrawal by Subject|1|||
128765556|NCT00633932|463433861|FG000|Overall Study|Lost to Follow-up|1|||
128765557|NCT00633932|463433862|FG001|Overall Study|Lost to Follow-up|0|||
128765558|NCT00633932|463433863|FG002|Overall Study|Lost to Follow-up|2|||
128765559|NCT00633932|463433861|FG000|Overall Study|Protocol Violation|5|||
128765560|NCT00633932|463433862|FG001|Overall Study|Protocol Violation|2|||
128765561|NCT00633932|463433863|FG002|Overall Study|Protocol Violation|3|||
128765562|NCT00633932|463433861|FG000|Overall Study|Physician Decision|0|||
128765563|NCT00633932|463433862|FG001|Overall Study|Physician Decision|0|||
128765564|NCT00633932|463433863|FG002|Overall Study|Physician Decision|1|||
128765565|NCT00633932|463433861|FG000|Overall Study|Doctor's judgement|1|||
128765566|NCT00633932|463433862|FG001|Overall Study|Doctor's judgement|0|||
128765567|NCT00633932|463433863|FG002|Overall Study|Doctor's judgement|0|||
128765568|NCT00633932|463433861|FG000|Overall Study|Moved Away|1|||
128765569|NCT00633932|463433862|FG001|Overall Study|Moved Away|0|||
128765570|NCT00633932|463433863|FG002|Overall Study|Moved Away|0|||
128765571|NCT00482274|463433864|FG000|Overall Study|Adverse Event|1|||
128765572|NCT04836858|463433865|FG000|Overall Study|Adverse Event|0|||
128913956|NCT03433781|463976520|FG000|Overall Study|Physician Decision|0|||
128765573|NCT04836858|463433866|FG001|Overall Study|Adverse Event|0|||
128765574|NCT04836858|463433867|FG002|Overall Study|Adverse Event|0|||
128765575|NCT04836858|463433868|FG003|Overall Study|Adverse Event|1|||
128765576|NCT04836858|463433865|FG000|Overall Study|Lost to Follow-up|1|||
128765577|NCT04836858|463433866|FG001|Overall Study|Lost to Follow-up|0|||
128697333|NCT01594281|463190395|FG000|Interventional Core Phase|Protocol Deviation|1|||
128697334|NCT01594281|463190396|FG001|Interventional Core Phase|Protocol Deviation|0|||
128697335|NCT01594281|463190397|FG002|Interventional Core Phase|Protocol Deviation|0|||
128697336|NCT01594281|463190395|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
128697337|NCT01594281|463190396|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
128697338|NCT01594281|463190397|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
128697339|NCT01594281|463190395|FG000|Interventional Core Phase|Death|1|||
128697340|NCT01594281|463190396|FG001|Interventional Core Phase|Death|1|||
128697341|NCT01594281|463190397|FG002|Interventional Core Phase|Death|2|||
128697342|NCT01594281|463190395|FG000|Interventional Core Phase|Lost to Follow-up|1|||
128697343|NCT01594281|463190396|FG001|Interventional Core Phase|Lost to Follow-up|4|||
128697344|NCT01594281|463190397|FG002|Interventional Core Phase|Lost to Follow-up|1|||
128697345|NCT01594281|463190395|FG000|Interventional Core Phase|Adverse Event|4|||
128697346|NCT01594281|463190396|FG001|Interventional Core Phase|Adverse Event|4|||
128697347|NCT01594281|463190397|FG002|Interventional Core Phase|Adverse Event|4|||
128697348|NCT01594281|463190395|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
128697349|NCT01594281|463190396|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
128697350|NCT01594281|463190397|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
128697351|NCT01594281|463190395|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
128697352|NCT01594281|463190396|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
128697353|NCT01594281|463190397|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
128697354|NCT01594281|463190395|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
128697355|NCT01594281|463190396|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
128697356|NCT01594281|463190397|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
128697357|NCT01020981|463190402|FG000|Overall Study|Did not return mailed survey|74|||
128697358|NCT01020981|463190403|FG001|Overall Study|Did not return mailed survey|58|||
128697359|NCT01020981|463190402|FG000|Overall Study|Survey returned undeliverable|8|||
128697360|NCT01020981|463190403|FG001|Overall Study|Survey returned undeliverable|32|||
128697361|NCT01020981|463190402|FG000|Overall Study|Participant declined to complete survey|2|||
128697362|NCT01020981|463190403|FG001|Overall Study|Participant declined to complete survey|0|||
128697363|NCT00885846|463190408|FG000|Overall Study|Withdrawal by Subject|2|||
128697364|NCT00885846|463190409|FG001|Overall Study|Withdrawal by Subject|5|||
128697365|NCT00885846|463190410|FG002|Overall Study|Withdrawal by Subject|2|||
128697366|NCT03570697|463190412|FG000|Overall Study|Lost to Follow-up|0|||
128697367|NCT03570697|463190413|FG001|Overall Study|Lost to Follow-up|1|||
128697368|NCT03570697|463190412|FG000|Overall Study|Death|2|||
128697369|NCT03570697|463190413|FG001|Overall Study|Death|0|||
128697370|NCT03570697|463190412|FG000|Overall Study|Withdrawal by Subject|4|||
128697371|NCT03570697|463190413|FG001|Overall Study|Withdrawal by Subject|2|||
128697372|NCT01776840|463190414|FG000|Overall Study|Lost to Follow-up|12|||
128697373|NCT01776840|463190415|FG001|Overall Study|Lost to Follow-up|7|||
128697374|NCT01776840|463190414|FG000|Overall Study|Withdrawal by Subject|32|||
128697375|NCT01776840|463190415|FG001|Overall Study|Withdrawal by Subject|48|||
128697376|NCT01776840|463190414|FG000|Overall Study|Sponsor decision|89|||
128697377|NCT01776840|463190415|FG001|Overall Study|Sponsor decision|87|||
128697378|NCT03068455|463190417|FG000|Pre-treatment Period|Disease progression|0|||
128697379|NCT03068455|463190418|FG001|Pre-treatment Period|Disease progression|1|||
128697380|NCT03068455|463190417|FG000|Pre-treatment Period|Participant withdrew consent|1|||
128697381|NCT03068455|463190418|FG001|Pre-treatment Period|Participant withdrew consent|1|||
128697382|NCT03068455|463190417|FG000|Pre-treatment Period|Poor/non-compliance|0|||
128697383|NCT03068455|463190418|FG001|Pre-treatment Period|Poor/non-compliance|1|||
128697384|NCT03068455|463190417|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
128697385|NCT03068455|463190418|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
128697386|NCT03068455|463190417|FG000|Pre-treatment Period|Not reported|2|||
128697387|NCT03068455|463190418|FG001|Pre-treatment Period|Not reported|1|||
128697388|NCT03068455|463190417|FG000|Treatment Period|Disease progression|166|||
128697389|NCT03068455|463190418|FG001|Treatment Period|Disease progression|208|||
128697390|NCT03068455|463190417|FG000|Treatment Period|Study drug toxicity|317|||
128697391|NCT03068455|463190418|FG001|Treatment Period|Study drug toxicity|104|||
128697392|NCT03068455|463190417|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
128697393|NCT03068455|463190418|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
128697394|NCT03068455|463190417|FG000|Treatment Period|Participant request to stop therapy|33|||
128697395|NCT03068455|463190418|FG001|Treatment Period|Participant request to stop therapy|20|||
128697396|NCT03068455|463190417|FG000|Treatment Period|Participant withdrew consent|5|||
128697397|NCT03068455|463190418|FG001|Treatment Period|Participant withdrew consent|10|||
128697398|NCT03068455|463190417|FG000|Treatment Period|Poor/non-compliance|3|||
128697399|NCT03068455|463190418|FG001|Treatment Period|Poor/non-compliance|0|||
128697400|NCT03068455|463190417|FG000|Treatment Period|Participant no longer meets study criteria|1|||
128765578|NCT04836858|463433867|FG002|Overall Study|Lost to Follow-up|0|||
128913957|NCT03433781|463976521|FG001|Overall Study|Physician Decision|1|||
128913958|NCT03433781|463976522|FG002|Overall Study|Physician Decision|0|||
128765579|NCT04836858|463433868|FG003|Overall Study|Lost to Follow-up|0|||
128765580|NCT04836858|463433865|FG000|Overall Study|Subject/Guardian decision|3|||
128765581|NCT04836858|463433866|FG001|Overall Study|Subject/Guardian decision|0|||
128765582|NCT04836858|463433867|FG002|Overall Study|Subject/Guardian decision|0|||
128765583|NCT04836858|463433868|FG003|Overall Study|Subject/Guardian decision|1|||
128765584|NCT04836858|463433865|FG000|Overall Study|Randomized but not treated|4|||
128765585|NCT04836858|463433866|FG001|Overall Study|Randomized but not treated|0|||
128765586|NCT04836858|463433867|FG002|Overall Study|Randomized but not treated|0|||
128765587|NCT04836858|463433868|FG003|Overall Study|Randomized but not treated|0|||
128765588|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
128765589|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
128765590|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Adverse Event|2|||
128765591|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Adverse Event|5|||
128765592|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
128765593|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
128765594|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
128765595|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
128765596|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Randomized by error|0|||
128765597|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Randomized by error|5|||
128765598|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
128765599|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
128765600|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
128765601|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
128765602|NCT02948959|463433869|FG000|52 Weeks Treatment Period|Change of residence location|0|||
128765603|NCT02948959|463433870|FG001|52 Weeks Treatment Period|Change of residence location|1|||
128765604|NCT02948959|463433869|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
128765605|NCT02948959|463433870|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
128765606|NCT02948959|463433869|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
128765607|NCT02948959|463433870|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
128765608|NCT02948959|463433869|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
128765609|NCT02948959|463433870|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
128765610|NCT02948959|463433869|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
128765611|NCT02948959|463433870|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
128765612|NCT02948959|463433869|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
128765613|NCT02948959|463433870|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
128765614|NCT02948959|463433869|FG000|12 Weeks Follow-up Period|Study site closure|1|||
128765615|NCT02948959|463433870|FG001|12 Weeks Follow-up Period|Study site closure|0|||
128765616|NCT00597714|463433873|FG000|Overall Study|Death|56|||
128765617|NCT00597714|463433874|FG001|Overall Study|Death|46|||
128913959|NCT00408694|463976523|FG000|Overall Study|Ineligible|1|||
128913960|NCT00408694|463976523|FG000|Overall Study|No protocol treatment|1|||
128913961|NCT03261531|463976524|FG000|Overall Study|Withdrawal by Subject|4|||
128913962|NCT00666926|463976527|FG000|Overall Study|Adverse Event|0|||
128913963|NCT00666926|463976528|FG001|Overall Study|Adverse Event|0|||
128913964|NCT00666926|463976529|FG002|Overall Study|Adverse Event|0|||
128913965|NCT00666926|463976530|FG003|Overall Study|Adverse Event|0|||
128913966|NCT00666926|463976531|FG004|Overall Study|Adverse Event|0|||
128913967|NCT00666926|463976532|FG005|Overall Study|Adverse Event|0|||
128913968|NCT00666926|463976533|FG006|Overall Study|Adverse Event|0|||
128913969|NCT00666926|463976534|FG007|Overall Study|Adverse Event|0|||
128913970|NCT00666926|463976535|FG008|Overall Study|Adverse Event|0|||
128913971|NCT00666926|463976536|FG009|Overall Study|Adverse Event|2|||
128913972|NCT00666926|463976537|FG010|Overall Study|Adverse Event|2|||
128913973|NCT00666926|463976538|FG011|Overall Study|Adverse Event|2|||
128913974|NCT00666926|463976539|FG012|Overall Study|Adverse Event|0|||
128913975|NCT00666926|463976540|FG013|Overall Study|Adverse Event|1|||
128913976|NCT00666926|463976541|FG014|Overall Study|Adverse Event|0|||
128913977|NCT00666926|463976542|FG015|Overall Study|Adverse Event|0|||
128765618|NCT00597714|463433875|FG002|Overall Study|Death|0|||
128765619|NCT00597714|463433873|FG000|Overall Study|Recipient death|0|||
128765620|NCT00597714|463433874|FG001|Overall Study|Recipient death|0|||
128765621|NCT00597714|463433875|FG002|Overall Study|Recipient death|10|||
128765622|NCT01350141|463433876|FG000|Overall Study|Lost to Follow-up|1|||
128765623|NCT01350141|463433877|FG001|Overall Study|Lost to Follow-up|0|||
128765624|NCT01350141|463433878|FG002|Overall Study|Lost to Follow-up|1|||
128765625|NCT01350141|463433876|FG000|Overall Study|Withdrawal by Subject|1|||
128913978|NCT00666926|463976527|FG000|Overall Study|Laboratory abnormality|0|||
128913979|NCT00666926|463976528|FG001|Overall Study|Laboratory abnormality|0|||
128913980|NCT00666926|463976529|FG002|Overall Study|Laboratory abnormality|0|||
128913981|NCT00666926|463976530|FG003|Overall Study|Laboratory abnormality|0|||
128913982|NCT00666926|463976531|FG004|Overall Study|Laboratory abnormality|0|||
128913983|NCT00666926|463976532|FG005|Overall Study|Laboratory abnormality|0|||
128913984|NCT00666926|463976533|FG006|Overall Study|Laboratory abnormality|0|||
128913985|NCT00666926|463976534|FG007|Overall Study|Laboratory abnormality|0|||
128697401|NCT03068455|463190418|FG001|Treatment Period|Participant no longer meets study criteria|3|||
128913986|NCT00666926|463976535|FG008|Overall Study|Laboratory abnormality|0|||
128913987|NCT00666926|463976536|FG009|Overall Study|Laboratory abnormality|0|||
128913988|NCT00666926|463976537|FG010|Overall Study|Laboratory abnormality|1|||
128913989|NCT00666926|463976538|FG011|Overall Study|Laboratory abnormality|0|||
128913990|NCT00666926|463976539|FG012|Overall Study|Laboratory abnormality|0|||
128913991|NCT00666926|463976540|FG013|Overall Study|Laboratory abnormality|0|||
128913992|NCT00666926|463976541|FG014|Overall Study|Laboratory abnormality|0|||
128913993|NCT00666926|463976542|FG015|Overall Study|Laboratory abnormality|1|||
128913994|NCT00666926|463976527|FG000|Overall Study|Lack of Efficacy|0|||
128913995|NCT00666926|463976528|FG001|Overall Study|Lack of Efficacy|0|||
128913996|NCT00666926|463976529|FG002|Overall Study|Lack of Efficacy|0|||
128913997|NCT00666926|463976530|FG003|Overall Study|Lack of Efficacy|0|||
128913998|NCT00666926|463976531|FG004|Overall Study|Lack of Efficacy|0|||
128913999|NCT00666926|463976532|FG005|Overall Study|Lack of Efficacy|1|||
128914000|NCT00666926|463976533|FG006|Overall Study|Lack of Efficacy|0|||
128914001|NCT00666926|463976534|FG007|Overall Study|Lack of Efficacy|0|||
128914002|NCT00666926|463976535|FG008|Overall Study|Lack of Efficacy|0|||
128914003|NCT00666926|463976536|FG009|Overall Study|Lack of Efficacy|0|||
128914004|NCT00666926|463976537|FG010|Overall Study|Lack of Efficacy|0|||
128914005|NCT00666926|463976538|FG011|Overall Study|Lack of Efficacy|1|||
128914006|NCT00666926|463976539|FG012|Overall Study|Lack of Efficacy|0|||
128914007|NCT00666926|463976540|FG013|Overall Study|Lack of Efficacy|0|||
128914008|NCT00666926|463976541|FG014|Overall Study|Lack of Efficacy|0|||
128914009|NCT00666926|463976542|FG015|Overall Study|Lack of Efficacy|0|||
128914010|NCT00666926|463976527|FG000|Overall Study|Lost to Follow-up|0|||
128914011|NCT00666926|463976528|FG001|Overall Study|Lost to Follow-up|0|||
128914012|NCT00666926|463976529|FG002|Overall Study|Lost to Follow-up|0|||
128914013|NCT00666926|463976530|FG003|Overall Study|Lost to Follow-up|1|||
128914014|NCT00666926|463976531|FG004|Overall Study|Lost to Follow-up|0|||
128914015|NCT00666926|463976532|FG005|Overall Study|Lost to Follow-up|0|||
128914016|NCT00666926|463976533|FG006|Overall Study|Lost to Follow-up|0|||
128914017|NCT00666926|463976534|FG007|Overall Study|Lost to Follow-up|0|||
128914018|NCT00666926|463976535|FG008|Overall Study|Lost to Follow-up|0|||
128914019|NCT00666926|463976536|FG009|Overall Study|Lost to Follow-up|0|||
128914020|NCT00666926|463976537|FG010|Overall Study|Lost to Follow-up|0|||
128914021|NCT00666926|463976538|FG011|Overall Study|Lost to Follow-up|0|||
128914022|NCT00666926|463976539|FG012|Overall Study|Lost to Follow-up|0|||
128914023|NCT00666926|463976540|FG013|Overall Study|Lost to Follow-up|0|||
128914024|NCT00666926|463976541|FG014|Overall Study|Lost to Follow-up|0|||
128914025|NCT00666926|463976542|FG015|Overall Study|Lost to Follow-up|0|||
128914026|NCT00666926|463976527|FG000|Overall Study|Other|2|||
128914027|NCT00666926|463976528|FG001|Overall Study|Other|4|||
128914028|NCT00666926|463976529|FG002|Overall Study|Other|3|||
128914029|NCT00666926|463976530|FG003|Overall Study|Other|3|||
128914030|NCT00666926|463976531|FG004|Overall Study|Other|3|||
128914031|NCT00666926|463976532|FG005|Overall Study|Other|3|||
128914032|NCT00666926|463976533|FG006|Overall Study|Other|4|||
128914033|NCT00666926|463976534|FG007|Overall Study|Other|0|||
128914034|NCT00666926|463976535|FG008|Overall Study|Other|3|||
128914035|NCT00666926|463976536|FG009|Overall Study|Other|5|||
128914036|NCT00666926|463976537|FG010|Overall Study|Other|3|||
128914037|NCT00666926|463976538|FG011|Overall Study|Other|26|||
128914038|NCT00666926|463976539|FG012|Overall Study|Other|3|||
128914039|NCT00666926|463976540|FG013|Overall Study|Other|2|||
128914040|NCT00666926|463976541|FG014|Overall Study|Other|4|||
128914041|NCT00666926|463976542|FG015|Overall Study|Other|4|||
128914042|NCT00666926|463976527|FG000|Overall Study|Withdrawal by Subject|0|||
128914043|NCT00666926|463976528|FG001|Overall Study|Withdrawal by Subject|0|||
128914044|NCT00666926|463976529|FG002|Overall Study|Withdrawal by Subject|0|||
128914045|NCT00666926|463976530|FG003|Overall Study|Withdrawal by Subject|0|||
128914046|NCT00666926|463976531|FG004|Overall Study|Withdrawal by Subject|0|||
128697402|NCT03068455|463190417|FG000|Treatment Period|Other reasons|12|||
128697403|NCT03068455|463190418|FG001|Treatment Period|Other reasons|4|||
128914047|NCT00666926|463976532|FG005|Overall Study|Withdrawal by Subject|0|||
128914048|NCT00666926|463976533|FG006|Overall Study|Withdrawal by Subject|0|||
128914049|NCT00666926|463976534|FG007|Overall Study|Withdrawal by Subject|1|||
128914050|NCT00666926|463976535|FG008|Overall Study|Withdrawal by Subject|0|||
128914051|NCT00666926|463976536|FG009|Overall Study|Withdrawal by Subject|3|||
128914052|NCT00666926|463976537|FG010|Overall Study|Withdrawal by Subject|0|||
128697404|NCT03863197|463190420|FG000|Overall Study|Lost to Follow-up|2|||
128914053|NCT00666926|463976538|FG011|Overall Study|Withdrawal by Subject|3|||
128914054|NCT00666926|463976539|FG012|Overall Study|Withdrawal by Subject|0|||
128914055|NCT00666926|463976540|FG013|Overall Study|Withdrawal by Subject|1|||
128914056|NCT00666926|463976541|FG014|Overall Study|Withdrawal by Subject|3|||
128914057|NCT00666926|463976542|FG015|Overall Study|Withdrawal by Subject|3|||
128914058|NCT00666926|463976527|FG000|Overall Study|Death|0|||
128914059|NCT00666926|463976528|FG001|Overall Study|Death|0|||
128914060|NCT00666926|463976529|FG002|Overall Study|Death|0|||
128914061|NCT00666926|463976530|FG003|Overall Study|Death|0|||
128914062|NCT00666926|463976531|FG004|Overall Study|Death|0|||
128914063|NCT00666926|463976532|FG005|Overall Study|Death|0|||
128914064|NCT00666926|463976533|FG006|Overall Study|Death|0|||
128914065|NCT00666926|463976534|FG007|Overall Study|Death|0|||
128914066|NCT00666926|463976535|FG008|Overall Study|Death|0|||
128914067|NCT00666926|463976536|FG009|Overall Study|Death|0|||
128914068|NCT00666926|463976537|FG010|Overall Study|Death|0|||
128914069|NCT00666926|463976538|FG011|Overall Study|Death|1|||
128914070|NCT00666926|463976539|FG012|Overall Study|Death|0|||
128914071|NCT00666926|463976540|FG013|Overall Study|Death|0|||
128914072|NCT00666926|463976541|FG014|Overall Study|Death|0|||
128914073|NCT00666926|463976542|FG015|Overall Study|Death|0|||
128914074|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
128914075|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
128914076|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
128914077|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Death|28|||
128914078|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Death|0|||
128914079|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Death|0|||
128914080|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
128914081|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
128914082|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
128914083|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
128914084|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
128914085|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
128914086|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
128914087|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
128914088|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
128914089|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
128914090|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
128914091|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
128914092|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
128914093|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
128914094|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
128914095|NCT00820755|463976543|FG000|Period 1: Combination Therapy Phase|Other|11|||
128914096|NCT00820755|463976544|FG001|Period 1: Combination Therapy Phase|Other|0|||
128914097|NCT00820755|463976545|FG002|Period 1: Combination Therapy Phase|Other|0|||
128914098|NCT00820755|463976543|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
128914099|NCT00820755|463976544|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
128914100|NCT00820755|463976545|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
128914101|NCT00573794|463976562|FG000|Overall Study|Adverse Event|81|||
128914102|NCT00573794|463976562|FG000|Overall Study|Withdrew Consent|90|||
128914103|NCT00573794|463976562|FG000|Overall Study|Lost to Follow-up|13|||
128914104|NCT00573794|463976562|FG000|Overall Study|Protocol Violation|6|||
128914105|NCT00573794|463976562|FG000|Overall Study|Lack of Efficacy|94|||
128914106|NCT00573794|463976562|FG000|Overall Study|Other|46|||
128914107|NCT01725750|463976563|FG000|Overall Study|Adverse Event|1|||
128914108|NCT01725750|463976564|FG001|Overall Study|Adverse Event|0|||
128914109|NCT01725750|463976563|FG000|Overall Study|Lost to Follow-up|1|||
128914110|NCT01725750|463976564|FG001|Overall Study|Lost to Follow-up|1|||
128914111|NCT01725750|463976563|FG000|Overall Study|Withdrawal by Subject|0|||
128914112|NCT01725750|463976564|FG001|Overall Study|Withdrawal by Subject|9|||
128914113|NCT02542072|463976565|FG000|First Intervention (1 Month)|Adverse Event|1|||
128914114|NCT02542072|463976566|FG001|First Intervention (1 Month)|Adverse Event|1|||
128914115|NCT02542072|463976565|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
128914116|NCT02542072|463976566|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
128914117|NCT02542072|463976565|FG000|First Intervention (1 Month)|Lens discomfort|1|||
128914118|NCT02542072|463976566|FG001|First Intervention (1 Month)|Lens discomfort|2|||
128914119|NCT02542072|463976565|FG000|First Intervention (1 Month)|Protocol Violation|1|||
128914120|NCT02542072|463976566|FG001|First Intervention (1 Month)|Protocol Violation|0|||
128914121|NCT02542072|463976565|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
128914122|NCT02542072|463976566|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
128914123|NCT02542072|463976565|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
128914124|NCT02542072|463976566|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
128914125|NCT00654498|463976571|FG000|Overall Study|Not Treated|1|||
128914126|NCT00654498|463976572|FG001|Overall Study|Not Treated|0|||
128914127|NCT00654498|463976571|FG000|Overall Study|Adverse Event|6|||
128914128|NCT00654498|463976572|FG001|Overall Study|Adverse Event|1|||
128914129|NCT00654498|463976571|FG000|Overall Study|Protocol Violation|1|||
129028784|NCT01496118|464396402|FG006|Overall Study|Disease progression|14|||
128914130|NCT00654498|463976572|FG001|Overall Study|Protocol Violation|1|||
128914131|NCT00654498|463976571|FG000|Overall Study|Lost to Follow-up|1|||
128914132|NCT00654498|463976572|FG001|Overall Study|Lost to Follow-up|5|||
128914133|NCT00654498|463976571|FG000|Overall Study|Withdrawal by Subject|1|||
129028785|NCT01496118|464396403|FG007|Overall Study|Disease progression|10|||
128914134|NCT00654498|463976572|FG001|Overall Study|Withdrawal by Subject|0|||
128914135|NCT00654498|463976571|FG000|Overall Study|Other reason not defined above|4|||
128914136|NCT00654498|463976572|FG001|Overall Study|Other reason not defined above|5|||
128914137|NCT00695565|463976573|FG000|Overall Study|Lost to Follow-up|4|||
128914138|NCT00695565|463976574|FG001|Overall Study|Lost to Follow-up|4|||
128914139|NCT00695565|463976573|FG000|Overall Study|Adverse Event|3|||
128914140|NCT00695565|463976574|FG001|Overall Study|Adverse Event|1|||
128914141|NCT00695565|463976573|FG000|Overall Study|Protocol Violation|3|||
128914142|NCT00695565|463976574|FG001|Overall Study|Protocol Violation|1|||
128914143|NCT00695565|463976573|FG000|Overall Study|Withdrawal by Subject|1|||
128914144|NCT00695565|463976574|FG001|Overall Study|Withdrawal by Subject|1|||
128914145|NCT00695565|463976573|FG000|Overall Study|Lack of Efficacy|1|||
128914146|NCT00695565|463976574|FG001|Overall Study|Lack of Efficacy|1|||
128914147|NCT00695565|463976573|FG000|Overall Study|Subject did not follow instructions|1|||
128914148|NCT00695565|463976574|FG001|Overall Study|Subject did not follow instructions|1|||
128914149|NCT01738971|463976577|FG000|Overall Study|Lost to Follow-up|19|||
128914150|NCT01738971|463976578|FG001|Overall Study|Lost to Follow-up|30|||
128914151|NCT01738971|463976579|FG002|Overall Study|Lost to Follow-up|17|||
128914152|NCT01031446|463976588|FG000|Overall Study|Disease Progression|38|||
128914153|NCT01031446|463976588|FG000|Overall Study|Adverse Event|9|||
128914154|NCT01031446|463976588|FG000|Overall Study|Physician Decision|4|||
128914155|NCT01031446|463976588|FG000|Overall Study|Withdrawal by Subject|3|||
128914156|NCT01031446|463976588|FG000|Overall Study|Still on treatment|1|||
128914157|NCT02531646|463976591|FG000|Overall Study|equip. image processing issue|5|||
128914158|NCT02531646|463976592|FG001|Overall Study|equip. image processing issue|1|||
128914159|NCT02531646|463976593|FG002|Overall Study|equip. image processing issue|0|||
128914160|NCT03631706|463976594|FG000|Overall Study|Randomized, not treated|1|||
128914161|NCT03631706|463976595|FG001|Overall Study|Randomized, not treated|0|||
128914162|NCT02152345|463978013|FG000|Overall Study|Case Cancellations|2|||
128914163|NCT02152345|463978014|FG001|Overall Study|Case Cancellations|4|||
128914164|NCT02152345|463978013|FG000|Overall Study|Withdrawal by Subject|2|||
128914165|NCT02152345|463978014|FG001|Overall Study|Withdrawal by Subject|1|||
128914166|NCT01916980|463978015|FG000|Overall Study|Adverse Event|4|||
128914167|NCT01916980|463978016|FG001|Overall Study|Adverse Event|2|||
128914168|NCT01916980|463978015|FG000|Overall Study|Lack of Efficacy|2|||
128914169|NCT01916980|463978016|FG001|Overall Study|Lack of Efficacy|2|||
128914170|NCT01916980|463978015|FG000|Overall Study|Withdrawal by Subject|1|||
128914171|NCT01916980|463978016|FG001|Overall Study|Withdrawal by Subject|0|||
128914172|NCT02324270|463978017|FG000|Overall Study|Withdrawal by Subject|0|||
128914173|NCT02324270|463978018|FG001|Overall Study|Withdrawal by Subject|1|||
128914174|NCT02324270|463978019|FG002|Overall Study|Withdrawal by Subject|0|||
128914175|NCT02324270|463978017|FG000|Overall Study|Lost to Follow-up|4|||
128914176|NCT02324270|463978018|FG001|Overall Study|Lost to Follow-up|3|||
128914177|NCT02324270|463978019|FG002|Overall Study|Lost to Follow-up|4|||
128914178|NCT02324270|463978017|FG000|Overall Study|Protocol Violation|0|||
128914179|NCT02324270|463978018|FG001|Overall Study|Protocol Violation|1|||
128914180|NCT02324270|463978019|FG002|Overall Study|Protocol Violation|1|||
129118871|NCT00746551|464731236|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
129118872|NCT00746551|464731235|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
129118873|NCT00746551|464731236|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
129118874|NCT00746551|464731235|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
129118875|NCT00746551|464731236|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
128914181|NCT02324270|463978017|FG000|Overall Study|Non Compliance with Study Drug|1|||
128914182|NCT02324270|463978018|FG001|Overall Study|Non Compliance with Study Drug|2|||
128914183|NCT02324270|463978019|FG002|Overall Study|Non Compliance with Study Drug|0|||
128914184|NCT03968419|463978020|FG000|Treatment Period|Adverse Event|0|||
128914185|NCT03968419|463978021|FG001|Treatment Period|Adverse Event|0|||
129118876|NCT00062166|464731237|FG000|Overall Study|Withdrawal by Subject|6|||
129118877|NCT00833755|464731238|FG000|Overall Study|Physician Decision|4|||
129118878|NCT00833755|464731239|FG001|Overall Study|Physician Decision|4|||
129118879|NCT00833755|464731240|FG002|Overall Study|Physician Decision|2|||
129215655|NCT03077412|465092788|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
129118880|NCT00833755|464731241|FG003|Overall Study|Physician Decision|6|||
129118881|NCT00833755|464731238|FG000|Overall Study|Subject had scheduling issues|0|||
129215656|NCT03077412|465092786|FG000|Overall Study|Adverse Event|1|||
129215657|NCT03077412|465092787|FG001|Overall Study|Adverse Event|2|||
129215658|NCT03077412|465092788|FG002|Overall Study|Adverse Event|2|||
128697405|NCT03863197|463190421|FG001|Overall Study|Lost to Follow-up|3|||
128697406|NCT03863197|463190420|FG000|Overall Study|Withdrawal by Subject|4|||
128914186|NCT03968419|463978022|FG002|Treatment Period|Adverse Event|1|||
128914187|NCT03968419|463978020|FG000|Safety Follow-up Period|Death|3|||
128914188|NCT03968419|463978021|FG001|Safety Follow-up Period|Death|2|||
128914189|NCT03968419|463978022|FG002|Safety Follow-up Period|Death|1|||
128914190|NCT03968419|463978020|FG000|Safety Follow-up Period|Subject Decision|2|||
128914191|NCT03968419|463978021|FG001|Safety Follow-up Period|Subject Decision|1|||
128914192|NCT03968419|463978022|FG002|Safety Follow-up Period|Subject Decision|0|||
128914193|NCT00568555|463978025|FG000|Overall Study|Withdrawal by Subject|1|||
128914194|NCT00568555|463978026|FG001|Overall Study|Withdrawal by Subject|1|||
128914195|NCT00804687|463978029|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
128914196|NCT00804687|463978030|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
128914197|NCT00804687|463978031|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
128914198|NCT00804687|463978032|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
128914199|NCT00804687|463978033|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
128914200|NCT00804687|463978034|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
128914201|NCT00804687|463978029|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
128914202|NCT00804687|463978030|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
128914203|NCT00804687|463978031|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
128914204|NCT00804687|463978032|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
128914205|NCT00804687|463978033|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
128914206|NCT00804687|463978034|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
128914207|NCT00804687|463978029|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
128914208|NCT00804687|463978030|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
128914209|NCT00804687|463978031|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
128914210|NCT00804687|463978032|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
128914211|NCT00804687|463978033|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
128914212|NCT00804687|463978034|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
128914213|NCT00804687|463978029|FG000|Period 5: Treatment Period|Positive drug test|1|||
128914214|NCT00804687|463978030|FG001|Period 5: Treatment Period|Positive drug test|0|||
128914215|NCT00804687|463978031|FG002|Period 5: Treatment Period|Positive drug test|0|||
128914216|NCT00804687|463978032|FG003|Period 5: Treatment Period|Positive drug test|0|||
128914217|NCT00804687|463978033|FG004|Period 5: Treatment Period|Positive drug test|0|||
128914218|NCT00804687|463978034|FG005|Period 5: Treatment Period|Positive drug test|0|||
128914219|NCT00688909|463978037|FG000|Overall Study|Adverse Event|28|||
128914220|NCT00688909|463978037|FG000|Overall Study|Patient withdrew consent|2|||
128914221|NCT00688909|463978037|FG000|Overall Study|Administrative problems|1|||
128914222|NCT00688909|463978037|FG000|Overall Study|Protocol Violation|2|||
128914223|NCT01220414|463978038|FG000|Overall Study|Withdrawal by Subject|1|||
128914224|NCT01220414|463978039|FG001|Overall Study|Withdrawal by Subject|0|||
128914225|NCT01220414|463978040|FG002|Overall Study|Withdrawal by Subject|0|||
128914226|NCT01220414|463978041|FG003|Overall Study|Withdrawal by Subject|1|||
128914227|NCT00860158|463978049|FG000|Overall Study|Study Terminated|1|||
128914228|NCT00669617|463978051|FG000|Period 1|Withdrawal by Subject|0|||
128914229|NCT00669617|463978052|FG001|Period 1|Withdrawal by Subject|0|||
128914230|NCT00669617|463978053|FG002|Period 1|Withdrawal by Subject|1|||
128914231|NCT00669617|463978054|FG003|Period 1|Withdrawal by Subject|0|||
128914232|NCT00669617|463978055|FG004|Period 1|Withdrawal by Subject|0|||
128914233|NCT00669617|463978051|FG000|Period 1|Protocol Deviation|0|||
128914234|NCT00669617|463978052|FG001|Period 1|Protocol Deviation|0|||
128914235|NCT00669617|463978053|FG002|Period 1|Protocol Deviation|0|||
128914236|NCT00669617|463978054|FG003|Period 1|Protocol Deviation|0|||
128914237|NCT00669617|463978055|FG004|Period 1|Protocol Deviation|1|||
128914238|NCT00669617|463978051|FG000|Period 3|Lost to Follow-up|1|||
128914239|NCT00669617|463978052|FG001|Period 3|Lost to Follow-up|0|||
128914240|NCT00669617|463978053|FG002|Period 3|Lost to Follow-up|0|||
128914241|NCT00669617|463978054|FG003|Period 3|Lost to Follow-up|0|||
128914242|NCT00669617|463978055|FG004|Period 3|Lost to Follow-up|0|||
128914243|NCT05499520|463978056|FG000|Overall Study|Lost to Follow-up|0|||
128914244|NCT05499520|463978057|FG001|Overall Study|Lost to Follow-up|0|||
128914245|NCT05499520|463978058|FG002|Overall Study|Lost to Follow-up|38|||
128914246|NCT05499520|463978059|FG003|Overall Study|Lost to Follow-up|41|||
129118882|NCT00833755|464731239|FG001|Overall Study|Subject had scheduling issues|1|||
128914247|NCT05499520|463978060|FG004|Overall Study|Lost to Follow-up|46|||
128914248|NCT05499520|463978061|FG005|Overall Study|Lost to Follow-up|0|||
128914249|NCT05499520|463978062|FG006|Overall Study|Lost to Follow-up|31|||
128914250|NCT05499520|463978063|FG007|Overall Study|Lost to Follow-up|45|||
128914251|NCT05499520|463978064|FG008|Overall Study|Lost to Follow-up|42|||
128914252|NCT05499520|463978065|FG009|Overall Study|Lost to Follow-up|0|||
128697407|NCT03863197|463190421|FG001|Overall Study|Withdrawal by Subject|0|||
128697408|NCT03863197|463190420|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
128914253|NCT05499520|463978066|FG010|Overall Study|Lost to Follow-up|0|||
128914254|NCT05499520|463978067|FG011|Overall Study|Lost to Follow-up|37|||
128914255|NCT05499520|463978068|FG012|Overall Study|Lost to Follow-up|53|||
128914256|NCT05499520|463978069|FG013|Overall Study|Lost to Follow-up|49|||
128914257|NCT05499520|463978070|FG014|Overall Study|Lost to Follow-up|0|||
128914258|NCT05499520|463978071|FG015|Overall Study|Lost to Follow-up|36|||
128914259|NCT05499520|463978072|FG016|Overall Study|Lost to Follow-up|58|||
128914260|NCT05499520|463978073|FG017|Overall Study|Lost to Follow-up|53|||
128914261|NCT00700180|463978074|FG000|Overall Study|Death|99|||
128914262|NCT00700180|463978075|FG001|Overall Study|Death|114|||
128697409|NCT03863197|463190421|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
128914263|NCT00700180|463978074|FG000|Overall Study|Alive on treatment|5|||
128914264|NCT00700180|463978075|FG001|Overall Study|Alive on treatment|3|||
128914265|NCT00700180|463978074|FG000|Overall Study|Alive in follow-up|46|||
128914266|NCT00700180|463978075|FG001|Overall Study|Alive in follow-up|27|||
128914267|NCT00700180|463978074|FG000|Overall Study|Lost to Follow-up|4|||
128914268|NCT00700180|463978075|FG001|Overall Study|Lost to Follow-up|5|||
128914269|NCT01613326|463978076|FG000|Overall Study|Adverse Event|7|||
128914270|NCT01613326|463978077|FG001|Overall Study|Adverse Event|5|||
128914271|NCT01613326|463978076|FG000|Overall Study|Withdrawal by Subject|3|||
128914272|NCT01613326|463978077|FG001|Overall Study|Withdrawal by Subject|4|||
128914273|NCT01613326|463978076|FG000|Overall Study|Abnormal test procedure result(s)|2|||
128914274|NCT01613326|463978077|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128914275|NCT01613326|463978076|FG000|Overall Study|inability to use device|1|||
128914276|NCT01613326|463978077|FG001|Overall Study|inability to use device|0|||
128914277|NCT01613326|463978076|FG000|Overall Study|Lack of Efficacy|0|||
128914278|NCT01613326|463978077|FG001|Overall Study|Lack of Efficacy|1|||
128914279|NCT01613326|463978076|FG000|Overall Study|Lost to Follow-up|0|||
128914280|NCT01613326|463978077|FG001|Overall Study|Lost to Follow-up|1|||
128914281|NCT01613326|463978076|FG000|Overall Study|Administrative|0|||
128914282|NCT01613326|463978077|FG001|Overall Study|Administrative|2|||
128914283|NCT01613326|463978076|FG000|Overall Study|Protocol Violation|0|||
128914284|NCT01613326|463978077|FG001|Overall Study|Protocol Violation|1|||
128914285|NCT03980938|463978078|FG000|Treatment Period 1|Study Terminated|1|||
128914286|NCT03980938|463978079|FG001|Treatment Period 1|Study Terminated|1|||
128914287|NCT03980938|463978078|FG000|Treatment Period 2|Study Terminated|2|||
128914288|NCT03980938|463978079|FG001|Treatment Period 2|Study Terminated|2|||
128914289|NCT00840827|463978080|FG000|Overall Study|Adverse Event|1|||
128914290|NCT00840827|463978080|FG000|Overall Study|Lack of Efficacy|4|||
128914291|NCT00840827|463978080|FG000|Overall Study|Physician Decision|1|||
128914292|NCT01445535|463978081|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
128914293|NCT01445535|463978082|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
128914294|NCT01445535|463978083|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
128914295|NCT01445535|463978084|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
128914296|NCT01445535|463978081|FG000|Overall Study|Disease progression|1|||
128914297|NCT01445535|463978082|FG001|Overall Study|Disease progression|0|||
128914298|NCT01445535|463978083|FG002|Overall Study|Disease progression|1|||
128914299|NCT01445535|463978084|FG003|Overall Study|Disease progression|0|||
128914300|NCT01445535|463978081|FG000|Overall Study|PI discretion|0|||
128914301|NCT01445535|463978082|FG001|Overall Study|PI discretion|0|||
128914302|NCT01445535|463978083|FG002|Overall Study|PI discretion|0|||
128914303|NCT01445535|463978084|FG003|Overall Study|PI discretion|1|||
128914304|NCT03569202|463978085|FG000|Part 3|Physician Decision|1|||
128914305|NCT03569202|463978086|FG001|Part 3|Physician Decision|0|||
128914306|NCT03569202|463978085|FG000|Part 3|Other|1|||
128914307|NCT03569202|463978086|FG001|Part 3|Other|1|||
128914308|NCT00420511|463978087|FG000|Overall Study|Adverse Event|1|||
128914309|NCT00420511|463978088|FG001|Overall Study|Adverse Event|1|||
128914310|NCT00420511|463978087|FG000|Overall Study|Lost to Follow-up|1|||
128914311|NCT00420511|463978088|FG001|Overall Study|Lost to Follow-up|0|||
128914312|NCT01337973|463978089|FG000|Overall Study|Lost to Follow-up|2|||
128914313|NCT01337973|463978090|FG001|Overall Study|Lost to Follow-up|4|||
128914314|NCT01337973|463978091|FG002|Overall Study|Lost to Follow-up|3|||
128914315|NCT01337973|463978089|FG000|Overall Study|Death|1|||
128914316|NCT01337973|463978090|FG001|Overall Study|Death|2|||
128914317|NCT01337973|463978091|FG002|Overall Study|Death|1|||
128914318|NCT01337973|463978089|FG000|Overall Study|Withdrawal by Subject|10|||
128914319|NCT01337973|463978090|FG001|Overall Study|Withdrawal by Subject|8|||
128914320|NCT01337973|463978091|FG002|Overall Study|Withdrawal by Subject|4|||
128914321|NCT01337973|463978089|FG000|Overall Study|missing data on primary outcome|3|||
128914322|NCT01337973|463978090|FG001|Overall Study|missing data on primary outcome|1|||
128914323|NCT01337973|463978091|FG002|Overall Study|missing data on primary outcome|3|||
128914324|NCT00254566|463978093|FG000|Overall Study|Death|1|||
128914325|NCT00254566|463978094|FG001|Overall Study|Death|0|||
128914326|NCT00254566|463978093|FG000|Overall Study|Adverse Event|5|||
128914327|NCT00254566|463978094|FG001|Overall Study|Adverse Event|4|||
128914328|NCT00254566|463978093|FG000|Overall Study|Lack of Efficacy|12|||
128914329|NCT00254566|463978094|FG001|Overall Study|Lack of Efficacy|9|||
128914330|NCT00254566|463978093|FG000|Overall Study|Other|1|||
128914331|NCT00254566|463978094|FG001|Overall Study|Other|5|||
128914332|NCT00254566|463978093|FG000|Overall Study|Withdrawal by Subject|5|||
128914333|NCT00254566|463978094|FG001|Overall Study|Withdrawal by Subject|6|||
129028786|NCT01496118|464396396|FG000|Overall Study|Physician Decision|0|||
129028787|NCT01496118|464396397|FG001|Overall Study|Physician Decision|0|||
129028788|NCT01496118|464396398|FG002|Overall Study|Physician Decision|0|||
129028789|NCT01496118|464396399|FG003|Overall Study|Physician Decision|0|||
129028790|NCT01496118|464396400|FG004|Overall Study|Physician Decision|1|||
129028791|NCT01496118|464396401|FG005|Overall Study|Physician Decision|0|||
128914334|NCT00254566|463978093|FG000|Overall Study|Lost to Follow-up|7|||
129028792|NCT01496118|464396402|FG006|Overall Study|Physician Decision|3|||
128914335|NCT00254566|463978094|FG001|Overall Study|Lost to Follow-up|2|||
128914336|NCT02624492|463978098|FG000|Overall Study|Adverse Event|2|||
128914337|NCT02624492|463978099|FG001|Overall Study|Adverse Event|2|||
128914338|NCT02624492|463978100|FG002|Overall Study|Adverse Event|2|||
128914339|NCT02624492|463978098|FG000|Overall Study|Progressive disease|0|||
128914340|NCT02624492|463978099|FG001|Overall Study|Progressive disease|2|||
128914341|NCT02624492|463978100|FG002|Overall Study|Progressive disease|3|||
128914342|NCT03555266|463978106|FG000|Overall Study|Protocol Violation|6|||
128914343|NCT03555266|463978107|FG001|Overall Study|Protocol Violation|4|||
128914344|NCT02167945|463978108|FG000|Overall Study|Adverse Event|16|||
128914345|NCT02167945|463978108|FG000|Overall Study|Withdrew Consent|42|||
128914346|NCT02167945|463978108|FG000|Overall Study|Lost to Follow-up|122|||
128914347|NCT02167945|463978108|FG000|Overall Study|COVID-19 logistical restrictions|6|||
128914348|NCT02167945|463978108|FG000|Overall Study|Other, not specified|63|||
128914349|NCT02239263|463978109|FG000|Overall Study|Protocol Violation|6|||
128914350|NCT01058096|463978111|FG000|Double-blind Treatment Phase|Adverse Event|11|||
128914351|NCT01058096|463978112|FG001|Double-blind Treatment Phase|Adverse Event|15|||
128914352|NCT01058096|463978111|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
128914353|NCT01058096|463978112|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
128914354|NCT01058096|463978111|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
128914355|NCT01058096|463978112|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
128914356|NCT01058096|463978111|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
128914357|NCT01058096|463978112|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
128914358|NCT01058096|463978111|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
128914359|NCT01058096|463978112|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
128914360|NCT01058096|463978111|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
128914361|NCT01058096|463978112|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
128914362|NCT04276207|463978113|FG000|Period 1|Withdrawal by Subject|0|||
128914363|NCT04276207|463978114|FG001|Period 1|Withdrawal by Subject|1|||
128914364|NCT04451330|463978115|FG000|Overall Study|Adverse Event|1|||
128914365|NCT04451330|463978116|FG001|Overall Study|Adverse Event|2|||
128914366|NCT04451330|463978115|FG000|Overall Study|Lost to Follow-up|5|||
128914367|NCT04451330|463978116|FG001|Overall Study|Lost to Follow-up|0|||
128914368|NCT04451330|463978115|FG000|Overall Study|Withdrawal by Subject|3|||
128914369|NCT04451330|463978116|FG001|Overall Study|Withdrawal by Subject|1|||
128914370|NCT04451330|463978115|FG000|Overall Study|Withdrawal by parent/guardian|1|||
128914371|NCT04451330|463978116|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128914372|NCT04451330|463978115|FG000|Overall Study|Other than specified|0|||
128914373|NCT04451330|463978116|FG001|Overall Study|Other than specified|1|||
128914374|NCT02769624|463978117|FG000|Overall Study|Lost to Follow-up|0|||
128914375|NCT02769624|463978118|FG001|Overall Study|Lost to Follow-up|1|||
128914376|NCT05099640|463978119|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
128914377|NCT05099640|463978120|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
128914378|NCT05099640|463978121|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
128697410|NCT04515394|463190422|FG000|Overall Study|Participant did not receive treatment|1|||
128697411|NCT01058655|463190425|FG000|Overall Study|Withdrawal by Subject|1|||
128697412|NCT01058655|463190426|FG001|Overall Study|Withdrawal by Subject|0|||
128697413|NCT01058655|463190427|FG002|Overall Study|Withdrawal by Subject|3|||
128697414|NCT01058655|463190428|FG003|Overall Study|Withdrawal by Subject|4|||
128697415|NCT01058655|463190425|FG000|Overall Study|Prolonged Treatment Delay|0|||
128697416|NCT01058655|463190426|FG001|Overall Study|Prolonged Treatment Delay|0|||
128697417|NCT01058655|463190427|FG002|Overall Study|Prolonged Treatment Delay|0|||
128697418|NCT01058655|463190428|FG003|Overall Study|Prolonged Treatment Delay|2|||
128697419|NCT01058655|463190425|FG000|Overall Study|Symptomatic Deterioration|0|||
128697420|NCT01058655|463190426|FG001|Overall Study|Symptomatic Deterioration|0|||
128697421|NCT01058655|463190427|FG002|Overall Study|Symptomatic Deterioration|0|||
128697422|NCT01058655|463190428|FG003|Overall Study|Symptomatic Deterioration|1|||
128697423|NCT01058655|463190425|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
128697424|NCT01058655|463190426|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
128697425|NCT01058655|463190427|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
128697426|NCT01058655|463190428|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
128697427|NCT01058655|463190425|FG000|Overall Study|Death|0|||
128697428|NCT01058655|463190426|FG001|Overall Study|Death|1|||
128697429|NCT01058655|463190427|FG002|Overall Study|Death|1|||
128697430|NCT01058655|463190428|FG003|Overall Study|Death|0|||
128697431|NCT01058655|463190425|FG000|Overall Study|Disease Progression|1|||
128697432|NCT01058655|463190426|FG001|Overall Study|Disease Progression|2|||
128697433|NCT01058655|463190427|FG002|Overall Study|Disease Progression|4|||
128697434|NCT01058655|463190428|FG003|Overall Study|Disease Progression|24|||
128914379|NCT05099640|463978119|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
128697435|NCT01058655|463190425|FG000|Overall Study|Other|0|||
128697436|NCT01058655|463190426|FG001|Overall Study|Other|0|||
128697437|NCT01058655|463190427|FG002|Overall Study|Other|0|||
128697438|NCT01058655|463190428|FG003|Overall Study|Other|4|||
128697439|NCT04472429|463190432|FG000|Randomized Period|Ongoing|90|||
128697440|NCT04472429|463190433|FG001|Randomized Period|Ongoing|40|||
128697441|NCT04472429|463190434|FG002|Randomized Period|Ongoing|0|||
128697442|NCT04472429|463190432|FG000|Randomized Period|Death|52|||
128697443|NCT04472429|463190433|FG001|Randomized Period|Death|37|||
128914380|NCT05099640|463978120|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
128914381|NCT05099640|463978121|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
128914382|NCT05099640|463978119|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
128914383|NCT05099640|463978120|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
128914384|NCT05099640|463978121|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
128914385|NCT05099640|463978119|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
128914386|NCT05099640|463978120|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
128914387|NCT05099640|463978121|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
128914388|NCT05099640|463978119|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
128914389|NCT05099640|463978120|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
128914390|NCT05099640|463978121|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
128914391|NCT05099640|463978119|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
128914392|NCT05099640|463978120|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
128914393|NCT05099640|463978121|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
128914394|NCT00179959|463978122|FG000|Overall Study|Lost to Follow-up|3|||
128914395|NCT00179959|463978123|FG001|Overall Study|Lost to Follow-up|1|||
128914396|NCT00179959|463978122|FG000|Overall Study|Withdrawal by Subject|3|||
128914397|NCT00179959|463978123|FG001|Overall Study|Withdrawal by Subject|2|||
128914398|NCT00448708|463978124|FG000|Overall Study|Death|21|||
128914399|NCT00448708|463978125|FG001|Overall Study|Death|17|||
128914400|NCT00448708|463978124|FG000|Overall Study|Withdrawal by Subject|8|||
128914401|NCT00448708|463978125|FG001|Overall Study|Withdrawal by Subject|4|||
128914402|NCT00448708|463978124|FG000|Overall Study|Lost to Follow-up|6|||
128914403|NCT00448708|463978125|FG001|Overall Study|Lost to Follow-up|8|||
128914404|NCT00448708|463978124|FG000|Overall Study|not listed|0|||
128914405|NCT00448708|463978125|FG001|Overall Study|not listed|2|||
129028793|NCT01496118|464396403|FG007|Overall Study|Physician Decision|6|||
129028794|NCT01496118|464396396|FG000|Overall Study|Adverse Event|1|||
129028795|NCT01496118|464396397|FG001|Overall Study|Adverse Event|1|||
129028796|NCT01496118|464396398|FG002|Overall Study|Adverse Event|0|||
129028797|NCT01496118|464396399|FG003|Overall Study|Adverse Event|0|||
129028798|NCT01496118|464396400|FG004|Overall Study|Adverse Event|0|||
129028799|NCT01496118|464396401|FG005|Overall Study|Adverse Event|0|||
129028800|NCT01496118|464396402|FG006|Overall Study|Adverse Event|6|||
129028801|NCT01496118|464396403|FG007|Overall Study|Adverse Event|10|||
129028802|NCT01496118|464396396|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129028803|NCT01496118|464396397|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129028804|NCT01496118|464396398|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129028805|NCT01496118|464396399|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129028806|NCT01496118|464396400|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129028807|NCT01496118|464396401|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129028808|NCT01496118|464396402|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
129028809|NCT01496118|464396403|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129028810|NCT01496118|464396396|FG000|Overall Study|Death|0|||
129028811|NCT01496118|464396397|FG001|Overall Study|Death|0|||
129028812|NCT01496118|464396398|FG002|Overall Study|Death|0|||
129028813|NCT01496118|464396399|FG003|Overall Study|Death|0|||
129028814|NCT01496118|464396400|FG004|Overall Study|Death|0|||
129028815|NCT01496118|464396401|FG005|Overall Study|Death|0|||
129028816|NCT01496118|464396402|FG006|Overall Study|Death|1|||
129028817|NCT01496118|464396403|FG007|Overall Study|Death|1|||
129028818|NCT01496118|464396396|FG000|Overall Study|Withdrawal by Subject|0|||
129028819|NCT01496118|464396397|FG001|Overall Study|Withdrawal by Subject|0|||
129028820|NCT01496118|464396398|FG002|Overall Study|Withdrawal by Subject|0|||
129028821|NCT01496118|464396399|FG003|Overall Study|Withdrawal by Subject|2|||
129028822|NCT01496118|464396400|FG004|Overall Study|Withdrawal by Subject|0|||
129028823|NCT01496118|464396401|FG005|Overall Study|Withdrawal by Subject|1|||
129028824|NCT01496118|464396402|FG006|Overall Study|Withdrawal by Subject|6|||
129028825|NCT01496118|464396403|FG007|Overall Study|Withdrawal by Subject|3|||
129028826|NCT02420353|464396410|FG000|Overall Study|Withdrawal by Subject|0|||
129028827|NCT02420353|464396411|FG001|Overall Study|Withdrawal by Subject|1|||
129028828|NCT04608448|464396412|FG000|Overall Study|Withdrawal by Subject|1|||
129028829|NCT04608448|464396412|FG000|Overall Study|Adverse Event|1|||
129028830|NCT01149057|464396413|FG000|Overall Study|Lack of Efficacy|16|||
129028831|NCT01149057|464396413|FG000|Overall Study|Adverse Event|13|||
129028832|NCT01149057|464396413|FG000|Overall Study|Withdrawal by Subject|9|||
129028833|NCT01149057|464396413|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
129028834|NCT01149057|464396413|FG000|Overall Study|B Cell Depletion|4|||
129028835|NCT01149057|464396413|FG000|Overall Study|Participant Non-Compliance|2|||
129028836|NCT01149057|464396413|FG000|Overall Study|Lost to Follow-up|1|||
128697444|NCT04472429|463190434|FG002|Randomized Period|Death|0|||
128914406|NCT04178772|463978126|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
128914407|NCT04178772|463978126|FG000|Overall Study|study terminated early due to COVID-19|7|||
128914408|NCT00713219|463978129|FG000|Overall Study|Death|1|||
128914409|NCT00713219|463978129|FG000|Overall Study|Protocol Violation|1|||
128914410|NCT00091832|463978132|FG000|Overall Study|Physician Decision|1|||
128914411|NCT00091832|463978133|FG001|Overall Study|Physician Decision|0|||
128914412|NCT00091832|463978134|FG002|Overall Study|Physician Decision|0|||
128914413|NCT00091832|463978135|FG003|Overall Study|Physician Decision|0|||
128914414|NCT00091832|463978136|FG004|Overall Study|Physician Decision|0|||
128914415|NCT00091832|463978137|FG005|Overall Study|Physician Decision|0|||
128914416|NCT00091832|463978132|FG000|Overall Study|Adverse Event|0|||
128914417|NCT00091832|463978133|FG001|Overall Study|Adverse Event|0|||
128914418|NCT00091832|463978134|FG002|Overall Study|Adverse Event|0|||
128914419|NCT00091832|463978135|FG003|Overall Study|Adverse Event|1|||
128914420|NCT00091832|463978136|FG004|Overall Study|Adverse Event|3|||
128914421|NCT00091832|463978137|FG005|Overall Study|Adverse Event|0|||
128914422|NCT00091832|463978132|FG000|Overall Study|Withdrawal by Subject|4|||
128914423|NCT00091832|463978133|FG001|Overall Study|Withdrawal by Subject|5|||
128914424|NCT00091832|463978134|FG002|Overall Study|Withdrawal by Subject|0|||
128914425|NCT00091832|463978135|FG003|Overall Study|Withdrawal by Subject|1|||
128914426|NCT00091832|463978136|FG004|Overall Study|Withdrawal by Subject|3|||
128914427|NCT00091832|463978137|FG005|Overall Study|Withdrawal by Subject|1|||
128914428|NCT00091832|463978132|FG000|Overall Study|Death|6|||
128914429|NCT00091832|463978133|FG001|Overall Study|Death|4|||
128914430|NCT00091832|463978134|FG002|Overall Study|Death|5|||
128914431|NCT00091832|463978135|FG003|Overall Study|Death|8|||
128914432|NCT00091832|463978136|FG004|Overall Study|Death|5|||
128914433|NCT00091832|463978137|FG005|Overall Study|Death|6|||
128914434|NCT00091832|463978132|FG000|Overall Study|Disease Progression|2|||
128914435|NCT00091832|463978133|FG001|Overall Study|Disease Progression|0|||
128914436|NCT00091832|463978134|FG002|Overall Study|Disease Progression|0|||
128914437|NCT00091832|463978135|FG003|Overall Study|Disease Progression|1|||
128914438|NCT00091832|463978136|FG004|Overall Study|Disease Progression|1|||
128914439|NCT00091832|463978137|FG005|Overall Study|Disease Progression|2|||
128914440|NCT00091832|463978132|FG000|Overall Study|Ineligibility Determined|0|||
128914441|NCT00091832|463978133|FG001|Overall Study|Ineligibility Determined|0|||
128914442|NCT00091832|463978134|FG002|Overall Study|Ineligibility Determined|1|||
128914443|NCT00091832|463978135|FG003|Overall Study|Ineligibility Determined|0|||
128914444|NCT00091832|463978136|FG004|Overall Study|Ineligibility Determined|1|||
128914445|NCT00091832|463978137|FG005|Overall Study|Ineligibility Determined|0|||
128914446|NCT00091832|463978132|FG000|Overall Study|Lost to Follow-up|1|||
128914447|NCT00091832|463978133|FG001|Overall Study|Lost to Follow-up|0|||
128914448|NCT00091832|463978134|FG002|Overall Study|Lost to Follow-up|3|||
128914449|NCT00091832|463978135|FG003|Overall Study|Lost to Follow-up|3|||
128697445|NCT04472429|463190432|FG000|Randomized Period|Lost to Follow-up|4|||
128697446|NCT04472429|463190433|FG001|Randomized Period|Lost to Follow-up|0|||
128914450|NCT00091832|463978136|FG004|Overall Study|Lost to Follow-up|2|||
128914451|NCT00091832|463978137|FG005|Overall Study|Lost to Follow-up|1|||
128914452|NCT00091832|463978132|FG000|Overall Study|Noncompliance|0|||
128914453|NCT00091832|463978133|FG001|Overall Study|Noncompliance|1|||
128914454|NCT00091832|463978134|FG002|Overall Study|Noncompliance|0|||
128914455|NCT00091832|463978135|FG003|Overall Study|Noncompliance|0|||
128914456|NCT00091832|463978136|FG004|Overall Study|Noncompliance|0|||
128914457|NCT00091832|463978137|FG005|Overall Study|Noncompliance|0|||
129028837|NCT01149057|464396413|FG000|Overall Study|High Parathyroid Hormone Value|1|||
128697447|NCT04472429|463190434|FG002|Randomized Period|Lost to Follow-up|0|||
128697448|NCT04472429|463190432|FG000|Randomized Period|Physician Decision|1|||
128697449|NCT04472429|463190433|FG001|Randomized Period|Physician Decision|2|||
128697450|NCT04472429|463190434|FG002|Randomized Period|Physician Decision|0|||
128697451|NCT04472429|463190432|FG000|Randomized Period|Withdrawal by Subject|6|||
128697452|NCT04472429|463190433|FG001|Randomized Period|Withdrawal by Subject|5|||
128697453|NCT04472429|463190434|FG002|Randomized Period|Withdrawal by Subject|0|||
128697454|NCT04472429|463190432|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
128697455|NCT04472429|463190433|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
128697456|NCT04472429|463190434|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
128697457|NCT04472429|463190432|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
128697458|NCT04472429|463190433|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
128697459|NCT04472429|463190434|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
128697460|NCT04472429|463190432|FG000|Open-label Monotherapy Period|Ongoing|0|||
128914458|NCT00091832|463978132|FG000|Overall Study|Other|0|||
128914459|NCT00091832|463978133|FG001|Overall Study|Other|1|||
128914460|NCT00091832|463978134|FG002|Overall Study|Other|2|||
128914461|NCT00091832|463978135|FG003|Overall Study|Other|0|||
128914462|NCT00091832|463978136|FG004|Overall Study|Other|0|||
128914463|NCT00091832|463978137|FG005|Overall Study|Other|0|||
128914464|NCT00091832|463978132|FG000|Overall Study|Protocol Violation|0|||
128697461|NCT04472429|463190433|FG001|Open-label Monotherapy Period|Ongoing|0|||
128697462|NCT04472429|463190434|FG002|Open-label Monotherapy Period|Ongoing|32|||
128914465|NCT00091832|463978133|FG001|Overall Study|Protocol Violation|0|||
128914466|NCT00091832|463978134|FG002|Overall Study|Protocol Violation|1|||
128914467|NCT00091832|463978135|FG003|Overall Study|Protocol Violation|0|||
128914468|NCT00091832|463978136|FG004|Overall Study|Protocol Violation|0|||
128914469|NCT00091832|463978137|FG005|Overall Study|Protocol Violation|1|||
128914470|NCT00464178|463978138|FG000|Overall Study|Protocol Violation|1|||
128914471|NCT00464178|463978138|FG000|Overall Study|Withdrawal by Subject|1|||
128914472|NCT00946309|463978141|FG000|Overall Study|Protocol Violation|1|||
128914473|NCT00946309|463978142|FG001|Overall Study|Protocol Violation|0|||
128914474|NCT00946309|463978141|FG000|Overall Study|Lost to Follow-up|0|||
128914475|NCT00946309|463978142|FG001|Overall Study|Lost to Follow-up|1|||
128914476|NCT00946309|463978141|FG000|Overall Study|Procedure cancelled/discontinued|0|||
128914477|NCT00946309|463978142|FG001|Overall Study|Procedure cancelled/discontinued|3|||
128914478|NCT01469000|463978147|FG000|Overall Study|Withdrawal by Subject|16|||
128765626|NCT01350141|463433877|FG001|Overall Study|Withdrawal by Subject|0|||
128914479|NCT01469000|463978148|FG001|Overall Study|Withdrawal by Subject|3|||
128914480|NCT01469000|463978147|FG000|Overall Study|Sponsor Decision|4|||
128914481|NCT01469000|463978148|FG001|Overall Study|Sponsor Decision|1|||
128914482|NCT00686647|463978156|FG000|Overall Study|Lost to Follow-up|1|||
128914483|NCT00686647|463978156|FG000|Overall Study|Death|1|||
128914484|NCT05501119|463978165|FG000|Overall Study|Withdrawal by Subject|2|||
128914485|NCT05501119|463978165|FG000|Overall Study|Lost to Follow-up|5|||
128914486|NCT01356589|463978169|FG000|Overall Study|Enrolled, but not treated|3|||
128914487|NCT01356589|463978169|FG000|Overall Study|Dose data not recorded|2|||
128914488|NCT01462266|463978170|FG000|Overall Study|Adverse Event|7|||
128914489|NCT01462266|463978171|FG001|Overall Study|Adverse Event|6|||
128914490|NCT01462266|463978170|FG000|Overall Study|Death|2|||
128914491|NCT01462266|463978171|FG001|Overall Study|Death|1|||
128914492|NCT01462266|463978170|FG000|Overall Study|Lack of Efficacy|0|||
128914493|NCT01462266|463978171|FG001|Overall Study|Lack of Efficacy|2|||
128914494|NCT01462266|463978170|FG000|Overall Study|Lost to Follow-up|4|||
128914495|NCT01462266|463978171|FG001|Overall Study|Lost to Follow-up|3|||
128914496|NCT01462266|463978170|FG000|Overall Study|Non-compliance with study drug|3|||
128914497|NCT01462266|463978171|FG001|Overall Study|Non-compliance with study drug|0|||
128914498|NCT01462266|463978170|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
128914499|NCT01462266|463978171|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
128914500|NCT01462266|463978170|FG000|Overall Study|Physician Decision|2|||
128914501|NCT01462266|463978171|FG001|Overall Study|Physician Decision|5|||
128914502|NCT01462266|463978170|FG000|Overall Study|Protocol Violation|1|||
128914503|NCT01462266|463978171|FG001|Overall Study|Protocol Violation|3|||
128914504|NCT01462266|463978170|FG000|Overall Study|Withdrawal by Subject|7|||
128914505|NCT01462266|463978171|FG001|Overall Study|Withdrawal by Subject|2|||
128914506|NCT01462266|463978170|FG000|Overall Study|Screen failure|1|||
128914507|NCT01462266|463978171|FG001|Overall Study|Screen failure|1|||
128914508|NCT01106846|463978172|FG000|Overall Study|Change in surgical procedure|0|||
128914509|NCT01106846|463978173|FG001|Overall Study|Change in surgical procedure|1|||
128914510|NCT02447848|463978182|FG000|Overall Study|Patient discharged|3|||
128914511|NCT02447848|463978182|FG000|Overall Study|Lack of Efficacy|4|||
128914512|NCT02447848|463978182|FG000|Overall Study|Withdrawal by Subject|4|||
128914513|NCT04698629|463978184|FG000|Overall Study|Adverse Event|1|||
128914514|NCT03344003|463978185|FG000|Overall Study|Switched to alternative treatment|1|||
128914515|NCT03344003|463978186|FG001|Overall Study|Switched to alternative treatment|0|||
128914516|NCT03344003|463978185|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
128914517|NCT03344003|463978186|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
128914518|NCT05888103|463979891|FG000|Overall Study|Participant decision|3|||
128914519|NCT05888103|463979892|FG001|Overall Study|Participant decision|3|||
128914520|NCT00680836|463979893|FG000|Overall Study|Withdrawal by Subject|3|||
128914521|NCT00680836|463979894|FG001|Overall Study|Withdrawal by Subject|0|||
128765627|NCT01350141|463433878|FG002|Overall Study|Withdrawal by Subject|0|||
128765628|NCT01350141|463433876|FG000|Overall Study|Randomized but not treated|1|||
128914522|NCT00680836|463979893|FG000|Overall Study|Lost to Follow-up|3|||
128914523|NCT00680836|463979894|FG001|Overall Study|Lost to Follow-up|1|||
128914524|NCT00680836|463979893|FG000|Overall Study|Physician Decision|2|||
128914525|NCT00680836|463979894|FG001|Overall Study|Physician Decision|1|||
128914526|NCT03786432|463979895|FG000|Overall Study|Screen Failure after consent|1|||
128914527|NCT03786432|463979895|FG000|Overall Study|Lost to Follow-up|4|||
128914528|NCT03786432|463979895|FG000|Overall Study|did not complete 12 month CT scan|1|||
128914529|NCT05512949|463979896|FG000|Overall Study|Lost to Follow-up|4|||
128914530|NCT05512949|463979897|FG001|Overall Study|Lost to Follow-up|6|||
128914531|NCT05512949|463979898|FG002|Overall Study|Lost to Follow-up|2|||
128914532|NCT05512949|463979896|FG000|Overall Study|Protocol Violation|0|||
128914533|NCT05512949|463979897|FG001|Overall Study|Protocol Violation|0|||
128914534|NCT05512949|463979898|FG002|Overall Study|Protocol Violation|1|||
128914535|NCT05512949|463979896|FG000|Overall Study|Withdrawal by Subject|1|||
128914536|NCT05512949|463979897|FG001|Overall Study|Withdrawal by Subject|1|||
128914537|NCT05512949|463979898|FG002|Overall Study|Withdrawal by Subject|2|||
129028838|NCT01149057|464396413|FG000|Overall Study|Other|6|||
128914538|NCT05512949|463979896|FG000|Overall Study|Completion status unknown|1|||
128914539|NCT05512949|463979897|FG001|Overall Study|Completion status unknown|3|||
128914540|NCT05512949|463979898|FG002|Overall Study|Completion status unknown|0|||
128914541|NCT01583179|463979899|FG000|Overall Study|Screen failure|1|||
128914542|NCT01583179|463979900|FG001|Overall Study|Screen failure|2|||
128914543|NCT02494596|463979903|FG000|Overall Study|Insufficient Therapeutic Response|3|||
128914544|NCT02494596|463979904|FG001|Overall Study|Insufficient Therapeutic Response|3|||
128914545|NCT02494596|463979905|FG002|Overall Study|Insufficient Therapeutic Response|1|||
128914546|NCT02494596|463979903|FG000|Overall Study|Adverse Event|0|||
128914547|NCT02494596|463979904|FG001|Overall Study|Adverse Event|1|||
128914548|NCT02494596|463979905|FG002|Overall Study|Adverse Event|0|||
128914549|NCT02494596|463979903|FG000|Overall Study|Refused Treatment|0|||
128914550|NCT02494596|463979904|FG001|Overall Study|Refused Treatment|1|||
128914551|NCT02494596|463979905|FG002|Overall Study|Refused Treatment|0|||
128914552|NCT00059202|463979906|FG000|Overall Study|Withdrawal by Subject|5|||
128914553|NCT00059202|463979907|FG001|Overall Study|Withdrawal by Subject|9|||
128914554|NCT00059202|463979906|FG000|Overall Study|Protocol Violation|1|||
128914555|NCT00059202|463979907|FG001|Overall Study|Protocol Violation|3|||
128914556|NCT00059202|463979906|FG000|Overall Study|drug toxicity|0|||
128914557|NCT00059202|463979907|FG001|Overall Study|drug toxicity|3|||
128914558|NCT00584194|463979908|FG000|Overall Study|Other|135|||
128914559|NCT00927368|463979910|FG000|Overall Study|enrollment in another study|1|||
128914560|NCT00927368|463979911|FG001|Overall Study|enrollment in another study|1|||
128914561|NCT00927368|463979912|FG002|Overall Study|enrollment in another study|2|||
128914562|NCT00927368|463979910|FG000|Overall Study|Lost to Follow-up|4|||
128914563|NCT00927368|463979911|FG001|Overall Study|Lost to Follow-up|0|||
128914564|NCT00927368|463979912|FG002|Overall Study|Lost to Follow-up|0|||
128914565|NCT00927368|463979910|FG000|Overall Study|equipment failure|1|||
128914566|NCT00927368|463979911|FG001|Overall Study|equipment failure|0|||
128914567|NCT00927368|463979912|FG002|Overall Study|equipment failure|0|||
128914568|NCT00927368|463979910|FG000|Overall Study|ineligible post randomization|0|||
128914569|NCT00927368|463979911|FG001|Overall Study|ineligible post randomization|3|||
128914570|NCT00927368|463979912|FG002|Overall Study|ineligible post randomization|1|||
128914571|NCT00927368|463979910|FG000|Overall Study|cancellation of surgery|0|||
128914572|NCT00927368|463979911|FG001|Overall Study|cancellation of surgery|1|||
128914573|NCT00927368|463979912|FG002|Overall Study|cancellation of surgery|2|||
128914574|NCT00331409|463979913|FG000|Overall Study|Lack of Efficacy|4|||
128914575|NCT00234039|463979914|FG000|Overall Study|Adverse Event|2|||
128914576|NCT00234039|463979914|FG000|Overall Study|Progression/relapse|34|||
128914577|NCT00234039|463979914|FG000|Overall Study|Other - Not Protocol Specified|3|||
128914578|NCT00234039|463979914|FG000|Overall Study|Ineligible|9|||
128914579|NCT00234039|463979914|FG000|Overall Study|No Protocol Treatment Received|2|||
128914580|NCT03683394|463979915|FG000|Overall Study|Withdrawal by Subject|4|||
128914581|NCT03683394|463979916|FG001|Overall Study|Withdrawal by Subject|8|||
128914582|NCT03683394|463979915|FG000|Overall Study|Lost to Follow-up|7|||
128914583|NCT03683394|463979916|FG001|Overall Study|Lost to Follow-up|0|||
128914584|NCT03683394|463979915|FG000|Overall Study|Death|3|||
128914585|NCT03683394|463979916|FG001|Overall Study|Death|1|||
128914586|NCT00559273|463979917|FG000|Correction Period (20 Weeks)|Death|3|||
128914587|NCT00559273|463979918|FG001|Correction Period (20 Weeks)|Death|4|||
128914588|NCT00559273|463979917|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
128914589|NCT00559273|463979918|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
128914590|NCT00559273|463979917|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
128914591|NCT00559273|463979918|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
128914592|NCT00559273|463979917|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
128914593|NCT00559273|463979918|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
128914594|NCT00559273|463979917|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
128914595|NCT00559273|463979918|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
128914596|NCT00559273|463979917|FG000|Evaluation Period (8 Weeks)|Death|1|||
128914597|NCT00559273|463979918|FG001|Evaluation Period (8 Weeks)|Death|3|||
128914598|NCT00559273|463979917|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
128914599|NCT00559273|463979918|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
128914600|NCT00559273|463979917|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
128765629|NCT01350141|463433877|FG001|Overall Study|Randomized but not treated|0|||
128914601|NCT00559273|463979918|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
128914602|NCT00559273|463979917|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
128914603|NCT00559273|463979918|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
128914604|NCT00395967|463979919|FG000|Treatment Period|Failed Mobilization|1|||
128914605|NCT00395967|463979919|FG000|Follow-up Period|Death|1|||
128914606|NCT00395967|463979919|FG000|Follow-up Period|Lost to Follow-up|1|||
128914607|NCT03653390|463979924|FG000|Overall Study|Lost to Follow-up|12|||
128914608|NCT03653390|463979925|FG001|Overall Study|Lost to Follow-up|8|||
128914609|NCT03653390|463979926|FG002|Overall Study|Lost to Follow-up|7|||
128914610|NCT03653390|463979924|FG000|Overall Study|Withdrawal by Subject|6|||
128914611|NCT03653390|463979925|FG001|Overall Study|Withdrawal by Subject|1|||
128914612|NCT03653390|463979926|FG002|Overall Study|Withdrawal by Subject|1|||
128697463|NCT04472429|463190432|FG000|Open-label Monotherapy Period|Death|0|||
128697464|NCT04472429|463190433|FG001|Open-label Monotherapy Period|Death|0|||
128697465|NCT04472429|463190434|FG002|Open-label Monotherapy Period|Death|35|||
128697466|NCT04472429|463190432|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
128697467|NCT04472429|463190433|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
128697468|NCT04472429|463190434|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
128697469|NCT01313312|463190437|FG000|Overall Study|Adverse Event|5|||
128697470|NCT01313312|463190437|FG000|Overall Study|Withdrawal by Subject|18|||
128697471|NCT01313312|463190437|FG000|Overall Study|Lack of Efficacy|3|||
128697472|NCT01313312|463190437|FG000|Overall Study|Investigator Decision|1|||
128697473|NCT01313312|463190437|FG000|Overall Study|Observational Phase|1|||
128697474|NCT01313312|463190437|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
128697475|NCT01313312|463190437|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
128697476|NCT01254331|463190439|FG000|Initial Phase|Adverse Event|3|||
128697477|NCT01254331|463190439|FG000|Initial Phase|Withdrawal by Subject|1|||
128697478|NCT01254331|463190439|FG000|Initial Phase|Pregnancy|1|||
128914613|NCT03653390|463979924|FG000|Overall Study|Death|1|||
128914614|NCT03653390|463979925|FG001|Overall Study|Death|0|||
128914615|NCT03653390|463979926|FG002|Overall Study|Death|0|||
128914616|NCT03653390|463979924|FG000|Overall Study|Paper Survey Lost|1|||
128914617|NCT03653390|463979925|FG001|Overall Study|Paper Survey Lost|0|||
128914618|NCT03653390|463979926|FG002|Overall Study|Paper Survey Lost|0|||
128914619|NCT03118947|463979927|FG000|Overall Study|Adverse Event|7|||
128914620|NCT03118947|463979927|FG000|Overall Study|Death|3|||
128697479|NCT01254331|463190439|FG000|Extension Phase|Lack of Efficacy|1|||
128697480|NCT01254331|463190439|FG000|Extension Phase|Lost to Follow-up|3|||
128697481|NCT00892047|463190440|FG000|Overall Study|Adverse Event|2|||
128697482|NCT00892047|463190441|FG001|Overall Study|Adverse Event|2|||
128697483|NCT00892047|463190440|FG000|Overall Study|subject burden|2|||
128697484|NCT00892047|463190441|FG001|Overall Study|subject burden|3|||
128697485|NCT00892047|463190440|FG000|Overall Study|Lack of Efficacy|0|||
128697486|NCT00892047|463190441|FG001|Overall Study|Lack of Efficacy|2|||
128697487|NCT05306977|463190442|FG000|Overall Study|Withdrawal by Subject|1|||
128697488|NCT01612858|463190447|FG000|Overall Study|Withdrawal by Subject|5|||
128697489|NCT01612858|463190448|FG001|Overall Study|Withdrawal by Subject|1|||
128697490|NCT00181155|463190451|FG000|Overall Study|Physician Decision|1|||
128697491|NCT00181155|463190452|FG001|Overall Study|Physician Decision|0|||
128697492|NCT00181155|463190451|FG000|Overall Study|Withdrawal by Subject|1|||
128697493|NCT00181155|463190452|FG001|Overall Study|Withdrawal by Subject|0|||
128697494|NCT01788228|463190453|FG000|Overall Study|Migrated/moved from study area|1|||
128697495|NCT01788228|463190454|FG001|Overall Study|Migrated/moved from study area|0|||
128697496|NCT01548287|463190458|FG000|Screening|No reason provided|0|||
128697497|NCT01548287|463190459|FG001|Screening|No reason provided|0|||
128697498|NCT01548287|463190460|FG002|Screening|No reason provided|0|||
128697499|NCT01548287|463190461|FG003|Screening|No reason provided|0|||
128697500|NCT01548287|463190462|FG004|Screening|No reason provided|9|||
128697501|NCT01548287|463190458|FG000|Screening|Did not meet eligibility criteria|0|||
128697502|NCT01548287|463190459|FG001|Screening|Did not meet eligibility criteria|0|||
128697503|NCT01548287|463190460|FG002|Screening|Did not meet eligibility criteria|0|||
128697504|NCT01548287|463190461|FG003|Screening|Did not meet eligibility criteria|0|||
128697505|NCT01548287|463190462|FG004|Screening|Did not meet eligibility criteria|74|||
128697506|NCT01548287|463190458|FG000|Randomized Period|Did not meet inclusion criteria|0|||
128697507|NCT01548287|463190459|FG001|Randomized Period|Did not meet inclusion criteria|0|||
128697508|NCT01548287|463190460|FG002|Randomized Period|Did not meet inclusion criteria|2|||
128697509|NCT01548287|463190461|FG003|Randomized Period|Did not meet inclusion criteria|0|||
128697510|NCT01548287|463190462|FG004|Randomized Period|Did not meet inclusion criteria|0|||
128697511|NCT01548287|463190458|FG000|Randomized Period|Adverse Event|0|||
128914621|NCT03118947|463979927|FG000|Overall Study|Lack of Efficacy|4|||
128914622|NCT03118947|463979927|FG000|Overall Study|Non-compliance with study drug|1|||
128914623|NCT03118947|463979927|FG000|Overall Study|Protocol Violation|2|||
128914624|NCT03118947|463979927|FG000|Overall Study|Withdrawal by Subject|3|||
128914625|NCT03118947|463979927|FG000|Overall Study|Withdrawal by caregiver|3|||
129028839|NCT00654186|464396414|FG000|Overall Study|Withdrawal by Subject|5|||
128697512|NCT01548287|463190459|FG001|Randomized Period|Adverse Event|2|||
129028840|NCT00577655|464396415|FG000|Overall Study|Patient Request|0|||
128697513|NCT01548287|463190460|FG002|Randomized Period|Adverse Event|5|||
128697514|NCT01548287|463190461|FG003|Randomized Period|Adverse Event|0|||
128697515|NCT01548287|463190462|FG004|Randomized Period|Adverse Event|0|||
128697516|NCT02762578|463190463|FG000|Overall Study|Adverse Event|1|||
128697517|NCT02762578|463190464|FG001|Overall Study|Adverse Event|6|||
128697518|NCT02762578|463190463|FG000|Overall Study|Protocol Violation|4|||
128697519|NCT02762578|463190464|FG001|Overall Study|Protocol Violation|2|||
128697520|NCT02762578|463190463|FG000|Overall Study|Withdrawal by Subject|4|||
128914626|NCT03118947|463979927|FG000|Overall Study|Change in patient's living situation|4|||
128914627|NCT03118947|463979927|FG000|Overall Study|Lost to Follow-up|2|||
129028841|NCT00577655|464396416|FG001|Overall Study|Patient Request|2|||
129028842|NCT00577655|464396415|FG000|Overall Study|Protocol Violation|0|||
128914628|NCT01109940|463979928|FG000|Overall Study|Administrative problems|2|||
128914629|NCT01109940|463979929|FG001|Overall Study|Administrative problems|0|||
128914630|NCT01109940|463979930|FG002|Overall Study|Administrative problems|0|||
128914631|NCT01109940|463979931|FG003|Overall Study|Administrative problems|0|||
128914632|NCT01109940|463979928|FG000|Overall Study|Serious Adverse Event|2|||
128914633|NCT01109940|463979929|FG001|Overall Study|Serious Adverse Event|1|||
128914634|NCT01109940|463979930|FG002|Overall Study|Serious Adverse Event|0|||
128914635|NCT01109940|463979931|FG003|Overall Study|Serious Adverse Event|0|||
128914636|NCT01109940|463979928|FG000|Overall Study|Lost to Follow-up|1|||
128914637|NCT01109940|463979929|FG001|Overall Study|Lost to Follow-up|0|||
128914638|NCT01109940|463979930|FG002|Overall Study|Lost to Follow-up|0|||
128914639|NCT01109940|463979931|FG003|Overall Study|Lost to Follow-up|0|||
128914640|NCT01109940|463979928|FG000|Overall Study|Patient withdrew consent|1|||
128914641|NCT01109940|463979929|FG001|Overall Study|Patient withdrew consent|1|||
128914642|NCT01109940|463979930|FG002|Overall Study|Patient withdrew consent|0|||
128914643|NCT01109940|463979931|FG003|Overall Study|Patient withdrew consent|0|||
128914644|NCT01109940|463979928|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128914645|NCT01109940|463979929|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128914646|NCT01109940|463979930|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
128914647|NCT01109940|463979931|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
128914648|NCT01262976|463979934|FG000|Up to Month 2|Serious Adverse Event|0|||
128914649|NCT01262976|463979935|FG001|Up to Month 2|Serious Adverse Event|0|||
128914650|NCT01262976|463979936|FG002|Up to Month 2|Serious Adverse Event|1|||
128914651|NCT01262976|463979937|FG003|Up to Month 2|Serious Adverse Event|0|||
128914652|NCT01262976|463979938|FG004|Up to Month 2|Serious Adverse Event|0|||
128914653|NCT01262976|463979939|FG005|Up to Month 2|Serious Adverse Event|0|||
128914654|NCT01262976|463979934|FG000|Up to Month 2|Withdrawal by Subject|1|||
128914655|NCT01262976|463979935|FG001|Up to Month 2|Withdrawal by Subject|0|||
128914656|NCT01262976|463979936|FG002|Up to Month 2|Withdrawal by Subject|0|||
128914657|NCT01262976|463979937|FG003|Up to Month 2|Withdrawal by Subject|0|||
128914658|NCT01262976|463979938|FG004|Up to Month 2|Withdrawal by Subject|0|||
128914659|NCT01262976|463979939|FG005|Up to Month 2|Withdrawal by Subject|0|||
128914660|NCT01262976|463979934|FG000|Up to Month 2|Migrated/moved from study area|0|||
128914661|NCT01262976|463979935|FG001|Up to Month 2|Migrated/moved from study area|1|||
128914662|NCT01262976|463979936|FG002|Up to Month 2|Migrated/moved from study area|0|||
128914663|NCT01262976|463979937|FG003|Up to Month 2|Migrated/moved from study area|0|||
128914664|NCT01262976|463979938|FG004|Up to Month 2|Migrated/moved from study area|1|||
128914665|NCT01262976|463979939|FG005|Up to Month 2|Migrated/moved from study area|1|||
128914666|NCT01262976|463979934|FG000|Up to Month 2|Lost to Follow-up|1|||
128914667|NCT01262976|463979935|FG001|Up to Month 2|Lost to Follow-up|0|||
128914668|NCT01262976|463979936|FG002|Up to Month 2|Lost to Follow-up|0|||
128914669|NCT01262976|463979937|FG003|Up to Month 2|Lost to Follow-up|1|||
128914670|NCT01262976|463979938|FG004|Up to Month 2|Lost to Follow-up|1|||
128914671|NCT01262976|463979939|FG005|Up to Month 2|Lost to Follow-up|1|||
128914672|NCT01262976|463979934|FG000|Up to Month 2|Other|1|||
128914673|NCT01262976|463979935|FG001|Up to Month 2|Other|0|||
128914674|NCT01262976|463979936|FG002|Up to Month 2|Other|0|||
128914675|NCT01262976|463979937|FG003|Up to Month 2|Other|1|||
128914676|NCT01262976|463979938|FG004|Up to Month 2|Other|0|||
128914677|NCT01262976|463979939|FG005|Up to Month 2|Other|2|||
128914678|NCT01262976|463979934|FG000|Up to Month 7|Serious Adverse Event|0|||
128914679|NCT01262976|463979935|FG001|Up to Month 7|Serious Adverse Event|0|||
128914680|NCT01262976|463979936|FG002|Up to Month 7|Serious Adverse Event|2|||
128914681|NCT01262976|463979937|FG003|Up to Month 7|Serious Adverse Event|0|||
128914682|NCT01262976|463979938|FG004|Up to Month 7|Serious Adverse Event|0|||
128914683|NCT01262976|463979939|FG005|Up to Month 7|Serious Adverse Event|0|||
128914684|NCT01262976|463979934|FG000|Up to Month 7|Withdrawal by Subject|1|||
128914685|NCT01262976|463979935|FG001|Up to Month 7|Withdrawal by Subject|0|||
128914686|NCT01262976|463979936|FG002|Up to Month 7|Withdrawal by Subject|0|||
128914687|NCT01262976|463979937|FG003|Up to Month 7|Withdrawal by Subject|0|||
128914688|NCT01262976|463979938|FG004|Up to Month 7|Withdrawal by Subject|0|||
128914689|NCT01262976|463979939|FG005|Up to Month 7|Withdrawal by Subject|0|||
128914690|NCT01262976|463979934|FG000|Up to Month 7|Migrated/moved from study area|0|||
129028843|NCT00577655|464396416|FG001|Overall Study|Protocol Violation|1|||
129028844|NCT00577655|464396415|FG000|Overall Study|Lost to Follow-up|1|||
129028845|NCT00577655|464396416|FG001|Overall Study|Lost to Follow-up|1|||
129028846|NCT00875524|464396418|FG000|Overall Study|Serious adverse event|0|||
129028847|NCT00875524|464396419|FG001|Overall Study|Serious adverse event|1|||
128914691|NCT01262976|463979935|FG001|Up to Month 7|Migrated/moved from study area|0|||
128914692|NCT01262976|463979936|FG002|Up to Month 7|Migrated/moved from study area|1|||
128914693|NCT01262976|463979937|FG003|Up to Month 7|Migrated/moved from study area|3|||
129028848|NCT00875524|464396418|FG000|Overall Study|Protocol Violation|4|||
129028849|NCT00875524|464396419|FG001|Overall Study|Protocol Violation|0|||
128914694|NCT01262976|463979938|FG004|Up to Month 7|Migrated/moved from study area|1|||
128914695|NCT01262976|463979939|FG005|Up to Month 7|Migrated/moved from study area|1|||
129028850|NCT00875524|464396418|FG000|Overall Study|Lost to Follow-up|1|||
129215659|NCT03077412|465092786|FG000|Overall Study|Investigator's Discretion|0|||
129215660|NCT03077412|465092787|FG001|Overall Study|Investigator's Discretion|1|||
129215661|NCT03077412|465092788|FG002|Overall Study|Investigator's Discretion|1|||
129215662|NCT03077412|465092786|FG000|Overall Study|Withdrew Consent|0|||
129215663|NCT03077412|465092787|FG001|Overall Study|Withdrew Consent|2|||
129215664|NCT03077412|465092788|FG002|Overall Study|Withdrew Consent|0|||
129215665|NCT02266888|465092789|FG000|Overall Study|Death|2|||
129215666|NCT02266888|465092790|FG001|Overall Study|Death|2|||
129215667|NCT02266888|465092791|FG002|Overall Study|Death|4|||
129215668|NCT02266888|465092792|FG003|Overall Study|Death|2|||
129215669|NCT02266888|465092789|FG000|Overall Study|Physician Decision|0|||
129215670|NCT02266888|465092790|FG001|Overall Study|Physician Decision|1|||
129215671|NCT02266888|465092791|FG002|Overall Study|Physician Decision|2|||
129215672|NCT02266888|465092792|FG003|Overall Study|Physician Decision|2|||
129215673|NCT02266888|465092789|FG000|Overall Study|Study Terminated|5|||
129215674|NCT02266888|465092790|FG001|Overall Study|Study Terminated|1|||
129215675|NCT02266888|465092791|FG002|Overall Study|Study Terminated|0|||
129215676|NCT02266888|465092792|FG003|Overall Study|Study Terminated|0|||
129215677|NCT02266888|465092789|FG000|Overall Study|No Longer Eligible|0|||
129215678|NCT02266888|465092790|FG001|Overall Study|No Longer Eligible|0|||
129215679|NCT02266888|465092791|FG002|Overall Study|No Longer Eligible|0|||
129215680|NCT02266888|465092792|FG003|Overall Study|No Longer Eligible|2|||
129215681|NCT02266888|465092789|FG000|Overall Study|Randomization Closed|0|||
129215682|NCT02266888|465092790|FG001|Overall Study|Randomization Closed|0|||
129215683|NCT02266888|465092791|FG002|Overall Study|Randomization Closed|4|||
129215684|NCT02266888|465092792|FG003|Overall Study|Randomization Closed|0|||
129215685|NCT02266888|465092789|FG000|Overall Study|Personnel unavailable at transplant|0|||
129215686|NCT02266888|465092790|FG001|Overall Study|Personnel unavailable at transplant|0|||
129215687|NCT02266888|465092791|FG002|Overall Study|Personnel unavailable at transplant|0|||
129215688|NCT02266888|465092792|FG003|Overall Study|Personnel unavailable at transplant|1|||
129215689|NCT02266888|465092789|FG000|Overall Study|Transfer of care|0|||
129215690|NCT02266888|465092790|FG001|Overall Study|Transfer of care|0|||
129215691|NCT02266888|465092791|FG002|Overall Study|Transfer of care|1|||
129215692|NCT02266888|465092792|FG003|Overall Study|Transfer of care|0|||
129215693|NCT02351856|465092793|FG000|Overall Study|Adverse Event|2|||
129215694|NCT02351856|465092793|FG000|Overall Study|Physician Decision|5|||
129215695|NCT02351856|465092793|FG000|Overall Study|Study terminated by sponsor|1|||
129215696|NCT01458392|465092794|FG000|Overall Study|Death|2|||
129215697|NCT01458392|465092795|FG001|Overall Study|Death|11|||
129215698|NCT01458392|465092796|FG002|Overall Study|Death|22|||
129215699|NCT01458392|465092794|FG000|Overall Study|At the discretion of the sponsor|0|||
129215700|NCT01458392|465092795|FG001|Overall Study|At the discretion of the sponsor|2|||
129215701|NCT01458392|465092796|FG002|Overall Study|At the discretion of the sponsor|7|||
129215702|NCT01458392|465092794|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
129215703|NCT01458392|465092795|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
129215704|NCT01458392|465092796|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
129215705|NCT01193244|465092799|FG000|Overall Study|Withdrawal by Subject|79|||
129215706|NCT01193244|465092800|FG001|Overall Study|Withdrawal by Subject|97|||
129215707|NCT01193244|465092799|FG000|Overall Study|Other|303|||
129215708|NCT01193244|465092800|FG001|Overall Study|Other|278|||
129215709|NCT01193244|465092799|FG000|Overall Study|Lost to Follow-up|6|||
129215710|NCT01193244|465092800|FG001|Overall Study|Lost to Follow-up|15|||
129215711|NCT03763877|465092810|FG000|Overall Study|Withdrawal by Subject|3|||
129215712|NCT03763877|465092811|FG001|Overall Study|Withdrawal by Subject|1|||
129215713|NCT03763877|465092812|FG002|Overall Study|Withdrawal by Subject|3|||
129215714|NCT03763877|465092813|FG003|Overall Study|Withdrawal by Subject|4|||
129215715|NCT03763877|465092810|FG000|Overall Study|Adverse Event|1|||
129215716|NCT03763877|465092811|FG001|Overall Study|Adverse Event|1|||
129215717|NCT03763877|465092812|FG002|Overall Study|Adverse Event|3|||
129215718|NCT03763877|465092813|FG003|Overall Study|Adverse Event|1|||
128914696|NCT01262976|463979934|FG000|Up to Month 7|Lost to Follow-up|1|||
128914697|NCT01262976|463979935|FG001|Up to Month 7|Lost to Follow-up|0|||
129215719|NCT03763877|465092810|FG000|Overall Study|Protocol Violation|1|||
129215720|NCT03763877|465092811|FG001|Overall Study|Protocol Violation|1|||
129215721|NCT03763877|465092812|FG002|Overall Study|Protocol Violation|0|||
128914698|NCT01262976|463979936|FG002|Up to Month 7|Lost to Follow-up|1|||
128914699|NCT01262976|463979937|FG003|Up to Month 7|Lost to Follow-up|3|||
128914700|NCT01262976|463979938|FG004|Up to Month 7|Lost to Follow-up|1|||
129215722|NCT03763877|465092813|FG003|Overall Study|Protocol Violation|0|||
129215723|NCT03763877|465092810|FG000|Overall Study|Lost to Follow-up|0|||
129215724|NCT03763877|465092811|FG001|Overall Study|Lost to Follow-up|1|||
129215725|NCT03763877|465092812|FG002|Overall Study|Lost to Follow-up|1|||
129215726|NCT03763877|465092813|FG003|Overall Study|Lost to Follow-up|0|||
129215727|NCT03040336|465092814|FG000|Overall Study|Death|1|||
129215728|NCT03040336|465092815|FG001|Overall Study|Death|0|||
129215729|NCT03040336|465092814|FG000|Overall Study|Withdrawal by Subject|2|||
129215730|NCT03040336|465092815|FG001|Overall Study|Withdrawal by Subject|3|||
129215731|NCT00068692|465092820|FG000|Step 1: Registration|Disese progression/relapse|5|||
129215732|NCT00068692|465092821|FG001|Step 1: Registration|Disese progression/relapse|0|||
128697521|NCT02762578|463190464|FG001|Overall Study|Withdrawal by Subject|2|||
128697522|NCT02762578|463190463|FG000|Overall Study|Unclassified|6|||
128914701|NCT01262976|463979939|FG005|Up to Month 7|Lost to Follow-up|3|||
128914702|NCT01262976|463979934|FG000|Up to Month 7|Other|3|||
128914703|NCT01262976|463979935|FG001|Up to Month 7|Other|0|||
128914704|NCT01262976|463979936|FG002|Up to Month 7|Other|2|||
128914705|NCT01262976|463979937|FG003|Up to Month 7|Other|0|||
128914706|NCT01262976|463979938|FG004|Up to Month 7|Other|0|||
129215733|NCT00068692|465092822|FG002|Step 1: Registration|Disese progression/relapse|0|||
129215734|NCT00068692|465092823|FG003|Step 1: Registration|Disese progression/relapse|0|||
129215735|NCT00068692|465092824|FG004|Step 1: Registration|Disese progression/relapse|0|||
129215736|NCT00068692|465092825|FG005|Step 1: Registration|Disese progression/relapse|0|||
129215737|NCT00068692|465092826|FG006|Step 1: Registration|Disese progression/relapse|0|||
129215738|NCT00068692|465092827|FG007|Step 1: Registration|Disese progression/relapse|0|||
129215739|NCT00068692|465092820|FG000|Step 1: Registration|Adverse Event|7|||
129215740|NCT00068692|465092821|FG001|Step 1: Registration|Adverse Event|0|||
129215741|NCT00068692|465092822|FG002|Step 1: Registration|Adverse Event|0|||
129215742|NCT00068692|465092823|FG003|Step 1: Registration|Adverse Event|0|||
129215743|NCT00068692|465092824|FG004|Step 1: Registration|Adverse Event|0|||
129215744|NCT00068692|465092825|FG005|Step 1: Registration|Adverse Event|0|||
129215745|NCT00068692|465092826|FG006|Step 1: Registration|Adverse Event|0|||
129215746|NCT00068692|465092827|FG007|Step 1: Registration|Adverse Event|0|||
129215747|NCT00068692|465092820|FG000|Step 1: Registration|Death|1|||
129215748|NCT00068692|465092821|FG001|Step 1: Registration|Death|0|||
129215749|NCT00068692|465092822|FG002|Step 1: Registration|Death|0|||
129215750|NCT00068692|465092823|FG003|Step 1: Registration|Death|0|||
129215751|NCT00068692|465092824|FG004|Step 1: Registration|Death|0|||
129215752|NCT00068692|465092825|FG005|Step 1: Registration|Death|0|||
129215753|NCT00068692|465092826|FG006|Step 1: Registration|Death|0|||
129215754|NCT00068692|465092827|FG007|Step 1: Registration|Death|0|||
129215755|NCT00068692|465092820|FG000|Step 1: Registration|Withdrawal by Subject|11|||
129215756|NCT00068692|465092821|FG001|Step 1: Registration|Withdrawal by Subject|0|||
129215757|NCT00068692|465092822|FG002|Step 1: Registration|Withdrawal by Subject|0|||
129215758|NCT00068692|465092823|FG003|Step 1: Registration|Withdrawal by Subject|0|||
129215759|NCT00068692|465092824|FG004|Step 1: Registration|Withdrawal by Subject|0|||
129215760|NCT00068692|465092825|FG005|Step 1: Registration|Withdrawal by Subject|0|||
129215761|NCT00068692|465092826|FG006|Step 1: Registration|Withdrawal by Subject|0|||
129215762|NCT00068692|465092827|FG007|Step 1: Registration|Withdrawal by Subject|0|||
129215763|NCT00068692|465092820|FG000|Step 1: Registration|Alternative therapy|2|||
129215764|NCT00068692|465092821|FG001|Step 1: Registration|Alternative therapy|0|||
129215765|NCT00068692|465092822|FG002|Step 1: Registration|Alternative therapy|0|||
129215766|NCT00068692|465092823|FG003|Step 1: Registration|Alternative therapy|0|||
129215767|NCT00068692|465092824|FG004|Step 1: Registration|Alternative therapy|0|||
129215768|NCT00068692|465092825|FG005|Step 1: Registration|Alternative therapy|0|||
129215769|NCT00068692|465092826|FG006|Step 1: Registration|Alternative therapy|0|||
129215770|NCT00068692|465092827|FG007|Step 1: Registration|Alternative therapy|0|||
129215771|NCT00068692|465092820|FG000|Step 1: Registration|Complicating disease|2|||
129215772|NCT00068692|465092821|FG001|Step 1: Registration|Complicating disease|0|||
129215773|NCT00068692|465092822|FG002|Step 1: Registration|Complicating disease|0|||
129215774|NCT00068692|465092823|FG003|Step 1: Registration|Complicating disease|0|||
129215775|NCT00068692|465092824|FG004|Step 1: Registration|Complicating disease|0|||
129215776|NCT00068692|465092825|FG005|Step 1: Registration|Complicating disease|0|||
129215777|NCT00068692|465092826|FG006|Step 1: Registration|Complicating disease|0|||
129215778|NCT00068692|465092827|FG007|Step 1: Registration|Complicating disease|0|||
129215779|NCT00068692|465092820|FG000|Step 1: Registration|Protocol Violation|1|||
128697523|NCT02762578|463190464|FG001|Overall Study|Unclassified|0|||
128697524|NCT00259610|463190465|FG000|Overall Study|Withdrawal by Subject|33|||
128697525|NCT00259610|463190466|FG001|Overall Study|Withdrawal by Subject|25|||
128697526|NCT00259610|463190467|FG002|Overall Study|Withdrawal by Subject|29|||
128697527|NCT00259610|463190468|FG003|Overall Study|Withdrawal by Subject|19|||
128697528|NCT00259610|463190465|FG000|Overall Study|Lost to Follow-up|19|||
128914707|NCT01262976|463979939|FG005|Up to Month 7|Other|0|||
128914708|NCT01262976|463979934|FG000|Up to Year 1|Serious Adverse Event|0|||
128914709|NCT01262976|463979935|FG001|Up to Year 1|Serious Adverse Event|0|||
128697529|NCT00259610|463190466|FG001|Overall Study|Lost to Follow-up|8|||
128914710|NCT01262976|463979936|FG002|Up to Year 1|Serious Adverse Event|2|||
129215780|NCT00068692|465092821|FG001|Step 1: Registration|Protocol Violation|0|||
129215781|NCT00068692|465092822|FG002|Step 1: Registration|Protocol Violation|0|||
128697530|NCT00259610|463190467|FG002|Overall Study|Lost to Follow-up|18|||
128914711|NCT01262976|463979937|FG003|Up to Year 1|Serious Adverse Event|0|||
128914712|NCT01262976|463979938|FG004|Up to Year 1|Serious Adverse Event|0|||
128914713|NCT01262976|463979939|FG005|Up to Year 1|Serious Adverse Event|0|||
129215782|NCT00068692|465092823|FG003|Step 1: Registration|Protocol Violation|0|||
129215783|NCT00068692|465092824|FG004|Step 1: Registration|Protocol Violation|0|||
129215784|NCT00068692|465092825|FG005|Step 1: Registration|Protocol Violation|0|||
128697531|NCT00259610|463190468|FG003|Overall Study|Lost to Follow-up|15|||
128914714|NCT01262976|463979934|FG000|Up to Year 1|Withdrawal by Subject|1|||
128914715|NCT01262976|463979935|FG001|Up to Year 1|Withdrawal by Subject|0|||
128914716|NCT01262976|463979936|FG002|Up to Year 1|Withdrawal by Subject|0|||
128914717|NCT01262976|463979937|FG003|Up to Year 1|Withdrawal by Subject|0|||
128914718|NCT01262976|463979938|FG004|Up to Year 1|Withdrawal by Subject|0|||
128914719|NCT01262976|463979939|FG005|Up to Year 1|Withdrawal by Subject|0|||
128914720|NCT01262976|463979934|FG000|Up to Year 1|Migrated/moved from study area|1|||
128914721|NCT01262976|463979935|FG001|Up to Year 1|Migrated/moved from study area|0|||
128914722|NCT01262976|463979936|FG002|Up to Year 1|Migrated/moved from study area|0|||
128914723|NCT01262976|463979937|FG003|Up to Year 1|Migrated/moved from study area|3|||
128914724|NCT01262976|463979938|FG004|Up to Year 1|Migrated/moved from study area|3|||
128914725|NCT01262976|463979939|FG005|Up to Year 1|Migrated/moved from study area|2|||
128914726|NCT01262976|463979934|FG000|Up to Year 1|Lost to Follow-up|4|||
128914727|NCT01262976|463979935|FG001|Up to Year 1|Lost to Follow-up|0|||
128914728|NCT01262976|463979936|FG002|Up to Year 1|Lost to Follow-up|0|||
128914729|NCT01262976|463979937|FG003|Up to Year 1|Lost to Follow-up|1|||
128914730|NCT01262976|463979938|FG004|Up to Year 1|Lost to Follow-up|6|||
128914731|NCT01262976|463979939|FG005|Up to Year 1|Lost to Follow-up|5|||
128914732|NCT01262976|463979934|FG000|Up to Year 1|Other|3|||
128914733|NCT01262976|463979935|FG001|Up to Year 1|Other|1|||
128914734|NCT01262976|463979936|FG002|Up to Year 1|Other|0|||
128914735|NCT01262976|463979937|FG003|Up to Year 1|Other|0|||
128914736|NCT01262976|463979938|FG004|Up to Year 1|Other|2|||
128914737|NCT01262976|463979939|FG005|Up to Year 1|Other|1|||
128697532|NCT00259610|463190465|FG000|Overall Study|Physician Decision|6|||
128697533|NCT00259610|463190466|FG001|Overall Study|Physician Decision|4|||
128697534|NCT00259610|463190467|FG002|Overall Study|Physician Decision|7|||
128697535|NCT00259610|463190468|FG003|Overall Study|Physician Decision|2|||
128697536|NCT00259610|463190465|FG000|Overall Study|Death|1|||
128697537|NCT00259610|463190466|FG001|Overall Study|Death|1|||
128697538|NCT00259610|463190467|FG002|Overall Study|Death|2|||
128914738|NCT01262976|463979934|FG000|Up to Year 1|Subjects with unknown completion status|0|||
128914739|NCT01262976|463979935|FG001|Up to Year 1|Subjects with unknown completion status|0|||
128914740|NCT01262976|463979936|FG002|Up to Year 1|Subjects with unknown completion status|1|||
128914741|NCT01262976|463979937|FG003|Up to Year 1|Subjects with unknown completion status|0|||
128914742|NCT01262976|463979938|FG004|Up to Year 1|Subjects with unknown completion status|0|||
128914743|NCT01262976|463979939|FG005|Up to Year 1|Subjects with unknown completion status|1|||
128914744|NCT01262976|463979934|FG000|Up to Year 2|Serious Adverse Event|0|||
128914745|NCT01262976|463979935|FG001|Up to Year 2|Serious Adverse Event|0|||
128914746|NCT01262976|463979936|FG002|Up to Year 2|Serious Adverse Event|2|||
128914747|NCT01262976|463979937|FG003|Up to Year 2|Serious Adverse Event|0|||
128914748|NCT01262976|463979938|FG004|Up to Year 2|Serious Adverse Event|0|||
128914749|NCT01262976|463979939|FG005|Up to Year 2|Serious Adverse Event|0|||
128914750|NCT01262976|463979934|FG000|Up to Year 2|Withdrawal by Subject|1|||
128914751|NCT01262976|463979935|FG001|Up to Year 2|Withdrawal by Subject|0|||
128914752|NCT01262976|463979936|FG002|Up to Year 2|Withdrawal by Subject|0|||
128914753|NCT01262976|463979937|FG003|Up to Year 2|Withdrawal by Subject|0|||
128914754|NCT01262976|463979938|FG004|Up to Year 2|Withdrawal by Subject|0|||
128914755|NCT01262976|463979939|FG005|Up to Year 2|Withdrawal by Subject|0|||
128914756|NCT01262976|463979934|FG000|Up to Year 2|Migrated/moved from study area|0|||
128914757|NCT01262976|463979935|FG001|Up to Year 2|Migrated/moved from study area|0|||
128914758|NCT01262976|463979936|FG002|Up to Year 2|Migrated/moved from study area|0|||
128914759|NCT01262976|463979937|FG003|Up to Year 2|Migrated/moved from study area|2|||
128914760|NCT01262976|463979938|FG004|Up to Year 2|Migrated/moved from study area|1|||
128914761|NCT01262976|463979939|FG005|Up to Year 2|Migrated/moved from study area|2|||
128914762|NCT01262976|463979934|FG000|Up to Year 2|Lost to Follow-up|1|||
128914763|NCT01262976|463979935|FG001|Up to Year 2|Lost to Follow-up|1|||
128914764|NCT01262976|463979936|FG002|Up to Year 2|Lost to Follow-up|2|||
128914765|NCT01262976|463979937|FG003|Up to Year 2|Lost to Follow-up|2|||
128697539|NCT00259610|463190468|FG003|Overall Study|Death|0|||
128697540|NCT00259610|463190465|FG000|Overall Study|non medical reason|6|||
128914766|NCT01262976|463979938|FG004|Up to Year 2|Lost to Follow-up|3|||
128914767|NCT01262976|463979939|FG005|Up to Year 2|Lost to Follow-up|3|||
128914768|NCT01262976|463979934|FG000|Up to Year 2|Subjects with unknown completion status|0|||
128914769|NCT01262976|463979935|FG001|Up to Year 2|Subjects with unknown completion status|0|||
128914770|NCT01262976|463979936|FG002|Up to Year 2|Subjects with unknown completion status|1|||
128914771|NCT01262976|463979937|FG003|Up to Year 2|Subjects with unknown completion status|0|||
128914772|NCT01262976|463979938|FG004|Up to Year 2|Subjects with unknown completion status|0|||
128914773|NCT01262976|463979939|FG005|Up to Year 2|Subjects with unknown completion status|0|||
128914774|NCT01262976|463979934|FG000|Up to Year 2|Other|3|||
128914775|NCT01262976|463979935|FG001|Up to Year 2|Other|0|||
128914776|NCT01262976|463979936|FG002|Up to Year 2|Other|0|||
128697541|NCT00259610|463190466|FG001|Overall Study|non medical reason|2|||
128914777|NCT01262976|463979937|FG003|Up to Year 2|Other|0|||
128697542|NCT00259610|463190467|FG002|Overall Study|non medical reason|10|||
128697543|NCT00259610|463190468|FG003|Overall Study|non medical reason|3|||
128914778|NCT01262976|463979938|FG004|Up to Year 2|Other|0|||
128914779|NCT01262976|463979939|FG005|Up to Year 2|Other|0|||
128914780|NCT01262976|463979934|FG000|Up to Year 3|Serious Adverse Event|0|||
128914781|NCT01262976|463979935|FG001|Up to Year 3|Serious Adverse Event|0|||
128914782|NCT01262976|463979936|FG002|Up to Year 3|Serious Adverse Event|2|||
128914783|NCT01262976|463979937|FG003|Up to Year 3|Serious Adverse Event|0|||
128914784|NCT01262976|463979938|FG004|Up to Year 3|Serious Adverse Event|0|||
128914785|NCT01262976|463979939|FG005|Up to Year 3|Serious Adverse Event|0|||
128914786|NCT01262976|463979934|FG000|Up to Year 3|Withdrawal by Subject|1|||
128914787|NCT01262976|463979935|FG001|Up to Year 3|Withdrawal by Subject|0|||
128914788|NCT01262976|463979936|FG002|Up to Year 3|Withdrawal by Subject|0|||
128914789|NCT01262976|463979937|FG003|Up to Year 3|Withdrawal by Subject|0|||
128914790|NCT01262976|463979938|FG004|Up to Year 3|Withdrawal by Subject|0|||
128914791|NCT01262976|463979939|FG005|Up to Year 3|Withdrawal by Subject|0|||
128914792|NCT01262976|463979934|FG000|Up to Year 3|Migrated/moved from study area|0|||
128914793|NCT01262976|463979935|FG001|Up to Year 3|Migrated/moved from study area|0|||
128914794|NCT01262976|463979936|FG002|Up to Year 3|Migrated/moved from study area|0|||
128914795|NCT01262976|463979937|FG003|Up to Year 3|Migrated/moved from study area|2|||
128914796|NCT01262976|463979938|FG004|Up to Year 3|Migrated/moved from study area|1|||
128914797|NCT01262976|463979939|FG005|Up to Year 3|Migrated/moved from study area|1|||
128914798|NCT01262976|463979934|FG000|Up to Year 3|Lost to Follow-up|2|||
128914799|NCT01262976|463979935|FG001|Up to Year 3|Lost to Follow-up|2|||
128914800|NCT01262976|463979936|FG002|Up to Year 3|Lost to Follow-up|4|||
128914801|NCT01262976|463979937|FG003|Up to Year 3|Lost to Follow-up|3|||
128914802|NCT01262976|463979938|FG004|Up to Year 3|Lost to Follow-up|1|||
128914803|NCT01262976|463979939|FG005|Up to Year 3|Lost to Follow-up|3|||
128914804|NCT01262976|463979934|FG000|Up to Year 3|Subjects with unknown completion status|0|||
128914805|NCT01262976|463979935|FG001|Up to Year 3|Subjects with unknown completion status|0|||
128914806|NCT01262976|463979936|FG002|Up to Year 3|Subjects with unknown completion status|1|||
128914807|NCT01262976|463979937|FG003|Up to Year 3|Subjects with unknown completion status|0|||
128914808|NCT01262976|463979938|FG004|Up to Year 3|Subjects with unknown completion status|0|||
128914809|NCT01262976|463979939|FG005|Up to Year 3|Subjects with unknown completion status|0|||
128914810|NCT01262976|463979934|FG000|Up to Year 3|Other|3|||
128914811|NCT01262976|463979935|FG001|Up to Year 3|Other|0|||
128914812|NCT01262976|463979936|FG002|Up to Year 3|Other|0|||
128914813|NCT01262976|463979937|FG003|Up to Year 3|Other|0|||
128914814|NCT01262976|463979938|FG004|Up to Year 3|Other|0|||
128914815|NCT01262976|463979939|FG005|Up to Year 3|Other|0|||
128914816|NCT02690194|463979942|FG000|Overall Study|Withdrawal by Subject|1|||
128914817|NCT02690194|463979943|FG001|Overall Study|Withdrawal by Subject|4|||
128914818|NCT02690194|463979944|FG002|Overall Study|Withdrawal by Subject|0|||
128914819|NCT02400255|463979947|FG000|Overall Study|Relapse|4|||
128914820|NCT02400255|463979948|FG001|Overall Study|Relapse|1|||
128914821|NCT02400255|463979949|FG002|Overall Study|Relapse|1|||
128914822|NCT02400255|463979950|FG003|Overall Study|Relapse|2|||
128914823|NCT02400255|463979947|FG000|Overall Study|Adverse Event|6|||
128914824|NCT02400255|463979948|FG001|Overall Study|Adverse Event|3|||
128914825|NCT02400255|463979949|FG002|Overall Study|Adverse Event|0|||
128914826|NCT02400255|463979950|FG003|Overall Study|Adverse Event|0|||
128914827|NCT02400255|463979947|FG000|Overall Study|Physician Decision|6|||
128914828|NCT02400255|463979948|FG001|Overall Study|Physician Decision|0|||
128914829|NCT02400255|463979949|FG002|Overall Study|Physician Decision|0|||
128914830|NCT02400255|463979950|FG003|Overall Study|Physician Decision|0|||
128914831|NCT02400255|463979947|FG000|Overall Study|Loss of insurance|1|||
128914832|NCT02400255|463979948|FG001|Overall Study|Loss of insurance|0|||
128914833|NCT02400255|463979949|FG002|Overall Study|Loss of insurance|0|||
128914834|NCT02400255|463979950|FG003|Overall Study|Loss of insurance|0|||
128914835|NCT01961544|463979951|FG000|Overall Study|Protocol Violation|1|||
128914836|NCT01961544|463979951|FG000|Overall Study|Withdrawal by Subject|7|||
128914837|NCT01961544|463979951|FG000|Overall Study|Adverse Event|1|||
128914838|NCT01961544|463979951|FG000|Overall Study|Physician Decision|2|||
128914839|NCT01961544|463979951|FG000|Overall Study|Poor Tolerance|1|||
128914840|NCT01961544|463979951|FG000|Overall Study|Aggravation of Steral Pain|1|||
128914841|NCT03665285|463979952|FG000|Overall Study|Started New Anticancer Treatment|1|||
128914842|NCT03665285|463979953|FG001|Overall Study|Started New Anticancer Treatment|1|||
128914843|NCT03665285|463979954|FG002|Overall Study|Started New Anticancer Treatment|2|||
128914844|NCT03665285|463979955|FG003|Overall Study|Started New Anticancer Treatment|4|||
128914845|NCT03665285|463979956|FG004|Overall Study|Started New Anticancer Treatment|1|||
128914846|NCT03665285|463979957|FG005|Overall Study|Started New Anticancer Treatment|1|||
128914847|NCT03665285|463979958|FG006|Overall Study|Started New Anticancer Treatment|2|||
128914848|NCT03665285|463979959|FG007|Overall Study|Started New Anticancer Treatment|15|||
128914849|NCT03665285|463979960|FG008|Overall Study|Started New Anticancer Treatment|1|||
128914850|NCT03665285|463979952|FG000|Overall Study|Disease Progression|0|||
128914851|NCT03665285|463979953|FG001|Overall Study|Disease Progression|0|||
128914852|NCT03665285|463979954|FG002|Overall Study|Disease Progression|3|||
128914853|NCT03665285|463979955|FG003|Overall Study|Disease Progression|1|||
128914854|NCT03665285|463979956|FG004|Overall Study|Disease Progression|0|||
129215785|NCT00068692|465092826|FG006|Step 1: Registration|Protocol Violation|0|||
129215786|NCT00068692|465092827|FG007|Step 1: Registration|Protocol Violation|0|||
129215787|NCT00068692|465092820|FG000|Step 1: Registration|Not eligible|6|||
129215788|NCT00068692|465092821|FG001|Step 1: Registration|Not eligible|0|||
129215789|NCT00068692|465092822|FG002|Step 1: Registration|Not eligible|0|||
129215790|NCT00068692|465092823|FG003|Step 1: Registration|Not eligible|0|||
129215791|NCT00068692|465092824|FG004|Step 1: Registration|Not eligible|0|||
129215792|NCT00068692|465092825|FG005|Step 1: Registration|Not eligible|0|||
129215793|NCT00068692|465092826|FG006|Step 1: Registration|Not eligible|0|||
129215794|NCT00068692|465092827|FG007|Step 1: Registration|Not eligible|0|||
129215795|NCT00068692|465092820|FG000|Step 1: Registration|Other|2|||
129215796|NCT00068692|465092821|FG001|Step 1: Registration|Other|0|||
129215797|NCT00068692|465092822|FG002|Step 1: Registration|Other|0|||
129215798|NCT00068692|465092823|FG003|Step 1: Registration|Other|0|||
129215799|NCT00068692|465092824|FG004|Step 1: Registration|Other|0|||
129215800|NCT00068692|465092825|FG005|Step 1: Registration|Other|0|||
129215801|NCT00068692|465092826|FG006|Step 1: Registration|Other|0|||
129215802|NCT00068692|465092827|FG007|Step 1: Registration|Other|0|||
129215803|NCT00068692|465092820|FG000|Step 1: Registration|Not start protocol therapy|3|||
129215804|NCT00068692|465092821|FG001|Step 1: Registration|Not start protocol therapy|0|||
129215805|NCT00068692|465092822|FG002|Step 1: Registration|Not start protocol therapy|0|||
129215806|NCT00068692|465092823|FG003|Step 1: Registration|Not start protocol therapy|0|||
129215807|NCT00068692|465092824|FG004|Step 1: Registration|Not start protocol therapy|0|||
129215808|NCT00068692|465092825|FG005|Step 1: Registration|Not start protocol therapy|0|||
129215809|NCT00068692|465092826|FG006|Step 1: Registration|Not start protocol therapy|0|||
128914855|NCT03665285|463979957|FG005|Overall Study|Disease Progression|0|||
128914856|NCT03665285|463979958|FG006|Overall Study|Disease Progression|0|||
128914857|NCT03665285|463979959|FG007|Overall Study|Disease Progression|7|||
128914858|NCT03665285|463979960|FG008|Overall Study|Disease Progression|1|||
128914859|NCT03665285|463979952|FG000|Overall Study|Hospice|0|||
128914860|NCT03665285|463979953|FG001|Overall Study|Hospice|0|||
128914861|NCT03665285|463979954|FG002|Overall Study|Hospice|0|||
128914862|NCT03665285|463979955|FG003|Overall Study|Hospice|0|||
128914863|NCT03665285|463979956|FG004|Overall Study|Hospice|0|||
128914864|NCT03665285|463979957|FG005|Overall Study|Hospice|0|||
128914865|NCT03665285|463979958|FG006|Overall Study|Hospice|0|||
128914866|NCT03665285|463979959|FG007|Overall Study|Hospice|2|||
128914867|NCT03665285|463979960|FG008|Overall Study|Hospice|0|||
128914868|NCT03665285|463979952|FG000|Overall Study|Withdrawal by Subject|0|||
128914869|NCT03665285|463979953|FG001|Overall Study|Withdrawal by Subject|0|||
128914870|NCT03665285|463979954|FG002|Overall Study|Withdrawal by Subject|0|||
128914871|NCT03665285|463979955|FG003|Overall Study|Withdrawal by Subject|0|||
128914872|NCT03665285|463979956|FG004|Overall Study|Withdrawal by Subject|1|||
128914873|NCT03665285|463979957|FG005|Overall Study|Withdrawal by Subject|0|||
128914874|NCT03665285|463979958|FG006|Overall Study|Withdrawal by Subject|0|||
128914875|NCT03665285|463979959|FG007|Overall Study|Withdrawal by Subject|2|||
128914876|NCT03665285|463979960|FG008|Overall Study|Withdrawal by Subject|0|||
128914877|NCT03665285|463979952|FG000|Overall Study|Physician Decision|0|||
128914878|NCT03665285|463979953|FG001|Overall Study|Physician Decision|0|||
128914879|NCT03665285|463979954|FG002|Overall Study|Physician Decision|0|||
128914880|NCT03665285|463979955|FG003|Overall Study|Physician Decision|0|||
128914881|NCT03665285|463979956|FG004|Overall Study|Physician Decision|0|||
128914882|NCT03665285|463979957|FG005|Overall Study|Physician Decision|0|||
128914883|NCT03665285|463979958|FG006|Overall Study|Physician Decision|0|||
128914884|NCT03665285|463979959|FG007|Overall Study|Physician Decision|2|||
128914885|NCT03665285|463979960|FG008|Overall Study|Physician Decision|0|||
128914886|NCT00354601|463979961|FG000|Overall Study|Protocol Violation|1|||
128914887|NCT00354601|463979961|FG000|Overall Study|progression|1|||
129215810|NCT00068692|465092827|FG007|Step 1: Registration|Not start protocol therapy|0|||
129215811|NCT00068692|465092820|FG000|Step 1: Registration|Registered but not randomized|0|||
129215812|NCT00068692|465092821|FG001|Step 1: Registration|Registered but not randomized|1|||
129215813|NCT00068692|465092822|FG002|Step 1: Registration|Registered but not randomized|0|||
128914888|NCT03603652|463979962|FG000|Overall Study|Death|2|||
128914889|NCT03213366|463979967|FG000|Overall Study|Lost to Follow-up|9|||
128914890|NCT03213366|463979968|FG001|Overall Study|Lost to Follow-up|4|||
128914891|NCT02532855|463979969|FG000|Overall Study|Lost to Follow-up|4|||
128914892|NCT02532855|463979970|FG001|Overall Study|Lost to Follow-up|3|||
128914893|NCT02532855|463979969|FG000|Overall Study|Withdrawal by Subject|4|||
128914894|NCT02532855|463979970|FG001|Overall Study|Withdrawal by Subject|8|||
128914895|NCT01727258|463979971|FG000|Overall Study|Adverse Event|0|||
128914896|NCT01727258|463979972|FG001|Overall Study|Adverse Event|2|||
128914897|NCT01727258|463979973|FG002|Overall Study|Adverse Event|0|||
128914898|NCT01727258|463979971|FG000|Overall Study|Noncompliance with Study Drug|0|||
128914899|NCT01727258|463979972|FG001|Overall Study|Noncompliance with Study Drug|0|||
128914900|NCT01727258|463979973|FG002|Overall Study|Noncompliance with Study Drug|1|||
128914901|NCT01727258|463979971|FG000|Overall Study|Withdrawal by Subject|1|||
128914902|NCT01727258|463979972|FG001|Overall Study|Withdrawal by Subject|1|||
128914903|NCT01727258|463979973|FG002|Overall Study|Withdrawal by Subject|0|||
128914904|NCT01727258|463979971|FG000|Overall Study|Lost to Follow-up|1|||
128914905|NCT01727258|463979972|FG001|Overall Study|Lost to Follow-up|0|||
128914906|NCT01727258|463979973|FG002|Overall Study|Lost to Follow-up|0|||
128914907|NCT01960855|463979974|FG000|Overall Study|Subject noncompliant|1|||
128914908|NCT01960855|463979975|FG001|Overall Study|Subject noncompliant|0|||
128914909|NCT01960855|463979976|FG002|Overall Study|Subject noncompliant|0|||
128914910|NCT01960855|463979977|FG003|Overall Study|Subject noncompliant|0|||
128914911|NCT01960855|463979978|FG004|Overall Study|Subject noncompliant|0|||
128914912|NCT01960855|463979974|FG000|Overall Study|Adverse Event|2|||
128914913|NCT01960855|463979975|FG001|Overall Study|Adverse Event|0|||
128914914|NCT01960855|463979976|FG002|Overall Study|Adverse Event|6|||
128914915|NCT01960855|463979977|FG003|Overall Study|Adverse Event|2|||
128914916|NCT01960855|463979978|FG004|Overall Study|Adverse Event|2|||
128914917|NCT01960855|463979974|FG000|Overall Study|Lack of Efficacy|1|||
128914918|NCT01960855|463979975|FG001|Overall Study|Lack of Efficacy|1|||
128914919|NCT01960855|463979976|FG002|Overall Study|Lack of Efficacy|0|||
128914920|NCT01960855|463979977|FG003|Overall Study|Lack of Efficacy|0|||
128914921|NCT01960855|463979978|FG004|Overall Study|Lack of Efficacy|0|||
128914922|NCT01960855|463979974|FG000|Overall Study|Other|2|||
128914923|NCT01960855|463979975|FG001|Overall Study|Other|1|||
128765630|NCT01350141|463433878|FG002|Overall Study|Randomized but not treated|0|||
128765631|NCT00519896|463433879|FG000|Overall Study|Protocol Violation|1|||
128765632|NCT00519896|463433879|FG000|Overall Study|Adverse Event|1|||
128765633|NCT00810082|463433880|FG000|Overall Study|Lost to Follow-up|0|||
128765634|NCT00810082|463433881|FG001|Overall Study|Lost to Follow-up|4|||
128765635|NCT01588990|463433882|FG000|Phase A|Withdrawal by Subject|5|||
128765636|NCT01588990|463433882|FG000|Phase A|Physician Decision|11|||
128765637|NCT01588990|463433882|FG000|Phase A|Other|14|||
128765638|NCT01588990|463433882|FG000|Phase A|Lost to Follow-up|1|||
128765639|NCT01588990|463433882|FG000|Phase A|Death|5|||
128765640|NCT01588990|463433882|FG000|Phase A|Adverse Event|28|||
128765641|NCT01588990|463433882|FG000|Phase A|Still on therapy at end of study|6|||
128765642|NCT01588990|463433882|FG000|Phase B|Adverse Event|2|||
128765643|NCT01588990|463433882|FG000|Phase B|Still on therapy at end of study|5|||
128765644|NCT01588990|463433882|FG000|Phase B|Withdrawal by Subject|3|||
128765645|NCT01588990|463433882|FG000|Phase B|Physician Decision|4|||
128765646|NCT01588990|463433882|FG000|Phase B|Other|2|||
128765647|NCT02367716|463433887|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
128765648|NCT02508532|463433890|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765649|NCT02508532|463433891|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765650|NCT02508532|463433892|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765651|NCT02508532|463433893|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765652|NCT02508532|463433894|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765653|NCT02508532|463433895|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765654|NCT02508532|463433896|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
128765655|NCT02508532|463433897|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765656|NCT02508532|463433898|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
128765657|NCT02508532|463433890|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765658|NCT02508532|463433891|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765659|NCT02508532|463433892|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765660|NCT02508532|463433893|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765661|NCT02508532|463433894|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765662|NCT02508532|463433895|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765663|NCT02508532|463433896|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765664|NCT02508532|463433897|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
128765665|NCT02508532|463433898|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
128765666|NCT02508532|463433890|FG000|Part 2 - Treatment|Disease Progression|0|||
128765667|NCT02508532|463433891|FG001|Part 2 - Treatment|Disease Progression|0|||
128765668|NCT02508532|463433892|FG002|Part 2 - Treatment|Disease Progression|0|||
128914924|NCT01960855|463979976|FG002|Overall Study|Other|1|||
128914925|NCT01960855|463979977|FG003|Overall Study|Other|1|||
128914926|NCT01960855|463979978|FG004|Overall Study|Other|0|||
128914927|NCT01960855|463979974|FG000|Overall Study|Consent withdrawn by subject|3|||
128914928|NCT01960855|463979975|FG001|Overall Study|Consent withdrawn by subject|1|||
128914929|NCT01960855|463979976|FG002|Overall Study|Consent withdrawn by subject|2|||
128914930|NCT01960855|463979977|FG003|Overall Study|Consent withdrawn by subject|1|||
128914931|NCT01960855|463979978|FG004|Overall Study|Consent withdrawn by subject|1|||
128914932|NCT01960855|463979974|FG000|Overall Study|Lost to Follow-up|2|||
128914933|NCT01960855|463979975|FG001|Overall Study|Lost to Follow-up|1|||
128914934|NCT01960855|463979976|FG002|Overall Study|Lost to Follow-up|0|||
128914935|NCT01960855|463979977|FG003|Overall Study|Lost to Follow-up|0|||
128914936|NCT01960855|463979978|FG004|Overall Study|Lost to Follow-up|2|||
128914937|NCT02058147|463979979|FG000|Overall Study|Randomized but not treated|0|||
128914938|NCT02058147|463979980|FG001|Overall Study|Randomized but not treated|0|||
128914939|NCT02058147|463979981|FG002|Overall Study|Randomized but not treated|1|||
128914940|NCT02058147|463979979|FG000|Overall Study|Adverse Event|12|||
128914941|NCT02058147|463979980|FG001|Overall Study|Adverse Event|9|||
128914942|NCT02058147|463979981|FG002|Overall Study|Adverse Event|21|||
128914943|NCT02058147|463979979|FG000|Overall Study|Lack of Efficacy|1|||
128914944|NCT02058147|463979980|FG001|Overall Study|Lack of Efficacy|0|||
128914945|NCT02058147|463979981|FG002|Overall Study|Lack of Efficacy|3|||
128914946|NCT02058147|463979979|FG000|Overall Study|Poor compliance to protocol|8|||
128914947|NCT02058147|463979980|FG001|Overall Study|Poor compliance to protocol|9|||
128914948|NCT02058147|463979981|FG002|Overall Study|Poor compliance to protocol|4|||
128914949|NCT02058147|463979979|FG000|Overall Study|Other than specified|8|||
128914950|NCT02058147|463979980|FG001|Overall Study|Other than specified|9|||
128914951|NCT02058147|463979981|FG002|Overall Study|Other than specified|0|||
128914952|NCT03604445|463979988|FG000|Overall Study|Death|0|||
128914953|NCT03604445|463979989|FG001|Overall Study|Death|0|||
128914954|NCT03604445|463979990|FG002|Overall Study|Death|0|||
128914955|NCT03604445|463979991|FG003|Overall Study|Death|0|||
128914956|NCT03604445|463979992|FG004|Overall Study|Death|0|||
128914957|NCT03604445|463979993|FG005|Overall Study|Death|0|||
128914958|NCT03604445|463979994|FG006|Overall Study|Death|0|||
128914959|NCT03604445|463979995|FG007|Overall Study|Death|0|||
128914960|NCT03604445|463979996|FG008|Overall Study|Death|1|||
128914961|NCT03604445|463979988|FG000|Overall Study|Withdrawal by Subject|0|||
128914962|NCT03604445|463979989|FG001|Overall Study|Withdrawal by Subject|0|||
128914963|NCT03604445|463979990|FG002|Overall Study|Withdrawal by Subject|0|||
128914964|NCT03604445|463979991|FG003|Overall Study|Withdrawal by Subject|0|||
128914965|NCT03604445|463979992|FG004|Overall Study|Withdrawal by Subject|0|||
128914966|NCT03604445|463979993|FG005|Overall Study|Withdrawal by Subject|0|||
128914967|NCT03604445|463979994|FG006|Overall Study|Withdrawal by Subject|1|||
128914968|NCT03604445|463979995|FG007|Overall Study|Withdrawal by Subject|0|||
128914969|NCT03604445|463979996|FG008|Overall Study|Withdrawal by Subject|0|||
128914970|NCT03604445|463979988|FG000|Overall Study|Missing visit|0|||
128914971|NCT03604445|463979989|FG001|Overall Study|Missing visit|0|||
128914972|NCT03604445|463979990|FG002|Overall Study|Missing visit|0|||
128914973|NCT03604445|463979991|FG003|Overall Study|Missing visit|0|||
128914974|NCT03604445|463979992|FG004|Overall Study|Missing visit|0|||
128914975|NCT03604445|463979993|FG005|Overall Study|Missing visit|1|||
128914976|NCT03604445|463979994|FG006|Overall Study|Missing visit|0|||
128914977|NCT03604445|463979995|FG007|Overall Study|Missing visit|1|||
128914978|NCT03604445|463979996|FG008|Overall Study|Missing visit|0|||
128914979|NCT03604445|463979988|FG000|Overall Study|Adverse Event|0|||
128914980|NCT03604445|463979989|FG001|Overall Study|Adverse Event|0|||
128914981|NCT03604445|463979990|FG002|Overall Study|Adverse Event|0|||
128914982|NCT03604445|463979991|FG003|Overall Study|Adverse Event|1|||
128914983|NCT03604445|463979992|FG004|Overall Study|Adverse Event|0|||
128914984|NCT03604445|463979993|FG005|Overall Study|Adverse Event|0|||
128914985|NCT03604445|463979994|FG006|Overall Study|Adverse Event|0|||
128914986|NCT03604445|463979995|FG007|Overall Study|Adverse Event|0|||
128914987|NCT03604445|463979996|FG008|Overall Study|Adverse Event|1|||
128914988|NCT01360645|463980001|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
128914989|NCT01360645|463980002|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
128914990|NCT01360645|463980003|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
128914991|NCT01360645|463980004|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
128914992|NCT01360645|463980001|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
128914993|NCT01360645|463980002|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
128914994|NCT01360645|463980003|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
128914995|NCT01360645|463980004|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
128914996|NCT01360645|463980001|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
128914997|NCT01360645|463980002|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
128914998|NCT01360645|463980003|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
128914999|NCT01360645|463980004|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
128915000|NCT01360645|463980001|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
128915001|NCT01360645|463980002|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
128915002|NCT01360645|463980003|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
128915003|NCT01360645|463980004|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
128915004|NCT01360645|463980001|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
128915005|NCT01360645|463980002|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
128915006|NCT01360645|463980003|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
128915007|NCT01360645|463980004|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
128915008|NCT01360645|463980001|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
128915009|NCT01360645|463980002|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
128915010|NCT01360645|463980003|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
128915011|NCT01360645|463980004|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
128915012|NCT01360645|463980001|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
128915013|NCT01360645|463980002|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
128915014|NCT01360645|463980003|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
128915015|NCT01360645|463980004|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
128915016|NCT01360645|463980001|FG000|Phase B (6 Weeks)|Adverse Event|0|||
128915017|NCT01360645|463980002|FG001|Phase B (6 Weeks)|Adverse Event|6|||
128915018|NCT01360645|463980003|FG002|Phase B (6 Weeks)|Adverse Event|0|||
128915019|NCT01360645|463980004|FG003|Phase B (6 Weeks)|Adverse Event|0|||
128915020|NCT01360645|463980001|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
128915021|NCT01360645|463980002|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
128915022|NCT01360645|463980003|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
128915023|NCT01360645|463980004|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
128915024|NCT01360645|463980001|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
128915025|NCT01360645|463980002|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
128915026|NCT01360645|463980003|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
128915027|NCT01360645|463980004|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
128915028|NCT01360645|463980001|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
128915029|NCT01360645|463980002|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
128915030|NCT01360645|463980003|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
128915031|NCT01360645|463980004|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
128915032|NCT01360645|463980001|FG000|Phase A+|Lost to Follow-up|0|||
128915033|NCT01360645|463980002|FG001|Phase A+|Lost to Follow-up|0|||
128915034|NCT01360645|463980003|FG002|Phase A+|Lost to Follow-up|0|||
128915035|NCT01360645|463980004|FG003|Phase A+|Lost to Follow-up|7|||
128915036|NCT01360645|463980001|FG000|Phase A+|Adverse Event|0|||
128915037|NCT01360645|463980002|FG001|Phase A+|Adverse Event|0|||
128915038|NCT01360645|463980003|FG002|Phase A+|Adverse Event|0|||
128915039|NCT01360645|463980004|FG003|Phase A+|Adverse Event|2|||
128915040|NCT01360645|463980001|FG000|Phase A+|Met Withdrawal Criteria|0|||
128915041|NCT01360645|463980002|FG001|Phase A+|Met Withdrawal Criteria|0|||
128915042|NCT01360645|463980003|FG002|Phase A+|Met Withdrawal Criteria|0|||
128915043|NCT01360645|463980004|FG003|Phase A+|Met Withdrawal Criteria|4|||
128915044|NCT01360645|463980001|FG000|Phase A+|Physician Decision|0|||
128915045|NCT01360645|463980002|FG001|Phase A+|Physician Decision|0|||
128915046|NCT01360645|463980003|FG002|Phase A+|Physician Decision|0|||
128915047|NCT01360645|463980004|FG003|Phase A+|Physician Decision|2|||
128915048|NCT01360645|463980001|FG000|Phase A+|Withdrawal by Subject|0|||
128915049|NCT01360645|463980002|FG001|Phase A+|Withdrawal by Subject|0|||
128915050|NCT01360645|463980003|FG002|Phase A+|Withdrawal by Subject|0|||
128915051|NCT01360645|463980004|FG003|Phase A+|Withdrawal by Subject|5|||
128915052|NCT01360645|463980001|FG000|Phase A+|Protocol Deviation|0|||
129028851|NCT00875524|464396419|FG001|Overall Study|Lost to Follow-up|0|||
129028852|NCT00875524|464396418|FG000|Overall Study|Withdrawal by Subject|3|||
129028853|NCT00875524|464396419|FG001|Overall Study|Withdrawal by Subject|5|||
129028854|NCT01087502|464396420|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
129028855|NCT01087502|464396421|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
129028856|NCT01087502|464396420|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
129028857|NCT01087502|464396421|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
129028858|NCT01087502|464396420|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
129028859|NCT01087502|464396421|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
129028860|NCT01087502|464396420|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
129028861|NCT01087502|464396421|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
129028862|NCT01087502|464396420|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
129028863|NCT01087502|464396421|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
128915053|NCT01360645|463980002|FG001|Phase A+|Protocol Deviation|0|||
128915054|NCT01360645|463980003|FG002|Phase A+|Protocol Deviation|0|||
128915055|NCT01360645|463980004|FG003|Phase A+|Protocol Deviation|4|||
128915056|NCT01014585|463980005|FG000|Overall Study|Adverse Event|0|||
128915057|NCT01014585|463980006|FG001|Overall Study|Adverse Event|2|||
128915058|NCT01014585|463980007|FG002|Overall Study|Adverse Event|0|||
128915059|NCT01014585|463980008|FG003|Overall Study|Adverse Event|3|||
128915060|NCT01014585|463980005|FG000|Overall Study|Withdrawal by Subject|2|||
128915061|NCT01014585|463980006|FG001|Overall Study|Withdrawal by Subject|0|||
128915062|NCT01014585|463980007|FG002|Overall Study|Withdrawal by Subject|1|||
128915063|NCT01014585|463980008|FG003|Overall Study|Withdrawal by Subject|3|||
128915064|NCT01014585|463980005|FG000|Overall Study|Lost to Follow-up|0|||
128915065|NCT01014585|463980006|FG001|Overall Study|Lost to Follow-up|0|||
128915066|NCT01014585|463980007|FG002|Overall Study|Lost to Follow-up|0|||
128915067|NCT01014585|463980008|FG003|Overall Study|Lost to Follow-up|2|||
128915068|NCT01014585|463980005|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
128915069|NCT01014585|463980006|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
128915070|NCT01014585|463980007|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
128915071|NCT01014585|463980008|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
128915072|NCT02817087|463980012|FG000|Overall Study|Withdrawal by Subject|2|||
128915073|NCT02817087|463980013|FG001|Overall Study|Withdrawal by Subject|0|||
128915074|NCT00508391|463980014|FG000|First Treatment|Withdrawal by Subject|6|||
128915075|NCT00508391|463980015|FG001|First Treatment|Withdrawal by Subject|3|||
128697544|NCT00259610|463190465|FG000|Overall Study|Adverse Event|3|||
128697545|NCT00259610|463190466|FG001|Overall Study|Adverse Event|4|||
128697546|NCT00259610|463190467|FG002|Overall Study|Adverse Event|5|||
128697547|NCT00259610|463190468|FG003|Overall Study|Adverse Event|2|||
128697548|NCT00259610|463190465|FG000|Overall Study|Serious Adverse Event|8|||
128697549|NCT00259610|463190466|FG001|Overall Study|Serious Adverse Event|2|||
128697550|NCT00259610|463190467|FG002|Overall Study|Serious Adverse Event|2|||
128697551|NCT00259610|463190468|FG003|Overall Study|Serious Adverse Event|2|||
128697552|NCT01611155|463190471|FG000|Overall Study|Adverse Event|1|||
128697553|NCT01611155|463190472|FG001|Overall Study|Adverse Event|1|||
128697554|NCT01611155|463190471|FG000|Overall Study|Refused further treatment|6|||
128697555|NCT01611155|463190472|FG001|Overall Study|Refused further treatment|4|||
128697556|NCT01611155|463190471|FG000|Overall Study|Disease progression|1|||
128697557|NCT01611155|463190472|FG001|Overall Study|Disease progression|0|||
128697558|NCT01611155|463190471|FG000|Overall Study|Withdrawal by Subject|1|||
128697559|NCT01611155|463190472|FG001|Overall Study|Withdrawal by Subject|0|||
128697560|NCT01611155|463190471|FG000|Overall Study|Alternative treatment|0|||
128697561|NCT01611155|463190472|FG001|Overall Study|Alternative treatment|1|||
128697562|NCT01611155|463190471|FG000|Overall Study|Ineligible patient|0|||
128697563|NCT01611155|463190472|FG001|Overall Study|Ineligible patient|1|||
128697564|NCT02699593|463190473|FG000|Period 1|Unsatisfactory Visual Response|0|||
128697565|NCT02699593|463190474|FG001|Period 1|Unsatisfactory Visual Response|1|||
128697566|NCT02699593|463190473|FG000|Period 1|Torn Contact Len|4|||
128697567|NCT02699593|463190474|FG001|Period 1|Torn Contact Len|3|||
128697568|NCT02699593|463190473|FG000|Period 1|Protocol Violation|0|||
128697569|NCT02699593|463190474|FG001|Period 1|Protocol Violation|1|||
128697570|NCT02699593|463190473|FG000|Period 1|Withdrawal by Subject|0|||
128697571|NCT02699593|463190474|FG001|Period 1|Withdrawal by Subject|1|||
128697572|NCT02699593|463190473|FG000|Period 1|Adverse Event|1|||
128697573|NCT02699593|463190474|FG001|Period 1|Adverse Event|1|||
128697574|NCT02699593|463190473|FG000|Period 2|Adverse Event|1|||
128697575|NCT02699593|463190474|FG001|Period 2|Adverse Event|1|||
128697576|NCT02699593|463190473|FG000|Period 2|Lost Contact Lens|0|||
128697577|NCT02699593|463190474|FG001|Period 2|Lost Contact Lens|1|||
128697578|NCT02699593|463190473|FG000|Period 2|Torn Contact Lens|1|||
128697579|NCT02699593|463190474|FG001|Period 2|Torn Contact Lens|0|||
128697580|NCT00868608|463190475|FG000|Overall Study|Withdrawal by Subject|3|||
128697581|NCT00868608|463190476|FG001|Overall Study|Withdrawal by Subject|1|||
128697582|NCT00868608|463190477|FG002|Overall Study|Withdrawal by Subject|0|||
128697583|NCT00868608|463190475|FG000|Overall Study|Lost to Follow-up|3|||
128697584|NCT00868608|463190476|FG001|Overall Study|Lost to Follow-up|0|||
128697585|NCT00868608|463190477|FG002|Overall Study|Lost to Follow-up|1|||
128697586|NCT00868608|463190475|FG000|Overall Study|Death|16|||
128697587|NCT00868608|463190476|FG001|Overall Study|Death|2|||
128697588|NCT00868608|463190477|FG002|Overall Study|Death|4|||
128765669|NCT02508532|463433893|FG003|Part 2 - Treatment|Disease Progression|0|||
128765670|NCT02508532|463433894|FG004|Part 2 - Treatment|Disease Progression|0|||
128915076|NCT00508391|463980014|FG000|Second Treatment|Withdrawal by Subject|2|||
128915077|NCT00508391|463980015|FG001|Second Treatment|Withdrawal by Subject|0|||
128915078|NCT00802360|463980016|FG000|Overall Study|Stimulation failure|4|||
128915079|NCT00802360|463980017|FG001|Overall Study|Stimulation failure|0|||
128915080|NCT00802360|463980018|FG002|Overall Study|Stimulation failure|3|||
128915081|NCT00802360|463980019|FG003|Overall Study|Stimulation failure|3|||
128915082|NCT00802360|463980016|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
128915083|NCT00802360|463980017|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
128915084|NCT00802360|463980018|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
128915085|NCT00802360|463980019|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
128915086|NCT00802360|463980016|FG000|Overall Study|Cycle cancelled|0|||
128915087|NCT00802360|463980017|FG001|Overall Study|Cycle cancelled|1|||
128915088|NCT00802360|463980018|FG002|Overall Study|Cycle cancelled|1|||
128915089|NCT00802360|463980019|FG003|Overall Study|Cycle cancelled|1|||
128915090|NCT00802360|463980016|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
128915091|NCT00802360|463980017|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
128915092|NCT00802360|463980018|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
128915093|NCT00802360|463980019|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
128915094|NCT00802360|463980016|FG000|Overall Study|No positive serum pregnancy|17|||
128915095|NCT00802360|463980017|FG001|Overall Study|No positive serum pregnancy|20|||
128697589|NCT00868608|463190475|FG000|Overall Study|Other - Unspecified|1|||
128915096|NCT00802360|463980018|FG002|Overall Study|No positive serum pregnancy|14|||
128915097|NCT00802360|463980019|FG003|Overall Study|No positive serum pregnancy|10|||
128697590|NCT00868608|463190476|FG001|Overall Study|Other - Unspecified|0|||
128697591|NCT00868608|463190477|FG002|Overall Study|Other - Unspecified|0|||
128697592|NCT03344796|463190478|FG000|Overall Study|Lost to Follow-up|0|||
128697593|NCT03344796|463190479|FG001|Overall Study|Lost to Follow-up|0|||
128697594|NCT03344796|463190480|FG002|Overall Study|Lost to Follow-up|0|||
128697595|NCT03344796|463190481|FG003|Overall Study|Lost to Follow-up|0|||
128697596|NCT03344796|463190482|FG004|Overall Study|Lost to Follow-up|0|||
128697597|NCT03344796|463190483|FG005|Overall Study|Lost to Follow-up|2|||
128915098|NCT00802360|463980016|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
128915099|NCT00802360|463980017|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
128915100|NCT00802360|463980018|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
128915101|NCT00802360|463980019|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
128915102|NCT00802360|463980016|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
128915103|NCT00802360|463980017|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
128915104|NCT00802360|463980018|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
128915105|NCT00802360|463980019|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
128915106|NCT00802360|463980016|FG000|Overall Study|Other|2|||
128915107|NCT00802360|463980017|FG001|Overall Study|Other|3|||
128915108|NCT00802360|463980018|FG002|Overall Study|Other|6|||
128915109|NCT00802360|463980019|FG003|Overall Study|Other|3|||
128915110|NCT02041962|463980020|FG000|Overall Study|Lost Aetna Coverage|43|||
128915111|NCT02041962|463980021|FG001|Overall Study|Lost Aetna Coverage|40|||
128915112|NCT02041962|463980020|FG000|Overall Study|Death|1|||
128915113|NCT02041962|463980021|FG001|Overall Study|Death|1|||
128915114|NCT02041962|463980020|FG000|Overall Study|Lost to Follow-up|37|||
128915115|NCT02041962|463980021|FG001|Overall Study|Lost to Follow-up|32|||
128915116|NCT02041962|463980020|FG000|Overall Study|Withdrawal by Subject|0|||
128915117|NCT02041962|463980021|FG001|Overall Study|Withdrawal by Subject|11|||
128915118|NCT01225562|463980022|FG000|Overall Study|Withdrawal by Subject|52|||
128915119|NCT01225562|463980023|FG001|Overall Study|Withdrawal by Subject|50|||
128915120|NCT01225562|463980024|FG002|Overall Study|Withdrawal by Subject|52|||
128915121|NCT01225562|463980022|FG000|Overall Study|Lost to Follow-up|3|||
128915122|NCT01225562|463980023|FG001|Overall Study|Lost to Follow-up|6|||
128915123|NCT01225562|463980024|FG002|Overall Study|Lost to Follow-up|1|||
128915124|NCT01481896|463980027|FG000|Overall Study|Lost to Follow-up|12|||
128915125|NCT01818726|463980028|FG000|Overall Study|Administrative reasons|5|||
128915126|NCT01818726|463980029|FG001|Overall Study|Administrative reasons|1|||
128915127|NCT01818726|463980028|FG000|Overall Study|Withdrawal by Subject|0|||
129028864|NCT01087502|464396420|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
128915128|NCT01818726|463980029|FG001|Overall Study|Withdrawal by Subject|1|||
129028865|NCT01087502|464396421|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
129028866|NCT01087502|464396420|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
129028867|NCT01087502|464396421|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
129028868|NCT01087502|464396420|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
129028869|NCT01087502|464396421|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
129028870|NCT01087502|464396420|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
129028871|NCT01087502|464396421|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
129028872|NCT01087502|464396420|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
129028873|NCT01087502|464396421|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
129028874|NCT01087502|464396420|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
129028875|NCT01087502|464396421|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
129028876|NCT01087502|464396420|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
129028877|NCT01087502|464396421|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
129028878|NCT01151618|464396422|FG000|Overall Study|Adverse Event|2|||
129028879|NCT01151618|464396422|FG000|Overall Study|Withdrawal by Subject|7|||
129028880|NCT01632306|464396423|FG000|Overall Study|Protocol Violation|1|||
129028881|NCT01632306|464396424|FG001|Overall Study|Protocol Violation|0|||
129028882|NCT01632306|464396425|FG002|Overall Study|Protocol Violation|0|||
129028883|NCT00380588|464396428|FG000|Overall Study|Unequivocal Disease Progression|25|||
129028884|NCT00380588|464396429|FG001|Overall Study|Unequivocal Disease Progression|34|||
129028885|NCT00380588|464396428|FG000|Overall Study|Next Cycle Not Started|4|||
129028886|NCT00380588|464396429|FG001|Overall Study|Next Cycle Not Started|0|||
129028887|NCT00380588|464396428|FG000|Overall Study|Adverse Event|7|||
129028888|NCT00380588|464396429|FG001|Overall Study|Adverse Event|3|||
129028889|NCT00380588|464396428|FG000|Overall Study|Withdrawal by Subject|1|||
129028890|NCT00380588|464396429|FG001|Overall Study|Withdrawal by Subject|3|||
129028891|NCT00380588|464396428|FG000|Overall Study|Physician Decision|2|||
129028892|NCT00380588|464396429|FG001|Overall Study|Physician Decision|0|||
129028893|NCT01663896|464396430|FG000|Overall Study|Various reasons|43|||
129028894|NCT01451541|464396431|FG000|Overall Study|Adverse Event|4|||
129028895|NCT01451541|464396432|FG001|Overall Study|Adverse Event|3|||
129028896|NCT01451541|464396433|FG002|Overall Study|Adverse Event|6|||
129028897|NCT01451541|464396431|FG000|Overall Study|Lack of Efficacy|2|||
129028898|NCT01451541|464396432|FG001|Overall Study|Lack of Efficacy|0|||
129028899|NCT01451541|464396433|FG002|Overall Study|Lack of Efficacy|0|||
129028900|NCT01451541|464396431|FG000|Overall Study|Lost to Follow-up|4|||
129028901|NCT01451541|464396432|FG001|Overall Study|Lost to Follow-up|4|||
129028902|NCT01451541|464396433|FG002|Overall Study|Lost to Follow-up|7|||
129028903|NCT01451541|464396431|FG000|Overall Study|Withdrawal by Subject|15|||
129028904|NCT01451541|464396432|FG001|Overall Study|Withdrawal by Subject|8|||
129028905|NCT01451541|464396433|FG002|Overall Study|Withdrawal by Subject|6|||
128915129|NCT01818726|463980028|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
128915130|NCT01818726|463980029|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
128915131|NCT01162421|463980030|FG000|Overall Study|Did not receive study drug|2|||
128915132|NCT01162421|463980031|FG001|Overall Study|Did not receive study drug|1|||
128915133|NCT01162421|463980030|FG000|Overall Study|Adverse Event|2|||
128915134|NCT01162421|463980031|FG001|Overall Study|Adverse Event|5|||
128915135|NCT01162421|463980030|FG000|Overall Study|Lost to Follow-up|0|||
128915136|NCT01162421|463980031|FG001|Overall Study|Lost to Follow-up|2|||
128915137|NCT01162421|463980030|FG000|Overall Study|Lack of Efficacy|2|||
128915138|NCT01162421|463980031|FG001|Overall Study|Lack of Efficacy|2|||
128915139|NCT01162421|463980030|FG000|Overall Study|Other|2|||
128915140|NCT01162421|463980031|FG001|Overall Study|Other|3|||
128915141|NCT03336502|463980032|FG000|Overall Study|Physician Decision|0|||
128915142|NCT03336502|463980033|FG001|Overall Study|Physician Decision|1|||
128915143|NCT03336502|463980032|FG000|Overall Study|Prohibited Drugs|1|||
128915144|NCT03336502|463980033|FG001|Overall Study|Prohibited Drugs|1|||
128915145|NCT03336502|463980032|FG000|Overall Study|Death|1|||
128915146|NCT03336502|463980033|FG001|Overall Study|Death|2|||
128915147|NCT03336502|463980032|FG000|Overall Study|Adverse Event|2|||
128915148|NCT03336502|463980033|FG001|Overall Study|Adverse Event|5|||
128915149|NCT00611247|463980034|FG000|Overall Study|Death|1|||
128915150|NCT00611247|463980035|FG001|Overall Study|Death|5|||
128915151|NCT00611247|463980034|FG000|Overall Study|Lack of Efficacy|1|||
128915152|NCT00611247|463980035|FG001|Overall Study|Lack of Efficacy|16|||
128915153|NCT01890421|463980036|FG000|Overall Study|Adverse Event|1|||
128915154|NCT01890421|463980036|FG000|Overall Study|Other reason|10|||
128915155|NCT01557166|463980045|FG000|Overall Study|Adverse Event|20|||
128915156|NCT01557166|463980046|FG001|Overall Study|Adverse Event|6|||
128915157|NCT01557166|463980045|FG000|Overall Study|Lack of Efficacy|2|||
128915158|NCT01557166|463980046|FG001|Overall Study|Lack of Efficacy|1|||
128915159|NCT01557166|463980045|FG000|Overall Study|Protocol Violation|8|||
128915160|NCT01557166|463980046|FG001|Overall Study|Protocol Violation|5|||
128915161|NCT01557166|463980045|FG000|Overall Study|Withdrawn consent|12|||
128915162|NCT01557166|463980046|FG001|Overall Study|Withdrawn consent|20|||
128915163|NCT01557166|463980045|FG000|Overall Study|Target dose not tolerated|1|||
128915164|NCT01557166|463980046|FG001|Overall Study|Target dose not tolerated|0|||
129028906|NCT01451541|464396431|FG000|Overall Study|randomization error, noncompliance|11|||
129028907|NCT01451541|464396432|FG001|Overall Study|randomization error, noncompliance|10|||
129028908|NCT01451541|464396433|FG002|Overall Study|randomization error, noncompliance|8|||
129028909|NCT03366428|464396434|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
129028910|NCT03366428|464396434|FG000|Overall Study|Adverse Event|12|||
129028911|NCT03366428|464396434|FG000|Overall Study|Clinical progression|2|||
129028912|NCT03366428|464396434|FG000|Overall Study|Withdrawal by Subject|4|||
129028913|NCT01046084|464396439|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
129028914|NCT01046084|464396440|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
129028915|NCT03614728|464396441|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
129028916|NCT03614728|464396442|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
129028917|NCT03614728|464396443|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
129028918|NCT03614728|464396444|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
129028919|NCT03614728|464396441|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
129028920|NCT03614728|464396442|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
129028921|NCT03614728|464396443|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
129028922|NCT03614728|464396444|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
129028923|NCT00379353|464396445|FG000|Overall Study|Hospitalization|3|||
129028924|NCT00379353|464396446|FG001|Overall Study|Hospitalization|3|||
129028925|NCT00379353|464396445|FG000|Overall Study|Withdrawal by Subject|5|||
129028926|NCT00379353|464396446|FG001|Overall Study|Withdrawal by Subject|2|||
129028927|NCT00379353|464396445|FG000|Overall Study|Death|1|||
129028928|NCT00379353|464396446|FG001|Overall Study|Death|0|||
129028929|NCT00379353|464396445|FG000|Overall Study|Cardiac Tamponade|1|||
129028930|NCT00379353|464396446|FG001|Overall Study|Cardiac Tamponade|0|||
129028931|NCT00379353|464396445|FG000|Overall Study|Non-compliance|1|||
129028932|NCT00379353|464396446|FG001|Overall Study|Non-compliance|0|||
129028933|NCT00379353|464396445|FG000|Overall Study|Conflicting drug treatment|0|||
129028934|NCT00379353|464396446|FG001|Overall Study|Conflicting drug treatment|1|||
129028935|NCT01824576|464396447|FG000|Overall Study|Device deficiency|2|||
129028936|NCT01958476|464396448|FG000|Overall Study|Parent requested exclusion from analysis|1|||
129028937|NCT01958476|464396449|FG001|Overall Study|Parent requested exclusion from analysis|0|||
129028938|NCT03727139|464396452|FG000|Overall Study|Protocol Violation|60|||
129028939|NCT01120028|464396453|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
129028940|NCT01120028|464396454|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
129028941|NCT01120028|464396455|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
128915165|NCT01557166|463980045|FG000|Overall Study|Psychiatric disorder|1|||
129028942|NCT01120028|464396456|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
129028943|NCT01120028|464396453|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
129028944|NCT01120028|464396454|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
128915166|NCT01557166|463980046|FG001|Overall Study|Psychiatric disorder|0|||
128915167|NCT01557166|463980045|FG000|Overall Study|Unclassified|2|||
128915168|NCT01557166|463980046|FG001|Overall Study|Unclassified|5|||
128915169|NCT04506294|463980047|FG000|Overall Study|Lost to Follow-up|70|||
128915170|NCT04506294|463980048|FG001|Overall Study|Lost to Follow-up|20|||
128915171|NCT04506294|463980047|FG000|Overall Study|Withdrawal by Subject|16|||
128915172|NCT04506294|463980048|FG001|Overall Study|Withdrawal by Subject|2|||
128915173|NCT01465659|463980049|FG000|Completed 1 Cycle of Treatment|Death|0|||
128915174|NCT01465659|463980050|FG001|Completed 1 Cycle of Treatment|Death|1|||
128915175|NCT01465659|463980051|FG002|Completed 1 Cycle of Treatment|Death|0|||
128915176|NCT01465659|463980052|FG003|Completed 1 Cycle of Treatment|Death|0|||
128915177|NCT01465659|463980049|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
128915178|NCT01465659|463980050|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
128915179|NCT01465659|463980051|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
128915180|NCT01465659|463980052|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
128915181|NCT01465659|463980049|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
128915182|NCT01465659|463980050|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
128915183|NCT01465659|463980051|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
128915184|NCT01465659|463980052|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
128915185|NCT01465659|463980049|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
128915186|NCT01465659|463980050|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
128915187|NCT01465659|463980051|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
128915188|NCT01465659|463980052|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
128915189|NCT01465659|463980049|FG000|Completed Follow for 1 Year|Death|6|||
128915190|NCT01465659|463980050|FG001|Completed Follow for 1 Year|Death|3|||
128915191|NCT01465659|463980051|FG002|Completed Follow for 1 Year|Death|2|||
128915192|NCT01465659|463980052|FG003|Completed Follow for 1 Year|Death|4|||
128915193|NCT02445586|463980053|FG000|Overall Study|Death|14|||
128915194|NCT02445586|463980053|FG000|Overall Study|Withdrawal by Subject|13|||
128915195|NCT02445586|463980053|FG000|Overall Study|Disease Progression|10|||
128915196|NCT02445586|463980053|FG000|Overall Study|Protocol Violation|1|||
128915197|NCT02445586|463980053|FG000|Overall Study|Medical Condition|1|||
128765671|NCT02508532|463433895|FG005|Part 2 - Treatment|Disease Progression|0|||
128915198|NCT00428597|463980054|FG000|Overall Study|Randomized but not treated|3|||
128915199|NCT00428597|463980055|FG001|Overall Study|Randomized but not treated|3|||
128915200|NCT00428597|463980054|FG000|Overall Study|Objective Progression or Relapse|19|||
128915201|NCT00428597|463980055|FG001|Overall Study|Objective Progression or Relapse|47|||
128915202|NCT00428597|463980054|FG000|Overall Study|Study Terminated by Sponsor|41|||
128915203|NCT00428597|463980055|FG001|Overall Study|Study Terminated by Sponsor|16|||
128915204|NCT00428597|463980054|FG000|Overall Study|Adverse Event|15|||
128915205|NCT00428597|463980055|FG001|Overall Study|Adverse Event|7|||
128915206|NCT00428597|463980054|FG000|Overall Study|Global Deterioration of Health Status|1|||
128915207|NCT00428597|463980055|FG001|Overall Study|Global Deterioration of Health Status|5|||
128915208|NCT00428597|463980054|FG000|Overall Study|Protocol Violation|2|||
128915209|NCT00428597|463980055|FG001|Overall Study|Protocol Violation|1|||
128915210|NCT00428597|463980054|FG000|Overall Study|Withdrawal by Subject|2|||
128915211|NCT00428597|463980055|FG001|Overall Study|Withdrawal by Subject|1|||
128915212|NCT00428597|463980054|FG000|Overall Study|Other|1|||
128915213|NCT00428597|463980055|FG001|Overall Study|Other|1|||
128915214|NCT00428597|463980054|FG000|Overall Study|Lost to Follow-up|0|||
128915215|NCT00428597|463980055|FG001|Overall Study|Lost to Follow-up|1|||
128915216|NCT00428597|463980054|FG000|Overall Study|Pregnancy|1|||
128915217|NCT00428597|463980055|FG001|Overall Study|Pregnancy|0|||
128915218|NCT00428597|463980054|FG000|Overall Study|Death|1|||
128915219|NCT00428597|463980055|FG001|Overall Study|Death|3|||
128915220|NCT01990261|463980057|FG000|Overall Study|Death Before Treatment Start|2|||
128915221|NCT01990261|463980057|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
128915222|NCT01990261|463980057|FG000|Overall Study|Death From other Causes|1|||
128915223|NCT01990261|463980057|FG000|Overall Study|Disease Progression (PD)|8|||
128915224|NCT01990261|463980057|FG000|Overall Study|PD Before Treatment Start|1|||
129028945|NCT01120028|464396455|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
129028946|NCT01120028|464396456|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
129028947|NCT00556673|464396457|FG000|Overall Study|Protocol deviation|3|||
129028948|NCT00556673|464396458|FG001|Overall Study|Protocol deviation|2|||
129028949|NCT01401062|464396461|FG000|Overall Study|Death|9|||
129028950|NCT01401062|464396462|FG001|Overall Study|Death|7|||
129028951|NCT01401062|464396461|FG000|Overall Study|Physician Decision|1|||
129028952|NCT01401062|464396462|FG001|Overall Study|Physician Decision|0|||
129028953|NCT01401062|464396461|FG000|Overall Study|Withdrawal by Subject|1|||
128915225|NCT01990261|463980057|FG000|Overall Study|Dossier not Approved|1|||
128915226|NCT01990261|463980057|FG000|Overall Study|Lost to Follow-up|2|||
128915227|NCT01445678|463980059|FG000|Overall Study|Adverse Event|12|||
128915228|NCT01445678|463980060|FG001|Overall Study|Adverse Event|8|||
128915229|NCT01445678|463980059|FG000|Overall Study|Lack of Efficacy|0|||
128915230|NCT01445678|463980060|FG001|Overall Study|Lack of Efficacy|2|||
128915231|NCT01445678|463980059|FG000|Overall Study|Lost to Follow-up|8|||
129028954|NCT01401062|464396462|FG001|Overall Study|Withdrawal by Subject|1|||
129028955|NCT01131260|464396463|FG000|Overall Study|Randomization error|5|||
128915232|NCT01445678|463980060|FG001|Overall Study|Lost to Follow-up|5|||
128915233|NCT01445678|463980059|FG000|Overall Study|Protocol Violation|1|||
128915234|NCT01445678|463980060|FG001|Overall Study|Protocol Violation|1|||
128915235|NCT01445678|463980059|FG000|Overall Study|Withdrawal by Subject|9|||
128915236|NCT01445678|463980060|FG001|Overall Study|Withdrawal by Subject|5|||
128915237|NCT02307370|463980061|FG000|Overall Study|Death|5|||
128915238|NCT02307370|463980061|FG000|Overall Study|Lost to Follow-up|1|||
128915239|NCT02307370|463980061|FG000|Overall Study|Withdrawal by Subject|1|||
128915240|NCT02307370|463980061|FG000|Overall Study|Declined Addendum ICF|6|||
128915241|NCT02307370|463980061|FG000|Overall Study|No response during telephone contact|5|||
128915242|NCT02307370|463980061|FG000|Overall Study|Protocol Violation|1|||
128915243|NCT05847686|463982773|FG000|Overall Study|Withdrawal by Subject|3|||
128915244|NCT06272370|463982774|FG000|Overall Study|Lost to Follow-up|0|||
128915245|NCT06272370|463982775|FG001|Overall Study|Lost to Follow-up|3|||
128915246|NCT06272370|463982776|FG002|Overall Study|Lost to Follow-up|1|||
128915247|NCT06272370|463982777|FG003|Overall Study|Lost to Follow-up|1|||
128915248|NCT00352534|463982779|FG000|Initial Staging|Ineligible|8|||
128915249|NCT00352534|463982780|FG001|Initial Staging|Ineligible|9|||
128915250|NCT00352534|463982781|FG002|Initial Staging|Ineligible|0|||
128915251|NCT00352534|463982782|FG003|Initial Staging|Ineligible|0|||
128915252|NCT00352534|463982783|FG004|Initial Staging|Ineligible|0|||
128915253|NCT00352534|463982784|FG005|Initial Staging|Ineligible|0|||
128915254|NCT00352534|463982785|FG006|Initial Staging|Ineligible|0|||
128915255|NCT00352534|463982779|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
128915256|NCT00352534|463982780|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
128915257|NCT00352534|463982781|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
128915258|NCT00352534|463982782|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
128915259|NCT00352534|463982783|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
128915260|NCT00352534|463982784|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
128915261|NCT00352534|463982785|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
128915262|NCT00352534|463982779|FG000|Final Risk Group Assignment|Physician Decision|0|||
128915263|NCT00352534|463982780|FG001|Final Risk Group Assignment|Physician Decision|0|||
128915264|NCT00352534|463982781|FG002|Final Risk Group Assignment|Physician Decision|0|||
128915265|NCT00352534|463982782|FG003|Final Risk Group Assignment|Physician Decision|0|||
128915266|NCT00352534|463982783|FG004|Final Risk Group Assignment|Physician Decision|0|||
128915267|NCT00352534|463982784|FG005|Final Risk Group Assignment|Physician Decision|8|||
128915268|NCT00352534|463982785|FG006|Final Risk Group Assignment|Physician Decision|0|||
128915269|NCT00352534|463982779|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
128915270|NCT00352534|463982780|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
128915271|NCT00352534|463982781|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
128915272|NCT00352534|463982782|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
128915273|NCT00352534|463982783|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
128915274|NCT00352534|463982784|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
128915275|NCT00352534|463982785|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
128915276|NCT00352534|463982779|FG000|Final Risk Group Assignment|Ineligible|0|||
128915277|NCT00352534|463982780|FG001|Final Risk Group Assignment|Ineligible|0|||
128915278|NCT00352534|463982781|FG002|Final Risk Group Assignment|Ineligible|3|||
128915279|NCT00352534|463982782|FG003|Final Risk Group Assignment|Ineligible|1|||
128915280|NCT00352534|463982783|FG004|Final Risk Group Assignment|Ineligible|0|||
128915281|NCT00352534|463982784|FG005|Final Risk Group Assignment|Ineligible|13|||
128915282|NCT00352534|463982785|FG006|Final Risk Group Assignment|Ineligible|0|||
128915283|NCT00352534|463982779|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
128915284|NCT00352534|463982780|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
128915285|NCT00352534|463982781|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
128915286|NCT00352534|463982782|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
128915287|NCT00352534|463982783|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
128915288|NCT00352534|463982784|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
128915289|NCT00352534|463982785|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
128915290|NCT00352534|463982779|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
128915291|NCT00352534|463982780|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
128915292|NCT00352534|463982781|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
128915293|NCT00352534|463982782|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
128915294|NCT00352534|463982783|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
128915295|NCT00352534|463982784|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
128915296|NCT00352534|463982785|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
128915297|NCT00352534|463982779|FG000|Final Risk Group Assignment|Death|0|||
128915298|NCT00352534|463982780|FG001|Final Risk Group Assignment|Death|0|||
128915299|NCT00352534|463982781|FG002|Final Risk Group Assignment|Death|0|||
128915300|NCT00352534|463982782|FG003|Final Risk Group Assignment|Death|0|||
128915301|NCT00352534|463982783|FG004|Final Risk Group Assignment|Death|0|||
128915302|NCT00352534|463982784|FG005|Final Risk Group Assignment|Death|2|||
128915303|NCT00352534|463982785|FG006|Final Risk Group Assignment|Death|0|||
128697598|NCT02564796|463190486|FG000|Overall Study|Physician Decision|2|||
128697599|NCT02564796|463190487|FG001|Overall Study|Physician Decision|2|||
128697600|NCT00453063|463190488|FG000|Overall Study|Adverse Event|1|||
128697601|NCT00453063|463190489|FG001|Overall Study|Adverse Event|2|||
128697602|NCT00453063|463190488|FG000|Overall Study|Withdrawal by Subject|1|||
128697603|NCT00453063|463190489|FG001|Overall Study|Withdrawal by Subject|1|||
128697604|NCT00453063|463190488|FG000|Overall Study|Protocol Violation|1|||
128697605|NCT00453063|463190489|FG001|Overall Study|Protocol Violation|0|||
128697606|NCT00289783|463190490|FG000|Primary Phase|Adverse Event|10|||
128697607|NCT00289783|463190491|FG001|Primary Phase|Adverse Event|1|||
128697608|NCT00289783|463190490|FG000|Primary Phase|Protocol Violation|27|||
128697609|NCT00289783|463190491|FG001|Primary Phase|Protocol Violation|6|||
128697610|NCT00289783|463190490|FG000|Primary Phase|Withdrawal by Subject|93|||
128697611|NCT00289783|463190491|FG001|Primary Phase|Withdrawal by Subject|40|||
128697612|NCT00289783|463190490|FG000|Primary Phase|Lost to Follow-up|60|||
128697613|NCT00289783|463190491|FG001|Primary Phase|Lost to Follow-up|14|||
128697614|NCT00289783|463190490|FG000|Primary Phase|Migration from the study area|26|||
128697615|NCT00289783|463190491|FG001|Primary Phase|Migration from the study area|10|||
128697616|NCT00289783|463190490|FG000|Primary Phase|Other|32|||
128697617|NCT00289783|463190491|FG001|Primary Phase|Other|12|||
128697618|NCT00289783|463190490|FG000|Fourth Dose Phase|Adverse Event|1|||
128697619|NCT00289783|463190491|FG001|Fourth Dose Phase|Adverse Event|0|||
128697620|NCT00289783|463190490|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
128697621|NCT00289783|463190491|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
128697622|NCT00289783|463190490|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
128697623|NCT00289783|463190491|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
128697624|NCT00289783|463190490|FG000|Fourth Dose Phase|Migration from the study area|1|||
128697625|NCT00289783|463190491|FG001|Fourth Dose Phase|Migration from the study area|1|||
128697626|NCT00289783|463190490|FG000|Fourth Dose Phase|Other|22|||
128697627|NCT00289783|463190491|FG001|Fourth Dose Phase|Other|10|||
128697628|NCT00566995|463190494|FG000|Overall Study|Toxicity|4|||
128697629|NCT00566995|463190494|FG000|Overall Study|Withdrew consent|3|||
128697630|NCT00228384|463190504|FG000|Overall Study|Death|9|||
128697631|NCT00228384|463190505|FG001|Overall Study|Death|3|||
128697632|NCT00228384|463190504|FG000|Overall Study|Lost to Follow-up|6|||
128697633|NCT00228384|463190505|FG001|Overall Study|Lost to Follow-up|10|||
128697634|NCT00228384|463190504|FG000|Overall Study|Surgical Intervention (bypass)|5|||
128697635|NCT00228384|463190505|FG001|Overall Study|Surgical Intervention (bypass)|5|||
128697636|NCT00228384|463190504|FG000|Overall Study|Withdrawal by Subject|9|||
128697637|NCT00228384|463190505|FG001|Overall Study|Withdrawal by Subject|10|||
128697638|NCT00228384|463190504|FG000|Overall Study|Physician Decision|0|||
128697639|NCT00228384|463190505|FG001|Overall Study|Physician Decision|1|||
128697640|NCT01785069|463190507|FG000|Overall Study|Implanted with nonstudy device|1|||
128697641|NCT01785069|463190508|FG001|Overall Study|Implanted with nonstudy device|2|||
128697642|NCT01785069|463190509|FG002|Overall Study|Implanted with nonstudy device|1|||
128697643|NCT01785069|463190510|FG003|Overall Study|Implanted with nonstudy device|0|||
128697644|NCT01785069|463190507|FG000|Overall Study|Death|0|||
128697645|NCT01785069|463190508|FG001|Overall Study|Death|0|||
128697646|NCT01785069|463190509|FG002|Overall Study|Death|2|||
128697647|NCT01785069|463190510|FG003|Overall Study|Death|0|||
128697648|NCT01785069|463190507|FG000|Overall Study|Subject choice|2|||
128697649|NCT01785069|463190508|FG001|Overall Study|Subject choice|2|||
128697650|NCT01785069|463190509|FG002|Overall Study|Subject choice|0|||
128697651|NCT01785069|463190510|FG003|Overall Study|Subject choice|1|||
128697652|NCT01785069|463190507|FG000|Overall Study|Lost to Follow-up|1|||
128697653|NCT01785069|463190508|FG001|Overall Study|Lost to Follow-up|2|||
128697654|NCT01785069|463190509|FG002|Overall Study|Lost to Follow-up|4|||
128697655|NCT01785069|463190510|FG003|Overall Study|Lost to Follow-up|1|||
128697656|NCT01785069|463190507|FG000|Overall Study|Reason not Specified|1|||
128697657|NCT01785069|463190508|FG001|Overall Study|Reason not Specified|2|||
128697658|NCT01785069|463190509|FG002|Overall Study|Reason not Specified|1|||
128697659|NCT01785069|463190510|FG003|Overall Study|Reason not Specified|4|||
128697660|NCT01785069|463190507|FG000|Overall Study|Not evaluable|7|||
128915304|NCT01602341|463982786|FG000|Overall Study|Adverse Event|0|||
128915305|NCT01602341|463982787|FG001|Overall Study|Adverse Event|1|||
128697661|NCT01785069|463190508|FG001|Overall Study|Not evaluable|4|||
128697662|NCT01785069|463190509|FG002|Overall Study|Not evaluable|5|||
128697663|NCT01785069|463190510|FG003|Overall Study|Not evaluable|8|||
128697664|NCT04997304|463190520|FG000|Overall Study|Lost to Follow-up|11|||
128697665|NCT04997304|463190520|FG000|Overall Study|Death|1|||
128697666|NCT04997304|463190520|FG000|Overall Study|Withdrawal by Subject|14|||
128697667|NCT01995825|463192156|FG000|Overall Study|Withdrawal by Subject|1|||
128697668|NCT01995825|463192157|FG001|Overall Study|Withdrawal by Subject|0|||
128697669|NCT01385566|463192158|FG000|Overall Study|Lost to Follow-up|1|||
128697670|NCT01385566|463192159|FG001|Overall Study|Lost to Follow-up|0|||
128697671|NCT01385566|463192160|FG002|Overall Study|Lost to Follow-up|0|||
128697672|NCT01385566|463192161|FG003|Overall Study|Lost to Follow-up|0|||
128697673|NCT01385566|463192162|FG004|Overall Study|Lost to Follow-up|0|||
128697674|NCT01385566|463192163|FG005|Overall Study|Lost to Follow-up|0|||
128915306|NCT04439279|463982788|FG000|Overall Study|Adverse Event|7|||
128915307|NCT04439279|463982788|FG000|Overall Study|Death|4|||
128915308|NCT04439279|463982788|FG000|Overall Study|Disease progression|17|||
128915309|NCT04439279|463982788|FG000|Overall Study|Complicating disease|3|||
128915310|NCT04439279|463982788|FG000|Overall Study|Withdrawal by Subject|2|||
128915311|NCT04439279|463982788|FG000|Overall Study|Ineligible|1|||
128915312|NCT04439279|463982788|FG000|Overall Study|Treatment still ongoing|1|||
128915313|NCT03521791|463982789|FG000|Overall Study|Protocol Violation|7|||
128915314|NCT03521791|463982790|FG001|Overall Study|Protocol Violation|17|||
128915315|NCT02090855|463982791|FG000|Overall Study|no evaluable Standard of Truth results|2|||
128915316|NCT03038308|463982793|FG000|Overall Study|Surgical resection|1|||
128915317|NCT03038308|463982793|FG000|Overall Study|Withdrawal by Subject|2|||
128915318|NCT03038308|463982793|FG000|Overall Study|Lost to Follow-up|1|||
128915319|NCT00544869|463982795|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
128915320|NCT00544869|463982796|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
128915321|NCT00544869|463982797|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
128915322|NCT00544869|463982795|FG000|Overall Study|Adverse Event|6|||
128915323|NCT00544869|463982796|FG001|Overall Study|Adverse Event|1|||
128915324|NCT00544869|463982797|FG002|Overall Study|Adverse Event|0|||
128915325|NCT00544869|463982795|FG000|Overall Study|Lack of Efficacy|1|||
128915326|NCT00544869|463982796|FG001|Overall Study|Lack of Efficacy|1|||
128915327|NCT00544869|463982797|FG002|Overall Study|Lack of Efficacy|0|||
128915328|NCT00544869|463982795|FG000|Overall Study|Physician Decision|2|||
128915329|NCT00544869|463982796|FG001|Overall Study|Physician Decision|0|||
128915330|NCT00544869|463982797|FG002|Overall Study|Physician Decision|0|||
128915331|NCT01777763|463982808|FG000|Overall Study|Adverse Event|2|||
128915332|NCT01777763|463982809|FG001|Overall Study|Adverse Event|32|||
128915333|NCT01777763|463982808|FG000|Overall Study|Protocol Violation|1|||
128915334|NCT01777763|463982809|FG001|Overall Study|Protocol Violation|7|||
128915335|NCT01777763|463982808|FG000|Overall Study|Withdrawal by Subject|0|||
128915336|NCT01777763|463982809|FG001|Overall Study|Withdrawal by Subject|2|||
128915337|NCT01777763|463982808|FG000|Overall Study|Treatment Failure|1|||
128915338|NCT01777763|463982809|FG001|Overall Study|Treatment Failure|6|||
128915339|NCT00925600|463982818|FG000|Overall Study|Withdrawal by Subject|16|||
128915340|NCT00925600|463982819|FG001|Overall Study|Withdrawal by Subject|14|||
128915341|NCT00925600|463982818|FG000|Overall Study|Death|4|||
128915342|NCT00925600|463982819|FG001|Overall Study|Death|3|||
128915343|NCT00925600|463982818|FG000|Overall Study|Lost to Follow-up|2|||
128915344|NCT00925600|463982819|FG001|Overall Study|Lost to Follow-up|2|||
128915345|NCT00925600|463982818|FG000|Overall Study|Disease Progression|1|||
128915346|NCT00925600|463982819|FG001|Overall Study|Disease Progression|3|||
128915347|NCT00925600|463982818|FG000|Overall Study|Administrative Decision|1|||
128915348|NCT00925600|463982819|FG001|Overall Study|Administrative Decision|1|||
128915349|NCT00925600|463982818|FG000|Overall Study|Noncompliance|2|||
128915350|NCT00925600|463982819|FG001|Overall Study|Noncompliance|0|||
128915351|NCT00925600|463982818|FG000|Overall Study|Ineligibility Determined|2|||
128915352|NCT00925600|463982819|FG001|Overall Study|Ineligibility Determined|0|||
128915353|NCT00925600|463982818|FG000|Overall Study|Protocol Deviation|0|||
128915354|NCT00925600|463982819|FG001|Overall Study|Protocol Deviation|1|||
128915355|NCT00925600|463982818|FG000|Overall Study|Requirement for Alternative Therapy|0|||
128915356|NCT00925600|463982819|FG001|Overall Study|Requirement for Alternative Therapy|1|||
128915357|NCT00925600|463982818|FG000|Overall Study|Other|3|||
128915358|NCT00925600|463982819|FG001|Overall Study|Other|1|||
128915359|NCT00925600|463982818|FG000|Overall Study|Adverse Event|1|||
128915360|NCT00925600|463982819|FG001|Overall Study|Adverse Event|2|||
128915361|NCT01974817|463982822|FG000|Overall Study|Death|4|||
128915362|NCT01974817|463982822|FG000|Overall Study|Lost to Follow-up|2|||
128915363|NCT01974817|463982822|FG000|Overall Study|Protocol Violation|2|||
128915364|NCT01246206|463982823|FG000|Overall Study|Patient did not receive study regiments.|1|||
128915365|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
128915366|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
128915367|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
128915368|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
128915369|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
128915370|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
128915371|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
128915372|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
128915373|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
128915374|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
128915375|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
128915376|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
128915377|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
128915378|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
128915379|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
128915380|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
128915381|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
128697675|NCT01385566|463192158|FG000|Overall Study|Withdrawal by Subject|0|||
128697676|NCT01385566|463192159|FG001|Overall Study|Withdrawal by Subject|0|||
128697677|NCT01385566|463192160|FG002|Overall Study|Withdrawal by Subject|0|||
128697678|NCT01385566|463192161|FG003|Overall Study|Withdrawal by Subject|1|||
128697679|NCT01385566|463192162|FG004|Overall Study|Withdrawal by Subject|0|||
128697680|NCT01385566|463192163|FG005|Overall Study|Withdrawal by Subject|0|||
128915382|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
128915383|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
128915384|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
128915385|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
128697681|NCT00403234|463192166|FG000|Overall Study|Withdrawal by Subject|0|||
128915386|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
128915387|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
128915388|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
128915389|NCT04660643|463982824|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
128915390|NCT04660643|463982825|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
128915391|NCT04660643|463982826|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
128915392|NCT04660643|463982824|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
128915393|NCT04660643|463982825|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
128915394|NCT04660643|463982826|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
128915395|NCT04660643|463982824|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
128697682|NCT00403234|463192167|FG001|Overall Study|Withdrawal by Subject|1|||
128697683|NCT00403234|463192168|FG002|Overall Study|Withdrawal by Subject|0|||
128697684|NCT00403234|463192169|FG003|Overall Study|Withdrawal by Subject|0|||
128697685|NCT00403234|463192166|FG000|Overall Study|Adverse Event|1|||
128697686|NCT00403234|463192167|FG001|Overall Study|Adverse Event|0|||
128697687|NCT00403234|463192168|FG002|Overall Study|Adverse Event|1|||
128697688|NCT00403234|463192169|FG003|Overall Study|Adverse Event|0|||
128697689|NCT04092582|463192170|FG000|Overall Study|Death|1|||
128697690|NCT04092582|463192171|FG001|Overall Study|Death|1|||
128697691|NCT04092582|463192170|FG000|Overall Study|Withdrawal by Subject|4|||
128697692|NCT04092582|463192171|FG001|Overall Study|Withdrawal by Subject|1|||
128697693|NCT04092582|463192170|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
128697694|NCT04092582|463192171|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
128697695|NCT00560105|463192178|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
128697696|NCT00560105|463192179|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
128697697|NCT02025621|463192187|FG000|Overall Study|Withdrawal by Subject|1|||
128697698|NCT02025621|463192188|FG001|Overall Study|Withdrawal by Subject|0|||
128697699|NCT02025621|463192187|FG000|Overall Study|Death|0|||
128697700|NCT02025621|463192188|FG001|Overall Study|Death|1|||
128697701|NCT02025621|463192187|FG000|Overall Study|No longer eligible|10|||
128697702|NCT02025621|463192188|FG001|Overall Study|No longer eligible|15|||
128697703|NCT02025621|463192187|FG000|Overall Study|Surgery initiated before infusion|3|||
128697704|NCT02025621|463192188|FG001|Overall Study|Surgery initiated before infusion|3|||
128697705|NCT00739674|463192189|FG000|Overall Study|Screening failures|19|||
128697706|NCT00739674|463192190|FG001|Overall Study|Screening failures|17|||
128697707|NCT00739674|463192189|FG000|Overall Study|Site 212 removal|19|||
128697708|NCT00739674|463192190|FG001|Overall Study|Site 212 removal|13|||
128697709|NCT00739674|463192189|FG000|Overall Study|No follow-up data|33|||
128697710|NCT00739674|463192190|FG001|Overall Study|No follow-up data|18|||
128697711|NCT00739674|463192189|FG000|Overall Study|Dietician consultation >30 days|1|||
128697712|NCT00739674|463192190|FG001|Overall Study|Dietician consultation >30 days|9|||
128697713|NCT00739674|463192189|FG000|Overall Study|Adverse Event|22|||
128697714|NCT00739674|463192190|FG001|Overall Study|Adverse Event|13|||
128697715|NCT00739674|463192189|FG000|Overall Study|Death|1|||
128697716|NCT00739674|463192190|FG001|Overall Study|Death|0|||
128697717|NCT00739674|463192189|FG000|Overall Study|Lack of Efficacy|1|||
128697718|NCT00739674|463192190|FG001|Overall Study|Lack of Efficacy|0|||
128697719|NCT00739674|463192189|FG000|Overall Study|Lost to Follow-up|52|||
128697720|NCT00739674|463192190|FG001|Overall Study|Lost to Follow-up|30|||
128697721|NCT00739674|463192189|FG000|Overall Study|Protocol Violation|5|||
128697722|NCT00739674|463192190|FG001|Overall Study|Protocol Violation|5|||
128697723|NCT00739674|463192189|FG000|Overall Study|Withdrawal by Subject|9|||
128697724|NCT00739674|463192190|FG001|Overall Study|Withdrawal by Subject|9|||
128697725|NCT00739674|463192189|FG000|Overall Study|Reason missing|2|||
128697726|NCT00739674|463192190|FG001|Overall Study|Reason missing|0|||
128697727|NCT00739674|463192189|FG000|Overall Study|Clinic closed|6|||
128697728|NCT00739674|463192190|FG001|Overall Study|Clinic closed|4|||
128697729|NCT00739674|463192189|FG000|Overall Study|Patient moved|3|||
128697730|NCT00739674|463192190|FG001|Overall Study|Patient moved|2|||
128697731|NCT00739674|463192189|FG000|Overall Study|Non compliant|4|||
128697732|NCT00739674|463192190|FG001|Overall Study|Non compliant|0|||
128697733|NCT00739674|463192189|FG000|Overall Study|Unable to attend visit|3|||
128697734|NCT00739674|463192190|FG001|Overall Study|Unable to attend visit|1|||
128915396|NCT04660643|463982825|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
128915397|NCT04660643|463982826|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
128915398|NCT04660643|463982824|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
128915399|NCT04660643|463982825|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
128915400|NCT04660643|463982826|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
128915401|NCT04660643|463982824|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
128915402|NCT04660643|463982825|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
128915403|NCT04660643|463982826|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
128915404|NCT04660643|463982824|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
128915405|NCT04660643|463982825|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
128915406|NCT04660643|463982826|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
128915407|NCT04660643|463982824|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
128915408|NCT04660643|463982825|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
128915409|NCT04660643|463982826|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
128915410|NCT04660643|463982824|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
128915411|NCT04660643|463982825|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
128915412|NCT04660643|463982826|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
128915413|NCT03988907|463982827|FG000|Overall Study|Unable to complete visit|0|||
128915414|NCT03988907|463982828|FG001|Overall Study|Unable to complete visit|1|||
128915415|NCT02810964|463982829|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
128915416|NCT02810964|463982830|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
128915417|NCT02810964|463982829|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
128915418|NCT02810964|463982830|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
128915419|NCT02810964|463982829|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
128915420|NCT02810964|463982830|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
128915421|NCT02810964|463982829|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
128915422|NCT02810964|463982830|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
128915423|NCT01097629|463982841|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
128915424|NCT01097629|463982842|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
128915425|NCT01097629|463982843|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
128915426|NCT01097629|463982844|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128915427|NCT01097629|463982845|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128915428|NCT01097629|463982846|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128915429|NCT01097629|463982847|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128915430|NCT01097629|463982848|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128915431|NCT01097629|463982841|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
128915432|NCT01097629|463982842|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
128915433|NCT01097629|463982843|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
128915434|NCT01097629|463982844|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128915435|NCT01097629|463982845|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128765672|NCT02508532|463433896|FG006|Part 2 - Treatment|Disease Progression|0|||
128765673|NCT02508532|463433897|FG007|Part 2 - Treatment|Disease Progression|0|||
128765674|NCT02508532|463433898|FG008|Part 2 - Treatment|Disease Progression|118|||
128765675|NCT02508532|463433890|FG000|Part 2 - Treatment|Adverse Event|0|||
128765676|NCT02508532|463433891|FG001|Part 2 - Treatment|Adverse Event|0|||
128765677|NCT02508532|463433892|FG002|Part 2 - Treatment|Adverse Event|0|||
128765678|NCT02508532|463433893|FG003|Part 2 - Treatment|Adverse Event|0|||
128765679|NCT02508532|463433894|FG004|Part 2 - Treatment|Adverse Event|0|||
128765680|NCT02508532|463433895|FG005|Part 2 - Treatment|Adverse Event|0|||
128765681|NCT02508532|463433896|FG006|Part 2 - Treatment|Adverse Event|0|||
128765682|NCT02508532|463433897|FG007|Part 2 - Treatment|Adverse Event|0|||
128765683|NCT02508532|463433898|FG008|Part 2 - Treatment|Adverse Event|49|||
128765684|NCT02508532|463433890|FG000|Part 2 - Treatment|Physician Decision|0|||
128915436|NCT01097629|463982846|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128915437|NCT01097629|463982847|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128915438|NCT01097629|463982848|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128915439|NCT01097629|463982841|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
128915440|NCT01097629|463982842|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
128915441|NCT01097629|463982843|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
128915442|NCT01097629|463982844|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128915443|NCT01097629|463982845|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128915444|NCT01097629|463982846|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128915445|NCT01097629|463982847|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128915446|NCT01097629|463982848|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128915447|NCT01097629|463982841|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
128915448|NCT01097629|463982842|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
128915449|NCT01097629|463982843|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
128915450|NCT01097629|463982844|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128915451|NCT01097629|463982845|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128915452|NCT01097629|463982846|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128915453|NCT01097629|463982847|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128915454|NCT01097629|463982848|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128915455|NCT01097629|463982841|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
128915456|NCT01097629|463982842|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
128915457|NCT01097629|463982843|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
128915458|NCT01097629|463982844|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128915459|NCT01097629|463982845|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128915460|NCT01097629|463982846|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128915461|NCT01097629|463982847|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128915462|NCT01097629|463982848|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128915463|NCT01097629|463982841|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
128915464|NCT01097629|463982842|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
128915465|NCT01097629|463982843|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128915466|NCT01097629|463982844|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128915467|NCT01097629|463982845|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128915468|NCT01097629|463982846|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128915469|NCT01097629|463982847|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128915470|NCT01097629|463982848|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128915471|NCT01097629|463982841|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
128915472|NCT01097629|463982842|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
128915473|NCT01097629|463982843|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
128915474|NCT01097629|463982844|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128915475|NCT01097629|463982845|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128915476|NCT01097629|463982846|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128915477|NCT01097629|463982847|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128915478|NCT01097629|463982848|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128915479|NCT01097629|463982841|FG000|DB RO Phase|Withdrawal by Subject|0|||
128915480|NCT01097629|463982842|FG001|DB RO Phase|Withdrawal by Subject|0|||
128915481|NCT01097629|463982843|FG002|DB RO Phase|Withdrawal by Subject|0|||
128915482|NCT01097629|463982844|FG003|DB RO Phase|Withdrawal by Subject|0|||
128915483|NCT01097629|463982845|FG004|DB RO Phase|Withdrawal by Subject|0|||
128915484|NCT01097629|463982846|FG005|DB RO Phase|Withdrawal by Subject|0|||
128915485|NCT01097629|463982847|FG006|DB RO Phase|Withdrawal by Subject|0|||
128915486|NCT01097629|463982848|FG007|DB RO Phase|Withdrawal by Subject|1|||
128915487|NCT01097629|463982841|FG000|DB RO Phase|Protocol Violation|0|||
128915488|NCT01097629|463982842|FG001|DB RO Phase|Protocol Violation|0|||
128915489|NCT01097629|463982843|FG002|DB RO Phase|Protocol Violation|0|||
128915490|NCT01097629|463982844|FG003|DB RO Phase|Protocol Violation|1|||
128915491|NCT01097629|463982845|FG004|DB RO Phase|Protocol Violation|0|||
128915492|NCT01097629|463982846|FG005|DB RO Phase|Protocol Violation|1|||
128915493|NCT01097629|463982847|FG006|DB RO Phase|Protocol Violation|1|||
128915494|NCT01097629|463982848|FG007|DB RO Phase|Protocol Violation|0|||
128915495|NCT01097629|463982841|FG000|DB RO Phase|Lost to Follow-up|0|||
128915496|NCT01097629|463982842|FG001|DB RO Phase|Lost to Follow-up|0|||
128915497|NCT01097629|463982843|FG002|DB RO Phase|Lost to Follow-up|0|||
128915498|NCT01097629|463982844|FG003|DB RO Phase|Lost to Follow-up|0|||
128915499|NCT01097629|463982845|FG004|DB RO Phase|Lost to Follow-up|0|||
128915500|NCT01097629|463982846|FG005|DB RO Phase|Lost to Follow-up|0|||
128915501|NCT01097629|463982847|FG006|DB RO Phase|Lost to Follow-up|2|||
128915502|NCT01097629|463982848|FG007|DB RO Phase|Lost to Follow-up|0|||
128915503|NCT01171820|463982850|FG000|Overall Study|Death|3|||
128915504|NCT01171820|463982851|FG001|Overall Study|Death|3|||
128915505|NCT01171820|463982850|FG000|Overall Study|Lost to Follow-up|0|||
128915506|NCT01171820|463982851|FG001|Overall Study|Lost to Follow-up|1|||
128915507|NCT01171820|463982850|FG000|Overall Study|Withdrawal by Subject|2|||
128915508|NCT01171820|463982851|FG001|Overall Study|Withdrawal by Subject|0|||
129028956|NCT01131260|464396464|FG001|Overall Study|Randomization error|1|||
128915509|NCT01171820|463982850|FG000|Overall Study|Physician Decision|0|||
128915510|NCT01171820|463982851|FG001|Overall Study|Physician Decision|1|||
128915511|NCT01171820|463982850|FG000|Overall Study|1-Year Missed Visit|1|||
128915512|NCT01171820|463982851|FG001|Overall Study|1-Year Missed Visit|1|||
128915513|NCT03969875|463982852|FG000|Overall Study|did not receive allocated intervention|3|||
128915514|NCT03969875|463982853|FG001|Overall Study|did not receive allocated intervention|3|||
128915515|NCT03969875|463982854|FG002|Overall Study|did not receive allocated intervention|4|||
129028957|NCT01131260|464396463|FG000|Overall Study|Declined to continue participation|8|||
128915516|NCT03969875|463982852|FG000|Overall Study|Protocol Violation|4|||
128915517|NCT03969875|463982853|FG001|Overall Study|Protocol Violation|2|||
128915518|NCT03969875|463982854|FG002|Overall Study|Protocol Violation|2|||
128915519|NCT01307033|463982855|FG000|8-week Double-blind Period|Adverse Event|2|||
128915520|NCT01307033|463982856|FG001|8-week Double-blind Period|Adverse Event|0|||
128915521|NCT01307033|463982857|FG002|8-week Double-blind Period|Adverse Event|0|||
128915522|NCT01307033|463982858|FG003|8-week Double-blind Period|Adverse Event|0|||
128915523|NCT01307033|463982855|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
128915524|NCT01307033|463982856|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
128915525|NCT01307033|463982857|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
128915526|NCT01307033|463982858|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
128915527|NCT01307033|463982855|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
128915528|NCT01307033|463982856|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
128915529|NCT01307033|463982857|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
128915530|NCT01307033|463982858|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
128915531|NCT01307033|463982855|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
128915532|NCT01307033|463982856|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
128915533|NCT01307033|463982857|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
128915534|NCT01307033|463982858|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
128915535|NCT01307033|463982855|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
128915536|NCT01307033|463982856|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
128915537|NCT01307033|463982857|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
128915538|NCT01307033|463982858|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
128915539|NCT01307033|463982855|FG000|44-week Open-label Extension|Adverse Event|0|||
128915540|NCT01307033|463982856|FG001|44-week Open-label Extension|Adverse Event|0|||
128915541|NCT01307033|463982857|FG002|44-week Open-label Extension|Adverse Event|2|||
128915542|NCT01307033|463982858|FG003|44-week Open-label Extension|Adverse Event|1|||
128915543|NCT01307033|463982855|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
128915544|NCT01307033|463982856|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
128915545|NCT01307033|463982857|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
128915546|NCT01307033|463982858|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
128915547|NCT01307033|463982855|FG000|44-week Open-label Extension|Physician Decision|0|||
128915548|NCT01307033|463982856|FG001|44-week Open-label Extension|Physician Decision|0|||
128915549|NCT01307033|463982857|FG002|44-week Open-label Extension|Physician Decision|1|||
128915550|NCT01307033|463982858|FG003|44-week Open-label Extension|Physician Decision|0|||
128915551|NCT01307033|463982855|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
128915552|NCT01307033|463982856|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
128915553|NCT01307033|463982857|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
128915554|NCT01307033|463982858|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
128915555|NCT01307033|463982855|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
128915556|NCT01307033|463982856|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
128915557|NCT01307033|463982857|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
128915558|NCT01307033|463982858|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
128915559|NCT01307033|463982855|FG000|44-week Open-label Extension|Death|0|||
128915560|NCT01307033|463982856|FG001|44-week Open-label Extension|Death|0|||
128915561|NCT01307033|463982857|FG002|44-week Open-label Extension|Death|0|||
128915562|NCT01307033|463982858|FG003|44-week Open-label Extension|Death|1|||
128915563|NCT01231555|463982859|FG000|Overall Study|Study terminated|8|||
128915564|NCT01231555|463982860|FG001|Overall Study|Study terminated|5|||
128915565|NCT01231555|463982861|FG002|Overall Study|Study terminated|8|||
128915566|NCT01231555|463982859|FG000|Overall Study|Withdrawal by Subject|0|||
128915567|NCT01231555|463982860|FG001|Overall Study|Withdrawal by Subject|2|||
128915568|NCT01231555|463982861|FG002|Overall Study|Withdrawal by Subject|0|||
128915569|NCT00947531|463982862|FG000|Overall Study|Withdrawal by Subject|10|||
128915570|NCT00947531|463982863|FG001|Overall Study|Withdrawal by Subject|7|||
128915571|NCT00947531|463982862|FG000|Overall Study|Administrative Reason|0|||
128915572|NCT00947531|463982863|FG001|Overall Study|Administrative Reason|1|||
128915573|NCT00947531|463982862|FG000|Overall Study|Adverse Event|2|||
128697735|NCT00739674|463192189|FG000|Overall Study|Home monitoring off meds|1|||
128697736|NCT00739674|463192190|FG001|Overall Study|Home monitoring off meds|0|||
128915574|NCT00947531|463982863|FG001|Overall Study|Adverse Event|2|||
128915575|NCT00947531|463982862|FG000|Overall Study|Lack of Efficacy|1|||
128915576|NCT00947531|463982863|FG001|Overall Study|Lack of Efficacy|0|||
128915577|NCT00947531|463982862|FG000|Overall Study|Other|1|||
128915578|NCT00947531|463982863|FG001|Overall Study|Other|1|||
128915579|NCT01773421|463982865|FG000|Treatment Phase|Other|0|||
128915580|NCT01773421|463982866|FG001|Treatment Phase|Other|0|||
128697737|NCT00739674|463192189|FG000|Overall Study|Erectile dysfunction|0|||
128915581|NCT01773421|463982867|FG002|Treatment Phase|Other|2|||
128915582|NCT01773421|463982868|FG003|Treatment Phase|Other|0|||
128915583|NCT01773421|463982869|FG004|Treatment Phase|Other|0|||
128915584|NCT01773421|463982870|FG005|Treatment Phase|Other|0|||
128697738|NCT00739674|463192190|FG001|Overall Study|Erectile dysfunction|1|||
128915585|NCT01773421|463982871|FG006|Treatment Phase|Other|0|||
128915586|NCT01773421|463982865|FG000|Treatment Phase|Adverse Event|0|||
128915587|NCT01773421|463982866|FG001|Treatment Phase|Adverse Event|0|||
128915588|NCT01773421|463982867|FG002|Treatment Phase|Adverse Event|3|||
128915589|NCT01773421|463982868|FG003|Treatment Phase|Adverse Event|1|||
128915590|NCT01773421|463982869|FG004|Treatment Phase|Adverse Event|0|||
128915591|NCT01773421|463982870|FG005|Treatment Phase|Adverse Event|0|||
128915592|NCT01773421|463982871|FG006|Treatment Phase|Adverse Event|0|||
128915593|NCT01773421|463982865|FG000|Treatment Phase|Withdrawal by Subject|0|||
128915594|NCT01773421|463982866|FG001|Treatment Phase|Withdrawal by Subject|0|||
128915595|NCT01773421|463982867|FG002|Treatment Phase|Withdrawal by Subject|1|||
128915596|NCT01773421|463982868|FG003|Treatment Phase|Withdrawal by Subject|1|||
128915597|NCT01773421|463982869|FG004|Treatment Phase|Withdrawal by Subject|0|||
128915598|NCT01773421|463982870|FG005|Treatment Phase|Withdrawal by Subject|0|||
128915599|NCT01773421|463982871|FG006|Treatment Phase|Withdrawal by Subject|0|||
128915600|NCT01773421|463982865|FG000|Extension Phase|Other|0|||
129215814|NCT00068692|465092823|FG003|Step 1: Registration|Registered but not randomized|0|||
129215815|NCT00068692|465092824|FG004|Step 1: Registration|Registered but not randomized|0|||
129215816|NCT00068692|465092825|FG005|Step 1: Registration|Registered but not randomized|0|||
129215817|NCT00068692|465092826|FG006|Step 1: Registration|Registered but not randomized|0|||
129215818|NCT00068692|465092827|FG007|Step 1: Registration|Registered but not randomized|0|||
129215819|NCT00068692|465092820|FG000|Step 2: Randomization|Disesae progression/replase|0|||
129215820|NCT00068692|465092821|FG001|Step 2: Randomization|Disesae progression/replase|0|||
129215821|NCT00068692|465092822|FG002|Step 2: Randomization|Disesae progression/replase|1|||
129215822|NCT00068692|465092823|FG003|Step 2: Randomization|Disesae progression/replase|1|||
129215823|NCT00068692|465092824|FG004|Step 2: Randomization|Disesae progression/replase|0|||
129215824|NCT00068692|465092825|FG005|Step 2: Randomization|Disesae progression/replase|0|||
129215825|NCT00068692|465092826|FG006|Step 2: Randomization|Disesae progression/replase|0|||
129215826|NCT00068692|465092827|FG007|Step 2: Randomization|Disesae progression/replase|0|||
129215827|NCT00068692|465092820|FG000|Step 2: Randomization|Adverse Event|0|||
129215828|NCT00068692|465092821|FG001|Step 2: Randomization|Adverse Event|0|||
129215829|NCT00068692|465092822|FG002|Step 2: Randomization|Adverse Event|4|||
129215830|NCT00068692|465092823|FG003|Step 2: Randomization|Adverse Event|2|||
129215831|NCT00068692|465092824|FG004|Step 2: Randomization|Adverse Event|2|||
129215832|NCT00068692|465092825|FG005|Step 2: Randomization|Adverse Event|3|||
129215833|NCT00068692|465092826|FG006|Step 2: Randomization|Adverse Event|4|||
128697739|NCT01871532|463192191|FG000|Overall Study|Withdrawal by Subject|1|||
128697740|NCT01871532|463192192|FG001|Overall Study|Withdrawal by Subject|2|||
128697741|NCT02195583|463192194|FG000|Overall Study|Lost to Follow-up|1|||
128697742|NCT02195583|463192194|FG000|Overall Study|Withdrawal by Subject|4|||
128697743|NCT02195583|463192194|FG000|Overall Study|Adverse Event|2|||
128697744|NCT02195583|463192194|FG000|Overall Study|Other Reason|2|||
128697745|NCT01709513|463192195|FG000|Overall Study|Randomized but not treated|0|||
128697746|NCT01709513|463192196|FG001|Overall Study|Randomized but not treated|1|||
128697747|NCT01709513|463192197|FG002|Overall Study|Randomized but not treated|0|||
128697748|NCT01709513|463192195|FG000|Overall Study|Adverse Event|16|||
128697749|NCT01709513|463192196|FG001|Overall Study|Adverse Event|31|||
128697750|NCT01709513|463192197|FG002|Overall Study|Adverse Event|23|||
128697751|NCT01709513|463192195|FG000|Overall Study|Poor compliance to protocol|2|||
128697752|NCT01709513|463192196|FG001|Overall Study|Poor compliance to protocol|0|||
128697753|NCT01709513|463192197|FG002|Overall Study|Poor compliance to protocol|0|||
128697754|NCT01709513|463192195|FG000|Overall Study|Other|3|||
128697755|NCT01709513|463192196|FG001|Overall Study|Other|11|||
128697756|NCT01709513|463192197|FG002|Overall Study|Other|7|||
128697757|NCT04218695|463192198|FG000|Overall Study|Adverse Event|1|||
128697758|NCT04218695|463192199|FG001|Overall Study|Adverse Event|0|||
128697759|NCT00983437|463192200|FG000|Overall Study|Adverse Event|9|||
128697760|NCT00983437|463192200|FG000|Overall Study|Lack of Efficacy|1|||
128697761|NCT00983437|463192200|FG000|Overall Study|Withdrawal by Subject|8|||
128697762|NCT00983437|463192200|FG000|Overall Study|Noncompliance to Study Procedures|1|||
128697763|NCT00983437|463192200|FG000|Overall Study|Lost to Follow-up|2|||
128697764|NCT00983437|463192200|FG000|Overall Study|Other Reason|26|||
128697765|NCT01543958|463192201|FG000|Overall Study|Loss to follow-up|3|||
128697766|NCT01543958|463192201|FG000|Overall Study|ART initiation|1|||
128697767|NCT04019288|463192202|FG000|Overall Study|Death|1|||
128915601|NCT01773421|463982866|FG001|Extension Phase|Other|0|||
128915602|NCT01773421|463982867|FG002|Extension Phase|Other|0|||
128915603|NCT01773421|463982868|FG003|Extension Phase|Other|0|||
128915604|NCT01773421|463982869|FG004|Extension Phase|Other|1|||
128915605|NCT01773421|463982870|FG005|Extension Phase|Other|2|||
128915606|NCT01773421|463982871|FG006|Extension Phase|Other|0|||
128915607|NCT01773421|463982865|FG000|Extension Phase|Adverse Event|0|||
128915608|NCT01773421|463982866|FG001|Extension Phase|Adverse Event|0|||
128915609|NCT01773421|463982867|FG002|Extension Phase|Adverse Event|0|||
128915610|NCT01773421|463982868|FG003|Extension Phase|Adverse Event|0|||
128915611|NCT01773421|463982869|FG004|Extension Phase|Adverse Event|2|||
128915612|NCT01773421|463982870|FG005|Extension Phase|Adverse Event|0|||
129215834|NCT00068692|465092827|FG007|Step 2: Randomization|Adverse Event|4|||
128697768|NCT04019288|463192203|FG001|Overall Study|Death|0|||
128697769|NCT04019288|463192204|FG002|Overall Study|Death|0|||
128697770|NCT01945281|463192205|FG000|Overall Study|Adverse Event|1|||
128697771|NCT01945281|463192206|FG001|Overall Study|Adverse Event|0|||
128697772|NCT01945281|463192205|FG000|Overall Study|Death|3|||
128697773|NCT01945281|463192206|FG001|Overall Study|Death|3|||
128915613|NCT01773421|463982871|FG006|Extension Phase|Adverse Event|0|||
128915614|NCT03502330|463982872|FG000|Overall Study|Adverse Event|2|||
128697774|NCT01945281|463192205|FG000|Overall Study|Physician Decision|1|||
128697775|NCT01945281|463192206|FG001|Overall Study|Physician Decision|1|||
128697776|NCT01945281|463192205|FG000|Overall Study|Technical Problems|1|||
128697777|NCT01945281|463192206|FG001|Overall Study|Technical Problems|0|||
128697778|NCT04401423|463192208|FG000|Overall Study|Withdrawal by Subject|3|||
128697779|NCT04401423|463192209|FG001|Overall Study|Withdrawal by Subject|1|||
128915615|NCT03502330|463982873|FG001|Overall Study|Adverse Event|1|||
128915616|NCT03502330|463982874|FG002|Overall Study|Adverse Event|0|||
128915617|NCT03502330|463982875|FG003|Overall Study|Adverse Event|0|||
128915618|NCT03502330|463982876|FG004|Overall Study|Adverse Event|1|||
128915619|NCT03502330|463982877|FG005|Overall Study|Adverse Event|0|||
128915620|NCT03502330|463982878|FG006|Overall Study|Adverse Event|1|||
128915621|NCT03502330|463982879|FG007|Overall Study|Adverse Event|1|||
128915622|NCT03502330|463982880|FG008|Overall Study|Adverse Event|0|||
128915623|NCT03502330|463982872|FG000|Overall Study|Lack of Efficacy|1|||
128915624|NCT03502330|463982873|FG001|Overall Study|Lack of Efficacy|5|||
128915625|NCT03502330|463982874|FG002|Overall Study|Lack of Efficacy|3|||
128915626|NCT03502330|463982875|FG003|Overall Study|Lack of Efficacy|5|||
128915627|NCT03502330|463982876|FG004|Overall Study|Lack of Efficacy|1|||
128915628|NCT03502330|463982877|FG005|Overall Study|Lack of Efficacy|5|||
128915629|NCT03502330|463982878|FG006|Overall Study|Lack of Efficacy|5|||
128915630|NCT03502330|463982879|FG007|Overall Study|Lack of Efficacy|6|||
128915631|NCT03502330|463982880|FG008|Overall Study|Lack of Efficacy|0|||
128915632|NCT03502330|463982872|FG000|Overall Study|Physician Decision|0|||
128915633|NCT03502330|463982873|FG001|Overall Study|Physician Decision|0|||
128915634|NCT03502330|463982874|FG002|Overall Study|Physician Decision|0|||
128915635|NCT03502330|463982875|FG003|Overall Study|Physician Decision|0|||
128915636|NCT03502330|463982876|FG004|Overall Study|Physician Decision|1|||
128915637|NCT03502330|463982877|FG005|Overall Study|Physician Decision|0|||
128915638|NCT03502330|463982878|FG006|Overall Study|Physician Decision|0|||
128915639|NCT03502330|463982879|FG007|Overall Study|Physician Decision|0|||
128915640|NCT03502330|463982880|FG008|Overall Study|Physician Decision|0|||
128915641|NCT03502330|463982872|FG000|Overall Study|Withdrawal by Subject|0|||
128915642|NCT03502330|463982873|FG001|Overall Study|Withdrawal by Subject|0|||
128915643|NCT03502330|463982874|FG002|Overall Study|Withdrawal by Subject|0|||
128915644|NCT03502330|463982875|FG003|Overall Study|Withdrawal by Subject|0|||
128915645|NCT03502330|463982876|FG004|Overall Study|Withdrawal by Subject|0|||
128915646|NCT03502330|463982877|FG005|Overall Study|Withdrawal by Subject|1|||
128915647|NCT03502330|463982878|FG006|Overall Study|Withdrawal by Subject|0|||
128915648|NCT03502330|463982879|FG007|Overall Study|Withdrawal by Subject|1|||
128915649|NCT03502330|463982880|FG008|Overall Study|Withdrawal by Subject|0|||
128915650|NCT03502330|463982872|FG000|Overall Study|Death|0|||
128915651|NCT03502330|463982873|FG001|Overall Study|Death|0|||
128915652|NCT03502330|463982874|FG002|Overall Study|Death|0|||
128915653|NCT03502330|463982875|FG003|Overall Study|Death|0|||
128915654|NCT03502330|463982876|FG004|Overall Study|Death|0|||
128915655|NCT03502330|463982877|FG005|Overall Study|Death|0|||
128915656|NCT03502330|463982878|FG006|Overall Study|Death|2|||
128915657|NCT03502330|463982879|FG007|Overall Study|Death|0|||
128915658|NCT03502330|463982880|FG008|Overall Study|Death|0|||
128915659|NCT02804763|463982881|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
128915660|NCT02804763|463982882|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
128915661|NCT02804763|463982883|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
128915662|NCT02804763|463982884|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
128915663|NCT02804763|463982881|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
128915664|NCT02804763|463982882|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
129215835|NCT00068692|465092820|FG000|Step 2: Randomization|Death|0|||
129215836|NCT00068692|465092821|FG001|Step 2: Randomization|Death|0|||
129215837|NCT00068692|465092822|FG002|Step 2: Randomization|Death|0|||
128765685|NCT02508532|463433891|FG001|Part 2 - Treatment|Physician Decision|0|||
128915665|NCT02804763|463982883|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
128915666|NCT02804763|463982884|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
128915667|NCT02804763|463982881|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
128915668|NCT02804763|463982882|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
128915669|NCT02804763|463982883|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
128915670|NCT02804763|463982884|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
128697780|NCT04401423|463192208|FG000|Overall Study|Physician Decision|2|||
128697781|NCT04401423|463192209|FG001|Overall Study|Physician Decision|1|||
128915671|NCT02804763|463982881|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
128915672|NCT02804763|463982882|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
128915673|NCT02804763|463982883|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
128915674|NCT02804763|463982884|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
128915675|NCT02804763|463982881|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
128915676|NCT02804763|463982882|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
128915677|NCT02804763|463982883|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
128915678|NCT02804763|463982884|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
128915679|NCT02804763|463982881|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
128915680|NCT02804763|463982882|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
128915681|NCT02804763|463982883|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
128915682|NCT02804763|463982884|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
128915683|NCT04656990|463982885|FG000|Baseline|pandemic|20|||
128915684|NCT04656990|463982886|FG001|Baseline|pandemic|24|||
128915685|NCT04656990|463982885|FG000|Follow Up Period|Lost to Follow-up|61|||
128915686|NCT04656990|463982886|FG001|Follow Up Period|Lost to Follow-up|73|||
128915687|NCT00282243|463982887|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
128915688|NCT00282243|463982887|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
128915689|NCT00282243|463982887|FG000|Extension Treatment Period|Adverse Event|15|||
128915690|NCT00282243|463982887|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
128915691|NCT00282243|463982887|FG000|Extension Treatment Period|Non-compliance|2|||
128915692|NCT00282243|463982887|FG000|Extension Treatment Period|Physician Decision|1|||
128915693|NCT01070329|463982888|FG000|Overall Study|Adverse Event|13|||
128915694|NCT01070329|463982889|FG001|Overall Study|Adverse Event|10|||
128915695|NCT01070329|463982888|FG000|Overall Study|Lost to Follow-up|22|||
128697782|NCT00799383|463192214|FG000|Overall Study|Protocol Violation|1|||
128697783|NCT00799383|463192215|FG001|Overall Study|Protocol Violation|1|||
128697784|NCT00799383|463192214|FG000|Overall Study|Adverse Event|0|||
128697785|NCT00799383|463192215|FG001|Overall Study|Adverse Event|1|||
128697786|NCT00799383|463192214|FG000|Overall Study|Lost to Follow-up|1|||
128697787|NCT00799383|463192215|FG001|Overall Study|Lost to Follow-up|2|||
128697788|NCT00799383|463192214|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
128697789|NCT00799383|463192215|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
128697790|NCT00799383|463192214|FG000|Overall Study|Withdrawal by Subject|0|||
128697791|NCT00799383|463192215|FG001|Overall Study|Withdrawal by Subject|1|||
128697792|NCT00612040|463192224|FG000|Overall Study|Adverse Event|0|||
128697793|NCT00612040|463192225|FG001|Overall Study|Adverse Event|2|||
128915696|NCT01070329|463982889|FG001|Overall Study|Lost to Follow-up|12|||
128915697|NCT01070329|463982888|FG000|Overall Study|Withdrawal by Subject|9|||
128915698|NCT01070329|463982889|FG001|Overall Study|Withdrawal by Subject|11|||
128915699|NCT01070329|463982888|FG000|Overall Study|Protocol Violation|3|||
128915700|NCT01070329|463982889|FG001|Overall Study|Protocol Violation|8|||
128915701|NCT01070329|463982888|FG000|Overall Study|Lack of Efficacy|2|||
128915702|NCT01070329|463982889|FG001|Overall Study|Lack of Efficacy|6|||
128915703|NCT01070329|463982888|FG000|Overall Study|Physician Decision|2|||
128915704|NCT01070329|463982889|FG001|Overall Study|Physician Decision|1|||
128915705|NCT01070329|463982888|FG000|Overall Study|Entry Criteria Not Met|1|||
128915706|NCT01070329|463982889|FG001|Overall Study|Entry Criteria Not Met|0|||
128915707|NCT01070329|463982888|FG000|Overall Study|Sponsor Decision|0|||
128915708|NCT01070329|463982889|FG001|Overall Study|Sponsor Decision|1|||
128697794|NCT00612040|463192226|FG002|Overall Study|Adverse Event|1|||
128697795|NCT00612040|463192224|FG000|Overall Study|Protocol Violation|1|||
128697796|NCT00612040|463192225|FG001|Overall Study|Protocol Violation|2|||
128697797|NCT00612040|463192226|FG002|Overall Study|Protocol Violation|1|||
128697798|NCT00612040|463192224|FG000|Overall Study|Lack of Efficacy|2|||
128697799|NCT00612040|463192225|FG001|Overall Study|Lack of Efficacy|1|||
128697800|NCT00612040|463192226|FG002|Overall Study|Lack of Efficacy|0|||
128697801|NCT00612040|463192224|FG000|Overall Study|Unclassified|2|||
128697802|NCT00612040|463192225|FG001|Overall Study|Unclassified|2|||
128697803|NCT00612040|463192226|FG002|Overall Study|Unclassified|5|||
128697804|NCT00319553|463192227|FG000|Overall Study|Protocol Violation|1|||
128697805|NCT00319553|463192228|FG001|Overall Study|Protocol Violation|2|||
128697806|NCT00319553|463192227|FG000|Overall Study|Lost to Follow-up|2|||
128697807|NCT00319553|463192228|FG001|Overall Study|Lost to Follow-up|1|||
128915709|NCT02863848|463982890|FG000|Overall Study|Lost to Follow-up|1|||
128915710|NCT02863848|463982891|FG001|Overall Study|Lost to Follow-up|1|||
128915711|NCT02863848|463982890|FG000|Overall Study|Protocol Violation|1|||
128915712|NCT02863848|463982891|FG001|Overall Study|Protocol Violation|2|||
128915713|NCT03588741|463982896|FG000|Overall Study|Withdrawal by Subject|1|||
128697808|NCT00319553|463192227|FG000|Overall Study|Withdrawal by Subject|1|||
128915714|NCT00548548|463982897|FG000|Overall Study|Death|345|||
128915715|NCT00548548|463982898|FG001|Overall Study|Death|348|||
128915716|NCT00548548|463982897|FG000|Overall Study|Lost to Follow-up|17|||
128915717|NCT00548548|463982898|FG001|Overall Study|Lost to Follow-up|18|||
128915718|NCT01705691|463982899|FG000|Overall Study|Death|1|||
128915719|NCT01705691|463982900|FG001|Overall Study|Death|2|||
128915720|NCT01705691|463982899|FG000|Overall Study|Withdrawal by Subject|1|||
128915721|NCT01705691|463982900|FG001|Overall Study|Withdrawal by Subject|2|||
128915722|NCT01705691|463982899|FG000|Overall Study|Lost to Follow-up|1|||
128915723|NCT01705691|463982900|FG001|Overall Study|Lost to Follow-up|1|||
128915724|NCT01705691|463982899|FG000|Overall Study|Other|0|||
128915725|NCT01705691|463982900|FG001|Overall Study|Other|1|||
128915726|NCT02913313|463982901|FG000|Overall Study|DISEASE PROGRESSION|1|||
128915727|NCT02913313|463982902|FG001|Overall Study|DISEASE PROGRESSION|2|||
128915728|NCT02913313|463982903|FG002|Overall Study|DISEASE PROGRESSION|2|||
128915729|NCT02913313|463982904|FG003|Overall Study|DISEASE PROGRESSION|4|||
128915730|NCT02913313|463982905|FG004|Overall Study|DISEASE PROGRESSION|6|||
128915731|NCT02913313|463982906|FG005|Overall Study|DISEASE PROGRESSION|4|||
128915732|NCT02913313|463982907|FG006|Overall Study|DISEASE PROGRESSION|19|||
128915733|NCT02913313|463982908|FG007|Overall Study|DISEASE PROGRESSION|3|||
128915734|NCT02913313|463982909|FG008|Overall Study|DISEASE PROGRESSION|4|||
128697809|NCT00319553|463192228|FG001|Overall Study|Withdrawal by Subject|1|||
128915735|NCT02913313|463982910|FG009|Overall Study|DISEASE PROGRESSION|4|||
128915736|NCT02913313|463982911|FG010|Overall Study|DISEASE PROGRESSION|11|||
128915737|NCT02913313|463982912|FG011|Overall Study|DISEASE PROGRESSION|5|||
128915738|NCT02913313|463982913|FG012|Overall Study|DISEASE PROGRESSION|14|||
128697810|NCT01281865|463192237|FG000|Overall Study|Adverse Event|1|||
128697811|NCT01281865|463192238|FG001|Overall Study|Adverse Event|1|||
128697812|NCT01281865|463192237|FG000|Overall Study|Withdrawal by Subject|1|||
128697813|NCT01281865|463192238|FG001|Overall Study|Withdrawal by Subject|0|||
128697814|NCT01281865|463192237|FG000|Overall Study|Lack of Efficacy|1|||
128697815|NCT01281865|463192238|FG001|Overall Study|Lack of Efficacy|0|||
128697816|NCT02747875|463192239|FG000|Overall Study|Physician Decision|1|||
128697817|NCT02747875|463192240|FG001|Overall Study|Physician Decision|0|||
128697818|NCT02747875|463192239|FG000|Overall Study|Adverse Event|0|||
128697819|NCT02747875|463192240|FG001|Overall Study|Adverse Event|1|||
128697820|NCT03478657|463192241|FG000|Overall Study|Withdrawal by Subject|0|||
128697821|NCT03478657|463192242|FG001|Overall Study|Withdrawal by Subject|1|||
128697822|NCT02590003|463192243|FG000|Overall Study|Death|1|||
128697823|NCT02590003|463192244|FG001|Overall Study|Death|2|||
128697824|NCT01702805|463192245|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
128697825|NCT01702805|463192246|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
128697826|NCT01702805|463192245|FG000|Overall Study|Incomplete Follow-up|18|||
128697827|NCT01702805|463192246|FG001|Overall Study|Incomplete Follow-up|15|||
128697828|NCT01702805|463192245|FG000|Overall Study|Vital Status Assessment Only|40|||
128697829|NCT01702805|463192246|FG001|Overall Study|Vital Status Assessment Only|39|||
128697830|NCT01702805|463192245|FG000|Overall Study|Lost to Follow-up|5|||
128697831|NCT01702805|463192246|FG001|Overall Study|Lost to Follow-up|5|||
128697832|NCT01849783|463192247|FG000|Overall Study|Adverse Event|5|||
128697833|NCT01849783|463192247|FG000|Overall Study|Death|2|||
128697834|NCT01849783|463192247|FG000|Overall Study|Physician Decision|1|||
128697835|NCT01849783|463192247|FG000|Overall Study|Withdrawal by Subject|1|||
128697836|NCT01849783|463192247|FG000|Overall Study|Unable to comply|2|||
128697837|NCT01849783|463192247|FG000|Overall Study|Disease progression|11|||
128697838|NCT03948581|463192248|FG000|Overall Study|Lost to Follow-up|0|||
128697839|NCT03948581|463192249|FG001|Overall Study|Lost to Follow-up|1|||
128697840|NCT04457336|463192252|FG000|Period 2: Part A|Withdrawal by Subject|0|||
128697841|NCT04457336|463192253|FG001|Period 2: Part A|Withdrawal by Subject|1|||
128697842|NCT04457336|463192254|FG002|Period 2: Part A|Withdrawal by Subject|1|||
128697843|NCT04457336|463192255|FG003|Period 2: Part A|Withdrawal by Subject|1|||
128697844|NCT04457336|463192256|FG004|Period 2: Part A|Withdrawal by Subject|0|||
128697845|NCT04457336|463192257|FG005|Period 2: Part A|Withdrawal by Subject|0|||
128697846|NCT04457336|463192258|FG006|Period 2: Part A|Withdrawal by Subject|0|||
128697847|NCT04457336|463192259|FG007|Period 2: Part A|Withdrawal by Subject|0|||
128697848|NCT04457336|463192252|FG000|Period 2: Part A|Adverse Event|0|||
128697849|NCT04457336|463192253|FG001|Period 2: Part A|Adverse Event|0|||
128697850|NCT04457336|463192254|FG002|Period 2: Part A|Adverse Event|1|||
128697851|NCT04457336|463192255|FG003|Period 2: Part A|Adverse Event|1|||
128697852|NCT04457336|463192256|FG004|Period 2: Part A|Adverse Event|0|||
128915739|NCT02913313|463982914|FG013|Overall Study|DISEASE PROGRESSION|3|||
128915740|NCT02913313|463982901|FG000|Overall Study|Not Reported|0|||
128697853|NCT04457336|463192257|FG005|Period 2: Part A|Adverse Event|0|||
128697854|NCT04457336|463192258|FG006|Period 2: Part A|Adverse Event|0|||
128697855|NCT04457336|463192259|FG007|Period 2: Part A|Adverse Event|0|||
128697856|NCT04457336|463192252|FG000|Period 2: Part A|Study Terminated|0|||
128697857|NCT04457336|463192253|FG001|Period 2: Part A|Study Terminated|0|||
128697858|NCT04457336|463192254|FG002|Period 2: Part A|Study Terminated|1|||
128697859|NCT04457336|463192255|FG003|Period 2: Part A|Study Terminated|0|||
128697860|NCT04457336|463192256|FG004|Period 2: Part A|Study Terminated|0|||
128697861|NCT04457336|463192257|FG005|Period 2: Part A|Study Terminated|0|||
128915741|NCT02913313|463982902|FG001|Overall Study|Not Reported|0|||
128697862|NCT04457336|463192258|FG006|Period 2: Part A|Study Terminated|0|||
128915742|NCT02913313|463982903|FG002|Overall Study|Not Reported|0|||
128915743|NCT02913313|463982904|FG003|Overall Study|Not Reported|0|||
128915744|NCT02913313|463982905|FG004|Overall Study|Not Reported|1|||
128915745|NCT02913313|463982906|FG005|Overall Study|Not Reported|0|||
128915746|NCT02913313|463982907|FG006|Overall Study|Not Reported|0|||
128915747|NCT02913313|463982908|FG007|Overall Study|Not Reported|0|||
128915748|NCT02913313|463982909|FG008|Overall Study|Not Reported|0|||
128915749|NCT02913313|463982910|FG009|Overall Study|Not Reported|0|||
128915750|NCT02913313|463982911|FG010|Overall Study|Not Reported|4|||
128915751|NCT02913313|463982912|FG011|Overall Study|Not Reported|0|||
128915752|NCT02913313|463982913|FG012|Overall Study|Not Reported|0|||
128915753|NCT02913313|463982914|FG013|Overall Study|Not Reported|0|||
128915754|NCT02913313|463982901|FG000|Overall Study|Other reasons|0|||
128915755|NCT02913313|463982902|FG001|Overall Study|Other reasons|0|||
128915756|NCT02913313|463982903|FG002|Overall Study|Other reasons|0|||
128915757|NCT02913313|463982904|FG003|Overall Study|Other reasons|0|||
128915758|NCT02913313|463982905|FG004|Overall Study|Other reasons|1|||
128915759|NCT02913313|463982906|FG005|Overall Study|Other reasons|0|||
128915760|NCT02913313|463982907|FG006|Overall Study|Other reasons|0|||
128915761|NCT02913313|463982908|FG007|Overall Study|Other reasons|0|||
128915762|NCT02913313|463982909|FG008|Overall Study|Other reasons|0|||
128915763|NCT02913313|463982910|FG009|Overall Study|Other reasons|0|||
128915764|NCT02913313|463982911|FG010|Overall Study|Other reasons|1|||
128915765|NCT02913313|463982912|FG011|Overall Study|Other reasons|0|||
128915766|NCT02913313|463982913|FG012|Overall Study|Other reasons|0|||
128915767|NCT02913313|463982914|FG013|Overall Study|Other reasons|0|||
128915768|NCT02913313|463982901|FG000|Overall Study|Withdrawal by Subject|0|||
128915769|NCT02913313|463982902|FG001|Overall Study|Withdrawal by Subject|0|||
128915770|NCT02913313|463982903|FG002|Overall Study|Withdrawal by Subject|1|||
128915771|NCT02913313|463982904|FG003|Overall Study|Withdrawal by Subject|0|||
128915772|NCT02913313|463982905|FG004|Overall Study|Withdrawal by Subject|0|||
128915773|NCT02913313|463982906|FG005|Overall Study|Withdrawal by Subject|0|||
128915774|NCT02913313|463982907|FG006|Overall Study|Withdrawal by Subject|1|||
128915775|NCT02913313|463982908|FG007|Overall Study|Withdrawal by Subject|1|||
128915776|NCT02913313|463982909|FG008|Overall Study|Withdrawal by Subject|0|||
128915777|NCT02913313|463982910|FG009|Overall Study|Withdrawal by Subject|0|||
128915778|NCT02913313|463982911|FG010|Overall Study|Withdrawal by Subject|1|||
128915779|NCT02913313|463982912|FG011|Overall Study|Withdrawal by Subject|0|||
128915780|NCT02913313|463982913|FG012|Overall Study|Withdrawal by Subject|0|||
128915781|NCT02913313|463982914|FG013|Overall Study|Withdrawal by Subject|0|||
128915782|NCT02913313|463982901|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915783|NCT02913313|463982902|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915784|NCT02913313|463982903|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915785|NCT02913313|463982904|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915786|NCT02913313|463982905|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915787|NCT02913313|463982906|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915788|NCT02913313|463982907|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915789|NCT02913313|463982908|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915790|NCT02913313|463982909|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915791|NCT02913313|463982910|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915792|NCT02913313|463982911|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
128915793|NCT02913313|463982912|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
128915794|NCT02913313|463982913|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
128915795|NCT02913313|463982914|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
128915796|NCT02913313|463982901|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
128915797|NCT02913313|463982902|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
128915798|NCT02913313|463982903|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
128915799|NCT02913313|463982904|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
128915800|NCT02913313|463982905|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
128915801|NCT02913313|463982906|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
128915802|NCT02913313|463982907|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
128915803|NCT02913313|463982908|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
128915804|NCT02913313|463982909|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
128915805|NCT02913313|463982910|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
128915806|NCT02913313|463982911|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
128915807|NCT02913313|463982912|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
128915808|NCT02913313|463982913|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
128915809|NCT02913313|463982914|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
128915810|NCT04088409|463982915|FG000|Part A|Withdrawal by Subject|2|||
128915811|NCT04088409|463982916|FG001|Part A|Withdrawal by Subject|1|||
128915812|NCT04088409|463982915|FG000|Part A|Did Not Meet Randomization Criteria|2|||
128915813|NCT04088409|463982916|FG001|Part A|Did Not Meet Randomization Criteria|0|||
128915814|NCT04088409|463982915|FG000|Part A|Lack of Efficacy|9|||
128915815|NCT04088409|463982916|FG001|Part A|Lack of Efficacy|0|||
128915816|NCT04088409|463982915|FG000|Part A|Lost to Follow-up|1|||
128915817|NCT04088409|463982916|FG001|Part A|Lost to Follow-up|0|||
128915818|NCT04088409|463982915|FG000|Part A|Adverse Event|1|||
128915819|NCT04088409|463982916|FG001|Part A|Adverse Event|0|||
129028958|NCT01131260|464396464|FG001|Overall Study|Declined to continue participation|13|||
129028959|NCT01131260|464396463|FG000|Overall Study|Physician Decision|22|||
129028960|NCT01131260|464396464|FG001|Overall Study|Physician Decision|24|||
128915820|NCT04088409|463982915|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
128915821|NCT04088409|463982916|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
128915822|NCT04088409|463982915|FG000|Part B|Ongoing Treatment|10|||
128915823|NCT04088409|463982916|FG001|Part B|Ongoing Treatment|0|||
128915824|NCT04233229|463982917|FG000|Overall Study|Withdrawal by Subject|0|||
128915825|NCT04233229|463982918|FG001|Overall Study|Withdrawal by Subject|1|||
128915826|NCT04233229|463982917|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
128915827|NCT04233229|463982918|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
128915828|NCT04233229|463982917|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
128915829|NCT04233229|463982918|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
128915830|NCT02614079|463982921|FG000|Overall Study|Withdrawal by Subject|1|||
128915831|NCT03370770|463982922|FG000|Overall Study|Patient was followed in another hospital center|1|||
128915832|NCT03370770|463982922|FG000|Overall Study|Progressive Disease|98|||
128915833|NCT03370770|463982922|FG000|Overall Study|Adverse Event|2|||
128915834|NCT03370770|463982922|FG000|Overall Study|Death|5|||
128915835|NCT04426695|463982925|FG000|Overall Study|Death|2|||
128915836|NCT04426695|463982926|FG001|Overall Study|Death|0|||
128915837|NCT04426695|463982927|FG002|Overall Study|Death|1|||
128915838|NCT04426695|463982928|FG003|Overall Study|Death|27|||
128915839|NCT04426695|463982929|FG004|Overall Study|Death|25|||
128915840|NCT04426695|463982930|FG005|Overall Study|Death|21|||
128915841|NCT04426695|463982931|FG006|Overall Study|Death|42|||
128915842|NCT04426695|463982932|FG007|Overall Study|Death|23|||
128915843|NCT04426695|463982933|FG008|Overall Study|Death|37|||
128915844|NCT04426695|463982934|FG009|Overall Study|Death|14|||
128915845|NCT04426695|463982935|FG010|Overall Study|Death|8|||
128915846|NCT04426695|463982936|FG011|Overall Study|Death|7|||
128915847|NCT04426695|463982937|FG012|Overall Study|Death|13|||
128915848|NCT04426695|463982938|FG013|Overall Study|Death|25|||
128915849|NCT04426695|463982939|FG014|Overall Study|Death|19|||
128915850|NCT04426695|463982940|FG015|Overall Study|Death|7|||
128915851|NCT04426695|463982941|FG016|Overall Study|Death|8|||
128915852|NCT04426695|463982942|FG017|Overall Study|Death|4|||
128915853|NCT04426695|463982925|FG000|Overall Study|Lost to Follow-up|2|||
128915854|NCT04426695|463982926|FG001|Overall Study|Lost to Follow-up|4|||
128915855|NCT04426695|463982927|FG002|Overall Study|Lost to Follow-up|1|||
128915856|NCT04426695|463982928|FG003|Overall Study|Lost to Follow-up|19|||
128915857|NCT04426695|463982929|FG004|Overall Study|Lost to Follow-up|10|||
128915858|NCT04426695|463982930|FG005|Overall Study|Lost to Follow-up|14|||
128915859|NCT04426695|463982931|FG006|Overall Study|Lost to Follow-up|5|||
128915860|NCT04426695|463982932|FG007|Overall Study|Lost to Follow-up|14|||
128915861|NCT04426695|463982933|FG008|Overall Study|Lost to Follow-up|10|||
128915862|NCT04426695|463982934|FG009|Overall Study|Lost to Follow-up|11|||
128915863|NCT04426695|463982935|FG010|Overall Study|Lost to Follow-up|12|||
128915864|NCT04426695|463982936|FG011|Overall Study|Lost to Follow-up|6|||
128915865|NCT04426695|463982937|FG012|Overall Study|Lost to Follow-up|2|||
128915866|NCT04426695|463982938|FG013|Overall Study|Lost to Follow-up|2|||
128915867|NCT04426695|463982939|FG014|Overall Study|Lost to Follow-up|2|||
128915868|NCT04426695|463982940|FG015|Overall Study|Lost to Follow-up|0|||
128915869|NCT04426695|463982941|FG016|Overall Study|Lost to Follow-up|0|||
128915870|NCT04426695|463982942|FG017|Overall Study|Lost to Follow-up|0|||
128915871|NCT04426695|463982925|FG000|Overall Study|Participant Decision|1|||
128915872|NCT04426695|463982926|FG001|Overall Study|Participant Decision|2|||
128915873|NCT04426695|463982927|FG002|Overall Study|Participant Decision|2|||
128915874|NCT04426695|463982928|FG003|Overall Study|Participant Decision|12|||
128915875|NCT04426695|463982929|FG004|Overall Study|Participant Decision|18|||
128915876|NCT04426695|463982930|FG005|Overall Study|Participant Decision|22|||
128915877|NCT04426695|463982931|FG006|Overall Study|Participant Decision|13|||
128697863|NCT04457336|463192259|FG007|Period 2: Part A|Study Terminated|0|||
128697864|NCT04457336|463192252|FG000|Period 2: Part A|Protocol Violation|0|||
128697865|NCT04457336|463192253|FG001|Period 2: Part A|Protocol Violation|1|||
128697866|NCT04457336|463192254|FG002|Period 2: Part A|Protocol Violation|0|||
128697867|NCT04457336|463192255|FG003|Period 2: Part A|Protocol Violation|0|||
128697868|NCT04457336|463192256|FG004|Period 2: Part A|Protocol Violation|0|||
128697869|NCT04457336|463192257|FG005|Period 2: Part A|Protocol Violation|0|||
128915878|NCT04426695|463982932|FG007|Overall Study|Participant Decision|13|||
128915879|NCT04426695|463982933|FG008|Overall Study|Participant Decision|10|||
128915880|NCT04426695|463982934|FG009|Overall Study|Participant Decision|15|||
128915881|NCT04426695|463982935|FG010|Overall Study|Participant Decision|16|||
128915882|NCT04426695|463982936|FG011|Overall Study|Participant Decision|17|||
128915883|NCT04426695|463982937|FG012|Overall Study|Participant Decision|2|||
128915884|NCT04426695|463982938|FG013|Overall Study|Participant Decision|1|||
128915885|NCT04426695|463982939|FG014|Overall Study|Participant Decision|2|||
128697870|NCT04457336|463192258|FG006|Period 2: Part A|Protocol Violation|0|||
128915886|NCT04426695|463982940|FG015|Overall Study|Participant Decision|0|||
128915887|NCT04426695|463982941|FG016|Overall Study|Participant Decision|0|||
128915888|NCT04426695|463982942|FG017|Overall Study|Participant Decision|0|||
128915889|NCT04426695|463982925|FG000|Overall Study|Adverse Event|0|||
128915890|NCT04426695|463982926|FG001|Overall Study|Adverse Event|0|||
128915891|NCT04426695|463982927|FG002|Overall Study|Adverse Event|0|||
128915892|NCT04426695|463982928|FG003|Overall Study|Adverse Event|0|||
128915893|NCT04426695|463982929|FG004|Overall Study|Adverse Event|0|||
128915894|NCT04426695|463982930|FG005|Overall Study|Adverse Event|0|||
128915895|NCT04426695|463982931|FG006|Overall Study|Adverse Event|0|||
128915896|NCT04426695|463982932|FG007|Overall Study|Adverse Event|1|||
128915897|NCT04426695|463982933|FG008|Overall Study|Adverse Event|0|||
128915898|NCT04426695|463982934|FG009|Overall Study|Adverse Event|0|||
128915899|NCT04426695|463982935|FG010|Overall Study|Adverse Event|1|||
128915900|NCT04426695|463982936|FG011|Overall Study|Adverse Event|1|||
128915901|NCT04426695|463982937|FG012|Overall Study|Adverse Event|0|||
128915902|NCT04426695|463982938|FG013|Overall Study|Adverse Event|0|||
128915903|NCT04426695|463982939|FG014|Overall Study|Adverse Event|0|||
128915904|NCT04426695|463982940|FG015|Overall Study|Adverse Event|0|||
128915905|NCT04426695|463982941|FG016|Overall Study|Adverse Event|0|||
128915906|NCT04426695|463982942|FG017|Overall Study|Adverse Event|0|||
128915907|NCT04426695|463982925|FG000|Overall Study|Sponsor Request|0|||
128915908|NCT04426695|463982926|FG001|Overall Study|Sponsor Request|0|||
128915909|NCT04426695|463982927|FG002|Overall Study|Sponsor Request|0|||
128915910|NCT04426695|463982928|FG003|Overall Study|Sponsor Request|0|||
128915911|NCT04426695|463982929|FG004|Overall Study|Sponsor Request|0|||
128915912|NCT04426695|463982930|FG005|Overall Study|Sponsor Request|0|||
128915913|NCT04426695|463982931|FG006|Overall Study|Sponsor Request|1|||
128915914|NCT04426695|463982932|FG007|Overall Study|Sponsor Request|0|||
128915915|NCT04426695|463982933|FG008|Overall Study|Sponsor Request|0|||
128915916|NCT04426695|463982934|FG009|Overall Study|Sponsor Request|0|||
128915917|NCT04426695|463982935|FG010|Overall Study|Sponsor Request|0|||
128915918|NCT04426695|463982936|FG011|Overall Study|Sponsor Request|0|||
128915919|NCT04426695|463982937|FG012|Overall Study|Sponsor Request|0|||
128915920|NCT04426695|463982938|FG013|Overall Study|Sponsor Request|0|||
128915921|NCT04426695|463982939|FG014|Overall Study|Sponsor Request|0|||
128915922|NCT04426695|463982940|FG015|Overall Study|Sponsor Request|0|||
128915923|NCT04426695|463982941|FG016|Overall Study|Sponsor Request|0|||
128915924|NCT04426695|463982942|FG017|Overall Study|Sponsor Request|0|||
128915925|NCT04426695|463982925|FG000|Overall Study|Physician Decision|0|||
128915926|NCT04426695|463982926|FG001|Overall Study|Physician Decision|0|||
128915927|NCT04426695|463982927|FG002|Overall Study|Physician Decision|0|||
128915928|NCT04426695|463982928|FG003|Overall Study|Physician Decision|0|||
128915929|NCT04426695|463982929|FG004|Overall Study|Physician Decision|0|||
128915930|NCT04426695|463982930|FG005|Overall Study|Physician Decision|0|||
128915931|NCT04426695|463982931|FG006|Overall Study|Physician Decision|0|||
128915932|NCT04426695|463982932|FG007|Overall Study|Physician Decision|0|||
128915933|NCT04426695|463982933|FG008|Overall Study|Physician Decision|0|||
128915934|NCT04426695|463982934|FG009|Overall Study|Physician Decision|1|||
128915935|NCT04426695|463982935|FG010|Overall Study|Physician Decision|0|||
128915936|NCT04426695|463982936|FG011|Overall Study|Physician Decision|0|||
128915937|NCT04426695|463982937|FG012|Overall Study|Physician Decision|1|||
128915938|NCT04426695|463982938|FG013|Overall Study|Physician Decision|0|||
128915939|NCT04426695|463982939|FG014|Overall Study|Physician Decision|0|||
128915940|NCT04426695|463982940|FG015|Overall Study|Physician Decision|0|||
128915941|NCT04426695|463982941|FG016|Overall Study|Physician Decision|0|||
128915942|NCT04426695|463982942|FG017|Overall Study|Physician Decision|0|||
128915943|NCT04426695|463982925|FG000|Overall Study|Randomized but Never Treated|3|||
128915944|NCT04426695|463982926|FG001|Overall Study|Randomized but Never Treated|1|||
128915945|NCT04426695|463982927|FG002|Overall Study|Randomized but Never Treated|0|||
128915946|NCT04426695|463982928|FG003|Overall Study|Randomized but Never Treated|4|||
129215838|NCT00068692|465092823|FG003|Step 2: Randomization|Death|0|||
128765686|NCT02508532|463433892|FG002|Part 2 - Treatment|Physician Decision|0|||
128765687|NCT02508532|463433893|FG003|Part 2 - Treatment|Physician Decision|0|||
128765688|NCT02508532|463433894|FG004|Part 2 - Treatment|Physician Decision|0|||
128765689|NCT02508532|463433895|FG005|Part 2 - Treatment|Physician Decision|0|||
128765690|NCT02508532|463433896|FG006|Part 2 - Treatment|Physician Decision|0|||
128915947|NCT04426695|463982929|FG004|Overall Study|Randomized but Never Treated|5|||
128915948|NCT04426695|463982930|FG005|Overall Study|Randomized but Never Treated|5|||
128915949|NCT04426695|463982931|FG006|Overall Study|Randomized but Never Treated|4|||
128915950|NCT04426695|463982932|FG007|Overall Study|Randomized but Never Treated|6|||
128915951|NCT04426695|463982933|FG008|Overall Study|Randomized but Never Treated|6|||
128915952|NCT04426695|463982934|FG009|Overall Study|Randomized but Never Treated|3|||
128915953|NCT04426695|463982935|FG010|Overall Study|Randomized but Never Treated|3|||
128915954|NCT04426695|463982936|FG011|Overall Study|Randomized but Never Treated|6|||
128915955|NCT04426695|463982937|FG012|Overall Study|Randomized but Never Treated|1|||
128915956|NCT04426695|463982938|FG013|Overall Study|Randomized but Never Treated|2|||
128915957|NCT04426695|463982939|FG014|Overall Study|Randomized but Never Treated|0|||
128915958|NCT04426695|463982940|FG015|Overall Study|Randomized but Never Treated|0|||
128915959|NCT04426695|463982941|FG016|Overall Study|Randomized but Never Treated|0|||
128915960|NCT04426695|463982942|FG017|Overall Study|Randomized but Never Treated|0|||
128915961|NCT01552681|463982943|FG000|Overall Study|Withdrawal by Subject|4|||
128915962|NCT01552681|463982944|FG001|Overall Study|Withdrawal by Subject|0|||
128915963|NCT01552681|463982943|FG000|Overall Study|Physician Decision|1|||
128915964|NCT01552681|463982944|FG001|Overall Study|Physician Decision|0|||
128915965|NCT01552681|463982943|FG000|Overall Study|Subject moved away|0|||
128915966|NCT01552681|463982944|FG001|Overall Study|Subject moved away|1|||
128915967|NCT03882424|463982945|FG000|Overall Study|Lost to Follow-up|3|||
128915968|NCT03882424|463982946|FG001|Overall Study|Lost to Follow-up|0|||
128915969|NCT03882424|463982947|FG002|Overall Study|Lost to Follow-up|0|||
128915970|NCT03882424|463982945|FG000|Overall Study|schedule conflict|1|||
128915971|NCT03882424|463982946|FG001|Overall Study|schedule conflict|0|||
128915972|NCT03882424|463982947|FG002|Overall Study|schedule conflict|0|||
128915973|NCT00236080|463982948|FG000|Overall Study|Adverse Event|0|||
128915974|NCT00236080|463982949|FG001|Overall Study|Adverse Event|0|||
128915975|NCT00236080|463982950|FG002|Overall Study|Adverse Event|3|||
128915976|NCT00236080|463982951|FG003|Overall Study|Adverse Event|1|||
128915977|NCT00236080|463982952|FG004|Overall Study|Adverse Event|0|||
128915978|NCT00236080|463982948|FG000|Overall Study|Lost to Follow-up|0|||
128915979|NCT00236080|463982949|FG001|Overall Study|Lost to Follow-up|1|||
128915980|NCT00236080|463982950|FG002|Overall Study|Lost to Follow-up|0|||
128915981|NCT00236080|463982951|FG003|Overall Study|Lost to Follow-up|0|||
128915982|NCT00236080|463982952|FG004|Overall Study|Lost to Follow-up|0|||
128915983|NCT00236080|463982948|FG000|Overall Study|Physician Decision|1|||
128915984|NCT00236080|463982949|FG001|Overall Study|Physician Decision|0|||
128915985|NCT00236080|463982950|FG002|Overall Study|Physician Decision|1|||
128915986|NCT00236080|463982951|FG003|Overall Study|Physician Decision|1|||
128915987|NCT00236080|463982952|FG004|Overall Study|Physician Decision|1|||
128915988|NCT00236080|463982948|FG000|Overall Study|Withdrawal by Subject|1|||
128915989|NCT00236080|463982949|FG001|Overall Study|Withdrawal by Subject|0|||
128915990|NCT00236080|463982950|FG002|Overall Study|Withdrawal by Subject|0|||
128915991|NCT00236080|463982951|FG003|Overall Study|Withdrawal by Subject|0|||
128915992|NCT00236080|463982952|FG004|Overall Study|Withdrawal by Subject|0|||
128915993|NCT00236080|463982948|FG000|Overall Study|Miscellaneous|0|||
128915994|NCT00236080|463982949|FG001|Overall Study|Miscellaneous|0|||
128915995|NCT00236080|463982950|FG002|Overall Study|Miscellaneous|1|||
128915996|NCT00236080|463982951|FG003|Overall Study|Miscellaneous|0|||
128915997|NCT00236080|463982952|FG004|Overall Study|Miscellaneous|0|||
128915998|NCT00130286|463982960|FG000|Overall Study|Withdrawal by Subject|0|||
128915999|NCT00130286|463982961|FG001|Overall Study|Withdrawal by Subject|1|||
128916000|NCT00130286|463982962|FG002|Overall Study|Withdrawal by Subject|2|||
129028961|NCT01131260|464396463|FG000|Overall Study|Technical problems|7|||
129028962|NCT01131260|464396464|FG001|Overall Study|Technical problems|6|||
129028963|NCT01131260|464396463|FG000|Overall Study|Staff error|2|||
129028964|NCT01131260|464396464|FG001|Overall Study|Staff error|1|||
129028965|NCT01131260|464396463|FG000|Overall Study|Ineligible|0|||
129028966|NCT01131260|464396464|FG001|Overall Study|Ineligible|2|||
129028967|NCT00757172|464396465|FG000|Overall Study|Withdrawal by Subject|4|||
129028968|NCT00757172|464396465|FG000|Overall Study|Physician Decision|3|||
129028969|NCT00757172|464396465|FG000|Overall Study|Progression|4|||
129028970|NCT03555695|464396466|FG000|Overall Study|Withdrawal by Subject|1|||
129028971|NCT03555695|464396466|FG000|Overall Study|Lost to Follow-up|1|||
129028972|NCT03555695|464396466|FG000|Overall Study|appendicitis (unrelated)|1|||
129028973|NCT03555695|464396466|FG000|Overall Study|pre-existing sciatica|1|||
129028974|NCT03247686|464398299|FG000|Overall Study|Withdrawal by Subject|1|||
129028975|NCT03247686|464398300|FG001|Overall Study|Withdrawal by Subject|2|||
129028976|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
129028977|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
129028978|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
129028979|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
129028980|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
129028981|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
129028982|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
129028983|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
129028984|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
129028985|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
129028986|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
128916001|NCT00130286|463982963|FG003|Overall Study|Withdrawal by Subject|2|||
128916002|NCT00130286|463982960|FG000|Overall Study|Adverse Event|0|||
128916003|NCT00130286|463982961|FG001|Overall Study|Adverse Event|0|||
128916004|NCT00130286|463982962|FG002|Overall Study|Adverse Event|2|||
128916005|NCT00130286|463982963|FG003|Overall Study|Adverse Event|0|||
128916006|NCT00130286|463982960|FG000|Overall Study|Missing lab specimens|0|||
128916007|NCT00130286|463982961|FG001|Overall Study|Missing lab specimens|2|||
128916008|NCT00130286|463982962|FG002|Overall Study|Missing lab specimens|0|||
128916009|NCT00130286|463982963|FG003|Overall Study|Missing lab specimens|0|||
128916010|NCT02154425|463982964|FG000|Screening Period|Adverse Event|1|||
128916011|NCT00773279|463982971|FG000|Period 1|Adverse Event|2|||
128697871|NCT04457336|463192259|FG007|Period 2: Part A|Protocol Violation|0|||
128697872|NCT04457336|463192252|FG000|Period 2: Part A|Lost to Follow-up|0|||
128697873|NCT04457336|463192253|FG001|Period 2: Part A|Lost to Follow-up|1|||
128697874|NCT04457336|463192254|FG002|Period 2: Part A|Lost to Follow-up|0|||
128697875|NCT04457336|463192255|FG003|Period 2: Part A|Lost to Follow-up|0|||
128697876|NCT04457336|463192256|FG004|Period 2: Part A|Lost to Follow-up|0|||
128697877|NCT04457336|463192257|FG005|Period 2: Part A|Lost to Follow-up|0|||
128697878|NCT04457336|463192258|FG006|Period 2: Part A|Lost to Follow-up|0|||
128697879|NCT04457336|463192259|FG007|Period 2: Part A|Lost to Follow-up|0|||
128697880|NCT04457336|463192252|FG000|Period 2: Part A|Other|0|||
128697881|NCT04457336|463192253|FG001|Period 2: Part A|Other|1|||
128697882|NCT04457336|463192254|FG002|Period 2: Part A|Other|0|||
128697883|NCT04457336|463192255|FG003|Period 2: Part A|Other|0|||
128697884|NCT04457336|463192256|FG004|Period 2: Part A|Other|0|||
128697885|NCT04457336|463192257|FG005|Period 2: Part A|Other|0|||
128697886|NCT04457336|463192258|FG006|Period 2: Part A|Other|0|||
128765691|NCT02508532|463433897|FG007|Part 2 - Treatment|Physician Decision|0|||
128765692|NCT02508532|463433898|FG008|Part 2 - Treatment|Physician Decision|12|||
128765693|NCT02508532|463433890|FG000|Part 2 - Treatment|Administrative|0|||
128765694|NCT02508532|463433891|FG001|Part 2 - Treatment|Administrative|0|||
128765695|NCT02508532|463433892|FG002|Part 2 - Treatment|Administrative|0|||
128916012|NCT00773279|463982972|FG001|Period 1|Adverse Event|1|||
128916013|NCT00773279|463982971|FG000|Period 1|Lack of Efficacy|0|||
128916014|NCT00773279|463982972|FG001|Period 1|Lack of Efficacy|2|||
128916015|NCT00773279|463982971|FG000|Period 1|Unclassified|5|||
128916016|NCT00773279|463982972|FG001|Period 1|Unclassified|1|||
128916017|NCT00773279|463982971|FG000|Period 2|Adverse Event|0|||
128916018|NCT00773279|463982972|FG001|Period 2|Adverse Event|1|||
128916019|NCT00773279|463982971|FG000|Period 2|Lack of Efficacy|1|||
128916020|NCT00773279|463982972|FG001|Period 2|Lack of Efficacy|0|||
128916021|NCT00773279|463982971|FG000|Period 2|Protocol Violation|0|||
128916022|NCT00773279|463982972|FG001|Period 2|Protocol Violation|3|||
128916023|NCT00773279|463982971|FG000|Period 2|Unclassified|2|||
128916024|NCT00773279|463982972|FG001|Period 2|Unclassified|2|||
128916025|NCT02908516|463982973|FG000|Overall Study|Study Terminated|3|||
128916026|NCT02908516|463982974|FG001|Overall Study|Study Terminated|3|||
128916027|NCT02251912|463982975|FG000|Overall Study|Withdrawal by Subject|2|||
128916028|NCT02251912|463982976|FG001|Overall Study|Withdrawal by Subject|3|||
128916029|NCT02251912|463982975|FG000|Overall Study|Adverse Event|0|||
128916030|NCT02251912|463982976|FG001|Overall Study|Adverse Event|2|||
128916031|NCT00480857|463982977|FG000|Overall Study|Lack of Efficacy|2|||
128916032|NCT01107444|463982978|FG000|Overall Study|Withdrawal by Subject|8|||
128916033|NCT01107444|463982979|FG001|Overall Study|Withdrawal by Subject|12|||
128916034|NCT01107444|463982978|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
128916035|NCT01107444|463982979|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
128916036|NCT01948830|463982980|FG000|Overall Study|Physician Decision|1|||
128916037|NCT01948830|463982981|FG001|Overall Study|Physician Decision|3|||
128916038|NCT01948830|463982980|FG000|Overall Study|Protocol deviation|1|||
128916039|NCT01948830|463982981|FG001|Overall Study|Protocol deviation|2|||
128916040|NCT01948830|463982980|FG000|Overall Study|Lost to Follow-up|5|||
128916041|NCT01948830|463982981|FG001|Overall Study|Lost to Follow-up|4|||
128916042|NCT01948830|463982980|FG000|Overall Study|Withdrawal by Subject|14|||
128916043|NCT01948830|463982981|FG001|Overall Study|Withdrawal by Subject|17|||
128916044|NCT01948830|463982980|FG000|Overall Study|Adverse Event|9|||
128916045|NCT01948830|463982981|FG001|Overall Study|Adverse Event|2|||
128916046|NCT01948830|463982980|FG000|Overall Study|Death|3|||
128916047|NCT01948830|463982981|FG001|Overall Study|Death|4|||
128916048|NCT00565617|463982982|FG000|Overall Study|Withdrawal by Subject|1|||
128916049|NCT01133171|463982983|FG000|Overall Study|Withdrawal by Subject|1|||
128916050|NCT01133171|463982984|FG001|Overall Study|Withdrawal by Subject|2|||
128765696|NCT02508532|463433893|FG003|Part 2 - Treatment|Administrative|0|||
128916051|NCT01133171|463982985|FG002|Overall Study|Withdrawal by Subject|0|||
128916052|NCT02526550|463982986|FG000|Overall Study|Lost to Follow-up|1|||
128916053|NCT03969888|463982989|FG000|Overall Study|Never Received Study Drug|0|||
129215839|NCT00068692|465092824|FG004|Step 2: Randomization|Death|1|||
128765697|NCT02508532|463433894|FG004|Part 2 - Treatment|Administrative|0|||
128916054|NCT03969888|463982990|FG001|Overall Study|Never Received Study Drug|0|||
128916055|NCT03969888|463982991|FG002|Overall Study|Never Received Study Drug|1|||
128916056|NCT03969888|463982992|FG003|Overall Study|Never Received Study Drug|0|||
128916057|NCT03969888|463982993|FG004|Overall Study|Never Received Study Drug|0|||
128916058|NCT03969888|463982994|FG005|Overall Study|Never Received Study Drug|0|||
128916059|NCT03969888|463982995|FG006|Overall Study|Never Received Study Drug|1|||
128916060|NCT03969888|463982996|FG007|Overall Study|Never Received Study Drug|0|||
128697887|NCT04457336|463192259|FG007|Period 2: Part A|Other|0|||
128697888|NCT04457336|463192252|FG000|Period 2: Part A|Physician Decision|0|||
128697889|NCT04457336|463192253|FG001|Period 2: Part A|Physician Decision|0|||
128697890|NCT04457336|463192254|FG002|Period 2: Part A|Physician Decision|0|||
128697891|NCT04457336|463192255|FG003|Period 2: Part A|Physician Decision|1|||
128916061|NCT03969888|463982989|FG000|Overall Study|Reason Not Specified|0|||
128916062|NCT03969888|463982990|FG001|Overall Study|Reason Not Specified|0|||
128916063|NCT03969888|463982991|FG002|Overall Study|Reason Not Specified|0|||
128916064|NCT03969888|463982992|FG003|Overall Study|Reason Not Specified|0|||
128916065|NCT03969888|463982993|FG004|Overall Study|Reason Not Specified|0|||
128916066|NCT03969888|463982994|FG005|Overall Study|Reason Not Specified|0|||
128916067|NCT03969888|463982995|FG006|Overall Study|Reason Not Specified|0|||
128916068|NCT03969888|463982996|FG007|Overall Study|Reason Not Specified|1|||
128916069|NCT01446419|463983000|FG000|Overall Study|Death|1|||
128916070|NCT01446419|463983001|FG001|Overall Study|Death|0|||
128916071|NCT01446419|463983000|FG000|Overall Study|Withdrawal by Subject|1|||
128916072|NCT01446419|463983001|FG001|Overall Study|Withdrawal by Subject|1|||
128916073|NCT01446419|463983000|FG000|Overall Study|Terminated per protocol|3|||
128916074|NCT01446419|463983001|FG001|Overall Study|Terminated per protocol|0|||
128916075|NCT02867761|463983002|FG000|Overall Study|Participant withdrawn by investigator|0|||
128916076|NCT02867761|463983003|FG001|Overall Study|Participant withdrawn by investigator|1|||
128916077|NCT02867761|463983002|FG000|Overall Study|Lost to Follow-up|25|||
128916078|NCT02867761|463983003|FG001|Overall Study|Lost to Follow-up|18|||
128916079|NCT02867761|463983002|FG000|Overall Study|Unable to complete protocol|3|||
128916080|NCT02867761|463983003|FG001|Overall Study|Unable to complete protocol|7|||
128916081|NCT01931059|463983005|FG000|Day 1|Pregnancy|0|||
128916082|NCT01931059|463983006|FG001|Day 1|Pregnancy|1|||
128916083|NCT01931059|463983005|FG000|Day3|Lost to Follow-up|1|||
128916084|NCT01931059|463983006|FG001|Day3|Lost to Follow-up|0|||
128916085|NCT00769119|463983007|FG000|Overall Study|Voluntary discontinuation|0|||
128916086|NCT00769119|463983008|FG001|Overall Study|Voluntary discontinuation|2|||
128916087|NCT00769119|463983007|FG000|Overall Study|Adverse Event|1|||
128916088|NCT00769119|463983008|FG001|Overall Study|Adverse Event|1|||
128916089|NCT00769119|463983007|FG000|Overall Study|Disallowed medication|1|||
128916090|NCT00769119|463983008|FG001|Overall Study|Disallowed medication|0|||
128916091|NCT01961115|463983012|FG000|Overall Study|Disease Progression|1|||
128916092|NCT01961115|463983013|FG001|Overall Study|Disease Progression|0|||
128916093|NCT01961115|463983014|FG002|Overall Study|Disease Progression|3|||
128916094|NCT01961115|463983012|FG000|Overall Study|Adverse Event|1|||
128916095|NCT01961115|463983013|FG001|Overall Study|Adverse Event|0|||
128916096|NCT01961115|463983014|FG002|Overall Study|Adverse Event|1|||
128916097|NCT00578643|463983015|FG000|Overall Study|Death|1|||
128916098|NCT00578643|463983015|FG000|Overall Study|Lost to Follow-up|1|||
128916099|NCT03828487|463983016|FG000|Overall Study|Physician Decision|1|||
128916100|NCT01078805|463983018|FG000|Overall Study|Clinically significant abnormal lab|5|||
128916101|NCT01078805|463983018|FG000|Overall Study|Death|134|||
128916102|NCT01078805|463983018|FG000|Overall Study|Lost to Follow-up|676|||
128916103|NCT01078805|463983018|FG000|Overall Study|Physician Decision|169|||
128916104|NCT01078805|463983018|FG000|Overall Study|Serious adverse event|26|||
128916105|NCT01078805|463983018|FG000|Overall Study|Sponsor decision|46|||
128916106|NCT01078805|463983018|FG000|Overall Study|Withdrawal by Subject|739|||
128916107|NCT01078805|463983018|FG000|Overall Study|Other|173|||
128916108|NCT01078805|463983018|FG000|Overall Study|Didn't take study drug|82|||
128916109|NCT00865020|463983026|FG000|Overall Study|Withdrawal by Subject|22|||
128916110|NCT00865020|463983027|FG001|Overall Study|Withdrawal by Subject|16|||
128916111|NCT00865020|463983026|FG000|Overall Study|Adverse Event|9|||
128916112|NCT00865020|463983027|FG001|Overall Study|Adverse Event|14|||
128916113|NCT00865020|463983026|FG000|Overall Study|Abnormal test procedure result(s)|6|||
128916114|NCT00865020|463983027|FG001|Overall Study|Abnormal test procedure result(s)|8|||
128916115|NCT00865020|463983026|FG000|Overall Study|Lost to Follow-up|6|||
128916116|NCT00865020|463983027|FG001|Overall Study|Lost to Follow-up|4|||
128916117|NCT00865020|463983026|FG000|Overall Study|Protocol deviation|4|||
128916118|NCT00865020|463983027|FG001|Overall Study|Protocol deviation|1|||
128916119|NCT00865020|463983026|FG000|Overall Study|Administrative problems|0|||
128916120|NCT00865020|463983027|FG001|Overall Study|Administrative problems|2|||
128916121|NCT00865020|463983026|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128916122|NCT00865020|463983027|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128916123|NCT00865020|463983026|FG000|Overall Study|Death|0|||
128916124|NCT00865020|463983027|FG001|Overall Study|Death|1|||
128916125|NCT00865020|463983026|FG000|Overall Study|Randomized but discontinued|2|||
128916126|NCT00865020|463983027|FG001|Overall Study|Randomized but discontinued|4|||
128916127|NCT03641560|463983028|FG000|Overall Study|Withdrawal by Subject|6|||
128916128|NCT03641560|463983028|FG000|Overall Study|Progressive disease|40|||
128916129|NCT03641560|463983028|FG000|Overall Study|Death|6|||
128916130|NCT00388947|463984987|FG000|Overall Study|Protocol Violation|47|||
128916131|NCT04187092|463984988|FG000|Overall Study|Lost to Follow-up|1|||
128916132|NCT04187092|463984989|FG001|Overall Study|Lost to Follow-up|1|||
128916133|NCT04187092|463984988|FG000|Overall Study|Withdrawal by Subject|1|||
129028987|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
129028988|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
129028989|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
128916134|NCT04187092|463984989|FG001|Overall Study|Withdrawal by Subject|1|||
128916135|NCT04187092|463984988|FG000|Overall Study|Adverse Event|0|||
128916136|NCT04187092|463984989|FG001|Overall Study|Adverse Event|1|||
128916137|NCT00778830|463984993|FG000|Overall Study|Ongoing at data cut-off|0|||
128916138|NCT00778830|463984994|FG001|Overall Study|Ongoing at data cut-off|1|||
128916139|NCT04047797|463984995|FG000|Overall Study|Progressive Disease|1|||
128916140|NCT03523351|463984996|FG000|Overall Study|Death|13|||
128916141|NCT03523351|463984997|FG001|Overall Study|Death|11|||
128916142|NCT03523351|463984996|FG000|Overall Study|Lost to Follow-up|2|||
128916143|NCT03523351|463984997|FG001|Overall Study|Lost to Follow-up|3|||
128916144|NCT03523351|463984996|FG000|Overall Study|Withdrawal by Subject|4|||
128916145|NCT03523351|463984997|FG001|Overall Study|Withdrawal by Subject|0|||
128916146|NCT03523351|463984996|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
128916147|NCT03523351|463984997|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
128916148|NCT00132041|463985004|FG000|Baseline|Ineligible|6|||
128916149|NCT00132041|463985004|FG000|3 Months Post Ablation|Transplant|1|||
128916150|NCT00132041|463985004|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
128916151|NCT00132041|463985004|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
128916152|NCT00132041|463985004|FG000|6 Months Post Ablation|Death|2|||
128916153|NCT00132041|463985004|FG000|6 Months Post Ablation|Transplant|6|||
128916154|NCT00132041|463985004|FG000|9 Months Post Ablation|Death|1|||
128916155|NCT00132041|463985004|FG000|9 Months Post Ablation|Transplant|1|||
128916156|NCT00132041|463985004|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
128916157|NCT00132041|463985004|FG000|12 Months Post Ablation|Death|1|||
128916158|NCT00132041|463985004|FG000|12 Months Post Ablation|Transplant|1|||
128916159|NCT00132041|463985004|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
128916160|NCT00132041|463985004|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
128916161|NCT00132041|463985004|FG000|15 Months Post Ablation|Death|1|||
128916162|NCT00132041|463985004|FG000|15 Months Post Ablation|Transplant|5|||
128916163|NCT00132041|463985004|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
128916164|NCT00132041|463985004|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
128916165|NCT00132041|463985004|FG000|18 Months Post Ablation|Transplant|1|||
128916166|NCT00132041|463985004|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
128916167|NCT00132041|463985004|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
128916168|NCT03609619|463985005|FG000|Overall Study|Adverse Event|1|||
128916169|NCT03609619|463985006|FG001|Overall Study|Adverse Event|0|||
128916170|NCT03609619|463985005|FG000|Overall Study|Lack of Efficacy|1|||
128916171|NCT03609619|463985006|FG001|Overall Study|Lack of Efficacy|2|||
128916172|NCT03609619|463985005|FG000|Overall Study|Protocol Violation|5|||
128916173|NCT03609619|463985006|FG001|Overall Study|Protocol Violation|0|||
128916174|NCT03609619|463985005|FG000|Overall Study|Withdrawal by Subject|2|||
128916175|NCT03609619|463985006|FG001|Overall Study|Withdrawal by Subject|3|||
128916176|NCT03609619|463985005|FG000|Overall Study|Lost to Follow-up|1|||
128916177|NCT03609619|463985006|FG001|Overall Study|Lost to Follow-up|1|||
128916178|NCT02327260|463985007|FG000|Overall Study|Lost to Follow-up|2|||
128916179|NCT02327260|463985008|FG001|Overall Study|Lost to Follow-up|3|||
128916180|NCT02327260|463985009|FG002|Overall Study|Lost to Follow-up|2|||
128916181|NCT02327260|463985007|FG000|Overall Study|invalid phone number|1|||
128916182|NCT02327260|463985008|FG001|Overall Study|invalid phone number|1|||
128916183|NCT02327260|463985009|FG002|Overall Study|invalid phone number|0|||
128916184|NCT02327260|463985007|FG000|Overall Study|non-adherence to protocol|2|||
128916185|NCT02327260|463985008|FG001|Overall Study|non-adherence to protocol|0|||
128916186|NCT02327260|463985009|FG002|Overall Study|non-adherence to protocol|0|||
128916187|NCT02327260|463985007|FG000|Overall Study|cognitive concerns|1|||
128916188|NCT02327260|463985008|FG001|Overall Study|cognitive concerns|0|||
128916189|NCT02327260|463985009|FG002|Overall Study|cognitive concerns|0|||
128916190|NCT02472847|463985011|FG000|Overall Study|Withdrawal by Subject|1|||
128916191|NCT02472847|463985012|FG001|Overall Study|Withdrawal by Subject|5|||
128916192|NCT00623831|463985015|FG000|Overall Study|Withdrawal by Subject|1|||
128916193|NCT00623831|463985016|FG001|Overall Study|Withdrawal by Subject|0|||
128916194|NCT00623831|463985015|FG000|Overall Study|Progressive Disease|0|||
128916195|NCT00623831|463985016|FG001|Overall Study|Progressive Disease|1|||
128916196|NCT00270894|463985017|FG000|Overall Study|Adverse Event|1|||
128916197|NCT00270894|463985017|FG000|Overall Study|Withdrawal by Subject|1|||
128916198|NCT01748071|463985020|FG000|Overall Study|Adverse Event|2|||
128916199|NCT01748071|463985021|FG001|Overall Study|Adverse Event|2|||
128916200|NCT01748071|463985022|FG002|Overall Study|Adverse Event|0|||
128916201|NCT00793793|463985023|FG000|Overall Study|Adverse Event|0|||
128916202|NCT00793793|463985024|FG001|Overall Study|Adverse Event|0|||
128916203|NCT00793793|463985025|FG002|Overall Study|Adverse Event|1|||
128916204|NCT00793793|463985026|FG003|Overall Study|Adverse Event|1|||
128916205|NCT00793793|463985027|FG004|Overall Study|Adverse Event|0|||
128916206|NCT00793793|463985028|FG005|Overall Study|Adverse Event|1|||
128916207|NCT00793793|463985029|FG006|Overall Study|Adverse Event|2|||
128916208|NCT00793793|463985030|FG007|Overall Study|Adverse Event|0|||
128916209|NCT00793793|463985031|FG008|Overall Study|Adverse Event|0|||
128916210|NCT00793793|463985032|FG009|Overall Study|Adverse Event|0|||
128916211|NCT00793793|463985033|FG010|Overall Study|Adverse Event|0|||
128916212|NCT00793793|463985034|FG011|Overall Study|Adverse Event|2|||
128916213|NCT00793793|463985023|FG000|Overall Study|Protocol Violation|0|||
128916214|NCT00793793|463985024|FG001|Overall Study|Protocol Violation|0|||
128697892|NCT04457336|463192256|FG004|Period 2: Part A|Physician Decision|0|||
128916215|NCT00793793|463985025|FG002|Overall Study|Protocol Violation|0|||
128916216|NCT00793793|463985026|FG003|Overall Study|Protocol Violation|1|||
128916217|NCT00793793|463985027|FG004|Overall Study|Protocol Violation|0|||
128916218|NCT00793793|463985028|FG005|Overall Study|Protocol Violation|0|||
128916219|NCT00793793|463985029|FG006|Overall Study|Protocol Violation|0|||
128916220|NCT00793793|463985030|FG007|Overall Study|Protocol Violation|0|||
128916221|NCT00793793|463985031|FG008|Overall Study|Protocol Violation|0|||
128916222|NCT00793793|463985032|FG009|Overall Study|Protocol Violation|0|||
128916223|NCT00793793|463985033|FG010|Overall Study|Protocol Violation|0|||
128916224|NCT00793793|463985034|FG011|Overall Study|Protocol Violation|0|||
128916225|NCT00793793|463985023|FG000|Overall Study|Lost to Follow-up|0|||
128916226|NCT00793793|463985024|FG001|Overall Study|Lost to Follow-up|0|||
128916227|NCT00793793|463985025|FG002|Overall Study|Lost to Follow-up|1|||
128916228|NCT00793793|463985026|FG003|Overall Study|Lost to Follow-up|0|||
128916229|NCT00793793|463985027|FG004|Overall Study|Lost to Follow-up|0|||
128916230|NCT00793793|463985028|FG005|Overall Study|Lost to Follow-up|0|||
128916231|NCT00793793|463985029|FG006|Overall Study|Lost to Follow-up|0|||
128916232|NCT00793793|463985030|FG007|Overall Study|Lost to Follow-up|0|||
128916233|NCT00793793|463985031|FG008|Overall Study|Lost to Follow-up|1|||
128916234|NCT00793793|463985032|FG009|Overall Study|Lost to Follow-up|3|||
128916235|NCT00793793|463985033|FG010|Overall Study|Lost to Follow-up|1|||
128916236|NCT00793793|463985034|FG011|Overall Study|Lost to Follow-up|0|||
128916237|NCT00793793|463985023|FG000|Overall Study|Withdrawal by Subject|0|||
128916238|NCT00793793|463985024|FG001|Overall Study|Withdrawal by Subject|0|||
128916239|NCT00793793|463985025|FG002|Overall Study|Withdrawal by Subject|0|||
128916240|NCT00793793|463985026|FG003|Overall Study|Withdrawal by Subject|0|||
128916241|NCT00793793|463985027|FG004|Overall Study|Withdrawal by Subject|1|||
128916242|NCT00793793|463985028|FG005|Overall Study|Withdrawal by Subject|0|||
128916243|NCT00793793|463985029|FG006|Overall Study|Withdrawal by Subject|0|||
128916244|NCT00793793|463985030|FG007|Overall Study|Withdrawal by Subject|0|||
128916245|NCT00793793|463985031|FG008|Overall Study|Withdrawal by Subject|1|||
128916246|NCT00793793|463985032|FG009|Overall Study|Withdrawal by Subject|0|||
128916247|NCT00793793|463985033|FG010|Overall Study|Withdrawal by Subject|0|||
128916248|NCT00793793|463985034|FG011|Overall Study|Withdrawal by Subject|0|||
128916249|NCT00793793|463985023|FG000|Overall Study|reason not specified|0|||
128916250|NCT00793793|463985024|FG001|Overall Study|reason not specified|1|||
128916251|NCT00793793|463985025|FG002|Overall Study|reason not specified|0|||
128916252|NCT00793793|463985026|FG003|Overall Study|reason not specified|1|||
128916253|NCT00793793|463985027|FG004|Overall Study|reason not specified|1|||
128916254|NCT00793793|463985028|FG005|Overall Study|reason not specified|1|||
128916255|NCT00793793|463985029|FG006|Overall Study|reason not specified|2|||
128916256|NCT00793793|463985030|FG007|Overall Study|reason not specified|0|||
128916257|NCT00793793|463985031|FG008|Overall Study|reason not specified|7|||
128916258|NCT00793793|463985032|FG009|Overall Study|reason not specified|6|||
128916259|NCT00793793|463985033|FG010|Overall Study|reason not specified|2|||
128916260|NCT00793793|463985034|FG011|Overall Study|reason not specified|4|||
128916261|NCT00950170|463985035|FG000|Overall Study|Parent/Legal Guardian Request|1|||
128916262|NCT00950170|463985035|FG000|Overall Study|Adverse Event|2|||
128916263|NCT00950170|463985035|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
128916264|NCT02522767|463985036|FG000|Double-blind|Withdrawal by Subject|8|||
128916265|NCT02522767|463985037|FG001|Double-blind|Withdrawal by Subject|11|||
128916266|NCT02522767|463985036|FG000|Double-blind|Lost to Follow-up|1|||
128916267|NCT02522767|463985037|FG001|Double-blind|Lost to Follow-up|0|||
128916268|NCT02522767|463985036|FG000|Double-blind|Adverse Event|1|||
128916269|NCT02522767|463985037|FG001|Double-blind|Adverse Event|10|||
128916270|NCT02522767|463985036|FG000|Double-blind|Protocol Violation|0|||
128916271|NCT02522767|463985037|FG001|Double-blind|Protocol Violation|1|||
128916272|NCT02522767|463985036|FG000|Double-blind|Lack of Efficacy|0|||
128916273|NCT02522767|463985037|FG001|Double-blind|Lack of Efficacy|2|||
128916274|NCT02522767|463985036|FG000|Double-blind|Protocol Deviation|1|||
128916275|NCT02522767|463985037|FG001|Double-blind|Protocol Deviation|0|||
128916276|NCT02522767|463985036|FG000|Open-label|Withdrawal by Subject|2|||
128916277|NCT02522767|463985037|FG001|Open-label|Withdrawal by Subject|3|||
128916278|NCT02522767|463985036|FG000|Open-label|Lost to Follow-up|0|||
128916279|NCT02522767|463985037|FG001|Open-label|Lost to Follow-up|1|||
128916280|NCT02522767|463985036|FG000|Open-label|Adverse Event|2|||
128697893|NCT04457336|463192257|FG005|Period 2: Part A|Physician Decision|0|||
128697894|NCT04457336|463192258|FG006|Period 2: Part A|Physician Decision|0|||
128916281|NCT02522767|463985037|FG001|Open-label|Adverse Event|1|||
128916282|NCT02522767|463985036|FG000|Open-label|Lack of Efficacy|1|||
128916283|NCT02522767|463985037|FG001|Open-label|Lack of Efficacy|1|||
129215840|NCT00068692|465092825|FG005|Step 2: Randomization|Death|0|||
129215841|NCT00068692|465092826|FG006|Step 2: Randomization|Death|0|||
128697895|NCT04457336|463192259|FG007|Period 2: Part A|Physician Decision|0|||
128916284|NCT02522767|463985036|FG000|Open-label|Protocol Violation|0|||
128916285|NCT02522767|463985037|FG001|Open-label|Protocol Violation|1|||
128916286|NCT00841763|463985038|FG000|Overall Study|Withdrawal by Subject|60|||
129215842|NCT00068692|465092827|FG007|Step 2: Randomization|Death|1|||
129215843|NCT00068692|465092820|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
129215844|NCT00068692|465092821|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
128916287|NCT00841763|463985039|FG001|Overall Study|Withdrawal by Subject|17|||
128916288|NCT00841763|463985040|FG002|Overall Study|Withdrawal by Subject|4|||
128916289|NCT00841763|463985041|FG003|Overall Study|Withdrawal by Subject|1|||
128916290|NCT00841763|463985038|FG000|Overall Study|Adverse Event|9|||
128916291|NCT00841763|463985039|FG001|Overall Study|Adverse Event|10|||
128916292|NCT00841763|463985040|FG002|Overall Study|Adverse Event|3|||
128916293|NCT00841763|463985041|FG003|Overall Study|Adverse Event|2|||
128916294|NCT00841763|463985038|FG000|Overall Study|Lost to Follow-up|63|||
128916295|NCT00841763|463985039|FG001|Overall Study|Lost to Follow-up|25|||
128916296|NCT00841763|463985040|FG002|Overall Study|Lost to Follow-up|0|||
128916297|NCT00841763|463985041|FG003|Overall Study|Lost to Follow-up|0|||
128916298|NCT00841763|463985038|FG000|Overall Study|Protocol Violation|20|||
128916299|NCT00841763|463985039|FG001|Overall Study|Protocol Violation|3|||
128916300|NCT00841763|463985040|FG002|Overall Study|Protocol Violation|1|||
128916301|NCT00841763|463985041|FG003|Overall Study|Protocol Violation|0|||
128916302|NCT00841763|463985038|FG000|Overall Study|Administrative Reasons|3|||
128916303|NCT00841763|463985039|FG001|Overall Study|Administrative Reasons|1|||
128916304|NCT00841763|463985040|FG002|Overall Study|Administrative Reasons|0|||
128916305|NCT00841763|463985041|FG003|Overall Study|Administrative Reasons|0|||
128916306|NCT00841763|463985038|FG000|Overall Study|Unable to Classify|7|||
128916307|NCT00841763|463985039|FG001|Overall Study|Unable to Classify|1|||
128916308|NCT00841763|463985040|FG002|Overall Study|Unable to Classify|0|||
128916309|NCT00841763|463985041|FG003|Overall Study|Unable to Classify|0|||
128916310|NCT02631538|463985042|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
128916311|NCT02631538|463985043|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
128916312|NCT02631538|463985044|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
128916313|NCT02631538|463985045|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
128916314|NCT02631538|463985042|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
128916315|NCT02631538|463985043|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
128916316|NCT02631538|463985044|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
128916317|NCT02631538|463985045|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
128916318|NCT02631538|463985042|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
128916319|NCT02631538|463985043|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
128916320|NCT02631538|463985044|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
128916321|NCT02631538|463985045|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
128916322|NCT02631538|463985042|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
128916323|NCT02631538|463985043|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
128916324|NCT02631538|463985044|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
128916325|NCT02631538|463985045|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
128916326|NCT02631538|463985042|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
128916327|NCT02631538|463985043|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
128916328|NCT02631538|463985044|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
128916329|NCT02631538|463985045|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
128916330|NCT02631538|463985042|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
128916331|NCT02631538|463985043|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
128916332|NCT02631538|463985044|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
128916333|NCT02631538|463985045|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
128916334|NCT00648167|463985046|FG000|Overall Study|Adverse Event|6|||
128916335|NCT00648167|463985046|FG000|Overall Study|unable to swallow tablets|1|||
128916336|NCT01482910|463985051|FG000|Overall Study|Adverse Event|6|||
128916337|NCT01482910|463985052|FG001|Overall Study|Adverse Event|5|||
128916338|NCT01482910|463985051|FG000|Overall Study|Lost to Follow-up|0|||
128916339|NCT01482910|463985052|FG001|Overall Study|Lost to Follow-up|1|||
128916340|NCT01482910|463985051|FG000|Overall Study|Protocol Violation|1|||
128916341|NCT01482910|463985052|FG001|Overall Study|Protocol Violation|1|||
128916342|NCT01482910|463985051|FG000|Overall Study|Withdrawal by Subject|7|||
128916343|NCT01482910|463985052|FG001|Overall Study|Withdrawal by Subject|2|||
128916344|NCT01482910|463985051|FG000|Overall Study|Death|1|||
128916345|NCT01482910|463985052|FG001|Overall Study|Death|0|||
128916346|NCT00440726|463985053|FG000|Phase 1|Dose-Limiting Toxicity|0|||
128916347|NCT00440726|463985054|FG001|Phase 1|Dose-Limiting Toxicity|1|||
128765698|NCT02508532|463433895|FG005|Part 2 - Treatment|Administrative|0|||
128765699|NCT02508532|463433896|FG006|Part 2 - Treatment|Administrative|0|||
128765700|NCT02508532|463433897|FG007|Part 2 - Treatment|Administrative|0|||
128765701|NCT02508532|463433898|FG008|Part 2 - Treatment|Administrative|3|||
128916348|NCT00440726|463985055|FG002|Phase 1|Dose-Limiting Toxicity|0|||
128916349|NCT00440726|463985053|FG000|Phase 1|Physician Decision|1|||
128916350|NCT00440726|463985054|FG001|Phase 1|Physician Decision|0|||
128916351|NCT00440726|463985055|FG002|Phase 1|Physician Decision|0|||
128916352|NCT00440726|463985053|FG000|Phase 2|Death|0|||
128916353|NCT00440726|463985054|FG001|Phase 2|Death|0|||
128916354|NCT00440726|463985055|FG002|Phase 2|Death|1|||
128916355|NCT00440726|463985053|FG000|Phase 2|Adverse Event|0|||
128916356|NCT00440726|463985054|FG001|Phase 2|Adverse Event|0|||
128916357|NCT00440726|463985055|FG002|Phase 2|Adverse Event|1|||
128916358|NCT00110019|463985057|FG000|Overall Study|Lack of Efficacy|253|||
128916359|NCT00110019|463985058|FG001|Overall Study|Lack of Efficacy|285|||
128916360|NCT00110019|463985057|FG000|Overall Study|Adverse Event|61|||
128916361|NCT00110019|463985058|FG001|Overall Study|Adverse Event|40|||
128916362|NCT00110019|463985057|FG000|Overall Study|Death|13|||
128916363|NCT00110019|463985058|FG001|Overall Study|Death|15|||
128916364|NCT00110019|463985057|FG000|Overall Study|Withdrawal by Subject|21|||
128916365|NCT00110019|463985058|FG001|Overall Study|Withdrawal by Subject|9|||
128916366|NCT00110019|463985057|FG000|Overall Study|alternative therapy|5|||
128916367|NCT00110019|463985058|FG001|Overall Study|alternative therapy|1|||
128916368|NCT00110019|463985057|FG000|Overall Study|complicating disease|1|||
128916369|NCT00110019|463985058|FG001|Overall Study|complicating disease|1|||
128916370|NCT00110019|463985057|FG000|Overall Study|symptom deterioration|13|||
128916371|NCT00110019|463985058|FG001|Overall Study|symptom deterioration|16|||
128916372|NCT00110019|463985057|FG000|Overall Study|Not start protocol therapy|17|||
128916373|NCT00110019|463985058|FG001|Overall Study|Not start protocol therapy|16|||
128916374|NCT00110019|463985057|FG000|Overall Study|other reasons|22|||
128916375|NCT00110019|463985058|FG001|Overall Study|other reasons|30|||
128916376|NCT04303000|463985061|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
128916377|NCT04303000|463985062|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
128916378|NCT04303000|463985063|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
128916379|NCT01987908|463985064|FG000|Placebo Lead-in Period|Adverse Event|2|||
128916380|NCT01987908|463985065|FG001|Placebo Lead-in Period|Adverse Event|0|||
128916381|NCT01987908|463985066|FG002|Placebo Lead-in Period|Adverse Event|0|||
128916382|NCT01987908|463985064|FG000|Placebo Lead-in Period|Physician Decision|2|||
128916383|NCT01987908|463985065|FG001|Placebo Lead-in Period|Physician Decision|0|||
128916384|NCT01987908|463985066|FG002|Placebo Lead-in Period|Physician Decision|0|||
128916385|NCT01987908|463985064|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
128916386|NCT01987908|463985065|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
128916387|NCT01987908|463985066|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
128916388|NCT01987908|463985064|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
128916389|NCT01987908|463985065|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
128916390|NCT01987908|463985066|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
128916391|NCT01987908|463985064|FG000|Treatment Period|Adverse Event|0|||
128916392|NCT01987908|463985065|FG001|Treatment Period|Adverse Event|1|||
128916393|NCT01987908|463985066|FG002|Treatment Period|Adverse Event|1|||
128916394|NCT01987908|463985064|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
128916395|NCT01987908|463985065|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
128916396|NCT01987908|463985066|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
128916397|NCT01987908|463985064|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
128916398|NCT01987908|463985065|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
128916399|NCT01987908|463985066|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
128916400|NCT00189462|463985067|FG000|Overall Study|Lack of Efficacy|5|||
128916401|NCT00189462|463985068|FG001|Overall Study|Lack of Efficacy|1|||
128916402|NCT00189462|463985067|FG000|Overall Study|Lost to Follow-up|18|||
128916403|NCT00189462|463985068|FG001|Overall Study|Lost to Follow-up|20|||
128916404|NCT00849667|463985069|FG000|Overall Study|Withdrawal by Subject|16|||
128916405|NCT00849667|463985070|FG001|Overall Study|Withdrawal by Subject|33|||
128916406|NCT00849667|463985071|FG002|Overall Study|Withdrawal by Subject|35|||
128697896|NCT04457336|463192252|FG000|Period 3: Part B|Study Terminated|0|||
128697897|NCT04457336|463192253|FG001|Period 3: Part B|Study Terminated|0|||
128697898|NCT04457336|463192254|FG002|Period 3: Part B|Study Terminated|0|||
128916407|NCT00849667|463985069|FG000|Overall Study|Lost to Follow-up|8|||
128916408|NCT00849667|463985070|FG001|Overall Study|Lost to Follow-up|8|||
128916409|NCT00849667|463985071|FG002|Overall Study|Lost to Follow-up|8|||
128916410|NCT00849667|463985069|FG000|Overall Study|Adverse Event|1|||
128916411|NCT00849667|463985070|FG001|Overall Study|Adverse Event|2|||
128916412|NCT00849667|463985071|FG002|Overall Study|Adverse Event|0|||
128916413|NCT00849667|463985069|FG000|Overall Study|Other|18|||
128916414|NCT00849667|463985070|FG001|Overall Study|Other|19|||
128916415|NCT00849667|463985071|FG002|Overall Study|Other|18|||
128916416|NCT00849667|463985069|FG000|Overall Study|Progressive disease|119|||
128916417|NCT00849667|463985070|FG001|Overall Study|Progressive disease|100|||
128916418|NCT00849667|463985071|FG002|Overall Study|Progressive disease|112|||
128916419|NCT00849667|463985069|FG000|Overall Study|Sponsor decision|208|||
128916420|NCT00849667|463985070|FG001|Overall Study|Sponsor decision|204|||
128916421|NCT00849667|463985071|FG002|Overall Study|Sponsor decision|190|||
128916422|NCT00849667|463985069|FG000|Overall Study|Investigator discretion|0|||
128916423|NCT00849667|463985070|FG001|Overall Study|Investigator discretion|0|||
128916424|NCT00849667|463985071|FG002|Overall Study|Investigator discretion|1|||
128916425|NCT01262625|463985077|FG000|Overall Study|Administrative Error|1|||
128916426|NCT01262625|463985078|FG001|Overall Study|Administrative Error|1|||
128916427|NCT01262625|463985077|FG000|Overall Study|Site Closed|1|||
128916428|NCT01262625|463985078|FG001|Overall Study|Site Closed|0|||
128916429|NCT02789657|463985079|FG000|Overall Study|Withdrawal by Subject|2|||
128916430|NCT02789657|463985080|FG001|Overall Study|Withdrawal by Subject|0|||
128916431|NCT02789657|463985081|FG002|Overall Study|Withdrawal by Subject|0|||
128916432|NCT02789657|463985082|FG003|Overall Study|Withdrawal by Subject|0|||
128916433|NCT01214044|463985083|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
128916434|NCT01214044|463985083|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
128916435|NCT01214044|463985083|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
128916436|NCT01214044|463985083|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
128916437|NCT01214044|463985083|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
128916438|NCT01214044|463985083|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
128916439|NCT02772757|463985084|FG000|Overall Study|Withdrawal by Subject|1|||
128916440|NCT02772757|463985085|FG001|Overall Study|Withdrawal by Subject|0|||
128916441|NCT02772757|463985086|FG002|Overall Study|Withdrawal by Subject|1|||
128916442|NCT02772757|463985084|FG000|Overall Study|Protocol Violation|0|||
128916443|NCT02772757|463985085|FG001|Overall Study|Protocol Violation|0|||
128916444|NCT02772757|463985086|FG002|Overall Study|Protocol Violation|1|||
128916445|NCT02772757|463985084|FG000|Overall Study|Physician Decision|0|||
128916446|NCT02772757|463985085|FG001|Overall Study|Physician Decision|3|||
128916447|NCT02772757|463985086|FG002|Overall Study|Physician Decision|3|||
128916448|NCT04698525|463985087|FG000|Overall Study|Lost to Follow-up|1|||
128916449|NCT04698525|463985088|FG001|Overall Study|Lost to Follow-up|2|||
128916450|NCT04698525|463985087|FG000|Overall Study|Three suffered of Covid-19|2|||
128916451|NCT04698525|463985088|FG001|Overall Study|Three suffered of Covid-19|1|||
128916452|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Adverse Event|21|||
128916453|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Adverse Event|6|||
128916454|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
128916455|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
128916456|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
128916457|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
128916458|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
128916459|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
128916460|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Physician Decision|0|||
128916461|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Physician Decision|3|||
128916462|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
128916463|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
128916464|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
128916465|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
128916466|NCT00510276|463985092|FG000|Acute Double-Blind Phase|Subject Decision|26|||
128916467|NCT00510276|463985093|FG001|Acute Double-Blind Phase|Subject Decision|28|||
128916468|NCT00510276|463985092|FG000|Extension Open-Label Phase|Adverse Event|9|||
128916469|NCT00510276|463985093|FG001|Extension Open-Label Phase|Adverse Event|18|||
128916470|NCT00510276|463985092|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
128916471|NCT00510276|463985093|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
128916472|NCT00510276|463985092|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
128916473|NCT00510276|463985093|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
128916474|NCT00510276|463985092|FG000|Extension Open-Label Phase|Physician Decision|2|||
128916475|NCT00510276|463985093|FG001|Extension Open-Label Phase|Physician Decision|3|||
128916476|NCT00510276|463985092|FG000|Extension Open-Label Phase|Protocol Violation|0|||
128916477|NCT00510276|463985093|FG001|Extension Open-Label Phase|Protocol Violation|1|||
128916478|NCT00510276|463985092|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
128916479|NCT00510276|463985093|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
128916480|NCT00510276|463985092|FG000|Extension Open-Label Phase|Subject Decision|7|||
128916481|NCT00510276|463985093|FG001|Extension Open-Label Phase|Subject Decision|9|||
128916482|NCT03486392|463985096|FG000|Overall Study|Lost to Follow-up|0|||
128916483|NCT03486392|463985097|FG001|Overall Study|Lost to Follow-up|0|||
128916484|NCT03486392|463985098|FG002|Overall Study|Lost to Follow-up|8|||
128916485|NCT03486392|463985099|FG003|Overall Study|Lost to Follow-up|5|||
128916486|NCT03486392|463985100|FG004|Overall Study|Lost to Follow-up|2|||
128916487|NCT03486392|463985096|FG000|Overall Study|Withdrawal by Subject|3|||
128916488|NCT03486392|463985097|FG001|Overall Study|Withdrawal by Subject|0|||
128697899|NCT04457336|463192255|FG003|Period 3: Part B|Study Terminated|0|||
128916489|NCT03486392|463985098|FG002|Overall Study|Withdrawal by Subject|6|||
128916490|NCT03486392|463985099|FG003|Overall Study|Withdrawal by Subject|4|||
128916491|NCT03486392|463985100|FG004|Overall Study|Withdrawal by Subject|1|||
128697900|NCT04457336|463192256|FG004|Period 3: Part B|Study Terminated|1|||
128916492|NCT03486392|463985096|FG000|Overall Study|Death|0|||
128916493|NCT03486392|463985097|FG001|Overall Study|Death|0|||
128916494|NCT03486392|463985098|FG002|Overall Study|Death|0|||
128697901|NCT04457336|463192257|FG005|Period 3: Part B|Study Terminated|10|||
128916495|NCT03486392|463985099|FG003|Overall Study|Death|0|||
128916496|NCT03486392|463985100|FG004|Overall Study|Death|1|||
128916497|NCT00441792|463985103|FG000|Overall Study|Lost to Follow-up|0|||
128916498|NCT00441792|463985104|FG001|Overall Study|Lost to Follow-up|2|||
128916499|NCT00888355|463985111|FG000|Overall Study|Adverse Event|10|||
128916500|NCT00888355|463985112|FG001|Overall Study|Adverse Event|0|||
128916501|NCT00888355|463985113|FG002|Overall Study|Adverse Event|3|||
128916502|NCT00888355|463985114|FG003|Overall Study|Adverse Event|3|||
128916503|NCT00888355|463985111|FG000|Overall Study|Lack of Efficacy|9|||
128916504|NCT00888355|463985112|FG001|Overall Study|Lack of Efficacy|2|||
128916505|NCT00888355|463985113|FG002|Overall Study|Lack of Efficacy|5|||
128916506|NCT00888355|463985114|FG003|Overall Study|Lack of Efficacy|2|||
128916507|NCT00888355|463985111|FG000|Overall Study|Lost to Follow-up|0|||
128916508|NCT00888355|463985112|FG001|Overall Study|Lost to Follow-up|2|||
128916509|NCT00888355|463985113|FG002|Overall Study|Lost to Follow-up|2|||
128916510|NCT00888355|463985114|FG003|Overall Study|Lost to Follow-up|0|||
128916511|NCT00888355|463985111|FG000|Overall Study|Protocol Violation|3|||
128916512|NCT00888355|463985112|FG001|Overall Study|Protocol Violation|2|||
128916513|NCT00888355|463985113|FG002|Overall Study|Protocol Violation|1|||
128916514|NCT00888355|463985114|FG003|Overall Study|Protocol Violation|2|||
128916515|NCT00888355|463985111|FG000|Overall Study|Withdrawal by Subject|0|||
128916516|NCT00888355|463985112|FG001|Overall Study|Withdrawal by Subject|3|||
128916517|NCT00888355|463985113|FG002|Overall Study|Withdrawal by Subject|1|||
128916518|NCT00888355|463985114|FG003|Overall Study|Withdrawal by Subject|3|||
128916519|NCT01551693|463985116|FG000|Overall Study|Disease Progression|1|||
128916520|NCT01551693|463985117|FG001|Overall Study|Disease Progression|0|||
128916521|NCT01551693|463985116|FG000|Overall Study|Adverse Event|0|||
128916522|NCT01551693|463985117|FG001|Overall Study|Adverse Event|1|||
128916523|NCT01551693|463985116|FG000|Overall Study|Withdrawal by Subject|0|||
128916524|NCT01551693|463985117|FG001|Overall Study|Withdrawal by Subject|1|||
128916525|NCT02211261|463985119|FG000|Overall Study|Withdrawal by Subject|0|||
128916526|NCT02211261|463985120|FG001|Overall Study|Withdrawal by Subject|0|||
128916527|NCT02211261|463985121|FG002|Overall Study|Withdrawal by Subject|1|||
128916528|NCT02211261|463985122|FG003|Overall Study|Withdrawal by Subject|0|||
128916529|NCT02211261|463985123|FG004|Overall Study|Withdrawal by Subject|2|||
128916530|NCT02211261|463985124|FG005|Overall Study|Withdrawal by Subject|0|||
128916531|NCT02211261|463985125|FG006|Overall Study|Withdrawal by Subject|0|||
128916532|NCT02211261|463985126|FG007|Overall Study|Withdrawal by Subject|0|||
128916533|NCT02211261|463985127|FG008|Overall Study|Withdrawal by Subject|0|||
128916534|NCT02211261|463985128|FG009|Overall Study|Withdrawal by Subject|0|||
128916535|NCT02211261|463985129|FG010|Overall Study|Withdrawal by Subject|0|||
128916536|NCT02211261|463985119|FG000|Overall Study|Other|0|||
128916537|NCT02211261|463985120|FG001|Overall Study|Other|0|||
128916538|NCT02211261|463985121|FG002|Overall Study|Other|0|||
128916539|NCT02211261|463985122|FG003|Overall Study|Other|0|||
128916540|NCT02211261|463985123|FG004|Overall Study|Other|0|||
128916541|NCT02211261|463985124|FG005|Overall Study|Other|1|||
128916542|NCT02211261|463985125|FG006|Overall Study|Other|0|||
128916543|NCT02211261|463985126|FG007|Overall Study|Other|0|||
128916544|NCT02211261|463985127|FG008|Overall Study|Other|0|||
128916545|NCT02211261|463985128|FG009|Overall Study|Other|2|||
128916546|NCT02211261|463985129|FG010|Overall Study|Other|0|||
128916547|NCT02211261|463985119|FG000|Overall Study|Lost to Follow-up|0|||
128916548|NCT02211261|463985120|FG001|Overall Study|Lost to Follow-up|0|||
128916549|NCT02211261|463985121|FG002|Overall Study|Lost to Follow-up|0|||
128916550|NCT02211261|463985122|FG003|Overall Study|Lost to Follow-up|0|||
128916551|NCT02211261|463985123|FG004|Overall Study|Lost to Follow-up|0|||
128916552|NCT02211261|463985124|FG005|Overall Study|Lost to Follow-up|0|||
128916553|NCT02211261|463985125|FG006|Overall Study|Lost to Follow-up|0|||
128916554|NCT02211261|463985126|FG007|Overall Study|Lost to Follow-up|1|||
128916555|NCT02211261|463985127|FG008|Overall Study|Lost to Follow-up|0|||
128916556|NCT02211261|463985128|FG009|Overall Study|Lost to Follow-up|0|||
128916557|NCT02211261|463985129|FG010|Overall Study|Lost to Follow-up|0|||
128916558|NCT04897867|463985130|FG000|Overall Study|Withdrawal of Consent|1|||
128916559|NCT04897867|463985130|FG000|Overall Study|Pregnancy|1|||
128916560|NCT04897867|463985130|FG000|Overall Study|Lost to Follow-up|7|||
128916561|NCT04897867|463985130|FG000|Overall Study|Reason not Specified|2|||
128916562|NCT01171612|463985135|FG000|Overall Study|Lost to Follow-up|51|||
128916563|NCT00243659|463985136|FG000|Overall Study|Withdrawal by Subject|1|||
128916564|NCT00243659|463985137|FG001|Overall Study|Withdrawal by Subject|1|||
128916565|NCT00243659|463985136|FG000|Overall Study|Protocol Violation|1|||
128916566|NCT00243659|463985137|FG001|Overall Study|Protocol Violation|2|||
128916567|NCT03310970|463985138|FG000|Overall Study|Withdrawal by Subject|0|||
128916568|NCT03310970|463985139|FG001|Overall Study|Withdrawal by Subject|1|||
128916569|NCT03430986|463985140|FG000|24-week Control Period|Adverse Event|1|||
128916570|NCT03430986|463985141|FG001|24-week Control Period|Adverse Event|0|||
128916571|NCT03430986|463985140|FG000|24-week Control Period|Lost to Follow-up|2|||
128916572|NCT03430986|463985141|FG001|24-week Control Period|Lost to Follow-up|2|||
128916573|NCT03430986|463985140|FG000|24-week Control Period|Withdrawal by Participant|5|||
128916574|NCT03430986|463985141|FG001|24-week Control Period|Withdrawal by Participant|0|||
128916575|NCT03430986|463985140|FG000|24-week Control Period|Protocol Deviation|0|||
128916576|NCT03430986|463985141|FG001|24-week Control Period|Protocol Deviation|2|||
128916577|NCT03430986|463985140|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
128916578|NCT03430986|463985141|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
128916579|NCT03430986|463985140|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
128916580|NCT03430986|463985141|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
128916581|NCT01609842|463985143|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
128916582|NCT01609842|463985144|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
128916583|NCT02474329|463985145|FG000|Overall Study|Withdraw or did not contribute data.|13|||
128916584|NCT05900115|463986740|FG000|Overall Study|Lost to Follow-up|129|||
128916585|NCT05900115|463986741|FG001|Overall Study|Lost to Follow-up|98|||
128916586|NCT00619502|463986742|FG000|Overall Study|Lost to Follow-up|8|||
128916587|NCT00619502|463986743|FG001|Overall Study|Lost to Follow-up|10|||
128916588|NCT00771472|463986744|FG000|Overall Study|Physician Decision|2|||
128916589|NCT00771472|463986745|FG001|Overall Study|Physician Decision|3|||
128916590|NCT00771472|463986744|FG000|Overall Study|Progressive Disease|3|||
128916591|NCT00771472|463986745|FG001|Overall Study|Progressive Disease|1|||
128916592|NCT00771472|463986744|FG000|Overall Study|Protocol Violation|1|||
128916593|NCT00771472|463986745|FG001|Overall Study|Protocol Violation|0|||
128916594|NCT00880750|463986748|FG000|First Intervention|Adverse Event|1|||
128916595|NCT00880750|463986749|FG001|First Intervention|Adverse Event|0|||
128916596|NCT00880750|463986748|FG000|First Intervention|Unable to collect urine|4|||
128916597|NCT00880750|463986749|FG001|First Intervention|Unable to collect urine|0|||
128916598|NCT00880750|463986748|FG000|First Intervention|Non-compliance with meals|0|||
128916599|NCT00880750|463986749|FG001|First Intervention|Non-compliance with meals|1|||
128916600|NCT00880750|463986748|FG000|First Intervention|Withdrawal by Subject|2|||
128916601|NCT00880750|463986749|FG001|First Intervention|Withdrawal by Subject|0|||
128916602|NCT00880750|463986748|FG000|First Intervention|Lost to Follow-up|2|||
128916603|NCT00880750|463986749|FG001|First Intervention|Lost to Follow-up|0|||
128916604|NCT00880750|463986748|FG000|Second Intervention|Withdrawal by Subject|2|||
128916605|NCT00880750|463986749|FG001|Second Intervention|Withdrawal by Subject|2|||
128916606|NCT00880750|463986748|FG000|Second Intervention|Protocol Violation|1|||
128916607|NCT00880750|463986749|FG001|Second Intervention|Protocol Violation|0|||
128916608|NCT00880750|463986748|FG000|Second Intervention|Unable to collect urine|1|||
128916609|NCT00880750|463986749|FG001|Second Intervention|Unable to collect urine|0|||
128916610|NCT00483327|463986750|FG000|Overall Study|Adverse Event|1|||
128916611|NCT00483327|463986750|FG000|Overall Study|Withdrawal by Subject|3|||
128916612|NCT00483327|463986750|FG000|Overall Study|Lost to Follow-up|4|||
128916613|NCT00483327|463986750|FG000|Overall Study|Patient Non Compliance|2|||
128916614|NCT00670007|463986751|FG000|Overall Study|Drug abuse|1|||
128916615|NCT00670007|463986751|FG000|Overall Study|Lung transplant|1|||
128916616|NCT00670007|463986751|FG000|Overall Study|Travel/Vacation|1|||
128916617|NCT00670007|463986751|FG000|Overall Study|Adverse event, serious fatal|1|||
128916618|NCT00670007|463986751|FG000|Overall Study|Adverse Event|1|||
128916619|NCT00670007|463986751|FG000|Overall Study|Withdrawal by Subject|4|||
128916620|NCT00618722|463986752|FG000|Overall Study|Refusal of Treatment|0|||
128916621|NCT00618722|463986753|FG001|Overall Study|Refusal of Treatment|0|||
128916622|NCT00618722|463986754|FG002|Overall Study|Refusal of Treatment|1|||
128916623|NCT00618722|463986755|FG003|Overall Study|Refusal of Treatment|0|||
128916624|NCT00618722|463986752|FG000|Overall Study|Patient Request|1|||
128916625|NCT00618722|463986753|FG001|Overall Study|Patient Request|1|||
128916626|NCT00618722|463986754|FG002|Overall Study|Patient Request|1|||
128916627|NCT00618722|463986755|FG003|Overall Study|Patient Request|1|||
128916628|NCT00618722|463986752|FG000|Overall Study|Inability to Complete Study Procedure|0|||
128916629|NCT00618722|463986753|FG001|Overall Study|Inability to Complete Study Procedure|1|||
128916630|NCT00618722|463986754|FG002|Overall Study|Inability to Complete Study Procedure|0|||
128916631|NCT00618722|463986755|FG003|Overall Study|Inability to Complete Study Procedure|0|||
128916632|NCT00618722|463986752|FG000|Overall Study|Lost to Follow-up|2|||
128916633|NCT00618722|463986753|FG001|Overall Study|Lost to Follow-up|0|||
128916634|NCT00618722|463986754|FG002|Overall Study|Lost to Follow-up|0|||
128916635|NCT00618722|463986755|FG003|Overall Study|Lost to Follow-up|2|||
128916636|NCT00618722|463986752|FG000|Overall Study|Miscellaneous Reasons|0|||
128916637|NCT00618722|463986753|FG001|Overall Study|Miscellaneous Reasons|0|||
128916638|NCT00618722|463986754|FG002|Overall Study|Miscellaneous Reasons|1|||
128916639|NCT00618722|463986755|FG003|Overall Study|Miscellaneous Reasons|1|||
128916640|NCT00200057|463986758|FG000|Overall Study|Lack of Efficacy|3|||
128916641|NCT00200057|463986758|FG000|Overall Study|Exited due to terminal illness of PI|2|||
128916642|NCT00200057|463986758|FG000|Overall Study|Withdrawal by Subject|1|||
128916643|NCT00200057|463986758|FG000|Overall Study|Change in medical condition|1|||
128916644|NCT00200057|463986758|FG000|Overall Study|Infection|1|||
128916645|NCT00200057|463986758|FG000|Overall Study|Death|1|||
128916646|NCT01891643|463986759|FG000|Overall Study|Adverse event unrelated to study drug|2|||
128916647|NCT01891643|463986760|FG001|Overall Study|Adverse event unrelated to study drug|5|||
128916648|NCT01891643|463986759|FG000|Overall Study|Disease Progression|4|||
128916649|NCT01891643|463986760|FG001|Overall Study|Disease Progression|3|||
128916650|NCT01891643|463986759|FG000|Overall Study|Study Drug Toxicity|3|||
128916651|NCT01891643|463986760|FG001|Overall Study|Study Drug Toxicity|0|||
128916652|NCT01891643|463986759|FG000|Overall Study|Maximum Clinical Benefit|0|||
128916653|NCT01891643|463986760|FG001|Overall Study|Maximum Clinical Benefit|1|||
128916654|NCT01891643|463986759|FG000|Overall Study|Poor/Non-compliance|0|||
128916655|NCT01891643|463986760|FG001|Overall Study|Poor/Non-compliance|1|||
128697902|NCT04457336|463192258|FG006|Period 3: Part B|Study Terminated|13|||
128697903|NCT04457336|463192259|FG007|Period 3: Part B|Study Terminated|0|||
128697904|NCT04457336|463192252|FG000|Period 3: Part B|Withdrawal by Subject|0|||
128697905|NCT04457336|463192253|FG001|Period 3: Part B|Withdrawal by Subject|0|||
128697906|NCT04457336|463192254|FG002|Period 3: Part B|Withdrawal by Subject|0|||
128697907|NCT04457336|463192255|FG003|Period 3: Part B|Withdrawal by Subject|0|||
128697908|NCT04457336|463192256|FG004|Period 3: Part B|Withdrawal by Subject|0|||
128697909|NCT04457336|463192257|FG005|Period 3: Part B|Withdrawal by Subject|1|||
128697910|NCT04457336|463192258|FG006|Period 3: Part B|Withdrawal by Subject|2|||
128697911|NCT04457336|463192259|FG007|Period 3: Part B|Withdrawal by Subject|0|||
128697912|NCT04457336|463192252|FG000|Period 4: Part C|Study Terminated|0|||
128697913|NCT04457336|463192253|FG001|Period 4: Part C|Study Terminated|0|||
128697914|NCT04457336|463192254|FG002|Period 4: Part C|Study Terminated|0|||
128697915|NCT04457336|463192255|FG003|Period 4: Part C|Study Terminated|0|||
128697916|NCT04457336|463192256|FG004|Period 4: Part C|Study Terminated|0|||
128697917|NCT04457336|463192257|FG005|Period 4: Part C|Study Terminated|0|||
128697918|NCT04457336|463192258|FG006|Period 4: Part C|Study Terminated|0|||
128697919|NCT04457336|463192259|FG007|Period 4: Part C|Study Terminated|30|||
128697920|NCT04457336|463192252|FG000|Period 4: Part C|Adverse Event|0|||
128697921|NCT04457336|463192253|FG001|Period 4: Part C|Adverse Event|0|||
128697922|NCT04457336|463192254|FG002|Period 4: Part C|Adverse Event|0|||
128697923|NCT04457336|463192255|FG003|Period 4: Part C|Adverse Event|0|||
128697924|NCT04457336|463192256|FG004|Period 4: Part C|Adverse Event|0|||
128697925|NCT04457336|463192257|FG005|Period 4: Part C|Adverse Event|0|||
128697926|NCT04457336|463192258|FG006|Period 4: Part C|Adverse Event|0|||
128697927|NCT04457336|463192259|FG007|Period 4: Part C|Adverse Event|2|||
128697928|NCT04457336|463192252|FG000|Period 4: Part C|Site Terminated|0|||
128697929|NCT04457336|463192253|FG001|Period 4: Part C|Site Terminated|0|||
128697930|NCT04457336|463192254|FG002|Period 4: Part C|Site Terminated|0|||
128697931|NCT04457336|463192255|FG003|Period 4: Part C|Site Terminated|0|||
128697932|NCT04457336|463192256|FG004|Period 4: Part C|Site Terminated|0|||
128697933|NCT04457336|463192257|FG005|Period 4: Part C|Site Terminated|0|||
128697934|NCT04457336|463192258|FG006|Period 4: Part C|Site Terminated|0|||
128697935|NCT04457336|463192259|FG007|Period 4: Part C|Site Terminated|1|||
128697936|NCT04457336|463192252|FG000|Period 4: Part C|Other|0|||
128697937|NCT04457336|463192253|FG001|Period 4: Part C|Other|0|||
128697938|NCT04457336|463192254|FG002|Period 4: Part C|Other|0|||
128697939|NCT04457336|463192255|FG003|Period 4: Part C|Other|0|||
128697940|NCT04457336|463192256|FG004|Period 4: Part C|Other|0|||
128697941|NCT04457336|463192257|FG005|Period 4: Part C|Other|0|||
128697942|NCT04457336|463192258|FG006|Period 4: Part C|Other|0|||
128697943|NCT04457336|463192259|FG007|Period 4: Part C|Other|2|||
128697944|NCT04457336|463192252|FG000|Period 4: Part C|Withdrawal by Subject|0|||
128697945|NCT04457336|463192253|FG001|Period 4: Part C|Withdrawal by Subject|0|||
128697946|NCT04457336|463192254|FG002|Period 4: Part C|Withdrawal by Subject|0|||
128697947|NCT04457336|463192255|FG003|Period 4: Part C|Withdrawal by Subject|0|||
128697948|NCT04457336|463192256|FG004|Period 4: Part C|Withdrawal by Subject|0|||
128697949|NCT04457336|463192257|FG005|Period 4: Part C|Withdrawal by Subject|0|||
128697950|NCT04457336|463192258|FG006|Period 4: Part C|Withdrawal by Subject|0|||
128697951|NCT04457336|463192259|FG007|Period 4: Part C|Withdrawal by Subject|3|||
128697952|NCT03330288|463192266|FG000|Overall Study|Other reason|1|||
128697953|NCT03330288|463192267|FG001|Overall Study|Other reason|1|||
128697954|NCT03330288|463192266|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
128697955|NCT03330288|463192267|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
128697956|NCT03330288|463192266|FG000|Overall Study|Adverse Event|1|||
128697957|NCT03330288|463192267|FG001|Overall Study|Adverse Event|0|||
128697958|NCT03330288|463192266|FG000|Overall Study|Withdrawal by Subject|1|||
128697959|NCT03330288|463192267|FG001|Overall Study|Withdrawal by Subject|0|||
128697960|NCT03330288|463192266|FG000|Overall Study|Lost to Follow-up|26|||
128697961|NCT03330288|463192267|FG001|Overall Study|Lost to Follow-up|7|||
128916656|NCT01891643|463986759|FG000|Overall Study|Participant request to discontinue|1|||
128916657|NCT01891643|463986760|FG001|Overall Study|Participant request to discontinue|0|||
128916658|NCT02965716|463986761|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
128916659|NCT02965716|463986762|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
128697962|NCT02693119|463192271|FG000|Open-Label Period|Withdrawal by Subject|0|||
128697963|NCT02693119|463192272|FG001|Open-Label Period|Withdrawal by Subject|1|||
128697964|NCT01719783|463192275|FG000|Dose 2|Physician Decision|1|||
128916660|NCT02965716|463986761|FG000|Overall Study|Progression/Relapse|8|||
128916661|NCT02965716|463986762|FG001|Overall Study|Progression/Relapse|16|||
128697965|NCT01719783|463192276|FG001|Dose 2|Physician Decision|0|||
128697966|NCT01350492|463192277|FG000|Intervention|Lost to Follow-up|2|||
128697967|NCT01350492|463192278|FG001|Intervention|Lost to Follow-up|5|||
128697968|NCT01350492|463192277|FG000|Intervention|Withdrawal by Subject|3|||
128697969|NCT01350492|463192278|FG001|Intervention|Withdrawal by Subject|1|||
128697970|NCT01350492|463192277|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
128697971|NCT01350492|463192278|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
128916662|NCT02965716|463986761|FG000|Overall Study|Death|1|||
128697972|NCT01350492|463192277|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
128916663|NCT02965716|463986762|FG001|Overall Study|Death|0|||
128916664|NCT02965716|463986761|FG000|Overall Study|Not Protocol Specified|1|||
128916665|NCT02965716|463986762|FG001|Overall Study|Not Protocol Specified|3|||
128916666|NCT02613208|463986764|FG000|Overall Study|Withdrawal by Subject|1|||
128916667|NCT02613208|463986764|FG000|Overall Study|Change of address|2|||
128916668|NCT02613208|463986764|FG000|Overall Study|Physician Decision|2|||
128916669|NCT02613208|463986764|FG000|Overall Study|Lost to Follow-up|5|||
128916670|NCT02613208|463986764|FG000|Overall Study|Death|37|||
128697973|NCT01350492|463192278|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
128916671|NCT02663895|463986765|FG000|Overall Study|Adverse Event|3|||
128916672|NCT02663895|463986765|FG000|Overall Study|Physician Decision|2|||
128916673|NCT02663895|463986765|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
128916674|NCT02663895|463986765|FG000|Overall Study|Withdrawal by Subject|1|||
128916675|NCT01276821|463986766|FG000|Overall Study|Protocol Violation|0|||
128916676|NCT01276821|463986767|FG001|Overall Study|Protocol Violation|1|||
128916677|NCT00605267|463986768|FG000|Overall Study|Adverse Event|0|||
128916678|NCT00605267|463986769|FG001|Overall Study|Adverse Event|1|||
128916679|NCT00605267|463986768|FG000|Overall Study|Lack of Efficacy|1|||
128916680|NCT00605267|463986769|FG001|Overall Study|Lack of Efficacy|5|||
128916681|NCT00605267|463986768|FG000|Overall Study|Withdrawal by Subject|2|||
128916682|NCT00605267|463986769|FG001|Overall Study|Withdrawal by Subject|3|||
128916683|NCT02720757|463986770|FG000|Overall Study|Other reason|5|||
128916684|NCT02720757|463986770|FG000|Overall Study|Loss of contact|4|||
128916685|NCT02720757|463986770|FG000|Overall Study|Informed consent withdrawal|1|||
128916686|NCT02720757|463986770|FG000|Overall Study|Patients wish to withdraw|2|||
128916687|NCT02720757|463986770|FG000|Overall Study|Missing|3|||
128916688|NCT02720757|463986770|FG000|Overall Study|General exclusion|3|||
128916689|NCT00988247|463986771|FG000|Overall Study|Adverse Event|17|||
128916690|NCT00988247|463986772|FG001|Overall Study|Adverse Event|3|||
128916691|NCT00988247|463986771|FG000|Overall Study|Withdrawal by Subject|44|||
128916692|NCT00988247|463986772|FG001|Overall Study|Withdrawal by Subject|13|||
128916693|NCT00988247|463986771|FG000|Overall Study|Pregnancy|1|||
128916694|NCT00988247|463986772|FG001|Overall Study|Pregnancy|2|||
128916695|NCT00988247|463986771|FG000|Overall Study|Lost to Follow-up|11|||
128916696|NCT00988247|463986772|FG001|Overall Study|Lost to Follow-up|2|||
128916697|NCT00988247|463986771|FG000|Overall Study|Protocol Violation|4|||
128916698|NCT00988247|463986772|FG001|Overall Study|Protocol Violation|5|||
128916699|NCT00988247|463986771|FG000|Overall Study|Sponsor requested withdrawal|3|||
128916700|NCT00988247|463986772|FG001|Overall Study|Sponsor requested withdrawal|1|||
128916701|NCT00988247|463986771|FG000|Overall Study|Other|3|||
128916702|NCT00988247|463986772|FG001|Overall Study|Other|0|||
128916703|NCT02661594|463986773|FG000|Overall Study|Protocol Violation|1|||
128916704|NCT02661594|463986774|FG001|Overall Study|Protocol Violation|0|||
128916705|NCT02661594|463986775|FG002|Overall Study|Protocol Violation|1|||
128916706|NCT02661594|463986776|FG003|Overall Study|Protocol Violation|0|||
128916707|NCT04173741|463986777|FG000|Overall Study|IVC measurement cannot be done|1|||
128916708|NCT04173741|463986778|FG001|Overall Study|IVC measurement cannot be done|1|||
128916709|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916710|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
128916711|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916712|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916713|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916714|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
128916715|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
128916716|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
128916717|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
128916718|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
128916719|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
128916720|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
128916721|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
128916722|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
128916723|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
128916724|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
128916725|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
128916726|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
128697974|NCT00939640|463192279|FG000|Overall Study|Physician Decision|1|||
128916727|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
128916728|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
128916729|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916730|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129028990|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
128697975|NCT01768286|463192284|FG000|Overall Study|Randomized But Not Treated|0|||
128765702|NCT02508532|463433890|FG000|Part 2 - Treatment|Sponsor Decision|0|||
128765703|NCT02508532|463433891|FG001|Part 2 - Treatment|Sponsor Decision|0|||
128765704|NCT02508532|463433892|FG002|Part 2 - Treatment|Sponsor Decision|0|||
128765705|NCT02508532|463433893|FG003|Part 2 - Treatment|Sponsor Decision|0|||
128765706|NCT02508532|463433894|FG004|Part 2 - Treatment|Sponsor Decision|0|||
128765707|NCT02508532|463433895|FG005|Part 2 - Treatment|Sponsor Decision|0|||
128765708|NCT02508532|463433896|FG006|Part 2 - Treatment|Sponsor Decision|0|||
128765709|NCT02508532|463433897|FG007|Part 2 - Treatment|Sponsor Decision|0|||
128765710|NCT02508532|463433898|FG008|Part 2 - Treatment|Sponsor Decision|28|||
128765711|NCT02508532|463433890|FG000|Part 2 - Treatment|Death|0|||
128765712|NCT02508532|463433891|FG001|Part 2 - Treatment|Death|0|||
128765713|NCT02508532|463433892|FG002|Part 2 - Treatment|Death|0|||
128765714|NCT02508532|463433893|FG003|Part 2 - Treatment|Death|0|||
128765715|NCT02508532|463433894|FG004|Part 2 - Treatment|Death|0|||
128765716|NCT02508532|463433895|FG005|Part 2 - Treatment|Death|0|||
128765717|NCT02508532|463433896|FG006|Part 2 - Treatment|Death|0|||
128765718|NCT02508532|463433897|FG007|Part 2 - Treatment|Death|0|||
128765719|NCT02508532|463433898|FG008|Part 2 - Treatment|Death|1|||
128765720|NCT02508532|463433890|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
128765721|NCT02508532|463433891|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
128765722|NCT02508532|463433892|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
128765723|NCT02508532|463433893|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
128765724|NCT02508532|463433894|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
128765725|NCT02508532|463433895|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
128765726|NCT02508532|463433896|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
128765727|NCT02508532|463433897|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
128765728|NCT02508532|463433898|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
128765729|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
128765730|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
128765731|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
128765732|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
128765733|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
128916731|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916732|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
128916733|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916734|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
128916735|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
128916736|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
128916737|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
128916738|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
128916739|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
128916740|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
128916741|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
128916742|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
128916743|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
128916744|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
128916745|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
128916746|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
128916747|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
128916748|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
128916749|NCT00289913|463986779|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
128916750|NCT00289913|463986780|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
128916751|NCT00289913|463986781|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
128916752|NCT00289913|463986782|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
128916753|NCT00289913|463986783|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
128916754|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916755|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916756|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
128916757|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916758|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916759|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
128916760|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
128916761|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
128916762|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
128765734|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
128765735|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
128765736|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
128765737|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
128697976|NCT01768286|463192285|FG001|Overall Study|Randomized But Not Treated|0|||
128697977|NCT01768286|463192286|FG002|Overall Study|Randomized But Not Treated|1|||
128697978|NCT01768286|463192287|FG003|Overall Study|Randomized But Not Treated|0|||
128697979|NCT01768286|463192284|FG000|Overall Study|Lack of Efficacy|7|||
128697980|NCT01768286|463192285|FG001|Overall Study|Lack of Efficacy|4|||
128697981|NCT01768286|463192286|FG002|Overall Study|Lack of Efficacy|0|||
128697982|NCT01768286|463192287|FG003|Overall Study|Lack of Efficacy|1|||
128697983|NCT01768286|463192284|FG000|Overall Study|Withdrew Consent|0|||
128697984|NCT01768286|463192285|FG001|Overall Study|Withdrew Consent|0|||
128697985|NCT01768286|463192286|FG002|Overall Study|Withdrew Consent|1|||
128697986|NCT01768286|463192287|FG003|Overall Study|Withdrew Consent|0|||
128697987|NCT00594659|463192289|FG000|Overall Study|Lost to Follow-up|13|||
128697988|NCT00594659|463192290|FG001|Overall Study|Lost to Follow-up|9|||
128697989|NCT00594659|463192291|FG002|Overall Study|Lost to Follow-up|7|||
128697990|NCT03298867|463192292|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
128697991|NCT03298867|463192293|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
128697992|NCT03298867|463192292|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
128697993|NCT03298867|463192293|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
128697994|NCT03298867|463192292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
128697995|NCT03298867|463192293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
128697996|NCT03298867|463192292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
128697997|NCT03298867|463192293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
128697998|NCT03298867|463192292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
128697999|NCT03298867|463192293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
128698000|NCT03298867|463192292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
128698001|NCT03298867|463192293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
128698002|NCT03298867|463192292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
128698003|NCT03298867|463192293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
128698004|NCT03298867|463192292|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
128698005|NCT03298867|463192293|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
128698006|NCT03298867|463192292|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
128698007|NCT03298867|463192293|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
128698008|NCT05358444|463192300|FG000|Overall Study|Withdrawal by Subject|0|||
128698009|NCT05358444|463192301|FG001|Overall Study|Withdrawal by Subject|1|||
128698010|NCT05358444|463192300|FG000|Overall Study|Lost to Follow-up|0|||
128698011|NCT05358444|463192301|FG001|Overall Study|Lost to Follow-up|3|||
128698012|NCT01453361|463192302|FG000|Overall Study|Disease Progression|6|||
128698013|NCT01453361|463192302|FG000|Overall Study|Screen-Failures|10|||
128698014|NCT04560998|463192303|FG000|Overall Study|Withdrawal by Subject|18|||
128698015|NCT04560998|463192304|FG001|Overall Study|Withdrawal by Subject|12|||
128698016|NCT04560998|463192303|FG000|Overall Study|Lost to Follow-up|8|||
128698017|NCT04560998|463192304|FG001|Overall Study|Lost to Follow-up|5|||
128698018|NCT04560998|463192303|FG000|Overall Study|Physician Decision|4|||
128698019|NCT04560998|463192304|FG001|Overall Study|Physician Decision|0|||
128765738|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
128765739|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
128916763|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
128916764|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
128916765|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
128916766|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
128698020|NCT01798004|463194153|FG000|Overall Study|Death|2|||
128698021|NCT01798004|463194153|FG000|Overall Study|Lack of Efficacy|8|||
128698022|NCT01798004|463194153|FG000|Overall Study|Physician Decision|25|||
128698023|NCT01798004|463194153|FG000|Overall Study|Withdrawal by Subject|4|||
128698024|NCT01798004|463194153|FG000|Overall Study|Ineligible|4|||
128698025|NCT01798004|463194153|FG000|Overall Study|Patient/parent refusal|7|||
128698026|NCT01798004|463194153|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
128698027|NCT01798004|463194153|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
128698028|NCT02323113|463194159|FG000|Overall Study|Adverse Event|3|||
128698029|NCT02323113|463194160|FG001|Overall Study|Adverse Event|3|||
128698030|NCT02323113|463194161|FG002|Overall Study|Adverse Event|2|||
128698031|NCT02323113|463194162|FG003|Overall Study|Adverse Event|5|||
128698032|NCT02323113|463194163|FG004|Overall Study|Adverse Event|8|||
128698033|NCT02323113|463194164|FG005|Overall Study|Adverse Event|3|||
128698034|NCT02323113|463194165|FG006|Overall Study|Adverse Event|6|||
128698035|NCT02323113|463194166|FG007|Overall Study|Adverse Event|0|||
128698036|NCT02323113|463194159|FG000|Overall Study|Progressive Disease|0|||
128698037|NCT02323113|463194160|FG001|Overall Study|Progressive Disease|1|||
128698038|NCT02323113|463194161|FG002|Overall Study|Progressive Disease|1|||
128698039|NCT02323113|463194162|FG003|Overall Study|Progressive Disease|0|||
128698040|NCT02323113|463194163|FG004|Overall Study|Progressive Disease|0|||
128698041|NCT02323113|463194164|FG005|Overall Study|Progressive Disease|3|||
128916767|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
128916768|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
128916769|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
128916770|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
128916771|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
128916772|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
128916773|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
128916774|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
128916775|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916776|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
128916777|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916778|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916779|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
128916780|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
128916781|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
128916782|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
128916783|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
128916784|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
128916785|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
128916786|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
128916787|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
128916788|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
128916789|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
128916790|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
128916791|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
128916792|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
128916793|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
128916794|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
128916795|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
128916796|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
128916797|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
128916798|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
128916799|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
128916800|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
128916801|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
128916802|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
128916803|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
128916804|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
128916805|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
128916806|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
128916807|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
128916808|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
128916809|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
128916810|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
128916811|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
128916812|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
128916813|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
128916814|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
128916815|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
128916816|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
128916817|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
128916818|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
128916819|NCT00289913|463986779|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
128916820|NCT00289913|463986780|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
128916821|NCT00289913|463986781|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
128916822|NCT00289913|463986782|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
128916823|NCT00289913|463986783|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
128916824|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916825|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
128916826|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916827|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128698042|NCT02323113|463194165|FG006|Overall Study|Progressive Disease|0|||
128698043|NCT02323113|463194166|FG007|Overall Study|Progressive Disease|0|||
128765740|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
128916828|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
128916829|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
128916830|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
128765741|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
128765742|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
128916831|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
128916832|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
128916833|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
128916834|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
128916835|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
128916836|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
128916837|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
128916838|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
128916839|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916840|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916841|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916842|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
128916843|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
128916844|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
128916845|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
128916846|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
128916847|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
128916848|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
128916849|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
128916850|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
128916851|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
128698044|NCT02323113|463194159|FG000|Overall Study|Symptomatic Deterioration|0|||
128698045|NCT02323113|463194160|FG001|Overall Study|Symptomatic Deterioration|0|||
128698046|NCT02323113|463194161|FG002|Overall Study|Symptomatic Deterioration|1|||
128698047|NCT02323113|463194162|FG003|Overall Study|Symptomatic Deterioration|0|||
128698048|NCT02323113|463194163|FG004|Overall Study|Symptomatic Deterioration|1|||
128698049|NCT02323113|463194164|FG005|Overall Study|Symptomatic Deterioration|0|||
128698050|NCT02323113|463194165|FG006|Overall Study|Symptomatic Deterioration|0|||
128698051|NCT02323113|463194166|FG007|Overall Study|Symptomatic Deterioration|0|||
128698052|NCT02323113|463194159|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
128698053|NCT02323113|463194160|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
128698054|NCT02323113|463194161|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
128698055|NCT02323113|463194162|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
128698056|NCT02323113|463194163|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
128698057|NCT02323113|463194164|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
128698058|NCT02323113|463194165|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
128698059|NCT02323113|463194166|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
128698060|NCT02323113|463194159|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
128698061|NCT02323113|463194160|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
128698062|NCT02323113|463194161|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
128698063|NCT02323113|463194162|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
128698064|NCT02323113|463194163|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
128698065|NCT02323113|463194164|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
128698066|NCT02323113|463194165|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
128698067|NCT02323113|463194166|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
128698068|NCT03281577|463194167|FG000|Overall Study|Adverse Event|0|||
128698069|NCT03281577|463194168|FG001|Overall Study|Adverse Event|0|||
128698070|NCT03281577|463194169|FG002|Overall Study|Adverse Event|0|||
128698071|NCT03281577|463194170|FG003|Overall Study|Adverse Event|1|||
128698072|NCT03281577|463194167|FG000|Overall Study|Withdrawal by Subject|1|||
128698073|NCT03281577|463194168|FG001|Overall Study|Withdrawal by Subject|0|||
128698074|NCT03281577|463194169|FG002|Overall Study|Withdrawal by Subject|0|||
128698075|NCT03281577|463194170|FG003|Overall Study|Withdrawal by Subject|0|||
128698076|NCT00443261|463194171|FG000|Overall Study|Death|1|||
128698077|NCT01663532|463194172|FG000|Overall Study|Lost to Follow-up|9|||
128698078|NCT01663532|463194173|FG001|Overall Study|Lost to Follow-up|10|||
128698079|NCT01663532|463194172|FG000|Overall Study|Adverse Event|7|||
128698080|NCT01663532|463194173|FG001|Overall Study|Adverse Event|13|||
128698081|NCT01663532|463194172|FG000|Overall Study|Met Withdrawal Criteria|7|||
128916852|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
128765743|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
128765744|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
128765745|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
128765746|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
128765747|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Death|0|||
128765748|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Death|4|||
128765749|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Death|2|||
128765750|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Death|4|||
128765751|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Death|3|||
128765752|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Death|0|||
128765753|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Death|0|||
128765754|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Death|1|||
128765755|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Death|111|||
128765756|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
128765757|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
128765758|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
128916853|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
128916854|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
128916855|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
128916856|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
128916857|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
128916858|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
128916859|NCT00289913|463986779|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
128916860|NCT00289913|463986780|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
128916861|NCT00289913|463986781|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
128916862|NCT00289913|463986782|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
128916863|NCT00289913|463986783|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
128916864|NCT00214461|463986786|FG000|Overall Study|Adverse Event|0|||
128916865|NCT00214461|463986787|FG001|Overall Study|Adverse Event|0|||
128916866|NCT00214461|463986788|FG002|Overall Study|Adverse Event|1|||
128916867|NCT00214461|463986789|FG003|Overall Study|Adverse Event|1|||
128916868|NCT00214461|463986786|FG000|Overall Study|Withdrawal by Subject|0|||
128916869|NCT00214461|463986787|FG001|Overall Study|Withdrawal by Subject|0|||
128916870|NCT00214461|463986788|FG002|Overall Study|Withdrawal by Subject|1|||
128916871|NCT00214461|463986789|FG003|Overall Study|Withdrawal by Subject|0|||
128916872|NCT03502187|463986790|FG000|Overall Study|Withdrawal by Subject|4|||
128916873|NCT03502187|463986791|FG001|Overall Study|Withdrawal by Subject|3|||
128916874|NCT03502187|463986792|FG002|Overall Study|Withdrawal by Subject|3|||
128916875|NCT03502187|463986790|FG000|Overall Study|Lost to Follow-up|5|||
128916876|NCT03502187|463986791|FG001|Overall Study|Lost to Follow-up|4|||
128916877|NCT03502187|463986792|FG002|Overall Study|Lost to Follow-up|5|||
128916878|NCT02908100|463986794|FG000|Overall Study|Adverse Event|7|||
128916879|NCT02908100|463986795|FG001|Overall Study|Adverse Event|6|||
128916880|NCT02908100|463986796|FG002|Overall Study|Adverse Event|9|||
128916881|NCT02908100|463986794|FG000|Overall Study|Death|2|||
128916882|NCT02908100|463986795|FG001|Overall Study|Death|0|||
128916883|NCT02908100|463986796|FG002|Overall Study|Death|0|||
128916884|NCT02908100|463986794|FG000|Overall Study|Lack of Efficacy|2|||
128916885|NCT02908100|463986795|FG001|Overall Study|Lack of Efficacy|3|||
128916886|NCT02908100|463986796|FG002|Overall Study|Lack of Efficacy|3|||
128916887|NCT02908100|463986794|FG000|Overall Study|Lost to Follow-up|0|||
128916888|NCT02908100|463986795|FG001|Overall Study|Lost to Follow-up|1|||
128916889|NCT02908100|463986796|FG002|Overall Study|Lost to Follow-up|2|||
128765759|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
128765760|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
128765761|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
128765762|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
128765763|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
128765764|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
128765765|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128765766|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128765767|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128765768|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128765769|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128765770|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128765771|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128765772|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
128916890|NCT02908100|463986794|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128916891|NCT02908100|463986795|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128916892|NCT02908100|463986796|FG002|Overall Study|Non-Compliance With Study Drug|2|||
128916893|NCT02908100|463986794|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
128916894|NCT02908100|463986795|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
128916895|NCT02908100|463986796|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
128916896|NCT02908100|463986794|FG000|Overall Study|Physician Decision|0|||
128916897|NCT02908100|463986795|FG001|Overall Study|Physician Decision|1|||
128916898|NCT02908100|463986796|FG002|Overall Study|Physician Decision|0|||
128916899|NCT02908100|463986794|FG000|Overall Study|Pregnancy|1|||
128916900|NCT02908100|463986795|FG001|Overall Study|Pregnancy|2|||
128916901|NCT02908100|463986796|FG002|Overall Study|Pregnancy|0|||
128916902|NCT02908100|463986794|FG000|Overall Study|Withdrawal by Subject|8|||
128916903|NCT02908100|463986795|FG001|Overall Study|Withdrawal by Subject|7|||
128916904|NCT02908100|463986796|FG002|Overall Study|Withdrawal by Subject|5|||
128916905|NCT02908100|463986794|FG000|Overall Study|Randomised in Error|1|||
128916906|NCT02908100|463986795|FG001|Overall Study|Randomised in Error|0|||
128916907|NCT02908100|463986796|FG002|Overall Study|Randomised in Error|0|||
128916908|NCT00400400|463986797|FG000|Overall Study|Adverse Event|9|||
128916909|NCT00400400|463986798|FG001|Overall Study|Adverse Event|8|||
128916910|NCT00400400|463986797|FG000|Overall Study|Protocol Violation|2|||
128916911|NCT00400400|463986798|FG001|Overall Study|Protocol Violation|0|||
128916912|NCT00400400|463986797|FG000|Overall Study|Withdrawal by Subject|1|||
128916913|NCT00400400|463986798|FG001|Overall Study|Withdrawal by Subject|3|||
128916914|NCT00400400|463986797|FG000|Overall Study|Administrative Problem|1|||
128916915|NCT00400400|463986798|FG001|Overall Study|Administrative Problem|0|||
128916916|NCT00400400|463986797|FG000|Overall Study|Lost to Follow-up|0|||
128916917|NCT00400400|463986798|FG001|Overall Study|Lost to Follow-up|1|||
128916918|NCT00400400|463986797|FG000|Overall Study|Did not receive study drug|1|||
128916919|NCT00400400|463986798|FG001|Overall Study|Did not receive study drug|3|||
128916920|NCT01688050|463986799|FG000|Overall Study|Death|7|||
128916921|NCT01688050|463986799|FG000|Overall Study|Conversion to open repair|1|||
128916922|NCT01688050|463986799|FG000|Overall Study|Lost to Follow-up|13|||
128916923|NCT01688050|463986799|FG000|Overall Study|Withdrawal by Subject|10|||
128916924|NCT01731678|463986816|FG000|Overall Study|Withdrawal by Subject|3|||
128916925|NCT01731678|463986816|FG000|Overall Study|Did not meet inclusion criteria|1|||
128916926|NCT01731678|463986816|FG000|Overall Study|RMT too high, making TMS difficult|3|||
128916927|NCT02649634|463986817|FG000|Overall Study|Withdrawal by Subject|3|||
128916928|NCT02649634|463986818|FG001|Overall Study|Withdrawal by Subject|5|||
128916929|NCT02649634|463986817|FG000|Overall Study|Lost to Follow-up|0|||
128916930|NCT02649634|463986818|FG001|Overall Study|Lost to Follow-up|1|||
128916931|NCT01318122|463986819|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128916932|NCT01318122|463986820|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128916933|NCT01318122|463986821|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
128916934|NCT01318122|463986822|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
128916935|NCT01318122|463986819|FG000|Enrolled - Long-Term Extension Study|Other|1|||
128916936|NCT01318122|463986820|FG001|Enrolled - Long-Term Extension Study|Other|0|||
128916937|NCT01318122|463986821|FG002|Enrolled - Long-Term Extension Study|Other|0|||
128916938|NCT01318122|463986822|FG003|Enrolled - Long-Term Extension Study|Other|0|||
128916939|NCT01318122|463986819|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
128916940|NCT01318122|463986820|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
128916941|NCT01318122|463986821|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
128916942|NCT01318122|463986822|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
128916943|NCT01318122|463986819|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
128765773|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
128765774|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
128765775|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
128765776|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
128765777|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
128765778|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
128765779|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
128765780|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
128765781|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
128765782|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
128765783|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128765784|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128916944|NCT01318122|463986820|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128916945|NCT01318122|463986821|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128765785|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128765786|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128765787|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128916946|NCT01318122|463986822|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128916947|NCT01318122|463986819|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
128916948|NCT01318122|463986820|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
128916949|NCT01318122|463986821|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
128916950|NCT01318122|463986822|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
128916951|NCT01318122|463986819|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
128916952|NCT01318122|463986820|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
128916953|NCT01318122|463986821|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
128916954|NCT01318122|463986822|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
128916955|NCT01486199|463986823|FG000|Two Year Period Between Study Days|Physician Decision|1|||
128916956|NCT01486199|463986824|FG001|Two Year Period Between Study Days|Physician Decision|0|||
128916957|NCT02471716|463986826|FG000|Overall Study|Withdrawal by Subject|0|||
128916958|NCT02471716|463986827|FG001|Overall Study|Withdrawal by Subject|1|||
128916959|NCT02471716|463986828|FG002|Overall Study|Withdrawal by Subject|0|||
128916960|NCT02471716|463986829|FG003|Overall Study|Withdrawal by Subject|2|||
128916961|NCT02471716|463986830|FG004|Overall Study|Withdrawal by Subject|5|||
128916962|NCT02471716|463986826|FG000|Overall Study|Study Terminiated by sponsor|0|||
128916963|NCT02471716|463986827|FG001|Overall Study|Study Terminiated by sponsor|0|||
128916964|NCT02471716|463986828|FG002|Overall Study|Study Terminiated by sponsor|0|||
128916965|NCT02471716|463986829|FG003|Overall Study|Study Terminiated by sponsor|1|||
128916966|NCT02471716|463986830|FG004|Overall Study|Study Terminiated by sponsor|0|||
128916967|NCT02471716|463986826|FG000|Overall Study|Lost to Follow-up|0|||
128916968|NCT02471716|463986827|FG001|Overall Study|Lost to Follow-up|0|||
128916969|NCT02471716|463986828|FG002|Overall Study|Lost to Follow-up|0|||
128916970|NCT02471716|463986829|FG003|Overall Study|Lost to Follow-up|3|||
128916971|NCT02471716|463986830|FG004|Overall Study|Lost to Follow-up|2|||
128916972|NCT02471716|463986826|FG000|Overall Study|Death|0|||
128916973|NCT02471716|463986827|FG001|Overall Study|Death|0|||
128916974|NCT02471716|463986828|FG002|Overall Study|Death|0|||
128916975|NCT02471716|463986829|FG003|Overall Study|Death|1|||
128916976|NCT02471716|463986830|FG004|Overall Study|Death|0|||
128916977|NCT02471716|463986826|FG000|Overall Study|Other|0|||
128916978|NCT02471716|463986827|FG001|Overall Study|Other|0|||
128916979|NCT02471716|463986828|FG002|Overall Study|Other|0|||
128916980|NCT02471716|463986829|FG003|Overall Study|Other|8|||
128916981|NCT02471716|463986830|FG004|Overall Study|Other|9|||
128916982|NCT01737931|463986835|FG000|Overall Study|Withdrawal by Subject|0|||
128916983|NCT01737931|463986836|FG001|Overall Study|Withdrawal by Subject|1|||
128916984|NCT01737931|463986837|FG002|Overall Study|Withdrawal by Subject|1|||
128916985|NCT01737931|463986835|FG000|Overall Study|Physician Decision|0|||
128916986|NCT01737931|463986836|FG001|Overall Study|Physician Decision|1|||
128916987|NCT01737931|463986837|FG002|Overall Study|Physician Decision|0|||
128916988|NCT03183128|463986838|FG000|Overall Study|Adverse Event|1|||
128916989|NCT03183128|463986839|FG001|Overall Study|Adverse Event|2|||
128916990|NCT03183128|463986838|FG000|Overall Study|Withdrawal by Subject|1|||
128916991|NCT03183128|463986839|FG001|Overall Study|Withdrawal by Subject|8|||
128916992|NCT03183128|463986838|FG000|Overall Study|Protocol Violation|2|||
128698082|NCT01663532|463194173|FG001|Overall Study|Met Withdrawal Criteria|6|||
128698083|NCT01663532|463194172|FG000|Overall Study|Physician Decision|1|||
128698084|NCT01663532|463194173|FG001|Overall Study|Physician Decision|1|||
128698085|NCT01663532|463194172|FG000|Overall Study|Withdrawal by Subject|35|||
128698086|NCT01663532|463194173|FG001|Overall Study|Withdrawal by Subject|17|||
128698087|NCT01663532|463194172|FG000|Overall Study|Lack of Efficacy|15|||
128916993|NCT03183128|463986839|FG001|Overall Study|Protocol Violation|0|||
128916994|NCT03183128|463986838|FG000|Overall Study|Lack of Efficacy|4|||
128916995|NCT03183128|463986839|FG001|Overall Study|Lack of Efficacy|27|||
128916996|NCT03183128|463986838|FG000|Overall Study|Lost to Follow-up|1|||
128916997|NCT03183128|463986839|FG001|Overall Study|Lost to Follow-up|0|||
128916998|NCT03183128|463986838|FG000|Overall Study|Death|2|||
128916999|NCT03183128|463986839|FG001|Overall Study|Death|0|||
128917000|NCT03183128|463986838|FG000|Overall Study|Physician Decision|1|||
128917001|NCT03183128|463986839|FG001|Overall Study|Physician Decision|0|||
128917002|NCT00364182|463986840|FG000|First Intervention|Secondary prophylaxis|1|||
128917003|NCT00364182|463986841|FG001|First Intervention|Secondary prophylaxis|0|||
128917004|NCT00364182|463986842|FG002|First Intervention|Secondary prophylaxis|0|||
128917005|NCT00364182|463986840|FG000|First Intervention|Withdrawal by Subject|2|||
128917006|NCT00364182|463986841|FG001|First Intervention|Withdrawal by Subject|0|||
128698088|NCT01663532|463194173|FG001|Overall Study|Lack of Efficacy|60|||
128698089|NCT01433991|463194179|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
128698090|NCT01433991|463194180|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
128765788|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128917007|NCT00364182|463986842|FG002|First Intervention|Withdrawal by Subject|0|||
128917008|NCT00364182|463986840|FG000|Second Intervention|non-compliance|0|||
128917009|NCT00364182|463986841|FG001|Second Intervention|non-compliance|1|||
128917010|NCT00364182|463986842|FG002|Second Intervention|non-compliance|1|||
128917011|NCT00364182|463986840|FG000|Second Intervention|Protocol Violation|0|||
128917012|NCT00364182|463986841|FG001|Second Intervention|Protocol Violation|1|||
128917013|NCT00364182|463986842|FG002|Second Intervention|Protocol Violation|0|||
128917014|NCT00364182|463986840|FG000|Second Intervention|Adverse Event|0|||
128917015|NCT00364182|463986841|FG001|Second Intervention|Adverse Event|0|||
128917016|NCT00364182|463986842|FG002|Second Intervention|Adverse Event|1|||
128917017|NCT00364182|463986840|FG000|Third Intervention|non-compliance|0|||
128917018|NCT00364182|463986841|FG001|Third Intervention|non-compliance|1|||
128917019|NCT00364182|463986842|FG002|Third Intervention|non-compliance|0|||
128917020|NCT00364182|463986840|FG000|Third Intervention|Lost to Follow-up|0|||
128917021|NCT00364182|463986841|FG001|Third Intervention|Lost to Follow-up|0|||
128917022|NCT00364182|463986842|FG002|Third Intervention|Lost to Follow-up|1|||
128917023|NCT02921425|463986843|FG000|Overall Study|Protocol Violation|9|||
128917024|NCT01227967|463986844|FG000|Overall Study|Protocol Violation|3|||
128917025|NCT01227967|463986845|FG001|Overall Study|Protocol Violation|1|||
128917026|NCT01227967|463986844|FG000|Overall Study|Death|0|||
128917027|NCT01227967|463986845|FG001|Overall Study|Death|1|||
128917028|NCT01227967|463986844|FG000|Overall Study|Lost to Follow-up|8|||
128917029|NCT01227967|463986845|FG001|Overall Study|Lost to Follow-up|3|||
128917030|NCT01227967|463986844|FG000|Overall Study|Withdrawal by Subject|4|||
128917031|NCT01227967|463986845|FG001|Overall Study|Withdrawal by Subject|3|||
128917032|NCT01227967|463986844|FG000|Overall Study|Physician Decision|0|||
128917033|NCT01227967|463986845|FG001|Overall Study|Physician Decision|1|||
128917034|NCT01227967|463986844|FG000|Overall Study|Never Started Treatment|0|||
128917035|NCT01227967|463986845|FG001|Overall Study|Never Started Treatment|4|||
128917036|NCT01227967|463986844|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
128917037|NCT01227967|463986845|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
128917038|NCT03403400|463986846|FG000|Overall Study|Lost to Follow-up|1|||
128917039|NCT03403400|463986847|FG001|Overall Study|Lost to Follow-up|0|||
128917040|NCT03403400|463986848|FG002|Overall Study|Lost to Follow-up|1|||
128917041|NCT03403400|463986846|FG000|Overall Study|Hospitalization|1|||
129215845|NCT00068692|465092822|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
129215846|NCT00068692|465092823|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
128698091|NCT01433991|463194181|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
128698092|NCT01433991|463194182|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
128698093|NCT01433991|463194179|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
128698094|NCT01433991|463194180|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
128698095|NCT01433991|463194181|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
128698096|NCT01433991|463194182|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
128698097|NCT01433991|463194179|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
128698098|NCT01433991|463194180|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
128698099|NCT01433991|463194181|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
128698100|NCT01433991|463194182|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
128698101|NCT01433991|463194179|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
128698102|NCT01433991|463194180|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
128698103|NCT01433991|463194181|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
128698104|NCT01433991|463194182|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
128698105|NCT01433991|463194179|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
128698106|NCT01433991|463194180|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
128698107|NCT01433991|463194181|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
128698108|NCT01433991|463194182|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
128698109|NCT01433991|463194179|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
128698110|NCT01433991|463194180|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
128698111|NCT01433991|463194181|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
128698112|NCT01433991|463194182|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
128698113|NCT01433991|463194179|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
128698114|NCT01433991|463194180|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
128698115|NCT01433991|463194181|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
128698116|NCT01433991|463194182|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
128698117|NCT03539081|463194184|FG000|Overall Study|Withdrawal by Subject|2|||
128698118|NCT03539081|463194185|FG001|Overall Study|Withdrawal by Subject|3|||
128698119|NCT03539081|463194186|FG002|Overall Study|Withdrawal by Subject|0|||
128698120|NCT03539081|463194184|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
128698121|NCT03539081|463194185|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
128698122|NCT03539081|463194186|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
128698123|NCT01673867|463194190|FG000|Randomization|Adverse event unrelated to study drug|1|||
128917042|NCT03403400|463986847|FG001|Overall Study|Hospitalization|0|||
128917043|NCT03403400|463986848|FG002|Overall Study|Hospitalization|0|||
128917044|NCT03403400|463986846|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
128917045|NCT03403400|463986847|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
128917046|NCT03403400|463986848|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
128917047|NCT01384292|463986852|FG000|Part B|Severe non-compliance to protocol|1|||
128917048|NCT01384292|463986853|FG001|Part B|Severe non-compliance to protocol|0|||
128917049|NCT01384292|463986854|FG002|Part B|Severe non-compliance to protocol|0|||
128917050|NCT04062214|463986855|FG000|Week 12|Death|1|||
128917051|NCT04062214|463986856|FG001|Week 12|Death|1|||
128917052|NCT04062214|463986855|FG000|Week 12|Withdrawal by Subject|14|||
128917053|NCT04062214|463986856|FG001|Week 12|Withdrawal by Subject|13|||
128917054|NCT04062214|463986855|FG000|Week 12|Lost to Follow-up|55|||
128917055|NCT04062214|463986856|FG001|Week 12|Lost to Follow-up|68|||
128917056|NCT04062214|463986855|FG000|Week 12|Intermittent missing|31|||
128917057|NCT04062214|463986856|FG001|Week 12|Intermittent missing|29|||
128917058|NCT04062214|463986855|FG000|Week 36|Withdrawal by Subject|4|||
128917059|NCT04062214|463986856|FG001|Week 36|Withdrawal by Subject|5|||
128917060|NCT04062214|463986855|FG000|Week 36|Lost to Follow-up|50|||
128917061|NCT04062214|463986856|FG001|Week 36|Lost to Follow-up|46|||
128917062|NCT04062214|463986855|FG000|Week 36|Death|0|||
128917063|NCT04062214|463986856|FG001|Week 36|Death|1|||
128917064|NCT04666038|463986857|FG000|Overall Study|Progressive Disease|2|||
128917065|NCT04666038|463986858|FG001|Overall Study|Progressive Disease|0|||
128917066|NCT04666038|463986857|FG000|Overall Study|Death|38|||
128917067|NCT04666038|463986858|FG001|Overall Study|Death|32|||
128917068|NCT04666038|463986857|FG000|Overall Study|Withdrawal by Subject|10|||
128917069|NCT04666038|463986858|FG001|Overall Study|Withdrawal by Subject|19|||
128917070|NCT04666038|463986857|FG000|Overall Study|Lost to Follow-up|0|||
128917071|NCT04666038|463986858|FG001|Overall Study|Lost to Follow-up|2|||
128917072|NCT04666038|463986857|FG000|Overall Study|On Study Treatment|46|||
128917073|NCT04666038|463986858|FG001|Overall Study|On Study Treatment|5|||
128917074|NCT04666038|463986857|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
128698124|NCT01673867|463194191|FG001|Randomization|Adverse event unrelated to study drug|0|||
128917075|NCT04666038|463986858|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
128917076|NCT01282229|463986869|FG000|Overall Study|Protocol Violation|2|||
128917077|NCT03094195|463986877|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
128917078|NCT03094195|463986878|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
128917079|NCT03094195|463986879|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
128917080|NCT03094195|463986880|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
128917081|NCT03094195|463986881|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
128917082|NCT03094195|463986882|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
128917083|NCT03094195|463986883|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
128917084|NCT03094195|463986884|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
128917085|NCT03094195|463986877|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
128698125|NCT01673867|463194190|FG000|Randomization|Participant request to discontinue study treatment|0|||
128698126|NCT01673867|463194191|FG001|Randomization|Participant request to discontinue study treatment|4|||
128698127|NCT01673867|463194190|FG000|Randomization|Withdrawal by participant|0|||
128698128|NCT01673867|463194191|FG001|Randomization|Withdrawal by participant|12|||
128698129|NCT01673867|463194190|FG000|Randomization|Lost to Follow-up|0|||
128917086|NCT03094195|463986878|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
128917087|NCT03094195|463986879|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
128917088|NCT03094195|463986880|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
128917089|NCT03094195|463986881|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
128917090|NCT03094195|463986882|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
128917091|NCT03094195|463986883|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
128917092|NCT03094195|463986884|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
128917093|NCT03094195|463986877|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
128698130|NCT01673867|463194191|FG001|Randomization|Lost to Follow-up|1|||
128698131|NCT01673867|463194190|FG000|Randomization|Participant no longer meets study criteria|4|||
128698132|NCT01673867|463194191|FG001|Randomization|Participant no longer meets study criteria|5|||
128698133|NCT01673867|463194190|FG000|Treatment|Disease Progression|208|||
128698134|NCT01673867|463194191|FG001|Treatment|Disease Progression|178|||
128698135|NCT01673867|463194190|FG000|Treatment|Study Drug Toxicity|23|||
128698136|NCT01673867|463194191|FG001|Treatment|Study Drug Toxicity|43|||
128698137|NCT01673867|463194190|FG000|Treatment|Death|2|||
128698138|NCT01673867|463194191|FG001|Treatment|Death|3|||
128698139|NCT01673867|463194190|FG000|Treatment|Adverse event unrelated to study drug|23|||
128698140|NCT01673867|463194191|FG001|Treatment|Adverse event unrelated to study drug|10|||
128698141|NCT01673867|463194190|FG000|Treatment|Participant request to discontinue study treatment|7|||
128698142|NCT01673867|463194191|FG001|Treatment|Participant request to discontinue study treatment|17|||
128698143|NCT01673867|463194190|FG000|Treatment|Withdrawal by participant|5|||
128698144|NCT01673867|463194191|FG001|Treatment|Withdrawal by participant|5|||
128698145|NCT01673867|463194190|FG000|Treatment|Maximum clinical benefit|1|||
128698146|NCT01673867|463194191|FG001|Treatment|Maximum clinical benefit|10|||
128698147|NCT01673867|463194190|FG000|Treatment|Participant no longer meets study criteria|2|||
128698148|NCT01673867|463194191|FG001|Treatment|Participant no longer meets study criteria|0|||
128698149|NCT01673867|463194190|FG000|Treatment|Administrative reason by sponsor|3|||
128698150|NCT01673867|463194191|FG001|Treatment|Administrative reason by sponsor|0|||
128765789|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128765790|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
128917094|NCT03094195|463986878|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
128917095|NCT03094195|463986879|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
129215847|NCT00068692|465092824|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
129215848|NCT00068692|465092825|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
129215849|NCT00068692|465092826|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
129215850|NCT00068692|465092827|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
129215851|NCT00068692|465092820|FG000|Step 2: Randomization|alternative therapy|0|||
129215852|NCT00068692|465092821|FG001|Step 2: Randomization|alternative therapy|0|||
129215853|NCT00068692|465092822|FG002|Step 2: Randomization|alternative therapy|0|||
129215854|NCT00068692|465092823|FG003|Step 2: Randomization|alternative therapy|1|||
129215855|NCT00068692|465092824|FG004|Step 2: Randomization|alternative therapy|1|||
129215856|NCT00068692|465092825|FG005|Step 2: Randomization|alternative therapy|0|||
129215857|NCT00068692|465092826|FG006|Step 2: Randomization|alternative therapy|0|||
129215858|NCT00068692|465092827|FG007|Step 2: Randomization|alternative therapy|0|||
129215859|NCT00068692|465092820|FG000|Step 2: Randomization|Physician Decision|0|||
129215860|NCT00068692|465092821|FG001|Step 2: Randomization|Physician Decision|0|||
129215861|NCT00068692|465092822|FG002|Step 2: Randomization|Physician Decision|0|||
129215862|NCT00068692|465092823|FG003|Step 2: Randomization|Physician Decision|1|||
129215863|NCT00068692|465092824|FG004|Step 2: Randomization|Physician Decision|1|||
129215864|NCT00068692|465092825|FG005|Step 2: Randomization|Physician Decision|0|||
129215865|NCT00068692|465092826|FG006|Step 2: Randomization|Physician Decision|0|||
129215866|NCT00068692|465092827|FG007|Step 2: Randomization|Physician Decision|0|||
129215867|NCT00068692|465092820|FG000|Step 2: Randomization|Other|0|||
129215868|NCT00068692|465092821|FG001|Step 2: Randomization|Other|0|||
129215869|NCT00068692|465092822|FG002|Step 2: Randomization|Other|0|||
129215870|NCT00068692|465092823|FG003|Step 2: Randomization|Other|1|||
129215871|NCT00068692|465092824|FG004|Step 2: Randomization|Other|0|||
129215872|NCT00068692|465092825|FG005|Step 2: Randomization|Other|1|||
129215873|NCT00068692|465092826|FG006|Step 2: Randomization|Other|0|||
129215874|NCT00068692|465092827|FG007|Step 2: Randomization|Other|0|||
129215875|NCT00068692|465092820|FG000|Step 2: Randomization|never start protocol therapy|0|||
129215876|NCT00068692|465092821|FG001|Step 2: Randomization|never start protocol therapy|0|||
129215877|NCT00068692|465092822|FG002|Step 2: Randomization|never start protocol therapy|1|||
129215878|NCT00068692|465092823|FG003|Step 2: Randomization|never start protocol therapy|0|||
129215879|NCT00068692|465092824|FG004|Step 2: Randomization|never start protocol therapy|1|||
129215880|NCT00068692|465092825|FG005|Step 2: Randomization|never start protocol therapy|0|||
129215881|NCT00068692|465092826|FG006|Step 2: Randomization|never start protocol therapy|0|||
129215882|NCT00068692|465092827|FG007|Step 2: Randomization|never start protocol therapy|0|||
129215883|NCT00248040|465092832|FG000|Overall Study|transplantectomy|2|||
129215884|NCT00248040|465092833|FG001|Overall Study|transplantectomy|1|||
129215885|NCT00248040|465092834|FG002|Overall Study|transplantectomy|3|||
129215886|NCT00248040|465092832|FG000|Overall Study|transplant cancelled post treat start|1|||
129215887|NCT00248040|465092833|FG001|Overall Study|transplant cancelled post treat start|0|||
129215888|NCT00248040|465092834|FG002|Overall Study|transplant cancelled post treat start|0|||
129215889|NCT00248040|465092832|FG000|Overall Study|Death|0|||
129215890|NCT00248040|465092833|FG001|Overall Study|Death|0|||
129215891|NCT00248040|465092834|FG002|Overall Study|Death|1|||
129215892|NCT00711191|465092841|FG000|Overall Study|Adverse Event|1|||
129215893|NCT00711191|465092842|FG001|Overall Study|Adverse Event|1|||
129215894|NCT00711191|465092843|FG002|Overall Study|Adverse Event|2|||
129215895|NCT00711191|465092841|FG000|Overall Study|Objective progression or relapse|2|||
129215896|NCT00711191|465092842|FG001|Overall Study|Objective progression or relapse|3|||
129215897|NCT00711191|465092843|FG002|Overall Study|Objective progression or relapse|7|||
129215898|NCT00711191|465092841|FG000|Overall Study|Withdrawal by Subject|0|||
129215899|NCT00711191|465092842|FG001|Overall Study|Withdrawal by Subject|1|||
129215900|NCT00711191|465092843|FG002|Overall Study|Withdrawal by Subject|3|||
129215901|NCT01002339|465092844|FG000|Overall Study|Withdrawal by Subject|0|||
129215902|NCT01002339|465092845|FG001|Overall Study|Withdrawal by Subject|1|||
129215903|NCT01002339|465092846|FG002|Overall Study|Withdrawal by Subject|0|||
128917096|NCT03094195|463986880|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
128917097|NCT03094195|463986881|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
128917098|NCT03094195|463986882|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
128917099|NCT03094195|463986883|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129215904|NCT01002339|465092844|FG000|Overall Study|Incorrect treatment assignment|0|||
128698151|NCT01673867|463194190|FG000|Treatment|Other reason|11|||
128917100|NCT03094195|463986884|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
128917101|NCT03094195|463986877|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129215905|NCT01002339|465092845|FG001|Overall Study|Incorrect treatment assignment|0|||
129215906|NCT01002339|465092846|FG002|Overall Study|Incorrect treatment assignment|1|||
129215907|NCT01002339|465092844|FG000|Overall Study|Protocol Violation|0|||
129215908|NCT01002339|465092845|FG001|Overall Study|Protocol Violation|0|||
129215909|NCT01002339|465092846|FG002|Overall Study|Protocol Violation|2|||
129215910|NCT01002339|465092844|FG000|Overall Study|Lung cancer detected before transplant|0|||
129215911|NCT01002339|465092845|FG001|Overall Study|Lung cancer detected before transplant|0|||
129215912|NCT01002339|465092846|FG002|Overall Study|Lung cancer detected before transplant|1|||
128917102|NCT03094195|463986878|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
128917103|NCT03094195|463986879|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
128917104|NCT03094195|463986880|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
128917105|NCT03094195|463986881|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
128917106|NCT03094195|463986882|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
128917107|NCT03094195|463986883|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
128917108|NCT03094195|463986884|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
128917109|NCT03887130|463986888|FG000|Overall Study|Progressive disease|23|||
128917110|NCT03887130|463986889|FG001|Overall Study|Progressive disease|14|||
128917111|NCT03887130|463986890|FG002|Overall Study|Progressive disease|7|||
128917112|NCT03887130|463986888|FG000|Overall Study|Protocol Violation|3|||
128917113|NCT03887130|463986889|FG001|Overall Study|Protocol Violation|1|||
128917114|NCT03887130|463986890|FG002|Overall Study|Protocol Violation|2|||
128917115|NCT03887130|463986888|FG000|Overall Study|Drug related toxicity|7|||
128917116|NCT03887130|463986889|FG001|Overall Study|Drug related toxicity|7|||
128917117|NCT03887130|463986890|FG002|Overall Study|Drug related toxicity|13|||
128917118|NCT03887130|463986888|FG000|Overall Study|Non drug related toxicity|3|||
128917119|NCT03887130|463986889|FG001|Overall Study|Non drug related toxicity|0|||
128917120|NCT03887130|463986890|FG002|Overall Study|Non drug related toxicity|0|||
128917121|NCT03887130|463986888|FG000|Overall Study|Death|2|||
128917122|NCT03887130|463986889|FG001|Overall Study|Death|2|||
128917123|NCT03887130|463986890|FG002|Overall Study|Death|1|||
128917124|NCT03887130|463986888|FG000|Overall Study|Withdrawal by Subject|7|||
128917125|NCT03887130|463986889|FG001|Overall Study|Withdrawal by Subject|6|||
128917126|NCT03887130|463986890|FG002|Overall Study|Withdrawal by Subject|11|||
128917127|NCT03887130|463986888|FG000|Overall Study|other reason|6|||
128917128|NCT03887130|463986889|FG001|Overall Study|other reason|20|||
128917129|NCT03887130|463986890|FG002|Overall Study|other reason|17|||
128917130|NCT04082663|463986891|FG000|Overall Study|Adverse Event|6|||
128917131|NCT04082663|463986891|FG000|Overall Study|Lost to Follow-up|1|||
128917132|NCT02440581|463986892|FG000|Overall Study|Death|0|||
128917133|NCT02440581|463986893|FG001|Overall Study|Death|0|||
128917134|NCT02440581|463986894|FG002|Overall Study|Death|7|||
128917135|NCT02440581|463986895|FG003|Overall Study|Death|5|||
128917136|NCT02440581|463986892|FG000|Overall Study|Transplanted|1|||
128917137|NCT02440581|463986893|FG001|Overall Study|Transplanted|0|||
128917138|NCT02440581|463986894|FG002|Overall Study|Transplanted|3|||
128917139|NCT02440581|463986895|FG003|Overall Study|Transplanted|2|||
128917140|NCT02440581|463986892|FG000|Overall Study|Withdrawal by Subject|4|||
128917141|NCT02440581|463986893|FG001|Overall Study|Withdrawal by Subject|11|||
128917142|NCT02440581|463986894|FG002|Overall Study|Withdrawal by Subject|3|||
128917143|NCT02440581|463986895|FG003|Overall Study|Withdrawal by Subject|7|||
128917144|NCT03186989|463986896|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128917145|NCT03186989|463986897|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128917146|NCT03186989|463986898|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
128917147|NCT03186989|463986899|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
128917148|NCT03186989|463986900|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
128917149|NCT03186989|463986901|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128917150|NCT03186989|463986902|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128917151|NCT03186989|463986903|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128917152|NCT03186989|463986904|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128765791|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
128765792|NCT02508532|463433890|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
128917153|NCT03186989|463986905|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128917154|NCT03186989|463986906|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
128917155|NCT03186989|463986896|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917156|NCT03186989|463986897|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917157|NCT03186989|463986898|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917158|NCT03186989|463986899|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917159|NCT03186989|463986900|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917160|NCT03186989|463986901|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
128917161|NCT03186989|463986902|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128765793|NCT02508532|463433891|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
128765794|NCT02508532|463433892|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
128917162|NCT03186989|463986903|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917163|NCT03186989|463986904|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917164|NCT03186989|463986905|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128765795|NCT02508532|463433893|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
128917165|NCT03186989|463986906|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
128917166|NCT03186989|463986896|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917167|NCT03186989|463986897|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917168|NCT03186989|463986898|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917169|NCT03186989|463986899|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917170|NCT03186989|463986900|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917171|NCT03186989|463986901|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917172|NCT03186989|463986902|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
128917173|NCT03186989|463986903|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917174|NCT03186989|463986904|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917175|NCT03186989|463986905|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917176|NCT03186989|463986906|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
128917177|NCT03186989|463986896|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917178|NCT03186989|463986897|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917179|NCT03186989|463986898|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917180|NCT03186989|463986899|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917181|NCT03186989|463986900|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917182|NCT03186989|463986901|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
128917183|NCT03186989|463986902|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
128917184|NCT03186989|463986903|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917185|NCT03186989|463986904|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
128917186|NCT03186989|463986905|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917187|NCT03186989|463986906|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
128917188|NCT01583374|463986907|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
128917189|NCT01583374|463986908|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
128917190|NCT01583374|463986909|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
128917191|NCT01583374|463986910|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128917192|NCT01583374|463986911|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128917193|NCT01583374|463986912|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128917194|NCT01583374|463986913|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128917195|NCT01583374|463986914|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128917196|NCT01583374|463986915|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128917197|NCT01583374|463986907|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
128917198|NCT01583374|463986908|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
128917199|NCT01583374|463986909|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
128917200|NCT01583374|463986910|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128917201|NCT01583374|463986911|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128917202|NCT01583374|463986912|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128917203|NCT01583374|463986913|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128917204|NCT01583374|463986914|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128917205|NCT01583374|463986915|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128917206|NCT01583374|463986907|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
128917207|NCT01583374|463986908|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
128917208|NCT01583374|463986909|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128917209|NCT01583374|463986910|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128917210|NCT01583374|463986911|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128917211|NCT01583374|463986912|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128917212|NCT01583374|463986913|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128917213|NCT01583374|463986914|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128917214|NCT01583374|463986915|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128917215|NCT01583374|463986907|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
128917216|NCT01583374|463986908|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
128917217|NCT01583374|463986909|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
128917218|NCT01583374|463986910|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128917219|NCT01583374|463986911|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128917220|NCT01583374|463986912|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128917221|NCT01583374|463986913|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128917222|NCT01583374|463986914|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128917223|NCT01583374|463986915|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128917224|NCT01583374|463986907|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
128917225|NCT01583374|463986908|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
128917226|NCT01583374|463986909|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
128917227|NCT01583374|463986910|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
128917228|NCT01583374|463986911|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
128917229|NCT01583374|463986912|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
128698152|NCT01673867|463194191|FG001|Treatment|Other reason|2|||
129215913|NCT01002339|465092844|FG000|Overall Study|Randomized. Not transplanted|0|||
129215914|NCT01002339|465092845|FG001|Overall Study|Randomized. Not transplanted|0|||
129215915|NCT01002339|465092846|FG002|Overall Study|Randomized. Not transplanted|1|||
129215916|NCT02118961|465092847|FG000|Overall Study|Withdrawal by Subject|1|||
128917230|NCT01583374|463986913|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129215917|NCT02118961|465092848|FG001|Overall Study|Withdrawal by Subject|0|||
128917231|NCT01583374|463986914|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
128917232|NCT01583374|463986915|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
128917233|NCT01583374|463986907|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128917234|NCT01583374|463986908|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128917235|NCT01583374|463986909|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
128917236|NCT01583374|463986910|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128917237|NCT01583374|463986911|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128917238|NCT01583374|463986912|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128917239|NCT01583374|463986913|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128917240|NCT01583374|463986914|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129215918|NCT00790842|465092849|FG000|Dose Level 1|Adverse Event|1|||
129215919|NCT00790842|465092850|FG001|Dose Level 1|Adverse Event|0|||
129215920|NCT00790842|465092851|FG002|Dose Level 1|Adverse Event|0|||
129215921|NCT00790842|465092852|FG003|Dose Level 1|Adverse Event|2|||
129215922|NCT00790842|465092853|FG004|Dose Level 1|Adverse Event|0|||
129215923|NCT00790842|465092854|FG005|Dose Level 1|Adverse Event|0|||
129215924|NCT00790842|465092855|FG006|Dose Level 1|Adverse Event|0|||
129215925|NCT00790842|465092856|FG007|Dose Level 1|Adverse Event|1|||
129215926|NCT00790842|465092857|FG008|Dose Level 1|Adverse Event|0|||
129215927|NCT00790842|465092858|FG009|Dose Level 1|Adverse Event|0|||
129215928|NCT00790842|465092859|FG010|Dose Level 1|Adverse Event|0|||
129215929|NCT00790842|465092849|FG000|Dose Level 1|Physician Decision|1|||
129215930|NCT00790842|465092850|FG001|Dose Level 1|Physician Decision|0|||
129215931|NCT00790842|465092851|FG002|Dose Level 1|Physician Decision|0|||
129215932|NCT00790842|465092852|FG003|Dose Level 1|Physician Decision|0|||
129215933|NCT00790842|465092853|FG004|Dose Level 1|Physician Decision|0|||
129215934|NCT00790842|465092854|FG005|Dose Level 1|Physician Decision|0|||
129215935|NCT00790842|465092855|FG006|Dose Level 1|Physician Decision|0|||
129215936|NCT00790842|465092856|FG007|Dose Level 1|Physician Decision|1|||
129215937|NCT00790842|465092857|FG008|Dose Level 1|Physician Decision|0|||
129215938|NCT00790842|465092858|FG009|Dose Level 1|Physician Decision|0|||
129215939|NCT00790842|465092859|FG010|Dose Level 1|Physician Decision|0|||
129215940|NCT00790842|465092849|FG000|Dose Level 1|Withdrawal by Subject|1|||
128698153|NCT02550106|463194194|FG000|Overall Study|Adverse Event|1|||
128917241|NCT01583374|463986915|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128917242|NCT01583374|463986907|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
128917243|NCT01583374|463986908|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
128917244|NCT01583374|463986909|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
128917245|NCT01583374|463986910|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
128917246|NCT01583374|463986911|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
128917247|NCT01583374|463986912|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
128917248|NCT01583374|463986913|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
128917249|NCT01583374|463986914|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
129215941|NCT00790842|465092850|FG001|Dose Level 1|Withdrawal by Subject|0|||
129215942|NCT00790842|465092851|FG002|Dose Level 1|Withdrawal by Subject|0|||
128698154|NCT02550106|463194194|FG000|Overall Study|Lack of Efficacy|3|||
128698155|NCT02550106|463194194|FG000|Overall Study|Protocol Violation|6|||
128698156|NCT02550106|463194194|FG000|Overall Study|Withdrawal by Subject|2|||
128698157|NCT00354744|463194195|FG000|Overall Study|Adverse Event|2|||
128698158|NCT00354744|463194195|FG000|Overall Study|Death|2|||
128917250|NCT01583374|463986915|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
128917251|NCT01583374|463986907|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129215943|NCT00790842|465092852|FG003|Dose Level 1|Withdrawal by Subject|0|||
129215944|NCT00790842|465092853|FG004|Dose Level 1|Withdrawal by Subject|0|||
129215945|NCT00790842|465092854|FG005|Dose Level 1|Withdrawal by Subject|0|||
129215946|NCT00790842|465092855|FG006|Dose Level 1|Withdrawal by Subject|0|||
129215947|NCT00790842|465092856|FG007|Dose Level 1|Withdrawal by Subject|0|||
128698159|NCT00354744|463194195|FG000|Overall Study|Lack of Efficacy|11|||
129215948|NCT00790842|465092857|FG008|Dose Level 1|Withdrawal by Subject|0|||
129215949|NCT00790842|465092858|FG009|Dose Level 1|Withdrawal by Subject|0|||
129215950|NCT00790842|465092859|FG010|Dose Level 1|Withdrawal by Subject|0|||
129215951|NCT00790842|465092849|FG000|Dose Level 2|Death|0|||
129215952|NCT00790842|465092850|FG001|Dose Level 2|Death|1|||
129215953|NCT00790842|465092851|FG002|Dose Level 2|Death|0|||
128698160|NCT00354744|463194195|FG000|Overall Study|Lost to Follow-up|2|||
128698161|NCT00354744|463194195|FG000|Overall Study|Physician Decision|11|||
129215954|NCT00790842|465092852|FG003|Dose Level 2|Death|0|||
128917252|NCT01583374|463986908|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129215955|NCT00790842|465092853|FG004|Dose Level 2|Death|1|||
128917253|NCT01583374|463986909|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
128917254|NCT01583374|463986910|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
128917255|NCT01583374|463986911|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
128917256|NCT01583374|463986912|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
128917257|NCT01583374|463986913|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
128917258|NCT01583374|463986914|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
128917259|NCT01583374|463986915|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
128917260|NCT01583374|463986907|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
128917261|NCT01583374|463986908|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
128917262|NCT01583374|463986909|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
128917263|NCT01583374|463986910|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
128917264|NCT01583374|463986911|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
128917265|NCT01583374|463986912|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
128917266|NCT01583374|463986913|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
128917267|NCT01583374|463986914|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
128917268|NCT01583374|463986915|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
128917269|NCT01583374|463986907|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
128917270|NCT01583374|463986908|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
128917271|NCT01583374|463986909|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
128917272|NCT01583374|463986910|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
128917273|NCT01583374|463986911|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
128917274|NCT01583374|463986912|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
128917275|NCT01583374|463986913|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
128917276|NCT01583374|463986914|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
128917277|NCT01583374|463986915|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
128917278|NCT01583374|463986907|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
128917279|NCT01583374|463986908|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
128917280|NCT01583374|463986909|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
128917281|NCT01583374|463986910|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
128917282|NCT01583374|463986911|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
128917283|NCT01583374|463986912|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
128917284|NCT01583374|463986913|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
128917285|NCT01583374|463986914|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
128917286|NCT01583374|463986915|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
128917287|NCT01583374|463986907|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
128917288|NCT01583374|463986908|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
128917289|NCT01583374|463986909|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
128917290|NCT01583374|463986910|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
128917291|NCT01583374|463986911|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
128917292|NCT01583374|463986912|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
128917293|NCT01583374|463986913|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
128917294|NCT01583374|463986914|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
128917295|NCT01583374|463986915|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
128917296|NCT01583374|463986907|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
128917297|NCT01583374|463986908|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
128917298|NCT01583374|463986909|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
128917299|NCT01583374|463986910|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
128917300|NCT01583374|463986911|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
128917301|NCT01583374|463986912|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
128917302|NCT01583374|463986913|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
128917303|NCT01583374|463986914|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
128917304|NCT01583374|463986915|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
128917305|NCT01583374|463986907|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
128917306|NCT01583374|463986908|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
128917307|NCT01583374|463986909|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
128917308|NCT01583374|463986910|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
128917309|NCT01583374|463986911|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
128917310|NCT01583374|463986912|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
128917311|NCT01583374|463986913|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
128917312|NCT01583374|463986914|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
128917313|NCT01583374|463986915|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
128917314|NCT01583374|463986907|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
128917315|NCT01583374|463986908|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
128765796|NCT02508532|463433894|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
128917316|NCT01583374|463986909|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
128917317|NCT01583374|463986910|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
128917318|NCT01583374|463986911|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
128917319|NCT01583374|463986912|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
128917320|NCT01583374|463986913|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
128917321|NCT01583374|463986914|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
128917322|NCT01583374|463986915|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
128917323|NCT01583374|463986907|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
128917324|NCT01583374|463986908|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
128917325|NCT01583374|463986909|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
128917326|NCT01583374|463986910|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
128917327|NCT01583374|463986911|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
128917328|NCT01583374|463986912|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
128917329|NCT01583374|463986913|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
128917330|NCT01583374|463986914|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
128917331|NCT01583374|463986915|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
128917332|NCT01583374|463986907|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
128917333|NCT01583374|463986908|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
128917334|NCT01583374|463986909|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
128917335|NCT01583374|463986910|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
128917336|NCT01583374|463986911|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
128917337|NCT01583374|463986912|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
128917338|NCT01583374|463986913|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
128917339|NCT01583374|463986914|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
128917340|NCT01583374|463986915|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
128917341|NCT01583374|463986907|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
128917342|NCT01583374|463986908|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
128917343|NCT01583374|463986909|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
128917344|NCT01583374|463986910|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
128917345|NCT01583374|463986911|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
128917346|NCT01583374|463986912|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
128917347|NCT01583374|463986913|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
128917348|NCT01583374|463986914|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
128917349|NCT01583374|463986915|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
128917350|NCT01583374|463986907|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
128917351|NCT01583374|463986908|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
128917352|NCT01583374|463986909|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
128917353|NCT01583374|463986910|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
128917354|NCT01583374|463986911|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
128917355|NCT01583374|463986912|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
128917356|NCT01583374|463986913|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
128917357|NCT01583374|463986914|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
128917358|NCT01583374|463986915|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
128917359|NCT01475734|463988549|FG000|Overall Study|Withdrawal by Subject|1|||
128917360|NCT01475734|463988550|FG001|Overall Study|Withdrawal by Subject|0|||
128917361|NCT01475734|463988549|FG000|Overall Study|Protocol Violation|1|||
128917362|NCT01475734|463988550|FG001|Overall Study|Protocol Violation|0|||
128917363|NCT01475734|463988549|FG000|Overall Study|Physician Decision|0|||
128917364|NCT01475734|463988550|FG001|Overall Study|Physician Decision|1|||
128917365|NCT00956943|463988554|FG000|Overall Study|Lost to Follow-up|9|||
128917366|NCT00956943|463988555|FG001|Overall Study|Lost to Follow-up|10|||
128917367|NCT01400932|463988559|FG000|Overall Study|Adverse Event|10|||
128917368|NCT01400932|463988560|FG001|Overall Study|Adverse Event|5|||
128917369|NCT01400932|463988559|FG000|Overall Study|Lack of Efficacy|0|||
128917370|NCT01400932|463988560|FG001|Overall Study|Lack of Efficacy|3|||
128917371|NCT01400932|463988559|FG000|Overall Study|Withdrawal by Subject|2|||
128917372|NCT01400932|463988560|FG001|Overall Study|Withdrawal by Subject|6|||
128917373|NCT01400932|463988559|FG000|Overall Study|Lost to Follow-up|1|||
128917374|NCT01400932|463988560|FG001|Overall Study|Lost to Follow-up|0|||
128917375|NCT01400932|463988559|FG000|Overall Study|Protocol Deviation|0|||
128917376|NCT01400932|463988560|FG001|Overall Study|Protocol Deviation|1|||
128917377|NCT01400932|463988559|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128917378|NCT01400932|463988560|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
128917379|NCT03244059|463988562|FG000|Specific Aim 1|Physician Decision|1|||
128917380|NCT03244059|463988563|FG001|Specific Aim 1|Physician Decision|0|||
128917381|NCT03244059|463988562|FG000|Specific Aim 2|Physician Decision|1|||
128917382|NCT03244059|463988563|FG001|Specific Aim 2|Physician Decision|0|||
128917383|NCT02939131|463988564|FG000|Overall Study|Unable to get to clinic|6|||
128917384|NCT02939131|463988565|FG001|Overall Study|Unable to get to clinic|4|||
128917385|NCT02939131|463988564|FG000|Overall Study|Lost to Follow-up|2|||
128917386|NCT02939131|463988565|FG001|Overall Study|Lost to Follow-up|4|||
128917387|NCT02939131|463988564|FG000|Overall Study|severe debilitation|1|||
128917388|NCT02939131|463988565|FG001|Overall Study|severe debilitation|0|||
128917389|NCT02939131|463988564|FG000|Overall Study|Other|0|||
128917390|NCT02939131|463988565|FG001|Overall Study|Other|1|||
128917391|NCT02939131|463988564|FG000|Overall Study|not willing to adhere to protocol|2|||
128917392|NCT02939131|463988565|FG001|Overall Study|not willing to adhere to protocol|0|||
128917393|NCT01254669|463988566|FG000|Overall Study|Withdrawal by Subject|0|||
128917394|NCT01254669|463988567|FG001|Overall Study|Withdrawal by Subject|1|||
128917395|NCT01254669|463988566|FG000|Overall Study|time constraint|2|||
128917396|NCT01254669|463988567|FG001|Overall Study|time constraint|2|||
128917397|NCT01254669|463988566|FG000|Overall Study|called to clinic during intervention|1|||
128917398|NCT01254669|463988567|FG001|Overall Study|called to clinic during intervention|1|||
128917399|NCT00883493|463988568|FG000|Overall Study|Adverse Event|11|||
128917400|NCT00883493|463988569|FG001|Overall Study|Adverse Event|12|||
128917401|NCT00883493|463988568|FG000|Overall Study|Lack of Efficacy|4|||
128917402|NCT00883493|463988569|FG001|Overall Study|Lack of Efficacy|3|||
128917403|NCT00883493|463988568|FG000|Overall Study|Lost to Follow-up|7|||
128917404|NCT00883493|463988569|FG001|Overall Study|Lost to Follow-up|6|||
128917405|NCT00883493|463988568|FG000|Overall Study|Withdrawal by Subject|11|||
128917406|NCT00883493|463988569|FG001|Overall Study|Withdrawal by Subject|20|||
128917407|NCT00883493|463988568|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
128917408|NCT00883493|463988569|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
128917409|NCT00883493|463988568|FG000|Overall Study|Study specific disc. criteria|2|||
128917410|NCT00883493|463988569|FG001|Overall Study|Study specific disc. criteria|0|||
128917411|NCT00883493|463988568|FG000|Overall Study|Other|5|||
128917412|NCT00883493|463988569|FG001|Overall Study|Other|3|||
128917413|NCT01084551|463988570|FG000|Overall Study|Adverse Event|2|||
128917414|NCT01084551|463988571|FG001|Overall Study|Adverse Event|9|||
128917415|NCT01084551|463988572|FG002|Overall Study|Adverse Event|4|||
128917416|NCT01084551|463988570|FG000|Overall Study|Lack of Efficacy|2|||
128917417|NCT01084551|463988571|FG001|Overall Study|Lack of Efficacy|0|||
128917418|NCT01084551|463988572|FG002|Overall Study|Lack of Efficacy|1|||
128917419|NCT01084551|463988570|FG000|Overall Study|Withdrawal by Subject|2|||
128917420|NCT01084551|463988571|FG001|Overall Study|Withdrawal by Subject|1|||
128917421|NCT01084551|463988572|FG002|Overall Study|Withdrawal by Subject|0|||
128917422|NCT01084551|463988570|FG000|Overall Study|Protocol Violation|2|||
128917423|NCT01084551|463988571|FG001|Overall Study|Protocol Violation|4|||
128917424|NCT01084551|463988572|FG002|Overall Study|Protocol Violation|0|||
128917425|NCT01084551|463988570|FG000|Overall Study|Lost to Follow-up|0|||
128917426|NCT01084551|463988571|FG001|Overall Study|Lost to Follow-up|0|||
128917427|NCT01084551|463988572|FG002|Overall Study|Lost to Follow-up|3|||
128917428|NCT01084551|463988570|FG000|Overall Study|Physician Decision|1|||
128917429|NCT01084551|463988571|FG001|Overall Study|Physician Decision|0|||
128917430|NCT01084551|463988572|FG002|Overall Study|Physician Decision|0|||
128917431|NCT00463476|463988575|FG000|Overall Study|Withdrawal by Subject|1|||
128917432|NCT00463476|463988576|FG001|Overall Study|Withdrawal by Subject|2|||
128917433|NCT00463476|463988575|FG000|Overall Study|Lost to Follow-up|1|||
128917434|NCT00463476|463988576|FG001|Overall Study|Lost to Follow-up|1|||
128917435|NCT01169779|463988581|FG000|Overall Study|Adverse Event|3|||
128917436|NCT01169779|463988582|FG001|Overall Study|Adverse Event|11|||
128917437|NCT01169779|463988581|FG000|Overall Study|Lack of Efficacy|1|||
128917438|NCT01169779|463988582|FG001|Overall Study|Lack of Efficacy|0|||
128765797|NCT02508532|463433895|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
128765798|NCT02508532|463433896|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
128765799|NCT02508532|463433897|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
128765800|NCT02508532|463433898|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
128765801|NCT03097861|463433899|FG000|Overall Study|Adverse Event|3|||
128765802|NCT03097861|463433900|FG001|Overall Study|Adverse Event|8|||
128765803|NCT03097861|463433901|FG002|Overall Study|Adverse Event|4|||
128765804|NCT03097861|463433899|FG000|Overall Study|Investigator Decision|0|||
128765805|NCT03097861|463433900|FG001|Overall Study|Investigator Decision|1|||
128765806|NCT03097861|463433901|FG002|Overall Study|Investigator Decision|0|||
128765807|NCT03097861|463433899|FG000|Overall Study|Lost to Follow-up|0|||
128765808|NCT03097861|463433900|FG001|Overall Study|Lost to Follow-up|7|||
128765809|NCT03097861|463433901|FG002|Overall Study|Lost to Follow-up|1|||
128765810|NCT03097861|463433899|FG000|Overall Study|Withdrawal by Subject|1|||
128765811|NCT03097861|463433900|FG001|Overall Study|Withdrawal by Subject|5|||
128765812|NCT03097861|463433901|FG002|Overall Study|Withdrawal by Subject|3|||
128765813|NCT03097861|463433899|FG000|Overall Study|Reason not provided|3|||
128765814|NCT03097861|463433900|FG001|Overall Study|Reason not provided|1|||
128765815|NCT03097861|463433901|FG002|Overall Study|Reason not provided|1|||
128765816|NCT00154310|463433902|FG000|Overall Study|Adverse Event|19|||
128917439|NCT01169779|463988581|FG000|Overall Study|Protocol Violation|1|||
128917440|NCT01169779|463988582|FG001|Overall Study|Protocol Violation|1|||
128917441|NCT01169779|463988581|FG000|Overall Study|Withdrawal by Subject|3|||
128917442|NCT01169779|463988582|FG001|Overall Study|Withdrawal by Subject|2|||
128917443|NCT01169779|463988581|FG000|Overall Study|Familial and personal reasons|3|||
128917444|NCT01169779|463988582|FG001|Overall Study|Familial and personal reasons|3|||
128917445|NCT01279057|463988584|FG000|Overall Study|Adverse Event|1|||
128917446|NCT01279057|463988585|FG001|Overall Study|Adverse Event|0|||
128917447|NCT01279057|463988586|FG002|Overall Study|Adverse Event|1|||
128917448|NCT01279057|463988584|FG000|Overall Study|Insufficient therapeutic response|0|||
128917449|NCT01279057|463988585|FG001|Overall Study|Insufficient therapeutic response|0|||
128917450|NCT01279057|463988586|FG002|Overall Study|Insufficient therapeutic response|1|||
128917451|NCT01279057|463988584|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
128917452|NCT01279057|463988585|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
128917453|NCT01279057|463988586|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
128917454|NCT01279057|463988584|FG000|Overall Study|Withdrew consent|2|||
128917455|NCT01279057|463988585|FG001|Overall Study|Withdrew consent|0|||
128917456|NCT01279057|463988586|FG002|Overall Study|Withdrew consent|1|||
128917457|NCT01279057|463988584|FG000|Overall Study|Pregnancy|0|||
128917458|NCT01279057|463988585|FG001|Overall Study|Pregnancy|1|||
128917459|NCT01279057|463988586|FG002|Overall Study|Pregnancy|0|||
128917460|NCT01279057|463988584|FG000|Overall Study|Other|3|||
128917461|NCT01279057|463988585|FG001|Overall Study|Other|3|||
128917462|NCT01279057|463988586|FG002|Overall Study|Other|0|||
128917463|NCT01427309|463988588|FG000|Overall Study|Lost to Follow-up|130|||
128917464|NCT01427309|463988589|FG001|Overall Study|Lost to Follow-up|145|||
128917465|NCT01427309|463988590|FG002|Overall Study|Lost to Follow-up|122|||
128917466|NCT01427309|463988591|FG003|Overall Study|Lost to Follow-up|135|||
128917467|NCT01427309|463988588|FG000|Overall Study|Protocol Violation|42|||
128917468|NCT01427309|463988589|FG001|Overall Study|Protocol Violation|69|||
128917469|NCT01427309|463988590|FG002|Overall Study|Protocol Violation|125|||
128917470|NCT01427309|463988591|FG003|Overall Study|Protocol Violation|124|||
128917471|NCT01427309|463988588|FG000|Overall Study|Adverse Event|0|||
128917472|NCT01427309|463988589|FG001|Overall Study|Adverse Event|0|||
128917473|NCT01427309|463988590|FG002|Overall Study|Adverse Event|3|||
128917474|NCT01427309|463988591|FG003|Overall Study|Adverse Event|1|||
128917475|NCT01427309|463988588|FG000|Overall Study|Serious adverse event|52|||
128917476|NCT01427309|463988589|FG001|Overall Study|Serious adverse event|45|||
128917477|NCT01427309|463988590|FG002|Overall Study|Serious adverse event|50|||
128765817|NCT00154310|463433903|FG001|Overall Study|Adverse Event|9|||
128765818|NCT00154310|463433902|FG000|Overall Study|Lack of Efficacy|5|||
128765819|NCT00154310|463433903|FG001|Overall Study|Lack of Efficacy|4|||
128765820|NCT00154310|463433902|FG000|Overall Study|Protocol Violation|4|||
128765821|NCT00154310|463433903|FG001|Overall Study|Protocol Violation|2|||
128765822|NCT00154310|463433902|FG000|Overall Study|Withdrawal by Subject|9|||
128765823|NCT00154310|463433903|FG001|Overall Study|Withdrawal by Subject|3|||
128765824|NCT00154310|463433902|FG000|Overall Study|Lost to Follow-up|0|||
128765825|NCT00154310|463433903|FG001|Overall Study|Lost to Follow-up|8|||
128765826|NCT00154310|463433902|FG000|Overall Study|Administrative problems|0|||
128765827|NCT00154310|463433903|FG001|Overall Study|Administrative problems|1|||
128765828|NCT00154310|463433902|FG000|Overall Study|Death|0|||
128765829|NCT00154310|463433903|FG001|Overall Study|Death|1|||
128765830|NCT04399356|463433904|FG000|Overall Study|Lost to Follow-up|1|||
128765831|NCT04399356|463433905|FG001|Overall Study|Lost to Follow-up|1|||
128765832|NCT04399356|463433904|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
128765833|NCT04399356|463433905|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
128765834|NCT04399356|463433904|FG000|Overall Study|Withdrawal by Subject|1|||
128765835|NCT04399356|463433905|FG001|Overall Study|Withdrawal by Subject|0|||
128765836|NCT01834222|463433913|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
128765837|NCT04251065|463433914|FG000|Overall Study|Death|2|||
128765838|NCT04251065|463433914|FG000|Overall Study|Lack of Efficacy|3|||
128765839|NCT04251065|463433914|FG000|Overall Study|Death|1|||
128765840|NCT01054573|463433915|FG000|Overall Study|Adverse Event|1|||
128917478|NCT01427309|463988591|FG003|Overall Study|Serious adverse event|61|||
128917479|NCT01427309|463988588|FG000|Overall Study|Withdrawal by Subject|148|||
128917480|NCT01427309|463988589|FG001|Overall Study|Withdrawal by Subject|148|||
128917481|NCT01427309|463988590|FG002|Overall Study|Withdrawal by Subject|61|||
129028991|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
129028992|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
128765841|NCT01054573|463433916|FG001|Overall Study|Adverse Event|0|||
128765842|NCT01054573|463433917|FG002|Overall Study|Adverse Event|1|||
128765843|NCT01054573|463433918|FG003|Overall Study|Adverse Event|1|||
128765844|NCT01054573|463433915|FG000|Overall Study|Lost to Follow-up|0|||
128765845|NCT01054573|463433916|FG001|Overall Study|Lost to Follow-up|2|||
128765846|NCT01054573|463433917|FG002|Overall Study|Lost to Follow-up|0|||
128765847|NCT01054573|463433918|FG003|Overall Study|Lost to Follow-up|0|||
128765848|NCT01054573|463433915|FG000|Overall Study|Withdrawal by Subject|0|||
128765849|NCT01054573|463433916|FG001|Overall Study|Withdrawal by Subject|2|||
128917482|NCT01427309|463988591|FG003|Overall Study|Withdrawal by Subject|55|||
128917483|NCT03617705|463988594|FG000|Overall Study|Withdrawal by Subject|2|||
128917484|NCT03617705|463988594|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
128917485|NCT03617705|463988594|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
128917486|NCT01061008|463988595|FG000|Overall Study|Badiocephalic fistula failed|3|||
128917487|NCT01061008|463988596|FG001|Overall Study|Badiocephalic fistula failed|2|||
128917488|NCT01061008|463988595|FG000|Overall Study|Death|1|||
128917489|NCT01061008|463988596|FG001|Overall Study|Death|0|||
128917490|NCT01061008|463988595|FG000|Overall Study|Withdrawal by Subject|1|||
128917491|NCT01061008|463988596|FG001|Overall Study|Withdrawal by Subject|3|||
128917492|NCT01061008|463988595|FG000|Overall Study|Unable to exercise following surgery|1|||
128917493|NCT01061008|463988596|FG001|Overall Study|Unable to exercise following surgery|0|||
128917494|NCT01061008|463988595|FG000|Overall Study|Adverse Event|0|||
128917495|NCT01061008|463988596|FG001|Overall Study|Adverse Event|1|||
128917496|NCT02024971|463988597|FG000|Overall Study|Data Not Available|30|||
128917497|NCT02024971|463988597|FG000|Overall Study|Lost to Follow-up|6|||
128917498|NCT01299727|463988601|FG000|Overall Study|Withdrawal by Subject|1|||
128917499|NCT01299727|463988602|FG001|Overall Study|Withdrawal by Subject|0|||
128917500|NCT01299727|463988603|FG002|Overall Study|Withdrawal by Subject|0|||
128917501|NCT01299727|463988601|FG000|Overall Study|Adverse Event|0|||
128917502|NCT01299727|463988602|FG001|Overall Study|Adverse Event|0|||
128917503|NCT01299727|463988603|FG002|Overall Study|Adverse Event|1|||
128917504|NCT01299727|463988601|FG000|Overall Study|Completed the Treatment Period|3|||
128917505|NCT01299727|463988602|FG001|Overall Study|Completed the Treatment Period|4|||
128917506|NCT01299727|463988603|FG002|Overall Study|Completed the Treatment Period|3|||
128917507|NCT00944034|463988608|FG000|Overall Study|Inappropriate enrollment|0|||
128917508|NCT00944034|463988609|FG001|Overall Study|Inappropriate enrollment|1|||
128917509|NCT00944034|463988610|FG002|Overall Study|Inappropriate enrollment|0|||
128917510|NCT00944034|463988611|FG003|Overall Study|Inappropriate enrollment|1|||
128917511|NCT00944034|463988612|FG004|Overall Study|Inappropriate enrollment|2|||
128917512|NCT00944034|463988613|FG005|Overall Study|Inappropriate enrollment|1|||
128917513|NCT00944034|463988614|FG006|Overall Study|Inappropriate enrollment|0|||
128917514|NCT00944034|463988615|FG007|Overall Study|Inappropriate enrollment|0|||
128917515|NCT00944034|463988616|FG008|Overall Study|Inappropriate enrollment|1|||
128917516|NCT00944034|463988617|FG009|Overall Study|Inappropriate enrollment|1|||
128917517|NCT00944034|463988618|FG010|Overall Study|Inappropriate enrollment|0|||
128917518|NCT00944034|463988619|FG011|Overall Study|Inappropriate enrollment|0|||
128917519|NCT00944034|463988608|FG000|Overall Study|Withdrawal by Subject|3|||
128917520|NCT00944034|463988609|FG001|Overall Study|Withdrawal by Subject|2|||
128917521|NCT00944034|463988610|FG002|Overall Study|Withdrawal by Subject|6|||
128917522|NCT00944034|463988611|FG003|Overall Study|Withdrawal by Subject|2|||
128917523|NCT00944034|463988612|FG004|Overall Study|Withdrawal by Subject|5|||
128917524|NCT00944034|463988613|FG005|Overall Study|Withdrawal by Subject|8|||
128917525|NCT00944034|463988614|FG006|Overall Study|Withdrawal by Subject|2|||
128917526|NCT00944034|463988615|FG007|Overall Study|Withdrawal by Subject|2|||
128917527|NCT00944034|463988616|FG008|Overall Study|Withdrawal by Subject|3|||
128917528|NCT00944034|463988617|FG009|Overall Study|Withdrawal by Subject|4|||
128917529|NCT00944034|463988618|FG010|Overall Study|Withdrawal by Subject|0|||
128917530|NCT00944034|463988619|FG011|Overall Study|Withdrawal by Subject|4|||
128917531|NCT00944034|463988608|FG000|Overall Study|Lost to Follow-up|0|||
128917532|NCT00944034|463988609|FG001|Overall Study|Lost to Follow-up|4|||
128917533|NCT00944034|463988610|FG002|Overall Study|Lost to Follow-up|2|||
128917534|NCT00944034|463988611|FG003|Overall Study|Lost to Follow-up|0|||
128917535|NCT00944034|463988612|FG004|Overall Study|Lost to Follow-up|5|||
128917536|NCT00944034|463988613|FG005|Overall Study|Lost to Follow-up|7|||
128917537|NCT00944034|463988614|FG006|Overall Study|Lost to Follow-up|0|||
128917538|NCT00944034|463988615|FG007|Overall Study|Lost to Follow-up|1|||
128917539|NCT00944034|463988616|FG008|Overall Study|Lost to Follow-up|5|||
128917540|NCT00944034|463988617|FG009|Overall Study|Lost to Follow-up|1|||
128917541|NCT00944034|463988618|FG010|Overall Study|Lost to Follow-up|1|||
128917542|NCT00944034|463988619|FG011|Overall Study|Lost to Follow-up|0|||
128917543|NCT00944034|463988608|FG000|Overall Study|Death|0|||
128917544|NCT00944034|463988609|FG001|Overall Study|Death|0|||
128917545|NCT00944034|463988610|FG002|Overall Study|Death|1|||
128917546|NCT00944034|463988611|FG003|Overall Study|Death|0|||
128917547|NCT00944034|463988612|FG004|Overall Study|Death|0|||
128917548|NCT00944034|463988613|FG005|Overall Study|Death|0|||
128917549|NCT00944034|463988614|FG006|Overall Study|Death|0|||
128917550|NCT00944034|463988615|FG007|Overall Study|Death|0|||
128917551|NCT00944034|463988616|FG008|Overall Study|Death|0|||
128917552|NCT00944034|463988617|FG009|Overall Study|Death|0|||
128917553|NCT00944034|463988618|FG010|Overall Study|Death|0|||
128917554|NCT00944034|463988619|FG011|Overall Study|Death|0|||
128917555|NCT00944034|463988608|FG000|Overall Study|Protocol Violation|2|||
128917556|NCT00944034|463988609|FG001|Overall Study|Protocol Violation|0|||
128917557|NCT00944034|463988610|FG002|Overall Study|Protocol Violation|0|||
128917558|NCT00944034|463988611|FG003|Overall Study|Protocol Violation|1|||
128917559|NCT00944034|463988612|FG004|Overall Study|Protocol Violation|2|||
128917560|NCT00944034|463988613|FG005|Overall Study|Protocol Violation|3|||
128917561|NCT00944034|463988614|FG006|Overall Study|Protocol Violation|0|||
128917562|NCT00944034|463988615|FG007|Overall Study|Protocol Violation|1|||
128917563|NCT00944034|463988616|FG008|Overall Study|Protocol Violation|1|||
128917564|NCT00944034|463988617|FG009|Overall Study|Protocol Violation|4|||
128917565|NCT00944034|463988618|FG010|Overall Study|Protocol Violation|0|||
128917566|NCT00944034|463988619|FG011|Overall Study|Protocol Violation|0|||
128917567|NCT00944034|463988608|FG000|Overall Study|Unable to classify|0|||
128917568|NCT00944034|463988609|FG001|Overall Study|Unable to classify|0|||
128917569|NCT00944034|463988610|FG002|Overall Study|Unable to classify|0|||
128917570|NCT00944034|463988611|FG003|Overall Study|Unable to classify|0|||
128917571|NCT00944034|463988612|FG004|Overall Study|Unable to classify|0|||
128917572|NCT00944034|463988613|FG005|Overall Study|Unable to classify|1|||
128917573|NCT00944034|463988614|FG006|Overall Study|Unable to classify|1|||
128917574|NCT00944034|463988615|FG007|Overall Study|Unable to classify|1|||
128917575|NCT00944034|463988616|FG008|Overall Study|Unable to classify|0|||
128917576|NCT00944034|463988617|FG009|Overall Study|Unable to classify|0|||
128917577|NCT00944034|463988618|FG010|Overall Study|Unable to classify|0|||
128917578|NCT00944034|463988619|FG011|Overall Study|Unable to classify|0|||
128917579|NCT00944034|463988608|FG000|Overall Study|Administrative reason|0|||
128917580|NCT00944034|463988609|FG001|Overall Study|Administrative reason|0|||
128917581|NCT00944034|463988610|FG002|Overall Study|Administrative reason|0|||
128917582|NCT00944034|463988611|FG003|Overall Study|Administrative reason|0|||
128917583|NCT00944034|463988612|FG004|Overall Study|Administrative reason|0|||
128917584|NCT00944034|463988613|FG005|Overall Study|Administrative reason|0|||
128917585|NCT00944034|463988614|FG006|Overall Study|Administrative reason|1|||
128917586|NCT00944034|463988615|FG007|Overall Study|Administrative reason|0|||
128917587|NCT00944034|463988616|FG008|Overall Study|Administrative reason|0|||
128917588|NCT00944034|463988617|FG009|Overall Study|Administrative reason|0|||
128917589|NCT00944034|463988618|FG010|Overall Study|Administrative reason|0|||
128917590|NCT00944034|463988619|FG011|Overall Study|Administrative reason|0|||
128917591|NCT00531960|463988622|FG000|Overall Study|Adverse Event|5|||
128917592|NCT00531960|463988623|FG001|Overall Study|Adverse Event|4|||
128917593|NCT00531960|463988622|FG000|Overall Study|Death|3|||
128917594|NCT00531960|463988623|FG001|Overall Study|Death|2|||
128917595|NCT00531960|463988622|FG000|Overall Study|Lack of Efficacy|42|||
128917596|NCT00531960|463988623|FG001|Overall Study|Lack of Efficacy|41|||
128917597|NCT00531960|463988622|FG000|Overall Study|Violation of Selection Criteria|2|||
128917598|NCT00531960|463988623|FG001|Overall Study|Violation of Selection Criteria|0|||
128917599|NCT00531960|463988622|FG000|Overall Study|Refused Treatment|5|||
128917600|NCT00531960|463988623|FG001|Overall Study|Refused Treatment|6|||
128917601|NCT00531960|463988622|FG000|Overall Study|Other|4|||
128917602|NCT00531960|463988623|FG001|Overall Study|Other|10|||
128917603|NCT01500057|463988624|FG000|Overall Study|Lost to Follow-up|6|||
128917604|NCT01500057|463988625|FG001|Overall Study|Lost to Follow-up|4|||
128917605|NCT00330187|463988633|FG000|Overall Study|Lost to Follow-up|12|||
128917606|NCT00330187|463988634|FG001|Overall Study|Lost to Follow-up|13|||
128917607|NCT00330187|463988635|FG002|Overall Study|Lost to Follow-up|14|||
128917608|NCT00330187|463988636|FG003|Overall Study|Lost to Follow-up|10|||
128917609|NCT00330187|463988633|FG000|Overall Study|Withdrawal by Subject|8|||
128917610|NCT00330187|463988634|FG001|Overall Study|Withdrawal by Subject|5|||
128917611|NCT00330187|463988635|FG002|Overall Study|Withdrawal by Subject|4|||
128917612|NCT00330187|463988636|FG003|Overall Study|Withdrawal by Subject|4|||
128917613|NCT03258814|463988637|FG000|Overall Study|Early Termination|4|||
128917614|NCT03258814|463988638|FG001|Overall Study|Early Termination|3|||
128917615|NCT03258814|463988639|FG002|Overall Study|Early Termination|10|||
128917616|NCT01413958|463988640|FG000|Overall Study|Lost to Follow-up|0|||
128917617|NCT01413958|463988641|FG001|Overall Study|Lost to Follow-up|1|||
128917618|NCT01900002|463988642|FG000|Overall Study|Withdrawal by Subject|2|||
128917619|NCT01900002|463988642|FG000|Overall Study|ineligible for Y-90|4|||
128917620|NCT01573910|463988649|FG000|Overall Study|Adverse Event|4|||
128917621|NCT01573910|463988650|FG001|Overall Study|Adverse Event|4|||
128917622|NCT01573910|463988649|FG000|Overall Study|Lost to Follow-up|2|||
128917623|NCT01573910|463988650|FG001|Overall Study|Lost to Follow-up|1|||
128917624|NCT01573910|463988649|FG000|Overall Study|Withdrawal by Subject|0|||
128917625|NCT01573910|463988650|FG001|Overall Study|Withdrawal by Subject|1|||
128917626|NCT01573910|463988649|FG000|Overall Study|Protocol Violation|3|||
128917627|NCT01573910|463988650|FG001|Overall Study|Protocol Violation|0|||
128917628|NCT01573910|463988649|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
128917629|NCT01573910|463988650|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
128917630|NCT02601573|463988660|FG000|Overall Study|Lost to Follow-up|0|||
128917631|NCT02601573|463988661|FG001|Overall Study|Lost to Follow-up|3|||
128917632|NCT02601573|463988662|FG002|Overall Study|Lost to Follow-up|1|||
128917633|NCT02601573|463988663|FG003|Overall Study|Lost to Follow-up|0|||
128917634|NCT02601573|463988664|FG004|Overall Study|Lost to Follow-up|2|||
128917635|NCT02601573|463988660|FG000|Overall Study|Withdrawal by Subject|0|||
128917636|NCT02601573|463988661|FG001|Overall Study|Withdrawal by Subject|1|||
128917637|NCT02601573|463988662|FG002|Overall Study|Withdrawal by Subject|0|||
128917638|NCT02601573|463988663|FG003|Overall Study|Withdrawal by Subject|1|||
128917639|NCT02601573|463988664|FG004|Overall Study|Withdrawal by Subject|0|||
128917640|NCT00974220|463988665|FG000|Treatment Period 1|Adverse Event|2|||
128917641|NCT00974220|463988666|FG001|Treatment Period 1|Adverse Event|1|||
128917642|NCT00974220|463988665|FG000|Treatment Period 1|noncompliant subjects|0|||
128917643|NCT00974220|463988666|FG001|Treatment Period 1|noncompliant subjects|1|||
128917644|NCT01763164|463988667|FG000|Treatment Phase|Participant/Guardian decision|26|||
128917645|NCT01763164|463988668|FG001|Treatment Phase|Participant/Guardian decision|14|||
128917646|NCT01763164|463988667|FG000|Treatment Phase|Protocol Violation|1|||
128917647|NCT01763164|463988668|FG001|Treatment Phase|Protocol Violation|1|||
128917648|NCT01763164|463988667|FG000|Treatment Phase|Progressive Disease|142|||
128917649|NCT01763164|463988668|FG001|Treatment Phase|Progressive Disease|76|||
128917650|NCT01763164|463988667|FG000|Treatment Phase|Physician Decision|24|||
128917651|NCT01763164|463988668|FG001|Treatment Phase|Physician Decision|13|||
128917652|NCT01763164|463988667|FG000|Treatment Phase|Death|10|||
128917653|NCT01763164|463988668|FG001|Treatment Phase|Death|1|||
128917654|NCT01763164|463988667|FG000|Treatment Phase|Adverse Event|66|||
128917655|NCT01763164|463988668|FG001|Treatment Phase|Adverse Event|8|||
128917656|NCT01763164|463988667|FG000|Treatment Phase|Randomized but not Treated|0|||
128917657|NCT01763164|463988668|FG001|Treatment Phase|Randomized but not Treated|19|||
128917658|NCT01763164|463988667|FG000|Treatment Phase|Other|0|||
128917659|NCT01763164|463988668|FG001|Treatment Phase|Other|1|||
128917660|NCT01763164|463988667|FG000|Follow up Phase|New therapy for study indication|12|||
128917661|NCT01763164|463988668|FG001|Follow up Phase|New therapy for study indication|3|||
128917662|NCT01763164|463988667|FG000|Follow up Phase|Death|21|||
128917663|NCT01763164|463988668|FG001|Follow up Phase|Death|4|||
128917664|NCT01763164|463988667|FG000|Follow up Phase|Subject/guardian decision|9|||
128917665|NCT01763164|463988668|FG001|Follow up Phase|Subject/guardian decision|2|||
128917666|NCT01763164|463988667|FG000|Follow up Phase|Progressive disease|127|||
128917667|NCT01763164|463988668|FG001|Follow up Phase|Progressive disease|62|||
128917668|NCT01763164|463988667|FG000|Follow up Phase|Physician Decision|10|||
128917669|NCT01763164|463988668|FG001|Follow up Phase|Physician Decision|3|||
128917670|NCT01763164|463988667|FG000|Follow up Phase|Lost to Follow-up|1|||
128917671|NCT01763164|463988668|FG001|Follow up Phase|Lost to Follow-up|0|||
128917672|NCT01763164|463988667|FG000|Follow up Phase|Adverse Event|17|||
128917673|NCT01763164|463988668|FG001|Follow up Phase|Adverse Event|1|||
128917674|NCT01273064|463988671|FG000|Overall Study|Adverse Event|5|||
128917675|NCT01273064|463988672|FG001|Overall Study|Adverse Event|1|||
128917676|NCT01273064|463988673|FG002|Overall Study|Adverse Event|3|||
128917677|NCT01273064|463988674|FG003|Overall Study|Adverse Event|2|||
128917678|NCT01273064|463988675|FG004|Overall Study|Adverse Event|1|||
128917679|NCT01273064|463988671|FG000|Overall Study|Withdrawal by Subject|4|||
128917680|NCT01273064|463988672|FG001|Overall Study|Withdrawal by Subject|2|||
128917681|NCT01273064|463988673|FG002|Overall Study|Withdrawal by Subject|2|||
128917682|NCT01273064|463988674|FG003|Overall Study|Withdrawal by Subject|2|||
128917683|NCT01273064|463988675|FG004|Overall Study|Withdrawal by Subject|0|||
128917684|NCT01273064|463988671|FG000|Overall Study|Study Termination|13|||
128917685|NCT01273064|463988672|FG001|Overall Study|Study Termination|27|||
128917686|NCT01273064|463988673|FG002|Overall Study|Study Termination|26|||
128917687|NCT01273064|463988674|FG003|Overall Study|Study Termination|16|||
128917688|NCT01273064|463988675|FG004|Overall Study|Study Termination|8|||
128917689|NCT01273064|463988671|FG000|Overall Study|Lost to Follow-up|1|||
128917690|NCT01273064|463988672|FG001|Overall Study|Lost to Follow-up|0|||
128917691|NCT01273064|463988673|FG002|Overall Study|Lost to Follow-up|0|||
128917692|NCT01273064|463988674|FG003|Overall Study|Lost to Follow-up|0|||
128917693|NCT01273064|463988675|FG004|Overall Study|Lost to Follow-up|0|||
128917694|NCT01273064|463988671|FG000|Overall Study|Physician Decision|0|||
128917695|NCT01273064|463988672|FG001|Overall Study|Physician Decision|0|||
128917696|NCT01273064|463988673|FG002|Overall Study|Physician Decision|0|||
128917697|NCT01273064|463988674|FG003|Overall Study|Physician Decision|0|||
128917698|NCT01273064|463988675|FG004|Overall Study|Physician Decision|1|||
128917699|NCT00291551|463988676|FG000|Overall Study|Death|7|||
128917700|NCT00291551|463988676|FG000|Overall Study|Withdrawal by Subject|6|||
128917701|NCT02658812|463988677|FG000|Overall Study|Disease Progression|7|||
128917702|NCT02658812|463988677|FG000|Overall Study|Unrelated to study treatment|1|||
128917703|NCT02658812|463988677|FG000|Overall Study|Adverse Event|1|||
128765850|NCT01054573|463433917|FG002|Overall Study|Withdrawal by Subject|2|||
128917704|NCT01512264|463988678|FG000|Overall Study|Lost to Follow-up|0|||
128765851|NCT01054573|463433918|FG003|Overall Study|Withdrawal by Subject|1|||
128917705|NCT01512264|463988679|FG001|Overall Study|Lost to Follow-up|0|||
128917706|NCT01512264|463988680|FG002|Overall Study|Lost to Follow-up|0|||
128917707|NCT01512264|463988681|FG003|Overall Study|Lost to Follow-up|1|||
128917708|NCT02411747|463988682|FG000|Overall Study|Withdrawal by Subject|1|||
128917709|NCT02411747|463988683|FG001|Overall Study|Withdrawal by Subject|0|||
128917710|NCT02411747|463988682|FG000|Overall Study|Protocol Violation|2|||
128917711|NCT02411747|463988683|FG001|Overall Study|Protocol Violation|4|||
128917712|NCT00996203|463988684|FG000|Overall Study|Adverse Event|3|||
128917713|NCT00996203|463988684|FG000|Overall Study|Lost to Follow-up|1|||
128917714|NCT00996203|463988684|FG000|Overall Study|Lack of Efficacy|1|||
128917715|NCT00996203|463988684|FG000|Overall Study|Protocol Violation|2|||
128917716|NCT03686969|463988686|FG000|Overall Study|Study terminated|1|||
128917717|NCT03686969|463988687|FG001|Overall Study|Study terminated|0|||
128917718|NCT00848120|463988688|FG000|Overall Study|Adverse Event|1|||
128917719|NCT00560755|463988689|FG000|Overall Study|Protocol Violation|15|||
128917720|NCT00560755|463988689|FG000|Overall Study|Withdrawal by Subject|26|||
128917721|NCT00560755|463988689|FG000|Overall Study|Lost to Follow-up|9|||
128917722|NCT00560755|463988689|FG000|Overall Study|Adverse Event|8|||
128917723|NCT00560755|463988689|FG000|Overall Study|Physician Decision|2|||
128917724|NCT01988090|463988695|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
128917725|NCT01988090|463988696|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
128917726|NCT01988090|463988695|FG000|Start Treament After Randomization|Protocol Violation|0|||
128917727|NCT01988090|463988696|FG001|Start Treament After Randomization|Protocol Violation|1|||
128917728|NCT01988090|463988695|FG000|Complete Study After Start|Withdrawal by Subject|2|||
128917729|NCT01988090|463988696|FG001|Complete Study After Start|Withdrawal by Subject|0|||
128917730|NCT01988090|463988695|FG000|Complete Study After Start|Protocol Violation|1|||
128917731|NCT01988090|463988696|FG001|Complete Study After Start|Protocol Violation|1|||
128917732|NCT01439945|463988701|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
128917733|NCT01439945|463988702|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
128917734|NCT01439945|463988703|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
128917735|NCT01439945|463988704|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
128917736|NCT01439945|463988701|FG000|Double-Blind Treatment Phase|Ineligible|1|||
128917737|NCT01439945|463988702|FG001|Double-Blind Treatment Phase|Ineligible|2|||
128917738|NCT01439945|463988703|FG002|Double-Blind Treatment Phase|Ineligible|0|||
128917739|NCT01439945|463988704|FG003|Double-Blind Treatment Phase|Ineligible|1|||
128917740|NCT00705263|463988705|FG000|Overall Study|Withdrawal by Subject|2|||
128917741|NCT01752023|463988706|FG000|Overall Study|Physician Decision|2|||
128917742|NCT01752023|463988707|FG001|Overall Study|Physician Decision|1|||
128917743|NCT01292057|463988713|FG000|Overall Study|Protocol Violation|1|||
128917744|NCT01292057|463988714|FG001|Overall Study|Protocol Violation|1|||
128917745|NCT01292057|463988713|FG000|Overall Study|Lost to Follow-up|1|||
128917746|NCT01292057|463988714|FG001|Overall Study|Lost to Follow-up|1|||
128917747|NCT00376961|463990242|FG000|Initial Registration|Adverse Event|1|||
128917748|NCT00376961|463990243|FG001|Initial Registration|Adverse Event|0|||
128917749|NCT00376961|463990242|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
128917750|NCT00376961|463990243|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
128917751|NCT00376961|463990242|FG000|Initial Registration|Progression/relapse|1|||
128917752|NCT00376961|463990243|FG001|Initial Registration|Progression/relapse|0|||
128917753|NCT00376961|463990242|FG000|Initial Registration|Ineligible|3|||
128917754|NCT00376961|463990243|FG001|Initial Registration|Ineligible|0|||
128917755|NCT00376961|463990242|FG000|Maintenance|Adverse Event|0|||
128917756|NCT00376961|463990243|FG001|Maintenance|Adverse Event|1|||
128917757|NCT00376961|463990242|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
128917758|NCT00376961|463990243|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
128917759|NCT00376961|463990242|FG000|Maintenance|Progression/relapse|0|||
128917760|NCT00376961|463990243|FG001|Maintenance|Progression/relapse|18|||
128917761|NCT00376961|463990242|FG000|Maintenance|Ineligible|0|||
128917762|NCT00376961|463990243|FG001|Maintenance|Ineligible|3|||
128917763|NCT01059448|463990245|FG000|Overall Study|Adverse Event|1|||
128917764|NCT01059448|463990246|FG001|Overall Study|Adverse Event|3|||
128917765|NCT01059448|463990247|FG002|Overall Study|Adverse Event|0|||
128917766|NCT01059448|463990248|FG003|Overall Study|Adverse Event|1|||
128917767|NCT01059448|463990245|FG000|Overall Study|Withdrawal by Subject|2|||
128917768|NCT01059448|463990246|FG001|Overall Study|Withdrawal by Subject|0|||
128917769|NCT01059448|463990247|FG002|Overall Study|Withdrawal by Subject|2|||
128917770|NCT01059448|463990248|FG003|Overall Study|Withdrawal by Subject|4|||
128917771|NCT01059448|463990245|FG000|Overall Study|Disease Progression|2|||
128917772|NCT01059448|463990246|FG001|Overall Study|Disease Progression|1|||
128917773|NCT01059448|463990247|FG002|Overall Study|Disease Progression|4|||
128917774|NCT01059448|463990248|FG003|Overall Study|Disease Progression|2|||
128917775|NCT01059448|463990245|FG000|Overall Study|Administrative Decision|43|||
128917776|NCT01059448|463990246|FG001|Overall Study|Administrative Decision|49|||
128917777|NCT01059448|463990247|FG002|Overall Study|Administrative Decision|45|||
129028993|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
129028994|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
129028995|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
129028996|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
129028997|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
129028998|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
129028999|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
129029000|NCT01710358|464398304|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
129215956|NCT00790842|465092854|FG005|Dose Level 2|Death|0|||
128917778|NCT01059448|463990248|FG003|Overall Study|Administrative Decision|46|||
128917779|NCT01059448|463990245|FG000|Overall Study|Lost to Follow-up|0|||
128917780|NCT01059448|463990246|FG001|Overall Study|Lost to Follow-up|0|||
128917781|NCT01059448|463990247|FG002|Overall Study|Lost to Follow-up|2|||
128917782|NCT01059448|463990248|FG003|Overall Study|Lost to Follow-up|0|||
128917783|NCT01059448|463990245|FG000|Overall Study|Death|0|||
128917784|NCT01059448|463990246|FG001|Overall Study|Death|1|||
128917785|NCT01059448|463990247|FG002|Overall Study|Death|0|||
128917786|NCT01059448|463990248|FG003|Overall Study|Death|0|||
128917787|NCT01059448|463990245|FG000|Overall Study|Other|1|||
128917788|NCT01059448|463990246|FG001|Overall Study|Other|1|||
128917789|NCT01059448|463990247|FG002|Overall Study|Other|0|||
128917790|NCT01059448|463990248|FG003|Overall Study|Other|1|||
128917791|NCT02591615|463990249|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
128917792|NCT02591615|463990250|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
128917793|NCT02591615|463990251|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
128917794|NCT02591615|463990252|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
128917795|NCT02591615|463990249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
128917796|NCT02591615|463990250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
128917797|NCT02591615|463990251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
128917798|NCT02591615|463990252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
128917799|NCT02591615|463990249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
128917800|NCT02591615|463990250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
128917801|NCT02591615|463990251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
128917802|NCT02591615|463990252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
128917803|NCT02591615|463990249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
128917804|NCT02591615|463990250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
128917805|NCT02591615|463990251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
128917806|NCT02591615|463990252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
128917807|NCT02591615|463990249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
128917808|NCT02591615|463990250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
128917809|NCT02591615|463990251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
128917810|NCT02591615|463990252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
128917811|NCT02591615|463990249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
128917812|NCT02591615|463990250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
128917813|NCT02591615|463990251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
128917814|NCT02591615|463990252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
128917815|NCT02591615|463990249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
128917816|NCT02591615|463990250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
128917817|NCT02591615|463990251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
128917818|NCT02591615|463990252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
128917819|NCT02591615|463990249|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
128917820|NCT02591615|463990250|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
128917821|NCT02591615|463990251|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
128917822|NCT02591615|463990252|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
128917823|NCT02591615|463990249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
128917824|NCT02591615|463990250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
128917825|NCT02591615|463990251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
128917826|NCT02591615|463990252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
128917827|NCT02591615|463990249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
128917828|NCT02591615|463990250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
128917829|NCT02591615|463990251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
128917830|NCT02591615|463990252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
128917831|NCT02591615|463990249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
128917832|NCT02591615|463990250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
128917833|NCT02591615|463990251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
128917834|NCT02591615|463990252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
128917835|NCT02591615|463990249|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
128917836|NCT02591615|463990250|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
128917837|NCT02591615|463990251|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
128917838|NCT02591615|463990252|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
128917839|NCT02591615|463990249|FG000|Maintenance MK-3475|Adverse Event|0|||
128917840|NCT02591615|463990250|FG001|Maintenance MK-3475|Adverse Event|3|||
128917841|NCT02591615|463990251|FG002|Maintenance MK-3475|Adverse Event|1|||
128917842|NCT02591615|463990252|FG003|Maintenance MK-3475|Adverse Event|2|||
128917843|NCT02591615|463990249|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
128917844|NCT02591615|463990250|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
128917845|NCT02591615|463990251|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
128917846|NCT02591615|463990252|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
128917847|NCT02591615|463990249|FG000|Maintenance MK-3475|Death|0|||
128917848|NCT02591615|463990250|FG001|Maintenance MK-3475|Death|1|||
128917849|NCT02591615|463990251|FG002|Maintenance MK-3475|Death|1|||
128917850|NCT02591615|463990252|FG003|Maintenance MK-3475|Death|0|||
128698162|NCT00354744|463194195|FG000|Overall Study|Withdrawal by Subject|14|||
128698163|NCT01193530|463194196|FG000|Overall Study|Withdrawal by Subject|2|||
128698164|NCT01193530|463194197|FG001|Overall Study|Withdrawal by Subject|2|||
128698165|NCT01193530|463194196|FG000|Overall Study|Began Contraindicated Therapy|1|||
128698166|NCT01193530|463194197|FG001|Overall Study|Began Contraindicated Therapy|0|||
128698167|NCT01193530|463194196|FG000|Overall Study|Lost Light Box|0|||
128698168|NCT01193530|463194197|FG001|Overall Study|Lost Light Box|1|||
128917851|NCT02591615|463990249|FG000|Maintenance MK-3475|Physician discretion|0|||
128917852|NCT02591615|463990250|FG001|Maintenance MK-3475|Physician discretion|0|||
128917853|NCT02591615|463990251|FG002|Maintenance MK-3475|Physician discretion|1|||
128917854|NCT02591615|463990252|FG003|Maintenance MK-3475|Physician discretion|0|||
128917855|NCT02591615|463990249|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
128917856|NCT02591615|463990250|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
128917857|NCT02591615|463990251|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
128917858|NCT02591615|463990252|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
128917859|NCT02591615|463990249|FG000|Maintenance MK-3475|In active treatment|2|||
128917860|NCT02591615|463990250|FG001|Maintenance MK-3475|In active treatment|0|||
128917861|NCT02591615|463990251|FG002|Maintenance MK-3475|In active treatment|0|||
128917862|NCT02591615|463990252|FG003|Maintenance MK-3475|In active treatment|1|||
128917863|NCT04188197|463990253|FG000|Overall Study|Lost to Follow-up|4|||
128917864|NCT04188197|463990254|FG001|Overall Study|Lost to Follow-up|1|||
128917865|NCT04188197|463990253|FG000|Overall Study|Withdrawal by Subject|1|||
128917866|NCT04188197|463990254|FG001|Overall Study|Withdrawal by Subject|1|||
128917867|NCT04188197|463990253|FG000|Overall Study|Pregnancy|0|||
128917868|NCT04188197|463990254|FG001|Overall Study|Pregnancy|1|||
128917869|NCT02107703|463990257|FG000|Overall Study|Withdrawal by Subject|46|||
128917870|NCT02107703|463990258|FG001|Overall Study|Withdrawal by Subject|21|||
128917871|NCT02107703|463990257|FG000|Overall Study|Lost to Follow-up|20|||
128917872|NCT02107703|463990258|FG001|Overall Study|Lost to Follow-up|9|||
128917873|NCT02107703|463990257|FG000|Overall Study|On study treatment/follow up|48|||
128917874|NCT02107703|463990258|FG001|Overall Study|On study treatment/follow up|5|||
128917875|NCT02911688|463990261|FG000|Washout|Lost to Follow-up|1|||
128917876|NCT02911688|463990262|FG001|Washout|Lost to Follow-up|1|||
128917877|NCT02911688|463990261|FG000|Washout|Withdrawal by Subject|0|||
128917878|NCT02911688|463990262|FG001|Washout|Withdrawal by Subject|1|||
128917879|NCT00809328|463990263|FG000|Overall Study|Lack of Efficacy|18|||
128917880|NCT00809328|463990263|FG000|Overall Study|Adverse Event|6|||
128917881|NCT00809328|463990263|FG000|Overall Study|Protocol Violation|3|||
128917882|NCT00809328|463990263|FG000|Overall Study|Withdrawal by Subject|2|||
128917883|NCT06441877|463990266|FG000|Overall Study|Withdrawal by Subject|0|||
128917884|NCT06441877|463990267|FG001|Overall Study|Withdrawal by Subject|2|||
128917885|NCT06441877|463990268|FG002|Overall Study|Withdrawal by Subject|0|||
128917886|NCT06441877|463990269|FG003|Overall Study|Withdrawal by Subject|0|||
128917887|NCT00066690|463990270|FG000|Overall Study|Adverse Event|145|||
128917888|NCT00066690|463990271|FG001|Overall Study|Adverse Event|58|||
128917889|NCT00066690|463990272|FG002|Overall Study|Adverse Event|126|||
128917890|NCT00066690|463990270|FG000|Overall Study|Death|3|||
128917891|NCT00066690|463990271|FG001|Overall Study|Death|0|||
128917892|NCT00066690|463990272|FG002|Overall Study|Death|2|||
128917893|NCT00066690|463990270|FG000|Overall Study|Lack of Efficacy|114|||
128917894|NCT00066690|463990271|FG001|Overall Study|Lack of Efficacy|110|||
128917895|NCT00066690|463990272|FG002|Overall Study|Lack of Efficacy|76|||
128917896|NCT00066690|463990270|FG000|Overall Study|Lost to Follow-up|40|||
128917897|NCT00066690|463990271|FG001|Overall Study|Lost to Follow-up|21|||
128917898|NCT00066690|463990272|FG002|Overall Study|Lost to Follow-up|29|||
128917899|NCT00066690|463990270|FG000|Overall Study|Withdrawal by Subject|50|||
128917900|NCT00066690|463990271|FG001|Overall Study|Withdrawal by Subject|55|||
128917901|NCT00066690|463990272|FG002|Overall Study|Withdrawal by Subject|49|||
128917902|NCT00066690|463990270|FG000|Overall Study|Treatment Ongoing|246|||
128917903|NCT00066690|463990271|FG001|Overall Study|Treatment Ongoing|278|||
128917904|NCT00066690|463990272|FG002|Overall Study|Treatment Ongoing|282|||
128917905|NCT03706365|463990276|FG000|Overall Study|Lost to Follow-up|7|||
128917906|NCT03706365|463990277|FG001|Overall Study|Lost to Follow-up|0|||
128917907|NCT03706365|463990276|FG000|Overall Study|Withdrawal by Subject|17|||
128917908|NCT03706365|463990277|FG001|Overall Study|Withdrawal by Subject|15|||
128917909|NCT03706365|463990276|FG000|Overall Study|On Study Treatment|51|||
128917910|NCT03706365|463990277|FG001|Overall Study|On Study Treatment|51|||
128917911|NCT03116113|463990278|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
128917912|NCT03116113|463990279|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
128917913|NCT03116113|463990280|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
128917914|NCT03116113|463990281|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
128917915|NCT03116113|463990282|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
128917916|NCT03116113|463990283|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
128917917|NCT03116113|463990284|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
128917918|NCT03116113|463990285|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
128917919|NCT03116113|463990286|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
128917920|NCT02159807|463990287|FG000|Overall Study|Adverse Event|0|||
128917921|NCT02159807|463990288|FG001|Overall Study|Adverse Event|0|||
128917922|NCT02159807|463990289|FG002|Overall Study|Adverse Event|1|||
128917923|NCT02159807|463990287|FG000|Overall Study|No CSF|1|||
128917924|NCT02159807|463990288|FG001|Overall Study|No CSF|1|||
128917925|NCT02159807|463990289|FG002|Overall Study|No CSF|1|||
128917926|NCT02159807|463990287|FG000|Overall Study|elevated blood pressure|0|||
128917927|NCT02159807|463990288|FG001|Overall Study|elevated blood pressure|0|||
128917928|NCT02159807|463990289|FG002|Overall Study|elevated blood pressure|1|||
128917929|NCT05195528|463990291|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
128917930|NCT05195528|463990292|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
128917931|NCT05195528|463990293|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
128917932|NCT05195528|463990294|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
128917933|NCT05195528|463990295|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
128917934|NCT05195528|463990291|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
128917935|NCT05195528|463990292|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
128917936|NCT05195528|463990293|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
128917937|NCT05195528|463990294|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
128917938|NCT05195528|463990295|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
128917939|NCT05195528|463990291|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
128917940|NCT05195528|463990292|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
129215957|NCT00790842|465092855|FG006|Dose Level 2|Death|0|||
129215958|NCT00790842|465092856|FG007|Dose Level 2|Death|0|||
129215959|NCT00790842|465092857|FG008|Dose Level 2|Death|0|||
129215960|NCT00790842|465092858|FG009|Dose Level 2|Death|0|||
128917941|NCT05195528|463990293|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
128917942|NCT05195528|463990294|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
128917943|NCT05195528|463990295|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
128917944|NCT05195528|463990291|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
128917945|NCT05195528|463990292|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
128917946|NCT05195528|463990293|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
128917947|NCT05195528|463990294|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
128917948|NCT05195528|463990295|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
128917949|NCT05195528|463990291|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
128917950|NCT05195528|463990292|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
128917951|NCT05195528|463990293|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
128917952|NCT05195528|463990294|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
128917953|NCT05195528|463990295|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
128917954|NCT05195528|463990291|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
128917955|NCT05195528|463990292|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
128917956|NCT05195528|463990293|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
128917957|NCT05195528|463990294|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
128917958|NCT05195528|463990295|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
128917959|NCT05195528|463990291|FG000|Placebo-controlled Treatment Period|Other|0|||
128917960|NCT05195528|463990292|FG001|Placebo-controlled Treatment Period|Other|0|||
128917961|NCT05195528|463990293|FG002|Placebo-controlled Treatment Period|Other|1|||
128917962|NCT05195528|463990294|FG003|Placebo-controlled Treatment Period|Other|0|||
128917963|NCT05195528|463990295|FG004|Placebo-controlled Treatment Period|Other|0|||
128917964|NCT05195528|463990291|FG000|Extension Period|PTE or AE or SAE|0|||
128917965|NCT05195528|463990292|FG001|Extension Period|PTE or AE or SAE|4|||
128917966|NCT05195528|463990293|FG002|Extension Period|PTE or AE or SAE|5|||
128917967|NCT05195528|463990294|FG003|Extension Period|PTE or AE or SAE|4|||
128917968|NCT05195528|463990295|FG004|Extension Period|PTE or AE or SAE|4|||
128917969|NCT05195528|463990291|FG000|Extension Period|Protocol Violation|0|||
128917970|NCT05195528|463990292|FG001|Extension Period|Protocol Violation|2|||
128917971|NCT05195528|463990293|FG002|Extension Period|Protocol Violation|1|||
128917972|NCT05195528|463990294|FG003|Extension Period|Protocol Violation|0|||
128917973|NCT05195528|463990295|FG004|Extension Period|Protocol Violation|1|||
128917974|NCT05195528|463990291|FG000|Extension Period|Lost to Follow-up|0|||
128917975|NCT05195528|463990292|FG001|Extension Period|Lost to Follow-up|6|||
128917976|NCT05195528|463990293|FG002|Extension Period|Lost to Follow-up|13|||
128917977|NCT05195528|463990294|FG003|Extension Period|Lost to Follow-up|3|||
128917978|NCT05195528|463990295|FG004|Extension Period|Lost to Follow-up|7|||
128917979|NCT05195528|463990291|FG000|Extension Period|Withdrawal by Subject|0|||
128917980|NCT05195528|463990292|FG001|Extension Period|Withdrawal by Subject|12|||
128917981|NCT05195528|463990293|FG002|Extension Period|Withdrawal by Subject|9|||
128917982|NCT05195528|463990294|FG003|Extension Period|Withdrawal by Subject|6|||
129215961|NCT00790842|465092859|FG010|Dose Level 2|Death|0|||
129215962|NCT00790842|465092849|FG000|Dose Level 2|Physician Decision|0|||
129215963|NCT00790842|465092850|FG001|Dose Level 2|Physician Decision|1|||
129215964|NCT00790842|465092851|FG002|Dose Level 2|Physician Decision|0|||
129215965|NCT00790842|465092852|FG003|Dose Level 2|Physician Decision|0|||
128917983|NCT05195528|463990295|FG004|Extension Period|Withdrawal by Subject|5|||
128917984|NCT05195528|463990291|FG000|Extension Period|Lack of Efficacy|0|||
129215966|NCT00790842|465092853|FG004|Dose Level 2|Physician Decision|0|||
129215967|NCT00790842|465092854|FG005|Dose Level 2|Physician Decision|0|||
129215968|NCT00790842|465092855|FG006|Dose Level 2|Physician Decision|0|||
128917985|NCT05195528|463990292|FG001|Extension Period|Lack of Efficacy|3|||
128917986|NCT05195528|463990293|FG002|Extension Period|Lack of Efficacy|0|||
128917987|NCT05195528|463990294|FG003|Extension Period|Lack of Efficacy|0|||
128917988|NCT05195528|463990295|FG004|Extension Period|Lack of Efficacy|2|||
128917989|NCT05195528|463990291|FG000|Extension Period|Not Treated|0|||
128917990|NCT05195528|463990292|FG001|Extension Period|Not Treated|0|||
128917991|NCT05195528|463990293|FG002|Extension Period|Not Treated|2|||
128917992|NCT05195528|463990294|FG003|Extension Period|Not Treated|3|||
128917993|NCT05195528|463990295|FG004|Extension Period|Not Treated|0|||
128917994|NCT05195528|463990291|FG000|Extension Period|Other|0|||
128917995|NCT05195528|463990292|FG001|Extension Period|Other|1|||
128917996|NCT05195528|463990293|FG002|Extension Period|Other|1|||
128917997|NCT05195528|463990294|FG003|Extension Period|Other|0|||
128917998|NCT05195528|463990295|FG004|Extension Period|Other|0|||
128917999|NCT01552902|463990296|FG000|Overall Study|Adverse Event|1|||
128918000|NCT01552902|463990297|FG001|Overall Study|Adverse Event|15|||
128918001|NCT01552902|463990298|FG002|Overall Study|Adverse Event|14|||
128918002|NCT01552902|463990296|FG000|Overall Study|Protocol Violation|3|||
128918003|NCT01552902|463990297|FG001|Overall Study|Protocol Violation|3|||
128698169|NCT01193530|463194196|FG000|Overall Study|Returned home - out of state|0|||
128698170|NCT01193530|463194197|FG001|Overall Study|Returned home - out of state|1|||
128698171|NCT01193530|463194196|FG000|Overall Study|Non-Compliance|0|||
128698172|NCT01193530|463194197|FG001|Overall Study|Non-Compliance|1|||
128698173|NCT00926328|463194200|FG000|Overall Study|Lost to Follow-up|12|||
128918004|NCT01552902|463990298|FG002|Overall Study|Protocol Violation|3|||
128918005|NCT01552902|463990296|FG000|Overall Study|Lack of Efficacy|4|||
128918006|NCT01552902|463990297|FG001|Overall Study|Lack of Efficacy|3|||
128698174|NCT00926328|463194201|FG001|Overall Study|Lost to Follow-up|14|||
128698175|NCT00726986|463194202|FG000|Induction Phase|Adverse Event|4|||
128698176|NCT00726986|463194202|FG000|Induction Phase|Withdrawal by Subject|2|||
128698177|NCT00726986|463194202|FG000|Induction Phase|Death|2|||
128698178|NCT00726986|463194202|FG000|Induction Phase|Lack of Efficacy|5|||
128698179|NCT00726986|463194202|FG000|Induction Phase|Secondary Disease|2|||
128698180|NCT00726986|463194202|FG000|Maintenance Phase|Adverse Event|1|||
128698181|NCT00726986|463194202|FG000|Maintenance Phase|Lack of Efficacy|2|||
128698182|NCT00289133|463194203|FG000|Overall Study|Non-study device implanted|12|||
128698183|NCT00289133|463194204|FG001|Overall Study|Non-study device implanted|0|||
128698184|NCT00289133|463194203|FG000|Overall Study|Protocol Violation|32|||
128698185|NCT00289133|463194204|FG001|Overall Study|Protocol Violation|38|||
128698186|NCT00289133|463194203|FG000|Overall Study|Withdrawal by Subject|9|||
128698187|NCT00289133|463194204|FG001|Overall Study|Withdrawal by Subject|10|||
128698188|NCT00289133|463194203|FG000|Overall Study|Death|5|||
128698189|NCT00289133|463194204|FG001|Overall Study|Death|10|||
128698190|NCT00289133|463194203|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
128698191|NCT00289133|463194204|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
128698192|NCT00289133|463194203|FG000|Overall Study|Physician Decision|41|||
128698193|NCT00289133|463194204|FG001|Overall Study|Physician Decision|45|||
128698194|NCT00289133|463194203|FG000|Overall Study|Revision|8|||
128698195|NCT00289133|463194204|FG001|Overall Study|Revision|6|||
128698196|NCT00289133|463194203|FG000|Overall Study|Lost to Follow-up|92|||
128698197|NCT00289133|463194204|FG001|Overall Study|Lost to Follow-up|115|||
128698198|NCT01513343|463194207|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
128698199|NCT01513343|463194208|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
128698200|NCT01513343|463194207|FG000|Post Data Collection|Dropped/withdrew from study|7|||
128698201|NCT01513343|463194208|FG001|Post Data Collection|Dropped/withdrew from study|1|||
128698202|NCT01513343|463194207|FG000|Post Data Collection|Lost to Follow-up|10|||
128698203|NCT01513343|463194208|FG001|Post Data Collection|Lost to Follow-up|23|||
128698204|NCT01513343|463194207|FG000|6-month Follow-up|Lost to Follow-up|28|||
128698205|NCT01513343|463194208|FG001|6-month Follow-up|Lost to Follow-up|17|||
128698206|NCT01513343|463194207|FG000|12-month Follow-up|Lost to Follow-up|10|||
128698207|NCT01513343|463194208|FG001|12-month Follow-up|Lost to Follow-up|3|||
128698208|NCT02165215|463194212|FG000|Induction Phase|Adverse Event|1|||
128698209|NCT02165215|463194213|FG001|Induction Phase|Adverse Event|0|||
128698210|NCT02165215|463194214|FG002|Induction Phase|Adverse Event|0|||
128698211|NCT02165215|463194212|FG000|Induction Phase|Withdrawal by Subject|10|||
128918007|NCT01552902|463990298|FG002|Overall Study|Lack of Efficacy|1|||
128918008|NCT01552902|463990296|FG000|Overall Study|Withdrawal by Subject|1|||
128918009|NCT01552902|463990297|FG001|Overall Study|Withdrawal by Subject|9|||
128698212|NCT02165215|463194213|FG001|Induction Phase|Withdrawal by Subject|0|||
128698213|NCT02165215|463194214|FG002|Induction Phase|Withdrawal by Subject|0|||
128698214|NCT02165215|463194212|FG000|Induction Phase|Protocol Violation|1|||
128698215|NCT02165215|463194213|FG001|Induction Phase|Protocol Violation|0|||
128698216|NCT02165215|463194214|FG002|Induction Phase|Protocol Violation|0|||
128698217|NCT02165215|463194212|FG000|Induction Phase|Physician Decision|1|||
128918010|NCT01552902|463990298|FG002|Overall Study|Withdrawal by Subject|6|||
128918011|NCT01552902|463990296|FG000|Overall Study|Lost to Follow-up|1|||
128918012|NCT01552902|463990297|FG001|Overall Study|Lost to Follow-up|3|||
128918013|NCT01552902|463990298|FG002|Overall Study|Lost to Follow-up|6|||
129215969|NCT00790842|465092856|FG007|Dose Level 2|Physician Decision|0|||
129215970|NCT00790842|465092857|FG008|Dose Level 2|Physician Decision|0|||
129215971|NCT00790842|465092858|FG009|Dose Level 2|Physician Decision|0|||
129215972|NCT00790842|465092859|FG010|Dose Level 2|Physician Decision|0|||
129215973|NCT00790842|465092849|FG000|Dose Level 2|Withdrawal by Subject|0|||
129215974|NCT00790842|465092850|FG001|Dose Level 2|Withdrawal by Subject|1|||
129215975|NCT00790842|465092851|FG002|Dose Level 2|Withdrawal by Subject|0|||
129215976|NCT00790842|465092852|FG003|Dose Level 2|Withdrawal by Subject|0|||
129215977|NCT00790842|465092853|FG004|Dose Level 2|Withdrawal by Subject|0|||
129215978|NCT00790842|465092854|FG005|Dose Level 2|Withdrawal by Subject|0|||
129215979|NCT00790842|465092855|FG006|Dose Level 2|Withdrawal by Subject|0|||
129215980|NCT00790842|465092856|FG007|Dose Level 2|Withdrawal by Subject|0|||
129215981|NCT00790842|465092857|FG008|Dose Level 2|Withdrawal by Subject|0|||
129215982|NCT00790842|465092858|FG009|Dose Level 2|Withdrawal by Subject|0|||
128765852|NCT05266963|463433922|FG000|Drug Period A|Withdrawal by Subject|0|||
128765853|NCT05266963|463433923|FG001|Drug Period A|Withdrawal by Subject|1|||
128765854|NCT01725386|463433924|FG000|Overall Study|Death|84|||
128765855|NCT01725386|463433925|FG001|Overall Study|Death|40|||
128918014|NCT01552902|463990296|FG000|Overall Study|Other|3|||
128918015|NCT01552902|463990297|FG001|Overall Study|Other|4|||
128918016|NCT01552902|463990298|FG002|Overall Study|Other|3|||
128918017|NCT02487108|463990304|FG000|Overall Study|Adverse Event|1|||
128918018|NCT02487108|463990305|FG001|Overall Study|Adverse Event|6|||
128918019|NCT02487108|463990306|FG002|Overall Study|Adverse Event|12|||
128918020|NCT02487108|463990307|FG003|Overall Study|Adverse Event|6|||
128918021|NCT02487108|463990304|FG000|Overall Study|Withdrawal by Subject|8|||
128918022|NCT02487108|463990305|FG001|Overall Study|Withdrawal by Subject|5|||
128918023|NCT02487108|463990306|FG002|Overall Study|Withdrawal by Subject|5|||
128918024|NCT02487108|463990307|FG003|Overall Study|Withdrawal by Subject|0|||
128918025|NCT02487108|463990304|FG000|Overall Study|Non-compliance to study medication|3|||
128918026|NCT02487108|463990305|FG001|Overall Study|Non-compliance to study medication|2|||
128918027|NCT02487108|463990306|FG002|Overall Study|Non-compliance to study medication|5|||
128918028|NCT02487108|463990307|FG003|Overall Study|Non-compliance to study medication|4|||
128918029|NCT02487108|463990304|FG000|Overall Study|Protocol Violation|1|||
128918030|NCT02487108|463990305|FG001|Overall Study|Protocol Violation|1|||
128918031|NCT02487108|463990306|FG002|Overall Study|Protocol Violation|2|||
128918032|NCT02487108|463990307|FG003|Overall Study|Protocol Violation|0|||
128918033|NCT02487108|463990304|FG000|Overall Study|Non-compliance to study procedures|0|||
128918034|NCT02487108|463990305|FG001|Overall Study|Non-compliance to study procedures|0|||
128918035|NCT02487108|463990306|FG002|Overall Study|Non-compliance to study procedures|0|||
128918036|NCT02487108|463990307|FG003|Overall Study|Non-compliance to study procedures|1|||
128918037|NCT02487108|463990304|FG000|Overall Study|Other than specified|3|||
128918038|NCT02487108|463990305|FG001|Overall Study|Other than specified|2|||
128918039|NCT02487108|463990306|FG002|Overall Study|Other than specified|2|||
128918040|NCT02487108|463990307|FG003|Overall Study|Other than specified|0|||
128918041|NCT02367521|463990308|FG000|Overall Study|severe headache after intervention|2|||
128918042|NCT02367521|463990309|FG001|Overall Study|severe headache after intervention|0|||
128918043|NCT02367521|463990308|FG000|Overall Study|unable to find transportation|2|||
128918044|NCT02367521|463990309|FG001|Overall Study|unable to find transportation|0|||
128918045|NCT00600171|463990310|FG000|Overall Study|Adverse Event|0|||
128918046|NCT00600171|463990311|FG001|Overall Study|Adverse Event|1|||
128918047|NCT00600171|463990312|FG002|Overall Study|Adverse Event|0|||
128918048|NCT00600171|463990313|FG003|Overall Study|Adverse Event|0|||
128918049|NCT00600171|463990314|FG004|Overall Study|Adverse Event|1|||
128918050|NCT00600171|463990315|FG005|Overall Study|Adverse Event|0|||
128918051|NCT00600171|463990310|FG000|Overall Study|Lack of Efficacy|9|||
128918052|NCT00600171|463990311|FG001|Overall Study|Lack of Efficacy|12|||
128918053|NCT00600171|463990312|FG002|Overall Study|Lack of Efficacy|3|||
128918054|NCT00600171|463990313|FG003|Overall Study|Lack of Efficacy|5|||
128918055|NCT00600171|463990314|FG004|Overall Study|Lack of Efficacy|4|||
128918056|NCT00600171|463990315|FG005|Overall Study|Lack of Efficacy|0|||
128918057|NCT00600171|463990310|FG000|Overall Study|Protocol Violation|1|||
128918058|NCT00600171|463990311|FG001|Overall Study|Protocol Violation|2|||
128918059|NCT00600171|463990312|FG002|Overall Study|Protocol Violation|0|||
128918060|NCT00600171|463990313|FG003|Overall Study|Protocol Violation|1|||
128918061|NCT00600171|463990314|FG004|Overall Study|Protocol Violation|0|||
128918062|NCT00600171|463990315|FG005|Overall Study|Protocol Violation|0|||
128918063|NCT00600171|463990310|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
128918064|NCT00600171|463990311|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128918065|NCT00600171|463990312|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
128918066|NCT00600171|463990313|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
128918067|NCT00600171|463990314|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
128918068|NCT00600171|463990315|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
128918069|NCT00600171|463990310|FG000|Overall Study|Withdrawal by Subject|3|||
128918070|NCT00600171|463990311|FG001|Overall Study|Withdrawal by Subject|0|||
129215983|NCT00790842|465092859|FG010|Dose Level 2|Withdrawal by Subject|0|||
128918071|NCT00600171|463990312|FG002|Overall Study|Withdrawal by Subject|0|||
128918072|NCT00600171|463990313|FG003|Overall Study|Withdrawal by Subject|1|||
128918073|NCT00600171|463990314|FG004|Overall Study|Withdrawal by Subject|1|||
128918074|NCT00600171|463990315|FG005|Overall Study|Withdrawal by Subject|1|||
128918075|NCT00600171|463990310|FG000|Overall Study|Physician Decision|0|||
128918076|NCT00600171|463990311|FG001|Overall Study|Physician Decision|1|||
128918077|NCT00600171|463990312|FG002|Overall Study|Physician Decision|0|||
128765856|NCT01725386|463433924|FG000|Overall Study|Lost to Follow-up|81|||
128765857|NCT01725386|463433925|FG001|Overall Study|Lost to Follow-up|6|||
128765858|NCT01725386|463433924|FG000|Overall Study|Withdrawal by Subject|10|||
128765859|NCT01725386|463433925|FG001|Overall Study|Withdrawal by Subject|0|||
128765860|NCT03812536|463433926|FG000|Overall Study|Protocol Violation|2|||
128765861|NCT03812536|463433927|FG001|Overall Study|Protocol Violation|0|||
128765862|NCT03812536|463433926|FG000|Overall Study|Withdrawal by Subject|1|||
128765863|NCT03812536|463433927|FG001|Overall Study|Withdrawal by Subject|1|||
128765864|NCT00152009|463433928|FG000|Overall Study|Adverse Event|9|||
128918078|NCT00600171|463990313|FG003|Overall Study|Physician Decision|1|||
128918079|NCT00600171|463990314|FG004|Overall Study|Physician Decision|0|||
128918080|NCT00600171|463990315|FG005|Overall Study|Physician Decision|2|||
128918081|NCT00600171|463990310|FG000|Overall Study|Lost to Follow-up|0|||
128918082|NCT00600171|463990311|FG001|Overall Study|Lost to Follow-up|0|||
128918083|NCT00600171|463990312|FG002|Overall Study|Lost to Follow-up|0|||
128918084|NCT00600171|463990313|FG003|Overall Study|Lost to Follow-up|1|||
128918085|NCT00600171|463990314|FG004|Overall Study|Lost to Follow-up|0|||
128918086|NCT00600171|463990315|FG005|Overall Study|Lost to Follow-up|0|||
128918087|NCT00542191|463990319|FG000|Overall Study|Death|3|||
128918088|NCT00469612|463990320|FG000|Overall Study|Study terminated before data collected|2|||
128918089|NCT00469612|463990321|FG001|Overall Study|Study terminated before data collected|0|||
128918090|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
128918091|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
128918092|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
128918093|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
128918094|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
128918095|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
128918096|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
128918097|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
128918098|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
128918099|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
128918100|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
128918101|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
128918102|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
128918103|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
128918104|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
128918105|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
128918106|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
128918107|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
128918108|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
128918109|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
128918110|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
128918111|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
128918112|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
128918113|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
128918114|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
128918115|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
128918116|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
128918117|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
128918118|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
128918119|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
128918120|NCT00849017|463990322|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
128918121|NCT00849017|463990323|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
128918122|NCT00849017|463990324|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
128918123|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
128918124|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
128918125|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
128918126|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
128918127|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
128918128|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
128765865|NCT00152009|463433929|FG001|Overall Study|Adverse Event|13|||
128765866|NCT00152009|463433930|FG002|Overall Study|Adverse Event|20|||
128765867|NCT00152009|463433931|FG003|Overall Study|Adverse Event|1|||
128918129|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
128918130|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
128918131|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
128918132|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
128918133|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
128918134|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
128918135|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
128918136|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
128918137|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
128918138|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
128918139|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
128918140|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
128918141|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
128918142|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
128918143|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
128918144|NCT00849017|463990322|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
128918145|NCT00849017|463990323|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
128918146|NCT00849017|463990324|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
128918147|NCT03075163|463990329|FG000|Overall Study|not eligible for treatment limb|138|||
128918148|NCT03075163|463990330|FG001|Overall Study|not eligible for treatment limb|138|||
128918149|NCT00110994|463990331|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
128918150|NCT00110994|463990332|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
128918151|NCT00110994|463990331|FG000|Double-blind (DB) Treatment|Death|1|||
128918152|NCT00110994|463990332|FG001|Double-blind (DB) Treatment|Death|0|||
128918153|NCT00110994|463990331|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
129215984|NCT00790842|465092849|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215985|NCT00790842|465092850|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215986|NCT00790842|465092851|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215987|NCT00790842|465092852|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215988|NCT00790842|465092853|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215989|NCT00790842|465092854|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215990|NCT00790842|465092855|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215991|NCT00790842|465092856|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215992|NCT00790842|465092857|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
129215993|NCT00790842|465092858|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215994|NCT00790842|465092859|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129215995|NCT00790842|465092849|FG000|Dose Level 3|Adverse Event|0|||
129215996|NCT00790842|465092850|FG001|Dose Level 3|Adverse Event|0|||
129215997|NCT00790842|465092851|FG002|Dose Level 3|Adverse Event|1|||
129215998|NCT00790842|465092852|FG003|Dose Level 3|Adverse Event|0|||
129215999|NCT00790842|465092853|FG004|Dose Level 3|Adverse Event|0|||
129216000|NCT00790842|465092854|FG005|Dose Level 3|Adverse Event|0|||
129216001|NCT00790842|465092855|FG006|Dose Level 3|Adverse Event|0|||
129216002|NCT00790842|465092856|FG007|Dose Level 3|Adverse Event|0|||
129216003|NCT00790842|465092857|FG008|Dose Level 3|Adverse Event|0|||
129216004|NCT00790842|465092858|FG009|Dose Level 3|Adverse Event|0|||
128698218|NCT02165215|463194213|FG001|Induction Phase|Physician Decision|0|||
128698219|NCT02165215|463194214|FG002|Induction Phase|Physician Decision|0|||
128698220|NCT02165215|463194212|FG000|Induction Phase|Lack of Efficacy|2|||
128698221|NCT02165215|463194213|FG001|Induction Phase|Lack of Efficacy|0|||
128698222|NCT02165215|463194214|FG002|Induction Phase|Lack of Efficacy|0|||
128698223|NCT02165215|463194212|FG000|Induction Phase|Non-Compliance|2|||
128698224|NCT02165215|463194213|FG001|Induction Phase|Non-Compliance|0|||
128698225|NCT02165215|463194214|FG002|Induction Phase|Non-Compliance|0|||
128698226|NCT02165215|463194212|FG000|Induction Phase|Lost to Follow-up|6|||
128698227|NCT02165215|463194213|FG001|Induction Phase|Lost to Follow-up|0|||
128698228|NCT02165215|463194214|FG002|Induction Phase|Lost to Follow-up|0|||
128698229|NCT02165215|463194212|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128698230|NCT02165215|463194213|FG001|Maintenance Phase|Withdrawal by Subject|7|||
128698231|NCT02165215|463194214|FG002|Maintenance Phase|Withdrawal by Subject|3|||
128698232|NCT02165215|463194212|FG000|Maintenance Phase|Multiple reasons|0|||
128698233|NCT02165215|463194213|FG001|Maintenance Phase|Multiple reasons|2|||
128698234|NCT02165215|463194214|FG002|Maintenance Phase|Multiple reasons|1|||
128698235|NCT02165215|463194212|FG000|Maintenance Phase|Lost to Follow-up|0|||
128698236|NCT02165215|463194213|FG001|Maintenance Phase|Lost to Follow-up|2|||
128698237|NCT02165215|463194214|FG002|Maintenance Phase|Lost to Follow-up|0|||
128698238|NCT02165215|463194212|FG000|Maintenance Phase|Adverse Event|0|||
128698239|NCT02165215|463194213|FG001|Maintenance Phase|Adverse Event|1|||
128698240|NCT02165215|463194214|FG002|Maintenance Phase|Adverse Event|1|||
128698241|NCT00064337|463194215|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
128698242|NCT00064337|463194215|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
128698243|NCT00064337|463194215|FG000|PBSCC or Induction/PBSCC|Progression|3|||
129216005|NCT00790842|465092859|FG010|Dose Level 3|Adverse Event|0|||
129216006|NCT00790842|465092849|FG000|Dose Level 3|Withdrawal by Subject|0|||
129216007|NCT00790842|465092850|FG001|Dose Level 3|Withdrawal by Subject|0|||
129216008|NCT00790842|465092851|FG002|Dose Level 3|Withdrawal by Subject|3|||
129029001|NCT01710358|464398305|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
129029002|NCT01710358|464398306|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
129029003|NCT01710358|464398304|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
129029004|NCT01710358|464398305|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
129029005|NCT01710358|464398306|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
129029006|NCT01710358|464398304|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
129029007|NCT01710358|464398305|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
129029008|NCT01710358|464398306|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
129029009|NCT01710358|464398304|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
129029010|NCT01710358|464398305|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
129029011|NCT01710358|464398306|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
129029012|NCT01710358|464398304|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
129029013|NCT01710358|464398305|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
129029014|NCT01710358|464398306|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
129029015|NCT01710358|464398304|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
129029016|NCT01710358|464398305|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
128698244|NCT00064337|463194215|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
128698245|NCT00064337|463194215|FG000|PBSCC or Induction/PBSCC|Death|2|||
128698246|NCT00064337|463194215|FG000|Transplant|Adverse Event|9|||
128698247|NCT00064337|463194215|FG000|Transplant|Not protocol-specified|5|||
128698248|NCT00064337|463194215|FG000|Transplant|Death|3|||
128698249|NCT00064337|463194215|FG000|Transplant|Patient Refusal|2|||
128698250|NCT00064337|463194215|FG000|Transplant|Progression|2|||
128698251|NCT00064337|463194215|FG000|Maintenance|Adverse Event|3|||
128698252|NCT00064337|463194215|FG000|Maintenance|Progression|2|||
128698253|NCT00064337|463194215|FG000|Maintenance|On treatment at time of analysis|2|||
128698254|NCT00064337|463194215|FG000|Maintenance|Not protocol-specified|2|||
128698255|NCT00064337|463194215|FG000|Maintenance|Death|1|||
128698256|NCT01397890|463194216|FG000|Overall Study|Withdrawal by Subject|7|||
128698257|NCT01397890|463194217|FG001|Overall Study|Withdrawal by Subject|11|||
128698258|NCT01397890|463194216|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
128698259|NCT01397890|463194217|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
128698260|NCT01397890|463194216|FG000|Overall Study|Death|2|||
128698261|NCT01397890|463194217|FG001|Overall Study|Death|3|||
128698262|NCT01397890|463194216|FG000|Overall Study|Lost to Follow-up|1|||
128698263|NCT01397890|463194217|FG001|Overall Study|Lost to Follow-up|4|||
128698264|NCT01397890|463194216|FG000|Overall Study|Condition under Investigation Worsened|1|||
128698265|NCT01397890|463194217|FG001|Overall Study|Condition under Investigation Worsened|3|||
128698266|NCT01397890|463194216|FG000|Overall Study|Adverse Event|1|||
128698267|NCT01397890|463194217|FG001|Overall Study|Adverse Event|2|||
128698268|NCT01397890|463194216|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
128698269|NCT01397890|463194217|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
128698270|NCT01397890|463194216|FG000|Overall Study|Others|2|||
128698271|NCT01397890|463194217|FG001|Overall Study|Others|1|||
128698272|NCT00002651|463194218|FG000|Induction|Adverse Event|44|||
128698273|NCT00002651|463194219|FG001|Induction|Adverse Event|0|||
128698274|NCT00002651|463194220|FG002|Induction|Adverse Event|0|||
128698275|NCT00002651|463194218|FG000|Induction|Refusal unrelated to adverse event|50|||
128698276|NCT00002651|463194219|FG001|Induction|Refusal unrelated to adverse event|0|||
128698277|NCT00002651|463194220|FG002|Induction|Refusal unrelated to adverse event|0|||
128698278|NCT00002651|463194218|FG000|Induction|Progression/relapse|274|||
128698279|NCT00002651|463194219|FG001|Induction|Progression/relapse|0|||
128698280|NCT00002651|463194220|FG002|Induction|Progression/relapse|0|||
128698281|NCT00002651|463194218|FG000|Induction|Death|62|||
128698282|NCT00002651|463194219|FG001|Induction|Death|0|||
128698283|NCT00002651|463194220|FG002|Induction|Death|0|||
128698284|NCT00002651|463194218|FG000|Induction|Other|823|||
128698285|NCT00002651|463194219|FG001|Induction|Other|0|||
128698286|NCT00002651|463194220|FG002|Induction|Other|0|||
128698287|NCT00002651|463194218|FG000|Induction|not eligible|90|||
128698288|NCT00002651|463194219|FG001|Induction|not eligible|0|||
128698289|NCT00002651|463194220|FG002|Induction|not eligible|0|||
128698290|NCT00002651|463194218|FG000|Consolidation and Randomization|Adverse Event|0|||
128698291|NCT00002651|463194219|FG001|Consolidation and Randomization|Adverse Event|36|||
128765868|NCT00152009|463433928|FG000|Overall Study|Protocol Violation|3|||
128765869|NCT00152009|463433929|FG001|Overall Study|Protocol Violation|0|||
129029017|NCT01710358|464398306|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
128698292|NCT00002651|463194220|FG002|Consolidation and Randomization|Adverse Event|14|||
128698293|NCT00002651|463194218|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
128698294|NCT00002651|463194219|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
128698295|NCT00002651|463194220|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
128698296|NCT00002651|463194218|FG000|Consolidation and Randomization|Progression/relapse|0|||
128698297|NCT00002651|463194219|FG001|Consolidation and Randomization|Progression/relapse|295|||
128698298|NCT00002651|463194220|FG002|Consolidation and Randomization|Progression/relapse|298|||
128918154|NCT00110994|463990332|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
128918155|NCT00110994|463990331|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
128918156|NCT00110994|463990332|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
128918157|NCT00110994|463990331|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
128918158|NCT00110994|463990332|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
128918159|NCT00110994|463990331|FG000|Double-blind (DB) Treatment|other reasons|2|||
128918160|NCT00110994|463990332|FG001|Double-blind (DB) Treatment|other reasons|3|||
128918161|NCT00110994|463990331|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
128918162|NCT00110994|463990332|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
128918163|NCT00110994|463990331|FG000|Active Follow-up|Other reasons|0|||
128698299|NCT00002651|463194218|FG000|Consolidation and Randomization|Death|0|||
128698300|NCT00002651|463194219|FG001|Consolidation and Randomization|Death|38|||
128698301|NCT00002651|463194220|FG002|Consolidation and Randomization|Death|48|||
128698302|NCT00002651|463194218|FG000|Consolidation and Randomization|Other|0|||
128698303|NCT00002651|463194219|FG001|Consolidation and Randomization|Other|314|||
128698304|NCT00002651|463194220|FG002|Consolidation and Randomization|Other|313|||
128698305|NCT00002651|463194218|FG000|Consolidation and Randomization|not eligible|0|||
128698306|NCT00002651|463194219|FG001|Consolidation and Randomization|not eligible|102|||
128698307|NCT00002651|463194220|FG002|Consolidation and Randomization|not eligible|112|||
128698308|NCT03741062|463194223|FG000|Overall Study|Protocol Violation|1|||
128698309|NCT03741062|463194224|FG001|Overall Study|Protocol Violation|0|||
128698310|NCT02763462|463194227|FG000|Overall Study|Protocol Violation|6|||
128698311|NCT03417219|463194228|FG000|Overall Study|Lost to Follow-up|0|||
128698312|NCT03417219|463194229|FG001|Overall Study|Lost to Follow-up|3|||
128698313|NCT00261807|463194230|FG000|Overall Study|Lost to Follow-up|2|||
128698314|NCT00261807|463194230|FG000|Overall Study|Adverse Event|2|||
128698315|NCT00261807|463194230|FG000|Overall Study|Death|1|||
129216009|NCT00790842|465092852|FG003|Dose Level 3|Withdrawal by Subject|0|||
129216010|NCT00790842|465092853|FG004|Dose Level 3|Withdrawal by Subject|0|||
129216011|NCT00790842|465092854|FG005|Dose Level 3|Withdrawal by Subject|0|||
128698316|NCT00261807|463194230|FG000|Overall Study|Protocol Violation|2|||
128698317|NCT02100514|463194233|FG000|Treatment Period|Adverse Event|0|||
128698318|NCT02100514|463194234|FG001|Treatment Period|Adverse Event|5|||
128698319|NCT02100514|463194235|FG002|Treatment Period|Adverse Event|0|||
128698320|NCT02100514|463194236|FG003|Treatment Period|Adverse Event|0|||
128698321|NCT02100514|463194237|FG004|Treatment Period|Adverse Event|0|||
128698322|NCT02100514|463194233|FG000|Treatment Period|Death|2|||
128698323|NCT02100514|463194234|FG001|Treatment Period|Death|2|||
128698324|NCT02100514|463194235|FG002|Treatment Period|Death|0|||
128698325|NCT02100514|463194236|FG003|Treatment Period|Death|0|||
128698326|NCT02100514|463194237|FG004|Treatment Period|Death|0|||
128698327|NCT02100514|463194233|FG000|Treatment Period|Lost to Follow-up|5|||
128698328|NCT02100514|463194234|FG001|Treatment Period|Lost to Follow-up|17|||
128698329|NCT02100514|463194235|FG002|Treatment Period|Lost to Follow-up|0|||
128698330|NCT02100514|463194236|FG003|Treatment Period|Lost to Follow-up|0|||
128698331|NCT02100514|463194237|FG004|Treatment Period|Lost to Follow-up|0|||
128698332|NCT02100514|463194233|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
128698333|NCT02100514|463194234|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
128698334|NCT02100514|463194235|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
128698335|NCT02100514|463194236|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
128698336|NCT02100514|463194237|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
128698337|NCT02100514|463194233|FG000|Treatment Period|Protocol Violation|1|||
128698338|NCT02100514|463194234|FG001|Treatment Period|Protocol Violation|1|||
128698339|NCT02100514|463194235|FG002|Treatment Period|Protocol Violation|0|||
128698340|NCT02100514|463194236|FG003|Treatment Period|Protocol Violation|0|||
128698341|NCT02100514|463194237|FG004|Treatment Period|Protocol Violation|0|||
128698342|NCT02100514|463194233|FG000|Treatment Period|Withdrawal by Subject|12|||
128698343|NCT02100514|463194234|FG001|Treatment Period|Withdrawal by Subject|37|||
128698344|NCT02100514|463194235|FG002|Treatment Period|Withdrawal by Subject|0|||
128698345|NCT02100514|463194236|FG003|Treatment Period|Withdrawal by Subject|0|||
128918164|NCT00110994|463990332|FG001|Active Follow-up|Other reasons|2|||
128698346|NCT02100514|463194237|FG004|Treatment Period|Withdrawal by Subject|0|||
128698347|NCT02100514|463194233|FG000|Treatment Period|Other|9|||
128698348|NCT02100514|463194234|FG001|Treatment Period|Other|11|||
128698349|NCT02100514|463194235|FG002|Treatment Period|Other|0|||
128698350|NCT02100514|463194236|FG003|Treatment Period|Other|0|||
128698351|NCT02100514|463194237|FG004|Treatment Period|Other|0|||
128698352|NCT02100514|463194233|FG000|Extension Period|Withdrew consent|0|||
128698353|NCT02100514|463194234|FG001|Extension Period|Withdrew consent|0|||
128698354|NCT02100514|463194235|FG002|Extension Period|Withdrew consent|2|||
128918165|NCT00110994|463990331|FG000|Long Term Follow-up|Death|19|||
128698355|NCT02100514|463194236|FG003|Extension Period|Withdrew consent|0|||
128698356|NCT02100514|463194237|FG004|Extension Period|Withdrew consent|0|||
128698357|NCT02021331|463194238|FG000|Overall Study|Adverse Event|0|||
128698358|NCT02021331|463194239|FG001|Overall Study|Adverse Event|2|||
128918166|NCT00110994|463990332|FG001|Long Term Follow-up|Death|17|||
129216012|NCT00790842|465092855|FG006|Dose Level 3|Withdrawal by Subject|0|||
128698359|NCT00762229|463194240|FG000|Overall Study|Lost to Follow-up|1|||
128698360|NCT00762229|463194241|FG001|Overall Study|Lost to Follow-up|1|||
128698361|NCT00762229|463194240|FG000|Overall Study|did not recveive intervention|0|||
128698362|NCT00762229|463194241|FG001|Overall Study|did not recveive intervention|1|||
128698363|NCT01896102|463194246|FG000|Overall Study|Death|1|||
128698364|NCT01896102|463194246|FG000|Overall Study|Participant to receive allogenic transplant|2|||
128698365|NCT04203498|463194248|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
128698366|NCT04203498|463194249|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
128698367|NCT04203498|463194248|FG000|Overall Study|Withdrawal of patient consent|7|||
128698368|NCT04203498|463194249|FG001|Overall Study|Withdrawal of patient consent|2|||
128698369|NCT04203498|463194248|FG000|Overall Study|Adverse Event|4|||
128698370|NCT04203498|463194249|FG001|Overall Study|Adverse Event|1|||
128698371|NCT04203498|463194248|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
128765870|NCT00152009|463433930|FG002|Overall Study|Protocol Violation|0|||
128765871|NCT00152009|463433931|FG003|Overall Study|Protocol Violation|1|||
128765872|NCT00152009|463433928|FG000|Overall Study|Withdrawal by Subject|2|||
128765873|NCT00152009|463433929|FG001|Overall Study|Withdrawal by Subject|3|||
128765874|NCT00152009|463433930|FG002|Overall Study|Withdrawal by Subject|4|||
128765875|NCT00152009|463433931|FG003|Overall Study|Withdrawal by Subject|9|||
128765876|NCT00152009|463433928|FG000|Overall Study|Lost to Follow-up|2|||
128765877|NCT00152009|463433929|FG001|Overall Study|Lost to Follow-up|4|||
128765878|NCT00152009|463433930|FG002|Overall Study|Lost to Follow-up|3|||
128765879|NCT00152009|463433931|FG003|Overall Study|Lost to Follow-up|3|||
128765880|NCT00152009|463433928|FG000|Overall Study|Lack of Efficacy|8|||
128765881|NCT00152009|463433929|FG001|Overall Study|Lack of Efficacy|6|||
128765882|NCT00152009|463433930|FG002|Overall Study|Lack of Efficacy|7|||
128765883|NCT00152009|463433931|FG003|Overall Study|Lack of Efficacy|15|||
128765884|NCT00152009|463433928|FG000|Overall Study|ECG abnormalities|2|||
128765885|NCT00152009|463433929|FG001|Overall Study|ECG abnormalities|2|||
128765886|NCT00152009|463433930|FG002|Overall Study|ECG abnormalities|2|||
128765887|NCT00152009|463433931|FG003|Overall Study|ECG abnormalities|1|||
128765888|NCT00152009|463433928|FG000|Overall Study|Sponsor's decision|3|||
128765889|NCT00152009|463433929|FG001|Overall Study|Sponsor's decision|3|||
128765890|NCT00152009|463433930|FG002|Overall Study|Sponsor's decision|1|||
128765891|NCT00152009|463433931|FG003|Overall Study|Sponsor's decision|3|||
128765892|NCT01306201|463433933|FG000|Overall Study|Arrhythmia|4|||
128765893|NCT01306201|463433933|FG000|Overall Study|Files could not be processed|3|||
128765894|NCT01306201|463433933|FG000|Overall Study|Files unreadable|3|||
128765895|NCT04702568|463433934|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
128765896|NCT04702568|463433935|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
128765897|NCT04702568|463433934|FG000|Overall Study|Pregnancy|1|||
128765898|NCT04702568|463433935|FG001|Overall Study|Pregnancy|0|||
128765899|NCT04702568|463433934|FG000|Overall Study|Bone marrow transplant|1|||
128765900|NCT04702568|463433935|FG001|Overall Study|Bone marrow transplant|0|||
128765901|NCT04702568|463433934|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
128765902|NCT04702568|463433935|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
128765903|NCT04702568|463433934|FG000|Overall Study|Withdrawal by Subject|0|||
128765904|NCT04702568|463433935|FG001|Overall Study|Withdrawal by Subject|2|||
128765905|NCT00393523|463433936|FG000|Overall Study|Lost to Follow-up|0|||
128765906|NCT00393523|463433937|FG001|Overall Study|Lost to Follow-up|0|||
128765907|NCT00393523|463433938|FG002|Overall Study|Lost to Follow-up|0|||
128765908|NCT00393523|463433939|FG003|Overall Study|Lost to Follow-up|2|||
128765909|NCT00393523|463433940|FG004|Overall Study|Lost to Follow-up|1|||
128765910|NCT00393523|463433936|FG000|Overall Study|Protocol Violation|6|||
128765911|NCT00393523|463433937|FG001|Overall Study|Protocol Violation|2|||
128765912|NCT00393523|463433938|FG002|Overall Study|Protocol Violation|0|||
128765913|NCT00393523|463433939|FG003|Overall Study|Protocol Violation|1|||
128765914|NCT00393523|463433940|FG004|Overall Study|Protocol Violation|0|||
128765915|NCT00393523|463433936|FG000|Overall Study|Withdrawal by Subject|6|||
128765916|NCT00393523|463433937|FG001|Overall Study|Withdrawal by Subject|7|||
128765917|NCT00393523|463433938|FG002|Overall Study|Withdrawal by Subject|2|||
128765918|NCT00393523|463433939|FG003|Overall Study|Withdrawal by Subject|3|||
128765919|NCT00393523|463433940|FG004|Overall Study|Withdrawal by Subject|0|||
128765920|NCT00393523|463433936|FG000|Overall Study|Difficulties in specimen collection|0|||
128765921|NCT00393523|463433937|FG001|Overall Study|Difficulties in specimen collection|0|||
128765922|NCT00393523|463433938|FG002|Overall Study|Difficulties in specimen collection|1|||
128765923|NCT00393523|463433939|FG003|Overall Study|Difficulties in specimen collection|0|||
128765924|NCT00393523|463433940|FG004|Overall Study|Difficulties in specimen collection|0|||
128765925|NCT00393523|463433936|FG000|Overall Study|Vaccine supply issue|0|||
128765926|NCT00393523|463433937|FG001|Overall Study|Vaccine supply issue|0|||
128765927|NCT00393523|463433938|FG002|Overall Study|Vaccine supply issue|1|||
128765928|NCT00393523|463433939|FG003|Overall Study|Vaccine supply issue|0|||
128765929|NCT00393523|463433940|FG004|Overall Study|Vaccine supply issue|0|||
128765930|NCT04091360|463433941|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128765931|NCT04091360|463433942|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128918167|NCT01570244|463990333|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
128918168|NCT04134494|463990337|FG000|Overall Study|Lost to Follow-up|2|||
128918169|NCT00781365|463990338|FG000|Overall Study|Withdrawal by Subject|13|||
128918170|NCT00781365|463990339|FG001|Overall Study|Withdrawal by Subject|8|||
128918171|NCT00781365|463990338|FG000|Overall Study|Did Not Attend Visit|20|||
128918172|NCT00781365|463990339|FG001|Overall Study|Did Not Attend Visit|28|||
128918173|NCT00781365|463990338|FG000|Overall Study|Language barrier|1|||
128918174|NCT00781365|463990339|FG001|Overall Study|Language barrier|0|||
128918175|NCT01879410|463990340|FG000|Overall Study|Adverse Event|9|||
129029018|NCT01710358|464398304|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
129029019|NCT01710358|464398305|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
129029020|NCT01710358|464398306|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
129029021|NCT01710358|464398304|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
129029022|NCT01710358|464398305|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
129029023|NCT01710358|464398306|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
129029024|NCT01710358|464398304|FG000|Rescue Period|Adverse Event|0|||
129029025|NCT01710358|464398305|FG001|Rescue Period|Adverse Event|15|||
129029026|NCT01710358|464398306|FG002|Rescue Period|Adverse Event|0|||
129029027|NCT01710358|464398304|FG000|Rescue Period|Death|0|||
129029028|NCT01710358|464398305|FG001|Rescue Period|Death|1|||
129029029|NCT01710358|464398306|FG002|Rescue Period|Death|0|||
129029030|NCT01710358|464398304|FG000|Rescue Period|Lack of Efficacy|0|||
129029031|NCT01710358|464398305|FG001|Rescue Period|Lack of Efficacy|7|||
129029032|NCT01710358|464398306|FG002|Rescue Period|Lack of Efficacy|0|||
129029033|NCT01710358|464398304|FG000|Rescue Period|Withdrawal by Subject|0|||
129029034|NCT01710358|464398305|FG001|Rescue Period|Withdrawal by Subject|8|||
129029035|NCT01710358|464398306|FG002|Rescue Period|Withdrawal by Subject|0|||
129029036|NCT03540160|464398310|FG000|Overall Study|Protocol Violation|1|||
129029037|NCT03540160|464398310|FG000|Overall Study|Physician Decision|8|||
129029038|NCT03540160|464398310|FG000|Overall Study|Lack of Efficacy|60|||
129029039|NCT03540160|464398310|FG000|Overall Study|Pregnancy|1|||
129029040|NCT03540160|464398310|FG000|Overall Study|Adverse Event|20|||
129029041|NCT03540160|464398310|FG000|Overall Study|Withdrawal by Subject|68|||
129029042|NCT03540160|464398310|FG000|Overall Study|COVID-19|2|||
129029043|NCT03540160|464398310|FG000|Overall Study|Study Closure|10|||
129029044|NCT03540160|464398310|FG000|Overall Study|Lost to Follow-up|18|||
129029045|NCT03540160|464398310|FG000|Overall Study|Sponsor decision|191|||
129029046|NCT03358147|464398315|FG000|Overall Study|Withdrawal by Subject|13|||
129029047|NCT03358147|464398316|FG001|Overall Study|Withdrawal by Subject|19|||
129029048|NCT03358147|464398317|FG002|Overall Study|Withdrawal by Subject|16|||
129029049|NCT03358147|464398318|FG003|Overall Study|Withdrawal by Subject|10|||
129029050|NCT03358147|464398319|FG004|Overall Study|Withdrawal by Subject|5|||
129029051|NCT03358147|464398315|FG000|Overall Study|Adverse Event|3|||
129029052|NCT03358147|464398316|FG001|Overall Study|Adverse Event|9|||
129029053|NCT03358147|464398317|FG002|Overall Study|Adverse Event|7|||
129029054|NCT03358147|464398318|FG003|Overall Study|Adverse Event|5|||
129029055|NCT03358147|464398319|FG004|Overall Study|Adverse Event|2|||
129029056|NCT03358147|464398315|FG000|Overall Study|Lost to Follow-up|4|||
129029057|NCT03358147|464398316|FG001|Overall Study|Lost to Follow-up|3|||
129029058|NCT03358147|464398317|FG002|Overall Study|Lost to Follow-up|7|||
129029059|NCT03358147|464398318|FG003|Overall Study|Lost to Follow-up|6|||
129029060|NCT03358147|464398319|FG004|Overall Study|Lost to Follow-up|4|||
129029061|NCT03358147|464398315|FG000|Overall Study|Major Protocol Deviation|11|||
129029062|NCT03358147|464398316|FG001|Overall Study|Major Protocol Deviation|3|||
129029063|NCT03358147|464398317|FG002|Overall Study|Major Protocol Deviation|2|||
129029064|NCT03358147|464398318|FG003|Overall Study|Major Protocol Deviation|3|||
129029065|NCT03358147|464398319|FG004|Overall Study|Major Protocol Deviation|1|||
129029066|NCT03358147|464398315|FG000|Overall Study|Protocol specified criteria|2|||
129029067|NCT03358147|464398316|FG001|Overall Study|Protocol specified criteria|3|||
129029068|NCT03358147|464398317|FG002|Overall Study|Protocol specified criteria|0|||
129029069|NCT03358147|464398318|FG003|Overall Study|Protocol specified criteria|3|||
129029070|NCT03358147|464398319|FG004|Overall Study|Protocol specified criteria|1|||
129029071|NCT03358147|464398315|FG000|Overall Study|Physician Decision|1|||
129029072|NCT03358147|464398316|FG001|Overall Study|Physician Decision|0|||
129029073|NCT03358147|464398317|FG002|Overall Study|Physician Decision|1|||
129029074|NCT03358147|464398318|FG003|Overall Study|Physician Decision|6|||
129029075|NCT03358147|464398319|FG004|Overall Study|Physician Decision|1|||
129029076|NCT03358147|464398315|FG000|Overall Study|Administrative reasons|0|||
129029077|NCT03358147|464398316|FG001|Overall Study|Administrative reasons|1|||
129029078|NCT03358147|464398317|FG002|Overall Study|Administrative reasons|0|||
129029079|NCT03358147|464398318|FG003|Overall Study|Administrative reasons|3|||
129029080|NCT03358147|464398319|FG004|Overall Study|Administrative reasons|0|||
129029081|NCT03358147|464398315|FG000|Overall Study|Lack of Efficacy|0|||
129029082|NCT03358147|464398316|FG001|Overall Study|Lack of Efficacy|1|||
129029083|NCT03358147|464398317|FG002|Overall Study|Lack of Efficacy|1|||
129029084|NCT03358147|464398318|FG003|Overall Study|Lack of Efficacy|0|||
129029085|NCT03358147|464398319|FG004|Overall Study|Lack of Efficacy|0|||
129029086|NCT02704091|464398320|FG000|Overall Study|Adverse Event|4|||
128765932|NCT04091360|463433943|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128765933|NCT04091360|463433944|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128765934|NCT04091360|463433945|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128765935|NCT04091360|463433946|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128765936|NCT04091360|463433947|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128765937|NCT04091360|463433948|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
128765938|NCT04091360|463433949|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
128765939|NCT04091360|463433950|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
128765940|NCT04091360|463433941|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765941|NCT04091360|463433942|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765942|NCT04091360|463433943|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765943|NCT04091360|463433944|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765944|NCT04091360|463433945|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765945|NCT04091360|463433946|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765946|NCT04091360|463433947|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
128765947|NCT04091360|463433948|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
128765948|NCT04091360|463433949|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765949|NCT04091360|463433950|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
128765950|NCT04091360|463433941|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765951|NCT04091360|463433942|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765952|NCT04091360|463433943|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765953|NCT04091360|463433944|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765954|NCT04091360|463433945|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765955|NCT04091360|463433946|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765956|NCT04091360|463433947|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
128765957|NCT04091360|463433948|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765958|NCT04091360|463433949|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
128765959|NCT04091360|463433950|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
128765960|NCT00423852|463433951|FG000|Overall Study|Removed pior to the high-dose portion|3|||
128765961|NCT01515189|463433953|FG000|Induction|Disease Progression|109|||
128765962|NCT01515189|463433954|FG001|Induction|Disease Progression|155|||
128765963|NCT01515189|463433953|FG000|Induction|Study drug toxicity|86|||
128765964|NCT01515189|463433954|FG001|Induction|Study drug toxicity|36|||
128765965|NCT01515189|463433953|FG000|Induction|Death|24|||
128765966|NCT01515189|463433954|FG001|Induction|Death|17|||
128765967|NCT01515189|463433953|FG000|Induction|Adverse Event|14|||
128765968|NCT01515189|463433954|FG001|Induction|Adverse Event|9|||
128765969|NCT01515189|463433953|FG000|Induction|Withdrawal by Subject|3|||
128765970|NCT01515189|463433954|FG001|Induction|Withdrawal by Subject|9|||
128765971|NCT01515189|463433953|FG000|Induction|No longer meets study criteria|0|||
128765972|NCT01515189|463433954|FG001|Induction|No longer meets study criteria|2|||
128765973|NCT01515189|463433953|FG000|Induction|Lost to Follow-up|1|||
128765974|NCT01515189|463433954|FG001|Induction|Lost to Follow-up|0|||
128765975|NCT01515189|463433953|FG000|Induction|Other|0|||
128765976|NCT01515189|463433954|FG001|Induction|Other|4|||
128765977|NCT01515189|463433953|FG000|First Re-Induction Phase|Disease progression|6|||
128765978|NCT01515189|463433954|FG001|First Re-Induction Phase|Disease progression|14|||
128765979|NCT01515189|463433953|FG000|First Re-Induction Phase|Study drug toxicity|5|||
128765980|NCT01515189|463433954|FG001|First Re-Induction Phase|Study drug toxicity|0|||
128765981|NCT01515189|463433953|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
128765982|NCT01515189|463433954|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
128765983|NCT01515189|463433953|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
128765984|NCT01515189|463433954|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
128765985|NCT01515189|463433953|FG000|First Re-Induction Phase|Other|1|||
128765986|NCT01515189|463433954|FG001|First Re-Induction Phase|Other|0|||
128918176|NCT01879410|463990341|FG001|Overall Study|Adverse Event|14|||
128918177|NCT01879410|463990340|FG000|Overall Study|Lack of Efficacy|4|||
128918178|NCT01879410|463990341|FG001|Overall Study|Lack of Efficacy|6|||
128918179|NCT01879410|463990340|FG000|Overall Study|Protocol Violation|1|||
128918180|NCT01879410|463990341|FG001|Overall Study|Protocol Violation|7|||
128918181|NCT01879410|463990340|FG000|Overall Study|Lost to Follow-up|2|||
128918182|NCT01879410|463990341|FG001|Overall Study|Lost to Follow-up|1|||
128918183|NCT01879410|463990340|FG000|Overall Study|Withdrawal by Subject|7|||
128765987|NCT03787680|463433955|FG000|Overall Study|Physician Decision|2|||
128765988|NCT03787680|463433956|FG001|Overall Study|Physician Decision|3|||
128765989|NCT03787680|463433955|FG000|Overall Study|Adverse Event|7|||
128918184|NCT01879410|463990341|FG001|Overall Study|Withdrawal by Subject|8|||
128765990|NCT03787680|463433956|FG001|Overall Study|Adverse Event|3|||
128918185|NCT01879410|463990340|FG000|Overall Study|Randomised in Error|1|||
128765991|NCT03787680|463433955|FG000|Overall Study|Withdrawal by Subject|2|||
128918186|NCT01879410|463990341|FG001|Overall Study|Randomised in Error|2|||
129029087|NCT02704091|464398321|FG001|Overall Study|Adverse Event|3|||
128918187|NCT01756456|463990349|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
128918188|NCT01756456|463990350|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
128918189|NCT01756456|463990351|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
128918190|NCT01756456|463990352|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
128918191|NCT01756456|463990353|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
128918192|NCT01756456|463990354|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
128918193|NCT01756456|463990349|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
128918194|NCT01756456|463990350|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
128918195|NCT01756456|463990351|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
128918196|NCT01756456|463990352|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
128918197|NCT01756456|463990353|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
128918198|NCT01756456|463990354|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
128918199|NCT01756456|463990349|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
128918200|NCT01756456|463990350|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
128918201|NCT01756456|463990351|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
128918202|NCT01756456|463990352|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
128918203|NCT01756456|463990353|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
128918204|NCT01756456|463990354|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
128918205|NCT01756456|463990349|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
128918206|NCT01756456|463990350|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
128918207|NCT01756456|463990351|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
128918208|NCT01756456|463990352|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
128918209|NCT01756456|463990353|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
128918210|NCT01756456|463990354|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
128918211|NCT01756456|463990349|FG000|Treatment Period: Phase I/II|Other causes|0|||
128918212|NCT01756456|463990350|FG001|Treatment Period: Phase I/II|Other causes|0|||
128918213|NCT01756456|463990351|FG002|Treatment Period: Phase I/II|Other causes|0|||
128918214|NCT01756456|463990352|FG003|Treatment Period: Phase I/II|Other causes|1|||
128918215|NCT01756456|463990353|FG004|Treatment Period: Phase I/II|Other causes|2|||
128918216|NCT01756456|463990354|FG005|Treatment Period: Phase I/II|Other causes|2|||
128918217|NCT01756456|463990349|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
128918218|NCT01756456|463990350|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
128918219|NCT01756456|463990351|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
128918220|NCT01756456|463990352|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
128918221|NCT01756456|463990353|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
128918222|NCT01756456|463990354|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
128918223|NCT01756456|463990349|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
128918224|NCT01756456|463990350|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
128918225|NCT01756456|463990351|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
128918226|NCT01756456|463990352|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
128918227|NCT01756456|463990353|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
128698372|NCT04203498|463194249|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
128698373|NCT04203498|463194248|FG000|Overall Study|Did not receive IMP|2|||
128918228|NCT01756456|463990354|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
128918229|NCT01756456|463990349|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
128918230|NCT01756456|463990350|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
128918231|NCT01756456|463990351|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
128918232|NCT01756456|463990352|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
128918233|NCT01756456|463990353|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
128918234|NCT01756456|463990354|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
128918235|NCT01756456|463990349|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
128918236|NCT01756456|463990350|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
128918237|NCT01756456|463990351|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
128918238|NCT01756456|463990352|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
128918239|NCT01756456|463990353|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
128918240|NCT01756456|463990354|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
128918241|NCT01756456|463990349|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
128918242|NCT01756456|463990350|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
128918243|NCT01756456|463990351|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
128918244|NCT01756456|463990352|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
128918245|NCT01756456|463990353|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
128918246|NCT01756456|463990354|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
128918247|NCT01756456|463990349|FG000|Follow Up Period Phase I/II|Other causes|0|||
128918248|NCT01756456|463990350|FG001|Follow Up Period Phase I/II|Other causes|0|||
128918249|NCT01756456|463990351|FG002|Follow Up Period Phase I/II|Other causes|0|||
128698374|NCT04203498|463194249|FG001|Overall Study|Did not receive IMP|0|||
128918250|NCT01756456|463990352|FG003|Follow Up Period Phase I/II|Other causes|1|||
128918251|NCT01756456|463990353|FG004|Follow Up Period Phase I/II|Other causes|3|||
129029088|NCT02704091|464398320|FG000|Overall Study|Protocol Violation|5|||
128918252|NCT01756456|463990354|FG005|Follow Up Period Phase I/II|Other causes|5|||
128918253|NCT00854828|463990357|FG000|Overall Study|Death|1|||
128918254|NCT00854828|463990358|FG001|Overall Study|Death|0|||
128918255|NCT00854828|463990359|FG002|Overall Study|Death|0|||
128918256|NCT00854828|463990360|FG003|Overall Study|Death|0|||
128918257|NCT00854828|463990357|FG000|Overall Study|Withdrawal by Subject|1|||
128918258|NCT00854828|463990358|FG001|Overall Study|Withdrawal by Subject|1|||
128918259|NCT00854828|463990359|FG002|Overall Study|Withdrawal by Subject|0|||
128918260|NCT00854828|463990360|FG003|Overall Study|Withdrawal by Subject|9|||
128918261|NCT00854828|463990357|FG000|Overall Study|Missed 24mo visit|1|||
128698375|NCT01235689|463194250|FG000|Overall Study|Adverse Event|12|||
128698376|NCT01235689|463194251|FG001|Overall Study|Adverse Event|16|||
128698377|NCT01235689|463194250|FG000|Overall Study|Lack of Efficacy|12|||
128698378|NCT01235689|463194251|FG001|Overall Study|Lack of Efficacy|5|||
128698379|NCT01235689|463194250|FG000|Overall Study|Withdrawal by Subject|3|||
128698380|NCT01235689|463194251|FG001|Overall Study|Withdrawal by Subject|4|||
128698381|NCT01235689|463194250|FG000|Overall Study|Lost to Follow-up|1|||
128698382|NCT01235689|463194251|FG001|Overall Study|Lost to Follow-up|2|||
128698383|NCT01235689|463194250|FG000|Overall Study|Miscellaneous|1|||
128698384|NCT01235689|463194251|FG001|Overall Study|Miscellaneous|5|||
128698385|NCT01443078|463194252|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
128698386|NCT01443078|463194252|FG000|Overall Study|Withdrawal by Subject|1|||
128698387|NCT01443078|463194252|FG000|Overall Study|Patient had brain mets|1|||
128698388|NCT00005044|463194257|FG000|Overall Study|Protocol Violation|37|||
128698389|NCT00005044|463194258|FG001|Overall Study|Protocol Violation|46|||
128698390|NCT00005044|463194257|FG000|Overall Study|Withdrawal by Subject|1|||
128698391|NCT00005044|463194258|FG001|Overall Study|Withdrawal by Subject|5|||
128698392|NCT00005044|463194257|FG000|Overall Study|No protocol treatment|0|||
128698393|NCT00005044|463194258|FG001|Overall Study|No protocol treatment|1|||
128698394|NCT03988088|463194259|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
128698395|NCT03988088|463194260|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
128698396|NCT03988088|463194261|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
128698397|NCT03988088|463194262|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
128698398|NCT03988088|463194259|FG000|Open-Label Addendum|Lost to Follow-up|0|||
128698399|NCT03988088|463194260|FG001|Open-Label Addendum|Lost to Follow-up|0|||
128698400|NCT03988088|463194261|FG002|Open-Label Addendum|Lost to Follow-up|1|||
128698401|NCT03988088|463194262|FG003|Open-Label Addendum|Lost to Follow-up|0|||
128698402|NCT04431453|463194263|FG000|Overall Study|Withdrew Consent|0|||
128698403|NCT04431453|463194264|FG001|Overall Study|Withdrew Consent|1|||
128698404|NCT04431453|463194265|FG002|Overall Study|Withdrew Consent|0|||
128698405|NCT04431453|463194266|FG003|Overall Study|Withdrew Consent|2|||
128698406|NCT04431453|463194267|FG004|Overall Study|Withdrew Consent|0|||
128698407|NCT04431453|463194268|FG005|Overall Study|Withdrew Consent|0|||
128698408|NCT04431453|463194269|FG006|Overall Study|Withdrew Consent|0|||
128698409|NCT04431453|463194270|FG007|Overall Study|Withdrew Consent|0|||
128698410|NCT04431453|463194263|FG000|Overall Study|Death|1|||
128698411|NCT04431453|463194264|FG001|Overall Study|Death|0|||
128698412|NCT04431453|463194265|FG002|Overall Study|Death|0|||
128698413|NCT04431453|463194266|FG003|Overall Study|Death|0|||
128698414|NCT04431453|463194267|FG004|Overall Study|Death|0|||
128698415|NCT04431453|463194268|FG005|Overall Study|Death|0|||
128698416|NCT04431453|463194269|FG006|Overall Study|Death|0|||
128698417|NCT04431453|463194270|FG007|Overall Study|Death|1|||
128698418|NCT04431453|463194263|FG000|Overall Study|Lost to Follow-up|0|||
128698419|NCT04431453|463194264|FG001|Overall Study|Lost to Follow-up|0|||
128698420|NCT04431453|463194265|FG002|Overall Study|Lost to Follow-up|1|||
128698421|NCT04431453|463194266|FG003|Overall Study|Lost to Follow-up|1|||
128698422|NCT04431453|463194267|FG004|Overall Study|Lost to Follow-up|0|||
128698423|NCT04431453|463194268|FG005|Overall Study|Lost to Follow-up|0|||
128698424|NCT04431453|463194269|FG006|Overall Study|Lost to Follow-up|0|||
128698425|NCT04431453|463194270|FG007|Overall Study|Lost to Follow-up|0|||
128698426|NCT04431453|463194263|FG000|Overall Study|Enrolled but Never Treated|0|||
128698427|NCT04431453|463194264|FG001|Overall Study|Enrolled but Never Treated|0|||
128698428|NCT04431453|463194265|FG002|Overall Study|Enrolled but Never Treated|0|||
128918262|NCT00854828|463990358|FG001|Overall Study|Missed 24mo visit|1|||
128698429|NCT04431453|463194266|FG003|Overall Study|Enrolled but Never Treated|0|||
128698430|NCT04431453|463194267|FG004|Overall Study|Enrolled but Never Treated|1|||
128698431|NCT04431453|463194268|FG005|Overall Study|Enrolled but Never Treated|0|||
128698432|NCT04431453|463194269|FG006|Overall Study|Enrolled but Never Treated|0|||
128698433|NCT04431453|463194270|FG007|Overall Study|Enrolled but Never Treated|0|||
128698434|NCT03546062|463194271|FG000|Overall Study|Adverse Event|6|||
128698435|NCT03546062|463194272|FG001|Overall Study|Adverse Event|5|||
128698436|NCT03546062|463194273|FG002|Overall Study|Adverse Event|8|||
128918263|NCT00854828|463990359|FG002|Overall Study|Missed 24mo visit|8|||
128918264|NCT00854828|463990360|FG003|Overall Study|Missed 24mo visit|8|||
128698437|NCT02083965|463194275|FG000|Treatment Period|Other|1|||
128698438|NCT02083965|463194276|FG001|Treatment Period|Other|0|||
128698439|NCT04502433|463194278|FG000|Overall Study|Death|2|||
128698440|NCT04502433|463194279|FG001|Overall Study|Death|4|||
128918265|NCT04957290|463990361|FG000|Overall Study|Progressive disease|3|||
128698441|NCT04502433|463194278|FG000|Overall Study|Lost to Follow-up|1|||
128698442|NCT04502433|463194279|FG001|Overall Study|Lost to Follow-up|0|||
128698443|NCT04502433|463194278|FG000|Overall Study|Physician Decision|0|||
128698444|NCT04502433|463194279|FG001|Overall Study|Physician Decision|1|||
128698445|NCT02935842|463194280|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
128698446|NCT02935842|463194281|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
128698447|NCT02935842|463194282|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
128698448|NCT02935842|463194283|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
128698449|NCT02935842|463194280|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
128698450|NCT02935842|463194281|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
128698451|NCT02935842|463194282|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
128698452|NCT02935842|463194283|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
128698453|NCT02935842|463194280|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
128698454|NCT02935842|463194281|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
128698455|NCT02935842|463194282|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
128698456|NCT02935842|463194283|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
128698457|NCT02935842|463194280|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
128698458|NCT02935842|463194281|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
128698459|NCT02935842|463194282|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
128698460|NCT02935842|463194283|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
128698461|NCT02935842|463194280|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
128698462|NCT02935842|463194281|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
128698463|NCT02935842|463194282|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
128698464|NCT02935842|463194283|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
128698465|NCT00911547|463194284|FG000|Overall Study|Adverse Event|8|||
128698466|NCT00911547|463194285|FG001|Overall Study|Adverse Event|27|||
128698467|NCT00911547|463194286|FG002|Overall Study|Adverse Event|11|||
128698468|NCT00911547|463194287|FG003|Overall Study|Adverse Event|6|||
128698469|NCT00911547|463194284|FG000|Overall Study|Lost to Follow-up|0|||
128698470|NCT00911547|463194285|FG001|Overall Study|Lost to Follow-up|0|||
128698471|NCT00911547|463194286|FG002|Overall Study|Lost to Follow-up|2|||
128698472|NCT00911547|463194287|FG003|Overall Study|Lost to Follow-up|1|||
128698473|NCT00911547|463194284|FG000|Overall Study|Protocol Violation|0|||
128698474|NCT00911547|463194285|FG001|Overall Study|Protocol Violation|5|||
128698475|NCT00911547|463194286|FG002|Overall Study|Protocol Violation|5|||
128698476|NCT00911547|463194287|FG003|Overall Study|Protocol Violation|1|||
128698477|NCT00911547|463194284|FG000|Overall Study|Withdrawal by Subject|3|||
128698478|NCT00911547|463194285|FG001|Overall Study|Withdrawal by Subject|10|||
128698479|NCT00911547|463194286|FG002|Overall Study|Withdrawal by Subject|4|||
128698480|NCT00911547|463194287|FG003|Overall Study|Withdrawal by Subject|8|||
128698481|NCT01201785|463194290|FG000|Overall Study|Lost to Follow-up|16|||
128698482|NCT04545385|463194291|FG000|Overall Study|Withdrawal by Subject|2|||
128698483|NCT04545385|463194292|FG001|Overall Study|Withdrawal by Subject|0|||
128698484|NCT04545385|463194291|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
128698485|NCT04545385|463194292|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
128698486|NCT04545385|463194291|FG000|Overall Study|Study termination|10|||
128698487|NCT04545385|463194292|FG001|Overall Study|Study termination|10|||
128698488|NCT04545385|463194291|FG000|Overall Study|Sponsor decision|2|||
128698489|NCT04545385|463194292|FG001|Overall Study|Sponsor decision|2|||
128698490|NCT04545385|463194291|FG000|Overall Study|Other than specified|1|||
128698491|NCT04545385|463194292|FG001|Overall Study|Other than specified|0|||
128698492|NCT00915278|463194293|FG000|Overall Study|Death|1|||
128698493|NCT00915278|463194294|FG001|Overall Study|Death|0|||
128698494|NCT00915278|463194295|FG002|Overall Study|Death|0|||
128698495|NCT00915278|463194296|FG003|Overall Study|Death|0|||
128698496|NCT00915278|463194297|FG004|Overall Study|Death|0|||
128698497|NCT00915278|463194298|FG005|Overall Study|Death|0|||
128698498|NCT00915278|463194293|FG000|Overall Study|Lost to Follow-up|0|||
128698499|NCT00915278|463194294|FG001|Overall Study|Lost to Follow-up|1|||
128698500|NCT00915278|463194295|FG002|Overall Study|Lost to Follow-up|0|||
129029089|NCT02704091|464398321|FG001|Overall Study|Protocol Violation|3|||
128698501|NCT00915278|463194296|FG003|Overall Study|Lost to Follow-up|0|||
129029090|NCT02704091|464398320|FG000|Overall Study|Consent withdrawn|4|||
129029091|NCT02704091|464398321|FG001|Overall Study|Consent withdrawn|4|||
129029092|NCT02704091|464398320|FG000|Overall Study|Lost to Follow-up|13|||
129029093|NCT02704091|464398321|FG001|Overall Study|Lost to Follow-up|5|||
129029094|NCT02704091|464398320|FG000|Overall Study|Other|2|||
129029095|NCT02704091|464398321|FG001|Overall Study|Other|8|||
129029096|NCT03073798|464398327|FG000|Overall Study|Adverse Event|1|||
129029097|NCT03073798|464398327|FG000|Overall Study|Withdrawal by Subject|1|||
129029098|NCT02640235|464398328|FG000|Overall Study|Withdrawal by Subject|7|||
129029099|NCT02640235|464398329|FG001|Overall Study|Withdrawal by Subject|6|||
129029100|NCT02640235|464398328|FG000|Overall Study|Lost to Follow-up|4|||
129029101|NCT02640235|464398329|FG001|Overall Study|Lost to Follow-up|3|||
129029102|NCT02640235|464398328|FG000|Overall Study|Death|2|||
129029103|NCT02640235|464398329|FG001|Overall Study|Death|3|||
128918266|NCT04957290|463990362|FG001|Overall Study|Progressive disease|3|||
128918267|NCT04957290|463990363|FG002|Overall Study|Progressive disease|2|||
128918268|NCT04957290|463990364|FG003|Overall Study|Progressive disease|0|||
128918269|NCT04957290|463990365|FG004|Overall Study|Progressive disease|0|||
128918270|NCT04957290|463990366|FG005|Overall Study|Progressive disease|0|||
128918271|NCT04957290|463990361|FG000|Overall Study|Withdrawal by Subject|1|||
128918272|NCT04957290|463990362|FG001|Overall Study|Withdrawal by Subject|0|||
128918273|NCT04957290|463990363|FG002|Overall Study|Withdrawal by Subject|1|||
128918274|NCT04957290|463990364|FG003|Overall Study|Withdrawal by Subject|0|||
128918275|NCT04957290|463990365|FG004|Overall Study|Withdrawal by Subject|0|||
128918276|NCT04957290|463990366|FG005|Overall Study|Withdrawal by Subject|0|||
128918277|NCT04957290|463990361|FG000|Overall Study|Death|0|||
128918278|NCT04957290|463990362|FG001|Overall Study|Death|2|||
128918279|NCT04957290|463990363|FG002|Overall Study|Death|1|||
128918280|NCT04957290|463990364|FG003|Overall Study|Death|0|||
128918281|NCT04957290|463990365|FG004|Overall Study|Death|0|||
128918282|NCT04957290|463990366|FG005|Overall Study|Death|0|||
128918283|NCT04957290|463990361|FG000|Overall Study|non compliance with study drug|0|||
128918284|NCT04957290|463990362|FG001|Overall Study|non compliance with study drug|1|||
128918285|NCT04957290|463990363|FG002|Overall Study|non compliance with study drug|0|||
128918286|NCT04957290|463990364|FG003|Overall Study|non compliance with study drug|0|||
128918287|NCT04957290|463990365|FG004|Overall Study|non compliance with study drug|0|||
128918288|NCT04957290|463990366|FG005|Overall Study|non compliance with study drug|0|||
128918289|NCT04957290|463990361|FG000|Overall Study|none specified.|0|||
128918290|NCT04957290|463990362|FG001|Overall Study|none specified.|1|||
128918291|NCT04957290|463990363|FG002|Overall Study|none specified.|2|||
128918292|NCT04957290|463990364|FG003|Overall Study|none specified.|0|||
128918293|NCT04957290|463990365|FG004|Overall Study|none specified.|0|||
128918294|NCT04957290|463990366|FG005|Overall Study|none specified.|0|||
128918295|NCT04957290|463990361|FG000|Overall Study|unacceptable toxicity|0|||
128918296|NCT04957290|463990362|FG001|Overall Study|unacceptable toxicity|0|||
128918297|NCT04957290|463990363|FG002|Overall Study|unacceptable toxicity|1|||
128918298|NCT04957290|463990364|FG003|Overall Study|unacceptable toxicity|0|||
128918299|NCT04957290|463990365|FG004|Overall Study|unacceptable toxicity|0|||
128918300|NCT04957290|463990366|FG005|Overall Study|unacceptable toxicity|0|||
128918301|NCT04957290|463990361|FG000|Overall Study|Adverse Event|0|||
128918302|NCT04957290|463990362|FG001|Overall Study|Adverse Event|0|||
128918303|NCT04957290|463990363|FG002|Overall Study|Adverse Event|1|||
128918304|NCT04957290|463990364|FG003|Overall Study|Adverse Event|0|||
128918305|NCT04957290|463990365|FG004|Overall Study|Adverse Event|0|||
128918306|NCT04957290|463990366|FG005|Overall Study|Adverse Event|0|||
128918307|NCT04957290|463990361|FG000|Overall Study|study terminated by sponsor|0|||
128918308|NCT04957290|463990362|FG001|Overall Study|study terminated by sponsor|0|||
128918309|NCT04957290|463990363|FG002|Overall Study|study terminated by sponsor|2|||
128918310|NCT04957290|463990364|FG003|Overall Study|study terminated by sponsor|0|||
128918311|NCT04957290|463990365|FG004|Overall Study|study terminated by sponsor|0|||
128918312|NCT04957290|463990366|FG005|Overall Study|study terminated by sponsor|0|||
128918313|NCT03158220|463990367|FG000|Overall Study|Screen Failure|0|||
128918314|NCT03158220|463990368|FG001|Overall Study|Screen Failure|1|||
128918315|NCT03158220|463990367|FG000|Overall Study|Withdrawal by Subject|8|||
128918316|NCT03158220|463990368|FG001|Overall Study|Withdrawal by Subject|9|||
128918317|NCT03158220|463990367|FG000|Overall Study|Status unknown|0|||
128918318|NCT03158220|463990368|FG001|Overall Study|Status unknown|1|||
128918319|NCT03158220|463990367|FG000|Overall Study|Lost to Follow-up|8|||
128918320|NCT03158220|463990368|FG001|Overall Study|Lost to Follow-up|5|||
128918321|NCT03158220|463990367|FG000|Overall Study|Physician Decision|1|||
128918322|NCT03158220|463990368|FG001|Overall Study|Physician Decision|0|||
128918323|NCT01015833|463990369|FG000|Overall Study|Death|1|||
128918324|NCT01015833|463990370|FG001|Overall Study|Death|0|||
128918325|NCT01015833|463990369|FG000|Overall Study|Withdrawal by Subject|3|||
128918326|NCT01015833|463990370|FG001|Overall Study|Withdrawal by Subject|2|||
128918327|NCT01015833|463990369|FG000|Overall Study|Adverse Event|0|||
128918328|NCT01015833|463990370|FG001|Overall Study|Adverse Event|1|||
128918329|NCT01015833|463990369|FG000|Overall Study|Physician Decision|2|||
128918330|NCT01015833|463990370|FG001|Overall Study|Physician Decision|0|||
128918331|NCT01015833|463990369|FG000|Overall Study|Symptomatic deterioration|0|||
128918332|NCT01015833|463990370|FG001|Overall Study|Symptomatic deterioration|1|||
128918333|NCT01015833|463990369|FG000|Overall Study|Other|5|||
128918334|NCT01015833|463990370|FG001|Overall Study|Other|1|||
128918335|NCT01015833|463990369|FG000|Overall Study|Motor Vehicle Accidents|1|||
128918336|NCT01015833|463990370|FG001|Overall Study|Motor Vehicle Accidents|0|||
128918337|NCT01015833|463990369|FG000|Overall Study|Did not start treatment|1|||
128918338|NCT01015833|463990370|FG001|Overall Study|Did not start treatment|0|||
128918339|NCT01671280|463990371|FG000|Overall Study|Withdrawal by Subject|2|||
128918340|NCT01959165|463990372|FG000|Overall Study|Adverse Event|0|||
128918341|NCT01959165|463990373|FG001|Overall Study|Adverse Event|0|||
128918342|NCT01959165|463990374|FG002|Overall Study|Adverse Event|0|||
128918343|NCT01959165|463990375|FG003|Overall Study|Adverse Event|1|||
128918344|NCT01959165|463990372|FG000|Overall Study|Lack of Efficacy|1|||
128698502|NCT00915278|463194297|FG004|Overall Study|Lost to Follow-up|0|||
128698503|NCT00915278|463194298|FG005|Overall Study|Lost to Follow-up|0|||
128698504|NCT00915278|463194293|FG000|Overall Study|Withdrawal by Subject|0|||
128698505|NCT00915278|463194294|FG001|Overall Study|Withdrawal by Subject|1|||
128698506|NCT00915278|463194295|FG002|Overall Study|Withdrawal by Subject|0|||
128698507|NCT00915278|463194296|FG003|Overall Study|Withdrawal by Subject|0|||
128698508|NCT00915278|463194297|FG004|Overall Study|Withdrawal by Subject|1|||
128698509|NCT00915278|463194298|FG005|Overall Study|Withdrawal by Subject|4|||
128698510|NCT00915278|463194293|FG000|Overall Study|Adverse Event|4|||
128698511|NCT00915278|463194294|FG001|Overall Study|Adverse Event|1|||
128698512|NCT00915278|463194295|FG002|Overall Study|Adverse Event|0|||
128698513|NCT00915278|463194296|FG003|Overall Study|Adverse Event|0|||
128698514|NCT00915278|463194297|FG004|Overall Study|Adverse Event|0|||
128698515|NCT00915278|463194298|FG005|Overall Study|Adverse Event|0|||
128698516|NCT00915278|463194293|FG000|Overall Study|Progressive disease/clinical progression|0|||
128698517|NCT00915278|463194294|FG001|Overall Study|Progressive disease/clinical progression|0|||
128698518|NCT00915278|463194295|FG002|Overall Study|Progressive disease/clinical progression|0|||
128698519|NCT00915278|463194296|FG003|Overall Study|Progressive disease/clinical progression|3|||
128918345|NCT01959165|463990373|FG001|Overall Study|Lack of Efficacy|0|||
128918346|NCT01959165|463990374|FG002|Overall Study|Lack of Efficacy|0|||
128918347|NCT01959165|463990375|FG003|Overall Study|Lack of Efficacy|0|||
128918348|NCT01959165|463990372|FG000|Overall Study|overdose|0|||
128918349|NCT01959165|463990373|FG001|Overall Study|overdose|0|||
128918350|NCT01959165|463990374|FG002|Overall Study|overdose|0|||
128918351|NCT01959165|463990375|FG003|Overall Study|overdose|1|||
128918352|NCT01959165|463990372|FG000|Overall Study|Welfare recipient|0|||
128918353|NCT01959165|463990373|FG001|Overall Study|Welfare recipient|1|||
128918354|NCT01959165|463990374|FG002|Overall Study|Welfare recipient|0|||
128918355|NCT01959165|463990375|FG003|Overall Study|Welfare recipient|0|||
128918356|NCT02899156|463990379|FG000|Overall Study|Death|1|||
128918357|NCT02899156|463990380|FG001|Overall Study|Death|0|||
128918358|NCT02899156|463990379|FG000|Overall Study|Physician Decision|0|||
128918359|NCT02899156|463990380|FG001|Overall Study|Physician Decision|1|||
128918360|NCT00787787|463990381|FG000|Overall Study|Lack of Efficacy|4|||
128918361|NCT00787787|463990381|FG000|Overall Study|Adverse Event|3|||
128918362|NCT01412957|463990383|FG000|Overall Study|Withdrawal by Subject|6|||
128918363|NCT01412957|463990384|FG001|Overall Study|Withdrawal by Subject|22|||
128918364|NCT01412957|463990383|FG000|Overall Study|Lost to Follow-up|7|||
128918365|NCT01412957|463990384|FG001|Overall Study|Lost to Follow-up|2|||
128918366|NCT01412957|463990383|FG000|Overall Study|Death|136|||
128918367|NCT01412957|463990384|FG001|Overall Study|Death|133|||
128918368|NCT04722991|463990390|FG000|Overall Study|Adverse Event|12|||
128918369|NCT04722991|463990391|FG001|Overall Study|Adverse Event|4|||
128918370|NCT04722991|463990390|FG000|Overall Study|Death|2|||
128918371|NCT04722991|463990391|FG001|Overall Study|Death|0|||
128918372|NCT04722991|463990390|FG000|Overall Study|Lost to Follow-up|1|||
128918373|NCT04722991|463990391|FG001|Overall Study|Lost to Follow-up|1|||
128918374|NCT04722991|463990390|FG000|Overall Study|Withdrawal cirterion met|2|||
128918375|NCT04722991|463990391|FG001|Overall Study|Withdrawal cirterion met|2|||
128918376|NCT04722991|463990390|FG000|Overall Study|Other|1|||
128918377|NCT04722991|463990391|FG001|Overall Study|Other|0|||
128918378|NCT04722991|463990390|FG000|Overall Study|Non-compliance|0|||
128918379|NCT04722991|463990391|FG001|Overall Study|Non-compliance|1|||
128918380|NCT04722991|463990390|FG000|Overall Study|Withdrawal by Subject|0|||
128918381|NCT04722991|463990391|FG001|Overall Study|Withdrawal by Subject|1|||
128698520|NCT00915278|463194297|FG004|Overall Study|Progressive disease/clinical progression|1|||
128698521|NCT00915278|463194298|FG005|Overall Study|Progressive disease/clinical progression|2|||
128698522|NCT00915278|463194293|FG000|Overall Study|Infusion related AEs|0|||
128698523|NCT00915278|463194294|FG001|Overall Study|Infusion related AEs|0|||
128698524|NCT00915278|463194295|FG002|Overall Study|Infusion related AEs|0|||
128698525|NCT00915278|463194296|FG003|Overall Study|Infusion related AEs|0|||
128698526|NCT00915278|463194297|FG004|Overall Study|Infusion related AEs|0|||
128698527|NCT00915278|463194298|FG005|Overall Study|Infusion related AEs|2|||
128698528|NCT00915278|463194293|FG000|Overall Study|Admission to hospice|0|||
128698529|NCT00915278|463194294|FG001|Overall Study|Admission to hospice|0|||
128698530|NCT00915278|463194295|FG002|Overall Study|Admission to hospice|1|||
128698531|NCT00915278|463194296|FG003|Overall Study|Admission to hospice|0|||
128698532|NCT00915278|463194297|FG004|Overall Study|Admission to hospice|0|||
128918382|NCT00413959|463990392|FG000|Overall Study|Pt had only one cycle.|1|||
128698533|NCT00915278|463194298|FG005|Overall Study|Admission to hospice|0|||
128918383|NCT04343651|463990396|FG000|Overall Study|Physician Decision|2|||
128918384|NCT04343651|463990397|FG001|Overall Study|Physician Decision|1|||
128918385|NCT04343651|463990396|FG000|Overall Study|Lost to Follow-up|2|||
128698534|NCT00939770|463194301|FG000|Overall Study|Adverse Event|1|||
128918386|NCT04343651|463990397|FG001|Overall Study|Lost to Follow-up|1|||
128918387|NCT04343651|463990396|FG000|Overall Study|Protocol Violation|4|||
128918388|NCT04343651|463990397|FG001|Overall Study|Protocol Violation|6|||
128918389|NCT04343651|463990396|FG000|Overall Study|Missing|3|||
128918390|NCT04343651|463990397|FG001|Overall Study|Missing|9|||
129216013|NCT00790842|465092856|FG007|Dose Level 3|Withdrawal by Subject|0|||
129216014|NCT00790842|465092857|FG008|Dose Level 3|Withdrawal by Subject|0|||
129216015|NCT00790842|465092858|FG009|Dose Level 3|Withdrawal by Subject|2|||
129216016|NCT00790842|465092859|FG010|Dose Level 3|Withdrawal by Subject|0|||
129216017|NCT00790842|465092849|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216018|NCT00790842|465092850|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216019|NCT00790842|465092851|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216020|NCT00790842|465092852|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216021|NCT00790842|465092853|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216022|NCT00790842|465092854|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
129216023|NCT00790842|465092855|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216024|NCT00790842|465092856|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216025|NCT00790842|465092857|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216026|NCT00790842|465092858|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
128698535|NCT00939770|463194302|FG001|Overall Study|Adverse Event|1|||
128698536|NCT00939770|463194303|FG002|Overall Study|Adverse Event|0|||
128698537|NCT00939770|463194304|FG003|Overall Study|Adverse Event|0|||
128698538|NCT00939770|463194305|FG004|Overall Study|Adverse Event|6|||
128698539|NCT00939770|463194306|FG005|Overall Study|Adverse Event|2|||
128698540|NCT00939770|463194307|FG006|Overall Study|Adverse Event|1|||
128698541|NCT00939770|463194308|FG007|Overall Study|Adverse Event|1|||
128698542|NCT00939770|463194301|FG000|Overall Study|Lack of Efficacy|4|||
128698543|NCT00939770|463194302|FG001|Overall Study|Lack of Efficacy|6|||
128698544|NCT00939770|463194303|FG002|Overall Study|Lack of Efficacy|13|||
128698545|NCT00939770|463194304|FG003|Overall Study|Lack of Efficacy|9|||
128698546|NCT00939770|463194305|FG004|Overall Study|Lack of Efficacy|16|||
128698547|NCT00939770|463194306|FG005|Overall Study|Lack of Efficacy|8|||
128698548|NCT00939770|463194307|FG006|Overall Study|Lack of Efficacy|11|||
128698549|NCT00939770|463194308|FG007|Overall Study|Lack of Efficacy|1|||
128698550|NCT00939770|463194301|FG000|Overall Study|Lost to Follow-up|0|||
128698551|NCT00939770|463194302|FG001|Overall Study|Lost to Follow-up|0|||
128698552|NCT00939770|463194303|FG002|Overall Study|Lost to Follow-up|0|||
128698553|NCT00939770|463194304|FG003|Overall Study|Lost to Follow-up|0|||
128698554|NCT00939770|463194305|FG004|Overall Study|Lost to Follow-up|1|||
128698555|NCT00939770|463194306|FG005|Overall Study|Lost to Follow-up|0|||
128698556|NCT00939770|463194307|FG006|Overall Study|Lost to Follow-up|0|||
128698557|NCT00939770|463194308|FG007|Overall Study|Lost to Follow-up|0|||
128698558|NCT00939770|463194301|FG000|Overall Study|Physician Decision|0|||
128698559|NCT00939770|463194302|FG001|Overall Study|Physician Decision|0|||
128698560|NCT00939770|463194303|FG002|Overall Study|Physician Decision|2|||
128698561|NCT00939770|463194304|FG003|Overall Study|Physician Decision|0|||
128698562|NCT00939770|463194305|FG004|Overall Study|Physician Decision|7|||
128698563|NCT00939770|463194306|FG005|Overall Study|Physician Decision|1|||
128698564|NCT00939770|463194307|FG006|Overall Study|Physician Decision|0|||
128698565|NCT00939770|463194308|FG007|Overall Study|Physician Decision|6|||
128698566|NCT00939770|463194301|FG000|Overall Study|Protocol Violation|0|||
128698567|NCT00939770|463194302|FG001|Overall Study|Protocol Violation|0|||
128698568|NCT00939770|463194303|FG002|Overall Study|Protocol Violation|0|||
128698569|NCT00939770|463194304|FG003|Overall Study|Protocol Violation|0|||
128698570|NCT00939770|463194305|FG004|Overall Study|Protocol Violation|1|||
128765992|NCT03787680|463433956|FG001|Overall Study|Withdrawal by Subject|1|||
128765993|NCT05229653|463433957|FG000|Overall Study|Lost to Follow-up|1|||
128918391|NCT04343651|463990396|FG000|Overall Study|Withdrawal by Subject|0|||
128918392|NCT04343651|463990397|FG001|Overall Study|Withdrawal by Subject|4|||
128918393|NCT04343651|463990396|FG000|Overall Study|Death|0|||
128918394|NCT04343651|463990397|FG001|Overall Study|Death|1|||
128918395|NCT04343651|463990396|FG000|Overall Study|Did not start treatment|1|||
128918396|NCT04343651|463990397|FG001|Overall Study|Did not start treatment|1|||
128918397|NCT04343651|463990396|FG000|Overall Study|Patient did not complete visits 3-6|0|||
128918398|NCT04343651|463990397|FG001|Overall Study|Patient did not complete visits 3-6|1|||
128918399|NCT02246621|463990398|FG000|Overall Study|Withdrawal by Subject|28|||
128918400|NCT02246621|463990399|FG001|Overall Study|Withdrawal by Subject|16|||
128918401|NCT02246621|463990398|FG000|Overall Study|Lost to Follow-up|1|||
128918402|NCT02246621|463990399|FG001|Overall Study|Lost to Follow-up|0|||
128918403|NCT02246621|463990398|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
128918404|NCT02246621|463990399|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
128918405|NCT01459614|463990400|FG000|Overall Study|Adverse Event|1|||
128918406|NCT01459614|463990401|FG001|Overall Study|Adverse Event|0|||
128918407|NCT01506882|463990405|FG000|Overall Study|Lack of Efficacy|4|||
128918408|NCT01506882|463990406|FG001|Overall Study|Lack of Efficacy|3|||
129216027|NCT00790842|465092859|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129216028|NCT00790842|465092849|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
128698571|NCT00939770|463194306|FG005|Overall Study|Protocol Violation|0|||
128698572|NCT00939770|463194307|FG006|Overall Study|Protocol Violation|0|||
128698573|NCT00939770|463194308|FG007|Overall Study|Protocol Violation|0|||
128698574|NCT00939770|463194301|FG000|Overall Study|Withdrawal by Subject|0|||
128698575|NCT00939770|463194302|FG001|Overall Study|Withdrawal by Subject|1|||
128698576|NCT00939770|463194303|FG002|Overall Study|Withdrawal by Subject|5|||
128698577|NCT00939770|463194304|FG003|Overall Study|Withdrawal by Subject|2|||
128698578|NCT00939770|463194305|FG004|Overall Study|Withdrawal by Subject|6|||
128698579|NCT00939770|463194306|FG005|Overall Study|Withdrawal by Subject|0|||
128698580|NCT00939770|463194307|FG006|Overall Study|Withdrawal by Subject|2|||
128698581|NCT00939770|463194308|FG007|Overall Study|Withdrawal by Subject|2|||
128698582|NCT01817530|463194313|FG000|Overall Study|Exclusionary Medication Received|0|||
128698583|NCT01817530|463194314|FG001|Overall Study|Exclusionary Medication Received|0|||
128698584|NCT01817530|463194315|FG002|Overall Study|Exclusionary Medication Received|0|||
128918409|NCT01506882|463990405|FG000|Overall Study|Lost to Follow-up|1|||
128698585|NCT01817530|463194316|FG003|Overall Study|Exclusionary Medication Received|0|||
128698586|NCT01817530|463194317|FG004|Overall Study|Exclusionary Medication Received|1|||
128698587|NCT01817530|463194318|FG005|Overall Study|Exclusionary Medication Received|0|||
128698588|NCT01817530|463194319|FG006|Overall Study|Exclusionary Medication Received|0|||
128698589|NCT01817530|463194320|FG007|Overall Study|Exclusionary Medication Received|0|||
128698590|NCT01817530|463194313|FG000|Overall Study|Adverse Event|6|||
128698591|NCT01817530|463194314|FG001|Overall Study|Adverse Event|3|||
128698592|NCT01817530|463194315|FG002|Overall Study|Adverse Event|2|||
128698593|NCT01817530|463194316|FG003|Overall Study|Adverse Event|5|||
128698594|NCT01817530|463194317|FG004|Overall Study|Adverse Event|0|||
128698595|NCT01817530|463194318|FG005|Overall Study|Adverse Event|10|||
128698596|NCT01817530|463194319|FG006|Overall Study|Adverse Event|5|||
128698597|NCT01817530|463194320|FG007|Overall Study|Adverse Event|8|||
128698598|NCT01817530|463194313|FG000|Overall Study|Subject Noncompliant|3|||
128698599|NCT01817530|463194314|FG001|Overall Study|Subject Noncompliant|1|||
128698600|NCT01817530|463194315|FG002|Overall Study|Subject Noncompliant|0|||
128698601|NCT01817530|463194316|FG003|Overall Study|Subject Noncompliant|4|||
128698602|NCT01817530|463194317|FG004|Overall Study|Subject Noncompliant|0|||
128698603|NCT01817530|463194318|FG005|Overall Study|Subject Noncompliant|1|||
128698604|NCT01817530|463194319|FG006|Overall Study|Subject Noncompliant|1|||
128698605|NCT01817530|463194320|FG007|Overall Study|Subject Noncompliant|1|||
128698606|NCT01817530|463194313|FG000|Overall Study|Lack of Efficacy|1|||
128698607|NCT01817530|463194314|FG001|Overall Study|Lack of Efficacy|0|||
128698608|NCT01817530|463194315|FG002|Overall Study|Lack of Efficacy|0|||
128698609|NCT01817530|463194316|FG003|Overall Study|Lack of Efficacy|0|||
128698610|NCT01817530|463194317|FG004|Overall Study|Lack of Efficacy|0|||
128698611|NCT01817530|463194318|FG005|Overall Study|Lack of Efficacy|1|||
128698612|NCT01817530|463194319|FG006|Overall Study|Lack of Efficacy|0|||
128698613|NCT01817530|463194320|FG007|Overall Study|Lack of Efficacy|1|||
128698614|NCT01817530|463194313|FG000|Overall Study|Pregnancy|0|||
128698615|NCT01817530|463194314|FG001|Overall Study|Pregnancy|0|||
128698616|NCT01817530|463194315|FG002|Overall Study|Pregnancy|0|||
128698617|NCT01817530|463194316|FG003|Overall Study|Pregnancy|0|||
128698618|NCT01817530|463194317|FG004|Overall Study|Pregnancy|0|||
128698619|NCT01817530|463194318|FG005|Overall Study|Pregnancy|1|||
128698620|NCT01817530|463194319|FG006|Overall Study|Pregnancy|0|||
128918410|NCT01506882|463990406|FG001|Overall Study|Lost to Follow-up|0|||
128918411|NCT01506882|463990405|FG000|Overall Study|Withdrawal by Subject|9|||
128918412|NCT01506882|463990406|FG001|Overall Study|Withdrawal by Subject|3|||
128918413|NCT01506882|463990405|FG000|Overall Study|SAE, non-fatal|2|||
128918414|NCT01506882|463990406|FG001|Overall Study|SAE, non-fatal|0|||
128918415|NCT01506882|463990405|FG000|Overall Study|AE, non-serious non-fatal|3|||
128918416|NCT01506882|463990406|FG001|Overall Study|AE, non-serious non-fatal|1|||
128918417|NCT01506882|463990405|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
128918418|NCT01506882|463990406|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
128918419|NCT01506882|463990405|FG000|Overall Study|Other Reason|2|||
128698621|NCT01817530|463194320|FG007|Overall Study|Pregnancy|0|||
128698622|NCT01817530|463194313|FG000|Overall Study|Other|0|||
128698623|NCT01817530|463194314|FG001|Overall Study|Other|1|||
128698624|NCT01817530|463194315|FG002|Overall Study|Other|0|||
128698625|NCT01817530|463194316|FG003|Overall Study|Other|0|||
128698626|NCT01817530|463194317|FG004|Overall Study|Other|1|||
128698627|NCT01817530|463194318|FG005|Overall Study|Other|0|||
128698628|NCT01817530|463194319|FG006|Overall Study|Other|5|||
128698629|NCT01817530|463194320|FG007|Overall Study|Other|0|||
128698630|NCT01817530|463194313|FG000|Overall Study|Surgery or Invasive Intervention|1|||
128698631|NCT01817530|463194314|FG001|Overall Study|Surgery or Invasive Intervention|0|||
128698632|NCT01817530|463194315|FG002|Overall Study|Surgery or Invasive Intervention|0|||
128698633|NCT01817530|463194316|FG003|Overall Study|Surgery or Invasive Intervention|0|||
128765994|NCT05229653|463433958|FG001|Overall Study|Lost to Follow-up|0|||
128918420|NCT01506882|463990406|FG001|Overall Study|Other Reason|0|||
128918421|NCT00821678|463990411|FG000|Overall Study|Withdrawal by Subject|8|||
128918422|NCT00821678|463990412|FG001|Overall Study|Withdrawal by Subject|0|||
128698634|NCT01817530|463194317|FG004|Overall Study|Surgery or Invasive Intervention|1|||
128698635|NCT01817530|463194318|FG005|Overall Study|Surgery or Invasive Intervention|1|||
128698636|NCT01817530|463194319|FG006|Overall Study|Surgery or Invasive Intervention|1|||
128698637|NCT01817530|463194320|FG007|Overall Study|Surgery or Invasive Intervention|0|||
128698638|NCT01817530|463194313|FG000|Overall Study|Consent Withdrawn by Subject|3|||
128698639|NCT01817530|463194314|FG001|Overall Study|Consent Withdrawn by Subject|4|||
128698640|NCT01817530|463194315|FG002|Overall Study|Consent Withdrawn by Subject|7|||
128698641|NCT01817530|463194316|FG003|Overall Study|Consent Withdrawn by Subject|3|||
128698642|NCT01817530|463194317|FG004|Overall Study|Consent Withdrawn by Subject|5|||
128698643|NCT01817530|463194318|FG005|Overall Study|Consent Withdrawn by Subject|3|||
128698644|NCT01817530|463194319|FG006|Overall Study|Consent Withdrawn by Subject|3|||
128698645|NCT01817530|463194320|FG007|Overall Study|Consent Withdrawn by Subject|10|||
128698646|NCT01817530|463194313|FG000|Overall Study|Lost to Follow-up|1|||
128698647|NCT01817530|463194314|FG001|Overall Study|Lost to Follow-up|4|||
128698648|NCT01817530|463194315|FG002|Overall Study|Lost to Follow-up|2|||
128698649|NCT01817530|463194316|FG003|Overall Study|Lost to Follow-up|1|||
128698650|NCT01817530|463194317|FG004|Overall Study|Lost to Follow-up|3|||
128698651|NCT01817530|463194318|FG005|Overall Study|Lost to Follow-up|2|||
128698652|NCT01817530|463194319|FG006|Overall Study|Lost to Follow-up|8|||
128698653|NCT01817530|463194320|FG007|Overall Study|Lost to Follow-up|4|||
128698654|NCT02279420|463195715|FG000|Overall Study|Lost to Follow-up|23|||
128698655|NCT01153347|463195718|FG000|Overall Study|Withdrawal by Subject|7|||
128698656|NCT01153347|463195719|FG001|Overall Study|Withdrawal by Subject|7|||
128698657|NCT01153347|463195720|FG002|Overall Study|Withdrawal by Subject|7|||
128698658|NCT01153347|463195721|FG003|Overall Study|Withdrawal by Subject|7|||
128698659|NCT01153347|463195718|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128698660|NCT01153347|463195719|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
128698661|NCT01153347|463195720|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
128698662|NCT01153347|463195721|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
128698663|NCT01153347|463195718|FG000|Overall Study|Adverse Event|3|||
128698664|NCT01153347|463195719|FG001|Overall Study|Adverse Event|9|||
128698665|NCT01153347|463195720|FG002|Overall Study|Adverse Event|21|||
128698666|NCT01153347|463195721|FG003|Overall Study|Adverse Event|7|||
128698667|NCT01153347|463195718|FG000|Overall Study|Severe non-compliance to protocol|6|||
128765995|NCT00594217|463433959|FG000|Overall Study|Withdrawal by Subject|1|||
128765996|NCT00594217|463433960|FG001|Overall Study|Withdrawal by Subject|3|||
128918423|NCT00821678|463990411|FG000|Overall Study|Lost to Follow-up|13|||
128918424|NCT00821678|463990412|FG001|Overall Study|Lost to Follow-up|12|||
128918425|NCT00821678|463990411|FG000|Overall Study|Death|0|||
128918426|NCT00821678|463990412|FG001|Overall Study|Death|2|||
128918427|NCT04574999|463992584|FG000|Overall Study|Adverse Event|1|||
128918428|NCT04574999|463992585|FG001|Overall Study|Adverse Event|0|||
128918429|NCT04574999|463992584|FG000|Overall Study|Lack of Efficacy|2|||
128918430|NCT04574999|463992585|FG001|Overall Study|Lack of Efficacy|3|||
128918431|NCT04574999|463992584|FG000|Overall Study|Protocol Violation|1|||
128918432|NCT04574999|463992585|FG001|Overall Study|Protocol Violation|0|||
128918433|NCT04574999|463992584|FG000|Overall Study|Withdrawal by Subject|2|||
128918434|NCT04574999|463992585|FG001|Overall Study|Withdrawal by Subject|2|||
128918435|NCT04574999|463992584|FG000|Overall Study|Lost to Follow-up|1|||
128918436|NCT04574999|463992585|FG001|Overall Study|Lost to Follow-up|0|||
128918437|NCT04574999|463992584|FG000|Overall Study|Personal problems|1|||
128918438|NCT04574999|463992585|FG001|Overall Study|Personal problems|0|||
128918439|NCT04574999|463992584|FG000|Overall Study|Previous planned surgery|1|||
128698668|NCT01153347|463195719|FG001|Overall Study|Severe non-compliance to protocol|7|||
128698669|NCT01153347|463195720|FG002|Overall Study|Severe non-compliance to protocol|4|||
128698670|NCT01153347|463195721|FG003|Overall Study|Severe non-compliance to protocol|3|||
128698671|NCT01153347|463195718|FG000|Overall Study|Condition under investigation worsened|1|||
128698672|NCT01153347|463195719|FG001|Overall Study|Condition under investigation worsened|1|||
128698673|NCT01153347|463195720|FG002|Overall Study|Condition under investigation worsened|0|||
128698674|NCT01153347|463195721|FG003|Overall Study|Condition under investigation worsened|0|||
128698675|NCT01153347|463195718|FG000|Overall Study|Lack of Efficacy|2|||
128698676|NCT01153347|463195719|FG001|Overall Study|Lack of Efficacy|2|||
128698677|NCT01153347|463195720|FG002|Overall Study|Lack of Efficacy|0|||
128698678|NCT01153347|463195721|FG003|Overall Study|Lack of Efficacy|4|||
128698679|NCT01153347|463195718|FG000|Overall Study|Study-specific withdrawal criteria|4|||
128698680|NCT01153347|463195719|FG001|Overall Study|Study-specific withdrawal criteria|3|||
128698681|NCT01153347|463195720|FG002|Overall Study|Study-specific withdrawal criteria|1|||
128698682|NCT01153347|463195721|FG003|Overall Study|Study-specific withdrawal criteria|2|||
128698683|NCT01153347|463195718|FG000|Overall Study|Lost to Follow-up|4|||
128698684|NCT01153347|463195719|FG001|Overall Study|Lost to Follow-up|9|||
128918440|NCT04574999|463992585|FG001|Overall Study|Previous planned surgery|0|||
128918441|NCT00317044|463992590|FG000|Overall Study|Protocol Violation|28|||
128918442|NCT00317044|463992591|FG001|Overall Study|Protocol Violation|22|||
128918443|NCT00317044|463992592|FG002|Overall Study|Protocol Violation|20|||
128918444|NCT00317044|463992590|FG000|Overall Study|Adverse Event|4|||
128918445|NCT00317044|463992591|FG001|Overall Study|Adverse Event|7|||
128698685|NCT01153347|463195720|FG002|Overall Study|Lost to Follow-up|11|||
128698686|NCT01153347|463195721|FG003|Overall Study|Lost to Follow-up|8|||
128698687|NCT01153347|463195718|FG000|Overall Study|Other|5|||
128698688|NCT01153347|463195719|FG001|Overall Study|Other|5|||
128698689|NCT01153347|463195720|FG002|Overall Study|Other|4|||
128918446|NCT00317044|463992592|FG002|Overall Study|Adverse Event|4|||
128918447|NCT00317044|463992590|FG000|Overall Study|Withdrawal by Subject|10|||
128918448|NCT00317044|463992591|FG001|Overall Study|Withdrawal by Subject|7|||
128918449|NCT00317044|463992592|FG002|Overall Study|Withdrawal by Subject|12|||
128918450|NCT00317044|463992590|FG000|Overall Study|Lost to Follow-up|0|||
128918451|NCT00317044|463992591|FG001|Overall Study|Lost to Follow-up|2|||
128918452|NCT00317044|463992592|FG002|Overall Study|Lost to Follow-up|3|||
128918453|NCT00317044|463992590|FG000|Overall Study|Multiple Reasons|6|||
128918454|NCT00317044|463992591|FG001|Overall Study|Multiple Reasons|2|||
128918455|NCT00317044|463992592|FG002|Overall Study|Multiple Reasons|6|||
128918456|NCT05742984|463992593|FG000|Overall Study|Adverse Event|0|||
128918457|NCT05742984|463992594|FG001|Overall Study|Adverse Event|0|||
128918458|NCT05742984|463992595|FG002|Overall Study|Adverse Event|1|||
128918459|NCT05742984|463992596|FG003|Overall Study|Adverse Event|0|||
128918460|NCT05742984|463992597|FG004|Overall Study|Adverse Event|1|||
128918461|NCT05742984|463992598|FG005|Overall Study|Adverse Event|1|||
128918462|NCT05742984|463992593|FG000|Overall Study|Withdrawal by Subject|0|||
128918463|NCT05742984|463992594|FG001|Overall Study|Withdrawal by Subject|1|||
128918464|NCT05742984|463992595|FG002|Overall Study|Withdrawal by Subject|0|||
128918465|NCT05742984|463992596|FG003|Overall Study|Withdrawal by Subject|0|||
128918466|NCT05742984|463992597|FG004|Overall Study|Withdrawal by Subject|0|||
128918467|NCT05742984|463992598|FG005|Overall Study|Withdrawal by Subject|2|||
128918468|NCT00379340|463992599|FG000|Overall Study|Death|0|||
128918469|NCT00379340|463992600|FG001|Overall Study|Death|0|||
128918470|NCT00379340|463992601|FG002|Overall Study|Death|0|||
128918471|NCT00379340|463992602|FG003|Overall Study|Death|2|||
128918472|NCT00379340|463992603|FG004|Overall Study|Death|0|||
128918473|NCT00379340|463992599|FG000|Overall Study|Lack of Efficacy|6|||
128918474|NCT00379340|463992600|FG001|Overall Study|Lack of Efficacy|1|||
128918475|NCT00379340|463992601|FG002|Overall Study|Lack of Efficacy|0|||
128918476|NCT00379340|463992602|FG003|Overall Study|Lack of Efficacy|4|||
128918477|NCT00379340|463992603|FG004|Overall Study|Lack of Efficacy|3|||
128918478|NCT00379340|463992599|FG000|Overall Study|Physician Decision|6|||
128918479|NCT00379340|463992600|FG001|Overall Study|Physician Decision|2|||
128918480|NCT00379340|463992601|FG002|Overall Study|Physician Decision|1|||
128918481|NCT00379340|463992602|FG003|Overall Study|Physician Decision|2|||
128918482|NCT00379340|463992603|FG004|Overall Study|Physician Decision|3|||
128918483|NCT00379340|463992599|FG000|Overall Study|Withdrawal by Subject|0|||
128918484|NCT00379340|463992600|FG001|Overall Study|Withdrawal by Subject|0|||
128918485|NCT00379340|463992601|FG002|Overall Study|Withdrawal by Subject|0|||
128918486|NCT00379340|463992602|FG003|Overall Study|Withdrawal by Subject|1|||
128918487|NCT00379340|463992603|FG004|Overall Study|Withdrawal by Subject|0|||
128918488|NCT00379340|463992599|FG000|Overall Study|Refusal of further protocol therapy|1|||
128918489|NCT00379340|463992600|FG001|Overall Study|Refusal of further protocol therapy|0|||
128918490|NCT00379340|463992601|FG002|Overall Study|Refusal of further protocol therapy|1|||
128918491|NCT00379340|463992602|FG003|Overall Study|Refusal of further protocol therapy|1|||
128918492|NCT00379340|463992603|FG004|Overall Study|Refusal of further protocol therapy|7|||
128918493|NCT00379340|463992599|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
128918494|NCT00379340|463992600|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
128918495|NCT00379340|463992601|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
128918496|NCT00379340|463992602|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
128918497|NCT00379340|463992603|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
128918498|NCT00379340|463992599|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
128918499|NCT00379340|463992600|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
128918500|NCT00379340|463992601|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
128918501|NCT00379340|463992602|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
128918502|NCT00379340|463992603|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
128918503|NCT02162862|463992607|FG000|Overall Study|Lost to Follow-up|0|||
128918504|NCT02162862|463992608|FG001|Overall Study|Lost to Follow-up|11|||
128918505|NCT02162862|463992609|FG002|Overall Study|Lost to Follow-up|0|||
128918506|NCT02162862|463992607|FG000|Overall Study|Subject did not feel the med was needed|0|||
128918507|NCT02162862|463992608|FG001|Overall Study|Subject did not feel the med was needed|0|||
128918508|NCT02162862|463992609|FG002|Overall Study|Subject did not feel the med was needed|4|||
128918509|NCT00430755|463992612|FG000|Overall Study|Withdrawal by Subject|53|||
128918510|NCT00103012|463992615|FG000|Overall Study|Withdrawal by Subject|2|||
128918511|NCT00103012|463992616|FG001|Overall Study|Withdrawal by Subject|1|||
128918512|NCT00103012|463992617|FG002|Overall Study|Withdrawal by Subject|2|||
128918513|NCT00103012|463992615|FG000|Overall Study|Pregnancy|1|||
128918514|NCT00103012|463992616|FG001|Overall Study|Pregnancy|0|||
128918515|NCT00103012|463992617|FG002|Overall Study|Pregnancy|0|||
128918516|NCT00103012|463992615|FG000|Overall Study|Adverse Event|0|||
128918517|NCT00103012|463992616|FG001|Overall Study|Adverse Event|0|||
128918518|NCT00103012|463992617|FG002|Overall Study|Adverse Event|1|||
128698690|NCT01153347|463195721|FG003|Overall Study|Other|0|||
128918519|NCT00103012|463992615|FG000|Overall Study|Subject non-compliant with medications|0|||
128918520|NCT00103012|463992616|FG001|Overall Study|Subject non-compliant with medications|0|||
128918521|NCT00103012|463992617|FG002|Overall Study|Subject non-compliant with medications|1|||
128698691|NCT01153347|463195718|FG000|Overall Study|Death|1|||
128698692|NCT01153347|463195719|FG001|Overall Study|Death|0|||
128698693|NCT01153347|463195720|FG002|Overall Study|Death|0|||
128698694|NCT01153347|463195721|FG003|Overall Study|Death|0|||
128698695|NCT00297830|463195722|FG000|6 Month Visit|Death|1|||
128698696|NCT00297830|463195723|FG001|6 Month Visit|Death|0|||
128698697|NCT00297830|463195724|FG002|6 Month Visit|Death|2|||
128698698|NCT00297830|463195722|FG000|6 Month Visit|Withdrawal by Subject|2|||
128698699|NCT00297830|463195723|FG001|6 Month Visit|Withdrawal by Subject|1|||
128698700|NCT00297830|463195724|FG002|6 Month Visit|Withdrawal by Subject|1|||
128698701|NCT00297830|463195722|FG000|6 Month Visit|Adverse Event|0|||
128698702|NCT00297830|463195723|FG001|6 Month Visit|Adverse Event|1|||
128698703|NCT00297830|463195724|FG002|6 Month Visit|Adverse Event|0|||
128698704|NCT00297830|463195722|FG000|12 Month Visit|Lost to Follow-up|1|||
128698705|NCT00297830|463195723|FG001|12 Month Visit|Lost to Follow-up|0|||
128698706|NCT00297830|463195724|FG002|12 Month Visit|Lost to Follow-up|0|||
128698707|NCT00297830|463195722|FG000|12 Month Visit|Adverse Event|0|||
128698708|NCT00297830|463195723|FG001|12 Month Visit|Adverse Event|3|||
128698709|NCT00297830|463195724|FG002|12 Month Visit|Adverse Event|0|||
128918522|NCT05019131|463992625|FG000|Overall Study|Lost to Follow-up|0|||
128918523|NCT05019131|463992626|FG001|Overall Study|Lost to Follow-up|3|||
128918524|NCT04684420|463992627|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128918525|NCT04684420|463992628|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128918526|NCT04684420|463992629|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
128918527|NCT04684420|463992630|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
128918528|NCT04684420|463992627|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
128918529|NCT04684420|463992628|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
128918530|NCT04684420|463992629|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
128918531|NCT04684420|463992630|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
128918532|NCT03480802|463992632|FG000|Overall Study|Lost to Follow-up|5|||
128918533|NCT03480802|463992633|FG001|Overall Study|Lost to Follow-up|1|||
128918534|NCT03480802|463992632|FG000|Overall Study|Withdrawal by Subject|2|||
128918535|NCT03480802|463992633|FG001|Overall Study|Withdrawal by Subject|1|||
128918536|NCT03480802|463992632|FG000|Overall Study|Relocated|0|||
128918537|NCT03480802|463992633|FG001|Overall Study|Relocated|1|||
128918538|NCT01703000|463992634|FG000|Overall Study|Death|1|||
128918539|NCT03822884|463992635|FG000|Overall Study|Withdrawal by Subject|0|||
128918540|NCT03822884|463992636|FG001|Overall Study|Withdrawal by Subject|0|||
128918541|NCT03822884|463992637|FG002|Overall Study|Withdrawal by Subject|0|||
128918542|NCT03822884|463992638|FG003|Overall Study|Withdrawal by Subject|0|||
128918543|NCT03822884|463992639|FG004|Overall Study|Withdrawal by Subject|1|||
128918544|NCT03822884|463992640|FG005|Overall Study|Withdrawal by Subject|0|||
128918545|NCT00432237|463992646|FG000|Overall Study|Adverse Event|0|||
128918546|NCT00432237|463992647|FG001|Overall Study|Adverse Event|0|||
128918547|NCT00432237|463992648|FG002|Overall Study|Adverse Event|0|||
128918548|NCT00432237|463992649|FG003|Overall Study|Adverse Event|1|||
128918549|NCT00432237|463992646|FG000|Overall Study|Lack of Efficacy|0|||
128918550|NCT00432237|463992647|FG001|Overall Study|Lack of Efficacy|0|||
128918551|NCT00432237|463992648|FG002|Overall Study|Lack of Efficacy|0|||
128918552|NCT00432237|463992649|FG003|Overall Study|Lack of Efficacy|1|||
128918553|NCT00432237|463992646|FG000|Overall Study|Lost to Follow-up|10|||
128918554|NCT00432237|463992647|FG001|Overall Study|Lost to Follow-up|10|||
128918555|NCT00432237|463992648|FG002|Overall Study|Lost to Follow-up|18|||
128918556|NCT00432237|463992649|FG003|Overall Study|Lost to Follow-up|18|||
128918557|NCT00432237|463992646|FG000|Overall Study|Physician Decision|1|||
128918558|NCT00432237|463992647|FG001|Overall Study|Physician Decision|3|||
128918559|NCT00432237|463992648|FG002|Overall Study|Physician Decision|2|||
128918560|NCT00432237|463992649|FG003|Overall Study|Physician Decision|1|||
128918561|NCT00432237|463992646|FG000|Overall Study|Pregnancy|0|||
128918562|NCT00432237|463992647|FG001|Overall Study|Pregnancy|1|||
128918563|NCT00432237|463992648|FG002|Overall Study|Pregnancy|0|||
129216029|NCT00790842|465092850|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
128698710|NCT00297830|463195722|FG000|12 Month Visit|Withdrawal by Subject|0|||
128698711|NCT00297830|463195723|FG001|12 Month Visit|Withdrawal by Subject|3|||
128698712|NCT00297830|463195724|FG002|12 Month Visit|Withdrawal by Subject|0|||
128698713|NCT05096221|463195727|FG000|Part 2|Physician Decision|0|||
128698714|NCT05096221|463195728|FG001|Part 2|Physician Decision|1|||
128698715|NCT04678661|463195730|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
128698716|NCT04678661|463195731|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
128918564|NCT00432237|463992649|FG003|Overall Study|Pregnancy|0|||
128918565|NCT00432237|463992646|FG000|Overall Study|Protocol Violation|13|||
128918566|NCT00432237|463992647|FG001|Overall Study|Protocol Violation|10|||
128918567|NCT00432237|463992648|FG002|Overall Study|Protocol Violation|11|||
128918568|NCT00432237|463992649|FG003|Overall Study|Protocol Violation|8|||
128918569|NCT00432237|463992646|FG000|Overall Study|Withdrawal by Subject|5|||
128918570|NCT00432237|463992647|FG001|Overall Study|Withdrawal by Subject|6|||
128918571|NCT00432237|463992648|FG002|Overall Study|Withdrawal by Subject|9|||
128918572|NCT00432237|463992649|FG003|Overall Study|Withdrawal by Subject|11|||
129216030|NCT00790842|465092851|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
129216031|NCT00790842|465092852|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216032|NCT00790842|465092853|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216033|NCT00790842|465092854|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216034|NCT00790842|465092855|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216035|NCT00790842|465092856|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216036|NCT00790842|465092857|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216037|NCT00790842|465092858|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216038|NCT00790842|465092859|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129216039|NCT00790842|465092849|FG000|Dose Level 4|Adverse Event|0|||
129216040|NCT00790842|465092850|FG001|Dose Level 4|Adverse Event|0|||
129216041|NCT00790842|465092851|FG002|Dose Level 4|Adverse Event|0|||
129216042|NCT00790842|465092852|FG003|Dose Level 4|Adverse Event|0|||
129216043|NCT00790842|465092853|FG004|Dose Level 4|Adverse Event|0|||
129216044|NCT00790842|465092854|FG005|Dose Level 4|Adverse Event|0|||
129216045|NCT00790842|465092855|FG006|Dose Level 4|Adverse Event|1|||
129216046|NCT00790842|465092856|FG007|Dose Level 4|Adverse Event|0|||
129216047|NCT00790842|465092857|FG008|Dose Level 4|Adverse Event|0|||
129216048|NCT00790842|465092858|FG009|Dose Level 4|Adverse Event|0|||
129216049|NCT00790842|465092859|FG010|Dose Level 4|Adverse Event|0|||
129216050|NCT00790842|465092849|FG000|Dose Level 4|Physician Decision|0|||
129216051|NCT00790842|465092850|FG001|Dose Level 4|Physician Decision|0|||
129216052|NCT00790842|465092851|FG002|Dose Level 4|Physician Decision|0|||
129216053|NCT00790842|465092852|FG003|Dose Level 4|Physician Decision|0|||
129216054|NCT00790842|465092853|FG004|Dose Level 4|Physician Decision|0|||
129216055|NCT00790842|465092854|FG005|Dose Level 4|Physician Decision|0|||
129216056|NCT00790842|465092855|FG006|Dose Level 4|Physician Decision|1|||
129216057|NCT00790842|465092856|FG007|Dose Level 4|Physician Decision|0|||
129216058|NCT00790842|465092857|FG008|Dose Level 4|Physician Decision|0|||
129216059|NCT00790842|465092858|FG009|Dose Level 4|Physician Decision|0|||
129216060|NCT00790842|465092859|FG010|Dose Level 4|Physician Decision|1|||
129216061|NCT00790842|465092849|FG000|Dose Level 4|Withdrawal by Subject|0|||
129216062|NCT00790842|465092850|FG001|Dose Level 4|Withdrawal by Subject|0|||
129216063|NCT00790842|465092851|FG002|Dose Level 4|Withdrawal by Subject|0|||
129216064|NCT00790842|465092852|FG003|Dose Level 4|Withdrawal by Subject|0|||
129216065|NCT00790842|465092853|FG004|Dose Level 4|Withdrawal by Subject|0|||
129216066|NCT00790842|465092854|FG005|Dose Level 4|Withdrawal by Subject|0|||
129216067|NCT00790842|465092855|FG006|Dose Level 4|Withdrawal by Subject|0|||
129216068|NCT00790842|465092856|FG007|Dose Level 4|Withdrawal by Subject|0|||
129216069|NCT00790842|465092857|FG008|Dose Level 4|Withdrawal by Subject|0|||
129216070|NCT00790842|465092858|FG009|Dose Level 4|Withdrawal by Subject|0|||
129216071|NCT00790842|465092859|FG010|Dose Level 4|Withdrawal by Subject|1|||
129216072|NCT00790842|465092849|FG000|Expansion Cohort|Adverse Event|0|||
129216073|NCT00790842|465092850|FG001|Expansion Cohort|Adverse Event|0|||
129216074|NCT00790842|465092851|FG002|Expansion Cohort|Adverse Event|0|||
129216075|NCT00790842|465092852|FG003|Expansion Cohort|Adverse Event|0|||
129216076|NCT00790842|465092853|FG004|Expansion Cohort|Adverse Event|0|||
129216077|NCT00790842|465092854|FG005|Expansion Cohort|Adverse Event|0|||
129216078|NCT00790842|465092855|FG006|Expansion Cohort|Adverse Event|1|||
129216079|NCT00790842|465092856|FG007|Expansion Cohort|Adverse Event|0|||
129216080|NCT00790842|465092857|FG008|Expansion Cohort|Adverse Event|0|||
129216081|NCT00790842|465092858|FG009|Expansion Cohort|Adverse Event|0|||
129216082|NCT00790842|465092859|FG010|Expansion Cohort|Adverse Event|0|||
129216083|NCT00790842|465092849|FG000|Expansion Cohort|Death|0|||
129216084|NCT00790842|465092850|FG001|Expansion Cohort|Death|0|||
129216085|NCT00790842|465092851|FG002|Expansion Cohort|Death|2|||
129216086|NCT00790842|465092852|FG003|Expansion Cohort|Death|0|||
129216087|NCT00790842|465092853|FG004|Expansion Cohort|Death|0|||
129216088|NCT00790842|465092854|FG005|Expansion Cohort|Death|0|||
129216089|NCT00790842|465092855|FG006|Expansion Cohort|Death|0|||
129216090|NCT00790842|465092856|FG007|Expansion Cohort|Death|0|||
129216091|NCT00790842|465092857|FG008|Expansion Cohort|Death|0|||
128698717|NCT04678661|463195730|FG000|Overall Study|Protocol Violation|2|||
128698718|NCT04678661|463195731|FG001|Overall Study|Protocol Violation|0|||
128698719|NCT04678661|463195730|FG000|Overall Study|Withdrawal by Subject|1|||
128698720|NCT04678661|463195731|FG001|Overall Study|Withdrawal by Subject|0|||
128698721|NCT04678661|463195730|FG000|Overall Study|Lost to Follow-up|2|||
129216092|NCT00790842|465092858|FG009|Expansion Cohort|Death|0|||
129216093|NCT00790842|465092859|FG010|Expansion Cohort|Death|0|||
129216094|NCT00790842|465092849|FG000|Expansion Cohort|Physician Decision|0|||
128698722|NCT04678661|463195731|FG001|Overall Study|Lost to Follow-up|0|||
129216095|NCT00790842|465092850|FG001|Expansion Cohort|Physician Decision|0|||
129216096|NCT00790842|465092851|FG002|Expansion Cohort|Physician Decision|1|||
129216097|NCT00790842|465092852|FG003|Expansion Cohort|Physician Decision|0|||
129216098|NCT00790842|465092853|FG004|Expansion Cohort|Physician Decision|0|||
129216099|NCT00790842|465092854|FG005|Expansion Cohort|Physician Decision|0|||
129216100|NCT00790842|465092855|FG006|Expansion Cohort|Physician Decision|0|||
129216101|NCT00790842|465092856|FG007|Expansion Cohort|Physician Decision|0|||
129216102|NCT00790842|465092857|FG008|Expansion Cohort|Physician Decision|0|||
128698723|NCT04678661|463195730|FG000|Overall Study|Death|2|||
128698724|NCT04678661|463195731|FG001|Overall Study|Death|0|||
128698725|NCT03094169|463195732|FG000|Overall Study|Lack of Efficacy|0|||
128698726|NCT03094169|463195733|FG001|Overall Study|Lack of Efficacy|0|||
128698727|NCT03094169|463195734|FG002|Overall Study|Lack of Efficacy|0|||
128698728|NCT03094169|463195735|FG003|Overall Study|Lack of Efficacy|0|||
128698729|NCT03094169|463195736|FG004|Overall Study|Lack of Efficacy|0|||
128698730|NCT03094169|463195737|FG005|Overall Study|Lack of Efficacy|0|||
128698731|NCT03094169|463195738|FG006|Overall Study|Lack of Efficacy|0|||
128698732|NCT03094169|463195739|FG007|Overall Study|Lack of Efficacy|21|||
128698733|NCT03094169|463195732|FG000|Overall Study|Adverse Event|0|||
128698734|NCT03094169|463195733|FG001|Overall Study|Adverse Event|0|||
128698735|NCT03094169|463195734|FG002|Overall Study|Adverse Event|0|||
128918573|NCT00432237|463992646|FG000|Overall Study|Lack of Qualifying Event|38|||
128918574|NCT00432237|463992647|FG001|Overall Study|Lack of Qualifying Event|71|||
128918575|NCT00432237|463992648|FG002|Overall Study|Lack of Qualifying Event|69|||
128918576|NCT00432237|463992649|FG003|Overall Study|Lack of Qualifying Event|84|||
128918577|NCT00191854|463992650|FG000|Overall Study|Death|26|||
128918578|NCT00191854|463992651|FG001|Overall Study|Death|23|||
128918579|NCT00191854|463992652|FG002|Overall Study|Death|29|||
128918580|NCT00191854|463992650|FG000|Overall Study|Lost to Follow-up|7|||
128918581|NCT00191854|463992651|FG001|Overall Study|Lost to Follow-up|5|||
128918582|NCT00191854|463992652|FG002|Overall Study|Lost to Follow-up|5|||
128918583|NCT00191854|463992650|FG000|Overall Study|Withdrawal by Subject|4|||
128918584|NCT00191854|463992651|FG001|Overall Study|Withdrawal by Subject|2|||
128918585|NCT00191854|463992652|FG002|Overall Study|Withdrawal by Subject|3|||
128918586|NCT00191854|463992650|FG000|Overall Study|Sponsor Decision|0|||
128918587|NCT00191854|463992651|FG001|Overall Study|Sponsor Decision|0|||
128918588|NCT00191854|463992652|FG002|Overall Study|Sponsor Decision|1|||
128918589|NCT00191854|463992650|FG000|Overall Study|Screen Failure|0|||
128918590|NCT00191854|463992651|FG001|Overall Study|Screen Failure|0|||
128918591|NCT00191854|463992652|FG002|Overall Study|Screen Failure|1|||
128918592|NCT05254418|463992656|FG000|Overall Study|Adverse Event|2|||
128918593|NCT06118385|463992657|FG000|Overall Study|Protocol Violation|0|||
129216103|NCT00790842|465092858|FG009|Expansion Cohort|Physician Decision|0|||
129216104|NCT00790842|465092859|FG010|Expansion Cohort|Physician Decision|0|||
129216105|NCT00790842|465092849|FG000|Expansion Cohort|Withdrawal by Subject|0|||
129216106|NCT00790842|465092850|FG001|Expansion Cohort|Withdrawal by Subject|0|||
129216107|NCT00790842|465092851|FG002|Expansion Cohort|Withdrawal by Subject|3|||
129216108|NCT00790842|465092852|FG003|Expansion Cohort|Withdrawal by Subject|0|||
129216109|NCT00790842|465092853|FG004|Expansion Cohort|Withdrawal by Subject|0|||
129216110|NCT00790842|465092854|FG005|Expansion Cohort|Withdrawal by Subject|0|||
128918594|NCT06118385|463992658|FG001|Overall Study|Protocol Violation|0|||
128918595|NCT06118385|463992659|FG002|Overall Study|Protocol Violation|0|||
128918596|NCT06118385|463992660|FG003|Overall Study|Protocol Violation|0|||
128918597|NCT06118385|463992661|FG004|Overall Study|Protocol Violation|0|||
128918598|NCT06118385|463992662|FG005|Overall Study|Protocol Violation|0|||
128918599|NCT06118385|463992663|FG006|Overall Study|Protocol Violation|0|||
128918600|NCT06118385|463992664|FG007|Overall Study|Protocol Violation|0|||
128918601|NCT06118385|463992665|FG008|Overall Study|Protocol Violation|1|||
128918602|NCT06118385|463992666|FG009|Overall Study|Protocol Violation|0|||
128918603|NCT06118385|463992667|FG010|Overall Study|Protocol Violation|0|||
128918604|NCT06118385|463992668|FG011|Overall Study|Protocol Violation|0|||
128918605|NCT06118385|463992657|FG000|Overall Study|Out-of-range blood tests|0|||
128918606|NCT06118385|463992658|FG001|Overall Study|Out-of-range blood tests|0|||
128918607|NCT06118385|463992659|FG002|Overall Study|Out-of-range blood tests|0|||
128918608|NCT06118385|463992660|FG003|Overall Study|Out-of-range blood tests|0|||
128918609|NCT06118385|463992661|FG004|Overall Study|Out-of-range blood tests|0|||
128918610|NCT06118385|463992662|FG005|Overall Study|Out-of-range blood tests|0|||
128918611|NCT06118385|463992663|FG006|Overall Study|Out-of-range blood tests|0|||
128918612|NCT06118385|463992664|FG007|Overall Study|Out-of-range blood tests|0|||
128918613|NCT06118385|463992665|FG008|Overall Study|Out-of-range blood tests|1|||
128918614|NCT06118385|463992666|FG009|Overall Study|Out-of-range blood tests|0|||
128918615|NCT06118385|463992667|FG010|Overall Study|Out-of-range blood tests|0|||
129216111|NCT00790842|465092855|FG006|Expansion Cohort|Withdrawal by Subject|0|||
128918616|NCT06118385|463992668|FG011|Overall Study|Out-of-range blood tests|0|||
128698736|NCT03094169|463195735|FG003|Overall Study|Adverse Event|0|||
128918617|NCT01323478|463992669|FG000|Overall Study|Adverse Event|7|||
128918618|NCT01323478|463992669|FG000|Overall Study|Lack of Efficacy|4|||
128698737|NCT03094169|463195736|FG004|Overall Study|Adverse Event|0|||
128698738|NCT03094169|463195737|FG005|Overall Study|Adverse Event|0|||
128698739|NCT03094169|463195738|FG006|Overall Study|Adverse Event|0|||
128698740|NCT03094169|463195739|FG007|Overall Study|Adverse Event|2|||
128698741|NCT03094169|463195732|FG000|Overall Study|Withdrawal by Subject|0|||
128918619|NCT01323478|463992669|FG000|Overall Study|Non-compliance With Study Product|3|||
128918620|NCT01323478|463992669|FG000|Overall Study|Protocol Violation|1|||
128918621|NCT01323478|463992669|FG000|Overall Study|Withdrawal of Consent|1|||
128918622|NCT01323478|463992669|FG000|Overall Study|Administrative or Other Reasons|8|||
129216112|NCT00790842|465092856|FG007|Expansion Cohort|Withdrawal by Subject|0|||
128918623|NCT02411448|463992670|FG000|Overall Study|Withdrawal by Subject|1|||
128918624|NCT02411448|463992671|FG001|Overall Study|Withdrawal by Subject|14|||
128918625|NCT02411448|463992672|FG002|Overall Study|Withdrawal by Subject|9|||
128918626|NCT02411448|463992670|FG000|Overall Study|Other|0|||
128918627|NCT02411448|463992671|FG001|Overall Study|Other|2|||
128918628|NCT02411448|463992672|FG002|Overall Study|Other|0|||
128918629|NCT02411448|463992670|FG000|Overall Study|Did not receive study treatment|0|||
128765997|NCT05672680|463433961|FG000|Overall Study|Patient Did Not Complete the Form|5|||
128765998|NCT05672680|463433962|FG001|Overall Study|Patient Did Not Complete the Form|4|||
128765999|NCT05672680|463433961|FG000|Overall Study|Procedure Aborted|1|||
128766000|NCT05672680|463433962|FG001|Overall Study|Procedure Aborted|0|||
128766001|NCT03635489|463433963|FG000|Overall Study|Death|19|||
128766002|NCT03635489|463433964|FG001|Overall Study|Death|13|||
128766003|NCT03635489|463433963|FG000|Overall Study|Lost to Follow-up|1|||
128766004|NCT03635489|463433964|FG001|Overall Study|Lost to Follow-up|2|||
128766005|NCT03635489|463433963|FG000|Overall Study|Withdrawal by Subject|1|||
128766006|NCT03635489|463433964|FG001|Overall Study|Withdrawal by Subject|2|||
128766007|NCT03635489|463433963|FG000|Overall Study|Study Ended by Sponsor|28|||
128766008|NCT03635489|463433964|FG001|Overall Study|Study Ended by Sponsor|34|||
128766009|NCT00943306|463433965|FG000|Overall Study|Physician Decision|1|||
128766010|NCT00943306|463433965|FG000|Overall Study|Death|1|||
128766011|NCT00943306|463433965|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
128766012|NCT01036022|463433966|FG000|Overall Study|Adverse Event|1|||
128766013|NCT01036022|463433967|FG001|Overall Study|Adverse Event|3|||
128766014|NCT01036022|463433968|FG002|Overall Study|Adverse Event|2|||
128766015|NCT01036022|463433969|FG003|Overall Study|Adverse Event|1|||
128766016|NCT01036022|463433970|FG004|Overall Study|Adverse Event|0|||
128766017|NCT01036022|463433971|FG005|Overall Study|Adverse Event|2|||
128766018|NCT01036022|463433966|FG000|Overall Study|Lack of Efficacy|1|||
128766019|NCT01036022|463433967|FG001|Overall Study|Lack of Efficacy|1|||
128766020|NCT01036022|463433968|FG002|Overall Study|Lack of Efficacy|1|||
128766021|NCT01036022|463433969|FG003|Overall Study|Lack of Efficacy|0|||
128766022|NCT01036022|463433970|FG004|Overall Study|Lack of Efficacy|1|||
128766023|NCT01036022|463433971|FG005|Overall Study|Lack of Efficacy|1|||
128766024|NCT01036022|463433966|FG000|Overall Study|Physician Decision|0|||
128766025|NCT01036022|463433967|FG001|Overall Study|Physician Decision|0|||
128766026|NCT01036022|463433968|FG002|Overall Study|Physician Decision|1|||
128766027|NCT01036022|463433969|FG003|Overall Study|Physician Decision|0|||
128766028|NCT01036022|463433970|FG004|Overall Study|Physician Decision|0|||
128766029|NCT01036022|463433971|FG005|Overall Study|Physician Decision|0|||
128766030|NCT01036022|463433966|FG000|Overall Study|Withdrawal by Subject|0|||
128766031|NCT01036022|463433967|FG001|Overall Study|Withdrawal by Subject|0|||
128766032|NCT01036022|463433968|FG002|Overall Study|Withdrawal by Subject|0|||
128766033|NCT01036022|463433969|FG003|Overall Study|Withdrawal by Subject|1|||
128766034|NCT01036022|463433970|FG004|Overall Study|Withdrawal by Subject|2|||
128766035|NCT01036022|463433971|FG005|Overall Study|Withdrawal by Subject|0|||
128766036|NCT00576732|463433972|FG000|DOUBLE BLIND|Adverse Event|0|||
128766037|NCT00576732|463433973|FG001|DOUBLE BLIND|Adverse Event|0|||
128766038|NCT00576732|463433974|FG002|DOUBLE BLIND|Adverse Event|1|||
128766039|NCT00576732|463433975|FG003|DOUBLE BLIND|Adverse Event|0|||
128766040|NCT00576732|463433976|FG004|DOUBLE BLIND|Adverse Event|0|||
128766041|NCT00576732|463433977|FG005|DOUBLE BLIND|Adverse Event|0|||
128766042|NCT00576732|463433972|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
128766043|NCT00576732|463433973|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
128766044|NCT00576732|463433974|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
128766045|NCT00576732|463433975|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
128766046|NCT00576732|463433976|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
128918630|NCT02411448|463992671|FG001|Overall Study|Did not receive study treatment|3|||
128918631|NCT02411448|463992672|FG002|Overall Study|Did not receive study treatment|0|||
128766047|NCT00576732|463433977|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
128766048|NCT00576732|463433972|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
128766049|NCT00576732|463433973|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
128766050|NCT00576732|463433974|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
128766051|NCT00576732|463433975|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
128766052|NCT00576732|463433976|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
128766053|NCT00576732|463433977|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
128766054|NCT00576732|463433972|FG000|DOUBLE BLIND|OTHER|0|||
128766055|NCT00576732|463433973|FG001|DOUBLE BLIND|OTHER|2|||
128766056|NCT00576732|463433974|FG002|DOUBLE BLIND|OTHER|1|||
128766057|NCT00576732|463433975|FG003|DOUBLE BLIND|OTHER|0|||
128766058|NCT00576732|463433976|FG004|DOUBLE BLIND|OTHER|0|||
128766059|NCT00576732|463433977|FG005|DOUBLE BLIND|OTHER|0|||
128766060|NCT00576732|463433972|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
128766061|NCT00576732|463433973|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
128918632|NCT02411448|463992670|FG000|Overall Study|Alive on study treatment|3|||
128766062|NCT00576732|463433974|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
128766063|NCT00576732|463433975|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
128766064|NCT00576732|463433976|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
128766065|NCT00576732|463433977|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
129029104|NCT02640235|464398328|FG000|Overall Study|Other|1|||
128698742|NCT03094169|463195733|FG001|Overall Study|Withdrawal by Subject|0|||
128698743|NCT03094169|463195734|FG002|Overall Study|Withdrawal by Subject|0|||
128698744|NCT03094169|463195735|FG003|Overall Study|Withdrawal by Subject|0|||
128698745|NCT03094169|463195736|FG004|Overall Study|Withdrawal by Subject|0|||
128698746|NCT03094169|463195737|FG005|Overall Study|Withdrawal by Subject|0|||
128698747|NCT03094169|463195738|FG006|Overall Study|Withdrawal by Subject|1|||
128698748|NCT03094169|463195739|FG007|Overall Study|Withdrawal by Subject|1|||
128698749|NCT03094169|463195732|FG000|Overall Study|Trial Termination|0|||
128698750|NCT03094169|463195733|FG001|Overall Study|Trial Termination|0|||
128698751|NCT03094169|463195734|FG002|Overall Study|Trial Termination|0|||
128698752|NCT03094169|463195735|FG003|Overall Study|Trial Termination|0|||
128698753|NCT03094169|463195736|FG004|Overall Study|Trial Termination|0|||
128698754|NCT03094169|463195737|FG005|Overall Study|Trial Termination|0|||
128698755|NCT03094169|463195738|FG006|Overall Study|Trial Termination|0|||
128698756|NCT03094169|463195739|FG007|Overall Study|Trial Termination|1|||
128698757|NCT04645953|463195740|FG000|Overall Study|Lost to Follow-up|2|||
128698758|NCT04645953|463195741|FG001|Overall Study|Lost to Follow-up|1|||
128698759|NCT04645953|463195742|FG002|Overall Study|Lost to Follow-up|1|||
128698760|NCT04645953|463195740|FG000|Overall Study|Withdrawal by Subject|0|||
128698761|NCT04645953|463195741|FG001|Overall Study|Withdrawal by Subject|1|||
128698762|NCT04645953|463195742|FG002|Overall Study|Withdrawal by Subject|0|||
128698763|NCT04645953|463195740|FG000|Overall Study|Physician Decision|0|||
128698764|NCT04645953|463195741|FG001|Overall Study|Physician Decision|1|||
128698765|NCT04645953|463195742|FG002|Overall Study|Physician Decision|0|||
128698766|NCT04645953|463195740|FG000|Overall Study|Discontinued Prior to Dosing|0|||
128698767|NCT04645953|463195741|FG001|Overall Study|Discontinued Prior to Dosing|0|||
128698768|NCT04645953|463195742|FG002|Overall Study|Discontinued Prior to Dosing|2|||
128698769|NCT04613375|463195743|FG000|Overall Study|Death|198|||
128698770|NCT04613375|463195743|FG000|Overall Study|Withdrawal by Subject|3|||
128698771|NCT01921387|463195744|FG000|Overall Study|Adverse Event|1|||
128918633|NCT02411448|463992671|FG001|Overall Study|Alive on study treatment|64|||
128918634|NCT02411448|463992672|FG002|Overall Study|Alive on study treatment|43|||
128918635|NCT02771522|463992675|FG000|Overall Study|Lost to Follow-up|3|||
128918636|NCT02771522|463992675|FG000|Overall Study|Withdrawal by Subject|2|||
128918637|NCT02771522|463992675|FG000|Overall Study|No white spot lesions|3|||
128918638|NCT05655377|463992678|FG000|Overall Study|Withdrawal by Subject|2|||
128918639|NCT01256177|463992679|FG000|Overall Study|Withdrawal by Subject|23|||
128918640|NCT01256177|463992680|FG001|Overall Study|Withdrawal by Subject|22|||
128918641|NCT01256177|463992679|FG000|Overall Study|Lost to Follow-up|2|||
128918642|NCT01256177|463992680|FG001|Overall Study|Lost to Follow-up|2|||
128918643|NCT01256177|463992679|FG000|Overall Study|Adverse Event|8|||
128918644|NCT01256177|463992680|FG001|Overall Study|Adverse Event|9|||
128918645|NCT01256177|463992679|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
128918646|NCT01256177|463992680|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
128918647|NCT01256177|463992679|FG000|Overall Study|Condition under Investigation Worsened|1|||
128918648|NCT01256177|463992680|FG001|Overall Study|Condition under Investigation Worsened|0|||
128698772|NCT01706146|463195747|FG000|Overall Study|Withdrawal by Subject|1|||
128698773|NCT01706146|463195747|FG000|Overall Study|Adverse Event|3|||
128698774|NCT01706146|463195747|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
128918649|NCT01256177|463992679|FG000|Overall Study|Lack of Efficacy|11|||
128918650|NCT01256177|463992680|FG001|Overall Study|Lack of Efficacy|2|||
128918651|NCT01256177|463992679|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
128918652|NCT01256177|463992680|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
128698775|NCT00675948|463195748|FG000|Overall Study|Adverse Event|23|||
128698776|NCT00675948|463195749|FG001|Overall Study|Adverse Event|1|||
128698777|NCT00675948|463195748|FG000|Overall Study|Lack of Efficacy|3|||
128698778|NCT00675948|463195749|FG001|Overall Study|Lack of Efficacy|0|||
128698779|NCT00675948|463195748|FG000|Overall Study|Withdrawal by Subject|7|||
128698780|NCT00675948|463195749|FG001|Overall Study|Withdrawal by Subject|0|||
128698781|NCT00675948|463195748|FG000|Overall Study|Lost to Follow-up|2|||
128918653|NCT03624946|463992684|FG000|Overall Study|Lost to Follow-up|0|||
128918654|NCT03624946|463992685|FG001|Overall Study|Lost to Follow-up|1|||
128918655|NCT01869348|463992686|FG000|Overall Study|Withdrawal by Subject|1|||
128918656|NCT01869348|463992687|FG001|Overall Study|Withdrawal by Subject|1|||
128698782|NCT00675948|463195749|FG001|Overall Study|Lost to Follow-up|0|||
128698783|NCT00675948|463195748|FG000|Overall Study|Protocol Violation|1|||
128698784|NCT00675948|463195749|FG001|Overall Study|Protocol Violation|0|||
128698785|NCT00675948|463195748|FG000|Overall Study|Pain under control|1|||
128698786|NCT00675948|463195749|FG001|Overall Study|Pain under control|0|||
128698787|NCT00675948|463195748|FG000|Overall Study|Sponsor decision|0|||
128698788|NCT00675948|463195749|FG001|Overall Study|Sponsor decision|1|||
128698789|NCT00675948|463195748|FG000|Overall Study|Patient died|1|||
128698790|NCT00675948|463195749|FG001|Overall Study|Patient died|0|||
128698791|NCT00675948|463195748|FG000|Overall Study|Patient unable to comply with diaries|1|||
128698792|NCT00675948|463195749|FG001|Overall Study|Patient unable to comply with diaries|0|||
128766066|NCT00576732|463433972|FG000|DOUBLE BLIND|Protocol Violation|1|||
128918657|NCT00624520|463992688|FG000|Overall Study|Withdrawal by Subject|12|||
128918658|NCT00624520|463992689|FG001|Overall Study|Withdrawal by Subject|7|||
128918659|NCT00624520|463992688|FG000|Overall Study|Death|0|||
128918660|NCT00624520|463992689|FG001|Overall Study|Death|1|||
128918661|NCT01925209|463992690|FG000|Treatment Epoch|Physician Decision|1|||
128918662|NCT01925209|463992691|FG001|Treatment Epoch|Physician Decision|0|||
129029105|NCT02640235|464398329|FG001|Overall Study|Other|2|||
129029106|NCT01370863|464398330|FG000|Overall Study|Adverse Event|1|||
129029107|NCT01370863|464398331|FG001|Overall Study|Adverse Event|1|||
129029108|NCT01370863|464398330|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
128918663|NCT01925209|463992692|FG002|Treatment Epoch|Physician Decision|0|||
129029109|NCT01370863|464398331|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
129029110|NCT01370863|464398330|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129029111|NCT01370863|464398331|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
128918664|NCT01925209|463992693|FG003|Treatment Epoch|Physician Decision|0|||
128918665|NCT01925209|463992690|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
128918666|NCT01925209|463992691|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
128918667|NCT01925209|463992692|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
128918668|NCT01925209|463992693|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
128918669|NCT01925209|463992690|FG000|Treatment Epoch|Death|1|||
128918670|NCT01925209|463992691|FG001|Treatment Epoch|Death|0|||
128918671|NCT01925209|463992692|FG002|Treatment Epoch|Death|0|||
128918672|NCT01925209|463992693|FG003|Treatment Epoch|Death|0|||
128918673|NCT01925209|463992690|FG000|Treatment Epoch|Protocol deviation|0|||
128918674|NCT01925209|463992691|FG001|Treatment Epoch|Protocol deviation|0|||
128918675|NCT01925209|463992692|FG002|Treatment Epoch|Protocol deviation|1|||
128918676|NCT01925209|463992693|FG003|Treatment Epoch|Protocol deviation|1|||
128918677|NCT01925209|463992690|FG000|Treatment Epoch|Withdrawal by Subject|4|||
128918678|NCT01925209|463992691|FG001|Treatment Epoch|Withdrawal by Subject|3|||
128918679|NCT01925209|463992692|FG002|Treatment Epoch|Withdrawal by Subject|3|||
128918680|NCT01925209|463992693|FG003|Treatment Epoch|Withdrawal by Subject|2|||
128698793|NCT00675948|463195748|FG000|Overall Study|Patient feels unable to take medication|0|||
128698794|NCT00675948|463195749|FG001|Overall Study|Patient feels unable to take medication|1|||
128698795|NCT02582983|463195750|FG000|Overall Study|Death|3|||
128698796|NCT02582983|463195750|FG000|Overall Study|Withdrawal by Subject|2|||
128698797|NCT02582983|463195750|FG000|Overall Study|Adverse Event|1|||
128698798|NCT02527161|463195751|FG000|Overall Study|Failed MRI|52|||
128698799|NCT02527161|463195751|FG000|Overall Study|Withdrawal by Subject|19|||
128698800|NCT02527161|463195751|FG000|Overall Study|Delay in or unfit for surgery|16|||
128698801|NCT02527161|463195751|FG000|Overall Study|MRI contraindication|6|||
128698802|NCT02527161|463195751|FG000|Overall Study|Consent violation|4|||
128698803|NCT02527161|463195751|FG000|Overall Study|Only Recruited to Part A|27|||
128698804|NCT02527161|463195751|FG000|Overall Study|Physician Decision|1|||
128698805|NCT02527161|463195751|FG000|Overall Study|Adverse Event|1|||
128698806|NCT02527161|463195751|FG000|Overall Study|Lost to Follow-up|6|||
128698807|NCT05209360|463195752|FG000|Overall Study|Withdrawal by Subject|0|||
128698808|NCT05209360|463195753|FG001|Overall Study|Withdrawal by Subject|0|||
128698809|NCT05209360|463195754|FG002|Overall Study|Withdrawal by Subject|1|||
128698810|NCT05209360|463195755|FG003|Overall Study|Withdrawal by Subject|0|||
128698811|NCT05209360|463195756|FG004|Overall Study|Withdrawal by Subject|0|||
128698812|NCT05209360|463195757|FG005|Overall Study|Withdrawal by Subject|0|||
128698813|NCT00724932|463195758|FG000|Overall Study|Lost to Follow-up|1|||
128698814|NCT00724932|463195759|FG001|Overall Study|Lost to Follow-up|0|||
128698815|NCT00724932|463195758|FG000|Overall Study|Not treated|4|||
128698816|NCT00724932|463195759|FG001|Overall Study|Not treated|3|||
128698817|NCT01081678|463195765|FG000|Overall Study|Ineligibility Determined|0|||
128698818|NCT01081678|463195766|FG001|Overall Study|Ineligibility Determined|0|||
128698819|NCT01081678|463195767|FG002|Overall Study|Ineligibility Determined|1|||
128698820|NCT01081678|463195768|FG003|Overall Study|Ineligibility Determined|1|||
128698821|NCT01081678|463195765|FG000|Overall Study|Noncompliance|3|||
128698822|NCT01081678|463195766|FG001|Overall Study|Noncompliance|4|||
128698823|NCT01081678|463195767|FG002|Overall Study|Noncompliance|5|||
128698824|NCT01081678|463195768|FG003|Overall Study|Noncompliance|2|||
128698825|NCT01081678|463195765|FG000|Overall Study|Adverse Event|2|||
128918681|NCT01925209|463992690|FG000|Treatment Epoch|Adverse Event|3|||
128918682|NCT01925209|463992691|FG001|Treatment Epoch|Adverse Event|5|||
128698826|NCT01081678|463195766|FG001|Overall Study|Adverse Event|1|||
128698827|NCT01081678|463195767|FG002|Overall Study|Adverse Event|2|||
128698828|NCT01081678|463195768|FG003|Overall Study|Adverse Event|2|||
128918683|NCT01925209|463992692|FG002|Treatment Epoch|Adverse Event|3|||
128918684|NCT01925209|463992693|FG003|Treatment Epoch|Adverse Event|1|||
128918685|NCT01925209|463992690|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
128918686|NCT01925209|463992691|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
128918687|NCT01925209|463992692|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
128918688|NCT01925209|463992693|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
129029112|NCT00301964|464398332|FG000|Overall Study|Second primary|2|||
129029113|NCT00301964|464398332|FG000|Overall Study|Wrong primary|1|||
128918689|NCT01925209|463992690|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
128918690|NCT01925209|463992691|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
128918691|NCT01925209|463992692|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
128918692|NCT01925209|463992693|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
128918693|NCT01925209|463992690|FG000|Follow-up|Adverse Event|1|||
128918694|NCT01925209|463992691|FG001|Follow-up|Adverse Event|4|||
128918695|NCT01925209|463992692|FG002|Follow-up|Adverse Event|0|||
128918696|NCT01925209|463992693|FG003|Follow-up|Adverse Event|1|||
128918697|NCT01925209|463992690|FG000|Follow-up|Physician Decision|0|||
128918698|NCT01925209|463992691|FG001|Follow-up|Physician Decision|0|||
128918699|NCT01925209|463992692|FG002|Follow-up|Physician Decision|1|||
128918700|NCT01925209|463992693|FG003|Follow-up|Physician Decision|0|||
128918701|NCT01925209|463992690|FG000|Follow-up|Non-compliance with study treatment|0|||
128918702|NCT01925209|463992691|FG001|Follow-up|Non-compliance with study treatment|0|||
128918703|NCT01925209|463992692|FG002|Follow-up|Non-compliance with study treatment|0|||
128918704|NCT01925209|463992693|FG003|Follow-up|Non-compliance with study treatment|1|||
128918705|NCT01925209|463992690|FG000|Follow-up|Withdrawal by Subject|0|||
128918706|NCT01925209|463992691|FG001|Follow-up|Withdrawal by Subject|2|||
128918707|NCT01925209|463992692|FG002|Follow-up|Withdrawal by Subject|0|||
128918708|NCT01925209|463992693|FG003|Follow-up|Withdrawal by Subject|2|||
128918709|NCT02796755|463992694|FG000|Overall Study|Adverse Event|2|||
128918710|NCT02796755|463992695|FG001|Overall Study|Adverse Event|0|||
128918711|NCT04398732|463992699|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
128918712|NCT00556426|463992700|FG000|Overall Study|Withdrawal by Subject|3|||
128918713|NCT00556426|463992700|FG000|Overall Study|Death|6|||
128918714|NCT01596257|463992702|FG000|Overall Study|Inadequate Collection|23|||
128918715|NCT01596257|463992703|FG001|Overall Study|Inadequate Collection|19|||
128918716|NCT00792298|463992707|FG000|Treatment Period 1|Adverse Event|0|||
128918717|NCT00792298|463992708|FG001|Treatment Period 1|Adverse Event|1|||
128918718|NCT00792298|463992709|FG002|Treatment Period 1|Adverse Event|0|||
128918719|NCT00792298|463992710|FG003|Treatment Period 1|Adverse Event|1|||
128918720|NCT00792298|463992711|FG004|Treatment Period 1|Adverse Event|0|||
128918721|NCT00792298|463992712|FG005|Treatment Period 1|Adverse Event|1|||
128918722|NCT00792298|463992713|FG006|Treatment Period 1|Adverse Event|1|||
128918723|NCT00792298|463992714|FG007|Treatment Period 1|Adverse Event|0|||
128918724|NCT00792298|463992707|FG000|Treatment Period 1|Lack of Efficacy|0|||
128918725|NCT00792298|463992708|FG001|Treatment Period 1|Lack of Efficacy|0|||
128918726|NCT00792298|463992709|FG002|Treatment Period 1|Lack of Efficacy|1|||
128918727|NCT00792298|463992710|FG003|Treatment Period 1|Lack of Efficacy|0|||
128918728|NCT00792298|463992711|FG004|Treatment Period 1|Lack of Efficacy|0|||
128918729|NCT00792298|463992712|FG005|Treatment Period 1|Lack of Efficacy|0|||
128918730|NCT00792298|463992713|FG006|Treatment Period 1|Lack of Efficacy|0|||
128918731|NCT00792298|463992714|FG007|Treatment Period 1|Lack of Efficacy|0|||
128918732|NCT00792298|463992707|FG000|Treatment Period 1|Withdrawal by Subject|1|||
128918733|NCT00792298|463992708|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128918734|NCT00792298|463992709|FG002|Treatment Period 1|Withdrawal by Subject|1|||
128918735|NCT00792298|463992710|FG003|Treatment Period 1|Withdrawal by Subject|2|||
128918736|NCT00792298|463992711|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128918737|NCT00792298|463992712|FG005|Treatment Period 1|Withdrawal by Subject|2|||
128918738|NCT00792298|463992713|FG006|Treatment Period 1|Withdrawal by Subject|1|||
128918739|NCT00792298|463992714|FG007|Treatment Period 1|Withdrawal by Subject|0|||
128918740|NCT00792298|463992707|FG000|Treatment Period 1|Lost to Follow-up|0|||
128918741|NCT00792298|463992708|FG001|Treatment Period 1|Lost to Follow-up|0|||
128918742|NCT00792298|463992709|FG002|Treatment Period 1|Lost to Follow-up|0|||
128918743|NCT00792298|463992710|FG003|Treatment Period 1|Lost to Follow-up|0|||
128918744|NCT00792298|463992711|FG004|Treatment Period 1|Lost to Follow-up|0|||
128918745|NCT00792298|463992712|FG005|Treatment Period 1|Lost to Follow-up|0|||
128918746|NCT00792298|463992713|FG006|Treatment Period 1|Lost to Follow-up|1|||
128918747|NCT00792298|463992714|FG007|Treatment Period 1|Lost to Follow-up|0|||
128918748|NCT00792298|463992707|FG000|Treatment Period 1|Physician Decision|0|||
128918749|NCT00792298|463992708|FG001|Treatment Period 1|Physician Decision|0|||
128918750|NCT00792298|463992709|FG002|Treatment Period 1|Physician Decision|0|||
128918751|NCT00792298|463992710|FG003|Treatment Period 1|Physician Decision|1|||
128918752|NCT00792298|463992711|FG004|Treatment Period 1|Physician Decision|0|||
128918753|NCT00792298|463992712|FG005|Treatment Period 1|Physician Decision|0|||
128918754|NCT00792298|463992713|FG006|Treatment Period 1|Physician Decision|1|||
128918755|NCT00792298|463992714|FG007|Treatment Period 1|Physician Decision|0|||
128918756|NCT00792298|463992707|FG000|Treatment Period 1|Protocol Violation|0|||
128918757|NCT00792298|463992708|FG001|Treatment Period 1|Protocol Violation|0|||
128918758|NCT00792298|463992709|FG002|Treatment Period 1|Protocol Violation|0|||
128918759|NCT00792298|463992710|FG003|Treatment Period 1|Protocol Violation|0|||
128918760|NCT00792298|463992711|FG004|Treatment Period 1|Protocol Violation|0|||
128918761|NCT00792298|463992712|FG005|Treatment Period 1|Protocol Violation|0|||
128918762|NCT00792298|463992713|FG006|Treatment Period 1|Protocol Violation|0|||
128918763|NCT00792298|463992714|FG007|Treatment Period 1|Protocol Violation|1|||
128918764|NCT00792298|463992707|FG000|Washout|Adverse Event|0|||
128918765|NCT00792298|463992708|FG001|Washout|Adverse Event|0|||
128918766|NCT00792298|463992709|FG002|Washout|Adverse Event|0|||
128918767|NCT00792298|463992710|FG003|Washout|Adverse Event|0|||
128918768|NCT00792298|463992711|FG004|Washout|Adverse Event|0|||
128918769|NCT00792298|463992712|FG005|Washout|Adverse Event|1|||
128918770|NCT00792298|463992713|FG006|Washout|Adverse Event|0|||
128918771|NCT00792298|463992714|FG007|Washout|Adverse Event|0|||
128918772|NCT00792298|463992707|FG000|Washout|Withdrawal by Subject|0|||
128918773|NCT00792298|463992708|FG001|Washout|Withdrawal by Subject|0|||
128918774|NCT00792298|463992709|FG002|Washout|Withdrawal by Subject|1|||
128918775|NCT00792298|463992710|FG003|Washout|Withdrawal by Subject|0|||
128918776|NCT00792298|463992711|FG004|Washout|Withdrawal by Subject|0|||
128918777|NCT00792298|463992712|FG005|Washout|Withdrawal by Subject|1|||
128918778|NCT00792298|463992713|FG006|Washout|Withdrawal by Subject|0|||
128918779|NCT00792298|463992714|FG007|Washout|Withdrawal by Subject|0|||
128918780|NCT00792298|463992707|FG000|Treatment Period 2|Lack of Efficacy|0|||
128918781|NCT00792298|463992708|FG001|Treatment Period 2|Lack of Efficacy|0|||
128918782|NCT00792298|463992709|FG002|Treatment Period 2|Lack of Efficacy|0|||
128918783|NCT00792298|463992710|FG003|Treatment Period 2|Lack of Efficacy|0|||
128918784|NCT00792298|463992711|FG004|Treatment Period 2|Lack of Efficacy|1|||
128918785|NCT00792298|463992712|FG005|Treatment Period 2|Lack of Efficacy|0|||
128918786|NCT00792298|463992713|FG006|Treatment Period 2|Lack of Efficacy|0|||
128918787|NCT00792298|463992714|FG007|Treatment Period 2|Lack of Efficacy|0|||
128918788|NCT00792298|463992707|FG000|Treatment Period 2|Physician Decision|0|||
128918789|NCT00792298|463992708|FG001|Treatment Period 2|Physician Decision|0|||
128918790|NCT00792298|463992709|FG002|Treatment Period 2|Physician Decision|0|||
128918791|NCT00792298|463992710|FG003|Treatment Period 2|Physician Decision|0|||
128918792|NCT00792298|463992711|FG004|Treatment Period 2|Physician Decision|0|||
128918793|NCT00792298|463992712|FG005|Treatment Period 2|Physician Decision|0|||
128918794|NCT00792298|463992713|FG006|Treatment Period 2|Physician Decision|1|||
128918795|NCT00792298|463992714|FG007|Treatment Period 2|Physician Decision|0|||
128918796|NCT00792298|463992707|FG000|Treatment Period 2|Pregnancy|0|||
128918797|NCT00792298|463992708|FG001|Treatment Period 2|Pregnancy|0|||
128918798|NCT00792298|463992709|FG002|Treatment Period 2|Pregnancy|1|||
128918799|NCT00792298|463992710|FG003|Treatment Period 2|Pregnancy|0|||
128918800|NCT00792298|463992711|FG004|Treatment Period 2|Pregnancy|0|||
128918801|NCT00792298|463992712|FG005|Treatment Period 2|Pregnancy|0|||
128918802|NCT00792298|463992713|FG006|Treatment Period 2|Pregnancy|0|||
128918803|NCT00792298|463992714|FG007|Treatment Period 2|Pregnancy|0|||
128918804|NCT00792298|463992707|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128918805|NCT00792298|463992708|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128918806|NCT00792298|463992709|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128918807|NCT00792298|463992710|FG003|Treatment Period 2|Withdrawal by Subject|2|||
128918808|NCT00792298|463992711|FG004|Treatment Period 2|Withdrawal by Subject|1|||
128918809|NCT00792298|463992712|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128918810|NCT00792298|463992713|FG006|Treatment Period 2|Withdrawal by Subject|0|||
128918811|NCT00792298|463992714|FG007|Treatment Period 2|Withdrawal by Subject|2|||
128918812|NCT04258579|463992720|FG000|Overall Study|Withdrawal by Subject|7|||
128918813|NCT04258579|463992720|FG000|Overall Study|Lost to Follow-up|3|||
128918814|NCT04258579|463992720|FG000|Overall Study|Protocol Violation|2|||
128918815|NCT04258579|463992720|FG000|Overall Study|Adverse Event|1|||
128918816|NCT01950819|463992726|FG000|Overall Study|Graft Loss|35|||
128918817|NCT01950819|463992727|FG001|Overall Study|Graft Loss|30|||
128918818|NCT01950819|463992726|FG000|Overall Study|Death|29|||
128918819|NCT01950819|463992727|FG001|Overall Study|Death|34|||
128918820|NCT01950819|463992726|FG000|Overall Study|Subject / Gardian decision|54|||
128918821|NCT01950819|463992727|FG001|Overall Study|Subject / Gardian decision|51|||
128918822|NCT01950819|463992726|FG000|Overall Study|technical problems|2|||
128918823|NCT01950819|463992727|FG001|Overall Study|technical problems|0|||
128698829|NCT01081678|463195765|FG000|Overall Study|Withdrawal by Subject|15|||
128918824|NCT01950819|463992726|FG000|Overall Study|Pregnancy|0|||
128918825|NCT01950819|463992727|FG001|Overall Study|Pregnancy|2|||
128918826|NCT01950819|463992726|FG000|Overall Study|Lost to Follow-up|9|||
128918827|NCT01950819|463992727|FG001|Overall Study|Lost to Follow-up|17|||
128918828|NCT02928952|463992728|FG000|Overall Study|Lost to Follow-up|5|||
128918829|NCT02928952|463992729|FG001|Overall Study|Lost to Follow-up|5|||
128918830|NCT02928952|463992728|FG000|Overall Study|Withdrawal by Subject|5|||
128918831|NCT02928952|463992729|FG001|Overall Study|Withdrawal by Subject|1|||
128918832|NCT02928952|463992728|FG000|Overall Study|Physician Decision|0|||
128918833|NCT02928952|463992729|FG001|Overall Study|Physician Decision|1|||
128918834|NCT01850615|463992730|FG000|Overall Study|Protocol Violation|4|||
128918835|NCT01850615|463992731|FG001|Overall Study|Protocol Violation|1|||
128918836|NCT01850615|463992730|FG000|Overall Study|Adverse Event|2|||
128918837|NCT01850615|463992731|FG001|Overall Study|Adverse Event|1|||
128918838|NCT01850615|463992730|FG000|Overall Study|Withdrawal by Subject|3|||
128918839|NCT01850615|463992731|FG001|Overall Study|Withdrawal by Subject|1|||
128918840|NCT01850615|463992730|FG000|Overall Study|Lost to Follow-up|0|||
128918841|NCT01850615|463992731|FG001|Overall Study|Lost to Follow-up|1|||
128918842|NCT01850615|463992730|FG000|Overall Study|Unclassified|0|||
128918843|NCT01850615|463992731|FG001|Overall Study|Unclassified|1|||
128918844|NCT04525703|463992735|FG000|Overall Study|Lost to Follow-up|6|||
128918845|NCT04525703|463992736|FG001|Overall Study|Lost to Follow-up|15|||
128918846|NCT04525703|463992737|FG002|Overall Study|Lost to Follow-up|8|||
128918847|NCT00712348|463992738|FG000|Overall Study|Withdrawal by Subject|1|||
128918848|NCT01375764|463992740|FG000|Overall Study|Lost to Follow-up|0|||
128698830|NCT01081678|463195766|FG001|Overall Study|Withdrawal by Subject|7|||
128698831|NCT01081678|463195767|FG002|Overall Study|Withdrawal by Subject|17|||
128698832|NCT01081678|463195768|FG003|Overall Study|Withdrawal by Subject|14|||
128698833|NCT01081678|463195765|FG000|Overall Study|Administrative Decision|1|||
128698834|NCT01081678|463195766|FG001|Overall Study|Administrative Decision|0|||
128698835|NCT01081678|463195767|FG002|Overall Study|Administrative Decision|0|||
128698836|NCT01081678|463195768|FG003|Overall Study|Administrative Decision|1|||
128698837|NCT01081678|463195765|FG000|Overall Study|Lost to Follow-up|4|||
128698838|NCT01081678|463195766|FG001|Overall Study|Lost to Follow-up|1|||
128698839|NCT01081678|463195767|FG002|Overall Study|Lost to Follow-up|4|||
128698840|NCT01081678|463195768|FG003|Overall Study|Lost to Follow-up|3|||
128698841|NCT01081678|463195765|FG000|Overall Study|Death|2|||
128698842|NCT01081678|463195766|FG001|Overall Study|Death|2|||
128698843|NCT01081678|463195767|FG002|Overall Study|Death|2|||
128698844|NCT01081678|463195768|FG003|Overall Study|Death|6|||
128698845|NCT01081678|463195765|FG000|Overall Study|Other|0|||
128698846|NCT01081678|463195766|FG001|Overall Study|Other|1|||
128698847|NCT01081678|463195767|FG002|Overall Study|Other|0|||
128698848|NCT01081678|463195768|FG003|Overall Study|Other|0|||
128698849|NCT00444912|463195769|FG000|Overall Study|Death|1|||
128698850|NCT00444912|463195770|FG001|Overall Study|Death|2|||
128698851|NCT00444912|463195769|FG000|Overall Study|Lost to Follow-up|1|||
128698852|NCT00444912|463195770|FG001|Overall Study|Lost to Follow-up|0|||
128698853|NCT00444912|463195769|FG000|Overall Study|Participant Failed Mobilization|1|||
128698854|NCT00444912|463195770|FG001|Overall Study|Participant Failed Mobilization|0|||
128698855|NCT01007812|463195773|FG000|Period 1, One Week|Lost to Follow-up|0|||
128698856|NCT01007812|463195774|FG001|Period 1, One Week|Lost to Follow-up|1|||
128698857|NCT01007812|463195773|FG000|Period 1, One Week|Discomfort|1|||
128698858|NCT01007812|463195774|FG001|Period 1, One Week|Discomfort|0|||
128698859|NCT01091974|463195775|FG000|Overall Study|Did not start intervention|3|||
128698860|NCT01091974|463195776|FG001|Overall Study|Did not start intervention|1|||
128698861|NCT01091974|463195777|FG002|Overall Study|Did not start intervention|3|||
128698862|NCT01091974|463195778|FG003|Overall Study|Did not start intervention|1|||
128698863|NCT01091974|463195775|FG000|Overall Study|resumed sleep medication|0|||
128698864|NCT01091974|463195776|FG001|Overall Study|resumed sleep medication|0|||
128918849|NCT01375764|463992741|FG001|Overall Study|Lost to Follow-up|1|||
128918850|NCT01375764|463992742|FG002|Overall Study|Lost to Follow-up|0|||
128918851|NCT01375764|463992743|FG003|Overall Study|Lost to Follow-up|0|||
128918852|NCT01375764|463992744|FG004|Overall Study|Lost to Follow-up|0|||
128766067|NCT00576732|463433973|FG001|DOUBLE BLIND|Protocol Violation|0|||
128766068|NCT00576732|463433974|FG002|DOUBLE BLIND|Protocol Violation|0|||
128766069|NCT00576732|463433975|FG003|DOUBLE BLIND|Protocol Violation|0|||
128766070|NCT00576732|463433976|FG004|DOUBLE BLIND|Protocol Violation|0|||
128766071|NCT00576732|463433977|FG005|DOUBLE BLIND|Protocol Violation|0|||
128766072|NCT00576732|463433972|FG000|OPEN LABEL|Adverse Event|0|||
128766073|NCT00576732|463433973|FG001|OPEN LABEL|Adverse Event|0|||
128766074|NCT00576732|463433974|FG002|OPEN LABEL|Adverse Event|0|||
128766075|NCT00576732|463433975|FG003|OPEN LABEL|Adverse Event|4|||
128766076|NCT00576732|463433976|FG004|OPEN LABEL|Adverse Event|0|||
128766077|NCT00576732|463433977|FG005|OPEN LABEL|Adverse Event|1|||
128766078|NCT00576732|463433972|FG000|OPEN LABEL|Lost to Follow-up|0|||
128918853|NCT01375764|463992740|FG000|Overall Study|Withdrawal by Subject|2|||
128918854|NCT01375764|463992741|FG001|Overall Study|Withdrawal by Subject|0|||
128918855|NCT01375764|463992742|FG002|Overall Study|Withdrawal by Subject|0|||
128698865|NCT01091974|463195777|FG002|Overall Study|resumed sleep medication|1|||
128698866|NCT01091974|463195778|FG003|Overall Study|resumed sleep medication|2|||
128766079|NCT00576732|463433973|FG001|OPEN LABEL|Lost to Follow-up|0|||
128766080|NCT00576732|463433974|FG002|OPEN LABEL|Lost to Follow-up|0|||
128766081|NCT00576732|463433975|FG003|OPEN LABEL|Lost to Follow-up|2|||
128766082|NCT00576732|463433976|FG004|OPEN LABEL|Lost to Follow-up|1|||
128766083|NCT00576732|463433977|FG005|OPEN LABEL|Lost to Follow-up|1|||
128918856|NCT01375764|463992743|FG003|Overall Study|Withdrawal by Subject|0|||
128918857|NCT01375764|463992744|FG004|Overall Study|Withdrawal by Subject|1|||
128918858|NCT01375764|463992740|FG000|Overall Study|Other|0|||
128918859|NCT01375764|463992741|FG001|Overall Study|Other|0|||
128918860|NCT01375764|463992742|FG002|Overall Study|Other|0|||
128918861|NCT01375764|463992743|FG003|Overall Study|Other|1|||
128918862|NCT01375764|463992744|FG004|Overall Study|Other|0|||
128698867|NCT01091974|463195775|FG000|Overall Study|Withdrawal by Subject|1|||
128698868|NCT01091974|463195776|FG001|Overall Study|Withdrawal by Subject|3|||
128698869|NCT01091974|463195777|FG002|Overall Study|Withdrawal by Subject|2|||
128698870|NCT01091974|463195778|FG003|Overall Study|Withdrawal by Subject|2|||
128698871|NCT01091974|463195775|FG000|Overall Study|side-effects|1|||
128698872|NCT01091974|463195776|FG001|Overall Study|side-effects|1|||
128766084|NCT00576732|463433972|FG000|OPEN LABEL|Withdrawal by Subject|0|||
128766085|NCT00576732|463433973|FG001|OPEN LABEL|Withdrawal by Subject|0|||
128766086|NCT00576732|463433974|FG002|OPEN LABEL|Withdrawal by Subject|0|||
128766087|NCT00576732|463433975|FG003|OPEN LABEL|Withdrawal by Subject|1|||
128766088|NCT00576732|463433976|FG004|OPEN LABEL|Withdrawal by Subject|0|||
128766089|NCT00576732|463433977|FG005|OPEN LABEL|Withdrawal by Subject|1|||
128766090|NCT00576732|463433972|FG000|OPEN LABEL|OTHER|0|||
128766091|NCT00576732|463433973|FG001|OPEN LABEL|OTHER|0|||
128766092|NCT00576732|463433974|FG002|OPEN LABEL|OTHER|0|||
128766093|NCT00576732|463433975|FG003|OPEN LABEL|OTHER|0|||
128766094|NCT00576732|463433976|FG004|OPEN LABEL|OTHER|0|||
128766095|NCT00576732|463433977|FG005|OPEN LABEL|OTHER|2|||
128766096|NCT00576732|463433972|FG000|OPEN LABEL|Lack of Efficacy|0|||
128766097|NCT00576732|463433973|FG001|OPEN LABEL|Lack of Efficacy|0|||
128766098|NCT00576732|463433974|FG002|OPEN LABEL|Lack of Efficacy|0|||
128766099|NCT00576732|463433975|FG003|OPEN LABEL|Lack of Efficacy|2|||
128766100|NCT00576732|463433976|FG004|OPEN LABEL|Lack of Efficacy|2|||
128766101|NCT00576732|463433977|FG005|OPEN LABEL|Lack of Efficacy|3|||
128766102|NCT00576732|463433972|FG000|OPEN LABEL|Protocol Violation|0|||
128766103|NCT00576732|463433973|FG001|OPEN LABEL|Protocol Violation|0|||
128766104|NCT00576732|463433974|FG002|OPEN LABEL|Protocol Violation|0|||
128918863|NCT03595280|463992745|FG000|Overall Study|Lost to Follow-up|6|||
128918864|NCT03595280|463992746|FG001|Overall Study|Lost to Follow-up|9|||
128766105|NCT00576732|463433975|FG003|OPEN LABEL|Protocol Violation|2|||
128766106|NCT00576732|463433976|FG004|OPEN LABEL|Protocol Violation|1|||
128766107|NCT00576732|463433977|FG005|OPEN LABEL|Protocol Violation|0|||
128918865|NCT03595280|463992747|FG002|Overall Study|Lost to Follow-up|15|||
128918866|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918867|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918868|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918869|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
128918870|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918871|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
128918872|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918873|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918874|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918875|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918876|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918877|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918878|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918879|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918880|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918881|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918882|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918883|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918884|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918885|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918886|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918887|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918888|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
128918889|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
128918890|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
128918891|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
128918892|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
128918893|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
128918894|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
128918895|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
128918896|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918897|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918898|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918899|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918900|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918901|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918902|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918903|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918904|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128766108|NCT01875185|463433979|FG000|Overall Study|study was terminated|52|||
128766109|NCT01875185|463433980|FG001|Overall Study|study was terminated|48|||
128766110|NCT04838613|463433981|FG000|Overall Study|Withdrawal by Subject|3|||
128918905|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128766111|NCT04838613|463433982|FG001|Overall Study|Withdrawal by Subject|6|||
128766112|NCT04838613|463433981|FG000|Overall Study|Protocol Deviation|3|||
128766113|NCT04838613|463433982|FG001|Overall Study|Protocol Deviation|2|||
128766114|NCT04838613|463433981|FG000|Overall Study|Technical Problems|0|||
128766115|NCT04838613|463433982|FG001|Overall Study|Technical Problems|5|||
128766116|NCT04838613|463433981|FG000|Overall Study|Physician Decision|2|||
128766117|NCT04838613|463433982|FG001|Overall Study|Physician Decision|0|||
128766118|NCT01686581|463433983|FG000|Overall Study|Side-effects or Health Problems|15|||
128766119|NCT01686581|463433983|FG000|Overall Study|Lack of Efficacy|90|||
128766120|NCT01686581|463433983|FG000|Overall Study|Participant Concerned about Risks|6|||
128766121|NCT01686581|463433983|FG000|Overall Study|Thinks Injections Too Painful|8|||
128766122|NCT01686581|463433983|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
128766123|NCT01686581|463433983|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
128766124|NCT01686581|463433983|FG000|Overall Study|Thinks it is Inconvenient|17|||
128766125|NCT01686581|463433983|FG000|Overall Study|Other Miscellaneous Reasons|36|||
128766126|NCT01686581|463433983|FG000|Overall Study|Reason Missing|1|||
128766127|NCT00399763|463433984|FG000|Overall Study|Lost to Follow-up|2|||
128766128|NCT00399763|463433985|FG001|Overall Study|Lost to Follow-up|3|||
128766129|NCT01657266|463433989|FG000|Overall Study|Lost to Follow-up|2|||
128766130|NCT01657266|463433990|FG001|Overall Study|Lost to Follow-up|2|||
128766131|NCT01657266|463433989|FG000|Overall Study|Adverse Event|2|||
128766132|NCT01657266|463433990|FG001|Overall Study|Adverse Event|3|||
128766133|NCT01807650|463433991|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
128766134|NCT01807650|463433991|FG000|Overall Study|Adverse Event|5|||
128918906|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918907|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918908|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918909|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918910|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918911|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
128918912|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
128918913|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
128918914|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
128918915|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
128918916|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
128918917|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
128918918|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
128918919|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
128918920|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918921|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918922|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918923|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918924|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918925|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918926|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918927|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918928|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918929|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918930|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918931|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918932|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918933|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918934|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
128918935|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918936|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918937|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
128918938|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918939|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
128918940|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918941|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918942|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918943|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918944|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128766135|NCT01807650|463433991|FG000|Overall Study|Other|2|||
128766136|NCT00736489|463433992|FG000|Period 1|Lost to Follow-up|1|||
128766137|NCT00736489|463433993|FG001|Period 1|Lost to Follow-up|0|||
128766138|NCT00736489|463433994|FG002|Period 1|Lost to Follow-up|0|||
128766139|NCT00736489|463433995|FG003|Period 1|Lost to Follow-up|0|||
128766140|NCT00736489|463433996|FG004|Period 1|Lost to Follow-up|0|||
128766141|NCT00736489|463433997|FG005|Period 1|Lost to Follow-up|0|||
128918945|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918946|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918947|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918948|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918949|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918950|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918951|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128698873|NCT01091974|463195777|FG002|Overall Study|side-effects|0|||
128698874|NCT01091974|463195778|FG003|Overall Study|side-effects|2|||
128698875|NCT02499783|463195779|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
128698876|NCT02499783|463195780|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
128698877|NCT02499783|463195781|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
128698878|NCT02499783|463195779|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
128698879|NCT02499783|463195780|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
128698880|NCT02499783|463195781|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
128698881|NCT02499783|463195779|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
128698882|NCT02499783|463195780|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
128698883|NCT02499783|463195781|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
128698884|NCT02499783|463195779|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
128698885|NCT02499783|463195780|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
128698886|NCT02499783|463195781|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
128698887|NCT02499783|463195779|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
128698888|NCT02499783|463195780|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
128698889|NCT02499783|463195781|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
128698890|NCT02499783|463195779|FG000|DB Period: Weeks 0-8|Other|1|||
128698891|NCT02499783|463195780|FG001|DB Period: Weeks 0-8|Other|1|||
128698892|NCT02499783|463195781|FG002|DB Period: Weeks 0-8|Other|0|||
128698893|NCT02499783|463195779|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
128698894|NCT02499783|463195780|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
128698895|NCT02499783|463195781|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
128698896|NCT02499783|463195779|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
128698897|NCT02499783|463195780|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
128698898|NCT02499783|463195781|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
128698899|NCT02499783|463195779|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
128698900|NCT02499783|463195780|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
128698901|NCT02499783|463195781|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
128698902|NCT02499783|463195779|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
128698903|NCT02499783|463195780|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
128698904|NCT02499783|463195781|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
128698905|NCT01866293|463195782|FG000|Overall Study|Adverse Event|2|||
128698906|NCT00555971|463195784|FG000|Overall Study|Adverse Event|1|||
128918952|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918953|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918954|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918955|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918956|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918957|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
128918958|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
128918959|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918960|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918961|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
128918962|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918963|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918964|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918965|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918966|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918967|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918968|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918969|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918970|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918971|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918972|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128698907|NCT00555971|463195785|FG001|Overall Study|Adverse Event|1|||
128918973|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918974|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128698908|NCT00518284|463195786|FG000|Overall Study|Adverse Event|0|||
128698909|NCT00518284|463195787|FG001|Overall Study|Adverse Event|1|||
128698910|NCT00518284|463195788|FG002|Overall Study|Adverse Event|0|||
128698911|NCT00518284|463195789|FG003|Overall Study|Adverse Event|0|||
128766142|NCT00736489|463433992|FG000|Period 1|Withdrawal by Subject|0|||
128766143|NCT00736489|463433993|FG001|Period 1|Withdrawal by Subject|0|||
128766144|NCT00736489|463433994|FG002|Period 1|Withdrawal by Subject|0|||
128766145|NCT00736489|463433995|FG003|Period 1|Withdrawal by Subject|0|||
128766146|NCT00736489|463433996|FG004|Period 1|Withdrawal by Subject|0|||
128766147|NCT00736489|463433997|FG005|Period 1|Withdrawal by Subject|1|||
128766148|NCT00429494|463435203|FG000|Overall Study|Withdrawal by Subject|9|||
128766149|NCT00429494|463435203|FG000|Overall Study|Death|6|||
128766150|NCT00976703|463435204|FG000|Overall Study|Physician Decision|1|||
128766151|NCT00976703|463435205|FG001|Overall Study|Physician Decision|1|||
128766152|NCT00976703|463435204|FG000|Overall Study|ineligible for study|2|||
128766153|NCT00976703|463435205|FG001|Overall Study|ineligible for study|2|||
128766154|NCT03075501|463435208|FG000|Overall Study|Scheduling difficulties|15|||
128766155|NCT03075501|463435209|FG001|Overall Study|Scheduling difficulties|9|||
128766156|NCT01062763|463435210|FG000|Overall Study|Adverse Event|3|||
128766157|NCT01062763|463435211|FG001|Overall Study|Adverse Event|4|||
128766158|NCT02494921|463435212|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
128766159|NCT02494921|463435213|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
128766160|NCT02494921|463435214|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
128766161|NCT02494921|463435215|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
128766162|NCT02494921|463435216|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
128766163|NCT02494921|463435212|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
128766164|NCT02494921|463435213|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
128766165|NCT02494921|463435214|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
128766166|NCT02494921|463435215|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
128766167|NCT02494921|463435216|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
128918975|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918976|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918977|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918978|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918979|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918980|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
128918981|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918982|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918983|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
128918984|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918985|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128698912|NCT00518284|463195786|FG000|Overall Study|Study Termination|0|||
128698913|NCT00518284|463195787|FG001|Overall Study|Study Termination|2|||
128698914|NCT00518284|463195788|FG002|Overall Study|Study Termination|1|||
128698915|NCT00518284|463195789|FG003|Overall Study|Study Termination|2|||
128698916|NCT00801632|463195790|FG000|Overall Study|Re-transplant|1|||
128698917|NCT02106975|463195793|FG000|Overall Study|Death|25|||
128698918|NCT02106975|463195794|FG001|Overall Study|Death|39|||
128698919|NCT02151110|463195795|FG000|Overall Study|Withdrawal by Subject|0|||
128698920|NCT02151110|463195796|FG001|Overall Study|Withdrawal by Subject|0|||
128698921|NCT02151110|463195797|FG002|Overall Study|Withdrawal by Subject|0|||
128698922|NCT02151110|463195798|FG003|Overall Study|Withdrawal by Subject|0|||
128698923|NCT02151110|463195799|FG004|Overall Study|Withdrawal by Subject|0|||
128698924|NCT02151110|463195800|FG005|Overall Study|Withdrawal by Subject|0|||
128698925|NCT02151110|463195801|FG006|Overall Study|Withdrawal by Subject|0|||
128698926|NCT02151110|463195802|FG007|Overall Study|Withdrawal by Subject|1|||
128698927|NCT02151110|463195795|FG000|Overall Study|Lost to Follow-up|0|||
128698928|NCT02151110|463195796|FG001|Overall Study|Lost to Follow-up|0|||
128698929|NCT02151110|463195797|FG002|Overall Study|Lost to Follow-up|0|||
128698930|NCT02151110|463195798|FG003|Overall Study|Lost to Follow-up|0|||
128698931|NCT02151110|463195799|FG004|Overall Study|Lost to Follow-up|0|||
128698932|NCT02151110|463195800|FG005|Overall Study|Lost to Follow-up|0|||
128698933|NCT02151110|463195801|FG006|Overall Study|Lost to Follow-up|0|||
128698934|NCT02151110|463195802|FG007|Overall Study|Lost to Follow-up|2|||
128698935|NCT02369016|463195803|FG000|Overall Study|AE associated with clinical disease progression|2|||
128698936|NCT02369016|463195804|FG001|Overall Study|AE associated with clinical disease progression|1|||
128766168|NCT02494921|463435212|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
128766169|NCT02494921|463435213|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
128766170|NCT02494921|463435214|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
128766171|NCT02494921|463435215|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
128766172|NCT02494921|463435216|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
128698937|NCT02369016|463195803|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
128698938|NCT02369016|463195804|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
128698939|NCT02369016|463195803|FG000|Overall Study|Progressive disease - clinical progression|1|||
128766173|NCT03447730|463435225|FG000|Overall Study|Adverse Event|0|||
128766174|NCT03447730|463435226|FG001|Overall Study|Adverse Event|2|||
128766175|NCT03447730|463435227|FG002|Overall Study|Adverse Event|0|||
128766176|NCT00572624|463435229|FG000|Overall Study|Lost to Follow-up|10|||
128766177|NCT00572624|463435230|FG001|Overall Study|Lost to Follow-up|4|||
128766178|NCT00572624|463435229|FG000|Overall Study|Wanted to do a different diet program|1|||
128766179|NCT00572624|463435230|FG001|Overall Study|Wanted to do a different diet program|0|||
128766180|NCT00572624|463435229|FG000|Overall Study|Medication change|1|||
128766181|NCT00572624|463435230|FG001|Overall Study|Medication change|0|||
128766182|NCT00572624|463435229|FG000|Overall Study|Started a new job-- no time for study|1|||
128766183|NCT00572624|463435230|FG001|Overall Study|Started a new job-- no time for study|0|||
128766184|NCT00572624|463435229|FG000|Overall Study|Admitted to being a smoker|1|||
128766185|NCT00572624|463435230|FG001|Overall Study|Admitted to being a smoker|0|||
128766186|NCT00572624|463435229|FG000|Overall Study|Refused to do the stress test|1|||
128918986|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918987|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918988|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918989|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918990|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918991|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918992|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918993|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918994|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918995|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918996|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918997|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918998|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128918999|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128919000|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128919001|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128919002|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128919003|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
128919004|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919005|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129216113|NCT00790842|465092857|FG008|Expansion Cohort|Withdrawal by Subject|0|||
129216114|NCT00790842|465092858|FG009|Expansion Cohort|Withdrawal by Subject|0|||
129216115|NCT00790842|465092859|FG010|Expansion Cohort|Withdrawal by Subject|0|||
129216116|NCT00790842|465092849|FG000|Expansion Cohort|Study Closure|0|||
129216117|NCT00790842|465092850|FG001|Expansion Cohort|Study Closure|0|||
129216118|NCT00790842|465092851|FG002|Expansion Cohort|Study Closure|1|||
129216119|NCT00790842|465092852|FG003|Expansion Cohort|Study Closure|0|||
129216120|NCT00790842|465092853|FG004|Expansion Cohort|Study Closure|0|||
129216121|NCT00790842|465092854|FG005|Expansion Cohort|Study Closure|0|||
129216122|NCT00790842|465092855|FG006|Expansion Cohort|Study Closure|0|||
129216123|NCT00790842|465092856|FG007|Expansion Cohort|Study Closure|0|||
129216124|NCT00790842|465092857|FG008|Expansion Cohort|Study Closure|0|||
129216125|NCT00790842|465092858|FG009|Expansion Cohort|Study Closure|0|||
129216126|NCT00790842|465092859|FG010|Expansion Cohort|Study Closure|0|||
129216127|NCT00419952|465092860|FG000|Overall Study|Adverse Event|8|||
129216128|NCT00419952|465092861|FG001|Overall Study|Adverse Event|10|||
129216129|NCT00419952|465092860|FG000|Overall Study|Withdrawal by Subject|44|||
128766187|NCT00572624|463435230|FG001|Overall Study|Refused to do the stress test|0|||
128766188|NCT00572624|463435229|FG000|Overall Study|Problem with vascular access|1|||
128766189|NCT00572624|463435230|FG001|Overall Study|Problem with vascular access|0|||
128766190|NCT00572624|463435229|FG000|Overall Study|Health issues unrelated to the study|1|||
128766191|NCT00572624|463435230|FG001|Overall Study|Health issues unrelated to the study|0|||
128766192|NCT05458024|463435233|FG000|Overall Study|Withdrawal by Subject|1|||
128766193|NCT05458024|463435234|FG001|Overall Study|Withdrawal by Subject|1|||
128766194|NCT02667886|463435238|FG000|Dose Escalation (Part A)|Adverse Event|1|||
128766195|NCT02667886|463435239|FG001|Dose Escalation (Part A)|Adverse Event|3|||
128766196|NCT02667886|463435240|FG002|Dose Escalation (Part A)|Adverse Event|1|||
128919006|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
128919007|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919008|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919009|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129216130|NCT00419952|465092861|FG001|Overall Study|Withdrawal by Subject|43|||
129216131|NCT00419952|465092860|FG000|Overall Study|Lost to Follow-up|43|||
129216132|NCT00419952|465092861|FG001|Overall Study|Lost to Follow-up|34|||
129216133|NCT00419952|465092860|FG000|Overall Study|Protocol Violation|32|||
129216134|NCT00419952|465092861|FG001|Overall Study|Protocol Violation|24|||
128766197|NCT02667886|463435241|FG003|Dose Escalation (Part A)|Adverse Event|0|||
129216135|NCT00419952|465092860|FG000|Overall Study|Pregnancy|4|||
129216136|NCT00419952|465092861|FG001|Overall Study|Pregnancy|2|||
128766198|NCT02667886|463435242|FG004|Dose Escalation (Part A)|Adverse Event|0|||
128766199|NCT02667886|463435238|FG000|Dose Escalation (Part A)|Disease Progression|1|||
129216137|NCT00419952|465092860|FG000|Overall Study|Physician Decision|1|||
128919010|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919011|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919012|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919013|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919014|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919015|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919016|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919017|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919018|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919019|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919020|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919021|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919022|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919023|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919024|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919025|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919026|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
128919027|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919028|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919029|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919030|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
128919031|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919032|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919033|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919034|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919035|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919036|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919037|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919038|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919039|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919040|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919041|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919042|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919043|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919044|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919045|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919046|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919047|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919048|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919049|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
128919050|NCT00896532|463992749|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128698940|NCT02369016|463195804|FG001|Overall Study|Progressive disease - clinical progression|4|||
128698941|NCT02369016|463195803|FG000|Overall Study|withdrawal by patient|4|||
128698942|NCT02369016|463195804|FG001|Overall Study|withdrawal by patient|0|||
128698943|NCT02369016|463195803|FG000|Overall Study|Progressive disease - radiological progression|6|||
128698944|NCT02369016|463195804|FG001|Overall Study|Progressive disease - radiological progression|2|||
128698945|NCT02229383|463195805|FG000|Overall Study|Adverse Event|7|||
128698946|NCT02229383|463195806|FG001|Overall Study|Adverse Event|4|||
128698947|NCT02229383|463195805|FG000|Overall Study|Death|0|||
128698948|NCT02229383|463195806|FG001|Overall Study|Death|1|||
128698949|NCT02229383|463195805|FG000|Overall Study|Lost to Follow-up|5|||
128919051|NCT00896532|463992750|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
128919052|NCT00896532|463992751|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919053|NCT00896532|463992752|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
128919054|NCT00896532|463992753|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
128919055|NCT00896532|463992754|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919056|NCT00896532|463992755|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919057|NCT00896532|463992756|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919058|NCT00896532|463992757|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919059|NCT00896532|463992758|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919060|NCT00896532|463992759|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919061|NCT00896532|463992760|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129216138|NCT00419952|465092861|FG001|Overall Study|Physician Decision|3|||
128698950|NCT02229383|463195806|FG001|Overall Study|Lost to Follow-up|3|||
128698951|NCT02229383|463195805|FG000|Overall Study|Withdrawal by Subject|4|||
128766200|NCT02667886|463435239|FG001|Dose Escalation (Part A)|Disease Progression|4|||
128698952|NCT02229383|463195806|FG001|Overall Study|Withdrawal by Subject|6|||
128698953|NCT02229383|463195805|FG000|Overall Study|Did not receive treatment|1|||
128698954|NCT02229383|463195806|FG001|Overall Study|Did not receive treatment|0|||
128698955|NCT02229383|463195805|FG000|Overall Study|Other|3|||
128698956|NCT02229383|463195806|FG001|Overall Study|Other|8|||
128919062|NCT00896532|463992761|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919063|NCT00896532|463992762|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919064|NCT00896532|463992763|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919065|NCT00896532|463992764|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919066|NCT00896532|463992765|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919067|NCT00896532|463992766|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919068|NCT00896532|463992767|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919069|NCT00896532|463992768|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919070|NCT00896532|463992769|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919071|NCT00896532|463992770|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128919072|NCT00896532|463992771|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
128698957|NCT01201850|463195809|FG000|Overall Study|Tumor progression|4|||
128698958|NCT00191139|463195810|FG000|Overall Study|Adverse Event|2|||
128698959|NCT00191139|463195811|FG001|Overall Study|Adverse Event|6|||
128698960|NCT00191139|463195810|FG000|Overall Study|Death|2|||
128919073|NCT00896532|463992749|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919074|NCT00896532|463992750|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919075|NCT00896532|463992751|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919076|NCT00896532|463992752|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919077|NCT00896532|463992753|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919078|NCT00896532|463992754|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919079|NCT00896532|463992755|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128698961|NCT00191139|463195811|FG001|Overall Study|Death|0|||
128919080|NCT00896532|463992756|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919081|NCT00896532|463992757|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
128919082|NCT00896532|463992758|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919083|NCT00896532|463992759|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919084|NCT00896532|463992760|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919085|NCT00896532|463992761|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919086|NCT00896532|463992762|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919087|NCT00896532|463992763|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919088|NCT00896532|463992764|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919089|NCT00896532|463992765|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919090|NCT00896532|463992766|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919091|NCT00896532|463992767|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919092|NCT00896532|463992768|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919093|NCT00896532|463992769|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919094|NCT00896532|463992770|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919095|NCT00896532|463992771|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
128919096|NCT00896532|463992749|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919097|NCT00896532|463992750|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919098|NCT00896532|463992751|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919099|NCT00896532|463992752|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919100|NCT00896532|463992753|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919101|NCT00896532|463992754|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919102|NCT00896532|463992755|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128698962|NCT00191139|463195810|FG000|Overall Study|Withdrawal by Subject|0|||
128698963|NCT00191139|463195811|FG001|Overall Study|Withdrawal by Subject|3|||
128698964|NCT00191139|463195810|FG000|Overall Study|Disease Progression|0|||
128698965|NCT00191139|463195811|FG001|Overall Study|Disease Progression|1|||
128698966|NCT00191139|463195810|FG000|Overall Study|Other|1|||
128698967|NCT00191139|463195811|FG001|Overall Study|Other|2|||
128766201|NCT02667886|463435240|FG002|Dose Escalation (Part A)|Disease Progression|3|||
128766202|NCT02667886|463435241|FG003|Dose Escalation (Part A)|Disease Progression|0|||
128919103|NCT00896532|463992756|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129029114|NCT00301964|464398332|FG000|Overall Study|Inadequate pathology|1|||
129029115|NCT01143337|464398333|FG000|Overall Study|Adverse Event|3|||
129029116|NCT01143337|464398334|FG001|Overall Study|Adverse Event|9|||
128698968|NCT00816595|463195812|FG000|Overall Study|Withdrawal by Subject|2|||
128698969|NCT00816595|463195813|FG001|Overall Study|Withdrawal by Subject|0|||
128698970|NCT03846804|463195816|FG000|Overall Study|Refused blood draw|1|||
128698971|NCT03846804|463195816|FG000|Overall Study|Protocol Violation|1|||
128698972|NCT00404235|463195817|FG000|Overall Study|Withdrawal by Subject|1|||
128919104|NCT00896532|463992757|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919105|NCT00896532|463992758|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919106|NCT00896532|463992759|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919107|NCT00896532|463992760|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919108|NCT00896532|463992761|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
128919109|NCT00896532|463992762|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919110|NCT00896532|463992763|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919111|NCT00896532|463992764|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919112|NCT00896532|463992765|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919113|NCT00896532|463992766|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919114|NCT00896532|463992767|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919115|NCT00896532|463992768|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919116|NCT00896532|463992769|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919117|NCT00896532|463992770|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919118|NCT00896532|463992771|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
128919119|NCT00896532|463992749|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919120|NCT00896532|463992750|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919121|NCT00896532|463992751|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919122|NCT00896532|463992752|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919123|NCT00896532|463992753|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919124|NCT00896532|463992754|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919125|NCT00896532|463992755|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919126|NCT00896532|463992756|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919127|NCT00896532|463992757|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919128|NCT00896532|463992758|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919129|NCT00896532|463992759|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
128919130|NCT00896532|463992760|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919131|NCT00896532|463992761|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
128698973|NCT00404235|463195818|FG001|Overall Study|Withdrawal by Subject|2|||
128698974|NCT00345839|463195820|FG000|Overall Study|Withdrawal by Subject|91|||
128919132|NCT00896532|463992762|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919133|NCT00896532|463992763|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919134|NCT00896532|463992764|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919135|NCT00896532|463992765|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919136|NCT00896532|463992766|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919137|NCT00896532|463992767|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919138|NCT00896532|463992768|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919139|NCT00896532|463992769|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919140|NCT00896532|463992770|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919141|NCT00896532|463992771|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
128919142|NCT00896532|463992749|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919143|NCT00896532|463992750|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919144|NCT00896532|463992751|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919145|NCT00896532|463992752|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919146|NCT00896532|463992753|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919147|NCT00896532|463992754|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919148|NCT00896532|463992755|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919149|NCT00896532|463992756|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919150|NCT00896532|463992757|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919151|NCT00896532|463992758|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919152|NCT00896532|463992759|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919153|NCT00896532|463992760|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919154|NCT00896532|463992761|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
128919155|NCT00896532|463992762|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
128919156|NCT00896532|463992763|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919157|NCT00896532|463992764|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919158|NCT00896532|463992765|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919159|NCT00896532|463992766|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919160|NCT00896532|463992767|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919161|NCT00896532|463992768|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919162|NCT00896532|463992769|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919163|NCT00896532|463992770|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128919164|NCT00896532|463992771|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
128698975|NCT00345839|463195821|FG001|Overall Study|Withdrawal by Subject|98|||
128919165|NCT00896532|463992749|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
128919166|NCT00896532|463992750|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
128919167|NCT00896532|463992751|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
128919168|NCT00896532|463992752|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
128919169|NCT00896532|463992753|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
128919170|NCT00896532|463992754|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
128919171|NCT00896532|463992755|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
128919172|NCT00896532|463992756|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
128919173|NCT00896532|463992757|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
128919174|NCT00896532|463992758|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
128919175|NCT00896532|463992759|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
128919176|NCT00896532|463992760|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
128919177|NCT00896532|463992761|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
128919178|NCT00896532|463992762|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
128919179|NCT00896532|463992763|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
128919180|NCT00896532|463992764|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
128919181|NCT00896532|463992765|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
128919182|NCT00896532|463992766|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
128919183|NCT00896532|463992767|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
128919184|NCT00896532|463992768|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
128919185|NCT00896532|463992769|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
128919186|NCT00896532|463992770|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
128919187|NCT00896532|463992771|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
128919188|NCT00896532|463992749|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919189|NCT00896532|463992750|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919190|NCT00896532|463992751|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919191|NCT00896532|463992752|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919192|NCT00896532|463992753|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919193|NCT00896532|463992754|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919194|NCT00896532|463992755|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919195|NCT00896532|463992756|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919196|NCT00896532|463992757|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919197|NCT00896532|463992758|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919198|NCT00896532|463992759|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919199|NCT00896532|463992760|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919200|NCT00896532|463992761|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919201|NCT00896532|463992762|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919202|NCT00896532|463992763|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919203|NCT00896532|463992764|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
128919204|NCT00896532|463992765|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
128919205|NCT00896532|463992766|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919206|NCT00896532|463992767|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919207|NCT00896532|463992768|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129029117|NCT01143337|464398335|FG002|Overall Study|Adverse Event|5|||
128698976|NCT00345839|463195820|FG000|Overall Study|Lost to Follow-up|58|||
128698977|NCT00345839|463195821|FG001|Overall Study|Lost to Follow-up|61|||
128698978|NCT00743483|463195831|FG000|Baseline Period|Physician Decision|1|||
128698979|NCT00743483|463195831|FG000|Treatment Period|Adverse Event|1|||
128698980|NCT00873912|463195833|FG000|Overall Study|Withdrawal by Subject|1|||
128698981|NCT00873912|463195834|FG001|Overall Study|Withdrawal by Subject|0|||
128698982|NCT00873912|463195833|FG000|Overall Study|Lost to Follow-up|2|||
128698983|NCT00873912|463195834|FG001|Overall Study|Lost to Follow-up|0|||
128698984|NCT01466153|463195835|FG000|Overall Study|Disease Progression|2|||
128698985|NCT01466153|463195836|FG001|Overall Study|Disease Progression|2|||
128698986|NCT01466153|463195837|FG002|Overall Study|Disease Progression|0|||
128919208|NCT00896532|463992769|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919209|NCT00896532|463992770|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919210|NCT00896532|463992771|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
128919211|NCT00896532|463992749|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919212|NCT00896532|463992750|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919213|NCT00896532|463992751|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919214|NCT00896532|463992752|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919215|NCT00896532|463992753|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919216|NCT00896532|463992754|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919217|NCT00896532|463992755|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129029118|NCT01143337|464398333|FG000|Overall Study|Lack of Efficacy|6|||
129029119|NCT01143337|464398334|FG001|Overall Study|Lack of Efficacy|2|||
128698987|NCT01466153|463195835|FG000|Overall Study|Adverse Event|14|||
128919218|NCT00896532|463992756|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129216139|NCT00419952|465092860|FG000|Overall Study|Incorrectly enrolled|10|||
129216140|NCT00419952|465092861|FG001|Overall Study|Incorrectly enrolled|3|||
129216141|NCT00419952|465092860|FG000|Overall Study|Intake of prohibited medication|2|||
129216142|NCT00419952|465092861|FG001|Overall Study|Intake of prohibited medication|2|||
128919219|NCT00896532|463992757|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919220|NCT00896532|463992758|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919221|NCT00896532|463992759|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129216143|NCT00419952|465092860|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
129216144|NCT00419952|465092861|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
129216145|NCT00419952|465092860|FG000|Overall Study|Diary or medication non-compliance|2|||
129216146|NCT00419952|465092861|FG001|Overall Study|Diary or medication non-compliance|4|||
129216147|NCT00419952|465092860|FG000|Overall Study|Abnormal ECG|1|||
129216148|NCT00419952|465092861|FG001|Overall Study|Abnormal ECG|0|||
129216149|NCT03126591|465092862|FG000|Overall Study|Death|6|||
129216150|NCT03126591|465092863|FG001|Overall Study|Death|3|||
129216151|NCT03126591|465092864|FG002|Overall Study|Death|17|||
129216152|NCT03126591|465092862|FG000|Overall Study|Progressive Disease|0|||
129216153|NCT03126591|465092863|FG001|Overall Study|Progressive Disease|1|||
129216154|NCT03126591|465092864|FG002|Overall Study|Progressive Disease|2|||
129216155|NCT03126591|465092862|FG000|Overall Study|Terminated by Sponsor|0|||
129216156|NCT03126591|465092863|FG001|Overall Study|Terminated by Sponsor|1|||
129216157|NCT03126591|465092864|FG002|Overall Study|Terminated by Sponsor|4|||
129216158|NCT03126591|465092862|FG000|Overall Study|Withdrawal by Subject|1|||
129216159|NCT03126591|465092863|FG001|Overall Study|Withdrawal by Subject|1|||
128698988|NCT01466153|463195836|FG001|Overall Study|Adverse Event|13|||
128698989|NCT01466153|463195837|FG002|Overall Study|Adverse Event|17|||
128698990|NCT01466153|463195835|FG000|Overall Study|Withdrawal of Consent|2|||
128698991|NCT01466153|463195836|FG001|Overall Study|Withdrawal of Consent|0|||
128698992|NCT01466153|463195837|FG002|Overall Study|Withdrawal of Consent|0|||
128698993|NCT01466153|463195835|FG000|Overall Study|Investigator Discretion|3|||
128698994|NCT01466153|463195836|FG001|Overall Study|Investigator Discretion|2|||
128698995|NCT01466153|463195837|FG002|Overall Study|Investigator Discretion|2|||
128698996|NCT01466153|463195835|FG000|Overall Study|Randomized-Not Treated|2|||
128698997|NCT01466153|463195836|FG001|Overall Study|Randomized-Not Treated|3|||
128698998|NCT01466153|463195837|FG002|Overall Study|Randomized-Not Treated|4|||
128698999|NCT01466153|463195835|FG000|Overall Study|Other-Unspecified|6|||
128699000|NCT01466153|463195836|FG001|Overall Study|Other-Unspecified|4|||
128699001|NCT01466153|463195837|FG002|Overall Study|Other-Unspecified|2|||
128699002|NCT01088997|463195842|FG000|Overall Study|Physician Decision|1|||
128699003|NCT01088997|463195843|FG001|Overall Study|Physician Decision|1|||
128699004|NCT01088997|463195842|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
128699005|NCT01088997|463195843|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
128699006|NCT01088997|463195842|FG000|Overall Study|Excluded prior to receiving drug|1|||
128699007|NCT01088997|463195843|FG001|Overall Study|Excluded prior to receiving drug|1|||
128699008|NCT05695209|463195847|FG000|3-months|Withdrawal by Subject|2|||
128699009|NCT05695209|463195848|FG001|3-months|Withdrawal by Subject|0|||
128699010|NCT05695209|463195847|FG000|3-months|Unable to contact for 3-month data collection|0|||
128699011|NCT05695209|463195848|FG001|3-months|Unable to contact for 3-month data collection|1|||
128699012|NCT05695209|463195847|FG000|6-months|Lost to Follow-up|1|||
128699013|NCT05695209|463195848|FG001|6-months|Lost to Follow-up|1|||
128699014|NCT03749447|463197871|FG000|Overall Study|Adverse Event|11|||
128699015|NCT03749447|463197872|FG001|Overall Study|Adverse Event|3|||
128699016|NCT03749447|463197871|FG000|Overall Study|Death|1|||
128699017|NCT03749447|463197872|FG001|Overall Study|Death|1|||
128699018|NCT03749447|463197871|FG000|Overall Study|Lost to Follow-up|2|||
128699019|NCT03749447|463197872|FG001|Overall Study|Lost to Follow-up|2|||
128699020|NCT03749447|463197871|FG000|Overall Study|Reason Not Specified|0|||
128699021|NCT03749447|463197872|FG001|Overall Study|Reason Not Specified|3|||
128699022|NCT03749447|463197871|FG000|Overall Study|Physician Decision|4|||
128766203|NCT02667886|463435242|FG004|Dose Escalation (Part A)|Disease Progression|0|||
128919222|NCT00896532|463992760|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919223|NCT00896532|463992761|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129216160|NCT03126591|465092864|FG002|Overall Study|Withdrawal by Subject|4|||
129216161|NCT02158546|465092865|FG000|Overall Study|Physician Decision|0|||
128699023|NCT03749447|463197872|FG001|Overall Study|Physician Decision|3|||
128699024|NCT03749447|463197871|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
128699025|NCT03749447|463197872|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
128699026|NCT03749447|463197871|FG000|Overall Study|Study Terminated By Sponsor|112|||
128699027|NCT03749447|463197872|FG001|Overall Study|Study Terminated By Sponsor|105|||
128699028|NCT03749447|463197871|FG000|Overall Study|Withdrawal by Subject|12|||
128699029|NCT03749447|463197872|FG001|Overall Study|Withdrawal by Subject|6|||
129216162|NCT02158546|465092866|FG001|Overall Study|Physician Decision|1|||
129216163|NCT02158546|465092867|FG002|Overall Study|Physician Decision|0|||
129216164|NCT02158546|465092868|FG003|Overall Study|Physician Decision|0|||
129216165|NCT02158546|465092865|FG000|Overall Study|Non-compliance|0|||
128766204|NCT02667886|463435238|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
128766205|NCT02667886|463435239|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
128766206|NCT02667886|463435240|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
128766207|NCT02667886|463435241|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
128766208|NCT02667886|463435242|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
128766209|NCT02667886|463435238|FG000|Dose Expansion (Part B)|Adverse Event|0|||
128766210|NCT02667886|463435239|FG001|Dose Expansion (Part B)|Adverse Event|0|||
128766211|NCT02667886|463435240|FG002|Dose Expansion (Part B)|Adverse Event|0|||
128766212|NCT02667886|463435241|FG003|Dose Expansion (Part B)|Adverse Event|9|||
128766213|NCT02667886|463435242|FG004|Dose Expansion (Part B)|Adverse Event|0|||
128766214|NCT02667886|463435238|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
128766215|NCT02667886|463435239|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
128766216|NCT02667886|463435240|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
128766217|NCT02667886|463435241|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
128766218|NCT02667886|463435242|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
128766219|NCT02667886|463435238|FG000|Dose Expansion (Part B)|Disease Progression|0|||
128766220|NCT02667886|463435239|FG001|Dose Expansion (Part B)|Disease Progression|0|||
128766221|NCT02667886|463435240|FG002|Dose Expansion (Part B)|Disease Progression|0|||
128766222|NCT02667886|463435241|FG003|Dose Expansion (Part B)|Disease Progression|38|||
128766223|NCT02667886|463435242|FG004|Dose Expansion (Part B)|Disease Progression|0|||
128766224|NCT02667886|463435238|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
128766225|NCT02667886|463435239|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
128766226|NCT02667886|463435240|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
128766227|NCT02667886|463435241|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
128766228|NCT02667886|463435242|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
128766229|NCT02667886|463435238|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
128766230|NCT02667886|463435239|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
128766231|NCT02667886|463435240|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
128766232|NCT02667886|463435241|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
128766233|NCT02667886|463435242|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
128766234|NCT02667886|463435238|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
128766235|NCT02667886|463435239|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
128766236|NCT02667886|463435240|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
128766237|NCT02667886|463435241|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
128766238|NCT02667886|463435242|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
128766239|NCT00747123|463435243|FG000|Overall Study|Investigator's request|0|||
128766240|NCT00747123|463435244|FG001|Overall Study|Investigator's request|0|||
128766241|NCT00747123|463435245|FG002|Overall Study|Investigator's request|1|||
128766242|NCT00747123|463435246|FG003|Overall Study|Investigator's request|0|||
128766243|NCT00747123|463435243|FG000|Overall Study|Withdrew consent|0|||
128766244|NCT00747123|463435244|FG001|Overall Study|Withdrew consent|1|||
128766245|NCT00747123|463435245|FG002|Overall Study|Withdrew consent|0|||
128766246|NCT00747123|463435246|FG003|Overall Study|Withdrew consent|0|||
128766247|NCT00747123|463435243|FG000|Overall Study|Adverse Event|0|||
128766248|NCT00747123|463435244|FG001|Overall Study|Adverse Event|1|||
128766249|NCT00747123|463435245|FG002|Overall Study|Adverse Event|0|||
128766250|NCT00747123|463435246|FG003|Overall Study|Adverse Event|1|||
128766251|NCT01395823|463435258|FG000|Overall Study|Death|4|||
128766252|NCT01395823|463435259|FG001|Overall Study|Death|4|||
128766253|NCT01395823|463435258|FG000|Overall Study|Physician Decision|3|||
128766254|NCT01395823|463435259|FG001|Overall Study|Physician Decision|1|||
128919224|NCT00896532|463992762|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919225|NCT00896532|463992763|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919226|NCT00896532|463992764|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
128919227|NCT00896532|463992765|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
128919228|NCT00896532|463992766|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
128919229|NCT00896532|463992767|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919230|NCT00896532|463992768|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129216166|NCT02158546|465092866|FG001|Overall Study|Non-compliance|1|||
129216167|NCT02158546|465092867|FG002|Overall Study|Non-compliance|0|||
129216168|NCT02158546|465092868|FG003|Overall Study|Non-compliance|1|||
129216169|NCT02158546|465092865|FG000|Overall Study|Failure to meet eligibility criteria|0|||
128766255|NCT01395823|463435258|FG000|Overall Study|Lost to Follow-up|1|||
128766256|NCT01395823|463435259|FG001|Overall Study|Lost to Follow-up|0|||
128766257|NCT01395823|463435258|FG000|Overall Study|Transplant|1|||
128766258|NCT01395823|463435259|FG001|Overall Study|Transplant|0|||
128766259|NCT01395823|463435258|FG000|Overall Study|GI symptoms|1|||
128766260|NCT01395823|463435259|FG001|Overall Study|GI symptoms|0|||
128766261|NCT01395823|463435258|FG000|Overall Study|Withdrawal by Subject|5|||
128766262|NCT01395823|463435259|FG001|Overall Study|Withdrawal by Subject|4|||
128766263|NCT05076149|463435263|FG000|Overall Study|Adverse Event|3|||
128766264|NCT05076149|463435264|FG001|Overall Study|Adverse Event|9|||
128919231|NCT00896532|463992769|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919232|NCT00896532|463992770|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919233|NCT00896532|463992771|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
128919234|NCT00896532|463992749|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919235|NCT00896532|463992750|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919236|NCT00896532|463992751|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919237|NCT00896532|463992752|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919238|NCT00896532|463992753|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919239|NCT00896532|463992754|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129216170|NCT02158546|465092866|FG001|Overall Study|Failure to meet eligibility criteria|1|||
129216171|NCT02158546|465092867|FG002|Overall Study|Failure to meet eligibility criteria|0|||
129216172|NCT02158546|465092868|FG003|Overall Study|Failure to meet eligibility criteria|0|||
129216173|NCT02158546|465092865|FG000|Overall Study|Lack of Efficacy|1|||
128919240|NCT00896532|463992755|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919241|NCT00896532|463992756|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919242|NCT00896532|463992757|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919243|NCT00896532|463992758|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919244|NCT00896532|463992759|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919245|NCT00896532|463992760|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919246|NCT00896532|463992761|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919247|NCT00896532|463992762|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129216174|NCT02158546|465092866|FG001|Overall Study|Lack of Efficacy|1|||
129216175|NCT02158546|465092867|FG002|Overall Study|Lack of Efficacy|0|||
129216176|NCT02158546|465092868|FG003|Overall Study|Lack of Efficacy|0|||
129216177|NCT02158546|465092865|FG000|Overall Study|Adverse Event|2|||
128919248|NCT00896532|463992763|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919249|NCT00896532|463992764|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919250|NCT00896532|463992765|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
128919251|NCT00896532|463992766|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919252|NCT00896532|463992767|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919253|NCT00896532|463992768|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919254|NCT00896532|463992769|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919255|NCT00896532|463992770|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919256|NCT00896532|463992771|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
128919257|NCT00896532|463992749|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
128919258|NCT00896532|463992750|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
128919259|NCT00896532|463992751|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
128919260|NCT00896532|463992752|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
128919261|NCT00896532|463992753|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
128919262|NCT00896532|463992754|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
128699030|NCT03749447|463197871|FG000|Overall Study|Non-compliance With Study Drug|0|||
128699031|NCT03749447|463197872|FG001|Overall Study|Non-compliance With Study Drug|1|||
128699032|NCT01218113|463197873|FG000|Overall Study|Withdrawal by Subject|1|||
128699033|NCT01218113|463197874|FG001|Overall Study|Withdrawal by Subject|0|||
128699034|NCT01218113|463197875|FG002|Overall Study|Withdrawal by Subject|1|||
128919263|NCT00896532|463992755|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
128919264|NCT00896532|463992756|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
128919265|NCT00896532|463992757|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
128919266|NCT00896532|463992758|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
128919267|NCT00896532|463992759|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
128919268|NCT00896532|463992760|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
128919269|NCT00896532|463992761|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
128919270|NCT00896532|463992762|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
128919271|NCT00896532|463992763|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
128919272|NCT00896532|463992764|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
128699035|NCT01218113|463197873|FG000|Overall Study|Lost to Follow-up|4|||
128699036|NCT01218113|463197874|FG001|Overall Study|Lost to Follow-up|1|||
128699037|NCT01218113|463197875|FG002|Overall Study|Lost to Follow-up|4|||
128699038|NCT01218113|463197873|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
128699039|NCT01218113|463197874|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
128699040|NCT01218113|463197875|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
128919273|NCT00896532|463992765|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
128919274|NCT00896532|463992766|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
128699041|NCT00967668|463197876|FG000|Overall Study|Withdrawal by Subject|13|||
128919275|NCT00896532|463992767|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
129216178|NCT02158546|465092866|FG001|Overall Study|Adverse Event|2|||
129216179|NCT02158546|465092867|FG002|Overall Study|Adverse Event|0|||
128699042|NCT00967668|463197877|FG001|Overall Study|Withdrawal by Subject|8|||
128699043|NCT00967668|463197878|FG002|Overall Study|Withdrawal by Subject|8|||
128919276|NCT00896532|463992768|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
128919277|NCT00896532|463992769|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
128919278|NCT00896532|463992770|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
128919279|NCT00896532|463992771|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
128699044|NCT00967668|463197876|FG000|Overall Study|Death|0|||
128699045|NCT00967668|463197877|FG001|Overall Study|Death|2|||
128699046|NCT00967668|463197878|FG002|Overall Study|Death|4|||
128699047|NCT00967668|463197876|FG000|Overall Study|Removed due to behavior|1|||
128699048|NCT00967668|463197877|FG001|Overall Study|Removed due to behavior|1|||
128699049|NCT00967668|463197878|FG002|Overall Study|Removed due to behavior|2|||
128699050|NCT00967668|463197876|FG000|Overall Study|Refused Year 2|11|||
128699051|NCT00967668|463197877|FG001|Overall Study|Refused Year 2|6|||
128699052|NCT00967668|463197878|FG002|Overall Study|Refused Year 2|4|||
128699053|NCT00967668|463197876|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
128699054|NCT00967668|463197877|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
128699055|NCT00967668|463197878|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
128699056|NCT00967668|463197876|FG000|Overall Study|Lost to Follow-up|15|||
128699057|NCT00967668|463197877|FG001|Overall Study|Lost to Follow-up|9|||
128699058|NCT00967668|463197878|FG002|Overall Study|Lost to Follow-up|16|||
128699059|NCT00967668|463197876|FG000|Overall Study|Refused 12-mo assessment|3|||
128699060|NCT00967668|463197877|FG001|Overall Study|Refused 12-mo assessment|1|||
128699061|NCT00967668|463197878|FG002|Overall Study|Refused 12-mo assessment|9|||
128699062|NCT00967668|463197876|FG000|Overall Study|Pregnancy|1|||
128699063|NCT00967668|463197877|FG001|Overall Study|Pregnancy|0|||
128699064|NCT00967668|463197878|FG002|Overall Study|Pregnancy|0|||
128699065|NCT00115739|463197879|FG000|Overall Study|Lost to Follow-up|3|||
128699066|NCT01751178|463197880|FG000|Overall Study|Adverse Event|2|||
128699067|NCT01751178|463197881|FG001|Overall Study|Adverse Event|0|||
128699068|NCT01751178|463197882|FG002|Overall Study|Adverse Event|0|||
128699069|NCT01751178|463197880|FG000|Overall Study|Other Reason (unknown)|1|||
128699070|NCT01751178|463197881|FG001|Overall Study|Other Reason (unknown)|0|||
128699071|NCT01751178|463197882|FG002|Overall Study|Other Reason (unknown)|2|||
128699072|NCT01010061|463197888|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
128699073|NCT01010061|463197889|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
128699074|NCT01010061|463197888|FG000|Overall Study|Disease Progression|2|||
128699075|NCT01010061|463197889|FG001|Overall Study|Disease Progression|8|||
128699076|NCT01010061|463197888|FG000|Overall Study|Withdrew Consent|5|||
128699077|NCT01010061|463197889|FG001|Overall Study|Withdrew Consent|1|||
128699078|NCT01010061|463197888|FG000|Overall Study|Death|3|||
128699079|NCT01010061|463197889|FG001|Overall Study|Death|6|||
128699080|NCT01010061|463197888|FG000|Overall Study|Administrative/Other|0|||
128699081|NCT01010061|463197889|FG001|Overall Study|Administrative/Other|1|||
128699082|NCT01010061|463197888|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
128699083|NCT01010061|463197889|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
128699084|NCT01010061|463197888|FG000|Overall Study|Insufficient Therapeutic Response|1|||
128699085|NCT01010061|463197889|FG001|Overall Study|Insufficient Therapeutic Response|5|||
128699086|NCT01010061|463197888|FG000|Overall Study|Violation of Selection Criteria|0|||
128699087|NCT01010061|463197889|FG001|Overall Study|Violation of Selection Criteria|1|||
128699088|NCT01010061|463197888|FG000|Overall Study|Did Not Receive Treatment|2|||
128699089|NCT01010061|463197889|FG001|Overall Study|Did Not Receive Treatment|2|||
128699090|NCT02571777|463197890|FG000|Overall Study|Subject/guardian decision|34|||
128699091|NCT02571777|463197891|FG001|Overall Study|Subject/guardian decision|26|||
128699092|NCT02571777|463197892|FG002|Overall Study|Subject/guardian decision|26|||
128699093|NCT02571777|463197893|FG003|Overall Study|Subject/guardian decision|25|||
128699094|NCT02571777|463197894|FG004|Overall Study|Subject/guardian decision|27|||
128699095|NCT02571777|463197890|FG000|Overall Study|Protocol Deviation|2|||
128699096|NCT02571777|463197891|FG001|Overall Study|Protocol Deviation|3|||
128699097|NCT02571777|463197892|FG002|Overall Study|Protocol Deviation|4|||
128699098|NCT02571777|463197893|FG003|Overall Study|Protocol Deviation|8|||
128699099|NCT02571777|463197894|FG004|Overall Study|Protocol Deviation|4|||
128699100|NCT02571777|463197890|FG000|Overall Study|Death|1|||
128919280|NCT00896532|463992749|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919281|NCT00896532|463992750|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128699101|NCT02571777|463197891|FG001|Overall Study|Death|1|||
128699102|NCT02571777|463197892|FG002|Overall Study|Death|4|||
128699103|NCT02571777|463197893|FG003|Overall Study|Death|0|||
128699104|NCT02571777|463197894|FG004|Overall Study|Death|0|||
128699105|NCT02571777|463197890|FG000|Overall Study|Lost to Follow-up|1|||
128699106|NCT02571777|463197891|FG001|Overall Study|Lost to Follow-up|1|||
128699107|NCT02571777|463197892|FG002|Overall Study|Lost to Follow-up|2|||
128699108|NCT02571777|463197893|FG003|Overall Study|Lost to Follow-up|0|||
128699109|NCT02571777|463197894|FG004|Overall Study|Lost to Follow-up|1|||
128699110|NCT02571777|463197890|FG000|Overall Study|Physician Decision|1|||
128699111|NCT02571777|463197891|FG001|Overall Study|Physician Decision|7|||
128699112|NCT02571777|463197892|FG002|Overall Study|Physician Decision|5|||
128699113|NCT02571777|463197893|FG003|Overall Study|Physician Decision|2|||
128699114|NCT02571777|463197894|FG004|Overall Study|Physician Decision|4|||
128699115|NCT02571777|463197890|FG000|Overall Study|Pregnancy|0|||
128766265|NCT05076149|463435263|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
128766266|NCT05076149|463435264|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
128766267|NCT05076149|463435263|FG000|Overall Study|Lost to Follow-up|0|||
128766268|NCT05076149|463435264|FG001|Overall Study|Lost to Follow-up|1|||
128766269|NCT05076149|463435263|FG000|Overall Study|Commercial drug is available for participant|0|||
128766270|NCT05076149|463435264|FG001|Overall Study|Commercial drug is available for participant|1|||
128766271|NCT05076149|463435263|FG000|Overall Study|Other non compliance|1|||
128766272|NCT05076149|463435264|FG001|Overall Study|Other non compliance|1|||
128766273|NCT05076149|463435263|FG000|Overall Study|Physician Decision|0|||
128766274|NCT05076149|463435264|FG001|Overall Study|Physician Decision|1|||
128766275|NCT05076149|463435263|FG000|Overall Study|Other|5|||
128766276|NCT05076149|463435264|FG001|Overall Study|Other|4|||
128766277|NCT05096208|463435265|FG000|Overall Study|Lost to Follow-up|3|||
128766278|NCT05096208|463435266|FG001|Overall Study|Lost to Follow-up|5|||
128766279|NCT05096208|463435267|FG002|Overall Study|Lost to Follow-up|5|||
128919282|NCT00896532|463992751|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919283|NCT00896532|463992752|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919284|NCT00896532|463992753|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919285|NCT00896532|463992754|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919286|NCT00896532|463992755|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919287|NCT00896532|463992756|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919288|NCT00896532|463992757|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919289|NCT00896532|463992758|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919290|NCT00896532|463992759|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919291|NCT00896532|463992760|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919292|NCT00896532|463992761|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919293|NCT00896532|463992762|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919294|NCT00896532|463992763|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919295|NCT00896532|463992764|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919296|NCT00896532|463992765|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
128919297|NCT00896532|463992766|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919298|NCT00896532|463992767|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919299|NCT00896532|463992768|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128766280|NCT05096208|463435268|FG003|Overall Study|Lost to Follow-up|2|||
128766281|NCT05096208|463435265|FG000|Overall Study|Withdrawal by Subject|0|||
128766282|NCT05096208|463435266|FG001|Overall Study|Withdrawal by Subject|1|||
128766283|NCT05096208|463435267|FG002|Overall Study|Withdrawal by Subject|2|||
128766284|NCT05096208|463435268|FG003|Overall Study|Withdrawal by Subject|3|||
128766285|NCT05096208|463435265|FG000|Overall Study|No longer met eligibility criteria|1|||
128766286|NCT05096208|463435266|FG001|Overall Study|No longer met eligibility criteria|0|||
128766287|NCT05096208|463435267|FG002|Overall Study|No longer met eligibility criteria|0|||
128766288|NCT05096208|463435268|FG003|Overall Study|No longer met eligibility criteria|0|||
129029120|NCT01143337|464398335|FG002|Overall Study|Lack of Efficacy|1|||
129029121|NCT01143337|464398333|FG000|Overall Study|Protocol Violation|1|||
128766289|NCT05096208|463435265|FG000|Overall Study|Other|0|||
128766290|NCT05096208|463435266|FG001|Overall Study|Other|0|||
129029122|NCT01143337|464398334|FG001|Overall Study|Protocol Violation|0|||
129029123|NCT01143337|464398335|FG002|Overall Study|Protocol Violation|0|||
129029124|NCT01143337|464398333|FG000|Overall Study|Withdrawal by Subject|0|||
129029125|NCT01143337|464398334|FG001|Overall Study|Withdrawal by Subject|0|||
129029126|NCT01143337|464398335|FG002|Overall Study|Withdrawal by Subject|1|||
129029127|NCT01143337|464398333|FG000|Overall Study|Other reason|0|||
129029128|NCT01143337|464398334|FG001|Overall Study|Other reason|0|||
129029129|NCT01143337|464398335|FG002|Overall Study|Other reason|5|||
129029130|NCT02761915|464398336|FG000|Overall Study|Death|3|||
129029131|NCT02761915|464398337|FG001|Overall Study|Death|1|||
129029132|NCT02761915|464398338|FG002|Overall Study|Death|1|||
129029133|NCT02761915|464398339|FG003|Overall Study|Death|1|||
129029134|NCT02761915|464398340|FG004|Overall Study|Death|0|||
129029135|NCT02761915|464398341|FG005|Overall Study|Death|1|||
129029136|NCT02761915|464398336|FG000|Overall Study|Withdrawal by Subject|1|||
129029137|NCT02761915|464398337|FG001|Overall Study|Withdrawal by Subject|0|||
129029138|NCT02761915|464398338|FG002|Overall Study|Withdrawal by Subject|0|||
129029139|NCT02761915|464398339|FG003|Overall Study|Withdrawal by Subject|0|||
129029140|NCT02761915|464398340|FG004|Overall Study|Withdrawal by Subject|1|||
129029141|NCT02761915|464398341|FG005|Overall Study|Withdrawal by Subject|2|||
129029142|NCT02761915|464398336|FG000|Overall Study|Disease Progression|0|||
128766291|NCT05096208|463435267|FG002|Overall Study|Other|1|||
128766292|NCT05096208|463435268|FG003|Overall Study|Other|0|||
128766293|NCT02087501|463435269|FG000|Overall Study|Death|7|||
129029143|NCT02761915|464398337|FG001|Overall Study|Disease Progression|0|||
129029144|NCT02761915|464398338|FG002|Overall Study|Disease Progression|0|||
128919300|NCT00896532|463992769|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919301|NCT00896532|463992770|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919302|NCT00896532|463992771|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
128919303|NCT00896532|463992749|FG000|Months 48-72: Follow-on Phase|Death|0|||
128919304|NCT00896532|463992750|FG001|Months 48-72: Follow-on Phase|Death|0|||
128919305|NCT00896532|463992751|FG002|Months 48-72: Follow-on Phase|Death|0|||
128919306|NCT00896532|463992752|FG003|Months 48-72: Follow-on Phase|Death|0|||
128919307|NCT00896532|463992753|FG004|Months 48-72: Follow-on Phase|Death|0|||
128919308|NCT00896532|463992754|FG005|Months 48-72: Follow-on Phase|Death|0|||
128919309|NCT00896532|463992755|FG006|Months 48-72: Follow-on Phase|Death|0|||
128919310|NCT00896532|463992756|FG007|Months 48-72: Follow-on Phase|Death|0|||
128919311|NCT00896532|463992757|FG008|Months 48-72: Follow-on Phase|Death|0|||
128919312|NCT00896532|463992758|FG009|Months 48-72: Follow-on Phase|Death|0|||
128919313|NCT00896532|463992759|FG010|Months 48-72: Follow-on Phase|Death|0|||
128919314|NCT00896532|463992760|FG011|Months 48-72: Follow-on Phase|Death|0|||
128919315|NCT00896532|463992761|FG012|Months 48-72: Follow-on Phase|Death|0|||
128919316|NCT00896532|463992762|FG013|Months 48-72: Follow-on Phase|Death|0|||
128919317|NCT00896532|463992763|FG014|Months 48-72: Follow-on Phase|Death|0|||
128919318|NCT00896532|463992764|FG015|Months 48-72: Follow-on Phase|Death|0|||
128919319|NCT00896532|463992765|FG016|Months 48-72: Follow-on Phase|Death|0|||
128919320|NCT00896532|463992766|FG017|Months 48-72: Follow-on Phase|Death|0|||
128919321|NCT00896532|463992767|FG018|Months 48-72: Follow-on Phase|Death|1|||
128919322|NCT00896532|463992768|FG019|Months 48-72: Follow-on Phase|Death|0|||
128919323|NCT00896532|463992769|FG020|Months 48-72: Follow-on Phase|Death|0|||
128919324|NCT00896532|463992770|FG021|Months 48-72: Follow-on Phase|Death|0|||
128919325|NCT00896532|463992771|FG022|Months 48-72: Follow-on Phase|Death|0|||
128919326|NCT00896532|463992749|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919327|NCT00896532|463992750|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919328|NCT00896532|463992751|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919329|NCT00896532|463992752|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919330|NCT00896532|463992753|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919331|NCT00896532|463992754|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919332|NCT00896532|463992755|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919333|NCT00896532|463992756|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919334|NCT00896532|463992757|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919335|NCT00896532|463992758|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919336|NCT00896532|463992759|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919337|NCT00896532|463992760|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919338|NCT00896532|463992761|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919339|NCT00896532|463992762|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919340|NCT00896532|463992763|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919341|NCT00896532|463992764|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919342|NCT00896532|463992765|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919343|NCT00896532|463992766|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919344|NCT00896532|463992767|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919345|NCT00896532|463992768|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128919346|NCT00896532|463992769|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128766294|NCT02087501|463435269|FG000|Overall Study|Open repair of aneurysm|1|||
128766295|NCT02087501|463435269|FG000|Overall Study|Lost to Follow-up|2|||
128766296|NCT00094328|463435270|FG000|Overall Study|Lost to Follow-up|1|||
128766297|NCT01483937|463435271|FG000|Overall Study|Withdrawal by Subject|4|||
128766298|NCT01483937|463435272|FG001|Overall Study|Withdrawal by Subject|3|||
128766299|NCT02213328|463435274|FG000|Overall Study|Withdrawal by Subject|10|||
128766300|NCT02213328|463435274|FG000|Overall Study|Physician Decision|2|||
128766301|NCT02213328|463435274|FG000|Overall Study|Lost to Follow-up|16|||
128766302|NCT02487095|463435280|FG000|Dose Expansion|Unable to scan/restage participant|0|||
128766303|NCT02487095|463435281|FG001|Dose Expansion|Unable to scan/restage participant|0|||
128766304|NCT02487095|463435282|FG002|Dose Expansion|Unable to scan/restage participant|0|||
128766305|NCT02487095|463435283|FG003|Dose Expansion|Unable to scan/restage participant|0|||
128766306|NCT02487095|463435284|FG004|Dose Expansion|Unable to scan/restage participant|1|||
128766307|NCT05778526|463435287|FG000|Overall Study|Lost to Follow-up|0|||
128766308|NCT05778526|463435288|FG001|Overall Study|Lost to Follow-up|1|||
128766309|NCT05778526|463435289|FG002|Overall Study|Lost to Follow-up|3|||
128766310|NCT05778526|463435287|FG000|Overall Study|Protocol Violation|0|||
128766311|NCT05778526|463435288|FG001|Overall Study|Protocol Violation|0|||
128766312|NCT05778526|463435289|FG002|Overall Study|Protocol Violation|8|||
128919347|NCT00896532|463992770|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
128766313|NCT01279343|463435292|FG000|Overall Study|Did not receive treatment|2|||
128919348|NCT00896532|463992771|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
128766314|NCT01279343|463435293|FG001|Overall Study|Did not receive treatment|6|||
128766315|NCT04534114|463435294|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
129029145|NCT02761915|464398339|FG003|Overall Study|Disease Progression|2|||
129029146|NCT02761915|464398340|FG004|Overall Study|Disease Progression|2|||
129029147|NCT02761915|464398341|FG005|Overall Study|Disease Progression|2|||
129029148|NCT00819169|464398355|FG000|Overall Study|Withdrawal by Subject|2|||
129029149|NCT00819169|464398356|FG001|Overall Study|Withdrawal by Subject|0|||
129029150|NCT00819169|464398357|FG002|Overall Study|Withdrawal by Subject|0|||
129029151|NCT00819169|464398358|FG003|Overall Study|Withdrawal by Subject|1|||
129029152|NCT00819169|464398359|FG004|Overall Study|Withdrawal by Subject|1|||
129029153|NCT00819169|464398360|FG005|Overall Study|Withdrawal by Subject|1|||
128699116|NCT02571777|463197891|FG001|Overall Study|Pregnancy|0|||
128699117|NCT02571777|463197892|FG002|Overall Study|Pregnancy|0|||
128699118|NCT02571777|463197893|FG003|Overall Study|Pregnancy|2|||
128699119|NCT02571777|463197894|FG004|Overall Study|Pregnancy|0|||
128699120|NCT03095612|463197900|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
128699121|NCT03095612|463197901|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
128699122|NCT03095612|463197902|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
128699123|NCT03095612|463197903|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
128699124|NCT03095612|463197904|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
128699125|NCT03095612|463197905|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
128699126|NCT03095612|463197906|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
128699127|NCT04447794|463197909|FG000|Overall Study|Lost to Follow-up|2|||
128699128|NCT04447794|463197910|FG001|Overall Study|Lost to Follow-up|3|||
128699129|NCT04447794|463197911|FG002|Overall Study|Lost to Follow-up|8|||
128699130|NCT04447794|463197909|FG000|Overall Study|Withdrawal by Subject|1|||
128699131|NCT04447794|463197910|FG001|Overall Study|Withdrawal by Subject|1|||
128699132|NCT04447794|463197911|FG002|Overall Study|Withdrawal by Subject|0|||
128699133|NCT00621582|463197912|FG000|Overall Study|Adverse Event|7|||
128699134|NCT00621582|463197912|FG000|Overall Study|Protocol Violation|57|||
128699135|NCT00621582|463197912|FG000|Overall Study|Lost to Follow-up|24|||
128699136|NCT00621582|463197912|FG000|Overall Study|issues not identified by investigators|18|||
128699137|NCT01387932|463197914|FG000|Randomized and Treated|Physician Decision|3|||
128699138|NCT01387932|463197915|FG001|Randomized and Treated|Physician Decision|2|||
128699139|NCT01387932|463197914|FG000|Randomized and Treated|Withdrawal by Subject|4|||
128699140|NCT01387932|463197915|FG001|Randomized and Treated|Withdrawal by Subject|2|||
128699141|NCT01387932|463197914|FG000|Survival Follow-up|Liver Transplant|24|||
128699142|NCT01387932|463197915|FG001|Survival Follow-up|Liver Transplant|28|||
128699143|NCT01387932|463197914|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
128699144|NCT01387932|463197915|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
128699145|NCT01387932|463197914|FG000|Survival Follow-up|Withdrawal by Subject|2|||
128699146|NCT01387932|463197915|FG001|Survival Follow-up|Withdrawal by Subject|4|||
128699147|NCT01387932|463197914|FG000|Survival Follow-up|Lost to Follow-up|6|||
128699148|NCT01387932|463197915|FG001|Survival Follow-up|Lost to Follow-up|5|||
128699149|NCT02571075|463197918|FG000|Overall Study|Lost to Follow-up|20|||
128699150|NCT02571075|463197919|FG001|Overall Study|Lost to Follow-up|24|||
128699151|NCT00963937|463197922|FG000|Overall Study|Protocol Violation|1|||
128699152|NCT00963937|463197923|FG001|Overall Study|Protocol Violation|1|||
128699153|NCT00963937|463197924|FG002|Overall Study|Protocol Violation|0|||
128699154|NCT00963937|463197922|FG000|Overall Study|Physician Decision|18|||
128699155|NCT00963937|463197923|FG001|Overall Study|Physician Decision|10|||
128699156|NCT00963937|463197924|FG002|Overall Study|Physician Decision|4|||
128699157|NCT00205881|463197925|FG000|Overall Study|Withdrawal by Subject|16|||
128699158|NCT00389597|463197932|FG000|Overall Study|Lost to Follow-up|8|||
128699159|NCT00389597|463197933|FG001|Overall Study|Lost to Follow-up|6|||
128699160|NCT00389597|463197934|FG002|Overall Study|Lost to Follow-up|4|||
128699161|NCT00389597|463197935|FG003|Overall Study|Lost to Follow-up|6|||
128699162|NCT00781274|463197936|FG000|Overall Study|Withdrawal by Subject|2|||
128699163|NCT02021773|463197937|FG000|Overall Study|Adverse Event|1|||
128699164|NCT02021773|463197938|FG001|Overall Study|Adverse Event|4|||
128699165|NCT02021773|463197939|FG002|Overall Study|Adverse Event|3|||
128699166|NCT02021773|463197937|FG000|Overall Study|Lack of Efficacy|2|||
128699167|NCT02021773|463197938|FG001|Overall Study|Lack of Efficacy|2|||
128699168|NCT02021773|463197939|FG002|Overall Study|Lack of Efficacy|2|||
128699169|NCT02021773|463197937|FG000|Overall Study|Protocol Violation|2|||
128699170|NCT02021773|463197938|FG001|Overall Study|Protocol Violation|3|||
128699171|NCT02021773|463197939|FG002|Overall Study|Protocol Violation|1|||
128699172|NCT02021773|463197937|FG000|Overall Study|Withdrawal by Subject|3|||
128699173|NCT02021773|463197938|FG001|Overall Study|Withdrawal by Subject|4|||
128699174|NCT02021773|463197939|FG002|Overall Study|Withdrawal by Subject|5|||
128699175|NCT02021773|463197937|FG000|Overall Study|Lost to Follow-up|1|||
128699176|NCT02021773|463197938|FG001|Overall Study|Lost to Follow-up|3|||
128699177|NCT02021773|463197939|FG002|Overall Study|Lost to Follow-up|0|||
128699178|NCT02021773|463197937|FG000|Overall Study|Reason not specified|3|||
128919349|NCT00896532|463992749|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919350|NCT00896532|463992750|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919351|NCT00896532|463992751|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919352|NCT00896532|463992752|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919353|NCT00896532|463992753|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919354|NCT00896532|463992754|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128699179|NCT02021773|463197938|FG001|Overall Study|Reason not specified|0|||
128699180|NCT02021773|463197939|FG002|Overall Study|Reason not specified|0|||
128699181|NCT02243696|463197940|FG000|Overall Study|Death|282|||
128699182|NCT02243696|463197940|FG000|Overall Study|Withdrawal by Subject|79|||
128699183|NCT02243696|463197940|FG000|Overall Study|Lost to Follow-up|57|||
128699184|NCT02243696|463197940|FG000|Overall Study|Subject No Longer has Study System|42|||
128699185|NCT02243696|463197940|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
128699186|NCT02243696|463197940|FG000|Overall Study|Study Terminated for EP PASSION|961|||
128699187|NCT01534962|463197941|FG000|Overall Study|Randomized but did not start treatment|2|||
128699188|NCT01534962|463197942|FG001|Overall Study|Randomized but did not start treatment|0|||
128699189|NCT01534962|463197943|FG002|Overall Study|Randomized but did not start treatment|0|||
128699190|NCT01534962|463197944|FG003|Overall Study|Randomized but did not start treatment|1|||
128699191|NCT01534962|463197941|FG000|Overall Study|Discontinued at AF recurrence|35|||
128699192|NCT01534962|463197942|FG001|Overall Study|Discontinued at AF recurrence|26|||
128699193|NCT01534962|463197943|FG002|Overall Study|Discontinued at AF recurrence|24|||
128699194|NCT01534962|463197944|FG003|Overall Study|Discontinued at AF recurrence|31|||
128699195|NCT00087607|463197945|FG000|Overall Study|Adverse Event|14|||
128699196|NCT00087607|463197946|FG001|Overall Study|Adverse Event|24|||
128699197|NCT00087607|463197945|FG000|Overall Study|Death|0|||
128699198|NCT00087607|463197946|FG001|Overall Study|Death|1|||
128699199|NCT00087607|463197945|FG000|Overall Study|Insufficient Therapeutic Response|53|||
128699200|NCT00087607|463197946|FG001|Overall Study|Insufficient Therapeutic Response|42|||
128699201|NCT00087607|463197945|FG000|Overall Study|Failure to return|21|||
128699202|NCT00087607|463197946|FG001|Overall Study|Failure to return|17|||
128699203|NCT00087607|463197945|FG000|Overall Study|Withdrew Consent|12|||
128699204|NCT00087607|463197946|FG001|Overall Study|Withdrew Consent|16|||
128699205|NCT00087607|463197945|FG000|Overall Study|Administrative|12|||
128699206|NCT00087607|463197946|FG001|Overall Study|Administrative|12|||
128699207|NCT00087607|463197945|FG000|Overall Study|Refused Treatment|5|||
128699208|NCT00087607|463197946|FG001|Overall Study|Refused Treatment|7|||
128699209|NCT00087607|463197945|FG000|Overall Study|Other Protocol Violation|5|||
128699210|NCT00087607|463197946|FG001|Overall Study|Other Protocol Violation|2|||
128699211|NCT00087607|463197945|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
128699212|NCT00087607|463197946|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
128699213|NCT00190671|463197947|FG000|Overall Study|Satisfactory Response|4|||
128699214|NCT00190671|463197948|FG001|Overall Study|Satisfactory Response|7|||
128699215|NCT00190671|463197947|FG000|Overall Study|Lack of Efficacy|19|||
128699216|NCT00190671|463197948|FG001|Overall Study|Lack of Efficacy|24|||
128699217|NCT00190671|463197947|FG000|Overall Study|Death from Study Disease|1|||
128699218|NCT00190671|463197948|FG001|Overall Study|Death from Study Disease|1|||
128699219|NCT00190671|463197947|FG000|Overall Study|Adverse Event|3|||
128699220|NCT00190671|463197948|FG001|Overall Study|Adverse Event|2|||
128699221|NCT00190671|463197947|FG000|Overall Study|Clinical Relapse|0|||
128699222|NCT00190671|463197948|FG001|Overall Study|Clinical Relapse|1|||
128699223|NCT00190671|463197947|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
128699224|NCT00190671|463197948|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
128919355|NCT00896532|463992755|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919356|NCT00896532|463992756|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919357|NCT00896532|463992757|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919358|NCT00896532|463992758|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919359|NCT00896532|463992759|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128699225|NCT00190671|463197947|FG000|Overall Study|Death from Other Causes|0|||
128699226|NCT00190671|463197948|FG001|Overall Study|Death from Other Causes|2|||
128699227|NCT00190671|463197947|FG000|Overall Study|Protocol Violation|0|||
128699228|NCT00190671|463197948|FG001|Overall Study|Protocol Violation|1|||
128699229|NCT00190671|463197947|FG000|Overall Study|Withdrawal by Subject|0|||
128699230|NCT00190671|463197948|FG001|Overall Study|Withdrawal by Subject|2|||
128699231|NCT00191269|463197949|FG000|Overall Study|Protocol Violation|0|||
128919360|NCT00896532|463992760|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128699232|NCT00191269|463197950|FG001|Overall Study|Protocol Violation|2|||
128699233|NCT00191269|463197949|FG000|Overall Study|Adverse Event|1|||
128699234|NCT00191269|463197950|FG001|Overall Study|Adverse Event|4|||
128699235|NCT00191269|463197949|FG000|Overall Study|Progression of Disease|4|||
128699236|NCT00191269|463197950|FG001|Overall Study|Progression of Disease|42|||
128699237|NCT00191269|463197949|FG000|Overall Study|Lack of Efficacy|1|||
128699238|NCT00191269|463197950|FG001|Overall Study|Lack of Efficacy|5|||
128699239|NCT00191269|463197949|FG000|Overall Study|Withdrawal by Subject|0|||
128699240|NCT00191269|463197950|FG001|Overall Study|Withdrawal by Subject|1|||
128919361|NCT00896532|463992761|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919362|NCT00896532|463992762|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919363|NCT00896532|463992763|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919364|NCT00896532|463992764|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919365|NCT00896532|463992765|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919366|NCT00896532|463992766|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919367|NCT00896532|463992767|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919368|NCT00896532|463992768|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919369|NCT00896532|463992769|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128919370|NCT00896532|463992770|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
128919371|NCT00896532|463992771|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
128699241|NCT00191269|463197949|FG000|Overall Study|Pathologic Aggrevation|0|||
128699242|NCT00191269|463197950|FG001|Overall Study|Pathologic Aggrevation|1|||
128699243|NCT00191269|463197949|FG000|Overall Study|Physician Decision|0|||
128699244|NCT00191269|463197950|FG001|Overall Study|Physician Decision|3|||
128699245|NCT02015754|463197954|FG000|Overall Study|Disease progression|5|||
128699246|NCT02015754|463197954|FG000|Overall Study|Change in treatment modality|5|||
128699247|NCT02015754|463197954|FG000|Overall Study|Lost to Follow-up|1|||
128699248|NCT04528732|463197961|FG000|Overall Study|Death|1|||
128699249|NCT04528732|463197962|FG001|Overall Study|Death|0|||
128699250|NCT04528732|463197963|FG002|Overall Study|Death|1|||
128699251|NCT04528732|463197961|FG000|Overall Study|Lost to Follow-up|0|||
128699252|NCT04528732|463197962|FG001|Overall Study|Lost to Follow-up|1|||
128699253|NCT04528732|463197963|FG002|Overall Study|Lost to Follow-up|2|||
128699254|NCT03408483|463197964|FG000|Overall Study|Physician Decision|3|||
128699255|NCT03408483|463197965|FG001|Overall Study|Physician Decision|3|||
128699256|NCT03408483|463197964|FG000|Overall Study|Lost to Follow-up|3|||
128699257|NCT03408483|463197965|FG001|Overall Study|Lost to Follow-up|0|||
128699258|NCT02094677|463197966|FG000|Overall Study|Screening|3|||
128699259|NCT02094677|463197967|FG001|Overall Study|Screening|1|||
128699260|NCT05399641|463197968|FG000|Overall Study|Adverse Event|0|||
128699261|NCT05399641|463197969|FG001|Overall Study|Adverse Event|1|||
128919372|NCT02149810|463992772|FG000|Overall Study|Physician Decision|1|||
128919373|NCT02149810|463992773|FG001|Overall Study|Physician Decision|2|||
128919374|NCT02149810|463992772|FG000|Overall Study|Lost to Follow-up|2|||
128919375|NCT02149810|463992773|FG001|Overall Study|Lost to Follow-up|1|||
128919376|NCT02149810|463992772|FG000|Overall Study|Withdrawal by Subject|5|||
128919377|NCT02149810|463992773|FG001|Overall Study|Withdrawal by Subject|1|||
128919378|NCT01176916|463992774|FG000|Overall Study|Adverse Event|61|||
128919379|NCT01176916|463992774|FG000|Overall Study|Death|1|||
128919380|NCT01176916|463992774|FG000|Overall Study|Lost to Follow-up|15|||
128919381|NCT01176916|463992774|FG000|Overall Study|Objective progression or relapse|17|||
128919382|NCT01176916|463992774|FG000|Overall Study|Protocol Violation|24|||
128919383|NCT01176916|463992774|FG000|Overall Study|Withdrawal by Subject|37|||
128919384|NCT01176916|463992774|FG000|Overall Study|Other|6|||
128919385|NCT01176916|463992774|FG000|Overall Study|Withdrawal prior to Treatment|6|||
128919386|NCT05032950|463992789|FG000|Overall Study|Adverse Event|0|||
128919387|NCT05032950|463992790|FG001|Overall Study|Adverse Event|0|||
128919388|NCT05032950|463992791|FG002|Overall Study|Adverse Event|1|||
128919389|NCT05032950|463992792|FG003|Overall Study|Adverse Event|1|||
128919390|NCT05032950|463992793|FG004|Overall Study|Adverse Event|0|||
128919391|NCT05032950|463992794|FG005|Overall Study|Adverse Event|0|||
128919392|NCT02959814|463992798|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
128919393|NCT02959814|463992798|FG000|Overall Study|Excluded based on anatomical criteria|2|||
128919394|NCT02959814|463992798|FG000|Overall Study|Protocol Violation|7|||
128919395|NCT02959814|463992798|FG000|Overall Study|FFR not measured|2|||
128919396|NCT02959814|463992798|FG000|Overall Study|In-procedure QFR not computed|6|||
128919397|NCT02959814|463992798|FG000|Overall Study|Excluded by FFR core-lab|24|||
128919398|NCT02116621|463992799|FG000|Baseline|Withdrawal by Subject|0|||
128919399|NCT02116621|463992800|FG001|Baseline|Withdrawal by Subject|4|||
128919400|NCT02116621|463992799|FG000|Three Month Follow-up|Death|1|||
128919401|NCT02116621|463992800|FG001|Three Month Follow-up|Death|1|||
128919402|NCT02116621|463992799|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
128919403|NCT02116621|463992800|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
128919404|NCT02116621|463992799|FG000|Three Month Follow-up|Lost to Follow-up|0|||
128919405|NCT02116621|463992800|FG001|Three Month Follow-up|Lost to Follow-up|1|||
128919406|NCT02116621|463992799|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
128919407|NCT02116621|463992800|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
128919408|NCT02116621|463992799|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
128919409|NCT02116621|463992800|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
128919410|NCT02116621|463992799|FG000|Six Month Follow-up|Lost to Follow-up|2|||
128919411|NCT02116621|463992800|FG001|Six Month Follow-up|Lost to Follow-up|1|||
128919412|NCT02116621|463992799|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
128919413|NCT02116621|463992800|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
128699262|NCT05399641|463197970|FG002|Overall Study|Adverse Event|1|||
128919414|NCT02116621|463992799|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
128919415|NCT02116621|463992800|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
128919416|NCT02116621|463992799|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
128919417|NCT02116621|463992800|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
128919418|NCT02116621|463992799|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
128919419|NCT02116621|463992800|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
128919420|NCT02116621|463992799|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
128919421|NCT02116621|463992800|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
128919422|NCT00961961|463992801|FG000|Phase I|Withdrawal by Subject|7|||
128919423|NCT00961961|463992802|FG001|Phase I|Withdrawal by Subject|0|||
128919424|NCT00961961|463992803|FG002|Phase I|Withdrawal by Subject|0|||
128919425|NCT00961961|463992804|FG003|Phase I|Withdrawal by Subject|0|||
128919426|NCT00961961|463992801|FG000|Phase I|Lost to Follow-up|10|||
128919427|NCT00961961|463992802|FG001|Phase I|Lost to Follow-up|0|||
128919428|NCT00961961|463992803|FG002|Phase I|Lost to Follow-up|0|||
128919429|NCT00961961|463992804|FG003|Phase I|Lost to Follow-up|0|||
128919430|NCT00961961|463992801|FG000|Phase I|Lack of Efficacy|94|||
128919431|NCT00961961|463992802|FG001|Phase I|Lack of Efficacy|0|||
128919432|NCT00961961|463992803|FG002|Phase I|Lack of Efficacy|0|||
128919433|NCT00961961|463992804|FG003|Phase I|Lack of Efficacy|0|||
128919434|NCT00961961|463992801|FG000|Phase I|Adverse Event|7|||
128919435|NCT00961961|463992802|FG001|Phase I|Adverse Event|0|||
128919436|NCT00961961|463992803|FG002|Phase I|Adverse Event|0|||
128919437|NCT00961961|463992804|FG003|Phase I|Adverse Event|0|||
128919438|NCT00961961|463992801|FG000|Phase I|Physician Decision|8|||
128919439|NCT00961961|463992802|FG001|Phase I|Physician Decision|0|||
128919440|NCT00961961|463992803|FG002|Phase I|Physician Decision|0|||
128919441|NCT00961961|463992804|FG003|Phase I|Physician Decision|0|||
128919442|NCT00961961|463992801|FG000|Phase II|Lost to Follow-up|0|||
128919443|NCT00961961|463992802|FG001|Phase II|Lost to Follow-up|0|||
128919444|NCT00961961|463992803|FG002|Phase II|Lost to Follow-up|10|||
128919445|NCT00961961|463992804|FG003|Phase II|Lost to Follow-up|7|||
128919446|NCT00961961|463992801|FG000|Phase II|Adverse Event|0|||
128919447|NCT00961961|463992802|FG001|Phase II|Adverse Event|0|||
128919448|NCT00961961|463992803|FG002|Phase II|Adverse Event|0|||
128919449|NCT00961961|463992804|FG003|Phase II|Adverse Event|1|||
128919450|NCT00961961|463992801|FG000|Phase II|Physician Decision|0|||
128919451|NCT00961961|463992802|FG001|Phase II|Physician Decision|0|||
128919452|NCT00961961|463992803|FG002|Phase II|Physician Decision|1|||
128919453|NCT00961961|463992804|FG003|Phase II|Physician Decision|0|||
128919454|NCT00961961|463992801|FG000|Phase II|Withdrawal by Subject|0|||
128919455|NCT00961961|463992802|FG001|Phase II|Withdrawal by Subject|0|||
128919456|NCT00961961|463992803|FG002|Phase II|Withdrawal by Subject|1|||
128919457|NCT00961961|463992804|FG003|Phase II|Withdrawal by Subject|0|||
128919458|NCT01929135|463992807|FG000|Overall Study|Lost to Follow-up|1|||
128919459|NCT01929135|463992808|FG001|Overall Study|Lost to Follow-up|1|||
128919460|NCT02425098|463992809|FG000|Overall Study|Lost to Follow-up|7|||
128919461|NCT02425098|463992810|FG001|Overall Study|Lost to Follow-up|7|||
128919462|NCT02425098|463992809|FG000|Overall Study|Withdrawal by Subject|4|||
128919463|NCT02425098|463992810|FG001|Overall Study|Withdrawal by Subject|8|||
128919464|NCT02425098|463992809|FG000|Overall Study|Pregnancy|2|||
128919465|NCT02425098|463992810|FG001|Overall Study|Pregnancy|0|||
128919466|NCT02425098|463992809|FG000|Overall Study|Reason not Specified|0|||
128919467|NCT02425098|463992810|FG001|Overall Study|Reason not Specified|1|||
128919468|NCT02078219|463992811|FG000|Overall Study|Other|2|||
128919469|NCT02078219|463992812|FG001|Overall Study|Other|2|||
128919470|NCT02078219|463992813|FG002|Overall Study|Other|3|||
128919471|NCT02078219|463992814|FG003|Overall Study|Other|0|||
128919472|NCT02078219|463992815|FG004|Overall Study|Other|1|||
128919473|NCT02078219|463992811|FG000|Overall Study|Withdrawal by Subject|0|||
128919474|NCT02078219|463992812|FG001|Overall Study|Withdrawal by Subject|1|||
128919475|NCT02078219|463992813|FG002|Overall Study|Withdrawal by Subject|0|||
128919476|NCT02078219|463992814|FG003|Overall Study|Withdrawal by Subject|1|||
128919477|NCT02078219|463992815|FG004|Overall Study|Withdrawal by Subject|1|||
128919478|NCT02078219|463992811|FG000|Overall Study|Protocol Violation|0|||
128919479|NCT02078219|463992812|FG001|Overall Study|Protocol Violation|0|||
128919480|NCT02078219|463992813|FG002|Overall Study|Protocol Violation|0|||
128919481|NCT02078219|463992814|FG003|Overall Study|Protocol Violation|1|||
128919482|NCT02078219|463992815|FG004|Overall Study|Protocol Violation|0|||
128919483|NCT02078219|463992811|FG000|Overall Study|Death|0|||
128919484|NCT02078219|463992812|FG001|Overall Study|Death|0|||
128919485|NCT02078219|463992813|FG002|Overall Study|Death|0|||
128919486|NCT02078219|463992814|FG003|Overall Study|Death|1|||
128919487|NCT02078219|463992815|FG004|Overall Study|Death|0|||
128919488|NCT02078219|463992811|FG000|Overall Study|Adverse Event|1|||
128919489|NCT02078219|463992812|FG001|Overall Study|Adverse Event|1|||
128919490|NCT02078219|463992813|FG002|Overall Study|Adverse Event|3|||
128919491|NCT02078219|463992814|FG003|Overall Study|Adverse Event|1|||
128919492|NCT02078219|463992815|FG004|Overall Study|Adverse Event|0|||
128919493|NCT03136107|463992822|FG000|Overall Study|Other (Not specified)|1|||
128919494|NCT03283085|463992823|FG000|Overall Study|Adverse Event|18|||
128919495|NCT03283085|463992824|FG001|Overall Study|Adverse Event|3|||
128699263|NCT05399641|463197968|FG000|Overall Study|Lost to Follow-up|1|||
128699264|NCT05399641|463197969|FG001|Overall Study|Lost to Follow-up|2|||
128699265|NCT05399641|463197970|FG002|Overall Study|Lost to Follow-up|2|||
128699266|NCT05399641|463197968|FG000|Overall Study|Physician Decision|1|||
128699267|NCT05399641|463197969|FG001|Overall Study|Physician Decision|3|||
128699268|NCT05399641|463197970|FG002|Overall Study|Physician Decision|3|||
128699269|NCT05399641|463197968|FG000|Overall Study|Withdrawal by Subject|4|||
128699270|NCT05399641|463197969|FG001|Overall Study|Withdrawal by Subject|11|||
128699271|NCT05399641|463197970|FG002|Overall Study|Withdrawal by Subject|7|||
128699272|NCT05399641|463197968|FG000|Overall Study|Reason not defined|3|||
128699273|NCT05399641|463197969|FG001|Overall Study|Reason not defined|5|||
128699274|NCT05399641|463197970|FG002|Overall Study|Reason not defined|6|||
128699275|NCT01300650|463197971|FG000|Overall Study|Adverse Event|1|||
128699276|NCT01702961|463197972|FG000|Overall Study|Additional treatment|3|||
128699277|NCT01702961|463197972|FG000|Overall Study|Progressive disease|5|||
128699278|NCT01702961|463197972|FG000|Overall Study|Relapse|20|||
128699279|NCT01702961|463197972|FG000|Overall Study|Death|6|||
128699280|NCT01702961|463197972|FG000|Overall Study|Lost to Follow-up|2|||
128699281|NCT01702961|463197972|FG000|Overall Study|Ongoing|11|||
128699282|NCT00674362|463197980|FG000|Double Blind|Adverse Event|6|||
128699283|NCT00674362|463197981|FG001|Double Blind|Adverse Event|6|||
128699284|NCT00674362|463197980|FG000|Double Blind|Lack of Efficacy|2|||
128699285|NCT00674362|463197981|FG001|Double Blind|Lack of Efficacy|6|||
128699286|NCT00674362|463197980|FG000|Double Blind|Loss of efficacy|0|||
128699287|NCT00674362|463197981|FG001|Double Blind|Loss of efficacy|1|||
129216180|NCT02158546|465092868|FG003|Overall Study|Adverse Event|0|||
129216181|NCT02158546|465092865|FG000|Overall Study|Withdrawal by Subject|6|||
129216182|NCT02158546|465092866|FG001|Overall Study|Withdrawal by Subject|2|||
129216183|NCT02158546|465092867|FG002|Overall Study|Withdrawal by Subject|1|||
129216184|NCT02158546|465092868|FG003|Overall Study|Withdrawal by Subject|0|||
128699288|NCT00674362|463197980|FG000|Double Blind|Withdrawal by Subject|4|||
128766316|NCT04534114|463435295|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
128766317|NCT04534114|463435296|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
128766318|NCT04534114|463435297|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
128766319|NCT04534114|463435294|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
128919496|NCT03283085|463992825|FG002|Overall Study|Adverse Event|13|||
128919497|NCT03283085|463992826|FG003|Overall Study|Adverse Event|0|||
128919498|NCT03283085|463992827|FG004|Overall Study|Adverse Event|0|||
128919499|NCT03283085|463992828|FG005|Overall Study|Adverse Event|5|||
128919500|NCT03283085|463992823|FG000|Overall Study|Death|0|||
128919501|NCT03283085|463992824|FG001|Overall Study|Death|0|||
128919502|NCT03283085|463992825|FG002|Overall Study|Death|3|||
128919503|NCT03283085|463992826|FG003|Overall Study|Death|1|||
128919504|NCT03283085|463992827|FG004|Overall Study|Death|0|||
128919505|NCT03283085|463992828|FG005|Overall Study|Death|0|||
128919506|NCT03283085|463992823|FG000|Overall Study|Withdrawal by Subject|42|||
128919507|NCT03283085|463992824|FG001|Overall Study|Withdrawal by Subject|21|||
128919508|NCT03283085|463992825|FG002|Overall Study|Withdrawal by Subject|66|||
128919509|NCT03283085|463992826|FG003|Overall Study|Withdrawal by Subject|3|||
128919510|NCT03283085|463992827|FG004|Overall Study|Withdrawal by Subject|3|||
128919511|NCT03283085|463992828|FG005|Overall Study|Withdrawal by Subject|5|||
128919512|NCT03283085|463992823|FG000|Overall Study|Physician Decision|14|||
128919513|NCT03283085|463992824|FG001|Overall Study|Physician Decision|8|||
128919514|NCT03283085|463992825|FG002|Overall Study|Physician Decision|19|||
128919515|NCT03283085|463992826|FG003|Overall Study|Physician Decision|0|||
128919516|NCT03283085|463992827|FG004|Overall Study|Physician Decision|0|||
128919517|NCT03283085|463992828|FG005|Overall Study|Physician Decision|2|||
129216185|NCT02158546|465092865|FG000|Overall Study|Lost to Follow-up|5|||
128919518|NCT03283085|463992823|FG000|Overall Study|Site Terminated by Sponsor|1|||
128919519|NCT03283085|463992824|FG001|Overall Study|Site Terminated by Sponsor|0|||
128919520|NCT03283085|463992825|FG002|Overall Study|Site Terminated by Sponsor|3|||
129216186|NCT02158546|465092866|FG001|Overall Study|Lost to Follow-up|4|||
129216187|NCT02158546|465092867|FG002|Overall Study|Lost to Follow-up|0|||
128699289|NCT00674362|463197981|FG001|Double Blind|Withdrawal by Subject|3|||
128919521|NCT03283085|463992826|FG003|Overall Study|Site Terminated by Sponsor|0|||
128919522|NCT03283085|463992827|FG004|Overall Study|Site Terminated by Sponsor|0|||
128919523|NCT03283085|463992828|FG005|Overall Study|Site Terminated by Sponsor|0|||
128699290|NCT00674362|463197980|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
128699291|NCT00674362|463197981|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
128699292|NCT00674362|463197980|FG000|Double Blind|Other: Surgery|0|||
128919524|NCT03283085|463992823|FG000|Overall Study|Lost to Follow-up|2|||
128919525|NCT03283085|463992824|FG001|Overall Study|Lost to Follow-up|0|||
128919526|NCT03283085|463992825|FG002|Overall Study|Lost to Follow-up|2|||
129216188|NCT02158546|465092868|FG003|Overall Study|Lost to Follow-up|1|||
129216189|NCT02158546|465092865|FG000|Overall Study|Site Excluded|5|||
128699293|NCT00674362|463197981|FG001|Double Blind|Other: Surgery|1|||
128699294|NCT00674362|463197980|FG000|Open Label|Adverse Event|1|||
128919527|NCT03283085|463992826|FG003|Overall Study|Lost to Follow-up|0|||
129216190|NCT02158546|465092866|FG001|Overall Study|Site Excluded|5|||
128699295|NCT00674362|463197981|FG001|Open Label|Adverse Event|0|||
128699296|NCT00674362|463197980|FG000|Open Label|Other: Subject moved to extension study|1|||
128699297|NCT00674362|463197981|FG001|Open Label|Other: Subject moved to extension study|0|||
128919528|NCT03283085|463992827|FG004|Overall Study|Lost to Follow-up|0|||
128919529|NCT03283085|463992828|FG005|Overall Study|Lost to Follow-up|1|||
128919530|NCT03283085|463992823|FG000|Overall Study|Pregnancy|0|||
128919531|NCT03283085|463992824|FG001|Overall Study|Pregnancy|0|||
128919532|NCT03283085|463992825|FG002|Overall Study|Pregnancy|1|||
128919533|NCT03283085|463992826|FG003|Overall Study|Pregnancy|0|||
128919534|NCT03283085|463992827|FG004|Overall Study|Pregnancy|0|||
128919535|NCT03283085|463992828|FG005|Overall Study|Pregnancy|0|||
128919536|NCT03283085|463992823|FG000|Overall Study|Lack of Efficacy|12|||
128919537|NCT03283085|463992824|FG001|Overall Study|Lack of Efficacy|6|||
128919538|NCT03283085|463992825|FG002|Overall Study|Lack of Efficacy|24|||
128919539|NCT03283085|463992826|FG003|Overall Study|Lack of Efficacy|1|||
128919540|NCT03283085|463992827|FG004|Overall Study|Lack of Efficacy|1|||
128919541|NCT03283085|463992828|FG005|Overall Study|Lack of Efficacy|0|||
128919542|NCT03283085|463992823|FG000|Overall Study|Reason not Specified|0|||
129029154|NCT00819169|464398361|FG006|Overall Study|Withdrawal by Subject|5|||
128919543|NCT03283085|463992824|FG001|Overall Study|Reason not Specified|4|||
128919544|NCT03283085|463992825|FG002|Overall Study|Reason not Specified|8|||
128919545|NCT03283085|463992826|FG003|Overall Study|Reason not Specified|0|||
128919546|NCT03283085|463992827|FG004|Overall Study|Reason not Specified|0|||
128919547|NCT03283085|463992828|FG005|Overall Study|Reason not Specified|1|||
128919548|NCT02292771|463992832|FG000|Overall Study|Withdrawal by Subject|2|||
128919549|NCT02292771|463992833|FG001|Overall Study|Withdrawal by Subject|1|||
128919550|NCT02292771|463992832|FG000|Overall Study|Lost to Follow-up|2|||
128919551|NCT02292771|463992833|FG001|Overall Study|Lost to Follow-up|1|||
128919552|NCT04025632|463994609|FG000|Overall Study|Adverse Event|1|||
128919553|NCT04025632|463994610|FG001|Overall Study|Adverse Event|1|||
128919554|NCT04025632|463994609|FG000|Overall Study|Withdrawal by Subject|1|||
128919555|NCT04025632|463994610|FG001|Overall Study|Withdrawal by Subject|1|||
128919556|NCT04025632|463994609|FG000|Overall Study|Study Terminated by Sponsor|10|||
128919557|NCT04025632|463994610|FG001|Overall Study|Study Terminated by Sponsor|9|||
128919558|NCT04025632|463994609|FG000|Overall Study|Physician Decision|3|||
128919559|NCT04025632|463994610|FG001|Overall Study|Physician Decision|1|||
128919560|NCT00127127|463994611|FG000|Overall Study|Adverse Event|0|||
128919561|NCT00127127|463994612|FG001|Overall Study|Adverse Event|2|||
128919562|NCT00127127|463994613|FG002|Overall Study|Adverse Event|0|||
128919563|NCT00127127|463994614|FG003|Overall Study|Adverse Event|1|||
128919564|NCT00127127|463994611|FG000|Overall Study|Lack of Efficacy|1|||
128919565|NCT00127127|463994612|FG001|Overall Study|Lack of Efficacy|3|||
129029155|NCT00819169|464398362|FG007|Overall Study|Withdrawal by Subject|1|||
128699298|NCT00668707|463197982|FG000|Overall Study|Cancer Recurrence|58|||
128699299|NCT00668707|463197983|FG001|Overall Study|Cancer Recurrence|58|||
128699300|NCT00668707|463197982|FG000|Overall Study|Withdrawal by Subject|117|||
128699301|NCT00668707|463197983|FG001|Overall Study|Withdrawal by Subject|100|||
128699302|NCT00668707|463197982|FG000|Overall Study|Lost to Follow-up|3|||
128699303|NCT00668707|463197983|FG001|Overall Study|Lost to Follow-up|6|||
128699304|NCT00668707|463197982|FG000|Overall Study|Protocol Violation|10|||
128699305|NCT00668707|463197983|FG001|Overall Study|Protocol Violation|12|||
128699306|NCT00668707|463197982|FG000|Overall Study|Death|11|||
128699307|NCT00668707|463197983|FG001|Overall Study|Death|4|||
128699308|NCT00923156|463197984|FG000|Overall Study|Adverse Event|0|||
128699309|NCT00923156|463197985|FG001|Overall Study|Adverse Event|2|||
128699310|NCT00923156|463197986|FG002|Overall Study|Adverse Event|1|||
128699311|NCT00923156|463197984|FG000|Overall Study|Abnormal laboratory values|0|||
128699312|NCT00923156|463197985|FG001|Overall Study|Abnormal laboratory values|0|||
128699313|NCT00923156|463197986|FG002|Overall Study|Abnormal laboratory values|1|||
128699314|NCT00923156|463197984|FG000|Overall Study|Withdrawal by Subject|0|||
128699315|NCT00923156|463197985|FG001|Overall Study|Withdrawal by Subject|1|||
128699316|NCT00923156|463197986|FG002|Overall Study|Withdrawal by Subject|0|||
128699317|NCT00923156|463197984|FG000|Overall Study|Death|0|||
128699318|NCT00923156|463197985|FG001|Overall Study|Death|1|||
128699319|NCT00923156|463197986|FG002|Overall Study|Death|0|||
128919566|NCT00127127|463994613|FG002|Overall Study|Lack of Efficacy|0|||
128919567|NCT00127127|463994614|FG003|Overall Study|Lack of Efficacy|2|||
128919568|NCT01524991|463994617|FG000|Overall Study|Adverse Event|12|||
128919569|NCT01524991|463994617|FG000|Overall Study|Death|1|||
128919570|NCT01524991|463994617|FG000|Overall Study|Disease ProgressionDu|17|||
128919571|NCT01524991|463994617|FG000|Overall Study|Other complicating disease|1|||
128919572|NCT01524991|463994617|FG000|Overall Study|Withdrawal by Subject|2|||
128919573|NCT01524991|463994617|FG000|Overall Study|Symptomatic Deterioration|1|||
128919574|NCT01805180|463994618|FG000|Lead-in Donor Phase|screen failure|1|||
128919575|NCT01805180|463994619|FG001|Lead-in Donor Phase|screen failure|0|||
128919576|NCT01805180|463994620|FG002|Lead-in Donor Phase|screen failure|0|||
128919577|NCT00398112|463994641|FG000|Overall Study|Adverse Event|4|||
128699320|NCT00923156|463197984|FG000|Overall Study|Lack of Efficacy|0|||
128919578|NCT00398112|463994641|FG000|Overall Study|Disease progression|9|||
128699321|NCT00923156|463197985|FG001|Overall Study|Lack of Efficacy|0|||
128699322|NCT00923156|463197986|FG002|Overall Study|Lack of Efficacy|1|||
128699323|NCT03137537|463197989|FG000|Overall Study|Adverse Event|0|||
128699324|NCT03137537|463197990|FG001|Overall Study|Adverse Event|1|||
128699325|NCT04066023|463197991|FG000|Overall Study|Adverse Event|0|||
128699326|NCT04066023|463197992|FG001|Overall Study|Adverse Event|0|||
128699327|NCT04066023|463197993|FG002|Overall Study|Adverse Event|1|||
128699328|NCT04066023|463197991|FG000|Overall Study|Sponsor decision|3|||
128699329|NCT04066023|463197992|FG001|Overall Study|Sponsor decision|6|||
128699330|NCT04066023|463197993|FG002|Overall Study|Sponsor decision|2|||
128919579|NCT00398112|463994641|FG000|Overall Study|Alternative treatment|1|||
128919580|NCT00398112|463994641|FG000|Overall Study|Withdrawal by Subject|3|||
128919581|NCT00398112|463994641|FG000|Overall Study|Death|1|||
128919582|NCT00008385|463994642|FG000|Overall Study|Off treatment reasons not reported|79|||
128919583|NCT00008385|463994643|FG001|Overall Study|Off treatment reasons not reported|70|||
128919584|NCT00008385|463994642|FG000|Overall Study|Progressive disease|52|||
128919585|NCT00008385|463994643|FG001|Overall Study|Progressive disease|117|||
128919586|NCT00008385|463994642|FG000|Overall Study|Adverse Event|8|||
128919587|NCT00008385|463994643|FG001|Overall Study|Adverse Event|20|||
128919588|NCT00008385|463994642|FG000|Overall Study|Death|12|||
128919589|NCT00008385|463994643|FG001|Overall Study|Death|18|||
128919590|NCT00008385|463994642|FG000|Overall Study|Withdrawal by Subject|67|||
128919591|NCT00008385|463994643|FG001|Overall Study|Withdrawal by Subject|157|||
128919592|NCT00008385|463994642|FG000|Overall Study|Start non-protocol therapy|3|||
128919593|NCT00008385|463994643|FG001|Overall Study|Start non-protocol therapy|1|||
128919594|NCT00008385|463994642|FG000|Overall Study|Other complicating disease|17|||
128919595|NCT00008385|463994643|FG001|Overall Study|Other complicating disease|30|||
128919596|NCT00008385|463994642|FG000|Overall Study|Maximum dose reached|0|||
128919597|NCT00008385|463994643|FG001|Overall Study|Maximum dose reached|2|||
128919598|NCT00008385|463994642|FG000|Overall Study|Other|105|||
128919599|NCT00008385|463994643|FG001|Overall Study|Other|212|||
128919600|NCT00008385|463994642|FG000|Overall Study|Not start protocol therapy|44|||
128919601|NCT00008385|463994643|FG001|Overall Study|Not start protocol therapy|175|||
128919602|NCT05148884|463994644|FG000|Overall Study|Withdrawal by Subject|3|||
128919603|NCT05148884|463994645|FG001|Overall Study|Withdrawal by Subject|0|||
128919604|NCT05148884|463994644|FG000|Overall Study|Deep brain stimulation operation|0|||
128919605|NCT05148884|463994645|FG001|Overall Study|Deep brain stimulation operation|1|||
128919606|NCT00582556|463994646|FG000|Overall Study|Withdrawal by Subject|0|||
128919607|NCT00582556|463994647|FG001|Overall Study|Withdrawal by Subject|1|||
128919608|NCT00582556|463994648|FG002|Overall Study|Withdrawal by Subject|1|||
128919609|NCT00582556|463994646|FG000|Overall Study|Physician Decision|0|||
128919610|NCT00582556|463994647|FG001|Overall Study|Physician Decision|0|||
128919611|NCT00582556|463994648|FG002|Overall Study|Physician Decision|1|||
128919612|NCT01993888|463994649|FG000|Overall Study|Death|1|||
128919613|NCT01993888|463994650|FG001|Overall Study|Death|1|||
128699331|NCT04066023|463197991|FG000|Overall Study|Physician Decision|0|||
128699332|NCT04066023|463197992|FG001|Overall Study|Physician Decision|0|||
128699333|NCT04066023|463197993|FG002|Overall Study|Physician Decision|1|||
128699334|NCT04066023|463197991|FG000|Overall Study|Lost to Follow-up|0|||
128699335|NCT04066023|463197992|FG001|Overall Study|Lost to Follow-up|1|||
128919614|NCT01993888|463994649|FG000|Overall Study|Lost to Follow-up|1|||
128919615|NCT01993888|463994650|FG001|Overall Study|Lost to Follow-up|1|||
128919616|NCT01993888|463994649|FG000|Overall Study|Withdrawal by Subject|0|||
128919617|NCT01993888|463994650|FG001|Overall Study|Withdrawal by Subject|1|||
128919618|NCT00365989|463994651|FG000|Overall Study|Withdrawal by Subject|1|||
128699336|NCT04066023|463197993|FG002|Overall Study|Lost to Follow-up|1|||
128766320|NCT04534114|463435295|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
128919619|NCT00365989|463994651|FG000|Overall Study|Non-compliance|1|||
128919620|NCT00832819|463994653|FG000|Overall Study|Adverse Event|0|||
128919621|NCT00832819|463994654|FG001|Overall Study|Adverse Event|1|||
128919622|NCT00832819|463994655|FG002|Overall Study|Adverse Event|0|||
128919623|NCT00832819|463994653|FG000|Overall Study|Protocol Violation|0|||
128919624|NCT00832819|463994654|FG001|Overall Study|Protocol Violation|0|||
128919625|NCT00832819|463994655|FG002|Overall Study|Protocol Violation|1|||
128919626|NCT00851903|463994656|FG000|Overall Study|Withdrawal by Subject|2|||
128919627|NCT02318095|463994657|FG000|Overall Study|Adverse Event|1|||
128699337|NCT04066023|463197991|FG000|Overall Study|Noncompliance|0|||
128699338|NCT04066023|463197992|FG001|Overall Study|Noncompliance|1|||
128699339|NCT04066023|463197993|FG002|Overall Study|Noncompliance|1|||
128919628|NCT00686127|463994658|FG000|Overall Study|Withdrawal by Subject|14|||
128919629|NCT00686127|463994659|FG001|Overall Study|Withdrawal by Subject|6|||
128919630|NCT02300129|463994660|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
128919631|NCT02300129|463994661|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
128919632|NCT02300129|463994662|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
128919633|NCT02300129|463994663|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
128919634|NCT02300129|463994660|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
128919635|NCT02300129|463994661|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
128699340|NCT03386448|463197994|FG000|Overall Study|Adverse Event|0|||
128699341|NCT03386448|463197995|FG001|Overall Study|Adverse Event|2|||
128699342|NCT03338010|463197996|FG000|Overall Study|Withdrawal by Subject|14|||
128919636|NCT02300129|463994662|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
128919637|NCT02300129|463994663|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
128919638|NCT02300129|463994660|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
128919639|NCT02300129|463994661|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
128919640|NCT02300129|463994662|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
128919641|NCT02300129|463994663|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
128919642|NCT00522392|463994666|FG000|Overall Study|Disease progression|0|||
128919643|NCT00522392|463994667|FG001|Overall Study|Disease progression|3|||
128919644|NCT00522392|463994666|FG000|Overall Study|Adverse Event|7|||
128919645|NCT00522392|463994667|FG001|Overall Study|Adverse Event|7|||
128919646|NCT00522392|463994666|FG000|Overall Study|Withdrawal by Subject|1|||
128919647|NCT00522392|463994667|FG001|Overall Study|Withdrawal by Subject|1|||
128919648|NCT00522392|463994666|FG000|Overall Study|Physician Decision|0|||
128919649|NCT00522392|463994667|FG001|Overall Study|Physician Decision|1|||
128919650|NCT00522392|463994666|FG000|Overall Study|Non-compliance|0|||
128919651|NCT00522392|463994667|FG001|Overall Study|Non-compliance|1|||
128919652|NCT00332709|463994670|FG000|Overall Study|Adverse Event|11|||
128919653|NCT00332709|463994671|FG001|Overall Study|Adverse Event|14|||
128919654|NCT00332709|463994670|FG000|Overall Study|Withdrawal by Subject|2|||
128919655|NCT00332709|463994671|FG001|Overall Study|Withdrawal by Subject|3|||
128919656|NCT00332709|463994670|FG000|Overall Study|Lost to Follow-up|2|||
128919657|NCT00332709|463994671|FG001|Overall Study|Lost to Follow-up|0|||
128919658|NCT00332709|463994670|FG000|Overall Study|Administrative Problems|0|||
128919659|NCT00332709|463994671|FG001|Overall Study|Administrative Problems|3|||
128919660|NCT00332709|463994670|FG000|Overall Study|Abnormal test procedure result|1|||
128919661|NCT00332709|463994671|FG001|Overall Study|Abnormal test procedure result|0|||
128919662|NCT01409928|463994673|FG000|Overall Study|Physician Decision|12|||
128919663|NCT01354132|463994676|FG000|Randomization|Physician Decision|1|||
128919664|NCT01354132|463994677|FG001|Randomization|Physician Decision|0|||
128919665|NCT01354132|463994676|FG000|Randomization|Withdrawal by Subject|0|||
128919666|NCT01354132|463994677|FG001|Randomization|Withdrawal by Subject|1|||
128919667|NCT01354132|463994676|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
128919668|NCT01354132|463994677|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
128919669|NCT01354132|463994676|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
128919670|NCT01354132|463994677|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
128919671|NCT01354132|463994676|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
128919672|NCT01354132|463994677|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
128919673|NCT00603239|463994678|FG000|Overall Study|Adverse Event|4|||
128919674|NCT00603239|463994679|FG001|Overall Study|Adverse Event|1|||
128919675|NCT00603239|463994678|FG000|Overall Study|Entry criteria not met|0|||
128919676|NCT00603239|463994679|FG001|Overall Study|Entry criteria not met|1|||
128919677|NCT00603239|463994678|FG000|Overall Study|Loss of glucose control|3|||
128919678|NCT00603239|463994679|FG001|Overall Study|Loss of glucose control|0|||
128919679|NCT00603239|463994678|FG000|Overall Study|Lost to Follow-up|2|||
128919680|NCT00603239|463994679|FG001|Overall Study|Lost to Follow-up|1|||
128919681|NCT00603239|463994678|FG000|Overall Study|Physician Decision|2|||
128919682|NCT00603239|463994679|FG001|Overall Study|Physician Decision|0|||
128919683|NCT00603239|463994678|FG000|Overall Study|Protocol Violation|2|||
128919684|NCT00603239|463994679|FG001|Overall Study|Protocol Violation|0|||
128919685|NCT00603239|463994678|FG000|Overall Study|Subject decision|2|||
128919686|NCT00603239|463994679|FG001|Overall Study|Subject decision|1|||
128919687|NCT02357420|463994680|FG000|Overall Study|Adverse Event|3|||
128919688|NCT02357420|463994681|FG001|Overall Study|Adverse Event|3|||
128699343|NCT03338010|463197997|FG001|Overall Study|Withdrawal by Subject|8|||
128699344|NCT03338010|463197996|FG000|Overall Study|Lost to Follow-up|4|||
128699345|NCT03338010|463197997|FG001|Overall Study|Lost to Follow-up|2|||
128699346|NCT03338010|463197996|FG000|Overall Study|Adverse Event|3|||
128699347|NCT03338010|463197997|FG001|Overall Study|Adverse Event|2|||
128919689|NCT02357420|463994682|FG002|Overall Study|Adverse Event|8|||
128699348|NCT03338010|463197996|FG000|Overall Study|Physician Decision|2|||
128919690|NCT02357420|463994683|FG003|Overall Study|Adverse Event|9|||
128919691|NCT02357420|463994680|FG000|Overall Study|Investigator Decision|1|||
128699349|NCT03338010|463197997|FG001|Overall Study|Physician Decision|2|||
128919692|NCT02357420|463994681|FG001|Overall Study|Investigator Decision|0|||
128699350|NCT03338010|463197996|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128699351|NCT03338010|463197997|FG001|Overall Study|Non-Compliance with Study Drug|3|||
128699352|NCT03338010|463197996|FG000|Overall Study|Protocol Violation|0|||
128919693|NCT02357420|463994682|FG002|Overall Study|Investigator Decision|0|||
128919694|NCT02357420|463994683|FG003|Overall Study|Investigator Decision|0|||
128919695|NCT02357420|463994680|FG000|Overall Study|Prohibited Medication|1|||
128919696|NCT02357420|463994681|FG001|Overall Study|Prohibited Medication|1|||
128919697|NCT02357420|463994682|FG002|Overall Study|Prohibited Medication|0|||
128919698|NCT02357420|463994683|FG003|Overall Study|Prohibited Medication|0|||
128919699|NCT02357420|463994680|FG000|Overall Study|Protocol Non-compliance|0|||
128919700|NCT02357420|463994681|FG001|Overall Study|Protocol Non-compliance|0|||
128699353|NCT03338010|463197997|FG001|Overall Study|Protocol Violation|1|||
128699354|NCT01146665|463198000|FG000|Overall Study|Withdrawal by Subject|10|||
128699355|NCT01146665|463198001|FG001|Overall Study|Withdrawal by Subject|16|||
128699356|NCT02465515|463198002|FG000|Overall Study|Investigator site closed|4|||
128699357|NCT02465515|463198003|FG001|Overall Study|Investigator site closed|5|||
128699358|NCT02465515|463198002|FG000|Overall Study|Withdrawal by Subject|74|||
128699359|NCT02465515|463198003|FG001|Overall Study|Withdrawal by Subject|43|||
128699360|NCT02465515|463198002|FG000|Overall Study|Physician Decision|8|||
128699361|NCT02465515|463198003|FG001|Overall Study|Physician Decision|12|||
128699362|NCT02465515|463198002|FG000|Overall Study|Lost to Follow-up|68|||
128699363|NCT02465515|463198003|FG001|Overall Study|Lost to Follow-up|51|||
128699364|NCT00293033|463198004|FG000|Open-label Titration Period|Adverse Event|10|||
128699365|NCT00293033|463198004|FG000|Open-label Titration Period|Death|3|||
128699366|NCT00293033|463198004|FG000|Open-label Titration Period|Lack of Efficacy|5|||
128699367|NCT00293033|463198004|FG000|Open-label Titration Period|Protocol Violation|2|||
128699368|NCT00293033|463198004|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
128699369|NCT00293033|463198004|FG000|Open-label Titration Period|Noncompliance and other|27|||
128699370|NCT00293033|463198004|FG000|Double-blind Treatment Period|Adverse Event|3|||
128699371|NCT00293033|463198004|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
128919701|NCT02357420|463994682|FG002|Overall Study|Protocol Non-compliance|0|||
128919702|NCT02357420|463994683|FG003|Overall Study|Protocol Non-compliance|1|||
128919703|NCT02357420|463994680|FG000|Overall Study|Withdrawn Consent|4|||
128919704|NCT02357420|463994681|FG001|Overall Study|Withdrawn Consent|8|||
128919705|NCT02357420|463994682|FG002|Overall Study|Withdrawn Consent|6|||
128919706|NCT02357420|463994683|FG003|Overall Study|Withdrawn Consent|6|||
128919707|NCT02357420|463994680|FG000|Overall Study|Lost to Follow-up|3|||
128919708|NCT02357420|463994681|FG001|Overall Study|Lost to Follow-up|0|||
128919709|NCT02357420|463994682|FG002|Overall Study|Lost to Follow-up|2|||
128919710|NCT02357420|463994683|FG003|Overall Study|Lost to Follow-up|3|||
128919711|NCT00928070|463994686|FG000|Overall Study|Lost to Follow-up|1|||
128919712|NCT00928070|463994687|FG001|Overall Study|Lost to Follow-up|2|||
128919713|NCT00928070|463994686|FG000|Overall Study|Withdrawal by Subject|10|||
128919714|NCT00928070|463994687|FG001|Overall Study|Withdrawal by Subject|3|||
128919715|NCT00928070|463994686|FG000|Overall Study|Adverse Event|14|||
128919716|NCT00928070|463994687|FG001|Overall Study|Adverse Event|26|||
128919717|NCT00928070|463994686|FG000|Overall Study|Lack of Efficacy|9|||
128919718|NCT00928070|463994687|FG001|Overall Study|Lack of Efficacy|5|||
128919719|NCT00928070|463994686|FG000|Overall Study|Did not meet entrance criteria|16|||
128919720|NCT00928070|463994687|FG001|Overall Study|Did not meet entrance criteria|9|||
128919721|NCT00928070|463994686|FG000|Overall Study|Protocol Violation|6|||
128919722|NCT00928070|463994687|FG001|Overall Study|Protocol Violation|5|||
128919723|NCT00928070|463994686|FG000|Overall Study|Randomized but not treated|2|||
128919724|NCT00928070|463994687|FG001|Overall Study|Randomized but not treated|2|||
128919725|NCT00928070|463994686|FG000|Overall Study|Other|5|||
128919726|NCT00928070|463994687|FG001|Overall Study|Other|5|||
128919727|NCT04067518|463994688|FG000|Overall Study|Adverse Event|1|||
128919728|NCT04067518|463994689|FG001|Overall Study|Adverse Event|3|||
128919729|NCT04067518|463994688|FG000|Overall Study|Screen failures|0|||
128919730|NCT04067518|463994689|FG001|Overall Study|Screen failures|1|||
128919731|NCT04067518|463994688|FG000|Overall Study|Enrolled but not treated|0|||
128919732|NCT04067518|463994689|FG001|Overall Study|Enrolled but not treated|1|||
128699372|NCT00293033|463198004|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
128699373|NCT00293033|463198004|FG000|Double-blind Treatment Period|Noncompliance|4|||
128699374|NCT03583697|463198005|FG000|Overall Study|Withdrawal by Subject|0|||
128699375|NCT03583697|463198006|FG001|Overall Study|Withdrawal by Subject|0|||
128919733|NCT00553462|463994690|FG000|Overall Study|Adverse Event|4|||
128919734|NCT00553462|463994690|FG000|Overall Study|Progression|4|||
128919735|NCT00553462|463994690|FG000|Overall Study|Withdrawal by Subject|5|||
128919736|NCT00553462|463994690|FG000|Overall Study|Physician Decision|1|||
128919737|NCT00862251|463994691|FG000|Overall Study|Adverse Event|8|||
128919738|NCT00862251|463994692|FG001|Overall Study|Adverse Event|3|||
128699376|NCT03583697|463198007|FG002|Overall Study|Withdrawal by Subject|1|||
128699377|NCT03583697|463198005|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
128699378|NCT03583697|463198006|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
128919739|NCT00862251|463994693|FG002|Overall Study|Adverse Event|1|||
128919740|NCT00862251|463994691|FG000|Overall Study|Lost to Follow-up|0|||
128699379|NCT03583697|463198007|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
128699380|NCT00114530|463198008|FG000|Overall Study|Death|3|||
128699381|NCT00114530|463198009|FG001|Overall Study|Death|11|||
128699382|NCT00114530|463198008|FG000|Overall Study|Lost to Follow-up|1|||
128919741|NCT00862251|463994692|FG001|Overall Study|Lost to Follow-up|0|||
128919742|NCT00862251|463994693|FG002|Overall Study|Lost to Follow-up|1|||
128919743|NCT00862251|463994691|FG000|Overall Study|Protocol Violation|2|||
128919744|NCT00862251|463994692|FG001|Overall Study|Protocol Violation|0|||
128919745|NCT00862251|463994693|FG002|Overall Study|Protocol Violation|1|||
128919746|NCT00862251|463994691|FG000|Overall Study|Withdrawal by Subject|9|||
128919747|NCT00862251|463994692|FG001|Overall Study|Withdrawal by Subject|2|||
128919748|NCT00862251|463994693|FG002|Overall Study|Withdrawal by Subject|6|||
128919749|NCT01728779|463994694|FG000|Overall Study|Withdrawal by Subject|1|||
128919750|NCT00675025|463994695|FG000|Overall Study|Study Terminated by Sponsor|38|||
128919751|NCT00675025|463994696|FG001|Overall Study|Study Terminated by Sponsor|42|||
128919752|NCT00675025|463994695|FG000|Overall Study|Adverse Event|6|||
128919753|NCT00675025|463994696|FG001|Overall Study|Adverse Event|11|||
128919754|NCT00675025|463994695|FG000|Overall Study|Lost to Follow-up|6|||
128919755|NCT00675025|463994696|FG001|Overall Study|Lost to Follow-up|4|||
128919756|NCT00675025|463994695|FG000|Overall Study|Withdrawal by Subject|4|||
128919757|NCT00675025|463994696|FG001|Overall Study|Withdrawal by Subject|6|||
128919758|NCT02054702|463994702|FG000|Overall Study|Lost to Follow-up|3|||
128919759|NCT02054702|463994703|FG001|Overall Study|Lost to Follow-up|5|||
128919760|NCT02054702|463994702|FG000|Overall Study|Adverse Event|3|||
128919761|NCT02054702|463994703|FG001|Overall Study|Adverse Event|1|||
128919762|NCT02054702|463994702|FG000|Overall Study|Met Withdrawal Criteria|4|||
128919763|NCT02054702|463994703|FG001|Overall Study|Met Withdrawal Criteria|1|||
128919764|NCT02054702|463994702|FG000|Overall Study|Physician Decision|0|||
128919765|NCT02054702|463994703|FG001|Overall Study|Physician Decision|1|||
128919766|NCT02054702|463994702|FG000|Overall Study|Withdrawal by Subject|14|||
128919767|NCT02054702|463994703|FG001|Overall Study|Withdrawal by Subject|4|||
128919768|NCT00934102|463994707|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
128919769|NCT00934102|463994708|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
128919770|NCT00934102|463994709|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
128919771|NCT02318784|463994710|FG000|Overall Study|Adverse Event|13|||
128919772|NCT02318784|463994710|FG000|Overall Study|Death|2|||
128919773|NCT02318784|463994710|FG000|Overall Study|Progressive Disease|37|||
128919774|NCT02318784|463994710|FG000|Overall Study|Withdrawal by Subject|10|||
128919775|NCT02304926|463994711|FG000|Overall Study|Lost to Follow-up|2|||
128919776|NCT02304926|463994712|FG001|Overall Study|Lost to Follow-up|1|||
128919777|NCT04007159|463994713|FG000|Induction Phase|(missed study visits)|16|||
128919778|NCT04007159|463994713|FG000|Induction Phase|Withdrawal by Subject|4|||
128919779|NCT04007159|463994713|FG000|Induction Phase|Adverse Event|2|||
128919780|NCT04007159|463994713|FG000|Challenge Phase|missed study visits|3|||
128919781|NCT02388295|463994715|FG000|Dose Escalation Week 1|Adverse Event|1|||
128919782|NCT02388295|463994716|FG001|Dose Escalation Week 1|Adverse Event|2|||
128919783|NCT02388295|463994717|FG002|Dose Escalation Week 1|Adverse Event|1|||
128919784|NCT02388295|463994715|FG000|Dose Escalation Week 1|Determined not eligible|1|||
128919785|NCT02388295|463994716|FG001|Dose Escalation Week 1|Determined not eligible|1|||
128919786|NCT02388295|463994717|FG002|Dose Escalation Week 1|Determined not eligible|1|||
128919787|NCT02388295|463994715|FG000|Dose Escalation Week 2|Protocol Violation|0|||
128919788|NCT02388295|463994716|FG001|Dose Escalation Week 2|Protocol Violation|1|||
128919789|NCT02388295|463994717|FG002|Dose Escalation Week 2|Protocol Violation|0|||
128919790|NCT02388295|463994715|FG000|Dose Escalation Week 2|Determined not eligible|1|||
128919791|NCT02388295|463994716|FG001|Dose Escalation Week 2|Determined not eligible|1|||
128919792|NCT02388295|463994717|FG002|Dose Escalation Week 2|Determined not eligible|1|||
128919793|NCT02388295|463994715|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
128919794|NCT02388295|463994716|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
129029156|NCT00819169|464398363|FG008|Overall Study|Withdrawal by Subject|4|||
129029157|NCT00819169|464398355|FG000|Overall Study|Lost to Follow-up|0|||
129029158|NCT00819169|464398356|FG001|Overall Study|Lost to Follow-up|2|||
129029159|NCT00819169|464398357|FG002|Overall Study|Lost to Follow-up|0|||
129029160|NCT00819169|464398358|FG003|Overall Study|Lost to Follow-up|1|||
129029161|NCT00819169|464398359|FG004|Overall Study|Lost to Follow-up|0|||
129029162|NCT00819169|464398360|FG005|Overall Study|Lost to Follow-up|6|||
129029163|NCT00819169|464398361|FG006|Overall Study|Lost to Follow-up|2|||
129029164|NCT00819169|464398362|FG007|Overall Study|Lost to Follow-up|2|||
129029165|NCT00819169|464398363|FG008|Overall Study|Lost to Follow-up|1|||
129029166|NCT00819169|464398355|FG000|Overall Study|Death|1|||
129029167|NCT00819169|464398356|FG001|Overall Study|Death|1|||
129029168|NCT00819169|464398357|FG002|Overall Study|Death|3|||
129029169|NCT00819169|464398358|FG003|Overall Study|Death|8|||
129029170|NCT00819169|464398359|FG004|Overall Study|Death|5|||
129029171|NCT00819169|464398360|FG005|Overall Study|Death|7|||
129029172|NCT00819169|464398361|FG006|Overall Study|Death|9|||
129029173|NCT00819169|464398362|FG007|Overall Study|Death|4|||
129029174|NCT00819169|464398363|FG008|Overall Study|Death|7|||
129029175|NCT00819169|464398355|FG000|Overall Study|Ineligibility determined|0|||
129029176|NCT00819169|464398356|FG001|Overall Study|Ineligibility determined|0|||
129029177|NCT00819169|464398357|FG002|Overall Study|Ineligibility determined|0|||
129029178|NCT00819169|464398358|FG003|Overall Study|Ineligibility determined|2|||
129029179|NCT00819169|464398359|FG004|Overall Study|Ineligibility determined|0|||
128919795|NCT02388295|463994717|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
128919796|NCT02076165|463994718|FG000|Overall Study|Lost to Follow-up|7|||
128919797|NCT02076165|463994719|FG001|Overall Study|Lost to Follow-up|5|||
128919798|NCT02076165|463994718|FG000|Overall Study|Refused follow-up assessment|1|||
129029180|NCT00819169|464398360|FG005|Overall Study|Ineligibility determined|0|||
129029181|NCT00819169|464398361|FG006|Overall Study|Ineligibility determined|0|||
129029182|NCT00819169|464398362|FG007|Overall Study|Ineligibility determined|0|||
128919799|NCT02076165|463994719|FG001|Overall Study|Refused follow-up assessment|1|||
128919800|NCT03157531|463994720|FG000|Overall Study|Death|2|||
128919801|NCT03157531|463994720|FG000|Overall Study|Lost to Follow-up|4|||
128919802|NCT03417440|463994727|FG000|Overall Study|Lost to Follow-up|0|||
128919803|NCT03417440|463994728|FG001|Overall Study|Lost to Follow-up|1|||
128919804|NCT03417440|463994729|FG002|Overall Study|Lost to Follow-up|0|||
128919805|NCT03417440|463994730|FG003|Overall Study|Lost to Follow-up|0|||
128919806|NCT03417440|463994731|FG004|Overall Study|Lost to Follow-up|1|||
128919807|NCT03417440|463994732|FG005|Overall Study|Lost to Follow-up|0|||
128919808|NCT03417440|463994733|FG006|Overall Study|Lost to Follow-up|0|||
128919809|NCT03417440|463994734|FG007|Overall Study|Lost to Follow-up|0|||
128919810|NCT03417440|463994727|FG000|Overall Study|Withdrawal by Subject|2|||
128919811|NCT03417440|463994728|FG001|Overall Study|Withdrawal by Subject|0|||
128919812|NCT03417440|463994729|FG002|Overall Study|Withdrawal by Subject|2|||
128919813|NCT03417440|463994730|FG003|Overall Study|Withdrawal by Subject|1|||
128919814|NCT03417440|463994731|FG004|Overall Study|Withdrawal by Subject|1|||
128919815|NCT03417440|463994732|FG005|Overall Study|Withdrawal by Subject|0|||
128919816|NCT03417440|463994733|FG006|Overall Study|Withdrawal by Subject|0|||
128919817|NCT03417440|463994734|FG007|Overall Study|Withdrawal by Subject|1|||
128919818|NCT00238264|463994737|FG000|Overall Study|Death|7|||
128919819|NCT00238264|463994737|FG000|Overall Study|Lost to Follow-up|18|||
128919820|NCT00238264|463994737|FG000|Overall Study|Withdrawal by Subject|4|||
128919821|NCT00238264|463994737|FG000|Overall Study|Ineligible|7|||
128919822|NCT02706938|463994738|FG000|First Period, 6 Weeks|Adverse Event|8|||
128919823|NCT02706938|463994739|FG001|First Period, 6 Weeks|Adverse Event|0|||
128919824|NCT02706938|463994738|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
128919825|NCT02706938|463994739|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
128919826|NCT02706938|463994738|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
129029183|NCT00819169|464398363|FG008|Overall Study|Ineligibility determined|1|||
128919827|NCT02706938|463994739|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
128919828|NCT02706938|463994738|FG000|Second Period, 6 Weeks|Adverse Event|0|||
129029184|NCT00819169|464398355|FG000|Overall Study|Adverse Event|0|||
129029185|NCT00819169|464398356|FG001|Overall Study|Adverse Event|0|||
129029186|NCT00819169|464398357|FG002|Overall Study|Adverse Event|0|||
129029187|NCT00819169|464398358|FG003|Overall Study|Adverse Event|0|||
129029188|NCT00819169|464398359|FG004|Overall Study|Adverse Event|1|||
129029189|NCT00819169|464398360|FG005|Overall Study|Adverse Event|0|||
129029190|NCT00819169|464398361|FG006|Overall Study|Adverse Event|0|||
129029191|NCT00819169|464398362|FG007|Overall Study|Adverse Event|0|||
129029192|NCT00819169|464398363|FG008|Overall Study|Adverse Event|0|||
129029193|NCT00819169|464398355|FG000|Overall Study|Administrative Decision|0|||
129029194|NCT00819169|464398356|FG001|Overall Study|Administrative Decision|0|||
129029195|NCT00819169|464398357|FG002|Overall Study|Administrative Decision|0|||
129029196|NCT00819169|464398358|FG003|Overall Study|Administrative Decision|0|||
129029197|NCT00819169|464398359|FG004|Overall Study|Administrative Decision|1|||
129029198|NCT00819169|464398360|FG005|Overall Study|Administrative Decision|2|||
129029199|NCT00819169|464398361|FG006|Overall Study|Administrative Decision|0|||
129029200|NCT00819169|464398362|FG007|Overall Study|Administrative Decision|2|||
129029201|NCT00819169|464398363|FG008|Overall Study|Administrative Decision|0|||
129029202|NCT00406393|464398364|FG000|Overall Study|Did not undergo transplantation|2|||
129029203|NCT00406393|464398365|FG001|Overall Study|Did not undergo transplantation|1|||
129029204|NCT01597791|464398366|FG000|Overall Study|Physician Decision|2|||
129029205|NCT01597791|464398367|FG001|Overall Study|Physician Decision|1|||
129029206|NCT01597791|464398366|FG000|Overall Study|Cesarean Section|6|||
129029207|NCT01597791|464398367|FG001|Overall Study|Cesarean Section|7|||
129029208|NCT01597791|464398366|FG000|Overall Study|Subject withdrawal|0|||
129029209|NCT01597791|464398367|FG001|Overall Study|Subject withdrawal|1|||
129029210|NCT01597791|464398366|FG000|Overall Study|Protocol Violation|0|||
129029211|NCT01597791|464398367|FG001|Overall Study|Protocol Violation|1|||
129029212|NCT05412121|464398370|FG000|Overall Study|Withdrawal by Subject|4|||
129029213|NCT05412121|464398370|FG000|Overall Study|Physician Decision|1|||
129029214|NCT05412121|464398370|FG000|Overall Study|Lost to Follow-up|5|||
129029215|NCT00537095|464398373|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
129029216|NCT00537095|464398374|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
128919829|NCT02706938|463994739|FG001|Second Period, 6 Weeks|Adverse Event|7|||
128919830|NCT02706938|463994738|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
128919831|NCT02706938|463994739|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
128919832|NCT01838044|463994740|FG000|Overall Study|Adverse Event|4|||
128919833|NCT01838044|463994741|FG001|Overall Study|Adverse Event|6|||
128919834|NCT01838044|463994740|FG000|Overall Study|Protocol Violation|3|||
128919835|NCT01838044|463994741|FG001|Overall Study|Protocol Violation|3|||
129029217|NCT00537095|464398373|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
129029218|NCT00537095|464398374|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
129029219|NCT00537095|464398373|FG000|Randomized Treatment Period (433 Days)|Death|3|||
129216191|NCT02158546|465092867|FG002|Overall Study|Site Excluded|3|||
128699383|NCT00114530|463198009|FG001|Overall Study|Lost to Follow-up|1|||
128919836|NCT01838044|463994740|FG000|Overall Study|Withdrawal by Subject|0|||
128919837|NCT01838044|463994741|FG001|Overall Study|Withdrawal by Subject|2|||
128919838|NCT01838044|463994740|FG000|Overall Study|Insufficient clinical response|1|||
128919839|NCT01838044|463994741|FG001|Overall Study|Insufficient clinical response|2|||
128919840|NCT01838044|463994740|FG000|Overall Study|Medication error without associated AE|0|||
128919841|NCT01838044|463994741|FG001|Overall Study|Medication error without associated AE|1|||
128919842|NCT01838044|463994740|FG000|Overall Study|Lost to Follow-up|0|||
128919843|NCT01838044|463994741|FG001|Overall Study|Lost to Follow-up|2|||
128919844|NCT00860470|463994745|FG000|Overall Study|Death|6|||
128919845|NCT00860470|463994746|FG001|Overall Study|Death|10|||
128919846|NCT00860470|463994745|FG000|Overall Study|Moved away|8|||
128919847|NCT00860470|463994746|FG001|Overall Study|Moved away|10|||
128919848|NCT00860470|463994745|FG000|Overall Study|Lost to Follow-up|34|||
128919849|NCT00860470|463994746|FG001|Overall Study|Lost to Follow-up|39|||
128919850|NCT00723957|463994748|FG000|Overall Study|Adverse event unrelated to study drug|1|||
128919851|NCT00723957|463994749|FG001|Overall Study|Adverse event unrelated to study drug|4|||
128919852|NCT00723957|463994748|FG000|Overall Study|Death|3|||
128919853|NCT00723957|463994749|FG001|Overall Study|Death|4|||
128919854|NCT00723957|463994748|FG000|Overall Study|Disease progression|27|||
128919855|NCT00723957|463994749|FG001|Overall Study|Disease progression|25|||
128919856|NCT00723957|463994748|FG000|Overall Study|Maximum clinical benefit|4|||
128919857|NCT00723957|463994749|FG001|Overall Study|Maximum clinical benefit|5|||
128919858|NCT00723957|463994748|FG000|Overall Study|Investigator decision|1|||
128919859|NCT00723957|463994749|FG001|Overall Study|Investigator decision|1|||
128919860|NCT00723957|463994748|FG000|Overall Study|Study drug toxicity|4|||
128919861|NCT00723957|463994749|FG001|Overall Study|Study drug toxicity|6|||
128919862|NCT00723957|463994748|FG000|Overall Study|Withdrawal by Subject|7|||
128919863|NCT00723957|463994749|FG001|Overall Study|Withdrawal by Subject|5|||
128919864|NCT00723957|463994748|FG000|Overall Study|Reason not analyzed|1|||
128919865|NCT00723957|463994749|FG001|Overall Study|Reason not analyzed|0|||
128919866|NCT00723957|463994748|FG000|Overall Study|Never received treatment|3|||
128919867|NCT00723957|463994749|FG001|Overall Study|Never received treatment|3|||
128919868|NCT00706628|463994751|FG000|Overall Study|Other Adverse Event|16|||
128919869|NCT00706628|463994752|FG001|Overall Study|Other Adverse Event|5|||
128919870|NCT00706628|463994753|FG002|Overall Study|Other Adverse Event|5|||
128919871|NCT00706628|463994754|FG003|Overall Study|Other Adverse Event|2|||
128919872|NCT00706628|463994751|FG000|Overall Study|Non compliant with protocol|0|||
128919873|NCT00706628|463994752|FG001|Overall Study|Non compliant with protocol|1|||
128919874|NCT00706628|463994753|FG002|Overall Study|Non compliant with protocol|0|||
128919875|NCT00706628|463994754|FG003|Overall Study|Non compliant with protocol|0|||
128919876|NCT00706628|463994751|FG000|Overall Study|Consent withdrawn|6|||
128919877|NCT00706628|463994752|FG001|Overall Study|Consent withdrawn|1|||
128919878|NCT00706628|463994753|FG002|Overall Study|Consent withdrawn|3|||
128919879|NCT00706628|463994754|FG003|Overall Study|Consent withdrawn|0|||
128919880|NCT00706628|463994751|FG000|Overall Study|Progressive disease|20|||
128919881|NCT00706628|463994752|FG001|Overall Study|Progressive disease|13|||
128919882|NCT00706628|463994753|FG002|Overall Study|Progressive disease|8|||
128919883|NCT00706628|463994754|FG003|Overall Study|Progressive disease|1|||
128919884|NCT00706628|463994751|FG000|Overall Study|Other than those stated above|4|||
128919885|NCT00706628|463994752|FG001|Overall Study|Other than those stated above|0|||
128919886|NCT00706628|463994753|FG002|Overall Study|Other than those stated above|0|||
128919887|NCT00706628|463994754|FG003|Overall Study|Other than those stated above|0|||
128919888|NCT00706628|463994751|FG000|Overall Study|Not treated|1|||
128919889|NCT00706628|463994752|FG001|Overall Study|Not treated|1|||
128919890|NCT00706628|463994753|FG002|Overall Study|Not treated|0|||
128919891|NCT00706628|463994754|FG003|Overall Study|Not treated|0|||
128919892|NCT02266433|463994759|FG000|Overall Study|Lost to Follow-up|54|||
128919893|NCT02266433|463994760|FG001|Overall Study|Lost to Follow-up|46|||
128919894|NCT02266433|463994759|FG000|Overall Study|Withdrawal by Subject|5|||
128919895|NCT02266433|463994760|FG001|Overall Study|Withdrawal by Subject|7|||
128919896|NCT01285349|463994761|FG000|Overall Study|Lost to Follow-up|27|||
128919897|NCT01285349|463994762|FG001|Overall Study|Lost to Follow-up|20|||
128699384|NCT00114530|463198008|FG000|Overall Study|Physician Decision|1|||
128699385|NCT00114530|463198009|FG001|Overall Study|Physician Decision|1|||
128699386|NCT00114530|463198008|FG000|Overall Study|Withdrawal by Subject|2|||
128699387|NCT00114530|463198009|FG001|Overall Study|Withdrawal by Subject|6|||
128699388|NCT00114530|463198008|FG000|Overall Study|Breast Cancer|1|||
128919898|NCT01285349|463994763|FG002|Overall Study|Lost to Follow-up|27|||
128919899|NCT01194440|463994768|FG000|Baseline (First Dose)|Reason not specified|4|||
128919900|NCT01194440|463994768|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
128919901|NCT01194440|463994768|FG000|Baseline (First Dose)|Change in therapy|1|||
128919902|NCT01194440|463994768|FG000|Baseline (First Dose)|Adverse Event|1|||
128919903|NCT01194440|463994768|FG000|6-months (2nd Dose)|Change in therapy|4|||
128919904|NCT02292212|463994769|FG000|ViE Phase|Withdrawal by Subject|1|||
128699389|NCT00114530|463198009|FG001|Overall Study|Breast Cancer|0|||
128699390|NCT00114530|463198008|FG000|Overall Study|Subject decision after endpoint failure|0|||
128919905|NCT02292212|463994769|FG000|ViE Phase|Protocol Violation|2|||
128919906|NCT00927563|463994772|FG000|Overall Study|Lost to Follow-up|1|||
128919907|NCT00927563|463994772|FG000|Overall Study|Withdrawal by Subject|1|||
128699391|NCT00114530|463198009|FG001|Overall Study|Subject decision after endpoint failure|1|||
128699392|NCT00114530|463198008|FG000|Overall Study|Ineligible|1|||
128699393|NCT00114530|463198009|FG001|Overall Study|Ineligible|0|||
128699394|NCT00365508|463198012|FG000|Overall Study|Lost to Follow-up|139|||
128699395|NCT00365508|463198013|FG001|Overall Study|Lost to Follow-up|154|||
128699396|NCT00751933|463198014|FG000|Overall Study|Withdrawal by Subject|0|||
128699397|NCT00751933|463198015|FG001|Overall Study|Withdrawal by Subject|1|||
128699398|NCT00751933|463198016|FG002|Overall Study|Withdrawal by Subject|0|||
128699399|NCT00751933|463198017|FG003|Overall Study|Withdrawal by Subject|0|||
128699400|NCT00751933|463198014|FG000|Overall Study|Physician Decision|0|||
128699401|NCT00751933|463198015|FG001|Overall Study|Physician Decision|0|||
128699402|NCT00751933|463198016|FG002|Overall Study|Physician Decision|1|||
128699403|NCT00751933|463198017|FG003|Overall Study|Physician Decision|1|||
128699404|NCT02538029|463198019|FG000|Overall Study|unable to complete cognitive assessments|1|||
128699405|NCT02538029|463198020|FG001|Overall Study|unable to complete cognitive assessments|0|||
128699406|NCT02538029|463198021|FG002|Overall Study|unable to complete cognitive assessments|1|||
128699407|NCT05248867|463198023|FG000|Double-blind Period|Lost to Follow-up|0|||
128699408|NCT05248867|463198024|FG001|Double-blind Period|Lost to Follow-up|3|||
128699409|NCT05248867|463198025|FG002|Double-blind Period|Lost to Follow-up|0|||
128699410|NCT05248867|463198026|FG003|Double-blind Period|Lost to Follow-up|0|||
128699411|NCT05248867|463198027|FG004|Double-blind Period|Lost to Follow-up|0|||
128699412|NCT05248867|463198028|FG005|Double-blind Period|Lost to Follow-up|0|||
128699413|NCT05248867|463198023|FG000|Double-blind Period|Withdrawal by Subject|5|||
128699414|NCT05248867|463198024|FG001|Double-blind Period|Withdrawal by Subject|14|||
128699415|NCT05248867|463198025|FG002|Double-blind Period|Withdrawal by Subject|0|||
128699416|NCT05248867|463198026|FG003|Double-blind Period|Withdrawal by Subject|0|||
128699417|NCT05248867|463198027|FG004|Double-blind Period|Withdrawal by Subject|0|||
128699418|NCT05248867|463198028|FG005|Double-blind Period|Withdrawal by Subject|0|||
128699419|NCT05248867|463198023|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
128699420|NCT05248867|463198024|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
128919908|NCT01468987|463994773|FG000|Overall Study|Adverse Event|12|||
128919909|NCT01468987|463994774|FG001|Overall Study|Adverse Event|9|||
128919910|NCT01468987|463994773|FG000|Overall Study|Death|4|||
128919911|NCT01468987|463994774|FG001|Overall Study|Death|1|||
128919912|NCT01468987|463994773|FG000|Overall Study|Lost to Follow-up|10|||
128919913|NCT01468987|463994774|FG001|Overall Study|Lost to Follow-up|5|||
128919914|NCT01468987|463994773|FG000|Overall Study|Protocol Violation|8|||
128919915|NCT01468987|463994774|FG001|Overall Study|Protocol Violation|2|||
128919916|NCT01468987|463994773|FG000|Overall Study|Withdrawal by Subject|28|||
128919917|NCT01468987|463994774|FG001|Overall Study|Withdrawal by Subject|28|||
128919918|NCT01468987|463994773|FG000|Overall Study|Physician Decision|8|||
128919919|NCT01468987|463994774|FG001|Overall Study|Physician Decision|15|||
128919920|NCT01468987|463994773|FG000|Overall Study|Sponsor Decision|1|||
128919921|NCT01468987|463994774|FG001|Overall Study|Sponsor Decision|0|||
128919922|NCT01245673|463994776|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
128919923|NCT02040142|463994779|FG000|Overall Study|Lost to Follow-up|5|||
128919924|NCT02040142|463994779|FG000|Overall Study|Death|17|||
128919925|NCT02040142|463994779|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
128919926|NCT01565980|463994781|FG000|Overall Study|Death|1|||
128919927|NCT01565980|463994782|FG001|Overall Study|Death|0|||
128919928|NCT01565980|463994781|FG000|Overall Study|Lost to Follow-up|1|||
128919929|NCT01565980|463994782|FG001|Overall Study|Lost to Follow-up|0|||
128919930|NCT01565980|463994781|FG000|Overall Study|health complications|1|||
128919931|NCT01565980|463994782|FG001|Overall Study|health complications|1|||
128919932|NCT01565980|463994781|FG000|Overall Study|stopped medical treatment|1|||
128919933|NCT01565980|463994782|FG001|Overall Study|stopped medical treatment|0|||
128919934|NCT01565980|463994781|FG000|Overall Study|Withdrawal by Subject|0|||
128919935|NCT01565980|463994782|FG001|Overall Study|Withdrawal by Subject|3|||
128919936|NCT01955707|463994791|FG000|Overall Study|Adverse Event|1|||
128919937|NCT01955707|463994792|FG001|Overall Study|Adverse Event|2|||
128919938|NCT01955707|463994791|FG000|Overall Study|Lost to Follow-up|2|||
128919939|NCT01955707|463994792|FG001|Overall Study|Lost to Follow-up|1|||
128919940|NCT01955707|463994791|FG000|Overall Study|Withdrawal by Subject|0|||
128919941|NCT01955707|463994792|FG001|Overall Study|Withdrawal by Subject|3|||
128919942|NCT01955707|463994791|FG000|Overall Study|Death|13|||
128919943|NCT01955707|463994792|FG001|Overall Study|Death|14|||
128919944|NCT01955707|463994791|FG000|Overall Study|Other|4|||
128919945|NCT01955707|463994792|FG001|Overall Study|Other|2|||
128699421|NCT05248867|463198025|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
128699422|NCT05248867|463198026|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
128699423|NCT05248867|463198027|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
128699424|NCT05248867|463198028|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
128699425|NCT05248867|463198023|FG000|Double-blind Period|Other, not specified|3|||
128699426|NCT05248867|463198024|FG001|Double-blind Period|Other, not specified|8|||
128699427|NCT05248867|463198025|FG002|Double-blind Period|Other, not specified|0|||
128919946|NCT05211336|463996879|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
129216192|NCT02158546|465092868|FG003|Overall Study|Site Excluded|4|||
129216193|NCT02351817|465092869|FG000|Period 1|Adverse Event|1|||
129216194|NCT02351817|465092870|FG001|Period 1|Adverse Event|2|||
129216195|NCT02351817|465092869|FG000|Period 1|Lack of Efficacy|0|||
129216196|NCT02351817|465092870|FG001|Period 1|Lack of Efficacy|1|||
129216197|NCT02351817|465092869|FG000|Period 2|Adverse Event|0|||
129216198|NCT02351817|465092870|FG001|Period 2|Adverse Event|2|||
129216199|NCT02351817|465092869|FG000|Period 2|Protocol Violation|1|||
129216200|NCT02351817|465092870|FG001|Period 2|Protocol Violation|0|||
129216201|NCT02488915|465092873|FG000|Overall Study|Death|21|||
129216202|NCT02488915|465092873|FG000|Overall Study|Lost to Follow-up|4|||
129216203|NCT02488915|465092873|FG000|Overall Study|Withdrawal by Subject|1|||
129216204|NCT02976038|465092874|FG000|Overall Study|Physician Decision|22|||
129216205|NCT02976038|465092874|FG000|Overall Study|Withdrawal by Subject|3|||
129216206|NCT02976038|465092874|FG000|Overall Study|Lost to Follow-up|2|||
129216207|NCT02976038|465092874|FG000|Overall Study|Adverse Event|1|||
129216208|NCT01046396|465092875|FG000|Overall Study|Withdrawal by Subject|5|||
129216209|NCT01208207|465092876|FG000|Part I|Adverse Event|19|||
129216210|NCT01208207|465092877|FG001|Part I|Adverse Event|2|||
129216211|NCT01208207|465092878|FG002|Part I|Adverse Event|6|||
129216212|NCT01208207|465092879|FG003|Part I|Adverse Event|0|||
129216213|NCT01208207|465092880|FG004|Part I|Adverse Event|0|||
129216214|NCT01208207|465092881|FG005|Part I|Adverse Event|0|||
129216215|NCT01208207|465092882|FG006|Part I|Adverse Event|0|||
129216216|NCT01208207|465092876|FG000|Part I|Lack of Efficacy|21|||
129216217|NCT01208207|465092877|FG001|Part I|Lack of Efficacy|3|||
129216218|NCT01208207|465092878|FG002|Part I|Lack of Efficacy|2|||
129216219|NCT01208207|465092879|FG003|Part I|Lack of Efficacy|0|||
129216220|NCT01208207|465092880|FG004|Part I|Lack of Efficacy|0|||
129216221|NCT01208207|465092881|FG005|Part I|Lack of Efficacy|0|||
129216222|NCT01208207|465092882|FG006|Part I|Lack of Efficacy|0|||
129216223|NCT01208207|465092876|FG000|Part I|Lost to Follow-up|6|||
129216224|NCT01208207|465092877|FG001|Part I|Lost to Follow-up|1|||
129216225|NCT01208207|465092878|FG002|Part I|Lost to Follow-up|0|||
129216226|NCT01208207|465092879|FG003|Part I|Lost to Follow-up|0|||
129216227|NCT01208207|465092880|FG004|Part I|Lost to Follow-up|0|||
129216228|NCT01208207|465092881|FG005|Part I|Lost to Follow-up|0|||
129216229|NCT01208207|465092882|FG006|Part I|Lost to Follow-up|0|||
129216230|NCT01208207|465092876|FG000|Part I|Non-Compliance With Study Drug|1|||
129216231|NCT01208207|465092877|FG001|Part I|Non-Compliance With Study Drug|0|||
129216232|NCT01208207|465092878|FG002|Part I|Non-Compliance With Study Drug|1|||
129216233|NCT01208207|465092879|FG003|Part I|Non-Compliance With Study Drug|0|||
129216234|NCT01208207|465092880|FG004|Part I|Non-Compliance With Study Drug|0|||
129216235|NCT01208207|465092881|FG005|Part I|Non-Compliance With Study Drug|0|||
129216236|NCT01208207|465092882|FG006|Part I|Non-Compliance With Study Drug|0|||
129216237|NCT01208207|465092876|FG000|Part I|Physician Decision|0|||
129216238|NCT01208207|465092877|FG001|Part I|Physician Decision|1|||
129216239|NCT01208207|465092878|FG002|Part I|Physician Decision|0|||
129216240|NCT01208207|465092879|FG003|Part I|Physician Decision|0|||
129216241|NCT01208207|465092880|FG004|Part I|Physician Decision|0|||
129216242|NCT01208207|465092881|FG005|Part I|Physician Decision|0|||
129216243|NCT01208207|465092882|FG006|Part I|Physician Decision|0|||
129216244|NCT01208207|465092876|FG000|Part I|Progressive Disease|1|||
129216245|NCT01208207|465092877|FG001|Part I|Progressive Disease|0|||
129216246|NCT01208207|465092878|FG002|Part I|Progressive Disease|0|||
129216247|NCT01208207|465092879|FG003|Part I|Progressive Disease|0|||
129216248|NCT01208207|465092880|FG004|Part I|Progressive Disease|0|||
129216249|NCT01208207|465092881|FG005|Part I|Progressive Disease|0|||
129216250|NCT01208207|465092882|FG006|Part I|Progressive Disease|0|||
129216251|NCT01208207|465092876|FG000|Part I|Protocol Violation|8|||
129216252|NCT01208207|465092877|FG001|Part I|Protocol Violation|0|||
128699428|NCT05248867|463198026|FG003|Double-blind Period|Other, not specified|0|||
128699429|NCT05248867|463198027|FG004|Double-blind Period|Other, not specified|0|||
129216253|NCT01208207|465092878|FG002|Part I|Protocol Violation|2|||
129216254|NCT01208207|465092879|FG003|Part I|Protocol Violation|0|||
129216255|NCT01208207|465092880|FG004|Part I|Protocol Violation|0|||
128699430|NCT05248867|463198028|FG005|Double-blind Period|Other, not specified|0|||
128919947|NCT05211336|463996880|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
129216256|NCT01208207|465092881|FG005|Part I|Protocol Violation|0|||
129216257|NCT01208207|465092882|FG006|Part I|Protocol Violation|0|||
129216258|NCT01208207|465092876|FG000|Part I|Withdrawal by Subject|14|||
129216259|NCT01208207|465092877|FG001|Part I|Withdrawal by Subject|4|||
129216260|NCT01208207|465092878|FG002|Part I|Withdrawal by Subject|4|||
129216261|NCT01208207|465092879|FG003|Part I|Withdrawal by Subject|0|||
129216262|NCT01208207|465092880|FG004|Part I|Withdrawal by Subject|0|||
129216263|NCT01208207|465092881|FG005|Part I|Withdrawal by Subject|0|||
129216264|NCT01208207|465092882|FG006|Part I|Withdrawal by Subject|0|||
129216265|NCT01208207|465092876|FG000|Part II|Withdrawal by Subject|0|||
129216266|NCT01208207|465092877|FG001|Part II|Withdrawal by Subject|0|||
129216267|NCT01208207|465092878|FG002|Part II|Withdrawal by Subject|0|||
129216268|NCT01208207|465092879|FG003|Part II|Withdrawal by Subject|10|||
129216269|NCT01208207|465092880|FG004|Part II|Withdrawal by Subject|9|||
129216270|NCT01208207|465092881|FG005|Part II|Withdrawal by Subject|3|||
128919948|NCT05211336|463996879|FG000|Overall Study|Progressive disease|0|||
128919949|NCT05211336|463996880|FG001|Overall Study|Progressive disease|4|||
128919950|NCT05211336|463996879|FG000|Overall Study|Death due to myocardial infarction|0|||
128919951|NCT05211336|463996880|FG001|Overall Study|Death due to myocardial infarction|1|||
128919952|NCT05211336|463996879|FG000|Overall Study|Death due to unknown cause|0|||
128919953|NCT05211336|463996880|FG001|Overall Study|Death due to unknown cause|1|||
128919954|NCT05211336|463996879|FG000|Overall Study|Worsening kidney function and quality of response|0|||
128919955|NCT05211336|463996880|FG001|Overall Study|Worsening kidney function and quality of response|1|||
128919956|NCT03575104|463996882|FG000|Overall Study|Adverse Event|4|||
128919957|NCT03575104|463996883|FG001|Overall Study|Adverse Event|3|||
128919958|NCT03575104|463996884|FG002|Overall Study|Adverse Event|4|||
128919959|NCT03575104|463996882|FG000|Overall Study|Withdrawal by Subject|13|||
128919960|NCT03575104|463996883|FG001|Overall Study|Withdrawal by Subject|16|||
128919961|NCT03575104|463996884|FG002|Overall Study|Withdrawal by Subject|11|||
128919962|NCT03575104|463996882|FG000|Overall Study|Other reasons|6|||
128919963|NCT03575104|463996883|FG001|Overall Study|Other reasons|8|||
128919964|NCT03575104|463996884|FG002|Overall Study|Other reasons|6|||
128919965|NCT03575104|463996882|FG000|Overall Study|Lost to Follow-up|1|||
128919966|NCT03575104|463996883|FG001|Overall Study|Lost to Follow-up|2|||
128919967|NCT03575104|463996884|FG002|Overall Study|Lost to Follow-up|1|||
128919968|NCT00434967|463996885|FG000|Overall Study|Adverse Event|2|||
128919969|NCT00434967|463996886|FG001|Overall Study|Adverse Event|4|||
128919970|NCT00434967|463996887|FG002|Overall Study|Adverse Event|3|||
128919971|NCT00434967|463996888|FG003|Overall Study|Adverse Event|3|||
128919972|NCT00434967|463996885|FG000|Overall Study|Lost to Follow-up|0|||
128919973|NCT00434967|463996886|FG001|Overall Study|Lost to Follow-up|0|||
128919974|NCT00434967|463996887|FG002|Overall Study|Lost to Follow-up|1|||
128919975|NCT00434967|463996888|FG003|Overall Study|Lost to Follow-up|0|||
128919976|NCT00434967|463996885|FG000|Overall Study|Withdrawal by Subject|2|||
128919977|NCT00434967|463996886|FG001|Overall Study|Withdrawal by Subject|2|||
128919978|NCT00434967|463996887|FG002|Overall Study|Withdrawal by Subject|4|||
128919979|NCT00434967|463996888|FG003|Overall Study|Withdrawal by Subject|6|||
128919980|NCT00434967|463996885|FG000|Overall Study|Randomized in error|0|||
128919981|NCT00434967|463996886|FG001|Overall Study|Randomized in error|0|||
128919982|NCT00434967|463996887|FG002|Overall Study|Randomized in error|0|||
128919983|NCT00434967|463996888|FG003|Overall Study|Randomized in error|1|||
128919984|NCT00434967|463996885|FG000|Overall Study|Protocol Violation|0|||
128919985|NCT00434967|463996886|FG001|Overall Study|Protocol Violation|1|||
128919986|NCT00434967|463996887|FG002|Overall Study|Protocol Violation|0|||
128919987|NCT00434967|463996888|FG003|Overall Study|Protocol Violation|1|||
128919988|NCT00434967|463996885|FG000|Overall Study|Physician Decision|1|||
128919989|NCT00434967|463996886|FG001|Overall Study|Physician Decision|1|||
128919990|NCT00434967|463996887|FG002|Overall Study|Physician Decision|1|||
128919991|NCT00434967|463996888|FG003|Overall Study|Physician Decision|0|||
128919992|NCT00434967|463996885|FG000|Overall Study|Patient Disposition Challenges|2|||
128919993|NCT00434967|463996886|FG001|Overall Study|Patient Disposition Challenges|0|||
128919994|NCT00434967|463996887|FG002|Overall Study|Patient Disposition Challenges|0|||
128919995|NCT00434967|463996888|FG003|Overall Study|Patient Disposition Challenges|3|||
128919996|NCT00408005|463996890|FG000|Induction|Adverse Event|19|||
128919997|NCT00408005|463996891|FG001|Induction|Adverse Event|3|||
128919998|NCT00408005|463996892|FG002|Induction|Adverse Event|0|||
128919999|NCT00408005|463996893|FG003|Induction|Adverse Event|0|||
128920000|NCT00408005|463996894|FG004|Induction|Adverse Event|0|||
128920001|NCT00408005|463996895|FG005|Induction|Adverse Event|0|||
128920002|NCT00408005|463996896|FG006|Induction|Adverse Event|0|||
128920003|NCT00408005|463996897|FG007|Induction|Adverse Event|0|||
128920004|NCT00408005|463996890|FG000|Induction|Death|6|||
128920005|NCT00408005|463996891|FG001|Induction|Death|0|||
128920006|NCT00408005|463996892|FG002|Induction|Death|0|||
128920007|NCT00408005|463996893|FG003|Induction|Death|0|||
128920008|NCT00408005|463996894|FG004|Induction|Death|0|||
128699431|NCT05248867|463198023|FG000|Open-label Period|Withdrawal by Subject|0|||
128920009|NCT00408005|463996895|FG005|Induction|Death|0|||
128920010|NCT00408005|463996896|FG006|Induction|Death|0|||
128920011|NCT00408005|463996897|FG007|Induction|Death|0|||
128920012|NCT00408005|463996890|FG000|Induction|Physician Decision|83|||
128920013|NCT00408005|463996891|FG001|Induction|Physician Decision|9|||
128920014|NCT00408005|463996892|FG002|Induction|Physician Decision|0|||
128699432|NCT05248867|463198024|FG001|Open-label Period|Withdrawal by Subject|0|||
128699433|NCT05248867|463198025|FG002|Open-label Period|Withdrawal by Subject|3|||
128920015|NCT00408005|463996893|FG003|Induction|Physician Decision|0|||
128920016|NCT00408005|463996894|FG004|Induction|Physician Decision|0|||
128920017|NCT00408005|463996895|FG005|Induction|Physician Decision|0|||
128920018|NCT00408005|463996896|FG006|Induction|Physician Decision|0|||
128920019|NCT00408005|463996897|FG007|Induction|Physician Decision|0|||
128699434|NCT05248867|463198026|FG003|Open-label Period|Withdrawal by Subject|1|||
128920020|NCT00408005|463996890|FG000|Induction|Withdrawal by Subject|2|||
128920021|NCT00408005|463996891|FG001|Induction|Withdrawal by Subject|4|||
128920022|NCT00408005|463996892|FG002|Induction|Withdrawal by Subject|0|||
128920023|NCT00408005|463996893|FG003|Induction|Withdrawal by Subject|0|||
128699435|NCT05248867|463198027|FG004|Open-label Period|Withdrawal by Subject|7|||
128699436|NCT05248867|463198028|FG005|Open-label Period|Withdrawal by Subject|9|||
128699437|NCT05248867|463198023|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
128699438|NCT05248867|463198024|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
128699439|NCT05248867|463198025|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
128699440|NCT05248867|463198026|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
128699441|NCT05248867|463198027|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
128699442|NCT05248867|463198028|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
128699443|NCT05248867|463198023|FG000|Open-label Period|Lost to Follow-up|0|||
128699444|NCT05248867|463198024|FG001|Open-label Period|Lost to Follow-up|0|||
128920024|NCT00408005|463996894|FG004|Induction|Withdrawal by Subject|0|||
128920025|NCT00408005|463996895|FG005|Induction|Withdrawal by Subject|0|||
128699445|NCT05248867|463198025|FG002|Open-label Period|Lost to Follow-up|0|||
128699446|NCT05248867|463198026|FG003|Open-label Period|Lost to Follow-up|0|||
128699447|NCT05248867|463198027|FG004|Open-label Period|Lost to Follow-up|5|||
128920026|NCT00408005|463996896|FG006|Induction|Withdrawal by Subject|0|||
128920027|NCT00408005|463996897|FG007|Induction|Withdrawal by Subject|0|||
128920028|NCT00408005|463996890|FG000|Induction|Ineligible|33|||
128920029|NCT00408005|463996891|FG001|Induction|Ineligible|14|||
128920030|NCT00408005|463996892|FG002|Induction|Ineligible|0|||
128920031|NCT00408005|463996893|FG003|Induction|Ineligible|0|||
128920032|NCT00408005|463996894|FG004|Induction|Ineligible|0|||
128920033|NCT00408005|463996895|FG005|Induction|Ineligible|0|||
128920034|NCT00408005|463996896|FG006|Induction|Ineligible|0|||
129216271|NCT01208207|465092882|FG006|Part II|Withdrawal by Subject|5|||
129216272|NCT01208207|465092876|FG000|Part II|Adverse Event|0|||
129216273|NCT01208207|465092877|FG001|Part II|Adverse Event|0|||
129216274|NCT01208207|465092878|FG002|Part II|Adverse Event|0|||
129216275|NCT01208207|465092879|FG003|Part II|Adverse Event|5|||
129216276|NCT01208207|465092880|FG004|Part II|Adverse Event|9|||
129216277|NCT01208207|465092881|FG005|Part II|Adverse Event|4|||
129216278|NCT01208207|465092882|FG006|Part II|Adverse Event|2|||
129216279|NCT01208207|465092876|FG000|Part II|Lack of Efficacy|0|||
129216280|NCT01208207|465092877|FG001|Part II|Lack of Efficacy|0|||
129216281|NCT01208207|465092878|FG002|Part II|Lack of Efficacy|0|||
129216282|NCT01208207|465092879|FG003|Part II|Lack of Efficacy|6|||
129216283|NCT01208207|465092880|FG004|Part II|Lack of Efficacy|4|||
129216284|NCT01208207|465092881|FG005|Part II|Lack of Efficacy|3|||
129216285|NCT01208207|465092882|FG006|Part II|Lack of Efficacy|3|||
129216286|NCT01208207|465092876|FG000|Part II|Lost to Follow-up|0|||
129216287|NCT01208207|465092877|FG001|Part II|Lost to Follow-up|0|||
129216288|NCT01208207|465092878|FG002|Part II|Lost to Follow-up|0|||
129216289|NCT01208207|465092879|FG003|Part II|Lost to Follow-up|4|||
129216290|NCT01208207|465092880|FG004|Part II|Lost to Follow-up|0|||
129216291|NCT01208207|465092881|FG005|Part II|Lost to Follow-up|2|||
129216292|NCT01208207|465092882|FG006|Part II|Lost to Follow-up|1|||
129216293|NCT01208207|465092876|FG000|Part II|Non-Compliance With Study Drug|0|||
129216294|NCT01208207|465092877|FG001|Part II|Non-Compliance With Study Drug|0|||
129216295|NCT01208207|465092878|FG002|Part II|Non-Compliance With Study Drug|0|||
129216296|NCT01208207|465092879|FG003|Part II|Non-Compliance With Study Drug|4|||
129216297|NCT01208207|465092880|FG004|Part II|Non-Compliance With Study Drug|1|||
129216298|NCT01208207|465092881|FG005|Part II|Non-Compliance With Study Drug|1|||
129216299|NCT01208207|465092882|FG006|Part II|Non-Compliance With Study Drug|0|||
129216300|NCT01208207|465092876|FG000|Part II|Physician Decision|0|||
129216301|NCT01208207|465092877|FG001|Part II|Physician Decision|0|||
128699448|NCT05248867|463198028|FG005|Open-label Period|Lost to Follow-up|2|||
128699449|NCT05248867|463198023|FG000|Open-label Period|COVID-19 Infection|0|||
128699450|NCT05248867|463198024|FG001|Open-label Period|COVID-19 Infection|0|||
128699451|NCT05248867|463198025|FG002|Open-label Period|COVID-19 Infection|0|||
128920035|NCT00408005|463996897|FG007|Induction|Ineligible|0|||
129216302|NCT01208207|465092878|FG002|Part II|Physician Decision|0|||
128920036|NCT00408005|463996890|FG000|Induction|Refusal of Further Protocol Therapy|225|||
128920037|NCT00408005|463996891|FG001|Induction|Refusal of Further Protocol Therapy|44|||
128920038|NCT00408005|463996892|FG002|Induction|Refusal of Further Protocol Therapy|0|||
129216303|NCT01208207|465092879|FG003|Part II|Physician Decision|1|||
129216304|NCT01208207|465092880|FG004|Part II|Physician Decision|0|||
129216305|NCT01208207|465092881|FG005|Part II|Physician Decision|2|||
129216306|NCT01208207|465092882|FG006|Part II|Physician Decision|0|||
128699452|NCT05248867|463198026|FG003|Open-label Period|COVID-19 Infection|0|||
128699453|NCT05248867|463198027|FG004|Open-label Period|COVID-19 Infection|1|||
128920039|NCT00408005|463996893|FG003|Induction|Refusal of Further Protocol Therapy|0|||
128920040|NCT00408005|463996894|FG004|Induction|Refusal of Further Protocol Therapy|0|||
128920041|NCT00408005|463996895|FG005|Induction|Refusal of Further Protocol Therapy|0|||
128920042|NCT00408005|463996896|FG006|Induction|Refusal of Further Protocol Therapy|0|||
128920043|NCT00408005|463996897|FG007|Induction|Refusal of Further Protocol Therapy|0|||
129216307|NCT01208207|465092876|FG000|Part II|Protocol Violation|0|||
129216308|NCT01208207|465092877|FG001|Part II|Protocol Violation|0|||
129216309|NCT01208207|465092878|FG002|Part II|Protocol Violation|0|||
129216310|NCT01208207|465092879|FG003|Part II|Protocol Violation|1|||
128920044|NCT00408005|463996890|FG000|Induction|Entered another COG therapeutic protocol|4|||
128920045|NCT00408005|463996891|FG001|Induction|Entered another COG therapeutic protocol|0|||
128920046|NCT00408005|463996892|FG002|Induction|Entered another COG therapeutic protocol|0|||
128920047|NCT00408005|463996893|FG003|Induction|Entered another COG therapeutic protocol|0|||
128920048|NCT00408005|463996894|FG004|Induction|Entered another COG therapeutic protocol|0|||
128920049|NCT00408005|463996895|FG005|Induction|Entered another COG therapeutic protocol|0|||
128920050|NCT00408005|463996896|FG006|Induction|Entered another COG therapeutic protocol|0|||
128920051|NCT00408005|463996897|FG007|Induction|Entered another COG therapeutic protocol|0|||
128920052|NCT00408005|463996890|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
128920053|NCT00408005|463996891|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
128920054|NCT00408005|463996892|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
128920055|NCT00408005|463996893|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
128920056|NCT00408005|463996894|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
128920057|NCT00408005|463996895|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
128920058|NCT00408005|463996896|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
128920059|NCT00408005|463996897|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
128920060|NCT00408005|463996890|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
128920061|NCT00408005|463996891|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
128920062|NCT00408005|463996892|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
128920063|NCT00408005|463996893|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
128920064|NCT00408005|463996894|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
128920065|NCT00408005|463996895|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
128920066|NCT00408005|463996896|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
128920067|NCT00408005|463996897|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
128920068|NCT00408005|463996890|FG000|Induction|Progressive Disease|0|||
128920069|NCT00408005|463996891|FG001|Induction|Progressive Disease|1|||
128920070|NCT00408005|463996892|FG002|Induction|Progressive Disease|0|||
128920071|NCT00408005|463996893|FG003|Induction|Progressive Disease|0|||
128920072|NCT00408005|463996894|FG004|Induction|Progressive Disease|0|||
128920073|NCT00408005|463996895|FG005|Induction|Progressive Disease|0|||
128920074|NCT00408005|463996896|FG006|Induction|Progressive Disease|0|||
128920075|NCT00408005|463996897|FG007|Induction|Progressive Disease|0|||
128920076|NCT00408005|463996890|FG000|Induction|Inevaluable|18|||
128920077|NCT00408005|463996891|FG001|Induction|Inevaluable|14|||
128920078|NCT00408005|463996892|FG002|Induction|Inevaluable|0|||
128920079|NCT00408005|463996893|FG003|Induction|Inevaluable|0|||
128920080|NCT00408005|463996894|FG004|Induction|Inevaluable|0|||
128920081|NCT00408005|463996895|FG005|Induction|Inevaluable|0|||
128920082|NCT00408005|463996896|FG006|Induction|Inevaluable|0|||
128920083|NCT00408005|463996897|FG007|Induction|Inevaluable|0|||
128920084|NCT00408005|463996890|FG000|Induction|Failed to Complete Randomization|3|||
128920085|NCT00408005|463996891|FG001|Induction|Failed to Complete Randomization|2|||
128920086|NCT00408005|463996892|FG002|Induction|Failed to Complete Randomization|0|||
128920087|NCT00408005|463996893|FG003|Induction|Failed to Complete Randomization|0|||
128920088|NCT00408005|463996894|FG004|Induction|Failed to Complete Randomization|0|||
128920089|NCT00408005|463996895|FG005|Induction|Failed to Complete Randomization|0|||
128920090|NCT00408005|463996896|FG006|Induction|Failed to Complete Randomization|0|||
128920091|NCT00408005|463996897|FG007|Induction|Failed to Complete Randomization|0|||
128920092|NCT00408005|463996890|FG000|Induction|Protocol Deviation|3|||
128920093|NCT00408005|463996891|FG001|Induction|Protocol Deviation|1|||
128920094|NCT00408005|463996892|FG002|Induction|Protocol Deviation|0|||
128920095|NCT00408005|463996893|FG003|Induction|Protocol Deviation|0|||
128920096|NCT00408005|463996894|FG004|Induction|Protocol Deviation|0|||
128920097|NCT00408005|463996895|FG005|Induction|Protocol Deviation|0|||
128920098|NCT00408005|463996896|FG006|Induction|Protocol Deviation|0|||
128920099|NCT00408005|463996897|FG007|Induction|Protocol Deviation|0|||
128920100|NCT00408005|463996890|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
128920101|NCT00408005|463996891|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
128920102|NCT00408005|463996892|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
128920103|NCT00408005|463996893|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
128920104|NCT00408005|463996894|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
128920105|NCT00408005|463996895|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
128920106|NCT00408005|463996896|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
128920107|NCT00408005|463996897|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
128920108|NCT00408005|463996890|FG000|Induction|Recurrent leukemia|1|||
128920109|NCT00408005|463996891|FG001|Induction|Recurrent leukemia|0|||
128920110|NCT00408005|463996892|FG002|Induction|Recurrent leukemia|0|||
128920111|NCT00408005|463996893|FG003|Induction|Recurrent leukemia|0|||
128920112|NCT00408005|463996894|FG004|Induction|Recurrent leukemia|0|||
128920113|NCT00408005|463996895|FG005|Induction|Recurrent leukemia|0|||
128920114|NCT00408005|463996896|FG006|Induction|Recurrent leukemia|0|||
128920115|NCT00408005|463996897|FG007|Induction|Recurrent leukemia|0|||
128920116|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
128920117|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
128699454|NCT05248867|463198028|FG005|Open-label Period|COVID-19 Infection|0|||
128699455|NCT05248867|463198023|FG000|Open-label Period|Other, not specified|0|||
128699456|NCT05248867|463198024|FG001|Open-label Period|Other, not specified|0|||
128699457|NCT05248867|463198025|FG002|Open-label Period|Other, not specified|0|||
128920118|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
128920119|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
128920120|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
128920121|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
128920122|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
128920123|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
128920124|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
128920125|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
128920126|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
128920127|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
128920128|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
128920129|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
128920130|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
128920131|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
128920132|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
128920133|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
128920134|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
128920135|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
128920136|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
128920137|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
128920138|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
128920139|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
128920140|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
128920141|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
128920142|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
128920143|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
128920144|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
128920145|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
128920146|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
128920147|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
128920148|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
128920149|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
128920150|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
128920151|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
128920152|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
128920153|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
128920154|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
128920155|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
128920156|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
128920157|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
128920158|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
128920159|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
128920160|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
128920161|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
128920162|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
128920163|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
128920164|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
128920165|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
128920166|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
128920167|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
128920168|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
128920169|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
128920170|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
128920171|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
128920172|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
128920173|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
128920174|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
128699458|NCT05248867|463198026|FG003|Open-label Period|Other, not specified|0|||
128699459|NCT05248867|463198027|FG004|Open-label Period|Other, not specified|4|||
128699460|NCT05248867|463198028|FG005|Open-label Period|Other, not specified|0|||
128699461|NCT01064310|463198029|FG000|Period 1|Adverse Event|7|||
128699462|NCT01064310|463198030|FG001|Period 1|Adverse Event|10|||
128699463|NCT01064310|463198031|FG002|Period 1|Adverse Event|0|||
128699464|NCT01064310|463198029|FG000|Period 1|Physician Decision|1|||
128699465|NCT01064310|463198030|FG001|Period 1|Physician Decision|0|||
128699466|NCT01064310|463198031|FG002|Period 1|Physician Decision|0|||
128699467|NCT01064310|463198029|FG000|Period 1|Withdrawal by Subject|2|||
128699468|NCT01064310|463198030|FG001|Period 1|Withdrawal by Subject|2|||
128699469|NCT01064310|463198031|FG002|Period 1|Withdrawal by Subject|0|||
128699470|NCT01064310|463198029|FG000|Period 1|Lack of Efficacy|3|||
128699471|NCT01064310|463198030|FG001|Period 1|Lack of Efficacy|5|||
128699472|NCT01064310|463198031|FG002|Period 1|Lack of Efficacy|0|||
128699473|NCT01064310|463198029|FG000|Period 1|Entered Open-label Period|1|||
128699474|NCT01064310|463198030|FG001|Period 1|Entered Open-label Period|1|||
128920175|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
128699475|NCT01064310|463198031|FG002|Period 1|Entered Open-label Period|0|||
128699476|NCT01064310|463198029|FG000|Period 2|Adverse Event|2|||
128699477|NCT01064310|463198030|FG001|Period 2|Adverse Event|1|||
128699478|NCT01064310|463198031|FG002|Period 2|Adverse Event|0|||
128699479|NCT01064310|463198029|FG000|Period 2|Physician Decision|0|||
128920176|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
128920177|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
128920178|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
128920179|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
128920180|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
128920181|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
128920182|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
128920183|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
128920184|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
128920185|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
128920186|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
128920187|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
128920188|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
128920189|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
128920190|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
128920191|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
128920192|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
128920193|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
128920194|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
128920195|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
128920196|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
128920197|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
128920198|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
128920199|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
128920200|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
128920201|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
128920202|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
128920203|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
128920204|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
128920205|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
128920206|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
128920207|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
128920208|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
128920209|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
128920210|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
128920211|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
128920212|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
128920213|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
128920214|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
128920215|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
128920216|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
128978048|NCT02743494|464205306|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
128920217|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
128920218|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
128699480|NCT01064310|463198030|FG001|Period 2|Physician Decision|1|||
128699481|NCT01064310|463198031|FG002|Period 2|Physician Decision|0|||
128699482|NCT01064310|463198029|FG000|Period 2|Entered Open-label Period|1|||
128699483|NCT01064310|463198030|FG001|Period 2|Entered Open-label Period|0|||
128699484|NCT01064310|463198031|FG002|Period 2|Entered Open-label Period|0|||
128699485|NCT01064310|463198029|FG000|Period 2|Lack of Efficacy|1|||
128699486|NCT01064310|463198030|FG001|Period 2|Lack of Efficacy|4|||
128920219|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
128920220|NCT00408005|463996890|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
128920221|NCT00408005|463996891|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
128920222|NCT00408005|463996892|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
128920223|NCT00408005|463996893|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
128920224|NCT00408005|463996894|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
128920225|NCT00408005|463996895|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
128920226|NCT00408005|463996896|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
128920227|NCT00408005|463996897|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
128920228|NCT03155997|463996898|FG000|Overall Study|Withdrawal by Subject|119|||
128920229|NCT03155997|463996899|FG001|Overall Study|Withdrawal by Subject|134|||
128920230|NCT03155997|463996898|FG000|Overall Study|Lost to Follow-up|12|||
128920231|NCT03155997|463996899|FG001|Overall Study|Lost to Follow-up|13|||
128920232|NCT03155997|463996898|FG000|Overall Study|Missing disposition data|0|||
128920233|NCT03155997|463996899|FG001|Overall Study|Missing disposition data|1|||
128920234|NCT03155997|463996898|FG000|Overall Study|On study treatment|2027|||
128920235|NCT03155997|463996899|FG001|Overall Study|On study treatment|2074|||
128920236|NCT01848145|463996900|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
128920237|NCT01848145|463996900|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
128920238|NCT01848145|463996900|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
128920239|NCT01848145|463996900|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
128920240|NCT01848145|463996900|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
128920241|NCT01848145|463996900|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
128920242|NCT01848145|463996900|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
128920243|NCT02347631|463996901|FG000|First Intervention (2 Months)|Adverse Event|1|||
128920244|NCT02347631|463996902|FG001|First Intervention (2 Months)|Adverse Event|1|||
128920245|NCT02347631|463996901|FG000|First Intervention (2 Months)|Pregnancy|1|||
128920246|NCT02347631|463996902|FG001|First Intervention (2 Months)|Pregnancy|0|||
128920247|NCT02347631|463996901|FG000|First Intervention (2 Months)|Moved out of area|0|||
128920248|NCT02347631|463996902|FG001|First Intervention (2 Months)|Moved out of area|2|||
128920249|NCT02347631|463996901|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
128920250|NCT02347631|463996902|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
128920251|NCT02347631|463996901|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
128920252|NCT02347631|463996902|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
128920253|NCT02347631|463996901|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
128920254|NCT02347631|463996902|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
129029220|NCT00537095|464398374|FG001|Randomized Treatment Period (433 Days)|Death|1|||
129029221|NCT00537095|464398373|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
129029222|NCT00537095|464398374|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
129029223|NCT00537095|464398373|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
129029224|NCT00537095|464398374|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
129029225|NCT00537095|464398373|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
129029226|NCT00537095|464398374|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
129029227|NCT00537095|464398373|FG000|Open-label Period (590 Days)|Adverse Event|2|||
129029228|NCT00537095|464398374|FG001|Open-label Period (590 Days)|Adverse Event|11|||
129029229|NCT00537095|464398373|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
129029230|NCT00537095|464398374|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
129029231|NCT00537095|464398373|FG000|Open-label Period (590 Days)|Death|2|||
128699487|NCT01064310|463198031|FG002|Period 2|Lack of Efficacy|0|||
128920255|NCT02347631|463996901|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
129029232|NCT00537095|464398374|FG001|Open-label Period (590 Days)|Death|2|||
129029233|NCT00537095|464398373|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
129029234|NCT00537095|464398374|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
129029235|NCT00537095|464398373|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
128699488|NCT01064310|463198029|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
128699489|NCT01064310|463198030|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
128699490|NCT01064310|463198031|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
128699491|NCT01064310|463198029|FG000|Open Label Pazopinib|Adverse Event|0|||
128920256|NCT02347631|463996902|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
128920257|NCT02347631|463996901|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
128920258|NCT02347631|463996902|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
128920259|NCT00501228|463996903|FG000|Overall Study|Withdrawal by Subject|1|||
128920260|NCT00331006|463996905|FG000|Screening Phase|Withdrawal by Subject|1|||
128920261|NCT00331006|463996905|FG000|Screening Phase|enrollment halted|1|||
128920262|NCT00331006|463996905|FG000|Screening Phase|Lost to Follow-up|1|||
128699492|NCT01064310|463198030|FG001|Open Label Pazopinib|Adverse Event|0|||
128699493|NCT01064310|463198031|FG002|Open Label Pazopinib|Adverse Event|12|||
128699494|NCT01064310|463198029|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
128699495|NCT01064310|463198030|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
128699496|NCT01064310|463198031|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
128699497|NCT01064310|463198029|FG000|Open Label Pazopinib|Physician Decision|0|||
128699498|NCT01064310|463198030|FG001|Open Label Pazopinib|Physician Decision|0|||
128699499|NCT01064310|463198031|FG002|Open Label Pazopinib|Physician Decision|20|||
128699500|NCT00679432|463198032|FG000|Overall Study|Adverse Event|5|||
128699501|NCT00679432|463198033|FG001|Overall Study|Adverse Event|6|||
128699502|NCT00679432|463198034|FG002|Overall Study|Adverse Event|10|||
128699503|NCT00679432|463198035|FG003|Overall Study|Adverse Event|7|||
128699504|NCT00679432|463198032|FG000|Overall Study|Protocol Violation|1|||
128699505|NCT00679432|463198033|FG001|Overall Study|Protocol Violation|1|||
128699506|NCT00679432|463198034|FG002|Overall Study|Protocol Violation|2|||
128699507|NCT00679432|463198035|FG003|Overall Study|Protocol Violation|1|||
128699508|NCT00679432|463198032|FG000|Overall Study|Withdrawal by Subject|8|||
128699509|NCT00679432|463198033|FG001|Overall Study|Withdrawal by Subject|11|||
128699510|NCT00679432|463198034|FG002|Overall Study|Withdrawal by Subject|10|||
128699511|NCT00679432|463198035|FG003|Overall Study|Withdrawal by Subject|9|||
128699512|NCT00679432|463198032|FG000|Overall Study|Lost to Follow-up|1|||
128699513|NCT00679432|463198033|FG001|Overall Study|Lost to Follow-up|5|||
128699514|NCT00679432|463198034|FG002|Overall Study|Lost to Follow-up|4|||
128699515|NCT00679432|463198035|FG003|Overall Study|Lost to Follow-up|2|||
128699516|NCT00679432|463198032|FG000|Overall Study|Physician Decision|3|||
128699517|NCT00679432|463198033|FG001|Overall Study|Physician Decision|2|||
128699518|NCT00679432|463198034|FG002|Overall Study|Physician Decision|2|||
128699519|NCT00679432|463198035|FG003|Overall Study|Physician Decision|2|||
128699520|NCT00679432|463198032|FG000|Overall Study|Sponsor decision|1|||
128699521|NCT00679432|463198033|FG001|Overall Study|Sponsor decision|0|||
128920263|NCT00331006|463996905|FG000|Screening Phase|Ineligible for treatment phase|4|||
128920264|NCT00331006|463996905|FG000|Treatment Phase|Withdrawal by Subject|1|||
128920265|NCT00331006|463996905|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
128920266|NCT00331006|463996905|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
128920267|NCT03804684|463996906|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
128920268|NCT03804684|463996907|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
128920269|NCT03304522|463996911|FG000|Overall Study|Adverse Event|0|||
128920270|NCT03304522|463996912|FG001|Overall Study|Adverse Event|4|||
128920271|NCT03304522|463996911|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
128920272|NCT03304522|463996912|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
128920273|NCT03304522|463996911|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
128920274|NCT03304522|463996912|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
128920275|NCT03304522|463996911|FG000|Overall Study|Other|0|||
128920276|NCT03304522|463996912|FG001|Overall Study|Other|1|||
128920277|NCT01670994|463996917|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
128920278|NCT01670994|463996918|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
128920279|NCT01670994|463996917|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
128920280|NCT01670994|463996918|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
128920281|NCT01670994|463996917|FG000|Overall Study|Patient experienced DLT|0|||
128920282|NCT01670994|463996918|FG001|Overall Study|Patient experienced DLT|1|||
128920283|NCT02013544|463996919|FG000|Overall Study|Adverse Event|5|||
128920284|NCT02013544|463996920|FG001|Overall Study|Adverse Event|5|||
128699522|NCT00679432|463198034|FG002|Overall Study|Sponsor decision|0|||
128699523|NCT00679432|463198035|FG003|Overall Study|Sponsor decision|0|||
128920285|NCT02013544|463996919|FG000|Overall Study|Lost to Follow-up|2|||
128920286|NCT02013544|463996920|FG001|Overall Study|Lost to Follow-up|3|||
128920287|NCT02013544|463996919|FG000|Overall Study|Withdrawal by Subject|2|||
128920288|NCT02013544|463996920|FG001|Overall Study|Withdrawal by Subject|8|||
128920289|NCT02013544|463996919|FG000|Overall Study|Physician Decision|0|||
128920290|NCT02013544|463996920|FG001|Overall Study|Physician Decision|1|||
128920291|NCT02013544|463996919|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
128699524|NCT00679432|463198032|FG000|Overall Study|Lack of Efficacy|13|||
128699525|NCT00679432|463198033|FG001|Overall Study|Lack of Efficacy|9|||
128699526|NCT00679432|463198034|FG002|Overall Study|Lack of Efficacy|14|||
128699527|NCT00679432|463198035|FG003|Overall Study|Lack of Efficacy|8|||
128699528|NCT00679432|463198032|FG000|Overall Study|Infectious colitis, normal histology|5|||
128699529|NCT00679432|463198033|FG001|Overall Study|Infectious colitis, normal histology|4|||
128699530|NCT00679432|463198034|FG002|Overall Study|Infectious colitis, normal histology|8|||
128699531|NCT00679432|463198035|FG003|Overall Study|Infectious colitis, normal histology|3|||
128699532|NCT00679432|463198032|FG000|Overall Study|Randomization error, return to prior Rx|0|||
128699533|NCT00679432|463198033|FG001|Overall Study|Randomization error, return to prior Rx|0|||
128699534|NCT00679432|463198034|FG002|Overall Study|Randomization error, return to prior Rx|3|||
128920292|NCT02013544|463996920|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
128920293|NCT01295125|463996921|FG000|Overall Study|Study stopped prematurely|9|||
128920294|NCT00885365|463996924|FG000|4 Weeks ON Treatment|Adverse Event|2|||
128920295|NCT00885365|463996925|FG001|4 Weeks ON Treatment|Adverse Event|4|||
128920296|NCT00885365|463996924|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
128920297|NCT00885365|463996925|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
128920298|NCT00885365|463996924|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
128920299|NCT00885365|463996925|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
128920300|NCT01824979|463996926|FG000|Overall Study|Withdrawal by Subject|5|||
128920301|NCT01824979|463996927|FG001|Overall Study|Withdrawal by Subject|0|||
128920302|NCT01824979|463996926|FG000|Overall Study|Physician Decision|2|||
128920303|NCT01824979|463996927|FG001|Overall Study|Physician Decision|0|||
128920304|NCT01824979|463996926|FG000|Overall Study|Protocol Violation|6|||
128920305|NCT01824979|463996927|FG001|Overall Study|Protocol Violation|13|||
128920306|NCT00888238|463996929|FG000|Washout Period After Period 2|Adverse Event|0|||
128920307|NCT00888238|463996930|FG001|Washout Period After Period 2|Adverse Event|0|||
128920308|NCT00888238|463996931|FG002|Washout Period After Period 2|Adverse Event|1|||
129216311|NCT01208207|465092880|FG004|Part II|Protocol Violation|0|||
129216312|NCT01208207|465092881|FG005|Part II|Protocol Violation|0|||
129216313|NCT01208207|465092882|FG006|Part II|Protocol Violation|0|||
128699535|NCT00679432|463198035|FG003|Overall Study|Randomization error, return to prior Rx|0|||
128920309|NCT03371355|463996940|FG000|Overall Study|Investigator judgment|0|||
128920310|NCT03371355|463996941|FG001|Overall Study|Investigator judgment|0|||
128920311|NCT03371355|463996942|FG002|Overall Study|Investigator judgment|1|||
128920312|NCT03371355|463996943|FG003|Overall Study|Investigator judgment|1|||
128920313|NCT03371355|463996940|FG000|Overall Study|Voluntary withdrawal|1|||
128920314|NCT03371355|463996941|FG001|Overall Study|Voluntary withdrawal|0|||
128920315|NCT03371355|463996942|FG002|Overall Study|Voluntary withdrawal|1|||
128920316|NCT03371355|463996943|FG003|Overall Study|Voluntary withdrawal|2|||
128920317|NCT03371355|463996940|FG000|Overall Study|Adverse Event|0|||
128920318|NCT03371355|463996941|FG001|Overall Study|Adverse Event|1|||
128920319|NCT03371355|463996942|FG002|Overall Study|Adverse Event|2|||
128920320|NCT03371355|463996943|FG003|Overall Study|Adverse Event|3|||
128920321|NCT03371355|463996940|FG000|Overall Study|Reason not Specified|0|||
128920322|NCT03371355|463996941|FG001|Overall Study|Reason not Specified|1|||
128920323|NCT03371355|463996942|FG002|Overall Study|Reason not Specified|0|||
128920324|NCT03371355|463996943|FG003|Overall Study|Reason not Specified|1|||
128920325|NCT01662648|463996944|FG000|Overall Study|Death|1|||
128920326|NCT01662648|463996945|FG001|Overall Study|Death|3|||
128920327|NCT01662648|463996944|FG000|Overall Study|Adverse Event|40|||
128920328|NCT01662648|463996945|FG001|Overall Study|Adverse Event|37|||
128920329|NCT01662648|463996944|FG000|Overall Study|Lack of Efficacy|17|||
128920330|NCT01662648|463996945|FG001|Overall Study|Lack of Efficacy|16|||
128920331|NCT01662648|463996944|FG000|Overall Study|Participant ineligible to continue trial|1|||
128920332|NCT01662648|463996945|FG001|Overall Study|Participant ineligible to continue trial|1|||
128920333|NCT01662648|463996944|FG000|Overall Study|Lost to Follow-up|24|||
128920334|NCT01662648|463996945|FG001|Overall Study|Lost to Follow-up|36|||
128920335|NCT01662648|463996944|FG000|Overall Study|Withdrawal by Subject|36|||
128920336|NCT01662648|463996945|FG001|Overall Study|Withdrawal by Subject|53|||
128920337|NCT01662648|463996944|FG000|Overall Study|Participant non-compliant|16|||
128920338|NCT01662648|463996945|FG001|Overall Study|Participant non-compliant|20|||
128920339|NCT01662648|463996944|FG000|Overall Study|Other|8|||
128920340|NCT01662648|463996945|FG001|Overall Study|Other|11|||
128920341|NCT01662648|463996944|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
128920342|NCT01662648|463996945|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
128920343|NCT01662648|463996944|FG000|Overall Study|LOE and other reason unspecified|1|||
128920344|NCT01662648|463996945|FG001|Overall Study|LOE and other reason unspecified|0|||
128920345|NCT01662648|463996944|FG000|Overall Study|LOE and Participant non-compliant|0|||
128920346|NCT01662648|463996945|FG001|Overall Study|LOE and Participant non-compliant|1|||
128920347|NCT03751111|463996947|FG000|Overall Study|Lack of Efficacy|9|||
128920348|NCT03751111|463996948|FG001|Overall Study|Lack of Efficacy|30|||
128920349|NCT03751111|463996947|FG000|Overall Study|Adverse Event|3|||
128699536|NCT02339584|463198036|FG000|Overall Study|Adverse Event|11|||
128920350|NCT03751111|463996948|FG001|Overall Study|Adverse Event|2|||
128920351|NCT01264939|463996949|FG000|Overall Study|Adverse Event|1|||
128920352|NCT01264939|463996950|FG001|Overall Study|Adverse Event|3|||
128920353|NCT01264939|463996949|FG000|Overall Study|Lost to Follow-up|0|||
128920354|NCT01264939|463996950|FG001|Overall Study|Lost to Follow-up|3|||
128920355|NCT01264939|463996949|FG000|Overall Study|Physician Decision|1|||
128920356|NCT01264939|463996950|FG001|Overall Study|Physician Decision|1|||
129216314|NCT01208207|465092876|FG000|Part II|Technical Problems|0|||
129029236|NCT00537095|464398374|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
129029237|NCT00566722|464398375|FG000|Overall Study|Adverse Event|0|||
128920357|NCT01264939|463996949|FG000|Overall Study|Patient/Guardian Decision|8|||
128920358|NCT01264939|463996950|FG001|Overall Study|Patient/Guardian Decision|10|||
128920359|NCT01264939|463996949|FG000|Overall Study|Disease Progression|8|||
128920360|NCT01264939|463996950|FG001|Overall Study|Disease Progression|11|||
128920361|NCT01145560|463996955|FG000|Overall Study|Withdrawal by Subject|2|||
128920362|NCT01145560|463996956|FG001|Overall Study|Withdrawal by Subject|1|||
128920363|NCT01145560|463996957|FG002|Overall Study|Withdrawal by Subject|0|||
128920364|NCT01145560|463996955|FG000|Overall Study|Lost to Follow-up|1|||
128920365|NCT01145560|463996956|FG001|Overall Study|Lost to Follow-up|1|||
128920366|NCT01145560|463996957|FG002|Overall Study|Lost to Follow-up|1|||
128920367|NCT01145560|463996955|FG000|Overall Study|No study drug by 24h after organ failure|1|||
128920368|NCT01145560|463996956|FG001|Overall Study|No study drug by 24h after organ failure|0|||
128920369|NCT01145560|463996957|FG002|Overall Study|No study drug by 24h after organ failure|0|||
128920370|NCT01145560|463996955|FG000|Overall Study|Accidental unblinding of study treatment|0|||
128920371|NCT01145560|463996956|FG001|Overall Study|Accidental unblinding of study treatment|1|||
128920372|NCT01145560|463996957|FG002|Overall Study|Accidental unblinding of study treatment|0|||
128920373|NCT01145560|463996955|FG000|Overall Study|False insurance information|0|||
128920374|NCT01145560|463996956|FG001|Overall Study|False insurance information|1|||
128920375|NCT01145560|463996957|FG002|Overall Study|False insurance information|0|||
128920376|NCT01145560|463996955|FG000|Overall Study|Withdrawal of therapy|0|||
128920377|NCT01145560|463996956|FG001|Overall Study|Withdrawal of therapy|0|||
128920378|NCT01145560|463996957|FG002|Overall Study|Withdrawal of therapy|1|||
128920379|NCT02452762|463996959|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
128920380|NCT02452762|463996960|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
128920381|NCT02452762|463996959|FG000|Overall Study|Withdrawal by Subject|1|||
128920382|NCT02452762|463996960|FG001|Overall Study|Withdrawal by Subject|0|||
128920383|NCT00584870|463996961|FG000|Overall Study|Adverse Event|4|||
128920384|NCT00584870|463996962|FG001|Overall Study|Adverse Event|3|||
128920385|NCT00584870|463996963|FG002|Overall Study|Adverse Event|2|||
129029238|NCT00566722|464398376|FG001|Overall Study|Adverse Event|1|||
129029239|NCT00566722|464398377|FG002|Overall Study|Adverse Event|0|||
129029240|NCT00566722|464398375|FG000|Overall Study|Withdrawal by Subject|0|||
129029241|NCT00566722|464398376|FG001|Overall Study|Withdrawal by Subject|0|||
129029242|NCT00566722|464398377|FG002|Overall Study|Withdrawal by Subject|1|||
129029243|NCT00566722|464398375|FG000|Overall Study|Lost to Follow-up|1|||
129029244|NCT00566722|464398376|FG001|Overall Study|Lost to Follow-up|1|||
129029245|NCT00566722|464398377|FG002|Overall Study|Lost to Follow-up|1|||
129029246|NCT00566722|464398375|FG000|Overall Study|Lack of Efficacy|1|||
129029247|NCT00566722|464398376|FG001|Overall Study|Lack of Efficacy|2|||
129029248|NCT00566722|464398377|FG002|Overall Study|Lack of Efficacy|4|||
128699537|NCT02339584|463198037|FG001|Overall Study|Adverse Event|7|||
128699538|NCT02339584|463198036|FG000|Overall Study|Lack of Efficacy|0|||
128699539|NCT02339584|463198037|FG001|Overall Study|Lack of Efficacy|1|||
128699540|NCT02339584|463198036|FG000|Overall Study|Physician Decision|1|||
128699541|NCT02339584|463198037|FG001|Overall Study|Physician Decision|2|||
128699542|NCT02339584|463198036|FG000|Overall Study|Protocol Violation|1|||
128699543|NCT02339584|463198037|FG001|Overall Study|Protocol Violation|1|||
128699544|NCT02339584|463198036|FG000|Overall Study|Withdrawal by Subject|2|||
128699545|NCT02339584|463198037|FG001|Overall Study|Withdrawal by Subject|4|||
128699546|NCT01084083|463198038|FG000|Overall Study|Adverse Event|5|||
128699547|NCT01084083|463198038|FG000|Overall Study|Death|1|||
128699548|NCT01084083|463198038|FG000|Overall Study|Withdrawal by Subject|2|||
128699549|NCT01084083|463198038|FG000|Overall Study|Complicating disease|1|||
128699550|NCT01084083|463198038|FG000|Overall Study|Other|2|||
128699551|NCT01084083|463198038|FG000|Overall Study|Never started assigned therapy|1|||
128699552|NCT01980940|463198039|FG000|Overall Study|Protocol Violation|0|||
128699553|NCT01980940|463198040|FG001|Overall Study|Protocol Violation|0|||
128699554|NCT01980940|463198041|FG002|Overall Study|Protocol Violation|0|||
128699555|NCT01980940|463198042|FG003|Overall Study|Protocol Violation|0|||
128699556|NCT01980940|463198043|FG004|Overall Study|Protocol Violation|0|||
128699557|NCT01980940|463198044|FG005|Overall Study|Protocol Violation|2|||
128699558|NCT01980940|463198045|FG006|Overall Study|Protocol Violation|0|||
128699559|NCT01980940|463198046|FG007|Overall Study|Protocol Violation|0|||
128699560|NCT05996718|463199725|FG000|Overall Study|Lost to Follow-up|3|||
128699561|NCT01713686|463199726|FG000|Overall Study|Lost to Follow-up|9|||
128920386|NCT00584870|463996961|FG000|Overall Study|Lost to Follow-up|4|||
128920387|NCT00584870|463996962|FG001|Overall Study|Lost to Follow-up|1|||
128920388|NCT00584870|463996963|FG002|Overall Study|Lost to Follow-up|1|||
128920389|NCT00584870|463996961|FG000|Overall Study|Lack of Efficacy|7|||
129029249|NCT00566722|464398375|FG000|Overall Study|Did not meet exclusion criteria|0|||
128699562|NCT01713686|463199726|FG000|Overall Study|Withdrawal by Subject|6|||
128699563|NCT01606800|463199727|FG000|Overall Study|Adverse Event|3|||
128699564|NCT01606800|463199728|FG001|Overall Study|Adverse Event|1|||
128699565|NCT01606800|463199727|FG000|Overall Study|Participant withdrew consent|0|||
128920390|NCT00584870|463996962|FG001|Overall Study|Lack of Efficacy|14|||
128920391|NCT00584870|463996963|FG002|Overall Study|Lack of Efficacy|8|||
128920392|NCT00584870|463996961|FG000|Overall Study|Withdrawal by Subject|10|||
128920393|NCT00584870|463996962|FG001|Overall Study|Withdrawal by Subject|5|||
128920394|NCT00584870|463996963|FG002|Overall Study|Withdrawal by Subject|3|||
128920395|NCT00584870|463996961|FG000|Overall Study|Protocol Violation|1|||
128920396|NCT00584870|463996962|FG001|Overall Study|Protocol Violation|1|||
128920397|NCT00584870|463996963|FG002|Overall Study|Protocol Violation|2|||
128920398|NCT00584870|463996961|FG000|Overall Study|Did not met entrance criteria|1|||
128920399|NCT00584870|463996962|FG001|Overall Study|Did not met entrance criteria|0|||
128920400|NCT00584870|463996963|FG002|Overall Study|Did not met entrance criteria|0|||
128920401|NCT00584870|463996961|FG000|Overall Study|Other|2|||
128920402|NCT00584870|463996962|FG001|Overall Study|Other|0|||
128920403|NCT00584870|463996963|FG002|Overall Study|Other|0|||
128920404|NCT00584870|463996961|FG000|Overall Study|Randomized but not treated|0|||
128920405|NCT00584870|463996962|FG001|Overall Study|Randomized but not treated|1|||
128920406|NCT00584870|463996963|FG002|Overall Study|Randomized but not treated|2|||
128920407|NCT02675075|463996964|FG000|Overall Study|Lost to Follow-up|3|||
128920408|NCT02675075|463996965|FG001|Overall Study|Lost to Follow-up|0|||
128920409|NCT00675597|463996966|FG000|Overall Study|Withdrawal by Subject|3|||
128920410|NCT00631137|463996967|FG000|Overall Study|Withdrawal by Subject|1|||
128920411|NCT00631137|463996968|FG001|Overall Study|Withdrawal by Subject|0|||
128920412|NCT03682120|463996969|FG000|Overall Study|Lost to Follow-up|11|||
128920413|NCT03682120|463996970|FG001|Overall Study|Lost to Follow-up|4|||
128920414|NCT03682120|463996971|FG002|Overall Study|Lost to Follow-up|5|||
128920415|NCT03682120|463996972|FG003|Overall Study|Lost to Follow-up|2|||
128920416|NCT03682120|463996969|FG000|Overall Study|Physician Decision|1|||
128920417|NCT03682120|463996970|FG001|Overall Study|Physician Decision|0|||
128920418|NCT03682120|463996971|FG002|Overall Study|Physician Decision|0|||
128920419|NCT03682120|463996972|FG003|Overall Study|Physician Decision|0|||
128920420|NCT03682120|463996969|FG000|Overall Study|Withdrawal by Subject|1|||
128920421|NCT03682120|463996970|FG001|Overall Study|Withdrawal by Subject|2|||
128920422|NCT03682120|463996971|FG002|Overall Study|Withdrawal by Subject|3|||
128920423|NCT03682120|463996972|FG003|Overall Study|Withdrawal by Subject|0|||
128920424|NCT03682120|463996969|FG000|Overall Study|Death|0|||
128920425|NCT03682120|463996970|FG001|Overall Study|Death|1|||
128920426|NCT03682120|463996971|FG002|Overall Study|Death|0|||
128920427|NCT03682120|463996972|FG003|Overall Study|Death|0|||
128920428|NCT03682120|463996969|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
128920429|NCT03682120|463996970|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
128920430|NCT03682120|463996971|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
128920431|NCT03682120|463996972|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
128920432|NCT03308188|463996973|FG000|Overall Study|Withdrawal by Subject|0|||
128920433|NCT03308188|463996974|FG001|Overall Study|Withdrawal by Subject|3|||
128920434|NCT03308188|463996973|FG000|Overall Study|Death|0|||
128920435|NCT03308188|463996974|FG001|Overall Study|Death|1|||
128920436|NCT01791855|463996975|FG000|Overall Study|Adverse Event|0|||
128920437|NCT01791855|463996976|FG001|Overall Study|Adverse Event|0|||
128920438|NCT01791855|463996977|FG002|Overall Study|Adverse Event|0|||
128920439|NCT01791855|463996978|FG003|Overall Study|Adverse Event|1|||
128920440|NCT01791855|463996975|FG000|Overall Study|Randomized, not treated|0|||
128920441|NCT01791855|463996976|FG001|Overall Study|Randomized, not treated|1|||
128920442|NCT01791855|463996977|FG002|Overall Study|Randomized, not treated|0|||
128920443|NCT01791855|463996978|FG003|Overall Study|Randomized, not treated|0|||
128920444|NCT00772447|463996979|FG000|Overall Study|Withdrawal by Subject|9|||
128920445|NCT00772447|463996980|FG001|Overall Study|Withdrawal by Subject|5|||
128920446|NCT00772447|463996979|FG000|Overall Study|Physician Decision|4|||
128920447|NCT00772447|463996980|FG001|Overall Study|Physician Decision|8|||
128920448|NCT00772447|463996979|FG000|Overall Study|Lost to Follow-up|2|||
128920449|NCT00772447|463996980|FG001|Overall Study|Lost to Follow-up|4|||
128920450|NCT00772447|463996979|FG000|Overall Study|incorrect enrolment|3|||
128920451|NCT00772447|463996980|FG001|Overall Study|incorrect enrolment|4|||
128920452|NCT00772447|463996979|FG000|Overall Study|Protocol Violation|0|||
128920453|NCT00772447|463996980|FG001|Overall Study|Protocol Violation|1|||
128920454|NCT00772447|463996979|FG000|Overall Study|all others|2|||
128920455|NCT00772447|463996980|FG001|Overall Study|all others|2|||
128920456|NCT01957137|463996984|FG000|Randomized Portion|Adverse Event|1|||
128920457|NCT01957137|463996984|FG000|Randomized Portion|Withdrawal by Subject|1|||
128920458|NCT03529409|463996985|FG000|Randomized|Lost to Follow-up|0|||
128920459|NCT03529409|463996986|FG001|Randomized|Lost to Follow-up|0|||
128920460|NCT03529409|463996987|FG002|Randomized|Lost to Follow-up|4|||
128920461|NCT03529409|463996985|FG000|Randomized|Excluded|0|||
128920462|NCT03529409|463996986|FG001|Randomized|Excluded|0|||
128920463|NCT03529409|463996987|FG002|Randomized|Excluded|1|||
128920464|NCT03529409|463996985|FG000|Post-treatment Assessment|Death|1|||
128920465|NCT03529409|463996986|FG001|Post-treatment Assessment|Death|0|||
128920466|NCT03529409|463996987|FG002|Post-treatment Assessment|Death|0|||
128920467|NCT03529409|463996985|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
128920468|NCT03529409|463996986|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
128920469|NCT03529409|463996987|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
128920470|NCT03529409|463996985|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
128920471|NCT03529409|463996986|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
128920472|NCT03529409|463996987|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
128920473|NCT03529409|463996985|FG000|Follow-up Assessment|Death|1|||
128920474|NCT03529409|463996986|FG001|Follow-up Assessment|Death|0|||
128920475|NCT03529409|463996987|FG002|Follow-up Assessment|Death|0|||
128920476|NCT03529409|463996985|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
129029250|NCT00566722|464398376|FG001|Overall Study|Did not meet exclusion criteria|0|||
129029251|NCT00566722|464398377|FG002|Overall Study|Did not meet exclusion criteria|2|||
128699566|NCT01606800|463199728|FG001|Overall Study|Participant withdrew consent|1|||
128699567|NCT01606800|463199727|FG000|Overall Study|Missing completion status|2|||
128699568|NCT01606800|463199728|FG001|Overall Study|Missing completion status|0|||
128699569|NCT03311724|463199729|FG000|Overall Study|Physician Decision|0|||
128699570|NCT03311724|463199730|FG001|Overall Study|Physician Decision|0|||
128699571|NCT03311724|463199731|FG002|Overall Study|Physician Decision|0|||
128699572|NCT03311724|463199732|FG003|Overall Study|Physician Decision|1|||
128699573|NCT03311724|463199729|FG000|Overall Study|Protocol Violation|1|||
128699574|NCT03311724|463199730|FG001|Overall Study|Protocol Violation|0|||
128699575|NCT03311724|463199731|FG002|Overall Study|Protocol Violation|1|||
128699576|NCT03311724|463199732|FG003|Overall Study|Protocol Violation|0|||
128699577|NCT03311724|463199729|FG000|Overall Study|Withdrawal by Subject|1|||
128699578|NCT03311724|463199730|FG001|Overall Study|Withdrawal by Subject|1|||
128699579|NCT03311724|463199731|FG002|Overall Study|Withdrawal by Subject|0|||
128699580|NCT03311724|463199732|FG003|Overall Study|Withdrawal by Subject|0|||
128699581|NCT03311724|463199729|FG000|Overall Study|Lost to Follow-up|1|||
128699582|NCT03311724|463199730|FG001|Overall Study|Lost to Follow-up|0|||
128699583|NCT03311724|463199731|FG002|Overall Study|Lost to Follow-up|0|||
128699584|NCT03311724|463199732|FG003|Overall Study|Lost to Follow-up|0|||
128699585|NCT03311724|463199729|FG000|Overall Study|Sponsor Decision|0|||
128699586|NCT03311724|463199730|FG001|Overall Study|Sponsor Decision|0|||
128699587|NCT03311724|463199731|FG002|Overall Study|Sponsor Decision|1|||
128699588|NCT03311724|463199732|FG003|Overall Study|Sponsor Decision|0|||
128699589|NCT03305575|463199745|FG000|Overall Study|Physician Decision|1|||
128699590|NCT03305575|463199746|FG001|Overall Study|Physician Decision|0|||
128699591|NCT03486223|463199759|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
128699592|NCT03486223|463199760|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
128699593|NCT01819831|463199761|FG000|Overall Study|Withdrawal by Subject|1|||
128699594|NCT01749137|463199762|FG000|Overall Study|Adverse Event|4|||
128699595|NCT01749137|463199763|FG001|Overall Study|Adverse Event|4|||
128699596|NCT01749137|463199762|FG000|Overall Study|Lost to Follow-up|2|||
128699597|NCT01749137|463199763|FG001|Overall Study|Lost to Follow-up|3|||
128699598|NCT01749137|463199762|FG000|Overall Study|Physician Decision|1|||
128699599|NCT01749137|463199763|FG001|Overall Study|Physician Decision|0|||
128699600|NCT01749137|463199762|FG000|Overall Study|Withdrawal by Subject|8|||
128699601|NCT01749137|463199763|FG001|Overall Study|Withdrawal by Subject|4|||
128699602|NCT02587234|463199779|FG000|Overall Study|Withdrawal by Subject|1|||
128699603|NCT02587234|463199780|FG001|Overall Study|Withdrawal by Subject|1|||
128699604|NCT02587234|463199779|FG000|Overall Study|Lost to Follow-up|0|||
128699605|NCT02587234|463199780|FG001|Overall Study|Lost to Follow-up|2|||
128699606|NCT03068130|463199781|FG000|Overall Study|Adverse Event|19|||
128699607|NCT03068130|463199781|FG000|Overall Study|Death|14|||
128699608|NCT03068130|463199781|FG000|Overall Study|Lost to Follow-up|4|||
128699609|NCT03068130|463199781|FG000|Overall Study|Withdrawal by Subject|26|||
128699610|NCT03068130|463199781|FG000|Overall Study|Administrative Reasons|3|||
128699611|NCT03068130|463199781|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
128699612|NCT03068130|463199781|FG000|Overall Study|Study terminated by sponsor|194|||
128699613|NCT03130257|463199788|FG000|Overall Study|Withdrawal by Subject|1|||
128699614|NCT03130257|463199789|FG001|Overall Study|Withdrawal by Subject|0|||
128699615|NCT03130257|463199790|FG002|Overall Study|Withdrawal by Subject|2|||
128699616|NCT02835820|463199791|FG000|Overall Study|Baseline Screen Failure|0|||
128699617|NCT02835820|463199792|FG001|Overall Study|Baseline Screen Failure|3|||
128699618|NCT03039283|463199795|FG000|Overall Study|Protocol Violation|2|||
128699619|NCT01867424|463199796|FG000|Overall Study|Patient noncompliance|2|||
128699620|NCT01867424|463199797|FG001|Overall Study|Patient noncompliance|1|||
128699621|NCT01056653|463199798|FG000|Overall Study|Lost to Follow-up|0|||
128699622|NCT01056653|463199799|FG001|Overall Study|Lost to Follow-up|0|||
128699623|NCT01056653|463199800|FG002|Overall Study|Lost to Follow-up|2|||
129216315|NCT01208207|465092877|FG001|Part II|Technical Problems|0|||
128699624|NCT05386680|463199801|FG000|Overall Study|Guardian decision|2|||
128699625|NCT01847274|463199802|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
128699626|NCT01847274|463199803|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
128699627|NCT01847274|463199804|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
128699628|NCT01847274|463199805|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
128699629|NCT01847274|463199806|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
128699630|NCT01847274|463199807|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
128699631|NCT01847274|463199808|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
128699632|NCT01847274|463199809|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
128699633|NCT01847274|463199810|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
128920477|NCT03529409|463996986|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
128920478|NCT03529409|463996987|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
128920479|NCT01497262|463996990|FG000|Overall Study|Abnormal Lab Values|4|||
128920480|NCT01497262|463996990|FG000|Overall Study|Abnormal Test Procedure Result|1|||
128920481|NCT01497262|463996990|FG000|Overall Study|Physician Decision|1|||
128920482|NCT01497262|463996990|FG000|Overall Study|Withdrawal by Subject|2|||
128920483|NCT01497262|463996990|FG000|Overall Study|Adverse Event|2|||
128920484|NCT01497262|463996990|FG000|Overall Study|Protocol Violation|1|||
128920485|NCT02497001|463996991|FG000|Overall Study|Lost to Follow-up|10|||
128920486|NCT02497001|463996992|FG001|Overall Study|Lost to Follow-up|2|||
128920487|NCT02497001|463996993|FG002|Overall Study|Lost to Follow-up|0|||
128920488|NCT02497001|463996994|FG003|Overall Study|Lost to Follow-up|2|||
128766321|NCT04534114|463435296|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
128920489|NCT02497001|463996991|FG000|Overall Study|Adverse Event|28|||
128920490|NCT02497001|463996992|FG001|Overall Study|Adverse Event|30|||
128920491|NCT02497001|463996993|FG002|Overall Study|Adverse Event|11|||
128920492|NCT02497001|463996994|FG003|Overall Study|Adverse Event|11|||
128920493|NCT02497001|463996991|FG000|Overall Study|Withdrawal by Subject|14|||
128920494|NCT02497001|463996992|FG001|Overall Study|Withdrawal by Subject|37|||
128920495|NCT02497001|463996993|FG002|Overall Study|Withdrawal by Subject|19|||
128920496|NCT02497001|463996994|FG003|Overall Study|Withdrawal by Subject|15|||
128920497|NCT02497001|463996991|FG000|Overall Study|Physician Decision|5|||
128920498|NCT02497001|463996992|FG001|Overall Study|Physician Decision|11|||
128920499|NCT02497001|463996993|FG002|Overall Study|Physician Decision|5|||
128920500|NCT02497001|463996994|FG003|Overall Study|Physician Decision|1|||
128920501|NCT02497001|463996991|FG000|Overall Study|subjects that were not treated|1|||
128920502|NCT02497001|463996992|FG001|Overall Study|subjects that were not treated|2|||
128920503|NCT02497001|463996993|FG002|Overall Study|subjects that were not treated|2|||
128920504|NCT02497001|463996994|FG003|Overall Study|subjects that were not treated|1|||
128920505|NCT02497001|463996991|FG000|Overall Study|Major Protocol Deviation|3|||
128920506|NCT02497001|463996992|FG001|Overall Study|Major Protocol Deviation|4|||
128920507|NCT02497001|463996993|FG002|Overall Study|Major Protocol Deviation|4|||
128920508|NCT02497001|463996994|FG003|Overall Study|Major Protocol Deviation|4|||
128920509|NCT02497001|463996991|FG000|Overall Study|Lack of Efficacy|10|||
128920510|NCT02497001|463996992|FG001|Overall Study|Lack of Efficacy|16|||
128920511|NCT02497001|463996993|FG002|Overall Study|Lack of Efficacy|6|||
128920512|NCT02497001|463996994|FG003|Overall Study|Lack of Efficacy|6|||
128920513|NCT02497001|463996991|FG000|Overall Study|Protocol Violation|3|||
128920514|NCT02497001|463996992|FG001|Overall Study|Protocol Violation|1|||
128920515|NCT02497001|463996993|FG002|Overall Study|Protocol Violation|3|||
128920516|NCT02497001|463996994|FG003|Overall Study|Protocol Violation|1|||
128920517|NCT03898063|463996995|FG000|Overall Study|Withdrawal by Subject|10|||
128920518|NCT03898063|463996996|FG001|Overall Study|Withdrawal by Subject|8|||
128920519|NCT02949830|463996997|FG000|Overall Study|Adverse Event|1|||
128920520|NCT02949830|463996997|FG000|Overall Study|Withdrawal by Subject|1|||
128920521|NCT00054132|463996998|FG000|Overall Study|Not Treated|1|||
128920522|NCT01290887|463996999|FG000|Overall Study|Adverse Event|6|||
129029252|NCT00566722|464398375|FG000|Overall Study|Serious adverse event|0|||
129029253|NCT00566722|464398376|FG001|Overall Study|Serious adverse event|1|||
129029254|NCT00566722|464398377|FG002|Overall Study|Serious adverse event|0|||
128699634|NCT01847274|463199811|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
128699635|NCT01847274|463199812|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
128699636|NCT01847274|463199802|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
128699637|NCT01847274|463199803|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
128699638|NCT01847274|463199804|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
128699639|NCT01847274|463199805|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
128699640|NCT01847274|463199806|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
128699641|NCT01847274|463199807|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
128766322|NCT04534114|463435297|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
128920523|NCT01290887|463997000|FG001|Overall Study|Adverse Event|11|||
128920524|NCT01290887|463996999|FG000|Overall Study|Lack of Efficacy|4|||
128920525|NCT01290887|463997000|FG001|Overall Study|Lack of Efficacy|5|||
128920526|NCT01290887|463996999|FG000|Overall Study|Withdrawal by Subject|26|||
128920527|NCT01290887|463997000|FG001|Overall Study|Withdrawal by Subject|32|||
128920528|NCT01290887|463996999|FG000|Overall Study|Protocol Violation|2|||
128920529|NCT01290887|463997000|FG001|Overall Study|Protocol Violation|1|||
128920530|NCT01290887|463996999|FG000|Overall Study|Lost to Follow-up|4|||
128920531|NCT01290887|463997000|FG001|Overall Study|Lost to Follow-up|4|||
129029255|NCT00566722|464398375|FG000|Overall Study|Noncompliant with drug administration|0|||
128699642|NCT01847274|463199808|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
128699643|NCT01847274|463199809|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
128699644|NCT01847274|463199810|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
128699645|NCT01847274|463199811|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
128699646|NCT01847274|463199812|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
128699647|NCT01847274|463199802|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
128699648|NCT01847274|463199803|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
128699649|NCT01847274|463199804|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
128699650|NCT01847274|463199805|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
128699651|NCT01847274|463199806|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
128699652|NCT01847274|463199807|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
128699653|NCT01847274|463199808|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
128699654|NCT01847274|463199809|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
128699655|NCT01847274|463199810|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
128699656|NCT01847274|463199811|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
128699657|NCT01847274|463199812|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
128766323|NCT04534114|463435294|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
128766324|NCT04534114|463435295|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
128766325|NCT04534114|463435296|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
128920532|NCT01290887|463996999|FG000|Overall Study|Non-compliance to study procedures|0|||
128920533|NCT01290887|463997000|FG001|Overall Study|Non-compliance to study procedures|1|||
128920534|NCT01290887|463996999|FG000|Overall Study|Non-compliance to study medications|1|||
128920535|NCT01290887|463997000|FG001|Overall Study|Non-compliance to study medications|0|||
128920536|NCT01290887|463996999|FG000|Overall Study|Sponsor closure of study|420|||
128920537|NCT01290887|463997000|FG001|Overall Study|Sponsor closure of study|476|||
128920538|NCT01290887|463996999|FG000|Overall Study|Other|3|||
128920539|NCT01290887|463997000|FG001|Overall Study|Other|6|||
128920540|NCT01795547|463997001|FG000|Overall Study|Adverse Event|16|||
128920541|NCT01795547|463997002|FG001|Overall Study|Adverse Event|27|||
128920542|NCT01795547|463997001|FG000|Overall Study|Lack of Efficacy|8|||
128920543|NCT01795547|463997002|FG001|Overall Study|Lack of Efficacy|3|||
128920544|NCT01795547|463997001|FG000|Overall Study|Protocol Violation|6|||
128920545|NCT01795547|463997002|FG001|Overall Study|Protocol Violation|4|||
128920546|NCT01795547|463997001|FG000|Overall Study|Lost to Follow-up|2|||
128920547|NCT01795547|463997002|FG001|Overall Study|Lost to Follow-up|5|||
128920548|NCT01795547|463997001|FG000|Overall Study|Withdrawal of consent|7|||
128920549|NCT01795547|463997002|FG001|Overall Study|Withdrawal of consent|12|||
128920550|NCT01795547|463997001|FG000|Overall Study|Not Treated|4|||
128920551|NCT01795547|463997002|FG001|Overall Study|Not Treated|10|||
128920552|NCT01795547|463997001|FG000|Overall Study|Non-compliance with IMP|1|||
128920553|NCT01795547|463997002|FG001|Overall Study|Non-compliance with IMP|1|||
128920554|NCT01795547|463997001|FG000|Overall Study|Others|4|||
128920555|NCT01795547|463997002|FG001|Overall Study|Others|1|||
128920556|NCT01795547|463997001|FG000|Overall Study|Not stated|0|||
128920557|NCT01795547|463997002|FG001|Overall Study|Not stated|1|||
128920558|NCT03437447|463997003|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128920559|NCT03437447|463997004|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128920560|NCT03437447|463997005|FG002|Treatment Period 1|Withdrawal by Subject|1|||
128920561|NCT01551745|463997006|FG000|Overall Study|Withdrawal by Subject|1|||
129029256|NCT00566722|464398376|FG001|Overall Study|Noncompliant with drug administration|0|||
129029257|NCT00566722|464398377|FG002|Overall Study|Noncompliant with drug administration|1|||
129029258|NCT02611323|464398378|FG000|Overall Study|Death|3|||
129029259|NCT02611323|464398379|FG001|Overall Study|Death|1|||
129029260|NCT02611323|464398380|FG002|Overall Study|Death|0|||
129029261|NCT02611323|464398381|FG003|Overall Study|Death|0|||
129029262|NCT02611323|464398382|FG004|Overall Study|Death|1|||
129029263|NCT02611323|464398383|FG005|Overall Study|Death|1|||
129029264|NCT02611323|464398384|FG006|Overall Study|Death|8|||
129029265|NCT02611323|464398385|FG007|Overall Study|Death|0|||
129029266|NCT02611323|464398386|FG008|Overall Study|Death|4|||
129029267|NCT02611323|464398387|FG009|Overall Study|Death|6|||
129029268|NCT02611323|464398388|FG010|Overall Study|Death|26|||
128766326|NCT04534114|463435297|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
128766327|NCT04534114|463435294|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
128920562|NCT01551745|463997006|FG000|Overall Study|Disease Progression|2|||
128920563|NCT02764541|463997007|FG000|Overall Study|Withdrawal by Subject|0|||
128920564|NCT02764541|463997008|FG001|Overall Study|Withdrawal by Subject|0|||
128920565|NCT02764541|463997009|FG002|Overall Study|Withdrawal by Subject|0|||
128920566|NCT02764541|463997010|FG003|Overall Study|Withdrawal by Subject|0|||
128920567|NCT02764541|463997011|FG004|Overall Study|Withdrawal by Subject|1|||
129029269|NCT02611323|464398378|FG000|Overall Study|Lost to Follow-up|1|||
129029270|NCT02611323|464398379|FG001|Overall Study|Lost to Follow-up|0|||
129029271|NCT02611323|464398380|FG002|Overall Study|Lost to Follow-up|0|||
129029272|NCT02611323|464398381|FG003|Overall Study|Lost to Follow-up|0|||
129029273|NCT02611323|464398382|FG004|Overall Study|Lost to Follow-up|0|||
128920568|NCT02764541|463997012|FG005|Overall Study|Withdrawal by Subject|1|||
128920569|NCT02764541|463997013|FG006|Overall Study|Withdrawal by Subject|0|||
128920570|NCT02764541|463997014|FG007|Overall Study|Withdrawal by Subject|1|||
128920571|NCT02764541|463997007|FG000|Overall Study|Adverse Event|1|||
128699658|NCT01847274|463199802|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128699659|NCT01847274|463199803|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128699660|NCT01847274|463199804|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128699661|NCT01847274|463199805|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
128920572|NCT02764541|463997008|FG001|Overall Study|Adverse Event|0|||
128920573|NCT02764541|463997009|FG002|Overall Study|Adverse Event|0|||
128920574|NCT02764541|463997010|FG003|Overall Study|Adverse Event|0|||
128920575|NCT02764541|463997011|FG004|Overall Study|Adverse Event|0|||
128920576|NCT02764541|463997012|FG005|Overall Study|Adverse Event|0|||
128920577|NCT02764541|463997013|FG006|Overall Study|Adverse Event|1|||
128920578|NCT02764541|463997014|FG007|Overall Study|Adverse Event|0|||
128920579|NCT02764541|463997007|FG000|Overall Study|Metastasis|1|||
128920580|NCT02764541|463997008|FG001|Overall Study|Metastasis|0|||
128920581|NCT02764541|463997009|FG002|Overall Study|Metastasis|0|||
128920582|NCT02764541|463997010|FG003|Overall Study|Metastasis|0|||
128920583|NCT02764541|463997011|FG004|Overall Study|Metastasis|0|||
128920584|NCT02764541|463997012|FG005|Overall Study|Metastasis|0|||
128920585|NCT02764541|463997013|FG006|Overall Study|Metastasis|0|||
128920586|NCT02764541|463997014|FG007|Overall Study|Metastasis|0|||
128920587|NCT02764541|463997007|FG000|Overall Study|Disease progression|1|||
128920588|NCT02764541|463997008|FG001|Overall Study|Disease progression|1|||
128699662|NCT01847274|463199806|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128699663|NCT01847274|463199807|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128699664|NCT01847274|463199808|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128920589|NCT02764541|463997009|FG002|Overall Study|Disease progression|0|||
128920590|NCT02764541|463997010|FG003|Overall Study|Disease progression|0|||
128920591|NCT02764541|463997011|FG004|Overall Study|Disease progression|0|||
128920592|NCT02764541|463997012|FG005|Overall Study|Disease progression|0|||
128920593|NCT02764541|463997013|FG006|Overall Study|Disease progression|0|||
128920594|NCT02764541|463997014|FG007|Overall Study|Disease progression|1|||
128920595|NCT02764541|463997007|FG000|Overall Study|Protocol Violation|0|||
128920596|NCT02764541|463997008|FG001|Overall Study|Protocol Violation|0|||
128920597|NCT02764541|463997009|FG002|Overall Study|Protocol Violation|0|||
128920598|NCT02764541|463997010|FG003|Overall Study|Protocol Violation|1|||
128920599|NCT02764541|463997011|FG004|Overall Study|Protocol Violation|0|||
128920600|NCT02764541|463997012|FG005|Overall Study|Protocol Violation|1|||
128920601|NCT02764541|463997013|FG006|Overall Study|Protocol Violation|0|||
128920602|NCT02764541|463997014|FG007|Overall Study|Protocol Violation|0|||
128920603|NCT02764541|463997007|FG000|Overall Study|Physician Decision|0|||
128920604|NCT02764541|463997008|FG001|Overall Study|Physician Decision|0|||
128920605|NCT02764541|463997009|FG002|Overall Study|Physician Decision|0|||
128920606|NCT02764541|463997010|FG003|Overall Study|Physician Decision|1|||
128920607|NCT02764541|463997011|FG004|Overall Study|Physician Decision|0|||
128920608|NCT02764541|463997012|FG005|Overall Study|Physician Decision|0|||
128920609|NCT02764541|463997013|FG006|Overall Study|Physician Decision|0|||
128920610|NCT02764541|463997014|FG007|Overall Study|Physician Decision|1|||
128920611|NCT02764541|463997007|FG000|Overall Study|Three Cycles completed before surgery|0|||
128920612|NCT02764541|463997008|FG001|Overall Study|Three Cycles completed before surgery|0|||
128920613|NCT02764541|463997009|FG002|Overall Study|Three Cycles completed before surgery|0|||
128920614|NCT02764541|463997010|FG003|Overall Study|Three Cycles completed before surgery|1|||
128920615|NCT02764541|463997011|FG004|Overall Study|Three Cycles completed before surgery|0|||
128920616|NCT02764541|463997012|FG005|Overall Study|Three Cycles completed before surgery|0|||
128920617|NCT02764541|463997013|FG006|Overall Study|Three Cycles completed before surgery|0|||
128920618|NCT02764541|463997014|FG007|Overall Study|Three Cycles completed before surgery|0|||
128920619|NCT02764541|463997007|FG000|Overall Study|Patient Compliance|0|||
128920620|NCT02764541|463997008|FG001|Overall Study|Patient Compliance|0|||
128920621|NCT02764541|463997009|FG002|Overall Study|Patient Compliance|1|||
128920622|NCT02764541|463997010|FG003|Overall Study|Patient Compliance|0|||
128920623|NCT02764541|463997011|FG004|Overall Study|Patient Compliance|0|||
128920624|NCT02764541|463997012|FG005|Overall Study|Patient Compliance|0|||
129216316|NCT01208207|465092878|FG002|Part II|Technical Problems|0|||
128920625|NCT02764541|463997013|FG006|Overall Study|Patient Compliance|0|||
128920626|NCT02764541|463997014|FG007|Overall Study|Patient Compliance|0|||
128920627|NCT02764541|463997007|FG000|Overall Study|Death|0|||
128920628|NCT02764541|463997008|FG001|Overall Study|Death|0|||
128920629|NCT02764541|463997009|FG002|Overall Study|Death|0|||
128920630|NCT02764541|463997010|FG003|Overall Study|Death|0|||
128920631|NCT02764541|463997011|FG004|Overall Study|Death|0|||
128920632|NCT02764541|463997012|FG005|Overall Study|Death|0|||
128920633|NCT02764541|463997013|FG006|Overall Study|Death|1|||
128920634|NCT02764541|463997014|FG007|Overall Study|Death|0|||
128920635|NCT02764541|463997007|FG000|Overall Study|Insurance reasons|0|||
128920636|NCT02764541|463997008|FG001|Overall Study|Insurance reasons|0|||
128920637|NCT02764541|463997009|FG002|Overall Study|Insurance reasons|0|||
128920638|NCT02764541|463997010|FG003|Overall Study|Insurance reasons|0|||
128920639|NCT02764541|463997011|FG004|Overall Study|Insurance reasons|0|||
128920640|NCT02764541|463997012|FG005|Overall Study|Insurance reasons|0|||
128920641|NCT02764541|463997013|FG006|Overall Study|Insurance reasons|1|||
128920642|NCT02764541|463997014|FG007|Overall Study|Insurance reasons|0|||
128920643|NCT00749190|463997015|FG000|Overall Study|Adverse Event|0|||
128920644|NCT00749190|463997016|FG001|Overall Study|Adverse Event|2|||
128920645|NCT00749190|463997017|FG002|Overall Study|Adverse Event|0|||
128920646|NCT00749190|463997018|FG003|Overall Study|Adverse Event|4|||
128699665|NCT01847274|463199809|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128920647|NCT00749190|463997019|FG004|Overall Study|Adverse Event|0|||
128920648|NCT00749190|463997020|FG005|Overall Study|Adverse Event|3|||
128920649|NCT00749190|463997021|FG006|Overall Study|Adverse Event|0|||
128920650|NCT00749190|463997015|FG000|Overall Study|Lack of Efficacy|3|||
128920651|NCT00749190|463997016|FG001|Overall Study|Lack of Efficacy|1|||
128920652|NCT00749190|463997017|FG002|Overall Study|Lack of Efficacy|1|||
128920653|NCT00749190|463997018|FG003|Overall Study|Lack of Efficacy|0|||
128920654|NCT00749190|463997019|FG004|Overall Study|Lack of Efficacy|0|||
128920655|NCT00749190|463997020|FG005|Overall Study|Lack of Efficacy|1|||
128920656|NCT00749190|463997021|FG006|Overall Study|Lack of Efficacy|0|||
128920657|NCT00749190|463997015|FG000|Overall Study|Withdrawal by Subject|2|||
128920658|NCT00749190|463997016|FG001|Overall Study|Withdrawal by Subject|1|||
129029274|NCT02611323|464398383|FG005|Overall Study|Lost to Follow-up|0|||
128699666|NCT01847274|463199810|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128699667|NCT01847274|463199811|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128766328|NCT04534114|463435295|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
128766329|NCT04534114|463435296|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
128766330|NCT04534114|463435297|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
128766331|NCT04534114|463435294|FG000|Main Treatment Period|Physician Decision|0|||
128766332|NCT04534114|463435295|FG001|Main Treatment Period|Physician Decision|0|||
128766333|NCT04534114|463435296|FG002|Main Treatment Period|Physician Decision|0|||
128766334|NCT04534114|463435297|FG003|Main Treatment Period|Physician Decision|1|||
128766335|NCT04534114|463435294|FG000|Main Treatment Period|Death|1|||
128766336|NCT04534114|463435295|FG001|Main Treatment Period|Death|0|||
128766337|NCT04534114|463435296|FG002|Main Treatment Period|Death|0|||
128766338|NCT04534114|463435297|FG003|Main Treatment Period|Death|1|||
128766339|NCT04534114|463435294|FG000|Main Treatment Period|Other reason|1|||
128766340|NCT04534114|463435295|FG001|Main Treatment Period|Other reason|1|||
128766341|NCT04534114|463435296|FG002|Main Treatment Period|Other reason|0|||
128766342|NCT04534114|463435297|FG003|Main Treatment Period|Other reason|0|||
128766343|NCT04534114|463435294|FG000|Main Treatment Period|Participant decision|1|||
128920659|NCT00749190|463997017|FG002|Overall Study|Withdrawal by Subject|0|||
128920660|NCT00749190|463997018|FG003|Overall Study|Withdrawal by Subject|0|||
128920661|NCT00749190|463997019|FG004|Overall Study|Withdrawal by Subject|0|||
128920662|NCT00749190|463997020|FG005|Overall Study|Withdrawal by Subject|1|||
128920663|NCT00749190|463997021|FG006|Overall Study|Withdrawal by Subject|0|||
129029275|NCT02611323|464398384|FG006|Overall Study|Lost to Follow-up|3|||
128699668|NCT01847274|463199812|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
128699669|NCT01847274|463199802|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
128699670|NCT01847274|463199803|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
128699671|NCT01847274|463199804|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
128699672|NCT01847274|463199805|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
128699673|NCT01847274|463199806|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
128699674|NCT01847274|463199807|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
128699675|NCT01847274|463199808|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
128699676|NCT01847274|463199809|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
128699677|NCT01847274|463199810|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
128699678|NCT01847274|463199811|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
128699679|NCT01847274|463199812|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
128699680|NCT01847274|463199802|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
128699681|NCT01847274|463199803|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
128699682|NCT01847274|463199804|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
128699683|NCT01847274|463199805|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
128699684|NCT01847274|463199806|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
128699685|NCT01847274|463199807|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
128699686|NCT01847274|463199808|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
128699687|NCT01847274|463199809|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
128699688|NCT01847274|463199810|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
128699689|NCT01847274|463199811|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
128699690|NCT01847274|463199812|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
128699691|NCT01847274|463199802|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
128766344|NCT04534114|463435295|FG001|Main Treatment Period|Participant decision|3|||
128766345|NCT04534114|463435296|FG002|Main Treatment Period|Participant decision|3|||
128766346|NCT04534114|463435297|FG003|Main Treatment Period|Participant decision|1|||
128766347|NCT04534114|463435294|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
128766348|NCT04534114|463435295|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
128766349|NCT04534114|463435296|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
128766350|NCT04534114|463435297|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
128766351|NCT04534114|463435294|FG000|Main Treatment Period|Adverse Event|4|||
128766352|NCT04534114|463435295|FG001|Main Treatment Period|Adverse Event|2|||
128766353|NCT04534114|463435296|FG002|Main Treatment Period|Adverse Event|1|||
128766354|NCT04534114|463435297|FG003|Main Treatment Period|Adverse Event|2|||
128766355|NCT04534114|463435294|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
128766356|NCT04534114|463435295|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
128766357|NCT04534114|463435296|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
128766358|NCT04534114|463435297|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
128766359|NCT04534114|463435294|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
128766360|NCT04534114|463435295|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
128766361|NCT04534114|463435296|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
128766362|NCT04534114|463435297|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
128766363|NCT04534114|463435294|FG000|Extension Treatment Period|Other reason|0|||
128766364|NCT04534114|463435295|FG001|Extension Treatment Period|Other reason|1|||
128766365|NCT04534114|463435296|FG002|Extension Treatment Period|Other reason|0|||
128766366|NCT04534114|463435297|FG003|Extension Treatment Period|Other reason|0|||
128766367|NCT04534114|463435294|FG000|Extension Treatment Period|Death|0|||
128766368|NCT04534114|463435295|FG001|Extension Treatment Period|Death|0|||
128766369|NCT04534114|463435296|FG002|Extension Treatment Period|Death|1|||
128766370|NCT04534114|463435297|FG003|Extension Treatment Period|Death|2|||
128766371|NCT04534114|463435294|FG000|Extension Treatment Period|Adverse Event|0|||
128766372|NCT04534114|463435295|FG001|Extension Treatment Period|Adverse Event|1|||
128766373|NCT04534114|463435296|FG002|Extension Treatment Period|Adverse Event|0|||
128766374|NCT04534114|463435297|FG003|Extension Treatment Period|Adverse Event|1|||
128766375|NCT04534114|463435294|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
128766376|NCT04534114|463435295|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
128766377|NCT04534114|463435296|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
128766378|NCT04534114|463435297|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
128766379|NCT03287414|463435298|FG000|Treatment Epoch|Adverse Event|0|||
128766380|NCT03287414|463435299|FG001|Treatment Epoch|Adverse Event|1|||
128766381|NCT03287414|463435298|FG000|Treatment Epoch|Study terminated by sponsor|2|||
128766382|NCT03287414|463435299|FG001|Treatment Epoch|Study terminated by sponsor|2|||
128766383|NCT03287414|463435298|FG000|Treatment Epoch|Subject/Guardian decision|4|||
128766384|NCT03287414|463435299|FG001|Treatment Epoch|Subject/Guardian decision|0|||
128766385|NCT03287414|463435298|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
128766386|NCT03287414|463435299|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
128766387|NCT03287414|463435298|FG000|Treatment Epoch|Withdrawal by Subject|1|||
128766388|NCT03287414|463435299|FG001|Treatment Epoch|Withdrawal by Subject|0|||
128766389|NCT03287414|463435298|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
128766390|NCT03287414|463435299|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
128766391|NCT03287414|463435298|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
128766392|NCT03287414|463435299|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
128766393|NCT02759185|463435300|FG000|Stage 1|Adverse Event|0|||
128766394|NCT02759185|463435301|FG001|Stage 1|Adverse Event|1|||
128766395|NCT02759185|463435302|FG002|Stage 1|Adverse Event|3|||
128766396|NCT02759185|463435303|FG003|Stage 1|Adverse Event|0|||
128766397|NCT02759185|463435304|FG004|Stage 1|Adverse Event|0|||
128766398|NCT02759185|463435305|FG005|Stage 1|Adverse Event|0|||
128766399|NCT02759185|463435306|FG006|Stage 1|Adverse Event|0|||
128766400|NCT02759185|463435300|FG000|Stage 1|Withdrawal by Subject|1|||
128766401|NCT02759185|463435301|FG001|Stage 1|Withdrawal by Subject|0|||
128766402|NCT02759185|463435302|FG002|Stage 1|Withdrawal by Subject|0|||
128766403|NCT02759185|463435303|FG003|Stage 1|Withdrawal by Subject|0|||
128766404|NCT02759185|463435304|FG004|Stage 1|Withdrawal by Subject|0|||
128766405|NCT02759185|463435305|FG005|Stage 1|Withdrawal by Subject|0|||
128766406|NCT02759185|463435306|FG006|Stage 1|Withdrawal by Subject|0|||
128766407|NCT02759185|463435300|FG000|Stage 2|Adverse Event|0|||
128766408|NCT02759185|463435301|FG001|Stage 2|Adverse Event|0|||
128766409|NCT02759185|463435302|FG002|Stage 2|Adverse Event|0|||
128766410|NCT02759185|463435303|FG003|Stage 2|Adverse Event|0|||
128766411|NCT02759185|463435304|FG004|Stage 2|Adverse Event|1|||
128766412|NCT02759185|463435305|FG005|Stage 2|Adverse Event|2|||
128766413|NCT02759185|463435306|FG006|Stage 2|Adverse Event|0|||
128766414|NCT02759185|463435300|FG000|Stage 2|Withdrawal by Subject|0|||
128766415|NCT02759185|463435301|FG001|Stage 2|Withdrawal by Subject|0|||
128766416|NCT02759185|463435302|FG002|Stage 2|Withdrawal by Subject|0|||
128766417|NCT02759185|463435303|FG003|Stage 2|Withdrawal by Subject|0|||
128766418|NCT02759185|463435304|FG004|Stage 2|Withdrawal by Subject|1|||
128766419|NCT02759185|463435305|FG005|Stage 2|Withdrawal by Subject|1|||
128766420|NCT02759185|463435306|FG006|Stage 2|Withdrawal by Subject|1|||
128766421|NCT02613221|463435312|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
128766422|NCT02613221|463435312|FG000|Overall Study|Adverse Event|2|||
128766423|NCT02613221|463435312|FG000|Overall Study|Voluntary Discontinuation|1|||
128766424|NCT02613221|463435312|FG000|Overall Study|Delayed Treatment|1|||
128766425|NCT02613221|463435312|FG000|Overall Study|Enrolled but Not Treated|1|||
128766426|NCT02668016|463435313|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
128766427|NCT02668016|463435313|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
128766428|NCT02668016|463435313|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
128766429|NCT02668016|463435313|FG000|Month 4|Withdrawal due to severe symptoms|1|||
128766430|NCT02668016|463435313|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
128766431|NCT02668016|463435313|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
128766432|NCT02668016|463435313|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
128766433|NCT02668016|463435313|FG000|Month 6|Withdrawal due to severe symptoms|2|||
128766434|NCT02668016|463435313|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
128766435|NCT02668016|463435313|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
128766436|NCT02668016|463435313|FG000|Month 8|Withdrawal due to severe symptoms|1|||
128766437|NCT02668016|463435313|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
128766438|NCT02668016|463435313|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
128766439|NCT02668016|463435313|FG000|Month 10|Withdrawal due to severe symptoms|1|||
128766440|NCT02668016|463435313|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
128766441|NCT02946918|463435323|FG000|Overall Study|Patient unblinded himself|1|||
128766442|NCT02946918|463435324|FG001|Overall Study|Patient unblinded himself|0|||
128766443|NCT02946918|463435323|FG000|Overall Study|Physician Decision|0|||
128766444|NCT02946918|463435324|FG001|Overall Study|Physician Decision|2|||
128766445|NCT02946918|463435323|FG000|Overall Study|Ran out of study medication|0|||
128766446|NCT02946918|463435324|FG001|Overall Study|Ran out of study medication|1|||
128766447|NCT01125722|463435325|FG000|Overall Study|Withdrawal by Subject|2|||
128766448|NCT01125722|463435326|FG001|Overall Study|Withdrawal by Subject|1|||
128766449|NCT01125722|463435325|FG000|Overall Study|Lost to Follow-up|1|||
128766450|NCT01125722|463435326|FG001|Overall Study|Lost to Follow-up|0|||
128766451|NCT00069784|463435327|FG000|Overall Study|Adverse Event|105|||
128766452|NCT00069784|463435328|FG001|Overall Study|Adverse Event|0|||
128766453|NCT00069784|463435327|FG000|Overall Study|Withdrawal by Subject|1090|||
128766454|NCT00069784|463435328|FG001|Overall Study|Withdrawal by Subject|0|||
128766455|NCT00069784|463435327|FG000|Overall Study|Other|17|||
128766456|NCT00069784|463435328|FG001|Overall Study|Other|0|||
128766457|NCT01672853|463435333|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
128766458|NCT01672853|463435334|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
128766459|NCT01672853|463435335|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
128766460|NCT01672853|463435333|FG000|Overall Study|Pregnancy|0|||
128766461|NCT01672853|463435334|FG001|Overall Study|Pregnancy|1|||
128766462|NCT01672853|463435335|FG002|Overall Study|Pregnancy|0|||
128766463|NCT01672853|463435333|FG000|Overall Study|Investigator's Discretion|1|||
128766464|NCT01672853|463435334|FG001|Overall Study|Investigator's Discretion|0|||
128766465|NCT01672853|463435335|FG002|Overall Study|Investigator's Discretion|0|||
128766466|NCT01672853|463435333|FG000|Overall Study|Withdrew Consent|5|||
128766467|NCT01672853|463435334|FG001|Overall Study|Withdrew Consent|5|||
128766468|NCT01672853|463435335|FG002|Overall Study|Withdrew Consent|5|||
128766469|NCT01672853|463435333|FG000|Overall Study|Adverse Event|4|||
128766470|NCT01672853|463435334|FG001|Overall Study|Adverse Event|6|||
128766471|NCT01672853|463435335|FG002|Overall Study|Adverse Event|8|||
128766472|NCT01672853|463435333|FG000|Overall Study|Lost to Follow-up|0|||
128766473|NCT01672853|463435334|FG001|Overall Study|Lost to Follow-up|1|||
128766474|NCT01672853|463435335|FG002|Overall Study|Lost to Follow-up|0|||
128766475|NCT01672853|463435333|FG000|Overall Study|Randomized but Never Treated|0|||
128766476|NCT01672853|463435334|FG001|Overall Study|Randomized but Never Treated|0|||
128766477|NCT01672853|463435335|FG002|Overall Study|Randomized but Never Treated|1|||
128766478|NCT00118898|463435337|FG000|Overall Study|Death|6|||
128766479|NCT00118898|463435338|FG001|Overall Study|Death|11|||
128766480|NCT00118898|463435339|FG002|Overall Study|Death|6|||
128766481|NCT00118898|463435340|FG003|Overall Study|Death|8|||
128766482|NCT00118898|463435337|FG000|Overall Study|Lost to Follow-up|26|||
128766483|NCT00118898|463435338|FG001|Overall Study|Lost to Follow-up|34|||
128766484|NCT00118898|463435339|FG002|Overall Study|Lost to Follow-up|33|||
129029276|NCT02611323|464398385|FG007|Overall Study|Lost to Follow-up|0|||
128766485|NCT00118898|463435340|FG003|Overall Study|Lost to Follow-up|33|||
128766486|NCT00118898|463435337|FG000|Overall Study|Withdrawal by Subject|10|||
128766487|NCT00118898|463435338|FG001|Overall Study|Withdrawal by Subject|5|||
129029277|NCT02611323|464398386|FG008|Overall Study|Lost to Follow-up|0|||
128920664|NCT00749190|463997015|FG000|Overall Study|Protocol Violation|0|||
128920665|NCT00749190|463997016|FG001|Overall Study|Protocol Violation|1|||
128699692|NCT01847274|463199803|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
128699693|NCT01847274|463199804|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
128699694|NCT01847274|463199805|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
128699695|NCT01847274|463199806|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
128699696|NCT01847274|463199807|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
128699697|NCT01847274|463199808|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
128699698|NCT01847274|463199809|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
128699699|NCT01847274|463199810|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
128699700|NCT01847274|463199811|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
128699701|NCT01847274|463199812|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
128699702|NCT01847274|463199802|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699703|NCT01847274|463199803|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699704|NCT01847274|463199804|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699705|NCT01847274|463199805|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699706|NCT01847274|463199806|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699707|NCT01847274|463199807|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
128699708|NCT01847274|463199808|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699709|NCT01847274|463199809|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699710|NCT01847274|463199810|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699711|NCT01847274|463199811|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699712|NCT01847274|463199812|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
128699713|NCT01847274|463199802|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699714|NCT01847274|463199803|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699715|NCT01847274|463199804|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699716|NCT01847274|463199805|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699717|NCT01847274|463199806|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
128699718|NCT01847274|463199807|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699719|NCT01847274|463199808|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699720|NCT01847274|463199809|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699721|NCT01847274|463199810|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699722|NCT01847274|463199811|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699723|NCT01847274|463199812|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
128699724|NCT01847274|463199802|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699725|NCT01847274|463199803|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699726|NCT01847274|463199804|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699727|NCT01847274|463199805|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699728|NCT01847274|463199806|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699729|NCT01847274|463199807|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699730|NCT01847274|463199808|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
128699731|NCT01847274|463199809|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699732|NCT01847274|463199810|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699733|NCT01847274|463199811|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699734|NCT01847274|463199812|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
128699735|NCT01847274|463199802|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699736|NCT01847274|463199803|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699737|NCT01847274|463199804|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699738|NCT01847274|463199805|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699739|NCT01847274|463199806|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699740|NCT01847274|463199807|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699741|NCT01847274|463199808|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
128699742|NCT01847274|463199809|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699743|NCT01847274|463199810|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699744|NCT01847274|463199811|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699745|NCT01847274|463199812|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
128699746|NCT01847274|463199802|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699747|NCT01847274|463199803|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699748|NCT01847274|463199804|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699749|NCT01847274|463199805|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699750|NCT01847274|463199806|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699751|NCT01847274|463199807|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699752|NCT01847274|463199808|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
128699753|NCT01847274|463199809|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699754|NCT01847274|463199810|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699755|NCT01847274|463199811|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128920666|NCT00749190|463997017|FG002|Overall Study|Protocol Violation|0|||
128920667|NCT00749190|463997018|FG003|Overall Study|Protocol Violation|0|||
128920668|NCT00749190|463997019|FG004|Overall Study|Protocol Violation|0|||
128920669|NCT00749190|463997020|FG005|Overall Study|Protocol Violation|0|||
128920670|NCT00749190|463997021|FG006|Overall Study|Protocol Violation|1|||
128920671|NCT00749190|463997015|FG000|Overall Study|Other reason not defined above|0|||
128920672|NCT00749190|463997016|FG001|Overall Study|Other reason not defined above|0|||
128920673|NCT00749190|463997017|FG002|Overall Study|Other reason not defined above|0|||
128920674|NCT00749190|463997018|FG003|Overall Study|Other reason not defined above|1|||
128920675|NCT00749190|463997019|FG004|Overall Study|Other reason not defined above|0|||
128920676|NCT00749190|463997020|FG005|Overall Study|Other reason not defined above|0|||
128920677|NCT00749190|463997021|FG006|Overall Study|Other reason not defined above|0|||
128920678|NCT00355121|463997022|FG000|Overall Study|Did not receive study vaccine|1|||
128920679|NCT00355121|463997023|FG001|Overall Study|Did not receive study vaccine|0|||
128920680|NCT00355121|463997024|FG002|Overall Study|Did not receive study vaccine|1|||
128920681|NCT00355121|463997022|FG000|Overall Study|Adverse Event|0|||
128920682|NCT00355121|463997023|FG001|Overall Study|Adverse Event|1|||
128920683|NCT00355121|463997024|FG002|Overall Study|Adverse Event|0|||
128920684|NCT00355121|463997022|FG000|Overall Study|Protocol Violation|7|||
128920685|NCT00355121|463997023|FG001|Overall Study|Protocol Violation|9|||
128920686|NCT00355121|463997024|FG002|Overall Study|Protocol Violation|1|||
128920687|NCT00355121|463997022|FG000|Overall Study|Lost to Follow-up|4|||
128920688|NCT00355121|463997023|FG001|Overall Study|Lost to Follow-up|7|||
128920689|NCT00355121|463997024|FG002|Overall Study|Lost to Follow-up|1|||
128920690|NCT00355121|463997022|FG000|Overall Study|Withdrawal by Subject|9|||
128920691|NCT00355121|463997023|FG001|Overall Study|Withdrawal by Subject|10|||
128920692|NCT00355121|463997024|FG002|Overall Study|Withdrawal by Subject|2|||
128920693|NCT00355121|463997022|FG000|Overall Study|Serious adverse events|0|||
128920694|NCT00355121|463997023|FG001|Overall Study|Serious adverse events|2|||
128920695|NCT00355121|463997024|FG002|Overall Study|Serious adverse events|0|||
128920696|NCT04752384|463997025|FG000|Overall Study|Withdrawal by Subject|1|||
128920697|NCT04752384|463997025|FG000|Overall Study|Death|1|||
128920698|NCT02330419|463997027|FG000|Overall Study|Lost to Follow-up|3|||
128920699|NCT02330419|463997028|FG001|Overall Study|Lost to Follow-up|7|||
128920700|NCT01813890|463997031|FG000|Overall Study|Adverse Event|0|||
128920701|NCT01813890|463997032|FG001|Overall Study|Adverse Event|3|||
128920702|NCT01813890|463997033|FG002|Overall Study|Adverse Event|4|||
128920703|NCT01813890|463997031|FG000|Overall Study|Lack of Efficacy|9|||
128920704|NCT01813890|463997032|FG001|Overall Study|Lack of Efficacy|1|||
128920705|NCT01813890|463997033|FG002|Overall Study|Lack of Efficacy|2|||
128699756|NCT01847274|463199812|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
128699757|NCT01847274|463199802|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
128699758|NCT01847274|463199803|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
128699759|NCT01847274|463199804|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
128699760|NCT01847274|463199805|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
128699761|NCT01847274|463199806|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
128699762|NCT01847274|463199807|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
128699763|NCT01847274|463199808|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
128699764|NCT01847274|463199809|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
128699765|NCT01847274|463199810|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
128699766|NCT01847274|463199811|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
128699767|NCT01847274|463199812|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
128699768|NCT01847274|463199802|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699769|NCT01847274|463199803|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699770|NCT01847274|463199804|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699771|NCT01847274|463199805|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699772|NCT01847274|463199806|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699773|NCT01847274|463199807|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699774|NCT01847274|463199808|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699775|NCT01847274|463199809|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
128920706|NCT03952559|463997034|FG000|Double Blind Treatment Period|Adverse Event|0|||
128920707|NCT03952559|463997035|FG001|Double Blind Treatment Period|Adverse Event|2|||
128920708|NCT03952559|463997036|FG002|Double Blind Treatment Period|Adverse Event|1|||
128920709|NCT03952559|463997037|FG003|Double Blind Treatment Period|Adverse Event|0|||
128920710|NCT03952559|463997038|FG004|Double Blind Treatment Period|Adverse Event|1|||
128920711|NCT03952559|463997034|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
128920712|NCT03952559|463997035|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
128920713|NCT03952559|463997036|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
128920714|NCT03952559|463997037|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
128699776|NCT01847274|463199810|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699777|NCT01847274|463199811|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
128699778|NCT01847274|463199812|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
128699779|NCT01847274|463199802|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699780|NCT01847274|463199803|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699781|NCT01847274|463199804|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699782|NCT01847274|463199805|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699783|NCT01847274|463199806|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699784|NCT01847274|463199807|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699785|NCT01847274|463199808|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699786|NCT01847274|463199809|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
128699787|NCT01847274|463199810|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
128699788|NCT01847274|463199811|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
128699789|NCT01847274|463199812|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
128699790|NCT01847274|463199802|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699791|NCT01847274|463199803|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699792|NCT01847274|463199804|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699793|NCT01847274|463199805|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699794|NCT01847274|463199806|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699795|NCT01847274|463199807|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699796|NCT01847274|463199808|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699797|NCT01847274|463199809|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699798|NCT01847274|463199810|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699799|NCT01847274|463199811|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
128699800|NCT01847274|463199812|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
128699801|NCT03727230|463199813|FG000|Overall Study|Lost to Follow-up|12|||
128699802|NCT04377620|463199815|FG000|Overall Study|Death|42|||
128699803|NCT04377620|463199816|FG001|Overall Study|Death|48|||
128699804|NCT04377620|463199817|FG002|Overall Study|Death|36|||
128699805|NCT04377620|463199815|FG000|Overall Study|Withdrawal by Subject|0|||
128699806|NCT04377620|463199816|FG001|Overall Study|Withdrawal by Subject|2|||
128699807|NCT04377620|463199817|FG002|Overall Study|Withdrawal by Subject|0|||
128920715|NCT03952559|463997038|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
128920716|NCT03952559|463997034|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
128920717|NCT03952559|463997035|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
128920718|NCT03952559|463997036|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
128920719|NCT03952559|463997037|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
128920720|NCT03952559|463997038|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
128920721|NCT03952559|463997034|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
128920722|NCT03952559|463997035|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
128920723|NCT03952559|463997036|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
128920724|NCT03952559|463997037|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
128920725|NCT03952559|463997038|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
128920726|NCT01870739|463997041|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
128920727|NCT01870739|463997042|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
128920728|NCT01870739|463997041|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
128920729|NCT01870739|463997042|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
128920730|NCT01870739|463997041|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
128699808|NCT00288054|463199818|FG000|Overall Study|Protocol Violation|2|||
128699809|NCT00288054|463199818|FG000|Overall Study|Lack of Efficacy|16|||
128699810|NCT00288054|463199818|FG000|Overall Study|Adverse Event|3|||
128699811|NCT00288054|463199818|FG000|Overall Study|Withdrawal by Subject|1|||
128699812|NCT00288054|463199818|FG000|Overall Study|Not protocol specified|2|||
128699813|NCT00289991|463199819|FG000|Overall Study|Death|35|||
128699814|NCT00289991|463199820|FG001|Overall Study|Death|38|||
128699815|NCT00289991|463199819|FG000|Overall Study|Adverse Event|15|||
128699816|NCT00289991|463199820|FG001|Overall Study|Adverse Event|13|||
128699817|NCT00289991|463199819|FG000|Overall Study|Failure of prophylaxis|1|||
128699818|NCT00289991|463199820|FG001|Overall Study|Failure of prophylaxis|1|||
128699819|NCT00289991|463199819|FG000|Overall Study|Fungal breakthrough infection|0|||
128699820|NCT00289991|463199820|FG001|Overall Study|Fungal breakthrough infection|1|||
128699821|NCT00289991|463199819|FG000|Overall Study|Lost to Follow-up|0|||
128699822|NCT00289991|463199820|FG001|Overall Study|Lost to Follow-up|1|||
128699823|NCT00289991|463199819|FG000|Overall Study|Withdrawal by Subject|2|||
128699824|NCT00289991|463199820|FG001|Overall Study|Withdrawal by Subject|12|||
128699825|NCT00289991|463199819|FG000|Overall Study|Other|5|||
128766488|NCT00118898|463435339|FG002|Overall Study|Withdrawal by Subject|8|||
128766489|NCT00118898|463435340|FG003|Overall Study|Withdrawal by Subject|8|||
129029278|NCT02611323|464398387|FG009|Overall Study|Lost to Follow-up|0|||
128699826|NCT00289991|463199820|FG001|Overall Study|Other|14|||
128920731|NCT01870739|463997042|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
128920732|NCT01870739|463997041|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
128920733|NCT01870739|463997042|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
128920734|NCT01870739|463997041|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
128920735|NCT01870739|463997042|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
128920736|NCT01870739|463997041|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
128920737|NCT01870739|463997042|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
128920738|NCT01870739|463997041|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
128920739|NCT01870739|463997042|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
128920740|NCT01986062|463997043|FG000|Overall Study|Lost to Follow-up|1|||
128920741|NCT01986062|463997044|FG001|Overall Study|Lost to Follow-up|0|||
128920742|NCT01986062|463997043|FG000|Overall Study|Withdrawal by Subject|0|||
128920743|NCT01986062|463997044|FG001|Overall Study|Withdrawal by Subject|1|||
128920744|NCT03538743|463997045|FG000|Overall Study|Adverse Event|0|||
128920745|NCT03538743|463997046|FG001|Overall Study|Adverse Event|0|||
128920746|NCT03538743|463997047|FG002|Overall Study|Adverse Event|1|||
128920747|NCT03538743|463997048|FG003|Overall Study|Adverse Event|1|||
128920748|NCT03538743|463997049|FG004|Overall Study|Adverse Event|0|||
128920749|NCT03538743|463997050|FG005|Overall Study|Adverse Event|0|||
128920750|NCT03538743|463997051|FG006|Overall Study|Adverse Event|0|||
128920751|NCT03538743|463997052|FG007|Overall Study|Adverse Event|0|||
128920752|NCT03538743|463997053|FG008|Overall Study|Adverse Event|0|||
128920753|NCT03538743|463997045|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
128920754|NCT03538743|463997046|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
128920755|NCT03538743|463997047|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
128920756|NCT03538743|463997048|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
128920757|NCT03538743|463997049|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
128920758|NCT03538743|463997050|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
128920759|NCT03538743|463997051|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
128920760|NCT03538743|463997052|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
128920761|NCT03538743|463997053|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
128920762|NCT03538743|463997045|FG000|Overall Study|Withdrawal by Subject|0|||
128920763|NCT03538743|463997046|FG001|Overall Study|Withdrawal by Subject|0|||
128920764|NCT03538743|463997047|FG002|Overall Study|Withdrawal by Subject|0|||
128920765|NCT03538743|463997048|FG003|Overall Study|Withdrawal by Subject|1|||
128920766|NCT03538743|463997049|FG004|Overall Study|Withdrawal by Subject|0|||
128920767|NCT03538743|463997050|FG005|Overall Study|Withdrawal by Subject|0|||
128920768|NCT03538743|463997051|FG006|Overall Study|Withdrawal by Subject|0|||
128920769|NCT03538743|463997052|FG007|Overall Study|Withdrawal by Subject|0|||
128920770|NCT03538743|463997053|FG008|Overall Study|Withdrawal by Subject|0|||
128920771|NCT04640766|463997054|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
128920772|NCT00630331|463997055|FG000|Overall Study|Death|2|||
128920773|NCT00630331|463997056|FG001|Overall Study|Death|1|||
128920774|NCT00630331|463997057|FG002|Overall Study|Death|1|||
128920775|NCT00630331|463997055|FG000|Overall Study|Adverse Event|1|||
128920776|NCT00630331|463997056|FG001|Overall Study|Adverse Event|0|||
128920777|NCT00630331|463997057|FG002|Overall Study|Adverse Event|0|||
128920778|NCT00630331|463997055|FG000|Overall Study|Withdrawal by Subject|12|||
128920779|NCT00630331|463997056|FG001|Overall Study|Withdrawal by Subject|7|||
128920780|NCT00630331|463997057|FG002|Overall Study|Withdrawal by Subject|5|||
128920781|NCT00630331|463997055|FG000|Overall Study|Lost to Follow-up|175|||
128920782|NCT00630331|463997056|FG001|Overall Study|Lost to Follow-up|143|||
128920783|NCT00630331|463997057|FG002|Overall Study|Lost to Follow-up|170|||
128920784|NCT00630331|463997055|FG000|Overall Study|Inappropriate enrollment|3|||
128920785|NCT00630331|463997056|FG001|Overall Study|Inappropriate enrollment|6|||
128920786|NCT00630331|463997057|FG002|Overall Study|Inappropriate enrollment|3|||
128920787|NCT00630331|463997055|FG000|Overall Study|Unable to classify|9|||
128920788|NCT00630331|463997056|FG001|Overall Study|Unable to classify|4|||
128920789|NCT00630331|463997057|FG002|Overall Study|Unable to classify|3|||
128920790|NCT00630331|463997055|FG000|Overall Study|Protocol Violation|4|||
128920791|NCT00630331|463997056|FG001|Overall Study|Protocol Violation|5|||
128920792|NCT00630331|463997057|FG002|Overall Study|Protocol Violation|6|||
128920793|NCT01827384|463997059|FG000|Overall Study|Switched to alternative treatment|0|||
128920794|NCT01827384|463997060|FG001|Overall Study|Switched to alternative treatment|0|||
128920795|NCT01827384|463997061|FG002|Overall Study|Switched to alternative treatment|0|||
128920796|NCT01827384|463997062|FG003|Overall Study|Switched to alternative treatment|0|||
128920797|NCT01827384|463997063|FG004|Overall Study|Switched to alternative treatment|0|||
128920798|NCT01827384|463997064|FG005|Overall Study|Switched to alternative treatment|0|||
128920799|NCT01827384|463997065|FG006|Overall Study|Switched to alternative treatment|0|||
128920800|NCT01827384|463997066|FG007|Overall Study|Switched to alternative treatment|0|||
128920801|NCT01827384|463997067|FG008|Overall Study|Switched to alternative treatment|0|||
128920802|NCT01827384|463997068|FG009|Overall Study|Switched to alternative treatment|0|||
128920803|NCT01827384|463997069|FG010|Overall Study|Switched to alternative treatment|0|||
128920804|NCT01827384|463997070|FG011|Overall Study|Switched to alternative treatment|0|||
128920805|NCT01827384|463997071|FG012|Overall Study|Switched to alternative treatment|0|||
128920806|NCT01827384|463997072|FG013|Overall Study|Switched to alternative treatment|2|||
128920807|NCT01827384|463997059|FG000|Overall Study|Disease progression before treatment|0|||
128920808|NCT01827384|463997060|FG001|Overall Study|Disease progression before treatment|0|||
128920809|NCT01827384|463997061|FG002|Overall Study|Disease progression before treatment|0|||
128920810|NCT01827384|463997062|FG003|Overall Study|Disease progression before treatment|0|||
128920811|NCT01827384|463997063|FG004|Overall Study|Disease progression before treatment|0|||
128920812|NCT01827384|463997064|FG005|Overall Study|Disease progression before treatment|0|||
128920813|NCT01827384|463997065|FG006|Overall Study|Disease progression before treatment|0|||
128920814|NCT01827384|463997066|FG007|Overall Study|Disease progression before treatment|0|||
128920815|NCT01827384|463997067|FG008|Overall Study|Disease progression before treatment|0|||
128920816|NCT01827384|463997068|FG009|Overall Study|Disease progression before treatment|0|||
128920817|NCT01827384|463997069|FG010|Overall Study|Disease progression before treatment|0|||
128920818|NCT01827384|463997070|FG011|Overall Study|Disease progression before treatment|0|||
128920819|NCT01827384|463997071|FG012|Overall Study|Disease progression before treatment|0|||
128920820|NCT01827384|463997072|FG013|Overall Study|Disease progression before treatment|4|||
128920821|NCT01827384|463997059|FG000|Overall Study|Ineligible|0|||
128920822|NCT01827384|463997060|FG001|Overall Study|Ineligible|0|||
128920823|NCT01827384|463997061|FG002|Overall Study|Ineligible|0|||
128920824|NCT01827384|463997062|FG003|Overall Study|Ineligible|0|||
128920825|NCT01827384|463997063|FG004|Overall Study|Ineligible|0|||
128920826|NCT01827384|463997064|FG005|Overall Study|Ineligible|0|||
128920827|NCT01827384|463997065|FG006|Overall Study|Ineligible|0|||
128920828|NCT01827384|463997066|FG007|Overall Study|Ineligible|0|||
128920829|NCT01827384|463997067|FG008|Overall Study|Ineligible|0|||
128920830|NCT01827384|463997068|FG009|Overall Study|Ineligible|0|||
128920831|NCT01827384|463997069|FG010|Overall Study|Ineligible|0|||
128920832|NCT01827384|463997070|FG011|Overall Study|Ineligible|0|||
128920833|NCT01827384|463997071|FG012|Overall Study|Ineligible|0|||
128920834|NCT01827384|463997072|FG013|Overall Study|Ineligible|19|||
128920835|NCT01827384|463997059|FG000|Overall Study|Participant died before treatment|0|||
128920836|NCT01827384|463997060|FG001|Overall Study|Participant died before treatment|0|||
128920837|NCT01827384|463997061|FG002|Overall Study|Participant died before treatment|0|||
128920838|NCT01827384|463997062|FG003|Overall Study|Participant died before treatment|0|||
128920839|NCT01827384|463997063|FG004|Overall Study|Participant died before treatment|0|||
128920840|NCT01827384|463997064|FG005|Overall Study|Participant died before treatment|0|||
128920841|NCT01827384|463997065|FG006|Overall Study|Participant died before treatment|0|||
128920842|NCT01827384|463997066|FG007|Overall Study|Participant died before treatment|0|||
128920843|NCT01827384|463997067|FG008|Overall Study|Participant died before treatment|0|||
128920844|NCT01827384|463997068|FG009|Overall Study|Participant died before treatment|0|||
128920845|NCT01827384|463997069|FG010|Overall Study|Participant died before treatment|0|||
128920846|NCT01827384|463997070|FG011|Overall Study|Participant died before treatment|0|||
128920847|NCT01827384|463997071|FG012|Overall Study|Participant died before treatment|0|||
128920848|NCT01827384|463997072|FG013|Overall Study|Participant died before treatment|5|||
128920849|NCT01827384|463997059|FG000|Overall Study|Insufficient tumor cells|0|||
128920850|NCT01827384|463997060|FG001|Overall Study|Insufficient tumor cells|0|||
129029279|NCT02611323|464398388|FG010|Overall Study|Lost to Follow-up|2|||
129029280|NCT02611323|464398378|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029281|NCT02611323|464398379|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029282|NCT02611323|464398380|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029283|NCT02611323|464398381|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029284|NCT02611323|464398382|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029285|NCT02611323|464398383|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029286|NCT02611323|464398384|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029287|NCT02611323|464398385|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029288|NCT02611323|464398386|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029289|NCT02611323|464398387|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
129029290|NCT02611323|464398388|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
129029291|NCT02611323|464398378|FG000|Overall Study|Progressive Disease|0|||
129029292|NCT02611323|464398379|FG001|Overall Study|Progressive Disease|0|||
129029293|NCT02611323|464398380|FG002|Overall Study|Progressive Disease|0|||
129029294|NCT02611323|464398381|FG003|Overall Study|Progressive Disease|0|||
129029295|NCT02611323|464398382|FG004|Overall Study|Progressive Disease|0|||
129029296|NCT02611323|464398383|FG005|Overall Study|Progressive Disease|0|||
129029297|NCT02611323|464398384|FG006|Overall Study|Progressive Disease|0|||
129029298|NCT02611323|464398385|FG007|Overall Study|Progressive Disease|0|||
129029299|NCT02611323|464398386|FG008|Overall Study|Progressive Disease|0|||
129029300|NCT02611323|464398387|FG009|Overall Study|Progressive Disease|0|||
129029301|NCT02611323|464398388|FG010|Overall Study|Progressive Disease|1|||
129029302|NCT02611323|464398378|FG000|Overall Study|Withdrawal by Subject|1|||
129029303|NCT02611323|464398379|FG001|Overall Study|Withdrawal by Subject|0|||
129029304|NCT02611323|464398380|FG002|Overall Study|Withdrawal by Subject|0|||
128699827|NCT01606007|463199826|FG000|Overall Study|Reason 'Other' in the protocol|0|||
128699828|NCT01606007|463199827|FG001|Overall Study|Reason 'Other' in the protocol|1|||
128699829|NCT01606007|463199828|FG002|Overall Study|Reason 'Other' in the protocol|1|||
128699830|NCT01606007|463199826|FG000|Overall Study|Pregnancy|0|||
128699831|NCT01606007|463199827|FG001|Overall Study|Pregnancy|1|||
128699832|NCT01606007|463199828|FG002|Overall Study|Pregnancy|1|||
128699833|NCT01606007|463199826|FG000|Overall Study|Withdrawal by Subject|8|||
128699834|NCT01606007|463199827|FG001|Overall Study|Withdrawal by Subject|6|||
128699835|NCT01606007|463199828|FG002|Overall Study|Withdrawal by Subject|1|||
128699836|NCT01606007|463199826|FG000|Overall Study|Adverse Event|0|||
128699837|NCT01606007|463199827|FG001|Overall Study|Adverse Event|1|||
128699838|NCT01606007|463199828|FG002|Overall Study|Adverse Event|1|||
128699839|NCT01606007|463199826|FG000|Overall Study|discontinue study treatment|0|||
128699840|NCT01606007|463199827|FG001|Overall Study|discontinue study treatment|2|||
128699841|NCT01606007|463199828|FG002|Overall Study|discontinue study treatment|1|||
128699842|NCT01606007|463199826|FG000|Overall Study|Lost to Follow-up|6|||
128699843|NCT01606007|463199827|FG001|Overall Study|Lost to Follow-up|8|||
128699844|NCT01606007|463199828|FG002|Overall Study|Lost to Follow-up|5|||
128699845|NCT01606007|463199826|FG000|Overall Study|Poor/Non-compliance|1|||
128699846|NCT01606007|463199827|FG001|Overall Study|Poor/Non-compliance|0|||
128699847|NCT01606007|463199828|FG002|Overall Study|Poor/Non-compliance|0|||
128699848|NCT03733470|463199833|FG000|Overall Study|PI Decision|1|||
128699849|NCT03733470|463199834|FG001|Overall Study|PI Decision|1|||
128699850|NCT03470441|463199835|FG000|Overall Study|Death|0|||
128699851|NCT03470441|463199836|FG001|Overall Study|Death|1|||
128699852|NCT03470441|463199837|FG002|Overall Study|Death|1|||
128699853|NCT03470441|463199838|FG003|Overall Study|Death|0|||
128699854|NCT03470441|463199835|FG000|Overall Study|Adverse Event|0|||
128699855|NCT03470441|463199836|FG001|Overall Study|Adverse Event|0|||
128699856|NCT03470441|463199837|FG002|Overall Study|Adverse Event|0|||
128699857|NCT03470441|463199838|FG003|Overall Study|Adverse Event|1|||
128699858|NCT03470441|463199835|FG000|Overall Study|Withdrawal by Subject|1|||
128699859|NCT03470441|463199836|FG001|Overall Study|Withdrawal by Subject|4|||
128699860|NCT03470441|463199837|FG002|Overall Study|Withdrawal by Subject|1|||
128699861|NCT03470441|463199838|FG003|Overall Study|Withdrawal by Subject|3|||
128699862|NCT03768414|463199839|FG000|Overall Study|Adverse Event or side effects|72|||
128699863|NCT03768414|463199840|FG001|Overall Study|Adverse Event or side effects|28|||
128699864|NCT03768414|463199839|FG000|Overall Study|Refusal unrelated to adverse event|33|||
128699865|NCT03768414|463199840|FG001|Overall Study|Refusal unrelated to adverse event|33|||
128699866|NCT03768414|463199839|FG000|Overall Study|Progression/relapse|132|||
128699867|NCT03768414|463199840|FG001|Overall Study|Progression/relapse|60|||
128699868|NCT03768414|463199839|FG000|Overall Study|Death|9|||
128699869|NCT03768414|463199840|FG001|Overall Study|Death|6|||
129216317|NCT01208207|465092879|FG003|Part II|Technical Problems|1|||
129216318|NCT01208207|465092880|FG004|Part II|Technical Problems|0|||
128699870|NCT03768414|463199839|FG000|Overall Study|Other - not protocol specified|45|||
128699871|NCT03768414|463199840|FG001|Overall Study|Other - not protocol specified|18|||
128699872|NCT03768414|463199839|FG000|Overall Study|Reason under review|3|||
128699873|NCT03768414|463199840|FG001|Overall Study|Reason under review|2|||
129029305|NCT02611323|464398381|FG003|Overall Study|Withdrawal by Subject|0|||
128699874|NCT03851705|463199841|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
128699875|NCT03851705|463199842|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
128699876|NCT03851705|463199843|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
128699877|NCT03851705|463199844|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
128699878|NCT03851705|463199841|FG000|Part 1: Double-Blind Period|Other reason|1|||
128699879|NCT03851705|463199842|FG001|Part 1: Double-Blind Period|Other reason|0|||
128699880|NCT03851705|463199843|FG002|Part 1: Double-Blind Period|Other reason|0|||
128699881|NCT03851705|463199844|FG003|Part 1: Double-Blind Period|Other reason|0|||
128699882|NCT03851705|463199841|FG000|Part 2: Open-Label Period|Other reason|0|||
128699883|NCT03851705|463199842|FG001|Part 2: Open-Label Period|Other reason|0|||
128699884|NCT03851705|463199843|FG002|Part 2: Open-Label Period|Other reason|0|||
128699885|NCT03851705|463199844|FG003|Part 2: Open-Label Period|Other reason|1|||
128699886|NCT03851705|463199841|FG000|Part 2: Open-Label Period|Death|0|||
128699887|NCT03851705|463199842|FG001|Part 2: Open-Label Period|Death|0|||
128699888|NCT03851705|463199843|FG002|Part 2: Open-Label Period|Death|3|||
128699889|NCT03851705|463199844|FG003|Part 2: Open-Label Period|Death|0|||
128699890|NCT03851705|463199841|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
128699891|NCT03851705|463199842|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
128699892|NCT03851705|463199843|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
128699893|NCT03851705|463199844|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
128699894|NCT02197520|463199851|FG000|Period 1|Withdrawal by Subject|1|||
128699895|NCT02197520|463199852|FG001|Period 1|Withdrawal by Subject|0|||
128699896|NCT02197520|463199851|FG000|Period 2|Adverse Event|0|||
128699897|NCT02197520|463199852|FG001|Period 2|Adverse Event|2|||
128699898|NCT02197520|463199851|FG000|Period 2|Withdrawal by Subject|1|||
128699899|NCT02197520|463199852|FG001|Period 2|Withdrawal by Subject|0|||
128699900|NCT01306942|463199853|FG000|Phase I|Adverse Event|2|||
128699901|NCT01306942|463199854|FG001|Phase I|Adverse Event|2|||
128699902|NCT01306942|463199855|FG002|Phase I|Adverse Event|0|||
128699903|NCT01306942|463199856|FG003|Phase I|Adverse Event|0|||
128699904|NCT01306942|463199853|FG000|Phase I|Physician Decision|3|||
128920851|NCT01827384|463997061|FG002|Overall Study|Insufficient tumor cells|0|||
128920852|NCT01827384|463997062|FG003|Overall Study|Insufficient tumor cells|0|||
128920853|NCT01827384|463997063|FG004|Overall Study|Insufficient tumor cells|0|||
128920854|NCT01827384|463997064|FG005|Overall Study|Insufficient tumor cells|0|||
128920855|NCT01827384|463997065|FG006|Overall Study|Insufficient tumor cells|0|||
128920856|NCT01827384|463997066|FG007|Overall Study|Insufficient tumor cells|0|||
128920857|NCT01827384|463997067|FG008|Overall Study|Insufficient tumor cells|0|||
128920858|NCT01827384|463997068|FG009|Overall Study|Insufficient tumor cells|0|||
128920859|NCT01827384|463997069|FG010|Overall Study|Insufficient tumor cells|0|||
128920860|NCT01827384|463997070|FG011|Overall Study|Insufficient tumor cells|0|||
128920861|NCT01827384|463997071|FG012|Overall Study|Insufficient tumor cells|0|||
128920862|NCT01827384|463997072|FG013|Overall Study|Insufficient tumor cells|13|||
128920863|NCT01827384|463997059|FG000|Overall Study|No actionable mutation|0|||
128920864|NCT01827384|463997060|FG001|Overall Study|No actionable mutation|0|||
128920865|NCT01827384|463997061|FG002|Overall Study|No actionable mutation|0|||
128920866|NCT01827384|463997062|FG003|Overall Study|No actionable mutation|0|||
128920867|NCT01827384|463997063|FG004|Overall Study|No actionable mutation|0|||
128920868|NCT01827384|463997064|FG005|Overall Study|No actionable mutation|0|||
128920869|NCT01827384|463997065|FG006|Overall Study|No actionable mutation|0|||
128920870|NCT01827384|463997066|FG007|Overall Study|No actionable mutation|0|||
128920871|NCT01827384|463997067|FG008|Overall Study|No actionable mutation|0|||
128920872|NCT01827384|463997068|FG009|Overall Study|No actionable mutation|0|||
128920873|NCT01827384|463997069|FG010|Overall Study|No actionable mutation|0|||
128920874|NCT01827384|463997070|FG011|Overall Study|No actionable mutation|0|||
128920875|NCT01827384|463997071|FG012|Overall Study|No actionable mutation|0|||
128920876|NCT01827384|463997072|FG013|Overall Study|No actionable mutation|73|||
128920877|NCT01827384|463997059|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
128920878|NCT01827384|463997060|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
128920879|NCT01827384|463997061|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
128920880|NCT01827384|463997062|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
128920881|NCT01827384|463997063|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
128920882|NCT01827384|463997064|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
128920883|NCT01827384|463997065|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
128920884|NCT01827384|463997066|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
128920885|NCT01827384|463997067|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
128920886|NCT01827384|463997068|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
128920887|NCT01827384|463997069|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
128920888|NCT01827384|463997070|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
128920889|NCT01827384|463997071|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
128920890|NCT01827384|463997072|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
128920891|NCT01817790|463997075|FG000|Overall Study|Adverse Event|0|||
128920892|NCT01817790|463997076|FG001|Overall Study|Adverse Event|2|||
128920893|NCT01817790|463997075|FG000|Overall Study|Lost to Follow-up|0|||
128920894|NCT01817790|463997076|FG001|Overall Study|Lost to Follow-up|1|||
128920895|NCT01817790|463997075|FG000|Overall Study|Protocol Violation|2|||
128920896|NCT01817790|463997076|FG001|Overall Study|Protocol Violation|1|||
128920897|NCT01817790|463997075|FG000|Overall Study|Withdrawal by Subject|1|||
128920898|NCT01817790|463997076|FG001|Overall Study|Withdrawal by Subject|3|||
128920899|NCT01817790|463997075|FG000|Overall Study|Other: Could not attend appointment|1|||
128699905|NCT01306942|463199854|FG001|Phase I|Physician Decision|1|||
128699906|NCT01306942|463199855|FG002|Phase I|Physician Decision|0|||
128699907|NCT01306942|463199856|FG003|Phase I|Physician Decision|0|||
128699908|NCT01306942|463199853|FG000|Phase II|Adverse Event|0|||
128699909|NCT01306942|463199854|FG001|Phase II|Adverse Event|0|||
128699910|NCT01306942|463199855|FG002|Phase II|Adverse Event|0|||
128699911|NCT01306942|463199856|FG003|Phase II|Adverse Event|6|||
128699912|NCT01306942|463199853|FG000|Phase II|Physician Decision|2|||
128699913|NCT01306942|463199854|FG001|Phase II|Physician Decision|0|||
128699914|NCT01306942|463199855|FG002|Phase II|Physician Decision|0|||
128699915|NCT01306942|463199856|FG003|Phase II|Physician Decision|5|||
128699916|NCT01306942|463199853|FG000|Phase II|Withdrawal by Subject|0|||
128699917|NCT01306942|463199854|FG001|Phase II|Withdrawal by Subject|0|||
128699918|NCT01306942|463199855|FG002|Phase II|Withdrawal by Subject|0|||
128699919|NCT01306942|463199856|FG003|Phase II|Withdrawal by Subject|2|||
128766490|NCT00118898|463435337|FG000|Overall Study|Site Closure|33|||
128766491|NCT00118898|463435338|FG001|Overall Study|Site Closure|31|||
128766492|NCT00118898|463435339|FG002|Overall Study|Site Closure|28|||
128920900|NCT01817790|463997076|FG001|Overall Study|Other: Could not attend appointment|1|||
128920901|NCT01671345|463997077|FG000|Overall Study|Lost to Follow-up|10|||
128920902|NCT01671345|463997078|FG001|Overall Study|Lost to Follow-up|6|||
128920903|NCT01671345|463997077|FG000|Overall Study|visit with non-participating physician|3|||
128920904|NCT01671345|463997078|FG001|Overall Study|visit with non-participating physician|3|||
128920905|NCT04280081|463997081|FG000|Overall Study|Adverse Event|4|||
128920906|NCT04280081|463997081|FG000|Overall Study|Death|2|||
128920907|NCT04280081|463997081|FG000|Overall Study|Progressive Disease|6|||
128920908|NCT01468311|463997082|FG000|Overall Study|mobilization failure|1|||
128920909|NCT01468311|463997082|FG000|Overall Study|Withdrawal by Subject|1|||
128920910|NCT03219164|463999199|FG000|Overall Study|Study Terminated by Sponsor|16|||
128920911|NCT03219164|463999200|FG001|Overall Study|Study Terminated by Sponsor|12|||
128920912|NCT03219164|463999199|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
128920913|NCT03219164|463999200|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
128920914|NCT03219164|463999199|FG000|Overall Study|Lost to Follow-up|1|||
128920915|NCT03219164|463999200|FG001|Overall Study|Lost to Follow-up|1|||
128920916|NCT03219164|463999199|FG000|Overall Study|Adverse Event|1|||
128920917|NCT03219164|463999200|FG001|Overall Study|Adverse Event|0|||
128920918|NCT03219164|463999199|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128920919|NCT03219164|463999200|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128920920|NCT03219164|463999199|FG000|Overall Study|Protocol Violation|0|||
128920921|NCT03219164|463999200|FG001|Overall Study|Protocol Violation|1|||
128920922|NCT03219164|463999199|FG000|Overall Study|Withdrew Assent|1|||
128920923|NCT03219164|463999200|FG001|Overall Study|Withdrew Assent|0|||
128920924|NCT02689492|463999201|FG000|Overall Study|Lost to Follow-up|61|||
128920925|NCT02689492|463999201|FG000|Overall Study|Withdrawal by Subject|11|||
128920926|NCT02689492|463999201|FG000|Overall Study|Death|9|||
128920927|NCT02689492|463999201|FG000|Overall Study|Physician Decision|2|||
128920928|NCT02689492|463999201|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
128920929|NCT02689492|463999201|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
128920930|NCT02689492|463999201|FG000|Overall Study|Other than listed|1|||
128920931|NCT02029976|463999202|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
128920932|NCT02029976|463999203|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
128920933|NCT02029976|463999202|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
128920934|NCT02029976|463999203|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
128920935|NCT02029976|463999202|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
128920936|NCT02029976|463999203|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
128920937|NCT02029976|463999202|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
128920938|NCT02029976|463999203|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
128920939|NCT01750918|463999204|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
128920940|NCT01750918|463999205|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
128920941|NCT01750918|463999206|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
128920942|NCT01750918|463999207|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
128920943|NCT01750918|463999208|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
128920944|NCT01750918|463999209|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
128920945|NCT01750918|463999210|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
128920946|NCT01750918|463999211|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
128920947|NCT01750918|463999204|FG000|Overall Study|Lost to Follow-up|0|||
128920948|NCT01750918|463999205|FG001|Overall Study|Lost to Follow-up|0|||
128920949|NCT01750918|463999206|FG002|Overall Study|Lost to Follow-up|2|||
128920950|NCT01750918|463999207|FG003|Overall Study|Lost to Follow-up|2|||
128699920|NCT01306942|463199853|FG000|Phase II|Death|0|||
128920951|NCT01750918|463999208|FG004|Overall Study|Lost to Follow-up|0|||
128920952|NCT01750918|463999209|FG005|Overall Study|Lost to Follow-up|0|||
128920953|NCT01750918|463999210|FG006|Overall Study|Lost to Follow-up|0|||
128920954|NCT01750918|463999211|FG007|Overall Study|Lost to Follow-up|1|||
128920955|NCT01750918|463999204|FG000|Overall Study|Withdrawal by Subject|0|||
128920956|NCT01750918|463999205|FG001|Overall Study|Withdrawal by Subject|0|||
128920957|NCT01750918|463999206|FG002|Overall Study|Withdrawal by Subject|1|||
128920958|NCT01750918|463999207|FG003|Overall Study|Withdrawal by Subject|2|||
128920959|NCT01750918|463999208|FG004|Overall Study|Withdrawal by Subject|1|||
128920960|NCT01750918|463999209|FG005|Overall Study|Withdrawal by Subject|1|||
128920961|NCT01750918|463999210|FG006|Overall Study|Withdrawal by Subject|2|||
128920962|NCT01750918|463999211|FG007|Overall Study|Withdrawal by Subject|2|||
128920963|NCT02338843|463999217|FG000|Overall Study|Adverse Event|2|||
128920964|NCT02338843|463999218|FG001|Overall Study|Adverse Event|1|||
128920965|NCT02338843|463999217|FG000|Overall Study|Death|40|||
128920966|NCT02338843|463999218|FG001|Overall Study|Death|53|||
128920967|NCT02338843|463999217|FG000|Overall Study|Physician Decision|1|||
128920968|NCT02338843|463999218|FG001|Overall Study|Physician Decision|0|||
128920969|NCT02338843|463999217|FG000|Overall Study|Withdrawal by Subject|0|||
128920970|NCT02338843|463999218|FG001|Overall Study|Withdrawal by Subject|2|||
128699921|NCT01306942|463199854|FG001|Phase II|Death|0|||
128699922|NCT01306942|463199855|FG002|Phase II|Death|0|||
128699923|NCT01306942|463199856|FG003|Phase II|Death|1|||
128920971|NCT02338843|463999217|FG000|Overall Study|Subject Recovered|0|||
128920972|NCT02338843|463999218|FG001|Overall Study|Subject Recovered|2|||
129216319|NCT01208207|465092881|FG005|Part II|Technical Problems|1|||
128920973|NCT02338843|463999217|FG000|Overall Study|Discontinued prior to randomizat|1|||
128920974|NCT02338843|463999218|FG001|Overall Study|Discontinued prior to randomizat|0|||
128920975|NCT00023322|463999219|FG000|Overall Study|Lost to Follow-up|1|||
128920976|NCT01793792|463999222|FG000|Overall Study|Death|5|||
128920977|NCT01793792|463999222|FG000|Overall Study|Lost to Follow-up|5|||
128920978|NCT01793792|463999222|FG000|Overall Study|Withdrawal by Subject|1|||
128920979|NCT01793792|463999222|FG000|Overall Study|Device Not Implanted|1|||
128920980|NCT02185521|463999225|FG000|Overall Study|Withdrawal by Subject|1|||
128920981|NCT02185521|463999225|FG000|Overall Study|Protocol Violation|1|||
128920982|NCT01341457|463999226|FG000|Overall Study|Adverse Event|2|||
128920983|NCT01341457|463999227|FG001|Overall Study|Adverse Event|0|||
128920984|NCT03124459|463999232|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
128920985|NCT03124459|463999233|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
128920986|NCT03124459|463999234|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
128920987|NCT03124459|463999235|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
128920988|NCT03124459|463999236|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
128920989|NCT03124459|463999237|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
128920990|NCT03124459|463999232|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
128920991|NCT03124459|463999233|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
128920992|NCT03124459|463999234|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
128920993|NCT03124459|463999235|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
128920994|NCT03124459|463999236|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
128920995|NCT03124459|463999237|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
128920996|NCT03124459|463999232|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
128920997|NCT03124459|463999233|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
128920998|NCT03124459|463999234|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
128920999|NCT03124459|463999235|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
128921000|NCT03124459|463999236|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
128921001|NCT03124459|463999237|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
128921002|NCT03124459|463999232|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
128921003|NCT03124459|463999233|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
128921004|NCT03124459|463999234|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
128921005|NCT03124459|463999235|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
128921006|NCT03124459|463999236|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
128921007|NCT03124459|463999237|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
128921008|NCT03124459|463999232|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
128921009|NCT03124459|463999233|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
128921010|NCT03124459|463999234|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
128921011|NCT03124459|463999235|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
128921012|NCT03124459|463999236|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
128921013|NCT03124459|463999237|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
128921014|NCT03124459|463999232|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
128921015|NCT03124459|463999233|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
128921016|NCT03124459|463999234|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
128921017|NCT03124459|463999235|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
128921018|NCT03124459|463999236|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
128921019|NCT03124459|463999237|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
128921020|NCT00496366|463999238|FG000|Overall Study|Death|1|||
128921021|NCT01717638|463999243|FG000|Overall Study|Lost to Follow-up|0|||
128921022|NCT01717638|463999244|FG001|Overall Study|Lost to Follow-up|0|||
128921023|NCT01717638|463999245|FG002|Overall Study|Lost to Follow-up|0|||
128921024|NCT01717638|463999246|FG003|Overall Study|Lost to Follow-up|0|||
128921025|NCT01717638|463999247|FG004|Overall Study|Lost to Follow-up|0|||
128921026|NCT01717638|463999248|FG005|Overall Study|Lost to Follow-up|1|||
128921027|NCT01717638|463999249|FG006|Overall Study|Lost to Follow-up|0|||
128921028|NCT01717638|463999250|FG007|Overall Study|Lost to Follow-up|0|||
128921029|NCT01717638|463999251|FG008|Overall Study|Lost to Follow-up|0|||
128921030|NCT01717638|463999252|FG009|Overall Study|Lost to Follow-up|0|||
128921031|NCT01717638|463999253|FG010|Overall Study|Lost to Follow-up|0|||
128921032|NCT01717638|463999254|FG011|Overall Study|Lost to Follow-up|0|||
128921033|NCT01717638|463999255|FG012|Overall Study|Lost to Follow-up|0|||
128699924|NCT01306942|463199853|FG000|Phase II|Not finished treatment|0|||
128699925|NCT01306942|463199854|FG001|Phase II|Not finished treatment|0|||
128699926|NCT01306942|463199855|FG002|Phase II|Not finished treatment|0|||
128921034|NCT01717638|463999243|FG000|Overall Study|Father in hospital|0|||
128921035|NCT01717638|463999244|FG001|Overall Study|Father in hospital|0|||
128921036|NCT01717638|463999245|FG002|Overall Study|Father in hospital|0|||
128921037|NCT01717638|463999246|FG003|Overall Study|Father in hospital|0|||
128699927|NCT01306942|463199856|FG003|Phase II|Not finished treatment|1|||
128699928|NCT01306942|463199853|FG000|Phase II|Protocol Violation|0|||
128699929|NCT01306942|463199854|FG001|Phase II|Protocol Violation|0|||
128699930|NCT01306942|463199855|FG002|Phase II|Protocol Violation|0|||
128921038|NCT01717638|463999247|FG004|Overall Study|Father in hospital|0|||
128921039|NCT01717638|463999248|FG005|Overall Study|Father in hospital|0|||
128921040|NCT01717638|463999249|FG006|Overall Study|Father in hospital|0|||
128921041|NCT01717638|463999250|FG007|Overall Study|Father in hospital|0|||
128921042|NCT01717638|463999251|FG008|Overall Study|Father in hospital|0|||
128921043|NCT01717638|463999252|FG009|Overall Study|Father in hospital|0|||
128921044|NCT01717638|463999253|FG010|Overall Study|Father in hospital|0|||
128921045|NCT01717638|463999254|FG011|Overall Study|Father in hospital|0|||
128921046|NCT01717638|463999255|FG012|Overall Study|Father in hospital|1|||
128921047|NCT01717638|463999243|FG000|Overall Study|Withdrawal by Subject|0|||
128921048|NCT01717638|463999244|FG001|Overall Study|Withdrawal by Subject|1|||
128921049|NCT01717638|463999245|FG002|Overall Study|Withdrawal by Subject|1|||
128921050|NCT01717638|463999246|FG003|Overall Study|Withdrawal by Subject|0|||
128921051|NCT01717638|463999247|FG004|Overall Study|Withdrawal by Subject|1|||
128921052|NCT01717638|463999248|FG005|Overall Study|Withdrawal by Subject|0|||
128921053|NCT01717638|463999249|FG006|Overall Study|Withdrawal by Subject|2|||
128921054|NCT01717638|463999250|FG007|Overall Study|Withdrawal by Subject|1|||
128921055|NCT01717638|463999251|FG008|Overall Study|Withdrawal by Subject|2|||
128921056|NCT01717638|463999252|FG009|Overall Study|Withdrawal by Subject|1|||
128921057|NCT01717638|463999253|FG010|Overall Study|Withdrawal by Subject|0|||
128921058|NCT01717638|463999254|FG011|Overall Study|Withdrawal by Subject|0|||
128921059|NCT01717638|463999255|FG012|Overall Study|Withdrawal by Subject|18|||
128921060|NCT01756274|463999256|FG000|Overall Study|Protocol Violation|2|||
128921061|NCT01756274|463999256|FG000|Overall Study|Laboratory error|1|||
128921062|NCT01147926|463999257|FG000|Overall Study|Subject Withdrew Consent|9|||
128921063|NCT01147926|463999258|FG001|Overall Study|Subject Withdrew Consent|10|||
128921064|NCT01147926|463999257|FG000|Overall Study|Adverse Event|7|||
128921065|NCT01147926|463999258|FG001|Overall Study|Adverse Event|6|||
128921066|NCT01147926|463999257|FG000|Overall Study|Subject Non-Compliant|5|||
128921067|NCT01147926|463999258|FG001|Overall Study|Subject Non-Compliant|4|||
128921068|NCT01147926|463999257|FG000|Overall Study|Principal investigator left hospital|1|||
128921069|NCT01147926|463999258|FG001|Overall Study|Principal investigator left hospital|3|||
128921070|NCT01147926|463999257|FG000|Overall Study|Selection criteria not met|3|||
128921071|NCT01147926|463999258|FG001|Overall Study|Selection criteria not met|1|||
128921072|NCT01147926|463999257|FG000|Overall Study|Lost to Follow-up|0|||
128921073|NCT01147926|463999258|FG001|Overall Study|Lost to Follow-up|2|||
128921074|NCT01147926|463999257|FG000|Overall Study|Sponsor's Decision|0|||
128921075|NCT01147926|463999258|FG001|Overall Study|Sponsor's Decision|1|||
128921076|NCT01147926|463999257|FG000|Overall Study|Lack of Efficacy|1|||
128921077|NCT01147926|463999258|FG001|Overall Study|Lack of Efficacy|0|||
128921078|NCT01147926|463999257|FG000|Overall Study|Too busy, no time for study|1|||
128921079|NCT01147926|463999258|FG001|Overall Study|Too busy, no time for study|0|||
128921080|NCT01147926|463999257|FG000|Overall Study|Went on holiday|0|||
128921081|NCT01147926|463999258|FG001|Overall Study|Went on holiday|1|||
128921082|NCT01147926|463999257|FG000|Overall Study|Colonoscopy result|0|||
128921083|NCT01147926|463999258|FG001|Overall Study|Colonoscopy result|1|||
128921084|NCT00486603|463999259|FG000|Overall Study|Withdrawal by Subject|1|||
128921085|NCT00486603|463999260|FG001|Overall Study|Withdrawal by Subject|0|||
128921086|NCT00486603|463999261|FG002|Overall Study|Withdrawal by Subject|0|||
128921087|NCT00486603|463999262|FG003|Overall Study|Withdrawal by Subject|0|||
128921088|NCT00486603|463999263|FG004|Overall Study|Withdrawal by Subject|0|||
128921089|NCT00486603|463999259|FG000|Overall Study|Physician Decision|0|||
128921090|NCT00486603|463999260|FG001|Overall Study|Physician Decision|1|||
128921091|NCT00486603|463999261|FG002|Overall Study|Physician Decision|0|||
128921092|NCT00486603|463999262|FG003|Overall Study|Physician Decision|0|||
128921093|NCT00486603|463999263|FG004|Overall Study|Physician Decision|0|||
128921094|NCT03514914|463999265|FG000|Overall Study|Death|3|||
128921095|NCT03514914|463999266|FG001|Overall Study|Death|3|||
128921096|NCT03514914|463999265|FG000|Overall Study|Lost to Follow-up|117|||
128921097|NCT03514914|463999266|FG001|Overall Study|Lost to Follow-up|89|||
128921098|NCT02978222|463999270|FG000|Overall Study|Withdrawal by Subject|2|||
128921099|NCT02978222|463999271|FG001|Overall Study|Withdrawal by Subject|2|||
128921100|NCT02978222|463999270|FG000|Overall Study|Physician Decision|2|||
128921101|NCT02978222|463999271|FG001|Overall Study|Physician Decision|0|||
128921102|NCT02978222|463999270|FG000|Overall Study|Adverse Event|0|||
128921103|NCT02978222|463999271|FG001|Overall Study|Adverse Event|1|||
128921104|NCT02978222|463999270|FG000|Overall Study|Death|1|||
128921105|NCT02978222|463999271|FG001|Overall Study|Death|0|||
128921106|NCT02978222|463999270|FG000|Overall Study|Disease Progression|32|||
128921107|NCT02978222|463999271|FG001|Overall Study|Disease Progression|32|||
128921108|NCT02978222|463999270|FG000|Overall Study|Early Study Termination|24|||
128921109|NCT02978222|463999271|FG001|Overall Study|Early Study Termination|21|||
128921110|NCT01686568|463999272|FG000|Main Study|Withdrawal by Subject|1|||
128921111|NCT01686568|463999273|FG001|Main Study|Withdrawal by Subject|3|||
128921112|NCT01686568|463999272|FG000|Main Study|Noncompliance with protocol|0|||
128921113|NCT01686568|463999273|FG001|Main Study|Noncompliance with protocol|1|||
128766493|NCT00118898|463435340|FG003|Overall Study|Site Closure|37|||
128766494|NCT00118898|463435337|FG000|Overall Study|Severe debilitation|1|||
128699931|NCT01306942|463199856|FG003|Phase II|Protocol Violation|1|||
128699932|NCT00369824|463199863|FG000|Overall Study|Adverse Event|0|||
128699933|NCT00369824|463199864|FG001|Overall Study|Adverse Event|2|||
128699934|NCT00369824|463199865|FG002|Overall Study|Adverse Event|0|||
128921114|NCT01686568|463999272|FG000|Main Study|Liver enzymes above range of exclusion|1|||
128921115|NCT01686568|463999273|FG001|Main Study|Liver enzymes above range of exclusion|0|||
128921116|NCT01686568|463999272|FG000|Sub-Study|Not consented for sub-study|2|||
128921117|NCT01686568|463999273|FG001|Sub-Study|Not consented for sub-study|2|||
128921118|NCT00813995|463999276|FG000|Overall Study|Clinical adverse event|9|||
128921119|NCT00813995|463999277|FG001|Overall Study|Clinical adverse event|3|||
128921120|NCT00813995|463999276|FG000|Overall Study|Laboratory adverse event|0|||
128921121|NCT00813995|463999277|FG001|Overall Study|Laboratory adverse event|2|||
128921122|NCT00813995|463999276|FG000|Overall Study|Lack of Efficacy|1|||
128699935|NCT00369824|463199866|FG003|Overall Study|Adverse Event|0|||
128699936|NCT00369824|463199867|FG004|Overall Study|Adverse Event|1|||
128766495|NCT00118898|463435338|FG001|Overall Study|Severe debilitation|4|||
128921123|NCT00813995|463999277|FG001|Overall Study|Lack of Efficacy|0|||
128921124|NCT00813995|463999276|FG000|Overall Study|Lost to Follow-up|4|||
128921125|NCT00813995|463999277|FG001|Overall Study|Lost to Follow-up|2|||
128921126|NCT00813995|463999276|FG000|Overall Study|Other reason|2|||
128921127|NCT00813995|463999277|FG001|Overall Study|Other reason|2|||
128921128|NCT00813995|463999276|FG000|Overall Study|Protocol Violation|3|||
128921129|NCT00813995|463999277|FG001|Overall Study|Protocol Violation|2|||
128921130|NCT00813995|463999276|FG000|Overall Study|Subject moved|4|||
128921131|NCT00813995|463999277|FG001|Overall Study|Subject moved|0|||
128921132|NCT00813995|463999276|FG000|Overall Study|Withdrawal by Subject|0|||
128921133|NCT00813995|463999277|FG001|Overall Study|Withdrawal by Subject|5|||
128921134|NCT02507349|463999278|FG000|Overall Study|Death|12|||
128921135|NCT02507349|463999279|FG001|Overall Study|Death|16|||
128921136|NCT02507349|463999278|FG000|Overall Study|Withdrawal by Subject|1|||
128921137|NCT02507349|463999279|FG001|Overall Study|Withdrawal by Subject|1|||
128921138|NCT02507349|463999278|FG000|Overall Study|Lost to Follow-up|174|||
128921139|NCT02507349|463999279|FG001|Overall Study|Lost to Follow-up|144|||
128921140|NCT01614964|463999280|FG000|Overall Study|Withdrawal by Subject|2|||
128921141|NCT01614964|463999281|FG001|Overall Study|Withdrawal by Subject|0|||
128921142|NCT01614964|463999280|FG000|Overall Study|Lost to Follow-up|3|||
128921143|NCT01614964|463999281|FG001|Overall Study|Lost to Follow-up|0|||
128921144|NCT02700984|463999290|FG000|Overall Study|Death|2|||
128921145|NCT02700984|463999291|FG001|Overall Study|Death|1|||
128921146|NCT02700984|463999290|FG000|Overall Study|Lost to Follow-up|2|||
128921147|NCT02700984|463999291|FG001|Overall Study|Lost to Follow-up|1|||
128921148|NCT02700984|463999290|FG000|Overall Study|Physician Decision|0|||
128921149|NCT02700984|463999291|FG001|Overall Study|Physician Decision|1|||
128921150|NCT02700984|463999290|FG000|Overall Study|Withdrawal by Subject|8|||
128921151|NCT02700984|463999291|FG001|Overall Study|Withdrawal by Subject|9|||
128921152|NCT02700984|463999290|FG000|Overall Study|Reason not specified|3|||
128921153|NCT02700984|463999291|FG001|Overall Study|Reason not specified|2|||
128921154|NCT00473876|463999292|FG000|Overall Study|Lost to Follow-up|3|||
128921155|NCT00473876|463999293|FG001|Overall Study|Lost to Follow-up|1|||
128921156|NCT01032629|463999295|FG000|Overall Study|Closed Site|21|||
128921157|NCT01032629|463999296|FG001|Overall Study|Closed Site|18|||
128921158|NCT01032629|463999297|FG002|Overall Study|Closed Site|16|||
128921159|NCT01032629|463999295|FG000|Overall Study|Withdrawal by Subject|50|||
128921160|NCT01032629|463999296|FG001|Overall Study|Withdrawal by Subject|36|||
128921161|NCT01032629|463999297|FG002|Overall Study|Withdrawal by Subject|35|||
128921162|NCT01032629|463999295|FG000|Overall Study|Lost to Follow-up|74|||
128921163|NCT01032629|463999296|FG001|Overall Study|Lost to Follow-up|47|||
128921164|NCT01032629|463999297|FG002|Overall Study|Lost to Follow-up|37|||
128921165|NCT00348140|463999298|FG000|Overall Study|Adverse Event|46|||
128921166|NCT00348140|463999299|FG001|Overall Study|Adverse Event|49|||
128921167|NCT00348140|463999300|FG002|Overall Study|Adverse Event|78|||
128921168|NCT00348140|463999298|FG000|Overall Study|Lost to Follow-up|4|||
128921169|NCT00348140|463999299|FG001|Overall Study|Lost to Follow-up|4|||
128921170|NCT00348140|463999300|FG002|Overall Study|Lost to Follow-up|4|||
128921171|NCT00348140|463999298|FG000|Overall Study|Protocol Violation|12|||
128921172|NCT00348140|463999299|FG001|Overall Study|Protocol Violation|13|||
128921173|NCT00348140|463999300|FG002|Overall Study|Protocol Violation|14|||
128699937|NCT00369824|463199868|FG005|Overall Study|Adverse Event|0|||
128699938|NCT00369824|463199863|FG000|Overall Study|Protocol Violation|0|||
128921174|NCT00348140|463999298|FG000|Overall Study|Withdrawal by Subject|32|||
128921175|NCT00348140|463999299|FG001|Overall Study|Withdrawal by Subject|40|||
128921176|NCT00348140|463999300|FG002|Overall Study|Withdrawal by Subject|40|||
128921177|NCT00348140|463999298|FG000|Overall Study|Non-compliance|8|||
128921178|NCT00348140|463999299|FG001|Overall Study|Non-compliance|13|||
128699939|NCT00369824|463199864|FG001|Overall Study|Protocol Violation|1|||
128921179|NCT00348140|463999300|FG002|Overall Study|Non-compliance|5|||
128699940|NCT00369824|463199865|FG002|Overall Study|Protocol Violation|0|||
128699941|NCT00369824|463199866|FG003|Overall Study|Protocol Violation|1|||
128699942|NCT00369824|463199867|FG004|Overall Study|Protocol Violation|1|||
128699943|NCT00369824|463199868|FG005|Overall Study|Protocol Violation|0|||
128699944|NCT00369824|463199863|FG000|Overall Study|Withdrawal by Subject|9|||
128699945|NCT00369824|463199864|FG001|Overall Study|Withdrawal by Subject|5|||
128921180|NCT00348140|463999298|FG000|Overall Study|Participant at risk due to study drug|2|||
128921181|NCT00348140|463999299|FG001|Overall Study|Participant at risk due to study drug|0|||
128921182|NCT00348140|463999300|FG002|Overall Study|Participant at risk due to study drug|0|||
128921183|NCT00348140|463999298|FG000|Overall Study|Conditional medication increased dose|1|||
128921184|NCT00348140|463999299|FG001|Overall Study|Conditional medication increased dose|0|||
128921185|NCT00348140|463999300|FG002|Overall Study|Conditional medication increased dose|0|||
128921186|NCT00348140|463999298|FG000|Overall Study|Caregiver related|4|||
128921187|NCT00348140|463999299|FG001|Overall Study|Caregiver related|7|||
128921188|NCT00348140|463999300|FG002|Overall Study|Caregiver related|3|||
128921189|NCT00348140|463999298|FG000|Overall Study|Participant hospitalised|3|||
128921190|NCT00348140|463999299|FG001|Overall Study|Participant hospitalised|0|||
128921191|NCT00348140|463999300|FG002|Overall Study|Participant hospitalised|0|||
128921192|NCT00348140|463999298|FG000|Overall Study|Efficacy related|1|||
128921193|NCT00348140|463999299|FG001|Overall Study|Efficacy related|1|||
128921194|NCT00348140|463999300|FG002|Overall Study|Efficacy related|0|||
128921195|NCT00348140|463999298|FG000|Overall Study|Administration related|3|||
128921196|NCT00348140|463999299|FG001|Overall Study|Administration related|1|||
128921197|NCT00348140|463999300|FG002|Overall Study|Administration related|1|||
128921198|NCT00348140|463999298|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
128921199|NCT00348140|463999299|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
128921200|NCT00348140|463999300|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
128921201|NCT00348140|463999298|FG000|Overall Study|Participant unwell|1|||
128921202|NCT00348140|463999299|FG001|Overall Study|Participant unwell|0|||
128921203|NCT00348140|463999300|FG002|Overall Study|Participant unwell|0|||
128921204|NCT00348140|463999298|FG000|Overall Study|Screen failure|1|||
128921205|NCT00348140|463999299|FG001|Overall Study|Screen failure|0|||
128921206|NCT00348140|463999300|FG002|Overall Study|Screen failure|0|||
128921207|NCT00348140|463999298|FG000|Overall Study|Investigator decided to discontinue|4|||
128921208|NCT00348140|463999299|FG001|Overall Study|Investigator decided to discontinue|1|||
128921209|NCT00348140|463999300|FG002|Overall Study|Investigator decided to discontinue|4|||
128921210|NCT00348140|463999298|FG000|Overall Study|Decided to discontinue on their own|1|||
128921211|NCT00348140|463999299|FG001|Overall Study|Decided to discontinue on their own|4|||
128921212|NCT00348140|463999300|FG002|Overall Study|Decided to discontinue on their own|1|||
128921213|NCT00348140|463999298|FG000|Overall Study|Use of prohibited drug|1|||
128921214|NCT00348140|463999299|FG001|Overall Study|Use of prohibited drug|0|||
128921215|NCT00348140|463999300|FG002|Overall Study|Use of prohibited drug|2|||
128921216|NCT00348140|463999298|FG000|Overall Study|Disease progression|1|||
128699946|NCT00369824|463199865|FG002|Overall Study|Withdrawal by Subject|5|||
128921217|NCT00348140|463999299|FG001|Overall Study|Disease progression|2|||
128921218|NCT00348140|463999300|FG002|Overall Study|Disease progression|5|||
128921219|NCT00348140|463999298|FG000|Overall Study|Increased risk of cardiac infarction|0|||
128921220|NCT00348140|463999299|FG001|Overall Study|Increased risk of cardiac infarction|1|||
128699947|NCT00369824|463199866|FG003|Overall Study|Withdrawal by Subject|4|||
128699948|NCT00369824|463199867|FG004|Overall Study|Withdrawal by Subject|6|||
128921221|NCT00348140|463999300|FG002|Overall Study|Increased risk of cardiac infarction|0|||
128921222|NCT00348140|463999298|FG000|Overall Study|Serious adverse event|0|||
128921223|NCT00348140|463999299|FG001|Overall Study|Serious adverse event|1|||
128921224|NCT00348140|463999300|FG002|Overall Study|Serious adverse event|0|||
128921225|NCT00348140|463999298|FG000|Overall Study|Abnormal ECG|0|||
128921226|NCT00348140|463999299|FG001|Overall Study|Abnormal ECG|1|||
128921227|NCT00348140|463999300|FG002|Overall Study|Abnormal ECG|3|||
128921228|NCT00348140|463999298|FG000|Overall Study|Participant died|0|||
128921229|NCT00348140|463999299|FG001|Overall Study|Participant died|1|||
128921230|NCT00348140|463999300|FG002|Overall Study|Participant died|0|||
128921231|NCT00348140|463999298|FG000|Overall Study|Exclusion criteria met|0|||
128921232|NCT00348140|463999299|FG001|Overall Study|Exclusion criteria met|0|||
128921233|NCT00348140|463999300|FG002|Overall Study|Exclusion criteria met|1|||
128921234|NCT00348140|463999298|FG000|Overall Study|Memory declined|0|||
128921235|NCT00348140|463999299|FG001|Overall Study|Memory declined|0|||
128921236|NCT00348140|463999300|FG002|Overall Study|Memory declined|1|||
128921237|NCT00977470|463999304|FG000|Overall Study|Lack of Efficacy|32|||
128699949|NCT00369824|463199868|FG005|Overall Study|Withdrawal by Subject|2|||
128921238|NCT00977470|463999305|FG001|Overall Study|Lack of Efficacy|30|||
128921239|NCT00977470|463999304|FG000|Overall Study|Physician Decision|2|||
128921240|NCT00977470|463999305|FG001|Overall Study|Physician Decision|0|||
128921241|NCT00977470|463999304|FG000|Overall Study|Adverse Event|1|||
128921242|NCT00977470|463999305|FG001|Overall Study|Adverse Event|2|||
128921243|NCT00977470|463999304|FG000|Overall Study|Protocol Violation|1|||
128921244|NCT00977470|463999305|FG001|Overall Study|Protocol Violation|0|||
128921245|NCT00977470|463999304|FG000|Overall Study|Withdrawal by Subject|0|||
128921246|NCT00977470|463999305|FG001|Overall Study|Withdrawal by Subject|2|||
128699950|NCT00369824|463199863|FG000|Overall Study|Lost to Follow-up|6|||
128699951|NCT00369824|463199864|FG001|Overall Study|Lost to Follow-up|11|||
128921247|NCT00977470|463999304|FG000|Overall Study|Death|0|||
128921248|NCT00977470|463999305|FG001|Overall Study|Death|2|||
128921249|NCT00977470|463999304|FG000|Overall Study|clinical decline|0|||
128921250|NCT00977470|463999305|FG001|Overall Study|clinical decline|1|||
128921251|NCT00977470|463999304|FG000|Overall Study|prolonged recovery post-surgery|0|||
128921252|NCT00977470|463999305|FG001|Overall Study|prolonged recovery post-surgery|1|||
128921253|NCT00977470|463999304|FG000|Overall Study|Still on-study|2|||
128921254|NCT00977470|463999305|FG001|Overall Study|Still on-study|0|||
128921255|NCT00737529|463999309|FG000|Overall Study|Disease Progression|95|||
128921256|NCT00737529|463999309|FG000|Overall Study|Adverse Event|24|||
128921257|NCT00737529|463999309|FG000|Overall Study|Withdrawal by Subject|5|||
128921258|NCT00737529|463999309|FG000|Overall Study|Death|4|||
128921259|NCT00737529|463999309|FG000|Overall Study|Protocol Violation|1|||
128921260|NCT00737529|463999309|FG000|Overall Study|Other|4|||
128921261|NCT01173653|463999316|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
128921262|NCT01173653|463999317|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
128921263|NCT01818297|463999318|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
128921264|NCT01818297|463999319|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
128921265|NCT01818297|463999318|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
128921266|NCT01818297|463999319|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
128921267|NCT01818297|463999318|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
128921268|NCT01818297|463999319|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
128921269|NCT01651780|463999327|FG000|Overall Study|Physician decision: No 30-day visit|2|||
128921270|NCT01651780|463999328|FG001|Overall Study|Physician decision: No 30-day visit|1|||
128921271|NCT01651780|463999327|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
128921272|NCT01651780|463999328|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
128921273|NCT01651780|463999327|FG000|Overall Study|Withdrawal by Subject|2|||
128921274|NCT01651780|463999328|FG001|Overall Study|Withdrawal by Subject|0|||
128921275|NCT01651780|463999327|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
128921276|NCT01651780|463999328|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128921277|NCT01651780|463999327|FG000|Overall Study|Lost to Follow-up|1|||
128921278|NCT01651780|463999328|FG001|Overall Study|Lost to Follow-up|2|||
128921279|NCT01651780|463999327|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
128921280|NCT01651780|463999328|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
128921281|NCT01628926|463999329|FG000|Overall Study|Adverse Event|13|||
128921282|NCT01628926|463999330|FG001|Overall Study|Adverse Event|11|||
128921283|NCT01628926|463999331|FG002|Overall Study|Adverse Event|9|||
128921284|NCT01628926|463999329|FG000|Overall Study|Lack of Efficacy|2|||
128921285|NCT01628926|463999330|FG001|Overall Study|Lack of Efficacy|1|||
128921286|NCT01628926|463999331|FG002|Overall Study|Lack of Efficacy|5|||
128921287|NCT01628926|463999329|FG000|Overall Study|Withdrawal by Subject|6|||
128921288|NCT01628926|463999330|FG001|Overall Study|Withdrawal by Subject|4|||
128921289|NCT01628926|463999331|FG002|Overall Study|Withdrawal by Subject|2|||
128921290|NCT01628926|463999329|FG000|Overall Study|Protocol Violation|0|||
128921291|NCT01628926|463999330|FG001|Overall Study|Protocol Violation|1|||
128921292|NCT01628926|463999331|FG002|Overall Study|Protocol Violation|0|||
128921293|NCT01628926|463999329|FG000|Overall Study|Discontinuation criteria|3|||
128921294|NCT01628926|463999330|FG001|Overall Study|Discontinuation criteria|4|||
128921295|NCT01628926|463999331|FG002|Overall Study|Discontinuation criteria|0|||
128921296|NCT01628926|463999329|FG000|Overall Study|Physician Decision|2|||
128921297|NCT01628926|463999330|FG001|Overall Study|Physician Decision|2|||
128921298|NCT01628926|463999331|FG002|Overall Study|Physician Decision|1|||
128921299|NCT03029832|463999332|FG000|Overall Study|Safety Follow-Up Completed|2|||
128921300|NCT03029832|463999333|FG001|Overall Study|Safety Follow-Up Completed|0|||
128921301|NCT03029832|463999332|FG000|Overall Study|Death due to Disease Progression|1|||
128921302|NCT03029832|463999333|FG001|Overall Study|Death due to Disease Progression|0|||
128921303|NCT03029832|463999332|FG000|Overall Study|Study Terminated By Sponsor|1|||
128921304|NCT03029832|463999333|FG001|Overall Study|Study Terminated By Sponsor|1|||
128921305|NCT01412229|463999334|FG000|Overall Study|Physician Decision|1|||
128921306|NCT00151892|463999341|FG000|Overall Study|Lack of Efficacy|50|||
128921307|NCT00151892|463999342|FG001|Overall Study|Lack of Efficacy|57|||
128921308|NCT00151892|463999341|FG000|Overall Study|Patient request|10|||
129029306|NCT02611323|464398382|FG004|Overall Study|Withdrawal by Subject|0|||
129029307|NCT02611323|464398383|FG005|Overall Study|Withdrawal by Subject|0|||
128699952|NCT00369824|463199865|FG002|Overall Study|Lost to Follow-up|7|||
128699953|NCT00369824|463199866|FG003|Overall Study|Lost to Follow-up|8|||
128921309|NCT00151892|463999342|FG001|Overall Study|Patient request|7|||
128921310|NCT00151892|463999341|FG000|Overall Study|Lost to Follow-up|5|||
128921311|NCT00151892|463999342|FG001|Overall Study|Lost to Follow-up|10|||
128921312|NCT00151892|463999341|FG000|Overall Study|Adverse Event|6|||
128921313|NCT00151892|463999342|FG001|Overall Study|Adverse Event|3|||
128921314|NCT00151892|463999341|FG000|Overall Study|Protocol Violation|3|||
128921315|NCT00151892|463999342|FG001|Overall Study|Protocol Violation|3|||
128921316|NCT00151892|463999341|FG000|Overall Study|Non-compliance|0|||
128921317|NCT00151892|463999342|FG001|Overall Study|Non-compliance|1|||
129029308|NCT02611323|464398384|FG006|Overall Study|Withdrawal by Subject|0|||
128921318|NCT00151892|463999341|FG000|Overall Study|Pregnancy|0|||
128921319|NCT00151892|463999342|FG001|Overall Study|Pregnancy|1|||
128921320|NCT00151892|463999341|FG000|Overall Study|Did not return for a visit|1|||
128921321|NCT00151892|463999342|FG001|Overall Study|Did not return for a visit|0|||
128921322|NCT00151892|463999341|FG000|Overall Study|Used prohibited corticosteroids|1|||
128921323|NCT00151892|463999342|FG001|Overall Study|Used prohibited corticosteroids|0|||
128921324|NCT00151892|463999341|FG000|Overall Study|Lack of study medication at center|0|||
128921325|NCT00151892|463999342|FG001|Overall Study|Lack of study medication at center|1|||
128921326|NCT02901431|463999343|FG000|PK Part|Adverse Event|0|||
128921327|NCT02901431|463999344|FG001|PK Part|Adverse Event|1|||
128921328|NCT02901431|463999345|FG002|PK Part|Adverse Event|0|||
128921329|NCT02901431|463999346|FG003|PK Part|Adverse Event|0|||
128921330|NCT02901431|463999347|FG004|PK Part|Adverse Event|0|||
128921331|NCT02901431|463999348|FG005|PK Part|Adverse Event|0|||
128921332|NCT02901431|463999349|FG006|PK Part|Adverse Event|0|||
128921333|NCT02901431|463999350|FG007|PK Part|Adverse Event|0|||
128921334|NCT02901431|463999351|FG008|PK Part|Adverse Event|0|||
128921335|NCT02901431|463999352|FG009|PK Part|Adverse Event|0|||
128921336|NCT02901431|463999353|FG010|PK Part|Adverse Event|0|||
128921337|NCT02901431|463999354|FG011|PK Part|Adverse Event|0|||
128921338|NCT02901431|463999355|FG012|PK Part|Adverse Event|0|||
128921339|NCT02901431|463999343|FG000|PK Part|Lost to Follow-up|0|||
128921340|NCT02901431|463999344|FG001|PK Part|Lost to Follow-up|0|||
128921341|NCT02901431|463999345|FG002|PK Part|Lost to Follow-up|1|||
128921342|NCT02901431|463999346|FG003|PK Part|Lost to Follow-up|0|||
128921343|NCT02901431|463999347|FG004|PK Part|Lost to Follow-up|0|||
128921344|NCT02901431|463999348|FG005|PK Part|Lost to Follow-up|0|||
128921345|NCT02901431|463999349|FG006|PK Part|Lost to Follow-up|0|||
128921346|NCT02901431|463999350|FG007|PK Part|Lost to Follow-up|0|||
128921347|NCT02901431|463999351|FG008|PK Part|Lost to Follow-up|0|||
128921348|NCT02901431|463999352|FG009|PK Part|Lost to Follow-up|0|||
128921349|NCT02901431|463999353|FG010|PK Part|Lost to Follow-up|0|||
128921350|NCT02901431|463999354|FG011|PK Part|Lost to Follow-up|0|||
128921351|NCT02901431|463999355|FG012|PK Part|Lost to Follow-up|0|||
128921352|NCT02901431|463999343|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
128921353|NCT02901431|463999344|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921354|NCT02901431|463999345|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921355|NCT02901431|463999346|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921356|NCT02901431|463999347|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921357|NCT02901431|463999348|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921358|NCT02901431|463999349|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921359|NCT02901431|463999350|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128699954|NCT00369824|463199867|FG004|Overall Study|Lost to Follow-up|9|||
128921360|NCT02901431|463999351|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921361|NCT02901431|463999352|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921362|NCT02901431|463999353|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921363|NCT02901431|463999354|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921364|NCT02901431|463999355|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
128921365|NCT02901431|463999343|FG000|PK Part|Pending dose confirmation|0|||
128921366|NCT02901431|463999344|FG001|PK Part|Pending dose confirmation|1|||
128921367|NCT02901431|463999345|FG002|PK Part|Pending dose confirmation|0|||
128921368|NCT02901431|463999346|FG003|PK Part|Pending dose confirmation|0|||
128921369|NCT02901431|463999347|FG004|PK Part|Pending dose confirmation|0|||
128921370|NCT02901431|463999348|FG005|PK Part|Pending dose confirmation|0|||
128921371|NCT02901431|463999349|FG006|PK Part|Pending dose confirmation|0|||
128921372|NCT02901431|463999350|FG007|PK Part|Pending dose confirmation|0|||
128921373|NCT02901431|463999351|FG008|PK Part|Pending dose confirmation|0|||
128921374|NCT02901431|463999352|FG009|PK Part|Pending dose confirmation|0|||
128921375|NCT02901431|463999353|FG010|PK Part|Pending dose confirmation|0|||
128921376|NCT02901431|463999354|FG011|PK Part|Pending dose confirmation|0|||
128921377|NCT02901431|463999355|FG012|PK Part|Pending dose confirmation|0|||
128921378|NCT02901431|463999343|FG000|PK Part|8 weeks of treatment ran out|2|||
128921379|NCT02901431|463999344|FG001|PK Part|8 weeks of treatment ran out|0|||
128699955|NCT00369824|463199868|FG005|Overall Study|Lost to Follow-up|6|||
128699956|NCT00369824|463199863|FG000|Overall Study|Other|0|||
128699957|NCT00369824|463199864|FG001|Overall Study|Other|0|||
128699958|NCT00369824|463199865|FG002|Overall Study|Other|0|||
128921380|NCT02901431|463999345|FG002|PK Part|8 weeks of treatment ran out|0|||
128921381|NCT02901431|463999346|FG003|PK Part|8 weeks of treatment ran out|0|||
128921382|NCT02901431|463999347|FG004|PK Part|8 weeks of treatment ran out|0|||
128921383|NCT02901431|463999348|FG005|PK Part|8 weeks of treatment ran out|0|||
128921384|NCT02901431|463999349|FG006|PK Part|8 weeks of treatment ran out|0|||
128921385|NCT02901431|463999350|FG007|PK Part|8 weeks of treatment ran out|0|||
128921386|NCT02901431|463999351|FG008|PK Part|8 weeks of treatment ran out|0|||
128699959|NCT00369824|463199866|FG003|Overall Study|Other|2|||
128699960|NCT00369824|463199867|FG004|Overall Study|Other|1|||
128921387|NCT02901431|463999352|FG009|PK Part|8 weeks of treatment ran out|0|||
128921388|NCT02901431|463999353|FG010|PK Part|8 weeks of treatment ran out|0|||
128921389|NCT02901431|463999354|FG011|PK Part|8 weeks of treatment ran out|0|||
128921390|NCT02901431|463999355|FG012|PK Part|8 weeks of treatment ran out|0|||
128921391|NCT02901431|463999343|FG000|PK Part|Stopped treatment after 8 weeks|1|||
128921392|NCT02901431|463999344|FG001|PK Part|Stopped treatment after 8 weeks|0|||
128921393|NCT02901431|463999345|FG002|PK Part|Stopped treatment after 8 weeks|1|||
128921394|NCT02901431|463999346|FG003|PK Part|Stopped treatment after 8 weeks|0|||
128921395|NCT02901431|463999347|FG004|PK Part|Stopped treatment after 8 weeks|0|||
128921396|NCT02901431|463999348|FG005|PK Part|Stopped treatment after 8 weeks|0|||
128921397|NCT02901431|463999349|FG006|PK Part|Stopped treatment after 8 weeks|0|||
128921398|NCT02901431|463999350|FG007|PK Part|Stopped treatment after 8 weeks|0|||
128921399|NCT02901431|463999351|FG008|PK Part|Stopped treatment after 8 weeks|0|||
128921400|NCT02901431|463999352|FG009|PK Part|Stopped treatment after 8 weeks|0|||
128921401|NCT02901431|463999353|FG010|PK Part|Stopped treatment after 8 weeks|0|||
128921402|NCT02901431|463999354|FG011|PK Part|Stopped treatment after 8 weeks|0|||
128921403|NCT02901431|463999355|FG012|PK Part|Stopped treatment after 8 weeks|0|||
128921404|NCT02901431|463999343|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
128921405|NCT02901431|463999344|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921406|NCT02901431|463999345|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
128921407|NCT02901431|463999346|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921408|NCT02901431|463999347|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921409|NCT02901431|463999348|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921410|NCT02901431|463999349|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921411|NCT02901431|463999350|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921412|NCT02901431|463999351|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921413|NCT02901431|463999352|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921414|NCT02901431|463999353|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921415|NCT02901431|463999354|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921416|NCT02901431|463999355|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
128921417|NCT02901431|463999343|FG000|PK Part|Discontinued per Sponsor|0|||
128921418|NCT02901431|463999344|FG001|PK Part|Discontinued per Sponsor|3|||
128921419|NCT02901431|463999345|FG002|PK Part|Discontinued per Sponsor|0|||
128921420|NCT02901431|463999346|FG003|PK Part|Discontinued per Sponsor|0|||
128921421|NCT02901431|463999347|FG004|PK Part|Discontinued per Sponsor|0|||
128921422|NCT02901431|463999348|FG005|PK Part|Discontinued per Sponsor|0|||
128921423|NCT02901431|463999349|FG006|PK Part|Discontinued per Sponsor|0|||
128921424|NCT02901431|463999350|FG007|PK Part|Discontinued per Sponsor|0|||
128921425|NCT02901431|463999351|FG008|PK Part|Discontinued per Sponsor|0|||
128921426|NCT02901431|463999352|FG009|PK Part|Discontinued per Sponsor|0|||
128921427|NCT02901431|463999353|FG010|PK Part|Discontinued per Sponsor|0|||
128921428|NCT02901431|463999354|FG011|PK Part|Discontinued per Sponsor|0|||
128921429|NCT02901431|463999355|FG012|PK Part|Discontinued per Sponsor|0|||
128921430|NCT02901431|463999343|FG000|PK Part|Withdrawal by Subject|1|||
128921431|NCT02901431|463999344|FG001|PK Part|Withdrawal by Subject|1|||
128921432|NCT02901431|463999345|FG002|PK Part|Withdrawal by Subject|3|||
128921433|NCT02901431|463999346|FG003|PK Part|Withdrawal by Subject|0|||
128921434|NCT02901431|463999347|FG004|PK Part|Withdrawal by Subject|0|||
128921435|NCT02901431|463999348|FG005|PK Part|Withdrawal by Subject|0|||
128921436|NCT02901431|463999349|FG006|PK Part|Withdrawal by Subject|0|||
128921437|NCT02901431|463999350|FG007|PK Part|Withdrawal by Subject|0|||
128921438|NCT02901431|463999351|FG008|PK Part|Withdrawal by Subject|0|||
128921439|NCT02901431|463999352|FG009|PK Part|Withdrawal by Subject|0|||
128921440|NCT02901431|463999353|FG010|PK Part|Withdrawal by Subject|0|||
128921441|NCT02901431|463999354|FG011|PK Part|Withdrawal by Subject|0|||
128921442|NCT02901431|463999355|FG012|PK Part|Withdrawal by Subject|0|||
128921443|NCT02901431|463999343|FG000|Main Treatment Part|Adverse Event|0|||
128921444|NCT02901431|463999344|FG001|Main Treatment Part|Adverse Event|0|||
128921445|NCT02901431|463999345|FG002|Main Treatment Part|Adverse Event|0|||
128921446|NCT02901431|463999346|FG003|Main Treatment Part|Adverse Event|3|||
128921447|NCT02901431|463999347|FG004|Main Treatment Part|Adverse Event|3|||
128921448|NCT02901431|463999348|FG005|Main Treatment Part|Adverse Event|4|||
128921449|NCT02901431|463999349|FG006|Main Treatment Part|Adverse Event|1|||
128921450|NCT02901431|463999350|FG007|Main Treatment Part|Adverse Event|0|||
128921451|NCT02901431|463999351|FG008|Main Treatment Part|Adverse Event|0|||
128921452|NCT02901431|463999352|FG009|Main Treatment Part|Adverse Event|0|||
128921453|NCT02901431|463999353|FG010|Main Treatment Part|Adverse Event|0|||
128921454|NCT02901431|463999354|FG011|Main Treatment Part|Adverse Event|0|||
128921455|NCT02901431|463999355|FG012|Main Treatment Part|Adverse Event|0|||
128921456|NCT02901431|463999343|FG000|Main Treatment Part|Lack of Efficacy|0|||
128921457|NCT02901431|463999344|FG001|Main Treatment Part|Lack of Efficacy|0|||
128921458|NCT02901431|463999345|FG002|Main Treatment Part|Lack of Efficacy|0|||
128921459|NCT02901431|463999346|FG003|Main Treatment Part|Lack of Efficacy|1|||
129029309|NCT02611323|464398385|FG007|Overall Study|Withdrawal by Subject|1|||
128699961|NCT00369824|463199868|FG005|Overall Study|Other|3|||
128921460|NCT02901431|463999347|FG004|Main Treatment Part|Lack of Efficacy|0|||
128921461|NCT02901431|463999348|FG005|Main Treatment Part|Lack of Efficacy|0|||
128921462|NCT02901431|463999349|FG006|Main Treatment Part|Lack of Efficacy|0|||
128921463|NCT02901431|463999350|FG007|Main Treatment Part|Lack of Efficacy|0|||
128921464|NCT02901431|463999351|FG008|Main Treatment Part|Lack of Efficacy|0|||
128921465|NCT02901431|463999352|FG009|Main Treatment Part|Lack of Efficacy|0|||
128921466|NCT02901431|463999353|FG010|Main Treatment Part|Lack of Efficacy|0|||
128921467|NCT02901431|463999354|FG011|Main Treatment Part|Lack of Efficacy|0|||
128921468|NCT02901431|463999355|FG012|Main Treatment Part|Lack of Efficacy|0|||
128921469|NCT02901431|463999343|FG000|Main Treatment Part|Lost to Follow-up|0|||
128921470|NCT02901431|463999344|FG001|Main Treatment Part|Lost to Follow-up|0|||
128921471|NCT02901431|463999345|FG002|Main Treatment Part|Lost to Follow-up|0|||
128921472|NCT02901431|463999346|FG003|Main Treatment Part|Lost to Follow-up|3|||
128921473|NCT02901431|463999347|FG004|Main Treatment Part|Lost to Follow-up|1|||
128921474|NCT02901431|463999348|FG005|Main Treatment Part|Lost to Follow-up|2|||
128921475|NCT02901431|463999349|FG006|Main Treatment Part|Lost to Follow-up|3|||
128921476|NCT02901431|463999350|FG007|Main Treatment Part|Lost to Follow-up|0|||
128921477|NCT02901431|463999351|FG008|Main Treatment Part|Lost to Follow-up|0|||
128921478|NCT02901431|463999352|FG009|Main Treatment Part|Lost to Follow-up|0|||
128921479|NCT02901431|463999353|FG010|Main Treatment Part|Lost to Follow-up|0|||
128921480|NCT02901431|463999354|FG011|Main Treatment Part|Lost to Follow-up|0|||
128921481|NCT02901431|463999355|FG012|Main Treatment Part|Lost to Follow-up|0|||
128921482|NCT02901431|463999343|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
128921483|NCT02901431|463999344|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
128921484|NCT02901431|463999345|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
128921485|NCT02901431|463999346|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
128921486|NCT02901431|463999347|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
128921487|NCT02901431|463999348|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
128921488|NCT02901431|463999349|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
128921489|NCT02901431|463999350|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
128921490|NCT02901431|463999351|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
128921491|NCT02901431|463999352|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
128921492|NCT02901431|463999353|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
128921493|NCT02901431|463999354|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
128921494|NCT02901431|463999355|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
128921495|NCT02901431|463999343|FG000|Main Treatment Part|Physician Decision|0|||
128921496|NCT02901431|463999344|FG001|Main Treatment Part|Physician Decision|0|||
128921497|NCT02901431|463999345|FG002|Main Treatment Part|Physician Decision|0|||
128921498|NCT02901431|463999346|FG003|Main Treatment Part|Physician Decision|1|||
128921499|NCT02901431|463999347|FG004|Main Treatment Part|Physician Decision|0|||
128921500|NCT02901431|463999348|FG005|Main Treatment Part|Physician Decision|0|||
128921501|NCT02901431|463999349|FG006|Main Treatment Part|Physician Decision|1|||
128921502|NCT02901431|463999350|FG007|Main Treatment Part|Physician Decision|0|||
128921503|NCT02901431|463999351|FG008|Main Treatment Part|Physician Decision|0|||
128921504|NCT02901431|463999352|FG009|Main Treatment Part|Physician Decision|0|||
128921505|NCT02901431|463999353|FG010|Main Treatment Part|Physician Decision|0|||
128921506|NCT02901431|463999354|FG011|Main Treatment Part|Physician Decision|0|||
128921507|NCT02901431|463999355|FG012|Main Treatment Part|Physician Decision|0|||
128921508|NCT02901431|463999343|FG000|Main Treatment Part|Withdrawal by Subject|0|||
128921509|NCT02901431|463999344|FG001|Main Treatment Part|Withdrawal by Subject|0|||
128921510|NCT02901431|463999345|FG002|Main Treatment Part|Withdrawal by Subject|0|||
128921511|NCT02901431|463999346|FG003|Main Treatment Part|Withdrawal by Subject|18|||
128921512|NCT02901431|463999347|FG004|Main Treatment Part|Withdrawal by Subject|3|||
128921513|NCT02901431|463999348|FG005|Main Treatment Part|Withdrawal by Subject|5|||
128921514|NCT02901431|463999349|FG006|Main Treatment Part|Withdrawal by Subject|6|||
128921515|NCT02901431|463999350|FG007|Main Treatment Part|Withdrawal by Subject|0|||
128921516|NCT02901431|463999351|FG008|Main Treatment Part|Withdrawal by Subject|0|||
128921517|NCT02901431|463999352|FG009|Main Treatment Part|Withdrawal by Subject|0|||
128921518|NCT02901431|463999353|FG010|Main Treatment Part|Withdrawal by Subject|0|||
128921519|NCT02901431|463999354|FG011|Main Treatment Part|Withdrawal by Subject|0|||
128921520|NCT02901431|463999355|FG012|Main Treatment Part|Withdrawal by Subject|0|||
128921521|NCT02901431|463999343|FG000|Open Label Part|Adverse Event|0|||
128921522|NCT02901431|463999344|FG001|Open Label Part|Adverse Event|0|||
128921523|NCT02901431|463999345|FG002|Open Label Part|Adverse Event|0|||
128921524|NCT02901431|463999346|FG003|Open Label Part|Adverse Event|0|||
128921525|NCT02901431|463999347|FG004|Open Label Part|Adverse Event|0|||
128921526|NCT02901431|463999348|FG005|Open Label Part|Adverse Event|0|||
128921527|NCT02901431|463999349|FG006|Open Label Part|Adverse Event|0|||
128921528|NCT02901431|463999350|FG007|Open Label Part|Adverse Event|0|||
128921529|NCT02901431|463999351|FG008|Open Label Part|Adverse Event|4|||
128921530|NCT02901431|463999352|FG009|Open Label Part|Adverse Event|4|||
128921531|NCT02901431|463999353|FG010|Open Label Part|Adverse Event|0|||
128921532|NCT02901431|463999354|FG011|Open Label Part|Adverse Event|4|||
128921533|NCT02901431|463999355|FG012|Open Label Part|Adverse Event|1|||
128921534|NCT02901431|463999343|FG000|Open Label Part|Lost to Follow-up|0|||
128921535|NCT02901431|463999344|FG001|Open Label Part|Lost to Follow-up|0|||
128921536|NCT02901431|463999345|FG002|Open Label Part|Lost to Follow-up|0|||
128921537|NCT02901431|463999346|FG003|Open Label Part|Lost to Follow-up|0|||
128921538|NCT02901431|463999347|FG004|Open Label Part|Lost to Follow-up|0|||
128921539|NCT02901431|463999348|FG005|Open Label Part|Lost to Follow-up|0|||
128921540|NCT02901431|463999349|FG006|Open Label Part|Lost to Follow-up|0|||
128921541|NCT02901431|463999350|FG007|Open Label Part|Lost to Follow-up|0|||
128921542|NCT02901431|463999351|FG008|Open Label Part|Lost to Follow-up|2|||
128921543|NCT02901431|463999352|FG009|Open Label Part|Lost to Follow-up|2|||
128921544|NCT02901431|463999353|FG010|Open Label Part|Lost to Follow-up|1|||
128921545|NCT02901431|463999354|FG011|Open Label Part|Lost to Follow-up|1|||
128921546|NCT02901431|463999355|FG012|Open Label Part|Lost to Follow-up|1|||
128921547|NCT02901431|463999343|FG000|Open Label Part|Physician Decision|0|||
128921548|NCT02901431|463999344|FG001|Open Label Part|Physician Decision|0|||
128921549|NCT02901431|463999345|FG002|Open Label Part|Physician Decision|0|||
128921550|NCT02901431|463999346|FG003|Open Label Part|Physician Decision|0|||
128921551|NCT02901431|463999347|FG004|Open Label Part|Physician Decision|0|||
128921552|NCT02901431|463999348|FG005|Open Label Part|Physician Decision|0|||
128921553|NCT02901431|463999349|FG006|Open Label Part|Physician Decision|0|||
128921554|NCT02901431|463999350|FG007|Open Label Part|Physician Decision|0|||
128921555|NCT02901431|463999351|FG008|Open Label Part|Physician Decision|1|||
128921556|NCT02901431|463999352|FG009|Open Label Part|Physician Decision|1|||
128921557|NCT02901431|463999353|FG010|Open Label Part|Physician Decision|0|||
128921558|NCT02901431|463999354|FG011|Open Label Part|Physician Decision|0|||
128921559|NCT02901431|463999355|FG012|Open Label Part|Physician Decision|0|||
128921560|NCT02901431|463999343|FG000|Open Label Part|Study Terminated By Sponsor|0|||
128921561|NCT02901431|463999344|FG001|Open Label Part|Study Terminated By Sponsor|0|||
128921562|NCT02901431|463999345|FG002|Open Label Part|Study Terminated By Sponsor|0|||
128921563|NCT02901431|463999346|FG003|Open Label Part|Study Terminated By Sponsor|0|||
128921564|NCT02901431|463999347|FG004|Open Label Part|Study Terminated By Sponsor|0|||
128921565|NCT02901431|463999348|FG005|Open Label Part|Study Terminated By Sponsor|0|||
128921566|NCT02901431|463999349|FG006|Open Label Part|Study Terminated By Sponsor|0|||
128921567|NCT02901431|463999350|FG007|Open Label Part|Study Terminated By Sponsor|0|||
128921568|NCT02901431|463999351|FG008|Open Label Part|Study Terminated By Sponsor|35|||
128921569|NCT02901431|463999352|FG009|Open Label Part|Study Terminated By Sponsor|12|||
128921570|NCT02901431|463999353|FG010|Open Label Part|Study Terminated By Sponsor|21|||
128921571|NCT02901431|463999354|FG011|Open Label Part|Study Terminated By Sponsor|31|||
128921572|NCT02901431|463999355|FG012|Open Label Part|Study Terminated By Sponsor|0|||
128921573|NCT02901431|463999343|FG000|Open Label Part|Withdrawal by Subject|0|||
128921574|NCT02901431|463999344|FG001|Open Label Part|Withdrawal by Subject|0|||
128921575|NCT02901431|463999345|FG002|Open Label Part|Withdrawal by Subject|0|||
128921576|NCT02901431|463999346|FG003|Open Label Part|Withdrawal by Subject|0|||
128921577|NCT02901431|463999347|FG004|Open Label Part|Withdrawal by Subject|0|||
128921578|NCT02901431|463999348|FG005|Open Label Part|Withdrawal by Subject|0|||
128921579|NCT02901431|463999349|FG006|Open Label Part|Withdrawal by Subject|0|||
128921580|NCT02901431|463999350|FG007|Open Label Part|Withdrawal by Subject|0|||
128921581|NCT02901431|463999351|FG008|Open Label Part|Withdrawal by Subject|6|||
128921582|NCT02901431|463999352|FG009|Open Label Part|Withdrawal by Subject|5|||
128921583|NCT02901431|463999353|FG010|Open Label Part|Withdrawal by Subject|7|||
128921584|NCT02901431|463999354|FG011|Open Label Part|Withdrawal by Subject|3|||
128921585|NCT02901431|463999355|FG012|Open Label Part|Withdrawal by Subject|1|||
128921586|NCT01889602|463999356|FG000|First Intervention|Adverse Event|1|||
128921587|NCT01889602|463999357|FG001|First Intervention|Adverse Event|1|||
128921588|NCT01889602|463999358|FG002|First Intervention|Adverse Event|1|||
128921589|NCT01889602|463999356|FG000|First Intervention|Protocol Violation|0|||
128921590|NCT01889602|463999357|FG001|First Intervention|Protocol Violation|1|||
128921591|NCT01889602|463999358|FG002|First Intervention|Protocol Violation|1|||
128921592|NCT01889602|463999356|FG000|First Intervention|Study ending|0|||
128921593|NCT01889602|463999357|FG001|First Intervention|Study ending|1|||
128921594|NCT01889602|463999358|FG002|First Intervention|Study ending|0|||
128921595|NCT01889602|463999356|FG000|Second Intervention|Adverse Event|0|||
128921596|NCT01889602|463999357|FG001|Second Intervention|Adverse Event|0|||
128921597|NCT01889602|463999358|FG002|Second Intervention|Adverse Event|1|||
128921598|NCT01889602|463999356|FG000|Second Intervention|Study ending|1|||
128921599|NCT01889602|463999357|FG001|Second Intervention|Study ending|0|||
128921600|NCT01889602|463999358|FG002|Second Intervention|Study ending|0|||
128921601|NCT01889602|463999356|FG000|Second Intervention|Withdrawal by Subject|0|||
128921602|NCT01889602|463999357|FG001|Second Intervention|Withdrawal by Subject|0|||
128921603|NCT01889602|463999358|FG002|Second Intervention|Withdrawal by Subject|1|||
128921604|NCT01889602|463999356|FG000|Third Intervention|Protocol Violation|1|||
128921605|NCT01889602|463999357|FG001|Third Intervention|Protocol Violation|0|||
128921606|NCT01889602|463999358|FG002|Third Intervention|Protocol Violation|0|||
128921607|NCT01889602|463999356|FG000|Third Intervention|Withdrawal by Subject|2|||
128921608|NCT01889602|463999357|FG001|Third Intervention|Withdrawal by Subject|2|||
128921609|NCT01889602|463999358|FG002|Third Intervention|Withdrawal by Subject|0|||
128921610|NCT00404092|463999359|FG000|Overall Study|Death|1|||
129029310|NCT02611323|464398386|FG008|Overall Study|Withdrawal by Subject|0|||
128921611|NCT00404092|463999360|FG001|Overall Study|Death|0|||
128921612|NCT00404092|463999361|FG002|Overall Study|Death|0|||
128921613|NCT00404092|463999362|FG003|Overall Study|Death|0|||
128921614|NCT00404092|463999359|FG000|Overall Study|Adverse Event|0|||
128921615|NCT00404092|463999360|FG001|Overall Study|Adverse Event|0|||
128921616|NCT00404092|463999361|FG002|Overall Study|Adverse Event|1|||
128921617|NCT00404092|463999362|FG003|Overall Study|Adverse Event|0|||
128921618|NCT04223609|463999367|FG000|Overall Study|Adverse Event|0|||
128921619|NCT04223609|463999368|FG001|Overall Study|Adverse Event|1|||
128921620|NCT04223609|463999367|FG000|Overall Study|Missed last visit|0|||
128921621|NCT04223609|463999368|FG001|Overall Study|Missed last visit|1|||
128921622|NCT03440944|463999371|FG000|Overall Study|Physician Decision|1|||
128921623|NCT03440944|463999372|FG001|Overall Study|Physician Decision|0|||
128921624|NCT03440944|463999371|FG000|Overall Study|No Acceptable Vasculature|0|||
128921625|NCT03440944|463999372|FG001|Overall Study|No Acceptable Vasculature|1|||
128921626|NCT00484315|463999373|FG000|12-Month Clinical Follow-up|Death|6|||
128921627|NCT00484315|463999374|FG001|12-Month Clinical Follow-up|Death|2|||
128921628|NCT00484315|463999373|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
128921629|NCT00484315|463999374|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
128921630|NCT00484315|463999373|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
128921631|NCT00484315|463999374|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
128921632|NCT00484315|463999373|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
128921633|NCT00484315|463999374|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
128921634|NCT00484315|463999373|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
128921635|NCT00484315|463999374|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
128921636|NCT00484315|463999373|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
128921637|NCT00484315|463999374|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
128921638|NCT00484315|463999373|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
128921639|NCT00484315|463999374|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
128921640|NCT00943683|463999375|FG000|Overall Study|Adverse Event|3|||
128921641|NCT00943683|463999376|FG001|Overall Study|Adverse Event|3|||
128921642|NCT00943683|463999375|FG000|Overall Study|Lost to Follow-up|1|||
128921643|NCT00943683|463999376|FG001|Overall Study|Lost to Follow-up|1|||
128921644|NCT00943683|463999375|FG000|Overall Study|Protocol Violation|1|||
128921645|NCT00943683|463999376|FG001|Overall Study|Protocol Violation|2|||
128921646|NCT00943683|463999375|FG000|Overall Study|Withdrawal by Subject|1|||
128921647|NCT00943683|463999376|FG001|Overall Study|Withdrawal by Subject|0|||
128921648|NCT00943683|463999375|FG000|Overall Study|Patient Moved|1|||
128921649|NCT00943683|463999376|FG001|Overall Study|Patient Moved|0|||
128921650|NCT04439123|463999388|FG000|Overall Study|Adverse Event|11|||
128921651|NCT04439123|463999388|FG000|Overall Study|Death|1|||
128921652|NCT04439123|463999388|FG000|Overall Study|Disease progression|19|||
128921653|NCT04439123|463999388|FG000|Overall Study|Withdrawal by Subject|2|||
128921654|NCT04439123|463999388|FG000|Overall Study|Still on treatment|2|||
128921655|NCT03636906|463999397|FG000|Overall Study|Adverse Event|0|||
128921656|NCT03636906|463999398|FG001|Overall Study|Adverse Event|0|||
128921657|NCT03636906|463999399|FG002|Overall Study|Adverse Event|1|||
128921658|NCT03636906|463999397|FG000|Overall Study|Lost to Follow-up|1|||
128921659|NCT03636906|463999398|FG001|Overall Study|Lost to Follow-up|0|||
128921660|NCT03636906|463999399|FG002|Overall Study|Lost to Follow-up|0|||
128921661|NCT03636906|463999397|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
128921662|NCT03636906|463999398|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
128921663|NCT03636906|463999399|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
128921664|NCT03636906|463999397|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
128921665|NCT03636906|463999398|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
128921666|NCT03636906|463999399|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
128921667|NCT03636906|463999397|FG000|Overall Study|Other|0|||
128921668|NCT03636906|463999398|FG001|Overall Study|Other|0|||
128921669|NCT03636906|463999399|FG002|Overall Study|Other|1|||
128921670|NCT03658889|464000790|FG000|Overall Study|Protocol Violation|2|||
128921671|NCT03658889|464000791|FG001|Overall Study|Protocol Violation|0|||
128921672|NCT01903876|464000798|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
128921673|NCT01903876|464000799|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
128921674|NCT01903876|464000798|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
128921675|NCT01903876|464000799|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
128921676|NCT04317690|464000802|FG000|Overall Study|did not have complete information for primary outcome|0|||
128921677|NCT04317690|464000803|FG001|Overall Study|did not have complete information for primary outcome|4|||
128921678|NCT04317690|464000804|FG002|Overall Study|did not have complete information for primary outcome|0|||
128921679|NCT04317690|464000805|FG003|Overall Study|did not have complete information for primary outcome|2|||
128921680|NCT04317690|464000806|FG004|Overall Study|did not have complete information for primary outcome|0|||
128921681|NCT01901224|464000812|FG000|Overall Study|study was not funded and terminated|2|||
128921682|NCT03902080|464000814|FG000|Overall Study|Adverse Event|17|||
128921683|NCT03902080|464000815|FG001|Overall Study|Adverse Event|15|||
128921684|NCT03902080|464000814|FG000|Overall Study|Withdrawal by Subject|28|||
128921685|NCT03902080|464000815|FG001|Overall Study|Withdrawal by Subject|35|||
128921686|NCT03902080|464000814|FG000|Overall Study|Lost to Follow-up|6|||
128921687|NCT03902080|464000815|FG001|Overall Study|Lost to Follow-up|7|||
128921688|NCT03902080|464000814|FG000|Overall Study|Other|3|||
128921689|NCT03902080|464000815|FG001|Overall Study|Other|5|||
128921690|NCT03902080|464000814|FG000|Overall Study|Non compliance|4|||
128921691|NCT03902080|464000815|FG001|Overall Study|Non compliance|3|||
128921692|NCT03902080|464000814|FG000|Overall Study|Physician Decision|5|||
128921693|NCT03902080|464000815|FG001|Overall Study|Physician Decision|1|||
128921694|NCT03902080|464000814|FG000|Overall Study|Protocol Violation|3|||
128921695|NCT03902080|464000815|FG001|Overall Study|Protocol Violation|3|||
128921696|NCT03902080|464000814|FG000|Overall Study|Lack of Efficacy|1|||
128921697|NCT03902080|464000815|FG001|Overall Study|Lack of Efficacy|3|||
128921698|NCT03902080|464000814|FG000|Overall Study|Withdrawn prior to dosing|0|||
128921699|NCT03902080|464000815|FG001|Overall Study|Withdrawn prior to dosing|1|||
128921700|NCT01919307|464000820|FG000|Overall Study|Withdrawal by Subject|9|||
128921701|NCT01701258|464000822|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
128921702|NCT01701258|464000823|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
128921703|NCT01701258|464000824|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
128921704|NCT01701258|464000825|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
128921705|NCT01701258|464000826|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
128921706|NCT01701258|464000827|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
128921707|NCT01701258|464000828|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
128921708|NCT01701258|464000829|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
128921709|NCT01701258|464000830|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
128921710|NCT01701258|464000831|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
128921711|NCT01701258|464000832|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
128921712|NCT01701258|464000833|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
128921713|NCT01701258|464000834|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
128921714|NCT01701258|464000822|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
128921715|NCT01701258|464000823|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
128921716|NCT01701258|464000824|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
128921717|NCT01701258|464000825|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
128921718|NCT01701258|464000826|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
128921719|NCT01701258|464000827|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
128921720|NCT01701258|464000828|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
128921721|NCT01701258|464000829|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
128921722|NCT01701258|464000830|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
128921723|NCT01701258|464000831|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
128921724|NCT01701258|464000832|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
129216320|NCT01208207|465092882|FG006|Part II|Technical Problems|0|||
128921725|NCT01701258|464000833|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
128921726|NCT01701258|464000834|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
128921727|NCT01701258|464000822|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
128921728|NCT01701258|464000823|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
128921729|NCT01701258|464000824|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
128921730|NCT01701258|464000825|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
128921731|NCT01701258|464000826|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
128921732|NCT01701258|464000827|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
128921733|NCT01701258|464000828|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
128921734|NCT01701258|464000829|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
128921735|NCT01701258|464000830|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
128921736|NCT01701258|464000831|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
128921737|NCT01701258|464000832|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
128921738|NCT01701258|464000833|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
128921739|NCT01701258|464000834|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
128921740|NCT01701258|464000822|FG000|Assessment and Scheduling|Investigator Terminated|2|||
128921741|NCT01701258|464000823|FG001|Assessment and Scheduling|Investigator Terminated|0|||
128921742|NCT01701258|464000824|FG002|Assessment and Scheduling|Investigator Terminated|0|||
128921743|NCT01701258|464000825|FG003|Assessment and Scheduling|Investigator Terminated|0|||
128921744|NCT01701258|464000826|FG004|Assessment and Scheduling|Investigator Terminated|0|||
128921745|NCT01701258|464000827|FG005|Assessment and Scheduling|Investigator Terminated|0|||
128699962|NCT02217878|463199869|FG000|Overall Study|required morphine due to chest pain|1|||
128699963|NCT02217878|463199870|FG001|Overall Study|required morphine due to chest pain|2|||
128699964|NCT02217878|463199869|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
128699965|NCT02217878|463199870|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
128699966|NCT00334958|463199871|FG000|Overall Study|Medication Noncompliance|0|||
128921746|NCT01701258|464000828|FG006|Assessment and Scheduling|Investigator Terminated|0|||
128921747|NCT01701258|464000829|FG007|Assessment and Scheduling|Investigator Terminated|0|||
128921748|NCT01701258|464000830|FG008|Assessment and Scheduling|Investigator Terminated|0|||
128921749|NCT01701258|464000831|FG009|Assessment and Scheduling|Investigator Terminated|0|||
128921750|NCT01701258|464000832|FG010|Assessment and Scheduling|Investigator Terminated|0|||
128921751|NCT01701258|464000833|FG011|Assessment and Scheduling|Investigator Terminated|0|||
128921752|NCT01701258|464000834|FG012|Assessment and Scheduling|Investigator Terminated|0|||
128766496|NCT00118898|463435339|FG002|Overall Study|Severe debilitation|6|||
128921753|NCT02429856|464000837|FG000|Overall Study|Death|12|||
128921754|NCT02429856|464000838|FG001|Overall Study|Death|13|||
128921755|NCT02429856|464000837|FG000|Overall Study|Lost to Follow-up|6|||
128921756|NCT02429856|464000838|FG001|Overall Study|Lost to Follow-up|5|||
128921757|NCT02429856|464000837|FG000|Overall Study|Withdrawal by Subject|1|||
128921758|NCT02429856|464000838|FG001|Overall Study|Withdrawal by Subject|1|||
128921759|NCT01355289|464000848|FG000|Core Study|Adverse Event, Non-Fatal|1|||
128921760|NCT01355289|464000849|FG001|Core Study|Adverse Event, Non-Fatal|0|||
128921761|NCT01355289|464000850|FG002|Core Study|Adverse Event, Non-Fatal|0|||
128921762|NCT01355289|464000851|FG003|Core Study|Adverse Event, Non-Fatal|0|||
128921763|NCT01355289|464000852|FG004|Core Study|Adverse Event, Non-Fatal|0|||
128921764|NCT01355289|464000848|FG000|Core Study|Inadequate Therapeutic Effect|0|||
128921765|NCT01355289|464000849|FG001|Core Study|Inadequate Therapeutic Effect|0|||
128921766|NCT01355289|464000850|FG002|Core Study|Inadequate Therapeutic Effect|0|||
128921767|NCT01355289|464000851|FG003|Core Study|Inadequate Therapeutic Effect|1|||
128921768|NCT01355289|464000852|FG004|Core Study|Inadequate Therapeutic Effect|0|||
128921769|NCT01355289|464000848|FG000|Core Study|Other|0|||
128921770|NCT01355289|464000849|FG001|Core Study|Other|0|||
128921771|NCT01355289|464000850|FG002|Core Study|Other|0|||
128921772|NCT01355289|464000851|FG003|Core Study|Other|1|||
128921773|NCT01355289|464000852|FG004|Core Study|Other|0|||
128921774|NCT01355289|464000848|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
128921775|NCT01355289|464000849|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
128921776|NCT01355289|464000850|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
128921777|NCT01355289|464000851|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
128921778|NCT01355289|464000852|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
128921779|NCT01355289|464000848|FG000|Open Label Extension|Lost to Follow-up|0|||
128921780|NCT01355289|464000849|FG001|Open Label Extension|Lost to Follow-up|0|||
128921781|NCT01355289|464000850|FG002|Open Label Extension|Lost to Follow-up|0|||
128921782|NCT01355289|464000851|FG003|Open Label Extension|Lost to Follow-up|0|||
128921783|NCT01355289|464000852|FG004|Open Label Extension|Lost to Follow-up|1|||
128921784|NCT01355289|464000848|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
128921785|NCT01355289|464000849|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
128921786|NCT01355289|464000850|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
128921787|NCT01355289|464000851|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
128921788|NCT01355289|464000852|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
128921789|NCT01355289|464000848|FG000|Open Label Extension|Other|0|||
128921790|NCT01355289|464000849|FG001|Open Label Extension|Other|0|||
128921791|NCT01355289|464000850|FG002|Open Label Extension|Other|0|||
128921792|NCT01355289|464000851|FG003|Open Label Extension|Other|0|||
128921793|NCT01355289|464000852|FG004|Open Label Extension|Other|3|||
128921794|NCT04336163|464000855|FG000|Overall Study|Lost to Follow-up|55|||
128921795|NCT04336163|464000856|FG001|Overall Study|Lost to Follow-up|0|||
128921796|NCT01085682|464000857|FG000|Overall Study|Withdrawal by Subject|25|||
128921797|NCT01085682|464000858|FG001|Overall Study|Withdrawal by Subject|25|||
128921798|NCT01451645|464000859|FG000|Overall Study|Protocol Violation|1|||
128921799|NCT01451645|464000860|FG001|Overall Study|Protocol Violation|0|||
128921800|NCT01451645|464000859|FG000|Overall Study|Adverse Event|0|||
128921801|NCT01451645|464000860|FG001|Overall Study|Adverse Event|3|||
128921802|NCT01451645|464000859|FG000|Overall Study|Withdrawal by Subject|4|||
128921803|NCT01451645|464000860|FG001|Overall Study|Withdrawal by Subject|2|||
128921804|NCT01451645|464000859|FG000|Overall Study|Lost to Follow-up|4|||
128921805|NCT01451645|464000860|FG001|Overall Study|Lost to Follow-up|3|||
128699967|NCT00334958|463199872|FG001|Overall Study|Medication Noncompliance|3|||
128699968|NCT00334958|463199871|FG000|Overall Study|Protocol Violation|2|||
128699969|NCT00334958|463199872|FG001|Overall Study|Protocol Violation|2|||
128766497|NCT00118898|463435340|FG003|Overall Study|Severe debilitation|4|||
128921806|NCT03838484|464000863|FG000|Overall Study|Lost to Follow-up|0|||
128921807|NCT03838484|464000864|FG001|Overall Study|Lost to Follow-up|1|||
128921808|NCT03838484|464000865|FG002|Overall Study|Lost to Follow-up|0|||
128921809|NCT03838484|464000866|FG003|Overall Study|Lost to Follow-up|0|||
128921810|NCT02868892|464000867|FG000|Overall Study|Investigator left site and no follow-up|6|||
128921811|NCT00619957|464000871|FG000|Month 24 Double-Blind|Adverse Event|9|||
128921812|NCT00619957|464000872|FG001|Month 24 Double-Blind|Adverse Event|7|||
128921813|NCT00619957|464000871|FG000|Month 24 Double-Blind|Protocol Violation|1|||
128921814|NCT00619957|464000872|FG001|Month 24 Double-Blind|Protocol Violation|0|||
128921815|NCT00619957|464000871|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
128921816|NCT00619957|464000872|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
128921817|NCT00619957|464000871|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
128921818|NCT00619957|464000872|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
128921819|NCT00619957|464000871|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
128921820|NCT00619957|464000872|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
128921821|NCT00619957|464000871|FG000|Month 48 Open-Label|Adverse Event|4|||
128921822|NCT00619957|464000872|FG001|Month 48 Open-Label|Adverse Event|4|||
128921823|NCT00619957|464000871|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
128921824|NCT00619957|464000872|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
128921825|NCT00619957|464000871|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
128699970|NCT00334958|463199871|FG000|Overall Study|Request of the investigator or sponsor|0|||
128699971|NCT00334958|463199872|FG001|Overall Study|Request of the investigator or sponsor|1|||
128699972|NCT00334958|463199871|FG000|Overall Study|Withdrawal by Subject|7|||
128699973|NCT00334958|463199872|FG001|Overall Study|Withdrawal by Subject|4|||
128699974|NCT00334958|463199871|FG000|Overall Study|Adverse Event|27|||
128699975|NCT00334958|463199872|FG001|Overall Study|Adverse Event|12|||
128699976|NCT00334958|463199871|FG000|Overall Study|Other|1|||
128699977|NCT00334958|463199872|FG001|Overall Study|Other|2|||
128699978|NCT00622401|463199873|FG000|Overall Study|Disease progression prior to treatment|3|||
128699979|NCT00622401|463199874|FG001|Overall Study|Disease progression prior to treatment|2|||
128699980|NCT00622401|463199875|FG002|Overall Study|Disease progression prior to treatment|0|||
128699981|NCT00282984|463199882|FG000|Overall Study|Death|2|||
128699982|NCT00282984|463199883|FG001|Overall Study|Death|5|||
128699983|NCT00282984|463199882|FG000|Overall Study|Adverse Event|8|||
128699984|NCT00282984|463199883|FG001|Overall Study|Adverse Event|5|||
128699985|NCT00282984|463199882|FG000|Overall Study|Lack of Efficacy|0|||
128699986|NCT00282984|463199883|FG001|Overall Study|Lack of Efficacy|2|||
128699987|NCT00282984|463199882|FG000|Overall Study|Lost to Follow-up|14|||
128699988|NCT00282984|463199883|FG001|Overall Study|Lost to Follow-up|10|||
128699989|NCT00282984|463199882|FG000|Overall Study|Withdrawal by Participant|22|||
128699990|NCT00282984|463199883|FG001|Overall Study|Withdrawal by Participant|34|||
128699991|NCT00282984|463199882|FG000|Overall Study|Participant stopped study medication|2|||
128699992|NCT00282984|463199883|FG001|Overall Study|Participant stopped study medication|2|||
128699993|NCT00282984|463199882|FG000|Overall Study|Participant only allowed phone follow-up|0|||
128699994|NCT00282984|463199883|FG001|Overall Study|Participant only allowed phone follow-up|1|||
128699995|NCT00282984|463199882|FG000|Overall Study|Participant used antipsychosis meds|0|||
128699996|NCT00282984|463199883|FG001|Overall Study|Participant used antipsychosis meds|1|||
128699997|NCT00282984|463199882|FG000|Overall Study|lack of motivation|1|||
128699998|NCT00282984|463199883|FG001|Overall Study|lack of motivation|0|||
128699999|NCT00282984|463199882|FG000|Overall Study|in prison|0|||
128700000|NCT00282984|463199883|FG001|Overall Study|in prison|1|||
128700001|NCT00282984|463199882|FG000|Overall Study|Protocol Violation|2|||
128700002|NCT00282984|463199883|FG001|Overall Study|Protocol Violation|0|||
128700003|NCT01128842|463199888|FG000|Overall Study|Adverse Event|1|||
128700004|NCT01128842|463199888|FG000|Overall Study|Disease Progression|6|||
128700005|NCT00824720|463199889|FG000|Overall Study|failed plug insertion|3|||
128700006|NCT00824720|463199890|FG001|Overall Study|failed plug insertion|1|||
128700007|NCT00824720|463199891|FG002|Overall Study|failed plug insertion|0|||
128700008|NCT00824720|463199889|FG000|Overall Study|Protocol Violation|0|||
128700009|NCT00824720|463199890|FG001|Overall Study|Protocol Violation|0|||
128700010|NCT00824720|463199891|FG002|Overall Study|Protocol Violation|1|||
128700011|NCT00688753|463201460|FG000|Overall Study|Disease progression|55|||
128700012|NCT00688753|463201460|FG000|Overall Study|Missing|1|||
128700013|NCT00688753|463201460|FG000|Overall Study|Death|9|||
128700014|NCT00688753|463201460|FG000|Overall Study|Withdrawal by Subject|3|||
128700015|NCT00688753|463201460|FG000|Overall Study|Adverse Event|20|||
128921826|NCT00619957|464000872|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
128921827|NCT00868790|464000873|FG000|Period 1|Adverse Event|1|||
128921828|NCT00868790|464000874|FG001|Period 1|Adverse Event|0|||
128921829|NCT00868790|464000875|FG002|Period 1|Adverse Event|0|||
128921830|NCT00868790|464000876|FG003|Period 1|Adverse Event|0|||
128921831|NCT00868790|464000877|FG004|Period 1|Adverse Event|0|||
128921832|NCT00868790|464000878|FG005|Period 1|Adverse Event|0|||
128921833|NCT00868790|464000879|FG006|Period 1|Adverse Event|0|||
128921834|NCT00868790|464000880|FG007|Period 1|Adverse Event|3|||
128921835|NCT00868790|464000881|FG008|Period 1|Adverse Event|1|||
128921836|NCT00868790|464000882|FG009|Period 1|Adverse Event|0|||
128921837|NCT00868790|464000883|FG010|Period 1|Adverse Event|0|||
128921838|NCT00868790|464000884|FG011|Period 1|Adverse Event|0|||
128921839|NCT00868790|464000885|FG012|Period 1|Adverse Event|0|||
128921840|NCT00868790|464000886|FG013|Period 1|Adverse Event|1|||
128921841|NCT00868790|464000873|FG000|Period 1|Protocol Violation|1|||
128921842|NCT00868790|464000874|FG001|Period 1|Protocol Violation|0|||
128700016|NCT00688753|463201460|FG000|Overall Study|Protocol Violation|1|||
128700017|NCT00688753|463201460|FG000|Overall Study|Lost to Follow-up|3|||
128700018|NCT03187197|463201461|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
128700019|NCT03187197|463201462|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
128700020|NCT03187197|463201463|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
128700021|NCT03187197|463201461|FG000|Overall Study|Withdrawal by Subject|8|||
128700022|NCT03187197|463201462|FG001|Overall Study|Withdrawal by Subject|63|||
128700023|NCT03187197|463201463|FG002|Overall Study|Withdrawal by Subject|4|||
128700024|NCT03187197|463201461|FG000|Overall Study|Lost to Follow-up|1|||
128700025|NCT03187197|463201462|FG001|Overall Study|Lost to Follow-up|60|||
128700026|NCT03187197|463201463|FG002|Overall Study|Lost to Follow-up|7|||
128700027|NCT03187197|463201461|FG000|Overall Study|Adverse Event|6|||
128921843|NCT00868790|464000875|FG002|Period 1|Protocol Violation|0|||
128921844|NCT00868790|464000876|FG003|Period 1|Protocol Violation|0|||
128921845|NCT00868790|464000877|FG004|Period 1|Protocol Violation|0|||
128921846|NCT00868790|464000878|FG005|Period 1|Protocol Violation|0|||
128921847|NCT00868790|464000879|FG006|Period 1|Protocol Violation|0|||
128921848|NCT00868790|464000880|FG007|Period 1|Protocol Violation|0|||
128700028|NCT03187197|463201462|FG001|Overall Study|Adverse Event|29|||
128921849|NCT00868790|464000881|FG008|Period 1|Protocol Violation|0|||
128921850|NCT00868790|464000882|FG009|Period 1|Protocol Violation|0|||
128921851|NCT00868790|464000883|FG010|Period 1|Protocol Violation|0|||
128921852|NCT00868790|464000884|FG011|Period 1|Protocol Violation|0|||
128921853|NCT00868790|464000885|FG012|Period 1|Protocol Violation|0|||
128921854|NCT00868790|464000886|FG013|Period 1|Protocol Violation|0|||
128921855|NCT00868790|464000873|FG000|Period 1|Withdrawal by Subject|0|||
128921856|NCT00868790|464000874|FG001|Period 1|Withdrawal by Subject|1|||
128921857|NCT00868790|464000875|FG002|Period 1|Withdrawal by Subject|0|||
128921858|NCT00868790|464000876|FG003|Period 1|Withdrawal by Subject|0|||
128921859|NCT00868790|464000877|FG004|Period 1|Withdrawal by Subject|0|||
128921860|NCT00868790|464000878|FG005|Period 1|Withdrawal by Subject|0|||
128921861|NCT00868790|464000879|FG006|Period 1|Withdrawal by Subject|0|||
128921862|NCT00868790|464000880|FG007|Period 1|Withdrawal by Subject|0|||
128921863|NCT00868790|464000881|FG008|Period 1|Withdrawal by Subject|0|||
128921864|NCT00868790|464000882|FG009|Period 1|Withdrawal by Subject|0|||
128921865|NCT00868790|464000883|FG010|Period 1|Withdrawal by Subject|0|||
128921866|NCT00868790|464000884|FG011|Period 1|Withdrawal by Subject|0|||
128921867|NCT00868790|464000885|FG012|Period 1|Withdrawal by Subject|0|||
128921868|NCT00868790|464000886|FG013|Period 1|Withdrawal by Subject|1|||
128921869|NCT00868790|464000873|FG000|Period 1|Abnormal Triglycerides|0|||
128921870|NCT00868790|464000874|FG001|Period 1|Abnormal Triglycerides|0|||
128700029|NCT03187197|463201463|FG002|Overall Study|Adverse Event|0|||
128700030|NCT03187197|463201461|FG000|Overall Study|Death|0|||
128700031|NCT03187197|463201462|FG001|Overall Study|Death|11|||
128921871|NCT00868790|464000875|FG002|Period 1|Abnormal Triglycerides|0|||
128921872|NCT00868790|464000876|FG003|Period 1|Abnormal Triglycerides|0|||
128921873|NCT00868790|464000877|FG004|Period 1|Abnormal Triglycerides|1|||
128921874|NCT00868790|464000878|FG005|Period 1|Abnormal Triglycerides|0|||
128921875|NCT00868790|464000879|FG006|Period 1|Abnormal Triglycerides|0|||
128921876|NCT00868790|464000880|FG007|Period 1|Abnormal Triglycerides|0|||
128921877|NCT00868790|464000881|FG008|Period 1|Abnormal Triglycerides|0|||
128921878|NCT00868790|464000882|FG009|Period 1|Abnormal Triglycerides|0|||
128921879|NCT00868790|464000883|FG010|Period 1|Abnormal Triglycerides|0|||
128921880|NCT00868790|464000884|FG011|Period 1|Abnormal Triglycerides|0|||
128921881|NCT00868790|464000885|FG012|Period 1|Abnormal Triglycerides|0|||
128921882|NCT00868790|464000886|FG013|Period 1|Abnormal Triglycerides|0|||
128921883|NCT00868790|464000873|FG000|Period 1|Lost to Follow-up|0|||
128921884|NCT00868790|464000874|FG001|Period 1|Lost to Follow-up|0|||
128921885|NCT00868790|464000875|FG002|Period 1|Lost to Follow-up|0|||
128921886|NCT00868790|464000876|FG003|Period 1|Lost to Follow-up|0|||
128921887|NCT00868790|464000877|FG004|Period 1|Lost to Follow-up|0|||
128921888|NCT00868790|464000878|FG005|Period 1|Lost to Follow-up|1|||
128921889|NCT00868790|464000879|FG006|Period 1|Lost to Follow-up|0|||
128700032|NCT03187197|463201463|FG002|Overall Study|Death|0|||
128700033|NCT03187197|463201461|FG000|Overall Study|Administrative problem|1|||
128700034|NCT03187197|463201462|FG001|Overall Study|Administrative problem|1|||
128700035|NCT03187197|463201463|FG002|Overall Study|Administrative problem|0|||
128700036|NCT03187197|463201461|FG000|Overall Study|Reason not listed|2|||
128700037|NCT03187197|463201462|FG001|Overall Study|Reason not listed|54|||
128700038|NCT03187197|463201463|FG002|Overall Study|Reason not listed|1|||
128700039|NCT03187197|463201461|FG000|Overall Study|Missing|1|||
128700040|NCT03187197|463201462|FG001|Overall Study|Missing|32|||
128700041|NCT03187197|463201463|FG002|Overall Study|Missing|3|||
128700042|NCT03187197|463201461|FG000|Overall Study|Status missing|2|||
128700043|NCT03187197|463201462|FG001|Overall Study|Status missing|33|||
128700044|NCT03187197|463201463|FG002|Overall Study|Status missing|3|||
128700045|NCT03187197|463201461|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
128700046|NCT03187197|463201462|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
128700047|NCT03187197|463201463|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
128700048|NCT04840615|463201464|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
128921890|NCT00868790|464000880|FG007|Period 1|Lost to Follow-up|0|||
128921891|NCT00868790|464000881|FG008|Period 1|Lost to Follow-up|0|||
128921892|NCT00868790|464000882|FG009|Period 1|Lost to Follow-up|0|||
128921893|NCT00868790|464000883|FG010|Period 1|Lost to Follow-up|0|||
128921894|NCT00868790|464000884|FG011|Period 1|Lost to Follow-up|0|||
128700049|NCT04840615|463201465|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
128700050|NCT04840615|463201466|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
128700051|NCT00709761|463201470|FG000|Overall Study|Withdrawal by Subject|8|||
128700052|NCT00709761|463201470|FG000|Overall Study|study closed/terminated|17|||
128921895|NCT00868790|464000885|FG012|Period 1|Lost to Follow-up|0|||
128921896|NCT00868790|464000886|FG013|Period 1|Lost to Follow-up|0|||
128921897|NCT00868790|464000873|FG000|Period 2|Adverse Event|0|||
128921898|NCT00868790|464000874|FG001|Period 2|Adverse Event|0|||
128921899|NCT00868790|464000875|FG002|Period 2|Adverse Event|0|||
128921900|NCT00868790|464000876|FG003|Period 2|Adverse Event|0|||
128921901|NCT00868790|464000877|FG004|Period 2|Adverse Event|0|||
128700053|NCT00709761|463201470|FG000|Overall Study|Lost to Follow-up|2|||
128700054|NCT00259649|463201471|FG000|Overall Study|Lost to Follow-up|7|||
128700055|NCT00259649|463201471|FG000|Overall Study|irregular menses|3|||
128700056|NCT02200211|463201474|FG000|Overall Study|Lost to Follow-up|7|||
128700057|NCT02200211|463201475|FG001|Overall Study|Lost to Follow-up|7|||
128700058|NCT02200211|463201476|FG002|Overall Study|Lost to Follow-up|1|||
128700059|NCT02200211|463201477|FG003|Overall Study|Lost to Follow-up|2|||
128700060|NCT02200211|463201474|FG000|Overall Study|Withdrawal by Subject|1|||
128700061|NCT02200211|463201475|FG001|Overall Study|Withdrawal by Subject|0|||
128700062|NCT02200211|463201476|FG002|Overall Study|Withdrawal by Subject|0|||
128700063|NCT02200211|463201477|FG003|Overall Study|Withdrawal by Subject|0|||
128700064|NCT01918774|463201478|FG000|Overall Study|Lost prior to first CBTw session|4|||
128700065|NCT01918774|463201478|FG000|Overall Study|Lost to Follow-up|1|||
128700066|NCT00717197|463201485|FG000|Overall Study|Unable to purchase study drug|5|||
128700067|NCT00717197|463201485|FG000|Overall Study|Tumor Progression|1|||
128700068|NCT00717197|463201485|FG000|Overall Study|Physician Decision|1|||
128700069|NCT00982137|463201486|FG000|Overall Study|Lost to Follow-up|0|||
128700070|NCT00982137|463201487|FG001|Overall Study|Lost to Follow-up|0|||
128700071|NCT00982137|463201488|FG002|Overall Study|Lost to Follow-up|0|||
128700072|NCT00982137|463201489|FG003|Overall Study|Lost to Follow-up|1|||
128766498|NCT00118898|463435337|FG000|Overall Study|Not compliant with requirements|11|||
128766499|NCT00118898|463435338|FG001|Overall Study|Not compliant with requirements|13|||
128766500|NCT00118898|463435339|FG002|Overall Study|Not compliant with requirements|11|||
128766501|NCT00118898|463435340|FG003|Overall Study|Not compliant with requirements|11|||
128921902|NCT00868790|464000878|FG005|Period 2|Adverse Event|0|||
128921903|NCT00868790|464000879|FG006|Period 2|Adverse Event|0|||
128921904|NCT00868790|464000880|FG007|Period 2|Adverse Event|0|||
128921905|NCT00868790|464000881|FG008|Period 2|Adverse Event|1|||
128921906|NCT00868790|464000882|FG009|Period 2|Adverse Event|0|||
128921907|NCT00868790|464000883|FG010|Period 2|Adverse Event|0|||
128921908|NCT00868790|464000884|FG011|Period 2|Adverse Event|0|||
128921909|NCT00868790|464000885|FG012|Period 2|Adverse Event|0|||
128921910|NCT00868790|464000886|FG013|Period 2|Adverse Event|0|||
128921911|NCT00868790|464000873|FG000|Period 2|Lost to Follow-up|0|||
128921912|NCT00868790|464000874|FG001|Period 2|Lost to Follow-up|1|||
128921913|NCT00868790|464000875|FG002|Period 2|Lost to Follow-up|0|||
128921914|NCT00868790|464000876|FG003|Period 2|Lost to Follow-up|0|||
128921915|NCT00868790|464000877|FG004|Period 2|Lost to Follow-up|0|||
128921916|NCT00868790|464000878|FG005|Period 2|Lost to Follow-up|1|||
128921917|NCT00868790|464000879|FG006|Period 2|Lost to Follow-up|0|||
128921918|NCT00868790|464000880|FG007|Period 2|Lost to Follow-up|0|||
128921919|NCT00868790|464000881|FG008|Period 2|Lost to Follow-up|0|||
128921920|NCT00868790|464000882|FG009|Period 2|Lost to Follow-up|0|||
128921921|NCT00868790|464000883|FG010|Period 2|Lost to Follow-up|0|||
128921922|NCT00868790|464000884|FG011|Period 2|Lost to Follow-up|0|||
128921923|NCT00868790|464000885|FG012|Period 2|Lost to Follow-up|0|||
128921924|NCT00868790|464000886|FG013|Period 2|Lost to Follow-up|0|||
128921925|NCT00868790|464000873|FG000|Period 2|Withdrawal by Subject|0|||
128921926|NCT00868790|464000874|FG001|Period 2|Withdrawal by Subject|0|||
128921927|NCT00868790|464000875|FG002|Period 2|Withdrawal by Subject|0|||
128921928|NCT00868790|464000876|FG003|Period 2|Withdrawal by Subject|0|||
128921929|NCT00868790|464000877|FG004|Period 2|Withdrawal by Subject|0|||
128921930|NCT00868790|464000878|FG005|Period 2|Withdrawal by Subject|0|||
128921931|NCT00868790|464000879|FG006|Period 2|Withdrawal by Subject|0|||
128766502|NCT00118898|463435337|FG000|Overall Study|Not able to get to clinic|34|||
128766503|NCT00118898|463435338|FG001|Overall Study|Not able to get to clinic|43|||
128766504|NCT00118898|463435339|FG002|Overall Study|Not able to get to clinic|31|||
128766505|NCT00118898|463435340|FG003|Overall Study|Not able to get to clinic|40|||
128766506|NCT01816763|463436540|FG000|Overall Study|The main reason for an incomplete survey|4|||
128766507|NCT01816763|463436541|FG001|Overall Study|The main reason for an incomplete survey|15|||
128766508|NCT01816763|463436542|FG002|Overall Study|The main reason for an incomplete survey|11|||
128766509|NCT00311155|463436545|FG000|Overall Study|Adverse Event|21|||
128766510|NCT00311155|463436545|FG000|Overall Study|Withdrawal by Subject|17|||
128921932|NCT00868790|464000880|FG007|Period 2|Withdrawal by Subject|0|||
128921933|NCT00868790|464000881|FG008|Period 2|Withdrawal by Subject|1|||
128921934|NCT00868790|464000882|FG009|Period 2|Withdrawal by Subject|0|||
128921935|NCT00868790|464000883|FG010|Period 2|Withdrawal by Subject|0|||
128921936|NCT00868790|464000884|FG011|Period 2|Withdrawal by Subject|0|||
129118883|NCT00833755|464731240|FG002|Overall Study|Subject had scheduling issues|0|||
128700073|NCT00982137|463201486|FG000|Overall Study|Withdrawal by Subject|0|||
128700074|NCT00982137|463201487|FG001|Overall Study|Withdrawal by Subject|1|||
128700075|NCT00982137|463201488|FG002|Overall Study|Withdrawal by Subject|0|||
128700076|NCT00982137|463201489|FG003|Overall Study|Withdrawal by Subject|0|||
128921937|NCT00868790|464000885|FG012|Period 2|Withdrawal by Subject|0|||
128921938|NCT00868790|464000886|FG013|Period 2|Withdrawal by Subject|1|||
128700077|NCT00787891|463201493|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
128921939|NCT00868790|464000873|FG000|Period 3|Adverse Event|0|||
128921940|NCT00868790|464000874|FG001|Period 3|Adverse Event|0|||
128921941|NCT00868790|464000875|FG002|Period 3|Adverse Event|0|||
128700078|NCT00787891|463201494|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
128700079|NCT00787891|463201493|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
128700080|NCT00787891|463201494|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
128700081|NCT00787891|463201493|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
128700082|NCT00787891|463201494|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
128700083|NCT00787891|463201493|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
128700084|NCT00787891|463201494|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
128700085|NCT00787891|463201493|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
128700086|NCT00787891|463201494|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
128700087|NCT00787891|463201493|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
128700088|NCT00787891|463201494|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
128700089|NCT00787891|463201493|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
128700090|NCT00787891|463201494|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
128700091|NCT00787891|463201493|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
128700092|NCT00787891|463201494|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
128700093|NCT00787891|463201493|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
128700094|NCT00787891|463201494|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
128700095|NCT00787891|463201493|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
128700096|NCT00787891|463201494|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
128700097|NCT02980601|463201497|FG000|Overall Study|Lost to Follow-up|2|||
128700098|NCT02980601|463201498|FG001|Overall Study|Lost to Follow-up|2|||
128700099|NCT02980601|463201497|FG000|Overall Study|Death|0|||
128700100|NCT02980601|463201498|FG001|Overall Study|Death|1|||
128700101|NCT02980601|463201497|FG000|Overall Study|Graft loss|1|||
128700102|NCT02980601|463201498|FG001|Overall Study|Graft loss|0|||
128700103|NCT02980601|463201497|FG000|Overall Study|Failed to sign consent|2|||
128700104|NCT02980601|463201498|FG001|Overall Study|Failed to sign consent|0|||
128700105|NCT01575769|463201499|FG000|Overall Study|Adverse Event|1|||
128700106|NCT01575769|463201499|FG000|Overall Study|Study terminated by sponsor|40|||
128700107|NCT00844831|463201500|FG000|Overall Study|Withdrawal by Subject|4|||
128700108|NCT00844831|463201500|FG000|Overall Study|Adverse Event|1|||
128700109|NCT00844831|463201500|FG000|Overall Study|Physician Decision|1|||
128700110|NCT00674700|463201503|FG000|Year 1|Adverse Event|17|||
128766511|NCT00311155|463436545|FG000|Overall Study|Did not meet entry criteria|55|||
128921942|NCT00868790|464000876|FG003|Period 3|Adverse Event|0|||
128921943|NCT00868790|464000877|FG004|Period 3|Adverse Event|0|||
128921944|NCT00868790|464000878|FG005|Period 3|Adverse Event|0|||
128921945|NCT00868790|464000879|FG006|Period 3|Adverse Event|0|||
128921946|NCT00868790|464000880|FG007|Period 3|Adverse Event|0|||
128921947|NCT00868790|464000881|FG008|Period 3|Adverse Event|0|||
128921948|NCT00868790|464000882|FG009|Period 3|Adverse Event|1|||
128921949|NCT00868790|464000883|FG010|Period 3|Adverse Event|0|||
128921950|NCT00868790|464000884|FG011|Period 3|Adverse Event|0|||
128921951|NCT00868790|464000885|FG012|Period 3|Adverse Event|0|||
128921952|NCT00868790|464000886|FG013|Period 3|Adverse Event|0|||
129029311|NCT02611323|464398387|FG009|Overall Study|Withdrawal by Subject|1|||
129029312|NCT02611323|464398388|FG010|Overall Study|Withdrawal by Subject|0|||
129029313|NCT02597049|464398389|FG000|Overall Study|Lost to Follow-up|0|||
129029314|NCT02597049|464398390|FG001|Overall Study|Lost to Follow-up|3|||
129029315|NCT02597049|464398391|FG002|Overall Study|Lost to Follow-up|2|||
129029316|NCT02597049|464398389|FG000|Overall Study|Withdrawal by Subject|2|||
129029317|NCT02597049|464398390|FG001|Overall Study|Withdrawal by Subject|2|||
129029318|NCT02597049|464398391|FG002|Overall Study|Withdrawal by Subject|1|||
129029319|NCT02597049|464398389|FG000|Overall Study|Adverse Event|2|||
129029320|NCT02597049|464398390|FG001|Overall Study|Adverse Event|0|||
129029321|NCT02597049|464398391|FG002|Overall Study|Adverse Event|0|||
129029322|NCT02597049|464398389|FG000|Overall Study|Death|2|||
129029323|NCT02597049|464398390|FG001|Overall Study|Death|0|||
129029324|NCT02597049|464398391|FG002|Overall Study|Death|0|||
129029325|NCT02597049|464398389|FG000|Overall Study|Noncompliant with Study Visits|1|||
129029326|NCT02597049|464398390|FG001|Overall Study|Noncompliant with Study Visits|0|||
128700111|NCT00674700|463201504|FG001|Year 1|Adverse Event|20|||
128700112|NCT00674700|463201505|FG002|Year 1|Adverse Event|5|||
128700113|NCT00674700|463201503|FG000|Year 1|Withdrawal by Subject|7|||
128700114|NCT00674700|463201504|FG001|Year 1|Withdrawal by Subject|7|||
128700115|NCT00674700|463201505|FG002|Year 1|Withdrawal by Subject|6|||
128921953|NCT00868790|464000873|FG000|Period 3|Protocol Violation|0|||
128921954|NCT00868790|464000874|FG001|Period 3|Protocol Violation|0|||
128921955|NCT00868790|464000875|FG002|Period 3|Protocol Violation|0|||
129029327|NCT02597049|464398391|FG002|Overall Study|Noncompliant with Study Visits|0|||
129029328|NCT00243347|464398394|FG000|Overall Study|Lack of Efficacy|4|||
129029329|NCT00243347|464398394|FG000|Overall Study|Adverse Event|2|||
129029330|NCT00243347|464398394|FG000|Overall Study|Death|1|||
129029331|NCT00243347|464398394|FG000|Overall Study|Withdrawal by Subject|5|||
129029332|NCT00243347|464398394|FG000|Overall Study|Condition worsened|7|||
129029333|NCT01899053|464398397|FG000|Overall Study|Progressive Disease|4|||
129029334|NCT01899053|464398398|FG001|Overall Study|Progressive Disease|0|||
128921956|NCT00868790|464000876|FG003|Period 3|Protocol Violation|0|||
128921957|NCT00868790|464000877|FG004|Period 3|Protocol Violation|0|||
128921958|NCT00868790|464000878|FG005|Period 3|Protocol Violation|0|||
128921959|NCT00868790|464000879|FG006|Period 3|Protocol Violation|0|||
128921960|NCT00868790|464000880|FG007|Period 3|Protocol Violation|0|||
128921961|NCT00868790|464000881|FG008|Period 3|Protocol Violation|0|||
128921962|NCT00868790|464000882|FG009|Period 3|Protocol Violation|0|||
128921963|NCT00868790|464000883|FG010|Period 3|Protocol Violation|1|||
128921964|NCT00868790|464000884|FG011|Period 3|Protocol Violation|0|||
128921965|NCT00868790|464000885|FG012|Period 3|Protocol Violation|0|||
128921966|NCT00868790|464000886|FG013|Period 3|Protocol Violation|0|||
128700116|NCT00674700|463201503|FG000|Year 1|Any other reason not above-mentioned|7|||
128700117|NCT00674700|463201504|FG001|Year 1|Any other reason not above-mentioned|7|||
128700118|NCT00674700|463201505|FG002|Year 1|Any other reason not above-mentioned|6|||
128700119|NCT00674700|463201503|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
128700120|NCT00674700|463201504|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
128700121|NCT00674700|463201505|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
128921967|NCT00868790|464000873|FG000|Period 3|Study Terminated by Sponsor|0|||
128921968|NCT00868790|464000874|FG001|Period 3|Study Terminated by Sponsor|0|||
129029335|NCT01899053|464398399|FG002|Overall Study|Progressive Disease|3|||
129029336|NCT01899053|464398400|FG003|Overall Study|Progressive Disease|0|||
129029337|NCT01899053|464398401|FG004|Overall Study|Progressive Disease|3|||
129029338|NCT01899053|464398402|FG005|Overall Study|Progressive Disease|1|||
129029339|NCT01899053|464398403|FG006|Overall Study|Progressive Disease|1|||
129029340|NCT01899053|464398404|FG007|Overall Study|Progressive Disease|1|||
129029341|NCT01899053|464398405|FG008|Overall Study|Progressive Disease|4|||
129029342|NCT01899053|464398406|FG009|Overall Study|Progressive Disease|3|||
129029343|NCT01899053|464398407|FG010|Overall Study|Progressive Disease|12|||
129029344|NCT01899053|464398408|FG011|Overall Study|Progressive Disease|5|||
129029345|NCT01899053|464398409|FG012|Overall Study|Progressive Disease|8|||
129029346|NCT01899053|464398410|FG013|Overall Study|Progressive Disease|17|||
129029347|NCT01899053|464398397|FG000|Overall Study|Adverse Event|1|||
129029348|NCT01899053|464398398|FG001|Overall Study|Adverse Event|1|||
129029349|NCT01899053|464398399|FG002|Overall Study|Adverse Event|1|||
129029350|NCT01899053|464398400|FG003|Overall Study|Adverse Event|3|||
129029351|NCT01899053|464398401|FG004|Overall Study|Adverse Event|1|||
129029352|NCT01899053|464398402|FG005|Overall Study|Adverse Event|1|||
129029353|NCT01899053|464398403|FG006|Overall Study|Adverse Event|1|||
129029354|NCT01899053|464398404|FG007|Overall Study|Adverse Event|0|||
129029355|NCT01899053|464398405|FG008|Overall Study|Adverse Event|2|||
129029356|NCT01899053|464398406|FG009|Overall Study|Adverse Event|0|||
129029357|NCT01899053|464398407|FG010|Overall Study|Adverse Event|3|||
129029358|NCT01899053|464398408|FG011|Overall Study|Adverse Event|1|||
129029359|NCT01899053|464398409|FG012|Overall Study|Adverse Event|2|||
129029360|NCT01899053|464398410|FG013|Overall Study|Adverse Event|2|||
129029361|NCT01899053|464398397|FG000|Overall Study|Reason Not Specified|0|||
129029362|NCT01899053|464398398|FG001|Overall Study|Reason Not Specified|0|||
129029363|NCT01899053|464398399|FG002|Overall Study|Reason Not Specified|0|||
129029364|NCT01899053|464398400|FG003|Overall Study|Reason Not Specified|0|||
129029365|NCT01899053|464398401|FG004|Overall Study|Reason Not Specified|0|||
129029366|NCT01899053|464398402|FG005|Overall Study|Reason Not Specified|0|||
129029367|NCT01899053|464398403|FG006|Overall Study|Reason Not Specified|1|||
129029368|NCT01899053|464398404|FG007|Overall Study|Reason Not Specified|0|||
129029369|NCT01899053|464398405|FG008|Overall Study|Reason Not Specified|0|||
129029370|NCT01899053|464398406|FG009|Overall Study|Reason Not Specified|0|||
129029371|NCT01899053|464398407|FG010|Overall Study|Reason Not Specified|0|||
129029372|NCT01899053|464398408|FG011|Overall Study|Reason Not Specified|0|||
129029373|NCT01899053|464398409|FG012|Overall Study|Reason Not Specified|1|||
129029374|NCT01899053|464398410|FG013|Overall Study|Reason Not Specified|0|||
129029375|NCT01899053|464398397|FG000|Overall Study|Withdrawal by Subject|1|||
129029376|NCT01899053|464398398|FG001|Overall Study|Withdrawal by Subject|1|||
129029377|NCT01899053|464398399|FG002|Overall Study|Withdrawal by Subject|2|||
129029378|NCT01899053|464398400|FG003|Overall Study|Withdrawal by Subject|0|||
129029379|NCT01899053|464398401|FG004|Overall Study|Withdrawal by Subject|2|||
129029380|NCT01899053|464398402|FG005|Overall Study|Withdrawal by Subject|0|||
129029381|NCT01899053|464398403|FG006|Overall Study|Withdrawal by Subject|0|||
129029382|NCT01899053|464398404|FG007|Overall Study|Withdrawal by Subject|1|||
129029383|NCT01899053|464398405|FG008|Overall Study|Withdrawal by Subject|0|||
128700122|NCT00674700|463201503|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
128921969|NCT00868790|464000875|FG002|Period 3|Study Terminated by Sponsor|0|||
128921970|NCT00868790|464000876|FG003|Period 3|Study Terminated by Sponsor|1|||
128921971|NCT00868790|464000877|FG004|Period 3|Study Terminated by Sponsor|0|||
128921972|NCT00868790|464000878|FG005|Period 3|Study Terminated by Sponsor|0|||
129029384|NCT01899053|464398406|FG009|Overall Study|Withdrawal by Subject|0|||
129029385|NCT01899053|464398407|FG010|Overall Study|Withdrawal by Subject|0|||
129029386|NCT01899053|464398408|FG011|Overall Study|Withdrawal by Subject|0|||
129029387|NCT01899053|464398409|FG012|Overall Study|Withdrawal by Subject|1|||
128921973|NCT00868790|464000879|FG006|Period 3|Study Terminated by Sponsor|0|||
128921974|NCT00868790|464000880|FG007|Period 3|Study Terminated by Sponsor|0|||
128921975|NCT00868790|464000881|FG008|Period 3|Study Terminated by Sponsor|0|||
128921976|NCT00868790|464000882|FG009|Period 3|Study Terminated by Sponsor|0|||
128921977|NCT00868790|464000883|FG010|Period 3|Study Terminated by Sponsor|0|||
128921978|NCT00868790|464000884|FG011|Period 3|Study Terminated by Sponsor|0|||
128921979|NCT00868790|464000885|FG012|Period 3|Study Terminated by Sponsor|0|||
128921980|NCT00868790|464000886|FG013|Period 3|Study Terminated by Sponsor|0|||
128921981|NCT00868790|464000873|FG000|Period 4|Adverse Event|0|||
128921982|NCT00868790|464000874|FG001|Period 4|Adverse Event|0|||
128921983|NCT00868790|464000875|FG002|Period 4|Adverse Event|0|||
128921984|NCT00868790|464000876|FG003|Period 4|Adverse Event|0|||
128921985|NCT00868790|464000877|FG004|Period 4|Adverse Event|0|||
128921986|NCT00868790|464000878|FG005|Period 4|Adverse Event|0|||
128921987|NCT00868790|464000879|FG006|Period 4|Adverse Event|0|||
128921988|NCT00868790|464000880|FG007|Period 4|Adverse Event|1|||
128921989|NCT00868790|464000881|FG008|Period 4|Adverse Event|0|||
128921990|NCT00868790|464000882|FG009|Period 4|Adverse Event|0|||
128921991|NCT00868790|464000883|FG010|Period 4|Adverse Event|1|||
128921992|NCT00868790|464000884|FG011|Period 4|Adverse Event|0|||
128921993|NCT00868790|464000885|FG012|Period 4|Adverse Event|1|||
128921994|NCT00868790|464000886|FG013|Period 4|Adverse Event|0|||
128921995|NCT00868790|464000873|FG000|Period 4|Lost to Follow-up|0|||
128921996|NCT00868790|464000874|FG001|Period 4|Lost to Follow-up|0|||
128921997|NCT00868790|464000875|FG002|Period 4|Lost to Follow-up|0|||
128921998|NCT00868790|464000876|FG003|Period 4|Lost to Follow-up|0|||
128921999|NCT00868790|464000877|FG004|Period 4|Lost to Follow-up|0|||
128922000|NCT00868790|464000878|FG005|Period 4|Lost to Follow-up|0|||
128922001|NCT00868790|464000879|FG006|Period 4|Lost to Follow-up|0|||
128922002|NCT00868790|464000880|FG007|Period 4|Lost to Follow-up|1|||
128922003|NCT00868790|464000881|FG008|Period 4|Lost to Follow-up|0|||
128922004|NCT00868790|464000882|FG009|Period 4|Lost to Follow-up|0|||
128922005|NCT00868790|464000883|FG010|Period 4|Lost to Follow-up|0|||
128922006|NCT00868790|464000884|FG011|Period 4|Lost to Follow-up|0|||
128922007|NCT00868790|464000885|FG012|Period 4|Lost to Follow-up|0|||
128922008|NCT00868790|464000886|FG013|Period 4|Lost to Follow-up|0|||
128922009|NCT00868790|464000873|FG000|Period 4|Study Terminated by Sponsor|2|||
128922010|NCT00868790|464000874|FG001|Period 4|Study Terminated by Sponsor|0|||
128922011|NCT00868790|464000875|FG002|Period 4|Study Terminated by Sponsor|0|||
128922012|NCT00868790|464000876|FG003|Period 4|Study Terminated by Sponsor|0|||
128922013|NCT00868790|464000877|FG004|Period 4|Study Terminated by Sponsor|0|||
128922014|NCT00868790|464000878|FG005|Period 4|Study Terminated by Sponsor|0|||
128922015|NCT00868790|464000879|FG006|Period 4|Study Terminated by Sponsor|0|||
128922016|NCT00868790|464000880|FG007|Period 4|Study Terminated by Sponsor|1|||
128922017|NCT00868790|464000881|FG008|Period 4|Study Terminated by Sponsor|2|||
128922018|NCT00868790|464000882|FG009|Period 4|Study Terminated by Sponsor|0|||
128922019|NCT00868790|464000883|FG010|Period 4|Study Terminated by Sponsor|2|||
128922020|NCT00868790|464000884|FG011|Period 4|Study Terminated by Sponsor|1|||
128922021|NCT00868790|464000885|FG012|Period 4|Study Terminated by Sponsor|0|||
128922022|NCT00868790|464000886|FG013|Period 4|Study Terminated by Sponsor|1|||
128922023|NCT00868790|464000873|FG000|Period 4|Abnormal ALT/AST|0|||
128922024|NCT00868790|464000874|FG001|Period 4|Abnormal ALT/AST|0|||
128922025|NCT00868790|464000875|FG002|Period 4|Abnormal ALT/AST|1|||
128922026|NCT00868790|464000876|FG003|Period 4|Abnormal ALT/AST|0|||
128922027|NCT00868790|464000877|FG004|Period 4|Abnormal ALT/AST|0|||
128922028|NCT00868790|464000878|FG005|Period 4|Abnormal ALT/AST|0|||
128922029|NCT00868790|464000879|FG006|Period 4|Abnormal ALT/AST|0|||
128922030|NCT00868790|464000880|FG007|Period 4|Abnormal ALT/AST|0|||
128922031|NCT00868790|464000881|FG008|Period 4|Abnormal ALT/AST|0|||
128922032|NCT00868790|464000882|FG009|Period 4|Abnormal ALT/AST|0|||
128922033|NCT00868790|464000883|FG010|Period 4|Abnormal ALT/AST|0|||
128922034|NCT00868790|464000884|FG011|Period 4|Abnormal ALT/AST|0|||
128922035|NCT00868790|464000885|FG012|Period 4|Abnormal ALT/AST|0|||
129216321|NCT00724698|465092883|FG000|Overall Study|Adverse Event|9|||
128922036|NCT00868790|464000886|FG013|Period 4|Abnormal ALT/AST|0|||
128922037|NCT00868790|464000873|FG000|Post-study|Withdrawal by Subject|0|||
128922038|NCT00868790|464000874|FG001|Post-study|Withdrawal by Subject|0|||
128922039|NCT00868790|464000875|FG002|Post-study|Withdrawal by Subject|0|||
128922040|NCT00868790|464000876|FG003|Post-study|Withdrawal by Subject|0|||
128922041|NCT00868790|464000877|FG004|Post-study|Withdrawal by Subject|1|||
128922042|NCT00868790|464000878|FG005|Post-study|Withdrawal by Subject|0|||
128922043|NCT00868790|464000879|FG006|Post-study|Withdrawal by Subject|0|||
128922044|NCT00868790|464000880|FG007|Post-study|Withdrawal by Subject|0|||
128922045|NCT00868790|464000881|FG008|Post-study|Withdrawal by Subject|0|||
128922046|NCT00868790|464000882|FG009|Post-study|Withdrawal by Subject|0|||
128922047|NCT00868790|464000883|FG010|Post-study|Withdrawal by Subject|0|||
128922048|NCT00868790|464000884|FG011|Post-study|Withdrawal by Subject|0|||
128922049|NCT00868790|464000885|FG012|Post-study|Withdrawal by Subject|0|||
128922050|NCT00868790|464000886|FG013|Post-study|Withdrawal by Subject|0|||
128922051|NCT00868790|464000873|FG000|Post-study|Excluded Medication|0|||
128922052|NCT00868790|464000874|FG001|Post-study|Excluded Medication|0|||
128922053|NCT00868790|464000875|FG002|Post-study|Excluded Medication|0|||
128922054|NCT00868790|464000876|FG003|Post-study|Excluded Medication|0|||
128922055|NCT00868790|464000877|FG004|Post-study|Excluded Medication|0|||
128922056|NCT00868790|464000878|FG005|Post-study|Excluded Medication|0|||
128922057|NCT00868790|464000879|FG006|Post-study|Excluded Medication|0|||
128922058|NCT00868790|464000880|FG007|Post-study|Excluded Medication|2|||
128922059|NCT00868790|464000881|FG008|Post-study|Excluded Medication|0|||
128922060|NCT00868790|464000882|FG009|Post-study|Excluded Medication|1|||
128922061|NCT00868790|464000883|FG010|Post-study|Excluded Medication|0|||
128922062|NCT00868790|464000884|FG011|Post-study|Excluded Medication|0|||
128922063|NCT00868790|464000885|FG012|Post-study|Excluded Medication|0|||
128922064|NCT00868790|464000886|FG013|Post-study|Excluded Medication|0|||
128922065|NCT03377634|464000890|FG000|Study Period|Adverse Event|1|||
128922066|NCT03377634|464000891|FG001|Study Period|Adverse Event|0|||
128922067|NCT03377634|464000890|FG000|Study Period|Withdrawal by Subject|1|||
128922068|NCT03377634|464000891|FG001|Study Period|Withdrawal by Subject|0|||
128922069|NCT03040024|464000892|FG000|Overall Study|Adverse Event|0|||
128922070|NCT03040024|464000893|FG001|Overall Study|Adverse Event|1|||
128922071|NCT03040024|464000894|FG002|Overall Study|Adverse Event|0|||
128922072|NCT03040024|464000892|FG000|Overall Study|Death|0|||
128922073|NCT03040024|464000893|FG001|Overall Study|Death|1|||
128922074|NCT03040024|464000894|FG002|Overall Study|Death|0|||
128922075|NCT03040024|464000892|FG000|Overall Study|Physician Decision|0|||
128922076|NCT03040024|464000893|FG001|Overall Study|Physician Decision|0|||
128922077|NCT03040024|464000894|FG002|Overall Study|Physician Decision|1|||
128922078|NCT01526148|464000896|FG000|Overall Study|Adverse Event|6|||
128922079|NCT01526148|464000897|FG001|Overall Study|Adverse Event|5|||
128922080|NCT01526148|464000896|FG000|Overall Study|Lost to Follow-up|3|||
128922081|NCT01526148|464000897|FG001|Overall Study|Lost to Follow-up|6|||
128922082|NCT01526148|464000896|FG000|Overall Study|Withdrawal by Subject|2|||
128922083|NCT01526148|464000897|FG001|Overall Study|Withdrawal by Subject|0|||
128922084|NCT01526148|464000896|FG000|Overall Study|Unstable Medical Condition|1|||
128922085|NCT01526148|464000897|FG001|Overall Study|Unstable Medical Condition|0|||
128922086|NCT01526148|464000896|FG000|Overall Study|Unable to discontinue concomitant med|1|||
128922087|NCT01526148|464000897|FG001|Overall Study|Unable to discontinue concomitant med|0|||
128922088|NCT01526148|464000896|FG000|Overall Study|Moved out of state|1|||
128922089|NCT01526148|464000897|FG001|Overall Study|Moved out of state|0|||
128922090|NCT01526148|464000896|FG000|Overall Study|Incarcerated|0|||
128922091|NCT01526148|464000897|FG001|Overall Study|Incarcerated|2|||
128922092|NCT01275222|464000898|FG000|Phase l by Treatment|Adverse Event|1|||
128922093|NCT01275222|464000899|FG001|Phase l by Treatment|Adverse Event|4|||
128922094|NCT01275222|464000900|FG002|Phase l by Treatment|Adverse Event|2|||
128922095|NCT01275222|464000901|FG003|Phase l by Treatment|Adverse Event|3|||
128922096|NCT01275222|464000902|FG004|Phase l by Treatment|Adverse Event|0|||
128922097|NCT01275222|464000903|FG005|Phase l by Treatment|Adverse Event|0|||
128922098|NCT01275222|464000898|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
128922099|NCT01275222|464000899|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
128922100|NCT01275222|464000900|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
128922101|NCT01275222|464000901|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
128922102|NCT01275222|464000902|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
128922103|NCT01275222|464000903|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
128922104|NCT01275222|464000898|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
128922105|NCT01275222|464000899|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
128700123|NCT00674700|463201504|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
128922106|NCT01275222|464000900|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
128922107|NCT01275222|464000901|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
128922108|NCT01275222|464000902|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
128922109|NCT01275222|464000903|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
128922110|NCT01275222|464000898|FG000|Phase l by Treatment|Disease progression|12|||
128922111|NCT01275222|464000899|FG001|Phase l by Treatment|Disease progression|8|||
128922112|NCT01275222|464000900|FG002|Phase l by Treatment|Disease progression|2|||
128922113|NCT01275222|464000901|FG003|Phase l by Treatment|Disease progression|5|||
128922114|NCT01275222|464000902|FG004|Phase l by Treatment|Disease progression|0|||
128922115|NCT01275222|464000903|FG005|Phase l by Treatment|Disease progression|0|||
128922116|NCT01275222|464000898|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
128922117|NCT01275222|464000899|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
128922118|NCT01275222|464000900|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
128922119|NCT01275222|464000901|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
128922120|NCT01275222|464000902|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
128922121|NCT01275222|464000903|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
128922122|NCT01275222|464000898|FG000|Phase l by Treatment|Death|0|||
128922123|NCT01275222|464000899|FG001|Phase l by Treatment|Death|1|||
128922124|NCT01275222|464000900|FG002|Phase l by Treatment|Death|0|||
128922125|NCT01275222|464000901|FG003|Phase l by Treatment|Death|1|||
128922126|NCT01275222|464000902|FG004|Phase l by Treatment|Death|0|||
128922127|NCT01275222|464000903|FG005|Phase l by Treatment|Death|0|||
128922128|NCT01275222|464000898|FG000|Phase ll by Stratum|Adverse Event|0|||
128922129|NCT01275222|464000899|FG001|Phase ll by Stratum|Adverse Event|0|||
128922130|NCT01275222|464000900|FG002|Phase ll by Stratum|Adverse Event|0|||
128922131|NCT01275222|464000901|FG003|Phase ll by Stratum|Adverse Event|0|||
128922132|NCT01275222|464000902|FG004|Phase ll by Stratum|Adverse Event|2|||
128922133|NCT01275222|464000903|FG005|Phase ll by Stratum|Adverse Event|10|||
128922134|NCT01275222|464000898|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
128922135|NCT01275222|464000899|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
128922136|NCT01275222|464000900|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
128922137|NCT01275222|464000901|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
128922138|NCT01275222|464000902|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
128922139|NCT01275222|464000903|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
128922140|NCT01275222|464000898|FG000|Phase ll by Stratum|Disease progression|0|||
128922141|NCT01275222|464000899|FG001|Phase ll by Stratum|Disease progression|0|||
128922142|NCT01275222|464000900|FG002|Phase ll by Stratum|Disease progression|0|||
128922143|NCT01275222|464000901|FG003|Phase ll by Stratum|Disease progression|0|||
128922144|NCT01275222|464000902|FG004|Phase ll by Stratum|Disease progression|23|||
128922145|NCT01275222|464000903|FG005|Phase ll by Stratum|Disease progression|31|||
128922146|NCT01275222|464000898|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
128922147|NCT01275222|464000899|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
128922148|NCT01275222|464000900|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
128922149|NCT01275222|464000901|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
128922150|NCT01275222|464000902|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
128922151|NCT01275222|464000903|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
128922152|NCT01275222|464000898|FG000|Phase ll by Stratum|Death|0|||
128922153|NCT01275222|464000899|FG001|Phase ll by Stratum|Death|0|||
128922154|NCT01275222|464000900|FG002|Phase ll by Stratum|Death|0|||
128922155|NCT01275222|464000901|FG003|Phase ll by Stratum|Death|0|||
128922156|NCT01275222|464000902|FG004|Phase ll by Stratum|Death|1|||
128922157|NCT01275222|464000903|FG005|Phase ll by Stratum|Death|1|||
128922158|NCT00591734|464000904|FG000|Overall Study|Lack of Efficacy|35|||
128922159|NCT00591734|464000904|FG000|Overall Study|Adverse Event|5|||
128922160|NCT00591734|464000904|FG000|Overall Study|Physician Decision|5|||
128922161|NCT00591734|464000904|FG000|Overall Study|Intercurrent Illness|8|||
128922162|NCT04672083|464000905|FG000|Overall Study|Lost to Follow-up|1|||
128922163|NCT04672083|464000906|FG001|Overall Study|Lost to Follow-up|0|||
128922164|NCT04672083|464000907|FG002|Overall Study|Lost to Follow-up|0|||
128922165|NCT04672083|464000908|FG003|Overall Study|Lost to Follow-up|0|||
128922166|NCT04672083|464000909|FG004|Overall Study|Lost to Follow-up|0|||
128922167|NCT01661790|464000910|FG000|Overall Study|Lost to Follow-up|0|||
128922168|NCT01661790|464000911|FG001|Overall Study|Lost to Follow-up|2|||
128922169|NCT02048904|464000912|FG000|Overall Study|Withdrawal by Subject|7|||
128922170|NCT02048904|464000912|FG000|Overall Study|Physician Decision|70|||
128922171|NCT00784758|464000913|FG000|Overall Study|Withdrawal by Subject|3|||
128922172|NCT00784758|464000914|FG001|Overall Study|Withdrawal by Subject|0|||
128922173|NCT00784758|464000913|FG000|Overall Study|Adverse Event|1|||
128922174|NCT00784758|464000914|FG001|Overall Study|Adverse Event|0|||
128922175|NCT00891202|464000915|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
128922176|NCT00891202|464000916|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
128922177|NCT00891202|464000917|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
128922178|NCT00891202|464000918|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
128922179|NCT00891202|464000915|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
128922180|NCT00891202|464000916|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
128922181|NCT00891202|464000917|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
128922182|NCT00891202|464000918|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
128922183|NCT00891202|464000915|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
128922184|NCT00891202|464000916|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
128922185|NCT00891202|464000917|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
128922186|NCT00891202|464000918|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
128922187|NCT00891202|464000915|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
128922188|NCT00891202|464000916|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
128922189|NCT00891202|464000917|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
128922190|NCT00891202|464000918|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
128922191|NCT01291017|464000921|FG000|Overall Study|Lost to Follow-up|2|||
128922192|NCT01291017|464000921|FG000|Overall Study|Withdrawal by Subject|3|||
128922193|NCT04980391|464000922|FG000|Overall Study|Death|0|||
128922194|NCT04980391|464000923|FG001|Overall Study|Death|0|||
128922195|NCT04980391|464000924|FG002|Overall Study|Death|1|||
128922196|NCT04980391|464000925|FG003|Overall Study|Death|1|||
128922197|NCT04980391|464000922|FG000|Overall Study|Lost to Follow-up|3|||
128922198|NCT04980391|464000923|FG001|Overall Study|Lost to Follow-up|3|||
128922199|NCT04980391|464000924|FG002|Overall Study|Lost to Follow-up|2|||
128922200|NCT04980391|464000925|FG003|Overall Study|Lost to Follow-up|3|||
128922201|NCT04980391|464000922|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
128922202|NCT04980391|464000923|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
129029388|NCT01899053|464398410|FG013|Overall Study|Withdrawal by Subject|1|||
128700124|NCT00674700|463201505|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
128700125|NCT00674700|463201503|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
128700126|NCT00674700|463201504|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
128700127|NCT00674700|463201505|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
128700128|NCT00395304|463201506|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128700129|NCT00395304|463201507|FG001|Treatment Period 1|Withdrawal by Subject|3|||
128700130|NCT00395304|463201508|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128700131|NCT00395304|463201509|FG003|Treatment Period 1|Withdrawal by Subject|2|||
128700132|NCT00395304|463201510|FG004|Treatment Period 1|Withdrawal by Subject|1|||
128700133|NCT00395304|463201511|FG005|Treatment Period 1|Withdrawal by Subject|1|||
128700134|NCT00395304|463201506|FG000|Treatment Period 1|Lost to Follow-up|1|||
128700135|NCT00395304|463201507|FG001|Treatment Period 1|Lost to Follow-up|0|||
128700136|NCT00395304|463201508|FG002|Treatment Period 1|Lost to Follow-up|0|||
128700137|NCT00395304|463201509|FG003|Treatment Period 1|Lost to Follow-up|1|||
128700138|NCT00395304|463201510|FG004|Treatment Period 1|Lost to Follow-up|0|||
128700139|NCT00395304|463201511|FG005|Treatment Period 1|Lost to Follow-up|1|||
128700140|NCT00395304|463201506|FG000|Treatment Period 1|Physician Decision|0|||
128700141|NCT00395304|463201507|FG001|Treatment Period 1|Physician Decision|1|||
128700142|NCT00395304|463201508|FG002|Treatment Period 1|Physician Decision|0|||
128700143|NCT00395304|463201509|FG003|Treatment Period 1|Physician Decision|0|||
128700144|NCT00395304|463201510|FG004|Treatment Period 1|Physician Decision|0|||
128700145|NCT00395304|463201511|FG005|Treatment Period 1|Physician Decision|0|||
128700146|NCT00395304|463201506|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128700147|NCT00395304|463201507|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128700148|NCT00395304|463201508|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128700149|NCT00395304|463201509|FG003|Treatment Period 2|Withdrawal by Subject|1|||
128700150|NCT00395304|463201510|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128700151|NCT00395304|463201511|FG005|Treatment Period 2|Withdrawal by Subject|2|||
128700152|NCT00395304|463201506|FG000|Treatment Period 2|Lost to Follow-up|0|||
128700153|NCT00395304|463201507|FG001|Treatment Period 2|Lost to Follow-up|3|||
128700154|NCT00395304|463201508|FG002|Treatment Period 2|Lost to Follow-up|0|||
128700155|NCT00395304|463201509|FG003|Treatment Period 2|Lost to Follow-up|0|||
128700156|NCT00395304|463201510|FG004|Treatment Period 2|Lost to Follow-up|0|||
128700157|NCT00395304|463201511|FG005|Treatment Period 2|Lost to Follow-up|0|||
128700158|NCT00395304|463201506|FG000|Treatment Period 2|Physician Decision|0|||
128700159|NCT00395304|463201507|FG001|Treatment Period 2|Physician Decision|0|||
128700160|NCT00395304|463201508|FG002|Treatment Period 2|Physician Decision|1|||
128700161|NCT00395304|463201509|FG003|Treatment Period 2|Physician Decision|0|||
128700162|NCT00395304|463201510|FG004|Treatment Period 2|Physician Decision|0|||
128700163|NCT00395304|463201511|FG005|Treatment Period 2|Physician Decision|0|||
128700164|NCT00395304|463201506|FG000|Treatment Period 2|Other|0|||
128700165|NCT00395304|463201507|FG001|Treatment Period 2|Other|1|||
128700166|NCT00395304|463201508|FG002|Treatment Period 2|Other|0|||
128700167|NCT00395304|463201509|FG003|Treatment Period 2|Other|0|||
128700168|NCT00395304|463201510|FG004|Treatment Period 2|Other|0|||
128700169|NCT00395304|463201511|FG005|Treatment Period 2|Other|0|||
128700170|NCT00395304|463201506|FG000|Treatment Period 3|Withdrawal by Subject|0|||
128700171|NCT00395304|463201507|FG001|Treatment Period 3|Withdrawal by Subject|0|||
128700172|NCT00395304|463201508|FG002|Treatment Period 3|Withdrawal by Subject|0|||
128700173|NCT00395304|463201509|FG003|Treatment Period 3|Withdrawal by Subject|1|||
128700174|NCT00395304|463201510|FG004|Treatment Period 3|Withdrawal by Subject|0|||
128700175|NCT00395304|463201511|FG005|Treatment Period 3|Withdrawal by Subject|1|||
128700176|NCT00395304|463201506|FG000|Treatment Period 3|Lost to Follow-up|1|||
128700177|NCT00395304|463201507|FG001|Treatment Period 3|Lost to Follow-up|1|||
128700178|NCT00395304|463201508|FG002|Treatment Period 3|Lost to Follow-up|0|||
128700179|NCT00395304|463201509|FG003|Treatment Period 3|Lost to Follow-up|0|||
128700180|NCT00395304|463201510|FG004|Treatment Period 3|Lost to Follow-up|0|||
128700181|NCT00395304|463201511|FG005|Treatment Period 3|Lost to Follow-up|0|||
128700182|NCT00395304|463201506|FG000|Treatment Period 3|Physician Decision|0|||
128700183|NCT00395304|463201507|FG001|Treatment Period 3|Physician Decision|1|||
128700184|NCT00395304|463201508|FG002|Treatment Period 3|Physician Decision|0|||
128700185|NCT00395304|463201509|FG003|Treatment Period 3|Physician Decision|0|||
128700186|NCT00395304|463201510|FG004|Treatment Period 3|Physician Decision|0|||
128700187|NCT00395304|463201511|FG005|Treatment Period 3|Physician Decision|0|||
128700188|NCT00395304|463201506|FG000|Treatment Period 3|Other|0|||
128700189|NCT00395304|463201507|FG001|Treatment Period 3|Other|0|||
128700190|NCT00395304|463201508|FG002|Treatment Period 3|Other|0|||
128700191|NCT00395304|463201509|FG003|Treatment Period 3|Other|1|||
128700192|NCT00395304|463201510|FG004|Treatment Period 3|Other|0|||
128700193|NCT00395304|463201511|FG005|Treatment Period 3|Other|0|||
128700194|NCT03797014|463201513|FG000|Overall Study|Withdrawal by Subject|1|||
128700195|NCT03797014|463201513|FG000|Overall Study|Lost to Follow-up|1|||
128700196|NCT03797014|463201513|FG000|Overall Study|Protocol Violation|1|||
128700197|NCT01970397|463201514|FG000|Overall Study|Adverse Event|0|||
128700198|NCT01970397|463201515|FG001|Overall Study|Adverse Event|1|||
128700199|NCT01970397|463201514|FG000|Overall Study|Lost to Follow-up|0|||
128700200|NCT01970397|463201515|FG001|Overall Study|Lost to Follow-up|1|||
128700201|NCT01970397|463201514|FG000|Overall Study|Personal Reasons|1|||
128700202|NCT01970397|463201515|FG001|Overall Study|Personal Reasons|2|||
128700203|NCT01970397|463201514|FG000|Overall Study|Protocol Violation|1|||
128700204|NCT01970397|463201515|FG001|Overall Study|Protocol Violation|1|||
128700205|NCT01389817|463201518|FG000|Overall Study|Physician Decision|1|||
128700206|NCT01389817|463201519|FG001|Overall Study|Physician Decision|0|||
128700207|NCT01389817|463201518|FG000|Overall Study|Lost to Follow-up|1|||
128700208|NCT01389817|463201519|FG001|Overall Study|Lost to Follow-up|0|||
128700209|NCT01389817|463201518|FG000|Overall Study|Withdrawal by Subject|2|||
128700210|NCT01389817|463201519|FG001|Overall Study|Withdrawal by Subject|0|||
128700211|NCT02871297|463201522|FG000|Overall Study|Adverse Event|34|||
128700212|NCT02871297|463201522|FG000|Overall Study|Lack of Efficacy|10|||
128700213|NCT02871297|463201522|FG000|Overall Study|Non-compliance with study drug|15|||
128700214|NCT02871297|463201522|FG000|Overall Study|Protocol Violation|3|||
128700215|NCT02871297|463201522|FG000|Overall Study|Withdrawal by Subject|20|||
128700216|NCT02871297|463201522|FG000|Overall Study|Lost to Follow-up|13|||
128700217|NCT02871297|463201522|FG000|Overall Study|Rolled over to 13546A|2|||
128700218|NCT02871297|463201522|FG000|Overall Study|Other than specified|39|||
128700219|NCT04115839|463201523|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
128700220|NCT04115839|463201524|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
128700221|NCT04115839|463201525|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
128700222|NCT04115839|463201526|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
128766512|NCT02243631|463436549|FG000|Overall Study|no synovial fluid on second aspirate|0|||
128766513|NCT02243631|463436550|FG001|Overall Study|no synovial fluid on second aspirate|1|||
128766514|NCT01785628|463436553|FG000|Overall Study|Lost to Follow-up|2|||
128766515|NCT01785628|463436554|FG001|Overall Study|Lost to Follow-up|3|||
128766516|NCT00840996|463436555|FG000|Overall Study|Withdrawal by Subject|1|||
128922203|NCT04980391|464000924|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
128922204|NCT04980391|464000925|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
128922205|NCT04980391|464000922|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128922206|NCT04980391|464000923|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128922207|NCT04980391|464000924|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
128922208|NCT04980391|464000925|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128922209|NCT04980391|464000922|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
128922210|NCT04980391|464000923|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
128922211|NCT04980391|464000924|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
128922212|NCT04980391|464000925|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
128922213|NCT03690869|464000926|FG000|Overall Study|Adverse Event|0|||
128922214|NCT03690869|464000927|FG001|Overall Study|Adverse Event|0|||
128922215|NCT03690869|464000928|FG002|Overall Study|Adverse Event|0|||
128922216|NCT03690869|464000929|FG003|Overall Study|Adverse Event|1|||
128922217|NCT03690869|464000930|FG004|Overall Study|Adverse Event|0|||
128922218|NCT03690869|464000931|FG005|Overall Study|Adverse Event|0|||
128922219|NCT03690869|464000932|FG006|Overall Study|Adverse Event|0|||
128922220|NCT03690869|464000933|FG007|Overall Study|Adverse Event|1|||
128922221|NCT03690869|464000934|FG008|Overall Study|Adverse Event|0|||
128922222|NCT03690869|464000935|FG009|Overall Study|Adverse Event|1|||
128922223|NCT03690869|464000926|FG000|Overall Study|Death|1|||
128922224|NCT03690869|464000927|FG001|Overall Study|Death|1|||
128922225|NCT03690869|464000928|FG002|Overall Study|Death|1|||
128922226|NCT03690869|464000929|FG003|Overall Study|Death|4|||
128922227|NCT03690869|464000930|FG004|Overall Study|Death|2|||
128922228|NCT03690869|464000931|FG005|Overall Study|Death|5|||
128922229|NCT03690869|464000932|FG006|Overall Study|Death|3|||
128922230|NCT03690869|464000933|FG007|Overall Study|Death|2|||
128700223|NCT04115839|463201527|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
128700224|NCT04115839|463201528|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
128766517|NCT00840996|463436556|FG001|Overall Study|Withdrawal by Subject|0|||
128766518|NCT02746575|463436557|FG000|Overall Study|Surgery cancelled or time chaned|13|||
128766519|NCT02746575|463436557|FG000|Overall Study|Received epidural|10|||
128766520|NCT02746575|463436557|FG000|Overall Study|Withdrawal by Subject|3|||
128922231|NCT03690869|464000934|FG008|Overall Study|Death|0|||
128700225|NCT04115839|463201529|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
128700226|NCT04115839|463201523|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
128766521|NCT02746575|463436557|FG000|Overall Study|Bradycardia/hypotension|9|||
128766522|NCT02746575|463436557|FG000|Overall Study|Study paused|8|||
128922232|NCT03690869|464000935|FG009|Overall Study|Death|3|||
128922233|NCT03690869|464000926|FG000|Overall Study|Lost to Follow-up|0|||
129216322|NCT00724698|465092883|FG000|Overall Study|Failure of Therapy|4|||
128700227|NCT04115839|463201524|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
128922234|NCT03690869|464000927|FG001|Overall Study|Lost to Follow-up|0|||
128700228|NCT04115839|463201525|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
128922235|NCT03690869|464000928|FG002|Overall Study|Lost to Follow-up|1|||
128922236|NCT03690869|464000929|FG003|Overall Study|Lost to Follow-up|0|||
128922237|NCT03690869|464000930|FG004|Overall Study|Lost to Follow-up|0|||
128922238|NCT03690869|464000931|FG005|Overall Study|Lost to Follow-up|0|||
128922239|NCT03690869|464000932|FG006|Overall Study|Lost to Follow-up|0|||
128922240|NCT03690869|464000933|FG007|Overall Study|Lost to Follow-up|0|||
128922241|NCT03690869|464000934|FG008|Overall Study|Lost to Follow-up|0|||
128922242|NCT03690869|464000935|FG009|Overall Study|Lost to Follow-up|0|||
128922243|NCT03690869|464000926|FG000|Overall Study|Other Treatment|1|||
128922244|NCT03690869|464000927|FG001|Overall Study|Other Treatment|1|||
128922245|NCT03690869|464000928|FG002|Overall Study|Other Treatment|1|||
128922246|NCT03690869|464000929|FG003|Overall Study|Other Treatment|2|||
128922247|NCT03690869|464000930|FG004|Overall Study|Other Treatment|3|||
128922248|NCT03690869|464000931|FG005|Overall Study|Other Treatment|1|||
128922249|NCT03690869|464000932|FG006|Overall Study|Other Treatment|2|||
128922250|NCT03690869|464000933|FG007|Overall Study|Other Treatment|7|||
128922251|NCT03690869|464000934|FG008|Overall Study|Other Treatment|0|||
128922252|NCT03690869|464000935|FG009|Overall Study|Other Treatment|3|||
128922253|NCT03690869|464000926|FG000|Overall Study|Physician Decision|0|||
128922254|NCT03690869|464000927|FG001|Overall Study|Physician Decision|1|||
128922255|NCT03690869|464000928|FG002|Overall Study|Physician Decision|0|||
128922256|NCT03690869|464000929|FG003|Overall Study|Physician Decision|0|||
128922257|NCT03690869|464000930|FG004|Overall Study|Physician Decision|0|||
128922258|NCT03690869|464000931|FG005|Overall Study|Physician Decision|0|||
128922259|NCT03690869|464000932|FG006|Overall Study|Physician Decision|0|||
128922260|NCT03690869|464000933|FG007|Overall Study|Physician Decision|0|||
128922261|NCT03690869|464000934|FG008|Overall Study|Physician Decision|0|||
128922262|NCT03690869|464000935|FG009|Overall Study|Physician Decision|0|||
128922263|NCT03690869|464000926|FG000|Overall Study|Progressive Disease|1|||
128922264|NCT03690869|464000927|FG001|Overall Study|Progressive Disease|2|||
128922265|NCT03690869|464000928|FG002|Overall Study|Progressive Disease|0|||
128922266|NCT03690869|464000929|FG003|Overall Study|Progressive Disease|1|||
128922267|NCT03690869|464000930|FG004|Overall Study|Progressive Disease|0|||
128922268|NCT03690869|464000931|FG005|Overall Study|Progressive Disease|0|||
128922269|NCT03690869|464000932|FG006|Overall Study|Progressive Disease|0|||
128922270|NCT03690869|464000933|FG007|Overall Study|Progressive Disease|0|||
128922271|NCT03690869|464000934|FG008|Overall Study|Progressive Disease|1|||
128922272|NCT03690869|464000935|FG009|Overall Study|Progressive Disease|1|||
128922273|NCT03690869|464000926|FG000|Overall Study|Subject Decision|0|||
128922274|NCT03690869|464000927|FG001|Overall Study|Subject Decision|0|||
128922275|NCT03690869|464000928|FG002|Overall Study|Subject Decision|0|||
128922276|NCT03690869|464000929|FG003|Overall Study|Subject Decision|1|||
128922277|NCT03690869|464000930|FG004|Overall Study|Subject Decision|0|||
128922278|NCT03690869|464000931|FG005|Overall Study|Subject Decision|0|||
128922279|NCT03690869|464000932|FG006|Overall Study|Subject Decision|0|||
128922280|NCT03690869|464000933|FG007|Overall Study|Subject Decision|1|||
128922281|NCT03690869|464000934|FG008|Overall Study|Subject Decision|0|||
128922282|NCT03690869|464000935|FG009|Overall Study|Subject Decision|0|||
128922283|NCT02732951|464003233|FG000|Overall Study|Other than listed|1|||
128922284|NCT02732951|464003234|FG001|Overall Study|Other than listed|0|||
128922285|NCT02732951|464003233|FG000|Overall Study|Lost to Follow-up|0|||
128922286|NCT02732951|464003234|FG001|Overall Study|Lost to Follow-up|1|||
128922287|NCT02732951|464003233|FG000|Overall Study|Adverse Event|4|||
128922288|NCT02732951|464003234|FG001|Overall Study|Adverse Event|4|||
128922289|NCT02732951|464003233|FG000|Overall Study|Protocol Violation|0|||
128922290|NCT02732951|464003234|FG001|Overall Study|Protocol Violation|1|||
128922291|NCT04840667|464003236|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
128922292|NCT05047523|464003247|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
128922293|NCT05047523|464003248|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
128922294|NCT05047523|464003249|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
128922295|NCT05047523|464003250|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
128922296|NCT05047523|464003251|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
128922297|NCT05047523|464003252|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
128922298|NCT05047523|464003247|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
128922299|NCT05047523|464003248|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
128922300|NCT05047523|464003249|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
128922301|NCT05047523|464003250|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
128922302|NCT05047523|464003251|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
128922303|NCT05047523|464003252|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
128922304|NCT05047523|464003247|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
128922305|NCT05047523|464003248|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
128922306|NCT05047523|464003249|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
128922307|NCT05047523|464003250|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
128922308|NCT05047523|464003251|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
128922309|NCT05047523|464003252|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
128922310|NCT05047523|464003247|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
128922311|NCT05047523|464003248|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128922312|NCT05047523|464003249|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128922313|NCT05047523|464003250|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128922314|NCT05047523|464003251|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128922315|NCT05047523|464003252|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
128922316|NCT05047523|464003247|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
128922317|NCT05047523|464003248|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
128922318|NCT05047523|464003249|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
128922319|NCT05047523|464003250|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
128922320|NCT05047523|464003251|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
128922321|NCT05047523|464003252|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
128922322|NCT05047523|464003247|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
128922323|NCT05047523|464003248|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
128922324|NCT05047523|464003249|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
128922325|NCT05047523|464003250|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
128922326|NCT05047523|464003251|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
128922327|NCT05047523|464003252|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
128922328|NCT00224016|464003253|FG000|Titration Period|Withdrawal by Subject|0|||
128922329|NCT00224016|464003254|FG001|Titration Period|Withdrawal by Subject|1|||
128922330|NCT00224016|464003253|FG000|Titration Period|Lost to Follow-up|1|||
128922331|NCT00224016|464003254|FG001|Titration Period|Lost to Follow-up|0|||
128922332|NCT00224016|464003253|FG000|Maintenance Period|Withdrawal by Subject|2|||
128922333|NCT00224016|464003254|FG001|Maintenance Period|Withdrawal by Subject|0|||
128922334|NCT00224016|464003253|FG000|Maintenance Period|Lost to Follow-up|0|||
128922335|NCT00224016|464003254|FG001|Maintenance Period|Lost to Follow-up|1|||
128922336|NCT01609933|464003255|FG000|Overall Study|Adverse Event|1|||
128922337|NCT01609933|464003255|FG000|Overall Study|Withdrawal by Subject|3|||
128922338|NCT01252966|464003256|FG000|Overall Study|Lost to Follow-up|16|||
128922339|NCT01252966|464003257|FG001|Overall Study|Lost to Follow-up|10|||
128922340|NCT01252966|464003256|FG000|Overall Study|Withdrawal by Subject|7|||
128922341|NCT01252966|464003257|FG001|Overall Study|Withdrawal by Subject|3|||
128922342|NCT00206726|464003265|FG000|Overall Study|Delayed recovery of blood counts|1|||
128922343|NCT00206726|464003265|FG000|Overall Study|Progressive disease or relapsed disease|18|||
128922344|NCT00206726|464003265|FG000|Overall Study|Placed on new protocol|1|||
128922345|NCT00206726|464003265|FG000|Overall Study|Bone marrow transplant|1|||
128922346|NCT00206726|464003265|FG000|Overall Study|Adverse Event|17|||
128922347|NCT00206726|464003265|FG000|Overall Study|Death|4|||
128922348|NCT00206726|464003265|FG000|Overall Study|Protocol Violation|1|||
128922349|NCT00206726|464003265|FG000|Overall Study|Withdrawal by Subject|8|||
128922350|NCT02612909|464003266|FG000|Phase 2|Withdrawal by Subject|2|||
128922351|NCT02612909|464003267|FG001|Phase 2|Withdrawal by Subject|5|||
128922352|NCT02612909|464003268|FG002|Phase 2|Withdrawal by Subject|0|||
128922353|NCT02612909|464003269|FG003|Phase 2|Withdrawal by Subject|0|||
128922354|NCT02612909|464003270|FG004|Phase 2|Withdrawal by Subject|0|||
128922355|NCT02612909|464003266|FG000|Phase 2|Pregnancy|0|||
128922356|NCT02612909|464003267|FG001|Phase 2|Pregnancy|0|||
128922357|NCT02612909|464003268|FG002|Phase 2|Pregnancy|1|||
128922358|NCT02612909|464003269|FG003|Phase 2|Pregnancy|0|||
128922359|NCT02612909|464003270|FG004|Phase 2|Pregnancy|0|||
128922360|NCT02612909|464003266|FG000|Phase 3|Withdrawal by Subject|0|||
128922361|NCT02612909|464003267|FG001|Phase 3|Withdrawal by Subject|0|||
128922362|NCT02612909|464003268|FG002|Phase 3|Withdrawal by Subject|0|||
128922363|NCT02612909|464003269|FG003|Phase 3|Withdrawal by Subject|1|||
128922364|NCT02612909|464003270|FG004|Phase 3|Withdrawal by Subject|0|||
128922365|NCT01719757|464003272|FG000|Overall Study|Adverse Event|38|||
128922366|NCT01719757|464003272|FG000|Overall Study|Withdrawal by Subject|15|||
128922367|NCT01719757|464003272|FG000|Overall Study|Lost to Follow-up|20|||
128922368|NCT01719757|464003272|FG000|Overall Study|Protocol Violation|1|||
128922369|NCT01719757|464003272|FG000|Overall Study|well controlled pain|27|||
128922370|NCT02626338|464003273|FG000|Overall Study|Lack of Efficacy|3|||
128922371|NCT02626338|464003274|FG001|Overall Study|Lack of Efficacy|2|||
128700229|NCT04115839|463201526|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
128700230|NCT04115839|463201527|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
128700231|NCT04115839|463201528|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
128700232|NCT04115839|463201529|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
128700233|NCT04115839|463201523|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
128922372|NCT02626338|464003275|FG002|Overall Study|Lack of Efficacy|0|||
128922373|NCT00450580|464003276|FG000|Overall Study|Adverse Event|5|||
128922374|NCT00450580|464003277|FG001|Overall Study|Adverse Event|7|||
128922375|NCT00450580|464003276|FG000|Overall Study|Lost to Follow-up|4|||
128922376|NCT00450580|464003277|FG001|Overall Study|Lost to Follow-up|5|||
128922377|NCT00450580|464003276|FG000|Overall Study|Withdrawal by Subject|2|||
128922378|NCT00450580|464003277|FG001|Overall Study|Withdrawal by Subject|2|||
128922379|NCT00450580|464003276|FG000|Overall Study|Protocol Violation|1|||
128922380|NCT00450580|464003277|FG001|Overall Study|Protocol Violation|1|||
128922381|NCT00450580|464003276|FG000|Overall Study|Protocol-defined virologic failure|1|||
128922382|NCT00450580|464003277|FG001|Overall Study|Protocol-defined virologic failure|0|||
128922383|NCT00450580|464003276|FG000|Overall Study|Could not comply with scheduled visits|1|||
128922384|NCT00450580|464003277|FG001|Overall Study|Could not comply with scheduled visits|0|||
128922385|NCT00450580|464003276|FG000|Overall Study|Patient went to Brazil|1|||
128922386|NCT00450580|464003277|FG001|Overall Study|Patient went to Brazil|0|||
128922387|NCT00450580|464003276|FG000|Overall Study|Patient could not swallow Norvir|1|||
128922388|NCT00450580|464003277|FG001|Overall Study|Patient could not swallow Norvir|0|||
128922389|NCT00450580|464003276|FG000|Overall Study|Withdrawal due to pregnancy|0|||
128922390|NCT00450580|464003277|FG001|Overall Study|Withdrawal due to pregnancy|1|||
128922391|NCT00393718|464003278|FG000|Overall Study|Adverse Event|20|||
128922392|NCT00393718|464003279|FG001|Overall Study|Adverse Event|8|||
128922393|NCT00393718|464003278|FG000|Overall Study|Protocol Violation|1|||
128922394|NCT00393718|464003279|FG001|Overall Study|Protocol Violation|2|||
128922395|NCT00393718|464003278|FG000|Overall Study|Lack of Efficacy|10|||
128922396|NCT00393718|464003279|FG001|Overall Study|Lack of Efficacy|9|||
128922397|NCT00393718|464003278|FG000|Overall Study|Hypoglycaemia|3|||
128922398|NCT00393718|464003279|FG001|Overall Study|Hypoglycaemia|2|||
128922399|NCT00393718|464003278|FG000|Overall Study|Subject decision|5|||
128922400|NCT00393718|464003279|FG001|Overall Study|Subject decision|0|||
128922401|NCT00393718|464003278|FG000|Overall Study|Withdrawal of consent|2|||
128922402|NCT00393718|464003279|FG001|Overall Study|Withdrawal of consent|1|||
128922403|NCT00393718|464003278|FG000|Overall Study|Missed measurement|1|||
128922404|NCT00393718|464003279|FG001|Overall Study|Missed measurement|0|||
128922405|NCT00393718|464003278|FG000|Overall Study|Move|1|||
128922406|NCT00393718|464003279|FG001|Overall Study|Move|0|||
128922407|NCT03293654|464003280|FG000|Overall Study|Lost to Follow-up|0|||
128922408|NCT03293654|464003281|FG001|Overall Study|Lost to Follow-up|1|||
128922409|NCT03293654|464003282|FG002|Overall Study|Lost to Follow-up|0|||
128922410|NCT00391976|464003283|FG000|Overall Study|Adverse Event|0|||
128922411|NCT00391976|464003284|FG001|Overall Study|Adverse Event|0|||
128922412|NCT00391976|464003285|FG002|Overall Study|Adverse Event|1|||
128922413|NCT00391976|464003283|FG000|Overall Study|Withdrawal of consent|0|||
128922414|NCT00391976|464003284|FG001|Overall Study|Withdrawal of consent|1|||
128922415|NCT00391976|464003285|FG002|Overall Study|Withdrawal of consent|1|||
128922416|NCT00391976|464003283|FG000|Overall Study|Lost to Follow-up|1|||
128922417|NCT00391976|464003284|FG001|Overall Study|Lost to Follow-up|2|||
128922418|NCT00391976|464003285|FG002|Overall Study|Lost to Follow-up|0|||
128922419|NCT00391976|464003283|FG000|Overall Study|Inappropriate enrollment|1|||
128922420|NCT00391976|464003284|FG001|Overall Study|Inappropriate enrollment|1|||
128922421|NCT00391976|464003285|FG002|Overall Study|Inappropriate enrollment|0|||
128922422|NCT00391976|464003283|FG000|Overall Study|Protocol deviation/violation|4|||
128922423|NCT00391976|464003284|FG001|Overall Study|Protocol deviation/violation|2|||
128922424|NCT00391976|464003285|FG002|Overall Study|Protocol deviation/violation|1|||
128922425|NCT00391976|464003283|FG000|Overall Study|Recurrence/no eradication of infection|21|||
128922426|NCT00391976|464003284|FG001|Overall Study|Recurrence/no eradication of infection|19|||
128922427|NCT00391976|464003285|FG002|Overall Study|Recurrence/no eradication of infection|0|||
128922428|NCT00391976|464003283|FG000|Overall Study|Unable to classify|0|||
128922429|NCT00391976|464003284|FG001|Overall Study|Unable to classify|0|||
128922430|NCT00391976|464003285|FG002|Overall Study|Unable to classify|1|||
128922431|NCT00391976|464003283|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
128922432|NCT00391976|464003284|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
128922433|NCT00391976|464003285|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
128922434|NCT03093402|464003290|FG000|Overall Study|Lost to Follow-up|1|||
128922435|NCT03093402|464003291|FG001|Overall Study|Lost to Follow-up|0|||
128922436|NCT03093402|464003292|FG002|Overall Study|Lost to Follow-up|0|||
128922437|NCT03093402|464003293|FG003|Overall Study|Lost to Follow-up|0|||
128922438|NCT03093402|464003290|FG000|Overall Study|Withdrawal by Subject|3|||
128922439|NCT03093402|464003291|FG001|Overall Study|Withdrawal by Subject|3|||
128922440|NCT03093402|464003292|FG002|Overall Study|Withdrawal by Subject|0|||
128922441|NCT03093402|464003293|FG003|Overall Study|Withdrawal by Subject|1|||
128922442|NCT03093402|464003290|FG000|Overall Study|Withdrew prior to dosing|2|||
128922443|NCT03093402|464003291|FG001|Overall Study|Withdrew prior to dosing|1|||
128766523|NCT02746575|463436557|FG000|Overall Study|put on beta-blocker|3|||
128922444|NCT03093402|464003292|FG002|Overall Study|Withdrew prior to dosing|2|||
128922445|NCT03093402|464003293|FG003|Overall Study|Withdrew prior to dosing|3|||
128922446|NCT03093402|464003290|FG000|Overall Study|Ineligible for study|1|||
128922447|NCT03093402|464003291|FG001|Overall Study|Ineligible for study|0|||
128922448|NCT03093402|464003292|FG002|Overall Study|Ineligible for study|0|||
128922449|NCT03093402|464003293|FG003|Overall Study|Ineligible for study|0|||
128922450|NCT03093402|464003290|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
128922451|NCT03093402|464003291|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
128922452|NCT03093402|464003292|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
128922453|NCT03093402|464003293|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
128922454|NCT02886702|464003294|FG000|Overall Study|Other|4|||
128766524|NCT02746575|463436557|FG000|Overall Study|type of surgery|1|||
128922455|NCT02886702|464003295|FG001|Overall Study|Other|3|||
128922456|NCT02886702|464003296|FG002|Overall Study|Other|9|||
128922457|NCT02886702|464003294|FG000|Overall Study|Withdrawal by Subject|24|||
128700234|NCT04115839|463201524|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
128700235|NCT04115839|463201525|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
128700236|NCT04115839|463201526|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
128700237|NCT04115839|463201527|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
128700238|NCT04115839|463201528|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
128700239|NCT04115839|463201529|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
128700240|NCT04115839|463201523|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128700241|NCT04115839|463201524|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128700242|NCT04115839|463201525|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
128700243|NCT04115839|463201526|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128700244|NCT04115839|463201527|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128700245|NCT04115839|463201528|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128700246|NCT04115839|463201529|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
128700247|NCT04115839|463201523|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
128700248|NCT04115839|463201524|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
128700249|NCT04115839|463201525|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
128700250|NCT04115839|463201526|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
128700251|NCT04115839|463201527|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
128700252|NCT04115839|463201528|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
128700253|NCT04115839|463201529|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
128700254|NCT04115839|463201523|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
128700255|NCT04115839|463201524|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
128700256|NCT04115839|463201525|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
128700257|NCT04115839|463201526|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
128922458|NCT02886702|464003295|FG001|Overall Study|Withdrawal by Subject|18|||
128922459|NCT02886702|464003296|FG002|Overall Study|Withdrawal by Subject|22|||
128922460|NCT02886702|464003294|FG000|Overall Study|Significant Worsening of Condition|0|||
128922461|NCT02886702|464003295|FG001|Overall Study|Significant Worsening of Condition|1|||
128922462|NCT02886702|464003296|FG002|Overall Study|Significant Worsening of Condition|0|||
128922463|NCT02886702|464003294|FG000|Overall Study|Protocol Violation|2|||
128922464|NCT02886702|464003295|FG001|Overall Study|Protocol Violation|2|||
128922465|NCT02886702|464003296|FG002|Overall Study|Protocol Violation|1|||
128922466|NCT02886702|464003294|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128922467|NCT02886702|464003295|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128922468|NCT02886702|464003296|FG002|Overall Study|Non-Compliance With Study Drug|4|||
128922469|NCT02886702|464003294|FG000|Overall Study|Lost to Follow-up|11|||
128922470|NCT02886702|464003295|FG001|Overall Study|Lost to Follow-up|13|||
128922471|NCT02886702|464003296|FG002|Overall Study|Lost to Follow-up|8|||
128922472|NCT02886702|464003294|FG000|Overall Study|Lack of Efficacy|3|||
128922473|NCT02886702|464003295|FG001|Overall Study|Lack of Efficacy|4|||
128922474|NCT02886702|464003296|FG002|Overall Study|Lack of Efficacy|5|||
128922475|NCT02886702|464003294|FG000|Overall Study|Adverse Event|4|||
128922476|NCT02886702|464003295|FG001|Overall Study|Adverse Event|9|||
128922477|NCT02886702|464003296|FG002|Overall Study|Adverse Event|3|||
128922478|NCT02886702|464003294|FG000|Overall Study|Administrative Reasons|0|||
128922479|NCT02886702|464003295|FG001|Overall Study|Administrative Reasons|0|||
128922480|NCT02886702|464003296|FG002|Overall Study|Administrative Reasons|1|||
128922481|NCT00763009|464003297|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
128922482|NCT00891735|464003298|FG000|Overall Study|Adverse Event|2|||
128922483|NCT00891735|464003299|FG001|Overall Study|Adverse Event|0|||
128922484|NCT00891735|464003300|FG002|Overall Study|Adverse Event|2|||
128922485|NCT00891735|464003301|FG003|Overall Study|Adverse Event|0|||
128922486|NCT00891735|464003298|FG000|Overall Study|Death|8|||
128922487|NCT00891735|464003299|FG001|Overall Study|Death|5|||
128922488|NCT00891735|464003300|FG002|Overall Study|Death|4|||
128700258|NCT04115839|463201527|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
128700259|NCT04115839|463201528|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
128700260|NCT04115839|463201529|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
128700261|NCT02034110|463201530|FG000|Overall Study|Physician Decision|0|||
128700262|NCT02034110|463201531|FG001|Overall Study|Physician Decision|0|||
128700263|NCT02034110|463201532|FG002|Overall Study|Physician Decision|0|||
128700264|NCT02034110|463201533|FG003|Overall Study|Physician Decision|0|||
128700265|NCT02034110|463201534|FG004|Overall Study|Physician Decision|2|||
128700266|NCT02034110|463201535|FG005|Overall Study|Physician Decision|0|||
128700267|NCT02034110|463201536|FG006|Overall Study|Physician Decision|1|||
128700268|NCT02034110|463201537|FG007|Overall Study|Physician Decision|0|||
128922489|NCT00891735|464003301|FG003|Overall Study|Death|5|||
128922490|NCT00891735|464003298|FG000|Overall Study|Lost to Follow-up|2|||
128922491|NCT00891735|464003299|FG001|Overall Study|Lost to Follow-up|2|||
128922492|NCT00891735|464003300|FG002|Overall Study|Lost to Follow-up|2|||
128922493|NCT00891735|464003301|FG003|Overall Study|Lost to Follow-up|2|||
128922494|NCT00891735|464003298|FG000|Overall Study|Physician's decision to withdraw patient|1|||
129029389|NCT01899053|464398397|FG000|Overall Study|Protocol Violation|0|||
129029390|NCT01899053|464398398|FG001|Overall Study|Protocol Violation|0|||
128922495|NCT00891735|464003299|FG001|Overall Study|Physician's decision to withdraw patient|0|||
128922496|NCT00891735|464003300|FG002|Overall Study|Physician's decision to withdraw patient|0|||
128922497|NCT00891735|464003301|FG003|Overall Study|Physician's decision to withdraw patient|0|||
128922498|NCT00891735|464003298|FG000|Overall Study|Patient's decision to withdraw|4|||
128922499|NCT00891735|464003299|FG001|Overall Study|Patient's decision to withdraw|9|||
128922500|NCT00891735|464003300|FG002|Overall Study|Patient's decision to withdraw|4|||
128922501|NCT00891735|464003301|FG003|Overall Study|Patient's decision to withdraw|8|||
128922502|NCT00158184|464003309|FG000|Overall Study|personal issues|3|||
128922503|NCT00158184|464003310|FG001|Overall Study|personal issues|1|||
128922504|NCT00158184|464003309|FG000|Overall Study|failed for follow unit/study rules|2|||
128922505|NCT00158184|464003310|FG001|Overall Study|failed for follow unit/study rules|0|||
128922506|NCT00158184|464003309|FG000|Overall Study|Adverse Event|1|||
128922507|NCT00158184|464003310|FG001|Overall Study|Adverse Event|1|||
128922508|NCT05340504|464003311|FG000|Overall Study|Withdrawal by Subject|1|||
128922509|NCT05340504|464003312|FG001|Overall Study|Withdrawal by Subject|0|||
128922510|NCT02393209|464003315|FG000|Overall Study|Study Terminated by Sponsor|1|||
128922511|NCT02393209|464003316|FG001|Overall Study|Study Terminated by Sponsor|1|||
128922512|NCT02393209|464003317|FG002|Overall Study|Study Terminated by Sponsor|0|||
128922513|NCT02393209|464003318|FG003|Overall Study|Study Terminated by Sponsor|0|||
128922514|NCT02393209|464003315|FG000|Overall Study|Withdrawal by Patient|1|||
128922515|NCT02393209|464003316|FG001|Overall Study|Withdrawal by Patient|0|||
128922516|NCT02393209|464003317|FG002|Overall Study|Withdrawal by Patient|0|||
128922517|NCT02393209|464003318|FG003|Overall Study|Withdrawal by Patient|0|||
128922518|NCT02393209|464003315|FG000|Overall Study|Death|2|||
128922519|NCT02393209|464003316|FG001|Overall Study|Death|2|||
128922520|NCT02393209|464003317|FG002|Overall Study|Death|0|||
128922521|NCT02393209|464003318|FG003|Overall Study|Death|0|||
128922522|NCT02393209|464003315|FG000|Overall Study|Death due to Disease Progression|2|||
128922523|NCT02393209|464003316|FG001|Overall Study|Death due to Disease Progression|2|||
128922524|NCT02393209|464003317|FG002|Overall Study|Death due to Disease Progression|0|||
128922525|NCT02393209|464003318|FG003|Overall Study|Death due to Disease Progression|0|||
128922526|NCT02393209|464003315|FG000|Overall Study|Death from Legionella Infection|0|||
128922527|NCT02393209|464003316|FG001|Overall Study|Death from Legionella Infection|1|||
128922528|NCT02393209|464003317|FG002|Overall Study|Death from Legionella Infection|0|||
128922529|NCT02393209|464003318|FG003|Overall Study|Death from Legionella Infection|0|||
128922530|NCT02393209|464003315|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
128922531|NCT02393209|464003316|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
128922532|NCT02393209|464003317|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
128922533|NCT02393209|464003318|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
128922534|NCT02393209|464003315|FG000|Overall Study|Lost to Follow-up|0|||
128922535|NCT02393209|464003316|FG001|Overall Study|Lost to Follow-up|1|||
128922536|NCT02393209|464003317|FG002|Overall Study|Lost to Follow-up|0|||
128922537|NCT02393209|464003318|FG003|Overall Study|Lost to Follow-up|0|||
128922538|NCT03545282|464003319|FG000|Overall Study|Lost to Follow-up|15|||
128922539|NCT03545282|464003320|FG001|Overall Study|Lost to Follow-up|10|||
128922540|NCT03545282|464003319|FG000|Overall Study|Withdrawal by Subject|2|||
128922541|NCT03545282|464003320|FG001|Overall Study|Withdrawal by Subject|2|||
128922542|NCT00755079|464003321|FG000|Overall Study|Lost to Follow-up|1|||
128922543|NCT00755079|464003322|FG001|Overall Study|Lost to Follow-up|3|||
128700269|NCT02034110|463201530|FG000|Overall Study|Lost to Follow-up|1|||
128700270|NCT02034110|463201531|FG001|Overall Study|Lost to Follow-up|0|||
128922544|NCT00755079|464003321|FG000|Overall Study|Adverse Event|0|||
128922545|NCT00755079|464003322|FG001|Overall Study|Adverse Event|1|||
128922546|NCT00755079|464003321|FG000|Overall Study|Withdrawal by Subject|0|||
128922547|NCT00755079|464003322|FG001|Overall Study|Withdrawal by Subject|2|||
128922548|NCT02582671|464003323|FG000|Overall Study|Failure to return|1|||
128922549|NCT02582671|464003323|FG000|Overall Study|Other, not specified|1|||
128700271|NCT02034110|463201532|FG002|Overall Study|Lost to Follow-up|0|||
128700272|NCT02034110|463201533|FG003|Overall Study|Lost to Follow-up|0|||
128700273|NCT02034110|463201534|FG004|Overall Study|Lost to Follow-up|1|||
128700274|NCT02034110|463201535|FG005|Overall Study|Lost to Follow-up|0|||
128700275|NCT02034110|463201536|FG006|Overall Study|Lost to Follow-up|1|||
128700276|NCT02034110|463201537|FG007|Overall Study|Lost to Follow-up|0|||
128700277|NCT02034110|463201530|FG000|Overall Study|Withdrawal by Subject|5|||
128700278|NCT02034110|463201531|FG001|Overall Study|Withdrawal by Subject|7|||
128700279|NCT02034110|463201532|FG002|Overall Study|Withdrawal by Subject|0|||
128700280|NCT02034110|463201533|FG003|Overall Study|Withdrawal by Subject|3|||
128700281|NCT02034110|463201534|FG004|Overall Study|Withdrawal by Subject|7|||
128700282|NCT02034110|463201535|FG005|Overall Study|Withdrawal by Subject|0|||
128700283|NCT02034110|463201536|FG006|Overall Study|Withdrawal by Subject|3|||
128700284|NCT02034110|463201537|FG007|Overall Study|Withdrawal by Subject|1|||
128700285|NCT02034110|463201530|FG000|Overall Study|Study closed by sponsor|6|||
128700286|NCT02034110|463201531|FG001|Overall Study|Study closed by sponsor|2|||
128700287|NCT02034110|463201532|FG002|Overall Study|Study closed by sponsor|0|||
128700288|NCT02034110|463201533|FG003|Overall Study|Study closed by sponsor|6|||
128922550|NCT01287104|464003324|FG000|Overall Study|Patient developed progressive disease|1|||
128922551|NCT01287104|464003325|FG001|Overall Study|Patient developed progressive disease|1|||
128922552|NCT01287104|464003326|FG002|Overall Study|Patient developed progressive disease|3|||
128922553|NCT01287104|464003327|FG003|Overall Study|Patient developed progressive disease|2|||
128922554|NCT01287104|464003324|FG000|Overall Study|Donor anaphylaxis|0|||
128922555|NCT01287104|464003325|FG001|Overall Study|Donor anaphylaxis|1|||
128922556|NCT01287104|464003326|FG002|Overall Study|Donor anaphylaxis|0|||
128922557|NCT01287104|464003327|FG003|Overall Study|Donor anaphylaxis|1|||
128922558|NCT01287104|464003324|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
128922559|NCT01287104|464003325|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
128922560|NCT01287104|464003326|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
128922561|NCT01287104|464003327|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
128922562|NCT01287104|464003324|FG000|Overall Study|Low donor chimerism|0|||
128700289|NCT02034110|463201534|FG004|Overall Study|Study closed by sponsor|7|||
128700290|NCT02034110|463201535|FG005|Overall Study|Study closed by sponsor|0|||
128700291|NCT02034110|463201536|FG006|Overall Study|Study closed by sponsor|42|||
128700292|NCT02034110|463201537|FG007|Overall Study|Study closed by sponsor|0|||
128700293|NCT00621985|463201538|FG000|Dexamethasone Admission|Adverse Event|1|||
128700294|NCT01877265|463201542|FG000|Treatment Period 1|Sponsor Decision|0|||
128700295|NCT01877265|463201543|FG001|Treatment Period 1|Sponsor Decision|0|||
128700296|NCT01877265|463201544|FG002|Treatment Period 1|Sponsor Decision|1|||
128700297|NCT01877265|463201545|FG003|Treatment Period 1|Sponsor Decision|0|||
128700298|NCT01877265|463201546|FG004|Treatment Period 1|Sponsor Decision|0|||
128700299|NCT01877265|463201547|FG005|Treatment Period 1|Sponsor Decision|0|||
128700300|NCT01877265|463201542|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
128700301|NCT01877265|463201543|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
128700302|NCT01877265|463201544|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
128700303|NCT01877265|463201545|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
128700304|NCT01877265|463201546|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
128700305|NCT01877265|463201547|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
128700306|NCT01877265|463201542|FG000|Treatment Period 3|Lost to Follow-up|1|||
128700307|NCT01877265|463201543|FG001|Treatment Period 3|Lost to Follow-up|0|||
128922563|NCT01287104|464003325|FG001|Overall Study|Low donor chimerism|1|||
128922564|NCT01287104|464003326|FG002|Overall Study|Low donor chimerism|0|||
128922565|NCT01287104|464003327|FG003|Overall Study|Low donor chimerism|0|||
128922566|NCT01287104|464003324|FG000|Overall Study|NK cells did not meet release criteria|0|||
128922567|NCT01287104|464003325|FG001|Overall Study|NK cells did not meet release criteria|1|||
128922568|NCT01287104|464003326|FG002|Overall Study|NK cells did not meet release criteria|0|||
128922569|NCT01287104|464003327|FG003|Overall Study|NK cells did not meet release criteria|0|||
128922570|NCT03068715|464003332|FG000|Overall Study|No longer met inclusion criteria|1|||
128922571|NCT03068715|464003333|FG001|Overall Study|No longer met inclusion criteria|0|||
128922572|NCT01276288|464003334|FG000|Overall Study|Adverse Event|1|||
128922573|NCT01276288|464003335|FG001|Overall Study|Adverse Event|1|||
128922574|NCT01276288|464003336|FG002|Overall Study|Adverse Event|0|||
128922575|NCT01276288|464003337|FG003|Overall Study|Adverse Event|0|||
128922576|NCT01276288|464003334|FG000|Overall Study|not treated|1|||
128922577|NCT01276288|464003335|FG001|Overall Study|not treated|0|||
128922578|NCT01276288|464003336|FG002|Overall Study|not treated|0|||
128922579|NCT01276288|464003337|FG003|Overall Study|not treated|0|||
128922580|NCT00481065|464003339|FG000|Overall Study|Adverse event or death|1|||
128922581|NCT00481065|464003340|FG001|Overall Study|Adverse event or death|1|||
128922582|NCT00481065|464003341|FG002|Overall Study|Adverse event or death|3|||
128922583|NCT00481065|464003342|FG003|Overall Study|Adverse event or death|0|||
128922584|NCT00481065|464003343|FG004|Overall Study|Adverse event or death|2|||
128922585|NCT00481065|464003344|FG005|Overall Study|Adverse event or death|0|||
128922586|NCT00481065|464003345|FG006|Overall Study|Adverse event or death|1|||
128922587|NCT00481065|464003346|FG007|Overall Study|Adverse event or death|1|||
128922588|NCT00481065|464003339|FG000|Overall Study|Withdrawal by Subject|11|||
128922589|NCT00481065|464003340|FG001|Overall Study|Withdrawal by Subject|12|||
128922590|NCT00481065|464003341|FG002|Overall Study|Withdrawal by Subject|7|||
128922591|NCT00481065|464003342|FG003|Overall Study|Withdrawal by Subject|11|||
128922592|NCT00481065|464003343|FG004|Overall Study|Withdrawal by Subject|13|||
128922593|NCT00481065|464003344|FG005|Overall Study|Withdrawal by Subject|12|||
128922594|NCT00481065|464003345|FG006|Overall Study|Withdrawal by Subject|9|||
128922595|NCT00481065|464003346|FG007|Overall Study|Withdrawal by Subject|10|||
128922596|NCT00481065|464003339|FG000|Overall Study|Lost to Follow-up|4|||
128922597|NCT00481065|464003340|FG001|Overall Study|Lost to Follow-up|2|||
128922598|NCT00481065|464003341|FG002|Overall Study|Lost to Follow-up|4|||
128700308|NCT01877265|463201544|FG002|Treatment Period 3|Lost to Follow-up|0|||
128700309|NCT01877265|463201545|FG003|Treatment Period 3|Lost to Follow-up|0|||
128700310|NCT01877265|463201546|FG004|Treatment Period 3|Lost to Follow-up|0|||
128700311|NCT01877265|463201547|FG005|Treatment Period 3|Lost to Follow-up|0|||
128700312|NCT00691015|463201548|FG000|Overall Study|Refused further treatment|1|||
128700313|NCT04160195|463201551|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
128922599|NCT00481065|464003342|FG003|Overall Study|Lost to Follow-up|3|||
128922600|NCT00481065|464003343|FG004|Overall Study|Lost to Follow-up|3|||
128922601|NCT00481065|464003344|FG005|Overall Study|Lost to Follow-up|3|||
128922602|NCT00481065|464003345|FG006|Overall Study|Lost to Follow-up|2|||
128922603|NCT00481065|464003346|FG007|Overall Study|Lost to Follow-up|5|||
128922604|NCT00481065|464003339|FG000|Overall Study|Inappropriate enrollment|4|||
128922605|NCT00481065|464003340|FG001|Overall Study|Inappropriate enrollment|0|||
128700314|NCT04160195|463201552|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
128700315|NCT03535844|463201553|FG000|Overall Study|Withdrawal by Subject|0|||
128922606|NCT00481065|464003341|FG002|Overall Study|Inappropriate enrollment|2|||
128700316|NCT03535844|463201554|FG001|Overall Study|Withdrawal by Subject|1|||
128700317|NCT00160693|463201556|FG000|Overall Study|Adverse Event|97|||
128700318|NCT00160693|463201556|FG000|Overall Study|Lack of Efficacy|30|||
128700319|NCT00160693|463201556|FG000|Overall Study|Protocol Violation|24|||
128700320|NCT00160693|463201556|FG000|Overall Study|Lost to Follow-up|15|||
128700321|NCT00160693|463201556|FG000|Overall Study|Withdrawal by Subject|54|||
128700322|NCT00160693|463201556|FG000|Overall Study|Study terminated by sponsor|15|||
128700323|NCT03706079|463201559|FG000|Predecessor Study|Death|0|||
128700324|NCT03706079|463201560|FG001|Predecessor Study|Death|2|||
128700325|NCT03706079|463201561|FG002|Predecessor Study|Death|0|||
128922607|NCT00481065|464003342|FG003|Overall Study|Inappropriate enrollment|0|||
128922608|NCT00481065|464003343|FG004|Overall Study|Inappropriate enrollment|2|||
128922609|NCT00481065|464003344|FG005|Overall Study|Inappropriate enrollment|1|||
128922610|NCT00481065|464003345|FG006|Overall Study|Inappropriate enrollment|0|||
128922611|NCT00481065|464003346|FG007|Overall Study|Inappropriate enrollment|1|||
128922612|NCT00481065|464003339|FG000|Overall Study|Administrative reason|0|||
128922613|NCT00481065|464003340|FG001|Overall Study|Administrative reason|0|||
128922614|NCT00481065|464003341|FG002|Overall Study|Administrative reason|0|||
128922615|NCT00481065|464003342|FG003|Overall Study|Administrative reason|0|||
128922616|NCT00481065|464003343|FG004|Overall Study|Administrative reason|0|||
128922617|NCT00481065|464003344|FG005|Overall Study|Administrative reason|2|||
128922618|NCT00481065|464003345|FG006|Overall Study|Administrative reason|1|||
128922619|NCT00481065|464003346|FG007|Overall Study|Administrative reason|0|||
128922620|NCT00481065|464003339|FG000|Overall Study|Protocol Violation|2|||
128922621|NCT00481065|464003340|FG001|Overall Study|Protocol Violation|1|||
128922622|NCT00481065|464003341|FG002|Overall Study|Protocol Violation|1|||
128700326|NCT03706079|463201562|FG003|Predecessor Study|Death|1|||
128700327|NCT03706079|463201563|FG004|Predecessor Study|Death|0|||
128766525|NCT02746575|463436557|FG000|Overall Study|typ of surgery|1|||
128766526|NCT02746575|463436557|FG000|Overall Study|PI unavailable|1|||
128766527|NCT02746575|463436557|FG000|Overall Study|Unknown history of CVA|1|||
128766528|NCT00957931|463436560|FG000|Overall Study|Death|4|||
128766529|NCT00857805|463436561|FG000|Overall Study|Withdrawal by Subject|1|||
128766530|NCT00857805|463436562|FG001|Overall Study|Withdrawal by Subject|1|||
128766531|NCT04867785|463436563|FG000|Overall Study|Adverse Event|1|||
128766532|NCT04867785|463436564|FG001|Overall Study|Adverse Event|0|||
128766533|NCT04867785|463436565|FG002|Overall Study|Adverse Event|1|||
128766534|NCT04867785|463436566|FG003|Overall Study|Adverse Event|0|||
128766535|NCT04867785|463436567|FG004|Overall Study|Adverse Event|0|||
128766536|NCT04867785|463436568|FG005|Overall Study|Adverse Event|0|||
128766537|NCT04867785|463436569|FG006|Overall Study|Adverse Event|0|||
128766538|NCT04867785|463436570|FG007|Overall Study|Adverse Event|2|||
128766539|NCT04867785|463436563|FG000|Overall Study|Lost to Follow-up|4|||
128766540|NCT04867785|463436564|FG001|Overall Study|Lost to Follow-up|4|||
128766541|NCT04867785|463436565|FG002|Overall Study|Lost to Follow-up|3|||
128766542|NCT04867785|463436566|FG003|Overall Study|Lost to Follow-up|2|||
128766543|NCT04867785|463436567|FG004|Overall Study|Lost to Follow-up|0|||
128766544|NCT04867785|463436568|FG005|Overall Study|Lost to Follow-up|1|||
128766545|NCT04867785|463436569|FG006|Overall Study|Lost to Follow-up|0|||
128766546|NCT04867785|463436570|FG007|Overall Study|Lost to Follow-up|1|||
128766547|NCT04867785|463436563|FG000|Overall Study|Withdrawal by Subject|6|||
128922623|NCT00481065|464003342|FG003|Overall Study|Protocol Violation|1|||
128922624|NCT00481065|464003343|FG004|Overall Study|Protocol Violation|2|||
128922625|NCT00481065|464003344|FG005|Overall Study|Protocol Violation|6|||
128922626|NCT00481065|464003345|FG006|Overall Study|Protocol Violation|3|||
128922627|NCT00481065|464003346|FG007|Overall Study|Protocol Violation|2|||
128922628|NCT00481065|464003339|FG000|Overall Study|Unable to classify|0|||
128700328|NCT03706079|463201564|FG005|Predecessor Study|Death|0|||
128700329|NCT03706079|463201559|FG000|Predecessor Study|Lost to Follow-up|5|||
128700330|NCT03706079|463201560|FG001|Predecessor Study|Lost to Follow-up|2|||
128766548|NCT04867785|463436564|FG001|Overall Study|Withdrawal by Subject|2|||
128766549|NCT04867785|463436565|FG002|Overall Study|Withdrawal by Subject|2|||
128766550|NCT04867785|463436566|FG003|Overall Study|Withdrawal by Subject|1|||
128766551|NCT04867785|463436567|FG004|Overall Study|Withdrawal by Subject|2|||
128766552|NCT04867785|463436568|FG005|Overall Study|Withdrawal by Subject|0|||
128766553|NCT04867785|463436569|FG006|Overall Study|Withdrawal by Subject|2|||
128922629|NCT00481065|464003340|FG001|Overall Study|Unable to classify|1|||
128700331|NCT03706079|463201561|FG002|Predecessor Study|Lost to Follow-up|0|||
128766554|NCT04867785|463436570|FG007|Overall Study|Withdrawal by Subject|5|||
128922630|NCT00481065|464003341|FG002|Overall Study|Unable to classify|2|||
128922631|NCT00481065|464003342|FG003|Overall Study|Unable to classify|0|||
128922632|NCT00481065|464003343|FG004|Overall Study|Unable to classify|1|||
128922633|NCT00481065|464003344|FG005|Overall Study|Unable to classify|0|||
128922634|NCT00481065|464003345|FG006|Overall Study|Unable to classify|0|||
128922635|NCT00481065|464003346|FG007|Overall Study|Unable to classify|0|||
128922636|NCT01709331|464003349|FG000|Overall Study|Adverse Event|1|||
128922637|NCT02500537|464003352|FG000|Overall Study|Death|2|||
128922638|NCT02500537|464003353|FG001|Overall Study|Death|0|||
128922639|NCT02500537|464003352|FG000|Overall Study|Lost to Follow-up|0|||
128922640|NCT02500537|464003353|FG001|Overall Study|Lost to Follow-up|1|||
128922641|NCT02500537|464003352|FG000|Overall Study|Withdrawal by Subject|1|||
128922642|NCT02500537|464003353|FG001|Overall Study|Withdrawal by Subject|0|||
128922643|NCT02875223|464003358|FG000|Overall Study|Other reasons|0|||
128922644|NCT02875223|464003359|FG001|Overall Study|Other reasons|0|||
128922645|NCT02875223|464003360|FG002|Overall Study|Other reasons|1|||
128766555|NCT04867785|463436563|FG000|Overall Study|Physician Decision|0|||
128766556|NCT04867785|463436564|FG001|Overall Study|Physician Decision|0|||
128766557|NCT04867785|463436565|FG002|Overall Study|Physician Decision|0|||
128766558|NCT04867785|463436566|FG003|Overall Study|Physician Decision|0|||
128766559|NCT04867785|463436567|FG004|Overall Study|Physician Decision|0|||
128766560|NCT04867785|463436568|FG005|Overall Study|Physician Decision|0|||
128766561|NCT04867785|463436569|FG006|Overall Study|Physician Decision|0|||
128766562|NCT04867785|463436570|FG007|Overall Study|Physician Decision|1|||
128766563|NCT04867785|463436563|FG000|Overall Study|Inadvertent Enrollment|0|||
128766564|NCT04867785|463436564|FG001|Overall Study|Inadvertent Enrollment|0|||
128766565|NCT04867785|463436565|FG002|Overall Study|Inadvertent Enrollment|0|||
128766566|NCT04867785|463436566|FG003|Overall Study|Inadvertent Enrollment|1|||
128766567|NCT04867785|463436567|FG004|Overall Study|Inadvertent Enrollment|1|||
128766568|NCT04867785|463436568|FG005|Overall Study|Inadvertent Enrollment|0|||
128766569|NCT04867785|463436569|FG006|Overall Study|Inadvertent Enrollment|0|||
128766570|NCT04867785|463436570|FG007|Overall Study|Inadvertent Enrollment|1|||
128766571|NCT04867785|463436563|FG000|Overall Study|Eligibility Criteria Not Met|0|||
128766572|NCT04867785|463436564|FG001|Overall Study|Eligibility Criteria Not Met|0|||
128766573|NCT04867785|463436565|FG002|Overall Study|Eligibility Criteria Not Met|0|||
128766574|NCT04867785|463436566|FG003|Overall Study|Eligibility Criteria Not Met|0|||
128766575|NCT04867785|463436567|FG004|Overall Study|Eligibility Criteria Not Met|0|||
128766576|NCT04867785|463436568|FG005|Overall Study|Eligibility Criteria Not Met|0|||
128766577|NCT04867785|463436569|FG006|Overall Study|Eligibility Criteria Not Met|0|||
128766578|NCT04867785|463436570|FG007|Overall Study|Eligibility Criteria Not Met|1|||
128766579|NCT01289041|463436571|FG000|Overall Study|Adverse Event|24|||
128766580|NCT01289041|463436571|FG000|Overall Study|Physician Decision|1|||
128766581|NCT01289041|463436571|FG000|Overall Study|Progressive Disease|41|||
128766582|NCT01289041|463436571|FG000|Overall Study|Withdrawal by Subject|3|||
128766583|NCT01289041|463436571|FG000|Overall Study|Death|1|||
128766584|NCT02714868|463436578|FG000|Overall Study|Withdrawal by Subject|3|||
128766585|NCT02714868|463436579|FG001|Overall Study|Withdrawal by Subject|0|||
128766586|NCT02714868|463436578|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
128766587|NCT02714868|463436579|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
128766588|NCT02714868|463436578|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
128766589|NCT02714868|463436579|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
128766590|NCT03239873|463436580|FG000|Overall Study|Lost to Follow-up|15|||
128766591|NCT03239873|463436581|FG001|Overall Study|Lost to Follow-up|16|||
128766592|NCT03239873|463436580|FG000|Overall Study|Physician Decision|1|||
128766593|NCT03239873|463436581|FG001|Overall Study|Physician Decision|0|||
128766594|NCT03239873|463436580|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
128766595|NCT03239873|463436581|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
128766596|NCT03239873|463436580|FG000|Overall Study|Withdrawal by Subject|2|||
128766597|NCT03239873|463436581|FG001|Overall Study|Withdrawal by Subject|0|||
128766598|NCT03239873|463436580|FG000|Overall Study|Contraindication to study medication|1|||
128922646|NCT02875223|464003361|FG003|Overall Study|Other reasons|0|||
128922647|NCT02875223|464003362|FG004|Overall Study|Other reasons|1|||
128922648|NCT02875223|464003363|FG005|Overall Study|Other reasons|2|||
128922649|NCT02875223|464003364|FG006|Overall Study|Other reasons|0|||
128922650|NCT02875223|464003365|FG007|Overall Study|Other reasons|2|||
128766599|NCT03239873|463436581|FG001|Overall Study|Contraindication to study medication|0|||
128766600|NCT03239873|463436580|FG000|Overall Study|Protocol Violation|1|||
128766601|NCT03239873|463436581|FG001|Overall Study|Protocol Violation|0|||
128766602|NCT00605319|463436586|FG000|Overall Study|Adverse Event|6|||
128766603|NCT02670538|463436587|FG000|Overall Study|Withdrawal of Consent|8|||
128766604|NCT02670538|463436588|FG001|Overall Study|Withdrawal of Consent|6|||
128766605|NCT02670538|463436589|FG002|Overall Study|Withdrawal of Consent|5|||
128766606|NCT02670538|463436587|FG000|Overall Study|Lost to Follow-up|8|||
128766607|NCT02670538|463436588|FG001|Overall Study|Lost to Follow-up|12|||
128766608|NCT02670538|463436589|FG002|Overall Study|Lost to Follow-up|7|||
128922651|NCT02875223|464003366|FG008|Overall Study|Other reasons|0|||
128922652|NCT02875223|464003367|FG009|Overall Study|Other reasons|0|||
128766609|NCT02670538|463436587|FG000|Overall Study|Adverse Event|5|||
128766610|NCT02670538|463436588|FG001|Overall Study|Adverse Event|5|||
128766611|NCT02670538|463436589|FG002|Overall Study|Adverse Event|11|||
128766612|NCT02670538|463436587|FG000|Overall Study|Lack of Efficacy|7|||
128766613|NCT02670538|463436588|FG001|Overall Study|Lack of Efficacy|1|||
128766614|NCT02670538|463436589|FG002|Overall Study|Lack of Efficacy|2|||
128766615|NCT02670538|463436587|FG000|Overall Study|Protocol Violation|3|||
128766616|NCT02670538|463436588|FG001|Overall Study|Protocol Violation|4|||
128766617|NCT02670538|463436589|FG002|Overall Study|Protocol Violation|1|||
128766618|NCT02670538|463436587|FG000|Overall Study|Noncompliance with Study Drug|1|||
128766619|NCT02670538|463436588|FG001|Overall Study|Noncompliance with Study Drug|3|||
128766620|NCT02670538|463436589|FG002|Overall Study|Noncompliance with Study Drug|2|||
128766621|NCT02670538|463436587|FG000|Overall Study|Other Miscellaneous Reasons|0|||
128766622|NCT02670538|463436588|FG001|Overall Study|Other Miscellaneous Reasons|1|||
128766623|NCT02670538|463436589|FG002|Overall Study|Other Miscellaneous Reasons|2|||
128766624|NCT01250119|463436590|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
128766625|NCT01250119|463436591|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
128766626|NCT01250119|463436590|FG000|Diagnostic Phase|Participants Not Tested|44|||
128766627|NCT01250119|463436591|FG001|Diagnostic Phase|Participants Not Tested|0|||
128766628|NCT01250119|463436590|FG000|Treatment Phase|Progressive Disease|0|||
128766629|NCT01250119|463436591|FG001|Treatment Phase|Progressive Disease|32|||
128766630|NCT01250119|463436590|FG000|Treatment Phase|Death|0|||
128766631|NCT01250119|463436591|FG001|Treatment Phase|Death|2|||
128766632|NCT01250119|463436590|FG000|Treatment Phase|Withdrawal by Subject|0|||
128766633|NCT01250119|463436591|FG001|Treatment Phase|Withdrawal by Subject|1|||
128766634|NCT01250119|463436590|FG000|Treatment Phase|Adverse Event|0|||
128766635|NCT01250119|463436591|FG001|Treatment Phase|Adverse Event|2|||
128766636|NCT01250119|463436590|FG000|Treatment Phase|Unknown reason|0|||
128766637|NCT01250119|463436591|FG001|Treatment Phase|Unknown reason|4|||
128766638|NCT02887989|463436592|FG000|Overall Study|Withdrawal by Subject|8|||
128766639|NCT02887989|463436593|FG001|Overall Study|Withdrawal by Subject|11|||
128766640|NCT02887989|463436592|FG000|Overall Study|Death|1|||
128766641|NCT02887989|463436593|FG001|Overall Study|Death|0|||
128766642|NCT05648357|463436597|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
128766643|NCT00255346|463436598|FG000|Overall Study|Adverse Event|1|||
128766644|NCT00255346|463436599|FG001|Overall Study|Adverse Event|0|||
128766645|NCT00255346|463436600|FG002|Overall Study|Adverse Event|0|||
128766646|NCT00255346|463436601|FG003|Overall Study|Adverse Event|0|||
128766647|NCT00255346|463436602|FG004|Overall Study|Adverse Event|0|||
128766648|NCT00674323|463436603|FG000|Overall Study|Adverse Event|0|||
128766649|NCT00674323|463436604|FG001|Overall Study|Adverse Event|1|||
128766650|NCT00674323|463436605|FG002|Overall Study|Adverse Event|0|||
128766651|NCT00674323|463436603|FG000|Overall Study|Protocol Violation|1|||
128766652|NCT00674323|463436604|FG001|Overall Study|Protocol Violation|0|||
128766653|NCT00674323|463436605|FG002|Overall Study|Protocol Violation|0|||
128922653|NCT02875223|464003368|FG010|Overall Study|Other reasons|0|||
128922654|NCT02875223|464003369|FG011|Overall Study|Other reasons|0|||
128922655|NCT02875223|464003370|FG012|Overall Study|Other reasons|0|||
128922656|NCT02875223|464003358|FG000|Overall Study|Withdrawal by Subject|0|||
128922657|NCT02875223|464003359|FG001|Overall Study|Withdrawal by Subject|0|||
128922658|NCT02875223|464003360|FG002|Overall Study|Withdrawal by Subject|0|||
128922659|NCT02875223|464003361|FG003|Overall Study|Withdrawal by Subject|0|||
128922660|NCT02875223|464003362|FG004|Overall Study|Withdrawal by Subject|1|||
128922661|NCT02875223|464003363|FG005|Overall Study|Withdrawal by Subject|1|||
128922662|NCT02875223|464003364|FG006|Overall Study|Withdrawal by Subject|0|||
128922663|NCT02875223|464003365|FG007|Overall Study|Withdrawal by Subject|0|||
128922664|NCT02875223|464003366|FG008|Overall Study|Withdrawal by Subject|1|||
128922665|NCT02875223|464003367|FG009|Overall Study|Withdrawal by Subject|0|||
128922666|NCT02875223|464003368|FG010|Overall Study|Withdrawal by Subject|0|||
128922667|NCT02875223|464003369|FG011|Overall Study|Withdrawal by Subject|0|||
128922668|NCT02875223|464003370|FG012|Overall Study|Withdrawal by Subject|0|||
128922669|NCT02875223|464003358|FG000|Overall Study|Progressive disease|0|||
128922670|NCT02875223|464003359|FG001|Overall Study|Progressive disease|0|||
128922671|NCT02875223|464003360|FG002|Overall Study|Progressive disease|1|||
128766654|NCT00409786|463436612|FG000|Overall Study|Withdrawal by Subject|3|||
128766655|NCT01077362|463436618|FG000|Overall Study|Lack of Efficacy|13|||
128766656|NCT01077362|463436619|FG001|Overall Study|Lack of Efficacy|8|||
128766657|NCT01077362|463436620|FG002|Overall Study|Lack of Efficacy|10|||
128766658|NCT01077362|463436618|FG000|Overall Study|Lost to Follow-up|1|||
128766659|NCT01077362|463436619|FG001|Overall Study|Lost to Follow-up|0|||
128766660|NCT01077362|463436620|FG002|Overall Study|Lost to Follow-up|3|||
128766661|NCT01077362|463436618|FG000|Overall Study|Adverse Event|12|||
128766662|NCT01077362|463436619|FG001|Overall Study|Adverse Event|7|||
128766663|NCT01077362|463436620|FG002|Overall Study|Adverse Event|4|||
128766664|NCT01077362|463436618|FG000|Overall Study|Withdrawal by Subject|5|||
128766665|NCT01077362|463436619|FG001|Overall Study|Withdrawal by Subject|3|||
128922672|NCT02875223|464003361|FG003|Overall Study|Progressive disease|0|||
128922673|NCT02875223|464003362|FG004|Overall Study|Progressive disease|0|||
128700332|NCT03706079|463201562|FG003|Predecessor Study|Lost to Follow-up|0|||
128700333|NCT03706079|463201563|FG004|Predecessor Study|Lost to Follow-up|1|||
128700334|NCT03706079|463201564|FG005|Predecessor Study|Lost to Follow-up|0|||
128700335|NCT03706079|463201559|FG000|Predecessor Study|Withdrawal by Subject|8|||
128700336|NCT03706079|463201560|FG001|Predecessor Study|Withdrawal by Subject|15|||
128700337|NCT03706079|463201561|FG002|Predecessor Study|Withdrawal by Subject|0|||
128700338|NCT03706079|463201562|FG003|Predecessor Study|Withdrawal by Subject|5|||
128700339|NCT03706079|463201563|FG004|Predecessor Study|Withdrawal by Subject|2|||
128700340|NCT03706079|463201564|FG005|Predecessor Study|Withdrawal by Subject|0|||
128700341|NCT03706079|463201559|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
128700342|NCT03706079|463201560|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
128700343|NCT03706079|463201561|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
128700344|NCT03706079|463201562|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
128700345|NCT03706079|463201563|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
128700346|NCT03706079|463201564|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
128700347|NCT03706079|463201559|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
128700348|NCT03706079|463201560|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
128700349|NCT03706079|463201561|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
128700350|NCT03706079|463201562|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
128700351|NCT03706079|463201563|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
128700352|NCT03706079|463201564|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
128700353|NCT03706079|463201559|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
128700354|NCT03706079|463201560|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
128700355|NCT03706079|463201561|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
128700356|NCT03706079|463201562|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
128700357|NCT03706079|463201563|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
128700358|NCT03706079|463201564|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
128700359|NCT03706079|463201559|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
128700360|NCT03706079|463201560|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
128700361|NCT03706079|463201561|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
128700362|NCT03706079|463201562|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
128700363|NCT03706079|463201563|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
128700364|NCT03706079|463201564|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
128766666|NCT01077362|463436620|FG002|Overall Study|Withdrawal by Subject|5|||
128766667|NCT01077362|463436618|FG000|Overall Study|Other|0|||
128766668|NCT01077362|463436619|FG001|Overall Study|Other|1|||
128766669|NCT01077362|463436620|FG002|Overall Study|Other|2|||
128922674|NCT02875223|464003363|FG005|Overall Study|Progressive disease|0|||
128922675|NCT02875223|464003364|FG006|Overall Study|Progressive disease|0|||
128922676|NCT02875223|464003365|FG007|Overall Study|Progressive disease|0|||
128922677|NCT02875223|464003366|FG008|Overall Study|Progressive disease|0|||
128922678|NCT02875223|464003367|FG009|Overall Study|Progressive disease|12|||
128922679|NCT02875223|464003368|FG010|Overall Study|Progressive disease|2|||
128922680|NCT02875223|464003369|FG011|Overall Study|Progressive disease|3|||
128922681|NCT02875223|464003370|FG012|Overall Study|Progressive disease|6|||
128922682|NCT02875223|464003358|FG000|Overall Study|Death|4|||
128922683|NCT02875223|464003359|FG001|Overall Study|Death|4|||
128922684|NCT02875223|464003360|FG002|Overall Study|Death|3|||
128922685|NCT02875223|464003361|FG003|Overall Study|Death|4|||
128922686|NCT02875223|464003362|FG004|Overall Study|Death|2|||
128922687|NCT02875223|464003363|FG005|Overall Study|Death|3|||
128922688|NCT02875223|464003364|FG006|Overall Study|Death|5|||
128922689|NCT02875223|464003365|FG007|Overall Study|Death|7|||
128922690|NCT02875223|464003366|FG008|Overall Study|Death|3|||
128922691|NCT02875223|464003367|FG009|Overall Study|Death|2|||
128922692|NCT02875223|464003368|FG010|Overall Study|Death|0|||
128922693|NCT02875223|464003369|FG011|Overall Study|Death|0|||
128922694|NCT02875223|464003370|FG012|Overall Study|Death|0|||
128922695|NCT02875223|464003358|FG000|Overall Study|Lost to Follow-up|0|||
128922696|NCT02875223|464003359|FG001|Overall Study|Lost to Follow-up|1|||
128922697|NCT02875223|464003360|FG002|Overall Study|Lost to Follow-up|1|||
128922698|NCT02875223|464003361|FG003|Overall Study|Lost to Follow-up|0|||
128922699|NCT02875223|464003362|FG004|Overall Study|Lost to Follow-up|1|||
128922700|NCT02875223|464003363|FG005|Overall Study|Lost to Follow-up|0|||
129216323|NCT00724698|465092883|FG000|Overall Study|Poor Compliance|16|||
128922701|NCT02875223|464003364|FG006|Overall Study|Lost to Follow-up|1|||
128922702|NCT02875223|464003365|FG007|Overall Study|Lost to Follow-up|1|||
128922703|NCT02875223|464003366|FG008|Overall Study|Lost to Follow-up|0|||
128922704|NCT02875223|464003367|FG009|Overall Study|Lost to Follow-up|0|||
128922705|NCT02875223|464003368|FG010|Overall Study|Lost to Follow-up|0|||
128922706|NCT02875223|464003369|FG011|Overall Study|Lost to Follow-up|0|||
128922707|NCT02875223|464003370|FG012|Overall Study|Lost to Follow-up|0|||
128922708|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
128922709|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
128922710|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
128922711|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
128922712|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
128922713|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
128922714|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
128700365|NCT03706079|463201559|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
128700366|NCT03706079|463201560|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
128700367|NCT03706079|463201561|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
128700368|NCT03706079|463201562|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
128700369|NCT03706079|463201563|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
128700370|NCT03706079|463201564|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
128700371|NCT03706079|463201559|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
128700372|NCT03706079|463201560|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
128700373|NCT03706079|463201561|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
128700374|NCT03706079|463201562|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
128700375|NCT03706079|463201563|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
128700376|NCT03706079|463201564|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
128700377|NCT03706079|463201559|FG000|Long Term Extension (DESTINATION)|Death|8|||
128700378|NCT03706079|463201560|FG001|Long Term Extension (DESTINATION)|Death|2|||
128700379|NCT03706079|463201561|FG002|Long Term Extension (DESTINATION)|Death|2|||
128700380|NCT03706079|463201562|FG003|Long Term Extension (DESTINATION)|Death|1|||
128700381|NCT03706079|463201563|FG004|Long Term Extension (DESTINATION)|Death|0|||
128700382|NCT03706079|463201564|FG005|Long Term Extension (DESTINATION)|Death|0|||
128700383|NCT00968513|463201565|FG000|Overall Study|Death|4|||
128700384|NCT00968513|463201566|FG001|Overall Study|Death|10|||
128700385|NCT00968513|463201567|FG002|Overall Study|Death|15|||
128700386|NCT05379231|463201568|FG000|Home Visit|Withdrawal by Subject|2|||
128700387|NCT05379231|463201568|FG000|In-lab Visit|Withdrawal by Subject|2|||
128700388|NCT01203098|463201575|FG000|Overall Study|Adverse Event|3|||
128700389|NCT01203098|463201576|FG001|Overall Study|Adverse Event|1|||
128700390|NCT01203098|463201577|FG002|Overall Study|Adverse Event|7|||
128700391|NCT01203098|463201575|FG000|Overall Study|Lost to Follow-up|0|||
128700392|NCT01203098|463201576|FG001|Overall Study|Lost to Follow-up|0|||
128922715|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
128922716|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
128922717|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
128922718|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
128922719|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
128700393|NCT01203098|463201577|FG002|Overall Study|Lost to Follow-up|1|||
128922720|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
128922721|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
128922722|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
128922723|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
128922724|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
128922725|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
128922726|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
128922727|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
128922728|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
128922729|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
128922730|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
128922731|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
128922732|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
128922733|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
128922734|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
128922735|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
128922736|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
128922737|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
128922738|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
128922739|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
128922740|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
128700394|NCT01203098|463201575|FG000|Overall Study|Physician Decision|2|||
128700395|NCT01203098|463201576|FG001|Overall Study|Physician Decision|2|||
128700396|NCT01203098|463201577|FG002|Overall Study|Physician Decision|0|||
128700397|NCT01203098|463201575|FG000|Overall Study|Withdrawal by Subject|1|||
128700398|NCT01203098|463201576|FG001|Overall Study|Withdrawal by Subject|1|||
128922741|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
129029391|NCT01899053|464398399|FG002|Overall Study|Protocol Violation|1|||
128922742|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
128922743|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
128922744|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
128922745|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
128922746|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
128922747|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
128922748|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
128922749|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
128922750|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
128922751|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
128922752|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
128922753|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
128922754|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
128922755|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
128922756|NCT01707992|464003373|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
128922757|NCT01707992|464003374|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
128922758|NCT01707992|464003375|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
128922759|NCT01707992|464003376|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
128922760|NCT01707992|464003377|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
128922761|NCT01707992|464003378|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
128922762|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
128922763|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
128922764|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
128922765|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
128922766|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
128922767|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
128922768|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
128922769|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
128922770|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
128922771|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
128922772|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
128922773|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
128922774|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
128922775|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
128922776|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
128922777|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
128922778|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
128922779|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
128922780|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
128922781|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
128922782|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
128922783|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
128922784|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
128922785|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
128922786|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
128922787|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
128922788|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
128922789|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
128922790|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
128922791|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
128922792|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Death|0|||
128922793|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Death|0|||
128922794|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Death|0|||
128922795|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Death|2|||
128922796|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Death|0|||
128922797|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Death|0|||
128922798|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
128922799|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
128922800|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
128922801|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
128922802|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
128922803|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
128922804|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
128922805|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
128922806|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
129216324|NCT00724698|465092883|FG000|Overall Study|Lost to Follow-up|36|||
129216325|NCT00724698|465092883|FG000|Overall Study|No Info|25|||
128700399|NCT01203098|463201577|FG002|Overall Study|Withdrawal by Subject|3|||
128700400|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
128700401|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
128700402|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
128922807|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
128922808|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
128922809|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
128922810|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
128922811|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
128922812|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
128922813|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
128922814|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
128922815|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
128922816|NCT01707992|464003373|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
128922817|NCT01707992|464003374|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
128922818|NCT01707992|464003375|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
128922819|NCT01707992|464003376|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
128922820|NCT01707992|464003377|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
128922821|NCT01707992|464003378|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
128922822|NCT02654002|464003382|FG000|Overall Study|Adverse Event|0|||
128922823|NCT02654002|464003383|FG001|Overall Study|Adverse Event|0|||
128922824|NCT02654002|464003384|FG002|Overall Study|Adverse Event|0|||
128922825|NCT02654002|464003385|FG003|Overall Study|Adverse Event|0|||
128922826|NCT02654002|464003386|FG004|Overall Study|Adverse Event|0|||
128922827|NCT02654002|464003387|FG005|Overall Study|Adverse Event|0|||
128922828|NCT02654002|464003388|FG006|Overall Study|Adverse Event|1|||
128922829|NCT02654002|464003389|FG007|Overall Study|Adverse Event|0|||
128922830|NCT02654002|464003390|FG008|Overall Study|Adverse Event|0|||
128700403|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
128700404|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
128922831|NCT02654002|464003382|FG000|Overall Study|Withdrew Consent|0|||
128922832|NCT02654002|464003383|FG001|Overall Study|Withdrew Consent|0|||
128700405|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
128700406|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
128700407|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
128700408|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
128700409|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
128700410|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
128700411|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
128700412|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
128700413|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
128700414|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
128700415|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
128700416|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
128700417|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
128700418|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
128766670|NCT00301080|463436621|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
128922833|NCT02654002|464003384|FG002|Overall Study|Withdrew Consent|0|||
128922834|NCT02654002|464003385|FG003|Overall Study|Withdrew Consent|0|||
128922835|NCT02654002|464003386|FG004|Overall Study|Withdrew Consent|0|||
128922836|NCT02654002|464003387|FG005|Overall Study|Withdrew Consent|1|||
128922837|NCT02654002|464003388|FG006|Overall Study|Withdrew Consent|0|||
129118884|NCT00833755|464731241|FG003|Overall Study|Subject had scheduling issues|0|||
129118885|NCT01776554|464731244|FG000|Overall Study|Adverse Event|1|||
129118886|NCT01776554|464731245|FG001|Overall Study|Adverse Event|0|||
129118887|NCT01776554|464731244|FG000|Overall Study|Withdrawal by Subject|3|||
129118888|NCT01776554|464731245|FG001|Overall Study|Withdrawal by Subject|8|||
129118889|NCT01776554|464731244|FG000|Overall Study|Lost to Follow-up|6|||
129118890|NCT01776554|464731245|FG001|Overall Study|Lost to Follow-up|9|||
129118891|NCT01776554|464731244|FG000|Overall Study|Administrative Reason|2|||
128700419|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
128700420|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
128922838|NCT02654002|464003389|FG007|Overall Study|Withdrew Consent|1|||
128922839|NCT02654002|464003390|FG008|Overall Study|Withdrew Consent|0|||
128922840|NCT01523873|464003391|FG000|Overall Study|Protocol Violation|422|||
128922841|NCT03313050|464003393|FG000|Stage 2: 12 Months|Adverse Event|0|||
128922842|NCT03313050|464003394|FG001|Stage 2: 12 Months|Adverse Event|0|||
129118892|NCT01776554|464731245|FG001|Overall Study|Administrative Reason|5|||
129118893|NCT01776554|464731244|FG000|Overall Study|Protocol Violation|1|||
129118894|NCT01776554|464731245|FG001|Overall Study|Protocol Violation|0|||
128922843|NCT03313050|464003395|FG002|Stage 2: 12 Months|Adverse Event|0|||
128922844|NCT03313050|464003396|FG003|Stage 2: 12 Months|Adverse Event|1|||
128922845|NCT03313050|464003393|FG000|Stage 2: 12 Months|Death|0|||
128922846|NCT03313050|464003394|FG001|Stage 2: 12 Months|Death|0|||
128922847|NCT03313050|464003395|FG002|Stage 2: 12 Months|Death|3|||
128922848|NCT03313050|464003396|FG003|Stage 2: 12 Months|Death|0|||
128922849|NCT03313050|464003393|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
128922850|NCT03313050|464003394|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
128766671|NCT00301080|463436622|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
128766672|NCT00301080|463436623|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
128766673|NCT00301080|463436624|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
128766674|NCT00301080|463436625|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
128766675|NCT01641926|463436626|FG000|Overall Study|Adverse Event|5|||
128766676|NCT01641926|463436627|FG001|Overall Study|Adverse Event|2|||
128766677|NCT01641926|463436628|FG002|Overall Study|Adverse Event|3|||
128766678|NCT01641926|463436629|FG003|Overall Study|Adverse Event|1|||
128766679|NCT01641926|463436626|FG000|Overall Study|Lost to Follow-up|2|||
128766680|NCT01641926|463436627|FG001|Overall Study|Lost to Follow-up|2|||
128766681|NCT01641926|463436628|FG002|Overall Study|Lost to Follow-up|1|||
128766682|NCT01641926|463436629|FG003|Overall Study|Lost to Follow-up|0|||
128766683|NCT01641926|463436626|FG000|Overall Study|Physician Decision|6|||
128766684|NCT01641926|463436627|FG001|Overall Study|Physician Decision|5|||
128766685|NCT01641926|463436628|FG002|Overall Study|Physician Decision|0|||
128766686|NCT01641926|463436629|FG003|Overall Study|Physician Decision|1|||
128766687|NCT01641926|463436626|FG000|Overall Study|Protocol Violation|1|||
128766688|NCT01641926|463436627|FG001|Overall Study|Protocol Violation|0|||
128766689|NCT01641926|463436628|FG002|Overall Study|Protocol Violation|0|||
128766690|NCT01641926|463436629|FG003|Overall Study|Protocol Violation|1|||
128766691|NCT01641926|463436626|FG000|Overall Study|Withdrawal by Subject|13|||
128766692|NCT01641926|463436627|FG001|Overall Study|Withdrawal by Subject|5|||
128766693|NCT01641926|463436628|FG002|Overall Study|Withdrawal by Subject|6|||
128766694|NCT01641926|463436629|FG003|Overall Study|Withdrawal by Subject|1|||
128766695|NCT01641926|463436626|FG000|Overall Study|Not Treated|1|||
128766696|NCT01641926|463436627|FG001|Overall Study|Not Treated|1|||
128766697|NCT01641926|463436628|FG002|Overall Study|Not Treated|1|||
128766698|NCT01641926|463436629|FG003|Overall Study|Not Treated|0|||
128766699|NCT02567825|463436636|FG000|Overall Study|No follow-up post-randomization|5|||
128766700|NCT02567825|463436637|FG001|Overall Study|No follow-up post-randomization|1|||
128766701|NCT02567825|463436636|FG000|Overall Study|Follow-up less than 23 months|16|||
128766702|NCT02567825|463436637|FG001|Overall Study|Follow-up less than 23 months|20|||
128766703|NCT01540565|463436639|FG000|Overall Study|Ineligible|2|||
128766704|NCT01678820|463436640|FG000|Overall Study|Study Terminated by Sponsor|45|||
128766705|NCT01678820|463436641|FG001|Overall Study|Study Terminated by Sponsor|43|||
128766706|NCT01678820|463436642|FG002|Overall Study|Study Terminated by Sponsor|43|||
128766707|NCT01678820|463436640|FG000|Overall Study|Withdrawal by Subject|2|||
128766708|NCT01678820|463436641|FG001|Overall Study|Withdrawal by Subject|5|||
128766709|NCT01678820|463436642|FG002|Overall Study|Withdrawal by Subject|2|||
128766710|NCT01678820|463436640|FG000|Overall Study|Protocol Specified Criteria|2|||
128766711|NCT01678820|463436641|FG001|Overall Study|Protocol Specified Criteria|3|||
128766712|NCT01678820|463436642|FG002|Overall Study|Protocol Specified Criteria|1|||
128766713|NCT01678820|463436640|FG000|Overall Study|Adverse Event|2|||
128766714|NCT01678820|463436641|FG001|Overall Study|Adverse Event|2|||
128766715|NCT01678820|463436642|FG002|Overall Study|Adverse Event|2|||
128766716|NCT01678820|463436640|FG000|Overall Study|Lost to Follow-up|7|||
128766717|NCT01678820|463436641|FG001|Overall Study|Lost to Follow-up|2|||
128766718|NCT01678820|463436642|FG002|Overall Study|Lost to Follow-up|2|||
128766719|NCT01678820|463436640|FG000|Overall Study|Non-compliance with study drug|0|||
128766720|NCT01678820|463436641|FG001|Overall Study|Non-compliance with study drug|1|||
128766721|NCT01678820|463436642|FG002|Overall Study|Non-compliance with study drug|0|||
128766722|NCT01678820|463436640|FG000|Overall Study|Physician Decision|0|||
128766723|NCT01678820|463436641|FG001|Overall Study|Physician Decision|0|||
128766724|NCT01678820|463436642|FG002|Overall Study|Physician Decision|1|||
128766725|NCT01678820|463436640|FG000|Overall Study|Protocol Violation|4|||
128766726|NCT01678820|463436641|FG001|Overall Study|Protocol Violation|5|||
128766727|NCT01678820|463436642|FG002|Overall Study|Protocol Violation|4|||
128766728|NCT01678820|463436640|FG000|Overall Study|Not treated with double-blind study drug|0|||
128766729|NCT01678820|463436641|FG001|Overall Study|Not treated with double-blind study drug|2|||
128922851|NCT03313050|464003395|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
129118895|NCT01776554|464731244|FG000|Overall Study|Unclassified|4|||
128766730|NCT01678820|463436642|FG002|Overall Study|Not treated with double-blind study drug|2|||
128766731|NCT02306265|463436643|FG000|Overall Study|Withdrawal by Subject|1|||
128766732|NCT04488003|463436644|FG000|Assessed for Eligibility|Screen Failure|24|||
128922852|NCT03313050|464003396|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
128766733|NCT04488003|463436645|FG001|Assessed for Eligibility|Screen Failure|0|||
128766734|NCT04488003|463436646|FG002|Assessed for Eligibility|Screen Failure|0|||
128766735|NCT04488003|463436644|FG000|Assessed for Eligibility|Adverse Event|1|||
128766736|NCT04488003|463436645|FG001|Assessed for Eligibility|Adverse Event|0|||
128922853|NCT03313050|464003393|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
128922854|NCT03313050|464003394|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
128922855|NCT03313050|464003395|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
128922856|NCT03313050|464003396|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
128922857|NCT03313050|464003393|FG000|Stage 2: 12 Months|Protocol deviation|0|||
128922858|NCT03313050|464003394|FG001|Stage 2: 12 Months|Protocol deviation|0|||
128922859|NCT03313050|464003395|FG002|Stage 2: 12 Months|Protocol deviation|7|||
129118896|NCT01776554|464731245|FG001|Overall Study|Unclassified|1|||
129118897|NCT02475369|464731246|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
129118898|NCT02475369|464731247|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
129118899|NCT03608826|464731249|FG000|Overall Study|Death|3|||
129118900|NCT03608826|464731249|FG000|Overall Study|Heart Transplant|3|||
129118901|NCT03608826|464731249|FG000|Overall Study|Physician Decision|4|||
129118902|NCT03122171|464731250|FG000|Overall Study|Withdrawal by Subject|1|||
129118903|NCT03415178|464731262|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
129118904|NCT03415178|464731263|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
129118905|NCT03415178|464731262|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
129118906|NCT03415178|464731263|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
129118907|NCT00753519|464733103|FG000|Overall Study|Withdrawal by Subject|0|||
129118908|NCT00753519|464733104|FG001|Overall Study|Withdrawal by Subject|2|||
129118909|NCT02807259|464733105|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
129118910|NCT02807259|464733106|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
129118911|NCT02807259|464733105|FG000|Midline (3 Months)|migration, refusal, not available|30|||
129118912|NCT02807259|464733106|FG001|Midline (3 Months)|migration, refusal, not available|34|||
129118913|NCT02807259|464733105|FG000|Endline (3 Months)|migration, refusal, not available|35|||
129118914|NCT02807259|464733106|FG001|Endline (3 Months)|migration, refusal, not available|87|||
129118915|NCT03861039|464733107|FG000|Overall Study|Adverse Event|2|||
129118916|NCT03861039|464733108|FG001|Overall Study|Adverse Event|5|||
129118917|NCT03861039|464733109|FG002|Overall Study|Adverse Event|11|||
129118918|NCT03861039|464733107|FG000|Overall Study|Withdrawal by Subject|1|||
129118919|NCT03861039|464733108|FG001|Overall Study|Withdrawal by Subject|3|||
129118920|NCT03861039|464733109|FG002|Overall Study|Withdrawal by Subject|4|||
129118921|NCT02791269|464733125|FG000|Overall Study|Lost to Follow-up|0|||
129118922|NCT02791269|464733126|FG001|Overall Study|Lost to Follow-up|1|||
129118923|NCT01799941|464733129|FG000|Overall Study|Adverse Event|34|||
128700421|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
128700422|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
128700423|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
128700424|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
128700425|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
128700426|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
128700427|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
128700428|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
128700429|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
128700430|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
128700431|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
128700432|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
128700433|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
128700434|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
128700435|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
128700436|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
128700437|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
128700438|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
128700439|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
128700440|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
128700441|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
128700442|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
128700443|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
128700444|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
128700445|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
128700446|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
128700447|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
128700448|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
128700449|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
128700450|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
128700451|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
128922860|NCT03313050|464003396|FG003|Stage 2: 12 Months|Protocol deviation|7|||
128700452|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
128700453|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
128700454|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
128700455|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
128700456|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
128700457|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
128700458|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
128700459|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
128700460|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
128700461|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
128700462|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
128700463|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
128922861|NCT03313050|464003393|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
128922862|NCT03313050|464003394|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
128922863|NCT03313050|464003395|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
128922864|NCT03313050|464003396|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
128922865|NCT03313050|464003393|FG000|Stage 2: 12 Months|Other|0|||
128922866|NCT03313050|464003394|FG001|Stage 2: 12 Months|Other|0|||
128922867|NCT03313050|464003395|FG002|Stage 2: 12 Months|Other|0|||
128922868|NCT03313050|464003396|FG003|Stage 2: 12 Months|Other|1|||
128922869|NCT04211337|464003397|FG000|Overall Study|On Treatment|175|||
128922870|NCT04211337|464003398|FG001|Overall Study|On Treatment|40|||
128922871|NCT04211337|464003397|FG000|Overall Study|Withdrawal by Subject|0|||
128922872|NCT04211337|464003398|FG001|Overall Study|Withdrawal by Subject|2|||
128922873|NCT02847598|464003409|FG000|Overall Study|Adverse Event|0|||
128922874|NCT02847598|464003410|FG001|Overall Study|Adverse Event|0|||
128922875|NCT02847598|464003411|FG002|Overall Study|Adverse Event|0|||
128922876|NCT02847598|464003412|FG003|Overall Study|Adverse Event|0|||
128922877|NCT02847598|464003413|FG004|Overall Study|Adverse Event|0|||
128922878|NCT02847598|464003414|FG005|Overall Study|Adverse Event|0|||
128922879|NCT02847598|464003415|FG006|Overall Study|Adverse Event|0|||
128922880|NCT02847598|464003416|FG007|Overall Study|Adverse Event|1|||
128922881|NCT02847598|464003409|FG000|Overall Study|Consent withdrawn|2|||
128922882|NCT02847598|464003410|FG001|Overall Study|Consent withdrawn|0|||
128922883|NCT02847598|464003411|FG002|Overall Study|Consent withdrawn|0|||
128922884|NCT02847598|464003412|FG003|Overall Study|Consent withdrawn|4|||
128922885|NCT02847598|464003413|FG004|Overall Study|Consent withdrawn|3|||
128922886|NCT02847598|464003414|FG005|Overall Study|Consent withdrawn|2|||
128922887|NCT02847598|464003415|FG006|Overall Study|Consent withdrawn|1|||
128922888|NCT02847598|464003416|FG007|Overall Study|Consent withdrawn|3|||
128922889|NCT02847598|464003409|FG000|Overall Study|Death|3|||
128922890|NCT02847598|464003410|FG001|Overall Study|Death|0|||
128922891|NCT02847598|464003411|FG002|Overall Study|Death|0|||
128922892|NCT02847598|464003412|FG003|Overall Study|Death|0|||
128922893|NCT02847598|464003413|FG004|Overall Study|Death|0|||
128922894|NCT02847598|464003414|FG005|Overall Study|Death|0|||
128922895|NCT02847598|464003415|FG006|Overall Study|Death|0|||
128922896|NCT02847598|464003416|FG007|Overall Study|Death|0|||
128922897|NCT02847598|464003409|FG000|Overall Study|Lost to Follow-up|0|||
128922898|NCT02847598|464003410|FG001|Overall Study|Lost to Follow-up|0|||
128922899|NCT02847598|464003411|FG002|Overall Study|Lost to Follow-up|0|||
128922900|NCT02847598|464003412|FG003|Overall Study|Lost to Follow-up|0|||
128922901|NCT02847598|464003413|FG004|Overall Study|Lost to Follow-up|0|||
128922902|NCT02847598|464003414|FG005|Overall Study|Lost to Follow-up|1|||
128922903|NCT02847598|464003415|FG006|Overall Study|Lost to Follow-up|1|||
128922904|NCT02847598|464003416|FG007|Overall Study|Lost to Follow-up|0|||
128922905|NCT02848833|464003417|FG000|Overall Study|subject who are duplicated|1|||
128766737|NCT04488003|463436646|FG002|Assessed for Eligibility|Adverse Event|0|||
128700464|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
128700465|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
128700466|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
128700467|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
128700468|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
128700469|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
128766738|NCT04488003|463436644|FG000|Assessed for Eligibility|Death|1|||
128766739|NCT04488003|463436645|FG001|Assessed for Eligibility|Death|0|||
128766740|NCT04488003|463436646|FG002|Assessed for Eligibility|Death|0|||
128922906|NCT02848833|464003417|FG000|Overall Study|have not taken the study drug|11|||
128922907|NCT02848833|464003417|FG000|Overall Study|follow-up failure|6|||
128922908|NCT02848833|464003417|FG000|Overall Study|Protocol Violation|119|||
128922909|NCT04167345|464003418|FG000|Overall Study|Other|1|||
128922910|NCT04167345|464003419|FG001|Overall Study|Other|1|||
128922911|NCT04167345|464003420|FG002|Overall Study|Other|0|||
128922912|NCT04167345|464003421|FG003|Overall Study|Other|0|||
128922913|NCT04167345|464003422|FG004|Overall Study|Other|0|||
128922914|NCT06119191|464003425|FG000|Overall Study|Adverse Event|0|||
128922915|NCT06119191|464003426|FG001|Overall Study|Adverse Event|1|||
128922916|NCT06119191|464003425|FG000|Overall Study|Protocol Violation|1|||
128922917|NCT06119191|464003426|FG001|Overall Study|Protocol Violation|0|||
128922918|NCT00500266|464005460|FG000|Overall Study|Death|3|||
128922919|NCT00500266|464005460|FG000|Overall Study|Lost to Follow-up|3|||
128922920|NCT00500266|464005460|FG000|Overall Study|Withdrawal by Subject|3|||
128922921|NCT00500266|464005460|FG000|Overall Study|Assigned, not treated|4|||
128700470|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Change of location|0|||
128922922|NCT03263806|464005461|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
128922923|NCT03263806|464005462|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
128922924|NCT03263806|464005461|FG000|Overall Study|Withdrawal by Subject|0|||
128922925|NCT03263806|464005462|FG001|Overall Study|Withdrawal by Subject|1|||
128922926|NCT03263806|464005461|FG000|Overall Study|Study Termination|5|||
128922927|NCT03263806|464005462|FG001|Overall Study|Study Termination|6|||
128922928|NCT01412879|464005465|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
128922929|NCT01412879|464005466|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
128922930|NCT01412879|464005467|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
128922931|NCT01412879|464005465|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
128922932|NCT01412879|464005466|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
128922933|NCT01412879|464005467|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
128922934|NCT01412879|464005465|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
128700471|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Change of location|0|||
128700472|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Change of location|0|||
128700473|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Change of location|1|||
128700474|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Change of location|0|||
128700475|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
128700476|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
128700477|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
128700478|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
128700479|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
128700480|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
128700481|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
128700482|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
128700483|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
128700484|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
128700485|NCT00730405|463201578|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
128700486|NCT00730405|463201579|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
128700487|NCT00730405|463201580|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
128700488|NCT00730405|463201581|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
128700489|NCT00730405|463201582|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
128700490|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
128700491|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
128700492|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
128700493|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
128700494|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
128700495|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
128700496|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
128700497|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
128700498|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
128700499|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
128700500|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
128700501|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
128700502|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
128700503|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
128700504|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
128700505|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Death|0|||
128700506|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Death|1|||
128922935|NCT01412879|464005466|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
128922936|NCT01412879|464005467|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
129029392|NCT01899053|464398400|FG003|Overall Study|Protocol Violation|0|||
129029393|NCT01899053|464398401|FG004|Overall Study|Protocol Violation|0|||
129029394|NCT01899053|464398402|FG005|Overall Study|Protocol Violation|0|||
129029395|NCT01899053|464398403|FG006|Overall Study|Protocol Violation|0|||
129029396|NCT01899053|464398404|FG007|Overall Study|Protocol Violation|0|||
129029397|NCT01899053|464398405|FG008|Overall Study|Protocol Violation|0|||
129029398|NCT01899053|464398406|FG009|Overall Study|Protocol Violation|0|||
129029399|NCT01899053|464398407|FG010|Overall Study|Protocol Violation|0|||
129029400|NCT01899053|464398408|FG011|Overall Study|Protocol Violation|0|||
129029401|NCT01899053|464398409|FG012|Overall Study|Protocol Violation|0|||
129029402|NCT01899053|464398410|FG013|Overall Study|Protocol Violation|0|||
128922937|NCT01412879|464005465|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
128922938|NCT01412879|464005466|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
128922939|NCT01412879|464005467|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
128922940|NCT01412879|464005465|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
128922941|NCT01412879|464005466|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
128922942|NCT01412879|464005467|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
128922943|NCT02109029|464005468|FG000|Part B|Adverse Event|0|||
128922944|NCT02109029|464005469|FG001|Part B|Adverse Event|0|||
128922945|NCT02109029|464005470|FG002|Part B|Adverse Event|0|||
128922946|NCT02109029|464005471|FG003|Part B|Adverse Event|0|||
128922947|NCT02109029|464005472|FG004|Part B|Adverse Event|1|||
128922948|NCT02109029|464005473|FG005|Part B|Adverse Event|1|||
128922949|NCT01445171|464005480|FG000|Overall Study|Lost to Follow-up|11|||
128922950|NCT01445171|464005480|FG000|Overall Study|Withdrawal by Subject|16|||
128922951|NCT01445171|464005480|FG000|Overall Study|Death|51|||
128922952|NCT01445171|464005480|FG000|Overall Study|Subjects declined to return for followup|9|||
128922953|NCT01445171|464005480|FG000|Overall Study|Consented but did not receive device|8|||
128922954|NCT03195894|464005481|FG000|Overall Study|"An example is Started other treatment."|4|||
128922955|NCT03195894|464005482|FG001|Overall Study|"An example is Started other treatment."|5|||
128922956|NCT03195894|464005481|FG000|Overall Study|Withdrawal by Subject|15|||
128922957|NCT03195894|464005482|FG001|Overall Study|Withdrawal by Subject|4|||
128922958|NCT03195894|464005481|FG000|Overall Study|Lost to Follow-up|14|||
128922959|NCT03195894|464005482|FG001|Overall Study|Lost to Follow-up|19|||
128922960|NCT00162773|464005486|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
128922961|NCT00110305|464005487|FG000|Overall Study|Adverse Event|46|||
128922962|NCT00110305|464005488|FG001|Overall Study|Adverse Event|13|||
128922963|NCT00110305|464005487|FG000|Overall Study|Sponsors Decision|1|||
128922964|NCT00110305|464005488|FG001|Overall Study|Sponsors Decision|0|||
128922965|NCT00110305|464005487|FG000|Overall Study|Subject Non-Compliant|9|||
128922966|NCT00110305|464005488|FG001|Overall Study|Subject Non-Compliant|2|||
128700507|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Death|0|||
128700508|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Death|1|||
128700509|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Death|0|||
128700510|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Change of location|1|||
128700511|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Change of location|1|||
128700512|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Change of location|0|||
128700513|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Change of location|1|||
128700514|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Change of location|0|||
128700515|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
128700516|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
128700517|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
128700518|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
128700519|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
128700520|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
128700521|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
128700522|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
128700523|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
128700524|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
128700525|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
128700526|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
128700527|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
128700528|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
128922967|NCT00110305|464005487|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
128922968|NCT00110305|464005488|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
128922969|NCT00110305|464005487|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
128922970|NCT00110305|464005488|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
128922971|NCT00110305|464005487|FG000|Overall Study|Protocol Violation|0|||
128922972|NCT00110305|464005488|FG001|Overall Study|Protocol Violation|1|||
128922973|NCT00110305|464005487|FG000|Overall Study|Withdrawal by Subject|7|||
128922974|NCT00110305|464005488|FG001|Overall Study|Withdrawal by Subject|7|||
128922975|NCT00110305|464005487|FG000|Overall Study|Lost to Follow-up|20|||
128922976|NCT00110305|464005488|FG001|Overall Study|Lost to Follow-up|3|||
129118924|NCT01799941|464733129|FG000|Overall Study|Withdrawal by Subject|21|||
128766741|NCT04488003|463436644|FG000|Assessed for Eligibility|Physician Decision|1|||
129118925|NCT01799941|464733129|FG000|Overall Study|Death|2|||
129118926|NCT01799941|464733129|FG000|Overall Study|Investigator Decision|4|||
128700529|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
128922977|NCT00110305|464005487|FG000|Overall Study|Other|8|||
128922978|NCT00110305|464005488|FG001|Overall Study|Other|2|||
128922979|NCT01887912|464005491|FG000|Overall Study|Serious adverse event|400|||
128922980|NCT01887912|464005492|FG001|Overall Study|Serious adverse event|198|||
128922981|NCT01887912|464005491|FG000|Overall Study|Other Adverse Event|34|||
128922982|NCT01887912|464005492|FG001|Overall Study|Other Adverse Event|15|||
128922983|NCT01887912|464005491|FG000|Overall Study|Protocol Violation|67|||
128922984|NCT01887912|464005492|FG001|Overall Study|Protocol Violation|37|||
128922985|NCT01887912|464005491|FG000|Overall Study|Lost to Follow-up|163|||
128922986|NCT01887912|464005492|FG001|Overall Study|Lost to Follow-up|74|||
128922987|NCT01887912|464005491|FG000|Overall Study|Withdrawal by Subject|606|||
128922988|NCT01887912|464005492|FG001|Overall Study|Withdrawal by Subject|349|||
128922989|NCT01887912|464005491|FG000|Overall Study|Other|122|||
128922990|NCT01887912|464005492|FG001|Overall Study|Other|58|||
128922991|NCT01154101|464005495|FG000|Overall Study|Adverse Event|0|||
128922992|NCT01154101|464005496|FG001|Overall Study|Adverse Event|2|||
128922993|NCT01154101|464005497|FG002|Overall Study|Adverse Event|1|||
128922994|NCT01154101|464005498|FG003|Overall Study|Adverse Event|1|||
128922995|NCT01154101|464005499|FG004|Overall Study|Adverse Event|0|||
128922996|NCT01154101|464005495|FG000|Overall Study|Lost to Follow-up|0|||
128922997|NCT01154101|464005496|FG001|Overall Study|Lost to Follow-up|1|||
128922998|NCT01154101|464005497|FG002|Overall Study|Lost to Follow-up|0|||
128922999|NCT01154101|464005498|FG003|Overall Study|Lost to Follow-up|1|||
128923000|NCT01154101|464005499|FG004|Overall Study|Lost to Follow-up|0|||
128923001|NCT01154101|464005495|FG000|Overall Study|Withdrawal by Subject|0|||
128923002|NCT01154101|464005496|FG001|Overall Study|Withdrawal by Subject|1|||
128923003|NCT01154101|464005497|FG002|Overall Study|Withdrawal by Subject|2|||
128923004|NCT01154101|464005498|FG003|Overall Study|Withdrawal by Subject|0|||
128923005|NCT01154101|464005499|FG004|Overall Study|Withdrawal by Subject|1|||
128923006|NCT04125680|464005501|FG000|Overall Study|Lost to Follow-up|15|||
128923007|NCT01562028|464005502|FG000|Overall Study|Withdrawal by Subject|1|||
128923008|NCT01562028|464005503|FG001|Overall Study|Withdrawal by Subject|1|||
128923009|NCT01562028|464005502|FG000|Overall Study|Lost to Follow-up|2|||
128923010|NCT01562028|464005503|FG001|Overall Study|Lost to Follow-up|1|||
128923011|NCT02360098|464005504|FG000|Overall Study|Physician Decision|7|||
128923012|NCT04938648|464005505|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
128923013|NCT04938648|464005506|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
128923014|NCT04938648|464005505|FG000|Overall Study|Patient too ill|0|||
128923015|NCT04938648|464005506|FG001|Overall Study|Patient too ill|1|||
128923016|NCT04938648|464005505|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
128923017|NCT04938648|464005506|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
128923018|NCT04938648|464005505|FG000|Overall Study|Patient did not have memory problems|1|||
128923019|NCT04938648|464005506|FG001|Overall Study|Patient did not have memory problems|1|||
128923020|NCT04938648|464005505|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
128923021|NCT04938648|464005506|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
128923022|NCT04938648|464005505|FG000|Overall Study|Care partner could not be reached|0|||
128923023|NCT04938648|464005506|FG001|Overall Study|Care partner could not be reached|1|||
128923024|NCT04938648|464005505|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
128923025|NCT04938648|464005506|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
128923026|NCT04938648|464005505|FG000|Overall Study|Withdrawal by Subject|2|||
128923027|NCT04938648|464005506|FG001|Overall Study|Withdrawal by Subject|1|||
128923028|NCT03619213|464005507|FG000|Overall Study|Lost to Follow-up|2|||
128923029|NCT03619213|464005508|FG001|Overall Study|Lost to Follow-up|1|||
128923030|NCT03619213|464005507|FG000|Overall Study|Withdrawal by Subject|8|||
128923031|NCT03619213|464005508|FG001|Overall Study|Withdrawal by Subject|10|||
128923032|NCT02542267|464005509|FG000|Overall Study|Withdrawal by Subject|10|||
128923033|NCT02542267|464005509|FG000|Overall Study|Physician Decision|6|||
128923034|NCT02542267|464005509|FG000|Overall Study|Lost to Follow-up|4|||
128923035|NCT02542267|464005509|FG000|Overall Study|Death|13|||
128923036|NCT02542267|464005509|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
128923037|NCT02542267|464005509|FG000|Overall Study|Other|9|||
128923038|NCT01974323|464005512|FG000|Overall Study|Other Reasons|25|||
128923039|NCT01974323|464005513|FG001|Overall Study|Other Reasons|28|||
128923040|NCT01974323|464005512|FG000|Overall Study|Protocol Violation|2|||
128923041|NCT01974323|464005513|FG001|Overall Study|Protocol Violation|2|||
128923042|NCT01974323|464005512|FG000|Overall Study|Personal Reasons|15|||
128923043|NCT01974323|464005513|FG001|Overall Study|Personal Reasons|19|||
128766742|NCT04488003|463436645|FG001|Assessed for Eligibility|Physician Decision|0|||
128923044|NCT01974323|464005512|FG000|Overall Study|Lost to Follow-up|45|||
128923045|NCT01974323|464005513|FG001|Overall Study|Lost to Follow-up|40|||
128923046|NCT01974323|464005512|FG000|Overall Study|Pregnancy|2|||
128923047|NCT01974323|464005513|FG001|Overall Study|Pregnancy|1|||
128923048|NCT01974323|464005512|FG000|Overall Study|Lack of Efficacy|1|||
128923049|NCT01974323|464005513|FG001|Overall Study|Lack of Efficacy|1|||
128923050|NCT01974323|464005512|FG000|Overall Study|Adverse Event|2|||
128923051|NCT01974323|464005513|FG001|Overall Study|Adverse Event|2|||
128923052|NCT00331760|464005514|FG000|Overall Study|Ineligible / no protocol treatment|15|||
128923053|NCT00331760|464005515|FG001|Overall Study|Ineligible / no protocol treatment|8|||
128923054|NCT00461175|464005516|FG000|Overall Study|Protocol Violation|522|||
128923055|NCT00461175|464005517|FG001|Overall Study|Protocol Violation|365|||
128923056|NCT00619229|464005518|FG000|Overall Study|Withdrawal by Subject|1|||
128923057|NCT00619229|464005519|FG001|Overall Study|Withdrawal by Subject|1|||
128923058|NCT00619229|464005518|FG000|Overall Study|Lost to Follow-up|1|||
128923059|NCT00619229|464005519|FG001|Overall Study|Lost to Follow-up|0|||
128923060|NCT00619229|464005518|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
128923061|NCT00619229|464005519|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
128923062|NCT00619229|464005518|FG000|Overall Study|Investigator planned Cataract Operation|1|||
128923063|NCT00619229|464005519|FG001|Overall Study|Investigator planned Cataract Operation|0|||
128923064|NCT02786901|464005520|FG000|Overall Study|Adverse Event|1|||
128923065|NCT02786901|464005521|FG001|Overall Study|Adverse Event|1|||
128923066|NCT02786901|464005522|FG002|Overall Study|Adverse Event|2|||
128923067|NCT02786901|464005520|FG000|Overall Study|Physician Decision|1|||
128923068|NCT02786901|464005521|FG001|Overall Study|Physician Decision|0|||
128923069|NCT02786901|464005522|FG002|Overall Study|Physician Decision|0|||
129118927|NCT01799941|464733129|FG000|Overall Study|Lack of Efficacy|3|||
129118928|NCT01799941|464733129|FG000|Overall Study|Lost to Follow-up|17|||
129118929|NCT01799941|464733129|FG000|Overall Study|Other|15|||
129118930|NCT00420745|464733130|FG000|Overall Study|Adverse Event|2|||
129118931|NCT00420745|464733131|FG001|Overall Study|Adverse Event|2|||
129118932|NCT00420745|464733130|FG000|Overall Study|Lost to Follow-up|10|||
129118933|NCT00420745|464733131|FG001|Overall Study|Lost to Follow-up|2|||
129118934|NCT00420745|464733130|FG000|Overall Study|Protocol Violation|1|||
129118935|NCT00420745|464733131|FG001|Overall Study|Protocol Violation|0|||
129118936|NCT00420745|464733130|FG000|Overall Study|Physician Decision|1|||
129118937|NCT00420745|464733131|FG001|Overall Study|Physician Decision|1|||
129118938|NCT00420745|464733130|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
128700530|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
128700531|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
128700532|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
128700533|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
128700534|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
128700535|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
128700536|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
128700537|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
128700538|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
128700539|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
128700540|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
128700541|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
128700542|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
128700543|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
128700544|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
128700545|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
128700546|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
128700547|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
128700548|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
128700549|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
128923070|NCT02786901|464005520|FG000|Overall Study|Rescue Therapy Use|71|||
128923071|NCT02786901|464005521|FG001|Overall Study|Rescue Therapy Use|49|||
128923072|NCT02786901|464005522|FG002|Overall Study|Rescue Therapy Use|33|||
128923073|NCT02786901|464005520|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
128923074|NCT02786901|464005521|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
128923075|NCT02786901|464005522|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
129118939|NCT00420745|464733131|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
129118940|NCT00420745|464733130|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
129118941|NCT00420745|464733131|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
129118942|NCT01125930|464733132|FG000|Overall Study|Adverse Event|0|||
128700550|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
128700551|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
128700552|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
128700553|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
128923076|NCT02786901|464005520|FG000|Overall Study|Disallowed medication|1|||
128923077|NCT02786901|464005521|FG001|Overall Study|Disallowed medication|1|||
128923078|NCT02786901|464005522|FG002|Overall Study|Disallowed medication|0|||
128923079|NCT02786901|464005520|FG000|Overall Study|Randomized in error|2|||
128923080|NCT02786901|464005521|FG001|Overall Study|Randomized in error|0|||
128923081|NCT02786901|464005522|FG002|Overall Study|Randomized in error|1|||
128923082|NCT01075178|464005523|FG000|Subject Matching|eligible but not matched|130|||
129118943|NCT01125930|464733133|FG001|Overall Study|Adverse Event|1|||
129118944|NCT01125930|464733132|FG000|Overall Study|Withdrawal by Subject|1|||
129118945|NCT01125930|464733133|FG001|Overall Study|Withdrawal by Subject|6|||
128923083|NCT01075178|464005524|FG001|Subject Matching|eligible but not matched|403|||
128923084|NCT01075178|464005523|FG000|Subject Chart Review|died before chart review period|0|||
128923085|NCT01075178|464005524|FG001|Subject Chart Review|died before chart review period|2|||
128923086|NCT01075178|464005523|FG000|Subject Chart Review|no data collected due to site closure|3|||
129118946|NCT01125930|464733132|FG000|Overall Study|Protocol Violation|0|||
129118947|NCT01125930|464733133|FG001|Overall Study|Protocol Violation|1|||
129118948|NCT01125930|464733132|FG000|Overall Study|Lost to Follow-up|0|||
129118949|NCT01125930|464733133|FG001|Overall Study|Lost to Follow-up|2|||
128700554|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
128700555|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
128700556|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
128700557|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
128700558|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
128700559|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
128700560|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
128700561|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
128700562|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
128700563|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
128700564|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
128700565|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Missing|0|||
128700566|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Missing|0|||
128700567|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Missing|2|||
128700568|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Missing|0|||
128700569|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Missing|0|||
128700570|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
128700571|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
128700572|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
128700573|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
128700574|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
128700575|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
128700576|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
128700577|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
128700578|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
128700579|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
128700580|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
128700581|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
129118950|NCT03098979|464733134|FG000|Overall Study|Adverse Event|1|||
129118951|NCT03098979|464733135|FG001|Overall Study|Adverse Event|0|||
129118952|NCT03098979|464733136|FG002|Overall Study|Adverse Event|1|||
129118953|NCT03098979|464733137|FG003|Overall Study|Adverse Event|4|||
129118954|NCT03098979|464733138|FG004|Overall Study|Adverse Event|6|||
129118955|NCT03098979|464733139|FG005|Overall Study|Adverse Event|1|||
129118956|NCT03098979|464733134|FG000|Overall Study|Withdrawal by Subject|2|||
129118957|NCT03098979|464733135|FG001|Overall Study|Withdrawal by Subject|1|||
129118958|NCT03098979|464733136|FG002|Overall Study|Withdrawal by Subject|1|||
129118959|NCT03098979|464733137|FG003|Overall Study|Withdrawal by Subject|1|||
129118960|NCT03098979|464733138|FG004|Overall Study|Withdrawal by Subject|2|||
129118961|NCT03098979|464733139|FG005|Overall Study|Withdrawal by Subject|1|||
129118962|NCT03098979|464733134|FG000|Overall Study|Death|1|||
129118963|NCT03098979|464733135|FG001|Overall Study|Death|0|||
129118964|NCT03098979|464733136|FG002|Overall Study|Death|2|||
129118965|NCT03098979|464733137|FG003|Overall Study|Death|0|||
129118966|NCT03098979|464733138|FG004|Overall Study|Death|1|||
129118967|NCT03098979|464733139|FG005|Overall Study|Death|0|||
128700582|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
128700583|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
128700584|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
128923087|NCT01075178|464005524|FG001|Subject Chart Review|no data collected due to site closure|4|||
128700585|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
129118968|NCT03098979|464733134|FG000|Overall Study|Physician Decision|2|||
129118969|NCT03098979|464733135|FG001|Overall Study|Physician Decision|1|||
129118970|NCT03098979|464733136|FG002|Overall Study|Physician Decision|0|||
129118971|NCT03098979|464733137|FG003|Overall Study|Physician Decision|0|||
129118972|NCT03098979|464733138|FG004|Overall Study|Physician Decision|0|||
129118973|NCT03098979|464733139|FG005|Overall Study|Physician Decision|0|||
129118974|NCT03098979|464733134|FG000|Overall Study|Non-compliance|0|||
128700586|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
128700587|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
129118975|NCT03098979|464733135|FG001|Overall Study|Non-compliance|0|||
129118976|NCT03098979|464733136|FG002|Overall Study|Non-compliance|0|||
129118977|NCT03098979|464733137|FG003|Overall Study|Non-compliance|0|||
129118978|NCT03098979|464733138|FG004|Overall Study|Non-compliance|0|||
128923088|NCT01075178|464005523|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
128923089|NCT01075178|464005524|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
128923090|NCT03367871|464005525|FG000|Overall Study|Lost to Follow-up|1|||
128923091|NCT02983604|464005526|FG000|Overall Study|Enrolled but not Treated|0|||
128923092|NCT02983604|464005527|FG001|Overall Study|Enrolled but not Treated|0|||
128923093|NCT02983604|464005528|FG002|Overall Study|Enrolled but not Treated|1|||
128700588|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
128700589|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
128923094|NCT02983604|464005529|FG003|Overall Study|Enrolled but not Treated|0|||
128923095|NCT01111604|464005530|FG000|Overall Study|Lost to Follow-up|0|||
128923096|NCT01111604|464005531|FG001|Overall Study|Lost to Follow-up|0|||
128923097|NCT01111604|464005532|FG002|Overall Study|Lost to Follow-up|1|||
128923098|NCT01111604|464005530|FG000|Overall Study|Withdrew Consent|3|||
128923099|NCT01111604|464005531|FG001|Overall Study|Withdrew Consent|0|||
128923100|NCT01111604|464005532|FG002|Overall Study|Withdrew Consent|2|||
128923101|NCT01111604|464005530|FG000|Overall Study|Withdrawal by Subject|2|||
128923102|NCT01111604|464005531|FG001|Overall Study|Withdrawal by Subject|0|||
128923103|NCT01111604|464005532|FG002|Overall Study|Withdrawal by Subject|0|||
128923104|NCT01111604|464005530|FG000|Overall Study|Death|1|||
128923105|NCT01111604|464005531|FG001|Overall Study|Death|0|||
128923106|NCT01111604|464005532|FG002|Overall Study|Death|0|||
128923107|NCT01111604|464005530|FG000|Overall Study|Met Exclusion Criteria|2|||
128923108|NCT01111604|464005531|FG001|Overall Study|Met Exclusion Criteria|0|||
128923109|NCT01111604|464005532|FG002|Overall Study|Met Exclusion Criteria|0|||
128923110|NCT00316264|464005534|FG000|Overall Study|Lost to Follow-up|0|||
128923111|NCT00316264|464005535|FG001|Overall Study|Lost to Follow-up|1|||
128923112|NCT00316264|464005536|FG002|Overall Study|Lost to Follow-up|0|||
128923113|NCT00316264|464005534|FG000|Overall Study|Withdrawal of Consent|3|||
128923114|NCT00316264|464005535|FG001|Overall Study|Withdrawal of Consent|5|||
128923115|NCT00316264|464005536|FG002|Overall Study|Withdrawal of Consent|6|||
128923116|NCT00316264|464005534|FG000|Overall Study|Death|2|||
128923117|NCT00316264|464005535|FG001|Overall Study|Death|0|||
128923118|NCT00316264|464005536|FG002|Overall Study|Death|0|||
128923119|NCT00316264|464005534|FG000|Overall Study|Other|1|||
128923120|NCT00316264|464005535|FG001|Overall Study|Other|1|||
128923121|NCT00316264|464005536|FG002|Overall Study|Other|0|||
128923122|NCT00607048|464005537|FG000|Overall Study|Adverse Event|0|||
128923123|NCT00607048|464005538|FG001|Overall Study|Adverse Event|1|||
128923124|NCT00607048|464005539|FG002|Overall Study|Adverse Event|0|||
128923125|NCT00607048|464005540|FG003|Overall Study|Adverse Event|0|||
128923126|NCT00607048|464005541|FG004|Overall Study|Adverse Event|4|||
128923127|NCT00607048|464005542|FG005|Overall Study|Adverse Event|0|||
128923128|NCT00607048|464005537|FG000|Overall Study|Global deterioration of health|1|||
128923129|NCT00607048|464005538|FG001|Overall Study|Global deterioration of health|0|||
128923130|NCT00607048|464005539|FG002|Overall Study|Global deterioration of health|0|||
128923131|NCT00607048|464005540|FG003|Overall Study|Global deterioration of health|0|||
128923132|NCT00607048|464005541|FG004|Overall Study|Global deterioration of health|0|||
128923133|NCT00607048|464005542|FG005|Overall Study|Global deterioration of health|0|||
128923134|NCT00607048|464005537|FG000|Overall Study|Objective disease progression - relapse|1|||
128923135|NCT00607048|464005538|FG001|Overall Study|Objective disease progression - relapse|2|||
128923136|NCT00607048|464005539|FG002|Overall Study|Objective disease progression - relapse|4|||
128923137|NCT00607048|464005540|FG003|Overall Study|Objective disease progression - relapse|2|||
128923138|NCT00607048|464005541|FG004|Overall Study|Objective disease progression - relapse|2|||
128923139|NCT00607048|464005542|FG005|Overall Study|Objective disease progression - relapse|2|||
128923140|NCT00607048|464005537|FG000|Overall Study|Withdrawal by Subject|0|||
128923141|NCT00607048|464005538|FG001|Overall Study|Withdrawal by Subject|0|||
128923142|NCT00607048|464005539|FG002|Overall Study|Withdrawal by Subject|0|||
128923143|NCT00607048|464005540|FG003|Overall Study|Withdrawal by Subject|1|||
128923144|NCT00607048|464005541|FG004|Overall Study|Withdrawal by Subject|0|||
128923145|NCT00607048|464005542|FG005|Overall Study|Withdrawal by Subject|2|||
128923146|NCT00607048|464005537|FG000|Overall Study|Other|1|||
128700590|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
128700591|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
128700592|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
128700593|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
128700594|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
128923147|NCT00607048|464005538|FG001|Overall Study|Other|1|||
128923148|NCT00607048|464005539|FG002|Overall Study|Other|0|||
128923149|NCT00607048|464005540|FG003|Overall Study|Other|0|||
128923150|NCT00607048|464005541|FG004|Overall Study|Other|0|||
128923151|NCT00607048|464005542|FG005|Overall Study|Other|1|||
128923152|NCT00355264|464005543|FG000|Extension (Variable Duration)|Adverse Event|1|||
128923153|NCT00355264|464005543|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
128923154|NCT01157117|464005544|FG000|Overall Study|Dosing Symptoms|0|||
128923155|NCT01157117|464005545|FG001|Overall Study|Dosing Symptoms|4|||
128923156|NCT01157117|464005546|FG002|Overall Study|Dosing Symptoms|0|||
128923157|NCT01157117|464005544|FG000|Overall Study|Withdrawal by Subject|4|||
128923158|NCT01157117|464005545|FG001|Overall Study|Withdrawal by Subject|1|||
128923159|NCT01157117|464005546|FG002|Overall Study|Withdrawal by Subject|1|||
128923160|NCT01157117|464005544|FG000|Overall Study|Lack of Efficacy|1|||
128923161|NCT01157117|464005545|FG001|Overall Study|Lack of Efficacy|1|||
128923162|NCT01157117|464005546|FG002|Overall Study|Lack of Efficacy|0|||
128923163|NCT01157117|464005544|FG000|Overall Study|Lost to Follow-up|0|||
128923164|NCT01157117|464005545|FG001|Overall Study|Lost to Follow-up|0|||
128923165|NCT01157117|464005546|FG002|Overall Study|Lost to Follow-up|1|||
128923166|NCT01157117|464005544|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
128923167|NCT01157117|464005545|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
128923168|NCT01157117|464005546|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
128923169|NCT00826514|464005547|FG000|Overall Study|Adverse Event|1|||
128923170|NCT00826514|464005548|FG001|Overall Study|Adverse Event|1|||
128923171|NCT00826514|464005547|FG000|Overall Study|Lack of Efficacy|0|||
128923172|NCT00826514|464005548|FG001|Overall Study|Lack of Efficacy|1|||
128923173|NCT00826514|464005547|FG000|Overall Study|Withdrawal by Subject|2|||
128923174|NCT00826514|464005548|FG001|Overall Study|Withdrawal by Subject|3|||
128923175|NCT03663166|464005551|FG000|Overall Study|Withdrawal by Subject|1|||
128923176|NCT03926143|464005553|FG000|Overall Study|Physician Decision|3|||
128923177|NCT03926143|464005553|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
128923178|NCT03926143|464005553|FG000|Overall Study|Adverse Event|2|||
128923179|NCT03926143|464005553|FG000|Overall Study|Progressive disease|3|||
128923180|NCT02207907|464005559|FG000|Overall Study|Lost to Follow-up|3|||
128923181|NCT02207907|464005560|FG001|Overall Study|Lost to Follow-up|1|||
128923182|NCT02207907|464005559|FG000|Overall Study|Withdrawal by Subject|5|||
128923183|NCT02207907|464005560|FG001|Overall Study|Withdrawal by Subject|6|||
128923184|NCT02207907|464005559|FG000|Overall Study|Did not meet study criteria|3|||
128923185|NCT02207907|464005560|FG001|Overall Study|Did not meet study criteria|0|||
128923186|NCT02207907|464005559|FG000|Overall Study|Pregnancy|0|||
128923187|NCT02207907|464005560|FG001|Overall Study|Pregnancy|1|||
128923188|NCT02620020|464005561|FG000|Overall Study|Adverse Event|8|||
128923189|NCT02620020|464005562|FG001|Overall Study|Adverse Event|4|||
128923190|NCT02620020|464005563|FG002|Overall Study|Adverse Event|3|||
128923191|NCT02620020|464005564|FG003|Overall Study|Adverse Event|5|||
128923192|NCT02620020|464005561|FG000|Overall Study|Lost to Follow-up|4|||
128923193|NCT02620020|464005562|FG001|Overall Study|Lost to Follow-up|8|||
128923194|NCT02620020|464005563|FG002|Overall Study|Lost to Follow-up|1|||
128923195|NCT02620020|464005564|FG003|Overall Study|Lost to Follow-up|4|||
128923196|NCT02620020|464005561|FG000|Overall Study|Physician Decision|7|||
128923197|NCT02620020|464005562|FG001|Overall Study|Physician Decision|4|||
128923198|NCT02620020|464005563|FG002|Overall Study|Physician Decision|3|||
128923199|NCT02620020|464005564|FG003|Overall Study|Physician Decision|4|||
128923200|NCT02620020|464005561|FG000|Overall Study|Protocol Violation|5|||
128923201|NCT02620020|464005562|FG001|Overall Study|Protocol Violation|2|||
128923202|NCT02620020|464005563|FG002|Overall Study|Protocol Violation|1|||
128923203|NCT02620020|464005564|FG003|Overall Study|Protocol Violation|1|||
128923204|NCT02620020|464005561|FG000|Overall Study|Withdrawal by Subject|20|||
128923205|NCT02620020|464005562|FG001|Overall Study|Withdrawal by Subject|16|||
128923206|NCT02620020|464005563|FG002|Overall Study|Withdrawal by Subject|17|||
128923207|NCT02620020|464005564|FG003|Overall Study|Withdrawal by Subject|12|||
128923208|NCT02620020|464005561|FG000|Overall Study|Death|0|||
128923209|NCT02620020|464005562|FG001|Overall Study|Death|1|||
128923210|NCT02620020|464005563|FG002|Overall Study|Death|0|||
128923211|NCT02620020|464005564|FG003|Overall Study|Death|0|||
128923212|NCT03168867|464005565|FG000|Overall Study|Withdrawal by Subject|1|||
128923213|NCT03168867|464005566|FG001|Overall Study|Withdrawal by Subject|5|||
128923214|NCT04348851|464005567|FG000|Post-Test 1|Withdrawal by Subject|0|||
128923215|NCT04348851|464005568|FG001|Post-Test 1|Withdrawal by Subject|1|||
128923216|NCT04348851|464005569|FG002|Post-Test 1|Withdrawal by Subject|0|||
128923217|NCT04348851|464005570|FG003|Post-Test 1|Withdrawal by Subject|0|||
128700595|NCT00730405|463201578|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
128923218|NCT04348851|464005567|FG000|Post-Test 1|Lost to Follow-up|0|||
128923219|NCT04348851|464005568|FG001|Post-Test 1|Lost to Follow-up|1|||
128700596|NCT00730405|463201579|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
128700597|NCT00730405|463201580|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
128700598|NCT00730405|463201581|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
128923220|NCT04348851|464005569|FG002|Post-Test 1|Lost to Follow-up|0|||
128700599|NCT00730405|463201582|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
128700600|NCT01496807|463201586|FG000|Overall Study|Progressive Disease|21|||
128700601|NCT01496807|463201586|FG000|Overall Study|Participant preference/toxicity|8|||
128923221|NCT04348851|464005570|FG003|Post-Test 1|Lost to Follow-up|0|||
128923222|NCT04348851|464005567|FG000|Post-Test 2|Stroke survivor death|0|||
128923223|NCT04348851|464005568|FG001|Post-Test 2|Stroke survivor death|1|||
128923224|NCT04348851|464005569|FG002|Post-Test 2|Stroke survivor death|0|||
129118979|NCT03098979|464733139|FG005|Overall Study|Non-compliance|1|||
128923225|NCT04348851|464005570|FG003|Post-Test 2|Stroke survivor death|1|||
128700602|NCT01496807|463201586|FG000|Overall Study|Change in diagnosis|1|||
128700603|NCT02591290|463201590|FG000|Overall Study|Withdrawal by Subject|2|||
128700604|NCT00913497|463201591|FG000|Overall Study|Adverse Event|1|||
128700605|NCT00913497|463201591|FG000|Overall Study|Withdrawal by Subject|2|||
128700606|NCT02002091|463201592|FG000|Screening|Lost to Follow-up|10|||
128700607|NCT02002091|463201593|FG001|Screening|Lost to Follow-up|12|||
128700608|NCT02002091|463201592|FG000|Screening|Death|3|||
128700609|NCT02002091|463201593|FG001|Screening|Death|2|||
128700610|NCT01390649|463201594|FG000|Overall Study|Physician Decision|1|||
128700611|NCT03385564|463201596|FG000|Overall Study|Adverse Event|0|||
128700612|NCT03385564|463201597|FG001|Overall Study|Adverse Event|0|||
128700613|NCT03385564|463201598|FG002|Overall Study|Adverse Event|3|||
128700614|NCT03385564|463201599|FG003|Overall Study|Adverse Event|3|||
128700615|NCT03385564|463201596|FG000|Overall Study|Other than listed|0|||
128700616|NCT03385564|463201597|FG001|Overall Study|Other than listed|0|||
128700617|NCT03385564|463201598|FG002|Overall Study|Other than listed|0|||
128700618|NCT03385564|463201599|FG003|Overall Study|Other than listed|5|||
128700619|NCT03385564|463201596|FG000|Overall Study|Withdrawal by Subject|0|||
128700620|NCT03385564|463201597|FG001|Overall Study|Withdrawal by Subject|1|||
128700621|NCT03385564|463201598|FG002|Overall Study|Withdrawal by Subject|1|||
128700622|NCT03385564|463201599|FG003|Overall Study|Withdrawal by Subject|0|||
128700623|NCT03385564|463201596|FG000|Overall Study|Lack of Efficacy|0|||
128700624|NCT03385564|463201597|FG001|Overall Study|Lack of Efficacy|0|||
128700625|NCT03385564|463201598|FG002|Overall Study|Lack of Efficacy|0|||
128700626|NCT03385564|463201599|FG003|Overall Study|Lack of Efficacy|1|||
128700627|NCT03385564|463201596|FG000|Overall Study|Death|0|||
128700628|NCT03385564|463201597|FG001|Overall Study|Death|0|||
128700629|NCT03385564|463201598|FG002|Overall Study|Death|1|||
128700630|NCT03385564|463201599|FG003|Overall Study|Death|0|||
128700631|NCT00478231|463201608|FG000|Overall Study|Death|7|||
128700632|NCT00478231|463201608|FG000|Overall Study|Lack of Efficacy|47|||
128700633|NCT00478231|463201608|FG000|Overall Study|Lost to Follow-up|7|||
128700634|NCT00478231|463201608|FG000|Overall Study|Withdrawal by Subject|6|||
128700635|NCT00478231|463201608|FG000|Overall Study|Other|9|||
128700636|NCT00478231|463201608|FG000|Overall Study|Adverse Event|5|||
128923226|NCT02965378|464005571|FG000|Overall Study|Progression|16|||
128923227|NCT02965378|464005572|FG001|Overall Study|Progression|4|||
128923228|NCT02965378|464005571|FG000|Overall Study|Adverse Event|5|||
128923229|NCT02965378|464005572|FG001|Overall Study|Adverse Event|2|||
128923230|NCT02965378|464005571|FG000|Overall Study|Death|2|||
128923231|NCT02965378|464005572|FG001|Overall Study|Death|0|||
128923232|NCT02965378|464005571|FG000|Overall Study|Refusal|2|||
128923233|NCT02965378|464005572|FG001|Overall Study|Refusal|1|||
128923234|NCT02965378|464005571|FG000|Overall Study|Not protocol specified|0|||
128923235|NCT02965378|464005572|FG001|Overall Study|Not protocol specified|2|||
128923236|NCT00629083|464005577|FG000|Overall Study|Adverse Event|0|||
128923237|NCT00629083|464005578|FG001|Overall Study|Adverse Event|2|||
128923238|NCT00629083|464005577|FG000|Overall Study|Lack of Efficacy|3|||
128923239|NCT00629083|464005578|FG001|Overall Study|Lack of Efficacy|1|||
128923240|NCT00629083|464005577|FG000|Overall Study|Withdrawal by Subject|10|||
128923241|NCT00629083|464005578|FG001|Overall Study|Withdrawal by Subject|2|||
128923242|NCT00629083|464005577|FG000|Overall Study|Lost to Follow-up|12|||
128923243|NCT00629083|464005578|FG001|Overall Study|Lost to Follow-up|8|||
128923244|NCT00629083|464005577|FG000|Overall Study|Moved out of country/state|2|||
128923245|NCT00629083|464005578|FG001|Overall Study|Moved out of country/state|1|||
128923246|NCT00629083|464005577|FG000|Overall Study|Refused to return for 12 month visit|1|||
128923247|NCT00629083|464005578|FG001|Overall Study|Refused to return for 12 month visit|0|||
128923248|NCT02909153|464005579|FG000|Overall Study|Withdrawal by Subject|0|||
128923249|NCT02909153|464005580|FG001|Overall Study|Withdrawal by Subject|1|||
128923250|NCT02909153|464005581|FG002|Overall Study|Withdrawal by Subject|0|||
128923251|NCT02909153|464005582|FG003|Overall Study|Withdrawal by Subject|0|||
128700637|NCT00478231|463201608|FG000|Overall Study|Randomized, not treated|3|||
128923252|NCT02909153|464005583|FG004|Overall Study|Withdrawal by Subject|0|||
128923253|NCT01147809|464005584|FG000|Phase I (168 Days)|Adverse Event|0|||
128923254|NCT01147809|464005585|FG001|Phase I (168 Days)|Adverse Event|0|||
128923255|NCT01147809|464005586|FG002|Phase I (168 Days)|Adverse Event|0|||
128923256|NCT01147809|464005587|FG003|Phase I (168 Days)|Adverse Event|1|||
128923257|NCT01147809|464005588|FG004|Phase I (168 Days)|Adverse Event|0|||
128923258|NCT01147809|464005589|FG005|Phase I (168 Days)|Adverse Event|0|||
128923259|NCT01147809|464005584|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
128923260|NCT01147809|464005585|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
128923261|NCT01147809|464005586|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
129118980|NCT03098979|464733134|FG000|Overall Study|Protocol Violation|0|||
129118981|NCT03098979|464733135|FG001|Overall Study|Protocol Violation|0|||
128700638|NCT04731363|463201613|FG000|Overall Study|Could not obtain samples|0|||
128700639|NCT04731363|463201614|FG001|Overall Study|Could not obtain samples|1|||
128923262|NCT01147809|464005587|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
128700640|NCT04731363|463201615|FG002|Overall Study|Could not obtain samples|0|||
128700641|NCT04731363|463201616|FG003|Overall Study|Could not obtain samples|0|||
128700642|NCT04731363|463201613|FG000|Overall Study|Physician Decision|0|||
128923263|NCT01147809|464005588|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
128923264|NCT01147809|464005589|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
128923265|NCT01147809|464005584|FG000|Phase I (168 Days)|Physician Decision|0|||
128923266|NCT01147809|464005585|FG001|Phase I (168 Days)|Physician Decision|1|||
128923267|NCT01147809|464005586|FG002|Phase I (168 Days)|Physician Decision|2|||
128923268|NCT01147809|464005587|FG003|Phase I (168 Days)|Physician Decision|0|||
128923269|NCT01147809|464005588|FG004|Phase I (168 Days)|Physician Decision|0|||
128923270|NCT01147809|464005589|FG005|Phase I (168 Days)|Physician Decision|0|||
128923271|NCT01147809|464005584|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
128923272|NCT01147809|464005585|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
128923273|NCT01147809|464005586|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
128923274|NCT01147809|464005587|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
128923275|NCT01147809|464005588|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
128923276|NCT01147809|464005589|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
128923277|NCT01147809|464005584|FG000|Phase II (168 Days)|Adverse Event|0|||
128923278|NCT01147809|464005585|FG001|Phase II (168 Days)|Adverse Event|0|||
128923279|NCT01147809|464005586|FG002|Phase II (168 Days)|Adverse Event|0|||
128923280|NCT01147809|464005587|FG003|Phase II (168 Days)|Adverse Event|0|||
128923281|NCT01147809|464005588|FG004|Phase II (168 Days)|Adverse Event|3|||
128923282|NCT01147809|464005589|FG005|Phase II (168 Days)|Adverse Event|6|||
128923283|NCT01147809|464005584|FG000|Phase II (168 Days)|Protocol Violation|0|||
128923284|NCT01147809|464005585|FG001|Phase II (168 Days)|Protocol Violation|0|||
128923285|NCT01147809|464005586|FG002|Phase II (168 Days)|Protocol Violation|0|||
128923286|NCT01147809|464005587|FG003|Phase II (168 Days)|Protocol Violation|0|||
128923287|NCT01147809|464005588|FG004|Phase II (168 Days)|Protocol Violation|0|||
128923288|NCT01147809|464005589|FG005|Phase II (168 Days)|Protocol Violation|1|||
128923289|NCT01147809|464005584|FG000|Phase II (168 Days)|Physician Decision|0|||
128923290|NCT01147809|464005585|FG001|Phase II (168 Days)|Physician Decision|0|||
128923291|NCT01147809|464005586|FG002|Phase II (168 Days)|Physician Decision|0|||
128923292|NCT01147809|464005587|FG003|Phase II (168 Days)|Physician Decision|0|||
128923293|NCT01147809|464005588|FG004|Phase II (168 Days)|Physician Decision|5|||
128923294|NCT01147809|464005589|FG005|Phase II (168 Days)|Physician Decision|11|||
128923295|NCT01147809|464005584|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
128923296|NCT01147809|464005585|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
129118982|NCT03098979|464733136|FG002|Overall Study|Protocol Violation|0|||
129118983|NCT03098979|464733137|FG003|Overall Study|Protocol Violation|0|||
129118984|NCT03098979|464733138|FG004|Overall Study|Protocol Violation|0|||
129118985|NCT03098979|464733139|FG005|Overall Study|Protocol Violation|1|||
129118986|NCT02369653|464733140|FG000|Overall Study|Lost to Follow-up|0|||
129118987|NCT02369653|464733141|FG001|Overall Study|Lost to Follow-up|1|||
129118988|NCT02369653|464733140|FG000|Overall Study|Administrative reason by sponsor|0|||
129118989|NCT02369653|464733141|FG001|Overall Study|Administrative reason by sponsor|1|||
129118990|NCT02369653|464733140|FG000|Overall Study|Death|1|||
129216326|NCT02177032|465092886|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
128923297|NCT01147809|464005586|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
128923298|NCT01147809|464005587|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
128923299|NCT01147809|464005588|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
128923300|NCT01147809|464005589|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
128923301|NCT01147809|464005584|FG000|Phase II (168 Days)|Ongoing|0|||
128923302|NCT01147809|464005585|FG001|Phase II (168 Days)|Ongoing|0|||
128923303|NCT01147809|464005586|FG002|Phase II (168 Days)|Ongoing|0|||
128923304|NCT01147809|464005587|FG003|Phase II (168 Days)|Ongoing|0|||
128923305|NCT01147809|464005588|FG004|Phase II (168 Days)|Ongoing|1|||
128923306|NCT01147809|464005589|FG005|Phase II (168 Days)|Ongoing|0|||
128923307|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
128923308|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
128923309|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
128923310|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128923311|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128923312|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128923313|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128923314|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128923315|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128923316|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
128923317|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
129029403|NCT01899053|464398397|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
129029404|NCT01899053|464398398|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
129029405|NCT01899053|464398399|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029406|NCT01899053|464398400|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029407|NCT01899053|464398401|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029408|NCT01899053|464398402|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029409|NCT01899053|464398403|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029410|NCT01899053|464398404|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029411|NCT01899053|464398405|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
128923318|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
128923319|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128923320|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128923321|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128923322|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128923323|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128923324|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128923325|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
128923326|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
128923327|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
128923328|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128923329|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128923330|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128923331|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128923332|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128923333|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128923334|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128923335|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128923336|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
129118991|NCT02369653|464733141|FG001|Overall Study|Death|2|||
129118992|NCT02369653|464733140|FG000|Overall Study|Participant withdrew consent|13|||
129118993|NCT02369653|464733141|FG001|Overall Study|Participant withdrew consent|3|||
129118994|NCT03157089|464733142|FG000|Overall Study|Treated only with pembrolizumab|1|||
129118995|NCT03157089|464733143|FG001|Overall Study|Treated only with pembrolizumab|0|||
129118996|NCT03157089|464733142|FG000|Overall Study|Adverse Event|5|||
129118997|NCT03157089|464733143|FG001|Overall Study|Adverse Event|4|||
129118998|NCT03157089|464733142|FG000|Overall Study|Progressive disease|6|||
129118999|NCT03157089|464733143|FG001|Overall Study|Progressive disease|8|||
129119000|NCT02300610|464733146|FG000|Overall Study|Withdrawal by Subject|1|||
129119001|NCT02300610|464733147|FG001|Overall Study|Withdrawal by Subject|0|||
129119002|NCT02300610|464733148|FG002|Overall Study|Withdrawal by Subject|1|||
129119003|NCT03363906|464733160|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
129119004|NCT03363906|464733161|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
129119005|NCT03363906|464733160|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
129119006|NCT03363906|464733161|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
129119007|NCT03363906|464733160|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
129119008|NCT03363906|464733161|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
129119009|NCT03363906|464733160|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
129119010|NCT03363906|464733161|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
129119011|NCT02714153|464733163|FG000|Overall Study|Death|1|||
129119012|NCT00087178|464733171|FG000|Overall Study|No follow up data|5|||
129119013|NCT00087178|464733172|FG001|Overall Study|No follow up data|15|||
129119014|NCT00087178|464733171|FG000|Overall Study|No clinical assessment|1|||
129119015|NCT00087178|464733172|FG001|Overall Study|No clinical assessment|2|||
129119016|NCT00087178|464733171|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
129119017|NCT00087178|464733172|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
129119018|NCT01692119|464733187|FG000|Overall Study|Protocol Violation|3|||
129119019|NCT01692119|464733188|FG001|Overall Study|Protocol Violation|1|||
129119020|NCT01692119|464733187|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
129119021|NCT01692119|464733188|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
129119022|NCT00997893|464733189|FG000|Overall Study|Adverse Event|1|||
129119023|NCT00997893|464733190|FG001|Overall Study|Adverse Event|0|||
129119024|NCT00997893|464733191|FG002|Overall Study|Adverse Event|0|||
129119025|NCT00997893|464733189|FG000|Overall Study|Unable to meet study timelines|1|||
129119026|NCT00997893|464733190|FG001|Overall Study|Unable to meet study timelines|0|||
129119027|NCT00997893|464733191|FG002|Overall Study|Unable to meet study timelines|0|||
129119028|NCT00997893|464733189|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
129119029|NCT00997893|464733190|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
129119030|NCT00997893|464733191|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
129119031|NCT01142336|464733192|FG000|Overall Study|Adverse Event|1|||
129216327|NCT02177032|465092887|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
128923337|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129119032|NCT01142336|464733193|FG001|Overall Study|Adverse Event|1|||
129119033|NCT01142336|464733192|FG000|Overall Study|Lost to Follow-up|0|||
129119034|NCT01142336|464733193|FG001|Overall Study|Lost to Follow-up|1|||
129216328|NCT02177032|465092888|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
129216329|NCT02177032|465092889|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
129119035|NCT02029417|464733194|FG000|Overall Study|Death|1|||
129119036|NCT02029417|464733194|FG000|Overall Study|Adverse Event|1|||
129119037|NCT05219162|464733197|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
128923338|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128923339|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128923340|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128923341|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128923342|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128923343|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
128923344|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
128923345|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
128923346|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128923347|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128923348|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128923349|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128923350|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128700643|NCT04731363|463201614|FG001|Overall Study|Physician Decision|1|||
128700644|NCT04731363|463201615|FG002|Overall Study|Physician Decision|0|||
128700645|NCT04731363|463201616|FG003|Overall Study|Physician Decision|0|||
128700646|NCT02513394|463201617|FG000|Overall Study|Withdrawal by Subject|11|||
128923351|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128923352|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
128923353|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128923354|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128923355|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128923356|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128923357|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128923358|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128923359|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128923360|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128700647|NCT02513394|463201618|FG001|Overall Study|Withdrawal by Subject|23|||
128700648|NCT02513394|463201617|FG000|Overall Study|Ineligible|1|||
128700649|NCT02513394|463201618|FG001|Overall Study|Ineligible|0|||
128700650|NCT04292743|463201619|FG000|Overall Study|Physician Decision|1|||
128700651|NCT04292743|463201620|FG001|Overall Study|Physician Decision|3|||
128700652|NCT04292743|463201621|FG002|Overall Study|Physician Decision|0|||
128923361|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
128923362|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
128700653|NCT04292743|463201622|FG003|Overall Study|Physician Decision|0|||
128700654|NCT04292743|463201619|FG000|Overall Study|Withdrawal by Subject|0|||
128700655|NCT04292743|463201620|FG001|Overall Study|Withdrawal by Subject|5|||
128700656|NCT04292743|463201621|FG002|Overall Study|Withdrawal by Subject|0|||
128700657|NCT04292743|463201622|FG003|Overall Study|Withdrawal by Subject|0|||
128700658|NCT04292743|463201619|FG000|Overall Study|Death|0|||
128700659|NCT04292743|463201620|FG001|Overall Study|Death|1|||
128700660|NCT04292743|463201621|FG002|Overall Study|Death|0|||
128700661|NCT04292743|463201622|FG003|Overall Study|Death|0|||
128700662|NCT04292743|463201619|FG000|Overall Study|Progression of Disease|2|||
128700663|NCT04292743|463201620|FG001|Overall Study|Progression of Disease|5|||
128700664|NCT04292743|463201621|FG002|Overall Study|Progression of Disease|0|||
128700665|NCT04292743|463201622|FG003|Overall Study|Progression of Disease|0|||
128700666|NCT04292743|463201619|FG000|Overall Study|No Treatment per protocol|0|||
128700667|NCT04292743|463201620|FG001|Overall Study|No Treatment per protocol|2|||
128700668|NCT04292743|463201621|FG002|Overall Study|No Treatment per protocol|0|||
128700669|NCT04292743|463201622|FG003|Overall Study|No Treatment per protocol|0|||
128700670|NCT05766423|463201623|FG000|Overall Study|Withdrawal by Subject|1|||
128700671|NCT05766423|463201624|FG001|Overall Study|Withdrawal by Subject|0|||
128700672|NCT05766423|463201623|FG000|Overall Study|Consented, not scheduled|3|||
128700673|NCT05766423|463201624|FG001|Overall Study|Consented, not scheduled|5|||
128700674|NCT02385045|463203384|FG000|Overall Study|Endoscopy could not be completed|4|||
128923363|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128923364|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128700675|NCT00381485|463203386|FG000|Open-Label Run-In Period|Adverse Event|9|||
128700676|NCT00381485|463203387|FG001|Open-Label Run-In Period|Adverse Event|0|||
128700677|NCT00381485|463203388|FG002|Open-Label Run-In Period|Adverse Event|0|||
128700678|NCT00381485|463203389|FG003|Open-Label Run-In Period|Adverse Event|0|||
128700679|NCT00381485|463203386|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
128700680|NCT00381485|463203387|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
128700681|NCT00381485|463203388|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
128766743|NCT04488003|463436646|FG002|Assessed for Eligibility|Physician Decision|0|||
128923365|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128923366|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128700682|NCT00381485|463203389|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
128700683|NCT00381485|463203386|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
128923367|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128923368|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128923369|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128923370|NCT01307423|464005590|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
128923371|NCT01307423|464005591|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
128923372|NCT01307423|464005592|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
128923373|NCT01307423|464005593|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
128923374|NCT01307423|464005594|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
128923375|NCT01307423|464005595|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
128923376|NCT01307423|464005596|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
128923377|NCT01307423|464005597|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
128923378|NCT01307423|464005598|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
128923379|NCT01307423|464005590|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
128923380|NCT01307423|464005591|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
128923381|NCT01307423|464005592|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
128923382|NCT01307423|464005593|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
128923383|NCT01307423|464005594|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
128923384|NCT01307423|464005595|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
128923385|NCT01307423|464005596|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
128923386|NCT01307423|464005597|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
128923387|NCT01307423|464005598|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
128923388|NCT01307423|464005590|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
128923389|NCT01307423|464005591|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
128923390|NCT01307423|464005592|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
128923391|NCT01307423|464005593|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
128923392|NCT01307423|464005594|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
128923393|NCT01307423|464005595|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
128923394|NCT01307423|464005596|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
128923395|NCT01307423|464005597|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
128923396|NCT01307423|464005598|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
128923397|NCT01307423|464005590|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923398|NCT01307423|464005591|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923399|NCT01307423|464005592|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923400|NCT01307423|464005593|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923401|NCT01307423|464005594|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923402|NCT01307423|464005595|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
128923403|NCT01307423|464005596|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923404|NCT01307423|464005597|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923405|NCT01307423|464005598|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
128923406|NCT01307423|464005590|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
128923407|NCT01307423|464005591|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
128923408|NCT01307423|464005592|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
128923409|NCT01307423|464005593|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
128923410|NCT01307423|464005594|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
128923411|NCT01307423|464005595|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
128923412|NCT01307423|464005596|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
128923413|NCT01307423|464005597|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
128923414|NCT01307423|464005598|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
128923415|NCT01307423|464005590|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923416|NCT01307423|464005591|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923417|NCT01307423|464005592|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923418|NCT01307423|464005593|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
128923419|NCT01307423|464005594|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923420|NCT01307423|464005595|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923421|NCT01307423|464005596|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923422|NCT01307423|464005597|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923423|NCT01307423|464005598|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
128923424|NCT01307423|464005590|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
128923425|NCT01307423|464005591|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
128923426|NCT01307423|464005592|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
128923427|NCT01307423|464005593|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
128923428|NCT01307423|464005594|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
128923429|NCT01307423|464005595|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
129216330|NCT02177032|465092886|FG000|Overall Study|Lost to Follow-up|0|||
128766744|NCT04488003|463436644|FG000|Allocated to Treatment|Progressive Disease|51|||
128923430|NCT01307423|464005596|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
128923431|NCT01307423|464005597|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
128923432|NCT01307423|464005598|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
128923433|NCT01307423|464005590|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923434|NCT01307423|464005591|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923435|NCT01307423|464005592|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923436|NCT01307423|464005593|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923437|NCT01307423|464005594|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923438|NCT01307423|464005595|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
128923439|NCT01307423|464005596|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923440|NCT01307423|464005597|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923441|NCT01307423|464005598|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
128923442|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128923443|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
128923444|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
128923445|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128923446|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128923447|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128923448|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128923449|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
128923450|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
128923451|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128923452|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
128923453|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
128923454|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128923455|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128923456|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128923457|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128923458|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
128923459|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
128923460|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923461|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923462|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
128923463|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923464|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923465|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923466|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923467|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923468|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
128923469|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128923470|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
128923471|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
128923472|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128923473|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128923474|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128923475|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128923476|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
128923477|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
128923478|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128923479|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
128923480|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128923481|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128923482|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128923483|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128923484|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128923485|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
128923486|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
128923487|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128923488|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
128923489|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
128923490|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128923491|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128923492|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128766745|NCT04488003|463436645|FG001|Allocated to Treatment|Progressive Disease|0|||
128923493|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128923494|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
129119038|NCT05219162|464733197|FG000|Overall Study|Withdrawal by Subject|23|||
129119039|NCT00171249|464733200|FG000|Overall Study|Withdrawal by Subject|2|||
128923495|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
128923496|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128923497|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
128923498|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
128923499|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128923500|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128923501|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128923502|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128923503|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
128923504|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
128923505|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
128923506|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
128923507|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
128923508|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
128923509|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
128923510|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
128923511|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
128923512|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
128923513|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
128923514|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128923515|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
128923516|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
128923517|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128923518|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128923519|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128923520|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128923521|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
128923522|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
128923523|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128923524|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
128923525|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
128923526|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128923527|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128923528|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128923529|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128923530|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
128923531|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
128923532|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128923533|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
128923534|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128923535|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128923536|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128923537|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128923538|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128923539|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
128923540|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128923541|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923542|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
128923543|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923544|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923545|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923546|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923547|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923548|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923549|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128923550|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128923551|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
128923552|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128923553|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128923554|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129216331|NCT02177032|465092887|FG001|Overall Study|Lost to Follow-up|2|||
128923555|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128923556|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128923557|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128923558|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
128923559|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128923560|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
129216332|NCT02177032|465092888|FG002|Overall Study|Lost to Follow-up|0|||
128923561|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
128923562|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128923563|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128923564|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128923565|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128923566|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
128923567|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
128923568|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923569|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923570|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
128923571|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923572|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923573|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923574|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923575|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923576|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128923577|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923578|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923579|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923580|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923581|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923582|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923583|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923584|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
128923585|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128923586|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128923587|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
128923588|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
128923589|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128923590|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128923591|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128923592|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128923593|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128923594|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
128923595|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128923596|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
128923597|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
128923598|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128923599|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128923600|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128923601|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128923602|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128923603|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128923604|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128700684|NCT00381485|463203387|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
128700685|NCT00381485|463203388|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
128700686|NCT00381485|463203389|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
128700687|NCT00381485|463203386|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
128700688|NCT00381485|463203387|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
128700689|NCT00381485|463203388|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
128700690|NCT00381485|463203389|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
128700691|NCT00381485|463203386|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
128700692|NCT00381485|463203387|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
128700693|NCT00381485|463203388|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
128700694|NCT00381485|463203389|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
128700695|NCT00381485|463203386|FG000|Open-Label Run-In Period|Treatment failure|1|||
128700696|NCT00381485|463203387|FG001|Open-Label Run-In Period|Treatment failure|0|||
128700697|NCT00381485|463203388|FG002|Open-Label Run-In Period|Treatment failure|0|||
128700698|NCT00381485|463203389|FG003|Open-Label Run-In Period|Treatment failure|0|||
128700699|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128700700|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Adverse Event|2|||
128700701|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Adverse Event|2|||
128700702|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Adverse Event|5|||
128700703|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
128700704|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
128700705|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
128700706|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
128700707|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128766746|NCT04488003|463436646|FG002|Allocated to Treatment|Progressive Disease|0|||
128766747|NCT04488003|463436644|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
128766748|NCT04488003|463436645|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
128766749|NCT04488003|463436646|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
128766750|NCT04488003|463436644|FG000|Allocated to Treatment|Adverse Event|6|||
128766751|NCT04488003|463436645|FG001|Allocated to Treatment|Adverse Event|0|||
128766752|NCT04488003|463436646|FG002|Allocated to Treatment|Adverse Event|0|||
128766753|NCT04488003|463436644|FG000|Allocated to Treatment|Other|5|||
128766754|NCT04488003|463436645|FG001|Allocated to Treatment|Other|0|||
128766755|NCT04488003|463436646|FG002|Allocated to Treatment|Other|0|||
128766756|NCT04488003|463436644|FG000|Allocated to Treatment|Physician Decision|4|||
128766757|NCT04488003|463436645|FG001|Allocated to Treatment|Physician Decision|0|||
128766758|NCT04488003|463436646|FG002|Allocated to Treatment|Physician Decision|0|||
128766759|NCT04488003|463436644|FG000|Allocated to Treatment|Death|4|||
128766760|NCT04488003|463436645|FG001|Allocated to Treatment|Death|0|||
128766761|NCT04488003|463436646|FG002|Allocated to Treatment|Death|0|||
128766762|NCT01350505|463436650|FG000|Overall Study|Lost to Follow-up|4|||
128766763|NCT04145037|463436653|FG000|Overall Study|Study terminated|2|||
128766764|NCT04145037|463436654|FG001|Overall Study|Study terminated|0|||
128766765|NCT04145037|463436653|FG000|Overall Study|Withdrawal by Subject|1|||
128766766|NCT04145037|463436654|FG001|Overall Study|Withdrawal by Subject|0|||
128766767|NCT04145037|463436653|FG000|Overall Study|Lost to Follow-up|1|||
128766768|NCT04145037|463436654|FG001|Overall Study|Lost to Follow-up|0|||
128766769|NCT02307513|463436657|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
128766770|NCT02307513|463436658|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
128766771|NCT02307513|463436657|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
128766772|NCT02307513|463436658|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
128766773|NCT02307513|463436657|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
128766774|NCT02307513|463436658|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
128766775|NCT02307513|463436657|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
128766776|NCT02307513|463436658|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
128766777|NCT02307513|463436657|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
128766778|NCT02307513|463436658|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
128700708|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
128923605|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
128923606|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
128923607|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128923608|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128923609|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128923610|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128923611|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128923612|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
128923613|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128923614|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
128923615|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128923616|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128700709|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
128700710|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
128700711|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
128700712|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
128700713|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
128700714|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
128700715|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
128700716|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
128700717|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
128700718|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
128700719|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
128700720|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
128700721|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
128700722|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
128766779|NCT02307513|463436657|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
128766780|NCT02307513|463436658|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
128766781|NCT02307513|463436657|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
128766782|NCT02307513|463436658|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
128766783|NCT02307513|463436657|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
128766784|NCT02307513|463436658|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
128923617|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128700723|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
128700724|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
128700725|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
128700726|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
128700727|NCT00381485|463203386|FG000|Double-Blind Treatment Period|Administrative|0|||
128700728|NCT00381485|463203387|FG001|Double-Blind Treatment Period|Administrative|1|||
128700729|NCT00381485|463203388|FG002|Double-Blind Treatment Period|Administrative|0|||
128700730|NCT00381485|463203389|FG003|Double-Blind Treatment Period|Administrative|1|||
128700731|NCT01235351|463203390|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
128700732|NCT01235351|463203391|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
128700733|NCT00042289|463203392|FG000|Overall Study|Lost to Follow-up|3|||
128700734|NCT00042289|463203393|FG001|Overall Study|Lost to Follow-up|0|||
128700735|NCT00042289|463203394|FG002|Overall Study|Lost to Follow-up|0|||
128700736|NCT00042289|463203395|FG003|Overall Study|Lost to Follow-up|1|||
128700737|NCT00042289|463203396|FG004|Overall Study|Lost to Follow-up|3|||
128700738|NCT00042289|463203397|FG005|Overall Study|Lost to Follow-up|3|||
128700739|NCT00042289|463203398|FG006|Overall Study|Lost to Follow-up|6|||
128700740|NCT00042289|463203399|FG007|Overall Study|Lost to Follow-up|1|||
128700741|NCT00042289|463203400|FG008|Overall Study|Lost to Follow-up|1|||
128700742|NCT00042289|463203401|FG009|Overall Study|Lost to Follow-up|0|||
128700743|NCT00042289|463203402|FG010|Overall Study|Lost to Follow-up|0|||
128700744|NCT00042289|463203403|FG011|Overall Study|Lost to Follow-up|0|||
128700745|NCT00042289|463203404|FG012|Overall Study|Lost to Follow-up|0|||
128700746|NCT00042289|463203405|FG013|Overall Study|Lost to Follow-up|0|||
128700747|NCT00042289|463203406|FG014|Overall Study|Lost to Follow-up|0|||
128700748|NCT00042289|463203407|FG015|Overall Study|Lost to Follow-up|1|||
128700749|NCT00042289|463203408|FG016|Overall Study|Lost to Follow-up|1|||
128700750|NCT00042289|463203409|FG017|Overall Study|Lost to Follow-up|0|||
128700751|NCT00042289|463203410|FG018|Overall Study|Lost to Follow-up|3|||
128700752|NCT00042289|463203411|FG019|Overall Study|Lost to Follow-up|2|||
128700753|NCT00042289|463203412|FG020|Overall Study|Lost to Follow-up|0|||
128700754|NCT00042289|463203413|FG021|Overall Study|Lost to Follow-up|0|||
128700755|NCT00042289|463203414|FG022|Overall Study|Lost to Follow-up|0|||
128700756|NCT00042289|463203415|FG023|Overall Study|Lost to Follow-up|0|||
128700757|NCT00042289|463203416|FG024|Overall Study|Lost to Follow-up|0|||
128700758|NCT00042289|463203417|FG025|Overall Study|Lost to Follow-up|0|||
128700759|NCT00042289|463203418|FG026|Overall Study|Lost to Follow-up|2|||
128700760|NCT00042289|463203419|FG027|Overall Study|Lost to Follow-up|2|||
128700761|NCT00042289|463203420|FG028|Overall Study|Lost to Follow-up|2|||
128700762|NCT00042289|463203421|FG029|Overall Study|Lost to Follow-up|0|||
128700763|NCT00042289|463203422|FG030|Overall Study|Lost to Follow-up|0|||
128700764|NCT00042289|463203423|FG031|Overall Study|Lost to Follow-up|2|||
128700765|NCT00042289|463203424|FG032|Overall Study|Lost to Follow-up|1|||
128700766|NCT00042289|463203425|FG033|Overall Study|Lost to Follow-up|1|||
128700767|NCT00042289|463203426|FG034|Overall Study|Lost to Follow-up|1|||
128700768|NCT00042289|463203427|FG035|Overall Study|Lost to Follow-up|2|||
128700769|NCT00042289|463203428|FG036|Overall Study|Lost to Follow-up|1|||
128700770|NCT00042289|463203429|FG037|Overall Study|Lost to Follow-up|1|||
128700771|NCT00042289|463203430|FG038|Overall Study|Lost to Follow-up|0|||
128700772|NCT00042289|463203431|FG039|Overall Study|Lost to Follow-up|5|||
128700773|NCT00042289|463203432|FG040|Overall Study|Lost to Follow-up|0|||
128700774|NCT00042289|463203433|FG041|Overall Study|Lost to Follow-up|2|||
128700775|NCT00042289|463203434|FG042|Overall Study|Lost to Follow-up|2|||
128700776|NCT00042289|463203435|FG043|Overall Study|Lost to Follow-up|0|||
128700777|NCT00042289|463203436|FG044|Overall Study|Lost to Follow-up|0|||
128700778|NCT00042289|463203437|FG045|Overall Study|Lost to Follow-up|1|||
128700779|NCT00042289|463203438|FG046|Overall Study|Lost to Follow-up|0|||
128700780|NCT00042289|463203392|FG000|Overall Study|Other reason|0|||
128700781|NCT00042289|463203393|FG001|Overall Study|Other reason|0|||
128700782|NCT00042289|463203394|FG002|Overall Study|Other reason|0|||
128700783|NCT00042289|463203395|FG003|Overall Study|Other reason|2|||
128700784|NCT00042289|463203396|FG004|Overall Study|Other reason|0|||
128700785|NCT00042289|463203397|FG005|Overall Study|Other reason|0|||
128700786|NCT00042289|463203398|FG006|Overall Study|Other reason|0|||
128700787|NCT00042289|463203399|FG007|Overall Study|Other reason|0|||
128700788|NCT00042289|463203400|FG008|Overall Study|Other reason|0|||
128700789|NCT00042289|463203401|FG009|Overall Study|Other reason|0|||
128700790|NCT00042289|463203402|FG010|Overall Study|Other reason|0|||
128700791|NCT00042289|463203403|FG011|Overall Study|Other reason|0|||
128700792|NCT00042289|463203404|FG012|Overall Study|Other reason|0|||
128700793|NCT00042289|463203405|FG013|Overall Study|Other reason|0|||
128700794|NCT00042289|463203406|FG014|Overall Study|Other reason|0|||
128923618|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128923619|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128923620|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128923621|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
128923622|NCT01307423|464005590|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128923623|NCT01307423|464005591|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128923624|NCT01307423|464005592|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
128923625|NCT01307423|464005593|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128923626|NCT01307423|464005594|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128923627|NCT01307423|464005595|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128923628|NCT01307423|464005596|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128923629|NCT01307423|464005597|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
128923630|NCT01307423|464005598|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
128923631|NCT00190775|464005599|FG000|Overall Study|Adverse Event|57|||
128923632|NCT00190775|464005600|FG001|Overall Study|Adverse Event|22|||
128923633|NCT00190775|464005599|FG000|Overall Study|Satisfactory Response|1|||
128923634|NCT00190775|464005600|FG001|Overall Study|Satisfactory Response|0|||
128923635|NCT00190775|464005599|FG000|Overall Study|Lack of Efficacy|28|||
128700795|NCT00042289|463203407|FG015|Overall Study|Other reason|0|||
128700796|NCT00042289|463203408|FG016|Overall Study|Other reason|0|||
128700797|NCT00042289|463203409|FG017|Overall Study|Other reason|0|||
128700798|NCT00042289|463203410|FG018|Overall Study|Other reason|1|||
128923636|NCT00190775|464005600|FG001|Overall Study|Lack of Efficacy|32|||
128923637|NCT00190775|464005599|FG000|Overall Study|Lost to Follow-up|31|||
128923638|NCT00190775|464005600|FG001|Overall Study|Lost to Follow-up|23|||
128923639|NCT00190775|464005599|FG000|Overall Study|Participant Moved|0|||
128923640|NCT00190775|464005600|FG001|Overall Study|Participant Moved|1|||
128923641|NCT00190775|464005599|FG000|Overall Study|Withdrawal by Subject|24|||
128923642|NCT00190775|464005600|FG001|Overall Study|Withdrawal by Subject|13|||
128923643|NCT00190775|464005599|FG000|Overall Study|Sponsor Decision|1|||
128923644|NCT00190775|464005600|FG001|Overall Study|Sponsor Decision|0|||
128923645|NCT00190775|464005599|FG000|Overall Study|Physician Decision|3|||
128923646|NCT00190775|464005600|FG001|Overall Study|Physician Decision|0|||
128923647|NCT00190775|464005599|FG000|Overall Study|Noncompliance|3|||
128923648|NCT00190775|464005600|FG001|Overall Study|Noncompliance|5|||
128923649|NCT00190775|464005599|FG000|Overall Study|Protocol Violation|0|||
128923650|NCT00190775|464005600|FG001|Overall Study|Protocol Violation|1|||
128923651|NCT00190775|464005599|FG000|Overall Study|Exclusion Criteria Met|1|||
128923652|NCT00190775|464005600|FG001|Overall Study|Exclusion Criteria Met|3|||
128923653|NCT00519077|464005601|FG000|Overall Study|Death|6|||
128923654|NCT00519077|464005601|FG000|Overall Study|Other|2|||
128923655|NCT01967225|464005602|FG000|Overall Study|Adverse Event|3|||
128923656|NCT01967225|464005603|FG001|Overall Study|Adverse Event|1|||
128923657|NCT01967225|464005602|FG000|Overall Study|Withdrawal by Subject|2|||
128923658|NCT01967225|464005603|FG001|Overall Study|Withdrawal by Subject|1|||
128923659|NCT01967225|464005602|FG000|Overall Study|Lack of Efficacy|1|||
128923660|NCT01967225|464005603|FG001|Overall Study|Lack of Efficacy|1|||
128923661|NCT01967225|464005602|FG000|Overall Study|Switching to other therapy|2|||
128923662|NCT01967225|464005603|FG001|Overall Study|Switching to other therapy|0|||
128923663|NCT01967225|464005602|FG000|Overall Study|Protocol driven decision point|1|||
128923664|NCT01967225|464005603|FG001|Overall Study|Protocol driven decision point|0|||
128923665|NCT01967225|464005602|FG000|Overall Study|Logistical difficulties|1|||
128923666|NCT01967225|464005603|FG001|Overall Study|Logistical difficulties|0|||
128700799|NCT00042289|463203411|FG019|Overall Study|Other reason|0|||
128700800|NCT00042289|463203412|FG020|Overall Study|Other reason|0|||
128923667|NCT01967225|464005602|FG000|Overall Study|Protocol Violation|2|||
128923668|NCT01967225|464005603|FG001|Overall Study|Protocol Violation|0|||
128923669|NCT03896295|464005604|FG000|Overall Study|Adverse Event|0|||
128923670|NCT03896295|464005605|FG001|Overall Study|Adverse Event|1|||
128923671|NCT03896295|464005604|FG000|Overall Study|COVID-19|7|||
128923672|NCT03896295|464005605|FG001|Overall Study|COVID-19|29|||
128923673|NCT00700804|464005606|FG000|Overall Study|Withdrawal by Subject|1|||
128923674|NCT00700804|464005607|FG001|Overall Study|Withdrawal by Subject|2|||
128923675|NCT00700804|464005606|FG000|Overall Study|Protocol Violation|1|||
128923676|NCT00700804|464005607|FG001|Overall Study|Protocol Violation|1|||
128923677|NCT00700804|464005606|FG000|Overall Study|Loose Stools|1|||
128923678|NCT00700804|464005607|FG001|Overall Study|Loose Stools|1|||
128923679|NCT01511445|464005608|FG000|Overall Study|Lost to Follow-up|3|||
128923680|NCT01511445|464005609|FG001|Overall Study|Lost to Follow-up|1|||
128923681|NCT01511445|464005608|FG000|Overall Study|Protocol Violation|1|||
128923682|NCT01511445|464005609|FG001|Overall Study|Protocol Violation|3|||
128923683|NCT01511445|464005608|FG000|Overall Study|Protocol Violation|1|||
128923684|NCT01511445|464005609|FG001|Overall Study|Protocol Violation|0|||
128923685|NCT04696861|464005610|FG000|Overall Study|Death|1|||
128923686|NCT04696861|464005611|FG001|Overall Study|Death|0|||
128923687|NCT04696861|464005610|FG000|Overall Study|Lost to Follow-up|3|||
128700801|NCT00042289|463203413|FG021|Overall Study|Other reason|0|||
128700802|NCT00042289|463203414|FG022|Overall Study|Other reason|0|||
128700803|NCT00042289|463203415|FG023|Overall Study|Other reason|1|||
128923688|NCT04696861|464005611|FG001|Overall Study|Lost to Follow-up|0|||
128923689|NCT01926626|464005612|FG000|Overall Study|Withdrawal by Subject|15|||
128923690|NCT01926626|464005612|FG000|Overall Study|Lost to Follow-up|7|||
128923691|NCT02382133|464005613|FG000|Overall Study|Death|22|||
128923692|NCT02382133|464005613|FG000|Overall Study|transfer out of ICU|4|||
128923693|NCT02382133|464005613|FG000|Overall Study|Physician Decision|2|||
128923694|NCT02382133|464005613|FG000|Overall Study|arterial catheter loss|4|||
128923695|NCT02382133|464005613|FG000|Overall Study|pressure injury both sites|1|||
128923696|NCT00655928|464005614|FG000|Overall Study|Withdrawal by Subject|2|||
128923697|NCT00655928|464005615|FG001|Overall Study|Withdrawal by Subject|1|||
128923698|NCT00655928|464005614|FG000|Overall Study|Physician Decision|1|||
128923699|NCT00655928|464005615|FG001|Overall Study|Physician Decision|1|||
128923700|NCT04906707|464005616|FG000|Overall Study|Withdrawal by Subject|2|||
128923701|NCT04906707|464005617|FG001|Overall Study|Withdrawal by Subject|0|||
128923702|NCT04906707|464005616|FG000|Overall Study|Withdrawal due to PI decision|1|||
128923703|NCT04906707|464005617|FG001|Overall Study|Withdrawal due to PI decision|0|||
128923704|NCT04906707|464005616|FG000|Overall Study|Lost to Follow-up|0|||
128923705|NCT04906707|464005617|FG001|Overall Study|Lost to Follow-up|1|||
128923706|NCT01976806|464005618|FG000|Overall Study|Lost to Follow-up|1|||
128766785|NCT02307513|463436657|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
128766786|NCT02307513|463436658|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
128766787|NCT02307513|463436657|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
128766788|NCT02307513|463436658|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
128766789|NCT02307513|463436657|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
128766790|NCT02307513|463436658|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
128766791|NCT02307513|463436657|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
128766792|NCT02307513|463436658|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
128766793|NCT02307513|463436657|FG000|Long-term Extension|Physician Decision|1|||
128766794|NCT02307513|463436658|FG001|Long-term Extension|Physician Decision|0|||
128766795|NCT00744263|463436659|FG000|Overall Study|Death|3006|||
128766796|NCT00744263|463436660|FG001|Overall Study|Death|3005|||
128766797|NCT00744263|463436659|FG000|Overall Study|Lost to Follow-up|2038|||
128766798|NCT00744263|463436660|FG001|Overall Study|Lost to Follow-up|2135|||
128766799|NCT00744263|463436659|FG000|Overall Study|Withdrawal by Subject|166|||
128766800|NCT00744263|463436660|FG001|Overall Study|Withdrawal by Subject|150|||
128766801|NCT00744263|463436659|FG000|Overall Study|Physician Decision|20|||
128766802|NCT00744263|463436660|FG001|Overall Study|Physician Decision|23|||
128766803|NCT00744263|463436659|FG000|Overall Study|Protocol Violation|3|||
128766804|NCT00744263|463436660|FG001|Overall Study|Protocol Violation|5|||
128766805|NCT00744263|463436659|FG000|Overall Study|Adverse Event|1|||
128766806|NCT00744263|463436660|FG001|Overall Study|Adverse Event|0|||
128766807|NCT00744263|463436659|FG000|Overall Study|Other|2|||
128923707|NCT01976806|464005619|FG001|Overall Study|Lost to Follow-up|4|||
128766808|NCT00744263|463436660|FG001|Overall Study|Other|2|||
128923708|NCT01976806|464005618|FG000|Overall Study|Adverse Event|1|||
128923709|NCT01976806|464005619|FG001|Overall Study|Adverse Event|1|||
128923710|NCT01976806|464005618|FG000|Overall Study|Withdrawal by Subject|1|||
128923711|NCT01976806|464005619|FG001|Overall Study|Withdrawal by Subject|1|||
128923712|NCT00998738|464005624|FG000|Overall Study|Uknown|1|||
128923713|NCT03946449|464005625|FG000|Treatment Extension II|Rolled over to another study|0|||
128923714|NCT03946449|464005626|FG001|Treatment Extension II|Rolled over to another study|0|||
128923715|NCT03946449|464005627|FG002|Treatment Extension II|Rolled over to another study|2|||
128923716|NCT03946449|464005625|FG000|Treatment Extension II|Withdrawal by Subject|0|||
128923717|NCT03946449|464005626|FG001|Treatment Extension II|Withdrawal by Subject|0|||
128923718|NCT03946449|464005627|FG002|Treatment Extension II|Withdrawal by Subject|1|||
128923719|NCT03896581|464007921|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
128923720|NCT03896581|464007922|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
128923721|NCT03896581|464007921|FG000|Overall Study|Withdrawal by Subject|4|||
128923722|NCT03896581|464007922|FG001|Overall Study|Withdrawal by Subject|1|||
128923723|NCT03896581|464007921|FG000|Overall Study|Lost to Follow-up|1|||
128923724|NCT03896581|464007922|FG001|Overall Study|Lost to Follow-up|0|||
128923725|NCT03896581|464007921|FG000|Overall Study|Lack of Efficacy|2|||
128923726|NCT03896581|464007922|FG001|Overall Study|Lack of Efficacy|1|||
128923727|NCT03896581|464007921|FG000|Overall Study|Adverse event, non-fatal|0|||
128923728|NCT03896581|464007922|FG001|Overall Study|Adverse event, non-fatal|2|||
128923729|NCT00960076|464007934|FG000|Overall Study|Adverse Event|1|||
128923730|NCT00960076|464007935|FG001|Overall Study|Adverse Event|7|||
128923731|NCT00960076|464007934|FG000|Overall Study|No longer met study criteria|1|||
128923732|NCT00960076|464007935|FG001|Overall Study|No longer met study criteria|5|||
128923733|NCT00960076|464007934|FG000|Overall Study|Withdrawal by Subject|1|||
128923734|NCT00960076|464007935|FG001|Overall Study|Withdrawal by Subject|2|||
128923735|NCT00960076|464007934|FG000|Overall Study|Lost to Follow-up|3|||
128923736|NCT00960076|464007935|FG001|Overall Study|Lost to Follow-up|3|||
128923737|NCT00960076|464007934|FG000|Overall Study|Severe non-compliance to protocol|1|||
128923738|NCT00960076|464007935|FG001|Overall Study|Severe non-compliance to protocol|2|||
128923739|NCT00960076|464007934|FG000|Overall Study|Hyperglycemia|1|||
128923740|NCT00960076|464007935|FG001|Overall Study|Hyperglycemia|5|||
128923741|NCT00960076|464007934|FG000|Overall Study|Did not attend the termination visit|0|||
128923742|NCT00960076|464007935|FG001|Overall Study|Did not attend the termination visit|1|||
128766809|NCT00130793|463436663|FG000|Overall Study|Lost to Follow-up|1|||
128766810|NCT00130793|463436664|FG001|Overall Study|Lost to Follow-up|4|||
128766811|NCT00130793|463436663|FG000|Overall Study|Withdrew consent|2|||
128700804|NCT00042289|463203416|FG024|Overall Study|Other reason|0|||
128700805|NCT00042289|463203417|FG025|Overall Study|Other reason|0|||
128700806|NCT00042289|463203418|FG026|Overall Study|Other reason|1|||
128700807|NCT00042289|463203419|FG027|Overall Study|Other reason|0|||
128700808|NCT00042289|463203420|FG028|Overall Study|Other reason|3|||
128700809|NCT00042289|463203421|FG029|Overall Study|Other reason|0|||
128700810|NCT00042289|463203422|FG030|Overall Study|Other reason|0|||
128700811|NCT00042289|463203423|FG031|Overall Study|Other reason|1|||
128700812|NCT00042289|463203424|FG032|Overall Study|Other reason|0|||
128700813|NCT00042289|463203425|FG033|Overall Study|Other reason|1|||
128700814|NCT00042289|463203426|FG034|Overall Study|Other reason|0|||
128700815|NCT00042289|463203427|FG035|Overall Study|Other reason|2|||
128700816|NCT00042289|463203428|FG036|Overall Study|Other reason|0|||
128700817|NCT00042289|463203429|FG037|Overall Study|Other reason|0|||
128700818|NCT00042289|463203430|FG038|Overall Study|Other reason|0|||
128700819|NCT00042289|463203431|FG039|Overall Study|Other reason|0|||
128700820|NCT00042289|463203432|FG040|Overall Study|Other reason|0|||
128700821|NCT00042289|463203433|FG041|Overall Study|Other reason|0|||
128700822|NCT00042289|463203434|FG042|Overall Study|Other reason|0|||
128700823|NCT00042289|463203435|FG043|Overall Study|Other reason|1|||
128700824|NCT00042289|463203436|FG044|Overall Study|Other reason|0|||
128700825|NCT00042289|463203437|FG045|Overall Study|Other reason|0|||
128700826|NCT00042289|463203438|FG046|Overall Study|Other reason|0|||
128700827|NCT00042289|463203392|FG000|Overall Study|Severe debilitation, unable to continue|0|||
128700828|NCT00042289|463203393|FG001|Overall Study|Severe debilitation, unable to continue|0|||
128923743|NCT01431287|464007936|FG000|Overall Study|not treated|0|||
128923744|NCT01431287|464007937|FG001|Overall Study|not treated|0|||
128923745|NCT01431287|464007938|FG002|Overall Study|not treated|1|||
128923746|NCT01431287|464007939|FG003|Overall Study|not treated|0|||
128923747|NCT01431287|464007940|FG004|Overall Study|not treated|0|||
128923748|NCT01431287|464007936|FG000|Overall Study|Adverse Event|59|||
128923749|NCT01431287|464007937|FG001|Overall Study|Adverse Event|57|||
128923750|NCT01431287|464007938|FG002|Overall Study|Adverse Event|53|||
128923751|NCT01431287|464007939|FG003|Overall Study|Adverse Event|33|||
128923752|NCT01431287|464007940|FG004|Overall Study|Adverse Event|41|||
129029412|NCT01899053|464398406|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
128923753|NCT01431287|464007936|FG000|Overall Study|Non compliant with protocol|6|||
128923754|NCT01431287|464007937|FG001|Overall Study|Non compliant with protocol|6|||
128923755|NCT01431287|464007938|FG002|Overall Study|Non compliant with protocol|5|||
128923756|NCT01431287|464007939|FG003|Overall Study|Non compliant with protocol|6|||
128923757|NCT01431287|464007940|FG004|Overall Study|Non compliant with protocol|5|||
128923758|NCT01431287|464007936|FG000|Overall Study|Lost to Follow-up|0|||
128923759|NCT01431287|464007937|FG001|Overall Study|Lost to Follow-up|3|||
128923760|NCT01431287|464007938|FG002|Overall Study|Lost to Follow-up|2|||
128923761|NCT01431287|464007939|FG003|Overall Study|Lost to Follow-up|3|||
128923762|NCT01431287|464007940|FG004|Overall Study|Lost to Follow-up|1|||
128923763|NCT01431287|464007936|FG000|Overall Study|Consent withdrawn not due to AE|29|||
128923764|NCT01431287|464007937|FG001|Overall Study|Consent withdrawn not due to AE|30|||
128923765|NCT01431287|464007938|FG002|Overall Study|Consent withdrawn not due to AE|34|||
128923766|NCT01431287|464007939|FG003|Overall Study|Consent withdrawn not due to AE|19|||
128923767|NCT01431287|464007940|FG004|Overall Study|Consent withdrawn not due to AE|29|||
128923768|NCT01431287|464007936|FG000|Overall Study|not stated above|4|||
128923769|NCT01431287|464007937|FG001|Overall Study|not stated above|2|||
128923770|NCT01431287|464007938|FG002|Overall Study|not stated above|2|||
128923771|NCT01431287|464007939|FG003|Overall Study|not stated above|2|||
128923772|NCT01431287|464007940|FG004|Overall Study|not stated above|1|||
128923773|NCT02224664|464007941|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
129029413|NCT01899053|464398407|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
128700829|NCT00042289|463203394|FG002|Overall Study|Severe debilitation, unable to continue|0|||
128700830|NCT00042289|463203395|FG003|Overall Study|Severe debilitation, unable to continue|0|||
128700831|NCT00042289|463203396|FG004|Overall Study|Severe debilitation, unable to continue|0|||
128700832|NCT00042289|463203397|FG005|Overall Study|Severe debilitation, unable to continue|0|||
128700833|NCT00042289|463203398|FG006|Overall Study|Severe debilitation, unable to continue|0|||
128700834|NCT00042289|463203399|FG007|Overall Study|Severe debilitation, unable to continue|0|||
128923774|NCT02224664|464007942|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
128700835|NCT00042289|463203400|FG008|Overall Study|Severe debilitation, unable to continue|0|||
128700836|NCT00042289|463203401|FG009|Overall Study|Severe debilitation, unable to continue|0|||
128700837|NCT00042289|463203402|FG010|Overall Study|Severe debilitation, unable to continue|0|||
128700838|NCT00042289|463203403|FG011|Overall Study|Severe debilitation, unable to continue|0|||
128700839|NCT00042289|463203404|FG012|Overall Study|Severe debilitation, unable to continue|0|||
128700840|NCT00042289|463203405|FG013|Overall Study|Severe debilitation, unable to continue|0|||
128923775|NCT02224664|464007943|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
129029414|NCT01899053|464398408|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
128700841|NCT00042289|463203406|FG014|Overall Study|Severe debilitation, unable to continue|0|||
128700842|NCT00042289|463203407|FG015|Overall Study|Severe debilitation, unable to continue|0|||
128766812|NCT00130793|463436664|FG001|Overall Study|Withdrew consent|0|||
128766813|NCT00453102|463436667|FG000|Overall Study|Withdrawal by Subject|2|||
128766814|NCT02234063|463436675|FG000|Overall Study|Lost to Follow-up|235|||
129029415|NCT01899053|464398409|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029416|NCT01899053|464398410|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
129029417|NCT01899053|464398397|FG000|Overall Study|Symptomatic Deterioration|0|||
128766815|NCT02234063|463436676|FG001|Overall Study|Lost to Follow-up|42|||
128766816|NCT02234063|463436675|FG000|Overall Study|Withdrawal by Subject|20|||
128766817|NCT02234063|463436676|FG001|Overall Study|Withdrawal by Subject|1|||
128766818|NCT02294474|463436679|FG000|Overall Study|Adverse Event|7|||
128766819|NCT02294474|463436680|FG001|Overall Study|Adverse Event|7|||
128766820|NCT02294474|463436679|FG000|Overall Study|Lack of Efficacy|2|||
128766821|NCT02294474|463436680|FG001|Overall Study|Lack of Efficacy|1|||
129119040|NCT00171249|464733201|FG001|Overall Study|Withdrawal by Subject|0|||
129119041|NCT00171249|464733202|FG002|Overall Study|Withdrawal by Subject|0|||
129119042|NCT00171249|464733203|FG003|Overall Study|Withdrawal by Subject|6|||
129119043|NCT00171249|464733204|FG004|Overall Study|Withdrawal by Subject|0|||
129119044|NCT00171249|464733205|FG005|Overall Study|Withdrawal by Subject|0|||
128766822|NCT02294474|463436679|FG000|Overall Study|Protocol Violation|4|||
129029418|NCT01899053|464398398|FG001|Overall Study|Symptomatic Deterioration|0|||
129029419|NCT01899053|464398399|FG002|Overall Study|Symptomatic Deterioration|0|||
129029420|NCT01899053|464398400|FG003|Overall Study|Symptomatic Deterioration|0|||
129029421|NCT01899053|464398401|FG004|Overall Study|Symptomatic Deterioration|0|||
129119045|NCT00171249|464733206|FG006|Overall Study|Withdrawal by Subject|0|||
129119046|NCT00171249|464733200|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
129119047|NCT00171249|464733201|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129029422|NCT01899053|464398402|FG005|Overall Study|Symptomatic Deterioration|1|||
129029423|NCT01899053|464398403|FG006|Overall Study|Symptomatic Deterioration|0|||
129029424|NCT01899053|464398404|FG007|Overall Study|Symptomatic Deterioration|1|||
129029425|NCT01899053|464398405|FG008|Overall Study|Symptomatic Deterioration|0|||
129029426|NCT01899053|464398406|FG009|Overall Study|Symptomatic Deterioration|0|||
129029427|NCT01899053|464398407|FG010|Overall Study|Symptomatic Deterioration|0|||
129029428|NCT01899053|464398408|FG011|Overall Study|Symptomatic Deterioration|1|||
129029429|NCT01899053|464398409|FG012|Overall Study|Symptomatic Deterioration|2|||
129029430|NCT01899053|464398410|FG013|Overall Study|Symptomatic Deterioration|0|||
129029431|NCT03105297|464398411|FG000|Baseline Phase (Day 1)|Other|21|||
129029432|NCT03105297|464398411|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
129029433|NCT03105297|464398411|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
129029434|NCT01390948|464398412|FG000|Overall Study|End of Study|1|||
129029435|NCT01390948|464398413|FG001|Overall Study|End of Study|0|||
129029436|NCT01390948|464398414|FG002|Overall Study|End of Study|0|||
129029437|NCT01390948|464398412|FG000|Overall Study|Withdrew consent|2|||
129029438|NCT01390948|464398413|FG001|Overall Study|Withdrew consent|2|||
129029439|NCT01390948|464398414|FG002|Overall Study|Withdrew consent|0|||
129029440|NCT01390948|464398412|FG000|Overall Study|Progressive Disease|2|||
129029441|NCT01390948|464398413|FG001|Overall Study|Progressive Disease|5|||
129029442|NCT01390948|464398414|FG002|Overall Study|Progressive Disease|0|||
129029443|NCT01390948|464398412|FG000|Overall Study|Death during follow-up|10|||
129029444|NCT01390948|464398413|FG001|Overall Study|Death during follow-up|11|||
129029445|NCT01390948|464398414|FG002|Overall Study|Death during follow-up|1|||
129029446|NCT05315713|464398416|FG000|Overall Study|Death|5|||
129029447|NCT05315713|464398416|FG000|Overall Study|Progressive disease|1|||
129029448|NCT05315713|464398416|FG000|Overall Study|Withdrawal by Subject|1|||
129029449|NCT05315713|464398416|FG000|Overall Study|Study terminated by sponsor|1|||
129029450|NCT03250117|464398419|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
129119048|NCT00171249|464733202|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
128700843|NCT00042289|463203408|FG016|Overall Study|Severe debilitation, unable to continue|0|||
128700844|NCT00042289|463203409|FG017|Overall Study|Severe debilitation, unable to continue|0|||
128700845|NCT00042289|463203410|FG018|Overall Study|Severe debilitation, unable to continue|0|||
128700846|NCT00042289|463203411|FG019|Overall Study|Severe debilitation, unable to continue|0|||
128700847|NCT00042289|463203412|FG020|Overall Study|Severe debilitation, unable to continue|0|||
128700848|NCT00042289|463203413|FG021|Overall Study|Severe debilitation, unable to continue|1|||
128700849|NCT00042289|463203414|FG022|Overall Study|Severe debilitation, unable to continue|0|||
128700850|NCT00042289|463203415|FG023|Overall Study|Severe debilitation, unable to continue|1|||
128700851|NCT00042289|463203416|FG024|Overall Study|Severe debilitation, unable to continue|0|||
128700852|NCT00042289|463203417|FG025|Overall Study|Severe debilitation, unable to continue|0|||
128700853|NCT00042289|463203418|FG026|Overall Study|Severe debilitation, unable to continue|0|||
128700854|NCT00042289|463203419|FG027|Overall Study|Severe debilitation, unable to continue|1|||
128700855|NCT00042289|463203420|FG028|Overall Study|Severe debilitation, unable to continue|0|||
128766823|NCT02294474|463436680|FG001|Overall Study|Protocol Violation|2|||
128766824|NCT02294474|463436679|FG000|Overall Study|Other than specified above|12|||
128766825|NCT02294474|463436680|FG001|Overall Study|Other than specified above|12|||
129029451|NCT03250117|464398420|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
128766826|NCT05200936|463436681|FG000|Overall Study|Withdrawal by Subject|2|||
128766827|NCT05200936|463436682|FG001|Overall Study|Withdrawal by Subject|2|||
129029452|NCT03250117|464398421|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
129029453|NCT03250117|464398422|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
129029454|NCT04194151|464398424|FG000|Overall Study|Physician Decision|1|||
129029455|NCT04194151|464398425|FG001|Overall Study|Physician Decision|1|||
129029456|NCT04194151|464398426|FG002|Overall Study|Physician Decision|1|||
129029457|NCT04194151|464398427|FG003|Overall Study|Physician Decision|1|||
129029458|NCT04194151|464398428|FG004|Overall Study|Physician Decision|0|||
129029459|NCT04194151|464398429|FG005|Overall Study|Physician Decision|1|||
129029460|NCT04194151|464398424|FG000|Overall Study|Monitorization problem|0|||
129029461|NCT04194151|464398425|FG001|Overall Study|Monitorization problem|1|||
129029462|NCT04194151|464398426|FG002|Overall Study|Monitorization problem|0|||
129029463|NCT04194151|464398427|FG003|Overall Study|Monitorization problem|0|||
129029464|NCT04194151|464398428|FG004|Overall Study|Monitorization problem|0|||
129029465|NCT04194151|464398429|FG005|Overall Study|Monitorization problem|0|||
129029466|NCT04203823|464398431|FG000|Overall Study|Withdrawal by Subject|2|||
129029467|NCT04203823|464398432|FG001|Overall Study|Withdrawal by Subject|2|||
128700856|NCT00042289|463203421|FG029|Overall Study|Severe debilitation, unable to continue|0|||
128700857|NCT00042289|463203422|FG030|Overall Study|Severe debilitation, unable to continue|0|||
128700858|NCT00042289|463203423|FG031|Overall Study|Severe debilitation, unable to continue|1|||
128700859|NCT00042289|463203424|FG032|Overall Study|Severe debilitation, unable to continue|1|||
128700860|NCT00042289|463203425|FG033|Overall Study|Severe debilitation, unable to continue|0|||
128700861|NCT00042289|463203426|FG034|Overall Study|Severe debilitation, unable to continue|0|||
128700862|NCT00042289|463203427|FG035|Overall Study|Severe debilitation, unable to continue|0|||
128700863|NCT00042289|463203428|FG036|Overall Study|Severe debilitation, unable to continue|0|||
128700864|NCT00042289|463203429|FG037|Overall Study|Severe debilitation, unable to continue|0|||
128700865|NCT00042289|463203430|FG038|Overall Study|Severe debilitation, unable to continue|0|||
128700866|NCT00042289|463203431|FG039|Overall Study|Severe debilitation, unable to continue|0|||
128700867|NCT00042289|463203432|FG040|Overall Study|Severe debilitation, unable to continue|0|||
128700868|NCT00042289|463203433|FG041|Overall Study|Severe debilitation, unable to continue|0|||
128700869|NCT00042289|463203434|FG042|Overall Study|Severe debilitation, unable to continue|0|||
128700870|NCT00042289|463203435|FG043|Overall Study|Severe debilitation, unable to continue|0|||
128700871|NCT00042289|463203436|FG044|Overall Study|Severe debilitation, unable to continue|0|||
128700872|NCT00042289|463203437|FG045|Overall Study|Severe debilitation, unable to continue|0|||
128700873|NCT00042289|463203438|FG046|Overall Study|Severe debilitation, unable to continue|0|||
128700874|NCT00042289|463203392|FG000|Overall Study|Site closed|0|||
128700875|NCT00042289|463203393|FG001|Overall Study|Site closed|0|||
128700876|NCT00042289|463203394|FG002|Overall Study|Site closed|0|||
128700877|NCT00042289|463203395|FG003|Overall Study|Site closed|0|||
128700878|NCT00042289|463203396|FG004|Overall Study|Site closed|0|||
128700879|NCT00042289|463203397|FG005|Overall Study|Site closed|0|||
128700880|NCT00042289|463203398|FG006|Overall Study|Site closed|0|||
128700881|NCT00042289|463203399|FG007|Overall Study|Site closed|0|||
128700882|NCT00042289|463203400|FG008|Overall Study|Site closed|0|||
128700883|NCT00042289|463203401|FG009|Overall Study|Site closed|0|||
128700884|NCT00042289|463203402|FG010|Overall Study|Site closed|0|||
128700885|NCT00042289|463203403|FG011|Overall Study|Site closed|0|||
128700886|NCT00042289|463203404|FG012|Overall Study|Site closed|0|||
128700887|NCT00042289|463203405|FG013|Overall Study|Site closed|0|||
128700888|NCT00042289|463203406|FG014|Overall Study|Site closed|0|||
128700889|NCT00042289|463203407|FG015|Overall Study|Site closed|0|||
128700890|NCT00042289|463203408|FG016|Overall Study|Site closed|0|||
128700891|NCT00042289|463203409|FG017|Overall Study|Site closed|0|||
128700892|NCT00042289|463203410|FG018|Overall Study|Site closed|0|||
128700893|NCT00042289|463203411|FG019|Overall Study|Site closed|0|||
128700894|NCT00042289|463203412|FG020|Overall Study|Site closed|0|||
128700895|NCT00042289|463203413|FG021|Overall Study|Site closed|0|||
128700896|NCT00042289|463203414|FG022|Overall Study|Site closed|0|||
128700897|NCT00042289|463203415|FG023|Overall Study|Site closed|0|||
128700898|NCT00042289|463203416|FG024|Overall Study|Site closed|0|||
128700899|NCT00042289|463203417|FG025|Overall Study|Site closed|0|||
128700900|NCT00042289|463203418|FG026|Overall Study|Site closed|0|||
128700901|NCT00042289|463203419|FG027|Overall Study|Site closed|0|||
128700902|NCT00042289|463203420|FG028|Overall Study|Site closed|0|||
128700903|NCT00042289|463203421|FG029|Overall Study|Site closed|0|||
128700904|NCT00042289|463203422|FG030|Overall Study|Site closed|0|||
128700905|NCT00042289|463203423|FG031|Overall Study|Site closed|3|||
128700906|NCT00042289|463203424|FG032|Overall Study|Site closed|0|||
128700907|NCT00042289|463203425|FG033|Overall Study|Site closed|0|||
128700908|NCT00042289|463203426|FG034|Overall Study|Site closed|0|||
128700909|NCT00042289|463203427|FG035|Overall Study|Site closed|0|||
128700910|NCT00042289|463203428|FG036|Overall Study|Site closed|1|||
128700911|NCT00042289|463203429|FG037|Overall Study|Site closed|0|||
128700912|NCT00042289|463203430|FG038|Overall Study|Site closed|0|||
128700913|NCT00042289|463203431|FG039|Overall Study|Site closed|0|||
128700914|NCT00042289|463203432|FG040|Overall Study|Site closed|0|||
128700915|NCT00042289|463203433|FG041|Overall Study|Site closed|0|||
129029468|NCT04203823|464398431|FG000|Overall Study|Adverse Event|1|||
129029469|NCT04203823|464398432|FG001|Overall Study|Adverse Event|1|||
129029470|NCT04203823|464398431|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129029471|NCT04203823|464398432|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
129029472|NCT01499043|464398433|FG000|Overall Study|Progressive disease (radiographic)|2|||
129029473|NCT01499043|464398433|FG000|Overall Study|Progressive disease (clinical)|1|||
129029474|NCT01499043|464398433|FG000|Overall Study|Withdrawal by Subject|2|||
129029475|NCT01499043|464398433|FG000|Overall Study|Adverse Event|1|||
129029476|NCT00438633|464398434|FG000|Overall Study|Withdrawal by Subject|1|||
129029477|NCT00438633|464398435|FG001|Overall Study|Withdrawal by Subject|0|||
129029478|NCT00438633|464398434|FG000|Overall Study|Lost to Follow-up|15|||
129029479|NCT00438633|464398435|FG001|Overall Study|Lost to Follow-up|17|||
129029480|NCT02286466|464398436|FG000|Overall Study|Death|1|||
129029481|NCT02286466|464398437|FG001|Overall Study|Death|3|||
129029482|NCT02286466|464398436|FG000|Overall Study|Withdrawal by Subject|5|||
129029483|NCT02286466|464398437|FG001|Overall Study|Withdrawal by Subject|2|||
129029484|NCT02286466|464398436|FG000|Overall Study|Lost to Follow-up|1|||
129029485|NCT02286466|464398437|FG001|Overall Study|Lost to Follow-up|4|||
129029486|NCT02286466|464398436|FG000|Overall Study|Declined Clinician Assessment|0|||
129029487|NCT02286466|464398437|FG001|Overall Study|Declined Clinician Assessment|1|||
129029488|NCT00835081|464398438|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129029489|NCT00835081|464398439|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
128700916|NCT00042289|463203434|FG042|Overall Study|Site closed|1|||
129029490|NCT00421304|464398440|FG000|Overall Study|Lost to Follow-up|5|||
129029491|NCT00421304|464398441|FG001|Overall Study|Lost to Follow-up|2|||
129029492|NCT00421304|464398442|FG002|Overall Study|Lost to Follow-up|5|||
129029493|NCT00421304|464398440|FG000|Overall Study|Withdrawal by Subject|2|||
129029494|NCT00421304|464398441|FG001|Overall Study|Withdrawal by Subject|2|||
129029495|NCT00421304|464398442|FG002|Overall Study|Withdrawal by Subject|2|||
129029496|NCT00421304|464398440|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
129029497|NCT00421304|464398441|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
129029498|NCT00421304|464398442|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
129029499|NCT00421304|464398440|FG000|Overall Study|Did not attend Day 360 visit|0|||
129029500|NCT00421304|464398441|FG001|Overall Study|Did not attend Day 360 visit|0|||
129029501|NCT00421304|464398442|FG002|Overall Study|Did not attend Day 360 visit|1|||
129029502|NCT03196284|464398443|FG000|Main Part|Withdrawal by Subject|0|||
129029503|NCT03196284|464398444|FG001|Main Part|Withdrawal by Subject|1|||
129029504|NCT03196284|464398445|FG002|Main Part|Withdrawal by Subject|0|||
129029505|NCT03196284|464398443|FG000|Extension Part|Lack of Efficacy|0|||
129029506|NCT03196284|464398444|FG001|Extension Part|Lack of Efficacy|0|||
129029507|NCT03196284|464398445|FG002|Extension Part|Lack of Efficacy|1|||
129029508|NCT03196284|464398443|FG000|Extension Part|Withdrawal by Subject|0|||
129029509|NCT03196284|464398444|FG001|Extension Part|Withdrawal by Subject|0|||
129029510|NCT03196284|464398445|FG002|Extension Part|Withdrawal by Subject|1|||
129029511|NCT03196284|464398443|FG000|Extension Part|Physician Decision|0|||
129029512|NCT03196284|464398444|FG001|Extension Part|Physician Decision|0|||
129029513|NCT03196284|464398445|FG002|Extension Part|Physician Decision|1|||
129029514|NCT01912807|464398446|FG000|Overall Study|Did not meet elegibility criteria|6|||
128700917|NCT00042289|463203435|FG043|Overall Study|Site closed|0|||
128700918|NCT00042289|463203436|FG044|Overall Study|Site closed|0|||
128700919|NCT00042289|463203437|FG045|Overall Study|Site closed|0|||
128700920|NCT00042289|463203438|FG046|Overall Study|Site closed|0|||
128700921|NCT00042289|463203392|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
128700922|NCT00042289|463203393|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
128700923|NCT00042289|463203394|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
128700924|NCT00042289|463203395|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
128700925|NCT00042289|463203396|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
128700926|NCT00042289|463203397|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
128700927|NCT00042289|463203398|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
128700928|NCT00042289|463203399|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
128700929|NCT00042289|463203400|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
129029515|NCT01912807|464398447|FG001|Overall Study|Did not meet elegibility criteria|4|||
128700930|NCT00042289|463203401|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
128700931|NCT00042289|463203402|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
128700932|NCT00042289|463203403|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
128700933|NCT00042289|463203404|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
128700934|NCT00042289|463203405|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
128700935|NCT00042289|463203406|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
128700936|NCT00042289|463203407|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
128700937|NCT00042289|463203408|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
129029516|NCT01912807|464398446|FG000|Overall Study|Lost to Follow-up|36|||
129029517|NCT01912807|464398447|FG001|Overall Study|Lost to Follow-up|37|||
128923776|NCT02224664|464007944|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
128923777|NCT02224664|464007945|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
128923778|NCT02224664|464007941|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
128923779|NCT02224664|464007942|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
128923780|NCT02224664|464007943|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
128923781|NCT02224664|464007944|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
128923782|NCT02224664|464007945|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
128923783|NCT02224664|464007941|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
128923784|NCT02224664|464007942|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
128923785|NCT02224664|464007943|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
128923786|NCT02224664|464007944|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
128923787|NCT02224664|464007945|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
128923788|NCT00215150|464007949|FG000|Open Label Phase|Lost to Follow-up|7|||
128923789|NCT00215150|464007949|FG000|Open Label Phase|Withdrawal by Subject|1|||
128923790|NCT00215150|464007949|FG000|Open Label Phase|Did not complete a post base visit|13|||
128923791|NCT00215150|464007949|FG000|Open Label Phase|Did not meet randomization criteria|9|||
128923792|NCT00215150|464007949|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
128923793|NCT00215150|464007949|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
128923794|NCT00215150|464007949|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
128923795|NCT02251743|464007950|FG000|Overall Study|Withdrawal by Subject|1|||
128923796|NCT02251743|464007951|FG001|Overall Study|Withdrawal by Subject|1|||
128923797|NCT01028352|464007956|FG000|Overall Study|Ineligible due to baseline average pain|5|||
128923798|NCT01028352|464007956|FG000|Overall Study|Withdrawal by Subject|1|||
128923799|NCT00260208|464007957|FG000|Overall Study|Subject withdrew consent|11|||
128923800|NCT00260208|464007958|FG001|Overall Study|Subject withdrew consent|7|||
128923801|NCT00260208|464007957|FG000|Overall Study|Lost to Follow-up|6|||
128923802|NCT00260208|464007958|FG001|Overall Study|Lost to Follow-up|1|||
128923803|NCT00260208|464007957|FG000|Overall Study|Death|12|||
128923804|NCT00260208|464007958|FG001|Overall Study|Death|10|||
128923805|NCT00260208|464007957|FG000|Overall Study|Missing|18|||
128923806|NCT00260208|464007958|FG001|Overall Study|Missing|16|||
128923807|NCT02091440|464007959|FG000|Overall Study|Death|2|||
128923808|NCT00768222|464007960|FG000|Overall Study|Lost to Follow-up|1|||
128923809|NCT00768222|464007961|FG001|Overall Study|Lost to Follow-up|1|||
128923810|NCT00768222|464007960|FG000|Overall Study|Withdrawal by Subject|3|||
128923811|NCT00768222|464007961|FG001|Overall Study|Withdrawal by Subject|1|||
128923812|NCT00768222|464007960|FG000|Overall Study|Protocol Violation|0|||
128923813|NCT00768222|464007961|FG001|Overall Study|Protocol Violation|2|||
128923814|NCT00278629|464007968|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
128923815|NCT03323749|464007969|FG000|Double-blind Period|Lost to Follow-up|4|||
128923816|NCT03323749|464007970|FG001|Double-blind Period|Lost to Follow-up|5|||
128923817|NCT03323749|464007969|FG000|Double-blind Period|Adverse Event|3|||
128923818|NCT03323749|464007970|FG001|Double-blind Period|Adverse Event|1|||
128923819|NCT03323749|464007969|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
128923820|NCT03323749|464007970|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
128923821|NCT03323749|464007969|FG000|Open-Label Period|Adverse Event|3|||
128923822|NCT03323749|464007970|FG001|Open-Label Period|Adverse Event|10|||
128923823|NCT03323749|464007969|FG000|Open-Label Period|Withdrawal by Subject|7|||
128923824|NCT03323749|464007970|FG001|Open-Label Period|Withdrawal by Subject|5|||
128923825|NCT02468193|464007972|FG000|Overall Study|Adverse Event|4|||
128923826|NCT02468193|464007972|FG000|Overall Study|Subject/ Guardian decision|2|||
128923827|NCT00826748|464007973|FG000|Overall Study|Withdrawal by Subject|0|||
129029518|NCT02535923|464398449|FG000|Overall Study|Lost to Follow-up|5|||
128766828|NCT05200936|463436681|FG000|Overall Study|Lost to Follow-up|2|||
128766829|NCT05200936|463436682|FG001|Overall Study|Lost to Follow-up|0|||
128766830|NCT05200936|463436681|FG000|Overall Study|Pregnancy|0|||
128766831|NCT05200936|463436682|FG001|Overall Study|Pregnancy|1|||
128766832|NCT03443713|463436683|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
128766833|NCT03443713|463436684|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
128766834|NCT03443713|463436685|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
128766835|NCT02944656|463436687|FG000|Overall Study|No longer eligible|3|||
128923828|NCT00826748|464007974|FG001|Overall Study|Withdrawal by Subject|0|||
128923829|NCT00826748|464007975|FG002|Overall Study|Withdrawal by Subject|2|||
128923830|NCT00826748|464007973|FG000|Overall Study|Physician Decision|0|||
129029519|NCT02535923|464398450|FG001|Overall Study|Lost to Follow-up|5|||
129029520|NCT02535923|464398449|FG000|Overall Study|Withdrawal by Subject|4|||
128766836|NCT02944656|463436688|FG001|Overall Study|No longer eligible|0|||
128766837|NCT02944656|463436687|FG000|Overall Study|Lost to Follow-up|7|||
128923831|NCT00826748|464007974|FG001|Overall Study|Physician Decision|0|||
128923832|NCT00826748|464007975|FG002|Overall Study|Physician Decision|1|||
128923833|NCT00826748|464007973|FG000|Overall Study|Samples Did Not pass QC|0|||
128923834|NCT00826748|464007974|FG001|Overall Study|Samples Did Not pass QC|0|||
128923835|NCT00826748|464007975|FG002|Overall Study|Samples Did Not pass QC|1|||
128923836|NCT03312218|464007978|FG000|Overall Study|Never signed in to access the app|54|||
129119049|NCT00171249|464733203|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
129119050|NCT00171249|464733204|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129119051|NCT00171249|464733205|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
129119052|NCT00171249|464733206|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129119053|NCT00171249|464733200|FG000|Overall Study|Death|7|||
129119054|NCT00171249|464733201|FG001|Overall Study|Death|1|||
129119055|NCT00171249|464733202|FG002|Overall Study|Death|0|||
129119056|NCT00171249|464733203|FG003|Overall Study|Death|4|||
129119057|NCT00171249|464733204|FG004|Overall Study|Death|0|||
129119058|NCT00171249|464733205|FG005|Overall Study|Death|3|||
129119059|NCT00171249|464733206|FG006|Overall Study|Death|1|||
129119060|NCT00171249|464733200|FG000|Overall Study|Other|10|||
128923837|NCT03312218|464007979|FG001|Overall Study|Never signed in to access the app|58|||
128923838|NCT05067127|464007980|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
128923839|NCT05067127|464007981|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
128923840|NCT05067127|464007982|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
128923841|NCT05067127|464007983|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
128923842|NCT05067127|464007980|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
128923843|NCT05067127|464007981|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
128923844|NCT05067127|464007982|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
128923845|NCT05067127|464007983|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
128923846|NCT05067127|464007980|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
128923847|NCT05067127|464007981|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
128923848|NCT05067127|464007982|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
128923849|NCT05067127|464007983|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
128923850|NCT05067127|464007980|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
128923851|NCT05067127|464007981|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
128923852|NCT05067127|464007982|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
128923853|NCT05067127|464007983|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
128923854|NCT05067127|464007980|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
128923855|NCT05067127|464007981|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
128923856|NCT05067127|464007982|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
128923857|NCT05067127|464007983|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
128923858|NCT05067127|464007980|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
128923859|NCT05067127|464007981|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
128923860|NCT05067127|464007982|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
128923861|NCT05067127|464007983|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
128923862|NCT05067127|464007980|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
128923863|NCT05067127|464007981|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
128923864|NCT05067127|464007982|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
128923865|NCT05067127|464007983|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
128923866|NCT04462536|464007984|FG000|Overall Study|Withdrawal by Subject|3|||
128923867|NCT04462536|464007985|FG001|Overall Study|Withdrawal by Subject|9|||
128923868|NCT04462536|464007984|FG000|Overall Study|Lost to Follow-up|2|||
128923869|NCT04462536|464007985|FG001|Overall Study|Lost to Follow-up|4|||
128923870|NCT06161012|464007993|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
128923871|NCT06161012|464007994|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
128923872|NCT02601950|464007995|FG000|Overall Study|Participant enrolled in rollover study|0|||
128923873|NCT02601950|464007996|FG001|Overall Study|Participant enrolled in rollover study|0|||
128923874|NCT02601950|464007997|FG002|Overall Study|Participant enrolled in rollover study|1|||
128923875|NCT02601950|464007998|FG003|Overall Study|Participant enrolled in rollover study|0|||
128923876|NCT02601950|464007999|FG004|Overall Study|Participant enrolled in rollover study|1|||
128923877|NCT02601950|464008000|FG005|Overall Study|Participant enrolled in rollover study|1|||
128923878|NCT02601950|464008001|FG006|Overall Study|Participant enrolled in rollover study|1|||
128923879|NCT02601950|464008002|FG007|Overall Study|Participant enrolled in rollover study|0|||
128923880|NCT02601950|464007995|FG000|Overall Study|Disease progression - radiological|21|||
128923881|NCT02601950|464007996|FG001|Overall Study|Disease progression - radiological|26|||
128923882|NCT02601950|464007997|FG002|Overall Study|Disease progression - radiological|22|||
128923883|NCT02601950|464007998|FG003|Overall Study|Disease progression - radiological|11|||
128923884|NCT02601950|464007999|FG004|Overall Study|Disease progression - radiological|46|||
128923885|NCT02601950|464008000|FG005|Overall Study|Disease progression - radiological|52|||
129119061|NCT00171249|464733201|FG001|Overall Study|Other|0|||
129119062|NCT00171249|464733202|FG002|Overall Study|Other|0|||
129119063|NCT00171249|464733203|FG003|Overall Study|Other|43|||
129119064|NCT00171249|464733204|FG004|Overall Study|Other|0|||
129216333|NCT02177032|465092889|FG003|Overall Study|Lost to Follow-up|0|||
128700938|NCT00042289|463203409|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
128766838|NCT02944656|463436688|FG001|Overall Study|Lost to Follow-up|10|||
129119065|NCT00171249|464733205|FG005|Overall Study|Other|2|||
129119066|NCT00171249|464733206|FG006|Overall Study|Other|0|||
128766839|NCT05879198|463436691|FG000|Overall Study|Lost to Follow-up|1|||
128766840|NCT00663117|463438047|FG000|Overall Study|Lack of Efficacy|1|||
128766841|NCT00663117|463438048|FG001|Overall Study|Lack of Efficacy|0|||
128766842|NCT01992549|463438053|FG000|Overall Study|Lost to Follow-up|2|||
128766843|NCT01992549|463438053|FG000|Overall Study|Serious Adverse Event|1|||
128766844|NCT01992549|463438053|FG000|Overall Study|Product Switch to Extend Half Life|1|||
128766845|NCT00767104|463438059|FG000|Overall Study|Lost to Follow-up|1|||
128766846|NCT00767104|463438060|FG001|Overall Study|Lost to Follow-up|2|||
128766847|NCT03285295|463438063|FG000|Alinity s HBsAg|Protocol Violation|11|||
128766848|NCT03285295|463438064|FG001|Alinity s HBsAg|Protocol Violation|0|||
128766849|NCT03285295|463438065|FG002|Alinity s HBsAg|Protocol Violation|0|||
128766850|NCT03285295|463438066|FG003|Alinity s HBsAg|Protocol Violation|0|||
128766851|NCT03285295|463438067|FG004|Alinity s HBsAg|Protocol Violation|0|||
128766852|NCT03285295|463438063|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
128766853|NCT03285295|463438064|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
128766854|NCT03285295|463438065|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
128766855|NCT03285295|463438066|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
128766856|NCT03285295|463438067|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
128766857|NCT03285295|463438063|FG000|Alinity s HBsAg|No Results Generated|74|||
128766858|NCT03285295|463438064|FG001|Alinity s HBsAg|No Results Generated|6|||
128766859|NCT03285295|463438065|FG002|Alinity s HBsAg|No Results Generated|0|||
128766860|NCT03285295|463438066|FG003|Alinity s HBsAg|No Results Generated|0|||
128766861|NCT03285295|463438067|FG004|Alinity s HBsAg|No Results Generated|0|||
128766862|NCT03285295|463438063|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
129029521|NCT02535923|464398450|FG001|Overall Study|Withdrawal by Subject|3|||
129029522|NCT00874276|464398456|FG000|Overall Study|Withdrawal by Subject|1|||
129029523|NCT00874276|464398457|FG001|Overall Study|Withdrawal by Subject|1|||
128766863|NCT03285295|463438064|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
128766864|NCT03285295|463438065|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
128766865|NCT03285295|463438066|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
128766866|NCT03285295|463438067|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
128766867|NCT03285295|463438063|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
128766868|NCT03285295|463438064|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
128766869|NCT03285295|463438065|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
128766870|NCT03285295|463438066|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
128766871|NCT03285295|463438067|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
128766872|NCT03285295|463438063|FG000|Alinity s HTLV I/II|No Results Generated|70|||
128766873|NCT03285295|463438064|FG001|Alinity s HTLV I/II|No Results Generated|0|||
129029524|NCT01253564|464398460|FG000|Overall Study|Disease Progression|22|||
129029525|NCT01253564|464398460|FG000|Overall Study|Withdrawal by Subject|1|||
129029526|NCT01253564|464398460|FG000|Overall Study|Serious Adverse Event|1|||
129029527|NCT03694197|464398463|FG000|Overall Study|Adverse Event|9|||
129029528|NCT03694197|464398463|FG000|Overall Study|Protocol became inconvenient to participate|1|||
129029529|NCT03694197|464398463|FG000|Overall Study|Physician Decision|4|||
129029530|NCT03694197|464398463|FG000|Overall Study|Study terminated by sponsor|1350|||
129029531|NCT03694197|464398463|FG000|Overall Study|Participant moved|5|||
129029532|NCT03694197|464398463|FG000|Overall Study|Participant withdrew consent|10|||
129029533|NCT03694197|464398463|FG000|Overall Study|Related to IMP administration|1|||
129029534|NCT03694197|464398463|FG000|Overall Study|Not disclosed|5|||
129029535|NCT03506633|464399865|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
129029536|NCT03506633|464399866|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
129029537|NCT01109849|464399869|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
129029538|NCT01109849|464399870|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
129029539|NCT01109849|464399871|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
129029540|NCT01109849|464399872|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
129029541|NCT01109849|464399873|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
129029542|NCT01109849|464399869|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
129029543|NCT01109849|464399870|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129029544|NCT01109849|464399871|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129029545|NCT01109849|464399872|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129029546|NCT01109849|464399873|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129029547|NCT01109849|464399869|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
129029548|NCT01109849|464399870|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
129216334|NCT02177032|465092886|FG000|Overall Study|OTHER|2|||
129216335|NCT02177032|465092887|FG001|Overall Study|OTHER|0|||
129216336|NCT02177032|465092888|FG002|Overall Study|OTHER|1|||
128766874|NCT03285295|463438065|FG002|Alinity s HTLV I/II|No Results Generated|0|||
128766875|NCT03285295|463438066|FG003|Alinity s HTLV I/II|No Results Generated|0|||
128766876|NCT03285295|463438067|FG004|Alinity s HTLV I/II|No Results Generated|0|||
128766877|NCT03285295|463438063|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
128766878|NCT03285295|463438064|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
128766879|NCT03285295|463438065|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
128766880|NCT03285295|463438066|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
128700939|NCT00042289|463203410|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
128700940|NCT00042289|463203411|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
128700941|NCT00042289|463203412|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
128700942|NCT00042289|463203413|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
128700943|NCT00042289|463203414|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
128700944|NCT00042289|463203415|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
128766881|NCT03285295|463438067|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
128766882|NCT03285295|463438063|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
128766883|NCT03285295|463438064|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
128766884|NCT03285295|463438065|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
128766885|NCT03285295|463438066|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
128766886|NCT03285295|463438067|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
128766887|NCT03285295|463438063|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
128766888|NCT03285295|463438064|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
128766889|NCT03285295|463438065|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
128766890|NCT03285295|463438066|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
128766891|NCT03285295|463438067|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
128766892|NCT03285295|463438063|FG000|Alinity s Anti-HCV|No Results Generated|71|||
128766893|NCT03285295|463438064|FG001|Alinity s Anti-HCV|No Results Generated|0|||
128766894|NCT03285295|463438065|FG002|Alinity s Anti-HCV|No Results Generated|0|||
128766895|NCT03285295|463438066|FG003|Alinity s Anti-HCV|No Results Generated|0|||
128766896|NCT03285295|463438067|FG004|Alinity s Anti-HCV|No Results Generated|0|||
128766897|NCT03285295|463438063|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
128766898|NCT03285295|463438064|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
128766899|NCT03285295|463438065|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
128766900|NCT03285295|463438066|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
128766901|NCT03285295|463438067|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
128700945|NCT00042289|463203416|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
128700946|NCT00042289|463203417|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
128700947|NCT00042289|463203418|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
128700948|NCT00042289|463203419|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
128700949|NCT00042289|463203420|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
128700950|NCT00042289|463203421|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
128700951|NCT00042289|463203422|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
128700952|NCT00042289|463203423|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
128700953|NCT00042289|463203424|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
128700954|NCT00042289|463203425|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
128700955|NCT00042289|463203426|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
128700956|NCT00042289|463203427|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
128700957|NCT00042289|463203428|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
128700958|NCT00042289|463203429|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
128700959|NCT00042289|463203430|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
128700960|NCT00042289|463203431|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
128700961|NCT00042289|463203432|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
128700962|NCT00042289|463203433|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
128700963|NCT00042289|463203434|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
128700964|NCT00042289|463203435|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
128700965|NCT00042289|463203436|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
128700966|NCT00042289|463203437|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
128700967|NCT00042289|463203438|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
128700968|NCT00042289|463203392|FG000|Overall Study|Protocol Violation|0|||
128766902|NCT03285295|463438063|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
128766903|NCT03285295|463438064|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
128766904|NCT03285295|463438065|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
128766905|NCT03285295|463438066|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
128766906|NCT03285295|463438067|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
128766907|NCT03285295|463438063|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
128700969|NCT00042289|463203393|FG001|Overall Study|Protocol Violation|0|||
128700970|NCT00042289|463203394|FG002|Overall Study|Protocol Violation|0|||
128700971|NCT00042289|463203395|FG003|Overall Study|Protocol Violation|0|||
128700972|NCT00042289|463203396|FG004|Overall Study|Protocol Violation|0|||
128700973|NCT00042289|463203397|FG005|Overall Study|Protocol Violation|1|||
128700974|NCT00042289|463203398|FG006|Overall Study|Protocol Violation|0|||
128700975|NCT00042289|463203399|FG007|Overall Study|Protocol Violation|1|||
128766908|NCT03285295|463438064|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
128766909|NCT03285295|463438065|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
128766910|NCT03285295|463438066|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129216337|NCT02177032|465092889|FG003|Overall Study|OTHER|0|||
128766911|NCT03285295|463438067|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
128766912|NCT03285295|463438063|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
128766913|NCT03285295|463438064|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
128766914|NCT03285295|463438065|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
128766915|NCT03285295|463438066|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
128766916|NCT03285295|463438067|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
128766917|NCT03285295|463438063|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
128766918|NCT03285295|463438064|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
128766919|NCT03285295|463438065|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
128766920|NCT03285295|463438066|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
128766921|NCT03285295|463438067|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
128766922|NCT03285295|463438063|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
128766923|NCT03285295|463438064|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
128766924|NCT03285295|463438065|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
128766925|NCT03285295|463438066|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
128766926|NCT03285295|463438067|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
128766927|NCT03285295|463438063|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
128766928|NCT03285295|463438064|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
128766929|NCT03285295|463438065|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
128766930|NCT03285295|463438066|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
128766931|NCT03285295|463438067|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
128766932|NCT03285295|463438063|FG000|Alinity s Anti-HBc|No Results Generated|70|||
128766933|NCT03285295|463438064|FG001|Alinity s Anti-HBc|No Results Generated|0|||
128766934|NCT03285295|463438065|FG002|Alinity s Anti-HBc|No Results Generated|0|||
128766935|NCT03285295|463438066|FG003|Alinity s Anti-HBc|No Results Generated|0|||
128766936|NCT03285295|463438067|FG004|Alinity s Anti-HBc|No Results Generated|0|||
128766937|NCT03285295|463438063|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
128766938|NCT03285295|463438064|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
128766939|NCT03285295|463438065|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
128766940|NCT03285295|463438066|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
128766941|NCT03285295|463438067|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
128923886|NCT02601950|464008001|FG006|Overall Study|Disease progression - radiological|7|||
128923887|NCT02601950|464008002|FG007|Overall Study|Disease progression - radiological|5|||
128923888|NCT02601950|464007995|FG000|Overall Study|Disease progression - clinical|3|||
128923889|NCT02601950|464007996|FG001|Overall Study|Disease progression - clinical|5|||
128923890|NCT02601950|464007997|FG002|Overall Study|Disease progression - clinical|4|||
128923891|NCT02601950|464007998|FG003|Overall Study|Disease progression - clinical|2|||
128923892|NCT02601950|464007999|FG004|Overall Study|Disease progression - clinical|6|||
128923893|NCT02601950|464008000|FG005|Overall Study|Disease progression - clinical|6|||
128923894|NCT02601950|464008001|FG006|Overall Study|Disease progression - clinical|5|||
128923895|NCT02601950|464008002|FG007|Overall Study|Disease progression - clinical|1|||
128923896|NCT02601950|464007995|FG000|Overall Study|Death|6|||
128923897|NCT02601950|464007996|FG001|Overall Study|Death|0|||
128923898|NCT02601950|464007997|FG002|Overall Study|Death|3|||
128923899|NCT02601950|464007998|FG003|Overall Study|Death|1|||
128923900|NCT02601950|464007999|FG004|Overall Study|Death|4|||
128923901|NCT02601950|464008000|FG005|Overall Study|Death|1|||
128923902|NCT02601950|464008001|FG006|Overall Study|Death|0|||
128923903|NCT02601950|464008002|FG007|Overall Study|Death|0|||
128923904|NCT02601950|464007995|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
128923905|NCT02601950|464007996|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
128923906|NCT02601950|464007997|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
128923907|NCT02601950|464007998|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
128923908|NCT02601950|464007999|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
128923909|NCT02601950|464008000|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
128923910|NCT02601950|464008001|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
128923911|NCT02601950|464008002|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
128923912|NCT02601950|464007995|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
128923913|NCT02601950|464007996|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
128923914|NCT02601950|464007997|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
128923915|NCT02601950|464007998|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
128766942|NCT03285295|463438063|FG000|Alinity s Chagas|Protocol Violation|76|||
128766943|NCT03285295|463438064|FG001|Alinity s Chagas|Protocol Violation|0|||
128766944|NCT03285295|463438065|FG002|Alinity s Chagas|Protocol Violation|0|||
128766945|NCT03285295|463438066|FG003|Alinity s Chagas|Protocol Violation|0|||
128766946|NCT03285295|463438067|FG004|Alinity s Chagas|Protocol Violation|0|||
128766947|NCT03285295|463438063|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
128766948|NCT03285295|463438064|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
128923916|NCT02601950|464007999|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
128923917|NCT02601950|464008000|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
128766949|NCT03285295|463438065|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
128766950|NCT03285295|463438066|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
128766951|NCT03285295|463438067|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
128766952|NCT03285295|463438063|FG000|Alinity s Chagas|No Results Generated|105|||
128766953|NCT03285295|463438064|FG001|Alinity s Chagas|No Results Generated|0|||
128766954|NCT03285295|463438065|FG002|Alinity s Chagas|No Results Generated|0|||
128766955|NCT03285295|463438066|FG003|Alinity s Chagas|No Results Generated|0|||
128766956|NCT03285295|463438067|FG004|Alinity s Chagas|No Results Generated|0|||
128766957|NCT03285295|463438063|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
128923918|NCT02601950|464008001|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
128923919|NCT02601950|464008002|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
128923920|NCT02601950|464007995|FG000|Overall Study|Non-compliance|0|||
128923921|NCT02601950|464007996|FG001|Overall Study|Non-compliance|1|||
128923922|NCT02601950|464007997|FG002|Overall Study|Non-compliance|0|||
128923923|NCT02601950|464007998|FG003|Overall Study|Non-compliance|0|||
128766958|NCT03285295|463438064|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
128766959|NCT03285295|463438065|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
128766960|NCT03285295|463438066|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
128923924|NCT02601950|464007999|FG004|Overall Study|Non-compliance|0|||
128923925|NCT02601950|464008000|FG005|Overall Study|Non-compliance|1|||
128923926|NCT02601950|464008001|FG006|Overall Study|Non-compliance|1|||
128923927|NCT02601950|464008002|FG007|Overall Study|Non-compliance|0|||
128923928|NCT02601950|464007995|FG000|Overall Study|Participant refused further study treatment|0|||
128923929|NCT02601950|464007996|FG001|Overall Study|Participant refused further study treatment|1|||
128923930|NCT02601950|464007997|FG002|Overall Study|Participant refused further study treatment|1|||
128923931|NCT02601950|464007998|FG003|Overall Study|Participant refused further study treatment|0|||
128923932|NCT02601950|464007999|FG004|Overall Study|Participant refused further study treatment|2|||
128923933|NCT02601950|464008000|FG005|Overall Study|Participant refused further study treatment|2|||
128923934|NCT02601950|464008001|FG006|Overall Study|Participant refused further study treatment|2|||
128923935|NCT02601950|464008002|FG007|Overall Study|Participant refused further study treatment|1|||
128923936|NCT02601950|464007995|FG000|Overall Study|Investigator discretion|1|||
128923937|NCT02601950|464007996|FG001|Overall Study|Investigator discretion|0|||
128923938|NCT02601950|464007997|FG002|Overall Study|Investigator discretion|1|||
128923939|NCT02601950|464007998|FG003|Overall Study|Investigator discretion|0|||
128923940|NCT02601950|464007999|FG004|Overall Study|Investigator discretion|1|||
128923941|NCT02601950|464008000|FG005|Overall Study|Investigator discretion|1|||
128923942|NCT02601950|464008001|FG006|Overall Study|Investigator discretion|1|||
128923943|NCT02601950|464008002|FG007|Overall Study|Investigator discretion|0|||
128923944|NCT02601950|464007995|FG000|Overall Study|Other|0|||
128923945|NCT02601950|464007996|FG001|Overall Study|Other|0|||
128923946|NCT02601950|464007997|FG002|Overall Study|Other|0|||
128923947|NCT02601950|464007998|FG003|Overall Study|Other|0|||
128923948|NCT02601950|464007999|FG004|Overall Study|Other|2|||
128923949|NCT02601950|464008000|FG005|Overall Study|Other|2|||
128923950|NCT02601950|464008001|FG006|Overall Study|Other|1|||
128923951|NCT02601950|464008002|FG007|Overall Study|Other|0|||
128923952|NCT05817045|464008003|FG000|Overall Study|Protocol Violation|0|||
128923953|NCT05817045|464008004|FG001|Overall Study|Protocol Violation|3|||
128923954|NCT05817045|464008003|FG000|Overall Study|Withdrawal by Subject|10|||
128923955|NCT05817045|464008004|FG001|Overall Study|Withdrawal by Subject|7|||
128923956|NCT05817045|464008003|FG000|Overall Study|Physician Decision|3|||
128766961|NCT03285295|463438067|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
128766962|NCT02045433|463438071|FG000|Overall Study|Withdrawal by Subject|1|||
128766963|NCT02176421|463438072|FG000|Overall Study|Lost to Follow-up|4|||
128766964|NCT02176421|463438072|FG000|Overall Study|Adverse Event|1|||
128766965|NCT02145078|463438075|FG000|Overall Study|Death|1|||
128766966|NCT02145078|463438075|FG000|Overall Study|Reason not given|3|||
128766967|NCT02440594|463438076|FG000|Overall Study|Lost to Follow-up|34|||
128766968|NCT02440594|463438077|FG001|Overall Study|Lost to Follow-up|33|||
128923957|NCT05817045|464008004|FG001|Overall Study|Physician Decision|0|||
129029549|NCT01109849|464399871|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
128766969|NCT02440594|463438078|FG002|Overall Study|Lost to Follow-up|54|||
128766970|NCT02440594|463438079|FG003|Overall Study|Lost to Follow-up|47|||
128923958|NCT05817045|464008003|FG000|Overall Study|Lost to Follow-up|0|||
128923959|NCT05817045|464008004|FG001|Overall Study|Lost to Follow-up|1|||
128923960|NCT05817045|464008003|FG000|Overall Study|Device Deficiency|1|||
128923961|NCT05817045|464008004|FG001|Overall Study|Device Deficiency|0|||
128923962|NCT05817045|464008003|FG000|Overall Study|System Error|1|||
128923963|NCT05817045|464008004|FG001|Overall Study|System Error|0|||
128923964|NCT05113940|464008011|FG000|Part A (18 Days)|Adverse Event|0|||
128923965|NCT05113940|464008012|FG001|Part A (18 Days)|Adverse Event|0|||
128923966|NCT05113940|464008013|FG002|Part A (18 Days)|Adverse Event|1|||
128923967|NCT05113940|464008014|FG003|Part A (18 Days)|Adverse Event|1|||
128923968|NCT05113940|464008015|FG004|Part A (18 Days)|Adverse Event|1|||
128766971|NCT02440594|463438080|FG004|Overall Study|Lost to Follow-up|5|||
128766972|NCT02440594|463438081|FG005|Overall Study|Lost to Follow-up|4|||
128700976|NCT00042289|463203400|FG008|Overall Study|Protocol Violation|0|||
128700977|NCT00042289|463203401|FG009|Overall Study|Protocol Violation|0|||
128700978|NCT00042289|463203402|FG010|Overall Study|Protocol Violation|0|||
128700979|NCT00042289|463203403|FG011|Overall Study|Protocol Violation|0|||
128700980|NCT00042289|463203404|FG012|Overall Study|Protocol Violation|0|||
128700981|NCT00042289|463203405|FG013|Overall Study|Protocol Violation|0|||
128700982|NCT00042289|463203406|FG014|Overall Study|Protocol Violation|0|||
128700983|NCT00042289|463203407|FG015|Overall Study|Protocol Violation|0|||
128700984|NCT00042289|463203408|FG016|Overall Study|Protocol Violation|0|||
128700985|NCT00042289|463203409|FG017|Overall Study|Protocol Violation|0|||
128700986|NCT00042289|463203410|FG018|Overall Study|Protocol Violation|0|||
128923969|NCT05113940|464008016|FG005|Part A (18 Days)|Adverse Event|0|||
128923970|NCT05113940|464008017|FG006|Part A (18 Days)|Adverse Event|0|||
128923971|NCT05113940|464008018|FG007|Part A (18 Days)|Adverse Event|0|||
128923972|NCT05113940|464008019|FG008|Part A (18 Days)|Adverse Event|0|||
128923973|NCT05113940|464008020|FG009|Part A (18 Days)|Adverse Event|0|||
128923974|NCT05113940|464008021|FG010|Part A (18 Days)|Adverse Event|0|||
128923975|NCT05113940|464008022|FG011|Part A (18 Days)|Adverse Event|2|||
128923976|NCT05113940|464008023|FG012|Part A (18 Days)|Adverse Event|0|||
128923977|NCT05113940|464008024|FG013|Part A (18 Days)|Adverse Event|0|||
128923978|NCT05113940|464008025|FG014|Part A (18 Days)|Adverse Event|0|||
128923979|NCT05113940|464008011|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923980|NCT05113940|464008012|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923981|NCT05113940|464008013|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
128700987|NCT00042289|463203411|FG019|Overall Study|Protocol Violation|0|||
128700988|NCT00042289|463203412|FG020|Overall Study|Protocol Violation|0|||
128700989|NCT00042289|463203413|FG021|Overall Study|Protocol Violation|0|||
128700990|NCT00042289|463203414|FG022|Overall Study|Protocol Violation|0|||
128700991|NCT00042289|463203415|FG023|Overall Study|Protocol Violation|1|||
128923982|NCT05113940|464008014|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923983|NCT05113940|464008015|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923984|NCT05113940|464008016|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923985|NCT05113940|464008017|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923986|NCT05113940|464008018|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923987|NCT05113940|464008019|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923988|NCT05113940|464008020|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923989|NCT05113940|464008021|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923990|NCT05113940|464008022|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923991|NCT05113940|464008023|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923992|NCT05113940|464008024|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
128923993|NCT05113940|464008025|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
128923994|NCT02688647|464008028|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
128923995|NCT02688647|464008029|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
128923996|NCT02688647|464008028|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
128923997|NCT02688647|464008029|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
128923998|NCT02688647|464008028|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
128923999|NCT02688647|464008029|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
128924000|NCT02688647|464008028|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
128924001|NCT02688647|464008029|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
128924002|NCT02688647|464008028|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
128924003|NCT02688647|464008029|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
128924004|NCT02688647|464008028|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
128924005|NCT02688647|464008029|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
128924006|NCT02688647|464008028|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
128924007|NCT02688647|464008029|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
128924008|NCT00382967|464008030|FG000|Overall Study|Protocol Violation|1|||
128924009|NCT00382967|464008031|FG001|Overall Study|Protocol Violation|1|||
128924010|NCT03049449|464008035|FG000|Overall Study|Did not receive treatment.|0|||
128924011|NCT03049449|464008036|FG001|Overall Study|Did not receive treatment.|0|||
128924012|NCT03049449|464008037|FG002|Overall Study|Did not receive treatment.|0|||
128924013|NCT03049449|464008038|FG003|Overall Study|Did not receive treatment.|0|||
128924014|NCT03049449|464008039|FG004|Overall Study|Did not receive treatment.|0|||
128924015|NCT03049449|464008040|FG005|Overall Study|Did not receive treatment.|0|||
128924016|NCT03049449|464008041|FG006|Overall Study|Did not receive treatment.|0|||
128924017|NCT03049449|464008042|FG007|Overall Study|Did not receive treatment.|0|||
128700992|NCT00042289|463203416|FG024|Overall Study|Protocol Violation|1|||
128700993|NCT00042289|463203417|FG025|Overall Study|Protocol Violation|0|||
128924018|NCT03049449|464008043|FG008|Overall Study|Did not receive treatment.|1|||
128924019|NCT03049449|464008044|FG009|Overall Study|Did not receive treatment.|0|||
128924020|NCT03049449|464008035|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
128924021|NCT03049449|464008036|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
128924022|NCT03049449|464008037|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
128700994|NCT00042289|463203418|FG026|Overall Study|Protocol Violation|2|||
128924023|NCT03049449|464008038|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
128924024|NCT03049449|464008039|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
128924025|NCT03049449|464008040|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
128924026|NCT03049449|464008041|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
128924027|NCT03049449|464008042|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
128924028|NCT03049449|464008043|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
128924029|NCT03049449|464008044|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
128924030|NCT03049449|464008035|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924031|NCT03049449|464008036|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924032|NCT03049449|464008037|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924033|NCT03049449|464008038|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924034|NCT03049449|464008039|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924035|NCT03049449|464008040|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924036|NCT03049449|464008041|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924037|NCT03049449|464008042|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
128924038|NCT03049449|464008043|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
128924039|NCT03049449|464008044|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
128924040|NCT00442598|464008045|FG000|Overall Study|Adverse Event|1|||
128924041|NCT00442598|464008046|FG001|Overall Study|Adverse Event|0|||
128924042|NCT00442598|464008047|FG002|Overall Study|Adverse Event|0|||
128924043|NCT00442598|464008045|FG000|Overall Study|Tumor progression|3|||
128924044|NCT00442598|464008046|FG001|Overall Study|Tumor progression|4|||
128924045|NCT00442598|464008047|FG002|Overall Study|Tumor progression|0|||
128924046|NCT00442598|464008045|FG000|Overall Study|Clinical deterioration|1|||
128924047|NCT00442598|464008046|FG001|Overall Study|Clinical deterioration|2|||
128924048|NCT00442598|464008047|FG002|Overall Study|Clinical deterioration|0|||
128924049|NCT00442598|464008045|FG000|Overall Study|CA125 progression|0|||
128924050|NCT00442598|464008046|FG001|Overall Study|CA125 progression|1|||
128924051|NCT00442598|464008047|FG002|Overall Study|CA125 progression|0|||
128924052|NCT00442598|464008045|FG000|Overall Study|Reduced creatinine clearance|1|||
128924053|NCT00442598|464008046|FG001|Overall Study|Reduced creatinine clearance|0|||
128924054|NCT00442598|464008047|FG002|Overall Study|Reduced creatinine clearance|0|||
128924055|NCT00442598|464008045|FG000|Overall Study|Death|0|||
128924056|NCT00442598|464008046|FG001|Overall Study|Death|1|||
128924057|NCT00442598|464008047|FG002|Overall Study|Death|0|||
128924058|NCT01147497|464008048|FG000|Overall Study|failed insertion|2|||
128924059|NCT01147497|464008049|FG001|Overall Study|failed insertion|0|||
128924060|NCT01262898|464008052|FG000|Overall Study|Protocol Violation|1|||
128924061|NCT01262898|464008053|FG001|Overall Study|Protocol Violation|1|||
128924062|NCT01262898|464008054|FG002|Overall Study|Protocol Violation|0|||
128924063|NCT01262898|464008055|FG003|Overall Study|Protocol Violation|0|||
128924064|NCT01262898|464008052|FG000|Overall Study|Lost to Follow-up|1|||
128924065|NCT01262898|464008053|FG001|Overall Study|Lost to Follow-up|0|||
128924066|NCT01262898|464008054|FG002|Overall Study|Lost to Follow-up|0|||
128924067|NCT01262898|464008055|FG003|Overall Study|Lost to Follow-up|0|||
128924068|NCT01262898|464008052|FG000|Overall Study|Withdrawal by Subject|1|||
128924069|NCT01262898|464008053|FG001|Overall Study|Withdrawal by Subject|1|||
128924070|NCT01262898|464008054|FG002|Overall Study|Withdrawal by Subject|0|||
128924071|NCT01262898|464008055|FG003|Overall Study|Withdrawal by Subject|0|||
128924072|NCT02731742|464008056|FG000|Overall Study|Death|1|||
128924073|NCT02731742|464008057|FG001|Overall Study|Death|2|||
128924074|NCT02731742|464008058|FG002|Overall Study|Death|5|||
128924075|NCT02731742|464008059|FG003|Overall Study|Death|0|||
129029550|NCT01109849|464399872|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
128700995|NCT00042289|463203419|FG027|Overall Study|Protocol Violation|0|||
128700996|NCT00042289|463203420|FG028|Overall Study|Protocol Violation|0|||
128700997|NCT00042289|463203421|FG029|Overall Study|Protocol Violation|0|||
128700998|NCT00042289|463203422|FG030|Overall Study|Protocol Violation|1|||
128700999|NCT00042289|463203423|FG031|Overall Study|Protocol Violation|0|||
128701000|NCT00042289|463203424|FG032|Overall Study|Protocol Violation|0|||
128701001|NCT00042289|463203425|FG033|Overall Study|Protocol Violation|0|||
128701002|NCT00042289|463203426|FG034|Overall Study|Protocol Violation|0|||
128701003|NCT00042289|463203427|FG035|Overall Study|Protocol Violation|0|||
129029551|NCT01109849|464399873|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
128701004|NCT00042289|463203428|FG036|Overall Study|Protocol Violation|0|||
128924076|NCT02731742|464008056|FG000|Overall Study|Physician Decision|0|||
128924077|NCT02731742|464008057|FG001|Overall Study|Physician Decision|0|||
128924078|NCT02731742|464008058|FG002|Overall Study|Physician Decision|0|||
128924079|NCT02731742|464008059|FG003|Overall Study|Physician Decision|1|||
128701005|NCT00042289|463203429|FG037|Overall Study|Protocol Violation|0|||
128701006|NCT00042289|463203430|FG038|Overall Study|Protocol Violation|0|||
128701007|NCT00042289|463203431|FG039|Overall Study|Protocol Violation|0|||
128701008|NCT00042289|463203432|FG040|Overall Study|Protocol Violation|0|||
128701009|NCT00042289|463203433|FG041|Overall Study|Protocol Violation|1|||
128701010|NCT00042289|463203434|FG042|Overall Study|Protocol Violation|1|||
128701011|NCT00042289|463203435|FG043|Overall Study|Protocol Violation|1|||
128701012|NCT00042289|463203436|FG044|Overall Study|Protocol Violation|0|||
128701013|NCT00042289|463203437|FG045|Overall Study|Protocol Violation|0|||
128701014|NCT00042289|463203438|FG046|Overall Study|Protocol Violation|0|||
128701015|NCT00042289|463203392|FG000|Overall Study|Withdrawal by Subject|4|||
128701016|NCT00042289|463203393|FG001|Overall Study|Withdrawal by Subject|1|||
128701017|NCT00042289|463203394|FG002|Overall Study|Withdrawal by Subject|0|||
128701018|NCT00042289|463203395|FG003|Overall Study|Withdrawal by Subject|2|||
128701019|NCT00042289|463203396|FG004|Overall Study|Withdrawal by Subject|0|||
128701020|NCT00042289|463203397|FG005|Overall Study|Withdrawal by Subject|2|||
128701021|NCT00042289|463203398|FG006|Overall Study|Withdrawal by Subject|0|||
128701022|NCT00042289|463203399|FG007|Overall Study|Withdrawal by Subject|0|||
128701023|NCT00042289|463203400|FG008|Overall Study|Withdrawal by Subject|0|||
128701024|NCT00042289|463203401|FG009|Overall Study|Withdrawal by Subject|1|||
128701025|NCT00042289|463203402|FG010|Overall Study|Withdrawal by Subject|0|||
128701026|NCT00042289|463203403|FG011|Overall Study|Withdrawal by Subject|0|||
128701027|NCT00042289|463203404|FG012|Overall Study|Withdrawal by Subject|2|||
128701028|NCT00042289|463203405|FG013|Overall Study|Withdrawal by Subject|0|||
128701029|NCT00042289|463203406|FG014|Overall Study|Withdrawal by Subject|0|||
128701030|NCT00042289|463203407|FG015|Overall Study|Withdrawal by Subject|0|||
128701031|NCT00042289|463203408|FG016|Overall Study|Withdrawal by Subject|0|||
128701032|NCT00042289|463203409|FG017|Overall Study|Withdrawal by Subject|0|||
128701033|NCT00042289|463203410|FG018|Overall Study|Withdrawal by Subject|0|||
128701034|NCT00042289|463203411|FG019|Overall Study|Withdrawal by Subject|0|||
128701035|NCT00042289|463203412|FG020|Overall Study|Withdrawal by Subject|0|||
128701036|NCT00042289|463203413|FG021|Overall Study|Withdrawal by Subject|1|||
128701037|NCT00042289|463203414|FG022|Overall Study|Withdrawal by Subject|1|||
128701038|NCT00042289|463203415|FG023|Overall Study|Withdrawal by Subject|1|||
128701039|NCT00042289|463203416|FG024|Overall Study|Withdrawal by Subject|0|||
128701040|NCT00042289|463203417|FG025|Overall Study|Withdrawal by Subject|0|||
128701041|NCT00042289|463203418|FG026|Overall Study|Withdrawal by Subject|1|||
128701042|NCT00042289|463203419|FG027|Overall Study|Withdrawal by Subject|0|||
128701043|NCT00042289|463203420|FG028|Overall Study|Withdrawal by Subject|2|||
128701044|NCT00042289|463203421|FG029|Overall Study|Withdrawal by Subject|0|||
128701045|NCT00042289|463203422|FG030|Overall Study|Withdrawal by Subject|0|||
128701046|NCT00042289|463203423|FG031|Overall Study|Withdrawal by Subject|1|||
128701047|NCT00042289|463203424|FG032|Overall Study|Withdrawal by Subject|2|||
128701048|NCT00042289|463203425|FG033|Overall Study|Withdrawal by Subject|1|||
128701049|NCT00042289|463203426|FG034|Overall Study|Withdrawal by Subject|0|||
128701050|NCT00042289|463203427|FG035|Overall Study|Withdrawal by Subject|0|||
128766973|NCT02440594|463438082|FG006|Overall Study|Lost to Follow-up|28|||
128766974|NCT02440594|463438083|FG007|Overall Study|Lost to Follow-up|48|||
128924080|NCT02731742|464008056|FG000|Overall Study|Study Terminated by Sponsor|2|||
128924081|NCT02731742|464008057|FG001|Overall Study|Study Terminated by Sponsor|1|||
128924082|NCT02731742|464008058|FG002|Overall Study|Study Terminated by Sponsor|1|||
128924083|NCT02731742|464008059|FG003|Overall Study|Study Terminated by Sponsor|1|||
128924084|NCT04026568|464008062|FG000|Overall Study|study terminated|0|||
128924085|NCT04026568|464008063|FG001|Overall Study|study terminated|1|||
128924086|NCT02197377|464008064|FG000|Overall Study|Insertion Failure|0|||
128924087|NCT02197377|464008065|FG001|Overall Study|Insertion Failure|3|||
128924088|NCT00502840|464008066|FG000|Overall Study|Adverse Event|5|||
128924089|NCT00502840|464008066|FG000|Overall Study|Additional or changed therapy|48|||
128924090|NCT00502840|464008066|FG000|Overall Study|Lack of Efficacy|11|||
128924091|NCT00502840|464008066|FG000|Overall Study|Protocol Violation|4|||
128924092|NCT00502840|464008066|FG000|Overall Study|Withdrawal by Subject|5|||
128924093|NCT00502840|464008066|FG000|Overall Study|Lost to Follow-up|6|||
128924094|NCT00502840|464008066|FG000|Overall Study|Administrative problems|1|||
128924095|NCT00502840|464008066|FG000|Overall Study|Other|20|||
128924096|NCT03093155|464008068|FG000|Overall Study|Not Eligible|1|||
128766975|NCT02440594|463438076|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
128701051|NCT00042289|463203428|FG036|Overall Study|Withdrawal by Subject|0|||
128701052|NCT00042289|463203429|FG037|Overall Study|Withdrawal by Subject|1|||
128701053|NCT00042289|463203430|FG038|Overall Study|Withdrawal by Subject|0|||
128924097|NCT03093155|464008069|FG001|Overall Study|Not Eligible|0|||
128924098|NCT03093155|464008068|FG000|Overall Study|Withdrawal by Subject|0|||
128924099|NCT03093155|464008069|FG001|Overall Study|Withdrawal by Subject|1|||
128924100|NCT01700829|464008070|FG000|Overall Study|Withdrawal by Subject|1|||
128924101|NCT01700829|464008071|FG001|Overall Study|Withdrawal by Subject|1|||
128701054|NCT00042289|463203431|FG039|Overall Study|Withdrawal by Subject|0|||
128701055|NCT00042289|463203432|FG040|Overall Study|Withdrawal by Subject|0|||
128701056|NCT00042289|463203433|FG041|Overall Study|Withdrawal by Subject|0|||
128924102|NCT02561156|464008072|FG000|Part 2|Adverse Event|0|||
128924103|NCT02561156|464008073|FG001|Part 2|Adverse Event|0|||
128924104|NCT02561156|464008074|FG002|Part 2|Adverse Event|0|||
128924105|NCT02561156|464008075|FG003|Part 2|Adverse Event|0|||
128924106|NCT02561156|464008076|FG004|Part 2|Adverse Event|0|||
128924107|NCT02561156|464008077|FG005|Part 2|Adverse Event|0|||
128924108|NCT02561156|464008078|FG006|Part 2|Adverse Event|0|||
128924109|NCT02561156|464008079|FG007|Part 2|Adverse Event|0|||
128924110|NCT02561156|464008080|FG008|Part 2|Adverse Event|0|||
128924111|NCT02561156|464008081|FG009|Part 2|Adverse Event|0|||
128924112|NCT02561156|464008082|FG010|Part 2|Adverse Event|0|||
128924113|NCT02561156|464008083|FG011|Part 2|Adverse Event|1|||
128924114|NCT02561156|464008084|FG012|Part 2|Adverse Event|0|||
128924115|NCT02209506|464008090|FG000|Overall Study|Withdrawal by Subject|0|||
128924116|NCT02209506|464008091|FG001|Overall Study|Withdrawal by Subject|0|||
128924117|NCT02209506|464008092|FG002|Overall Study|Withdrawal by Subject|0|||
128924118|NCT02209506|464008093|FG003|Overall Study|Withdrawal by Subject|0|||
128924119|NCT02209506|464008094|FG004|Overall Study|Withdrawal by Subject|1|||
128924120|NCT00098787|464008095|FG000|Overall Study|Never started treatment|3|||
128924121|NCT00098787|464008096|FG001|Overall Study|Never started treatment|2|||
128924122|NCT00098787|464008097|FG002|Overall Study|Never started treatment|1|||
128924123|NCT00098787|464008095|FG000|Overall Study|Ineligible|9|||
128924124|NCT00098787|464008096|FG001|Overall Study|Ineligible|7|||
128924125|NCT00098787|464008097|FG002|Overall Study|Ineligible|3|||
128924126|NCT00098787|464008095|FG000|Overall Study|Disease progression|28|||
128924127|NCT00098787|464008096|FG001|Overall Study|Disease progression|17|||
128924128|NCT00098787|464008097|FG002|Overall Study|Disease progression|23|||
128924129|NCT00098787|464008095|FG000|Overall Study|Adverse Event|8|||
128924130|NCT00098787|464008096|FG001|Overall Study|Adverse Event|17|||
128924131|NCT00098787|464008097|FG002|Overall Study|Adverse Event|8|||
128924132|NCT00098787|464008095|FG000|Overall Study|Death|6|||
128924133|NCT00098787|464008096|FG001|Overall Study|Death|1|||
128924134|NCT00098787|464008097|FG002|Overall Study|Death|0|||
128924135|NCT00098787|464008095|FG000|Overall Study|Withdrawal by Subject|4|||
128924136|NCT00098787|464008096|FG001|Overall Study|Withdrawal by Subject|12|||
128924137|NCT00098787|464008097|FG002|Overall Study|Withdrawal by Subject|6|||
128924138|NCT00098787|464008095|FG000|Overall Study|Alternative therapy|8|||
128924139|NCT00098787|464008096|FG001|Overall Study|Alternative therapy|13|||
128924140|NCT00098787|464008097|FG002|Overall Study|Alternative therapy|13|||
128924141|NCT00098787|464008095|FG000|Overall Study|Other|7|||
128924142|NCT00098787|464008096|FG001|Overall Study|Other|6|||
128924143|NCT00098787|464008097|FG002|Overall Study|Other|9|||
128924144|NCT01360996|464008098|FG000|Overall Study|Withdrawal by Subject|4|||
128924145|NCT01360996|464008099|FG001|Overall Study|Withdrawal by Subject|3|||
128924146|NCT01360996|464008100|FG002|Overall Study|Withdrawal by Subject|2|||
128924147|NCT01360996|464008098|FG000|Overall Study|Noncompliant|2|||
128924148|NCT01360996|464008099|FG001|Overall Study|Noncompliant|0|||
128924149|NCT01360996|464008100|FG002|Overall Study|Noncompliant|0|||
128924150|NCT04964258|464008102|FG000|Overall Study|Lost to Follow-up|1|||
128924151|NCT04964258|464008103|FG001|Overall Study|Lost to Follow-up|0|||
128924152|NCT04964258|464008104|FG002|Overall Study|Lost to Follow-up|0|||
128924153|NCT04964258|464008105|FG003|Overall Study|Lost to Follow-up|0|||
128924154|NCT04964258|464008106|FG004|Overall Study|Lost to Follow-up|0|||
128924155|NCT04964258|464008107|FG005|Overall Study|Lost to Follow-up|1|||
128924156|NCT04964258|464008108|FG006|Overall Study|Lost to Follow-up|0|||
128924157|NCT04964258|464008109|FG007|Overall Study|Lost to Follow-up|0|||
128924158|NCT04964258|464008110|FG008|Overall Study|Lost to Follow-up|0|||
128924159|NCT04964258|464008111|FG009|Overall Study|Lost to Follow-up|0|||
128924160|NCT04964258|464008112|FG010|Overall Study|Lost to Follow-up|0|||
128924161|NCT01499290|464008115|FG000|Overall Study|Withdrawal by Subject|22|||
128924162|NCT01499290|464008116|FG001|Overall Study|Withdrawal by Subject|15|||
128924163|NCT01499290|464008115|FG000|Overall Study|Not specified in study report|11|||
128924164|NCT01499290|464008116|FG001|Overall Study|Not specified in study report|5|||
128924165|NCT01499290|464008115|FG000|Overall Study|Condition improved/subject recovered|1|||
128924166|NCT01499290|464008116|FG001|Overall Study|Condition improved/subject recovered|0|||
128924167|NCT01499290|464008115|FG000|Overall Study|Lack of Efficacy|7|||
128924168|NCT01499290|464008116|FG001|Overall Study|Lack of Efficacy|8|||
128924169|NCT01499290|464008115|FG000|Overall Study|Adverse Event|14|||
129216338|NCT02177032|465092886|FG000|Overall Study|Withdrawal by Subject|1|||
128924170|NCT01499290|464008116|FG001|Overall Study|Adverse Event|7|||
128924171|NCT04052139|464008117|FG000|Overall Study|Lost to Follow-up|2|||
128924172|NCT04052139|464008118|FG001|Overall Study|Lost to Follow-up|0|||
128924173|NCT04052139|464008119|FG002|Overall Study|Lost to Follow-up|0|||
128924174|NCT04052139|464008117|FG000|Overall Study|Withdrawal by Subject|1|||
128924175|NCT04052139|464008118|FG001|Overall Study|Withdrawal by Subject|0|||
128924176|NCT04052139|464008119|FG002|Overall Study|Withdrawal by Subject|0|||
129216339|NCT02177032|465092887|FG001|Overall Study|Withdrawal by Subject|0|||
128924177|NCT03406962|464008120|FG000|Overall Study|Death|2|||
128924178|NCT03406962|464008120|FG000|Overall Study|Adverse Event|1|||
128924179|NCT00327444|464008121|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
128924180|NCT00327444|464008122|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
128924181|NCT00327444|464008121|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
128924182|NCT00327444|464008122|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
128924183|NCT00327444|464008121|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
128924184|NCT00327444|464008122|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
128924185|NCT00327444|464008121|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
128924186|NCT00327444|464008122|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
128924187|NCT00327444|464008121|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
128924188|NCT00327444|464008122|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
128924189|NCT00327444|464008121|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
128924190|NCT00327444|464008122|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
128924191|NCT00327444|464008121|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
128924192|NCT00327444|464008122|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
128924193|NCT00327444|464008121|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
128924194|NCT00327444|464008122|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
128924195|NCT04439344|464008123|FG000|Overall Study|Never started threapy|3|||
128924196|NCT04439344|464008123|FG000|Overall Study|Ineligible|3|||
128924197|NCT04439344|464008123|FG000|Overall Study|Adverse Event|13|||
128924198|NCT04439344|464008123|FG000|Overall Study|Death|2|||
128924199|NCT04439344|464008123|FG000|Overall Study|Disease progression|29|||
128924200|NCT04439344|464008123|FG000|Overall Study|Withdrawal by Subject|2|||
128924201|NCT04439344|464008123|FG000|Overall Study|Alternative therapy|1|||
128924202|NCT00552110|464008124|FG000|Overall Study|Serious or Life-Threatening AE|0|||
128924203|NCT00552110|464008125|FG001|Overall Study|Serious or Life-Threatening AE|0|||
128924204|NCT00552110|464008126|FG002|Overall Study|Serious or Life-Threatening AE|1|||
128924205|NCT00552110|464008127|FG003|Overall Study|Serious or Life-Threatening AE|0|||
128924206|NCT00552110|464008128|FG004|Overall Study|Serious or Life-Threatening AE|0|||
128924207|NCT00552110|464008124|FG000|Overall Study|Lack of Efficacy|1|||
128924208|NCT00552110|464008125|FG001|Overall Study|Lack of Efficacy|0|||
128924209|NCT00552110|464008126|FG002|Overall Study|Lack of Efficacy|0|||
128924210|NCT00552110|464008127|FG003|Overall Study|Lack of Efficacy|1|||
128924211|NCT00552110|464008128|FG004|Overall Study|Lack of Efficacy|4|||
128924212|NCT00552110|464008124|FG000|Overall Study|Withdrawal by Subject|0|||
128924213|NCT00552110|464008125|FG001|Overall Study|Withdrawal by Subject|2|||
128924214|NCT00552110|464008126|FG002|Overall Study|Withdrawal by Subject|0|||
128924215|NCT00552110|464008127|FG003|Overall Study|Withdrawal by Subject|3|||
128924216|NCT00552110|464008128|FG004|Overall Study|Withdrawal by Subject|2|||
128924217|NCT00552110|464008124|FG000|Overall Study|Lost to Follow-up|0|||
128924218|NCT00552110|464008125|FG001|Overall Study|Lost to Follow-up|0|||
128924219|NCT00552110|464008126|FG002|Overall Study|Lost to Follow-up|0|||
128924220|NCT00552110|464008127|FG003|Overall Study|Lost to Follow-up|1|||
128924221|NCT00552110|464008128|FG004|Overall Study|Lost to Follow-up|1|||
128924222|NCT00552110|464008124|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
128924223|NCT00552110|464008125|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
128924224|NCT00552110|464008126|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
128924225|NCT00552110|464008127|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
128924226|NCT00552110|464008128|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
128924227|NCT00552110|464008124|FG000|Overall Study|Withdrawn per Sponsor|0|||
128924228|NCT00552110|464008125|FG001|Overall Study|Withdrawn per Sponsor|1|||
128701057|NCT00042289|463203434|FG042|Overall Study|Withdrawal by Subject|1|||
128701058|NCT00042289|463203435|FG043|Overall Study|Withdrawal by Subject|0|||
128924229|NCT00552110|464008126|FG002|Overall Study|Withdrawn per Sponsor|0|||
128924230|NCT00552110|464008127|FG003|Overall Study|Withdrawn per Sponsor|0|||
128924231|NCT00552110|464008128|FG004|Overall Study|Withdrawn per Sponsor|1|||
128924232|NCT00552110|464008124|FG000|Overall Study|Use of Prohibited Medication|1|||
128924233|NCT00552110|464008125|FG001|Overall Study|Use of Prohibited Medication|1|||
128924234|NCT00552110|464008126|FG002|Overall Study|Use of Prohibited Medication|0|||
128924235|NCT00552110|464008127|FG003|Overall Study|Use of Prohibited Medication|0|||
128924236|NCT00552110|464008128|FG004|Overall Study|Use of Prohibited Medication|0|||
128924237|NCT00552110|464008124|FG000|Overall Study|Delay of Study due to Relabeling|0|||
128924238|NCT00552110|464008125|FG001|Overall Study|Delay of Study due to Relabeling|0|||
128924239|NCT00552110|464008126|FG002|Overall Study|Delay of Study due to Relabeling|0|||
128924240|NCT00552110|464008127|FG003|Overall Study|Delay of Study due to Relabeling|1|||
128924241|NCT00552110|464008128|FG004|Overall Study|Delay of Study due to Relabeling|0|||
128924242|NCT00552110|464008124|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
128924243|NCT00552110|464008125|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
128924244|NCT00552110|464008126|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
128924245|NCT00552110|464008127|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
128924246|NCT00552110|464008128|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
128924247|NCT00552110|464008124|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
128924248|NCT00552110|464008125|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
128924249|NCT00552110|464008126|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
128924250|NCT00552110|464008127|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
128924251|NCT00552110|464008128|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
128924252|NCT04375761|464010485|FG000|Overall Study|Death|1|||
128924253|NCT04375761|464010486|FG001|Overall Study|Death|2|||
128924254|NCT04375761|464010485|FG000|Overall Study|Lost to Follow-up|203|||
128924255|NCT04375761|464010486|FG001|Overall Study|Lost to Follow-up|380|||
128924256|NCT04375761|464010485|FG000|Overall Study|Withdrawal by Subject|47|||
128924257|NCT04375761|464010486|FG001|Overall Study|Withdrawal by Subject|98|||
128924258|NCT04375761|464010485|FG000|Overall Study|Noncompliance with study procedure|121|||
128924259|NCT04375761|464010486|FG001|Overall Study|Noncompliance with study procedure|251|||
128924260|NCT04375761|464010485|FG000|Overall Study|Reimbursement not enough|1|||
128924261|NCT04375761|464010486|FG001|Overall Study|Reimbursement not enough|2|||
128924262|NCT04375761|464010485|FG000|Overall Study|Unforeseen family circumstances|1|||
128924263|NCT04375761|464010486|FG001|Overall Study|Unforeseen family circumstances|3|||
128924264|NCT04375761|464010485|FG000|Overall Study|Test too painful|1|||
128924265|NCT04375761|464010486|FG001|Overall Study|Test too painful|1|||
128924266|NCT04375761|464010485|FG000|Overall Study|Moved|0|||
128924267|NCT04375761|464010486|FG001|Overall Study|Moved|2|||
128924268|NCT04375761|464010485|FG000|Overall Study|Nonresponsive|0|||
128924269|NCT04375761|464010486|FG001|Overall Study|Nonresponsive|5|||
128924270|NCT03797001|464010487|FG000|Overall Study|Withdrawn due to COVID19|4|||
128924271|NCT03797001|464010488|FG001|Overall Study|Withdrawn due to COVID19|0|||
128924272|NCT03797001|464010487|FG000|Overall Study|Withdrawal by Subject|7|||
128924273|NCT03797001|464010488|FG001|Overall Study|Withdrawal by Subject|6|||
128924274|NCT03797001|464010487|FG000|Overall Study|Adverse Event|0|||
128924275|NCT03797001|464010488|FG001|Overall Study|Adverse Event|1|||
128924276|NCT05630846|464010491|FG000|Overall Study|Death|1|||
128924277|NCT05630846|464010492|FG001|Overall Study|Death|0|||
128924278|NCT05630846|464010493|FG002|Overall Study|Death|0|||
128924279|NCT05630846|464010494|FG003|Overall Study|Death|0|||
128924280|NCT05630846|464010491|FG000|Overall Study|Withdrawal by Subject|3|||
128924281|NCT05630846|464010492|FG001|Overall Study|Withdrawal by Subject|3|||
128924282|NCT05630846|464010493|FG002|Overall Study|Withdrawal by Subject|4|||
128924283|NCT05630846|464010494|FG003|Overall Study|Withdrawal by Subject|1|||
128924284|NCT05630846|464010491|FG000|Overall Study|Lost to Follow-up|6|||
128924285|NCT05630846|464010492|FG001|Overall Study|Lost to Follow-up|5|||
128924286|NCT05630846|464010493|FG002|Overall Study|Lost to Follow-up|2|||
128924287|NCT05630846|464010494|FG003|Overall Study|Lost to Follow-up|5|||
128766976|NCT02440594|463438077|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
128766977|NCT02440594|463438078|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
128766978|NCT02440594|463438079|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
128766979|NCT02440594|463438080|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
128924288|NCT05630846|464010491|FG000|Overall Study|Other|1|||
128924289|NCT05630846|464010492|FG001|Overall Study|Other|0|||
128924290|NCT05630846|464010493|FG002|Overall Study|Other|0|||
128924291|NCT05630846|464010494|FG003|Overall Study|Other|0|||
128924292|NCT05556616|464010495|FG000|Overall Study|Withdrawal by Subject|1|||
128924293|NCT05556616|464010496|FG001|Overall Study|Withdrawal by Subject|0|||
128924294|NCT05556616|464010497|FG002|Overall Study|Withdrawal by Subject|0|||
128924295|NCT05556616|464010498|FG003|Overall Study|Withdrawal by Subject|0|||
128924296|NCT05556616|464010499|FG004|Overall Study|Withdrawal by Subject|0|||
128924297|NCT05556616|464010500|FG005|Overall Study|Withdrawal by Subject|0|||
128924298|NCT05556616|464010501|FG006|Overall Study|Withdrawal by Subject|0|||
128924299|NCT05556616|464010495|FG000|Overall Study|Death|0|||
128924300|NCT05556616|464010496|FG001|Overall Study|Death|0|||
128924301|NCT05556616|464010497|FG002|Overall Study|Death|2|||
128924302|NCT05556616|464010498|FG003|Overall Study|Death|1|||
128924303|NCT05556616|464010499|FG004|Overall Study|Death|0|||
128924304|NCT05556616|464010500|FG005|Overall Study|Death|0|||
128924305|NCT05556616|464010501|FG006|Overall Study|Death|0|||
128924306|NCT05556616|464010495|FG000|Overall Study|Study Terminated by Sponsor|0|||
128924307|NCT05556616|464010496|FG001|Overall Study|Study Terminated by Sponsor|3|||
128924308|NCT05556616|464010497|FG002|Overall Study|Study Terminated by Sponsor|0|||
128924309|NCT05556616|464010498|FG003|Overall Study|Study Terminated by Sponsor|0|||
128924310|NCT05556616|464010499|FG004|Overall Study|Study Terminated by Sponsor|0|||
128924311|NCT05556616|464010500|FG005|Overall Study|Study Terminated by Sponsor|0|||
128924312|NCT05556616|464010501|FG006|Overall Study|Study Terminated by Sponsor|0|||
128924313|NCT00075881|464010502|FG000|Overall Study|Lack of Efficacy|18|||
128924314|NCT00075881|464010502|FG000|Overall Study|Adverse Event|7|||
128924315|NCT00075881|464010502|FG000|Overall Study|Death|1|||
128924316|NCT00075881|464010502|FG000|Overall Study|Withdrawal by Subject|2|||
128924317|NCT00075881|464010502|FG000|Overall Study|Protocol Violation|4|||
128924318|NCT00075881|464010502|FG000|Overall Study|other complicating disease|3|||
128924319|NCT00075881|464010502|FG000|Overall Study|other|4|||
128924320|NCT00075881|464010502|FG000|Overall Study|missing data|2|||
128924321|NCT00075881|464010502|FG000|Overall Study|Ineligible|1|||
128924322|NCT00075881|464010502|FG000|Overall Study|never start protocol therapy|1|||
128924323|NCT03019549|464010503|FG000|Washout|DId not meet genotype criteria|11|||
128924324|NCT03019549|464010503|FG000|Period 2|Adverse Event|2|||
128766980|NCT02440594|463438081|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
128924325|NCT03019549|464010503|FG000|Period 2|Physician Decision|2|||
128924326|NCT03019549|464010503|FG000|Period 2|Withdrawal by Subject|1|||
128924327|NCT03263091|464010505|FG000|OL Component|Withdrawal by Subject|1|||
128924328|NCT03263091|464010506|FG001|OL Component|Withdrawal by Subject|1|||
128924329|NCT03263091|464010507|FG002|OL Component|Withdrawal by Subject|0|||
128924330|NCT03263091|464010508|FG003|OL Component|Withdrawal by Subject|0|||
128924331|NCT03263091|464010509|FG004|OL Component|Withdrawal by Subject|0|||
128924332|NCT03263091|464010510|FG005|OL Component|Withdrawal by Subject|0|||
128924333|NCT03263091|464010505|FG000|OL Component|Physician Decision|0|||
128924334|NCT03263091|464010506|FG001|OL Component|Physician Decision|1|||
128924335|NCT03263091|464010507|FG002|OL Component|Physician Decision|2|||
128924336|NCT03263091|464010508|FG003|OL Component|Physician Decision|0|||
128924337|NCT03263091|464010509|FG004|OL Component|Physician Decision|0|||
128924338|NCT03263091|464010510|FG005|OL Component|Physician Decision|0|||
128924339|NCT03263091|464010505|FG000|OL Component|Death|1|||
128924340|NCT03263091|464010506|FG001|OL Component|Death|0|||
128924341|NCT03263091|464010507|FG002|OL Component|Death|0|||
128924342|NCT03263091|464010508|FG003|OL Component|Death|0|||
128924343|NCT03263091|464010509|FG004|OL Component|Death|0|||
128924344|NCT03263091|464010510|FG005|OL Component|Death|0|||
128924345|NCT03263091|464010505|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
128924346|NCT03263091|464010506|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
128924347|NCT03263091|464010507|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
128924348|NCT03263091|464010508|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
128924349|NCT03263091|464010509|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
128924350|NCT03263091|464010510|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
128924351|NCT03263091|464010505|FG000|OL High-EPO Component|Physician Decision|0|||
128924352|NCT03263091|464010506|FG001|OL High-EPO Component|Physician Decision|0|||
128924353|NCT03263091|464010507|FG002|OL High-EPO Component|Physician Decision|0|||
128924354|NCT03263091|464010508|FG003|OL High-EPO Component|Physician Decision|1|||
128924355|NCT03263091|464010509|FG004|OL High-EPO Component|Physician Decision|0|||
128924356|NCT03263091|464010510|FG005|OL High-EPO Component|Physician Decision|0|||
128924357|NCT03263091|464010505|FG000|OL High-EPO Component|Death|0|||
128924358|NCT03263091|464010506|FG001|OL High-EPO Component|Death|0|||
128924359|NCT03263091|464010507|FG002|OL High-EPO Component|Death|0|||
128924360|NCT03263091|464010508|FG003|OL High-EPO Component|Death|3|||
128924361|NCT03263091|464010509|FG004|OL High-EPO Component|Death|0|||
128924362|NCT03263091|464010510|FG005|OL High-EPO Component|Death|0|||
128924363|NCT03263091|464010505|FG000|DB Component|Withdrawal by Subject|0|||
128924364|NCT03263091|464010506|FG001|DB Component|Withdrawal by Subject|0|||
128924365|NCT03263091|464010507|FG002|DB Component|Withdrawal by Subject|0|||
128924366|NCT03263091|464010508|FG003|DB Component|Withdrawal by Subject|0|||
128924367|NCT03263091|464010509|FG004|DB Component|Withdrawal by Subject|22|||
128924368|NCT03263091|464010510|FG005|DB Component|Withdrawal by Subject|8|||
128924369|NCT03263091|464010505|FG000|DB Component|Physician Decision|0|||
128924370|NCT03263091|464010506|FG001|DB Component|Physician Decision|0|||
128924371|NCT03263091|464010507|FG002|DB Component|Physician Decision|0|||
128924372|NCT03263091|464010508|FG003|DB Component|Physician Decision|0|||
128924373|NCT03263091|464010509|FG004|DB Component|Physician Decision|3|||
128924374|NCT03263091|464010510|FG005|DB Component|Physician Decision|1|||
128924375|NCT03263091|464010505|FG000|DB Component|Adverse Event|0|||
128924376|NCT03263091|464010506|FG001|DB Component|Adverse Event|0|||
128924377|NCT03263091|464010507|FG002|DB Component|Adverse Event|0|||
128924378|NCT03263091|464010508|FG003|DB Component|Adverse Event|0|||
128924379|NCT03263091|464010509|FG004|DB Component|Adverse Event|2|||
128924380|NCT03263091|464010510|FG005|DB Component|Adverse Event|1|||
128924381|NCT03263091|464010505|FG000|DB Component|Lost to Follow-up|0|||
128924382|NCT03263091|464010506|FG001|DB Component|Lost to Follow-up|0|||
128924383|NCT03263091|464010507|FG002|DB Component|Lost to Follow-up|0|||
128924384|NCT03263091|464010508|FG003|DB Component|Lost to Follow-up|0|||
128924385|NCT03263091|464010509|FG004|DB Component|Lost to Follow-up|2|||
128924386|NCT03263091|464010510|FG005|DB Component|Lost to Follow-up|1|||
128924387|NCT03263091|464010505|FG000|DB Component|Death|0|||
129029552|NCT01109849|464399869|FG000|Initial Randomization: ADHD Treatment|move away|2|||
129029553|NCT01109849|464399870|FG001|Initial Randomization: ADHD Treatment|move away|7|||
129029554|NCT01109849|464399871|FG002|Initial Randomization: ADHD Treatment|move away|0|||
129029555|NCT01109849|464399872|FG003|Initial Randomization: ADHD Treatment|move away|0|||
129029556|NCT01109849|464399873|FG004|Initial Randomization: ADHD Treatment|move away|0|||
128924388|NCT03263091|464010506|FG001|DB Component|Death|0|||
128924389|NCT03263091|464010507|FG002|DB Component|Death|0|||
128924390|NCT03263091|464010508|FG003|DB Component|Death|0|||
128924391|NCT03263091|464010509|FG004|DB Component|Death|7|||
128924392|NCT03263091|464010510|FG005|DB Component|Death|4|||
128924393|NCT03263091|464010505|FG000|DB Component|Other than specified|0|||
128924394|NCT03263091|464010506|FG001|DB Component|Other than specified|0|||
128924395|NCT03263091|464010507|FG002|DB Component|Other than specified|0|||
128924396|NCT03263091|464010508|FG003|DB Component|Other than specified|0|||
128924397|NCT03263091|464010509|FG004|DB Component|Other than specified|8|||
128924398|NCT03263091|464010510|FG005|DB Component|Other than specified|6|||
128924399|NCT00742781|464010511|FG000|Overall Study|Withdrawal by Subject|3|||
128924400|NCT00824564|464010527|FG000|Overall Study|Lost to Follow-up|5|||
128924401|NCT00824564|464010528|FG001|Overall Study|Lost to Follow-up|7|||
128924402|NCT00824564|464010527|FG000|Overall Study|Withdrawal by Subject|1|||
128924403|NCT00824564|464010528|FG001|Overall Study|Withdrawal by Subject|1|||
128924404|NCT00824564|464010527|FG000|Overall Study|Other|1|||
128701059|NCT00042289|463203436|FG044|Overall Study|Withdrawal by Subject|0|||
128701060|NCT00042289|463203437|FG045|Overall Study|Withdrawal by Subject|0|||
128924405|NCT00824564|464010528|FG001|Overall Study|Other|2|||
128924406|NCT00824564|464010527|FG000|Overall Study|Randomized, but not treated|1|||
128924407|NCT00824564|464010528|FG001|Overall Study|Randomized, but not treated|0|||
128924408|NCT01552057|464010535|FG000|Overall Study|Adverse Event|14|||
128924409|NCT01552057|464010536|FG001|Overall Study|Adverse Event|15|||
128924410|NCT01552057|464010535|FG000|Overall Study|Lack of Efficacy|8|||
128924411|NCT01552057|464010536|FG001|Overall Study|Lack of Efficacy|23|||
128924412|NCT01552057|464010535|FG000|Overall Study|Withdrawal by Subject|5|||
129216340|NCT02177032|465092888|FG002|Overall Study|Withdrawal by Subject|1|||
129216341|NCT02177032|465092889|FG003|Overall Study|Withdrawal by Subject|0|||
128701061|NCT00042289|463203438|FG046|Overall Study|Withdrawal by Subject|0|||
128701062|NCT01687998|463203440|FG000|Overall Study|Withdrawal by Subject|49|||
128924413|NCT01552057|464010536|FG001|Overall Study|Withdrawal by Subject|8|||
128924414|NCT01552057|464010535|FG000|Overall Study|Entry Criteria Not Met|2|||
128924415|NCT01552057|464010536|FG001|Overall Study|Entry Criteria Not Met|2|||
128924416|NCT01552057|464010535|FG000|Overall Study|Physician Decision|1|||
128924417|NCT01552057|464010536|FG001|Overall Study|Physician Decision|0|||
128924418|NCT05127486|464010538|FG000|Overall Study|Adverse Event|2|||
128924419|NCT05127486|464010539|FG001|Overall Study|Adverse Event|4|||
128924420|NCT05127486|464010538|FG000|Overall Study|Lack of Efficacy|1|||
128924421|NCT05127486|464010539|FG001|Overall Study|Lack of Efficacy|0|||
128924422|NCT05127486|464010538|FG000|Overall Study|Pregnancy|0|||
128924423|NCT05127486|464010539|FG001|Overall Study|Pregnancy|1|||
128924424|NCT05127486|464010538|FG000|Overall Study|Physician Decision|4|||
128924425|NCT05127486|464010539|FG001|Overall Study|Physician Decision|1|||
128924426|NCT05127486|464010538|FG000|Overall Study|Withdrawal by Subject|14|||
128924427|NCT05127486|464010539|FG001|Overall Study|Withdrawal by Subject|13|||
128924428|NCT05127486|464010538|FG000|Overall Study|Lost to Follow-up|5|||
128924429|NCT05127486|464010539|FG001|Overall Study|Lost to Follow-up|8|||
128924430|NCT01287754|464010540|FG000|Overall Study|Death|2|||
128924431|NCT01287754|464010541|FG001|Overall Study|Death|12|||
128924432|NCT01287754|464010540|FG000|Overall Study|Lost to Follow-up|1|||
128924433|NCT01287754|464010541|FG001|Overall Study|Lost to Follow-up|6|||
128924434|NCT01287754|464010540|FG000|Overall Study|Protocol Violation|0|||
128924435|NCT01287754|464010541|FG001|Overall Study|Protocol Violation|3|||
128924436|NCT04439266|464010552|FG000|Overall Study|Ineligible|1|||
128924437|NCT04439266|464010552|FG000|Overall Study|Adverse Event|1|||
128924438|NCT04439266|464010552|FG000|Overall Study|Death|1|||
128924439|NCT04439266|464010552|FG000|Overall Study|Disease progression|1|||
128701063|NCT01687998|463203441|FG001|Overall Study|Withdrawal by Subject|51|||
128701064|NCT01687998|463203440|FG000|Overall Study|Known to be Alive at Study End|54|||
128701065|NCT01687998|463203441|FG001|Overall Study|Known to be Alive at Study End|62|||
128924440|NCT04439266|464010552|FG000|Overall Study|Still on treatment|1|||
128924441|NCT04971226|464010553|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
128924442|NCT04971226|464010554|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
128924443|NCT04971226|464010555|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
128924444|NCT04971226|464010556|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
128924445|NCT04971226|464010553|FG000|Overall Study|Adverse Event|6|||
128924446|NCT04971226|464010554|FG001|Overall Study|Adverse Event|5|||
128701066|NCT01687998|463203440|FG000|Overall Study|Lost to Follow-up|9|||
128701067|NCT01687998|463203441|FG001|Overall Study|Lost to Follow-up|7|||
128701068|NCT00745823|463203442|FG000|Overall Study|Adverse Event|5|||
128701069|NCT00745823|463203443|FG001|Overall Study|Adverse Event|3|||
128701070|NCT00745823|463203442|FG000|Overall Study|Lack of Efficacy|20|||
128701071|NCT00745823|463203443|FG001|Overall Study|Lack of Efficacy|6|||
128701072|NCT00745823|463203442|FG000|Overall Study|Lost to Follow-up|10|||
128766981|NCT02440594|463438082|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
128701073|NCT00745823|463203443|FG001|Overall Study|Lost to Follow-up|11|||
128701074|NCT00745823|463203442|FG000|Overall Study|Physician Decision|10|||
128924447|NCT04971226|464010555|FG002|Overall Study|Adverse Event|11|||
128924448|NCT04971226|464010556|FG003|Overall Study|Adverse Event|10|||
128924449|NCT04971226|464010553|FG000|Overall Study|Progressive disease|2|||
128924450|NCT04971226|464010554|FG001|Overall Study|Progressive disease|0|||
128924451|NCT04971226|464010555|FG002|Overall Study|Progressive disease|3|||
128924452|NCT04971226|464010556|FG003|Overall Study|Progressive disease|1|||
128924453|NCT04971226|464010553|FG000|Overall Study|Protocol Deviation|1|||
128924454|NCT04971226|464010554|FG001|Overall Study|Protocol Deviation|0|||
128924455|NCT04971226|464010555|FG002|Overall Study|Protocol Deviation|1|||
128924456|NCT04971226|464010556|FG003|Overall Study|Protocol Deviation|1|||
128924457|NCT04971226|464010553|FG000|Overall Study|Subject Decision|0|||
128924458|NCT04971226|464010554|FG001|Overall Study|Subject Decision|1|||
128924459|NCT04971226|464010555|FG002|Overall Study|Subject Decision|1|||
128924460|NCT04971226|464010556|FG003|Overall Study|Subject Decision|1|||
128924461|NCT04971226|464010553|FG000|Overall Study|Pregnancy|0|||
128924462|NCT04971226|464010554|FG001|Overall Study|Pregnancy|0|||
128924463|NCT04971226|464010555|FG002|Overall Study|Pregnancy|0|||
128924464|NCT04971226|464010556|FG003|Overall Study|Pregnancy|1|||
128924465|NCT04971226|464010553|FG000|Overall Study|Participants not treated|1|||
128924466|NCT04971226|464010554|FG001|Overall Study|Participants not treated|0|||
128924467|NCT04971226|464010555|FG002|Overall Study|Participants not treated|2|||
128924468|NCT04971226|464010556|FG003|Overall Study|Participants not treated|1|||
128924469|NCT00001337|464010558|FG000|Overall Study|Switched to alternate treatment|2|||
128924470|NCT00001337|464010559|FG001|Overall Study|Switched to alternate treatment|2|||
128924471|NCT00001337|464010560|FG002|Overall Study|Switched to alternate treatment|0|||
128924472|NCT00001337|464010558|FG000|Overall Study|Refused further treatment|2|||
128924473|NCT00001337|464010559|FG001|Overall Study|Refused further treatment|1|||
128924474|NCT00001337|464010560|FG002|Overall Study|Refused further treatment|0|||
128924475|NCT00001337|464010558|FG000|Overall Study|Began other Tx|1|||
128924476|NCT00001337|464010559|FG001|Overall Study|Began other Tx|0|||
128924477|NCT00001337|464010560|FG002|Overall Study|Began other Tx|0|||
128924478|NCT00001337|464010558|FG000|Overall Study|Physician Decision|3|||
128924479|NCT00001337|464010559|FG001|Overall Study|Physician Decision|1|||
128924480|NCT00001337|464010560|FG002|Overall Study|Physician Decision|0|||
128924481|NCT00001337|464010558|FG000|Overall Study|Doesn't have NHL|0|||
128924482|NCT00001337|464010559|FG001|Overall Study|Doesn't have NHL|1|||
128924483|NCT00001337|464010560|FG002|Overall Study|Doesn't have NHL|0|||
128924484|NCT00001337|464010558|FG000|Overall Study|Non protocol tx needed|3|||
128924485|NCT00001337|464010559|FG001|Overall Study|Non protocol tx needed|1|||
128924486|NCT00001337|464010560|FG002|Overall Study|Non protocol tx needed|0|||
128924487|NCT00001337|464010558|FG000|Overall Study|Protocol change|1|||
128924488|NCT00001337|464010559|FG001|Overall Study|Protocol change|0|||
128924489|NCT00001337|464010560|FG002|Overall Study|Protocol change|0|||
128924490|NCT00001337|464010558|FG000|Overall Study|2nd primary disease|0|||
128924491|NCT00001337|464010559|FG001|Overall Study|2nd primary disease|0|||
128924492|NCT00001337|464010560|FG002|Overall Study|2nd primary disease|1|||
128924493|NCT00001337|464010558|FG000|Overall Study|Death during follow up period|9|||
128924494|NCT00001337|464010559|FG001|Overall Study|Death during follow up period|4|||
128924495|NCT00001337|464010560|FG002|Overall Study|Death during follow up period|0|||
128924496|NCT00001337|464010558|FG000|Overall Study|Death on study|19|||
128924497|NCT00001337|464010559|FG001|Overall Study|Death on study|9|||
128924498|NCT00001337|464010560|FG002|Overall Study|Death on study|0|||
128924499|NCT00001337|464010558|FG000|Overall Study|Disease progression during follow-up period|3|||
128924500|NCT00001337|464010559|FG001|Overall Study|Disease progression during follow-up period|1|||
128924501|NCT00001337|464010560|FG002|Overall Study|Disease progression during follow-up period|0|||
128924502|NCT00001337|464010558|FG000|Overall Study|Disease progression on study|33|||
128924503|NCT00001337|464010559|FG001|Overall Study|Disease progression on study|41|||
128924504|NCT00001337|464010560|FG002|Overall Study|Disease progression on study|0|||
128924505|NCT00001337|464010558|FG000|Overall Study|Lost to further follow-up|10|||
128924506|NCT00001337|464010559|FG001|Overall Study|Lost to further follow-up|6|||
128924507|NCT00001337|464010560|FG002|Overall Study|Lost to further follow-up|0|||
128924508|NCT00001337|464010558|FG000|Overall Study|2nd malignancy|1|||
128924509|NCT00001337|464010559|FG001|Overall Study|2nd malignancy|0|||
128924510|NCT00001337|464010560|FG002|Overall Study|2nd malignancy|0|||
128924511|NCT00001337|464010558|FG000|Overall Study|Treatment for second lymphoma|0|||
128924512|NCT00001337|464010559|FG001|Overall Study|Treatment for second lymphoma|1|||
128924513|NCT00001337|464010560|FG002|Overall Study|Treatment for second lymphoma|0|||
128924514|NCT00001337|464010558|FG000|Overall Study|Transfer to transplant|0|||
128924515|NCT00001337|464010559|FG001|Overall Study|Transfer to transplant|1|||
128701075|NCT00745823|463203443|FG001|Overall Study|Physician Decision|5|||
128924516|NCT00001337|464010560|FG002|Overall Study|Transfer to transplant|0|||
128701076|NCT00745823|463203442|FG000|Overall Study|Pregnancy|0|||
128701077|NCT00745823|463203443|FG001|Overall Study|Pregnancy|4|||
128701078|NCT00745823|463203442|FG000|Overall Study|Withdrawal by Subject|14|||
128701079|NCT00745823|463203443|FG001|Overall Study|Withdrawal by Subject|8|||
128924517|NCT04889209|464010567|FG000|All Cohorts Except 15E|Adverse Event|0|||
128924518|NCT04889209|464010568|FG001|All Cohorts Except 15E|Adverse Event|0|||
128924519|NCT04889209|464010569|FG002|All Cohorts Except 15E|Adverse Event|0|||
128924520|NCT04889209|464010570|FG003|All Cohorts Except 15E|Adverse Event|0|||
128924521|NCT04889209|464010571|FG004|All Cohorts Except 15E|Adverse Event|0|||
128701080|NCT00745823|463203442|FG000|Overall Study|Study Terminated by Sponsor|326|||
128701081|NCT00745823|463203443|FG001|Overall Study|Study Terminated by Sponsor|349|||
128924522|NCT04889209|464010572|FG005|All Cohorts Except 15E|Adverse Event|0|||
128924523|NCT04889209|464010573|FG006|All Cohorts Except 15E|Adverse Event|1|||
128924524|NCT04889209|464010574|FG007|All Cohorts Except 15E|Adverse Event|0|||
128924525|NCT04889209|464010575|FG008|All Cohorts Except 15E|Adverse Event|0|||
128924526|NCT04889209|464010576|FG009|All Cohorts Except 15E|Adverse Event|0|||
128924527|NCT04889209|464010577|FG010|All Cohorts Except 15E|Adverse Event|0|||
129216342|NCT00665652|465092890|FG000|Overall Study|Adverse Event|4|||
128924528|NCT04889209|464010578|FG011|All Cohorts Except 15E|Adverse Event|0|||
128924529|NCT04889209|464010579|FG012|All Cohorts Except 15E|Adverse Event|0|||
128924530|NCT04889209|464010580|FG013|All Cohorts Except 15E|Adverse Event|0|||
128924531|NCT04889209|464010581|FG014|All Cohorts Except 15E|Adverse Event|0|||
128924532|NCT04889209|464010582|FG015|All Cohorts Except 15E|Adverse Event|0|||
128924533|NCT04889209|464010583|FG016|All Cohorts Except 15E|Adverse Event|0|||
128924534|NCT04889209|464010584|FG017|All Cohorts Except 15E|Adverse Event|0|||
128924535|NCT04889209|464010567|FG000|All Cohorts Except 15E|Death|0|||
128924536|NCT04889209|464010568|FG001|All Cohorts Except 15E|Death|1|||
128924537|NCT04889209|464010569|FG002|All Cohorts Except 15E|Death|0|||
128924538|NCT04889209|464010570|FG003|All Cohorts Except 15E|Death|0|||
128924539|NCT04889209|464010571|FG004|All Cohorts Except 15E|Death|0|||
128924540|NCT04889209|464010572|FG005|All Cohorts Except 15E|Death|0|||
128924541|NCT04889209|464010573|FG006|All Cohorts Except 15E|Death|0|||
128924542|NCT04889209|464010574|FG007|All Cohorts Except 15E|Death|0|||
128924543|NCT04889209|464010575|FG008|All Cohorts Except 15E|Death|0|||
128924544|NCT04889209|464010576|FG009|All Cohorts Except 15E|Death|0|||
128924545|NCT04889209|464010577|FG010|All Cohorts Except 15E|Death|0|||
128924546|NCT04889209|464010578|FG011|All Cohorts Except 15E|Death|0|||
128924547|NCT04889209|464010579|FG012|All Cohorts Except 15E|Death|0|||
128924548|NCT04889209|464010580|FG013|All Cohorts Except 15E|Death|0|||
128924549|NCT04889209|464010581|FG014|All Cohorts Except 15E|Death|0|||
128924550|NCT04889209|464010582|FG015|All Cohorts Except 15E|Death|0|||
128924551|NCT04889209|464010583|FG016|All Cohorts Except 15E|Death|0|||
128924552|NCT04889209|464010584|FG017|All Cohorts Except 15E|Death|0|||
128924553|NCT04889209|464010567|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
128924554|NCT04889209|464010568|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
128924555|NCT04889209|464010569|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
128924556|NCT04889209|464010570|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
128924557|NCT04889209|464010571|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
128924558|NCT04889209|464010572|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
128924559|NCT04889209|464010573|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
128924560|NCT04889209|464010574|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
128924561|NCT04889209|464010575|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
128924562|NCT04889209|464010576|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
128924563|NCT04889209|464010577|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
128924564|NCT04889209|464010578|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
128924565|NCT04889209|464010579|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
128924566|NCT04889209|464010580|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
128924567|NCT04889209|464010581|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
128924568|NCT04889209|464010582|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
128924569|NCT04889209|464010583|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
128924570|NCT04889209|464010584|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
128924571|NCT04889209|464010567|FG000|All Cohorts Except 15E|Physician Decision|0|||
128924572|NCT04889209|464010568|FG001|All Cohorts Except 15E|Physician Decision|0|||
128924573|NCT04889209|464010569|FG002|All Cohorts Except 15E|Physician Decision|0|||
128924574|NCT04889209|464010570|FG003|All Cohorts Except 15E|Physician Decision|0|||
128924575|NCT04889209|464010571|FG004|All Cohorts Except 15E|Physician Decision|1|||
128924576|NCT04889209|464010572|FG005|All Cohorts Except 15E|Physician Decision|0|||
128924577|NCT04889209|464010573|FG006|All Cohorts Except 15E|Physician Decision|0|||
128924578|NCT04889209|464010574|FG007|All Cohorts Except 15E|Physician Decision|1|||
128924579|NCT04889209|464010575|FG008|All Cohorts Except 15E|Physician Decision|0|||
128924580|NCT04889209|464010576|FG009|All Cohorts Except 15E|Physician Decision|1|||
128924581|NCT04889209|464010577|FG010|All Cohorts Except 15E|Physician Decision|0|||
128924582|NCT04889209|464010578|FG011|All Cohorts Except 15E|Physician Decision|1|||
128924583|NCT04889209|464010579|FG012|All Cohorts Except 15E|Physician Decision|1|||
128924584|NCT04889209|464010580|FG013|All Cohorts Except 15E|Physician Decision|0|||
128924585|NCT04889209|464010581|FG014|All Cohorts Except 15E|Physician Decision|0|||
128924586|NCT04889209|464010582|FG015|All Cohorts Except 15E|Physician Decision|0|||
128924587|NCT04889209|464010583|FG016|All Cohorts Except 15E|Physician Decision|0|||
128924588|NCT04889209|464010584|FG017|All Cohorts Except 15E|Physician Decision|0|||
128924589|NCT04889209|464010567|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
128924590|NCT04889209|464010568|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
128924591|NCT04889209|464010569|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
128924592|NCT04889209|464010570|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
128924593|NCT04889209|464010571|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
128924594|NCT04889209|464010572|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924595|NCT04889209|464010573|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924596|NCT04889209|464010574|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
128924597|NCT04889209|464010575|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924598|NCT04889209|464010576|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924599|NCT04889209|464010577|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924600|NCT04889209|464010578|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924601|NCT04889209|464010579|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924602|NCT04889209|464010580|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
129216343|NCT00665652|465092890|FG000|Overall Study|Death|1|||
128924603|NCT04889209|464010581|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
128924604|NCT04889209|464010582|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
128924605|NCT04889209|464010583|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
128924606|NCT04889209|464010584|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
128924607|NCT04889209|464010567|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
128924608|NCT04889209|464010568|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
128924609|NCT04889209|464010569|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924610|NCT04889209|464010570|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924611|NCT04889209|464010571|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924612|NCT04889209|464010572|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
128924613|NCT04889209|464010573|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924614|NCT04889209|464010574|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
128924615|NCT04889209|464010575|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924616|NCT04889209|464010576|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
128924617|NCT04889209|464010577|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924618|NCT04889209|464010578|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924619|NCT04889209|464010579|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924620|NCT04889209|464010580|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924621|NCT04889209|464010581|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924622|NCT04889209|464010582|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924623|NCT04889209|464010583|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
128924624|NCT04889209|464010584|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
128924625|NCT04889209|464010567|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924626|NCT04889209|464010568|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924627|NCT04889209|464010569|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924628|NCT04889209|464010570|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
128924629|NCT04889209|464010571|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924630|NCT04889209|464010572|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924631|NCT04889209|464010573|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924632|NCT04889209|464010574|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924633|NCT04889209|464010575|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924634|NCT04889209|464010576|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924635|NCT04889209|464010577|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924636|NCT04889209|464010578|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924637|NCT04889209|464010579|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924638|NCT04889209|464010580|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924639|NCT04889209|464010581|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924640|NCT04889209|464010582|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924641|NCT04889209|464010583|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924642|NCT04889209|464010584|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
128924643|NCT04889209|464010567|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924644|NCT04889209|464010568|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924645|NCT04889209|464010569|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924646|NCT04889209|464010570|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924647|NCT04889209|464010571|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
128924648|NCT04889209|464010572|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924649|NCT04889209|464010573|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
128924650|NCT04889209|464010574|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
128924651|NCT04889209|464010575|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924652|NCT04889209|464010576|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
128924653|NCT04889209|464010577|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
128924654|NCT04889209|464010578|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924655|NCT04889209|464010579|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
128924656|NCT04889209|464010580|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924657|NCT04889209|464010581|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924658|NCT04889209|464010582|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128978049|NCT02743494|464205305|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
128924659|NCT04889209|464010583|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
128924660|NCT04889209|464010584|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
128924661|NCT04889209|464010567|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924662|NCT04889209|464010568|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924663|NCT04889209|464010569|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924664|NCT04889209|464010570|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924665|NCT04889209|464010571|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924666|NCT04889209|464010572|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128701082|NCT00126191|463203446|FG000|Overall Study|Physician Decision|0|||
128924667|NCT04889209|464010573|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924668|NCT04889209|464010574|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924669|NCT04889209|464010575|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924670|NCT04889209|464010576|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924671|NCT04889209|464010577|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128701083|NCT00126191|463203447|FG001|Overall Study|Physician Decision|1|||
128701084|NCT00126191|463203446|FG000|Overall Study|Death|0|||
128701085|NCT00126191|463203447|FG001|Overall Study|Death|1|||
128701086|NCT01898806|463203448|FG000|Overall Study|Withdrawal by Subject|2|||
128701087|NCT01898806|463203448|FG000|Overall Study|Physician Decision|1|||
128701088|NCT01648101|463203449|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
128701089|NCT01648101|463203450|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
128701090|NCT01648101|463203451|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
128701091|NCT01648101|463203449|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
128701092|NCT01648101|463203450|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
128701093|NCT01648101|463203451|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
128701094|NCT01648101|463203449|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
128701095|NCT01648101|463203450|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
128701096|NCT01648101|463203451|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
128701097|NCT01648101|463203449|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
128701098|NCT01648101|463203450|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
128701099|NCT01648101|463203451|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
128701100|NCT01648101|463203449|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
128701101|NCT01648101|463203450|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
128701102|NCT01648101|463203451|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
128701103|NCT01648101|463203449|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
128701104|NCT01648101|463203450|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
128701105|NCT01648101|463203451|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
128701106|NCT01648101|463203449|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
128924672|NCT04889209|464010578|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924673|NCT04889209|464010579|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924674|NCT04889209|464010580|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924675|NCT04889209|464010581|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924676|NCT04889209|464010582|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924677|NCT04889209|464010583|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
128924678|NCT04889209|464010584|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
128924679|NCT04889209|464010567|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924680|NCT04889209|464010568|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924681|NCT04889209|464010569|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924682|NCT04889209|464010570|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924683|NCT04889209|464010571|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924684|NCT04889209|464010572|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924685|NCT04889209|464010573|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924686|NCT04889209|464010574|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924687|NCT04889209|464010575|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924688|NCT04889209|464010576|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924689|NCT04889209|464010577|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924690|NCT04889209|464010578|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924691|NCT04889209|464010579|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924692|NCT04889209|464010580|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924693|NCT04889209|464010581|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924694|NCT04889209|464010582|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128701107|NCT01648101|463203450|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
128701108|NCT01648101|463203451|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
128701109|NCT01648101|463203449|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
128701110|NCT01648101|463203450|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
128701111|NCT01648101|463203451|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
128924695|NCT04889209|464010583|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
128924696|NCT04889209|464010584|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
128766982|NCT02440594|463438083|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
128766983|NCT02440594|463438076|FG000|Overall Study|Withdrawal by Subject|81|||
128766984|NCT02440594|463438077|FG001|Overall Study|Withdrawal by Subject|67|||
128766985|NCT02440594|463438078|FG002|Overall Study|Withdrawal by Subject|59|||
128766986|NCT02440594|463438079|FG003|Overall Study|Withdrawal by Subject|38|||
128766987|NCT02440594|463438080|FG004|Overall Study|Withdrawal by Subject|2|||
128766988|NCT02440594|463438081|FG005|Overall Study|Withdrawal by Subject|2|||
128766989|NCT02440594|463438082|FG006|Overall Study|Withdrawal by Subject|7|||
128766990|NCT02440594|463438083|FG007|Overall Study|Withdrawal by Subject|7|||
128766991|NCT02440594|463438076|FG000|Overall Study|Administratively w/drawn|3|||
128766992|NCT02440594|463438077|FG001|Overall Study|Administratively w/drawn|2|||
128766993|NCT02440594|463438078|FG002|Overall Study|Administratively w/drawn|0|||
128766994|NCT02440594|463438079|FG003|Overall Study|Administratively w/drawn|0|||
128766995|NCT02440594|463438080|FG004|Overall Study|Administratively w/drawn|0|||
128766996|NCT02440594|463438081|FG005|Overall Study|Administratively w/drawn|0|||
128766997|NCT02440594|463438082|FG006|Overall Study|Administratively w/drawn|2|||
128766998|NCT02440594|463438083|FG007|Overall Study|Administratively w/drawn|1|||
128766999|NCT02341456|463438084|FG000|Overall Study|Disease progression|2|||
128767000|NCT02341456|463438085|FG001|Overall Study|Disease progression|3|||
128767001|NCT02341456|463438086|FG002|Overall Study|Disease progression|1|||
128767002|NCT02341456|463438084|FG000|Overall Study|Death|1|||
128701112|NCT01648101|463203449|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
128701113|NCT01648101|463203450|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
128701114|NCT01648101|463203451|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
128701115|NCT01648101|463203449|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
128701116|NCT01648101|463203450|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
128701117|NCT01648101|463203451|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
128701118|NCT01648101|463203449|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
128701119|NCT01648101|463203450|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
128701120|NCT01648101|463203451|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
128701121|NCT03003390|463203452|FG000|Overall Study|Physician Decision|2|||
128701122|NCT03003390|463203453|FG001|Overall Study|Physician Decision|0|||
128701123|NCT03003390|463203452|FG000|Overall Study|Parent refused intervention|2|||
128701124|NCT03003390|463203453|FG001|Overall Study|Parent refused intervention|0|||
128701125|NCT00307294|463203469|FG000|Overall Study|Withdrawal by Subject|1|||
128701126|NCT00612690|463203470|FG000|Overall Study|Lost to Follow-up|72|||
128701127|NCT00612690|463203471|FG001|Overall Study|Lost to Follow-up|98|||
128701128|NCT00612690|463203470|FG000|Overall Study|Withdrawal by Subject|32|||
128701129|NCT00612690|463203471|FG001|Overall Study|Withdrawal by Subject|20|||
128701130|NCT00612690|463203470|FG000|Overall Study|Withdrawal by Site|11|||
128701131|NCT00612690|463203471|FG001|Overall Study|Withdrawal by Site|0|||
128701132|NCT02955602|463203472|FG000|Overall Study|Adverse Event|0|||
128701133|NCT02955602|463203473|FG001|Overall Study|Adverse Event|3|||
128701134|NCT02955602|463203474|FG002|Overall Study|Adverse Event|0|||
128701135|NCT02955602|463203472|FG000|Overall Study|Withdrawal of informed consent|1|||
128701136|NCT02955602|463203473|FG001|Overall Study|Withdrawal of informed consent|3|||
128701137|NCT02955602|463203474|FG002|Overall Study|Withdrawal of informed consent|2|||
128701138|NCT02955602|463203472|FG000|Overall Study|Lost to Follow-up|0|||
128701139|NCT02955602|463203473|FG001|Overall Study|Lost to Follow-up|0|||
128701140|NCT02955602|463203474|FG002|Overall Study|Lost to Follow-up|1|||
128701141|NCT02955602|463203472|FG000|Overall Study|Other|0|||
128701142|NCT02955602|463203473|FG001|Overall Study|Other|1|||
128701143|NCT02955602|463203474|FG002|Overall Study|Other|3|||
128701144|NCT01581931|463203479|FG000|Washout|Adverse Event|0|||
128701145|NCT01581931|463203480|FG001|Washout|Adverse Event|1|||
128701146|NCT03156543|463203481|FG000|Overall Study|Withdrawal by Subject|1|||
128701147|NCT03156543|463203482|FG001|Overall Study|Withdrawal by Subject|0|||
128767003|NCT02341456|463438085|FG001|Overall Study|Death|1|||
128767004|NCT02341456|463438086|FG002|Overall Study|Death|1|||
128701148|NCT02954237|463203483|FG000|Overall Study|Withdrawal by Subject|25|||
128701149|NCT02954237|463203483|FG000|Overall Study|Missed visit|16|||
128701150|NCT02954237|463203483|FG000|Overall Study|Death|2|||
128701151|NCT01434667|463203487|FG000|Overall Study|Lost to Follow-up|5|||
128701152|NCT01434667|463203488|FG001|Overall Study|Lost to Follow-up|10|||
128701153|NCT02966028|463203489|FG000|Overall Study|Adverse Event|7|||
128701154|NCT02966028|463203490|FG001|Overall Study|Adverse Event|13|||
128701155|NCT02966028|463203491|FG002|Overall Study|Adverse Event|10|||
128924697|NCT04889209|464010567|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128701156|NCT02966028|463203489|FG000|Overall Study|Physician Decision|1|||
128701157|NCT02966028|463203490|FG001|Overall Study|Physician Decision|0|||
128701158|NCT02966028|463203491|FG002|Overall Study|Physician Decision|2|||
128701159|NCT02966028|463203489|FG000|Overall Study|Withdrawal by Subject|7|||
128701160|NCT02966028|463203490|FG001|Overall Study|Withdrawal by Subject|5|||
128767005|NCT02341456|463438084|FG000|Overall Study|Withdrawal by Subject|0|||
128767006|NCT02341456|463438085|FG001|Overall Study|Withdrawal by Subject|1|||
128767007|NCT02341456|463438086|FG002|Overall Study|Withdrawal by Subject|1|||
128767008|NCT02341456|463438084|FG000|Overall Study|Moved to local access programme.|0|||
128924698|NCT04889209|464010568|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924699|NCT04889209|464010569|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924700|NCT04889209|464010570|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924701|NCT04889209|464010571|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924702|NCT04889209|464010572|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924703|NCT04889209|464010573|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924704|NCT04889209|464010574|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924705|NCT04889209|464010575|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924706|NCT04889209|464010576|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924707|NCT04889209|464010577|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924708|NCT04889209|464010578|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924709|NCT04889209|464010579|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924710|NCT04889209|464010580|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924711|NCT04889209|464010581|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
128924712|NCT04889209|464010582|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924713|NCT04889209|464010583|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924714|NCT04889209|464010584|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
128924715|NCT01725165|464010585|FG000|Overall Study|Death|11|||
128924716|NCT01725165|464010586|FG001|Overall Study|Death|18|||
128924717|NCT00474240|464010592|FG000|Overall Study|Withdrawal by Subject|1|||
128701161|NCT02966028|463203491|FG002|Overall Study|Withdrawal by Subject|5|||
128701162|NCT02966028|463203489|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
128701163|NCT02966028|463203490|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
128701164|NCT02966028|463203491|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
128701165|NCT00590720|463203496|FG000|Overall Study|Lost to Follow-up|1|||
128924718|NCT00474240|464010593|FG001|Overall Study|Withdrawal by Subject|1|||
128701166|NCT00590720|463203497|FG001|Overall Study|Lost to Follow-up|0|||
128701167|NCT00590720|463203496|FG000|Overall Study|Withdrawal by Subject|0|||
128701168|NCT00590720|463203497|FG001|Overall Study|Withdrawal by Subject|1|||
128701169|NCT01001377|463203498|FG000|Overall Study|Ineligibility determined|2|||
128701170|NCT01001377|463203499|FG001|Overall Study|Ineligibility determined|0|||
128701171|NCT01001377|463203498|FG000|Overall Study|Withdrawal by Subject|19|||
128701172|NCT01001377|463203499|FG001|Overall Study|Withdrawal by Subject|20|||
128701173|NCT01001377|463203498|FG000|Overall Study|Lost to Follow-up|14|||
128701174|NCT01001377|463203499|FG001|Overall Study|Lost to Follow-up|17|||
128701175|NCT01001377|463203498|FG000|Overall Study|Death|391|||
128701176|NCT01001377|463203499|FG001|Overall Study|Death|384|||
128701177|NCT02193867|463203502|FG000|Overall Study|Death|2|||
128701178|NCT02193867|463203502|FG000|Overall Study|Sponsor Study Termination|2|||
128701179|NCT03600818|463203503|FG000|Overall Study|Adverse Event|4|||
128701180|NCT03600818|463203504|FG001|Overall Study|Adverse Event|7|||
128701181|NCT03600818|463203503|FG000|Overall Study|Lack of Efficacy|9|||
128701182|NCT03600818|463203504|FG001|Overall Study|Lack of Efficacy|4|||
128701183|NCT03600818|463203503|FG000|Overall Study|Withdrawal by Subject|4|||
128701184|NCT03600818|463203504|FG001|Overall Study|Withdrawal by Subject|3|||
128701185|NCT03600818|463203503|FG000|Overall Study|Other-unspecified|5|||
128701186|NCT03600818|463203504|FG001|Overall Study|Other-unspecified|3|||
128701187|NCT03600818|463203503|FG000|Overall Study|Randomized and not treated|0|||
128701188|NCT03600818|463203504|FG001|Overall Study|Randomized and not treated|1|||
128701189|NCT04930965|463203508|FG000|Overall Study|Lost to Follow-up|7|||
128701190|NCT04930965|463203509|FG001|Overall Study|Lost to Follow-up|5|||
128701191|NCT02849678|463203512|FG000|Overall Study|Protocol Violation|3|||
128701192|NCT02849678|463203513|FG001|Overall Study|Protocol Violation|6|||
128701193|NCT01471171|463203514|FG000|Treatment Period 1|Adverse Event|4|||
128701194|NCT01471171|463203515|FG001|Treatment Period 1|Adverse Event|1|||
128701195|NCT01471171|463203514|FG000|Treatment Period 2|Adverse Event|1|||
128924719|NCT00474240|464010594|FG002|Overall Study|Withdrawal by Subject|0|||
128924720|NCT00474240|464010595|FG003|Overall Study|Withdrawal by Subject|2|||
128924721|NCT00474240|464010596|FG004|Overall Study|Withdrawal by Subject|3|||
129029557|NCT01109849|464399869|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
128701196|NCT01471171|463203515|FG001|Treatment Period 2|Adverse Event|0|||
129216344|NCT00665652|465092890|FG000|Overall Study|No longer met inclusion criteria.|1|||
128701197|NCT03478930|463203517|FG000|Overall Study|Adverse Event|0|||
128701198|NCT03478930|463203518|FG001|Overall Study|Adverse Event|1|||
128701199|NCT03478930|463203517|FG000|Overall Study|Lack of Efficacy|3|||
128701200|NCT03478930|463203518|FG001|Overall Study|Lack of Efficacy|3|||
128701201|NCT03478930|463203517|FG000|Overall Study|Withdrawal by Subject|6|||
128701202|NCT03478930|463203518|FG001|Overall Study|Withdrawal by Subject|5|||
128701203|NCT04189081|463203519|FG000|Overall Study|Lost to Follow-up|1|||
128701204|NCT04189081|463203520|FG001|Overall Study|Lost to Follow-up|0|||
128701205|NCT04189081|463203521|FG002|Overall Study|Lost to Follow-up|0|||
128701206|NCT04189081|463203519|FG000|Overall Study|Withdrawal by Subject|0|||
128701207|NCT04189081|463203520|FG001|Overall Study|Withdrawal by Subject|0|||
128701208|NCT04189081|463203521|FG002|Overall Study|Withdrawal by Subject|1|||
128701209|NCT02228460|463203527|FG000|Overall Study|Adverse Event|1|||
128924722|NCT00474240|464010597|FG005|Overall Study|Withdrawal by Subject|1|||
128924723|NCT00474240|464010592|FG000|Overall Study|Adverse Event|0|||
128924724|NCT00474240|464010593|FG001|Overall Study|Adverse Event|0|||
128924725|NCT00474240|464010594|FG002|Overall Study|Adverse Event|9|||
128924726|NCT00474240|464010595|FG003|Overall Study|Adverse Event|14|||
128924727|NCT00474240|464010596|FG004|Overall Study|Adverse Event|5|||
128924728|NCT00474240|464010597|FG005|Overall Study|Adverse Event|16|||
128924729|NCT00474240|464010592|FG000|Overall Study|Removed due to lab value|0|||
128924730|NCT00474240|464010593|FG001|Overall Study|Removed due to lab value|0|||
128924731|NCT00474240|464010594|FG002|Overall Study|Removed due to lab value|0|||
128924732|NCT00474240|464010595|FG003|Overall Study|Removed due to lab value|0|||
128924733|NCT00474240|464010596|FG004|Overall Study|Removed due to lab value|0|||
128924734|NCT00474240|464010597|FG005|Overall Study|Removed due to lab value|1|||
128924735|NCT01071070|464010601|FG000|Overall Study|Adverse Event|0|||
128924736|NCT01071070|464010602|FG001|Overall Study|Adverse Event|3|||
128924737|NCT01071070|464010601|FG000|Overall Study|Withdrawal by Subject|1|||
128924738|NCT01071070|464010602|FG001|Overall Study|Withdrawal by Subject|0|||
128924739|NCT01071070|464010601|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
128924740|NCT01071070|464010602|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
128924741|NCT01071070|464010601|FG000|Overall Study|Hypercalcemia|1|||
128924742|NCT01071070|464010602|FG001|Overall Study|Hypercalcemia|0|||
128924743|NCT02203149|464010605|FG000|Part 1|Adverse Event|0|||
128924744|NCT02203149|464010606|FG001|Part 1|Adverse Event|1|||
128924745|NCT02203149|464010607|FG002|Part 1|Adverse Event|0|||
128924746|NCT02203149|464010608|FG003|Part 1|Adverse Event|0|||
128924747|NCT02203149|464010609|FG004|Part 1|Adverse Event|0|||
128924748|NCT02203149|464010605|FG000|Part 2|Death|0|||
128924749|NCT02203149|464010606|FG001|Part 2|Death|0|||
128924750|NCT02203149|464010607|FG002|Part 2|Death|1|||
128924751|NCT02203149|464010608|FG003|Part 2|Death|1|||
128924752|NCT02203149|464010609|FG004|Part 2|Death|0|||
128924753|NCT02203149|464010605|FG000|Part 2|Withdrawal by Subject|0|||
128924754|NCT02203149|464010606|FG001|Part 2|Withdrawal by Subject|0|||
128924755|NCT02203149|464010607|FG002|Part 2|Withdrawal by Subject|0|||
128924756|NCT02203149|464010608|FG003|Part 2|Withdrawal by Subject|1|||
128924757|NCT02203149|464010609|FG004|Part 2|Withdrawal by Subject|0|||
128924758|NCT02203149|464010605|FG000|Part 2|Adverse Event|0|||
128924759|NCT02203149|464010606|FG001|Part 2|Adverse Event|0|||
128924760|NCT02203149|464010607|FG002|Part 2|Adverse Event|0|||
128924761|NCT02203149|464010608|FG003|Part 2|Adverse Event|1|||
128924762|NCT02203149|464010609|FG004|Part 2|Adverse Event|1|||
128924763|NCT02537678|464010610|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
128924764|NCT02537678|464010611|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
128924765|NCT02537678|464010610|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
128924766|NCT02537678|464010611|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
128924767|NCT02537678|464010610|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
128924768|NCT02537678|464010611|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
128924769|NCT02537678|464010610|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
128924770|NCT02537678|464010611|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
128924771|NCT02537678|464010610|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
128924772|NCT02537678|464010611|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
128924773|NCT02537678|464010610|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
128924774|NCT02537678|464010611|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
128924775|NCT02537678|464010610|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
128924776|NCT02537678|464010611|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
128924777|NCT01454076|464010612|FG000|Overall Study|Other|2|||
128924778|NCT01454076|464010613|FG001|Overall Study|Other|0|||
128924779|NCT01454076|464010614|FG002|Overall Study|Other|0|||
128924780|NCT01454076|464010615|FG003|Overall Study|Other|1|||
128924781|NCT01454076|464010616|FG004|Overall Study|Other|2|||
128924782|NCT01454076|464010612|FG000|Overall Study|Withdrawal by Subject|3|||
128701210|NCT02228460|463203527|FG000|Overall Study|Lost to Follow-up|1|||
128701211|NCT01243892|463203528|FG000|Overall Study|Did not meet eligibility criteria|2|||
128701212|NCT01243892|463203529|FG001|Overall Study|Did not meet eligibility criteria|0|||
128924783|NCT01454076|464010613|FG001|Overall Study|Withdrawal by Subject|4|||
128924784|NCT01454076|464010614|FG002|Overall Study|Withdrawal by Subject|2|||
128924785|NCT01454076|464010615|FG003|Overall Study|Withdrawal by Subject|1|||
128924786|NCT01454076|464010616|FG004|Overall Study|Withdrawal by Subject|2|||
128924787|NCT01454076|464010612|FG000|Overall Study|Adverse Event|8|||
128924788|NCT01454076|464010613|FG001|Overall Study|Adverse Event|2|||
128924789|NCT01454076|464010614|FG002|Overall Study|Adverse Event|7|||
128701213|NCT03087643|463203535|FG000|Overall Study|Withdrawal by Subject|2|||
128701214|NCT03087643|463203536|FG001|Overall Study|Withdrawal by Subject|4|||
128924790|NCT01454076|464010615|FG003|Overall Study|Adverse Event|0|||
128924791|NCT01454076|464010616|FG004|Overall Study|Adverse Event|2|||
128924792|NCT01478958|464010617|FG000|Overall Study|Withdrawal by Subject|1|||
128924793|NCT01478958|464010618|FG001|Overall Study|Withdrawal by Subject|1|||
128924794|NCT01478958|464010619|FG002|Overall Study|Withdrawal by Subject|1|||
128924795|NCT01478958|464010617|FG000|Overall Study|Weight loss|1|||
128924796|NCT01478958|464010618|FG001|Overall Study|Weight loss|0|||
128924797|NCT01478958|464010619|FG002|Overall Study|Weight loss|0|||
128924798|NCT01478958|464010617|FG000|Overall Study|Re-located|0|||
128924799|NCT01478958|464010618|FG001|Overall Study|Re-located|1|||
128924800|NCT01478958|464010619|FG002|Overall Study|Re-located|0|||
128924801|NCT01478958|464010617|FG000|Overall Study|Unable to comply|0|||
128924802|NCT01478958|464010618|FG001|Overall Study|Unable to comply|0|||
128924803|NCT01478958|464010619|FG002|Overall Study|Unable to comply|2|||
128924804|NCT01193686|464010620|FG000|Overall Study|Withdrawal by Subject|4|||
128924805|NCT01193686|464010621|FG001|Overall Study|Withdrawal by Subject|1|||
128924806|NCT01193686|464010620|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
128924807|NCT01193686|464010621|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
128924808|NCT03401749|464010622|FG000|Overall Study|Lost to Follow-up|20|||
128924809|NCT03401749|464010623|FG001|Overall Study|Lost to Follow-up|16|||
128924810|NCT03401749|464010624|FG002|Overall Study|Lost to Follow-up|26|||
128924811|NCT03075839|464010625|FG000|Overall Study|Lost to Follow-up|4|||
128924812|NCT03853694|464010626|FG000|Overall Study|Protocol Violation|3|||
128924813|NCT03853694|464010627|FG001|Overall Study|Protocol Violation|5|||
128924814|NCT03853694|464010628|FG002|Overall Study|Protocol Violation|3|||
128924815|NCT03853694|464010626|FG000|Overall Study|Delivered early|0|||
128924816|NCT03853694|464010627|FG001|Overall Study|Delivered early|1|||
128924817|NCT03853694|464010628|FG002|Overall Study|Delivered early|0|||
128924818|NCT03853694|464010626|FG000|Overall Study|not suitable to proceed|0|||
128924819|NCT03853694|464010627|FG001|Overall Study|not suitable to proceed|1|||
128924820|NCT03853694|464010628|FG002|Overall Study|not suitable to proceed|0|||
128924821|NCT03853694|464010626|FG000|Overall Study|difficult surgery|0|||
128924822|NCT03853694|464010627|FG001|Overall Study|difficult surgery|0|||
128924823|NCT03853694|464010628|FG002|Overall Study|difficult surgery|1|||
128924824|NCT03853694|464010626|FG000|Overall Study|Lost to Follow-up|0|||
128924825|NCT03853694|464010627|FG001|Overall Study|Lost to Follow-up|1|||
128924826|NCT03853694|464010628|FG002|Overall Study|Lost to Follow-up|0|||
128924827|NCT03853694|464010626|FG000|Overall Study|Withdrawal by Subject|0|||
128924828|NCT03853694|464010627|FG001|Overall Study|Withdrawal by Subject|1|||
128924829|NCT03853694|464010628|FG002|Overall Study|Withdrawal by Subject|0|||
128924830|NCT05089708|464010629|FG000|Overall Study|Lost to Follow-up|9|||
128924831|NCT05089708|464010630|FG001|Overall Study|Lost to Follow-up|7|||
128924832|NCT05089708|464010629|FG000|Overall Study|Withdrawal by Subject|3|||
128924833|NCT05089708|464010630|FG001|Overall Study|Withdrawal by Subject|1|||
128924834|NCT05089708|464010629|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
128924835|NCT05089708|464010630|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
128924836|NCT05089708|464010629|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
128924837|NCT05089708|464010630|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
128924838|NCT02305563|464010632|FG000|Treatment Period|Disease progression|0|||
128924839|NCT02305563|464010633|FG001|Treatment Period|Disease progression|0|||
128924840|NCT02305563|464010634|FG002|Treatment Period|Disease progression|15|||
128701215|NCT03087643|463203535|FG000|Overall Study|Death|2|||
128701216|NCT03087643|463203536|FG001|Overall Study|Death|2|||
128701217|NCT02083783|463203537|FG000|Overall Study|Withdrawal by Subject|1|||
128701218|NCT02083783|463203538|FG001|Overall Study|Withdrawal by Subject|0|||
128701219|NCT01546883|463203541|FG000|Overall Study|Withdrawal by Subject|3|||
128701220|NCT01546883|463203541|FG000|Overall Study|Adverse Event|4|||
128701221|NCT01546883|463203541|FG000|Overall Study|Lost to Follow-up|2|||
128701222|NCT01546883|463203541|FG000|Overall Study|early closure of study|2|||
128701223|NCT01546883|463203541|FG000|Overall Study|other unrelated illness|1|||
128701224|NCT02256631|463203545|FG000|Overall Study|Lost to Follow-up|1|||
128701225|NCT02256631|463203546|FG001|Overall Study|Lost to Follow-up|1|||
128701226|NCT02256631|463203547|FG002|Overall Study|Lost to Follow-up|0|||
128701227|NCT02256631|463203548|FG003|Overall Study|Lost to Follow-up|2|||
128701228|NCT02256631|463203549|FG004|Overall Study|Lost to Follow-up|0|||
128701229|NCT02256631|463203550|FG005|Overall Study|Lost to Follow-up|4|||
128701230|NCT02256631|463203551|FG006|Overall Study|Lost to Follow-up|1|||
128701231|NCT02256631|463203545|FG000|Overall Study|Withdrawal by Subject|0|||
128924841|NCT02305563|464010635|FG003|Treatment Period|Disease progression|6|||
128924842|NCT02305563|464010636|FG004|Treatment Period|Disease progression|6|||
128924843|NCT02305563|464010632|FG000|Treatment Period|Study drug toxicity|0|||
128924844|NCT02305563|464010633|FG001|Treatment Period|Study drug toxicity|0|||
128924845|NCT02305563|464010634|FG002|Treatment Period|Study drug toxicity|0|||
128924846|NCT02305563|464010635|FG003|Treatment Period|Study drug toxicity|1|||
128924847|NCT02305563|464010636|FG004|Treatment Period|Study drug toxicity|2|||
128701232|NCT02256631|463203546|FG001|Overall Study|Withdrawal by Subject|0|||
128701233|NCT02256631|463203547|FG002|Overall Study|Withdrawal by Subject|0|||
128701234|NCT02256631|463203548|FG003|Overall Study|Withdrawal by Subject|1|||
128924848|NCT02305563|464010632|FG000|Treatment Period|Death|0|||
128924849|NCT02305563|464010633|FG001|Treatment Period|Death|0|||
128924850|NCT02305563|464010634|FG002|Treatment Period|Death|1|||
128924851|NCT02305563|464010635|FG003|Treatment Period|Death|2|||
128924852|NCT02305563|464010636|FG004|Treatment Period|Death|1|||
128924853|NCT02305563|464010632|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
128924854|NCT02305563|464010633|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
128924855|NCT02305563|464010634|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
128924856|NCT02305563|464010635|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
128924857|NCT02305563|464010636|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
128924858|NCT02305563|464010632|FG000|Treatment Period|Participant request to stop therapy|0|||
128924859|NCT02305563|464010633|FG001|Treatment Period|Participant request to stop therapy|2|||
128924860|NCT02305563|464010634|FG002|Treatment Period|Participant request to stop therapy|0|||
128924861|NCT02305563|464010635|FG003|Treatment Period|Participant request to stop therapy|1|||
128924862|NCT02305563|464010636|FG004|Treatment Period|Participant request to stop therapy|0|||
128924863|NCT02305563|464010632|FG000|Treatment Period|Participant withdrew consent|0|||
128924864|NCT02305563|464010633|FG001|Treatment Period|Participant withdrew consent|0|||
128924865|NCT02305563|464010634|FG002|Treatment Period|Participant withdrew consent|1|||
128924866|NCT02305563|464010635|FG003|Treatment Period|Participant withdrew consent|1|||
128924867|NCT02305563|464010636|FG004|Treatment Period|Participant withdrew consent|1|||
128924868|NCT02305563|464010632|FG000|Treatment Period|Maximum clinical benefit|0|||
128924869|NCT02305563|464010633|FG001|Treatment Period|Maximum clinical benefit|0|||
128924870|NCT02305563|464010634|FG002|Treatment Period|Maximum clinical benefit|0|||
128924871|NCT02305563|464010635|FG003|Treatment Period|Maximum clinical benefit|0|||
128924872|NCT02305563|464010636|FG004|Treatment Period|Maximum clinical benefit|1|||
128924873|NCT02305563|464010632|FG000|Treatment Period|Poor/non-compliance|0|||
128924874|NCT02305563|464010633|FG001|Treatment Period|Poor/non-compliance|0|||
128924875|NCT02305563|464010634|FG002|Treatment Period|Poor/non-compliance|0|||
128924876|NCT02305563|464010635|FG003|Treatment Period|Poor/non-compliance|0|||
128924877|NCT02305563|464010636|FG004|Treatment Period|Poor/non-compliance|1|||
128924878|NCT02305563|464010632|FG000|Treatment Period|Administrative reason by Sponsor|0|||
128924879|NCT02305563|464010633|FG001|Treatment Period|Administrative reason by Sponsor|0|||
128924880|NCT02305563|464010634|FG002|Treatment Period|Administrative reason by Sponsor|0|||
128924881|NCT02305563|464010635|FG003|Treatment Period|Administrative reason by Sponsor|0|||
128924882|NCT02305563|464010636|FG004|Treatment Period|Administrative reason by Sponsor|1|||
128924883|NCT02305563|464010632|FG000|Treatment Period|other reason|2|||
128924884|NCT02305563|464010633|FG001|Treatment Period|other reason|0|||
128924885|NCT02305563|464010634|FG002|Treatment Period|other reason|2|||
128924886|NCT02305563|464010635|FG003|Treatment Period|other reason|2|||
128924887|NCT02305563|464010636|FG004|Treatment Period|other reason|1|||
128924888|NCT02305563|464010632|FG000|Treatment Period|Randomized but not treated|0|||
128924889|NCT02305563|464010633|FG001|Treatment Period|Randomized but not treated|0|||
128924890|NCT02305563|464010634|FG002|Treatment Period|Randomized but not treated|0|||
128924891|NCT02305563|464010635|FG003|Treatment Period|Randomized but not treated|0|||
128924892|NCT02305563|464010636|FG004|Treatment Period|Randomized but not treated|2|||
128924893|NCT02305563|464010632|FG000|Treatment Period|added ULO, then disease progression|0|||
128924894|NCT02305563|464010633|FG001|Treatment Period|added ULO, then disease progression|0|||
128924895|NCT02305563|464010634|FG002|Treatment Period|added ULO, then disease progression|0|||
128924896|NCT02305563|464010635|FG003|Treatment Period|added ULO, then disease progression|0|||
128924897|NCT02305563|464010636|FG004|Treatment Period|added ULO, then disease progression|4|||
128924898|NCT02305563|464010632|FG000|Treatment Period|added ULO; then other reason|0|||
128924899|NCT02305563|464010633|FG001|Treatment Period|added ULO; then other reason|0|||
128924900|NCT02305563|464010634|FG002|Treatment Period|added ULO; then other reason|0|||
128924901|NCT02305563|464010635|FG003|Treatment Period|added ULO; then other reason|0|||
128924902|NCT02305563|464010636|FG004|Treatment Period|added ULO; then other reason|1|||
128924903|NCT02305563|464010632|FG000|Treatment Period|added ULO, then request to stop|0|||
128924904|NCT02305563|464010633|FG001|Treatment Period|added ULO, then request to stop|0|||
128924905|NCT02305563|464010634|FG002|Treatment Period|added ULO, then request to stop|0|||
128924906|NCT02305563|464010635|FG003|Treatment Period|added ULO, then request to stop|0|||
128924907|NCT02305563|464010636|FG004|Treatment Period|added ULO, then request to stop|1|||
128924908|NCT02305563|464010632|FG000|Follow-up Period|Death|0|||
128924909|NCT02305563|464010633|FG001|Follow-up Period|Death|0|||
128924910|NCT02305563|464010634|FG002|Follow-up Period|Death|5|||
128924911|NCT02305563|464010635|FG003|Follow-up Period|Death|4|||
128924912|NCT02305563|464010636|FG004|Follow-up Period|Death|7|||
128924913|NCT02305563|464010632|FG000|Follow-up Period|Participant withdrew consent|0|||
128924914|NCT02305563|464010633|FG001|Follow-up Period|Participant withdrew consent|0|||
128924915|NCT02305563|464010634|FG002|Follow-up Period|Participant withdrew consent|2|||
128924916|NCT02305563|464010635|FG003|Follow-up Period|Participant withdrew consent|1|||
128924917|NCT02305563|464010636|FG004|Follow-up Period|Participant withdrew consent|0|||
128924918|NCT02305563|464010632|FG000|Follow-up Period|other reason|0|||
128924919|NCT02305563|464010633|FG001|Follow-up Period|other reason|0|||
128924920|NCT02305563|464010634|FG002|Follow-up Period|other reason|0|||
128924921|NCT02305563|464010635|FG003|Follow-up Period|other reason|0|||
128924922|NCT02305563|464010636|FG004|Follow-up Period|other reason|1|||
128924923|NCT02305563|464010632|FG000|Follow-up Period|Followup no longer required per protocol|3|||
128924924|NCT02305563|464010633|FG001|Follow-up Period|Followup no longer required per protocol|3|||
128924925|NCT02305563|464010634|FG002|Follow-up Period|Followup no longer required per protocol|4|||
128924926|NCT02305563|464010635|FG003|Follow-up Period|Followup no longer required per protocol|1|||
128924927|NCT02305563|464010636|FG004|Follow-up Period|Followup no longer required per protocol|4|||
128924928|NCT02700451|464010637|FG000|Overall Study|Protocol Violation|2|||
128924929|NCT02700451|464010638|FG001|Overall Study|Protocol Violation|2|||
128924930|NCT02700451|464010639|FG002|Overall Study|Protocol Violation|3|||
128924931|NCT02700451|464010637|FG000|Overall Study|Discontinued intervention|14|||
128924932|NCT02700451|464010638|FG001|Overall Study|Discontinued intervention|15|||
128924933|NCT02700451|464010639|FG002|Overall Study|Discontinued intervention|14|||
128924934|NCT04373460|464010640|FG000|Overall Study|Did not receive tranfusion|18|||
128924935|NCT04373460|464010641|FG001|Overall Study|Did not receive tranfusion|26|||
128924936|NCT00454207|464010642|FG000|Overall Study|Adverse Event|3|||
128924937|NCT00454207|464010643|FG001|Overall Study|Adverse Event|1|||
128924938|NCT00454207|464010642|FG000|Overall Study|Lack of Efficacy|1|||
128924939|NCT00454207|464010643|FG001|Overall Study|Lack of Efficacy|0|||
128924940|NCT00454207|464010642|FG000|Overall Study|Protocol Violation|0|||
128924941|NCT00454207|464010643|FG001|Overall Study|Protocol Violation|1|||
128924942|NCT01672957|464010644|FG000|Overall Study|Protocol Violation|48|||
128924943|NCT01672957|464010644|FG000|Overall Study|Death|2|||
128924944|NCT01672957|464010644|FG000|Overall Study|ICF Signed After Transplantation|5|||
128924945|NCT00642642|464010646|FG000|Treatment & Follow Up|Adverse Event|2|||
128924946|NCT00642642|464010646|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
128924947|NCT00642642|464010646|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
128924948|NCT02337387|464010651|FG000|Overall Study|Adverse Event|0|||
128924949|NCT02337387|464010652|FG001|Overall Study|Adverse Event|1|||
128924950|NCT02337387|464010653|FG002|Overall Study|Adverse Event|0|||
128924951|NCT02337387|464010654|FG003|Overall Study|Adverse Event|0|||
128924952|NCT02337387|464010651|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
128924953|NCT02337387|464010652|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
128924954|NCT02337387|464010653|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
128924955|NCT02337387|464010654|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
128924956|NCT02272790|464010655|FG000|Overall Study|Physician Decision|0|||
128924957|NCT02272790|464010656|FG001|Overall Study|Physician Decision|1|||
128924958|NCT02272790|464010657|FG002|Overall Study|Physician Decision|0|||
128924959|NCT02272790|464010658|FG003|Overall Study|Physician Decision|0|||
128924960|NCT02272790|464010659|FG004|Overall Study|Physician Decision|0|||
128924961|NCT02272790|464010660|FG005|Overall Study|Physician Decision|0|||
128924962|NCT00332202|464010661|FG000|Overall Study|Adverse Event|72|||
128924963|NCT00332202|464010662|FG001|Overall Study|Adverse Event|28|||
128924964|NCT00332202|464010661|FG000|Overall Study|Lost to Follow-up|2|||
128924965|NCT00332202|464010662|FG001|Overall Study|Lost to Follow-up|1|||
128924966|NCT00332202|464010661|FG000|Overall Study|Physician Decision|6|||
128924967|NCT00332202|464010662|FG001|Overall Study|Physician Decision|8|||
128924968|NCT00332202|464010661|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
128924969|NCT00332202|464010662|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
128924970|NCT00332202|464010661|FG000|Overall Study|Protocol Violation|7|||
128924971|NCT00332202|464010662|FG001|Overall Study|Protocol Violation|2|||
128924972|NCT00332202|464010661|FG000|Overall Study|Sponsor Decision|1|||
128924973|NCT00332202|464010662|FG001|Overall Study|Sponsor Decision|2|||
128924974|NCT00332202|464010661|FG000|Overall Study|Withdrawal by Subject|36|||
128924975|NCT00332202|464010662|FG001|Overall Study|Withdrawal by Subject|17|||
128924976|NCT00332202|464010661|FG000|Overall Study|Progressive Disease|106|||
128924977|NCT00332202|464010662|FG001|Overall Study|Progressive Disease|60|||
128924978|NCT00332202|464010661|FG000|Overall Study|Death|5|||
128924979|NCT00332202|464010662|FG001|Overall Study|Death|2|||
128924980|NCT05202808|464010663|FG000|Overall Study|Lost to Follow-up|3|||
128924981|NCT05202808|464010664|FG001|Overall Study|Lost to Follow-up|1|||
128924982|NCT02495948|464010667|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
129029558|NCT01109849|464399870|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
129216345|NCT02556177|465092893|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
128924983|NCT02495948|464010668|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
128924984|NCT02495948|464010667|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
128924985|NCT02495948|464010668|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
128924986|NCT00490542|464010669|FG000|Overall Study|Lost to Follow-up|3|||
128924987|NCT00490542|464010670|FG001|Overall Study|Lost to Follow-up|0|||
128924988|NCT00490542|464010669|FG000|Overall Study|Adverse Event|3|||
128924989|NCT00490542|464010670|FG001|Overall Study|Adverse Event|3|||
128924990|NCT00490542|464010669|FG000|Overall Study|Lack of Efficacy|1|||
128924991|NCT00490542|464010670|FG001|Overall Study|Lack of Efficacy|1|||
128924992|NCT00818259|464010671|FG000|Part I|Withdrawal by Subject|1|||
128924993|NCT00818259|464010672|FG001|Part I|Withdrawal by Subject|0|||
128924994|NCT00818259|464010673|FG002|Part I|Withdrawal by Subject|0|||
128924995|NCT00818259|464010674|FG003|Part I|Withdrawal by Subject|0|||
128924996|NCT00818259|464010675|FG004|Part I|Withdrawal by Subject|0|||
128924997|NCT00818259|464010676|FG005|Part I|Withdrawal by Subject|0|||
128924998|NCT00818259|464010677|FG006|Part I|Withdrawal by Subject|0|||
128924999|NCT00818259|464010678|FG007|Part I|Withdrawal by Subject|0|||
128925000|NCT00818259|464010679|FG008|Part I|Withdrawal by Subject|0|||
128925001|NCT00818259|464010671|FG000|Part II|Physician Decision|0|||
128925002|NCT00818259|464010672|FG001|Part II|Physician Decision|0|||
128925003|NCT00818259|464010673|FG002|Part II|Physician Decision|1|||
128925004|NCT00818259|464010674|FG003|Part II|Physician Decision|0|||
128925005|NCT00818259|464010675|FG004|Part II|Physician Decision|0|||
128925006|NCT00818259|464010676|FG005|Part II|Physician Decision|0|||
128925007|NCT00818259|464010677|FG006|Part II|Physician Decision|0|||
128925008|NCT00818259|464010678|FG007|Part II|Physician Decision|0|||
128925009|NCT00818259|464010679|FG008|Part II|Physician Decision|0|||
128925010|NCT00818259|464010671|FG000|Part II|Lack of Efficacy|0|||
128925011|NCT00818259|464010672|FG001|Part II|Lack of Efficacy|0|||
128925012|NCT00818259|464010673|FG002|Part II|Lack of Efficacy|0|||
128925013|NCT00818259|464010674|FG003|Part II|Lack of Efficacy|1|||
128925014|NCT00818259|464010675|FG004|Part II|Lack of Efficacy|0|||
128925015|NCT00818259|464010676|FG005|Part II|Lack of Efficacy|0|||
128925016|NCT00818259|464010677|FG006|Part II|Lack of Efficacy|0|||
128925017|NCT00818259|464010678|FG007|Part II|Lack of Efficacy|0|||
128925018|NCT00818259|464010679|FG008|Part II|Lack of Efficacy|0|||
128925019|NCT00818259|464010671|FG000|Part II|Not Treated|0|||
128925020|NCT00818259|464010672|FG001|Part II|Not Treated|0|||
128925021|NCT00818259|464010673|FG002|Part II|Not Treated|0|||
128925022|NCT00818259|464010674|FG003|Part II|Not Treated|1|||
128925023|NCT00818259|464010675|FG004|Part II|Not Treated|0|||
128925024|NCT00818259|464010676|FG005|Part II|Not Treated|0|||
128925025|NCT00818259|464010677|FG006|Part II|Not Treated|0|||
128925026|NCT00818259|464010678|FG007|Part II|Not Treated|0|||
128925027|NCT00818259|464010679|FG008|Part II|Not Treated|0|||
128925028|NCT00818259|464010671|FG000|Part IV|Physician Decision|0|||
128925029|NCT00818259|464010672|FG001|Part IV|Physician Decision|0|||
128925030|NCT00818259|464010673|FG002|Part IV|Physician Decision|0|||
128925031|NCT00818259|464010674|FG003|Part IV|Physician Decision|0|||
128925032|NCT00818259|464010675|FG004|Part IV|Physician Decision|0|||
128925033|NCT00818259|464010676|FG005|Part IV|Physician Decision|1|||
128925034|NCT00818259|464010677|FG006|Part IV|Physician Decision|0|||
128925035|NCT00818259|464010678|FG007|Part IV|Physician Decision|0|||
128925036|NCT00818259|464010679|FG008|Part IV|Physician Decision|0|||
128925037|NCT00818259|464010671|FG000|Part V|Adverse Event|0|||
128925038|NCT00818259|464010672|FG001|Part V|Adverse Event|0|||
128925039|NCT00818259|464010673|FG002|Part V|Adverse Event|0|||
128925040|NCT00818259|464010674|FG003|Part V|Adverse Event|0|||
128701235|NCT02256631|463203549|FG004|Overall Study|Withdrawal by Subject|1|||
128701236|NCT02256631|463203550|FG005|Overall Study|Withdrawal by Subject|0|||
128701237|NCT02256631|463203551|FG006|Overall Study|Withdrawal by Subject|1|||
128701238|NCT02256631|463203545|FG000|Overall Study|Unable to get to clinic|0|||
128701239|NCT02256631|463203546|FG001|Overall Study|Unable to get to clinic|2|||
128701240|NCT02256631|463203547|FG002|Overall Study|Unable to get to clinic|0|||
128701241|NCT02256631|463203548|FG003|Overall Study|Unable to get to clinic|1|||
128701242|NCT02256631|463203549|FG004|Overall Study|Unable to get to clinic|0|||
128701243|NCT02256631|463203550|FG005|Overall Study|Unable to get to clinic|1|||
128701244|NCT02256631|463203551|FG006|Overall Study|Unable to get to clinic|2|||
128701245|NCT00457301|463203552|FG000|Overall Study|Withdrawal by Subject|3|||
128701246|NCT00457301|463203553|FG001|Overall Study|Withdrawal by Subject|3|||
128701247|NCT00457301|463203552|FG000|Overall Study|Censored out of the study|15|||
128701248|NCT00457301|463203553|FG001|Overall Study|Censored out of the study|14|||
128701249|NCT00457301|463203552|FG000|Overall Study|Death|5|||
128701250|NCT00457301|463203553|FG001|Overall Study|Death|7|||
128701251|NCT00001880|463203555|FG000|Overall Study|Death|14|||
128701252|NCT00873015|463203556|FG000|Overall Study|Withdrawal by Subject|0|||
128925041|NCT00818259|464010675|FG004|Part V|Adverse Event|0|||
128925042|NCT00818259|464010676|FG005|Part V|Adverse Event|0|||
128925043|NCT00818259|464010677|FG006|Part V|Adverse Event|0|||
128925044|NCT00818259|464010678|FG007|Part V|Adverse Event|1|||
129029559|NCT01109849|464399871|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
129216346|NCT02556177|465092894|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
128701253|NCT00873015|463203557|FG001|Overall Study|Withdrawal by Subject|1|||
128701254|NCT00873015|463203558|FG002|Overall Study|Withdrawal by Subject|0|||
128925045|NCT00818259|464010679|FG008|Part V|Adverse Event|0|||
128925046|NCT01053429|464010683|FG000|Overall Study|Adverse Event|64|||
128925047|NCT01053429|464010683|FG000|Overall Study|Other|309|||
128925048|NCT01237951|464010684|FG000|Overall Study|Death|1|||
128925049|NCT00752986|464010687|FG000|Overall Study|Withdrawal by Subject|2|||
128925050|NCT00752986|464010688|FG001|Overall Study|Withdrawal by Subject|1|||
128925051|NCT00752986|464010689|FG002|Overall Study|Withdrawal by Subject|2|||
128925052|NCT00752986|464010687|FG000|Overall Study|Protocol Violation|3|||
128925053|NCT00752986|464010688|FG001|Overall Study|Protocol Violation|0|||
128925054|NCT00752986|464010689|FG002|Overall Study|Protocol Violation|0|||
128925055|NCT00924703|464010693|FG000|Overall Study|Withdrawal by Subject|11|||
128925056|NCT00924703|464010693|FG000|Overall Study|Physician Decision|5|||
128925057|NCT00924703|464010693|FG000|Overall Study|Lost to Follow-up|3|||
128925058|NCT00924703|464010693|FG000|Overall Study|Adverse Event|2|||
128925059|NCT00924703|464010693|FG000|Overall Study|Withdrawal by Sponsor|1|||
128925060|NCT00666562|464010694|FG000|Overall Study|Withdrawal by Subject|0|||
128925061|NCT00666562|464010695|FG001|Overall Study|Withdrawal by Subject|1|||
128925062|NCT00666562|464010696|FG002|Overall Study|Withdrawal by Subject|0|||
128925063|NCT00666562|464010694|FG000|Overall Study|Concomitant Medication|0|||
128925064|NCT00666562|464010695|FG001|Overall Study|Concomitant Medication|1|||
128925065|NCT00666562|464010696|FG002|Overall Study|Concomitant Medication|0|||
128925066|NCT01587989|464010698|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
128925067|NCT01587989|464010699|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
128925068|NCT01587989|464010700|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
128925069|NCT01587989|464010698|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
128925070|NCT01587989|464010699|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
128925071|NCT01587989|464010700|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
128925072|NCT01587989|464010698|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
128925073|NCT01587989|464010699|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
128925074|NCT01587989|464010700|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
128925075|NCT01587989|464010698|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
128925076|NCT01587989|464010699|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
128925077|NCT01587989|464010700|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
128925078|NCT01587989|464010698|FG000|Randomized Study Treatment|Screening failure|0|||
128925079|NCT01587989|464010699|FG001|Randomized Study Treatment|Screening failure|1|||
128925080|NCT01587989|464010700|FG002|Randomized Study Treatment|Screening failure|0|||
128925081|NCT01587989|464010698|FG000|Randomized Study Treatment|Physician Decision|0|||
128925082|NCT01587989|464010699|FG001|Randomized Study Treatment|Physician Decision|0|||
128925083|NCT01587989|464010700|FG002|Randomized Study Treatment|Physician Decision|1|||
128925084|NCT00275561|464010703|FG000|Overall Study|Withdrawal by Subject|0|||
128925085|NCT00275561|464010704|FG001|Overall Study|Withdrawal by Subject|1|||
128925086|NCT00275561|464010703|FG000|Overall Study|Travel|1|||
128925087|NCT00275561|464010704|FG001|Overall Study|Travel|1|||
128925088|NCT00275561|464010703|FG000|Overall Study|Scheduling|1|||
128925089|NCT00275561|464010704|FG001|Overall Study|Scheduling|2|||
128925090|NCT00275561|464010703|FG000|Overall Study|Family Issues|0|||
128925091|NCT00275561|464010704|FG001|Overall Study|Family Issues|2|||
128925092|NCT00684177|464010712|FG000|Overall Study|Adverse Event|4|||
128925093|NCT00684177|464010713|FG001|Overall Study|Adverse Event|3|||
128925094|NCT00684177|464010712|FG000|Overall Study|Lack of Efficacy|10|||
128925095|NCT00684177|464010713|FG001|Overall Study|Lack of Efficacy|15|||
128925096|NCT00684177|464010712|FG000|Overall Study|Protocol Violation|1|||
128925097|NCT00684177|464010713|FG001|Overall Study|Protocol Violation|0|||
128925098|NCT00684177|464010712|FG000|Overall Study|Lost to Follow-up|2|||
128925099|NCT00684177|464010713|FG001|Overall Study|Lost to Follow-up|1|||
128925100|NCT00684177|464010712|FG000|Overall Study|Physician Decision|2|||
128925101|NCT00684177|464010713|FG001|Overall Study|Physician Decision|0|||
128925102|NCT00684177|464010712|FG000|Overall Study|Withdrawal by Subject|1|||
128925103|NCT00684177|464010713|FG001|Overall Study|Withdrawal by Subject|2|||
128925104|NCT00684177|464010712|FG000|Overall Study|Other|1|||
128925105|NCT00684177|464010713|FG001|Overall Study|Other|2|||
128925106|NCT02031679|464012372|FG000|Overall Study|Protocol Violation|0|||
128925107|NCT02031679|464012373|FG001|Overall Study|Protocol Violation|1|||
128925108|NCT02031679|464012372|FG000|Overall Study|Lack of Efficacy|0|||
128925109|NCT02031679|464012373|FG001|Overall Study|Lack of Efficacy|1|||
128925110|NCT04030195|464012374|FG000|Overall Study|Withdrawal by Subject|2|||
128925111|NCT04030195|464012375|FG001|Overall Study|Withdrawal by Subject|0|||
128925112|NCT04030195|464012376|FG002|Overall Study|Withdrawal by Subject|0|||
128925113|NCT03539432|464012377|FG000|Overall Study|Lost to Follow-up|0|||
128925114|NCT03539432|464012378|FG001|Overall Study|Lost to Follow-up|1|||
128925115|NCT02443402|464012379|FG000|Overall Study|Withdrawal by Subject|3|||
128925116|NCT02443402|464012380|FG001|Overall Study|Withdrawal by Subject|1|||
128925117|NCT02443402|464012379|FG000|Overall Study|Screen Failure|1|||
128925118|NCT02443402|464012380|FG001|Overall Study|Screen Failure|2|||
128925119|NCT00476086|464012383|FG000|Overall Study|Alternative therapy|1|||
129119067|NCT00171249|464733200|FG000|Overall Study|No Longer Requires Study Drug|4|||
129119068|NCT00171249|464733201|FG001|Overall Study|No Longer Requires Study Drug|0|||
128925120|NCT00476086|464012383|FG000|Overall Study|Progressive Disease|4|||
128925121|NCT02900092|464012384|FG000|Overall Study|Adverse Event|1|||
129119069|NCT00171249|464733202|FG002|Overall Study|No Longer Requires Study Drug|0|||
128925122|NCT04178590|464012385|FG000|Overall Study|Pregnancy|1|||
128925123|NCT04178590|464012385|FG000|Overall Study|Lost to Follow-up|1|||
128925124|NCT01389245|464012386|FG000|Overall Study|Protocol Violation|10|||
128925125|NCT01389245|464012386|FG000|Overall Study|Lost to Follow-up|3|||
128925126|NCT01389245|464012386|FG000|Overall Study|Withdrawal by Subject|2|||
128925127|NCT02292849|464012387|FG000|Overall Study|Lost to Follow-up|0|||
128925128|NCT02292849|464012388|FG001|Overall Study|Lost to Follow-up|2|||
128925129|NCT02292849|464012389|FG002|Overall Study|Lost to Follow-up|2|||
128925130|NCT02292849|464012387|FG000|Overall Study|Physician Decision|4|||
128925131|NCT02292849|464012388|FG001|Overall Study|Physician Decision|0|||
128925132|NCT02292849|464012389|FG002|Overall Study|Physician Decision|0|||
128925133|NCT00886938|464012390|FG000|Overall Study|Adverse Event|1|||
128925134|NCT00886938|464012390|FG000|Overall Study|Withdrawal by Subject|1|||
128925135|NCT00364793|464012391|FG000|Overall Study|Adverse Event|2|||
128925136|NCT00364793|464012392|FG001|Overall Study|Adverse Event|0|||
128925137|NCT00364793|464012393|FG002|Overall Study|Adverse Event|0|||
128925138|NCT00364793|464012394|FG003|Overall Study|Adverse Event|0|||
128925139|NCT00364793|464012391|FG000|Overall Study|Death|1|||
128925140|NCT00364793|464012392|FG001|Overall Study|Death|0|||
128925141|NCT00364793|464012393|FG002|Overall Study|Death|1|||
128925142|NCT00364793|464012394|FG003|Overall Study|Death|0|||
128925143|NCT00364793|464012391|FG000|Overall Study|Lack of Efficacy|3|||
128925144|NCT00364793|464012392|FG001|Overall Study|Lack of Efficacy|3|||
128925145|NCT00364793|464012393|FG002|Overall Study|Lack of Efficacy|1|||
128925146|NCT00364793|464012394|FG003|Overall Study|Lack of Efficacy|1|||
128925147|NCT00364793|464012391|FG000|Overall Study|Lost to Follow-up|1|||
128925148|NCT00364793|464012392|FG001|Overall Study|Lost to Follow-up|0|||
128925149|NCT00364793|464012393|FG002|Overall Study|Lost to Follow-up|2|||
128925150|NCT00364793|464012394|FG003|Overall Study|Lost to Follow-up|0|||
128925151|NCT00364793|464012391|FG000|Overall Study|Poor or non-compliance|1|||
128925152|NCT00364793|464012392|FG001|Overall Study|Poor or non-compliance|1|||
128925153|NCT00364793|464012393|FG002|Overall Study|Poor or non-compliance|0|||
128925154|NCT00364793|464012394|FG003|Overall Study|Poor or non-compliance|1|||
128925155|NCT00364793|464012391|FG000|Overall Study|No longer meets criteria|0|||
128925156|NCT00364793|464012392|FG001|Overall Study|No longer meets criteria|0|||
128925157|NCT00364793|464012393|FG002|Overall Study|No longer meets criteria|0|||
128925158|NCT00364793|464012394|FG003|Overall Study|No longer meets criteria|1|||
128925159|NCT00364793|464012391|FG000|Overall Study|Withdrawal by Subject|0|||
128925160|NCT00364793|464012392|FG001|Overall Study|Withdrawal by Subject|1|||
128925161|NCT00364793|464012393|FG002|Overall Study|Withdrawal by Subject|0|||
128925162|NCT00364793|464012394|FG003|Overall Study|Withdrawal by Subject|0|||
128925163|NCT00363415|464012397|FG000|Overall Study|Progressive Disease|196|||
128925164|NCT00363415|464012398|FG001|Overall Study|Progressive Disease|107|||
128925165|NCT00363415|464012397|FG000|Overall Study|Sponsor Decision|67|||
128925166|NCT00363415|464012398|FG001|Overall Study|Sponsor Decision|31|||
128925167|NCT00363415|464012397|FG000|Overall Study|Death|32|||
128925168|NCT00363415|464012398|FG001|Overall Study|Death|29|||
128925169|NCT00363415|464012397|FG000|Overall Study|Adverse Event|24|||
128925170|NCT00363415|464012398|FG001|Overall Study|Adverse Event|15|||
128925171|NCT00363415|464012397|FG000|Overall Study|Physician Decision|18|||
128925172|NCT00363415|464012398|FG001|Overall Study|Physician Decision|35|||
128925173|NCT00363415|464012397|FG000|Overall Study|Entry Criteria Not Met|11|||
128925174|NCT00363415|464012398|FG001|Overall Study|Entry Criteria Not Met|10|||
128925175|NCT00363415|464012397|FG000|Overall Study|Withdrawal by Subject|9|||
128925176|NCT00363415|464012398|FG001|Overall Study|Withdrawal by Subject|15|||
128925177|NCT00363415|464012397|FG000|Overall Study|Lost to Follow-up|3|||
128925178|NCT00363415|464012398|FG001|Overall Study|Lost to Follow-up|3|||
128925179|NCT00363415|464012397|FG000|Overall Study|Protocol Violation|1|||
128925180|NCT00363415|464012398|FG001|Overall Study|Protocol Violation|4|||
128925181|NCT05027802|464012401|FG000|Overall Study|Adverse Event|2|||
128925182|NCT05027802|464012401|FG000|Overall Study|Withdrawal by Subject|18|||
128925183|NCT05027802|464012401|FG000|Overall Study|Death|2|||
128925184|NCT05027802|464012401|FG000|Overall Study|Other|1|||
128925185|NCT02725788|464012402|FG000|Overall Study|Lost to Follow-up|1|||
128701255|NCT00873015|463203559|FG003|Overall Study|Withdrawal by Subject|0|||
128925186|NCT02725788|464012403|FG001|Overall Study|Lost to Follow-up|1|||
128925187|NCT02725788|464012402|FG000|Overall Study|Protocol Violation|0|||
128701256|NCT04094883|463203560|FG000|Overall Study|Withdrawal by Subject|1|||
128701257|NCT01382212|463203561|FG000|Overall Study|Kidney transplant|1|||
128701258|NCT01382212|463203561|FG000|Overall Study|Withdrew consent|1|||
128925188|NCT02725788|464012403|FG001|Overall Study|Protocol Violation|1|||
128925189|NCT05590377|464012404|FG000|Overall Study|Death|1|||
128925190|NCT05590377|464012405|FG001|Overall Study|Death|1|||
128925191|NCT05590377|464012406|FG002|Overall Study|Death|2|||
128925192|NCT05590377|464012407|FG003|Overall Study|Death|0|||
128925193|NCT05590377|464012408|FG004|Overall Study|Death|0|||
129119070|NCT00171249|464733203|FG003|Overall Study|No Longer Requires Study Drug|3|||
129119071|NCT00171249|464733204|FG004|Overall Study|No Longer Requires Study Drug|0|||
128925194|NCT05590377|464012404|FG000|Overall Study|Study Terminated by Sponsor|1|||
129119072|NCT00171249|464733205|FG005|Overall Study|No Longer Requires Study Drug|5|||
128925195|NCT05590377|464012405|FG001|Overall Study|Study Terminated by Sponsor|5|||
129216347|NCT01055197|465092904|FG000|Overall Study|Protocol Violation|7|||
128925196|NCT05590377|464012406|FG002|Overall Study|Study Terminated by Sponsor|4|||
128925197|NCT05590377|464012407|FG003|Overall Study|Study Terminated by Sponsor|0|||
128925198|NCT05590377|464012408|FG004|Overall Study|Study Terminated by Sponsor|0|||
128925199|NCT05590377|464012404|FG000|Overall Study|Withdrawal by Subject|1|||
128925200|NCT05590377|464012405|FG001|Overall Study|Withdrawal by Subject|0|||
128925201|NCT05590377|464012406|FG002|Overall Study|Withdrawal by Subject|0|||
128925202|NCT05590377|464012407|FG003|Overall Study|Withdrawal by Subject|0|||
128925203|NCT05590377|464012408|FG004|Overall Study|Withdrawal by Subject|0|||
128925204|NCT00828464|464012409|FG000|Overall Study|Withdrawal by Subject|1|||
128925205|NCT00809133|464012410|FG000|Overall Study|Progressive disease|2|||
128925206|NCT00809133|464012411|FG001|Overall Study|Progressive disease|5|||
128925207|NCT00809133|464012412|FG002|Overall Study|Progressive disease|5|||
128925208|NCT00809133|464012413|FG003|Overall Study|Progressive disease|3|||
128925209|NCT00809133|464012414|FG004|Overall Study|Progressive disease|4|||
128925210|NCT00809133|464012415|FG005|Overall Study|Progressive disease|1|||
128925211|NCT00809133|464012416|FG006|Overall Study|Progressive disease|3|||
128925212|NCT00809133|464012417|FG007|Overall Study|Progressive disease|3|||
128925213|NCT00809133|464012418|FG008|Overall Study|Progressive disease|3|||
128925214|NCT00809133|464012419|FG009|Overall Study|Progressive disease|9|||
128925215|NCT00809133|464012420|FG010|Overall Study|Progressive disease|5|||
128925216|NCT00809133|464012421|FG011|Overall Study|Progressive disease|7|||
128925217|NCT00809133|464012422|FG012|Overall Study|Progressive disease|5|||
128925218|NCT00809133|464012423|FG013|Overall Study|Progressive disease|4|||
128925219|NCT00809133|464012410|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925220|NCT00809133|464012411|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925221|NCT00809133|464012412|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128701259|NCT01273597|463203562|FG000|Overall Study|Adverse Event|5|||
128701260|NCT01273597|463203562|FG000|Overall Study|Underwent Kidney Transplantation|2|||
128701261|NCT01273597|463203562|FG000|Overall Study|Reason Not Reported|1|||
128701262|NCT01063868|463203563|FG000|Overall Study|Adverse Event|9|||
128701263|NCT01063868|463203564|FG001|Overall Study|Adverse Event|7|||
128701264|NCT01063868|463203563|FG000|Overall Study|Withdrawal by Subject|3|||
128701265|NCT01063868|463203564|FG001|Overall Study|Withdrawal by Subject|1|||
128701266|NCT01063868|463203563|FG000|Overall Study|Study Terminated By Sponsor|23|||
128701267|NCT01063868|463203564|FG001|Overall Study|Study Terminated By Sponsor|4|||
128701268|NCT03329573|463203567|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
128701269|NCT03329573|463203568|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
128701270|NCT03329573|463203569|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
128701271|NCT03329573|463203570|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
128701272|NCT03329573|463203567|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
128701273|NCT03329573|463203568|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
128701274|NCT03329573|463203569|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128701275|NCT03329573|463203570|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128701276|NCT03329573|463203567|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
128701277|NCT03329573|463203568|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
128701278|NCT03329573|463203569|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
128701279|NCT03329573|463203570|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
128701280|NCT03329573|463203567|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
128701281|NCT03329573|463203568|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
128701282|NCT03329573|463203569|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
128701283|NCT03329573|463203570|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
128701284|NCT02777333|463203573|FG000|Overall Study|Withdrawal by Subject|0|||
128701285|NCT02777333|463203574|FG001|Overall Study|Withdrawal by Subject|1|||
128701286|NCT02777333|463203573|FG000|Overall Study|Lost to Follow-up|0|||
128701287|NCT02777333|463203574|FG001|Overall Study|Lost to Follow-up|1|||
128701288|NCT00837811|463203575|FG000|Overall Study|Adverse Event|4|||
128701289|NCT00837811|463203576|FG001|Overall Study|Adverse Event|6|||
128701290|NCT00837811|463203577|FG002|Overall Study|Adverse Event|0|||
128701291|NCT00837811|463203575|FG000|Overall Study|Death|1|||
128701292|NCT00837811|463203576|FG001|Overall Study|Death|1|||
128701293|NCT00837811|463203577|FG002|Overall Study|Death|0|||
128701294|NCT00837811|463203575|FG000|Overall Study|Lack of Efficacy|0|||
128701295|NCT00837811|463203576|FG001|Overall Study|Lack of Efficacy|11|||
128701296|NCT00837811|463203577|FG002|Overall Study|Lack of Efficacy|0|||
128701297|NCT00837811|463203575|FG000|Overall Study|Lost to Follow-up|1|||
128701298|NCT00837811|463203576|FG001|Overall Study|Lost to Follow-up|3|||
128701299|NCT00837811|463203577|FG002|Overall Study|Lost to Follow-up|0|||
128701300|NCT00837811|463203575|FG000|Overall Study|Physician Decision|0|||
128925222|NCT00809133|464012413|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925223|NCT00809133|464012414|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925224|NCT00809133|464012415|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
128925225|NCT00809133|464012416|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
128701301|NCT00837811|463203576|FG001|Overall Study|Physician Decision|2|||
128701302|NCT00837811|463203577|FG002|Overall Study|Physician Decision|1|||
128925226|NCT00809133|464012417|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
128925227|NCT00809133|464012418|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925228|NCT00809133|464012419|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925229|NCT00809133|464012420|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925230|NCT00809133|464012421|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925231|NCT00809133|464012422|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128925232|NCT00809133|464012423|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
128925233|NCT00809133|464012410|FG000|Overall Study|Other adverse event|1|||
128925234|NCT00809133|464012411|FG001|Overall Study|Other adverse event|1|||
128925235|NCT00809133|464012412|FG002|Overall Study|Other adverse event|1|||
128925236|NCT00809133|464012413|FG003|Overall Study|Other adverse event|0|||
128925237|NCT00809133|464012414|FG004|Overall Study|Other adverse event|0|||
128925238|NCT00809133|464012415|FG005|Overall Study|Other adverse event|3|||
128925239|NCT00809133|464012416|FG006|Overall Study|Other adverse event|2|||
128925240|NCT00809133|464012417|FG007|Overall Study|Other adverse event|4|||
128925241|NCT00809133|464012418|FG008|Overall Study|Other adverse event|0|||
128925242|NCT00809133|464012419|FG009|Overall Study|Other adverse event|0|||
129029560|NCT01109849|464399872|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
129029561|NCT01109849|464399873|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
129029562|NCT01109849|464399869|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
129216348|NCT01055197|465092905|FG001|Overall Study|Protocol Violation|2|||
129216349|NCT01055197|465092904|FG000|Overall Study|Withdrawal by Subject|2|||
128925243|NCT00809133|464012420|FG010|Overall Study|Other adverse event|1|||
129216350|NCT01055197|465092905|FG001|Overall Study|Withdrawal by Subject|0|||
129216351|NCT00538902|465092906|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
128925244|NCT00809133|464012421|FG011|Overall Study|Other adverse event|1|||
128925245|NCT00809133|464012422|FG012|Overall Study|Other adverse event|0|||
128925246|NCT00809133|464012423|FG013|Overall Study|Other adverse event|1|||
128925247|NCT00809133|464012410|FG000|Overall Study|Lost to Follow-up|0|||
128925248|NCT00809133|464012411|FG001|Overall Study|Lost to Follow-up|0|||
128925249|NCT00809133|464012412|FG002|Overall Study|Lost to Follow-up|0|||
128925250|NCT00809133|464012413|FG003|Overall Study|Lost to Follow-up|0|||
128925251|NCT00809133|464012414|FG004|Overall Study|Lost to Follow-up|0|||
128925252|NCT00809133|464012415|FG005|Overall Study|Lost to Follow-up|1|||
128925253|NCT00809133|464012416|FG006|Overall Study|Lost to Follow-up|0|||
128925254|NCT00809133|464012417|FG007|Overall Study|Lost to Follow-up|0|||
128925255|NCT00809133|464012418|FG008|Overall Study|Lost to Follow-up|0|||
128925256|NCT00809133|464012419|FG009|Overall Study|Lost to Follow-up|0|||
128925257|NCT00809133|464012420|FG010|Overall Study|Lost to Follow-up|0|||
128925258|NCT00809133|464012421|FG011|Overall Study|Lost to Follow-up|0|||
128925259|NCT00809133|464012422|FG012|Overall Study|Lost to Follow-up|0|||
128925260|NCT00809133|464012423|FG013|Overall Study|Lost to Follow-up|0|||
128925261|NCT00809133|464012410|FG000|Overall Study|Consent withdrawn|0|||
129216352|NCT00538902|465092907|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
129216353|NCT00538902|465092908|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
129216354|NCT00538902|465092906|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
129216355|NCT00538902|465092907|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
129216356|NCT00538902|465092908|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
129216357|NCT00538902|465092906|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
129216358|NCT00538902|465092907|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
129216359|NCT00538902|465092908|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
129216360|NCT00538902|465092906|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
129216361|NCT00538902|465092907|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
129216362|NCT00538902|465092908|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
129216363|NCT00538902|465092906|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
129216364|NCT00538902|465092907|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
129216365|NCT00538902|465092908|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
128701303|NCT00837811|463203575|FG000|Overall Study|Withdrawal by Subject|1|||
128701304|NCT00837811|463203576|FG001|Overall Study|Withdrawal by Subject|9|||
128701305|NCT00837811|463203577|FG002|Overall Study|Withdrawal by Subject|0|||
128701306|NCT00837811|463203575|FG000|Overall Study|Sponsor Decision|0|||
128701307|NCT00837811|463203576|FG001|Overall Study|Sponsor Decision|2|||
128701308|NCT00837811|463203577|FG002|Overall Study|Sponsor Decision|0|||
128701309|NCT03307967|463203578|FG000|Overall Study|Lost to Follow-up|4|||
128701310|NCT02578316|463203579|FG000|Extension Phase|Progression of disease|6|||
128701311|NCT05372419|463203580|FG000|Overall Study|Protocol Deviation|1|||
128701312|NCT05372419|463203580|FG000|Overall Study|Withdrawal by Subject|5|||
128701313|NCT05372419|463203580|FG000|Overall Study|Lost to Follow-up|7|||
128701314|NCT04362072|463203584|FG000|Treatment|Adverse Event|1|||
128701315|NCT04362072|463203584|FG000|Treatment|Death|9|||
128701316|NCT04362072|463203584|FG000|Treatment|Physician Decision|2|||
128701317|NCT04362072|463203584|FG000|Treatment|Progressive disease|27|||
128701318|NCT04362072|463203584|FG000|Treatment|Withdrawal by Subject|4|||
128925262|NCT00809133|464012411|FG001|Overall Study|Consent withdrawn|0|||
128925263|NCT00809133|464012412|FG002|Overall Study|Consent withdrawn|0|||
128925264|NCT00809133|464012413|FG003|Overall Study|Consent withdrawn|0|||
128925265|NCT00809133|464012414|FG004|Overall Study|Consent withdrawn|1|||
128925266|NCT00809133|464012415|FG005|Overall Study|Consent withdrawn|0|||
128925267|NCT00809133|464012416|FG006|Overall Study|Consent withdrawn|0|||
128925268|NCT00809133|464012417|FG007|Overall Study|Consent withdrawn|0|||
128925269|NCT00809133|464012418|FG008|Overall Study|Consent withdrawn|0|||
128925270|NCT00809133|464012419|FG009|Overall Study|Consent withdrawn|0|||
128925271|NCT00809133|464012420|FG010|Overall Study|Consent withdrawn|0|||
128925272|NCT00809133|464012421|FG011|Overall Study|Consent withdrawn|0|||
128925273|NCT00809133|464012422|FG012|Overall Study|Consent withdrawn|0|||
128925274|NCT00809133|464012423|FG013|Overall Study|Consent withdrawn|0|||
128925275|NCT00809133|464012410|FG000|Overall Study|Other not mentioned above|0|||
128925276|NCT00809133|464012411|FG001|Overall Study|Other not mentioned above|1|||
128925277|NCT00809133|464012412|FG002|Overall Study|Other not mentioned above|0|||
128925278|NCT00809133|464012413|FG003|Overall Study|Other not mentioned above|0|||
128925279|NCT00809133|464012414|FG004|Overall Study|Other not mentioned above|0|||
128925280|NCT00809133|464012415|FG005|Overall Study|Other not mentioned above|1|||
128925281|NCT00809133|464012416|FG006|Overall Study|Other not mentioned above|0|||
128925282|NCT00809133|464012417|FG007|Overall Study|Other not mentioned above|0|||
128925283|NCT00809133|464012418|FG008|Overall Study|Other not mentioned above|0|||
128925284|NCT00809133|464012419|FG009|Overall Study|Other not mentioned above|0|||
128925285|NCT00809133|464012420|FG010|Overall Study|Other not mentioned above|0|||
128925286|NCT00809133|464012421|FG011|Overall Study|Other not mentioned above|0|||
128925287|NCT00809133|464012422|FG012|Overall Study|Other not mentioned above|0|||
128925288|NCT00809133|464012423|FG013|Overall Study|Other not mentioned above|0|||
128925289|NCT00833092|464012424|FG000|Overall Study|Withdrawal by Subject|2|||
128925290|NCT00833092|464012425|FG001|Overall Study|Withdrawal by Subject|3|||
128925291|NCT00833092|464012424|FG000|Overall Study|Protocol Violation|2|||
128925292|NCT00833092|464012425|FG001|Overall Study|Protocol Violation|1|||
128925293|NCT00833092|464012424|FG000|Overall Study|Diarrhea|0|||
128925294|NCT00833092|464012425|FG001|Overall Study|Diarrhea|2|||
128925295|NCT00833092|464012424|FG000|Overall Study|constipation|0|||
128925296|NCT00833092|464012425|FG001|Overall Study|constipation|1|||
128925297|NCT00699192|464012426|FG000|Overall Study|Missing|1|||
128925298|NCT00699192|464012427|FG001|Overall Study|Missing|1|||
128925299|NCT00699192|464012428|FG002|Overall Study|Missing|1|||
128925300|NCT00699192|464012426|FG000|Overall Study|Adverse Event|9|||
128925301|NCT00699192|464012427|FG001|Overall Study|Adverse Event|4|||
128925302|NCT00699192|464012428|FG002|Overall Study|Adverse Event|3|||
128925303|NCT00699192|464012426|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128925304|NCT00699192|464012427|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128925305|NCT00699192|464012428|FG002|Overall Study|Abnormal test procedure result(s)|1|||
128925306|NCT00699192|464012426|FG000|Overall Study|Lack of Efficacy|0|||
128925307|NCT00699192|464012427|FG001|Overall Study|Lack of Efficacy|0|||
128925308|NCT00699192|464012428|FG002|Overall Study|Lack of Efficacy|1|||
128925309|NCT00699192|464012426|FG000|Overall Study|Withdrawal by Subject|3|||
128925310|NCT00699192|464012427|FG001|Overall Study|Withdrawal by Subject|2|||
128925311|NCT00699192|464012428|FG002|Overall Study|Withdrawal by Subject|4|||
128925312|NCT00699192|464012426|FG000|Overall Study|Administrative problems|1|||
128925313|NCT00699192|464012427|FG001|Overall Study|Administrative problems|3|||
128925314|NCT00699192|464012428|FG002|Overall Study|Administrative problems|1|||
128925315|NCT00699192|464012426|FG000|Overall Study|Protocol Violation|2|||
128925316|NCT00699192|464012427|FG001|Overall Study|Protocol Violation|2|||
128925317|NCT00699192|464012428|FG002|Overall Study|Protocol Violation|0|||
128925318|NCT01773473|464012429|FG000|Overall Study|Adverse Event|3|||
128925319|NCT01773473|464012430|FG001|Overall Study|Adverse Event|2|||
128925320|NCT01773473|464012429|FG000|Overall Study|Protocol Violation|0|||
128925321|NCT01773473|464012430|FG001|Overall Study|Protocol Violation|4|||
128925322|NCT01773473|464012429|FG000|Overall Study|Physician Decision|3|||
128925323|NCT01773473|464012430|FG001|Overall Study|Physician Decision|5|||
128925324|NCT01773473|464012429|FG000|Overall Study|Sponsor Decision|2|||
128925325|NCT01773473|464012430|FG001|Overall Study|Sponsor Decision|0|||
128925326|NCT01773473|464012429|FG000|Overall Study|Lack of Efficacy|0|||
128925327|NCT01773473|464012430|FG001|Overall Study|Lack of Efficacy|1|||
128925328|NCT01773473|464012429|FG000|Overall Study|Non-Compliance with study drug|1|||
128925329|NCT01773473|464012430|FG001|Overall Study|Non-Compliance with study drug|4|||
128925330|NCT01773473|464012429|FG000|Overall Study|Withdrawal by Subject|5|||
128925331|NCT01773473|464012430|FG001|Overall Study|Withdrawal by Subject|3|||
129029563|NCT01109849|464399870|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
128925332|NCT01773473|464012429|FG000|Overall Study|Lost to Follow-up|2|||
128925333|NCT01773473|464012430|FG001|Overall Study|Lost to Follow-up|0|||
128925334|NCT01025635|464012440|FG000|Overall Study|Withdrawal by Subject|6|||
128925335|NCT01025635|464012441|FG001|Overall Study|Withdrawal by Subject|7|||
128925336|NCT01025635|464012440|FG000|Overall Study|Protocol Violation|4|||
128925337|NCT01025635|464012441|FG001|Overall Study|Protocol Violation|2|||
128925338|NCT01025635|464012440|FG000|Overall Study|Lack of Efficacy|0|||
128925339|NCT01025635|464012441|FG001|Overall Study|Lack of Efficacy|1|||
128925340|NCT01025635|464012440|FG000|Overall Study|Lost to Follow-up|9|||
128925341|NCT01025635|464012441|FG001|Overall Study|Lost to Follow-up|13|||
128925342|NCT01025635|464012440|FG000|Overall Study|Reason not known|4|||
128925343|NCT01025635|464012441|FG001|Overall Study|Reason not known|2|||
128925344|NCT00727402|464012442|FG000|Overall Study|Physician Decision|116|||
128925345|NCT00929240|464012443|FG000|Initial Treatment Phase|Adverse Event|31|||
128925346|NCT00929240|464012444|FG001|Initial Treatment Phase|Adverse Event|0|||
128925347|NCT00929240|464012445|FG002|Initial Treatment Phase|Adverse Event|0|||
128925348|NCT00929240|464012443|FG000|Initial Treatment Phase|Disease progression|41|||
128925349|NCT00929240|464012444|FG001|Initial Treatment Phase|Disease progression|0|||
128925350|NCT00929240|464012445|FG002|Initial Treatment Phase|Disease progression|0|||
128925351|NCT00929240|464012443|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
128925352|NCT00929240|464012444|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
128925353|NCT00929240|464012445|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
128925354|NCT00929240|464012443|FG000|Initial Treatment Phase|Protocol Violation|5|||
128925355|NCT00929240|464012444|FG001|Initial Treatment Phase|Protocol Violation|0|||
128925356|NCT00929240|464012445|FG002|Initial Treatment Phase|Protocol Violation|0|||
128925357|NCT00929240|464012443|FG000|Initial Treatment Phase|Death|2|||
128925358|NCT00929240|464012444|FG001|Initial Treatment Phase|Death|0|||
128925359|NCT00929240|464012445|FG002|Initial Treatment Phase|Death|0|||
128925360|NCT00929240|464012443|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
128925361|NCT00929240|464012444|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
128925362|NCT00929240|464012445|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
128925363|NCT00929240|464012443|FG000|Initial Treatment Phase|Physician Decision|4|||
128925364|NCT00929240|464012444|FG001|Initial Treatment Phase|Physician Decision|0|||
128925365|NCT00929240|464012445|FG002|Initial Treatment Phase|Physician Decision|0|||
128925366|NCT00929240|464012443|FG000|Maintenance Phase|Disease progression|0|||
128925367|NCT00929240|464012444|FG001|Maintenance Phase|Disease progression|73|||
128925368|NCT00929240|464012445|FG002|Maintenance Phase|Disease progression|60|||
128925369|NCT00929240|464012443|FG000|Maintenance Phase|Adverse Event|0|||
128925370|NCT00929240|464012444|FG001|Maintenance Phase|Adverse Event|9|||
128925371|NCT00929240|464012445|FG002|Maintenance Phase|Adverse Event|12|||
128925372|NCT00929240|464012443|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128925373|NCT00929240|464012444|FG001|Maintenance Phase|Withdrawal by Subject|2|||
128925374|NCT00929240|464012445|FG002|Maintenance Phase|Withdrawal by Subject|6|||
128925375|NCT00929240|464012443|FG000|Maintenance Phase|Protocol Violation|0|||
128701319|NCT04362072|463203584|FG000|Treatment|Global deterioration of health status|1|||
128701320|NCT04362072|463203584|FG000|Treatment|Switched to commercial Lorlatinib|13|||
128701321|NCT04362072|463203584|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
128701322|NCT04362072|463203584|FG000|Treatment|Other|3|||
128701323|NCT04362072|463203584|FG000|Follow up|Death|2|||
128701324|NCT04362072|463203584|FG000|Follow up|Other|2|||
128925376|NCT00929240|464012444|FG001|Maintenance Phase|Protocol Violation|1|||
128925377|NCT00929240|464012445|FG002|Maintenance Phase|Protocol Violation|0|||
129119073|NCT00171249|464733206|FG006|Overall Study|No Longer Requires Study Drug|0|||
129119074|NCT00171249|464733200|FG000|Overall Study|Administrative Problems|1|||
128701325|NCT01133522|463203585|FG000|Overall Study|Withdrawal by Subject|0|||
128701326|NCT01133522|463203586|FG001|Overall Study|Withdrawal by Subject|1|||
128701327|NCT01133522|463203587|FG002|Overall Study|Withdrawal by Subject|0|||
128701328|NCT01133522|463203588|FG003|Overall Study|Withdrawal by Subject|1|||
128701329|NCT01133522|463203589|FG004|Overall Study|Withdrawal by Subject|0|||
128701330|NCT01133522|463203590|FG005|Overall Study|Withdrawal by Subject|0|||
128701331|NCT01133522|463203591|FG006|Overall Study|Withdrawal by Subject|0|||
128701332|NCT01133522|463203592|FG007|Overall Study|Withdrawal by Subject|0|||
128701333|NCT01133522|463203593|FG008|Overall Study|Withdrawal by Subject|0|||
128701334|NCT01133522|463203594|FG009|Overall Study|Withdrawal by Subject|0|||
128701335|NCT01133522|463203585|FG000|Overall Study|Physician Decision|0|||
128701336|NCT01133522|463203586|FG001|Overall Study|Physician Decision|0|||
128701337|NCT01133522|463203587|FG002|Overall Study|Physician Decision|0|||
128701338|NCT01133522|463203588|FG003|Overall Study|Physician Decision|0|||
128701339|NCT01133522|463203589|FG004|Overall Study|Physician Decision|1|||
128701340|NCT01133522|463203590|FG005|Overall Study|Physician Decision|0|||
128701341|NCT01133522|463203591|FG006|Overall Study|Physician Decision|0|||
128701342|NCT01133522|463203592|FG007|Overall Study|Physician Decision|0|||
128701343|NCT01133522|463203593|FG008|Overall Study|Physician Decision|0|||
128701344|NCT01133522|463203594|FG009|Overall Study|Physician Decision|0|||
128701345|NCT01664533|463205576|FG000|Overall Study|Death|42|||
128701346|NCT01664533|463205576|FG000|Overall Study|Lost to Follow-up|3|||
128701347|NCT01664533|463205576|FG000|Overall Study|Study termination|9|||
128701348|NCT01664533|463205576|FG000|Overall Study|Protocol Violation|3|||
128925378|NCT00929240|464012443|FG000|Maintenance Phase|Health authority/Study termination|0|||
128925379|NCT00929240|464012444|FG001|Maintenance Phase|Health authority/Study termination|1|||
128925380|NCT00929240|464012445|FG002|Maintenance Phase|Health authority/Study termination|2|||
128925381|NCT00929240|464012443|FG000|Maintenance Phase|Physician Decision|0|||
128701349|NCT00290888|463205577|FG000|Overall Study|Physician Decision|3|||
128701350|NCT00290888|463205578|FG001|Overall Study|Physician Decision|1|||
128701351|NCT03000439|463205579|FG000|Open Label Part 1|Adverse Event|6|||
129119075|NCT00171249|464733201|FG001|Overall Study|Administrative Problems|0|||
128701352|NCT03000439|463205580|FG001|Open Label Part 1|Adverse Event|0|||
128701353|NCT03000439|463205581|FG002|Open Label Part 1|Adverse Event|0|||
128701354|NCT03000439|463205582|FG003|Open Label Part 1|Adverse Event|0|||
128701355|NCT03000439|463205579|FG000|Open Label Part 1|Other|2|||
128701356|NCT03000439|463205580|FG001|Open Label Part 1|Other|0|||
128925382|NCT00929240|464012444|FG001|Maintenance Phase|Physician Decision|2|||
128925383|NCT00929240|464012445|FG002|Maintenance Phase|Physician Decision|1|||
128925384|NCT00929240|464012443|FG000|Maintenance Phase|Change of treatment|0|||
128925385|NCT00929240|464012444|FG001|Maintenance Phase|Change of treatment|4|||
128925386|NCT00929240|464012445|FG002|Maintenance Phase|Change of treatment|0|||
128925387|NCT00929240|464012443|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
128925388|NCT00929240|464012444|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
128925389|NCT00929240|464012445|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
128925390|NCT00929240|464012443|FG000|Maintenance Phase|Participant not treated|0|||
128925391|NCT00929240|464012444|FG001|Maintenance Phase|Participant not treated|2|||
128925392|NCT00929240|464012445|FG002|Maintenance Phase|Participant not treated|0|||
128925393|NCT05292755|464012446|FG000|Overall Study|Lost to Follow-up|5|||
128925394|NCT05292755|464012447|FG001|Overall Study|Lost to Follow-up|9|||
128925395|NCT00432809|464012448|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
128925396|NCT00432809|464012449|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
128925397|NCT00432809|464012450|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
128925398|NCT00432809|464012448|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
128925399|NCT00432809|464012449|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
128925400|NCT00432809|464012450|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
128925401|NCT04433117|464012451|FG000|Overall Study|Withdrawal by Subject|1|||
128925402|NCT04433117|464012452|FG001|Overall Study|Withdrawal by Subject|0|||
128925403|NCT01051739|464012453|FG000|Overall Study|Death|3|||
128925404|NCT01051739|464012454|FG001|Overall Study|Death|3|||
128925405|NCT01051739|464012453|FG000|Overall Study|Withdrawal by Subject|25|||
128925406|NCT01051739|464012454|FG001|Overall Study|Withdrawal by Subject|10|||
128925407|NCT00707577|464012455|FG000|Overall Study|Withdrawal by Subject|3|||
128925408|NCT00707577|464012456|FG001|Overall Study|Withdrawal by Subject|2|||
128925409|NCT00707577|464012455|FG000|Overall Study|Lost to Follow-up|34|||
128925410|NCT00707577|464012456|FG001|Overall Study|Lost to Follow-up|25|||
128925411|NCT00707577|464012455|FG000|Overall Study|Left employment|13|||
128925412|NCT00707577|464012456|FG001|Overall Study|Left employment|10|||
128925413|NCT00707577|464012455|FG000|Overall Study|Pregnancy|4|||
128925414|NCT00707577|464012456|FG001|Overall Study|Pregnancy|1|||
128925415|NCT02499952|464012457|FG000|Overall Study|Lost to Follow-up|1|||
128925416|NCT02499952|464012457|FG000|Overall Study|Death|9|||
128925417|NCT02209766|464012458|FG000|Overall Study|Withdrawal by Subject|0|||
128925418|NCT02209766|464012459|FG001|Overall Study|Withdrawal by Subject|0|||
128925419|NCT02209766|464012460|FG002|Overall Study|Withdrawal by Subject|0|||
128925420|NCT02209766|464012461|FG003|Overall Study|Withdrawal by Subject|1|||
128925421|NCT02209766|464012462|FG004|Overall Study|Withdrawal by Subject|0|||
128925422|NCT00805207|464012463|FG000|Overall Study|Protocol Violation|0|||
128925423|NCT00805207|464012464|FG001|Overall Study|Protocol Violation|0|||
128925424|NCT00805207|464012465|FG002|Overall Study|Protocol Violation|1|||
128925425|NCT00805207|464012466|FG003|Overall Study|Protocol Violation|0|||
128925426|NCT00805207|464012467|FG004|Overall Study|Protocol Violation|0|||
128925427|NCT00805207|464012468|FG005|Overall Study|Protocol Violation|0|||
128925428|NCT00805207|464012469|FG006|Overall Study|Protocol Violation|0|||
128925429|NCT00805207|464012470|FG007|Overall Study|Protocol Violation|0|||
128925430|NCT00805207|464012471|FG008|Overall Study|Protocol Violation|0|||
128925431|NCT00805207|464012463|FG000|Overall Study|Physician Decision|0|||
128925432|NCT00805207|464012464|FG001|Overall Study|Physician Decision|1|||
128925433|NCT00805207|464012465|FG002|Overall Study|Physician Decision|0|||
128925434|NCT00805207|464012466|FG003|Overall Study|Physician Decision|0|||
128925435|NCT00805207|464012467|FG004|Overall Study|Physician Decision|0|||
128925436|NCT00805207|464012468|FG005|Overall Study|Physician Decision|1|||
128925437|NCT00805207|464012469|FG006|Overall Study|Physician Decision|0|||
128925438|NCT00805207|464012470|FG007|Overall Study|Physician Decision|0|||
128925439|NCT00805207|464012471|FG008|Overall Study|Physician Decision|0|||
128925440|NCT00805207|464012463|FG000|Overall Study|Withdrawal by Subject|0|||
128925441|NCT00805207|464012464|FG001|Overall Study|Withdrawal by Subject|1|||
128925442|NCT00805207|464012465|FG002|Overall Study|Withdrawal by Subject|0|||
128925443|NCT00805207|464012466|FG003|Overall Study|Withdrawal by Subject|0|||
128925444|NCT00805207|464012467|FG004|Overall Study|Withdrawal by Subject|1|||
128925445|NCT00805207|464012468|FG005|Overall Study|Withdrawal by Subject|2|||
128925446|NCT00805207|464012469|FG006|Overall Study|Withdrawal by Subject|0|||
128925447|NCT00805207|464012470|FG007|Overall Study|Withdrawal by Subject|0|||
128925448|NCT00805207|464012471|FG008|Overall Study|Withdrawal by Subject|0|||
128925449|NCT00064701|464012472|FG000|One Year Post-transplant|Did not receive study drug|7|||
128925450|NCT00064701|464012473|FG001|One Year Post-transplant|Did not receive study drug|12|||
128925451|NCT00064701|464012474|FG002|One Year Post-transplant|Did not receive study drug|11|||
128925452|NCT00064701|464012472|FG000|One Year Post-transplant|Adverse Event|23|||
128925453|NCT00064701|464012473|FG001|One Year Post-transplant|Adverse Event|19|||
128925454|NCT00064701|464012474|FG002|One Year Post-transplant|Adverse Event|37|||
128925455|NCT00064701|464012472|FG000|One Year Post-transplant|Rejection|0|||
128925456|NCT00064701|464012473|FG001|One Year Post-transplant|Rejection|1|||
128925457|NCT00064701|464012474|FG002|One Year Post-transplant|Rejection|16|||
128925458|NCT00064701|464012472|FG000|One Year Post-transplant|Non-compliance|4|||
128925459|NCT00064701|464012473|FG001|One Year Post-transplant|Non-compliance|2|||
128925460|NCT00064701|464012474|FG002|One Year Post-transplant|Non-compliance|5|||
128925461|NCT00064701|464012472|FG000|One Year Post-transplant|Graft Failure|3|||
128925462|NCT00064701|464012473|FG001|One Year Post-transplant|Graft Failure|2|||
128925463|NCT00064701|464012474|FG002|One Year Post-transplant|Graft Failure|1|||
128925464|NCT00064701|464012472|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
128925465|NCT00064701|464012473|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
128925466|NCT00064701|464012474|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
128925467|NCT00064701|464012472|FG000|One Year Post-transplant|Lost to Follow-up|1|||
128925468|NCT00064701|464012473|FG001|One Year Post-transplant|Lost to Follow-up|0|||
128925469|NCT00064701|464012474|FG002|One Year Post-transplant|Lost to Follow-up|0|||
128925470|NCT00064701|464012472|FG000|One Year Post-transplant|Converted to rapamycin|1|||
128925471|NCT00064701|464012473|FG001|One Year Post-transplant|Converted to rapamycin|0|||
128925472|NCT00064701|464012474|FG002|One Year Post-transplant|Converted to rapamycin|0|||
128925473|NCT00064701|464012472|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
128925474|NCT00064701|464012473|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
128925475|NCT00064701|464012474|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
128925476|NCT00064701|464012472|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
128925477|NCT00064701|464012473|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
128925478|NCT00064701|464012474|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
128925479|NCT00064701|464012472|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
128925480|NCT00064701|464012473|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
128925481|NCT00064701|464012474|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
128925482|NCT00064701|464012472|FG000|One Year Post-transplant|Poor absorption|0|||
128925483|NCT00064701|464012473|FG001|One Year Post-transplant|Poor absorption|1|||
128925484|NCT00064701|464012474|FG002|One Year Post-transplant|Poor absorption|0|||
128925485|NCT00064701|464012472|FG000|One Year Post-transplant|Pancreas transplant|0|||
128925486|NCT00064701|464012473|FG001|One Year Post-transplant|Pancreas transplant|0|||
128925487|NCT00064701|464012474|FG002|One Year Post-transplant|Pancreas transplant|1|||
128925488|NCT00064701|464012472|FG000|Clinical Continuation Phase|Adverse Event|12|||
128925489|NCT00064701|464012473|FG001|Clinical Continuation Phase|Adverse Event|21|||
128925490|NCT00064701|464012474|FG002|Clinical Continuation Phase|Adverse Event|14|||
128925491|NCT00064701|464012472|FG000|Clinical Continuation Phase|Non-compliance|8|||
128925492|NCT00064701|464012473|FG001|Clinical Continuation Phase|Non-compliance|6|||
128925493|NCT00064701|464012474|FG002|Clinical Continuation Phase|Non-compliance|7|||
128925494|NCT00064701|464012472|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
128925495|NCT00064701|464012473|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
128925496|NCT00064701|464012474|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
128925497|NCT00064701|464012472|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
128925498|NCT00064701|464012473|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
128925499|NCT00064701|464012474|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
128925500|NCT00064701|464012472|FG000|Clinical Continuation Phase|Graft Failure|5|||
128925501|NCT00064701|464012473|FG001|Clinical Continuation Phase|Graft Failure|5|||
128925502|NCT00064701|464012474|FG002|Clinical Continuation Phase|Graft Failure|2|||
128925503|NCT00064701|464012472|FG000|Clinical Continuation Phase|Rejection|1|||
128925504|NCT00064701|464012473|FG001|Clinical Continuation Phase|Rejection|2|||
128925505|NCT00064701|464012474|FG002|Clinical Continuation Phase|Rejection|2|||
128925506|NCT00064701|464012472|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
128925507|NCT00064701|464012473|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
128925508|NCT00064701|464012474|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
128925509|NCT00064701|464012472|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
128925510|NCT00064701|464012473|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
128925511|NCT00064701|464012474|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
128925512|NCT00064701|464012472|FG000|Clinical Continuation Phase|Physician Decision|1|||
128925513|NCT00064701|464012473|FG001|Clinical Continuation Phase|Physician Decision|3|||
128925514|NCT00064701|464012474|FG002|Clinical Continuation Phase|Physician Decision|0|||
128925515|NCT00064701|464012472|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
128925516|NCT00064701|464012473|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
128925517|NCT00064701|464012474|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
128925518|NCT00064701|464012472|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
128925519|NCT00064701|464012473|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
128925520|NCT00064701|464012474|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
128925521|NCT00064701|464012472|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
128925522|NCT00064701|464012473|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
128925523|NCT00064701|464012474|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
128925524|NCT00064701|464012472|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
128925525|NCT00064701|464012473|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
128925526|NCT00064701|464012474|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
128925527|NCT00064701|464012472|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
128925528|NCT00064701|464012473|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
128925529|NCT00064701|464012474|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
128925530|NCT00064701|464012472|FG000|Clinical Continuation Phase|Patient opted out|0|||
128925531|NCT00064701|464012473|FG001|Clinical Continuation Phase|Patient opted out|0|||
128925532|NCT00064701|464012474|FG002|Clinical Continuation Phase|Patient opted out|1|||
128925533|NCT01491945|464012476|FG000|Overall Study|Death|30|||
128925534|NCT01491945|464012476|FG000|Overall Study|Withdrwan/LTF|16|||
128925535|NCT01491945|464012476|FG000|Overall Study|Conversion|4|||
128925536|NCT01491945|464012476|FG000|Overall Study|Missed Visit|1|||
128925537|NCT05681715|464012477|FG000|Training Period (6-weeks)|Adverse Event|3|||
128925538|NCT05681715|464012478|FG001|Training Period (6-weeks)|Adverse Event|0|||
128925539|NCT05681715|464012479|FG002|Training Period (6-weeks)|Adverse Event|0|||
128925540|NCT05681715|464012477|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
128925541|NCT05681715|464012478|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
128925542|NCT05681715|464012479|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
128925543|NCT05681715|464012477|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
128925544|NCT05681715|464012478|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
128925545|NCT05681715|464012479|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
128925546|NCT05681715|464012477|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
128925547|NCT05681715|464012478|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
128925548|NCT05681715|464012479|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
128925549|NCT05681715|464012477|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
128925550|NCT05681715|464012478|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
128925551|NCT05681715|464012479|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
128925552|NCT05681715|464012477|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
128925553|NCT05681715|464012478|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
128925554|NCT05681715|464012479|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
128925555|NCT05681715|464012477|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
128925556|NCT05681715|464012478|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
128925557|NCT05681715|464012479|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
128925558|NCT05681715|464012477|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
128925559|NCT05681715|464012478|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
128925560|NCT05681715|464012479|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
128925561|NCT03770403|464012480|FG000|Overall Study|Adverse Event|8|||
128925562|NCT03770403|464012480|FG000|Overall Study|Death|5|||
128925563|NCT03770403|464012480|FG000|Overall Study|Physician Decision|1|||
128925564|NCT03770403|464012480|FG000|Overall Study|Sponsor decision|1|||
128925565|NCT03770403|464012480|FG000|Overall Study|Study terminated by Sponsor|1|||
128925566|NCT03770403|464012480|FG000|Overall Study|Withdrawal by Subject|13|||
128925567|NCT03770403|464012480|FG000|Overall Study|Other|88|||
128925568|NCT02115308|464012495|FG000|Overall Study|Safety Screening|2|||
128925569|NCT02115308|464012496|FG001|Overall Study|Safety Screening|2|||
128925570|NCT04325503|464012497|FG000|Overall Study|Withdrawal by Subject|1|||
128925571|NCT04325503|464012497|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
128925572|NCT01856114|464012498|FG000|Overall Study|Withdrawal by Subject|1|||
128925573|NCT01856114|464012499|FG001|Overall Study|Withdrawal by Subject|0|||
128925574|NCT01856114|464012498|FG000|Overall Study|Adverse Event|1|||
128925575|NCT01856114|464012499|FG001|Overall Study|Adverse Event|0|||
128925576|NCT00981526|464012500|FG000|Overall Study|Withdrawal by Subject|0|||
128925577|NCT00981526|464012501|FG001|Overall Study|Withdrawal by Subject|2|||
128925578|NCT00981526|464012500|FG000|Overall Study|Physician Decision|4|||
129119076|NCT00171249|464733202|FG002|Overall Study|Administrative Problems|0|||
129119077|NCT00171249|464733203|FG003|Overall Study|Administrative Problems|2|||
129119078|NCT00171249|464733204|FG004|Overall Study|Administrative Problems|0|||
129119079|NCT00171249|464733205|FG005|Overall Study|Administrative Problems|0|||
129119080|NCT00171249|464733206|FG006|Overall Study|Administrative Problems|0|||
129119081|NCT00171249|464733200|FG000|Overall Study|Adverse Event|3|||
129119082|NCT00171249|464733201|FG001|Overall Study|Adverse Event|1|||
129119083|NCT00171249|464733202|FG002|Overall Study|Adverse Event|0|||
128925579|NCT00981526|464012501|FG001|Overall Study|Physician Decision|4|||
129119084|NCT00171249|464733203|FG003|Overall Study|Adverse Event|15|||
129119085|NCT00171249|464733204|FG004|Overall Study|Adverse Event|0|||
128701357|NCT03000439|463205581|FG002|Open Label Part 1|Other|0|||
128925580|NCT01564784|464012502|FG000|Overall Study|Other|1|||
128925581|NCT01564784|464012503|FG001|Overall Study|Other|0|||
128925582|NCT01564784|464012502|FG000|Overall Study|Subject refused further follow-up|1|||
129119086|NCT00171249|464733205|FG005|Overall Study|Adverse Event|2|||
128925583|NCT01564784|464012503|FG001|Overall Study|Subject refused further follow-up|6|||
128925584|NCT01564784|464012502|FG000|Overall Study|Lost to Follow-up|1|||
128925585|NCT01564784|464012503|FG001|Overall Study|Lost to Follow-up|1|||
128925586|NCT01564784|464012502|FG000|Overall Study|Death|131|||
128925587|NCT01564784|464012503|FG001|Overall Study|Death|126|||
128925588|NCT03871491|464012504|FG000|Overall Study|Withdrawal by Subject|14|||
128925589|NCT03871491|464012505|FG001|Overall Study|Withdrawal by Subject|14|||
128925590|NCT03871491|464012506|FG002|Overall Study|Withdrawal by Subject|14|||
128925591|NCT03871491|464012507|FG003|Overall Study|Withdrawal by Subject|14|||
128925592|NCT03871491|464012504|FG000|Overall Study|Physician Decision|0|||
129029564|NCT01109849|464399871|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
129029565|NCT01109849|464399872|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
129029566|NCT01109849|464399873|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
129029567|NCT03969641|464399874|FG000|Overall Study|Lost to Follow-up|5|||
128925593|NCT03871491|464012505|FG001|Overall Study|Physician Decision|0|||
128925594|NCT03871491|464012506|FG002|Overall Study|Physician Decision|1|||
128925595|NCT03871491|464012507|FG003|Overall Study|Physician Decision|1|||
128925596|NCT03871491|464012504|FG000|Overall Study|Lost to Follow-up|50|||
128925597|NCT03871491|464012505|FG001|Overall Study|Lost to Follow-up|15|||
128925598|NCT03871491|464012506|FG002|Overall Study|Lost to Follow-up|36|||
128925599|NCT03871491|464012507|FG003|Overall Study|Lost to Follow-up|11|||
128925600|NCT04439331|464012508|FG000|Overall Study|Never Start Protocol Therapy|2|||
128925601|NCT04439331|464012508|FG000|Overall Study|Ineligible|2|||
128925602|NCT04439331|464012508|FG000|Overall Study|Mutation Status Not Confirmed|1|||
128925603|NCT04439331|464012508|FG000|Overall Study|Adverse Event|1|||
128925604|NCT04439331|464012508|FG000|Overall Study|Death|1|||
128925605|NCT04439331|464012508|FG000|Overall Study|Disease Progression|20|||
128925606|NCT04439331|464012508|FG000|Overall Study|Withdrawal by Subject|6|||
128925607|NCT04439331|464012508|FG000|Overall Study|Physician Decision|1|||
128925608|NCT04439331|464012508|FG000|Overall Study|Other Complicating Disease|1|||
128925609|NCT02747004|464012510|FG000|Overall Study|Withdrawal by Subject|8|||
128925610|NCT02747004|464012511|FG001|Overall Study|Withdrawal by Subject|5|||
128925611|NCT02747004|464012512|FG002|Overall Study|Withdrawal by Subject|4|||
128925612|NCT02747004|464012510|FG000|Overall Study|Lost to Follow-up|1|||
128925613|NCT02747004|464012511|FG001|Overall Study|Lost to Follow-up|2|||
128925614|NCT02747004|464012512|FG002|Overall Study|Lost to Follow-up|2|||
128925615|NCT02747004|464012510|FG000|Overall Study|on study treatment/follow-up|48|||
128925616|NCT02747004|464012511|FG001|Overall Study|on study treatment/follow-up|42|||
128925617|NCT02747004|464012512|FG002|Overall Study|on study treatment/follow-up|41|||
128925618|NCT06218251|464012513|FG000|Overall Study|Lost to Follow-up|4|||
128925619|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
128925620|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
128925621|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
128925622|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
128925623|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
128925624|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
128925625|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
128925626|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
128925627|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
128925628|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
128925629|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
128925630|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129029568|NCT03969641|464399875|FG001|Overall Study|Lost to Follow-up|3|||
129029569|NCT03969641|464399874|FG000|Overall Study|Withdrawal by Subject|1|||
129029570|NCT03969641|464399875|FG001|Overall Study|Withdrawal by Subject|2|||
129029571|NCT03969641|464399874|FG000|Overall Study|Found to be ineligible|1|||
129029572|NCT03969641|464399875|FG001|Overall Study|Found to be ineligible|1|||
128925631|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
128925632|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129029573|NCT03969641|464399874|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
129029574|NCT03969641|464399875|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
129029575|NCT03969641|464399874|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
129029576|NCT03969641|464399875|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
129029577|NCT03969641|464399874|FG000|Overall Study|Elective termination|0|||
128925633|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
128925634|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
128925635|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
128925636|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
128925637|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
128925638|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
128925639|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Death|0|||
128925640|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Death|1|||
128925641|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Death|0|||
128925642|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Death|0|||
128925643|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Death|0|||
128925644|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
128925645|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
128925646|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
128701358|NCT03000439|463205582|FG003|Open Label Part 1|Other|0|||
128701359|NCT03000439|463205579|FG000|Open Label Part 1|Insufficient clinical response|16|||
128701360|NCT03000439|463205580|FG001|Open Label Part 1|Insufficient clinical response|0|||
128701361|NCT03000439|463205581|FG002|Open Label Part 1|Insufficient clinical response|0|||
128701362|NCT03000439|463205582|FG003|Open Label Part 1|Insufficient clinical response|0|||
128701363|NCT03000439|463205579|FG000|Open Label Part 2|Other|0|||
128925647|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
128925648|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
128925649|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
128925650|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
128925651|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
128925652|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
128925653|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
128925654|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
128925655|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
128925656|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
128925657|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
128925658|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
128925659|NCT05087030|464012514|FG000|Main Period (Week 0 to Week 52)|Other|1|||
128925660|NCT05087030|464012515|FG001|Main Period (Week 0 to Week 52)|Other|2|||
128925661|NCT05087030|464012516|FG002|Main Period (Week 0 to Week 52)|Other|0|||
128925662|NCT05087030|464012517|FG003|Main Period (Week 0 to Week 52)|Other|0|||
128925663|NCT05087030|464012518|FG004|Main Period (Week 0 to Week 52)|Other|0|||
128925664|NCT05087030|464012514|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
128925665|NCT05087030|464012515|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
128925666|NCT05087030|464012516|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
128925667|NCT05087030|464012517|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
128925668|NCT05087030|464012518|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
128925669|NCT01444300|464012519|FG000|Overall Study|Adverse Event|4|||
128925670|NCT01444300|464012520|FG001|Overall Study|Adverse Event|0|||
128925671|NCT01769105|464012525|FG000|First Intervention|Protocol Violation|2|||
128925672|NCT01769105|464012526|FG001|First Intervention|Protocol Violation|2|||
128925673|NCT01769105|464012525|FG000|Cross-over|Lost to Follow-up|5|||
128925674|NCT01769105|464012526|FG001|Cross-over|Lost to Follow-up|0|||
128925675|NCT02660580|464014669|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
128925676|NCT02660580|464014670|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
128925677|NCT02660580|464014671|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
128925678|NCT02660580|464014672|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
128925679|NCT02660580|464014673|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
128925680|NCT02660580|464014669|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
128925681|NCT02660580|464014670|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
128925682|NCT02660580|464014671|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
128925683|NCT02660580|464014672|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
128925684|NCT02660580|464014673|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
128925685|NCT02660580|464014669|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
128925686|NCT02660580|464014670|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
128925687|NCT02660580|464014671|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
128925688|NCT02660580|464014672|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
128925689|NCT02660580|464014673|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
128925690|NCT02660580|464014669|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
128925691|NCT02660580|464014670|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
128925692|NCT02660580|464014671|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
128925693|NCT02660580|464014672|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
128925694|NCT02660580|464014673|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
128925695|NCT02660580|464014669|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
129029578|NCT03969641|464399875|FG001|Overall Study|Elective termination|1|||
128701364|NCT03000439|463205580|FG001|Open Label Part 2|Other|5|||
128925696|NCT02660580|464014670|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
129029579|NCT01541215|464399876|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
128701365|NCT03000439|463205581|FG002|Open Label Part 2|Other|0|||
128925697|NCT02660580|464014671|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
129029580|NCT01541215|464399877|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
128701366|NCT03000439|463205582|FG003|Open Label Part 2|Other|0|||
128925698|NCT02660580|464014672|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
128925699|NCT02660580|464014673|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
128925700|NCT02660580|464014669|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
128925701|NCT02660580|464014670|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
128925702|NCT02660580|464014671|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
128925703|NCT02660580|464014672|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
128925704|NCT02660580|464014673|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
128925705|NCT02660580|464014669|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
128925706|NCT02660580|464014670|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
128925707|NCT02660580|464014671|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
128925708|NCT02660580|464014672|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
128925709|NCT02660580|464014673|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
128925710|NCT02660580|464014669|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
128925711|NCT02660580|464014670|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
128925712|NCT02660580|464014671|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
128925713|NCT02660580|464014672|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
128925714|NCT02660580|464014673|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
128925715|NCT02660580|464014669|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
128925716|NCT02660580|464014670|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
128925717|NCT02660580|464014671|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
128925718|NCT02660580|464014672|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
128925719|NCT02660580|464014673|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
128925720|NCT02660580|464014669|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
128925721|NCT02660580|464014670|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
128925722|NCT02660580|464014671|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
128925723|NCT02660580|464014672|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
129029581|NCT01541215|464399876|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
128925724|NCT02660580|464014673|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
128925725|NCT02660580|464014669|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
128925726|NCT02660580|464014670|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
128925727|NCT02660580|464014671|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
128925728|NCT02660580|464014672|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
128925729|NCT02660580|464014673|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
128925730|NCT02660580|464014669|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
128925731|NCT02660580|464014670|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
128925732|NCT02660580|464014671|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
128701367|NCT03000439|463205579|FG000|Open Label Part 2|Insufficient clinical response|0|||
128701368|NCT03000439|463205580|FG001|Open Label Part 2|Insufficient clinical response|12|||
128701369|NCT03000439|463205581|FG002|Open Label Part 2|Insufficient clinical response|0|||
128701370|NCT03000439|463205582|FG003|Open Label Part 2|Insufficient clinical response|0|||
128701371|NCT03000439|463205579|FG000|Double Blind Phase|Adverse Event|0|||
128701372|NCT03000439|463205580|FG001|Double Blind Phase|Adverse Event|0|||
128701373|NCT03000439|463205581|FG002|Double Blind Phase|Adverse Event|2|||
128701374|NCT03000439|463205582|FG003|Double Blind Phase|Adverse Event|1|||
128701375|NCT03000439|463205579|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
128701376|NCT03000439|463205580|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
128701377|NCT03000439|463205581|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
128701378|NCT03000439|463205582|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
128701379|NCT03000439|463205579|FG000|Double Blind Phase|Other|0|||
128701380|NCT03000439|463205580|FG001|Double Blind Phase|Other|0|||
128701381|NCT03000439|463205581|FG002|Double Blind Phase|Other|10|||
128701382|NCT03000439|463205582|FG003|Double Blind Phase|Other|11|||
128925733|NCT02660580|464014672|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
128925734|NCT02660580|464014673|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
129029582|NCT01541215|464399877|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
128925735|NCT02660580|464014669|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
128925736|NCT02660580|464014670|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
129029583|NCT01541215|464399876|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
128701383|NCT03000439|463205579|FG000|Double Blind Phase|Insufficient clinical response|0|||
128701384|NCT03000439|463205580|FG001|Double Blind Phase|Insufficient clinical response|0|||
128701385|NCT03000439|463205581|FG002|Double Blind Phase|Insufficient clinical response|0|||
128701386|NCT03000439|463205582|FG003|Double Blind Phase|Insufficient clinical response|2|||
128701387|NCT00592384|463205583|FG000|Overall Study|Withdrawal by Subject|5|||
128701388|NCT00592384|463205584|FG001|Overall Study|Withdrawal by Subject|6|||
128701389|NCT02151591|463205586|FG000|Overall Study|Lost to Follow-up|6|||
129119087|NCT00171249|464733206|FG006|Overall Study|Adverse Event|0|||
128701390|NCT02151591|463205587|FG001|Overall Study|Lost to Follow-up|3|||
128701391|NCT00684593|463205593|FG000|Overall Study|Adverse Event|0|||
128701392|NCT00684593|463205594|FG001|Overall Study|Adverse Event|2|||
128701393|NCT00964860|463205596|FG000|Overall Study|Withdrawal by Subject|0|||
128701394|NCT00964860|463205597|FG001|Overall Study|Withdrawal by Subject|1|||
128701395|NCT03716024|463205598|FG000|Overall Study|Randomized, not Treated|7|||
128701396|NCT03716024|463205599|FG001|Overall Study|Randomized, not Treated|8|||
128925737|NCT02660580|464014671|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
128925738|NCT02660580|464014672|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
128701397|NCT03716024|463205598|FG000|Overall Study|Adverse Event|1|||
128701398|NCT03716024|463205599|FG001|Overall Study|Adverse Event|2|||
128701399|NCT03716024|463205598|FG000|Overall Study|Treatment Failure|1|||
128701400|NCT03716024|463205599|FG001|Overall Study|Treatment Failure|0|||
128701401|NCT03716024|463205598|FG000|Overall Study|Lost to Follow-up|2|||
128701402|NCT03716024|463205599|FG001|Overall Study|Lost to Follow-up|6|||
128701403|NCT03716024|463205598|FG000|Overall Study|Withdrawal by Subject|0|||
128701404|NCT03716024|463205599|FG001|Overall Study|Withdrawal by Subject|1|||
128701405|NCT03716024|463205598|FG000|Overall Study|Missing Reason|0|||
128701406|NCT03716024|463205599|FG001|Overall Study|Missing Reason|1|||
128925739|NCT02660580|464014673|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
128925740|NCT00377962|464014674|FG000|Core Study: 0-12 Months|Adverse Event|18|||
128925741|NCT00377962|464014675|FG001|Core Study: 0-12 Months|Adverse Event|2|||
128925742|NCT00377962|464014674|FG000|Core Study: 0-12 Months|Death|3|||
128925743|NCT00377962|464014675|FG001|Core Study: 0-12 Months|Death|0|||
128925744|NCT00377962|464014674|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
128925745|NCT00377962|464014675|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
128925746|NCT00377962|464014674|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
128925747|NCT00377962|464014675|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
128925748|NCT00377962|464014674|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
128925749|NCT00377962|464014675|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
128925750|NCT00377962|464014674|FG000|Extension Study: 12-24 Months|Death|1|||
128925751|NCT00377962|464014675|FG001|Extension Study: 12-24 Months|Death|1|||
128925752|NCT00377962|464014674|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
128925753|NCT00377962|464014675|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
128925754|NCT00377962|464014674|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
128925755|NCT00377962|464014675|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
128925756|NCT00377962|464014674|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
128925757|NCT00377962|464014675|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
128925758|NCT03095703|464014681|FG000|Overall Study|Withdrawal by Subject|1|||
128925759|NCT02665689|464014682|FG000|Overall Study|Adverse Event|1|||
128925760|NCT02665689|464014683|FG001|Overall Study|Adverse Event|0|||
128925761|NCT02665689|464014682|FG000|Overall Study|Trial termination|1|||
128925762|NCT02665689|464014683|FG001|Overall Study|Trial termination|1|||
128925763|NCT02665689|464014682|FG000|Overall Study|Lost to Follow-up|0|||
128767009|NCT02341456|463438085|FG001|Overall Study|Moved to local access programme.|1|||
128767010|NCT02341456|463438086|FG002|Overall Study|Moved to local access programme.|1|||
128767011|NCT02341456|463438084|FG000|Overall Study|Physician Decision|1|||
128925764|NCT02665689|464014683|FG001|Overall Study|Lost to Follow-up|1|||
128925765|NCT00486902|464014684|FG000|Overall Study|Withdrawal by Subject|1|||
128925766|NCT00486902|464014685|FG001|Overall Study|Withdrawal by Subject|2|||
128701407|NCT00867568|463205600|FG000|Overall Study|Lack of Efficacy|10|||
128701408|NCT00867568|463205600|FG000|Overall Study|Adverse Event|4|||
128701409|NCT00867568|463205600|FG000|Overall Study|Withdrawal by Subject|1|||
128701410|NCT04343261|463205601|FG000|Overall Study|Adverse Event|1|||
128767012|NCT02341456|463438085|FG001|Overall Study|Physician Decision|0|||
128767013|NCT02341456|463438086|FG002|Overall Study|Physician Decision|0|||
128925767|NCT00486902|464014684|FG000|Overall Study|decision for postpartum tubal ligation|3|||
128925768|NCT00486902|464014685|FG001|Overall Study|decision for postpartum tubal ligation|1|||
128925769|NCT00486902|464014684|FG000|Overall Study|spinal anesthetic protocal violation|1|||
128925770|NCT00486902|464014685|FG001|Overall Study|spinal anesthetic protocal violation|1|||
128925771|NCT00486902|464014684|FG000|Overall Study|Did not meet inclusion criteria|1|||
128925772|NCT00486902|464014685|FG001|Overall Study|Did not meet inclusion criteria|0|||
128925773|NCT00486902|464014684|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
128925774|NCT00486902|464014685|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
128925775|NCT00541307|464014688|FG000|Overall Study|Death|5|||
128925776|NCT00541307|464014688|FG000|Overall Study|Physician Decision|3|||
128925777|NCT00541307|464014688|FG000|Overall Study|Withdrawal by Subject|6|||
128925778|NCT00541307|464014688|FG000|Overall Study|Lost to Follow-up|4|||
128925779|NCT00541307|464014688|FG000|Overall Study|Subject returned early (outside window)|1|||
128701411|NCT04343261|463205601|FG000|Overall Study|received inadequate amount of antibodies|7|||
128701412|NCT05275400|463205609|FG000|Treatment Period|Adverse Event|7|||
128701413|NCT05275400|463205610|FG001|Treatment Period|Adverse Event|1|||
128701414|NCT05275400|463205609|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
128925780|NCT00541307|464014688|FG000|Overall Study|Surgical Bypass|5|||
128925781|NCT03615222|464014689|FG000|Overall Study|Ineligible|26|||
128925782|NCT03615222|464014689|FG000|Overall Study|Withdrawal by Subject|7|||
128925783|NCT03615222|464014689|FG000|Overall Study|Death|1|||
128925784|NCT00733902|464014690|FG000|Overall Study|Death|0|||
128701415|NCT05275400|463205610|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
128925785|NCT00733902|464014691|FG001|Overall Study|Death|0|||
128925786|NCT00733902|464014692|FG002|Overall Study|Death|0|||
128925787|NCT00733902|464014693|FG003|Overall Study|Death|1|||
128925788|NCT00733902|464014690|FG000|Overall Study|Adverse Event|3|||
128925789|NCT00733902|464014691|FG001|Overall Study|Adverse Event|4|||
128925790|NCT00733902|464014692|FG002|Overall Study|Adverse Event|7|||
128925791|NCT00733902|464014693|FG003|Overall Study|Adverse Event|11|||
128925792|NCT00733902|464014690|FG000|Overall Study|Lack of Efficacy|56|||
128925793|NCT00733902|464014691|FG001|Overall Study|Lack of Efficacy|21|||
128925794|NCT00733902|464014692|FG002|Overall Study|Lack of Efficacy|34|||
128925795|NCT00733902|464014693|FG003|Overall Study|Lack of Efficacy|23|||
128925796|NCT00733902|464014690|FG000|Overall Study|Protocol Violation|4|||
128925797|NCT00733902|464014691|FG001|Overall Study|Protocol Violation|6|||
128925798|NCT00733902|464014692|FG002|Overall Study|Protocol Violation|3|||
128925799|NCT00733902|464014693|FG003|Overall Study|Protocol Violation|3|||
128925800|NCT00733902|464014690|FG000|Overall Study|Withdrawal by Subject|10|||
128925801|NCT00733902|464014691|FG001|Overall Study|Withdrawal by Subject|5|||
128925802|NCT00733902|464014692|FG002|Overall Study|Withdrawal by Subject|4|||
128925803|NCT00733902|464014693|FG003|Overall Study|Withdrawal by Subject|16|||
128925804|NCT00733902|464014690|FG000|Overall Study|Entered extension study|89|||
128925805|NCT00733902|464014691|FG001|Overall Study|Entered extension study|124|||
128925806|NCT00733902|464014692|FG002|Overall Study|Entered extension study|111|||
128925807|NCT00733902|464014693|FG003|Overall Study|Entered extension study|109|||
128925808|NCT00733902|464014690|FG000|Overall Study|Randomized but not treated|2|||
128701416|NCT05275400|463205609|FG000|Treatment Period|Death|5|||
128701417|NCT05275400|463205610|FG001|Treatment Period|Death|2|||
128701418|NCT05275400|463205609|FG000|Treatment Period|Protocol Violation|1|||
128701419|NCT05275400|463205610|FG001|Treatment Period|Protocol Violation|0|||
128925809|NCT00733902|464014691|FG001|Overall Study|Randomized but not treated|2|||
128925810|NCT00733902|464014692|FG002|Overall Study|Randomized but not treated|2|||
128925811|NCT00733902|464014693|FG003|Overall Study|Randomized but not treated|1|||
128925812|NCT00775021|464014694|FG000|First Intervention|Lost to Follow-up|1|||
128925813|NCT00775021|464014695|FG001|First Intervention|Lost to Follow-up|0|||
128925814|NCT00775021|464014694|FG000|Second Intervention|Adverse Event|0|||
128925815|NCT00775021|464014695|FG001|Second Intervention|Adverse Event|1|||
128925816|NCT00870688|464014696|FG000|Overall Study|Lost to Follow-up|2|||
128925817|NCT00870688|464014696|FG000|Overall Study|Death, Unrelated|1|||
128925818|NCT00870688|464014696|FG000|Overall Study|Granules in the Stools|1|||
128925819|NCT03872180|464014705|FG000|Overall Study|Adverse Event|4|||
128925820|NCT03872180|464014705|FG000|Overall Study|Lack of Efficacy|2|||
128925821|NCT01506141|464014706|FG000|Overall Study|Adverse Event|0|||
128925822|NCT01506141|464014707|FG001|Overall Study|Adverse Event|2|||
128925823|NCT01506141|464014706|FG000|Overall Study|Participation Terminated by Investigator|1|||
128925824|NCT01506141|464014707|FG001|Overall Study|Participation Terminated by Investigator|1|||
128925825|NCT01506141|464014706|FG000|Overall Study|Site Terminated by Sponsor|2|||
128925826|NCT01506141|464014707|FG001|Overall Study|Site Terminated by Sponsor|0|||
128925827|NCT01506141|464014706|FG000|Overall Study|Reason Not Specified|4|||
128925828|NCT01506141|464014707|FG001|Overall Study|Reason Not Specified|2|||
128925829|NCT04607408|464014708|FG000|Overall Study|Lost to Follow-up|0|||
128925830|NCT04607408|464014709|FG001|Overall Study|Lost to Follow-up|0|||
128925831|NCT04607408|464014710|FG002|Overall Study|Lost to Follow-up|0|||
128925832|NCT04607408|464014711|FG003|Overall Study|Lost to Follow-up|1|||
128925833|NCT04607408|464014712|FG004|Overall Study|Lost to Follow-up|0|||
128925834|NCT04607408|464014708|FG000|Overall Study|Withdrawal by Subject|0|||
128925835|NCT04607408|464014709|FG001|Overall Study|Withdrawal by Subject|1|||
128925836|NCT04607408|464014710|FG002|Overall Study|Withdrawal by Subject|0|||
128925837|NCT04607408|464014711|FG003|Overall Study|Withdrawal by Subject|1|||
128925838|NCT04607408|464014712|FG004|Overall Study|Withdrawal by Subject|0|||
128925839|NCT02599402|464014717|FG000|Overall Study|Disease progression|153|||
128925840|NCT02599402|464014717|FG000|Overall Study|Study drug toxicity|201|||
128925841|NCT02599402|464014717|FG000|Overall Study|Death|26|||
128925842|NCT02599402|464014717|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
128925843|NCT02599402|464014717|FG000|Overall Study|Participant request to discontinue study treatment|13|||
128925844|NCT02599402|464014717|FG000|Overall Study|Participant withdrew consent|5|||
128925845|NCT02599402|464014717|FG000|Overall Study|Lost to Follow-up|1|||
128701420|NCT05275400|463205609|FG000|Treatment Period|Physician Decision|5|||
128925846|NCT02599402|464014717|FG000|Overall Study|Maximum Clinical Benefit|7|||
128925847|NCT02599402|464014717|FG000|Overall Study|Poor/non-compliance|1|||
128701421|NCT05275400|463205610|FG001|Treatment Period|Physician Decision|4|||
128925848|NCT02599402|464014717|FG000|Overall Study|Pregnancy|1|||
128925849|NCT02599402|464014717|FG000|Overall Study|Participant no longer met study criteria|7|||
128925850|NCT02599402|464014717|FG000|Overall Study|Other Reasons|95|||
128925851|NCT04919564|464014720|FG000|Overall Study|Lost to Follow-up|1|||
128925852|NCT04919564|464014721|FG001|Overall Study|Lost to Follow-up|0|||
128925853|NCT04919564|464014720|FG000|Overall Study|Physician Decision|1|||
128925854|NCT04919564|464014721|FG001|Overall Study|Physician Decision|1|||
128925855|NCT01241786|464014722|FG000|Overall Study|Lack of Efficacy|5|||
128925856|NCT01440101|464014724|FG000|Overall Study|Adverse Event|2|||
128925857|NCT01440101|464014725|FG001|Overall Study|Adverse Event|0|||
128925858|NCT01440101|464014726|FG002|Overall Study|Adverse Event|0|||
128925859|NCT01440101|464014724|FG000|Overall Study|Withdrawal by Subject|0|||
128925860|NCT01440101|464014725|FG001|Overall Study|Withdrawal by Subject|3|||
128925861|NCT01440101|464014726|FG002|Overall Study|Withdrawal by Subject|1|||
128925862|NCT01440101|464014724|FG000|Overall Study|Other|0|||
128925863|NCT01440101|464014725|FG001|Overall Study|Other|1|||
128925864|NCT01440101|464014726|FG002|Overall Study|Other|0|||
128925865|NCT00636818|464014730|FG000|Overall Study|Adverse Event|1|||
128925866|NCT00636818|464014730|FG000|Overall Study|Lost to Follow-up|2|||
128925867|NCT00636818|464014730|FG000|Overall Study|Entry Criteria Exclusion|3|||
128925868|NCT00636818|464014730|FG000|Overall Study|Protocol Violation|1|||
128925869|NCT00636818|464014730|FG000|Overall Study|Withdrawal by Subject|4|||
128925870|NCT00074958|464014731|FG000|Overall Study|Adverse Event|1|||
128925871|NCT01658514|464014746|FG000|Overall Study|Protocol Violation|1|||
128925872|NCT01658514|464014747|FG001|Overall Study|Protocol Violation|0|||
128925873|NCT01658514|464014748|FG002|Overall Study|Protocol Violation|2|||
128925874|NCT02344576|464014752|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
128925875|NCT02344576|464014753|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
128925876|NCT02344576|464014754|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
128925877|NCT02344576|464014755|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
128925878|NCT02344576|464014752|FG000|1-Month Follow-Up|Death|13|||
128925879|NCT02344576|464014753|FG001|1-Month Follow-Up|Death|8|||
128925880|NCT02344576|464014754|FG002|1-Month Follow-Up|Death|0|||
128925881|NCT02344576|464014755|FG003|1-Month Follow-Up|Death|0|||
128925882|NCT02344576|464014752|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
128925883|NCT02344576|464014753|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
128925884|NCT02344576|464014754|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
128925885|NCT02344576|464014755|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
128925886|NCT02344576|464014752|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
128925887|NCT02344576|464014753|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
128925888|NCT02344576|464014754|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
128925889|NCT02344576|464014755|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
128925890|NCT02344576|464014752|FG000|6-Month Follow-Up|Death|14|||
128925891|NCT02344576|464014753|FG001|6-Month Follow-Up|Death|14|||
128925892|NCT02344576|464014754|FG002|6-Month Follow-Up|Death|0|||
128925893|NCT02344576|464014755|FG003|6-Month Follow-Up|Death|0|||
128925894|NCT02344576|464014752|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
128925895|NCT02344576|464014753|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
128925896|NCT02344576|464014754|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
128925897|NCT02344576|464014755|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
128925898|NCT02344576|464014752|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
128925899|NCT02344576|464014753|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
128925900|NCT02344576|464014754|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
128925901|NCT02344576|464014755|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
128925902|NCT03832387|464014770|FG000|Overall Study|Protocol Violation|2|||
128925903|NCT03832387|464014771|FG001|Overall Study|Protocol Violation|6|||
128925904|NCT03832387|464014770|FG000|Overall Study|EXCLUSION CRITERIA|3|||
128925905|NCT03832387|464014771|FG001|Overall Study|EXCLUSION CRITERIA|1|||
128925906|NCT00144170|464014772|FG000|Overall Study|Adverse Event|84|||
128925907|NCT00144170|464014773|FG001|Overall Study|Adverse Event|41|||
128925908|NCT00144170|464014772|FG000|Overall Study|Protocol Violation|23|||
128925909|NCT00144170|464014773|FG001|Overall Study|Protocol Violation|16|||
128925910|NCT00144170|464014772|FG000|Overall Study|Lost to Follow-up|5|||
128925911|NCT00144170|464014773|FG001|Overall Study|Lost to Follow-up|10|||
128925912|NCT00144170|464014772|FG000|Overall Study|Withdrawal by Subject|29|||
128925913|NCT00144170|464014773|FG001|Overall Study|Withdrawal by Subject|13|||
128925914|NCT00144170|464014772|FG000|Overall Study|Other reason not defined above|211|||
128925915|NCT00144170|464014773|FG001|Overall Study|Other reason not defined above|316|||
128925916|NCT02370121|464014774|FG000|Overall Study|Lost to Follow-up|1|||
128925917|NCT02370121|464014775|FG001|Overall Study|Lost to Follow-up|1|||
128925918|NCT04429022|464014776|FG000|Overall Study|Protocol Violation|18|||
128925919|NCT04429022|464014777|FG001|Overall Study|Protocol Violation|1|||
128925920|NCT00963807|464014778|FG000|Overall Study|Physician Decision|2|||
128925921|NCT00963807|464014778|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
128925922|NCT00963807|464014778|FG000|Overall Study|Disease progression|15|||
128767014|NCT01111838|463438089|FG000|Overall Study|Patient Ineligible|2|||
128925923|NCT00045032|464014787|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
128925924|NCT00045032|464014788|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
128767015|NCT01111838|463438089|FG000|Overall Study|Not Treated|3|||
128925925|NCT00045032|464014789|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
128925926|NCT00045032|464014787|FG000|Overall Study|Death|22|||
128767016|NCT01111838|463438089|FG000|Overall Study|Clinical deterioration|1|||
128925927|NCT00045032|464014788|FG001|Overall Study|Death|24|||
128767017|NCT01111838|463438089|FG000|Overall Study|Other Complicating Disease|1|||
128767018|NCT00641719|463438090|FG000|Overall Study|Lack of Efficacy|1|||
128925928|NCT00045032|464014789|FG002|Overall Study|Death|17|||
128767019|NCT00641719|463438091|FG001|Overall Study|Lack of Efficacy|2|||
128925929|NCT00045032|464014787|FG000|Overall Study|Insufficient Therapeutic Response|542|||
128925930|NCT00045032|464014788|FG001|Overall Study|Insufficient Therapeutic Response|437|||
128925931|NCT00045032|464014789|FG002|Overall Study|Insufficient Therapeutic Response|445|||
128925932|NCT00045032|464014787|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
128925933|NCT00045032|464014788|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
128925934|NCT00045032|464014789|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
128925935|NCT00045032|464014787|FG000|Overall Study|Other Protocol Violation|2|||
128925936|NCT00045032|464014788|FG001|Overall Study|Other Protocol Violation|0|||
128925937|NCT00045032|464014789|FG002|Overall Study|Other Protocol Violation|1|||
128925938|NCT00045032|464014787|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
128925939|NCT00045032|464014788|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
128925940|NCT00045032|464014789|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
128925941|NCT00045032|464014787|FG000|Overall Study|Failure to Return|57|||
128925942|NCT00045032|464014788|FG001|Overall Study|Failure to Return|62|||
128925943|NCT00045032|464014789|FG002|Overall Study|Failure to Return|61|||
128925944|NCT00045032|464014787|FG000|Overall Study|Other|93|||
128925945|NCT00045032|464014788|FG001|Overall Study|Other|84|||
128925946|NCT00045032|464014789|FG002|Overall Study|Other|105|||
128925947|NCT02582658|464014790|FG000|Overall Study|Failure to Return|10|||
128925948|NCT02582658|464014790|FG000|Overall Study|Insufficient Virological Response|2|||
128925949|NCT02582658|464014790|FG000|Overall Study|Withdrawn Consent|1|||
128925950|NCT02582658|464014790|FG000|Overall Study|Death|1|||
128925951|NCT02582658|464014790|FG000|Overall Study|Not further specified|11|||
128925952|NCT02581995|464014798|FG000|Overall Study|Unspecified other|3|||
128925953|NCT02581995|464014798|FG000|Overall Study|Adverse Event|6|||
128925954|NCT02581995|464014798|FG000|Overall Study|Lost to Follow-up|5|||
128925955|NCT02581995|464014798|FG000|Overall Study|Withdrawal by participant|12|||
128925956|NCT02581995|464014798|FG000|Overall Study|Physician Decision|1|||
128925957|NCT02581995|464014798|FG000|Overall Study|Death|4|||
128925958|NCT01024244|464016954|FG000|Overall Study|Adverse Event|1|||
128925959|NCT01024244|464016955|FG001|Overall Study|Adverse Event|2|||
128925960|NCT01024244|464016956|FG002|Overall Study|Adverse Event|0|||
128925961|NCT01024244|464016957|FG003|Overall Study|Adverse Event|1|||
128925962|NCT01024244|464016958|FG004|Overall Study|Adverse Event|2|||
128925963|NCT01024244|464016954|FG000|Overall Study|Entry Criteria Not Met|0|||
128925964|NCT01024244|464016955|FG001|Overall Study|Entry Criteria Not Met|1|||
128925965|NCT01024244|464016956|FG002|Overall Study|Entry Criteria Not Met|0|||
128925966|NCT01024244|464016957|FG003|Overall Study|Entry Criteria Not Met|0|||
128925967|NCT01024244|464016958|FG004|Overall Study|Entry Criteria Not Met|0|||
128925968|NCT01024244|464016954|FG000|Overall Study|Lack of Efficacy|1|||
128925969|NCT01024244|464016955|FG001|Overall Study|Lack of Efficacy|0|||
128925970|NCT01024244|464016956|FG002|Overall Study|Lack of Efficacy|0|||
128925971|NCT01024244|464016957|FG003|Overall Study|Lack of Efficacy|0|||
128925972|NCT01024244|464016958|FG004|Overall Study|Lack of Efficacy|0|||
128925973|NCT01024244|464016954|FG000|Overall Study|Protocol Violation|1|||
128925974|NCT01024244|464016955|FG001|Overall Study|Protocol Violation|0|||
128925975|NCT01024244|464016956|FG002|Overall Study|Protocol Violation|0|||
128925976|NCT01024244|464016957|FG003|Overall Study|Protocol Violation|0|||
128925977|NCT01024244|464016958|FG004|Overall Study|Protocol Violation|2|||
128925978|NCT01024244|464016954|FG000|Overall Study|Sponsor Decision|14|||
128925979|NCT01024244|464016955|FG001|Overall Study|Sponsor Decision|7|||
128925980|NCT01024244|464016956|FG002|Overall Study|Sponsor Decision|14|||
128925981|NCT01024244|464016957|FG003|Overall Study|Sponsor Decision|12|||
128925982|NCT01024244|464016958|FG004|Overall Study|Sponsor Decision|10|||
128925983|NCT01024244|464016954|FG000|Overall Study|Withdrawal by Subject|0|||
128925984|NCT01024244|464016955|FG001|Overall Study|Withdrawal by Subject|1|||
128925985|NCT01024244|464016956|FG002|Overall Study|Withdrawal by Subject|0|||
128925986|NCT01024244|464016957|FG003|Overall Study|Withdrawal by Subject|0|||
128925987|NCT01024244|464016958|FG004|Overall Study|Withdrawal by Subject|0|||
128925988|NCT01381094|464016959|FG000|Overall Study|Adverse Event|1|||
128925989|NCT01381094|464016960|FG001|Overall Study|Adverse Event|2|||
128925990|NCT01381094|464016961|FG002|Overall Study|Adverse Event|0|||
128925991|NCT01381094|464016962|FG003|Overall Study|Adverse Event|1|||
128925992|NCT01381094|464016963|FG004|Overall Study|Adverse Event|0|||
128925993|NCT01381094|464016959|FG000|Overall Study|Lost to Follow-up|0|||
128925994|NCT01381094|464016960|FG001|Overall Study|Lost to Follow-up|0|||
128925995|NCT01381094|464016961|FG002|Overall Study|Lost to Follow-up|0|||
129216366|NCT00538902|465092906|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
129216367|NCT00538902|465092907|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
128925996|NCT01381094|464016962|FG003|Overall Study|Lost to Follow-up|0|||
128925997|NCT01381094|464016963|FG004|Overall Study|Lost to Follow-up|1|||
128925998|NCT01381094|464016959|FG000|Overall Study|Withdrawal of informed consent|0|||
128767020|NCT00641719|463438090|FG000|Overall Study|Adverse Event|24|||
128925999|NCT01381094|464016960|FG001|Overall Study|Withdrawal of informed consent|1|||
128926000|NCT01381094|464016961|FG002|Overall Study|Withdrawal of informed consent|0|||
128926001|NCT01381094|464016962|FG003|Overall Study|Withdrawal of informed consent|0|||
128926002|NCT01381094|464016963|FG004|Overall Study|Withdrawal of informed consent|0|||
128926003|NCT01381094|464016959|FG000|Overall Study|Participant given Aranesp injection|1|||
128926004|NCT01381094|464016960|FG001|Overall Study|Participant given Aranesp injection|0|||
128926005|NCT01381094|464016961|FG002|Overall Study|Participant given Aranesp injection|0|||
128926006|NCT01381094|464016962|FG003|Overall Study|Participant given Aranesp injection|0|||
128926007|NCT01381094|464016963|FG004|Overall Study|Participant given Aranesp injection|0|||
128926008|NCT01934504|464016966|FG000|Overall Study|Protocol Deviation|0|||
128926009|NCT01934504|464016967|FG001|Overall Study|Protocol Deviation|0|||
128926010|NCT01934504|464016968|FG002|Overall Study|Protocol Deviation|0|||
128926011|NCT01934504|464016969|FG003|Overall Study|Protocol Deviation|2|||
128926012|NCT01934504|464016966|FG000|Overall Study|Study Terminated by Sponsor|1|||
128926013|NCT01934504|464016967|FG001|Overall Study|Study Terminated by Sponsor|0|||
128926014|NCT01934504|464016968|FG002|Overall Study|Study Terminated by Sponsor|5|||
128926015|NCT01934504|464016969|FG003|Overall Study|Study Terminated by Sponsor|5|||
128926016|NCT03895203|464016970|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
128926017|NCT03895203|464016971|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
128926018|NCT03895203|464016972|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
128926019|NCT03895203|464016973|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
128926020|NCT03895203|464016974|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
128926021|NCT03895203|464016975|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
128926022|NCT03895203|464016970|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
128926023|NCT03895203|464016971|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
128926024|NCT03895203|464016972|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
128926025|NCT03895203|464016973|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
128926026|NCT03895203|464016974|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
128926027|NCT03895203|464016975|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
128926028|NCT03895203|464016970|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
128926029|NCT03895203|464016971|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
128926030|NCT03895203|464016972|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
128926031|NCT03895203|464016973|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
128926032|NCT03895203|464016974|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
128926033|NCT03895203|464016975|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
128926034|NCT03895203|464016970|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
128926035|NCT03895203|464016971|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
128926036|NCT03895203|464016972|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
128926037|NCT03895203|464016973|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
128926038|NCT03895203|464016974|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
128926039|NCT03895203|464016975|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
128926040|NCT03895203|464016970|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
128926041|NCT03895203|464016971|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
128926042|NCT03895203|464016972|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
128926043|NCT03895203|464016973|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
128926044|NCT03895203|464016974|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
128926045|NCT03895203|464016975|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
128926046|NCT03895203|464016970|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
128926047|NCT03895203|464016971|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
128926048|NCT03895203|464016972|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
128926049|NCT03895203|464016973|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
128701422|NCT05275400|463205609|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
128701423|NCT05275400|463205610|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
128926050|NCT03895203|464016974|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
128926051|NCT03895203|464016975|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
128926052|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
128926053|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
128926054|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
128926055|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
128926056|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
128926057|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
128926058|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
128701424|NCT05275400|463205609|FG000|Treatment Period|Withdrawal by Subject|30|||
128926059|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
128926060|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
128926061|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
128926062|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
128926063|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
128926064|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
128701425|NCT05275400|463205610|FG001|Treatment Period|Withdrawal by Subject|12|||
128701426|NCT05275400|463205609|FG000|Treatment Period|Lost to Follow-up|1|||
128701427|NCT05275400|463205610|FG001|Treatment Period|Lost to Follow-up|5|||
128701428|NCT05275400|463205609|FG000|Treatment Period|Lack of Efficacy|1|||
128701429|NCT05275400|463205610|FG001|Treatment Period|Lack of Efficacy|0|||
128701430|NCT05275400|463205609|FG000|Treatment Period|Sponsor Decision|1|||
129029584|NCT01541215|464399877|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
129029585|NCT01541215|464399876|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
129029586|NCT01541215|464399877|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
129029587|NCT01541215|464399876|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
129029588|NCT01541215|464399877|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
129029589|NCT01541215|464399876|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
129029590|NCT01541215|464399877|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
129029591|NCT00754052|464399889|FG000|Overall Study|Study terminated by Sponsor|5|||
129029592|NCT00754052|464399890|FG001|Overall Study|Study terminated by Sponsor|3|||
129029593|NCT02658019|464399892|FG000|Overall Study|Adverse Event|1|||
129029594|NCT04364854|464399896|FG000|Overall Study|Withdrawal by Subject|1|||
129029595|NCT04364854|464399897|FG001|Overall Study|Withdrawal by Subject|0|||
128926065|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
128926066|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
128926067|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
128926068|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
128926069|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
128926070|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
129029596|NCT04364854|464399898|FG002|Overall Study|Withdrawal by Subject|1|||
129029597|NCT04364854|464399899|FG003|Overall Study|Withdrawal by Subject|3|||
129029598|NCT04364854|464399896|FG000|Overall Study|Death|1|||
129029599|NCT04364854|464399897|FG001|Overall Study|Death|0|||
129029600|NCT04364854|464399898|FG002|Overall Study|Death|0|||
128701431|NCT05275400|463205610|FG001|Treatment Period|Sponsor Decision|0|||
128701432|NCT05275400|463205609|FG000|Follow-Up Period|Death|2|||
128701433|NCT05275400|463205610|FG001|Follow-Up Period|Death|0|||
128701434|NCT05275400|463205609|FG000|Follow-Up Period|Protocol Violation|1|||
128701435|NCT05275400|463205610|FG001|Follow-Up Period|Protocol Violation|0|||
128701436|NCT05275400|463205609|FG000|Follow-Up Period|Withdrawal by Subject|3|||
128701437|NCT05275400|463205610|FG001|Follow-Up Period|Withdrawal by Subject|0|||
128926071|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
129029601|NCT04364854|464399899|FG003|Overall Study|Death|0|||
128701438|NCT02585960|463205611|FG000|PK/Safety Assessment Period|Physician Decision|0|||
129029602|NCT04364854|464399896|FG000|Overall Study|Lost to Follow-up|0|||
129029603|NCT04364854|464399897|FG001|Overall Study|Lost to Follow-up|0|||
128926072|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
128926073|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
128926074|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
128926075|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
128701439|NCT02585960|463205612|FG001|PK/Safety Assessment Period|Physician Decision|1|||
128701440|NCT02585960|463205613|FG002|PK/Safety Assessment Period|Physician Decision|0|||
128701441|NCT02585960|463205611|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
128701442|NCT02585960|463205612|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
128701443|NCT02585960|463205613|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
128701444|NCT02585960|463205611|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
128701445|NCT02585960|463205612|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
128701446|NCT02585960|463205613|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
128767021|NCT00641719|463438091|FG001|Overall Study|Adverse Event|29|||
128926076|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
128926077|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
128926078|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
128926079|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
128926080|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
128926081|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
128926082|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
128926083|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
129029604|NCT04364854|464399898|FG002|Overall Study|Lost to Follow-up|0|||
128767022|NCT00641719|463438090|FG000|Overall Study|Withdrawal by Subject|4|||
129029605|NCT04364854|464399899|FG003|Overall Study|Lost to Follow-up|1|||
128767023|NCT00641719|463438091|FG001|Overall Study|Withdrawal by Subject|4|||
129029606|NCT02435433|464399900|FG000|Overall Study|Withdrawal by Subject|2|||
129119088|NCT00171249|464733200|FG000|Overall Study|Lost to Follow-up|5|||
129029607|NCT02435433|464399901|FG001|Overall Study|Withdrawal by Subject|3|||
129029608|NCT02435433|464399902|FG002|Overall Study|Withdrawal by Subject|1|||
128701447|NCT02585960|463205611|FG000|PK/Safety Assessment Period|Other|4|||
128701448|NCT02585960|463205612|FG001|PK/Safety Assessment Period|Other|4|||
128767024|NCT00641719|463438090|FG000|Overall Study|Reason Not Specified|1|||
128926084|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
128926085|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
128926086|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
128926087|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
128926088|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
128926089|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
128926090|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
128926091|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
128926092|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
128926093|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
128926094|NCT03895203|464016970|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
128926095|NCT03895203|464016971|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
128926096|NCT03895203|464016972|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
128926097|NCT03895203|464016973|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
128926098|NCT03895203|464016974|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
128926099|NCT03895203|464016975|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
128926100|NCT00996840|464016976|FG000|Overall Study|Adverse Event|0|||
128926101|NCT00996840|464016977|FG001|Overall Study|Adverse Event|1|||
128926102|NCT00996840|464016978|FG002|Overall Study|Adverse Event|0|||
128926103|NCT00996840|464016979|FG003|Overall Study|Adverse Event|0|||
128926104|NCT00996840|464016980|FG004|Overall Study|Adverse Event|0|||
128926105|NCT00996840|464016976|FG000|Overall Study|Physician Decision|0|||
128926106|NCT00996840|464016977|FG001|Overall Study|Physician Decision|0|||
128926107|NCT00996840|464016978|FG002|Overall Study|Physician Decision|1|||
128926108|NCT00996840|464016979|FG003|Overall Study|Physician Decision|1|||
128926109|NCT00996840|464016980|FG004|Overall Study|Physician Decision|2|||
128926110|NCT00996840|464016976|FG000|Overall Study|Withdrawal by Subject|1|||
128926111|NCT00996840|464016977|FG001|Overall Study|Withdrawal by Subject|1|||
128926112|NCT00996840|464016978|FG002|Overall Study|Withdrawal by Subject|0|||
128926113|NCT00996840|464016979|FG003|Overall Study|Withdrawal by Subject|0|||
128926114|NCT00996840|464016980|FG004|Overall Study|Withdrawal by Subject|0|||
128926115|NCT04645797|464016981|FG000|Overall Study|Disease Progression|3|||
128926116|NCT04645797|464016982|FG001|Overall Study|Disease Progression|3|||
128926117|NCT04645797|464016983|FG002|Overall Study|Disease Progression|1|||
128926118|NCT04645797|464016984|FG003|Overall Study|Disease Progression|0|||
128926119|NCT04645797|464016985|FG004|Overall Study|Disease Progression|0|||
128926120|NCT04645797|464016986|FG005|Overall Study|Disease Progression|0|||
128926121|NCT04645797|464016987|FG006|Overall Study|Disease Progression|0|||
128926122|NCT04645797|464016981|FG000|Overall Study|Death|3|||
128926123|NCT04645797|464016982|FG001|Overall Study|Death|1|||
128926124|NCT04645797|464016983|FG002|Overall Study|Death|0|||
128926125|NCT04645797|464016984|FG003|Overall Study|Death|0|||
128926126|NCT04645797|464016985|FG004|Overall Study|Death|0|||
128926127|NCT04645797|464016986|FG005|Overall Study|Death|0|||
128926128|NCT04645797|464016987|FG006|Overall Study|Death|0|||
128926129|NCT01485614|464016989|FG000|Randomization|Not Treated|1|||
128926130|NCT01485614|464016990|FG001|Randomization|Not Treated|0|||
128926131|NCT01485614|464016991|FG002|Randomization|Not Treated|0|||
128926132|NCT01485614|464016992|FG003|Randomization|Not Treated|0|||
128926133|NCT01485614|464016989|FG000|Weeks 0-20|Lost to Follow-up|2|||
128926134|NCT01485614|464016990|FG001|Weeks 0-20|Lost to Follow-up|0|||
128926135|NCT01485614|464016991|FG002|Weeks 0-20|Lost to Follow-up|0|||
128926136|NCT01485614|464016992|FG003|Weeks 0-20|Lost to Follow-up|0|||
128926137|NCT01485614|464016989|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
128926138|NCT01485614|464016990|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
128926139|NCT01485614|464016991|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
128926140|NCT01485614|464016992|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
128926141|NCT01485614|464016989|FG000|Weeks 0-20|Withdrawal by Subject|3|||
128926142|NCT01485614|464016990|FG001|Weeks 0-20|Withdrawal by Subject|2|||
128926143|NCT01485614|464016991|FG002|Weeks 0-20|Withdrawal by Subject|1|||
128926144|NCT01485614|464016992|FG003|Weeks 0-20|Withdrawal by Subject|0|||
128701449|NCT02585960|463205613|FG002|PK/Safety Assessment Period|Other|0|||
128701450|NCT02585960|463205611|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
128701451|NCT02585960|463205612|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
128701452|NCT02585960|463205613|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
128926145|NCT01485614|464016989|FG000|Weeks 20-54|Lost to Follow-up|4|||
128926146|NCT01485614|464016990|FG001|Weeks 20-54|Lost to Follow-up|3|||
128926147|NCT01485614|464016991|FG002|Weeks 20-54|Lost to Follow-up|1|||
128926148|NCT01485614|464016992|FG003|Weeks 20-54|Lost to Follow-up|0|||
128926149|NCT01485614|464016989|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
129119089|NCT00171249|464733201|FG001|Overall Study|Lost to Follow-up|0|||
129119090|NCT00171249|464733202|FG002|Overall Study|Lost to Follow-up|0|||
129119091|NCT00171249|464733203|FG003|Overall Study|Lost to Follow-up|9|||
128701453|NCT02585960|463205611|FG000|PK/Safety Assessment Period|Screen Failure|0|||
128926150|NCT01485614|464016990|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
128926151|NCT01485614|464016991|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
128926152|NCT01485614|464016992|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
128926153|NCT01485614|464016989|FG000|Weeks 20-54|Withdrawal by Subject|5|||
128926154|NCT01485614|464016990|FG001|Weeks 20-54|Withdrawal by Subject|3|||
128926155|NCT01485614|464016991|FG002|Weeks 20-54|Withdrawal by Subject|0|||
128926156|NCT01485614|464016992|FG003|Weeks 20-54|Withdrawal by Subject|0|||
128926157|NCT02210780|464016993|FG000|Overall Study|Adverse Event|0|||
128926158|NCT02210780|464016994|FG001|Overall Study|Adverse Event|5|||
128926159|NCT02210780|464016993|FG000|Overall Study|Lost to Follow-up|2|||
128926160|NCT02210780|464016994|FG001|Overall Study|Lost to Follow-up|1|||
128926161|NCT02210780|464016993|FG000|Overall Study|Withdrawal by Subject|1|||
128926162|NCT02210780|464016994|FG001|Overall Study|Withdrawal by Subject|1|||
128926163|NCT02210780|464016993|FG000|Overall Study|Physician Decision|1|||
128926164|NCT02210780|464016994|FG001|Overall Study|Physician Decision|0|||
128926165|NCT02210780|464016993|FG000|Overall Study|Protocol Violation|1|||
128926166|NCT02210780|464016994|FG001|Overall Study|Protocol Violation|0|||
128926167|NCT02210780|464016993|FG000|Overall Study|Other than specified above|0|||
128926168|NCT02210780|464016994|FG001|Overall Study|Other than specified above|1|||
128926169|NCT00049127|464016995|FG000|Overall Study|Withdrawal by Subject|0|||
128926170|NCT00049127|464016996|FG001|Overall Study|Withdrawal by Subject|0|||
128926171|NCT00049127|464016997|FG002|Overall Study|Withdrawal by Subject|1|||
128926172|NCT00049127|464016998|FG003|Overall Study|Withdrawal by Subject|0|||
128926173|NCT00049127|464016999|FG004|Overall Study|Withdrawal by Subject|0|||
128926174|NCT02582515|464017000|FG000|Overall Study|Withdrawal by Subject|0|||
128926175|NCT02582515|464017001|FG001|Overall Study|Withdrawal by Subject|1|||
128926176|NCT04927312|464017002|FG000|Overall Study|Adverse Event|1|||
128926177|NCT04927312|464017002|FG000|Overall Study|Death|1|||
128926178|NCT04927312|464017002|FG000|Overall Study|Withdrawal by Subject|1|||
128926179|NCT04927312|464017002|FG000|Overall Study|Other|1|||
128926180|NCT01122927|464017003|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
128926181|NCT01122927|464017004|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
128926182|NCT01122927|464017003|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
128926183|NCT01122927|464017004|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
128926184|NCT01122927|464017003|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
128926185|NCT01122927|464017004|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
128926186|NCT01122927|464017003|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
128926187|NCT01122927|464017004|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
128926188|NCT01122927|464017003|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
128926189|NCT01122927|464017004|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
128926190|NCT01122927|464017003|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
128926191|NCT01122927|464017004|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
128926192|NCT01122927|464017003|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
128926193|NCT01122927|464017004|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
128926194|NCT01122927|464017003|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
128926195|NCT01122927|464017004|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
128926196|NCT01122927|464017003|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
128926197|NCT01122927|464017004|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
128926198|NCT01122927|464017003|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
128926199|NCT01122927|464017004|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
128926200|NCT01122927|464017003|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
128926201|NCT01122927|464017004|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
128926202|NCT01122927|464017003|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
128926203|NCT01122927|464017004|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
129029609|NCT02435433|464399903|FG003|Overall Study|Withdrawal by Subject|0|||
129029610|NCT02435433|464399904|FG004|Overall Study|Withdrawal by Subject|0|||
129029611|NCT02435433|464399900|FG000|Overall Study|Lost to Follow-up|2|||
129216368|NCT00538902|465092908|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
128701454|NCT02585960|463205612|FG001|PK/Safety Assessment Period|Screen Failure|0|||
128701455|NCT02585960|463205613|FG002|PK/Safety Assessment Period|Screen Failure|1|||
128701456|NCT02585960|463205611|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
128926204|NCT00684814|464017007|FG000|Washout Period of 7 Days|Adverse Event|1|||
128926205|NCT00684814|464017008|FG001|Washout Period of 7 Days|Adverse Event|2|||
128926206|NCT00684814|464017007|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
128926207|NCT00684814|464017008|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
129029612|NCT02435433|464399901|FG001|Overall Study|Lost to Follow-up|2|||
128926208|NCT00684814|464017007|FG000|Second Intervention|Adverse Event|1|||
128926209|NCT00684814|464017008|FG001|Second Intervention|Adverse Event|0|||
128926210|NCT01676961|464017009|FG000|Overall Study|Death|3|||
128926211|NCT01676961|464017009|FG000|Overall Study|Lost to Follow-up|1|||
128926212|NCT01676961|464017009|FG000|Overall Study|Withdrawal by Subject|1|||
129029613|NCT02435433|464399902|FG002|Overall Study|Lost to Follow-up|4|||
129029614|NCT02435433|464399903|FG003|Overall Study|Lost to Follow-up|1|||
128767025|NCT00641719|463438091|FG001|Overall Study|Reason Not Specified|2|||
128767026|NCT03303469|463438092|FG000|Overall Study|Lost to Follow-up|2|||
128767027|NCT00980005|463438095|FG000|Overall Study|Withdrawal by Subject|6|||
129029615|NCT02435433|464399904|FG004|Overall Study|Lost to Follow-up|0|||
129029616|NCT00757705|464399905|FG000|Overall Study|Adverse Event|19|||
129029617|NCT00757705|464399905|FG000|Overall Study|Lost to Follow-up|16|||
129029618|NCT00757705|464399905|FG000|Overall Study|Withdrawal by Subject|25|||
128767028|NCT00980005|463438096|FG001|Overall Study|Withdrawal by Subject|17|||
128767029|NCT00980005|463438095|FG000|Overall Study|Lost to Follow-up|37|||
128767030|NCT00980005|463438096|FG001|Overall Study|Lost to Follow-up|43|||
128767031|NCT00980005|463438095|FG000|Overall Study|Other|4|||
128767032|NCT00980005|463438096|FG001|Overall Study|Other|3|||
128767033|NCT00692406|463438097|FG000|Overall Study|PI dropped, bad data|57|||
128767034|NCT05952297|463438099|FG000|Overall Study|Withdrawal by Subject|1|||
128767035|NCT05952297|463438100|FG001|Overall Study|Withdrawal by Subject|0|||
128767036|NCT02541383|463438103|FG000|Overall Study|Death|50|||
128767037|NCT02541383|463438104|FG001|Overall Study|Death|37|||
128926213|NCT00117312|464017010|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
128926214|NCT00117312|464017011|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
128926215|NCT00117312|464017012|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
128926216|NCT00117312|464017013|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
128926217|NCT00117312|464017010|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
128926218|NCT00117312|464017011|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
128926219|NCT00117312|464017012|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
128926220|NCT00117312|464017013|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
128926221|NCT00117312|464017010|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
128767038|NCT02541383|463438105|FG002|Overall Study|Death|48|||
128926222|NCT00117312|464017011|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
128926223|NCT00117312|464017012|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
128926224|NCT00117312|464017013|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
129029619|NCT00757705|464399905|FG000|Overall Study|Insufficient Response|26|||
129029620|NCT00757705|464399905|FG000|Overall Study|Ineligible to continue|8|||
129029621|NCT00757705|464399905|FG000|Overall Study|Non-compliant|9|||
128926225|NCT00117312|464017010|FG000|Overall Study|Other|0|||
128926226|NCT00117312|464017011|FG001|Overall Study|Other|1|||
128926227|NCT00117312|464017012|FG002|Overall Study|Other|3|||
128926228|NCT00117312|464017013|FG003|Overall Study|Other|1|||
128926229|NCT00117312|464017010|FG000|Overall Study|Patient choice|0|||
128926230|NCT00117312|464017011|FG001|Overall Study|Patient choice|0|||
128926231|NCT00117312|464017012|FG002|Overall Study|Patient choice|2|||
128926232|NCT00117312|464017013|FG003|Overall Study|Patient choice|1|||
128926233|NCT00117312|464017010|FG000|Overall Study|Adverse Event|0|||
128926234|NCT00117312|464017011|FG001|Overall Study|Adverse Event|2|||
128926235|NCT00117312|464017012|FG002|Overall Study|Adverse Event|0|||
129029622|NCT00757705|464399905|FG000|Overall Study|Other|18|||
129029623|NCT00659815|464399906|FG000|Overall Study|Study related symptoms and complaints|2|||
128926236|NCT00117312|464017013|FG003|Overall Study|Adverse Event|0|||
128926237|NCT00117312|464017010|FG000|Overall Study|Protocol Violation|0|||
128926238|NCT00117312|464017011|FG001|Overall Study|Protocol Violation|1|||
128926239|NCT00117312|464017012|FG002|Overall Study|Protocol Violation|3|||
128926240|NCT00117312|464017013|FG003|Overall Study|Protocol Violation|0|||
128926241|NCT00117312|464017010|FG000|Overall Study|PSA decrease <=50%|0|||
128926242|NCT00117312|464017011|FG001|Overall Study|PSA decrease <=50%|2|||
128926243|NCT00117312|464017012|FG002|Overall Study|PSA decrease <=50%|2|||
128926244|NCT00117312|464017013|FG003|Overall Study|PSA decrease <=50%|4|||
128926245|NCT00117312|464017010|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
128926246|NCT00117312|464017011|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
128926247|NCT00117312|464017012|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
128926248|NCT00117312|464017013|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
128926249|NCT00117312|464017010|FG000|Overall Study|Hepatic abnormality|0|||
128926250|NCT00117312|464017011|FG001|Overall Study|Hepatic abnormality|1|||
128926251|NCT00117312|464017012|FG002|Overall Study|Hepatic abnormality|0|||
128926252|NCT00117312|464017013|FG003|Overall Study|Hepatic abnormality|1|||
128926253|NCT00117312|464017010|FG000|Overall Study|Withdrawal by Subject|0|||
128926254|NCT00117312|464017011|FG001|Overall Study|Withdrawal by Subject|2|||
129029624|NCT00659815|464399907|FG001|Overall Study|Study related symptoms and complaints|1|||
128767039|NCT02541383|463438106|FG003|Overall Study|Death|41|||
129029625|NCT00659815|464399906|FG000|Overall Study|Inability to maintain wearing schedule|1|||
129216369|NCT00538902|465092906|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
128926255|NCT00117312|464017012|FG002|Overall Study|Withdrawal by Subject|0|||
128926256|NCT00117312|464017013|FG003|Overall Study|Withdrawal by Subject|0|||
128926257|NCT00195650|464017014|FG000|Overall Study|Adverse Event|194|||
128926258|NCT00195650|464017014|FG000|Overall Study|Lack of Efficacy|99|||
128926259|NCT00195650|464017014|FG000|Overall Study|Withdrawal by Subject|67|||
128926260|NCT00195650|464017014|FG000|Overall Study|Lost to Follow-up|44|||
128926261|NCT00195650|464017014|FG000|Overall Study|Death|23|||
128767040|NCT02541383|463438107|FG004|Overall Study|Death|21|||
128926262|NCT00195650|464017014|FG000|Overall Study|Protocol Violation|15|||
128926263|NCT00195650|464017014|FG000|Overall Study|Administrative reasons|83|||
128926264|NCT02371629|464017016|FG000|Overall Study|Patient decision|14|||
128926265|NCT02371629|464017017|FG001|Overall Study|Patient decision|10|||
128926266|NCT02371629|464017016|FG000|Overall Study|Adverse Event|8|||
128926267|NCT02371629|464017017|FG001|Overall Study|Adverse Event|8|||
128926268|NCT02371629|464017016|FG000|Overall Study|Physician Decision|2|||
128926269|NCT02371629|464017017|FG001|Overall Study|Physician Decision|3|||
128926270|NCT02371629|464017016|FG000|Overall Study|Death|1|||
128926271|NCT02371629|464017017|FG001|Overall Study|Death|1|||
128926272|NCT02371629|464017016|FG000|Overall Study|Noncompliance with study treatment|1|||
128926273|NCT02371629|464017017|FG001|Overall Study|Noncompliance with study treatment|0|||
128926274|NCT02371629|464017016|FG000|Overall Study|Lack of Efficacy|0|||
128926275|NCT02371629|464017017|FG001|Overall Study|Lack of Efficacy|2|||
128926276|NCT02371629|464017016|FG000|Overall Study|Protocol deviation|0|||
128926277|NCT02371629|464017017|FG001|Overall Study|Protocol deviation|1|||
128926278|NCT00201851|464017018|FG000|Overall Study|Lost to Follow-up|2|||
128926279|NCT00201851|464017019|FG001|Overall Study|Lost to Follow-up|1|||
128926280|NCT00201851|464017020|FG002|Overall Study|Lost to Follow-up|0|||
128926281|NCT00201851|464017018|FG000|Overall Study|Ineligible post enrollment|6|||
128926282|NCT00201851|464017019|FG001|Overall Study|Ineligible post enrollment|1|||
128926283|NCT00201851|464017020|FG002|Overall Study|Ineligible post enrollment|1|||
128926284|NCT02469246|464017021|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
128926285|NCT02469246|464017022|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
128926286|NCT02469246|464017021|FG000|Double-Blind Phase|Adverse Event|12|||
128926287|NCT02469246|464017022|FG001|Double-Blind Phase|Adverse Event|9|||
128926288|NCT02469246|464017021|FG000|Double-Blind Phase|Death|2|||
128926289|NCT02469246|464017022|FG001|Double-Blind Phase|Death|0|||
128926290|NCT02469246|464017021|FG000|Double-Blind Phase|Lack of Efficacy|2|||
128926291|NCT02469246|464017022|FG001|Double-Blind Phase|Lack of Efficacy|1|||
128926292|NCT02469246|464017021|FG000|Double-Blind Phase|Investigator's Discretion|8|||
128926293|NCT02469246|464017022|FG001|Double-Blind Phase|Investigator's Discretion|8|||
128926294|NCT02469246|464017021|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
128926295|NCT02469246|464017022|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
128926296|NCT02469246|464017021|FG000|Double-Blind Phase|Protocol Violation|1|||
128926297|NCT02469246|464017022|FG001|Double-Blind Phase|Protocol Violation|1|||
128926298|NCT02469246|464017021|FG000|Double-Blind Phase|Withdrew Consent|25|||
128926299|NCT02469246|464017022|FG001|Double-Blind Phase|Withdrew Consent|25|||
128926300|NCT02469246|464017021|FG000|Double-Blind Phase|Lost to Follow-up|9|||
128926301|NCT02469246|464017022|FG001|Double-Blind Phase|Lost to Follow-up|5|||
128926302|NCT00749203|464017026|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
128926303|NCT00749203|464017027|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
128926304|NCT00749203|464017026|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
128926305|NCT00749203|464017027|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
128926306|NCT00749203|464017026|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
128926307|NCT00749203|464017027|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
128926308|NCT00749203|464017026|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
128926309|NCT00749203|464017027|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
128926310|NCT00749203|464017026|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
128926311|NCT00749203|464017027|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
128926312|NCT00749203|464017026|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
128926313|NCT00749203|464017027|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
128926314|NCT02853760|464017028|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
128926315|NCT02853760|464017029|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
128926316|NCT02853760|464017030|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
128926317|NCT02853760|464017031|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
128926318|NCT02853760|464017032|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
128926319|NCT02853760|464017033|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
128926320|NCT01642212|464017034|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
128926321|NCT01642212|464017035|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
128926322|NCT01642212|464017036|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
128926323|NCT01642212|464017037|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
128926324|NCT01642212|464017038|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
128926325|NCT01642212|464017034|FG000|Double-blind Treatment|Other|0|||
128926326|NCT01642212|464017035|FG001|Double-blind Treatment|Other|2|||
128926327|NCT01642212|464017036|FG002|Double-blind Treatment|Other|1|||
128926328|NCT01642212|464017037|FG003|Double-blind Treatment|Other|0|||
129029626|NCT00659815|464399907|FG001|Overall Study|Inability to maintain wearing schedule|2|||
129029627|NCT00659815|464399906|FG000|Overall Study|Withdrawal by Subject|1|||
128926329|NCT01642212|464017038|FG004|Double-blind Treatment|Other|0|||
128926330|NCT01642212|464017034|FG000|Double-blind Treatment|Non-compliance|0|||
128926331|NCT01642212|464017035|FG001|Double-blind Treatment|Non-compliance|1|||
128926332|NCT01642212|464017036|FG002|Double-blind Treatment|Non-compliance|0|||
128926333|NCT01642212|464017037|FG003|Double-blind Treatment|Non-compliance|0|||
128926334|NCT01642212|464017038|FG004|Double-blind Treatment|Non-compliance|0|||
128926335|NCT01642212|464017034|FG000|Double-blind Treatment|Adverse Event|0|||
128926336|NCT01642212|464017035|FG001|Double-blind Treatment|Adverse Event|0|||
128926337|NCT01642212|464017036|FG002|Double-blind Treatment|Adverse Event|1|||
128926338|NCT01642212|464017037|FG003|Double-blind Treatment|Adverse Event|0|||
128926339|NCT01642212|464017038|FG004|Double-blind Treatment|Adverse Event|0|||
128926340|NCT01642212|464017034|FG000|Open-label Extension|Adverse Event|0|||
128926341|NCT01642212|464017035|FG001|Open-label Extension|Adverse Event|0|||
128926342|NCT01642212|464017036|FG002|Open-label Extension|Adverse Event|0|||
128926343|NCT01642212|464017037|FG003|Open-label Extension|Adverse Event|3|||
128926344|NCT01642212|464017038|FG004|Open-label Extension|Adverse Event|0|||
128926345|NCT01642212|464017034|FG000|Open-label Extension|Sponsor Decision|0|||
128926346|NCT01642212|464017035|FG001|Open-label Extension|Sponsor Decision|0|||
128926347|NCT01642212|464017036|FG002|Open-label Extension|Sponsor Decision|0|||
128926348|NCT01642212|464017037|FG003|Open-label Extension|Sponsor Decision|7|||
128926349|NCT01642212|464017038|FG004|Open-label Extension|Sponsor Decision|4|||
128926350|NCT01642212|464017034|FG000|Open-label Extension|Consent Withdrawn|0|||
128926351|NCT01642212|464017035|FG001|Open-label Extension|Consent Withdrawn|0|||
128926352|NCT01642212|464017036|FG002|Open-label Extension|Consent Withdrawn|0|||
128926353|NCT01642212|464017037|FG003|Open-label Extension|Consent Withdrawn|0|||
128926354|NCT01642212|464017038|FG004|Open-label Extension|Consent Withdrawn|2|||
128926355|NCT01642212|464017034|FG000|Open-label Extension|Lost to Follow-up|0|||
128926356|NCT01642212|464017035|FG001|Open-label Extension|Lost to Follow-up|0|||
128926357|NCT01642212|464017036|FG002|Open-label Extension|Lost to Follow-up|0|||
128926358|NCT01642212|464017037|FG003|Open-label Extension|Lost to Follow-up|0|||
128926359|NCT01642212|464017038|FG004|Open-label Extension|Lost to Follow-up|1|||
128926360|NCT01642212|464017034|FG000|Open-label Extension|Other|0|||
128926361|NCT01642212|464017035|FG001|Open-label Extension|Other|0|||
128926362|NCT01642212|464017036|FG002|Open-label Extension|Other|0|||
128926363|NCT01642212|464017037|FG003|Open-label Extension|Other|0|||
128926364|NCT01642212|464017038|FG004|Open-label Extension|Other|1|||
128926365|NCT01243268|464017039|FG000|Overall Study|Lost to Follow-up|4|||
128926366|NCT01243268|464017039|FG000|Overall Study|Protocol Violation|51|||
128926367|NCT01243268|464017039|FG000|Overall Study|Deviation with contract date|7|||
128926368|NCT01243268|464017039|FG000|Overall Study|Duplicate subject|2|||
128926369|NCT00957853|464017040|FG000|Overall Study|Withdrawal by Subject|1|||
128926370|NCT00957853|464017041|FG001|Overall Study|Withdrawal by Subject|0|||
128926371|NCT00957853|464017042|FG002|Overall Study|Withdrawal by Subject|0|||
128926372|NCT00004980|464017043|FG000|Overall Study|Withdrawal by Subject|1|||
128926373|NCT00004980|464017044|FG001|Overall Study|Withdrawal by Subject|0|||
128926374|NCT00004980|464017043|FG000|Overall Study|memory difficulties|1|||
128926375|NCT00004980|464017044|FG001|Overall Study|memory difficulties|1|||
128926376|NCT00004980|464017043|FG000|Overall Study|Physician Decision|0|||
128926377|NCT00004980|464017044|FG001|Overall Study|Physician Decision|1|||
128926378|NCT00702143|464017045|FG000|Overall Study|Lost to Follow-up|0|||
128926379|NCT00702143|464017046|FG001|Overall Study|Lost to Follow-up|0|||
128926380|NCT00702143|464017047|FG002|Overall Study|Lost to Follow-up|1|||
128926381|NCT03577990|464017048|FG000|Overall Study|Lost to Follow-up|4|||
128926382|NCT03577990|464017049|FG001|Overall Study|Lost to Follow-up|6|||
128926383|NCT03577990|464017048|FG000|Overall Study|Withdrawal by Subject|4|||
128926384|NCT03577990|464017049|FG001|Overall Study|Withdrawal by Subject|7|||
128926385|NCT04996797|464017054|FG000|Overall Study|Adverse Event|0|||
128926386|NCT04996797|464017055|FG001|Overall Study|Adverse Event|2|||
128926387|NCT04996797|464017056|FG002|Overall Study|Adverse Event|0|||
128926388|NCT04996797|464017057|FG003|Overall Study|Adverse Event|1|||
128926389|NCT04996797|464017054|FG000|Overall Study|Lack of Efficacy|0|||
128926390|NCT04996797|464017055|FG001|Overall Study|Lack of Efficacy|2|||
128926391|NCT04996797|464017056|FG002|Overall Study|Lack of Efficacy|0|||
128926392|NCT04996797|464017057|FG003|Overall Study|Lack of Efficacy|0|||
128926393|NCT04996797|464017054|FG000|Overall Study|Prohibited Medication|0|||
128926394|NCT04996797|464017055|FG001|Overall Study|Prohibited Medication|1|||
128926395|NCT04996797|464017056|FG002|Overall Study|Prohibited Medication|0|||
128926396|NCT04996797|464017057|FG003|Overall Study|Prohibited Medication|0|||
128926397|NCT04996797|464017054|FG000|Overall Study|Ongoing|68|||
128926398|NCT04996797|464017055|FG001|Overall Study|Ongoing|60|||
128926399|NCT04996797|464017056|FG002|Overall Study|Ongoing|22|||
128926400|NCT04996797|464017057|FG003|Overall Study|Ongoing|20|||
128926401|NCT04996797|464017054|FG000|Overall Study|Withdrawal by Subject|0|||
128926402|NCT04996797|464017055|FG001|Overall Study|Withdrawal by Subject|2|||
128926403|NCT04996797|464017056|FG002|Overall Study|Withdrawal by Subject|0|||
128926404|NCT04996797|464017057|FG003|Overall Study|Withdrawal by Subject|0|||
128926405|NCT02793544|464017058|FG000|Overall Study|Death|10|||
129029628|NCT00659815|464399907|FG001|Overall Study|Withdrawal by Subject|1|||
128926406|NCT02793544|464017059|FG001|Overall Study|Death|8|||
128926407|NCT02793544|464017058|FG000|Overall Study|Lost to Follow-up|2|||
128926408|NCT02793544|464017059|FG001|Overall Study|Lost to Follow-up|0|||
128926409|NCT02793544|464017058|FG000|Overall Study|Withdrawal by Subject|1|||
128926410|NCT02793544|464017059|FG001|Overall Study|Withdrawal by Subject|0|||
128926411|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
128926412|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
128926413|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
128926414|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
128926415|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
128926416|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
128926417|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
128926418|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
128926419|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
128926420|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
128926421|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
128926422|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
128926423|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
128926424|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
128926425|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
128926426|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
128926427|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
128926428|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
128926429|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
128926430|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
128926431|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
128926432|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
128926433|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
128926434|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
128926435|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
128926436|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
128926437|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
128926438|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
128926439|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
128926440|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
128926441|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
128926442|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
128926443|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
128926444|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
128926445|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
128926446|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
128926447|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
128926448|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
128926449|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
128926450|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
128926451|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
128926452|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
128926453|NCT00100048|464017062|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
128926454|NCT00100048|464017063|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
128926455|NCT00100048|464017064|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
128926456|NCT00100048|464017065|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
128926457|NCT00100048|464017066|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
128926458|NCT00100048|464017067|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
128926459|NCT01624142|464017068|FG000|Overall Study|Withdrawal by Subject|14|||
128926460|NCT01624142|464017069|FG001|Overall Study|Withdrawal by Subject|4|||
128926461|NCT01624142|464017068|FG000|Overall Study|Death|3|||
128926462|NCT01624142|464017069|FG001|Overall Study|Death|6|||
128926463|NCT01624142|464017068|FG000|Overall Study|Study Closure|12|||
128926464|NCT01624142|464017069|FG001|Overall Study|Study Closure|6|||
128926465|NCT01624142|464017068|FG000|Overall Study|Lost to Follow-up|2|||
128926466|NCT01624142|464017069|FG001|Overall Study|Lost to Follow-up|0|||
128926467|NCT01624142|464017068|FG000|Overall Study|Other|1|||
128926468|NCT01624142|464017069|FG001|Overall Study|Other|0|||
128926469|NCT04826900|464017072|FG000|Overall Study|Family factor|1|||
129119092|NCT00171249|464733204|FG004|Overall Study|Lost to Follow-up|0|||
128926470|NCT04826900|464017073|FG001|Overall Study|Family factor|1|||
128926471|NCT03372941|464017074|FG000|Overall Study|Lost to Follow-up|2|||
128926472|NCT03372941|464017075|FG001|Overall Study|Lost to Follow-up|4|||
128926473|NCT00741819|464017076|FG000|Overall Study|Adverse Event|3|||
128926474|NCT00741819|464017076|FG000|Overall Study|Withdrawal by Subject|3|||
129119093|NCT00171249|464733205|FG005|Overall Study|Lost to Follow-up|0|||
129119094|NCT00171249|464733206|FG006|Overall Study|Lost to Follow-up|0|||
128926475|NCT00741819|464017076|FG000|Overall Study|Death|1|||
128926476|NCT00741819|464017076|FG000|Overall Study|Disease progression|1|||
128926477|NCT01126580|464017077|FG000|Overall Study|Adverse Event|14|||
128926478|NCT01126580|464017078|FG001|Overall Study|Adverse Event|8|||
128926479|NCT01126580|464017079|FG002|Overall Study|Adverse Event|12|||
128926480|NCT01126580|464017077|FG000|Overall Study|Withdrawal by Subject|11|||
128926481|NCT01126580|464017078|FG001|Overall Study|Withdrawal by Subject|19|||
128926482|NCT01126580|464017079|FG002|Overall Study|Withdrawal by Subject|14|||
128926483|NCT01126580|464017077|FG000|Overall Study|Sponsor Decision|5|||
128926484|NCT01126580|464017078|FG001|Overall Study|Sponsor Decision|4|||
128926485|NCT01126580|464017079|FG002|Overall Study|Sponsor Decision|7|||
128926486|NCT01126580|464017077|FG000|Overall Study|Physician Decision|1|||
128926487|NCT01126580|464017078|FG001|Overall Study|Physician Decision|1|||
128926488|NCT01126580|464017079|FG002|Overall Study|Physician Decision|2|||
128926489|NCT01126580|464017077|FG000|Overall Study|Entry Criteria Not Met|1|||
128926490|NCT01126580|464017078|FG001|Overall Study|Entry Criteria Not Met|1|||
128926491|NCT01126580|464017079|FG002|Overall Study|Entry Criteria Not Met|2|||
128926492|NCT01126580|464017077|FG000|Overall Study|Lack of Efficacy|2|||
128926493|NCT01126580|464017078|FG001|Overall Study|Lack of Efficacy|3|||
128926494|NCT01126580|464017079|FG002|Overall Study|Lack of Efficacy|4|||
128926495|NCT01126580|464017077|FG000|Overall Study|Protocol Violation|0|||
128926496|NCT01126580|464017078|FG001|Overall Study|Protocol Violation|1|||
128926497|NCT01126580|464017079|FG002|Overall Study|Protocol Violation|2|||
128926498|NCT01126580|464017077|FG000|Overall Study|Lost to Follow-up|15|||
128926499|NCT01126580|464017078|FG001|Overall Study|Lost to Follow-up|13|||
128926500|NCT01126580|464017079|FG002|Overall Study|Lost to Follow-up|9|||
128926501|NCT01126580|464017077|FG000|Overall Study|Treatment Non-compliance|0|||
128926502|NCT01126580|464017078|FG001|Overall Study|Treatment Non-compliance|2|||
128926503|NCT01126580|464017079|FG002|Overall Study|Treatment Non-compliance|3|||
128926504|NCT00609622|464017080|FG000|Overall Study|Adverse Event|14|||
128926505|NCT00609622|464017081|FG001|Overall Study|Adverse Event|10|||
128926506|NCT00609622|464017080|FG000|Overall Study|Withdrawal by Subject|4|||
128926507|NCT00609622|464017081|FG001|Overall Study|Withdrawal by Subject|20|||
128926508|NCT00609622|464017080|FG000|Overall Study|Death|1|||
128926509|NCT00609622|464017081|FG001|Overall Study|Death|4|||
128926510|NCT00609622|464017080|FG000|Overall Study|Protocol Violation|1|||
128926511|NCT00609622|464017081|FG001|Overall Study|Protocol Violation|1|||
128926512|NCT00609622|464017080|FG000|Overall Study|Objective progression or relapse|47|||
128926513|NCT00609622|464017081|FG001|Overall Study|Objective progression or relapse|41|||
128926514|NCT00609622|464017080|FG000|Overall Study|Study terminated by sponsor|16|||
128926515|NCT00609622|464017081|FG001|Overall Study|Study terminated by sponsor|3|||
128926516|NCT00609622|464017080|FG000|Overall Study|Other|7|||
128926517|NCT00609622|464017081|FG001|Overall Study|Other|14|||
128926518|NCT00609622|464017080|FG000|Overall Study|Global deterioration of health status|6|||
128926519|NCT00609622|464017081|FG001|Overall Study|Global deterioration of health status|2|||
128926520|NCT00686543|464017082|FG000|Overall Study|Adverse Event|9|||
128926521|NCT00686543|464017083|FG001|Overall Study|Adverse Event|1|||
128926522|NCT00686543|464017084|FG002|Overall Study|Adverse Event|3|||
128926523|NCT00686543|464017085|FG003|Overall Study|Adverse Event|2|||
128926524|NCT00686543|464017082|FG000|Overall Study|Withdrawal by Subject|2|||
128926525|NCT00686543|464017083|FG001|Overall Study|Withdrawal by Subject|0|||
128926526|NCT00686543|464017084|FG002|Overall Study|Withdrawal by Subject|0|||
128926527|NCT00686543|464017085|FG003|Overall Study|Withdrawal by Subject|0|||
128926528|NCT00686543|464017082|FG000|Overall Study|Protocol Violation|3|||
128926529|NCT00686543|464017083|FG001|Overall Study|Protocol Violation|0|||
128926530|NCT00686543|464017084|FG002|Overall Study|Protocol Violation|2|||
128926531|NCT00686543|464017085|FG003|Overall Study|Protocol Violation|1|||
128926532|NCT01708057|464017089|FG000|Overall Study|Withdrawal due to study termination.|1|||
128926533|NCT01708057|464017090|FG001|Overall Study|Withdrawal due to study termination.|1|||
128926534|NCT01708057|464017091|FG002|Overall Study|Withdrawal due to study termination.|1|||
128926535|NCT04194944|464017094|FG000|Overall Study|Lost to Follow-up|3|||
128926536|NCT04194944|464017095|FG001|Overall Study|Lost to Follow-up|0|||
128926537|NCT04194944|464017094|FG000|Overall Study|Withdrawal by Subject|2|||
128926538|NCT04194944|464017095|FG001|Overall Study|Withdrawal by Subject|2|||
128926539|NCT04194944|464017094|FG000|Overall Study|On Treatment|93|||
128926540|NCT04194944|464017095|FG001|Overall Study|On Treatment|30|||
128926541|NCT03277196|464017102|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
128926542|NCT03277196|464017102|FG000|Overall Study|Lost to Follow-up|3|||
128926543|NCT03277196|464017102|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
128926544|NCT03277196|464017102|FG000|Overall Study|Other|2|||
128926545|NCT00473694|464018669|FG000|Overall Study|Adverse Event|0|||
128926546|NCT00473694|464018670|FG001|Overall Study|Adverse Event|1|||
128926547|NCT00473694|464018671|FG002|Overall Study|Adverse Event|0|||
128926548|NCT00473694|464018672|FG003|Overall Study|Adverse Event|0|||
128926549|NCT00473694|464018669|FG000|Overall Study|Participants did not receive treatment|11|||
128926550|NCT00473694|464018670|FG001|Overall Study|Participants did not receive treatment|3|||
128926551|NCT00473694|464018671|FG002|Overall Study|Participants did not receive treatment|5|||
128926552|NCT00473694|464018672|FG003|Overall Study|Participants did not receive treatment|6|||
129029629|NCT00735696|464399908|FG000|Overall Study|Withdrawal by Subject|1|||
128926553|NCT00473694|464018669|FG000|Overall Study|Lost to Follow-up|0|||
128926554|NCT00473694|464018670|FG001|Overall Study|Lost to Follow-up|0|||
128926555|NCT00473694|464018671|FG002|Overall Study|Lost to Follow-up|0|||
128926556|NCT00473694|464018672|FG003|Overall Study|Lost to Follow-up|1|||
128926557|NCT00506389|464018680|FG000|In-treatment Period|Other|3|||
128926558|NCT00506389|464018681|FG001|In-treatment Period|Other|3|||
128926559|NCT00506389|464018682|FG002|In-treatment Period|Other|4|||
128926560|NCT00506389|464018680|FG000|In-treatment Period|Lost to Follow-up|0|||
128926561|NCT00506389|464018681|FG001|In-treatment Period|Lost to Follow-up|0|||
128926562|NCT00506389|464018682|FG002|In-treatment Period|Lost to Follow-up|1|||
128926563|NCT00506389|464018680|FG000|In-treatment Period|Lack of compliance|1|||
128926564|NCT00506389|464018681|FG001|In-treatment Period|Lack of compliance|0|||
128926565|NCT00506389|464018682|FG002|In-treatment Period|Lack of compliance|0|||
128926566|NCT00506389|464018680|FG000|In-treatment Period|Reasons not related to trial|4|||
128926567|NCT00506389|464018681|FG001|In-treatment Period|Reasons not related to trial|1|||
128926568|NCT00506389|464018682|FG002|In-treatment Period|Reasons not related to trial|0|||
128926569|NCT00506389|464018680|FG000|In-treatment Period|Withdrawal by Subject|3|||
128926570|NCT00506389|464018681|FG001|In-treatment Period|Withdrawal by Subject|3|||
128926571|NCT00506389|464018682|FG002|In-treatment Period|Withdrawal by Subject|4|||
128926572|NCT00506389|464018680|FG000|In-treatment Period|Lack of Efficacy|0|||
128926573|NCT00506389|464018681|FG001|In-treatment Period|Lack of Efficacy|2|||
128926574|NCT00506389|464018682|FG002|In-treatment Period|Lack of Efficacy|0|||
128926575|NCT00506389|464018680|FG000|In-treatment Period|Adverse Event|11|||
128926576|NCT00506389|464018681|FG001|In-treatment Period|Adverse Event|5|||
128926577|NCT00506389|464018682|FG002|In-treatment Period|Adverse Event|2|||
128926578|NCT00506389|464018680|FG000|In-treatment Period|Randomized but not treated|4|||
128926579|NCT00506389|464018681|FG001|In-treatment Period|Randomized but not treated|1|||
128926580|NCT00506389|464018682|FG002|In-treatment Period|Randomized but not treated|1|||
128926581|NCT05224258|464018683|FG000|Overall Study|Withdrawal by Subject|1|||
128926582|NCT05224258|464018684|FG001|Overall Study|Withdrawal by Subject|1|||
128926583|NCT05224258|464018683|FG000|Overall Study|Physician Decision|1|||
128926584|NCT05224258|464018684|FG001|Overall Study|Physician Decision|1|||
128926585|NCT05224258|464018683|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
128926586|NCT05224258|464018684|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128926587|NCT05224258|464018683|FG000|Overall Study|Study Product No Longer in Use|1|||
128926588|NCT05224258|464018684|FG001|Overall Study|Study Product No Longer in Use|0|||
128926589|NCT05224258|464018683|FG000|Overall Study|Adverse Event|0|||
128926590|NCT05224258|464018684|FG001|Overall Study|Adverse Event|1|||
128926591|NCT05224258|464018683|FG000|Overall Study|Protocol Deviation|0|||
128926592|NCT05224258|464018684|FG001|Overall Study|Protocol Deviation|1|||
128926593|NCT03812510|464018698|FG000|Overall Study|Lost to Follow-up|39|||
128926594|NCT03812510|464018698|FG000|Overall Study|Withdrawal by Subject|42|||
129029630|NCT00735696|464399908|FG000|Overall Study|Enrolled but never Treated|1|||
128926595|NCT03812510|464018698|FG000|Overall Study|Physician Decision|2|||
128926596|NCT03812510|464018698|FG000|Overall Study|Study Terminated by Sponsor|9|||
128926597|NCT03812510|464018698|FG000|Overall Study|Did Not Start Study Medication|55|||
128926598|NCT03812510|464018698|FG000|Overall Study|Adverse Event|5|||
128926599|NCT00768560|464018699|FG000|Intervention Set 1|Adverse Event|0|||
128926600|NCT00768560|464018700|FG001|Intervention Set 1|Adverse Event|1|||
128926601|NCT00768560|464018701|FG002|Intervention Set 1|Adverse Event|0|||
128926602|NCT00768560|464018702|FG003|Intervention Set 1|Adverse Event|0|||
128926603|NCT00768560|464018703|FG004|Intervention Set 1|Adverse Event|0|||
128767041|NCT02541383|463438108|FG005|Overall Study|Death|25|||
128926604|NCT00768560|464018704|FG005|Intervention Set 1|Adverse Event|0|||
128926605|NCT01128387|464018705|FG000|Overall Study|Physician Decision|0|||
128926606|NCT01128387|464018706|FG001|Overall Study|Physician Decision|1|||
128926607|NCT02635204|464018707|FG000|Overall Study|Adverse Event|1|||
128926608|NCT02635204|464018708|FG001|Overall Study|Adverse Event|0|||
128926609|NCT02635204|464018707|FG000|Overall Study|Lost to Follow-up|1|||
128926610|NCT02635204|464018708|FG001|Overall Study|Lost to Follow-up|1|||
129029631|NCT00640393|464399913|FG000|Part 1|Lost to Follow-up|2|||
129029632|NCT00640393|464399914|FG001|Part 1|Lost to Follow-up|0|||
128926611|NCT01535235|464018709|FG000|Overall Study|Adverse Event|1|||
128926612|NCT01535235|464018710|FG001|Overall Study|Adverse Event|0|||
129216370|NCT00538902|465092907|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
129029633|NCT00640393|464399915|FG002|Part 1|Lost to Follow-up|0|||
129216371|NCT00538902|465092908|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
128926613|NCT00858832|464018711|FG000|Overall Study|became ineligible: delivered vaginally|1|||
128926614|NCT00858832|464018712|FG001|Overall Study|became ineligible: delivered vaginally|0|||
128926615|NCT00858832|464018711|FG000|Overall Study|Adverse Event|0|||
128926616|NCT00858832|464018712|FG001|Overall Study|Adverse Event|1|||
128926617|NCT00389207|464018714|FG000|Overall Study|Adverse Event|26|||
128926618|NCT00389207|464018715|FG001|Overall Study|Adverse Event|32|||
128926619|NCT00389207|464018716|FG002|Overall Study|Adverse Event|10|||
129029634|NCT00640393|464399913|FG000|Part 1|Withdrawal by Subject|3|||
128926620|NCT00389207|464018714|FG000|Overall Study|Protocol Violation|3|||
128926621|NCT00389207|464018715|FG001|Overall Study|Protocol Violation|1|||
128926622|NCT00389207|464018716|FG002|Overall Study|Protocol Violation|4|||
128926623|NCT00389207|464018714|FG000|Overall Study|Lost to Follow-up|12|||
128926624|NCT00389207|464018715|FG001|Overall Study|Lost to Follow-up|9|||
128926625|NCT00389207|464018716|FG002|Overall Study|Lost to Follow-up|7|||
128926626|NCT00389207|464018714|FG000|Overall Study|Withdrawal by Subject|5|||
128926627|NCT00389207|464018715|FG001|Overall Study|Withdrawal by Subject|7|||
128926628|NCT00389207|464018716|FG002|Overall Study|Withdrawal by Subject|11|||
128926629|NCT00389207|464018714|FG000|Overall Study|Other|17|||
128926630|NCT00389207|464018715|FG001|Overall Study|Other|23|||
128926631|NCT00389207|464018716|FG002|Overall Study|Other|9|||
128926632|NCT03293680|464018721|FG000|Overall Study|Death|1|||
128767042|NCT02541383|463438103|FG000|Overall Study|Lost to Follow-up|5|||
128767043|NCT02541383|463438104|FG001|Overall Study|Lost to Follow-up|3|||
128767044|NCT02541383|463438105|FG002|Overall Study|Lost to Follow-up|1|||
128767045|NCT02541383|463438106|FG003|Overall Study|Lost to Follow-up|1|||
128926633|NCT03293680|464018721|FG000|Overall Study|Did not meet inclusion criteria|8|||
128926634|NCT02690701|464018724|FG000|Treatment Period 1|Adverse Event|2|||
128926635|NCT02690701|464018725|FG001|Treatment Period 1|Adverse Event|2|||
128926636|NCT02690701|464018724|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128926637|NCT02690701|464018725|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128926638|NCT02690701|464018724|FG000|Treatment Period 2|Adverse Event|2|||
128926639|NCT02690701|464018725|FG001|Treatment Period 2|Adverse Event|0|||
128926640|NCT02690701|464018724|FG000|Treatment Period 2|Lack of Efficacy|1|||
128926641|NCT02690701|464018725|FG001|Treatment Period 2|Lack of Efficacy|0|||
128926642|NCT02690701|464018724|FG000|Treatment Period 2|Lost to Follow-up|0|||
128926643|NCT02690701|464018725|FG001|Treatment Period 2|Lost to Follow-up|2|||
128926644|NCT02690701|464018724|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128926645|NCT02690701|464018725|FG001|Treatment Period 2|Withdrawal by Subject|2|||
128926646|NCT02690701|464018724|FG000|Treatment Period 2|Protocol Violation|0|||
128926647|NCT02690701|464018725|FG001|Treatment Period 2|Protocol Violation|1|||
128926648|NCT01309737|464018726|FG000|Week 0 to 16|Death|1|||
128926649|NCT01309737|464018727|FG001|Week 0 to 16|Death|0|||
128926650|NCT01309737|464018728|FG002|Week 0 to 16|Death|1|||
128926651|NCT01309737|464018729|FG003|Week 0 to 16|Death|0|||
128926652|NCT01309737|464018730|FG004|Week 0 to 16|Death|0|||
128926653|NCT01309737|464018726|FG000|Week 0 to 16|Adverse Event|11|||
128926654|NCT01309737|464018727|FG001|Week 0 to 16|Adverse Event|10|||
128926655|NCT01309737|464018728|FG002|Week 0 to 16|Adverse Event|5|||
128926656|NCT01309737|464018729|FG003|Week 0 to 16|Adverse Event|0|||
128926657|NCT01309737|464018730|FG004|Week 0 to 16|Adverse Event|0|||
128926658|NCT01309737|464018726|FG000|Week 0 to 16|Lack of Efficacy|15|||
128926659|NCT01309737|464018727|FG001|Week 0 to 16|Lack of Efficacy|2|||
128926660|NCT01309737|464018728|FG002|Week 0 to 16|Lack of Efficacy|24|||
128926661|NCT01309737|464018729|FG003|Week 0 to 16|Lack of Efficacy|0|||
128926662|NCT01309737|464018730|FG004|Week 0 to 16|Lack of Efficacy|0|||
128926663|NCT01309737|464018726|FG000|Week 0 to 16|Lost to Follow-up|7|||
128926664|NCT01309737|464018727|FG001|Week 0 to 16|Lost to Follow-up|8|||
128926665|NCT01309737|464018728|FG002|Week 0 to 16|Lost to Follow-up|3|||
128926666|NCT01309737|464018729|FG003|Week 0 to 16|Lost to Follow-up|0|||
128926667|NCT01309737|464018730|FG004|Week 0 to 16|Lost to Follow-up|0|||
128926668|NCT01309737|464018726|FG000|Week 0 to 16|Withdrawal by Subject|7|||
128926669|NCT01309737|464018727|FG001|Week 0 to 16|Withdrawal by Subject|6|||
128926670|NCT01309737|464018728|FG002|Week 0 to 16|Withdrawal by Subject|7|||
128926671|NCT01309737|464018729|FG003|Week 0 to 16|Withdrawal by Subject|0|||
128926672|NCT01309737|464018730|FG004|Week 0 to 16|Withdrawal by Subject|0|||
129029635|NCT00640393|464399914|FG001|Part 1|Withdrawal by Subject|0|||
129029636|NCT00640393|464399915|FG002|Part 1|Withdrawal by Subject|0|||
129029637|NCT00640393|464399913|FG000|Randomization|Withdrawn per protocol|17|||
128926673|NCT01309737|464018726|FG000|Week 0 to 16|Other|10|||
129029638|NCT00640393|464399914|FG001|Randomization|Withdrawn per protocol|0|||
129029639|NCT00640393|464399915|FG002|Randomization|Withdrawn per protocol|0|||
128926674|NCT01309737|464018727|FG001|Week 0 to 16|Other|14|||
128926675|NCT01309737|464018728|FG002|Week 0 to 16|Other|4|||
128926676|NCT01309737|464018729|FG003|Week 0 to 16|Other|0|||
128926677|NCT01309737|464018730|FG004|Week 0 to 16|Other|0|||
128926678|NCT01309737|464018726|FG000|Week 0 to 16|Randomized, but not treated|1|||
129029640|NCT00640393|464399913|FG000|Randomization|Never randomized by site|2|||
128767046|NCT02541383|463438107|FG004|Overall Study|Lost to Follow-up|3|||
128926679|NCT01309737|464018727|FG001|Week 0 to 16|Randomized, but not treated|0|||
128926680|NCT01309737|464018728|FG002|Week 0 to 16|Randomized, but not treated|0|||
128926681|NCT01309737|464018729|FG003|Week 0 to 16|Randomized, but not treated|0|||
128926682|NCT01309737|464018730|FG004|Week 0 to 16|Randomized, but not treated|0|||
128926683|NCT01309737|464018726|FG000|Week 16 to 52|Death|0|||
128926684|NCT01309737|464018727|FG001|Week 16 to 52|Death|0|||
128926685|NCT01309737|464018728|FG002|Week 16 to 52|Death|0|||
128926686|NCT01309737|464018729|FG003|Week 16 to 52|Death|0|||
128926687|NCT01309737|464018730|FG004|Week 16 to 52|Death|1|||
129029641|NCT00640393|464399914|FG001|Randomization|Never randomized by site|0|||
128767047|NCT02541383|463438108|FG005|Overall Study|Lost to Follow-up|0|||
128767048|NCT02541383|463438103|FG000|Overall Study|Consent withdrawn|5|||
128767049|NCT02541383|463438104|FG001|Overall Study|Consent withdrawn|6|||
128767050|NCT02541383|463438105|FG002|Overall Study|Consent withdrawn|1|||
128767051|NCT02541383|463438106|FG003|Overall Study|Consent withdrawn|1|||
128767052|NCT02541383|463438107|FG004|Overall Study|Consent withdrawn|0|||
128767053|NCT02541383|463438108|FG005|Overall Study|Consent withdrawn|0|||
128767054|NCT02541383|463438103|FG000|Overall Study|Sponsor's decision|1|||
128767055|NCT02541383|463438104|FG001|Overall Study|Sponsor's decision|1|||
128767056|NCT02541383|463438105|FG002|Overall Study|Sponsor's decision|0|||
128767057|NCT02541383|463438106|FG003|Overall Study|Sponsor's decision|0|||
128767058|NCT02541383|463438107|FG004|Overall Study|Sponsor's decision|0|||
128767059|NCT02541383|463438108|FG005|Overall Study|Sponsor's decision|0|||
128767060|NCT03500640|463438109|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
128767061|NCT03500640|463438110|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
128767062|NCT03500640|463438111|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
128767063|NCT03500640|463438109|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
128767064|NCT03500640|463438110|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
128767065|NCT03500640|463438111|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
128767066|NCT03500640|463438109|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
128767067|NCT03500640|463438110|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
128767068|NCT03500640|463438111|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
128767069|NCT03500640|463438109|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
128767070|NCT03500640|463438110|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
128767071|NCT03500640|463438111|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
128767072|NCT03500640|463438109|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
128767073|NCT03500640|463438110|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
128767074|NCT03500640|463438111|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
128767075|NCT03500640|463438109|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
128767076|NCT03500640|463438110|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
128767077|NCT03500640|463438111|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
128767078|NCT03500640|463438109|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
128767079|NCT03500640|463438110|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
128767080|NCT03500640|463438111|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
128767081|NCT03500640|463438109|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
128767082|NCT03500640|463438110|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
128767083|NCT03500640|463438111|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
128767084|NCT03500640|463438109|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
128767085|NCT03500640|463438110|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
128767086|NCT03500640|463438111|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
128767087|NCT03500640|463438109|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
128767088|NCT03500640|463438110|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
128767089|NCT03500640|463438111|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
128767090|NCT01650519|463438112|FG000|Overall Study|Withdrawal by Subject|1|||
128767091|NCT01650519|463438113|FG001|Overall Study|Withdrawal by Subject|0|||
128767092|NCT02690077|463438116|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
128767093|NCT02690077|463438117|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
128926688|NCT01309737|464018726|FG000|Week 16 to 52|Adverse Event|7|||
128926689|NCT01309737|464018727|FG001|Week 16 to 52|Adverse Event|7|||
128926690|NCT01309737|464018728|FG002|Week 16 to 52|Adverse Event|0|||
128926691|NCT01309737|464018729|FG003|Week 16 to 52|Adverse Event|6|||
128926692|NCT01309737|464018730|FG004|Week 16 to 52|Adverse Event|5|||
128926693|NCT01309737|464018726|FG000|Week 16 to 52|Lack of Efficacy|107|||
128926694|NCT01309737|464018727|FG001|Week 16 to 52|Lack of Efficacy|76|||
128926695|NCT01309737|464018728|FG002|Week 16 to 52|Lack of Efficacy|0|||
128926696|NCT01309737|464018729|FG003|Week 16 to 52|Lack of Efficacy|25|||
128926697|NCT01309737|464018730|FG004|Week 16 to 52|Lack of Efficacy|21|||
128926698|NCT01309737|464018726|FG000|Week 16 to 52|Lost to Follow-up|4|||
128926699|NCT01309737|464018727|FG001|Week 16 to 52|Lost to Follow-up|2|||
128926700|NCT01309737|464018728|FG002|Week 16 to 52|Lost to Follow-up|0|||
129029642|NCT00640393|464399915|FG002|Randomization|Never randomized by site|0|||
129029643|NCT00640393|464399913|FG000|Part 2|Lost to Follow-up|0|||
128767094|NCT02690077|463438116|FG000|Overall Study|Withdrawal by Subject|0|||
128767095|NCT02690077|463438117|FG001|Overall Study|Withdrawal by Subject|5|||
128767096|NCT02690077|463438116|FG000|Overall Study|Excluded by IRB|0|||
128767097|NCT02690077|463438117|FG001|Overall Study|Excluded by IRB|2|||
128926701|NCT01309737|464018729|FG003|Week 16 to 52|Lost to Follow-up|1|||
128926702|NCT01309737|464018730|FG004|Week 16 to 52|Lost to Follow-up|4|||
128767098|NCT01845974|463438118|FG000|Overall Study|screen failure|1|||
128767099|NCT01845974|463438119|FG001|Overall Study|screen failure|0|||
128926703|NCT01309737|464018726|FG000|Week 16 to 52|Withdrawal by Subject|5|||
128926704|NCT01309737|464018727|FG001|Week 16 to 52|Withdrawal by Subject|6|||
129029644|NCT00640393|464399914|FG001|Part 2|Lost to Follow-up|2|||
128926705|NCT01309737|464018728|FG002|Week 16 to 52|Withdrawal by Subject|0|||
128926706|NCT01309737|464018729|FG003|Week 16 to 52|Withdrawal by Subject|0|||
128926707|NCT01309737|464018730|FG004|Week 16 to 52|Withdrawal by Subject|2|||
128926708|NCT01309737|464018726|FG000|Week 16 to 52|Other|10|||
128926709|NCT01309737|464018727|FG001|Week 16 to 52|Other|12|||
128926710|NCT01309737|464018728|FG002|Week 16 to 52|Other|0|||
128926711|NCT01309737|464018729|FG003|Week 16 to 52|Other|2|||
128926712|NCT01309737|464018730|FG004|Week 16 to 52|Other|0|||
128926713|NCT01442181|464018731|FG000|Overall Study|patient refused surgery|1|||
128926714|NCT01442181|464018732|FG001|Overall Study|patient refused surgery|0|||
129029645|NCT00640393|464399915|FG002|Part 2|Lost to Follow-up|2|||
129029646|NCT00640393|464399913|FG000|Part 2|Withdrawal by Subject|0|||
129029647|NCT00640393|464399914|FG001|Part 2|Withdrawal by Subject|6|||
129029648|NCT00640393|464399915|FG002|Part 2|Withdrawal by Subject|1|||
129029649|NCT00640393|464399913|FG000|Part 2|Non-adherence|0|||
129029650|NCT00640393|464399914|FG001|Part 2|Non-adherence|1|||
129029651|NCT00640393|464399915|FG002|Part 2|Non-adherence|0|||
129029652|NCT00640393|464399913|FG000|Part 2|Adverse Event|0|||
129029653|NCT00640393|464399914|FG001|Part 2|Adverse Event|1|||
129029654|NCT00640393|464399915|FG002|Part 2|Adverse Event|0|||
129029655|NCT04406194|464399917|FG000|Period 1|Withdrawal by Subject|0|||
129029656|NCT04406194|464399918|FG001|Period 1|Withdrawal by Subject|1|||
129029657|NCT02998541|464399919|FG000|Overall Study|Adverse Event|4|||
129029658|NCT02998541|464399920|FG001|Overall Study|Adverse Event|5|||
129029659|NCT02998541|464399921|FG002|Overall Study|Adverse Event|1|||
129029660|NCT02998541|464399919|FG000|Overall Study|Protocol Violation|1|||
129029661|NCT02998541|464399920|FG001|Overall Study|Protocol Violation|0|||
129029662|NCT02998541|464399921|FG002|Overall Study|Protocol Violation|0|||
129029663|NCT02998541|464399919|FG000|Overall Study|Withdrawal by Subject|3|||
129029664|NCT02998541|464399920|FG001|Overall Study|Withdrawal by Subject|1|||
129029665|NCT02998541|464399921|FG002|Overall Study|Withdrawal by Subject|0|||
129029666|NCT02998541|464399919|FG000|Overall Study|Lost to Follow-up|0|||
129029667|NCT02998541|464399920|FG001|Overall Study|Lost to Follow-up|3|||
129029668|NCT02998541|464399921|FG002|Overall Study|Lost to Follow-up|1|||
129029669|NCT02998541|464399919|FG000|Overall Study|Physician Decision|0|||
129029670|NCT02998541|464399920|FG001|Overall Study|Physician Decision|0|||
129029671|NCT02998541|464399921|FG002|Overall Study|Physician Decision|3|||
129029672|NCT02998541|464399919|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129029673|NCT02998541|464399920|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129029674|NCT02998541|464399921|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
128926715|NCT01442181|464018731|FG000|Overall Study|no insurance for surgery|1|||
128926716|NCT01442181|464018732|FG001|Overall Study|no insurance for surgery|0|||
128926717|NCT01442181|464018731|FG000|Overall Study|low ejection factor|0|||
128926718|NCT01442181|464018732|FG001|Overall Study|low ejection factor|1|||
128926719|NCT01442181|464018731|FG000|Overall Study|Lost to Follow-up|1|||
128926720|NCT01442181|464018732|FG001|Overall Study|Lost to Follow-up|1|||
128926721|NCT01442181|464018731|FG000|Overall Study|patient in an additional study|1|||
128926722|NCT01442181|464018732|FG001|Overall Study|patient in an additional study|0|||
128926723|NCT01442181|464018731|FG000|Overall Study|atrial fibrillation not noted|0|||
128926724|NCT01442181|464018732|FG001|Overall Study|atrial fibrillation not noted|1|||
128926725|NCT00709202|464018733|FG000|Overall Study|Withdrawal by Subject|6|||
128926726|NCT00709202|464018734|FG001|Overall Study|Withdrawal by Subject|6|||
128926727|NCT01822561|464018736|FG000|Overall Study|Withdrawal by Subject|2|||
128926728|NCT02597062|464018737|FG000|Overall Study|Ineligible|1|||
128926729|NCT00947349|464018738|FG000|Triple Treatment Combination Period|Adverse Event|0|||
128926730|NCT00947349|464018739|FG001|Triple Treatment Combination Period|Adverse Event|1|||
128926731|NCT00947349|464018740|FG002|Triple Treatment Combination Period|Adverse Event|0|||
128926732|NCT00947349|464018741|FG003|Triple Treatment Combination Period|Adverse Event|0|||
128926733|NCT00947349|464018738|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
128926734|NCT00947349|464018739|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
128926735|NCT00947349|464018740|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
128926736|NCT00947349|464018741|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
128926737|NCT00947349|464018738|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
128926738|NCT00947349|464018739|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
128926739|NCT00947349|464018740|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
128926740|NCT00947349|464018741|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
129029675|NCT00396162|464399922|FG000|Overall Study|Withdrawal by Subject|2|||
129029676|NCT00396162|464399923|FG001|Overall Study|Withdrawal by Subject|3|||
128926741|NCT00947349|464018738|FG000|Overall Study Standard of Care|Other|0|||
128926742|NCT00947349|464018739|FG001|Overall Study Standard of Care|Other|0|||
128926743|NCT00947349|464018740|FG002|Overall Study Standard of Care|Other|0|||
128926744|NCT00947349|464018741|FG003|Overall Study Standard of Care|Other|1|||
129029677|NCT01664039|464399925|FG000|Overall Study|Adverse Event|3|||
129029678|NCT01664039|464399926|FG001|Overall Study|Adverse Event|4|||
129029679|NCT01664039|464399925|FG000|Overall Study|Lost to Follow-up|1|||
129029680|NCT01664039|464399926|FG001|Overall Study|Lost to Follow-up|1|||
129029681|NCT01664039|464399925|FG000|Overall Study|Withdrawal by Subject|1|||
128926745|NCT00538681|464018742|FG000|Overall Study|Progressive Disease|7|||
128926746|NCT00538681|464018743|FG001|Overall Study|Progressive Disease|0|||
128926747|NCT00538681|464018744|FG002|Overall Study|Progressive Disease|1|||
128926748|NCT00538681|464018745|FG003|Overall Study|Progressive Disease|0|||
128926749|NCT00538681|464018742|FG000|Overall Study|Sponsor Decision|1|||
128926750|NCT00538681|464018743|FG001|Overall Study|Sponsor Decision|3|||
129029682|NCT01664039|464399926|FG001|Overall Study|Withdrawal by Subject|3|||
129029683|NCT01664039|464399925|FG000|Overall Study|Noncompliance|1|||
129029684|NCT01664039|464399926|FG001|Overall Study|Noncompliance|1|||
129029685|NCT01186458|464399930|FG000|Overall Study|Adverse Event|1|||
128926751|NCT00538681|464018744|FG002|Overall Study|Sponsor Decision|8|||
128926752|NCT00538681|464018745|FG003|Overall Study|Sponsor Decision|9|||
128926753|NCT00538681|464018742|FG000|Overall Study|Adverse Event|1|||
128926754|NCT00538681|464018743|FG001|Overall Study|Adverse Event|1|||
128926755|NCT00538681|464018744|FG002|Overall Study|Adverse Event|1|||
128926756|NCT00538681|464018745|FG003|Overall Study|Adverse Event|0|||
128926757|NCT00538681|464018742|FG000|Overall Study|Death|0|||
128926758|NCT00538681|464018743|FG001|Overall Study|Death|0|||
128926759|NCT00538681|464018744|FG002|Overall Study|Death|1|||
128926760|NCT00538681|464018745|FG003|Overall Study|Death|1|||
128926761|NCT00538681|464018742|FG000|Overall Study|Investigator Decision|0|||
128926762|NCT00538681|464018743|FG001|Overall Study|Investigator Decision|0|||
128926763|NCT00538681|464018744|FG002|Overall Study|Investigator Decision|0|||
128926764|NCT00538681|464018745|FG003|Overall Study|Investigator Decision|1|||
128926765|NCT02970929|464018746|FG000|Overall Study|Adverse Event|18|||
128926766|NCT02970929|464018746|FG000|Overall Study|Lack of Efficacy|8|||
128926767|NCT02970929|464018746|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
128926768|NCT02970929|464018746|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
128926769|NCT02970929|464018746|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
128926770|NCT02970929|464018746|FG000|Overall Study|LOST TO FOLLOWUP|6|||
128926771|NCT02970929|464018746|FG000|Overall Study|MOVED OUT OF STATE|1|||
128926772|NCT02970929|464018746|FG000|Overall Study|Withdrawal by Subject|16|||
128926773|NCT05369806|464018749|FG000|Overall Study|Lost to Follow-up|1|||
128926774|NCT03929250|464018756|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
128926775|NCT03929250|464018757|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
128926776|NCT05262764|464018762|FG000|Overall Study|Case report form not collected|9|||
128926777|NCT05262764|464018762|FG000|Overall Study|No patient visits after entry|23|||
128926778|NCT05262764|464018762|FG000|Overall Study|Registration rule not followed|2|||
128926779|NCT05262764|464018762|FG000|Overall Study|Patient of non-chronic heart failure|1|||
128926780|NCT01392183|464018763|FG000|First Drug Administration|Adverse Event|3|||
128926781|NCT01392183|464018764|FG001|First Drug Administration|Adverse Event|2|||
128926782|NCT01392183|464018763|FG000|First Drug Administration|Death|1|||
128926783|NCT01392183|464018764|FG001|First Drug Administration|Death|0|||
128926784|NCT01392183|464018763|FG000|First Drug Administration|Withdrawal by Subject|10|||
128926785|NCT01392183|464018764|FG001|First Drug Administration|Withdrawal by Subject|17|||
128926786|NCT04321343|464018765|FG000|Overall Study|Adverse Event|0|||
128926787|NCT04321343|464018766|FG001|Overall Study|Adverse Event|0|||
128926788|NCT04321343|464018767|FG002|Overall Study|Adverse Event|1|||
128926789|NCT04321343|464018768|FG003|Overall Study|Adverse Event|0|||
128926790|NCT04321343|464018765|FG000|Overall Study|Death|0|||
128926791|NCT04321343|464018766|FG001|Overall Study|Death|0|||
128926792|NCT04321343|464018767|FG002|Overall Study|Death|0|||
128926793|NCT04321343|464018768|FG003|Overall Study|Death|1|||
128926794|NCT04321343|464018765|FG000|Overall Study|Pregnancy|1|||
128926795|NCT04321343|464018766|FG001|Overall Study|Pregnancy|0|||
128926796|NCT04321343|464018767|FG002|Overall Study|Pregnancy|0|||
128926797|NCT04321343|464018768|FG003|Overall Study|Pregnancy|0|||
128926798|NCT04321343|464018765|FG000|Overall Study|Protocol Violation|1|||
128926799|NCT04321343|464018766|FG001|Overall Study|Protocol Violation|1|||
128926800|NCT04321343|464018767|FG002|Overall Study|Protocol Violation|1|||
128926801|NCT04321343|464018768|FG003|Overall Study|Protocol Violation|1|||
129029686|NCT00354835|464399931|FG000|Overall Study|Death|1|||
129029687|NCT00354835|464399932|FG001|Overall Study|Death|1|||
129029688|NCT00354835|464399931|FG000|Overall Study|Physician Decision|8|||
129029689|NCT00354835|464399932|FG001|Overall Study|Physician Decision|13|||
129029690|NCT00354835|464399931|FG000|Overall Study|Withdrawal by Subject|2|||
128926802|NCT04321343|464018765|FG000|Overall Study|Withdrawal by Subject|0|||
128926803|NCT04321343|464018766|FG001|Overall Study|Withdrawal by Subject|6|||
128926804|NCT04321343|464018767|FG002|Overall Study|Withdrawal by Subject|0|||
128926805|NCT04321343|464018768|FG003|Overall Study|Withdrawal by Subject|2|||
129029691|NCT00354835|464399932|FG001|Overall Study|Withdrawal by Subject|1|||
129029692|NCT00354835|464399931|FG000|Overall Study|Ineligible|17|||
128926806|NCT04321343|464018765|FG000|Overall Study|Lost to Follow-up|2|||
128926807|NCT04321343|464018766|FG001|Overall Study|Lost to Follow-up|2|||
128926808|NCT04321343|464018767|FG002|Overall Study|Lost to Follow-up|1|||
128926809|NCT04321343|464018768|FG003|Overall Study|Lost to Follow-up|3|||
129029693|NCT00354835|464399932|FG001|Overall Study|Ineligible|16|||
129029694|NCT00354835|464399931|FG000|Overall Study|Disease progression or relapse|15|||
128926810|NCT03430310|464018769|FG000|Overall Study|Protocol Violation|2|||
128926811|NCT03430310|464018770|FG001|Overall Study|Protocol Violation|0|||
128926812|NCT03430310|464018769|FG000|Overall Study|Withdrawal by Subject|3|||
128926813|NCT03430310|464018770|FG001|Overall Study|Withdrawal by Subject|2|||
128926814|NCT03430310|464018769|FG000|Overall Study|COVID shutdown March 2020|0|||
128926815|NCT03430310|464018770|FG001|Overall Study|COVID shutdown March 2020|1|||
128926816|NCT03476239|464018772|FG000|Overall Study|Withdrawal by Subject|10|||
128926817|NCT03476239|464018772|FG000|Overall Study|Death|80|||
128926818|NCT03476239|464018772|FG000|Overall Study|Lost to Follow-up|8|||
128926819|NCT01446809|464018776|FG000|Overall Study|Adverse Event|0|||
128926820|NCT01446809|464018777|FG001|Overall Study|Adverse Event|0|||
128926821|NCT01446809|464018778|FG002|Overall Study|Adverse Event|1|||
128926822|NCT01446809|464018776|FG000|Overall Study|Failure to complete study procedures|0|||
128926823|NCT01446809|464018777|FG001|Overall Study|Failure to complete study procedures|0|||
128926824|NCT01446809|464018778|FG002|Overall Study|Failure to complete study procedures|1|||
128926825|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
128926826|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
128926827|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
128926828|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
128926829|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
128926830|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
128926831|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
128926832|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
128926833|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
128926834|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
128926835|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
128926836|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
128926837|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
128926838|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
128926839|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
128926840|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
128926841|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
128926842|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
128926843|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
128926844|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
128926845|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
128926846|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
128926847|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
128926848|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
128926849|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
128926850|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
128926851|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
128926852|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
128926853|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
128926854|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
128926855|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
128926856|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
128926857|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
128926858|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
128926859|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
128926860|NCT00785577|464018779|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
128926861|NCT00785577|464018780|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
128926862|NCT00785577|464018781|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
128926863|NCT00785577|464018782|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
128926864|NCT00785577|464018783|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
128926865|NCT00785577|464018779|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
128926866|NCT00785577|464018780|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
128926867|NCT00785577|464018781|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
128926868|NCT00785577|464018782|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
129216372|NCT00538902|465092906|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
129216373|NCT00538902|465092907|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
129216374|NCT00538902|465092908|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
128926869|NCT00785577|464018783|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
128926870|NCT00785577|464018779|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
128926871|NCT00785577|464018780|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
128926872|NCT00785577|464018781|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
128926873|NCT00785577|464018782|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
128926874|NCT00785577|464018783|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
128926875|NCT01097044|464018784|FG000|Overall Study|Withdrawal by Subject|4|||
129216375|NCT03739203|465092909|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
128926876|NCT01097044|464018785|FG001|Overall Study|Withdrawal by Subject|4|||
128926877|NCT01097044|464018784|FG000|Overall Study|Lost to Follow-up|1|||
128926878|NCT01097044|464018785|FG001|Overall Study|Lost to Follow-up|0|||
128926879|NCT01097044|464018784|FG000|Overall Study|Withdrawal by Sponsor|0|||
128926880|NCT01097044|464018785|FG001|Overall Study|Withdrawal by Sponsor|1|||
128926881|NCT01331161|464018786|FG000|Overall Study|Physician Decision|1|||
128926882|NCT01331161|464018787|FG001|Overall Study|Physician Decision|0|||
128926883|NCT01331161|464018786|FG000|Overall Study|Lost to Follow-up|0|||
128926884|NCT01331161|464018787|FG001|Overall Study|Lost to Follow-up|1|||
128926885|NCT01331161|464018786|FG000|Overall Study|Pregnancy|0|||
128926886|NCT01331161|464018787|FG001|Overall Study|Pregnancy|1|||
128926887|NCT01682044|464018788|FG000|Overall Study|Death|1|||
128926888|NCT01682044|464018788|FG000|Overall Study|Progression|3|||
128926889|NCT01826214|464020344|FG000|Overall Study|Adverse Event|7|||
128926890|NCT01826214|464020345|FG001|Overall Study|Adverse Event|6|||
128926891|NCT01826214|464020344|FG000|Overall Study|Death|3|||
128926892|NCT01826214|464020345|FG001|Overall Study|Death|1|||
128926893|NCT01826214|464020344|FG000|Overall Study|Lost to Follow-up|1|||
128926894|NCT01826214|464020345|FG001|Overall Study|Lost to Follow-up|0|||
128926895|NCT01826214|464020344|FG000|Overall Study|Physician Decision|0|||
128926896|NCT01826214|464020345|FG001|Overall Study|Physician Decision|2|||
128926897|NCT01826214|464020344|FG000|Overall Study|Progressive disease|22|||
128926898|NCT01826214|464020345|FG001|Overall Study|Progressive disease|21|||
128926899|NCT01826214|464020344|FG000|Overall Study|Study terminated by Sponsor|0|||
128926900|NCT01826214|464020345|FG001|Overall Study|Study terminated by Sponsor|1|||
128926901|NCT01826214|464020344|FG000|Overall Study|Subject/guardian decision|2|||
128926902|NCT01826214|464020345|FG001|Overall Study|Subject/guardian decision|3|||
128926903|NCT01056107|464020348|FG000|Overall Study|Withdrawal by Subject|0|||
128926904|NCT01056107|464020349|FG001|Overall Study|Withdrawal by Subject|1|||
128926905|NCT01056107|464020350|FG002|Overall Study|Withdrawal by Subject|3|||
128926906|NCT01056107|464020351|FG003|Overall Study|Withdrawal by Subject|0|||
128926907|NCT02017444|464020352|FG000|Overall Study|Physician Decision|1|||
128926908|NCT02017444|464020353|FG001|Overall Study|Physician Decision|0|||
128926909|NCT02017444|464020352|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
128926910|NCT02017444|464020353|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
128926911|NCT01614457|464020354|FG000|Overall Study|Non-Compliance|1|||
128926912|NCT01614457|464020355|FG001|Overall Study|Non-Compliance|0|||
128926913|NCT01614457|464020354|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
128926914|NCT01614457|464020355|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
128926915|NCT00374556|464020358|FG000|Overall Study|Lost to Follow-up|1|||
128926916|NCT00374556|464020359|FG001|Overall Study|Lost to Follow-up|0|||
128926917|NCT00374556|464020358|FG000|Overall Study|Removed at baseline due to medical cond|0|||
128926918|NCT00374556|464020359|FG001|Overall Study|Removed at baseline due to medical cond|1|||
128926919|NCT03874234|464020365|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926920|NCT03874234|464020366|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926921|NCT03874234|464020367|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926922|NCT03874234|464020368|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
128926923|NCT03874234|464020369|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926924|NCT03874234|464020370|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926925|NCT03874234|464020371|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926926|NCT03874234|464020372|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926927|NCT03874234|464020373|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926928|NCT03874234|464020374|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926929|NCT03874234|464020375|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926930|NCT03874234|464020376|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926931|NCT03874234|464020377|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
128926932|NCT03874234|464020365|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
128926933|NCT03874234|464020366|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926934|NCT03874234|464020367|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926935|NCT03874234|464020368|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926936|NCT03874234|464020369|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926937|NCT03874234|464020370|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926938|NCT03874234|464020371|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926939|NCT03874234|464020372|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926940|NCT03874234|464020373|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926941|NCT03874234|464020374|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926942|NCT03874234|464020375|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926943|NCT03874234|464020376|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926944|NCT03874234|464020377|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
128926945|NCT03874234|464020365|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926946|NCT03874234|464020366|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926947|NCT03874234|464020367|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926948|NCT03874234|464020368|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
128926949|NCT03874234|464020369|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926950|NCT03874234|464020370|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926951|NCT03874234|464020371|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926952|NCT03874234|464020372|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926953|NCT03874234|464020373|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926954|NCT03874234|464020374|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926955|NCT03874234|464020375|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926956|NCT03874234|464020376|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926957|NCT03874234|464020377|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
128926958|NCT03874234|464020365|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926959|NCT03874234|464020366|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926960|NCT03874234|464020367|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926961|NCT03874234|464020368|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926962|NCT03874234|464020369|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
128926963|NCT03874234|464020370|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926964|NCT03874234|464020371|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926965|NCT03874234|464020372|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926966|NCT03874234|464020373|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128767100|NCT05408468|463438120|FG000|Overall Study|Lost to Follow-up|3|||
128926967|NCT03874234|464020374|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926968|NCT03874234|464020375|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926969|NCT03874234|464020376|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926970|NCT03874234|464020377|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
128926971|NCT03874234|464020365|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926972|NCT03874234|464020366|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926973|NCT03874234|464020367|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926974|NCT03874234|464020368|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926975|NCT03874234|464020369|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926976|NCT03874234|464020370|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926977|NCT03874234|464020371|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926978|NCT03874234|464020372|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
128926979|NCT03874234|464020373|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926980|NCT03874234|464020374|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926981|NCT03874234|464020375|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926982|NCT03874234|464020376|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926983|NCT03874234|464020377|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
128926984|NCT03874234|464020365|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926985|NCT03874234|464020366|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926986|NCT03874234|464020367|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926987|NCT03874234|464020368|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128767101|NCT05408468|463438121|FG001|Overall Study|Lost to Follow-up|1|||
128767102|NCT05408468|463438120|FG000|Overall Study|Physician Decision|1|||
128767103|NCT05408468|463438121|FG001|Overall Study|Physician Decision|0|||
128767104|NCT05408468|463438120|FG000|Overall Study|Overwhelmed by clinical situation|3|||
128767105|NCT05408468|463438121|FG001|Overall Study|Overwhelmed by clinical situation|0|||
128926988|NCT03874234|464020369|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
128926989|NCT03874234|464020370|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
128926990|NCT03874234|464020371|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926991|NCT03874234|464020372|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926992|NCT03874234|464020373|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926993|NCT03874234|464020374|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926994|NCT03874234|464020375|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926995|NCT03874234|464020376|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926996|NCT03874234|464020377|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
128926997|NCT03874234|464020365|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129119095|NCT01041859|464733207|FG000|Open-Label Titration|Adverse Event|69|||
129119096|NCT01041859|464733208|FG001|Open-Label Titration|Adverse Event|0|||
129119097|NCT01041859|464733209|FG002|Open-Label Titration|Adverse Event|0|||
129119098|NCT01041859|464733207|FG000|Open-Label Titration|Lack of Efficacy|3|||
129119099|NCT01041859|464733208|FG001|Open-Label Titration|Lack of Efficacy|0|||
129119100|NCT01041859|464733209|FG002|Open-Label Titration|Lack of Efficacy|0|||
129119101|NCT01041859|464733207|FG000|Open-Label Titration|Lost to Follow-up|1|||
129119102|NCT01041859|464733208|FG001|Open-Label Titration|Lost to Follow-up|0|||
129119103|NCT01041859|464733209|FG002|Open-Label Titration|Lost to Follow-up|0|||
129119104|NCT01041859|464733207|FG000|Open-Label Titration|Physician Decision|1|||
129119105|NCT01041859|464733208|FG001|Open-Label Titration|Physician Decision|0|||
129119106|NCT01041859|464733209|FG002|Open-Label Titration|Physician Decision|0|||
129119107|NCT01041859|464733207|FG000|Open-Label Titration|Protocol Violation|1|||
128926998|NCT03874234|464020366|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128926999|NCT03874234|464020367|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927000|NCT03874234|464020368|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927001|NCT03874234|464020369|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927002|NCT03874234|464020370|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927003|NCT03874234|464020371|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
128927004|NCT03874234|464020372|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927005|NCT03874234|464020373|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927006|NCT03874234|464020374|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927007|NCT03874234|464020375|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927008|NCT03874234|464020376|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927009|NCT03874234|464020377|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
128927010|NCT03874234|464020365|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927011|NCT03874234|464020366|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927012|NCT03874234|464020367|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927013|NCT03874234|464020368|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927014|NCT03874234|464020369|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
128927015|NCT03874234|464020370|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927016|NCT03874234|464020371|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927017|NCT03874234|464020372|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927018|NCT03874234|464020373|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927019|NCT03874234|464020374|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927020|NCT03874234|464020375|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927021|NCT03874234|464020376|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927022|NCT03874234|464020377|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
128927023|NCT01821963|464020379|FG000|Overall Study|Adverse Event|1|||
128927024|NCT00783289|464020380|FG000|Overall Study|Protocol Violation|0|||
128927025|NCT00783289|464020381|FG001|Overall Study|Protocol Violation|1|||
128927026|NCT00783289|464020382|FG002|Overall Study|Protocol Violation|0|||
128927027|NCT00783289|464020383|FG003|Overall Study|Protocol Violation|0|||
128927028|NCT01896232|464020384|FG000|Overall Study|Death|6|||
128927029|NCT01896232|464020385|FG001|Overall Study|Death|10|||
128927030|NCT01896232|464020384|FG000|Overall Study|Withdrawal by Subject|32|||
128927031|NCT01896232|464020385|FG001|Overall Study|Withdrawal by Subject|31|||
128927032|NCT01896232|464020384|FG000|Overall Study|Sponsor Decision|2|||
128927033|NCT01896232|464020385|FG001|Overall Study|Sponsor Decision|0|||
128927034|NCT01896232|464020384|FG000|Overall Study|Lost to Follow-up|9|||
128927035|NCT01896232|464020385|FG001|Overall Study|Lost to Follow-up|12|||
128927036|NCT00686205|464020392|FG000|Overall Study|Protocol Violation|127|||
128927037|NCT00686205|464020393|FG001|Overall Study|Protocol Violation|0|||
128927038|NCT00686205|464020392|FG000|Overall Study|Withdrawal by Subject|2|||
128927039|NCT00686205|464020393|FG001|Overall Study|Withdrawal by Subject|0|||
128927040|NCT00686205|464020392|FG000|Overall Study|Specimen handling procedure altered|5878|||
128927041|NCT00686205|464020393|FG001|Overall Study|Specimen handling procedure altered|0|||
128927042|NCT00686205|464020392|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
128927043|NCT00686205|464020393|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
128927044|NCT00265941|464020394|FG000|Overall Study|Protocol Violation|22|||
128927045|NCT00265941|464020395|FG001|Overall Study|Protocol Violation|25|||
128927046|NCT00265941|464020394|FG000|Overall Study|Lost to Follow-up|1|||
128927047|NCT00265941|464020395|FG001|Overall Study|Lost to Follow-up|1|||
128927048|NCT03816995|464020398|FG000|Overall Study|Withdrawal by Subject|3|||
128927049|NCT03816995|464020399|FG001|Overall Study|Withdrawal by Subject|1|||
128927050|NCT03816995|464020398|FG000|Overall Study|Cancelled Surgery|8|||
128927051|NCT03816995|464020399|FG001|Overall Study|Cancelled Surgery|12|||
128927052|NCT03816995|464020398|FG000|Overall Study|No wound protector used|11|||
128927053|NCT03816995|464020399|FG001|Overall Study|No wound protector used|17|||
128927054|NCT03816995|464020398|FG000|Overall Study|Protocol Violation|2|||
128927055|NCT03816995|464020399|FG001|Overall Study|Protocol Violation|3|||
128927056|NCT01324830|464020401|FG000|Overall Study|Progressive Disease|3|||
128927057|NCT01324830|464020402|FG001|Overall Study|Progressive Disease|2|||
128927058|NCT01324830|464020403|FG002|Overall Study|Progressive Disease|3|||
128927059|NCT01324830|464020404|FG003|Overall Study|Progressive Disease|3|||
128927060|NCT01324830|464020405|FG004|Overall Study|Progressive Disease|6|||
128927061|NCT01324830|464020406|FG005|Overall Study|Progressive Disease|6|||
128927062|NCT01324830|464020407|FG006|Overall Study|Progressive Disease|3|||
128767106|NCT05408468|463438120|FG000|Overall Study|Personal illness precluding participation|1|||
128927063|NCT01324830|464020408|FG007|Overall Study|Progressive Disease|3|||
128927064|NCT01324830|464020409|FG008|Overall Study|Progressive Disease|3|||
128927065|NCT01324830|464020410|FG009|Overall Study|Progressive Disease|6|||
128927066|NCT01324830|464020411|FG010|Overall Study|Progressive Disease|2|||
128927067|NCT01324830|464020412|FG011|Overall Study|Progressive Disease|1|||
128927068|NCT01324830|464020413|FG012|Overall Study|Progressive Disease|1|||
128927069|NCT01324830|464020414|FG013|Overall Study|Progressive Disease|1|||
128927070|NCT01324830|464020415|FG014|Overall Study|Progressive Disease|1|||
128927071|NCT01324830|464020416|FG015|Overall Study|Progressive Disease|3|||
128927072|NCT01324830|464020417|FG016|Overall Study|Progressive Disease|2|||
128927073|NCT01324830|464020418|FG017|Overall Study|Progressive Disease|3|||
128927074|NCT01324830|464020419|FG018|Overall Study|Progressive Disease|4|||
128927075|NCT01324830|464020401|FG000|Overall Study|Dose limiting toxicity|0|||
128927076|NCT01324830|464020402|FG001|Overall Study|Dose limiting toxicity|0|||
128927077|NCT01324830|464020403|FG002|Overall Study|Dose limiting toxicity|0|||
128927078|NCT01324830|464020404|FG003|Overall Study|Dose limiting toxicity|0|||
128927079|NCT01324830|464020405|FG004|Overall Study|Dose limiting toxicity|1|||
128927080|NCT01324830|464020406|FG005|Overall Study|Dose limiting toxicity|0|||
128927081|NCT01324830|464020407|FG006|Overall Study|Dose limiting toxicity|0|||
128927082|NCT01324830|464020408|FG007|Overall Study|Dose limiting toxicity|0|||
128927083|NCT01324830|464020409|FG008|Overall Study|Dose limiting toxicity|0|||
128927084|NCT01324830|464020410|FG009|Overall Study|Dose limiting toxicity|0|||
128927085|NCT01324830|464020411|FG010|Overall Study|Dose limiting toxicity|0|||
128927086|NCT01324830|464020412|FG011|Overall Study|Dose limiting toxicity|0|||
128927087|NCT01324830|464020413|FG012|Overall Study|Dose limiting toxicity|0|||
128927088|NCT01324830|464020414|FG013|Overall Study|Dose limiting toxicity|0|||
128927089|NCT01324830|464020415|FG014|Overall Study|Dose limiting toxicity|0|||
128927090|NCT01324830|464020416|FG015|Overall Study|Dose limiting toxicity|0|||
128927091|NCT01324830|464020417|FG016|Overall Study|Dose limiting toxicity|1|||
128927092|NCT01324830|464020418|FG017|Overall Study|Dose limiting toxicity|1|||
128927093|NCT01324830|464020419|FG018|Overall Study|Dose limiting toxicity|1|||
128927094|NCT01324830|464020401|FG000|Overall Study|Reason not mentioned above|0|||
128927095|NCT01324830|464020402|FG001|Overall Study|Reason not mentioned above|0|||
128927096|NCT01324830|464020403|FG002|Overall Study|Reason not mentioned above|0|||
128927097|NCT01324830|464020404|FG003|Overall Study|Reason not mentioned above|0|||
128927098|NCT01324830|464020405|FG004|Overall Study|Reason not mentioned above|0|||
128927099|NCT01324830|464020406|FG005|Overall Study|Reason not mentioned above|0|||
128927100|NCT01324830|464020407|FG006|Overall Study|Reason not mentioned above|0|||
128927101|NCT01324830|464020408|FG007|Overall Study|Reason not mentioned above|0|||
128927102|NCT01324830|464020409|FG008|Overall Study|Reason not mentioned above|0|||
128927103|NCT01324830|464020410|FG009|Overall Study|Reason not mentioned above|0|||
128927104|NCT01324830|464020411|FG010|Overall Study|Reason not mentioned above|0|||
128927105|NCT01324830|464020412|FG011|Overall Study|Reason not mentioned above|0|||
128927106|NCT01324830|464020413|FG012|Overall Study|Reason not mentioned above|0|||
128927107|NCT01324830|464020414|FG013|Overall Study|Reason not mentioned above|0|||
128927108|NCT01324830|464020415|FG014|Overall Study|Reason not mentioned above|0|||
128927109|NCT01324830|464020416|FG015|Overall Study|Reason not mentioned above|0|||
128927110|NCT01324830|464020417|FG016|Overall Study|Reason not mentioned above|0|||
128927111|NCT01324830|464020418|FG017|Overall Study|Reason not mentioned above|1|||
128927112|NCT01324830|464020419|FG018|Overall Study|Reason not mentioned above|0|||
128927113|NCT01324830|464020401|FG000|Overall Study|Adverse Event, serious fatal|0|||
128927114|NCT01324830|464020402|FG001|Overall Study|Adverse Event, serious fatal|1|||
128927115|NCT01324830|464020403|FG002|Overall Study|Adverse Event, serious fatal|0|||
128927116|NCT01324830|464020404|FG003|Overall Study|Adverse Event, serious fatal|0|||
128927117|NCT01324830|464020405|FG004|Overall Study|Adverse Event, serious fatal|0|||
128927118|NCT01324830|464020406|FG005|Overall Study|Adverse Event, serious fatal|0|||
128927119|NCT01324830|464020407|FG006|Overall Study|Adverse Event, serious fatal|0|||
128927120|NCT01324830|464020408|FG007|Overall Study|Adverse Event, serious fatal|0|||
128927121|NCT01324830|464020409|FG008|Overall Study|Adverse Event, serious fatal|0|||
128927122|NCT01324830|464020410|FG009|Overall Study|Adverse Event, serious fatal|0|||
128927123|NCT01324830|464020411|FG010|Overall Study|Adverse Event, serious fatal|0|||
128927124|NCT01324830|464020412|FG011|Overall Study|Adverse Event, serious fatal|0|||
128927125|NCT01324830|464020413|FG012|Overall Study|Adverse Event, serious fatal|0|||
128927126|NCT01324830|464020414|FG013|Overall Study|Adverse Event, serious fatal|0|||
128927127|NCT01324830|464020415|FG014|Overall Study|Adverse Event, serious fatal|0|||
128927128|NCT01324830|464020416|FG015|Overall Study|Adverse Event, serious fatal|0|||
128927129|NCT01324830|464020417|FG016|Overall Study|Adverse Event, serious fatal|0|||
128927130|NCT01324830|464020418|FG017|Overall Study|Adverse Event, serious fatal|0|||
128927131|NCT01324830|464020419|FG018|Overall Study|Adverse Event, serious fatal|0|||
128927132|NCT01324830|464020401|FG000|Overall Study|Adverse Event, non-fatal|0|||
128927133|NCT01324830|464020402|FG001|Overall Study|Adverse Event, non-fatal|0|||
128927134|NCT01324830|464020403|FG002|Overall Study|Adverse Event, non-fatal|0|||
128927135|NCT01324830|464020404|FG003|Overall Study|Adverse Event, non-fatal|0|||
128927136|NCT01324830|464020405|FG004|Overall Study|Adverse Event, non-fatal|0|||
128927137|NCT01324830|464020406|FG005|Overall Study|Adverse Event, non-fatal|0|||
128927138|NCT01324830|464020407|FG006|Overall Study|Adverse Event, non-fatal|0|||
129029695|NCT00354835|464399932|FG001|Overall Study|Disease progression or relapse|22|||
129029696|NCT00354835|464399931|FG000|Overall Study|Adverse Event|6|||
129216376|NCT03739203|465092910|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
129216377|NCT03739203|465092911|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
128927139|NCT01324830|464020408|FG007|Overall Study|Adverse Event, non-fatal|0|||
129216378|NCT03739203|465092909|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
128927140|NCT01324830|464020409|FG008|Overall Study|Adverse Event, non-fatal|2|||
128927141|NCT01324830|464020410|FG009|Overall Study|Adverse Event, non-fatal|0|||
128927142|NCT01324830|464020411|FG010|Overall Study|Adverse Event, non-fatal|1|||
128927143|NCT01324830|464020412|FG011|Overall Study|Adverse Event, non-fatal|0|||
128927144|NCT01324830|464020413|FG012|Overall Study|Adverse Event, non-fatal|0|||
128927145|NCT01324830|464020414|FG013|Overall Study|Adverse Event, non-fatal|0|||
128927146|NCT01324830|464020415|FG014|Overall Study|Adverse Event, non-fatal|0|||
128927147|NCT01324830|464020416|FG015|Overall Study|Adverse Event, non-fatal|0|||
128927148|NCT01324830|464020417|FG016|Overall Study|Adverse Event, non-fatal|0|||
128927149|NCT01324830|464020418|FG017|Overall Study|Adverse Event, non-fatal|1|||
128927150|NCT01324830|464020419|FG018|Overall Study|Adverse Event, non-fatal|0|||
128927151|NCT01324830|464020401|FG000|Overall Study|Withdrawal by Subject|0|||
128927152|NCT01324830|464020402|FG001|Overall Study|Withdrawal by Subject|0|||
128927153|NCT01324830|464020403|FG002|Overall Study|Withdrawal by Subject|0|||
128927154|NCT01324830|464020404|FG003|Overall Study|Withdrawal by Subject|0|||
128927155|NCT01324830|464020405|FG004|Overall Study|Withdrawal by Subject|0|||
128927156|NCT01324830|464020406|FG005|Overall Study|Withdrawal by Subject|1|||
128927157|NCT01324830|464020407|FG006|Overall Study|Withdrawal by Subject|0|||
128927158|NCT01324830|464020408|FG007|Overall Study|Withdrawal by Subject|0|||
128927159|NCT01324830|464020409|FG008|Overall Study|Withdrawal by Subject|0|||
128927160|NCT01324830|464020410|FG009|Overall Study|Withdrawal by Subject|0|||
128927161|NCT01324830|464020411|FG010|Overall Study|Withdrawal by Subject|1|||
128927162|NCT01324830|464020412|FG011|Overall Study|Withdrawal by Subject|0|||
128927163|NCT01324830|464020413|FG012|Overall Study|Withdrawal by Subject|0|||
128927164|NCT01324830|464020414|FG013|Overall Study|Withdrawal by Subject|0|||
128927165|NCT01324830|464020415|FG014|Overall Study|Withdrawal by Subject|0|||
128927166|NCT01324830|464020416|FG015|Overall Study|Withdrawal by Subject|0|||
128927167|NCT01324830|464020417|FG016|Overall Study|Withdrawal by Subject|0|||
128927168|NCT01324830|464020418|FG017|Overall Study|Withdrawal by Subject|0|||
128927169|NCT01324830|464020419|FG018|Overall Study|Withdrawal by Subject|1|||
128927170|NCT00942409|464020420|FG000|Overall Study|Lack of Efficacy|1|||
128927171|NCT00942409|464020420|FG000|Overall Study|study drug unavailable|2|||
128927172|NCT01503021|464020425|FG000|Overall Study|Adverse Event|7|||
128927173|NCT01503021|464020426|FG001|Overall Study|Adverse Event|6|||
128927174|NCT01503021|464020425|FG000|Overall Study|Death|0|||
128927175|NCT01503021|464020426|FG001|Overall Study|Death|2|||
128927176|NCT01503021|464020425|FG000|Overall Study|Lost to Follow-up|2|||
128927177|NCT01503021|464020426|FG001|Overall Study|Lost to Follow-up|0|||
128927178|NCT01503021|464020425|FG000|Overall Study|Physician Decision|3|||
128927179|NCT01503021|464020426|FG001|Overall Study|Physician Decision|0|||
128927180|NCT01503021|464020425|FG000|Overall Study|Protocol Violation|1|||
128927181|NCT01503021|464020426|FG001|Overall Study|Protocol Violation|3|||
128927182|NCT01503021|464020425|FG000|Overall Study|Withdrawal by Subject|9|||
128927183|NCT01503021|464020426|FG001|Overall Study|Withdrawal by Subject|8|||
128927184|NCT01503021|464020425|FG000|Overall Study|Moved, received transplant, etc.|5|||
128927185|NCT01503021|464020426|FG001|Overall Study|Moved, received transplant, etc.|7|||
128927186|NCT00817414|464020427|FG000|Overall Study|Adverse Event|1|||
128927187|NCT00817414|464020428|FG001|Overall Study|Adverse Event|1|||
128927188|NCT00817414|464020429|FG002|Overall Study|Adverse Event|1|||
128927189|NCT00817414|464020430|FG003|Overall Study|Adverse Event|0|||
128927190|NCT00817414|464020431|FG004|Overall Study|Adverse Event|0|||
128927191|NCT00817414|464020427|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
128927192|NCT00817414|464020428|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
128927193|NCT00817414|464020429|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
128927194|NCT00817414|464020430|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
128927195|NCT00817414|464020431|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
128927196|NCT00817414|464020427|FG000|Overall Study|Withdrawal by Subject|1|||
128927197|NCT00817414|464020428|FG001|Overall Study|Withdrawal by Subject|1|||
128767107|NCT05408468|463438121|FG001|Overall Study|Personal illness precluding participation|0|||
128767108|NCT05408468|463438120|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
128767109|NCT05408468|463438121|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
128767110|NCT04186403|463438122|FG000|Overall Study|Adverse Event|1|||
128927198|NCT00817414|464020429|FG002|Overall Study|Withdrawal by Subject|0|||
128927199|NCT00817414|464020430|FG003|Overall Study|Withdrawal by Subject|0|||
128927200|NCT00817414|464020431|FG004|Overall Study|Withdrawal by Subject|0|||
128927201|NCT00817414|464020427|FG000|Overall Study|Lost to Follow-up|0|||
128927202|NCT00817414|464020428|FG001|Overall Study|Lost to Follow-up|0|||
128927203|NCT00817414|464020429|FG002|Overall Study|Lost to Follow-up|1|||
128927204|NCT00817414|464020430|FG003|Overall Study|Lost to Follow-up|1|||
128927205|NCT00817414|464020431|FG004|Overall Study|Lost to Follow-up|1|||
128927206|NCT00817414|464020427|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
128927207|NCT00817414|464020428|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
128927208|NCT00817414|464020429|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
129029697|NCT00354835|464399932|FG001|Overall Study|Adverse Event|0|||
128767111|NCT04186403|463438123|FG001|Overall Study|Adverse Event|8|||
128767112|NCT04186403|463438122|FG000|Overall Study|Lost to Follow-up|7|||
128767113|NCT04186403|463438123|FG001|Overall Study|Lost to Follow-up|3|||
128767114|NCT04186403|463438122|FG000|Overall Study|Physician Decision|1|||
128767115|NCT04186403|463438123|FG001|Overall Study|Physician Decision|0|||
128767116|NCT04186403|463438122|FG000|Overall Study|Withdrawal by Subject|7|||
128767117|NCT04186403|463438123|FG001|Overall Study|Withdrawal by Subject|8|||
128767118|NCT04186403|463438122|FG000|Overall Study|Other: Not Related to Covid-19|3|||
128767119|NCT04186403|463438123|FG001|Overall Study|Other: Not Related to Covid-19|0|||
128767120|NCT00405639|463438126|FG000|Overall Study|Withdrawal by Subject|1|||
128927209|NCT00817414|464020430|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
128927210|NCT00817414|464020431|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
128927211|NCT00817414|464020427|FG000|Overall Study|Protocol Violation|0|||
128927212|NCT00817414|464020428|FG001|Overall Study|Protocol Violation|0|||
128927213|NCT00817414|464020429|FG002|Overall Study|Protocol Violation|0|||
128927214|NCT00817414|464020430|FG003|Overall Study|Protocol Violation|0|||
128927215|NCT00817414|464020431|FG004|Overall Study|Protocol Violation|1|||
128927216|NCT00097539|464020434|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
128927217|NCT00097539|464020435|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
128927218|NCT00097539|464020436|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
128767121|NCT00405639|463438127|FG001|Overall Study|Withdrawal by Subject|0|||
128767122|NCT00405639|463438126|FG000|Overall Study|Adverse Event|1|||
128767123|NCT00405639|463438127|FG001|Overall Study|Adverse Event|0|||
128767124|NCT00405639|463438126|FG000|Overall Study|Seizure prior to receiving BNP|1|||
128767125|NCT00405639|463438127|FG001|Overall Study|Seizure prior to receiving BNP|0|||
128767126|NCT00265330|463438128|FG000|Overall Study|Adverse Event|41|||
128767127|NCT00265330|463438128|FG000|Overall Study|Lost to Follow-up|8|||
128767128|NCT00265330|463438128|FG000|Overall Study|Withdrawal by Subject|34|||
128767129|NCT00265330|463438128|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
128767130|NCT00265330|463438128|FG000|Overall Study|Lack of Efficacy|4|||
128767131|NCT00265330|463438128|FG000|Overall Study|Family Scheduling Conflicts|1|||
128767132|NCT00265330|463438128|FG000|Overall Study|Began Taking Formulary Geodon|1|||
128767133|NCT00265330|463438128|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
128767134|NCT00265330|463438128|FG000|Overall Study|Site Closed by Sponsor|1|||
128767135|NCT00265330|463438128|FG000|Overall Study|Principal Investigators Request|1|||
128767136|NCT00265330|463438128|FG000|Overall Study|Withdrew Consent|1|||
128767137|NCT00265330|463438128|FG000|Overall Study|Protocol Violation|1|||
129029698|NCT00354835|464399931|FG000|Overall Study|Refusal of further therapy|3|||
129029699|NCT00354835|464399932|FG001|Overall Study|Refusal of further therapy|8|||
129029700|NCT01968551|464399937|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
128927219|NCT00097539|464020437|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
128927220|NCT00097539|464020438|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
128927221|NCT00097539|464020439|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
128927222|NCT00097539|464020440|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
128927223|NCT00097539|464020434|FG000|Overall Study|Withdrawal by Subject|925|||
129029701|NCT01968551|464399938|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
129029702|NCT01968551|464399939|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
129029703|NCT01968551|464399937|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
129029704|NCT01968551|464399938|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
129029705|NCT01968551|464399939|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
128767138|NCT03108157|463438129|FG000|Overall Study|Protocol Violation|15|||
128767139|NCT03108157|463438130|FG001|Overall Study|Protocol Violation|4|||
128767140|NCT01008475|463438133|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
128927224|NCT00097539|464020435|FG001|Overall Study|Withdrawal by Subject|323|||
129029706|NCT01968551|464399937|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
129029707|NCT01968551|464399938|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
129119108|NCT01041859|464733208|FG001|Open-Label Titration|Protocol Violation|0|||
128927225|NCT00097539|464020436|FG002|Overall Study|Withdrawal by Subject|346|||
128927226|NCT00097539|464020437|FG003|Overall Study|Withdrawal by Subject|217|||
128927227|NCT00097539|464020438|FG004|Overall Study|Withdrawal by Subject|68|||
128927228|NCT00097539|464020439|FG005|Overall Study|Withdrawal by Subject|229|||
128927229|NCT00097539|464020440|FG006|Overall Study|Withdrawal by Subject|3|||
128927230|NCT00097539|464020434|FG000|Overall Study|Participant Non-compliant|2140|||
128927231|NCT00097539|464020435|FG001|Overall Study|Participant Non-compliant|567|||
128927232|NCT00097539|464020436|FG002|Overall Study|Participant Non-compliant|1067|||
128927233|NCT00097539|464020437|FG003|Overall Study|Participant Non-compliant|353|||
129029708|NCT01968551|464399939|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
129029709|NCT01968551|464399937|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
128767141|NCT01008475|463438134|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
128767142|NCT01008475|463438135|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
128767143|NCT01008475|463438136|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
128767144|NCT01008475|463438137|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
128927234|NCT00097539|464020438|FG004|Overall Study|Participant Non-compliant|136|||
128927235|NCT00097539|464020439|FG005|Overall Study|Participant Non-compliant|543|||
128927236|NCT00097539|464020440|FG006|Overall Study|Participant Non-compliant|18|||
128927237|NCT00097539|464020434|FG000|Overall Study|Lack of Efficacy|249|||
128927238|NCT00097539|464020435|FG001|Overall Study|Lack of Efficacy|122|||
128927239|NCT00097539|464020436|FG002|Overall Study|Lack of Efficacy|202|||
128927240|NCT00097539|464020437|FG003|Overall Study|Lack of Efficacy|105|||
128927241|NCT00097539|464020438|FG004|Overall Study|Lack of Efficacy|45|||
128927242|NCT00097539|464020439|FG005|Overall Study|Lack of Efficacy|228|||
128927243|NCT00097539|464020440|FG006|Overall Study|Lack of Efficacy|5|||
128927244|NCT00097539|464020434|FG000|Overall Study|Adverse Event|78|||
128927245|NCT00097539|464020435|FG001|Overall Study|Adverse Event|133|||
128927246|NCT00097539|464020436|FG002|Overall Study|Adverse Event|37|||
128927247|NCT00097539|464020437|FG003|Overall Study|Adverse Event|27|||
128927248|NCT00097539|464020438|FG004|Overall Study|Adverse Event|30|||
128927249|NCT00097539|464020439|FG005|Overall Study|Adverse Event|59|||
128927250|NCT00097539|464020440|FG006|Overall Study|Adverse Event|1|||
128927251|NCT00097539|464020434|FG000|Overall Study|Death|2|||
128927252|NCT00097539|464020435|FG001|Overall Study|Death|7|||
128927253|NCT00097539|464020436|FG002|Overall Study|Death|0|||
128927254|NCT00097539|464020437|FG003|Overall Study|Death|0|||
128927255|NCT00097539|464020438|FG004|Overall Study|Death|1|||
128927256|NCT00097539|464020439|FG005|Overall Study|Death|3|||
128927257|NCT00097539|464020440|FG006|Overall Study|Death|0|||
128927258|NCT00097539|464020434|FG000|Overall Study|Reasons Other Than Above|3602|||
128927259|NCT00097539|464020435|FG001|Overall Study|Reasons Other Than Above|1382|||
128927260|NCT00097539|464020436|FG002|Overall Study|Reasons Other Than Above|1757|||
128927261|NCT00097539|464020437|FG003|Overall Study|Reasons Other Than Above|692|||
128927262|NCT00097539|464020438|FG004|Overall Study|Reasons Other Than Above|361|||
128927263|NCT00097539|464020439|FG005|Overall Study|Reasons Other Than Above|1244|||
128927264|NCT00097539|464020440|FG006|Overall Study|Reasons Other Than Above|34|||
128927265|NCT00097539|464020434|FG000|Overall Study|Reason not Specified|111|||
128927266|NCT00097539|464020435|FG001|Overall Study|Reason not Specified|49|||
128927267|NCT00097539|464020436|FG002|Overall Study|Reason not Specified|53|||
128927268|NCT00097539|464020437|FG003|Overall Study|Reason not Specified|21|||
128927269|NCT00097539|464020438|FG004|Overall Study|Reason not Specified|11|||
128927270|NCT00097539|464020439|FG005|Overall Study|Reason not Specified|40|||
128927271|NCT00097539|464020440|FG006|Overall Study|Reason not Specified|2|||
128927272|NCT02015819|464020441|FG000|Overall Study|Rickham catheter was misaligned|0|||
128927273|NCT02015819|464020442|FG001|Overall Study|Rickham catheter was misaligned|0|||
128927274|NCT02015819|464020443|FG002|Overall Study|Rickham catheter was misaligned|0|||
128927275|NCT02015819|464020444|FG003|Overall Study|Rickham catheter was misaligned|1|||
128927276|NCT02945657|464020445|FG000|Overall Study|Adverse Event|1|||
128927277|NCT02945657|464020445|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
128927278|NCT01486264|464020447|FG000|Overall Study|Death|1|||
128927279|NCT01486264|464020448|FG001|Overall Study|Death|1|||
128927280|NCT01486264|464020447|FG000|Overall Study|Adverse Event|3|||
128927281|NCT01486264|464020448|FG001|Overall Study|Adverse Event|3|||
128927282|NCT01486264|464020447|FG000|Overall Study|Lack of Efficacy|6|||
128927283|NCT01486264|464020448|FG001|Overall Study|Lack of Efficacy|10|||
128927284|NCT01486264|464020447|FG000|Overall Study|Withdrawal by Subject|7|||
128927285|NCT01486264|464020448|FG001|Overall Study|Withdrawal by Subject|18|||
128927286|NCT01486264|464020447|FG000|Overall Study|Physician Decision|1|||
128927287|NCT01486264|464020448|FG001|Overall Study|Physician Decision|1|||
128927288|NCT01486264|464020447|FG000|Overall Study|Protocol Violation|3|||
128927289|NCT01486264|464020448|FG001|Overall Study|Protocol Violation|0|||
128927290|NCT01486264|464020447|FG000|Overall Study|Lost to Follow-up|3|||
128927291|NCT01486264|464020448|FG001|Overall Study|Lost to Follow-up|2|||
128927292|NCT01486264|464020447|FG000|Overall Study|Other|5|||
128927293|NCT01486264|464020448|FG001|Overall Study|Other|11|||
128927294|NCT01486264|464020447|FG000|Overall Study|Not treated|0|||
128927295|NCT01486264|464020448|FG001|Overall Study|Not treated|1|||
128927296|NCT00813748|464020449|FG000|Skin Test Substudy|Physician Decision|0|||
128927297|NCT00813748|464020450|FG001|Skin Test Substudy|Physician Decision|1|||
128927298|NCT00283387|464020451|FG000|First Intervention|Subject non-compliant|1|||
128927299|NCT00283387|464020452|FG001|First Intervention|Subject non-compliant|1|||
128927300|NCT00283387|464020451|FG000|First Intervention|Withdrawal by Subject|0|||
128927301|NCT00283387|464020452|FG001|First Intervention|Withdrawal by Subject|1|||
128927302|NCT03584009|464020457|FG000|Overall Study|Death|25|||
128927303|NCT03584009|464020458|FG001|Overall Study|Death|18|||
128927304|NCT03584009|464020457|FG000|Overall Study|Lost to Follow-up|0|||
128927305|NCT03584009|464020458|FG001|Overall Study|Lost to Follow-up|1|||
128927306|NCT03584009|464020457|FG000|Overall Study|Physician Decision|1|||
128927307|NCT03584009|464020458|FG001|Overall Study|Physician Decision|1|||
128927308|NCT03584009|464020457|FG000|Overall Study|Study Terminated by Sponsor|22|||
128927309|NCT03584009|464020458|FG001|Overall Study|Study Terminated by Sponsor|30|||
128927310|NCT03584009|464020457|FG000|Overall Study|Withdrawal by Subject|3|||
128927311|NCT03584009|464020458|FG001|Overall Study|Withdrawal by Subject|2|||
128927312|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
128927313|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
128927314|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
128927315|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
128927316|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
128927317|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
128927318|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
128927319|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
128927320|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
128927321|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
128927322|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
128927323|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
128927324|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
128927325|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
128927326|NCT00446030|464020459|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
128927327|NCT00446030|464020460|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
128927328|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
128927329|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
128927330|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
128927331|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
128927332|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
128927333|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
128927334|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
128927335|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
128927336|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
128927337|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
128927338|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
128927339|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
128927340|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
128927341|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
128927342|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
128927343|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
128927344|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
128927345|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
128927346|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
128767145|NCT01008475|463438138|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
128767146|NCT01008475|463438139|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
128767147|NCT02917941|463438141|FG000|Treatment Period|Adverse Event|11|||
128767148|NCT02917941|463438141|FG000|Treatment Period|Progressive Disease|11|||
128927347|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
128927348|NCT00446030|464020459|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
128927349|NCT00446030|464020460|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
128927350|NCT02886715|464020461|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128927351|NCT02886715|464020462|FG001|Overall Study|Non-Compliance With Study Drug|2|||
128927352|NCT02886715|464020463|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128927353|NCT02886715|464020461|FG000|Overall Study|Adverse Event|4|||
128927354|NCT02886715|464020462|FG001|Overall Study|Adverse Event|2|||
128927355|NCT02886715|464020463|FG002|Overall Study|Adverse Event|0|||
128927356|NCT02886715|464020461|FG000|Overall Study|Lack of Efficacy|0|||
128927357|NCT02886715|464020462|FG001|Overall Study|Lack of Efficacy|2|||
128927358|NCT02886715|464020463|FG002|Overall Study|Lack of Efficacy|1|||
128927359|NCT02886715|464020461|FG000|Overall Study|Lost to Follow-up|29|||
128927360|NCT02886715|464020462|FG001|Overall Study|Lost to Follow-up|26|||
128927361|NCT02886715|464020463|FG002|Overall Study|Lost to Follow-up|10|||
128927362|NCT02886715|464020461|FG000|Overall Study|Pregnancy|1|||
128927363|NCT02886715|464020462|FG001|Overall Study|Pregnancy|1|||
128927364|NCT02886715|464020463|FG002|Overall Study|Pregnancy|1|||
128767149|NCT02917941|463438141|FG000|Treatment Period|Reason not Specified|2|||
128927365|NCT02886715|464020461|FG000|Overall Study|Protocol Violation|3|||
128927366|NCT02886715|464020462|FG001|Overall Study|Protocol Violation|2|||
128927367|NCT02886715|464020463|FG002|Overall Study|Protocol Violation|1|||
128927368|NCT02886715|464020461|FG000|Overall Study|Withdrawal by Subject|20|||
128927369|NCT02886715|464020462|FG001|Overall Study|Withdrawal by Subject|18|||
128927370|NCT02886715|464020463|FG002|Overall Study|Withdrawal by Subject|5|||
128927371|NCT02886715|464020461|FG000|Overall Study|missing|7|||
128927372|NCT02886715|464020462|FG001|Overall Study|missing|2|||
128927373|NCT02886715|464020463|FG002|Overall Study|missing|2|||
128927374|NCT00222105|464020464|FG000|Overall Study|Removed due to wrong diagnosis|1|||
128927375|NCT00222105|464020464|FG000|Overall Study|Withdrawal by Subject|1|||
128927376|NCT00222105|464020464|FG000|Overall Study|Adverse Event|8|||
128927377|NCT00222105|464020464|FG000|Overall Study|Treatment delays|2|||
128927378|NCT00222105|464020464|FG000|Overall Study|Death|2|||
128927379|NCT00503399|464020465|FG000|Overall Study|Death|2|||
128927380|NCT00503399|464020466|FG001|Overall Study|Death|1|||
128767150|NCT02917941|463438141|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
128767151|NCT02917941|463438141|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
128767152|NCT05067933|463438153|FG000|Overall Study|Withdrawal by Subject|2|||
128767153|NCT05067933|463438154|FG001|Overall Study|Withdrawal by Subject|0|||
128767154|NCT05067933|463438155|FG002|Overall Study|Withdrawal by Subject|0|||
128767155|NCT05067933|463438156|FG003|Overall Study|Withdrawal by Subject|0|||
128767156|NCT05067933|463438157|FG004|Overall Study|Withdrawal by Subject|0|||
129029710|NCT01968551|464399938|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
129029711|NCT01968551|464399939|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
129029712|NCT01968551|464399937|FG000|Extension Phase|Adverse Event|0|||
128767157|NCT05067933|463438158|FG005|Overall Study|Withdrawal by Subject|0|||
128767158|NCT05067933|463438153|FG000|Overall Study|Lost to Follow-up|1|||
128767159|NCT05067933|463438154|FG001|Overall Study|Lost to Follow-up|1|||
128767160|NCT05067933|463438155|FG002|Overall Study|Lost to Follow-up|1|||
128767161|NCT05067933|463438156|FG003|Overall Study|Lost to Follow-up|2|||
128767162|NCT05067933|463438157|FG004|Overall Study|Lost to Follow-up|1|||
128767163|NCT05067933|463438158|FG005|Overall Study|Lost to Follow-up|0|||
128767164|NCT05067933|463438153|FG000|Overall Study|Miscellaneous|1|||
128927381|NCT00503399|464020465|FG000|Overall Study|Protocol Violation|1|||
128927382|NCT00503399|464020466|FG001|Overall Study|Protocol Violation|0|||
128927383|NCT00503399|464020465|FG000|Overall Study|Withdrawal by Subject|4|||
128927384|NCT00503399|464020466|FG001|Overall Study|Withdrawal by Subject|2|||
128927385|NCT00503399|464020465|FG000|Overall Study|Adverse Event|0|||
128927386|NCT00503399|464020466|FG001|Overall Study|Adverse Event|3|||
128927387|NCT00503399|464020465|FG000|Overall Study|Lost to Follow-up|0|||
128927388|NCT00503399|464020466|FG001|Overall Study|Lost to Follow-up|2|||
128927389|NCT01120626|464020469|FG000|Overall Study|Withdrawal by Subject|1|||
128927390|NCT01120626|464020470|FG001|Overall Study|Withdrawal by Subject|0|||
128927391|NCT01073943|464020484|FG000|Overall Study|Withdrawal by Subject|8|||
128927392|NCT01073943|464020485|FG001|Overall Study|Withdrawal by Subject|2|||
128927393|NCT01073943|464020484|FG000|Overall Study|Protocol Violation|2|||
128927394|NCT01073943|464020485|FG001|Overall Study|Protocol Violation|1|||
128927395|NCT01073943|464020484|FG000|Overall Study|Adverse Event|1|||
128927396|NCT01073943|464020485|FG001|Overall Study|Adverse Event|1|||
128927397|NCT01073943|464020484|FG000|Overall Study|Lost to Follow-up|0|||
128927398|NCT01073943|464020485|FG001|Overall Study|Lost to Follow-up|2|||
128927399|NCT01073943|464020484|FG000|Overall Study|Power outage; colonoscopy not done|1|||
128927400|NCT01073943|464020485|FG001|Overall Study|Power outage; colonoscopy not done|0|||
128927401|NCT01073943|464020484|FG000|Overall Study|Subject forgot|0|||
128927402|NCT01073943|464020485|FG001|Overall Study|Subject forgot|1|||
128927403|NCT01073943|464020484|FG000|Overall Study|Unable to return for follow-up|0|||
128927404|NCT01073943|464020485|FG001|Overall Study|Unable to return for follow-up|1|||
128927405|NCT01073943|464020484|FG000|Overall Study|Could not tolerate prep|1|||
128927406|NCT01073943|464020485|FG001|Overall Study|Could not tolerate prep|0|||
128927407|NCT01794780|464020488|FG000|Overall Study|Adverse Event|0|||
128767165|NCT05067933|463438154|FG001|Overall Study|Miscellaneous|0|||
128767166|NCT05067933|463438155|FG002|Overall Study|Miscellaneous|0|||
128767167|NCT05067933|463438156|FG003|Overall Study|Miscellaneous|0|||
128767168|NCT05067933|463438157|FG004|Overall Study|Miscellaneous|0|||
128927408|NCT01794780|464020489|FG001|Overall Study|Adverse Event|1|||
128927409|NCT01794780|464020490|FG002|Overall Study|Adverse Event|2|||
128927410|NCT01794780|464020491|FG003|Overall Study|Adverse Event|0|||
128927411|NCT01794780|464020492|FG004|Overall Study|Adverse Event|0|||
128927412|NCT01794780|464020493|FG005|Overall Study|Adverse Event|0|||
128927413|NCT01794780|464020494|FG006|Overall Study|Adverse Event|0|||
128927414|NCT01794780|464020495|FG007|Overall Study|Adverse Event|0|||
128927415|NCT01794780|464020488|FG000|Overall Study|Death|0|||
128927416|NCT01794780|464020489|FG001|Overall Study|Death|2|||
128927417|NCT01794780|464020490|FG002|Overall Study|Death|14|||
128927418|NCT01794780|464020491|FG003|Overall Study|Death|1|||
128927419|NCT01794780|464020492|FG004|Overall Study|Death|0|||
128927420|NCT01794780|464020493|FG005|Overall Study|Death|9|||
128927421|NCT01794780|464020494|FG006|Overall Study|Death|4|||
128927422|NCT01794780|464020495|FG007|Overall Study|Death|0|||
128927423|NCT01794780|464020488|FG000|Overall Study|Lost to Follow-up|10|||
128927424|NCT01794780|464020489|FG001|Overall Study|Lost to Follow-up|64|||
128927425|NCT01794780|464020490|FG002|Overall Study|Lost to Follow-up|165|||
128927426|NCT01794780|464020491|FG003|Overall Study|Lost to Follow-up|53|||
128927427|NCT01794780|464020492|FG004|Overall Study|Lost to Follow-up|2|||
129029713|NCT01968551|464399938|FG001|Extension Phase|Adverse Event|0|||
128927428|NCT01794780|464020493|FG005|Overall Study|Lost to Follow-up|99|||
128927429|NCT01794780|464020494|FG006|Overall Study|Lost to Follow-up|30|||
128927430|NCT01794780|464020495|FG007|Overall Study|Lost to Follow-up|5|||
129029714|NCT01968551|464399939|FG002|Extension Phase|Adverse Event|2|||
128767169|NCT05067933|463438158|FG005|Overall Study|Miscellaneous|0|||
128767170|NCT05067933|463438153|FG000|Overall Study|Death|0|||
128767171|NCT05067933|463438154|FG001|Overall Study|Death|0|||
128767172|NCT05067933|463438155|FG002|Overall Study|Death|0|||
128767173|NCT05067933|463438156|FG003|Overall Study|Death|1|||
128927431|NCT01794780|464020488|FG000|Overall Study|Withdrew informed consent|7|||
128767174|NCT05067933|463438157|FG004|Overall Study|Death|0|||
128767175|NCT05067933|463438158|FG005|Overall Study|Death|0|||
128767176|NCT01065350|463438164|FG000|Overall Study|Received incorrect drug allocation|0|||
128767177|NCT01065350|463438165|FG001|Overall Study|Received incorrect drug allocation|1|||
128767178|NCT02716038|463438178|FG000|Overall Study|Not evaluable|1|||
128767179|NCT02716038|463438178|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
128767180|NCT02716038|463438178|FG000|Overall Study|Unresectable|3|||
128767181|NCT03573908|463438179|FG000|Treatment Period|Adverse Event|4|||
128767182|NCT03573908|463438180|FG001|Treatment Period|Adverse Event|9|||
128767183|NCT03573908|463438181|FG002|Treatment Period|Adverse Event|0|||
128767184|NCT03573908|463438182|FG003|Treatment Period|Adverse Event|0|||
128767185|NCT03573908|463438183|FG004|Treatment Period|Adverse Event|0|||
128767186|NCT03573908|463438179|FG000|Treatment Period|Protocol Violation|1|||
128767187|NCT03573908|463438180|FG001|Treatment Period|Protocol Violation|0|||
128767188|NCT03573908|463438181|FG002|Treatment Period|Protocol Violation|0|||
128767189|NCT03573908|463438182|FG003|Treatment Period|Protocol Violation|0|||
128767190|NCT03573908|463438183|FG004|Treatment Period|Protocol Violation|0|||
128767191|NCT03573908|463438179|FG000|Treatment Period|Withdrawal by Subject|7|||
128767192|NCT03573908|463438180|FG001|Treatment Period|Withdrawal by Subject|5|||
128767193|NCT03573908|463438181|FG002|Treatment Period|Withdrawal by Subject|0|||
128767194|NCT03573908|463438182|FG003|Treatment Period|Withdrawal by Subject|0|||
128767195|NCT03573908|463438183|FG004|Treatment Period|Withdrawal by Subject|0|||
128767196|NCT03573908|463438179|FG000|Treatment Period|Lost to Follow-up|7|||
128767197|NCT03573908|463438180|FG001|Treatment Period|Lost to Follow-up|6|||
128767198|NCT03573908|463438181|FG002|Treatment Period|Lost to Follow-up|0|||
128767199|NCT03573908|463438182|FG003|Treatment Period|Lost to Follow-up|0|||
128767200|NCT03573908|463438183|FG004|Treatment Period|Lost to Follow-up|0|||
128767201|NCT03573908|463438179|FG000|Treatment Period|Pregnancy|1|||
128767202|NCT03573908|463438180|FG001|Treatment Period|Pregnancy|0|||
128927432|NCT01794780|464020489|FG001|Overall Study|Withdrew informed consent|17|||
128927433|NCT01794780|464020490|FG002|Overall Study|Withdrew informed consent|36|||
128927434|NCT01794780|464020491|FG003|Overall Study|Withdrew informed consent|9|||
128927435|NCT01794780|464020492|FG004|Overall Study|Withdrew informed consent|0|||
128927436|NCT01794780|464020493|FG005|Overall Study|Withdrew informed consent|48|||
128927437|NCT01794780|464020494|FG006|Overall Study|Withdrew informed consent|4|||
128927438|NCT01794780|464020495|FG007|Overall Study|Withdrew informed consent|3|||
128927439|NCT01794780|464020488|FG000|Overall Study|Other|0|||
128927440|NCT01794780|464020489|FG001|Overall Study|Other|12|||
128927441|NCT01794780|464020490|FG002|Overall Study|Other|25|||
128927442|NCT01794780|464020491|FG003|Overall Study|Other|20|||
128927443|NCT01794780|464020492|FG004|Overall Study|Other|1|||
128927444|NCT01794780|464020493|FG005|Overall Study|Other|24|||
128927445|NCT01794780|464020494|FG006|Overall Study|Other|4|||
128927446|NCT01794780|464020495|FG007|Overall Study|Other|1|||
128927447|NCT03527043|464020496|FG000|Overall Study|Withdrawal by Subject|1|||
128927448|NCT03527043|464020497|FG001|Overall Study|Withdrawal by Subject|0|||
128927449|NCT02286102|464020498|FG000|Overall Study|Screen Failure|1|||
128927450|NCT02286102|464020499|FG001|Overall Study|Screen Failure|1|||
128927451|NCT03830281|464020500|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
128927452|NCT03830281|464020501|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
128927453|NCT03830281|464020500|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
128927454|NCT03830281|464020501|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
128927455|NCT03830281|464020500|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
128927456|NCT03830281|464020501|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
128927457|NCT03830281|464020500|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
128927458|NCT03830281|464020501|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
128927459|NCT03830281|464020500|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
128927460|NCT03830281|464020501|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
128927461|NCT03830281|464020500|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
128927462|NCT03830281|464020501|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
128927463|NCT03830281|464020500|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
128927464|NCT03830281|464020501|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
129216379|NCT03739203|465092910|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128767203|NCT03573908|463438181|FG002|Treatment Period|Pregnancy|0|||
128767204|NCT03573908|463438182|FG003|Treatment Period|Pregnancy|0|||
128927465|NCT03830281|464020500|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
128927466|NCT03830281|464020501|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
128927467|NCT03830281|464020500|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
128927468|NCT03830281|464020501|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
128767205|NCT03573908|463438183|FG004|Treatment Period|Pregnancy|0|||
128767206|NCT03573908|463438179|FG000|Treatment Period|Other, Not Specified|4|||
128767207|NCT03573908|463438180|FG001|Treatment Period|Other, Not Specified|6|||
128767208|NCT03573908|463438181|FG002|Treatment Period|Other, Not Specified|0|||
128767209|NCT03573908|463438182|FG003|Treatment Period|Other, Not Specified|0|||
128767210|NCT03573908|463438183|FG004|Treatment Period|Other, Not Specified|0|||
128767211|NCT03573908|463438179|FG000|Randomized Withdrawal Period|Adverse Event|0|||
128767212|NCT03573908|463438180|FG001|Randomized Withdrawal Period|Adverse Event|0|||
128767213|NCT03573908|463438181|FG002|Randomized Withdrawal Period|Adverse Event|3|||
128767214|NCT03573908|463438182|FG003|Randomized Withdrawal Period|Adverse Event|0|||
128767215|NCT03573908|463438183|FG004|Randomized Withdrawal Period|Adverse Event|0|||
128767216|NCT03573908|463438179|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128767217|NCT03573908|463438180|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128767218|NCT03573908|463438181|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128767219|NCT03573908|463438182|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128767220|NCT03573908|463438183|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
128767221|NCT03573908|463438179|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
128767222|NCT03573908|463438180|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
128767223|NCT03573908|463438181|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
128767224|NCT03573908|463438182|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
128767225|NCT03573908|463438183|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
128767226|NCT03573908|463438179|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
128767227|NCT03573908|463438180|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
128767228|NCT03573908|463438181|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
128767229|NCT03573908|463438182|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
128767230|NCT03573908|463438183|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
128767231|NCT04006925|463438184|FG000|Overall Study|Side effects|2|||
128767232|NCT04006925|463438185|FG001|Overall Study|Side effects|0|||
128767233|NCT02669095|463438190|FG000|Overall Study|Adverse Event|1|||
128767234|NCT02669095|463438191|FG001|Overall Study|Adverse Event|0|||
128767235|NCT02669095|463438190|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
128767236|NCT02669095|463438191|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
128767237|NCT02669095|463438190|FG000|Overall Study|Torn Lens|0|||
128767238|NCT02669095|463438191|FG001|Overall Study|Torn Lens|1|||
128767239|NCT02669095|463438190|FG000|Overall Study|Visit 5 assessments not completed|0|||
128767240|NCT02669095|463438191|FG001|Overall Study|Visit 5 assessments not completed|1|||
128767241|NCT01555164|463438193|FG000|Overall Study|Adverse Event|5|||
128767242|NCT01555164|463438194|FG001|Overall Study|Adverse Event|7|||
128767243|NCT01555164|463438193|FG000|Overall Study|Hyperglycemia|0|||
128767244|NCT01555164|463438194|FG001|Overall Study|Hyperglycemia|1|||
128767245|NCT01555164|463438193|FG000|Overall Study|Investigator's Discretion|2|||
128767246|NCT01555164|463438194|FG001|Overall Study|Investigator's Discretion|2|||
128767247|NCT01555164|463438193|FG000|Overall Study|Lost to Follow-up|4|||
128767248|NCT01555164|463438194|FG001|Overall Study|Lost to Follow-up|3|||
128767249|NCT01555164|463438193|FG000|Overall Study|Protocol Violation|9|||
128767250|NCT01555164|463438194|FG001|Overall Study|Protocol Violation|5|||
128767251|NCT01555164|463438193|FG000|Overall Study|Subject Non-compliance|14|||
128767252|NCT01555164|463438194|FG001|Overall Study|Subject Non-compliance|6|||
128767253|NCT01555164|463438193|FG000|Overall Study|Subject Withdrew Consent|6|||
128767254|NCT01555164|463438194|FG001|Overall Study|Subject Withdrew Consent|11|||
128767255|NCT00926003|463438195|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
128767256|NCT00926003|463438196|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
128767257|NCT00926003|463438197|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
128767258|NCT00926003|463438195|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
128767259|NCT00926003|463438196|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
128767260|NCT00926003|463438197|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
128767261|NCT01396317|463438200|FG000|Overall Study|Adverse Event|1|||
128767262|NCT01396317|463438201|FG001|Overall Study|Adverse Event|0|||
128767263|NCT01709305|463438202|FG000|Phase 1|Clinical Adverse Event|80|||
128767264|NCT01709305|463438203|FG001|Phase 1|Clinical Adverse Event|0|||
128767265|NCT01709305|463438204|FG002|Phase 1|Clinical Adverse Event|0|||
128767266|NCT01709305|463438205|FG003|Phase 1|Clinical Adverse Event|0|||
128767267|NCT01709305|463438206|FG004|Phase 1|Clinical Adverse Event|0|||
128767268|NCT01709305|463438202|FG000|Phase 1|Death|2|||
128767269|NCT01709305|463438203|FG001|Phase 1|Death|0|||
128767270|NCT01709305|463438204|FG002|Phase 1|Death|0|||
128767271|NCT01709305|463438205|FG003|Phase 1|Death|0|||
128767272|NCT01709305|463438206|FG004|Phase 1|Death|0|||
128767273|NCT01709305|463438202|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
128767274|NCT01709305|463438203|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129029715|NCT01968551|464399937|FG000|Extension Phase|Death|0|||
128767275|NCT01709305|463438204|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
128767276|NCT01709305|463438205|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
128767277|NCT01709305|463438206|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
128767278|NCT01709305|463438202|FG000|Phase 1|Laboratory Adverse Event|16|||
128767279|NCT01709305|463438203|FG001|Phase 1|Laboratory Adverse Event|0|||
128767280|NCT01709305|463438204|FG002|Phase 1|Laboratory Adverse Event|0|||
128767281|NCT01709305|463438205|FG003|Phase 1|Laboratory Adverse Event|0|||
128767282|NCT01709305|463438206|FG004|Phase 1|Laboratory Adverse Event|0|||
128767283|NCT01709305|463438202|FG000|Phase 1|Lost to Follow-up|147|||
128767284|NCT01709305|463438203|FG001|Phase 1|Lost to Follow-up|0|||
128767285|NCT01709305|463438204|FG002|Phase 1|Lost to Follow-up|0|||
128767286|NCT01709305|463438205|FG003|Phase 1|Lost to Follow-up|0|||
128767287|NCT01709305|463438206|FG004|Phase 1|Lost to Follow-up|0|||
128927469|NCT01985321|464020503|FG000|Overall Study|Protocol Violation|4|||
128927470|NCT01985321|464020504|FG001|Overall Study|Protocol Violation|3|||
128927471|NCT01985321|464020503|FG000|Overall Study|Withdrawal by Subject|1|||
128927472|NCT01985321|464020504|FG001|Overall Study|Withdrawal by Subject|0|||
128927473|NCT01985321|464020503|FG000|Overall Study|Lost to Follow-up|5|||
128927474|NCT01985321|464020504|FG001|Overall Study|Lost to Follow-up|2|||
128927475|NCT01985321|464020503|FG000|Overall Study|Subject treated wrong type of sore|1|||
128927476|NCT01985321|464020504|FG001|Overall Study|Subject treated wrong type of sore|0|||
128927477|NCT02201940|464020505|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
128927478|NCT02201940|464020506|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
128927479|NCT02201940|464020505|FG000|Overall Study|Lack of Efficacy|2|||
128927480|NCT02201940|464020506|FG001|Overall Study|Lack of Efficacy|113|||
128927481|NCT02201940|464020505|FG000|Overall Study|Lost to Follow-up|5|||
128927482|NCT02201940|464020506|FG001|Overall Study|Lost to Follow-up|0|||
128927483|NCT02201940|464020505|FG000|Overall Study|Withdrew Consent|2|||
128927484|NCT02201940|464020506|FG001|Overall Study|Withdrew Consent|1|||
128927485|NCT02201940|464020505|FG000|Overall Study|Investigator's Discretion|1|||
128927486|NCT02201940|464020506|FG001|Overall Study|Investigator's Discretion|1|||
128927487|NCT02201940|464020505|FG000|Overall Study|Death|1|||
128927488|NCT02201940|464020506|FG001|Overall Study|Death|0|||
128927489|NCT02201940|464020505|FG000|Overall Study|Adverse Event|0|||
128927490|NCT02201940|464020506|FG001|Overall Study|Adverse Event|1|||
128927491|NCT03192904|464020507|FG000|Overall Study|Physician Decision|3|||
128927492|NCT03192904|464020508|FG001|Overall Study|Physician Decision|1|||
128927493|NCT03192904|464020507|FG000|Overall Study|Lost to Follow-up|0|||
128927494|NCT03192904|464020508|FG001|Overall Study|Lost to Follow-up|1|||
128927495|NCT03934684|464020510|FG000|Overall Study|Participants continuing in study|11|||
128927496|NCT03934684|464020511|FG001|Overall Study|Participants continuing in study|4|||
128927497|NCT03934684|464020510|FG000|Overall Study|Discontinuation of carfilzomib|20|||
128927498|NCT03934684|464020511|FG001|Overall Study|Discontinuation of carfilzomib|30|||
128927499|NCT03934684|464020510|FG000|Overall Study|Death|2|||
128927500|NCT03934684|464020511|FG001|Overall Study|Death|2|||
128927501|NCT03934684|464020510|FG000|Overall Study|Lost to Follow-up|2|||
128927502|NCT03934684|464020511|FG001|Overall Study|Lost to Follow-up|5|||
128927503|NCT03934684|464020510|FG000|Overall Study|Withdrawal by Subject|7|||
128927504|NCT03934684|464020511|FG001|Overall Study|Withdrawal by Subject|8|||
128927505|NCT05662332|464020512|FG000|Overall Study|Death|3|||
128927506|NCT05662332|464020513|FG001|Overall Study|Death|3|||
128927507|NCT05662332|464020512|FG000|Overall Study|Lost to Follow-up|3|||
128927508|NCT05662332|464020513|FG001|Overall Study|Lost to Follow-up|8|||
128927509|NCT05662332|464020512|FG000|Overall Study|Physician Decision|1|||
128927510|NCT05662332|464020513|FG001|Overall Study|Physician Decision|2|||
128927511|NCT05662332|464020512|FG000|Overall Study|Protocol Deviation|2|||
128927512|NCT05662332|464020513|FG001|Overall Study|Protocol Deviation|1|||
128927513|NCT05662332|464020512|FG000|Overall Study|Withdrawal by Subject|14|||
128927514|NCT05662332|464020513|FG001|Overall Study|Withdrawal by Subject|14|||
128927515|NCT05662332|464020512|FG000|Overall Study|Assigned Treatment by Mistake|5|||
128927516|NCT05662332|464020513|FG001|Overall Study|Assigned Treatment by Mistake|7|||
128927517|NCT05662332|464020512|FG000|Overall Study|Non-compliance with study drug|4|||
128927518|NCT05662332|464020513|FG001|Overall Study|Non-compliance with study drug|1|||
128927519|NCT05662332|464020512|FG000|Overall Study|Due to Bariatric surgery|1|||
128927520|NCT05662332|464020513|FG001|Overall Study|Due to Bariatric surgery|0|||
128927521|NCT05662332|464020512|FG000|Overall Study|Subject Moving out of State|0|||
129119109|NCT01041859|464733209|FG002|Open-Label Titration|Protocol Violation|0|||
129119110|NCT01041859|464733207|FG000|Open-Label Titration|Other|7|||
129119111|NCT01041859|464733208|FG001|Open-Label Titration|Other|0|||
129119112|NCT01041859|464733209|FG002|Open-Label Titration|Other|0|||
129119113|NCT01041859|464733207|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
129119114|NCT01041859|464733208|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
129119115|NCT01041859|464733209|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
129119116|NCT01041859|464733207|FG000|Open-Label Titration|Withdrawal by Subject|11|||
129119117|NCT01041859|464733208|FG001|Open-Label Titration|Withdrawal by Subject|0|||
129119118|NCT01041859|464733209|FG002|Open-Label Titration|Withdrawal by Subject|0|||
129119119|NCT01041859|464733207|FG000|Double-Blind Maintenance|Adverse Event|0|||
129119120|NCT01041859|464733208|FG001|Double-Blind Maintenance|Adverse Event|23|||
128927522|NCT05662332|464020513|FG001|Overall Study|Subject Moving out of State|1|||
128927523|NCT05662332|464020512|FG000|Overall Study|Subject Missed the Schedule|1|||
128927524|NCT05662332|464020513|FG001|Overall Study|Subject Missed the Schedule|0|||
128927525|NCT05662332|464020512|FG000|Overall Study|The Patient Moved to Another City|1|||
128927526|NCT05662332|464020513|FG001|Overall Study|The Patient Moved to Another City|0|||
128927527|NCT00256295|464020514|FG000|Overall Study|Withdrawal by Subject|3|||
128927528|NCT00256295|464020514|FG000|Overall Study|Death|1|||
128927529|NCT01697345|464020517|FG000|Overall Study|Withdrawal by Subject|1|||
128927530|NCT00140855|464020518|FG000|Overall Study|Progressive disease|2|||
129119121|NCT01041859|464733209|FG002|Double-Blind Maintenance|Adverse Event|13|||
128927531|NCT02770807|464020520|FG000|Overall Study|Adverse Event|3|||
128701457|NCT02585960|463205612|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
128701458|NCT02585960|463205613|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
128701459|NCT02585960|463205611|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
128701460|NCT02585960|463205612|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
128701461|NCT02585960|463205613|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
128927532|NCT02770807|464020521|FG001|Overall Study|Adverse Event|3|||
128927533|NCT02770807|464020522|FG002|Overall Study|Adverse Event|1|||
128927534|NCT02770807|464020520|FG000|Overall Study|Withdrawal by Subject|7|||
128927535|NCT02770807|464020521|FG001|Overall Study|Withdrawal by Subject|3|||
128927536|NCT02770807|464020522|FG002|Overall Study|Withdrawal by Subject|4|||
128927537|NCT02770807|464020520|FG000|Overall Study|Other|0|||
128927538|NCT02770807|464020521|FG001|Overall Study|Other|1|||
128927539|NCT02770807|464020522|FG002|Overall Study|Other|0|||
128927540|NCT02770807|464020520|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
128927541|NCT02770807|464020521|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
128927542|NCT02770807|464020522|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
128927543|NCT02770807|464020520|FG000|Overall Study|Physician Decision|0|||
128927544|NCT02770807|464020521|FG001|Overall Study|Physician Decision|0|||
128927545|NCT02770807|464020522|FG002|Overall Study|Physician Decision|1|||
128927546|NCT00942162|464022126|FG000|Overall Study|Death|45|||
128927547|NCT00942162|464022127|FG001|Overall Study|Death|35|||
128927548|NCT00942162|464022128|FG002|Overall Study|Death|0|||
128927549|NCT00942162|464022126|FG000|Overall Study|Withdrawal by Subject|7|||
128927550|NCT00942162|464022127|FG001|Overall Study|Withdrawal by Subject|2|||
128927551|NCT00942162|464022128|FG002|Overall Study|Withdrawal by Subject|0|||
128927552|NCT00942162|464022126|FG000|Overall Study|Lost to Follow-up|4|||
128927553|NCT00942162|464022127|FG001|Overall Study|Lost to Follow-up|0|||
128927554|NCT00942162|464022128|FG002|Overall Study|Lost to Follow-up|0|||
128927555|NCT00942162|464022126|FG000|Overall Study|Other|14|||
128927556|NCT00942162|464022127|FG001|Overall Study|Other|13|||
128927557|NCT00942162|464022128|FG002|Overall Study|Other|2|||
128927558|NCT02799381|464022137|FG000|Overall Study|Withdrew consent|3|||
128927559|NCT02799381|464022138|FG001|Overall Study|Withdrew consent|2|||
128927560|NCT02799381|464022137|FG000|Overall Study|Adverse Event|0|||
128927561|NCT02799381|464022138|FG001|Overall Study|Adverse Event|1|||
128927562|NCT02799381|464022137|FG000|Overall Study|Participant did not take any study drug|1|||
128927563|NCT02799381|464022138|FG001|Overall Study|Participant did not take any study drug|0|||
128927564|NCT03952130|464022139|FG000|Overall Study|Adverse Event|0|||
128927565|NCT03952130|464022140|FG001|Overall Study|Adverse Event|1|||
128927566|NCT03952130|464022139|FG000|Overall Study|Lost to Follow-up|1|||
128927567|NCT03952130|464022140|FG001|Overall Study|Lost to Follow-up|0|||
128927568|NCT03952130|464022139|FG000|Overall Study|Withdrawal by Subject|1|||
128927569|NCT03952130|464022140|FG001|Overall Study|Withdrawal by Subject|5|||
128927570|NCT01713348|464022141|FG000|Overall Study|Withdrawal by Subject|3|||
128927571|NCT01713348|464022142|FG001|Overall Study|Withdrawal by Subject|2|||
128927572|NCT01713348|464022143|FG002|Overall Study|Withdrawal by Subject|2|||
128927573|NCT01713348|464022144|FG003|Overall Study|Withdrawal by Subject|0|||
128927574|NCT01713348|464022141|FG000|Overall Study|Lost to Follow-up|1|||
128927575|NCT01713348|464022142|FG001|Overall Study|Lost to Follow-up|0|||
128927576|NCT01713348|464022143|FG002|Overall Study|Lost to Follow-up|0|||
128927577|NCT01713348|464022144|FG003|Overall Study|Lost to Follow-up|0|||
128927578|NCT05882890|464022147|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
128927579|NCT00613314|464022150|FG000|Overall Study|Adverse Event|5|||
128927580|NCT00613314|464022150|FG000|Overall Study|Protocol Violation|14|||
128927581|NCT00613314|464022150|FG000|Overall Study|Lost to Follow-up|46|||
128927582|NCT00613314|464022150|FG000|Overall Study|Other reason not defined above|90|||
128927583|NCT01584024|464022151|FG000|Overall Study|Lost to Follow-up|10|||
128927584|NCT01584024|464022151|FG000|Overall Study|Withdrawal by Subject|3|||
128927585|NCT01217606|464022152|FG000|Initial Treatment Phase|Other Reasons|0|||
128927586|NCT01217606|464022153|FG001|Initial Treatment Phase|Other Reasons|2|||
128927587|NCT01217606|464022152|FG000|Initial Treatment Phase|Protocol Violation|3|||
128927588|NCT01217606|464022153|FG001|Initial Treatment Phase|Protocol Violation|2|||
128701462|NCT03639935|463205614|FG000|Overall Study|Death|3|||
128927589|NCT01217606|464022152|FG000|Initial Treatment Phase|Personal Reasons|0|||
128927590|NCT01217606|464022153|FG001|Initial Treatment Phase|Personal Reasons|2|||
128927591|NCT01217606|464022152|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
128927592|NCT01217606|464022153|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
128927593|NCT01217606|464022152|FG000|Initial Treatment Phase|Adverse Event|10|||
128927594|NCT01217606|464022153|FG001|Initial Treatment Phase|Adverse Event|6|||
128927595|NCT01217606|464022152|FG000|9-Month Masked Extension|Adverse Event|3|||
128927596|NCT01217606|464022153|FG001|9-Month Masked Extension|Adverse Event|6|||
128927597|NCT01217606|464022152|FG000|9-Month Masked Extension|Other Reasons|4|||
128927598|NCT01217606|464022153|FG001|9-Month Masked Extension|Other Reasons|4|||
128927599|NCT01217606|464022152|FG000|9-Month Masked Extension|Personal Reasons|2|||
128927600|NCT01217606|464022153|FG001|9-Month Masked Extension|Personal Reasons|1|||
128927601|NCT01217606|464022152|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
128927602|NCT01217606|464022153|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
128927603|NCT01217606|464022152|FG000|9-Month Masked Extension|Pregnancy|1|||
128927604|NCT01217606|464022153|FG001|9-Month Masked Extension|Pregnancy|0|||
128927605|NCT01217606|464022152|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
128927606|NCT01217606|464022153|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
128927607|NCT03090191|464022160|FG000|Overall Study|Adverse Event|90|||
128927608|NCT03090191|464022161|FG001|Overall Study|Adverse Event|72|||
128927609|NCT03090191|464022160|FG000|Overall Study|Death|365|||
128927610|NCT03090191|464022161|FG001|Overall Study|Death|358|||
128927611|NCT03090191|464022160|FG000|Overall Study|Lost to Follow-up|382|||
128927612|NCT03090191|464022161|FG001|Overall Study|Lost to Follow-up|394|||
128927613|NCT03090191|464022160|FG000|Overall Study|Physician Decision|77|||
128927614|NCT03090191|464022161|FG001|Overall Study|Physician Decision|66|||
128927615|NCT03090191|464022160|FG000|Overall Study|Protocol Violation|43|||
128927616|NCT03090191|464022161|FG001|Overall Study|Protocol Violation|52|||
128927617|NCT03090191|464022160|FG000|Overall Study|Withdrawal by Subject|2160|||
128927618|NCT03090191|464022161|FG001|Overall Study|Withdrawal by Subject|2133|||
128927619|NCT03090191|464022160|FG000|Overall Study|Site terminated|7|||
128927620|NCT03090191|464022161|FG001|Overall Study|Site terminated|8|||
128927621|NCT03090191|464022160|FG000|Overall Study|Other|66|||
128927622|NCT03090191|464022161|FG001|Overall Study|Other|60|||
128927623|NCT03090191|464022160|FG000|Overall Study|Withdrawn before any study vaccination|43|||
128927624|NCT03090191|464022161|FG001|Overall Study|Withdrawn before any study vaccination|52|||
128927625|NCT04723537|464022163|FG000|Overall Study|Withdrawal by Subject|3|||
128927626|NCT04723537|464022164|FG001|Overall Study|Withdrawal by Subject|0|||
128927627|NCT04723537|464022165|FG002|Overall Study|Withdrawal by Subject|0|||
128927628|NCT04723537|464022163|FG000|Overall Study|Physician Decision|0|||
128927629|NCT04723537|464022164|FG001|Overall Study|Physician Decision|0|||
128927630|NCT04723537|464022165|FG002|Overall Study|Physician Decision|1|||
128927631|NCT04723537|464022163|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
128927632|NCT04723537|464022164|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
128927633|NCT04723537|464022165|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
128927634|NCT02432807|464022166|FG000|Overall Study|Adverse Event|0|||
128927635|NCT02432807|464022167|FG001|Overall Study|Adverse Event|2|||
128927636|NCT02432807|464022166|FG000|Overall Study|Lost to Follow-up|1|||
128927637|NCT02432807|464022167|FG001|Overall Study|Lost to Follow-up|0|||
128927638|NCT02432807|464022166|FG000|Overall Study|Withdrawal by Subject|1|||
128927639|NCT02432807|464022167|FG001|Overall Study|Withdrawal by Subject|1|||
128927640|NCT02432807|464022166|FG000|Overall Study|Other|1|||
128927641|NCT02432807|464022167|FG001|Overall Study|Other|1|||
128927642|NCT04419506|464022168|FG000|Overall Study|Adverse Event|0|||
128927643|NCT04419506|464022169|FG001|Overall Study|Adverse Event|10|||
128927644|NCT04419506|464022170|FG002|Overall Study|Adverse Event|0|||
128927645|NCT04419506|464022171|FG003|Overall Study|Adverse Event|3|||
128927646|NCT04419506|464022168|FG000|Overall Study|Withdrawal by Subject|0|||
128927647|NCT04419506|464022169|FG001|Overall Study|Withdrawal by Subject|0|||
128927648|NCT04419506|464022170|FG002|Overall Study|Withdrawal by Subject|0|||
128927649|NCT04419506|464022171|FG003|Overall Study|Withdrawal by Subject|1|||
128927650|NCT04419506|464022168|FG000|Overall Study|poor-compliance|0|||
128927651|NCT04419506|464022169|FG001|Overall Study|poor-compliance|0|||
128927652|NCT04419506|464022170|FG002|Overall Study|poor-compliance|0|||
128927653|NCT04419506|464022171|FG003|Overall Study|poor-compliance|1|||
128927654|NCT01845025|464022172|FG000|Overall Study|Adverse Event|6|||
128927655|NCT01845025|464022173|FG001|Overall Study|Adverse Event|3|||
128927656|NCT01845025|464022172|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
128927657|NCT01845025|464022173|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128927658|NCT01845025|464022172|FG000|Overall Study|Withdrawal by Subject|48|||
128927659|NCT01845025|464022173|FG001|Overall Study|Withdrawal by Subject|44|||
128927660|NCT01845025|464022172|FG000|Overall Study|Lost to Follow-up|13|||
128927661|NCT01845025|464022173|FG001|Overall Study|Lost to Follow-up|13|||
128927662|NCT01845025|464022172|FG000|Overall Study|Administrative problems|8|||
128927663|NCT01845025|464022173|FG001|Overall Study|Administrative problems|8|||
128767288|NCT01709305|463438202|FG000|Phase 1|Travel, moving, etc.|30|||
128927664|NCT01845025|464022172|FG000|Overall Study|Death|2|||
129119122|NCT01041859|464733207|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
128767289|NCT01709305|463438203|FG001|Phase 1|Travel, moving, etc.|0|||
128927665|NCT01845025|464022173|FG001|Overall Study|Death|0|||
128927666|NCT01845025|464022172|FG000|Overall Study|Protocol deviation|3|||
128927667|NCT01845025|464022173|FG001|Overall Study|Protocol deviation|6|||
129119123|NCT01041859|464733208|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
128927668|NCT01845025|464022172|FG000|Overall Study|Missing|1|||
128927669|NCT01845025|464022173|FG001|Overall Study|Missing|1|||
128927670|NCT03976401|464022174|FG000|Overall Study|Adverse Event|2|||
128927671|NCT03976401|464022175|FG001|Overall Study|Adverse Event|0|||
128927672|NCT03976401|464022176|FG002|Overall Study|Adverse Event|4|||
128927673|NCT03976401|464022177|FG003|Overall Study|Adverse Event|1|||
128927674|NCT03976401|464022178|FG004|Overall Study|Adverse Event|1|||
128927675|NCT03976401|464022179|FG005|Overall Study|Adverse Event|0|||
128927676|NCT03976401|464022174|FG000|Overall Study|Withdrawal by Subject|0|||
128927677|NCT03976401|464022175|FG001|Overall Study|Withdrawal by Subject|1|||
128927678|NCT03976401|464022176|FG002|Overall Study|Withdrawal by Subject|0|||
128927679|NCT03976401|464022177|FG003|Overall Study|Withdrawal by Subject|0|||
128927680|NCT03976401|464022178|FG004|Overall Study|Withdrawal by Subject|0|||
128927681|NCT03976401|464022179|FG005|Overall Study|Withdrawal by Subject|1|||
128927682|NCT03976401|464022174|FG000|Overall Study|Physician Decision|0|||
128927683|NCT03976401|464022175|FG001|Overall Study|Physician Decision|0|||
128927684|NCT03976401|464022176|FG002|Overall Study|Physician Decision|1|||
128927685|NCT03976401|464022177|FG003|Overall Study|Physician Decision|0|||
128927686|NCT03976401|464022178|FG004|Overall Study|Physician Decision|0|||
128927687|NCT03976401|464022179|FG005|Overall Study|Physician Decision|0|||
128927688|NCT03976401|464022174|FG000|Overall Study|Lost to Follow-up|1|||
128927689|NCT03976401|464022175|FG001|Overall Study|Lost to Follow-up|2|||
128927690|NCT03976401|464022176|FG002|Overall Study|Lost to Follow-up|0|||
128927691|NCT03976401|464022177|FG003|Overall Study|Lost to Follow-up|0|||
128927692|NCT03976401|464022178|FG004|Overall Study|Lost to Follow-up|0|||
128927693|NCT03976401|464022179|FG005|Overall Study|Lost to Follow-up|0|||
128927694|NCT03976401|464022174|FG000|Overall Study|Protocol Violation|0|||
128927695|NCT03976401|464022175|FG001|Overall Study|Protocol Violation|1|||
128927696|NCT03976401|464022176|FG002|Overall Study|Protocol Violation|0|||
128927697|NCT03976401|464022177|FG003|Overall Study|Protocol Violation|0|||
128927698|NCT03976401|464022178|FG004|Overall Study|Protocol Violation|0|||
128927699|NCT03976401|464022179|FG005|Overall Study|Protocol Violation|0|||
128927700|NCT03976401|464022174|FG000|Overall Study|Withdrew Consent|0|||
128927701|NCT03976401|464022175|FG001|Overall Study|Withdrew Consent|0|||
128927702|NCT03976401|464022176|FG002|Overall Study|Withdrew Consent|0|||
128927703|NCT03976401|464022177|FG003|Overall Study|Withdrew Consent|1|||
128927704|NCT03976401|464022178|FG004|Overall Study|Withdrew Consent|0|||
128927705|NCT03976401|464022179|FG005|Overall Study|Withdrew Consent|0|||
128927706|NCT02966314|464022187|FG000|Overall Study|Lost to Follow-up|1|||
128927707|NCT02966314|464022188|FG001|Overall Study|Lost to Follow-up|0|||
128927708|NCT03941548|464022189|FG000|Overall Study|Adverse Event|0|||
128927709|NCT03941548|464022190|FG001|Overall Study|Adverse Event|1|||
128927710|NCT03941548|464022189|FG000|Overall Study|Lost to Follow-up|0|||
128927711|NCT03941548|464022190|FG001|Overall Study|Lost to Follow-up|1|||
128927712|NCT03941548|464022189|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
128927713|NCT03941548|464022190|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
128927714|NCT01242111|464022193|FG000|Overall Study|Adverse Event|1|||
128927715|NCT01242111|464022193|FG000|Overall Study|Withdrawal by Subject|1|||
128927716|NCT01242111|464022193|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
128927717|NCT01021007|464022196|FG000|Overall Study|Lost to Follow-up|1|||
128927718|NCT01021007|464022197|FG001|Overall Study|Lost to Follow-up|1|||
128927719|NCT01021007|464022196|FG000|Overall Study|Adverse Event|1|||
128927720|NCT01021007|464022197|FG001|Overall Study|Adverse Event|3|||
128927721|NCT00824421|464022211|FG000|Overall Study|Adverse Event|6|||
128927722|NCT00824421|464022212|FG001|Overall Study|Adverse Event|6|||
128927723|NCT00824421|464022213|FG002|Overall Study|Adverse Event|6|||
128927724|NCT00824421|464022211|FG000|Overall Study|Death|0|||
128927725|NCT00824421|464022212|FG001|Overall Study|Death|1|||
128927726|NCT00824421|464022213|FG002|Overall Study|Death|0|||
128927727|NCT00824421|464022211|FG000|Overall Study|Lack of Efficacy|5|||
128927728|NCT00824421|464022212|FG001|Overall Study|Lack of Efficacy|7|||
128927729|NCT00824421|464022213|FG002|Overall Study|Lack of Efficacy|4|||
128927730|NCT00824421|464022211|FG000|Overall Study|Lost to Follow-up|2|||
128927731|NCT00824421|464022212|FG001|Overall Study|Lost to Follow-up|3|||
128701463|NCT03639935|463205614|FG000|Overall Study|Adverse Event|1|||
128927732|NCT00824421|464022213|FG002|Overall Study|Lost to Follow-up|0|||
128927733|NCT00824421|464022211|FG000|Overall Study|Pregnancy|1|||
128927734|NCT00824421|464022212|FG001|Overall Study|Pregnancy|0|||
128927735|NCT00824421|464022213|FG002|Overall Study|Pregnancy|1|||
128927736|NCT00824421|464022211|FG000|Overall Study|Withdrawal by Subject|2|||
128701464|NCT06333613|463205615|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
128701465|NCT03616600|463205617|FG000|Overall Study|Withdrawal by Subject|1|||
128701466|NCT03616600|463205618|FG001|Overall Study|Withdrawal by Subject|0|||
128927737|NCT00824421|464022212|FG001|Overall Study|Withdrawal by Subject|3|||
128927738|NCT00824421|464022213|FG002|Overall Study|Withdrawal by Subject|3|||
128927739|NCT00824421|464022211|FG000|Overall Study|Randomized but not Treated|1|||
128927740|NCT00824421|464022212|FG001|Overall Study|Randomized but not Treated|1|||
128701467|NCT03648541|463205619|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
128927741|NCT00824421|464022213|FG002|Overall Study|Randomized but not Treated|0|||
128927742|NCT00824421|464022211|FG000|Overall Study|Other|0|||
128927743|NCT00824421|464022212|FG001|Overall Study|Other|1|||
128927744|NCT00824421|464022213|FG002|Overall Study|Other|0|||
128927745|NCT02120417|464022216|FG000|Overall Study|Death|5|||
128927746|NCT02120417|464022217|FG001|Overall Study|Death|1|||
128927747|NCT02120417|464022216|FG000|Overall Study|Adverse Event|3|||
128927748|NCT02120417|464022217|FG001|Overall Study|Adverse Event|9|||
129029716|NCT01968551|464399938|FG001|Extension Phase|Death|1|||
129029717|NCT01968551|464399939|FG002|Extension Phase|Death|0|||
128927749|NCT02120417|464022216|FG000|Overall Study|Participant decision|4|||
128927750|NCT02120417|464022217|FG001|Overall Study|Participant decision|4|||
128927751|NCT02120417|464022216|FG000|Overall Study|Disease progression|41|||
128927752|NCT02120417|464022217|FG001|Overall Study|Disease progression|45|||
128927753|NCT02120417|464022216|FG000|Overall Study|Noncompliance with study treatment|0|||
128927754|NCT02120417|464022217|FG001|Overall Study|Noncompliance with study treatment|2|||
128927755|NCT02120417|464022216|FG000|Overall Study|Physician Decision|2|||
128927756|NCT02120417|464022217|FG001|Overall Study|Physician Decision|3|||
128927757|NCT02120417|464022216|FG000|Overall Study|Other unspecified|5|||
128927758|NCT02120417|464022217|FG001|Overall Study|Other unspecified|4|||
128927759|NCT00594399|464022218|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
128927760|NCT00594399|464022219|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
128927761|NCT00594399|464022220|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
128927762|NCT00594399|464022218|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
128927763|NCT00594399|464022219|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
128927764|NCT00594399|464022220|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
128927765|NCT00594399|464022218|FG000|Initial 3 Month Counseling|Personal issues|2|||
128927766|NCT00594399|464022219|FG001|Initial 3 Month Counseling|Personal issues|0|||
128927767|NCT00594399|464022220|FG002|Initial 3 Month Counseling|Personal issues|0|||
128927768|NCT00594399|464022218|FG000|Initial 3 Month Counseling|Too busy|7|||
128927769|NCT00594399|464022219|FG001|Initial 3 Month Counseling|Too busy|1|||
128927770|NCT00594399|464022220|FG002|Initial 3 Month Counseling|Too busy|0|||
128927771|NCT00594399|464022218|FG000|Initial 3 Month Counseling|Pain|2|||
128927772|NCT00594399|464022219|FG001|Initial 3 Month Counseling|Pain|0|||
128927773|NCT00594399|464022220|FG002|Initial 3 Month Counseling|Pain|0|||
128927774|NCT00594399|464022218|FG000|Initial 3 Month Counseling|Moved|1|||
128927775|NCT00594399|464022219|FG001|Initial 3 Month Counseling|Moved|0|||
128927776|NCT00594399|464022220|FG002|Initial 3 Month Counseling|Moved|0|||
128927777|NCT00594399|464022218|FG000|Initial 3 Month Counseling|Family illness|1|||
128927778|NCT00594399|464022219|FG001|Initial 3 Month Counseling|Family illness|0|||
128927779|NCT00594399|464022220|FG002|Initial 3 Month Counseling|Family illness|0|||
128927780|NCT00594399|464022218|FG000|Rerandomization Arm 1 Only|Death|2|||
128927781|NCT00594399|464022219|FG001|Rerandomization Arm 1 Only|Death|1|||
128927782|NCT00594399|464022220|FG002|Rerandomization Arm 1 Only|Death|0|||
128927783|NCT00594399|464022218|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
128927784|NCT00594399|464022219|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
128927785|NCT00594399|464022220|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
128927786|NCT03953118|464022221|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
128927787|NCT03953118|464022222|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
128927788|NCT00424398|464022223|FG000|Overall Study|Withdrawal by Subject|2|||
128927789|NCT00424398|464022224|FG001|Overall Study|Withdrawal by Subject|1|||
128927790|NCT00424398|464022225|FG002|Overall Study|Withdrawal by Subject|0|||
128927791|NCT00424398|464022223|FG000|Overall Study|Subject met exclusion criteria|1|||
128927792|NCT00424398|464022224|FG001|Overall Study|Subject met exclusion criteria|0|||
128701468|NCT03648541|463205620|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
128701469|NCT03648541|463205619|FG000|Re-induction Period Only|Lack of Efficacy|7|||
128701470|NCT03648541|463205620|FG001|Re-induction Period Only|Lack of Efficacy|0|||
128701471|NCT03648541|463205619|FG000|Maintenance Period Only|Missing|0|||
128701472|NCT03648541|463205620|FG001|Maintenance Period Only|Missing|1|||
128701473|NCT03648541|463205619|FG000|Maintenance Period Only|Other not listed below|0|||
128701474|NCT03648541|463205620|FG001|Maintenance Period Only|Other not listed below|4|||
128701475|NCT03648541|463205619|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
128701476|NCT03648541|463205620|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
128701477|NCT03648541|463205619|FG000|Maintenance Period Only|Protocol Violation|0|||
128927793|NCT00424398|464022225|FG002|Overall Study|Subject met exclusion criteria|0|||
128927794|NCT01023789|464022226|FG000|3 - Year Visit|Death|29|||
128927795|NCT01023789|464022226|FG000|3 - Year Visit|Withdrawal of consent|1|||
128927796|NCT01023789|464022226|FG000|3 - Year Visit|Lost to Follow-up|13|||
128927797|NCT02034123|464022231|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927798|NCT02034123|464022232|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927799|NCT02034123|464022233|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927800|NCT02034123|464022234|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927801|NCT02034123|464022235|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
128927802|NCT02034123|464022236|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927803|NCT02034123|464022237|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128701478|NCT03648541|463205620|FG001|Maintenance Period Only|Protocol Violation|1|||
128701479|NCT03648541|463205619|FG000|Maintenance Period Only|Lack of Efficacy|0|||
128701480|NCT03648541|463205620|FG001|Maintenance Period Only|Lack of Efficacy|18|||
128927804|NCT02034123|464022238|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
128927805|NCT02034123|464022239|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
128927806|NCT02034123|464022240|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927807|NCT02034123|464022241|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128701481|NCT03648541|463205619|FG000|Maintenance Period Only|Adverse Event|0|||
128701482|NCT03648541|463205620|FG001|Maintenance Period Only|Adverse Event|4|||
128701483|NCT03648541|463205619|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
128701484|NCT03648541|463205620|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
128701485|NCT04623216|463205623|FG000|Overall Study|Death|5|||
128701486|NCT04623216|463205624|FG001|Overall Study|Death|2|||
128701487|NCT04623216|463205625|FG002|Overall Study|Death|0|||
128701488|NCT04623216|463205626|FG003|Overall Study|Death|0|||
128701489|NCT04623216|463205623|FG000|Overall Study|Terminated by Sponsor|3|||
128701490|NCT04623216|463205624|FG001|Overall Study|Terminated by Sponsor|2|||
128701491|NCT04623216|463205625|FG002|Overall Study|Terminated by Sponsor|2|||
128701492|NCT04623216|463205626|FG003|Overall Study|Terminated by Sponsor|0|||
128701493|NCT04623216|463205623|FG000|Overall Study|Physician Decision|1|||
128701494|NCT04623216|463205624|FG001|Overall Study|Physician Decision|0|||
128701495|NCT04623216|463205625|FG002|Overall Study|Physician Decision|0|||
128701496|NCT04623216|463205626|FG003|Overall Study|Physician Decision|0|||
128701497|NCT01651039|463205627|FG000|Overall Study|Non-evaluables|5|||
128701498|NCT01651039|463205627|FG000|Overall Study|Physician Decision|2|||
128701499|NCT01651039|463205627|FG000|Overall Study|Withdrawal by Subject|1|||
128701500|NCT01651039|463205627|FG000|Overall Study|Progressive Disease|22|||
128701501|NCT02059395|463205628|FG000|Overall Study|Lost to Follow-up|2|||
128701502|NCT02059395|463205629|FG001|Overall Study|Lost to Follow-up|4|||
128701503|NCT00134082|463205630|FG000|Overall Study|Adverse Event|2|||
128701504|NCT00134082|463205630|FG000|Overall Study|Death|1|||
128701505|NCT01488370|463205631|FG000|Overall Study|Protocol Violation|0|||
128927808|NCT02034123|464022242|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927809|NCT02034123|464022243|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927810|NCT02034123|464022244|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927811|NCT02034123|464022245|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927812|NCT02034123|464022246|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927813|NCT02034123|464022247|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927814|NCT02034123|464022248|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
128927815|NCT02034123|464022231|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927816|NCT02034123|464022232|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927817|NCT02034123|464022233|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927818|NCT02034123|464022234|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
128927819|NCT02034123|464022235|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927820|NCT02034123|464022236|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927821|NCT02034123|464022237|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927822|NCT02034123|464022238|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927823|NCT02034123|464022239|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927824|NCT02034123|464022240|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927825|NCT02034123|464022241|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927826|NCT02034123|464022242|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927827|NCT02034123|464022243|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927828|NCT02034123|464022244|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927829|NCT02034123|464022245|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927830|NCT02034123|464022246|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927831|NCT02034123|464022247|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927832|NCT02034123|464022248|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
128927833|NCT02034123|464022231|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927834|NCT02034123|464022232|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927835|NCT02034123|464022233|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927836|NCT02034123|464022234|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927837|NCT02034123|464022235|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927838|NCT02034123|464022236|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927839|NCT02034123|464022237|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129119124|NCT01041859|464733209|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
129119125|NCT01041859|464733207|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
129119126|NCT01041859|464733208|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
129119127|NCT01041859|464733209|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
129119128|NCT01041859|464733207|FG000|Double-Blind Maintenance|Physician Decision|0|||
128701506|NCT01488370|463205632|FG001|Overall Study|Protocol Violation|1|||
128927840|NCT02034123|464022238|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927841|NCT02034123|464022239|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
128701507|NCT01488370|463205633|FG002|Overall Study|Protocol Violation|1|||
128701508|NCT00044083|463205634|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
128701509|NCT00044083|463205635|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
128767290|NCT01709305|463438204|FG002|Phase 1|Travel, moving, etc.|0|||
128767291|NCT01709305|463438205|FG003|Phase 1|Travel, moving, etc.|0|||
128927842|NCT02034123|464022240|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927843|NCT02034123|464022241|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927844|NCT02034123|464022242|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927845|NCT02034123|464022243|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927846|NCT02034123|464022244|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927847|NCT02034123|464022245|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927848|NCT02034123|464022246|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927849|NCT02034123|464022247|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927850|NCT02034123|464022248|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
128927851|NCT02034123|464022231|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927852|NCT02034123|464022232|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927853|NCT02034123|464022233|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927854|NCT02034123|464022234|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
128927855|NCT02034123|464022235|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
128927856|NCT02034123|464022236|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927857|NCT02034123|464022237|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927858|NCT02034123|464022238|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927859|NCT02034123|464022239|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927860|NCT02034123|464022240|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927861|NCT02034123|464022241|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927862|NCT02034123|464022242|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927863|NCT02034123|464022243|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927864|NCT02034123|464022244|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927865|NCT02034123|464022245|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927866|NCT02034123|464022246|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927867|NCT02034123|464022247|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927868|NCT02034123|464022248|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
128927869|NCT03133767|464022250|FG000|Overall Study|Lost to Follow-up|38|||
128927870|NCT03133767|464022251|FG001|Overall Study|Lost to Follow-up|24|||
128927871|NCT03133767|464022250|FG000|Overall Study|Protocol Violation|0|||
128927872|NCT03133767|464022251|FG001|Overall Study|Protocol Violation|1|||
128927873|NCT02240706|464022254|FG000|Overall Study|Lack of Efficacy|2|||
128927874|NCT02240706|464022255|FG001|Overall Study|Lack of Efficacy|2|||
128927875|NCT02240706|464022256|FG002|Overall Study|Lack of Efficacy|2|||
128927876|NCT02240706|464022257|FG003|Overall Study|Lack of Efficacy|2|||
128927877|NCT02240706|464022258|FG004|Overall Study|Lack of Efficacy|5|||
128927878|NCT02240706|464022259|FG005|Overall Study|Lack of Efficacy|0|||
128927879|NCT02240706|464022260|FG006|Overall Study|Lack of Efficacy|0|||
128927880|NCT02240706|464022254|FG000|Overall Study|Adverse Event|1|||
128927881|NCT02240706|464022255|FG001|Overall Study|Adverse Event|0|||
128927882|NCT02240706|464022256|FG002|Overall Study|Adverse Event|1|||
128927883|NCT02240706|464022257|FG003|Overall Study|Adverse Event|0|||
128927884|NCT02240706|464022258|FG004|Overall Study|Adverse Event|2|||
128927885|NCT02240706|464022259|FG005|Overall Study|Adverse Event|0|||
128927886|NCT02240706|464022260|FG006|Overall Study|Adverse Event|0|||
128927887|NCT02240706|464022254|FG000|Overall Study|Progressive disease|0|||
128927888|NCT02240706|464022255|FG001|Overall Study|Progressive disease|0|||
128927889|NCT02240706|464022256|FG002|Overall Study|Progressive disease|0|||
128927890|NCT02240706|464022257|FG003|Overall Study|Progressive disease|0|||
128927891|NCT02240706|464022258|FG004|Overall Study|Progressive disease|1|||
128927892|NCT02240706|464022259|FG005|Overall Study|Progressive disease|0|||
128927893|NCT02240706|464022260|FG006|Overall Study|Progressive disease|0|||
128927894|NCT02240706|464022254|FG000|Overall Study|Dose limiting toxicity|0|||
128927895|NCT02240706|464022255|FG001|Overall Study|Dose limiting toxicity|0|||
128927896|NCT02240706|464022256|FG002|Overall Study|Dose limiting toxicity|0|||
128927897|NCT02240706|464022257|FG003|Overall Study|Dose limiting toxicity|0|||
129119129|NCT01041859|464733208|FG001|Double-Blind Maintenance|Physician Decision|2|||
128767292|NCT01709305|463438206|FG004|Phase 1|Travel, moving, etc.|0|||
128767293|NCT01709305|463438202|FG000|Phase 1|Physician Decision|13|||
128927898|NCT02240706|464022258|FG004|Overall Study|Dose limiting toxicity|1|||
128927899|NCT02240706|464022259|FG005|Overall Study|Dose limiting toxicity|0|||
128927900|NCT02240706|464022260|FG006|Overall Study|Dose limiting toxicity|0|||
128927901|NCT02240706|464022254|FG000|Overall Study|Refused to continue taking medication|0|||
128927902|NCT02240706|464022255|FG001|Overall Study|Refused to continue taking medication|1|||
128927903|NCT02240706|464022256|FG002|Overall Study|Refused to continue taking medication|3|||
128927904|NCT02240706|464022257|FG003|Overall Study|Refused to continue taking medication|1|||
129119130|NCT01041859|464733209|FG002|Double-Blind Maintenance|Physician Decision|1|||
129119131|NCT01041859|464733207|FG000|Double-Blind Maintenance|Protocol Violation|0|||
128767294|NCT01709305|463438203|FG001|Phase 1|Physician Decision|0|||
128927905|NCT02240706|464022258|FG004|Overall Study|Refused to continue taking medication|2|||
128927906|NCT02240706|464022259|FG005|Overall Study|Refused to continue taking medication|0|||
128927907|NCT02240706|464022260|FG006|Overall Study|Refused to continue taking medication|0|||
128927908|NCT02240706|464022254|FG000|Overall Study|Insurance billing concerns|0|||
128927909|NCT02240706|464022255|FG001|Overall Study|Insurance billing concerns|0|||
128927910|NCT02240706|464022256|FG002|Overall Study|Insurance billing concerns|0|||
128927911|NCT02240706|464022257|FG003|Overall Study|Insurance billing concerns|1|||
128927912|NCT02240706|464022258|FG004|Overall Study|Insurance billing concerns|0|||
128927913|NCT02240706|464022259|FG005|Overall Study|Insurance billing concerns|0|||
128927914|NCT02240706|464022260|FG006|Overall Study|Insurance billing concerns|0|||
128927915|NCT03301857|464022261|FG000|Overall Study|Death|0|||
128927916|NCT03301857|464022262|FG001|Overall Study|Death|2|||
128927917|NCT03301857|464022261|FG000|Overall Study|Lost to Follow-up|4|||
128927918|NCT03301857|464022262|FG001|Overall Study|Lost to Follow-up|2|||
128927919|NCT03301857|464022261|FG000|Overall Study|Decision by Sponsor|6|||
128927920|NCT03301857|464022262|FG001|Overall Study|Decision by Sponsor|0|||
128927921|NCT03301857|464022261|FG000|Overall Study|Withdrawal by Subject|12|||
128927922|NCT03301857|464022262|FG001|Overall Study|Withdrawal by Subject|4|||
128927923|NCT00855439|464022263|FG000|Overall Study|Withdrawal by Subject|2|||
128927924|NCT00855439|464022264|FG001|Overall Study|Withdrawal by Subject|0|||
128927925|NCT00855439|464022263|FG000|Overall Study|Pregnancy|1|||
128927926|NCT00855439|464022264|FG001|Overall Study|Pregnancy|0|||
128927927|NCT00613626|464022270|FG000|Overall Study|Ineligible|0|||
128927928|NCT00613626|464022271|FG001|Overall Study|Ineligible|1|||
128927929|NCT00613626|464022272|FG002|Overall Study|Ineligible|0|||
128927930|NCT01299025|464022273|FG000|Overall Study|Withdrawal by Subject|2|||
128927931|NCT01299025|464022274|FG001|Overall Study|Withdrawal by Subject|1|||
128927932|NCT01299025|464022273|FG000|Overall Study|Lost to Follow-up|1|||
128927933|NCT01299025|464022274|FG001|Overall Study|Lost to Follow-up|0|||
128927934|NCT04091217|464022275|FG000|Overall Study|Lost to Follow-up|2|||
128927935|NCT04885257|464022276|FG000|Overall Study|Withdrawal by Subject|1|||
128927936|NCT04885257|464022277|FG001|Overall Study|Withdrawal by Subject|0|||
128927937|NCT01731002|464022278|FG000|Overall Study|Adverse Event|0|||
128927938|NCT01731002|464022279|FG001|Overall Study|Adverse Event|2|||
128927939|NCT01731002|464022280|FG002|Overall Study|Adverse Event|2|||
128927940|NCT01731002|464022278|FG000|Overall Study|Non-Compliant|0|||
128927941|NCT01731002|464022279|FG001|Overall Study|Non-Compliant|1|||
128927942|NCT01731002|464022280|FG002|Overall Study|Non-Compliant|0|||
128927943|NCT01731002|464022278|FG000|Overall Study|Lost to Follow-up|1|||
128927944|NCT01731002|464022279|FG001|Overall Study|Lost to Follow-up|0|||
128927945|NCT01731002|464022280|FG002|Overall Study|Lost to Follow-up|0|||
128927946|NCT01731002|464022278|FG000|Overall Study|Test Agent Discontinuation|0|||
128927947|NCT01731002|464022279|FG001|Overall Study|Test Agent Discontinuation|1|||
128927948|NCT01731002|464022280|FG002|Overall Study|Test Agent Discontinuation|0|||
128927949|NCT01731002|464022278|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
128927950|NCT01731002|464022279|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
128927951|NCT01731002|464022280|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
128927952|NCT01731002|464022278|FG000|Overall Study|Elevated IOP|1|||
128927953|NCT01731002|464022279|FG001|Overall Study|Elevated IOP|0|||
128927954|NCT01731002|464022280|FG002|Overall Study|Elevated IOP|0|||
128927955|NCT01731002|464022278|FG000|Overall Study|Inappropriate use of study medications|0|||
128927956|NCT01731002|464022279|FG001|Overall Study|Inappropriate use of study medications|0|||
128927957|NCT01731002|464022280|FG002|Overall Study|Inappropriate use of study medications|1|||
128927958|NCT01659151|464022284|FG000|Overall Study|Inadequate TIL growth|1|||
128927959|NCT03972488|464022285|FG000|Overall Study|Progressive disease|42|||
128927960|NCT03972488|464022286|FG001|Overall Study|Progressive disease|44|||
128927961|NCT03972488|464022285|FG000|Overall Study|Physician Decision|13|||
128927962|NCT03972488|464022286|FG001|Overall Study|Physician Decision|7|||
129119132|NCT01041859|464733208|FG001|Double-Blind Maintenance|Protocol Violation|1|||
129119133|NCT01041859|464733209|FG002|Double-Blind Maintenance|Protocol Violation|3|||
129119134|NCT01041859|464733207|FG000|Double-Blind Maintenance|Other|0|||
129119135|NCT01041859|464733208|FG001|Double-Blind Maintenance|Other|6|||
129119136|NCT01041859|464733209|FG002|Double-Blind Maintenance|Other|2|||
129119137|NCT01041859|464733207|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
129119138|NCT01041859|464733208|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
129216380|NCT03739203|465092911|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
128927963|NCT03972488|464022285|FG000|Overall Study|Adverse Event|8|||
128927964|NCT03972488|464022286|FG001|Overall Study|Adverse Event|1|||
128927965|NCT03972488|464022285|FG000|Overall Study|Death|4|||
128927966|NCT03972488|464022286|FG001|Overall Study|Death|4|||
128927967|NCT03972488|464022285|FG000|Overall Study|Withdrawal by Subject|3|||
128927968|NCT03972488|464022286|FG001|Overall Study|Withdrawal by Subject|4|||
128927969|NCT03972488|464022285|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
128927970|NCT03972488|464022286|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
129119139|NCT01041859|464733209|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
128927971|NCT04865731|464022287|FG000|Overall Study|Physician Decision|2|||
128927972|NCT04865731|464022288|FG001|Overall Study|Physician Decision|1|||
128927973|NCT04865731|464022287|FG000|Overall Study|Adverse Event|1|||
128927974|NCT04865731|464022288|FG001|Overall Study|Adverse Event|0|||
128927975|NCT04865731|464022287|FG000|Overall Study|Withdrawal by Subject|0|||
128927976|NCT04865731|464022288|FG001|Overall Study|Withdrawal by Subject|1|||
128927977|NCT01672892|464023447|FG000|Overall Study|Protocol Violation|7|||
128927978|NCT01672892|464023448|FG001|Overall Study|Protocol Violation|3|||
128927979|NCT00886821|464023460|FG000|Stage 2|Adverse Event|0|||
128927980|NCT00886821|464023461|FG001|Stage 2|Adverse Event|0|||
128927981|NCT00886821|464023462|FG002|Stage 2|Adverse Event|0|||
128927982|NCT00886821|464023463|FG003|Stage 2|Adverse Event|0|||
128927983|NCT00886821|464023464|FG004|Stage 2|Adverse Event|0|||
128927984|NCT00886821|464023465|FG005|Stage 2|Adverse Event|0|||
128927985|NCT00886821|464023466|FG006|Stage 2|Adverse Event|0|||
128927986|NCT00886821|464023467|FG007|Stage 2|Adverse Event|0|||
128927987|NCT00886821|464023468|FG008|Stage 2|Adverse Event|0|||
128927988|NCT00886821|464023469|FG009|Stage 2|Adverse Event|0|||
128927989|NCT00886821|464023470|FG010|Stage 2|Adverse Event|0|||
128927990|NCT00886821|464023471|FG011|Stage 2|Adverse Event|1|||
128927991|NCT00886821|464023472|FG012|Stage 2|Adverse Event|3|||
128927992|NCT00886821|464023473|FG013|Stage 2|Adverse Event|0|||
128927993|NCT00886821|464023460|FG000|Stage 2|Lost to Follow-up|0|||
128927994|NCT00886821|464023461|FG001|Stage 2|Lost to Follow-up|0|||
128927995|NCT00886821|464023462|FG002|Stage 2|Lost to Follow-up|0|||
128927996|NCT00886821|464023463|FG003|Stage 2|Lost to Follow-up|0|||
128927997|NCT00886821|464023464|FG004|Stage 2|Lost to Follow-up|0|||
128927998|NCT00886821|464023465|FG005|Stage 2|Lost to Follow-up|0|||
128927999|NCT00886821|464023466|FG006|Stage 2|Lost to Follow-up|0|||
128928000|NCT00886821|464023467|FG007|Stage 2|Lost to Follow-up|0|||
128928001|NCT00886821|464023468|FG008|Stage 2|Lost to Follow-up|0|||
128928002|NCT00886821|464023469|FG009|Stage 2|Lost to Follow-up|0|||
128928003|NCT00886821|464023470|FG010|Stage 2|Lost to Follow-up|0|||
128928004|NCT00886821|464023471|FG011|Stage 2|Lost to Follow-up|0|||
128928005|NCT00886821|464023472|FG012|Stage 2|Lost to Follow-up|2|||
128928006|NCT00886821|464023473|FG013|Stage 2|Lost to Follow-up|1|||
128928007|NCT00914628|464023474|FG000|Overall Study|Death|35|||
128928008|NCT00914628|464023475|FG001|Overall Study|Death|17|||
128928009|NCT00914628|464023474|FG000|Overall Study|Medical decision|4|||
128928010|NCT00914628|464023475|FG001|Overall Study|Medical decision|0|||
128928011|NCT00914628|464023474|FG000|Overall Study|Protocol Violation|1|||
128928012|NCT00914628|464023475|FG001|Overall Study|Protocol Violation|0|||
128928013|NCT00914628|464023474|FG000|Overall Study|Lack of Efficacy|1|||
128928014|NCT00914628|464023475|FG001|Overall Study|Lack of Efficacy|0|||
128928015|NCT00914628|464023474|FG000|Overall Study|non-randomized|1|||
128928016|NCT00914628|464023475|FG001|Overall Study|non-randomized|0|||
128928017|NCT00914628|464023474|FG000|Overall Study|Relapse|1|||
128928018|NCT00914628|464023475|FG001|Overall Study|Relapse|2|||
128928019|NCT00914628|464023474|FG000|Overall Study|Study terminated by Sponsor|14|||
128928020|NCT00914628|464023475|FG001|Overall Study|Study terminated by Sponsor|8|||
128928021|NCT00914628|464023474|FG000|Overall Study|Patients who did not receive a single dose|7|||
128928022|NCT00914628|464023475|FG001|Overall Study|Patients who did not receive a single dose|1|||
128928023|NCT03311126|464023476|FG000|Induction|Death|1|||
128928024|NCT03311126|464023476|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
128928025|NCT02579603|464023477|FG000|Overall Study|Not treated|1|||
128928026|NCT02579603|464023478|FG001|Overall Study|Not treated|0|||
128928027|NCT02579603|464023477|FG000|Overall Study|Adverse Event|2|||
128928028|NCT02579603|464023478|FG001|Overall Study|Adverse Event|2|||
128928029|NCT02579603|464023477|FG000|Overall Study|Other than stated|1|||
128928030|NCT02579603|464023478|FG001|Overall Study|Other than stated|0|||
128928031|NCT00469079|464023479|FG000|Overall Study|Lack of Efficacy|3|||
128928032|NCT00469079|464023480|FG001|Overall Study|Lack of Efficacy|8|||
128928033|NCT00469079|464023481|FG002|Overall Study|Lack of Efficacy|5|||
128928034|NCT00469079|464023479|FG000|Overall Study|Adverse Event|1|||
128928035|NCT00469079|464023480|FG001|Overall Study|Adverse Event|3|||
128928036|NCT00469079|464023481|FG002|Overall Study|Adverse Event|2|||
128928037|NCT00469079|464023479|FG000|Overall Study|Lost to Follow-up|4|||
128928038|NCT00469079|464023480|FG001|Overall Study|Lost to Follow-up|8|||
128928039|NCT00469079|464023481|FG002|Overall Study|Lost to Follow-up|10|||
128928040|NCT00469079|464023479|FG000|Overall Study|Withdrawal by Subject|1|||
128928041|NCT00469079|464023480|FG001|Overall Study|Withdrawal by Subject|2|||
128928042|NCT00469079|464023481|FG002|Overall Study|Withdrawal by Subject|2|||
128928043|NCT00469079|464023479|FG000|Overall Study|Ineligible|0|||
128928044|NCT00469079|464023480|FG001|Overall Study|Ineligible|1|||
128928045|NCT00469079|464023481|FG002|Overall Study|Ineligible|0|||
128928046|NCT01006356|464023482|FG000|Overall Study|Adverse Event|6|||
128928047|NCT01006356|464023482|FG000|Overall Study|Physician Decision|1|||
128928048|NCT01006356|464023482|FG000|Overall Study|Paticipants did not cooperate|6|||
128928049|NCT01006356|464023482|FG000|Overall Study|Withdrawal by Subject|1|||
128928050|NCT01006356|464023482|FG000|Overall Study|Choice by participants|2|||
128928051|NCT01006356|464023482|FG000|Overall Study|Protocol Violation|3|||
128928052|NCT01006356|464023482|FG000|Overall Study|Other|23|||
129029718|NCT01968551|464399937|FG000|Extension Phase|Withdrew Consent|0|||
129029719|NCT01968551|464399938|FG001|Extension Phase|Withdrew Consent|0|||
128767295|NCT01709305|463438204|FG002|Phase 1|Physician Decision|0|||
128767296|NCT01709305|463438205|FG003|Phase 1|Physician Decision|0|||
128767297|NCT01709305|463438206|FG004|Phase 1|Physician Decision|0|||
128767298|NCT01709305|463438202|FG000|Phase 1|Protocol Violation|118|||
128767299|NCT01709305|463438203|FG001|Phase 1|Protocol Violation|0|||
128767300|NCT01709305|463438204|FG002|Phase 1|Protocol Violation|0|||
128928053|NCT01756157|464023487|FG000|First Intervention Period|Withdrawal by Subject|1|||
128928054|NCT01756157|464023488|FG001|First Intervention Period|Withdrawal by Subject|0|||
128928055|NCT01756157|464023487|FG000|First Intervention Period|Lost to Follow-up|0|||
129029720|NCT01968551|464399939|FG002|Extension Phase|Withdrew Consent|1|||
129029721|NCT01968551|464399937|FG000|Extension Phase|Lost to Follow-up|1|||
129029722|NCT01968551|464399938|FG001|Extension Phase|Lost to Follow-up|0|||
129029723|NCT01968551|464399939|FG002|Extension Phase|Lost to Follow-up|1|||
129029724|NCT00573313|464399942|FG000|Overall Study|Protocol Violation|5|||
129029725|NCT00573313|464399943|FG001|Overall Study|Protocol Violation|0|||
129029726|NCT00573313|464399944|FG002|Overall Study|Protocol Violation|6|||
129029727|NCT00573313|464399945|FG003|Overall Study|Protocol Violation|0|||
129029728|NCT00467597|464399955|FG000|Overall Study|Withdrawal by Subject|2|||
129029729|NCT00467597|464399956|FG001|Overall Study|Withdrawal by Subject|0|||
129029730|NCT02096705|464399957|FG000|Treatment|Adverse Event|6|||
129029731|NCT02096705|464399958|FG001|Treatment|Adverse Event|3|||
129029732|NCT02096705|464399957|FG000|Treatment|Subject request to discontinue treatment|1|||
129029733|NCT02096705|464399958|FG001|Treatment|Subject request to discontinue treatment|1|||
129029734|NCT02096705|464399957|FG000|Treatment|Withdrawal by Subject|1|||
129029735|NCT02096705|464399958|FG001|Treatment|Withdrawal by Subject|0|||
129029736|NCT02096705|464399957|FG000|Treatment|Other|1|||
129029737|NCT02096705|464399958|FG001|Treatment|Other|1|||
129029738|NCT02096705|464399957|FG000|Follow-up|Withdrawal by Subject|1|||
129029739|NCT02096705|464399958|FG001|Follow-up|Withdrawal by Subject|0|||
129029740|NCT02096705|464399957|FG000|Follow-up|Adverse Event|2|||
129029741|NCT02096705|464399958|FG001|Follow-up|Adverse Event|2|||
129029742|NCT02096705|464399957|FG000|Follow-up|Subjects not reporting status|1|||
129029743|NCT02096705|464399958|FG001|Follow-up|Subjects not reporting status|2|||
129029744|NCT03277248|464399959|FG000|Overall Study|Adverse Event|3|||
129029745|NCT03277248|464399960|FG001|Overall Study|Adverse Event|1|||
129029746|NCT03277248|464399959|FG000|Overall Study|Subject Withdrawal of Consent|6|||
129029747|NCT03277248|464399960|FG001|Overall Study|Subject Withdrawal of Consent|23|||
129029748|NCT03277248|464399959|FG000|Overall Study|Investigator/Sponsor Decision|2|||
129029749|NCT03277248|464399960|FG001|Overall Study|Investigator/Sponsor Decision|2|||
129029750|NCT03277248|464399959|FG000|Overall Study|Pregnancy|4|||
129029751|NCT03277248|464399960|FG001|Overall Study|Pregnancy|1|||
128928056|NCT01756157|464023488|FG001|First Intervention Period|Lost to Follow-up|2|||
128928057|NCT03368859|464023489|FG000|Overall Study|Withdrew Consent|5|||
128928058|NCT03368859|464023490|FG001|Overall Study|Withdrew Consent|4|||
128928059|NCT03368859|464023489|FG000|Overall Study|Death|12|||
128928060|NCT03368859|464023490|FG001|Overall Study|Death|6|||
128928061|NCT03368859|464023489|FG000|Overall Study|Study terminated by Sponsor|18|||
128928062|NCT03368859|464023490|FG001|Overall Study|Study terminated by Sponsor|23|||
128928063|NCT03368859|464023489|FG000|Overall Study|Other|1|||
128928064|NCT03368859|464023490|FG001|Overall Study|Other|1|||
128928065|NCT00573131|464023495|FG000|Overall Study|Withdrawal by Subject|10|||
128928066|NCT00573131|464023496|FG001|Overall Study|Withdrawal by Subject|8|||
128928067|NCT00893789|464023497|FG000|Overall Study|Withdrawal by Subject|3|||
128928068|NCT00893789|464023498|FG001|Overall Study|Withdrawal by Subject|1|||
129029752|NCT03277248|464399959|FG000|Overall Study|Lost to Follow-up|0|||
129029753|NCT03277248|464399960|FG001|Overall Study|Lost to Follow-up|2|||
129029754|NCT03277248|464399959|FG000|Overall Study|Lack of Efficacy|0|||
129029755|NCT03277248|464399960|FG001|Overall Study|Lack of Efficacy|2|||
129119140|NCT01041859|464733207|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
128767301|NCT01709305|463438205|FG003|Phase 1|Protocol Violation|0|||
128767302|NCT01709305|463438206|FG004|Phase 1|Protocol Violation|0|||
128767303|NCT01709305|463438202|FG000|Phase 1|Withdrawal by Subject|218|||
129029756|NCT03277248|464399959|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
129029757|NCT03277248|464399960|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
129029758|NCT02166606|464399963|FG000|Overall Study|Adverse Event|3|||
129029759|NCT02166606|464399963|FG000|Overall Study|Death|31|||
129029760|NCT02166606|464399963|FG000|Overall Study|Protocol Violation|7|||
129029761|NCT02166606|464399963|FG000|Overall Study|Lost to Follow-up|30|||
129029762|NCT02166606|464399963|FG000|Overall Study|Withdrawal by Subject|1|||
128767304|NCT01709305|463438203|FG001|Phase 1|Withdrawal by Subject|0|||
128767305|NCT01709305|463438204|FG002|Phase 1|Withdrawal by Subject|0|||
129029763|NCT02166606|464399963|FG000|Overall Study|Physician Decision|1|||
129029764|NCT02166606|464399963|FG000|Overall Study|Device upgrade|1|||
128928069|NCT00893789|464023499|FG002|Overall Study|Withdrawal by Subject|3|||
128928070|NCT00893789|464023500|FG003|Overall Study|Withdrawal by Subject|1|||
128928071|NCT00893789|464023497|FG000|Overall Study|Noncompliance With Study Drug|1|||
129029765|NCT02166606|464399963|FG000|Overall Study|Enrolled after End of Enrollment|4|||
129029766|NCT00884390|464399966|FG000|Overall Study|Adverse Event|0|||
129029767|NCT00884390|464399967|FG001|Overall Study|Adverse Event|1|||
129029768|NCT00884390|464399966|FG000|Overall Study|Lost to Follow-up|0|||
129029769|NCT00884390|464399967|FG001|Overall Study|Lost to Follow-up|1|||
129029770|NCT00884390|464399966|FG000|Overall Study|Physician Decision|2|||
129029771|NCT00884390|464399967|FG001|Overall Study|Physician Decision|1|||
129029772|NCT00884390|464399966|FG000|Overall Study|Protocol Violation|4|||
129029773|NCT00884390|464399967|FG001|Overall Study|Protocol Violation|1|||
129029774|NCT00884390|464399966|FG000|Overall Study|Withdrawal by Subject|4|||
129029775|NCT00884390|464399967|FG001|Overall Study|Withdrawal by Subject|1|||
129029776|NCT00884390|464399966|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
129029777|NCT00884390|464399967|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
129029778|NCT00884390|464399966|FG000|Overall Study|Other|11|||
129029779|NCT00884390|464399967|FG001|Overall Study|Other|1|||
129029780|NCT01691612|464399968|FG000|Overall Study|deemed ineligible after 1st visit|6|||
129029781|NCT01691612|464399968|FG000|Overall Study|Adverse Event|1|||
129029782|NCT02670551|464399972|FG000|Overall Study|Adverse Event|4|||
129029783|NCT02670551|464399973|FG001|Overall Study|Adverse Event|7|||
129029784|NCT02670551|464399974|FG002|Overall Study|Adverse Event|9|||
129029785|NCT02670551|464399972|FG000|Overall Study|Lack of Efficacy|2|||
129029786|NCT02670551|464399973|FG001|Overall Study|Lack of Efficacy|0|||
129029787|NCT02670551|464399974|FG002|Overall Study|Lack of Efficacy|3|||
129029788|NCT02670551|464399972|FG000|Overall Study|Withdrawal of Consent|6|||
129029789|NCT02670551|464399973|FG001|Overall Study|Withdrawal of Consent|3|||
129029790|NCT02670551|464399974|FG002|Overall Study|Withdrawal of Consent|8|||
129029791|NCT02670551|464399972|FG000|Overall Study|Lost to Follow-up|5|||
129029792|NCT02670551|464399973|FG001|Overall Study|Lost to Follow-up|7|||
129029793|NCT02670551|464399974|FG002|Overall Study|Lost to Follow-up|6|||
129029794|NCT02670551|464399972|FG000|Overall Study|Protocol Violation|1|||
129029795|NCT02670551|464399973|FG001|Overall Study|Protocol Violation|0|||
129029796|NCT02670551|464399974|FG002|Overall Study|Protocol Violation|0|||
129029797|NCT02670551|464399972|FG000|Overall Study|Noncompliance with study drug|3|||
129029798|NCT02670551|464399973|FG001|Overall Study|Noncompliance with study drug|3|||
129029799|NCT02670551|464399974|FG002|Overall Study|Noncompliance with study drug|2|||
129029800|NCT02670551|464399972|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129029801|NCT02670551|464399973|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129029802|NCT02670551|464399974|FG002|Overall Study|Other Miscellaneous Reasons|3|||
129029803|NCT02670551|464399972|FG000|Overall Study|Did Not Receive Treatment|5|||
129029804|NCT02670551|464399973|FG001|Overall Study|Did Not Receive Treatment|3|||
129029805|NCT02670551|464399974|FG002|Overall Study|Did Not Receive Treatment|0|||
129029806|NCT04476277|464399975|FG000|Overall Study|Withdrawal by Subject|0|||
129029807|NCT04476277|464399976|FG001|Overall Study|Withdrawal by Subject|0|||
129029808|NCT04476277|464399977|FG002|Overall Study|Withdrawal by Subject|1|||
129029809|NCT04476277|464399978|FG003|Overall Study|Withdrawal by Subject|0|||
129029810|NCT01971645|464399979|FG000|Overall Study|Adverse Event|1|||
129029811|NCT01971645|464399980|FG001|Overall Study|Adverse Event|0|||
129029812|NCT01971645|464399981|FG002|Overall Study|Adverse Event|0|||
129029813|NCT01971645|464399979|FG000|Overall Study|Lost to Follow-up|1|||
129029814|NCT01971645|464399980|FG001|Overall Study|Lost to Follow-up|0|||
129029815|NCT01971645|464399981|FG002|Overall Study|Lost to Follow-up|1|||
129029816|NCT01971645|464399979|FG000|Overall Study|Protocol Violation|0|||
129029817|NCT01971645|464399980|FG001|Overall Study|Protocol Violation|0|||
129029818|NCT01971645|464399981|FG002|Overall Study|Protocol Violation|1|||
129029819|NCT01962298|464399982|FG000|Overall Study|Protocol Violation|1|||
129029820|NCT01962298|464399983|FG001|Overall Study|Protocol Violation|0|||
129029821|NCT01962298|464399984|FG002|Overall Study|Protocol Violation|1|||
129029822|NCT01962298|464399985|FG003|Overall Study|Protocol Violation|1|||
129029823|NCT01962298|464399986|FG004|Overall Study|Protocol Violation|0|||
129029824|NCT01962298|464399982|FG000|Overall Study|Data quality insufficient|2|||
129029825|NCT01962298|464399983|FG001|Overall Study|Data quality insufficient|0|||
129029826|NCT01962298|464399984|FG002|Overall Study|Data quality insufficient|3|||
128701510|NCT00044083|463205634|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
128701511|NCT00044083|463205635|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
128701512|NCT00044083|463205634|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
129029827|NCT01962298|464399985|FG003|Overall Study|Data quality insufficient|1|||
129029828|NCT01962298|464399986|FG004|Overall Study|Data quality insufficient|4|||
129029829|NCT01962298|464399982|FG000|Overall Study|Insufficient data|0|||
129029830|NCT01962298|464399983|FG001|Overall Study|Insufficient data|2|||
129029831|NCT01962298|464399984|FG002|Overall Study|Insufficient data|1|||
129029832|NCT01962298|464399985|FG003|Overall Study|Insufficient data|0|||
129029833|NCT01962298|464399986|FG004|Overall Study|Insufficient data|1|||
129029834|NCT01962298|464399982|FG000|Overall Study|Incorrect data recorded|0|||
129029835|NCT01962298|464399983|FG001|Overall Study|Incorrect data recorded|1|||
129029836|NCT01962298|464399984|FG002|Overall Study|Incorrect data recorded|0|||
129029837|NCT01962298|464399985|FG003|Overall Study|Incorrect data recorded|0|||
129029838|NCT01962298|464399986|FG004|Overall Study|Incorrect data recorded|0|||
128928072|NCT00893789|464023498|FG001|Overall Study|Noncompliance With Study Drug|0|||
128928073|NCT00893789|464023499|FG002|Overall Study|Noncompliance With Study Drug|1|||
128928074|NCT00893789|464023500|FG003|Overall Study|Noncompliance With Study Drug|2|||
128928075|NCT00893789|464023497|FG000|Overall Study|Noncompliance With Study Procedures|1|||
128928076|NCT00893789|464023498|FG001|Overall Study|Noncompliance With Study Procedures|0|||
128928077|NCT00893789|464023499|FG002|Overall Study|Noncompliance With Study Procedures|0|||
128928078|NCT00893789|464023500|FG003|Overall Study|Noncompliance With Study Procedures|0|||
128928079|NCT00893789|464023497|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
128928080|NCT00893789|464023498|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
128928081|NCT00893789|464023499|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
128928082|NCT00893789|464023500|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
128928083|NCT00893789|464023497|FG000|Overall Study|Adverse Event|0|||
128928084|NCT00893789|464023498|FG001|Overall Study|Adverse Event|2|||
128928085|NCT00893789|464023499|FG002|Overall Study|Adverse Event|1|||
128928086|NCT00893789|464023500|FG003|Overall Study|Adverse Event|5|||
128928087|NCT00893789|464023497|FG000|Overall Study|Protocol Violation|0|||
128928088|NCT00893789|464023498|FG001|Overall Study|Protocol Violation|1|||
128928089|NCT00893789|464023499|FG002|Overall Study|Protocol Violation|1|||
128928090|NCT00893789|464023500|FG003|Overall Study|Protocol Violation|4|||
128928091|NCT00893789|464023497|FG000|Overall Study|Lost to Follow-up|0|||
128928092|NCT00893789|464023498|FG001|Overall Study|Lost to Follow-up|0|||
128928093|NCT00893789|464023499|FG002|Overall Study|Lost to Follow-up|0|||
128928094|NCT00893789|464023500|FG003|Overall Study|Lost to Follow-up|1|||
128928095|NCT02024464|464023501|FG000|Overall Study|Discontinued|5|||
128928096|NCT02024464|464023502|FG001|Overall Study|Discontinued|4|||
128928097|NCT02024464|464023501|FG000|Overall Study|Missed Visits|1|||
128928098|NCT02024464|464023502|FG001|Overall Study|Missed Visits|0|||
128928099|NCT02024464|464023501|FG000|Overall Study|Lost to Follow-up|4|||
128928100|NCT02024464|464023502|FG001|Overall Study|Lost to Follow-up|7|||
128928101|NCT01973283|464023505|FG000|Overall Study|Lost to Follow-up|4|||
128928102|NCT00087438|464023507|FG000|Overall Study|Ineligible / No protocol treatment|4|||
128928103|NCT00466505|464023508|FG000|Overall Study|disease progression|13|||
128928104|NCT00466505|464023508|FG000|Overall Study|Adverse Event|4|||
128928105|NCT00811252|464023509|FG000|Overall Study|Adverse Event|6|||
128928106|NCT00811252|464023510|FG001|Overall Study|Adverse Event|10|||
128928107|NCT00811252|464023511|FG002|Overall Study|Adverse Event|15|||
128928108|NCT00811252|464023509|FG000|Overall Study|Lack of Efficacy|7|||
128928109|NCT00811252|464023510|FG001|Overall Study|Lack of Efficacy|2|||
128928110|NCT00811252|464023511|FG002|Overall Study|Lack of Efficacy|0|||
128928111|NCT00811252|464023509|FG000|Overall Study|Protocol Violation|3|||
128928112|NCT00811252|464023510|FG001|Overall Study|Protocol Violation|3|||
128928113|NCT00811252|464023511|FG002|Overall Study|Protocol Violation|2|||
128928114|NCT00811252|464023509|FG000|Overall Study|Withdrawal of Consent|1|||
128928115|NCT00811252|464023510|FG001|Overall Study|Withdrawal of Consent|2|||
128928116|NCT00811252|464023511|FG002|Overall Study|Withdrawal of Consent|2|||
128928117|NCT00811252|464023509|FG000|Overall Study|Lost to Follow-up|0|||
128928118|NCT00811252|464023510|FG001|Overall Study|Lost to Follow-up|0|||
128928119|NCT00811252|464023511|FG002|Overall Study|Lost to Follow-up|2|||
128928120|NCT00811252|464023509|FG000|Overall Study|Administrative or Other Reasons|0|||
128928121|NCT00811252|464023510|FG001|Overall Study|Administrative or Other Reasons|3|||
128928122|NCT00811252|464023511|FG002|Overall Study|Administrative or Other Reasons|2|||
128928123|NCT01931865|464023512|FG000|Overall Study|Lost to Follow-up|2|||
128928124|NCT01931865|464023512|FG000|Overall Study|Withdrawal by Subject|2|||
128928125|NCT00728416|464023518|FG000|Overall Study|Adverse Event|1|||
128928126|NCT00728416|464023519|FG001|Overall Study|Adverse Event|1|||
128928127|NCT00728416|464023518|FG000|Overall Study|Treatment Failure|0|||
128928128|NCT00728416|464023519|FG001|Overall Study|Treatment Failure|1|||
128928129|NCT00728416|464023518|FG000|Overall Study|Withdrawal by Subject|1|||
128928130|NCT00728416|464023519|FG001|Overall Study|Withdrawal by Subject|0|||
128928131|NCT00356915|464023524|FG000|Overall Study|Non compliance|1|||
128928132|NCT00356915|464023525|FG001|Overall Study|Non compliance|2|||
128928133|NCT00356915|464023526|FG002|Overall Study|Non compliance|1|||
128701513|NCT00044083|463205635|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
128928134|NCT00356915|464023524|FG000|Overall Study|Protocol Violation|2|||
128928135|NCT00356915|464023525|FG001|Overall Study|Protocol Violation|3|||
128928136|NCT00356915|464023526|FG002|Overall Study|Protocol Violation|2|||
128928137|NCT00356915|464023524|FG000|Overall Study|Withdrawal by Subject|14|||
128928138|NCT00356915|464023525|FG001|Overall Study|Withdrawal by Subject|14|||
128928139|NCT00356915|464023526|FG002|Overall Study|Withdrawal by Subject|10|||
128928140|NCT00356915|464023524|FG000|Overall Study|Lack of Efficacy|0|||
128701514|NCT00044083|463205634|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
129216381|NCT03739203|465092909|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
128928141|NCT00356915|464023525|FG001|Overall Study|Lack of Efficacy|0|||
128928142|NCT00356915|464023526|FG002|Overall Study|Lack of Efficacy|3|||
128928143|NCT00356915|464023524|FG000|Overall Study|Lost to Follow-up|27|||
128928144|NCT00356915|464023525|FG001|Overall Study|Lost to Follow-up|34|||
128928145|NCT00356915|464023526|FG002|Overall Study|Lost to Follow-up|14|||
128928146|NCT00356915|464023524|FG000|Overall Study|Administrative Decision|0|||
128928147|NCT00356915|464023525|FG001|Overall Study|Administrative Decision|0|||
128928148|NCT00356915|464023526|FG002|Overall Study|Administrative Decision|1|||
128928149|NCT00356915|464023524|FG000|Overall Study|Physician Decision|0|||
128928150|NCT00356915|464023525|FG001|Overall Study|Physician Decision|2|||
128928151|NCT00356915|464023526|FG002|Overall Study|Physician Decision|0|||
128928152|NCT00356915|464023524|FG000|Overall Study|Adverse Event|21|||
128928153|NCT00356915|464023525|FG001|Overall Study|Adverse Event|31|||
128928154|NCT00356915|464023526|FG002|Overall Study|Adverse Event|8|||
128928155|NCT00356915|464023524|FG000|Overall Study|Miscellaneous reasons|11|||
128928156|NCT00356915|464023525|FG001|Overall Study|Miscellaneous reasons|8|||
128928157|NCT00356915|464023526|FG002|Overall Study|Miscellaneous reasons|3|||
128928158|NCT00509106|464023527|FG000|Overall Study|Adverse Event|3|||
128928159|NCT00509106|464023528|FG001|Overall Study|Adverse Event|2|||
128928160|NCT00509106|464023527|FG000|Overall Study|Noncompliance|0|||
128928161|NCT00509106|464023528|FG001|Overall Study|Noncompliance|1|||
128928162|NCT00509106|464023527|FG000|Overall Study|At the request of sponsor/investigator|1|||
128928163|NCT00509106|464023528|FG001|Overall Study|At the request of sponsor/investigator|2|||
128928164|NCT00509106|464023527|FG000|Overall Study|Withdrew consent|4|||
128928165|NCT00509106|464023528|FG001|Overall Study|Withdrew consent|8|||
128928166|NCT00509106|464023527|FG000|Overall Study|Lost to Follow-up|16|||
128928167|NCT00509106|464023528|FG001|Overall Study|Lost to Follow-up|10|||
128928168|NCT00509106|464023527|FG000|Overall Study|Other|1|||
128928169|NCT00509106|464023528|FG001|Overall Study|Other|0|||
128928170|NCT00509106|464023527|FG000|Overall Study|Death|6|||
128928171|NCT00509106|464023528|FG001|Overall Study|Death|6|||
128928172|NCT00488631|464023529|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
128928173|NCT00488631|464023530|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
128928174|NCT00488631|464023531|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
128928175|NCT00488631|464023532|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
128928176|NCT00488631|464023533|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
128928177|NCT00488631|464023534|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
128928178|NCT00488631|464023535|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
128928179|NCT00488631|464023536|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
128928180|NCT00488631|464023537|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
128928181|NCT00488631|464023538|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
128928182|NCT00488631|464023529|FG000|Double Blind Period (Week 0-54)|Death|0|||
128928183|NCT00488631|464023530|FG001|Double Blind Period (Week 0-54)|Death|0|||
128928184|NCT00488631|464023531|FG002|Double Blind Period (Week 0-54)|Death|0|||
128928185|NCT00488631|464023532|FG003|Double Blind Period (Week 0-54)|Death|0|||
128928186|NCT00488631|464023533|FG004|Double Blind Period (Week 0-54)|Death|0|||
128928187|NCT00488631|464023534|FG005|Double Blind Period (Week 0-54)|Death|1|||
128928188|NCT00488631|464023535|FG006|Double Blind Period (Week 0-54)|Death|0|||
128928189|NCT00488631|464023536|FG007|Double Blind Period (Week 0-54)|Death|0|||
128928190|NCT00488631|464023537|FG008|Double Blind Period (Week 0-54)|Death|0|||
128928191|NCT00488631|464023538|FG009|Double Blind Period (Week 0-54)|Death|0|||
128928192|NCT00488631|464023529|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
128928193|NCT00488631|464023530|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
128928194|NCT00488631|464023531|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
128928195|NCT00488631|464023532|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
128928196|NCT00488631|464023533|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
128928197|NCT00488631|464023534|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
128928198|NCT00488631|464023535|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
128928199|NCT00488631|464023536|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
128928200|NCT00488631|464023537|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
128928201|NCT00488631|464023538|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
128928202|NCT00488631|464023529|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
128928203|NCT00488631|464023530|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
128928204|NCT00488631|464023531|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
128928205|NCT00488631|464023532|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
128928206|NCT00488631|464023533|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
128928207|NCT00488631|464023534|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
128928208|NCT00488631|464023535|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
128928209|NCT00488631|464023536|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
128928210|NCT00488631|464023537|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
129216382|NCT03739203|465092910|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
128928211|NCT00488631|464023538|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
128928212|NCT00488631|464023529|FG000|Double Blind Period (Week 0-54)|Other|6|||
128928213|NCT00488631|464023530|FG001|Double Blind Period (Week 0-54)|Other|12|||
128928214|NCT00488631|464023531|FG002|Double Blind Period (Week 0-54)|Other|10|||
128928215|NCT00488631|464023532|FG003|Double Blind Period (Week 0-54)|Other|11|||
128928216|NCT00488631|464023533|FG004|Double Blind Period (Week 0-54)|Other|14|||
128928217|NCT00488631|464023534|FG005|Double Blind Period (Week 0-54)|Other|34|||
128928218|NCT00488631|464023535|FG006|Double Blind Period (Week 0-54)|Other|0|||
128928219|NCT00488631|464023536|FG007|Double Blind Period (Week 0-54)|Other|0|||
128928220|NCT00488631|464023537|FG008|Double Blind Period (Week 0-54)|Other|0|||
128928221|NCT00488631|464023538|FG009|Double Blind Period (Week 0-54)|Other|0|||
128928222|NCT00488631|464023529|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
128928223|NCT00488631|464023530|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
128928224|NCT00488631|464023531|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
128928225|NCT00488631|464023532|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
128928226|NCT00488631|464023533|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
128928227|NCT00488631|464023534|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
128928228|NCT00488631|464023535|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
128928229|NCT00488631|464023536|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
128928230|NCT00488631|464023537|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
128928231|NCT00488631|464023538|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
128928232|NCT00488631|464023529|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
128928233|NCT00488631|464023530|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
128928234|NCT00488631|464023531|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
128701515|NCT00044083|463205635|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
128701516|NCT00044083|463205634|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
128928235|NCT00488631|464023532|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
128928236|NCT00488631|464023533|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
128928237|NCT00488631|464023534|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
128928238|NCT00488631|464023535|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
128928239|NCT00488631|464023536|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
128928240|NCT00488631|464023537|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
128928241|NCT00488631|464023538|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
128928242|NCT00488631|464023529|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
128928243|NCT00488631|464023530|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
128928244|NCT00488631|464023531|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
128928245|NCT00488631|464023532|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
128928246|NCT00488631|464023533|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
128928247|NCT00488631|464023534|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
128928248|NCT00488631|464023535|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
128928249|NCT00488631|464023536|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
128928250|NCT00488631|464023537|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
128928251|NCT00488631|464023538|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
128928252|NCT00488631|464023529|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928253|NCT00488631|464023530|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928254|NCT00488631|464023531|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928255|NCT00488631|464023532|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928256|NCT00488631|464023533|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928257|NCT00488631|464023534|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928258|NCT00488631|464023535|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
128928259|NCT00488631|464023536|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928260|NCT00488631|464023537|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
128928261|NCT00488631|464023538|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
128928262|NCT00488631|464023529|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
128928263|NCT00488631|464023530|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
128928264|NCT00488631|464023531|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
128928265|NCT00488631|464023532|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
128928266|NCT00488631|464023533|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
128928267|NCT00488631|464023534|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
128928268|NCT00488631|464023535|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
128928269|NCT00488631|464023536|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
128928270|NCT00488631|464023537|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
128928271|NCT00488631|464023538|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
128928272|NCT00927485|464023539|FG000|Overall Study|Adverse Event|4|||
128928273|NCT00927485|464023540|FG001|Overall Study|Adverse Event|2|||
128928274|NCT00927485|464023539|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
128928275|NCT00927485|464023540|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
128928276|NCT03486314|464023541|FG000|Part A|Adverse Event|1|||
128928277|NCT03486314|464023542|FG001|Part A|Adverse Event|0|||
128928278|NCT03486314|464023543|FG002|Part A|Adverse Event|0|||
128928279|NCT03486314|464023541|FG000|Part A|Symptomatic Deterioration|2|||
128928280|NCT03486314|464023542|FG001|Part A|Symptomatic Deterioration|0|||
128928281|NCT03486314|464023543|FG002|Part A|Symptomatic Deterioration|0|||
128928282|NCT00659438|464023544|FG000|Overall Study|Withdrawal by Subject|2|||
128928283|NCT00659438|464023545|FG001|Overall Study|Withdrawal by Subject|2|||
128928284|NCT00659438|464023544|FG000|Overall Study|Death|11|||
128928285|NCT00659438|464023545|FG001|Overall Study|Death|6|||
128928286|NCT00659438|464023544|FG000|Overall Study|Lost to Follow-up|1|||
128928287|NCT00659438|464023545|FG001|Overall Study|Lost to Follow-up|0|||
128928288|NCT00246259|464023547|FG000|Overall Study|Other|3|||
128928289|NCT00246259|464023548|FG001|Overall Study|Other|3|||
128928290|NCT00246259|464023547|FG000|Overall Study|Not stable by Week 18|2|||
128928291|NCT00246259|464023548|FG001|Overall Study|Not stable by Week 18|1|||
128928292|NCT00246259|464023547|FG000|Overall Study|Participant non-compliant|4|||
128928293|NCT00246259|464023548|FG001|Overall Study|Participant non-compliant|9|||
128928294|NCT00246259|464023547|FG000|Overall Study|Lack of Efficacy|2|||
128928295|NCT00246259|464023548|FG001|Overall Study|Lack of Efficacy|2|||
128928296|NCT00246259|464023547|FG000|Overall Study|Investigator withdrew participant|2|||
128928297|NCT00246259|464023548|FG001|Overall Study|Investigator withdrew participant|0|||
128928298|NCT00246259|464023547|FG000|Overall Study|Adverse Event|5|||
128928299|NCT00246259|464023548|FG001|Overall Study|Adverse Event|0|||
128928300|NCT00246259|464023547|FG000|Overall Study|Lost to Follow-up|3|||
128928301|NCT00246259|464023548|FG001|Overall Study|Lost to Follow-up|4|||
128928302|NCT00246259|464023547|FG000|Overall Study|Withdrawal by Subject|5|||
128928303|NCT00246259|464023548|FG001|Overall Study|Withdrawal by Subject|1|||
128928304|NCT00246259|464023547|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
128928305|NCT00246259|464023548|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
128928306|NCT05480514|464023549|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
128928307|NCT05480514|464023550|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
128928308|NCT05480514|464023549|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
128928309|NCT05480514|464023550|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
128928310|NCT05480514|464023549|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
128928311|NCT05480514|464023550|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
128928312|NCT05480514|464023549|FG000|Period 1|Covid-19 Related|1|||
128928313|NCT05480514|464023550|FG001|Period 1|Covid-19 Related|0|||
128928314|NCT05480514|464023549|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
128928315|NCT05480514|464023550|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
128928316|NCT00457639|464023551|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
128928317|NCT00457639|464023552|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
128928318|NCT00457639|464023551|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
128928319|NCT00457639|464023552|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
128928320|NCT00457639|464023551|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
128928321|NCT00457639|464023552|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
128928322|NCT00628355|464023564|FG000|Overall Study|Withdrawal by Subject|1|||
128928323|NCT00628355|464023565|FG001|Overall Study|Withdrawal by Subject|1|||
128928324|NCT03542682|464023566|FG000|Overall Study|COVID-19 Protocol|0|||
128928325|NCT03542682|464023567|FG001|Overall Study|COVID-19 Protocol|1|||
128928326|NCT01901328|464023568|FG000|Overall Study|Lost to Follow-up|1|||
128928327|NCT01901328|464023569|FG001|Overall Study|Lost to Follow-up|0|||
128928328|NCT01901328|464023568|FG000|Overall Study|Physician Decision|0|||
128928329|NCT01901328|464023569|FG001|Overall Study|Physician Decision|1|||
128928330|NCT01901328|464023568|FG000|Overall Study|Protocol Violation|1|||
128928331|NCT01901328|464023569|FG001|Overall Study|Protocol Violation|1|||
128928332|NCT01901328|464023568|FG000|Overall Study|Study Terminated by Sponsor|19|||
128928333|NCT01901328|464023569|FG001|Overall Study|Study Terminated by Sponsor|16|||
128928334|NCT01901328|464023568|FG000|Overall Study|Withdrawal by Subject|1|||
128928335|NCT01901328|464023569|FG001|Overall Study|Withdrawal by Subject|2|||
128928336|NCT01901328|464023568|FG000|Overall Study|Lack of Efficacy|0|||
128928337|NCT01901328|464023569|FG001|Overall Study|Lack of Efficacy|1|||
128928338|NCT03232073|464023570|FG000|Overall Study|Death|1|||
128928339|NCT03232073|464023571|FG001|Overall Study|Death|0|||
128928340|NCT03232073|464023570|FG000|Overall Study|Adverse Event|7|||
128928341|NCT03232073|464023571|FG001|Overall Study|Adverse Event|12|||
128928342|NCT03232073|464023570|FG000|Overall Study|Lost to Follow-up|6|||
128928343|NCT03232073|464023571|FG001|Overall Study|Lost to Follow-up|6|||
128928344|NCT03232073|464023570|FG000|Overall Study|Lack of Efficacy|10|||
128928345|NCT03232073|464023571|FG001|Overall Study|Lack of Efficacy|8|||
128928346|NCT03232073|464023570|FG000|Overall Study|Physician Decision|9|||
128928347|NCT03232073|464023571|FG001|Overall Study|Physician Decision|2|||
128928348|NCT03232073|464023570|FG000|Overall Study|Withdrawal by Subject|54|||
128928349|NCT03232073|464023571|FG001|Overall Study|Withdrawal by Subject|39|||
128928350|NCT00853632|464025214|FG000|Overall Study|Death|88|||
128928351|NCT00853632|464025214|FG000|Overall Study|Withdrawal by Subject|45|||
128928352|NCT00853632|464025214|FG000|Overall Study|Lost to Follow-up|30|||
128928353|NCT00853632|464025214|FG000|Overall Study|Reoperation/Explant|17|||
128928354|NCT00853632|464025214|FG000|Overall Study|Exit with other reason|22|||
128928355|NCT02698410|464025215|FG000|Overall Study|Adverse Event|2|||
128928356|NCT02698410|464025215|FG000|Overall Study|Withdrawal by Subject|1|||
128928357|NCT02698410|464025215|FG000|Overall Study|Other|1|||
129029839|NCT01962298|464399982|FG000|Overall Study|Physician Decision|0|||
129029840|NCT01962298|464399983|FG001|Overall Study|Physician Decision|1|||
129029841|NCT01962298|464399984|FG002|Overall Study|Physician Decision|0|||
129029842|NCT01962298|464399985|FG003|Overall Study|Physician Decision|0|||
129029843|NCT01962298|464399986|FG004|Overall Study|Physician Decision|1|||
129029844|NCT00533507|464399987|FG000|Overall Study|Withdrawal by Subject|1|||
129029845|NCT01576705|464399988|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
129029846|NCT01576705|464399989|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
129029847|NCT01576705|464399990|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
129029848|NCT01576705|464399991|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
129029849|NCT01576705|464399988|FG000|Overall Study|invalid ICF|0|||
129029850|NCT01576705|464399989|FG001|Overall Study|invalid ICF|1|||
129029851|NCT01576705|464399990|FG002|Overall Study|invalid ICF|0|||
129029852|NCT01576705|464399991|FG003|Overall Study|invalid ICF|0|||
129029853|NCT02896296|464399992|FG000|Overall Study|Adverse Event|1|||
129029854|NCT02896296|464399992|FG000|Overall Study|Lost to Follow-up|19|||
129029855|NCT02896296|464399992|FG000|Overall Study|Pregnancy|1|||
129029856|NCT02896296|464399992|FG000|Overall Study|Physician Decision|2|||
129029857|NCT02896296|464399992|FG000|Overall Study|Withdrawal by Subject|10|||
129029858|NCT02896296|464399992|FG000|Overall Study|Site closing|7|||
129029859|NCT02896296|464399992|FG000|Overall Study|Incarceration|1|||
129029860|NCT02896296|464399992|FG000|Overall Study|Relocation|1|||
129029861|NCT00045162|464399993|FG000|Overall Study|Ineligible|12|||
129029862|NCT00045162|464399994|FG001|Overall Study|Ineligible|8|||
129029863|NCT00045162|464399993|FG000|Overall Study|Not treated|7|||
129029864|NCT00045162|464399994|FG001|Overall Study|Not treated|2|||
128928358|NCT04331899|464025223|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
128928359|NCT04331899|464025224|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
128928360|NCT02424539|464025227|FG000|Overall Study|Adverse Event|0|||
128928361|NCT02424539|464025228|FG001|Overall Study|Adverse Event|0|||
128928362|NCT02424539|464025229|FG002|Overall Study|Adverse Event|1|||
128928363|NCT02424539|464025227|FG000|Overall Study|Physician Decision|0|||
128928364|NCT02424539|464025228|FG001|Overall Study|Physician Decision|0|||
128928365|NCT02424539|464025229|FG002|Overall Study|Physician Decision|1|||
128928366|NCT02424539|464025227|FG000|Overall Study|Withdrawal by Subject|3|||
128928367|NCT02424539|464025228|FG001|Overall Study|Withdrawal by Subject|1|||
128928368|NCT02424539|464025229|FG002|Overall Study|Withdrawal by Subject|0|||
128928369|NCT02424539|464025227|FG000|Overall Study|Other: Reached stopping criteria|11|||
128928370|NCT02424539|464025228|FG001|Overall Study|Other: Reached stopping criteria|7|||
128928371|NCT02424539|464025229|FG002|Overall Study|Other: Reached stopping criteria|6|||
128928372|NCT00719810|464025230|FG000|Overall Study|Adverse Event|0|||
128928373|NCT00719810|464025231|FG001|Overall Study|Adverse Event|2|||
128928374|NCT00719810|464025232|FG002|Overall Study|Adverse Event|3|||
128928375|NCT00719810|464025230|FG000|Overall Study|Lost to Follow-up|2|||
128928376|NCT00719810|464025231|FG001|Overall Study|Lost to Follow-up|0|||
128928377|NCT00719810|464025232|FG002|Overall Study|Lost to Follow-up|3|||
128928378|NCT00719810|464025230|FG000|Overall Study|Physician Decision|0|||
128928379|NCT00719810|464025231|FG001|Overall Study|Physician Decision|1|||
128928380|NCT00719810|464025232|FG002|Overall Study|Physician Decision|0|||
128928381|NCT00719810|464025230|FG000|Overall Study|Withdrawal by Subject|1|||
128928382|NCT00719810|464025231|FG001|Overall Study|Withdrawal by Subject|1|||
128928383|NCT00719810|464025232|FG002|Overall Study|Withdrawal by Subject|2|||
128928384|NCT04893265|464025235|FG000|Overall Study|Withdrawal by Subject|2|||
128928385|NCT04893265|464025236|FG001|Overall Study|Withdrawal by Subject|5|||
128928386|NCT04893265|464025235|FG000|Overall Study|Lost to Follow-up|0|||
128928387|NCT04893265|464025236|FG001|Overall Study|Lost to Follow-up|4|||
128928388|NCT05408858|464025239|FG000|Overall Study|no longer met eligibility criteria|1|||
128928389|NCT02037919|464025243|FG000|Overall Study|Lost to Follow-up|30|||
128928390|NCT02037919|464025244|FG001|Overall Study|Lost to Follow-up|45|||
128928391|NCT03717922|464025252|FG000|Overall Study|Lost to Follow-up|2|||
129029865|NCT00045162|464399993|FG000|Overall Study|Adverse Event|55|||
129029866|NCT00045162|464399994|FG001|Overall Study|Adverse Event|50|||
129029867|NCT00045162|464399993|FG000|Overall Study|Lack of Efficacy|32|||
129216383|NCT03739203|465092911|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
128701517|NCT00044083|463205635|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
128928392|NCT03717922|464025253|FG001|Overall Study|Lost to Follow-up|2|||
129029868|NCT00045162|464399994|FG001|Overall Study|Lack of Efficacy|29|||
129029869|NCT00045162|464399993|FG000|Overall Study|Death|10|||
129029870|NCT00045162|464399994|FG001|Overall Study|Death|10|||
129029871|NCT00045162|464399993|FG000|Overall Study|Withdrawal by Subject|5|||
128928393|NCT01929083|464025263|FG000|Intervention 1|Lost to Follow-up|2|||
128928394|NCT01929083|464025264|FG001|Intervention 1|Lost to Follow-up|0|||
128928395|NCT01929083|464025263|FG000|Intervention 1|Nonadherent to study medications|1|||
128928396|NCT01929083|464025264|FG001|Intervention 1|Nonadherent to study medications|0|||
128928397|NCT01929083|464025263|FG000|Intervention 2|Adverse Event|0|||
128928398|NCT01929083|464025264|FG001|Intervention 2|Adverse Event|1|||
128928399|NCT02586805|464025267|FG000|Overall Study|Withdrawal by Subject|3|||
128928400|NCT02586805|464025268|FG001|Overall Study|Withdrawal by Subject|1|||
129029872|NCT00045162|464399994|FG001|Overall Study|Withdrawal by Subject|3|||
128928401|NCT02586805|464025269|FG002|Overall Study|Withdrawal by Subject|1|||
128928402|NCT02586805|464025270|FG003|Overall Study|Withdrawal by Subject|2|||
128928403|NCT02586805|464025267|FG000|Overall Study|Adverse Event|2|||
128928404|NCT02586805|464025268|FG001|Overall Study|Adverse Event|0|||
128928405|NCT02586805|464025269|FG002|Overall Study|Adverse Event|1|||
128928406|NCT02586805|464025270|FG003|Overall Study|Adverse Event|0|||
128928407|NCT02586805|464025267|FG000|Overall Study|Lost to Follow-up|0|||
128928408|NCT02586805|464025268|FG001|Overall Study|Lost to Follow-up|0|||
128928409|NCT02586805|464025269|FG002|Overall Study|Lost to Follow-up|1|||
128928410|NCT02586805|464025270|FG003|Overall Study|Lost to Follow-up|0|||
128928411|NCT02586805|464025267|FG000|Overall Study|Physician Decision|1|||
128928412|NCT02586805|464025268|FG001|Overall Study|Physician Decision|0|||
128928413|NCT02586805|464025269|FG002|Overall Study|Physician Decision|0|||
128928414|NCT02586805|464025270|FG003|Overall Study|Physician Decision|0|||
128928415|NCT01829048|464025271|FG000|Overall Study|Withdrawal by Subject|0|||
128928416|NCT01829048|464025272|FG001|Overall Study|Withdrawal by Subject|0|||
128928417|NCT01829048|464025273|FG002|Overall Study|Withdrawal by Subject|0|||
128928418|NCT01829048|464025274|FG003|Overall Study|Withdrawal by Subject|2|||
128928419|NCT01829048|464025275|FG004|Overall Study|Withdrawal by Subject|0|||
128928420|NCT02317510|464025279|FG000|Overall Study|Adverse Event|0|||
128928421|NCT02317510|464025280|FG001|Overall Study|Adverse Event|1|||
128928422|NCT00500071|464025281|FG000|Screening and Washout Phase|Protocol Violation|1|||
128928423|NCT00500071|464025281|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
128928424|NCT00500071|464025281|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
128928425|NCT00500071|464025281|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
128928426|NCT00500071|464025281|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
128928427|NCT00500071|464025281|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
128928428|NCT00500071|464025281|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
128928429|NCT00472303|464025282|FG000|Titration Phase|Adverse Event|22|||
128928430|NCT00472303|464025283|FG001|Titration Phase|Adverse Event|12|||
128928431|NCT00472303|464025284|FG002|Titration Phase|Adverse Event|0|||
128928432|NCT00472303|464025282|FG000|Titration Phase|Death|4|||
128928433|NCT00472303|464025283|FG001|Titration Phase|Death|2|||
128928434|NCT00472303|464025284|FG002|Titration Phase|Death|0|||
128928435|NCT00472303|464025282|FG000|Titration Phase|Lack of Efficacy|10|||
128928436|NCT00472303|464025283|FG001|Titration Phase|Lack of Efficacy|0|||
128928437|NCT00472303|464025284|FG002|Titration Phase|Lack of Efficacy|0|||
128928438|NCT00472303|464025282|FG000|Titration Phase|Withdrawal by Subject|16|||
128928439|NCT00472303|464025283|FG001|Titration Phase|Withdrawal by Subject|13|||
128928440|NCT00472303|464025284|FG002|Titration Phase|Withdrawal by Subject|0|||
128928441|NCT00472303|464025282|FG000|Titration Phase|Trial Medication non-compliant|4|||
128928442|NCT00472303|464025283|FG001|Titration Phase|Trial Medication non-compliant|1|||
128928443|NCT00472303|464025284|FG002|Titration Phase|Trial Medication non-compliant|0|||
128928444|NCT00472303|464025282|FG000|Titration Phase|Other|3|||
128928445|NCT00472303|464025283|FG001|Titration Phase|Other|1|||
128928446|NCT00472303|464025284|FG002|Titration Phase|Other|0|||
128928447|NCT00472303|464025282|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
128928448|NCT00472303|464025283|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
128928449|NCT00472303|464025284|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
128928450|NCT00472303|464025282|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
128928451|NCT00472303|464025283|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
128928452|NCT00472303|464025284|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
128928453|NCT00472303|464025282|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
128928454|NCT00472303|464025283|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
128928455|NCT00472303|464025284|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
128928456|NCT00472303|464025282|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
128928457|NCT00472303|464025283|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
128928458|NCT00472303|464025284|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
128928459|NCT00472303|464025282|FG000|Discontinuations After Titration Phase|Other|5|||
128928460|NCT00472303|464025283|FG001|Discontinuations After Titration Phase|Other|0|||
128928461|NCT00472303|464025284|FG002|Discontinuations After Titration Phase|Other|0|||
128928462|NCT00472303|464025282|FG000|Maintenance Phase|Adverse Event|5|||
128928463|NCT00472303|464025283|FG001|Maintenance Phase|Adverse Event|6|||
128928464|NCT00472303|464025284|FG002|Maintenance Phase|Adverse Event|6|||
128928465|NCT00472303|464025282|FG000|Maintenance Phase|Death|3|||
128928466|NCT00472303|464025283|FG001|Maintenance Phase|Death|0|||
128928467|NCT00472303|464025284|FG002|Maintenance Phase|Death|2|||
128928468|NCT00472303|464025282|FG000|Maintenance Phase|Lack of Efficacy|2|||
128928469|NCT00472303|464025283|FG001|Maintenance Phase|Lack of Efficacy|2|||
128928470|NCT00472303|464025284|FG002|Maintenance Phase|Lack of Efficacy|4|||
128928471|NCT00472303|464025282|FG000|Maintenance Phase|Withdrawal by Subject|6|||
128928472|NCT00472303|464025283|FG001|Maintenance Phase|Withdrawal by Subject|7|||
128928473|NCT00472303|464025284|FG002|Maintenance Phase|Withdrawal by Subject|3|||
128928474|NCT00472303|464025282|FG000|Maintenance Phase|Trial medication non-compliant|0|||
128928475|NCT00472303|464025283|FG001|Maintenance Phase|Trial medication non-compliant|0|||
128928476|NCT00472303|464025284|FG002|Maintenance Phase|Trial medication non-compliant|1|||
128928477|NCT00472303|464025282|FG000|Maintenance Phase|Resolution of pain|0|||
128928478|NCT00472303|464025283|FG001|Maintenance Phase|Resolution of pain|0|||
128928479|NCT00472303|464025284|FG002|Maintenance Phase|Resolution of pain|1|||
128928480|NCT00472303|464025282|FG000|Maintenance Phase|Other|1|||
128928481|NCT00472303|464025283|FG001|Maintenance Phase|Other|1|||
128928482|NCT00472303|464025284|FG002|Maintenance Phase|Other|0|||
128928483|NCT01244737|464025301|FG000|Overall Study|Physician Decision|2|||
128928484|NCT01244737|464025302|FG001|Overall Study|Physician Decision|18|||
128928485|NCT01244737|464025303|FG002|Overall Study|Physician Decision|5|||
128928486|NCT01244737|464025301|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
128928487|NCT01244737|464025302|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
128928488|NCT01244737|464025303|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
128928489|NCT01244737|464025301|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
128928490|NCT01244737|464025302|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
128928491|NCT01244737|464025303|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
128928492|NCT01244737|464025301|FG000|Overall Study|MIB immunopathology results not available|3|||
128928493|NCT01244737|464025302|FG001|Overall Study|MIB immunopathology results not available|2|||
128928494|NCT01244737|464025303|FG002|Overall Study|MIB immunopathology results not available|0|||
128928495|NCT01244737|464025301|FG000|Overall Study|PET data failure|0|||
128928496|NCT01244737|464025302|FG001|Overall Study|PET data failure|1|||
128928497|NCT01244737|464025303|FG002|Overall Study|PET data failure|0|||
128928498|NCT01244737|464025301|FG000|Overall Study|Withdrawal by Subject|0|||
128928499|NCT01244737|464025302|FG001|Overall Study|Withdrawal by Subject|0|||
128928500|NCT01244737|464025303|FG002|Overall Study|Withdrawal by Subject|1|||
128928501|NCT01873950|464025305|FG000|Period 5|Withdrawal by Subject|0|||
128928502|NCT01873950|464025306|FG001|Period 5|Withdrawal by Subject|0|||
128928503|NCT01873950|464025307|FG002|Period 5|Withdrawal by Subject|0|||
128928504|NCT01873950|464025308|FG003|Period 5|Withdrawal by Subject|1|||
128928505|NCT01873950|464025309|FG004|Period 5|Withdrawal by Subject|0|||
128928506|NCT00730236|464025310|FG000|Overall Study|Adverse Event|4|||
128928507|NCT00730236|464025310|FG000|Overall Study|Withdrawal by Subject|1|||
128928508|NCT00730236|464025310|FG000|Overall Study|Non-compliance|1|||
128928509|NCT01772134|464025315|FG000|Overall Study|Adverse Event|6|||
128928510|NCT01772134|464025316|FG001|Overall Study|Adverse Event|5|||
128928511|NCT01772134|464025317|FG002|Overall Study|Adverse Event|10|||
128928512|NCT01772134|464025315|FG000|Overall Study|Withdrew Consent|3|||
128928513|NCT01772134|464025316|FG001|Overall Study|Withdrew Consent|1|||
128928514|NCT01772134|464025317|FG002|Overall Study|Withdrew Consent|5|||
128928515|NCT01772134|464025315|FG000|Overall Study|Lost to Follow-up|2|||
128928516|NCT01772134|464025316|FG001|Overall Study|Lost to Follow-up|0|||
128928517|NCT01772134|464025317|FG002|Overall Study|Lost to Follow-up|0|||
128928518|NCT01772134|464025315|FG000|Overall Study|Protocol Deviation|4|||
128928519|NCT01772134|464025316|FG001|Overall Study|Protocol Deviation|3|||
128928520|NCT01772134|464025317|FG002|Overall Study|Protocol Deviation|3|||
128928521|NCT01772134|464025315|FG000|Overall Study|Lack of Efficacy|11|||
128928522|NCT01772134|464025316|FG001|Overall Study|Lack of Efficacy|5|||
128928523|NCT01772134|464025317|FG002|Overall Study|Lack of Efficacy|3|||
128928524|NCT01772134|464025315|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
128928525|NCT01772134|464025316|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
128928526|NCT01772134|464025317|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
128928527|NCT01772134|464025315|FG000|Overall Study|Randomized Study Medication Not Received|2|||
128928528|NCT01772134|464025316|FG001|Overall Study|Randomized Study Medication Not Received|0|||
128928529|NCT01772134|464025317|FG002|Overall Study|Randomized Study Medication Not Received|1|||
128928530|NCT02604264|464025324|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
128928531|NCT02604264|464025325|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
128928532|NCT04003610|464025326|FG000|Overall Study|Lost to Follow-up|0|||
128928533|NCT04003610|464025327|FG001|Overall Study|Lost to Follow-up|1|||
128928534|NCT04003610|464025328|FG002|Overall Study|Lost to Follow-up|0|||
128928535|NCT04003610|464025326|FG000|Overall Study|Death|0|||
128767306|NCT01709305|463438205|FG003|Phase 1|Withdrawal by Subject|0|||
128767307|NCT01709305|463438206|FG004|Phase 1|Withdrawal by Subject|0|||
128928536|NCT04003610|464025327|FG001|Overall Study|Death|0|||
128928537|NCT04003610|464025328|FG002|Overall Study|Death|3|||
128928538|NCT04003610|464025326|FG000|Overall Study|Study Terminated by Sponsor|0|||
128928539|NCT04003610|464025327|FG001|Overall Study|Study Terminated by Sponsor|0|||
128928540|NCT04003610|464025328|FG002|Overall Study|Study Terminated by Sponsor|3|||
128928541|NCT05502289|464025333|FG000|Period 1|Out Of Window|1|||
128928542|NCT05502289|464025334|FG001|Period 1|Out Of Window|0|||
128928543|NCT02333227|464025340|FG000|Overall Study|Lost to Follow-up|137|||
128928544|NCT02333227|464025341|FG001|Overall Study|Lost to Follow-up|106|||
128928545|NCT02333227|464025340|FG000|Overall Study|Pregnancy Interrupted|42|||
128928546|NCT02333227|464025341|FG001|Overall Study|Pregnancy Interrupted|89|||
129029873|NCT00045162|464399993|FG000|Overall Study|Other|21|||
129119141|NCT01041859|464733208|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
129119142|NCT01041859|464733209|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
129119143|NCT02908347|464733215|FG000|Overall Study|Adverse Event|0|||
129119144|NCT02908347|464733216|FG001|Overall Study|Adverse Event|1|||
129119145|NCT02908347|464733215|FG000|Overall Study|Lost to Follow-up|1|||
129119146|NCT02908347|464733216|FG001|Overall Study|Lost to Follow-up|0|||
129119147|NCT01326871|464733217|FG000|Overall Study|Major surgery|0|||
129119148|NCT01326871|464733218|FG001|Overall Study|Major surgery|1|||
129119149|NCT01326871|464733219|FG002|Overall Study|Major surgery|0|||
129119150|NCT01326871|464733217|FG000|Overall Study|SAE and death|0|||
129119151|NCT01326871|464733218|FG001|Overall Study|SAE and death|2|||
129119152|NCT01326871|464733219|FG002|Overall Study|SAE and death|0|||
129119153|NCT01326871|464733217|FG000|Overall Study|Physician decision and decreased performance status|0|||
129119154|NCT01326871|464733218|FG001|Overall Study|Physician decision and decreased performance status|1|||
129119155|NCT01326871|464733219|FG002|Overall Study|Physician decision and decreased performance status|0|||
129119156|NCT01326871|464733217|FG000|Overall Study|Disease progression|0|||
129119157|NCT01326871|464733218|FG001|Overall Study|Disease progression|11|||
129119158|NCT01326871|464733219|FG002|Overall Study|Disease progression|5|||
128701518|NCT00044083|463205634|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
128701519|NCT00044083|463205635|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
128928547|NCT02333227|464025340|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
128928548|NCT02333227|464025341|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
128928549|NCT00816036|464025344|FG000|Overall Study|Death|47|||
128928550|NCT00816036|464025345|FG001|Overall Study|Death|28|||
128928551|NCT00816036|464025344|FG000|Overall Study|Lost to Follow-up|75|||
128928552|NCT00816036|464025345|FG001|Overall Study|Lost to Follow-up|57|||
128928553|NCT00816036|464025344|FG000|Overall Study|Withdrawal by Subject|54|||
128928554|NCT00816036|464025345|FG001|Overall Study|Withdrawal by Subject|23|||
128928555|NCT01624194|464025346|FG000|Overall Study|Lost to Follow-up|1|||
128928556|NCT01624194|464025347|FG001|Overall Study|Lost to Follow-up|0|||
128928557|NCT01624194|464025346|FG000|Overall Study|Withdrawal by Subject|1|||
128928558|NCT01624194|464025347|FG001|Overall Study|Withdrawal by Subject|0|||
128928559|NCT03212261|464025348|FG000|Overall Study|Became ineligible d/t tech|2|||
128928560|NCT03212261|464025348|FG000|Overall Study|Tech Trouble- No first study visit|1|||
128928561|NCT03212261|464025348|FG000|Overall Study|Lost to Follow-up|7|||
128928562|NCT03212261|464025348|FG000|Overall Study|Family Emergency|1|||
128928563|NCT03212261|464025348|FG000|Overall Study|Too busy/ No time|5|||
128928564|NCT01076179|464025349|FG000|Overall Study|Withdrawal by Subject|1|||
128928565|NCT03822468|464025350|FG000|Treatment Period|Progressive disease|98|||
128928566|NCT03822468|464025351|FG001|Treatment Period|Progressive disease|94|||
128928567|NCT03822468|464025350|FG000|Treatment Period|Adverse Event|21|||
128928568|NCT03822468|464025351|FG001|Treatment Period|Adverse Event|24|||
128928569|NCT03822468|464025350|FG000|Treatment Period|Withdrawal by Subject|9|||
128928570|NCT03822468|464025351|FG001|Treatment Period|Withdrawal by Subject|5|||
128928571|NCT03822468|464025350|FG000|Treatment Period|Physician Decision|9|||
128928572|NCT03822468|464025351|FG001|Treatment Period|Physician Decision|7|||
128928573|NCT03822468|464025350|FG000|Treatment Period|Protocol Violation|2|||
128928574|NCT03822468|464025351|FG001|Treatment Period|Protocol Violation|1|||
128928575|NCT03822468|464025350|FG000|Treatment Period|Death|2|||
128928576|NCT03822468|464025351|FG001|Treatment Period|Death|3|||
128928577|NCT03822468|464025350|FG000|Treatment Period|Lost to Follow-up|1|||
128928578|NCT03822468|464025351|FG001|Treatment Period|Lost to Follow-up|1|||
128928579|NCT03822468|464025350|FG000|Treatment Period|Sponsor decision|46|||
128928580|NCT03822468|464025351|FG001|Treatment Period|Sponsor decision|53|||
128928581|NCT03822468|464025350|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
128928582|NCT03822468|464025351|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
128928583|NCT03822468|464025350|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
128928584|NCT03822468|464025351|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
128928585|NCT03822468|464025350|FG000|Post-treatment Efficacy Follow-up|Death|1|||
128928586|NCT03822468|464025351|FG001|Post-treatment Efficacy Follow-up|Death|0|||
128928587|NCT03822468|464025350|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
128701520|NCT00044083|463205634|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
128701521|NCT00044083|463205635|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
128701522|NCT00044083|463205634|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
128701523|NCT00044083|463205635|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
128928588|NCT03822468|464025351|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
128928589|NCT03822468|464025350|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
128928590|NCT03822468|464025351|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128928591|NCT03822468|464025350|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
128928592|NCT03822468|464025351|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129119159|NCT01326871|464733217|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
128928593|NCT03822468|464025350|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
128928594|NCT03822468|464025351|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
128928595|NCT02117687|464025352|FG000|Overall Study|Lost to Follow-up|0|||
128928596|NCT02117687|464025353|FG001|Overall Study|Lost to Follow-up|1|||
128928597|NCT02117687|464025352|FG000|Overall Study|Adverse Event|0|||
128928598|NCT02117687|464025353|FG001|Overall Study|Adverse Event|2|||
128928599|NCT02117687|464025352|FG000|Overall Study|Other Reasons|1|||
128928600|NCT02117687|464025353|FG001|Overall Study|Other Reasons|1|||
128928601|NCT04909463|464027361|FG000|Overall Study|Withdrawal by Subject|0|||
128928602|NCT04909463|464027362|FG001|Overall Study|Withdrawal by Subject|1|||
128928603|NCT04909463|464027363|FG002|Overall Study|Withdrawal by Subject|0|||
128928604|NCT04909463|464027364|FG003|Overall Study|Withdrawal by Subject|0|||
128928605|NCT04909463|464027361|FG000|Overall Study|Lost to Follow-up|2|||
128928606|NCT04909463|464027362|FG001|Overall Study|Lost to Follow-up|1|||
128928607|NCT04909463|464027363|FG002|Overall Study|Lost to Follow-up|1|||
128928608|NCT04909463|464027364|FG003|Overall Study|Lost to Follow-up|0|||
128928609|NCT01416181|464027367|FG000|Part 1|Other|10|||
128928610|NCT01416181|464027368|FG001|Part 1|Other|24|||
128928611|NCT01416181|464027367|FG000|Part 1|Death|0|||
128928612|NCT01416181|464027368|FG001|Part 1|Death|1|||
128928613|NCT01416181|464027367|FG000|Part 1|Investigator Decision|7|||
128928614|NCT01416181|464027368|FG001|Part 1|Investigator Decision|6|||
128928615|NCT01416181|464027367|FG000|Part 1|Withdrawal by Subject|74|||
128928616|NCT01416181|464027368|FG001|Part 1|Withdrawal by Subject|48|||
128928617|NCT01416181|464027367|FG000|Part 1|Lack of Efficacy|16|||
128928618|NCT01416181|464027368|FG001|Part 1|Lack of Efficacy|8|||
128928619|NCT01416181|464027367|FG000|Part 1|Lost to Follow-up|1|||
128928620|NCT01416181|464027368|FG001|Part 1|Lost to Follow-up|1|||
128928621|NCT01416181|464027367|FG000|Part 1|Adverse Event|15|||
129119160|NCT01326871|464733218|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
129119161|NCT01326871|464733219|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
129119162|NCT01326871|464733217|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
129119163|NCT01326871|464733218|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
129119164|NCT01326871|464733219|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
128928622|NCT01416181|464027368|FG001|Part 1|Adverse Event|18|||
128928623|NCT01416181|464027367|FG000|Part 1|Ongoing in Follow-Up|14|||
128928624|NCT01416181|464027368|FG001|Part 1|Ongoing in Follow-Up|8|||
128928625|NCT01416181|464027367|FG000|Part 2|Adverse Event|11|||
128928626|NCT01416181|464027368|FG001|Part 2|Adverse Event|4|||
128928627|NCT01416181|464027367|FG000|Part 2|Other|234|||
128928628|NCT01416181|464027368|FG001|Part 2|Other|267|||
128928629|NCT01416181|464027367|FG000|Part 2|Investigator Decision|6|||
128928630|NCT01416181|464027368|FG001|Part 2|Investigator Decision|7|||
128928631|NCT01416181|464027367|FG000|Part 2|Withdrawal by Subject|14|||
128928632|NCT01416181|464027368|FG001|Part 2|Withdrawal by Subject|5|||
128928633|NCT01416181|464027367|FG000|Part 2|Lack of Efficacy|4|||
128928634|NCT01416181|464027368|FG001|Part 2|Lack of Efficacy|1|||
128928635|NCT01416181|464027367|FG000|Part 2|Lost to Follow-up|2|||
128928636|NCT01416181|464027368|FG001|Part 2|Lost to Follow-up|2|||
128928637|NCT02981472|464027369|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
128928638|NCT02981472|464027370|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
128928639|NCT02981472|464027369|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
128928640|NCT02981472|464027370|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
128928641|NCT02981472|464027369|FG000|Treatment Period|Adverse Event|6|||
128928642|NCT02981472|464027370|FG001|Treatment Period|Adverse Event|1|||
128928643|NCT02981472|464027369|FG000|Treatment Period|Participant withdrew consent|1|||
128928644|NCT02981472|464027370|FG001|Treatment Period|Participant withdrew consent|0|||
128928645|NCT02981472|464027369|FG000|Treatment Period|Lost to Follow-up|0|||
128928646|NCT02981472|464027370|FG001|Treatment Period|Lost to Follow-up|1|||
128928647|NCT00621023|464027373|FG000|Overall Study|Death|5|||
128928648|NCT00621023|464027373|FG000|Overall Study|Follow up discontinued|1|||
128928649|NCT04430348|464027384|FG000|Overall Study|Death|3|||
128928650|NCT04430348|464027385|FG001|Overall Study|Death|2|||
128928651|NCT04430348|464027386|FG002|Overall Study|Death|2|||
128928652|NCT04430348|464027387|FG003|Overall Study|Death|2|||
128928653|NCT04430348|464027388|FG004|Overall Study|Death|2|||
128928654|NCT04430348|464027389|FG005|Overall Study|Death|3|||
128928655|NCT04430348|464027384|FG000|Overall Study|Lost to Follow-up|0|||
128928656|NCT04430348|464027385|FG001|Overall Study|Lost to Follow-up|0|||
128928657|NCT04430348|464027386|FG002|Overall Study|Lost to Follow-up|0|||
128928658|NCT04430348|464027387|FG003|Overall Study|Lost to Follow-up|1|||
128928659|NCT04430348|464027388|FG004|Overall Study|Lost to Follow-up|0|||
128928660|NCT04430348|464027389|FG005|Overall Study|Lost to Follow-up|0|||
128928661|NCT04430348|464027384|FG000|Overall Study|Adverse Event|0|||
128928662|NCT04430348|464027385|FG001|Overall Study|Adverse Event|0|||
128928663|NCT04430348|464027386|FG002|Overall Study|Adverse Event|0|||
128928664|NCT04430348|464027387|FG003|Overall Study|Adverse Event|0|||
128928665|NCT04430348|464027388|FG004|Overall Study|Adverse Event|0|||
128928666|NCT04430348|464027389|FG005|Overall Study|Adverse Event|1|||
128928667|NCT04430348|464027384|FG000|Overall Study|Withdrawal by Subject|0|||
128928668|NCT04430348|464027385|FG001|Overall Study|Withdrawal by Subject|1|||
128928669|NCT04430348|464027386|FG002|Overall Study|Withdrawal by Subject|0|||
129029874|NCT00045162|464399994|FG001|Overall Study|Other|16|||
129029875|NCT01044433|464399995|FG000|Overall Study|Lost to Follow-up|3|||
129029876|NCT01044433|464399995|FG000|Overall Study|Withdrawal by Subject|3|||
129029877|NCT05065619|464399996|FG000|Up to Day 42|Lost to Follow-up|1|||
129029878|NCT05065619|464399997|FG001|Up to Day 42|Lost to Follow-up|0|||
129029879|NCT05065619|464399996|FG000|Up to Day 42|Withdrawal by Subject|1|||
129029880|NCT05065619|464399997|FG001|Up to Day 42|Withdrawal by Subject|0|||
129029881|NCT05065619|464399996|FG000|After Day 43|Lost to Follow-up|1|||
129029882|NCT05065619|464399997|FG001|After Day 43|Lost to Follow-up|0|||
129029883|NCT05065619|464399996|FG000|After Day 43|Physician Decision|3|||
129029884|NCT05065619|464399997|FG001|After Day 43|Physician Decision|0|||
129029885|NCT05065619|464399996|FG000|After Day 43|Withdrawal by Subject|1|||
129029886|NCT05065619|464399997|FG001|After Day 43|Withdrawal by Subject|2|||
129029887|NCT05065619|464399996|FG000|After Day 43|Public vaccination|6|||
129029888|NCT05065619|464399997|FG001|After Day 43|Public vaccination|8|||
129029889|NCT05065619|464399996|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
129029890|NCT05065619|464399997|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
129029891|NCT05065619|464399996|FG000|After Day 43|Study Terminated by Sponsor|88|||
129029892|NCT05065619|464399997|FG001|After Day 43|Study Terminated by Sponsor|16|||
129029893|NCT00714051|464400002|FG000|Overall Study|Withdrawal by Subject|1|||
129029894|NCT00714051|464400003|FG001|Overall Study|Withdrawal by Subject|0|||
129029895|NCT00714051|464400002|FG000|Overall Study|Death|0|||
129029896|NCT00714051|464400003|FG001|Overall Study|Death|1|||
129029897|NCT03868631|464400004|FG000|Baseline to Week 6|Adverse Event|0|||
129029898|NCT03868631|464400005|FG001|Baseline to Week 6|Adverse Event|3|||
129029899|NCT03868631|464400004|FG000|Baseline to Week 6|Protocol Violation|1|||
129029900|NCT03868631|464400005|FG001|Baseline to Week 6|Protocol Violation|1|||
129029901|NCT03868631|464400004|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
129029902|NCT03868631|464400005|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
129029903|NCT03868631|464400004|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
129029904|NCT03868631|464400005|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
128928670|NCT04430348|464027387|FG003|Overall Study|Withdrawal by Subject|0|||
128928671|NCT04430348|464027388|FG004|Overall Study|Withdrawal by Subject|0|||
128928672|NCT04430348|464027389|FG005|Overall Study|Withdrawal by Subject|1|||
128928673|NCT04430348|464027384|FG000|Overall Study|Study Terminated by Sponsor|0|||
128928674|NCT04430348|464027385|FG001|Overall Study|Study Terminated by Sponsor|0|||
128928675|NCT04430348|464027386|FG002|Overall Study|Study Terminated by Sponsor|2|||
128928676|NCT04430348|464027387|FG003|Overall Study|Study Terminated by Sponsor|0|||
128928677|NCT04430348|464027388|FG004|Overall Study|Study Terminated by Sponsor|1|||
128928678|NCT04430348|464027389|FG005|Overall Study|Study Terminated by Sponsor|1|||
128928679|NCT02559505|464027390|FG000|Overall Study|Lost to Follow-up|23|||
128928680|NCT02559505|464027391|FG001|Overall Study|Lost to Follow-up|20|||
128928681|NCT02559505|464027390|FG000|Overall Study|Withdrawal by Subject|4|||
128928682|NCT02559505|464027391|FG001|Overall Study|Withdrawal by Subject|2|||
128928683|NCT00698516|464027392|FG000|Overall Study|Study Termination|2|||
128928684|NCT00698516|464027392|FG000|Overall Study|Withdrawal by Subject|3|||
128928685|NCT00756002|464027399|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
128928686|NCT00756002|464027400|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
128928687|NCT00756002|464027399|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128928688|NCT00756002|464027400|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
128928689|NCT00756002|464027399|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
128928690|NCT00756002|464027400|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
128928691|NCT00756002|464027399|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
128928692|NCT00756002|464027400|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
128928693|NCT00756002|464027399|FG000|Double-Blind Treatment Period|Other|2|||
128928694|NCT00756002|464027400|FG001|Double-Blind Treatment Period|Other|2|||
129029905|NCT03868631|464400004|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
129029906|NCT03868631|464400005|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
129029907|NCT03868631|464400004|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
129029908|NCT03868631|464400005|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
129029909|NCT05740098|464400009|FG000|Overall Study|Lost to Follow-up|26|||
129029910|NCT05740098|464400010|FG001|Overall Study|Lost to Follow-up|17|||
129029911|NCT05740098|464400011|FG002|Overall Study|Lost to Follow-up|21|||
129029912|NCT02452463|464400012|FG000|Overall Study|Death|1|||
129119165|NCT01326871|464733217|FG000|Overall Study|Withdrawal by Subject|0|||
129119166|NCT01326871|464733218|FG001|Overall Study|Withdrawal by Subject|1|||
129119167|NCT01326871|464733219|FG002|Overall Study|Withdrawal by Subject|0|||
129119168|NCT01326871|464733217|FG000|Overall Study|DLT|0|||
129119169|NCT01326871|464733218|FG001|Overall Study|DLT|2|||
129119170|NCT01326871|464733219|FG002|Overall Study|DLT|0|||
129119171|NCT01326871|464733217|FG000|Overall Study|SAE, disease progression and subject decision|0|||
129119172|NCT01326871|464733218|FG001|Overall Study|SAE, disease progression and subject decision|1|||
128928695|NCT01697215|464027405|FG000|Overall Study|Physician Decision|5|||
128928696|NCT01697215|464027405|FG000|Overall Study|Malfunction|9|||
128928697|NCT01697215|464027405|FG000|Overall Study|CXR not available|9|||
128767308|NCT01709305|463438202|FG000|Phase 2|Clinical Adverse Event|0|||
128928698|NCT00900796|464027408|FG000|Phase 1|Lacked sufficient information|4|||
128928699|NCT00900796|464027408|FG000|Phase 1|Missing information at Week 16|7|||
128928700|NCT00900796|464027408|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
128928701|NCT00900796|464027408|FG000|Phase 2|Lost to Follow-up|5|||
128928702|NCT00504257|464027412|FG000|Overall Study|Withdrawal by Subject|2|||
128928703|NCT00504257|464027412|FG000|Overall Study|ineligible histology|2|||
128928704|NCT02750410|464027413|FG000|Double-Blind Treatment Period|Adverse Event|2|||
128928705|NCT02750410|464027414|FG001|Double-Blind Treatment Period|Adverse Event|2|||
128928706|NCT02750410|464027413|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128928707|NCT02750410|464027414|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128928708|NCT02750410|464027413|FG000|Open-Label Extension Period|Adverse Event|5|||
128928709|NCT02750410|464027414|FG001|Open-Label Extension Period|Adverse Event|3|||
128928710|NCT02750410|464027413|FG000|Open-Label Extension Period|Protocol Violation|0|||
128928711|NCT02750410|464027414|FG001|Open-Label Extension Period|Protocol Violation|1|||
128928712|NCT02750410|464027413|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
128928713|NCT02750410|464027414|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
128928714|NCT02504541|464027415|FG000|Overall Study|Adverse Event|4|||
128928715|NCT02504541|464027415|FG000|Overall Study|Withdrawal by Subject|4|||
128928716|NCT02504541|464027415|FG000|Overall Study|Lost to Follow-up|1|||
128928717|NCT02504541|464027415|FG000|Overall Study|Met Stopping Criteria|1|||
128928718|NCT02504541|464027415|FG000|Overall Study|Protocol Violation|2|||
128928719|NCT02504541|464027415|FG000|Overall Study|Termination by Sponsor|1|||
128928720|NCT02504541|464027415|FG000|Overall Study|Other|2|||
128928721|NCT02504541|464027415|FG000|Overall Study|Multiple|5|||
128928722|NCT01531725|464027419|FG000|Overall Study|Protocol Violation|5|||
128928723|NCT03182738|464027420|FG000|Overall Study|Lost to Follow-up|9|||
128928724|NCT03182738|464027421|FG001|Overall Study|Lost to Follow-up|3|||
128928725|NCT03182738|464027420|FG000|Overall Study|Pregnancy|0|||
128928726|NCT03182738|464027421|FG001|Overall Study|Pregnancy|1|||
128928727|NCT03182738|464027420|FG000|Overall Study|Withdrawal by Subject|0|||
128928728|NCT03182738|464027421|FG001|Overall Study|Withdrawal by Subject|1|||
128928729|NCT03596164|464027423|FG000|Overall Study|Adverse Event|0|||
128928730|NCT03596164|464027424|FG001|Overall Study|Adverse Event|1|||
128928731|NCT03596164|464027423|FG000|Overall Study|Death|1|||
128928732|NCT03596164|464027424|FG001|Overall Study|Death|0|||
128928733|NCT04112914|464027425|FG000|Overall Study|Lost to Follow-up|13|||
128928734|NCT04112914|464027426|FG001|Overall Study|Lost to Follow-up|9|||
128928735|NCT04112914|464027425|FG000|Overall Study|Withdrawal by Subject|1|||
128928736|NCT04112914|464027426|FG001|Overall Study|Withdrawal by Subject|0|||
128928737|NCT03427073|464027427|FG000|Overall Study|Disease Progression|1|||
128928738|NCT03427073|464027428|FG001|Overall Study|Disease Progression|1|||
128928739|NCT03427073|464027429|FG002|Overall Study|Disease Progression|1|||
128928740|NCT03427073|464027430|FG003|Overall Study|Disease Progression|3|||
128928741|NCT03427073|464027431|FG004|Overall Study|Disease Progression|3|||
128928742|NCT03427073|464027432|FG005|Overall Study|Disease Progression|4|||
128928743|NCT03427073|464027433|FG006|Overall Study|Disease Progression|2|||
128928744|NCT03427073|464027434|FG007|Overall Study|Disease Progression|3|||
128928745|NCT03427073|464027427|FG000|Overall Study|Physician Decision|0|||
128928746|NCT03427073|464027428|FG001|Overall Study|Physician Decision|0|||
128928747|NCT03427073|464027429|FG002|Overall Study|Physician Decision|0|||
128928748|NCT03427073|464027430|FG003|Overall Study|Physician Decision|0|||
128928749|NCT03427073|464027431|FG004|Overall Study|Physician Decision|0|||
129119173|NCT01326871|464733219|FG002|Overall Study|SAE, disease progression and subject decision|0|||
129119174|NCT01326871|464733217|FG000|Overall Study|Death|0|||
129119175|NCT01326871|464733218|FG001|Overall Study|Death|1|||
129119176|NCT01326871|464733219|FG002|Overall Study|Death|0|||
129119177|NCT01326871|464733217|FG000|Overall Study|Other|0|||
129119178|NCT01326871|464733218|FG001|Overall Study|Other|3|||
129119179|NCT01326871|464733219|FG002|Overall Study|Other|0|||
129119180|NCT01326871|464733217|FG000|Overall Study|SAE and disease progression|0|||
129119181|NCT01326871|464733218|FG001|Overall Study|SAE and disease progression|0|||
129119182|NCT01326871|464733219|FG002|Overall Study|SAE and disease progression|1|||
129119183|NCT01326871|464733217|FG000|Overall Study|SAE and physician decision|0|||
129119184|NCT01326871|464733218|FG001|Overall Study|SAE and physician decision|0|||
129119185|NCT01326871|464733219|FG002|Overall Study|SAE and physician decision|1|||
129119186|NCT01326871|464733217|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
129119187|NCT01326871|464733218|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
129119188|NCT01326871|464733219|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
129216384|NCT03739203|465092909|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
128928750|NCT03427073|464027432|FG005|Overall Study|Physician Decision|0|||
128928751|NCT03427073|464027433|FG006|Overall Study|Physician Decision|1|||
128928752|NCT03427073|464027434|FG007|Overall Study|Physician Decision|1|||
128928753|NCT01486238|464027438|FG000|Overall Study|Death|0|||
128928754|NCT01486238|464027439|FG001|Overall Study|Death|2|||
128928755|NCT01486238|464027438|FG000|Overall Study|Withdrawal by Subject|2|||
128701524|NCT00044083|463205634|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
128701525|NCT00044083|463205635|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
128701526|NCT00044083|463205634|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
128701527|NCT00044083|463205635|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
128928756|NCT01486238|464027439|FG001|Overall Study|Withdrawal by Subject|1|||
128928757|NCT01486238|464027438|FG000|Overall Study|Lost to Follow-up|0|||
128928758|NCT01486238|464027439|FG001|Overall Study|Lost to Follow-up|3|||
128928759|NCT02835495|464027441|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
128928760|NCT02835495|464027442|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
128928761|NCT02835495|464027441|FG000|Overall Study|Declined in-person follow-up visit|4|||
128928762|NCT02835495|464027442|FG001|Overall Study|Declined in-person follow-up visit|2|||
128928763|NCT02318602|464027443|FG000|Overall Study|Adverse Event|0|||
128928764|NCT02318602|464027444|FG001|Overall Study|Adverse Event|1|||
128928765|NCT02318602|464027445|FG002|Overall Study|Adverse Event|1|||
128928766|NCT02318602|464027443|FG000|Overall Study|Withdrawal by Subject|0|||
128928767|NCT02318602|464027444|FG001|Overall Study|Withdrawal by Subject|3|||
128928768|NCT02318602|464027445|FG002|Overall Study|Withdrawal by Subject|0|||
128928769|NCT02318602|464027443|FG000|Overall Study|Death|1|||
128928770|NCT02318602|464027444|FG001|Overall Study|Death|0|||
128928771|NCT02318602|464027445|FG002|Overall Study|Death|0|||
128928772|NCT02318602|464027443|FG000|Overall Study|Guardian decision to withdraw|0|||
128928773|NCT02318602|464027444|FG001|Overall Study|Guardian decision to withdraw|0|||
128928774|NCT02318602|464027445|FG002|Overall Study|Guardian decision to withdraw|1|||
128928775|NCT00693706|464027446|FG000|Overall Study|Protocol Violation|0|||
128928776|NCT00693706|464027447|FG001|Overall Study|Protocol Violation|1|||
128928777|NCT05421754|464027448|FG000|Overall Study|Technical issue with sensor|1|||
128928778|NCT02580058|464027449|FG000|Overall Study|Adverse Event|16|||
128928779|NCT02580058|464027450|FG001|Overall Study|Adverse Event|30|||
128928780|NCT02580058|464027451|FG002|Overall Study|Adverse Event|20|||
128928781|NCT02580058|464027449|FG000|Overall Study|Death|4|||
128928782|NCT02580058|464027450|FG001|Overall Study|Death|4|||
128928783|NCT02580058|464027451|FG002|Overall Study|Death|5|||
128928784|NCT02580058|464027449|FG000|Overall Study|Physician Decision|1|||
128928785|NCT02580058|464027450|FG001|Overall Study|Physician Decision|3|||
128928786|NCT02580058|464027451|FG002|Overall Study|Physician Decision|11|||
128928787|NCT02580058|464027449|FG000|Overall Study|Other|5|||
128928788|NCT02580058|464027450|FG001|Overall Study|Other|1|||
128928789|NCT02580058|464027451|FG002|Overall Study|Other|3|||
128928790|NCT02580058|464027449|FG000|Overall Study|Withdrawal by Subject|4|||
128928791|NCT02580058|464027450|FG001|Overall Study|Withdrawal by Subject|7|||
128928792|NCT02580058|464027451|FG002|Overall Study|Withdrawal by Subject|31|||
128928793|NCT02580058|464027449|FG000|Overall Study|Global Deterioration of Health Status|19|||
128928794|NCT02580058|464027450|FG001|Overall Study|Global Deterioration of Health Status|18|||
128928795|NCT02580058|464027451|FG002|Overall Study|Global Deterioration of Health Status|24|||
128928796|NCT02580058|464027449|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
128928797|NCT02580058|464027450|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
128928798|NCT02580058|464027451|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
128928799|NCT02580058|464027449|FG000|Overall Study|Progressive Disease|137|||
128928800|NCT02580058|464027450|FG001|Overall Study|Progressive Disease|125|||
128928801|NCT02580058|464027451|FG002|Overall Study|Progressive Disease|94|||
128928802|NCT02580058|464027449|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128928803|NCT02580058|464027450|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128928804|NCT02580058|464027451|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128928805|NCT01193335|464027452|FG000|After Infant Series|Lost to Follow-up|1|||
128928806|NCT01193335|464027453|FG001|After Infant Series|Lost to Follow-up|2|||
128928807|NCT01193335|464027452|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
128928808|NCT01193335|464027453|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
128928809|NCT01193335|464027452|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
128928810|NCT01193335|464027453|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
128701528|NCT00705484|463205636|FG000|Overall Study|Adverse Event|28|||
128701529|NCT00705484|463205637|FG001|Overall Study|Adverse Event|27|||
128701530|NCT00705484|463205636|FG000|Overall Study|Lost to Follow-up|169|||
128701531|NCT00705484|463205637|FG001|Overall Study|Lost to Follow-up|250|||
128701532|NCT00705484|463205636|FG000|Overall Study|Withdrawal by Subject|96|||
128928811|NCT01193335|464027452|FG000|1-Year Follow-up|Lost to Follow-up|4|||
128928812|NCT01193335|464027453|FG001|1-Year Follow-up|Lost to Follow-up|0|||
128928813|NCT01193335|464027452|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
129029913|NCT02452463|464400013|FG001|Overall Study|Death|0|||
129029914|NCT02452463|464400014|FG002|Overall Study|Death|0|||
128701533|NCT00705484|463205637|FG001|Overall Study|Withdrawal by Subject|72|||
128928814|NCT01193335|464027453|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
129029915|NCT02452463|464400012|FG000|Overall Study|Study Suspended|1|||
128928815|NCT01193335|464027452|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
128928816|NCT01193335|464027453|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
128928817|NCT01733329|464027455|FG000|Overall Study|Protocol Violation|1|||
128928818|NCT01733329|464027456|FG001|Overall Study|Protocol Violation|1|||
128928819|NCT01733329|464027455|FG000|Overall Study|Uterine artery injury|1|||
128928820|NCT01733329|464027456|FG001|Overall Study|Uterine artery injury|0|||
128928821|NCT00542828|464027457|FG000|Overall Study|Physician Decision|1|||
128928822|NCT00542828|464027457|FG000|Overall Study|Need for Prohibited Treatment|3|||
128928823|NCT00542828|464027457|FG000|Overall Study|Study Prematurely Discontinued|7|||
128928824|NCT00542828|464027457|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
128928825|NCT03228186|464027458|FG000|Overall Study|Patient never started treatment|1|||
128928826|NCT04246047|464027459|FG000|Overall Study|Death|50|||
128928827|NCT04246047|464027460|FG001|Overall Study|Death|77|||
128928828|NCT04246047|464027459|FG000|Overall Study|Lost to Follow-up|1|||
128928829|NCT04246047|464027460|FG001|Overall Study|Lost to Follow-up|3|||
128928830|NCT04246047|464027459|FG000|Overall Study|Physician Decision|4|||
128928831|NCT04246047|464027460|FG001|Overall Study|Physician Decision|10|||
128928832|NCT04246047|464027459|FG000|Overall Study|Withdrawal by Subject|19|||
128928833|NCT04246047|464027460|FG001|Overall Study|Withdrawal by Subject|26|||
128928834|NCT04246047|464027459|FG000|Overall Study|Ongoing|169|||
128928835|NCT04246047|464027460|FG001|Overall Study|Ongoing|135|||
128928836|NCT05139030|464027464|FG000|Overall Study|Withdrawal by Subject|1|||
128928837|NCT05139030|464027465|FG001|Overall Study|Withdrawal by Subject|3|||
128928838|NCT05139030|464027464|FG000|Overall Study|Adverse Event|0|||
128928839|NCT05139030|464027465|FG001|Overall Study|Adverse Event|1|||
128928840|NCT05139030|464027464|FG000|Overall Study|Failure to meet continuation criteria|0|||
128928841|NCT05139030|464027465|FG001|Overall Study|Failure to meet continuation criteria|1|||
128928842|NCT02502864|464027473|FG000|Overall Study|Withdrawal by Subject|1|||
128928843|NCT03772327|464027474|FG000|Overall Study|Lost to Follow-up|3|||
128928844|NCT03772327|464027475|FG001|Overall Study|Lost to Follow-up|4|||
128928845|NCT03772327|464027474|FG000|Overall Study|Withdrawal by Subject|2|||
128928846|NCT03772327|464027475|FG001|Overall Study|Withdrawal by Subject|3|||
128928847|NCT04233424|464027483|FG000|Overall Study|Death|15|||
128928848|NCT04233424|464027484|FG001|Overall Study|Death|16|||
128928849|NCT04233424|464027483|FG000|Overall Study|Withdrawal by Subject|2|||
128928850|NCT04233424|464027484|FG001|Overall Study|Withdrawal by Subject|8|||
128928851|NCT04233424|464027483|FG000|Overall Study|Physician Decision|1|||
128928852|NCT04233424|464027484|FG001|Overall Study|Physician Decision|3|||
128928853|NCT04233424|464027483|FG000|Overall Study|Protocol Violation|3|||
128928854|NCT04233424|464027484|FG001|Overall Study|Protocol Violation|1|||
128928855|NCT04233424|464027483|FG000|Overall Study|Lost to Follow-up|1|||
128928856|NCT04233424|464027484|FG001|Overall Study|Lost to Follow-up|3|||
128928857|NCT04233424|464027483|FG000|Overall Study|subject refuse to visit site|2|||
128928858|NCT04233424|464027484|FG001|Overall Study|subject refuse to visit site|0|||
128928859|NCT03517436|464027485|FG000|Overall Study|Death|3|||
128928860|NCT03517436|464027485|FG000|Overall Study|Withdrawal by Subject|4|||
128928861|NCT03517436|464027485|FG000|Overall Study|Did not receive study valve.|1|||
128928862|NCT02698189|464027486|FG000|Overall Study|Physician Decision|3|||
128928863|NCT02698189|464027487|FG001|Overall Study|Physician Decision|0|||
128928864|NCT02698189|464027486|FG000|Overall Study|Progressive disease|0|||
128928865|NCT02698189|464027487|FG001|Overall Study|Progressive disease|5|||
128928866|NCT02698189|464027486|FG000|Overall Study|Study terminated by sponsor|0|||
128928867|NCT02698189|464027487|FG001|Overall Study|Study terminated by sponsor|1|||
128928868|NCT01254344|464027490|FG000|Overall Study|Adverse Event|2|||
128928869|NCT01254344|464027491|FG001|Overall Study|Adverse Event|5|||
128928870|NCT01254344|464027490|FG000|Overall Study|Physician Decision|7|||
128928871|NCT01254344|464027491|FG001|Overall Study|Physician Decision|4|||
128928872|NCT01254344|464027490|FG000|Overall Study|Protocol Violation|1|||
128928873|NCT01254344|464027491|FG001|Overall Study|Protocol Violation|4|||
128928874|NCT01254344|464027490|FG000|Overall Study|Withdrawal by Subject|3|||
129119189|NCT01326871|464733217|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
129119190|NCT01326871|464733218|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
129119191|NCT01326871|464733219|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
129119192|NCT01326871|464733217|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
129119193|NCT01326871|464733218|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
128767309|NCT01709305|463438203|FG001|Phase 2|Clinical Adverse Event|10|||
128928875|NCT01254344|464027491|FG001|Overall Study|Withdrawal by Subject|6|||
128928876|NCT03022461|464027492|FG000|Overall Study|Death|3|||
128928877|NCT01982630|464027493|FG000|Overall Study|Adverse Event|2|||
128928878|NCT01982630|464027494|FG001|Overall Study|Adverse Event|0|||
128928879|NCT01982630|464027495|FG002|Overall Study|Adverse Event|1|||
128928880|NCT01982630|464027496|FG003|Overall Study|Adverse Event|0|||
128928881|NCT01982630|464027497|FG004|Overall Study|Adverse Event|1|||
128928882|NCT01982630|464027498|FG005|Overall Study|Adverse Event|2|||
128928883|NCT01982630|464027499|FG006|Overall Study|Adverse Event|1|||
128928884|NCT01982630|464027500|FG007|Overall Study|Adverse Event|0|||
128928885|NCT01982630|464027493|FG000|Overall Study|Physician Decision|1|||
128928886|NCT01982630|464027494|FG001|Overall Study|Physician Decision|0|||
128928887|NCT01982630|464027495|FG002|Overall Study|Physician Decision|2|||
128701534|NCT00705484|463205636|FG000|Overall Study|Administrative|89|||
128701535|NCT00705484|463205637|FG001|Overall Study|Administrative|59|||
128701536|NCT01619423|463205638|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
128701537|NCT01619423|463205639|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
128701538|NCT01619423|463205640|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
128701539|NCT01619423|463205641|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
128701540|NCT02340975|463205644|FG000|Overall Study|Death|6|||
128701541|NCT02340975|463205645|FG001|Overall Study|Death|23|||
128928888|NCT01982630|464027496|FG003|Overall Study|Physician Decision|1|||
128928889|NCT01982630|464027497|FG004|Overall Study|Physician Decision|2|||
128928890|NCT01982630|464027498|FG005|Overall Study|Physician Decision|0|||
128928891|NCT01982630|464027499|FG006|Overall Study|Physician Decision|0|||
128928892|NCT01982630|464027500|FG007|Overall Study|Physician Decision|0|||
128928893|NCT01982630|464027493|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
128928894|NCT01982630|464027494|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
128928895|NCT01982630|464027495|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
128928896|NCT01982630|464027496|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
128928897|NCT01982630|464027497|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
128928898|NCT01982630|464027498|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
128928899|NCT01982630|464027499|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
128928900|NCT01982630|464027500|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
128928901|NCT01982630|464027493|FG000|Overall Study|Withdrawal by Subject|0|||
128928902|NCT01982630|464027494|FG001|Overall Study|Withdrawal by Subject|0|||
128928903|NCT01982630|464027495|FG002|Overall Study|Withdrawal by Subject|0|||
128928904|NCT01982630|464027496|FG003|Overall Study|Withdrawal by Subject|0|||
128928905|NCT01982630|464027497|FG004|Overall Study|Withdrawal by Subject|0|||
128928906|NCT01982630|464027498|FG005|Overall Study|Withdrawal by Subject|1|||
128928907|NCT01982630|464027499|FG006|Overall Study|Withdrawal by Subject|0|||
128928908|NCT01982630|464027500|FG007|Overall Study|Withdrawal by Subject|0|||
128928909|NCT03459040|464027501|FG000|Overall Study|Death|8|||
128928910|NCT03459040|464027501|FG000|Overall Study|Withdrawal by Subject|1|||
128928911|NCT00986349|464027504|FG000|Overall Study|Unsuccessful implant procedure|3|||
128928912|NCT00986349|464027504|FG000|Overall Study|Adverse Event|2|||
128928913|NCT00986349|464027504|FG000|Overall Study|Physician Decision|1|||
128928914|NCT00986349|464027504|FG000|Overall Study|device migration|1|||
128928915|NCT02299934|464027505|FG000|Overall Study|Termination of study|13|||
128928916|NCT00561353|464027506|FG000|Overall Study|Subject reached a virologic endpoint|2|||
128928917|NCT00561353|464027507|FG001|Overall Study|Subject reached a virologic endpoint|1|||
128928918|NCT00561353|464027508|FG002|Overall Study|Subject reached a virologic endpoint|1|||
128928919|NCT00561353|464027509|FG003|Overall Study|Subject reached a virologic endpoint|4|||
128928920|NCT00561353|464027510|FG004|Overall Study|Subject reached a virologic endpoint|1|||
128928921|NCT00561353|464027511|FG005|Overall Study|Subject reached a virologic endpoint|3|||
128928922|NCT00561353|464027512|FG006|Overall Study|Subject reached a virologic endpoint|4|||
128928923|NCT00561353|464027513|FG007|Overall Study|Subject reached a virologic endpoint|4|||
128928924|NCT00561353|464027514|FG008|Overall Study|Subject reached a virologic endpoint|5|||
128928925|NCT00561353|464027515|FG009|Overall Study|Subject reached a virologic endpoint|0|||
128928926|NCT00561353|464027506|FG000|Overall Study|Subject ineligible to continue the trial|0|||
128928927|NCT00561353|464027507|FG001|Overall Study|Subject ineligible to continue the trial|0|||
128928928|NCT00561353|464027508|FG002|Overall Study|Subject ineligible to continue the trial|0|||
128928929|NCT00561353|464027509|FG003|Overall Study|Subject ineligible to continue the trial|0|||
128928930|NCT00561353|464027510|FG004|Overall Study|Subject ineligible to continue the trial|0|||
128928931|NCT00561353|464027511|FG005|Overall Study|Subject ineligible to continue the trial|1|||
128928932|NCT00561353|464027512|FG006|Overall Study|Subject ineligible to continue the trial|1|||
128928933|NCT00561353|464027513|FG007|Overall Study|Subject ineligible to continue the trial|0|||
128928934|NCT00561353|464027514|FG008|Overall Study|Subject ineligible to continue the trial|2|||
128928935|NCT00561353|464027515|FG009|Overall Study|Subject ineligible to continue the trial|1|||
128928936|NCT00561353|464027506|FG000|Overall Study|Other|1|||
128928937|NCT00561353|464027507|FG001|Overall Study|Other|0|||
128928938|NCT00561353|464027508|FG002|Overall Study|Other|1|||
128928939|NCT00561353|464027509|FG003|Overall Study|Other|0|||
128928940|NCT00561353|464027510|FG004|Overall Study|Other|0|||
128928941|NCT00561353|464027511|FG005|Overall Study|Other|2|||
128928942|NCT00561353|464027512|FG006|Overall Study|Other|0|||
128928943|NCT00561353|464027513|FG007|Overall Study|Other|0|||
128928944|NCT00561353|464027514|FG008|Overall Study|Other|0|||
128701542|NCT02340975|463205646|FG002|Overall Study|Death|21|||
128701543|NCT02340975|463205647|FG003|Overall Study|Death|7|||
128701544|NCT02340975|463205648|FG004|Overall Study|Death|21|||
128928945|NCT00561353|464027515|FG009|Overall Study|Other|0|||
128928946|NCT00561353|464027506|FG000|Overall Study|Adverse Event|0|||
128928947|NCT00561353|464027507|FG001|Overall Study|Adverse Event|0|||
128928948|NCT00561353|464027508|FG002|Overall Study|Adverse Event|0|||
128928949|NCT00561353|464027509|FG003|Overall Study|Adverse Event|2|||
128928950|NCT00561353|464027510|FG004|Overall Study|Adverse Event|0|||
128928951|NCT00561353|464027511|FG005|Overall Study|Adverse Event|0|||
128928952|NCT00561353|464027512|FG006|Overall Study|Adverse Event|1|||
128928953|NCT00561353|464027513|FG007|Overall Study|Adverse Event|0|||
128928954|NCT00561353|464027514|FG008|Overall Study|Adverse Event|0|||
128928955|NCT00561353|464027515|FG009|Overall Study|Adverse Event|1|||
128928956|NCT00561353|464027506|FG000|Overall Study|Lost to Follow-up|2|||
128928957|NCT00561353|464027507|FG001|Overall Study|Lost to Follow-up|0|||
128928958|NCT00561353|464027508|FG002|Overall Study|Lost to Follow-up|1|||
128928959|NCT00561353|464027509|FG003|Overall Study|Lost to Follow-up|0|||
128928960|NCT00561353|464027510|FG004|Overall Study|Lost to Follow-up|0|||
128928961|NCT00561353|464027511|FG005|Overall Study|Lost to Follow-up|0|||
128928962|NCT00561353|464027512|FG006|Overall Study|Lost to Follow-up|0|||
128928963|NCT00561353|464027513|FG007|Overall Study|Lost to Follow-up|0|||
128928964|NCT00561353|464027514|FG008|Overall Study|Lost to Follow-up|0|||
128928965|NCT00561353|464027515|FG009|Overall Study|Lost to Follow-up|0|||
128928966|NCT00561353|464027506|FG000|Overall Study|Withdrawal by Subject|0|||
128928967|NCT00561353|464027507|FG001|Overall Study|Withdrawal by Subject|2|||
128928968|NCT00561353|464027508|FG002|Overall Study|Withdrawal by Subject|0|||
128928969|NCT00561353|464027509|FG003|Overall Study|Withdrawal by Subject|0|||
128928970|NCT00561353|464027510|FG004|Overall Study|Withdrawal by Subject|0|||
128928971|NCT00561353|464027511|FG005|Overall Study|Withdrawal by Subject|0|||
128928972|NCT00561353|464027512|FG006|Overall Study|Withdrawal by Subject|0|||
128928973|NCT00561353|464027513|FG007|Overall Study|Withdrawal by Subject|0|||
128928974|NCT00561353|464027514|FG008|Overall Study|Withdrawal by Subject|0|||
128928975|NCT00561353|464027515|FG009|Overall Study|Withdrawal by Subject|0|||
128928976|NCT01273818|464027516|FG000|Overall Study|Physician Decision|13|||
128928977|NCT01273818|464027517|FG001|Overall Study|Physician Decision|2|||
128928978|NCT01273818|464027518|FG002|Overall Study|Physician Decision|9|||
128928979|NCT03815175|464027519|FG000|Overall Study|Subject Lost to Follow-up|6|||
128928980|NCT03815175|464027519|FG000|Overall Study|Subject Withdrew Consent|48|||
128928981|NCT03815175|464027519|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
128928982|NCT03815175|464027519|FG000|Overall Study|Death|86|||
128928983|NCT03815175|464027519|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
128928984|NCT03815175|464027519|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
128928985|NCT03815175|464027519|FG000|Overall Study|Other Status Change Reason|1|||
128928986|NCT03815175|464027519|FG000|Overall Study|Missed Visit|12|||
128928987|NCT00820040|464027520|FG000|Overall Study|Death|1|||
128928988|NCT00820040|464027520|FG000|Overall Study|Sponsor terminated study|1|||
128928989|NCT00820040|464027520|FG000|Overall Study|Screen failure|1|||
128928990|NCT01084252|464029081|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928991|NCT01084252|464029082|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928992|NCT01084252|464029083|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928993|NCT01084252|464029084|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928994|NCT01084252|464029085|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928995|NCT01084252|464029086|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928996|NCT01084252|464029087|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928997|NCT01084252|464029088|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928998|NCT01084252|464029089|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128928999|NCT01084252|464029090|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128929000|NCT01084252|464029091|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128929001|NCT01084252|464029092|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128929002|NCT01084252|464029093|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
128929003|NCT01084252|464029094|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
128929004|NCT03528681|464029095|FG000|Open-Label Phase|Physician Decision|2|||
128929005|NCT03528681|464029096|FG001|Open-Label Phase|Physician Decision|0|||
128929006|NCT03528681|464029097|FG002|Open-Label Phase|Physician Decision|0|||
128929007|NCT03528681|464029098|FG003|Open-Label Phase|Physician Decision|0|||
128929008|NCT03528681|464029095|FG000|Open-Label Phase|Withdrawal by Subject|8|||
128929009|NCT03528681|464029096|FG001|Open-Label Phase|Withdrawal by Subject|0|||
128929010|NCT03528681|464029097|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129216385|NCT03739203|465092910|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
128929011|NCT03528681|464029098|FG003|Open-Label Phase|Withdrawal by Subject|0|||
128929012|NCT03528681|464029095|FG000|Open-Label Phase|(Not collected)|4|||
128929013|NCT03528681|464029096|FG001|Open-Label Phase|(Not collected)|0|||
128929014|NCT03528681|464029097|FG002|Open-Label Phase|(Not collected)|0|||
128929015|NCT03528681|464029098|FG003|Open-Label Phase|(Not collected)|0|||
128929016|NCT03528681|464029095|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
128929017|NCT03528681|464029096|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
128929018|NCT03528681|464029097|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
128929019|NCT03528681|464029098|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
128929020|NCT03528681|464029095|FG000|Randomized Treatment Phase|Physician Decision|0|||
128929021|NCT03528681|464029096|FG001|Randomized Treatment Phase|Physician Decision|5|||
128929022|NCT03528681|464029097|FG002|Randomized Treatment Phase|Physician Decision|1|||
128929023|NCT03528681|464029098|FG003|Randomized Treatment Phase|Physician Decision|2|||
128929024|NCT03528681|464029095|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
128929025|NCT03528681|464029096|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
128929026|NCT03528681|464029097|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
128929027|NCT03528681|464029098|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
128929028|NCT03528681|464029095|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
128929029|NCT03528681|464029096|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
128929030|NCT03528681|464029097|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
128929031|NCT03528681|464029098|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
128929032|NCT03528681|464029095|FG000|Randomized Treatment Phase|(Not collected)|0|||
128929033|NCT03528681|464029096|FG001|Randomized Treatment Phase|(Not collected)|4|||
128929034|NCT03528681|464029097|FG002|Randomized Treatment Phase|(Not collected)|6|||
128929035|NCT03528681|464029098|FG003|Randomized Treatment Phase|(Not collected)|5|||
128929036|NCT00955110|464029099|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
128929037|NCT00955110|464029099|FG000|Treatment Phase|Adverse Event|2|||
128929038|NCT00955110|464029099|FG000|Treatment Phase|Administrative reasons|2|||
128929039|NCT00955110|464029099|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
128929040|NCT00955110|464029099|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
128929041|NCT03715465|464029107|FG000|Overall Study|Withdrawal by Subject|1|||
128929042|NCT03715465|464029108|FG001|Overall Study|Withdrawal by Subject|2|||
128929043|NCT02158533|464029116|FG000|Stage 1|Adverse Event|6|||
128929044|NCT02158533|464029117|FG001|Stage 1|Adverse Event|4|||
128929045|NCT02158533|464029118|FG002|Stage 1|Adverse Event|7|||
128929046|NCT02158533|464029119|FG003|Stage 1|Adverse Event|0|||
128929047|NCT02158533|464029120|FG004|Stage 1|Adverse Event|0|||
128929048|NCT02158533|464029121|FG005|Stage 1|Adverse Event|0|||
128929049|NCT02158533|464029116|FG000|Stage 1|Withdrawal by Subject|3|||
128929050|NCT02158533|464029117|FG001|Stage 1|Withdrawal by Subject|2|||
128929051|NCT02158533|464029118|FG002|Stage 1|Withdrawal by Subject|1|||
128929052|NCT02158533|464029119|FG003|Stage 1|Withdrawal by Subject|0|||
128929053|NCT02158533|464029120|FG004|Stage 1|Withdrawal by Subject|0|||
128929054|NCT02158533|464029121|FG005|Stage 1|Withdrawal by Subject|0|||
128929055|NCT02158533|464029116|FG000|Stage 1|Lack of Efficacy|1|||
128929056|NCT02158533|464029117|FG001|Stage 1|Lack of Efficacy|0|||
128929057|NCT02158533|464029118|FG002|Stage 1|Lack of Efficacy|0|||
128929058|NCT02158533|464029119|FG003|Stage 1|Lack of Efficacy|0|||
128929059|NCT02158533|464029120|FG004|Stage 1|Lack of Efficacy|0|||
128929060|NCT02158533|464029121|FG005|Stage 1|Lack of Efficacy|0|||
128929061|NCT02158533|464029116|FG000|Stage 1|Lost to Follow-up|3|||
128929062|NCT02158533|464029117|FG001|Stage 1|Lost to Follow-up|1|||
128929063|NCT02158533|464029118|FG002|Stage 1|Lost to Follow-up|0|||
128929064|NCT02158533|464029119|FG003|Stage 1|Lost to Follow-up|0|||
128929065|NCT02158533|464029120|FG004|Stage 1|Lost to Follow-up|0|||
128929066|NCT02158533|464029121|FG005|Stage 1|Lost to Follow-up|0|||
128929067|NCT02158533|464029116|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
128929068|NCT02158533|464029117|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
128929069|NCT02158533|464029118|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
128929070|NCT02158533|464029119|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
128929071|NCT02158533|464029120|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
128929072|NCT02158533|464029121|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
128929073|NCT02158533|464029116|FG000|Stage 1|Non-compliance with study visits|1|||
128929074|NCT02158533|464029117|FG001|Stage 1|Non-compliance with study visits|0|||
128929075|NCT02158533|464029118|FG002|Stage 1|Non-compliance with study visits|0|||
128929076|NCT02158533|464029119|FG003|Stage 1|Non-compliance with study visits|0|||
128929077|NCT02158533|464029120|FG004|Stage 1|Non-compliance with study visits|0|||
128929078|NCT02158533|464029121|FG005|Stage 1|Non-compliance with study visits|0|||
128929079|NCT02158533|464029116|FG000|Stage 2|Adverse Event|0|||
128929080|NCT02158533|464029117|FG001|Stage 2|Adverse Event|0|||
128929081|NCT02158533|464029118|FG002|Stage 2|Adverse Event|0|||
128929082|NCT02158533|464029119|FG003|Stage 2|Adverse Event|0|||
128929083|NCT02158533|464029120|FG004|Stage 2|Adverse Event|0|||
128929084|NCT02158533|464029121|FG005|Stage 2|Adverse Event|1|||
128929085|NCT02158533|464029116|FG000|Stage 2|Lack of Efficacy|0|||
128929086|NCT02158533|464029117|FG001|Stage 2|Lack of Efficacy|0|||
128929087|NCT02158533|464029118|FG002|Stage 2|Lack of Efficacy|0|||
128929088|NCT02158533|464029119|FG003|Stage 2|Lack of Efficacy|0|||
128929089|NCT02158533|464029120|FG004|Stage 2|Lack of Efficacy|1|||
128929090|NCT02158533|464029121|FG005|Stage 2|Lack of Efficacy|0|||
128929091|NCT02158533|464029116|FG000|Stage 2|Lost to Follow-up|0|||
128929092|NCT02158533|464029117|FG001|Stage 2|Lost to Follow-up|0|||
128929093|NCT02158533|464029118|FG002|Stage 2|Lost to Follow-up|0|||
128929094|NCT02158533|464029119|FG003|Stage 2|Lost to Follow-up|1|||
128929095|NCT02158533|464029120|FG004|Stage 2|Lost to Follow-up|1|||
128929096|NCT02158533|464029121|FG005|Stage 2|Lost to Follow-up|2|||
128929097|NCT02158533|464029116|FG000|Stage 2|Withdrawal by Subject|0|||
128929098|NCT02158533|464029117|FG001|Stage 2|Withdrawal by Subject|0|||
128929099|NCT02158533|464029118|FG002|Stage 2|Withdrawal by Subject|0|||
128929100|NCT02158533|464029119|FG003|Stage 2|Withdrawal by Subject|0|||
128929101|NCT02158533|464029120|FG004|Stage 2|Withdrawal by Subject|1|||
128929102|NCT02158533|464029121|FG005|Stage 2|Withdrawal by Subject|2|||
128929103|NCT02158533|464029116|FG000|Stage 2|Physician Decision|0|||
128929104|NCT02158533|464029117|FG001|Stage 2|Physician Decision|0|||
128929105|NCT02158533|464029118|FG002|Stage 2|Physician Decision|0|||
128929106|NCT02158533|464029119|FG003|Stage 2|Physician Decision|0|||
128929107|NCT02158533|464029120|FG004|Stage 2|Physician Decision|1|||
128929108|NCT02158533|464029121|FG005|Stage 2|Physician Decision|0|||
128929109|NCT02158533|464029116|FG000|Stage 2|Pregnancy|0|||
128929110|NCT02158533|464029117|FG001|Stage 2|Pregnancy|0|||
128929111|NCT02158533|464029118|FG002|Stage 2|Pregnancy|0|||
128929112|NCT02158533|464029119|FG003|Stage 2|Pregnancy|1|||
128929113|NCT02158533|464029120|FG004|Stage 2|Pregnancy|0|||
128929114|NCT02158533|464029121|FG005|Stage 2|Pregnancy|0|||
128929115|NCT02158533|464029116|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
128929116|NCT02158533|464029117|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
128701545|NCT02340975|463205649|FG005|Overall Study|Death|13|||
128701546|NCT02340975|463205644|FG000|Overall Study|Lost to Follow-up|0|||
128701547|NCT02340975|463205645|FG001|Overall Study|Lost to Follow-up|0|||
128701548|NCT02340975|463205646|FG002|Overall Study|Lost to Follow-up|0|||
128929117|NCT02158533|464029118|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
128929118|NCT02158533|464029119|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
129029916|NCT02452463|464400013|FG001|Overall Study|Study Suspended|0|||
129029917|NCT02452463|464400014|FG002|Overall Study|Study Suspended|0|||
129029918|NCT02452463|464400012|FG000|Overall Study|Recommended by DSMB|0|||
129029919|NCT02452463|464400013|FG001|Overall Study|Recommended by DSMB|1|||
129029920|NCT02452463|464400014|FG002|Overall Study|Recommended by DSMB|0|||
129029921|NCT02452463|464400012|FG000|Overall Study|Withdrawal by Subject|0|||
129029922|NCT02452463|464400013|FG001|Overall Study|Withdrawal by Subject|1|||
129029923|NCT02452463|464400014|FG002|Overall Study|Withdrawal by Subject|0|||
129029924|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
129029925|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
129029926|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
129029927|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
129029928|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
129029929|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
129029930|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
129029931|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
129029932|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
129029933|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
129029934|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
129029935|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
129029936|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
129029937|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
129029938|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
129029939|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
129029940|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
129029941|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
129029942|NCT00950300|464400019|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
129029943|NCT00950300|464400020|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
129029944|NCT00950300|464400019|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
129029945|NCT00950300|464400020|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
129029946|NCT00950300|464400019|FG000|TFFU Period|Death|4|||
129029947|NCT00950300|464400020|FG001|TFFU Period|Death|1|||
129029948|NCT00950300|464400019|FG000|TFFU Period|Refused Treatment|10|||
129029949|NCT00950300|464400020|FG001|TFFU Period|Refused Treatment|11|||
129029950|NCT00950300|464400019|FG000|TFFU Period|Failure to Return|16|||
129029951|NCT00950300|464400020|FG001|TFFU Period|Failure to Return|16|||
129029952|NCT00950300|464400019|FG000|TFFU Period|Recurrence of Disease|63|||
129029953|NCT00950300|464400020|FG001|TFFU Period|Recurrence of Disease|72|||
129029954|NCT00950300|464400019|FG000|TFFU Period|Other|4|||
129029955|NCT00950300|464400020|FG001|TFFU Period|Other|3|||
129029956|NCT00950300|464400019|FG000|SFU Period|Death|44|||
129029957|NCT00950300|464400020|FG001|SFU Period|Death|42|||
129029958|NCT00950300|464400019|FG000|SFU Period|Lost to Follow-up|30|||
129029959|NCT00950300|464400020|FG001|SFU Period|Lost to Follow-up|28|||
129029960|NCT00950300|464400019|FG000|SFU Period|Withdrawal by Subject|4|||
129029961|NCT00950300|464400020|FG001|SFU Period|Withdrawal by Subject|8|||
128929119|NCT02158533|464029120|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
129029962|NCT01717040|464400021|FG000|Overall Study|Lost to Follow-up|2|||
129029963|NCT01717040|464400022|FG001|Overall Study|Lost to Follow-up|3|||
129029964|NCT01717040|464400021|FG000|Overall Study|Lack of Efficacy|1|||
129029965|NCT01717040|464400022|FG001|Overall Study|Lack of Efficacy|1|||
129029966|NCT01717040|464400021|FG000|Overall Study|Adverse Event|1|||
128929120|NCT02158533|464029121|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
128929121|NCT02158533|464029116|FG000|Stage 2|Non-adherence with study visits|0|||
128929122|NCT02158533|464029117|FG001|Stage 2|Non-adherence with study visits|0|||
128929123|NCT02158533|464029118|FG002|Stage 2|Non-adherence with study visits|0|||
128929124|NCT02158533|464029119|FG003|Stage 2|Non-adherence with study visits|0|||
128929125|NCT02158533|464029120|FG004|Stage 2|Non-adherence with study visits|0|||
128929126|NCT02158533|464029121|FG005|Stage 2|Non-adherence with study visits|1|||
128929127|NCT00917384|464029126|FG000|Overall Study|Lost to Follow-up|4|||
128929128|NCT00917384|464029127|FG001|Overall Study|Lost to Follow-up|2|||
128929129|NCT00917384|464029126|FG000|Overall Study|Withdrawal by Subject|10|||
128929130|NCT00917384|464029127|FG001|Overall Study|Withdrawal by Subject|2|||
128929131|NCT04899271|464029130|FG000|Overall Study|Lost to Follow-up|1|||
128929132|NCT04899271|464029131|FG001|Overall Study|Lost to Follow-up|0|||
128929133|NCT04899271|464029130|FG000|Overall Study|Subject request/consent withdrawal|2|||
128929134|NCT04899271|464029131|FG001|Overall Study|Subject request/consent withdrawal|0|||
128929135|NCT01859403|464029134|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
128929136|NCT01859403|464029135|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
128929137|NCT01859403|464029134|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
128929138|NCT01859403|464029135|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
128929139|NCT01859403|464029134|FG000|Primary Endpoint Measure|Physician Decision|0|||
128929140|NCT01859403|464029135|FG001|Primary Endpoint Measure|Physician Decision|1|||
128929141|NCT01859403|464029134|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
128929142|NCT01859403|464029135|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
128929143|NCT01121406|464029142|FG000|Overall Study|Progressive disease RECIST|44|||
128929144|NCT01121406|464029143|FG001|Overall Study|Progressive disease RECIST|28|||
128929145|NCT01121406|464029142|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
128929146|NCT01121406|464029143|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
128929147|NCT01121406|464029142|FG000|Overall Study|Other AE|3|||
128929148|NCT01121406|464029143|FG001|Overall Study|Other AE|10|||
128929149|NCT01121406|464029142|FG000|Overall Study|Non-compliant with protocol|0|||
128929150|NCT01121406|464029143|FG001|Overall Study|Non-compliant with protocol|2|||
128929151|NCT01121406|464029142|FG000|Overall Study|Lost to Follow-up|0|||
128929152|NCT01121406|464029143|FG001|Overall Study|Lost to Follow-up|1|||
128929153|NCT01121406|464029142|FG000|Overall Study|Refused continuation of study med.|1|||
129029967|NCT01717040|464400022|FG001|Overall Study|Adverse Event|0|||
129029968|NCT01717040|464400021|FG000|Overall Study|Required Medication Change|0|||
129029969|NCT01717040|464400022|FG001|Overall Study|Required Medication Change|1|||
129029970|NCT01717040|464400021|FG000|Overall Study|New Substance Use Disorder|1|||
129029971|NCT01717040|464400022|FG001|Overall Study|New Substance Use Disorder|0|||
129029972|NCT00087529|464400023|FG000|Overall Study|Death|1|||
129029973|NCT00087529|464400024|FG001|Overall Study|Death|0|||
129029974|NCT00087529|464400023|FG000|Overall Study|Adverse Event|0|||
129029975|NCT00087529|464400024|FG001|Overall Study|Adverse Event|8|||
129029976|NCT00087529|464400023|FG000|Overall Study|Pregnancy|0|||
129029977|NCT00087529|464400024|FG001|Overall Study|Pregnancy|1|||
129029978|NCT00087529|464400023|FG000|Overall Study|Lost to Follow-up|2|||
129029979|NCT00087529|464400024|FG001|Overall Study|Lost to Follow-up|3|||
129029980|NCT00087529|464400023|FG000|Overall Study|Participant Decision|14|||
129029981|NCT00087529|464400024|FG001|Overall Study|Participant Decision|37|||
129029982|NCT00087529|464400023|FG000|Overall Study|Physician Decision|4|||
129029983|NCT00087529|464400024|FG001|Overall Study|Physician Decision|8|||
129029984|NCT00087529|464400023|FG000|Overall Study|Initiation of Excluded Therapy|0|||
129029985|NCT00087529|464400024|FG001|Overall Study|Initiation of Excluded Therapy|1|||
129029986|NCT00087529|464400023|FG000|Overall Study|Participant Noncompliance|0|||
129029987|NCT00087529|464400024|FG001|Overall Study|Participant Noncompliance|1|||
129029988|NCT00087529|464400023|FG000|Overall Study|Disease Progression|5|||
129029989|NCT00087529|464400024|FG001|Overall Study|Disease Progression|4|||
129029990|NCT00087529|464400023|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
129029991|NCT00087529|464400024|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
129029992|NCT04573309|464401543|FG000|Overall Study|Protocol Violation|1|||
129029993|NCT04573309|464401544|FG001|Overall Study|Protocol Violation|0|||
129029994|NCT01894230|464401545|FG000|Overall Study|Lost to Follow-up|2|||
129029995|NCT01894230|464401546|FG001|Overall Study|Lost to Follow-up|2|||
129029996|NCT01894230|464401545|FG000|Overall Study|Withdrawal by Subject|4|||
129029997|NCT01894230|464401546|FG001|Overall Study|Withdrawal by Subject|4|||
129029998|NCT01894230|464401545|FG000|Overall Study|Non-adherent|0|||
129029999|NCT01894230|464401546|FG001|Overall Study|Non-adherent|1|||
129030000|NCT01894230|464401545|FG000|Overall Study|Death|1|||
129030001|NCT01894230|464401546|FG001|Overall Study|Death|0|||
129030002|NCT02300987|464401547|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
129030003|NCT02300987|464401548|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
129030004|NCT02300987|464401547|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
129030005|NCT02300987|464401548|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
129030006|NCT02300987|464401547|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
129030007|NCT02300987|464401548|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
129030008|NCT02300987|464401547|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
129119194|NCT01326871|464733219|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
129119195|NCT01326871|464733217|FG000|Overall Study|Physician Decision|0|||
129119196|NCT01326871|464733218|FG001|Overall Study|Physician Decision|0|||
129119197|NCT01326871|464733219|FG002|Overall Study|Physician Decision|1|||
129119198|NCT01326871|464733217|FG000|Overall Study|SAE|0|||
129119199|NCT01326871|464733218|FG001|Overall Study|SAE|0|||
129119200|NCT01326871|464733219|FG002|Overall Study|SAE|1|||
129119201|NCT01326871|464733217|FG000|Overall Study|Disease progression and death|0|||
129119202|NCT01326871|464733218|FG001|Overall Study|Disease progression and death|0|||
129119203|NCT01326871|464733219|FG002|Overall Study|Disease progression and death|1|||
129119204|NCT01326871|464733217|FG000|Overall Study|Subject decision|0|||
129119205|NCT01326871|464733218|FG001|Overall Study|Subject decision|0|||
129119206|NCT01326871|464733219|FG002|Overall Study|Subject decision|1|||
129119207|NCT01200329|464733220|FG000|Overall Study|Lack of financial coverage|2|||
129119208|NCT01200329|464733220|FG000|Overall Study|Progressive disease|1|||
129119209|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
129119210|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
129119211|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
129119212|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
129119213|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
129119214|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
129119215|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
129119216|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129119217|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129119218|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129119219|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
129119220|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
129119221|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
129119222|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
129119223|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
129119224|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
129119225|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
129119226|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129119227|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129119228|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129119229|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
129119230|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
129119231|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129119232|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129119233|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129119234|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
129119235|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
129119236|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
129119237|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
129119238|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
129119239|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
129119240|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
129119241|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
129119242|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
129119243|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
128701549|NCT02340975|463205647|FG003|Overall Study|Lost to Follow-up|0|||
128701550|NCT02340975|463205648|FG004|Overall Study|Lost to Follow-up|2|||
128701551|NCT02340975|463205649|FG005|Overall Study|Lost to Follow-up|0|||
128701552|NCT02340975|463205644|FG000|Overall Study|Withdrawal by Subject|0|||
128701553|NCT02340975|463205645|FG001|Overall Study|Withdrawal by Subject|0|||
128929154|NCT01121406|464029143|FG001|Overall Study|Refused continuation of study med.|2|||
128929155|NCT01121406|464029142|FG000|Overall Study|Reason other than specified above|2|||
128929156|NCT01121406|464029143|FG001|Overall Study|Reason other than specified above|6|||
128929157|NCT01121406|464029142|FG000|Overall Study|Not treated|1|||
128929158|NCT01121406|464029143|FG001|Overall Study|Not treated|0|||
128929159|NCT02500550|464029150|FG000|Overall Study|Death|7|||
128929160|NCT02388776|464029151|FG000|Overall Study|Death|1|||
128929161|NCT02388776|464029151|FG000|Overall Study|Lost to Follow-up|1|||
128929162|NCT03826914|464029152|FG000|Overall Study|Withdrawal by Subject|1|||
128929163|NCT03826914|464029153|FG001|Overall Study|Withdrawal by Subject|1|||
128929164|NCT04334148|464029154|FG000|Overall Study|positive nasal swab at baseline|0|||
128701554|NCT02340975|463205646|FG002|Overall Study|Withdrawal by Subject|3|||
128929165|NCT04334148|464029155|FG001|Overall Study|positive nasal swab at baseline|1|||
128929166|NCT00922935|464029158|FG000|Overall Study|Protocol Violation|0|||
129119244|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
129119245|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
129119246|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
129119247|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
129119248|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
129119249|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
129119250|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
129119251|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
128701555|NCT02340975|463205647|FG003|Overall Study|Withdrawal by Subject|3|||
128701556|NCT02340975|463205648|FG004|Overall Study|Withdrawal by Subject|2|||
128701557|NCT02340975|463205649|FG005|Overall Study|Withdrawal by Subject|0|||
128701558|NCT02340975|463205644|FG000|Overall Study|Other|0|||
128701559|NCT02340975|463205645|FG001|Overall Study|Other|4|||
128701560|NCT02340975|463205646|FG002|Overall Study|Other|0|||
128701561|NCT02340975|463205647|FG003|Overall Study|Other|2|||
128701562|NCT02340975|463205648|FG004|Overall Study|Other|0|||
128701563|NCT02340975|463205649|FG005|Overall Study|Other|6|||
128929167|NCT00922935|464029159|FG001|Overall Study|Protocol Violation|3|||
128929168|NCT00922935|464029160|FG002|Overall Study|Protocol Violation|0|||
128929169|NCT00922935|464029158|FG000|Overall Study|Physician Decision|1|||
128929170|NCT00922935|464029159|FG001|Overall Study|Physician Decision|1|||
128929171|NCT00922935|464029160|FG002|Overall Study|Physician Decision|0|||
128929172|NCT00922935|464029158|FG000|Overall Study|Lost to Follow-up|0|||
128929173|NCT00922935|464029159|FG001|Overall Study|Lost to Follow-up|1|||
128929174|NCT00922935|464029160|FG002|Overall Study|Lost to Follow-up|0|||
128929175|NCT01499576|464029163|FG000|Overall Study|Physician Decision|12|||
128929176|NCT01499576|464029163|FG000|Overall Study|Withdrawal by Subject|9|||
128701564|NCT03982368|463205656|FG000|Overall Study|Adverse Event|6|||
128701565|NCT03982368|463205657|FG001|Overall Study|Adverse Event|4|||
128701566|NCT03982368|463205658|FG002|Overall Study|Adverse Event|3|||
128701567|NCT03982368|463205656|FG000|Overall Study|Lost to Follow-up|2|||
128929177|NCT04283461|464029164|FG000|Overall Study|Enrolled in separate trial|0|||
128929178|NCT04283461|464029165|FG001|Overall Study|Enrolled in separate trial|0|||
128929179|NCT04283461|464029166|FG002|Overall Study|Enrolled in separate trial|8|||
128929180|NCT04283461|464029167|FG003|Overall Study|Enrolled in separate trial|13|||
128929181|NCT04283461|464029168|FG004|Overall Study|Enrolled in separate trial|12|||
128929182|NCT04283461|464029169|FG005|Overall Study|Enrolled in separate trial|0|||
128929183|NCT04283461|464029170|FG006|Overall Study|Enrolled in separate trial|0|||
128929184|NCT04283461|464029171|FG007|Overall Study|Enrolled in separate trial|8|||
128929185|NCT04283461|464029172|FG008|Overall Study|Enrolled in separate trial|0|||
128929186|NCT04283461|464029173|FG009|Overall Study|Enrolled in separate trial|0|||
128929187|NCT04283461|464029174|FG010|Overall Study|Enrolled in separate trial|0|||
128929188|NCT04283461|464029175|FG011|Overall Study|Enrolled in separate trial|7|||
128929189|NCT04283461|464029176|FG012|Overall Study|Enrolled in separate trial|0|||
128929190|NCT04375878|464029181|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
128929191|NCT04375878|464029182|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
128929192|NCT04375878|464029183|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
128929193|NCT04375878|464029184|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
128929194|NCT04375878|464029185|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
128929195|NCT04375878|464029186|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
128929196|NCT04375878|464029181|FG000|Crossover First and Second Interventions|Adverse Event|0|||
128929197|NCT04375878|464029182|FG001|Crossover First and Second Interventions|Adverse Event|0|||
128929198|NCT04375878|464029183|FG002|Crossover First and Second Interventions|Adverse Event|1|||
128929199|NCT04375878|464029184|FG003|Crossover First and Second Interventions|Adverse Event|0|||
128929200|NCT04375878|464029185|FG004|Crossover First and Second Interventions|Adverse Event|0|||
128701568|NCT03982368|463205657|FG001|Overall Study|Lost to Follow-up|1|||
128701569|NCT03982368|463205658|FG002|Overall Study|Lost to Follow-up|0|||
128701570|NCT03982368|463205656|FG000|Overall Study|Withdrawal by Subject|1|||
128701571|NCT03982368|463205657|FG001|Overall Study|Withdrawal by Subject|2|||
128701572|NCT03982368|463205658|FG002|Overall Study|Withdrawal by Subject|0|||
128701573|NCT03982368|463205656|FG000|Overall Study|unknow|4|||
128701574|NCT03982368|463205657|FG001|Overall Study|unknow|0|||
128701575|NCT03982368|463205658|FG002|Overall Study|unknow|2|||
128701576|NCT05393895|463205661|FG000|Overall Study|Adverse Event|2|||
128701577|NCT05393895|463205662|FG001|Overall Study|Adverse Event|3|||
128701578|NCT05393895|463205661|FG000|Overall Study|Lost to Follow-up|4|||
128701579|NCT05393895|463205662|FG001|Overall Study|Lost to Follow-up|3|||
128701580|NCT05393895|463205661|FG000|Overall Study|Protocol Violation|1|||
128701581|NCT05393895|463205662|FG001|Overall Study|Protocol Violation|0|||
128701582|NCT05393895|463205661|FG000|Overall Study|Withdrawal by Subject|1|||
128701583|NCT05393895|463205662|FG001|Overall Study|Withdrawal by Subject|4|||
128701584|NCT05537883|463205663|FG000|Overall Study|revisional surgery|4|||
128701585|NCT05537883|463205664|FG001|Overall Study|revisional surgery|2|||
128701586|NCT05537883|463205663|FG000|Overall Study|surgeries were cancelled|0|||
128929201|NCT04375878|464029186|FG005|Crossover First and Second Interventions|Adverse Event|0|||
128929202|NCT04375878|464029181|FG000|Extension Phase|Withdrawal by Subject|0|||
128929203|NCT04375878|464029182|FG001|Extension Phase|Withdrawal by Subject|0|||
128929204|NCT04375878|464029183|FG002|Extension Phase|Withdrawal by Subject|0|||
128929205|NCT04375878|464029184|FG003|Extension Phase|Withdrawal by Subject|0|||
128929206|NCT04375878|464029185|FG004|Extension Phase|Withdrawal by Subject|1|||
128929207|NCT04375878|464029186|FG005|Extension Phase|Withdrawal by Subject|0|||
128929208|NCT00195351|464029187|FG000|Overall Study|Lost to Follow-up|9|||
128929209|NCT00195351|464029188|FG001|Overall Study|Lost to Follow-up|9|||
128929210|NCT00195351|464029187|FG000|Overall Study|Withdrawal by Subject|6|||
128929211|NCT00195351|464029188|FG001|Overall Study|Withdrawal by Subject|3|||
128929212|NCT00195351|464029187|FG000|Overall Study|Protocol Deviation|3|||
128929213|NCT00195351|464029188|FG001|Overall Study|Protocol Deviation|2|||
128929214|NCT00195351|464029187|FG000|Overall Study|Death|3|||
128929215|NCT00195351|464029188|FG001|Overall Study|Death|1|||
128929216|NCT00195351|464029187|FG000|Overall Study|Lack of Efficacy|0|||
128929217|NCT00195351|464029188|FG001|Overall Study|Lack of Efficacy|1|||
128929218|NCT02493751|464029191|FG000|Overall Study|Withdrawal by Subject|2|||
128929219|NCT02493751|464029192|FG001|Overall Study|Withdrawal by Subject|8|||
128929220|NCT02493751|464029191|FG000|Overall Study|Death|6|||
128929221|NCT02493751|464029192|FG001|Overall Study|Death|13|||
128929222|NCT02493751|464029191|FG000|Overall Study|Lost to Follow-up|2|||
128929223|NCT02493751|464029192|FG001|Overall Study|Lost to Follow-up|3|||
128701587|NCT05537883|463205664|FG001|Overall Study|surgeries were cancelled|2|||
128701588|NCT05537883|463205663|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
128701589|NCT05537883|463205664|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
128701590|NCT02296320|463205669|FG000|Overall Study|Withdrawal by Subject|4|||
128701591|NCT02296320|463205670|FG001|Overall Study|Withdrawal by Subject|0|||
128701592|NCT02296320|463205671|FG002|Overall Study|Withdrawal by Subject|2|||
128701593|NCT02296320|463205669|FG000|Overall Study|Death|24|||
128701594|NCT02296320|463205670|FG001|Overall Study|Death|3|||
128701595|NCT02296320|463205671|FG002|Overall Study|Death|27|||
128701596|NCT02296320|463205669|FG000|Overall Study|Lost to Follow-up|5|||
128701597|NCT02296320|463205670|FG001|Overall Study|Lost to Follow-up|2|||
128929224|NCT02493751|464029191|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
128701598|NCT02296320|463205671|FG002|Overall Study|Lost to Follow-up|7|||
128701599|NCT02296320|463205669|FG000|Overall Study|Not treated|2|||
128701600|NCT02296320|463205670|FG001|Overall Study|Not treated|0|||
128701601|NCT02296320|463205671|FG002|Overall Study|Not treated|0|||
128701602|NCT02296320|463205669|FG000|Overall Study|Not - specified|0|||
128701603|NCT02296320|463205670|FG001|Overall Study|Not - specified|0|||
128701604|NCT02296320|463205671|FG002|Overall Study|Not - specified|1|||
128701605|NCT03310021|463205675|FG000|Overall Study|Withdrawal by Subject|0|||
128701606|NCT03310021|463205676|FG001|Overall Study|Withdrawal by Subject|0|||
128701607|NCT03310021|463205677|FG002|Overall Study|Withdrawal by Subject|0|||
128701608|NCT03310021|463205678|FG003|Overall Study|Withdrawal by Subject|0|||
128701609|NCT03310021|463205679|FG004|Overall Study|Withdrawal by Subject|0|||
128701610|NCT03310021|463205680|FG005|Overall Study|Withdrawal by Subject|0|||
128701611|NCT03310021|463205681|FG006|Overall Study|Withdrawal by Subject|1|||
128701612|NCT03310021|463205682|FG007|Overall Study|Withdrawal by Subject|0|||
128701613|NCT03310021|463205683|FG008|Overall Study|Withdrawal by Subject|0|||
128701614|NCT03310021|463205684|FG009|Overall Study|Withdrawal by Subject|0|||
128701615|NCT03310021|463205685|FG010|Overall Study|Withdrawal by Subject|0|||
128701616|NCT03310021|463205686|FG011|Overall Study|Withdrawal by Subject|0|||
128701617|NCT03310021|463205687|FG012|Overall Study|Withdrawal by Subject|0|||
128701618|NCT03310021|463205688|FG013|Overall Study|Withdrawal by Subject|0|||
128701619|NCT03310021|463205689|FG014|Overall Study|Withdrawal by Subject|0|||
128701620|NCT03310021|463205690|FG015|Overall Study|Withdrawal by Subject|0|||
128701621|NCT03310021|463205691|FG016|Overall Study|Withdrawal by Subject|0|||
129119252|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
129119253|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
129119254|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
129119255|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
129119256|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
129119257|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
129119258|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
129119259|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
128701622|NCT03310021|463205692|FG017|Overall Study|Withdrawal by Subject|0|||
128701623|NCT03310021|463205693|FG018|Overall Study|Withdrawal by Subject|0|||
128929225|NCT02493751|464029192|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
128929226|NCT01259466|464029195|FG000|Overall Study|Withdrawal by Subject|1|||
128929227|NCT01259466|464029196|FG001|Overall Study|Withdrawal by Subject|9|||
128929228|NCT01824602|464029197|FG000|Overall Study|Withdrawal by Subject|0|||
128929229|NCT01824602|464029198|FG001|Overall Study|Withdrawal by Subject|0|||
128701624|NCT03310021|463205694|FG019|Overall Study|Withdrawal by Subject|0|||
128929230|NCT01824602|464029199|FG002|Overall Study|Withdrawal by Subject|1|||
128929231|NCT01824602|464029200|FG003|Overall Study|Withdrawal by Subject|2|||
128929232|NCT01824602|464029197|FG000|Overall Study|Patient non-compliance|0|||
128929233|NCT01824602|464029198|FG001|Overall Study|Patient non-compliance|0|||
128929234|NCT01824602|464029199|FG002|Overall Study|Patient non-compliance|1|||
128929235|NCT01824602|464029200|FG003|Overall Study|Patient non-compliance|0|||
128929236|NCT01824602|464029197|FG000|Overall Study|Adverse Event|1|||
128929237|NCT01824602|464029198|FG001|Overall Study|Adverse Event|0|||
128929238|NCT01824602|464029199|FG002|Overall Study|Adverse Event|2|||
128929239|NCT01824602|464029200|FG003|Overall Study|Adverse Event|2|||
128929240|NCT01824602|464029197|FG000|Overall Study|Treatment failure|0|||
128929241|NCT01824602|464029198|FG001|Overall Study|Treatment failure|0|||
128929242|NCT01824602|464029199|FG002|Overall Study|Treatment failure|0|||
128929243|NCT01824602|464029200|FG003|Overall Study|Treatment failure|1|||
128929244|NCT02485717|464029203|FG000|Overall Study|Lost to Follow-up|6|||
128929245|NCT02485717|464029204|FG001|Overall Study|Lost to Follow-up|0|||
128929246|NCT02485717|464029205|FG002|Overall Study|Lost to Follow-up|0|||
128929247|NCT02485717|464029203|FG000|Overall Study|Withdrawal by Subject|0|||
128929248|NCT02485717|464029204|FG001|Overall Study|Withdrawal by Subject|0|||
128929249|NCT02485717|464029205|FG002|Overall Study|Withdrawal by Subject|1|||
128929250|NCT02485717|464029203|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
128929251|NCT02485717|464029204|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
128929252|NCT02485717|464029205|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
128929253|NCT02485717|464029203|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
128929254|NCT02485717|464029204|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
128929255|NCT02485717|464029205|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
128929256|NCT05300087|464029208|FG000|Overall Study|Withdrawal by Subject|0|||
128929257|NCT05300087|464029209|FG001|Overall Study|Withdrawal by Subject|1|||
128929258|NCT03248128|464029210|FG000|Overall Study|Lost to Follow-up|1|||
128929259|NCT03248128|464029211|FG001|Overall Study|Lost to Follow-up|0|||
128929260|NCT03248128|464029210|FG000|Overall Study|Withdrawal by Subject|16|||
128929261|NCT03248128|464029211|FG001|Overall Study|Withdrawal by Subject|14|||
128929262|NCT03248128|464029210|FG000|Overall Study|Site Closed|4|||
128929263|NCT03248128|464029211|FG001|Overall Study|Site Closed|3|||
128929264|NCT03248128|464029210|FG000|Overall Study|Randomized, but did not receive treatment|1|||
129119260|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
129119261|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
129119262|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
129119263|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
129119264|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
129119265|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129119266|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129119267|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129119268|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129119269|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
129119270|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129119271|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129119272|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129119273|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129119274|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129119275|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
129119276|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129119277|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129119278|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129119279|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
129119280|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
129119281|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
129119282|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
129119283|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
128929265|NCT03248128|464029211|FG001|Overall Study|Randomized, but did not receive treatment|3|||
128929266|NCT01914679|464029212|FG000|Overall Study|Lack of Efficacy|1|||
128929267|NCT01914679|464029212|FG000|Overall Study|Sponsor terminated study|4|||
128701625|NCT03310021|463205675|FG000|Overall Study|Lost to Follow-up|0|||
128929268|NCT02722044|464029213|FG000|Overall Study|Adverse Event|2|||
128929269|NCT02722044|464029213|FG000|Overall Study|Physician Decision|1|||
128929270|NCT02722044|464029213|FG000|Overall Study|Withdrawal by Subject|1|||
128929271|NCT02722044|464029213|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
128929272|NCT00002850|464029215|FG000|Overall Study|Death|4|||
128929273|NCT00002850|464029216|FG001|Overall Study|Death|1|||
128929274|NCT00002850|464029217|FG002|Overall Study|Death|3|||
128929275|NCT00002850|464029215|FG000|Overall Study|Protocol Violation|1|||
128929276|NCT00002850|464029216|FG001|Overall Study|Protocol Violation|0|||
128929277|NCT00002850|464029217|FG002|Overall Study|Protocol Violation|1|||
128929278|NCT00002850|464029215|FG000|Overall Study|Withdrawal by Subject|0|||
128929279|NCT00002850|464029216|FG001|Overall Study|Withdrawal by Subject|1|||
128929280|NCT00002850|464029217|FG002|Overall Study|Withdrawal by Subject|0|||
128929281|NCT01877655|464029229|FG000|Overall Study|Death|57|||
128929282|NCT01877655|464029230|FG001|Overall Study|Death|52|||
128929283|NCT01877655|464029229|FG000|Overall Study|Withdrawal by Subject|18|||
128929284|NCT01877655|464029230|FG001|Overall Study|Withdrawal by Subject|26|||
128929285|NCT01877655|464029229|FG000|Overall Study|Physician Decision|11|||
128929286|NCT01877655|464029230|FG001|Overall Study|Physician Decision|10|||
128929287|NCT01877655|464029229|FG000|Overall Study|Miscellaneous|4|||
128929288|NCT01877655|464029230|FG001|Overall Study|Miscellaneous|4|||
128929289|NCT01877655|464029229|FG000|Overall Study|Randomized but Never Received Drug|8|||
128929290|NCT01877655|464029230|FG001|Overall Study|Randomized but Never Received Drug|5|||
128929291|NCT02332915|464029231|FG000|Overall Study|Moved out of region|3|||
128929292|NCT02332915|464029232|FG001|Overall Study|Moved out of region|0|||
128929293|NCT02332915|464029231|FG000|Overall Study|Unrelated illness|1|||
128929294|NCT02332915|464029232|FG001|Overall Study|Unrelated illness|1|||
128929295|NCT02332915|464029231|FG000|Overall Study|Travel distance prohibitive|0|||
128929296|NCT02332915|464029232|FG001|Overall Study|Travel distance prohibitive|1|||
128929297|NCT02332915|464029231|FG000|Overall Study|did not meet inclusion criteria|2|||
128929298|NCT02332915|464029232|FG001|Overall Study|did not meet inclusion criteria|4|||
128929299|NCT05847881|464029236|FG000|Overall Study|Principal Investigator Decision|8|||
128929300|NCT05847881|464029236|FG000|Overall Study|Withdrawal by Subject|2|||
128929301|NCT04513158|464029239|FG000|Overall Study|Screen Failure|1|||
128929302|NCT04493619|464030521|FG000|Overall Study|Death|4|||
128929303|NCT04493619|464030522|FG001|Overall Study|Death|3|||
128929304|NCT04493619|464030523|FG002|Overall Study|Death|3|||
128929305|NCT04493619|464030524|FG003|Overall Study|Death|4|||
128929306|NCT04493619|464030521|FG000|Overall Study|Study discontinued early|10|||
128929307|NCT04493619|464030522|FG001|Overall Study|Study discontinued early|0|||
129119284|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129119285|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
129119286|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129119287|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129119288|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129119289|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
129119290|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129119291|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129119292|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129119293|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129119294|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129119295|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
129119296|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129119297|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129119298|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129119299|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
129119300|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129119301|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129119302|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129119303|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129119304|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
129119305|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
129119306|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
129119307|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
129119308|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
128929308|NCT04493619|464030523|FG002|Overall Study|Study discontinued early|4|||
128929309|NCT04493619|464030524|FG003|Overall Study|Study discontinued early|8|||
128929310|NCT04493619|464030521|FG000|Overall Study|Lost to Follow-up|0|||
128929311|NCT04493619|464030522|FG001|Overall Study|Lost to Follow-up|0|||
128929312|NCT04493619|464030523|FG002|Overall Study|Lost to Follow-up|0|||
128929313|NCT04493619|464030524|FG003|Overall Study|Lost to Follow-up|1|||
128929314|NCT02128490|464030527|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
128929315|NCT02128490|464030528|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
128929316|NCT02128490|464030529|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
128929317|NCT02128490|464030530|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
128929318|NCT02128490|464030531|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
128929319|NCT02128490|464030527|FG000|Overall Study|Major Protocol Deviation|1|||
128929320|NCT02128490|464030528|FG001|Overall Study|Major Protocol Deviation|2|||
128929321|NCT02128490|464030529|FG002|Overall Study|Major Protocol Deviation|0|||
128929322|NCT02128490|464030530|FG003|Overall Study|Major Protocol Deviation|2|||
128929323|NCT02128490|464030531|FG004|Overall Study|Major Protocol Deviation|2|||
128929324|NCT02128490|464030527|FG000|Overall Study|Lost to Follow-up|0|||
128929325|NCT02128490|464030528|FG001|Overall Study|Lost to Follow-up|0|||
128929326|NCT02128490|464030529|FG002|Overall Study|Lost to Follow-up|1|||
128929327|NCT02128490|464030530|FG003|Overall Study|Lost to Follow-up|1|||
128929328|NCT02128490|464030531|FG004|Overall Study|Lost to Follow-up|1|||
128929329|NCT02128490|464030527|FG000|Overall Study|Voluntary Withdrawal|3|||
128929330|NCT02128490|464030528|FG001|Overall Study|Voluntary Withdrawal|3|||
128929331|NCT02128490|464030529|FG002|Overall Study|Voluntary Withdrawal|1|||
128929332|NCT02128490|464030530|FG003|Overall Study|Voluntary Withdrawal|1|||
128929333|NCT02128490|464030531|FG004|Overall Study|Voluntary Withdrawal|2|||
128929334|NCT02128490|464030527|FG000|Overall Study|Lack of Efficacy|0|||
128929335|NCT02128490|464030528|FG001|Overall Study|Lack of Efficacy|1|||
128929336|NCT02128490|464030529|FG002|Overall Study|Lack of Efficacy|0|||
128929337|NCT02128490|464030530|FG003|Overall Study|Lack of Efficacy|0|||
128929338|NCT02128490|464030531|FG004|Overall Study|Lack of Efficacy|0|||
128929339|NCT02128490|464030527|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
128929340|NCT02128490|464030528|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
128929341|NCT02128490|464030529|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
128929342|NCT02128490|464030530|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
128929343|NCT02128490|464030531|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
128929344|NCT02128490|464030527|FG000|Overall Study|Other Miscellaneous Reasons|0|||
128929345|NCT02128490|464030528|FG001|Overall Study|Other Miscellaneous Reasons|0|||
128929346|NCT02128490|464030529|FG002|Overall Study|Other Miscellaneous Reasons|2|||
128929347|NCT02128490|464030530|FG003|Overall Study|Other Miscellaneous Reasons|1|||
128929348|NCT02128490|464030531|FG004|Overall Study|Other Miscellaneous Reasons|1|||
128929349|NCT02243176|464030532|FG000|Overall Study|Other reason|1|||
128929350|NCT02243176|464030533|FG001|Overall Study|Other reason|2|||
128929351|NCT02243176|464030532|FG000|Overall Study|protocol specified withdrawal critera|1|||
128929352|NCT02243176|464030533|FG001|Overall Study|protocol specified withdrawal critera|3|||
128929353|NCT02243176|464030532|FG000|Overall Study|Protocol Violation|2|||
128929354|NCT02243176|464030533|FG001|Overall Study|Protocol Violation|1|||
128929355|NCT02243176|464030532|FG000|Overall Study|Withdrawal by Subject|8|||
128929356|NCT02243176|464030533|FG001|Overall Study|Withdrawal by Subject|7|||
128929357|NCT02243176|464030532|FG000|Overall Study|Adverse Event|2|||
128929358|NCT02243176|464030533|FG001|Overall Study|Adverse Event|2|||
128929359|NCT02342171|464030537|FG000|Overall Study|Death|4|||
128929360|NCT02342171|464030538|FG001|Overall Study|Death|87|||
128929361|NCT02342171|464030537|FG000|Overall Study|Received favipiravir|10|||
128929362|NCT02342171|464030538|FG001|Overall Study|Received favipiravir|0|||
128929363|NCT02342171|464030537|FG000|Overall Study|Missing cycle treshold value|1|||
128929364|NCT02342171|464030538|FG001|Overall Study|Missing cycle treshold value|0|||
128929365|NCT02342171|464030537|FG000|Overall Study|Unknown outcome|0|||
128929366|NCT02342171|464030538|FG001|Overall Study|Unknown outcome|1|||
128929367|NCT02342171|464030537|FG000|Overall Study|Missing age data|0|||
128929368|NCT02342171|464030538|FG001|Overall Study|Missing age data|1|||
128929369|NCT03518840|464030541|FG000|Overall Study|Lost to Follow-up|6|||
128929370|NCT03704051|464030542|FG000|Overall Study|Withdrawal by Subject|4|||
128929371|NCT03704051|464030543|FG001|Overall Study|Withdrawal by Subject|0|||
128929372|NCT01335971|464030546|FG000|Overall Study|Withdrawal by Subject|1|||
128929373|NCT01335971|464030547|FG001|Overall Study|Withdrawal by Subject|0|||
128929374|NCT01335971|464030548|FG002|Overall Study|Withdrawal by Subject|0|||
128929375|NCT01335971|464030546|FG000|Overall Study|Did not complete bronchoscopy|1|||
128929376|NCT01335971|464030547|FG001|Overall Study|Did not complete bronchoscopy|1|||
128701626|NCT03310021|463205676|FG001|Overall Study|Lost to Follow-up|0|||
128701627|NCT03310021|463205677|FG002|Overall Study|Lost to Follow-up|0|||
128701628|NCT03310021|463205678|FG003|Overall Study|Lost to Follow-up|0|||
128701629|NCT03310021|463205679|FG004|Overall Study|Lost to Follow-up|0|||
128929377|NCT01335971|464030548|FG002|Overall Study|Did not complete bronchoscopy|1|||
128929378|NCT00384956|464030549|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
128929379|NCT00149214|464030553|FG000|Overall Study|Adverse Event|12|||
128929380|NCT00149214|464030554|FG001|Overall Study|Adverse Event|9|||
128929381|NCT00149214|464030553|FG000|Overall Study|Withdrawal by Subject|4|||
128929382|NCT00149214|464030554|FG001|Overall Study|Withdrawal by Subject|1|||
128929383|NCT00149214|464030553|FG000|Overall Study|Physician Decision|3|||
128929384|NCT00149214|464030554|FG001|Overall Study|Physician Decision|3|||
128929385|NCT00149214|464030553|FG000|Overall Study|Sponsor Decision|0|||
128929386|NCT00149214|464030554|FG001|Overall Study|Sponsor Decision|1|||
128929387|NCT00149214|464030553|FG000|Overall Study|Progressive Disease|7|||
128929388|NCT00149214|464030554|FG001|Overall Study|Progressive Disease|3|||
128929389|NCT00174941|464030557|FG000|Overall Study|Adverse Event|1|||
128929390|NCT00174941|464030558|FG001|Overall Study|Adverse Event|10|||
128929391|NCT00174941|464030559|FG002|Overall Study|Adverse Event|2|||
128929392|NCT00174941|464030560|FG003|Overall Study|Adverse Event|13|||
128929393|NCT00174941|464030557|FG000|Overall Study|Protocol Violation|0|||
128929394|NCT00174941|464030558|FG001|Overall Study|Protocol Violation|1|||
128929395|NCT00174941|464030559|FG002|Overall Study|Protocol Violation|0|||
128929396|NCT00174941|464030560|FG003|Overall Study|Protocol Violation|1|||
128929397|NCT00174941|464030557|FG000|Overall Study|Lost to Follow-up|0|||
128929398|NCT00174941|464030558|FG001|Overall Study|Lost to Follow-up|3|||
128929399|NCT00174941|464030559|FG002|Overall Study|Lost to Follow-up|2|||
128929400|NCT00174941|464030560|FG003|Overall Study|Lost to Follow-up|5|||
128929401|NCT00174941|464030557|FG000|Overall Study|Personal Reason(s)|0|||
128929402|NCT00174941|464030558|FG001|Overall Study|Personal Reason(s)|14|||
128929403|NCT00174941|464030559|FG002|Overall Study|Personal Reason(s)|8|||
128929404|NCT00174941|464030560|FG003|Overall Study|Personal Reason(s)|22|||
128929405|NCT00174941|464030557|FG000|Overall Study|Gout Flare|0|||
128929406|NCT00174941|464030558|FG001|Overall Study|Gout Flare|4|||
128929407|NCT00174941|464030559|FG002|Overall Study|Gout Flare|4|||
128929408|NCT00174941|464030560|FG003|Overall Study|Gout Flare|8|||
128929409|NCT00174941|464030557|FG000|Overall Study|Reason Not Specified|1|||
128929410|NCT00174941|464030558|FG001|Overall Study|Reason Not Specified|6|||
128929411|NCT00174941|464030559|FG002|Overall Study|Reason Not Specified|2|||
128929412|NCT00174941|464030560|FG003|Overall Study|Reason Not Specified|9|||
128929413|NCT03126227|464030561|FG000|Overall Study|Adverse Event|43|||
128929414|NCT03126227|464030562|FG001|Overall Study|Adverse Event|4|||
128929415|NCT03126227|464030561|FG000|Overall Study|Death|0|||
128929416|NCT03126227|464030562|FG001|Overall Study|Death|1|||
128929417|NCT03126227|464030561|FG000|Overall Study|Lost to Follow-up|0|||
128929418|NCT03126227|464030562|FG001|Overall Study|Lost to Follow-up|1|||
128929419|NCT03126227|464030561|FG000|Overall Study|Physician Decision|2|||
128929420|NCT03126227|464030562|FG001|Overall Study|Physician Decision|0|||
128929421|NCT03126227|464030561|FG000|Overall Study|Protocol Violation|1|||
128929422|NCT03126227|464030562|FG001|Overall Study|Protocol Violation|0|||
128929423|NCT03126227|464030561|FG000|Overall Study|Withdrawal by Subject|19|||
128929424|NCT03126227|464030562|FG001|Overall Study|Withdrawal by Subject|3|||
128929425|NCT03126227|464030561|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
128929426|NCT03126227|464030562|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
128929427|NCT03126227|464030561|FG000|Overall Study|Lack of dosing compliance|2|||
128929428|NCT03126227|464030562|FG001|Overall Study|Lack of dosing compliance|0|||
128929429|NCT03126227|464030561|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
128929430|NCT03126227|464030562|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
128929431|NCT03126227|464030561|FG000|Overall Study|Scheduling conflict|1|||
128929432|NCT03126227|464030562|FG001|Overall Study|Scheduling conflict|0|||
128929433|NCT03230097|464030565|FG000|Overall Study|Adverse Event|2|||
128929434|NCT03230097|464030566|FG001|Overall Study|Adverse Event|1|||
128929435|NCT03230097|464030565|FG000|Overall Study|non-compliance|0|||
128929436|NCT03230097|464030566|FG001|Overall Study|non-compliance|1|||
128929437|NCT03230097|464030565|FG000|Overall Study|Lost to Follow-up|2|||
128929438|NCT03230097|464030566|FG001|Overall Study|Lost to Follow-up|4|||
128929439|NCT03230097|464030565|FG000|Overall Study|Withdrawal by Subject|7|||
128929440|NCT03230097|464030566|FG001|Overall Study|Withdrawal by Subject|3|||
128929441|NCT03230097|464030565|FG000|Overall Study|Trial termination|4|||
128929442|NCT03230097|464030566|FG001|Overall Study|Trial termination|5|||
128929443|NCT03230097|464030565|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
128929444|NCT03230097|464030566|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
128929445|NCT03230097|464030565|FG000|Overall Study|outcome event|0|||
128929446|NCT03230097|464030566|FG001|Overall Study|outcome event|1|||
128929447|NCT01126619|464030571|FG000|Overall Study|Not eligible for the study|2|||
128929448|NCT01126619|464030571|FG000|Overall Study|Investigator decision|4|||
128929449|NCT01126619|464030571|FG000|Overall Study|Serious adverse event|1|||
128929450|NCT01126619|464030571|FG000|Overall Study|Withdrawal by Subject|9|||
128929451|NCT01126619|464030571|FG000|Overall Study|Non-compliance|1|||
128929452|NCT03351244|464030572|FG000|Overall Study|Adverse Event|7|||
129030009|NCT02300987|464401548|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
129030010|NCT02300987|464401547|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
129030011|NCT02300987|464401548|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
128929453|NCT03351244|464030573|FG001|Overall Study|Adverse Event|11|||
128929454|NCT03351244|464030574|FG002|Overall Study|Adverse Event|12|||
128929455|NCT03351244|464030572|FG000|Overall Study|Investigator's decision|0|||
128929456|NCT03351244|464030573|FG001|Overall Study|Investigator's decision|0|||
128929457|NCT03351244|464030574|FG002|Overall Study|Investigator's decision|2|||
128929458|NCT03351244|464030572|FG000|Overall Study|System error|0|||
128929459|NCT03351244|464030573|FG001|Overall Study|System error|0|||
128929460|NCT03351244|464030574|FG002|Overall Study|System error|2|||
128929461|NCT03351244|464030572|FG000|Overall Study|COVID-19 restrictions|3|||
128929462|NCT03351244|464030573|FG001|Overall Study|COVID-19 restrictions|0|||
128929463|NCT03351244|464030574|FG002|Overall Study|COVID-19 restrictions|1|||
128929464|NCT03351244|464030572|FG000|Overall Study|Non-compliance|2|||
129030012|NCT02488109|464401549|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
129030013|NCT02488109|464401550|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
129030014|NCT02488109|464401549|FG000|12-month Follow-Up|Lost to Follow-up|4|||
129030015|NCT02488109|464401550|FG001|12-month Follow-Up|Lost to Follow-up|7|||
129030016|NCT02651987|464401555|FG000|Overall Study|Adverse Event|2|||
129030017|NCT02651987|464401556|FG001|Overall Study|Adverse Event|2|||
129030018|NCT02651987|464401555|FG000|Overall Study|Consent Withdrawn|2|||
129030019|NCT02651987|464401556|FG001|Overall Study|Consent Withdrawn|0|||
129030020|NCT02651987|464401555|FG000|Overall Study|Local PD|0|||
129030021|NCT02651987|464401556|FG001|Overall Study|Local PD|2|||
129030022|NCT02651987|464401555|FG000|Overall Study|Investigator Decision|1|||
129030023|NCT02651987|464401556|FG001|Overall Study|Investigator Decision|1|||
129030024|NCT00522041|464401557|FG000|Overall Study|Adverse Event|9|||
129030025|NCT00522041|464401558|FG001|Overall Study|Adverse Event|3|||
129030026|NCT00522041|464401557|FG000|Overall Study|Protocol Violation|2|||
129030027|NCT00522041|464401558|FG001|Overall Study|Protocol Violation|0|||
129030028|NCT00522041|464401557|FG000|Overall Study|Lost to Follow-up|1|||
129030029|NCT00522041|464401558|FG001|Overall Study|Lost to Follow-up|4|||
129119309|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
129119310|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129119311|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129119312|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129119313|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129119314|NCT02717195|464733223|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
129119315|NCT02717195|464733224|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129119316|NCT02717195|464733225|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129119317|NCT02717195|464733226|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129119318|NCT02717195|464733227|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129119319|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
129119320|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
129119321|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
129119322|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
129119323|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
129119324|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
129119325|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
129119326|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
129119327|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
129119328|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
129119329|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
129119330|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
129119331|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
129216386|NCT03739203|465092911|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
128929465|NCT03351244|464030573|FG001|Overall Study|Non-compliance|5|||
128929466|NCT03351244|464030574|FG002|Overall Study|Non-compliance|0|||
128929467|NCT03351244|464030572|FG000|Overall Study|Withdrawal by Subject|11|||
128929468|NCT03351244|464030573|FG001|Overall Study|Withdrawal by Subject|16|||
128929469|NCT03351244|464030574|FG002|Overall Study|Withdrawal by Subject|13|||
128929470|NCT03351244|464030572|FG000|Overall Study|Lost to Follow-up|2|||
128929471|NCT03351244|464030573|FG001|Overall Study|Lost to Follow-up|6|||
128929472|NCT03351244|464030574|FG002|Overall Study|Lost to Follow-up|4|||
128929473|NCT03351244|464030572|FG000|Overall Study|Protocol Violation|2|||
128929474|NCT03351244|464030573|FG001|Overall Study|Protocol Violation|2|||
128929475|NCT03351244|464030574|FG002|Overall Study|Protocol Violation|0|||
128929476|NCT00892437|464030575|FG000|Randomized Phase|Randomized but not treated|6|||
128929477|NCT00892437|464030576|FG001|Randomized Phase|Randomized but not treated|0|||
128929478|NCT00892437|464030575|FG000|Randomized Phase|Adverse Event|2|||
128929479|NCT00892437|464030576|FG001|Randomized Phase|Adverse Event|2|||
128929480|NCT00892437|464030575|FG000|Randomized Phase|Lost to Follow-up|1|||
128929481|NCT00892437|464030576|FG001|Randomized Phase|Lost to Follow-up|3|||
128929482|NCT00892437|464030575|FG000|Randomized Phase|Investigator's Discretion|1|||
128929483|NCT00892437|464030576|FG001|Randomized Phase|Investigator's Discretion|0|||
128929484|NCT00892437|464030575|FG000|Randomized Phase|Withdrew Consent|1|||
128929485|NCT00892437|464030576|FG001|Randomized Phase|Withdrew Consent|0|||
129030030|NCT00522041|464401557|FG000|Overall Study|Voluntary withdrawal|5|||
129030031|NCT00522041|464401558|FG001|Overall Study|Voluntary withdrawal|4|||
129030032|NCT00522041|464401557|FG000|Overall Study|Did not receive treatment|0|||
129030033|NCT00522041|464401558|FG001|Overall Study|Did not receive treatment|1|||
129030034|NCT00486434|464401559|FG000|Overall Study|Withdrawal by Subject|34|||
128929486|NCT00892437|464030575|FG000|Open-Label Extension Phase|Adverse Event|4|||
128929487|NCT00892437|464030576|FG001|Open-Label Extension Phase|Adverse Event|2|||
128929488|NCT00892437|464030575|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
128929489|NCT00892437|464030576|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
128929490|NCT00892437|464030575|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
128929491|NCT00892437|464030576|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
128929492|NCT00892437|464030575|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
128929493|NCT00892437|464030576|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
128929494|NCT00892437|464030575|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
128929495|NCT00892437|464030576|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
128929496|NCT03185130|464030578|FG000|Overall Study|Withdrawal by Subject|0|||
128929497|NCT03185130|464030579|FG001|Overall Study|Withdrawal by Subject|2|||
128929498|NCT01925703|464030580|FG000|Overall Study|Physician Decision|1|||
128929499|NCT01925703|464030580|FG000|Overall Study|Lost to Follow-up|2|||
128929500|NCT01925703|464030580|FG000|Overall Study|Discharge prior to full iron repletion|1|||
128929501|NCT03215277|464030582|FG000|Overall Study|Adverse Event|2|||
128929502|NCT03215277|464030583|FG001|Overall Study|Adverse Event|3|||
128929503|NCT03215277|464030582|FG000|Overall Study|Death|1|||
128929504|NCT03215277|464030583|FG001|Overall Study|Death|0|||
128929505|NCT03215277|464030582|FG000|Overall Study|Lost to Follow-up|0|||
128929506|NCT03215277|464030583|FG001|Overall Study|Lost to Follow-up|1|||
128929507|NCT03215277|464030582|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
128929508|NCT03215277|464030583|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
128929509|NCT03794986|464030584|FG000|Overall Study|0 Sessions Attended|34|||
128929510|NCT03794986|464030585|FG001|Overall Study|0 Sessions Attended|37|||
128929511|NCT03794986|464030584|FG000|Overall Study|Withdrawal by Subject|4|||
128929512|NCT03794986|464030585|FG001|Overall Study|Withdrawal by Subject|6|||
128929513|NCT03794986|464030584|FG000|Overall Study|Protocol Violation|1|||
128929514|NCT03794986|464030585|FG001|Overall Study|Protocol Violation|0|||
128929515|NCT01238120|464030588|FG000|Overall Study|Withdrawal by Subject|4|||
128929516|NCT01238120|464030589|FG001|Overall Study|Withdrawal by Subject|1|||
128929517|NCT01238120|464030590|FG002|Overall Study|Withdrawal by Subject|2|||
128929518|NCT01238120|464030591|FG003|Overall Study|Withdrawal by Subject|5|||
128929519|NCT01238120|464030588|FG000|Overall Study|Lost to Follow-up|2|||
128929520|NCT01238120|464030589|FG001|Overall Study|Lost to Follow-up|0|||
128929521|NCT01238120|464030590|FG002|Overall Study|Lost to Follow-up|1|||
128929522|NCT01238120|464030591|FG003|Overall Study|Lost to Follow-up|1|||
128929523|NCT01238120|464030588|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
128929524|NCT01238120|464030589|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
128929525|NCT01238120|464030590|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
128929526|NCT01238120|464030591|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
128929527|NCT02498652|464030596|FG000|Overall Study|Protocol Violation|0|||
128929528|NCT02498652|464030597|FG001|Overall Study|Protocol Violation|1|||
128929529|NCT00465569|464030599|FG000|Overall Study|persistent eczema during dose escalation|1|||
128929530|NCT00465569|464030600|FG001|Overall Study|persistent eczema during dose escalation|0|||
128929531|NCT00095303|464030601|FG000|Main Study|Lost to Follow-up|91|||
128929532|NCT00095303|464030602|FG001|Main Study|Lost to Follow-up|87|||
128929533|NCT00095303|464030601|FG000|Follow Up Study|Lost to Follow-up|59|||
128929534|NCT00095303|464030602|FG001|Follow Up Study|Lost to Follow-up|58|||
128929535|NCT01364467|464030603|FG000|Overall Study|Lost to Follow-up|1|||
128929536|NCT01364467|464030604|FG001|Overall Study|Lost to Follow-up|2|||
128929537|NCT01634243|464030605|FG000|Overall Study|Adverse Event|5|||
128929538|NCT01634243|464030606|FG001|Overall Study|Adverse Event|5|||
128929539|NCT01634243|464030605|FG000|Overall Study|Lack of Efficacy|1|||
128929540|NCT01634243|464030606|FG001|Overall Study|Lack of Efficacy|0|||
129030035|NCT00486434|464401560|FG001|Overall Study|Withdrawal by Subject|39|||
129030036|NCT00486434|464401559|FG000|Overall Study|Adverse Event|118|||
129030037|NCT00486434|464401560|FG001|Overall Study|Adverse Event|44|||
129030038|NCT00486434|464401559|FG000|Overall Study|Protocol Violation|22|||
129030039|NCT00486434|464401560|FG001|Overall Study|Protocol Violation|21|||
129030040|NCT00486434|464401559|FG000|Overall Study|Lack of Efficacy|12|||
129030041|NCT00486434|464401560|FG001|Overall Study|Lack of Efficacy|19|||
129030042|NCT00486434|464401559|FG000|Overall Study|Lost to Follow-up|2|||
129030043|NCT00486434|464401560|FG001|Overall Study|Lost to Follow-up|3|||
129030044|NCT00486434|464401559|FG000|Overall Study|Death|1|||
129030045|NCT00486434|464401560|FG001|Overall Study|Death|2|||
129030046|NCT00486434|464401559|FG000|Overall Study|Personal reasons|5|||
129030047|NCT00486434|464401560|FG001|Overall Study|Personal reasons|6|||
129030048|NCT01944722|464401568|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
129030049|NCT01944722|464401568|FG000|Overall Study|Specimen Shipping Issues|34|||
129030050|NCT01944722|464401568|FG000|Overall Study|Improper Storage/Transport|5|||
129030051|NCT01944722|464401568|FG000|Overall Study|Insufficient Volume for Test|1|||
129030052|NCT01944722|464401568|FG000|Overall Study|Missing Specimens|3|||
129030053|NCT01944722|464401568|FG000|Overall Study|Specimens Mislabeled|2|||
129030054|NCT01944722|464401568|FG000|Overall Study|Withdrawal by Subject|8|||
129030055|NCT01944722|464401568|FG000|Overall Study|NILM Subjects <30 years old|8106|||
129030056|NCT01944722|464401568|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
129030057|NCT01944722|464401568|FG000|Overall Study|>ASCUS Cytology|1122|||
129030058|NCT02906917|464401569|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
129030059|NCT02906917|464401570|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
129030060|NCT02906917|464401569|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
129030061|NCT02906917|464401570|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
129030062|NCT02906917|464401569|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
129030063|NCT02906917|464401570|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
129030064|NCT02906917|464401569|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
129030065|NCT02906917|464401570|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
129030066|NCT02906917|464401569|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
129030067|NCT02906917|464401570|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
129030068|NCT02906917|464401569|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
129030069|NCT02906917|464401570|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
129030070|NCT02906917|464401569|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
129030071|NCT02906917|464401570|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
129030072|NCT02906917|464401569|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
129030073|NCT02906917|464401570|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
129030074|NCT00210639|464401571|FG000|Overall Study|Lost to Follow-up|37|||
129030075|NCT00210639|464401572|FG001|Overall Study|Lost to Follow-up|29|||
129030076|NCT00210639|464401571|FG000|Overall Study|Withdrawal by Subject|8|||
129030077|NCT00210639|464401572|FG001|Overall Study|Withdrawal by Subject|1|||
129030078|NCT00210639|464401571|FG000|Overall Study|Other|18|||
129030079|NCT00210639|464401572|FG001|Overall Study|Other|12|||
129030080|NCT02854800|464401574|FG000|Overall Study|Protocol Violation|16|||
129030081|NCT02854800|464401575|FG001|Overall Study|Protocol Violation|11|||
129030082|NCT02854800|464401576|FG002|Overall Study|Protocol Violation|3|||
129030083|NCT02854800|464401574|FG000|Overall Study|Withdrawal by Subject|4|||
129030084|NCT02854800|464401575|FG001|Overall Study|Withdrawal by Subject|2|||
129030085|NCT02854800|464401576|FG002|Overall Study|Withdrawal by Subject|3|||
129030086|NCT02627963|464401582|FG000|Overall Study|Randomized but not treated|2|||
129030087|NCT02627963|464401583|FG001|Overall Study|Randomized but not treated|6|||
129030088|NCT05278858|464401584|FG000|Overall Study|Withdrawal by Subject|1|||
129030089|NCT00503867|464401588|FG000|Overall Study|Lost to Follow-up|1|||
129030090|NCT00503867|464401588|FG000|Overall Study|Adverse Event|1|||
129030091|NCT00323258|464401591|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
129030092|NCT00323258|464401592|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
129119332|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
129119333|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
129119334|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
129119335|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
129119336|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
129119337|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
129119338|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
129119339|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129119340|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129119341|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
129119342|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
129119343|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
129119344|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
129119345|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
129119346|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
129119347|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
129119348|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
129119349|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129119350|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129119351|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
129119352|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129119353|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129119354|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
129119355|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
129119356|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
129119357|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
129030093|NCT00323258|464401591|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
129030094|NCT00323258|464401592|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
129030095|NCT00323258|464401591|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
129119358|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
129030096|NCT00323258|464401592|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
129030097|NCT00323258|464401591|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
129030098|NCT00323258|464401592|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
129030099|NCT00323258|464401591|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
129030100|NCT00323258|464401592|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
128701630|NCT03310021|463205680|FG005|Overall Study|Lost to Follow-up|0|||
128701631|NCT03310021|463205681|FG006|Overall Study|Lost to Follow-up|0|||
128701632|NCT03310021|463205682|FG007|Overall Study|Lost to Follow-up|0|||
128701633|NCT03310021|463205683|FG008|Overall Study|Lost to Follow-up|0|||
128701634|NCT03310021|463205684|FG009|Overall Study|Lost to Follow-up|0|||
128701635|NCT03310021|463205685|FG010|Overall Study|Lost to Follow-up|1|||
128701636|NCT03310021|463205686|FG011|Overall Study|Lost to Follow-up|0|||
128701637|NCT03310021|463205687|FG012|Overall Study|Lost to Follow-up|0|||
128701638|NCT03310021|463205688|FG013|Overall Study|Lost to Follow-up|0|||
128701639|NCT03310021|463205689|FG014|Overall Study|Lost to Follow-up|0|||
128701640|NCT03310021|463205690|FG015|Overall Study|Lost to Follow-up|0|||
128701641|NCT03310021|463205691|FG016|Overall Study|Lost to Follow-up|0|||
128701642|NCT03310021|463205692|FG017|Overall Study|Lost to Follow-up|0|||
128701643|NCT03310021|463205693|FG018|Overall Study|Lost to Follow-up|0|||
128701644|NCT03310021|463205694|FG019|Overall Study|Lost to Follow-up|0|||
128701645|NCT00622284|463205695|FG000|Overall Study|Lack of Efficacy|45|||
128701646|NCT00622284|463205696|FG001|Overall Study|Lack of Efficacy|15|||
128701647|NCT00622284|463205695|FG000|Overall Study|Adverse Event|61|||
128701648|NCT00622284|463205696|FG001|Overall Study|Adverse Event|90|||
128701649|NCT00622284|463205695|FG000|Overall Study|Protocol Violation|12|||
128701650|NCT00622284|463205696|FG001|Overall Study|Protocol Violation|5|||
128701651|NCT00622284|463205695|FG000|Overall Study|Lost to Follow-up|11|||
128701652|NCT00622284|463205696|FG001|Overall Study|Lost to Follow-up|13|||
128701653|NCT00622284|463205695|FG000|Overall Study|Withdrawal by Subject|27|||
128701654|NCT00622284|463205696|FG001|Overall Study|Withdrawal by Subject|24|||
128701655|NCT00622284|463205695|FG000|Overall Study|Other reason (not specified)|33|||
128701656|NCT00622284|463205696|FG001|Overall Study|Other reason (not specified)|24|||
128701657|NCT00880009|463205697|FG000|Overall Study|Study terminated by sponsor|14|||
128701658|NCT00880009|463205697|FG000|Overall Study|Withdrawal by Subject|1|||
128701659|NCT00880009|463205697|FG000|Overall Study|Protocol Violation|1|||
128701660|NCT02412618|463205700|FG000|Overall Study|Withdrawal by Subject|1|||
128701661|NCT02412618|463205701|FG001|Overall Study|Withdrawal by Subject|1|||
128701662|NCT02412618|463205700|FG000|Overall Study|Expulsion|1|||
128701663|NCT02412618|463205701|FG001|Overall Study|Expulsion|1|||
128701664|NCT01253408|463205703|FG000|Overall Study|Adverse Event|0|||
128701665|NCT01253408|463205704|FG001|Overall Study|Adverse Event|1|||
128701666|NCT01253408|463205705|FG002|Overall Study|Adverse Event|0|||
128701667|NCT03035409|463205709|FG000|Overall Study|Adverse Event|5|||
128701668|NCT03035409|463205709|FG000|Overall Study|Death|2|||
128701669|NCT03035409|463205709|FG000|Overall Study|Withdrawal by Subject|2|||
128701670|NCT03035409|463205709|FG000|Overall Study|Non compliance|4|||
128701671|NCT03035409|463205709|FG000|Overall Study|Patient was jittery|1|||
128701672|NCT03035409|463205709|FG000|Overall Study|Did not like Questionnaire|1|||
128701673|NCT03035409|463205709|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
128701674|NCT03035409|463205709|FG000|Overall Study|Did not like taking drugs|1|||
128701675|NCT01552694|463205712|FG000|Overall Study|Lost to Follow-up|0|||
128701676|NCT01552694|463205713|FG001|Overall Study|Lost to Follow-up|1|||
128929541|NCT00519623|464030617|FG000|Overall Study|Adverse Event|1|||
128929542|NCT02296840|464030620|FG000|Overall Study|Adverse Event|1|||
128929543|NCT02296840|464030621|FG001|Overall Study|Adverse Event|1|||
128929544|NCT02296840|464030620|FG000|Overall Study|Protocol Violation|2|||
128929545|NCT02296840|464030621|FG001|Overall Study|Protocol Violation|1|||
128929546|NCT02296840|464030620|FG000|Overall Study|Lost to Follow-up|6|||
128929547|NCT02296840|464030621|FG001|Overall Study|Lost to Follow-up|17|||
128929548|NCT00104871|464030624|FG000|Overall Study|Not evaluable|1|||
128701677|NCT01552694|463205712|FG000|Overall Study|Protocol Violation|0|||
128701678|NCT01552694|463205713|FG001|Overall Study|Protocol Violation|1|||
128701679|NCT03724032|463205714|FG000|Overall Study|Physician Decision|1|||
128701680|NCT03724032|463205715|FG001|Overall Study|Physician Decision|0|||
128701681|NCT03724032|463205716|FG002|Overall Study|Physician Decision|0|||
128701682|NCT03724032|463205714|FG000|Overall Study|Protocol Violation|2|||
128701683|NCT03724032|463205715|FG001|Overall Study|Protocol Violation|2|||
128701684|NCT03724032|463205716|FG002|Overall Study|Protocol Violation|1|||
128701685|NCT02657369|463205720|FG000|Overall Study|Death|27|||
128701686|NCT02657369|463205720|FG000|Overall Study|Study terminated by sponsor|7|||
128701687|NCT00361569|463205721|FG000|Overall Study|Protocol Violation|3|||
128701688|NCT00361569|463205722|FG001|Overall Study|Protocol Violation|2|||
128701689|NCT00361569|463205723|FG002|Overall Study|Protocol Violation|4|||
128701690|NCT00361569|463205724|FG003|Overall Study|Protocol Violation|2|||
128701691|NCT00361569|463205721|FG000|Overall Study|Withdrawal by Subject|2|||
128701692|NCT00361569|463205722|FG001|Overall Study|Withdrawal by Subject|1|||
128701693|NCT00361569|463205723|FG002|Overall Study|Withdrawal by Subject|9|||
128701694|NCT00361569|463205724|FG003|Overall Study|Withdrawal by Subject|14|||
128701695|NCT00361569|463205721|FG000|Overall Study|Adverse Event|3|||
128701696|NCT00361569|463205722|FG001|Overall Study|Adverse Event|5|||
128701697|NCT00361569|463205723|FG002|Overall Study|Adverse Event|2|||
128701698|NCT00361569|463205724|FG003|Overall Study|Adverse Event|2|||
128701699|NCT00361569|463205721|FG000|Overall Study|Lost to Follow-up|2|||
128701700|NCT00361569|463205722|FG001|Overall Study|Lost to Follow-up|3|||
128929549|NCT00761215|464030625|FG000|Overall Study|Randomized but didn't receive drug|1|||
128701701|NCT00361569|463205723|FG002|Overall Study|Lost to Follow-up|3|||
129119359|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
129119360|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
129119361|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
129119362|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
129119363|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
129119364|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129119365|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129119366|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129119367|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129119368|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
129119369|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
129119370|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
129119371|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
129119372|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
129119373|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
129119374|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129119375|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129119376|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129119377|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129119378|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
129119379|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129119380|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129119381|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
129119382|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129119383|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129119384|NCT02717195|464733223|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
129119385|NCT02717195|464733224|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
129119386|NCT02717195|464733225|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
129119387|NCT02717195|464733226|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
129119388|NCT02717195|464733227|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
129119389|NCT03087058|464733228|FG000|Overall Study|Withdrawal by Subject|2|||
129119390|NCT03087058|464733229|FG001|Overall Study|Withdrawal by Subject|0|||
129119391|NCT03087058|464733230|FG002|Overall Study|Withdrawal by Subject|0|||
129119392|NCT02577029|464733231|FG000|Overall Study|Adverse Event|1|||
129119393|NCT02577029|464733232|FG001|Overall Study|Adverse Event|0|||
129119394|NCT02577029|464733233|FG002|Overall Study|Adverse Event|2|||
129119395|NCT02577029|464733234|FG003|Overall Study|Adverse Event|0|||
129119396|NCT02577029|464733235|FG004|Overall Study|Adverse Event|1|||
129119397|NCT02577029|464733236|FG005|Overall Study|Adverse Event|0|||
129119398|NCT02577029|464733237|FG006|Overall Study|Adverse Event|0|||
129119399|NCT02577029|464733238|FG007|Overall Study|Adverse Event|0|||
129119400|NCT02577029|464733231|FG000|Overall Study|Withdrawal by Subject|0|||
129119401|NCT02577029|464733232|FG001|Overall Study|Withdrawal by Subject|0|||
129119402|NCT02577029|464733233|FG002|Overall Study|Withdrawal by Subject|0|||
129119403|NCT02577029|464733234|FG003|Overall Study|Withdrawal by Subject|0|||
129119404|NCT02577029|464733235|FG004|Overall Study|Withdrawal by Subject|0|||
129119405|NCT02577029|464733236|FG005|Overall Study|Withdrawal by Subject|1|||
129119406|NCT02577029|464733237|FG006|Overall Study|Withdrawal by Subject|0|||
129119407|NCT02577029|464733238|FG007|Overall Study|Withdrawal by Subject|0|||
129119408|NCT02577029|464733231|FG000|Overall Study|Sponsor Termination of the Study|9|||
129119409|NCT02577029|464733232|FG001|Overall Study|Sponsor Termination of the Study|2|||
129119410|NCT02577029|464733233|FG002|Overall Study|Sponsor Termination of the Study|5|||
128929550|NCT00761215|464030626|FG001|Overall Study|Randomized but didn't receive drug|1|||
128929551|NCT00761215|464030627|FG002|Overall Study|Randomized but didn't receive drug|2|||
128929552|NCT00761215|464030625|FG000|Overall Study|Lost to Follow-up|6|||
128929553|NCT00761215|464030626|FG001|Overall Study|Lost to Follow-up|3|||
128929554|NCT00761215|464030627|FG002|Overall Study|Lost to Follow-up|6|||
128929555|NCT00761215|464030625|FG000|Overall Study|Withdrawal by Subject|1|||
128929556|NCT00761215|464030626|FG001|Overall Study|Withdrawal by Subject|0|||
128929557|NCT00761215|464030627|FG002|Overall Study|Withdrawal by Subject|0|||
129119411|NCT02577029|464733234|FG003|Overall Study|Sponsor Termination of the Study|12|||
128929558|NCT00761215|464030625|FG000|Overall Study|Bacteremia|1|||
128929559|NCT00761215|464030626|FG001|Overall Study|Bacteremia|0|||
128929560|NCT00761215|464030627|FG002|Overall Study|Bacteremia|0|||
128929561|NCT01687673|464030634|FG000|Overall Study|Physician Decision|1|||
128929562|NCT02234622|464030635|FG000|Overall Study|Withdrawal by Subject|16|||
129119412|NCT02577029|464733235|FG004|Overall Study|Sponsor Termination of the Study|10|||
129119413|NCT02577029|464733236|FG005|Overall Study|Sponsor Termination of the Study|12|||
128701702|NCT00361569|463205724|FG003|Overall Study|Lost to Follow-up|2|||
128701703|NCT00361569|463205721|FG000|Overall Study|Not specified by investigator|2|||
128701704|NCT00361569|463205722|FG001|Overall Study|Not specified by investigator|0|||
128929563|NCT02234622|464030636|FG001|Overall Study|Withdrawal by Subject|22|||
128929564|NCT02234622|464030635|FG000|Overall Study|Lost to Follow-up|27|||
128929565|NCT02234622|464030636|FG001|Overall Study|Lost to Follow-up|14|||
128929566|NCT00618956|464030637|FG000|Overall Study|Adverse Event|10|||
128929567|NCT00618956|464030638|FG001|Overall Study|Adverse Event|34|||
128929568|NCT00618956|464030637|FG000|Overall Study|Lack of Efficacy|2|||
128929569|NCT00618956|464030638|FG001|Overall Study|Lack of Efficacy|1|||
128929570|NCT00618956|464030637|FG000|Overall Study|Withdrawal by Subject|5|||
128929571|NCT00618956|464030638|FG001|Overall Study|Withdrawal by Subject|7|||
128929572|NCT00618956|464030637|FG000|Overall Study|Lost to Follow-up|4|||
128929573|NCT00618956|464030638|FG001|Overall Study|Lost to Follow-up|5|||
128929574|NCT00618956|464030637|FG000|Overall Study|Protocol Violation|2|||
128929575|NCT00618956|464030638|FG001|Overall Study|Protocol Violation|2|||
128929576|NCT00618956|464030637|FG000|Overall Study|did not meet criteria, non-compliance|2|||
128929577|NCT00618956|464030638|FG001|Overall Study|did not meet criteria, non-compliance|1|||
128929578|NCT02006576|464030639|FG000|Overall Study|Withdrawal by Subject|4|||
128929579|NCT02006576|464030640|FG001|Overall Study|Withdrawal by Subject|6|||
128929580|NCT02006576|464030641|FG002|Overall Study|Withdrawal by Subject|2|||
128929581|NCT02006576|464030639|FG000|Overall Study|Death|0|||
128929582|NCT02006576|464030640|FG001|Overall Study|Death|0|||
128929583|NCT02006576|464030641|FG002|Overall Study|Death|1|||
128929584|NCT02006576|464030639|FG000|Overall Study|Lost to Follow-up|1|||
128929585|NCT02006576|464030640|FG001|Overall Study|Lost to Follow-up|0|||
128929586|NCT02006576|464030641|FG002|Overall Study|Lost to Follow-up|1|||
128701705|NCT00361569|463205723|FG002|Overall Study|Not specified by investigator|0|||
128701706|NCT00361569|463205724|FG003|Overall Study|Not specified by investigator|1|||
128701707|NCT02639065|463205725|FG000|Study Treatment|Disease Progression|13|||
128929587|NCT02006576|464030639|FG000|Overall Study|Screen Failure, too sick, other|13|||
128929588|NCT02006576|464030640|FG001|Overall Study|Screen Failure, too sick, other|1|||
128929589|NCT02006576|464030641|FG002|Overall Study|Screen Failure, too sick, other|13|||
128929590|NCT03478683|464030642|FG000|Overall Study|Adverse Event|5|||
128929591|NCT03478683|464030643|FG001|Overall Study|Adverse Event|3|||
128701708|NCT02639065|463205725|FG000|Study Treatment|Adverse Event|9|||
128929592|NCT03478683|464030642|FG000|Overall Study|Lost to Follow-up|0|||
128929593|NCT03478683|464030643|FG001|Overall Study|Lost to Follow-up|5|||
128929594|NCT03478683|464030642|FG000|Overall Study|Physician Decision|1|||
128929595|NCT03478683|464030643|FG001|Overall Study|Physician Decision|3|||
128929596|NCT03478683|464030642|FG000|Overall Study|Withdrawal by Subject|7|||
128929597|NCT03478683|464030643|FG001|Overall Study|Withdrawal by Subject|7|||
128929598|NCT04090164|464030646|FG000|Overall Study|incomplete data on file|245|||
128929599|NCT04090164|464030647|FG001|Overall Study|incomplete data on file|0|||
128929600|NCT01650805|464030648|FG000|Overall Study|Withdrawal by Subject|1|||
128929601|NCT01650805|464030649|FG001|Overall Study|Withdrawal by Subject|0|||
128929602|NCT02452359|464030650|FG000|Overall Study|Adverse Event|1|||
128929603|NCT02452359|464030650|FG000|Overall Study|Lost to Follow-up|15|||
128929604|NCT02452359|464030650|FG000|Overall Study|Pregnancy|1|||
128929605|NCT02452359|464030650|FG000|Overall Study|Withdrawal by Subject|4|||
128929606|NCT01887210|464030651|FG000|Overall Study|Withdrawal by Subject|1|||
128929607|NCT01887210|464030652|FG001|Overall Study|Withdrawal by Subject|3|||
128929608|NCT01887210|464030651|FG000|Overall Study|Lost to Follow-up|0|||
128929609|NCT01887210|464030652|FG001|Overall Study|Lost to Follow-up|1|||
128929610|NCT03497689|464030661|FG000|Overall Study|Adverse Event|2|||
128929611|NCT03497689|464030661|FG000|Overall Study|Death|1|||
128929612|NCT03497689|464030661|FG000|Overall Study|Physician Decision|1|||
128929613|NCT03497689|464030661|FG000|Overall Study|Withdrawal by Subject|1|||
128929614|NCT03497689|464030661|FG000|Overall Study|Protocol Violation|2|||
128929615|NCT03191786|464030662|FG000|Overall Study|Death|236|||
128929616|NCT03191786|464030663|FG001|Overall Study|Death|127|||
128929617|NCT03191786|464030662|FG000|Overall Study|Lost to Follow-up|9|||
128929618|NCT03191786|464030663|FG001|Overall Study|Lost to Follow-up|3|||
128929619|NCT03191786|464030662|FG000|Overall Study|Physician Decision|1|||
128929620|NCT03191786|464030663|FG001|Overall Study|Physician Decision|0|||
128929621|NCT03191786|464030662|FG000|Overall Study|Moved to Post Trial Access Program|30|||
128929622|NCT03191786|464030663|FG001|Overall Study|Moved to Post Trial Access Program|5|||
128929623|NCT03191786|464030662|FG000|Overall Study|Withdrawal by Subject|26|||
128929624|NCT03191786|464030663|FG001|Overall Study|Withdrawal by Subject|16|||
128978050|NCT02743494|464205306|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
128767310|NCT01709305|463438204|FG002|Phase 2|Clinical Adverse Event|10|||
128978051|NCT02743494|464205305|FG000|Treatment Period|Completed treatment|229|||
128978052|NCT02743494|464205306|FG001|Treatment Period|Completed treatment|99|||
128978053|NCT02743494|464205305|FG000|Treatment Period|Disease recurrence|149|||
128978054|NCT02743494|464205306|FG001|Treatment Period|Disease recurrence|113|||
128978055|NCT02743494|464205305|FG000|Treatment Period|Study drug toxicity|57|||
128978056|NCT02743494|464205306|FG001|Treatment Period|Study drug toxicity|8|||
128978057|NCT02743494|464205305|FG000|Treatment Period|Death|1|||
128701709|NCT02639065|463205725|FG000|Study Treatment|Withdrawal by Subject|1|||
128701710|NCT02639065|463205725|FG000|Follow up|Subject refused to follow up|1|||
128929625|NCT05635838|464032772|FG000|16-Week DBVC Period|Adverse Event|2|||
129119414|NCT02577029|464733237|FG006|Overall Study|Sponsor Termination of the Study|12|||
129119415|NCT02577029|464733238|FG007|Overall Study|Sponsor Termination of the Study|12|||
129119416|NCT02078817|464733239|FG000|Overall Study|Withdrawal by Subject|1|||
129119417|NCT01420536|464733240|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
129119418|NCT01420536|464733241|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
129119419|NCT01265498|464733246|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
129119420|NCT01265498|464733247|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
129119421|NCT01652690|464733249|FG000|Overall Study|Withdrawal by Subject|16|||
129119422|NCT01652690|464733250|FG001|Overall Study|Withdrawal by Subject|4|||
129119423|NCT01652690|464733249|FG000|Overall Study|Other|8|||
129119424|NCT01652690|464733250|FG001|Overall Study|Other|9|||
129119425|NCT01652690|464733249|FG000|Overall Study|Lost to Follow-up|6|||
129119426|NCT01652690|464733250|FG001|Overall Study|Lost to Follow-up|6|||
129119427|NCT01652690|464733249|FG000|Overall Study|Death|5|||
129119428|NCT01652690|464733250|FG001|Overall Study|Death|2|||
129119429|NCT00617279|464733253|FG000|Overall Study|Study terminated by Sponsor|10|||
129119430|NCT00617279|464733254|FG001|Overall Study|Study terminated by Sponsor|15|||
129119431|NCT00617279|464733253|FG000|Overall Study|Graft abandonment|2|||
129119432|NCT00617279|464733254|FG001|Overall Study|Graft abandonment|0|||
129119433|NCT00617279|464733253|FG000|Overall Study|Lost to Follow-up|1|||
129119434|NCT00617279|464733254|FG001|Overall Study|Lost to Follow-up|0|||
129119435|NCT00617279|464733253|FG000|Overall Study|Death|1|||
129119436|NCT00617279|464733254|FG001|Overall Study|Death|2|||
129119437|NCT00921024|464733257|FG000|Overall Study|Lost to Follow-up|2|||
129119438|NCT00921024|464733258|FG001|Overall Study|Lost to Follow-up|0|||
129119439|NCT00921024|464733257|FG000|Overall Study|Received concomittant therapy|2|||
129119440|NCT00921024|464733258|FG001|Overall Study|Received concomittant therapy|0|||
129119441|NCT00921024|464733257|FG000|Overall Study|Withdrawal by Subject|0|||
129119442|NCT00921024|464733258|FG001|Overall Study|Withdrawal by Subject|3|||
129119443|NCT03225287|464733259|FG000|Overall Study|Adverse Event|0|||
129119444|NCT03225287|464733260|FG001|Overall Study|Adverse Event|0|||
129119445|NCT03225287|464733261|FG002|Overall Study|Adverse Event|1|||
129119446|NCT03225287|464733259|FG000|Overall Study|Protocol non-compliance|0|||
129119447|NCT03225287|464733260|FG001|Overall Study|Protocol non-compliance|0|||
129119448|NCT03225287|464733261|FG002|Overall Study|Protocol non-compliance|1|||
129119449|NCT03225287|464733259|FG000|Overall Study|Subject withdraws consent|3|||
129119450|NCT03225287|464733260|FG001|Overall Study|Subject withdraws consent|0|||
129119451|NCT03225287|464733261|FG002|Overall Study|Subject withdraws consent|0|||
129119452|NCT03225287|464733259|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
129119453|NCT03225287|464733260|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
129119454|NCT03225287|464733261|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
129119455|NCT03225287|464733259|FG000|Overall Study|Trial drug not effective|0|||
129119456|NCT03225287|464733260|FG001|Overall Study|Trial drug not effective|1|||
129119457|NCT03225287|464733261|FG002|Overall Study|Trial drug not effective|0|||
129119458|NCT03225287|464733259|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
129119459|NCT03225287|464733260|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
129119460|NCT03225287|464733261|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
129119461|NCT03225287|464733259|FG000|Overall Study|Stem cell transplantation|0|||
129119462|NCT03225287|464733260|FG001|Overall Study|Stem cell transplantation|1|||
128929626|NCT05635838|464032773|FG001|16-Week DBVC Period|Adverse Event|0|||
128929627|NCT05635838|464032774|FG002|16-Week DBVC Period|Adverse Event|0|||
128929628|NCT05635838|464032775|FG003|16-Week DBVC Period|Adverse Event|0|||
128929629|NCT05635838|464032772|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
128929630|NCT05635838|464032773|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
128929631|NCT05635838|464032774|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
128929632|NCT05635838|464032775|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
128929633|NCT05635838|464032772|FG000|16-Week DBVC Period|Physician Decision|0|||
128929634|NCT05635838|464032773|FG001|16-Week DBVC Period|Physician Decision|1|||
128929635|NCT05635838|464032774|FG002|16-Week DBVC Period|Physician Decision|0|||
128929636|NCT05635838|464032775|FG003|16-Week DBVC Period|Physician Decision|0|||
128929637|NCT05635838|464032772|FG000|16-Week DBVC Period|Protocol Violation|1|||
128929638|NCT05635838|464032773|FG001|16-Week DBVC Period|Protocol Violation|0|||
128929639|NCT05635838|464032774|FG002|16-Week DBVC Period|Protocol Violation|0|||
129119463|NCT03225287|464733261|FG002|Overall Study|Stem cell transplantation|0|||
128701711|NCT02639065|463205725|FG000|Follow up|Symptomatic Deterioration|2|||
128929640|NCT05635838|464032775|FG003|16-Week DBVC Period|Protocol Violation|0|||
128929641|NCT05635838|464032772|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
128929642|NCT05635838|464032773|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
129119464|NCT04030598|464733263|FG000|Overall Study|Voluntary Withdrawal|0|||
129119465|NCT04030598|464733264|FG001|Overall Study|Voluntary Withdrawal|1|||
129119466|NCT04030598|464733265|FG002|Overall Study|Voluntary Withdrawal|0|||
129119467|NCT02426684|464734965|FG000|Overall Study|Physician Decision|1|||
129119468|NCT04459338|464734966|FG000|Overall Study|Loss of IV during study|1|||
129030101|NCT00323258|464401591|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
129030102|NCT00323258|464401592|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
129030103|NCT00323258|464401591|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
129030104|NCT00323258|464401592|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
129030105|NCT02372006|464401602|FG000|Overall Study|Progressive disease|8|||
129030106|NCT02372006|464401603|FG001|Overall Study|Progressive disease|7|||
129030107|NCT02372006|464401604|FG002|Overall Study|Progressive disease|34|||
129030108|NCT02372006|464401602|FG000|Overall Study|Dose limiting toxicity|0|||
129030109|NCT02372006|464401603|FG001|Overall Study|Dose limiting toxicity|1|||
129030110|NCT02372006|464401604|FG002|Overall Study|Dose limiting toxicity|0|||
129030111|NCT02372006|464401602|FG000|Overall Study|Adverse Event|0|||
129030112|NCT02372006|464401603|FG001|Overall Study|Adverse Event|0|||
129030113|NCT02372006|464401604|FG002|Overall Study|Adverse Event|3|||
129030114|NCT02372006|464401602|FG000|Overall Study|Withdrawal by Subject|0|||
129030115|NCT02372006|464401603|FG001|Overall Study|Withdrawal by Subject|1|||
129030116|NCT02372006|464401604|FG002|Overall Study|Withdrawal by Subject|1|||
129030117|NCT02372006|464401602|FG000|Overall Study|Other reason for not completing|0|||
129030118|NCT02372006|464401603|FG001|Overall Study|Other reason for not completing|0|||
129030119|NCT02372006|464401604|FG002|Overall Study|Other reason for not completing|1|||
129030120|NCT01859598|464401609|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
129030121|NCT03255980|464401614|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
129030122|NCT03255980|464401615|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
129030123|NCT03255980|464401616|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
129030124|NCT03255980|464401617|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
129030125|NCT03255980|464401614|FG000|Overall Study|Adverse Event|1|||
129030126|NCT03255980|464401615|FG001|Overall Study|Adverse Event|1|||
129030127|NCT03255980|464401616|FG002|Overall Study|Adverse Event|0|||
129030128|NCT03255980|464401617|FG003|Overall Study|Adverse Event|1|||
129030129|NCT03255980|464401614|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
129030130|NCT03255980|464401615|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
129030131|NCT03255980|464401616|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
129030132|NCT03255980|464401617|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
129030133|NCT03255980|464401614|FG000|Overall Study|Lost to Follow-up|1|||
129030134|NCT03255980|464401615|FG001|Overall Study|Lost to Follow-up|1|||
129030135|NCT03255980|464401616|FG002|Overall Study|Lost to Follow-up|0|||
129030136|NCT03255980|464401617|FG003|Overall Study|Lost to Follow-up|3|||
129030137|NCT03255980|464401614|FG000|Overall Study|Withdrawal by Subject|0|||
129030138|NCT03255980|464401615|FG001|Overall Study|Withdrawal by Subject|1|||
129030139|NCT03255980|464401616|FG002|Overall Study|Withdrawal by Subject|0|||
129030140|NCT03255980|464401617|FG003|Overall Study|Withdrawal by Subject|3|||
129030141|NCT02611362|464401618|FG000|Overall Study|Withdrawal by Subject|7|||
129030142|NCT02611362|464401619|FG001|Overall Study|Withdrawal by Subject|2|||
129030143|NCT02611362|464401618|FG000|Overall Study|Lost to Follow-up|2|||
129030144|NCT02611362|464401619|FG001|Overall Study|Lost to Follow-up|4|||
129119469|NCT04459338|464734967|FG001|Overall Study|Loss of IV during study|0|||
129119470|NCT01454284|464734968|FG000|Overall Study|Adverse Event|20|||
129119471|NCT01454284|464734969|FG001|Overall Study|Adverse Event|7|||
129119472|NCT01454284|464734968|FG000|Overall Study|Death|0|||
129119473|NCT01454284|464734969|FG001|Overall Study|Death|3|||
129119474|NCT01454284|464734968|FG000|Overall Study|Lost to Follow-up|13|||
129119475|NCT01454284|464734969|FG001|Overall Study|Lost to Follow-up|8|||
129119476|NCT01454284|464734968|FG000|Overall Study|Protocol Violation|9|||
129119477|NCT01454284|464734969|FG001|Overall Study|Protocol Violation|6|||
129119478|NCT01454284|464734968|FG000|Overall Study|Withdrawal by Subject|58|||
129119479|NCT01454284|464734969|FG001|Overall Study|Withdrawal by Subject|36|||
129119480|NCT01454284|464734968|FG000|Overall Study|Physician Decision|16|||
129119481|NCT01454284|464734969|FG001|Overall Study|Physician Decision|11|||
129119482|NCT01454284|464734968|FG000|Overall Study|Sponsor Decision|0|||
128701712|NCT02639065|463205725|FG000|Follow up|Death|2|||
128701713|NCT02639065|463205725|FG000|Follow up|Study Terminated|1|||
128701714|NCT02639065|463205725|FG000|Follow up|Disease Progression|3|||
129119483|NCT01454284|464734969|FG001|Overall Study|Sponsor Decision|2|||
129119484|NCT02665117|464734970|FG000|Overall Study|Physician Decision|1|||
129119485|NCT02665117|464734971|FG001|Overall Study|Physician Decision|0|||
129119486|NCT03248037|464734976|FG000|Overall Study|Withdrawal by Subject|6|||
129119487|NCT03248037|464734977|FG001|Overall Study|Withdrawal by Subject|9|||
128701715|NCT00481078|463205726|FG000|Overall Study|Progression of disease|11|||
129030145|NCT01155531|464401620|FG000|Overall Study|Adverse Event|0|||
129030146|NCT01155531|464401621|FG001|Overall Study|Adverse Event|0|||
129030147|NCT01155531|464401622|FG002|Overall Study|Adverse Event|1|||
129030148|NCT01155531|464401623|FG003|Overall Study|Adverse Event|0|||
129030149|NCT01155531|464401620|FG000|Overall Study|Lost to Follow-up|0|||
129030150|NCT01155531|464401621|FG001|Overall Study|Lost to Follow-up|0|||
129030151|NCT01155531|464401622|FG002|Overall Study|Lost to Follow-up|0|||
129119488|NCT03248037|464734976|FG000|Overall Study|Adverse Event|15|||
129119489|NCT03248037|464734977|FG001|Overall Study|Adverse Event|0|||
129119490|NCT02897349|464734979|FG000|Overall Study|Lost to Follow-up|2|||
128767311|NCT01709305|463438205|FG003|Phase 2|Clinical Adverse Event|6|||
128929643|NCT05635838|464032774|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
128929644|NCT05635838|464032775|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
128929645|NCT05635838|464032772|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
128929646|NCT05635838|464032773|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
128929647|NCT05635838|464032774|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
128929648|NCT05635838|464032775|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
128929649|NCT05635838|464032772|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
128929650|NCT05635838|464032773|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
129119491|NCT02897349|464734980|FG001|Overall Study|Lost to Follow-up|2|||
129119492|NCT02897349|464734979|FG000|Overall Study|Adverse Event|3|||
129119493|NCT02897349|464734980|FG001|Overall Study|Adverse Event|3|||
129119494|NCT02897349|464734979|FG000|Overall Study|Other than listed above|0|||
129119495|NCT02897349|464734980|FG001|Overall Study|Other than listed above|1|||
129119496|NCT00671749|464734989|FG000|Overall Study|Adverse Event|2|||
129119497|NCT00671749|464734989|FG000|Overall Study|Withdrawal by Subject|4|||
129119498|NCT00671749|464734989|FG000|Overall Study|Protocol Violation|1|||
129119499|NCT00671749|464734989|FG000|Overall Study|Lost to Follow-up|1|||
129119500|NCT02515227|464734990|FG000|Overall Study|Adverse Event|0|||
129119501|NCT02515227|464734991|FG001|Overall Study|Adverse Event|2|||
129119502|NCT02515227|464734990|FG000|Overall Study|Progressive disease|2|||
129119503|NCT02515227|464734991|FG001|Overall Study|Progressive disease|9|||
129119504|NCT01259245|464734992|FG000|Overall Study|Withdrawal by Subject|27|||
129119505|NCT01259245|464734993|FG001|Overall Study|Withdrawal by Subject|24|||
129119506|NCT01259245|464734992|FG000|Overall Study|Death|1|||
129119507|NCT01259245|464734993|FG001|Overall Study|Death|2|||
129119508|NCT03451071|464734994|FG000|First Vaccine|Withdrawal by Subject|1|||
129119509|NCT03451071|464734994|FG000|Second Vaccine|Lost to Follow-up|19|||
129119510|NCT03451071|464734994|FG000|Third Vaccine|Lost to Follow-up|22|||
129119511|NCT03451071|464734994|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
129119512|NCT02065557|464734995|FG000|Induction Period|Withdrawal by Subject|2|||
129119513|NCT02065557|464734996|FG001|Induction Period|Withdrawal by Subject|1|||
129119514|NCT02065557|464734997|FG002|Induction Period|Withdrawal by Subject|0|||
129119515|NCT02065557|464734998|FG003|Induction Period|Withdrawal by Subject|0|||
129119516|NCT02065557|464734999|FG004|Induction Period|Withdrawal by Subject|0|||
129119517|NCT02065557|464735000|FG005|Induction Period|Withdrawal by Subject|0|||
129119518|NCT02065557|464734995|FG000|Induction Period|Lack of Efficacy|2|||
129119519|NCT02065557|464734996|FG001|Induction Period|Lack of Efficacy|1|||
129119520|NCT02065557|464734997|FG002|Induction Period|Lack of Efficacy|1|||
129119521|NCT02065557|464734998|FG003|Induction Period|Lack of Efficacy|0|||
129119522|NCT02065557|464734999|FG004|Induction Period|Lack of Efficacy|0|||
129119523|NCT02065557|464735000|FG005|Induction Period|Lack of Efficacy|0|||
129119524|NCT02065557|464734995|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
129119525|NCT02065557|464734996|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
129119526|NCT02065557|464734997|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
129119527|NCT02065557|464734998|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
129119528|NCT02065557|464734999|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
129119529|NCT02065557|464735000|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
129119530|NCT02065557|464734995|FG000|Induction Period|Non-Responder at Week 8|4|||
129119531|NCT02065557|464734996|FG001|Induction Period|Non-Responder at Week 8|4|||
129119532|NCT02065557|464734997|FG002|Induction Period|Non-Responder at Week 8|0|||
129119533|NCT02065557|464734998|FG003|Induction Period|Non-Responder at Week 8|0|||
129119534|NCT02065557|464734999|FG004|Induction Period|Non-Responder at Week 8|0|||
129119535|NCT02065557|464735000|FG005|Induction Period|Non-Responder at Week 8|0|||
129119536|NCT02065557|464734995|FG000|Induction Period|Adverse Event|1|||
129119537|NCT02065557|464734996|FG001|Induction Period|Adverse Event|1|||
129119538|NCT02065557|464734997|FG002|Induction Period|Adverse Event|0|||
129119539|NCT02065557|464734998|FG003|Induction Period|Adverse Event|0|||
129119540|NCT02065557|464734999|FG004|Induction Period|Adverse Event|0|||
129119541|NCT02065557|464735000|FG005|Induction Period|Adverse Event|0|||
129119542|NCT02065557|464734995|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
129119543|NCT02065557|464734996|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
128767312|NCT01709305|463438206|FG004|Phase 2|Clinical Adverse Event|11|||
129119544|NCT02065557|464734997|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
129119545|NCT02065557|464734998|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
129119546|NCT02065557|464734999|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
129119547|NCT02065557|464735000|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
128767313|NCT01709305|463438202|FG000|Phase 2|Death|0|||
128929651|NCT05635838|464032774|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
128929652|NCT05635838|464032775|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
128929653|NCT05635838|464032772|FG000|16-Week OLE Period|Adverse Event|0|||
129119548|NCT02065557|464734995|FG000|Maintenance Period|Withdrawal by Subject|0|||
129119549|NCT02065557|464734996|FG001|Maintenance Period|Withdrawal by Subject|0|||
129119550|NCT02065557|464734997|FG002|Maintenance Period|Withdrawal by Subject|0|||
129119551|NCT02065557|464734998|FG003|Maintenance Period|Withdrawal by Subject|0|||
129216387|NCT03739203|465092909|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
129216388|NCT03739203|465092910|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
129216389|NCT03739203|465092911|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
129216390|NCT03739203|465092909|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
129216391|NCT03739203|465092910|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
129216392|NCT03739203|465092911|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
129216393|NCT03739203|465092909|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
129216394|NCT03739203|465092910|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
129216395|NCT03739203|465092911|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
129216396|NCT03739203|465092909|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
129216397|NCT03739203|465092910|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
129216398|NCT03739203|465092911|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
129216399|NCT03739203|465092909|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
129216400|NCT03739203|465092910|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
129216401|NCT03739203|465092911|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
129216402|NCT03739203|465092909|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
129216403|NCT03739203|465092910|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
129216404|NCT03739203|465092911|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
129216405|NCT03739203|465092909|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
129216406|NCT03739203|465092910|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
129216407|NCT03739203|465092911|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
129216408|NCT00830440|465092912|FG000|Overall Study|Protocol Violation|1|||
129216409|NCT00830440|465092913|FG001|Overall Study|Protocol Violation|0|||
129216410|NCT00830440|465092912|FG000|Overall Study|Withdrawal by Subject|1|||
129216411|NCT00830440|465092913|FG001|Overall Study|Withdrawal by Subject|0|||
129216412|NCT00830440|465092912|FG000|Overall Study|unsuccessful procedure|4|||
129216413|NCT00830440|465092913|FG001|Overall Study|unsuccessful procedure|0|||
129216414|NCT00830440|465092912|FG000|Overall Study|Adverse Event|2|||
129216415|NCT00830440|465092913|FG001|Overall Study|Adverse Event|0|||
129216416|NCT00942604|465092919|FG000|Overall Study|Protocol Violation|1|||
129216417|NCT00942604|465092920|FG001|Overall Study|Protocol Violation|1|||
129216418|NCT00942604|465092919|FG000|Overall Study|Adverse Event|0|||
129216419|NCT00942604|465092920|FG001|Overall Study|Adverse Event|1|||
129216420|NCT00942604|465092919|FG000|Overall Study|Withdrawal by Subject|0|||
129216421|NCT00942604|465092920|FG001|Overall Study|Withdrawal by Subject|1|||
129216422|NCT00942604|465092919|FG000|Overall Study|Patient relocation|1|||
129216423|NCT00942604|465092920|FG001|Overall Study|Patient relocation|1|||
129216424|NCT01188343|465092921|FG000|Overall Study|Not vaccinated|0|||
129216425|NCT01188343|465092922|FG001|Overall Study|Not vaccinated|2|||
129216426|NCT01188343|465092923|FG002|Overall Study|Not vaccinated|1|||
129216427|NCT01188343|465092921|FG000|Overall Study|Withdrawal by Subject|1|||
129216428|NCT01188343|465092922|FG001|Overall Study|Withdrawal by Subject|24|||
129216429|NCT01188343|465092923|FG002|Overall Study|Withdrawal by Subject|0|||
129216430|NCT01143246|465092924|FG000|Overall Study|Adverse Event|24|||
128929654|NCT05635838|464032773|FG001|16-Week OLE Period|Adverse Event|0|||
128929655|NCT05635838|464032774|FG002|16-Week OLE Period|Adverse Event|0|||
128929656|NCT05635838|464032775|FG003|16-Week OLE Period|Adverse Event|2|||
128929657|NCT05635838|464032772|FG000|16-Week OLE Period|Lost to Follow-up|0|||
128929658|NCT05635838|464032773|FG001|16-Week OLE Period|Lost to Follow-up|0|||
128929659|NCT05635838|464032774|FG002|16-Week OLE Period|Lost to Follow-up|1|||
128929660|NCT05635838|464032775|FG003|16-Week OLE Period|Lost to Follow-up|3|||
128929661|NCT05635838|464032772|FG000|16-Week OLE Period|Physician Decision|0|||
128929662|NCT05635838|464032773|FG001|16-Week OLE Period|Physician Decision|0|||
128929663|NCT05635838|464032774|FG002|16-Week OLE Period|Physician Decision|0|||
128929664|NCT05635838|464032775|FG003|16-Week OLE Period|Physician Decision|1|||
128929665|NCT05635838|464032772|FG000|16-Week OLE Period|Protocol Violation|0|||
128929666|NCT05635838|464032773|FG001|16-Week OLE Period|Protocol Violation|0|||
128929667|NCT05635838|464032774|FG002|16-Week OLE Period|Protocol Violation|1|||
128929668|NCT05635838|464032775|FG003|16-Week OLE Period|Protocol Violation|1|||
128929669|NCT05635838|464032772|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
128929670|NCT05635838|464032773|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
128929671|NCT05635838|464032774|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
129216431|NCT01143246|465092925|FG001|Overall Study|Adverse Event|28|||
129216432|NCT01143246|465092924|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
128929672|NCT05635838|464032775|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
128929673|NCT05635838|464032772|FG000|16-Week OLE Period|Pregnancy|0|||
129216433|NCT01143246|465092925|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
129216434|NCT01143246|465092924|FG000|Overall Study|Lost to Follow-up|0|||
128929674|NCT05635838|464032773|FG001|16-Week OLE Period|Pregnancy|0|||
128929675|NCT05635838|464032774|FG002|16-Week OLE Period|Pregnancy|1|||
129216435|NCT01143246|465092925|FG001|Overall Study|Lost to Follow-up|1|||
129216436|NCT01143246|465092924|FG000|Overall Study|Death|16|||
129216437|NCT01143246|465092925|FG001|Overall Study|Death|15|||
129030152|NCT01155531|464401623|FG003|Overall Study|Lost to Follow-up|1|||
129030153|NCT01155531|464401620|FG000|Overall Study|Withdrawal by Subject|1|||
129030154|NCT01155531|464401621|FG001|Overall Study|Withdrawal by Subject|0|||
129030155|NCT01155531|464401622|FG002|Overall Study|Withdrawal by Subject|1|||
129030156|NCT01155531|464401623|FG003|Overall Study|Withdrawal by Subject|0|||
129030157|NCT00354159|464401624|FG000|Randomized Study Period|Withdrawal by Subject|5|||
129030158|NCT00354159|464401625|FG001|Randomized Study Period|Withdrawal by Subject|3|||
129030159|NCT00354159|464401624|FG000|Randomized Study Period|Physician Decision|6|||
129030160|NCT00354159|464401625|FG001|Randomized Study Period|Physician Decision|10|||
129030161|NCT00354159|464401624|FG000|Randomized Study Period|Lost to Follow-up|4|||
129030162|NCT00354159|464401625|FG001|Randomized Study Period|Lost to Follow-up|0|||
129030163|NCT00354159|464401624|FG000|Randomized Study Period|Death|7|||
129030164|NCT00354159|464401625|FG001|Randomized Study Period|Death|9|||
129030165|NCT00354159|464401624|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
129030166|NCT00354159|464401625|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
129030167|NCT00354159|464401624|FG000|Long-term Follow-up|Physician Decision|127|||
129030168|NCT00354159|464401625|FG001|Long-term Follow-up|Physician Decision|122|||
129030169|NCT00354159|464401624|FG000|Long-term Follow-up|Lost to Follow-up|1|||
129030170|NCT00354159|464401625|FG001|Long-term Follow-up|Lost to Follow-up|0|||
129030171|NCT00354159|464401624|FG000|Long-term Follow-up|Death|14|||
129030172|NCT00354159|464401625|FG001|Long-term Follow-up|Death|11|||
129030173|NCT00354159|464401624|FG000|Long-term Follow-up|Study Closed|29|||
129030174|NCT00354159|464401625|FG001|Long-term Follow-up|Study Closed|34|||
129030175|NCT01653704|464401626|FG000|Overall Study|Technical failure during recording|1|||
129030176|NCT01653704|464401627|FG001|Overall Study|Technical failure during recording|1|||
129030177|NCT01653704|464401626|FG000|Overall Study|Performance not reflective of training|1|||
129030178|NCT01653704|464401627|FG001|Overall Study|Performance not reflective of training|0|||
128701716|NCT00481078|463205727|FG001|Overall Study|Progression of disease|11|||
128701717|NCT00481078|463205726|FG000|Overall Study|Adverse Event|15|||
129030179|NCT01728116|464401628|FG000|Overall Study|Sponsor Terminated Study|106|||
129030180|NCT01728116|464401629|FG001|Overall Study|Sponsor Terminated Study|35|||
129030181|NCT01728116|464401628|FG000|Overall Study|Withdrawal by Subject|16|||
129030182|NCT01728116|464401629|FG001|Overall Study|Withdrawal by Subject|9|||
129030183|NCT01728116|464401628|FG000|Overall Study|Adverse Event|13|||
129030184|NCT01728116|464401629|FG001|Overall Study|Adverse Event|0|||
129030185|NCT01728116|464401628|FG000|Overall Study|Procedure/device failure|7|||
129030186|NCT01728116|464401629|FG001|Overall Study|Procedure/device failure|0|||
129030187|NCT01728116|464401628|FG000|Overall Study|Lost to Follow-up|9|||
129030188|NCT01728116|464401629|FG001|Overall Study|Lost to Follow-up|2|||
129030189|NCT01728116|464401628|FG000|Overall Study|Physician Decision|2|||
129030190|NCT01728116|464401629|FG001|Overall Study|Physician Decision|0|||
129119552|NCT02065557|464734999|FG004|Maintenance Period|Withdrawal by Subject|2|||
129119553|NCT02065557|464735000|FG005|Maintenance Period|Withdrawal by Subject|1|||
129119554|NCT02065557|464734995|FG000|Maintenance Period|Lack of Efficacy|0|||
129119555|NCT02065557|464734996|FG001|Maintenance Period|Lack of Efficacy|0|||
129119556|NCT02065557|464734997|FG002|Maintenance Period|Lack of Efficacy|0|||
129119557|NCT02065557|464734998|FG003|Maintenance Period|Lack of Efficacy|0|||
129119558|NCT02065557|464734999|FG004|Maintenance Period|Lack of Efficacy|5|||
129119559|NCT02065557|464735000|FG005|Maintenance Period|Lack of Efficacy|2|||
129119560|NCT02065557|464734995|FG000|Maintenance Period|Subject Non-Compliance|0|||
129119561|NCT02065557|464734996|FG001|Maintenance Period|Subject Non-Compliance|0|||
129119562|NCT02065557|464734997|FG002|Maintenance Period|Subject Non-Compliance|0|||
129119563|NCT02065557|464734998|FG003|Maintenance Period|Subject Non-Compliance|0|||
129119564|NCT02065557|464734999|FG004|Maintenance Period|Subject Non-Compliance|0|||
129119565|NCT02065557|464735000|FG005|Maintenance Period|Subject Non-Compliance|1|||
129119566|NCT00250588|464735001|FG000|Overall Study|Withdrawal by Subject|3|||
128701718|NCT00481078|463205727|FG001|Overall Study|Adverse Event|3|||
128701719|NCT00481078|463205726|FG000|Overall Study|Death|5|||
128701720|NCT00481078|463205727|FG001|Overall Study|Death|3|||
129030191|NCT01728116|464401628|FG000|Overall Study|Subject Non-Compliance|2|||
129030192|NCT01728116|464401629|FG001|Overall Study|Subject Non-Compliance|0|||
129030193|NCT01728116|464401628|FG000|Overall Study|Inter-current finding at procedure|1|||
129030194|NCT01728116|464401629|FG001|Overall Study|Inter-current finding at procedure|0|||
129030195|NCT01728116|464401628|FG000|Overall Study|Incorrectly enrolled in Study|0|||
129030196|NCT01728116|464401629|FG001|Overall Study|Incorrectly enrolled in Study|1|||
129030197|NCT01728116|464401628|FG000|Overall Study|various not noted previously|5|||
128701721|NCT00481078|463205726|FG000|Overall Study|Intercurrent illness|1|||
128701722|NCT00481078|463205727|FG001|Overall Study|Intercurrent illness|0|||
129030198|NCT01728116|464401629|FG001|Overall Study|various not noted previously|0|||
129030199|NCT03141151|464401642|FG000|Overall Study|Lost to Follow-up|3|||
129030200|NCT03141151|464401643|FG001|Overall Study|Lost to Follow-up|2|||
129119567|NCT00250588|464735002|FG001|Overall Study|Withdrawal by Subject|6|||
129119568|NCT00250588|464735003|FG002|Overall Study|Withdrawal by Subject|0|||
129030201|NCT03141151|464401642|FG000|Overall Study|Withdrawal by Subject|3|||
129030202|NCT03141151|464401643|FG001|Overall Study|Withdrawal by Subject|2|||
129030203|NCT01874535|464401644|FG000|Overall Study|Lost to Follow-up|10|||
128929676|NCT05635838|464032775|FG003|16-Week OLE Period|Pregnancy|0|||
128929677|NCT00875420|464032776|FG000|Overall Study|Adverse Event|0|||
128929678|NCT00875420|464032777|FG001|Overall Study|Adverse Event|1|||
128929679|NCT00875420|464032778|FG002|Overall Study|Adverse Event|1|||
128929680|NCT00875420|464032779|FG003|Overall Study|Adverse Event|0|||
128929681|NCT00875420|464032780|FG004|Overall Study|Adverse Event|0|||
128929682|NCT00875420|464032776|FG000|Overall Study|Inability to complete study procedures|1|||
128929683|NCT00875420|464032777|FG001|Overall Study|Inability to complete study procedures|0|||
128929684|NCT00875420|464032778|FG002|Overall Study|Inability to complete study procedures|1|||
128929685|NCT00875420|464032779|FG003|Overall Study|Inability to complete study procedures|1|||
128929686|NCT00875420|464032780|FG004|Overall Study|Inability to complete study procedures|1|||
128929687|NCT00875420|464032776|FG000|Overall Study|Lost to Follow-up|1|||
128929688|NCT00875420|464032777|FG001|Overall Study|Lost to Follow-up|0|||
128929689|NCT00875420|464032778|FG002|Overall Study|Lost to Follow-up|0|||
128929690|NCT00875420|464032779|FG003|Overall Study|Lost to Follow-up|0|||
128929691|NCT00875420|464032780|FG004|Overall Study|Lost to Follow-up|0|||
128929692|NCT00875420|464032776|FG000|Overall Study|Personal reason|0|||
128929693|NCT00875420|464032777|FG001|Overall Study|Personal reason|0|||
128929694|NCT00875420|464032778|FG002|Overall Study|Personal reason|0|||
128929695|NCT00875420|464032779|FG003|Overall Study|Personal reason|0|||
129119569|NCT00250588|464735001|FG000|Overall Study|Lost to Follow-up|6|||
129119570|NCT00250588|464735002|FG001|Overall Study|Lost to Follow-up|13|||
129119571|NCT00250588|464735003|FG002|Overall Study|Lost to Follow-up|13|||
129119572|NCT03502798|464735004|FG000|Overall Study|equipment failure|0|||
129119573|NCT03502798|464735005|FG001|Overall Study|equipment failure|7|||
129119574|NCT00485303|464735007|FG000|Overall Study|Adverse Event|5|||
129119575|NCT00485303|464735007|FG000|Overall Study|Progressive Disease|44|||
129119576|NCT00485303|464735007|FG000|Overall Study|Other|3|||
129119577|NCT00485303|464735007|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
129119578|NCT00485303|464735007|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
129119579|NCT00296335|464735009|FG000|Overall Study|Recurrence|3|||
129119580|NCT00296335|464735010|FG001|Overall Study|Recurrence|51|||
129119581|NCT00296335|464735009|FG000|Overall Study|Adverse Event|17|||
129119582|NCT00296335|464735010|FG001|Overall Study|Adverse Event|27|||
129119583|NCT00296335|464735009|FG000|Overall Study|Lost to Follow-up|7|||
129119584|NCT00296335|464735010|FG001|Overall Study|Lost to Follow-up|33|||
129119585|NCT00296335|464735009|FG000|Overall Study|Physician Decision|3|||
129119586|NCT00296335|464735010|FG001|Overall Study|Physician Decision|11|||
129119587|NCT01401322|464735011|FG000|Overall Study|Withdrawal by Subject|1|||
129119588|NCT01401322|464735011|FG000|Overall Study|Physician Decision|1|||
129119589|NCT02737722|464735012|FG000|Overall Study|Physician Decision|0|||
129119590|NCT02737722|464735013|FG001|Overall Study|Physician Decision|0|||
129119591|NCT02737722|464735014|FG002|Overall Study|Physician Decision|1|||
129119592|NCT02737722|464735015|FG003|Overall Study|Physician Decision|0|||
129119593|NCT00112957|464735022|FG000|Overall Study|Progressive disease|18|||
129119594|NCT00112957|464735022|FG000|Overall Study|Physician Decision|1|||
129119595|NCT03444584|464735032|FG000|Overall Study|Withdrawal by Subject|0|||
129119596|NCT03444584|464735033|FG001|Overall Study|Withdrawal by Subject|1|||
129119597|NCT03444584|464735032|FG000|Overall Study|Other|0|||
129119598|NCT03444584|464735033|FG001|Overall Study|Other|1|||
129119599|NCT03451045|464735034|FG000|Overall Study|Lack of Efficacy|3|||
129119600|NCT03451045|464735035|FG001|Overall Study|Lack of Efficacy|2|||
129119601|NCT03451045|464735036|FG002|Overall Study|Lack of Efficacy|2|||
129119602|NCT03451045|464735034|FG000|Overall Study|Physician Decision|1|||
129119603|NCT03451045|464735035|FG001|Overall Study|Physician Decision|1|||
129119604|NCT03451045|464735036|FG002|Overall Study|Physician Decision|1|||
129119605|NCT03451045|464735034|FG000|Overall Study|Withdrawal by Subject|4|||
128929696|NCT00875420|464032780|FG004|Overall Study|Personal reason|1|||
128929697|NCT00875420|464032776|FG000|Overall Study|Prohibited medication|0|||
128929698|NCT00875420|464032777|FG001|Overall Study|Prohibited medication|0|||
128929699|NCT00875420|464032778|FG002|Overall Study|Prohibited medication|0|||
128929700|NCT00875420|464032779|FG003|Overall Study|Prohibited medication|1|||
128929701|NCT00875420|464032780|FG004|Overall Study|Prohibited medication|0|||
128929702|NCT00875420|464032776|FG000|Overall Study|Sponsor decision|0|||
128929703|NCT00875420|464032777|FG001|Overall Study|Sponsor decision|1|||
129119606|NCT03451045|464735035|FG001|Overall Study|Withdrawal by Subject|0|||
129119607|NCT03451045|464735036|FG002|Overall Study|Withdrawal by Subject|5|||
129119608|NCT03451045|464735034|FG000|Overall Study|Pregnancy|0|||
129119609|NCT03451045|464735035|FG001|Overall Study|Pregnancy|0|||
129119610|NCT03451045|464735036|FG002|Overall Study|Pregnancy|2|||
128929704|NCT00875420|464032778|FG002|Overall Study|Sponsor decision|0|||
128929705|NCT00875420|464032779|FG003|Overall Study|Sponsor decision|0|||
128929706|NCT00875420|464032780|FG004|Overall Study|Sponsor decision|0|||
128929707|NCT00875420|464032776|FG000|Overall Study|Withdrawal by Subject|0|||
129119611|NCT03451045|464735034|FG000|Overall Study|Adverse Event|7|||
129119612|NCT03451045|464735035|FG001|Overall Study|Adverse Event|1|||
129119613|NCT03451045|464735036|FG002|Overall Study|Adverse Event|3|||
129119614|NCT03451045|464735034|FG000|Overall Study|Non-compliance with study|2|||
129119615|NCT03451045|464735035|FG001|Overall Study|Non-compliance with study|0|||
128929708|NCT00875420|464032777|FG001|Overall Study|Withdrawal by Subject|0|||
128929709|NCT00875420|464032778|FG002|Overall Study|Withdrawal by Subject|1|||
128929710|NCT00875420|464032779|FG003|Overall Study|Withdrawal by Subject|0|||
128929711|NCT00875420|464032780|FG004|Overall Study|Withdrawal by Subject|0|||
128929712|NCT03705494|464032781|FG000|Overall Study|Lost to Follow-up|2|||
128929713|NCT03705494|464032782|FG001|Overall Study|Lost to Follow-up|1|||
128929714|NCT03705494|464032781|FG000|Overall Study|Withdrawal by Subject|5|||
128929715|NCT03705494|464032782|FG001|Overall Study|Withdrawal by Subject|2|||
128929716|NCT02629393|464032783|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
128929717|NCT02629393|464032783|FG000|Overall Study|Physician Decision|1|||
128929718|NCT03716726|464032787|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
128929719|NCT03716726|464032788|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
128929720|NCT03716726|464032787|FG000|12 Months Followup|Lost to Follow-up|10|||
128929721|NCT03716726|464032788|FG001|12 Months Followup|Lost to Follow-up|17|||
128929722|NCT01981187|464032791|FG000|Overall Study|Participant/guardian decision|2|||
128929723|NCT01981187|464032791|FG000|Overall Study|Physician Decision|1|||
128929724|NCT01981187|464032791|FG000|Overall Study|Disease progression|2|||
128929725|NCT01981187|464032791|FG000|Overall Study|Adverse Event|7|||
128929726|NCT01943539|464032795|FG000|Overall Study|Non-compliance with at-home intervention|4|||
128929727|NCT01943539|464032796|FG001|Overall Study|Non-compliance with at-home intervention|0|||
128929728|NCT02413255|464032797|FG000|Overall Study|Voluntary Withdrawal|0|||
128929729|NCT02413255|464032798|FG001|Overall Study|Voluntary Withdrawal|0|||
128929730|NCT02413255|464032799|FG002|Overall Study|Voluntary Withdrawal|0|||
128929731|NCT02413255|464032800|FG003|Overall Study|Voluntary Withdrawal|0|||
128929732|NCT02413255|464032801|FG004|Overall Study|Voluntary Withdrawal|0|||
128929733|NCT02413255|464032802|FG005|Overall Study|Voluntary Withdrawal|0|||
128929734|NCT02413255|464032803|FG006|Overall Study|Voluntary Withdrawal|0|||
128929735|NCT02413255|464032804|FG007|Overall Study|Voluntary Withdrawal|0|||
128929736|NCT02413255|464032805|FG008|Overall Study|Voluntary Withdrawal|0|||
128929737|NCT02413255|464032806|FG009|Overall Study|Voluntary Withdrawal|0|||
128929738|NCT02413255|464032807|FG010|Overall Study|Voluntary Withdrawal|0|||
128929739|NCT02413255|464032808|FG011|Overall Study|Voluntary Withdrawal|0|||
128929740|NCT02413255|464032809|FG012|Overall Study|Voluntary Withdrawal|0|||
128929741|NCT02413255|464032810|FG013|Overall Study|Voluntary Withdrawal|0|||
128929742|NCT02413255|464032811|FG014|Overall Study|Voluntary Withdrawal|1|||
128929743|NCT02413255|464032812|FG015|Overall Study|Voluntary Withdrawal|0|||
128929744|NCT02413255|464032813|FG016|Overall Study|Voluntary Withdrawal|0|||
128929745|NCT03199911|464032814|FG000|Overall Study|Lost to Follow-up|5|||
128929746|NCT03199911|464032815|FG001|Overall Study|Lost to Follow-up|5|||
128929747|NCT03199911|464032814|FG000|Overall Study|Did not proceed with surgery|2|||
128929748|NCT03199911|464032815|FG001|Overall Study|Did not proceed with surgery|1|||
129119616|NCT03451045|464735036|FG002|Overall Study|Non-compliance with study|1|||
129119617|NCT03451045|464735034|FG000|Overall Study|any other reason|10|||
129119618|NCT03451045|464735035|FG001|Overall Study|any other reason|2|||
129119619|NCT03451045|464735036|FG002|Overall Study|any other reason|13|||
129119620|NCT00863707|464735037|FG000|Overall Study|Randomized, but drug not received|4|||
129119621|NCT00863707|464735038|FG001|Overall Study|Randomized, but drug not received|3|||
129119622|NCT03704064|464735039|FG000|Overall Study|Lost to Follow-up|8|||
129119623|NCT03704064|464735040|FG001|Overall Study|Lost to Follow-up|4|||
129119624|NCT03704064|464735039|FG000|Overall Study|Withdrawal by Subject|1|||
129119625|NCT03704064|464735040|FG001|Overall Study|Withdrawal by Subject|1|||
129119626|NCT03704064|464735039|FG000|Overall Study|No longer available for study visits|0|||
129119627|NCT03704064|464735040|FG001|Overall Study|No longer available for study visits|1|||
129119628|NCT03704064|464735039|FG000|Overall Study|Censoring event|1|||
129119629|NCT03704064|464735040|FG001|Overall Study|Censoring event|0|||
129119630|NCT04142242|464735041|FG000|Stage I|Non-compliance with the protocol|1|||
129119631|NCT04142242|464735042|FG001|Stage I|Non-compliance with the protocol|0|||
129119632|NCT04142242|464735043|FG002|Stage I|Non-compliance with the protocol|0|||
129119633|NCT04142242|464735044|FG003|Stage I|Non-compliance with the protocol|0|||
129119634|NCT04142242|464735045|FG004|Stage I|Non-compliance with the protocol|0|||
129119635|NCT04142242|464735046|FG005|Stage I|Non-compliance with the protocol|1|||
129119636|NCT04142242|464735041|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129119637|NCT04142242|464735042|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
129119638|NCT04142242|464735043|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129119639|NCT04142242|464735044|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129119640|NCT04142242|464735045|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
128929749|NCT01009463|464032816|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
128929750|NCT01009463|464032817|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128929751|NCT01009463|464032818|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128929752|NCT01009463|464032819|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128978058|NCT02743494|464205306|FG001|Treatment Period|Death|0|||
129119641|NCT04142242|464735046|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129030204|NCT01874535|464401645|FG001|Overall Study|Lost to Follow-up|9|||
129030205|NCT01874535|464401644|FG000|Overall Study|incomplete symptom resolution|45|||
129030206|NCT01874535|464401645|FG001|Overall Study|incomplete symptom resolution|35|||
129030207|NCT01215721|464401646|FG000|Overall Study|Adverse Event|2|||
129030208|NCT02943096|464401647|FG000|Overall Study|Lack of Efficacy|0|||
129030209|NCT02943096|464401648|FG001|Overall Study|Lack of Efficacy|1|||
129030210|NCT02119936|464401658|FG000|Overall Study|Lost to Follow-up|10|||
129030211|NCT00570128|464401659|FG000|Overall Study|Adverse Event|1|||
129030212|NCT00570128|464401660|FG001|Overall Study|Adverse Event|0|||
129030213|NCT00570128|464401659|FG000|Overall Study|Lost to Follow-up|1|||
129030214|NCT00570128|464401660|FG001|Overall Study|Lost to Follow-up|0|||
129030215|NCT00570128|464401659|FG000|Overall Study|Withdrawal by Subject|2|||
129030216|NCT00570128|464401660|FG001|Overall Study|Withdrawal by Subject|0|||
129030217|NCT01929681|464401661|FG000|Overall Study|Withdrawal by Subject|1|||
129030218|NCT01929681|464401662|FG001|Overall Study|Withdrawal by Subject|0|||
129030219|NCT01929681|464401661|FG000|Overall Study|Physician Decision|1|||
129030220|NCT01929681|464401662|FG001|Overall Study|Physician Decision|1|||
129030221|NCT02218216|464401663|FG000|Overall Study|Study terminated before completed|6|||
129030222|NCT02218216|464401664|FG001|Overall Study|Study terminated before completed|0|||
129030223|NCT02218216|464401665|FG002|Overall Study|Study terminated before completed|0|||
129030224|NCT01073631|464401668|FG000|Overall Study|Death|82|||
129030225|NCT01073631|464401668|FG000|Overall Study|Adverse Event|24|||
129030226|NCT01073631|464401668|FG000|Overall Study|Other|63|||
129030227|NCT01528735|464401669|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
129030228|NCT01528735|464401670|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
129030229|NCT01528735|464401669|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
129030230|NCT01528735|464401670|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
129119642|NCT04142242|464735041|FG000|Stage II|Non-compliance with the protocol|0|||
129119643|NCT04142242|464735042|FG001|Stage II|Non-compliance with the protocol|0|||
129119644|NCT04142242|464735043|FG002|Stage II|Non-compliance with the protocol|0|||
129119645|NCT04142242|464735044|FG003|Stage II|Non-compliance with the protocol|2|||
129119646|NCT04142242|464735045|FG004|Stage II|Non-compliance with the protocol|0|||
129119647|NCT04142242|464735046|FG005|Stage II|Non-compliance with the protocol|0|||
129119648|NCT04142242|464735041|FG000|Stage II|Lost to Follow-up|0|||
129119649|NCT04142242|464735042|FG001|Stage II|Lost to Follow-up|0|||
129119650|NCT04142242|464735043|FG002|Stage II|Lost to Follow-up|1|||
129119651|NCT04142242|464735044|FG003|Stage II|Lost to Follow-up|2|||
129119652|NCT04142242|464735045|FG004|Stage II|Lost to Follow-up|0|||
129119653|NCT04142242|464735046|FG005|Stage II|Lost to Follow-up|0|||
129119654|NCT04142242|464735041|FG000|Stage II|Withdrawal by Subject|0|||
129119655|NCT04142242|464735042|FG001|Stage II|Withdrawal by Subject|0|||
129119656|NCT04142242|464735043|FG002|Stage II|Withdrawal by Subject|5|||
129119657|NCT04142242|464735044|FG003|Stage II|Withdrawal by Subject|9|||
129119658|NCT04142242|464735045|FG004|Stage II|Withdrawal by Subject|0|||
129119659|NCT04142242|464735046|FG005|Stage II|Withdrawal by Subject|0|||
129119660|NCT00289276|464735049|FG000|Second Part of FAST Study (Expansion)|Death|0|||
129119661|NCT00289276|464735050|FG001|Second Part of FAST Study (Expansion)|Death|2|||
129119662|NCT00289276|464735049|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
129119663|NCT00289276|464735050|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
129119664|NCT03040726|464735051|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
129119665|NCT03040726|464735052|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
129119666|NCT03040726|464735051|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
129119667|NCT03040726|464735052|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
129119668|NCT03040726|464735051|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
129119669|NCT03040726|464735052|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
129119670|NCT03040726|464735051|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
129119671|NCT03040726|464735052|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
129119672|NCT03040726|464735051|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
129119673|NCT03040726|464735052|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
129119674|NCT02783911|464735053|FG000|Overall Study|Lost to Follow-up|3|||
129119675|NCT02783911|464735054|FG001|Overall Study|Lost to Follow-up|32|||
129119676|NCT00071981|464735055|FG000|Overall Study|Lack of Efficacy|37|||
129119677|NCT00071981|464735056|FG001|Overall Study|Lack of Efficacy|29|||
129119678|NCT00071981|464735057|FG002|Overall Study|Lack of Efficacy|30|||
129119679|NCT00071981|464735058|FG003|Overall Study|Lack of Efficacy|43|||
129119680|NCT00071981|464735055|FG000|Overall Study|Adverse Event|4|||
129216438|NCT01143246|465092924|FG000|Overall Study|Reason not Specified|3|||
129216439|NCT01143246|465092925|FG001|Overall Study|Reason not Specified|5|||
129030231|NCT01971554|464401671|FG000|Overall Study|Lost to Follow-up|1|||
129030232|NCT01971554|464401672|FG001|Overall Study|Lost to Follow-up|0|||
129030233|NCT01971554|464401673|FG002|Overall Study|Lost to Follow-up|0|||
129030234|NCT01971554|464401674|FG003|Overall Study|Lost to Follow-up|0|||
129030235|NCT01426854|464401675|FG000|Overall Study|Adverse Event|1|||
129119681|NCT00071981|464735056|FG001|Overall Study|Adverse Event|4|||
129119682|NCT00071981|464735057|FG002|Overall Study|Adverse Event|3|||
129119683|NCT00071981|464735058|FG003|Overall Study|Adverse Event|1|||
129119684|NCT00071981|464735055|FG000|Overall Study|Death|0|||
129119685|NCT00071981|464735056|FG001|Overall Study|Death|0|||
129216440|NCT04119414|465092926|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
129216441|NCT03326713|465092930|FG000|Overall Study|Death|2|||
129216442|NCT03326713|465092931|FG001|Overall Study|Death|1|||
129216443|NCT03326713|465092932|FG002|Overall Study|Death|0|||
129216444|NCT03326713|465092930|FG000|Overall Study|Lost to Follow-up|20|||
129216445|NCT03326713|465092931|FG001|Overall Study|Lost to Follow-up|21|||
129216446|NCT03326713|465092932|FG002|Overall Study|Lost to Follow-up|33|||
129216447|NCT03326713|465092930|FG000|Overall Study|Withdrawal by Subject|1|||
129216448|NCT03326713|465092931|FG001|Overall Study|Withdrawal by Subject|2|||
129216449|NCT03326713|465092932|FG002|Overall Study|Withdrawal by Subject|11|||
129216450|NCT03326713|465092930|FG000|Overall Study|Found Ineligible|11|||
129216451|NCT03326713|465092931|FG001|Overall Study|Found Ineligible|11|||
129216452|NCT03326713|465092932|FG002|Overall Study|Found Ineligible|8|||
129216453|NCT01394016|465092935|FG000|Overall Study|Progressive Disease|2|||
129216454|NCT01394016|465092936|FG001|Overall Study|Progressive Disease|0|||
129216455|NCT01394016|465092937|FG002|Overall Study|Progressive Disease|0|||
129216456|NCT01394016|465092938|FG003|Overall Study|Progressive Disease|0|||
129216457|NCT01394016|465092939|FG004|Overall Study|Progressive Disease|0|||
129216458|NCT01394016|465092940|FG005|Overall Study|Progressive Disease|0|||
129216459|NCT01394016|465092941|FG006|Overall Study|Progressive Disease|0|||
129216460|NCT01394016|465092942|FG007|Overall Study|Progressive Disease|0|||
129216461|NCT01394016|465092943|FG008|Overall Study|Progressive Disease|0|||
129216462|NCT01394016|465092944|FG009|Overall Study|Progressive Disease|0|||
129216463|NCT01394016|465092945|FG010|Overall Study|Progressive Disease|0|||
129216464|NCT01394016|465092946|FG011|Overall Study|Progressive Disease|0|||
129216465|NCT01394016|465092947|FG012|Overall Study|Progressive Disease|0|||
129216466|NCT01394016|465092948|FG013|Overall Study|Progressive Disease|0|||
129216467|NCT01394016|465092949|FG014|Overall Study|Progressive Disease|0|||
129216468|NCT01394016|465092950|FG015|Overall Study|Progressive Disease|0|||
129216469|NCT01394016|465092951|FG016|Overall Study|Progressive Disease|0|||
129216470|NCT01394016|465092952|FG017|Overall Study|Progressive Disease|0|||
129216471|NCT01394016|465092953|FG018|Overall Study|Progressive Disease|0|||
129216472|NCT01394016|465092935|FG000|Overall Study|Withdrawal by Subject|0|||
129216473|NCT01394016|465092936|FG001|Overall Study|Withdrawal by Subject|0|||
129216474|NCT01394016|465092937|FG002|Overall Study|Withdrawal by Subject|0|||
128929753|NCT01009463|464032820|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
128929754|NCT01009463|464032816|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
128929755|NCT01009463|464032817|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
129119686|NCT00071981|464735057|FG002|Overall Study|Death|1|||
129119687|NCT00071981|464735058|FG003|Overall Study|Death|1|||
129119688|NCT00071981|464735055|FG000|Overall Study|Withdrawal by Subject|3|||
129119689|NCT00071981|464735056|FG001|Overall Study|Withdrawal by Subject|1|||
129119690|NCT00071981|464735057|FG002|Overall Study|Withdrawal by Subject|0|||
129119691|NCT00071981|464735058|FG003|Overall Study|Withdrawal by Subject|0|||
129119692|NCT00071981|464735055|FG000|Overall Study|No protocol therapy|2|||
129119693|NCT00071981|464735056|FG001|Overall Study|No protocol therapy|5|||
129119694|NCT00071981|464735057|FG002|Overall Study|No protocol therapy|1|||
129119695|NCT00071981|464735058|FG003|Overall Study|No protocol therapy|0|||
129119696|NCT00071981|464735055|FG000|Overall Study|others (not specified in the study)|0|||
129119697|NCT00071981|464735056|FG001|Overall Study|others (not specified in the study)|2|||
129119698|NCT00071981|464735057|FG002|Overall Study|others (not specified in the study)|2|||
129119699|NCT00071981|464735058|FG003|Overall Study|others (not specified in the study)|0|||
129119700|NCT01123655|464735059|FG000|Overall Study|Medication for RA had to be changed|1|||
128929756|NCT01009463|464032818|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
128929757|NCT01009463|464032819|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
128929758|NCT01009463|464032820|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
128929759|NCT01009463|464032816|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
128929760|NCT01009463|464032817|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129119701|NCT01123655|464735060|FG001|Overall Study|Medication for RA had to be changed|0|||
129119702|NCT01123655|464735061|FG002|Overall Study|Medication for RA had to be changed|0|||
129119703|NCT01123655|464735059|FG000|Overall Study|new illness|0|||
129216475|NCT01394016|465092938|FG003|Overall Study|Withdrawal by Subject|0|||
129216476|NCT01394016|465092939|FG004|Overall Study|Withdrawal by Subject|0|||
129216477|NCT01394016|465092940|FG005|Overall Study|Withdrawal by Subject|0|||
129216478|NCT01394016|465092941|FG006|Overall Study|Withdrawal by Subject|0|||
129216479|NCT01394016|465092942|FG007|Overall Study|Withdrawal by Subject|1|||
129216480|NCT01394016|465092943|FG008|Overall Study|Withdrawal by Subject|1|||
129216481|NCT01394016|465092944|FG009|Overall Study|Withdrawal by Subject|1|||
129216482|NCT01394016|465092945|FG010|Overall Study|Withdrawal by Subject|4|||
128929761|NCT01009463|464032818|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129119704|NCT01123655|464735060|FG001|Overall Study|new illness|1|||
129216483|NCT01394016|465092946|FG011|Overall Study|Withdrawal by Subject|0|||
129216484|NCT01394016|465092947|FG012|Overall Study|Withdrawal by Subject|0|||
129216485|NCT01394016|465092948|FG013|Overall Study|Withdrawal by Subject|3|||
129216486|NCT01394016|465092949|FG014|Overall Study|Withdrawal by Subject|1|||
129216487|NCT01394016|465092950|FG015|Overall Study|Withdrawal by Subject|3|||
129216488|NCT01394016|465092951|FG016|Overall Study|Withdrawal by Subject|1|||
129216489|NCT01394016|465092952|FG017|Overall Study|Withdrawal by Subject|1|||
129216490|NCT01394016|465092953|FG018|Overall Study|Withdrawal by Subject|2|||
129216491|NCT01394016|465092935|FG000|Overall Study|Adverse Event|0|||
129216492|NCT01394016|465092936|FG001|Overall Study|Adverse Event|0|||
129216493|NCT01394016|465092937|FG002|Overall Study|Adverse Event|0|||
128929762|NCT01009463|464032819|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
128929763|NCT01009463|464032820|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
128929764|NCT01009463|464032816|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
128929765|NCT01009463|464032817|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
129119705|NCT01123655|464735061|FG002|Overall Study|new illness|0|||
129119706|NCT01123655|464735059|FG000|Overall Study|began prohibitive drug|0|||
129119707|NCT01123655|464735060|FG001|Overall Study|began prohibitive drug|0|||
129119708|NCT01123655|464735061|FG002|Overall Study|began prohibitive drug|1|||
129119709|NCT00885118|464735064|FG000|Overall Study|Adverse Event|1|||
129119710|NCT00885118|464735065|FG001|Overall Study|Adverse Event|0|||
129119711|NCT00885118|464735066|FG002|Overall Study|Adverse Event|0|||
129119712|NCT00885118|464735067|FG003|Overall Study|Adverse Event|0|||
129119713|NCT00885118|464735068|FG004|Overall Study|Adverse Event|0|||
129119714|NCT00885118|464735064|FG000|Overall Study|Withdrawal by Subject|0|||
129119715|NCT00885118|464735065|FG001|Overall Study|Withdrawal by Subject|0|||
129119716|NCT00885118|464735066|FG002|Overall Study|Withdrawal by Subject|0|||
129119717|NCT00885118|464735067|FG003|Overall Study|Withdrawal by Subject|0|||
129119718|NCT00885118|464735068|FG004|Overall Study|Withdrawal by Subject|1|||
129119719|NCT00885118|464735064|FG000|Overall Study|Other reason not defined above|0|||
129119720|NCT00885118|464735065|FG001|Overall Study|Other reason not defined above|0|||
129119721|NCT00885118|464735066|FG002|Overall Study|Other reason not defined above|1|||
129119722|NCT00885118|464735067|FG003|Overall Study|Other reason not defined above|0|||
129216494|NCT01394016|465092938|FG003|Overall Study|Adverse Event|0|||
129216495|NCT01394016|465092939|FG004|Overall Study|Adverse Event|0|||
129216496|NCT01394016|465092940|FG005|Overall Study|Adverse Event|0|||
129216497|NCT01394016|465092941|FG006|Overall Study|Adverse Event|0|||
129216498|NCT01394016|465092942|FG007|Overall Study|Adverse Event|0|||
129216499|NCT01394016|465092943|FG008|Overall Study|Adverse Event|0|||
129216500|NCT01394016|465092944|FG009|Overall Study|Adverse Event|1|||
129216501|NCT01394016|465092945|FG010|Overall Study|Adverse Event|0|||
129216502|NCT01394016|465092946|FG011|Overall Study|Adverse Event|0|||
129216503|NCT01394016|465092947|FG012|Overall Study|Adverse Event|0|||
129216504|NCT01394016|465092948|FG013|Overall Study|Adverse Event|0|||
129216505|NCT01394016|465092949|FG014|Overall Study|Adverse Event|0|||
129216506|NCT01394016|465092950|FG015|Overall Study|Adverse Event|0|||
128701723|NCT00481078|463205726|FG000|Overall Study|Withdrawal by Subject|7|||
128701724|NCT00481078|463205727|FG001|Overall Study|Withdrawal by Subject|1|||
128701725|NCT00481078|463205726|FG000|Overall Study|Information not available|1|||
128701726|NCT00481078|463205727|FG001|Overall Study|Information not available|0|||
128701727|NCT00481078|463205726|FG000|Overall Study|Received other treatment|2|||
128701728|NCT00481078|463205727|FG001|Overall Study|Received other treatment|1|||
129216507|NCT01394016|465092951|FG016|Overall Study|Adverse Event|1|||
128701729|NCT00481078|463205726|FG000|Overall Study|Brain metastasis|0|||
128701730|NCT00481078|463205727|FG001|Overall Study|Brain metastasis|1|||
129119723|NCT00885118|464735068|FG004|Overall Study|Other reason not defined above|0|||
129119724|NCT03054428|464735073|FG000|Overall Study|Physician Decision|0|||
129119725|NCT03054428|464735074|FG001|Overall Study|Physician Decision|1|||
129119726|NCT03054428|464735075|FG002|Overall Study|Physician Decision|1|||
129119727|NCT03054428|464735073|FG000|Overall Study|Lack of Efficacy|3|||
129119728|NCT03054428|464735074|FG001|Overall Study|Lack of Efficacy|1|||
129119729|NCT03054428|464735075|FG002|Overall Study|Lack of Efficacy|0|||
129119730|NCT03054428|464735073|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
129119731|NCT03054428|464735074|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
129119732|NCT03054428|464735075|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
129119733|NCT03054428|464735073|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
129216508|NCT01394016|465092952|FG017|Overall Study|Adverse Event|1|||
128767314|NCT01709305|463438203|FG001|Phase 2|Death|0|||
129216509|NCT01394016|465092953|FG018|Overall Study|Adverse Event|0|||
128701731|NCT01558271|463205728|FG000|Overall Study|Adverse Event|6|||
128767315|NCT01709305|463438204|FG002|Phase 2|Death|1|||
129119734|NCT03054428|464735074|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
128701732|NCT01558271|463205729|FG001|Overall Study|Adverse Event|3|||
128701733|NCT01558271|463205730|FG002|Overall Study|Adverse Event|4|||
128767316|NCT01709305|463438205|FG003|Phase 2|Death|0|||
129216510|NCT01394016|465092935|FG000|Overall Study|Sponsor Decision|0|||
129216511|NCT01394016|465092936|FG001|Overall Study|Sponsor Decision|0|||
129216512|NCT01394016|465092937|FG002|Overall Study|Sponsor Decision|0|||
129030236|NCT01426854|464401676|FG001|Overall Study|Adverse Event|5|||
129030237|NCT01426854|464401675|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
129030238|NCT01426854|464401676|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
129030239|NCT01426854|464401675|FG000|Overall Study|Lost to Follow-up|3|||
129030240|NCT01426854|464401676|FG001|Overall Study|Lost to Follow-up|0|||
129030241|NCT01426854|464401675|FG000|Overall Study|Noncompliance|0|||
129030242|NCT01426854|464401676|FG001|Overall Study|Noncompliance|1|||
129030243|NCT01426854|464401675|FG000|Overall Study|Treatment Failure|0|||
129030244|NCT01426854|464401676|FG001|Overall Study|Treatment Failure|16|||
129030245|NCT01426854|464401675|FG000|Overall Study|Protocol Deviation|0|||
129030246|NCT01426854|464401676|FG001|Overall Study|Protocol Deviation|1|||
129030247|NCT01426854|464401675|FG000|Overall Study|Other|3|||
129030248|NCT01426854|464401676|FG001|Overall Study|Other|2|||
129030249|NCT01942135|464401678|FG000|Overall Study|Adverse Event|21|||
129030250|NCT01942135|464401679|FG001|Overall Study|Adverse Event|7|||
129030251|NCT01942135|464401678|FG000|Overall Study|Global Deterioration of Health Status|9|||
129030252|NCT01942135|464401679|FG001|Overall Study|Global Deterioration of Health Status|6|||
129030253|NCT01942135|464401678|FG000|Overall Study|Randomized Not Treated|2|||
129030254|NCT01942135|464401679|FG001|Overall Study|Randomized Not Treated|2|||
129030255|NCT01942135|464401678|FG000|Overall Study|Death|2|||
129030256|NCT01942135|464401679|FG001|Overall Study|Death|1|||
129030257|NCT01942135|464401678|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
129030258|NCT01942135|464401679|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
129030259|NCT01942135|464401678|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
129030260|NCT01942135|464401679|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
129030261|NCT01942135|464401678|FG000|Overall Study|Withdrawal by Subject|4|||
129030262|NCT01942135|464401679|FG001|Overall Study|Withdrawal by Subject|3|||
129030263|NCT01942135|464401678|FG000|Overall Study|Protocol Violation|1|||
129030264|NCT01942135|464401679|FG001|Overall Study|Protocol Violation|0|||
129030265|NCT01942135|464401678|FG000|Overall Study|Other|19|||
129030266|NCT01942135|464401679|FG001|Overall Study|Other|4|||
129030267|NCT00494013|464401680|FG000|Overall Study|Adverse Event|0|||
129030268|NCT00494013|464401681|FG001|Overall Study|Adverse Event|1|||
129030269|NCT00494013|464401680|FG000|Overall Study|Entry Criteria Not Met|1|||
129030270|NCT00494013|464401681|FG001|Overall Study|Entry Criteria Not Met|4|||
129030271|NCT00494013|464401680|FG000|Overall Study|Lost to Follow-up|5|||
129030272|NCT00494013|464401681|FG001|Overall Study|Lost to Follow-up|6|||
129030273|NCT00494013|464401680|FG000|Overall Study|Physician Decision|3|||
129030274|NCT00494013|464401681|FG001|Overall Study|Physician Decision|5|||
129030275|NCT00494013|464401680|FG000|Overall Study|Protocol Violation|8|||
129030276|NCT00494013|464401681|FG001|Overall Study|Protocol Violation|5|||
129030277|NCT00494013|464401680|FG000|Overall Study|Withdrawal by Subject|13|||
129030278|NCT00494013|464401681|FG001|Overall Study|Withdrawal by Subject|14|||
129030279|NCT00494013|464401680|FG000|Overall Study|Sponsor Decision|0|||
129030280|NCT00494013|464401681|FG001|Overall Study|Sponsor Decision|1|||
129030281|NCT03193021|464401682|FG000|Overall Study|Lost to Follow-up|1|||
129030282|NCT03193021|464401683|FG001|Overall Study|Lost to Follow-up|1|||
128767317|NCT01709305|463438206|FG004|Phase 2|Death|0|||
128767318|NCT01709305|463438202|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
128767319|NCT01709305|463438203|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
128767320|NCT01709305|463438204|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
128767321|NCT01709305|463438205|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
128767322|NCT01709305|463438206|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
128767323|NCT01709305|463438202|FG000|Phase 2|Laboratory Adverse Event|0|||
128767324|NCT01709305|463438203|FG001|Phase 2|Laboratory Adverse Event|1|||
128767325|NCT01709305|463438204|FG002|Phase 2|Laboratory Adverse Event|0|||
128767326|NCT01709305|463438205|FG003|Phase 2|Laboratory Adverse Event|1|||
128767327|NCT01709305|463438206|FG004|Phase 2|Laboratory Adverse Event|1|||
128767328|NCT01709305|463438202|FG000|Phase 2|Lost to Follow-up|0|||
128767329|NCT01709305|463438203|FG001|Phase 2|Lost to Follow-up|10|||
128767330|NCT01709305|463438204|FG002|Phase 2|Lost to Follow-up|6|||
128767331|NCT01709305|463438205|FG003|Phase 2|Lost to Follow-up|9|||
128767332|NCT01709305|463438206|FG004|Phase 2|Lost to Follow-up|5|||
128767333|NCT01709305|463438202|FG000|Phase 2|Travel, moving, etc.|0|||
128767334|NCT01709305|463438203|FG001|Phase 2|Travel, moving, etc.|2|||
128767335|NCT01709305|463438204|FG002|Phase 2|Travel, moving, etc.|3|||
129030283|NCT01139762|464401684|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
129030284|NCT01139762|464401685|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
129030285|NCT01139762|464401686|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
129030286|NCT01139762|464401684|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
129030287|NCT01139762|464401685|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
129030288|NCT01139762|464401686|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
129030289|NCT01139762|464401684|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
129030290|NCT01139762|464401685|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
129030291|NCT01139762|464401686|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
129030292|NCT01139762|464401684|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
128929766|NCT01009463|464032818|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
128929767|NCT01009463|464032819|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
128929768|NCT01009463|464032820|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
128929769|NCT01009463|464032816|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
128929770|NCT01009463|464032817|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128929771|NCT01009463|464032818|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128929772|NCT01009463|464032819|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128929773|NCT01009463|464032820|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
128929774|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
128929775|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
128929776|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
128929777|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
128929778|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
128929779|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
128929780|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
128929781|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
128929782|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
128929783|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
128929784|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
128929785|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
128929786|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
128929787|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
128929788|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
128929789|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
128929790|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
128929791|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
128929792|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
128929793|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
129216513|NCT01394016|465092938|FG003|Overall Study|Sponsor Decision|0|||
129216514|NCT01394016|465092939|FG004|Overall Study|Sponsor Decision|0|||
128929794|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
128929795|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
128978059|NCT02743494|464205305|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
128978060|NCT02743494|464205306|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
128978061|NCT02743494|464205305|FG000|Treatment Period|Participant request to discontinue treatment|30|||
128978062|NCT02743494|464205306|FG001|Treatment Period|Participant request to discontinue treatment|5|||
128978063|NCT02743494|464205305|FG000|Treatment Period|Participant withdrew consent|12|||
128978064|NCT02743494|464205306|FG001|Treatment Period|Participant withdrew consent|4|||
128978065|NCT02743494|464205305|FG000|Treatment Period|Lost to Follow-up|0|||
128978066|NCT02743494|464205306|FG001|Treatment Period|Lost to Follow-up|1|||
128978067|NCT02743494|464205305|FG000|Treatment Period|Poor/Non-compliance|1|||
128978068|NCT02743494|464205306|FG001|Treatment Period|Poor/Non-compliance|0|||
128978069|NCT02743494|464205305|FG000|Treatment Period|Other reasons|7|||
128978070|NCT02743494|464205306|FG001|Treatment Period|Other reasons|2|||
128978071|NCT03529162|464205307|FG000|Overall Study|Lost to Follow-up|2|||
128978072|NCT03529162|464205308|FG001|Overall Study|Lost to Follow-up|2|||
128978073|NCT00983827|464205309|FG000|Overall Study|Withdrawal by Subject|1|||
128978074|NCT01521494|464205310|FG000|Overall Study|Adverse Event|1|||
128978075|NCT01521494|464205311|FG001|Overall Study|Adverse Event|2|||
128978076|NCT01521494|464205312|FG002|Overall Study|Adverse Event|9|||
128978077|NCT01521494|464205313|FG003|Overall Study|Adverse Event|6|||
128978078|NCT01521494|464205314|FG004|Overall Study|Adverse Event|2|||
128978079|NCT01521494|464205310|FG000|Overall Study|Lack of Efficacy|0|||
128978080|NCT01521494|464205311|FG001|Overall Study|Lack of Efficacy|0|||
128978081|NCT01521494|464205312|FG002|Overall Study|Lack of Efficacy|0|||
128978082|NCT01521494|464205313|FG003|Overall Study|Lack of Efficacy|0|||
128978083|NCT01521494|464205314|FG004|Overall Study|Lack of Efficacy|2|||
128978084|NCT01521494|464205310|FG000|Overall Study|Withdrawal by Subject|1|||
128978085|NCT01521494|464205311|FG001|Overall Study|Withdrawal by Subject|1|||
128978086|NCT01521494|464205312|FG002|Overall Study|Withdrawal by Subject|0|||
128978087|NCT01521494|464205313|FG003|Overall Study|Withdrawal by Subject|2|||
128978088|NCT01521494|464205314|FG004|Overall Study|Withdrawal by Subject|0|||
128978089|NCT01521494|464205310|FG000|Overall Study|Decrease in serum phosphate|0|||
128978090|NCT01521494|464205311|FG001|Overall Study|Decrease in serum phosphate|2|||
128978091|NCT01521494|464205312|FG002|Overall Study|Decrease in serum phosphate|3|||
128978092|NCT01521494|464205313|FG003|Overall Study|Decrease in serum phosphate|12|||
128978093|NCT01521494|464205314|FG004|Overall Study|Decrease in serum phosphate|0|||
128978094|NCT01521494|464205310|FG000|Overall Study|Decrease in serum calcium|0|||
128978095|NCT01521494|464205311|FG001|Overall Study|Decrease in serum calcium|0|||
128701734|NCT01558271|463205728|FG000|Overall Study|Lost to Follow-up|1|||
128701735|NCT01558271|463205729|FG001|Overall Study|Lost to Follow-up|0|||
129119735|NCT03054428|464735075|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
129119736|NCT03054428|464735073|FG000|Overall Study|Transitioned to OLE study|76|||
129119737|NCT03054428|464735074|FG001|Overall Study|Transitioned to OLE study|76|||
129119738|NCT03054428|464735075|FG002|Overall Study|Transitioned to OLE study|73|||
129119739|NCT03054428|464735073|FG000|Overall Study|Withdrawal by Subject|3|||
129119740|NCT03054428|464735074|FG001|Overall Study|Withdrawal by Subject|2|||
129119741|NCT03054428|464735075|FG002|Overall Study|Withdrawal by Subject|3|||
129119742|NCT03054428|464735073|FG000|Overall Study|Lost to Follow-up|0|||
129119743|NCT03054428|464735074|FG001|Overall Study|Lost to Follow-up|0|||
129119744|NCT03054428|464735075|FG002|Overall Study|Lost to Follow-up|1|||
129119745|NCT06996301|464735082|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
129119746|NCT06996301|464735083|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
129119747|NCT06996301|464735082|FG000|Overall Study|Patients with discordant diagnostic results|107|||
129119748|NCT06996301|464735083|FG001|Overall Study|Patients with discordant diagnostic results|90|||
129119749|NCT06996301|464735082|FG000|Overall Study|Lost to Follow-up|31|||
129119750|NCT06996301|464735083|FG001|Overall Study|Lost to Follow-up|56|||
129119751|NCT06996301|464735082|FG000|Overall Study|Withdrawal by Subject|12|||
129119752|NCT06996301|464735083|FG001|Overall Study|Withdrawal by Subject|7|||
129119753|NCT01884597|464735086|FG000|Overall Study|Adverse Event|0|||
129119754|NCT01884597|464735087|FG001|Overall Study|Adverse Event|0|||
129119755|NCT01884597|464735088|FG002|Overall Study|Adverse Event|1|||
129119756|NCT01884597|464735086|FG000|Overall Study|Lack of Efficacy|1|||
129119757|NCT01884597|464735087|FG001|Overall Study|Lack of Efficacy|0|||
129119758|NCT01884597|464735088|FG002|Overall Study|Lack of Efficacy|0|||
129119759|NCT01884597|464735086|FG000|Overall Study|Death|0|||
129119760|NCT01884597|464735087|FG001|Overall Study|Death|1|||
129119761|NCT01884597|464735088|FG002|Overall Study|Death|0|||
129119762|NCT02097823|464735089|FG000|Overall Study|Withdrawal by Subject|1|||
129119763|NCT02097823|464735090|FG001|Overall Study|Withdrawal by Subject|1|||
129119764|NCT03082729|464735092|FG000|Overall Study|Lost to Follow-up|7|||
129119765|NCT03082729|464735092|FG000|Overall Study|Physician Decision|2|||
129119766|NCT03082729|464735092|FG000|Overall Study|Withdrawal by Subject|1|||
129119767|NCT03082729|464735092|FG000|Overall Study|Lack of Efficacy|9|||
129119768|NCT03082729|464735092|FG000|Overall Study|Adverse Event|4|||
129119769|NCT03082729|464735092|FG000|Overall Study|Protocol Violation|6|||
129119770|NCT03082729|464735092|FG000|Overall Study|Fear of study procedure|1|||
129119771|NCT03082729|464735092|FG000|Overall Study|Scheduling conflict|1|||
129119772|NCT01093846|464735093|FG000|Overall Study|Adverse Event|0|||
129119773|NCT01093846|464735094|FG001|Overall Study|Adverse Event|0|||
129119774|NCT01093846|464735095|FG002|Overall Study|Adverse Event|1|||
129119775|NCT01093846|464735093|FG000|Overall Study|Lack of Efficacy|0|||
129119776|NCT01093846|464735094|FG001|Overall Study|Lack of Efficacy|0|||
129119777|NCT01093846|464735095|FG002|Overall Study|Lack of Efficacy|4|||
129119778|NCT01093846|464735093|FG000|Overall Study|Condition no longer required study drug|1|||
129119779|NCT01093846|464735094|FG001|Overall Study|Condition no longer required study drug|1|||
129119780|NCT01093846|464735095|FG002|Overall Study|Condition no longer required study drug|1|||
129119781|NCT01093846|464735093|FG000|Overall Study|Administrative Problems|18|||
129119782|NCT01093846|464735094|FG001|Overall Study|Administrative Problems|17|||
129119783|NCT01093846|464735095|FG002|Overall Study|Administrative Problems|15|||
129119784|NCT00666237|464735098|FG000|Overall Study|Death|5|||
129119785|NCT00666237|464735099|FG001|Overall Study|Death|5|||
129119786|NCT00666237|464735098|FG000|Overall Study|Lost to Follow-up|29|||
129119787|NCT00666237|464735099|FG001|Overall Study|Lost to Follow-up|25|||
129119788|NCT03321721|464735100|FG000|Overall Study|Lost to Follow-up|4|||
129119789|NCT03321721|464735101|FG001|Overall Study|Lost to Follow-up|8|||
129119790|NCT03321721|464735102|FG002|Overall Study|Lost to Follow-up|11|||
129119791|NCT01416571|464735103|FG000|Overall Study|Lost to Follow-up|2|||
129119792|NCT03353220|464735104|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
129119793|NCT03353220|464735105|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
129119794|NCT00959751|464736983|FG000|Overall Study|Lost to Follow-up|2|||
129119795|NCT00959751|464736984|FG001|Overall Study|Lost to Follow-up|3|||
129119796|NCT00959751|464736983|FG000|Overall Study|Consent Withdrawn|0|||
129119797|NCT00959751|464736984|FG001|Overall Study|Consent Withdrawn|1|||
129119798|NCT00959751|464736983|FG000|Overall Study|Non-compliance to Study Procedures|0|||
128701736|NCT01558271|463205730|FG002|Overall Study|Lost to Follow-up|0|||
129119799|NCT00959751|464736984|FG001|Overall Study|Non-compliance to Study Procedures|1|||
129119800|NCT00959751|464736983|FG000|Overall Study|No migraine headache without aura|7|||
129216515|NCT01394016|465092940|FG005|Overall Study|Sponsor Decision|0|||
128701737|NCT01558271|463205728|FG000|Overall Study|Protocol Violation|1|||
128701738|NCT01558271|463205729|FG001|Overall Study|Protocol Violation|0|||
129119801|NCT00959751|464736984|FG001|Overall Study|No migraine headache without aura|7|||
129119802|NCT01648764|464736990|FG000|Overall Study|Progressive Disease|0|||
129119803|NCT01648764|464736991|FG001|Overall Study|Progressive Disease|1|||
129119804|NCT01648764|464736992|FG002|Overall Study|Progressive Disease|0|||
128701739|NCT01558271|463205730|FG002|Overall Study|Protocol Violation|0|||
128701740|NCT01558271|463205728|FG000|Overall Study|Withdrawal by Subject|10|||
128701741|NCT01558271|463205729|FG001|Overall Study|Withdrawal by Subject|6|||
129030293|NCT01139762|464401685|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
129030294|NCT01139762|464401686|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
129030295|NCT01139762|464401684|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
129030296|NCT01139762|464401685|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
129030297|NCT01139762|464401686|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
129030298|NCT01139762|464401684|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
129030299|NCT01139762|464401685|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
129030300|NCT01139762|464401686|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
129030301|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
129030302|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
129030303|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
129030304|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Death|0|||
129030305|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Death|1|||
129030306|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Death|1|||
129030307|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
128701742|NCT01558271|463205730|FG002|Overall Study|Withdrawal by Subject|12|||
128701743|NCT01558271|463205728|FG000|Overall Study|Physician Decision|0|||
128701744|NCT01558271|463205729|FG001|Overall Study|Physician Decision|2|||
128701745|NCT01558271|463205730|FG002|Overall Study|Physician Decision|1|||
128701746|NCT01845831|463205731|FG000|Inpatient Phase|Withdrawal by Subject|1|||
128701747|NCT01845831|463205732|FG001|Inpatient Phase|Withdrawal by Subject|1|||
128701748|NCT01845831|463205733|FG002|Inpatient Phase|Withdrawal by Subject|0|||
128701749|NCT01845831|463205734|FG003|Inpatient Phase|Withdrawal by Subject|0|||
128701750|NCT01845831|463205735|FG004|Inpatient Phase|Withdrawal by Subject|0|||
128701751|NCT02610725|463205736|FG000|Overall Study|Lost to Follow-up|197|||
128701752|NCT02610725|463205736|FG000|Overall Study|self-reported contraindication|9|||
128701753|NCT00826943|463205737|FG000|Overall Study|Withdrawal by Subject|0|||
128701754|NCT00826943|463205738|FG001|Overall Study|Withdrawal by Subject|0|||
128701755|NCT00826943|463205739|FG002|Overall Study|Withdrawal by Subject|0|||
128701756|NCT00826943|463205740|FG003|Overall Study|Withdrawal by Subject|0|||
128701757|NCT00826943|463205741|FG004|Overall Study|Withdrawal by Subject|1|||
128701758|NCT00826943|463205742|FG005|Overall Study|Withdrawal by Subject|0|||
128701759|NCT01348165|463205743|FG000|Overall Study|Adverse Event|0|||
128701760|NCT01348165|463205744|FG001|Overall Study|Adverse Event|0|||
128701761|NCT01348165|463205745|FG002|Overall Study|Adverse Event|0|||
128701762|NCT01348165|463205746|FG003|Overall Study|Adverse Event|0|||
128701763|NCT01348165|463205747|FG004|Overall Study|Adverse Event|0|||
128701764|NCT01348165|463205748|FG005|Overall Study|Adverse Event|0|||
128701765|NCT01348165|463205749|FG006|Overall Study|Adverse Event|1|||
128701766|NCT01594762|463205750|FG000|Overall Study|Withdrawal by Subject|1|||
128701767|NCT01594762|463205751|FG001|Overall Study|Withdrawal by Subject|0|||
128701768|NCT01594762|463205750|FG000|Overall Study|Lost to Follow-up|10|||
128701769|NCT01594762|463205751|FG001|Overall Study|Lost to Follow-up|10|||
128701770|NCT05570500|463205752|FG000|Overall Study|Lost to Follow-up|7|||
128701771|NCT05570500|463205753|FG001|Overall Study|Lost to Follow-up|5|||
128701772|NCT04706091|463205754|FG000|Treatment 2|Withdrawal by Subject|1|||
128701773|NCT04706091|463205755|FG001|Treatment 2|Withdrawal by Subject|0|||
128701774|NCT02612727|463205756|FG000|Overall Study|Parent request|4|||
128701775|NCT02612727|463205757|FG001|Overall Study|Parent request|1|||
128701776|NCT02612727|463205756|FG000|Overall Study|Needed treatment incompatible with PT|1|||
128701777|NCT02612727|463205757|FG001|Overall Study|Needed treatment incompatible with PT|1|||
128701778|NCT02612727|463205756|FG000|Overall Study|Direct hyperbilirubinemia|0|||
128701779|NCT02612727|463205757|FG001|Overall Study|Direct hyperbilirubinemia|2|||
128701780|NCT01446289|463205758|FG000|Overall Study|Withdrawal by Subject|1|||
128701781|NCT01446289|463205759|FG001|Overall Study|Withdrawal by Subject|0|||
128701782|NCT01446289|463205760|FG002|Overall Study|Withdrawal by Subject|1|||
128701783|NCT01446289|463205761|FG003|Overall Study|Withdrawal by Subject|0|||
128701784|NCT02302807|463205762|FG000|Overall Study|Withdrawal by Subject|28|||
128701785|NCT02302807|463205763|FG001|Overall Study|Withdrawal by Subject|11|||
128701786|NCT02302807|463205762|FG000|Overall Study|Lost to Follow-up|4|||
128701787|NCT02302807|463205763|FG001|Overall Study|Lost to Follow-up|6|||
128701788|NCT02302807|463205762|FG000|Overall Study|Death|397|||
129030308|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
129216516|NCT01394016|465092941|FG006|Overall Study|Sponsor Decision|0|||
129216517|NCT01394016|465092942|FG007|Overall Study|Sponsor Decision|0|||
128701789|NCT02302807|463205763|FG001|Overall Study|Death|385|||
128701790|NCT02302807|463205762|FG000|Overall Study|Study Terminated By Sponsor|35|||
128701791|NCT02302807|463205763|FG001|Overall Study|Study Terminated By Sponsor|64|||
128701792|NCT02302807|463205762|FG000|Overall Study|Physician Decision|0|||
128701793|NCT02302807|463205763|FG001|Overall Study|Physician Decision|1|||
128701794|NCT05243641|463205764|FG000|Overall Study|Adverse Event|3|||
129030309|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
128701795|NCT05243641|463205765|FG001|Overall Study|Adverse Event|0|||
128701796|NCT05243641|463205766|FG002|Overall Study|Adverse Event|0|||
128701797|NCT05243641|463205767|FG003|Overall Study|Adverse Event|1|||
128701798|NCT05243641|463205768|FG004|Overall Study|Adverse Event|0|||
128701799|NCT05243641|463205769|FG005|Overall Study|Adverse Event|0|||
128701800|NCT05243641|463205764|FG000|Overall Study|Disease progression|4|||
128701801|NCT05243641|463205765|FG001|Overall Study|Disease progression|0|||
128701802|NCT05243641|463205766|FG002|Overall Study|Disease progression|0|||
128701803|NCT05243641|463205767|FG003|Overall Study|Disease progression|2|||
128701804|NCT05243641|463205768|FG004|Overall Study|Disease progression|0|||
128701805|NCT05243641|463205769|FG005|Overall Study|Disease progression|0|||
128701806|NCT04518306|463205770|FG000|Double-Blind Period|Run in failure|0|||
128701807|NCT04518306|463205771|FG001|Double-Blind Period|Run in failure|0|||
128701808|NCT04518306|463205772|FG002|Double-Blind Period|Run in failure|1|||
128701809|NCT04518306|463205770|FG000|Double-Blind Period|Adverse Event|0|||
128701810|NCT04518306|463205771|FG001|Double-Blind Period|Adverse Event|2|||
128701811|NCT04518306|463205772|FG002|Double-Blind Period|Adverse Event|2|||
128701812|NCT04518306|463205770|FG000|Double-Blind Period|Lost to Follow-up|1|||
128701813|NCT04518306|463205771|FG001|Double-Blind Period|Lost to Follow-up|2|||
128701814|NCT04518306|463205772|FG002|Double-Blind Period|Lost to Follow-up|2|||
128701815|NCT04518306|463205770|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
128701816|NCT04518306|463205771|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
128701817|NCT04518306|463205772|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
128701818|NCT04518306|463205770|FG000|Double-Blind Period|Other|0|||
128701819|NCT04518306|463205771|FG001|Double-Blind Period|Other|2|||
128701820|NCT04518306|463205772|FG002|Double-Blind Period|Other|0|||
128701821|NCT04518306|463205770|FG000|Double-Blind Period|Missing|0|||
128701822|NCT04518306|463205771|FG001|Double-Blind Period|Missing|1|||
128701823|NCT04518306|463205772|FG002|Double-Blind Period|Missing|0|||
128701824|NCT03904043|463205773|FG000|Overall Study|Adverse Event|1|||
128701825|NCT03904043|463205774|FG001|Overall Study|Adverse Event|1|||
128701826|NCT03904043|463205773|FG000|Overall Study|Withdrawal by Subject|1|||
128701827|NCT03904043|463205774|FG001|Overall Study|Withdrawal by Subject|0|||
128701828|NCT03904043|463205773|FG000|Overall Study|Non-compliance|1|||
128701829|NCT03904043|463205774|FG001|Overall Study|Non-compliance|0|||
128701830|NCT03904043|463205773|FG000|Overall Study|Did not start treatment|1|||
128701831|NCT03904043|463205774|FG001|Overall Study|Did not start treatment|0|||
128701832|NCT02469298|463207467|FG000|Overall Study|Protocol Violation|0|||
128701833|NCT02469298|463207468|FG001|Overall Study|Protocol Violation|1|||
128701834|NCT02469298|463207469|FG002|Overall Study|Protocol Violation|1|||
128701835|NCT02469298|463207470|FG003|Overall Study|Protocol Violation|0|||
128701836|NCT02469298|463207467|FG000|Overall Study|Lost to Follow-up|1|||
128701837|NCT02469298|463207468|FG001|Overall Study|Lost to Follow-up|0|||
128701838|NCT02469298|463207469|FG002|Overall Study|Lost to Follow-up|1|||
128701839|NCT02469298|463207470|FG003|Overall Study|Lost to Follow-up|0|||
128701840|NCT02469298|463207467|FG000|Overall Study|Physician Decision|0|||
128701841|NCT02469298|463207468|FG001|Overall Study|Physician Decision|0|||
128701842|NCT02469298|463207469|FG002|Overall Study|Physician Decision|0|||
128701843|NCT02469298|463207470|FG003|Overall Study|Physician Decision|1|||
128701844|NCT02469298|463207467|FG000|Overall Study|Withdrawal by Subject|0|||
128701845|NCT02469298|463207468|FG001|Overall Study|Withdrawal by Subject|0|||
128701846|NCT02469298|463207469|FG002|Overall Study|Withdrawal by Subject|0|||
128701847|NCT02469298|463207470|FG003|Overall Study|Withdrawal by Subject|1|||
128701848|NCT02370160|463207474|FG000|Overall Study|Death|3|||
128701849|NCT02370160|463207475|FG001|Overall Study|Death|4|||
128701850|NCT02370160|463207476|FG002|Overall Study|Death|1|||
128701851|NCT04487730|463207477|FG000|Overall Study|Withdrawal by Subject|3|||
128701852|NCT04487730|463207478|FG001|Overall Study|Withdrawal by Subject|1|||
128701853|NCT04487730|463207477|FG000|Overall Study|Lost to Follow-up|0|||
128701854|NCT04487730|463207478|FG001|Overall Study|Lost to Follow-up|1|||
128701855|NCT04487730|463207477|FG000|Overall Study|Physician Decision|0|||
128701856|NCT04487730|463207478|FG001|Overall Study|Physician Decision|1|||
128701857|NCT03291808|463207483|FG000|Overall Study|Lost to Follow-up|6|||
128701858|NCT03291808|463207483|FG000|Overall Study|Research burden|4|||
128701859|NCT01892293|463207486|FG000|Overall Study|Apheresed but not treated|4|||
128701860|NCT03602482|463207487|FG000|Overall Study|Withdrawal by Subject|6|||
128701861|NCT03602482|463207488|FG001|Overall Study|Withdrawal by Subject|7|||
128701862|NCT03602482|463207489|FG002|Overall Study|Withdrawal by Subject|0|||
128701863|NCT03602482|463207490|FG003|Overall Study|Withdrawal by Subject|0|||
128701864|NCT02397278|463207491|FG000|Overall Study|Withdrawal by Subject|0|||
128701865|NCT02397278|463207492|FG001|Overall Study|Withdrawal by Subject|2|||
128701866|NCT02397278|463207491|FG000|Overall Study|Deemed ineligible following surgery|1|||
128701867|NCT02397278|463207492|FG001|Overall Study|Deemed ineligible following surgery|1|||
128701868|NCT01397084|463207497|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
128701869|NCT01397084|463207497|FG000|Overall Study|Protocol Violation|2|||
128701870|NCT01397084|463207497|FG000|Overall Study|Adverse Event|2|||
128701871|NCT01397084|463207497|FG000|Overall Study|Withdrawal by Subject|1|||
128701872|NCT01397084|463207497|FG000|Overall Study|Lost to Follow-up|1|||
129119805|NCT01648764|464736993|FG003|Overall Study|Progressive Disease|0|||
129119806|NCT01648764|464736994|FG004|Overall Study|Progressive Disease|0|||
129119807|NCT01648764|464736995|FG005|Overall Study|Progressive Disease|1|||
129119808|NCT01648764|464736996|FG006|Overall Study|Progressive Disease|1|||
129119809|NCT01648764|464736997|FG007|Overall Study|Progressive Disease|0|||
129119810|NCT01648764|464736998|FG008|Overall Study|Progressive Disease|0|||
129119811|NCT01648764|464736999|FG009|Overall Study|Progressive Disease|2|||
129119812|NCT01648764|464737000|FG010|Overall Study|Progressive Disease|0|||
129119813|NCT01648764|464737001|FG011|Overall Study|Progressive Disease|1|||
129119814|NCT01648764|464737002|FG012|Overall Study|Progressive Disease|2|||
129119815|NCT01648764|464737003|FG013|Overall Study|Progressive Disease|1|||
129119816|NCT01648764|464736990|FG000|Overall Study|Adverse Event|0|||
129119817|NCT01648764|464736991|FG001|Overall Study|Adverse Event|0|||
129119818|NCT01648764|464736992|FG002|Overall Study|Adverse Event|0|||
129119819|NCT01648764|464736993|FG003|Overall Study|Adverse Event|0|||
129119820|NCT01648764|464736994|FG004|Overall Study|Adverse Event|0|||
129119821|NCT01648764|464736995|FG005|Overall Study|Adverse Event|1|||
129119822|NCT01648764|464736996|FG006|Overall Study|Adverse Event|0|||
129119823|NCT01648764|464736997|FG007|Overall Study|Adverse Event|0|||
129119824|NCT01648764|464736998|FG008|Overall Study|Adverse Event|0|||
129119825|NCT01648764|464736999|FG009|Overall Study|Adverse Event|1|||
129119826|NCT01648764|464737000|FG010|Overall Study|Adverse Event|0|||
129119827|NCT01648764|464737001|FG011|Overall Study|Adverse Event|3|||
129119828|NCT01648764|464737002|FG012|Overall Study|Adverse Event|1|||
129119829|NCT01648764|464737003|FG013|Overall Study|Adverse Event|1|||
129119830|NCT01648764|464736990|FG000|Overall Study|Death|0|||
129119831|NCT01648764|464736991|FG001|Overall Study|Death|0|||
129119832|NCT01648764|464736992|FG002|Overall Study|Death|0|||
129119833|NCT01648764|464736993|FG003|Overall Study|Death|0|||
129119834|NCT01648764|464736994|FG004|Overall Study|Death|0|||
129119835|NCT01648764|464736995|FG005|Overall Study|Death|0|||
129119836|NCT01648764|464736996|FG006|Overall Study|Death|1|||
129119837|NCT01648764|464736997|FG007|Overall Study|Death|0|||
129119838|NCT01648764|464736998|FG008|Overall Study|Death|0|||
129119839|NCT01648764|464736999|FG009|Overall Study|Death|0|||
129119840|NCT01648764|464737000|FG010|Overall Study|Death|0|||
129119841|NCT01648764|464737001|FG011|Overall Study|Death|0|||
129119842|NCT01648764|464737002|FG012|Overall Study|Death|0|||
129119843|NCT01648764|464737003|FG013|Overall Study|Death|1|||
129119844|NCT01648764|464736990|FG000|Overall Study|Withdrawal by Subject|0|||
129119845|NCT01648764|464736991|FG001|Overall Study|Withdrawal by Subject|0|||
129119846|NCT01648764|464736992|FG002|Overall Study|Withdrawal by Subject|0|||
129119847|NCT01648764|464736993|FG003|Overall Study|Withdrawal by Subject|0|||
129119848|NCT01648764|464736994|FG004|Overall Study|Withdrawal by Subject|0|||
129119849|NCT01648764|464736995|FG005|Overall Study|Withdrawal by Subject|0|||
129119850|NCT01648764|464736996|FG006|Overall Study|Withdrawal by Subject|2|||
129119851|NCT01648764|464736997|FG007|Overall Study|Withdrawal by Subject|0|||
129119852|NCT01648764|464736998|FG008|Overall Study|Withdrawal by Subject|0|||
129119853|NCT01648764|464736999|FG009|Overall Study|Withdrawal by Subject|0|||
129119854|NCT01648764|464737000|FG010|Overall Study|Withdrawal by Subject|0|||
129119855|NCT01648764|464737001|FG011|Overall Study|Withdrawal by Subject|0|||
129119856|NCT01648764|464737002|FG012|Overall Study|Withdrawal by Subject|1|||
129119857|NCT01648764|464737003|FG013|Overall Study|Withdrawal by Subject|0|||
129119858|NCT01648764|464736990|FG000|Overall Study|Investigator Decision|0|||
129119859|NCT01648764|464736991|FG001|Overall Study|Investigator Decision|0|||
129119860|NCT01648764|464736992|FG002|Overall Study|Investigator Decision|0|||
129119861|NCT01648764|464736993|FG003|Overall Study|Investigator Decision|0|||
129119862|NCT01648764|464736994|FG004|Overall Study|Investigator Decision|0|||
129119863|NCT01648764|464736995|FG005|Overall Study|Investigator Decision|0|||
129119864|NCT01648764|464736996|FG006|Overall Study|Investigator Decision|1|||
129119865|NCT01648764|464736997|FG007|Overall Study|Investigator Decision|0|||
129119866|NCT01648764|464736998|FG008|Overall Study|Investigator Decision|0|||
129119867|NCT01648764|464736999|FG009|Overall Study|Investigator Decision|0|||
129119868|NCT01648764|464737000|FG010|Overall Study|Investigator Decision|0|||
129119869|NCT01648764|464737001|FG011|Overall Study|Investigator Decision|1|||
129119870|NCT01648764|464737002|FG012|Overall Study|Investigator Decision|0|||
128978096|NCT01521494|464205312|FG002|Overall Study|Decrease in serum calcium|0|||
129119871|NCT01648764|464737003|FG013|Overall Study|Investigator Decision|0|||
129119872|NCT00715208|464737004|FG000|Overall Study|Withdrawal by Subject|1|||
129119873|NCT00715208|464737005|FG001|Overall Study|Withdrawal by Subject|1|||
129119874|NCT00715208|464737004|FG000|Overall Study|Adverse Event|0|||
129119875|NCT00715208|464737005|FG001|Overall Study|Adverse Event|6|||
129216518|NCT01394016|465092943|FG008|Overall Study|Sponsor Decision|0|||
129119876|NCT00715208|464737004|FG000|Overall Study|Lack of Efficacy|0|||
129119877|NCT00715208|464737005|FG001|Overall Study|Lack of Efficacy|2|||
129119878|NCT01715831|464737006|FG000|Overall Study|Adverse Event|1|||
129119879|NCT00900562|464737007|FG000|Overall Study|Progressive disease|9|||
129119880|NCT00900562|464737008|FG001|Overall Study|Progressive disease|5|||
129119881|NCT00900562|464737007|FG000|Overall Study|Toxicity|1|||
129119882|NCT00900562|464737008|FG001|Overall Study|Toxicity|0|||
128929796|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
128929797|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
128929798|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
128929799|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
128929800|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
128929801|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
129119883|NCT00900562|464737007|FG000|Overall Study|Death|1|||
129119884|NCT00900562|464737008|FG001|Overall Study|Death|1|||
129119885|NCT00900562|464737007|FG000|Overall Study|Withdrawal by Subject|0|||
128929802|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
128929803|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
128929804|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128929805|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
128929806|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
128929807|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
128929808|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
128929809|NCT01009463|464032816|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
128929810|NCT01009463|464032817|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
128929811|NCT01009463|464032818|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
128929812|NCT01009463|464032819|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
128929813|NCT01009463|464032820|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
128929814|NCT02333331|464032821|FG000|Overall Study|Adverse Event|1|||
128929815|NCT02333331|464032822|FG001|Overall Study|Adverse Event|0|||
128929816|NCT02333331|464032823|FG002|Overall Study|Adverse Event|4|||
128929817|NCT02333331|464032824|FG003|Overall Study|Adverse Event|1|||
128929818|NCT02333331|464032821|FG000|Overall Study|Death|0|||
129119886|NCT00900562|464737008|FG001|Overall Study|Withdrawal by Subject|1|||
129119887|NCT00900562|464737007|FG000|Overall Study|Unrelated adverse event|1|||
129119888|NCT00900562|464737008|FG001|Overall Study|Unrelated adverse event|0|||
129119889|NCT03587636|464737009|FG000|Overall Study|Lost to Follow-up|2|||
129119890|NCT03587636|464737010|FG001|Overall Study|Lost to Follow-up|5|||
129119891|NCT00316004|464737011|FG000|Overall Study|Subject was not given study fluid.|14|||
129119892|NCT00316004|464737012|FG001|Overall Study|Subject was not given study fluid.|14|||
129119893|NCT00316004|464737013|FG002|Overall Study|Subject was not given study fluid.|21|||
129119894|NCT01118299|464737016|FG000|Overall Study|Death|7|||
129119895|NCT01118299|464737017|FG001|Overall Study|Death|5|||
129119896|NCT01118299|464737016|FG000|Overall Study|Withdrawal by Subject|8|||
129119897|NCT01118299|464737017|FG001|Overall Study|Withdrawal by Subject|8|||
129119898|NCT01118299|464737016|FG000|Overall Study|Lost to Follow-up|2|||
129119899|NCT01118299|464737017|FG001|Overall Study|Lost to Follow-up|1|||
129119900|NCT01118299|464737016|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
129119901|NCT01118299|464737017|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
129119902|NCT00784875|464737018|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
129119903|NCT00784875|464737019|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
129119904|NCT00784875|464737020|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
129119905|NCT00784875|464737021|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
129119906|NCT00784875|464737018|FG000|Period A - Baseline|Adverse Event|0|||
129119907|NCT00784875|464737019|FG001|Period A - Baseline|Adverse Event|0|||
129119908|NCT00784875|464737020|FG002|Period A - Baseline|Adverse Event|0|||
129119909|NCT00784875|464737021|FG003|Period A - Baseline|Adverse Event|8|||
129119910|NCT00784875|464737018|FG000|Period A - Baseline|Protocol Violation|0|||
129119911|NCT00784875|464737019|FG001|Period A - Baseline|Protocol Violation|0|||
129119912|NCT00784875|464737020|FG002|Period A - Baseline|Protocol Violation|0|||
129119913|NCT00784875|464737021|FG003|Period A - Baseline|Protocol Violation|25|||
129119914|NCT00784875|464737018|FG000|Period A - Baseline|Withdrawal by Subject|0|||
129119915|NCT00784875|464737019|FG001|Period A - Baseline|Withdrawal by Subject|0|||
129119916|NCT00784875|464737020|FG002|Period A - Baseline|Withdrawal by Subject|0|||
128701873|NCT01397084|463207497|FG000|Overall Study|Used other proton pump inhibitor|1|||
128701874|NCT00618072|463207503|FG000|Overall Study|Lost to Follow-up|2|||
128701875|NCT00618072|463207504|FG001|Overall Study|Lost to Follow-up|0|||
128701876|NCT00618072|463207505|FG002|Overall Study|Lost to Follow-up|3|||
128701877|NCT00618072|463207503|FG000|Overall Study|Physician Decision|0|||
129119917|NCT00784875|464737021|FG003|Period A - Baseline|Withdrawal by Subject|27|||
129119918|NCT00784875|464737018|FG000|Period A - Baseline|Physician Decision|0|||
129119919|NCT00784875|464737019|FG001|Period A - Baseline|Physician Decision|0|||
128929819|NCT02333331|464032822|FG001|Overall Study|Death|0|||
128929820|NCT02333331|464032823|FG002|Overall Study|Death|2|||
128929821|NCT02333331|464032824|FG003|Overall Study|Death|0|||
129119920|NCT00784875|464737020|FG002|Period A - Baseline|Physician Decision|0|||
129119921|NCT00784875|464737021|FG003|Period A - Baseline|Physician Decision|2|||
129119922|NCT00784875|464737018|FG000|Period A - Baseline|Sponsor Decision|0|||
129119923|NCT00784875|464737019|FG001|Period A - Baseline|Sponsor Decision|0|||
129119924|NCT00784875|464737020|FG002|Period A - Baseline|Sponsor Decision|0|||
129119925|NCT00784875|464737021|FG003|Period A - Baseline|Sponsor Decision|113|||
129119926|NCT00784875|464737018|FG000|Period A - Baseline|Lost to Follow-up|0|||
129119927|NCT00784875|464737019|FG001|Period A - Baseline|Lost to Follow-up|0|||
129119928|NCT00784875|464737020|FG002|Period A - Baseline|Lost to Follow-up|0|||
129119929|NCT00784875|464737021|FG003|Period A - Baseline|Lost to Follow-up|2|||
129119930|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
129119931|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
129119932|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
129119933|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
128701878|NCT00618072|463207504|FG001|Overall Study|Physician Decision|1|||
128701879|NCT00618072|463207505|FG002|Overall Study|Physician Decision|1|||
128701880|NCT03292588|463207506|FG000|Overall Study|Death|1|||
128701881|NCT03292588|463207507|FG001|Overall Study|Death|0|||
128701882|NCT03292588|463207506|FG000|Overall Study|Lost to Follow-up|12|||
128701883|NCT03292588|463207507|FG001|Overall Study|Lost to Follow-up|16|||
128701884|NCT03292588|463207506|FG000|Overall Study|Physician Decision|0|||
128701885|NCT03292588|463207507|FG001|Overall Study|Physician Decision|1|||
128701886|NCT03292588|463207506|FG000|Overall Study|Withdrawal by Subject|4|||
128701887|NCT03292588|463207507|FG001|Overall Study|Withdrawal by Subject|4|||
128701888|NCT03292588|463207506|FG000|Overall Study|Move out of town|1|||
128701889|NCT03292588|463207507|FG001|Overall Study|Move out of town|0|||
128701890|NCT03292588|463207506|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
128701891|NCT03292588|463207507|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
128701892|NCT00062374|463207508|FG000|Overall Study|Not treated|12|||
128701893|NCT04932096|463207511|FG000|Overall Study|Withdrawal by Subject|1|||
128701894|NCT04932096|463207512|FG001|Overall Study|Withdrawal by Subject|1|||
128701895|NCT04932096|463207511|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
128701896|NCT04932096|463207512|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
128701897|NCT02170298|463207513|FG000|Overall Study|Withdrawal by Subject|0|||
128701898|NCT02170298|463207514|FG001|Overall Study|Withdrawal by Subject|1|||
128701899|NCT02170298|463207513|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
128701900|NCT02170298|463207514|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
128701901|NCT02853604|463207515|FG000|Overall Study|Withdrawal by Subject|12|||
128701902|NCT02853604|463207516|FG001|Overall Study|Withdrawal by Subject|35|||
128701903|NCT02853604|463207515|FG000|Overall Study|Lost to Follow-up|4|||
128701904|NCT02853604|463207516|FG001|Overall Study|Lost to Follow-up|8|||
128701905|NCT02853604|463207515|FG000|Overall Study|Death|1|||
128701906|NCT02853604|463207516|FG001|Overall Study|Death|5|||
128701907|NCT02853604|463207515|FG000|Overall Study|Miscellaneous|11|||
128701908|NCT02853604|463207516|FG001|Overall Study|Miscellaneous|2|||
128701909|NCT02853604|463207515|FG000|Overall Study|Progressive Disease|0|||
128701910|NCT02853604|463207516|FG001|Overall Study|Progressive Disease|2|||
128701911|NCT04213079|463207517|FG000|Overall Study|Lost to Follow-up|0|||
128701912|NCT04213079|463207518|FG001|Overall Study|Lost to Follow-up|2|||
128701913|NCT00119106|463207525|FG000|Overall Study|HIV infected at baseline|179|||
128701914|NCT00119106|463207526|FG001|Overall Study|HIV infected at baseline|178|||
128701915|NCT03066804|463207527|FG000|Overall Study|Physician Decision|0|||
128701916|NCT03066804|463207528|FG001|Overall Study|Physician Decision|4|||
128701917|NCT03066804|463207527|FG000|Overall Study|Death|23|||
128701918|NCT03066804|463207528|FG001|Overall Study|Death|17|||
128701919|NCT03066804|463207527|FG000|Overall Study|Withdrawal by Subject|19|||
128701920|NCT03066804|463207528|FG001|Overall Study|Withdrawal by Subject|25|||
128701921|NCT03066804|463207527|FG000|Overall Study|Lost to Follow-up|2|||
128701922|NCT03066804|463207528|FG001|Overall Study|Lost to Follow-up|0|||
128701923|NCT03066804|463207527|FG000|Overall Study|Adverse Event|2|||
128701924|NCT03066804|463207528|FG001|Overall Study|Adverse Event|3|||
128701925|NCT03066804|463207527|FG000|Overall Study|Technical problems|5|||
128701926|NCT03066804|463207528|FG001|Overall Study|Technical problems|1|||
128701927|NCT00329238|463207529|FG000|Overall Study|Adverse Event|147|||
128701928|NCT00329238|463207530|FG001|Overall Study|Adverse Event|129|||
128701929|NCT00329238|463207529|FG000|Overall Study|Protocol Violation|23|||
128701930|NCT00329238|463207530|FG001|Overall Study|Protocol Violation|34|||
128701931|NCT00329238|463207529|FG000|Overall Study|Lost to Follow-up|2|||
128701932|NCT00329238|463207530|FG001|Overall Study|Lost to Follow-up|6|||
129119934|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
128701933|NCT00329238|463207529|FG000|Overall Study|Withdrawal by Subject|64|||
129119935|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
129216519|NCT01394016|465092944|FG009|Overall Study|Sponsor Decision|0|||
129216520|NCT01394016|465092945|FG010|Overall Study|Sponsor Decision|0|||
128701934|NCT00329238|463207530|FG001|Overall Study|Withdrawal by Subject|58|||
128701935|NCT00329238|463207529|FG000|Overall Study|Other reason (not specified)|40|||
128701936|NCT00329238|463207530|FG001|Overall Study|Other reason (not specified)|54|||
128929822|NCT02333331|464032821|FG000|Overall Study|Lost to Follow-up|0|||
128929823|NCT02333331|464032822|FG001|Overall Study|Lost to Follow-up|0|||
128929824|NCT02333331|464032823|FG002|Overall Study|Lost to Follow-up|1|||
128929825|NCT02333331|464032824|FG003|Overall Study|Lost to Follow-up|0|||
129216521|NCT01394016|465092946|FG011|Overall Study|Sponsor Decision|0|||
129216522|NCT01394016|465092947|FG012|Overall Study|Sponsor Decision|1|||
129216523|NCT01394016|465092948|FG013|Overall Study|Sponsor Decision|0|||
129216524|NCT01394016|465092949|FG014|Overall Study|Sponsor Decision|0|||
129216525|NCT01394016|465092950|FG015|Overall Study|Sponsor Decision|0|||
129216526|NCT01394016|465092951|FG016|Overall Study|Sponsor Decision|0|||
129216527|NCT01394016|465092952|FG017|Overall Study|Sponsor Decision|0|||
129216528|NCT01394016|465092953|FG018|Overall Study|Sponsor Decision|0|||
129216529|NCT01394016|465092935|FG000|Overall Study|Lost to Follow-up|0|||
129216530|NCT01394016|465092936|FG001|Overall Study|Lost to Follow-up|0|||
129216531|NCT01394016|465092937|FG002|Overall Study|Lost to Follow-up|0|||
129216532|NCT01394016|465092938|FG003|Overall Study|Lost to Follow-up|0|||
129216533|NCT01394016|465092939|FG004|Overall Study|Lost to Follow-up|0|||
129216534|NCT01394016|465092940|FG005|Overall Study|Lost to Follow-up|0|||
128701941|NCT01328431|463207535|FG000|Baseline|Protocol Violation|0|||
128701942|NCT01328431|463207536|FG001|Baseline|Protocol Violation|2|||
128929826|NCT02333331|464032821|FG000|Overall Study|Physician Decision|0|||
128929827|NCT02333331|464032822|FG001|Overall Study|Physician Decision|1|||
128929828|NCT02333331|464032823|FG002|Overall Study|Physician Decision|0|||
128929829|NCT02333331|464032824|FG003|Overall Study|Physician Decision|0|||
128929830|NCT02333331|464032821|FG000|Overall Study|Protocol Deviation|0|||
128929831|NCT02333331|464032822|FG001|Overall Study|Protocol Deviation|3|||
128929832|NCT02333331|464032823|FG002|Overall Study|Protocol Deviation|2|||
128929833|NCT02333331|464032824|FG003|Overall Study|Protocol Deviation|1|||
128929834|NCT02333331|464032821|FG000|Overall Study|Patient/Guardian Decision|1|||
128929835|NCT02333331|464032822|FG001|Overall Study|Patient/Guardian Decision|2|||
128929836|NCT02333331|464032823|FG002|Overall Study|Patient/Guardian Decision|9|||
128929837|NCT02333331|464032824|FG003|Overall Study|Patient/Guardian Decision|1|||
128929838|NCT01494038|464032825|FG000|Overall Study|Protocol Violation|1|||
128929839|NCT01494038|464032826|FG001|Overall Study|Protocol Violation|1|||
128929840|NCT01494038|464032825|FG000|Overall Study|Lost to Follow-up|18|||
128929841|NCT01494038|464032826|FG001|Overall Study|Lost to Follow-up|20|||
128929842|NCT01494038|464032825|FG000|Overall Study|Withdrawal by Subject|44|||
128929843|NCT01494038|464032826|FG001|Overall Study|Withdrawal by Subject|34|||
128929844|NCT01494038|464032825|FG000|Overall Study|Not able to get to clinic|21|||
128929845|NCT01494038|464032826|FG001|Overall Study|Not able to get to clinic|15|||
128929846|NCT01494038|464032825|FG000|Overall Study|Not willing to adhere to reqs|2|||
128929847|NCT01494038|464032826|FG001|Overall Study|Not willing to adhere to reqs|9|||
128929848|NCT01494038|464032825|FG000|Overall Study|Death|2|||
128929849|NCT01494038|464032826|FG001|Overall Study|Death|4|||
128929850|NCT05309668|464032828|FG000|Overall Study|Ongoing at data cut-off|14|||
128929851|NCT05309668|464032829|FG001|Overall Study|Ongoing at data cut-off|17|||
128929852|NCT05309668|464032830|FG002|Overall Study|Ongoing at data cut-off|4|||
128929853|NCT02401256|464032833|FG000|Overall Study|Adverse Event|5|||
128929854|NCT02401256|464032833|FG000|Overall Study|Withdrawal by Subject|12|||
128929855|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
128929856|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
128929857|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
129216535|NCT01394016|465092941|FG006|Overall Study|Lost to Follow-up|0|||
129216536|NCT01394016|465092942|FG007|Overall Study|Lost to Follow-up|0|||
129216537|NCT01394016|465092943|FG008|Overall Study|Lost to Follow-up|0|||
129216538|NCT01394016|465092944|FG009|Overall Study|Lost to Follow-up|0|||
128701943|NCT01328431|463207535|FG000|1 Month (1M)|Lost to Follow-up|55|||
128701944|NCT01328431|463207536|FG001|1 Month (1M)|Lost to Follow-up|58|||
129216539|NCT01394016|465092945|FG010|Overall Study|Lost to Follow-up|0|||
128701945|NCT01328431|463207535|FG000|3 Month (3M)|Death|2|||
128701946|NCT01328431|463207536|FG001|3 Month (3M)|Death|2|||
128701947|NCT01328431|463207535|FG000|3 Month (3M)|Lost to Follow-up|75|||
128701948|NCT01328431|463207536|FG001|3 Month (3M)|Lost to Follow-up|70|||
128701949|NCT01328431|463207535|FG000|12 Month (12M)|Death|2|||
128701950|NCT01328431|463207536|FG001|12 Month (12M)|Death|6|||
128701951|NCT01328431|463207535|FG000|12 Month (12M)|Lost to Follow-up|82|||
129216540|NCT01394016|465092946|FG011|Overall Study|Lost to Follow-up|0|||
129216541|NCT01394016|465092947|FG012|Overall Study|Lost to Follow-up|0|||
128701952|NCT01328431|463207536|FG001|12 Month (12M)|Lost to Follow-up|91|||
128701953|NCT01427972|463207547|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128701954|NCT01427972|463207548|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128767336|NCT01709305|463438205|FG003|Phase 2|Travel, moving, etc.|3|||
128929858|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
128701955|NCT01427972|463207549|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128929859|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
128929860|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
128701956|NCT01427972|463207550|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128767337|NCT01709305|463438206|FG004|Phase 2|Travel, moving, etc.|5|||
128929861|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
128929862|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
128929863|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
129216542|NCT01394016|465092948|FG013|Overall Study|Lost to Follow-up|0|||
128929864|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
128929865|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
128929866|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
128929867|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
128929868|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
128929869|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
128929870|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
128929871|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
128929872|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
128929873|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Death|0|||
128929874|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Death|1|||
128929875|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Death|0|||
128929876|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
128929877|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
128929878|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
128929879|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
128929880|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
128929881|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
128929882|NCT00430781|464032834|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
128929883|NCT00430781|464032835|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
128929884|NCT00430781|464032836|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
128929885|NCT00430781|464032834|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
128929886|NCT00430781|464032835|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
128929887|NCT00430781|464032836|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
128929888|NCT00430781|464032834|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
128929889|NCT00430781|464032835|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
128929890|NCT00430781|464032836|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
128929891|NCT00430781|464032834|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
128929892|NCT00430781|464032835|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
128929893|NCT00430781|464032836|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
128929894|NCT00430781|464032834|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
128929895|NCT00430781|464032835|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
128929896|NCT00430781|464032836|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
128929897|NCT00430781|464032834|FG000|Final Analysis; 31 July 2008|Other|0|||
129119936|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
129119937|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
128929898|NCT00430781|464032835|FG001|Final Analysis; 31 July 2008|Other|1|||
128929899|NCT00430781|464032836|FG002|Final Analysis; 31 July 2008|Other|0|||
129119938|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
129119939|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
129119940|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
129119941|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
129119942|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
129119943|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
129119944|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
129119945|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
129119946|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
129119947|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
129119948|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
129119949|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
129119950|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
129119951|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
129119952|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
129119953|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
129119954|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
129119955|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
129119956|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
129119957|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
129119958|NCT00784875|464737018|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
129119959|NCT00784875|464737019|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
129119960|NCT00784875|464737020|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
129119961|NCT00784875|464737021|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
128701957|NCT01427972|463207551|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129119962|NCT00784875|464737018|FG000|Period C|Adverse Event|1|||
129119963|NCT00784875|464737019|FG001|Period C|Adverse Event|0|||
129119964|NCT00784875|464737020|FG002|Period C|Adverse Event|4|||
128929900|NCT00430781|464032834|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
128929901|NCT00430781|464032835|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
128929902|NCT00430781|464032836|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
129216543|NCT01394016|465092949|FG014|Overall Study|Lost to Follow-up|0|||
129216544|NCT01394016|465092950|FG015|Overall Study|Lost to Follow-up|0|||
129216545|NCT01394016|465092951|FG016|Overall Study|Lost to Follow-up|0|||
129216546|NCT01394016|465092952|FG017|Overall Study|Lost to Follow-up|0|||
129216547|NCT01394016|465092953|FG018|Overall Study|Lost to Follow-up|1|||
129216548|NCT03534804|465092954|FG000|Overall Study|Withdrawal by Subject|1|||
129216549|NCT00174187|465092955|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
129216550|NCT00174187|465092956|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
129216551|NCT00174187|465092957|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
129216552|NCT00174187|465092955|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
129216553|NCT00174187|465092956|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
129216554|NCT00174187|465092957|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
129216555|NCT00174187|465092955|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
129216556|NCT00174187|465092956|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
129216557|NCT00174187|465092957|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
129216558|NCT00174187|465092955|FG000|Period 1 (up to 3 Years)|Other|0|||
129216559|NCT00174187|465092956|FG001|Period 1 (up to 3 Years)|Other|1|||
129216560|NCT00174187|465092957|FG002|Period 1 (up to 3 Years)|Other|0|||
129216561|NCT00174187|465092955|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
129216562|NCT00174187|465092956|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
129216563|NCT00174187|465092957|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
129216564|NCT00174187|465092955|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
129216565|NCT00174187|465092956|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
129216566|NCT00174187|465092957|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
129216567|NCT00174187|465092955|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
128701958|NCT01427972|463207552|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128701959|NCT01427972|463207553|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128929903|NCT00430781|464032834|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
128929904|NCT00430781|464032835|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
128929905|NCT00430781|464032836|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
128929906|NCT00430781|464032834|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
128929907|NCT00430781|464032835|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
128929908|NCT00430781|464032836|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
128929909|NCT00430781|464032834|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
128929910|NCT00430781|464032835|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
129030310|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
129030311|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
129030312|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
129030313|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
129030314|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
129030315|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
129030316|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
129030317|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
129030318|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
129030319|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
129030320|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
129030321|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
129030322|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
129030323|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
129030324|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
129030325|NCT01139762|464401684|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
129030326|NCT01139762|464401685|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
129030327|NCT01139762|464401686|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
129030328|NCT04750239|464401687|FG000|Overall Study|Withdrawal by Subject|2|||
129030329|NCT04750239|464401687|FG000|Overall Study|Trial terminated by sponsor|1|||
129030330|NCT00903877|464401688|FG000|Overall Study|Did not meet study criteria|33|||
129030331|NCT00903877|464401688|FG000|Overall Study|Withdrawal by Subject|3|||
129030332|NCT00903877|464401688|FG000|Overall Study|Adverse Event|2|||
129030333|NCT00903877|464401688|FG000|Overall Study|Lost to Follow-up|1|||
129030334|NCT00903877|464401688|FG000|Overall Study|Participation put on hold|4|||
129030335|NCT00919711|464401689|FG000|Overall Study|Withdrawal by Subject|15|||
129030336|NCT00919711|464401690|FG001|Overall Study|Withdrawal by Subject|7|||
129216568|NCT00174187|465092956|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
128929911|NCT00430781|464032836|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
128929912|NCT00430781|464032834|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
129030337|NCT00919711|464401689|FG000|Overall Study|Adverse Event|13|||
129030338|NCT00919711|464401690|FG001|Overall Study|Adverse Event|3|||
129216569|NCT00174187|465092957|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
129030339|NCT00919711|464401689|FG000|Overall Study|Other|1|||
129030340|NCT00919711|464401690|FG001|Overall Study|Other|2|||
129030341|NCT00919711|464401689|FG000|Overall Study|Administrative Decision|0|||
129030342|NCT00919711|464401690|FG001|Overall Study|Administrative Decision|1|||
129030343|NCT00919711|464401689|FG000|Overall Study|Lost to Follow-up|2|||
129030344|NCT00919711|464401690|FG001|Overall Study|Lost to Follow-up|0|||
129030345|NCT00919711|464401689|FG000|Overall Study|Death|1|||
129030346|NCT00919711|464401690|FG001|Overall Study|Death|0|||
129030347|NCT00919711|464401689|FG000|Overall Study|Noncompliance|1|||
129030348|NCT00919711|464401690|FG001|Overall Study|Noncompliance|0|||
129030349|NCT00685334|464401693|FG000|Overall Study|Withdrawal by Subject|5|||
129030350|NCT00685334|464401694|FG001|Overall Study|Withdrawal by Subject|6|||
129030351|NCT00685334|464401693|FG000|Overall Study|Lost to Follow-up|4|||
129030352|NCT00685334|464401694|FG001|Overall Study|Lost to Follow-up|0|||
129030353|NCT00685334|464401693|FG000|Overall Study|Chose to enter hospital|1|||
129030354|NCT00685334|464401694|FG001|Overall Study|Chose to enter hospital|1|||
129030355|NCT01891357|464401695|FG000|Overall Study|Protocol Violation|3|||
129030356|NCT02817828|464403093|FG000|Overall Study|Lost to Follow-up|41|||
129030357|NCT02817828|464403093|FG000|Overall Study|Adverse event not related to bleeding|104|||
129030358|NCT02817828|464403093|FG000|Overall Study|Adverse event related to bleeding|53|||
129030359|NCT02817828|464403093|FG000|Overall Study|Protocol Violation|11|||
129030360|NCT02817828|464403093|FG000|Overall Study|Pregnancy|7|||
129030361|NCT02817828|464403093|FG000|Overall Study|Pregnancy wish|15|||
129030362|NCT02817828|464403093|FG000|Overall Study|Withdrawal by Subject|78|||
129030363|NCT02817828|464403093|FG000|Overall Study|Other|26|||
129030364|NCT03387462|464403101|FG000|Overall Study|Lost to Follow-up|1|||
129030365|NCT01460628|464403104|FG000|Overall Study|Adverse Event|3|||
129030366|NCT01460628|464403104|FG000|Overall Study|Withdrawal by Subject|2|||
129030367|NCT00874822|464403107|FG000|Overall Study|excluded by criteria|8|||
129030368|NCT04281472|464403109|FG000|Stage A|Lack of Efficacy|8|||
129030369|NCT04281472|464403110|FG001|Stage A|Lack of Efficacy|0|||
129030370|NCT04281472|464403111|FG002|Stage A|Lack of Efficacy|0|||
129030371|NCT04281472|464403109|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
129030372|NCT04281472|464403110|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
129030373|NCT04281472|464403111|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
129030374|NCT04281472|464403109|FG000|Stage A|Adverse Event|20|||
129030375|NCT04281472|464403110|FG001|Stage A|Adverse Event|0|||
129030376|NCT04281472|464403111|FG002|Stage A|Adverse Event|0|||
129030377|NCT04281472|464403109|FG000|Stage A|Death|1|||
129030378|NCT04281472|464403110|FG001|Stage A|Death|0|||
129030379|NCT04281472|464403111|FG002|Stage A|Death|0|||
129030380|NCT04281472|464403109|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
129030381|NCT04281472|464403110|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
129030382|NCT04281472|464403111|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
129030383|NCT04281472|464403109|FG000|Stage A|Lost to Follow-up|2|||
129030384|NCT04281472|464403110|FG001|Stage A|Lost to Follow-up|0|||
129030385|NCT04281472|464403111|FG002|Stage A|Lost to Follow-up|0|||
129030386|NCT04281472|464403109|FG000|Stage A|Non-compliance with study drug|1|||
129030387|NCT04281472|464403110|FG001|Stage A|Non-compliance with study drug|0|||
129030388|NCT04281472|464403111|FG002|Stage A|Non-compliance with study drug|0|||
129030389|NCT04281472|464403109|FG000|Stage A|Physician Decision|1|||
129030390|NCT04281472|464403110|FG001|Stage A|Physician Decision|0|||
129030391|NCT04281472|464403111|FG002|Stage A|Physician Decision|0|||
129030392|NCT04281472|464403109|FG000|Stage A|Prohibited medications|2|||
129030393|NCT04281472|464403110|FG001|Stage A|Prohibited medications|0|||
129030394|NCT04281472|464403111|FG002|Stage A|Prohibited medications|0|||
129119965|NCT00784875|464737021|FG003|Period C|Adverse Event|2|||
129119966|NCT00784875|464737018|FG000|Period C|Protocol Violation|0|||
129119967|NCT00784875|464737019|FG001|Period C|Protocol Violation|0|||
129119968|NCT00784875|464737020|FG002|Period C|Protocol Violation|1|||
129119969|NCT00784875|464737021|FG003|Period C|Protocol Violation|2|||
129119970|NCT00784875|464737018|FG000|Period C|Lack of Efficacy|0|||
129119971|NCT00784875|464737019|FG001|Period C|Lack of Efficacy|0|||
129119972|NCT00784875|464737020|FG002|Period C|Lack of Efficacy|1|||
129030395|NCT04281472|464403109|FG000|Stage A|Withdrawal by Subject|11|||
129030396|NCT04281472|464403110|FG001|Stage A|Withdrawal by Subject|0|||
129030397|NCT04281472|464403111|FG002|Stage A|Withdrawal by Subject|0|||
129030398|NCT04281472|464403109|FG000|Stage A|Other|5|||
129030399|NCT04281472|464403110|FG001|Stage A|Other|0|||
129030400|NCT04281472|464403111|FG002|Stage A|Other|0|||
129030401|NCT04281472|464403109|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
129030402|NCT04281472|464403110|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
129030403|NCT04281472|464403111|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
129030404|NCT04281472|464403109|FG000|Stage B|Adverse Event|0|||
129030405|NCT04281472|464403110|FG001|Stage B|Adverse Event|3|||
129030406|NCT04281472|464403111|FG002|Stage B|Adverse Event|0|||
129030407|NCT04281472|464403109|FG000|Stage B|Death|0|||
129030408|NCT04281472|464403110|FG001|Stage B|Death|0|||
129030409|NCT04281472|464403111|FG002|Stage B|Death|1|||
129030410|NCT04281472|464403109|FG000|Stage B|Lack of Efficacy|0|||
129030411|NCT04281472|464403110|FG001|Stage B|Lack of Efficacy|0|||
129030412|NCT04281472|464403111|FG002|Stage B|Lack of Efficacy|1|||
129030413|NCT04281472|464403109|FG000|Stage B|Lost to Follow-up|0|||
129030414|NCT04281472|464403110|FG001|Stage B|Lost to Follow-up|0|||
129030415|NCT04281472|464403111|FG002|Stage B|Lost to Follow-up|2|||
129030416|NCT04281472|464403109|FG000|Stage B|Prohibited medications|0|||
129030417|NCT04281472|464403110|FG001|Stage B|Prohibited medications|2|||
129030418|NCT04281472|464403111|FG002|Stage B|Prohibited medications|1|||
129030419|NCT04281472|464403109|FG000|Stage B|Protocol Violation|0|||
129030420|NCT04281472|464403110|FG001|Stage B|Protocol Violation|1|||
129030421|NCT04281472|464403111|FG002|Stage B|Protocol Violation|1|||
129030422|NCT04281472|464403109|FG000|Stage B|Sponsor decision|0|||
129030423|NCT04281472|464403110|FG001|Stage B|Sponsor decision|0|||
129030424|NCT04281472|464403111|FG002|Stage B|Sponsor decision|1|||
129030425|NCT04281472|464403109|FG000|Stage B|Withdrawal by Subject|0|||
129030426|NCT04281472|464403110|FG001|Stage B|Withdrawal by Subject|3|||
129030427|NCT04281472|464403111|FG002|Stage B|Withdrawal by Subject|3|||
129030428|NCT04281472|464403109|FG000|Stage B|Other|0|||
129030429|NCT04281472|464403110|FG001|Stage B|Other|3|||
129030430|NCT04281472|464403111|FG002|Stage B|Other|0|||
129030431|NCT00152451|464403114|FG000|Overall Study|Adverse Event|4|||
129030432|NCT04697173|464403117|FG000|Overall Study|Withdrawal by Subject|34|||
129030433|NCT04697173|464403118|FG001|Overall Study|Withdrawal by Subject|38|||
129030434|NCT03807440|464403119|FG000|Overall Study|No documentation of index date 2|320|||
129030435|NCT03807440|464403119|FG000|Overall Study|No informed consent for index date 2|117|||
129030436|NCT01055834|464403124|FG000|Treatment Period I|Adverse Event|1|||
129030437|NCT01055834|464403125|FG001|Treatment Period I|Adverse Event|0|||
129030438|NCT05004649|464403126|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
129119973|NCT00784875|464737021|FG003|Period C|Lack of Efficacy|0|||
129119974|NCT00784875|464737018|FG000|Period C|Withdrawal by Subject|1|||
129119975|NCT00784875|464737019|FG001|Period C|Withdrawal by Subject|1|||
128767338|NCT01709305|463438202|FG000|Phase 2|Physician Decision|0|||
128767339|NCT01709305|463438203|FG001|Phase 2|Physician Decision|2|||
128767340|NCT01709305|463438204|FG002|Phase 2|Physician Decision|0|||
128767341|NCT01709305|463438205|FG003|Phase 2|Physician Decision|1|||
128767342|NCT01709305|463438206|FG004|Phase 2|Physician Decision|2|||
128767343|NCT01709305|463438202|FG000|Phase 2|Protocol Violation|0|||
128767344|NCT01709305|463438203|FG001|Phase 2|Protocol Violation|19|||
128767345|NCT01709305|463438204|FG002|Phase 2|Protocol Violation|19|||
128767346|NCT01709305|463438205|FG003|Phase 2|Protocol Violation|13|||
128767347|NCT01709305|463438206|FG004|Phase 2|Protocol Violation|9|||
128767348|NCT01709305|463438202|FG000|Phase 2|Withdrawal by Subject|0|||
128767349|NCT01709305|463438203|FG001|Phase 2|Withdrawal by Subject|8|||
128767350|NCT01709305|463438204|FG002|Phase 2|Withdrawal by Subject|6|||
128767351|NCT01709305|463438205|FG003|Phase 2|Withdrawal by Subject|15|||
128767352|NCT01709305|463438206|FG004|Phase 2|Withdrawal by Subject|12|||
128767353|NCT00171873|463438213|FG000|Overall Study|Withdrawal by Subject|4|||
128767354|NCT00171873|463438214|FG001|Overall Study|Withdrawal by Subject|2|||
128767355|NCT00171873|463438213|FG000|Overall Study|Adverse Event|5|||
128767356|NCT00171873|463438214|FG001|Overall Study|Adverse Event|0|||
128767357|NCT00171873|463438213|FG000|Overall Study|Switched to Octreotide|0|||
128767358|NCT00171873|463438214|FG001|Overall Study|Switched to Octreotide|1|||
128767359|NCT02073097|463438217|FG000|Overall Study|Adverse Event|0|||
128767360|NCT02073097|463438218|FG001|Overall Study|Adverse Event|0|||
128767361|NCT02073097|463438219|FG002|Overall Study|Adverse Event|0|||
128767362|NCT02073097|463438220|FG003|Overall Study|Adverse Event|0|||
128767363|NCT02073097|463438221|FG004|Overall Study|Adverse Event|0|||
128767364|NCT02073097|463438222|FG005|Overall Study|Adverse Event|0|||
128767365|NCT02073097|463438223|FG006|Overall Study|Adverse Event|0|||
128767366|NCT02073097|463438224|FG007|Overall Study|Adverse Event|2|||
128767367|NCT02073097|463438217|FG000|Overall Study|Withdrawal by Subject|0|||
128767368|NCT02073097|463438218|FG001|Overall Study|Withdrawal by Subject|0|||
128767369|NCT02073097|463438219|FG002|Overall Study|Withdrawal by Subject|0|||
129030439|NCT05004649|464403126|FG000|Overall Study|Lost to Follow-up|1|||
128767370|NCT02073097|463438220|FG003|Overall Study|Withdrawal by Subject|0|||
128767371|NCT02073097|463438221|FG004|Overall Study|Withdrawal by Subject|0|||
128767372|NCT02073097|463438222|FG005|Overall Study|Withdrawal by Subject|0|||
128767373|NCT02073097|463438223|FG006|Overall Study|Withdrawal by Subject|0|||
129030440|NCT05004649|464403126|FG000|Overall Study|Withdrawal by Subject|2|||
128767374|NCT02073097|463438224|FG007|Overall Study|Withdrawal by Subject|2|||
128767375|NCT02073097|463438217|FG000|Overall Study|Death|0|||
129030441|NCT05004649|464403126|FG000|Overall Study|COVID-19|1|||
129030442|NCT01717313|464403127|FG000|Phase A (Weeks 0 to 24)|Death|0|||
129030443|NCT01717313|464403128|FG001|Phase A (Weeks 0 to 24)|Death|1|||
129030444|NCT01717313|464403127|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
129030445|NCT01717313|464403128|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
129030446|NCT01717313|464403127|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
129030447|NCT01717313|464403128|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
129030448|NCT01717313|464403127|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
128701960|NCT01427972|463207554|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
128701961|NCT01427972|463207555|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128701962|NCT01427972|463207556|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128701963|NCT01427972|463207557|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128929913|NCT00430781|464032835|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
128929914|NCT00430781|464032836|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
128929915|NCT00430781|464032834|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
128929916|NCT00430781|464032835|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
128929917|NCT00430781|464032836|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
128929918|NCT00430781|464032834|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
128929919|NCT00430781|464032835|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
128929920|NCT00430781|464032836|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
128929921|NCT04329949|464032840|FG000|Overall Study|Death|36|||
128929922|NCT04329949|464032840|FG000|Overall Study|Withdrawal by Subject|4|||
128929923|NCT04329949|464032840|FG000|Overall Study|Termination of study by sponsor|3|||
128929924|NCT00345605|464032843|FG000|Arm 1|Adverse Event|0|||
128929925|NCT00345605|464032844|FG001|Arm 1|Adverse Event|1|||
128929926|NCT00345605|464032843|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
128929927|NCT00345605|464032844|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
128929928|NCT01059812|464032845|FG000|Overall Study|Adverse Event|9|||
128929929|NCT01059812|464032846|FG001|Overall Study|Adverse Event|5|||
128929930|NCT01059812|464032845|FG000|Overall Study|Lack of Efficacy|2|||
128929931|NCT01059812|464032846|FG001|Overall Study|Lack of Efficacy|2|||
128929932|NCT01059812|464032845|FG000|Overall Study|Protocol Violation|3|||
128929933|NCT01059812|464032846|FG001|Overall Study|Protocol Violation|1|||
128929934|NCT01059812|464032845|FG000|Overall Study|Withdrawal Criteria|9|||
128929935|NCT01059812|464032846|FG001|Overall Study|Withdrawal Criteria|4|||
128929936|NCT01059812|464032845|FG000|Overall Study|Unclassified|14|||
128929937|NCT01059812|464032846|FG001|Overall Study|Unclassified|4|||
128929938|NCT03180736|464032847|FG000|Overall Study|Adverse Event|3|||
128929939|NCT03180736|464032848|FG001|Overall Study|Adverse Event|4|||
128929940|NCT03180736|464032847|FG000|Overall Study|Death|10|||
128929941|NCT03180736|464032848|FG001|Overall Study|Death|7|||
128929942|NCT03180736|464032847|FG000|Overall Study|Withdrawal by Subject|5|||
128929943|NCT03180736|464032848|FG001|Overall Study|Withdrawal by Subject|12|||
128929944|NCT03180736|464032847|FG000|Overall Study|Lost to Follow-up|1|||
128929945|NCT03180736|464032848|FG001|Overall Study|Lost to Follow-up|0|||
128929946|NCT03180736|464032847|FG000|Overall Study|Lack of Efficacy|66|||
128929947|NCT03180736|464032848|FG001|Overall Study|Lack of Efficacy|87|||
128929948|NCT03180736|464032847|FG000|Overall Study|Physician Decision|4|||
128929949|NCT03180736|464032848|FG001|Overall Study|Physician Decision|7|||
129119976|NCT00784875|464737020|FG002|Period C|Withdrawal by Subject|2|||
129119977|NCT00784875|464737021|FG003|Period C|Withdrawal by Subject|0|||
129119978|NCT00784875|464737018|FG000|Period C|Physician Decision|0|||
129119979|NCT00784875|464737019|FG001|Period C|Physician Decision|0|||
129119980|NCT00784875|464737020|FG002|Period C|Physician Decision|1|||
129119981|NCT00784875|464737021|FG003|Period C|Physician Decision|1|||
129119982|NCT00784875|464737018|FG000|Period C|Sponsor Decision|5|||
129119983|NCT00784875|464737019|FG001|Period C|Sponsor Decision|5|||
128929950|NCT03180736|464032847|FG000|Overall Study|randomized but not treated|2|||
128929951|NCT03180736|464032848|FG001|Overall Study|randomized but not treated|3|||
128701964|NCT01427972|463207558|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
128701965|NCT01427972|463207547|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128701966|NCT01427972|463207548|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128929952|NCT01451515|464032851|FG000|Overall Study|Death|0|||
128929953|NCT01451515|464032852|FG001|Overall Study|Death|1|||
128929954|NCT01451515|464032853|FG002|Overall Study|Death|0|||
128929955|NCT01451515|464032851|FG000|Overall Study|Withdrawal by Subject|0|||
128929956|NCT01451515|464032852|FG001|Overall Study|Withdrawal by Subject|1|||
128929957|NCT01451515|464032853|FG002|Overall Study|Withdrawal by Subject|0|||
128929958|NCT01451515|464032851|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
128929959|NCT01451515|464032852|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
129119984|NCT00784875|464737020|FG002|Period C|Sponsor Decision|4|||
129119985|NCT00784875|464737021|FG003|Period C|Sponsor Decision|2|||
128701967|NCT01427972|463207549|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128701968|NCT01427972|463207550|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128929960|NCT01451515|464032853|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
128929961|NCT01451515|464032851|FG000|Overall Study|Relapse (except CNS)|1|||
128929962|NCT01451515|464032852|FG001|Overall Study|Relapse (except CNS)|1|||
128929963|NCT01451515|464032853|FG002|Overall Study|Relapse (except CNS)|0|||
128929964|NCT01458340|464032856|FG000|Overall Study|Adverse Event|5|||
128929965|NCT01458340|464032857|FG001|Overall Study|Adverse Event|4|||
128929966|NCT01458340|464032858|FG002|Overall Study|Adverse Event|2|||
129119986|NCT00784875|464737018|FG000|Period D|Adverse Event|0|||
129119987|NCT00784875|464737019|FG001|Period D|Adverse Event|2|||
129119988|NCT00784875|464737020|FG002|Period D|Adverse Event|2|||
129119989|NCT00784875|464737021|FG003|Period D|Adverse Event|0|||
128929967|NCT01458340|464032856|FG000|Overall Study|Lost to Follow-up|3|||
128929968|NCT01458340|464032857|FG001|Overall Study|Lost to Follow-up|3|||
128929969|NCT01458340|464032858|FG002|Overall Study|Lost to Follow-up|10|||
128929970|NCT01458340|464032856|FG000|Overall Study|Miscellaneous|0|||
128929971|NCT01458340|464032857|FG001|Overall Study|Miscellaneous|1|||
128929972|NCT01458340|464032858|FG002|Overall Study|Miscellaneous|0|||
128929973|NCT01458340|464032856|FG000|Overall Study|Physician Decision|1|||
128929974|NCT01458340|464032857|FG001|Overall Study|Physician Decision|1|||
128929975|NCT01458340|464032858|FG002|Overall Study|Physician Decision|2|||
128929976|NCT01458340|464032856|FG000|Overall Study|Protocol Violation|6|||
128767376|NCT02073097|463438218|FG001|Overall Study|Death|0|||
128929977|NCT01458340|464032857|FG001|Overall Study|Protocol Violation|6|||
128929978|NCT01458340|464032858|FG002|Overall Study|Protocol Violation|5|||
128929979|NCT01458340|464032856|FG000|Overall Study|Withdrawal by Subject|12|||
128929980|NCT01458340|464032857|FG001|Overall Study|Withdrawal by Subject|6|||
128929981|NCT01458340|464032858|FG002|Overall Study|Withdrawal by Subject|4|||
128929982|NCT00091793|464032859|FG000|Overall Study|Adverse Event|1|||
128929983|NCT00091793|464032860|FG001|Overall Study|Adverse Event|2|||
128929984|NCT00091793|464032859|FG000|Overall Study|Withdrawal by Subject|10|||
128929985|NCT00091793|464032860|FG001|Overall Study|Withdrawal by Subject|15|||
128929986|NCT00091793|464032859|FG000|Overall Study|Ineligibility determined|2|||
128929987|NCT00091793|464032860|FG001|Overall Study|Ineligibility determined|0|||
128929988|NCT00091793|464032859|FG000|Overall Study|Lost to Follow-up|7|||
128929989|NCT00091793|464032860|FG001|Overall Study|Lost to Follow-up|5|||
128929990|NCT00091793|464032859|FG000|Overall Study|Noncompliance|2|||
128929991|NCT00091793|464032860|FG001|Overall Study|Noncompliance|0|||
128929992|NCT00091793|464032859|FG000|Overall Study|Other|2|||
128929993|NCT00091793|464032860|FG001|Overall Study|Other|0|||
128929994|NCT05309083|464032861|FG000|Overall Study|Withdrawal by Subject|2|||
128929995|NCT01165229|464032862|FG000|Overall Study|Serious Adverse Event|456|||
128929996|NCT01165229|464032863|FG001|Overall Study|Serious Adverse Event|487|||
128929997|NCT01165229|464032862|FG000|Overall Study|Non-Serious Adverse Event|47|||
128929998|NCT01165229|464032863|FG001|Overall Study|Non-Serious Adverse Event|15|||
128929999|NCT01165229|464032862|FG000|Overall Study|Protocol Violation|6|||
128930000|NCT01165229|464032863|FG001|Overall Study|Protocol Violation|8|||
128767377|NCT02073097|463438219|FG002|Overall Study|Death|0|||
128930001|NCT01165229|464032862|FG000|Overall Study|Withdrawal by Subject|387|||
128930002|NCT01165229|464032863|FG001|Overall Study|Withdrawal by Subject|396|||
128930003|NCT01165229|464032862|FG000|Overall Study|Migrated/moved from study area|51|||
128930004|NCT01165229|464032863|FG001|Overall Study|Migrated/moved from study area|46|||
128930005|NCT01165229|464032862|FG000|Overall Study|Lost to Follow-up|123|||
128930006|NCT01165229|464032863|FG001|Overall Study|Lost to Follow-up|133|||
128930007|NCT01165229|464032862|FG000|Overall Study|Suspected HZ Episode|2|||
128930008|NCT01165229|464032863|FG001|Overall Study|Suspected HZ Episode|2|||
128930009|NCT01165229|464032862|FG000|Overall Study|No reason from the subject|108|||
128930010|NCT01165229|464032863|FG001|Overall Study|No reason from the subject|102|||
128930011|NCT01165229|464032862|FG000|Overall Study|Unknown completion status|0|||
128930012|NCT01165229|464032863|FG001|Overall Study|Unknown completion status|1|||
128930013|NCT00881205|464032867|FG000|Overall Study|Adverse Event|8|||
128930014|NCT00881205|464032868|FG001|Overall Study|Adverse Event|3|||
128930015|NCT00881205|464032867|FG000|Overall Study|Withdrawal by Subject|1|||
128930016|NCT00881205|464032868|FG001|Overall Study|Withdrawal by Subject|2|||
128930017|NCT00881205|464032867|FG000|Overall Study|Lost to Follow-up|0|||
128930018|NCT00881205|464032868|FG001|Overall Study|Lost to Follow-up|1|||
128930019|NCT00881205|464032867|FG000|Overall Study|Administrative problems|1|||
128930020|NCT00881205|464032868|FG001|Overall Study|Administrative problems|1|||
128930021|NCT00881205|464032867|FG000|Overall Study|Condition no longer requires drug|1|||
128930022|NCT00881205|464032868|FG001|Overall Study|Condition no longer requires drug|0|||
128930023|NCT04786210|464032869|FG000|Overall Study|Lost to Follow-up|2|||
128930024|NCT04786210|464032869|FG000|Overall Study|Withdrawal by Subject|4|||
128930025|NCT00849212|464032870|FG000|Overall Study|Lack of Efficacy|1|||
128930026|NCT00849212|464032870|FG000|Overall Study|Withdrawal by Subject|3|||
128930027|NCT00849212|464032870|FG000|Overall Study|Adverse Event|2|||
128930028|NCT00849212|464032870|FG000|Overall Study|Miscellaneous|1|||
128930029|NCT00845429|464032878|FG000|Overall Study|Protocol Violation|5|||
128930030|NCT00845429|464032879|FG001|Overall Study|Protocol Violation|4|||
128767378|NCT02073097|463438220|FG003|Overall Study|Death|0|||
128930031|NCT00845429|464032880|FG002|Overall Study|Protocol Violation|7|||
128930032|NCT00845429|464032878|FG000|Overall Study|Lost to Follow-up|7|||
128930033|NCT00845429|464032879|FG001|Overall Study|Lost to Follow-up|9|||
128930034|NCT00845429|464032880|FG002|Overall Study|Lost to Follow-up|10|||
128930035|NCT00845429|464032878|FG000|Overall Study|Withdrawal by Subject|2|||
128930036|NCT00845429|464032879|FG001|Overall Study|Withdrawal by Subject|2|||
128930037|NCT00845429|464032880|FG002|Overall Study|Withdrawal by Subject|2|||
128930038|NCT00845429|464032878|FG000|Overall Study|Serious adverse event|0|||
128930039|NCT00845429|464032879|FG001|Overall Study|Serious adverse event|0|||
128930040|NCT00845429|464032880|FG002|Overall Study|Serious adverse event|1|||
129119990|NCT00784875|464737018|FG000|Period D|Protocol Violation|1|||
128930041|NCT00587223|464032884|FG000|Overall Study|Adverse Event|1|||
128930042|NCT02111369|464032885|FG000|Overall Study|Lost to Follow-up|2|||
128930043|NCT02111369|464032885|FG000|Overall Study|Withdrawal by Subject|1|||
128930044|NCT03240081|464032889|FG000|Overall Study|Withdrawal by Subject|0|||
128930045|NCT03240081|464032890|FG001|Overall Study|Withdrawal by Subject|2|||
128930046|NCT03240081|464032889|FG000|Overall Study|Lost to Follow-up|0|||
128930047|NCT03240081|464032890|FG001|Overall Study|Lost to Follow-up|1|||
128930048|NCT00883753|464032891|FG000|Overall Study|Adverse Event|37|||
128930049|NCT00883753|464032891|FG000|Overall Study|Death|2|||
128930050|NCT00883753|464032891|FG000|Overall Study|Insufficient therapeutic response|16|||
129030449|NCT01717313|464403128|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
129030450|NCT01717313|464403127|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
129119991|NCT00784875|464737019|FG001|Period D|Protocol Violation|0|||
129119992|NCT00784875|464737020|FG002|Period D|Protocol Violation|0|||
129119993|NCT00784875|464737021|FG003|Period D|Protocol Violation|0|||
129119994|NCT00784875|464737018|FG000|Period D|Withdrawal by Subject|2|||
129119995|NCT00784875|464737019|FG001|Period D|Withdrawal by Subject|0|||
129119996|NCT00784875|464737020|FG002|Period D|Withdrawal by Subject|2|||
129119997|NCT00784875|464737021|FG003|Period D|Withdrawal by Subject|0|||
129119998|NCT00784875|464737018|FG000|Period D|Physician Decision|0|||
129119999|NCT00784875|464737019|FG001|Period D|Physician Decision|1|||
129120000|NCT00784875|464737020|FG002|Period D|Physician Decision|0|||
129120001|NCT00784875|464737021|FG003|Period D|Physician Decision|0|||
129120002|NCT00784875|464737018|FG000|Period D|Sponsor Decision|1|||
129120003|NCT00784875|464737019|FG001|Period D|Sponsor Decision|1|||
129120004|NCT00784875|464737020|FG002|Period D|Sponsor Decision|1|||
129120005|NCT00784875|464737021|FG003|Period D|Sponsor Decision|0|||
129120006|NCT00784875|464737018|FG000|Period D|Lost to Follow-up|1|||
129120007|NCT00784875|464737019|FG001|Period D|Lost to Follow-up|0|||
129120008|NCT00784875|464737020|FG002|Period D|Lost to Follow-up|1|||
129120009|NCT00784875|464737021|FG003|Period D|Lost to Follow-up|1|||
129120010|NCT03743194|464737022|FG000|Overall Study|Protocol Violation|7|||
129120011|NCT03743194|464737023|FG001|Overall Study|Protocol Violation|7|||
129120012|NCT03743194|464737022|FG000|Overall Study|Physician Decision|0|||
129120013|NCT03743194|464737023|FG001|Overall Study|Physician Decision|2|||
129120014|NCT01829347|464737026|FG000|VTI-210|Death|5|||
129120015|NCT01829347|464737027|FG001|VTI-210|Death|3|||
129120016|NCT01829347|464737026|FG000|VTI-210|Withdrawal by Subject|1|||
129120017|NCT01829347|464737027|FG001|VTI-210|Withdrawal by Subject|0|||
129120018|NCT01829347|464737026|FG000|VTI-210E|Death|2|||
129120019|NCT01829347|464737027|FG001|VTI-210E|Death|1|||
129120020|NCT01829347|464737026|FG000|VTI-210E|Study terminated prematurely|1|||
129120021|NCT01829347|464737027|FG001|VTI-210E|Study terminated prematurely|5|||
129120022|NCT04018066|464737028|FG000|Overall Study|participants started taking medications during the study period|3|||
129120023|NCT04018066|464737028|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
129030451|NCT01717313|464403128|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
129030452|NCT01717313|464403127|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
129030453|NCT01717313|464403128|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
129030454|NCT01717313|464403127|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
129030455|NCT01717313|464403128|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
129030456|NCT01717313|464403127|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
129030457|NCT01717313|464403128|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
129030458|NCT01717313|464403127|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
129030459|NCT01717313|464403128|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
129030460|NCT03504085|464403129|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
129030461|NCT03504085|464403130|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
129030462|NCT03504085|464403129|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
129030463|NCT03504085|464403130|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
129030464|NCT04133311|464403131|FG000|Period 1 Double Masked Treatment Period|Death|1|||
129030465|NCT04133311|464403132|FG001|Period 1 Double Masked Treatment Period|Death|0|||
129030466|NCT04133311|464403133|FG002|Period 1 Double Masked Treatment Period|Death|0|||
129030467|NCT04133311|464403134|FG003|Period 1 Double Masked Treatment Period|Death|0|||
129030468|NCT04133311|464403131|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
129030469|NCT04133311|464403132|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
129120024|NCT03817528|464737029|FG000|Overall Study|Withdrawal by Subject|1|||
129120025|NCT03817528|464737029|FG000|Overall Study|Adverse Event|2|||
129120026|NCT01027949|464737031|FG000|Overall Study|Death|174|||
129120027|NCT01027949|464737031|FG000|Overall Study|Progressive Disease|163|||
129120028|NCT01027949|464737031|FG000|Overall Study|Adverse Event|172|||
129120029|NCT01027949|464737031|FG000|Overall Study|Withdrawal by Subject|113|||
129120030|NCT01027949|464737031|FG000|Overall Study|Lost to Follow-up|17|||
129120031|NCT01027949|464737031|FG000|Overall Study|Protocol Violation|13|||
128930051|NCT00883753|464032891|FG000|Overall Study|Lost to Follow-up|4|||
128930052|NCT00883753|464032891|FG000|Overall Study|Violation of selection criteria at entry|7|||
129030470|NCT04133311|464403133|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
129120032|NCT01027949|464737031|FG000|Overall Study|PI Decision|8|||
128930053|NCT00883753|464032891|FG000|Overall Study|Protocol Violation|2|||
129120033|NCT01027949|464737031|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
129120034|NCT01027949|464737031|FG000|Overall Study|Non-compliance with Study Procedures|7|||
129120035|NCT01027949|464737031|FG000|Overall Study|Lung Transplant|5|||
129120036|NCT01027949|464737031|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
129120037|NCT01027949|464737031|FG000|Overall Study|Use of Excluded Medication|2|||
129120038|NCT01027949|464737031|FG000|Overall Study|Patient Self-discontinuation|1|||
129120039|NCT01027949|464737031|FG000|Overall Study|Pregnancy|1|||
129120040|NCT01027949|464737031|FG000|Overall Study|Surgery|1|||
129120041|NCT02152007|464737043|FG000|Overall Study|Withdrawal by Subject|1|||
129120042|NCT00706797|464737046|FG000|Overall Study|Lack of Efficacy|3|||
129120043|NCT00706797|464737047|FG001|Overall Study|Lack of Efficacy|0|||
129120044|NCT00706797|464737046|FG000|Overall Study|Adverse Event|0|||
129120045|NCT00706797|464737047|FG001|Overall Study|Adverse Event|3|||
129120046|NCT00706797|464737046|FG000|Overall Study|Withdrawal by Subject|8|||
129120047|NCT00706797|464737047|FG001|Overall Study|Withdrawal by Subject|1|||
129120048|NCT00706797|464737046|FG000|Overall Study|Death|1|||
129120049|NCT00706797|464737047|FG001|Overall Study|Death|0|||
129120050|NCT00706797|464737046|FG000|Overall Study|Discontinuation of study by sponsor|52|||
129120051|NCT00706797|464737047|FG001|Overall Study|Discontinuation of study by sponsor|63|||
129120052|NCT00706797|464737046|FG000|Overall Study|Protocol Violation|3|||
129120053|NCT00706797|464737047|FG001|Overall Study|Protocol Violation|2|||
129120054|NCT00706797|464737046|FG000|Overall Study|Lost to Follow-up|1|||
129120055|NCT00706797|464737047|FG001|Overall Study|Lost to Follow-up|2|||
129120056|NCT00706797|464737046|FG000|Overall Study|Other|1|||
129120057|NCT00706797|464737047|FG001|Overall Study|Other|0|||
129120058|NCT05144945|464737050|FG000|Overall Study|Withdrawal by Subject|1|||
129120059|NCT05144945|464737051|FG001|Overall Study|Withdrawal by Subject|0|||
129120060|NCT00284856|464737052|FG000|Overall Study|Adverse Event|3|||
129120061|NCT00284856|464737053|FG001|Overall Study|Adverse Event|3|||
129120062|NCT00284856|464737054|FG002|Overall Study|Adverse Event|3|||
129120063|NCT00284856|464737052|FG000|Overall Study|Lack of Efficacy|2|||
128930054|NCT00883753|464032891|FG000|Overall Study|Refused treatment|4|||
129120064|NCT00284856|464737053|FG001|Overall Study|Lack of Efficacy|1|||
129120065|NCT00284856|464737054|FG002|Overall Study|Lack of Efficacy|8|||
129120066|NCT00284856|464737052|FG000|Overall Study|Lost to Follow-up|25|||
129120067|NCT00284856|464737053|FG001|Overall Study|Lost to Follow-up|21|||
129120068|NCT00284856|464737054|FG002|Overall Study|Lost to Follow-up|22|||
129120069|NCT00284856|464737052|FG000|Overall Study|Protocol Violation|5|||
129120070|NCT00284856|464737053|FG001|Overall Study|Protocol Violation|4|||
129120071|NCT00284856|464737054|FG002|Overall Study|Protocol Violation|5|||
129120072|NCT00284856|464737052|FG000|Overall Study|Withdrawal by Subject|12|||
129120073|NCT00284856|464737053|FG001|Overall Study|Withdrawal by Subject|16|||
129120074|NCT00284856|464737054|FG002|Overall Study|Withdrawal by Subject|18|||
129120075|NCT00284856|464737052|FG000|Overall Study|Other|4|||
129120076|NCT00284856|464737053|FG001|Overall Study|Other|5|||
129120077|NCT00284856|464737054|FG002|Overall Study|Other|4|||
129120078|NCT01192815|464737055|FG000|Overall Study|Withdrawal by Subject|1|||
129120079|NCT01192815|464737055|FG000|Overall Study|Lack of Efficacy|1|||
129120080|NCT00465179|464737056|FG000|Overall Study|Adverse Event|4|||
128701969|NCT01427972|463207551|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128701970|NCT01427972|463207552|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
128701971|NCT01427972|463207553|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128701972|NCT01427972|463207554|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128701973|NCT01427972|463207555|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128701974|NCT01427972|463207556|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128930055|NCT00883753|464032891|FG000|Overall Study|Withdrew consent|10|||
128930056|NCT00883753|464032891|FG000|Overall Study|Investigator's decision|17|||
128930057|NCT00883753|464032891|FG000|Overall Study|Administrative/Other|8|||
128930058|NCT01480180|464032892|FG000|Main Phase|Withdrawal criteria|12|||
128930059|NCT01480180|464032893|FG001|Main Phase|Withdrawal criteria|1|||
128930060|NCT01480180|464032894|FG002|Main Phase|Withdrawal criteria|0|||
128930061|NCT01480180|464032895|FG003|Main Phase|Withdrawal criteria|0|||
128701975|NCT01427972|463207557|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128701976|NCT01427972|463207558|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
128930062|NCT01480180|464032896|FG004|Main Phase|Withdrawal criteria|0|||
128930063|NCT01480180|464032897|FG005|Main Phase|Withdrawal criteria|0|||
128930064|NCT01480180|464032892|FG000|Main Phase|Lack of Efficacy|1|||
128930065|NCT01480180|464032893|FG001|Main Phase|Lack of Efficacy|0|||
128930066|NCT01480180|464032894|FG002|Main Phase|Lack of Efficacy|0|||
128930067|NCT01480180|464032895|FG003|Main Phase|Lack of Efficacy|0|||
129120081|NCT00465179|464737056|FG000|Overall Study|Withdrawal by Subject|2|||
129120082|NCT00465179|464737056|FG000|Overall Study|Progression of Disease|47|||
129120083|NCT00262925|464737057|FG000|Overall Study|Lack of Efficacy|3|||
129120084|NCT00262925|464737057|FG000|Overall Study|Adverse Event|4|||
129120085|NCT00262925|464737057|FG000|Overall Study|Death|2|||
129120086|NCT00262925|464737057|FG000|Overall Study|alternative therapy|1|||
129120087|NCT00262925|464737057|FG000|Overall Study|Other|1|||
129120088|NCT00560404|464737058|FG000|Overall Study|Adverse Event|2|||
128930068|NCT01480180|464032896|FG004|Main Phase|Lack of Efficacy|0|||
128930069|NCT01480180|464032897|FG005|Main Phase|Lack of Efficacy|0|||
128930070|NCT01480180|464032892|FG000|Main Phase|Non-compliance|3|||
128930071|NCT01480180|464032893|FG001|Main Phase|Non-compliance|0|||
128930072|NCT01480180|464032894|FG002|Main Phase|Non-compliance|0|||
128930073|NCT01480180|464032895|FG003|Main Phase|Non-compliance|0|||
128930074|NCT01480180|464032896|FG004|Main Phase|Non-compliance|0|||
128930075|NCT01480180|464032897|FG005|Main Phase|Non-compliance|0|||
128930076|NCT01480180|464032892|FG000|Main Phase|Unclassified|3|||
128930077|NCT01480180|464032893|FG001|Main Phase|Unclassified|0|||
128930078|NCT01480180|464032894|FG002|Main Phase|Unclassified|0|||
129120089|NCT00560404|464737059|FG001|Overall Study|Adverse Event|3|||
129120090|NCT00560404|464737058|FG000|Overall Study|Death|3|||
129120091|NCT00560404|464737059|FG001|Overall Study|Death|3|||
129120092|NCT00560404|464737058|FG000|Overall Study|Protocol Violation|12|||
129120093|NCT00560404|464737059|FG001|Overall Study|Protocol Violation|7|||
129120094|NCT00560404|464737058|FG000|Overall Study|Administrative Reasons|1|||
129120095|NCT00560404|464737059|FG001|Overall Study|Administrative Reasons|1|||
129120096|NCT00560404|464737058|FG000|Overall Study|Withdrew Consent|4|||
129120097|NCT00560404|464737059|FG001|Overall Study|Withdrew Consent|0|||
129120098|NCT00560404|464737058|FG000|Overall Study|Failure to return|1|||
129120099|NCT00560404|464737059|FG001|Overall Study|Failure to return|2|||
129120100|NCT00560404|464737058|FG000|Overall Study|Other withdrawal reason|13|||
129120101|NCT00560404|464737059|FG001|Overall Study|Other withdrawal reason|5|||
129120102|NCT02187783|464737060|FG000|Overall Study|Adverse Event|8|||
129120103|NCT02187783|464737060|FG000|Overall Study|Death|3|||
129120104|NCT02187783|464737060|FG000|Overall Study|Progressive disease|80|||
129120105|NCT02187783|464737060|FG000|Overall Study|Protocol Violation|3|||
129120106|NCT02187783|464737060|FG000|Overall Study|Physician Decision|2|||
129120107|NCT02187783|464737060|FG000|Overall Study|Withdrawal by Subject|9|||
129120108|NCT02187783|464737060|FG000|Overall Study|Study terminated by sponsor|1|||
129120109|NCT00471497|464737061|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
129120110|NCT00471497|464737062|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
129120111|NCT00471497|464737063|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
129120112|NCT00471497|464737061|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
129120113|NCT00471497|464737062|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
129120114|NCT00471497|464737063|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
129120115|NCT00471497|464737061|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
129120116|NCT00471497|464737062|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
129120117|NCT00471497|464737063|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
129120118|NCT00471497|464737061|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
129120119|NCT00471497|464737062|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
129120120|NCT00471497|464737063|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
129120121|NCT00471497|464737061|FG000|Core Treatment Phase|Lost to Follow-up|6|||
129120122|NCT00471497|464737062|FG001|Core Treatment Phase|Lost to Follow-up|6|||
129120123|NCT00471497|464737063|FG002|Core Treatment Phase|Lost to Follow-up|3|||
129120124|NCT00471497|464737061|FG000|Core Treatment Phase|Death|3|||
129120125|NCT00471497|464737062|FG001|Core Treatment Phase|Death|9|||
129120126|NCT00471497|464737063|FG002|Core Treatment Phase|Death|3|||
129120127|NCT00471497|464737061|FG000|Core Treatment Phase|Disease Progression|10|||
129120128|NCT00471497|464737062|FG001|Core Treatment Phase|Disease Progression|2|||
129120129|NCT00471497|464737063|FG002|Core Treatment Phase|Disease Progression|4|||
129120130|NCT00471497|464737061|FG000|Core Treatment Phase|Protocol Violation|6|||
129120131|NCT00471497|464737062|FG001|Core Treatment Phase|Protocol Violation|15|||
129120132|NCT00471497|464737063|FG002|Core Treatment Phase|Protocol Violation|11|||
129120133|NCT00471497|464737061|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
129120134|NCT00471497|464737062|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
129120135|NCT00471497|464737063|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
129120136|NCT00471497|464737061|FG000|Core Treatment Phase|Administrative problems|14|||
128930079|NCT01480180|464032895|FG003|Main Phase|Unclassified|0|||
128930080|NCT01480180|464032896|FG004|Main Phase|Unclassified|0|||
129120137|NCT00471497|464737062|FG001|Core Treatment Phase|Administrative problems|14|||
129120138|NCT00471497|464737063|FG002|Core Treatment Phase|Administrative problems|12|||
129120139|NCT00471497|464737061|FG000|Core Treatment Phase|Adverse Event|43|||
129120140|NCT00471497|464737062|FG001|Core Treatment Phase|Adverse Event|53|||
128930081|NCT01480180|464032897|FG005|Main Phase|Unclassified|0|||
129120141|NCT00471497|464737063|FG002|Core Treatment Phase|Adverse Event|89|||
129120142|NCT00471497|464737061|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
129120143|NCT00471497|464737062|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
129120144|NCT00471497|464737063|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
129120145|NCT00471497|464737061|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
129120146|NCT00471497|464737062|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
129120147|NCT00471497|464737063|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
128930082|NCT01480180|464032892|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
128930083|NCT01480180|464032893|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
128930084|NCT01480180|464032894|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
128930085|NCT01480180|464032895|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
128930086|NCT01480180|464032896|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
128930087|NCT01480180|464032897|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
128930088|NCT01480180|464032892|FG000|Extension Phase, Part 1|Unclassified|0|||
128930089|NCT01480180|464032893|FG001|Extension Phase, Part 1|Unclassified|0|||
128930090|NCT01480180|464032894|FG002|Extension Phase, Part 1|Unclassified|1|||
128930091|NCT01480180|464032895|FG003|Extension Phase, Part 1|Unclassified|0|||
129120148|NCT00471497|464737061|FG000|Extension Phase|Adverse Event|9|||
129120149|NCT00471497|464737062|FG001|Extension Phase|Adverse Event|5|||
129120150|NCT00471497|464737063|FG002|Extension Phase|Adverse Event|1|||
129120151|NCT00471497|464737061|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
129120152|NCT00471497|464737062|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
129120153|NCT00471497|464737063|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
129120154|NCT00471497|464737061|FG000|Extension Phase|Withdrawal by Subject|3|||
129120155|NCT00471497|464737062|FG001|Extension Phase|Withdrawal by Subject|1|||
129120156|NCT00471497|464737063|FG002|Extension Phase|Withdrawal by Subject|0|||
129120157|NCT00471497|464737061|FG000|Extension Phase|Lost to Follow-up|2|||
129120158|NCT00471497|464737062|FG001|Extension Phase|Lost to Follow-up|0|||
129120159|NCT00471497|464737063|FG002|Extension Phase|Lost to Follow-up|0|||
129120160|NCT00471497|464737061|FG000|Extension Phase|Death|1|||
129120161|NCT00471497|464737062|FG001|Extension Phase|Death|0|||
129120162|NCT00471497|464737063|FG002|Extension Phase|Death|0|||
129120163|NCT00471497|464737061|FG000|Extension Phase|Disease progression|2|||
129120164|NCT00471497|464737062|FG001|Extension Phase|Disease progression|0|||
129120165|NCT00471497|464737063|FG002|Extension Phase|Disease progression|0|||
129120166|NCT00471497|464737061|FG000|Extension Phase|Protocol Violation|2|||
129120167|NCT00471497|464737062|FG001|Extension Phase|Protocol Violation|2|||
129120168|NCT00471497|464737063|FG002|Extension Phase|Protocol Violation|0|||
129120169|NCT00392223|464737064|FG000|Overall Study|Adverse Event|5|||
129120170|NCT00392223|464737065|FG001|Overall Study|Adverse Event|4|||
129120171|NCT00392223|464737064|FG000|Overall Study|Lost to Follow-up|1|||
129120172|NCT00392223|464737065|FG001|Overall Study|Lost to Follow-up|4|||
129120173|NCT00392223|464737064|FG000|Overall Study|Protocol Violation|0|||
129120174|NCT00392223|464737065|FG001|Overall Study|Protocol Violation|3|||
129120175|NCT00392223|464737064|FG000|Overall Study|Withdrawal by Subject|3|||
129120176|NCT00392223|464737065|FG001|Overall Study|Withdrawal by Subject|2|||
129120177|NCT00402831|464737068|FG000|Overall Study|Lost to Follow-up|1|||
129120178|NCT00402831|464737069|FG001|Overall Study|Lost to Follow-up|2|||
129120179|NCT00402831|464737068|FG000|Overall Study|Non-compliance with protocol|0|||
129120180|NCT00402831|464737069|FG001|Overall Study|Non-compliance with protocol|1|||
129120181|NCT01114724|464737072|FG000|Overall Study|Death|8|||
129120182|NCT01114724|464737072|FG000|Overall Study|Lost to Follow-up|1|||
129120183|NCT01114724|464737072|FG000|Overall Study|Withdrawal by Subject|1|||
129120184|NCT02814526|464737078|FG000|Overall Study|Adverse Event|4|||
129120185|NCT02814526|464737079|FG001|Overall Study|Adverse Event|3|||
129120186|NCT02814526|464737078|FG000|Overall Study|Death|1|||
129120187|NCT02814526|464737079|FG001|Overall Study|Death|1|||
128701977|NCT01427972|463207547|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701978|NCT01427972|463207548|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
128701979|NCT01427972|463207549|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701980|NCT01427972|463207550|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701981|NCT01427972|463207551|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701982|NCT01427972|463207552|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701983|NCT01427972|463207553|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701984|NCT01427972|463207554|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701985|NCT01427972|463207555|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701986|NCT01427972|463207556|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701987|NCT01427972|463207557|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701988|NCT01427972|463207558|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
128701989|NCT00530946|463207559|FG000|Overall Study|Adverse Event|1|||
128701990|NCT00530946|463207560|FG001|Overall Study|Adverse Event|2|||
128701991|NCT00530946|463207561|FG002|Overall Study|Adverse Event|1|||
128701992|NCT00530946|463207562|FG003|Overall Study|Adverse Event|1|||
128701993|NCT00530946|463207559|FG000|Overall Study|Protocol Violation|0|||
128701994|NCT00530946|463207560|FG001|Overall Study|Protocol Violation|0|||
128701995|NCT00530946|463207561|FG002|Overall Study|Protocol Violation|0|||
128701996|NCT00530946|463207562|FG003|Overall Study|Protocol Violation|1|||
128701997|NCT00530946|463207559|FG000|Overall Study|Noncompliance|1|||
128701998|NCT00530946|463207560|FG001|Overall Study|Noncompliance|0|||
129120188|NCT02814526|464737078|FG000|Overall Study|Lost to Follow-up|3|||
129120189|NCT02814526|464737079|FG001|Overall Study|Lost to Follow-up|4|||
129120190|NCT02814526|464737078|FG000|Overall Study|non site physician decision|1|||
129120191|NCT02814526|464737079|FG001|Overall Study|non site physician decision|0|||
129120192|NCT02814526|464737078|FG000|Overall Study|participant noncompliance|1|||
129120193|NCT02814526|464737079|FG001|Overall Study|participant noncompliance|1|||
128930092|NCT01480180|464032896|FG004|Extension Phase, Part 1|Unclassified|0|||
128930093|NCT01480180|464032897|FG005|Extension Phase, Part 1|Unclassified|0|||
128930094|NCT01480180|464032892|FG000|Extension Phase, Part 1|Adverse Event|0|||
128930095|NCT01480180|464032893|FG001|Extension Phase, Part 1|Adverse Event|0|||
128930096|NCT01480180|464032894|FG002|Extension Phase, Part 1|Adverse Event|4|||
128930097|NCT01480180|464032895|FG003|Extension Phase, Part 1|Adverse Event|1|||
128930098|NCT01480180|464032896|FG004|Extension Phase, Part 1|Adverse Event|0|||
128930099|NCT01480180|464032897|FG005|Extension Phase, Part 1|Adverse Event|0|||
128930100|NCT01480180|464032892|FG000|Extension Phase, Part 1|Change of treatment|0|||
128930101|NCT01480180|464032893|FG001|Extension Phase, Part 1|Change of treatment|0|||
128930102|NCT01480180|464032894|FG002|Extension Phase, Part 1|Change of treatment|0|||
128930103|NCT01480180|464032895|FG003|Extension Phase, Part 1|Change of treatment|9|||
128930104|NCT01480180|464032896|FG004|Extension Phase, Part 1|Change of treatment|0|||
128930105|NCT01480180|464032897|FG005|Extension Phase, Part 1|Change of treatment|0|||
128930106|NCT01480180|464032892|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
128930107|NCT01480180|464032893|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
128930108|NCT01480180|464032894|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
128930109|NCT01480180|464032895|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
128930110|NCT01480180|464032896|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
128930111|NCT01480180|464032897|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
128930112|NCT01480180|464032892|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
128930113|NCT01480180|464032893|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
128930114|NCT01480180|464032894|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
128930115|NCT01480180|464032895|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
128930116|NCT01480180|464032896|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
128930117|NCT01480180|464032897|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
128930118|NCT01480180|464032892|FG000|Extension Phase, Part 2|Unclassified|0|||
128930119|NCT01480180|464032893|FG001|Extension Phase, Part 2|Unclassified|0|||
128930120|NCT01480180|464032894|FG002|Extension Phase, Part 2|Unclassified|3|||
128930121|NCT01480180|464032895|FG003|Extension Phase, Part 2|Unclassified|1|||
128930122|NCT01480180|464032896|FG004|Extension Phase, Part 2|Unclassified|1|||
128930123|NCT01480180|464032897|FG005|Extension Phase, Part 2|Unclassified|0|||
128930124|NCT00971321|464032898|FG000|Up to Month 7|Withdrawal by Subject|1|||
128930125|NCT00971321|464032899|FG001|Up to Month 7|Withdrawal by Subject|0|||
128930126|NCT00971321|464032898|FG000|Up to Month 7|Migrated/moved from study area|3|||
128930127|NCT00971321|464032899|FG001|Up to Month 7|Migrated/moved from study area|2|||
128930128|NCT00971321|464032898|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
128930129|NCT00971321|464032899|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
128930130|NCT00971321|464032898|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
128930131|NCT00971321|464032899|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
128930132|NCT00971321|464032898|FG000|Up to Month 11-12|Lost to Follow-up|1|||
128930133|NCT00971321|464032899|FG001|Up to Month 11-12|Lost to Follow-up|0|||
128930134|NCT01476787|464032915|FG000|Treatment|Progression|64|||
128930135|NCT01476787|464032916|FG001|Treatment|Progression|71|||
128930136|NCT01476787|464032915|FG000|Treatment|Toxicity|44|||
128930137|NCT01476787|464032916|FG001|Treatment|Toxicity|16|||
128930138|NCT01476787|464032915|FG000|Treatment|Death|0|||
128930139|NCT01476787|464032916|FG001|Treatment|Death|1|||
128930140|NCT01476787|464032915|FG000|Treatment|Withdrawal by Subject|3|||
128930141|NCT01476787|464032916|FG001|Treatment|Withdrawal by Subject|14|||
128930142|NCT01476787|464032915|FG000|Treatment|Major protocol violation|1|||
128930143|NCT01476787|464032916|FG001|Treatment|Major protocol violation|6|||
128930144|NCT01476787|464032915|FG000|Treatment|Other reasons|10|||
128930145|NCT01476787|464032916|FG001|Treatment|Other reasons|22|||
128930146|NCT01476787|464032915|FG000|Treatment|Concurrent illness|12|||
128930147|NCT01476787|464032916|FG001|Treatment|Concurrent illness|9|||
128930148|NCT01476787|464032915|FG000|Treatment|Insufficient response|15|||
128930149|NCT01476787|464032916|FG001|Treatment|Insufficient response|3|||
128930150|NCT01476787|464032915|FG000|Treatment|Voluntary treatment discontinuation|8|||
128930151|NCT01476787|464032916|FG001|Treatment|Voluntary treatment discontinuation|4|||
128930152|NCT01450137|464032917|FG000|Up to Week 12|Adverse Event|2|||
128930153|NCT01450137|464032918|FG001|Up to Week 12|Adverse Event|1|||
128930154|NCT01450137|464032917|FG000|Up to Week 12|Withdrawal by Subject|0|||
128930155|NCT01450137|464032918|FG001|Up to Week 12|Withdrawal by Subject|2|||
128930156|NCT01450137|464032917|FG000|Week 12 to Study End|Death|0|||
128930157|NCT01450137|464032918|FG001|Week 12 to Study End|Death|1|||
128930158|NCT01450137|464032917|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
128930159|NCT01450137|464032918|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
128930160|NCT01926886|464032920|FG000|Overall Study|Administrative/other|1|||
128930161|NCT01926886|464032921|FG001|Overall Study|Administrative/other|0|||
128930162|NCT01926886|464032920|FG000|Overall Study|Adverse event/intercurrent illness|4|||
128930163|NCT01926886|464032921|FG001|Overall Study|Adverse event/intercurrent illness|0|||
128930164|NCT01926886|464032920|FG000|Overall Study|Disease progression/recurrence|4|||
128930165|NCT01926886|464032921|FG001|Overall Study|Disease progression/recurrence|0|||
128930166|NCT01926886|464032920|FG000|Overall Study|Withdrawal by Subject|15|||
128930167|NCT01926886|464032921|FG001|Overall Study|Withdrawal by Subject|0|||
128930168|NCT01926886|464032920|FG000|Overall Study|Failure to return|3|||
128930169|NCT01926886|464032921|FG001|Overall Study|Failure to return|0|||
128930170|NCT01926886|464032920|FG000|Overall Study|Recurrence of disease|1|||
128930171|NCT01926886|464032921|FG001|Overall Study|Recurrence of disease|0|||
128930172|NCT01926886|464032920|FG000|Overall Study|Progression of disease|2|||
128930173|NCT01926886|464032921|FG001|Overall Study|Progression of disease|0|||
128930174|NCT01926886|464032920|FG000|Overall Study|Death|1|||
128930175|NCT01926886|464032921|FG001|Overall Study|Death|0|||
128930176|NCT01926886|464032920|FG000|Overall Study|Did not cooperate|1|||
128930177|NCT01926886|464032921|FG001|Overall Study|Did not cooperate|0|||
128930178|NCT01450540|464032922|FG000|Overall Study|Withdrawal by Subject|19|||
128930179|NCT01450540|464032923|FG001|Overall Study|Withdrawal by Subject|13|||
128930180|NCT01450540|464032922|FG000|Overall Study|protocol deviation|3|||
128930181|NCT01450540|464032923|FG001|Overall Study|protocol deviation|23|||
128930182|NCT01662999|464032932|FG000|Period 3|Withdrawal by Subject|0|||
128930183|NCT01662999|464032933|FG001|Period 3|Withdrawal by Subject|1|||
128930184|NCT01662999|464032934|FG002|Period 3|Withdrawal by Subject|0|||
128930185|NCT01662999|464032935|FG003|Period 3|Withdrawal by Subject|0|||
128930186|NCT01662999|464032936|FG004|Period 3|Withdrawal by Subject|0|||
128930187|NCT01662999|464032937|FG005|Period 3|Withdrawal by Subject|0|||
128930188|NCT02932267|464032938|FG000|Overall Study|Withdrawal by Subject|3|||
128930189|NCT02932267|464032938|FG000|Overall Study|Lost to Follow-up|4|||
128930190|NCT02932267|464032938|FG000|Overall Study|Pregnancy|1|||
128930191|NCT01919411|464032939|FG000|Overall Study|Lost to Follow-up|2|||
128930192|NCT01919411|464032940|FG001|Overall Study|Lost to Follow-up|4|||
128930193|NCT01919411|464032939|FG000|Overall Study|Physician Decision|1|||
128930194|NCT01919411|464032940|FG001|Overall Study|Physician Decision|0|||
128930195|NCT01919411|464032939|FG000|Overall Study|Protocol Violation|2|||
128930196|NCT01919411|464032940|FG001|Overall Study|Protocol Violation|1|||
128930197|NCT00524303|464032941|FG000|Overall Study|Lost to Follow-up|6|||
128930198|NCT00524303|464032942|FG001|Overall Study|Lost to Follow-up|0|||
128930199|NCT00524303|464032943|FG002|Overall Study|Lost to Follow-up|3|||
128930200|NCT00524303|464032941|FG000|Overall Study|Protocol Violation|0|||
128930201|NCT00524303|464032942|FG001|Overall Study|Protocol Violation|1|||
128930202|NCT00524303|464032943|FG002|Overall Study|Protocol Violation|1|||
128930203|NCT00524303|464032941|FG000|Overall Study|Withdrawal by Subject|3|||
128930204|NCT00524303|464032942|FG001|Overall Study|Withdrawal by Subject|0|||
128930205|NCT00524303|464032943|FG002|Overall Study|Withdrawal by Subject|4|||
128930206|NCT00524303|464032941|FG000|Overall Study|Death|0|||
128930207|NCT00524303|464032942|FG001|Overall Study|Death|2|||
128930208|NCT00524303|464032943|FG002|Overall Study|Death|3|||
128930209|NCT00524303|464032941|FG000|Overall Study|Adverse Event|1|||
128930210|NCT00524303|464032942|FG001|Overall Study|Adverse Event|2|||
128930211|NCT00524303|464032943|FG002|Overall Study|Adverse Event|3|||
128930212|NCT00524303|464032941|FG000|Overall Study|Did not Complete Study Dosing|1|||
128930213|NCT00524303|464032942|FG001|Overall Study|Did not Complete Study Dosing|0|||
128930214|NCT00524303|464032943|FG002|Overall Study|Did not Complete Study Dosing|0|||
128930215|NCT00524303|464032941|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
129030471|NCT04133311|464403134|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
129030472|NCT04133311|464403131|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
129030473|NCT04133311|464403132|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
129030474|NCT04133311|464403133|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
129030475|NCT04133311|464403134|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
129030476|NCT04133311|464403131|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
129030477|NCT04133311|464403132|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
129030478|NCT04133311|464403133|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
129120194|NCT02814526|464737078|FG000|Overall Study|Withdrawal by Subject|20|||
129120195|NCT02814526|464737079|FG001|Overall Study|Withdrawal by Subject|14|||
128701999|NCT00530946|463207561|FG002|Overall Study|Noncompliance|0|||
128702000|NCT00530946|463207562|FG003|Overall Study|Noncompliance|0|||
128702001|NCT03322631|463207567|FG000|Overall Study|Withdrawal by Subject|0|||
128702002|NCT03322631|463207568|FG001|Overall Study|Withdrawal by Subject|1|||
128930216|NCT00524303|464032942|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
128930217|NCT00524303|464032943|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
128930218|NCT00524303|464032941|FG000|Overall Study|Disease Progression|0|||
128930219|NCT00524303|464032942|FG001|Overall Study|Disease Progression|4|||
128930220|NCT00524303|464032943|FG002|Overall Study|Disease Progression|1|||
128930221|NCT00524303|464032941|FG000|Overall Study|Disease Recurrence|0|||
128930222|NCT00524303|464032942|FG001|Overall Study|Disease Recurrence|1|||
128930223|NCT00524303|464032943|FG002|Overall Study|Disease Recurrence|0|||
128930224|NCT00524303|464032941|FG000|Overall Study|Sponsor Request|0|||
128930225|NCT00524303|464032942|FG001|Overall Study|Sponsor Request|0|||
128930226|NCT00524303|464032943|FG002|Overall Study|Sponsor Request|1|||
128930227|NCT00524303|464032941|FG000|Overall Study|Physician Decision|0|||
128930228|NCT00524303|464032942|FG001|Overall Study|Physician Decision|0|||
128930229|NCT00524303|464032943|FG002|Overall Study|Physician Decision|1|||
128930230|NCT00524303|464032941|FG000|Overall Study|Completed 5 years|0|||
128930231|NCT00524303|464032942|FG001|Overall Study|Completed 5 years|0|||
128930232|NCT00524303|464032943|FG002|Overall Study|Completed 5 years|1|||
128930233|NCT03750838|464032944|FG000|Overall Study|Lost to Follow-up|10|||
128930234|NCT03750838|464032945|FG001|Overall Study|Lost to Follow-up|6|||
128930235|NCT00630032|464032947|FG000|Overall Study|Death|55|||
128930236|NCT00630032|464032948|FG001|Overall Study|Death|49|||
128930237|NCT00630032|464032947|FG000|Overall Study|Withdrawal by Subject|3|||
128930238|NCT00630032|464032948|FG001|Overall Study|Withdrawal by Subject|2|||
128930239|NCT00630032|464032947|FG000|Overall Study|Lost to Follow-up|18|||
128930240|NCT00630032|464032948|FG001|Overall Study|Lost to Follow-up|31|||
128930241|NCT00630032|464032947|FG000|Overall Study|Protocol Violation|1|||
128930242|NCT00630032|464032948|FG001|Overall Study|Protocol Violation|0|||
128930243|NCT00630032|464032947|FG000|Overall Study|Patient has moved|1|||
128930244|NCT00630032|464032948|FG001|Overall Study|Patient has moved|1|||
128930245|NCT00630032|464032947|FG000|Overall Study|Disease progression|1|||
128930246|NCT00630032|464032948|FG001|Overall Study|Disease progression|1|||
129120196|NCT02814526|464737078|FG000|Overall Study|safety risk|2|||
129120197|NCT02814526|464737079|FG001|Overall Study|safety risk|1|||
129120198|NCT02814526|464737078|FG000|Overall Study|early termination-study terminated|1|||
129120199|NCT02814526|464737079|FG001|Overall Study|early termination-study terminated|2|||
129120200|NCT02814526|464737078|FG000|Overall Study|Other|0|||
129120201|NCT02814526|464737079|FG001|Overall Study|Other|4|||
129120202|NCT03883386|464737080|FG000|First Assignment|Lost to Follow-up|1|||
129120203|NCT03883386|464737081|FG001|First Assignment|Lost to Follow-up|0|||
129120204|NCT03883386|464737080|FG000|First Assignment|Withdrawal by Subject|1|||
129120205|NCT03883386|464737081|FG001|First Assignment|Withdrawal by Subject|1|||
129120206|NCT00251758|464737082|FG000|Overall Study|Adverse Event|7|||
129120207|NCT00251758|464737083|FG001|Overall Study|Adverse Event|9|||
129120208|NCT00251758|464737084|FG002|Overall Study|Adverse Event|11|||
129120209|NCT00251758|464737082|FG000|Overall Study|Lost to Follow-up|4|||
129120210|NCT00251758|464737083|FG001|Overall Study|Lost to Follow-up|2|||
129120211|NCT00251758|464737084|FG002|Overall Study|Lost to Follow-up|5|||
128767379|NCT02073097|463438221|FG004|Overall Study|Death|0|||
128767380|NCT02073097|463438222|FG005|Overall Study|Death|0|||
128767381|NCT02073097|463438223|FG006|Overall Study|Death|0|||
128767382|NCT02073097|463438224|FG007|Overall Study|Death|1|||
128930247|NCT00630032|464032947|FG000|Overall Study|End of monitoring in US centers|11|||
128930248|NCT00630032|464032948|FG001|Overall Study|End of monitoring in US centers|11|||
128930249|NCT03439345|464034485|FG000|Overall Study|Lost to Follow-up|0|||
128930250|NCT03439345|464034486|FG001|Overall Study|Lost to Follow-up|1|||
128930251|NCT03439345|464034485|FG000|Overall Study|Consent withdrawn|0|||
128930252|NCT03439345|464034486|FG001|Overall Study|Consent withdrawn|1|||
128930253|NCT05165394|464034490|FG000|Overall Study|Withdrawal by Subject|5|||
128930254|NCT05165394|464034491|FG001|Overall Study|Withdrawal by Subject|1|||
128930255|NCT05165394|464034490|FG000|Overall Study|Lost to Follow-up|1|||
128930256|NCT05165394|464034491|FG001|Overall Study|Lost to Follow-up|2|||
128930257|NCT05165394|464034490|FG000|Overall Study|Other Than Specified|0|||
128930258|NCT05165394|464034491|FG001|Overall Study|Other Than Specified|1|||
128930259|NCT00001259|464034495|FG000|Study 2|Adverse Event|0|||
128930260|NCT00001259|464034496|FG001|Study 2|Adverse Event|0|||
128930261|NCT00001259|464034497|FG002|Study 2|Adverse Event|0|||
128930262|NCT00001259|464034498|FG003|Study 2|Adverse Event|0|||
128930263|NCT00001259|464034499|FG004|Study 2|Adverse Event|2|||
128930264|NCT00001259|464034500|FG005|Study 2|Adverse Event|0|||
128930265|NCT00001259|464034501|FG006|Study 2|Adverse Event|0|||
128930266|NCT02517515|464034507|FG000|Overall Study|Adverse Event|0|||
128930267|NCT02517515|464034508|FG001|Overall Study|Adverse Event|1|||
128930268|NCT02517515|464034507|FG000|Overall Study|Withdrew Consent|0|||
128930269|NCT02517515|464034508|FG001|Overall Study|Withdrew Consent|1|||
128930270|NCT02517515|464034507|FG000|Overall Study|Lost to Follow-up|1|||
128930271|NCT02517515|464034508|FG001|Overall Study|Lost to Follow-up|0|||
128930272|NCT02517515|464034507|FG000|Overall Study|Other|1|||
128930273|NCT02517515|464034508|FG001|Overall Study|Other|0|||
128930274|NCT02786537|464034509|FG000|As Randomized|Adverse Event|0|||
128930275|NCT02786537|464034510|FG001|As Randomized|Adverse Event|11|||
128930276|NCT02786537|464034511|FG002|As Randomized|Adverse Event|0|||
128930277|NCT02786537|464034512|FG003|As Randomized|Adverse Event|4|||
129120212|NCT00251758|464737082|FG000|Overall Study|Withdrawal by Subject|13|||
129120213|NCT00251758|464737083|FG001|Overall Study|Withdrawal by Subject|7|||
129120214|NCT00251758|464737084|FG002|Overall Study|Withdrawal by Subject|3|||
128767383|NCT02073097|463438217|FG000|Overall Study|Physician Decision|0|||
128767384|NCT02073097|463438218|FG001|Overall Study|Physician Decision|0|||
128767385|NCT02073097|463438219|FG002|Overall Study|Physician Decision|0|||
128930278|NCT02786537|464034513|FG004|As Randomized|Adverse Event|6|||
128930279|NCT02786537|464034514|FG005|As Randomized|Adverse Event|2|||
128930280|NCT02786537|464034509|FG000|As Randomized|Lack of Efficacy|0|||
128930281|NCT02786537|464034510|FG001|As Randomized|Lack of Efficacy|0|||
128930282|NCT02786537|464034511|FG002|As Randomized|Lack of Efficacy|0|||
128930283|NCT02786537|464034512|FG003|As Randomized|Lack of Efficacy|1|||
128930284|NCT02786537|464034513|FG004|As Randomized|Lack of Efficacy|0|||
128702003|NCT03322631|463207569|FG002|Overall Study|Withdrawal by Subject|0|||
128702004|NCT03322631|463207570|FG003|Overall Study|Withdrawal by Subject|0|||
128930285|NCT02786537|464034514|FG005|As Randomized|Lack of Efficacy|0|||
128930286|NCT02786537|464034509|FG000|As Randomized|Withdrawal by Subject|1|||
128930287|NCT02786537|464034510|FG001|As Randomized|Withdrawal by Subject|2|||
128930288|NCT02786537|464034511|FG002|As Randomized|Withdrawal by Subject|0|||
128930289|NCT02786537|464034512|FG003|As Randomized|Withdrawal by Subject|1|||
128930290|NCT02786537|464034513|FG004|As Randomized|Withdrawal by Subject|1|||
128930291|NCT02786537|464034514|FG005|As Randomized|Withdrawal by Subject|0|||
128930292|NCT02786537|464034509|FG000|As Randomized|Death|0|||
128930293|NCT02786537|464034510|FG001|As Randomized|Death|2|||
128930294|NCT02786537|464034511|FG002|As Randomized|Death|0|||
128930295|NCT02786537|464034512|FG003|As Randomized|Death|3|||
128930296|NCT02786537|464034513|FG004|As Randomized|Death|1|||
128930297|NCT02786537|464034514|FG005|As Randomized|Death|0|||
128930298|NCT02786537|464034509|FG000|As Randomized|Non-compliance with study drug|1|||
128930299|NCT02786537|464034510|FG001|As Randomized|Non-compliance with study drug|11|||
128930300|NCT02786537|464034511|FG002|As Randomized|Non-compliance with study drug|0|||
128930301|NCT02786537|464034512|FG003|As Randomized|Non-compliance with study drug|1|||
128930302|NCT02786537|464034513|FG004|As Randomized|Non-compliance with study drug|0|||
128930303|NCT02786537|464034514|FG005|As Randomized|Non-compliance with study drug|1|||
128930304|NCT02786537|464034509|FG000|As Randomized|Lost to treatment follow-up|4|||
128930305|NCT02786537|464034510|FG001|As Randomized|Lost to treatment follow-up|32|||
128930306|NCT02786537|464034511|FG002|As Randomized|Lost to treatment follow-up|0|||
128930307|NCT02786537|464034512|FG003|As Randomized|Lost to treatment follow-up|24|||
128930308|NCT02786537|464034513|FG004|As Randomized|Lost to treatment follow-up|4|||
128930309|NCT02786537|464034514|FG005|As Randomized|Lost to treatment follow-up|4|||
128930310|NCT02786537|464034509|FG000|As Randomized|Incarceration|0|||
128930311|NCT02786537|464034510|FG001|As Randomized|Incarceration|1|||
128930312|NCT02786537|464034511|FG002|As Randomized|Incarceration|0|||
128930313|NCT02786537|464034512|FG003|As Randomized|Incarceration|0|||
128930314|NCT02786537|464034513|FG004|As Randomized|Incarceration|0|||
128930315|NCT02786537|464034514|FG005|As Randomized|Incarceration|0|||
128930316|NCT02786537|464034509|FG000|As Randomized|Opiate Dependency Relapse|0|||
128930317|NCT02786537|464034510|FG001|As Randomized|Opiate Dependency Relapse|1|||
128930318|NCT02786537|464034511|FG002|As Randomized|Opiate Dependency Relapse|0|||
128930319|NCT02786537|464034512|FG003|As Randomized|Opiate Dependency Relapse|0|||
128930320|NCT02786537|464034513|FG004|As Randomized|Opiate Dependency Relapse|0|||
128930321|NCT02786537|464034514|FG005|As Randomized|Opiate Dependency Relapse|0|||
128930322|NCT02786537|464034509|FG000|As Randomized|HCV drugs stolen from pt|0|||
128930323|NCT02786537|464034510|FG001|As Randomized|HCV drugs stolen from pt|1|||
128930324|NCT02786537|464034511|FG002|As Randomized|HCV drugs stolen from pt|0|||
128930325|NCT02786537|464034512|FG003|As Randomized|HCV drugs stolen from pt|0|||
128930326|NCT02786537|464034513|FG004|As Randomized|HCV drugs stolen from pt|0|||
128930327|NCT02786537|464034514|FG005|As Randomized|HCV drugs stolen from pt|0|||
128930328|NCT02786537|464034509|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
128930329|NCT02786537|464034510|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
128930330|NCT02786537|464034511|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
128930331|NCT02786537|464034512|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
128930332|NCT02786537|464034513|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
128930333|NCT02786537|464034514|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
128930334|NCT02786537|464034509|FG000|As Randomized|Subject lost insurance|0|||
128930335|NCT02786537|464034510|FG001|As Randomized|Subject lost insurance|0|||
128930336|NCT02786537|464034511|FG002|As Randomized|Subject lost insurance|0|||
128930337|NCT02786537|464034512|FG003|As Randomized|Subject lost insurance|1|||
128930338|NCT02786537|464034513|FG004|As Randomized|Subject lost insurance|0|||
128930339|NCT02786537|464034514|FG005|As Randomized|Subject lost insurance|0|||
128930340|NCT02786537|464034509|FG000|As Treated|Adverse Event|0|||
128930341|NCT02786537|464034510|FG001|As Treated|Adverse Event|11|||
128930342|NCT02786537|464034511|FG002|As Treated|Adverse Event|0|||
128930343|NCT02786537|464034512|FG003|As Treated|Adverse Event|4|||
129030479|NCT04133311|464403134|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
128702005|NCT03322631|463207567|FG000|Overall Study|Adverse Event|0|||
128702006|NCT03322631|463207568|FG001|Overall Study|Adverse Event|0|||
128702007|NCT03322631|463207569|FG002|Overall Study|Adverse Event|1|||
128702008|NCT03322631|463207570|FG003|Overall Study|Adverse Event|0|||
128702009|NCT02378961|463207571|FG000|Overall Study|Lack of Efficacy|4|||
128702010|NCT02378961|463207572|FG001|Overall Study|Lack of Efficacy|2|||
128702011|NCT02378961|463207573|FG002|Overall Study|Lack of Efficacy|0|||
128702012|NCT02378961|463207574|FG003|Overall Study|Lack of Efficacy|1|||
128930344|NCT02786537|464034513|FG004|As Treated|Adverse Event|6|||
128930345|NCT02786537|464034514|FG005|As Treated|Adverse Event|2|||
129030480|NCT04133311|464403131|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
128702013|NCT02378961|463207571|FG000|Overall Study|Death|0|||
128702014|NCT02378961|463207572|FG001|Overall Study|Death|0|||
128930346|NCT02786537|464034509|FG000|As Treated|Death|0|||
128930347|NCT02786537|464034510|FG001|As Treated|Death|2|||
128702015|NCT02378961|463207573|FG002|Overall Study|Death|1|||
128702016|NCT02378961|463207574|FG003|Overall Study|Death|0|||
128702017|NCT01217801|463207575|FG000|Period 1|Protocol Violation|1|||
128702018|NCT01217801|463207576|FG001|Period 1|Protocol Violation|1|||
128702019|NCT01217801|463207575|FG000|Period 1|Withdrawal by Subject|0|||
128702020|NCT01217801|463207576|FG001|Period 1|Withdrawal by Subject|1|||
128702021|NCT04967443|463207578|FG000|Open Label Treatment|Death|1|||
128702022|NCT04967443|463207579|FG001|Open Label Treatment|Death|0|||
128702023|NCT04967443|463207580|FG002|Open Label Treatment|Death|0|||
128702024|NCT04967443|463207581|FG003|Open Label Treatment|Death|0|||
128702025|NCT04967443|463207582|FG004|Open Label Treatment|Death|0|||
128702026|NCT04967443|463207583|FG005|Open Label Treatment|Death|0|||
128702027|NCT04967443|463207584|FG006|Open Label Treatment|Death|0|||
128767386|NCT02073097|463438220|FG003|Overall Study|Physician Decision|0|||
128767387|NCT02073097|463438221|FG004|Overall Study|Physician Decision|0|||
128767388|NCT02073097|463438222|FG005|Overall Study|Physician Decision|0|||
128767389|NCT02073097|463438223|FG006|Overall Study|Physician Decision|0|||
128767390|NCT02073097|463438224|FG007|Overall Study|Physician Decision|1|||
128767391|NCT02769065|463440239|FG000|Overall Study|Voluntary Withdrawal|1|||
128767392|NCT02769065|463440240|FG001|Overall Study|Voluntary Withdrawal|0|||
128767393|NCT02769065|463440241|FG002|Overall Study|Voluntary Withdrawal|0|||
128767394|NCT02769065|463440242|FG003|Overall Study|Voluntary Withdrawal|0|||
128702028|NCT04967443|463207585|FG007|Open Label Treatment|Death|0|||
128702029|NCT04967443|463207578|FG000|Open Label Treatment|Lost to Follow-up|0|||
128702030|NCT04967443|463207579|FG001|Open Label Treatment|Lost to Follow-up|0|||
128702031|NCT04967443|463207580|FG002|Open Label Treatment|Lost to Follow-up|1|||
128702032|NCT04967443|463207581|FG003|Open Label Treatment|Lost to Follow-up|0|||
128702033|NCT04967443|463207582|FG004|Open Label Treatment|Lost to Follow-up|0|||
128702034|NCT04967443|463207583|FG005|Open Label Treatment|Lost to Follow-up|0|||
128702035|NCT04967443|463207584|FG006|Open Label Treatment|Lost to Follow-up|0|||
128702036|NCT04967443|463207585|FG007|Open Label Treatment|Lost to Follow-up|0|||
128702037|NCT04967443|463207578|FG000|Open Label Treatment|Withdrawal by Subject|0|||
128702038|NCT04967443|463207579|FG001|Open Label Treatment|Withdrawal by Subject|1|||
128702039|NCT04967443|463207580|FG002|Open Label Treatment|Withdrawal by Subject|0|||
128702040|NCT04967443|463207581|FG003|Open Label Treatment|Withdrawal by Subject|1|||
128702041|NCT04967443|463207582|FG004|Open Label Treatment|Withdrawal by Subject|0|||
128702042|NCT04967443|463207583|FG005|Open Label Treatment|Withdrawal by Subject|1|||
128767395|NCT02769065|463440243|FG004|Overall Study|Voluntary Withdrawal|0|||
128767396|NCT02769065|463440244|FG005|Overall Study|Voluntary Withdrawal|0|||
128767397|NCT02769065|463440245|FG006|Overall Study|Voluntary Withdrawal|0|||
128767398|NCT02769065|463440246|FG007|Overall Study|Voluntary Withdrawal|0|||
128767399|NCT02769065|463440247|FG008|Overall Study|Voluntary Withdrawal|0|||
129120215|NCT00251758|464737082|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129120216|NCT00251758|464737083|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
129120217|NCT00251758|464737084|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
129120218|NCT00251758|464737082|FG000|Overall Study|Lack of Efficacy|3|||
129120219|NCT00251758|464737083|FG001|Overall Study|Lack of Efficacy|0|||
129120220|NCT00251758|464737084|FG002|Overall Study|Lack of Efficacy|0|||
129120221|NCT00251758|464737082|FG000|Overall Study|Noncompliant|0|||
129120222|NCT00251758|464737083|FG001|Overall Study|Noncompliant|2|||
129120223|NCT00251758|464737084|FG002|Overall Study|Noncompliant|2|||
129120224|NCT00251758|464737082|FG000|Overall Study|Pregnancy|0|||
129120225|NCT00251758|464737083|FG001|Overall Study|Pregnancy|1|||
129120226|NCT00251758|464737084|FG002|Overall Study|Pregnancy|0|||
129120227|NCT00251758|464737082|FG000|Overall Study|Per Subject Request|0|||
129120228|NCT00251758|464737083|FG001|Overall Study|Per Subject Request|0|||
129120229|NCT00251758|464737084|FG002|Overall Study|Per Subject Request|1|||
129120230|NCT00251758|464737082|FG000|Overall Study|Per Investigator Request|1|||
129120231|NCT00251758|464737083|FG001|Overall Study|Per Investigator Request|0|||
129120232|NCT00251758|464737084|FG002|Overall Study|Per Investigator Request|0|||
129120233|NCT01387269|464737086|FG000|Overall Study|Death|38|||
129120234|NCT01387269|464737087|FG001|Overall Study|Death|20|||
128702043|NCT04967443|463207584|FG006|Open Label Treatment|Withdrawal by Subject|2|||
128702044|NCT04967443|463207585|FG007|Open Label Treatment|Withdrawal by Subject|3|||
128767400|NCT02769065|463440248|FG009|Overall Study|Voluntary Withdrawal|0|||
128767401|NCT02769065|463440249|FG010|Overall Study|Voluntary Withdrawal|0|||
128767402|NCT02769065|463440250|FG011|Overall Study|Voluntary Withdrawal|0|||
129120235|NCT01387269|464737086|FG000|Overall Study|Other|8|||
129120236|NCT01387269|464737087|FG001|Overall Study|Other|7|||
129120237|NCT01387269|464737086|FG000|Overall Study|Unrelated AE|12|||
129120238|NCT01387269|464737087|FG001|Overall Study|Unrelated AE|3|||
129120239|NCT01387269|464737086|FG000|Overall Study|Withdrawal by patient|32|||
129120240|NCT01387269|464737087|FG001|Overall Study|Withdrawal by patient|10|||
128702045|NCT04967443|463207578|FG000|Follow-Up|Death|1|||
128702046|NCT04967443|463207579|FG001|Follow-Up|Death|0|||
128702047|NCT04967443|463207580|FG002|Follow-Up|Death|0|||
128702048|NCT04967443|463207581|FG003|Follow-Up|Death|0|||
128702049|NCT04967443|463207582|FG004|Follow-Up|Death|0|||
128702050|NCT04967443|463207583|FG005|Follow-Up|Death|0|||
128930348|NCT02786537|464034511|FG002|As Treated|Death|0|||
128930349|NCT02786537|464034512|FG003|As Treated|Death|3|||
128767403|NCT02769065|463440251|FG012|Overall Study|Voluntary Withdrawal|0|||
128767404|NCT02769065|463440252|FG013|Overall Study|Voluntary Withdrawal|0|||
128930350|NCT02786537|464034513|FG004|As Treated|Death|1|||
128930351|NCT02786537|464034514|FG005|As Treated|Death|0|||
128930352|NCT02786537|464034509|FG000|As Treated|Lack of Efficacy|0|||
128930353|NCT02786537|464034510|FG001|As Treated|Lack of Efficacy|0|||
128930354|NCT02786537|464034511|FG002|As Treated|Lack of Efficacy|0|||
128930355|NCT02786537|464034512|FG003|As Treated|Lack of Efficacy|1|||
128930356|NCT02786537|464034513|FG004|As Treated|Lack of Efficacy|0|||
128767405|NCT02769065|463440253|FG014|Overall Study|Voluntary Withdrawal|0|||
128767406|NCT02769065|463440254|FG015|Overall Study|Voluntary Withdrawal|0|||
128767407|NCT02769065|463440255|FG016|Overall Study|Voluntary Withdrawal|0|||
128767408|NCT02769065|463440256|FG017|Overall Study|Voluntary Withdrawal|0|||
128930357|NCT02786537|464034514|FG005|As Treated|Lack of Efficacy|0|||
128930358|NCT02786537|464034509|FG000|As Treated|Lost to Follow-up|4|||
128930359|NCT02786537|464034510|FG001|As Treated|Lost to Follow-up|32|||
128930360|NCT02786537|464034511|FG002|As Treated|Lost to Follow-up|0|||
128930361|NCT02786537|464034512|FG003|As Treated|Lost to Follow-up|25|||
128930362|NCT02786537|464034513|FG004|As Treated|Lost to Follow-up|4|||
128702051|NCT04967443|463207584|FG006|Follow-Up|Death|0|||
128702052|NCT04967443|463207585|FG007|Follow-Up|Death|0|||
128702053|NCT04967443|463207578|FG000|Follow-Up|Lost to Follow-up|0|||
128702054|NCT04967443|463207579|FG001|Follow-Up|Lost to Follow-up|0|||
128702055|NCT04967443|463207580|FG002|Follow-Up|Lost to Follow-up|1|||
128702056|NCT04967443|463207581|FG003|Follow-Up|Lost to Follow-up|1|||
128702057|NCT04967443|463207582|FG004|Follow-Up|Lost to Follow-up|0|||
128702058|NCT04967443|463207583|FG005|Follow-Up|Lost to Follow-up|0|||
128702059|NCT04967443|463207584|FG006|Follow-Up|Lost to Follow-up|0|||
128702060|NCT04967443|463207585|FG007|Follow-Up|Lost to Follow-up|0|||
128702061|NCT04967443|463207578|FG000|Follow-Up|Withdrawal by Subject|0|||
128702062|NCT04967443|463207579|FG001|Follow-Up|Withdrawal by Subject|1|||
128702063|NCT04967443|463207580|FG002|Follow-Up|Withdrawal by Subject|0|||
128702064|NCT04967443|463207581|FG003|Follow-Up|Withdrawal by Subject|1|||
128702065|NCT04967443|463207582|FG004|Follow-Up|Withdrawal by Subject|0|||
128702066|NCT04967443|463207583|FG005|Follow-Up|Withdrawal by Subject|1|||
128702067|NCT04967443|463207584|FG006|Follow-Up|Withdrawal by Subject|2|||
128702068|NCT04967443|463207585|FG007|Follow-Up|Withdrawal by Subject|3|||
128702069|NCT02405780|463207586|FG000|Period I|Adverse Event|8|||
128702070|NCT02405780|463207587|FG001|Period I|Adverse Event|0|||
128702071|NCT02405780|463207588|FG002|Period I|Adverse Event|3|||
128702072|NCT02405780|463207589|FG003|Period I|Adverse Event|7|||
128702073|NCT02405780|463207586|FG000|Period I|Medical reasons|1|||
128702074|NCT02405780|463207587|FG001|Period I|Medical reasons|1|||
128702075|NCT02405780|463207588|FG002|Period I|Medical reasons|0|||
128702076|NCT02405780|463207589|FG003|Period I|Medical reasons|1|||
128702077|NCT02405780|463207586|FG000|Period I|Screening Failure|1|||
128702078|NCT02405780|463207587|FG001|Period I|Screening Failure|0|||
128702079|NCT02405780|463207588|FG002|Period I|Screening Failure|1|||
128702080|NCT02405780|463207589|FG003|Period I|Screening Failure|0|||
128702081|NCT02405780|463207586|FG000|Period I|Withdrawal by Subject|9|||
128702082|NCT02405780|463207587|FG001|Period I|Withdrawal by Subject|1|||
128702083|NCT02405780|463207588|FG002|Period I|Withdrawal by Subject|3|||
128702084|NCT02405780|463207589|FG003|Period I|Withdrawal by Subject|4|||
128702085|NCT02405780|463207586|FG000|Period I|Non-compliance with study procedures|8|||
128702086|NCT02405780|463207587|FG001|Period I|Non-compliance with study procedures|6|||
128702087|NCT02405780|463207588|FG002|Period I|Non-compliance with study procedures|8|||
128702088|NCT02405780|463207589|FG003|Period I|Non-compliance with study procedures|11|||
128702089|NCT02405780|463207586|FG000|Period II|Adverse Event|3|||
128702090|NCT02405780|463207587|FG001|Period II|Adverse Event|5|||
128702091|NCT02405780|463207588|FG002|Period II|Adverse Event|4|||
128930363|NCT02786537|464034514|FG005|As Treated|Lost to Follow-up|4|||
128702092|NCT02405780|463207589|FG003|Period II|Adverse Event|11|||
128702093|NCT02405780|463207586|FG000|Period II|Medical reason|0|||
128702094|NCT02405780|463207587|FG001|Period II|Medical reason|1|||
128702095|NCT02405780|463207588|FG002|Period II|Medical reason|0|||
128702096|NCT02405780|463207589|FG003|Period II|Medical reason|0|||
128767409|NCT02769065|463440257|FG018|Overall Study|Voluntary Withdrawal|0|||
128767410|NCT02769065|463440258|FG019|Overall Study|Voluntary Withdrawal|0|||
128930364|NCT02786537|464034509|FG000|As Treated|Non-compliance with study drug|1|||
128930365|NCT02786537|464034510|FG001|As Treated|Non-compliance with study drug|11|||
128702097|NCT02405780|463207586|FG000|Period II|Pregnancy|0|||
128702098|NCT02405780|463207587|FG001|Period II|Pregnancy|0|||
128702099|NCT02405780|463207588|FG002|Period II|Pregnancy|1|||
128702100|NCT02405780|463207589|FG003|Period II|Pregnancy|0|||
128702101|NCT02405780|463207586|FG000|Period II|Withdrawal by Subject|7|||
128702102|NCT02405780|463207587|FG001|Period II|Withdrawal by Subject|4|||
128702103|NCT02405780|463207588|FG002|Period II|Withdrawal by Subject|0|||
128702104|NCT02405780|463207589|FG003|Period II|Withdrawal by Subject|3|||
128767411|NCT02769065|463440259|FG020|Overall Study|Voluntary Withdrawal|0|||
128930366|NCT02786537|464034511|FG002|As Treated|Non-compliance with study drug|0|||
128702105|NCT02405780|463207586|FG000|Period II|Non-compliance with study procedures|5|||
128702106|NCT02405780|463207587|FG001|Period II|Non-compliance with study procedures|2|||
128702107|NCT02405780|463207588|FG002|Period II|Non-compliance with study procedures|7|||
128702108|NCT02405780|463207589|FG003|Period II|Non-compliance with study procedures|4|||
128702109|NCT01654536|463207590|FG000|Overall Study|Lost to Follow-up|5|||
128702110|NCT01654536|463207591|FG001|Overall Study|Lost to Follow-up|5|||
128702111|NCT01654536|463207590|FG000|Overall Study|Physician Decision|12|||
128702112|NCT01654536|463207591|FG001|Overall Study|Physician Decision|8|||
128702113|NCT01654536|463207590|FG000|Overall Study|Withdrawal by Subject|27|||
128702114|NCT01654536|463207591|FG001|Overall Study|Withdrawal by Subject|25|||
128702115|NCT04502693|463207595|FG000|Overall Study|Adverse Event|7|||
128702116|NCT04502693|463207596|FG001|Overall Study|Adverse Event|6|||
128702117|NCT04502693|463207597|FG002|Overall Study|Adverse Event|11|||
128702118|NCT04502693|463207598|FG003|Overall Study|Adverse Event|1|||
128702119|NCT04502693|463207595|FG000|Overall Study|Lost to Follow-up|32|||
128702120|NCT04502693|463207596|FG001|Overall Study|Lost to Follow-up|36|||
128702121|NCT04502693|463207597|FG002|Overall Study|Lost to Follow-up|69|||
128702122|NCT04502693|463207598|FG003|Overall Study|Lost to Follow-up|4|||
128702123|NCT04502693|463207595|FG000|Overall Study|Protocol Violation|8|||
128702124|NCT04502693|463207596|FG001|Overall Study|Protocol Violation|8|||
128702125|NCT04502693|463207597|FG002|Overall Study|Protocol Violation|16|||
128702126|NCT04502693|463207598|FG003|Overall Study|Protocol Violation|1|||
128702127|NCT04502693|463207595|FG000|Overall Study|Withdrawal by Subject|46|||
128702128|NCT04502693|463207596|FG001|Overall Study|Withdrawal by Subject|38|||
128702129|NCT04502693|463207597|FG002|Overall Study|Withdrawal by Subject|54|||
128702130|NCT04502693|463207598|FG003|Overall Study|Withdrawal by Subject|7|||
128702131|NCT04502693|463207595|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
128702132|NCT04502693|463207596|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
128702133|NCT04502693|463207597|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
128702134|NCT04502693|463207598|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128702135|NCT04502693|463207595|FG000|Overall Study|Other|1|||
128702136|NCT04502693|463207596|FG001|Overall Study|Other|0|||
128702137|NCT04502693|463207597|FG002|Overall Study|Other|1|||
128702138|NCT04502693|463207598|FG003|Overall Study|Other|1|||
128702139|NCT00602797|463207599|FG000|Overall Study|Adverse Event|1|||
128702140|NCT03943147|463207602|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
128702141|NCT03943147|463207603|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
128702142|NCT03943147|463207602|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
128702143|NCT03943147|463207603|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
128702144|NCT03943147|463207602|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
128702145|NCT03943147|463207603|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
128702146|NCT03943147|463207602|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
128702147|NCT03943147|463207603|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
128702148|NCT03943147|463207602|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
128702149|NCT03943147|463207603|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
128702150|NCT03943147|463207602|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
128702151|NCT03943147|463207603|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
128702152|NCT01318993|463207604|FG000|Overall Study|Adverse Event|53|||
128702153|NCT01318993|463207604|FG000|Overall Study|Lack of Efficacy|121|||
128702154|NCT01318993|463207604|FG000|Overall Study|Protocol Violation|3|||
128702155|NCT01318993|463207604|FG000|Overall Study|Protocol based stopping criteria|6|||
128702156|NCT01318993|463207604|FG000|Overall Study|Study closed or terminated|174|||
128702157|NCT01318993|463207604|FG000|Overall Study|Lost to Follow-up|4|||
128702158|NCT01318993|463207604|FG000|Overall Study|Physician Decision|13|||
128702159|NCT01318993|463207604|FG000|Overall Study|Withdrawal by Subject|24|||
128702160|NCT00629707|463207607|FG000|Overall Study|Withdrawal by Subject|0|||
128702161|NCT00629707|463207608|FG001|Overall Study|Withdrawal by Subject|1|||
128702162|NCT00629707|463207607|FG000|Overall Study|Physician Decision|0|||
128702163|NCT00629707|463207608|FG001|Overall Study|Physician Decision|1|||
128702164|NCT03736447|463207609|FG000|Overall Study|Adverse Event|5|||
128702165|NCT03736447|463207610|FG001|Overall Study|Adverse Event|1|||
128930367|NCT02786537|464034512|FG003|As Treated|Non-compliance with study drug|1|||
128930368|NCT02786537|464034513|FG004|As Treated|Non-compliance with study drug|0|||
128702166|NCT03736447|463207609|FG000|Overall Study|Withdrawal by Subject|5|||
128702167|NCT03736447|463207610|FG001|Overall Study|Withdrawal by Subject|1|||
128702168|NCT03736447|463207609|FG000|Overall Study|Lost to Follow-up|1|||
128702169|NCT03736447|463207610|FG001|Overall Study|Lost to Follow-up|0|||
128702170|NCT03736447|463207609|FG000|Overall Study|Physician Decision|1|||
128702171|NCT03736447|463207610|FG001|Overall Study|Physician Decision|0|||
128702172|NCT03736447|463207609|FG000|Overall Study|Continued commitment to study treatment|3|||
128702173|NCT03736447|463207610|FG001|Overall Study|Continued commitment to study treatment|0|||
128702174|NCT03736447|463207609|FG000|Overall Study|Taste aversion to study product|0|||
128702175|NCT03736447|463207610|FG001|Overall Study|Taste aversion to study product|1|||
128930369|NCT02786537|464034514|FG005|As Treated|Non-compliance with study drug|1|||
129120241|NCT01387269|464737086|FG000|Overall Study|Study drug-related AE|1|||
129120242|NCT01387269|464737087|FG001|Overall Study|Study drug-related AE|0|||
129120243|NCT01387269|464737086|FG000|Overall Study|Lost to Follow-up|1|||
129120244|NCT01387269|464737087|FG001|Overall Study|Lost to Follow-up|0|||
129120245|NCT01981616|464737092|FG000|Overall Study|Adverse Event|0|||
129120246|NCT01981616|464737093|FG001|Overall Study|Adverse Event|1|||
129120247|NCT01981616|464737092|FG000|Overall Study|Protocol Violation|1|||
129120248|NCT01981616|464737093|FG001|Overall Study|Protocol Violation|0|||
129120249|NCT01020123|464737094|FG000|Main Period|Withdrawal by Subject|6|||
129120250|NCT01020123|464737095|FG001|Main Period|Withdrawal by Subject|5|||
129120251|NCT01020123|464737096|FG002|Main Period|Withdrawal by Subject|3|||
129120252|NCT01020123|464737097|FG003|Main Period|Withdrawal by Subject|1|||
129120253|NCT01020123|464737098|FG004|Main Period|Withdrawal by Subject|6|||
129120254|NCT01020123|464737099|FG005|Main Period|Withdrawal by Subject|3|||
129120255|NCT01020123|464737100|FG006|Main Period|Withdrawal by Subject|2|||
129120256|NCT01020123|464737094|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
129120257|NCT01020123|464737095|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
129120258|NCT01020123|464737096|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
129120259|NCT01020123|464737097|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
129120260|NCT01020123|464737098|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
129120261|NCT01020123|464737099|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
129120262|NCT01020123|464737100|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
129120263|NCT01020123|464737094|FG000|Main Period|Adverse Event|5|||
129120264|NCT01020123|464737095|FG001|Main Period|Adverse Event|2|||
129120265|NCT01020123|464737096|FG002|Main Period|Adverse Event|2|||
129120266|NCT01020123|464737097|FG003|Main Period|Adverse Event|1|||
129120267|NCT01020123|464737098|FG004|Main Period|Adverse Event|1|||
129120268|NCT01020123|464737099|FG005|Main Period|Adverse Event|2|||
129120269|NCT01020123|464737100|FG006|Main Period|Adverse Event|1|||
129120270|NCT01020123|464737094|FG000|Main Period|Protocol Violation|4|||
129120271|NCT01020123|464737095|FG001|Main Period|Protocol Violation|4|||
129120272|NCT01020123|464737096|FG002|Main Period|Protocol Violation|2|||
129120273|NCT01020123|464737097|FG003|Main Period|Protocol Violation|5|||
129120274|NCT01020123|464737098|FG004|Main Period|Protocol Violation|2|||
129120275|NCT01020123|464737099|FG005|Main Period|Protocol Violation|3|||
128702176|NCT02619175|463207611|FG000|Overall Study|Withdrawal by Subject|1|||
128702177|NCT02619175|463207612|FG001|Overall Study|Withdrawal by Subject|0|||
128702178|NCT02619175|463207611|FG000|Overall Study|foot pain|1|||
128702179|NCT02619175|463207612|FG001|Overall Study|foot pain|0|||
128702180|NCT00221403|463207613|FG000|Overall Study|Protocol Violation|1|||
129030481|NCT04133311|464403132|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
129030482|NCT04133311|464403133|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
129030483|NCT04133311|464403134|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
129030484|NCT04133311|464403131|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
129030485|NCT04133311|464403132|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
129030486|NCT04133311|464403133|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
129030487|NCT04133311|464403134|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
129030488|NCT04133311|464403131|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
129030489|NCT04133311|464403132|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
129030490|NCT04133311|464403133|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
129030491|NCT04133311|464403134|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
129030492|NCT04133311|464403131|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
129030493|NCT04133311|464403132|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
129030494|NCT04133311|464403133|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
129030495|NCT04133311|464403134|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
129030496|NCT00728754|464403135|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
129030497|NCT00728754|464403136|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
129030498|NCT00728754|464403135|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
129030499|NCT00728754|464403136|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
129030500|NCT00728754|464403135|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
129030501|NCT00728754|464403136|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
129030502|NCT01926119|464403137|FG000|Overall Study|Withdrawal by Subject|1|||
129030503|NCT02654145|464403138|FG000|Overall Study|Lack of Efficacy|1|||
129030504|NCT02654145|464403138|FG000|Overall Study|Protocol Violation|1|||
129120276|NCT01020123|464737100|FG006|Main Period|Protocol Violation|2|||
129120277|NCT01020123|464737094|FG000|Main Period|Lost to Follow-up|0|||
128702181|NCT00221403|463207614|FG001|Overall Study|Protocol Violation|0|||
128702182|NCT00221403|463207615|FG002|Overall Study|Protocol Violation|0|||
129120278|NCT01020123|464737095|FG001|Main Period|Lost to Follow-up|2|||
129120279|NCT01020123|464737096|FG002|Main Period|Lost to Follow-up|0|||
129120280|NCT01020123|464737097|FG003|Main Period|Lost to Follow-up|0|||
129120281|NCT01020123|464737098|FG004|Main Period|Lost to Follow-up|0|||
129120282|NCT01020123|464737099|FG005|Main Period|Lost to Follow-up|0|||
129120283|NCT01020123|464737100|FG006|Main Period|Lost to Follow-up|0|||
129120284|NCT01020123|464737094|FG000|Main Period|Unclasified|2|||
129030505|NCT02654145|464403138|FG000|Overall Study|Withdrawal by Subject|5|||
128702183|NCT00221403|463207613|FG000|Overall Study|Physician Decision|1|||
128702184|NCT00221403|463207614|FG001|Overall Study|Physician Decision|0|||
128702185|NCT00221403|463207615|FG002|Overall Study|Physician Decision|0|||
128702186|NCT00221403|463207613|FG000|Overall Study|Withdrawal by Subject|0|||
128930370|NCT02786537|464034509|FG000|As Treated|Lost insurance|0|||
128930371|NCT02786537|464034510|FG001|As Treated|Lost insurance|0|||
129120285|NCT01020123|464737095|FG001|Main Period|Unclasified|0|||
129120286|NCT01020123|464737096|FG002|Main Period|Unclasified|1|||
129120287|NCT01020123|464737097|FG003|Main Period|Unclasified|0|||
129120288|NCT01020123|464737098|FG004|Main Period|Unclasified|1|||
129120289|NCT01020123|464737099|FG005|Main Period|Unclasified|3|||
129120290|NCT01020123|464737100|FG006|Main Period|Unclasified|6|||
129120291|NCT01020123|464737094|FG000|Extention Period|Withdrawal by Subject|2|||
129120292|NCT01020123|464737095|FG001|Extention Period|Withdrawal by Subject|1|||
129120293|NCT01020123|464737096|FG002|Extention Period|Withdrawal by Subject|1|||
129120294|NCT01020123|464737097|FG003|Extention Period|Withdrawal by Subject|0|||
129120295|NCT01020123|464737098|FG004|Extention Period|Withdrawal by Subject|0|||
129120296|NCT01020123|464737099|FG005|Extention Period|Withdrawal by Subject|0|||
129120297|NCT01020123|464737100|FG006|Extention Period|Withdrawal by Subject|0|||
129120298|NCT01020123|464737094|FG000|Extention Period|Adverse Event|0|||
129120299|NCT01020123|464737095|FG001|Extention Period|Adverse Event|0|||
129120300|NCT01020123|464737096|FG002|Extention Period|Adverse Event|0|||
129120301|NCT01020123|464737097|FG003|Extention Period|Adverse Event|1|||
129120302|NCT01020123|464737098|FG004|Extention Period|Adverse Event|0|||
129120303|NCT01020123|464737099|FG005|Extention Period|Adverse Event|0|||
129120304|NCT01020123|464737100|FG006|Extention Period|Adverse Event|0|||
129120305|NCT01020123|464737094|FG000|Extention Period|Protocol Violation|1|||
129120306|NCT01020123|464737095|FG001|Extention Period|Protocol Violation|1|||
129120307|NCT01020123|464737096|FG002|Extention Period|Protocol Violation|1|||
129120308|NCT01020123|464737097|FG003|Extention Period|Protocol Violation|0|||
129120309|NCT01020123|464737098|FG004|Extention Period|Protocol Violation|0|||
129120310|NCT01020123|464737099|FG005|Extention Period|Protocol Violation|0|||
129120311|NCT01020123|464737100|FG006|Extention Period|Protocol Violation|1|||
129120312|NCT01020123|464737094|FG000|Extention Period|Lost to Follow-up|0|||
129120313|NCT01020123|464737095|FG001|Extention Period|Lost to Follow-up|0|||
129120314|NCT01020123|464737096|FG002|Extention Period|Lost to Follow-up|0|||
129120315|NCT01020123|464737097|FG003|Extention Period|Lost to Follow-up|0|||
129120316|NCT01020123|464737098|FG004|Extention Period|Lost to Follow-up|0|||
129120317|NCT01020123|464737099|FG005|Extention Period|Lost to Follow-up|2|||
129120318|NCT01020123|464737100|FG006|Extention Period|Lost to Follow-up|0|||
129120319|NCT00094445|464737101|FG000|Overall Study|Withdrawal by Subject|3|||
129120320|NCT00094445|464737101|FG000|Overall Study|Lost to Follow-up|1|||
129120321|NCT00094445|464737101|FG000|Overall Study|Progressive Disease|2|||
129120322|NCT00769561|464737106|FG000|Overall Study|Withdrawal by Subject|2|||
129120323|NCT00769561|464737107|FG001|Overall Study|Withdrawal by Subject|2|||
129120324|NCT00769561|464737106|FG000|Overall Study|Lost to Follow-up|1|||
129120325|NCT00769561|464737107|FG001|Overall Study|Lost to Follow-up|3|||
129120326|NCT04711005|464737108|FG000|Overall Study|Withdrawal by Subject|0|||
129120327|NCT04711005|464737109|FG001|Overall Study|Withdrawal by Subject|0|||
129120328|NCT04711005|464737110|FG002|Overall Study|Withdrawal by Subject|0|||
129120329|NCT04711005|464737111|FG003|Overall Study|Withdrawal by Subject|0|||
129120330|NCT04711005|464737112|FG004|Overall Study|Withdrawal by Subject|0|||
129120331|NCT04711005|464737113|FG005|Overall Study|Withdrawal by Subject|0|||
129120332|NCT04711005|464737114|FG006|Overall Study|Withdrawal by Subject|0|||
129120333|NCT04711005|464737115|FG007|Overall Study|Withdrawal by Subject|1|||
129120334|NCT04711005|464737116|FG008|Overall Study|Withdrawal by Subject|0|||
129120335|NCT04711005|464737117|FG009|Overall Study|Withdrawal by Subject|0|||
128702187|NCT00221403|463207614|FG001|Overall Study|Withdrawal by Subject|3|||
128702188|NCT00221403|463207615|FG002|Overall Study|Withdrawal by Subject|0|||
128702189|NCT00221403|463207613|FG000|Overall Study|Lack of Efficacy|0|||
128702190|NCT00221403|463207614|FG001|Overall Study|Lack of Efficacy|1|||
128702191|NCT00221403|463207615|FG002|Overall Study|Lack of Efficacy|0|||
128930372|NCT02786537|464034511|FG002|As Treated|Lost insurance|0|||
128930373|NCT02786537|464034512|FG003|As Treated|Lost insurance|1|||
129120336|NCT04711005|464737108|FG000|Overall Study|Physician Decision|0|||
129120337|NCT04711005|464737109|FG001|Overall Study|Physician Decision|0|||
129120338|NCT04711005|464737110|FG002|Overall Study|Physician Decision|0|||
129120339|NCT04711005|464737111|FG003|Overall Study|Physician Decision|0|||
129120340|NCT04711005|464737112|FG004|Overall Study|Physician Decision|0|||
129120341|NCT04711005|464737113|FG005|Overall Study|Physician Decision|0|||
129120342|NCT04711005|464737114|FG006|Overall Study|Physician Decision|0|||
129120343|NCT04711005|464737115|FG007|Overall Study|Physician Decision|2|||
129120344|NCT04711005|464737116|FG008|Overall Study|Physician Decision|1|||
129120345|NCT04711005|464737117|FG009|Overall Study|Physician Decision|0|||
128702192|NCT00221403|463207613|FG000|Overall Study|Adverse Event|0|||
129120346|NCT03824561|464737125|FG000|Overall Study|Protocol Violation|19|||
129120347|NCT01773928|464737126|FG000|Overall Study|Adverse Event|0|||
129120348|NCT01773928|464737127|FG001|Overall Study|Adverse Event|0|||
129120349|NCT01773928|464737128|FG002|Overall Study|Adverse Event|0|||
128767412|NCT02769065|463440260|FG021|Overall Study|Voluntary Withdrawal|0|||
128767413|NCT02769065|463440261|FG022|Overall Study|Voluntary Withdrawal|0|||
128767414|NCT02769065|463440262|FG023|Overall Study|Voluntary Withdrawal|0|||
128767415|NCT02769065|463440263|FG024|Overall Study|Voluntary Withdrawal|0|||
128767416|NCT02769065|463440264|FG025|Overall Study|Voluntary Withdrawal|0|||
128767417|NCT02769065|463440265|FG026|Overall Study|Voluntary Withdrawal|0|||
128767418|NCT02769065|463440266|FG027|Overall Study|Voluntary Withdrawal|0|||
128767419|NCT02769065|463440267|FG028|Overall Study|Voluntary Withdrawal|0|||
128767420|NCT02769065|463440268|FG029|Overall Study|Voluntary Withdrawal|0|||
128767421|NCT02769065|463440239|FG000|Overall Study|Reason Not Specified|0|||
128767422|NCT02769065|463440240|FG001|Overall Study|Reason Not Specified|0|||
128767423|NCT02769065|463440241|FG002|Overall Study|Reason Not Specified|0|||
128767424|NCT02769065|463440242|FG003|Overall Study|Reason Not Specified|0|||
128767425|NCT02769065|463440243|FG004|Overall Study|Reason Not Specified|0|||
128767426|NCT02769065|463440244|FG005|Overall Study|Reason Not Specified|0|||
128767427|NCT02769065|463440245|FG006|Overall Study|Reason Not Specified|1|||
128767428|NCT02769065|463440246|FG007|Overall Study|Reason Not Specified|0|||
128767429|NCT02769065|463440247|FG008|Overall Study|Reason Not Specified|0|||
128767430|NCT02769065|463440248|FG009|Overall Study|Reason Not Specified|0|||
128767431|NCT02769065|463440249|FG010|Overall Study|Reason Not Specified|0|||
128767432|NCT02769065|463440250|FG011|Overall Study|Reason Not Specified|0|||
128767433|NCT02769065|463440251|FG012|Overall Study|Reason Not Specified|0|||
128767434|NCT02769065|463440252|FG013|Overall Study|Reason Not Specified|0|||
128767435|NCT02769065|463440253|FG014|Overall Study|Reason Not Specified|0|||
128767436|NCT02769065|463440254|FG015|Overall Study|Reason Not Specified|0|||
128767437|NCT02769065|463440255|FG016|Overall Study|Reason Not Specified|0|||
128767438|NCT02769065|463440256|FG017|Overall Study|Reason Not Specified|0|||
128767439|NCT02769065|463440257|FG018|Overall Study|Reason Not Specified|0|||
128767440|NCT02769065|463440258|FG019|Overall Study|Reason Not Specified|0|||
128767441|NCT02769065|463440259|FG020|Overall Study|Reason Not Specified|0|||
128767442|NCT02769065|463440260|FG021|Overall Study|Reason Not Specified|0|||
128767443|NCT02769065|463440261|FG022|Overall Study|Reason Not Specified|0|||
128767444|NCT02769065|463440262|FG023|Overall Study|Reason Not Specified|0|||
128767445|NCT02769065|463440263|FG024|Overall Study|Reason Not Specified|0|||
128767446|NCT02769065|463440264|FG025|Overall Study|Reason Not Specified|0|||
128767447|NCT02769065|463440265|FG026|Overall Study|Reason Not Specified|0|||
128767448|NCT02769065|463440266|FG027|Overall Study|Reason Not Specified|0|||
129120350|NCT01773928|464737129|FG003|Overall Study|Adverse Event|0|||
129120351|NCT01773928|464737130|FG004|Overall Study|Adverse Event|0|||
129216570|NCT00174187|465092955|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
129216571|NCT00174187|465092956|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
129216572|NCT00174187|465092957|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
129216573|NCT00174187|465092955|FG000|Period 2 (After 3 Years)|Other|0|||
129216574|NCT00174187|465092956|FG001|Period 2 (After 3 Years)|Other|0|||
129216575|NCT00174187|465092957|FG002|Period 2 (After 3 Years)|Other|5|||
129216576|NCT00759941|465092958|FG000|Overall Study|Use of medication|1|||
129216577|NCT00759941|465092959|FG001|Overall Study|Use of medication|0|||
129216578|NCT00759941|465092958|FG000|Overall Study|Adverse Event|1|||
129216579|NCT00759941|465092959|FG001|Overall Study|Adverse Event|0|||
129216580|NCT00759941|465092958|FG000|Overall Study|Exited in error by site|1|||
129216581|NCT00759941|465092959|FG001|Overall Study|Exited in error by site|1|||
129216582|NCT06078124|465092960|FG000|Overall Study|Lost to Follow-up|14|||
129216583|NCT06078124|465092961|FG001|Overall Study|Lost to Follow-up|14|||
129216584|NCT01198977|465092962|FG000|Overall Study|Lost to Follow-up|1|||
129216585|NCT01198977|465092963|FG001|Overall Study|Lost to Follow-up|0|||
128767449|NCT02769065|463440267|FG028|Overall Study|Reason Not Specified|0|||
129120352|NCT01773928|464737131|FG005|Overall Study|Adverse Event|0|||
129120353|NCT01773928|464737132|FG006|Overall Study|Adverse Event|0|||
129120354|NCT01773928|464737133|FG007|Overall Study|Adverse Event|1|||
129120355|NCT01773928|464737134|FG008|Overall Study|Adverse Event|0|||
129120356|NCT01773928|464737126|FG000|Overall Study|Physician Decision|0|||
129120357|NCT01773928|464737127|FG001|Overall Study|Physician Decision|0|||
129120358|NCT01773928|464737128|FG002|Overall Study|Physician Decision|0|||
128767450|NCT02769065|463440268|FG029|Overall Study|Reason Not Specified|0|||
128767451|NCT02769065|463440239|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767452|NCT02769065|463440240|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767453|NCT02769065|463440241|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767454|NCT02769065|463440242|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767455|NCT02769065|463440243|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
129120359|NCT01773928|464737129|FG003|Overall Study|Physician Decision|1|||
129120360|NCT01773928|464737130|FG004|Overall Study|Physician Decision|0|||
129120361|NCT01773928|464737131|FG005|Overall Study|Physician Decision|0|||
129216586|NCT01285557|465092964|FG000|Overall Study|Death|173|||
129216587|NCT01285557|465092965|FG001|Overall Study|Death|90|||
129216588|NCT01285557|465092964|FG000|Overall Study|Lost to Follow-up|6|||
129216589|NCT01285557|465092965|FG001|Overall Study|Lost to Follow-up|2|||
129216590|NCT01285557|465092964|FG000|Overall Study|Withdrew Consent|6|||
129120362|NCT01773928|464737132|FG006|Overall Study|Physician Decision|0|||
129120363|NCT01773928|464737133|FG007|Overall Study|Physician Decision|0|||
129120364|NCT01773928|464737134|FG008|Overall Study|Physician Decision|0|||
129120365|NCT01773928|464737126|FG000|Overall Study|Withdrawal by Subject|5|||
128702193|NCT00221403|463207614|FG001|Overall Study|Adverse Event|1|||
128702194|NCT00221403|463207615|FG002|Overall Study|Adverse Event|0|||
128702195|NCT00074152|463207616|FG000|Overall Study|Death|21|||
128702196|NCT00074152|463207617|FG001|Overall Study|Death|9|||
128702197|NCT00074152|463207616|FG000|Overall Study|Lack of Efficacy|34|||
128702198|NCT00074152|463207617|FG001|Overall Study|Lack of Efficacy|24|||
128702199|NCT03547583|463207619|FG000|Overall Study|Adverse Event|16|||
128702200|NCT03547583|463207620|FG001|Overall Study|Adverse Event|11|||
128702201|NCT03547583|463207621|FG002|Overall Study|Adverse Event|10|||
128702202|NCT03547583|463207619|FG000|Overall Study|Death|11|||
128702203|NCT03547583|463207620|FG001|Overall Study|Death|7|||
128702204|NCT03547583|463207621|FG002|Overall Study|Death|4|||
128930374|NCT02786537|464034513|FG004|As Treated|Lost insurance|0|||
129120366|NCT01773928|464737127|FG001|Overall Study|Withdrawal by Subject|4|||
129120367|NCT01773928|464737128|FG002|Overall Study|Withdrawal by Subject|4|||
129120368|NCT01773928|464737129|FG003|Overall Study|Withdrawal by Subject|4|||
129120369|NCT01773928|464737130|FG004|Overall Study|Withdrawal by Subject|7|||
129120370|NCT01773928|464737131|FG005|Overall Study|Withdrawal by Subject|1|||
129120371|NCT01773928|464737132|FG006|Overall Study|Withdrawal by Subject|0|||
129120372|NCT01773928|464737133|FG007|Overall Study|Withdrawal by Subject|0|||
129216591|NCT01285557|465092965|FG001|Overall Study|Withdrew Consent|1|||
128930375|NCT02786537|464034514|FG005|As Treated|Lost insurance|0|||
128930376|NCT02786537|464034509|FG000|As Treated|Withdrawal by Subject|1|||
128930377|NCT02786537|464034510|FG001|As Treated|Withdrawal by Subject|2|||
128930378|NCT02786537|464034511|FG002|As Treated|Withdrawal by Subject|0|||
128930379|NCT02786537|464034512|FG003|As Treated|Withdrawal by Subject|0|||
128930380|NCT02786537|464034513|FG004|As Treated|Withdrawal by Subject|1|||
128930381|NCT02786537|464034514|FG005|As Treated|Withdrawal by Subject|0|||
128930382|NCT02786537|464034509|FG000|As Treated|Incarceration|0|||
128930383|NCT02786537|464034510|FG001|As Treated|Incarceration|1|||
128930384|NCT02786537|464034511|FG002|As Treated|Incarceration|0|||
128930385|NCT02786537|464034512|FG003|As Treated|Incarceration|0|||
128930386|NCT02786537|464034513|FG004|As Treated|Incarceration|0|||
128930387|NCT02786537|464034514|FG005|As Treated|Incarceration|0|||
128930388|NCT02786537|464034509|FG000|As Treated|Opiate dependency relapse|0|||
128930389|NCT02786537|464034510|FG001|As Treated|Opiate dependency relapse|1|||
128930390|NCT02786537|464034511|FG002|As Treated|Opiate dependency relapse|0|||
128930391|NCT02786537|464034512|FG003|As Treated|Opiate dependency relapse|0|||
128930392|NCT02786537|464034513|FG004|As Treated|Opiate dependency relapse|0|||
128930393|NCT02786537|464034514|FG005|As Treated|Opiate dependency relapse|0|||
128930394|NCT02786537|464034509|FG000|As Treated|Drugs stolen from patient|0|||
128930395|NCT02786537|464034510|FG001|As Treated|Drugs stolen from patient|1|||
128930396|NCT02786537|464034511|FG002|As Treated|Drugs stolen from patient|0|||
128930397|NCT02786537|464034512|FG003|As Treated|Drugs stolen from patient|0|||
128930398|NCT02786537|464034513|FG004|As Treated|Drugs stolen from patient|0|||
128930399|NCT02786537|464034514|FG005|As Treated|Drugs stolen from patient|0|||
128930400|NCT02786537|464034509|FG000|As Treated|Advised to stop tx after loss of meds|0|||
128930401|NCT02786537|464034510|FG001|As Treated|Advised to stop tx after loss of meds|1|||
128930402|NCT02786537|464034511|FG002|As Treated|Advised to stop tx after loss of meds|0|||
128930403|NCT02786537|464034512|FG003|As Treated|Advised to stop tx after loss of meds|0|||
128930404|NCT02786537|464034513|FG004|As Treated|Advised to stop tx after loss of meds|0|||
129216592|NCT01285557|465092964|FG000|Overall Study|Sponsor Study Termination|23|||
129216593|NCT01285557|465092965|FG001|Overall Study|Sponsor Study Termination|13|||
129216594|NCT01285557|465092964|FG000|Overall Study|Randomized but not treated|1|||
128930405|NCT02786537|464034514|FG005|As Treated|Advised to stop tx after loss of meds|0|||
128930406|NCT02638012|464034515|FG000|Overall Study|Lost to Follow-up|1|||
128930407|NCT00443560|464034516|FG000|Overall Study|No intrathecal dose|58|||
128930408|NCT00443560|464034517|FG001|Overall Study|No intrathecal dose|26|||
128930409|NCT00443560|464034516|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
129216595|NCT01285557|465092965|FG001|Overall Study|Randomized but not treated|1|||
129216596|NCT01285557|465092964|FG000|Overall Study|Study follow-up ongoing|28|||
129216597|NCT01285557|465092965|FG001|Overall Study|Study follow-up ongoing|14|||
128702205|NCT03547583|463207619|FG000|Overall Study|Lost to Follow-up|1|||
128702206|NCT03547583|463207620|FG001|Overall Study|Lost to Follow-up|0|||
128767456|NCT02769065|463440244|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930410|NCT00443560|464034517|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
128930411|NCT01389128|464034520|FG000|Overall Study|Fetal distress|1|||
128930412|NCT01389128|464034521|FG001|Overall Study|Fetal distress|0|||
128930413|NCT01389128|464034520|FG000|Overall Study|Cervix dilation stop|1|||
128930414|NCT01389128|464034521|FG001|Overall Study|Cervix dilation stop|2|||
129120373|NCT01773928|464737134|FG008|Overall Study|Withdrawal by Subject|1|||
129120374|NCT01773928|464737126|FG000|Overall Study|Lost to Follow-up|0|||
129120375|NCT01773928|464737127|FG001|Overall Study|Lost to Follow-up|0|||
128702207|NCT03547583|463207621|FG002|Overall Study|Lost to Follow-up|0|||
128930415|NCT01389128|464034520|FG000|Overall Study|Rapid labor evolution|3|||
128930416|NCT01389128|464034521|FG001|Overall Study|Rapid labor evolution|2|||
128930417|NCT01389128|464034520|FG000|Overall Study|Intolerance to procedure|0|||
128930418|NCT01389128|464034521|FG001|Overall Study|Intolerance to procedure|2|||
128930419|NCT03056287|464034522|FG000|Overall Study|Withdrawal by Subject|0|||
129120376|NCT01773928|464737128|FG002|Overall Study|Lost to Follow-up|0|||
129120377|NCT01773928|464737129|FG003|Overall Study|Lost to Follow-up|0|||
129120378|NCT01773928|464737130|FG004|Overall Study|Lost to Follow-up|0|||
129120379|NCT01773928|464737131|FG005|Overall Study|Lost to Follow-up|1|||
129120380|NCT01773928|464737132|FG006|Overall Study|Lost to Follow-up|0|||
129120381|NCT01773928|464737133|FG007|Overall Study|Lost to Follow-up|0|||
129120382|NCT01773928|464737134|FG008|Overall Study|Lost to Follow-up|0|||
129120383|NCT01773928|464737126|FG000|Overall Study|Subject misrepresented age|0|||
129120384|NCT01773928|464737127|FG001|Overall Study|Subject misrepresented age|1|||
129120385|NCT01773928|464737128|FG002|Overall Study|Subject misrepresented age|0|||
129120386|NCT01773928|464737129|FG003|Overall Study|Subject misrepresented age|0|||
129120387|NCT01773928|464737130|FG004|Overall Study|Subject misrepresented age|0|||
129120388|NCT01773928|464737131|FG005|Overall Study|Subject misrepresented age|0|||
129120389|NCT01773928|464737132|FG006|Overall Study|Subject misrepresented age|0|||
129120390|NCT01773928|464737133|FG007|Overall Study|Subject misrepresented age|0|||
129120391|NCT01773928|464737134|FG008|Overall Study|Subject misrepresented age|0|||
129120392|NCT01773928|464737126|FG000|Overall Study|Subject met exclusion criteria|0|||
129120393|NCT01773928|464737127|FG001|Overall Study|Subject met exclusion criteria|0|||
129120394|NCT01773928|464737128|FG002|Overall Study|Subject met exclusion criteria|0|||
129120395|NCT01773928|464737129|FG003|Overall Study|Subject met exclusion criteria|0|||
129120396|NCT01773928|464737130|FG004|Overall Study|Subject met exclusion criteria|0|||
129120397|NCT01773928|464737131|FG005|Overall Study|Subject met exclusion criteria|0|||
129120398|NCT01773928|464737132|FG006|Overall Study|Subject met exclusion criteria|0|||
129120399|NCT01773928|464737133|FG007|Overall Study|Subject met exclusion criteria|0|||
129120400|NCT01773928|464737134|FG008|Overall Study|Subject met exclusion criteria|1|||
129120401|NCT01773928|464737126|FG000|Overall Study|Randomized, had to leave, never returned|0|||
129120402|NCT01773928|464737127|FG001|Overall Study|Randomized, had to leave, never returned|0|||
129120403|NCT01773928|464737128|FG002|Overall Study|Randomized, had to leave, never returned|0|||
129120404|NCT01773928|464737129|FG003|Overall Study|Randomized, had to leave, never returned|1|||
129120405|NCT01773928|464737130|FG004|Overall Study|Randomized, had to leave, never returned|0|||
129120406|NCT01773928|464737131|FG005|Overall Study|Randomized, had to leave, never returned|0|||
129120407|NCT01773928|464737132|FG006|Overall Study|Randomized, had to leave, never returned|0|||
129120408|NCT01773928|464737133|FG007|Overall Study|Randomized, had to leave, never returned|0|||
129120409|NCT01773928|464737134|FG008|Overall Study|Randomized, had to leave, never returned|0|||
129120410|NCT01773928|464737126|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
129120411|NCT01773928|464737127|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
129120412|NCT01773928|464737128|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
129120413|NCT01773928|464737129|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
129120414|NCT01773928|464737130|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
129120415|NCT01773928|464737131|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
129120416|NCT01773928|464737132|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
129120417|NCT01773928|464737133|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
129120418|NCT01773928|464737134|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
129120419|NCT03092752|464737135|FG000|Overall Study|Aged <40 years|14209|||
129120420|NCT03092752|464737135|FG000|Overall Study|At least one claim with T2DM|61299|||
129120421|NCT03092752|464737135|FG000|Overall Study|Having no claim of study drugs|29282|||
129120422|NCT03092752|464737135|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
129120423|NCT03092752|464737135|FG000|Overall Study|<6 month history|245900|||
129120424|NCT03573297|464737139|FG000|Open Label Treatment Period|Adverse Event|67|||
129120425|NCT03573297|464737140|FG001|Open Label Treatment Period|Adverse Event|0|||
129120426|NCT03573297|464737141|FG002|Open Label Treatment Period|Adverse Event|0|||
129120427|NCT03573297|464737142|FG003|Open Label Treatment Period|Adverse Event|0|||
129120428|NCT03573297|464737139|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
129120429|NCT03573297|464737140|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
129120430|NCT03573297|464737141|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
129120431|NCT03573297|464737142|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
129120432|NCT03573297|464737139|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
128930420|NCT03056287|464034523|FG001|Overall Study|Withdrawal by Subject|1|||
128767457|NCT02769065|463440245|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930421|NCT03056287|464034524|FG002|Overall Study|Withdrawal by Subject|0|||
129120433|NCT03573297|464737140|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
129120434|NCT03573297|464737141|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
129120435|NCT03573297|464737142|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
129120436|NCT03573297|464737139|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
129120437|NCT03573297|464737140|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
129120438|NCT03573297|464737141|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
129120439|NCT03573297|464737142|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
128702208|NCT03547583|463207619|FG000|Overall Study|Non-compliance with study drug|0|||
128702209|NCT03547583|463207620|FG001|Overall Study|Non-compliance with study drug|0|||
128930422|NCT03056287|464034525|FG003|Overall Study|Withdrawal by Subject|0|||
128930423|NCT03056287|464034522|FG000|Overall Study|move out of area|0|||
128930424|NCT03056287|464034523|FG001|Overall Study|move out of area|0|||
128702210|NCT03547583|463207621|FG002|Overall Study|Non-compliance with study drug|1|||
128702211|NCT03547583|463207619|FG000|Overall Study|Physician Decision|1|||
128702212|NCT03547583|463207620|FG001|Overall Study|Physician Decision|0|||
128702213|NCT03547583|463207621|FG002|Overall Study|Physician Decision|3|||
128702214|NCT03547583|463207619|FG000|Overall Study|Protocol Violation|2|||
128702215|NCT03547583|463207620|FG001|Overall Study|Protocol Violation|1|||
128702216|NCT03547583|463207621|FG002|Overall Study|Protocol Violation|1|||
128702217|NCT03547583|463207619|FG000|Overall Study|Withdrawal by Subject|12|||
128702218|NCT03547583|463207620|FG001|Overall Study|Withdrawal by Subject|19|||
128702219|NCT03547583|463207621|FG002|Overall Study|Withdrawal by Subject|10|||
128702220|NCT03547583|463207619|FG000|Overall Study|Other|2|||
128702221|NCT03547583|463207620|FG001|Overall Study|Other|2|||
128702222|NCT03547583|463207621|FG002|Overall Study|Other|3|||
128702223|NCT00382252|463207622|FG000|Overall Study|Death|4|||
128702224|NCT00382252|463207622|FG000|Overall Study|Protocol Violation|8|||
128702225|NCT00382252|463207622|FG000|Overall Study|Not treated by RFA|1|||
128702226|NCT02166905|463207628|FG000|Overall Study|Withdrawal by Subject|1|||
128702227|NCT02166905|463207629|FG001|Overall Study|Withdrawal by Subject|0|||
128702228|NCT02166905|463207630|FG002|Overall Study|Withdrawal by Subject|0|||
128702229|NCT02166905|463207631|FG003|Overall Study|Withdrawal by Subject|0|||
128702230|NCT02617628|463207632|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
128702231|NCT02617628|463207633|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
128702232|NCT03278873|463207637|FG000|Overall Study|Withdrawal by Subject|0|||
128702233|NCT03278873|463207638|FG001|Overall Study|Withdrawal by Subject|1|||
128702234|NCT03278873|463207639|FG002|Overall Study|Withdrawal by Subject|0|||
128930425|NCT03056287|464034524|FG002|Overall Study|move out of area|1|||
128930426|NCT03056287|464034525|FG003|Overall Study|move out of area|1|||
128930427|NCT00947154|464034529|FG000|Overall Study|Lost to Follow-up|1|||
128930428|NCT02286960|464034539|FG000|Overall Study|Lost to Follow-up|3|||
129030506|NCT00009945|464403143|FG000|Overall Study|no follow up data|7|||
129030507|NCT00009945|464403144|FG001|Overall Study|no follow up data|5|||
129030508|NCT02637141|464403145|FG000|Overall Study|Adverse Event|1|||
129030509|NCT02637141|464403146|FG001|Overall Study|Adverse Event|1|||
129030510|NCT02637141|464403147|FG002|Overall Study|Adverse Event|0|||
129030511|NCT02637141|464403145|FG000|Overall Study|Withdrawal by Subject|1|||
129030512|NCT02637141|464403146|FG001|Overall Study|Withdrawal by Subject|1|||
129030513|NCT02637141|464403147|FG002|Overall Study|Withdrawal by Subject|1|||
129030514|NCT01943435|464403151|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
129030515|NCT01943435|464403152|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
129030516|NCT01943435|464403153|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
129030517|NCT01943435|464403151|FG000|Intervention Period|Withdrawal by Subject|3|||
129030518|NCT01943435|464403152|FG001|Intervention Period|Withdrawal by Subject|3|||
129030519|NCT01943435|464403153|FG002|Intervention Period|Withdrawal by Subject|4|||
129030520|NCT01943435|464403151|FG000|2 Month Follow up|Lost to Follow-up|2|||
129030521|NCT01943435|464403152|FG001|2 Month Follow up|Lost to Follow-up|3|||
129030522|NCT01943435|464403153|FG002|2 Month Follow up|Lost to Follow-up|0|||
129030523|NCT01943435|464403151|FG000|6 Month Follow up|Lost to Follow-up|12|||
129030524|NCT01943435|464403152|FG001|6 Month Follow up|Lost to Follow-up|7|||
129030525|NCT01943435|464403153|FG002|6 Month Follow up|Lost to Follow-up|15|||
129030526|NCT00295490|464403154|FG000|Overall Study|Protocol Violation|0|||
129030527|NCT00295490|464403155|FG001|Overall Study|Protocol Violation|0|||
129030528|NCT00295490|464403156|FG002|Overall Study|Protocol Violation|3|||
129030529|NCT00295490|464403157|FG003|Overall Study|Protocol Violation|3|||
129030530|NCT00295490|464403154|FG000|Overall Study|Withdrawal by Subject|0|||
129030531|NCT00295490|464403155|FG001|Overall Study|Withdrawal by Subject|2|||
129030532|NCT00295490|464403156|FG002|Overall Study|Withdrawal by Subject|0|||
129030533|NCT00295490|464403157|FG003|Overall Study|Withdrawal by Subject|1|||
128702235|NCT03278873|463207640|FG003|Overall Study|Withdrawal by Subject|0|||
128702236|NCT03278873|463207637|FG000|Overall Study|Sponsor's decision|0|||
128702237|NCT03278873|463207638|FG001|Overall Study|Sponsor's decision|1|||
128702238|NCT03278873|463207639|FG002|Overall Study|Sponsor's decision|0|||
128702239|NCT03278873|463207640|FG003|Overall Study|Sponsor's decision|0|||
128702240|NCT03278873|463207637|FG000|Overall Study|Early Termination|2|||
128702241|NCT03278873|463207638|FG001|Overall Study|Early Termination|6|||
128702242|NCT03278873|463207639|FG002|Overall Study|Early Termination|0|||
128930429|NCT02286960|464034540|FG001|Overall Study|Lost to Follow-up|3|||
128930430|NCT00440401|464034541|FG000|Overall Study|Adverse Event|2|||
128930431|NCT00440401|464034542|FG001|Overall Study|Adverse Event|1|||
128930432|NCT00440401|464034541|FG000|Overall Study|Other|2|||
129030534|NCT00295490|464403154|FG000|Overall Study|Lost to Follow-up|0|||
129030535|NCT00295490|464403155|FG001|Overall Study|Lost to Follow-up|0|||
129030536|NCT00295490|464403156|FG002|Overall Study|Lost to Follow-up|1|||
129120440|NCT03573297|464737139|FG000|Open Label Treatment Period|Pregnancy|1|||
128930433|NCT00440401|464034542|FG001|Overall Study|Other|5|||
128930434|NCT00550238|464034544|FG000|Overall Study|Adverse Event|88|||
128930435|NCT00550238|464034544|FG000|Overall Study|Death|34|||
128930436|NCT00550238|464034544|FG000|Overall Study|Disease progression|46|||
128930437|NCT00550238|464034544|FG000|Overall Study|Withdrawal by Subject|167|||
128930438|NCT00550238|464034544|FG000|Overall Study|Physician Decision|31|||
128930439|NCT00550238|464034544|FG000|Overall Study|Patient noncompliance|25|||
128930440|NCT00550238|464034544|FG000|Overall Study|Lost to Follow-up|13|||
128930441|NCT00550238|464034544|FG000|Overall Study|Sponsor decision|55|||
128930442|NCT00779038|464034545|FG000|Overall Study|Study Prematurely Terminated|13|||
128930443|NCT00537745|464034546|FG000|Overall Study|Did not meet eligibility criteria|2|||
128930444|NCT00537745|464034546|FG000|Overall Study|Withdrawal by Subject|2|||
128930445|NCT00537745|464034546|FG000|Overall Study|Subject unable to provide Interlock info|1|||
128930446|NCT05370157|464034547|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
128930447|NCT05370157|464034548|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
128930448|NCT05370157|464034547|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
128930449|NCT05370157|464034548|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
128930450|NCT03700892|464034549|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
128930451|NCT03700892|464034550|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
128930452|NCT03700892|464034551|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
128930453|NCT00258154|464034561|FG000|Overall Study|Adverse Event|1|||
128930454|NCT00258154|464034562|FG001|Overall Study|Adverse Event|0|||
128930455|NCT00258154|464034561|FG000|Overall Study|Lost to Follow-up|0|||
128930456|NCT00258154|464034562|FG001|Overall Study|Lost to Follow-up|1|||
128930457|NCT00258154|464034561|FG000|Overall Study|Protocol Violation|2|||
128930458|NCT00258154|464034562|FG001|Overall Study|Protocol Violation|1|||
128930459|NCT00258154|464034561|FG000|Overall Study|Withdrawal by Subject|3|||
128930460|NCT00258154|464034562|FG001|Overall Study|Withdrawal by Subject|4|||
128930461|NCT00258154|464034561|FG000|Overall Study|Patient Moved|3|||
128930462|NCT00258154|464034562|FG001|Overall Study|Patient Moved|1|||
128930463|NCT01856673|464034563|FG000|Overall Study|Withdrawal by Subject|44|||
128930464|NCT01856673|464034564|FG001|Overall Study|Withdrawal by Subject|50|||
128930465|NCT01856673|464034565|FG002|Overall Study|Withdrawal by Subject|33|||
128930466|NCT01856673|464034563|FG000|Overall Study|Lost to Follow-up|31|||
128930467|NCT01856673|464034564|FG001|Overall Study|Lost to Follow-up|34|||
128930468|NCT01856673|464034565|FG002|Overall Study|Lost to Follow-up|0|||
128930469|NCT01856673|464034563|FG000|Overall Study|Unknown reasons|9|||
128930470|NCT01856673|464034564|FG001|Overall Study|Unknown reasons|0|||
128930471|NCT01856673|464034565|FG002|Overall Study|Unknown reasons|0|||
128930472|NCT01856673|464034563|FG000|Overall Study|Psychologist decision|1|||
128930473|NCT01856673|464034564|FG001|Overall Study|Psychologist decision|0|||
128930474|NCT01856673|464034565|FG002|Overall Study|Psychologist decision|0|||
128930475|NCT01856673|464034563|FG000|Overall Study|Paperwork errors|8|||
128930476|NCT01856673|464034564|FG001|Overall Study|Paperwork errors|0|||
128930477|NCT01856673|464034565|FG002|Overall Study|Paperwork errors|0|||
128930478|NCT01856673|464034563|FG000|Overall Study|Death|1|||
128930479|NCT01856673|464034564|FG001|Overall Study|Death|1|||
128930480|NCT01856673|464034565|FG002|Overall Study|Death|0|||
128930481|NCT01856673|464034563|FG000|Overall Study|Protocol Violation|1|||
128930482|NCT01856673|464034564|FG001|Overall Study|Protocol Violation|0|||
129120441|NCT03573297|464737140|FG001|Open Label Treatment Period|Pregnancy|0|||
128930483|NCT01856673|464034565|FG002|Overall Study|Protocol Violation|1|||
128930484|NCT00184054|464034566|FG000|Overall Study|Adverse Event|1|||
128930485|NCT00667277|464034569|FG000|Overall Study|Withdrawal by Subject|2|||
129120442|NCT03573297|464737141|FG002|Open Label Treatment Period|Pregnancy|0|||
129120443|NCT03573297|464737142|FG003|Open Label Treatment Period|Pregnancy|0|||
128930486|NCT05121103|464034570|FG000|Overall Study|Progressive disease|2|||
128930487|NCT05121103|464034571|FG001|Overall Study|Progressive disease|1|||
128930488|NCT05121103|464034572|FG002|Overall Study|Progressive disease|6|||
128930489|NCT05121103|464034570|FG000|Overall Study|Physician Decision|2|||
128930490|NCT05121103|464034571|FG001|Overall Study|Physician Decision|1|||
128930491|NCT05121103|464034572|FG002|Overall Study|Physician Decision|0|||
128930492|NCT05121103|464034570|FG000|Overall Study|Withdrawal by Subject|0|||
128930493|NCT05121103|464034571|FG001|Overall Study|Withdrawal by Subject|1|||
128930494|NCT05121103|464034572|FG002|Overall Study|Withdrawal by Subject|0|||
128930495|NCT03138564|464034573|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
128930496|NCT03138564|464034574|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
128930497|NCT03138564|464034573|FG000|Overall Study|Lost to Follow-up|16|||
128930498|NCT03138564|464034574|FG001|Overall Study|Lost to Follow-up|2|||
128930499|NCT03138564|464034573|FG000|Overall Study|Withdrawal by Subject|48|||
128930500|NCT03138564|464034574|FG001|Overall Study|Withdrawal by Subject|4|||
128930501|NCT03138564|464034573|FG000|Overall Study|No longer met eligibility criteria|2|||
128930502|NCT03138564|464034574|FG001|Overall Study|No longer met eligibility criteria|0|||
129120444|NCT03573297|464737139|FG000|Open Label Treatment Period|Protocol Violation|17|||
129120445|NCT03573297|464737140|FG001|Open Label Treatment Period|Protocol Violation|0|||
129216598|NCT01285557|465092964|FG000|Overall Study|Sponsor Decision|2|||
129216599|NCT01285557|465092965|FG001|Overall Study|Sponsor Decision|1|||
129216600|NCT03467750|465092966|FG000|Overall Study|Surgery canceled|1|||
129216601|NCT03467750|465092967|FG001|Overall Study|Surgery canceled|0|||
128930503|NCT03138564|464034573|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
128702243|NCT03278873|463207640|FG003|Overall Study|Early Termination|4|||
128767458|NCT02769065|463440246|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767459|NCT02769065|463440247|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930504|NCT03138564|464034574|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
128930505|NCT03138564|464034573|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
128930506|NCT03138564|464034574|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
128930507|NCT03138564|464034573|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
128930508|NCT03138564|464034574|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
128930509|NCT03138564|464034573|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
128930510|NCT03138564|464034574|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
128930511|NCT00814710|464034575|FG000|Overall Study|Adverse Event|1|||
128930512|NCT00814710|464034576|FG001|Overall Study|Adverse Event|0|||
128930513|NCT00814710|464034575|FG000|Overall Study|Lost to Follow-up|7|||
128930514|NCT00814710|464034576|FG001|Overall Study|Lost to Follow-up|3|||
128930515|NCT05593432|464034578|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
128930516|NCT05593432|464034579|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
128930517|NCT05593432|464034580|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
128930518|NCT05593432|464034581|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
128930519|NCT05593432|464034578|FG000|16-Week OLE Period|Lack of Efficacy|0|||
128930520|NCT05593432|464034579|FG001|16-Week OLE Period|Lack of Efficacy|0|||
128930521|NCT05593432|464034580|FG002|16-Week OLE Period|Lack of Efficacy|0|||
128930522|NCT05593432|464034581|FG003|16-Week OLE Period|Lack of Efficacy|1|||
128930523|NCT05593432|464034578|FG000|16-Week OLE Period|Lost to Follow-up|0|||
128930524|NCT05593432|464034579|FG001|16-Week OLE Period|Lost to Follow-up|0|||
128930525|NCT05593432|464034580|FG002|16-Week OLE Period|Lost to Follow-up|1|||
128930526|NCT05593432|464034581|FG003|16-Week OLE Period|Lost to Follow-up|2|||
128930527|NCT05593432|464034578|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
128930528|NCT05593432|464034579|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
128930529|NCT05593432|464034580|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
128930530|NCT05593432|464034581|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
128930531|NCT03885284|464034582|FG000|Overall Study|Disease Progression|1|||
128930532|NCT03885284|464034583|FG001|Overall Study|Disease Progression|3|||
128930533|NCT03885284|464034582|FG000|Overall Study|Physician Decision|0|||
128930534|NCT03885284|464034583|FG001|Overall Study|Physician Decision|1|||
128930535|NCT01591330|464034586|FG000|Period 1|Adverse Event|1|||
128930536|NCT01591330|464034587|FG001|Period 1|Adverse Event|0|||
128930537|NCT01591330|464034588|FG002|Period 1|Adverse Event|0|||
128930538|NCT01591330|464034589|FG003|Period 1|Adverse Event|0|||
128930539|NCT01591330|464034586|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
128930540|NCT01591330|464034587|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
128930541|NCT01591330|464034588|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
129216602|NCT03467750|465092966|FG000|Overall Study|Protocol Violation|1|||
129216603|NCT03467750|465092967|FG001|Overall Study|Protocol Violation|1|||
128702244|NCT03278873|463207637|FG000|Overall Study|Lost to Follow-up|0|||
128702245|NCT03278873|463207638|FG001|Overall Study|Lost to Follow-up|0|||
128702246|NCT03278873|463207639|FG002|Overall Study|Lost to Follow-up|2|||
128702247|NCT03278873|463207640|FG003|Overall Study|Lost to Follow-up|0|||
128702248|NCT03278873|463207637|FG000|Overall Study|The patient decided to withdraw via email|1|||
128702249|NCT03278873|463207638|FG001|Overall Study|The patient decided to withdraw via email|0|||
128702250|NCT03278873|463207639|FG002|Overall Study|The patient decided to withdraw via email|0|||
128702251|NCT03278873|463207640|FG003|Overall Study|The patient decided to withdraw via email|0|||
128702252|NCT03278873|463207637|FG000|Overall Study|The patient was unresponsive to contact|0|||
128702253|NCT03278873|463207638|FG001|Overall Study|The patient was unresponsive to contact|0|||
128702254|NCT03278873|463207639|FG002|Overall Study|The patient was unresponsive to contact|0|||
128702255|NCT03278873|463207640|FG003|Overall Study|The patient was unresponsive to contact|4|||
128702256|NCT03278873|463207637|FG000|Overall Study|The patient wished to participate no longer|0|||
128702257|NCT03278873|463207638|FG001|Overall Study|The patient wished to participate no longer|1|||
128930542|NCT01591330|464034589|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
128702258|NCT03278873|463207639|FG002|Overall Study|The patient wished to participate no longer|0|||
128702259|NCT03278873|463207640|FG003|Overall Study|The patient wished to participate no longer|0|||
128702260|NCT03278873|463207637|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
128930543|NCT01591330|464034586|FG000|Period 2|Adverse Event|1|||
128930544|NCT01591330|464034587|FG001|Period 2|Adverse Event|0|||
128930545|NCT01591330|464034588|FG002|Period 2|Adverse Event|0|||
128930546|NCT01591330|464034589|FG003|Period 2|Adverse Event|0|||
129216604|NCT03467750|465092966|FG000|Overall Study|Withdrawal by Subject|0|||
129216605|NCT03467750|465092967|FG001|Overall Study|Withdrawal by Subject|1|||
128930547|NCT04800315|464034593|FG000|Randomization|Did not receive study treatment|1|||
128702261|NCT03278873|463207638|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
128702262|NCT03278873|463207639|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
128702263|NCT03278873|463207640|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
128702264|NCT02801331|463207641|FG000|Overall Study|Transferred to another hospital|8|||
128930548|NCT04800315|464034594|FG001|Randomization|Did not receive study treatment|0|||
128930549|NCT04800315|464034595|FG002|Randomization|Did not receive study treatment|0|||
128930550|NCT04800315|464034596|FG003|Randomization|Did not receive study treatment|0|||
128930551|NCT04800315|464034593|FG000|Treatment Period|Adverse Event|4|||
128930552|NCT04800315|464034594|FG001|Treatment Period|Adverse Event|2|||
128930553|NCT04800315|464034595|FG002|Treatment Period|Adverse Event|1|||
128930554|NCT04800315|464034596|FG003|Treatment Period|Adverse Event|2|||
128930555|NCT04800315|464034593|FG000|Treatment Period|Lack of Efficacy|1|||
128930556|NCT04800315|464034594|FG001|Treatment Period|Lack of Efficacy|0|||
128930557|NCT04800315|464034595|FG002|Treatment Period|Lack of Efficacy|0|||
128930558|NCT04800315|464034596|FG003|Treatment Period|Lack of Efficacy|3|||
128930559|NCT04800315|464034593|FG000|Treatment Period|Lost to Follow-up|0|||
128930560|NCT04800315|464034594|FG001|Treatment Period|Lost to Follow-up|1|||
128930561|NCT04800315|464034595|FG002|Treatment Period|Lost to Follow-up|2|||
128930562|NCT04800315|464034596|FG003|Treatment Period|Lost to Follow-up|2|||
128930563|NCT04800315|464034593|FG000|Treatment Period|Withdrawal by participant|0|||
128930564|NCT04800315|464034594|FG001|Treatment Period|Withdrawal by participant|0|||
128930565|NCT04800315|464034595|FG002|Treatment Period|Withdrawal by participant|0|||
128930566|NCT04800315|464034596|FG003|Treatment Period|Withdrawal by participant|4|||
128930567|NCT04800315|464034593|FG000|Treatment Period|Other Reasons|0|||
128930568|NCT04800315|464034594|FG001|Treatment Period|Other Reasons|2|||
128930569|NCT04800315|464034595|FG002|Treatment Period|Other Reasons|0|||
128930570|NCT04800315|464034596|FG003|Treatment Period|Other Reasons|1|||
128930571|NCT02453841|464034601|FG000|Overall Study|Protocol Violation|1|||
128930572|NCT02453841|464034601|FG000|Overall Study|Unable to obtain blood samples|2|||
128930573|NCT03851510|464034602|FG000|Overall Study|Screen Fail|1|||
128930574|NCT03851510|464034602|FG000|Overall Study|Adverse Event|1|||
128930575|NCT03851510|464034602|FG000|Overall Study|Withdrawal by Subject|1|||
128930576|NCT01151137|464034603|FG000|Overall Study|Death|15|||
128930577|NCT01151137|464034604|FG001|Overall Study|Death|27|||
128930578|NCT01151137|464034603|FG000|Overall Study|Lost to Follow-up|1|||
128930579|NCT01151137|464034604|FG001|Overall Study|Lost to Follow-up|1|||
128930580|NCT02426086|464034608|FG000|Overall Study|Death|33|||
128930581|NCT02426086|464034609|FG001|Overall Study|Death|36|||
128930582|NCT02426086|464034608|FG000|Overall Study|Lost to Follow-up|2|||
128930583|NCT02426086|464034609|FG001|Overall Study|Lost to Follow-up|0|||
128930584|NCT02426086|464034608|FG000|Overall Study|Study Terminated by Sponsor|5|||
128930585|NCT02426086|464034609|FG001|Overall Study|Study Terminated by Sponsor|14|||
128930586|NCT02426086|464034608|FG000|Overall Study|Withdrawal by Subject|8|||
128930587|NCT02426086|464034609|FG001|Overall Study|Withdrawal by Subject|9|||
128930588|NCT00840463|464034613|FG000|Overall Study|Adverse Event|1|||
128930589|NCT00840463|464034614|FG001|Overall Study|Adverse Event|0|||
128930590|NCT02515669|464034617|FG000|228 Week Open-Label Phase|Other|0|||
128930591|NCT02515669|464034618|FG001|228 Week Open-Label Phase|Other|0|||
128930592|NCT02515669|464034619|FG002|228 Week Open-Label Phase|Other|1|||
128930593|NCT02515669|464034620|FG003|228 Week Open-Label Phase|Other|4|||
128930594|NCT02515669|464034617|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
128930595|NCT02515669|464034618|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
128930596|NCT02515669|464034619|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
128930597|NCT02515669|464034620|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
128930598|NCT02515669|464034617|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
128930599|NCT02515669|464034618|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
128930600|NCT02515669|464034619|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
128930601|NCT02515669|464034620|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
128930602|NCT02515669|464034617|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
128930603|NCT02515669|464034618|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
128930604|NCT02515669|464034619|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
128930605|NCT02515669|464034620|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
128930606|NCT02515669|464034617|FG000|228 Week Open-Label Phase|Missing|0|||
128930607|NCT02515669|464034618|FG001|228 Week Open-Label Phase|Missing|2|||
129030537|NCT00295490|464403157|FG003|Overall Study|Lost to Follow-up|0|||
128930608|NCT02515669|464034619|FG002|228 Week Open-Label Phase|Missing|2|||
128930609|NCT02515669|464034620|FG003|228 Week Open-Label Phase|Missing|2|||
128930610|NCT01739595|464034621|FG000|Overall Study|Adverse Event|3|||
128930611|NCT01739595|464034622|FG001|Overall Study|Adverse Event|0|||
128930612|NCT01739595|464034623|FG002|Overall Study|Adverse Event|0|||
128930613|NCT01739595|464034621|FG000|Overall Study|Lost to Follow-up|2|||
128930614|NCT01739595|464034622|FG001|Overall Study|Lost to Follow-up|0|||
128930615|NCT01739595|464034623|FG002|Overall Study|Lost to Follow-up|0|||
129120446|NCT03573297|464737141|FG002|Open Label Treatment Period|Protocol Violation|0|||
129120447|NCT03573297|464737142|FG003|Open Label Treatment Period|Protocol Violation|0|||
129120448|NCT03573297|464737139|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
129120449|NCT03573297|464737140|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
128702265|NCT02801331|463207642|FG001|Overall Study|Transferred to another hospital|7|||
128702266|NCT02801331|463207641|FG000|Overall Study|Withdrawal by Subject|0|||
128702267|NCT02801331|463207642|FG001|Overall Study|Withdrawal by Subject|4|||
128702268|NCT02801331|463207641|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
128702269|NCT02801331|463207642|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
128702270|NCT04698187|463207649|FG000|Overall Study|Withdrawal by Subject|7|||
128702271|NCT04698187|463207649|FG000|Overall Study|Death|21|||
128702272|NCT04698187|463207649|FG000|Overall Study|Sponsor Decision|15|||
128702273|NCT04698187|463207649|FG000|Overall Study|In-transit Disease|1|||
128702274|NCT01473836|463209330|FG000|Overall Study|Adverse Event|4|||
128702275|NCT01473836|463209330|FG000|Overall Study|Lack of Efficacy|1|||
128702276|NCT01473836|463209330|FG000|Overall Study|Does not meet entrance criteria|1|||
128702277|NCT03364023|463209331|FG000|Overall Study|Lost to Follow-up|3|||
128702278|NCT03364023|463209331|FG000|Overall Study|Death|14|||
128702279|NCT03633695|463209334|FG000|Overall Study|Lost to Follow-up|4|||
128702280|NCT03633695|463209335|FG001|Overall Study|Lost to Follow-up|5|||
128702281|NCT03633695|463209334|FG000|Overall Study|Discontinued|8|||
128702282|NCT03633695|463209335|FG001|Overall Study|Discontinued|4|||
128702283|NCT01751867|463209343|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
128702284|NCT01751867|463209344|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
128702285|NCT01751867|463209343|FG000|Overall Study|Diease Progression|4|||
128702286|NCT01751867|463209344|FG001|Overall Study|Diease Progression|18|||
129120450|NCT03573297|464737141|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
129120451|NCT03573297|464737142|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
129120452|NCT03573297|464737139|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
129120453|NCT03573297|464737140|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
129120454|NCT03573297|464737141|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
129120455|NCT03573297|464737142|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
129120456|NCT03573297|464737139|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
129120457|NCT03573297|464737140|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
129120458|NCT03573297|464737141|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
129120459|NCT03573297|464737142|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
129120460|NCT03573297|464737139|FG000|Open Label Treatment Period|Other, Not Specified|7|||
129120461|NCT03573297|464737140|FG001|Open Label Treatment Period|Other, Not Specified|0|||
129120462|NCT03573297|464737141|FG002|Open Label Treatment Period|Other, Not Specified|0|||
129120463|NCT03573297|464737142|FG003|Open Label Treatment Period|Other, Not Specified|0|||
129120464|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
129120465|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
129120466|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
129120467|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
129120468|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129120469|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Adverse Event|1|||
128702287|NCT01751867|463209343|FG000|Overall Study|Adverse Event|8|||
129120470|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Adverse Event|5|||
129120471|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Adverse Event|1|||
129120472|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129120473|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
129120474|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
129120475|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
129120476|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129120477|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
129120478|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
129120479|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
129120480|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129120481|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
129120482|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
129120483|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
129120484|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129120485|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
129120486|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
129120487|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
129120488|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
129120489|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
129120490|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
128930616|NCT01739595|464034621|FG000|Overall Study|Withdrawal by Subject|2|||
128930617|NCT01739595|464034622|FG001|Overall Study|Withdrawal by Subject|1|||
128930618|NCT01739595|464034623|FG002|Overall Study|Withdrawal by Subject|2|||
128930619|NCT01739595|464034621|FG000|Overall Study|Eligibility issue|3|||
128930620|NCT01739595|464034622|FG001|Overall Study|Eligibility issue|0|||
128930621|NCT01739595|464034623|FG002|Overall Study|Eligibility issue|0|||
128930622|NCT01739595|464034621|FG000|Overall Study|Protocol Violation|1|||
128930623|NCT01739595|464034622|FG001|Overall Study|Protocol Violation|0|||
128930624|NCT01739595|464034623|FG002|Overall Study|Protocol Violation|0|||
128930625|NCT01739595|464034621|FG000|Overall Study|Lab assessment|1|||
128930626|NCT01739595|464034622|FG001|Overall Study|Lab assessment|0|||
128930627|NCT01739595|464034623|FG002|Overall Study|Lab assessment|0|||
128930628|NCT01739595|464034621|FG000|Overall Study|Drug discrepancy|1|||
128930629|NCT01739595|464034622|FG001|Overall Study|Drug discrepancy|0|||
128930630|NCT01739595|464034623|FG002|Overall Study|Drug discrepancy|0|||
128930631|NCT01676116|464034626|FG000|Overall Study|Withdrawal criteria|2|||
128930632|NCT01676116|464034627|FG001|Overall Study|Withdrawal criteria|14|||
128930633|NCT01676116|464034626|FG000|Overall Study|Adverse Event|1|||
128930634|NCT01676116|464034627|FG001|Overall Study|Adverse Event|2|||
128930635|NCT01676116|464034626|FG000|Overall Study|Unclassified|4|||
128930636|NCT01676116|464034627|FG001|Overall Study|Unclassified|10|||
128930637|NCT01676116|464034626|FG000|Overall Study|Protocol Violation|9|||
128930638|NCT01676116|464034627|FG001|Overall Study|Protocol Violation|3|||
128930639|NCT01287117|464034628|FG000|Overall Study|Adverse Event|2|||
128930640|NCT01287117|464034629|FG001|Overall Study|Adverse Event|1|||
129120491|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
129120492|NCT03573297|464737139|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
129120493|NCT03573297|464737140|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
129120494|NCT03573297|464737141|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
129120495|NCT03573297|464737142|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
129120496|NCT01499810|464737143|FG000|Overall Study|Lost to Follow-up|10|||
129120497|NCT01499810|464737143|FG000|Overall Study|Protocol Violation|1|||
129120498|NCT01499810|464737143|FG000|Overall Study|Withdrawal by Subject|1|||
129120499|NCT02273167|464737146|FG000|Overall Study|Adverse Event|1|||
129120500|NCT02273167|464737147|FG001|Overall Study|Adverse Event|0|||
129120501|NCT02273167|464737148|FG002|Overall Study|Adverse Event|0|||
129120502|NCT02273167|464737146|FG000|Overall Study|Protocol Violation|3|||
129120503|NCT02273167|464737147|FG001|Overall Study|Protocol Violation|1|||
129120504|NCT02273167|464737148|FG002|Overall Study|Protocol Violation|1|||
129120505|NCT02273167|464737146|FG000|Overall Study|Lost to Follow-up|0|||
129120506|NCT02273167|464737147|FG001|Overall Study|Lost to Follow-up|1|||
129120507|NCT02273167|464737148|FG002|Overall Study|Lost to Follow-up|1|||
129120508|NCT02273167|464737146|FG000|Overall Study|Withdrawal by Subject|10|||
129120509|NCT02273167|464737147|FG001|Overall Study|Withdrawal by Subject|12|||
129120510|NCT02273167|464737148|FG002|Overall Study|Withdrawal by Subject|11|||
129120511|NCT02273167|464737146|FG000|Overall Study|Various|10|||
129120512|NCT02273167|464737147|FG001|Overall Study|Various|9|||
129120513|NCT02273167|464737148|FG002|Overall Study|Various|8|||
129120514|NCT02781324|464737149|FG000|Overall Study|Withdrawal by Subject|1|||
129120515|NCT02781324|464737150|FG001|Overall Study|Withdrawal by Subject|0|||
129120516|NCT02781324|464737149|FG000|Overall Study|Physician Decision|1|||
129120517|NCT02781324|464737150|FG001|Overall Study|Physician Decision|2|||
129120518|NCT00661388|464737154|FG000|Overall Study|Adverse Event|14|||
129120519|NCT00661388|464737154|FG000|Overall Study|Protocol Violation|7|||
129120520|NCT00661388|464737154|FG000|Overall Study|Renal transplantation|1|||
129120521|NCT00661388|464737154|FG000|Overall Study|Dialysis initiation|1|||
129120522|NCT00661388|464737154|FG000|Overall Study|Administrative reasons|1|||
129120523|NCT03370172|464738978|FG000|Overall Study|Withdrawal by Subject|0|||
128767460|NCT02769065|463440248|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767461|NCT02769065|463440249|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
128767462|NCT02769065|463440250|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930641|NCT01287117|464034630|FG002|Overall Study|Adverse Event|1|||
128930642|NCT01287117|464034631|FG003|Overall Study|Adverse Event|1|||
128930643|NCT01287117|464034628|FG000|Overall Study|Lost to Follow-up|1|||
128930644|NCT01287117|464034629|FG001|Overall Study|Lost to Follow-up|1|||
129120524|NCT03370172|464738979|FG001|Overall Study|Withdrawal by Subject|1|||
128930645|NCT01287117|464034630|FG002|Overall Study|Lost to Follow-up|0|||
129120525|NCT01171534|464738987|FG000|Overall Study|Lost to Follow-up|0|||
129120526|NCT01171534|464738988|FG001|Overall Study|Lost to Follow-up|2|||
129120527|NCT01171534|464738987|FG000|Overall Study|screen failure|0|||
129120528|NCT01171534|464738988|FG001|Overall Study|screen failure|1|||
129120529|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
129120530|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
129120531|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
128767463|NCT02769065|463440251|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
129120532|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
128930646|NCT01287117|464034631|FG003|Overall Study|Lost to Follow-up|0|||
128930647|NCT01287117|464034628|FG000|Overall Study|Physician Decision|0|||
128767464|NCT02769065|463440252|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767465|NCT02769065|463440253|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767466|NCT02769065|463440254|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767467|NCT02769065|463440255|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767468|NCT02769065|463440256|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767469|NCT02769065|463440257|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767470|NCT02769065|463440258|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930648|NCT01287117|464034629|FG001|Overall Study|Physician Decision|1|||
128930649|NCT01287117|464034630|FG002|Overall Study|Physician Decision|1|||
128930650|NCT01287117|464034631|FG003|Overall Study|Physician Decision|1|||
128930651|NCT01287117|464034628|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
128930652|NCT01287117|464034629|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
128930653|NCT01287117|464034630|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
128930654|NCT01287117|464034631|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
128930655|NCT01287117|464034628|FG000|Overall Study|Disease Progression|10|||
128930656|NCT01287117|464034629|FG001|Overall Study|Disease Progression|5|||
128930657|NCT01287117|464034630|FG002|Overall Study|Disease Progression|6|||
128930658|NCT01287117|464034631|FG003|Overall Study|Disease Progression|5|||
128930659|NCT01769404|464034634|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
128930660|NCT01769404|464034635|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
128930661|NCT01769404|464034634|FG000|Treatment Period 1|Withdrawal by Subject|3|||
128930662|NCT01769404|464034635|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128930663|NCT01769404|464034634|FG000|Treatment Period 1|Sponsor decision|1|||
128930664|NCT01769404|464034635|FG001|Treatment Period 1|Sponsor decision|0|||
128930665|NCT01769404|464034634|FG000|Treatment Period 2|Sponsor decision|7|||
128930666|NCT01769404|464034635|FG001|Treatment Period 2|Sponsor decision|0|||
128930667|NCT00538733|464034636|FG000|Overall Study|Adverse Event|8|||
128930668|NCT00538733|464034636|FG000|Overall Study|Death|1|||
128930669|NCT00538733|464034636|FG000|Overall Study|declined to participate|2|||
128930670|NCT00538733|464034636|FG000|Overall Study|still on therapy|1|||
128930671|NCT00095121|464034639|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
128930672|NCT00095121|464034640|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
128930673|NCT00095121|464034639|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
128930674|NCT00095121|464034640|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
128930675|NCT01266148|464036533|FG000|Overall Study|Adverse Event|2|||
128930676|NCT01266148|464036534|FG001|Overall Study|Adverse Event|0|||
128930677|NCT01266148|464036533|FG000|Overall Study|Ongoing rejection|1|||
128930678|NCT01266148|464036534|FG001|Overall Study|Ongoing rejection|0|||
128930679|NCT01266148|464036533|FG000|Overall Study|2 2R rejections|1|||
128930680|NCT01266148|464036534|FG001|Overall Study|2 2R rejections|0|||
128930681|NCT01266148|464036533|FG000|Overall Study|Death|2|||
128930682|NCT01266148|464036534|FG001|Overall Study|Death|3|||
128930683|NCT01266148|464036533|FG000|Overall Study|missing mGFR value + AE|1|||
128930684|NCT01266148|464036534|FG001|Overall Study|missing mGFR value + AE|0|||
128930685|NCT01853228|464036535|FG000|Phase 1|Lack of Efficacy|8|||
128930686|NCT01853228|464036536|FG001|Phase 1|Lack of Efficacy|0|||
128930687|NCT01853228|464036535|FG000|Phase 1|Other|1|||
128930688|NCT01853228|464036536|FG001|Phase 1|Other|0|||
128930689|NCT01853228|464036535|FG000|Phase 2|Physician Decision|0|||
128930690|NCT01853228|464036536|FG001|Phase 2|Physician Decision|1|||
128930691|NCT01853228|464036535|FG000|Phase 2|Proceed To Transplant|0|||
128930692|NCT01853228|464036536|FG001|Phase 2|Proceed To Transplant|3|||
128930693|NCT01853228|464036535|FG000|Phase 2|Lack of Efficacy|0|||
128767471|NCT02769065|463440259|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930694|NCT01853228|464036536|FG001|Phase 2|Lack of Efficacy|4|||
128930695|NCT03167619|464036537|FG000|Overall Study|Death|11|||
128930696|NCT03167619|464036538|FG001|Overall Study|Death|8|||
128930697|NCT03167619|464036537|FG000|Overall Study|Withdrawal by Subject|1|||
128930698|NCT03167619|464036538|FG001|Overall Study|Withdrawal by Subject|2|||
128930699|NCT03167619|464036537|FG000|Overall Study|Physician Decision|0|||
128767472|NCT02769065|463440260|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930700|NCT03167619|464036538|FG001|Overall Study|Physician Decision|1|||
128930701|NCT01348919|464036540|FG000|Overall Study|Adverse Event|3|||
128930702|NCT01348919|464036541|FG001|Overall Study|Adverse Event|1|||
128930703|NCT01348919|464036542|FG002|Overall Study|Adverse Event|0|||
128930704|NCT01348919|464036540|FG000|Overall Study|Withdrawal by Subject|0|||
128767473|NCT02769065|463440261|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930705|NCT01348919|464036541|FG001|Overall Study|Withdrawal by Subject|1|||
128930706|NCT01348919|464036542|FG002|Overall Study|Withdrawal by Subject|0|||
128930707|NCT01348919|464036540|FG000|Overall Study|Disease progression|0|||
128930708|NCT01348919|464036541|FG001|Overall Study|Disease progression|1|||
128930709|NCT01348919|464036542|FG002|Overall Study|Disease progression|1|||
128930710|NCT02089737|464036543|FG000|Overall Study|Survey form not completed|5|||
128767474|NCT02769065|463440262|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767475|NCT02769065|463440263|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
128930711|NCT02089737|464036543|FG000|Overall Study|Not treated|1|||
128930712|NCT02082184|464036545|FG000|Overall Study|Adverse Event|1|||
128767476|NCT02769065|463440264|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767477|NCT02769065|463440265|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767478|NCT02769065|463440266|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767479|NCT02769065|463440267|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767480|NCT02769065|463440268|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
128767481|NCT02764775|463440271|FG000|Overall Study|Death|1|||
128767482|NCT02764775|463440271|FG000|Overall Study|Lost to Follow-up|2|||
128767483|NCT02764775|463440271|FG000|Overall Study|Withdrawal by Subject|3|||
128767484|NCT01590771|463440275|FG000|Overall Study|Other Protocol Specified Criteria|5|||
128767485|NCT01590771|463440276|FG001|Overall Study|Other Protocol Specified Criteria|14|||
128767486|NCT01590771|463440275|FG000|Overall Study|Withdrawal by Subject|8|||
128767487|NCT01590771|463440276|FG001|Overall Study|Withdrawal by Subject|15|||
128767488|NCT01590771|463440275|FG000|Overall Study|Protocol Violation|1|||
128767489|NCT01590771|463440276|FG001|Overall Study|Protocol Violation|2|||
128767490|NCT01590771|463440275|FG000|Overall Study|Lost to Follow-up|1|||
128767491|NCT01590771|463440276|FG001|Overall Study|Lost to Follow-up|1|||
128767492|NCT01590771|463440275|FG000|Overall Study|Lack of Efficacy|1|||
128767493|NCT01590771|463440276|FG001|Overall Study|Lack of Efficacy|0|||
128767494|NCT01590771|463440275|FG000|Overall Study|Adverse Event|3|||
128767495|NCT01590771|463440276|FG001|Overall Study|Adverse Event|7|||
128930713|NCT02082184|464036546|FG001|Overall Study|Adverse Event|0|||
128930714|NCT02082184|464036545|FG000|Overall Study|Medical diagnosis|1|||
128930715|NCT02082184|464036546|FG001|Overall Study|Medical diagnosis|2|||
128930716|NCT02082184|464036545|FG000|Overall Study|Device associated symptoms|5|||
128930717|NCT02082184|464036546|FG001|Overall Study|Device associated symptoms|0|||
128930718|NCT02082184|464036545|FG000|Overall Study|Withdrawal by Subject|3|||
129030538|NCT00295490|464403154|FG000|Overall Study|Adverse Event|1|||
129030539|NCT00295490|464403155|FG001|Overall Study|Adverse Event|0|||
129030540|NCT00295490|464403156|FG002|Overall Study|Adverse Event|0|||
129030541|NCT00295490|464403157|FG003|Overall Study|Adverse Event|0|||
129030542|NCT00295490|464403154|FG000|Overall Study|Other|0|||
129030543|NCT00295490|464403155|FG001|Overall Study|Other|2|||
129030544|NCT00295490|464403156|FG002|Overall Study|Other|0|||
129030545|NCT00295490|464403157|FG003|Overall Study|Other|1|||
129030546|NCT03885934|464403162|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
129120533|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
129120534|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
129120535|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
129120536|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
128767496|NCT04022889|463440277|FG000|Stage 1: Period 1|Adverse Event|1|||
128767497|NCT04022889|463440278|FG001|Stage 1: Period 1|Adverse Event|0|||
128767498|NCT04022889|463440279|FG002|Stage 1: Period 1|Adverse Event|0|||
128767499|NCT04022889|463440277|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
128767500|NCT04022889|463440278|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
128767501|NCT04022889|463440279|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
128767502|NCT04022889|463440277|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
128767503|NCT04022889|463440278|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
128930719|NCT02082184|464036546|FG001|Overall Study|Withdrawal by Subject|2|||
128930720|NCT02082184|464036545|FG000|Overall Study|Protocol Violation|0|||
128930721|NCT02082184|464036546|FG001|Overall Study|Protocol Violation|6|||
128930722|NCT02082184|464036545|FG000|Overall Study|Lost to Follow-up|0|||
128930723|NCT02082184|464036546|FG001|Overall Study|Lost to Follow-up|2|||
128930724|NCT02082184|464036545|FG000|Overall Study|Subject non-compliance|0|||
128930725|NCT02082184|464036546|FG001|Overall Study|Subject non-compliance|1|||
128930726|NCT02413398|464036557|FG000|Overall Study|Lost to Follow-up|2|||
128930727|NCT02413398|464036558|FG001|Overall Study|Lost to Follow-up|4|||
128930728|NCT02413398|464036557|FG000|Overall Study|Withdrawal by Subject|1|||
128930729|NCT02413398|464036558|FG001|Overall Study|Withdrawal by Subject|1|||
128930730|NCT02413398|464036557|FG000|Overall Study|Other Eligibility criteria|1|||
128930731|NCT02413398|464036558|FG001|Overall Study|Other Eligibility criteria|2|||
128930732|NCT02874794|464036561|FG000|Overall Study|Physician Decision|3|||
128930733|NCT02874794|464036562|FG001|Overall Study|Physician Decision|2|||
128930734|NCT02874794|464036561|FG000|Overall Study|Withdrawal by Subject|2|||
128930735|NCT02874794|464036562|FG001|Overall Study|Withdrawal by Subject|8|||
128930736|NCT02874794|464036561|FG000|Overall Study|Death|2|||
128930737|NCT02874794|464036562|FG001|Overall Study|Death|1|||
128930738|NCT00537940|464036563|FG000|Overall Study|Adverse Event|20|||
129030547|NCT03885934|464403163|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
128767504|NCT04022889|463440279|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
128767505|NCT04022889|463440277|FG000|Stage 2|Screen Failure|0|||
128930739|NCT00537940|464036564|FG001|Overall Study|Adverse Event|19|||
128930740|NCT00537940|464036563|FG000|Overall Study|Lack of Efficacy|8|||
128930741|NCT00537940|464036564|FG001|Overall Study|Lack of Efficacy|16|||
128930742|NCT00537940|464036563|FG000|Overall Study|Lost to Follow-up|23|||
129030548|NCT03885934|464403164|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
129030549|NCT03885934|464403165|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
129120537|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
128702288|NCT01751867|463209344|FG001|Overall Study|Adverse Event|15|||
128702289|NCT01751867|463209343|FG000|Overall Study|Poor Compliance|0|||
128702290|NCT01751867|463209344|FG001|Overall Study|Poor Compliance|5|||
128702291|NCT01751867|463209343|FG000|Overall Study|Withdrawal by Subject|3|||
128702292|NCT01751867|463209344|FG001|Overall Study|Withdrawal by Subject|1|||
128702293|NCT01751867|463209343|FG000|Overall Study|Physician Decision|4|||
128702294|NCT01751867|463209344|FG001|Overall Study|Physician Decision|7|||
128702295|NCT01751867|463209343|FG000|Overall Study|Protocol Violation|0|||
128702296|NCT01751867|463209344|FG001|Overall Study|Protocol Violation|2|||
128702297|NCT01751867|463209343|FG000|Overall Study|Death|0|||
128702298|NCT01751867|463209344|FG001|Overall Study|Death|5|||
128702299|NCT01751867|463209343|FG000|Overall Study|Other|11|||
128702300|NCT01751867|463209344|FG001|Overall Study|Other|37|||
128702301|NCT01751867|463209343|FG000|Overall Study|Randomized but not treated.|2|||
128702302|NCT01751867|463209344|FG001|Overall Study|Randomized but not treated.|1|||
128702303|NCT01976338|463209346|FG000|Overall Study|Physician Decision|0|||
128702304|NCT01976338|463209347|FG001|Overall Study|Physician Decision|1|||
128702305|NCT01976338|463209346|FG000|Overall Study|Lost to Follow-up|3|||
128702306|NCT01976338|463209347|FG001|Overall Study|Lost to Follow-up|0|||
128702307|NCT01976338|463209346|FG000|Overall Study|Withdrawal by Subject|5|||
128702308|NCT01976338|463209347|FG001|Overall Study|Withdrawal by Subject|2|||
128702309|NCT01976338|463209346|FG000|Overall Study|Adverse Event|5|||
128702310|NCT01976338|463209347|FG001|Overall Study|Adverse Event|1|||
128702311|NCT00777608|463209348|FG000|Overall Study|Lost to Follow-up|1|||
128702312|NCT00777608|463209349|FG001|Overall Study|Lost to Follow-up|1|||
128702313|NCT00777608|463209348|FG000|Overall Study|Withdrawal by Subject|1|||
128702314|NCT00777608|463209349|FG001|Overall Study|Withdrawal by Subject|3|||
128702315|NCT00777608|463209348|FG000|Overall Study|Protocol Violation|1|||
128702316|NCT00777608|463209349|FG001|Overall Study|Protocol Violation|0|||
128702317|NCT00777608|463209348|FG000|Overall Study|Investigator Decision|1|||
128702318|NCT00777608|463209349|FG001|Overall Study|Investigator Decision|2|||
128702319|NCT03766581|463209351|FG000|Randomization|Other reasons|2|||
128702320|NCT03766581|463209352|FG001|Randomization|Other reasons|1|||
128702321|NCT03766581|463209353|FG002|Randomization|Other reasons|0|||
128702322|NCT03766581|463209354|FG003|Randomization|Other reasons|1|||
128702323|NCT03766581|463209355|FG004|Randomization|Other reasons|0|||
128702324|NCT03766581|463209356|FG005|Randomization|Other reasons|0|||
128702325|NCT03766581|463209357|FG006|Randomization|Other reasons|0|||
128702326|NCT03766581|463209358|FG007|Randomization|Other reasons|0|||
128702327|NCT03766581|463209351|FG000|Randomization|Participant no longer meets study criteria|5|||
128702328|NCT03766581|463209352|FG001|Randomization|Participant no longer meets study criteria|3|||
128702329|NCT03766581|463209353|FG002|Randomization|Participant no longer meets study criteria|4|||
128702330|NCT03766581|463209354|FG003|Randomization|Participant no longer meets study criteria|0|||
128702331|NCT03766581|463209355|FG004|Randomization|Participant no longer meets study criteria|2|||
128702332|NCT03766581|463209356|FG005|Randomization|Participant no longer meets study criteria|3|||
128702333|NCT03766581|463209357|FG006|Randomization|Participant no longer meets study criteria|0|||
128702334|NCT03766581|463209358|FG007|Randomization|Participant no longer meets study criteria|1|||
128702335|NCT03766581|463209351|FG000|Randomization|Participant request to discontinue study treatment|1|||
128702336|NCT03766581|463209352|FG001|Randomization|Participant request to discontinue study treatment|0|||
128702337|NCT03766581|463209353|FG002|Randomization|Participant request to discontinue study treatment|0|||
128702338|NCT03766581|463209354|FG003|Randomization|Participant request to discontinue study treatment|0|||
128702339|NCT03766581|463209355|FG004|Randomization|Participant request to discontinue study treatment|1|||
128702340|NCT03766581|463209356|FG005|Randomization|Participant request to discontinue study treatment|2|||
128702341|NCT03766581|463209357|FG006|Randomization|Participant request to discontinue study treatment|0|||
128702342|NCT03766581|463209358|FG007|Randomization|Participant request to discontinue study treatment|0|||
128702343|NCT03766581|463209351|FG000|Randomization|Participant withdrew consent|1|||
128702344|NCT03766581|463209352|FG001|Randomization|Participant withdrew consent|0|||
128702345|NCT03766581|463209353|FG002|Randomization|Participant withdrew consent|1|||
128702346|NCT03766581|463209354|FG003|Randomization|Participant withdrew consent|2|||
128702347|NCT03766581|463209355|FG004|Randomization|Participant withdrew consent|1|||
128702348|NCT03766581|463209356|FG005|Randomization|Participant withdrew consent|1|||
128702349|NCT03766581|463209357|FG006|Randomization|Participant withdrew consent|0|||
128702350|NCT03766581|463209358|FG007|Randomization|Participant withdrew consent|0|||
128702351|NCT03766581|463209351|FG000|Treatment|Adverse Event|82|||
128702352|NCT03766581|463209352|FG001|Treatment|Adverse Event|44|||
128702353|NCT03766581|463209353|FG002|Treatment|Adverse Event|47|||
128702354|NCT03766581|463209354|FG003|Treatment|Adverse Event|46|||
129120538|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
129120539|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
128702355|NCT03766581|463209355|FG004|Treatment|Adverse Event|50|||
128702356|NCT03766581|463209356|FG005|Treatment|Adverse Event|77|||
128702357|NCT03766581|463209357|FG006|Treatment|Adverse Event|5|||
128702358|NCT03766581|463209358|FG007|Treatment|Adverse Event|2|||
128767506|NCT04022889|463440278|FG001|Stage 2|Screen Failure|0|||
128767507|NCT04022889|463440279|FG002|Stage 2|Screen Failure|3|||
128767508|NCT04022889|463440277|FG000|Stage 2|Ineligible for apheresis donation|0|||
128767509|NCT04022889|463440278|FG001|Stage 2|Ineligible for apheresis donation|0|||
128767510|NCT04022889|463440279|FG002|Stage 2|Ineligible for apheresis donation|2|||
128767511|NCT04022889|463440277|FG000|Stage 2|Adverse Event|0|||
128767512|NCT04022889|463440278|FG001|Stage 2|Adverse Event|0|||
128767513|NCT04022889|463440279|FG002|Stage 2|Adverse Event|2|||
128767514|NCT04022889|463440277|FG000|Stage 2|Protocol Violation|0|||
128767515|NCT04022889|463440278|FG001|Stage 2|Protocol Violation|0|||
128767516|NCT04022889|463440279|FG002|Stage 2|Protocol Violation|1|||
128767517|NCT04022889|463440277|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
128767518|NCT04022889|463440278|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
128767519|NCT04022889|463440279|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
128767520|NCT01900054|463440287|FG000|Overall Study|Physician Decision|1|||
128767521|NCT01900054|463440287|FG000|Overall Study|Withdrawal by Subject|1|||
128767522|NCT01186328|463440288|FG000|Overall Study|Death|1|||
128767523|NCT01186328|463440289|FG001|Overall Study|Death|0|||
129030550|NCT03885934|464403166|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
129030551|NCT03885934|464403167|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
128767524|NCT01186328|463440290|FG002|Overall Study|Death|0|||
128767525|NCT03015116|463440293|FG000|Overall Study|Lost to Follow-up|3|||
129030552|NCT01617096|464403168|FG000|Overall Study|Withdrawal by Subject|96|||
129030553|NCT01617096|464403169|FG001|Overall Study|Withdrawal by Subject|81|||
129030554|NCT01617096|464403168|FG000|Overall Study|Lost to Follow-up|37|||
129030555|NCT01617096|464403169|FG001|Overall Study|Lost to Follow-up|32|||
129030556|NCT01617096|464403168|FG000|Overall Study|Physician Decision|10|||
129030557|NCT01617096|464403169|FG001|Overall Study|Physician Decision|18|||
129030558|NCT01617096|464403168|FG000|Overall Study|Death|4|||
129030559|NCT01617096|464403169|FG001|Overall Study|Death|3|||
128702359|NCT03766581|463209351|FG000|Treatment|Participant request to discontinue treatment|34|||
128702360|NCT03766581|463209352|FG001|Treatment|Participant request to discontinue treatment|6|||
128702361|NCT03766581|463209353|FG002|Treatment|Participant request to discontinue treatment|10|||
128767526|NCT03015116|463440294|FG001|Overall Study|Lost to Follow-up|0|||
128767527|NCT03015116|463440295|FG002|Overall Study|Lost to Follow-up|2|||
128767528|NCT03015116|463440293|FG000|Overall Study|Withdrawal by Subject|3|||
128702362|NCT03766581|463209354|FG003|Treatment|Participant request to discontinue treatment|10|||
128702363|NCT03766581|463209355|FG004|Treatment|Participant request to discontinue treatment|14|||
128702364|NCT03766581|463209356|FG005|Treatment|Participant request to discontinue treatment|15|||
128702365|NCT03766581|463209357|FG006|Treatment|Participant request to discontinue treatment|0|||
128702366|NCT03766581|463209358|FG007|Treatment|Participant request to discontinue treatment|1|||
128702367|NCT03766581|463209351|FG000|Treatment|Participant withdrew consent|11|||
128702368|NCT03766581|463209352|FG001|Treatment|Participant withdrew consent|4|||
128702369|NCT03766581|463209353|FG002|Treatment|Participant withdrew consent|5|||
128702370|NCT03766581|463209354|FG003|Treatment|Participant withdrew consent|5|||
128702371|NCT03766581|463209355|FG004|Treatment|Participant withdrew consent|4|||
128702372|NCT03766581|463209356|FG005|Treatment|Participant withdrew consent|4|||
128702373|NCT03766581|463209357|FG006|Treatment|Participant withdrew consent|0|||
128702374|NCT03766581|463209358|FG007|Treatment|Participant withdrew consent|0|||
128702375|NCT03766581|463209351|FG000|Treatment|Death|1|||
128702376|NCT03766581|463209352|FG001|Treatment|Death|0|||
128702377|NCT03766581|463209353|FG002|Treatment|Death|0|||
128702378|NCT03766581|463209354|FG003|Treatment|Death|0|||
128702379|NCT03766581|463209355|FG004|Treatment|Death|0|||
128702380|NCT03766581|463209356|FG005|Treatment|Death|0|||
128702381|NCT03766581|463209357|FG006|Treatment|Death|0|||
128702382|NCT03766581|463209358|FG007|Treatment|Death|0|||
128702383|NCT03766581|463209351|FG000|Treatment|Lost to Follow-up|1|||
128702384|NCT03766581|463209352|FG001|Treatment|Lost to Follow-up|0|||
128702385|NCT03766581|463209353|FG002|Treatment|Lost to Follow-up|0|||
128702386|NCT03766581|463209354|FG003|Treatment|Lost to Follow-up|1|||
128702387|NCT03766581|463209355|FG004|Treatment|Lost to Follow-up|0|||
128702388|NCT03766581|463209356|FG005|Treatment|Lost to Follow-up|0|||
128702389|NCT03766581|463209357|FG006|Treatment|Lost to Follow-up|0|||
128702390|NCT03766581|463209358|FG007|Treatment|Lost to Follow-up|0|||
128702391|NCT03766581|463209351|FG000|Treatment|Poor/Non compliance|2|||
128702392|NCT03766581|463209352|FG001|Treatment|Poor/Non compliance|2|||
128702393|NCT03766581|463209353|FG002|Treatment|Poor/Non compliance|1|||
128767529|NCT03015116|463440294|FG001|Overall Study|Withdrawal by Subject|1|||
128767530|NCT03015116|463440295|FG002|Overall Study|Withdrawal by Subject|0|||
128767531|NCT03015116|463440293|FG000|Overall Study|Subject has New Medical Status|1|||
128702394|NCT03766581|463209354|FG003|Treatment|Poor/Non compliance|1|||
128702395|NCT03766581|463209355|FG004|Treatment|Poor/Non compliance|1|||
128702396|NCT03766581|463209356|FG005|Treatment|Poor/Non compliance|1|||
128702397|NCT03766581|463209357|FG006|Treatment|Poor/Non compliance|0|||
128767532|NCT03015116|463440294|FG001|Overall Study|Subject has New Medical Status|0|||
128767533|NCT03015116|463440295|FG002|Overall Study|Subject has New Medical Status|0|||
129030560|NCT01617096|464403168|FG000|Overall Study|Other|1|||
129030561|NCT01617096|464403169|FG001|Overall Study|Other|3|||
129030562|NCT04473326|464403174|FG000|Overall Study|Death|0|||
128930743|NCT00537940|464036564|FG001|Overall Study|Lost to Follow-up|29|||
128930744|NCT00537940|464036563|FG000|Overall Study|Withdrawal by Subject|113|||
128930745|NCT00537940|464036564|FG001|Overall Study|Withdrawal by Subject|95|||
128930746|NCT00537940|464036563|FG000|Overall Study|Protocol Violation|6|||
128930747|NCT00537940|464036564|FG001|Overall Study|Protocol Violation|4|||
128930748|NCT00537940|464036563|FG000|Overall Study|Pregnancy|1|||
128930749|NCT00537940|464036564|FG001|Overall Study|Pregnancy|1|||
128930750|NCT00537940|464036563|FG000|Overall Study|Study terminated by sponsor|2|||
128930751|NCT00537940|464036564|FG001|Overall Study|Study terminated by sponsor|3|||
128930752|NCT00537940|464036563|FG000|Overall Study|Other|10|||
128930753|NCT00537940|464036564|FG001|Overall Study|Other|12|||
128930754|NCT01062399|464036565|FG000|Overall Study|Protocol Violation|0|||
128930755|NCT01062399|464036566|FG001|Overall Study|Protocol Violation|1|||
128930756|NCT01062399|464036567|FG002|Overall Study|Protocol Violation|0|||
128930757|NCT01062399|464036568|FG003|Overall Study|Protocol Violation|6|||
128930758|NCT01062399|464036569|FG004|Overall Study|Protocol Violation|4|||
128930759|NCT00634543|464036571|FG000|Overall Study|Other|1|||
128930760|NCT00634543|464036572|FG001|Overall Study|Other|2|||
128930761|NCT00634543|464036571|FG000|Overall Study|Protocol Violation|3|||
128930762|NCT00634543|464036572|FG001|Overall Study|Protocol Violation|3|||
128930763|NCT00634543|464036571|FG000|Overall Study|Adverse Event|11|||
128930764|NCT00634543|464036572|FG001|Overall Study|Adverse Event|11|||
128930765|NCT00634543|464036571|FG000|Overall Study|Withdrawal by Subject|4|||
128930766|NCT00634543|464036572|FG001|Overall Study|Withdrawal by Subject|4|||
128930767|NCT00634543|464036571|FG000|Overall Study|Lost to Follow-up|0|||
128930768|NCT00634543|464036572|FG001|Overall Study|Lost to Follow-up|1|||
128930769|NCT02465034|464036575|FG000|Overall Study|Withdrawal by Subject|1|||
128930770|NCT02465034|464036576|FG001|Overall Study|Withdrawal by Subject|1|||
128930771|NCT02465034|464036575|FG000|Overall Study|Screen fail|2|||
128930772|NCT02465034|464036576|FG001|Overall Study|Screen fail|0|||
128930773|NCT02465034|464036575|FG000|Overall Study|Could not be scheduled for study visit|0|||
128930774|NCT02465034|464036576|FG001|Overall Study|Could not be scheduled for study visit|5|||
128930775|NCT02397655|464036577|FG000|Overall Study|data not completed|1301|||
128930776|NCT01736683|464036578|FG000|Overall Study|Disease Relapse|0|||
128930777|NCT01736683|464036579|FG001|Overall Study|Disease Relapse|0|||
128930778|NCT01736683|464036580|FG002|Overall Study|Disease Relapse|2|||
128930779|NCT01736683|464036581|FG003|Overall Study|Disease Relapse|1|||
128930780|NCT01736683|464036582|FG004|Overall Study|Disease Relapse|0|||
128930781|NCT01736683|464036578|FG000|Overall Study|Adverse Event|0|||
128930782|NCT01736683|464036579|FG001|Overall Study|Adverse Event|2|||
128930783|NCT01736683|464036580|FG002|Overall Study|Adverse Event|2|||
128930784|NCT01736683|464036581|FG003|Overall Study|Adverse Event|3|||
128930785|NCT01736683|464036582|FG004|Overall Study|Adverse Event|2|||
128930786|NCT01736683|464036578|FG000|Overall Study|Withdrawal by Subject|0|||
128930787|NCT01736683|464036579|FG001|Overall Study|Withdrawal by Subject|0|||
128930788|NCT01736683|464036580|FG002|Overall Study|Withdrawal by Subject|3|||
128930789|NCT01736683|464036581|FG003|Overall Study|Withdrawal by Subject|1|||
128930790|NCT01736683|464036582|FG004|Overall Study|Withdrawal by Subject|1|||
128930791|NCT01736683|464036578|FG000|Overall Study|Lack of Therapeutic Effect|7|||
128930792|NCT01736683|464036579|FG001|Overall Study|Lack of Therapeutic Effect|4|||
128930793|NCT01736683|464036580|FG002|Overall Study|Lack of Therapeutic Effect|13|||
128930794|NCT01736683|464036581|FG003|Overall Study|Lack of Therapeutic Effect|20|||
128930795|NCT01736683|464036582|FG004|Overall Study|Lack of Therapeutic Effect|1|||
128930796|NCT01736683|464036578|FG000|Overall Study|Progressive Disease|0|||
128930797|NCT01736683|464036579|FG001|Overall Study|Progressive Disease|0|||
129120540|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
129120541|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
129120542|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
128930798|NCT01736683|464036580|FG002|Overall Study|Progressive Disease|0|||
128930799|NCT01736683|464036581|FG003|Overall Study|Progressive Disease|1|||
128930800|NCT01736683|464036582|FG004|Overall Study|Progressive Disease|0|||
128930801|NCT01736683|464036578|FG000|Overall Study|Other|0|||
128930802|NCT01736683|464036579|FG001|Overall Study|Other|0|||
128930803|NCT01736683|464036580|FG002|Overall Study|Other|1|||
128930804|NCT01736683|464036581|FG003|Overall Study|Other|9|||
128930805|NCT01736683|464036582|FG004|Overall Study|Other|1|||
128930806|NCT01588197|464036583|FG000|Overall Study|Lack of Efficacy|0|||
128930807|NCT01588197|464036584|FG001|Overall Study|Lack of Efficacy|1|||
128930808|NCT01588197|464036583|FG000|Overall Study|No MRI|1|||
128930809|NCT01588197|464036584|FG001|Overall Study|No MRI|0|||
128930810|NCT01570491|464036593|FG000|Overall Study|Lost to Follow-up|3|||
128930811|NCT01570491|464036594|FG001|Overall Study|Lost to Follow-up|1|||
129120543|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
128930812|NCT01570491|464036593|FG000|Overall Study|treatment: not given or discontinued|2|||
128930813|NCT01570491|464036594|FG001|Overall Study|treatment: not given or discontinued|0|||
128930814|NCT03047213|464036595|FG000|Overall Study|Withdrawal by Subject|2|||
128930815|NCT03047213|464036596|FG001|Overall Study|Withdrawal by Subject|0|||
128930816|NCT03047213|464036595|FG000|Overall Study|Adverse Event|2|||
128930817|NCT03047213|464036596|FG001|Overall Study|Adverse Event|0|||
128930818|NCT00482001|464036597|FG000|Overall Study|Protocol Violation|1|||
128930819|NCT00482001|464036598|FG001|Overall Study|Protocol Violation|1|||
128930820|NCT00847613|464036599|FG000|Overall Study|Ongoing at cut-off date|250|||
128930821|NCT00847613|464036600|FG001|Overall Study|Ongoing at cut-off date|265|||
128930822|NCT00847613|464036601|FG002|Overall Study|Ongoing at cut-off date|64|||
128930823|NCT00847613|464036602|FG003|Overall Study|Ongoing at cut-off date|64|||
128930824|NCT00847613|464036599|FG000|Overall Study|Death|1|||
128930825|NCT00847613|464036600|FG001|Overall Study|Death|1|||
128930826|NCT00847613|464036601|FG002|Overall Study|Death|0|||
128930827|NCT00847613|464036602|FG003|Overall Study|Death|0|||
128930828|NCT00847613|464036599|FG000|Overall Study|Adverse Event|36|||
128930829|NCT00847613|464036600|FG001|Overall Study|Adverse Event|26|||
128930830|NCT00847613|464036601|FG002|Overall Study|Adverse Event|5|||
128930831|NCT00847613|464036602|FG003|Overall Study|Adverse Event|6|||
128930832|NCT00847613|464036599|FG000|Overall Study|Lack of Efficacy|7|||
128930833|NCT00847613|464036600|FG001|Overall Study|Lack of Efficacy|3|||
128930834|NCT00847613|464036601|FG002|Overall Study|Lack of Efficacy|3|||
128930835|NCT00847613|464036602|FG003|Overall Study|Lack of Efficacy|1|||
128930836|NCT00847613|464036599|FG000|Overall Study|Study terminated by Sponsor|1|||
128930837|NCT00847613|464036600|FG001|Overall Study|Study terminated by Sponsor|0|||
128930838|NCT00847613|464036601|FG002|Overall Study|Study terminated by Sponsor|2|||
128930839|NCT00847613|464036602|FG003|Overall Study|Study terminated by Sponsor|1|||
128930840|NCT00847613|464036599|FG000|Overall Study|Lost to Follow-up|5|||
128930841|NCT00847613|464036600|FG001|Overall Study|Lost to Follow-up|0|||
128930842|NCT00847613|464036601|FG002|Overall Study|Lost to Follow-up|0|||
128930843|NCT00847613|464036602|FG003|Overall Study|Lost to Follow-up|3|||
128930844|NCT00847613|464036599|FG000|Overall Study|Protocol Violation|6|||
128930845|NCT00847613|464036600|FG001|Overall Study|Protocol Violation|6|||
128930846|NCT00847613|464036601|FG002|Overall Study|Protocol Violation|3|||
128930847|NCT00847613|464036602|FG003|Overall Study|Protocol Violation|1|||
128930848|NCT00847613|464036599|FG000|Overall Study|Pregnancy|1|||
128930849|NCT00847613|464036600|FG001|Overall Study|Pregnancy|1|||
128930850|NCT00847613|464036601|FG002|Overall Study|Pregnancy|0|||
128930851|NCT00847613|464036602|FG003|Overall Study|Pregnancy|0|||
128930852|NCT00847613|464036599|FG000|Overall Study|Site closure|1|||
128930853|NCT00847613|464036600|FG001|Overall Study|Site closure|0|||
128930854|NCT00847613|464036601|FG002|Overall Study|Site closure|0|||
128930855|NCT00847613|464036602|FG003|Overall Study|Site closure|1|||
128930856|NCT00847613|464036599|FG000|Overall Study|Withdrawal by Subject|8|||
128930857|NCT00847613|464036600|FG001|Overall Study|Withdrawal by Subject|11|||
128930858|NCT00847613|464036601|FG002|Overall Study|Withdrawal by Subject|2|||
128930859|NCT00847613|464036602|FG003|Overall Study|Withdrawal by Subject|2|||
128930860|NCT00847613|464036599|FG000|Overall Study|Participant moved|4|||
128930861|NCT00847613|464036600|FG001|Overall Study|Participant moved|1|||
128930862|NCT00847613|464036601|FG002|Overall Study|Participant moved|0|||
128930863|NCT00847613|464036602|FG003|Overall Study|Participant moved|0|||
128930864|NCT00847613|464036599|FG000|Overall Study|Sponsor request|0|||
128930865|NCT00847613|464036600|FG001|Overall Study|Sponsor request|1|||
128930866|NCT00847613|464036601|FG002|Overall Study|Sponsor request|0|||
128930867|NCT00847613|464036602|FG003|Overall Study|Sponsor request|0|||
128930868|NCT00847613|464036599|FG000|Overall Study|Randomized, but not treated|0|||
128930869|NCT00847613|464036600|FG001|Overall Study|Randomized, but not treated|3|||
128930870|NCT00847613|464036601|FG002|Overall Study|Randomized, but not treated|0|||
128930871|NCT00847613|464036602|FG003|Overall Study|Randomized, but not treated|0|||
128930872|NCT00847613|464036599|FG000|Overall Study|Other|1|||
128930873|NCT00847613|464036600|FG001|Overall Study|Other|1|||
128930874|NCT00847613|464036601|FG002|Overall Study|Other|2|||
128930875|NCT00847613|464036602|FG003|Overall Study|Other|0|||
128930876|NCT01009294|464036603|FG000|Overall Study|Study discontinued by Sponsor|6|||
128930877|NCT04925570|464036604|FG000|Overall Study|Protocol Violation|24|||
128930878|NCT04925570|464036605|FG001|Overall Study|Protocol Violation|30|||
128930879|NCT04925570|464036604|FG000|Overall Study|Withdrawal by Subject|0|||
128930880|NCT04925570|464036605|FG001|Overall Study|Withdrawal by Subject|2|||
129030563|NCT04473326|464403175|FG001|Overall Study|Death|1|||
128702398|NCT03766581|463209358|FG007|Treatment|Poor/Non compliance|0|||
128702399|NCT03766581|463209351|FG000|Treatment|Participant no longer meets study criteria|9|||
128702400|NCT03766581|463209352|FG001|Treatment|Participant no longer meets study criteria|1|||
128702401|NCT03766581|463209353|FG002|Treatment|Participant no longer meets study criteria|5|||
128702402|NCT03766581|463209354|FG003|Treatment|Participant no longer meets study criteria|4|||
128930881|NCT00658333|464036606|FG000|Overall Study|Adverse Event|2|||
128930882|NCT00658333|464036607|FG001|Overall Study|Adverse Event|1|||
128930883|NCT00828451|464036610|FG000|Overall Study|Death|2|||
128930884|NCT00828451|464036610|FG000|Overall Study|Lack of intravenous line|7|||
128930885|NCT00828451|464036610|FG000|Overall Study|Withdrawal by Subject|1|||
128930886|NCT00828451|464036610|FG000|Overall Study|Deterioration in clinical status|1|||
128930887|NCT00519532|464036611|FG000|Overall Study|Adverse Event|11|||
128930888|NCT00519532|464036611|FG000|Overall Study|Withdrawal by Subject|5|||
128930889|NCT00519532|464036611|FG000|Overall Study|Lost to Follow-up|2|||
128930890|NCT00624338|464036614|FG000|Overall Study|Adverse Event|14|||
128930891|NCT00624338|464036615|FG001|Overall Study|Adverse Event|14|||
128930892|NCT00624338|464036616|FG002|Overall Study|Adverse Event|18|||
128930893|NCT00624338|464036614|FG000|Overall Study|Lost to Follow-up|1|||
128930894|NCT00624338|464036615|FG001|Overall Study|Lost to Follow-up|0|||
128930895|NCT00624338|464036616|FG002|Overall Study|Lost to Follow-up|0|||
128930896|NCT00624338|464036614|FG000|Overall Study|Lack of Efficacy|11|||
128930897|NCT00624338|464036615|FG001|Overall Study|Lack of Efficacy|3|||
128930898|NCT00624338|464036616|FG002|Overall Study|Lack of Efficacy|14|||
128930899|NCT00624338|464036614|FG000|Overall Study|Protocol Violation|3|||
128930900|NCT00624338|464036615|FG001|Overall Study|Protocol Violation|3|||
128930901|NCT00624338|464036616|FG002|Overall Study|Protocol Violation|2|||
128930902|NCT00624338|464036614|FG000|Overall Study|Death|0|||
128930903|NCT00624338|464036615|FG001|Overall Study|Death|2|||
128930904|NCT00624338|464036616|FG002|Overall Study|Death|0|||
128930905|NCT00624338|464036614|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
128930906|NCT00624338|464036615|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
128930907|NCT00624338|464036616|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
128930908|NCT00624338|464036614|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
128930909|NCT00624338|464036615|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
128930910|NCT00624338|464036616|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
128930911|NCT00624338|464036614|FG000|Overall Study|Other|15|||
128930912|NCT00624338|464036615|FG001|Overall Study|Other|5|||
128930913|NCT00624338|464036616|FG002|Overall Study|Other|9|||
128930914|NCT00624338|464036614|FG000|Overall Study|Randomized but not treated|2|||
128930915|NCT00624338|464036615|FG001|Overall Study|Randomized but not treated|1|||
128930916|NCT00624338|464036616|FG002|Overall Study|Randomized but not treated|3|||
128930917|NCT01548638|464036617|FG000|Overall Study|Protocol Violation|3|||
128930918|NCT01548638|464036617|FG000|Overall Study|Withdrawal by Subject|1|||
128930919|NCT02609399|464036621|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
128930920|NCT02609399|464036622|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
128930921|NCT02609399|464036621|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
128930922|NCT02609399|464036622|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
128930923|NCT02609399|464036621|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
128930924|NCT02609399|464036622|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
128930925|NCT00753922|464036623|FG000|Overall Study|Lost to Follow-up|155|||
128930926|NCT00753922|464036624|FG001|Overall Study|Lost to Follow-up|24|||
128930927|NCT00753922|464036625|FG002|Overall Study|Lost to Follow-up|28|||
128930928|NCT00753922|464036626|FG003|Overall Study|Lost to Follow-up|5|||
128930929|NCT00753922|464036623|FG000|Overall Study|Withdrawal by Subject|9|||
128930930|NCT00753922|464036624|FG001|Overall Study|Withdrawal by Subject|11|||
128930931|NCT00753922|464036625|FG002|Overall Study|Withdrawal by Subject|4|||
128930932|NCT00753922|464036626|FG003|Overall Study|Withdrawal by Subject|2|||
128930933|NCT00753922|464036623|FG000|Overall Study|Patient Non-compliance|55|||
128930934|NCT00753922|464036624|FG001|Overall Study|Patient Non-compliance|22|||
128930935|NCT00753922|464036625|FG002|Overall Study|Patient Non-compliance|14|||
128930936|NCT00753922|464036626|FG003|Overall Study|Patient Non-compliance|11|||
128930937|NCT00753922|464036623|FG000|Overall Study|Patients Not Completing Visit|11|||
128930938|NCT00753922|464036624|FG001|Overall Study|Patients Not Completing Visit|0|||
128930939|NCT00753922|464036625|FG002|Overall Study|Patients Not Completing Visit|1|||
128930940|NCT00753922|464036626|FG003|Overall Study|Patients Not Completing Visit|0|||
128930941|NCT00753922|464036623|FG000|Overall Study|Death|2|||
128930942|NCT00753922|464036624|FG001|Overall Study|Death|23|||
128930943|NCT00753922|464036625|FG002|Overall Study|Death|2|||
128930944|NCT00753922|464036626|FG003|Overall Study|Death|1|||
128930945|NCT00753922|464036623|FG000|Overall Study|Discontinuation Due to Explantation|14|||
128930946|NCT00753922|464036624|FG001|Overall Study|Discontinuation Due to Explantation|14|||
128930947|NCT00753922|464036625|FG002|Overall Study|Discontinuation Due to Explantation|14|||
128930948|NCT00753922|464036626|FG003|Overall Study|Discontinuation Due to Explantation|4|||
128930949|NCT02190591|464036627|FG000|Overall Study|Withdrawal by Subject|1|||
128930950|NCT02190591|464036628|FG001|Overall Study|Withdrawal by Subject|8|||
128930951|NCT02190591|464036627|FG000|Overall Study|Protocol Violation|1|||
128930952|NCT02190591|464036628|FG001|Overall Study|Protocol Violation|0|||
128930953|NCT02190591|464036627|FG000|Overall Study|did not use peanut ball as instructed|0|||
128930954|NCT02190591|464036628|FG001|Overall Study|did not use peanut ball as instructed|2|||
128930955|NCT02190591|464036627|FG000|Overall Study|face presentation so she was ineligible|0|||
128930956|NCT02190591|464036628|FG001|Overall Study|face presentation so she was ineligible|1|||
129030564|NCT04473326|464403174|FG000|Overall Study|Withdrawal by Subject|1|||
129030565|NCT04473326|464403175|FG001|Overall Study|Withdrawal by Subject|2|||
128767534|NCT03015116|463440293|FG000|Overall Study|Physician Decision|0|||
128930957|NCT03598777|464036629|FG000|Overall Study|Study Terminated by Sponsor|3|||
128930958|NCT03598777|464036630|FG001|Overall Study|Study Terminated by Sponsor|0|||
128930959|NCT03598777|464036631|FG002|Overall Study|Study Terminated by Sponsor|0|||
128930960|NCT03598777|464036632|FG003|Overall Study|Study Terminated by Sponsor|0|||
128930961|NCT03598777|464036633|FG004|Overall Study|Study Terminated by Sponsor|15|||
128930962|NCT03598777|464036629|FG000|Overall Study|Withdrawal by Subject|1|||
128930963|NCT03598777|464036630|FG001|Overall Study|Withdrawal by Subject|1|||
128930964|NCT03598777|464036631|FG002|Overall Study|Withdrawal by Subject|0|||
128930965|NCT03598777|464036632|FG003|Overall Study|Withdrawal by Subject|0|||
128930966|NCT03598777|464036633|FG004|Overall Study|Withdrawal by Subject|0|||
128930967|NCT03598777|464036629|FG000|Overall Study|Adverse Event|1|||
128930968|NCT03598777|464036630|FG001|Overall Study|Adverse Event|0|||
128930969|NCT03598777|464036631|FG002|Overall Study|Adverse Event|0|||
128930970|NCT03598777|464036632|FG003|Overall Study|Adverse Event|0|||
128930971|NCT03598777|464036633|FG004|Overall Study|Adverse Event|0|||
129120544|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
129120545|NCT00849056|464738989|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
129120546|NCT00849056|464738990|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
129120547|NCT00849056|464738989|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
129120548|NCT00849056|464738990|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
129120549|NCT00849056|464738989|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
129120550|NCT00849056|464738990|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
129120551|NCT00849056|464738989|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
129120552|NCT00849056|464738990|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
129120553|NCT00849056|464738989|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
129120554|NCT00849056|464738990|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
129120555|NCT00849056|464738989|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
129120556|NCT00849056|464738990|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
129120557|NCT00849056|464738989|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
129120558|NCT00849056|464738990|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
129120559|NCT00849056|464738989|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
129120560|NCT00849056|464738990|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
129120561|NCT01673386|464738991|FG000|Overall Study|Study terminated by sponsor|16|||
129120562|NCT01673386|464738992|FG001|Overall Study|Study terminated by sponsor|22|||
129120563|NCT01673386|464738991|FG000|Overall Study|Adverse Event|5|||
129120564|NCT01673386|464738992|FG001|Overall Study|Adverse Event|2|||
129120565|NCT01673386|464738991|FG000|Overall Study|Progressive disease|4|||
129120566|NCT01673386|464738992|FG001|Overall Study|Progressive disease|1|||
129120567|NCT01673386|464738991|FG000|Overall Study|Withdrawal by Subject|0|||
129120568|NCT01673386|464738992|FG001|Overall Study|Withdrawal by Subject|2|||
129120569|NCT02934178|464738996|FG000|Received Vaccination 2|Death|0|||
129120570|NCT02934178|464738997|FG001|Received Vaccination 2|Death|1|||
129120571|NCT02934178|464738996|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
129120572|NCT02934178|464738997|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
129120573|NCT01898078|464739000|FG000|Overall Study|Progressive Disease|1|||
129120574|NCT01898078|464739001|FG001|Overall Study|Progressive Disease|5|||
129120575|NCT01898078|464739000|FG000|Overall Study|Adverse Event|2|||
129120576|NCT01898078|464739001|FG001|Overall Study|Adverse Event|1|||
129120577|NCT01898078|464739000|FG000|Overall Study|Withdrawal by Subject|1|||
129120578|NCT01898078|464739001|FG001|Overall Study|Withdrawal by Subject|1|||
129120579|NCT01898078|464739000|FG000|Overall Study|Symptomatic Deterioration|2|||
129120580|NCT01898078|464739001|FG001|Overall Study|Symptomatic Deterioration|0|||
129120581|NCT01898078|464739000|FG000|Overall Study|Reason not Specified|0|||
129120582|NCT01898078|464739001|FG001|Overall Study|Reason not Specified|1|||
129120583|NCT01075048|464739003|FG000|Overall Study|Death|4|||
129120584|NCT01075048|464739004|FG001|Overall Study|Death|17|||
129120585|NCT01075048|464739005|FG002|Overall Study|Death|12|||
129120586|NCT01075048|464739003|FG000|Overall Study|Start of other or new therapy|4|||
129120587|NCT01075048|464739004|FG001|Overall Study|Start of other or new therapy|36|||
129120588|NCT01075048|464739005|FG002|Overall Study|Start of other or new therapy|46|||
129120589|NCT01075048|464739003|FG000|Overall Study|Withdrawal by Subject|1|||
129120590|NCT01075048|464739004|FG001|Overall Study|Withdrawal by Subject|6|||
129120591|NCT01075048|464739005|FG002|Overall Study|Withdrawal by Subject|3|||
129120592|NCT01075048|464739003|FG000|Overall Study|Lost to Follow-up|0|||
129120593|NCT01075048|464739004|FG001|Overall Study|Lost to Follow-up|1|||
129120594|NCT01075048|464739005|FG002|Overall Study|Lost to Follow-up|1|||
129120595|NCT01287936|464739006|FG000|Overall Study|Lost to Follow-up|0|||
129120596|NCT01287936|464739007|FG001|Overall Study|Lost to Follow-up|1|||
129120597|NCT01287936|464739008|FG002|Overall Study|Lost to Follow-up|1|||
129120598|NCT01140906|464739009|FG000|Overall Study|Adverse Event|7|||
129120599|NCT01140906|464739010|FG001|Overall Study|Adverse Event|10|||
129120600|NCT01140906|464739011|FG002|Overall Study|Adverse Event|17|||
129120601|NCT01140906|464739012|FG003|Overall Study|Adverse Event|7|||
129120602|NCT01140906|464739009|FG000|Overall Study|Lack of Efficacy|6|||
129120603|NCT01140906|464739010|FG001|Overall Study|Lack of Efficacy|8|||
129120604|NCT01140906|464739011|FG002|Overall Study|Lack of Efficacy|2|||
129120605|NCT01140906|464739012|FG003|Overall Study|Lack of Efficacy|1|||
129120606|NCT01140906|464739009|FG000|Overall Study|Non-compliance|0|||
129120607|NCT01140906|464739010|FG001|Overall Study|Non-compliance|1|||
128930972|NCT03598777|464036629|FG000|Overall Study|Lost to Follow-up|1|||
129120608|NCT01140906|464739011|FG002|Overall Study|Non-compliance|0|||
129120609|NCT01140906|464739012|FG003|Overall Study|Non-compliance|1|||
128702403|NCT03766581|463209355|FG004|Treatment|Participant no longer meets study criteria|4|||
128702404|NCT03766581|463209356|FG005|Treatment|Participant no longer meets study criteria|4|||
128702405|NCT03766581|463209357|FG006|Treatment|Participant no longer meets study criteria|2|||
128702406|NCT03766581|463209358|FG007|Treatment|Participant no longer meets study criteria|0|||
128702407|NCT03766581|463209351|FG000|Treatment|Other reasons|13|||
128702408|NCT03766581|463209352|FG001|Treatment|Other reasons|8|||
128702409|NCT03766581|463209353|FG002|Treatment|Other reasons|3|||
128702410|NCT03766581|463209354|FG003|Treatment|Other reasons|7|||
128702411|NCT03766581|463209355|FG004|Treatment|Other reasons|3|||
128702412|NCT03766581|463209356|FG005|Treatment|Other reasons|3|||
128702413|NCT03766581|463209357|FG006|Treatment|Other reasons|0|||
128702414|NCT03766581|463209358|FG007|Treatment|Other reasons|0|||
128702415|NCT02732119|463209359|FG000|Phase I|Adverse Event|1|||
128702416|NCT02732119|463209360|FG001|Phase I|Adverse Event|3|||
128702417|NCT02732119|463209361|FG002|Phase I|Adverse Event|1|||
128702418|NCT02732119|463209362|FG003|Phase I|Adverse Event|0|||
128702419|NCT02732119|463209363|FG004|Phase I|Adverse Event|0|||
128702420|NCT02732119|463209359|FG000|Phase I|Progressive disease|7|||
128702421|NCT02732119|463209360|FG001|Phase I|Progressive disease|3|||
128702422|NCT02732119|463209361|FG002|Phase I|Progressive disease|2|||
128702423|NCT02732119|463209362|FG003|Phase I|Progressive disease|0|||
128702424|NCT02732119|463209363|FG004|Phase I|Progressive disease|0|||
128702425|NCT02732119|463209359|FG000|Phase I|Protocol deviation|0|||
128702426|NCT02732119|463209360|FG001|Phase I|Protocol deviation|1|||
128702427|NCT02732119|463209361|FG002|Phase I|Protocol deviation|0|||
128702428|NCT02732119|463209362|FG003|Phase I|Protocol deviation|0|||
128702429|NCT02732119|463209363|FG004|Phase I|Protocol deviation|0|||
128702430|NCT02732119|463209359|FG000|Phase I|Physician Decision|0|||
128702431|NCT02732119|463209360|FG001|Phase I|Physician Decision|3|||
128702432|NCT02732119|463209361|FG002|Phase I|Physician Decision|4|||
128702433|NCT02732119|463209362|FG003|Phase I|Physician Decision|0|||
128702434|NCT02732119|463209363|FG004|Phase I|Physician Decision|0|||
128702435|NCT02732119|463209359|FG000|Phase II|Adverse Event|0|||
128702436|NCT02732119|463209360|FG001|Phase II|Adverse Event|0|||
128702437|NCT02732119|463209361|FG002|Phase II|Adverse Event|0|||
128702438|NCT02732119|463209362|FG003|Phase II|Adverse Event|3|||
128702439|NCT02732119|463209363|FG004|Phase II|Adverse Event|3|||
128702440|NCT02732119|463209359|FG000|Phase II|Death|0|||
128702441|NCT02732119|463209360|FG001|Phase II|Death|0|||
128702442|NCT02732119|463209361|FG002|Phase II|Death|0|||
128702443|NCT02732119|463209362|FG003|Phase II|Death|1|||
128702444|NCT02732119|463209363|FG004|Phase II|Death|0|||
128702445|NCT02732119|463209359|FG000|Phase II|Progressive dissease|0|||
128702446|NCT02732119|463209360|FG001|Phase II|Progressive dissease|0|||
128702447|NCT02732119|463209361|FG002|Phase II|Progressive dissease|0|||
128702448|NCT02732119|463209362|FG003|Phase II|Progressive dissease|30|||
128702449|NCT02732119|463209363|FG004|Phase II|Progressive dissease|23|||
128702450|NCT02732119|463209359|FG000|Phase II|Study terminated by sponsor|0|||
128702451|NCT02732119|463209360|FG001|Phase II|Study terminated by sponsor|0|||
128702452|NCT02732119|463209361|FG002|Phase II|Study terminated by sponsor|0|||
128702453|NCT02732119|463209362|FG003|Phase II|Study terminated by sponsor|2|||
128702454|NCT02732119|463209363|FG004|Phase II|Study terminated by sponsor|2|||
128702455|NCT02732119|463209359|FG000|Phase II|Other|0|||
128702456|NCT02732119|463209360|FG001|Phase II|Other|0|||
128702457|NCT02732119|463209361|FG002|Phase II|Other|0|||
128702458|NCT02732119|463209362|FG003|Phase II|Other|2|||
128702459|NCT02732119|463209363|FG004|Phase II|Other|0|||
128702460|NCT02732119|463209359|FG000|Phase II|Physician Decision|0|||
128702461|NCT02732119|463209360|FG001|Phase II|Physician Decision|0|||
128702462|NCT02732119|463209361|FG002|Phase II|Physician Decision|0|||
128930973|NCT03598777|464036630|FG001|Overall Study|Lost to Follow-up|0|||
128930974|NCT03598777|464036631|FG002|Overall Study|Lost to Follow-up|0|||
128702463|NCT02732119|463209362|FG003|Phase II|Physician Decision|8|||
128702464|NCT02732119|463209363|FG004|Phase II|Physician Decision|5|||
128702465|NCT00003479|463209365|FG000|Overall Study|Not evaluable|3|||
128702466|NCT02128113|463209368|FG000|Overall Study|Withdrawal by Subject|3|||
128702467|NCT02128113|463209369|FG001|Overall Study|Withdrawal by Subject|1|||
128702468|NCT02128113|463209370|FG002|Overall Study|Withdrawal by Subject|0|||
128767535|NCT03015116|463440294|FG001|Overall Study|Physician Decision|1|||
128702469|NCT02128113|463209368|FG000|Overall Study|Protocol Violation|0|||
128702470|NCT02128113|463209369|FG001|Overall Study|Protocol Violation|1|||
128702471|NCT02128113|463209370|FG002|Overall Study|Protocol Violation|0|||
128702472|NCT02128113|463209368|FG000|Overall Study|Surgery cancelled|0|||
128702473|NCT02128113|463209369|FG001|Overall Study|Surgery cancelled|1|||
128702474|NCT02128113|463209370|FG002|Overall Study|Surgery cancelled|0|||
128702475|NCT02128113|463209368|FG000|Overall Study|Adverse Event|0|||
128702476|NCT02128113|463209369|FG001|Overall Study|Adverse Event|0|||
128702477|NCT02128113|463209370|FG002|Overall Study|Adverse Event|1|||
128702478|NCT01061177|463209371|FG000|Overall Study|Adverse Event|117|||
128702479|NCT01061177|463209371|FG000|Overall Study|Withdrawal by Subject|27|||
128702480|NCT01061177|463209371|FG000|Overall Study|Disease progression|17|||
128702481|NCT01061177|463209371|FG000|Overall Study|Protocol Violation|11|||
128930975|NCT03598777|464036632|FG003|Overall Study|Lost to Follow-up|0|||
128930976|NCT03598777|464036633|FG004|Overall Study|Lost to Follow-up|0|||
128930977|NCT00072189|464036634|FG000|Overall Study|Withdrawal by Subject|1|||
128930978|NCT00144300|464036635|FG000|Overall Study|Adverse Event|18|||
128930979|NCT00144300|464036636|FG001|Overall Study|Adverse Event|16|||
128930980|NCT00144300|464036635|FG000|Overall Study|Protocol Violation|1|||
128930981|NCT00144300|464036636|FG001|Overall Study|Protocol Violation|3|||
128930982|NCT00144300|464036635|FG000|Overall Study|Lost to Follow-up|3|||
128930983|NCT00144300|464036636|FG001|Overall Study|Lost to Follow-up|0|||
128930984|NCT00144300|464036635|FG000|Overall Study|Withdrawal by Subject|6|||
128930985|NCT00144300|464036636|FG001|Overall Study|Withdrawal by Subject|6|||
129216606|NCT04145349|465094722|FG000|Overall Study|Withdrawal by Subject|3|||
129216607|NCT04145349|465094723|FG001|Overall Study|Withdrawal by Subject|0|||
129216608|NCT04145349|465094722|FG000|Overall Study|Lost to Follow-up|0|||
129216609|NCT04145349|465094723|FG001|Overall Study|Lost to Follow-up|1|||
129216610|NCT04145349|465094722|FG000|Overall Study|On study treatment (Ongoing)|0|||
129216611|NCT04145349|465094723|FG001|Overall Study|On study treatment (Ongoing)|1|||
129216612|NCT01148979|465094733|FG000|Overall Study|Lost to Follow-up|0|||
129216613|NCT01148979|465094734|FG001|Overall Study|Lost to Follow-up|1|||
129216614|NCT00775190|465094735|FG000|Overall Study|Lost to Follow-up|2|||
129216615|NCT00775190|465094736|FG001|Overall Study|Lost to Follow-up|3|||
129216616|NCT00775190|465094735|FG000|Overall Study|Withdrawal by Subject|1|||
129216617|NCT00775190|465094736|FG001|Overall Study|Withdrawal by Subject|2|||
129216618|NCT00775190|465094735|FG000|Overall Study|Protocol Violation|1|||
129216619|NCT00775190|465094736|FG001|Overall Study|Protocol Violation|0|||
129216620|NCT04610281|465094741|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
129216621|NCT04610281|465094742|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
129216622|NCT00918255|465094744|FG000|Overall Study|Adverse Event|1|||
129216623|NCT00918255|465094745|FG001|Overall Study|Adverse Event|0|||
129216624|NCT00918255|465094746|FG002|Overall Study|Adverse Event|0|||
129216625|NCT00918255|465094744|FG000|Overall Study|Withdrawal by Subject|1|||
129216626|NCT00918255|465094745|FG001|Overall Study|Withdrawal by Subject|0|||
129216627|NCT00918255|465094746|FG002|Overall Study|Withdrawal by Subject|2|||
129216628|NCT00918255|465094744|FG000|Overall Study|Lack of Efficacy|1|||
129216629|NCT00918255|465094745|FG001|Overall Study|Lack of Efficacy|0|||
129216630|NCT00918255|465094746|FG002|Overall Study|Lack of Efficacy|0|||
129216631|NCT00918255|465094744|FG000|Overall Study|Lost to Follow-up|1|||
129216632|NCT00918255|465094745|FG001|Overall Study|Lost to Follow-up|0|||
129216633|NCT00918255|465094746|FG002|Overall Study|Lost to Follow-up|2|||
129216634|NCT00918255|465094744|FG000|Overall Study|Exceeded allowed number of interventions|0|||
129216635|NCT00918255|465094745|FG001|Overall Study|Exceeded allowed number of interventions|0|||
129216636|NCT00918255|465094746|FG002|Overall Study|Exceeded allowed number of interventions|1|||
128702482|NCT01061177|463209371|FG000|Overall Study|Lost to Follow-up|9|||
128702483|NCT01061177|463209371|FG000|Overall Study|New cancer therapy|9|||
128702484|NCT01061177|463209371|FG000|Overall Study|Abnormal laboratory values|6|||
128702485|NCT01061177|463209371|FG000|Overall Study|Abnormal test procedure results|4|||
128702486|NCT01061177|463209371|FG000|Overall Study|Administratie problems|4|||
128702487|NCT01061177|463209371|FG000|Overall Study|Death|4|||
128702488|NCT00587054|463209372|FG000|Overall Study|Patient not treated|9|||
128702489|NCT02099708|463209400|FG000|Overall Study|Data Not Available|30|||
128702490|NCT02099708|463209400|FG000|Overall Study|Lost to Follow-up|141|||
128702491|NCT02099708|463209400|FG000|Overall Study|Other|29|||
128702492|NCT05466682|463209404|FG000|Overall Study|Withdrawal by Subject|0|||
128702493|NCT05466682|463209405|FG001|Overall Study|Withdrawal by Subject|2|||
128702494|NCT05466682|463209404|FG000|Overall Study|Lost to Follow-up|2|||
128702495|NCT05466682|463209405|FG001|Overall Study|Lost to Follow-up|1|||
128702496|NCT01697566|463209406|FG000|Overall Study|Withdrawal by Subject|0|||
128702497|NCT01697566|463209407|FG001|Overall Study|Withdrawal by Subject|0|||
128702498|NCT01697566|463209408|FG002|Overall Study|Withdrawal by Subject|1|||
128702499|NCT01697566|463209409|FG003|Overall Study|Withdrawal by Subject|1|||
128702500|NCT01697566|463209406|FG000|Overall Study|Final biopsy not obtained|0|||
128702501|NCT01697566|463209407|FG001|Overall Study|Final biopsy not obtained|0|||
128702502|NCT01697566|463209408|FG002|Overall Study|Final biopsy not obtained|1|||
128702503|NCT01697566|463209409|FG003|Overall Study|Final biopsy not obtained|0|||
128702504|NCT01930123|463209410|FG000|Overall Study|Adverse Event|1|||
128767536|NCT03015116|463440295|FG002|Overall Study|Physician Decision|0|||
128767537|NCT02200939|463440297|FG000|Overall Study|Participant withdrew consent|0|||
128702505|NCT01930123|463209411|FG001|Overall Study|Adverse Event|0|||
128702506|NCT01930123|463209410|FG000|Overall Study|Physician Decision|21|||
128702507|NCT01930123|463209411|FG001|Overall Study|Physician Decision|8|||
128702508|NCT01930123|463209410|FG000|Overall Study|Withdrawal by Subject|1|||
128702509|NCT01930123|463209411|FG001|Overall Study|Withdrawal by Subject|0|||
128702510|NCT01447433|463209414|FG000|Overall Study|Lost to Follow-up|0|||
128702511|NCT01447433|463209415|FG001|Overall Study|Lost to Follow-up|2|||
128930986|NCT00144300|464036635|FG000|Overall Study|Other reason (not specified)|1|||
128930987|NCT00144300|464036636|FG001|Overall Study|Other reason (not specified)|3|||
128930988|NCT01933672|464036637|FG000|Metformin Run-in Period|Adverse Event|1|||
128702512|NCT01447433|463209414|FG000|Overall Study|Withdrawal by Subject|3|||
128702513|NCT01447433|463209415|FG001|Overall Study|Withdrawal by Subject|3|||
128702514|NCT01447433|463209414|FG000|Overall Study|Protocol Violation|1|||
128702515|NCT01447433|463209415|FG001|Overall Study|Protocol Violation|1|||
128702516|NCT00036270|463209416|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
128702517|NCT00036270|463209417|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
128702518|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
128702519|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
128702520|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
128702521|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
128702522|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
128702523|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
128702524|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Other|277|||
128702525|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Other|288|||
128702526|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
128702527|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
128702528|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
128702529|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
128702530|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
128702531|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
128702532|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
128930989|NCT01933672|464036638|FG001|Metformin Run-in Period|Adverse Event|0|||
128930990|NCT01933672|464036639|FG002|Metformin Run-in Period|Adverse Event|0|||
128930991|NCT01933672|464036640|FG003|Metformin Run-in Period|Adverse Event|0|||
128930992|NCT01933672|464036641|FG004|Metformin Run-in Period|Adverse Event|0|||
128930993|NCT01933672|464036642|FG005|Metformin Run-in Period|Adverse Event|0|||
128930994|NCT01933672|464036643|FG006|Metformin Run-in Period|Adverse Event|0|||
128930995|NCT01933672|464036637|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
128930996|NCT01933672|464036638|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
128930997|NCT01933672|464036639|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
128930998|NCT01933672|464036640|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
128930999|NCT01933672|464036641|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
128931000|NCT01933672|464036642|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
128931001|NCT01933672|464036643|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
128931002|NCT01933672|464036637|FG000|Metformin Run-in Period|Other|5|||
128931003|NCT01933672|464036638|FG001|Metformin Run-in Period|Other|0|||
128931004|NCT01933672|464036639|FG002|Metformin Run-in Period|Other|0|||
128931005|NCT01933672|464036640|FG003|Metformin Run-in Period|Other|0|||
128931006|NCT01933672|464036641|FG004|Metformin Run-in Period|Other|0|||
128931007|NCT01933672|464036642|FG005|Metformin Run-in Period|Other|0|||
128931008|NCT01933672|464036643|FG006|Metformin Run-in Period|Other|0|||
128931009|NCT01933672|464036637|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931010|NCT01933672|464036638|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931011|NCT01933672|464036639|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931012|NCT01933672|464036640|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931013|NCT01933672|464036641|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
128931014|NCT01933672|464036642|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931015|NCT01933672|464036643|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931016|NCT01933672|464036637|FG000|First Intervention Period (12-16 Days)|Other|0|||
128931017|NCT01933672|464036638|FG001|First Intervention Period (12-16 Days)|Other|0|||
128931018|NCT01933672|464036639|FG002|First Intervention Period (12-16 Days)|Other|1|||
128931019|NCT01933672|464036640|FG003|First Intervention Period (12-16 Days)|Other|0|||
128931020|NCT01933672|464036641|FG004|First Intervention Period (12-16 Days)|Other|0|||
128931021|NCT01933672|464036642|FG005|First Intervention Period (12-16 Days)|Other|1|||
128931022|NCT01933672|464036643|FG006|First Intervention Period (12-16 Days)|Other|0|||
128931023|NCT01933672|464036637|FG000|Second Intervention Period (12-16 Days)|Other|0|||
128931024|NCT01933672|464036638|FG001|Second Intervention Period (12-16 Days)|Other|1|||
128931025|NCT01933672|464036639|FG002|Second Intervention Period (12-16 Days)|Other|1|||
128931026|NCT01933672|464036640|FG003|Second Intervention Period (12-16 Days)|Other|0|||
128931027|NCT01933672|464036641|FG004|Second Intervention Period (12-16 Days)|Other|0|||
128931028|NCT01933672|464036642|FG005|Second Intervention Period (12-16 Days)|Other|0|||
128931029|NCT01933672|464036643|FG006|Second Intervention Period (12-16 Days)|Other|0|||
128931030|NCT01933672|464036637|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931031|NCT01933672|464036638|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129030566|NCT02046122|464403176|FG000|Overall Study|Physician Decision|8|||
129030567|NCT02046122|464403176|FG000|Overall Study|Withdrawal by Subject|1|||
129030568|NCT01559116|464403179|FG000|Overall Study|Adverse Event|10|||
128702533|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
128702534|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
128702535|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
128702536|NCT00036270|463209416|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
128702537|NCT00036270|463209417|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
128702538|NCT01964430|463209418|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
128702539|NCT01964430|463209419|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
128702540|NCT01964430|463209418|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
128702541|NCT01964430|463209419|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
128702542|NCT01964430|463209418|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
128702543|NCT01964430|463209419|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
128702544|NCT01964430|463209418|FG000|Treatment Period|Adverse Event|71|||
128702545|NCT01964430|463209419|FG001|Treatment Period|Adverse Event|37|||
128702546|NCT01964430|463209418|FG000|Treatment Period|Withdrawal by Subject|36|||
128702547|NCT01964430|463209419|FG001|Treatment Period|Withdrawal by Subject|27|||
128702548|NCT01964430|463209418|FG000|Treatment Period|Death|1|||
128702549|NCT01964430|463209419|FG001|Treatment Period|Death|3|||
128702550|NCT01964430|463209418|FG000|Treatment Period|Protocol Deviation|0|||
128702551|NCT01964430|463209419|FG001|Treatment Period|Protocol Deviation|1|||
128702552|NCT01964430|463209418|FG000|Treatment Period|Physician Decision|5|||
128702553|NCT01964430|463209419|FG001|Treatment Period|Physician Decision|4|||
128702554|NCT01964430|463209418|FG000|Treatment Period|Disease Relapse|28|||
128702555|NCT01964430|463209419|FG001|Treatment Period|Disease Relapse|38|||
128702556|NCT01964430|463209418|FG000|Treatment Period|Other reasons|1|||
128702557|NCT01964430|463209419|FG001|Treatment Period|Other reasons|3|||
128702558|NCT02516163|463209420|FG000|Overall Study|Withdrawal by Subject|1|||
128702559|NCT02516163|463209420|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
128702560|NCT02516163|463209420|FG000|Overall Study|Unfit/delay in surgery|3|||
128702561|NCT02516163|463209420|FG000|Overall Study|Use of incorrect measurement technique|5|||
128702562|NCT02516163|463209420|FG000|Overall Study|Data not recorded|2|||
128702563|NCT02516163|463209420|FG000|Overall Study|MRI contraindication exclusion|6|||
128702564|NCT02801396|463209421|FG000|Period 1|Withdrawal by Subject|0|||
128931032|NCT01933672|464036639|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931033|NCT01933672|464036640|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
128931034|NCT01933672|464036641|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931035|NCT01933672|464036642|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931036|NCT01933672|464036643|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
128931037|NCT01933672|464036637|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
128702565|NCT02801396|463209422|FG001|Period 1|Withdrawal by Subject|0|||
128702566|NCT02801396|463209423|FG002|Period 1|Withdrawal by Subject|0|||
128702567|NCT02801396|463209424|FG003|Period 1|Withdrawal by Subject|0|||
128702568|NCT02801396|463209425|FG004|Period 1|Withdrawal by Subject|1|||
128702569|NCT02801396|463209426|FG005|Period 1|Withdrawal by Subject|0|||
128702570|NCT01658072|463209429|FG000|Overall Study|Protocol Violation|4|||
128702571|NCT01658072|463209430|FG001|Overall Study|Protocol Violation|2|||
128702572|NCT01874054|463209432|FG000|Overall Study|Withdrawal by Subject|3|||
128702573|NCT01874054|463209432|FG000|Overall Study|Study Termination by Sponsor|42|||
128702574|NCT01874054|463209432|FG000|Overall Study|Lost to Follow-up|5|||
128702575|NCT01874054|463209432|FG000|Overall Study|Death|5|||
128702576|NCT00702923|463209433|FG000|Overall Study|Adverse Event|1|||
128702577|NCT03953820|463209435|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
128702578|NCT03953820|463209436|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
128702579|NCT03953820|463209437|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
128702580|NCT03953820|463209435|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
128931038|NCT01933672|464036638|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
128702581|NCT03953820|463209436|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
128702582|NCT03953820|463209437|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
128702583|NCT00799422|463209444|FG000|First Week of Wear|Lost to Follow-up|0|||
128702584|NCT00799422|463209445|FG001|First Week of Wear|Lost to Follow-up|0|||
128702585|NCT00799422|463209446|FG002|First Week of Wear|Lost to Follow-up|1|||
128931039|NCT01933672|464036639|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
129120610|NCT01140906|464739009|FG000|Overall Study|Protocol Violation|5|||
129120611|NCT01140906|464739010|FG001|Overall Study|Protocol Violation|3|||
129120612|NCT01140906|464739011|FG002|Overall Study|Protocol Violation|2|||
129120613|NCT01140906|464739012|FG003|Overall Study|Protocol Violation|1|||
129120614|NCT01140906|464739009|FG000|Overall Study|Withdrawal of consent|6|||
128702586|NCT00799422|463209447|FG003|First Week of Wear|Lost to Follow-up|0|||
128702587|NCT00799422|463209448|FG004|First Week of Wear|Lost to Follow-up|0|||
128702588|NCT00799422|463209449|FG005|First Week of Wear|Lost to Follow-up|0|||
128702589|NCT00799422|463209444|FG000|First Week of Wear|Adverse Event|0|||
128931040|NCT01933672|464036640|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
128702590|NCT00799422|463209445|FG001|First Week of Wear|Adverse Event|0|||
128702591|NCT00799422|463209446|FG002|First Week of Wear|Adverse Event|0|||
128702592|NCT00799422|463209447|FG003|First Week of Wear|Adverse Event|1|||
128702593|NCT00799422|463209448|FG004|First Week of Wear|Adverse Event|0|||
129120615|NCT01140906|464739010|FG001|Overall Study|Withdrawal of consent|6|||
129120616|NCT01140906|464739011|FG002|Overall Study|Withdrawal of consent|2|||
129120617|NCT01140906|464739012|FG003|Overall Study|Withdrawal of consent|2|||
129120618|NCT01140906|464739009|FG000|Overall Study|Lost to Follow-up|1|||
129120619|NCT01140906|464739010|FG001|Overall Study|Lost to Follow-up|1|||
129120620|NCT01140906|464739011|FG002|Overall Study|Lost to Follow-up|0|||
129120621|NCT01140906|464739012|FG003|Overall Study|Lost to Follow-up|2|||
129120622|NCT01140906|464739009|FG000|Overall Study|Administrative or other reason|0|||
129120623|NCT01140906|464739010|FG001|Overall Study|Administrative or other reason|5|||
129120624|NCT01140906|464739011|FG002|Overall Study|Administrative or other reason|3|||
129120625|NCT01140906|464739012|FG003|Overall Study|Administrative or other reason|2|||
129120626|NCT00703534|464739013|FG000|Overall Study|Adverse Event|14|||
129120627|NCT00703534|464739014|FG001|Overall Study|Adverse Event|3|||
129120628|NCT00703534|464739013|FG000|Overall Study|Withdrawal by Subject|8|||
129120629|NCT00703534|464739014|FG001|Overall Study|Withdrawal by Subject|7|||
129120630|NCT00703534|464739013|FG000|Overall Study|Incorrect Enrollment|6|||
129120631|NCT00703534|464739014|FG001|Overall Study|Incorrect Enrollment|6|||
129120632|NCT00703534|464739013|FG000|Overall Study|Lost to Follow-up|1|||
129120633|NCT00703534|464739014|FG001|Overall Study|Lost to Follow-up|4|||
129120634|NCT00703534|464739013|FG000|Overall Study|Severe Non Compliance|1|||
129120635|NCT00703534|464739014|FG001|Overall Study|Severe Non Compliance|5|||
129120636|NCT00336544|464739015|FG000|Overall Study|Lack of Efficacy|8|||
129120637|NCT00336544|464739016|FG001|Overall Study|Lack of Efficacy|5|||
129120638|NCT00336544|464739015|FG000|Overall Study|Adverse Event|4|||
129120639|NCT00336544|464739016|FG001|Overall Study|Adverse Event|9|||
129120640|NCT00336544|464739015|FG000|Overall Study|Withdrawal by Subject|4|||
129120641|NCT00336544|464739016|FG001|Overall Study|Withdrawal by Subject|3|||
129120642|NCT00336544|464739015|FG000|Overall Study|Other|3|||
129120643|NCT00336544|464739016|FG001|Overall Study|Other|5|||
129120644|NCT01649765|464739017|FG000|Overall Study|Adverse Event|5|||
129120645|NCT01649765|464739018|FG001|Overall Study|Adverse Event|3|||
129120646|NCT01649765|464739017|FG000|Overall Study|Lack of Efficacy|1|||
129120647|NCT01649765|464739018|FG001|Overall Study|Lack of Efficacy|1|||
129120648|NCT01649765|464739017|FG000|Overall Study|Physician Decision|0|||
129120649|NCT01649765|464739018|FG001|Overall Study|Physician Decision|3|||
129120650|NCT01649765|464739017|FG000|Overall Study|Protocol Violation|1|||
129120651|NCT01649765|464739018|FG001|Overall Study|Protocol Violation|0|||
129120652|NCT01649765|464739017|FG000|Overall Study|Withdrawal by Subject|2|||
129120653|NCT01649765|464739018|FG001|Overall Study|Withdrawal by Subject|1|||
129120654|NCT01316614|464739019|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
129120655|NCT01316614|464739019|FG000|Overall Study|Cytology slides not available for review|4|||
129120656|NCT01316614|464739019|FG000|Overall Study|Cystic lesion|5|||
129120657|NCT01316614|464739019|FG000|Overall Study|Inadequate number of passes|2|||
129120658|NCT01316614|464739019|FG000|Overall Study|Medically unstable|1|||
129120659|NCT03427411|464739020|FG000|Overall Study|Screen failure - platelets too low|0|||
129120660|NCT03427411|464739021|FG001|Overall Study|Screen failure - platelets too low|1|||
129120661|NCT00076570|464739022|FG000|Overall Study|Drug intolerance|8|||
129120662|NCT00076570|464739023|FG001|Overall Study|Drug intolerance|8|||
129120663|NCT04889040|464739024|FG000|Overall Study|Withdrawal by Subject|3|||
129120664|NCT04889040|464739025|FG001|Overall Study|Withdrawal by Subject|3|||
129120665|NCT04889040|464739024|FG000|Overall Study|Lost to Follow-up|0|||
129120666|NCT04889040|464739025|FG001|Overall Study|Lost to Follow-up|1|||
129120667|NCT04889040|464739024|FG000|Overall Study|Adverse Event|2|||
129120668|NCT04889040|464739025|FG001|Overall Study|Adverse Event|1|||
129120669|NCT02058095|464739026|FG000|Overall Study|Adverse Event|1|||
129120670|NCT02058095|464739027|FG001|Overall Study|Adverse Event|0|||
129120671|NCT00998946|464739028|FG000|Overall Study|Lost to Follow-up|1|||
129120672|NCT00998946|464739028|FG000|Overall Study|Withdrawal by Subject|1|||
129120673|NCT00998946|464739028|FG000|Overall Study|Death|2|||
129120674|NCT00998946|464739028|FG000|Overall Study|Reason Unspecified|3|||
129120675|NCT00998946|464739028|FG000|Overall Study|Enrolled but not Dosed|2|||
129120676|NCT00977197|464739031|FG000|Overall Study|Withdrawal by Subject|3|||
129120677|NCT00977197|464739032|FG001|Overall Study|Withdrawal by Subject|4|||
129120678|NCT00977197|464739031|FG000|Overall Study|Adverse Event|3|||
129120679|NCT00977197|464739032|FG001|Overall Study|Adverse Event|1|||
129120680|NCT00977197|464739031|FG000|Overall Study|Lack of Efficacy|1|||
129120681|NCT00977197|464739032|FG001|Overall Study|Lack of Efficacy|0|||
129120682|NCT00977197|464739031|FG000|Overall Study|Lost to Follow-up|1|||
129120683|NCT00977197|464739032|FG001|Overall Study|Lost to Follow-up|3|||
129120684|NCT00977197|464739031|FG000|Overall Study|Nonadherence|1|||
129120685|NCT00977197|464739032|FG001|Overall Study|Nonadherence|1|||
129120686|NCT02842866|464739033|FG000|Overall Study|Serious Adverse Event|0|||
129120687|NCT02842866|464739034|FG001|Overall Study|Serious Adverse Event|1|||
129120688|NCT02842866|464739033|FG000|Overall Study|Protocol Violation|4|||
129120689|NCT02842866|464739034|FG001|Overall Study|Protocol Violation|2|||
129120690|NCT02842866|464739033|FG000|Overall Study|Lost to Follow-up|2|||
129120691|NCT02842866|464739034|FG001|Overall Study|Lost to Follow-up|0|||
129120692|NCT02842866|464739033|FG000|Overall Study|Withdrawal by Subject|1|||
128931041|NCT01933672|464036641|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
128931042|NCT01933672|464036642|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
128931043|NCT01933672|464036643|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
128931044|NCT00778999|464036653|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
128931045|NCT00778999|464036654|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
128931046|NCT00778999|464036653|FG000|Overall Study|Did not receive recFSH|14|||
128931047|NCT00778999|464036654|FG001|Overall Study|Did not receive recFSH|20|||
128931048|NCT02032524|464036655|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
128931049|NCT02032524|464036656|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
128931050|NCT02032524|464036657|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
128931051|NCT02032524|464036658|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
128931052|NCT02032524|464036659|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
128931053|NCT02032524|464036660|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
128931054|NCT02032524|464036655|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
128931055|NCT02032524|464036656|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
128931056|NCT02032524|464036657|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
128931057|NCT02032524|464036658|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
128931058|NCT02032524|464036659|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
128931059|NCT02032524|464036660|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
128931060|NCT02032524|464036655|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
128931061|NCT02032524|464036656|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
128931062|NCT02032524|464036657|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
128931063|NCT02032524|464036658|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
128931064|NCT02032524|464036659|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
128931065|NCT02032524|464036660|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
129120693|NCT02842866|464739034|FG001|Overall Study|Withdrawal by Subject|0|||
129120694|NCT00577408|464739035|FG000|Overall Study|Stopped attending study visits|9|||
129120695|NCT00577408|464739036|FG001|Overall Study|Stopped attending study visits|11|||
129120696|NCT00577408|464739035|FG000|Overall Study|Continued opioid use|3|||
129120697|NCT00577408|464739036|FG001|Overall Study|Continued opioid use|2|||
129120698|NCT00577408|464739035|FG000|Overall Study|Non-compliance with study meds|0|||
129120699|NCT00577408|464739036|FG001|Overall Study|Non-compliance with study meds|3|||
129120700|NCT00577408|464739035|FG000|Overall Study|Refused Oral Naltrexone|0|||
129120701|NCT00577408|464739036|FG001|Overall Study|Refused Oral Naltrexone|1|||
129120702|NCT00577408|464739035|FG000|Overall Study|Moved out of state|0|||
129120703|NCT00577408|464739036|FG001|Overall Study|Moved out of state|1|||
129120704|NCT00577408|464739035|FG000|Overall Study|Scheduling Issues|0|||
129120705|NCT00577408|464739036|FG001|Overall Study|Scheduling Issues|3|||
129120706|NCT00577408|464739035|FG000|Overall Study|Death|0|||
129120707|NCT00577408|464739036|FG001|Overall Study|Death|1|||
129120708|NCT00577408|464739035|FG000|Overall Study|Psychiatric hospitalization|0|||
129120709|NCT00577408|464739036|FG001|Overall Study|Psychiatric hospitalization|1|||
129120710|NCT00656617|464739037|FG000|Overall Study|Adverse Event|1|||
129120711|NCT00656617|464739037|FG000|Overall Study|Death|2|||
129120712|NCT00656617|464739037|FG000|Overall Study|Insurance Issues|2|||
129120713|NCT00656617|464739037|FG000|Overall Study|Move to different clinical trial|2|||
129120714|NCT02349386|464739046|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
129120715|NCT02349386|464739047|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
129120716|NCT02349386|464739048|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
129120717|NCT02349386|464739049|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
129120718|NCT02349386|464739046|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
129120719|NCT02349386|464739047|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
129120720|NCT02349386|464739048|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
129120721|NCT02349386|464739049|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
129120722|NCT02349386|464739046|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
129120723|NCT02349386|464739047|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
128931066|NCT02032524|464036655|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
128931067|NCT02032524|464036656|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
128931068|NCT02032524|464036657|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
128931069|NCT02032524|464036658|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
128931070|NCT02032524|464036659|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
128931071|NCT02032524|464036660|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
128931072|NCT02032524|464036655|FG000|Period 2: LTS13769 Study|Other|0|||
128931073|NCT02032524|464036656|FG001|Period 2: LTS13769 Study|Other|0|||
129120724|NCT02349386|464739048|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
129120725|NCT02349386|464739049|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
129120726|NCT02349386|464739046|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
129120727|NCT02349386|464739047|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
129120728|NCT02349386|464739048|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
129132910|NCT02609633|464778564|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
129132911|NCT02609633|464778565|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
128931074|NCT02032524|464036657|FG002|Period 2: LTS13769 Study|Other|0|||
128931075|NCT02032524|464036658|FG003|Period 2: LTS13769 Study|Other|0|||
128931076|NCT02032524|464036659|FG004|Period 2: LTS13769 Study|Other|0|||
128931077|NCT02032524|464036660|FG005|Period 2: LTS13769 Study|Other|1|||
128931078|NCT02975349|464036661|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128931079|NCT02975349|464036662|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128931080|NCT02975349|464036663|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129030569|NCT01559116|464403179|FG000|Overall Study|Lack of Efficacy|1|||
129030570|NCT01559116|464403179|FG000|Overall Study|Lost to Follow-up|1|||
129216637|NCT00918255|465094744|FG000|Overall Study|Non-compliance|1|||
129216638|NCT00918255|465094745|FG001|Overall Study|Non-compliance|0|||
129216639|NCT00918255|465094746|FG002|Overall Study|Non-compliance|0|||
129216640|NCT00918255|465094744|FG000|Overall Study|Investigator discretion|1|||
129216641|NCT00918255|465094745|FG001|Overall Study|Investigator discretion|0|||
129216642|NCT00918255|465094746|FG002|Overall Study|Investigator discretion|0|||
129216643|NCT03557034|465094747|FG000|Overall Study|Withdrawal by Subject|1|||
129216644|NCT03557034|465094748|FG001|Overall Study|Withdrawal by Subject|0|||
129216645|NCT00719472|465094749|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
129216646|NCT00719472|465094749|FG000|Enrolled in Study|Subject decision to withdraw|8|||
128931081|NCT02975349|464036664|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
129030571|NCT01559116|464403179|FG000|Overall Study|Protocol Violation|1|||
129030572|NCT01559116|464403179|FG000|Overall Study|Withdrawal by Subject|4|||
129030573|NCT01559116|464403179|FG000|Overall Study|other than stated above|9|||
129030574|NCT01196390|464403180|FG000|Overall Study|Protocol Violation|4|||
129030575|NCT01196390|464403181|FG001|Overall Study|Protocol Violation|5|||
129030576|NCT01532908|464403182|FG000|Overall Study|Not Transplanted|1|||
129030577|NCT01532908|464403183|FG001|Overall Study|Not Transplanted|0|||
129030578|NCT04610580|464403184|FG000|Two-way Crossover Period|Adverse Event|1|||
129030579|NCT04610580|464403185|FG001|Two-way Crossover Period|Adverse Event|0|||
129030580|NCT04610580|464403186|FG002|Two-way Crossover Period|Adverse Event|0|||
129030581|NCT04610580|464403187|FG003|Two-way Crossover Period|Adverse Event|0|||
129030582|NCT04610580|464403188|FG004|Two-way Crossover Period|Adverse Event|0|||
129216647|NCT00719472|465094749|FG000|Enrolled in Study|Various Reasons|17|||
129216648|NCT00719472|465094749|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
128702594|NCT00799422|463209449|FG005|First Week of Wear|Adverse Event|0|||
128702595|NCT00291577|463209450|FG000|Overall Study|Adverse Event|1|||
128702596|NCT00291577|463209450|FG000|Overall Study|Other|4|||
128931082|NCT02975349|464036665|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
128931083|NCT02975349|464036666|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128931084|NCT02975349|464036667|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128931085|NCT02975349|464036661|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
128931086|NCT02975349|464036662|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128931087|NCT02975349|464036663|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128931088|NCT02975349|464036664|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128931089|NCT02975349|464036665|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128931090|NCT02975349|464036666|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128931091|NCT02975349|464036667|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128931092|NCT02975349|464036661|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
128931093|NCT02975349|464036662|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
128931094|NCT02975349|464036663|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
128931095|NCT02975349|464036664|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
128931096|NCT02975349|464036665|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
128931097|NCT02975349|464036666|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
128931098|NCT02975349|464036667|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
128931099|NCT02975349|464036661|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
128931100|NCT02975349|464036662|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
128931101|NCT02975349|464036663|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
128931102|NCT02975349|464036664|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
128931103|NCT02975349|464036665|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
128931104|NCT02975349|464036666|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
128931105|NCT02975349|464036667|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
128931106|NCT02975349|464036661|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
128931107|NCT02975349|464036662|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
128931108|NCT02975349|464036663|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
128931109|NCT02975349|464036664|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
128931110|NCT02975349|464036665|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
128931111|NCT02975349|464036666|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
128931112|NCT02975349|464036667|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
128931113|NCT02975349|464036661|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
129030583|NCT04610580|464403189|FG005|Two-way Crossover Period|Adverse Event|0|||
129030584|NCT04610580|464403184|FG000|Two-way Crossover Period|Physician Decision|1|||
128702597|NCT00291577|463209450|FG000|Overall Study|Withdrawal by Subject|2|||
129120729|NCT02349386|464739049|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
129120730|NCT02349386|464739046|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
129120731|NCT02349386|464739047|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
129120732|NCT02349386|464739048|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
129120733|NCT02349386|464739049|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
129120734|NCT02349386|464739046|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
129120735|NCT02349386|464739047|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
129120736|NCT02349386|464739048|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
129120737|NCT02349386|464739049|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
129120738|NCT00676143|464739050|FG000|Overall Study|Adverse Event|34|||
129120739|NCT00676143|464739051|FG001|Overall Study|Adverse Event|60|||
129120740|NCT00676143|464739050|FG000|Overall Study|Death|4|||
129120741|NCT00676143|464739051|FG001|Overall Study|Death|4|||
129120742|NCT00676143|464739050|FG000|Overall Study|Lack of Efficacy|0|||
129120743|NCT00676143|464739051|FG001|Overall Study|Lack of Efficacy|6|||
129120744|NCT00676143|464739050|FG000|Overall Study|Lost to Follow-up|0|||
129120745|NCT00676143|464739051|FG001|Overall Study|Lost to Follow-up|13|||
129120746|NCT00676143|464739050|FG000|Overall Study|Physician Decision|5|||
129120747|NCT00676143|464739051|FG001|Overall Study|Physician Decision|8|||
129120748|NCT00676143|464739050|FG000|Overall Study|Protocol Violation|4|||
129120749|NCT00676143|464739051|FG001|Overall Study|Protocol Violation|8|||
129120750|NCT00676143|464739050|FG000|Overall Study|Withdrawal by Subject|24|||
129120751|NCT00676143|464739051|FG001|Overall Study|Withdrawal by Subject|42|||
129120752|NCT00676143|464739050|FG000|Overall Study|Discontinuation of study by sponsor|65|||
129120753|NCT00676143|464739051|FG001|Overall Study|Discontinuation of study by sponsor|88|||
129120754|NCT00676143|464739050|FG000|Overall Study|Failed to return|2|||
129120755|NCT00676143|464739051|FG001|Overall Study|Failed to return|1|||
129120756|NCT00676143|464739050|FG000|Overall Study|Loss of caregiver|5|||
129120757|NCT00676143|464739051|FG001|Overall Study|Loss of caregiver|3|||
129120758|NCT00676143|464739050|FG000|Overall Study|Other|11|||
129120759|NCT00676143|464739051|FG001|Overall Study|Other|20|||
129120760|NCT00676143|464739050|FG000|Overall Study|Participant participation unknown|1|||
129120761|NCT00676143|464739051|FG001|Overall Study|Participant participation unknown|4|||
129120762|NCT00676143|464739050|FG000|Overall Study|Vasogenic edema recurrence|1|||
129120763|NCT00676143|464739051|FG001|Overall Study|Vasogenic edema recurrence|3|||
129120764|NCT01901185|464739052|FG000|Overall Study|Withdrawal by Subject|2|||
129120765|NCT02309359|464739055|FG000|Overall Study|Adverse Event|4|||
129120766|NCT02309359|464739056|FG001|Overall Study|Adverse Event|5|||
129120767|NCT02309359|464739057|FG002|Overall Study|Adverse Event|5|||
129120768|NCT02309359|464739058|FG003|Overall Study|Adverse Event|4|||
129120769|NCT02309359|464739059|FG004|Overall Study|Adverse Event|4|||
129120770|NCT02309359|464739055|FG000|Overall Study|Death|1|||
129120771|NCT02309359|464739056|FG001|Overall Study|Death|0|||
129120772|NCT02309359|464739057|FG002|Overall Study|Death|0|||
129120773|NCT02309359|464739058|FG003|Overall Study|Death|0|||
129120774|NCT02309359|464739059|FG004|Overall Study|Death|0|||
129120775|NCT02309359|464739055|FG000|Overall Study|Withdrawal by Subject|2|||
129120776|NCT02309359|464739056|FG001|Overall Study|Withdrawal by Subject|2|||
129120777|NCT02309359|464739057|FG002|Overall Study|Withdrawal by Subject|4|||
129120778|NCT02309359|464739058|FG003|Overall Study|Withdrawal by Subject|4|||
129120779|NCT02309359|464739059|FG004|Overall Study|Withdrawal by Subject|0|||
129120780|NCT02309359|464739055|FG000|Overall Study|Lack of Efficacy|3|||
129120781|NCT02309359|464739056|FG001|Overall Study|Lack of Efficacy|1|||
128931114|NCT02975349|464036662|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
128931115|NCT02975349|464036663|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
128931116|NCT02975349|464036664|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
128931117|NCT02975349|464036665|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
128931118|NCT02975349|464036666|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
128931119|NCT02975349|464036667|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
128931120|NCT02975349|464036661|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
128931121|NCT02975349|464036662|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
128931122|NCT02975349|464036663|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
128931123|NCT02975349|464036664|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
128931124|NCT02975349|464036665|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
128931125|NCT02975349|464036666|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
129120782|NCT02309359|464739057|FG002|Overall Study|Lack of Efficacy|0|||
129120783|NCT02309359|464739058|FG003|Overall Study|Lack of Efficacy|0|||
129120784|NCT02309359|464739059|FG004|Overall Study|Lack of Efficacy|3|||
129120785|NCT02309359|464739055|FG000|Overall Study|Lost to Follow-up|0|||
129120786|NCT02309359|464739056|FG001|Overall Study|Lost to Follow-up|0|||
129120787|NCT02309359|464739057|FG002|Overall Study|Lost to Follow-up|0|||
129120788|NCT02309359|464739058|FG003|Overall Study|Lost to Follow-up|1|||
129120789|NCT02309359|464739059|FG004|Overall Study|Lost to Follow-up|0|||
129120790|NCT02309359|464739055|FG000|Overall Study|Other|2|||
129120791|NCT02309359|464739056|FG001|Overall Study|Other|0|||
129120792|NCT02309359|464739057|FG002|Overall Study|Other|2|||
129120793|NCT02309359|464739058|FG003|Overall Study|Other|3|||
129120794|NCT02309359|464739059|FG004|Overall Study|Other|2|||
129120795|NCT00701363|464739061|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
129120796|NCT00701363|464739062|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
129120797|NCT00701363|464739063|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
129120798|NCT00701363|464739064|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
129120799|NCT00701363|464739061|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
129120800|NCT00701363|464739062|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
129120801|NCT00701363|464739063|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
129120802|NCT00701363|464739064|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
129120803|NCT00701363|464739061|FG000|Treatment Phase 1|Adverse Event|7|||
129120804|NCT00701363|464739062|FG001|Treatment Phase 1|Adverse Event|0|||
129120805|NCT00701363|464739063|FG002|Treatment Phase 1|Adverse Event|0|||
129120806|NCT00701363|464739064|FG003|Treatment Phase 1|Adverse Event|0|||
129120807|NCT00701363|464739061|FG000|Treatment Phase 1|Protocol Violation|1|||
129120808|NCT00701363|464739062|FG001|Treatment Phase 1|Protocol Violation|0|||
129120809|NCT00701363|464739063|FG002|Treatment Phase 1|Protocol Violation|0|||
129120810|NCT00701363|464739064|FG003|Treatment Phase 1|Protocol Violation|0|||
128931126|NCT02975349|464036667|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
128931127|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
128931128|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
128931129|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
128931130|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
128931131|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
128931132|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
128931133|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
128931134|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
128931135|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
128931136|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
128931137|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
128931138|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
128931139|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
128931140|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
128931141|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
128931142|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
128931143|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
128931144|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
128931145|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
128931146|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
128931147|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
128931148|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
128931149|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
128931150|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
128931151|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
128931152|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
128931153|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
128931154|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
128931155|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
128931156|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
128931157|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
128931158|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
128931159|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
128931160|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
128931161|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
128931162|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
128931163|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
128931164|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
128931165|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
129120811|NCT00701363|464739061|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
128931166|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
128931167|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
128931168|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
128931169|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
128931170|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
129120812|NCT00701363|464739062|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
129120813|NCT00701363|464739063|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
129120814|NCT00701363|464739064|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
129030585|NCT04610580|464403185|FG001|Two-way Crossover Period|Physician Decision|0|||
129030586|NCT04610580|464403186|FG002|Two-way Crossover Period|Physician Decision|0|||
129030587|NCT04610580|464403187|FG003|Two-way Crossover Period|Physician Decision|0|||
129030588|NCT04610580|464403188|FG004|Two-way Crossover Period|Physician Decision|0|||
129030589|NCT04610580|464403189|FG005|Two-way Crossover Period|Physician Decision|0|||
129030590|NCT04610580|464403184|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
129030591|NCT04610580|464403185|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
129030592|NCT04610580|464403186|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
129030593|NCT04610580|464403187|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
129030594|NCT04610580|464403188|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
129030595|NCT04610580|464403189|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
129030596|NCT04610580|464403184|FG000|Two-way Crossover Period|Other than specified|0|||
129030597|NCT04610580|464403185|FG001|Two-way Crossover Period|Other than specified|1|||
129030598|NCT04610580|464403186|FG002|Two-way Crossover Period|Other than specified|0|||
129030599|NCT04610580|464403187|FG003|Two-way Crossover Period|Other than specified|0|||
129030600|NCT04610580|464403188|FG004|Two-way Crossover Period|Other than specified|0|||
129030601|NCT04610580|464403189|FG005|Two-way Crossover Period|Other than specified|0|||
129030602|NCT04610580|464403184|FG000|Washout Before Extension Period|Other than specified|0|||
129030603|NCT04610580|464403185|FG001|Washout Before Extension Period|Other than specified|1|||
129030604|NCT04610580|464403186|FG002|Washout Before Extension Period|Other than specified|0|||
129030605|NCT04610580|464403187|FG003|Washout Before Extension Period|Other than specified|0|||
129030606|NCT04610580|464403188|FG004|Washout Before Extension Period|Other than specified|0|||
129030607|NCT04610580|464403189|FG005|Washout Before Extension Period|Other than specified|0|||
129030608|NCT04610580|464403184|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
129030609|NCT04610580|464403185|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
129030610|NCT04610580|464403186|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
129030611|NCT04610580|464403187|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
129030612|NCT04610580|464403188|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
129030613|NCT04610580|464403189|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
129030614|NCT04610580|464403184|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129030615|NCT04610580|464403185|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129030616|NCT04610580|464403186|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129030617|NCT04610580|464403187|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129120815|NCT00701363|464739061|FG000|Treatment Phase 1|Lack of Efficacy|1|||
129120816|NCT00701363|464739062|FG001|Treatment Phase 1|Lack of Efficacy|0|||
129120817|NCT00701363|464739063|FG002|Treatment Phase 1|Lack of Efficacy|0|||
129120818|NCT00701363|464739064|FG003|Treatment Phase 1|Lack of Efficacy|0|||
129120819|NCT00701363|464739061|FG000|Treatment Phase 2|Adverse Event|0|||
129120820|NCT00701363|464739062|FG001|Treatment Phase 2|Adverse Event|0|||
129120821|NCT00701363|464739063|FG002|Treatment Phase 2|Adverse Event|1|||
129120822|NCT00701363|464739064|FG003|Treatment Phase 2|Adverse Event|0|||
129120823|NCT00701363|464739061|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
129120824|NCT00701363|464739062|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
129120825|NCT00701363|464739063|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
129120826|NCT00701363|464739064|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
129120827|NCT04759131|464739065|FG000|Overall Study|Investigator's discretion|1|||
129120828|NCT04759131|464739066|FG001|Overall Study|Investigator's discretion|0|||
129120829|NCT04759131|464739065|FG000|Overall Study|Subject withdrawal|1|||
129120830|NCT04759131|464739066|FG001|Overall Study|Subject withdrawal|0|||
129120831|NCT01286129|464739069|FG000|Overall Study|Withdrawal by Subject|4|||
129120832|NCT01286129|464739070|FG001|Overall Study|Withdrawal by Subject|1|||
129120833|NCT01286129|464739069|FG000|Overall Study|Could not comply with study requirements|4|||
129120834|NCT01286129|464739070|FG001|Overall Study|Could not comply with study requirements|4|||
129120835|NCT00869960|464739071|FG000|Overall Study|Lost to Follow-up|2|||
129120836|NCT01394276|464739073|FG000|Overall Study|Related Adverse event (AEs)|15|||
129120837|NCT01394276|464739073|FG000|Overall Study|Not related AEs|9|||
129120838|NCT01394276|464739073|FG000|Overall Study|Remission of disease|2|||
129120839|NCT01394276|464739073|FG000|Overall Study|Insufficient therapeutic effect|17|||
129120840|NCT01394276|464739073|FG000|Overall Study|Insufficient compliance|9|||
128702598|NCT00291577|463209450|FG000|Overall Study|Lack of Efficacy|14|||
129120841|NCT01394276|464739073|FG000|Overall Study|Lost to Follow-up|5|||
129120842|NCT01394276|464739073|FG000|Overall Study|Participant moved to another site|1|||
129120843|NCT01394276|464739073|FG000|Overall Study|Pregnancy|1|||
129120844|NCT01394276|464739073|FG000|Overall Study|unavailability of drug at the Hospital|2|||
128702599|NCT01587001|463209458|FG000|Overall Study|Lost to Follow-up|2|||
128702600|NCT01587001|463209459|FG001|Overall Study|Lost to Follow-up|0|||
129030618|NCT04610580|464403188|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
129120845|NCT01394276|464739073|FG000|Overall Study|Symptoms of concurrent diseases|1|||
129120846|NCT04682301|464739078|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
129120847|NCT04682301|464739078|FG000|Overall Study|Death|2|||
129120848|NCT01654276|464739085|FG000|Overall Study|Lack of Efficacy|1|||
129120849|NCT01654276|464739085|FG000|Overall Study|Lost to Follow-up|4|||
129120850|NCT01654276|464739085|FG000|Overall Study|Withdrawal by Subject|1|||
129120851|NCT01991795|464739086|FG000|Overall Study|Lost to Follow-up|6|||
129120852|NCT01991795|464739087|FG001|Overall Study|Lost to Follow-up|4|||
129120853|NCT01991795|464739086|FG000|Overall Study|Withdrawal by Subject|117|||
129120854|NCT01991795|464739087|FG001|Overall Study|Withdrawal by Subject|94|||
129120855|NCT01991795|464739086|FG000|Overall Study|Site prematurely closed by sponsor|26|||
129120856|NCT01991795|464739087|FG001|Overall Study|Site prematurely closed by sponsor|25|||
129120857|NCT03344757|464739088|FG000|Overall Study|Withdrawal by Subject|18|||
129120858|NCT03344757|464739089|FG001|Overall Study|Withdrawal by Subject|16|||
129120859|NCT03344757|464739088|FG000|Overall Study|Lost to Follow-up|0|||
129120860|NCT03344757|464739089|FG001|Overall Study|Lost to Follow-up|2|||
129120861|NCT03104374|464739093|FG000|Period 1|Adverse Event|7|||
129120862|NCT03104374|464739094|FG001|Period 1|Adverse Event|7|||
129120863|NCT03104374|464739095|FG002|Period 1|Adverse Event|12|||
129120864|NCT03104374|464739096|FG003|Period 1|Adverse Event|14|||
129120865|NCT03104374|464739093|FG000|Period 1|Withdrawal by Subject|18|||
129120866|NCT03104374|464739094|FG001|Period 1|Withdrawal by Subject|9|||
129120867|NCT03104374|464739095|FG002|Period 1|Withdrawal by Subject|10|||
129120868|NCT03104374|464739096|FG003|Period 1|Withdrawal by Subject|17|||
129120869|NCT03104374|464739093|FG000|Period 1|Lost to Follow-up|4|||
129120870|NCT03104374|464739094|FG001|Period 1|Lost to Follow-up|4|||
129120871|NCT03104374|464739095|FG002|Period 1|Lost to Follow-up|6|||
129120872|NCT03104374|464739096|FG003|Period 1|Lost to Follow-up|8|||
129120873|NCT03104374|464739093|FG000|Period 1|Lack of Efficacy|6|||
129120874|NCT03104374|464739094|FG001|Period 1|Lack of Efficacy|7|||
129120875|NCT03104374|464739095|FG002|Period 1|Lack of Efficacy|12|||
129120876|NCT03104374|464739096|FG003|Period 1|Lack of Efficacy|6|||
129120877|NCT03104374|464739093|FG000|Period 1|Other|2|||
129120878|NCT03104374|464739094|FG001|Period 1|Other|2|||
129120879|NCT03104374|464739095|FG002|Period 1|Other|4|||
129120880|NCT03104374|464739096|FG003|Period 1|Other|7|||
129120881|NCT03104374|464739093|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
129120882|NCT03104374|464739094|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
129120883|NCT03104374|464739095|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
129120884|NCT03104374|464739096|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
129120885|NCT03104374|464739093|FG000|Period 2|Adverse Event|4|||
129120886|NCT03104374|464739094|FG001|Period 2|Adverse Event|7|||
129120887|NCT03104374|464739095|FG002|Period 2|Adverse Event|10|||
129120888|NCT03104374|464739096|FG003|Period 2|Adverse Event|10|||
129120889|NCT03104374|464739093|FG000|Period 2|Withdrawal by Subject|3|||
129120890|NCT03104374|464739094|FG001|Period 2|Withdrawal by Subject|7|||
129120891|NCT03104374|464739095|FG002|Period 2|Withdrawal by Subject|13|||
129120892|NCT03104374|464739096|FG003|Period 2|Withdrawal by Subject|16|||
129120893|NCT03104374|464739093|FG000|Period 2|Lost to Follow-up|2|||
129120894|NCT03104374|464739094|FG001|Period 2|Lost to Follow-up|2|||
129120895|NCT03104374|464739095|FG002|Period 2|Lost to Follow-up|3|||
129120896|NCT03104374|464739096|FG003|Period 2|Lost to Follow-up|5|||
129120897|NCT03104374|464739093|FG000|Period 2|Lack of Efficacy|2|||
129120898|NCT03104374|464739094|FG001|Period 2|Lack of Efficacy|4|||
129120899|NCT03104374|464739095|FG002|Period 2|Lack of Efficacy|7|||
129120900|NCT03104374|464739096|FG003|Period 2|Lack of Efficacy|4|||
129120901|NCT03104374|464739093|FG000|Period 2|COVID-19 Infection|0|||
129120902|NCT03104374|464739094|FG001|Period 2|COVID-19 Infection|0|||
129120903|NCT03104374|464739095|FG002|Period 2|COVID-19 Infection|1|||
129120904|NCT03104374|464739096|FG003|Period 2|COVID-19 Infection|0|||
129120905|NCT03104374|464739093|FG000|Period 2|Other|3|||
129120906|NCT03104374|464739094|FG001|Period 2|Other|2|||
129120907|NCT03104374|464739095|FG002|Period 2|Other|2|||
129120908|NCT03104374|464739096|FG003|Period 2|Other|4|||
129120909|NCT02121210|464739099|FG000|Overall Study|Adverse Event|5|||
129120910|NCT02121210|464739100|FG001|Overall Study|Adverse Event|7|||
129120911|NCT02121210|464739099|FG000|Overall Study|Lack of Efficacy|2|||
129120912|NCT02121210|464739100|FG001|Overall Study|Lack of Efficacy|0|||
129120913|NCT02121210|464739099|FG000|Overall Study|Other than specified above|0|||
129120914|NCT02121210|464739100|FG001|Overall Study|Other than specified above|2|||
129120915|NCT04609514|464739101|FG000|Overall Study|Lost to Follow-up|5|||
129120916|NCT04609514|464739102|FG001|Overall Study|Lost to Follow-up|4|||
129216649|NCT00719472|465094749|FG000|Received Cycle 1 Treatment|Death|5|||
128767538|NCT02200939|463440298|FG001|Overall Study|Participant withdrew consent|1|||
129120917|NCT04609514|464739101|FG000|Overall Study|Withdrawal by PI|0|||
129120918|NCT04609514|464739102|FG001|Overall Study|Withdrawal by PI|2|||
129120919|NCT00909870|464739103|FG000|Overall Study|Adverse Event|13|||
129120920|NCT00909870|464739104|FG001|Overall Study|Adverse Event|7|||
129120921|NCT00909870|464739103|FG000|Overall Study|Protocol Violation|1|||
129120922|NCT00909870|464739104|FG001|Overall Study|Protocol Violation|2|||
129120923|NCT00909870|464739103|FG000|Overall Study|Withdrawal by Subject|5|||
129120924|NCT00909870|464739104|FG001|Overall Study|Withdrawal by Subject|8|||
129120925|NCT00909870|464739103|FG000|Overall Study|Lost to Follow-up|3|||
129120926|NCT00909870|464739104|FG001|Overall Study|Lost to Follow-up|3|||
128931171|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
128931172|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
128931173|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
128931174|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
128931175|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
128931176|NCT02975349|464036661|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
128931177|NCT02975349|464036662|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
128931178|NCT02975349|464036663|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
128931179|NCT02975349|464036664|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
128931180|NCT02975349|464036665|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
128931181|NCT02975349|464036666|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
128931182|NCT02975349|464036667|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
128931183|NCT03567187|464036670|FG000|Overall Study|Lost to Follow-up|18|||
128931184|NCT02032875|464036673|FG000|Treatment Period|Adverse Event|1|||
128931185|NCT02032875|464036674|FG001|Treatment Period|Adverse Event|0|||
128931186|NCT02032875|464036673|FG000|Treatment Period|Liver transplant, No extension needed|0|||
128931187|NCT02032875|464036674|FG001|Treatment Period|Liver transplant, No extension needed|1|||
128931188|NCT02032875|464036673|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
128931189|NCT02032875|464036674|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
128931190|NCT02032875|464036673|FG000|Follow-up Period|Death|0|||
128931191|NCT02032875|464036674|FG001|Follow-up Period|Death|1|||
128931192|NCT02032875|464036673|FG000|Follow-up Period|Virologic Relapse|3|||
128931193|NCT02032875|464036674|FG001|Follow-up Period|Virologic Relapse|10|||
128931194|NCT04358458|464036675|FG000|Overall Study|Death|1|||
128931195|NCT04358458|464036676|FG001|Overall Study|Death|1|||
128931196|NCT04358458|464036677|FG002|Overall Study|Death|3|||
128931197|NCT04358458|464036678|FG003|Overall Study|Death|8|||
128931198|NCT04358458|464036679|FG004|Overall Study|Death|1|||
128931199|NCT04358458|464036680|FG005|Overall Study|Death|6|||
128931200|NCT04358458|464036681|FG006|Overall Study|Death|2|||
128931201|NCT04358458|464036682|FG007|Overall Study|Death|3|||
128931202|NCT04358458|464036675|FG000|Overall Study|Lost to Follow-up|0|||
128931203|NCT04358458|464036676|FG001|Overall Study|Lost to Follow-up|0|||
128931204|NCT04358458|464036677|FG002|Overall Study|Lost to Follow-up|0|||
128931205|NCT04358458|464036678|FG003|Overall Study|Lost to Follow-up|0|||
128931206|NCT04358458|464036679|FG004|Overall Study|Lost to Follow-up|0|||
128931207|NCT04358458|464036680|FG005|Overall Study|Lost to Follow-up|0|||
128931208|NCT04358458|464036681|FG006|Overall Study|Lost to Follow-up|0|||
128931209|NCT04358458|464036682|FG007|Overall Study|Lost to Follow-up|1|||
128931210|NCT04358458|464036675|FG000|Overall Study|Site is closing study participation|0|||
128931211|NCT04358458|464036676|FG001|Overall Study|Site is closing study participation|0|||
128931212|NCT04358458|464036677|FG002|Overall Study|Site is closing study participation|0|||
128931213|NCT04358458|464036678|FG003|Overall Study|Site is closing study participation|1|||
128931214|NCT04358458|464036679|FG004|Overall Study|Site is closing study participation|0|||
128931215|NCT04358458|464036680|FG005|Overall Study|Site is closing study participation|0|||
128931216|NCT04358458|464036681|FG006|Overall Study|Site is closing study participation|0|||
128931217|NCT04358458|464036682|FG007|Overall Study|Site is closing study participation|0|||
128931218|NCT04358458|464036675|FG000|Overall Study|Sponsor request|2|||
128931219|NCT04358458|464036676|FG001|Overall Study|Sponsor request|3|||
128931220|NCT04358458|464036677|FG002|Overall Study|Sponsor request|3|||
128931221|NCT04358458|464036678|FG003|Overall Study|Sponsor request|0|||
128931222|NCT04358458|464036679|FG004|Overall Study|Sponsor request|2|||
128931223|NCT04358458|464036680|FG005|Overall Study|Sponsor request|3|||
128931224|NCT04358458|464036681|FG006|Overall Study|Sponsor request|1|||
128931225|NCT04358458|464036682|FG007|Overall Study|Sponsor request|1|||
128931226|NCT04358458|464036675|FG000|Overall Study|Withdrawal by Subject|0|||
128931227|NCT04358458|464036676|FG001|Overall Study|Withdrawal by Subject|0|||
128931228|NCT04358458|464036677|FG002|Overall Study|Withdrawal by Subject|1|||
128931229|NCT04358458|464036678|FG003|Overall Study|Withdrawal by Subject|1|||
128931230|NCT04358458|464036679|FG004|Overall Study|Withdrawal by Subject|0|||
128931231|NCT04358458|464036680|FG005|Overall Study|Withdrawal by Subject|1|||
128931232|NCT04358458|464036681|FG006|Overall Study|Withdrawal by Subject|0|||
128931233|NCT04358458|464036682|FG007|Overall Study|Withdrawal by Subject|1|||
128931234|NCT00151411|464037890|FG000|Overall Study|Lost to Follow-up|15|||
128931235|NCT00151411|464037891|FG001|Overall Study|Lost to Follow-up|19|||
128931236|NCT00151411|464037890|FG000|Overall Study|Withdrawal by Subject|12|||
128931237|NCT00151411|464037891|FG001|Overall Study|Withdrawal by Subject|20|||
128931238|NCT00151411|464037890|FG000|Overall Study|Adverse Event|6|||
128931239|NCT00151411|464037891|FG001|Overall Study|Adverse Event|0|||
128931240|NCT00151411|464037890|FG000|Overall Study|Pregnancy|0|||
128931241|NCT00151411|464037891|FG001|Overall Study|Pregnancy|4|||
128931242|NCT01712438|464037892|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
128931243|NCT01712438|464037892|FG000|Overall Study|Ongoing ITI treatment|6|||
128931244|NCT01712438|464037892|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
128767539|NCT02200939|463440297|FG000|Overall Study|Lost to Follow-up|2|||
129030619|NCT04610580|464403189|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129030620|NCT01097694|464403190|FG000|Overall Study|Adverse Event|5|||
128767540|NCT02200939|463440298|FG001|Overall Study|Lost to Follow-up|9|||
128767541|NCT02200939|463440297|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
128767542|NCT02200939|463440298|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
129030621|NCT01097694|464403191|FG001|Overall Study|Adverse Event|0|||
129030622|NCT01097694|464403190|FG000|Overall Study|Lost to Follow-up|0|||
129030623|NCT01097694|464403191|FG001|Overall Study|Lost to Follow-up|3|||
129030624|NCT01097694|464403190|FG000|Overall Study|Withdrawal by Subject|3|||
129030625|NCT01097694|464403191|FG001|Overall Study|Withdrawal by Subject|1|||
129030626|NCT02377349|464403192|FG000|Overall Study|Serious Adverse Event|1|||
129030627|NCT02377349|464403193|FG001|Overall Study|Serious Adverse Event|0|||
129030628|NCT02377349|464403192|FG000|Overall Study|Protocol Violation|3|||
129030629|NCT02377349|464403193|FG001|Overall Study|Protocol Violation|2|||
129030630|NCT02377349|464403192|FG000|Overall Study|Withdrawal by Subject|5|||
129030631|NCT02377349|464403193|FG001|Overall Study|Withdrawal by Subject|3|||
129030632|NCT02377349|464403192|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
129030633|NCT02377349|464403193|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
129030634|NCT02377349|464403192|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
129030635|NCT02377349|464403193|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
129030636|NCT02377349|464403192|FG000|Overall Study|Other|0|||
129030637|NCT02377349|464403193|FG001|Overall Study|Other|1|||
129030638|NCT03259165|464403194|FG000|Overall Study|COVID 19 pandemic|1|||
129120927|NCT00909870|464739103|FG000|Overall Study|Physician Decision|0|||
129120928|NCT00909870|464739104|FG001|Overall Study|Physician Decision|2|||
129120929|NCT00909870|464739103|FG000|Overall Study|Other|1|||
129120930|NCT00909870|464739104|FG001|Overall Study|Other|5|||
129120931|NCT01316575|464739105|FG000|Overall Study|Withdrawal by Subject|2|||
129120932|NCT01316575|464739106|FG001|Overall Study|Withdrawal by Subject|0|||
129120933|NCT01316575|464739105|FG000|Overall Study|Required alternate treatment|0|||
129120934|NCT01316575|464739106|FG001|Overall Study|Required alternate treatment|1|||
129120935|NCT01232283|464739107|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
129120936|NCT01232283|464739108|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
129120937|NCT01232283|464739109|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120938|NCT01232283|464739110|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120939|NCT01232283|464739111|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120940|NCT01232283|464739112|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120941|NCT01232283|464739113|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120942|NCT01232283|464739114|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120943|NCT01232283|464739115|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120944|NCT01232283|464739116|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129120945|NCT01232283|464739107|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
129120946|NCT01232283|464739108|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
129120947|NCT01232283|464739109|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120948|NCT01232283|464739110|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120949|NCT01232283|464739111|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120950|NCT01232283|464739112|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120951|NCT01232283|464739113|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120952|NCT01232283|464739114|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120953|NCT01232283|464739115|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120954|NCT01232283|464739116|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129120955|NCT01232283|464739107|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
129120956|NCT01232283|464739108|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120957|NCT01232283|464739109|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120958|NCT01232283|464739110|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120959|NCT01232283|464739111|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120960|NCT01232283|464739112|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120961|NCT01232283|464739113|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120962|NCT01232283|464739114|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120963|NCT01232283|464739115|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120964|NCT01232283|464739116|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129120965|NCT01232283|464739107|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
128767543|NCT02762981|463440299|FG000|Overall Study|Adverse Event|2|||
129030639|NCT03259165|464403195|FG001|Overall Study|COVID 19 pandemic|1|||
129030640|NCT01949532|464403196|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
129030641|NCT01949532|464403197|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
129030642|NCT00939523|464403202|FG000|Overall Study|Lack of Efficacy|1|||
129030643|NCT00939523|464403202|FG000|Overall Study|Physician Decision|2|||
129030644|NCT00024258|464403203|FG000|Overall Study|Withdrawal by Subject|1|||
129030645|NCT00024258|464403203|FG000|Overall Study|Disease Progression|8|||
129030646|NCT01050764|464403204|FG000|Overall Study|Death, before HSCT|1|||
129030647|NCT01050764|464403204|FG000|Overall Study|Donor mobilization failure, death|1|||
129030648|NCT01050764|464403204|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
129030649|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Adverse Event|8|||
129030650|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Adverse Event|5|||
129030651|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Adverse Event|9|||
129030652|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Adverse Event|0|||
129030653|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Adverse Event|0|||
129030654|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Adverse Event|0|||
129030655|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
129030656|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
129030657|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
129030658|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
129030659|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
129120966|NCT01232283|464739108|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
129120967|NCT01232283|464739109|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120968|NCT01232283|464739110|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120969|NCT01232283|464739111|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120970|NCT01232283|464739112|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120971|NCT01232283|464739113|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120972|NCT01232283|464739114|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120973|NCT01232283|464739115|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120974|NCT01232283|464739116|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129120975|NCT01232283|464739107|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
129120976|NCT01232283|464739108|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
129120977|NCT01232283|464739109|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120978|NCT01232283|464739110|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120979|NCT01232283|464739111|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120980|NCT01232283|464739112|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120981|NCT01232283|464739113|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120982|NCT01232283|464739114|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120983|NCT01232283|464739115|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120984|NCT01232283|464739116|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129120985|NCT01232283|464739107|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
129120986|NCT01232283|464739108|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
129120987|NCT01232283|464739109|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120988|NCT01232283|464739110|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120989|NCT01232283|464739111|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120990|NCT01232283|464739112|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120991|NCT01232283|464739113|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120992|NCT01232283|464739114|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120993|NCT01232283|464739115|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120994|NCT01232283|464739116|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129120995|NCT01232283|464739107|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
129120996|NCT01232283|464739108|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
129120997|NCT01232283|464739109|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129120998|NCT01232283|464739110|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129120999|NCT01232283|464739111|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129121000|NCT01232283|464739112|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129121001|NCT01232283|464739113|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129121002|NCT01232283|464739114|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129121003|NCT01232283|464739115|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129121004|NCT01232283|464739116|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129121005|NCT01232283|464739107|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129121006|NCT01232283|464739108|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129030660|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
129121007|NCT01232283|464739109|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
129121008|NCT01232283|464739110|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
129121009|NCT01232283|464739111|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129121010|NCT01232283|464739112|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129121011|NCT01232283|464739113|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129121012|NCT01232283|464739114|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129121013|NCT01232283|464739115|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128767544|NCT02762981|463440300|FG001|Overall Study|Adverse Event|3|||
129030661|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
129030662|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
129121014|NCT01232283|464739116|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
128931245|NCT01712438|464037892|FG000|Overall Study|Prematurely Discontinued|25|||
128931246|NCT04426630|464037893|FG000|Overall Study|Death|4|||
128931247|NCT04426630|464037893|FG000|Overall Study|Lost to Follow-up|2|||
128931248|NCT01157169|464037896|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
128931249|NCT01157169|464037897|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
128931250|NCT01157169|464037896|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
128931251|NCT01157169|464037897|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
128931252|NCT01123889|464037898|FG000|Overall Study|Lost to Follow-up|3|||
128931253|NCT01123889|464037899|FG001|Overall Study|Lost to Follow-up|1|||
128931254|NCT03846947|464037904|FG000|Overall Study|technical issues with imaging sequence|2|||
128931255|NCT01362322|464037907|FG000|Overall Study|Withdrawal by Subject|3|||
128931256|NCT01362322|464037908|FG001|Overall Study|Withdrawal by Subject|1|||
128931257|NCT01362322|464037907|FG000|Overall Study|Lost to Follow-up|2|||
128931258|NCT01362322|464037908|FG001|Overall Study|Lost to Follow-up|6|||
128931259|NCT05299892|464037914|FG000|Overall Study|Withdrawal by Subject|2|||
128931260|NCT03334214|464037915|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
128931261|NCT03334214|464037916|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
128931262|NCT03334214|464037915|FG000|Overall Study|Withdrawal by Subject|0|||
128931263|NCT03334214|464037916|FG001|Overall Study|Withdrawal by Subject|1|||
128931264|NCT03334214|464037915|FG000|Overall Study|Other|1|||
128931265|NCT03334214|464037916|FG001|Overall Study|Other|0|||
128931266|NCT01260181|464037919|FG000|Overall Study|Decision of Investigator|1|||
128931267|NCT01844076|464037922|FG000|Overall Study|Adverse Event|1|||
128931268|NCT01844076|464037923|FG001|Overall Study|Adverse Event|0|||
128931269|NCT01844076|464037924|FG002|Overall Study|Adverse Event|0|||
128931270|NCT01844076|464037925|FG003|Overall Study|Adverse Event|0|||
128931271|NCT01844076|464037922|FG000|Overall Study|Withdrawal by Subject|1|||
128931272|NCT01844076|464037923|FG001|Overall Study|Withdrawal by Subject|0|||
128931273|NCT01844076|464037924|FG002|Overall Study|Withdrawal by Subject|0|||
128931274|NCT01844076|464037925|FG003|Overall Study|Withdrawal by Subject|0|||
128931275|NCT01937312|464037927|FG000|Overall Study|Adverse Event|10|||
128931276|NCT01937312|464037928|FG001|Overall Study|Adverse Event|1|||
128931277|NCT01937312|464037927|FG000|Overall Study|Lack of Efficacy|0|||
128931278|NCT01937312|464037928|FG001|Overall Study|Lack of Efficacy|1|||
128931279|NCT01937312|464037927|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
128931280|NCT01937312|464037928|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
128931281|NCT01025336|464037931|FG000|Overall Study|Protocol Violation|0|||
128931282|NCT01025336|464037932|FG001|Overall Study|Protocol Violation|0|||
128931283|NCT01025336|464037933|FG002|Overall Study|Protocol Violation|0|||
128931284|NCT01025336|464037934|FG003|Overall Study|Protocol Violation|2|||
128931285|NCT01025336|464037935|FG004|Overall Study|Protocol Violation|0|||
128931286|NCT00474253|464037936|FG000|Overall Study|Withdrew consent|2|||
128931287|NCT00474253|464037937|FG001|Overall Study|Withdrew consent|0|||
128931288|NCT00474253|464037936|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
128931289|NCT00474253|464037937|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
128931290|NCT00474253|464037936|FG000|Overall Study|Lost to Follow-up|1|||
128931291|NCT00474253|464037937|FG001|Overall Study|Lost to Follow-up|0|||
128931292|NCT00474253|464037936|FG000|Overall Study|Discharged prior to study completion|0|||
128931293|NCT00474253|464037937|FG001|Overall Study|Discharged prior to study completion|1|||
128931294|NCT03133481|464037938|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
128931295|NCT03133481|464037939|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
128931296|NCT00637728|464037946|FG000|Double-blind Phase|Adverse Event|1|||
128931297|NCT00637728|464037947|FG001|Double-blind Phase|Adverse Event|0|||
128931298|NCT00637728|464037948|FG002|Double-blind Phase|Adverse Event|0|||
128931299|NCT00637728|464037946|FG000|Double-blind Phase|Non-compliance|2|||
128931300|NCT00637728|464037947|FG001|Double-blind Phase|Non-compliance|0|||
128931301|NCT00637728|464037948|FG002|Double-blind Phase|Non-compliance|0|||
128931302|NCT00637728|464037946|FG000|Double-blind Phase|Study Discontinued|1|||
128931303|NCT00637728|464037947|FG001|Double-blind Phase|Study Discontinued|1|||
128931304|NCT00637728|464037948|FG002|Double-blind Phase|Study Discontinued|0|||
128931305|NCT00593112|464037951|FG000|Overall Study|Scan Anxiety|3|||
128931306|NCT00593112|464037952|FG001|Overall Study|Scan Anxiety|0|||
129216650|NCT00719472|465094749|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
129216651|NCT00719472|465094749|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
129216652|NCT00719472|465094749|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
129216653|NCT00719472|465094749|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
128931307|NCT00593112|464037951|FG000|Overall Study|Abnormal Scan|1|||
128931308|NCT00593112|464037952|FG001|Overall Study|Abnormal Scan|0|||
128931309|NCT00593112|464037951|FG000|Overall Study|Unreadable Scan|1|||
128931310|NCT00593112|464037952|FG001|Overall Study|Unreadable Scan|0|||
128931311|NCT00593112|464037951|FG000|Overall Study|Withdrawal by Subject|5|||
128931312|NCT00593112|464037952|FG001|Overall Study|Withdrawal by Subject|0|||
128931313|NCT02723630|464037953|FG000|Intervention Period 1|Adverse Event|1|||
128931314|NCT02723630|464037954|FG001|Intervention Period 1|Adverse Event|0|||
128931315|NCT02723630|464037955|FG002|Intervention Period 1|Adverse Event|0|||
128931316|NCT02723630|464037956|FG003|Intervention Period 1|Adverse Event|0|||
128931317|NCT02723630|464037957|FG004|Intervention Period 1|Adverse Event|0|||
128931318|NCT02723630|464037958|FG005|Intervention Period 1|Adverse Event|0|||
128931319|NCT02723630|464037953|FG000|Intervention Period 3|consumption of restricted item|0|||
128931320|NCT02723630|464037954|FG001|Intervention Period 3|consumption of restricted item|1|||
128931321|NCT02723630|464037955|FG002|Intervention Period 3|consumption of restricted item|0|||
128931322|NCT02723630|464037956|FG003|Intervention Period 3|consumption of restricted item|0|||
128931323|NCT02723630|464037957|FG004|Intervention Period 3|consumption of restricted item|0|||
129216654|NCT00719472|465094749|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
129216655|NCT00719472|465094749|FG000|Received Cycle 2 Treatment|Death|6|||
128767545|NCT02762981|463440301|FG002|Overall Study|Adverse Event|1|||
128931324|NCT02723630|464037958|FG005|Intervention Period 3|consumption of restricted item|0|||
128931325|NCT01184989|464037959|FG000|Overall Study|Adverse Event|11|||
128931326|NCT01184989|464037959|FG000|Overall Study|Withdrawal by Subject|1|||
128931327|NCT04407507|464037962|FG000|Overall Study|Withdrawal by Subject|0|||
128931328|NCT04407507|464037963|FG001|Overall Study|Withdrawal by Subject|1|||
129030663|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
129030664|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
129030665|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
129030666|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
129030667|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Physician Decision|4|||
129030668|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Physician Decision|0|||
129030669|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Physician Decision|2|||
129030670|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Physician Decision|0|||
129030671|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Physician Decision|0|||
129030672|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Physician Decision|0|||
129030673|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Pregnancy|1|||
129030674|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Pregnancy|2|||
129030675|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Pregnancy|0|||
129030676|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Pregnancy|0|||
129030677|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Pregnancy|0|||
129030678|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Pregnancy|0|||
129030679|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
129030680|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
129030681|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
129030682|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
129030683|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
129030684|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
129030685|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
129030686|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
129030687|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
129030688|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
129030689|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
129030690|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
129030691|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
129030692|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
129030693|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
129030694|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
129030695|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129030696|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129030697|NCT02614196|464403207|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
129030698|NCT02614196|464403208|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
129030699|NCT02614196|464403209|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
129030700|NCT02614196|464403210|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
129030701|NCT02614196|464403211|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
129030702|NCT02614196|464403212|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
129030703|NCT02614196|464403207|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
129030704|NCT02614196|464403208|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
129030705|NCT02614196|464403209|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
129030706|NCT02614196|464403210|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
129030707|NCT02614196|464403211|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
129030708|NCT02614196|464403212|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
129030709|NCT02614196|464403207|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
129030710|NCT02614196|464403208|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
129030711|NCT02614196|464403209|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
129030712|NCT02614196|464403210|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
129030713|NCT02614196|464403211|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
129030714|NCT02614196|464403212|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
129030715|NCT02614196|464403207|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
129030716|NCT02614196|464403208|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
128931329|NCT00754390|464037968|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
128931330|NCT00754390|464037968|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
128931331|NCT00754390|464037968|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
128931332|NCT00754390|464037968|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
128931333|NCT04332419|464037971|FG000|Overall Study|Withdrawal by Subject|1|||
128931334|NCT02436239|464037972|FG000|Open-Lable Treatment Period|Adverse Event|12|||
128931335|NCT02436239|464037973|FG001|Open-Lable Treatment Period|Adverse Event|3|||
128931336|NCT02436239|464037974|FG002|Open-Lable Treatment Period|Adverse Event|4|||
128931337|NCT02436239|464037975|FG003|Open-Lable Treatment Period|Adverse Event|2|||
128931338|NCT02436239|464037972|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
128931339|NCT02436239|464037973|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
128931340|NCT02436239|464037974|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
128931341|NCT02436239|464037975|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
128931342|NCT02436239|464037972|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
128931343|NCT02436239|464037973|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
128931344|NCT02436239|464037974|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
128931345|NCT02436239|464037975|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
128931346|NCT02436239|464037972|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
128931347|NCT02436239|464037973|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
128931348|NCT02436239|464037974|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
128931349|NCT02436239|464037975|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
128931350|NCT02436239|464037972|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
128931351|NCT02436239|464037973|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
128931352|NCT02436239|464037974|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
128931353|NCT02436239|464037975|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
128931354|NCT02436239|464037972|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
128931355|NCT02436239|464037973|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
128931356|NCT02436239|464037974|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
128931357|NCT02436239|464037975|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
128931358|NCT02436239|464037972|FG000|Open-Lable Treatment Period|Other Reason|1|||
128931359|NCT02436239|464037973|FG001|Open-Lable Treatment Period|Other Reason|1|||
128931360|NCT02436239|464037974|FG002|Open-Lable Treatment Period|Other Reason|0|||
128931361|NCT02436239|464037975|FG003|Open-Lable Treatment Period|Other Reason|0|||
128931362|NCT02436239|464037972|FG000|Down-Taper Period|Withdrawal by Subject|4|||
128931363|NCT02436239|464037973|FG001|Down-Taper Period|Withdrawal by Subject|4|||
128931364|NCT02436239|464037974|FG002|Down-Taper Period|Withdrawal by Subject|1|||
128931365|NCT02436239|464037975|FG003|Down-Taper Period|Withdrawal by Subject|2|||
128931366|NCT04222725|464037978|FG000|Overall Study|Adverse Event|0|||
128931367|NCT04222725|464037979|FG001|Overall Study|Adverse Event|1|||
128931368|NCT04222725|464037980|FG002|Overall Study|Adverse Event|0|||
128931369|NCT04222725|464037981|FG003|Overall Study|Adverse Event|0|||
128931370|NCT02986373|464037987|FG000|Overall Study|Adverse Event|4|||
128931371|NCT02986373|464037987|FG000|Overall Study|Lost to Follow-up|1|||
128931372|NCT02986373|464037987|FG000|Overall Study|Withdrawal by Subject|10|||
128931373|NCT02986373|464037987|FG000|Overall Study|Other|24|||
128931374|NCT00995371|464037993|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
128931375|NCT00995371|464037994|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
128931376|NCT04725682|464037995|FG000|Overall Study|Withdrawal by Subject|7|||
128931377|NCT04725682|464037996|FG001|Overall Study|Withdrawal by Subject|5|||
128931378|NCT04725682|464037995|FG000|Overall Study|Failed to comply with the requirements|2|||
128931379|NCT04725682|464037996|FG001|Overall Study|Failed to comply with the requirements|1|||
128931380|NCT04725682|464037995|FG000|Overall Study|Adverse Event|1|||
128931381|NCT04725682|464037996|FG001|Overall Study|Adverse Event|1|||
128931382|NCT04725682|464037995|FG000|Overall Study|Death|0|||
128931383|NCT04725682|464037996|FG001|Overall Study|Death|1|||
128931384|NCT01607892|464037998|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
128931385|NCT01607892|464037999|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
128931386|NCT01607892|464038000|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
128931387|NCT01607892|464038001|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
128931388|NCT01607892|464038002|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
128931389|NCT01607892|464037998|FG000|Overall Study|Death|4|||
128931390|NCT01607892|464037999|FG001|Overall Study|Death|2|||
128931391|NCT01607892|464038000|FG002|Overall Study|Death|8|||
129030717|NCT02614196|464403209|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
129030718|NCT02614196|464403210|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
129030719|NCT02614196|464403211|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
129030720|NCT02614196|464403212|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
129030721|NCT02614196|464403207|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
128931392|NCT01607892|464038001|FG003|Overall Study|Death|10|||
128931393|NCT01607892|464038002|FG004|Overall Study|Death|3|||
128931394|NCT01607892|464037998|FG000|Overall Study|Investigator discretion|2|||
129030722|NCT02614196|464403208|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
128931395|NCT01607892|464037999|FG001|Overall Study|Investigator discretion|4|||
128931396|NCT01607892|464038000|FG002|Overall Study|Investigator discretion|4|||
128931397|NCT01607892|464038001|FG003|Overall Study|Investigator discretion|8|||
128931398|NCT01607892|464038002|FG004|Overall Study|Investigator discretion|0|||
128931399|NCT01607892|464037998|FG000|Overall Study|Other treatments became available|1|||
128931400|NCT01607892|464037999|FG001|Overall Study|Other treatments became available|1|||
128931401|NCT01607892|464038000|FG002|Overall Study|Other treatments became available|0|||
128931402|NCT01607892|464038001|FG003|Overall Study|Other treatments became available|0|||
128931403|NCT01607892|464038002|FG004|Overall Study|Other treatments became available|2|||
128931404|NCT01607892|464037998|FG000|Overall Study|Intercurrent illness|1|||
128931405|NCT01607892|464037999|FG001|Overall Study|Intercurrent illness|0|||
128931406|NCT01607892|464038000|FG002|Overall Study|Intercurrent illness|0|||
128931407|NCT01607892|464038001|FG003|Overall Study|Intercurrent illness|3|||
128931408|NCT01607892|464038002|FG004|Overall Study|Intercurrent illness|0|||
128931409|NCT01607892|464037998|FG000|Overall Study|Non-Compliance with study procedures|0|||
128931410|NCT01607892|464037999|FG001|Overall Study|Non-Compliance with study procedures|0|||
128931411|NCT01607892|464038000|FG002|Overall Study|Non-Compliance with study procedures|1|||
128931412|NCT01607892|464038001|FG003|Overall Study|Non-Compliance with study procedures|0|||
128931413|NCT01607892|464038002|FG004|Overall Study|Non-Compliance with study procedures|0|||
128931414|NCT01607892|464037998|FG000|Overall Study|Consent withdrawn by participant|9|||
128931415|NCT01607892|464037999|FG001|Overall Study|Consent withdrawn by participant|4|||
128931416|NCT01607892|464038000|FG002|Overall Study|Consent withdrawn by participant|24|||
128931417|NCT01607892|464038001|FG003|Overall Study|Consent withdrawn by participant|14|||
128931418|NCT01607892|464038002|FG004|Overall Study|Consent withdrawn by participant|4|||
128931419|NCT01607892|464037998|FG000|Overall Study|Disease progression|38|||
128931420|NCT01607892|464037999|FG001|Overall Study|Disease progression|13|||
128931421|NCT01607892|464038000|FG002|Overall Study|Disease progression|37|||
128931422|NCT01607892|464038001|FG003|Overall Study|Disease progression|57|||
128931423|NCT01607892|464038002|FG004|Overall Study|Disease progression|9|||
128931424|NCT01607892|464037998|FG000|Overall Study|Incidence or severity of Adverse events|3|||
128931425|NCT01607892|464037999|FG001|Overall Study|Incidence or severity of Adverse events|3|||
128931426|NCT01607892|464038000|FG002|Overall Study|Incidence or severity of Adverse events|7|||
128931427|NCT01607892|464038001|FG003|Overall Study|Incidence or severity of Adverse events|2|||
128931428|NCT01607892|464038002|FG004|Overall Study|Incidence or severity of Adverse events|6|||
128931429|NCT03414359|464038003|FG000|Overall Study|Lack of Efficacy|1|||
128931430|NCT03414359|464038004|FG001|Overall Study|Lack of Efficacy|1|||
128931431|NCT03414359|464038003|FG000|Overall Study|Protocol Violation|0|||
128931432|NCT03414359|464038004|FG001|Overall Study|Protocol Violation|1|||
128931433|NCT02273973|464038007|FG000|Overall Study|Adverse Event|4|||
128931434|NCT02273973|464038008|FG001|Overall Study|Adverse Event|0|||
128931435|NCT02273973|464038007|FG000|Overall Study|Withdrawal by Subject|2|||
128931436|NCT02273973|464038008|FG001|Overall Study|Withdrawal by Subject|3|||
128931437|NCT02273973|464038007|FG000|Overall Study|Death|1|||
128931438|NCT02273973|464038008|FG001|Overall Study|Death|0|||
128931439|NCT02273973|464038007|FG000|Overall Study|Non-compliance|1|||
128931440|NCT02273973|464038008|FG001|Overall Study|Non-compliance|0|||
128931441|NCT02273973|464038007|FG000|Overall Study|Protocol Violation|1|||
128931442|NCT02273973|464038008|FG001|Overall Study|Protocol Violation|0|||
128931443|NCT02273973|464038007|FG000|Overall Study|Progression of disease|0|||
128931444|NCT02273973|464038008|FG001|Overall Study|Progression of disease|2|||
128931445|NCT02273973|464038007|FG000|Overall Study|Lost to Follow-up|0|||
128931446|NCT02273973|464038008|FG001|Overall Study|Lost to Follow-up|1|||
128931447|NCT02273973|464038007|FG000|Overall Study|Physician Decision|0|||
128931448|NCT02273973|464038008|FG001|Overall Study|Physician Decision|1|||
128931449|NCT02273973|464038007|FG000|Overall Study|Reason not specified|0|||
128931450|NCT02273973|464038008|FG001|Overall Study|Reason not specified|1|||
128931451|NCT03022422|464038010|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
128931452|NCT03022422|464038011|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
128931453|NCT03022422|464038012|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
128931454|NCT03022422|464038013|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
128931455|NCT03022422|464038014|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
128931456|NCT03022422|464038015|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
128931457|NCT01282814|464038016|FG000|First Intervention|Emesis During Dosing Interval|0|||
128931458|NCT01282814|464038017|FG001|First Intervention|Emesis During Dosing Interval|3|||
128931459|NCT01282814|464038016|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
128931460|NCT01282814|464038017|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
128931461|NCT02403206|464038018|FG000|Overall Study|Lost to Follow-up|4|||
128931462|NCT02403206|464038019|FG001|Overall Study|Lost to Follow-up|3|||
129030723|NCT02614196|464403209|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
128767546|NCT02762981|463440302|FG003|Overall Study|Adverse Event|1|||
128931463|NCT02403206|464038018|FG000|Overall Study|Physician Decision|2|||
128931464|NCT02403206|464038019|FG001|Overall Study|Physician Decision|0|||
128931465|NCT02403206|464038018|FG000|Overall Study|Withdrawal by Subject|3|||
128931466|NCT02403206|464038019|FG001|Overall Study|Withdrawal by Subject|3|||
129121015|NCT01232283|464739107|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121016|NCT01232283|464739108|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121017|NCT01232283|464739109|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
129121018|NCT01232283|464739110|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
129121019|NCT01232283|464739111|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121020|NCT01232283|464739112|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121021|NCT01232283|464739113|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121022|NCT01232283|464739114|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121023|NCT01232283|464739115|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121024|NCT01232283|464739116|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129121025|NCT01232283|464739107|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129121026|NCT01232283|464739108|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129216656|NCT00719472|465094749|FG000|Received Cycle 2 Treatment|Disease progression|3|||
129216657|NCT00719472|465094749|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
128931467|NCT02403206|464038018|FG000|Overall Study|Reason not given|2|||
128931468|NCT02403206|464038019|FG001|Overall Study|Reason not given|4|||
128931469|NCT00957372|464038020|FG000|PART I|Lost to Follow-up|0|||
128931470|NCT00957372|464038021|FG001|PART I|Lost to Follow-up|0|||
128931471|NCT00957372|464038022|FG002|PART I|Lost to Follow-up|1|||
128931472|NCT00957372|464038023|FG003|PART I|Lost to Follow-up|0|||
128931473|NCT00957372|464038020|FG000|PART II|Withdrawal by Subject|0|||
128931474|NCT00957372|464038021|FG001|PART II|Withdrawal by Subject|0|||
128931475|NCT00957372|464038022|FG002|PART II|Withdrawal by Subject|0|||
128931476|NCT00957372|464038023|FG003|PART II|Withdrawal by Subject|8|||
128931477|NCT00957372|464038020|FG000|PART II|Physician Decision|0|||
128931478|NCT00957372|464038021|FG001|PART II|Physician Decision|0|||
128931479|NCT00957372|464038022|FG002|PART II|Physician Decision|0|||
128931480|NCT00957372|464038023|FG003|PART II|Physician Decision|1|||
128931481|NCT00957372|464038020|FG000|PART II|Pregnancy|0|||
128931482|NCT00957372|464038021|FG001|PART II|Pregnancy|0|||
128931483|NCT00957372|464038022|FG002|PART II|Pregnancy|0|||
128931484|NCT00957372|464038023|FG003|PART II|Pregnancy|1|||
128931485|NCT00957372|464038020|FG000|PART II|Not Know|0|||
128931486|NCT00957372|464038021|FG001|PART II|Not Know|0|||
128931487|NCT00957372|464038022|FG002|PART II|Not Know|0|||
128931488|NCT00957372|464038023|FG003|PART II|Not Know|20|||
128931489|NCT00957372|464038020|FG000|PART II|Adverse Event|0|||
128931490|NCT00957372|464038021|FG001|PART II|Adverse Event|0|||
128931491|NCT00957372|464038022|FG002|PART II|Adverse Event|0|||
128931492|NCT00957372|464038023|FG003|PART II|Adverse Event|10|||
128931493|NCT00957372|464038020|FG000|PART II|Patient non-compliance|0|||
128931494|NCT00957372|464038021|FG001|PART II|Patient non-compliance|0|||
128931495|NCT00957372|464038022|FG002|PART II|Patient non-compliance|0|||
128931496|NCT00957372|464038023|FG003|PART II|Patient non-compliance|4|||
128931497|NCT01444391|464038024|FG000|Overall Study|Death|1|||
128931498|NCT02209597|464038027|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
128931499|NCT02209597|464038027|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
128931500|NCT02209597|464038027|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
128931501|NCT02209597|464038027|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
128931502|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Adverse Event|37|||
128931503|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Adverse Event|0|||
128931504|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Adverse Event|0|||
128931505|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Adverse Event|0|||
128931506|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Death|2|||
128931507|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Death|0|||
128931508|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Death|0|||
128931509|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Death|0|||
128931510|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
128931511|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
128931512|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
128931513|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
128931514|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
128931515|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
128767547|NCT02762981|463440303|FG004|Overall Study|Adverse Event|3|||
128931516|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
128931517|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
129121027|NCT01232283|464739109|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
129121028|NCT01232283|464739110|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
128931518|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
128931519|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
128931520|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
128931521|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
128931522|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
128931523|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
128931524|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
128931525|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
129121029|NCT01232283|464739111|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129121030|NCT01232283|464739112|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129121031|NCT01232283|464739113|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129121032|NCT01232283|464739114|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129121033|NCT01232283|464739115|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129121034|NCT01232283|464739116|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129121035|NCT01232283|464739107|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121036|NCT01232283|464739108|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121037|NCT01232283|464739109|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
129121038|NCT01232283|464739110|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
129121039|NCT01232283|464739111|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121040|NCT01232283|464739112|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121041|NCT01232283|464739113|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121042|NCT01232283|464739114|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121043|NCT01232283|464739115|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121044|NCT01232283|464739116|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129121045|NCT01232283|464739107|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121046|NCT01232283|464739108|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121047|NCT01232283|464739109|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
129121048|NCT01232283|464739110|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
129121049|NCT01232283|464739111|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121050|NCT01232283|464739112|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121051|NCT01232283|464739113|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121052|NCT01232283|464739114|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121053|NCT01232283|464739115|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121054|NCT01232283|464739116|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129121055|NCT01232283|464739107|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
129121056|NCT01232283|464739108|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
129121057|NCT01232283|464739109|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
129121058|NCT01232283|464739110|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
129121059|NCT01232283|464739111|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
129121060|NCT01232283|464739112|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
129121061|NCT01232283|464739113|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
129121062|NCT01232283|464739114|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
129121063|NCT01232283|464739115|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
129121064|NCT01232283|464739116|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
129121065|NCT01232283|464739107|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129121066|NCT01232283|464739108|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129121067|NCT01232283|464739109|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129121068|NCT01232283|464739110|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129121069|NCT01232283|464739111|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
129121070|NCT01232283|464739112|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
129121071|NCT01232283|464739113|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129216658|NCT00719472|465094749|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
129216659|NCT00719472|465094749|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
129216660|NCT00719472|465094749|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
128702601|NCT01587001|463209458|FG000|Overall Study|Insufficient samples to complete testing|4|||
128702602|NCT01587001|463209459|FG001|Overall Study|Insufficient samples to complete testing|1|||
128931526|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Physician Decision|4|||
128931527|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Physician Decision|0|||
128931528|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Physician Decision|0|||
128931529|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Physician Decision|0|||
128931530|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Pregnancy|1|||
128931531|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Pregnancy|0|||
128931532|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Pregnancy|0|||
128931533|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Pregnancy|0|||
128931534|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
128931535|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
128931536|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
128931537|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
128931538|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
128702603|NCT02756013|463209462|FG000|Overall Study|Adverse Event|1|||
128702604|NCT02756013|463209462|FG000|Overall Study|Hypersensitivity|1|||
128702605|NCT03334539|463209463|FG000|Overall Study|Adverse Event|3|||
128702606|NCT03334539|463209464|FG001|Overall Study|Adverse Event|5|||
128702607|NCT03334539|463209465|FG002|Overall Study|Adverse Event|0|||
128702608|NCT03334539|463209463|FG000|Overall Study|Withdrawal by Subject|0|||
128931539|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
128931540|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
128931541|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
128931542|NCT01855789|464038029|FG000|1) Baseline up to Week 24|Other|4|||
128931543|NCT01855789|464038030|FG001|1) Baseline up to Week 24|Other|0|||
128931544|NCT01855789|464038031|FG002|1) Baseline up to Week 24|Other|0|||
128931545|NCT01855789|464038032|FG003|1) Baseline up to Week 24|Other|0|||
128931546|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
128931547|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
128931548|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
128931549|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
128931550|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
128931551|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
128931552|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
128931553|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
128931554|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
128931555|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
128931556|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
128931557|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
128931558|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
128931559|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
128931560|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
128931561|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
128767548|NCT02762981|463440299|FG000|Overall Study|Physician Decision|0|||
128931562|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
129121072|NCT01232283|464739114|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
129121073|NCT01232283|464739115|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129121074|NCT01232283|464739116|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129121075|NCT01232283|464739107|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129121076|NCT01232283|464739108|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129121077|NCT01232283|464739109|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129121078|NCT01232283|464739110|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129121079|NCT01232283|464739111|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
129121080|NCT01232283|464739112|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129121081|NCT01232283|464739113|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
129121082|NCT01232283|464739114|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
129121083|NCT01232283|464739115|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129121084|NCT01232283|464739116|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129121085|NCT01232283|464739107|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129121086|NCT01232283|464739108|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129121087|NCT01232283|464739109|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129121088|NCT01232283|464739110|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129121089|NCT01232283|464739111|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
129121090|NCT01232283|464739112|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
129121091|NCT01232283|464739113|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
129121092|NCT01232283|464739114|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
129121093|NCT01232283|464739115|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129121094|NCT01232283|464739116|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129121095|NCT01232283|464739107|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121096|NCT01232283|464739108|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121097|NCT01232283|464739109|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121098|NCT01232283|464739110|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121099|NCT01232283|464739111|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
129121100|NCT01232283|464739112|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121101|NCT01232283|464739113|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121102|NCT01232283|464739114|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121103|NCT01232283|464739115|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121104|NCT01232283|464739116|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129121105|NCT01232283|464739107|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129121106|NCT01232283|464739108|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129121107|NCT01232283|464739109|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129216661|NCT01244893|465094750|FG000|Baseline|Protocol Violation|0|||
129216662|NCT01244893|465094751|FG001|Baseline|Protocol Violation|1|||
128931563|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
128931564|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
128931565|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
128931566|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
128931567|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
128931568|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
129121108|NCT01232283|464739110|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129121109|NCT01232283|464739111|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
129121110|NCT01232283|464739112|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129121111|NCT01232283|464739113|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
129121112|NCT01232283|464739114|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
129121113|NCT01232283|464739115|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129121114|NCT01232283|464739116|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129121115|NCT01232283|464739107|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121116|NCT01232283|464739108|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121117|NCT01232283|464739109|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121118|NCT01232283|464739110|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121119|NCT01232283|464739111|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121120|NCT01232283|464739112|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121121|NCT01232283|464739113|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121122|NCT01232283|464739114|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
129121123|NCT01232283|464739115|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121124|NCT01232283|464739116|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129121125|NCT01232283|464739107|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121126|NCT01232283|464739108|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121127|NCT01232283|464739109|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121128|NCT01232283|464739110|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121129|NCT01232283|464739111|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121130|NCT01232283|464739112|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
129121131|NCT01232283|464739113|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121132|NCT01232283|464739114|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121133|NCT01232283|464739115|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121134|NCT01232283|464739116|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129121135|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121136|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121137|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121138|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121139|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121140|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121141|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121142|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129121143|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
129121144|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
129121145|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121146|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121147|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121148|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121149|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121150|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121151|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121152|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129121153|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
129121154|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
129121155|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121156|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121157|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121158|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121159|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121160|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121161|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121162|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129121163|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
129121164|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
128931569|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
128931570|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
128931571|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
128931572|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
128931573|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
128931574|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
128931575|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
128931576|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
129121165|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121166|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121167|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121168|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121169|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121170|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121171|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121172|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129121173|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
129121174|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
129121175|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121176|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121177|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121178|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121179|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121180|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121181|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121182|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129121183|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
129121184|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
129121185|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121186|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121187|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121188|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121189|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121190|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121191|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121192|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121193|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
129121194|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129121195|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121196|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121197|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121198|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121199|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121200|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121201|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121202|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121203|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
129121204|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129121205|NCT01232283|464739107|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121206|NCT01232283|464739108|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121207|NCT01232283|464739109|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121208|NCT01232283|464739110|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121209|NCT01232283|464739111|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121210|NCT01232283|464739112|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121211|NCT01232283|464739113|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121212|NCT01232283|464739114|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129121213|NCT01232283|464739115|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
129121214|NCT01232283|464739116|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
129121215|NCT02792504|464739119|FG000|Overall Study|Lost to Follow-up|24|||
129121216|NCT02792504|464739119|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
129121217|NCT00848497|464739126|FG000|Overall Study|Screen failure|2|||
129121218|NCT00848497|464739127|FG001|Overall Study|Screen failure|0|||
129121219|NCT00848497|464739126|FG000|Overall Study|Withdrawal by Subject|0|||
129121220|NCT00848497|464739127|FG001|Overall Study|Withdrawal by Subject|1|||
129121221|NCT02966834|464739128|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129121222|NCT02966834|464739129|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129121223|NCT02966834|464739130|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129121224|NCT02966834|464739131|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129121225|NCT02966834|464739132|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
129216663|NCT01244893|465094750|FG000|1-Week Follow Up|Lost to Follow-up|1|||
129216664|NCT01244893|465094751|FG001|1-Week Follow Up|Lost to Follow-up|0|||
129216665|NCT00357552|465094752|FG000|Screening|Did not meet eligibility criteria|84|||
129216666|NCT00357552|465094752|FG000|Weeks 0 to 24|Death|1|||
129216667|NCT00357552|465094752|FG000|Weeks 24 to 104|Death|3|||
129121226|NCT02966834|464739133|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129121227|NCT02966834|464739128|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
129121228|NCT02966834|464739129|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129121229|NCT02966834|464739130|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129121230|NCT02966834|464739131|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129121231|NCT02966834|464739132|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129121232|NCT02966834|464739133|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129121233|NCT02966834|464739128|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
129121234|NCT02966834|464739129|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
129121235|NCT02966834|464739130|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
129121236|NCT02966834|464739131|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
129121237|NCT02966834|464739132|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
129121238|NCT02966834|464739133|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
129121239|NCT02966834|464739128|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
129121240|NCT02966834|464739129|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
129121241|NCT02966834|464739130|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
129121242|NCT02966834|464739131|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
129121243|NCT02966834|464739132|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
129121244|NCT02966834|464739133|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
129121245|NCT02966834|464739128|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129121246|NCT02966834|464739129|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129121247|NCT02966834|464739130|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129121248|NCT02966834|464739131|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
129121249|NCT02966834|464739132|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128931577|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
128931578|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
128931579|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
129121250|NCT02966834|464739133|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129121251|NCT02966834|464739128|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129121252|NCT02966834|464739129|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129121253|NCT02966834|464739130|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129121254|NCT02966834|464739131|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
129121255|NCT02966834|464739132|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
128931580|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
128931581|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
128931582|NCT01855789|464038029|FG000|2) Week 24 up to End of Study|Other|0|||
129121256|NCT02966834|464739133|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129121257|NCT03729362|464741100|FG000|Overall Study|Withdrawal by Subject|2|||
129121258|NCT03729362|464741101|FG001|Overall Study|Withdrawal by Subject|0|||
129121259|NCT03729362|464741100|FG000|Overall Study|Physician Decision|1|||
129121260|NCT03729362|464741101|FG001|Overall Study|Physician Decision|0|||
129121261|NCT03729362|464741100|FG000|Overall Study|COVID-19 Pandemic|1|||
129121262|NCT03729362|464741101|FG001|Overall Study|COVID-19 Pandemic|0|||
129121263|NCT03729362|464741100|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
129121264|NCT03729362|464741101|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
129121265|NCT03729362|464741100|FG000|Overall Study|Adverse Event|0|||
129121266|NCT03729362|464741101|FG001|Overall Study|Adverse Event|1|||
129121267|NCT03729362|464741100|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
129121268|NCT03729362|464741101|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
129121269|NCT02711137|464741102|FG000|Overall Study|Death|1|||
129121270|NCT02711137|464741103|FG001|Overall Study|Death|4|||
129121271|NCT02711137|464741104|FG002|Overall Study|Death|5|||
129121272|NCT02711137|464741105|FG003|Overall Study|Death|5|||
129121273|NCT02711137|464741106|FG004|Overall Study|Death|3|||
129121274|NCT02711137|464741107|FG005|Overall Study|Death|1|||
129121275|NCT02711137|464741108|FG006|Overall Study|Death|61|||
129121276|NCT02711137|464741109|FG007|Overall Study|Death|3|||
128931583|NCT01855789|464038030|FG001|2) Week 24 up to End of Study|Other|0|||
128931584|NCT01855789|464038031|FG002|2) Week 24 up to End of Study|Other|0|||
129121277|NCT02711137|464741110|FG008|Overall Study|Death|0|||
128931585|NCT01855789|464038032|FG003|2) Week 24 up to End of Study|Other|1|||
128931586|NCT03067311|464038033|FG000|Overall Study|Lost to Follow-up|1|||
129121278|NCT02711137|464741111|FG009|Overall Study|Death|1|||
129121279|NCT02711137|464741112|FG010|Overall Study|Death|1|||
129121280|NCT02711137|464741113|FG011|Overall Study|Death|1|||
129121281|NCT02711137|464741114|FG012|Overall Study|Death|0|||
129121282|NCT02711137|464741115|FG013|Overall Study|Death|0|||
129121283|NCT02711137|464741116|FG014|Overall Study|Death|0|||
129121284|NCT02711137|464741102|FG000|Overall Study|Study Terminated by Sponsor|0|||
129121285|NCT02711137|464741103|FG001|Overall Study|Study Terminated by Sponsor|0|||
128931587|NCT03067311|464038034|FG001|Overall Study|Lost to Follow-up|1|||
128931588|NCT03067311|464038033|FG000|Overall Study|Moved away|1|||
129121286|NCT02711137|464741104|FG002|Overall Study|Study Terminated by Sponsor|1|||
129121287|NCT02711137|464741105|FG003|Overall Study|Study Terminated by Sponsor|0|||
129121288|NCT02711137|464741106|FG004|Overall Study|Study Terminated by Sponsor|0|||
129121289|NCT02711137|464741107|FG005|Overall Study|Study Terminated by Sponsor|0|||
128931589|NCT03067311|464038034|FG001|Overall Study|Moved away|1|||
128931590|NCT02031146|464039547|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
129121290|NCT02711137|464741108|FG006|Overall Study|Study Terminated by Sponsor|1|||
129121291|NCT02711137|464741109|FG007|Overall Study|Study Terminated by Sponsor|0|||
129121292|NCT02711137|464741110|FG008|Overall Study|Study Terminated by Sponsor|0|||
129121293|NCT02711137|464741111|FG009|Overall Study|Study Terminated by Sponsor|0|||
129121294|NCT02711137|464741112|FG010|Overall Study|Study Terminated by Sponsor|0|||
129121295|NCT02711137|464741113|FG011|Overall Study|Study Terminated by Sponsor|0|||
129121296|NCT02711137|464741114|FG012|Overall Study|Study Terminated by Sponsor|0|||
129121297|NCT02711137|464741115|FG013|Overall Study|Study Terminated by Sponsor|0|||
129121298|NCT02711137|464741116|FG014|Overall Study|Study Terminated by Sponsor|0|||
129121299|NCT02711137|464741102|FG000|Overall Study|Physician Decision|1|||
129121300|NCT02711137|464741103|FG001|Overall Study|Physician Decision|0|||
129121301|NCT02711137|464741104|FG002|Overall Study|Physician Decision|2|||
129121302|NCT02711137|464741105|FG003|Overall Study|Physician Decision|1|||
129121303|NCT02711137|464741106|FG004|Overall Study|Physician Decision|1|||
129121304|NCT02711137|464741107|FG005|Overall Study|Physician Decision|0|||
129121305|NCT02711137|464741108|FG006|Overall Study|Physician Decision|12|||
129121306|NCT02711137|464741109|FG007|Overall Study|Physician Decision|2|||
129121307|NCT02711137|464741110|FG008|Overall Study|Physician Decision|1|||
129121308|NCT02711137|464741111|FG009|Overall Study|Physician Decision|1|||
129121309|NCT02711137|464741112|FG010|Overall Study|Physician Decision|3|||
129121310|NCT02711137|464741113|FG011|Overall Study|Physician Decision|2|||
129121311|NCT02711137|464741114|FG012|Overall Study|Physician Decision|1|||
129121312|NCT02711137|464741115|FG013|Overall Study|Physician Decision|1|||
129121313|NCT02711137|464741116|FG014|Overall Study|Physician Decision|2|||
129121314|NCT02711137|464741102|FG000|Overall Study|Other|0|||
129121315|NCT02711137|464741103|FG001|Overall Study|Other|1|||
129121316|NCT02711137|464741104|FG002|Overall Study|Other|0|||
129121317|NCT02711137|464741105|FG003|Overall Study|Other|0|||
129121318|NCT02711137|464741106|FG004|Overall Study|Other|0|||
129121319|NCT02711137|464741107|FG005|Overall Study|Other|0|||
129121320|NCT02711137|464741108|FG006|Overall Study|Other|3|||
129121321|NCT02711137|464741109|FG007|Overall Study|Other|0|||
129121322|NCT02711137|464741110|FG008|Overall Study|Other|0|||
129121323|NCT02711137|464741111|FG009|Overall Study|Other|0|||
129121324|NCT02711137|464741112|FG010|Overall Study|Other|0|||
129121325|NCT02711137|464741113|FG011|Overall Study|Other|0|||
129121326|NCT02711137|464741114|FG012|Overall Study|Other|0|||
129121327|NCT02711137|464741115|FG013|Overall Study|Other|0|||
129121328|NCT02711137|464741116|FG014|Overall Study|Other|1|||
129121329|NCT02711137|464741102|FG000|Overall Study|Withdrawal by Subject|1|||
129121330|NCT02711137|464741103|FG001|Overall Study|Withdrawal by Subject|0|||
129121331|NCT02711137|464741104|FG002|Overall Study|Withdrawal by Subject|0|||
129121332|NCT02711137|464741105|FG003|Overall Study|Withdrawal by Subject|1|||
129121333|NCT02711137|464741106|FG004|Overall Study|Withdrawal by Subject|1|||
129121334|NCT02711137|464741107|FG005|Overall Study|Withdrawal by Subject|0|||
129121335|NCT02711137|464741108|FG006|Overall Study|Withdrawal by Subject|7|||
129121336|NCT02711137|464741109|FG007|Overall Study|Withdrawal by Subject|0|||
129216668|NCT00357552|465094752|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
129216669|NCT00882557|465094755|FG000|Overall Study|Withdrawal by Subject|1|||
128931591|NCT02031146|464039548|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
128931592|NCT02031146|464039549|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
128931593|NCT02031146|464039550|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
128931594|NCT02031146|464039551|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
128978097|NCT01521494|464205313|FG003|Overall Study|Decrease in serum calcium|1|||
129121337|NCT02711137|464741110|FG008|Overall Study|Withdrawal by Subject|0|||
129121338|NCT02711137|464741111|FG009|Overall Study|Withdrawal by Subject|0|||
129121339|NCT02711137|464741112|FG010|Overall Study|Withdrawal by Subject|0|||
129121340|NCT02711137|464741113|FG011|Overall Study|Withdrawal by Subject|0|||
129121341|NCT02711137|464741114|FG012|Overall Study|Withdrawal by Subject|0|||
129121342|NCT02711137|464741115|FG013|Overall Study|Withdrawal by Subject|1|||
129121343|NCT02711137|464741116|FG014|Overall Study|Withdrawal by Subject|0|||
129121344|NCT02711137|464741102|FG000|Overall Study|Lost to Follow-up|1|||
129121345|NCT02711137|464741103|FG001|Overall Study|Lost to Follow-up|0|||
129121346|NCT02711137|464741104|FG002|Overall Study|Lost to Follow-up|0|||
129121347|NCT02711137|464741105|FG003|Overall Study|Lost to Follow-up|0|||
129121348|NCT02711137|464741106|FG004|Overall Study|Lost to Follow-up|0|||
129121349|NCT02711137|464741107|FG005|Overall Study|Lost to Follow-up|0|||
129121350|NCT02711137|464741108|FG006|Overall Study|Lost to Follow-up|2|||
129121351|NCT02711137|464741109|FG007|Overall Study|Lost to Follow-up|0|||
129121352|NCT02711137|464741110|FG008|Overall Study|Lost to Follow-up|0|||
129121353|NCT02711137|464741111|FG009|Overall Study|Lost to Follow-up|0|||
129216670|NCT00882557|465094756|FG001|Overall Study|Withdrawal by Subject|0|||
129121354|NCT02711137|464741112|FG010|Overall Study|Lost to Follow-up|0|||
129121355|NCT02711137|464741113|FG011|Overall Study|Lost to Follow-up|0|||
129121356|NCT02711137|464741114|FG012|Overall Study|Lost to Follow-up|0|||
129121357|NCT02711137|464741115|FG013|Overall Study|Lost to Follow-up|0|||
129121358|NCT02711137|464741116|FG014|Overall Study|Lost to Follow-up|0|||
129121359|NCT01113749|464741117|FG000|Overall Study|Lost to Follow-up|1|||
129121360|NCT01113749|464741118|FG001|Overall Study|Lost to Follow-up|2|||
129121361|NCT03427892|464741119|FG000|Overall Study|Lost to Follow-up|2|||
129121362|NCT00548327|464741120|FG000|Overall Study|Adverse Event|0|||
129121363|NCT00548327|464741121|FG001|Overall Study|Adverse Event|1|||
129121364|NCT00274456|464741125|FG000|Overall Study|Still on treatment|2|||
129121365|NCT00274456|464741126|FG001|Overall Study|Still on treatment|3|||
129121366|NCT00274456|464741127|FG002|Overall Study|Still on treatment|5|||
129121367|NCT00274456|464741128|FG003|Overall Study|Still on treatment|1|||
129121368|NCT00274456|464741125|FG000|Overall Study|Unacceptable toxicity|10|||
129121369|NCT00274456|464741126|FG001|Overall Study|Unacceptable toxicity|5|||
129121370|NCT00274456|464741127|FG002|Overall Study|Unacceptable toxicity|12|||
129121371|NCT00274456|464741128|FG003|Overall Study|Unacceptable toxicity|16|||
129121372|NCT00274456|464741125|FG000|Overall Study|Adverse Event|0|||
129121373|NCT00274456|464741126|FG001|Overall Study|Adverse Event|1|||
129121374|NCT00274456|464741127|FG002|Overall Study|Adverse Event|2|||
129121375|NCT00274456|464741128|FG003|Overall Study|Adverse Event|2|||
129121376|NCT00274456|464741125|FG000|Overall Study|Physician Decision|7|||
129121377|NCT00274456|464741126|FG001|Overall Study|Physician Decision|5|||
129121378|NCT00274456|464741127|FG002|Overall Study|Physician Decision|6|||
129121379|NCT00274456|464741128|FG003|Overall Study|Physician Decision|13|||
129121380|NCT00274456|464741125|FG000|Overall Study|Lost to Follow-up|0|||
129121381|NCT00274456|464741126|FG001|Overall Study|Lost to Follow-up|0|||
129121382|NCT00274456|464741127|FG002|Overall Study|Lost to Follow-up|1|||
129121383|NCT00274456|464741128|FG003|Overall Study|Lost to Follow-up|0|||
129121384|NCT00274456|464741125|FG000|Overall Study|Withdrawal by Subject|18|||
129121385|NCT00274456|464741126|FG001|Overall Study|Withdrawal by Subject|13|||
129121386|NCT00274456|464741127|FG002|Overall Study|Withdrawal by Subject|9|||
129121387|NCT00274456|464741128|FG003|Overall Study|Withdrawal by Subject|13|||
129121388|NCT03255187|464741129|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
129121389|NCT03255187|464741130|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
129121390|NCT03255187|464741129|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
129121391|NCT03255187|464741130|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
128702609|NCT03334539|463209464|FG001|Overall Study|Withdrawal by Subject|1|||
128702610|NCT03334539|463209465|FG002|Overall Study|Withdrawal by Subject|1|||
128702611|NCT03334539|463209463|FG000|Overall Study|Administrative Reasons|1|||
128702612|NCT03334539|463209464|FG001|Overall Study|Administrative Reasons|0|||
128702613|NCT03334539|463209465|FG002|Overall Study|Administrative Reasons|0|||
128931595|NCT02031146|464039552|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
128931596|NCT02031146|464039553|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
128931597|NCT03937986|464039564|FG000|Overall Study|COVID-19 Pandemic|1|||
129216671|NCT00882557|465094755|FG000|Overall Study|Trouble with Vein Access|1|||
129216672|NCT00882557|465094756|FG001|Overall Study|Trouble with Vein Access|0|||
129216673|NCT00882557|465094755|FG000|Overall Study|Randomized Not Treated|0|||
129216674|NCT00882557|465094756|FG001|Overall Study|Randomized Not Treated|1|||
129216675|NCT03038880|465094761|FG000|Overall Study|Death|1|||
128931598|NCT02114203|464039569|FG000|Overall Study|Adverse Event|0|||
128931599|NCT02114203|464039570|FG001|Overall Study|Adverse Event|1|||
128931600|NCT02114203|464039571|FG002|Overall Study|Adverse Event|0|||
128931601|NCT02114203|464039569|FG000|Overall Study|Withdrawal by Subject|0|||
128931602|NCT02114203|464039570|FG001|Overall Study|Withdrawal by Subject|1|||
129121392|NCT00375752|464741131|FG000|Overall Study|Lack of Efficacy|4|||
129121393|NCT00375752|464741132|FG001|Overall Study|Lack of Efficacy|4|||
129121394|NCT00375752|464741131|FG000|Overall Study|Adverse Event|1|||
129121395|NCT00375752|464741132|FG001|Overall Study|Adverse Event|6|||
129216676|NCT03038880|465094762|FG001|Overall Study|Death|2|||
129216677|NCT03038880|465094763|FG002|Overall Study|Death|0|||
128931603|NCT02114203|464039571|FG002|Overall Study|Withdrawal by Subject|0|||
129121396|NCT00375752|464741131|FG000|Overall Study|Withdrawal by Subject|6|||
129121397|NCT00375752|464741132|FG001|Overall Study|Withdrawal by Subject|1|||
129121398|NCT00375752|464741131|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129121399|NCT00375752|464741132|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
129121400|NCT00375752|464741131|FG000|Overall Study|Protocol Violation|0|||
129121401|NCT00375752|464741132|FG001|Overall Study|Protocol Violation|2|||
129121402|NCT00375752|464741131|FG000|Overall Study|Administrative Problems|0|||
129121403|NCT00375752|464741132|FG001|Overall Study|Administrative Problems|1|||
129216678|NCT03038880|465094761|FG000|Overall Study|Physician Decision|2|||
128702614|NCT03334539|463209463|FG000|Overall Study|Hypertension Not Controlled|0|||
128931604|NCT01518699|464039572|FG000|Period 2|Protocol Violation|1|||
129121404|NCT02034006|464741133|FG000|Overall Study|Withdrawal by Subject|7|||
129121405|NCT02034006|464741133|FG000|Overall Study|Lost to Follow-up|5|||
129216679|NCT03038880|465094762|FG001|Overall Study|Physician Decision|1|||
129216680|NCT03038880|465094763|FG002|Overall Study|Physician Decision|0|||
128702615|NCT03334539|463209464|FG001|Overall Study|Hypertension Not Controlled|1|||
128702616|NCT03334539|463209465|FG002|Overall Study|Hypertension Not Controlled|0|||
128702617|NCT00968201|463209466|FG000|Base Study - (Period II)|Adverse Event|8|||
128702618|NCT00968201|463209467|FG001|Base Study - (Period II)|Adverse Event|0|||
128931605|NCT01518699|464039573|FG001|Period 2|Protocol Violation|1|||
128931606|NCT01518699|464039574|FG002|Period 2|Protocol Violation|0|||
128931607|NCT01518699|464039575|FG003|Period 2|Protocol Violation|0|||
128931608|NCT01518699|464039576|FG004|Period 2|Protocol Violation|0|||
128931609|NCT01518699|464039577|FG005|Period 2|Protocol Violation|0|||
128931610|NCT01518699|464039572|FG000|Period 2|Lost to Follow-up|0|||
128931611|NCT01518699|464039573|FG001|Period 2|Lost to Follow-up|1|||
128931612|NCT01518699|464039574|FG002|Period 2|Lost to Follow-up|0|||
128931613|NCT01518699|464039575|FG003|Period 2|Lost to Follow-up|0|||
128931614|NCT01518699|464039576|FG004|Period 2|Lost to Follow-up|0|||
128931615|NCT01518699|464039577|FG005|Period 2|Lost to Follow-up|0|||
128931616|NCT01518699|464039572|FG000|Period 2|Adverse Event|1|||
128931617|NCT01518699|464039573|FG001|Period 2|Adverse Event|0|||
128931618|NCT01518699|464039574|FG002|Period 2|Adverse Event|0|||
128931619|NCT01518699|464039575|FG003|Period 2|Adverse Event|0|||
128931620|NCT01518699|464039576|FG004|Period 2|Adverse Event|0|||
128931621|NCT01518699|464039577|FG005|Period 2|Adverse Event|0|||
128931622|NCT02839746|464039579|FG000|Overall Study|Not met selection criteria|12|||
129030724|NCT02614196|464403210|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
129030725|NCT02614196|464403211|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
129030726|NCT02614196|464403212|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
129030727|NCT00640341|464404677|FG000|Overall Study|Adverse Event|0|||
129030728|NCT00640341|464404678|FG001|Overall Study|Adverse Event|0|||
129030729|NCT00640341|464404679|FG002|Overall Study|Adverse Event|1|||
129030730|NCT00640341|464404677|FG000|Overall Study|Positive Slit Lamp Findings|0|||
129030731|NCT00640341|464404678|FG001|Overall Study|Positive Slit Lamp Findings|0|||
129030732|NCT00640341|464404679|FG002|Overall Study|Positive Slit Lamp Findings|1|||
129030733|NCT00640341|464404677|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
129030734|NCT00640341|464404678|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
129030735|NCT00640341|464404679|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
129030736|NCT00640341|464404677|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
129030737|NCT00640341|464404678|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
129030738|NCT00640341|464404679|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
129030739|NCT00640341|464404677|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
129030740|NCT00640341|464404678|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
129030741|NCT00640341|464404679|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
129030742|NCT00640341|464404677|FG000|Overall Study|Lost to Follow-up|2|||
129030743|NCT00640341|464404678|FG001|Overall Study|Lost to Follow-up|0|||
129030744|NCT00640341|464404679|FG002|Overall Study|Lost to Follow-up|0|||
129030745|NCT00640341|464404677|FG000|Overall Study|Withdrawal by Subject|4|||
129030746|NCT00640341|464404678|FG001|Overall Study|Withdrawal by Subject|0|||
129030747|NCT00640341|464404679|FG002|Overall Study|Withdrawal by Subject|1|||
129030748|NCT00640341|464404677|FG000|Overall Study|Unacceptable Lens Movement|1|||
129030749|NCT00640341|464404678|FG001|Overall Study|Unacceptable Lens Movement|0|||
129030750|NCT00640341|464404679|FG002|Overall Study|Unacceptable Lens Movement|0|||
129030751|NCT00640341|464404677|FG000|Overall Study|Poor fit/Uncomfortable|4|||
129030752|NCT00640341|464404678|FG001|Overall Study|Poor fit/Uncomfortable|0|||
129030753|NCT00640341|464404679|FG002|Overall Study|Poor fit/Uncomfortable|0|||
129030754|NCT00640341|464404677|FG000|Overall Study|Ineligable at Baseline|5|||
129030755|NCT00640341|464404678|FG001|Overall Study|Ineligable at Baseline|3|||
129030756|NCT00640341|464404679|FG002|Overall Study|Ineligable at Baseline|2|||
129030757|NCT00640341|464404677|FG000|Overall Study|Adverse event and positive slit lamp|1|||
129030758|NCT00640341|464404678|FG001|Overall Study|Adverse event and positive slit lamp|0|||
129030759|NCT00640341|464404679|FG002|Overall Study|Adverse event and positive slit lamp|0|||
129030760|NCT01691430|464404680|FG000|Overall Study|Death|17|||
129030761|NCT01691430|464404681|FG001|Overall Study|Death|16|||
129030762|NCT01691430|464404680|FG000|Overall Study|Withdrawal by Subject|5|||
129030763|NCT01691430|464404681|FG001|Overall Study|Withdrawal by Subject|1|||
129030764|NCT01691430|464404680|FG000|Overall Study|Lost to Follow-up|0|||
129030765|NCT01691430|464404681|FG001|Overall Study|Lost to Follow-up|3|||
129030766|NCT00660387|464404685|FG000|Overall Study|Adverse Event|1|||
129030767|NCT00660387|464404686|FG001|Overall Study|Adverse Event|2|||
129030768|NCT00660387|464404685|FG000|Overall Study|Lack of Efficacy|0|||
129030769|NCT00660387|464404686|FG001|Overall Study|Lack of Efficacy|1|||
129030770|NCT00660387|464404685|FG000|Overall Study|Protocol Violation|1|||
129030771|NCT00660387|464404686|FG001|Overall Study|Protocol Violation|0|||
128931623|NCT00744055|464039580|FG000|Overall Study|Withdrawal by Subject|6|||
128931624|NCT00744055|464039581|FG001|Overall Study|Withdrawal by Subject|9|||
128931625|NCT00744055|464039580|FG000|Overall Study|Lack of Efficacy|0|||
128931626|NCT00744055|464039581|FG001|Overall Study|Lack of Efficacy|1|||
128931627|NCT00744055|464039580|FG000|Overall Study|Physician Decision|0|||
129121406|NCT02034006|464741133|FG000|Overall Study|Death|1|||
129121407|NCT02034006|464741133|FG000|Overall Study|Pregnancy|1|||
129121408|NCT00109343|464741134|FG000|Overall Study|Adverse Event|1|||
129121409|NCT00109343|464741135|FG001|Overall Study|Adverse Event|0|||
129121410|NCT00109343|464741136|FG002|Overall Study|Adverse Event|2|||
129121411|NCT00109343|464741134|FG000|Overall Study|Lack of Efficacy|1|||
129121412|NCT00109343|464741135|FG001|Overall Study|Lack of Efficacy|0|||
129121413|NCT00109343|464741136|FG002|Overall Study|Lack of Efficacy|0|||
128702619|NCT00968201|463209468|FG002|Base Study - (Period II)|Adverse Event|16|||
128702620|NCT00968201|463209466|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
128702621|NCT00968201|463209467|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
128702622|NCT00968201|463209468|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
128702623|NCT00968201|463209466|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
128702624|NCT00968201|463209467|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
128702625|NCT00968201|463209468|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
128702626|NCT00968201|463209466|FG000|Base Study - (Period II)|Protocol Violation|12|||
128702627|NCT00968201|463209467|FG001|Base Study - (Period II)|Protocol Violation|0|||
128702628|NCT00968201|463209468|FG002|Base Study - (Period II)|Protocol Violation|12|||
128702629|NCT00968201|463209466|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
128702630|NCT00968201|463209467|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
128702631|NCT00968201|463209468|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
128702632|NCT00968201|463209466|FG000|Base Study - (Period II)|Site Error|0|||
128702633|NCT00968201|463209467|FG001|Base Study - (Period II)|Site Error|0|||
128702634|NCT00968201|463209468|FG002|Base Study - (Period II)|Site Error|1|||
128702635|NCT00968201|463209466|FG000|Extension Study - (Period III)|Adverse Event|0|||
128702636|NCT00968201|463209467|FG001|Extension Study - (Period III)|Adverse Event|5|||
128702637|NCT00968201|463209468|FG002|Extension Study - (Period III)|Adverse Event|22|||
128702638|NCT00968201|463209466|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
128702639|NCT00968201|463209467|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
128702640|NCT00968201|463209468|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
128702641|NCT00968201|463209466|FG000|Extension Study - (Period III)|Protocol Violation|0|||
128702642|NCT00968201|463209467|FG001|Extension Study - (Period III)|Protocol Violation|17|||
128702643|NCT00968201|463209468|FG002|Extension Study - (Period III)|Protocol Violation|14|||
128702644|NCT00968201|463209466|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
128702645|NCT00968201|463209467|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
128702646|NCT00968201|463209468|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
128702647|NCT00968201|463209466|FG000|Extension Study - (Period III)|Patient Relocated|0|||
128702648|NCT00968201|463209467|FG001|Extension Study - (Period III)|Patient Relocated|1|||
128702649|NCT00968201|463209468|FG002|Extension Study - (Period III)|Patient Relocated|1|||
128702650|NCT00968201|463209466|FG000|Extension Study - (Period III)|Noncompliance|0|||
128702651|NCT00968201|463209467|FG001|Extension Study - (Period III)|Noncompliance|0|||
128702652|NCT00968201|463209468|FG002|Extension Study - (Period III)|Noncompliance|3|||
128702653|NCT00968201|463209466|FG000|Extension Study - (Period III)|Other|0|||
128702654|NCT00968201|463209467|FG001|Extension Study - (Period III)|Other|0|||
128702655|NCT00968201|463209468|FG002|Extension Study - (Period III)|Other|2|||
128702656|NCT00968201|463209466|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
128702657|NCT00968201|463209467|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
128702658|NCT00968201|463209468|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
128702659|NCT04974697|463209470|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
128702660|NCT04974697|463209470|FG000|Overall Study|Lens discomfort|1|||
128702661|NCT03706456|463209471|FG000|Overall Study|Adverse Event|1|||
128702662|NCT03706456|463209471|FG000|Overall Study|Lack of Efficacy|2|||
128702663|NCT02784431|463209472|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
128702664|NCT02784431|463209472|FG000|Overall Study|Early Study Termination|19|||
128931628|NCT00744055|464039581|FG001|Overall Study|Physician Decision|2|||
128931629|NCT00744055|464039580|FG000|Overall Study|Protocol Violation|1|||
128931630|NCT00744055|464039581|FG001|Overall Study|Protocol Violation|1|||
128931631|NCT00744055|464039580|FG000|Overall Study|Lost to Follow-up|0|||
129121414|NCT00109343|464741134|FG000|Overall Study|Lost to Follow-up|35|||
128702665|NCT02010775|463209473|FG000|Overall Study|Adverse Event|0|||
128702666|NCT02010775|463209474|FG001|Overall Study|Adverse Event|0|||
128702667|NCT02010775|463209475|FG002|Overall Study|Adverse Event|0|||
128931632|NCT00744055|464039581|FG001|Overall Study|Lost to Follow-up|1|||
129121415|NCT00109343|464741135|FG001|Overall Study|Lost to Follow-up|20|||
129121416|NCT00109343|464741136|FG002|Overall Study|Lost to Follow-up|14|||
129121417|NCT00109343|464741134|FG000|Overall Study|Protocol Violation|1|||
129121418|NCT00109343|464741135|FG001|Overall Study|Protocol Violation|2|||
128702668|NCT02010775|463209476|FG003|Overall Study|Adverse Event|0|||
128702669|NCT02010775|463209477|FG004|Overall Study|Adverse Event|1|||
128702670|NCT02010775|463209473|FG000|Overall Study|Pregnancy|0|||
128702671|NCT02010775|463209474|FG001|Overall Study|Pregnancy|0|||
128702672|NCT02010775|463209475|FG002|Overall Study|Pregnancy|2|||
128702673|NCT02010775|463209476|FG003|Overall Study|Pregnancy|0|||
128931633|NCT02767570|464039582|FG000|Overall Study|Lost to Follow-up|3|||
129121419|NCT00109343|464741136|FG002|Overall Study|Protocol Violation|2|||
128931634|NCT02767570|464039583|FG001|Overall Study|Lost to Follow-up|0|||
128931635|NCT02767570|464039582|FG000|Overall Study|COVID shutdown|2|||
128931636|NCT02767570|464039583|FG001|Overall Study|COVID shutdown|5|||
128931637|NCT02767570|464039582|FG000|Overall Study|Increased pain|2|||
128931638|NCT02767570|464039583|FG001|Overall Study|Increased pain|0|||
128931639|NCT02767570|464039582|FG000|Overall Study|Withdrawal by Subject|1|||
128931640|NCT02767570|464039583|FG001|Overall Study|Withdrawal by Subject|3|||
128931641|NCT02767570|464039582|FG000|Overall Study|Unrelated medical issue|1|||
128931642|NCT02767570|464039583|FG001|Overall Study|Unrelated medical issue|1|||
128931643|NCT02767570|464039582|FG000|Overall Study|Received intra-articular injection|0|||
128931644|NCT02767570|464039583|FG001|Overall Study|Received intra-articular injection|1|||
128931645|NCT04328623|464039586|FG000|Overall Study|Protocol Violation|0|||
128931646|NCT04328623|464039587|FG001|Overall Study|Protocol Violation|1|||
128931647|NCT00849693|464039588|FG000|Acute Treatment Phase|Adverse Event|12|||
128931648|NCT00849693|464039589|FG001|Acute Treatment Phase|Adverse Event|7|||
128931649|NCT00849693|464039590|FG002|Acute Treatment Phase|Adverse Event|6|||
128931650|NCT00849693|464039591|FG003|Acute Treatment Phase|Adverse Event|4|||
128931651|NCT00849693|464039588|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
128931652|NCT00849693|464039589|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
128931653|NCT00849693|464039590|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
128931654|NCT00849693|464039591|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
128931655|NCT00849693|464039588|FG000|Acute Treatment Phase|Protocol Violation|1|||
128931656|NCT00849693|464039589|FG001|Acute Treatment Phase|Protocol Violation|5|||
128931657|NCT00849693|464039590|FG002|Acute Treatment Phase|Protocol Violation|2|||
128931658|NCT00849693|464039591|FG003|Acute Treatment Phase|Protocol Violation|6|||
128931659|NCT00849693|464039588|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
128931660|NCT00849693|464039589|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
128931661|NCT00849693|464039590|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
128931662|NCT00849693|464039591|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
128931663|NCT00849693|464039588|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
128931664|NCT00849693|464039589|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
128931665|NCT00849693|464039590|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
128931666|NCT00849693|464039591|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
128931667|NCT00849693|464039588|FG000|Acute Treatment Phase|Physician Decision|2|||
128931668|NCT00849693|464039589|FG001|Acute Treatment Phase|Physician Decision|1|||
128931669|NCT00849693|464039590|FG002|Acute Treatment Phase|Physician Decision|2|||
128931670|NCT00849693|464039591|FG003|Acute Treatment Phase|Physician Decision|1|||
128931671|NCT00849693|464039588|FG000|Acute Treatment Phase|Sponsor decision|0|||
128931672|NCT00849693|464039589|FG001|Acute Treatment Phase|Sponsor decision|0|||
128931673|NCT00849693|464039590|FG002|Acute Treatment Phase|Sponsor decision|1|||
128931674|NCT00849693|464039591|FG003|Acute Treatment Phase|Sponsor decision|0|||
128931675|NCT00849693|464039588|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
128931676|NCT00849693|464039589|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
128931677|NCT00849693|464039590|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
128931678|NCT00849693|464039591|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
128931679|NCT00849693|464039588|FG000|Extension Phase|Adverse Event|4|||
128931680|NCT00849693|464039589|FG001|Extension Phase|Adverse Event|6|||
128931681|NCT00849693|464039590|FG002|Extension Phase|Adverse Event|3|||
128931682|NCT00849693|464039591|FG003|Extension Phase|Adverse Event|7|||
128931683|NCT00849693|464039588|FG000|Extension Phase|Lost to Follow-up|7|||
128931684|NCT00849693|464039589|FG001|Extension Phase|Lost to Follow-up|5|||
128931685|NCT00849693|464039590|FG002|Extension Phase|Lost to Follow-up|6|||
128931686|NCT00849693|464039591|FG003|Extension Phase|Lost to Follow-up|6|||
128931687|NCT00849693|464039588|FG000|Extension Phase|Protocol Violation|0|||
128931688|NCT00849693|464039589|FG001|Extension Phase|Protocol Violation|3|||
128931689|NCT00849693|464039590|FG002|Extension Phase|Protocol Violation|2|||
128931690|NCT00849693|464039591|FG003|Extension Phase|Protocol Violation|3|||
128931691|NCT00849693|464039588|FG000|Extension Phase|Withdrawal by Subject|6|||
128931692|NCT00849693|464039589|FG001|Extension Phase|Withdrawal by Subject|9|||
128931693|NCT00849693|464039590|FG002|Extension Phase|Withdrawal by Subject|10|||
128931694|NCT00849693|464039591|FG003|Extension Phase|Withdrawal by Subject|15|||
128931695|NCT00849693|464039588|FG000|Extension Phase|Parent or caregiver decision|9|||
128931696|NCT00849693|464039589|FG001|Extension Phase|Parent or caregiver decision|4|||
128931697|NCT00849693|464039590|FG002|Extension Phase|Parent or caregiver decision|10|||
128931698|NCT00849693|464039591|FG003|Extension Phase|Parent or caregiver decision|5|||
128931699|NCT00849693|464039588|FG000|Extension Phase|Physician Decision|1|||
128931700|NCT00849693|464039589|FG001|Extension Phase|Physician Decision|1|||
129030772|NCT01023061|464404691|FG000|Overall Study|Withdrawal prior to treatment|2|||
129030773|NCT02966340|464404692|FG000|Overall Study|Adverse Event|0|||
128767549|NCT02762981|463440300|FG001|Overall Study|Physician Decision|1|||
128931701|NCT00849693|464039590|FG002|Extension Phase|Physician Decision|2|||
128931702|NCT00849693|464039591|FG003|Extension Phase|Physician Decision|0|||
129030774|NCT02966340|464404693|FG001|Overall Study|Adverse Event|1|||
128931703|NCT00849693|464039588|FG000|Extension Phase|Sponsor decision|1|||
128931704|NCT00849693|464039589|FG001|Extension Phase|Sponsor decision|0|||
129121420|NCT00109343|464741134|FG000|Overall Study|Withdrawal by Subject|15|||
129121421|NCT00109343|464741135|FG001|Overall Study|Withdrawal by Subject|11|||
128931705|NCT00849693|464039590|FG002|Extension Phase|Sponsor decision|0|||
128931706|NCT00849693|464039591|FG003|Extension Phase|Sponsor decision|1|||
129121422|NCT00109343|464741136|FG002|Overall Study|Withdrawal by Subject|10|||
129121423|NCT00109343|464741134|FG000|Overall Study|Subject Moved|6|||
129121424|NCT00109343|464741135|FG001|Overall Study|Subject Moved|2|||
129121425|NCT00109343|464741136|FG002|Overall Study|Subject Moved|1|||
129121426|NCT00109343|464741134|FG000|Overall Study|Other|5|||
129121427|NCT00109343|464741135|FG001|Overall Study|Other|2|||
129121428|NCT00109343|464741136|FG002|Overall Study|Other|1|||
129121429|NCT00750269|464741137|FG000|Overall Study|Protocol Violation|0|||
129121430|NCT00750269|464741138|FG001|Overall Study|Protocol Violation|1|||
129121431|NCT00750269|464741139|FG002|Overall Study|Protocol Violation|1|||
129121432|NCT00750269|464741140|FG003|Overall Study|Protocol Violation|2|||
129121433|NCT00750269|464741141|FG004|Overall Study|Protocol Violation|4|||
129121434|NCT00750269|464741137|FG000|Overall Study|Withdrawal by Subject|0|||
129121435|NCT00750269|464741138|FG001|Overall Study|Withdrawal by Subject|0|||
129121436|NCT00750269|464741139|FG002|Overall Study|Withdrawal by Subject|2|||
128931707|NCT00849693|464039588|FG000|Extension Phase|Lack of Efficacy|2|||
128931708|NCT00849693|464039589|FG001|Extension Phase|Lack of Efficacy|2|||
128931709|NCT00849693|464039590|FG002|Extension Phase|Lack of Efficacy|2|||
128931710|NCT00849693|464039591|FG003|Extension Phase|Lack of Efficacy|1|||
128931711|NCT00882713|464039593|FG000|Overall Study|Adverse Event|2|||
128931712|NCT00882713|464039593|FG000|Overall Study|Death|3|||
128931713|NCT00882713|464039593|FG000|Overall Study|Administrative reasons|4|||
128931714|NCT00882713|464039593|FG000|Overall Study|refused treatment/withdrew consent|4|||
128931715|NCT00882713|464039593|FG000|Overall Study|Blood transfusion|2|||
128931716|NCT00882713|464039593|FG000|Overall Study|Insufficient therapeutic response|3|||
128931717|NCT00882713|464039593|FG000|Overall Study|Failure to return|2|||
128931718|NCT00882713|464039593|FG000|Overall Study|Other - Reasons|2|||
128931719|NCT01408537|464039596|FG000|Overall Study|Withdrawal by Subject|2|||
128931720|NCT01408537|464039596|FG000|Overall Study|Protocol Violation|3|||
128931721|NCT01408537|464039596|FG000|Overall Study|Lost to Follow-up|3|||
128931722|NCT02760602|464039599|FG000|Overall Study|Withdrawal by Subject|1|||
128931723|NCT02760602|464039600|FG001|Overall Study|Withdrawal by Subject|0|||
128931724|NCT02760602|464039599|FG000|Overall Study|Terminated by sponsor|12|||
128931725|NCT02760602|464039600|FG001|Overall Study|Terminated by sponsor|13|||
128931726|NCT02046564|464039612|FG000|Overall Study|Adverse Event|6|||
128931727|NCT02046564|464039613|FG001|Overall Study|Adverse Event|3|||
128931728|NCT02046564|464039612|FG000|Overall Study|Physician Decision|0|||
128931729|NCT02046564|464039613|FG001|Overall Study|Physician Decision|1|||
128931730|NCT02046564|464039612|FG000|Overall Study|Protocol Violation|3|||
128931731|NCT02046564|464039613|FG001|Overall Study|Protocol Violation|1|||
128931732|NCT02046564|464039612|FG000|Overall Study|Withdrawal by Subject|4|||
128931733|NCT02046564|464039613|FG001|Overall Study|Withdrawal by Subject|10|||
128931734|NCT02046564|464039612|FG000|Overall Study|Subject met withdrawal criteria|2|||
128931735|NCT02046564|464039613|FG001|Overall Study|Subject met withdrawal criteria|5|||
128931736|NCT00984659|464039614|FG000|2-week Run-in Period|Adverse Event|8|||
129121437|NCT00750269|464741140|FG003|Overall Study|Withdrawal by Subject|2|||
129121438|NCT00750269|464741141|FG004|Overall Study|Withdrawal by Subject|2|||
129121439|NCT00750269|464741137|FG000|Overall Study|Physician Decision|0|||
129121440|NCT00750269|464741138|FG001|Overall Study|Physician Decision|0|||
129121441|NCT00750269|464741139|FG002|Overall Study|Physician Decision|0|||
129121442|NCT00750269|464741140|FG003|Overall Study|Physician Decision|0|||
129121443|NCT00750269|464741141|FG004|Overall Study|Physician Decision|2|||
129121444|NCT00750269|464741137|FG000|Overall Study|Patient too large for positioning|0|||
129121445|NCT00750269|464741138|FG001|Overall Study|Patient too large for positioning|0|||
129121446|NCT00750269|464741139|FG002|Overall Study|Patient too large for positioning|1|||
129121447|NCT00750269|464741140|FG003|Overall Study|Patient too large for positioning|0|||
129121448|NCT00750269|464741141|FG004|Overall Study|Patient too large for positioning|0|||
129121449|NCT00750269|464741137|FG000|Overall Study|Site error|0|||
129121450|NCT00750269|464741138|FG001|Overall Study|Site error|0|||
129121451|NCT00750269|464741139|FG002|Overall Study|Site error|0|||
129121452|NCT00750269|464741140|FG003|Overall Study|Site error|1|||
129121453|NCT00750269|464741141|FG004|Overall Study|Site error|0|||
129121454|NCT00750269|464741137|FG000|Overall Study|SBRT plan could not be drawn|0|||
129121455|NCT00750269|464741138|FG001|Overall Study|SBRT plan could not be drawn|0|||
128931737|NCT00984659|464039615|FG001|2-week Run-in Period|Adverse Event|0|||
128931738|NCT00984659|464039616|FG002|2-week Run-in Period|Adverse Event|0|||
128931739|NCT00984659|464039617|FG003|2-week Run-in Period|Adverse Event|0|||
128931740|NCT00984659|464039614|FG000|2-week Run-in Period|Protocol Violation|5|||
128931741|NCT00984659|464039615|FG001|2-week Run-in Period|Protocol Violation|0|||
128931742|NCT00984659|464039616|FG002|2-week Run-in Period|Protocol Violation|0|||
128931743|NCT00984659|464039617|FG003|2-week Run-in Period|Protocol Violation|0|||
128931744|NCT00984659|464039614|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
128931745|NCT00984659|464039615|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
128931746|NCT00984659|464039616|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
129216681|NCT00602472|465094764|FG000|Overall Study|Adverse Event|5|||
129216682|NCT00602472|465094765|FG001|Overall Study|Adverse Event|23|||
129216683|NCT00602472|465094764|FG000|Overall Study|Protocol Violation|4|||
129216684|NCT00602472|465094765|FG001|Overall Study|Protocol Violation|19|||
129216685|NCT00602472|465094764|FG000|Overall Study|Withdrawal by Subject|8|||
128767550|NCT02762981|463440301|FG002|Overall Study|Physician Decision|0|||
128767551|NCT02762981|463440302|FG003|Overall Study|Physician Decision|0|||
128767552|NCT02762981|463440303|FG004|Overall Study|Physician Decision|1|||
128767553|NCT02762981|463440299|FG000|Overall Study|Disease progression|11|||
128767554|NCT02762981|463440300|FG001|Overall Study|Disease progression|23|||
128767555|NCT02762981|463440301|FG002|Overall Study|Disease progression|4|||
128767556|NCT02762981|463440302|FG003|Overall Study|Disease progression|10|||
128767557|NCT02762981|463440303|FG004|Overall Study|Disease progression|1|||
128767558|NCT02762981|463440299|FG000|Overall Study|Enrolled not treated|1|||
128767559|NCT02762981|463440300|FG001|Overall Study|Enrolled not treated|5|||
128767560|NCT02762981|463440301|FG002|Overall Study|Enrolled not treated|0|||
128767561|NCT02762981|463440302|FG003|Overall Study|Enrolled not treated|2|||
128767562|NCT02762981|463440303|FG004|Overall Study|Enrolled not treated|0|||
128767563|NCT02762981|463440299|FG000|Overall Study|Other|2|||
128767564|NCT02762981|463440300|FG001|Overall Study|Other|3|||
128767565|NCT02762981|463440301|FG002|Overall Study|Other|1|||
129216686|NCT00602472|465094765|FG001|Overall Study|Withdrawal by Subject|14|||
129216687|NCT00602472|465094764|FG000|Overall Study|Other incl. lack of efficacy|4|||
129216688|NCT00602472|465094765|FG001|Overall Study|Other incl. lack of efficacy|2|||
129216689|NCT02803580|465094766|FG000|Overall Study|Death|13|||
129216690|NCT02803580|465094766|FG000|Overall Study|Lost to Follow-up|19|||
129216691|NCT02803580|465094766|FG000|Overall Study|Withdrawal by Subject|3|||
129216692|NCT02803580|465094766|FG000|Overall Study|Inclusion in clinical trial|1|||
129216693|NCT02054104|465094771|FG000|Overall Study|Did not want to continue due to college classes|1|||
129216694|NCT02054104|465094772|FG001|Overall Study|Did not want to continue due to college classes|0|||
129216695|NCT02054104|465094771|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
129216696|NCT02054104|465094772|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
129216697|NCT02054104|465094771|FG000|Overall Study|No evidence of immunologic response|2|||
129216698|NCT02054104|465094772|FG001|Overall Study|No evidence of immunologic response|2|||
129216699|NCT02054104|465094771|FG000|Overall Study|Disease Progression On Study|4|||
129216700|NCT02054104|465094772|FG001|Overall Study|Disease Progression On Study|5|||
129216701|NCT02054104|465094771|FG000|Overall Study|Diagnosis of lymphoma|0|||
129216702|NCT02054104|465094772|FG001|Overall Study|Diagnosis of lymphoma|1|||
129216703|NCT02054104|465094771|FG000|Overall Study|Inconclusive response|0|||
129216704|NCT02054104|465094772|FG001|Overall Study|Inconclusive response|1|||
129216705|NCT02612779|465094775|FG000|Overall Study|Administrative reason by sponsor|4|||
129216706|NCT02612779|465094776|FG001|Overall Study|Administrative reason by sponsor|1|||
129216707|NCT02612779|465094775|FG000|Overall Study|No longer meet study criteria|0|||
129216708|NCT02612779|465094776|FG001|Overall Study|No longer meet study criteria|1|||
129216709|NCT02612779|465094775|FG000|Overall Study|Disease progression|29|||
129216710|NCT02612779|465094776|FG001|Overall Study|Disease progression|2|||
129216711|NCT02612779|465094775|FG000|Overall Study|Study drug toxicity|10|||
129216712|NCT02612779|465094776|FG001|Overall Study|Study drug toxicity|1|||
129216713|NCT02612779|465094775|FG000|Overall Study|Death|1|||
129216714|NCT02612779|465094776|FG001|Overall Study|Death|0|||
128767566|NCT02762981|463440302|FG003|Overall Study|Other|0|||
128767567|NCT02762981|463440303|FG004|Overall Study|Other|0|||
128767568|NCT02762981|463440299|FG000|Overall Study|Missing|1|||
128767569|NCT02762981|463440300|FG001|Overall Study|Missing|0|||
128767570|NCT02762981|463440301|FG002|Overall Study|Missing|0|||
128767571|NCT02762981|463440302|FG003|Overall Study|Missing|0|||
128767572|NCT02762981|463440303|FG004|Overall Study|Missing|0|||
128767573|NCT02762981|463440299|FG000|Overall Study|Withdrawal by Subject|0|||
128767574|NCT02762981|463440300|FG001|Overall Study|Withdrawal by Subject|5|||
128767575|NCT02762981|463440301|FG002|Overall Study|Withdrawal by Subject|1|||
128767576|NCT02762981|463440302|FG003|Overall Study|Withdrawal by Subject|3|||
128767577|NCT02762981|463440303|FG004|Overall Study|Withdrawal by Subject|0|||
128767578|NCT02291432|463440304|FG000|Overall Study|Withdrawal by Subject|2|||
128767579|NCT03327402|463440305|FG000|Overall Study|Withdrawal by Subject|1|||
128767580|NCT03327402|463440305|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
128767581|NCT03810313|463440309|FG000|Overall Study|Study terminated by sponsor|164|||
128767582|NCT03810313|463440310|FG001|Overall Study|Study terminated by sponsor|159|||
128767583|NCT03810313|463440309|FG000|Overall Study|Subject decision|10|||
129216715|NCT02612779|465094775|FG000|Overall Study|Adverse event unrelated to study drug|5|||
129216716|NCT02612779|465094776|FG001|Overall Study|Adverse event unrelated to study drug|0|||
129216717|NCT02612779|465094775|FG000|Overall Study|Participant withdrew consent|4|||
128767584|NCT03810313|463440310|FG001|Overall Study|Subject decision|11|||
128767585|NCT03810313|463440309|FG000|Overall Study|Lost to Follow-up|3|||
128767586|NCT03810313|463440310|FG001|Overall Study|Lost to Follow-up|3|||
128767587|NCT03810313|463440309|FG000|Overall Study|Adverse Event|2|||
128767588|NCT03810313|463440310|FG001|Overall Study|Adverse Event|1|||
128767589|NCT03810313|463440309|FG000|Overall Study|Death|2|||
128767590|NCT03810313|463440310|FG001|Overall Study|Death|1|||
128767591|NCT03810313|463440309|FG000|Overall Study|Physician Decision|0|||
128767592|NCT03810313|463440310|FG001|Overall Study|Physician Decision|1|||
128767593|NCT00584805|463440311|FG000|Overall Study|No longer at risk of exposure|39|||
128767594|NCT00584805|463440311|FG000|Overall Study|Relocation|36|||
129121456|NCT00750269|464741139|FG002|Overall Study|SBRT plan could not be drawn|0|||
129121457|NCT00750269|464741140|FG003|Overall Study|SBRT plan could not be drawn|0|||
128931747|NCT00984659|464039617|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
128931748|NCT00984659|464039614|FG000|2-week Run-in Period|Lost to Follow-up|3|||
128931749|NCT00984659|464039615|FG001|2-week Run-in Period|Lost to Follow-up|0|||
128931750|NCT00984659|464039616|FG002|2-week Run-in Period|Lost to Follow-up|0|||
128931751|NCT00984659|464039617|FG003|2-week Run-in Period|Lost to Follow-up|0|||
128931752|NCT00984659|464039614|FG000|2-week Run-in Period|Physician Decision|10|||
128931753|NCT00984659|464039615|FG001|2-week Run-in Period|Physician Decision|0|||
128931754|NCT00984659|464039616|FG002|2-week Run-in Period|Physician Decision|0|||
128931755|NCT00984659|464039617|FG003|2-week Run-in Period|Physician Decision|0|||
128931756|NCT00984659|464039614|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
128931757|NCT00984659|464039615|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
128931758|NCT00984659|464039616|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
128931759|NCT00984659|464039617|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
128931760|NCT00984659|464039614|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
128931761|NCT00984659|464039615|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
128931762|NCT00984659|464039616|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
128931763|NCT00984659|464039617|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
128931764|NCT00984659|464039614|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
128931765|NCT00984659|464039615|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
128931766|NCT00984659|464039616|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
128931767|NCT00984659|464039617|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
128931768|NCT00984659|464039614|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
128931769|NCT00984659|464039615|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
128931770|NCT00984659|464039616|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
128931771|NCT00984659|464039617|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
128931772|NCT00984659|464039614|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
128931773|NCT00984659|464039615|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
128931774|NCT00984659|464039616|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
128931775|NCT00984659|464039617|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
128931776|NCT00984659|464039614|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
128931777|NCT00984659|464039615|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
128931778|NCT00984659|464039616|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
128931779|NCT00984659|464039617|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
128931780|NCT00984659|464039614|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
128931781|NCT00984659|464039615|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
128931782|NCT00984659|464039616|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
129121458|NCT00750269|464741141|FG004|Overall Study|SBRT plan could not be drawn|1|||
129121459|NCT00750269|464741137|FG000|Overall Study|Fiducials could not be placed|0|||
129121460|NCT00750269|464741138|FG001|Overall Study|Fiducials could not be placed|0|||
129121461|NCT00750269|464741139|FG002|Overall Study|Fiducials could not be placed|0|||
129121462|NCT00750269|464741140|FG003|Overall Study|Fiducials could not be placed|0|||
129121463|NCT00750269|464741141|FG004|Overall Study|Fiducials could not be placed|1|||
129121464|NCT02100631|464741143|FG000|Overall Study|Withdrawal by Subject|1|||
129121465|NCT02100631|464741144|FG001|Overall Study|Withdrawal by Subject|0|||
129121466|NCT02100631|464741145|FG002|Overall Study|Withdrawal by Subject|0|||
129121467|NCT02100631|464741143|FG000|Overall Study|Lost to Follow-up|3|||
129216718|NCT02612779|465094776|FG001|Overall Study|Participant withdrew consent|0|||
128767595|NCT00584805|463440311|FG000|Overall Study|Withdrawal by Subject|18|||
128767596|NCT00584805|463440311|FG000|Overall Study|Non-compliance|1|||
128767597|NCT00584805|463440311|FG000|Overall Study|Lost to follow up|3|||
128767598|NCT00584805|463440311|FG000|Overall Study|Screen failures|2|||
128767599|NCT03029780|463440312|FG000|Overall Study|Disease Progression|20|||
128931783|NCT00984659|464039617|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
128931784|NCT00635102|464039620|FG000|Overall Study|Withdrawal by Subject|7|||
128931785|NCT00635102|464039621|FG001|Overall Study|Withdrawal by Subject|8|||
128931786|NCT01938625|464039622|FG000|Overall Study|Withdrawal by Subject|0|||
128931787|NCT01938625|464039623|FG001|Overall Study|Withdrawal by Subject|1|||
128931788|NCT01938625|464039622|FG000|Overall Study|Adverse Event|0|||
128931789|NCT01938625|464039623|FG001|Overall Study|Adverse Event|1|||
128931790|NCT02088034|464039624|FG000|Overall Study|Lost to Follow-up|1|||
129121468|NCT02100631|464741144|FG001|Overall Study|Lost to Follow-up|4|||
128767600|NCT03029780|463440313|FG001|Overall Study|Disease Progression|22|||
128767601|NCT03029780|463440312|FG000|Overall Study|Study Drug Toxicity|15|||
128931791|NCT02088034|464039625|FG001|Overall Study|Lost to Follow-up|1|||
128931792|NCT02088034|464039626|FG002|Overall Study|Lost to Follow-up|0|||
128931793|NCT02088034|464039624|FG000|Overall Study|Pregnancy|2|||
128767602|NCT03029780|463440313|FG001|Overall Study|Study Drug Toxicity|11|||
128767603|NCT03029780|463440312|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
128931794|NCT02088034|464039625|FG001|Overall Study|Pregnancy|1|||
128931795|NCT02088034|464039626|FG002|Overall Study|Pregnancy|2|||
128931796|NCT03043365|464039630|FG000|Weeks 0 to Week 8|Adverse Event|1|||
128931797|NCT03043365|464039631|FG001|Weeks 0 to Week 8|Adverse Event|3|||
128931798|NCT03043365|464039630|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
128931799|NCT03043365|464039631|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
128931800|NCT03043365|464039630|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
128931801|NCT03043365|464039631|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
128931802|NCT02873221|464039632|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
128931803|NCT02873221|464039633|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
128931804|NCT02873221|464039634|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
128931805|NCT02873221|464039632|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
128931806|NCT02873221|464039633|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
128931807|NCT02873221|464039634|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
128931808|NCT02873221|464039632|FG000|Treatment Period|Protocol Violation|2|||
128931809|NCT02873221|464039633|FG001|Treatment Period|Protocol Violation|5|||
128931810|NCT02873221|464039634|FG002|Treatment Period|Protocol Violation|8|||
128931811|NCT02873221|464039632|FG000|Treatment Period|Pregnancy|4|||
128767604|NCT03029780|463440313|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
128767605|NCT03029780|463440312|FG000|Overall Study|Participant request to discontinue study treatment|4|||
128767606|NCT03029780|463440313|FG001|Overall Study|Participant request to discontinue study treatment|1|||
128767607|NCT03029780|463440312|FG000|Overall Study|Maximum clinical benefit|1|||
128767608|NCT03029780|463440313|FG001|Overall Study|Maximum clinical benefit|0|||
128767609|NCT03029780|463440312|FG000|Overall Study|Participant no longer meets study criteria|0|||
128767610|NCT03029780|463440313|FG001|Overall Study|Participant no longer meets study criteria|1|||
128767611|NCT03029780|463440312|FG000|Overall Study|Other reasons|6|||
128767612|NCT03029780|463440313|FG001|Overall Study|Other reasons|6|||
128767613|NCT03029780|463440312|FG000|Overall Study|Not reported|1|||
128767614|NCT03029780|463440313|FG001|Overall Study|Not reported|1|||
128767615|NCT03029780|463440312|FG000|Overall Study|Death|2|||
128767616|NCT03029780|463440313|FG001|Overall Study|Death|6|||
128767617|NCT03066622|463440314|FG000|Overall Study|Lost to Follow-up|24|||
128767618|NCT03066622|463440315|FG001|Overall Study|Lost to Follow-up|25|||
128767619|NCT03066622|463440314|FG000|Overall Study|Withdrawal by Subject|2|||
128767620|NCT03066622|463440315|FG001|Overall Study|Withdrawal by Subject|1|||
128767621|NCT04741802|463440316|FG000|Overall Study|Death|1|||
128767622|NCT04741802|463440316|FG000|Overall Study|Lost to Follow-up|11|||
128767623|NCT01785563|463440317|FG000|Overall Study|Physician Decision|10|||
128767624|NCT01785563|463440317|FG000|Overall Study|Withdrawal by Subject|1|||
128767625|NCT01785563|463440317|FG000|Overall Study|Protocol Violation|2|||
128767626|NCT01872910|463440318|FG000|Overall Study|Lost to Follow-up|2|||
128767627|NCT01872910|463440319|FG001|Overall Study|Lost to Follow-up|0|||
128767628|NCT01872910|463440320|FG002|Overall Study|Lost to Follow-up|2|||
128767629|NCT01872910|463440321|FG003|Overall Study|Lost to Follow-up|0|||
128767630|NCT01872910|463440322|FG004|Overall Study|Lost to Follow-up|0|||
128767631|NCT01872910|463440323|FG005|Overall Study|Lost to Follow-up|0|||
128767632|NCT01616771|463440324|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
128767633|NCT00100932|463440325|FG000|Overall Study|Adverse Event|11|||
128767634|NCT00100932|463440326|FG001|Overall Study|Adverse Event|2|||
128767635|NCT00100932|463440325|FG000|Overall Study|Withdrawal by Subject|6|||
128767636|NCT00100932|463440326|FG001|Overall Study|Withdrawal by Subject|0|||
128767637|NCT00100932|463440325|FG000|Overall Study|Progressive Disease|44|||
128767638|NCT00100932|463440326|FG001|Overall Study|Progressive Disease|18|||
128767639|NCT00100932|463440325|FG000|Overall Study|Physician Decision|7|||
128767640|NCT00100932|463440326|FG001|Overall Study|Physician Decision|5|||
128767641|NCT00100932|463440325|FG000|Overall Study|Other|5|||
128767642|NCT00100932|463440326|FG001|Overall Study|Other|2|||
128767643|NCT00744328|463440327|FG000|Overall Study|Lost to Follow-up|2|||
128767644|NCT00744328|463440328|FG001|Overall Study|Lost to Follow-up|5|||
129121469|NCT02100631|464741145|FG002|Overall Study|Lost to Follow-up|0|||
129132912|NCT02609633|464778564|FG000|Overall Study|Reason not Specified|2|||
128767645|NCT00744328|463440329|FG002|Overall Study|Lost to Follow-up|3|||
128767646|NCT00744328|463440327|FG000|Overall Study|Withdrawal by Subject|5|||
128767647|NCT00744328|463440328|FG001|Overall Study|Withdrawal by Subject|3|||
128767648|NCT00744328|463440329|FG002|Overall Study|Withdrawal by Subject|4|||
128931812|NCT02873221|464039633|FG001|Treatment Period|Pregnancy|6|||
128931813|NCT02873221|464039634|FG002|Treatment Period|Pregnancy|3|||
128931814|NCT02873221|464039632|FG000|Treatment Period|Lack of Qualifying Event|0|||
128931815|NCT02873221|464039633|FG001|Treatment Period|Lack of Qualifying Event|3|||
128931816|NCT02873221|464039634|FG002|Treatment Period|Lack of Qualifying Event|1|||
128931817|NCT02873221|464039632|FG000|Treatment Period|Withdrawal of Consent|52|||
128931818|NCT02873221|464039633|FG001|Treatment Period|Withdrawal of Consent|51|||
129121470|NCT02100631|464741143|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
129121471|NCT02100631|464741144|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
129121472|NCT02100631|464741145|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
129121473|NCT03944616|464741146|FG000|Overall Study|Lost to Follow-up|0|||
129121474|NCT03944616|464741147|FG001|Overall Study|Lost to Follow-up|2|||
129121475|NCT01721798|464741148|FG000|Overall Study|Death|0|||
129121476|NCT01721798|464741149|FG001|Overall Study|Death|0|||
129121477|NCT01721798|464741150|FG002|Overall Study|Death|1|||
129121478|NCT01721798|464741151|FG003|Overall Study|Death|1|||
129121479|NCT01721798|464741148|FG000|Overall Study|Lost to Follow-up|2|||
129121480|NCT01721798|464741149|FG001|Overall Study|Lost to Follow-up|2|||
129121481|NCT01721798|464741150|FG002|Overall Study|Lost to Follow-up|9|||
129121482|NCT01721798|464741151|FG003|Overall Study|Lost to Follow-up|9|||
129121483|NCT01721798|464741148|FG000|Overall Study|Pregnancy|0|||
129121484|NCT01721798|464741149|FG001|Overall Study|Pregnancy|0|||
129121485|NCT01721798|464741150|FG002|Overall Study|Pregnancy|1|||
129121486|NCT01721798|464741151|FG003|Overall Study|Pregnancy|1|||
129121487|NCT01721798|464741148|FG000|Overall Study|Withdrawal by Subject|1|||
129121488|NCT01721798|464741149|FG001|Overall Study|Withdrawal by Subject|0|||
128931819|NCT02873221|464039634|FG002|Treatment Period|Withdrawal of Consent|41|||
128931820|NCT02873221|464039632|FG000|Treatment Period|Lack of Efficacy|0|||
128931821|NCT02873221|464039633|FG001|Treatment Period|Lack of Efficacy|17|||
128931822|NCT02873221|464039634|FG002|Treatment Period|Lack of Efficacy|12|||
128931823|NCT02873221|464039632|FG000|Treatment Period|Adverse Event|4|||
128931824|NCT02873221|464039633|FG001|Treatment Period|Adverse Event|9|||
128931825|NCT02873221|464039634|FG002|Treatment Period|Adverse Event|11|||
128931826|NCT02873221|464039632|FG000|Treatment Period|Lost to Follow-up|26|||
128931827|NCT02873221|464039633|FG001|Treatment Period|Lost to Follow-up|30|||
128931828|NCT02873221|464039634|FG002|Treatment Period|Lost to Follow-up|26|||
128931829|NCT02873221|464039632|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
128931830|NCT02873221|464039633|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
128931831|NCT02873221|464039634|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
128931832|NCT02873221|464039632|FG000|Safety Follow-up Period|Protocol Violation|0|||
128931833|NCT02873221|464039633|FG001|Safety Follow-up Period|Protocol Violation|0|||
128931834|NCT02873221|464039634|FG002|Safety Follow-up Period|Protocol Violation|1|||
128931835|NCT02873221|464039632|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
128931836|NCT02873221|464039633|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
128931837|NCT02873221|464039634|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
128931838|NCT02873221|464039632|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
128931839|NCT02873221|464039633|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
128931840|NCT02873221|464039634|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
128931841|NCT01325493|464039637|FG000|Overall Study|Protocol Violation|0|||
128931842|NCT01325493|464039638|FG001|Overall Study|Protocol Violation|1|||
128931843|NCT01325493|464039637|FG000|Overall Study|loss of neuromonitoring signals|0|||
128931844|NCT01325493|464039638|FG001|Overall Study|loss of neuromonitoring signals|2|||
128931845|NCT01325493|464039637|FG000|Overall Study|Allergy|1|||
128931846|NCT01325493|464039638|FG001|Overall Study|Allergy|0|||
128931847|NCT05372315|464039641|FG000|Overall Study|Withdrawal by Subject|1|||
128931848|NCT05372315|464039642|FG001|Overall Study|Withdrawal by Subject|0|||
128931849|NCT01508676|464039645|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
128931850|NCT01508676|464039646|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
128931851|NCT01508676|464039645|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
128931852|NCT01508676|464039646|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
128931853|NCT01508676|464039645|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
128931854|NCT01508676|464039646|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
128931855|NCT01508676|464039645|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
128931856|NCT01508676|464039646|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
128931857|NCT01508676|464039645|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
128931858|NCT01508676|464039646|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
129121489|NCT01721798|464741150|FG002|Overall Study|Withdrawal by Subject|2|||
128931859|NCT00650585|464039647|FG000|Overall Study|Lost to Follow-up|505|||
129121490|NCT01721798|464741151|FG003|Overall Study|Withdrawal by Subject|1|||
129121491|NCT01721798|464741148|FG000|Overall Study|Not eligible for 24 month visit|1|||
128931860|NCT00650585|464039648|FG001|Overall Study|Lost to Follow-up|482|||
128931861|NCT00650585|464039647|FG000|Overall Study|No parental consent|935|||
128931862|NCT00650585|464039648|FG001|Overall Study|No parental consent|866|||
129121492|NCT01721798|464741149|FG001|Overall Study|Not eligible for 24 month visit|0|||
129121493|NCT01721798|464741150|FG002|Overall Study|Not eligible for 24 month visit|8|||
129121494|NCT01721798|464741151|FG003|Overall Study|Not eligible for 24 month visit|7|||
128931863|NCT00650585|464039647|FG000|Overall Study|Excluded/ruled ineligible|357|||
128931864|NCT00650585|464039648|FG001|Overall Study|Excluded/ruled ineligible|129|||
128931865|NCT02532543|464039650|FG000|Overall Study|Lost to Follow-up|0|||
128931866|NCT02532543|464039651|FG001|Overall Study|Lost to Follow-up|0|||
128931867|NCT02532543|464039652|FG002|Overall Study|Lost to Follow-up|1|||
128931868|NCT02532543|464039653|FG003|Overall Study|Lost to Follow-up|0|||
129121495|NCT01432951|464741152|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
129121496|NCT00853385|464741153|FG000|Overall Study|Death|0|||
129121497|NCT00853385|464741154|FG001|Overall Study|Death|0|||
129121498|NCT00853385|464741155|FG002|Overall Study|Death|0|||
129121499|NCT00853385|464741156|FG003|Overall Study|Death|0|||
129121500|NCT00853385|464741157|FG004|Overall Study|Death|1|||
129121501|NCT00853385|464741153|FG000|Overall Study|Adverse Event|24|||
129121502|NCT00853385|464741154|FG001|Overall Study|Adverse Event|24|||
129121503|NCT00853385|464741155|FG002|Overall Study|Adverse Event|2|||
129121504|NCT00853385|464741156|FG003|Overall Study|Adverse Event|5|||
129121505|NCT00853385|464741157|FG004|Overall Study|Adverse Event|22|||
129121506|NCT00853385|464741153|FG000|Overall Study|Lack of Efficacy|6|||
129121507|NCT00853385|464741154|FG001|Overall Study|Lack of Efficacy|7|||
129121508|NCT00853385|464741155|FG002|Overall Study|Lack of Efficacy|3|||
129121509|NCT00853385|464741156|FG003|Overall Study|Lack of Efficacy|3|||
129121510|NCT00853385|464741157|FG004|Overall Study|Lack of Efficacy|6|||
129121511|NCT00853385|464741153|FG000|Overall Study|Lost to Follow-up|2|||
129121512|NCT00853385|464741154|FG001|Overall Study|Lost to Follow-up|1|||
129121513|NCT00853385|464741155|FG002|Overall Study|Lost to Follow-up|0|||
129216719|NCT02612779|465094775|FG000|Overall Study|Lost to Follow-up|1|||
129216720|NCT02612779|465094776|FG001|Overall Study|Lost to Follow-up|0|||
129216721|NCT02612779|465094775|FG000|Overall Study|Maximum clinical benefit|10|||
129216722|NCT02612779|465094776|FG001|Overall Study|Maximum clinical benefit|1|||
129216723|NCT02612779|465094775|FG000|Overall Study|Other reasons|4|||
129216724|NCT02612779|465094776|FG001|Overall Study|Other reasons|0|||
129216725|NCT03809104|465094777|FG000|Overall Study|Withdrawal by Subject|3|||
129216726|NCT02968004|465094778|FG000|Main Study Phase|Adverse Event|1|||
129216727|NCT02968004|465094779|FG001|Main Study Phase|Adverse Event|0|||
128931869|NCT00923091|464039655|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
128931870|NCT00923091|464039656|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
128931871|NCT00923091|464039657|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
128931872|NCT00923091|464039658|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
128931873|NCT00923091|464039659|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
128931874|NCT00923091|464039660|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
128931875|NCT00923091|464039661|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
128931876|NCT00923091|464039662|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
128931877|NCT00923091|464039663|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
128931878|NCT00923091|464039664|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
128931879|NCT00923091|464039665|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
128931880|NCT00923091|464039666|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
128931881|NCT00923091|464039667|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
128931882|NCT00923091|464039655|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
128931883|NCT00923091|464039656|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
128931884|NCT00923091|464039657|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
128931885|NCT00923091|464039658|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
128931886|NCT00923091|464039659|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
128931887|NCT00923091|464039660|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
128931888|NCT00923091|464039661|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
128931889|NCT00923091|464039662|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
128931890|NCT00923091|464039663|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
129216728|NCT02968004|465094778|FG000|Main Study Phase|Withdrawal by Subject|0|||
128931891|NCT00923091|464039664|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
128931892|NCT00923091|464039665|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
129121514|NCT00853385|464741156|FG003|Overall Study|Lost to Follow-up|0|||
129216729|NCT02968004|465094779|FG001|Main Study Phase|Withdrawal by Subject|1|||
129216730|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
129216731|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
128931893|NCT00923091|464039666|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
128931894|NCT00923091|464039667|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
128931895|NCT00923091|464039655|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
128931896|NCT00923091|464039656|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
128931897|NCT00923091|464039657|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
128931898|NCT00923091|464039658|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
128931899|NCT00923091|464039659|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
128931900|NCT00923091|464039660|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
128931901|NCT00923091|464039661|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
128931902|NCT00923091|464039662|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
129121515|NCT00853385|464741157|FG004|Overall Study|Lost to Follow-up|0|||
129121516|NCT00853385|464741153|FG000|Overall Study|Withdrawal by Subject|4|||
129121517|NCT00853385|464741154|FG001|Overall Study|Withdrawal by Subject|2|||
129121518|NCT00853385|464741155|FG002|Overall Study|Withdrawal by Subject|0|||
128931903|NCT00923091|464039663|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
129121519|NCT00853385|464741156|FG003|Overall Study|Withdrawal by Subject|1|||
129121520|NCT00853385|464741157|FG004|Overall Study|Withdrawal by Subject|1|||
128931904|NCT00923091|464039664|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
128931905|NCT00923091|464039665|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
128931906|NCT00923091|464039666|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
128931907|NCT00923091|464039667|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
128931908|NCT00923091|464039655|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931909|NCT00923091|464039656|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931910|NCT00923091|464039657|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931911|NCT00923091|464039658|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129121521|NCT00853385|464741153|FG000|Overall Study|Other|18|||
129121522|NCT00853385|464741154|FG001|Overall Study|Other|9|||
129121523|NCT00853385|464741155|FG002|Overall Study|Other|4|||
129121524|NCT00853385|464741156|FG003|Overall Study|Other|4|||
128931912|NCT00923091|464039659|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931913|NCT00923091|464039660|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
128931914|NCT00923091|464039661|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931915|NCT00923091|464039662|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931916|NCT00923091|464039663|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931917|NCT00923091|464039664|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931918|NCT00923091|464039665|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931919|NCT00923091|464039666|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931920|NCT00923091|464039667|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
128931921|NCT00923091|464039655|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931922|NCT00923091|464039656|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
128931923|NCT00923091|464039657|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931924|NCT00923091|464039658|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
128931925|NCT00923091|464039659|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931926|NCT00923091|464039660|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
128931927|NCT00923091|464039661|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931928|NCT00923091|464039662|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931929|NCT00923091|464039663|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931930|NCT00923091|464039664|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931931|NCT00923091|464039665|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931932|NCT00923091|464039666|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931933|NCT00923091|464039667|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
128931934|NCT00923091|464039655|FG000|Period III (Single-Blind)|Adverse Event|5|||
128931935|NCT00923091|464039656|FG001|Period III (Single-Blind)|Adverse Event|0|||
128931936|NCT00923091|464039657|FG002|Period III (Single-Blind)|Adverse Event|0|||
128931937|NCT00923091|464039658|FG003|Period III (Single-Blind)|Adverse Event|0|||
128931938|NCT00923091|464039659|FG004|Period III (Single-Blind)|Adverse Event|0|||
128931939|NCT00923091|464039660|FG005|Period III (Single-Blind)|Adverse Event|0|||
128931940|NCT00923091|464039661|FG006|Period III (Single-Blind)|Adverse Event|0|||
128931941|NCT00923091|464039662|FG007|Period III (Single-Blind)|Adverse Event|0|||
128931942|NCT00923091|464039663|FG008|Period III (Single-Blind)|Adverse Event|0|||
128931943|NCT00923091|464039664|FG009|Period III (Single-Blind)|Adverse Event|0|||
128931944|NCT00923091|464039665|FG010|Period III (Single-Blind)|Adverse Event|0|||
128931945|NCT00923091|464039666|FG011|Period III (Single-Blind)|Adverse Event|0|||
128931946|NCT00923091|464039667|FG012|Period III (Single-Blind)|Adverse Event|0|||
128931947|NCT00923091|464039655|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
128931948|NCT00923091|464039656|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931949|NCT00923091|464039657|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931950|NCT00923091|464039658|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931951|NCT00923091|464039659|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931952|NCT00923091|464039660|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931953|NCT00923091|464039661|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931954|NCT00923091|464039662|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931955|NCT00923091|464039663|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931956|NCT00923091|464039664|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931957|NCT00923091|464039665|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931958|NCT00923091|464039666|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931959|NCT00923091|464039667|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
128931960|NCT00923091|464039655|FG000|Period III (Single-Blind)|Protocol Violation|3|||
128931961|NCT00923091|464039656|FG001|Period III (Single-Blind)|Protocol Violation|0|||
128931962|NCT00923091|464039657|FG002|Period III (Single-Blind)|Protocol Violation|0|||
128931963|NCT00923091|464039658|FG003|Period III (Single-Blind)|Protocol Violation|0|||
128931964|NCT00923091|464039659|FG004|Period III (Single-Blind)|Protocol Violation|0|||
129121525|NCT00853385|464741157|FG004|Overall Study|Other|12|||
129121526|NCT00915525|464741160|FG000|Overall Study|Protocol Violation|9|||
128931965|NCT00923091|464039660|FG005|Period III (Single-Blind)|Protocol Violation|0|||
128931966|NCT00923091|464039661|FG006|Period III (Single-Blind)|Protocol Violation|0|||
128931967|NCT00923091|464039662|FG007|Period III (Single-Blind)|Protocol Violation|0|||
128931968|NCT00923091|464039663|FG008|Period III (Single-Blind)|Protocol Violation|0|||
128931969|NCT00923091|464039664|FG009|Period III (Single-Blind)|Protocol Violation|0|||
128931970|NCT00923091|464039665|FG010|Period III (Single-Blind)|Protocol Violation|0|||
128931971|NCT00923091|464039666|FG011|Period III (Single-Blind)|Protocol Violation|0|||
128931972|NCT00923091|464039667|FG012|Period III (Single-Blind)|Protocol Violation|0|||
128931973|NCT00923091|464039655|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
128931974|NCT00923091|464039656|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
128931975|NCT00923091|464039657|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
128931976|NCT00923091|464039658|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
128931977|NCT00923091|464039659|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
128931978|NCT00923091|464039660|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
128931979|NCT00923091|464039661|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
128931980|NCT00923091|464039662|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
128931981|NCT00923091|464039663|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
128931982|NCT00923091|464039664|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
128931983|NCT00923091|464039665|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
128931984|NCT00923091|464039666|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
128931985|NCT00923091|464039667|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
128931986|NCT00923091|464039655|FG000|Period IV (Double-Blind)|Adverse Event|2|||
128931987|NCT00923091|464039656|FG001|Period IV (Double-Blind)|Adverse Event|0|||
128931988|NCT00923091|464039657|FG002|Period IV (Double-Blind)|Adverse Event|0|||
128931989|NCT00923091|464039658|FG003|Period IV (Double-Blind)|Adverse Event|0|||
128931990|NCT00923091|464039659|FG004|Period IV (Double-Blind)|Adverse Event|0|||
128931991|NCT00923091|464039660|FG005|Period IV (Double-Blind)|Adverse Event|0|||
128931992|NCT00923091|464039661|FG006|Period IV (Double-Blind)|Adverse Event|0|||
128931993|NCT00923091|464039662|FG007|Period IV (Double-Blind)|Adverse Event|0|||
128931994|NCT00923091|464039663|FG008|Period IV (Double-Blind)|Adverse Event|0|||
128931995|NCT00923091|464039664|FG009|Period IV (Double-Blind)|Adverse Event|0|||
128931996|NCT00923091|464039665|FG010|Period IV (Double-Blind)|Adverse Event|0|||
128931997|NCT00923091|464039666|FG011|Period IV (Double-Blind)|Adverse Event|0|||
128931998|NCT00923091|464039667|FG012|Period IV (Double-Blind)|Adverse Event|0|||
128931999|NCT00923091|464039655|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932000|NCT00923091|464039656|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
128932001|NCT00923091|464039657|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932002|NCT00923091|464039658|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932003|NCT00923091|464039659|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932004|NCT00923091|464039660|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932005|NCT00923091|464039661|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932006|NCT00923091|464039662|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932007|NCT00923091|464039663|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932008|NCT00923091|464039664|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932009|NCT00923091|464039665|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932010|NCT00923091|464039666|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932011|NCT00923091|464039667|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
128932012|NCT00923091|464039655|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
128932013|NCT00923091|464039656|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
128932014|NCT00923091|464039657|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
128932015|NCT00923091|464039658|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
128932016|NCT00923091|464039659|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
128932017|NCT00923091|464039660|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
128702674|NCT02010775|463209477|FG004|Overall Study|Pregnancy|0|||
128702675|NCT02010775|463209473|FG000|Overall Study|Lost to Follow-up|2|||
128702676|NCT02010775|463209474|FG001|Overall Study|Lost to Follow-up|0|||
128932018|NCT00923091|464039661|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
128932019|NCT00923091|464039662|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
128932020|NCT00923091|464039663|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
128932021|NCT00923091|464039664|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
128932022|NCT00923091|464039665|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
128932023|NCT00923091|464039666|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
128932024|NCT00923091|464039667|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
128932025|NCT00923091|464039655|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932026|NCT00923091|464039656|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932027|NCT00923091|464039657|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
128702677|NCT02010775|463209475|FG002|Overall Study|Lost to Follow-up|0|||
128702678|NCT02010775|463209476|FG003|Overall Study|Lost to Follow-up|1|||
128932028|NCT00923091|464039658|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932029|NCT00923091|464039659|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
128702679|NCT02010775|463209477|FG004|Overall Study|Lost to Follow-up|1|||
128702680|NCT02010775|463209473|FG000|Overall Study|Personal Reasons|3|||
128702681|NCT02010775|463209474|FG001|Overall Study|Personal Reasons|3|||
128702682|NCT02010775|463209475|FG002|Overall Study|Personal Reasons|1|||
128702683|NCT02010775|463209476|FG003|Overall Study|Personal Reasons|2|||
128702684|NCT02010775|463209477|FG004|Overall Study|Personal Reasons|4|||
128932030|NCT00923091|464039660|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932031|NCT00923091|464039661|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932032|NCT00923091|464039662|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932033|NCT00923091|464039663|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
128932034|NCT00923091|464039664|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932035|NCT00923091|464039665|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932036|NCT00923091|464039666|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
128932037|NCT00923091|464039667|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
128932038|NCT00923091|464039655|FG000|Period V (Double -Blind)|Protocol Violation|0|||
128932039|NCT00923091|464039656|FG001|Period V (Double -Blind)|Protocol Violation|0|||
128932040|NCT00923091|464039657|FG002|Period V (Double -Blind)|Protocol Violation|0|||
128932041|NCT00923091|464039658|FG003|Period V (Double -Blind)|Protocol Violation|0|||
128932042|NCT00923091|464039659|FG004|Period V (Double -Blind)|Protocol Violation|0|||
128932043|NCT00923091|464039660|FG005|Period V (Double -Blind)|Protocol Violation|0|||
128932044|NCT00923091|464039661|FG006|Period V (Double -Blind)|Protocol Violation|0|||
128932045|NCT00923091|464039662|FG007|Period V (Double -Blind)|Protocol Violation|0|||
128932046|NCT00923091|464039663|FG008|Period V (Double -Blind)|Protocol Violation|0|||
128932047|NCT00923091|464039664|FG009|Period V (Double -Blind)|Protocol Violation|0|||
128932048|NCT00923091|464039665|FG010|Period V (Double -Blind)|Protocol Violation|0|||
128932049|NCT00923091|464039666|FG011|Period V (Double -Blind)|Protocol Violation|0|||
128932050|NCT00923091|464039667|FG012|Period V (Double -Blind)|Protocol Violation|1|||
128932051|NCT00923091|464039655|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
128932052|NCT00923091|464039656|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
128932053|NCT00923091|464039657|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
128932054|NCT00923091|464039658|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
128932055|NCT00923091|464039659|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
128932056|NCT00923091|464039660|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
128932057|NCT00923091|464039661|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
128932058|NCT00923091|464039662|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
128932059|NCT00923091|464039663|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
128932060|NCT00923091|464039664|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
128932061|NCT00923091|464039665|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
128932062|NCT00923091|464039666|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
128932063|NCT00923091|464039667|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
128932064|NCT00923091|464039655|FG000|Period VI (Open-Label)|Adverse Event|17|||
128932065|NCT00923091|464039656|FG001|Period VI (Open-Label)|Adverse Event|0|||
128932066|NCT00923091|464039657|FG002|Period VI (Open-Label)|Adverse Event|4|||
128932067|NCT00923091|464039658|FG003|Period VI (Open-Label)|Adverse Event|1|||
128932068|NCT00923091|464039659|FG004|Period VI (Open-Label)|Adverse Event|1|||
128932069|NCT00923091|464039660|FG005|Period VI (Open-Label)|Adverse Event|0|||
128932070|NCT00923091|464039661|FG006|Period VI (Open-Label)|Adverse Event|0|||
129216732|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
129216733|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
129216734|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
129216735|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
129216736|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
129216737|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
129216738|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
129216739|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
129216740|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
128932071|NCT00923091|464039662|FG007|Period VI (Open-Label)|Adverse Event|0|||
128932072|NCT00923091|464039663|FG008|Period VI (Open-Label)|Adverse Event|0|||
128932073|NCT00923091|464039664|FG009|Period VI (Open-Label)|Adverse Event|0|||
128932074|NCT00923091|464039665|FG010|Period VI (Open-Label)|Adverse Event|0|||
128932075|NCT00923091|464039666|FG011|Period VI (Open-Label)|Adverse Event|0|||
128932076|NCT00923091|464039667|FG012|Period VI (Open-Label)|Adverse Event|0|||
128702685|NCT02030041|463209480|FG000|Overall Study|Withdrawal by Subject|2|||
128702686|NCT02030041|463209481|FG001|Overall Study|Withdrawal by Subject|2|||
128932077|NCT00923091|464039655|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
128932078|NCT00923091|464039656|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
128932079|NCT00923091|464039657|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
128932080|NCT00923091|464039658|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932081|NCT00923091|464039659|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
128932082|NCT00923091|464039660|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932083|NCT00923091|464039661|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
128702687|NCT02030041|463209482|FG002|Overall Study|Withdrawal by Subject|1|||
128717879|NCT02113956|463264077|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
128702688|NCT05201703|463209483|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
128702689|NCT05201703|463209484|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
128932084|NCT00923091|464039662|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932085|NCT00923091|464039663|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932086|NCT00923091|464039664|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932087|NCT00923091|464039665|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932088|NCT00923091|464039666|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932089|NCT00923091|464039667|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
128932090|NCT00923091|464039655|FG000|Period VI (Open-Label)|Protocol Violation|6|||
128932091|NCT00923091|464039656|FG001|Period VI (Open-Label)|Protocol Violation|1|||
128932092|NCT00923091|464039657|FG002|Period VI (Open-Label)|Protocol Violation|3|||
128932093|NCT00923091|464039658|FG003|Period VI (Open-Label)|Protocol Violation|1|||
128932094|NCT00923091|464039659|FG004|Period VI (Open-Label)|Protocol Violation|4|||
128932095|NCT00923091|464039660|FG005|Period VI (Open-Label)|Protocol Violation|0|||
128932096|NCT00923091|464039661|FG006|Period VI (Open-Label)|Protocol Violation|0|||
128932097|NCT00923091|464039662|FG007|Period VI (Open-Label)|Protocol Violation|0|||
128932098|NCT00923091|464039663|FG008|Period VI (Open-Label)|Protocol Violation|0|||
128932099|NCT00923091|464039664|FG009|Period VI (Open-Label)|Protocol Violation|0|||
128932100|NCT00923091|464039665|FG010|Period VI (Open-Label)|Protocol Violation|0|||
128932101|NCT00923091|464039666|FG011|Period VI (Open-Label)|Protocol Violation|0|||
128932102|NCT00923091|464039667|FG012|Period VI (Open-Label)|Protocol Violation|0|||
128932103|NCT00923091|464039655|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
128932104|NCT00923091|464039656|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
128932105|NCT00923091|464039657|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
128932106|NCT00923091|464039658|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
128932107|NCT00923091|464039659|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
128932108|NCT00923091|464039660|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
128932109|NCT00923091|464039661|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
128932110|NCT00923091|464039662|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
128932111|NCT00923091|464039663|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
128932112|NCT00923091|464039664|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
128932113|NCT00923091|464039665|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
128932114|NCT00923091|464039666|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
128932115|NCT00923091|464039667|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
128932116|NCT00923091|464039655|FG000|Period VI (Open-Label)|Other Reason|0|||
128932117|NCT00923091|464039656|FG001|Period VI (Open-Label)|Other Reason|0|||
128932118|NCT00923091|464039657|FG002|Period VI (Open-Label)|Other Reason|0|||
128932119|NCT00923091|464039658|FG003|Period VI (Open-Label)|Other Reason|1|||
128932120|NCT00923091|464039659|FG004|Period VI (Open-Label)|Other Reason|1|||
128932121|NCT00923091|464039660|FG005|Period VI (Open-Label)|Other Reason|0|||
128932122|NCT00923091|464039661|FG006|Period VI (Open-Label)|Other Reason|0|||
128932123|NCT00923091|464039662|FG007|Period VI (Open-Label)|Other Reason|0|||
128932124|NCT00923091|464039663|FG008|Period VI (Open-Label)|Other Reason|0|||
128932125|NCT00923091|464039664|FG009|Period VI (Open-Label)|Other Reason|0|||
128932126|NCT00923091|464039665|FG010|Period VI (Open-Label)|Other Reason|0|||
128932127|NCT00923091|464039666|FG011|Period VI (Open-Label)|Other Reason|0|||
128932128|NCT00923091|464039667|FG012|Period VI (Open-Label)|Other Reason|0|||
128932129|NCT00467649|464039668|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
128932130|NCT00467649|464039669|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
128932131|NCT00467649|464039670|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
128932132|NCT00467649|464039671|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
128932133|NCT00467649|464039672|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
128932134|NCT00467649|464039673|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
128932135|NCT00467649|464039668|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
128932136|NCT00467649|464039669|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
128932137|NCT00467649|464039670|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
128932138|NCT00467649|464039671|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
128932139|NCT00467649|464039672|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
128932140|NCT00467649|464039673|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
128932141|NCT00467649|464039668|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
128932142|NCT00467649|464039669|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
128932143|NCT00467649|464039670|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
128932144|NCT00467649|464039671|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
128932145|NCT00467649|464039672|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
128932146|NCT00467649|464039673|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
129216741|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
128932147|NCT00467649|464039668|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
128932148|NCT00467649|464039669|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
128932149|NCT00467649|464039670|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
129216742|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
129216743|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
128702690|NCT05201703|463209483|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
128702691|NCT05201703|463209484|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
128702692|NCT01197560|463209485|FG000|Overall Study|Adverse Event|6|||
128702693|NCT01197560|463209486|FG001|Overall Study|Adverse Event|8|||
128702694|NCT01197560|463209485|FG000|Overall Study|Death|3|||
128702695|NCT01197560|463209486|FG001|Overall Study|Death|5|||
128702696|NCT01197560|463209485|FG000|Overall Study|Withdrawal by Subject|1|||
128702697|NCT01197560|463209486|FG001|Overall Study|Withdrawal by Subject|1|||
128702698|NCT01197560|463209485|FG000|Overall Study|Disease progression|40|||
128702699|NCT01197560|463209486|FG001|Overall Study|Disease progression|35|||
128702700|NCT01197560|463209485|FG000|Overall Study|Miscellaneous|4|||
128702701|NCT01197560|463209486|FG001|Overall Study|Miscellaneous|3|||
128702702|NCT01197560|463209485|FG000|Overall Study|Missing|0|||
128702703|NCT01197560|463209486|FG001|Overall Study|Missing|1|||
128702704|NCT02006719|463209487|FG000|Overall Study|Withdrawal by Subject|10|||
128702705|NCT02006719|463209488|FG001|Overall Study|Withdrawal by Subject|2|||
128702706|NCT02006719|463209487|FG000|Overall Study|Lost to Follow-up|5|||
128702707|NCT02006719|463209488|FG001|Overall Study|Lost to Follow-up|1|||
128702708|NCT02006719|463209487|FG000|Overall Study|Protocol Violation|2|||
128702709|NCT02006719|463209488|FG001|Overall Study|Protocol Violation|0|||
128702710|NCT02006719|463209487|FG000|Overall Study|Adverse Event|1|||
128702711|NCT02006719|463209488|FG001|Overall Study|Adverse Event|1|||
128702712|NCT02006719|463209487|FG000|Overall Study|Other/Unknown|0|||
128702713|NCT02006719|463209488|FG001|Overall Study|Other/Unknown|1|||
128702714|NCT04659161|463209489|FG000|Overall Study|Adverse Event|10|||
128702715|NCT04659161|463209490|FG001|Overall Study|Adverse Event|6|||
128702716|NCT04659161|463209489|FG000|Overall Study|Withdrawal by Subject|13|||
128702717|NCT04659161|463209490|FG001|Overall Study|Withdrawal by Subject|12|||
128702718|NCT04659161|463209489|FG000|Overall Study|Other|9|||
128702719|NCT04659161|463209490|FG001|Overall Study|Other|8|||
128702720|NCT02197130|463209491|FG000|Overall Study|Adverse Event|13|||
128932150|NCT00467649|464039671|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
128932151|NCT00467649|464039672|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
128932152|NCT00467649|464039673|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
128932153|NCT00467649|464039668|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
128932154|NCT00467649|464039669|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
128932155|NCT00467649|464039670|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
128932156|NCT00467649|464039671|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
128932157|NCT00467649|464039672|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
128932158|NCT00467649|464039673|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
128932159|NCT00467649|464039668|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
128932160|NCT00467649|464039669|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
128932161|NCT00467649|464039670|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
128932162|NCT00467649|464039671|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
128932163|NCT00467649|464039672|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
128932164|NCT00467649|464039673|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
128932165|NCT00467649|464039668|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
128932166|NCT00467649|464039669|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
128932167|NCT00467649|464039670|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
128932168|NCT00467649|464039671|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
128932169|NCT00467649|464039672|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
128932170|NCT00467649|464039673|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
128932171|NCT03633331|464039676|FG000|Overall Study|Withdrawal by Subject|1|||
128932172|NCT03233048|464039677|FG000|Overall Study|Withdrawal by Subject|1|||
128932173|NCT03443024|464039682|FG000|Overall Study|Adverse Event|2|||
128932174|NCT03443024|464039683|FG001|Overall Study|Adverse Event|4|||
128932175|NCT03443024|464039684|FG002|Overall Study|Adverse Event|3|||
128932176|NCT03443024|464039685|FG003|Overall Study|Adverse Event|1|||
128932177|NCT03443024|464039682|FG000|Overall Study|Lost to Follow-up|9|||
128932178|NCT03443024|464039683|FG001|Overall Study|Lost to Follow-up|9|||
128702721|NCT02197130|463209492|FG001|Overall Study|Adverse Event|4|||
128702722|NCT02197130|463209493|FG002|Overall Study|Adverse Event|23|||
128702723|NCT02197130|463209491|FG000|Overall Study|Death|0|||
128702724|NCT02197130|463209492|FG001|Overall Study|Death|1|||
128702725|NCT02197130|463209493|FG002|Overall Study|Death|0|||
128702726|NCT02197130|463209491|FG000|Overall Study|Lost to Follow-up|2|||
128702727|NCT02197130|463209492|FG001|Overall Study|Lost to Follow-up|0|||
128702728|NCT02197130|463209493|FG002|Overall Study|Lost to Follow-up|1|||
128702729|NCT02197130|463209491|FG000|Overall Study|Does not meet entrance criteria|0|||
128702730|NCT02197130|463209492|FG001|Overall Study|Does not meet entrance criteria|0|||
128702731|NCT02197130|463209493|FG002|Overall Study|Does not meet entrance criteria|1|||
128702732|NCT02197130|463209491|FG000|Overall Study|Withdrawal by Subject|0|||
128702733|NCT02197130|463209492|FG001|Overall Study|Withdrawal by Subject|3|||
128932179|NCT03443024|464039684|FG002|Overall Study|Lost to Follow-up|7|||
128932180|NCT03443024|464039685|FG003|Overall Study|Lost to Follow-up|5|||
128932181|NCT03443024|464039682|FG000|Overall Study|Withdrawal by Subject|8|||
129121527|NCT00915525|464741161|FG001|Overall Study|Protocol Violation|4|||
129121528|NCT00915525|464741160|FG000|Overall Study|Withdrawal by Subject|59|||
129121529|NCT00915525|464741161|FG001|Overall Study|Withdrawal by Subject|21|||
128932182|NCT03443024|464039683|FG001|Overall Study|Withdrawal by Subject|15|||
128932183|NCT03443024|464039684|FG002|Overall Study|Withdrawal by Subject|9|||
128932184|NCT03443024|464039685|FG003|Overall Study|Withdrawal by Subject|23|||
128932185|NCT03443024|464039682|FG000|Overall Study|Physician Decision|1|||
128932186|NCT03443024|464039683|FG001|Overall Study|Physician Decision|2|||
128932187|NCT03443024|464039684|FG002|Overall Study|Physician Decision|0|||
128932188|NCT03443024|464039685|FG003|Overall Study|Physician Decision|1|||
128932189|NCT03443024|464039682|FG000|Overall Study|Sponsor Decision|1|||
128932190|NCT03443024|464039683|FG001|Overall Study|Sponsor Decision|1|||
128932191|NCT03443024|464039684|FG002|Overall Study|Sponsor Decision|0|||
128932192|NCT03443024|464039685|FG003|Overall Study|Sponsor Decision|0|||
128932193|NCT03443024|464039682|FG000|Overall Study|Protocol Deviation|0|||
128932194|NCT03443024|464039683|FG001|Overall Study|Protocol Deviation|0|||
128932195|NCT03443024|464039684|FG002|Overall Study|Protocol Deviation|0|||
128932196|NCT03443024|464039685|FG003|Overall Study|Protocol Deviation|2|||
128932197|NCT05897853|464039686|FG000|Overall Study|Lost to Follow-up|2|||
128932198|NCT05897853|464039687|FG001|Overall Study|Lost to Follow-up|0|||
128932199|NCT05897853|464039686|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
128932200|NCT05897853|464039687|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
129121530|NCT00915525|464741160|FG000|Overall Study|Lost to Follow-up|27|||
129121531|NCT00915525|464741161|FG001|Overall Study|Lost to Follow-up|16|||
129121532|NCT00915525|464741160|FG000|Overall Study|Pregnancy|2|||
129121533|NCT00915525|464741161|FG001|Overall Study|Pregnancy|0|||
129121534|NCT00915525|464741160|FG000|Overall Study|Lack of Efficacy|15|||
129121535|NCT00915525|464741161|FG001|Overall Study|Lack of Efficacy|32|||
129121536|NCT00915525|464741160|FG000|Overall Study|Adverse Event|29|||
129121537|NCT00915525|464741161|FG001|Overall Study|Adverse Event|13|||
129121538|NCT00915525|464741160|FG000|Overall Study|Missing|12|||
129121539|NCT00915525|464741161|FG001|Overall Study|Missing|1|||
129121540|NCT00915525|464741160|FG000|Overall Study|Other Reason|35|||
129121541|NCT00915525|464741161|FG001|Overall Study|Other Reason|12|||
129121542|NCT00915525|464741160|FG000|Overall Study|Site Closed|27|||
128932201|NCT02782715|464039691|FG000|Overall Study|Withdrawal by Subject|1|||
128932202|NCT04458857|464039692|FG000|Overall Study|Adverse Event|0|||
128932203|NCT04458857|464039693|FG001|Overall Study|Adverse Event|1|||
128932204|NCT04458857|464039694|FG002|Overall Study|Adverse Event|0|||
128932205|NCT04458857|464039692|FG000|Overall Study|Withdrawal by Subject|2|||
128932206|NCT04458857|464039693|FG001|Overall Study|Withdrawal by Subject|0|||
128932207|NCT04458857|464039694|FG002|Overall Study|Withdrawal by Subject|0|||
128932208|NCT04458857|464039692|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128932209|NCT04458857|464039693|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128932210|NCT04458857|464039694|FG002|Overall Study|Withdrawal by parent/guardian|1|||
128932211|NCT04458857|464039692|FG000|Overall Study|Non-compliance with study drug|0|||
128932212|NCT04458857|464039693|FG001|Overall Study|Non-compliance with study drug|1|||
128932213|NCT04458857|464039694|FG002|Overall Study|Non-compliance with study drug|0|||
128932214|NCT04458857|464039692|FG000|Overall Study|Lost to Follow-up|4|||
128932215|NCT04458857|464039693|FG001|Overall Study|Lost to Follow-up|1|||
128932216|NCT04458857|464039694|FG002|Overall Study|Lost to Follow-up|0|||
128932217|NCT03368404|464039697|FG000|Overall Study|Adverse Event|2|||
128932218|NCT03368404|464039698|FG001|Overall Study|Adverse Event|1|||
128932219|NCT03368404|464039697|FG000|Overall Study|Withdrawal by Subject|1|||
128932220|NCT03368404|464039698|FG001|Overall Study|Withdrawal by Subject|1|||
128932221|NCT02983292|464039699|FG000|Overall Study|Participant unwell & cannot travel|2|||
128932222|NCT02983292|464039699|FG000|Overall Study|Lost to Follow-up|3|||
128932223|NCT02983292|464039699|FG000|Overall Study|Participant withdrew consent|2|||
128932224|NCT02983292|464039699|FG000|Overall Study|Revision|7|||
128932225|NCT02983292|464039699|FG000|Overall Study|Death|1|||
128932226|NCT02983292|464039699|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
128932227|NCT02983292|464039699|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
128932228|NCT02983292|464039699|FG000|Overall Study|Participant relocation|1|||
128932229|NCT00964795|464039700|FG000|Overall Study|Withdrawal by Subject|79|||
128932230|NCT00964795|464039700|FG000|Overall Study|Adverse Event|12|||
128932231|NCT00964795|464039700|FG000|Overall Study|Death|14|||
128932232|NCT00964795|464039700|FG000|Overall Study|Lost to Follow-up|7|||
128932233|NCT00964795|464039700|FG000|Overall Study|Termination of Study by Sponsor|169|||
129121543|NCT00915525|464741161|FG001|Overall Study|Site Closed|9|||
129121544|NCT00915525|464741160|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
129121545|NCT00915525|464741161|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
129121546|NCT00915525|464741160|FG000|Overall Study|Study Burden|28|||
129121547|NCT00915525|464741161|FG001|Overall Study|Study Burden|12|||
129121548|NCT00915525|464741160|FG000|Overall Study|Non-Compliance|3|||
129121549|NCT00915525|464741161|FG001|Overall Study|Non-Compliance|1|||
129121550|NCT00915525|464741160|FG000|Overall Study|Patient Moved|15|||
128932234|NCT00964795|464039700|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
128932235|NCT00964795|464039700|FG000|Overall Study|Other|23|||
128932236|NCT00586690|464039705|FG000|Overall Study|Death|2|||
128932237|NCT00586690|464039706|FG001|Overall Study|Death|0|||
128932238|NCT00586690|464039705|FG000|Overall Study|Disease Progression|10|||
128932239|NCT00586690|464039706|FG001|Overall Study|Disease Progression|0|||
128932240|NCT00586690|464039705|FG000|Overall Study|Adverse Event|1|||
128932241|NCT00586690|464039706|FG001|Overall Study|Adverse Event|0|||
128932242|NCT00586690|464039705|FG000|Overall Study|Lack of Efficacy|2|||
128932243|NCT00586690|464039706|FG001|Overall Study|Lack of Efficacy|0|||
129121551|NCT00915525|464741161|FG001|Overall Study|Patient Moved|9|||
129121552|NCT02765035|464741162|FG000|First Intervention (90 Days)|Adverse Event|1|||
129121553|NCT02765035|464741163|FG001|First Intervention (90 Days)|Adverse Event|1|||
129121554|NCT02765035|464741162|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
129121555|NCT02765035|464741163|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
129121556|NCT01712178|464741172|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
129121557|NCT01712178|464741173|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
129121558|NCT01712178|464741172|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
129121559|NCT01712178|464741173|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
129121560|NCT01712178|464741172|FG000|Overall Study|Lost to Follow-up|0|||
128932244|NCT00586690|464039705|FG000|Overall Study|Lab can't accommodate|1|||
128932245|NCT00586690|464039706|FG001|Overall Study|Lab can't accommodate|0|||
128932246|NCT00857246|464039707|FG000|Induction Regimen|Adverse Event|1|||
128932247|NCT00857246|464039707|FG000|Induction Regimen|disease-related complications|1|||
128932248|NCT00857246|464039707|FG000|Induction Regimen|Withdrawal by Subject|1|||
128932249|NCT00857246|464039707|FG000|Surgery (Curative)|disease progression|6|||
128932250|NCT00857246|464039707|FG000|ChemoRT|Withdrawal by Subject|1|||
128932251|NCT00857246|464039707|FG000|ChemoRT|Adverse Event|2|||
128932252|NCT02704429|464039711|FG000|Part A: 24 Weeks|Adverse Event|3|||
128932253|NCT02704429|464039712|FG001|Part A: 24 Weeks|Adverse Event|0|||
128932254|NCT02704429|464039711|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
128932255|NCT02704429|464039712|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
128932256|NCT00907738|464039713|FG000|Overall Study|Adverse Event|2|||
128932257|NCT00907738|464039714|FG001|Overall Study|Adverse Event|0|||
128932258|NCT00907738|464039715|FG002|Overall Study|Adverse Event|1|||
128932259|NCT00907738|464039716|FG003|Overall Study|Adverse Event|0|||
128932260|NCT00907738|464039717|FG004|Overall Study|Adverse Event|0|||
128932261|NCT00907738|464039713|FG000|Overall Study|not specified or withdrew consent|3|||
128932262|NCT00907738|464039714|FG001|Overall Study|not specified or withdrew consent|0|||
128932263|NCT00907738|464039715|FG002|Overall Study|not specified or withdrew consent|0|||
128932264|NCT00907738|464039716|FG003|Overall Study|not specified or withdrew consent|0|||
128932265|NCT00907738|464039717|FG004|Overall Study|not specified or withdrew consent|0|||
128932266|NCT00907738|464039713|FG000|Overall Study|Disease progression|8|||
129121561|NCT01712178|464741173|FG001|Overall Study|Lost to Follow-up|1|||
129121562|NCT00091819|464741174|FG000|Overall Study|Adverse Event|1|||
129121563|NCT00091819|464741175|FG001|Overall Study|Adverse Event|1|||
129121564|NCT00091819|464741174|FG000|Overall Study|Death|4|||
129121565|NCT00091819|464741175|FG001|Overall Study|Death|5|||
129121566|NCT00091819|464741174|FG000|Overall Study|Lost to Follow-up|26|||
129121567|NCT00091819|464741175|FG001|Overall Study|Lost to Follow-up|23|||
129121568|NCT00091819|464741174|FG000|Overall Study|Withdrawal by Subject|5|||
129121569|NCT00091819|464741175|FG001|Overall Study|Withdrawal by Subject|8|||
129121570|NCT00091819|464741174|FG000|Overall Study|Protocol Violation|1|||
129121571|NCT00091819|464741175|FG001|Overall Study|Protocol Violation|2|||
129121572|NCT00091819|464741174|FG000|Overall Study|Other|2|||
129121573|NCT00091819|464741175|FG001|Overall Study|Other|3|||
129121574|NCT00091819|464741174|FG000|Overall Study|Never received study treatment|3|||
129121575|NCT00091819|464741175|FG001|Overall Study|Never received study treatment|4|||
129121576|NCT00984867|464741176|FG000|Overall Study|Adverse Event|3|||
129121577|NCT00984867|464741177|FG001|Overall Study|Adverse Event|7|||
128932267|NCT00907738|464039714|FG001|Overall Study|Disease progression|1|||
129121578|NCT00984867|464741176|FG000|Overall Study|Death|1|||
129121579|NCT00984867|464741177|FG001|Overall Study|Death|0|||
128932268|NCT00907738|464039715|FG002|Overall Study|Disease progression|6|||
128932269|NCT00907738|464039716|FG003|Overall Study|Disease progression|4|||
128932270|NCT00907738|464039717|FG004|Overall Study|Disease progression|2|||
128932271|NCT01089725|464039718|FG000|Overall Study|Adverse Event|1|||
129121580|NCT00984867|464741176|FG000|Overall Study|Withdrawal by Subject|13|||
129121581|NCT00984867|464741177|FG001|Overall Study|Withdrawal by Subject|4|||
129121582|NCT00984867|464741176|FG000|Overall Study|Lost to Follow-up|3|||
128932272|NCT01089725|464039719|FG001|Overall Study|Adverse Event|1|||
128932273|NCT01089725|464039720|FG002|Overall Study|Adverse Event|0|||
128932274|NCT01089725|464039721|FG003|Overall Study|Adverse Event|0|||
128932275|NCT01089725|464039722|FG004|Overall Study|Adverse Event|2|||
128932276|NCT01089725|464039718|FG000|Overall Study|Lack of Efficacy|4|||
128932277|NCT01089725|464039719|FG001|Overall Study|Lack of Efficacy|3|||
128932278|NCT01089725|464039720|FG002|Overall Study|Lack of Efficacy|1|||
128932279|NCT01089725|464039721|FG003|Overall Study|Lack of Efficacy|0|||
128932280|NCT01089725|464039722|FG004|Overall Study|Lack of Efficacy|4|||
128932281|NCT01089725|464039718|FG000|Overall Study|Lost to Follow-up|2|||
128932282|NCT01089725|464039719|FG001|Overall Study|Lost to Follow-up|2|||
128932283|NCT01089725|464039720|FG002|Overall Study|Lost to Follow-up|0|||
128932284|NCT01089725|464039721|FG003|Overall Study|Lost to Follow-up|3|||
128932285|NCT01089725|464039722|FG004|Overall Study|Lost to Follow-up|0|||
128932286|NCT01089725|464039718|FG000|Overall Study|Protocol Violation|0|||
128932287|NCT01089725|464039719|FG001|Overall Study|Protocol Violation|0|||
128932288|NCT01089725|464039720|FG002|Overall Study|Protocol Violation|1|||
128932289|NCT01089725|464039721|FG003|Overall Study|Protocol Violation|1|||
128932290|NCT01089725|464039722|FG004|Overall Study|Protocol Violation|0|||
128932291|NCT01089725|464039718|FG000|Overall Study|Withdrawal by Subject|5|||
128932292|NCT01089725|464039719|FG001|Overall Study|Withdrawal by Subject|5|||
128932293|NCT01089725|464039720|FG002|Overall Study|Withdrawal by Subject|4|||
128932294|NCT01089725|464039721|FG003|Overall Study|Withdrawal by Subject|5|||
128932295|NCT01089725|464039722|FG004|Overall Study|Withdrawal by Subject|4|||
128932296|NCT01089725|464039718|FG000|Overall Study|Study Terminated by Sponsor|51|||
128932297|NCT01089725|464039719|FG001|Overall Study|Study Terminated by Sponsor|56|||
128932298|NCT01089725|464039720|FG002|Overall Study|Study Terminated by Sponsor|53|||
128932299|NCT01089725|464039721|FG003|Overall Study|Study Terminated by Sponsor|68|||
128932300|NCT01089725|464039722|FG004|Overall Study|Study Terminated by Sponsor|68|||
128932301|NCT01089725|464039718|FG000|Overall Study|Randomized, but not treated|0|||
128932302|NCT01089725|464039719|FG001|Overall Study|Randomized, but not treated|1|||
128932303|NCT01089725|464039720|FG002|Overall Study|Randomized, but not treated|2|||
128932304|NCT01089725|464039721|FG003|Overall Study|Randomized, but not treated|1|||
128932305|NCT01089725|464039722|FG004|Overall Study|Randomized, but not treated|2|||
128932306|NCT01089725|464039718|FG000|Overall Study|Other|3|||
128932307|NCT01089725|464039719|FG001|Overall Study|Other|0|||
128932308|NCT01089725|464039720|FG002|Overall Study|Other|0|||
128932309|NCT01089725|464039721|FG003|Overall Study|Other|1|||
128932310|NCT01089725|464039722|FG004|Overall Study|Other|0|||
128932311|NCT01582282|464041380|FG000|Overall Study|Adverse Event|1|||
128932312|NCT01582282|464041381|FG001|Overall Study|Adverse Event|1|||
128932313|NCT01582282|464041382|FG002|Overall Study|Adverse Event|0|||
128932314|NCT01582282|464041380|FG000|Overall Study|Lost to Follow-up|1|||
128932315|NCT01582282|464041381|FG001|Overall Study|Lost to Follow-up|0|||
128932316|NCT01582282|464041382|FG002|Overall Study|Lost to Follow-up|0|||
128932317|NCT01582282|464041380|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
128932318|NCT01582282|464041381|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
128932319|NCT01582282|464041382|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
128932320|NCT01486316|464041383|FG000|Overall Study|Device explanted with/without re-implant|3|||
128932321|NCT01486316|464041384|FG001|Overall Study|Device explanted with/without re-implant|2|||
128932322|NCT01486316|464041385|FG002|Overall Study|Device explanted with/without re-implant|0|||
128932323|NCT01486316|464041386|FG003|Overall Study|Device explanted with/without re-implant|2|||
128932324|NCT01486316|464041383|FG000|Overall Study|Not meeting eligibility criteria|0|||
128932325|NCT01486316|464041384|FG001|Overall Study|Not meeting eligibility criteria|0|||
128932326|NCT01486316|464041385|FG002|Overall Study|Not meeting eligibility criteria|1|||
128932327|NCT01486316|464041386|FG003|Overall Study|Not meeting eligibility criteria|0|||
128932328|NCT01486316|464041383|FG000|Overall Study|Withdrawal by Subject|1|||
128932329|NCT01486316|464041384|FG001|Overall Study|Withdrawal by Subject|0|||
128932330|NCT01486316|464041385|FG002|Overall Study|Withdrawal by Subject|3|||
128932331|NCT01486316|464041386|FG003|Overall Study|Withdrawal by Subject|0|||
128932332|NCT01486316|464041383|FG000|Overall Study|Physician Decision|0|||
128932333|NCT01486316|464041384|FG001|Overall Study|Physician Decision|0|||
128932334|NCT01486316|464041385|FG002|Overall Study|Physician Decision|1|||
128932335|NCT01486316|464041386|FG003|Overall Study|Physician Decision|0|||
128932336|NCT01486316|464041383|FG000|Overall Study|Death|0|||
128932337|NCT01486316|464041384|FG001|Overall Study|Death|1|||
128932338|NCT01486316|464041385|FG002|Overall Study|Death|0|||
128932339|NCT01486316|464041386|FG003|Overall Study|Death|0|||
128932340|NCT02495077|464041395|FG000|Overall Study|Adverse Event|0|||
128932341|NCT02495077|464041396|FG001|Overall Study|Adverse Event|1|||
128932342|NCT02495077|464041397|FG002|Overall Study|Adverse Event|1|||
128932343|NCT02495077|464041398|FG003|Overall Study|Adverse Event|0|||
128932344|NCT02495077|464041395|FG000|Overall Study|Death|3|||
128932345|NCT02495077|464041396|FG001|Overall Study|Death|5|||
129030775|NCT02966340|464404692|FG000|Overall Study|Lost to Follow-up|0|||
128702734|NCT02197130|463209493|FG002|Overall Study|Withdrawal by Subject|4|||
128932346|NCT02495077|464041397|FG002|Overall Study|Death|0|||
128932347|NCT02495077|464041398|FG003|Overall Study|Death|0|||
128932348|NCT02495077|464041395|FG000|Overall Study|Lost to Follow-up|6|||
128932349|NCT02495077|464041396|FG001|Overall Study|Lost to Follow-up|4|||
128932350|NCT02495077|464041397|FG002|Overall Study|Lost to Follow-up|0|||
128932351|NCT02495077|464041398|FG003|Overall Study|Lost to Follow-up|0|||
128932352|NCT02495077|464041395|FG000|Overall Study|Physician Decision|2|||
128932353|NCT02495077|464041396|FG001|Overall Study|Physician Decision|1|||
128702735|NCT02197130|463209491|FG000|Overall Study|Other|1|||
128702736|NCT02197130|463209492|FG001|Overall Study|Other|0|||
128767649|NCT00744328|463440327|FG000|Overall Study|Found ineligible after randomization|0|||
128767650|NCT00744328|463440328|FG001|Overall Study|Found ineligible after randomization|0|||
128767651|NCT00744328|463440329|FG002|Overall Study|Found ineligible after randomization|1|||
128767652|NCT02387216|463440334|FG000|Overall Study|Progressive disease|2|||
128767653|NCT02387216|463440335|FG001|Overall Study|Progressive disease|0|||
128767654|NCT02387216|463440334|FG000|Overall Study|Withdrawal by Subject|3|||
128767655|NCT02387216|463440335|FG001|Overall Study|Withdrawal by Subject|5|||
128767656|NCT02387216|463440334|FG000|Overall Study|Physician Decision|2|||
128767657|NCT02387216|463440335|FG001|Overall Study|Physician Decision|0|||
128767658|NCT02387216|463440334|FG000|Overall Study|Sponsor Decision|28|||
128767659|NCT02387216|463440335|FG001|Overall Study|Sponsor Decision|12|||
128767660|NCT02387216|463440334|FG000|Overall Study|Death|60|||
128702737|NCT02197130|463209493|FG002|Overall Study|Other|3|||
128702738|NCT03288129|463209497|FG000|Overall Study|Adverse Event|10|||
128702739|NCT03288129|463209497|FG000|Overall Study|Lost to Follow-up|3|||
128767661|NCT02387216|463440335|FG001|Overall Study|Death|23|||
128767662|NCT02387216|463440334|FG000|Overall Study|Other|5|||
128767663|NCT02387216|463440335|FG001|Overall Study|Other|4|||
128767664|NCT02387216|463440334|FG000|Overall Study|Lost to Follow-up|0|||
128767665|NCT02387216|463440335|FG001|Overall Study|Lost to Follow-up|3|||
128767666|NCT03101241|463440336|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
128767667|NCT03101241|463440337|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
128767668|NCT03101241|463440336|FG000|Overall Study|Participant withdrew consent|3|||
128702740|NCT03288129|463209497|FG000|Overall Study|Withdrawal by Subject|3|||
128702741|NCT03288129|463209497|FG000|Overall Study|Withdrawal of consent/assent|1|||
128702742|NCT03288129|463209497|FG000|Overall Study|Other|5|||
128702743|NCT00558558|463209502|FG000|Overall Study|Unable to swallow|1|||
128702744|NCT00558558|463209502|FG000|Overall Study|Withdrawal by Subject|1|||
128702745|NCT00558558|463209502|FG000|Overall Study|Lack of Efficacy|4|||
128702746|NCT00540514|463211281|FG000|Overall Study|Still on treatment|3|||
128702747|NCT00540514|463211282|FG001|Overall Study|Still on treatment|0|||
128702748|NCT00540514|463211281|FG000|Overall Study|Unacceptable Toxicity|61|||
128702749|NCT00540514|463211282|FG001|Overall Study|Unacceptable Toxicity|62|||
128702750|NCT00540514|463211281|FG000|Overall Study|Adverse Event|20|||
128702751|NCT00540514|463211282|FG001|Overall Study|Adverse Event|24|||
128702752|NCT00540514|463211281|FG000|Overall Study|Physician Decision|86|||
128702753|NCT00540514|463211282|FG001|Overall Study|Physician Decision|99|||
128702754|NCT00540514|463211281|FG000|Overall Study|Protocol Deviation|3|||
128702755|NCT00540514|463211282|FG001|Overall Study|Protocol Deviation|4|||
128702756|NCT00540514|463211281|FG000|Overall Study|Lost to Follow-up|1|||
128702757|NCT00540514|463211282|FG001|Overall Study|Lost to Follow-up|1|||
128702758|NCT00540514|463211281|FG000|Overall Study|Withdrawal by Subject|65|||
128702759|NCT00540514|463211282|FG001|Overall Study|Withdrawal by Subject|67|||
128702760|NCT00540514|463211281|FG000|Overall Study|Excluded prior to treatment|7|||
128702761|NCT00540514|463211282|FG001|Overall Study|Excluded prior to treatment|7|||
128702762|NCT00540514|463211281|FG000|Overall Study|Paclitaxel not available|0|||
128702763|NCT00540514|463211282|FG001|Overall Study|Paclitaxel not available|2|||
128702764|NCT02501473|463211283|FG000|Overall Study|Study Terminated|2|||
128702765|NCT02501473|463211284|FG001|Overall Study|Study Terminated|3|||
128702766|NCT02501473|463211285|FG002|Overall Study|Study Terminated|7|||
128702767|NCT02501473|463211286|FG003|Overall Study|Study Terminated|9|||
128702768|NCT02501473|463211287|FG004|Overall Study|Study Terminated|2|||
128702769|NCT02501473|463211288|FG005|Overall Study|Study Terminated|10|||
128702770|NCT02501473|463211289|FG006|Overall Study|Study Terminated|1|||
128702771|NCT02501473|463211290|FG007|Overall Study|Study Terminated|0|||
128702772|NCT02501473|463211283|FG000|Overall Study|Withdrawal by Subject|0|||
128767669|NCT03101241|463440337|FG001|Overall Study|Participant withdrew consent|1|||
128767670|NCT03101241|463440336|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
128767671|NCT03101241|463440337|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
128932354|NCT02495077|464041397|FG002|Overall Study|Physician Decision|4|||
128932355|NCT02495077|464041398|FG003|Overall Study|Physician Decision|0|||
128932356|NCT02495077|464041395|FG000|Overall Study|Protocol Violation|0|||
128932357|NCT02495077|464041396|FG001|Overall Study|Protocol Violation|1|||
128932358|NCT02495077|464041397|FG002|Overall Study|Protocol Violation|0|||
128932359|NCT02495077|464041398|FG003|Overall Study|Protocol Violation|0|||
128932360|NCT02495077|464041395|FG000|Overall Study|Screen Failure|0|||
128932361|NCT02495077|464041396|FG001|Overall Study|Screen Failure|0|||
128702773|NCT02501473|463211284|FG001|Overall Study|Withdrawal by Subject|0|||
128702774|NCT02501473|463211285|FG002|Overall Study|Withdrawal by Subject|3|||
128702775|NCT02501473|463211286|FG003|Overall Study|Withdrawal by Subject|3|||
128702776|NCT02501473|463211287|FG004|Overall Study|Withdrawal by Subject|2|||
128702777|NCT02501473|463211288|FG005|Overall Study|Withdrawal by Subject|2|||
128702778|NCT02501473|463211289|FG006|Overall Study|Withdrawal by Subject|0|||
128702779|NCT02501473|463211290|FG007|Overall Study|Withdrawal by Subject|0|||
128702780|NCT02501473|463211283|FG000|Overall Study|Death|0|||
128932362|NCT02495077|464041397|FG002|Overall Study|Screen Failure|0|||
128932363|NCT02495077|464041398|FG003|Overall Study|Screen Failure|48|||
128932364|NCT02495077|464041395|FG000|Overall Study|Withdrawal by Subject|7|||
128932365|NCT02495077|464041396|FG001|Overall Study|Withdrawal by Subject|7|||
128932366|NCT02495077|464041397|FG002|Overall Study|Withdrawal by Subject|7|||
128932367|NCT02495077|464041398|FG003|Overall Study|Withdrawal by Subject|0|||
128932368|NCT02495077|464041395|FG000|Overall Study|Covid-19 research restrictions|1|||
128932369|NCT02495077|464041396|FG001|Overall Study|Covid-19 research restrictions|0|||
128932370|NCT02495077|464041397|FG002|Overall Study|Covid-19 research restrictions|0|||
128932371|NCT02495077|464041398|FG003|Overall Study|Covid-19 research restrictions|0|||
128932372|NCT02495077|464041395|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
128932373|NCT02495077|464041396|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
128932374|NCT02495077|464041397|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
128932375|NCT02495077|464041398|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
128932376|NCT02495077|464041395|FG000|Overall Study|Incarcerated|0|||
128932377|NCT02495077|464041396|FG001|Overall Study|Incarcerated|1|||
128932378|NCT02495077|464041397|FG002|Overall Study|Incarcerated|0|||
128932379|NCT02495077|464041398|FG003|Overall Study|Incarcerated|0|||
128932380|NCT02495077|464041395|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
128932381|NCT02495077|464041396|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
128932382|NCT02495077|464041397|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
128932383|NCT02495077|464041398|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
128932384|NCT02495077|464041395|FG000|Overall Study|Timing of transplant and randomization|0|||
128932385|NCT02495077|464041396|FG001|Overall Study|Timing of transplant and randomization|0|||
128932386|NCT02495077|464041397|FG002|Overall Study|Timing of transplant and randomization|5|||
128932387|NCT02495077|464041398|FG003|Overall Study|Timing of transplant and randomization|0|||
128932388|NCT02742649|464041399|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
128932389|NCT02742649|464041400|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
128932390|NCT02742649|464041401|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
128932391|NCT02742649|464041402|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
128932392|NCT02742649|464041403|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
128932393|NCT02742649|464041399|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128932394|NCT02742649|464041400|FG001|Double-Blind Treatment Period|Adverse Event|1|||
128932395|NCT02742649|464041401|FG002|Double-Blind Treatment Period|Adverse Event|0|||
128932396|NCT02742649|464041402|FG003|Double-Blind Treatment Period|Adverse Event|0|||
128932397|NCT02742649|464041403|FG004|Double-Blind Treatment Period|Adverse Event|0|||
128932398|NCT02742649|464041399|FG000|Open-Label Period|Lost to Follow-up|0|||
128932399|NCT02742649|464041400|FG001|Open-Label Period|Lost to Follow-up|0|||
128932400|NCT02742649|464041401|FG002|Open-Label Period|Lost to Follow-up|0|||
128932401|NCT02742649|464041402|FG003|Open-Label Period|Lost to Follow-up|0|||
128932402|NCT02742649|464041403|FG004|Open-Label Period|Lost to Follow-up|1|||
128932403|NCT00417612|464041415|FG000|Overall Study|Errant diagnosis|0|||
128932404|NCT00417612|464041416|FG001|Overall Study|Errant diagnosis|1|||
128932405|NCT00417612|464041415|FG000|Overall Study|Adverse Event|2|||
128932406|NCT00417612|464041416|FG001|Overall Study|Adverse Event|0|||
128932407|NCT00417612|464041415|FG000|Overall Study|Protocol Violation|0|||
128932408|NCT00417612|464041416|FG001|Overall Study|Protocol Violation|2|||
128932409|NCT00417612|464041415|FG000|Overall Study|Lost to Follow-up|1|||
128932410|NCT00417612|464041416|FG001|Overall Study|Lost to Follow-up|0|||
128932411|NCT01330381|464041419|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
128932412|NCT01330381|464041420|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
128932413|NCT01330381|464041421|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
128932414|NCT01330381|464041419|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
128932415|NCT01330381|464041420|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
128932416|NCT01330381|464041421|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
128932417|NCT01330381|464041419|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
128932418|NCT01330381|464041420|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
128932419|NCT01330381|464041421|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
129121583|NCT00984867|464741177|FG001|Overall Study|Lost to Follow-up|4|||
129121584|NCT00984867|464741176|FG000|Overall Study|Poor/non-compliance|0|||
129121585|NCT00984867|464741177|FG001|Overall Study|Poor/non-compliance|1|||
128702781|NCT02501473|463211284|FG001|Overall Study|Death|0|||
128932420|NCT01330381|464041419|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
128932421|NCT01330381|464041420|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
128932422|NCT01330381|464041421|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
128932423|NCT01330381|464041419|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
128932424|NCT01330381|464041420|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
128932425|NCT01330381|464041421|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
128932426|NCT01330381|464041419|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
128932427|NCT01330381|464041420|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
128932428|NCT01330381|464041421|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
128932429|NCT01330381|464041419|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
128932430|NCT01330381|464041420|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
128932431|NCT01330381|464041421|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
128932432|NCT01330381|464041419|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
128932433|NCT01330381|464041420|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
128702782|NCT02501473|463211285|FG002|Overall Study|Death|1|||
128702783|NCT02501473|463211286|FG003|Overall Study|Death|1|||
128702784|NCT02501473|463211287|FG004|Overall Study|Death|0|||
128702785|NCT02501473|463211288|FG005|Overall Study|Death|1|||
128932434|NCT01330381|464041421|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
128932435|NCT01330381|464041419|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
128932436|NCT01330381|464041420|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
128932437|NCT01330381|464041421|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
128932438|NCT01330381|464041419|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
128932439|NCT01330381|464041420|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
129121586|NCT00984867|464741176|FG000|Overall Study|Subject no longer meets study criteria|1|||
129121587|NCT00984867|464741177|FG001|Overall Study|Subject no longer meets study criteria|1|||
129121588|NCT00984867|464741176|FG000|Overall Study|site closing|1|||
129121589|NCT00984867|464741177|FG001|Overall Study|site closing|0|||
129121590|NCT00984867|464741176|FG000|Overall Study|lack of efficacy and subject compliance|1|||
129121591|NCT00984867|464741177|FG001|Overall Study|lack of efficacy and subject compliance|0|||
129121592|NCT00634504|464741182|FG000|Overall Study|Protocol Violation|1|||
129121593|NCT00634504|464741183|FG001|Overall Study|Protocol Violation|0|||
129121594|NCT05001620|464741186|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
129121595|NCT05001620|464741187|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
129121596|NCT00481676|464741188|FG000|Overall Study|Adverse Event|0|||
128932440|NCT01330381|464041421|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
128932441|NCT00224107|464041422|FG000|Overall Study|Adverse Event|20|||
128932442|NCT00224107|464041423|FG001|Overall Study|Adverse Event|6|||
128932443|NCT00224107|464041422|FG000|Overall Study|Protocol Violation|2|||
128932444|NCT00224107|464041423|FG001|Overall Study|Protocol Violation|3|||
128932445|NCT00224107|464041422|FG000|Overall Study|Withdrawal by Subject|1|||
128932446|NCT00224107|464041423|FG001|Overall Study|Withdrawal by Subject|4|||
128932447|NCT00224107|464041422|FG000|Overall Study|Lack of Efficacy|2|||
128932448|NCT00224107|464041423|FG001|Overall Study|Lack of Efficacy|0|||
128932449|NCT00224107|464041422|FG000|Overall Study|Lost to Follow-up|4|||
128932450|NCT00224107|464041423|FG001|Overall Study|Lost to Follow-up|0|||
128932451|NCT00224107|464041422|FG000|Overall Study|Physician Decision|1|||
128932452|NCT00224107|464041423|FG001|Overall Study|Physician Decision|0|||
128932453|NCT00224107|464041422|FG000|Overall Study|Other|1|||
128932454|NCT00224107|464041423|FG001|Overall Study|Other|1|||
128932455|NCT00685178|464041424|FG000|Overall Study|Adverse Event|1|||
128932456|NCT00685178|464041425|FG001|Overall Study|Adverse Event|5|||
128932457|NCT00685178|464041426|FG002|Overall Study|Adverse Event|2|||
129121597|NCT00481676|464741189|FG001|Overall Study|Adverse Event|1|||
129121598|NCT00481676|464741188|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129121599|NCT00481676|464741189|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129121600|NCT00481676|464741188|FG000|Overall Study|Administrative problem|1|||
128702786|NCT02501473|463211289|FG006|Overall Study|Death|0|||
128702787|NCT02501473|463211290|FG007|Overall Study|Death|0|||
128702788|NCT02501473|463211283|FG000|Overall Study|Lost to Follow-up|1|||
128702789|NCT02501473|463211284|FG001|Overall Study|Lost to Follow-up|0|||
128702790|NCT02501473|463211285|FG002|Overall Study|Lost to Follow-up|1|||
128702791|NCT02501473|463211286|FG003|Overall Study|Lost to Follow-up|0|||
128702792|NCT02501473|463211287|FG004|Overall Study|Lost to Follow-up|0|||
128702793|NCT02501473|463211288|FG005|Overall Study|Lost to Follow-up|1|||
128702794|NCT02501473|463211289|FG006|Overall Study|Lost to Follow-up|0|||
128702795|NCT02501473|463211290|FG007|Overall Study|Lost to Follow-up|0|||
128702796|NCT02501473|463211283|FG000|Overall Study|Reason not specified|0|||
128702797|NCT02501473|463211284|FG001|Overall Study|Reason not specified|0|||
128702798|NCT02501473|463211285|FG002|Overall Study|Reason not specified|1|||
128702799|NCT02501473|463211286|FG003|Overall Study|Reason not specified|1|||
128702800|NCT02501473|463211287|FG004|Overall Study|Reason not specified|0|||
128702801|NCT02501473|463211288|FG005|Overall Study|Reason not specified|0|||
128702802|NCT02501473|463211289|FG006|Overall Study|Reason not specified|0|||
128767672|NCT03101241|463440336|FG000|Overall Study|Lost to Follow-up|2|||
128932458|NCT00685178|464041427|FG003|Overall Study|Adverse Event|4|||
128932459|NCT00685178|464041424|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
128932460|NCT00685178|464041425|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
128932461|NCT00685178|464041426|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
128932462|NCT00685178|464041427|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
128932463|NCT00685178|464041424|FG000|Overall Study|voluntary study discharge|4|||
129216744|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
129121601|NCT00481676|464741189|FG001|Overall Study|Administrative problem|0|||
129121602|NCT03937778|464741190|FG000|Overall Study|Withdrawal by Subject|1|||
129121603|NCT03937778|464741190|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
128932464|NCT00685178|464041425|FG001|Overall Study|voluntary study discharge|5|||
128932465|NCT00685178|464041426|FG002|Overall Study|voluntary study discharge|1|||
128932466|NCT00685178|464041427|FG003|Overall Study|voluntary study discharge|1|||
128932467|NCT00685178|464041424|FG000|Overall Study|incarcerated|1|||
128932468|NCT00685178|464041425|FG001|Overall Study|incarcerated|3|||
128932469|NCT00685178|464041426|FG002|Overall Study|incarcerated|7|||
128932470|NCT00685178|464041427|FG003|Overall Study|incarcerated|0|||
128932471|NCT00685178|464041424|FG000|Overall Study|administrative (disciplinary) discharge|0|||
128932472|NCT00685178|464041425|FG001|Overall Study|administrative (disciplinary) discharge|1|||
128932473|NCT00685178|464041426|FG002|Overall Study|administrative (disciplinary) discharge|0|||
128932474|NCT00685178|464041427|FG003|Overall Study|administrative (disciplinary) discharge|2|||
128932475|NCT00685178|464041424|FG000|Overall Study|Pregnancy|0|||
128932476|NCT00685178|464041425|FG001|Overall Study|Pregnancy|0|||
128932477|NCT00685178|464041426|FG002|Overall Study|Pregnancy|0|||
128932478|NCT00685178|464041427|FG003|Overall Study|Pregnancy|1|||
128932479|NCT00077623|464041428|FG000|Overall Study|Adverse Event|1|||
128932480|NCT00077623|464041429|FG001|Overall Study|Adverse Event|0|||
128932481|NCT00077623|464041430|FG002|Overall Study|Adverse Event|1|||
128932482|NCT00077623|464041428|FG000|Overall Study|Withdrawal by Subject|2|||
128932483|NCT00077623|464041429|FG001|Overall Study|Withdrawal by Subject|10|||
128932484|NCT00077623|464041430|FG002|Overall Study|Withdrawal by Subject|1|||
128932485|NCT00077623|464041428|FG000|Overall Study|Other-Non safety reason|18|||
128932486|NCT00077623|464041429|FG001|Overall Study|Other-Non safety reason|15|||
128932487|NCT00077623|464041430|FG002|Overall Study|Other-Non safety reason|19|||
128932488|NCT00077623|464041428|FG000|Overall Study|Insufficient therapeutic response|2|||
128932489|NCT00077623|464041429|FG001|Overall Study|Insufficient therapeutic response|0|||
128932490|NCT00077623|464041430|FG002|Overall Study|Insufficient therapeutic response|0|||
128932491|NCT00077623|464041428|FG000|Overall Study|Death|12|||
128932492|NCT00077623|464041429|FG001|Overall Study|Death|18|||
128932493|NCT00077623|464041430|FG002|Overall Study|Death|11|||
128932494|NCT00077623|464041428|FG000|Overall Study|Failure to return|1|||
128932495|NCT00077623|464041429|FG001|Overall Study|Failure to return|0|||
128932496|NCT00077623|464041430|FG002|Overall Study|Failure to return|0|||
128932497|NCT04220866|464041433|FG000|Overall Study|Death|4|||
128932498|NCT04220866|464041434|FG001|Overall Study|Death|5|||
128932499|NCT04220866|464041433|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
128932500|NCT04220866|464041434|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
128932501|NCT04220866|464041433|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
128932502|NCT04220866|464041434|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
128932503|NCT04220866|464041433|FG000|Overall Study|Withdrawal by Subject|0|||
128932504|NCT04220866|464041434|FG001|Overall Study|Withdrawal by Subject|1|||
128932505|NCT02138110|464041435|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
129121604|NCT00819039|464741191|FG000|Overall Study|Physician Decision|1|||
129121605|NCT00819039|464741192|FG001|Overall Study|Physician Decision|0|||
129121606|NCT00819039|464741193|FG002|Overall Study|Physician Decision|1|||
129121607|NCT00819039|464741191|FG000|Overall Study|Protocol Violation|1|||
129121608|NCT00819039|464741192|FG001|Overall Study|Protocol Violation|0|||
129121609|NCT00819039|464741193|FG002|Overall Study|Protocol Violation|0|||
129121610|NCT01513590|464741194|FG000|Overall Study|Adverse Event|2|||
129121611|NCT01513590|464741195|FG001|Overall Study|Adverse Event|3|||
129121612|NCT01513590|464741194|FG000|Overall Study|Withdrawal Criteria|3|||
129121613|NCT01513590|464741195|FG001|Overall Study|Withdrawal Criteria|0|||
129121614|NCT01513590|464741194|FG000|Overall Study|Unclassified|5|||
129121615|NCT01513590|464741195|FG001|Overall Study|Unclassified|10|||
129121616|NCT01240694|464741196|FG000|Overall Study|Adverse Event|9|||
129121617|NCT01240694|464741196|FG000|Overall Study|Lack of Efficacy|6|||
129121618|NCT01240694|464741196|FG000|Overall Study|Withdrawal by Subject|6|||
128767673|NCT03101241|463440337|FG001|Overall Study|Lost to Follow-up|0|||
128767674|NCT03101241|463440336|FG000|Overall Study|Lack of Efficacy|0|||
128767675|NCT03101241|463440337|FG001|Overall Study|Lack of Efficacy|1|||
128932506|NCT02138110|464041435|FG000|Overall Scaffold Implantation|Death|3|||
128932507|NCT03515538|464041436|FG000|Overall Study|Lack of Efficacy|2|||
128932508|NCT03515538|464041437|FG001|Overall Study|Lack of Efficacy|0|||
128932509|NCT03515538|464041438|FG002|Overall Study|Lack of Efficacy|2|||
128932510|NCT03515538|464041439|FG003|Overall Study|Lack of Efficacy|0|||
128932511|NCT03515538|464041436|FG000|Overall Study|Death|0|||
128932512|NCT03515538|464041437|FG001|Overall Study|Death|0|||
128932513|NCT03515538|464041438|FG002|Overall Study|Death|1|||
128932514|NCT03515538|464041439|FG003|Overall Study|Death|0|||
129121619|NCT01240694|464741196|FG000|Overall Study|Protocol Violation|2|||
129121620|NCT01240694|464741196|FG000|Overall Study|Lost to Follow-up|2|||
129121621|NCT01240694|464741196|FG000|Overall Study|Other than specified|3|||
129121622|NCT01240694|464741196|FG000|Overall Study|Withdrawn due to early study termination|107|||
129121623|NCT01206764|464741197|FG000|Overall Study|Adverse Event|20|||
128932515|NCT03515538|464041436|FG000|Overall Study|Protocol Violation|0|||
128932516|NCT03515538|464041437|FG001|Overall Study|Protocol Violation|0|||
129121624|NCT01206764|464741197|FG000|Overall Study|Abnormal laboratory value|2|||
129121625|NCT01206764|464741197|FG000|Overall Study|Abnormal test procedure result|1|||
129121626|NCT01206764|464741197|FG000|Overall Study|Patient withdrew consent|5|||
129121627|NCT01206764|464741197|FG000|Overall Study|Lost to Follow-up|6|||
129121628|NCT01206764|464741197|FG000|Overall Study|Death|11|||
129121629|NCT01206764|464741197|FG000|Overall Study|New cancer therapy|2|||
129121630|NCT01206764|464741197|FG000|Overall Study|Disease progression|88|||
129121631|NCT01206764|464741197|FG000|Overall Study|Protocol deviation|3|||
129121632|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
129121633|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
129121634|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
129121635|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
129121636|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
129121637|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
129121638|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
129121639|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
129121640|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
129121641|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
129121642|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
129121643|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
129121644|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
129121645|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
129121646|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
129121647|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
129121648|NCT00410163|464741199|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
129121649|NCT00410163|464741200|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
129121650|NCT00410163|464741199|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
129121651|NCT00410163|464741200|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
128932517|NCT03515538|464041438|FG002|Overall Study|Protocol Violation|0|||
128932518|NCT03515538|464041439|FG003|Overall Study|Protocol Violation|1|||
128932519|NCT03515538|464041436|FG000|Overall Study|Screen failure (baseline dropout)|0|||
128932520|NCT03515538|464041437|FG001|Overall Study|Screen failure (baseline dropout)|1|||
128932521|NCT03515538|464041438|FG002|Overall Study|Screen failure (baseline dropout)|0|||
128932522|NCT03515538|464041439|FG003|Overall Study|Screen failure (baseline dropout)|0|||
128932523|NCT03515538|464041436|FG000|Overall Study|Withdrawal by Subject|2|||
128932524|NCT03515538|464041437|FG001|Overall Study|Withdrawal by Subject|2|||
128932525|NCT03515538|464041438|FG002|Overall Study|Withdrawal by Subject|1|||
128932526|NCT03515538|464041439|FG003|Overall Study|Withdrawal by Subject|3|||
128932527|NCT03515538|464041436|FG000|Overall Study|Physician Decision|1|||
128932528|NCT03515538|464041437|FG001|Overall Study|Physician Decision|0|||
128932529|NCT03515538|464041438|FG002|Overall Study|Physician Decision|0|||
128932530|NCT03515538|464041439|FG003|Overall Study|Physician Decision|1|||
128932531|NCT00308620|464041444|FG000|Overall Study|Death|1|||
128932532|NCT00308620|464041445|FG001|Overall Study|Death|1|||
128932533|NCT00308620|464041446|FG002|Overall Study|Death|0|||
128932534|NCT00308620|464041444|FG000|Overall Study|Lost to Follow-up|0|||
128932535|NCT00308620|464041445|FG001|Overall Study|Lost to Follow-up|0|||
128932536|NCT00308620|464041446|FG002|Overall Study|Lost to Follow-up|1|||
128932537|NCT00546351|464041447|FG000|Overall Study|Adverse Event|76|||
128932538|NCT00546351|464041447|FG000|Overall Study|Lack of Efficacy|15|||
128932539|NCT00546351|464041447|FG000|Overall Study|Withdrawal by Subject|109|||
128932540|NCT00546351|464041447|FG000|Overall Study|Lost to Follow-up|9|||
128932541|NCT00546351|464041447|FG000|Overall Study|Protocol Deviation|1|||
128932542|NCT00546351|464041447|FG000|Overall Study|Unsatisfactory compliance|9|||
128932543|NCT00546351|464041447|FG000|Overall Study|Other reasons for premature termination|17|||
128932544|NCT03952650|464041448|FG000|Overall Study|TRAVEL|0|||
128702803|NCT02501473|463211290|FG007|Overall Study|Reason not specified|0|||
128702804|NCT00907777|463211291|FG000|Overall Study|Withdrawal by Subject|0|||
128702805|NCT00907777|463211292|FG001|Overall Study|Withdrawal by Subject|1|||
128702806|NCT00105469|463211305|FG000|Overall Study|Adverse Event|9|||
128932545|NCT03952650|464041449|FG001|Overall Study|TRAVEL|4|||
128932546|NCT03952650|464041450|FG002|Overall Study|TRAVEL|0|||
128932547|NCT03952650|464041451|FG003|Overall Study|TRAVEL|4|||
128932548|NCT03952650|464041452|FG004|Overall Study|TRAVEL|0|||
128932549|NCT03952650|464041453|FG005|Overall Study|TRAVEL|3|||
128932550|NCT03952650|464041454|FG006|Overall Study|TRAVEL|2|||
128932551|NCT03952650|464041448|FG000|Overall Study|Withdrawal by Subject|0|||
128932552|NCT03952650|464041449|FG001|Overall Study|Withdrawal by Subject|2|||
128932553|NCT03952650|464041450|FG002|Overall Study|Withdrawal by Subject|0|||
128932554|NCT03952650|464041451|FG003|Overall Study|Withdrawal by Subject|3|||
128932555|NCT03952650|464041452|FG004|Overall Study|Withdrawal by Subject|0|||
128767676|NCT03101241|463440336|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
128767677|NCT03101241|463440337|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
128767678|NCT04498247|463440338|FG000|Overall Study|Lost to Follow-up|0|||
128767679|NCT04498247|463440339|FG001|Overall Study|Lost to Follow-up|0|||
128767680|NCT04498247|463440340|FG002|Overall Study|Lost to Follow-up|0|||
128767681|NCT04498247|463440341|FG003|Overall Study|Lost to Follow-up|1|||
128767682|NCT04498247|463440342|FG004|Overall Study|Lost to Follow-up|0|||
128767683|NCT04498247|463440343|FG005|Overall Study|Lost to Follow-up|0|||
128767684|NCT04498247|463440344|FG006|Overall Study|Lost to Follow-up|0|||
128767685|NCT04498247|463440345|FG007|Overall Study|Lost to Follow-up|0|||
128767686|NCT04498247|463440338|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
128767687|NCT04498247|463440339|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
128767688|NCT04498247|463440340|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
128767689|NCT04498247|463440341|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
128767690|NCT04498247|463440342|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
128767691|NCT04498247|463440343|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
128767692|NCT04498247|463440344|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
129030776|NCT02966340|464404693|FG001|Overall Study|Lost to Follow-up|1|||
129030777|NCT02966340|464404692|FG000|Overall Study|Withdrawal by Subject|1|||
129030778|NCT02966340|464404693|FG001|Overall Study|Withdrawal by Subject|0|||
129030779|NCT02966340|464404692|FG000|Overall Study|data acquisition error|1|||
129030780|NCT02966340|464404693|FG001|Overall Study|data acquisition error|0|||
129030781|NCT02966340|464404692|FG000|Overall Study|startle non-responder|1|||
129030782|NCT02966340|464404693|FG001|Overall Study|startle non-responder|1|||
129030783|NCT01622660|464404694|FG000|Overall Study|Adverse Event|1|||
129030784|NCT01120899|464404695|FG000|Overall Study|Withdrawal by Subject|3|||
129030785|NCT00820599|464404696|FG000|Overall Study|Death|129|||
129030786|NCT00820599|464404696|FG000|Overall Study|Withdrawal by Subject|2|||
129030787|NCT03686215|464404697|FG000|Overall Study|Adverse Event|0|||
129030788|NCT03686215|464404698|FG001|Overall Study|Adverse Event|0|||
129030789|NCT03686215|464404699|FG002|Overall Study|Adverse Event|7|||
129030790|NCT03686215|464404697|FG000|Overall Study|Physician Decision|0|||
129030791|NCT03686215|464404698|FG001|Overall Study|Physician Decision|0|||
129030792|NCT03686215|464404699|FG002|Overall Study|Physician Decision|1|||
129030793|NCT03686215|464404697|FG000|Overall Study|Protocol Violation|0|||
129030794|NCT03686215|464404698|FG001|Overall Study|Protocol Violation|0|||
129030795|NCT03686215|464404699|FG002|Overall Study|Protocol Violation|4|||
129030796|NCT03686215|464404697|FG000|Overall Study|Device issue|1|||
129030797|NCT03686215|464404698|FG001|Overall Study|Device issue|0|||
129030798|NCT03686215|464404699|FG002|Overall Study|Device issue|2|||
129030799|NCT00202839|464404702|FG000|Overall Study|Adverse Event|1|||
129030800|NCT00202839|464404703|FG001|Overall Study|Adverse Event|5|||
129030801|NCT00202839|464404702|FG000|Overall Study|Physician Decision|12|||
129030802|NCT00202839|464404703|FG001|Overall Study|Physician Decision|0|||
129030803|NCT00202839|464404702|FG000|Overall Study|Withdrawal by Subject|6|||
129030804|NCT00202839|464404703|FG001|Overall Study|Withdrawal by Subject|2|||
129030805|NCT00202839|464404702|FG000|Overall Study|Protocol Violation|2|||
129030806|NCT00202839|464404703|FG001|Overall Study|Protocol Violation|1|||
129030807|NCT00202839|464404702|FG000|Overall Study|Lost to Follow-up|3|||
129030808|NCT00202839|464404703|FG001|Overall Study|Lost to Follow-up|2|||
128702807|NCT00105469|463211306|FG001|Overall Study|Adverse Event|8|||
128702808|NCT00105469|463211305|FG000|Overall Study|Protocol Violation|4|||
128702809|NCT00105469|463211306|FG001|Overall Study|Protocol Violation|0|||
128702810|NCT00105469|463211305|FG000|Overall Study|Withdrawal by Subject|2|||
128702811|NCT00105469|463211306|FG001|Overall Study|Withdrawal by Subject|3|||
128702812|NCT00105469|463211305|FG000|Overall Study|Lost to Follow-up|1|||
128702813|NCT00105469|463211306|FG001|Overall Study|Lost to Follow-up|0|||
128702814|NCT00105469|463211305|FG000|Overall Study|Lack of Efficacy|2|||
128702815|NCT00105469|463211306|FG001|Overall Study|Lack of Efficacy|0|||
128702816|NCT00105469|463211305|FG000|Overall Study|Other Reason|4|||
128702817|NCT00105469|463211306|FG001|Overall Study|Other Reason|0|||
128702818|NCT00599924|463211308|FG000|Overall Study|Lack of Efficacy|3|||
128702819|NCT00599924|463211309|FG001|Overall Study|Lack of Efficacy|5|||
128702820|NCT00599924|463211310|FG002|Overall Study|Lack of Efficacy|1|||
128702821|NCT00599924|463211311|FG003|Overall Study|Lack of Efficacy|2|||
128702822|NCT00599924|463211312|FG004|Overall Study|Lack of Efficacy|3|||
128767693|NCT04498247|463440345|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
128767694|NCT04498247|463440338|FG000|Overall Study|Withdrawal by Subject|0|||
128702823|NCT00599924|463211313|FG005|Overall Study|Lack of Efficacy|2|||
128702824|NCT00599924|463211314|FG006|Overall Study|Lack of Efficacy|0|||
129030809|NCT00442351|464404704|FG000|Overall Study|Administrative|6|||
129030810|NCT00442351|464404705|FG001|Overall Study|Administrative|5|||
129030811|NCT00442351|464404704|FG000|Overall Study|Did not meet protocol eligibility|1|||
129030812|NCT00442351|464404705|FG001|Overall Study|Did not meet protocol eligibility|0|||
129030813|NCT00442351|464404704|FG000|Overall Study|Other|0|||
129030814|NCT00442351|464404705|FG001|Overall Study|Other|1|||
128702825|NCT00599924|463211308|FG000|Overall Study|Adverse Event|0|||
128767695|NCT04498247|463440339|FG001|Overall Study|Withdrawal by Subject|8|||
129030815|NCT01813435|464404711|FG000|Overall Study|did not finish experimental regimen|1902|||
129030816|NCT01813435|464404712|FG001|Overall Study|did not finish experimental regimen|770|||
129030817|NCT01813435|464404711|FG000|Overall Study|Lost to Follow-up|268|||
129030818|NCT01813435|464404712|FG001|Overall Study|Lost to Follow-up|237|||
129030819|NCT00452348|464404713|FG000|Overall Study|Adverse Event|6|||
129030820|NCT00452348|464404714|FG001|Overall Study|Adverse Event|9|||
129030821|NCT00452348|464404713|FG000|Overall Study|Lack of Efficacy|10|||
129030822|NCT00452348|464404714|FG001|Overall Study|Lack of Efficacy|9|||
129030823|NCT00452348|464404713|FG000|Overall Study|Lost to Follow-up|14|||
129030824|NCT00452348|464404714|FG001|Overall Study|Lost to Follow-up|8|||
129030825|NCT00452348|464404713|FG000|Overall Study|Protocol Violation|22|||
129030826|NCT00452348|464404714|FG001|Overall Study|Protocol Violation|28|||
129030827|NCT00452348|464404713|FG000|Overall Study|Withdrawal by Subject|18|||
129030828|NCT00452348|464404714|FG001|Overall Study|Withdrawal by Subject|21|||
129030829|NCT00452348|464404713|FG000|Overall Study|Other|9|||
129030830|NCT00452348|464404714|FG001|Overall Study|Other|9|||
129030831|NCT01490190|464404715|FG000|Overall Study|Withdrawal by Subject|9|||
129030832|NCT01490190|464404715|FG000|Overall Study|Adverse Event|17|||
129030833|NCT01490190|464404715|FG000|Overall Study|Protocol Violation|5|||
129030834|NCT01490190|464404715|FG000|Overall Study|Lost to Follow-up|13|||
129030835|NCT01490190|464404715|FG000|Overall Study|Relocation|1|||
129030836|NCT01490190|464404715|FG000|Overall Study|Inconvenience|1|||
129121652|NCT00410163|464741199|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
129121653|NCT00410163|464741200|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
129030837|NCT01490190|464404715|FG000|Overall Study|Ring expulsion|2|||
129030838|NCT00960154|464404721|FG000|Overall Study|Study termination|25|||
129030839|NCT00960154|464404722|FG001|Overall Study|Study termination|25|||
129030840|NCT00544167|464404726|FG000|Overall Study|Adverse Event|21|||
129030841|NCT00544167|464404726|FG000|Overall Study|Physician Decision|8|||
129030842|NCT00856349|464404727|FG000|Overall Study|Death|418|||
129030843|NCT00856349|464404727|FG000|Overall Study|Withdrawal by Subject|116|||
129030844|NCT00856349|464404727|FG000|Overall Study|Lost to Follow-up|91|||
129030845|NCT00856349|464404727|FG000|Overall Study|Protocol Violation|38|||
129121654|NCT00410163|464741199|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
129121655|NCT00410163|464741200|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
129121656|NCT00410163|464741199|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
129121657|NCT00410163|464741200|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
129121658|NCT00410163|464741199|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
129121659|NCT00410163|464741200|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
129121660|NCT00797563|464741202|FG000|Overall Study|Adverse Event|1|||
129121661|NCT00688597|464741203|FG000|Overall Study|Adverse Event|2|||
129121662|NCT00688597|464741204|FG001|Overall Study|Adverse Event|0|||
129121663|NCT00688597|464741205|FG002|Overall Study|Adverse Event|0|||
129121664|NCT00688597|464741203|FG000|Overall Study|Physician Decision|1|||
129121665|NCT00688597|464741204|FG001|Overall Study|Physician Decision|0|||
129121666|NCT00688597|464741205|FG002|Overall Study|Physician Decision|0|||
129121667|NCT05853120|464741206|FG000|Overall Study|Lost to Follow-up|4|||
129121668|NCT05853120|464741207|FG001|Overall Study|Lost to Follow-up|4|||
129121669|NCT05853120|464741206|FG000|Overall Study|Physician Decision|3|||
129121670|NCT05853120|464741207|FG001|Overall Study|Physician Decision|0|||
129121671|NCT05853120|464741206|FG000|Overall Study|Withdrawal by Subject|5|||
129121672|NCT05853120|464741207|FG001|Overall Study|Withdrawal by Subject|2|||
129121673|NCT03692949|464741208|FG000|Overall Study|Lost to Follow-up|0|||
129121674|NCT03692949|464741209|FG001|Overall Study|Lost to Follow-up|0|||
129121675|NCT03692949|464741210|FG002|Overall Study|Lost to Follow-up|0|||
129121676|NCT03692949|464741211|FG003|Overall Study|Lost to Follow-up|0|||
129030846|NCT00856349|464404727|FG000|Overall Study|Physician Decision|13|||
129030847|NCT00856349|464404727|FG000|Overall Study|Subject relocation|104|||
129030848|NCT00856349|464404727|FG000|Overall Study|Device explant|33|||
129030849|NCT00856349|464404727|FG000|Overall Study|Site closure|78|||
129030850|NCT00856349|464404727|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
128767696|NCT04498247|463440340|FG002|Overall Study|Withdrawal by Subject|0|||
129121677|NCT03692949|464741212|FG004|Overall Study|Lost to Follow-up|0|||
129121678|NCT03692949|464741213|FG005|Overall Study|Lost to Follow-up|0|||
129121679|NCT03692949|464741214|FG006|Overall Study|Lost to Follow-up|0|||
129121680|NCT03692949|464741215|FG007|Overall Study|Lost to Follow-up|1|||
129121681|NCT02592824|464741221|FG000|Overall Study|Protocol Violation|5|||
129030851|NCT02725515|464404728|FG000|Overall Study|Refused infusion (no study treatment)|1|||
129030852|NCT02725515|464404729|FG001|Overall Study|Refused infusion (no study treatment)|0|||
129030853|NCT02725515|464404728|FG000|Overall Study|Loss of Improvement per Protocol|14|||
129030854|NCT02725515|464404729|FG001|Overall Study|Loss of Improvement per Protocol|25|||
129030855|NCT02725515|464404728|FG000|Overall Study|Withdrawal by Subject|2|||
129030856|NCT02725515|464404729|FG001|Overall Study|Withdrawal by Subject|1|||
129030857|NCT02725515|464404728|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129030858|NCT02725515|464404729|FG001|Overall Study|Non-Compliance With Study Drug|3|||
129030859|NCT02725515|464404728|FG000|Overall Study|Lost to Follow-up|1|||
129121682|NCT02592824|464741222|FG001|Overall Study|Protocol Violation|3|||
128932556|NCT03952650|464041453|FG005|Overall Study|Withdrawal by Subject|1|||
128932557|NCT03952650|464041454|FG006|Overall Study|Withdrawal by Subject|1|||
128932558|NCT03952650|464041448|FG000|Overall Study|Lost to Follow-up|0|||
128932559|NCT03952650|464041449|FG001|Overall Study|Lost to Follow-up|1|||
128932560|NCT03952650|464041450|FG002|Overall Study|Lost to Follow-up|0|||
128932561|NCT03952650|464041451|FG003|Overall Study|Lost to Follow-up|0|||
128932562|NCT03952650|464041452|FG004|Overall Study|Lost to Follow-up|0|||
129216745|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
129216746|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
128932563|NCT03952650|464041453|FG005|Overall Study|Lost to Follow-up|1|||
128932564|NCT03952650|464041454|FG006|Overall Study|Lost to Follow-up|1|||
128932565|NCT03952650|464041448|FG000|Overall Study|Received wrong vaccine and travelled|0|||
128932566|NCT03952650|464041449|FG001|Overall Study|Received wrong vaccine and travelled|0|||
128932567|NCT03952650|464041450|FG002|Overall Study|Received wrong vaccine and travelled|0|||
128932568|NCT03952650|464041451|FG003|Overall Study|Received wrong vaccine and travelled|0|||
128932569|NCT03952650|464041452|FG004|Overall Study|Received wrong vaccine and travelled|0|||
128932570|NCT03952650|464041453|FG005|Overall Study|Received wrong vaccine and travelled|1|||
128932571|NCT03952650|464041454|FG006|Overall Study|Received wrong vaccine and travelled|0|||
128932572|NCT03952650|464041448|FG000|Overall Study|Unable to make study visit|0|||
128932573|NCT03952650|464041449|FG001|Overall Study|Unable to make study visit|0|||
128932574|NCT03952650|464041450|FG002|Overall Study|Unable to make study visit|0|||
128932575|NCT03952650|464041451|FG003|Overall Study|Unable to make study visit|0|||
128932576|NCT03952650|464041452|FG004|Overall Study|Unable to make study visit|0|||
128932577|NCT03952650|464041453|FG005|Overall Study|Unable to make study visit|1|||
128932578|NCT03952650|464041454|FG006|Overall Study|Unable to make study visit|0|||
128932579|NCT02424149|464041455|FG000|Overall Study|surgery cancelled|2|||
128932580|NCT02424149|464041456|FG001|Overall Study|surgery cancelled|0|||
128932581|NCT02424149|464041455|FG000|Overall Study|Withdrawal by Subject|0|||
128932582|NCT02424149|464041456|FG001|Overall Study|Withdrawal by Subject|1|||
128932583|NCT00592683|464041457|FG000|Overall Study|Found ineligible|0|||
128932584|NCT00592683|464041458|FG001|Overall Study|Found ineligible|1|||
128932585|NCT00592683|464041457|FG000|Overall Study|Withdrawal by Subject|1|||
128932586|NCT00592683|464041458|FG001|Overall Study|Withdrawal by Subject|0|||
128932587|NCT00592683|464041457|FG000|Overall Study|Adverse Event|0|||
128932588|NCT00592683|464041458|FG001|Overall Study|Adverse Event|2|||
128932589|NCT00592683|464041457|FG000|Overall Study|Protocol Violation|1|||
128932590|NCT00592683|464041458|FG001|Overall Study|Protocol Violation|0|||
128932591|NCT00592683|464041457|FG000|Overall Study|Study drug expired|1|||
128932592|NCT00592683|464041458|FG001|Overall Study|Study drug expired|0|||
128932593|NCT00592683|464041457|FG000|Overall Study|Other|1|||
128932594|NCT00592683|464041458|FG001|Overall Study|Other|0|||
128932595|NCT00592683|464041457|FG000|Overall Study|Lost to Follow-up|0|||
128932596|NCT00592683|464041458|FG001|Overall Study|Lost to Follow-up|1|||
128932597|NCT01357239|464041461|FG000|Stratum: All Patients|Adverse Event|0|||
128932598|NCT01357239|464041462|FG001|Stratum: All Patients|Adverse Event|0|||
128932599|NCT01357239|464041463|FG002|Stratum: All Patients|Adverse Event|1|||
128932600|NCT01357239|464041464|FG003|Stratum: All Patients|Adverse Event|1|||
128932601|NCT01357239|464041461|FG000|Stratum: All Patients|Subject withdrew consent|0|||
128932602|NCT01357239|464041462|FG001|Stratum: All Patients|Subject withdrew consent|0|||
128932603|NCT01357239|464041463|FG002|Stratum: All Patients|Subject withdrew consent|1|||
128932604|NCT01357239|464041464|FG003|Stratum: All Patients|Subject withdrew consent|1|||
128932605|NCT01357239|464041461|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
128932606|NCT01357239|464041462|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
128932607|NCT01357239|464041463|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
128932608|NCT01357239|464041464|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
128932609|NCT01357239|464041461|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
128932610|NCT01357239|464041462|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
128932611|NCT01357239|464041463|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
128932612|NCT01357239|464041464|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
128932613|NCT01357239|464041461|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
128932614|NCT01357239|464041462|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
128932615|NCT01357239|464041463|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
128932616|NCT01357239|464041464|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
128932617|NCT00545818|464041471|FG000|Overall Study|Protocol Violation|1|||
128932618|NCT00545818|464041472|FG001|Overall Study|Protocol Violation|0|||
128932619|NCT00545818|464041471|FG000|Overall Study|Adverse Event|1|||
129216747|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
128932620|NCT00545818|464041472|FG001|Overall Study|Adverse Event|1|||
128932621|NCT00545818|464041471|FG000|Overall Study|Lost to Follow-up|1|||
128932622|NCT00545818|464041472|FG001|Overall Study|Lost to Follow-up|6|||
128932623|NCT00609609|464041473|FG000|Overall Study|Withdrawal by Subject|2|||
128932624|NCT00609609|464041474|FG001|Overall Study|Withdrawal by Subject|0|||
128932625|NCT00609609|464041473|FG000|Overall Study|Progression|4|||
128932626|NCT00609609|464041474|FG001|Overall Study|Progression|2|||
128932627|NCT01050062|464041475|FG000|Overall Study|Adverse Event|75|||
128932628|NCT01050062|464041476|FG001|Overall Study|Adverse Event|22|||
128932629|NCT01050062|464041475|FG000|Overall Study|Lost to Follow-up|83|||
128932630|NCT01050062|464041476|FG001|Overall Study|Lost to Follow-up|35|||
128932631|NCT01050062|464041475|FG000|Overall Study|Lack of Efficacy|22|||
128932632|NCT01050062|464041476|FG001|Overall Study|Lack of Efficacy|35|||
128932633|NCT01050062|464041475|FG000|Overall Study|Physician Decision|74|||
128932634|NCT01050062|464041476|FG001|Overall Study|Physician Decision|9|||
128932635|NCT01050062|464041475|FG000|Overall Study|Others|17|||
128932636|NCT01050062|464041476|FG001|Overall Study|Others|11|||
128932637|NCT00670111|464041479|FG000|Enrollment to One Month|Testing Failure|0|||
128932638|NCT00670111|464041480|FG001|Enrollment to One Month|Testing Failure|0|||
128932639|NCT00670111|464041481|FG002|Enrollment to One Month|Testing Failure|13|||
128932640|NCT00670111|464041479|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
128932641|NCT00670111|464041480|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
128932642|NCT00670111|464041481|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
128932643|NCT00670111|464041479|FG000|Enrollment to One Month|Physician Decision|1|||
128932644|NCT00670111|464041480|FG001|Enrollment to One Month|Physician Decision|0|||
128932645|NCT00670111|464041481|FG002|Enrollment to One Month|Physician Decision|0|||
128932646|NCT03988751|464041482|FG000|Overall Study|Withdrawal by Subject|1|||
128932647|NCT03988751|464041483|FG001|Overall Study|Withdrawal by Subject|0|||
128932648|NCT03988751|464041482|FG000|Overall Study|Protocol Violation|0|||
128932649|NCT03988751|464041483|FG001|Overall Study|Protocol Violation|1|||
128932650|NCT00844883|464041486|FG000|Overall Study|Bridged to liver transplant|3|||
128932651|NCT00844883|464041486|FG000|Overall Study|Bridged to resection|1|||
128932652|NCT02623361|464041487|FG000|Overall Study|Protocol Violation|0|||
128932653|NCT02623361|464041488|FG001|Overall Study|Protocol Violation|1|||
128932654|NCT02623361|464041487|FG000|Overall Study|Withdrawal by Subject|0|||
128932655|NCT02623361|464041488|FG001|Overall Study|Withdrawal by Subject|1|||
128932656|NCT03894540|464041489|FG000|Overall Study|Adverse Event|0|||
128932657|NCT03894540|464041490|FG001|Overall Study|Adverse Event|0|||
128932658|NCT03894540|464041491|FG002|Overall Study|Adverse Event|0|||
128932659|NCT03894540|464041492|FG003|Overall Study|Adverse Event|0|||
128932660|NCT03894540|464041493|FG004|Overall Study|Adverse Event|1|||
128932661|NCT03894540|464041494|FG005|Overall Study|Adverse Event|0|||
128932662|NCT03894540|464041489|FG000|Overall Study|Withdrawal by Subject|0|||
128932663|NCT03894540|464041490|FG001|Overall Study|Withdrawal by Subject|0|||
128932664|NCT03894540|464041491|FG002|Overall Study|Withdrawal by Subject|0|||
128932665|NCT03894540|464041492|FG003|Overall Study|Withdrawal by Subject|0|||
128932666|NCT03894540|464041493|FG004|Overall Study|Withdrawal by Subject|1|||
128932667|NCT03894540|464041494|FG005|Overall Study|Withdrawal by Subject|0|||
128932668|NCT03894540|464041489|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
128932669|NCT03894540|464041490|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
128932670|NCT03894540|464041491|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
128932671|NCT03894540|464041492|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
128932672|NCT03894540|464041493|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
128932673|NCT03894540|464041494|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
128932674|NCT03894540|464041489|FG000|Overall Study|Progressive Disease Clinical|1|||
128932675|NCT03894540|464041490|FG001|Overall Study|Progressive Disease Clinical|1|||
128932676|NCT03894540|464041491|FG002|Overall Study|Progressive Disease Clinical|0|||
128932677|NCT03894540|464041492|FG003|Overall Study|Progressive Disease Clinical|1|||
128932678|NCT03894540|464041493|FG004|Overall Study|Progressive Disease Clinical|5|||
128932679|NCT03894540|464041494|FG005|Overall Study|Progressive Disease Clinical|1|||
128932680|NCT03894540|464041489|FG000|Overall Study|Study termination by sponsor|0|||
128932681|NCT03894540|464041490|FG001|Overall Study|Study termination by sponsor|0|||
128932682|NCT03894540|464041491|FG002|Overall Study|Study termination by sponsor|0|||
128932683|NCT03894540|464041492|FG003|Overall Study|Study termination by sponsor|0|||
128932684|NCT03894540|464041493|FG004|Overall Study|Study termination by sponsor|2|||
128932685|NCT03894540|464041494|FG005|Overall Study|Study termination by sponsor|0|||
128932686|NCT03000452|464041497|FG000|Treatment Period|Death|1|||
128932687|NCT03000452|464041497|FG000|Treatment Period|Progressive Disease (PD)|14|||
128932688|NCT03000452|464041497|FG000|Treatment Period|Physician Decision|1|||
128932689|NCT03000452|464041497|FG000|Treatment Period|Miscellaneous|2|||
128932690|NCT03000452|464041497|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
128932691|NCT03000452|464041497|FG000|Follow-Up Period|Death|3|||
128932692|NCT03000452|464041497|FG000|Follow-Up Period|Withdrawal by Subject|3|||
128932693|NCT00537823|464041500|FG000|Overall Study|Adverse Event|2|||
128932694|NCT00537823|464041501|FG001|Overall Study|Adverse Event|0|||
128932695|NCT03065530|464041502|FG000|Overall Study|Lack of Efficacy|1|||
128932696|NCT03065530|464041503|FG001|Overall Study|Lack of Efficacy|1|||
128932697|NCT03065530|464041504|FG002|Overall Study|Lack of Efficacy|0|||
128932698|NCT03065530|464041505|FG003|Overall Study|Lack of Efficacy|1|||
128932699|NCT03065530|464041502|FG000|Overall Study|Protocol Violation|1|||
128932700|NCT03065530|464041503|FG001|Overall Study|Protocol Violation|0|||
129121683|NCT02592824|464741221|FG000|Overall Study|Lost to Follow-up|2|||
129121684|NCT02592824|464741222|FG001|Overall Study|Lost to Follow-up|1|||
129121685|NCT03426878|464741223|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
129121686|NCT03426878|464741223|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
129121687|NCT03426878|464741223|FG000|Overall Study|Declined to receive results|3|||
129121688|NCT03426878|464741223|FG000|Overall Study|Received negative results by mailed letter|65|||
129121689|NCT03426878|464741223|FG000|Overall Study|Lost to Follow-up|177|||
129121690|NCT02855268|464741224|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
129121691|NCT02855268|464741225|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
129121692|NCT02855268|464741224|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
128702826|NCT00599924|463211309|FG001|Overall Study|Adverse Event|0|||
128702827|NCT00599924|463211310|FG002|Overall Study|Adverse Event|0|||
128702828|NCT00599924|463211311|FG003|Overall Study|Adverse Event|2|||
128702829|NCT00599924|463211312|FG004|Overall Study|Adverse Event|0|||
128702830|NCT00599924|463211313|FG005|Overall Study|Adverse Event|0|||
128932701|NCT03065530|464041504|FG002|Overall Study|Protocol Violation|1|||
128932702|NCT03065530|464041505|FG003|Overall Study|Protocol Violation|1|||
128932703|NCT03455543|464041506|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
128932704|NCT03455543|464041507|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
128932705|NCT03455543|464041508|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
128932706|NCT03455543|464041506|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
129121693|NCT02855268|464741225|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
129121694|NCT02855268|464741224|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
129121695|NCT02855268|464741225|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
129121696|NCT02855268|464741224|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
129121697|NCT02855268|464741225|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
129121698|NCT02855268|464741224|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
129121699|NCT02855268|464741225|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
129121700|NCT02855268|464741224|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
129121701|NCT02855268|464741225|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
129121702|NCT00465517|464741226|FG000|Overall Study|Adverse Event|7|||
129121703|NCT00465517|464741227|FG001|Overall Study|Adverse Event|3|||
129121704|NCT00465517|464741226|FG000|Overall Study|Lost to Follow-up|1|||
129121705|NCT00465517|464741227|FG001|Overall Study|Lost to Follow-up|0|||
129121706|NCT00465517|464741226|FG000|Overall Study|Withdrawal by Subject|4|||
129121707|NCT00465517|464741227|FG001|Overall Study|Withdrawal by Subject|1|||
129121708|NCT05233761|464741234|FG000|Treatment Period A|Withdrawal by Subject|12|||
129121709|NCT05233761|464741235|FG001|Treatment Period A|Withdrawal by Subject|10|||
129121710|NCT05233761|464741234|FG000|Treatment Period A|Lost to Follow-up|6|||
129121711|NCT05233761|464741235|FG001|Treatment Period A|Lost to Follow-up|12|||
129121712|NCT05233761|464741234|FG000|Treatment Period A|Protocol Violation|8|||
129121713|NCT05233761|464741235|FG001|Treatment Period A|Protocol Violation|15|||
129121714|NCT01604785|464741236|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
129121715|NCT01604785|464741237|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
129121716|NCT04798027|464741240|FG000|Overall Study|Protocol Violation|0|||
129121717|NCT04798027|464741241|FG001|Overall Study|Protocol Violation|0|||
129121718|NCT04798027|464741242|FG002|Overall Study|Protocol Violation|0|||
129121719|NCT04798027|464741243|FG003|Overall Study|Protocol Violation|0|||
129121720|NCT04798027|464741244|FG004|Overall Study|Protocol Violation|1|||
129121721|NCT04798027|464741245|FG005|Overall Study|Protocol Violation|0|||
129121722|NCT04798027|464741246|FG006|Overall Study|Protocol Violation|0|||
129121723|NCT04798027|464741247|FG007|Overall Study|Protocol Violation|1|||
129121724|NCT04798027|464741248|FG008|Overall Study|Protocol Violation|0|||
129121725|NCT04798027|464741240|FG000|Overall Study|Withdrawal by Subject|1|||
129121726|NCT04798027|464741241|FG001|Overall Study|Withdrawal by Subject|0|||
129121727|NCT04798027|464741242|FG002|Overall Study|Withdrawal by Subject|1|||
128702831|NCT00599924|463211314|FG006|Overall Study|Adverse Event|2|||
128702832|NCT00599924|463211308|FG000|Overall Study|Death|0|||
128702833|NCT00599924|463211309|FG001|Overall Study|Death|0|||
128702834|NCT00599924|463211310|FG002|Overall Study|Death|0|||
128702835|NCT00599924|463211311|FG003|Overall Study|Death|2|||
128702836|NCT00599924|463211312|FG004|Overall Study|Death|0|||
128702837|NCT00599924|463211313|FG005|Overall Study|Death|2|||
128702838|NCT00599924|463211314|FG006|Overall Study|Death|1|||
128702839|NCT00599924|463211308|FG000|Overall Study|Protocol Violation|0|||
128702840|NCT00599924|463211309|FG001|Overall Study|Protocol Violation|0|||
128702841|NCT00599924|463211310|FG002|Overall Study|Protocol Violation|0|||
128702842|NCT00599924|463211311|FG003|Overall Study|Protocol Violation|1|||
128702843|NCT00599924|463211312|FG004|Overall Study|Protocol Violation|0|||
128702844|NCT00599924|463211313|FG005|Overall Study|Protocol Violation|0|||
128702845|NCT00599924|463211314|FG006|Overall Study|Protocol Violation|0|||
128702846|NCT00599924|463211308|FG000|Overall Study|Withdrawal by Subject|0|||
128702847|NCT00599924|463211309|FG001|Overall Study|Withdrawal by Subject|0|||
128702848|NCT00599924|463211310|FG002|Overall Study|Withdrawal by Subject|1|||
128702849|NCT00599924|463211311|FG003|Overall Study|Withdrawal by Subject|0|||
128702850|NCT00599924|463211312|FG004|Overall Study|Withdrawal by Subject|1|||
128932707|NCT03455543|464041507|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
128932708|NCT03455543|464041508|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
128932709|NCT03455543|464041506|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
128932710|NCT03455543|464041507|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
128932711|NCT03455543|464041508|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
128932712|NCT03455543|464041506|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
128932713|NCT03455543|464041507|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
128932714|NCT03455543|464041508|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
128932715|NCT03455543|464041506|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
128932716|NCT03455543|464041507|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
128932717|NCT03455543|464041508|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
128932718|NCT03455543|464041506|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
128932719|NCT03455543|464041507|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
128932720|NCT03455543|464041508|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
128932721|NCT03455543|464041506|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
128932722|NCT03455543|464041507|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
128932723|NCT03455543|464041508|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
128932724|NCT03455543|464041506|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
128932725|NCT03455543|464041507|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
128932726|NCT03455543|464041508|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
128932727|NCT03455543|464041506|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
128932728|NCT03455543|464041507|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
128932729|NCT03455543|464041508|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
128932730|NCT00852930|464041509|FG000|Overall Study|Withdrawal by Subject|1|||
128932731|NCT00852930|464041510|FG001|Overall Study|Withdrawal by Subject|1|||
128932732|NCT00852930|464041511|FG002|Overall Study|Withdrawal by Subject|1|||
128932733|NCT00852930|464041509|FG000|Overall Study|Physician Decision|0|||
128932734|NCT00852930|464041510|FG001|Overall Study|Physician Decision|0|||
128932735|NCT00852930|464041511|FG002|Overall Study|Physician Decision|1|||
128932736|NCT00479466|464041512|FG000|Overall Study|Adverse Event|5|||
128932737|NCT00479466|464041513|FG001|Overall Study|Adverse Event|1|||
128932738|NCT00479466|464041514|FG002|Overall Study|Adverse Event|0|||
128932739|NCT00479466|464041515|FG003|Overall Study|Adverse Event|1|||
128932740|NCT00479466|464041516|FG004|Overall Study|Adverse Event|2|||
128932741|NCT00479466|464041517|FG005|Overall Study|Adverse Event|0|||
128932742|NCT00479466|464041512|FG000|Overall Study|Hyperglycemia|0|||
128932743|NCT00479466|464041513|FG001|Overall Study|Hyperglycemia|0|||
128932744|NCT00479466|464041514|FG002|Overall Study|Hyperglycemia|0|||
128932745|NCT00479466|464041515|FG003|Overall Study|Hyperglycemia|0|||
128932746|NCT00479466|464041516|FG004|Overall Study|Hyperglycemia|0|||
128932747|NCT00479466|464041517|FG005|Overall Study|Hyperglycemia|1|||
128932748|NCT00479466|464041512|FG000|Overall Study|Lack of Efficacy|2|||
128932749|NCT00479466|464041513|FG001|Overall Study|Lack of Efficacy|0|||
128932750|NCT00479466|464041514|FG002|Overall Study|Lack of Efficacy|1|||
128932751|NCT00479466|464041515|FG003|Overall Study|Lack of Efficacy|0|||
128932752|NCT00479466|464041516|FG004|Overall Study|Lack of Efficacy|0|||
129121728|NCT04798027|464741243|FG003|Overall Study|Withdrawal by Subject|1|||
128702851|NCT00599924|463211313|FG005|Overall Study|Withdrawal by Subject|0|||
128702852|NCT00599924|463211314|FG006|Overall Study|Withdrawal by Subject|0|||
128702853|NCT00599924|463211308|FG000|Overall Study|Other|0|||
128702854|NCT00599924|463211309|FG001|Overall Study|Other|0|||
128702855|NCT00599924|463211310|FG002|Overall Study|Other|0|||
128702856|NCT00599924|463211311|FG003|Overall Study|Other|1|||
128702857|NCT00599924|463211312|FG004|Overall Study|Other|2|||
128702858|NCT00599924|463211313|FG005|Overall Study|Other|0|||
128702859|NCT00599924|463211314|FG006|Overall Study|Other|2|||
128702860|NCT01806298|463211315|FG000|Overall Study|Adverse Event|3|||
128702861|NCT01806298|463211315|FG000|Overall Study|Protocol Non-compliance|1|||
128702862|NCT01806298|463211315|FG000|Overall Study|Withdrawal by Subject|1|||
128702863|NCT01806298|463211315|FG000|Overall Study|Other|5|||
128702864|NCT02601469|463211316|FG000|Overall Study|Enrolled in Error|1|||
128932753|NCT00479466|464041517|FG005|Overall Study|Lack of Efficacy|0|||
128932754|NCT00479466|464041512|FG000|Overall Study|Lost to Follow-up|0|||
128932755|NCT00479466|464041513|FG001|Overall Study|Lost to Follow-up|1|||
128932756|NCT00479466|464041514|FG002|Overall Study|Lost to Follow-up|1|||
128932757|NCT00479466|464041515|FG003|Overall Study|Lost to Follow-up|0|||
128932758|NCT00479466|464041516|FG004|Overall Study|Lost to Follow-up|2|||
128702865|NCT02601469|463211317|FG001|Overall Study|Enrolled in Error|0|||
128932759|NCT00479466|464041517|FG005|Overall Study|Lost to Follow-up|2|||
129121729|NCT04798027|464741244|FG004|Overall Study|Withdrawal by Subject|1|||
128702866|NCT03808545|463211318|FG000|Overall Study|Withdrawal by Subject|1|||
128702867|NCT03808545|463211319|FG001|Overall Study|Withdrawal by Subject|1|||
128702868|NCT00980057|463211324|FG000|Overall Study|Death|13|||
128702869|NCT00980057|463211325|FG001|Overall Study|Death|3|||
128702870|NCT00980057|463211324|FG000|Overall Study|Adverse Event|0|||
128702871|NCT00980057|463211325|FG001|Overall Study|Adverse Event|1|||
128702872|NCT00980057|463211324|FG000|Overall Study|Physician Decision|4|||
128702873|NCT00980057|463211325|FG001|Overall Study|Physician Decision|0|||
128702874|NCT00980057|463211324|FG000|Overall Study|Lost to Follow-up|1|||
128702875|NCT00980057|463211325|FG001|Overall Study|Lost to Follow-up|0|||
128702876|NCT00980057|463211324|FG000|Overall Study|Withdrawal by Subject|1|||
128702877|NCT00980057|463211325|FG001|Overall Study|Withdrawal by Subject|1|||
128702878|NCT04980040|463211326|FG000|Overall Study|Violated the Inclusion Criteria|260|||
128702879|NCT04980040|463211326|FG000|Overall Study|Violated the Administration & Dosage|225|||
128702880|NCT04980040|463211326|FG000|Overall Study|Lost to Safety-Follow-up|4|||
128702881|NCT04980040|463211326|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
128702882|NCT01408485|463211330|FG000|Overall Study|Withdrawal by Subject|21|||
128702883|NCT01315678|463211331|FG000|Overall Study|Withdrawal by Subject|7|||
128702884|NCT01315678|463211332|FG001|Overall Study|Withdrawal by Subject|3|||
128702885|NCT01315678|463211331|FG000|Overall Study|Adverse Event|3|||
128702886|NCT01315678|463211332|FG001|Overall Study|Adverse Event|1|||
128702887|NCT01315678|463211331|FG000|Overall Study|Lost to Follow-up|1|||
128702888|NCT01315678|463211332|FG001|Overall Study|Lost to Follow-up|0|||
128702889|NCT01315678|463211331|FG000|Overall Study|similar reason to those listed above|3|||
128702890|NCT01315678|463211332|FG001|Overall Study|similar reason to those listed above|2|||
128702891|NCT00573469|463211333|FG000|Overall Study|Adverse Event|1|||
128702892|NCT00573469|463211334|FG001|Overall Study|Adverse Event|1|||
128702893|NCT00573469|463211335|FG002|Overall Study|Adverse Event|1|||
128702894|NCT00573469|463211333|FG000|Overall Study|Withdrawal by Subject|0|||
128702895|NCT00573469|463211334|FG001|Overall Study|Withdrawal by Subject|2|||
128702896|NCT00573469|463211335|FG002|Overall Study|Withdrawal by Subject|0|||
128702897|NCT00573469|463211333|FG000|Overall Study|Other|5|||
128702898|NCT00573469|463211334|FG001|Overall Study|Other|1|||
128702899|NCT00573469|463211335|FG002|Overall Study|Other|3|||
128702900|NCT00187486|463211336|FG000|Overall Study|Protocol Violation|1|||
128702901|NCT02380677|463211337|FG000|Overall Study|Adverse Event|0|||
128702902|NCT02380677|463211338|FG001|Overall Study|Adverse Event|0|||
128702903|NCT02380677|463211339|FG002|Overall Study|Adverse Event|0|||
128702904|NCT02380677|463211340|FG003|Overall Study|Adverse Event|1|||
128702905|NCT02380677|463211341|FG004|Overall Study|Adverse Event|1|||
128702906|NCT02380677|463211342|FG005|Overall Study|Adverse Event|4|||
128702907|NCT02380677|463211343|FG006|Overall Study|Adverse Event|2|||
128702908|NCT02380677|463211344|FG007|Overall Study|Adverse Event|2|||
128702909|NCT02380677|463211345|FG008|Overall Study|Adverse Event|2|||
128702910|NCT02380677|463211346|FG009|Overall Study|Adverse Event|1|||
128702911|NCT02380677|463211347|FG010|Overall Study|Adverse Event|2|||
128702912|NCT02380677|463211348|FG011|Overall Study|Adverse Event|1|||
128702913|NCT02380677|463211337|FG000|Overall Study|Physician Decision|1|||
128702914|NCT02380677|463211338|FG001|Overall Study|Physician Decision|0|||
128702915|NCT02380677|463211339|FG002|Overall Study|Physician Decision|1|||
128702916|NCT02380677|463211340|FG003|Overall Study|Physician Decision|1|||
128702917|NCT02380677|463211341|FG004|Overall Study|Physician Decision|0|||
128702918|NCT02380677|463211342|FG005|Overall Study|Physician Decision|0|||
128702919|NCT02380677|463211343|FG006|Overall Study|Physician Decision|0|||
128702920|NCT02380677|463211344|FG007|Overall Study|Physician Decision|0|||
128932760|NCT00479466|464041512|FG000|Overall Study|Physician Decision|2|||
128932761|NCT00479466|464041513|FG001|Overall Study|Physician Decision|1|||
128932762|NCT00479466|464041514|FG002|Overall Study|Physician Decision|1|||
128932763|NCT00479466|464041515|FG003|Overall Study|Physician Decision|0|||
128702921|NCT02380677|463211345|FG008|Overall Study|Physician Decision|0|||
128702922|NCT02380677|463211346|FG009|Overall Study|Physician Decision|0|||
128702923|NCT02380677|463211347|FG010|Overall Study|Physician Decision|0|||
128767697|NCT04498247|463440341|FG003|Overall Study|Withdrawal by Subject|7|||
128932764|NCT00479466|464041516|FG004|Overall Study|Physician Decision|0|||
128932765|NCT00479466|464041517|FG005|Overall Study|Physician Decision|0|||
128702924|NCT02380677|463211348|FG011|Overall Study|Physician Decision|0|||
128702925|NCT02380677|463211337|FG000|Overall Study|Lack of Efficacy|0|||
128702926|NCT02380677|463211338|FG001|Overall Study|Lack of Efficacy|1|||
128702927|NCT02380677|463211339|FG002|Overall Study|Lack of Efficacy|2|||
128702928|NCT02380677|463211340|FG003|Overall Study|Lack of Efficacy|0|||
128702929|NCT02380677|463211341|FG004|Overall Study|Lack of Efficacy|4|||
128702930|NCT02380677|463211342|FG005|Overall Study|Lack of Efficacy|1|||
128932766|NCT00479466|464041512|FG000|Overall Study|Pregnancy|0|||
128702931|NCT02380677|463211343|FG006|Overall Study|Lack of Efficacy|1|||
128702932|NCT02380677|463211344|FG007|Overall Study|Lack of Efficacy|2|||
128702933|NCT02380677|463211345|FG008|Overall Study|Lack of Efficacy|2|||
128702934|NCT02380677|463211346|FG009|Overall Study|Lack of Efficacy|0|||
128702935|NCT02380677|463211347|FG010|Overall Study|Lack of Efficacy|2|||
128932767|NCT00479466|464041513|FG001|Overall Study|Pregnancy|0|||
128932768|NCT00479466|464041514|FG002|Overall Study|Pregnancy|0|||
128702936|NCT02380677|463211348|FG011|Overall Study|Lack of Efficacy|1|||
128702937|NCT02380677|463211337|FG000|Overall Study|Withdrawal by Subject|0|||
128702938|NCT02380677|463211338|FG001|Overall Study|Withdrawal by Subject|0|||
128932769|NCT00479466|464041515|FG003|Overall Study|Pregnancy|0|||
128932770|NCT00479466|464041516|FG004|Overall Study|Pregnancy|1|||
128932771|NCT00479466|464041517|FG005|Overall Study|Pregnancy|0|||
128932772|NCT00479466|464041512|FG000|Overall Study|Protocol Violation|1|||
128932773|NCT00479466|464041513|FG001|Overall Study|Protocol Violation|0|||
128932774|NCT00479466|464041514|FG002|Overall Study|Protocol Violation|0|||
128932775|NCT00479466|464041515|FG003|Overall Study|Protocol Violation|0|||
128932776|NCT00479466|464041516|FG004|Overall Study|Protocol Violation|0|||
128932777|NCT00479466|464041517|FG005|Overall Study|Protocol Violation|0|||
128932778|NCT00479466|464041512|FG000|Overall Study|Withdrawal by Subject|3|||
128932779|NCT00479466|464041513|FG001|Overall Study|Withdrawal by Subject|5|||
128932780|NCT00479466|464041514|FG002|Overall Study|Withdrawal by Subject|0|||
128932781|NCT00479466|464041515|FG003|Overall Study|Withdrawal by Subject|2|||
128932782|NCT00479466|464041516|FG004|Overall Study|Withdrawal by Subject|3|||
128932783|NCT00479466|464041517|FG005|Overall Study|Withdrawal by Subject|1|||
128932784|NCT02614794|464041524|FG000|Overall Study|Death|258|||
128932785|NCT02614794|464041525|FG001|Overall Study|Death|151|||
128932786|NCT02614794|464041524|FG000|Overall Study|Study closure by Sponsor|119|||
128932787|NCT02614794|464041525|FG001|Overall Study|Study closure by Sponsor|45|||
128932788|NCT02614794|464041524|FG000|Overall Study|Withdrawal by Subject|24|||
128932789|NCT02614794|464041525|FG001|Overall Study|Withdrawal by Subject|5|||
128932790|NCT02614794|464041524|FG000|Overall Study|Lost to Follow-up|7|||
128932791|NCT02614794|464041525|FG001|Overall Study|Lost to Follow-up|0|||
128932792|NCT02614794|464041524|FG000|Overall Study|Physician Decision|1|||
128932793|NCT02614794|464041525|FG001|Overall Study|Physician Decision|1|||
128932794|NCT02614794|464041524|FG000|Overall Study|Hospital closure|1|||
128932795|NCT02614794|464041525|FG001|Overall Study|Hospital closure|0|||
128932796|NCT01743027|464041539|FG000|Overall Study|Adverse Event|2|||
128932797|NCT01743027|464041540|FG001|Overall Study|Adverse Event|0|||
128932798|NCT01743027|464041541|FG002|Overall Study|Adverse Event|0|||
128932799|NCT01743027|464041542|FG003|Overall Study|Adverse Event|0|||
128932800|NCT01743027|464041539|FG000|Overall Study|Lost to Follow-up|0|||
128932801|NCT01743027|464041540|FG001|Overall Study|Lost to Follow-up|0|||
128932802|NCT01743027|464041541|FG002|Overall Study|Lost to Follow-up|2|||
128932803|NCT01743027|464041542|FG003|Overall Study|Lost to Follow-up|0|||
128932804|NCT01743027|464041539|FG000|Overall Study|Progressive Disease|1|||
128932805|NCT01743027|464041540|FG001|Overall Study|Progressive Disease|4|||
128932806|NCT01743027|464041541|FG002|Overall Study|Progressive Disease|3|||
128932807|NCT01743027|464041542|FG003|Overall Study|Progressive Disease|0|||
128932808|NCT01743027|464041539|FG000|Overall Study|Protocol Violation|1|||
128932809|NCT01743027|464041540|FG001|Overall Study|Protocol Violation|1|||
128932810|NCT01743027|464041541|FG002|Overall Study|Protocol Violation|1|||
128932811|NCT01743027|464041542|FG003|Overall Study|Protocol Violation|0|||
128932812|NCT01743027|464041539|FG000|Overall Study|Withdrawal by Subject|1|||
128932813|NCT01743027|464041540|FG001|Overall Study|Withdrawal by Subject|0|||
128932814|NCT01743027|464041541|FG002|Overall Study|Withdrawal by Subject|3|||
128702939|NCT02380677|463211339|FG002|Overall Study|Withdrawal by Subject|0|||
128702940|NCT02380677|463211340|FG003|Overall Study|Withdrawal by Subject|0|||
128702941|NCT02380677|463211341|FG004|Overall Study|Withdrawal by Subject|0|||
128702942|NCT02380677|463211342|FG005|Overall Study|Withdrawal by Subject|0|||
128702943|NCT02380677|463211343|FG006|Overall Study|Withdrawal by Subject|0|||
128932815|NCT01743027|464041542|FG003|Overall Study|Withdrawal by Subject|1|||
128932816|NCT00069121|464041547|FG000|Overall Study|Death|286|||
128932817|NCT00069121|464041548|FG001|Overall Study|Death|242|||
128932818|NCT00069121|464041547|FG000|Overall Study|Withdrawal by Subject|18|||
128932819|NCT00069121|464041548|FG001|Overall Study|Withdrawal by Subject|20|||
128932820|NCT00069121|464041547|FG000|Overall Study|Lost to Follow-up|63|||
128932821|NCT00069121|464041548|FG001|Overall Study|Lost to Follow-up|63|||
128932822|NCT00231478|464041554|FG000|Overall Study|Protocol Violation|3|||
128932823|NCT00231478|464041555|FG001|Overall Study|Protocol Violation|2|||
128932824|NCT00231478|464041554|FG000|Overall Study|Refused Treatment|1|||
128932825|NCT00231478|464041555|FG001|Overall Study|Refused Treatment|1|||
128932826|NCT00231478|464041554|FG000|Overall Study|Withdrawal by Subject|1|||
128932827|NCT00231478|464041555|FG001|Overall Study|Withdrawal by Subject|0|||
128932828|NCT00231478|464041554|FG000|Overall Study|Adverse Event|0|||
128932829|NCT00231478|464041555|FG001|Overall Study|Adverse Event|1|||
128932830|NCT00231478|464041554|FG000|Overall Study|Administrative|3|||
128702944|NCT02380677|463211344|FG007|Overall Study|Withdrawal by Subject|0|||
128702945|NCT02380677|463211345|FG008|Overall Study|Withdrawal by Subject|0|||
128702946|NCT02380677|463211346|FG009|Overall Study|Withdrawal by Subject|1|||
128702947|NCT02380677|463211347|FG010|Overall Study|Withdrawal by Subject|0|||
128932831|NCT00231478|464041555|FG001|Overall Study|Administrative|2|||
128932832|NCT00393458|464041560|FG000|Overall Study|Adverse Event|35|||
128932833|NCT00393458|464041561|FG001|Overall Study|Adverse Event|24|||
128932834|NCT00393458|464041562|FG002|Overall Study|Adverse Event|40|||
128932835|NCT00393458|464041563|FG003|Overall Study|Adverse Event|35|||
128932836|NCT00393458|464041560|FG000|Overall Study|Subject withdrew consent|27|||
128932837|NCT00393458|464041561|FG001|Overall Study|Subject withdrew consent|40|||
128932838|NCT00393458|464041562|FG002|Overall Study|Subject withdrew consent|33|||
128932839|NCT00393458|464041563|FG003|Overall Study|Subject withdrew consent|50|||
128932840|NCT00393458|464041560|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
128932841|NCT00393458|464041561|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
128932842|NCT00393458|464041562|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
128932843|NCT00393458|464041563|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
128932844|NCT00393458|464041560|FG000|Overall Study|Protocol deviation|11|||
128932845|NCT00393458|464041561|FG001|Overall Study|Protocol deviation|11|||
128932846|NCT00393458|464041562|FG002|Overall Study|Protocol deviation|11|||
128932847|NCT00393458|464041563|FG003|Overall Study|Protocol deviation|10|||
128932848|NCT00393458|464041560|FG000|Overall Study|Administrative problems|7|||
128932849|NCT00393458|464041561|FG001|Overall Study|Administrative problems|8|||
128932850|NCT00393458|464041562|FG002|Overall Study|Administrative problems|5|||
128932851|NCT00393458|464041563|FG003|Overall Study|Administrative problems|2|||
128932852|NCT00393458|464041560|FG000|Overall Study|Lost to Follow-up|5|||
128932853|NCT00393458|464041561|FG001|Overall Study|Lost to Follow-up|6|||
128932854|NCT00393458|464041562|FG002|Overall Study|Lost to Follow-up|5|||
128932855|NCT00393458|464041563|FG003|Overall Study|Lost to Follow-up|3|||
128932856|NCT00393458|464041560|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128932857|NCT00393458|464041561|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128932858|NCT00393458|464041562|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128932859|NCT00393458|464041563|FG003|Overall Study|Abnormal laboratory value(s)|0|||
128932860|NCT00393458|464041560|FG000|Overall Study|Death|1|||
128932861|NCT00393458|464041561|FG001|Overall Study|Death|1|||
128932862|NCT00393458|464041562|FG002|Overall Study|Death|5|||
128932863|NCT00393458|464041563|FG003|Overall Study|Death|5|||
128932864|NCT00393458|464041560|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128932865|NCT00393458|464041561|FG001|Overall Study|Abnormal test procedure result(s)|1|||
128932866|NCT00393458|464041562|FG002|Overall Study|Abnormal test procedure result(s)|1|||
128932867|NCT00393458|464041563|FG003|Overall Study|Abnormal test procedure result(s)|2|||
128932868|NCT00393458|464041560|FG000|Overall Study|Subject no longer requires study drug|0|||
128932869|NCT00393458|464041561|FG001|Overall Study|Subject no longer requires study drug|1|||
128932870|NCT00393458|464041562|FG002|Overall Study|Subject no longer requires study drug|0|||
128932871|NCT00393458|464041563|FG003|Overall Study|Subject no longer requires study drug|0|||
128932872|NCT02104180|464041572|FG000|Overall Study|Protocol Violation|1|||
128932873|NCT02104180|464041573|FG001|Overall Study|Protocol Violation|0|||
128932874|NCT01524289|464041574|FG000|Overall Study|Lost to Follow-up|0|||
128932875|NCT01524289|464041575|FG001|Overall Study|Lost to Follow-up|1|||
128932876|NCT01524289|464041574|FG000|Overall Study|Physician Decision|1|||
128932877|NCT01524289|464041575|FG001|Overall Study|Physician Decision|0|||
128932878|NCT01524289|464041574|FG000|Overall Study|Protocol Violation|5|||
128932879|NCT01524289|464041575|FG001|Overall Study|Protocol Violation|1|||
128932880|NCT01524289|464041574|FG000|Overall Study|Withdrawal by Subject|11|||
128932881|NCT01524289|464041575|FG001|Overall Study|Withdrawal by Subject|7|||
129121730|NCT04798027|464741245|FG005|Overall Study|Withdrawal by Subject|1|||
129121731|NCT04798027|464741246|FG006|Overall Study|Withdrawal by Subject|3|||
129121732|NCT04798027|464741247|FG007|Overall Study|Withdrawal by Subject|2|||
129121733|NCT04798027|464741248|FG008|Overall Study|Withdrawal by Subject|2|||
129121734|NCT04798027|464741240|FG000|Overall Study|Lost to Follow-up|1|||
129121735|NCT04798027|464741241|FG001|Overall Study|Lost to Follow-up|3|||
129121736|NCT04798027|464741242|FG002|Overall Study|Lost to Follow-up|0|||
129121737|NCT04798027|464741243|FG003|Overall Study|Lost to Follow-up|0|||
129121738|NCT04798027|464741244|FG004|Overall Study|Lost to Follow-up|0|||
129121739|NCT04798027|464741245|FG005|Overall Study|Lost to Follow-up|1|||
129121740|NCT04798027|464741246|FG006|Overall Study|Lost to Follow-up|0|||
129121741|NCT04798027|464741247|FG007|Overall Study|Lost to Follow-up|0|||
129121742|NCT04798027|464741248|FG008|Overall Study|Lost to Follow-up|1|||
129121743|NCT04798027|464741240|FG000|Overall Study|Withdrawal by Sponsor|8|||
129121744|NCT04798027|464741241|FG001|Overall Study|Withdrawal by Sponsor|22|||
128932882|NCT01524289|464041574|FG000|Overall Study|Adverse Event|12|||
129121745|NCT04798027|464741242|FG002|Overall Study|Withdrawal by Sponsor|9|||
129121746|NCT04798027|464741243|FG003|Overall Study|Withdrawal by Sponsor|26|||
128932883|NCT01524289|464041575|FG001|Overall Study|Adverse Event|5|||
128932884|NCT01524289|464041574|FG000|Overall Study|Did not take study medication|1|||
128932885|NCT01524289|464041575|FG001|Overall Study|Did not take study medication|0|||
128932886|NCT00104104|464041578|FG000|Overall Study|Adverse Event|8|||
128932887|NCT00104104|464041579|FG001|Overall Study|Adverse Event|8|||
128932888|NCT00104104|464041578|FG000|Overall Study|Abnormal laboratory value(s)|20|||
128932889|NCT00104104|464041579|FG001|Overall Study|Abnormal laboratory value(s)|14|||
128932890|NCT00104104|464041578|FG000|Overall Study|Lack of Efficacy|0|||
128932891|NCT00104104|464041579|FG001|Overall Study|Lack of Efficacy|3|||
128932892|NCT00104104|464041578|FG000|Overall Study|Condition no longer requires study drug|7|||
128932893|NCT00104104|464041579|FG001|Overall Study|Condition no longer requires study drug|4|||
128932894|NCT00104104|464041578|FG000|Overall Study|Protocol Violation|5|||
129121747|NCT04798027|464741244|FG004|Overall Study|Withdrawal by Sponsor|24|||
129121748|NCT04798027|464741245|FG005|Overall Study|Withdrawal by Sponsor|11|||
129121749|NCT04798027|464741246|FG006|Overall Study|Withdrawal by Sponsor|25|||
128767698|NCT04498247|463440342|FG004|Overall Study|Withdrawal by Subject|0|||
128767699|NCT04498247|463440343|FG005|Overall Study|Withdrawal by Subject|0|||
128767700|NCT04498247|463440344|FG006|Overall Study|Withdrawal by Subject|1|||
128767701|NCT04498247|463440345|FG007|Overall Study|Withdrawal by Subject|0|||
128767702|NCT04498247|463440338|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
128767703|NCT04498247|463440339|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
128767704|NCT04498247|463440340|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
128767705|NCT04498247|463440341|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
128767706|NCT04498247|463440342|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
128767707|NCT04498247|463440343|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
128767708|NCT04498247|463440344|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
128767709|NCT04498247|463440345|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
128767710|NCT03469349|463440346|FG000|Overall Study|Withdrawal by Subject|1|||
128767711|NCT03469349|463440347|FG001|Overall Study|Withdrawal by Subject|3|||
128767712|NCT03469349|463440346|FG000|Overall Study|Progressive Disease|0|||
128767713|NCT03469349|463440347|FG001|Overall Study|Progressive Disease|1|||
128767714|NCT03469349|463440346|FG000|Overall Study|Lost to Follow-up|2|||
128767715|NCT03469349|463440347|FG001|Overall Study|Lost to Follow-up|2|||
128767716|NCT03469349|463440346|FG000|Overall Study|Adverse Event|2|||
128767717|NCT03469349|463440347|FG001|Overall Study|Adverse Event|4|||
128767718|NCT04041440|463440349|FG000|Overall Study|Withdrawal by Subject|0|||
128767719|NCT04041440|463440350|FG001|Overall Study|Withdrawal by Subject|1|||
128932895|NCT00104104|464041579|FG001|Overall Study|Protocol Violation|2|||
128932896|NCT00104104|464041578|FG000|Overall Study|Withdrawal by Subject|11|||
128932897|NCT00104104|464041579|FG001|Overall Study|Withdrawal by Subject|15|||
128932898|NCT00104104|464041578|FG000|Overall Study|Lost to Follow-up|3|||
128932899|NCT00104104|464041579|FG001|Overall Study|Lost to Follow-up|7|||
128932900|NCT00104104|464041578|FG000|Overall Study|Administrative problems|12|||
128932901|NCT00104104|464041579|FG001|Overall Study|Administrative problems|13|||
128932902|NCT00104104|464041578|FG000|Overall Study|Death|9|||
128932903|NCT00104104|464041579|FG001|Overall Study|Death|6|||
128932904|NCT01821677|464041582|FG000|Overall Study|Adverse Event|4|||
128932905|NCT01821677|464041583|FG001|Overall Study|Adverse Event|6|||
128932906|NCT01821677|464041584|FG002|Overall Study|Adverse Event|5|||
128932907|NCT01821677|464041582|FG000|Overall Study|Physician Decision|1|||
128932908|NCT01821677|464041583|FG001|Overall Study|Physician Decision|4|||
128932909|NCT01821677|464041584|FG002|Overall Study|Physician Decision|1|||
128932910|NCT01821677|464041582|FG000|Overall Study|Non-compliance|0|||
128932911|NCT01821677|464041583|FG001|Overall Study|Non-compliance|1|||
128932912|NCT01821677|464041584|FG002|Overall Study|Non-compliance|2|||
128932913|NCT01821677|464041582|FG000|Overall Study|Lost to Follow-up|2|||
128932914|NCT01821677|464041583|FG001|Overall Study|Lost to Follow-up|1|||
128932915|NCT01821677|464041584|FG002|Overall Study|Lost to Follow-up|3|||
128932916|NCT01821677|464041582|FG000|Overall Study|Protocol Violation|0|||
128932917|NCT01821677|464041583|FG001|Overall Study|Protocol Violation|0|||
128932918|NCT01821677|464041584|FG002|Overall Study|Protocol Violation|2|||
128932919|NCT01821677|464041582|FG000|Overall Study|Withdrawal by Subject|7|||
128932920|NCT01821677|464041583|FG001|Overall Study|Withdrawal by Subject|3|||
128932921|NCT01821677|464041584|FG002|Overall Study|Withdrawal by Subject|2|||
128932922|NCT01821677|464041582|FG000|Overall Study|Other|9|||
128932923|NCT01821677|464041583|FG001|Overall Study|Other|0|||
128932924|NCT01821677|464041584|FG002|Overall Study|Other|0|||
128932925|NCT00035815|464041586|FG000|Overall Study|Withdrawal by Subject|17|||
128932926|NCT00035815|464041587|FG001|Overall Study|Withdrawal by Subject|11|||
128932927|NCT01894516|464043504|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
128932928|NCT01894516|464043505|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
129121750|NCT04798027|464741247|FG007|Overall Study|Withdrawal by Sponsor|26|||
129121751|NCT04798027|464741248|FG008|Overall Study|Withdrawal by Sponsor|11|||
129121752|NCT00834041|464741255|FG000|Overall Study|Withdrawal by Subject|1|||
129121753|NCT00834041|464741256|FG001|Overall Study|Withdrawal by Subject|0|||
129121754|NCT00834041|464741255|FG000|Overall Study|Lost to Follow-up|0|||
129121755|NCT00834041|464741256|FG001|Overall Study|Lost to Follow-up|1|||
129121756|NCT00961064|464742642|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
128767720|NCT04041440|463440349|FG000|Overall Study|Lost to Follow-up|0|||
128932929|NCT01894516|464043506|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
128932930|NCT01894516|464043507|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
128932931|NCT01894516|464043504|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
128932932|NCT01894516|464043505|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128932933|NCT01894516|464043506|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128932934|NCT01894516|464043507|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128932935|NCT01894516|464043504|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
129121757|NCT00961064|464742642|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
128767721|NCT04041440|463440350|FG001|Overall Study|Lost to Follow-up|1|||
128767722|NCT01381874|463440351|FG000|Overall Study|Lost to Follow-up|1|||
128767723|NCT01381874|463440352|FG001|Overall Study|Lost to Follow-up|1|||
128702948|NCT02380677|463211348|FG011|Overall Study|Withdrawal by Subject|3|||
128702949|NCT02380677|463211337|FG000|Overall Study|Other|0|||
128702950|NCT02380677|463211338|FG001|Overall Study|Other|0|||
128702951|NCT02380677|463211339|FG002|Overall Study|Other|0|||
128702952|NCT02380677|463211340|FG003|Overall Study|Other|1|||
128702953|NCT02380677|463211341|FG004|Overall Study|Other|1|||
128702954|NCT02380677|463211342|FG005|Overall Study|Other|1|||
128702955|NCT02380677|463211343|FG006|Overall Study|Other|0|||
128702956|NCT02380677|463211344|FG007|Overall Study|Other|0|||
128702957|NCT02380677|463211345|FG008|Overall Study|Other|0|||
128702958|NCT02380677|463211346|FG009|Overall Study|Other|0|||
128702959|NCT02380677|463211347|FG010|Overall Study|Other|0|||
128702960|NCT02380677|463211348|FG011|Overall Study|Other|0|||
128702961|NCT00617773|463211352|FG000|Overall Study|Physician Decision|1|||
128702962|NCT00617773|463211352|FG000|Overall Study|Lack of compliance with the protocol|1|||
128702963|NCT00617773|463211352|FG000|Overall Study|Withdrawal by Subject|1|||
128702964|NCT00617773|463211352|FG000|Overall Study|Death|1|||
128702965|NCT00617773|463211352|FG000|Overall Study|Progressive disease|19|||
128702966|NCT00617773|463211352|FG000|Overall Study|Protocol Violation|1|||
128702967|NCT05035550|463211361|FG000|Overall Study|Withdrawal by Subject|3|||
128702968|NCT05035550|463211362|FG001|Overall Study|Withdrawal by Subject|0|||
128702969|NCT01806545|463211363|FG000|Overall Study|Adverse Event|2|||
128702970|NCT01806545|463211364|FG001|Overall Study|Adverse Event|3|||
128702971|NCT01806545|463211363|FG000|Overall Study|Lost to Follow-up|1|||
128702972|NCT01806545|463211364|FG001|Overall Study|Lost to Follow-up|0|||
128702973|NCT01806545|463211363|FG000|Overall Study|Withdrawal by Subject|3|||
128702974|NCT01806545|463211364|FG001|Overall Study|Withdrawal by Subject|2|||
128702975|NCT01508650|463211365|FG000|Overall Study|Lost to Follow-up|0|||
128702976|NCT01508650|463211366|FG001|Overall Study|Lost to Follow-up|3|||
128702977|NCT02064894|463211367|FG000|Overall Study|Withdrawal by Subject|43|||
128702978|NCT02064894|463211368|FG001|Overall Study|Withdrawal by Subject|102|||
128702979|NCT02064894|463211369|FG002|Overall Study|Withdrawal by Subject|115|||
128702980|NCT01396148|463211370|FG000|Overall Study|Patient Decision|1|||
128702981|NCT00884312|463211379|FG000|Overall Study|Non-fatal Progressive Disease|0|||
128702982|NCT00884312|463211380|FG001|Overall Study|Non-fatal Progressive Disease|8|||
128702983|NCT00884312|463211379|FG000|Overall Study|Fatal Progressive Disease|0|||
128702984|NCT00884312|463211380|FG001|Overall Study|Fatal Progressive Disease|1|||
128702985|NCT00884312|463211379|FG000|Overall Study|Non-fatal Adverse Event|1|||
128702986|NCT00884312|463211380|FG001|Overall Study|Non-fatal Adverse Event|0|||
128702987|NCT00884312|463211379|FG000|Overall Study|Fatal Adverse Event|1|||
128702988|NCT00884312|463211380|FG001|Overall Study|Fatal Adverse Event|4|||
128702989|NCT00884312|463211379|FG000|Overall Study|Withdrawal by Subject|0|||
128702990|NCT00884312|463211380|FG001|Overall Study|Withdrawal by Subject|6|||
128702991|NCT00884312|463211379|FG000|Overall Study|Physician Decision|0|||
128702992|NCT00884312|463211380|FG001|Overall Study|Physician Decision|1|||
128702993|NCT00884312|463211379|FG000|Overall Study|Other|0|||
128702994|NCT00884312|463211380|FG001|Overall Study|Other|4|||
128702995|NCT00884312|463211379|FG000|Overall Study|Did Not Receive Study Drug|0|||
128702996|NCT00884312|463211380|FG001|Overall Study|Did Not Receive Study Drug|1|||
128702997|NCT00224042|463211381|FG000|Overall Study|Adverse Event|2|||
128702998|NCT00224042|463211382|FG001|Overall Study|Adverse Event|1|||
128702999|NCT00224042|463211381|FG000|Overall Study|Protocol Violation|0|||
128703000|NCT00224042|463211382|FG001|Overall Study|Protocol Violation|1|||
128703001|NCT00224042|463211381|FG000|Overall Study|Physician Decision|0|||
128703002|NCT00224042|463211382|FG001|Overall Study|Physician Decision|1|||
128703003|NCT00224042|463211381|FG000|Overall Study|Did not meet lab incusion criteria|2|||
128703004|NCT00224042|463211382|FG001|Overall Study|Did not meet lab incusion criteria|3|||
128703005|NCT00224042|463211381|FG000|Overall Study|Other|2|||
128703006|NCT00224042|463211382|FG001|Overall Study|Other|0|||
128703007|NCT00840450|463211383|FG000|Overall Study|Adverse Event|1|||
128703008|NCT00840450|463211383|FG000|Overall Study|Lack of Efficacy|2|||
128703009|NCT00617123|463211384|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
129030860|NCT02725515|464404729|FG001|Overall Study|Lost to Follow-up|1|||
128703010|NCT00617123|463211385|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
128767724|NCT01381874|463440353|FG002|Overall Study|Lost to Follow-up|0|||
128703011|NCT00617123|463211384|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
128703012|NCT00617123|463211385|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
128703013|NCT00617123|463211384|FG000|Referral Screening Period|Adverse Event|0|||
128703014|NCT00617123|463211385|FG001|Referral Screening Period|Adverse Event|1|||
128703015|NCT00617123|463211384|FG000|Study Treatment Period|Withdrawal by Subject|8|||
128703016|NCT00617123|463211385|FG001|Study Treatment Period|Withdrawal by Subject|12|||
128703017|NCT00617123|463211384|FG000|Study Treatment Period|Adverse Event|7|||
128703018|NCT00617123|463211385|FG001|Study Treatment Period|Adverse Event|3|||
128703019|NCT00617123|463211384|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
128703020|NCT00617123|463211385|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
128703021|NCT00617123|463211384|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
128767725|NCT01381874|463440351|FG000|Overall Study|Withdrawal by Subject|9|||
129030861|NCT02725515|464404728|FG000|Overall Study|Adverse Event|7|||
128703022|NCT00617123|463211385|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
128703023|NCT00133952|463211387|FG000|Overall Study|Adverse Event|1|||
128703024|NCT00133952|463211388|FG001|Overall Study|Adverse Event|2|||
128703025|NCT00133952|463211387|FG000|Overall Study|Death|3|||
128703026|NCT00133952|463211388|FG001|Overall Study|Death|2|||
128703027|NCT00133952|463211387|FG000|Overall Study|Lost to Follow-up|9|||
128703028|NCT00133952|463211388|FG001|Overall Study|Lost to Follow-up|14|||
128703029|NCT00133952|463211387|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
128703030|NCT00133952|463211388|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
128703031|NCT00133952|463211387|FG000|Overall Study|Protocol Violation|1|||
128703032|NCT00133952|463211388|FG001|Overall Study|Protocol Violation|1|||
128703033|NCT00133952|463211387|FG000|Overall Study|Withdrawal by Subject|20|||
128703034|NCT00133952|463211388|FG001|Overall Study|Withdrawal by Subject|4|||
128703035|NCT00133952|463211387|FG000|Overall Study|Physician Decision|4|||
128703036|NCT00133952|463211388|FG001|Overall Study|Physician Decision|3|||
128703037|NCT00133952|463211387|FG000|Overall Study|Sponsor Decision|0|||
128703038|NCT00133952|463211388|FG001|Overall Study|Sponsor Decision|1|||
128703039|NCT00520936|463211389|FG000|Overall Study|Physician Decision|0|||
128703040|NCT00520936|463211390|FG001|Overall Study|Physician Decision|2|||
128703041|NCT00520936|463211391|FG002|Overall Study|Physician Decision|1|||
128703042|NCT00520936|463211392|FG003|Overall Study|Physician Decision|0|||
128703043|NCT00520936|463211393|FG004|Overall Study|Physician Decision|0|||
128703044|NCT00520936|463211394|FG005|Overall Study|Physician Decision|0|||
128703045|NCT00520936|463211395|FG006|Overall Study|Physician Decision|0|||
128703046|NCT00520936|463211396|FG007|Overall Study|Physician Decision|0|||
128703047|NCT00520936|463211389|FG000|Overall Study|Withdrawal by Subject|0|||
128703048|NCT00520936|463211390|FG001|Overall Study|Withdrawal by Subject|0|||
128703049|NCT00520936|463211391|FG002|Overall Study|Withdrawal by Subject|0|||
128703050|NCT00520936|463211392|FG003|Overall Study|Withdrawal by Subject|0|||
128703051|NCT00520936|463211393|FG004|Overall Study|Withdrawal by Subject|0|||
128703052|NCT00520936|463211394|FG005|Overall Study|Withdrawal by Subject|0|||
128703053|NCT00520936|463211395|FG006|Overall Study|Withdrawal by Subject|0|||
128703054|NCT00520936|463211396|FG007|Overall Study|Withdrawal by Subject|1|||
128703055|NCT00520936|463211389|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
128703056|NCT00520936|463211390|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
128703057|NCT00520936|463211391|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
128703058|NCT00520936|463211392|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
128703059|NCT00520936|463211393|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
128703060|NCT00520936|463211394|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
128703061|NCT00520936|463211395|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
128703062|NCT00520936|463211396|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
128703063|NCT00520936|463211389|FG000|Overall Study|Death|0|||
128703064|NCT00520936|463211390|FG001|Overall Study|Death|0|||
128703065|NCT00520936|463211391|FG002|Overall Study|Death|0|||
128703066|NCT00520936|463211392|FG003|Overall Study|Death|0|||
128703067|NCT00520936|463211393|FG004|Overall Study|Death|0|||
128703068|NCT00520936|463211394|FG005|Overall Study|Death|0|||
128703069|NCT00520936|463211395|FG006|Overall Study|Death|1|||
128703070|NCT00520936|463211396|FG007|Overall Study|Death|0|||
128703071|NCT00520936|463211389|FG000|Overall Study|Protocol Violation|0|||
128703072|NCT00520936|463211390|FG001|Overall Study|Protocol Violation|1|||
128703073|NCT00520936|463211391|FG002|Overall Study|Protocol Violation|1|||
128703074|NCT00520936|463211392|FG003|Overall Study|Protocol Violation|0|||
128703075|NCT00520936|463211393|FG004|Overall Study|Protocol Violation|1|||
128703076|NCT00520936|463211394|FG005|Overall Study|Protocol Violation|0|||
128703077|NCT00520936|463211395|FG006|Overall Study|Protocol Violation|1|||
128703078|NCT00520936|463211396|FG007|Overall Study|Protocol Violation|0|||
128703079|NCT00847379|463211397|FG000|Overall Study|Study terminated by Sponsor|59|||
128703080|NCT00847379|463211398|FG001|Overall Study|Study terminated by Sponsor|57|||
128703081|NCT00847379|463211399|FG002|Overall Study|Study terminated by Sponsor|57|||
128703082|NCT02864498|463211400|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
128703083|NCT02864498|463211401|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
128703084|NCT02864498|463211402|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
128703085|NCT02864498|463211400|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
128703086|NCT02864498|463211401|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
128703087|NCT02864498|463211402|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
128703088|NCT02864498|463211400|FG000|Overall Study|Investigator Discretion|0|||
128703089|NCT02864498|463211401|FG001|Overall Study|Investigator Discretion|2|||
128703090|NCT02864498|463211402|FG002|Overall Study|Investigator Discretion|1|||
128703091|NCT02864498|463211400|FG000|Overall Study|Lost to Follow-up|8|||
128703092|NCT02864498|463211401|FG001|Overall Study|Lost to Follow-up|6|||
128703093|NCT02864498|463211402|FG002|Overall Study|Lost to Follow-up|3|||
128703094|NCT02864498|463211400|FG000|Overall Study|Lack of Efficacy|5|||
128703095|NCT02864498|463211401|FG001|Overall Study|Lack of Efficacy|3|||
128703096|NCT02864498|463211402|FG002|Overall Study|Lack of Efficacy|3|||
129030862|NCT02725515|464404729|FG001|Overall Study|Adverse Event|2|||
129216748|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
128932936|NCT01894516|464043505|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
128932937|NCT01894516|464043506|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
128932938|NCT01894516|464043507|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
128932939|NCT01894516|464043504|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
128932940|NCT01894516|464043505|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
128932941|NCT01894516|464043506|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
128932942|NCT01894516|464043507|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
128932943|NCT01894516|464043504|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
129030863|NCT02725515|464404728|FG000|Overall Study|No Documented Disease Improvement|0|||
128932944|NCT01894516|464043505|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
128932945|NCT01894516|464043506|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
128932946|NCT01894516|464043507|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
128932947|NCT01894516|464043504|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
128932948|NCT01894516|464043505|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
128932949|NCT01894516|464043506|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
128932950|NCT01894516|464043507|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
128932951|NCT01894516|464043504|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
128932952|NCT01894516|464043505|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
128932953|NCT01894516|464043506|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
128932954|NCT01894516|464043507|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
128932955|NCT01894516|464043504|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
128932956|NCT01894516|464043505|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
128932957|NCT01894516|464043506|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
128932958|NCT01894516|464043507|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
128932959|NCT03191396|464043509|FG000|Overall Study|Lost to Follow-up|0|||
128932960|NCT03191396|464043510|FG001|Overall Study|Lost to Follow-up|3|||
128932961|NCT03191396|464043509|FG000|Overall Study|Withdrawal by Subject|3|||
128932962|NCT03191396|464043510|FG001|Overall Study|Withdrawal by Subject|2|||
128932963|NCT03635190|464043511|FG000|Overall Study|Lost to Follow-up|4|||
128932964|NCT03635190|464043511|FG000|Overall Study|Death|3|||
128932965|NCT03635190|464043511|FG000|Overall Study|Withdrawal by Subject|1|||
128932966|NCT03635190|464043511|FG000|Overall Study|Patient moved and did not return for follow up|1|||
128932967|NCT03692910|464043512|FG000|Overall Study|Lost to Follow-up|4|||
128932968|NCT03692910|464043513|FG001|Overall Study|Lost to Follow-up|0|||
128932969|NCT03692910|464043514|FG002|Overall Study|Lost to Follow-up|0|||
128932970|NCT03692910|464043512|FG000|Overall Study|Withdrawal by Subject|2|||
128932971|NCT03692910|464043513|FG001|Overall Study|Withdrawal by Subject|0|||
128932972|NCT03692910|464043514|FG002|Overall Study|Withdrawal by Subject|0|||
128932973|NCT01981122|464043517|FG000|Overall Study|Withdrawal by Subject|0|||
128932974|NCT01981122|464043518|FG001|Overall Study|Withdrawal by Subject|2|||
128932975|NCT01981122|464043517|FG000|Overall Study|Protocol Violation|0|||
128932976|NCT01981122|464043518|FG001|Overall Study|Protocol Violation|1|||
128932977|NCT01981122|464043517|FG000|Overall Study|Lost to Follow-up|0|||
128932978|NCT01981122|464043518|FG001|Overall Study|Lost to Follow-up|1|||
128932979|NCT01981122|464043517|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
128932980|NCT01981122|464043518|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
128932981|NCT01981122|464043517|FG000|Overall Study|Death|14|||
128932982|NCT01981122|464043518|FG001|Overall Study|Death|15|||
128932983|NCT03060577|464043519|FG000|Overall Study|Withdrawal by Subject|25|||
128932984|NCT03060577|464043520|FG001|Overall Study|Withdrawal by Subject|5|||
128932985|NCT03060577|464043519|FG000|Overall Study|Physician Decision|4|||
128932986|NCT03060577|464043520|FG001|Overall Study|Physician Decision|3|||
128932987|NCT03060577|464043519|FG000|Overall Study|Lost to Follow-up|3|||
128932988|NCT03060577|464043520|FG001|Overall Study|Lost to Follow-up|0|||
128932989|NCT03060577|464043519|FG000|Overall Study|Death|7|||
128932990|NCT03060577|464043520|FG001|Overall Study|Death|1|||
128932991|NCT03060577|464043519|FG000|Overall Study|Adverse Event|9|||
129030864|NCT02725515|464404729|FG001|Overall Study|No Documented Disease Improvement|1|||
129030865|NCT02725515|464404728|FG000|Overall Study|Completed Study Under Original Protocol|0|||
129030866|NCT02725515|464404729|FG001|Overall Study|Completed Study Under Original Protocol|1|||
129030867|NCT02725515|464404728|FG000|Overall Study|Lack of Response|0|||
129030868|NCT02725515|464404729|FG001|Overall Study|Lack of Response|1|||
129030869|NCT00874549|464404730|FG000|Overall Study|Adverse Event|0|||
129030870|NCT00874549|464404731|FG001|Overall Study|Adverse Event|0|||
129030871|NCT00874549|464404732|FG002|Overall Study|Adverse Event|1|||
129030872|NCT00874549|464404733|FG003|Overall Study|Adverse Event|0|||
129030873|NCT00874549|464404730|FG000|Overall Study|Protocol Violation|1|||
129216749|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
128932992|NCT03060577|464043520|FG001|Overall Study|Adverse Event|1|||
129030874|NCT00874549|464404731|FG001|Overall Study|Protocol Violation|0|||
129030875|NCT00874549|464404732|FG002|Overall Study|Protocol Violation|2|||
129030876|NCT00874549|464404733|FG003|Overall Study|Protocol Violation|1|||
128932993|NCT03060577|464043519|FG000|Overall Study|Inclusion/Exclusion|1|||
128932994|NCT03060577|464043520|FG001|Overall Study|Inclusion/Exclusion|0|||
128932995|NCT03060577|464043519|FG000|Overall Study|Other|8|||
128932996|NCT03060577|464043520|FG001|Overall Study|Other|2|||
128932997|NCT03216265|464043524|FG000|Overall Study|Adverse Event|2|||
128932998|NCT03216265|464043525|FG001|Overall Study|Adverse Event|0|||
128932999|NCT03216265|464043526|FG002|Overall Study|Adverse Event|2|||
128933000|NCT03216265|464043524|FG000|Overall Study|Lost to Follow-up|0|||
128933001|NCT03216265|464043525|FG001|Overall Study|Lost to Follow-up|1|||
128933002|NCT03216265|464043526|FG002|Overall Study|Lost to Follow-up|0|||
128933003|NCT03216265|464043524|FG000|Overall Study|Withdrawal by Subject|0|||
128933004|NCT03216265|464043525|FG001|Overall Study|Withdrawal by Subject|0|||
128933005|NCT03216265|464043526|FG002|Overall Study|Withdrawal by Subject|1|||
128933006|NCT01277289|464043528|FG000|Overall Study|fragile vein|1|||
128933007|NCT01277289|464043529|FG001|Overall Study|fragile vein|0|||
128933008|NCT01277289|464043528|FG000|Overall Study|Physician Decision|1|||
128933009|NCT01277289|464043529|FG001|Overall Study|Physician Decision|0|||
128933010|NCT01277289|464043528|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
128933011|NCT01277289|464043529|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
128933012|NCT01277289|464043528|FG000|Overall Study|Protocol Violation|1|||
128933013|NCT01277289|464043529|FG001|Overall Study|Protocol Violation|1|||
128933014|NCT01277289|464043528|FG000|Overall Study|Adverse Event|2|||
128933015|NCT01277289|464043529|FG001|Overall Study|Adverse Event|1|||
128933016|NCT01277289|464043528|FG000|Overall Study|consent withdrawn|1|||
128933017|NCT01277289|464043529|FG001|Overall Study|consent withdrawn|1|||
128933018|NCT01277289|464043528|FG000|Overall Study|premature closure of the study|4|||
128933019|NCT01277289|464043529|FG001|Overall Study|premature closure of the study|2|||
128933020|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
128933021|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
128933022|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
128933023|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
128933024|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
128933025|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
128933026|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
128933027|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
128933028|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
128933029|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
128933030|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
128933031|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
128933032|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
128933033|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
128933034|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
128933035|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
128933036|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
128933037|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
128933038|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
128933039|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
128933040|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
128933041|NCT00092547|464043530|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
128933042|NCT00092547|464043531|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
128933043|NCT00092547|464043532|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
128933044|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
128933045|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
128933046|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
128933047|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
128933048|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
128933049|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
128933050|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
128933051|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
129030877|NCT00874549|464404730|FG000|Overall Study|Lost to Follow-up|0|||
128933052|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
128933053|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
128933054|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
128933055|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
128933056|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
128933057|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
128933058|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
128933059|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
128933060|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
128933061|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
128933062|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
128933063|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
128933064|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
128933065|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
128933066|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
128933067|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
128933068|NCT00092547|464043530|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
128933069|NCT00092547|464043531|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
128933070|NCT00092547|464043532|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
128933071|NCT00092547|464043530|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
128933072|NCT00092547|464043531|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
128933073|NCT00092547|464043532|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
128933074|NCT00092547|464043530|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
128933075|NCT00092547|464043531|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
128933076|NCT00092547|464043532|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
128933077|NCT00092547|464043530|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
128933078|NCT00092547|464043531|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
128933079|NCT00092547|464043532|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
128933080|NCT00092547|464043530|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
128933081|NCT00092547|464043531|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
128933082|NCT00092547|464043532|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
128933083|NCT01539837|464043533|FG000|Overall Study|reduce neutrophil level|0|||
128933084|NCT01539837|464043534|FG001|Overall Study|reduce neutrophil level|1|||
128933085|NCT01539837|464043535|FG002|Overall Study|reduce neutrophil level|1|||
128933086|NCT01539837|464043533|FG000|Overall Study|bad compliance|0|||
128933087|NCT01539837|464043534|FG001|Overall Study|bad compliance|0|||
128933088|NCT01539837|464043535|FG002|Overall Study|bad compliance|1|||
128933089|NCT01978912|464043537|FG000|Overall Study|Adverse Event|0|||
128933090|NCT01978912|464043538|FG001|Overall Study|Adverse Event|1|||
128933091|NCT01978912|464043539|FG002|Overall Study|Adverse Event|0|||
128933092|NCT01978912|464043540|FG003|Overall Study|Adverse Event|0|||
128933093|NCT01978912|464043537|FG000|Overall Study|Lost to Follow-up|1|||
128933094|NCT01978912|464043538|FG001|Overall Study|Lost to Follow-up|1|||
128933095|NCT01978912|464043539|FG002|Overall Study|Lost to Follow-up|0|||
128933096|NCT01978912|464043540|FG003|Overall Study|Lost to Follow-up|1|||
128933097|NCT01978912|464043537|FG000|Overall Study|Withdrawal by Subject|1|||
128933098|NCT01978912|464043538|FG001|Overall Study|Withdrawal by Subject|0|||
128933099|NCT01978912|464043539|FG002|Overall Study|Withdrawal by Subject|2|||
128933100|NCT01978912|464043540|FG003|Overall Study|Withdrawal by Subject|2|||
128933101|NCT01978912|464043537|FG000|Overall Study|Lumbar Surgery|1|||
128933102|NCT01978912|464043538|FG001|Overall Study|Lumbar Surgery|0|||
128933103|NCT01978912|464043539|FG002|Overall Study|Lumbar Surgery|1|||
128933104|NCT01978912|464043540|FG003|Overall Study|Lumbar Surgery|0|||
128933105|NCT01978912|464043537|FG000|Overall Study|Intradiscal Steroid Injection|0|||
128933106|NCT01978912|464043538|FG001|Overall Study|Intradiscal Steroid Injection|1|||
128933107|NCT01978912|464043539|FG002|Overall Study|Intradiscal Steroid Injection|0|||
128933108|NCT01978912|464043540|FG003|Overall Study|Intradiscal Steroid Injection|0|||
128933109|NCT00401973|464043541|FG000|Overall Study|Adverse Event|2|||
128933110|NCT00401973|464043542|FG001|Overall Study|Adverse Event|8|||
128933111|NCT00401973|464043543|FG002|Overall Study|Adverse Event|4|||
128933112|NCT00401973|464043541|FG000|Overall Study|Clinical Relapse|0|||
128767726|NCT01381874|463440352|FG001|Overall Study|Withdrawal by Subject|10|||
128767727|NCT01381874|463440353|FG002|Overall Study|Withdrawal by Subject|9|||
128933113|NCT00401973|464043542|FG001|Overall Study|Clinical Relapse|1|||
128933114|NCT00401973|464043543|FG002|Overall Study|Clinical Relapse|1|||
128933115|NCT00401973|464043541|FG000|Overall Study|Lack of Efficacy|0|||
128933116|NCT00401973|464043542|FG001|Overall Study|Lack of Efficacy|0|||
128933117|NCT00401973|464043543|FG002|Overall Study|Lack of Efficacy|3|||
128933118|NCT00401973|464043541|FG000|Overall Study|Lost to Follow-up|2|||
128933119|NCT00401973|464043542|FG001|Overall Study|Lost to Follow-up|2|||
129030878|NCT00874549|464404731|FG001|Overall Study|Lost to Follow-up|0|||
128933120|NCT00401973|464043543|FG002|Overall Study|Lost to Follow-up|2|||
128933121|NCT00401973|464043541|FG000|Overall Study|Physician Decision|2|||
128933122|NCT00401973|464043542|FG001|Overall Study|Physician Decision|0|||
128933123|NCT00401973|464043543|FG002|Overall Study|Physician Decision|1|||
128933124|NCT00401973|464043541|FG000|Overall Study|Protocol Violation|1|||
128933125|NCT00401973|464043542|FG001|Overall Study|Protocol Violation|2|||
128933126|NCT00401973|464043543|FG002|Overall Study|Protocol Violation|3|||
128933127|NCT00401973|464043541|FG000|Overall Study|Sponsor Decision|0|||
128933128|NCT00401973|464043542|FG001|Overall Study|Sponsor Decision|1|||
129030879|NCT00874549|464404732|FG002|Overall Study|Lost to Follow-up|1|||
129030880|NCT00874549|464404733|FG003|Overall Study|Lost to Follow-up|0|||
128767728|NCT01381874|463440351|FG000|Overall Study|Other|67|||
128933129|NCT00401973|464043543|FG002|Overall Study|Sponsor Decision|0|||
128933130|NCT00401973|464043541|FG000|Overall Study|Withdrawal by Subject|4|||
128933131|NCT00401973|464043542|FG001|Overall Study|Withdrawal by Subject|12|||
128933132|NCT00401973|464043543|FG002|Overall Study|Withdrawal by Subject|9|||
128933133|NCT05523362|464043544|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
128933134|NCT05523362|464043544|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
128933135|NCT05523362|464043544|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
128933136|NCT05523362|464043544|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
128933137|NCT04075604|464043545|FG000|Overall Study|Adverse Event|0|||
128933138|NCT04075604|464043546|FG001|Overall Study|Adverse Event|0|||
128933139|NCT04075604|464043547|FG002|Overall Study|Adverse Event|3|||
128933140|NCT04075604|464043545|FG000|Overall Study|Participant request to discontinue study treatment|0|||
128933141|NCT04075604|464043546|FG001|Overall Study|Participant request to discontinue study treatment|0|||
128933142|NCT04075604|464043547|FG002|Overall Study|Participant request to discontinue study treatment|1|||
128933143|NCT04075604|464043545|FG000|Overall Study|Participant withdrew consent|0|||
128933144|NCT04075604|464043546|FG001|Overall Study|Participant withdrew consent|0|||
128933145|NCT04075604|464043547|FG002|Overall Study|Participant withdrew consent|1|||
128933146|NCT04075604|464043545|FG000|Overall Study|Other reasons|1|||
128933147|NCT04075604|464043546|FG001|Overall Study|Other reasons|0|||
128933148|NCT04075604|464043547|FG002|Overall Study|Other reasons|0|||
128933149|NCT04075604|464043545|FG000|Overall Study|Disease progression|0|||
128933150|NCT04075604|464043546|FG001|Overall Study|Disease progression|1|||
128933151|NCT04075604|464043547|FG002|Overall Study|Disease progression|0|||
128933152|NCT04075604|464043545|FG000|Overall Study|Study drug toxicity|0|||
128933153|NCT04075604|464043546|FG001|Overall Study|Study drug toxicity|5|||
128933154|NCT04075604|464043547|FG002|Overall Study|Study drug toxicity|1|||
128933155|NCT01650779|464043550|FG000|Overall Study|Withdrawal by Subject|1|||
128933156|NCT03666143|464043551|FG000|Overall Study|Death|158|||
128933157|NCT03666143|464043551|FG000|Overall Study|Sponsor Decision|31|||
128933158|NCT03666143|464043551|FG000|Overall Study|Withdrawal by Subject|11|||
128933159|NCT03666143|464043551|FG000|Overall Study|Lost to Follow-up|5|||
128933160|NCT03666143|464043551|FG000|Overall Study|Physician Decision|1|||
128933161|NCT03666143|464043551|FG000|Overall Study|Rolled into extension study|9|||
128933162|NCT03666143|464043551|FG000|Overall Study|Progressive Disease|1|||
128933163|NCT01183858|464043554|FG000|Overall Study|Death not related to Progressive Disease|5|||
128933164|NCT01183858|464043555|FG001|Overall Study|Death not related to Progressive Disease|6|||
128933165|NCT01183858|464043554|FG000|Overall Study|Adverse Event|14|||
128933166|NCT01183858|464043555|FG001|Overall Study|Adverse Event|11|||
128933167|NCT01183858|464043554|FG000|Overall Study|Investigator's Decision|0|||
128933168|NCT01183858|464043555|FG001|Overall Study|Investigator's Decision|3|||
128933169|NCT01183858|464043554|FG000|Overall Study|Insufficient Therapeutic Response|2|||
128933170|NCT01183858|464043555|FG001|Overall Study|Insufficient Therapeutic Response|0|||
128933171|NCT01183858|464043554|FG000|Overall Study|Refused Treatment|1|||
128933172|NCT01183858|464043555|FG001|Overall Study|Refused Treatment|4|||
128933173|NCT01183858|464043554|FG000|Overall Study|Withdrew Consent|4|||
128933174|NCT01183858|464043555|FG001|Overall Study|Withdrew Consent|4|||
128933175|NCT01183858|464043554|FG000|Overall Study|Discontinued Smoking|3|||
128933176|NCT01183858|464043555|FG001|Overall Study|Discontinued Smoking|1|||
128933177|NCT01183858|464043554|FG000|Overall Study|Protocol Violation|1|||
128933178|NCT01183858|464043555|FG001|Overall Study|Protocol Violation|0|||
128933179|NCT01183858|464043554|FG000|Overall Study|Administrative/Other|6|||
128933180|NCT01183858|464043555|FG001|Overall Study|Administrative/Other|6|||
128933181|NCT01183858|464043554|FG000|Overall Study|Progressive Disease|112|||
128933182|NCT01183858|464043555|FG001|Overall Study|Progressive Disease|115|||
128933183|NCT01183858|464043554|FG000|Overall Study|Death related to Progressive Disease|4|||
129121758|NCT00961064|464742642|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
128933184|NCT01183858|464043555|FG001|Overall Study|Death related to Progressive Disease|5|||
128933185|NCT01183858|464043554|FG000|Overall Study|Lost to Follow-up|1|||
128933186|NCT01183858|464043555|FG001|Overall Study|Lost to Follow-up|1|||
128933187|NCT02747043|464043556|FG000|Overall Study|Other|1|||
128933188|NCT02747043|464043557|FG001|Overall Study|Other|1|||
128933189|NCT02747043|464043556|FG000|Overall Study|Adverse Event|3|||
128933190|NCT02747043|464043557|FG001|Overall Study|Adverse Event|1|||
128933191|NCT02747043|464043556|FG000|Overall Study|Withdrawal by Subject|1|||
128933192|NCT02747043|464043557|FG001|Overall Study|Withdrawal by Subject|1|||
128933193|NCT02747043|464043556|FG000|Overall Study|Physician Decision|1|||
129121759|NCT00961064|464742642|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
129121760|NCT00961064|464742642|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
128933194|NCT02747043|464043557|FG001|Overall Study|Physician Decision|1|||
128933195|NCT02747043|464043556|FG000|Overall Study|Protocol Violation|0|||
128933196|NCT02747043|464043557|FG001|Overall Study|Protocol Violation|1|||
128933197|NCT02747043|464043556|FG000|Overall Study|Disease progression|4|||
128933198|NCT02747043|464043557|FG001|Overall Study|Disease progression|0|||
128933199|NCT01295905|464043564|FG000|Overall Study|Did not meet inclusion criteria|1|||
128933200|NCT01295905|464043565|FG001|Overall Study|Did not meet inclusion criteria|0|||
128933201|NCT01295905|464043564|FG000|Overall Study|Met exclusion criteria|1|||
128933202|NCT01295905|464043565|FG001|Overall Study|Met exclusion criteria|0|||
128703097|NCT02864498|463211400|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
128703098|NCT02864498|463211401|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
128703099|NCT02864498|463211402|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
128703100|NCT02864498|463211400|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
128703101|NCT02864498|463211401|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
128703102|NCT02864498|463211402|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
128703103|NCT02864498|463211400|FG000|Overall Study|Subject moved out of the country.|0|||
128703104|NCT02864498|463211401|FG001|Overall Study|Subject moved out of the country.|0|||
128703105|NCT02864498|463211402|FG002|Overall Study|Subject moved out of the country.|1|||
128703106|NCT02197247|463211403|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
128703107|NCT02197247|463211403|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
128703108|NCT02197247|463211403|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
128703109|NCT02197247|463211403|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
128703110|NCT02197247|463211403|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
128703111|NCT02197247|463211403|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
128703112|NCT02197247|463211403|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
128703113|NCT02197247|463211403|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
128703114|NCT00851747|463211405|FG000|Overall Study|Physician Decision|6|||
128703115|NCT00851747|463211406|FG001|Overall Study|Physician Decision|6|||
128703116|NCT00851747|463211407|FG002|Overall Study|Physician Decision|6|||
128703117|NCT01854710|463211408|FG000|Overall Study|Withdrawal by Subject|2|||
128703118|NCT01854710|463211409|FG001|Overall Study|Withdrawal by Subject|1|||
128703119|NCT01854710|463211410|FG002|Overall Study|Withdrawal by Subject|0|||
128703120|NCT01854710|463211411|FG003|Overall Study|Withdrawal by Subject|0|||
128703121|NCT01854710|463211412|FG004|Overall Study|Withdrawal by Subject|0|||
128703122|NCT01854710|463211413|FG005|Overall Study|Withdrawal by Subject|0|||
128703123|NCT01854710|463211408|FG000|Overall Study|CRI procedural error|2|||
128703124|NCT01854710|463211409|FG001|Overall Study|CRI procedural error|2|||
128703125|NCT01854710|463211410|FG002|Overall Study|CRI procedural error|2|||
128703126|NCT01854710|463211411|FG003|Overall Study|CRI procedural error|2|||
128703127|NCT01854710|463211412|FG004|Overall Study|CRI procedural error|2|||
128703128|NCT01854710|463211413|FG005|Overall Study|CRI procedural error|2|||
128703129|NCT00370032|463211414|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
128703130|NCT00370032|463211415|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
128703131|NCT00370032|463211414|FG000|Washout Period|Withdrawal by Subject|0|||
128703132|NCT00370032|463211415|FG001|Washout Period|Withdrawal by Subject|1|||
128703133|NCT00370032|463211414|FG000|Washout Period|Lost to Follow-up|0|||
128703134|NCT00370032|463211415|FG001|Washout Period|Lost to Follow-up|1|||
128703135|NCT00370032|463211414|FG000|Washout Period|Adverse Event|1|||
128703136|NCT00370032|463211415|FG001|Washout Period|Adverse Event|0|||
128703137|NCT00370032|463211414|FG000|Follow-up Period|Withdrawal by Subject|1|||
128703138|NCT00370032|463211415|FG001|Follow-up Period|Withdrawal by Subject|0|||
128703139|NCT03302234|463211421|FG000|Overall Study|Death|191|||
128703140|NCT03302234|463211422|FG001|Overall Study|Death|192|||
128703141|NCT03302234|463211421|FG000|Overall Study|Withdrawal by Subject|2|||
128703142|NCT03302234|463211422|FG001|Overall Study|Withdrawal by Subject|2|||
128703143|NCT03302234|463211421|FG000|Overall Study|Sponsor Decision|90|||
128703144|NCT03302234|463211422|FG001|Overall Study|Sponsor Decision|89|||
128703145|NCT03302234|463211421|FG000|Overall Study|Laryngeal carcinoma|0|||
128703146|NCT03302234|463211422|FG001|Overall Study|Laryngeal carcinoma|1|||
128703147|NCT03302234|463211421|FG000|Overall Study|Not Reported|1|||
128703148|NCT03302234|463211422|FG001|Overall Study|Not Reported|0|||
128703149|NCT02795832|463211425|FG000|Overall Study|Adverse Event|0|||
128703150|NCT02795832|463211426|FG001|Overall Study|Adverse Event|0|||
128703151|NCT02795832|463211427|FG002|Overall Study|Adverse Event|0|||
128703152|NCT02795832|463211428|FG003|Overall Study|Adverse Event|0|||
128703153|NCT02795832|463211429|FG004|Overall Study|Adverse Event|0|||
128703154|NCT02795832|463211430|FG005|Overall Study|Adverse Event|3|||
128703155|NCT04523220|463211431|FG000|Main Treatment Period|Physician Decision|1|||
128703156|NCT04523220|463211432|FG001|Main Treatment Period|Physician Decision|1|||
128703157|NCT04523220|463211433|FG002|Main Treatment Period|Physician Decision|0|||
128703158|NCT04523220|463211431|FG000|Main Treatment Period|Other|5|||
128703159|NCT04523220|463211432|FG001|Main Treatment Period|Other|2|||
128703160|NCT04523220|463211433|FG002|Main Treatment Period|Other|4|||
128703161|NCT04523220|463211431|FG000|Main Treatment Period|Subject Decision|5|||
128703162|NCT04523220|463211432|FG001|Main Treatment Period|Subject Decision|7|||
128703163|NCT04523220|463211433|FG002|Main Treatment Period|Subject Decision|3|||
128703164|NCT04523220|463211431|FG000|Main Treatment Period|Death|5|||
128703165|NCT04523220|463211432|FG001|Main Treatment Period|Death|11|||
128703166|NCT04523220|463211433|FG002|Main Treatment Period|Death|4|||
128767729|NCT01381874|463440352|FG001|Overall Study|Other|52|||
128767730|NCT01381874|463440353|FG002|Overall Study|Other|67|||
128767731|NCT02247804|463440358|FG000|Treatment Period 1|Adverse Event|9|||
128767732|NCT02247804|463440359|FG001|Treatment Period 1|Adverse Event|2|||
128767733|NCT02247804|463440360|FG002|Treatment Period 1|Adverse Event|0|||
128767734|NCT02247804|463440358|FG000|Treatment Period 1|Lack of Efficacy|0|||
128767735|NCT02247804|463440359|FG001|Treatment Period 1|Lack of Efficacy|0|||
128767736|NCT02247804|463440360|FG002|Treatment Period 1|Lack of Efficacy|2|||
128767737|NCT02247804|463440358|FG000|Treatment Period 1|Lost to Follow-up|1|||
128767738|NCT02247804|463440359|FG001|Treatment Period 1|Lost to Follow-up|0|||
128767739|NCT02247804|463440360|FG002|Treatment Period 1|Lost to Follow-up|2|||
128767740|NCT02247804|463440358|FG000|Treatment Period 1|Personal Reasons|7|||
128767741|NCT02247804|463440359|FG001|Treatment Period 1|Personal Reasons|1|||
128933203|NCT03842709|464043567|FG000|Overall Study|Withdrawal by Subject|3|||
128933204|NCT03842709|464043568|FG001|Overall Study|Withdrawal by Subject|3|||
128933205|NCT03842709|464043567|FG000|Overall Study|Lost to Follow-up|1|||
128933206|NCT03842709|464043568|FG001|Overall Study|Lost to Follow-up|0|||
128933207|NCT00791128|464043569|FG000|Overall Study|Adverse Event|4|||
128933208|NCT00791128|464043569|FG000|Overall Study|Device migration|2|||
128933209|NCT00791128|464043569|FG000|Overall Study|non-compliance by subject|2|||
128933210|NCT00791128|464043569|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
128933211|NCT01629667|464043570|FG000|Overall Study|Lost to Follow-up|0|||
128933212|NCT01629667|464043571|FG001|Overall Study|Lost to Follow-up|1|||
128933213|NCT01629667|464043572|FG002|Overall Study|Lost to Follow-up|1|||
128933214|NCT01629667|464043570|FG000|Overall Study|Withdrawal by Subject|31|||
128933215|NCT01629667|464043571|FG001|Overall Study|Withdrawal by Subject|20|||
128933216|NCT01629667|464043572|FG002|Overall Study|Withdrawal by Subject|28|||
128933217|NCT01629667|464043570|FG000|Overall Study|Death|1|||
128933218|NCT01629667|464043571|FG001|Overall Study|Death|5|||
128933219|NCT01629667|464043572|FG002|Overall Study|Death|3|||
128933220|NCT01629667|464043570|FG000|Overall Study|Randomized, not treated|2|||
129030881|NCT00874549|464404730|FG000|Overall Study|Withdrawal by Subject|0|||
129030882|NCT00874549|464404731|FG001|Overall Study|Withdrawal by Subject|1|||
129030883|NCT00874549|464404732|FG002|Overall Study|Withdrawal by Subject|0|||
129030884|NCT00874549|464404733|FG003|Overall Study|Withdrawal by Subject|1|||
128703167|NCT04523220|463211431|FG000|Main Treatment Period|Adverse Event|11|||
128703168|NCT04523220|463211432|FG001|Main Treatment Period|Adverse Event|9|||
128703169|NCT04523220|463211433|FG002|Main Treatment Period|Adverse Event|9|||
128703170|NCT04523220|463211431|FG000|Main Treatment Period|Withdrawal by Subject|3|||
128703171|NCT04523220|463211432|FG001|Main Treatment Period|Withdrawal by Subject|3|||
129030885|NCT02697617|464404741|FG000|Overall Study|Withdrawal by Subject|0|||
129030886|NCT02697617|464404742|FG001|Overall Study|Withdrawal by Subject|2|||
129030887|NCT02697617|464404741|FG000|Overall Study|Pregnancy|1|||
128703172|NCT04523220|463211433|FG002|Main Treatment Period|Withdrawal by Subject|4|||
128703173|NCT04523220|463211431|FG000|Main Treatment Period|Study drug never adminstered|10|||
128703174|NCT04523220|463211432|FG001|Main Treatment Period|Study drug never adminstered|3|||
128703175|NCT04523220|463211433|FG002|Main Treatment Period|Study drug never adminstered|5|||
128703176|NCT04523220|463211431|FG000|Extension Treatment Period|Physician Decision|1|||
128703177|NCT04523220|463211432|FG001|Extension Treatment Period|Physician Decision|0|||
128703178|NCT04523220|463211433|FG002|Extension Treatment Period|Physician Decision|3|||
128703179|NCT04523220|463211431|FG000|Extension Treatment Period|Other|2|||
128703180|NCT04523220|463211432|FG001|Extension Treatment Period|Other|6|||
128703181|NCT04523220|463211433|FG002|Extension Treatment Period|Other|6|||
128703182|NCT04523220|463211431|FG000|Extension Treatment Period|Subject Decision|5|||
128933221|NCT01629667|464043571|FG001|Overall Study|Randomized, not treated|1|||
128933222|NCT01629667|464043572|FG002|Overall Study|Randomized, not treated|0|||
129030888|NCT02697617|464404742|FG001|Overall Study|Pregnancy|0|||
129030889|NCT02460835|464404743|FG000|Overall Study|Disease progression prior to treatment|3|||
129030890|NCT02460835|464404743|FG000|Overall Study|Unable to complete planning scans|2|||
129030891|NCT02460835|464404743|FG000|Overall Study|Decrease in performance status|1|||
129030892|NCT02460835|464404743|FG000|Overall Study|Withdrawal by Subject|3|||
129030893|NCT02460835|464404743|FG000|Overall Study|Underwent fractionated RT|10|||
129030894|NCT02460835|464404743|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
128703183|NCT04523220|463211432|FG001|Extension Treatment Period|Subject Decision|2|||
128767742|NCT02247804|463440360|FG002|Treatment Period 1|Personal Reasons|2|||
128767743|NCT02247804|463440358|FG000|Treatment Period 1|Protocol Deviation|0|||
129030895|NCT01157234|464404744|FG000|Overall Study|Withdrawal by Subject|1|||
129030896|NCT01157234|464404745|FG001|Overall Study|Withdrawal by Subject|0|||
129030897|NCT00517192|464404749|FG000|Overall Study|Adverse Event|1|||
129121761|NCT00961064|464742642|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
128767744|NCT02247804|463440359|FG001|Treatment Period 1|Protocol Deviation|0|||
128933223|NCT01629667|464043570|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
128933224|NCT01629667|464043571|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
128933225|NCT01629667|464043572|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
128933226|NCT01629667|464043570|FG000|Overall Study|Requiring lung transplant|2|||
128767745|NCT02247804|463440360|FG002|Treatment Period 1|Protocol Deviation|1|||
128767746|NCT02247804|463440358|FG000|Treatment Period 1|Randomized but not Treated|5|||
128767747|NCT02247804|463440359|FG001|Treatment Period 1|Randomized but not Treated|1|||
128767748|NCT02247804|463440360|FG002|Treatment Period 1|Randomized but not Treated|1|||
128767749|NCT02247804|463440358|FG000|Treatment Period 2|Adverse Event|6|||
128933227|NCT01629667|464043571|FG001|Overall Study|Requiring lung transplant|1|||
128933228|NCT01629667|464043572|FG002|Overall Study|Requiring lung transplant|3|||
128933229|NCT01629667|464043570|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
128933230|NCT01629667|464043571|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
128933231|NCT01629667|464043572|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
128933232|NCT01629667|464043570|FG000|Overall Study|Started other medicine|1|||
128933233|NCT01629667|464043571|FG001|Overall Study|Started other medicine|0|||
128933234|NCT01629667|464043572|FG002|Overall Study|Started other medicine|1|||
128933235|NCT01629667|464043570|FG000|Overall Study|Site error in safety follow-up|0|||
128933236|NCT01629667|464043571|FG001|Overall Study|Site error in safety follow-up|0|||
128933237|NCT01629667|464043572|FG002|Overall Study|Site error in safety follow-up|1|||
128933238|NCT01629667|464043570|FG000|Overall Study|Enrolled in another clinical study|0|||
128933239|NCT01629667|464043571|FG001|Overall Study|Enrolled in another clinical study|1|||
128933240|NCT01629667|464043572|FG002|Overall Study|Enrolled in another clinical study|0|||
128933241|NCT01629667|464043570|FG000|Overall Study|Code break|1|||
128933242|NCT01629667|464043571|FG001|Overall Study|Code break|0|||
128933243|NCT01629667|464043572|FG002|Overall Study|Code break|0|||
128933244|NCT01512368|464043576|FG000|Overall Study|Protocol Violation|3|||
128767750|NCT02247804|463440359|FG001|Treatment Period 2|Adverse Event|3|||
128767751|NCT02247804|463440360|FG002|Treatment Period 2|Adverse Event|3|||
128767752|NCT02247804|463440358|FG000|Treatment Period 2|Lack of Efficacy|0|||
128933245|NCT02717546|464043578|FG000|Overall Study|Lost to Follow-up|12|||
128933246|NCT01645280|464043584|FG000|Overall Study|Death|0|||
128933247|NCT01645280|464043585|FG001|Overall Study|Death|1|||
128933248|NCT01645280|464043586|FG002|Overall Study|Death|0|||
128933249|NCT01645280|464043587|FG003|Overall Study|Death|0|||
128933250|NCT01645280|464043588|FG004|Overall Study|Death|0|||
128933251|NCT01645280|464043584|FG000|Overall Study|Withdrawal by Subject|4|||
128933252|NCT01645280|464043585|FG001|Overall Study|Withdrawal by Subject|0|||
128933253|NCT01645280|464043586|FG002|Overall Study|Withdrawal by Subject|2|||
128933254|NCT01645280|464043587|FG003|Overall Study|Withdrawal by Subject|4|||
128933255|NCT01645280|464043588|FG004|Overall Study|Withdrawal by Subject|5|||
128933256|NCT01645280|464043584|FG000|Overall Study|Lost to Follow-up|0|||
128933257|NCT01645280|464043585|FG001|Overall Study|Lost to Follow-up|0|||
128767753|NCT02247804|463440359|FG001|Treatment Period 2|Lack of Efficacy|0|||
128767754|NCT02247804|463440360|FG002|Treatment Period 2|Lack of Efficacy|1|||
128767755|NCT02247804|463440358|FG000|Treatment Period 2|Lost to Follow-up|0|||
128767756|NCT02247804|463440359|FG001|Treatment Period 2|Lost to Follow-up|1|||
128767757|NCT02247804|463440360|FG002|Treatment Period 2|Lost to Follow-up|1|||
128767758|NCT02247804|463440358|FG000|Treatment Period 2|Personal Reasons|2|||
128767759|NCT02247804|463440359|FG001|Treatment Period 2|Personal Reasons|1|||
128767760|NCT02247804|463440360|FG002|Treatment Period 2|Personal Reasons|1|||
128767761|NCT02247804|463440358|FG000|Treatment Period 2|Reason not Specified|0|||
128767762|NCT02247804|463440359|FG001|Treatment Period 2|Reason not Specified|0|||
128767763|NCT02247804|463440360|FG002|Treatment Period 2|Reason not Specified|2|||
128767764|NCT02247804|463440358|FG000|Treatment Period 3|Adverse Event|4|||
128767765|NCT02247804|463440359|FG001|Treatment Period 3|Adverse Event|3|||
128767766|NCT02247804|463440360|FG002|Treatment Period 3|Adverse Event|3|||
128767767|NCT02247804|463440358|FG000|Treatment Period 3|Lack of Efficacy|0|||
128767768|NCT02247804|463440359|FG001|Treatment Period 3|Lack of Efficacy|1|||
128767769|NCT02247804|463440360|FG002|Treatment Period 3|Lack of Efficacy|0|||
128767770|NCT02247804|463440358|FG000|Treatment Period 3|Lost to Follow-up|1|||
128767771|NCT02247804|463440359|FG001|Treatment Period 3|Lost to Follow-up|2|||
128767772|NCT02247804|463440360|FG002|Treatment Period 3|Lost to Follow-up|2|||
128767773|NCT02247804|463440358|FG000|Treatment Period 3|Personal Reasons|4|||
128933258|NCT01645280|464043586|FG002|Overall Study|Lost to Follow-up|0|||
128933259|NCT01645280|464043587|FG003|Overall Study|Lost to Follow-up|2|||
128933260|NCT01645280|464043588|FG004|Overall Study|Lost to Follow-up|1|||
129030898|NCT00517192|464404750|FG001|Overall Study|Adverse Event|1|||
128767774|NCT02247804|463440359|FG001|Treatment Period 3|Personal Reasons|3|||
128767775|NCT02247804|463440360|FG002|Treatment Period 3|Personal Reasons|2|||
128767776|NCT02247804|463440358|FG000|Treatment Period 3|Reason not Specified|2|||
128767777|NCT02247804|463440359|FG001|Treatment Period 3|Reason not Specified|1|||
128933261|NCT01645280|464043584|FG000|Overall Study|Other|1|||
128933262|NCT01645280|464043585|FG001|Overall Study|Other|1|||
128933263|NCT01645280|464043586|FG002|Overall Study|Other|2|||
128933264|NCT01645280|464043587|FG003|Overall Study|Other|0|||
128933265|NCT01645280|464043588|FG004|Overall Study|Other|0|||
128933266|NCT01645280|464043584|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
128933267|NCT01645280|464043585|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
128933268|NCT01645280|464043586|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
129030899|NCT00517192|464404749|FG000|Overall Study|Lost to Follow-up|1|||
128933269|NCT01645280|464043587|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
128933270|NCT01645280|464043588|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
128933271|NCT00234104|464043589|FG000|Overall Study|Adverse Event|4|||
128933272|NCT00234104|464043590|FG001|Overall Study|Adverse Event|0|||
128933273|NCT00234104|464043591|FG002|Overall Study|Adverse Event|3|||
128933274|NCT00234104|464043592|FG003|Overall Study|Adverse Event|5|||
128933275|NCT00234104|464043589|FG000|Overall Study|Protocol Violation|0|||
128933276|NCT00234104|464043590|FG001|Overall Study|Protocol Violation|0|||
128933277|NCT00234104|464043591|FG002|Overall Study|Protocol Violation|0|||
128933278|NCT00234104|464043592|FG003|Overall Study|Protocol Violation|1|||
128933279|NCT00234104|464043589|FG000|Overall Study|Physician Decision|0|||
128933280|NCT00234104|464043590|FG001|Overall Study|Physician Decision|1|||
128933281|NCT00234104|464043591|FG002|Overall Study|Physician Decision|2|||
128933282|NCT00234104|464043592|FG003|Overall Study|Physician Decision|2|||
128933283|NCT02460822|464043593|FG000|Overall Study|Withdrawal by Subject|1|||
128933284|NCT01633060|464043594|FG000|Randomization Phase|Protocol deviation|1|||
128933285|NCT01633060|464043595|FG001|Randomization Phase|Protocol deviation|2|||
128933286|NCT01633060|464043594|FG000|Randomization Phase|Technical problem|0|||
128933287|NCT01633060|464043595|FG001|Randomization Phase|Technical problem|1|||
128703184|NCT04523220|463211433|FG002|Extension Treatment Period|Subject Decision|4|||
128933288|NCT01633060|464043594|FG000|Treatment Phase|Adverse Event|24|||
128933289|NCT01633060|464043595|FG001|Treatment Phase|Adverse Event|3|||
128933290|NCT01633060|464043594|FG000|Treatment Phase|Lost to Follow-up|1|||
128933291|NCT01633060|464043595|FG001|Treatment Phase|Lost to Follow-up|0|||
128933292|NCT01633060|464043594|FG000|Treatment Phase|Physician Decision|16|||
128933293|NCT01633060|464043595|FG001|Treatment Phase|Physician Decision|7|||
128933294|NCT01633060|464043594|FG000|Treatment Phase|Progressive Disease|210|||
128933295|NCT01633060|464043595|FG001|Treatment Phase|Progressive Disease|120|||
128933296|NCT01633060|464043594|FG000|Treatment Phase|Protocol Deviation|1|||
128933297|NCT01633060|464043595|FG001|Treatment Phase|Protocol Deviation|0|||
128933298|NCT01633060|464043594|FG000|Treatment Phase|Study Terminated by sponsor|7|||
128933299|NCT01633060|464043595|FG001|Treatment Phase|Study Terminated by sponsor|3|||
128933300|NCT01633060|464043594|FG000|Treatment Phase|Subject/guardian decision|25|||
128933301|NCT01633060|464043595|FG001|Treatment Phase|Subject/guardian decision|4|||
128933302|NCT01633060|464043594|FG000|Treatment Phase|Death|4|||
128933303|NCT01633060|464043595|FG001|Treatment Phase|Death|3|||
128933304|NCT01633060|464043594|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
128933305|NCT01633060|464043595|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
128933306|NCT01633060|464043594|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
128933307|NCT01633060|464043595|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
128933308|NCT01633060|464043594|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
128933309|NCT01633060|464043595|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
128933310|NCT01633060|464043594|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
128933311|NCT01633060|464043595|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
128933312|NCT01633060|464043594|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
128933313|NCT01633060|464043595|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
128933314|NCT01633060|464043594|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
128933315|NCT01633060|464043595|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
128933316|NCT01396525|464043603|FG000|Overall Study|Withdrawal by Subject|8|||
128933317|NCT01396525|464043603|FG000|Overall Study|Death|14|||
128933318|NCT01396525|464043603|FG000|Overall Study|Lost to Follow-up|4|||
128933319|NCT03114969|464043604|FG000|Overall Study|Lost to Follow-up|0|||
128933320|NCT03114969|464043605|FG001|Overall Study|Lost to Follow-up|0|||
128933321|NCT03114969|464043606|FG002|Overall Study|Lost to Follow-up|3|||
128933322|NCT03114969|464043607|FG003|Overall Study|Lost to Follow-up|2|||
128933323|NCT03114969|464043608|FG004|Overall Study|Lost to Follow-up|0|||
128933324|NCT03114969|464043609|FG005|Overall Study|Lost to Follow-up|0|||
128933325|NCT03114969|464043610|FG006|Overall Study|Lost to Follow-up|0|||
128933326|NCT03114969|464043611|FG007|Overall Study|Lost to Follow-up|0|||
128933327|NCT03114969|464043612|FG008|Overall Study|Lost to Follow-up|0|||
128933328|NCT03114969|464043604|FG000|Overall Study|Adverse Event|0|||
128933329|NCT03114969|464043605|FG001|Overall Study|Adverse Event|0|||
128933330|NCT03114969|464043606|FG002|Overall Study|Adverse Event|1|||
128933331|NCT03114969|464043607|FG003|Overall Study|Adverse Event|0|||
128933332|NCT03114969|464043608|FG004|Overall Study|Adverse Event|0|||
128933333|NCT03114969|464043609|FG005|Overall Study|Adverse Event|1|||
128933334|NCT03114969|464043610|FG006|Overall Study|Adverse Event|1|||
128933335|NCT03114969|464043611|FG007|Overall Study|Adverse Event|0|||
128933336|NCT03114969|464043612|FG008|Overall Study|Adverse Event|2|||
128933337|NCT00949650|464043613|FG000|Overall Study|Progressive disease|188|||
128933338|NCT00949650|464043614|FG001|Overall Study|Progressive disease|19|||
128933339|NCT00949650|464043613|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
128933340|NCT00949650|464043614|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
128933341|NCT00949650|464043613|FG000|Overall Study|Other Adverse Event (AE)|28|||
128933342|NCT00949650|464043614|FG001|Overall Study|Other Adverse Event (AE)|17|||
128933343|NCT00949650|464043613|FG000|Overall Study|Protocol Violation|1|||
128933344|NCT00949650|464043614|FG001|Overall Study|Protocol Violation|4|||
128933345|NCT00949650|464043613|FG000|Overall Study|Refusal to continue medication|7|||
128933346|NCT00949650|464043614|FG001|Overall Study|Refusal to continue medication|11|||
128933347|NCT00949650|464043613|FG000|Overall Study|Not treated|1|||
128933348|NCT00949650|464043614|FG001|Overall Study|Not treated|4|||
128933349|NCT00949650|464043613|FG000|Overall Study|Other not specified above|5|||
128933350|NCT00949650|464043614|FG001|Overall Study|Other not specified above|0|||
128933351|NCT04601272|464043616|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
128933352|NCT04601272|464043617|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
128933353|NCT04601272|464043618|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
128933354|NCT00414440|464043619|FG000|Core Period|Withdrawal by Subject|70|||
128933355|NCT00414440|464043620|FG001|Core Period|Withdrawal by Subject|32|||
128933356|NCT00414440|464043619|FG000|Extension Period|Lost to Follow-up|44|||
128933357|NCT00414440|464043620|FG001|Extension Period|Lost to Follow-up|52|||
128933358|NCT00414440|464043619|FG000|Extension Period|Did not consent to continue follow up|61|||
128933359|NCT00414440|464043620|FG001|Extension Period|Did not consent to continue follow up|54|||
128933360|NCT00414440|464043619|FG000|Extension Period|Other|1|||
128933361|NCT00414440|464043620|FG001|Extension Period|Other|1|||
128933362|NCT00414440|464043619|FG000|Extension Period|Administrative|16|||
128933363|NCT00414440|464043620|FG001|Extension Period|Administrative|16|||
128933364|NCT00414440|464043619|FG000|Extension Period|Death|1|||
128933365|NCT00414440|464043620|FG001|Extension Period|Death|2|||
128933366|NCT00414440|464043619|FG000|Extension Period|Withdrawal by Subject|9|||
128933367|NCT00414440|464043620|FG001|Extension Period|Withdrawal by Subject|7|||
128933368|NCT00414440|464043619|FG000|Extension Period|Not included in follow up period|18|||
128933369|NCT00414440|464043620|FG001|Extension Period|Not included in follow up period|8|||
128933370|NCT02168946|464043621|FG000|Overall Study|Adverse Event|8|||
128933371|NCT02168946|464043622|FG001|Overall Study|Adverse Event|5|||
128933372|NCT02168946|464043621|FG000|Overall Study|Lost to Follow-up|3|||
128933373|NCT02168946|464043622|FG001|Overall Study|Lost to Follow-up|0|||
128933374|NCT02168946|464043621|FG000|Overall Study|Subject unable to come back for visits|1|||
128933375|NCT02168946|464043622|FG001|Overall Study|Subject unable to come back for visits|0|||
128933376|NCT00450866|464043623|FG000|Overall Study|Adverse Event|0|||
128933377|NCT00450866|464043624|FG001|Overall Study|Adverse Event|1|||
128933378|NCT00450866|464043623|FG000|Overall Study|Withdrawal by Subject|5|||
128933379|NCT00450866|464043624|FG001|Overall Study|Withdrawal by Subject|2|||
128933380|NCT00450866|464043623|FG000|Overall Study|Death|1|||
128933381|NCT00450866|464043624|FG001|Overall Study|Death|0|||
128933382|NCT00450866|464043623|FG000|Overall Study|Physician Decision|1|||
128933383|NCT00450866|464043624|FG001|Overall Study|Physician Decision|0|||
128933384|NCT02498821|464043625|FG000|Overall Study|Screen failure|3|||
128933385|NCT02498821|464043626|FG001|Overall Study|Screen failure|5|||
128933386|NCT00553787|464043627|FG000|Overall Study|Adverse Event|34|||
128933387|NCT00553787|464043628|FG001|Overall Study|Adverse Event|21|||
128933388|NCT00553787|464043629|FG002|Overall Study|Adverse Event|67|||
128933389|NCT00553787|464043627|FG000|Overall Study|Lost to Follow-up|132|||
128933390|NCT00553787|464043628|FG001|Overall Study|Lost to Follow-up|44|||
128933391|NCT00553787|464043629|FG002|Overall Study|Lost to Follow-up|78|||
128933392|NCT00553787|464043627|FG000|Overall Study|Withdrawal by Subject|151|||
128933393|NCT00553787|464043628|FG001|Overall Study|Withdrawal by Subject|40|||
128933394|NCT00553787|464043629|FG002|Overall Study|Withdrawal by Subject|83|||
128933395|NCT00553787|464043627|FG000|Overall Study|Lack of Efficacy|31|||
128933396|NCT00553787|464043628|FG001|Overall Study|Lack of Efficacy|1|||
128933397|NCT00553787|464043629|FG002|Overall Study|Lack of Efficacy|3|||
128933398|NCT00553787|464043627|FG000|Overall Study|Pregnancy|0|||
128933399|NCT00553787|464043628|FG001|Overall Study|Pregnancy|1|||
128933400|NCT00553787|464043629|FG002|Overall Study|Pregnancy|2|||
129121762|NCT00961064|464742642|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
129121763|NCT00961064|464742642|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
129121764|NCT00576758|464742643|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
129121765|NCT00576758|464742644|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
129121766|NCT00576758|464742643|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
129121767|NCT00576758|464742644|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
128933401|NCT00553787|464043627|FG000|Overall Study|non compliance|4|||
128933402|NCT00553787|464043628|FG001|Overall Study|non compliance|0|||
128933403|NCT00553787|464043629|FG002|Overall Study|non compliance|11|||
129121768|NCT00576758|464742643|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
128933404|NCT00553787|464043627|FG000|Overall Study|Requirement for restricted medication|8|||
128933405|NCT00553787|464043628|FG001|Overall Study|Requirement for restricted medication|7|||
128933406|NCT00553787|464043629|FG002|Overall Study|Requirement for restricted medication|5|||
128933407|NCT00553787|464043627|FG000|Overall Study|Other|18|||
128933408|NCT00553787|464043628|FG001|Overall Study|Other|10|||
128933409|NCT00553787|464043629|FG002|Overall Study|Other|13|||
128933410|NCT02285010|464043630|FG000|Overall Study|not abdominal hysterectomy|2|||
128767778|NCT02247804|463440360|FG002|Treatment Period 3|Reason not Specified|3|||
128767779|NCT02917265|463440361|FG000|Overall Study|Physician Decision|1|||
128767780|NCT02917265|463440362|FG001|Overall Study|Physician Decision|0|||
128767781|NCT02917265|463440361|FG000|Overall Study|Withdrawal by Subject|1|||
128767782|NCT02917265|463440362|FG001|Overall Study|Withdrawal by Subject|0|||
128767783|NCT00452413|463440363|FG000|Overall Study|Progressive Disease|4|||
128767784|NCT00452413|463440364|FG001|Overall Study|Progressive Disease|11|||
128767785|NCT00452413|463440365|FG002|Overall Study|Progressive Disease|30|||
128767786|NCT00452413|463440363|FG000|Overall Study|Withdrawal by Subject|0|||
128767787|NCT00452413|463440364|FG001|Overall Study|Withdrawal by Subject|1|||
128767788|NCT00452413|463440365|FG002|Overall Study|Withdrawal by Subject|4|||
128767789|NCT00452413|463440363|FG000|Overall Study|Adverse Event|0|||
128767790|NCT00452413|463440364|FG001|Overall Study|Adverse Event|0|||
128767791|NCT00452413|463440365|FG002|Overall Study|Adverse Event|5|||
128767792|NCT00452413|463440363|FG000|Overall Study|Physician Decision|0|||
128767793|NCT00452413|463440364|FG001|Overall Study|Physician Decision|0|||
128767794|NCT00452413|463440365|FG002|Overall Study|Physician Decision|4|||
128767795|NCT00452413|463440363|FG000|Overall Study|Death due to study disease|0|||
128767796|NCT00452413|463440364|FG001|Overall Study|Death due to study disease|0|||
128767797|NCT00452413|463440365|FG002|Overall Study|Death due to study disease|2|||
128767798|NCT00452413|463440363|FG000|Overall Study|Death due to adverse event (AE)|0|||
128767799|NCT00452413|463440364|FG001|Overall Study|Death due to adverse event (AE)|0|||
128767800|NCT00452413|463440365|FG002|Overall Study|Death due to adverse event (AE)|1|||
128767801|NCT00452413|463440363|FG000|Overall Study|On treatment|0|||
128767802|NCT00452413|463440364|FG001|Overall Study|On treatment|0|||
128767803|NCT00452413|463440365|FG002|Overall Study|On treatment|3|||
128767804|NCT01248962|463440366|FG000|Overall Study|Withdrawal by Subject|1|||
128767805|NCT01248962|463440367|FG001|Overall Study|Withdrawal by Subject|1|||
128767806|NCT01248962|463440366|FG000|Overall Study|Adverse Event|2|||
128767807|NCT01248962|463440367|FG001|Overall Study|Adverse Event|1|||
128767808|NCT01248962|463440366|FG000|Overall Study|Complete Response after 4 Cycles|1|||
128767809|NCT01248962|463440367|FG001|Overall Study|Complete Response after 4 Cycles|0|||
128767810|NCT01248962|463440366|FG000|Overall Study|Complete Response after 3 Cycles|0|||
128767811|NCT01248962|463440367|FG001|Overall Study|Complete Response after 3 Cycles|1|||
128767812|NCT01248962|463440366|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
128767813|NCT01248962|463440367|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
128767814|NCT03283696|463440369|FG000|Overall Study|Physician Decision|5|||
128767815|NCT03283696|463440370|FG001|Overall Study|Physician Decision|6|||
128767816|NCT03283696|463440369|FG000|Overall Study|Withdrawal by Subject|2|||
128767817|NCT03283696|463440370|FG001|Overall Study|Withdrawal by Subject|0|||
128767818|NCT01539863|463440374|FG000|Overall Study|Lost to Follow-up|5|||
128767819|NCT01539863|463440375|FG001|Overall Study|Lost to Follow-up|4|||
128767820|NCT02765490|463440378|FG000|Overall Study|Lost to Follow-up|1|||
128933411|NCT02285010|464043631|FG001|Overall Study|not abdominal hysterectomy|0|||
128933412|NCT02285010|464043630|FG000|Overall Study|Not spinal anesthesia|3|||
128933413|NCT02285010|464043631|FG001|Overall Study|Not spinal anesthesia|1|||
128933414|NCT02111811|464043632|FG000|Treatment Phase|Lost to Follow-up|22|||
128933415|NCT02111811|464043633|FG001|Treatment Phase|Lost to Follow-up|18|||
128933416|NCT02111811|464043632|FG000|Treatment Phase|Death|2|||
128933417|NCT02111811|464043633|FG001|Treatment Phase|Death|0|||
128767821|NCT02765490|463440379|FG001|Overall Study|Lost to Follow-up|1|||
128767822|NCT02765490|463440378|FG000|Overall Study|Other|0|||
128767823|NCT02765490|463440379|FG001|Overall Study|Other|1|||
128933418|NCT02111811|464043632|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
128933419|NCT02111811|464043633|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
128933420|NCT02111811|464043632|FG000|Follow up Period (Aim 2)|Death|2|||
128933421|NCT02111811|464043633|FG001|Follow up Period (Aim 2)|Death|0|||
128933422|NCT05258058|464043653|FG000|Overall Study|Withdrawal by Subject|2|||
128933423|NCT04579393|464043658|FG000|Overall Study|Withdrawal by Subject|2|||
128933424|NCT04579393|464043659|FG001|Overall Study|Withdrawal by Subject|2|||
128933425|NCT04579393|464043658|FG000|Overall Study|Death|1|||
128933426|NCT04579393|464043659|FG001|Overall Study|Death|3|||
128933427|NCT02725177|464043669|FG000|Overall Study|Physician Decision|4|||
128933428|NCT02725177|464043669|FG000|Overall Study|Adverse Event|1|||
128933429|NCT00793585|464043670|FG000|Overall Study|Adverse Event|1|||
128933430|NCT00793585|464043671|FG001|Overall Study|Adverse Event|1|||
128933431|NCT00793585|464043670|FG000|Overall Study|Protocol Violation|1|||
128767824|NCT02765490|463440378|FG000|Overall Study|Death|0|||
128767825|NCT02765490|463440379|FG001|Overall Study|Death|1|||
128767826|NCT00007475|463440382|FG000|Overall Study|Withdrawal by Subject|1|||
128767827|NCT00007475|463440383|FG001|Overall Study|Withdrawal by Subject|0|||
128933432|NCT00793585|464043671|FG001|Overall Study|Protocol Violation|2|||
128933433|NCT02699515|464045455|FG000|Overall Study|Death|3|||
128933434|NCT02699515|464045456|FG001|Overall Study|Death|3|||
128933435|NCT02699515|464045457|FG002|Overall Study|Death|3|||
128933436|NCT02699515|464045458|FG003|Overall Study|Death|23|||
128933437|NCT02699515|464045459|FG004|Overall Study|Death|22|||
128933438|NCT02699515|464045460|FG005|Overall Study|Death|23|||
128933439|NCT02699515|464045461|FG006|Overall Study|Death|3|||
129216750|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
128933440|NCT02699515|464045462|FG007|Overall Study|Death|5|||
128933441|NCT02699515|464045455|FG000|Overall Study|Withdrawal by Subject|0|||
128933442|NCT02699515|464045456|FG001|Overall Study|Withdrawal by Subject|0|||
128933443|NCT02699515|464045457|FG002|Overall Study|Withdrawal by Subject|3|||
128933444|NCT02699515|464045458|FG003|Overall Study|Withdrawal by Subject|1|||
128933445|NCT02699515|464045459|FG004|Overall Study|Withdrawal by Subject|5|||
128933446|NCT02699515|464045460|FG005|Overall Study|Withdrawal by Subject|3|||
128933447|NCT02699515|464045461|FG006|Overall Study|Withdrawal by Subject|0|||
128933448|NCT02699515|464045462|FG007|Overall Study|Withdrawal by Subject|1|||
128933449|NCT02699515|464045455|FG000|Overall Study|Other|1|||
128933450|NCT02699515|464045456|FG001|Overall Study|Other|0|||
128933451|NCT02699515|464045457|FG002|Overall Study|Other|1|||
128933452|NCT02699515|464045458|FG003|Overall Study|Other|6|||
128933453|NCT02699515|464045459|FG004|Overall Study|Other|4|||
128933454|NCT02699515|464045460|FG005|Overall Study|Other|3|||
128933455|NCT02699515|464045461|FG006|Overall Study|Other|0|||
128933456|NCT02699515|464045462|FG007|Overall Study|Other|0|||
128933457|NCT00375934|464045463|FG000|Overall Study|Adverse Event|1|||
128933458|NCT00375934|464045464|FG001|Overall Study|Adverse Event|1|||
128933459|NCT00375934|464045463|FG000|Overall Study|Withdrawal by Subject|2|||
128933460|NCT00375934|464045464|FG001|Overall Study|Withdrawal by Subject|2|||
128933461|NCT00375934|464045463|FG000|Overall Study|Lack of Efficacy|0|||
128933462|NCT00375934|464045464|FG001|Overall Study|Lack of Efficacy|2|||
128933463|NCT00375934|464045463|FG000|Overall Study|Physician Decision|0|||
128933464|NCT00375934|464045464|FG001|Overall Study|Physician Decision|1|||
128933465|NCT01300286|464045465|FG000|Overall Study|did not get dosed|1|||
128933466|NCT02584634|464045472|FG000|Overall Study|Adverse Event|3|||
128933467|NCT02584634|464045473|FG001|Overall Study|Adverse Event|5|||
128933468|NCT02584634|464045472|FG000|Overall Study|Death|0|||
128933469|NCT02584634|464045473|FG001|Overall Study|Death|1|||
128933470|NCT02584634|464045472|FG000|Overall Study|Lost to Follow-up|0|||
128933471|NCT02584634|464045473|FG001|Overall Study|Lost to Follow-up|1|||
128933472|NCT02584634|464045472|FG000|Overall Study|Physician Decision|1|||
128933473|NCT02584634|464045473|FG001|Overall Study|Physician Decision|2|||
128933474|NCT02584634|464045472|FG000|Overall Study|Progressive disease|7|||
128933475|NCT02584634|464045473|FG001|Overall Study|Progressive disease|15|||
128933476|NCT02584634|464045472|FG000|Overall Study|Withdrawal by Subject|1|||
128933477|NCT02584634|464045473|FG001|Overall Study|Withdrawal by Subject|1|||
128933478|NCT02584634|464045472|FG000|Overall Study|Other|0|||
128933479|NCT02584634|464045473|FG001|Overall Study|Other|6|||
128933480|NCT00283712|464045474|FG000|Overall Study|Death|0|||
128933481|NCT00283712|464045475|FG001|Overall Study|Death|1|||
128933482|NCT04329923|464045476|FG000|Overall Study|Withdrawal by Subject|1|||
128933483|NCT04329923|464045477|FG001|Overall Study|Withdrawal by Subject|4|||
128933484|NCT04329923|464045478|FG002|Overall Study|Withdrawal by Subject|1|||
128933485|NCT04329923|464045479|FG003|Overall Study|Withdrawal by Subject|1|||
128933486|NCT04329923|464045480|FG004|Overall Study|Withdrawal by Subject|1|||
128933487|NCT04329923|464045481|FG005|Overall Study|Withdrawal by Subject|1|||
128933488|NCT04329923|464045476|FG000|Overall Study|early termination of study|0|||
128933489|NCT04329923|464045477|FG001|Overall Study|early termination of study|0|||
128933490|NCT04329923|464045478|FG002|Overall Study|early termination of study|0|||
128933491|NCT04329923|464045479|FG003|Overall Study|early termination of study|0|||
128703185|NCT04523220|463211431|FG000|Extension Treatment Period|Death|6|||
128933492|NCT04329923|464045480|FG004|Overall Study|early termination of study|1|||
128703186|NCT04523220|463211432|FG001|Extension Treatment Period|Death|4|||
128933493|NCT04329923|464045481|FG005|Overall Study|early termination of study|2|||
128933494|NCT04329923|464045476|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
128933495|NCT04329923|464045477|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
128933496|NCT04329923|464045478|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
128933497|NCT04329923|464045479|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
128933498|NCT04329923|464045480|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
128933499|NCT04329923|464045481|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
128933500|NCT01272180|464045482|FG000|Overall Study|Adverse Event|0|||
128933501|NCT01272180|464045483|FG001|Overall Study|Adverse Event|0|||
128933502|NCT01272180|464045484|FG002|Overall Study|Adverse Event|1|||
128933503|NCT01272180|464045485|FG003|Overall Study|Adverse Event|0|||
128933504|NCT01272180|464045482|FG000|Overall Study|Withdrawal by Subject|2|||
128933505|NCT01272180|464045483|FG001|Overall Study|Withdrawal by Subject|6|||
128933506|NCT01272180|464045484|FG002|Overall Study|Withdrawal by Subject|3|||
128933507|NCT01272180|464045485|FG003|Overall Study|Withdrawal by Subject|2|||
128933508|NCT01272180|464045482|FG000|Overall Study|Lost to Follow-up|15|||
128933509|NCT01272180|464045483|FG001|Overall Study|Lost to Follow-up|14|||
128933510|NCT01272180|464045484|FG002|Overall Study|Lost to Follow-up|8|||
128703187|NCT04523220|463211433|FG002|Extension Treatment Period|Death|7|||
128933511|NCT01272180|464045485|FG003|Overall Study|Lost to Follow-up|10|||
128933512|NCT01272180|464045482|FG000|Overall Study|Inappropriate enrollment|0|||
128933513|NCT01272180|464045483|FG001|Overall Study|Inappropriate enrollment|0|||
128933514|NCT01272180|464045484|FG002|Overall Study|Inappropriate enrollment|1|||
129030900|NCT00517192|464404750|FG001|Overall Study|Lost to Follow-up|1|||
128703188|NCT04523220|463211431|FG000|Extension Treatment Period|Adverse Event|6|||
128703189|NCT04523220|463211432|FG001|Extension Treatment Period|Adverse Event|7|||
128703190|NCT04523220|463211433|FG002|Extension Treatment Period|Adverse Event|9|||
128703191|NCT04523220|463211431|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
128703192|NCT04523220|463211432|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
128703193|NCT04523220|463211433|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
128703194|NCT04523220|463211431|FG000|Extension Treatment Period|Study drug never administered|0|||
128703195|NCT04523220|463211432|FG001|Extension Treatment Period|Study drug never administered|1|||
128703196|NCT04523220|463211433|FG002|Extension Treatment Period|Study drug never administered|0|||
128703197|NCT00571948|463211434|FG000|Overall Study|Lost to Follow-up|2|||
128703198|NCT00571948|463211435|FG001|Overall Study|Lost to Follow-up|0|||
128703199|NCT00571948|463211434|FG000|Overall Study|Withdrawal by Subject|1|||
128703200|NCT00571948|463211435|FG001|Overall Study|Withdrawal by Subject|2|||
128703201|NCT00571948|463211434|FG000|Overall Study|Protocol Violation|3|||
128703202|NCT00571948|463211435|FG001|Overall Study|Protocol Violation|3|||
128703203|NCT00571948|463211434|FG000|Overall Study|infant refused study meal|3|||
128703204|NCT00571948|463211435|FG001|Overall Study|infant refused study meal|4|||
128703205|NCT00571948|463211434|FG000|Overall Study|Parent were afraid of blood colection|2|||
128703206|NCT00571948|463211435|FG001|Overall Study|Parent were afraid of blood colection|5|||
128703207|NCT02605824|463211436|FG000|Overall Study|Physician Decision|1|||
128703208|NCT02605824|463211437|FG001|Overall Study|Physician Decision|0|||
128703209|NCT04112784|463211438|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
128703210|NCT04112784|463211438|FG000|Overall Study|Screen Failures|4|||
128703211|NCT00256750|463211439|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
128703212|NCT00256750|463211440|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
128703213|NCT00256750|463211441|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
128703214|NCT00256750|463211439|FG000|Transplanted Pre-Treatment|Other|2|||
128703215|NCT00256750|463211440|FG001|Transplanted Pre-Treatment|Other|0|||
128703216|NCT00256750|463211441|FG002|Transplanted Pre-Treatment|Other|0|||
128703217|NCT00256750|463211439|FG000|Transplanted Pre-Treatment|Death|1|||
128703218|NCT00256750|463211440|FG001|Transplanted Pre-Treatment|Death|0|||
128703219|NCT00256750|463211441|FG002|Transplanted Pre-Treatment|Death|0|||
128703220|NCT00256750|463211439|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
128703221|NCT00256750|463211440|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
128703222|NCT00256750|463211441|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
128703223|NCT00256750|463211439|FG000|Post-Transplant Treated (12 Months)|Death|3|||
128703224|NCT00256750|463211440|FG001|Post-Transplant Treated (12 Months)|Death|2|||
128703225|NCT00256750|463211441|FG002|Post-Transplant Treated (12 Months)|Death|4|||
128703226|NCT00256750|463211439|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
128703227|NCT00256750|463211440|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
128703228|NCT00256750|463211441|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
128703229|NCT00256750|463211439|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
128703230|NCT00256750|463211440|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
128703231|NCT00256750|463211441|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
128703232|NCT00256750|463211439|FG000|Post-Transplant Treated (12 Months)|Other|5|||
128703233|NCT00256750|463211440|FG001|Post-Transplant Treated (12 Months)|Other|4|||
128703234|NCT00256750|463211441|FG002|Post-Transplant Treated (12 Months)|Other|2|||
128703235|NCT00256750|463211439|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
128703236|NCT00256750|463211440|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
128703237|NCT00256750|463211441|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
128703238|NCT00256750|463211439|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
128703239|NCT00256750|463211440|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
128703240|NCT00256750|463211441|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
128703241|NCT00256750|463211439|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
128703242|NCT00256750|463211440|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
128703243|NCT00256750|463211441|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
128703244|NCT00256750|463211439|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
128703245|NCT00256750|463211440|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
128703246|NCT00256750|463211441|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
129030901|NCT00517192|464404749|FG000|Overall Study|Withdrawal by Subject|1|||
129030902|NCT00517192|464404750|FG001|Overall Study|Withdrawal by Subject|0|||
128703247|NCT00256750|463211439|FG000|Post-Transplant Treated (24 Months)|Death|3|||
128703248|NCT00256750|463211440|FG001|Post-Transplant Treated (24 Months)|Death|0|||
128703249|NCT00256750|463211441|FG002|Post-Transplant Treated (24 Months)|Death|0|||
128703250|NCT00256750|463211439|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
128703251|NCT00256750|463211440|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
128703252|NCT00256750|463211441|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
128703253|NCT00256750|463211439|FG000|Post-Transplant Treated (24 Months)|Other|2|||
129030903|NCT00517192|464404749|FG000|Overall Study|Early termination of the trial|16|||
129030904|NCT00517192|464404750|FG001|Overall Study|Early termination of the trial|18|||
129030905|NCT02733627|464404751|FG000|Overall Study|Adverse Event|0|||
129030906|NCT02733627|464404752|FG001|Overall Study|Adverse Event|1|||
129030907|NCT02733627|464404753|FG002|Overall Study|Adverse Event|1|||
129030908|NCT02733627|464404754|FG003|Overall Study|Adverse Event|0|||
129030909|NCT02733627|464404751|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
129030910|NCT02733627|464404752|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
129030911|NCT02733627|464404753|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
129030912|NCT02733627|464404754|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
129030913|NCT00183196|464404755|FG000|Overall Study|Withdrawal by Subject|18|||
129030914|NCT00183196|464404756|FG001|Overall Study|Withdrawal by Subject|11|||
129030915|NCT00183196|464404757|FG002|Overall Study|Withdrawal by Subject|13|||
128933515|NCT01272180|464045485|FG003|Overall Study|Inappropriate enrollment|1|||
128933516|NCT01272180|464045482|FG000|Overall Study|Protocol Violation|0|||
128933517|NCT01272180|464045483|FG001|Overall Study|Protocol Violation|1|||
128933518|NCT01272180|464045484|FG002|Overall Study|Protocol Violation|0|||
128933519|NCT01272180|464045485|FG003|Overall Study|Protocol Violation|1|||
128933520|NCT03707977|464045488|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
128933521|NCT03707977|464045489|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
128933522|NCT03707977|464045490|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
128933523|NCT03707977|464045488|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
128933524|NCT03707977|464045489|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
128933525|NCT03707977|464045490|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
128933526|NCT02564120|464045491|FG000|Overall Study|Did not return release forms|160|||
128933527|NCT02564120|464045491|FG000|Overall Study|Death|58|||
128933528|NCT02564120|464045491|FG000|Overall Study|Withdrawal by Subject|204|||
128933529|NCT02564120|464045491|FG000|Overall Study|Other medical condition|24|||
128933530|NCT00641147|464045492|FG000|Completed 4 Months.|Physician Decision|1|||
128933531|NCT00641147|464045493|FG001|Completed 4 Months.|Physician Decision|0|||
128933532|NCT00641147|464045492|FG000|Completed 4 Months.|Adverse Event|1|||
128933533|NCT00641147|464045493|FG001|Completed 4 Months.|Adverse Event|0|||
128933534|NCT00641147|464045492|FG000|Completed 8 Months.|Physician Decision|2|||
128933535|NCT00641147|464045493|FG001|Completed 8 Months.|Physician Decision|1|||
128933536|NCT00641147|464045492|FG000|Completed 8 Months.|non compliance|1|||
128933537|NCT00641147|464045493|FG001|Completed 8 Months.|non compliance|0|||
128933538|NCT00641147|464045492|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
128933539|NCT00641147|464045493|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
128933540|NCT00641147|464045492|FG000|Completed 12 Months.|Physician Decision|1|||
128933541|NCT00641147|464045493|FG001|Completed 12 Months.|Physician Decision|1|||
128933542|NCT00641147|464045492|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
128933543|NCT00641147|464045493|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
128933544|NCT00641147|464045492|FG000|Completed 16 Months.|Physician Decision|1|||
128933545|NCT00641147|464045493|FG001|Completed 16 Months.|Physician Decision|0|||
128933546|NCT00641147|464045492|FG000|Completed 16 Months.|Lost to Follow-up|1|||
128933547|NCT00641147|464045493|FG001|Completed 16 Months.|Lost to Follow-up|0|||
128933548|NCT01966731|464045496|FG000|Overall Study|Death|2|||
128933549|NCT01966731|464045496|FG000|Overall Study|Lost to Follow-up|1|||
128933550|NCT01966731|464045496|FG000|Overall Study|Physician Decision|2|||
128933551|NCT01966731|464045496|FG000|Overall Study|Follow up is not complete|600|||
128933552|NCT01966731|464045496|FG000|Overall Study|Screening Failure|29|||
128933553|NCT01966731|464045496|FG000|Overall Study|Found to be ineligible|1|||
128933554|NCT01380093|464045498|FG000|Naloxone Challenge Phase|Screen failures|21|||
128933555|NCT01380093|464045499|FG001|Naloxone Challenge Phase|Screen failures|0|||
128933556|NCT01380093|464045500|FG002|Naloxone Challenge Phase|Screen failures|0|||
128933557|NCT01380093|464045501|FG003|Naloxone Challenge Phase|Screen failures|0|||
128933558|NCT01380093|464045502|FG004|Naloxone Challenge Phase|Screen failures|0|||
128933559|NCT01380093|464045503|FG005|Naloxone Challenge Phase|Screen failures|0|||
128933560|NCT01380093|464045504|FG006|Naloxone Challenge Phase|Screen failures|0|||
129030916|NCT00183196|464404755|FG000|Overall Study|Adverse Event|1|||
129030917|NCT00183196|464404756|FG001|Overall Study|Adverse Event|2|||
129030918|NCT00183196|464404757|FG002|Overall Study|Adverse Event|2|||
128703254|NCT00256750|463211440|FG001|Post-Transplant Treated (24 Months)|Other|0|||
128933561|NCT01380093|464045505|FG007|Naloxone Challenge Phase|Screen failures|0|||
128933562|NCT01380093|464045506|FG008|Naloxone Challenge Phase|Screen failures|0|||
128933563|NCT01380093|464045498|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
128933564|NCT01380093|464045499|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
128933565|NCT01380093|464045500|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
128933566|NCT01380093|464045501|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
128933567|NCT01380093|464045502|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
128933568|NCT01380093|464045503|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
128933569|NCT01380093|464045504|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129030919|NCT00183196|464404755|FG000|Overall Study|Legal event|1|||
129030920|NCT00183196|464404756|FG001|Overall Study|Legal event|1|||
128933570|NCT01380093|464045505|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
128933571|NCT01380093|464045506|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
128933572|NCT01380093|464045498|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
128933573|NCT01380093|464045499|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
128933574|NCT01380093|464045500|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
128933575|NCT01380093|464045501|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129121769|NCT00576758|464742644|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
129121770|NCT00576758|464742643|FG000|Induction Treatment Period|Death|1|||
129121771|NCT00576758|464742644|FG001|Induction Treatment Period|Death|0|||
129121772|NCT00576758|464742643|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
129121773|NCT00576758|464742644|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
129121774|NCT00576758|464742643|FG000|Induction Treatment Period|Withdrew consent|1|||
129121775|NCT00576758|464742644|FG001|Induction Treatment Period|Withdrew consent|0|||
129121776|NCT00576758|464742643|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
129121777|NCT00576758|464742644|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
128933576|NCT01380093|464045502|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
128933577|NCT01380093|464045503|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
128933578|NCT01380093|464045504|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
128933579|NCT01380093|464045505|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
128933580|NCT01380093|464045506|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
128933581|NCT01380093|464045498|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933582|NCT01380093|464045499|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
128933583|NCT01380093|464045500|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933584|NCT01380093|464045501|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933585|NCT01380093|464045502|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933586|NCT01380093|464045503|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933587|NCT01380093|464045504|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933588|NCT01380093|464045505|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933589|NCT01380093|464045506|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
128933590|NCT01380093|464045498|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
128933591|NCT01380093|464045499|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
129030921|NCT00183196|464404757|FG002|Overall Study|Legal event|1|||
129030922|NCT00183196|464404755|FG000|Overall Study|Required more intensive care|0|||
129030923|NCT00183196|464404756|FG001|Overall Study|Required more intensive care|1|||
129030924|NCT00183196|464404757|FG002|Overall Study|Required more intensive care|2|||
129030925|NCT01513239|464404758|FG000|Period 1: Main Phase|Adverse Event|1|||
129030926|NCT01513239|464404759|FG001|Period 1: Main Phase|Adverse Event|1|||
129030927|NCT01513239|464404760|FG002|Period 1: Main Phase|Adverse Event|2|||
129030928|NCT01513239|464404761|FG003|Period 1: Main Phase|Adverse Event|0|||
129030929|NCT01513239|464404762|FG004|Period 1: Main Phase|Adverse Event|0|||
129030930|NCT01513239|464404763|FG005|Period 1: Main Phase|Adverse Event|0|||
129030931|NCT01513239|464404758|FG000|Period 1: Main Phase|Death|29|||
129030932|NCT01513239|464404759|FG001|Period 1: Main Phase|Death|22|||
129030933|NCT01513239|464404760|FG002|Period 1: Main Phase|Death|32|||
129030934|NCT01513239|464404761|FG003|Period 1: Main Phase|Death|0|||
129030935|NCT01513239|464404762|FG004|Period 1: Main Phase|Death|0|||
129030936|NCT01513239|464404763|FG005|Period 1: Main Phase|Death|0|||
129030937|NCT01513239|464404758|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
129030938|NCT01513239|464404759|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
129030939|NCT01513239|464404760|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
129030940|NCT01513239|464404761|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
129030941|NCT01513239|464404762|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
129030942|NCT01513239|464404763|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
129030943|NCT01513239|464404758|FG000|Period 1: Main Phase|Physician Decision|4|||
129030944|NCT01513239|464404759|FG001|Period 1: Main Phase|Physician Decision|4|||
129030945|NCT01513239|464404760|FG002|Period 1: Main Phase|Physician Decision|4|||
129030946|NCT01513239|464404761|FG003|Period 1: Main Phase|Physician Decision|0|||
129030947|NCT01513239|464404762|FG004|Period 1: Main Phase|Physician Decision|0|||
129030948|NCT01513239|464404763|FG005|Period 1: Main Phase|Physician Decision|0|||
129030949|NCT01513239|464404758|FG000|Period 1: Main Phase|Protocol Violation|2|||
129030950|NCT01513239|464404759|FG001|Period 1: Main Phase|Protocol Violation|2|||
129121778|NCT00576758|464742643|FG000|Extension Treatment Period|Death|1|||
129121779|NCT00576758|464742644|FG001|Extension Treatment Period|Death|1|||
128933592|NCT01380093|464045500|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
129030951|NCT01513239|464404760|FG002|Period 1: Main Phase|Protocol Violation|2|||
129030952|NCT01513239|464404761|FG003|Period 1: Main Phase|Protocol Violation|0|||
129030953|NCT01513239|464404762|FG004|Period 1: Main Phase|Protocol Violation|0|||
129030954|NCT01513239|464404763|FG005|Period 1: Main Phase|Protocol Violation|0|||
129030955|NCT01513239|464404758|FG000|Period 1: Main Phase|Technical Problems|1|||
129030956|NCT01513239|464404759|FG001|Period 1: Main Phase|Technical Problems|2|||
129030957|NCT01513239|464404760|FG002|Period 1: Main Phase|Technical Problems|0|||
128703255|NCT00256750|463211441|FG002|Post-Transplant Treated (24 Months)|Other|1|||
128703256|NCT00256750|463211439|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
128703257|NCT00256750|463211440|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
128703258|NCT00256750|463211441|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
128703259|NCT00256750|463211439|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
128703260|NCT00256750|463211440|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
128703261|NCT00256750|463211441|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
128933593|NCT01380093|464045501|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
128933594|NCT01380093|464045502|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
128933595|NCT01380093|464045503|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
128933596|NCT01380093|464045504|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
128933597|NCT01380093|464045505|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
128933598|NCT01380093|464045506|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
128933599|NCT01380093|464045498|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
128933600|NCT01380093|464045499|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
128933601|NCT01380093|464045500|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
128933602|NCT01380093|464045501|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
128933603|NCT01380093|464045502|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
128933604|NCT01380093|464045503|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
128933605|NCT01380093|464045504|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
128933606|NCT01380093|464045505|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
128933607|NCT01380093|464045506|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
128933608|NCT01380093|464045498|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933609|NCT01380093|464045499|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933610|NCT01380093|464045500|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
128933611|NCT01380093|464045501|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933612|NCT01380093|464045502|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933613|NCT01380093|464045503|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933614|NCT01380093|464045504|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933615|NCT01380093|464045505|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933616|NCT01380093|464045506|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
128933617|NCT01380093|464045498|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933618|NCT01380093|464045499|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933619|NCT01380093|464045500|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
128933620|NCT01380093|464045501|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933621|NCT01380093|464045502|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933622|NCT01380093|464045503|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933623|NCT01380093|464045504|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933624|NCT01380093|464045505|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933625|NCT01380093|464045506|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
128933626|NCT01380093|464045498|FG000|Treatment Phase: Second Intervention|Other|0|||
128933627|NCT01380093|464045499|FG001|Treatment Phase: Second Intervention|Other|0|||
128703262|NCT00256750|463211439|FG000|Post-Transplant Treated (36 Months)|Death|0|||
128703263|NCT00256750|463211440|FG001|Post-Transplant Treated (36 Months)|Death|2|||
128703264|NCT00256750|463211441|FG002|Post-Transplant Treated (36 Months)|Death|1|||
128703265|NCT00256750|463211439|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
128703266|NCT00256750|463211440|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
128703267|NCT00256750|463211441|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
128703268|NCT00256750|463211439|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
128703269|NCT00256750|463211440|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
128703270|NCT00256750|463211441|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
128703271|NCT00256750|463211439|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
128703272|NCT00256750|463211440|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
128703273|NCT00256750|463211441|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
128703274|NCT00256750|463211439|FG000|Post-Transplant Treated (36 Months)|Other|0|||
128703275|NCT00256750|463211440|FG001|Post-Transplant Treated (36 Months)|Other|1|||
128703276|NCT00256750|463211441|FG002|Post-Transplant Treated (36 Months)|Other|1|||
128703277|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
128703278|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
128703279|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
128703280|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
128703281|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
128703282|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
128933628|NCT01380093|464045500|FG002|Treatment Phase: Second Intervention|Other|0|||
128933629|NCT01380093|464045501|FG003|Treatment Phase: Second Intervention|Other|1|||
128933630|NCT01380093|464045502|FG004|Treatment Phase: Second Intervention|Other|0|||
128933631|NCT01380093|464045503|FG005|Treatment Phase: Second Intervention|Other|0|||
129121780|NCT00576758|464742643|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
129121781|NCT00576758|464742644|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
129121782|NCT00576758|464742643|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
129121783|NCT00576758|464742644|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
129121784|NCT00576758|464742643|FG000|Extension Treatment Period|Administrative/Other|3|||
129121785|NCT00576758|464742644|FG001|Extension Treatment Period|Administrative/Other|1|||
129121786|NCT00576758|464742643|FG000|Follow-up Period|Administrative/Other|6|||
129121787|NCT00576758|464742644|FG001|Follow-up Period|Administrative/Other|8|||
129121788|NCT00576758|464742643|FG000|Follow-up Period|Death|3|||
129121789|NCT00576758|464742644|FG001|Follow-up Period|Death|3|||
129121790|NCT00576758|464742643|FG000|Follow-up Period|Insufficient therapeutic response|16|||
128933632|NCT01380093|464045504|FG006|Treatment Phase: Second Intervention|Other|0|||
128933633|NCT01380093|464045505|FG007|Treatment Phase: Second Intervention|Other|0|||
128933634|NCT01380093|464045506|FG008|Treatment Phase: Second Intervention|Other|0|||
128933635|NCT01380093|464045498|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
128933636|NCT01380093|464045499|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
128933637|NCT01380093|464045500|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
128933638|NCT01380093|464045501|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
128933639|NCT01380093|464045502|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
128933640|NCT01380093|464045503|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
128933641|NCT01380093|464045504|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
128933642|NCT01380093|464045505|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
128933643|NCT01380093|464045506|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
128933644|NCT01380093|464045498|FG000|Treatment Phase: Third Intervention|Other|0|||
128933645|NCT01380093|464045499|FG001|Treatment Phase: Third Intervention|Other|0|||
128933646|NCT01380093|464045500|FG002|Treatment Phase: Third Intervention|Other|0|||
128933647|NCT01380093|464045501|FG003|Treatment Phase: Third Intervention|Other|0|||
128933648|NCT01380093|464045502|FG004|Treatment Phase: Third Intervention|Other|0|||
128933649|NCT01380093|464045503|FG005|Treatment Phase: Third Intervention|Other|0|||
128933650|NCT01380093|464045504|FG006|Treatment Phase: Third Intervention|Other|0|||
128933651|NCT01380093|464045505|FG007|Treatment Phase: Third Intervention|Other|0|||
128933652|NCT01380093|464045506|FG008|Treatment Phase: Third Intervention|Other|1|||
128933653|NCT04734873|464045507|FG000|Overall Study|Lost to Follow-up|1|||
128933654|NCT04734873|464045508|FG001|Overall Study|Lost to Follow-up|3|||
128933655|NCT04734873|464045509|FG002|Overall Study|Lost to Follow-up|2|||
128933656|NCT04734873|464045507|FG000|Overall Study|Randomized but not dosed|1|||
128933657|NCT04734873|464045508|FG001|Overall Study|Randomized but not dosed|0|||
128933658|NCT04734873|464045509|FG002|Overall Study|Randomized but not dosed|1|||
128933659|NCT02441803|464045512|FG000|Overall Study|Physician Decision|0|||
128933660|NCT02441803|464045513|FG001|Overall Study|Physician Decision|2|||
128933661|NCT02441803|464045514|FG002|Overall Study|Physician Decision|2|||
128933662|NCT00328198|464045517|FG000|Treatment|Adverse Event|21|||
128933663|NCT00328198|464045517|FG000|Treatment|Death|1|||
128933664|NCT00328198|464045517|FG000|Treatment|Physician Decision|5|||
128933665|NCT00328198|464045517|FG000|Treatment|Withdrawal by Subject|5|||
128933666|NCT00328198|464045517|FG000|Treatment|Evidence of disease progression|2|||
128933667|NCT00328198|464045517|FG000|Treatment|Non-compliance|1|||
128933668|NCT00328198|464045517|FG000|Treatment|Confirmed complete response, MRD -|3|||
128933669|NCT00328198|464045517|FG000|Follow-up|Lost to Follow-up|4|||
128933670|NCT00328198|464045517|FG000|Follow-up|Death|31|||
128933671|NCT03396471|464045518|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
128933672|NCT03396471|464045518|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
128933673|NCT03396471|464045518|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
128933674|NCT03396471|464045518|FG000|Study Treatment - Up to 22 Months|Death|2|||
128933675|NCT03396471|464045518|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
128933676|NCT03396471|464045518|FG000|Follow up - Up to 2 Years|Death|9|||
128933677|NCT03396471|464045518|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
128933678|NCT03396471|464045518|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
128933679|NCT03396471|464045518|FG000|Follow up - Up to 2 Years|study terminated|1|||
128933680|NCT03396471|464045518|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
128933681|NCT03396471|464045518|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
128933682|NCT03237845|464045519|FG000|Overall Study|Adverse Event|0|||
128933683|NCT03237845|464045520|FG001|Overall Study|Adverse Event|1|||
128933684|NCT03237845|464045519|FG000|Overall Study|Lost to Follow-up|13|||
129121791|NCT00576758|464742644|FG001|Follow-up Period|Insufficient therapeutic response|5|||
128933685|NCT03237845|464045520|FG001|Overall Study|Lost to Follow-up|10|||
129121792|NCT00576758|464742643|FG000|Follow-up Period|Withdrew consent|2|||
129121793|NCT00576758|464742644|FG001|Follow-up Period|Withdrew consent|1|||
129121794|NCT01294046|464742645|FG000|Overall Study|Infection and surgical explant|1|||
128933686|NCT03237845|464045519|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
128933687|NCT03237845|464045520|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
128703283|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
128703284|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
128703285|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
128703286|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
128703287|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
128703288|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
128703289|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
128703290|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
128703291|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
128703292|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
128703293|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
128703294|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
128703295|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
128703296|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
128703297|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
128703298|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
128703299|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
128703300|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
128703301|NCT00256750|463211439|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
128703302|NCT00256750|463211440|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
128703303|NCT00256750|463211441|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
128703304|NCT00393029|463211442|FG000|Overall Study|Not treated|0|||
128703305|NCT00393029|463211443|FG001|Overall Study|Not treated|1|||
128703306|NCT03715530|463211444|FG000|Overall Study|Lost to Follow-up|3|||
128703307|NCT03715530|463211445|FG001|Overall Study|Lost to Follow-up|1|||
128703308|NCT03715530|463211446|FG002|Overall Study|Lost to Follow-up|2|||
128703309|NCT01929343|463211447|FG000|Overall Study|Physician Decision|0|||
128703310|NCT01929343|463211448|FG001|Overall Study|Physician Decision|2|||
128703311|NCT01929343|463211449|FG002|Overall Study|Physician Decision|0|||
128703312|NCT01929343|463211447|FG000|Overall Study|Withdrawal by Subject|1|||
128703313|NCT01929343|463211448|FG001|Overall Study|Withdrawal by Subject|0|||
128703314|NCT01929343|463211449|FG002|Overall Study|Withdrawal by Subject|0|||
128703315|NCT00211510|463211457|FG000|Overall Study|Physician Decision|3|||
128703316|NCT00211510|463211458|FG001|Overall Study|Physician Decision|1|||
128703317|NCT00211510|463211457|FG000|Overall Study|Withdrawal by Subject|3|||
128703318|NCT00211510|463211458|FG001|Overall Study|Withdrawal by Subject|1|||
128703319|NCT01962896|463211459|FG000|Overall Study|Lack of Efficacy|4|||
128703320|NCT01737697|463211460|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703321|NCT01737697|463211461|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
128703322|NCT01737697|463211462|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703323|NCT01737697|463211463|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
128703324|NCT01737697|463211464|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
128703325|NCT01737697|463211465|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703326|NCT01737697|463211466|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703327|NCT01737697|463211467|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703328|NCT01737697|463211468|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703329|NCT01737697|463211469|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703330|NCT01737697|463211470|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703331|NCT01737697|463211471|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703332|NCT01737697|463211472|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703333|NCT01737697|463211473|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703334|NCT01737697|463211474|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
128703335|NCT01737697|463211460|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
128703336|NCT01737697|463211461|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
128703337|NCT01737697|463211462|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
128703338|NCT01737697|463211463|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703339|NCT01737697|463211464|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703340|NCT01737697|463211465|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703341|NCT01737697|463211466|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703342|NCT01737697|463211467|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703343|NCT01737697|463211468|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703344|NCT01737697|463211469|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703345|NCT01737697|463211470|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703346|NCT01737697|463211471|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129030958|NCT01513239|464404761|FG003|Period 1: Main Phase|Technical Problems|0|||
129030959|NCT01513239|464404762|FG004|Period 1: Main Phase|Technical Problems|0|||
129030960|NCT01513239|464404763|FG005|Period 1: Main Phase|Technical Problems|0|||
129030961|NCT01513239|464404758|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
129030962|NCT01513239|464404759|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
128703347|NCT01737697|463211472|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129030963|NCT01513239|464404760|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
129216751|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
129216752|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
129216753|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
129216754|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
129216755|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
129216756|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
129216757|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
129216758|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
129216759|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
129216760|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
129216761|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
129216762|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
129216763|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
129216764|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
129216765|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
129216766|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
129121795|NCT01294046|464742645|FG000|Overall Study|Eligibility criteria expanded|1|||
129121796|NCT01294046|464742645|FG000|Overall Study|Stimulation response inadqequate|1|||
129121797|NCT00761319|464742646|FG000|Overall Study|Protocol Violation|21|||
129121798|NCT00761319|464742647|FG001|Overall Study|Protocol Violation|14|||
129121799|NCT00761319|464742646|FG000|Overall Study|Adverse Event|11|||
129121800|NCT00761319|464742647|FG001|Overall Study|Adverse Event|7|||
129216767|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
128933688|NCT03237845|464045519|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
128933689|NCT03237845|464045520|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
128933690|NCT03237845|464045519|FG000|Overall Study|Physician Decision|1|||
128933691|NCT03237845|464045520|FG001|Overall Study|Physician Decision|2|||
128933692|NCT03237845|464045519|FG000|Overall Study|Pregnancy|1|||
128933693|NCT03237845|464045520|FG001|Overall Study|Pregnancy|0|||
128933694|NCT03237845|464045519|FG000|Overall Study|Protocol Deviation|0|||
128933695|NCT03237845|464045520|FG001|Overall Study|Protocol Deviation|1|||
128933696|NCT03237845|464045519|FG000|Overall Study|Technical Problems|8|||
128933697|NCT03237845|464045520|FG001|Overall Study|Technical Problems|1|||
128933698|NCT03237845|464045519|FG000|Overall Study|Withdrawal by Subject|3|||
128933699|NCT03237845|464045520|FG001|Overall Study|Withdrawal by Subject|3|||
128933700|NCT03237845|464045519|FG000|Overall Study|Other Reasons|4|||
128933701|NCT03237845|464045520|FG001|Overall Study|Other Reasons|0|||
128933702|NCT02117050|464045524|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
128933703|NCT03865407|464045525|FG000|Overall Study|Adverse Event|1|||
128933704|NCT03865407|464045526|FG001|Overall Study|Adverse Event|0|||
128933705|NCT03865407|464045525|FG000|Overall Study|Withdrawal by Subject|1|||
128933706|NCT03865407|464045526|FG001|Overall Study|Withdrawal by Subject|0|||
128933707|NCT03865407|464045525|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
128933708|NCT03865407|464045526|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
128933709|NCT00546819|464045533|FG000|Overall Study|Adverse Event|2|||
128933710|NCT00546819|464045534|FG001|Overall Study|Adverse Event|3|||
128933711|NCT00546819|464045533|FG000|Overall Study|Lost to Follow-up|2|||
128933712|NCT00546819|464045534|FG001|Overall Study|Lost to Follow-up|1|||
128933713|NCT00546819|464045533|FG000|Overall Study|Withdrawal by Subject|4|||
128933714|NCT00546819|464045534|FG001|Overall Study|Withdrawal by Subject|2|||
128933715|NCT02052960|464045536|FG000|Overall Study|Adverse Event|19|||
128933716|NCT02052960|464045537|FG001|Overall Study|Adverse Event|17|||
128933717|NCT02052960|464045536|FG000|Overall Study|Protocol Violation|4|||
128933718|NCT02052960|464045537|FG001|Overall Study|Protocol Violation|3|||
128933719|NCT02052960|464045536|FG000|Overall Study|Withdrawal by Subject|6|||
128933720|NCT02052960|464045537|FG001|Overall Study|Withdrawal by Subject|11|||
128933721|NCT02052960|464045536|FG000|Overall Study|Other|25|||
128933722|NCT02052960|464045537|FG001|Overall Study|Other|15|||
128933723|NCT03849560|464045538|FG000|Overall Study|Withdrawal by Subject|1|||
128933724|NCT03849560|464045539|FG001|Overall Study|Withdrawal by Subject|0|||
128933725|NCT03849560|464045540|FG002|Overall Study|Withdrawal by Subject|0|||
128933726|NCT04045613|464045541|FG000|Overall Study|Adverse Event|2|||
128933727|NCT04045613|464045542|FG001|Overall Study|Adverse Event|2|||
128933728|NCT04045613|464045543|FG002|Overall Study|Adverse Event|1|||
128933729|NCT04045613|464045544|FG003|Overall Study|Adverse Event|1|||
128933730|NCT04045613|464045545|FG004|Overall Study|Adverse Event|0|||
129216768|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
128933731|NCT04045613|464045546|FG005|Overall Study|Adverse Event|0|||
128933732|NCT04045613|464045547|FG006|Overall Study|Adverse Event|1|||
128933733|NCT04045613|464045541|FG000|Overall Study|Withdrawal by Subject|0|||
129121801|NCT00761319|464742646|FG000|Overall Study|Withdrawal by Subject|8|||
129121802|NCT00761319|464742647|FG001|Overall Study|Withdrawal by Subject|7|||
129121803|NCT00761319|464742646|FG000|Overall Study|Noncompliance|4|||
128933734|NCT04045613|464045542|FG001|Overall Study|Withdrawal by Subject|5|||
128933735|NCT04045613|464045543|FG002|Overall Study|Withdrawal by Subject|0|||
128933736|NCT04045613|464045544|FG003|Overall Study|Withdrawal by Subject|0|||
128933737|NCT04045613|464045545|FG004|Overall Study|Withdrawal by Subject|0|||
128933738|NCT04045613|464045546|FG005|Overall Study|Withdrawal by Subject|1|||
128933739|NCT04045613|464045547|FG006|Overall Study|Withdrawal by Subject|0|||
128933740|NCT04045613|464045541|FG000|Overall Study|Physician Decision|2|||
128933741|NCT04045613|464045542|FG001|Overall Study|Physician Decision|0|||
128933742|NCT04045613|464045543|FG002|Overall Study|Physician Decision|0|||
128933743|NCT04045613|464045544|FG003|Overall Study|Physician Decision|0|||
128933744|NCT04045613|464045545|FG004|Overall Study|Physician Decision|1|||
128933745|NCT04045613|464045546|FG005|Overall Study|Physician Decision|0|||
128933746|NCT04045613|464045547|FG006|Overall Study|Physician Decision|0|||
128933747|NCT04045613|464045541|FG000|Overall Study|Death|3|||
128933748|NCT04045613|464045542|FG001|Overall Study|Death|0|||
128933749|NCT04045613|464045543|FG002|Overall Study|Death|0|||
128933750|NCT04045613|464045544|FG003|Overall Study|Death|0|||
128933751|NCT04045613|464045545|FG004|Overall Study|Death|0|||
128933752|NCT04045613|464045546|FG005|Overall Study|Death|0|||
128933753|NCT04045613|464045547|FG006|Overall Study|Death|1|||
128933754|NCT04045613|464045541|FG000|Overall Study|Other reasons|0|||
128933755|NCT04045613|464045542|FG001|Overall Study|Other reasons|1|||
128933756|NCT04045613|464045543|FG002|Overall Study|Other reasons|0|||
128933757|NCT04045613|464045544|FG003|Overall Study|Other reasons|0|||
128933758|NCT04045613|464045545|FG004|Overall Study|Other reasons|0|||
128933759|NCT04045613|464045546|FG005|Overall Study|Other reasons|0|||
128933760|NCT04045613|464045547|FG006|Overall Study|Other reasons|1|||
128933761|NCT04045613|464045541|FG000|Overall Study|Progressive disease: Clinical progression|1|||
128933762|NCT04045613|464045542|FG001|Overall Study|Progressive disease: Clinical progression|0|||
128933763|NCT04045613|464045543|FG002|Overall Study|Progressive disease: Clinical progression|3|||
128933764|NCT04045613|464045544|FG003|Overall Study|Progressive disease: Clinical progression|1|||
128933765|NCT04045613|464045545|FG004|Overall Study|Progressive disease: Clinical progression|1|||
128933766|NCT04045613|464045546|FG005|Overall Study|Progressive disease: Clinical progression|3|||
128933767|NCT04045613|464045547|FG006|Overall Study|Progressive disease: Clinical progression|3|||
128933768|NCT04045613|464045541|FG000|Overall Study|Progressive disease: Radiological progression|24|||
128933769|NCT04045613|464045542|FG001|Overall Study|Progressive disease: Radiological progression|6|||
128933770|NCT04045613|464045543|FG002|Overall Study|Progressive disease: Radiological progression|8|||
128933771|NCT04045613|464045544|FG003|Overall Study|Progressive disease: Radiological progression|0|||
128933772|NCT04045613|464045545|FG004|Overall Study|Progressive disease: Radiological progression|6|||
128933773|NCT04045613|464045546|FG005|Overall Study|Progressive disease: Radiological progression|6|||
128933774|NCT04045613|464045547|FG006|Overall Study|Progressive disease: Radiological progression|11|||
128933775|NCT01174784|464045550|FG000|Overall Study|Screen fails|4|||
128933776|NCT01716169|464045553|FG000|Overall Study|Adverse Event|1|||
128933777|NCT01716169|464045553|FG000|Overall Study|Lost to Follow-up|1|||
128933778|NCT01716169|464045553|FG000|Overall Study|Withdrawal by Subject|1|||
128933779|NCT01716169|464045553|FG000|Overall Study|inconsistent dressing application|1|||
128933780|NCT01478347|464045558|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
128933781|NCT01478347|464045558|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
128933782|NCT01478347|464045558|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
128933783|NCT00196937|464045559|FG000|Overall Study|Serious Adverse Event|1|||
128933784|NCT00196937|464045560|FG001|Overall Study|Serious Adverse Event|0|||
128933785|NCT00196937|464045561|FG002|Overall Study|Serious Adverse Event|0|||
128933786|NCT00196937|464045559|FG000|Overall Study|Non-serious adverse event|1|||
128933787|NCT00196937|464045560|FG001|Overall Study|Non-serious adverse event|1|||
128933788|NCT00196937|464045561|FG002|Overall Study|Non-serious adverse event|1|||
128933789|NCT00196937|464045559|FG000|Overall Study|Withdrawal by Subject|0|||
128933790|NCT00196937|464045560|FG001|Overall Study|Withdrawal by Subject|0|||
128933791|NCT00196937|464045561|FG002|Overall Study|Withdrawal by Subject|2|||
129216769|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
129216770|NCT02968004|465094778|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
129216771|NCT02968004|465094779|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
129216772|NCT00885170|465094790|FG000|Overall Study|Adverse Event|12|||
128933792|NCT00196937|464045559|FG000|Overall Study|Lost to Follow-up|4|||
128933793|NCT00196937|464045560|FG001|Overall Study|Lost to Follow-up|3|||
128933794|NCT00196937|464045561|FG002|Overall Study|Lost to Follow-up|3|||
128933795|NCT00196937|464045559|FG000|Overall Study|Other|3|||
128933796|NCT00196937|464045560|FG001|Overall Study|Other|1|||
128933797|NCT00196937|464045561|FG002|Overall Study|Other|1|||
128933798|NCT02973815|464045564|FG000|Post Intervention|Death|1|||
128933799|NCT02973815|464045565|FG001|Post Intervention|Death|0|||
128933800|NCT02973815|464045564|FG000|Post Intervention|Lost to Follow-up|7|||
128933801|NCT02973815|464045565|FG001|Post Intervention|Lost to Follow-up|24|||
128933802|NCT02973815|464045564|FG000|Follow-up|Lost to Follow-up|2|||
128933803|NCT02973815|464045565|FG001|Follow-up|Lost to Follow-up|0|||
128933804|NCT01787591|464045571|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
128933805|NCT01787591|464045572|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
128933806|NCT01787591|464045573|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
128933807|NCT01787591|464045574|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
128933808|NCT02489630|464045575|FG000|Overall Study|Oversedation|1|||
128933809|NCT02489630|464045576|FG001|Overall Study|Oversedation|1|||
128933810|NCT02489630|464045575|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
128933811|NCT02489630|464045576|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
128933812|NCT01326962|464045577|FG000|Overall Study|Adverse Event|1|||
128933813|NCT01326962|464045577|FG000|Overall Study|Withdrawal by Subject|1|||
128933814|NCT01326962|464045577|FG000|Overall Study|Lost to Follow-up|3|||
128933815|NCT01326962|464045577|FG000|Overall Study|Other|2|||
128933816|NCT01056523|464045578|FG000|Overall Study|Death|1|||
128933817|NCT01056523|464045579|FG001|Overall Study|Death|0|||
128933818|NCT01056523|464045580|FG002|Overall Study|Death|2|||
128933819|NCT01056523|464045581|FG003|Overall Study|Death|3|||
128933820|NCT01056523|464045582|FG004|Overall Study|Death|0|||
128933821|NCT01056523|464045583|FG005|Overall Study|Death|0|||
128933822|NCT01056523|464045584|FG006|Overall Study|Death|1|||
128933823|NCT03429556|464045587|FG000|Overall Study|Lost to Follow-up|0|||
128933824|NCT03429556|464045588|FG001|Overall Study|Lost to Follow-up|1|||
128933825|NCT03429556|464045589|FG002|Overall Study|Lost to Follow-up|0|||
128933826|NCT03429556|464045590|FG003|Overall Study|Lost to Follow-up|0|||
128933827|NCT00377299|464045591|FG000|Overall Study|Lost to Follow-up|14|||
128933828|NCT00377299|464045592|FG001|Overall Study|Lost to Follow-up|19|||
128933829|NCT00377299|464045591|FG000|Overall Study|Adverse Event|0|||
129121804|NCT00761319|464742647|FG001|Overall Study|Noncompliance|3|||
129121805|NCT00761319|464742646|FG000|Overall Study|Lost to Follow-up|1|||
129121806|NCT00761319|464742647|FG001|Overall Study|Lost to Follow-up|1|||
129121807|NCT00761319|464742646|FG000|Overall Study|Nonspecified|2|||
129121808|NCT00761319|464742647|FG001|Overall Study|Nonspecified|2|||
129121809|NCT00761319|464742646|FG000|Overall Study|Missing|1|||
128933830|NCT00377299|464045592|FG001|Overall Study|Adverse Event|1|||
128933831|NCT00377299|464045591|FG000|Overall Study|Withdrawal by Subject|5|||
128933832|NCT00377299|464045592|FG001|Overall Study|Withdrawal by Subject|4|||
128933833|NCT01863758|464045597|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
128933834|NCT01863758|464045597|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
128933835|NCT02369510|464045598|FG000|Overall Study|Spilled Medication|1|||
128933836|NCT02369510|464045599|FG001|Overall Study|Spilled Medication|2|||
128933837|NCT02369510|464045600|FG002|Overall Study|Spilled Medication|1|||
128933838|NCT02369510|464045598|FG000|Overall Study|Epidural Activation|1|||
128933839|NCT02369510|464045599|FG001|Overall Study|Epidural Activation|1|||
128933840|NCT02369510|464045600|FG002|Overall Study|Epidural Activation|5|||
128933841|NCT04952389|464045601|FG000|Overall Study|Withdrawal by Subject|8|||
128933842|NCT04952389|464045602|FG001|Overall Study|Withdrawal by Subject|4|||
128933843|NCT02050048|464045603|FG000|Overall Study|Lost to Follow-up|0|||
128933844|NCT02050048|464045604|FG001|Overall Study|Lost to Follow-up|1|||
128933845|NCT02050048|464045603|FG000|Overall Study|Death|1|||
128933846|NCT02050048|464045604|FG001|Overall Study|Death|0|||
128933847|NCT02050048|464045603|FG000|Overall Study|Ineligible after ERCP|4|||
128933848|NCT02050048|464045604|FG001|Overall Study|Ineligible after ERCP|1|||
128933849|NCT04285723|464045608|FG000|Overall Study|Subject decision|1|||
128933850|NCT04285723|464045609|FG001|Overall Study|Subject decision|2|||
128933851|NCT04285723|464045608|FG000|Overall Study|Physician Decision|1|||
128933852|NCT04285723|464045609|FG001|Overall Study|Physician Decision|0|||
128933853|NCT04285723|464045608|FG000|Overall Study|No efficiency|1|||
128933854|NCT04285723|464045609|FG001|Overall Study|No efficiency|0|||
128933855|NCT01507246|464045610|FG000|Overall Study|Required different surgical procedures|2|||
128933856|NCT01507246|464045611|FG001|Overall Study|Required different surgical procedures|1|||
128933857|NCT02903511|464045615|FG000|Overall Study|Withdrawal by Subject|1|||
128933858|NCT02903511|464045616|FG001|Overall Study|Withdrawal by Subject|0|||
128933859|NCT02903511|464045615|FG000|Overall Study|Lost to Follow-up|3|||
128933860|NCT02903511|464045616|FG001|Overall Study|Lost to Follow-up|2|||
128933861|NCT00969618|464045617|FG000|Overall Study|Adverse Event|29|||
128933862|NCT00969618|464045617|FG000|Overall Study|Entry Criteria Not Met|3|||
128933863|NCT00969618|464045617|FG000|Overall Study|Lack of Efficacy|2|||
128933864|NCT00969618|464045617|FG000|Overall Study|Lost to Follow-up|7|||
129121810|NCT00761319|464742647|FG001|Overall Study|Missing|0|||
129121811|NCT03738696|464742648|FG000|Overall Study|Withdrawal by Subject|0|||
128933865|NCT00969618|464045617|FG000|Overall Study|Physician Decision|1|||
128933866|NCT00969618|464045617|FG000|Overall Study|Protocol Violation|9|||
128933867|NCT00969618|464045617|FG000|Overall Study|Withdrawal by Subject|27|||
128933868|NCT05363293|464045622|FG000|Overall Study|Withdrawal by Subject|1|||
128933869|NCT05363293|464045623|FG001|Overall Study|Withdrawal by Subject|0|||
128933870|NCT05363293|464045624|FG002|Overall Study|Withdrawal by Subject|0|||
128933871|NCT05363293|464045625|FG003|Overall Study|Withdrawal by Subject|0|||
128933872|NCT05363293|464045626|FG004|Overall Study|Withdrawal by Subject|0|||
129121812|NCT03738696|464742649|FG001|Overall Study|Withdrawal by Subject|1|||
129121813|NCT03738696|464742648|FG000|Overall Study|Lost to Follow-up|8|||
129121814|NCT03738696|464742649|FG001|Overall Study|Lost to Follow-up|14|||
128933873|NCT05363293|464045627|FG005|Overall Study|Withdrawal by Subject|0|||
128933874|NCT05363293|464045628|FG006|Overall Study|Withdrawal by Subject|0|||
128933875|NCT05363293|464045629|FG007|Overall Study|Withdrawal by Subject|0|||
128933876|NCT05363293|464045630|FG008|Overall Study|Withdrawal by Subject|0|||
128933877|NCT05363293|464045631|FG009|Overall Study|Withdrawal by Subject|0|||
128933878|NCT02400346|464047974|FG000|Overall Study|Adverse Event|24|||
128933879|NCT02400346|464047974|FG000|Overall Study|Lack of Efficacy|9|||
128933880|NCT02400346|464047974|FG000|Overall Study|Non-compliance with IMP|1|||
128933881|NCT02400346|464047974|FG000|Overall Study|Withdrawal by Subject|7|||
128933882|NCT02400346|464047974|FG000|Overall Study|Administrative or other reason(s)|2|||
128933883|NCT02400346|464047974|FG000|Overall Study|Lost to Follow-up|1|||
128933884|NCT00486226|464047975|FG000|Overall Study|Death|3|||
128933885|NCT00486226|464047975|FG000|Overall Study|Adverse Event|1|||
128933886|NCT00486226|464047975|FG000|Overall Study|Withdrawal by Subject|1|||
128933887|NCT00486226|464047975|FG000|Overall Study|Lost to Follow-up|8|||
128933888|NCT01259492|464047976|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
128933889|NCT01259492|464047977|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
128933890|NCT01259492|464047978|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
128933891|NCT01259492|464047979|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
128933892|NCT01259492|464047976|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
128933893|NCT01259492|464047977|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
128933894|NCT01259492|464047978|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
128933895|NCT01259492|464047979|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
128933896|NCT01259492|464047976|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
128933897|NCT01259492|464047977|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
128933898|NCT01259492|464047978|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
128933899|NCT01259492|464047979|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
128933900|NCT01259492|464047976|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
128933901|NCT01259492|464047977|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
128933902|NCT01259492|464047978|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
128933903|NCT01259492|464047979|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
128933904|NCT01259492|464047976|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
128933905|NCT01259492|464047977|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
128933906|NCT01259492|464047978|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
128933907|NCT01259492|464047979|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
128933908|NCT01259492|464047976|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
128933909|NCT01259492|464047977|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
128933910|NCT01259492|464047978|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
128933911|NCT01259492|464047979|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
128933912|NCT01259492|464047976|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
128933913|NCT01259492|464047977|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
128933914|NCT01259492|464047978|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
128933915|NCT01259492|464047979|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
128933916|NCT01259492|464047976|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
128933917|NCT01259492|464047977|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
128933918|NCT01259492|464047978|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
128933919|NCT01259492|464047979|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
128933920|NCT01259492|464047976|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
128933921|NCT01259492|464047977|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
128933922|NCT01259492|464047978|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
128933923|NCT01259492|464047979|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
128933924|NCT01259492|464047976|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
128933925|NCT01259492|464047977|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
128933926|NCT01259492|464047978|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
128933927|NCT01259492|464047979|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
128933928|NCT01259492|464047976|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
128933929|NCT01259492|464047977|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
128933930|NCT01259492|464047978|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
128933931|NCT01259492|464047979|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
128933932|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
128933933|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
128933934|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
128933935|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
128933936|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
128933937|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
128767828|NCT00007475|463440384|FG002|Overall Study|Withdrawal by Subject|0|||
128767829|NCT00007475|463440385|FG003|Overall Study|Withdrawal by Subject|0|||
128933938|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
128933939|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
128933940|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
128933941|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
128978098|NCT01521494|464205314|FG004|Overall Study|Decrease in serum calcium|1|||
129216773|NCT00885170|465094791|FG001|Overall Study|Adverse Event|4|||
129216774|NCT00885170|465094790|FG000|Overall Study|Excessive bone loss|6|||
128767830|NCT00007475|463440382|FG000|Overall Study|Adverse Event|3|||
128767831|NCT00007475|463440383|FG001|Overall Study|Adverse Event|0|||
128767832|NCT00007475|463440384|FG002|Overall Study|Adverse Event|0|||
128767833|NCT00007475|463440385|FG003|Overall Study|Adverse Event|0|||
128767834|NCT01512745|463440387|FG000|Overall Study|Adverse Event|22|||
128767835|NCT01512745|463440388|FG001|Overall Study|Adverse Event|3|||
128767836|NCT01512745|463440387|FG000|Overall Study|Death|9|||
128767837|NCT01512745|463440388|FG001|Overall Study|Death|13|||
128767838|NCT01512745|463440387|FG000|Overall Study|Withdrawal by Subject|2|||
128767839|NCT01512745|463440388|FG001|Overall Study|Withdrawal by Subject|2|||
128767840|NCT01512745|463440387|FG000|Overall Study|Lost to Follow-up|4|||
128767841|NCT01512745|463440388|FG001|Overall Study|Lost to Follow-up|0|||
128767842|NCT01512745|463440387|FG000|Overall Study|Lack of Efficacy|2|||
128767843|NCT01512745|463440388|FG001|Overall Study|Lack of Efficacy|2|||
128767844|NCT01512745|463440387|FG000|Overall Study|Protocol Violation|1|||
128767845|NCT01512745|463440388|FG001|Overall Study|Protocol Violation|0|||
128767846|NCT02357810|463440389|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
128767847|NCT02357810|463440389|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
128767848|NCT02357810|463440389|FG000|Reached 12 Weeks Response|Adverse Event|5|||
128767849|NCT02357810|463440389|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
128767850|NCT02357810|463440389|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
128767851|NCT02357810|463440389|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
128767852|NCT02357810|463440389|FG000|Reached 12 Weeks Response|Death|1|||
128767853|NCT02357810|463440389|FG000|Reached 12 Weeks Response|Physician Decision|1|||
128767854|NCT02357810|463440389|FG000|Reached 12 Weeks Response|Other|1|||
128767855|NCT02357810|463440389|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
129030964|NCT01513239|464404761|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
129030965|NCT01513239|464404762|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
128767856|NCT02357810|463440389|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
128767857|NCT02357810|463440389|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
128767858|NCT02357810|463440389|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
129030966|NCT01513239|464404763|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
129030967|NCT01513239|464404758|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
129030968|NCT01513239|464404759|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
129030969|NCT01513239|464404760|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
129030970|NCT01513239|464404761|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
129030971|NCT01513239|464404762|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
129030972|NCT01513239|464404763|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
129030973|NCT01513239|464404758|FG000|Period 2: 9 Month Extension Phase|Death|0|||
129030974|NCT01513239|464404759|FG001|Period 2: 9 Month Extension Phase|Death|0|||
129030975|NCT01513239|464404760|FG002|Period 2: 9 Month Extension Phase|Death|0|||
129030976|NCT01513239|464404761|FG003|Period 2: 9 Month Extension Phase|Death|2|||
129030977|NCT01513239|464404762|FG004|Period 2: 9 Month Extension Phase|Death|5|||
129030978|NCT01513239|464404763|FG005|Period 2: 9 Month Extension Phase|Death|2|||
129030979|NCT01513239|464404758|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129121815|NCT02566005|464742652|FG000|Overall Study|vaginal bleeding|0|||
129121816|NCT02566005|464742653|FG001|Overall Study|vaginal bleeding|1|||
129121817|NCT02566005|464742652|FG000|Overall Study|received foley|8|||
129121818|NCT02566005|464742653|FG001|Overall Study|received foley|0|||
128767859|NCT02357810|463440389|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
128767860|NCT02357810|463440389|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
128767861|NCT00936221|463440390|FG000|Overall Study|Withdrawal by Subject|1|||
128767862|NCT00936221|463440391|FG001|Overall Study|Withdrawal by Subject|1|||
128767863|NCT03151395|463440392|FG000|Overall Study|Adverse Event|2|||
128767864|NCT03151395|463440392|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
129030980|NCT01513239|464404759|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129121819|NCT02566005|464742652|FG000|Overall Study|did not receive foley|0|||
129121820|NCT02566005|464742653|FG001|Overall Study|did not receive foley|1|||
129121821|NCT02566005|464742652|FG000|Overall Study|labor after randomization|0|||
129121822|NCT02566005|464742653|FG001|Overall Study|labor after randomization|4|||
129121823|NCT03261401|464742654|FG000|Overall Study|Withdrawal by Subject|0|||
129121824|NCT03261401|464742655|FG001|Overall Study|Withdrawal by Subject|0|||
129216775|NCT00885170|465094791|FG001|Overall Study|Excessive bone loss|3|||
129216776|NCT00885170|465094790|FG000|Overall Study|Lost to Follow-up|2|||
129121825|NCT03261401|464742656|FG002|Overall Study|Withdrawal by Subject|0|||
129121826|NCT03261401|464742657|FG003|Overall Study|Withdrawal by Subject|0|||
129121827|NCT03261401|464742658|FG004|Overall Study|Withdrawal by Subject|0|||
128767865|NCT03151395|463440392|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
128767866|NCT03151395|463440392|FG000|Overall Study|Unspecified reason|4|||
128767867|NCT00879996|463440393|FG000|Overall Study|Lost to Follow-up|7|||
128767868|NCT00879996|463440394|FG001|Overall Study|Lost to Follow-up|6|||
128933942|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
128933943|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
128933944|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
128933945|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
128933946|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
128933947|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
128933948|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
128933949|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
128933950|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
128933951|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
128933952|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
128933953|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
128933954|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
128933955|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
128933956|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
128933957|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
128933958|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
128933959|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
128933960|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
128933961|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
128933962|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
128933963|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
128933964|NCT01259492|464047976|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
128933965|NCT01259492|464047977|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
128933966|NCT01259492|464047978|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
128933967|NCT01259492|464047979|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
128933968|NCT00663858|464047982|FG000|Overall Study|Adverse Event|9|||
128933969|NCT00663858|464047983|FG001|Overall Study|Adverse Event|1|||
128933970|NCT00663858|464047984|FG002|Overall Study|Adverse Event|6|||
128933971|NCT00663858|464047982|FG000|Overall Study|Lack of Efficacy|5|||
128933972|NCT00663858|464047983|FG001|Overall Study|Lack of Efficacy|1|||
128933973|NCT00663858|464047984|FG002|Overall Study|Lack of Efficacy|3|||
128933974|NCT00663858|464047982|FG000|Overall Study|Withdrawal by Subject|7|||
128933975|NCT00663858|464047983|FG001|Overall Study|Withdrawal by Subject|3|||
128933976|NCT00663858|464047984|FG002|Overall Study|Withdrawal by Subject|3|||
128933977|NCT00663858|464047982|FG000|Overall Study|Protocol Violation|5|||
128933978|NCT00663858|464047983|FG001|Overall Study|Protocol Violation|3|||
128933979|NCT00663858|464047984|FG002|Overall Study|Protocol Violation|4|||
128933980|NCT00663858|464047982|FG000|Overall Study|Other|8|||
128933981|NCT00663858|464047983|FG001|Overall Study|Other|2|||
128933982|NCT00663858|464047984|FG002|Overall Study|Other|4|||
128933983|NCT01166659|464047991|FG000|Overall Study|Subject Decision|8|||
128933984|NCT01166659|464047991|FG000|Overall Study|Investigator Decision|2|||
128933985|NCT01166659|464047991|FG000|Overall Study|Death|1|||
128933986|NCT01166659|464047991|FG000|Overall Study|Lost to Follow-up|1|||
128703348|NCT01737697|463211473|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703349|NCT01737697|463211474|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
128703350|NCT01737697|463211460|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703351|NCT01737697|463211461|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703352|NCT01737697|463211462|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703353|NCT01737697|463211463|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
128933987|NCT01166659|464047991|FG000|Overall Study|Study Closed at Site|1|||
128933988|NCT01371838|464048005|FG000|Overall Study|Withdrawal by Subject|27|||
129030981|NCT01513239|464404760|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129030982|NCT01513239|464404761|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
129030983|NCT01513239|464404762|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
129030984|NCT01513239|464404763|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129030985|NCT01513239|464404758|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129030986|NCT01513239|464404759|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129030987|NCT01513239|464404760|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129216777|NCT00885170|465094791|FG001|Overall Study|Lost to Follow-up|1|||
128703354|NCT01737697|463211464|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703355|NCT01737697|463211465|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703356|NCT01737697|463211466|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703357|NCT01737697|463211467|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
128933989|NCT01371838|464048006|FG001|Overall Study|Withdrawal by Subject|33|||
128933990|NCT01371838|464048005|FG000|Overall Study|Lost to Follow-up|10|||
128933991|NCT01371838|464048006|FG001|Overall Study|Lost to Follow-up|20|||
128933992|NCT01371838|464048005|FG000|Overall Study|Death|3|||
128933993|NCT01371838|464048006|FG001|Overall Study|Death|4|||
128703358|NCT01737697|463211468|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703359|NCT01737697|463211469|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
128933994|NCT01371838|464048005|FG000|Overall Study|Protocol Violation|3|||
128933995|NCT01371838|464048006|FG001|Overall Study|Protocol Violation|0|||
128933996|NCT01371838|464048005|FG000|Overall Study|Investigator Decision|3|||
128933997|NCT01371838|464048006|FG001|Overall Study|Investigator Decision|8|||
128933998|NCT01371838|464048005|FG000|Overall Study|Last follow-up visit not conducted|2|||
128933999|NCT01371838|464048006|FG001|Overall Study|Last follow-up visit not conducted|0|||
128934000|NCT01371838|464048005|FG000|Overall Study|Lack of therapeutic response|0|||
128934001|NCT01371838|464048006|FG001|Overall Study|Lack of therapeutic response|1|||
128934002|NCT01371838|464048005|FG000|Overall Study|Surgery|1|||
128934003|NCT01371838|464048006|FG001|Overall Study|Surgery|0|||
128934004|NCT01334125|464048007|FG000|Overall Study|Lost to Follow-up|3|||
128934005|NCT01334125|464048008|FG001|Overall Study|Lost to Follow-up|3|||
128703360|NCT01737697|463211470|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703361|NCT01737697|463211471|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703362|NCT01737697|463211472|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703363|NCT01737697|463211473|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703364|NCT01737697|463211474|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
128703365|NCT01737697|463211460|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703366|NCT01737697|463211461|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
128703367|NCT01737697|463211462|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703368|NCT01737697|463211463|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703369|NCT01737697|463211464|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703370|NCT01737697|463211465|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703371|NCT01737697|463211466|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703372|NCT01737697|463211467|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703373|NCT01737697|463211468|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128767869|NCT00879996|463440393|FG000|Overall Study|non-compliance|6|||
128767870|NCT00879996|463440394|FG001|Overall Study|non-compliance|4|||
128767871|NCT00879996|463440393|FG000|Overall Study|Physician Decision|1|||
128767872|NCT00879996|463440394|FG001|Overall Study|Physician Decision|2|||
128767873|NCT00879996|463440393|FG000|Overall Study|psychiatric problem|0|||
128767874|NCT00879996|463440394|FG001|Overall Study|psychiatric problem|1|||
128767875|NCT00879996|463440393|FG000|Overall Study|put on parole|1|||
128767876|NCT00879996|463440394|FG001|Overall Study|put on parole|0|||
128767877|NCT02597933|463440396|FG000|Overall Study|Withdrawal by Subject|7|||
128934006|NCT00641043|464048013|FG000|Overall Study|Adverse Event|6|||
128703374|NCT01737697|463211469|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703375|NCT01737697|463211470|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703376|NCT01737697|463211471|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703377|NCT01737697|463211472|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703378|NCT01737697|463211473|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703379|NCT01737697|463211474|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
128703380|NCT01737697|463211460|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703381|NCT01737697|463211461|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703382|NCT01737697|463211462|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703383|NCT01737697|463211463|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703384|NCT01737697|463211464|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
128703385|NCT01737697|463211465|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703386|NCT01737697|463211466|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703387|NCT01737697|463211467|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703388|NCT01737697|463211468|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703389|NCT01737697|463211469|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703390|NCT01737697|463211470|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703391|NCT01737697|463211471|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703392|NCT01737697|463211472|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703393|NCT01737697|463211473|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703394|NCT01737697|463211474|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
128703395|NCT01737697|463211460|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703396|NCT01737697|463211461|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
128767878|NCT02597933|463440397|FG001|Overall Study|Withdrawal by Subject|5|||
128934007|NCT00641043|464048014|FG001|Overall Study|Adverse Event|4|||
128934008|NCT00641043|464048013|FG000|Overall Study|Protocol Violation|2|||
128934009|NCT00641043|464048014|FG001|Overall Study|Protocol Violation|3|||
128934010|NCT00641043|464048013|FG000|Overall Study|Lost to Follow-up|3|||
128934011|NCT00641043|464048014|FG001|Overall Study|Lost to Follow-up|2|||
128934012|NCT00641043|464048013|FG000|Overall Study|Withdrawal by Subject|4|||
128767879|NCT02597933|463440396|FG000|Overall Study|Protocol Violation|2|||
128767880|NCT02597933|463440397|FG001|Overall Study|Protocol Violation|2|||
128767881|NCT02597933|463440396|FG000|Overall Study|Adverse Event|20|||
128767882|NCT02597933|463440397|FG001|Overall Study|Adverse Event|28|||
128934013|NCT00641043|464048014|FG001|Overall Study|Withdrawal by Subject|4|||
128934014|NCT00641043|464048013|FG000|Overall Study|Other incl. lack of efficacy|4|||
128767883|NCT02597933|463440396|FG000|Overall Study|Not treated|2|||
128767884|NCT02597933|463440397|FG001|Overall Study|Not treated|2|||
128934015|NCT00641043|464048014|FG001|Overall Study|Other incl. lack of efficacy|2|||
128934016|NCT04275310|464048015|FG000|Overall Study|Non-randomized due to running out of funding|4|||
128934017|NCT04275310|464048016|FG001|Overall Study|Non-randomized due to running out of funding|0|||
128934018|NCT00098345|464048018|FG000|Overall Study|Adverse Event|7|||
128934019|NCT00098345|464048018|FG000|Overall Study|Withdrawal by Subject|2|||
128934020|NCT00098345|464048018|FG000|Overall Study|progression|4|||
128934021|NCT00201201|464048021|FG000|Overall Study|Death|0|||
128934022|NCT00201201|464048022|FG001|Overall Study|Death|2|||
128934023|NCT00201201|464048021|FG000|Overall Study|Withdrawal by Subject|5|||
128934024|NCT00201201|464048022|FG001|Overall Study|Withdrawal by Subject|5|||
128934025|NCT01342640|464048024|FG000|Overall Study|Adverse Event|3|||
128934026|NCT01342640|464048024|FG000|Overall Study|Protocol Violation|16|||
128934027|NCT01342640|464048024|FG000|Overall Study|Lost to Follow-up|21|||
128934028|NCT01342640|464048024|FG000|Overall Study|Other|1|||
128934029|NCT04101422|464048028|FG000|Overall Study|Ineligible|1|||
128934030|NCT04101422|464048029|FG001|Overall Study|Ineligible|0|||
128934031|NCT04101422|464048030|FG002|Overall Study|Ineligible|9|||
128934032|NCT04101422|464048031|FG003|Overall Study|Ineligible|0|||
128934033|NCT04101422|464048028|FG000|Overall Study|Withdrawal by Subject|0|||
128934034|NCT04101422|464048029|FG001|Overall Study|Withdrawal by Subject|0|||
128934035|NCT04101422|464048030|FG002|Overall Study|Withdrawal by Subject|1|||
128934036|NCT04101422|464048031|FG003|Overall Study|Withdrawal by Subject|0|||
128934037|NCT04101422|464048028|FG000|Overall Study|Not attending to the stimuli|0|||
128934038|NCT04101422|464048029|FG001|Overall Study|Not attending to the stimuli|0|||
128934039|NCT04101422|464048030|FG002|Overall Study|Not attending to the stimuli|4|||
128934040|NCT04101422|464048031|FG003|Overall Study|Not attending to the stimuli|0|||
128934041|NCT04101422|464048028|FG000|Overall Study|Did not download app|0|||
128934042|NCT04101422|464048029|FG001|Overall Study|Did not download app|0|||
128934043|NCT04101422|464048030|FG002|Overall Study|Did not download app|0|||
128934044|NCT04101422|464048031|FG003|Overall Study|Did not download app|17|||
128934045|NCT04101422|464048028|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
128934046|NCT04101422|464048029|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
128934047|NCT04101422|464048030|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
128934048|NCT04101422|464048031|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
128934049|NCT02640612|464048032|FG000|Overall Study|Adverse Event|6|||
128934050|NCT02640612|464048033|FG001|Overall Study|Adverse Event|7|||
128934051|NCT02640612|464048034|FG002|Overall Study|Adverse Event|2|||
128934052|NCT02640612|464048032|FG000|Overall Study|Death|1|||
128934053|NCT02640612|464048033|FG001|Overall Study|Death|0|||
128934054|NCT02640612|464048034|FG002|Overall Study|Death|0|||
128934055|NCT02640612|464048032|FG000|Overall Study|Withdrawal by Subject|10|||
128767885|NCT02597933|463440396|FG000|Overall Study|Other than stated above|7|||
128767886|NCT02597933|463440397|FG001|Overall Study|Other than stated above|14|||
128767887|NCT01617005|463440400|FG000|Overall Study|Pregnancy|1|||
128767888|NCT01617005|463440400|FG000|Overall Study|Lack of motivation for treatment|1|||
128934056|NCT02640612|464048033|FG001|Overall Study|Withdrawal by Subject|3|||
128934057|NCT02640612|464048034|FG002|Overall Study|Withdrawal by Subject|3|||
128934058|NCT02640612|464048032|FG000|Overall Study|Lost to Follow-up|4|||
128934059|NCT02640612|464048033|FG001|Overall Study|Lost to Follow-up|1|||
128934060|NCT02640612|464048034|FG002|Overall Study|Lost to Follow-up|1|||
128934061|NCT02640612|464048032|FG000|Overall Study|Protocol Violation|0|||
128934062|NCT02640612|464048033|FG001|Overall Study|Protocol Violation|2|||
128934063|NCT02640612|464048034|FG002|Overall Study|Protocol Violation|0|||
128934064|NCT02640612|464048032|FG000|Overall Study|Lack of Efficacy|1|||
128934065|NCT02640612|464048033|FG001|Overall Study|Lack of Efficacy|1|||
128934066|NCT02640612|464048034|FG002|Overall Study|Lack of Efficacy|0|||
128934067|NCT01720667|464048035|FG000|Overall Study|Adverse Event|1|||
128934068|NCT01720667|464048036|FG001|Overall Study|Adverse Event|1|||
128934069|NCT01720667|464048035|FG000|Overall Study|Withdrawal by Subject|3|||
128934070|NCT01720667|464048036|FG001|Overall Study|Withdrawal by Subject|0|||
128767889|NCT00525265|463440406|FG000|Overall Study|Protocol Violation|1|||
128934071|NCT03472534|464048037|FG000|Overall Study|Withdrawal by Subject|9|||
128934072|NCT03472534|464048037|FG000|Overall Study|Adverse Event|2|||
128934073|NCT01319929|464048043|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
128934074|NCT01319929|464048044|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
128934075|NCT01319929|464048043|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
128934076|NCT01319929|464048044|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
128934077|NCT01319929|464048043|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
128934078|NCT01319929|464048044|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
128934079|NCT01319929|464048043|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
128934080|NCT01319929|464048044|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
128934081|NCT01319929|464048043|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
128934082|NCT01319929|464048044|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
128767890|NCT00525265|463440407|FG001|Overall Study|Protocol Violation|0|||
129121828|NCT03261401|464742659|FG005|Overall Study|Withdrawal by Subject|1|||
129121829|NCT03261401|464742660|FG006|Overall Study|Withdrawal by Subject|0|||
129121830|NCT03261401|464742661|FG007|Overall Study|Withdrawal by Subject|0|||
129121831|NCT03261401|464742662|FG008|Overall Study|Withdrawal by Subject|0|||
129121832|NCT03261401|464742663|FG009|Overall Study|Withdrawal by Subject|0|||
129121833|NCT03261401|464742664|FG010|Overall Study|Withdrawal by Subject|0|||
129121834|NCT03261401|464742665|FG011|Overall Study|Withdrawal by Subject|0|||
129121835|NCT03261401|464742666|FG012|Overall Study|Withdrawal by Subject|0|||
129121836|NCT03261401|464742654|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
129121837|NCT03261401|464742655|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
129121838|NCT03261401|464742656|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
129121839|NCT03261401|464742657|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
129121840|NCT03261401|464742658|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
129121841|NCT03261401|464742659|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
129121842|NCT03261401|464742660|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
129121843|NCT03261401|464742661|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
129121844|NCT03261401|464742662|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
129121845|NCT03261401|464742663|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
129121846|NCT03261401|464742664|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
129121847|NCT03261401|464742665|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
129121848|NCT03261401|464742666|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
129121849|NCT01715298|464742667|FG000|Overall Study|Lost to Follow-up|0|||
129121850|NCT01715298|464742668|FG001|Overall Study|Lost to Follow-up|2|||
129121851|NCT01715298|464742667|FG000|Overall Study|Patient/guardian decision|7|||
129121852|NCT01715298|464742668|FG001|Overall Study|Patient/guardian decision|9|||
129121853|NCT01499511|464742673|FG000|Overall Study|Death|1|||
129121854|NCT01499511|464742674|FG001|Overall Study|Death|0|||
129121855|NCT00726453|464742676|FG000|Primary Enrollment Group|Death|18|||
129121856|NCT00726453|464742677|FG001|Primary Enrollment Group|Death|0|||
129121857|NCT00726453|464742676|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
129121858|NCT00726453|464742677|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
128703397|NCT01737697|463211462|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
128703398|NCT01737697|463211463|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
128703399|NCT01737697|463211464|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
128703400|NCT01737697|463211465|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703401|NCT01737697|463211466|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703402|NCT01737697|463211467|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703403|NCT01737697|463211468|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703404|NCT01737697|463211469|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703405|NCT01737697|463211470|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703406|NCT01737697|463211471|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703407|NCT01737697|463211472|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703408|NCT01737697|463211473|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703409|NCT01737697|463211474|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
128703410|NCT01737697|463211460|FG000|Subacute Phase|Adverse Event|0|||
128703411|NCT01737697|463211461|FG001|Subacute Phase|Adverse Event|0|||
128703412|NCT01737697|463211462|FG002|Subacute Phase|Adverse Event|0|||
128703413|NCT01737697|463211463|FG003|Subacute Phase|Adverse Event|0|||
128703414|NCT01737697|463211464|FG004|Subacute Phase|Adverse Event|0|||
128703415|NCT01737697|463211465|FG005|Subacute Phase|Adverse Event|1|||
128703416|NCT01737697|463211466|FG006|Subacute Phase|Adverse Event|1|||
128703417|NCT01737697|463211467|FG007|Subacute Phase|Adverse Event|1|||
128703418|NCT01737697|463211468|FG008|Subacute Phase|Adverse Event|1|||
128703419|NCT01737697|463211469|FG009|Subacute Phase|Adverse Event|1|||
128703420|NCT01737697|463211470|FG010|Subacute Phase|Adverse Event|4|||
128703421|NCT01737697|463211471|FG011|Subacute Phase|Adverse Event|1|||
128703422|NCT01737697|463211472|FG012|Subacute Phase|Adverse Event|1|||
128703423|NCT01737697|463211473|FG013|Subacute Phase|Adverse Event|0|||
128703424|NCT01737697|463211474|FG014|Subacute Phase|Adverse Event|0|||
128703425|NCT01737697|463211460|FG000|Subacute Phase|Withdrawal by Subject|0|||
128703426|NCT01737697|463211461|FG001|Subacute Phase|Withdrawal by Subject|0|||
128703427|NCT01737697|463211462|FG002|Subacute Phase|Withdrawal by Subject|0|||
128703428|NCT01737697|463211463|FG003|Subacute Phase|Withdrawal by Subject|0|||
128703429|NCT01737697|463211464|FG004|Subacute Phase|Withdrawal by Subject|0|||
128703430|NCT01737697|463211465|FG005|Subacute Phase|Withdrawal by Subject|1|||
128703431|NCT01737697|463211466|FG006|Subacute Phase|Withdrawal by Subject|0|||
128703432|NCT01737697|463211467|FG007|Subacute Phase|Withdrawal by Subject|2|||
128703433|NCT01737697|463211468|FG008|Subacute Phase|Withdrawal by Subject|0|||
128703434|NCT01737697|463211469|FG009|Subacute Phase|Withdrawal by Subject|1|||
128703435|NCT01737697|463211470|FG010|Subacute Phase|Withdrawal by Subject|0|||
128703436|NCT01737697|463211471|FG011|Subacute Phase|Withdrawal by Subject|1|||
128978099|NCT01521494|464205310|FG000|Overall Study|Physician Decision|0|||
129121859|NCT00726453|464742676|FG000|38 mm Length Group|Death|0|||
129216778|NCT00885170|465094790|FG000|Overall Study|Physician Decision|2|||
129216779|NCT00885170|465094791|FG001|Overall Study|Physician Decision|1|||
129216780|NCT00885170|465094790|FG000|Overall Study|Protocol Violation|3|||
129216781|NCT00885170|465094791|FG001|Overall Study|Protocol Violation|1|||
129216782|NCT00885170|465094790|FG000|Overall Study|Withdrawal by Subject|13|||
129216783|NCT00885170|465094791|FG001|Overall Study|Withdrawal by Subject|13|||
129216784|NCT03771664|465094792|FG000|Overall Study|Adverse Event|1|||
129216785|NCT03771664|465094793|FG001|Overall Study|Adverse Event|0|||
129216786|NCT03771664|465094792|FG000|Overall Study|Lost to Follow-up|1|||
129216787|NCT03771664|465094793|FG001|Overall Study|Lost to Follow-up|0|||
129216788|NCT03771664|465094792|FG000|Overall Study|Withdrawal by Participant|1|||
129216789|NCT03771664|465094793|FG001|Overall Study|Withdrawal by Participant|4|||
129216790|NCT03771664|465094792|FG000|Overall Study|Randomized but not Treated|0|||
129216791|NCT03771664|465094793|FG001|Overall Study|Randomized but not Treated|1|||
129216792|NCT00561925|465094794|FG000|14 Day Lead-In Period|Adverse Event|38|||
129216793|NCT00561925|465094795|FG001|14 Day Lead-In Period|Adverse Event|0|||
129216794|NCT00561925|465094796|FG002|14 Day Lead-In Period|Adverse Event|0|||
129216795|NCT00561925|465094797|FG003|14 Day Lead-In Period|Adverse Event|0|||
129216796|NCT00561925|465094798|FG004|14 Day Lead-In Period|Adverse Event|0|||
129216797|NCT00561925|465094794|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
129216798|NCT00561925|465094795|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
129216799|NCT00561925|465094796|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
129216800|NCT00561925|465094797|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
129216801|NCT00561925|465094798|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
129216802|NCT00561925|465094794|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
129216803|NCT00561925|465094795|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
129216804|NCT00561925|465094796|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
129216805|NCT00561925|465094797|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
129216806|NCT00561925|465094798|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
129216807|NCT00561925|465094794|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
129216808|NCT00561925|465094795|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
129216809|NCT00561925|465094796|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
129216810|NCT00561925|465094797|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
129216811|NCT00561925|465094798|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
129216812|NCT00561925|465094794|FG000|14 Day Lead-In Period|Other|5|||
129216813|NCT00561925|465094795|FG001|14 Day Lead-In Period|Other|0|||
129216814|NCT00561925|465094796|FG002|14 Day Lead-In Period|Other|0|||
128767891|NCT03107377|463440408|FG000|Overall Study|Adverse Event|3|||
128767892|NCT03107377|463440409|FG001|Overall Study|Adverse Event|3|||
128767893|NCT03107377|463440408|FG000|Overall Study|Protocol Violation|9|||
128767894|NCT03107377|463440409|FG001|Overall Study|Protocol Violation|12|||
128767895|NCT03107377|463440408|FG000|Overall Study|Physician Decision|3|||
128767896|NCT03107377|463440409|FG001|Overall Study|Physician Decision|6|||
128767897|NCT03107377|463440408|FG000|Overall Study|Pregnancy|7|||
128767898|NCT03107377|463440409|FG001|Overall Study|Pregnancy|7|||
128767899|NCT03107377|463440408|FG000|Overall Study|Withdrawal by Subject|16|||
128934083|NCT00718861|464048045|FG000|Overall Study|Withdrawal by Subject|15|||
128934084|NCT00718861|464048046|FG001|Overall Study|Withdrawal by Subject|10|||
128934085|NCT00718861|464048045|FG000|Overall Study|Adverse Event|2|||
128934086|NCT00718861|464048046|FG001|Overall Study|Adverse Event|1|||
128934087|NCT00718861|464048045|FG000|Overall Study|Lost to Follow-up|2|||
128934088|NCT00718861|464048046|FG001|Overall Study|Lost to Follow-up|1|||
128934089|NCT00718861|464048045|FG000|Overall Study|Administrative Problems|1|||
128934090|NCT00718861|464048046|FG001|Overall Study|Administrative Problems|1|||
128934091|NCT00718861|464048045|FG000|Overall Study|Death|1|||
128934092|NCT00718861|464048046|FG001|Overall Study|Death|5|||
128934093|NCT01749735|464048048|FG000|Overall Study|Withdrawal by Subject|1|||
128934094|NCT01749735|464048049|FG001|Overall Study|Withdrawal by Subject|0|||
128934095|NCT01221233|464048050|FG000|Overall Study|Withdrawal by Subject|3|||
128934096|NCT01221233|464048051|FG001|Overall Study|Withdrawal by Subject|1|||
128934097|NCT00611455|464048054|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
128934098|NCT00611455|464048055|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
128934099|NCT00611455|464048056|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
128934100|NCT00611455|464048054|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
129216815|NCT00561925|465094797|FG003|14 Day Lead-In Period|Other|0|||
128934101|NCT00611455|464048055|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129216816|NCT00561925|465094798|FG004|14 Day Lead-In Period|Other|0|||
129216817|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
128934102|NCT00611455|464048056|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129216818|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
128934103|NCT00611455|464048054|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
129216819|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
128767900|NCT03107377|463440409|FG001|Overall Study|Withdrawal by Subject|22|||
128767901|NCT03107377|463440408|FG000|Overall Study|Lost to Follow-up|37|||
128934104|NCT00611455|464048055|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
128934105|NCT00611455|464048056|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
128703437|NCT01737697|463211472|FG012|Subacute Phase|Withdrawal by Subject|1|||
128934106|NCT00611455|464048054|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
128934107|NCT00611455|464048055|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
128934108|NCT00611455|464048056|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128934109|NCT00611455|464048054|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
128934110|NCT00611455|464048055|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
128934111|NCT00611455|464048056|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
128934112|NCT00611455|464048054|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
128934113|NCT00611455|464048055|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
128934114|NCT00611455|464048056|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
128934115|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
128934116|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
128934117|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
128934118|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
128934119|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
128934120|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
128934121|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
128934122|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
128934123|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
128934124|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
128934125|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
128934126|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
128934127|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
128934128|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
128934129|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
128934130|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
128934131|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
128934132|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
128934133|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
128934134|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
128934135|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
128934136|NCT00611455|464048054|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
128934137|NCT00611455|464048055|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
128934138|NCT00611455|464048056|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
128934139|NCT00611455|464048054|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
128934140|NCT00611455|464048055|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
128934141|NCT00611455|464048056|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
128934142|NCT00611455|464048054|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
128934143|NCT00611455|464048055|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
128934144|NCT00611455|464048056|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
128934145|NCT00611455|464048054|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
128934146|NCT00611455|464048055|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
128934147|NCT00611455|464048056|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
128934148|NCT00611455|464048054|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
128934149|NCT00611455|464048055|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
128934150|NCT00611455|464048056|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
128934151|NCT00611455|464048054|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
128934152|NCT00611455|464048055|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
128934153|NCT00611455|464048056|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
128934154|NCT00611455|464048054|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
128934155|NCT00611455|464048055|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
128934156|NCT00611455|464048056|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
128934157|NCT00611455|464048054|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
128934158|NCT00611455|464048055|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
128934159|NCT00611455|464048056|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
128934160|NCT04983901|464048057|FG000|Overall Study|Death|1|||
128934161|NCT04983901|464048058|FG001|Overall Study|Death|4|||
128934162|NCT04983901|464048057|FG000|Overall Study|Lost to Follow-up|3|||
128934163|NCT04983901|464048058|FG001|Overall Study|Lost to Follow-up|0|||
128934164|NCT04983901|464048057|FG000|Overall Study|Protocol Violation|1|||
128703438|NCT01737697|463211473|FG013|Subacute Phase|Withdrawal by Subject|1|||
128703439|NCT01737697|463211474|FG014|Subacute Phase|Withdrawal by Subject|0|||
128703440|NCT01737697|463211460|FG000|Subacute Phase|Lost to Follow-up|0|||
128703441|NCT01737697|463211461|FG001|Subacute Phase|Lost to Follow-up|0|||
128934165|NCT04983901|464048058|FG001|Overall Study|Protocol Violation|0|||
128703442|NCT01737697|463211462|FG002|Subacute Phase|Lost to Follow-up|0|||
128767902|NCT03107377|463440409|FG001|Overall Study|Lost to Follow-up|34|||
128767903|NCT03107377|463440408|FG000|Overall Study|Other reason not specified|16|||
128767904|NCT03107377|463440409|FG001|Overall Study|Other reason not specified|15|||
128767905|NCT00211237|463440410|FG000|Baseline|Withdrew|1|||
128767906|NCT00211237|463440411|FG001|Baseline|Withdrew|3|||
128767907|NCT00211237|463440412|FG002|Baseline|Withdrew|0|||
128767908|NCT00211237|463440410|FG000|Baseline|Refused random assignment|1|||
129216820|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
129216821|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
129216822|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
129216823|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
129216824|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
129216825|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
129216826|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
129216827|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
128703443|NCT01737697|463211463|FG003|Subacute Phase|Lost to Follow-up|0|||
128703444|NCT01737697|463211464|FG004|Subacute Phase|Lost to Follow-up|0|||
128703445|NCT01737697|463211465|FG005|Subacute Phase|Lost to Follow-up|0|||
128703446|NCT01737697|463211466|FG006|Subacute Phase|Lost to Follow-up|0|||
128703447|NCT01737697|463211467|FG007|Subacute Phase|Lost to Follow-up|0|||
128703448|NCT01737697|463211468|FG008|Subacute Phase|Lost to Follow-up|0|||
128703449|NCT01737697|463211469|FG009|Subacute Phase|Lost to Follow-up|0|||
128703450|NCT01737697|463211470|FG010|Subacute Phase|Lost to Follow-up|0|||
128703451|NCT01737697|463211471|FG011|Subacute Phase|Lost to Follow-up|0|||
128703452|NCT01737697|463211472|FG012|Subacute Phase|Lost to Follow-up|0|||
128703453|NCT01737697|463211473|FG013|Subacute Phase|Lost to Follow-up|0|||
128703454|NCT01737697|463211474|FG014|Subacute Phase|Lost to Follow-up|1|||
128703455|NCT01737697|463211460|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
128703456|NCT01737697|463211461|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
128703457|NCT01737697|463211462|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
128703458|NCT01737697|463211463|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
128703459|NCT01737697|463211464|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
128703460|NCT01737697|463211465|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
128703461|NCT01737697|463211466|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
128703462|NCT01737697|463211467|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
128703463|NCT01737697|463211468|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
128703464|NCT01737697|463211469|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
128703465|NCT01737697|463211470|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
128703466|NCT01737697|463211471|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
128703467|NCT01737697|463211472|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
128703468|NCT01737697|463211473|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
128703469|NCT01737697|463211474|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
128703470|NCT01737697|463211460|FG000|Subacute Phase|Protocol Violation|0|||
128703471|NCT01737697|463211461|FG001|Subacute Phase|Protocol Violation|0|||
128703472|NCT01737697|463211462|FG002|Subacute Phase|Protocol Violation|0|||
128703473|NCT01737697|463211463|FG003|Subacute Phase|Protocol Violation|0|||
128703474|NCT01737697|463211464|FG004|Subacute Phase|Protocol Violation|0|||
128703475|NCT01737697|463211465|FG005|Subacute Phase|Protocol Violation|1|||
128703476|NCT01737697|463211466|FG006|Subacute Phase|Protocol Violation|0|||
128703477|NCT01737697|463211467|FG007|Subacute Phase|Protocol Violation|0|||
128703478|NCT01737697|463211468|FG008|Subacute Phase|Protocol Violation|0|||
128934166|NCT04983901|464048057|FG000|Overall Study|Withdrawal by Subject|1|||
128934167|NCT04983901|464048058|FG001|Overall Study|Withdrawal by Subject|2|||
128934168|NCT00491530|464048059|FG000|Overall Study|Adverse Event|6|||
128934169|NCT00491530|464048060|FG001|Overall Study|Adverse Event|1|||
128934170|NCT00491530|464048061|FG002|Overall Study|Adverse Event|2|||
128934171|NCT00491530|464048059|FG000|Overall Study|Withdrawal by Subject|3|||
128934172|NCT00491530|464048060|FG001|Overall Study|Withdrawal by Subject|0|||
128934173|NCT00491530|464048061|FG002|Overall Study|Withdrawal by Subject|0|||
128934174|NCT00491530|464048059|FG000|Overall Study|Lost to Follow-up|3|||
128934175|NCT00491530|464048060|FG001|Overall Study|Lost to Follow-up|2|||
128934176|NCT00491530|464048061|FG002|Overall Study|Lost to Follow-up|2|||
128934177|NCT00491530|464048059|FG000|Overall Study|Lack of Efficacy|0|||
128934178|NCT00491530|464048060|FG001|Overall Study|Lack of Efficacy|1|||
128934179|NCT00491530|464048061|FG002|Overall Study|Lack of Efficacy|0|||
128703479|NCT01737697|463211469|FG009|Subacute Phase|Protocol Violation|0|||
128703480|NCT01737697|463211470|FG010|Subacute Phase|Protocol Violation|1|||
128703481|NCT01737697|463211471|FG011|Subacute Phase|Protocol Violation|0|||
128703482|NCT01737697|463211472|FG012|Subacute Phase|Protocol Violation|0|||
128703483|NCT01737697|463211473|FG013|Subacute Phase|Protocol Violation|0|||
128703484|NCT01737697|463211474|FG014|Subacute Phase|Protocol Violation|0|||
128767909|NCT00211237|463440411|FG001|Baseline|Refused random assignment|0|||
128934180|NCT00491530|464048059|FG000|Overall Study|Investigator Discretion|0|||
128934181|NCT00491530|464048060|FG001|Overall Study|Investigator Discretion|1|||
128934182|NCT00491530|464048061|FG002|Overall Study|Investigator Discretion|0|||
128703485|NCT01737697|463211460|FG000|Subacute Phase|Physician Decision|0|||
128703486|NCT01737697|463211461|FG001|Subacute Phase|Physician Decision|0|||
128703487|NCT01737697|463211462|FG002|Subacute Phase|Physician Decision|0|||
128703488|NCT01737697|463211463|FG003|Subacute Phase|Physician Decision|0|||
128703489|NCT01737697|463211464|FG004|Subacute Phase|Physician Decision|0|||
128703490|NCT01737697|463211465|FG005|Subacute Phase|Physician Decision|0|||
128703491|NCT01737697|463211466|FG006|Subacute Phase|Physician Decision|0|||
128703492|NCT01737697|463211467|FG007|Subacute Phase|Physician Decision|0|||
128934183|NCT00491530|464048059|FG000|Overall Study|Patient Request|0|||
128934184|NCT00491530|464048060|FG001|Overall Study|Patient Request|1|||
128934185|NCT00491530|464048061|FG002|Overall Study|Patient Request|0|||
128934186|NCT00491530|464048059|FG000|Overall Study|Use of Prohibited Medication|0|||
128934187|NCT00491530|464048060|FG001|Overall Study|Use of Prohibited Medication|0|||
128934188|NCT00491530|464048061|FG002|Overall Study|Use of Prohibited Medication|1|||
128934189|NCT02859415|464048062|FG000|Overall Study|Physician Decision|1|||
128934190|NCT02859415|464048063|FG001|Overall Study|Physician Decision|0|||
128934191|NCT02859415|464048062|FG000|Overall Study|Off treatment due to cardiac event|0|||
128934192|NCT02859415|464048063|FG001|Overall Study|Off treatment due to cardiac event|1|||
128934193|NCT03671369|464048068|FG000|Overall Study|Other|1|||
128934194|NCT03671369|464048068|FG000|Overall Study|Withdrawal by Subject|289|||
128934195|NCT03671369|464048068|FG000|Overall Study|Not willing to be vaccinated|1|||
128934196|NCT02732912|464048069|FG000|Overall Study|Discharged before night|2|||
128934197|NCT02732912|464048070|FG001|Overall Study|Discharged before night|6|||
128934198|NCT02732912|464048069|FG000|Overall Study|Incomplete completion of questionnaire|2|||
128934199|NCT02732912|464048070|FG001|Overall Study|Incomplete completion of questionnaire|3|||
128934200|NCT02732912|464048069|FG000|Overall Study|No outcome; discharged or refused|6|||
128934201|NCT02732912|464048070|FG001|Overall Study|No outcome; discharged or refused|9|||
128934202|NCT04382651|464048071|FG000|Overall Study|Death|26|||
128934203|NCT04382651|464048072|FG001|Overall Study|Death|23|||
128934204|NCT04382651|464048071|FG000|Overall Study|Lost to Follow-up|3|||
128934205|NCT04382651|464048072|FG001|Overall Study|Lost to Follow-up|4|||
128934206|NCT04382651|464048071|FG000|Overall Study|Withdrawal by Subject|2|||
128934207|NCT04382651|464048072|FG001|Overall Study|Withdrawal by Subject|0|||
128934208|NCT04382651|464048071|FG000|Overall Study|Physician Decision|0|||
128934209|NCT04382651|464048072|FG001|Overall Study|Physician Decision|1|||
128934210|NCT01507545|464048073|FG000|Overall Study|Withdrawal by Subject|6|||
128934211|NCT01507545|464048074|FG001|Overall Study|Withdrawal by Subject|2|||
128934212|NCT01507545|464048073|FG000|Overall Study|Lost to Follow-up|1|||
128934213|NCT01507545|464048074|FG001|Overall Study|Lost to Follow-up|0|||
128934214|NCT01507545|464048073|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
128934215|NCT01507545|464048074|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
128934216|NCT01507545|464048073|FG000|Overall Study|Progressive disease|60|||
128934217|NCT01507545|464048074|FG001|Overall Study|Progressive disease|27|||
128934218|NCT01507545|464048073|FG000|Overall Study|Other|6|||
128934219|NCT01507545|464048074|FG001|Overall Study|Other|4|||
128934220|NCT01873742|464048075|FG000|Overall Study|Lost to Follow-up|68|||
128934221|NCT01873742|464048076|FG001|Overall Study|Lost to Follow-up|76|||
128934222|NCT00790296|464048078|FG000|Overall Study|Did not meet study eligibility criteria|1|||
128934223|NCT00790296|464048079|FG001|Overall Study|Did not meet study eligibility criteria|1|||
128934224|NCT00790296|464048078|FG000|Overall Study|Adverse Event|0|||
128934225|NCT00790296|464048079|FG001|Overall Study|Adverse Event|1|||
128934226|NCT01671488|464048080|FG000|Overall Study|Withdrawal by Subject|1|||
128934227|NCT02612077|464048081|FG000|Overall Study|Adverse Event|3|||
128934228|NCT02612077|464048081|FG000|Overall Study|Withdrawal by Subject|9|||
128934229|NCT02612077|464048081|FG000|Overall Study|Protocol Violation|28|||
128934230|NCT02612077|464048081|FG000|Overall Study|Lost to Follow-up|20|||
128934231|NCT02612077|464048081|FG000|Overall Study|Death|377|||
128934232|NCT02612077|464048081|FG000|Overall Study|Moved or Changed Medical Team|23|||
128934233|NCT02612077|464048081|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
128934234|NCT02612077|464048081|FG000|Overall Study|Disease Progression|3|||
128934235|NCT02612077|464048081|FG000|Overall Study|Unknown reason|2|||
128934236|NCT01022853|464048082|FG000|Overall Study|Progressive disease|2|||
128703493|NCT01737697|463211468|FG008|Subacute Phase|Physician Decision|1|||
128703494|NCT01737697|463211469|FG009|Subacute Phase|Physician Decision|0|||
128767910|NCT00211237|463440412|FG002|Baseline|Refused random assignment|0|||
128767911|NCT00211237|463440410|FG000|1 Month|Death|2|||
128703495|NCT01737697|463211470|FG010|Subacute Phase|Physician Decision|0|||
128934237|NCT01022853|464048083|FG001|Overall Study|Progressive disease|3|||
128934238|NCT01022853|464048084|FG002|Overall Study|Progressive disease|11|||
128703496|NCT01737697|463211471|FG011|Subacute Phase|Physician Decision|0|||
128934239|NCT01022853|464048085|FG003|Overall Study|Progressive disease|7|||
128934240|NCT01022853|464048086|FG004|Overall Study|Progressive disease|1|||
128934241|NCT01022853|464048082|FG000|Overall Study|Dose-limiting toxicity|0|||
128934242|NCT01022853|464048083|FG001|Overall Study|Dose-limiting toxicity|0|||
128934243|NCT01022853|464048084|FG002|Overall Study|Dose-limiting toxicity|0|||
128934244|NCT01022853|464048085|FG003|Overall Study|Dose-limiting toxicity|0|||
128934245|NCT01022853|464048086|FG004|Overall Study|Dose-limiting toxicity|1|||
128703497|NCT01737697|463211472|FG012|Subacute Phase|Physician Decision|0|||
128934246|NCT01022853|464048082|FG000|Overall Study|Withdrawal by Subject|0|||
128703498|NCT01737697|463211473|FG013|Subacute Phase|Physician Decision|0|||
128978100|NCT01521494|464205311|FG001|Overall Study|Physician Decision|0|||
128703499|NCT01737697|463211474|FG014|Subacute Phase|Physician Decision|0|||
128703500|NCT01737697|463211460|FG000|Subacute Phase|Death|0|||
128703501|NCT01737697|463211461|FG001|Subacute Phase|Death|0|||
129121860|NCT00726453|464742677|FG001|38 mm Length Group|Death|3|||
129121861|NCT00941928|464742679|FG000|Overall Study|Withdrawal by Subject|1|||
129121862|NCT00941928|464742679|FG000|Overall Study|Disease Progression|1|||
129121863|NCT03482024|464742686|FG000|Overall Study|Physician Decision|1|||
129121864|NCT03482024|464742687|FG001|Overall Study|Physician Decision|0|||
129121865|NCT03482024|464742688|FG002|Overall Study|Physician Decision|0|||
129121866|NCT03482024|464742689|FG003|Overall Study|Physician Decision|0|||
129121867|NCT03482024|464742690|FG004|Overall Study|Physician Decision|0|||
129121868|NCT01056276|464742691|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
129121869|NCT01056276|464742692|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
129121870|NCT01056276|464742691|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
129121871|NCT01056276|464742692|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
129121872|NCT01056276|464742691|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
129121873|NCT01056276|464742692|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
129121874|NCT01056276|464742691|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
129121875|NCT01056276|464742692|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
129121876|NCT01056276|464742691|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
128703502|NCT01737697|463211462|FG002|Subacute Phase|Death|0|||
128703503|NCT01737697|463211463|FG003|Subacute Phase|Death|0|||
128703504|NCT01737697|463211464|FG004|Subacute Phase|Death|0|||
128703505|NCT01737697|463211465|FG005|Subacute Phase|Death|0|||
128703506|NCT01737697|463211466|FG006|Subacute Phase|Death|0|||
128703507|NCT01737697|463211467|FG007|Subacute Phase|Death|0|||
128703508|NCT01737697|463211468|FG008|Subacute Phase|Death|0|||
128703509|NCT01737697|463211469|FG009|Subacute Phase|Death|0|||
128703510|NCT01737697|463211470|FG010|Subacute Phase|Death|1|||
128703511|NCT01737697|463211471|FG011|Subacute Phase|Death|0|||
128703512|NCT01737697|463211472|FG012|Subacute Phase|Death|0|||
128767912|NCT00211237|463440411|FG001|1 Month|Death|1|||
128767913|NCT00211237|463440412|FG002|1 Month|Death|0|||
128934247|NCT01022853|464048083|FG001|Overall Study|Withdrawal by Subject|1|||
128934248|NCT01022853|464048084|FG002|Overall Study|Withdrawal by Subject|1|||
128934249|NCT01022853|464048085|FG003|Overall Study|Withdrawal by Subject|1|||
128934250|NCT01022853|464048086|FG004|Overall Study|Withdrawal by Subject|0|||
128934251|NCT01022853|464048082|FG000|Overall Study|Other not stated above|1|||
128934252|NCT01022853|464048083|FG001|Overall Study|Other not stated above|0|||
128934253|NCT01022853|464048084|FG002|Overall Study|Other not stated above|1|||
128934254|NCT01022853|464048085|FG003|Overall Study|Other not stated above|0|||
128934255|NCT01022853|464048086|FG004|Overall Study|Other not stated above|0|||
128934256|NCT01753518|464048087|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
128934257|NCT01753518|464048088|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
128934258|NCT01753518|464048087|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
128934259|NCT01753518|464048088|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
128934260|NCT01753518|464048087|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
128934261|NCT01753518|464048088|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
128934262|NCT01753518|464048087|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
128934263|NCT01753518|464048088|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
128934264|NCT01971476|464048089|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
128934265|NCT01971476|464048090|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
128934266|NCT01971476|464048091|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
128934267|NCT01971476|464048089|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
128934268|NCT01971476|464048090|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
128934269|NCT01971476|464048091|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
128934270|NCT01971476|464048089|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
128934271|NCT01971476|464048090|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
128934272|NCT01971476|464048091|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
128934273|NCT02075255|464048092|FG000|Overall Study|Study specific withdrawal criteria|0|||
129121877|NCT01056276|464742692|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
128934274|NCT02075255|464048093|FG001|Overall Study|Study specific withdrawal criteria|1|||
128934275|NCT02075255|464048094|FG002|Overall Study|Study specific withdrawal criteria|1|||
129121878|NCT01056276|464742691|FG000|Treatment Period-Cycles 1-8|Death|3|||
129121879|NCT01056276|464742692|FG001|Treatment Period-Cycles 1-8|Death|1|||
129121880|NCT01056276|464742691|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
128703513|NCT01737697|463211473|FG013|Subacute Phase|Death|0|||
128934276|NCT02075255|464048092|FG000|Overall Study|Withdrawal by Subject|4|||
128934277|NCT02075255|464048093|FG001|Overall Study|Withdrawal by Subject|1|||
128978101|NCT01521494|464205312|FG002|Overall Study|Physician Decision|0|||
129121881|NCT01056276|464742692|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
128703514|NCT01737697|463211474|FG014|Subacute Phase|Death|0|||
128703515|NCT03338998|463211478|FG000|Treatment Period|Withdrawal by Subject|1|||
128703516|NCT03338998|463211479|FG001|Treatment Period|Withdrawal by Subject|1|||
128703517|NCT03338998|463211478|FG000|Treatment Period|Adverse Event|0|||
128767914|NCT00211237|463440410|FG000|1 Month|Lost to Follow-up|0|||
128767915|NCT00211237|463440411|FG001|1 Month|Lost to Follow-up|2|||
128934278|NCT02075255|464048094|FG002|Overall Study|Withdrawal by Subject|0|||
128934279|NCT02075255|464048092|FG000|Overall Study|Lost to Follow-up|0|||
128934280|NCT02075255|464048093|FG001|Overall Study|Lost to Follow-up|0|||
128934281|NCT02075255|464048094|FG002|Overall Study|Lost to Follow-up|1|||
128934282|NCT02075255|464048092|FG000|Overall Study|Adverse Event|0|||
128934283|NCT02075255|464048093|FG001|Overall Study|Adverse Event|0|||
128934284|NCT02075255|464048094|FG002|Overall Study|Adverse Event|1|||
128934285|NCT02075255|464048092|FG000|Overall Study|Death|0|||
128934286|NCT02075255|464048093|FG001|Overall Study|Death|2|||
128934287|NCT02075255|464048094|FG002|Overall Study|Death|0|||
128934288|NCT01088412|464048095|FG000|Overall Study|Adverse Event|38|||
128934289|NCT01088412|464048096|FG001|Overall Study|Adverse Event|0|||
128934290|NCT01088412|464048097|FG002|Overall Study|Adverse Event|0|||
128934291|NCT01088412|464048095|FG000|Overall Study|Death|42|||
128934292|NCT01088412|464048096|FG001|Overall Study|Death|6|||
128934293|NCT01088412|464048097|FG002|Overall Study|Death|0|||
128934294|NCT01088412|464048095|FG000|Overall Study|Other Reason per Case Report Form|2089|||
128934295|NCT01088412|464048096|FG001|Overall Study|Other Reason per Case Report Form|103|||
128934296|NCT01088412|464048097|FG002|Overall Study|Other Reason per Case Report Form|9|||
128934297|NCT01088412|464048095|FG000|Overall Study|Withdrawal by Subject|1761|||
128934298|NCT01088412|464048096|FG001|Overall Study|Withdrawal by Subject|25|||
128934299|NCT01088412|464048097|FG002|Overall Study|Withdrawal by Subject|1|||
128934300|NCT01088412|464048095|FG000|Overall Study|Received Another GH Product|79|||
128934301|NCT01088412|464048096|FG001|Overall Study|Received Another GH Product|0|||
128934302|NCT01088412|464048097|FG002|Overall Study|Received Another GH Product|0|||
128934303|NCT01088412|464048095|FG000|Overall Study|Participant Moved|601|||
128934304|NCT01088412|464048096|FG001|Overall Study|Participant Moved|21|||
128934305|NCT01088412|464048097|FG002|Overall Study|Participant Moved|2|||
128934306|NCT01088412|464048095|FG000|Overall Study|Physician Decision|1041|||
128934307|NCT01088412|464048096|FG001|Overall Study|Physician Decision|8|||
128934308|NCT01088412|464048097|FG002|Overall Study|Physician Decision|4|||
128934309|NCT01088412|464048095|FG000|Overall Study|Sponsor Decision|4467|||
128934310|NCT01088412|464048096|FG001|Overall Study|Sponsor Decision|79|||
128934311|NCT01088412|464048097|FG002|Overall Study|Sponsor Decision|23|||
128934312|NCT01088412|464048095|FG000|Overall Study|Third Party Required to Change Brand|487|||
128934313|NCT01088412|464048096|FG001|Overall Study|Third Party Required to Change Brand|0|||
128934314|NCT01088412|464048097|FG002|Overall Study|Third Party Required to Change Brand|0|||
128934315|NCT01088412|464048095|FG000|Overall Study|Lost to Follow-up|3052|||
128934316|NCT01088412|464048096|FG001|Overall Study|Lost to Follow-up|130|||
128934317|NCT01088412|464048097|FG002|Overall Study|Lost to Follow-up|11|||
128934318|NCT01088412|464048095|FG000|Overall Study|Study Summary Not Completed|4360|||
128934319|NCT01088412|464048096|FG001|Overall Study|Study Summary Not Completed|64|||
128934320|NCT01088412|464048097|FG002|Overall Study|Study Summary Not Completed|22|||
128934321|NCT01208181|464048099|FG000|Part 1|Withdrawal by Subject|11|||
128934322|NCT01208181|464048100|FG001|Part 1|Withdrawal by Subject|10|||
128934323|NCT01208181|464048101|FG002|Part 1|Withdrawal by Subject|0|||
128934324|NCT01208181|464048102|FG003|Part 1|Withdrawal by Subject|0|||
128934325|NCT01208181|464048103|FG004|Part 1|Withdrawal by Subject|0|||
128934326|NCT01208181|464048099|FG000|Part 1|Technical problem|5|||
128934327|NCT01208181|464048100|FG001|Part 1|Technical problem|0|||
128934328|NCT01208181|464048101|FG002|Part 1|Technical problem|0|||
128934329|NCT01208181|464048102|FG003|Part 1|Technical problem|0|||
128934330|NCT01208181|464048103|FG004|Part 1|Technical problem|0|||
128934331|NCT01208181|464048099|FG000|Part 1|Protocol Violation|10|||
128934332|NCT01208181|464048100|FG001|Part 1|Protocol Violation|5|||
128934333|NCT01208181|464048101|FG002|Part 1|Protocol Violation|0|||
128934334|NCT01208181|464048102|FG003|Part 1|Protocol Violation|0|||
128934335|NCT01208181|464048103|FG004|Part 1|Protocol Violation|0|||
128934336|NCT01208181|464048099|FG000|Part 1|Physician Decision|4|||
128934337|NCT01208181|464048100|FG001|Part 1|Physician Decision|0|||
128934338|NCT01208181|464048101|FG002|Part 1|Physician Decision|0|||
128934339|NCT01208181|464048102|FG003|Part 1|Physician Decision|0|||
128934340|NCT01208181|464048103|FG004|Part 1|Physician Decision|0|||
128934341|NCT01208181|464048099|FG000|Part 1|Non-compliance with study drug|1|||
128934342|NCT01208181|464048100|FG001|Part 1|Non-compliance with study drug|1|||
128934343|NCT01208181|464048101|FG002|Part 1|Non-compliance with study drug|0|||
129030988|NCT01513239|464404761|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
129030989|NCT01513239|464404762|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129030990|NCT01513239|464404763|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129030991|NCT01513239|464404758|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
129030992|NCT01513239|464404759|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
129030993|NCT01513239|464404760|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
128767916|NCT00211237|463440412|FG002|1 Month|Lost to Follow-up|0|||
128934344|NCT01208181|464048102|FG003|Part 1|Non-compliance with study drug|0|||
128934345|NCT01208181|464048103|FG004|Part 1|Non-compliance with study drug|0|||
129030994|NCT01513239|464404761|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
128934346|NCT01208181|464048099|FG000|Part 1|Lost to Follow-up|5|||
128934347|NCT01208181|464048100|FG001|Part 1|Lost to Follow-up|3|||
128934348|NCT01208181|464048101|FG002|Part 1|Lost to Follow-up|0|||
128767917|NCT00211237|463440410|FG000|1 Month|Withdrew|0|||
128767918|NCT00211237|463440411|FG001|1 Month|Withdrew|4|||
128767919|NCT00211237|463440412|FG002|1 Month|Withdrew|0|||
128767920|NCT00211237|463440410|FG000|1 Month|Additional surgery needed|1|||
128767921|NCT00211237|463440411|FG001|1 Month|Additional surgery needed|0|||
128767922|NCT00211237|463440412|FG002|1 Month|Additional surgery needed|0|||
128767923|NCT00211237|463440410|FG000|1 Month|Non-medical problem|0|||
128767924|NCT00211237|463440411|FG001|1 Month|Non-medical problem|2|||
128703518|NCT03338998|463211479|FG001|Treatment Period|Adverse Event|2|||
128703519|NCT03338998|463211478|FG000|Treatment Period|Protocol deviation|1|||
128703520|NCT03338998|463211479|FG001|Treatment Period|Protocol deviation|0|||
128703521|NCT03338998|463211478|FG000|Treatment Period|Physician Decision|2|||
128703522|NCT03338998|463211479|FG001|Treatment Period|Physician Decision|0|||
128703523|NCT03338998|463211478|FG000|Treatment Period|Subject failed swallow test|4|||
128767925|NCT00211237|463440412|FG002|1 Month|Non-medical problem|0|||
128767926|NCT00211237|463440410|FG000|3 Months|Death|7|||
128767927|NCT00211237|463440411|FG001|3 Months|Death|3|||
128767928|NCT00211237|463440412|FG002|3 Months|Death|0|||
128767929|NCT00211237|463440410|FG000|3 Months|Could not comply with protocol|1|||
128767930|NCT00211237|463440411|FG001|3 Months|Could not comply with protocol|0|||
128767931|NCT00211237|463440412|FG002|3 Months|Could not comply with protocol|0|||
128767932|NCT00211237|463440410|FG000|3 Months|Withdrew|0|||
128767933|NCT00211237|463440411|FG001|3 Months|Withdrew|1|||
128767934|NCT00211237|463440412|FG002|3 Months|Withdrew|0|||
128767935|NCT00211237|463440410|FG000|3 Months|Non-medical problem|0|||
128767936|NCT00211237|463440411|FG001|3 Months|Non-medical problem|0|||
128767937|NCT00211237|463440412|FG002|3 Months|Non-medical problem|1|||
128767938|NCT00211237|463440410|FG000|6 Months|Death|6|||
128767939|NCT00211237|463440411|FG001|6 Months|Death|0|||
128767940|NCT00211237|463440412|FG002|6 Months|Death|3|||
128767941|NCT00211237|463440410|FG000|6 Months|Lost to Follow-up|2|||
128767942|NCT00211237|463440411|FG001|6 Months|Lost to Follow-up|0|||
128767943|NCT00211237|463440412|FG002|6 Months|Lost to Follow-up|0|||
128767944|NCT00211237|463440410|FG000|6 Months|Could not comply with protocol|0|||
128767945|NCT00211237|463440411|FG001|6 Months|Could not comply with protocol|2|||
129121882|NCT01056276|464742691|FG000|Maintenance Therapy|Toxicity|0|||
129121883|NCT01056276|464742692|FG001|Maintenance Therapy|Toxicity|2|||
129121884|NCT01056276|464742691|FG000|Maintenance Therapy|Progressive Disease|0|||
128703524|NCT03338998|463211479|FG001|Treatment Period|Subject failed swallow test|0|||
128703525|NCT03338998|463211478|FG000|Safety Follow-Up Period|Adverse Event|0|||
128703526|NCT03338998|463211479|FG001|Safety Follow-Up Period|Adverse Event|1|||
128703527|NCT03338998|463211478|FG000|Safety Follow-Up Period|Protocol deviation|1|||
128703528|NCT03338998|463211479|FG001|Safety Follow-Up Period|Protocol deviation|0|||
128703529|NCT03338998|463211478|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
128703530|NCT03338998|463211479|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
128703531|NCT05255068|463213428|FG000|Overall Study|Lost to Follow-up|0|||
128703532|NCT05255068|463213429|FG001|Overall Study|Lost to Follow-up|1|||
128703533|NCT02820753|463213432|FG000|2 Month|Withdrawal by Subject|3|||
128703534|NCT02820753|463213433|FG001|2 Month|Withdrawal by Subject|3|||
128703535|NCT02820753|463213432|FG000|2 Month|Lost to Follow-up|24|||
128703536|NCT02820753|463213433|FG001|2 Month|Lost to Follow-up|26|||
128703537|NCT02820753|463213432|FG000|2 Month|Stopped per NIH Hold|51|||
128703538|NCT02820753|463213433|FG001|2 Month|Stopped per NIH Hold|13|||
128703539|NCT02820753|463213432|FG000|6 Month|Withdrawal by Subject|2|||
128703540|NCT02820753|463213433|FG001|6 Month|Withdrawal by Subject|2|||
129121885|NCT01056276|464742692|FG001|Maintenance Therapy|Progressive Disease|9|||
129121886|NCT01056276|464742691|FG000|Maintenance Therapy|Physician Decision|0|||
129121887|NCT01056276|464742692|FG001|Maintenance Therapy|Physician Decision|1|||
129121888|NCT01056276|464742691|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
129121889|NCT01056276|464742692|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
129121890|NCT01056276|464742691|FG000|Maintenance Therapy|Intercurrent Illness|0|||
129121891|NCT01056276|464742692|FG001|Maintenance Therapy|Intercurrent Illness|1|||
129121892|NCT01056276|464742691|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
129121893|NCT01056276|464742692|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
128703541|NCT02820753|463213432|FG000|6 Month|Lost to Follow-up|20|||
128767946|NCT00211237|463440412|FG002|6 Months|Could not comply with protocol|0|||
129121894|NCT01881425|464742693|FG000|Overall Study|Death|5|||
128767947|NCT00211237|463440410|FG000|12 Months|Death|8|||
128767948|NCT00211237|463440411|FG001|12 Months|Death|2|||
128767949|NCT00211237|463440412|FG002|12 Months|Death|3|||
128767950|NCT00211237|463440410|FG000|12 Months|Lost to Follow-up|1|||
128767951|NCT00211237|463440411|FG001|12 Months|Lost to Follow-up|0|||
128767952|NCT00211237|463440412|FG002|12 Months|Lost to Follow-up|1|||
128703542|NCT02820753|463213433|FG001|6 Month|Lost to Follow-up|27|||
128703543|NCT02820753|463213432|FG000|6 Month|Stopped per NIH Hold|81|||
128703544|NCT02820753|463213433|FG001|6 Month|Stopped per NIH Hold|81|||
128703545|NCT02820753|463213432|FG000|6 Month|Death|0|||
128703546|NCT02820753|463213433|FG001|6 Month|Death|1|||
128703547|NCT02161731|463213434|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
128767953|NCT00211237|463440410|FG000|12 Months|Withdrew|0|||
128767954|NCT00211237|463440411|FG001|12 Months|Withdrew|0|||
128934349|NCT01208181|464048102|FG003|Part 1|Lost to Follow-up|0|||
128934350|NCT01208181|464048103|FG004|Part 1|Lost to Follow-up|1|||
128934351|NCT01208181|464048099|FG000|Part 1|Lack of Efficacy|37|||
128934352|NCT01208181|464048100|FG001|Part 1|Lack of Efficacy|12|||
128934353|NCT01208181|464048101|FG002|Part 1|Lack of Efficacy|0|||
128934354|NCT01208181|464048102|FG003|Part 1|Lack of Efficacy|0|||
128934355|NCT01208181|464048103|FG004|Part 1|Lack of Efficacy|17|||
128934356|NCT01208181|464048099|FG000|Part 1|Adverse Event|26|||
128934357|NCT01208181|464048100|FG001|Part 1|Adverse Event|24|||
128934358|NCT01208181|464048101|FG002|Part 1|Adverse Event|0|||
128934359|NCT01208181|464048102|FG003|Part 1|Adverse Event|0|||
128934360|NCT01208181|464048103|FG004|Part 1|Adverse Event|4|||
128934361|NCT01208181|464048099|FG000|Part 2|Adverse Event|0|||
128934362|NCT01208181|464048100|FG001|Part 2|Adverse Event|0|||
128934363|NCT01208181|464048101|FG002|Part 2|Adverse Event|6|||
128934364|NCT01208181|464048102|FG003|Part 2|Adverse Event|7|||
128934365|NCT01208181|464048103|FG004|Part 2|Adverse Event|0|||
128934366|NCT01208181|464048099|FG000|Part 2|Withdrawal by Subject|0|||
128934367|NCT01208181|464048100|FG001|Part 2|Withdrawal by Subject|0|||
128934368|NCT01208181|464048101|FG002|Part 2|Withdrawal by Subject|1|||
128934369|NCT01208181|464048102|FG003|Part 2|Withdrawal by Subject|1|||
128934370|NCT01208181|464048103|FG004|Part 2|Withdrawal by Subject|0|||
128934371|NCT01208181|464048099|FG000|Part 2|Protocol Violation|0|||
128934372|NCT01208181|464048100|FG001|Part 2|Protocol Violation|0|||
128934373|NCT01208181|464048101|FG002|Part 2|Protocol Violation|1|||
128934374|NCT01208181|464048102|FG003|Part 2|Protocol Violation|0|||
128934375|NCT01208181|464048103|FG004|Part 2|Protocol Violation|0|||
128934376|NCT01208181|464048099|FG000|Part 2|Physician Decision|0|||
128934377|NCT01208181|464048100|FG001|Part 2|Physician Decision|0|||
128934378|NCT01208181|464048101|FG002|Part 2|Physician Decision|1|||
128934379|NCT01208181|464048102|FG003|Part 2|Physician Decision|2|||
128934380|NCT01208181|464048103|FG004|Part 2|Physician Decision|0|||
128934381|NCT01208181|464048099|FG000|Part 2|Non-compliance with study drug|0|||
128934382|NCT01208181|464048100|FG001|Part 2|Non-compliance with study drug|0|||
128934383|NCT01208181|464048101|FG002|Part 2|Non-compliance with study drug|1|||
128934384|NCT01208181|464048102|FG003|Part 2|Non-compliance with study drug|1|||
128934385|NCT01208181|464048103|FG004|Part 2|Non-compliance with study drug|0|||
128934386|NCT01208181|464048099|FG000|Part 2|Lost to Follow-up|0|||
128934387|NCT01208181|464048100|FG001|Part 2|Lost to Follow-up|0|||
128934388|NCT01208181|464048101|FG002|Part 2|Lost to Follow-up|1|||
128934389|NCT01208181|464048102|FG003|Part 2|Lost to Follow-up|2|||
128934390|NCT01208181|464048103|FG004|Part 2|Lost to Follow-up|0|||
128934391|NCT01208181|464048099|FG000|Part 2|Lack of Efficacy|0|||
128934392|NCT01208181|464048100|FG001|Part 2|Lack of Efficacy|0|||
128934393|NCT01208181|464048101|FG002|Part 2|Lack of Efficacy|5|||
128934394|NCT01208181|464048102|FG003|Part 2|Lack of Efficacy|7|||
128934395|NCT01208181|464048103|FG004|Part 2|Lack of Efficacy|0|||
128934396|NCT00942708|464048104|FG000|Overall Study|Withdrawal by Subject|1|||
128934397|NCT01426386|464048109|FG000|Overall Study|Adverse Event|0|||
128934398|NCT01426386|464048110|FG001|Overall Study|Adverse Event|1|||
128934399|NCT01426386|464048111|FG002|Overall Study|Adverse Event|0|||
128934400|NCT01426386|464048112|FG003|Overall Study|Adverse Event|0|||
128934401|NCT01426386|464048113|FG004|Overall Study|Adverse Event|0|||
128934402|NCT01426386|464048114|FG005|Overall Study|Adverse Event|0|||
128934403|NCT01426386|464048109|FG000|Overall Study|Did not attend scheduled visit|1|||
128934404|NCT01426386|464048110|FG001|Overall Study|Did not attend scheduled visit|4|||
128934405|NCT01426386|464048111|FG002|Overall Study|Did not attend scheduled visit|0|||
129030995|NCT01513239|464404762|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
128934406|NCT01426386|464048112|FG003|Overall Study|Did not attend scheduled visit|0|||
129030996|NCT01513239|464404763|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
129030997|NCT03167606|464404766|FG000|Overall Study|Lost to Follow-up|73|||
129030998|NCT03167606|464404767|FG001|Overall Study|Lost to Follow-up|64|||
129030999|NCT03167606|464404766|FG000|Overall Study|Withdrawal by Subject|6|||
128934407|NCT01426386|464048113|FG004|Overall Study|Did not attend scheduled visit|2|||
128934408|NCT01426386|464048114|FG005|Overall Study|Did not attend scheduled visit|1|||
128934409|NCT01426386|464048109|FG000|Overall Study|Poor response|2|||
128934410|NCT01426386|464048110|FG001|Overall Study|Poor response|1|||
128934411|NCT01426386|464048111|FG002|Overall Study|Poor response|2|||
128703548|NCT02161731|463213435|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
128934412|NCT01426386|464048112|FG003|Overall Study|Poor response|0|||
128934413|NCT01426386|464048113|FG004|Overall Study|Poor response|1|||
128934414|NCT01426386|464048114|FG005|Overall Study|Poor response|0|||
128934415|NCT01426386|464048109|FG000|Overall Study|Personal reasons|0|||
128934416|NCT01426386|464048110|FG001|Overall Study|Personal reasons|0|||
128934417|NCT01426386|464048111|FG002|Overall Study|Personal reasons|0|||
128934418|NCT01426386|464048112|FG003|Overall Study|Personal reasons|0|||
128934419|NCT01426386|464048113|FG004|Overall Study|Personal reasons|1|||
128934420|NCT01426386|464048114|FG005|Overall Study|Personal reasons|0|||
128934421|NCT01457339|464048115|FG000|Period 3 (100 mg)|Adverse Event|0|||
129031000|NCT03167606|464404767|FG001|Overall Study|Withdrawal by Subject|5|||
128934422|NCT01457339|464048116|FG001|Period 3 (100 mg)|Adverse Event|1|||
128934423|NCT01457339|464048115|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
128767955|NCT00211237|463440412|FG002|12 Months|Withdrew|1|||
128767956|NCT00211237|463440410|FG000|12 Months|unrelated medical problem|0|||
128767957|NCT00211237|463440411|FG001|12 Months|unrelated medical problem|0|||
128767958|NCT00211237|463440412|FG002|12 Months|unrelated medical problem|1|||
128767959|NCT04078035|463440413|FG000|Session 2|Lost to Follow-up|3|||
128767960|NCT04078035|463440414|FG001|Session 2|Lost to Follow-up|1|||
128767961|NCT04078035|463440413|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
128767962|NCT04078035|463440414|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
128767963|NCT01013792|463440415|FG000|Overall Study|Study suspended|2|||
128767964|NCT01013792|463440416|FG001|Overall Study|Study suspended|1|||
128767965|NCT01013792|463440415|FG000|Overall Study|Adverse Event|0|||
129031001|NCT03167606|464404766|FG000|Overall Study|Withdrawal by Investigator|0|||
129031002|NCT03167606|464404767|FG001|Overall Study|Withdrawal by Investigator|2|||
129031003|NCT00059332|464404768|FG000|Overall Study|Withdrawal by Subject|2|||
129031004|NCT00059332|464404769|FG001|Overall Study|Withdrawal by Subject|1|||
129031005|NCT00059332|464404768|FG000|Overall Study|Lost to Follow-up|1|||
129031006|NCT00059332|464404769|FG001|Overall Study|Lost to Follow-up|1|||
129031007|NCT00413049|464404771|FG000|Overall Study|Adverse Event|10|||
129031008|NCT00413049|464404772|FG001|Overall Study|Adverse Event|8|||
129031009|NCT00413049|464404771|FG000|Overall Study|Withdrawal by Subject|7|||
129121895|NCT01881425|464742694|FG001|Overall Study|Death|1|||
129121896|NCT01881425|464742693|FG000|Overall Study|Withdrawal by Subject|8|||
129121897|NCT01881425|464742694|FG001|Overall Study|Withdrawal by Subject|3|||
129121898|NCT01881425|464742693|FG000|Overall Study|Physician Decision|2|||
129121899|NCT01881425|464742694|FG001|Overall Study|Physician Decision|1|||
129121900|NCT01881425|464742693|FG000|Overall Study|Adverse Event|3|||
129121901|NCT01881425|464742694|FG001|Overall Study|Adverse Event|0|||
129121902|NCT01881425|464742693|FG000|Overall Study|General Anesthesia panic attack|0|||
129121903|NCT01881425|464742694|FG001|Overall Study|General Anesthesia panic attack|1|||
129121904|NCT01881425|464742693|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
129121905|NCT01881425|464742694|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
129121906|NCT01881425|464742693|FG000|Overall Study|Lost to Follow-up|7|||
129121907|NCT01881425|464742694|FG001|Overall Study|Lost to Follow-up|2|||
129121908|NCT01200355|464742701|FG000|Overall Study|Death|7|||
129121909|NCT01200355|464742702|FG001|Overall Study|Death|2|||
129121910|NCT04424901|464742703|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
129121911|NCT04424901|464742704|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
129121912|NCT00147238|464742705|FG000|Overall Study|Inevaluable|8|||
129121913|NCT03185208|464742708|FG000|Overall Study|Did not start study medication|0|||
129121914|NCT03185208|464742709|FG001|Overall Study|Did not start study medication|3|||
129121915|NCT03834350|464742710|FG000|Overall Study|Withdrawal by Subject|1|||
129121916|NCT02765165|464742711|FG000|Treatment Period|Progressive disease|3|||
129121917|NCT02765165|464742712|FG001|Treatment Period|Progressive disease|2|||
129121918|NCT02765165|464742713|FG002|Treatment Period|Progressive disease|3|||
128703549|NCT02161731|463213434|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
128703550|NCT02161731|463213435|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
128703551|NCT03761277|463213436|FG000|Enrollment to Implant|Screen Failure|17|||
128703552|NCT03761277|463213436|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
128703553|NCT03761277|463213436|FG000|Enrollment to Implant|Physician Decision|2|||
128703554|NCT03761277|463213436|FG000|Enrollment to Implant|Site Closure|3|||
128703555|NCT03761277|463213436|FG000|Enrollment to Implant|Sponsor Request|2|||
128703556|NCT03761277|463213436|FG000|Post-Implant to 6 Months|Adverse Event|2|||
128703557|NCT03761277|463213436|FG000|Post-Implant to 6 Months|Death|1|||
128703558|NCT03761277|463213436|FG000|Post-Implant to 6 Months|Site Closure|2|||
128703559|NCT03761277|463213436|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
128703560|NCT03761277|463213436|FG000|6 Months to 12 Months|Physician Decision|2|||
128703561|NCT03761277|463213436|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
128703562|NCT00004978|463213437|FG000|Overall Study|Death|107|||
128703563|NCT00004978|463213438|FG001|Overall Study|Death|116|||
128767966|NCT01013792|463440416|FG001|Overall Study|Adverse Event|3|||
128767967|NCT01013792|463440415|FG000|Overall Study|Lost to Follow-up|0|||
128767968|NCT01013792|463440416|FG001|Overall Study|Lost to Follow-up|1|||
129031010|NCT00413049|464404772|FG001|Overall Study|Withdrawal by Subject|5|||
129031011|NCT00413049|464404771|FG000|Overall Study|Lost to Follow-up|2|||
129121919|NCT02765165|464742714|FG003|Treatment Period|Progressive disease|3|||
129121920|NCT02765165|464742715|FG004|Treatment Period|Progressive disease|4|||
129121921|NCT02765165|464742716|FG005|Treatment Period|Progressive disease|2|||
129121922|NCT02765165|464742717|FG006|Treatment Period|Progressive disease|2|||
129121923|NCT02765165|464742711|FG000|Treatment Period|Physician Decision|0|||
128703564|NCT00004978|463213437|FG000|Overall Study|Lost to Follow-up|101|||
128703565|NCT00004978|463213438|FG001|Overall Study|Lost to Follow-up|108|||
128703566|NCT00004978|463213437|FG000|Overall Study|Withdrawal by Subject|17|||
128703567|NCT00004978|463213438|FG001|Overall Study|Withdrawal by Subject|26|||
128703568|NCT00004978|463213437|FG000|Overall Study|site closure - not in analysis cohort|19|||
128703569|NCT00004978|463213438|FG001|Overall Study|site closure - not in analysis cohort|20|||
128767969|NCT02100722|463440417|FG000|Overall Study|Withdrawal pre-procedure|4|||
128767970|NCT02100722|463440418|FG001|Overall Study|Withdrawal pre-procedure|9|||
128767971|NCT02100722|463440417|FG000|Overall Study|Withdrawal post-procedure|0|||
128767972|NCT02100722|463440418|FG001|Overall Study|Withdrawal post-procedure|3|||
128767973|NCT02100722|463440417|FG000|Overall Study|Lost to Follow-up|2|||
128767974|NCT02100722|463440418|FG001|Overall Study|Lost to Follow-up|2|||
128767975|NCT02100722|463440417|FG000|Overall Study|Continuing on study|751|||
128767976|NCT02100722|463440418|FG001|Overall Study|Continuing on study|729|||
128767977|NCT05796518|463440424|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
128767978|NCT00612534|463440425|FG000|Overall Study|Adverse Event|0|||
128767979|NCT00612534|463440426|FG001|Overall Study|Adverse Event|4|||
128767980|NCT00612534|463440427|FG002|Overall Study|Adverse Event|2|||
128767981|NCT00612534|463440428|FG003|Overall Study|Adverse Event|1|||
128767982|NCT00612534|463440425|FG000|Overall Study|Lack of Efficacy|13|||
128767983|NCT00612534|463440426|FG001|Overall Study|Lack of Efficacy|12|||
128767984|NCT00612534|463440427|FG002|Overall Study|Lack of Efficacy|5|||
128767985|NCT00612534|463440428|FG003|Overall Study|Lack of Efficacy|16|||
128767986|NCT00612534|463440425|FG000|Overall Study|Other Reason|0|||
128767987|NCT00612534|463440426|FG001|Overall Study|Other Reason|1|||
128767988|NCT00612534|463440427|FG002|Overall Study|Other Reason|0|||
128767989|NCT00612534|463440428|FG003|Overall Study|Other Reason|0|||
128934424|NCT01457339|464048116|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
128934425|NCT01457339|464048115|FG000|Period 6 (250 mg)|Family Emergency|1|||
128934426|NCT01457339|464048116|FG001|Period 6 (250 mg)|Family Emergency|0|||
128934427|NCT01457339|464048115|FG000|Period 6 (250 mg)|Personal appointment|0|||
128934428|NCT01457339|464048116|FG001|Period 6 (250 mg)|Personal appointment|1|||
128934429|NCT01096667|464048117|FG000|Overall Study|Lost to Follow-up|1|||
128934430|NCT01096667|464048118|FG001|Overall Study|Lost to Follow-up|1|||
128934431|NCT01096667|464048119|FG002|Overall Study|Lost to Follow-up|1|||
128934432|NCT01096667|464048120|FG003|Overall Study|Lost to Follow-up|0|||
128934433|NCT01096667|464048121|FG004|Overall Study|Lost to Follow-up|0|||
128934434|NCT01096667|464048117|FG000|Overall Study|Withdrawal by Subject|1|||
128934435|NCT01096667|464048118|FG001|Overall Study|Withdrawal by Subject|0|||
129121924|NCT02765165|464742712|FG001|Treatment Period|Physician Decision|1|||
129121925|NCT02765165|464742713|FG002|Treatment Period|Physician Decision|0|||
129121926|NCT02765165|464742714|FG003|Treatment Period|Physician Decision|0|||
129121927|NCT02765165|464742715|FG004|Treatment Period|Physician Decision|0|||
129121928|NCT02765165|464742716|FG005|Treatment Period|Physician Decision|0|||
129121929|NCT02765165|464742717|FG006|Treatment Period|Physician Decision|0|||
129121930|NCT02765165|464742711|FG000|Treatment Period|Adverse Event|0|||
129121931|NCT02765165|464742712|FG001|Treatment Period|Adverse Event|1|||
129121932|NCT02765165|464742713|FG002|Treatment Period|Adverse Event|0|||
129121933|NCT02765165|464742714|FG003|Treatment Period|Adverse Event|0|||
129121934|NCT02765165|464742715|FG004|Treatment Period|Adverse Event|0|||
129121935|NCT02765165|464742716|FG005|Treatment Period|Adverse Event|0|||
129121936|NCT02765165|464742717|FG006|Treatment Period|Adverse Event|0|||
129121937|NCT02765165|464742711|FG000|Treatment Period|Withdrawal by Subject|0|||
129121938|NCT02765165|464742712|FG001|Treatment Period|Withdrawal by Subject|0|||
129121939|NCT02765165|464742713|FG002|Treatment Period|Withdrawal by Subject|0|||
129121940|NCT02765165|464742714|FG003|Treatment Period|Withdrawal by Subject|0|||
129121941|NCT02765165|464742715|FG004|Treatment Period|Withdrawal by Subject|2|||
129121942|NCT02765165|464742716|FG005|Treatment Period|Withdrawal by Subject|0|||
129121943|NCT02765165|464742717|FG006|Treatment Period|Withdrawal by Subject|0|||
129121944|NCT02765165|464742711|FG000|Treatment Period|Study terminated|0|||
129121945|NCT02765165|464742712|FG001|Treatment Period|Study terminated|0|||
129121946|NCT02765165|464742713|FG002|Treatment Period|Study terminated|0|||
129121947|NCT02765165|464742714|FG003|Treatment Period|Study terminated|0|||
129121948|NCT02765165|464742715|FG004|Treatment Period|Study terminated|0|||
129121949|NCT02765165|464742716|FG005|Treatment Period|Study terminated|1|||
129121950|NCT02765165|464742717|FG006|Treatment Period|Study terminated|2|||
129121951|NCT02765165|464742711|FG000|Post-treatment Follow-up|Death|1|||
129121952|NCT02765165|464742712|FG001|Post-treatment Follow-up|Death|2|||
128934436|NCT01096667|464048119|FG002|Overall Study|Withdrawal by Subject|0|||
128934437|NCT01096667|464048120|FG003|Overall Study|Withdrawal by Subject|1|||
128934438|NCT01096667|464048121|FG004|Overall Study|Withdrawal by Subject|0|||
129121953|NCT02765165|464742713|FG002|Post-treatment Follow-up|Death|1|||
128767990|NCT02223754|463440429|FG000|Period 1|Adverse Event|1|||
128767991|NCT02223754|463440430|FG001|Period 1|Adverse Event|0|||
129121954|NCT02765165|464742714|FG003|Post-treatment Follow-up|Death|1|||
128934439|NCT01096667|464048117|FG000|Overall Study|Reason not available|0|||
128934440|NCT01096667|464048118|FG001|Overall Study|Reason not available|1|||
129121955|NCT02765165|464742715|FG004|Post-treatment Follow-up|Death|1|||
129121956|NCT02765165|464742716|FG005|Post-treatment Follow-up|Death|1|||
129121957|NCT02765165|464742717|FG006|Post-treatment Follow-up|Death|0|||
129121958|NCT02765165|464742711|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
128767992|NCT02223754|463440429|FG000|Period 1|Lost to Follow-up|0|||
129121959|NCT02765165|464742712|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
129121960|NCT02765165|464742713|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
128767993|NCT02223754|463440430|FG001|Period 1|Lost to Follow-up|1|||
128767994|NCT02223754|463440429|FG000|Period 1|Protocol Violation|2|||
128767995|NCT02223754|463440430|FG001|Period 1|Protocol Violation|4|||
128767996|NCT02223754|463440429|FG000|Period 1|Withdrawal by Subject|0|||
128767997|NCT02223754|463440430|FG001|Period 1|Withdrawal by Subject|4|||
128767998|NCT02223754|463440429|FG000|Period 1|Test Article No Longer Available|1|||
128767999|NCT02223754|463440430|FG001|Period 1|Test Article No Longer Available|5|||
128934441|NCT01096667|464048119|FG002|Overall Study|Reason not available|1|||
128934442|NCT01096667|464048120|FG003|Overall Study|Reason not available|1|||
128934443|NCT01096667|464048121|FG004|Overall Study|Reason not available|0|||
128934444|NCT01096667|464048117|FG000|Overall Study|Protocol Violation|0|||
128934445|NCT01096667|464048118|FG001|Overall Study|Protocol Violation|0|||
128934446|NCT01096667|464048119|FG002|Overall Study|Protocol Violation|0|||
128934447|NCT01096667|464048120|FG003|Overall Study|Protocol Violation|1|||
128934448|NCT01096667|464048121|FG004|Overall Study|Protocol Violation|0|||
128934449|NCT01096667|464048117|FG000|Overall Study|Not treated|1|||
128934450|NCT01096667|464048118|FG001|Overall Study|Not treated|0|||
128934451|NCT01096667|464048119|FG002|Overall Study|Not treated|0|||
128934452|NCT01096667|464048120|FG003|Overall Study|Not treated|0|||
128934453|NCT01096667|464048121|FG004|Overall Study|Not treated|0|||
128934454|NCT01751646|464048122|FG000|Overall Study|Lost to Follow-up|5|||
128934455|NCT01751646|464048123|FG001|Overall Study|Lost to Follow-up|1|||
128934456|NCT01751646|464048122|FG000|Overall Study|Withdrawal by Subject|0|||
128934457|NCT01751646|464048123|FG001|Overall Study|Withdrawal by Subject|4|||
128934458|NCT01751646|464048122|FG000|Overall Study|Starting hormone therapy|1|||
128934459|NCT01751646|464048123|FG001|Overall Study|Starting hormone therapy|0|||
128934460|NCT01751646|464048122|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
128934461|NCT01751646|464048123|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
128934462|NCT01751646|464048122|FG000|Overall Study|Inadvertent enrollment|1|||
129031012|NCT00413049|464404772|FG001|Overall Study|Lost to Follow-up|3|||
129031013|NCT00413049|464404771|FG000|Overall Study|Protocol Violation|3|||
129031014|NCT00413049|464404772|FG001|Overall Study|Protocol Violation|1|||
129031015|NCT00413049|464404771|FG000|Overall Study|Subject no longer requires study drug|0|||
129031016|NCT00413049|464404772|FG001|Overall Study|Subject no longer requires study drug|1|||
129031017|NCT00413049|464404771|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129031018|NCT00413049|464404772|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129031019|NCT00413049|464404771|FG000|Overall Study|Lack of Efficacy|1|||
129031020|NCT00413049|464404772|FG001|Overall Study|Lack of Efficacy|0|||
129031021|NCT02587143|464404773|FG000|Overall Study|Adverse Event|1|||
129031022|NCT02587143|464404774|FG001|Overall Study|Adverse Event|0|||
129031023|NCT03314857|464404777|FG000|Overall Study|Death|4|||
129031024|NCT03314857|464404777|FG000|Overall Study|Physician Decision|1|||
129031025|NCT01119625|464404778|FG000|Overall Study|Lost to Follow-up|1|||
129031026|NCT01119625|464404779|FG001|Overall Study|Lost to Follow-up|2|||
129031027|NCT01119625|464404778|FG000|Overall Study|Withdrawal by Subject|2|||
129031028|NCT01119625|464404779|FG001|Overall Study|Withdrawal by Subject|1|||
129031029|NCT01119625|464404778|FG000|Overall Study|Other|0|||
129031030|NCT01119625|464404779|FG001|Overall Study|Other|1|||
129031031|NCT01721772|464404786|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
129031032|NCT01721772|464404787|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
129031033|NCT01721772|464404786|FG000|Pre-Treatment|Poor/non-compliance|0|||
129031034|NCT01721772|464404787|FG001|Pre-Treatment|Poor/non-compliance|1|||
129031035|NCT01721772|464404786|FG000|Pre-Treatment|Participant withdrew consent|0|||
129031036|NCT01721772|464404787|FG001|Pre-Treatment|Participant withdrew consent|1|||
129031037|NCT01721772|464404786|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
129031038|NCT01721772|464404787|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
129031039|NCT01721772|464404786|FG000|Treatment|Disease progression|119|||
129031040|NCT01721772|464404787|FG001|Treatment|Disease progression|168|||
129031041|NCT01721772|464404786|FG000|Treatment|Study drug toxicity|19|||
129031042|NCT01721772|464404787|FG001|Treatment|Study drug toxicity|10|||
129031043|NCT01721772|464404786|FG000|Treatment|Adverse event unrelated to study drug|7|||
129031044|NCT01721772|464404787|FG001|Treatment|Adverse event unrelated to study drug|7|||
129031045|NCT01721772|464404786|FG000|Treatment|Maximum clinical benefit|16|||
129121961|NCT02765165|464742714|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
129121962|NCT02765165|464742715|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
129121963|NCT02765165|464742716|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
129121964|NCT02765165|464742717|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
129121965|NCT02765165|464742711|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
128934463|NCT01751646|464048123|FG001|Overall Study|Inadvertent enrollment|1|||
128934464|NCT01751646|464048122|FG000|Overall Study|Moved out of the area|1|||
128934465|NCT01751646|464048123|FG001|Overall Study|Moved out of the area|5|||
128934466|NCT01751646|464048122|FG000|Overall Study|Inability to attend required visits|0|||
129031046|NCT01721772|464404787|FG001|Treatment|Maximum clinical benefit|4|||
129031047|NCT01721772|464404786|FG000|Treatment|Other|19|||
129031048|NCT01721772|464404787|FG001|Treatment|Other|2|||
129031049|NCT01721772|464404786|FG000|Treatment|Participant withdrew consent|2|||
129031050|NCT01721772|464404787|FG001|Treatment|Participant withdrew consent|5|||
129216828|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
128934467|NCT01751646|464048123|FG001|Overall Study|Inability to attend required visits|1|||
128934468|NCT01751646|464048122|FG000|Overall Study|Off study due to multiple obligations|0|||
128934469|NCT01751646|464048123|FG001|Overall Study|Off study due to multiple obligations|1|||
128934470|NCT01751646|464048122|FG000|Overall Study|Fails to comply with study requirements|0|||
128934471|NCT01751646|464048123|FG001|Overall Study|Fails to comply with study requirements|1|||
128934472|NCT01751646|464048122|FG000|Overall Study|Childcare issues|1|||
128703570|NCT03555591|463213439|FG000|Overall Study|Protocol Violation|77|||
128703571|NCT01029795|463213444|FG000|Overall Study|Entry Criteria Not Met|2|||
128703572|NCT01029795|463213445|FG001|Overall Study|Entry Criteria Not Met|1|||
128703573|NCT01029795|463213444|FG000|Overall Study|Physician Decision|2|||
128703574|NCT01029795|463213445|FG001|Overall Study|Physician Decision|1|||
128703575|NCT01029795|463213444|FG000|Overall Study|Sponsor Decision|11|||
128703576|NCT01029795|463213445|FG001|Overall Study|Sponsor Decision|17|||
128703577|NCT01029795|463213444|FG000|Overall Study|Withdrawal by Subject|1|||
128934473|NCT01751646|464048123|FG001|Overall Study|Childcare issues|1|||
128934474|NCT02335450|464048124|FG000|Overall Study|Pregnancy|1|||
128934475|NCT02613572|464048125|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
128934476|NCT02613572|464048126|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
128934477|NCT02613572|464048127|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
128934478|NCT02613572|464048125|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
128934479|NCT02613572|464048126|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
128934480|NCT02613572|464048127|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
128934481|NCT04542291|464048128|FG000|Overall Study|Adverse Event|1|||
128934482|NCT04542291|464048128|FG000|Overall Study|Physician Decision|2|||
128934483|NCT00853905|464048129|FG000|Overall Study|Lost to Follow-up|1|||
128934484|NCT00853905|464048130|FG001|Overall Study|Lost to Follow-up|3|||
128934485|NCT00853905|464048129|FG000|Overall Study|Withdrawal by Subject|0|||
128934486|NCT00853905|464048130|FG001|Overall Study|Withdrawal by Subject|1|||
128934487|NCT00853905|464048129|FG000|Overall Study|never had surgery|1|||
128934488|NCT00853905|464048130|FG001|Overall Study|never had surgery|0|||
128934489|NCT00970294|464048133|FG000|Overall Study|Physician Decision|4|||
128934490|NCT00970294|464048133|FG000|Overall Study|Withdrawal by Subject|1|||
128934491|NCT00847561|464048134|FG000|Overall Study|Withdrawal by Subject|4|||
128934492|NCT00847561|464048135|FG001|Overall Study|Withdrawal by Subject|3|||
128934493|NCT00847561|464048134|FG000|Overall Study|Unable to schedule|9|||
128934494|NCT00847561|464048135|FG001|Overall Study|Unable to schedule|1|||
128934495|NCT01333189|464048136|FG000|Overall Study|Time constraints|1|||
128934496|NCT01333189|464048137|FG001|Overall Study|Time constraints|0|||
128934497|NCT01333189|464048136|FG000|Overall Study|Adverse Event|1|||
128934498|NCT01333189|464048137|FG001|Overall Study|Adverse Event|0|||
128934499|NCT01333189|464048136|FG000|Overall Study|Transportation difficulties|0|||
128934500|NCT01333189|464048137|FG001|Overall Study|Transportation difficulties|1|||
128934501|NCT01333189|464048136|FG000|Overall Study|Moved from region|0|||
128934502|NCT01333189|464048137|FG001|Overall Study|Moved from region|1|||
128934503|NCT00465738|464048139|FG000|Overall Study|Lost to Follow-up|2|||
128934504|NCT00465738|464048140|FG001|Overall Study|Lost to Follow-up|0|||
128934505|NCT00465738|464048139|FG000|Overall Study|Adverse Event|0|||
128934506|NCT00465738|464048140|FG001|Overall Study|Adverse Event|1|||
128934507|NCT00465738|464048139|FG000|Overall Study|Withdrawal by Subject|2|||
128934508|NCT00465738|464048140|FG001|Overall Study|Withdrawal by Subject|0|||
128934509|NCT00465738|464048139|FG000|Overall Study|Other|2|||
129031051|NCT01721772|464404786|FG000|Treatment|Participant request to discontinue study treatment|21|||
129031052|NCT01721772|464404787|FG001|Treatment|Participant request to discontinue study treatment|8|||
129031053|NCT01721772|464404786|FG000|Treatment|Death|1|||
129031054|NCT01721772|464404787|FG001|Treatment|Death|0|||
129031055|NCT01721772|464404786|FG000|Treatment|Not reported|1|||
129031056|NCT01721772|464404787|FG001|Treatment|Not reported|0|||
129031057|NCT01721772|464404786|FG000|Treatment|Poor/non-compliance|1|||
129031058|NCT01721772|464404787|FG001|Treatment|Poor/non-compliance|0|||
129031059|NCT01721772|464404786|FG000|Treatment|Lost to Follow-up|0|||
129031060|NCT01721772|464404787|FG001|Treatment|Lost to Follow-up|1|||
129031061|NCT00397254|464404795|FG000|Overall Study|Lost to Follow-up|2|||
129031062|NCT00397254|464404796|FG001|Overall Study|Lost to Follow-up|2|||
129031063|NCT02340780|464404797|FG000|Overall Study|Ineligible|1|||
129216829|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
128703578|NCT01029795|463213445|FG001|Overall Study|Withdrawal by Subject|3|||
128703579|NCT03217175|463213446|FG000|Overall Study|Physician Decision|4|||
128703580|NCT03217175|463213447|FG001|Overall Study|Physician Decision|1|||
128934510|NCT00465738|464048140|FG001|Overall Study|Other|5|||
128934511|NCT01318902|464048143|FG000|Overall Study|Symptomatic Deterioration|0|||
128934512|NCT01318902|464048144|FG001|Overall Study|Symptomatic Deterioration|1|||
128934513|NCT01318902|464048145|FG002|Overall Study|Symptomatic Deterioration|1|||
128934514|NCT01318902|464048146|FG003|Overall Study|Symptomatic Deterioration|2|||
129031064|NCT04535986|464404801|FG000|Overall Study|Death|4|||
129031065|NCT04535986|464404802|FG001|Overall Study|Death|5|||
128703581|NCT03052725|463213451|FG000|Overall Study|Adverse Event|2|||
128934515|NCT01318902|464048143|FG000|Overall Study|Withdrawal by Patient|0|||
128934516|NCT01318902|464048144|FG001|Overall Study|Withdrawal by Patient|1|||
128934517|NCT01318902|464048145|FG002|Overall Study|Withdrawal by Patient|0|||
128934518|NCT01318902|464048146|FG003|Overall Study|Withdrawal by Patient|3|||
128934519|NCT01318902|464048143|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
128934520|NCT01318902|464048144|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
128934521|NCT01318902|464048145|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
128934522|NCT01318902|464048146|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
128934523|NCT01318902|464048143|FG000|Overall Study|Adverse Event|0|||
128934524|NCT01318902|464048144|FG001|Overall Study|Adverse Event|1|||
128934525|NCT01318902|464048145|FG002|Overall Study|Adverse Event|0|||
128934526|NCT01318902|464048146|FG003|Overall Study|Adverse Event|0|||
128934527|NCT01318902|464048143|FG000|Overall Study|Terminated by Sponsor|0|||
128934528|NCT01318902|464048144|FG001|Overall Study|Terminated by Sponsor|0|||
128934529|NCT01318902|464048145|FG002|Overall Study|Terminated by Sponsor|1|||
128934530|NCT01318902|464048146|FG003|Overall Study|Terminated by Sponsor|0|||
128934531|NCT05243550|464049350|FG000|Overall Study|Ongoing in the Study|171|||
128934532|NCT05243550|464049350|FG000|Overall Study|Withdrawal by Subject|10|||
128934533|NCT05243550|464049350|FG000|Overall Study|Lost to Follow-up|7|||
128934534|NCT05243550|464049350|FG000|Overall Study|Adverse Event|3|||
128934535|NCT05243550|464049350|FG000|Overall Study|Noncompliance|1|||
128934536|NCT05243550|464049350|FG000|Overall Study|Physician Decision|1|||
128934537|NCT05243550|464049350|FG000|Overall Study|Other Reason|4|||
128934538|NCT02452970|464049359|FG000|Overall Study|Adverse Event|1|||
128934539|NCT00893113|464049360|FG000|Overall Study|Lost to Follow-up|4|||
128934540|NCT00893113|464049361|FG001|Overall Study|Lost to Follow-up|8|||
128934541|NCT00893113|464049360|FG000|Overall Study|Early Termination|1|||
128934542|NCT00893113|464049361|FG001|Overall Study|Early Termination|1|||
128934543|NCT00893113|464049360|FG000|Overall Study|Withdrew Consent|8|||
128934544|NCT00893113|464049361|FG001|Overall Study|Withdrew Consent|7|||
128934545|NCT00128206|464049370|FG000|Overall Study|Lost to Follow-up|137|||
128934546|NCT00128206|464049371|FG001|Overall Study|Lost to Follow-up|118|||
128934547|NCT00128206|464049370|FG000|Overall Study|Adverse Event|0|||
128934548|NCT00128206|464049371|FG001|Overall Study|Adverse Event|2|||
128934549|NCT03270085|464049372|FG000|Overall Study|Withdrawal by Subject|1|||
128934550|NCT03270085|464049373|FG001|Overall Study|Withdrawal by Subject|0|||
128934551|NCT01269125|464049374|FG000|Overall Study|Adverse Event|3|||
128934552|NCT01269125|464049375|FG001|Overall Study|Adverse Event|5|||
128934553|NCT01269125|464049376|FG002|Overall Study|Adverse Event|0|||
128934554|NCT01269125|464049374|FG000|Overall Study|Lost to Follow-up|4|||
128934555|NCT01269125|464049375|FG001|Overall Study|Lost to Follow-up|0|||
128934556|NCT01269125|464049376|FG002|Overall Study|Lost to Follow-up|0|||
128934557|NCT01283581|464049379|FG000|Overall Study|Lost to Follow-up|8|||
128934558|NCT01283581|464049380|FG001|Overall Study|Lost to Follow-up|6|||
128934559|NCT01283581|464049381|FG002|Overall Study|Lost to Follow-up|8|||
128934560|NCT01283581|464049379|FG000|Overall Study|Withdrawal by Subject|2|||
128934561|NCT01283581|464049380|FG001|Overall Study|Withdrawal by Subject|5|||
128934562|NCT01283581|464049381|FG002|Overall Study|Withdrawal by Subject|2|||
128934563|NCT01283581|464049379|FG000|Overall Study|Adverse Event|1|||
128934564|NCT01283581|464049380|FG001|Overall Study|Adverse Event|1|||
128934565|NCT01283581|464049381|FG002|Overall Study|Adverse Event|4|||
128934566|NCT01283581|464049379|FG000|Overall Study|Physician Decision|0|||
128934567|NCT01283581|464049380|FG001|Overall Study|Physician Decision|1|||
128934568|NCT01283581|464049381|FG002|Overall Study|Physician Decision|2|||
128934569|NCT01283581|464049379|FG000|Overall Study|Protocol Violation|0|||
128934570|NCT01283581|464049380|FG001|Overall Study|Protocol Violation|1|||
128934571|NCT01283581|464049381|FG002|Overall Study|Protocol Violation|2|||
128934572|NCT01283581|464049379|FG000|Overall Study|Noncompliance|1|||
128934573|NCT01283581|464049380|FG001|Overall Study|Noncompliance|0|||
128934574|NCT01283581|464049381|FG002|Overall Study|Noncompliance|0|||
128934575|NCT01283581|464049379|FG000|Overall Study|Investigator unblinded|0|||
128934576|NCT01283581|464049380|FG001|Overall Study|Investigator unblinded|0|||
128934577|NCT01283581|464049381|FG002|Overall Study|Investigator unblinded|1|||
128934578|NCT01283581|464049379|FG000|Overall Study|"Early termination"|0|||
128934579|NCT01283581|464049380|FG001|Overall Study|"Early termination"|0|||
128934580|NCT01283581|464049381|FG002|Overall Study|"Early termination"|1|||
128934581|NCT02241512|464049382|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
128934582|NCT02241512|464049383|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
128934583|NCT00474630|464049386|FG000|Overall Study|Adverse Event|98|||
128934584|NCT00474630|464049387|FG001|Overall Study|Adverse Event|26|||
128934585|NCT00474630|464049386|FG000|Overall Study|Lost to Follow-up|22|||
128934586|NCT00474630|464049387|FG001|Overall Study|Lost to Follow-up|15|||
128934587|NCT00474630|464049386|FG000|Overall Study|Withdrawal by Subject|21|||
128934588|NCT00474630|464049387|FG001|Overall Study|Withdrawal by Subject|15|||
128934589|NCT00474630|464049386|FG000|Overall Study|Protocol Violation|3|||
128934590|NCT00474630|464049387|FG001|Overall Study|Protocol Violation|4|||
128934591|NCT00474630|464049386|FG000|Overall Study|Lack of Efficacy|5|||
128934592|NCT00474630|464049387|FG001|Overall Study|Lack of Efficacy|6|||
128934593|NCT00474630|464049386|FG000|Overall Study|Drug noncompliance, other|11|||
128934594|NCT00474630|464049387|FG001|Overall Study|Drug noncompliance, other|4|||
128934595|NCT03088605|464049388|FG000|Overall Study|Withdrawal by Subject|1|||
128934596|NCT03088605|464049389|FG001|Overall Study|Withdrawal by Subject|0|||
128934597|NCT02225223|464049390|FG000|Overall Study|Death|10|||
128934598|NCT02225223|464049391|FG001|Overall Study|Death|1|||
128934599|NCT02225223|464049390|FG000|Overall Study|Lost to Follow-up|5|||
128934600|NCT02225223|464049391|FG001|Overall Study|Lost to Follow-up|0|||
128934601|NCT02225223|464049390|FG000|Overall Study|Other|1|||
128934602|NCT02225223|464049391|FG001|Overall Study|Other|2|||
128934603|NCT02225223|464049390|FG000|Overall Study|Physician Decision|1|||
128934604|NCT02225223|464049391|FG001|Overall Study|Physician Decision|0|||
128934605|NCT02225223|464049390|FG000|Overall Study|Withdrawal by Subject|2|||
128934606|NCT02225223|464049391|FG001|Overall Study|Withdrawal by Subject|2|||
128934607|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
128934608|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
128934609|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
128703582|NCT03052725|463213452|FG001|Overall Study|Adverse Event|0|||
128934610|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
128934611|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
128934612|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
128934613|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
128934614|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
128934615|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
128934616|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
128934617|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
128934618|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
128934619|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
128934620|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
128934621|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
128934622|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
128934623|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
128934624|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
128934625|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
128934626|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
128934627|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
128934628|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
128934629|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
128934630|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
128934631|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
128934632|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
128934633|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
128934634|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
128934635|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
128934636|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
128934637|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
128934638|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
128934639|NCT00958568|464049393|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
128934640|NCT00958568|464049394|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
128934641|NCT00958568|464049395|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
128934642|NCT00958568|464049396|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
128934643|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
128934644|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
128934645|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
128934646|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
128934647|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
128934648|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
128934649|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
128934650|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
128934651|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
128934652|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
128934653|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
129121966|NCT02765165|464742712|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
129121967|NCT02765165|464742713|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
129121968|NCT02765165|464742714|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
129121969|NCT02765165|464742715|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
128703583|NCT03052725|463213451|FG000|Overall Study|Withdrawal by Subject|3|||
128934654|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
128934655|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
128934656|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
128934657|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
128934658|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
128934659|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
128934660|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
128934661|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
128934662|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
128934663|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
128934664|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
128934665|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
128934666|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
128934667|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
128934668|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
128934669|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
128934670|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
128934671|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
128934672|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
128934673|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
128934674|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
128934675|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
128934676|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
128934677|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
128934678|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
128934679|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
128934680|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
128934681|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
128934682|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
128934683|NCT00958568|464049393|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
128934684|NCT00958568|464049394|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
128934685|NCT00958568|464049395|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
128934686|NCT00958568|464049396|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
128934687|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
128934688|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
128934689|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
128934690|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
128934691|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
128934692|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
128934693|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
128934694|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
128934695|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
128934696|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
128934697|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
128934698|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
128934699|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
128934700|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
128934701|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
128934702|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
128934703|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
128934704|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
128934705|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
128934706|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
128934707|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
128934708|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
128934709|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
128978102|NCT01521494|464205313|FG003|Overall Study|Physician Decision|0|||
129121970|NCT02765165|464742716|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
129121971|NCT02765165|464742717|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
129121972|NCT02765165|464742711|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129121973|NCT02765165|464742712|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
128768000|NCT02223754|463440429|FG000|Period 1|Unsatisfactory Visual Response|0|||
128768001|NCT02223754|463440430|FG001|Period 1|Unsatisfactory Visual Response|1|||
129121974|NCT02765165|464742713|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
129121975|NCT02765165|464742714|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
128934710|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
128934711|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
128934712|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
128934713|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
128934714|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
128934715|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
128934716|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
128934717|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
128934718|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
128934719|NCT00958568|464049393|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
128934720|NCT00958568|464049394|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
128934721|NCT00958568|464049395|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
128934722|NCT00958568|464049396|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
128934723|NCT01936649|464049407|FG000|Overall Study|Withdrawal by Subject|4|||
128934724|NCT01936649|464049407|FG000|Overall Study|Physician Decision|2|||
128934725|NCT01936649|464049407|FG000|Overall Study|Protocol Violation|2|||
128934726|NCT01936649|464049407|FG000|Overall Study|Other than specified above|5|||
128934727|NCT04655586|464049414|FG000|Overall Study|Physician Decision|1|||
128934728|NCT04655586|464049415|FG001|Overall Study|Physician Decision|3|||
128934729|NCT04655586|464049416|FG002|Overall Study|Physician Decision|4|||
128934730|NCT04655586|464049414|FG000|Overall Study|Withdrawal by Subject|1|||
128934731|NCT04655586|464049415|FG001|Overall Study|Withdrawal by Subject|3|||
128934732|NCT04655586|464049416|FG002|Overall Study|Withdrawal by Subject|1|||
128934733|NCT02927171|464049423|FG000|Overall Study|Lost to Follow-up|0|||
128934734|NCT02927171|464049424|FG001|Overall Study|Lost to Follow-up|1|||
128934735|NCT00552305|464049430|FG000|Overall Study|Adverse Event|43|||
128934736|NCT00552305|464049430|FG000|Overall Study|Lack of Efficacy|120|||
128934737|NCT00552305|464049430|FG000|Overall Study|Lost to Follow-up|4|||
128934738|NCT00552305|464049430|FG000|Overall Study|Protocol Violation|3|||
128934739|NCT00552305|464049430|FG000|Overall Study|Withdrawal by Subject|44|||
128934740|NCT00552305|464049430|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
128934741|NCT00552305|464049430|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
128934742|NCT00552305|464049430|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
128934743|NCT00552305|464049430|FG000|Overall Study|Unsatisfactory compliance|11|||
128934744|NCT00552305|464049430|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
128934745|NCT00552305|464049430|FG000|Overall Study|AE/Other: prohibited drug required|1|||
128934746|NCT00552305|464049430|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
128934747|NCT00552305|464049430|FG000|Overall Study|Other: Site closed|4|||
128934748|NCT00552305|464049430|FG000|Overall Study|Other: Personal problems|1|||
128934749|NCT00552305|464049430|FG000|Overall Study|Other: Unable to attend visits|1|||
128934750|NCT00552305|464049430|FG000|Overall Study|Other: Subject underwent surgery|4|||
128934751|NCT00552305|464049430|FG000|Overall Study|Other: Subject became pregnant|1|||
128934752|NCT00552305|464049430|FG000|Overall Study|Other: Health problems, not drug related|1|||
128934753|NCT00552305|464049430|FG000|Overall Study|Other: Subject moved from area|2|||
128934754|NCT00552305|464049430|FG000|Overall Study|Other: Subject incarcerated|1|||
128934755|NCT00552305|464049430|FG000|Overall Study|Other: Subject went to rehab|1|||
128934756|NCT03503773|464049431|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
128934757|NCT03503773|464049432|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
128934758|NCT03503773|464049431|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
128934759|NCT03503773|464049432|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
128934760|NCT03503773|464049431|FG000|Overall Study|Not completing the primary ABPM|3|||
128934761|NCT03503773|464049432|FG001|Overall Study|Not completing the primary ABPM|1|||
128934762|NCT03503773|464049431|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
128934763|NCT03503773|464049432|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
128934764|NCT02675517|464049435|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
128934765|NCT02675517|464049435|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
128934766|NCT00425438|464049436|FG000|Overall Study|Termination by Sponsor|25|||
128934767|NCT00425438|464049437|FG001|Overall Study|Termination by Sponsor|27|||
129121976|NCT02765165|464742715|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129121977|NCT02765165|464742716|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
128934768|NCT02619253|464049438|FG000|Overall Study|Adverse Event|0|||
128934769|NCT02619253|464049439|FG001|Overall Study|Adverse Event|0|||
128934770|NCT02619253|464049440|FG002|Overall Study|Adverse Event|1|||
128934771|NCT02619253|464049441|FG003|Overall Study|Adverse Event|1|||
128934772|NCT02619253|464049442|FG004|Overall Study|Adverse Event|3|||
128934773|NCT02619253|464049438|FG000|Overall Study|Alternative Therapy|0|||
128768002|NCT02223754|463440429|FG000|Period 2|Adverse Event|0|||
128768003|NCT02223754|463440430|FG001|Period 2|Adverse Event|1|||
128934774|NCT02619253|464049439|FG001|Overall Study|Alternative Therapy|0|||
128934775|NCT02619253|464049440|FG002|Overall Study|Alternative Therapy|1|||
128934776|NCT02619253|464049441|FG003|Overall Study|Alternative Therapy|0|||
128934777|NCT02619253|464049442|FG004|Overall Study|Alternative Therapy|0|||
128934778|NCT02619253|464049438|FG000|Overall Study|Death|0|||
128934779|NCT02619253|464049439|FG001|Overall Study|Death|0|||
128934780|NCT02619253|464049440|FG002|Overall Study|Death|0|||
128934781|NCT02619253|464049441|FG003|Overall Study|Death|1|||
128934782|NCT02619253|464049442|FG004|Overall Study|Death|0|||
128934783|NCT02619253|464049438|FG000|Overall Study|Disease Progression|4|||
128934784|NCT02619253|464049439|FG001|Overall Study|Disease Progression|2|||
128934785|NCT02619253|464049440|FG002|Overall Study|Disease Progression|8|||
128934786|NCT02619253|464049441|FG003|Overall Study|Disease Progression|9|||
128934787|NCT02619253|464049442|FG004|Overall Study|Disease Progression|10|||
128934788|NCT02619253|464049438|FG000|Overall Study|Needed a disqualifying therapy|0|||
128934789|NCT02619253|464049439|FG001|Overall Study|Needed a disqualifying therapy|0|||
128934790|NCT02619253|464049440|FG002|Overall Study|Needed a disqualifying therapy|1|||
128934791|NCT02619253|464049441|FG003|Overall Study|Needed a disqualifying therapy|0|||
128934792|NCT02619253|464049442|FG004|Overall Study|Needed a disqualifying therapy|0|||
128934793|NCT02619253|464049438|FG000|Overall Study|Transferred to hospice|0|||
128934794|NCT02619253|464049439|FG001|Overall Study|Transferred to hospice|0|||
128934795|NCT02619253|464049440|FG002|Overall Study|Transferred to hospice|1|||
128934796|NCT02619253|464049441|FG003|Overall Study|Transferred to hospice|0|||
128934797|NCT02619253|464049442|FG004|Overall Study|Transferred to hospice|0|||
128934798|NCT02619253|464049438|FG000|Overall Study|Physician Decision|0|||
128934799|NCT02619253|464049439|FG001|Overall Study|Physician Decision|1|||
128934800|NCT02619253|464049440|FG002|Overall Study|Physician Decision|2|||
128934801|NCT02619253|464049441|FG003|Overall Study|Physician Decision|3|||
128934802|NCT02619253|464049442|FG004|Overall Study|Physician Decision|0|||
128934803|NCT02619253|464049438|FG000|Overall Study|Withdrawal by Subject|0|||
128934804|NCT02619253|464049439|FG001|Overall Study|Withdrawal by Subject|1|||
128934805|NCT02619253|464049440|FG002|Overall Study|Withdrawal by Subject|0|||
128934806|NCT02619253|464049441|FG003|Overall Study|Withdrawal by Subject|0|||
128934807|NCT02619253|464049442|FG004|Overall Study|Withdrawal by Subject|2|||
128934808|NCT00514449|464049443|FG000|Overall Study|Withdrawal by Subject|1|||
128934809|NCT00514449|464049444|FG001|Overall Study|Withdrawal by Subject|2|||
128934810|NCT00514449|464049443|FG000|Overall Study|Protocol Violation|1|||
128934811|NCT00514449|464049444|FG001|Overall Study|Protocol Violation|2|||
128934812|NCT00514449|464049443|FG000|Overall Study|Lost to Follow-up|1|||
128934813|NCT00514449|464049444|FG001|Overall Study|Lost to Follow-up|0|||
128934814|NCT00301067|464049448|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
128934815|NCT00301067|464049449|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
128934816|NCT00301067|464049450|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
128934817|NCT00301067|464049451|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
128934818|NCT00301067|464049448|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
128934819|NCT00301067|464049449|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
128934820|NCT00301067|464049450|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
128934821|NCT00301067|464049451|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
128934822|NCT00301067|464049448|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
128934823|NCT00301067|464049449|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
128934824|NCT00301067|464049450|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
128934825|NCT00301067|464049451|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
128934826|NCT00301067|464049448|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
128934827|NCT00301067|464049449|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
128934828|NCT00301067|464049450|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
128934829|NCT00301067|464049451|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
128934830|NCT00301067|464049448|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
128934831|NCT00301067|464049449|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
128934832|NCT00301067|464049450|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
128934833|NCT00301067|464049451|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
128934834|NCT00301067|464049448|FG000|Follow up Until Death|Alive at last data cut point|1|||
128934835|NCT00301067|464049449|FG001|Follow up Until Death|Alive at last data cut point|0|||
128934836|NCT00301067|464049450|FG002|Follow up Until Death|Alive at last data cut point|0|||
128934837|NCT00301067|464049451|FG003|Follow up Until Death|Alive at last data cut point|1|||
128934838|NCT00149825|464049452|FG000|Overall Study|Intolerance to medication side effects|1|||
128934839|NCT00149825|464049453|FG001|Overall Study|Intolerance to medication side effects|2|||
128934840|NCT00149825|464049452|FG000|Overall Study|Time commitments|2|||
128934841|NCT00149825|464049453|FG001|Overall Study|Time commitments|1|||
128934842|NCT00149825|464049452|FG000|Overall Study|Not liking insomnia therapy|1|||
128934843|NCT00149825|464049453|FG001|Overall Study|Not liking insomnia therapy|0|||
128768004|NCT02223754|463440429|FG000|Period 2|Protocol Violation|1|||
128934844|NCT00149825|464049452|FG000|Overall Study|Other|1|||
128934845|NCT00149825|464049453|FG001|Overall Study|Other|0|||
128934846|NCT01359982|464049454|FG000|Overall Study|Adverse Event|2|||
128934847|NCT01359982|464049455|FG001|Overall Study|Adverse Event|0|||
128934848|NCT01359982|464049456|FG002|Overall Study|Adverse Event|0|||
128934849|NCT01359982|464049457|FG003|Overall Study|Adverse Event|1|||
128934850|NCT01359982|464049458|FG004|Overall Study|Adverse Event|0|||
128934851|NCT01359982|464049459|FG005|Overall Study|Adverse Event|0|||
128934852|NCT01359982|464049454|FG000|Overall Study|Death|1|||
128934853|NCT01359982|464049455|FG001|Overall Study|Death|0|||
128934854|NCT01359982|464049456|FG002|Overall Study|Death|0|||
128934855|NCT01359982|464049457|FG003|Overall Study|Death|0|||
128934856|NCT01359982|464049458|FG004|Overall Study|Death|0|||
128934857|NCT01359982|464049459|FG005|Overall Study|Death|0|||
128934858|NCT03694522|464049461|FG000|Overall Study|Withdrawal by Subject|8|||
128934859|NCT03694522|464049462|FG001|Overall Study|Withdrawal by Subject|10|||
128934860|NCT03694522|464049461|FG000|Overall Study|Physician Decision|53|||
128934861|NCT03694522|464049462|FG001|Overall Study|Physician Decision|54|||
128934862|NCT03694522|464049461|FG000|Overall Study|Other|1|||
128934863|NCT03694522|464049462|FG001|Overall Study|Other|1|||
128934864|NCT03694522|464049461|FG000|Overall Study|Lost to Follow-up|0|||
128934865|NCT03694522|464049462|FG001|Overall Study|Lost to Follow-up|1|||
128934866|NCT01164501|464049463|FG000|Overall Study|Not treated|2|||
128934867|NCT01164501|464049464|FG001|Overall Study|Not treated|0|||
128934868|NCT01164501|464049465|FG002|Overall Study|Not treated|1|||
128934869|NCT01164501|464049463|FG000|Overall Study|Adverse Event|18|||
128934870|NCT01164501|464049464|FG001|Overall Study|Adverse Event|4|||
128934871|NCT01164501|464049465|FG002|Overall Study|Adverse Event|21|||
128934872|NCT01164501|464049463|FG000|Overall Study|Lack of Efficacy|0|||
128934873|NCT01164501|464049464|FG001|Overall Study|Lack of Efficacy|0|||
128934874|NCT01164501|464049465|FG002|Overall Study|Lack of Efficacy|1|||
128934875|NCT01164501|464049463|FG000|Overall Study|Non compliant with protocol|1|||
128934876|NCT01164501|464049464|FG001|Overall Study|Non compliant with protocol|1|||
128934877|NCT01164501|464049465|FG002|Overall Study|Non compliant with protocol|4|||
128934878|NCT01164501|464049463|FG000|Overall Study|Lost to Follow-up|3|||
128934879|NCT01164501|464049464|FG001|Overall Study|Lost to Follow-up|0|||
128934880|NCT01164501|464049465|FG002|Overall Study|Lost to Follow-up|3|||
128934881|NCT01164501|464049463|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
128934882|NCT01164501|464049464|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
128934883|NCT01164501|464049465|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
128934884|NCT01164501|464049463|FG000|Overall Study|Other reason not defined above|9|||
128934885|NCT01164501|464049464|FG001|Overall Study|Other reason not defined above|1|||
128934886|NCT01164501|464049465|FG002|Overall Study|Other reason not defined above|4|||
128934887|NCT00306891|464049466|FG000|Part A|Withdrawal by Subject|1|||
128934888|NCT00306891|464049467|FG001|Part A|Withdrawal by Subject|1|||
128934889|NCT00306891|464049468|FG002|Part A|Withdrawal by Subject|0|||
128934890|NCT00306891|464049469|FG003|Part A|Withdrawal by Subject|0|||
128934891|NCT00306891|464049466|FG000|Part A|Condition under investigation worsened|2|||
128934892|NCT00306891|464049467|FG001|Part A|Condition under investigation worsened|2|||
128934893|NCT00306891|464049468|FG002|Part A|Condition under investigation worsened|0|||
128934894|NCT00306891|464049469|FG003|Part A|Condition under investigation worsened|0|||
128934895|NCT00306891|464049466|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
128934896|NCT00306891|464049467|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
128934897|NCT00306891|464049468|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
128934898|NCT00306891|464049469|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
128934899|NCT00306891|464049466|FG000|Part A|Partial bowel obstruction|1|||
128934900|NCT00306891|464049467|FG001|Part A|Partial bowel obstruction|0|||
128934901|NCT00306891|464049468|FG002|Part A|Partial bowel obstruction|0|||
128934902|NCT00306891|464049469|FG003|Part A|Partial bowel obstruction|0|||
128934903|NCT00306891|464049466|FG000|Part A|Reaccumul. of ascites following drainage|0|||
128934904|NCT00306891|464049467|FG001|Part A|Reaccumul. of ascites following drainage|1|||
128934905|NCT00306891|464049468|FG002|Part A|Reaccumul. of ascites following drainage|0|||
128934906|NCT00306891|464049469|FG003|Part A|Reaccumul. of ascites following drainage|0|||
128934907|NCT00306891|464049466|FG000|Part A|Suspicion of second malignancy|0|||
128934908|NCT00306891|464049467|FG001|Part A|Suspicion of second malignancy|1|||
128934909|NCT00306891|464049468|FG002|Part A|Suspicion of second malignancy|0|||
128934910|NCT00306891|464049469|FG003|Part A|Suspicion of second malignancy|0|||
128934911|NCT00306891|464049466|FG000|Part A|QTC interval outwith elig. criteria|1|||
129031066|NCT04535986|464404801|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
129031067|NCT04535986|464404802|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
129031068|NCT04535986|464404801|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
129031069|NCT04535986|464404802|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
129031070|NCT04535986|464404801|FG000|Overall Study|Adverse Event|10|||
129031071|NCT04535986|464404802|FG001|Overall Study|Adverse Event|1|||
129031072|NCT04535986|464404801|FG000|Overall Study|Lack of Efficacy|3|||
128768005|NCT02223754|463440430|FG001|Period 2|Protocol Violation|0|||
128934912|NCT00306891|464049467|FG001|Part A|QTC interval outwith elig. criteria|0|||
128934913|NCT00306891|464049468|FG002|Part A|QTC interval outwith elig. criteria|0|||
128934914|NCT00306891|464049469|FG003|Part A|QTC interval outwith elig. criteria|0|||
128934915|NCT00306891|464049466|FG000|Part B|Death|0|||
128934916|NCT00306891|464049467|FG001|Part B|Death|0|||
128934917|NCT00306891|464049468|FG002|Part B|Death|1|||
128934918|NCT00306891|464049469|FG003|Part B|Death|2|||
128934919|NCT00306891|464049466|FG000|Part B|Adverse Event|0|||
128934920|NCT00306891|464049467|FG001|Part B|Adverse Event|0|||
128934921|NCT00306891|464049468|FG002|Part B|Adverse Event|5|||
128934922|NCT00306891|464049469|FG003|Part B|Adverse Event|5|||
128934923|NCT00306891|464049466|FG000|Part B|Withdrawal by Subject|0|||
128934924|NCT00306891|464049467|FG001|Part B|Withdrawal by Subject|0|||
128934925|NCT00306891|464049468|FG002|Part B|Withdrawal by Subject|3|||
128934926|NCT00306891|464049469|FG003|Part B|Withdrawal by Subject|1|||
128934927|NCT00306891|464049466|FG000|Part B|Condition under investigation worsened|0|||
128934928|NCT00306891|464049467|FG001|Part B|Condition under investigation worsened|0|||
128934929|NCT00306891|464049468|FG002|Part B|Condition under investigation worsened|2|||
128934930|NCT00306891|464049469|FG003|Part B|Condition under investigation worsened|8|||
128934931|NCT00306891|464049466|FG000|Part B|Development of study specific disc crit.|0|||
128934932|NCT00306891|464049467|FG001|Part B|Development of study specific disc crit.|0|||
128934933|NCT00306891|464049468|FG002|Part B|Development of study specific disc crit.|0|||
128934934|NCT00306891|464049469|FG003|Part B|Development of study specific disc crit.|1|||
128934935|NCT00673673|464049470|FG000|Overall Study|Progressive disease|27|||
128934936|NCT00673673|464049470|FG000|Overall Study|Adverse Event|4|||
128934937|NCT00673673|464049470|FG000|Overall Study|Withdrawal by Subject|3|||
128934938|NCT00673673|464049470|FG000|Overall Study|Investigators' discretion|2|||
128934939|NCT04538950|464049471|FG000|Overall Study|Pulmonary Issues|2|||
128934940|NCT04538950|464049471|FG000|Overall Study|illness|2|||
128934941|NCT02792777|464049472|FG000|Overall Study|Withdrawal by Subject|2|||
128934942|NCT02792777|464049473|FG001|Overall Study|Withdrawal by Subject|0|||
128934943|NCT02792777|464049472|FG000|Overall Study|Recording malfunction|2|||
128934944|NCT02792777|464049473|FG001|Overall Study|Recording malfunction|0|||
128934945|NCT02792777|464049472|FG000|Overall Study|Later determined to be ineligible|2|||
128934946|NCT02792777|464049473|FG001|Overall Study|Later determined to be ineligible|0|||
128934947|NCT02792777|464049472|FG000|Overall Study|Participant interviewed twice|1|||
128934948|NCT02792777|464049473|FG001|Overall Study|Participant interviewed twice|0|||
128934949|NCT04799782|464049475|FG000|Washout|Physician Decision|2|||
128934950|NCT04799782|464049476|FG001|Washout|Physician Decision|0|||
128934951|NCT04799782|464049475|FG000|Washout|Withdrawal by Subject|0|||
128934952|NCT04799782|464049476|FG001|Washout|Withdrawal by Subject|2|||
128934953|NCT04799782|464049475|FG000|Washout|Lost to Follow-up|0|||
128934954|NCT04799782|464049476|FG001|Washout|Lost to Follow-up|1|||
128934955|NCT02606877|464049477|FG000|Overall Study|Adverse Event|3|||
128934956|NCT02606877|464049478|FG001|Overall Study|Adverse Event|0|||
128934957|NCT02606877|464049477|FG000|Overall Study|Non-compliance with protocol|0|||
128934958|NCT02606877|464049478|FG001|Overall Study|Non-compliance with protocol|1|||
128934959|NCT02606877|464049477|FG000|Overall Study|Other than listed above|1|||
128934960|NCT02606877|464049478|FG001|Overall Study|Other than listed above|0|||
128934961|NCT00515463|464049490|FG000|Overall Study|Physician Decision|4|||
128934962|NCT00515463|464049491|FG001|Overall Study|Physician Decision|2|||
128934963|NCT00515463|464049490|FG000|Overall Study|Adverse Event|1|||
128934964|NCT00515463|464049491|FG001|Overall Study|Adverse Event|2|||
128934965|NCT00515463|464049490|FG000|Overall Study|Withdrawal by Subject|3|||
128934966|NCT00515463|464049491|FG001|Overall Study|Withdrawal by Subject|4|||
128934967|NCT00515463|464049490|FG000|Overall Study|Lost to Follow-up|6|||
128934968|NCT00515463|464049491|FG001|Overall Study|Lost to Follow-up|5|||
128934969|NCT00515463|464049490|FG000|Overall Study|Other|0|||
128934970|NCT00515463|464049491|FG001|Overall Study|Other|1|||
128934971|NCT01040832|464050860|FG000|Overall Study|Adverse Event|4|||
128934972|NCT01040832|464050861|FG001|Overall Study|Adverse Event|5|||
128934973|NCT01040832|464050860|FG000|Overall Study|Death|4|||
128934974|NCT01040832|464050861|FG001|Overall Study|Death|6|||
128934975|NCT01040832|464050860|FG000|Overall Study|Withdrawal by Subject|2|||
128934976|NCT01040832|464050861|FG001|Overall Study|Withdrawal by Subject|3|||
128934977|NCT01040832|464050860|FG000|Overall Study|Progressive disease|32|||
128934978|NCT01040832|464050861|FG001|Overall Study|Progressive disease|17|||
128934979|NCT01040832|464050860|FG000|Overall Study|Symptomatic deterioration|2|||
128934980|NCT01040832|464050861|FG001|Overall Study|Symptomatic deterioration|5|||
128934981|NCT01040832|464050860|FG000|Overall Study|Other|2|||
128934982|NCT01040832|464050861|FG001|Overall Study|Other|1|||
128934983|NCT01058369|464050867|FG000|Overall Study|Adverse Event|1|||
128934984|NCT01058369|464050867|FG000|Overall Study|Early termination study|1|||
129031073|NCT04535986|464404802|FG001|Overall Study|Lack of Efficacy|2|||
128934985|NCT02940886|464050868|FG000|Overall Study|Adverse Event|7|||
128934986|NCT02940886|464050869|FG001|Overall Study|Adverse Event|3|||
128934987|NCT02940886|464050868|FG000|Overall Study|Protocol Violation|0|||
128934988|NCT02940886|464050869|FG001|Overall Study|Protocol Violation|2|||
128934989|NCT02940886|464050868|FG000|Overall Study|Withdrawal by Subject|28|||
128934990|NCT02940886|464050869|FG001|Overall Study|Withdrawal by Subject|20|||
128934991|NCT02940886|464050868|FG000|Overall Study|Death|1|||
128934992|NCT02940886|464050869|FG001|Overall Study|Death|0|||
128934993|NCT02940886|464050868|FG000|Overall Study|Lack of Efficacy|1|||
128934994|NCT02940886|464050869|FG001|Overall Study|Lack of Efficacy|0|||
128934995|NCT02940886|464050868|FG000|Overall Study|Lost to Follow-up|49|||
128934996|NCT02940886|464050869|FG001|Overall Study|Lost to Follow-up|21|||
128934997|NCT02940886|464050868|FG000|Overall Study|Physician Decision|9|||
128934998|NCT02940886|464050869|FG001|Overall Study|Physician Decision|4|||
128934999|NCT02940886|464050868|FG000|Overall Study|Sponsor decision|0|||
128935000|NCT02940886|464050869|FG001|Overall Study|Sponsor decision|1|||
128935001|NCT02940886|464050868|FG000|Overall Study|No treatment|7|||
128935002|NCT02940886|464050869|FG001|Overall Study|No treatment|2|||
128935003|NCT02940886|464050868|FG000|Overall Study|Enrolment error|0|||
128935004|NCT02940886|464050869|FG001|Overall Study|Enrolment error|1|||
128935005|NCT01306058|464050871|FG000|Overall Study|Death|1|||
128935006|NCT01306058|464050871|FG000|Overall Study|Enrolled but did not get treatment|1|||
128935007|NCT01666444|464050872|FG000|Overall Study|Did not initiate treatment|2|||
128935008|NCT01666444|464050873|FG001|Overall Study|Did not initiate treatment|1|||
128935009|NCT00592358|464050876|FG000|Overall Study|Withdrawal by Subject|2|||
128935010|NCT00592358|464050876|FG000|Overall Study|Adverse Event|1|||
128935011|NCT00592358|464050876|FG000|Overall Study|Lack of Efficacy|2|||
128935012|NCT00592358|464050876|FG000|Overall Study|Inability to swallow pills|1|||
128935013|NCT00084682|464050877|FG000|Overall Study|Withdrawal by Subject|1|||
128935014|NCT03238248|464050885|FG000|Overall Study|Death|5|||
128935015|NCT03238248|464050885|FG000|Overall Study|Withdrawal by Subject|7|||
128935016|NCT03238248|464050885|FG000|Overall Study|Participant proceeding to transplant|10|||
128935017|NCT03238248|464050885|FG000|Overall Study|Lack of Efficacy|4|||
128935018|NCT03238248|464050885|FG000|Overall Study|Physician Decision|3|||
128935019|NCT03238248|464050885|FG000|Overall Study|Transitioning to another study|1|||
128935020|NCT03238248|464050885|FG000|Overall Study|No longer benefiting|1|||
128935021|NCT03238248|464050885|FG000|Overall Study|Other complicating disease|1|||
128935022|NCT03238248|464050885|FG000|Overall Study|Adverse Event|5|||
128935023|NCT03238248|464050885|FG000|Overall Study|Disease progression|26|||
128935024|NCT03238248|464050885|FG000|Overall Study|N/A participant is still on treatment|1|||
128935025|NCT03238248|464050885|FG000|Overall Study|Decline in condition|1|||
128935026|NCT03238248|464050885|FG000|Overall Study|Alternative therapy|2|||
128935027|NCT01013883|464050887|FG000|Overall Study|Lost to Follow-up|2|||
128935028|NCT01013883|464050888|FG001|Overall Study|Lost to Follow-up|2|||
128935029|NCT03268746|464050893|FG000|Overall Study|Withdrawal by Subject|1|||
128935030|NCT00891657|464050896|FG000|Overall Study|Withdrawal by Subject|1|||
128935031|NCT00891657|464050897|FG001|Overall Study|Withdrawal by Subject|1|||
128935032|NCT04530825|464050898|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
128935033|NCT04530825|464050899|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
128935034|NCT04530825|464050900|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
128935035|NCT04530825|464050901|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
128935036|NCT04530825|464050898|FG000|Overall Study|Did not complete follow-up|3|||
128935037|NCT04530825|464050899|FG001|Overall Study|Did not complete follow-up|0|||
128935038|NCT04530825|464050900|FG002|Overall Study|Did not complete follow-up|0|||
128935039|NCT04530825|464050901|FG003|Overall Study|Did not complete follow-up|0|||
128935040|NCT00850499|464050902|FG000|Overall Study|Adverse Event|3|||
128935041|NCT00850499|464050903|FG001|Overall Study|Adverse Event|1|||
128935042|NCT00850499|464050902|FG000|Overall Study|Lack of Efficacy|0|||
128935043|NCT00850499|464050903|FG001|Overall Study|Lack of Efficacy|1|||
128935044|NCT04498910|464050904|FG000|Overall Study|Lost to Follow-up|0|||
128935045|NCT04498910|464050905|FG001|Overall Study|Lost to Follow-up|1|||
128935046|NCT04498910|464050904|FG000|Overall Study|Withdrawal by Subject|2|||
128935047|NCT04498910|464050905|FG001|Overall Study|Withdrawal by Subject|1|||
128935048|NCT04498910|464050904|FG000|Overall Study|Adverse Event|1|||
128935049|NCT04498910|464050905|FG001|Overall Study|Adverse Event|0|||
128935050|NCT01849848|464050906|FG000|Overall Study|Physician Decision|1|||
128935051|NCT01849848|464050906|FG000|Overall Study|Progression of the primary disease|3|||
128935052|NCT00909090|464050907|FG000|Overall Study|Lost to Follow-up|17|||
128935053|NCT00909090|464050908|FG001|Overall Study|Lost to Follow-up|17|||
128935054|NCT02926573|464050910|FG000|Overall Study|Nausea|1|||
128935055|NCT02926573|464050911|FG001|Overall Study|Nausea|0|||
128935056|NCT02926573|464050910|FG000|Overall Study|Remain intubated|2|||
128935057|NCT02926573|464050911|FG001|Overall Study|Remain intubated|2|||
128935058|NCT02926573|464050910|FG000|Overall Study|Change in surgery plan|3|||
128935059|NCT02926573|464050911|FG001|Overall Study|Change in surgery plan|1|||
128768006|NCT02223754|463440429|FG000|Period 2|Lens Discomfort|1|||
128935060|NCT02926573|464050910|FG000|Overall Study|Change to outpatient status|5|||
128935061|NCT02926573|464050911|FG001|Overall Study|Change to outpatient status|1|||
128935062|NCT02926573|464050910|FG000|Overall Study|Withdrawal by Subject|0|||
128935063|NCT02926573|464050911|FG001|Overall Study|Withdrawal by Subject|2|||
128935064|NCT02926573|464050910|FG000|Overall Study|Return to operating room|0|||
128935065|NCT02926573|464050911|FG001|Overall Study|Return to operating room|2|||
128935066|NCT02926573|464050910|FG000|Overall Study|Delirium|0|||
128935067|NCT02926573|464050911|FG001|Overall Study|Delirium|1|||
128935068|NCT00858702|464050914|FG000|Overall Study|Lack of Efficacy|1|||
128935069|NCT00858702|464050915|FG001|Overall Study|Lack of Efficacy|0|||
129031074|NCT04535986|464404801|FG000|Overall Study|Investigator discretion|3|||
129031075|NCT04535986|464404802|FG001|Overall Study|Investigator discretion|0|||
129031076|NCT04535986|464404801|FG000|Overall Study|Withdrawal by Subject|32|||
129031077|NCT04535986|464404802|FG001|Overall Study|Withdrawal by Subject|14|||
129031078|NCT04535986|464404801|FG000|Overall Study|Lost to Follow-up|5|||
129031079|NCT04535986|464404802|FG001|Overall Study|Lost to Follow-up|3|||
129031080|NCT04535986|464404801|FG000|Overall Study|Other|7|||
129031081|NCT04535986|464404802|FG001|Overall Study|Other|3|||
129031082|NCT02179190|464404803|FG000|Enrollment|Exit Prior to Device Attempt|11|||
129031083|NCT02179190|464404803|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
129031084|NCT02179190|464404803|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
129031085|NCT02179190|464404803|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
129031086|NCT02179190|464404803|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
129031087|NCT02179190|464404803|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
129031088|NCT01993940|464404806|FG000|Overall Study|Adverse Event|16|||
129031089|NCT01993940|464404807|FG001|Overall Study|Adverse Event|11|||
129031090|NCT01993940|464404806|FG000|Overall Study|Withdrawal by Subject|15|||
129031091|NCT01993940|464404807|FG001|Overall Study|Withdrawal by Subject|19|||
129031092|NCT01993940|464404806|FG000|Overall Study|Lost to Follow-up|2|||
129031093|NCT01993940|464404807|FG001|Overall Study|Lost to Follow-up|5|||
129031094|NCT01993940|464404806|FG000|Overall Study|Protocol Violation|5|||
129031095|NCT01993940|464404807|FG001|Overall Study|Protocol Violation|8|||
129031096|NCT01993940|464404806|FG000|Overall Study|Death|1|||
129031097|NCT01993940|464404807|FG001|Overall Study|Death|0|||
129031098|NCT01993940|464404806|FG000|Overall Study|Other - Miscellaneous|1|||
129031099|NCT01993940|464404807|FG001|Overall Study|Other - Miscellaneous|1|||
129031100|NCT01567527|464404808|FG000|Conversion Phase.|Protocol deviation|3|||
129031101|NCT01567527|464404809|FG001|Conversion Phase.|Protocol deviation|0|||
129031102|NCT01567527|464404810|FG002|Conversion Phase.|Protocol deviation|0|||
129031103|NCT01567527|464404811|FG003|Conversion Phase.|Protocol deviation|0|||
129031104|NCT01567527|464404812|FG004|Conversion Phase.|Protocol deviation|0|||
129031105|NCT01567527|464404808|FG000|Conversion Phase.|Met withdrawal criteria|10|||
129031106|NCT01567527|464404809|FG001|Conversion Phase.|Met withdrawal criteria|0|||
129031107|NCT01567527|464404810|FG002|Conversion Phase.|Met withdrawal criteria|0|||
129031108|NCT01567527|464404811|FG003|Conversion Phase.|Met withdrawal criteria|0|||
129031109|NCT01567527|464404812|FG004|Conversion Phase.|Met withdrawal criteria|0|||
129031110|NCT01567527|464404808|FG000|Conversion Phase.|Withdrawal by Subject|32|||
129031111|NCT01567527|464404809|FG001|Conversion Phase.|Withdrawal by Subject|0|||
129031112|NCT01567527|464404810|FG002|Conversion Phase.|Withdrawal by Subject|0|||
129031113|NCT01567527|464404811|FG003|Conversion Phase.|Withdrawal by Subject|0|||
129031114|NCT01567527|464404812|FG004|Conversion Phase.|Withdrawal by Subject|0|||
129031115|NCT01567527|464404808|FG000|Conversion Phase.|Lost to Follow-up|16|||
129031116|NCT01567527|464404809|FG001|Conversion Phase.|Lost to Follow-up|0|||
129031117|NCT01567527|464404810|FG002|Conversion Phase.|Lost to Follow-up|0|||
129031118|NCT01567527|464404811|FG003|Conversion Phase.|Lost to Follow-up|0|||
129031119|NCT01567527|464404812|FG004|Conversion Phase.|Lost to Follow-up|0|||
129031120|NCT01567527|464404808|FG000|Conversion Phase.|Lack of Efficacy|2|||
129031121|NCT01567527|464404809|FG001|Conversion Phase.|Lack of Efficacy|0|||
129031122|NCT01567527|464404810|FG002|Conversion Phase.|Lack of Efficacy|0|||
129031123|NCT01567527|464404811|FG003|Conversion Phase.|Lack of Efficacy|0|||
129031124|NCT01567527|464404812|FG004|Conversion Phase.|Lack of Efficacy|0|||
129031125|NCT01567527|464404808|FG000|Conversion Phase.|Adverse Event|33|||
129031126|NCT01567527|464404809|FG001|Conversion Phase.|Adverse Event|0|||
129031127|NCT01567527|464404810|FG002|Conversion Phase.|Adverse Event|0|||
129031128|NCT01567527|464404811|FG003|Conversion Phase.|Adverse Event|0|||
129031129|NCT01567527|464404812|FG004|Conversion Phase.|Adverse Event|0|||
129031130|NCT01567527|464404808|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
129031131|NCT01567527|464404809|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
128703584|NCT03052725|463213452|FG001|Overall Study|Withdrawal by Subject|4|||
128703585|NCT03052725|463213451|FG000|Overall Study|Pregnancy|0|||
128703586|NCT03052725|463213452|FG001|Overall Study|Pregnancy|1|||
128703587|NCT03052725|463213451|FG000|Overall Study|Site closure|0|||
129031132|NCT01567527|464404810|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
129031133|NCT01567527|464404811|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
129031134|NCT01567527|464404812|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
129121978|NCT02765165|464742717|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129121979|NCT02765165|464742711|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
129121980|NCT02765165|464742712|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
129121981|NCT02765165|464742713|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
129031135|NCT01567527|464404808|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
129031136|NCT01567527|464404809|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
129031137|NCT01567527|464404810|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
129031138|NCT01567527|464404811|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
128703588|NCT03052725|463213452|FG001|Overall Study|Site closure|1|||
128703589|NCT03052725|463213451|FG000|Overall Study|Study terminated by sponsor|143|||
129121982|NCT02765165|464742714|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
129121983|NCT02765165|464742715|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
129121984|NCT02765165|464742716|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
129121985|NCT02765165|464742717|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
129121986|NCT02765165|464742711|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
129121987|NCT02765165|464742712|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
129121988|NCT02765165|464742713|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
128935070|NCT00858702|464050914|FG000|Overall Study|Protocol Violation|1|||
128935071|NCT00858702|464050915|FG001|Overall Study|Protocol Violation|1|||
128935072|NCT00858702|464050914|FG000|Overall Study|Other|2|||
128935073|NCT00858702|464050915|FG001|Overall Study|Other|1|||
128935074|NCT00858702|464050914|FG000|Overall Study|Withdrawal by Subject|1|||
128935075|NCT00858702|464050915|FG001|Overall Study|Withdrawal by Subject|0|||
128935076|NCT01214434|464050924|FG000|Overall Study|Withdrawal by Subject|1|||
128935077|NCT01214434|464050925|FG001|Overall Study|Withdrawal by Subject|0|||
128935078|NCT01214434|464050924|FG000|Overall Study|Lost to Follow-up|2|||
128935079|NCT01214434|464050925|FG001|Overall Study|Lost to Follow-up|2|||
128935080|NCT01214434|464050924|FG000|Overall Study|Site error|1|||
128935081|NCT01214434|464050925|FG001|Overall Study|Site error|0|||
128935082|NCT00138151|464050926|FG000|Overall Study|Withdrawal by Subject|3|||
128935083|NCT00138151|464050926|FG000|Overall Study|Physician Decision|1|||
128935084|NCT02902809|464050930|FG000|Overall Study|Discontinuation of asthma program|28|||
128935085|NCT00532259|464050931|FG000|Overall Study|Withdrawal by Subject|2|||
128935086|NCT00532259|464050931|FG000|Overall Study|Adverse Event|1|||
128935087|NCT00532259|464050931|FG000|Overall Study|Death|1|||
128935088|NCT00532259|464050931|FG000|Overall Study|Lack of Efficacy|21|||
128935089|NCT00532259|464050931|FG000|Overall Study|Lost to Follow-up|3|||
128935090|NCT00532259|464050931|FG000|Overall Study|Physician Decision|3|||
128935091|NCT00532259|464050931|FG000|Overall Study|Protocol Violation|1|||
128935092|NCT00793104|464050932|FG000|Overall Study|Lost to Follow-up|1|||
128935093|NCT01302769|464050933|FG000|Overall Study|Lost to Follow-up|1|||
128935094|NCT01302769|464050934|FG001|Overall Study|Lost to Follow-up|1|||
128935095|NCT03494725|464050935|FG000|Overall Study|Withdrawal by Subject|0|||
128935096|NCT03494725|464050936|FG001|Overall Study|Withdrawal by Subject|2|||
128935097|NCT03494725|464050935|FG000|Overall Study|Antibiotic use|1|||
128935098|NCT03494725|464050936|FG001|Overall Study|Antibiotic use|0|||
128935099|NCT04983940|464050937|FG000|Overall Study|Lost to Follow-up|14|||
128935100|NCT04983940|464050937|FG000|Overall Study|Lack of Efficacy|2|||
128935101|NCT02760407|464050940|FG000|Overall Study|Death|2|||
128935102|NCT02760407|464050941|FG001|Overall Study|Death|3|||
128935103|NCT02760407|464050942|FG002|Overall Study|Death|1|||
128935104|NCT02760407|464050943|FG003|Overall Study|Death|1|||
128935105|NCT02760407|464050940|FG000|Overall Study|Lost to Follow-up|1|||
128935106|NCT02760407|464050941|FG001|Overall Study|Lost to Follow-up|7|||
128935107|NCT02760407|464050942|FG002|Overall Study|Lost to Follow-up|4|||
128935108|NCT02760407|464050943|FG003|Overall Study|Lost to Follow-up|6|||
128935109|NCT02760407|464050940|FG000|Overall Study|Withdrawal by Subject|25|||
128935110|NCT02760407|464050941|FG001|Overall Study|Withdrawal by Subject|31|||
128935111|NCT02760407|464050942|FG002|Overall Study|Withdrawal by Subject|37|||
128935112|NCT02760407|464050943|FG003|Overall Study|Withdrawal by Subject|25|||
128935113|NCT02760407|464050940|FG000|Overall Study|Violation of Eligibility criteria|0|||
128935114|NCT02760407|464050941|FG001|Overall Study|Violation of Eligibility criteria|0|||
128935115|NCT02760407|464050942|FG002|Overall Study|Violation of Eligibility criteria|1|||
128935116|NCT02760407|464050943|FG003|Overall Study|Violation of Eligibility criteria|1|||
128935117|NCT02760407|464050940|FG000|Overall Study|Personal reasons|0|||
128935118|NCT02760407|464050941|FG001|Overall Study|Personal reasons|0|||
128935119|NCT02760407|464050942|FG002|Overall Study|Personal reasons|0|||
128935120|NCT02760407|464050943|FG003|Overall Study|Personal reasons|1|||
128935121|NCT02760407|464050940|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
128935122|NCT02760407|464050941|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
128935123|NCT02760407|464050942|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
128935124|NCT02760407|464050943|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
128935125|NCT02760407|464050940|FG000|Overall Study|Use of prohibited Medication|0|||
128935126|NCT02760407|464050941|FG001|Overall Study|Use of prohibited Medication|0|||
128935127|NCT02760407|464050942|FG002|Overall Study|Use of prohibited Medication|1|||
128935128|NCT02760407|464050943|FG003|Overall Study|Use of prohibited Medication|0|||
128935129|NCT02760407|464050940|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
128935130|NCT02760407|464050941|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
128935131|NCT02760407|464050942|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
128935132|NCT02760407|464050943|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
129121989|NCT02765165|464742714|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
128935133|NCT02760407|464050940|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
129031139|NCT01567527|464404812|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
129031140|NCT01567527|464404808|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129031141|NCT01567527|464404809|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
129031142|NCT01567527|464404810|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129031143|NCT01567527|464404811|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129031144|NCT01567527|464404812|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129031145|NCT01567527|464404808|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129031146|NCT01567527|464404809|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
129031147|NCT01567527|464404810|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129031148|NCT01567527|464404811|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129031149|NCT01567527|464404812|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129031150|NCT01567527|464404808|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
129031151|NCT01567527|464404809|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
129031152|NCT01567527|464404810|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
128935134|NCT02760407|464050941|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
128935135|NCT02760407|464050942|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
128935136|NCT02760407|464050943|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
128935137|NCT02760407|464050940|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
128935138|NCT02760407|464050941|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
128935139|NCT02760407|464050942|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
128935140|NCT02760407|464050943|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
128935141|NCT02760407|464050940|FG000|Overall Study|Inadequately Enrolled|0|||
128935142|NCT02760407|464050941|FG001|Overall Study|Inadequately Enrolled|0|||
128935143|NCT02760407|464050942|FG002|Overall Study|Inadequately Enrolled|0|||
128935144|NCT02760407|464050943|FG003|Overall Study|Inadequately Enrolled|1|||
128935145|NCT02760407|464050940|FG000|Overall Study|Withdrawal By PI's Decision|0|||
128935146|NCT02760407|464050941|FG001|Overall Study|Withdrawal By PI's Decision|1|||
128935147|NCT02760407|464050942|FG002|Overall Study|Withdrawal By PI's Decision|0|||
128935148|NCT02760407|464050943|FG003|Overall Study|Withdrawal By PI's Decision|0|||
128935149|NCT02760407|464050940|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
128935150|NCT02760407|464050941|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
128935151|NCT02760407|464050942|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
128935152|NCT02760407|464050943|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
128935153|NCT02760407|464050940|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
128935154|NCT02760407|464050941|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
128935155|NCT02760407|464050942|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
128935156|NCT02760407|464050943|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
128935157|NCT02760407|464050940|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
128935158|NCT02760407|464050941|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
128935159|NCT02760407|464050942|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
128935160|NCT02760407|464050943|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
128935161|NCT02760407|464050940|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
128935162|NCT02760407|464050941|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
128935163|NCT02760407|464050942|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
128935164|NCT02760407|464050943|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
128935165|NCT02760407|464050940|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
128935166|NCT02760407|464050941|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
128935167|NCT02760407|464050942|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
128935168|NCT02760407|464050943|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
128935169|NCT02760407|464050940|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
129031153|NCT01567527|464404811|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
129031154|NCT01567527|464404812|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
129031155|NCT01567527|464404808|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129121990|NCT02765165|464742715|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
129121991|NCT02765165|464742716|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
129121992|NCT02765165|464742717|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
129121993|NCT02567188|464742718|FG000|Overall Study|Death|10|||
128935170|NCT02760407|464050941|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
128935171|NCT02760407|464050942|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
128935172|NCT02760407|464050943|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
129031156|NCT01567527|464404809|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
129031157|NCT01567527|464404810|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129031158|NCT01567527|464404811|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129031159|NCT01567527|464404812|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129031160|NCT01567527|464404808|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129031161|NCT01567527|464404809|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
129031162|NCT01567527|464404810|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129031163|NCT01567527|464404811|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129031164|NCT01567527|464404812|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129031165|NCT01567527|464404808|FG000|IM Depot Stabilization.|Protocol deviation|0|||
129031166|NCT01567527|464404809|FG001|IM Depot Stabilization.|Protocol deviation|0|||
129031167|NCT01567527|464404810|FG002|IM Depot Stabilization.|Protocol deviation|5|||
129031168|NCT01567527|464404811|FG003|IM Depot Stabilization.|Protocol deviation|0|||
129031169|NCT01567527|464404812|FG004|IM Depot Stabilization.|Protocol deviation|0|||
129031170|NCT01567527|464404808|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
129031171|NCT01567527|464404809|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
129031172|NCT01567527|464404810|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
129031173|NCT01567527|464404811|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
129031174|NCT01567527|464404812|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
129031175|NCT01567527|464404808|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
129031176|NCT01567527|464404809|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
129031177|NCT01567527|464404810|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
129031178|NCT01567527|464404811|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
128935173|NCT02760407|464050940|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
128935174|NCT02760407|464050941|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
128935175|NCT02760407|464050942|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
128935176|NCT02760407|464050943|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
128935177|NCT02760407|464050940|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
128935178|NCT02760407|464050941|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
128935179|NCT02760407|464050942|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
128935180|NCT02760407|464050943|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
128935181|NCT02760407|464050940|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
128935182|NCT02760407|464050941|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
128935183|NCT02760407|464050942|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
128935184|NCT02760407|464050943|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
128935185|NCT01748760|464050944|FG000|Overall Study|Withdrawal by Subject|1|||
128935186|NCT01748760|464050945|FG001|Overall Study|Withdrawal by Subject|1|||
128935187|NCT01748760|464050944|FG000|Overall Study|Lost to Follow-up|5|||
128935188|NCT01748760|464050945|FG001|Overall Study|Lost to Follow-up|1|||
128935189|NCT03245814|464050946|FG000|Overall Study|Lost to Follow-up|5|||
128935190|NCT03245814|464050947|FG001|Overall Study|Lost to Follow-up|8|||
128935191|NCT03245814|464050946|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
128935192|NCT03245814|464050947|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
128935193|NCT02263365|464050948|FG000|Overall Study|Physician Decision|22|||
128935194|NCT02263365|464050949|FG001|Overall Study|Physician Decision|18|||
128935195|NCT00206518|464050950|FG000|Overall Study|Lack of Efficacy|6|||
128935196|NCT00206518|464050951|FG001|Overall Study|Lack of Efficacy|4|||
128935197|NCT00206518|464050950|FG000|Overall Study|Adverse Event|2|||
128935198|NCT00206518|464050951|FG001|Overall Study|Adverse Event|1|||
128935199|NCT00206518|464050950|FG000|Overall Study|Physician Decision|1|||
128935200|NCT00206518|464050951|FG001|Overall Study|Physician Decision|0|||
128935201|NCT00206518|464050950|FG000|Overall Study|Protocol Violation|1|||
128935202|NCT00206518|464050951|FG001|Overall Study|Protocol Violation|1|||
128935203|NCT00394914|464050954|FG000|Treatment Period|Adverse Event|0|||
128935204|NCT00394914|464050955|FG001|Treatment Period|Adverse Event|3|||
128935205|NCT00394914|464050956|FG002|Treatment Period|Adverse Event|1|||
128935206|NCT00394914|464050954|FG000|Treatment Period|Lost to Follow-up|0|||
128935207|NCT00394914|464050955|FG001|Treatment Period|Lost to Follow-up|1|||
128935208|NCT00394914|464050956|FG002|Treatment Period|Lost to Follow-up|0|||
129121994|NCT02567188|464742718|FG000|Overall Study|Terminated Mircera Treatment|9|||
129121995|NCT02567188|464742718|FG000|Overall Study|Lost to Follow-up|5|||
129121996|NCT02567188|464742718|FG000|Overall Study|Adverse Event|1|||
129121997|NCT02567188|464742718|FG000|Overall Study|Withdrawal by Subject|1|||
129121998|NCT02567188|464742718|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
129121999|NCT02567188|464742718|FG000|Overall Study|Moved and Changed Clinic|1|||
129122000|NCT02567188|464742718|FG000|Overall Study|Started Hemodialysis|2|||
128935209|NCT00394914|464050954|FG000|Treatment Period|Withdrawal by Subject|0|||
128935210|NCT00394914|464050955|FG001|Treatment Period|Withdrawal by Subject|2|||
128935211|NCT00394914|464050956|FG002|Treatment Period|Withdrawal by Subject|2|||
129122001|NCT02567188|464742718|FG000|Overall Study|Protocol Violation|5|||
128935212|NCT00394914|464050954|FG000|Treatment Period|Noncompliance with protocol|0|||
128935213|NCT00394914|464050955|FG001|Treatment Period|Noncompliance with protocol|3|||
128935214|NCT00394914|464050956|FG002|Treatment Period|Noncompliance with protocol|2|||
128935215|NCT00394914|464050954|FG000|Treatment Period|Did not meet protocol eligibility|0|||
128935216|NCT00394914|464050955|FG001|Treatment Period|Did not meet protocol eligibility|1|||
128935217|NCT00394914|464050956|FG002|Treatment Period|Did not meet protocol eligibility|1|||
128935218|NCT00872898|464050959|FG000|Part Two - Double Blind|Adverse Event|4|||
128935219|NCT00872898|464050960|FG001|Part Two - Double Blind|Adverse Event|3|||
128935220|NCT00872898|464050959|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
128935221|NCT00872898|464050960|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
128935222|NCT00872898|464050959|FG000|Part Two - Double Blind|Protocol Violation|1|||
128935223|NCT00872898|464050960|FG001|Part Two - Double Blind|Protocol Violation|0|||
128935224|NCT00872898|464050959|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
128935225|NCT00872898|464050960|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
128935226|NCT00872898|464050959|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
128935227|NCT00872898|464050960|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
128935228|NCT00872898|464050959|FG000|Part Two - Double Blind|Other reasons|2|||
128935229|NCT00872898|464050960|FG001|Part Two - Double Blind|Other reasons|0|||
128935230|NCT01004146|464050961|FG000|Overall Study|Withdrawal by Subject|4|||
128935231|NCT01004146|464050962|FG001|Overall Study|Withdrawal by Subject|5|||
128935232|NCT01001494|464050963|FG000|Overall Study|Adverse Event|8|||
128935233|NCT01001494|464050964|FG001|Overall Study|Adverse Event|4|||
128935234|NCT01001494|464050965|FG002|Overall Study|Adverse Event|6|||
128935235|NCT01001494|464050963|FG000|Overall Study|Protocol Violation|0|||
128935236|NCT01001494|464050964|FG001|Overall Study|Protocol Violation|1|||
128935237|NCT01001494|464050965|FG002|Overall Study|Protocol Violation|1|||
128935238|NCT01001494|464050963|FG000|Overall Study|Lost to Follow-up|2|||
128935239|NCT01001494|464050964|FG001|Overall Study|Lost to Follow-up|0|||
128935240|NCT01001494|464050965|FG002|Overall Study|Lost to Follow-up|1|||
128935241|NCT01001494|464050963|FG000|Overall Study|Withdrawal by Subject|9|||
128935242|NCT01001494|464050964|FG001|Overall Study|Withdrawal by Subject|7|||
128935243|NCT01001494|464050965|FG002|Overall Study|Withdrawal by Subject|17|||
128935244|NCT01001494|464050963|FG000|Overall Study|COPD exacerbation|3|||
128935245|NCT01001494|464050964|FG001|Overall Study|COPD exacerbation|4|||
128935246|NCT01001494|464050965|FG002|Overall Study|COPD exacerbation|5|||
128935247|NCT01001494|464050963|FG000|Overall Study|Lack of Efficacy|2|||
128935248|NCT01001494|464050964|FG001|Overall Study|Lack of Efficacy|0|||
128935249|NCT01001494|464050965|FG002|Overall Study|Lack of Efficacy|8|||
128935250|NCT01001494|464050963|FG000|Overall Study|Other|0|||
128935251|NCT01001494|464050964|FG001|Overall Study|Other|1|||
128935252|NCT01001494|464050965|FG002|Overall Study|Other|3|||
128935253|NCT02179398|464050966|FG000|Overall Study|Lack of obligatory data|3|||
128935254|NCT02179398|464050967|FG001|Overall Study|Lack of obligatory data|3|||
128935255|NCT02179398|464050966|FG000|Overall Study|Lost to Follow-up|0|||
128935256|NCT02179398|464050967|FG001|Overall Study|Lost to Follow-up|1|||
128935257|NCT00408681|464050974|FG000|Overall Study|Lack of Efficacy|2|||
128935258|NCT00408681|464050974|FG000|Overall Study|Adverse Event|7|||
128935259|NCT00447421|464050977|FG000|Overall Study|Lack of Efficacy|1|||
128935260|NCT00447421|464050977|FG000|Overall Study|Adverse Event|3|||
128935261|NCT00447421|464050977|FG000|Overall Study|Sponsor Decision|2|||
128935262|NCT02124798|464050979|FG000|Overall Study|Adverse Event|3|||
128935263|NCT02124798|464050979|FG000|Overall Study|Lost to Follow-up|1|||
129122002|NCT00321763|464742719|FG000|Overall Study|Adverse Event|1|||
129122003|NCT00321763|464742720|FG001|Overall Study|Adverse Event|1|||
129122004|NCT00321763|464742721|FG002|Overall Study|Adverse Event|0|||
129122005|NCT00321763|464742722|FG003|Overall Study|Adverse Event|1|||
129122006|NCT00321763|464742719|FG000|Overall Study|Withdrawal by Subject|2|||
129122007|NCT00321763|464742720|FG001|Overall Study|Withdrawal by Subject|0|||
129122008|NCT00321763|464742721|FG002|Overall Study|Withdrawal by Subject|1|||
128703590|NCT03052725|463213452|FG001|Overall Study|Study terminated by sponsor|144|||
128703591|NCT02548650|463213458|FG000|Triple Therapy|Adverse Event|1|||
128703592|NCT02548650|463213459|FG001|Triple Therapy|Adverse Event|0|||
128935264|NCT01707147|464050982|FG000|Overall Study|Administered Trajenta prior to contract|5|||
128935265|NCT01707147|464050982|FG000|Overall Study|Patients who have not taken Trajenta|1|||
129122009|NCT00321763|464742722|FG003|Overall Study|Withdrawal by Subject|0|||
128935266|NCT01707147|464050982|FG000|Overall Study|Follow-up failure|17|||
128935267|NCT01707147|464050982|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
128935268|NCT02053246|464050983|FG000|Overall Study|Withdrawal by Subject|3|||
128935269|NCT02053246|464050983|FG000|Overall Study|Physician Decision|1|||
128935270|NCT00638846|464050987|FG000|Overall Study|Adverse Event|0|||
128935271|NCT00638846|464050988|FG001|Overall Study|Adverse Event|1|||
128935272|NCT00638846|464050987|FG000|Overall Study|Lost to Follow-up|3|||
128935273|NCT00638846|464050988|FG001|Overall Study|Lost to Follow-up|2|||
129122010|NCT00321763|464742719|FG000|Overall Study|Lost to Follow-up|3|||
128935274|NCT00638846|464050987|FG000|Overall Study|lens issue|1|||
128935275|NCT00638846|464050988|FG001|Overall Study|lens issue|3|||
128935276|NCT01171521|464050991|FG000|Overall Study|Lost to Follow-up|5|||
128768007|NCT02223754|463440430|FG001|Period 2|Lens Discomfort|1|||
128935277|NCT01171521|464050991|FG000|Overall Study|screen failure|1|||
128935278|NCT00734929|464050996|FG000|Overall Study|Lost to Follow-up|1|||
128935279|NCT00734929|464050997|FG001|Overall Study|Lost to Follow-up|2|||
128935280|NCT00734929|464050996|FG000|Overall Study|No intervention/ screen fail|5|||
128935281|NCT00734929|464050997|FG001|Overall Study|No intervention/ screen fail|3|||
128935282|NCT01422304|464050998|FG000|Overall Study|Adverse Event|0|||
128935283|NCT01422304|464050999|FG001|Overall Study|Adverse Event|1|||
128935284|NCT01422304|464050998|FG000|Overall Study|Lost to Follow-up|14|||
128935285|NCT01422304|464050999|FG001|Overall Study|Lost to Follow-up|20|||
128935286|NCT01422304|464050998|FG000|Overall Study|Never Entered Follow-up|2|||
128935287|NCT01422304|464050999|FG001|Overall Study|Never Entered Follow-up|1|||
128935288|NCT01422304|464050998|FG000|Overall Study|Protocol Violation|1|||
128935289|NCT01422304|464050999|FG001|Overall Study|Protocol Violation|0|||
128935290|NCT01422304|464050998|FG000|Overall Study|Withdrawal by Subject|4|||
128935291|NCT01422304|464050999|FG001|Overall Study|Withdrawal by Subject|2|||
128935292|NCT01422304|464050998|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
128935293|NCT01422304|464050999|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
128935294|NCT01422304|464050998|FG000|Overall Study|Not Treated|3|||
128935295|NCT01422304|464050999|FG001|Overall Study|Not Treated|11|||
128935296|NCT02190435|464051000|FG000|Overall Study|First 12 patients were lead-ins|12|||
128935297|NCT02190435|464051001|FG001|Overall Study|First 12 patients were lead-ins|0|||
128935298|NCT02190435|464051000|FG000|Overall Study|3 consented screen fails|3|||
128935299|NCT02190435|464051001|FG001|Overall Study|3 consented screen fails|0|||
128935300|NCT02269319|464051002|FG000|Overall Study|Lost to Follow-up|4|||
128935301|NCT02269319|464051003|FG001|Overall Study|Lost to Follow-up|3|||
128935302|NCT02269319|464051002|FG000|Overall Study|Adverse Event|0|||
128935303|NCT02269319|464051003|FG001|Overall Study|Adverse Event|1|||
128935304|NCT02269319|464051002|FG000|Overall Study|Instructions not followed|1|||
128935305|NCT02269319|464051003|FG001|Overall Study|Instructions not followed|0|||
128935306|NCT01589094|464051004|FG000|Overall Study|Did not receive treatment|2|||
128935307|NCT03575468|464051005|FG000|Overall Study|Withdrawal by Subject|3|||
128935308|NCT03575468|464051006|FG001|Overall Study|Withdrawal by Subject|0|||
128935309|NCT03575468|464051005|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
128935310|NCT03575468|464051006|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
128935311|NCT03575468|464051005|FG000|Overall Study|Lost to Follow-up|13|||
128935312|NCT03575468|464051006|FG001|Overall Study|Lost to Follow-up|17|||
128935313|NCT05270694|464052205|FG000|Overall Study|Death|1|||
128935314|NCT05270694|464052205|FG000|Overall Study|Medical issues impacted ability to participate|2|||
128935315|NCT05270694|464052205|FG000|Overall Study|Lost to Follow-up|3|||
128935316|NCT05270694|464052205|FG000|Overall Study|Withdrawal by Subject|3|||
128935317|NCT01991977|464052206|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
128935318|NCT01991977|464052206|FG000|Overall Study|Withdrew after start of treatment|5|||
128935319|NCT02531035|464052213|FG000|Overall Study|Death|0|||
128935320|NCT02531035|464052214|FG001|Overall Study|Death|1|||
128935321|NCT02531035|464052213|FG000|Overall Study|Protocol Violation|1|||
128935322|NCT02531035|464052214|FG001|Overall Study|Protocol Violation|1|||
128935323|NCT02531035|464052213|FG000|Overall Study|Noncompliance with study drug|8|||
128935324|NCT02531035|464052214|FG001|Overall Study|Noncompliance with study drug|3|||
128935325|NCT02531035|464052213|FG000|Overall Study|Physician Decision|1|||
128935326|NCT02531035|464052214|FG001|Overall Study|Physician Decision|0|||
128935327|NCT02531035|464052213|FG000|Overall Study|Adverse Event|16|||
128935328|NCT02531035|464052214|FG001|Overall Study|Adverse Event|45|||
128935329|NCT02531035|464052213|FG000|Overall Study|Other|3|||
128935330|NCT02531035|464052214|FG001|Overall Study|Other|2|||
128935331|NCT02531035|464052213|FG000|Overall Study|Withdrawal by Subject|42|||
128935332|NCT02531035|464052214|FG001|Overall Study|Withdrawal by Subject|32|||
128935333|NCT02531035|464052213|FG000|Overall Study|Lost to Follow-up|8|||
128935334|NCT02531035|464052214|FG001|Overall Study|Lost to Follow-up|10|||
128935335|NCT02531035|464052213|FG000|Overall Study|Randomized, not treated|2|||
128935336|NCT02531035|464052214|FG001|Overall Study|Randomized, not treated|1|||
128935337|NCT03032068|464052224|FG000|Overall Study|Adverse Event|1|||
128935338|NCT01597622|464052225|FG000|Overall Study|Adverse Event|7|||
128935339|NCT01597622|464052225|FG000|Overall Study|Lack of Efficacy|3|||
128935340|NCT01597622|464052225|FG000|Overall Study|Protocol Violation|1|||
128935341|NCT01597622|464052225|FG000|Overall Study|Lost to Follow-up|1|||
128935342|NCT01597622|464052225|FG000|Overall Study|Investigator Discretion|5|||
128935343|NCT01597622|464052225|FG000|Overall Study|Withdrawal by Subject|20|||
128935344|NCT01597622|464052225|FG000|Overall Study|Death|1|||
128935345|NCT03042611|464052230|FG000|Core Phase|Withdrawal by Subject|13|||
128935346|NCT03042611|464052231|FG001|Core Phase|Withdrawal by Subject|4|||
128935347|NCT03042611|464052232|FG002|Core Phase|Withdrawal by Subject|0|||
128935348|NCT03042611|464052233|FG003|Core Phase|Withdrawal by Subject|0|||
129122011|NCT00321763|464742720|FG001|Overall Study|Lost to Follow-up|1|||
129122012|NCT00321763|464742721|FG002|Overall Study|Lost to Follow-up|5|||
128935349|NCT03042611|464052230|FG000|Core Phase|Death|232|||
128935350|NCT03042611|464052231|FG001|Core Phase|Death|110|||
128935351|NCT03042611|464052232|FG002|Core Phase|Death|0|||
128935352|NCT03042611|464052233|FG003|Core Phase|Death|0|||
128935353|NCT03042611|464052230|FG000|Core Phase|Lost to Follow-up|4|||
128935354|NCT03042611|464052231|FG001|Core Phase|Lost to Follow-up|7|||
128935355|NCT03042611|464052232|FG002|Core Phase|Lost to Follow-up|0|||
128935356|NCT03042611|464052233|FG003|Core Phase|Lost to Follow-up|0|||
128935357|NCT03042611|464052230|FG000|Core Phase|Physician Decision|7|||
128935358|NCT03042611|464052231|FG001|Core Phase|Physician Decision|2|||
128935359|NCT03042611|464052232|FG002|Core Phase|Physician Decision|0|||
128935360|NCT03042611|464052233|FG003|Core Phase|Physician Decision|0|||
128935361|NCT03042611|464052230|FG000|Core Phase|Study Closed|0|||
128935362|NCT03042611|464052231|FG001|Core Phase|Study Closed|1|||
128935363|NCT03042611|464052232|FG002|Core Phase|Study Closed|0|||
128935364|NCT03042611|464052233|FG003|Core Phase|Study Closed|0|||
128935365|NCT03042611|464052230|FG000|Extension Phase|Death|0|||
128935366|NCT03042611|464052231|FG001|Extension Phase|Death|0|||
128935367|NCT03042611|464052232|FG002|Extension Phase|Death|34|||
128935368|NCT03042611|464052233|FG003|Extension Phase|Death|16|||
128935369|NCT03042611|464052230|FG000|Extension Phase|Lost to Follow-up|0|||
128935370|NCT03042611|464052231|FG001|Extension Phase|Lost to Follow-up|0|||
128935371|NCT03042611|464052232|FG002|Extension Phase|Lost to Follow-up|1|||
128935372|NCT03042611|464052233|FG003|Extension Phase|Lost to Follow-up|1|||
128935373|NCT03042611|464052230|FG000|Extension Phase|Study Closed|0|||
128935374|NCT03042611|464052231|FG001|Extension Phase|Study Closed|0|||
128935375|NCT03042611|464052232|FG002|Extension Phase|Study Closed|17|||
128935376|NCT03042611|464052233|FG003|Extension Phase|Study Closed|11|||
128935377|NCT00090285|464052238|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
128935378|NCT00090285|464052239|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
128935379|NCT00090285|464052240|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
128935380|NCT00090285|464052241|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
128935381|NCT00090285|464052242|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
128935382|NCT00090285|464052243|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
128935383|NCT00090285|464052238|FG000|Base Study Vaccination Period|Adverse Event|2|||
128935384|NCT00090285|464052239|FG001|Base Study Vaccination Period|Adverse Event|4|||
128935385|NCT00090285|464052240|FG002|Base Study Vaccination Period|Adverse Event|0|||
128935386|NCT00090285|464052241|FG003|Base Study Vaccination Period|Adverse Event|0|||
128935387|NCT00090285|464052242|FG004|Base Study Vaccination Period|Adverse Event|0|||
128935388|NCT00090285|464052243|FG005|Base Study Vaccination Period|Adverse Event|0|||
128935389|NCT00090285|464052238|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
128935390|NCT00090285|464052239|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
128935391|NCT00090285|464052240|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
128935392|NCT00090285|464052241|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
128935393|NCT00090285|464052242|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
128935394|NCT00090285|464052243|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
128935395|NCT00090285|464052238|FG000|Base Study Vaccination Period|Protocol Violation|2|||
128935396|NCT00090285|464052239|FG001|Base Study Vaccination Period|Protocol Violation|3|||
128935397|NCT00090285|464052240|FG002|Base Study Vaccination Period|Protocol Violation|0|||
128935398|NCT00090285|464052241|FG003|Base Study Vaccination Period|Protocol Violation|0|||
128935399|NCT00090285|464052242|FG004|Base Study Vaccination Period|Protocol Violation|0|||
128935400|NCT00090285|464052243|FG005|Base Study Vaccination Period|Protocol Violation|0|||
128935401|NCT00090285|464052238|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
128935402|NCT00090285|464052239|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
128935403|NCT00090285|464052240|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
128935404|NCT00090285|464052241|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
128935405|NCT00090285|464052242|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
128935406|NCT00090285|464052243|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
128935407|NCT00090285|464052238|FG000|Base Study Vaccination Period|Uncooperative|2|||
128935408|NCT00090285|464052239|FG001|Base Study Vaccination Period|Uncooperative|2|||
128935409|NCT00090285|464052240|FG002|Base Study Vaccination Period|Uncooperative|0|||
128935410|NCT00090285|464052241|FG003|Base Study Vaccination Period|Uncooperative|0|||
128935411|NCT00090285|464052242|FG004|Base Study Vaccination Period|Uncooperative|0|||
128935412|NCT00090285|464052243|FG005|Base Study Vaccination Period|Uncooperative|0|||
128935413|NCT00090285|464052238|FG000|Base Study Vaccination Period|Moved|20|||
128935414|NCT00090285|464052239|FG001|Base Study Vaccination Period|Moved|21|||
128935415|NCT00090285|464052240|FG002|Base Study Vaccination Period|Moved|0|||
128935416|NCT00090285|464052241|FG003|Base Study Vaccination Period|Moved|0|||
128935417|NCT00090285|464052242|FG004|Base Study Vaccination Period|Moved|0|||
128935418|NCT00090285|464052243|FG005|Base Study Vaccination Period|Moved|0|||
129031179|NCT01567527|464404812|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
129031180|NCT01567527|464404808|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
129031181|NCT01567527|464404809|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
129031182|NCT01567527|464404810|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
129031183|NCT01567527|464404811|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
129031184|NCT01567527|464404812|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
128935419|NCT00090285|464052238|FG000|Base Study Vaccination Period|Site Terminated|1|||
128935420|NCT00090285|464052239|FG001|Base Study Vaccination Period|Site Terminated|0|||
128935421|NCT00090285|464052240|FG002|Base Study Vaccination Period|Site Terminated|0|||
128935422|NCT00090285|464052241|FG003|Base Study Vaccination Period|Site Terminated|0|||
128935423|NCT00090285|464052242|FG004|Base Study Vaccination Period|Site Terminated|0|||
128935424|NCT00090285|464052243|FG005|Base Study Vaccination Period|Site Terminated|0|||
128935425|NCT00090285|464052238|FG000|Base Study Vaccination Period|Other|2|||
128935426|NCT00090285|464052239|FG001|Base Study Vaccination Period|Other|2|||
128935427|NCT00090285|464052240|FG002|Base Study Vaccination Period|Other|0|||
128935428|NCT00090285|464052241|FG003|Base Study Vaccination Period|Other|0|||
128935429|NCT00090285|464052242|FG004|Base Study Vaccination Period|Other|0|||
128935430|NCT00090285|464052243|FG005|Base Study Vaccination Period|Other|0|||
128935431|NCT00090285|464052238|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
128935432|NCT00090285|464052239|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
128935433|NCT00090285|464052240|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
128935434|NCT00090285|464052241|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
128935435|NCT00090285|464052242|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
128935436|NCT00090285|464052243|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
128935437|NCT00090285|464052238|FG000|Base Study Vaccination Period|HIV positive|1|||
128935438|NCT00090285|464052239|FG001|Base Study Vaccination Period|HIV positive|1|||
128935439|NCT00090285|464052240|FG002|Base Study Vaccination Period|HIV positive|0|||
128935440|NCT00090285|464052241|FG003|Base Study Vaccination Period|HIV positive|0|||
128935441|NCT00090285|464052242|FG004|Base Study Vaccination Period|HIV positive|0|||
128935442|NCT00090285|464052243|FG005|Base Study Vaccination Period|HIV positive|0|||
128935443|NCT00090285|464052238|FG000|Base Study Follow-up Period|Adverse Event|3|||
128935444|NCT00090285|464052239|FG001|Base Study Follow-up Period|Adverse Event|10|||
128935445|NCT00090285|464052240|FG002|Base Study Follow-up Period|Adverse Event|0|||
128935446|NCT00090285|464052241|FG003|Base Study Follow-up Period|Adverse Event|0|||
128935447|NCT00090285|464052242|FG004|Base Study Follow-up Period|Adverse Event|0|||
128935448|NCT00090285|464052243|FG005|Base Study Follow-up Period|Adverse Event|0|||
128935449|NCT00090285|464052238|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
128935450|NCT00090285|464052239|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
128935451|NCT00090285|464052240|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
128935452|NCT00090285|464052241|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
128935453|NCT00090285|464052242|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
128935454|NCT00090285|464052243|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
128935455|NCT00090285|464052238|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
128935456|NCT00090285|464052239|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
128935457|NCT00090285|464052240|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
128935458|NCT00090285|464052241|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
128935459|NCT00090285|464052242|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
128935460|NCT00090285|464052243|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
128935461|NCT00090285|464052238|FG000|Base Study Follow-up Period|Moved|41|||
128935462|NCT00090285|464052239|FG001|Base Study Follow-up Period|Moved|36|||
128935463|NCT00090285|464052240|FG002|Base Study Follow-up Period|Moved|0|||
128935464|NCT00090285|464052241|FG003|Base Study Follow-up Period|Moved|0|||
128935465|NCT00090285|464052242|FG004|Base Study Follow-up Period|Moved|0|||
128935466|NCT00090285|464052243|FG005|Base Study Follow-up Period|Moved|0|||
128935467|NCT00090285|464052238|FG000|Base Study Follow-up Period|Other|2|||
128935468|NCT00090285|464052239|FG001|Base Study Follow-up Period|Other|0|||
128935469|NCT00090285|464052240|FG002|Base Study Follow-up Period|Other|0|||
128935470|NCT00090285|464052241|FG003|Base Study Follow-up Period|Other|0|||
128935471|NCT00090285|464052242|FG004|Base Study Follow-up Period|Other|0|||
128935472|NCT00090285|464052243|FG005|Base Study Follow-up Period|Other|0|||
128703593|NCT02548650|463213458|FG000|Triple Therapy|Withdrawal by Subject|0|||
128935473|NCT00090285|464052238|FG000|Base Study Follow-up Period|Protocol Violation|1|||
128935474|NCT00090285|464052239|FG001|Base Study Follow-up Period|Protocol Violation|0|||
128935475|NCT00090285|464052240|FG002|Base Study Follow-up Period|Protocol Violation|0|||
128935476|NCT00090285|464052241|FG003|Base Study Follow-up Period|Protocol Violation|0|||
128935477|NCT00090285|464052242|FG004|Base Study Follow-up Period|Protocol Violation|0|||
128935478|NCT00090285|464052243|FG005|Base Study Follow-up Period|Protocol Violation|0|||
128935479|NCT00090285|464052238|FG000|Base Study Follow-up Period|Uncooperative|3|||
128935480|NCT00090285|464052239|FG001|Base Study Follow-up Period|Uncooperative|4|||
128935481|NCT00090285|464052240|FG002|Base Study Follow-up Period|Uncooperative|0|||
128935482|NCT00090285|464052241|FG003|Base Study Follow-up Period|Uncooperative|0|||
128935483|NCT00090285|464052242|FG004|Base Study Follow-up Period|Uncooperative|0|||
128935484|NCT00090285|464052243|FG005|Base Study Follow-up Period|Uncooperative|0|||
128935485|NCT00090285|464052238|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
128935486|NCT00090285|464052239|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
128935487|NCT00090285|464052240|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
128935488|NCT00090285|464052241|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
128703594|NCT02548650|463213459|FG001|Triple Therapy|Withdrawal by Subject|4|||
128935489|NCT00090285|464052242|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
128935490|NCT00090285|464052243|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
128935491|NCT00090285|464052238|FG000|Extension 1|Adverse Event|0|||
128935492|NCT00090285|464052239|FG001|Extension 1|Adverse Event|0|||
128935493|NCT00090285|464052240|FG002|Extension 1|Adverse Event|2|||
128935494|NCT00090285|464052241|FG003|Extension 1|Adverse Event|0|||
128935495|NCT00090285|464052242|FG004|Extension 1|Adverse Event|0|||
128935496|NCT00090285|464052243|FG005|Extension 1|Adverse Event|0|||
128935497|NCT00090285|464052238|FG000|Extension 1|Lost to Follow-up|0|||
128935498|NCT00090285|464052239|FG001|Extension 1|Lost to Follow-up|0|||
128935499|NCT00090285|464052240|FG002|Extension 1|Lost to Follow-up|35|||
128935500|NCT00090285|464052241|FG003|Extension 1|Lost to Follow-up|0|||
128935501|NCT00090285|464052242|FG004|Extension 1|Lost to Follow-up|0|||
128935502|NCT00090285|464052243|FG005|Extension 1|Lost to Follow-up|0|||
128935503|NCT00090285|464052238|FG000|Extension 1|Withdrawal by Subject|0|||
128935504|NCT00090285|464052239|FG001|Extension 1|Withdrawal by Subject|0|||
128935505|NCT00090285|464052240|FG002|Extension 1|Withdrawal by Subject|13|||
128935506|NCT00090285|464052241|FG003|Extension 1|Withdrawal by Subject|1|||
128935507|NCT00090285|464052242|FG004|Extension 1|Withdrawal by Subject|0|||
128935508|NCT00090285|464052243|FG005|Extension 1|Withdrawal by Subject|0|||
128935509|NCT00090285|464052238|FG000|Extension 1|Other|0|||
128935510|NCT00090285|464052239|FG001|Extension 1|Other|0|||
128935511|NCT00090285|464052240|FG002|Extension 1|Other|4|||
128935512|NCT00090285|464052241|FG003|Extension 1|Other|0|||
128935513|NCT00090285|464052242|FG004|Extension 1|Other|0|||
128935514|NCT00090285|464052243|FG005|Extension 1|Other|0|||
128935515|NCT00090285|464052238|FG000|Extension 1|Moved|0|||
128935516|NCT00090285|464052239|FG001|Extension 1|Moved|0|||
128935517|NCT00090285|464052240|FG002|Extension 1|Moved|3|||
128935518|NCT00090285|464052241|FG003|Extension 1|Moved|0|||
128935519|NCT00090285|464052242|FG004|Extension 1|Moved|0|||
128935520|NCT00090285|464052243|FG005|Extension 1|Moved|0|||
128935521|NCT00090285|464052238|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
128935522|NCT00090285|464052239|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
128935523|NCT00090285|464052240|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
128935524|NCT00090285|464052241|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
128935525|NCT00090285|464052242|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
128935526|NCT00090285|464052243|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
128935527|NCT00090285|464052238|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
128935528|NCT00090285|464052239|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
128935529|NCT00090285|464052240|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
128935530|NCT00090285|464052241|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
128935531|NCT00090285|464052242|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
128935532|NCT00090285|464052243|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
128935533|NCT00090285|464052238|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
128935534|NCT00090285|464052239|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
128935535|NCT00090285|464052240|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
128935536|NCT00090285|464052241|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
128935537|NCT00090285|464052242|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
128935538|NCT00090285|464052243|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
128935539|NCT00090285|464052238|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
128935540|NCT00090285|464052239|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
128935541|NCT00090285|464052240|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
128935542|NCT00090285|464052241|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
128935543|NCT00090285|464052242|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
128935544|NCT00090285|464052243|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
128935545|NCT00907478|464052244|FG000|Overall Study|Ineligibility determined|0|||
128935546|NCT00907478|464052245|FG001|Overall Study|Ineligibility determined|0|||
128935547|NCT00907478|464052246|FG002|Overall Study|Ineligibility determined|1|||
128935548|NCT00907478|464052244|FG000|Overall Study|Noncompliance|0|||
128935549|NCT00907478|464052245|FG001|Overall Study|Noncompliance|0|||
128935550|NCT00907478|464052246|FG002|Overall Study|Noncompliance|1|||
128935551|NCT00907478|464052244|FG000|Overall Study|Adverse Event|3|||
128703595|NCT02548650|463213458|FG000|Double Therapy|Adverse Event|1|||
128703596|NCT02548650|463213459|FG001|Double Therapy|Adverse Event|1|||
128935552|NCT00907478|464052245|FG001|Overall Study|Adverse Event|1|||
128935553|NCT00907478|464052246|FG002|Overall Study|Adverse Event|2|||
128935554|NCT00907478|464052244|FG000|Overall Study|Withdrawal by Subject|8|||
128935555|NCT00907478|464052245|FG001|Overall Study|Withdrawal by Subject|9|||
128935556|NCT00907478|464052246|FG002|Overall Study|Withdrawal by Subject|6|||
128935557|NCT00907478|464052244|FG000|Overall Study|Requirement for alternative therapy|1|||
128935558|NCT00907478|464052245|FG001|Overall Study|Requirement for alternative therapy|2|||
128935559|NCT00907478|464052246|FG002|Overall Study|Requirement for alternative therapy|3|||
128703597|NCT02548650|463213458|FG000|Double Therapy|Withdrawal by Subject|0|||
128935560|NCT00907478|464052244|FG000|Overall Study|Physician Decision|2|||
128935561|NCT00907478|464052245|FG001|Overall Study|Physician Decision|0|||
128935562|NCT00907478|464052246|FG002|Overall Study|Physician Decision|3|||
128935563|NCT00907478|464052244|FG000|Overall Study|Death|4|||
128935564|NCT00907478|464052245|FG001|Overall Study|Death|2|||
128935565|NCT00907478|464052246|FG002|Overall Study|Death|1|||
128935566|NCT00907478|464052244|FG000|Overall Study|Protocol-specified criteria|5|||
128935567|NCT00907478|464052245|FG001|Overall Study|Protocol-specified criteria|2|||
128935568|NCT00907478|464052246|FG002|Overall Study|Protocol-specified criteria|3|||
128935569|NCT00907478|464052244|FG000|Overall Study|Pregnancy|0|||
128935570|NCT00907478|464052245|FG001|Overall Study|Pregnancy|1|||
128935571|NCT00907478|464052246|FG002|Overall Study|Pregnancy|1|||
128935572|NCT00907478|464052244|FG000|Overall Study|Lost to Follow-up|1|||
128935573|NCT00907478|464052245|FG001|Overall Study|Lost to Follow-up|0|||
128935574|NCT00907478|464052246|FG002|Overall Study|Lost to Follow-up|0|||
128935575|NCT00907478|464052244|FG000|Overall Study|Other|3|||
128935576|NCT00907478|464052245|FG001|Overall Study|Other|0|||
128935577|NCT00907478|464052246|FG002|Overall Study|Other|1|||
128935578|NCT02639182|464052247|FG000|Overall Study|Disease Progression|50|||
128935579|NCT02639182|464052248|FG001|Overall Study|Disease Progression|49|||
128935580|NCT02639182|464052247|FG000|Overall Study|Adverse Event|7|||
128935581|NCT02639182|464052248|FG001|Overall Study|Adverse Event|5|||
128935582|NCT02639182|464052247|FG000|Overall Study|Physician Decision|3|||
128935583|NCT02639182|464052248|FG001|Overall Study|Physician Decision|3|||
128935584|NCT02639182|464052247|FG000|Overall Study|Withdrew Consent|5|||
128935585|NCT02639182|464052248|FG001|Overall Study|Withdrew Consent|4|||
128935586|NCT02639182|464052247|FG000|Overall Study|Lost to Follow-up|0|||
128935587|NCT02639182|464052248|FG001|Overall Study|Lost to Follow-up|1|||
128935588|NCT02639182|464052247|FG000|Overall Study|Study Closure|1|||
128935589|NCT02639182|464052248|FG001|Overall Study|Study Closure|2|||
128935590|NCT02639182|464052247|FG000|Overall Study|Sponsor Ended Study|0|||
128935591|NCT02639182|464052248|FG001|Overall Study|Sponsor Ended Study|1|||
128935592|NCT02639182|464052247|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
128935593|NCT02639182|464052248|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
128935594|NCT03069690|464052249|FG000|Pregnancy Intervention|Pregnancy loss|9|||
128935595|NCT03069690|464052250|FG001|Pregnancy Intervention|Pregnancy loss|4|||
128935596|NCT03069690|464052251|FG002|Pregnancy Intervention|Pregnancy loss|0|||
128935597|NCT03069690|464052252|FG003|Pregnancy Intervention|Pregnancy loss|0|||
128935598|NCT03069690|464052253|FG004|Pregnancy Intervention|Pregnancy loss|0|||
128935599|NCT03069690|464052254|FG005|Pregnancy Intervention|Pregnancy loss|0|||
128935600|NCT03069690|464052249|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
128935601|NCT03069690|464052250|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
128935602|NCT03069690|464052251|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
128935603|NCT03069690|464052252|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
128935604|NCT03069690|464052253|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
128935605|NCT03069690|464052254|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
128935606|NCT03069690|464052249|FG000|Postpartum Intervention|Lost to Follow-up|0|||
128935607|NCT03069690|464052250|FG001|Postpartum Intervention|Lost to Follow-up|0|||
128935608|NCT03069690|464052251|FG002|Postpartum Intervention|Lost to Follow-up|5|||
128935609|NCT03069690|464052252|FG003|Postpartum Intervention|Lost to Follow-up|5|||
128935610|NCT03069690|464052253|FG004|Postpartum Intervention|Lost to Follow-up|2|||
128935611|NCT03069690|464052254|FG005|Postpartum Intervention|Lost to Follow-up|4|||
128935612|NCT01372878|464052255|FG000|Overall Study|Withdrawal by Subject|63|||
128935613|NCT01372878|464052255|FG000|Overall Study|Protocol Violation|17|||
128935614|NCT01372878|464052255|FG000|Overall Study|incomplete study procedure|104|||
128935615|NCT04504032|464052256|FG000|Overall Study|Adverse Event|1|||
128935616|NCT04504032|464052257|FG001|Overall Study|Adverse Event|2|||
128935617|NCT04504032|464052256|FG000|Overall Study|Lost to Follow-up|6|||
128935618|NCT04504032|464052257|FG001|Overall Study|Lost to Follow-up|9|||
128935619|NCT04504032|464052256|FG000|Overall Study|Protocol Violation|2|||
128935620|NCT04504032|464052257|FG001|Overall Study|Protocol Violation|0|||
128935621|NCT04504032|464052256|FG000|Overall Study|Study terminated by sponsor|1|||
128935622|NCT04504032|464052257|FG001|Overall Study|Study terminated by sponsor|2|||
128935623|NCT04504032|464052256|FG000|Overall Study|Withdrawal by Subject|9|||
128935624|NCT04504032|464052257|FG001|Overall Study|Withdrawal by Subject|11|||
128935625|NCT04504032|464052256|FG000|Overall Study|Disease progression prior to dosing|15|||
128935626|NCT04504032|464052257|FG001|Overall Study|Disease progression prior to dosing|3|||
128935627|NCT04504032|464052256|FG000|Overall Study|Drug supply issues|1|||
128935628|NCT04504032|464052257|FG001|Overall Study|Drug supply issues|1|||
128935629|NCT04504032|464052256|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
128935630|NCT04504032|464052257|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
128935631|NCT01839188|464052258|FG000|Overall Study|Withdrawal by Subject|1|||
128935632|NCT02416908|464052261|FG000|Dose Escalation Phase|Adverse Event|0|||
128935633|NCT02416908|464052262|FG001|Dose Escalation Phase|Adverse Event|0|||
128935634|NCT02416908|464052263|FG002|Dose Escalation Phase|Adverse Event|3|||
128935635|NCT02416908|464052264|FG003|Dose Escalation Phase|Adverse Event|0|||
128935636|NCT02416908|464052261|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
128935637|NCT02416908|464052262|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
128935638|NCT02416908|464052263|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
128935639|NCT02416908|464052264|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
128935640|NCT00940342|464052267|FG000|Overall Study|Adverse Event|0|||
128935641|NCT00940342|464052268|FG001|Overall Study|Adverse Event|2|||
128935642|NCT00940342|464052269|FG002|Overall Study|Adverse Event|1|||
128935643|NCT03792750|464052271|FG000|Overall Study|Death|3|||
128935644|NCT00700752|464052276|FG000|First Intervention|Withdrawal by Subject|0|||
128935645|NCT00700752|464052277|FG001|First Intervention|Withdrawal by Subject|2|||
128935646|NCT01645930|464052278|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
128935647|NCT01645930|464052278|FG000|Overall Study|Progressive Disease|12|||
128935648|NCT01645930|464052278|FG000|Overall Study|Adverse Event|4|||
128935649|NCT01645930|464052278|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
128935650|NCT01645930|464052278|FG000|Overall Study|Withdrawal by Participant|2|||
128935651|NCT01645930|464052278|FG000|Overall Study|Reason not Defined|1|||
128935652|NCT02522377|464052279|FG000|Overall Study|Withdrawal by Subject|1|||
128935653|NCT02522377|464052280|FG001|Overall Study|Withdrawal by Subject|0|||
128935654|NCT02522377|464052279|FG000|Overall Study|Remission Achieved|3|||
128935655|NCT02522377|464052280|FG001|Overall Study|Remission Achieved|0|||
128935656|NCT01158950|464052284|FG000|1st Intervention (1 Day)|Physician Decision|1|||
128935657|NCT01158950|464052285|FG001|1st Intervention (1 Day)|Physician Decision|2|||
128935658|NCT00945191|464052286|FG000|Overall Study|Did not achieve a complete response|18|||
128935659|NCT00945191|464052286|FG000|Overall Study|Participant relocated to another state|1|||
128935660|NCT00945191|464052286|FG000|Overall Study|Disease progression|3|||
128935661|NCT00945191|464052286|FG000|Overall Study|Serious adverse event or adverse event|1|||
128935662|NCT00945191|464052286|FG000|Overall Study|Investigator's discretion|1|||
128935663|NCT00312377|464052292|FG000|Overall Study|Death|403|||
128935664|NCT00312377|464052293|FG001|Overall Study|Death|418|||
128935665|NCT00312377|464052292|FG000|Overall Study|Withdrawal by Subject|23|||
128935666|NCT00312377|464052293|FG001|Overall Study|Withdrawal by Subject|30|||
128935667|NCT00312377|464052292|FG000|Overall Study|Lost to Follow-up|9|||
128935668|NCT00312377|464052293|FG001|Overall Study|Lost to Follow-up|12|||
128935669|NCT00312377|464052292|FG000|Overall Study|Non-compliance|0|||
128935670|NCT00312377|464052293|FG001|Overall Study|Non-compliance|2|||
128935671|NCT00312377|464052292|FG000|Overall Study|Randomised but never received treatment|6|||
128935672|NCT00312377|464052293|FG001|Overall Study|Randomised but never received treatment|6|||
128935673|NCT00312377|464052292|FG000|Overall Study|Discontinue treatment survival follow up|202|||
128935674|NCT00312377|464052293|FG001|Overall Study|Discontinue treatment survival follow up|200|||
128935675|NCT00312377|464052292|FG000|Overall Study|Site ended participation in study|1|||
128935676|NCT00312377|464052293|FG001|Overall Study|Site ended participation in study|0|||
128935677|NCT02519231|464052308|FG000|Overall Study|Lost to Follow-up|2|||
128935678|NCT02519231|464052309|FG001|Overall Study|Lost to Follow-up|5|||
128935679|NCT02519231|464052308|FG000|Overall Study|Withdrawal by Subject|0|||
128935680|NCT02519231|464052309|FG001|Overall Study|Withdrawal by Subject|1|||
128935681|NCT02795156|464052311|FG000|Overall Study|Progressive Disease|22|||
128935682|NCT02795156|464052312|FG001|Overall Study|Progressive Disease|7|||
128935683|NCT02795156|464052313|FG002|Overall Study|Progressive Disease|34|||
128935684|NCT02795156|464052314|FG003|Overall Study|Progressive Disease|7|||
128935685|NCT02795156|464052311|FG000|Overall Study|Adverse Event|13|||
128935686|NCT02795156|464052312|FG001|Overall Study|Adverse Event|2|||
128935687|NCT02795156|464052313|FG002|Overall Study|Adverse Event|3|||
128935688|NCT02795156|464052314|FG003|Overall Study|Adverse Event|2|||
128935689|NCT02795156|464052311|FG000|Overall Study|Death|1|||
128935690|NCT02795156|464052312|FG001|Overall Study|Death|1|||
128935691|NCT02795156|464052313|FG002|Overall Study|Death|1|||
128935692|NCT02795156|464052314|FG003|Overall Study|Death|0|||
128935693|NCT02795156|464052311|FG000|Overall Study|Physician Decision|1|||
128935694|NCT02795156|464052312|FG001|Overall Study|Physician Decision|0|||
128935695|NCT02795156|464052313|FG002|Overall Study|Physician Decision|1|||
128935696|NCT02795156|464052314|FG003|Overall Study|Physician Decision|0|||
128935697|NCT02795156|464052311|FG000|Overall Study|Withdrawal by Subject|2|||
128935698|NCT02795156|464052312|FG001|Overall Study|Withdrawal by Subject|0|||
128935699|NCT02795156|464052313|FG002|Overall Study|Withdrawal by Subject|3|||
128935700|NCT02795156|464052314|FG003|Overall Study|Withdrawal by Subject|0|||
128935701|NCT02707757|464052315|FG000|Overall Study|Protocol Violation|3|||
128935702|NCT02707757|464052316|FG001|Overall Study|Protocol Violation|2|||
128935703|NCT02707757|464052315|FG000|Overall Study|Withdrawal by Subject|2|||
128935704|NCT02707757|464052316|FG001|Overall Study|Withdrawal by Subject|0|||
128935705|NCT02707757|464052315|FG000|Overall Study|Death|0|||
129122013|NCT00321763|464742722|FG003|Overall Study|Lost to Follow-up|4|||
129122014|NCT01572792|464742723|FG000|Lead-in Study|Lost to Follow-up|5|||
129122015|NCT01572792|464742724|FG001|Lead-in Study|Lost to Follow-up|9|||
129122016|NCT01572792|464742725|FG002|Lead-in Study|Lost to Follow-up|4|||
128768008|NCT02223754|463440429|FG000|Period 2|Lost to Follow-up|1|||
128935706|NCT02707757|464052316|FG001|Overall Study|Death|1|||
128935707|NCT02707757|464052315|FG000|Overall Study|Adverse Event|6|||
128935708|NCT02707757|464052316|FG001|Overall Study|Adverse Event|4|||
128935709|NCT02707757|464052315|FG000|Overall Study|Renal transplant/elective operation|1|||
128935710|NCT02707757|464052316|FG001|Overall Study|Renal transplant/elective operation|5|||
128935711|NCT00815308|464052317|FG000|Overall Study|Adverse Event|4|||
128935712|NCT00815308|464052317|FG000|Overall Study|Withdrawal by Subject|0|||
128935713|NCT00815308|464052317|FG000|Overall Study|Protocol Violation|6|||
129122017|NCT01572792|464742726|FG003|Lead-in Study|Lost to Follow-up|2|||
128768009|NCT02223754|463440430|FG001|Period 2|Lost to Follow-up|0|||
128768010|NCT02223754|463440429|FG000|Period 2|Test Article No Longer Available|0|||
128935714|NCT00652093|464052318|FG000|Overall Study|Withdrawal by Subject|0|||
128935715|NCT00652093|464052319|FG001|Overall Study|Withdrawal by Subject|0|||
128935716|NCT00652093|464052320|FG002|Overall Study|Withdrawal by Subject|1|||
128935717|NCT00652093|464052321|FG003|Overall Study|Withdrawal by Subject|0|||
128935718|NCT00652093|464052322|FG004|Overall Study|Withdrawal by Subject|1|||
128935719|NCT00652093|464052323|FG005|Overall Study|Withdrawal by Subject|0|||
128935720|NCT00652093|464052318|FG000|Overall Study|Physician Decision|0|||
128935721|NCT00652093|464052319|FG001|Overall Study|Physician Decision|0|||
128935722|NCT00652093|464052320|FG002|Overall Study|Physician Decision|0|||
128935723|NCT00652093|464052321|FG003|Overall Study|Physician Decision|0|||
128935724|NCT00652093|464052322|FG004|Overall Study|Physician Decision|1|||
128935725|NCT00652093|464052323|FG005|Overall Study|Physician Decision|0|||
128935726|NCT03176966|464052327|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
128935727|NCT03176966|464052328|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
128935728|NCT03176966|464052327|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
128935729|NCT03176966|464052328|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
128935730|NCT03176966|464052327|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
128935731|NCT03176966|464052328|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
128935732|NCT03176966|464052327|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
128935733|NCT03176966|464052328|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
128935734|NCT03176966|464052327|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
128935735|NCT03176966|464052328|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
128935736|NCT03176966|464052327|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
128935737|NCT03176966|464052328|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
128935738|NCT03176966|464052327|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
128935739|NCT03176966|464052328|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
128935740|NCT02955186|464052329|FG000|Overall Study|Withdrawal by Subject|6|||
128935741|NCT02955186|464052330|FG001|Overall Study|Withdrawal by Subject|2|||
128935742|NCT02955186|464052329|FG000|Overall Study|Protocol Violation|1|||
128935743|NCT02955186|464052330|FG001|Overall Study|Protocol Violation|0|||
128935744|NCT01696877|464052333|FG000|Overall Study|Adverse Event|0|||
128935745|NCT01696877|464052334|FG001|Overall Study|Adverse Event|1|||
128935746|NCT02961764|464052335|FG000|Overall Study|Protocol Violation|0|||
128935747|NCT02961764|464052336|FG001|Overall Study|Protocol Violation|1|||
128935748|NCT02961764|464052335|FG000|Overall Study|Death|2|||
128935749|NCT02961764|464052336|FG001|Overall Study|Death|0|||
128935750|NCT02961764|464052335|FG000|Overall Study|Lost to Follow-up|35|||
128935751|NCT02961764|464052336|FG001|Overall Study|Lost to Follow-up|24|||
128935752|NCT02961764|464052335|FG000|Overall Study|Withdrawal by Subject|2|||
128935753|NCT02961764|464052336|FG001|Overall Study|Withdrawal by Subject|0|||
128935754|NCT00469014|464052337|FG000|Initial Phase Randomization|Disease Progression|0|||
128935755|NCT00469014|464052338|FG001|Initial Phase Randomization|Disease Progression|1|||
128935756|NCT00469014|464052339|FG002|Initial Phase Randomization|Disease Progression|1|||
128935757|NCT00469014|464052340|FG003|Initial Phase Randomization|Disease Progression|0|||
128935758|NCT00469014|464052337|FG000|Initial Phase Randomization|No Response|1|||
128935759|NCT00469014|464052338|FG001|Initial Phase Randomization|No Response|0|||
128935760|NCT00469014|464052339|FG002|Initial Phase Randomization|No Response|0|||
128935761|NCT00469014|464052340|FG003|Initial Phase Randomization|No Response|1|||
128935762|NCT00469014|464052337|FG000|Adaptive Randomization|Not Evaluable|1|||
128935763|NCT00469014|464052338|FG001|Adaptive Randomization|Not Evaluable|0|||
128935764|NCT00469014|464052339|FG002|Adaptive Randomization|Not Evaluable|0|||
128935765|NCT00469014|464052340|FG003|Adaptive Randomization|Not Evaluable|1|||
128935766|NCT00469014|464052337|FG000|Adaptive Randomization|No Response|0|||
128935767|NCT00469014|464052338|FG001|Adaptive Randomization|No Response|1|||
128935768|NCT00469014|464052339|FG002|Adaptive Randomization|No Response|0|||
128935769|NCT00469014|464052340|FG003|Adaptive Randomization|No Response|0|||
128935770|NCT00469014|464052337|FG000|Adaptive Randomization|Death|0|||
128935771|NCT00469014|464052338|FG001|Adaptive Randomization|Death|0|||
128935772|NCT00469014|464052339|FG002|Adaptive Randomization|Death|1|||
128935773|NCT00469014|464052340|FG003|Adaptive Randomization|Death|0|||
128935774|NCT00866294|464052341|FG000|Overall Study|Adverse Event|12|||
128935775|NCT00866294|464052342|FG001|Overall Study|Adverse Event|13|||
128935776|NCT00866294|464052343|FG002|Overall Study|Adverse Event|9|||
128935777|NCT00866294|464052341|FG000|Overall Study|Lack of Efficacy|7|||
128935778|NCT00866294|464052342|FG001|Overall Study|Lack of Efficacy|1|||
128935779|NCT00866294|464052343|FG002|Overall Study|Lack of Efficacy|0|||
128935780|NCT00866294|464052341|FG000|Overall Study|Protocol Violation|2|||
128935781|NCT00866294|464052342|FG001|Overall Study|Protocol Violation|0|||
128768011|NCT02223754|463440430|FG001|Period 2|Test Article No Longer Available|1|||
128768012|NCT00510458|463440431|FG000|Overall Study|5 year not evaluable/missed|21|||
128935782|NCT00866294|464052343|FG002|Overall Study|Protocol Violation|0|||
128935783|NCT00866294|464052341|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
128935784|NCT00866294|464052342|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128935785|NCT00866294|464052343|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128935786|NCT00866294|464052341|FG000|Overall Study|Lost to Follow-up|1|||
128935787|NCT00866294|464052342|FG001|Overall Study|Lost to Follow-up|3|||
128935788|NCT00866294|464052343|FG002|Overall Study|Lost to Follow-up|0|||
128935789|NCT00866294|464052341|FG000|Overall Study|Physician Decision|6|||
128935790|NCT00866294|464052342|FG001|Overall Study|Physician Decision|2|||
128935791|NCT00866294|464052343|FG002|Overall Study|Physician Decision|1|||
128935792|NCT01903434|464052347|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
128935793|NCT01903434|464052348|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
128935794|NCT01903434|464052347|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
128935795|NCT01903434|464052348|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
128935796|NCT01469052|464052351|FG000|Overall Study|Adverse Event|2|||
128935797|NCT01469052|464052352|FG001|Overall Study|Adverse Event|3|||
128935798|NCT01469052|464052353|FG002|Overall Study|Adverse Event|0|||
128935799|NCT01469052|464052354|FG003|Overall Study|Adverse Event|2|||
128935800|NCT01469052|464052355|FG004|Overall Study|Adverse Event|0|||
128935801|NCT01469052|464052356|FG005|Overall Study|Adverse Event|1|||
128935802|NCT01469052|464052351|FG000|Overall Study|Progressive disease|3|||
128935803|NCT01469052|464052352|FG001|Overall Study|Progressive disease|0|||
128935804|NCT01469052|464052353|FG002|Overall Study|Progressive disease|5|||
128935805|NCT01469052|464052354|FG003|Overall Study|Progressive disease|3|||
128935806|NCT01469052|464052355|FG004|Overall Study|Progressive disease|7|||
128935807|NCT01469052|464052356|FG005|Overall Study|Progressive disease|2|||
128935808|NCT01469052|464052351|FG000|Overall Study|Lack of Efficacy|0|||
128935809|NCT01469052|464052352|FG001|Overall Study|Lack of Efficacy|0|||
129031185|NCT01567527|464404808|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
129031186|NCT01567527|464404809|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
129031187|NCT01567527|464404810|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
129031188|NCT01567527|464404811|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
128703598|NCT02548650|463213459|FG001|Double Therapy|Withdrawal by Subject|1|||
128703599|NCT00299104|463213460|FG000|Treatment Period|Adverse Event|14|||
128703600|NCT00299104|463213461|FG001|Treatment Period|Adverse Event|9|||
128703601|NCT00299104|463213462|FG002|Treatment Period|Adverse Event|7|||
128768013|NCT00510458|463440431|FG000|Overall Study|Death|1|||
128768014|NCT00510458|463440431|FG000|Overall Study|Terminated|14|||
128768015|NCT00510458|463440431|FG000|Overall Study|Lost to Follow-up|6|||
128768016|NCT00510458|463440431|FG000|Overall Study|Withdrawal by Subject|3|||
128768017|NCT00510458|463440431|FG000|Overall Study|Revision|2|||
128768018|NCT00539279|463440432|FG000|Treatment|Withdrawal by Subject|10|||
128768019|NCT00539279|463440433|FG001|Treatment|Withdrawal by Subject|8|||
128703602|NCT00299104|463213460|FG000|Treatment Period|Death|1|||
128703603|NCT00299104|463213461|FG001|Treatment Period|Death|1|||
128935810|NCT01469052|464052353|FG002|Overall Study|Lack of Efficacy|0|||
128935811|NCT01469052|464052354|FG003|Overall Study|Lack of Efficacy|0|||
129031189|NCT01567527|464404812|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
128703604|NCT00299104|463213462|FG002|Treatment Period|Death|1|||
128703605|NCT00299104|463213460|FG000|Treatment Period|Insufficient therapeutic response|34|||
128703606|NCT00299104|463213461|FG001|Treatment Period|Insufficient therapeutic response|13|||
128703607|NCT00299104|463213462|FG002|Treatment Period|Insufficient therapeutic response|8|||
128703608|NCT00299104|463213460|FG000|Treatment Period|Failure to return|9|||
128703609|NCT00299104|463213461|FG001|Treatment Period|Failure to return|8|||
128703610|NCT00299104|463213462|FG002|Treatment Period|Failure to return|8|||
128703611|NCT00299104|463213460|FG000|Treatment Period|Violation of selection criteria|1|||
128703612|NCT00299104|463213461|FG001|Treatment Period|Violation of selection criteria|2|||
128703613|NCT00299104|463213462|FG002|Treatment Period|Violation of selection criteria|0|||
128703614|NCT00299104|463213460|FG000|Treatment Period|Protocol Violation|1|||
128703615|NCT00299104|463213461|FG001|Treatment Period|Protocol Violation|1|||
128703616|NCT00299104|463213462|FG002|Treatment Period|Protocol Violation|0|||
128703617|NCT00299104|463213460|FG000|Treatment Period|Refused treatment|9|||
128703618|NCT00299104|463213461|FG001|Treatment Period|Refused treatment|2|||
128703619|NCT00299104|463213462|FG002|Treatment Period|Refused treatment|2|||
128703620|NCT00299104|463213460|FG000|Treatment Period|Withdrew consent|14|||
128703621|NCT00299104|463213461|FG001|Treatment Period|Withdrew consent|19|||
128703622|NCT00299104|463213462|FG002|Treatment Period|Withdrew consent|9|||
128703623|NCT00299104|463213460|FG000|Treatment Period|Administrative reasons|106|||
128703624|NCT00299104|463213461|FG001|Treatment Period|Administrative reasons|120|||
128703625|NCT00299104|463213462|FG002|Treatment Period|Administrative reasons|137|||
128703626|NCT00299104|463213460|FG000|Safety Follow-Up (SFU) Period|Death|3|||
128703627|NCT00299104|463213461|FG001|Safety Follow-Up (SFU) Period|Death|2|||
128703628|NCT00299104|463213462|FG002|Safety Follow-Up (SFU) Period|Death|1|||
128703629|NCT00299104|463213460|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
128768020|NCT00539279|463440432|FG000|Treatment|Death|1|||
128768021|NCT00539279|463440433|FG001|Treatment|Death|0|||
128768022|NCT00539279|463440432|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
128935812|NCT01469052|464052355|FG004|Overall Study|Lack of Efficacy|0|||
128768023|NCT00539279|463440433|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
128935813|NCT01469052|464052356|FG005|Overall Study|Lack of Efficacy|2|||
129122018|NCT01572792|464742727|FG004|Lead-in Study|Lost to Follow-up|4|||
128703630|NCT00299104|463213461|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
128703631|NCT00299104|463213462|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
128703632|NCT00299104|463213460|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
128703633|NCT00299104|463213461|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
128703634|NCT00299104|463213462|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
128703635|NCT00299104|463213460|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
128703636|NCT00299104|463213461|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
128703637|NCT00299104|463213462|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
128703638|NCT00299104|463213460|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
128703639|NCT00299104|463213461|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
128703640|NCT00299104|463213462|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
128703641|NCT00299104|463213460|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
128703642|NCT00299104|463213461|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
128703643|NCT00299104|463213462|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
128703644|NCT00299104|463213460|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
128703645|NCT00299104|463213461|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
128703646|NCT00299104|463213462|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
128703647|NCT00299104|463213460|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
128703648|NCT00299104|463213461|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
128703649|NCT00299104|463213462|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
128703650|NCT01909674|463213463|FG000|Overall Study|Withdrawal by Subject|5|||
128703651|NCT01909674|463213464|FG001|Overall Study|Withdrawal by Subject|2|||
128703652|NCT00521014|463213465|FG000|Overall Study|Inevaluable, not treated|1|||
128703653|NCT02969369|463213466|FG000|Study|Adverse Event|1|||
128703654|NCT02969369|463213467|FG001|Study|Adverse Event|6|||
128703655|NCT02969369|463213466|FG000|Study|Lack of Efficacy|0|||
128703656|NCT02969369|463213467|FG001|Study|Lack of Efficacy|1|||
128703657|NCT02969369|463213466|FG000|Study|Lost to Follow-up|0|||
128703658|NCT02969369|463213467|FG001|Study|Lost to Follow-up|1|||
128703659|NCT02969369|463213466|FG000|Study|Withdrawal by Subject|3|||
128703660|NCT02969369|463213467|FG001|Study|Withdrawal by Subject|5|||
128703661|NCT02969369|463213466|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
128703662|NCT02969369|463213467|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
128703663|NCT02969369|463213466|FG000|Double-blind Period|Adverse Event|1|||
128703664|NCT02969369|463213467|FG001|Double-blind Period|Adverse Event|5|||
128703665|NCT02969369|463213466|FG000|Double-blind Period|Lost to Follow-up|0|||
128703666|NCT02969369|463213467|FG001|Double-blind Period|Lost to Follow-up|1|||
128703667|NCT02969369|463213466|FG000|Double-blind Period|Withdrawal by Subject|2|||
128703668|NCT02969369|463213467|FG001|Double-blind Period|Withdrawal by Subject|3|||
128703669|NCT02969369|463213466|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
128703670|NCT02969369|463213467|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
128703671|NCT02969369|463213466|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
128703672|NCT02969369|463213467|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
128703673|NCT02969369|463213466|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
128703674|NCT02969369|463213467|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
128703675|NCT02969369|463213466|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
128703676|NCT02969369|463213467|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
128703677|NCT04390191|463213468|FG000|Overall Study|Withdrawal by Subject|1|||
128703678|NCT04390191|463213469|FG001|Overall Study|Withdrawal by Subject|0|||
128703679|NCT02794883|463213470|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
128703680|NCT02794883|463213471|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
128703681|NCT02794883|463213472|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
128703682|NCT02794883|463213470|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
128703683|NCT02794883|463213471|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
128703684|NCT02794883|463213472|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
128703685|NCT02794883|463213470|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
128703686|NCT02794883|463213471|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
128703687|NCT02794883|463213472|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
128703688|NCT02794883|463213470|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
128703689|NCT02794883|463213471|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
128703690|NCT02794883|463213472|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
128703691|NCT02794883|463213470|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
128703692|NCT02794883|463213471|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
128703693|NCT02794883|463213472|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
128703694|NCT02794883|463213470|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
128703695|NCT02794883|463213471|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
129031190|NCT01567527|464404808|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
128703696|NCT02794883|463213472|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
128703697|NCT02794883|463213470|FG000|Follow-up Period (up to 2 Years)|Death|12|||
128703698|NCT02794883|463213471|FG001|Follow-up Period (up to 2 Years)|Death|10|||
128703699|NCT02794883|463213472|FG002|Follow-up Period (up to 2 Years)|Death|10|||
128703700|NCT03978832|463213473|FG000|Overall Study|Adverse Event|1|||
128703701|NCT03978832|463213473|FG000|Overall Study|Lost to Follow-up|1|||
128703702|NCT03978832|463213473|FG000|Overall Study|Withdrawal by Subject|6|||
128703703|NCT03978832|463213473|FG000|Overall Study|Physician Decision|2|||
128703704|NCT03978832|463213473|FG000|Overall Study|did not pass screening criteria|44|||
128703705|NCT00003499|463213474|FG000|Overall Study|Not evaluable|8|||
128703706|NCT01727297|463213479|FG000|Overall Study|Death|13|||
128703707|NCT01727297|463213480|FG001|Overall Study|Death|0|||
128703708|NCT01727297|463213479|FG000|Overall Study|Protocol Violation|1|||
128703709|NCT01727297|463213480|FG001|Overall Study|Protocol Violation|10|||
128703710|NCT01727297|463213479|FG000|Overall Study|Adverse Event|3|||
128703711|NCT01727297|463213480|FG001|Overall Study|Adverse Event|1|||
128703712|NCT01727297|463213479|FG000|Overall Study|Lost to Follow-up|11|||
128703713|NCT01727297|463213480|FG001|Overall Study|Lost to Follow-up|0|||
128703714|NCT01727297|463213479|FG000|Overall Study|Withdrawal by Subject|26|||
128703715|NCT01727297|463213480|FG001|Overall Study|Withdrawal by Subject|27|||
128703716|NCT01727297|463213479|FG000|Overall Study|Physician Decision|19|||
128703717|NCT01727297|463213480|FG001|Overall Study|Physician Decision|5|||
128703718|NCT01727297|463213479|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
128703719|NCT01727297|463213480|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
128703720|NCT02042183|463213481|FG000|Overall Study|Physician Decision|7|||
128703721|NCT02042183|463213482|FG001|Overall Study|Physician Decision|2|||
128703722|NCT02042183|463213481|FG000|Overall Study|Lack of Efficacy|4|||
128703723|NCT02042183|463213482|FG001|Overall Study|Lack of Efficacy|3|||
128703724|NCT02042183|463213481|FG000|Overall Study|Non-compliance with Study Drug|2|||
128703725|NCT02042183|463213482|FG001|Overall Study|Non-compliance with Study Drug|3|||
128703726|NCT02042183|463213481|FG000|Overall Study|Adverse Event|17|||
128703727|NCT02042183|463213482|FG001|Overall Study|Adverse Event|6|||
128703728|NCT02042183|463213481|FG000|Overall Study|Other|3|||
128703729|NCT02042183|463213482|FG001|Overall Study|Other|3|||
128703730|NCT02042183|463213481|FG000|Overall Study|Withdrawal by Subject|21|||
128703731|NCT02042183|463213482|FG001|Overall Study|Withdrawal by Subject|16|||
128703732|NCT02042183|463213481|FG000|Overall Study|Site Terminated by Sponsor|2|||
128703733|NCT02042183|463213482|FG001|Overall Study|Site Terminated by Sponsor|1|||
128703734|NCT02042183|463213481|FG000|Overall Study|Lost to Follow-up|9|||
128703735|NCT02042183|463213482|FG001|Overall Study|Lost to Follow-up|2|||
128703736|NCT02244606|463213483|FG000|Overall Study|Adverse Event|0|||
128703737|NCT02244606|463213484|FG001|Overall Study|Adverse Event|1|||
128703738|NCT02244606|463213485|FG002|Overall Study|Adverse Event|1|||
128703739|NCT02244606|463213486|FG003|Overall Study|Adverse Event|0|||
128703740|NCT02244606|463213483|FG000|Overall Study|Lost to Follow-up|2|||
128703741|NCT02244606|463213484|FG001|Overall Study|Lost to Follow-up|2|||
128703742|NCT02244606|463213485|FG002|Overall Study|Lost to Follow-up|1|||
128703743|NCT02244606|463213486|FG003|Overall Study|Lost to Follow-up|0|||
128703744|NCT02244606|463213483|FG000|Overall Study|Protocol Violation|0|||
128703745|NCT02244606|463213484|FG001|Overall Study|Protocol Violation|0|||
128703746|NCT02244606|463213485|FG002|Overall Study|Protocol Violation|0|||
128703747|NCT02244606|463213486|FG003|Overall Study|Protocol Violation|1|||
128703748|NCT02244606|463213483|FG000|Overall Study|Withdrawal by Subject|1|||
128703749|NCT02244606|463213484|FG001|Overall Study|Withdrawal by Subject|1|||
128703750|NCT02244606|463213485|FG002|Overall Study|Withdrawal by Subject|0|||
128703751|NCT02244606|463213486|FG003|Overall Study|Withdrawal by Subject|0|||
128703752|NCT02244606|463213483|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
128703753|NCT02244606|463213484|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
128703754|NCT02244606|463213485|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
128703755|NCT02244606|463213486|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
128703756|NCT00378378|463213489|FG000|Overall Study|Withdrawal by Subject|0|||
128703757|NCT00378378|463213490|FG001|Overall Study|Withdrawal by Subject|1|||
128703758|NCT00378378|463213491|FG002|Overall Study|Withdrawal by Subject|0|||
128703759|NCT00378378|463213489|FG000|Overall Study|Treatment Failure|0|||
128703760|NCT00378378|463213490|FG001|Overall Study|Treatment Failure|0|||
128703761|NCT00378378|463213491|FG002|Overall Study|Treatment Failure|1|||
128703762|NCT00378378|463213489|FG000|Overall Study|Non-compliance with protocol|0|||
128703763|NCT00378378|463213490|FG001|Overall Study|Non-compliance with protocol|0|||
128935814|NCT01469052|464052351|FG000|Overall Study|Moved to rollover protocol|1|||
128935815|NCT01469052|464052352|FG001|Overall Study|Moved to rollover protocol|0|||
128935816|NCT01469052|464052353|FG002|Overall Study|Moved to rollover protocol|1|||
128703764|NCT00378378|463213491|FG002|Overall Study|Non-compliance with protocol|1|||
128703765|NCT00407797|463213492|FG000|Overall Study|Lost to Follow-up|2|||
128703766|NCT00407797|463213492|FG000|Overall Study|Adverse Event|6|||
128703767|NCT00407797|463213492|FG000|Overall Study|Other|7|||
128703768|NCT00407797|463213492|FG000|Overall Study|Withdrawal by Subject|3|||
128703769|NCT01812174|463213493|FG000|Overall Study|Death|1|||
128703770|NCT01812174|463213494|FG001|Overall Study|Death|0|||
128703771|NCT01812174|463213493|FG000|Overall Study|Protocol Violation|2|||
128935817|NCT01469052|464052354|FG003|Overall Study|Moved to rollover protocol|0|||
128935818|NCT01469052|464052355|FG004|Overall Study|Moved to rollover protocol|0|||
128703772|NCT01812174|463213494|FG001|Overall Study|Protocol Violation|0|||
128703773|NCT00553644|463213497|FG000|Overall Study|Adverse Event|17|||
128703774|NCT00553644|463213497|FG000|Overall Study|Withdrawal by Subject|4|||
128703775|NCT00553644|463213497|FG000|Overall Study|Physician Decision|1|||
128703776|NCT00553644|463213497|FG000|Overall Study|Alternative therapy|6|||
128703777|NCT03782792|463213498|FG000|Overall Study|Patient left the country|0|||
128703778|NCT03782792|463213499|FG001|Overall Study|Patient left the country|1|||
128703779|NCT03782792|463213498|FG000|Overall Study|Withdrawal by Subject|1|||
128703780|NCT03782792|463213499|FG001|Overall Study|Withdrawal by Subject|2|||
128703781|NCT03132220|463213501|FG000|Overall Study|Lost to Follow-up|17|||
128703782|NCT03132220|463213502|FG001|Overall Study|Lost to Follow-up|8|||
128703783|NCT03132220|463213501|FG000|Overall Study|Withdrawal by Subject|1|||
128703784|NCT03132220|463213502|FG001|Overall Study|Withdrawal by Subject|4|||
128703785|NCT01051323|463213505|FG000|Overall Study|Discontinuation of treatment|103|||
128703786|NCT01051323|463213505|FG000|Overall Study|Transplantation|28|||
128703787|NCT01051323|463213505|FG000|Overall Study|Dialysis dependency|22|||
128703788|NCT01051323|463213505|FG000|Overall Study|Withdrawal by Subject|13|||
128703789|NCT01051323|463213505|FG000|Overall Study|Lost to Follow-up|31|||
128703790|NCT01051323|463213505|FG000|Overall Study|Death|129|||
128703791|NCT01051323|463213505|FG000|Overall Study|Hospitalization|28|||
128703792|NCT01051323|463213505|FG000|Overall Study|Other|148|||
128703793|NCT01051323|463213505|FG000|Overall Study|Missing|37|||
128703794|NCT00601458|463213506|FG000|Overall Study|Dosing Error|1|||
128703795|NCT00601458|463213507|FG001|Overall Study|Dosing Error|0|||
128703796|NCT00601458|463213508|FG002|Overall Study|Dosing Error|0|||
128703797|NCT00601458|463213506|FG000|Overall Study|Incomplete Data|0|||
128703798|NCT00601458|463213507|FG001|Overall Study|Incomplete Data|2|||
128703799|NCT00601458|463213508|FG002|Overall Study|Incomplete Data|0|||
128703800|NCT00601458|463213506|FG000|Overall Study|Protocol Violation|3|||
128703801|NCT00601458|463213507|FG001|Overall Study|Protocol Violation|2|||
128703802|NCT00601458|463213508|FG002|Overall Study|Protocol Violation|1|||
128703803|NCT00601458|463213506|FG000|Overall Study|Early Termination|0|||
128703804|NCT00601458|463213507|FG001|Overall Study|Early Termination|1|||
128703805|NCT00601458|463213508|FG002|Overall Study|Early Termination|1|||
128703806|NCT01578187|463213509|FG000|Usability Phase|Withdrawal by Subject|1|||
128703807|NCT03208244|463213510|FG000|Overall Study|Death|1|||
128703808|NCT01709162|463213511|FG000|Overall Study|Disease progression|3|||
128703809|NCT01709162|463213512|FG001|Overall Study|Disease progression|3|||
129216830|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
129216831|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
129216832|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
129216833|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
129216834|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
129216835|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
129216836|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
129216837|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
129216838|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
129216839|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
129216840|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
129216841|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
129216842|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
129216843|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
129216844|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
129216845|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
129216846|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
129216847|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Death|0|||
128703810|NCT01709162|463213511|FG000|Overall Study|Study drug toxicity|2|||
129216848|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Death|6|||
129216849|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Death|3|||
128703811|NCT01709162|463213512|FG001|Overall Study|Study drug toxicity|0|||
128703812|NCT01709162|463213511|FG000|Overall Study|Administrative reason by sponsor|0|||
128703813|NCT01709162|463213512|FG001|Overall Study|Administrative reason by sponsor|1|||
128703814|NCT01709162|463213511|FG000|Overall Study|Other|1|||
128935819|NCT01469052|464052356|FG005|Overall Study|Moved to rollover protocol|1|||
128935820|NCT01469052|464052351|FG000|Overall Study|Other|0|||
128935821|NCT01469052|464052352|FG001|Overall Study|Other|1|||
128935822|NCT01469052|464052353|FG002|Overall Study|Other|0|||
128703815|NCT01709162|463213512|FG001|Overall Study|Other|0|||
128703816|NCT01709162|463213511|FG000|Overall Study|Withdrawal by Subject|0|||
128703817|NCT01709162|463213512|FG001|Overall Study|Withdrawal by Subject|1|||
128703818|NCT01844518|463213514|FG000|Overall Study|Adverse Event|7|||
128703819|NCT01844518|463213515|FG001|Overall Study|Adverse Event|1|||
128703820|NCT01844518|463213514|FG000|Overall Study|Lack of Efficacy|17|||
128703821|NCT01844518|463213515|FG001|Overall Study|Lack of Efficacy|5|||
128703822|NCT01844518|463213514|FG000|Overall Study|Participant's request to discontinue|4|||
128935823|NCT01469052|464052354|FG003|Overall Study|Other|0|||
128703823|NCT01844518|463213515|FG001|Overall Study|Participant's request to discontinue|1|||
128703824|NCT01844518|463213514|FG000|Overall Study|Poor/Non-compliance|1|||
128703825|NCT01844518|463213515|FG001|Overall Study|Poor/Non-compliance|0|||
129216850|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Death|0|||
129122019|NCT01572792|464742723|FG000|Lead-in Study|Withdrawal by Subject|22|||
129122020|NCT01572792|464742724|FG001|Lead-in Study|Withdrawal by Subject|11|||
129122021|NCT01572792|464742725|FG002|Lead-in Study|Withdrawal by Subject|12|||
129122022|NCT01572792|464742726|FG003|Lead-in Study|Withdrawal by Subject|24|||
129122023|NCT01572792|464742727|FG004|Lead-in Study|Withdrawal by Subject|11|||
129122024|NCT01572792|464742723|FG000|Lead-in Study|Protocol Violation|19|||
129122025|NCT01572792|464742724|FG001|Lead-in Study|Protocol Violation|10|||
129122026|NCT01572792|464742725|FG002|Lead-in Study|Protocol Violation|12|||
129122027|NCT01572792|464742726|FG003|Lead-in Study|Protocol Violation|13|||
129122028|NCT01572792|464742727|FG004|Lead-in Study|Protocol Violation|21|||
129122029|NCT01572792|464742723|FG000|Lead-in Study|Lack of Efficacy|20|||
129122030|NCT01572792|464742724|FG001|Lead-in Study|Lack of Efficacy|5|||
129122031|NCT01572792|464742725|FG002|Lead-in Study|Lack of Efficacy|4|||
129122032|NCT01572792|464742726|FG003|Lead-in Study|Lack of Efficacy|8|||
129122033|NCT01572792|464742727|FG004|Lead-in Study|Lack of Efficacy|10|||
129122034|NCT01572792|464742723|FG000|Lead-in Study|Adverse Event|21|||
129122035|NCT01572792|464742724|FG001|Lead-in Study|Adverse Event|21|||
129122036|NCT01572792|464742725|FG002|Lead-in Study|Adverse Event|22|||
129122037|NCT01572792|464742726|FG003|Lead-in Study|Adverse Event|16|||
129122038|NCT01572792|464742727|FG004|Lead-in Study|Adverse Event|14|||
129122039|NCT01572792|464742723|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
129122040|NCT01572792|464742724|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
129122041|NCT01572792|464742725|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
129122042|NCT01572792|464742726|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
129122043|NCT01572792|464742727|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
129122044|NCT01572792|464742723|FG000|Extension Study|Lost to Follow-up|6|||
129122045|NCT01572792|464742724|FG001|Extension Study|Lost to Follow-up|2|||
129122046|NCT01572792|464742725|FG002|Extension Study|Lost to Follow-up|0|||
129122047|NCT01572792|464742726|FG003|Extension Study|Lost to Follow-up|3|||
129122048|NCT01572792|464742727|FG004|Extension Study|Lost to Follow-up|3|||
129122049|NCT01572792|464742723|FG000|Extension Study|Withdrawal by Subject|7|||
129122050|NCT01572792|464742724|FG001|Extension Study|Withdrawal by Subject|6|||
129122051|NCT01572792|464742725|FG002|Extension Study|Withdrawal by Subject|11|||
129122052|NCT01572792|464742726|FG003|Extension Study|Withdrawal by Subject|8|||
129122053|NCT01572792|464742727|FG004|Extension Study|Withdrawal by Subject|14|||
129122054|NCT01572792|464742723|FG000|Extension Study|Protocol Violation|0|||
129122055|NCT01572792|464742724|FG001|Extension Study|Protocol Violation|4|||
129122056|NCT01572792|464742725|FG002|Extension Study|Protocol Violation|3|||
129122057|NCT01572792|464742726|FG003|Extension Study|Protocol Violation|4|||
129122058|NCT01572792|464742727|FG004|Extension Study|Protocol Violation|3|||
129122059|NCT01572792|464742723|FG000|Extension Study|Lack of Efficacy|2|||
129122060|NCT01572792|464742724|FG001|Extension Study|Lack of Efficacy|3|||
129122061|NCT01572792|464742725|FG002|Extension Study|Lack of Efficacy|3|||
129122062|NCT01572792|464742726|FG003|Extension Study|Lack of Efficacy|2|||
129122063|NCT01572792|464742727|FG004|Extension Study|Lack of Efficacy|2|||
129122064|NCT01572792|464742723|FG000|Extension Study|Adverse Event|7|||
129122065|NCT01572792|464742724|FG001|Extension Study|Adverse Event|6|||
129122066|NCT01572792|464742725|FG002|Extension Study|Adverse Event|5|||
129122067|NCT01572792|464742726|FG003|Extension Study|Adverse Event|6|||
129216851|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Death|0|||
129216852|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
129216853|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
128703826|NCT01844518|463213514|FG000|Overall Study|No Longer Met Study Criteria|2|||
128703827|NCT01844518|463213515|FG001|Overall Study|No Longer Met Study Criteria|0|||
128703828|NCT01844518|463213514|FG000|Overall Study|Withdrawal by Subject|9|||
128703829|NCT01844518|463213515|FG001|Overall Study|Withdrawal by Subject|0|||
128703830|NCT01844518|463213514|FG000|Overall Study|Pregnancy|1|||
128935824|NCT01469052|464052355|FG004|Overall Study|Other|1|||
128935825|NCT01469052|464052356|FG005|Overall Study|Other|0|||
128935826|NCT01519427|464052361|FG000|Overall Study|disease progression|2|||
129122068|NCT01572792|464742727|FG004|Extension Study|Adverse Event|4|||
129122069|NCT01572792|464742723|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
129122070|NCT01572792|464742724|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
129122071|NCT01572792|464742725|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
129122072|NCT01572792|464742726|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
129122073|NCT01572792|464742727|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
129122074|NCT01129128|464742728|FG000|Overall Study|Lost to Follow-up|2|||
129122075|NCT01129128|464742729|FG001|Overall Study|Lost to Follow-up|2|||
129122076|NCT01129128|464742730|FG002|Overall Study|Lost to Follow-up|1|||
129122077|NCT01129128|464742728|FG000|Overall Study|Protocol Violation|0|||
128703831|NCT01844518|463213515|FG001|Overall Study|Pregnancy|0|||
128978103|NCT01521494|464205314|FG004|Overall Study|Physician Decision|2|||
128703832|NCT04584645|463213517|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
128703833|NCT04584645|463213518|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
128703834|NCT00390468|463213519|FG000|Overall Study|Protocol Violation|2|||
128703835|NCT00390468|463213519|FG000|Overall Study|Lack of Efficacy|1|||
128703836|NCT03129100|463213520|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
128703837|NCT03129100|463213521|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
128703838|NCT03129100|463213522|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
128703839|NCT03129100|463213523|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
128703840|NCT03129100|463213524|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
128703841|NCT03129100|463213525|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
128703842|NCT03129100|463213526|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
128703843|NCT03129100|463213527|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
128703844|NCT03129100|463213528|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
128703845|NCT03129100|463213529|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
128703846|NCT03129100|463213530|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
128703847|NCT03129100|463213531|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
128703848|NCT03129100|463213532|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
128703849|NCT03129100|463213533|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
128703850|NCT03129100|463213534|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
128703851|NCT03129100|463213535|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
128703852|NCT03129100|463213536|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
128703853|NCT03129100|463213537|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
128703854|NCT03129100|463213538|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
128703855|NCT03129100|463213539|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
128703856|NCT03129100|463213540|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
128703857|NCT03129100|463213541|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
128703858|NCT03129100|463213542|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
128703859|NCT03129100|463213543|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
128703860|NCT03129100|463213544|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
128703861|NCT03129100|463213545|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
128703862|NCT03129100|463213520|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
128703863|NCT03129100|463213521|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703864|NCT03129100|463213522|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703865|NCT03129100|463213523|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703866|NCT03129100|463213524|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703867|NCT03129100|463213525|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703868|NCT03129100|463213526|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703869|NCT03129100|463213527|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703870|NCT03129100|463213528|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703871|NCT03129100|463213529|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703872|NCT03129100|463213530|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703873|NCT03129100|463213531|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703874|NCT03129100|463213532|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703875|NCT03129100|463213533|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703876|NCT03129100|463213534|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703877|NCT03129100|463213535|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703878|NCT03129100|463213536|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703879|NCT03129100|463213537|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703880|NCT03129100|463213538|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703881|NCT03129100|463213539|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703882|NCT03129100|463213540|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703883|NCT03129100|463213541|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703884|NCT03129100|463213542|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703885|NCT03129100|463213543|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703886|NCT03129100|463213544|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703887|NCT03129100|463213545|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
128703888|NCT03129100|463213520|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
128703889|NCT03129100|463213521|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
128703890|NCT03129100|463213522|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703891|NCT03129100|463213523|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703892|NCT03129100|463213524|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703893|NCT03129100|463213525|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703894|NCT03129100|463213526|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703895|NCT03129100|463213527|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703896|NCT03129100|463213528|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703897|NCT03129100|463213529|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703898|NCT03129100|463213530|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703899|NCT03129100|463213531|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703900|NCT03129100|463213532|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703901|NCT03129100|463213533|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703902|NCT03129100|463213534|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129031191|NCT01567527|464404809|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
129031192|NCT01567527|464404810|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
129031193|NCT01567527|464404811|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
129031194|NCT01567527|464404812|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
129031195|NCT01567527|464404808|FG000|IM Depot Stabilization.|Adverse Event|0|||
129031196|NCT01567527|464404809|FG001|IM Depot Stabilization.|Adverse Event|0|||
129031197|NCT01567527|464404810|FG002|IM Depot Stabilization.|Adverse Event|37|||
129031198|NCT01567527|464404811|FG003|IM Depot Stabilization.|Adverse Event|0|||
129031199|NCT01567527|464404812|FG004|IM Depot Stabilization.|Adverse Event|0|||
129031200|NCT01567527|464404808|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129031201|NCT01567527|464404809|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129031202|NCT01567527|464404810|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
129031203|NCT01567527|464404811|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129031204|NCT01567527|464404812|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129031205|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
129031206|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
129031207|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
129031208|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
129031209|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
129031210|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
129031211|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
129031212|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
129031213|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
129031214|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
129031215|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
129031216|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
129031217|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
129031218|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
129031219|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
128703903|NCT03129100|463213535|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703904|NCT03129100|463213536|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128768024|NCT00539279|463440432|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
128768025|NCT00539279|463440433|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
128768026|NCT01382940|463441991|FG000|Overall Study|Adverse Event|19|||
128768027|NCT01382940|463441991|FG000|Overall Study|Lost to Follow-up|4|||
128768028|NCT01382940|463441991|FG000|Overall Study|Physician Decision|7|||
128768029|NCT01382940|463441991|FG000|Overall Study|Withdrawal by Subject|23|||
128768030|NCT01382940|463441991|FG000|Overall Study|Protocol Violation|20|||
128703905|NCT03129100|463213537|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703906|NCT03129100|463213538|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703907|NCT03129100|463213539|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703908|NCT03129100|463213540|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703909|NCT03129100|463213541|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703910|NCT03129100|463213542|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703911|NCT03129100|463213543|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703912|NCT03129100|463213544|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703913|NCT03129100|463213545|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
128703914|NCT03129100|463213520|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
128703915|NCT03129100|463213521|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
128703916|NCT03129100|463213522|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703917|NCT03129100|463213523|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703918|NCT03129100|463213524|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703919|NCT03129100|463213525|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703920|NCT03129100|463213526|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703921|NCT03129100|463213527|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703922|NCT03129100|463213528|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703923|NCT03129100|463213529|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703924|NCT03129100|463213530|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703925|NCT03129100|463213531|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703926|NCT03129100|463213532|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128768031|NCT00976482|463441994|FG000|Overall Study|Death|208|||
128768032|NCT00976482|463441994|FG000|Overall Study|Withdrawal by Subject|45|||
128768033|NCT00976482|463441994|FG000|Overall Study|Center terminated|1|||
129031220|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
128768034|NCT00976482|463441994|FG000|Overall Study|Protocol Violation|5|||
128768035|NCT00720902|463441997|FG000|Overall Study|Withdrawal by Subject|1|||
128768036|NCT00720902|463441998|FG001|Overall Study|Withdrawal by Subject|0|||
128768037|NCT00720902|463441997|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
129122078|NCT01129128|464742729|FG001|Overall Study|Protocol Violation|1|||
129122079|NCT01129128|464742730|FG002|Overall Study|Protocol Violation|0|||
129122080|NCT01129128|464742728|FG000|Overall Study|Withdrawal by Subject|0|||
129122081|NCT01129128|464742729|FG001|Overall Study|Withdrawal by Subject|1|||
129122082|NCT01129128|464742730|FG002|Overall Study|Withdrawal by Subject|3|||
129122083|NCT01129128|464742728|FG000|Overall Study|Physician Decision|1|||
129122084|NCT01129128|464742729|FG001|Overall Study|Physician Decision|0|||
129122085|NCT01129128|464742730|FG002|Overall Study|Physician Decision|0|||
129122086|NCT00961415|464742731|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
129122087|NCT00961415|464742732|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
129122088|NCT00961415|464742733|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
128703927|NCT03129100|463213533|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703928|NCT03129100|463213534|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703929|NCT03129100|463213535|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703930|NCT03129100|463213536|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703931|NCT03129100|463213537|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703932|NCT03129100|463213538|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703933|NCT03129100|463213539|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703934|NCT03129100|463213540|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703935|NCT03129100|463213541|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703936|NCT03129100|463213542|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703937|NCT03129100|463213543|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703938|NCT03129100|463213544|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703939|NCT03129100|463213545|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
128703940|NCT03129100|463213520|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703941|NCT03129100|463213521|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
128703942|NCT03129100|463213522|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703943|NCT03129100|463213523|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703944|NCT03129100|463213524|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703945|NCT03129100|463213525|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703946|NCT03129100|463213526|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703947|NCT03129100|463213527|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703948|NCT03129100|463213528|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703949|NCT03129100|463213529|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703950|NCT03129100|463213530|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703951|NCT03129100|463213531|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703952|NCT03129100|463213532|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703953|NCT03129100|463213533|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703954|NCT03129100|463213534|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703955|NCT03129100|463213535|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703956|NCT03129100|463213536|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703957|NCT03129100|463213537|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703958|NCT03129100|463213538|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703959|NCT03129100|463213539|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703960|NCT03129100|463213540|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703961|NCT03129100|463213541|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703962|NCT03129100|463213542|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703963|NCT03129100|463213543|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703964|NCT03129100|463213544|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703965|NCT03129100|463213545|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
128703966|NCT03129100|463213520|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703967|NCT03129100|463213521|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703968|NCT03129100|463213522|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
128703969|NCT03129100|463213523|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
128703970|NCT03129100|463213524|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703971|NCT03129100|463213525|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
128703972|NCT03129100|463213526|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703973|NCT03129100|463213527|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703974|NCT03129100|463213528|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703975|NCT03129100|463213529|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703976|NCT03129100|463213530|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703977|NCT03129100|463213531|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703978|NCT03129100|463213532|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703979|NCT03129100|463213533|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703980|NCT03129100|463213534|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129122089|NCT00961415|464742731|FG000|Induction Treatment Phase|Death|77|||
129122090|NCT00961415|464742732|FG001|Induction Treatment Phase|Death|0|||
129122091|NCT00961415|464742733|FG002|Induction Treatment Phase|Death|0|||
129122092|NCT00961415|464742731|FG000|Induction Treatment Phase|Protocol Violation|1|||
129122093|NCT00961415|464742732|FG001|Induction Treatment Phase|Protocol Violation|0|||
128703981|NCT03129100|463213535|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703982|NCT03129100|463213536|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703983|NCT03129100|463213537|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703984|NCT03129100|463213538|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703985|NCT03129100|463213539|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703986|NCT03129100|463213540|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703987|NCT03129100|463213541|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703988|NCT03129100|463213542|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703989|NCT03129100|463213543|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703990|NCT03129100|463213544|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703991|NCT03129100|463213545|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
128703992|NCT03129100|463213520|FG000|Period2 Extension Period (Group A and B)|Death|0|||
128703993|NCT03129100|463213521|FG001|Period2 Extension Period (Group A and B)|Death|0|||
128703994|NCT03129100|463213522|FG002|Period2 Extension Period (Group A and B)|Death|1|||
128703995|NCT03129100|463213523|FG003|Period2 Extension Period (Group A and B)|Death|0|||
128703996|NCT03129100|463213524|FG004|Period2 Extension Period (Group A and B)|Death|0|||
128703997|NCT03129100|463213525|FG005|Period2 Extension Period (Group A and B)|Death|0|||
128703998|NCT03129100|463213526|FG006|Period2 Extension Period (Group A and B)|Death|0|||
128703999|NCT03129100|463213527|FG007|Period2 Extension Period (Group A and B)|Death|0|||
128704000|NCT03129100|463213528|FG008|Period2 Extension Period (Group A and B)|Death|0|||
128704001|NCT03129100|463213529|FG009|Period2 Extension Period (Group A and B)|Death|0|||
128704002|NCT03129100|463213530|FG010|Period2 Extension Period (Group A and B)|Death|0|||
128704003|NCT03129100|463213531|FG011|Period2 Extension Period (Group A and B)|Death|0|||
128704004|NCT03129100|463213532|FG012|Period2 Extension Period (Group A and B)|Death|0|||
128704005|NCT03129100|463213533|FG013|Period2 Extension Period (Group A and B)|Death|0|||
128704006|NCT03129100|463213534|FG014|Period2 Extension Period (Group A and B)|Death|0|||
128704007|NCT03129100|463213535|FG015|Period2 Extension Period (Group A and B)|Death|0|||
128704008|NCT03129100|463213536|FG016|Period2 Extension Period (Group A and B)|Death|0|||
128704009|NCT03129100|463213537|FG017|Period2 Extension Period (Group A and B)|Death|0|||
128704010|NCT03129100|463213538|FG018|Period2 Extension Period (Group A and B)|Death|0|||
128704011|NCT03129100|463213539|FG019|Period2 Extension Period (Group A and B)|Death|0|||
128704012|NCT03129100|463213540|FG020|Period2 Extension Period (Group A and B)|Death|0|||
128704013|NCT03129100|463213541|FG021|Period2 Extension Period (Group A and B)|Death|0|||
128704014|NCT03129100|463213542|FG022|Period2 Extension Period (Group A and B)|Death|0|||
128704015|NCT03129100|463213543|FG023|Period2 Extension Period (Group A and B)|Death|0|||
128704016|NCT03129100|463213544|FG024|Period2 Extension Period (Group A and B)|Death|0|||
128704017|NCT03129100|463213545|FG025|Period2 Extension Period (Group A and B)|Death|0|||
128704018|NCT03129100|463213520|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704019|NCT03129100|463213521|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704020|NCT03129100|463213522|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
128704021|NCT03129100|463213523|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
128704022|NCT03129100|463213524|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
128704023|NCT03129100|463213525|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
128704024|NCT03129100|463213526|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
128704025|NCT03129100|463213527|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704026|NCT03129100|463213528|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704027|NCT03129100|463213529|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704028|NCT03129100|463213530|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704029|NCT03129100|463213531|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704030|NCT03129100|463213532|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704031|NCT03129100|463213533|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704032|NCT03129100|463213534|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704033|NCT03129100|463213535|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704034|NCT03129100|463213536|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704035|NCT03129100|463213537|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704036|NCT03129100|463213538|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704037|NCT03129100|463213539|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704038|NCT03129100|463213540|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704039|NCT03129100|463213541|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704040|NCT03129100|463213542|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129122094|NCT00961415|464742733|FG002|Induction Treatment Phase|Protocol Violation|0|||
129122095|NCT00961415|464742731|FG000|Induction Treatment Phase|Physician Decision|2|||
129122096|NCT00961415|464742732|FG001|Induction Treatment Phase|Physician Decision|0|||
128704041|NCT03129100|463213543|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129122097|NCT00961415|464742733|FG002|Induction Treatment Phase|Physician Decision|0|||
129122098|NCT00961415|464742731|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
128704042|NCT03129100|463213544|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704043|NCT03129100|463213545|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
128704044|NCT03129100|463213520|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704045|NCT03129100|463213521|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704046|NCT03129100|463213522|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
128704047|NCT03129100|463213523|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704048|NCT03129100|463213524|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704049|NCT03129100|463213525|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704050|NCT03129100|463213526|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704051|NCT03129100|463213527|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704052|NCT03129100|463213528|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704053|NCT03129100|463213529|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704054|NCT03129100|463213530|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704055|NCT03129100|463213531|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704056|NCT03129100|463213532|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704057|NCT03129100|463213533|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704058|NCT03129100|463213534|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704059|NCT03129100|463213535|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704060|NCT03129100|463213536|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704061|NCT03129100|463213537|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704062|NCT03129100|463213538|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704063|NCT03129100|463213539|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704064|NCT03129100|463213540|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704065|NCT03129100|463213541|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704066|NCT03129100|463213542|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704067|NCT03129100|463213543|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704068|NCT03129100|463213544|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704069|NCT03129100|463213545|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
128704070|NCT03129100|463213520|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704071|NCT03129100|463213521|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704072|NCT03129100|463213522|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
128704073|NCT03129100|463213523|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704074|NCT03129100|463213524|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704075|NCT03129100|463213525|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704076|NCT03129100|463213526|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704077|NCT03129100|463213527|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704078|NCT03129100|463213528|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704079|NCT03129100|463213529|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704080|NCT03129100|463213530|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704081|NCT03129100|463213531|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704082|NCT03129100|463213532|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704083|NCT03129100|463213533|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704084|NCT03129100|463213534|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704085|NCT03129100|463213535|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704086|NCT03129100|463213536|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704087|NCT03129100|463213537|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704088|NCT03129100|463213538|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129122099|NCT00961415|464742732|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
128704089|NCT03129100|463213539|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704090|NCT03129100|463213540|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704091|NCT03129100|463213541|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704092|NCT03129100|463213542|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704093|NCT03129100|463213543|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704094|NCT03129100|463213544|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704095|NCT03129100|463213545|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
128704096|NCT03129100|463213520|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704097|NCT03129100|463213521|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704098|NCT03129100|463213522|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
128704099|NCT03129100|463213523|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704100|NCT03129100|463213524|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704101|NCT03129100|463213525|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129122100|NCT00961415|464742733|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
129122101|NCT00961415|464742731|FG000|Induction Treatment Phase|Other Reason|5|||
128704102|NCT03129100|463213526|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704103|NCT03129100|463213527|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704104|NCT03129100|463213528|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704105|NCT03129100|463213529|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704106|NCT03129100|463213530|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704107|NCT03129100|463213531|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704108|NCT03129100|463213532|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704109|NCT03129100|463213533|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704110|NCT03129100|463213534|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704111|NCT03129100|463213535|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704112|NCT03129100|463213536|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704113|NCT03129100|463213537|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704114|NCT03129100|463213538|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704115|NCT03129100|463213539|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704116|NCT03129100|463213540|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704117|NCT03129100|463213541|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704118|NCT03129100|463213542|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704119|NCT03129100|463213543|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704120|NCT03129100|463213544|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704121|NCT03129100|463213545|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
128704122|NCT03129100|463213520|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704123|NCT03129100|463213521|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704124|NCT03129100|463213522|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704125|NCT03129100|463213523|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704126|NCT03129100|463213524|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
128704127|NCT03129100|463213525|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
128704128|NCT03129100|463213526|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
128704129|NCT03129100|463213527|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704130|NCT03129100|463213528|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704131|NCT03129100|463213529|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704132|NCT03129100|463213530|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704133|NCT03129100|463213531|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704134|NCT03129100|463213532|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704135|NCT03129100|463213533|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704136|NCT03129100|463213534|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704137|NCT03129100|463213535|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704138|NCT03129100|463213536|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704139|NCT03129100|463213537|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704140|NCT03129100|463213538|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704141|NCT03129100|463213539|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704142|NCT03129100|463213540|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704143|NCT03129100|463213541|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704144|NCT03129100|463213542|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704145|NCT03129100|463213543|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704146|NCT03129100|463213544|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704147|NCT03129100|463213545|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
128704148|NCT03129100|463213520|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704149|NCT03129100|463213521|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704150|NCT03129100|463213522|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704151|NCT03129100|463213523|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704152|NCT03129100|463213524|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704153|NCT03129100|463213525|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704154|NCT03129100|463213526|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704155|NCT03129100|463213527|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129122102|NCT00961415|464742732|FG001|Induction Treatment Phase|Other Reason|0|||
129122103|NCT00961415|464742733|FG002|Induction Treatment Phase|Other Reason|0|||
129122104|NCT00961415|464742731|FG000|Maintenance Treatment Phase|Death|0|||
128704156|NCT03129100|463213528|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704157|NCT03129100|463213529|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
129122105|NCT00961415|464742732|FG001|Maintenance Treatment Phase|Death|42|||
129122106|NCT00961415|464742733|FG002|Maintenance Treatment Phase|Death|34|||
129122107|NCT00961415|464742731|FG000|Maintenance Treatment Phase|Investigators decision|0|||
129122108|NCT00961415|464742732|FG001|Maintenance Treatment Phase|Investigators decision|2|||
128704158|NCT03129100|463213530|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704159|NCT03129100|463213531|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704160|NCT03129100|463213532|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704161|NCT03129100|463213533|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704162|NCT03129100|463213534|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704163|NCT03129100|463213535|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704164|NCT03129100|463213536|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704165|NCT03129100|463213537|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704166|NCT03129100|463213538|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704167|NCT03129100|463213539|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704168|NCT03129100|463213540|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129031221|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
129031222|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
129031223|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
129031224|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
129031225|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129031226|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129031227|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
128704169|NCT03129100|463213541|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704170|NCT03129100|463213542|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704171|NCT03129100|463213543|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704172|NCT03129100|463213544|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704173|NCT03129100|463213545|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
128704174|NCT03129100|463213520|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704175|NCT03129100|463213521|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704176|NCT03129100|463213522|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704177|NCT03129100|463213523|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704178|NCT03129100|463213524|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704179|NCT03129100|463213525|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704180|NCT03129100|463213526|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704181|NCT03129100|463213527|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704182|NCT03129100|463213528|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704183|NCT03129100|463213529|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704184|NCT03129100|463213530|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704185|NCT03129100|463213531|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
128704186|NCT03129100|463213532|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704187|NCT03129100|463213533|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704188|NCT03129100|463213534|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704189|NCT03129100|463213535|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704190|NCT03129100|463213536|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704191|NCT03129100|463213537|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704192|NCT03129100|463213538|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704193|NCT03129100|463213539|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704194|NCT03129100|463213540|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704195|NCT03129100|463213541|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704196|NCT03129100|463213542|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704197|NCT03129100|463213543|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704198|NCT03129100|463213544|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704199|NCT03129100|463213545|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
128704200|NCT03129100|463213520|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704201|NCT03129100|463213521|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704202|NCT03129100|463213522|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704203|NCT03129100|463213523|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704204|NCT03129100|463213524|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704205|NCT03129100|463213525|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704206|NCT03129100|463213526|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704207|NCT03129100|463213527|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704208|NCT03129100|463213528|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704209|NCT03129100|463213529|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704210|NCT03129100|463213530|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704211|NCT03129100|463213531|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
128768038|NCT00720902|463441998|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
128704212|NCT03129100|463213532|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
128704213|NCT03129100|463213533|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
128704214|NCT03129100|463213534|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
128704215|NCT03129100|463213535|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704216|NCT03129100|463213536|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704217|NCT03129100|463213537|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704218|NCT03129100|463213538|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704219|NCT03129100|463213539|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704220|NCT03129100|463213540|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704221|NCT03129100|463213541|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704222|NCT03129100|463213542|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704223|NCT03129100|463213543|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704224|NCT03129100|463213544|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704225|NCT03129100|463213545|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
128704226|NCT03129100|463213520|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704227|NCT03129100|463213521|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704228|NCT03129100|463213522|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704229|NCT03129100|463213523|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704230|NCT03129100|463213524|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704231|NCT03129100|463213525|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704232|NCT03129100|463213526|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704233|NCT03129100|463213527|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704234|NCT03129100|463213528|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704235|NCT03129100|463213529|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704236|NCT03129100|463213530|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704237|NCT03129100|463213531|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
128704238|NCT03129100|463213532|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704239|NCT03129100|463213533|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
128704240|NCT03129100|463213534|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
128704241|NCT03129100|463213535|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704242|NCT03129100|463213536|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704243|NCT03129100|463213537|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704244|NCT03129100|463213538|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704245|NCT03129100|463213539|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704246|NCT03129100|463213540|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704247|NCT03129100|463213541|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704248|NCT03129100|463213542|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704249|NCT03129100|463213543|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704250|NCT03129100|463213544|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704251|NCT03129100|463213545|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
128704252|NCT03129100|463213520|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704253|NCT03129100|463213521|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704254|NCT03129100|463213522|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704255|NCT03129100|463213523|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704256|NCT03129100|463213524|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704257|NCT03129100|463213525|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704258|NCT03129100|463213526|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704259|NCT03129100|463213527|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704260|NCT03129100|463213528|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704261|NCT03129100|463213529|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704262|NCT03129100|463213530|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704263|NCT03129100|463213531|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704264|NCT03129100|463213532|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704265|NCT03129100|463213533|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704266|NCT03129100|463213534|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704267|NCT03129100|463213535|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
128704268|NCT03129100|463213536|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704269|NCT03129100|463213537|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704270|NCT03129100|463213538|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704271|NCT03129100|463213539|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704272|NCT03129100|463213540|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704273|NCT03129100|463213541|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704274|NCT03129100|463213542|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704275|NCT03129100|463213543|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704276|NCT03129100|463213544|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704277|NCT03129100|463213545|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
128704278|NCT03129100|463213520|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704279|NCT03129100|463213521|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704280|NCT03129100|463213522|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704281|NCT03129100|463213523|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704282|NCT03129100|463213524|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704283|NCT03129100|463213525|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704284|NCT03129100|463213526|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704285|NCT03129100|463213527|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704286|NCT03129100|463213528|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704287|NCT03129100|463213529|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704288|NCT03129100|463213530|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704289|NCT03129100|463213531|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704290|NCT03129100|463213532|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
128704291|NCT03129100|463213533|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704292|NCT03129100|463213534|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
128704293|NCT03129100|463213535|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
128704294|NCT03129100|463213536|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704295|NCT03129100|463213537|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704296|NCT03129100|463213538|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704297|NCT03129100|463213539|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704298|NCT03129100|463213540|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704299|NCT03129100|463213541|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704300|NCT03129100|463213542|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704301|NCT03129100|463213543|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704302|NCT03129100|463213544|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704303|NCT03129100|463213545|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
128704304|NCT03129100|463213520|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704305|NCT03129100|463213521|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704306|NCT03129100|463213522|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704307|NCT03129100|463213523|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704308|NCT03129100|463213524|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704309|NCT03129100|463213525|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704310|NCT03129100|463213526|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704311|NCT03129100|463213527|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704312|NCT03129100|463213528|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704313|NCT03129100|463213529|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704314|NCT03129100|463213530|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704315|NCT03129100|463213531|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704316|NCT03129100|463213532|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704317|NCT03129100|463213533|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704318|NCT03129100|463213534|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704319|NCT03129100|463213535|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704320|NCT03129100|463213536|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704321|NCT03129100|463213537|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
128704322|NCT03129100|463213538|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704323|NCT03129100|463213539|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
128704324|NCT03129100|463213540|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704325|NCT03129100|463213541|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704326|NCT03129100|463213542|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704327|NCT03129100|463213543|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704328|NCT03129100|463213544|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704329|NCT03129100|463213545|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
128704330|NCT03129100|463213520|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704331|NCT03129100|463213521|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704332|NCT03129100|463213522|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704333|NCT03129100|463213523|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704334|NCT03129100|463213524|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704335|NCT03129100|463213525|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704336|NCT03129100|463213526|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704337|NCT03129100|463213527|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704338|NCT03129100|463213528|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704339|NCT03129100|463213529|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704340|NCT03129100|463213530|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704341|NCT03129100|463213531|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704342|NCT03129100|463213532|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704343|NCT03129100|463213533|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704344|NCT03129100|463213534|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704345|NCT03129100|463213535|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704346|NCT03129100|463213536|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704347|NCT03129100|463213537|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704348|NCT03129100|463213538|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704349|NCT03129100|463213539|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704350|NCT03129100|463213540|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
128704351|NCT03129100|463213541|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704352|NCT03129100|463213542|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129216854|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
128704353|NCT03129100|463213543|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704354|NCT03129100|463213544|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704355|NCT03129100|463213545|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
128704356|NCT03129100|463213520|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
128704357|NCT03129100|463213521|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
128704358|NCT03129100|463213522|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
128704359|NCT03129100|463213523|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
128704360|NCT03129100|463213524|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
128704361|NCT03129100|463213525|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
128704362|NCT03129100|463213526|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
128704363|NCT03129100|463213527|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
128704364|NCT03129100|463213528|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
128704365|NCT03129100|463213529|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
128704366|NCT03129100|463213530|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
128704367|NCT03129100|463213531|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
128704368|NCT03129100|463213532|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
128704369|NCT03129100|463213533|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
128704370|NCT03129100|463213534|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
128704371|NCT03129100|463213535|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
128704372|NCT03129100|463213536|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
128704373|NCT03129100|463213537|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
128704374|NCT03129100|463213538|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
128704375|NCT03129100|463213539|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
128704376|NCT03129100|463213540|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
128704377|NCT03129100|463213541|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
128704378|NCT03129100|463213542|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
128704379|NCT03129100|463213543|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
128704380|NCT03129100|463213544|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
128704381|NCT03129100|463213545|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
128704382|NCT03129100|463213520|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704383|NCT03129100|463213521|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704384|NCT03129100|463213522|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704385|NCT03129100|463213523|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704386|NCT03129100|463213524|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704387|NCT03129100|463213525|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704388|NCT03129100|463213526|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704389|NCT03129100|463213527|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704390|NCT03129100|463213528|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704391|NCT03129100|463213529|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704392|NCT03129100|463213530|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704393|NCT03129100|463213531|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704394|NCT03129100|463213532|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704395|NCT03129100|463213533|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704396|NCT03129100|463213534|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704397|NCT03129100|463213535|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704398|NCT03129100|463213536|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704399|NCT03129100|463213537|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704400|NCT03129100|463213538|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704401|NCT03129100|463213539|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704402|NCT03129100|463213540|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
128704403|NCT03129100|463213541|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704404|NCT03129100|463213542|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704405|NCT03129100|463213543|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704406|NCT03129100|463213544|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704407|NCT03129100|463213545|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
128704408|NCT03129100|463213520|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
128704409|NCT03129100|463213521|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
128704410|NCT03129100|463213522|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
128704411|NCT03129100|463213523|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
128704412|NCT03129100|463213524|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
128704413|NCT03129100|463213525|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
128704414|NCT03129100|463213526|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
128704415|NCT03129100|463213527|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
128704416|NCT03129100|463213528|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
128704417|NCT03129100|463213529|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
128704418|NCT03129100|463213530|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
128704419|NCT03129100|463213531|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
128704420|NCT03129100|463213532|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
128704421|NCT03129100|463213533|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
128704422|NCT03129100|463213534|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
128704423|NCT03129100|463213535|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
128704424|NCT03129100|463213536|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
128704425|NCT03129100|463213537|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
128704426|NCT03129100|463213538|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
128704427|NCT03129100|463213539|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
128704428|NCT03129100|463213540|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
128704429|NCT03129100|463213541|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
128704430|NCT03129100|463213542|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
128704431|NCT03129100|463213543|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
128704432|NCT03129100|463213544|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
128704433|NCT03129100|463213545|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
128704434|NCT03129100|463213520|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704435|NCT03129100|463213521|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704436|NCT03129100|463213522|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704437|NCT03129100|463213523|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704438|NCT03129100|463213524|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704439|NCT03129100|463213525|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704440|NCT03129100|463213526|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704441|NCT03129100|463213527|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704442|NCT03129100|463213528|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704443|NCT03129100|463213529|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704444|NCT03129100|463213530|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704445|NCT03129100|463213531|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704446|NCT03129100|463213532|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704447|NCT03129100|463213533|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704448|NCT03129100|463213534|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704449|NCT03129100|463213535|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704450|NCT03129100|463213536|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704451|NCT03129100|463213537|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704452|NCT03129100|463213538|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704453|NCT03129100|463213539|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704454|NCT03129100|463213540|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704455|NCT03129100|463213541|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704456|NCT03129100|463213542|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704457|NCT03129100|463213543|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
128704458|NCT03129100|463213544|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
128704459|NCT03129100|463213545|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
128704460|NCT03129100|463213520|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704461|NCT03129100|463213521|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704462|NCT03129100|463213522|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704463|NCT03129100|463213523|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704464|NCT03129100|463213524|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704465|NCT03129100|463213525|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704466|NCT03129100|463213526|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704467|NCT03129100|463213527|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704468|NCT03129100|463213528|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704469|NCT03129100|463213529|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704470|NCT03129100|463213530|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704471|NCT03129100|463213531|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704472|NCT03129100|463213532|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704473|NCT03129100|463213533|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704474|NCT03129100|463213534|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704475|NCT03129100|463213535|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704476|NCT03129100|463213536|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704477|NCT03129100|463213537|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704478|NCT03129100|463213538|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704479|NCT03129100|463213539|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704480|NCT03129100|463213540|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704481|NCT03129100|463213541|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704482|NCT03129100|463213542|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
128704483|NCT03129100|463213543|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
128704484|NCT03129100|463213544|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
128704485|NCT03129100|463213545|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
128704486|NCT03129100|463213520|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704487|NCT03129100|463213521|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704488|NCT03129100|463213522|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704489|NCT03129100|463213523|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704490|NCT03129100|463213524|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704491|NCT03129100|463213525|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704492|NCT03129100|463213526|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704493|NCT03129100|463213527|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704494|NCT03129100|463213528|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704495|NCT03129100|463213529|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704496|NCT03129100|463213530|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704497|NCT03129100|463213531|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704498|NCT03129100|463213532|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704499|NCT03129100|463213533|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704500|NCT03129100|463213534|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704501|NCT03129100|463213535|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704502|NCT03129100|463213536|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704503|NCT03129100|463213537|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704504|NCT03129100|463213538|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704505|NCT03129100|463213539|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704506|NCT03129100|463213540|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704507|NCT03129100|463213541|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704508|NCT03129100|463213542|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704509|NCT03129100|463213543|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704510|NCT03129100|463213544|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
128704511|NCT03129100|463213545|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
128704512|NCT03129100|463213520|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704513|NCT03129100|463213521|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704514|NCT03129100|463213522|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704515|NCT03129100|463213523|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704516|NCT03129100|463213524|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704517|NCT03129100|463213525|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704518|NCT03129100|463213526|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704519|NCT03129100|463213527|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704520|NCT03129100|463213528|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704521|NCT03129100|463213529|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704522|NCT03129100|463213530|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704523|NCT03129100|463213531|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704524|NCT03129100|463213532|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704525|NCT03129100|463213533|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704526|NCT03129100|463213534|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704527|NCT03129100|463213535|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704528|NCT03129100|463213536|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704529|NCT03129100|463213537|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704530|NCT03129100|463213538|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704531|NCT03129100|463213539|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704532|NCT03129100|463213540|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704533|NCT03129100|463213541|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704534|NCT03129100|463213542|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129122109|NCT00961415|464742733|FG002|Maintenance Treatment Phase|Investigators decision|0|||
129122110|NCT00961415|464742731|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128704535|NCT03129100|463213543|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704536|NCT03129100|463213544|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
128704537|NCT03129100|463213545|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
128704538|NCT03129100|463213520|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
128704539|NCT03129100|463213521|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
128704540|NCT03129100|463213522|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
128704541|NCT03129100|463213523|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
128704542|NCT03129100|463213524|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
129122111|NCT00961415|464742732|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
128768039|NCT01486758|463441999|FG000|Overall Study|Lost to Follow-up|0|||
128768040|NCT01486758|463442000|FG001|Overall Study|Lost to Follow-up|1|||
128768041|NCT02254408|463442010|FG000|Overall Study|Randomized But Not Treated|1|||
128768042|NCT02254408|463442011|FG001|Overall Study|Randomized But Not Treated|3|||
128768043|NCT02254408|463442010|FG000|Overall Study|Adverse Event|1|||
128768044|NCT02254408|463442011|FG001|Overall Study|Adverse Event|0|||
128768045|NCT02254408|463442010|FG000|Overall Study|Death|2|||
128768046|NCT02254408|463442011|FG001|Overall Study|Death|3|||
128768047|NCT02254408|463442010|FG000|Overall Study|Investigator's Discretion|0|||
128768048|NCT02254408|463442011|FG001|Overall Study|Investigator's Discretion|1|||
128768049|NCT02254408|463442010|FG000|Overall Study|Withdrawal by Subject|3|||
128768050|NCT02254408|463442011|FG001|Overall Study|Withdrawal by Subject|3|||
128768051|NCT02254408|463442010|FG000|Overall Study|Lost to Follow-up|1|||
128768052|NCT02254408|463442011|FG001|Overall Study|Lost to Follow-up|0|||
128768053|NCT02914184|463442013|FG000|Overall Study|Lost to Follow-up|7|||
128768054|NCT02914184|463442014|FG001|Overall Study|Lost to Follow-up|10|||
128768055|NCT02914184|463442015|FG002|Overall Study|Lost to Follow-up|8|||
128768056|NCT02914184|463442016|FG003|Overall Study|Lost to Follow-up|7|||
128768057|NCT02914184|463442013|FG000|Overall Study|Withdrawal by Subject|4|||
128768058|NCT02914184|463442014|FG001|Overall Study|Withdrawal by Subject|2|||
128768059|NCT02914184|463442015|FG002|Overall Study|Withdrawal by Subject|7|||
128768060|NCT02914184|463442016|FG003|Overall Study|Withdrawal by Subject|3|||
128768061|NCT02914184|463442013|FG000|Overall Study|Other|1|||
128768062|NCT02914184|463442014|FG001|Overall Study|Other|0|||
128768063|NCT02914184|463442015|FG002|Overall Study|Other|0|||
128768064|NCT02914184|463442016|FG003|Overall Study|Other|0|||
128768065|NCT02914184|463442013|FG000|Overall Study|Migrated/moved from the study area|2|||
128768066|NCT02914184|463442014|FG001|Overall Study|Migrated/moved from the study area|1|||
128768067|NCT02914184|463442015|FG002|Overall Study|Migrated/moved from the study area|2|||
128768068|NCT02914184|463442016|FG003|Overall Study|Migrated/moved from the study area|1|||
128768069|NCT00798174|463442017|FG000|Overall Study|inability to implant azygos coil|3|||
128768070|NCT00798174|463442018|FG001|Overall Study|inability to implant azygos coil|3|||
128768071|NCT00798174|463442017|FG000|Overall Study|Inability to sedate for DFT testing|1|||
128768072|NCT00798174|463442018|FG001|Overall Study|Inability to sedate for DFT testing|0|||
128768073|NCT01478113|463442019|FG000|Overall Study|Withdrawal by Subject|0|||
128768074|NCT01478113|463442020|FG001|Overall Study|Withdrawal by Subject|1|||
128768075|NCT01478113|463442019|FG000|Overall Study|Physician Decision|1|||
128768076|NCT01478113|463442020|FG001|Overall Study|Physician Decision|0|||
128768077|NCT03093428|463442028|FG000|Overall Study|Not eligible for treatment|2|||
128768078|NCT03093428|463442029|FG001|Overall Study|Not eligible for treatment|1|||
128768079|NCT03093428|463442028|FG000|Overall Study|Progression|14|||
128768080|NCT03093428|463442029|FG001|Overall Study|Progression|4|||
128768081|NCT03093428|463442028|FG000|Overall Study|Death|1|||
128768082|NCT03093428|463442029|FG001|Overall Study|Death|0|||
128768083|NCT03093428|463442028|FG000|Overall Study|Adverse Event|1|||
128768084|NCT03093428|463442029|FG001|Overall Study|Adverse Event|0|||
128768085|NCT03093428|463442028|FG000|Overall Study|Withdrawal by Subject|1|||
128768086|NCT03093428|463442029|FG001|Overall Study|Withdrawal by Subject|1|||
128768087|NCT01642602|463442031|FG000|Overall Study|Adverse Event|2|||
128768088|NCT01112514|463442032|FG000|Overall Study|Lost to Follow-up|1|||
128768089|NCT01118455|463442033|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
128768090|NCT01118455|463442034|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
128768091|NCT01993823|463442035|FG000|Overall Study|Requested by the patient|6|||
128768092|NCT01993823|463442036|FG001|Overall Study|Requested by the patient|11|||
128768093|NCT01993823|463442035|FG000|Overall Study|Protocol Violation|0|||
128768094|NCT01993823|463442036|FG001|Overall Study|Protocol Violation|1|||
128768095|NCT01993823|463442035|FG000|Overall Study|Lost to Follow-up|1|||
128768096|NCT01993823|463442036|FG001|Overall Study|Lost to Follow-up|4|||
128768097|NCT01460160|463442037|FG000|Treatment Phase|Lack of Efficacy|3|||
128768098|NCT01460160|463442037|FG000|Treatment Phase|Study Drug Toxicity|2|||
128768099|NCT01460160|463442037|FG000|Treatment Phase|Adverse Event|8|||
128768100|NCT01460160|463442037|FG000|Treatment Phase|Withdrawal by Subject|4|||
128768101|NCT01460160|463442037|FG000|Treatment Phase|Death|2|||
128768102|NCT01460160|463442037|FG000|Treatment Phase|Other reasons|9|||
128768103|NCT01460160|463442037|FG000|Follow-up Phase|Withdrawal by Subject|4|||
128768104|NCT01460160|463442037|FG000|Follow-up Phase|Death|14|||
128768105|NCT01460160|463442037|FG000|Follow-up Phase|Lost to Follow-up|7|||
128768106|NCT01460160|463442037|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
128768107|NCT01460160|463442037|FG000|Follow-up Phase|Other and not reported reasons|5|||
128768108|NCT02091739|463442040|FG000|MP: 16 Weeks|Adverse Event|1|||
128768109|NCT02091739|463442041|FG001|MP: 16 Weeks|Adverse Event|1|||
128768110|NCT02091739|463442042|FG002|MP: 16 Weeks|Adverse Event|1|||
128768111|NCT02091739|463442043|FG003|MP: 16 Weeks|Adverse Event|0|||
128768112|NCT02091739|463442044|FG004|MP: 16 Weeks|Adverse Event|0|||
128768113|NCT02091739|463442040|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
128768114|NCT02091739|463442041|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
128768115|NCT02091739|463442042|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
128768116|NCT02091739|463442043|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
128704543|NCT03129100|463213525|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
128704544|NCT03129100|463213526|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
128704545|NCT03129100|463213527|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
128704546|NCT03129100|463213528|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
128704547|NCT03129100|463213529|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
128704548|NCT03129100|463213530|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
128704549|NCT03129100|463213531|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
128704550|NCT03129100|463213532|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
128704551|NCT03129100|463213533|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
128704552|NCT03129100|463213534|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
128704553|NCT03129100|463213535|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
128704554|NCT03129100|463213536|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
128704555|NCT03129100|463213537|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
128704556|NCT03129100|463213538|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
128704557|NCT03129100|463213539|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
128704558|NCT03129100|463213540|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
128704559|NCT03129100|463213541|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
128704560|NCT03129100|463213542|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
128704561|NCT03129100|463213543|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
128704562|NCT03129100|463213544|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
128704563|NCT03129100|463213545|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
128704564|NCT03845985|463213546|FG000|Overall Study|Lost to Follow-up|2|||
129122112|NCT00961415|464742733|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
129122113|NCT00961415|464742731|FG000|Maintenance Treatment Phase|Other reason|0|||
129122114|NCT00961415|464742732|FG001|Maintenance Treatment Phase|Other reason|1|||
129122115|NCT00961415|464742733|FG002|Maintenance Treatment Phase|Other reason|3|||
129122116|NCT00639509|464742744|FG000|Overall Study|Death|1|||
129122117|NCT01933594|464742745|FG000|Overall Study|Lost to Follow-up|1|||
129122118|NCT01933594|464742746|FG001|Overall Study|Lost to Follow-up|0|||
129122119|NCT01933594|464742747|FG002|Overall Study|Lost to Follow-up|0|||
129122120|NCT01933594|464742748|FG003|Overall Study|Lost to Follow-up|0|||
129122121|NCT01933594|464742749|FG004|Overall Study|Lost to Follow-up|1|||
129122122|NCT01933594|464742750|FG005|Overall Study|Lost to Follow-up|0|||
129122123|NCT01933594|464742745|FG000|Overall Study|Ineligible for subsequent study step|0|||
129122124|NCT01933594|464742746|FG001|Overall Study|Ineligible for subsequent study step|0|||
129122125|NCT01933594|464742747|FG002|Overall Study|Ineligible for subsequent study step|0|||
129122126|NCT01933594|464742748|FG003|Overall Study|Ineligible for subsequent study step|0|||
129122127|NCT01933594|464742749|FG004|Overall Study|Ineligible for subsequent study step|1|||
129122128|NCT01933594|464742750|FG005|Overall Study|Ineligible for subsequent study step|0|||
129122129|NCT05049122|464742751|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
129122130|NCT05049122|464742751|FG000|Overall Study|Participant moved|1|||
129122131|NCT05049122|464742751|FG000|Overall Study|At the direction of the doctor|1|||
129122132|NCT05722015|464742752|FG000|Overall Study|Death|57|||
129122133|NCT05722015|464742753|FG001|Overall Study|Death|37|||
129122134|NCT05722015|464742752|FG000|Overall Study|Lost to Follow-up|1|||
129122135|NCT05722015|464742753|FG001|Overall Study|Lost to Follow-up|0|||
129122136|NCT05722015|464742752|FG000|Overall Study|Withdrawal by Subject|5|||
129122137|NCT05722015|464742753|FG001|Overall Study|Withdrawal by Subject|1|||
129122138|NCT05722015|464742752|FG000|Overall Study|Participants Ongoing|188|||
129122139|NCT05722015|464742753|FG001|Overall Study|Participants Ongoing|88|||
129122140|NCT04513366|464742754|FG000|Treatment Phase|Withdrawal by Subject|6|||
129122141|NCT04513366|464742755|FG001|Treatment Phase|Withdrawal by Subject|8|||
129122142|NCT04513366|464742756|FG002|Treatment Phase|Withdrawal by Subject|3|||
129122143|NCT04513366|464742754|FG000|Treatment Phase|Lost to Follow-up|1|||
129122144|NCT04513366|464742755|FG001|Treatment Phase|Lost to Follow-up|2|||
129122145|NCT04513366|464742756|FG002|Treatment Phase|Lost to Follow-up|5|||
129122146|NCT04513366|464742754|FG000|Treatment Phase|Other than Specified|1|||
128704565|NCT03845985|463213547|FG001|Overall Study|Lost to Follow-up|1|||
128704566|NCT03845985|463213546|FG000|Overall Study|Physician Decision|1|||
128704567|NCT03845985|463213547|FG001|Overall Study|Physician Decision|0|||
128704568|NCT03845985|463213546|FG000|Overall Study|Withdrawal by Subject|4|||
128704569|NCT03845985|463213547|FG001|Overall Study|Withdrawal by Subject|1|||
128704570|NCT03708328|463213551|FG000|Overall Study|Death|3|||
129122147|NCT04513366|464742755|FG001|Treatment Phase|Other than Specified|0|||
129122148|NCT04513366|464742756|FG002|Treatment Phase|Other than Specified|2|||
129122149|NCT04513366|464742754|FG000|Treatment Phase|Physician Decision|2|||
129122150|NCT04513366|464742755|FG001|Treatment Phase|Physician Decision|0|||
129122151|NCT04513366|464742756|FG002|Treatment Phase|Physician Decision|0|||
129122152|NCT04513366|464742754|FG000|Treatment Phase|Adverse Event|0|||
129122153|NCT04513366|464742755|FG001|Treatment Phase|Adverse Event|1|||
129122154|NCT04513366|464742756|FG002|Treatment Phase|Adverse Event|1|||
129122155|NCT04513366|464742754|FG000|Extension Phase|Withdrawal by Subject|3|||
129122156|NCT04513366|464742755|FG001|Extension Phase|Withdrawal by Subject|1|||
128704571|NCT03708328|463213552|FG001|Overall Study|Death|3|||
128704572|NCT03708328|463213553|FG002|Overall Study|Death|4|||
129122157|NCT04513366|464742756|FG002|Extension Phase|Withdrawal by Subject|1|||
128704573|NCT03708328|463213554|FG003|Overall Study|Death|2|||
128704574|NCT03708328|463213555|FG004|Overall Study|Death|2|||
128704575|NCT03708328|463213556|FG005|Overall Study|Death|13|||
128704576|NCT03708328|463213557|FG006|Overall Study|Death|26|||
128704577|NCT03708328|463213558|FG007|Overall Study|Death|18|||
128704578|NCT03708328|463213559|FG008|Overall Study|Death|13|||
128704579|NCT03708328|463213560|FG009|Overall Study|Death|8|||
128704580|NCT03708328|463213551|FG000|Overall Study|Lost to Follow-up|0|||
128704581|NCT03708328|463213552|FG001|Overall Study|Lost to Follow-up|1|||
128704582|NCT03708328|463213553|FG002|Overall Study|Lost to Follow-up|0|||
128704583|NCT03708328|463213554|FG003|Overall Study|Lost to Follow-up|1|||
128704584|NCT03708328|463213555|FG004|Overall Study|Lost to Follow-up|0|||
128704585|NCT03708328|463213556|FG005|Overall Study|Lost to Follow-up|3|||
128704586|NCT03708328|463213557|FG006|Overall Study|Lost to Follow-up|3|||
128704587|NCT03708328|463213558|FG007|Overall Study|Lost to Follow-up|0|||
128704588|NCT03708328|463213559|FG008|Overall Study|Lost to Follow-up|0|||
128704589|NCT03708328|463213560|FG009|Overall Study|Lost to Follow-up|1|||
128704590|NCT03708328|463213551|FG000|Overall Study|Physician Decision|0|||
128704591|NCT03708328|463213552|FG001|Overall Study|Physician Decision|0|||
128704592|NCT03708328|463213553|FG002|Overall Study|Physician Decision|0|||
128704593|NCT03708328|463213554|FG003|Overall Study|Physician Decision|0|||
128704594|NCT03708328|463213555|FG004|Overall Study|Physician Decision|0|||
128704595|NCT03708328|463213556|FG005|Overall Study|Physician Decision|1|||
128704596|NCT03708328|463213557|FG006|Overall Study|Physician Decision|0|||
128704597|NCT03708328|463213558|FG007|Overall Study|Physician Decision|0|||
128704598|NCT03708328|463213559|FG008|Overall Study|Physician Decision|0|||
128704599|NCT03708328|463213560|FG009|Overall Study|Physician Decision|0|||
128704600|NCT03708328|463213551|FG000|Overall Study|Withdrawal by Subject|0|||
128704601|NCT03708328|463213552|FG001|Overall Study|Withdrawal by Subject|0|||
128704602|NCT03708328|463213553|FG002|Overall Study|Withdrawal by Subject|0|||
128704603|NCT03708328|463213554|FG003|Overall Study|Withdrawal by Subject|0|||
128704604|NCT03708328|463213555|FG004|Overall Study|Withdrawal by Subject|1|||
128704605|NCT03708328|463213556|FG005|Overall Study|Withdrawal by Subject|0|||
128704606|NCT03708328|463213557|FG006|Overall Study|Withdrawal by Subject|2|||
128704607|NCT03708328|463213558|FG007|Overall Study|Withdrawal by Subject|4|||
128704608|NCT03708328|463213559|FG008|Overall Study|Withdrawal by Subject|1|||
128704609|NCT03708328|463213560|FG009|Overall Study|Withdrawal by Subject|5|||
128704610|NCT03708328|463213551|FG000|Overall Study|Study Closed Locally|0|||
128704611|NCT03708328|463213552|FG001|Overall Study|Study Closed Locally|0|||
128704612|NCT03708328|463213553|FG002|Overall Study|Study Closed Locally|0|||
128704613|NCT03708328|463213554|FG003|Overall Study|Study Closed Locally|0|||
128704614|NCT03708328|463213555|FG004|Overall Study|Study Closed Locally|0|||
128704615|NCT03708328|463213556|FG005|Overall Study|Study Closed Locally|0|||
128704616|NCT03708328|463213557|FG006|Overall Study|Study Closed Locally|0|||
128704617|NCT03708328|463213558|FG007|Overall Study|Study Closed Locally|1|||
128704618|NCT03708328|463213559|FG008|Overall Study|Study Closed Locally|0|||
128704619|NCT03708328|463213560|FG009|Overall Study|Study Closed Locally|0|||
128704620|NCT03708328|463213551|FG000|Overall Study|Study Ended By Sponsor|0|||
128704621|NCT03708328|463213552|FG001|Overall Study|Study Ended By Sponsor|0|||
128704622|NCT03708328|463213553|FG002|Overall Study|Study Ended By Sponsor|0|||
128704623|NCT03708328|463213554|FG003|Overall Study|Study Ended By Sponsor|0|||
128704624|NCT03708328|463213555|FG004|Overall Study|Study Ended By Sponsor|0|||
128704625|NCT03708328|463213556|FG005|Overall Study|Study Ended By Sponsor|1|||
128704626|NCT03708328|463213557|FG006|Overall Study|Study Ended By Sponsor|0|||
128704627|NCT03708328|463213558|FG007|Overall Study|Study Ended By Sponsor|1|||
128704628|NCT03708328|463213559|FG008|Overall Study|Study Ended By Sponsor|0|||
128704629|NCT03708328|463213560|FG009|Overall Study|Study Ended By Sponsor|0|||
128704630|NCT03708328|463213551|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704631|NCT03708328|463213552|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704632|NCT03708328|463213553|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704633|NCT03708328|463213554|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704634|NCT03708328|463213555|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704635|NCT03708328|463213556|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704636|NCT03708328|463213557|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704637|NCT03708328|463213558|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704638|NCT03708328|463213559|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
128704639|NCT03708328|463213560|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
128704640|NCT03648983|463213562|FG000|Overall Study|Study was terminated due to PI departure|95|||
128704641|NCT01269463|463213563|FG000|First Intervention|Withdrawal by Subject|1|||
128704642|NCT01269463|463213564|FG001|First Intervention|Withdrawal by Subject|0|||
128704643|NCT01269463|463213563|FG000|First Intervention|Adverse Event|1|||
128704644|NCT01269463|463213564|FG001|First Intervention|Adverse Event|0|||
128704645|NCT01269463|463213563|FG000|First Intervention|Lack of Efficacy|0|||
128704646|NCT01269463|463213564|FG001|First Intervention|Lack of Efficacy|1|||
128704647|NCT01269463|463213563|FG000|First Intervention|Physician Decision|0|||
128704648|NCT01269463|463213564|FG001|First Intervention|Physician Decision|1|||
128704649|NCT04404361|463213568|FG000|Overall Study|Death|12|||
128704650|NCT04404361|463213569|FG001|Overall Study|Death|12|||
128704651|NCT04404361|463213568|FG000|Overall Study|Withdrawal by Subject|13|||
128704652|NCT04404361|463213569|FG001|Overall Study|Withdrawal by Subject|5|||
128704653|NCT04404361|463213568|FG000|Overall Study|Lost to Follow-up|6|||
128704654|NCT04404361|463213569|FG001|Overall Study|Lost to Follow-up|3|||
128704655|NCT04404361|463213568|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
128704656|NCT04404361|463213569|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
128704657|NCT02862171|463213570|FG000|Overall Study|Death|1|||
128704658|NCT02862171|463213570|FG000|Overall Study|Lost to Follow-up|13|||
128704659|NCT02862171|463213570|FG000|Overall Study|Withdrawal by Subject|57|||
128704660|NCT02862171|463213570|FG000|Overall Study|Non-compliance|4|||
128704661|NCT02862171|463213570|FG000|Overall Study|HIV-1 seroconversion|18|||
128704662|NCT02549937|463213572|FG000|Overall Study|Death|0|||
128704663|NCT02549937|463213573|FG001|Overall Study|Death|1|||
128704664|NCT02549937|463213574|FG002|Overall Study|Death|0|||
128704665|NCT02549937|463213575|FG003|Overall Study|Death|1|||
128704666|NCT02549937|463213576|FG004|Overall Study|Death|0|||
128704667|NCT02549937|463213577|FG005|Overall Study|Death|8|||
128704668|NCT02549937|463213578|FG006|Overall Study|Death|0|||
128704669|NCT02549937|463213579|FG007|Overall Study|Death|0|||
128704670|NCT02549937|463213580|FG008|Overall Study|Death|19|||
128704671|NCT02549937|463213572|FG000|Overall Study|No follow up required|3|||
128704672|NCT02549937|463213573|FG001|Overall Study|No follow up required|6|||
128704673|NCT02549937|463213574|FG002|Overall Study|No follow up required|3|||
128704674|NCT02549937|463213575|FG003|Overall Study|No follow up required|8|||
128704675|NCT02549937|463213576|FG004|Overall Study|No follow up required|12|||
128704676|NCT02549937|463213577|FG005|Overall Study|No follow up required|21|||
128704677|NCT02549937|463213578|FG006|Overall Study|No follow up required|9|||
128704678|NCT02549937|463213579|FG007|Overall Study|No follow up required|11|||
128704679|NCT02549937|463213580|FG008|Overall Study|No follow up required|0|||
128704680|NCT02549937|463213572|FG000|Overall Study|Other|0|||
128704681|NCT02549937|463213573|FG001|Overall Study|Other|0|||
128704682|NCT02549937|463213574|FG002|Overall Study|Other|0|||
128704683|NCT02549937|463213575|FG003|Overall Study|Other|0|||
128704684|NCT02549937|463213576|FG004|Overall Study|Other|1|||
128704685|NCT02549937|463213577|FG005|Overall Study|Other|0|||
128704686|NCT02549937|463213578|FG006|Overall Study|Other|3|||
128704687|NCT02549937|463213579|FG007|Overall Study|Other|2|||
128704688|NCT02549937|463213580|FG008|Overall Study|Other|3|||
128704689|NCT02549937|463213572|FG000|Overall Study|Lost to Follow-up|0|||
128704690|NCT02549937|463213573|FG001|Overall Study|Lost to Follow-up|0|||
128704691|NCT02549937|463213574|FG002|Overall Study|Lost to Follow-up|0|||
128704692|NCT02549937|463213575|FG003|Overall Study|Lost to Follow-up|0|||
128704693|NCT02549937|463213576|FG004|Overall Study|Lost to Follow-up|0|||
128704694|NCT02549937|463213577|FG005|Overall Study|Lost to Follow-up|0|||
128704695|NCT02549937|463213578|FG006|Overall Study|Lost to Follow-up|0|||
128704696|NCT02549937|463213579|FG007|Overall Study|Lost to Follow-up|0|||
128704697|NCT02549937|463213580|FG008|Overall Study|Lost to Follow-up|3|||
128704698|NCT02549937|463213572|FG000|Overall Study|Withdrawal by Subject|0|||
128704699|NCT02549937|463213573|FG001|Overall Study|Withdrawal by Subject|0|||
128704700|NCT02549937|463213574|FG002|Overall Study|Withdrawal by Subject|0|||
128704701|NCT02549937|463213575|FG003|Overall Study|Withdrawal by Subject|0|||
128704702|NCT02549937|463213576|FG004|Overall Study|Withdrawal by Subject|0|||
128704703|NCT02549937|463213577|FG005|Overall Study|Withdrawal by Subject|1|||
128704704|NCT02549937|463213578|FG006|Overall Study|Withdrawal by Subject|4|||
128704705|NCT02549937|463213579|FG007|Overall Study|Withdrawal by Subject|3|||
128704706|NCT02549937|463213580|FG008|Overall Study|Withdrawal by Subject|2|||
128704707|NCT02549937|463213572|FG000|Overall Study|Sponsor Decision|0|||
128704708|NCT02549937|463213573|FG001|Overall Study|Sponsor Decision|0|||
128704709|NCT02549937|463213574|FG002|Overall Study|Sponsor Decision|0|||
128704710|NCT02549937|463213575|FG003|Overall Study|Sponsor Decision|0|||
128704711|NCT02549937|463213576|FG004|Overall Study|Sponsor Decision|0|||
128704712|NCT02549937|463213577|FG005|Overall Study|Sponsor Decision|0|||
128704713|NCT02549937|463213578|FG006|Overall Study|Sponsor Decision|0|||
128704714|NCT02549937|463213579|FG007|Overall Study|Sponsor Decision|0|||
128704715|NCT02549937|463213580|FG008|Overall Study|Sponsor Decision|6|||
128704716|NCT03930797|463213581|FG000|Overall Study|Lost to Follow-up|3|||
128704717|NCT03930797|463213582|FG001|Overall Study|Lost to Follow-up|10|||
128704718|NCT00662012|463213583|FG000|Overall Study|Lost to Follow-up|85|||
128704719|NCT00662012|463213583|FG000|Overall Study|Death|1|||
128704720|NCT00662012|463213583|FG000|Overall Study|Withdrawal by Subject|1|||
128704721|NCT02144012|463213586|FG000|Overall Study|Adverse Event|1|||
129031228|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
128704722|NCT02144012|463213587|FG001|Overall Study|Adverse Event|0|||
128704723|NCT02144012|463213586|FG000|Overall Study|Death|1|||
128704724|NCT02144012|463213587|FG001|Overall Study|Death|0|||
128704725|NCT02144012|463213586|FG000|Overall Study|Withdrawal by Subject|11|||
128704726|NCT02144012|463213587|FG001|Overall Study|Withdrawal by Subject|3|||
128704727|NCT02144012|463213586|FG000|Overall Study|Study Terminated by Sponsor|18|||
128704728|NCT02144012|463213587|FG001|Overall Study|Study Terminated by Sponsor|12|||
128704729|NCT02144012|463213586|FG000|Overall Study|Other|3|||
128704730|NCT02144012|463213587|FG001|Overall Study|Other|0|||
128704731|NCT01949506|463213588|FG000|Overall Study|Physician Decision|1|||
128704732|NCT02915016|463213589|FG000|Overall Study|Lost to Follow-up|4|||
128704733|NCT02915016|463213590|FG001|Overall Study|Lost to Follow-up|2|||
128704734|NCT02915016|463213591|FG002|Overall Study|Lost to Follow-up|5|||
128704735|NCT02915016|463213592|FG003|Overall Study|Lost to Follow-up|3|||
128704736|NCT02915016|463213593|FG004|Overall Study|Lost to Follow-up|5|||
128704737|NCT02915016|463213594|FG005|Overall Study|Lost to Follow-up|2|||
128704738|NCT02915016|463213595|FG006|Overall Study|Lost to Follow-up|8|||
128704739|NCT02915016|463213596|FG007|Overall Study|Lost to Follow-up|2|||
128704740|NCT02915016|463213589|FG000|Overall Study|Physician Decision|0|||
128704741|NCT02915016|463213590|FG001|Overall Study|Physician Decision|0|||
128704742|NCT02915016|463213591|FG002|Overall Study|Physician Decision|1|||
128704743|NCT02915016|463213592|FG003|Overall Study|Physician Decision|0|||
128704744|NCT02915016|463213593|FG004|Overall Study|Physician Decision|0|||
128704745|NCT02915016|463213594|FG005|Overall Study|Physician Decision|1|||
128704746|NCT02915016|463213595|FG006|Overall Study|Physician Decision|2|||
128704747|NCT02915016|463213596|FG007|Overall Study|Physician Decision|0|||
128704748|NCT02915016|463213589|FG000|Overall Study|Withdrawal by Subject|2|||
128704749|NCT02915016|463213590|FG001|Overall Study|Withdrawal by Subject|0|||
128704750|NCT02915016|463213591|FG002|Overall Study|Withdrawal by Subject|1|||
128704751|NCT02915016|463213592|FG003|Overall Study|Withdrawal by Subject|0|||
128704752|NCT02915016|463213593|FG004|Overall Study|Withdrawal by Subject|1|||
128704753|NCT02915016|463213594|FG005|Overall Study|Withdrawal by Subject|3|||
128704754|NCT02915016|463213595|FG006|Overall Study|Withdrawal by Subject|1|||
128704755|NCT02915016|463213596|FG007|Overall Study|Withdrawal by Subject|1|||
128704756|NCT02915016|463213589|FG000|Overall Study|Elected not to continue|0|||
128704757|NCT02915016|463213590|FG001|Overall Study|Elected not to continue|0|||
128704758|NCT02915016|463213591|FG002|Overall Study|Elected not to continue|0|||
128704759|NCT02915016|463213592|FG003|Overall Study|Elected not to continue|1|||
128704760|NCT02915016|463213593|FG004|Overall Study|Elected not to continue|0|||
128704761|NCT02915016|463213594|FG005|Overall Study|Elected not to continue|0|||
128704762|NCT02915016|463213595|FG006|Overall Study|Elected not to continue|1|||
128704763|NCT02915016|463213596|FG007|Overall Study|Elected not to continue|0|||
128704764|NCT02915016|463213589|FG000|Overall Study|HIV infection|1|||
128704765|NCT02915016|463213590|FG001|Overall Study|HIV infection|1|||
128704766|NCT02915016|463213591|FG002|Overall Study|HIV infection|1|||
128704767|NCT02915016|463213592|FG003|Overall Study|HIV infection|0|||
128704768|NCT02915016|463213593|FG004|Overall Study|HIV infection|1|||
128704769|NCT02915016|463213594|FG005|Overall Study|HIV infection|0|||
128704770|NCT02915016|463213595|FG006|Overall Study|HIV infection|0|||
128704771|NCT02915016|463213596|FG007|Overall Study|HIV infection|0|||
128704772|NCT02915016|463213589|FG000|Overall Study|Participant unable to adhere|0|||
128704773|NCT02915016|463213590|FG001|Overall Study|Participant unable to adhere|0|||
128704774|NCT02915016|463213591|FG002|Overall Study|Participant unable to adhere|0|||
128704775|NCT02915016|463213592|FG003|Overall Study|Participant unable to adhere|0|||
128704776|NCT02915016|463213593|FG004|Overall Study|Participant unable to adhere|0|||
128704777|NCT02915016|463213594|FG005|Overall Study|Participant unable to adhere|0|||
128704778|NCT02915016|463213595|FG006|Overall Study|Participant unable to adhere|0|||
128704779|NCT02915016|463213596|FG007|Overall Study|Participant unable to adhere|1|||
128704780|NCT05425745|463213611|FG000|Overall Study|Withdrawal of Consent|3|||
128704781|NCT05425745|463213612|FG001|Overall Study|Withdrawal of Consent|3|||
128704782|NCT05425745|463213611|FG000|Overall Study|Death|2|||
128704783|NCT05425745|463213612|FG001|Overall Study|Death|3|||
128704784|NCT05425745|463213611|FG000|Overall Study|Lost to Follow-up|1|||
128704785|NCT05425745|463213612|FG001|Overall Study|Lost to Follow-up|2|||
128704786|NCT05425745|463213611|FG000|Overall Study|Adverse Event|0|||
128704787|NCT05425745|463213612|FG001|Overall Study|Adverse Event|1|||
128704788|NCT05425745|463213611|FG000|Overall Study|Did not return for end of study visit|0|||
128704789|NCT05425745|463213612|FG001|Overall Study|Did not return for end of study visit|1|||
128704790|NCT05425745|463213611|FG000|Overall Study|End of study visit completed by phone|1|||
128768117|NCT02091739|463442044|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
129031229|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
128704791|NCT05425745|463213612|FG001|Overall Study|End of study visit completed by phone|0|||
128704792|NCT05425745|463213611|FG000|Overall Study|Subject decision|1|||
128704793|NCT05425745|463213612|FG001|Overall Study|Subject decision|0|||
128704794|NCT02674529|463215084|FG000|Overall Study|Lost to Follow-up|1|||
128704795|NCT02674529|463215085|FG001|Overall Study|Lost to Follow-up|2|||
128704796|NCT02674529|463215084|FG000|Overall Study|Withdrawal by Subject|2|||
128704797|NCT02674529|463215085|FG001|Overall Study|Withdrawal by Subject|1|||
128704798|NCT02674529|463215084|FG000|Overall Study|Physician Decision|0|||
128704799|NCT02674529|463215085|FG001|Overall Study|Physician Decision|1|||
128704800|NCT02674529|463215084|FG000|Overall Study|Protocol Violation|0|||
128704801|NCT02674529|463215085|FG001|Overall Study|Protocol Violation|1|||
128704802|NCT02891850|463215086|FG000|Overall Study|Adverse Event|3|||
128704803|NCT02891850|463215087|FG001|Overall Study|Adverse Event|0|||
128704804|NCT02891850|463215086|FG000|Overall Study|Death|0|||
128704805|NCT02891850|463215087|FG001|Overall Study|Death|4|||
128704806|NCT02891850|463215086|FG000|Overall Study|Physician Decision|1|||
128704807|NCT02891850|463215087|FG001|Overall Study|Physician Decision|0|||
128704808|NCT02891850|463215086|FG000|Overall Study|Pregnancy|1|||
128704809|NCT02891850|463215087|FG001|Overall Study|Pregnancy|0|||
128704810|NCT02891850|463215086|FG000|Overall Study|Withdrawal by Subject|2|||
128704811|NCT02891850|463215087|FG001|Overall Study|Withdrawal by Subject|3|||
128704812|NCT00630396|463215088|FG000|Overall Study|Death|4|||
128704813|NCT00630396|463215088|FG000|Overall Study|Lost to Follow-up|3|||
128704814|NCT00790023|463215092|FG000|Overall Study|Adverse Event|2|||
128704815|NCT00790023|463215093|FG001|Overall Study|Adverse Event|1|||
128704816|NCT00790023|463215094|FG002|Overall Study|Adverse Event|4|||
128704817|NCT00790023|463215092|FG000|Overall Study|Protocol Violation|2|||
128704818|NCT00790023|463215093|FG001|Overall Study|Protocol Violation|4|||
128704819|NCT00790023|463215094|FG002|Overall Study|Protocol Violation|2|||
128704820|NCT00790023|463215092|FG000|Overall Study|Withdrawal by Subject|2|||
128704821|NCT00790023|463215093|FG001|Overall Study|Withdrawal by Subject|0|||
128704822|NCT00790023|463215094|FG002|Overall Study|Withdrawal by Subject|6|||
128704823|NCT00790023|463215092|FG000|Overall Study|Lost to Follow-up|0|||
128704824|NCT00790023|463215093|FG001|Overall Study|Lost to Follow-up|0|||
128704825|NCT00790023|463215094|FG002|Overall Study|Lost to Follow-up|1|||
128704826|NCT00790023|463215092|FG000|Overall Study|Other|5|||
128704827|NCT00790023|463215093|FG001|Overall Study|Other|5|||
128704828|NCT00790023|463215094|FG002|Overall Study|Other|8|||
128704829|NCT00331682|463215095|FG000|Overall Study|Adverse Event|1|||
128704830|NCT01338792|463215096|FG000|Overall Study|Adverse Event|2|||
128704831|NCT01338792|463215096|FG000|Overall Study|Death|1|||
128704832|NCT01338792|463215096|FG000|Overall Study|Withdrawal by Subject|1|||
128704833|NCT02468414|463215097|FG000|Overall Study|Early Study Termination by Sponsor|1|||
128704834|NCT02468414|463215098|FG001|Overall Study|Early Study Termination by Sponsor|0|||
128704835|NCT02468414|463215097|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
128704836|NCT02468414|463215098|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
128704837|NCT02468414|463215097|FG000|Overall Study|Screen Failure|1|||
128704838|NCT02468414|463215098|FG001|Overall Study|Screen Failure|0|||
128704839|NCT01652703|463215099|FG000|Overall Study|Withdrawal by Subject|0|||
128704840|NCT01652703|463215100|FG001|Overall Study|Withdrawal by Subject|1|||
128704841|NCT01652703|463215101|FG002|Overall Study|Withdrawal by Subject|3|||
128704842|NCT01652703|463215102|FG003|Overall Study|Withdrawal by Subject|1|||
128704843|NCT01652703|463215103|FG004|Overall Study|Withdrawal by Subject|0|||
128704844|NCT01652703|463215104|FG005|Overall Study|Withdrawal by Subject|1|||
128704845|NCT01652703|463215099|FG000|Overall Study|Other|0|||
128704846|NCT01652703|463215100|FG001|Overall Study|Other|0|||
128704847|NCT01652703|463215101|FG002|Overall Study|Other|0|||
128704848|NCT01652703|463215102|FG003|Overall Study|Other|1|||
128704849|NCT01652703|463215103|FG004|Overall Study|Other|1|||
128704850|NCT01652703|463215104|FG005|Overall Study|Other|1|||
128704851|NCT02155608|463215108|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
128704852|NCT02155608|463215109|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
128704853|NCT02155608|463215108|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
129216855|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
128704854|NCT02155608|463215109|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
128704855|NCT00903695|463215110|FG000|Overall Study|medical exclusion after 1st testing|1|||
128704856|NCT00903695|463215111|FG001|Overall Study|medical exclusion after 1st testing|0|||
128704857|NCT00903695|463215110|FG000|Overall Study|lung cancer|1|||
128704858|NCT00903695|463215111|FG001|Overall Study|lung cancer|0|||
128704859|NCT01532414|463215112|FG000|Overall Study|Lost to Follow-up|3|||
128704860|NCT01532414|463215113|FG001|Overall Study|Lost to Follow-up|0|||
128704861|NCT01532414|463215114|FG002|Overall Study|Lost to Follow-up|1|||
128704862|NCT01532414|463215112|FG000|Overall Study|Withdrawal by Subject|3|||
128704863|NCT01532414|463215113|FG001|Overall Study|Withdrawal by Subject|0|||
128704864|NCT01532414|463215114|FG002|Overall Study|Withdrawal by Subject|0|||
128704865|NCT01532414|463215112|FG000|Overall Study|No V6 semen sample|0|||
128704866|NCT01532414|463215113|FG001|Overall Study|No V6 semen sample|1|||
128704867|NCT01532414|463215114|FG002|Overall Study|No V6 semen sample|0|||
128704868|NCT01532414|463215112|FG000|Overall Study|Adverse Event|0|||
128704869|NCT01532414|463215113|FG001|Overall Study|Adverse Event|1|||
128704870|NCT01532414|463215114|FG002|Overall Study|Adverse Event|1|||
128704871|NCT01532414|463215112|FG000|Overall Study|Unable to complete 24 hour PK|0|||
128704872|NCT01532414|463215113|FG001|Overall Study|Unable to complete 24 hour PK|0|||
128704873|NCT01532414|463215114|FG002|Overall Study|Unable to complete 24 hour PK|1|||
128704874|NCT01532414|463215112|FG000|Overall Study|Withdrawn by sponsor|1|||
128704875|NCT01532414|463215113|FG001|Overall Study|Withdrawn by sponsor|0|||
128704876|NCT01532414|463215114|FG002|Overall Study|Withdrawn by sponsor|0|||
128704877|NCT00578812|463215115|FG000|Overall Study|Not treated|6|||
128704878|NCT00578812|463215116|FG001|Overall Study|Not treated|7|||
128704879|NCT04532164|463215119|FG000|Overall Study|Adverse Event|1|||
128704880|NCT04532164|463215119|FG000|Overall Study|Protocol Violation|5|||
128704881|NCT04532164|463215119|FG000|Overall Study|Lost to Follow-up|1|||
128704882|NCT04532164|463215119|FG000|Overall Study|Found to be Ineligible|3|||
128704883|NCT04532164|463215119|FG000|Overall Study|Withdrawal by Subject|14|||
128704884|NCT00429273|463215125|FG000|Overall Study|Lost to Follow-up|1|||
128704885|NCT00429273|463215126|FG001|Overall Study|Lost to Follow-up|2|||
128704886|NCT00429273|463215127|FG002|Overall Study|Lost to Follow-up|2|||
128704887|NCT00429273|463215125|FG000|Overall Study|Physician Decision|6|||
128704888|NCT00429273|463215126|FG001|Overall Study|Physician Decision|5|||
128704889|NCT00429273|463215127|FG002|Overall Study|Physician Decision|5|||
128704890|NCT00429273|463215125|FG000|Overall Study|Adverse Event|1|||
128704891|NCT00429273|463215126|FG001|Overall Study|Adverse Event|1|||
128704892|NCT00429273|463215127|FG002|Overall Study|Adverse Event|2|||
128704893|NCT01438957|463215128|FG000|Overall Study|Physician Decision|1|||
128704894|NCT01438957|463215129|FG001|Overall Study|Physician Decision|1|||
128704895|NCT01438957|463215130|FG002|Overall Study|Physician Decision|0|||
128704896|NCT01438957|463215131|FG003|Overall Study|Physician Decision|1|||
128704897|NCT01438957|463215132|FG004|Overall Study|Physician Decision|0|||
128704898|NCT00727025|463215136|FG000|Overall Study|Physician Decision|23|||
128704899|NCT02269241|463215137|FG000|Overall Study|Lost to Follow-up|269|||
128704900|NCT02269241|463215137|FG000|Overall Study|Withdrawal by Subject|155|||
128704901|NCT02269241|463215137|FG000|Overall Study|Protocol Violation|1|||
128704902|NCT02269241|463215137|FG000|Overall Study|Physician Decision|7|||
128704903|NCT02269241|463215137|FG000|Overall Study|Pregnancy|15|||
128704904|NCT02269241|463215137|FG000|Overall Study|Wish for pregnancy|5|||
128704905|NCT02269241|463215137|FG000|Overall Study|Development of an exclusion criteria|16|||
128704906|NCT02269241|463215137|FG000|Overall Study|Adverse Event|113|||
128704907|NCT02269241|463215137|FG000|Overall Study|At the specific request of the sponsor|20|||
128704908|NCT02269241|463215137|FG000|Overall Study|Several reasons not classified|53|||
128704909|NCT02269241|463215137|FG000|Overall Study|Screening failures|546|||
128704910|NCT02270957|463215138|FG000|Overall Study|Lack of Efficacy|2|||
128704911|NCT02270957|463215139|FG001|Overall Study|Lack of Efficacy|4|||
128704912|NCT02270957|463215138|FG000|Overall Study|Adverse Event|2|||
128704913|NCT02270957|463215139|FG001|Overall Study|Adverse Event|0|||
128704914|NCT00489541|463215144|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
128704915|NCT00489541|463215145|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
128704916|NCT00489541|463215144|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
128704917|NCT00489541|463215145|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
128704918|NCT00489541|463215144|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
128704919|NCT00489541|463215145|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
128704920|NCT00489541|463215144|FG000|12-Month Clinical Follow-up|Death|3|||
128704921|NCT00489541|463215145|FG001|12-Month Clinical Follow-up|Death|2|||
128704922|NCT00489541|463215144|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
128704923|NCT00489541|463215145|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
128704924|NCT00489541|463215144|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
128704925|NCT00489541|463215145|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
128704926|NCT03266107|463215146|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
128704927|NCT03266107|463215146|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
128704928|NCT03266107|463215146|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
128935827|NCT03894904|464052362|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
128704929|NCT03266107|463215146|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
128704930|NCT01191801|463215149|FG000|Overall Study|Death|36|||
128704931|NCT01191801|463215150|FG001|Overall Study|Death|12|||
128704932|NCT01191801|463215149|FG000|Overall Study|Lack of Efficacy|176|||
128704933|NCT01191801|463215150|FG001|Overall Study|Lack of Efficacy|258|||
128704934|NCT01191801|463215149|FG000|Overall Study|Adverse Event|9|||
128935828|NCT03894904|464052363|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
128935829|NCT03894904|464052362|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
128935830|NCT03894904|464052363|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
128935831|NCT01781026|464052364|FG000|Overall Study|Lack of Efficacy|2|||
128935832|NCT01240811|464053849|FG000|Overall Study|Physician Decision|0|||
128935833|NCT01240811|464053850|FG001|Overall Study|Physician Decision|1|||
128935834|NCT01240811|464053851|FG002|Overall Study|Physician Decision|0|||
128935835|NCT01240811|464053849|FG000|Overall Study|Withdrawal by Subject|0|||
128935836|NCT01240811|464053850|FG001|Overall Study|Withdrawal by Subject|0|||
128935837|NCT01240811|464053851|FG002|Overall Study|Withdrawal by Subject|1|||
128935838|NCT01543490|464053855|FG000|Overall Study|Adverse Event|4|||
128935839|NCT01543490|464053856|FG001|Overall Study|Adverse Event|0|||
128935840|NCT01543490|464053855|FG000|Overall Study|Physician Decision|1|||
128704935|NCT01191801|463215150|FG001|Overall Study|Adverse Event|8|||
128704936|NCT01191801|463215149|FG000|Overall Study|Protocol Violation|2|||
128704937|NCT01191801|463215150|FG001|Overall Study|Protocol Violation|4|||
128704938|NCT01191801|463215149|FG000|Overall Study|Physician Decision|47|||
129122158|NCT04513366|464742754|FG000|Extension Phase|Other than Specified|4|||
129122159|NCT04513366|464742755|FG001|Extension Phase|Other than Specified|0|||
128704939|NCT01191801|463215150|FG001|Overall Study|Physician Decision|24|||
128704940|NCT01191801|463215149|FG000|Overall Study|Withdrawal by Subject|1|||
128704941|NCT01191801|463215150|FG001|Overall Study|Withdrawal by Subject|4|||
128704942|NCT01191801|463215149|FG000|Overall Study|Not Provided|45|||
128704943|NCT01191801|463215150|FG001|Overall Study|Not Provided|27|||
128704944|NCT05147350|463215154|FG000|Overall Study|Death|2|||
128704945|NCT05147350|463215155|FG001|Overall Study|Death|3|||
128704946|NCT05147350|463215156|FG002|Overall Study|Death|3|||
128704947|NCT05147350|463215157|FG003|Overall Study|Death|2|||
128704948|NCT05147350|463215158|FG004|Overall Study|Death|2|||
128704949|NCT05147350|463215159|FG005|Overall Study|Death|1|||
128704950|NCT05147350|463215160|FG006|Overall Study|Death|1|||
128704951|NCT05147350|463215161|FG007|Overall Study|Death|3|||
128704952|NCT05147350|463215154|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
128704953|NCT05147350|463215155|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
128704954|NCT05147350|463215156|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
128704955|NCT05147350|463215157|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
128704956|NCT05147350|463215158|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
128704957|NCT05147350|463215159|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
128704958|NCT05147350|463215160|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
128704959|NCT05147350|463215161|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
128704960|NCT05147350|463215154|FG000|Overall Study|Withdrawal by Subject|0|||
128704961|NCT05147350|463215155|FG001|Overall Study|Withdrawal by Subject|0|||
128704962|NCT05147350|463215156|FG002|Overall Study|Withdrawal by Subject|3|||
128704963|NCT05147350|463215157|FG003|Overall Study|Withdrawal by Subject|1|||
128704964|NCT05147350|463215158|FG004|Overall Study|Withdrawal by Subject|1|||
128704965|NCT05147350|463215159|FG005|Overall Study|Withdrawal by Subject|0|||
128704966|NCT05147350|463215160|FG006|Overall Study|Withdrawal by Subject|1|||
128704967|NCT05147350|463215161|FG007|Overall Study|Withdrawal by Subject|0|||
128704968|NCT05147350|463215154|FG000|Overall Study|Other Reasons|0|||
128704969|NCT05147350|463215155|FG001|Overall Study|Other Reasons|0|||
128704970|NCT05147350|463215156|FG002|Overall Study|Other Reasons|2|||
128704971|NCT05147350|463215157|FG003|Overall Study|Other Reasons|0|||
128704972|NCT05147350|463215158|FG004|Overall Study|Other Reasons|0|||
128704973|NCT05147350|463215159|FG005|Overall Study|Other Reasons|2|||
128704974|NCT05147350|463215160|FG006|Overall Study|Other Reasons|1|||
128704975|NCT05147350|463215161|FG007|Overall Study|Other Reasons|1|||
128704976|NCT01539538|463215162|FG000|Overall Study|Adverse Event|13|||
128704977|NCT01539538|463215163|FG001|Overall Study|Adverse Event|18|||
128704978|NCT01539538|463215162|FG000|Overall Study|Lack of Efficacy|13|||
128704979|NCT01539538|463215163|FG001|Overall Study|Lack of Efficacy|16|||
128704980|NCT01539538|463215162|FG000|Overall Study|Withdrawal by Subject|2|||
128704981|NCT01539538|463215163|FG001|Overall Study|Withdrawal by Subject|3|||
128704982|NCT01539538|463215162|FG000|Overall Study|PCA no longer required or PCA problem|3|||
128704983|NCT01539538|463215163|FG001|Overall Study|PCA no longer required or PCA problem|7|||
128704984|NCT01192516|463215168|FG000|Overall Study|Lost to Follow-up|7|||
128704985|NCT01192516|463215169|FG001|Overall Study|Lost to Follow-up|10|||
128704986|NCT01192516|463215170|FG002|Overall Study|Lost to Follow-up|7|||
128704987|NCT01192516|463215168|FG000|Overall Study|Withdrawal by Subject|4|||
128704988|NCT01192516|463215169|FG001|Overall Study|Withdrawal by Subject|4|||
128704989|NCT01192516|463215170|FG002|Overall Study|Withdrawal by Subject|1|||
128704990|NCT01192516|463215168|FG000|Overall Study|started new treatment|5|||
129122160|NCT04513366|464742756|FG002|Extension Phase|Other than Specified|1|||
129122161|NCT04513366|464742754|FG000|Extension Phase|Lost to Follow-up|1|||
129122162|NCT04513366|464742755|FG001|Extension Phase|Lost to Follow-up|1|||
129122163|NCT04513366|464742756|FG002|Extension Phase|Lost to Follow-up|1|||
129122164|NCT04513366|464742754|FG000|Extension Phase|Sponsor Decision|0|||
129122165|NCT04513366|464742755|FG001|Extension Phase|Sponsor Decision|1|||
129122166|NCT04513366|464742756|FG002|Extension Phase|Sponsor Decision|0|||
129122167|NCT04513366|464742754|FG000|Extension Phase|Death|0|||
129122168|NCT04513366|464742755|FG001|Extension Phase|Death|1|||
129122169|NCT04513366|464742756|FG002|Extension Phase|Death|0|||
129122170|NCT04513366|464742754|FG000|Extension Phase|Adverse Event|0|||
128704991|NCT01192516|463215169|FG001|Overall Study|started new treatment|1|||
128704992|NCT01192516|463215170|FG002|Overall Study|started new treatment|0|||
128704993|NCT01192516|463215168|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
128704994|NCT01192516|463215169|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
128704995|NCT01192516|463215170|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
128704996|NCT02321800|463215171|FG000|Overall Study|Withdrawal by Subject|3|||
128704997|NCT02321800|463215172|FG001|Overall Study|Withdrawal by Subject|3|||
128704998|NCT02321800|463215171|FG000|Overall Study|Death|1|||
128768118|NCT02091739|463442040|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
129122171|NCT04513366|464742755|FG001|Extension Phase|Adverse Event|0|||
129122172|NCT04513366|464742756|FG002|Extension Phase|Adverse Event|1|||
129122173|NCT04478266|464742760|FG000|Overall Study|Adverse Event|20|||
129122174|NCT04478266|464742761|FG001|Overall Study|Adverse Event|21|||
129216856|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
129216857|NCT00561925|465094794|FG000|144-week Double-blind, Double-dummy|Other|0|||
129216858|NCT00561925|465094795|FG001|144-week Double-blind, Double-dummy|Other|8|||
129216859|NCT00561925|465094796|FG002|144-week Double-blind, Double-dummy|Other|11|||
129216860|NCT00561925|465094797|FG003|144-week Double-blind, Double-dummy|Other|0|||
129216861|NCT00561925|465094798|FG004|144-week Double-blind, Double-dummy|Other|0|||
129216862|NCT00561925|465094794|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
129216863|NCT00561925|465094795|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
129216864|NCT00561925|465094796|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
129216865|NCT00561925|465094797|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
129216866|NCT00561925|465094798|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
129216867|NCT00891904|465094799|FG000|Overall Study|Death|1|||
129216868|NCT00891904|465094799|FG000|Overall Study|Adverse Event|1|||
129216869|NCT05021978|465094800|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
129216870|NCT05021978|465094801|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
129216871|NCT05021978|465094802|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
129216872|NCT05021978|465094803|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
129216873|NCT05021978|465094800|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
129216874|NCT05021978|465094801|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
129216875|NCT05021978|465094802|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
129216876|NCT05021978|465094803|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
129216877|NCT03096288|465094805|FG000|Overall Study|Withdrawal by Subject|0|||
129216878|NCT03096288|465094806|FG001|Overall Study|Withdrawal by Subject|1|||
129216879|NCT03096288|465094807|FG002|Overall Study|Withdrawal by Subject|0|||
129216880|NCT03096288|465094808|FG003|Overall Study|Withdrawal by Subject|1|||
129216881|NCT04639258|465094813|FG000|Overall Study|Screen failure|5|||
129216882|NCT04639258|465094813|FG000|Overall Study|Physician Decision|2|||
129216883|NCT04639258|465094813|FG000|Overall Study|Early study termination|3|||
129216884|NCT04639258|465094813|FG000|Overall Study|Withdrawal by Subject|1|||
129216885|NCT02819804|465094815|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
129216886|NCT00389610|465094817|FG000|Overall Study|Disease Progression|0|||
129216887|NCT00389610|465094818|FG001|Overall Study|Disease Progression|19|||
129216888|NCT00389610|465094817|FG000|Overall Study|Death|0|||
129216889|NCT00389610|465094818|FG001|Overall Study|Death|1|||
129216890|NCT00389610|465094817|FG000|Overall Study|Physician Decision|0|||
129216891|NCT00389610|465094818|FG001|Overall Study|Physician Decision|1|||
129216892|NCT00389610|465094817|FG000|Overall Study|Withdrawal by Subject|0|||
129216893|NCT00389610|465094818|FG001|Overall Study|Withdrawal by Subject|1|||
129216894|NCT03131570|465094819|FG000|Overall Study|Adverse Event|1|||
129216895|NCT03131570|465094820|FG001|Overall Study|Adverse Event|0|||
129216896|NCT01782378|465094821|FG000|First Series|Lost to Follow-up|7|||
129216897|NCT01782378|465094822|FG001|First Series|Lost to Follow-up|8|||
129216898|NCT01782378|465094821|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
129216899|NCT01782378|465094822|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
129216900|NCT01782378|465094821|FG000|Second Series|Lost to Follow-up|8|||
129216901|NCT01782378|465094822|FG001|Second Series|Lost to Follow-up|7|||
129216902|NCT01782378|465094821|FG000|Second Series|Did not choose to complete S2 Optional|18|||
129216903|NCT01782378|465094822|FG001|Second Series|Did not choose to complete S2 Optional|0|||
129216904|NCT05567783|465094823|FG000|Overall Study|Death|2|||
129216905|NCT05567783|465094824|FG001|Overall Study|Death|3|||
129216906|NCT05567783|465094825|FG002|Overall Study|Death|0|||
129216907|NCT05567783|465094823|FG000|Overall Study|Lost to Follow-up|25|||
129216908|NCT05567783|465094824|FG001|Overall Study|Lost to Follow-up|19|||
129216909|NCT05567783|465094825|FG002|Overall Study|Lost to Follow-up|17|||
129216910|NCT05567783|465094823|FG000|Overall Study|Physician Decision|10|||
128768119|NCT02091739|463442041|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
128768120|NCT02091739|463442042|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
129216911|NCT05567783|465094824|FG001|Overall Study|Physician Decision|7|||
129216912|NCT05567783|465094825|FG002|Overall Study|Physician Decision|9|||
129216913|NCT05567783|465094823|FG000|Overall Study|Study Terminated by Sponsor|924|||
129216914|NCT05567783|465094824|FG001|Overall Study|Study Terminated by Sponsor|937|||
129216915|NCT05567783|465094825|FG002|Overall Study|Study Terminated by Sponsor|941|||
129216916|NCT05567783|465094823|FG000|Overall Study|Withdrawal by Subject|23|||
129216917|NCT05567783|465094824|FG001|Overall Study|Withdrawal by Subject|27|||
129216918|NCT05567783|465094825|FG002|Overall Study|Withdrawal by Subject|24|||
129216919|NCT05567783|465094823|FG000|Overall Study|Incarcerated|1|||
129216920|NCT05567783|465094824|FG001|Overall Study|Incarcerated|0|||
129216921|NCT05567783|465094825|FG002|Overall Study|Incarcerated|0|||
129216922|NCT05567783|465094823|FG000|Overall Study|Participant randomized in error|4|||
129216923|NCT05567783|465094824|FG001|Overall Study|Participant randomized in error|2|||
129216924|NCT05567783|465094825|FG002|Overall Study|Participant randomized in error|2|||
129216925|NCT03944577|465094831|FG000|Overall Study|Adverse Event|3|||
129216926|NCT03058146|465094832|FG000|Overall Study|Withdrawal by Subject|4|||
129216927|NCT03058146|465094833|FG001|Overall Study|Withdrawal by Subject|1|||
129216928|NCT03058146|465094832|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
128704999|NCT02321800|463215172|FG001|Overall Study|Death|0|||
128705000|NCT02321800|463215171|FG000|Overall Study|Protocol Violation|1|||
128705001|NCT02321800|463215172|FG001|Overall Study|Protocol Violation|0|||
128705002|NCT02321800|463215171|FG000|Overall Study|Lost to Follow-up|10|||
128705003|NCT02321800|463215172|FG001|Overall Study|Lost to Follow-up|4|||
128705004|NCT02321800|463215171|FG000|Overall Study|Adverse Event|2|||
128705005|NCT02321800|463215172|FG001|Overall Study|Adverse Event|3|||
128705006|NCT02321800|463215171|FG000|Overall Study|Other, Miscellaneous|3|||
128705007|NCT02321800|463215172|FG001|Overall Study|Other, Miscellaneous|1|||
128705008|NCT01537393|463215173|FG000|Overall Study|Exclude prior to study|32|||
128705009|NCT01537393|463215174|FG001|Overall Study|Exclude prior to study|44|||
128705010|NCT01537393|463215173|FG000|Overall Study|Death|20|||
128705011|NCT01537393|463215174|FG001|Overall Study|Death|32|||
128705012|NCT01537393|463215173|FG000|Overall Study|Withdrawal by Subject|18|||
128705013|NCT01537393|463215174|FG001|Overall Study|Withdrawal by Subject|17|||
128705014|NCT01537393|463215173|FG000|Overall Study|Lost to Follow-up|53|||
128705015|NCT01537393|463215174|FG001|Overall Study|Lost to Follow-up|48|||
128705016|NCT01537393|463215173|FG000|Overall Study|Failure - Regrafted|28|||
128705017|NCT01537393|463215174|FG001|Overall Study|Failure - Regrafted|43|||
128705018|NCT01537393|463215173|FG000|Overall Study|Failure - Not regrafted|2|||
128705019|NCT01537393|463215174|FG001|Overall Study|Failure - Not regrafted|6|||
128705020|NCT01537393|463215173|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
128705021|NCT01537393|463215174|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
128705022|NCT01637272|463215181|FG000|Overall Study|Adverse Event|6|||
128705023|NCT01637272|463215181|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128705024|NCT01637272|463215181|FG000|Overall Study|Withdrawal by Subject|3|||
128705025|NCT01637272|463215181|FG000|Overall Study|Lost to Follow-up|2|||
128705026|NCT01637272|463215181|FG000|Overall Study|completed core, did not enter ext. phase|4|||
128705027|NCT01637272|463215181|FG000|Overall Study|Administrative problems|1|||
128705028|NCT01637272|463215181|FG000|Overall Study|Protocol Violation|2|||
128705029|NCT01496612|463215182|FG000|1st Intervention|Adverse Event|1|||
128705030|NCT01496612|463215183|FG001|1st Intervention|Adverse Event|0|||
128705031|NCT01496612|463215182|FG000|1st Intervention|Withdrawal by Subject|1|||
128705032|NCT01496612|463215183|FG001|1st Intervention|Withdrawal by Subject|0|||
128705033|NCT02695329|463215189|FG000|Overall Study|Adverse Event|1|||
128705034|NCT02695329|463215190|FG001|Overall Study|Adverse Event|0|||
128705035|NCT02695329|463215189|FG000|Overall Study|Poor X-ray quality for measurement|4|||
128705036|NCT02695329|463215190|FG001|Overall Study|Poor X-ray quality for measurement|5|||
128705037|NCT01866930|463215192|FG000|Treatment Period|Other|1|||
128705038|NCT01866930|463215193|FG001|Treatment Period|Other|0|||
128705039|NCT01866930|463215192|FG000|Treatment Period|Death|0|||
128705040|NCT01866930|463215193|FG001|Treatment Period|Death|2|||
128705041|NCT01866930|463215192|FG000|Treatment Period|Poor/non compliance|0|||
128705042|NCT01866930|463215193|FG001|Treatment Period|Poor/non compliance|2|||
128705043|NCT01866930|463215192|FG000|Treatment Period|No longer meets study criteria|0|||
128705044|NCT01866930|463215193|FG001|Treatment Period|No longer meets study criteria|1|||
128705045|NCT01866930|463215192|FG000|Treatment Period|Withdrawal by Subject|2|||
128705046|NCT01866930|463215193|FG001|Treatment Period|Withdrawal by Subject|8|||
128705047|NCT01866930|463215192|FG000|Treatment Period|Lack of Efficacy|1|||
128705048|NCT01866930|463215193|FG001|Treatment Period|Lack of Efficacy|9|||
128705049|NCT01866930|463215192|FG000|Treatment Period|Adverse Event|4|||
128768121|NCT02091739|463442043|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
129122175|NCT04478266|464742760|FG000|Overall Study|Progressive disease|146|||
129122176|NCT04478266|464742761|FG001|Overall Study|Progressive disease|168|||
129122177|NCT04478266|464742760|FG000|Overall Study|Poor compliance to protocol|1|||
129122178|NCT04478266|464742761|FG001|Overall Study|Poor compliance to protocol|0|||
129122179|NCT04478266|464742760|FG000|Overall Study|Withdrawal by Subject|19|||
129122180|NCT04478266|464742761|FG001|Overall Study|Withdrawal by Subject|16|||
129122181|NCT04478266|464742760|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
129122182|NCT04478266|464742761|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
129122183|NCT04478266|464742760|FG000|Overall Study|Study terminated by sponsor|33|||
129122184|NCT04478266|464742761|FG001|Overall Study|Study terminated by sponsor|35|||
129122185|NCT04478266|464742760|FG000|Overall Study|Other: unspecified|5|||
129216929|NCT03058146|465094833|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
128705050|NCT01866930|463215193|FG001|Treatment Period|Adverse Event|12|||
128705051|NCT01866930|463215192|FG000|Treatment Period|Lost to Follow-up|1|||
128705052|NCT01866930|463215193|FG001|Treatment Period|Lost to Follow-up|1|||
128705053|NCT01866930|463215192|FG000|Follow-up Period|Lost to Follow-up|1|||
128705054|NCT01866930|463215193|FG001|Follow-up Period|Lost to Follow-up|1|||
128705055|NCT01866930|463215192|FG000|Follow-up Period|Other|1|||
128705056|NCT01866930|463215193|FG001|Follow-up Period|Other|5|||
128705057|NCT01866930|463215192|FG000|Follow-up Period|No longer required per protocol|1|||
128705058|NCT01866930|463215193|FG001|Follow-up Period|No longer required per protocol|0|||
129122186|NCT04478266|464742761|FG001|Overall Study|Other: unspecified|7|||
129216930|NCT01352793|465094837|FG000|Overall Study|Lost to Follow-up|289|||
128705059|NCT01866930|463215192|FG000|Follow-up Period|Withdrawal by Subject|3|||
128705060|NCT01866930|463215193|FG001|Follow-up Period|Withdrawal by Subject|3|||
128705061|NCT00317356|463215199|FG000|Overall Study|Adverse Event|0|||
128705062|NCT00317356|463215200|FG001|Overall Study|Adverse Event|0|||
128705063|NCT00317356|463215201|FG002|Overall Study|Adverse Event|1|||
128705064|NCT00317356|463215202|FG003|Overall Study|Adverse Event|0|||
128705065|NCT00317356|463215199|FG000|Overall Study|Lack of Efficacy|1|||
128705066|NCT00317356|463215200|FG001|Overall Study|Lack of Efficacy|1|||
128705067|NCT00317356|463215201|FG002|Overall Study|Lack of Efficacy|0|||
128705068|NCT00317356|463215202|FG003|Overall Study|Lack of Efficacy|3|||
128705069|NCT00317356|463215199|FG000|Overall Study|Physician Decision|0|||
128705070|NCT00317356|463215200|FG001|Overall Study|Physician Decision|1|||
128705071|NCT00317356|463215201|FG002|Overall Study|Physician Decision|0|||
128705072|NCT00317356|463215202|FG003|Overall Study|Physician Decision|0|||
128705073|NCT00621153|463215209|FG000|Overall Study|Safety Reason|8|||
128705074|NCT00621153|463215210|FG001|Overall Study|Safety Reason|7|||
128705075|NCT00621153|463215209|FG000|Overall Study|Adverse Event|3|||
128705076|NCT00621153|463215210|FG001|Overall Study|Adverse Event|2|||
128705077|NCT00621153|463215209|FG000|Overall Study|Lost to Follow-up|5|||
128705078|NCT00621153|463215210|FG001|Overall Study|Lost to Follow-up|1|||
128705079|NCT00621153|463215209|FG000|Overall Study|Withdrawal by Subject|4|||
128705080|NCT00621153|463215210|FG001|Overall Study|Withdrawal by Subject|5|||
128705081|NCT00753415|463215211|FG000|Part A|Disease progression|1|||
128705082|NCT00753415|463215212|FG001|Part A|Disease progression|0|||
128705083|NCT00753415|463215213|FG002|Part A|Disease progression|1|||
128705084|NCT00753415|463215214|FG003|Part A|Disease progression|2|||
128705085|NCT00753415|463215215|FG004|Part A|Disease progression|0|||
128705086|NCT00753415|463215216|FG005|Part A|Disease progression|0|||
128705087|NCT00753415|463215217|FG006|Part A|Disease progression|0|||
128705088|NCT00753415|463215218|FG007|Part A|Disease progression|0|||
128705089|NCT00753415|463215219|FG008|Part A|Disease progression|0|||
128705090|NCT00753415|463215220|FG009|Part A|Disease progression|0|||
128705091|NCT00753415|463215211|FG000|Part A|Withdrawal by Subject|0|||
128705092|NCT00753415|463215212|FG001|Part A|Withdrawal by Subject|0|||
128705093|NCT00753415|463215213|FG002|Part A|Withdrawal by Subject|1|||
128705094|NCT00753415|463215214|FG003|Part A|Withdrawal by Subject|0|||
128705095|NCT00753415|463215215|FG004|Part A|Withdrawal by Subject|0|||
128705096|NCT00753415|463215216|FG005|Part A|Withdrawal by Subject|0|||
128705097|NCT00753415|463215217|FG006|Part A|Withdrawal by Subject|0|||
128705098|NCT00753415|463215218|FG007|Part A|Withdrawal by Subject|0|||
128705099|NCT00753415|463215219|FG008|Part A|Withdrawal by Subject|0|||
128705100|NCT00753415|463215220|FG009|Part A|Withdrawal by Subject|0|||
128705101|NCT00753415|463215211|FG000|Part B|Lost to Follow-up|0|||
128705102|NCT00753415|463215212|FG001|Part B|Lost to Follow-up|0|||
128705103|NCT00753415|463215213|FG002|Part B|Lost to Follow-up|0|||
128705104|NCT00753415|463215214|FG003|Part B|Lost to Follow-up|0|||
128705105|NCT00753415|463215215|FG004|Part B|Lost to Follow-up|0|||
128705106|NCT00753415|463215216|FG005|Part B|Lost to Follow-up|0|||
128705107|NCT00753415|463215217|FG006|Part B|Lost to Follow-up|0|||
128705108|NCT00753415|463215218|FG007|Part B|Lost to Follow-up|1|||
128705109|NCT00753415|463215219|FG008|Part B|Lost to Follow-up|1|||
128705110|NCT00753415|463215220|FG009|Part B|Lost to Follow-up|0|||
128705111|NCT00753415|463215211|FG000|Part B|Disease progression|0|||
128705112|NCT00753415|463215212|FG001|Part B|Disease progression|0|||
128705113|NCT00753415|463215213|FG002|Part B|Disease progression|0|||
128705114|NCT00753415|463215214|FG003|Part B|Disease progression|0|||
128705115|NCT00753415|463215215|FG004|Part B|Disease progression|0|||
128705116|NCT00753415|463215216|FG005|Part B|Disease progression|0|||
128705117|NCT00753415|463215217|FG006|Part B|Disease progression|0|||
128705118|NCT00753415|463215218|FG007|Part B|Disease progression|0|||
128705119|NCT00753415|463215219|FG008|Part B|Disease progression|2|||
128705120|NCT00753415|463215220|FG009|Part B|Disease progression|1|||
128705121|NCT04212650|463215221|FG000|Overall Study|Withdrawal by Subject|1|||
128705122|NCT04212650|463215222|FG001|Overall Study|Withdrawal by Subject|0|||
128705123|NCT04419714|463215223|FG000|Overall Study|Technical Fault|5|||
128705124|NCT04419714|463215223|FG000|Overall Study|Protocol Deviation|2|||
128705125|NCT04419714|463215223|FG000|Overall Study|Withdrawal by Subject|1|||
128717838|NCT05104567|463264062|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
128717839|NCT05104567|463264063|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
128717840|NCT05104567|463264064|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
128717841|NCT05104567|463264065|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
128717842|NCT05104567|463264066|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
128717843|NCT05104567|463264067|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
128717844|NCT05104567|463264068|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
128717845|NCT05104567|463264062|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
128717846|NCT05104567|463264063|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
128768122|NCT02091739|463442044|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
128717847|NCT05104567|463264064|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
128717848|NCT05104567|463264065|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
128705126|NCT04023526|463217011|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
128705127|NCT04023526|463217012|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
128705128|NCT04023526|463217011|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
128705129|NCT04023526|463217012|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
128705130|NCT00056316|463217014|FG000|Overall Study|Withdrawal by Subject|2|||
128705131|NCT00056316|463217015|FG001|Overall Study|Withdrawal by Subject|2|||
128705132|NCT00056316|463217014|FG000|Overall Study|Death/NH placement of pt|1|||
128705133|NCT00056316|463217015|FG001|Overall Study|Death/NH placement of pt|1|||
128705134|NCT00543140|463217017|FG000|Overall Study|Lost to Follow-up|33|||
128705135|NCT00543140|463217017|FG000|Overall Study|Withdrawal by Subject|13|||
128705136|NCT00543140|463217017|FG000|Overall Study|Protocol Violation|10|||
128705137|NCT00543140|463217017|FG000|Overall Study|Insufficient weight loss|10|||
128705138|NCT00543140|463217017|FG000|Overall Study|SAE leading to explant of SAGB|3|||
128705139|NCT00543140|463217017|FG000|Overall Study|Death|1|||
128705140|NCT00543140|463217017|FG000|Overall Study|Subject moved|1|||
128705141|NCT00543140|463217017|FG000|Overall Study|Conversion to different procedure|1|||
128705142|NCT02599129|463217018|FG000|Overall Study|Lack of Efficacy|2|||
128705143|NCT02599129|463217019|FG001|Overall Study|Lack of Efficacy|2|||
128705144|NCT02599129|463217018|FG000|Overall Study|Lost to Follow-up|1|||
128705145|NCT02599129|463217019|FG001|Overall Study|Lost to Follow-up|0|||
128705146|NCT02599129|463217018|FG000|Overall Study|Withdrawal by Subject|2|||
128705147|NCT02599129|463217019|FG001|Overall Study|Withdrawal by Subject|1|||
128705148|NCT03489720|463217020|FG000|Overall Study|Withdrawal by Subject|2|||
128705149|NCT03489720|463217021|FG001|Overall Study|Withdrawal by Subject|0|||
128705150|NCT00166114|463217027|FG000|Overall Study|Protocol Violation|2|||
128705151|NCT00166114|463217028|FG001|Overall Study|Protocol Violation|1|||
128705152|NCT00166114|463217027|FG000|Overall Study|Withdrawal by Subject|10|||
128705153|NCT00166114|463217028|FG001|Overall Study|Withdrawal by Subject|4|||
128705154|NCT00166114|463217027|FG000|Overall Study|Adverse Event|2|||
128705155|NCT00166114|463217028|FG001|Overall Study|Adverse Event|1|||
128705156|NCT01218204|463217035|FG000|Part B Washout|Adverse Event|0|||
128705157|NCT01218204|463217036|FG001|Part B Washout|Adverse Event|1|||
128705158|NCT01218204|463217037|FG002|Part B Washout|Adverse Event|0|||
128705159|NCT01218204|463217038|FG003|Part B Washout|Adverse Event|0|||
128705160|NCT01218204|463217035|FG000|Part B Washout|Lost to Follow-up|0|||
128705161|NCT01218204|463217036|FG001|Part B Washout|Lost to Follow-up|2|||
128705162|NCT01218204|463217037|FG002|Part B Washout|Lost to Follow-up|0|||
128705163|NCT01218204|463217038|FG003|Part B Washout|Lost to Follow-up|0|||
128705164|NCT01218204|463217035|FG000|Part B Washout|Physician Decision|0|||
128705165|NCT01218204|463217036|FG001|Part B Washout|Physician Decision|14|||
128705166|NCT01218204|463217037|FG002|Part B Washout|Physician Decision|0|||
128705167|NCT01218204|463217038|FG003|Part B Washout|Physician Decision|0|||
128705168|NCT01218204|463217035|FG000|Part B Washout|Withdrawal by Subject|0|||
128705169|NCT01218204|463217036|FG001|Part B Washout|Withdrawal by Subject|14|||
128705170|NCT01218204|463217037|FG002|Part B Washout|Withdrawal by Subject|0|||
128705171|NCT01218204|463217038|FG003|Part B Washout|Withdrawal by Subject|0|||
128705172|NCT01218204|463217035|FG000|Part B Washout|Reached defined stopping criteria|0|||
128705173|NCT01218204|463217036|FG001|Part B Washout|Reached defined stopping criteria|2|||
128705174|NCT01218204|463217037|FG002|Part B Washout|Reached defined stopping criteria|0|||
128705175|NCT01218204|463217038|FG003|Part B Washout|Reached defined stopping criteria|0|||
128705176|NCT01218204|463217035|FG000|Part B Washout|Did not meet continuation criteria|0|||
128705177|NCT01218204|463217036|FG001|Part B Washout|Did not meet continuation criteria|112|||
128705178|NCT01218204|463217037|FG002|Part B Washout|Did not meet continuation criteria|0|||
128705179|NCT01218204|463217038|FG003|Part B Washout|Did not meet continuation criteria|0|||
128705180|NCT01218204|463217035|FG000|Part B Run-in|Adverse Event|0|||
128705181|NCT01218204|463217036|FG001|Part B Run-in|Adverse Event|0|||
128705182|NCT01218204|463217037|FG002|Part B Run-in|Adverse Event|1|||
128705183|NCT01218204|463217038|FG003|Part B Run-in|Adverse Event|0|||
128705184|NCT01218204|463217035|FG000|Part B Run-in|Protocol Violation|0|||
128705185|NCT01218204|463217036|FG001|Part B Run-in|Protocol Violation|0|||
128705186|NCT01218204|463217037|FG002|Part B Run-in|Protocol Violation|2|||
129122187|NCT04478266|464742760|FG000|Overall Study|Randomized but not treated|1|||
129122188|NCT04478266|464742761|FG001|Overall Study|Randomized but not treated|1|||
129122189|NCT04058717|464742762|FG000|Randomization Period|Lost to Follow-up|2|||
128705187|NCT01218204|463217038|FG003|Part B Run-in|Protocol Violation|0|||
128705188|NCT01218204|463217035|FG000|Part B Run-in|Withdrawal by Subject|0|||
128705189|NCT01218204|463217036|FG001|Part B Run-in|Withdrawal by Subject|0|||
129122190|NCT04058717|464742763|FG001|Randomization Period|Lost to Follow-up|3|||
128705190|NCT01218204|463217037|FG002|Part B Run-in|Withdrawal by Subject|3|||
128705191|NCT01218204|463217038|FG003|Part B Run-in|Withdrawal by Subject|0|||
128705192|NCT01218204|463217035|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
128705193|NCT01218204|463217036|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
128705194|NCT01218204|463217037|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
128705195|NCT01218204|463217038|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
128705196|NCT01218204|463217035|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
128705197|NCT01218204|463217036|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
128705198|NCT01218204|463217037|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
128705199|NCT01218204|463217038|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
128705200|NCT00545168|463217039|FG000|Overall Study|Lost to Follow-up|5|||
128705201|NCT00545168|463217040|FG001|Overall Study|Lost to Follow-up|5|||
128705202|NCT00545168|463217041|FG002|Overall Study|Lost to Follow-up|5|||
128705203|NCT00545168|463217039|FG000|Overall Study|Withdrawal by Subject|9|||
128705204|NCT00545168|463217040|FG001|Overall Study|Withdrawal by Subject|0|||
128705205|NCT00545168|463217041|FG002|Overall Study|Withdrawal by Subject|13|||
128705206|NCT00545168|463217039|FG000|Overall Study|Protocol Violation|1|||
128705207|NCT00545168|463217040|FG001|Overall Study|Protocol Violation|0|||
128705208|NCT00545168|463217041|FG002|Overall Study|Protocol Violation|1|||
128705209|NCT00545168|463217039|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
128705210|NCT00545168|463217040|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
128705211|NCT00545168|463217041|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
128705212|NCT00127660|463217042|FG000|Overall Study|Protocol Violation|3|||
128705213|NCT00127660|463217043|FG001|Overall Study|Protocol Violation|3|||
128705214|NCT00127660|463217044|FG002|Overall Study|Protocol Violation|5|||
128705215|NCT00127660|463217045|FG003|Overall Study|Protocol Violation|0|||
128705216|NCT01987505|463217046|FG000|Overall Study|Other|9|||
128705217|NCT01987505|463217046|FG000|Overall Study|Withdrawal by Subject|2|||
128705218|NCT01987505|463217046|FG000|Overall Study|Other Reason|2|||
128705219|NCT01987505|463217046|FG000|Overall Study|Lost to Follow-up|15|||
128705220|NCT01987505|463217046|FG000|Overall Study|Investigator Decision|2|||
128705221|NCT01987505|463217046|FG000|Overall Study|Death|4|||
128705222|NCT05131646|463217047|FG000|Overall Study|Withdrawal by Subject|1|||
128705223|NCT05131646|463217048|FG001|Overall Study|Withdrawal by Subject|0|||
128705224|NCT05131646|463217049|FG002|Overall Study|Withdrawal by Subject|0|||
128705225|NCT01256008|463217056|FG000|Overall Study|Lost to Follow-up|6|||
128705226|NCT01256008|463217057|FG001|Overall Study|Lost to Follow-up|4|||
128705227|NCT01256008|463217058|FG002|Overall Study|Lost to Follow-up|11|||
128705228|NCT01256008|463217056|FG000|Overall Study|Withdrawal by Subject|2|||
128705229|NCT01256008|463217057|FG001|Overall Study|Withdrawal by Subject|3|||
128705230|NCT01256008|463217058|FG002|Overall Study|Withdrawal by Subject|10|||
128705231|NCT05228132|463217064|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
128705232|NCT05228132|463217064|FG000|Overall Study|Adverse Event|3|||
128705233|NCT05228132|463217064|FG000|Overall Study|Lost to Follow-up|1|||
128705234|NCT05228132|463217064|FG000|Overall Study|Arteriovenous-fistula mature|1|||
128705235|NCT01336764|463217065|FG000|Overall Study|Withdrawal by Subject|5|||
128705236|NCT01336764|463217066|FG001|Overall Study|Withdrawal by Subject|5|||
128705237|NCT00730132|463217067|FG000|Overall Study|Protocol Violation|154|||
128705238|NCT00730132|463217067|FG000|Overall Study|Death|1|||
128705239|NCT01626391|463217068|FG000|Overall Study|Physician Decision|1|||
128705240|NCT01626391|463217069|FG001|Overall Study|Physician Decision|0|||
128705241|NCT01626391|463217068|FG000|Overall Study|Withdrawal by Subject|1|||
128705242|NCT01626391|463217069|FG001|Overall Study|Withdrawal by Subject|0|||
128705243|NCT00320411|463217072|FG000|Overall Study|No investigational product admin.|4|||
128705244|NCT00518986|463217073|FG000|Overall Study|Adverse Event|12|||
128705245|NCT00518986|463217074|FG001|Overall Study|Adverse Event|7|||
128705246|NCT00518986|463217073|FG000|Overall Study|Lack of Efficacy|0|||
128705247|NCT00518986|463217074|FG001|Overall Study|Lack of Efficacy|2|||
128705248|NCT00518986|463217073|FG000|Overall Study|Lost to Follow-up|3|||
128705249|NCT00518986|463217074|FG001|Overall Study|Lost to Follow-up|2|||
128705250|NCT00518986|463217073|FG000|Overall Study|Physician Decision|0|||
128705251|NCT00518986|463217074|FG001|Overall Study|Physician Decision|3|||
128705252|NCT00518986|463217073|FG000|Overall Study|Protocol Violation|5|||
128705253|NCT00518986|463217074|FG001|Overall Study|Protocol Violation|7|||
128705254|NCT00518986|463217073|FG000|Overall Study|Withdrawal by Subject|4|||
128705255|NCT00518986|463217074|FG001|Overall Study|Withdrawal by Subject|4|||
128705256|NCT00518986|463217073|FG000|Overall Study|Non-Specific|2|||
128705257|NCT00518986|463217074|FG001|Overall Study|Non-Specific|1|||
128705258|NCT05683249|463217075|FG000|Overall Study|Adverse Event|3|||
128705259|NCT05683249|463217076|FG001|Overall Study|Adverse Event|1|||
128705260|NCT05683249|463217075|FG000|Overall Study|Lack of Efficacy|0|||
128705261|NCT05683249|463217076|FG001|Overall Study|Lack of Efficacy|2|||
128705262|NCT05683249|463217075|FG000|Overall Study|Lost to Follow-up|6|||
128705263|NCT05683249|463217076|FG001|Overall Study|Lost to Follow-up|5|||
128705264|NCT05683249|463217075|FG000|Overall Study|Non-compliance with Study Drug|2|||
128705265|NCT05683249|463217076|FG001|Overall Study|Non-compliance with Study Drug|0|||
128705266|NCT05683249|463217075|FG000|Overall Study|Protocol Violation|6|||
128705267|NCT05683249|463217076|FG001|Overall Study|Protocol Violation|3|||
128705268|NCT05683249|463217075|FG000|Overall Study|Withdrawal by Subject|9|||
128705269|NCT05683249|463217076|FG001|Overall Study|Withdrawal by Subject|8|||
128705270|NCT05683249|463217075|FG000|Overall Study|Other|0|||
128705271|NCT05683249|463217076|FG001|Overall Study|Other|2|||
128768123|NCT02091739|463442040|FG000|EP: 48 Weeks|Other|0|||
128768124|NCT02091739|463442041|FG001|EP: 48 Weeks|Other|0|||
128705272|NCT05229406|463217077|FG000|Overall Study|Withdrawal by Subject|1|||
128705273|NCT05229406|463217078|FG001|Overall Study|Withdrawal by Subject|2|||
128705274|NCT00459953|463217079|FG000|Overall Study|not analyzed-household member in study|1|||
128705275|NCT00459953|463217080|FG001|Overall Study|not analyzed-household member in study|1|||
128705276|NCT01233258|463217082|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
128705277|NCT01233258|463217083|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
128705278|NCT01233258|463217084|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
128705279|NCT01233258|463217085|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
128705280|NCT01233258|463217086|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
128705281|NCT01233258|463217087|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
128705282|NCT01233258|463217082|FG000|First Intervention (6 Months)|Protocol Violation|0|||
128705283|NCT01233258|463217083|FG001|First Intervention (6 Months)|Protocol Violation|0|||
128705284|NCT01233258|463217084|FG002|First Intervention (6 Months)|Protocol Violation|1|||
128705285|NCT01233258|463217085|FG003|First Intervention (6 Months)|Protocol Violation|0|||
128705286|NCT01233258|463217086|FG004|First Intervention (6 Months)|Protocol Violation|0|||
128705287|NCT01233258|463217087|FG005|First Intervention (6 Months)|Protocol Violation|0|||
128705288|NCT01233258|463217082|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
128705289|NCT01233258|463217083|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
128705290|NCT01233258|463217084|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
128705291|NCT01233258|463217085|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
128705292|NCT01233258|463217086|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
128705293|NCT01233258|463217087|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
128705294|NCT01049308|463217088|FG000|Pill Counts|Withdrawal by Subject|83|||
128705295|NCT03926169|463217093|FG000|Period A|Adverse Event|2|||
128705296|NCT03926169|463217094|FG001|Period A|Adverse Event|2|||
128705297|NCT03926169|463217095|FG002|Period A|Adverse Event|1|||
128705298|NCT03926169|463217093|FG000|Period A|Withdrawal by Subject|2|||
128705299|NCT03926169|463217094|FG001|Period A|Withdrawal by Subject|2|||
128705300|NCT03926169|463217095|FG002|Period A|Withdrawal by Subject|2|||
128705301|NCT03926169|463217093|FG000|Period A|Lost to Follow-up|3|||
128705302|NCT03926169|463217094|FG001|Period A|Lost to Follow-up|1|||
128705303|NCT03926169|463217095|FG002|Period A|Lost to Follow-up|0|||
128705304|NCT03926169|463217093|FG000|Period A|Lack of Efficacy|0|||
128705305|NCT03926169|463217094|FG001|Period A|Lack of Efficacy|2|||
128705306|NCT03926169|463217095|FG002|Period A|Lack of Efficacy|2|||
128705307|NCT03926169|463217093|FG000|Period A|COVID-19 Infection|0|||
128705308|NCT03926169|463217094|FG001|Period A|COVID-19 Infection|1|||
128705309|NCT03926169|463217095|FG002|Period A|COVID-19 Infection|0|||
128705310|NCT03926169|463217093|FG000|Period A|COVID-19 Logistical Restrictions|0|||
128705311|NCT03926169|463217094|FG001|Period A|COVID-19 Logistical Restrictions|2|||
128705312|NCT03926169|463217095|FG002|Period A|COVID-19 Logistical Restrictions|1|||
128705313|NCT03926169|463217093|FG000|Period A|Other, Not Specified|1|||
128705314|NCT03926169|463217094|FG001|Period A|Other, Not Specified|0|||
128705315|NCT03926169|463217095|FG002|Period A|Other, Not Specified|0|||
128705316|NCT03926169|463217093|FG000|Period B|Adverse Event|3|||
128705317|NCT03926169|463217094|FG001|Period B|Adverse Event|1|||
128705318|NCT03926169|463217095|FG002|Period B|Adverse Event|1|||
129122191|NCT04058717|464742764|FG002|Randomization Period|Lost to Follow-up|4|||
129122192|NCT04058717|464742765|FG003|Randomization Period|Lost to Follow-up|4|||
129122193|NCT04058717|464742762|FG000|Randomization Period|Withdrawal by Subject|1|||
129122194|NCT04058717|464742763|FG001|Randomization Period|Withdrawal by Subject|3|||
129122195|NCT04058717|464742764|FG002|Randomization Period|Withdrawal by Subject|3|||
129122196|NCT04058717|464742765|FG003|Randomization Period|Withdrawal by Subject|3|||
129122197|NCT04058717|464742762|FG000|Randomization Period|PI decision|0|||
129122198|NCT04058717|464742763|FG001|Randomization Period|PI decision|1|||
129122199|NCT04058717|464742764|FG002|Randomization Period|PI decision|0|||
129122200|NCT04058717|464742765|FG003|Randomization Period|PI decision|0|||
129122201|NCT00671788|464742766|FG000|Overall Study|Adverse Event|8|||
129122202|NCT00671788|464742766|FG000|Overall Study|Refused further treatment|3|||
129122203|NCT00671788|464742766|FG000|Overall Study|Ineligible|1|||
129122204|NCT00671788|464742766|FG000|Overall Study|MD Decision|1|||
129122205|NCT00671788|464742766|FG000|Overall Study|Other|1|||
129122206|NCT01832766|464742767|FG000|Washout|Lost to Follow-up|0|||
129122207|NCT01832766|464742768|FG001|Washout|Lost to Follow-up|1|||
129122208|NCT03074500|464742773|FG000|Overall Study|Lost to Follow-up|1|||
128705319|NCT03926169|463217093|FG000|Period B|Withdrawal by Subject|1|||
129122209|NCT03074500|464742774|FG001|Overall Study|Lost to Follow-up|0|||
128705320|NCT03926169|463217094|FG001|Period B|Withdrawal by Subject|3|||
128705321|NCT03926169|463217095|FG002|Period B|Withdrawal by Subject|0|||
128705322|NCT03926169|463217093|FG000|Period B|Lack of Efficacy|3|||
128705323|NCT03926169|463217094|FG001|Period B|Lack of Efficacy|1|||
128705324|NCT03926169|463217095|FG002|Period B|Lack of Efficacy|1|||
128705325|NCT03926169|463217093|FG000|Period B|Lost to Follow-up|1|||
128705326|NCT03926169|463217094|FG001|Period B|Lost to Follow-up|1|||
129122210|NCT03074500|464742775|FG002|Overall Study|Lost to Follow-up|0|||
129122211|NCT03074500|464742773|FG000|Overall Study|Lack of Efficacy|0|||
129122212|NCT03074500|464742774|FG001|Overall Study|Lack of Efficacy|1|||
129122213|NCT03074500|464742775|FG002|Overall Study|Lack of Efficacy|0|||
129216931|NCT01352793|465094838|FG001|Overall Study|Lost to Follow-up|125|||
129216932|NCT01352793|465094837|FG000|Overall Study|Withdrawal by Subject|120|||
129216933|NCT01352793|465094838|FG001|Overall Study|Withdrawal by Subject|55|||
129216934|NCT01352793|465094837|FG000|Overall Study|Protocol Violation|44|||
129216935|NCT01352793|465094838|FG001|Overall Study|Protocol Violation|23|||
129216936|NCT01352793|465094837|FG000|Overall Study|Adverse Event|44|||
129216937|NCT01352793|465094838|FG001|Overall Study|Adverse Event|10|||
129216938|NCT01352793|465094837|FG000|Overall Study|Physician Decision|1|||
129216939|NCT01352793|465094838|FG001|Overall Study|Physician Decision|0|||
129216940|NCT01352793|465094837|FG000|Overall Study|Pregnancy|26|||
128705327|NCT03926169|463217095|FG002|Period B|Lost to Follow-up|4|||
128705328|NCT03926169|463217093|FG000|Period B|Other, Not Specified|62|||
128705329|NCT03926169|463217094|FG001|Period B|Other, Not Specified|57|||
128705330|NCT03926169|463217095|FG002|Period B|Other, Not Specified|65|||
128705331|NCT01032837|463217096|FG000|Overall Study|Adverse event/internal illness|0|||
128705332|NCT01032837|463217097|FG001|Overall Study|Adverse event/internal illness|1|||
128705333|NCT01032837|463217098|FG002|Overall Study|Adverse event/internal illness|0|||
128705334|NCT01032837|463217099|FG003|Overall Study|Adverse event/internal illness|1|||
128705335|NCT01032837|463217096|FG000|Overall Study|Withdrew consent|0|||
128705336|NCT01032837|463217097|FG001|Overall Study|Withdrew consent|2|||
128705337|NCT01032837|463217098|FG002|Overall Study|Withdrew consent|0|||
128705338|NCT01032837|463217099|FG003|Overall Study|Withdrew consent|1|||
128705339|NCT01032837|463217096|FG000|Overall Study|Failed to return|0|||
128705340|NCT01032837|463217097|FG001|Overall Study|Failed to return|0|||
128705341|NCT01032837|463217098|FG002|Overall Study|Failed to return|1|||
128705342|NCT01032837|463217099|FG003|Overall Study|Failed to return|0|||
128705343|NCT01032837|463217096|FG000|Overall Study|Refused treatment|0|||
128705344|NCT01032837|463217097|FG001|Overall Study|Refused treatment|0|||
128705345|NCT01032837|463217098|FG002|Overall Study|Refused treatment|0|||
128705346|NCT01032837|463217099|FG003|Overall Study|Refused treatment|1|||
128705347|NCT02439138|463217100|FG000|Overall Study|Adverse Event|1|||
128705348|NCT02439138|463217100|FG000|Overall Study|PI decision to terminate the study|2|||
128705349|NCT02615145|463217102|FG000|Overall Study|Did Not Start Treatment|0|||
128705350|NCT02615145|463217103|FG001|Overall Study|Did Not Start Treatment|0|||
128705351|NCT02615145|463217104|FG002|Overall Study|Did Not Start Treatment|1|||
128705352|NCT02615145|463217105|FG003|Overall Study|Did Not Start Treatment|1|||
128705353|NCT02615145|463217102|FG000|Overall Study|Failure to Return|20|||
128705354|NCT02615145|463217103|FG001|Overall Study|Failure to Return|10|||
128705355|NCT02615145|463217104|FG002|Overall Study|Failure to Return|7|||
128705356|NCT02615145|463217105|FG003|Overall Study|Failure to Return|0|||
128705357|NCT02615145|463217102|FG000|Overall Study|Death|2|||
128705358|NCT02615145|463217103|FG001|Overall Study|Death|3|||
128705359|NCT02615145|463217104|FG002|Overall Study|Death|0|||
128705360|NCT02615145|463217105|FG003|Overall Study|Death|0|||
128705361|NCT02615145|463217102|FG000|Overall Study|Other, Not Specified|5|||
128705362|NCT02615145|463217103|FG001|Overall Study|Other, Not Specified|2|||
128705363|NCT02615145|463217104|FG002|Overall Study|Other, Not Specified|0|||
128705364|NCT02615145|463217105|FG003|Overall Study|Other, Not Specified|0|||
128705365|NCT00006237|463217106|FG000|Overall Study|Adverse Event|39|||
128705366|NCT00006237|463217107|FG001|Overall Study|Adverse Event|29|||
128705367|NCT00006237|463217106|FG000|Overall Study|Death|1|||
128705368|NCT00006237|463217107|FG001|Overall Study|Death|0|||
128705369|NCT00006237|463217106|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
128705370|NCT00006237|463217107|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
128705371|NCT00006237|463217106|FG000|Overall Study|Progression/relapse|54|||
128705372|NCT00006237|463217107|FG001|Overall Study|Progression/relapse|2|||
128705373|NCT00006237|463217106|FG000|Overall Study|Not eligible|9|||
128705374|NCT00006237|463217107|FG001|Overall Study|Not eligible|20|||
128705375|NCT00006237|463217106|FG000|Overall Study|Withdrawal by Subject|0|||
129122214|NCT03074500|464742773|FG000|Overall Study|Adverse Event|0|||
129122215|NCT03074500|464742774|FG001|Overall Study|Adverse Event|0|||
129122216|NCT03074500|464742775|FG002|Overall Study|Adverse Event|1|||
129132913|NCT02609633|464778565|FG001|Overall Study|Reason not Specified|1|||
129132914|NCT05987540|464778566|FG000|Overall Study|Withdrawal by Subject|2|||
129132915|NCT05987540|464778566|FG000|Overall Study|Death|1|||
129132916|NCT05987540|464778566|FG000|Overall Study|Study Termination|1|||
129132917|NCT05987540|464778566|FG000|Overall Study|Adverse Event|2|||
129132918|NCT00471107|464778567|FG000|Overall Study|Technical problems/data loss|3|||
129132919|NCT00471107|464778568|FG001|Overall Study|Technical problems/data loss|1|||
129132920|NCT00471107|464778569|FG002|Overall Study|Technical problems/data loss|3|||
128705376|NCT00006237|463217107|FG001|Overall Study|Withdrawal by Subject|1|||
128705377|NCT00006237|463217106|FG000|Overall Study|Not protocol specified|14|||
128705378|NCT00006237|463217107|FG001|Overall Study|Not protocol specified|5|||
128768125|NCT02091739|463442042|FG002|EP: 48 Weeks|Other|0|||
128768126|NCT02091739|463442043|FG003|EP: 48 Weeks|Other|1|||
129132921|NCT01769443|464778570|FG000|Overall Study|Study closure|1|||
129216941|NCT01352793|465094838|FG001|Overall Study|Pregnancy|8|||
128768127|NCT02091739|463442044|FG004|EP: 48 Weeks|Other|0|||
129216942|NCT01352793|465094837|FG000|Overall Study|Other|25|||
128705379|NCT03727347|463217108|FG000|Overall Study|Withdrawal by Subject|2|||
128705380|NCT03727347|463217108|FG000|Overall Study|Lost to Follow-up|1|||
128705381|NCT01846416|463217111|FG000|Treatment Phase|Death|2|||
128705382|NCT01846416|463217112|FG001|Treatment Phase|Death|9|||
128705383|NCT01846416|463217113|FG002|Treatment Phase|Death|1|||
128705384|NCT01846416|463217111|FG000|Treatment Phase|Withdrawal by Subject|2|||
128705385|NCT01846416|463217112|FG001|Treatment Phase|Withdrawal by Subject|4|||
128705386|NCT01846416|463217113|FG002|Treatment Phase|Withdrawal by Subject|2|||
128705387|NCT01846416|463217111|FG000|Treatment Phase|Other|1|||
128705388|NCT01846416|463217112|FG001|Treatment Phase|Other|5|||
128705389|NCT01846416|463217113|FG002|Treatment Phase|Other|1|||
128705390|NCT01846416|463217111|FG000|Treatment Phase|Physician Decision|1|||
128705391|NCT01846416|463217112|FG001|Treatment Phase|Physician Decision|2|||
128705392|NCT01846416|463217113|FG002|Treatment Phase|Physician Decision|0|||
128705393|NCT01846416|463217111|FG000|Treatment Phase|Adverse Event|3|||
128705394|NCT01846416|463217112|FG001|Treatment Phase|Adverse Event|4|||
128705395|NCT01846416|463217113|FG002|Treatment Phase|Adverse Event|0|||
128705396|NCT01846416|463217111|FG000|Treatment Phase|Non-compliance|0|||
128705397|NCT01846416|463217112|FG001|Treatment Phase|Non-compliance|2|||
128705398|NCT01846416|463217113|FG002|Treatment Phase|Non-compliance|0|||
128705399|NCT01846416|463217111|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
128705400|NCT01846416|463217112|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
128705401|NCT01846416|463217113|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
128705402|NCT01846416|463217111|FG000|Treatment Phase|Progressive Disease|21|||
128705403|NCT01846416|463217112|FG001|Treatment Phase|Progressive Disease|63|||
128705404|NCT01846416|463217113|FG002|Treatment Phase|Progressive Disease|9|||
128705405|NCT01846416|463217111|FG000|Survival Follow-up|Death|21|||
128705406|NCT01846416|463217112|FG001|Survival Follow-up|Death|62|||
128705407|NCT01846416|463217113|FG002|Survival Follow-up|Death|9|||
128705408|NCT01846416|463217111|FG000|Survival Follow-up|Lost to Follow-up|0|||
128705409|NCT01846416|463217112|FG001|Survival Follow-up|Lost to Follow-up|2|||
128705410|NCT01846416|463217113|FG002|Survival Follow-up|Lost to Follow-up|2|||
128705411|NCT01846416|463217111|FG000|Survival Follow-up|Withdrawal by Subject|2|||
128705412|NCT01846416|463217112|FG001|Survival Follow-up|Withdrawal by Subject|7|||
128705413|NCT01846416|463217113|FG002|Survival Follow-up|Withdrawal by Subject|0|||
128705414|NCT01846416|463217111|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
128705415|NCT01846416|463217112|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
128705416|NCT01846416|463217113|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
128705417|NCT01846416|463217111|FG000|Survival Follow-up|Other|3|||
128705418|NCT01846416|463217112|FG001|Survival Follow-up|Other|1|||
128705419|NCT01846416|463217113|FG002|Survival Follow-up|Other|1|||
128705420|NCT01487200|463217116|FG000|Overall Study|Withdrawal by Subject|0|||
128705421|NCT01487200|463217117|FG001|Overall Study|Withdrawal by Subject|1|||
128705422|NCT01487200|463217118|FG002|Overall Study|Withdrawal by Subject|0|||
128705423|NCT01487200|463217119|FG003|Overall Study|Withdrawal by Subject|0|||
128705424|NCT02837783|463217120|FG000|Overall Study|Adverse Event|1|||
128705425|NCT02837783|463217121|FG001|Overall Study|Adverse Event|0|||
128705426|NCT02837783|463217120|FG000|Overall Study|Other, Not Specified|1|||
128705427|NCT02837783|463217121|FG001|Overall Study|Other, Not Specified|2|||
128705428|NCT02216591|463217122|FG000|Overall Study|Lost to Follow-up|0|||
128705429|NCT02216591|463217123|FG001|Overall Study|Lost to Follow-up|1|||
128705430|NCT02207244|463217124|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
128705431|NCT02207244|463217125|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
128705432|NCT02207244|463217126|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
128705433|NCT02207244|463217127|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705434|NCT02207244|463217128|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705435|NCT02207244|463217129|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705436|NCT02207244|463217130|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705437|NCT02207244|463217131|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705438|NCT02207244|463217132|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705439|NCT02207244|463217133|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705440|NCT02207244|463217134|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
128705441|NCT02207244|463217124|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
129122217|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
129122218|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
129122219|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Death|1|||
128705442|NCT02207244|463217125|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705443|NCT02207244|463217126|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
128705444|NCT02207244|463217127|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705445|NCT02207244|463217128|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705446|NCT02207244|463217129|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705447|NCT02207244|463217130|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705448|NCT02207244|463217131|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705449|NCT02207244|463217132|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129216943|NCT01352793|465094838|FG001|Overall Study|Other|7|||
129216944|NCT01352793|465094837|FG000|Overall Study|Medication error|2|||
129216945|NCT01352793|465094838|FG001|Overall Study|Medication error|2|||
129216946|NCT01352793|465094837|FG000|Overall Study|Death|1|||
129216947|NCT01352793|465094838|FG001|Overall Study|Death|0|||
129216948|NCT01352793|465094837|FG000|Overall Study|Randomized but not vaccinated|8|||
129216949|NCT01352793|465094838|FG001|Overall Study|Randomized but not vaccinated|0|||
129216950|NCT01352793|465094837|FG000|Overall Study|No longer meets eligibility criteria|25|||
129216951|NCT01352793|465094838|FG001|Overall Study|No longer meets eligibility criteria|15|||
129216952|NCT01716234|465094841|FG000|Overall Study|Protocol Violation|0|||
129216953|NCT01716234|465094842|FG001|Overall Study|Protocol Violation|0|||
129216954|NCT01716234|465094843|FG002|Overall Study|Protocol Violation|0|||
129216955|NCT01716234|465094844|FG003|Overall Study|Protocol Violation|1|||
129216956|NCT01716234|465094845|FG004|Overall Study|Protocol Violation|1|||
129216957|NCT01716234|465094846|FG005|Overall Study|Protocol Violation|1|||
129216958|NCT01716234|465094847|FG006|Overall Study|Protocol Violation|0|||
129216959|NCT01716234|465094841|FG000|Overall Study|Lack of Efficacy|0|||
129216960|NCT01716234|465094842|FG001|Overall Study|Lack of Efficacy|0|||
129216961|NCT01716234|465094843|FG002|Overall Study|Lack of Efficacy|0|||
129216962|NCT01716234|465094844|FG003|Overall Study|Lack of Efficacy|1|||
129216963|NCT01716234|465094845|FG004|Overall Study|Lack of Efficacy|0|||
129216964|NCT01716234|465094846|FG005|Overall Study|Lack of Efficacy|0|||
129216965|NCT01716234|465094847|FG006|Overall Study|Lack of Efficacy|0|||
129216966|NCT01716234|465094841|FG000|Overall Study|Did not meet protocol eligibility|0|||
129216967|NCT01716234|465094842|FG001|Overall Study|Did not meet protocol eligibility|0|||
129216968|NCT01716234|465094843|FG002|Overall Study|Did not meet protocol eligibility|1|||
129216969|NCT01716234|465094844|FG003|Overall Study|Did not meet protocol eligibility|0|||
129216970|NCT01716234|465094845|FG004|Overall Study|Did not meet protocol eligibility|0|||
129216971|NCT01716234|465094846|FG005|Overall Study|Did not meet protocol eligibility|4|||
129216972|NCT01716234|465094847|FG006|Overall Study|Did not meet protocol eligibility|0|||
129216973|NCT01716234|465094841|FG000|Overall Study|Adverse Event|7|||
129216974|NCT01716234|465094842|FG001|Overall Study|Adverse Event|10|||
129216975|NCT01716234|465094843|FG002|Overall Study|Adverse Event|2|||
129216976|NCT01716234|465094844|FG003|Overall Study|Adverse Event|8|||
129216977|NCT01716234|465094845|FG004|Overall Study|Adverse Event|3|||
129216978|NCT01716234|465094846|FG005|Overall Study|Adverse Event|6|||
129122220|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Death|3|||
129122221|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
129122222|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
129122223|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
129122224|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
129122225|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
129122226|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
129122227|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
129122228|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
129122229|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
129122230|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
129122231|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
129122232|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
129122233|NCT00362232|464744027|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
129122234|NCT00362232|464744028|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
129122235|NCT00362232|464744027|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
129122236|NCT00362232|464744028|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
129122237|NCT00362232|464744027|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
129122238|NCT00362232|464744028|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
129216979|NCT01716234|465094847|FG006|Overall Study|Adverse Event|0|||
129216980|NCT01716234|465094841|FG000|Overall Study|Withdrawal by Subject|3|||
128705450|NCT02207244|463217133|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705451|NCT02207244|463217134|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
128705452|NCT02207244|463217124|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
128705453|NCT02207244|463217125|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
128705454|NCT02207244|463217126|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
128705455|NCT02207244|463217127|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129122239|NCT00362232|464744027|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
129122240|NCT00362232|464744028|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
128705456|NCT02207244|463217128|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
128768128|NCT02091739|463442040|FG000|EP: 48 Weeks|Death|0|||
129122241|NCT00362232|464744027|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
129216981|NCT01716234|465094842|FG001|Overall Study|Withdrawal by Subject|0|||
129216982|NCT01716234|465094843|FG002|Overall Study|Withdrawal by Subject|2|||
129216983|NCT01716234|465094844|FG003|Overall Study|Withdrawal by Subject|2|||
129216984|NCT01716234|465094845|FG004|Overall Study|Withdrawal by Subject|1|||
129216985|NCT01716234|465094846|FG005|Overall Study|Withdrawal by Subject|3|||
129216986|NCT01716234|465094847|FG006|Overall Study|Withdrawal by Subject|0|||
128705457|NCT02207244|463217129|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
128705458|NCT02207244|463217130|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
128705459|NCT02207244|463217131|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
128705460|NCT02207244|463217132|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
128705461|NCT02207244|463217133|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
128705462|NCT02207244|463217134|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
128705463|NCT02207244|463217124|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
128705464|NCT02207244|463217125|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
128705465|NCT02207244|463217126|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705466|NCT02207244|463217127|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705467|NCT02207244|463217128|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705468|NCT02207244|463217129|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705469|NCT02207244|463217130|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705470|NCT02207244|463217131|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705471|NCT02207244|463217132|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705472|NCT02207244|463217133|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705473|NCT02207244|463217134|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
128705474|NCT02207244|463217124|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
128705475|NCT02207244|463217125|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
128705476|NCT02207244|463217126|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
128705477|NCT02207244|463217127|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705478|NCT02207244|463217128|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705479|NCT02207244|463217129|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705480|NCT02207244|463217130|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705481|NCT02207244|463217131|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705482|NCT02207244|463217132|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705483|NCT02207244|463217133|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705484|NCT02207244|463217134|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
128705485|NCT02207244|463217124|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705486|NCT02207244|463217125|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
128705487|NCT02207244|463217126|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
128705488|NCT02207244|463217127|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705489|NCT02207244|463217128|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705490|NCT02207244|463217129|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705491|NCT02207244|463217130|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705492|NCT02207244|463217131|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705493|NCT02207244|463217132|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705494|NCT02207244|463217133|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705495|NCT02207244|463217134|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
128705496|NCT02207244|463217124|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
129122242|NCT00362232|464744028|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
129122243|NCT02233413|464744031|FG000|Overall Study|Lost to Follow-up|7|||
129122244|NCT02233413|464744032|FG001|Overall Study|Lost to Follow-up|9|||
129122245|NCT02233413|464744031|FG000|Overall Study|Withdrawal by Subject|4|||
129122246|NCT02233413|464744032|FG001|Overall Study|Withdrawal by Subject|5|||
129122247|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
129122248|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
129122249|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
129122250|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
129122251|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
129122252|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
129122253|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
129122254|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
129122255|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
129122256|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
129122257|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
129122258|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
129122259|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
129122260|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
128705497|NCT02207244|463217125|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
129122261|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
128705498|NCT02207244|463217126|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
129122262|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
129122263|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
129122264|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
129122265|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
129122266|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
129122267|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
129122268|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
129122269|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
129122270|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
129122271|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
129122272|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
129122273|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
129122274|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
129122275|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
129122276|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
129122277|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
129122278|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
129122279|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
129122280|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
129122281|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
129122282|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
129122283|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
129122284|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
129122285|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
129122286|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
129122287|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
129122288|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
129122289|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
129122290|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
129122291|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
129122292|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
129122293|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
129122294|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
129122295|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
129122296|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
129122297|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
129122298|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
129122299|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
129122300|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
129122301|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
129122302|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
129122303|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
129122304|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
129122305|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
129122306|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
129122307|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
129122308|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
129122309|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
129122310|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
129122311|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
129122312|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
129122313|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
129122314|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
129122315|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
129122316|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
129122317|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
129122318|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
129122319|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
129122320|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
129122321|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
129122322|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
129122323|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
129122324|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
129122325|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
128705499|NCT02207244|463217127|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
129122326|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
129122327|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
129122328|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
129122329|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
129122330|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
129122331|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
129122332|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
129122333|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
129122334|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
129122335|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
129122336|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
129122337|NCT00090103|464744033|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
129122338|NCT00090103|464744034|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
129122339|NCT00090103|464744035|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
129122340|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
129122341|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
129122342|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
129122343|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
129122344|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
129122345|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
129122346|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
128705500|NCT02207244|463217128|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
128705501|NCT02207244|463217129|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
129122347|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
129122348|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
129122349|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
129122350|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
129122351|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
129122352|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
129122353|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
129122354|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
129122355|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
129122356|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
129122357|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
129122358|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
129122359|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
129122360|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
129122361|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
129122362|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
129122363|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
129122364|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
129122365|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
129122366|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
129122367|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
129122368|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
129122369|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
129122370|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
129122371|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
129122372|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
129122373|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
129122374|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
129122375|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
129122376|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
129122377|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
129122378|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
129122379|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
129122380|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
129122381|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
129122382|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
129122383|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
129122384|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
129216987|NCT03815929|465094850|FG000|Overall Study|Lost to Follow-up|2|||
128705502|NCT02207244|463217130|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
128705503|NCT02207244|463217131|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
128705504|NCT02207244|463217132|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
128705505|NCT02207244|463217133|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
128705506|NCT02207244|463217134|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
128705507|NCT02207244|463217124|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705508|NCT02207244|463217125|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705509|NCT02207244|463217126|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705510|NCT02207244|463217127|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705511|NCT02207244|463217128|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
128705512|NCT02207244|463217129|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
128705513|NCT02207244|463217130|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705514|NCT02207244|463217131|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705515|NCT02207244|463217132|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705516|NCT02207244|463217133|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705517|NCT02207244|463217134|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
128705518|NCT02207244|463217124|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705519|NCT02207244|463217125|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705520|NCT02207244|463217126|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705521|NCT02207244|463217127|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705522|NCT02207244|463217128|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705523|NCT02207244|463217129|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
128705524|NCT02207244|463217130|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705525|NCT02207244|463217131|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705526|NCT02207244|463217132|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705527|NCT02207244|463217133|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705528|NCT02207244|463217134|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
128705529|NCT02207244|463217124|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705530|NCT02207244|463217125|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705531|NCT02207244|463217126|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705532|NCT02207244|463217127|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
128705533|NCT02207244|463217128|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
128705534|NCT02207244|463217129|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
128705535|NCT02207244|463217130|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705536|NCT02207244|463217131|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705537|NCT02207244|463217132|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705538|NCT02207244|463217133|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705539|NCT02207244|463217134|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
128705540|NCT02207244|463217124|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705541|NCT02207244|463217125|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705542|NCT02207244|463217126|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705543|NCT02207244|463217127|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
128705544|NCT02207244|463217128|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
128705545|NCT02207244|463217129|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
128705546|NCT02207244|463217130|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705547|NCT02207244|463217131|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705548|NCT02207244|463217132|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705549|NCT02207244|463217133|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705550|NCT02207244|463217134|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
128705551|NCT02207244|463217124|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705552|NCT02207244|463217125|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705553|NCT02207244|463217126|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705554|NCT02207244|463217127|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
128705555|NCT02207244|463217128|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705556|NCT02207244|463217129|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
128705557|NCT02207244|463217130|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705558|NCT02207244|463217131|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705559|NCT02207244|463217132|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128768129|NCT02091739|463442041|FG001|EP: 48 Weeks|Death|0|||
128768130|NCT02091739|463442042|FG002|EP: 48 Weeks|Death|0|||
129031230|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
128705560|NCT02207244|463217133|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705561|NCT02207244|463217134|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
128705562|NCT02207244|463217124|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
128768131|NCT02091739|463442043|FG003|EP: 48 Weeks|Death|3|||
128768132|NCT02091739|463442044|FG004|EP: 48 Weeks|Death|2|||
129031231|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
128768133|NCT02091739|463442040|FG000|EP: 48 Weeks|Adverse Event|0|||
128768134|NCT02091739|463442041|FG001|EP: 48 Weeks|Adverse Event|0|||
128768135|NCT02091739|463442042|FG002|EP: 48 Weeks|Adverse Event|0|||
128768136|NCT02091739|463442043|FG003|EP: 48 Weeks|Adverse Event|2|||
128768137|NCT02091739|463442044|FG004|EP: 48 Weeks|Adverse Event|6|||
128768138|NCT02091739|463442040|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
128768139|NCT02091739|463442041|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
128768140|NCT02091739|463442042|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
128768141|NCT02091739|463442043|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
128768142|NCT02091739|463442044|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
128768143|NCT01737996|463442051|FG000|Overall Study|Adverse Event|0|||
128768144|NCT01737996|463442052|FG001|Overall Study|Adverse Event|1|||
128768145|NCT01737996|463442053|FG002|Overall Study|Adverse Event|1|||
128768146|NCT01737996|463442051|FG000|Overall Study|Withdrawal by Subject|0|||
128768147|NCT01737996|463442052|FG001|Overall Study|Withdrawal by Subject|0|||
128768148|NCT01737996|463442053|FG002|Overall Study|Withdrawal by Subject|1|||
128768149|NCT03119610|463442054|FG000|Overall Study|Adverse Event|1|||
128768150|NCT03119610|463442055|FG001|Overall Study|Adverse Event|0|||
128768151|NCT03119610|463442054|FG000|Overall Study|Lost to Follow-up|0|||
128768152|NCT03119610|463442055|FG001|Overall Study|Lost to Follow-up|1|||
128768153|NCT00114634|463442056|FG000|Overall Study|failure to return forms|3|||
128768154|NCT00557622|463442057|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
128768155|NCT00557622|463442058|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
128768156|NCT00557622|463442057|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
128768157|NCT00557622|463442058|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
128768158|NCT00557622|463442057|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
128768159|NCT00557622|463442058|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
128768160|NCT01468922|463442059|FG000|Overall Study|Screening failure|0|||
128768161|NCT01468922|463442060|FG001|Overall Study|Screening failure|0|||
128768162|NCT01468922|463442061|FG002|Overall Study|Screening failure|0|||
128768163|NCT01468922|463442062|FG003|Overall Study|Screening failure|0|||
128768164|NCT01468922|463442063|FG004|Overall Study|Screening failure|0|||
128768165|NCT01468922|463442064|FG005|Overall Study|Screening failure|0|||
128768166|NCT01468922|463442065|FG006|Overall Study|Screening failure|0|||
128768167|NCT01468922|463442066|FG007|Overall Study|Screening failure|0|||
128768168|NCT01468922|463442067|FG008|Overall Study|Screening failure|1|||
128768169|NCT01468922|463442059|FG000|Overall Study|Per patient choice|1|||
128768170|NCT01468922|463442060|FG001|Overall Study|Per patient choice|0|||
128768171|NCT01468922|463442061|FG002|Overall Study|Per patient choice|0|||
128768172|NCT01468922|463442062|FG003|Overall Study|Per patient choice|0|||
128768173|NCT01468922|463442063|FG004|Overall Study|Per patient choice|0|||
128768174|NCT01468922|463442064|FG005|Overall Study|Per patient choice|0|||
128768175|NCT01468922|463442065|FG006|Overall Study|Per patient choice|0|||
128768176|NCT01468922|463442066|FG007|Overall Study|Per patient choice|0|||
128768177|NCT01468922|463442067|FG008|Overall Study|Per patient choice|0|||
128768178|NCT01468922|463442059|FG000|Overall Study|Switched to alternative treatment|1|||
128768179|NCT01468922|463442060|FG001|Overall Study|Switched to alternative treatment|0|||
128768180|NCT01468922|463442061|FG002|Overall Study|Switched to alternative treatment|0|||
128768181|NCT01468922|463442062|FG003|Overall Study|Switched to alternative treatment|0|||
128768182|NCT01468922|463442063|FG004|Overall Study|Switched to alternative treatment|1|||
128768183|NCT01468922|463442064|FG005|Overall Study|Switched to alternative treatment|0|||
128768184|NCT01468922|463442065|FG006|Overall Study|Switched to alternative treatment|0|||
128768185|NCT01468922|463442066|FG007|Overall Study|Switched to alternative treatment|0|||
128768186|NCT01468922|463442067|FG008|Overall Study|Switched to alternative treatment|0|||
128768187|NCT01468922|463442059|FG000|Overall Study|Enrolled on new protocol|0|||
128768188|NCT01468922|463442060|FG001|Overall Study|Enrolled on new protocol|0|||
128768189|NCT01468922|463442061|FG002|Overall Study|Enrolled on new protocol|0|||
128768190|NCT01468922|463442062|FG003|Overall Study|Enrolled on new protocol|0|||
128768191|NCT01468922|463442063|FG004|Overall Study|Enrolled on new protocol|1|||
128768192|NCT01468922|463442064|FG005|Overall Study|Enrolled on new protocol|0|||
128768193|NCT01468922|463442065|FG006|Overall Study|Enrolled on new protocol|0|||
128768194|NCT01468922|463442066|FG007|Overall Study|Enrolled on new protocol|0|||
128768195|NCT01468922|463442067|FG008|Overall Study|Enrolled on new protocol|0|||
128768196|NCT01468922|463442059|FG000|Overall Study|Adverse Event|0|||
128768197|NCT01468922|463442060|FG001|Overall Study|Adverse Event|0|||
128768198|NCT01468922|463442061|FG002|Overall Study|Adverse Event|0|||
128768199|NCT01468922|463442062|FG003|Overall Study|Adverse Event|0|||
128768200|NCT01468922|463442063|FG004|Overall Study|Adverse Event|0|||
129031232|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
129031233|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
129031234|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
129132922|NCT01769443|464778571|FG001|Overall Study|Study closure|0|||
128768201|NCT01468922|463442064|FG005|Overall Study|Adverse Event|0|||
128768202|NCT01468922|463442065|FG006|Overall Study|Adverse Event|0|||
128768203|NCT01468922|463442066|FG007|Overall Study|Adverse Event|1|||
128768204|NCT01468922|463442067|FG008|Overall Study|Adverse Event|0|||
128768205|NCT01468922|463442059|FG000|Overall Study|Infection of blood|0|||
129216988|NCT03815929|465094851|FG001|Overall Study|Lost to Follow-up|1|||
129216989|NCT03815929|465094852|FG002|Overall Study|Lost to Follow-up|0|||
129216990|NCT03815929|465094850|FG000|Overall Study|Physician Decision|2|||
129216991|NCT03815929|465094851|FG001|Overall Study|Physician Decision|2|||
129216992|NCT03815929|465094852|FG002|Overall Study|Physician Decision|0|||
129216993|NCT03815929|465094850|FG000|Overall Study|Withdrawal by Subject|0|||
129216994|NCT03815929|465094851|FG001|Overall Study|Withdrawal by Subject|0|||
129216995|NCT03815929|465094852|FG002|Overall Study|Withdrawal by Subject|1|||
128705563|NCT02207244|463217125|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705564|NCT02207244|463217126|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705565|NCT02207244|463217127|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
128705566|NCT02207244|463217128|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705567|NCT02207244|463217129|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705568|NCT02207244|463217130|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705569|NCT02207244|463217131|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705570|NCT02207244|463217132|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705571|NCT02207244|463217133|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705572|NCT02207244|463217134|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
128705573|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
128705574|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
128705575|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
128705576|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
128705577|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
128705578|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
128705579|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
128705580|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
128705581|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
128705582|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
128705583|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
128705584|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705585|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705586|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705587|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705588|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705589|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705590|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705591|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
128705592|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705593|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705594|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
128705595|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
128705596|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
128705597|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
128705598|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
128705599|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
128705600|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
128705601|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
128705602|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
128705603|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
128705604|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
128705605|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
128705606|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
128705607|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
128705608|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129031235|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
128705609|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
128705610|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
128705611|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
128705612|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
128705613|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
128705614|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
128705615|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
128705616|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
128705617|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129216996|NCT02205736|465094853|FG000|Overall Study|Lost to Follow-up|106|||
128768206|NCT01468922|463442060|FG001|Overall Study|Infection of blood|0|||
129216997|NCT05615922|465094859|FG000|Overall Study|Lost to Follow-up|1|||
129216998|NCT03173248|465094863|FG000|Overall Study|Death|28|||
129216999|NCT03173248|465094864|FG001|Overall Study|Death|46|||
129217000|NCT03173248|465094863|FG000|Overall Study|Lost to Follow-up|0|||
129217001|NCT03173248|465094864|FG001|Overall Study|Lost to Follow-up|1|||
129217002|NCT03173248|465094863|FG000|Overall Study|Withdrawal by Subject|6|||
129217003|NCT03173248|465094864|FG001|Overall Study|Withdrawal by Subject|4|||
129217004|NCT03173248|465094863|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
129217005|NCT03173248|465094864|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
129217006|NCT02991768|465094866|FG000|Overall Study|Physician Decision|4|||
129217007|NCT04500158|465094869|FG000|Overall Study|Physician Decision|17|||
129217008|NCT04500158|465094870|FG001|Overall Study|Physician Decision|11|||
129217009|NCT02807402|465094873|FG000|Overall Study|Failure to Return|1|||
129217010|NCT02807402|465094873|FG000|Overall Study|Death|3|||
129217011|NCT02807402|465094873|FG000|Overall Study|Other|2|||
129217012|NCT04922216|465094875|FG000|Overall Study|Withdrawal by Subject|0|||
129217013|NCT04922216|465094876|FG001|Overall Study|Withdrawal by Subject|1|||
129217014|NCT04922216|465094877|FG002|Overall Study|Withdrawal by Subject|0|||
129217015|NCT04922216|465094878|FG003|Overall Study|Withdrawal by Subject|0|||
129217016|NCT04922216|465094879|FG004|Overall Study|Withdrawal by Subject|0|||
129217017|NCT04922216|465094880|FG005|Overall Study|Withdrawal by Subject|0|||
129217018|NCT04922216|465094881|FG006|Overall Study|Withdrawal by Subject|0|||
129217019|NCT04922216|465094882|FG007|Overall Study|Withdrawal by Subject|2|||
128705618|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
128705619|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
128705620|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
128705621|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
128705622|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
128705623|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
128705624|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
128705625|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
128705626|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
128705627|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
128705628|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705629|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705630|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705631|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705632|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705633|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705634|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705635|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
128705636|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
128705637|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705638|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
128705639|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705640|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705641|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705642|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705643|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705644|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705645|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705646|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705647|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
128705648|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705649|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
128705650|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705651|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705652|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705653|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705654|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705655|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705656|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705657|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
129217020|NCT04922216|465094883|FG008|Overall Study|Withdrawal by Subject|0|||
128705658|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129217021|NCT04922216|465094884|FG009|Overall Study|Withdrawal by Subject|0|||
129217022|NCT04922216|465094885|FG010|Overall Study|Withdrawal by Subject|0|||
128705659|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128705660|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
128768207|NCT01468922|463442061|FG002|Overall Study|Infection of blood|0|||
129217023|NCT04922216|465094886|FG011|Overall Study|Withdrawal by Subject|0|||
129217024|NCT04922216|465094887|FG012|Overall Study|Withdrawal by Subject|1|||
128705661|NCT02207244|463217124|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705662|NCT02207244|463217125|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705663|NCT02207244|463217126|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705664|NCT02207244|463217127|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705665|NCT02207244|463217128|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705666|NCT02207244|463217129|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705667|NCT02207244|463217130|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
128705668|NCT02207244|463217131|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705669|NCT02207244|463217132|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705670|NCT02207244|463217133|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705671|NCT02207244|463217134|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
128705672|NCT02207244|463217124|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705673|NCT02207244|463217125|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705674|NCT02207244|463217126|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705675|NCT02207244|463217127|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705676|NCT02207244|463217128|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705677|NCT02207244|463217129|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705678|NCT02207244|463217130|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705679|NCT02207244|463217131|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705680|NCT02207244|463217132|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
128705681|NCT02207244|463217133|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
128705682|NCT02207244|463217134|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
128705683|NCT02207244|463217124|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128705684|NCT02207244|463217125|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128705685|NCT02207244|463217126|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128705686|NCT02207244|463217127|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128705687|NCT02207244|463217128|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128705688|NCT02207244|463217129|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128705689|NCT02207244|463217130|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128705690|NCT02207244|463217131|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128768208|NCT01468922|463442062|FG003|Overall Study|Infection of blood|0|||
128935841|NCT01543490|464053856|FG001|Overall Study|Physician Decision|0|||
128935842|NCT01543490|464053855|FG000|Overall Study|Lack of Efficacy|3|||
128935843|NCT01543490|464053856|FG001|Overall Study|Lack of Efficacy|3|||
128935844|NCT01543490|464053855|FG000|Overall Study|Lost to Follow-up|5|||
128935845|NCT01543490|464053856|FG001|Overall Study|Lost to Follow-up|0|||
128935846|NCT01543490|464053855|FG000|Overall Study|Withdrawal by Subject|2|||
128935847|NCT01543490|464053856|FG001|Overall Study|Withdrawal by Subject|0|||
128935848|NCT01543490|464053855|FG000|Overall Study|Other-Various Administrative Reasons|1|||
128935849|NCT01543490|464053856|FG001|Overall Study|Other-Various Administrative Reasons|2|||
128935850|NCT04168645|464053858|FG000|Overall Study|Lost to Follow-up|23|||
128935851|NCT04168645|464053859|FG001|Overall Study|Lost to Follow-up|28|||
128935852|NCT04168645|464053860|FG002|Overall Study|Lost to Follow-up|15|||
128935853|NCT04168645|464053861|FG003|Overall Study|Lost to Follow-up|12|||
128935854|NCT04168645|464053858|FG000|Overall Study|Death|1|||
128935855|NCT04168645|464053859|FG001|Overall Study|Death|1|||
128935856|NCT04168645|464053860|FG002|Overall Study|Death|0|||
128935857|NCT04168645|464053861|FG003|Overall Study|Death|0|||
128935858|NCT04168645|464053858|FG000|Overall Study|Withdrawal by Subject|5|||
128935859|NCT04168645|464053859|FG001|Overall Study|Withdrawal by Subject|2|||
128935860|NCT04168645|464053860|FG002|Overall Study|Withdrawal by Subject|2|||
128935861|NCT04168645|464053861|FG003|Overall Study|Withdrawal by Subject|2|||
128935862|NCT04168645|464053858|FG000|Overall Study|Administrative Withdrawal|3|||
128935863|NCT04168645|464053859|FG001|Overall Study|Administrative Withdrawal|1|||
128935864|NCT04168645|464053860|FG002|Overall Study|Administrative Withdrawal|1|||
128935865|NCT04168645|464053861|FG003|Overall Study|Administrative Withdrawal|3|||
128935866|NCT03132805|464053864|FG000|Overall Study|Lost to Follow-up|142|||
128935867|NCT03132805|464053865|FG001|Overall Study|Lost to Follow-up|141|||
128935868|NCT03132805|464053866|FG002|Overall Study|Lost to Follow-up|113|||
128935869|NCT03918642|464053867|FG000|Overall Study|Lost to Follow-up|12|||
129031236|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
129031237|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
129031238|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
129031239|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
129031240|NCT01567527|464404808|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129031241|NCT01567527|464404809|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129031242|NCT01567527|464404810|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
128768209|NCT01468922|463442063|FG004|Overall Study|Infection of blood|0|||
128768210|NCT01468922|463442064|FG005|Overall Study|Infection of blood|0|||
128768211|NCT01468922|463442065|FG006|Overall Study|Infection of blood|0|||
128768212|NCT01468922|463442066|FG007|Overall Study|Infection of blood|1|||
128768213|NCT01468922|463442067|FG008|Overall Study|Infection of blood|0|||
128768214|NCT01468922|463442059|FG000|Overall Study|Patient choice - surgery|0|||
128768215|NCT01468922|463442060|FG001|Overall Study|Patient choice - surgery|0|||
128768216|NCT01468922|463442061|FG002|Overall Study|Patient choice - surgery|0|||
128768217|NCT01468922|463442062|FG003|Overall Study|Patient choice - surgery|0|||
128768218|NCT01468922|463442063|FG004|Overall Study|Patient choice - surgery|0|||
128768219|NCT01468922|463442064|FG005|Overall Study|Patient choice - surgery|0|||
128768220|NCT01468922|463442065|FG006|Overall Study|Patient choice - surgery|0|||
128768221|NCT01468922|463442066|FG007|Overall Study|Patient choice - surgery|1|||
128768222|NCT01468922|463442067|FG008|Overall Study|Patient choice - surgery|0|||
128768223|NCT01468922|463442059|FG000|Overall Study|Refused further treatment|0|||
128768224|NCT01468922|463442060|FG001|Overall Study|Refused further treatment|0|||
128768225|NCT01468922|463442061|FG002|Overall Study|Refused further treatment|0|||
128768226|NCT01468922|463442062|FG003|Overall Study|Refused further treatment|0|||
128768227|NCT01468922|463442063|FG004|Overall Study|Refused further treatment|0|||
128768228|NCT01468922|463442064|FG005|Overall Study|Refused further treatment|0|||
128768229|NCT01468922|463442065|FG006|Overall Study|Refused further treatment|0|||
128768230|NCT01468922|463442066|FG007|Overall Study|Refused further treatment|1|||
128768231|NCT01468922|463442067|FG008|Overall Study|Refused further treatment|0|||
128768232|NCT01225822|463442083|FG000|Overall Study|Adverse Event|13|||
128768233|NCT01225822|463442084|FG001|Overall Study|Adverse Event|31|||
128768234|NCT01225822|463442085|FG002|Overall Study|Adverse Event|18|||
128768235|NCT01225822|463442086|FG003|Overall Study|Adverse Event|23|||
128768236|NCT01225822|463442087|FG004|Overall Study|Adverse Event|14|||
128768237|NCT01225822|463442083|FG000|Overall Study|Protocol Violation|6|||
128768238|NCT01225822|463442084|FG001|Overall Study|Protocol Violation|8|||
128768239|NCT01225822|463442085|FG002|Overall Study|Protocol Violation|6|||
128768240|NCT01225822|463442086|FG003|Overall Study|Protocol Violation|7|||
128768241|NCT01225822|463442087|FG004|Overall Study|Protocol Violation|4|||
128768242|NCT01225822|463442083|FG000|Overall Study|Lost to Follow-up|0|||
128768243|NCT01225822|463442084|FG001|Overall Study|Lost to Follow-up|0|||
128768244|NCT01225822|463442085|FG002|Overall Study|Lost to Follow-up|0|||
128768245|NCT01225822|463442086|FG003|Overall Study|Lost to Follow-up|1|||
128768246|NCT01225822|463442087|FG004|Overall Study|Lost to Follow-up|0|||
128768247|NCT01225822|463442083|FG000|Overall Study|Withdrawal by Subject|6|||
128768248|NCT01225822|463442084|FG001|Overall Study|Withdrawal by Subject|7|||
128768249|NCT01225822|463442085|FG002|Overall Study|Withdrawal by Subject|7|||
128768250|NCT01225822|463442086|FG003|Overall Study|Withdrawal by Subject|11|||
128768251|NCT01225822|463442087|FG004|Overall Study|Withdrawal by Subject|6|||
128768252|NCT01225822|463442083|FG000|Overall Study|Other|13|||
128768253|NCT01225822|463442084|FG001|Overall Study|Other|10|||
128768254|NCT01225822|463442085|FG002|Overall Study|Other|7|||
128768255|NCT01225822|463442086|FG003|Overall Study|Other|10|||
128768256|NCT01225822|463442087|FG004|Overall Study|Other|7|||
128768257|NCT03679767|463442088|FG000|Overall Study|Death|16|||
128768258|NCT03679767|463442089|FG001|Overall Study|Death|11|||
128768259|NCT03679767|463442090|FG002|Overall Study|Death|17|||
128768260|NCT03679767|463442091|FG003|Overall Study|Death|10|||
128768261|NCT03679767|463442088|FG000|Overall Study|Lost to Follow-up|1|||
128768262|NCT03679767|463442089|FG001|Overall Study|Lost to Follow-up|1|||
128768263|NCT03679767|463442090|FG002|Overall Study|Lost to Follow-up|1|||
128768264|NCT03679767|463442091|FG003|Overall Study|Lost to Follow-up|1|||
128768265|NCT03679767|463442088|FG000|Overall Study|Withdrawal by Subject|0|||
128768266|NCT03679767|463442089|FG001|Overall Study|Withdrawal by Subject|0|||
128768267|NCT03679767|463442090|FG002|Overall Study|Withdrawal by Subject|0|||
128768268|NCT03679767|463442091|FG003|Overall Study|Withdrawal by Subject|1|||
128768269|NCT03679767|463442088|FG000|Overall Study|Follow-up Completed|18|||
128768270|NCT03679767|463442089|FG001|Overall Study|Follow-up Completed|11|||
128768271|NCT03679767|463442090|FG002|Overall Study|Follow-up Completed|11|||
129122385|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
129122386|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
129122387|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
129122388|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Death|1|||
129122389|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Death|0|||
129122390|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Death|1|||
128768272|NCT03679767|463442091|FG003|Overall Study|Follow-up Completed|20|||
128768273|NCT03679767|463442088|FG000|Overall Study|Entered Hospice Care|0|||
129122391|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
128768274|NCT03679767|463442089|FG001|Overall Study|Entered Hospice Care|0|||
128768275|NCT03679767|463442090|FG002|Overall Study|Entered Hospice Care|0|||
128768276|NCT03679767|463442091|FG003|Overall Study|Entered Hospice Care|1|||
128768277|NCT03679767|463442088|FG000|Overall Study|Progressive Disease|0|||
128768278|NCT03679767|463442089|FG001|Overall Study|Progressive Disease|0|||
128768279|NCT03679767|463442090|FG002|Overall Study|Progressive Disease|0|||
128768280|NCT03679767|463442091|FG003|Overall Study|Progressive Disease|1|||
128768281|NCT02954458|463442092|FG000|Overall Study|Adverse Event|0|||
128768282|NCT02954458|463442093|FG001|Overall Study|Adverse Event|0|||
128768283|NCT02954458|463442094|FG002|Overall Study|Adverse Event|0|||
128768284|NCT02954458|463442095|FG003|Overall Study|Adverse Event|1|||
128768285|NCT02954458|463442092|FG000|Overall Study|Withdrawal by Subject|0|||
128768286|NCT02954458|463442093|FG001|Overall Study|Withdrawal by Subject|0|||
128768287|NCT02954458|463442094|FG002|Overall Study|Withdrawal by Subject|0|||
128768288|NCT02954458|463442095|FG003|Overall Study|Withdrawal by Subject|1|||
128768289|NCT02954458|463442092|FG000|Overall Study|Physician Decision|0|||
128768290|NCT02954458|463442093|FG001|Overall Study|Physician Decision|0|||
128768291|NCT02954458|463442094|FG002|Overall Study|Physician Decision|1|||
128768292|NCT02954458|463442095|FG003|Overall Study|Physician Decision|1|||
128935870|NCT03918642|464053868|FG001|Overall Study|Lost to Follow-up|10|||
128768293|NCT02954458|463442092|FG000|Overall Study|Lost to Follow-up|1|||
128768294|NCT02954458|463442093|FG001|Overall Study|Lost to Follow-up|0|||
128935871|NCT03825042|464053869|FG000|Overall Study|Adverse Event|1|||
128935872|NCT03825042|464053870|FG001|Overall Study|Adverse Event|0|||
128935873|NCT03825042|464053869|FG000|Overall Study|Withdrawal by Subject|1|||
128935874|NCT03825042|464053870|FG001|Overall Study|Withdrawal by Subject|0|||
128935875|NCT00500149|464053876|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
128935876|NCT00500149|464053877|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
128935877|NCT00500149|464053876|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
128935878|NCT00500149|464053877|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
128935879|NCT00500149|464053876|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
128935880|NCT00500149|464053877|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
128935881|NCT00500149|464053876|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
128935882|NCT00500149|464053877|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
128935883|NCT00500149|464053876|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
128935884|NCT00500149|464053877|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
128935885|NCT00500149|464053876|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
128935886|NCT00500149|464053877|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
128935887|NCT00500149|464053876|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
128935888|NCT00500149|464053877|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
128935889|NCT01158534|464053878|FG000|Overall Study|Withdrawal by Subject|1|||
128935890|NCT01158534|464053878|FG000|Overall Study|Death|1|||
128935891|NCT01158534|464053878|FG000|Overall Study|Other|1|||
128935892|NCT00521339|464053879|FG000|Treatment Phase|Adverse Event|2|||
128935893|NCT00521339|464053880|FG001|Treatment Phase|Adverse Event|0|||
128935894|NCT00521339|464053881|FG002|Treatment Phase|Adverse Event|0|||
128935895|NCT00521339|464053879|FG000|Treatment Phase|Intolerability to study drug|2|||
128935896|NCT00521339|464053880|FG001|Treatment Phase|Intolerability to study drug|0|||
128935897|NCT00521339|464053881|FG002|Treatment Phase|Intolerability to study drug|0|||
128935898|NCT00521339|464053879|FG000|Treatment Phase|Lack of Efficacy|3|||
128935899|NCT00521339|464053880|FG001|Treatment Phase|Lack of Efficacy|0|||
128935900|NCT00521339|464053881|FG002|Treatment Phase|Lack of Efficacy|0|||
128935901|NCT00521339|464053879|FG000|Treatment Phase|Withdrawal by Subject|3|||
128935902|NCT00521339|464053880|FG001|Treatment Phase|Withdrawal by Subject|0|||
128935903|NCT00521339|464053881|FG002|Treatment Phase|Withdrawal by Subject|0|||
128935904|NCT00521339|464053879|FG000|Treatment Phase|Lost to Follow-up|1|||
128935905|NCT00521339|464053880|FG001|Treatment Phase|Lost to Follow-up|0|||
128935906|NCT00521339|464053881|FG002|Treatment Phase|Lost to Follow-up|0|||
128935907|NCT00521339|464053879|FG000|Treatment Phase|Protocol Violation|1|||
128935908|NCT00521339|464053880|FG001|Treatment Phase|Protocol Violation|0|||
128935909|NCT00521339|464053881|FG002|Treatment Phase|Protocol Violation|0|||
128935910|NCT00521339|464053879|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
128935911|NCT00521339|464053880|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
128935912|NCT00521339|464053881|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
128935913|NCT00521339|464053879|FG000|Treatment Extension Phase|Death|0|||
128935914|NCT00521339|464053880|FG001|Treatment Extension Phase|Death|0|||
128935915|NCT00521339|464053881|FG002|Treatment Extension Phase|Death|1|||
128935916|NCT01988012|464053882|FG000|Overall Study|Adverse Event|5|||
128935917|NCT01988012|464053882|FG000|Overall Study|Insufficient Therapeutic Response|3|||
128935918|NCT01988012|464053882|FG000|Overall Study|Patient Withdrawal of Consent|4|||
128935919|NCT01988012|464053882|FG000|Overall Study|Lost to Follow-up|1|||
128935920|NCT01988012|464053882|FG000|Overall Study|Physician Decision|1|||
128935921|NCT01988012|464053882|FG000|Overall Study|Protocol Violation|1|||
128935922|NCT00089843|464053883|FG000|Overall Study|Withdrawal by Subject|1|||
128935923|NCT00089843|464053884|FG001|Overall Study|Withdrawal by Subject|4|||
128935924|NCT00089843|464053885|FG002|Overall Study|Withdrawal by Subject|5|||
128935925|NCT00089843|464053886|FG003|Overall Study|Withdrawal by Subject|6|||
128935926|NCT00089843|464053883|FG000|Overall Study|Physician Decision|1|||
129132923|NCT04996264|464778572|FG000|Overall Study|Lost to Follow-up|0|||
128768295|NCT02954458|463442094|FG002|Overall Study|Lost to Follow-up|0|||
128768296|NCT02954458|463442095|FG003|Overall Study|Lost to Follow-up|1|||
128935927|NCT00089843|464053884|FG001|Overall Study|Physician Decision|0|||
128935928|NCT00089843|464053885|FG002|Overall Study|Physician Decision|0|||
128935929|NCT00089843|464053886|FG003|Overall Study|Physician Decision|1|||
128935930|NCT00950690|464053887|FG000|Overall Study|Death|4|||
128935931|NCT00950690|464053887|FG000|Overall Study|Adverse Event|15|||
128935932|NCT00950690|464053887|FG000|Overall Study|Lack of Efficacy|22|||
128935933|NCT00950690|464053887|FG000|Overall Study|Lost to Follow-up|40|||
128935934|NCT00950690|464053887|FG000|Overall Study|Other|163|||
128935935|NCT01713036|464053888|FG000|Overall Study|Death|1|||
128935936|NCT03567291|464053889|FG000|Period I|Adverse Event|14|||
128935937|NCT03567291|464053890|FG001|Period I|Adverse Event|0|||
128935938|NCT03567291|464053891|FG002|Period I|Adverse Event|0|||
128935939|NCT03567291|464053892|FG003|Period I|Adverse Event|0|||
128935940|NCT03567291|464053889|FG000|Period I|Protocol Violation|1|||
128935941|NCT03567291|464053890|FG001|Period I|Protocol Violation|0|||
128935942|NCT03567291|464053891|FG002|Period I|Protocol Violation|0|||
128935943|NCT03567291|464053892|FG003|Period I|Protocol Violation|0|||
128935944|NCT03567291|464053889|FG000|Period I|Withdrawal by Subject|23|||
128935945|NCT03567291|464053890|FG001|Period I|Withdrawal by Subject|0|||
128935946|NCT03567291|464053891|FG002|Period I|Withdrawal by Subject|0|||
128935947|NCT03567291|464053892|FG003|Period I|Withdrawal by Subject|0|||
128935948|NCT03567291|464053889|FG000|Period I|Lost to Follow-up|2|||
128935949|NCT03567291|464053890|FG001|Period I|Lost to Follow-up|0|||
128935950|NCT03567291|464053891|FG002|Period I|Lost to Follow-up|0|||
128935951|NCT03567291|464053892|FG003|Period I|Lost to Follow-up|0|||
128935952|NCT03567291|464053889|FG000|Period I|Terminated by sponsor|44|||
128935953|NCT03567291|464053890|FG001|Period I|Terminated by sponsor|0|||
128935954|NCT03567291|464053891|FG002|Period I|Terminated by sponsor|0|||
128935955|NCT03567291|464053892|FG003|Period I|Terminated by sponsor|0|||
128935956|NCT03567291|464053889|FG000|Period I|Missing or unknown|7|||
128935957|NCT03567291|464053890|FG001|Period I|Missing or unknown|0|||
128935958|NCT03567291|464053891|FG002|Period I|Missing or unknown|0|||
128935959|NCT03567291|464053892|FG003|Period I|Missing or unknown|0|||
128935960|NCT03567291|464053889|FG000|Period II|Adverse Event|0|||
128935961|NCT03567291|464053890|FG001|Period II|Adverse Event|1|||
128935962|NCT03567291|464053891|FG002|Period II|Adverse Event|0|||
128935963|NCT03567291|464053892|FG003|Period II|Adverse Event|0|||
128935964|NCT03567291|464053889|FG000|Period II|Missing or unknown|0|||
128935965|NCT03567291|464053890|FG001|Period II|Missing or unknown|2|||
128935966|NCT03567291|464053891|FG002|Period II|Missing or unknown|1|||
128935967|NCT03567291|464053892|FG003|Period II|Missing or unknown|0|||
128935968|NCT03567291|464053889|FG000|Period III|Adverse Event|0|||
128935969|NCT03567291|464053890|FG001|Period III|Adverse Event|0|||
128935970|NCT03567291|464053891|FG002|Period III|Adverse Event|0|||
128935971|NCT03567291|464053892|FG003|Period III|Adverse Event|4|||
128935972|NCT03567291|464053889|FG000|Period III|Withdrawal by Subject|0|||
128935973|NCT03567291|464053890|FG001|Period III|Withdrawal by Subject|0|||
128935974|NCT03567291|464053891|FG002|Period III|Withdrawal by Subject|0|||
128935975|NCT03567291|464053892|FG003|Period III|Withdrawal by Subject|4|||
128935976|NCT03567291|464053889|FG000|Period III|Lost to Follow-up|0|||
128935977|NCT03567291|464053890|FG001|Period III|Lost to Follow-up|0|||
128935978|NCT03567291|464053891|FG002|Period III|Lost to Follow-up|0|||
128935979|NCT03567291|464053892|FG003|Period III|Lost to Follow-up|1|||
128935980|NCT03567291|464053889|FG000|Period III|Terminated by sponsor|0|||
128935981|NCT03567291|464053890|FG001|Period III|Terminated by sponsor|0|||
129122392|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
129122393|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
129122394|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
129122395|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
129122396|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
129122397|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
128935982|NCT03567291|464053891|FG002|Period III|Terminated by sponsor|0|||
128935983|NCT03567291|464053892|FG003|Period III|Terminated by sponsor|68|||
128935984|NCT03567291|464053889|FG000|Period III|Missing or unknown|0|||
128935985|NCT03567291|464053890|FG001|Period III|Missing or unknown|0|||
128935986|NCT03567291|464053891|FG002|Period III|Missing or unknown|0|||
128935987|NCT03567291|464053892|FG003|Period III|Missing or unknown|8|||
128935988|NCT01103349|464053893|FG000|Overall Study|Adverse Event|8|||
129122398|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
128935989|NCT01103349|464053894|FG001|Overall Study|Adverse Event|5|||
128935990|NCT01103349|464053895|FG002|Overall Study|Adverse Event|3|||
128935991|NCT01103349|464053893|FG000|Overall Study|Consent withdrawn|1|||
128935992|NCT01103349|464053894|FG001|Overall Study|Consent withdrawn|0|||
128935993|NCT01103349|464053895|FG002|Overall Study|Consent withdrawn|0|||
128935994|NCT01103349|464053893|FG000|Overall Study|Incorrectly included in the trial|1|||
128935995|NCT01103349|464053894|FG001|Overall Study|Incorrectly included in the trial|0|||
128935996|NCT01103349|464053895|FG002|Overall Study|Incorrectly included in the trial|0|||
128935997|NCT01103349|464053893|FG000|Overall Study|Withdrawal by Subject|1|||
128935998|NCT01103349|464053894|FG001|Overall Study|Withdrawal by Subject|1|||
128935999|NCT01103349|464053895|FG002|Overall Study|Withdrawal by Subject|0|||
128936000|NCT01103349|464053893|FG000|Overall Study|did not want to take trial medication|0|||
128936001|NCT01103349|464053894|FG001|Overall Study|did not want to take trial medication|1|||
128936002|NCT01103349|464053895|FG002|Overall Study|did not want to take trial medication|0|||
128936003|NCT01103349|464053893|FG000|Overall Study|forgot to take medication|0|||
128936004|NCT01103349|464053894|FG001|Overall Study|forgot to take medication|0|||
128936005|NCT01103349|464053895|FG002|Overall Study|forgot to take medication|1|||
128936006|NCT00553059|464053898|FG000|Overall Study|Deemed ineligible|1|||
128936007|NCT00553059|464053899|FG001|Overall Study|Deemed ineligible|1|||
128936008|NCT00553059|464053898|FG000|Overall Study|Drug supply not available|0|||
128936009|NCT00553059|464053899|FG001|Overall Study|Drug supply not available|1|||
128936010|NCT00117338|464053900|FG000|Overall Study|Adverse Event|0|||
128936011|NCT00117338|464053901|FG001|Overall Study|Adverse Event|1|||
128936012|NCT00117338|464053900|FG000|Overall Study|Protocol Violation|3|||
128936013|NCT00117338|464053901|FG001|Overall Study|Protocol Violation|2|||
128936014|NCT00117338|464053900|FG000|Overall Study|Withdrawal by Subject|1|||
128936015|NCT00117338|464053901|FG001|Overall Study|Withdrawal by Subject|0|||
128936016|NCT00117338|464053900|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
128936017|NCT00117338|464053901|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
128936018|NCT00117338|464053900|FG000|Overall Study|Lack of Efficacy|0|||
128936019|NCT00117338|464053901|FG001|Overall Study|Lack of Efficacy|1|||
128936020|NCT02240628|464053904|FG000|Overall Study|Physician Decision|6|||
128936021|NCT02240628|464053905|FG001|Overall Study|Physician Decision|5|||
128936022|NCT02385123|464053906|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
128936023|NCT01070303|464053910|FG000|Overall Study|Adverse Event|39|||
128936024|NCT01070303|464053910|FG000|Overall Study|Withdrawal by Subject|20|||
128936025|NCT01070303|464053910|FG000|Overall Study|Lost to Follow-up|9|||
128936026|NCT01070303|464053910|FG000|Overall Study|Protocol Violation|0|||
128936027|NCT01070303|464053910|FG000|Overall Study|Lack of Efficacy|2|||
128936028|NCT01070303|464053910|FG000|Overall Study|Administrative Reason|1|||
128936029|NCT01070303|464053910|FG000|Overall Study|Other|18|||
128936030|NCT02345434|464053911|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
128936031|NCT02345434|464053912|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
128936032|NCT00859898|464053914|FG000|Overall Study|Lack of Efficacy|0|||
128936033|NCT00859898|464053915|FG001|Overall Study|Lack of Efficacy|1|||
128936034|NCT00859898|464053916|FG002|Overall Study|Lack of Efficacy|1|||
128936035|NCT00859898|464053914|FG000|Overall Study|Adverse Event|4|||
128936036|NCT00859898|464053915|FG001|Overall Study|Adverse Event|9|||
128936037|NCT00859898|464053916|FG002|Overall Study|Adverse Event|8|||
128936038|NCT00859898|464053914|FG000|Overall Study|Withdrawal by Subject|11|||
128936039|NCT00859898|464053915|FG001|Overall Study|Withdrawal by Subject|8|||
128936040|NCT00859898|464053916|FG002|Overall Study|Withdrawal by Subject|11|||
128936041|NCT00859898|464053914|FG000|Overall Study|Death|0|||
128936042|NCT00859898|464053915|FG001|Overall Study|Death|0|||
128936043|NCT00859898|464053916|FG002|Overall Study|Death|1|||
128936044|NCT00859898|464053914|FG000|Overall Study|Lost to Follow-up|10|||
128936045|NCT00859898|464053915|FG001|Overall Study|Lost to Follow-up|11|||
128936046|NCT00859898|464053916|FG002|Overall Study|Lost to Follow-up|5|||
128936047|NCT00859898|464053914|FG000|Overall Study|poor/non-compliance|2|||
128936048|NCT00859898|464053915|FG001|Overall Study|poor/non-compliance|0|||
128936049|NCT00859898|464053916|FG002|Overall Study|poor/non-compliance|0|||
128936050|NCT00859898|464053914|FG000|Overall Study|No longer meets criteria|0|||
128936051|NCT00859898|464053915|FG001|Overall Study|No longer meets criteria|1|||
128936052|NCT00859898|464053916|FG002|Overall Study|No longer meets criteria|0|||
128936053|NCT00859898|464053914|FG000|Overall Study|non-specified|1|||
128936054|NCT00859898|464053915|FG001|Overall Study|non-specified|1|||
128936055|NCT00859898|464053916|FG002|Overall Study|non-specified|1|||
128936056|NCT01302041|464053917|FG000|Overall Study|Death|5|||
128936057|NCT01302041|464053917|FG000|Overall Study|Withdrawal by Subject|4|||
128936058|NCT01302041|464053917|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
128936059|NCT01302041|464053917|FG000|Overall Study|Other-Miscellaneous Reason|2|||
128936060|NCT00771030|464053920|FG000|Overall Study|Adverse Event|0|||
128936061|NCT00771030|464053921|FG001|Overall Study|Adverse Event|1|||
128936062|NCT00771030|464053922|FG002|Overall Study|Adverse Event|0|||
128936063|NCT00771030|464053923|FG003|Overall Study|Adverse Event|0|||
128936064|NCT00771030|464053924|FG004|Overall Study|Adverse Event|0|||
128936065|NCT00771030|464053925|FG005|Overall Study|Adverse Event|0|||
128936066|NCT00771030|464053926|FG006|Overall Study|Adverse Event|0|||
128936067|NCT01327339|464053936|FG000|Overall Study|Protocol Violation|8|||
128936068|NCT01097330|464053939|FG000|Overall Study|Study terminated early|7|||
128936069|NCT01097330|464053940|FG001|Overall Study|Study terminated early|5|||
128936070|NCT00510692|464053942|FG000|Overall Study|Adverse Event|1|||
128936071|NCT00510692|464053943|FG001|Overall Study|Adverse Event|3|||
128936072|NCT00510692|464053942|FG000|Overall Study|Withdrawal by Subject|1|||
128936073|NCT00510692|464053943|FG001|Overall Study|Withdrawal by Subject|0|||
128936074|NCT01845077|464053944|FG000|Washout Period|Lost to Follow-up|0|||
128936075|NCT01845077|464053945|FG001|Washout Period|Lost to Follow-up|1|||
128936076|NCT01845077|464053946|FG002|Washout Period|Lost to Follow-up|0|||
128936077|NCT01845077|464053947|FG003|Washout Period|Lost to Follow-up|1|||
128936078|NCT01845077|464053948|FG004|Washout Period|Lost to Follow-up|0|||
128936079|NCT01845077|464053949|FG005|Washout Period|Lost to Follow-up|1|||
128936080|NCT01845077|464053944|FG000|Washout Period|Adverse Event|1|||
128936081|NCT01845077|464053945|FG001|Washout Period|Adverse Event|0|||
128936082|NCT01845077|464053946|FG002|Washout Period|Adverse Event|0|||
128936083|NCT01845077|464053947|FG003|Washout Period|Adverse Event|0|||
128936084|NCT01845077|464053948|FG004|Washout Period|Adverse Event|0|||
128936085|NCT01845077|464053949|FG005|Washout Period|Adverse Event|0|||
128936086|NCT01845077|464053944|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
128936087|NCT01845077|464053945|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
128936088|NCT01845077|464053946|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
128936089|NCT01845077|464053947|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
128936090|NCT01845077|464053948|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
128936091|NCT01845077|464053949|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
128936092|NCT01845077|464053944|FG000|Washout Period|Protocol Violation|0|||
128936093|NCT01845077|464053945|FG001|Washout Period|Protocol Violation|0|||
128768297|NCT02954458|463442092|FG000|Overall Study|Death|0|||
128768298|NCT02954458|463442093|FG001|Overall Study|Death|0|||
128768299|NCT02954458|463442094|FG002|Overall Study|Death|0|||
128768300|NCT02954458|463442095|FG003|Overall Study|Death|1|||
128768301|NCT02954458|463442092|FG000|Overall Study|Other|0|||
128768302|NCT02954458|463442093|FG001|Overall Study|Other|0|||
128768303|NCT02954458|463442094|FG002|Overall Study|Other|0|||
128768304|NCT02954458|463442095|FG003|Overall Study|Other|7|||
128768305|NCT01407354|463442096|FG000|First Intervention|Withdrawal by Subject|0|||
128768306|NCT01407354|463442097|FG001|First Intervention|Withdrawal by Subject|2|||
128768307|NCT01407354|463442096|FG000|First Intervention|Adverse Event|1|||
128768308|NCT01407354|463442097|FG001|First Intervention|Adverse Event|0|||
128768309|NCT01407354|463442096|FG000|First Intervention|Physician Decision|1|||
128768310|NCT01407354|463442097|FG001|First Intervention|Physician Decision|0|||
128768311|NCT04395183|463442100|FG000|Overall Study|Withdrawal by Subject|1|||
128768312|NCT04395183|463442101|FG001|Overall Study|Withdrawal by Subject|0|||
128768313|NCT04395183|463442102|FG002|Overall Study|Withdrawal by Subject|2|||
128768314|NCT04395183|463442103|FG003|Overall Study|Withdrawal by Subject|2|||
128768315|NCT03556358|463442104|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
128768316|NCT03556358|463442105|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
128768317|NCT03556358|463442104|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
128768318|NCT03556358|463442105|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
128768319|NCT03556358|463442104|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
128768320|NCT03556358|463442105|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
128768321|NCT03556358|463442104|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
128768322|NCT03556358|463442105|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
128768323|NCT03556358|463442104|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
128768324|NCT03556358|463442105|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
128768325|NCT03556358|463442104|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
128768326|NCT03556358|463442105|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
128768327|NCT03556358|463442104|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
128768328|NCT03556358|463442105|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
128768329|NCT01351025|463442109|FG000|Week 0 - 20|Lost to Follow-up|2|||
128768330|NCT01351025|463442110|FG001|Week 0 - 20|Lost to Follow-up|1|||
128768331|NCT01351025|463442109|FG000|Week 0 - 20|Withdrawal by Subject|1|||
128936094|NCT01845077|464053946|FG002|Washout Period|Protocol Violation|0|||
128936095|NCT01845077|464053947|FG003|Washout Period|Protocol Violation|1|||
128936096|NCT01845077|464053948|FG004|Washout Period|Protocol Violation|1|||
128936097|NCT01845077|464053949|FG005|Washout Period|Protocol Violation|0|||
128936098|NCT01797432|464053950|FG000|Overall Study|Lost to Follow-up|1|||
128936099|NCT01797432|464053950|FG000|Overall Study|Adverse Event|1|||
128936100|NCT01797432|464053950|FG000|Overall Study|Withdrawal by Subject|1|||
128936101|NCT01797432|464053950|FG000|Overall Study|lived too far from study site|1|||
128936102|NCT01137435|464053951|FG000|Overall Study|Lost to Follow-up|24|||
128936103|NCT01137435|464053951|FG000|Overall Study|Off label usage|4|||
129031243|NCT01567527|464404811|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
129031244|NCT01567527|464404812|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
129031245|NCT02004691|464404813|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
129031246|NCT02004691|464404814|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
129031247|NCT02004691|464404813|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
129031248|NCT02004691|464404814|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
129031249|NCT02004691|464404813|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
128768332|NCT01351025|463442110|FG001|Week 0 - 20|Withdrawal by Subject|0|||
128936104|NCT00501852|464053957|FG000|Overall Study|Adverse Event|3|||
128936105|NCT00501852|464053957|FG000|Overall Study|Withdrawal by Subject|2|||
128936106|NCT01416610|464053961|FG000|Overall Study|Adverse Event|4|||
128936107|NCT01416610|464053961|FG000|Overall Study|Adverse Event -Patient decision|3|||
128936108|NCT01416610|464053961|FG000|Overall Study|Lack of Efficacy|4|||
128936109|NCT01416610|464053961|FG000|Overall Study|No reason given|5|||
128936110|NCT01416610|464053961|FG000|Overall Study|Withdrawal by Subject|13|||
128936111|NCT01416610|464053961|FG000|Overall Study|Lost to Follow-up|7|||
128936112|NCT01416610|464053961|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
128936113|NCT01927562|464053962|FG000|Overall Study|Lost to Follow-up|30|||
128936114|NCT01927562|464053962|FG000|Overall Study|Withdrawal by Subject|3|||
128936115|NCT01927562|464053962|FG000|Overall Study|Physician Decision|5|||
128936116|NCT00642616|464053963|FG000|Overall Study|Adverse Event|2|||
128936117|NCT00642616|464053964|FG001|Overall Study|Adverse Event|0|||
128936118|NCT00642616|464053965|FG002|Overall Study|Adverse Event|1|||
128936119|NCT00642616|464053966|FG003|Overall Study|Adverse Event|0|||
128936120|NCT00642616|464053963|FG000|Overall Study|Study Terminated by Sponsor|7|||
128936121|NCT00642616|464053964|FG001|Overall Study|Study Terminated by Sponsor|6|||
128936122|NCT00642616|464053965|FG002|Overall Study|Study Terminated by Sponsor|4|||
128936123|NCT00642616|464053966|FG003|Overall Study|Study Terminated by Sponsor|5|||
128936124|NCT00642616|464053963|FG000|Overall Study|Withdrawal by Subject|0|||
128936125|NCT00642616|464053964|FG001|Overall Study|Withdrawal by Subject|1|||
128936126|NCT00642616|464053965|FG002|Overall Study|Withdrawal by Subject|1|||
128936127|NCT00642616|464053966|FG003|Overall Study|Withdrawal by Subject|1|||
128936128|NCT00642616|464053963|FG000|Overall Study|Protocol Violation|0|||
128936129|NCT00642616|464053964|FG001|Overall Study|Protocol Violation|0|||
128936130|NCT00642616|464053965|FG002|Overall Study|Protocol Violation|2|||
128936131|NCT00642616|464053966|FG003|Overall Study|Protocol Violation|0|||
128705691|NCT02207244|463217132|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
128936132|NCT00642616|464053963|FG000|Overall Study|Physician Decision|0|||
128936133|NCT00642616|464053964|FG001|Overall Study|Physician Decision|0|||
128936134|NCT00642616|464053965|FG002|Overall Study|Physician Decision|1|||
128936135|NCT00642616|464053966|FG003|Overall Study|Physician Decision|1|||
128936136|NCT00492921|464053967|FG000|Overall Study|Death|1|||
128936137|NCT00492921|464053968|FG001|Overall Study|Death|0|||
128936138|NCT00492921|464053969|FG002|Overall Study|Death|1|||
128936139|NCT00399802|464053970|FG000|Overall Study|Adverse Event|0|||
128936140|NCT00399802|464053971|FG001|Overall Study|Adverse Event|2|||
128936141|NCT00399802|464053970|FG000|Overall Study|Participant discontinued by mistake|0|||
128936142|NCT00399802|464053971|FG001|Overall Study|Participant discontinued by mistake|1|||
128936143|NCT00542815|464053972|FG000|Overall Study|Adverse Event|19|||
128936144|NCT00542815|464053973|FG001|Overall Study|Adverse Event|6|||
128936145|NCT00542815|464053974|FG002|Overall Study|Adverse Event|9|||
128936146|NCT00542815|464053972|FG000|Overall Study|Death|10|||
128936147|NCT00542815|464053973|FG001|Overall Study|Death|7|||
128936148|NCT00542815|464053974|FG002|Overall Study|Death|3|||
128936149|NCT00542815|464053972|FG000|Overall Study|Lack of Efficacy|9|||
128936150|NCT00542815|464053973|FG001|Overall Study|Lack of Efficacy|2|||
128936151|NCT00542815|464053974|FG002|Overall Study|Lack of Efficacy|0|||
128936152|NCT00542815|464053972|FG000|Overall Study|Physician Decision|2|||
129132924|NCT04996264|464778573|FG001|Overall Study|Lost to Follow-up|1|||
128705692|NCT02207244|463217133|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
128936153|NCT00542815|464053973|FG001|Overall Study|Physician Decision|1|||
128936154|NCT00542815|464053974|FG002|Overall Study|Physician Decision|0|||
128936155|NCT00542815|464053972|FG000|Overall Study|Protocol Violation|1|||
129132925|NCT04996264|464778572|FG000|Overall Study|Withdrawal by Subject|4|||
129132926|NCT04996264|464778573|FG001|Overall Study|Withdrawal by Subject|3|||
129132927|NCT04996264|464778572|FG000|Overall Study|1 left AMA|0|||
129132928|NCT04996264|464778573|FG001|Overall Study|1 left AMA|1|||
129132929|NCT04996264|464778572|FG000|Overall Study|Subject changed hospitals|0|||
129132930|NCT04996264|464778573|FG001|Overall Study|Subject changed hospitals|1|||
129132931|NCT04996264|464778572|FG000|Overall Study|unable to complete due to work|0|||
129132932|NCT04996264|464778573|FG001|Overall Study|unable to complete due to work|1|||
129132933|NCT04433975|464778574|FG000|1-month Follow Up|Withdrawal by Subject|1|||
129132934|NCT04433975|464778575|FG001|1-month Follow Up|Withdrawal by Subject|1|||
129132935|NCT04433975|464778574|FG000|1-month Follow Up|Lost to Follow-up|21|||
129132936|NCT04433975|464778575|FG001|1-month Follow Up|Lost to Follow-up|25|||
129132937|NCT04433975|464778574|FG000|3-month Follow Up|Lost to Follow-up|20|||
129132938|NCT04433975|464778575|FG001|3-month Follow Up|Lost to Follow-up|24|||
129132939|NCT04433975|464778574|FG000|3-month Follow Up|Death|1|||
129132940|NCT04433975|464778575|FG001|3-month Follow Up|Death|0|||
129132941|NCT04433975|464778574|FG000|3-month Follow Up|Withdrawal by Subject|2|||
129132942|NCT04433975|464778575|FG001|3-month Follow Up|Withdrawal by Subject|0|||
129132943|NCT04433975|464778574|FG000|6-month Follow Up|Lost to Follow-up|23|||
129132944|NCT04433975|464778575|FG001|6-month Follow Up|Lost to Follow-up|28|||
129132945|NCT04433975|464778574|FG000|6-month Follow Up|Withdrawal by Subject|1|||
129132946|NCT04433975|464778575|FG001|6-month Follow Up|Withdrawal by Subject|1|||
129132947|NCT04433975|464778574|FG000|9-month Follow Up|Lost to Follow-up|27|||
129132948|NCT04433975|464778575|FG001|9-month Follow Up|Lost to Follow-up|36|||
128936156|NCT00542815|464053973|FG001|Overall Study|Protocol Violation|1|||
128936157|NCT00542815|464053974|FG002|Overall Study|Protocol Violation|2|||
128936158|NCT00542815|464053972|FG000|Overall Study|Withdrawal by Subject|41|||
128936159|NCT00542815|464053973|FG001|Overall Study|Withdrawal by Subject|5|||
128936160|NCT00542815|464053974|FG002|Overall Study|Withdrawal by Subject|8|||
128936161|NCT00542815|464053972|FG000|Overall Study|Other reasons|24|||
128936162|NCT00542815|464053973|FG001|Overall Study|Other reasons|10|||
128936163|NCT00542815|464053974|FG002|Overall Study|Other reasons|10|||
128936164|NCT01632878|464053975|FG000|Screening|Physician Decision|268|||
128936165|NCT01632878|464053975|FG000|Treatment|Lost to Follow-up|41|||
128936166|NCT01632878|464053975|FG000|Treatment|Withdrawal by Subject|36|||
128936167|NCT01632878|464053975|FG000|Treatment|Physician Decision|34|||
128936168|NCT01632878|464053975|FG000|Treatment|missing information|4|||
128936169|NCT01632878|464053975|FG000|Treatment|no information on study completion|43|||
128936170|NCT00081289|464053976|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
128936171|NCT00081289|464053977|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
128936172|NCT00081289|464053976|FG000|Overall Study|Ineligible / no protocol treatment|3|||
128936173|NCT00081289|464053977|FG001|Overall Study|Ineligible / no protocol treatment|4|||
128936174|NCT01558089|464053978|FG000|Overall Study|Adverse Event|1|||
128936175|NCT01558089|464053978|FG000|Overall Study|Lack of Efficacy|1|||
128936176|NCT01558089|464053978|FG000|Overall Study|Lost to Follow-up|5|||
128936177|NCT01558089|464053978|FG000|Overall Study|Withdrawal by Subject|6|||
128936178|NCT00916721|464053979|FG000|Overall Study|Lost to Follow-up|0|||
128936179|NCT00916721|464053980|FG001|Overall Study|Lost to Follow-up|1|||
128936180|NCT00916721|464053979|FG000|Overall Study|Adverse Event|6|||
128936181|NCT00916721|464053980|FG001|Overall Study|Adverse Event|3|||
128936182|NCT00916721|464053979|FG000|Overall Study|Withdrawal by Subject|2|||
128936183|NCT00916721|464053980|FG001|Overall Study|Withdrawal by Subject|2|||
128936184|NCT00916721|464053979|FG000|Overall Study|Protocol Violation|2|||
128936185|NCT00916721|464053980|FG001|Overall Study|Protocol Violation|4|||
128936186|NCT02749370|464053981|FG000|Overall Study|Withdrawal by Subject|11|||
128936187|NCT02749370|464053981|FG000|Overall Study|Lost to Follow-up|3|||
128936188|NCT00227877|464053984|FG000|Pre-visit Assessment|Technical difficulties|7|||
128936189|NCT00227877|464053985|FG001|Pre-visit Assessment|Technical difficulties|3|||
129122399|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
129122400|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
129122401|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
129122402|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
129122403|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
129122404|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
129122405|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
129122406|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
129122407|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
129122408|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
129122409|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
129122410|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
129122411|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
129122412|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Depression|0|||
129122413|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Depression|1|||
129122414|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Depression|0|||
129122415|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
129122416|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
129122417|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
129122418|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Jailed|0|||
129122419|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Jailed|1|||
129122420|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Jailed|0|||
129122421|NCT00090103|464744033|FG000|16-Week Safety Follow-up Period|Other|0|||
129122422|NCT00090103|464744034|FG001|16-Week Safety Follow-up Period|Other|1|||
129122423|NCT00090103|464744035|FG002|16-Week Safety Follow-up Period|Other|0|||
129122424|NCT01799889|464744036|FG000|Overall Study|Adverse Event|4|||
129122425|NCT01799889|464744037|FG001|Overall Study|Adverse Event|4|||
129122426|NCT01799889|464744038|FG002|Overall Study|Adverse Event|5|||
129122427|NCT01799889|464744039|FG003|Overall Study|Adverse Event|1|||
129122428|NCT01799889|464744040|FG004|Overall Study|Adverse Event|11|||
129122429|NCT01799889|464744041|FG005|Overall Study|Adverse Event|1|||
129122430|NCT01799889|464744042|FG006|Overall Study|Adverse Event|5|||
129122431|NCT01799889|464744043|FG007|Overall Study|Adverse Event|2|||
129122432|NCT01799889|464744044|FG008|Overall Study|Adverse Event|3|||
129122433|NCT01799889|464744045|FG009|Overall Study|Adverse Event|1|||
129122434|NCT01799889|464744046|FG010|Overall Study|Adverse Event|1|||
129122435|NCT01799889|464744047|FG011|Overall Study|Adverse Event|0|||
129122436|NCT01799889|464744036|FG000|Overall Study|Death|1|||
129122437|NCT01799889|464744037|FG001|Overall Study|Death|0|||
129122438|NCT01799889|464744038|FG002|Overall Study|Death|5|||
128936190|NCT00227877|464053986|FG002|Pre-visit Assessment|Technical difficulties|0|||
128705693|NCT02207244|463217134|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
128705694|NCT02207244|463217124|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705695|NCT02207244|463217125|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705696|NCT02207244|463217126|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705697|NCT02207244|463217127|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705698|NCT02207244|463217128|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705699|NCT02207244|463217129|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128936191|NCT00227877|464053987|FG003|Pre-visit Assessment|Technical difficulties|0|||
128936192|NCT00227877|464053984|FG000|Post-visit Checklist|Lost to Follow-up|24|||
128936193|NCT00227877|464053985|FG001|Post-visit Checklist|Lost to Follow-up|13|||
128936194|NCT00227877|464053986|FG002|Post-visit Checklist|Lost to Follow-up|1|||
128936195|NCT00227877|464053987|FG003|Post-visit Checklist|Lost to Follow-up|0|||
128936196|NCT00227877|464053984|FG000|3-months Follow-up|Completed late|135|||
128936197|NCT00227877|464053985|FG001|3-months Follow-up|Completed late|128|||
128936198|NCT00227877|464053986|FG002|3-months Follow-up|Completed late|34|||
128936199|NCT00227877|464053987|FG003|3-months Follow-up|Completed late|8|||
129031250|NCT02004691|464404814|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
129031251|NCT02004691|464404813|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
129031252|NCT02004691|464404814|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
129031253|NCT02004691|464404813|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
129031254|NCT02004691|464404814|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
129031255|NCT02004691|464404813|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
129031256|NCT02004691|464404814|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
129031257|NCT00021541|464404815|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
129031258|NCT00021541|464404816|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
129031259|NCT00021541|464404815|FG000|Period 1-First Treatment|Adverse Event|2|||
129031260|NCT00021541|464404816|FG001|Period 1-First Treatment|Adverse Event|1|||
129031261|NCT00021541|464404815|FG000|Period 1-First Treatment|non-adherence|3|||
129031262|NCT00021541|464404816|FG001|Period 1-First Treatment|non-adherence|0|||
129031263|NCT00021541|464404815|FG000|Period 1-First Treatment|Death|1|||
129031264|NCT00021541|464404816|FG001|Period 1-First Treatment|Death|0|||
129031265|NCT00021541|464404815|FG000|Period 1-First Treatment|Pts that did not progress|2|||
129031266|NCT00021541|464404816|FG001|Period 1-First Treatment|Pts that did not progress|2|||
129031267|NCT00021541|464404815|FG000|Period 1-First Treatment|Ineligible|0|||
129031268|NCT00021541|464404816|FG001|Period 1-First Treatment|Ineligible|2|||
129031269|NCT00021541|464404815|FG000|Period 2-crossover|refused phase B|2|||
129031270|NCT00021541|464404816|FG001|Period 2-crossover|refused phase B|2|||
129031271|NCT00021541|464404815|FG000|Period 2-crossover|Withdrawal by Subject|3|||
129031272|NCT00021541|464404816|FG001|Period 2-crossover|Withdrawal by Subject|4|||
129031273|NCT00021541|464404815|FG000|Period 2-crossover|Adverse Event|2|||
129031274|NCT00021541|464404816|FG001|Period 2-crossover|Adverse Event|2|||
129031275|NCT00021541|464404815|FG000|Period 2-crossover|non-adherence|1|||
129031276|NCT00021541|464404816|FG001|Period 2-crossover|non-adherence|0|||
129031277|NCT00021541|464404815|FG000|Period 2-crossover|Pts that did not progress|2|||
129031278|NCT00021541|464404816|FG001|Period 2-crossover|Pts that did not progress|3|||
129031279|NCT01547728|464404817|FG000|Overall Study|Change in procedure and equipment|1|||
129031280|NCT01547728|464404817|FG000|Overall Study|Drug not ready for subject|1|||
129031281|NCT01547728|464404817|FG000|Overall Study|Screen failure|39|||
129031282|NCT03828539|464404818|FG000|Overall Study|Adverse Event|3|||
129031283|NCT03828539|464404819|FG001|Overall Study|Adverse Event|12|||
129031284|NCT03828539|464404818|FG000|Overall Study|Patient's/guardian's decision|3|||
129031285|NCT03828539|464404819|FG001|Overall Study|Patient's/guardian's decision|5|||
129031286|NCT03828539|464404818|FG000|Overall Study|Lost to Follow-up|4|||
129031287|NCT03828539|464404819|FG001|Overall Study|Lost to Follow-up|2|||
129031288|NCT03828539|464404818|FG000|Overall Study|Protocol Violation|3|||
129031289|NCT03828539|464404819|FG001|Overall Study|Protocol Violation|2|||
129031290|NCT03828539|464404818|FG000|Overall Study|Withdrawal of informed consent|2|||
129031291|NCT03828539|464404819|FG001|Overall Study|Withdrawal of informed consent|1|||
129031292|NCT03828539|464404818|FG000|Overall Study|New therapy for study indication|1|||
129031293|NCT03828539|464404819|FG001|Overall Study|New therapy for study indication|0|||
129031294|NCT01341405|464404820|FG000|Overall Study|Adverse Event|0|||
129031295|NCT01341405|464404821|FG001|Overall Study|Adverse Event|1|||
129031296|NCT01341405|464404822|FG002|Overall Study|Adverse Event|1|||
129031297|NCT01341405|464404820|FG000|Overall Study|Withdrawal by Subject|3|||
129031298|NCT01341405|464404821|FG001|Overall Study|Withdrawal by Subject|2|||
129031299|NCT01341405|464404822|FG002|Overall Study|Withdrawal by Subject|1|||
129122439|NCT01799889|464744039|FG003|Overall Study|Death|3|||
129122440|NCT01799889|464744040|FG004|Overall Study|Death|1|||
129122441|NCT01799889|464744041|FG005|Overall Study|Death|0|||
129122442|NCT01799889|464744042|FG006|Overall Study|Death|0|||
129122443|NCT01799889|464744043|FG007|Overall Study|Death|0|||
129122444|NCT01799889|464744044|FG008|Overall Study|Death|1|||
129122445|NCT01799889|464744045|FG009|Overall Study|Death|0|||
129122446|NCT01799889|464744046|FG010|Overall Study|Death|1|||
129122447|NCT01799889|464744047|FG011|Overall Study|Death|0|||
128936200|NCT00227877|464053984|FG000|3-months Follow-up|Lost to Follow-up|178|||
128936201|NCT00227877|464053985|FG001|3-months Follow-up|Lost to Follow-up|139|||
128936202|NCT00227877|464053986|FG002|3-months Follow-up|Lost to Follow-up|18|||
128936203|NCT00227877|464053987|FG003|3-months Follow-up|Lost to Follow-up|13|||
128936204|NCT00227877|464053984|FG000|12-months Follow-up|Completed late|78|||
128936205|NCT00227877|464053985|FG001|12-months Follow-up|Completed late|74|||
128936206|NCT00227877|464053986|FG002|12-months Follow-up|Completed late|1|||
128936207|NCT00227877|464053987|FG003|12-months Follow-up|Completed late|0|||
128936208|NCT00227877|464053984|FG000|12-months Follow-up|Lost to Follow-up|232|||
128936209|NCT00227877|464053985|FG001|12-months Follow-up|Lost to Follow-up|189|||
128936210|NCT00227877|464053986|FG002|12-months Follow-up|Lost to Follow-up|30|||
128936211|NCT00227877|464053987|FG003|12-months Follow-up|Lost to Follow-up|26|||
128936212|NCT02522481|464053989|FG000|Overall Study|discontinued|1|||
128936213|NCT02522481|464053989|FG000|Overall Study|Not dosed|2|||
128936214|NCT00404768|464053992|FG000|Part A and B|Withdrawn due to labor progression|1|||
128936215|NCT00404768|464053993|FG001|Part A and B|Withdrawn due to labor progression|0|||
128936216|NCT00404768|464053994|FG002|Part A and B|Withdrawn due to labor progression|0|||
128936217|NCT00404768|464053995|FG003|Part A and B|Withdrawn due to labor progression|0|||
128936218|NCT00404768|464053992|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
128936219|NCT00404768|464053993|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
128936220|NCT00404768|464053994|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
128936221|NCT00404768|464053995|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
128936222|NCT00404768|464053992|FG000|Part C|Adverse Event|0|||
128936223|NCT00404768|464053993|FG001|Part C|Adverse Event|0|||
128936224|NCT00404768|464053994|FG002|Part C|Adverse Event|0|||
128936225|NCT00404768|464053995|FG003|Part C|Adverse Event|3|||
128936226|NCT00404768|464053992|FG000|Part C|Lost to Follow-up|0|||
128936227|NCT00404768|464053993|FG001|Part C|Lost to Follow-up|0|||
128936228|NCT00404768|464053994|FG002|Part C|Lost to Follow-up|3|||
128936229|NCT00404768|464053995|FG003|Part C|Lost to Follow-up|1|||
128936230|NCT00404768|464053992|FG000|Part C|Withdrawal by Subject|0|||
128936231|NCT00404768|464053993|FG001|Part C|Withdrawal by Subject|0|||
128936232|NCT00404768|464053994|FG002|Part C|Withdrawal by Subject|2|||
128936233|NCT00404768|464053995|FG003|Part C|Withdrawal by Subject|1|||
128936234|NCT00404768|464053992|FG000|Part C|Early withdrawal from study medication|0|||
128936235|NCT00404768|464053993|FG001|Part C|Early withdrawal from study medication|0|||
128936236|NCT00404768|464053994|FG002|Part C|Early withdrawal from study medication|1|||
128936237|NCT00404768|464053995|FG003|Part C|Early withdrawal from study medication|0|||
128936238|NCT00404768|464053992|FG000|Part C|Participant did not respond to therapy|0|||
128936239|NCT00404768|464053993|FG001|Part C|Participant did not respond to therapy|0|||
128936240|NCT00404768|464053994|FG002|Part C|Participant did not respond to therapy|1|||
128936241|NCT00404768|464053995|FG003|Part C|Participant did not respond to therapy|1|||
128936242|NCT00404768|464053992|FG000|Part C|Physician withdrew the study medication|0|||
129122448|NCT01799889|464744036|FG000|Overall Study|Lack of Efficacy|1|||
129122449|NCT01799889|464744037|FG001|Overall Study|Lack of Efficacy|1|||
129122450|NCT01799889|464744038|FG002|Overall Study|Lack of Efficacy|0|||
129122451|NCT01799889|464744039|FG003|Overall Study|Lack of Efficacy|1|||
129122452|NCT01799889|464744040|FG004|Overall Study|Lack of Efficacy|2|||
129122453|NCT01799889|464744041|FG005|Overall Study|Lack of Efficacy|2|||
129122454|NCT01799889|464744042|FG006|Overall Study|Lack of Efficacy|0|||
129122455|NCT01799889|464744043|FG007|Overall Study|Lack of Efficacy|0|||
129122456|NCT01799889|464744044|FG008|Overall Study|Lack of Efficacy|2|||
129122457|NCT01799889|464744045|FG009|Overall Study|Lack of Efficacy|0|||
129122458|NCT01799889|464744046|FG010|Overall Study|Lack of Efficacy|1|||
129122459|NCT01799889|464744047|FG011|Overall Study|Lack of Efficacy|0|||
129122460|NCT01799889|464744036|FG000|Overall Study|Lost to Follow-up|0|||
129122461|NCT01799889|464744037|FG001|Overall Study|Lost to Follow-up|1|||
129122462|NCT01799889|464744038|FG002|Overall Study|Lost to Follow-up|0|||
128705700|NCT02207244|463217130|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705701|NCT02207244|463217131|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705702|NCT02207244|463217132|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
128936243|NCT00404768|464053993|FG001|Part C|Physician withdrew the study medication|0|||
128936244|NCT00404768|464053994|FG002|Part C|Physician withdrew the study medication|1|||
128936245|NCT00404768|464053995|FG003|Part C|Physician withdrew the study medication|0|||
128936246|NCT00404768|464053992|FG000|Part C|Participant delivered baby|0|||
128936247|NCT00404768|464053993|FG001|Part C|Participant delivered baby|0|||
128936248|NCT00404768|464053994|FG002|Part C|Participant delivered baby|0|||
128936249|NCT00404768|464053995|FG003|Part C|Participant delivered baby|1|||
129122463|NCT01799889|464744039|FG003|Overall Study|Lost to Follow-up|0|||
129122464|NCT01799889|464744040|FG004|Overall Study|Lost to Follow-up|0|||
128936250|NCT00404768|464053992|FG000|Part C|Unsatisfactory uterine response to IP|0|||
128936251|NCT00404768|464053993|FG001|Part C|Unsatisfactory uterine response to IP|0|||
129122465|NCT01799889|464744041|FG005|Overall Study|Lost to Follow-up|0|||
129122466|NCT01799889|464744042|FG006|Overall Study|Lost to Follow-up|0|||
129122467|NCT01799889|464744043|FG007|Overall Study|Lost to Follow-up|0|||
129122468|NCT01799889|464744044|FG008|Overall Study|Lost to Follow-up|0|||
128936252|NCT00404768|464053994|FG002|Part C|Unsatisfactory uterine response to IP|0|||
128936253|NCT00404768|464053995|FG003|Part C|Unsatisfactory uterine response to IP|1|||
128936254|NCT00404768|464053992|FG000|Part C|Active labor|0|||
128936255|NCT00404768|464053993|FG001|Part C|Active labor|0|||
128936256|NCT00404768|464053994|FG002|Part C|Active labor|0|||
128936257|NCT00404768|464053995|FG003|Part C|Active labor|1|||
128936258|NCT00404768|464053992|FG000|Part C|Lack of Efficacy|0|||
128936259|NCT00404768|464053993|FG001|Part C|Lack of Efficacy|0|||
128936260|NCT00404768|464053994|FG002|Part C|Lack of Efficacy|0|||
128936261|NCT00404768|464053995|FG003|Part C|Lack of Efficacy|2|||
128936262|NCT00404768|464053992|FG000|Part C|Treatment failure|0|||
128936263|NCT00404768|464053993|FG001|Part C|Treatment failure|0|||
128936264|NCT00404768|464053994|FG002|Part C|Treatment failure|0|||
128936265|NCT00404768|464053995|FG003|Part C|Treatment failure|1|||
128936266|NCT00404768|464053992|FG000|Part C|Investigator discretion|0|||
128936267|NCT00404768|464053993|FG001|Part C|Investigator discretion|0|||
128936268|NCT00404768|464053994|FG002|Part C|Investigator discretion|0|||
128936269|NCT00404768|464053995|FG003|Part C|Investigator discretion|1|||
128936270|NCT00404768|464053992|FG000|Part C|Researcher suspended study medication|0|||
128936271|NCT00404768|464053993|FG001|Part C|Researcher suspended study medication|0|||
128936272|NCT00404768|464053994|FG002|Part C|Researcher suspended study medication|0|||
128936273|NCT00404768|464053995|FG003|Part C|Researcher suspended study medication|1|||
128936274|NCT03123939|464053996|FG000|Overall Study|Lack of Efficacy|6|||
128936275|NCT03123939|464053996|FG000|Overall Study|Death|5|||
128936276|NCT03123939|464053996|FG000|Overall Study|Physician Decision|2|||
128936277|NCT03123939|464053996|FG000|Overall Study|Subject/guardian decision|2|||
128936278|NCT03123939|464053996|FG000|Overall Study|Lost to Follow-up|1|||
128936279|NCT03123939|464053996|FG000|Overall Study|New therapy for study indication|1|||
128936280|NCT03123939|464053996|FG000|Overall Study|Protocol deviation|1|||
128936281|NCT03123939|464053996|FG000|Overall Study|Progressive disease|18|||
128936282|NCT03123939|464053996|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
128936283|NCT03123939|464053996|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
128936284|NCT01118143|464053997|FG000|Overall Study|Withdrawal by Subject|2|||
128936285|NCT01118143|464053998|FG001|Overall Study|Withdrawal by Subject|5|||
128936286|NCT02112448|464053999|FG000|Overall Study|lab values precluding use of ketorolac|2|||
128936287|NCT02112448|464054000|FG001|Overall Study|lab values precluding use of ketorolac|2|||
128936288|NCT02112448|464053999|FG000|Overall Study|Protocol Violation|1|||
128936289|NCT02112448|464054000|FG001|Overall Study|Protocol Violation|2|||
128936290|NCT02112448|464053999|FG000|Overall Study|Physician Decision|4|||
128936291|NCT02112448|464054000|FG001|Overall Study|Physician Decision|6|||
128936292|NCT02112448|464053999|FG000|Overall Study|required heparin so could not use ketoro|1|||
128936293|NCT02112448|464054000|FG001|Overall Study|required heparin so could not use ketoro|0|||
128936294|NCT05094154|464055396|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
128936295|NCT05094154|464055397|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
128936296|NCT05094154|464055396|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
128936297|NCT05094154|464055397|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
128936298|NCT01937130|464055398|FG000|Overall Study|Withdrawal by Subject|0|||
128936299|NCT01937130|464055399|FG001|Overall Study|Withdrawal by Subject|0|||
128936300|NCT01937130|464055400|FG002|Overall Study|Withdrawal by Subject|0|||
128936301|NCT01937130|464055401|FG003|Overall Study|Withdrawal by Subject|1|||
128936302|NCT01937130|464055398|FG000|Overall Study|Adverse Event|0|||
128936303|NCT01937130|464055399|FG001|Overall Study|Adverse Event|1|||
128936304|NCT01937130|464055400|FG002|Overall Study|Adverse Event|0|||
128936305|NCT01937130|464055401|FG003|Overall Study|Adverse Event|1|||
128936306|NCT01937130|464055398|FG000|Overall Study|Death|1|||
128936307|NCT01937130|464055399|FG001|Overall Study|Death|1|||
128936308|NCT01937130|464055400|FG002|Overall Study|Death|1|||
129122469|NCT01799889|464744045|FG009|Overall Study|Lost to Follow-up|0|||
128768333|NCT01351025|463442109|FG000|Week 24 - 44|Lost to Follow-up|0|||
128768334|NCT01351025|463442110|FG001|Week 24 - 44|Lost to Follow-up|2|||
128768335|NCT01351025|463442109|FG000|Week 24 - 44|Site closed|0|||
128936309|NCT01937130|464055401|FG003|Overall Study|Death|0|||
128936310|NCT01937130|464055398|FG000|Overall Study|Lost to Follow-up|2|||
128936311|NCT01937130|464055399|FG001|Overall Study|Lost to Follow-up|0|||
128936312|NCT01937130|464055400|FG002|Overall Study|Lost to Follow-up|2|||
128936313|NCT01937130|464055401|FG003|Overall Study|Lost to Follow-up|0|||
128936314|NCT01937130|464055398|FG000|Overall Study|Physician Decision|0|||
128936315|NCT01937130|464055399|FG001|Overall Study|Physician Decision|1|||
128936316|NCT01937130|464055400|FG002|Overall Study|Physician Decision|0|||
129122470|NCT01799889|464744046|FG010|Overall Study|Lost to Follow-up|0|||
129122471|NCT01799889|464744047|FG011|Overall Study|Lost to Follow-up|0|||
128768336|NCT01351025|463442110|FG001|Week 24 - 44|Site closed|1|||
128936317|NCT01937130|464055401|FG003|Overall Study|Physician Decision|0|||
128936318|NCT01937130|464055398|FG000|Overall Study|Patients unable to swallow|0|||
128936319|NCT01937130|464055399|FG001|Overall Study|Patients unable to swallow|1|||
128936320|NCT01937130|464055400|FG002|Overall Study|Patients unable to swallow|0|||
128936321|NCT01937130|464055401|FG003|Overall Study|Patients unable to swallow|0|||
128936322|NCT01937130|464055398|FG000|Overall Study|Patient lost to FU due to death|2|||
128936323|NCT01937130|464055399|FG001|Overall Study|Patient lost to FU due to death|0|||
128936324|NCT01937130|464055400|FG002|Overall Study|Patient lost to FU due to death|0|||
128936325|NCT01937130|464055401|FG003|Overall Study|Patient lost to FU due to death|0|||
128936326|NCT02100657|464055402|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
128936327|NCT02100657|464055403|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
128936328|NCT02100657|464055404|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
128936329|NCT02100657|464055402|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
128936330|NCT02100657|464055403|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
128936331|NCT02100657|464055404|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
128936332|NCT02100657|464055402|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
128936333|NCT02100657|464055403|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
128936334|NCT02100657|464055404|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
128936335|NCT02100657|464055402|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
128936336|NCT02100657|464055403|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
128936337|NCT02100657|464055404|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
128936338|NCT02100657|464055402|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
128768337|NCT01351025|463442109|FG000|Week 24 - 44|unable to get to clinic|1|||
128768338|NCT01351025|463442110|FG001|Week 24 - 44|unable to get to clinic|1|||
128768339|NCT02569710|463442115|FG000|Overall Study|Adverse Event|1|||
128768340|NCT02569710|463442116|FG001|Overall Study|Adverse Event|0|||
128768341|NCT02569710|463442117|FG002|Overall Study|Adverse Event|0|||
128768342|NCT02569710|463442118|FG003|Overall Study|Adverse Event|0|||
128936339|NCT02100657|464055403|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
128936340|NCT02100657|464055404|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
128936341|NCT02100657|464055402|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
128936342|NCT02100657|464055403|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
128936343|NCT02100657|464055404|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
128936344|NCT02100657|464055402|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
128936345|NCT02100657|464055403|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
128936346|NCT02100657|464055404|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
128936347|NCT02100657|464055402|FG000|Cohort 3: Dose Level 3|Death|0|||
128936348|NCT02100657|464055403|FG001|Cohort 3: Dose Level 3|Death|0|||
128936349|NCT02100657|464055404|FG002|Cohort 3: Dose Level 3|Death|1|||
128936350|NCT02100657|464055402|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
128936351|NCT02100657|464055403|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
128936352|NCT02100657|464055404|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
128936353|NCT02100657|464055402|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
128936354|NCT02100657|464055403|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
128936355|NCT02100657|464055404|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
128936356|NCT02100657|464055402|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
128936357|NCT02100657|464055403|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
128936358|NCT02100657|464055404|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
128936359|NCT02100657|464055402|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
128936360|NCT02100657|464055403|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
128936361|NCT02100657|464055404|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
128936362|NCT02100657|464055402|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
128936363|NCT02100657|464055403|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
128936364|NCT02100657|464055404|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
128936365|NCT02115815|464055406|FG000|Overall Study|Withdrawal by Subject|2|||
128936366|NCT02115815|464055407|FG001|Overall Study|Withdrawal by Subject|0|||
128936367|NCT02115815|464055408|FG002|Overall Study|Withdrawal by Subject|0|||
128936368|NCT02115815|464055409|FG003|Overall Study|Withdrawal by Subject|0|||
128936369|NCT02115815|464055410|FG004|Overall Study|Withdrawal by Subject|0|||
128936370|NCT02115815|464055411|FG005|Overall Study|Withdrawal by Subject|0|||
128936371|NCT02115815|464055412|FG006|Overall Study|Withdrawal by Subject|0|||
128936372|NCT02115815|464055406|FG000|Overall Study|Not enough drug to dose participant|0|||
128936373|NCT02115815|464055407|FG001|Overall Study|Not enough drug to dose participant|0|||
128936374|NCT02115815|464055408|FG002|Overall Study|Not enough drug to dose participant|0|||
128936375|NCT02115815|464055409|FG003|Overall Study|Not enough drug to dose participant|0|||
128936376|NCT02115815|464055410|FG004|Overall Study|Not enough drug to dose participant|0|||
128936377|NCT02115815|464055411|FG005|Overall Study|Not enough drug to dose participant|1|||
128936378|NCT02115815|464055412|FG006|Overall Study|Not enough drug to dose participant|0|||
128936379|NCT02115815|464055406|FG000|Overall Study|Missed appointment, randomized in error|0|||
128936380|NCT02115815|464055407|FG001|Overall Study|Missed appointment, randomized in error|0|||
128936381|NCT02115815|464055408|FG002|Overall Study|Missed appointment, randomized in error|0|||
128936382|NCT02115815|464055409|FG003|Overall Study|Missed appointment, randomized in error|0|||
128936383|NCT02115815|464055410|FG004|Overall Study|Missed appointment, randomized in error|0|||
128768343|NCT02569710|463442119|FG004|Overall Study|Adverse Event|0|||
128768344|NCT02569710|463442120|FG005|Overall Study|Adverse Event|0|||
128768345|NCT02569710|463442121|FG006|Overall Study|Adverse Event|0|||
128936384|NCT02115815|464055411|FG005|Overall Study|Missed appointment, randomized in error|1|||
128936385|NCT02115815|464055412|FG006|Overall Study|Missed appointment, randomized in error|0|||
128936386|NCT01228071|464055413|FG000|Overall Study|Protocol Violation|1|||
128936387|NCT01228071|464055413|FG000|Overall Study|Withdrawal by Subject|1|||
128936388|NCT03314519|464055414|FG000|Overall Study|Protocol Violation|3|||
128936389|NCT03314519|464055415|FG001|Overall Study|Protocol Violation|2|||
128936390|NCT04003155|464055416|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
128936391|NCT04003155|464055417|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
128936392|NCT04003155|464055418|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
128936393|NCT04003155|464055419|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
128936394|NCT04003155|464055420|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
128936395|NCT04003155|464055416|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
128936396|NCT04003155|464055417|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
128936397|NCT04003155|464055418|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
128936398|NCT04003155|464055419|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
128936399|NCT04003155|464055420|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
128936400|NCT04003155|464055416|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
128936401|NCT04003155|464055417|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
128936402|NCT04003155|464055418|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
128936403|NCT04003155|464055419|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
128936404|NCT04003155|464055420|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
128936405|NCT04003155|464055416|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
128936406|NCT04003155|464055417|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
128936407|NCT04003155|464055418|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
128936408|NCT04003155|464055419|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
128936409|NCT04003155|464055420|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
128936410|NCT04003155|464055416|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
128936411|NCT04003155|464055417|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
128936412|NCT04003155|464055418|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
128936413|NCT04003155|464055419|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
128936414|NCT04003155|464055420|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
128936415|NCT04003155|464055416|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
128936416|NCT04003155|464055417|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
128936417|NCT04003155|464055418|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
128936418|NCT04003155|464055419|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
128936419|NCT04003155|464055420|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
128936420|NCT04003155|464055416|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
128936421|NCT04003155|464055417|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
128936422|NCT04003155|464055418|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
128936423|NCT04003155|464055419|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
128936424|NCT04003155|464055420|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
128936425|NCT04003155|464055416|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
128936426|NCT04003155|464055417|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
128936427|NCT04003155|464055418|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
128936428|NCT04003155|464055419|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
128936429|NCT04003155|464055420|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
128936430|NCT04003155|464055416|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
128936431|NCT04003155|464055417|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
128936432|NCT04003155|464055418|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
128936433|NCT04003155|464055419|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
128936434|NCT04003155|464055420|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
128936435|NCT01912872|464055421|FG000|Overall Study|Lost to Follow-up|2|||
128936436|NCT01912872|464055422|FG001|Overall Study|Lost to Follow-up|3|||
128936437|NCT01912872|464055423|FG002|Overall Study|Lost to Follow-up|5|||
128936438|NCT01912872|464055424|FG003|Overall Study|Lost to Follow-up|5|||
128936439|NCT01912872|464055421|FG000|Overall Study|Other unspecified|3|||
128936440|NCT01912872|464055422|FG001|Overall Study|Other unspecified|1|||
128936441|NCT01912872|464055423|FG002|Overall Study|Other unspecified|3|||
128705703|NCT02207244|463217133|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
128705704|NCT02207244|463217134|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
128705705|NCT02207244|463217124|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705706|NCT02207244|463217125|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705707|NCT02207244|463217126|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705708|NCT02207244|463217127|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705709|NCT02207244|463217128|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705710|NCT02207244|463217129|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128936442|NCT01912872|464055424|FG003|Overall Study|Other unspecified|0|||
128936443|NCT01912872|464055421|FG000|Overall Study|Informed consent withdrawn|0|||
128936444|NCT01912872|464055422|FG001|Overall Study|Informed consent withdrawn|0|||
128936445|NCT01912872|464055423|FG002|Overall Study|Informed consent withdrawn|1|||
128936446|NCT01912872|464055424|FG003|Overall Study|Informed consent withdrawn|1|||
128936447|NCT01912872|464055421|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
128936448|NCT01912872|464055422|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
128936449|NCT01912872|464055423|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
128936450|NCT01912872|464055424|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
128936451|NCT01912872|464055421|FG000|Overall Study|Protocol Violation|0|||
128936452|NCT01912872|464055422|FG001|Overall Study|Protocol Violation|0|||
128936453|NCT01912872|464055423|FG002|Overall Study|Protocol Violation|1|||
128936454|NCT01912872|464055424|FG003|Overall Study|Protocol Violation|0|||
128936455|NCT01912872|464055421|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128936456|NCT01912872|464055422|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128936457|NCT01912872|464055423|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
128936458|NCT01912872|464055424|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
128936459|NCT01912872|464055421|FG000|Overall Study|Withdrawal of study medication|0|||
128936460|NCT01912872|464055422|FG001|Overall Study|Withdrawal of study medication|0|||
128936461|NCT01912872|464055423|FG002|Overall Study|Withdrawal of study medication|0|||
128936462|NCT01912872|464055424|FG003|Overall Study|Withdrawal of study medication|2|||
128936463|NCT01912872|464055421|FG000|Overall Study|Missing|0|||
128936464|NCT01912872|464055422|FG001|Overall Study|Missing|0|||
128936465|NCT01912872|464055423|FG002|Overall Study|Missing|0|||
128936466|NCT01912872|464055424|FG003|Overall Study|Missing|1|||
128936467|NCT02778867|464055425|FG000|Phase 1|Withdrawal by Subject|2|||
128936468|NCT02778867|464055426|FG001|Phase 1|Withdrawal by Subject|3|||
128936469|NCT02778867|464055427|FG002|Phase 1|Withdrawal by Subject|0|||
128936470|NCT02778867|464055428|FG003|Phase 1|Withdrawal by Subject|0|||
128936471|NCT02778867|464055425|FG000|Phase 2|Withdrawal by Subject|0|||
128936472|NCT02778867|464055426|FG001|Phase 2|Withdrawal by Subject|0|||
128936473|NCT02778867|464055427|FG002|Phase 2|Withdrawal by Subject|1|||
128936474|NCT02778867|464055428|FG003|Phase 2|Withdrawal by Subject|0|||
128936475|NCT02778867|464055425|FG000|Phase 2|Physician Decision|0|||
128936476|NCT02778867|464055426|FG001|Phase 2|Physician Decision|0|||
128936477|NCT02778867|464055427|FG002|Phase 2|Physician Decision|0|||
128936478|NCT02778867|464055428|FG003|Phase 2|Physician Decision|1|||
128936479|NCT02778867|464055425|FG000|Phase 2|Adverse Event|0|||
128936480|NCT02778867|464055426|FG001|Phase 2|Adverse Event|0|||
128936481|NCT02778867|464055427|FG002|Phase 2|Adverse Event|0|||
128936482|NCT02778867|464055428|FG003|Phase 2|Adverse Event|1|||
128936483|NCT02546856|464055434|FG000|4 Months Evaluation|Death|2|||
128936484|NCT02546856|464055435|FG001|4 Months Evaluation|Death|3|||
128936485|NCT02546856|464055434|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
128936486|NCT02546856|464055435|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
128936487|NCT02546856|464055434|FG000|4 Months Evaluation|Lost to Follow-up|3|||
128936488|NCT02546856|464055435|FG001|4 Months Evaluation|Lost to Follow-up|3|||
128936489|NCT02546856|464055434|FG000|4 Months Evaluation|Physician Decision|3|||
128936490|NCT02546856|464055435|FG001|4 Months Evaluation|Physician Decision|0|||
128936491|NCT02546856|464055434|FG000|4 Months Evaluation|Working or living abroad|5|||
128936492|NCT02546856|464055435|FG001|4 Months Evaluation|Working or living abroad|1|||
128936493|NCT02546856|464055434|FG000|4 Months Evaluation|reasons not due to titration|4|||
128936494|NCT02546856|464055435|FG001|4 Months Evaluation|reasons not due to titration|1|||
128936495|NCT02546856|464055434|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
128936496|NCT02546856|464055435|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
128936497|NCT02546856|464055434|FG000|6 Months Evaluation|Death|1|||
128936498|NCT02546856|464055435|FG001|6 Months Evaluation|Death|1|||
128936499|NCT02546856|464055434|FG000|6 Months Evaluation|Lost to Follow-up|1|||
128936500|NCT02546856|464055435|FG001|6 Months Evaluation|Lost to Follow-up|1|||
128936501|NCT02546856|464055434|FG000|6 Months Evaluation|Working or living abroad|6|||
128936502|NCT02546856|464055435|FG001|6 Months Evaluation|Working or living abroad|4|||
128936503|NCT02546856|464055434|FG000|6 Months Evaluation|reasons not due to titration|0|||
128936504|NCT02546856|464055435|FG001|6 Months Evaluation|reasons not due to titration|1|||
129031300|NCT00826241|464404823|FG000|Overall Study|Withdrawal from Follow-up|1|||
129031301|NCT00826241|464404823|FG000|Overall Study|Withdrew consent|2|||
128936505|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
128936506|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
128936507|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
128936508|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128936509|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128936510|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128936511|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128936512|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
128936513|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
128936514|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
129031302|NCT00826241|464404823|FG000|Overall Study|Death|4|||
128936515|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
129122472|NCT01799889|464744036|FG000|Overall Study|Physician Decision|3|||
128768346|NCT02569710|463442122|FG007|Overall Study|Adverse Event|0|||
128768347|NCT02569710|463442123|FG008|Overall Study|Adverse Event|0|||
128768348|NCT02569710|463442124|FG009|Overall Study|Adverse Event|0|||
128768349|NCT02569710|463442115|FG000|Overall Study|Lost to Follow-up|0|||
128768350|NCT02569710|463442116|FG001|Overall Study|Lost to Follow-up|0|||
128768351|NCT02569710|463442117|FG002|Overall Study|Lost to Follow-up|0|||
128768352|NCT02569710|463442118|FG003|Overall Study|Lost to Follow-up|0|||
128768353|NCT02569710|463442119|FG004|Overall Study|Lost to Follow-up|0|||
128768354|NCT02569710|463442120|FG005|Overall Study|Lost to Follow-up|0|||
128768355|NCT02569710|463442121|FG006|Overall Study|Lost to Follow-up|1|||
128768356|NCT02569710|463442122|FG007|Overall Study|Lost to Follow-up|0|||
128768357|NCT02569710|463442123|FG008|Overall Study|Lost to Follow-up|1|||
128768358|NCT02569710|463442124|FG009|Overall Study|Lost to Follow-up|0|||
128768359|NCT02569710|463442115|FG000|Overall Study|Virologic failure|0|||
128768360|NCT02569710|463442116|FG001|Overall Study|Virologic failure|0|||
128768361|NCT02569710|463442117|FG002|Overall Study|Virologic failure|0|||
128768362|NCT02569710|463442118|FG003|Overall Study|Virologic failure|0|||
128768363|NCT02569710|463442119|FG004|Overall Study|Virologic failure|1|||
128768364|NCT02569710|463442120|FG005|Overall Study|Virologic failure|0|||
128768365|NCT02569710|463442121|FG006|Overall Study|Virologic failure|1|||
128768366|NCT02569710|463442122|FG007|Overall Study|Virologic failure|0|||
128768367|NCT02569710|463442123|FG008|Overall Study|Virologic failure|0|||
128768368|NCT02569710|463442124|FG009|Overall Study|Virologic failure|0|||
128768369|NCT02569710|463442115|FG000|Overall Study|Withdrawal by Subject|0|||
128768370|NCT02569710|463442116|FG001|Overall Study|Withdrawal by Subject|0|||
128768371|NCT02569710|463442117|FG002|Overall Study|Withdrawal by Subject|0|||
128768372|NCT02569710|463442118|FG003|Overall Study|Withdrawal by Subject|0|||
128768373|NCT02569710|463442119|FG004|Overall Study|Withdrawal by Subject|0|||
128768374|NCT02569710|463442120|FG005|Overall Study|Withdrawal by Subject|1|||
128768375|NCT02569710|463442121|FG006|Overall Study|Withdrawal by Subject|0|||
128768376|NCT02569710|463442122|FG007|Overall Study|Withdrawal by Subject|0|||
128768377|NCT02569710|463442123|FG008|Overall Study|Withdrawal by Subject|0|||
128768378|NCT02569710|463442124|FG009|Overall Study|Withdrawal by Subject|0|||
128768379|NCT01861522|463442125|FG000|Overall Study|Adverse Event|1|||
128768380|NCT01861522|463442126|FG001|Overall Study|Adverse Event|0|||
128768381|NCT01861522|463442125|FG000|Overall Study|Withdrawal by Subject|2|||
129122473|NCT01799889|464744037|FG001|Overall Study|Physician Decision|2|||
129122474|NCT01799889|464744038|FG002|Overall Study|Physician Decision|4|||
129122475|NCT01799889|464744039|FG003|Overall Study|Physician Decision|4|||
129122476|NCT01799889|464744040|FG004|Overall Study|Physician Decision|5|||
129122477|NCT01799889|464744041|FG005|Overall Study|Physician Decision|5|||
129122478|NCT01799889|464744042|FG006|Overall Study|Physician Decision|5|||
128768382|NCT01861522|463442126|FG001|Overall Study|Withdrawal by Subject|0|||
128768383|NCT00550550|463442127|FG000|Overall Study|Adverse Event|13|||
128768384|NCT00550550|463442128|FG001|Overall Study|Adverse Event|5|||
128768385|NCT00550550|463442127|FG000|Overall Study|Treatment Failure|0|||
128768386|NCT00550550|463442128|FG001|Overall Study|Treatment Failure|1|||
128768387|NCT00550550|463442127|FG000|Overall Study|Lost to Follow-up|4|||
128768388|NCT00550550|463442128|FG001|Overall Study|Lost to Follow-up|0|||
128768389|NCT00550550|463442127|FG000|Overall Study|Withdrawal by Subject|10|||
128936516|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128936517|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128936518|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129122479|NCT01799889|464744043|FG007|Overall Study|Physician Decision|2|||
128936519|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128936520|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
128936521|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
128936522|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
128936523|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
128936524|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128936525|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128936526|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128936527|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
128936528|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129122480|NCT01799889|464744044|FG008|Overall Study|Physician Decision|6|||
129122481|NCT01799889|464744045|FG009|Overall Study|Physician Decision|0|||
128768390|NCT00550550|463442128|FG001|Overall Study|Withdrawal by Subject|8|||
128768391|NCT00550550|463442127|FG000|Overall Study|Protocol Violation|5|||
128768392|NCT00550550|463442128|FG001|Overall Study|Protocol Violation|14|||
128768393|NCT00550550|463442127|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
128768394|NCT00550550|463442128|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
128768395|NCT00550550|463442127|FG000|Overall Study|Randomized But Not Treated|1|||
128768396|NCT00550550|463442128|FG001|Overall Study|Randomized But Not Treated|0|||
128768397|NCT01338012|463442131|FG000|Overall Study|Death|4|||
128768398|NCT01338012|463442131|FG000|Overall Study|Study terminated|4|||
129031303|NCT00826241|464404823|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
129031304|NCT00826241|464404823|FG000|Overall Study|Non-compliance|1|||
129031305|NCT00826241|464404823|FG000|Overall Study|Progression of disease|1|||
129031306|NCT00826241|464404823|FG000|Overall Study|Patient refused follow-up|3|||
129031307|NCT00826241|464404823|FG000|Overall Study|Lost to Follow-up|9|||
129031308|NCT00826241|464404823|FG000|Overall Study|Could not obtain records|1|||
129031309|NCT00826241|464404823|FG000|Overall Study|Screen failure|2|||
129031310|NCT00826241|464404823|FG000|Overall Study|Pt unable to proceed to registration|1|||
129031311|NCT00826241|464404823|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
129031312|NCT04142658|464404824|FG000|Overall Study|Death|2|||
129031313|NCT04142658|464404825|FG001|Overall Study|Death|1|||
129031314|NCT04142658|464404824|FG000|Overall Study|Lost to Follow-up|4|||
129031315|NCT04142658|464404825|FG001|Overall Study|Lost to Follow-up|13|||
129031316|NCT04142658|464404824|FG000|Overall Study|Withdrawal by Subject|9|||
129031317|NCT04142658|464404825|FG001|Overall Study|Withdrawal by Subject|16|||
129031318|NCT04194008|464404830|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
129031319|NCT04194008|464404830|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
129031320|NCT04194008|464404830|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
129031321|NCT04194008|464404830|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
129031322|NCT04194008|464404830|FG000|Treatment Phase With Nerivio|Missing data|4|||
129031323|NCT04194008|464404830|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
129031324|NCT01539239|464404831|FG000|Overall Study|Death|5|||
129031325|NCT01539239|464404832|FG001|Overall Study|Death|5|||
129031326|NCT01539239|464404831|FG000|Overall Study|Lost to Follow-up|7|||
129031327|NCT01539239|464404832|FG001|Overall Study|Lost to Follow-up|12|||
129031328|NCT03201003|464404836|FG000|Overall Study|Adverse Event|14|||
129031329|NCT03201003|464404837|FG001|Overall Study|Adverse Event|1|||
129031330|NCT03201003|464404836|FG000|Overall Study|Other reasons|5|||
129031331|NCT03201003|464404837|FG001|Overall Study|Other reasons|1|||
129031332|NCT03201003|464404836|FG000|Overall Study|Withdrawal by Subject|4|||
129031333|NCT03201003|464404837|FG001|Overall Study|Withdrawal by Subject|1|||
129031334|NCT03201003|464404836|FG000|Overall Study|Lost to Follow-up|2|||
129031335|NCT03201003|464404837|FG001|Overall Study|Lost to Follow-up|0|||
129031336|NCT03201003|464404836|FG000|Overall Study|Protocol Violation|1|||
129031337|NCT03201003|464404837|FG001|Overall Study|Protocol Violation|0|||
129031338|NCT00834613|464404838|FG000|First Intervention|Protocol Violation|1|||
128705711|NCT02207244|463217130|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705712|NCT02207244|463217131|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705713|NCT02207244|463217132|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
128705714|NCT02207244|463217133|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
128705715|NCT02207244|463217134|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
128705716|NCT02207244|463217124|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
128705717|NCT02207244|463217125|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
128705718|NCT02207244|463217126|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
128705719|NCT02207244|463217127|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
128705720|NCT02207244|463217128|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
128705721|NCT02207244|463217129|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
128705722|NCT02207244|463217130|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
128705723|NCT02207244|463217131|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
128705724|NCT02207244|463217132|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
128705725|NCT02207244|463217133|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
128705726|NCT02207244|463217134|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
128705727|NCT02207244|463217124|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
128705728|NCT02207244|463217125|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
128705729|NCT02207244|463217126|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
128705730|NCT02207244|463217127|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
128705731|NCT02207244|463217128|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
128705732|NCT02207244|463217129|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
128705733|NCT02207244|463217130|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
128705734|NCT02207244|463217131|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
128705735|NCT02207244|463217132|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
128705736|NCT02207244|463217133|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
128705737|NCT02207244|463217134|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
128705738|NCT02207244|463217124|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705739|NCT02207244|463217125|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705740|NCT02207244|463217126|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705741|NCT02207244|463217127|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705742|NCT02207244|463217128|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129031339|NCT00834613|464404839|FG001|First Intervention|Protocol Violation|0|||
129031340|NCT01751087|464404840|FG000|Overall Study|Withdrawal by Subject|1|||
129031341|NCT01751087|464404841|FG001|Overall Study|Withdrawal by Subject|0|||
129031342|NCT01751087|464404842|FG002|Overall Study|Withdrawal by Subject|0|||
129031343|NCT01751087|464404840|FG000|Overall Study|Physician Decision|0|||
129031344|NCT01751087|464404841|FG001|Overall Study|Physician Decision|0|||
129031345|NCT01751087|464404842|FG002|Overall Study|Physician Decision|1|||
129217025|NCT04922216|465094888|FG013|Overall Study|Withdrawal by Subject|1|||
129217026|NCT04922216|465094889|FG014|Overall Study|Withdrawal by Subject|1|||
128768399|NCT02714205|463442132|FG000|Overall Study|Cannot tolerate medication|1|||
128768400|NCT02714205|463442133|FG001|Overall Study|Cannot tolerate medication|0|||
128768401|NCT02714205|463442132|FG000|Overall Study|Adverse Event|2|||
128936529|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
128936530|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
128936531|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128936532|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128936533|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128936534|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128936535|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128936536|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
128936537|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
128936538|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
128936539|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
128936540|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128936541|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128936542|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128936543|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128936544|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
128936545|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
128936546|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
128936547|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
128936548|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
128936549|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
128936550|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
128936551|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
128936552|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
128936553|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
128936554|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
128936555|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128936556|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128936557|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128936558|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128936559|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128936560|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
128936561|NCT01097616|464055437|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128936562|NCT01097616|464055438|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128936563|NCT01097616|464055439|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
128936564|NCT01097616|464055440|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128936565|NCT01097616|464055441|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128936566|NCT01097616|464055442|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128936567|NCT01097616|464055443|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128936568|NCT01097616|464055444|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
128936569|NCT01097616|464055437|FG000|Optional DB EXT Phase|Adverse Event|0|||
128936570|NCT01097616|464055438|FG001|Optional DB EXT Phase|Adverse Event|7|||
128936571|NCT01097616|464055439|FG002|Optional DB EXT Phase|Adverse Event|2|||
128936572|NCT01097616|464055440|FG003|Optional DB EXT Phase|Adverse Event|0|||
128936573|NCT01097616|464055441|FG004|Optional DB EXT Phase|Adverse Event|0|||
128936574|NCT01097616|464055442|FG005|Optional DB EXT Phase|Adverse Event|0|||
128936575|NCT01097616|464055443|FG006|Optional DB EXT Phase|Adverse Event|0|||
129031346|NCT00697619|464404843|FG000|Overall Study|Lack of Efficacy|2|||
128768402|NCT02714205|463442133|FG001|Overall Study|Adverse Event|0|||
128768403|NCT02714205|463442132|FG000|Overall Study|Too busy|1|||
128768404|NCT02714205|463442133|FG001|Overall Study|Too busy|0|||
128768405|NCT02714205|463442132|FG000|Overall Study|Incomplete outcome data|0|||
128936576|NCT01097616|464055444|FG007|Optional DB EXT Phase|Adverse Event|0|||
128936577|NCT01097616|464055437|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
128936578|NCT01097616|464055438|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
128936579|NCT01097616|464055439|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
128936580|NCT01097616|464055440|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
129031347|NCT00697619|464404844|FG001|Overall Study|Lack of Efficacy|2|||
129031348|NCT00697619|464404843|FG000|Overall Study|Adverse Event|4|||
128936581|NCT01097616|464055441|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
128936582|NCT01097616|464055442|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
129031349|NCT00697619|464404844|FG001|Overall Study|Adverse Event|6|||
129217027|NCT04922216|465094890|FG015|Overall Study|Withdrawal by Subject|0|||
128936583|NCT01097616|464055443|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
128705743|NCT02207244|463217129|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705744|NCT02207244|463217130|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705745|NCT02207244|463217131|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705746|NCT02207244|463217132|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705747|NCT02207244|463217133|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
128705748|NCT02207244|463217134|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
128705749|NCT00039130|463217135|FG000|Overall Study|Adverse Event|11|||
128705750|NCT00039130|463217135|FG000|Overall Study|Death|9|||
128705751|NCT00039130|463217135|FG000|Overall Study|Withdrawal by Subject|3|||
128705752|NCT00039130|463217135|FG000|Overall Study|Progression|2|||
128705753|NCT00039130|463217135|FG000|Overall Study|Subsequent treatment|2|||
128705754|NCT00039130|463217135|FG000|Overall Study|Physician Decision|3|||
128705755|NCT00279305|463217138|FG000|Overall Study|Pregnancy|1|||
128705756|NCT00279305|463217139|FG001|Overall Study|Pregnancy|0|||
128705757|NCT00279305|463217138|FG000|Overall Study|Withdrawal by Subject|2|||
128705758|NCT00279305|463217139|FG001|Overall Study|Withdrawal by Subject|0|||
128705759|NCT00279305|463217138|FG000|Overall Study|Dificulting establishing IV|1|||
128705760|NCT00279305|463217139|FG001|Overall Study|Dificulting establishing IV|0|||
128705761|NCT00279305|463217138|FG000|Overall Study|FDA Safety Alert|4|||
128705762|NCT00279305|463217139|FG001|Overall Study|FDA Safety Alert|1|||
128705763|NCT03200860|463217140|FG000|Overall Study|Withdrawal by Subject|1|||
128705764|NCT03200860|463217141|FG001|Overall Study|Withdrawal by Subject|0|||
128705765|NCT01744197|463217143|FG000|Overall Study|Received 1 patch|2|||
128705766|NCT01744197|463217144|FG001|Overall Study|Received 1 patch|1|||
128705767|NCT01744197|463217143|FG000|Overall Study|No patch received|2|||
128705768|NCT01744197|463217144|FG001|Overall Study|No patch received|2|||
128705769|NCT03919799|463217145|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
128705770|NCT03919799|463217146|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
128705771|NCT03919799|463217147|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
128936584|NCT01097616|464055444|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
128936585|NCT01097616|464055437|FG000|Optional DB EXT Phase|Protocol Violation|0|||
128936586|NCT01097616|464055438|FG001|Optional DB EXT Phase|Protocol Violation|2|||
128936587|NCT01097616|464055439|FG002|Optional DB EXT Phase|Protocol Violation|3|||
128936588|NCT01097616|464055440|FG003|Optional DB EXT Phase|Protocol Violation|0|||
128936589|NCT01097616|464055441|FG004|Optional DB EXT Phase|Protocol Violation|0|||
128936590|NCT01097616|464055442|FG005|Optional DB EXT Phase|Protocol Violation|0|||
128936591|NCT01097616|464055443|FG006|Optional DB EXT Phase|Protocol Violation|0|||
128936592|NCT01097616|464055444|FG007|Optional DB EXT Phase|Protocol Violation|0|||
128936593|NCT01097616|464055437|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
128936594|NCT01097616|464055438|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
128936595|NCT01097616|464055439|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
128936596|NCT01097616|464055440|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
128936597|NCT01097616|464055441|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
128936598|NCT01097616|464055442|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
128936599|NCT01097616|464055443|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
128936600|NCT01097616|464055444|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
128936601|NCT01097616|464055437|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
128936602|NCT01097616|464055438|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
128936603|NCT01097616|464055439|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
128936604|NCT01097616|464055440|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
128936605|NCT01097616|464055441|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
128936606|NCT01097616|464055442|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
128936607|NCT01097616|464055443|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
128936608|NCT01097616|464055444|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
128936609|NCT01097616|464055437|FG000|Optional DB EXT Phase|Physician Decision|1|||
128936610|NCT01097616|464055438|FG001|Optional DB EXT Phase|Physician Decision|0|||
128936611|NCT01097616|464055439|FG002|Optional DB EXT Phase|Physician Decision|0|||
129031350|NCT00258856|464406434|FG000|Overall Study|Lost to Follow-up|1|||
129217028|NCT04922216|465094891|FG016|Overall Study|Withdrawal by Subject|0|||
128705772|NCT03919799|463217148|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
128705773|NCT03919799|463217149|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
128768406|NCT02714205|463442133|FG001|Overall Study|Incomplete outcome data|1|||
129217029|NCT04922216|465094892|FG017|Overall Study|Withdrawal by Subject|1|||
129217030|NCT04922216|465094893|FG018|Overall Study|Withdrawal by Subject|1|||
128705774|NCT03919799|463217145|FG000|DB Period (28 Weeks)|Adverse Event|1|||
128705775|NCT03919799|463217146|FG001|DB Period (28 Weeks)|Adverse Event|1|||
128705776|NCT03919799|463217147|FG002|DB Period (28 Weeks)|Adverse Event|1|||
128705777|NCT03919799|463217148|FG003|DB Period (28 Weeks)|Adverse Event|0|||
128705778|NCT03919799|463217149|FG004|DB Period (28 Weeks)|Adverse Event|0|||
128768407|NCT00381641|463442134|FG000|Overall Study|Withdrawal by Subject|0|||
128936612|NCT01097616|464055440|FG003|Optional DB EXT Phase|Physician Decision|0|||
128936613|NCT01097616|464055441|FG004|Optional DB EXT Phase|Physician Decision|0|||
128936614|NCT01097616|464055442|FG005|Optional DB EXT Phase|Physician Decision|0|||
128936615|NCT01097616|464055443|FG006|Optional DB EXT Phase|Physician Decision|0|||
128936616|NCT01097616|464055444|FG007|Optional DB EXT Phase|Physician Decision|0|||
128936617|NCT01097616|464055437|FG000|DB RO Phase|Adverse Event|0|||
129122482|NCT01799889|464744046|FG010|Overall Study|Physician Decision|0|||
128936618|NCT01097616|464055438|FG001|DB RO Phase|Adverse Event|0|||
128936619|NCT01097616|464055439|FG002|DB RO Phase|Adverse Event|0|||
128936620|NCT01097616|464055440|FG003|DB RO Phase|Adverse Event|0|||
128936621|NCT01097616|464055441|FG004|DB RO Phase|Adverse Event|0|||
128936622|NCT01097616|464055442|FG005|DB RO Phase|Adverse Event|0|||
128936623|NCT01097616|464055443|FG006|DB RO Phase|Adverse Event|1|||
128936624|NCT01097616|464055444|FG007|DB RO Phase|Adverse Event|0|||
128936625|NCT01097616|464055437|FG000|DB RO Phase|Withdrawal by Subject|0|||
128936626|NCT01097616|464055438|FG001|DB RO Phase|Withdrawal by Subject|0|||
128936627|NCT01097616|464055439|FG002|DB RO Phase|Withdrawal by Subject|0|||
128936628|NCT01097616|464055440|FG003|DB RO Phase|Withdrawal by Subject|0|||
128936629|NCT01097616|464055441|FG004|DB RO Phase|Withdrawal by Subject|0|||
128936630|NCT01097616|464055442|FG005|DB RO Phase|Withdrawal by Subject|1|||
128936631|NCT01097616|464055443|FG006|DB RO Phase|Withdrawal by Subject|0|||
128936632|NCT01097616|464055444|FG007|DB RO Phase|Withdrawal by Subject|0|||
128936633|NCT01097616|464055437|FG000|DB RO Phase|Lost to Follow-up|0|||
128936634|NCT01097616|464055438|FG001|DB RO Phase|Lost to Follow-up|0|||
128936635|NCT01097616|464055439|FG002|DB RO Phase|Lost to Follow-up|0|||
128936636|NCT01097616|464055440|FG003|DB RO Phase|Lost to Follow-up|1|||
128936637|NCT01097616|464055441|FG004|DB RO Phase|Lost to Follow-up|1|||
128936638|NCT01097616|464055442|FG005|DB RO Phase|Lost to Follow-up|0|||
128936639|NCT01097616|464055443|FG006|DB RO Phase|Lost to Follow-up|0|||
128936640|NCT01097616|464055444|FG007|DB RO Phase|Lost to Follow-up|1|||
128936641|NCT01097616|464055437|FG000|DB RO Phase|Not Treated in RO|0|||
128936642|NCT01097616|464055438|FG001|DB RO Phase|Not Treated in RO|0|||
128936643|NCT01097616|464055439|FG002|DB RO Phase|Not Treated in RO|0|||
128936644|NCT01097616|464055440|FG003|DB RO Phase|Not Treated in RO|0|||
128936645|NCT01097616|464055441|FG004|DB RO Phase|Not Treated in RO|0|||
128936646|NCT01097616|464055442|FG005|DB RO Phase|Not Treated in RO|1|||
129122483|NCT01799889|464744047|FG011|Overall Study|Physician Decision|1|||
129122484|NCT01799889|464744036|FG000|Overall Study|Progressive Disease|30|||
129122485|NCT01799889|464744037|FG001|Overall Study|Progressive Disease|26|||
129122486|NCT01799889|464744038|FG002|Overall Study|Progressive Disease|25|||
129122487|NCT01799889|464744039|FG003|Overall Study|Progressive Disease|30|||
128705779|NCT03919799|463217145|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
128705780|NCT03919799|463217146|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
128705781|NCT03919799|463217147|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
128705782|NCT03919799|463217148|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
128705783|NCT03919799|463217149|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
128705784|NCT03919799|463217145|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
128705785|NCT03919799|463217146|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
128705786|NCT03919799|463217147|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
128705787|NCT03919799|463217148|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
128705788|NCT03919799|463217149|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
128705789|NCT03919799|463217145|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
128705790|NCT03919799|463217146|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
128768408|NCT00381641|463442135|FG001|Overall Study|Withdrawal by Subject|2|||
128705791|NCT03919799|463217147|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
128768409|NCT01598298|463442136|FG000|Overall Study|Not eligible|5|||
128768410|NCT01598298|463442137|FG001|Overall Study|Not eligible|5|||
128936647|NCT01097616|464055443|FG006|DB RO Phase|Not Treated in RO|0|||
128936648|NCT01097616|464055444|FG007|DB RO Phase|Not Treated in RO|0|||
128936649|NCT00130208|464055445|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
128936650|NCT00130208|464055446|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
128936651|NCT00130208|464055445|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
128936652|NCT00130208|464055446|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
128936653|NCT00130208|464055445|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
128936654|NCT00130208|464055446|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
128936655|NCT00130208|464055445|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
129031351|NCT00258856|464406435|FG001|Overall Study|Lost to Follow-up|0|||
129031352|NCT00258856|464406436|FG002|Overall Study|Lost to Follow-up|2|||
129031353|NCT00258856|464406437|FG003|Overall Study|Lost to Follow-up|0|||
129031354|NCT00258856|464406434|FG000|Overall Study|Non-compliance|2|||
129031355|NCT00258856|464406435|FG001|Overall Study|Non-compliance|0|||
129031356|NCT00258856|464406436|FG002|Overall Study|Non-compliance|0|||
129031357|NCT00258856|464406437|FG003|Overall Study|Non-compliance|1|||
129031358|NCT02219009|464406440|FG000|Overall Study|Withdrawal by Subject|5|||
129031359|NCT02219009|464406441|FG001|Overall Study|Withdrawal by Subject|1|||
129031360|NCT02219009|464406440|FG000|Overall Study|Adverse Event|2|||
129031361|NCT02219009|464406441|FG001|Overall Study|Adverse Event|4|||
129031362|NCT02219009|464406440|FG000|Overall Study|Lost to Follow-up|2|||
129031363|NCT02219009|464406441|FG001|Overall Study|Lost to Follow-up|2|||
129031364|NCT02219009|464406440|FG000|Overall Study|Protocol deviation|1|||
129031365|NCT02219009|464406441|FG001|Overall Study|Protocol deviation|0|||
129031366|NCT02219009|464406440|FG000|Overall Study|Physician Decision|0|||
129031367|NCT02219009|464406441|FG001|Overall Study|Physician Decision|1|||
129031368|NCT03086135|464406444|FG000|Overall Study|Adverse Event|1|||
128705792|NCT03919799|463217148|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
128705793|NCT03919799|463217149|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
128705794|NCT05475236|463217151|FG000|Overall Study|Withdrawal by Subject|0|||
128705795|NCT05475236|463217152|FG001|Overall Study|Withdrawal by Subject|1|||
128705796|NCT00638378|463218456|FG000|Overall Study|Death|2|||
128705797|NCT00638378|463218456|FG000|Overall Study|Adverse Event|1|||
128705798|NCT00638378|463218456|FG000|Overall Study|Disease progression|15|||
128705799|NCT00638378|463218456|FG000|Overall Study|Physician Decision|4|||
128705800|NCT01411774|463218471|FG000|Overall Study|Withdrawal by Subject|0|||
128705801|NCT01411774|463218472|FG001|Overall Study|Withdrawal by Subject|3|||
128705802|NCT02990910|463218478|FG000|Overall Study|Lack of Efficacy|6|||
128705803|NCT02990910|463218479|FG001|Overall Study|Lack of Efficacy|10|||
128705804|NCT00814164|463218484|FG000|Overall Study|Progression|7|||
128705805|NCT00814164|463218484|FG000|Overall Study|not stated|7|||
128705806|NCT00814164|463218484|FG000|Overall Study|Death|5|||
128705807|NCT01169493|463218490|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
128705808|NCT01169493|463218491|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
128705809|NCT01169493|463218492|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
128705810|NCT01169493|463218493|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
128705811|NCT01169493|463218494|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
128705812|NCT01169493|463218495|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
128705813|NCT01169493|463218490|FG000|Period 3 (6 Months)|Adverse Event|0|||
128705814|NCT01169493|463218491|FG001|Period 3 (6 Months)|Adverse Event|1|||
128705815|NCT01169493|463218492|FG002|Period 3 (6 Months)|Adverse Event|0|||
128705816|NCT01169493|463218493|FG003|Period 3 (6 Months)|Adverse Event|0|||
128936656|NCT00130208|464055446|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
128936657|NCT00130208|464055445|FG000|Maintenance Period (26 Weeks)|Other|1|||
128705817|NCT01169493|463218494|FG004|Period 3 (6 Months)|Adverse Event|0|||
128705818|NCT01169493|463218495|FG005|Period 3 (6 Months)|Adverse Event|0|||
128705819|NCT01169493|463218490|FG000|Period 3 (6 Months)|Physician Decision|0|||
128705820|NCT01169493|463218491|FG001|Period 3 (6 Months)|Physician Decision|1|||
128705821|NCT01169493|463218492|FG002|Period 3 (6 Months)|Physician Decision|1|||
128705822|NCT01169493|463218493|FG003|Period 3 (6 Months)|Physician Decision|0|||
128705823|NCT01169493|463218494|FG004|Period 3 (6 Months)|Physician Decision|0|||
128936658|NCT00130208|464055446|FG001|Maintenance Period (26 Weeks)|Other|1|||
128936659|NCT00130208|464055445|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
128936660|NCT00130208|464055446|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
128936661|NCT00130208|464055445|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
128936662|NCT00130208|464055446|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
128936663|NCT00130208|464055445|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
128936664|NCT00130208|464055446|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
128936665|NCT00130208|464055445|FG000|Washout Period (8 Weeks)|Other|1|||
128936666|NCT00130208|464055446|FG001|Washout Period (8 Weeks)|Other|1|||
128936667|NCT00589472|464055448|FG000|Overall Study|Adverse Event|1|||
128705824|NCT01169493|463218495|FG005|Period 3 (6 Months)|Physician Decision|0|||
128705825|NCT00420927|463218499|FG000|Period 1|Adverse Event|19|||
128705826|NCT00420927|463218500|FG001|Period 1|Adverse Event|15|||
128705827|NCT00420927|463218501|FG002|Period 1|Adverse Event|0|||
128705828|NCT00420927|463218502|FG003|Period 1|Adverse Event|0|||
128705829|NCT00420927|463218503|FG004|Period 1|Adverse Event|0|||
128705830|NCT00420927|463218504|FG005|Period 1|Adverse Event|0|||
128705831|NCT00420927|463218505|FG006|Period 1|Adverse Event|0|||
128705832|NCT00420927|463218499|FG000|Period 1|Withdrawal by Subject|7|||
128705833|NCT00420927|463218500|FG001|Period 1|Withdrawal by Subject|12|||
128705834|NCT00420927|463218501|FG002|Period 1|Withdrawal by Subject|0|||
128705835|NCT00420927|463218502|FG003|Period 1|Withdrawal by Subject|0|||
128705836|NCT00420927|463218503|FG004|Period 1|Withdrawal by Subject|0|||
128705837|NCT00420927|463218504|FG005|Period 1|Withdrawal by Subject|0|||
128705838|NCT00420927|463218505|FG006|Period 1|Withdrawal by Subject|0|||
128705839|NCT00420927|463218499|FG000|Period 1|Lost to Follow-up|8|||
128705840|NCT00420927|463218500|FG001|Period 1|Lost to Follow-up|6|||
128705841|NCT00420927|463218501|FG002|Period 1|Lost to Follow-up|0|||
128705842|NCT00420927|463218502|FG003|Period 1|Lost to Follow-up|0|||
128705843|NCT00420927|463218503|FG004|Period 1|Lost to Follow-up|0|||
128705844|NCT00420927|463218504|FG005|Period 1|Lost to Follow-up|0|||
128705845|NCT00420927|463218505|FG006|Period 1|Lost to Follow-up|0|||
128705846|NCT00420927|463218499|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
128705847|NCT00420927|463218500|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
128705848|NCT00420927|463218501|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
128705849|NCT00420927|463218502|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
128705850|NCT00420927|463218503|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
128705851|NCT00420927|463218504|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
128705852|NCT00420927|463218505|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
128705853|NCT00420927|463218499|FG000|Period 1|Death|2|||
128705854|NCT00420927|463218500|FG001|Period 1|Death|0|||
128705855|NCT00420927|463218501|FG002|Period 1|Death|0|||
128705856|NCT00420927|463218502|FG003|Period 1|Death|0|||
128936668|NCT01703819|464055451|FG000|Overall Study|Adverse Event|0|||
128936669|NCT01703819|464055452|FG001|Overall Study|Adverse Event|1|||
128768411|NCT01598298|463442136|FG000|Overall Study|Adverse Event|21|||
128768412|NCT01598298|463442137|FG001|Overall Study|Adverse Event|19|||
128768413|NCT01598298|463442136|FG000|Overall Study|Progression/relapse|0|||
129031369|NCT03086135|464406444|FG000|Overall Study|Lost to Follow-up|2|||
129031370|NCT00762411|464406445|FG000|Initial Treatment|Death|7|||
129031371|NCT00762411|464406446|FG001|Initial Treatment|Death|6|||
129031372|NCT00762411|464406445|FG000|Initial Treatment|Adverse Event|132|||
129031373|NCT00762411|464406446|FG001|Initial Treatment|Adverse Event|40|||
129031374|NCT00762411|464406445|FG000|Initial Treatment|Protocol Violation|4|||
129031375|NCT00762411|464406446|FG001|Initial Treatment|Protocol Violation|1|||
129031376|NCT00762411|464406445|FG000|Initial Treatment|Withdrawal by Subject|65|||
129031377|NCT00762411|464406446|FG001|Initial Treatment|Withdrawal by Subject|52|||
129031378|NCT00762411|464406445|FG000|Initial Treatment|Physician Decision|1|||
129031379|NCT00762411|464406446|FG001|Initial Treatment|Physician Decision|0|||
129031380|NCT00762411|464406445|FG000|Initial Treatment|Sponsor Decision|293|||
129031381|NCT00762411|464406446|FG001|Initial Treatment|Sponsor Decision|401|||
129031382|NCT00762411|464406445|FG000|Initial Treatment|Lost to Follow-up|5|||
129031383|NCT00762411|464406446|FG001|Initial Treatment|Lost to Follow-up|0|||
129031384|NCT00762411|464406445|FG000|Initial Treatment|Caregiver Decision|21|||
129031385|NCT00762411|464406446|FG001|Initial Treatment|Caregiver Decision|16|||
129031386|NCT00762411|464406445|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
129217031|NCT04922216|465094894|FG019|Overall Study|Withdrawal by Subject|1|||
129217032|NCT04922216|465094895|FG020|Overall Study|Withdrawal by Subject|1|||
129217033|NCT04922216|465094896|FG021|Overall Study|Withdrawal by Subject|0|||
129217034|NCT04922216|465094897|FG022|Overall Study|Withdrawal by Subject|0|||
129217035|NCT04922216|465094898|FG023|Overall Study|Withdrawal by Subject|2|||
129217036|NCT04922216|465094899|FG024|Overall Study|Withdrawal by Subject|0|||
129217037|NCT04922216|465094900|FG025|Overall Study|Withdrawal by Subject|0|||
129217038|NCT04922216|465094901|FG026|Overall Study|Withdrawal by Subject|1|||
129217039|NCT04922216|465094902|FG027|Overall Study|Withdrawal by Subject|0|||
129217040|NCT04922216|465094903|FG028|Overall Study|Withdrawal by Subject|0|||
129217041|NCT04922216|465094904|FG029|Overall Study|Withdrawal by Subject|0|||
129217042|NCT04922216|465094905|FG030|Overall Study|Withdrawal by Subject|1|||
129217043|NCT04922216|465094906|FG031|Overall Study|Withdrawal by Subject|0|||
129217044|NCT04922216|465094875|FG000|Overall Study|Lost to Follow-up|1|||
129217045|NCT04922216|465094876|FG001|Overall Study|Lost to Follow-up|0|||
129217046|NCT04922216|465094877|FG002|Overall Study|Lost to Follow-up|2|||
129217047|NCT04922216|465094878|FG003|Overall Study|Lost to Follow-up|0|||
129217048|NCT04922216|465094879|FG004|Overall Study|Lost to Follow-up|0|||
129217049|NCT04922216|465094880|FG005|Overall Study|Lost to Follow-up|2|||
129217050|NCT04922216|465094881|FG006|Overall Study|Lost to Follow-up|0|||
129217051|NCT04922216|465094882|FG007|Overall Study|Lost to Follow-up|1|||
129217052|NCT04922216|465094883|FG008|Overall Study|Lost to Follow-up|1|||
129217053|NCT04922216|465094884|FG009|Overall Study|Lost to Follow-up|2|||
129217054|NCT04922216|465094885|FG010|Overall Study|Lost to Follow-up|2|||
129031387|NCT00762411|464406446|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
129031388|NCT00762411|464406445|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
129031389|NCT00762411|464406446|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
129031390|NCT00762411|464406445|FG000|Delayed Start|Adverse Event|0|||
129031391|NCT00762411|464406446|FG001|Delayed Start|Adverse Event|4|||
129031392|NCT00762411|464406445|FG000|Delayed Start|Protocol Violation|0|||
129031393|NCT00762411|464406446|FG001|Delayed Start|Protocol Violation|1|||
129031394|NCT00762411|464406445|FG000|Delayed Start|Sponsor Decision|16|||
129031395|NCT00762411|464406446|FG001|Delayed Start|Sponsor Decision|20|||
129031396|NCT00762411|464406445|FG000|Delayed Start|Caregiver Decision|1|||
129031397|NCT00762411|464406446|FG001|Delayed Start|Caregiver Decision|1|||
129031398|NCT00762411|464406445|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
129217055|NCT04922216|465094886|FG011|Overall Study|Lost to Follow-up|1|||
129217056|NCT04922216|465094887|FG012|Overall Study|Lost to Follow-up|1|||
129217057|NCT04922216|465094888|FG013|Overall Study|Lost to Follow-up|0|||
129217058|NCT04922216|465094889|FG014|Overall Study|Lost to Follow-up|1|||
128768414|NCT01598298|463442137|FG001|Overall Study|Progression/relapse|2|||
128768415|NCT01598298|463442136|FG000|Overall Study|Withdrawal by Subject|10|||
128768416|NCT01598298|463442137|FG001|Overall Study|Withdrawal by Subject|15|||
129031399|NCT00762411|464406446|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
129217059|NCT04922216|465094890|FG015|Overall Study|Lost to Follow-up|0|||
129217060|NCT04922216|465094891|FG016|Overall Study|Lost to Follow-up|0|||
128768417|NCT01598298|463442136|FG000|Overall Study|Other reason (not protocol specified)|4|||
128768418|NCT01598298|463442137|FG001|Overall Study|Other reason (not protocol specified)|0|||
128768419|NCT03813147|463442138|FG000|Overall Study|Lack of Efficacy|4|||
129031400|NCT00762411|464406445|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
129031401|NCT00762411|464406446|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
129031402|NCT00762411|464406445|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
129031403|NCT00762411|464406446|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
129031404|NCT00762411|464406445|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
129031405|NCT00762411|464406446|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
129217061|NCT04922216|465094892|FG017|Overall Study|Lost to Follow-up|2|||
128705857|NCT00420927|463218503|FG004|Period 1|Death|0|||
128705858|NCT00420927|463218504|FG005|Period 1|Death|0|||
128705859|NCT00420927|463218505|FG006|Period 1|Death|0|||
128705860|NCT00420927|463218499|FG000|Period 1|Subject moved/relocated|0|||
128705861|NCT00420927|463218500|FG001|Period 1|Subject moved/relocated|2|||
128705862|NCT00420927|463218501|FG002|Period 1|Subject moved/relocated|0|||
128705863|NCT00420927|463218502|FG003|Period 1|Subject moved/relocated|0|||
128705864|NCT00420927|463218503|FG004|Period 1|Subject moved/relocated|0|||
128705865|NCT00420927|463218504|FG005|Period 1|Subject moved/relocated|0|||
128705866|NCT00420927|463218505|FG006|Period 1|Subject moved/relocated|0|||
128705867|NCT00420927|463218499|FG000|Period 1|Noncompliant with study drug|1|||
128705868|NCT00420927|463218500|FG001|Period 1|Noncompliant with study drug|1|||
128705869|NCT00420927|463218501|FG002|Period 1|Noncompliant with study drug|0|||
128705870|NCT00420927|463218502|FG003|Period 1|Noncompliant with study drug|0|||
128705871|NCT00420927|463218503|FG004|Period 1|Noncompliant with study drug|0|||
128705872|NCT00420927|463218504|FG005|Period 1|Noncompliant with study drug|0|||
128705873|NCT00420927|463218505|FG006|Period 1|Noncompliant with study drug|0|||
128705874|NCT00420927|463218499|FG000|Period 1|Randomization error|1|||
128705875|NCT00420927|463218500|FG001|Period 1|Randomization error|0|||
128705876|NCT00420927|463218501|FG002|Period 1|Randomization error|0|||
128705877|NCT00420927|463218502|FG003|Period 1|Randomization error|0|||
128705878|NCT00420927|463218503|FG004|Period 1|Randomization error|0|||
128705879|NCT00420927|463218504|FG005|Period 1|Randomization error|0|||
128705880|NCT00420927|463218505|FG006|Period 1|Randomization error|0|||
128705881|NCT00420927|463218499|FG000|Period 1|Suspected tuberculosis/positive test|1|||
128705882|NCT00420927|463218500|FG001|Period 1|Suspected tuberculosis/positive test|1|||
128705883|NCT00420927|463218501|FG002|Period 1|Suspected tuberculosis/positive test|0|||
128705884|NCT00420927|463218502|FG003|Period 1|Suspected tuberculosis/positive test|0|||
128705885|NCT00420927|463218503|FG004|Period 1|Suspected tuberculosis/positive test|0|||
128705886|NCT00420927|463218504|FG005|Period 1|Suspected tuberculosis/positive test|0|||
128705887|NCT00420927|463218505|FG006|Period 1|Suspected tuberculosis/positive test|0|||
128705888|NCT00420927|463218499|FG000|Period 1|Study site closure|0|||
128705889|NCT00420927|463218500|FG001|Period 1|Study site closure|1|||
128705890|NCT00420927|463218501|FG002|Period 1|Study site closure|0|||
128705891|NCT00420927|463218502|FG003|Period 1|Study site closure|0|||
128936670|NCT01703819|464055451|FG000|Overall Study|Withdrawal by Subject|0|||
128936671|NCT01703819|464055452|FG001|Overall Study|Withdrawal by Subject|1|||
128936672|NCT02145156|464055453|FG000|Overall Study|No match to vaccination records|60|||
128936673|NCT02145156|464055454|FG001|Overall Study|No match to vaccination records|52|||
128936674|NCT02145156|464055455|FG002|Overall Study|No match to vaccination records|41|||
128936675|NCT00532883|464055456|FG000|Overall Study|Adverse Event|1|||
128936676|NCT00532883|464055457|FG001|Overall Study|Adverse Event|0|||
128705892|NCT00420927|463218503|FG004|Period 1|Study site closure|0|||
128705893|NCT00420927|463218504|FG005|Period 1|Study site closure|0|||
129031406|NCT00762411|464406445|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
129031407|NCT00762411|464406446|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
128705894|NCT00420927|463218505|FG006|Period 1|Study site closure|0|||
128705895|NCT00420927|463218499|FG000|Period 1|Subject received new diagnosis|0|||
128705896|NCT00420927|463218500|FG001|Period 1|Subject received new diagnosis|2|||
128705897|NCT00420927|463218501|FG002|Period 1|Subject received new diagnosis|0|||
128936677|NCT00532883|464055458|FG002|Overall Study|Adverse Event|0|||
128936678|NCT00532883|464055459|FG003|Overall Study|Adverse Event|1|||
129031408|NCT00762411|464406445|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
129031409|NCT00762411|464406446|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
129031410|NCT02259348|464406449|FG000|Overall Study|Donors|6|||
129031411|NCT02259348|464406449|FG000|Overall Study|Death|4|||
129031412|NCT04211766|464406450|FG000|Overall Study|Withdrawal by Subject|5|||
129031413|NCT04211766|464406451|FG001|Overall Study|Withdrawal by Subject|1|||
129031414|NCT04556734|464406453|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
129031415|NCT04556734|464406454|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129031416|NCT04556734|464406455|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
129031417|NCT04556734|464406456|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129031418|NCT04556734|464406457|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129031419|NCT04556734|464406458|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129031420|NCT04556734|464406459|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129031421|NCT04556734|464406460|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129031422|NCT04556734|464406453|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
129122488|NCT01799889|464744040|FG004|Overall Study|Progressive Disease|23|||
129122489|NCT01799889|464744041|FG005|Overall Study|Progressive Disease|9|||
129031423|NCT04556734|464406454|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129031424|NCT04556734|464406455|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129122490|NCT01799889|464744042|FG006|Overall Study|Progressive Disease|8|||
129122491|NCT01799889|464744043|FG007|Overall Study|Progressive Disease|13|||
129122492|NCT01799889|464744044|FG008|Overall Study|Progressive Disease|18|||
128936679|NCT00532883|464055456|FG000|Overall Study|Lost to Follow-up|1|||
129122493|NCT01799889|464744045|FG009|Overall Study|Progressive Disease|5|||
128705898|NCT00420927|463218502|FG003|Period 1|Subject received new diagnosis|0|||
128705899|NCT00420927|463218503|FG004|Period 1|Subject received new diagnosis|0|||
128705900|NCT00420927|463218504|FG005|Period 1|Subject received new diagnosis|0|||
128705901|NCT00420927|463218505|FG006|Period 1|Subject received new diagnosis|0|||
128705902|NCT00420927|463218499|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
128705903|NCT00420927|463218500|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
128705904|NCT00420927|463218501|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
128705905|NCT00420927|463218502|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
128705906|NCT00420927|463218503|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
128705907|NCT00420927|463218504|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
128705908|NCT00420927|463218505|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
128705909|NCT00420927|463218499|FG000|Period 1|Failed to meet entry criteria|8|||
128705910|NCT00420927|463218500|FG001|Period 1|Failed to meet entry criteria|7|||
128705911|NCT00420927|463218501|FG002|Period 1|Failed to meet entry criteria|0|||
128705912|NCT00420927|463218502|FG003|Period 1|Failed to meet entry criteria|0|||
128705913|NCT00420927|463218503|FG004|Period 1|Failed to meet entry criteria|0|||
128705914|NCT00420927|463218504|FG005|Period 1|Failed to meet entry criteria|0|||
128705915|NCT00420927|463218505|FG006|Period 1|Failed to meet entry criteria|0|||
128705916|NCT00420927|463218499|FG000|Period 1|Took prohibited medication|1|||
128705917|NCT00420927|463218500|FG001|Period 1|Took prohibited medication|3|||
128705918|NCT00420927|463218501|FG002|Period 1|Took prohibited medication|0|||
128705919|NCT00420927|463218502|FG003|Period 1|Took prohibited medication|0|||
128705920|NCT00420927|463218503|FG004|Period 1|Took prohibited medication|0|||
128705921|NCT00420927|463218504|FG005|Period 1|Took prohibited medication|0|||
128705922|NCT00420927|463218505|FG006|Period 1|Took prohibited medication|0|||
128705923|NCT00420927|463218499|FG000|Period 2|Adverse Event|0|||
128705924|NCT00420927|463218500|FG001|Period 2|Adverse Event|0|||
128705925|NCT00420927|463218501|FG002|Period 2|Adverse Event|7|||
128705926|NCT00420927|463218502|FG003|Period 2|Adverse Event|3|||
128705927|NCT00420927|463218503|FG004|Period 2|Adverse Event|17|||
128705928|NCT00420927|463218504|FG005|Period 2|Adverse Event|6|||
128705929|NCT00420927|463218505|FG006|Period 2|Adverse Event|20|||
128705930|NCT00420927|463218499|FG000|Period 2|Withdrawal by Subject|0|||
128705931|NCT00420927|463218500|FG001|Period 2|Withdrawal by Subject|0|||
128705932|NCT00420927|463218501|FG002|Period 2|Withdrawal by Subject|1|||
128705933|NCT00420927|463218502|FG003|Period 2|Withdrawal by Subject|3|||
128705934|NCT00420927|463218503|FG004|Period 2|Withdrawal by Subject|11|||
128705935|NCT00420927|463218504|FG005|Period 2|Withdrawal by Subject|2|||
128705936|NCT00420927|463218505|FG006|Period 2|Withdrawal by Subject|12|||
128705937|NCT00420927|463218499|FG000|Period 2|Lost to Follow-up|0|||
128705938|NCT00420927|463218500|FG001|Period 2|Lost to Follow-up|0|||
128705939|NCT00420927|463218501|FG002|Period 2|Lost to Follow-up|2|||
128705940|NCT00420927|463218502|FG003|Period 2|Lost to Follow-up|2|||
128705941|NCT00420927|463218503|FG004|Period 2|Lost to Follow-up|6|||
128705942|NCT00420927|463218504|FG005|Period 2|Lost to Follow-up|3|||
128705943|NCT00420927|463218505|FG006|Period 2|Lost to Follow-up|9|||
128705944|NCT00420927|463218499|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
128705945|NCT00420927|463218500|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
128705946|NCT00420927|463218501|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
128705947|NCT00420927|463218502|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
128705948|NCT00420927|463218503|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
128705949|NCT00420927|463218504|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
128705950|NCT00420927|463218505|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
128705951|NCT00420927|463218499|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
128705952|NCT00420927|463218500|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
128705953|NCT00420927|463218501|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
128705954|NCT00420927|463218502|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
128705955|NCT00420927|463218503|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
128936680|NCT00532883|464055457|FG001|Overall Study|Lost to Follow-up|1|||
129122494|NCT01799889|464744046|FG010|Overall Study|Progressive Disease|3|||
129122495|NCT01799889|464744047|FG011|Overall Study|Progressive Disease|1|||
129122496|NCT01799889|464744036|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
128936681|NCT00532883|464055458|FG002|Overall Study|Lost to Follow-up|1|||
128936682|NCT00532883|464055459|FG003|Overall Study|Lost to Follow-up|0|||
128936683|NCT00532883|464055456|FG000|Overall Study|Withdrawal by Subject|0|||
128705956|NCT00420927|463218504|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
128705957|NCT00420927|463218505|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
128705958|NCT00420927|463218499|FG000|Period 2|Subject unable to find transportation|0|||
128705959|NCT00420927|463218500|FG001|Period 2|Subject unable to find transportation|0|||
128705960|NCT00420927|463218501|FG002|Period 2|Subject unable to find transportation|0|||
128705961|NCT00420927|463218502|FG003|Period 2|Subject unable to find transportation|0|||
128705962|NCT00420927|463218503|FG004|Period 2|Subject unable to find transportation|0|||
128705963|NCT00420927|463218504|FG005|Period 2|Subject unable to find transportation|0|||
128705964|NCT00420927|463218505|FG006|Period 2|Subject unable to find transportation|1|||
128705965|NCT00420927|463218499|FG000|Period 2|Physician Decision|0|||
129132949|NCT04433975|464778574|FG000|9-month Follow Up|Death|0|||
129217062|NCT04922216|465094893|FG018|Overall Study|Lost to Follow-up|1|||
129217063|NCT04922216|465094894|FG019|Overall Study|Lost to Follow-up|0|||
129217064|NCT04922216|465094895|FG020|Overall Study|Lost to Follow-up|1|||
129217065|NCT04922216|465094896|FG021|Overall Study|Lost to Follow-up|0|||
129217066|NCT04922216|465094897|FG022|Overall Study|Lost to Follow-up|2|||
129217067|NCT04922216|465094898|FG023|Overall Study|Lost to Follow-up|1|||
129217068|NCT04922216|465094899|FG024|Overall Study|Lost to Follow-up|0|||
129217069|NCT04922216|465094900|FG025|Overall Study|Lost to Follow-up|2|||
129217070|NCT04922216|465094901|FG026|Overall Study|Lost to Follow-up|0|||
129217071|NCT04922216|465094902|FG027|Overall Study|Lost to Follow-up|0|||
129217072|NCT04922216|465094903|FG028|Overall Study|Lost to Follow-up|1|||
128936684|NCT00532883|464055457|FG001|Overall Study|Withdrawal by Subject|1|||
128936685|NCT00532883|464055458|FG002|Overall Study|Withdrawal by Subject|1|||
128936686|NCT00532883|464055459|FG003|Overall Study|Withdrawal by Subject|0|||
128936687|NCT00532883|464055456|FG000|Overall Study|Subject was Nonadherent|0|||
128936688|NCT00532883|464055457|FG001|Overall Study|Subject was Nonadherent|1|||
128936689|NCT00532883|464055458|FG002|Overall Study|Subject was Nonadherent|1|||
128936690|NCT00532883|464055459|FG003|Overall Study|Subject was Nonadherent|0|||
128936691|NCT00532883|464055456|FG000|Overall Study|Early Study Termination|4|||
128936692|NCT00532883|464055457|FG001|Overall Study|Early Study Termination|4|||
128936693|NCT00532883|464055458|FG002|Overall Study|Early Study Termination|1|||
128936694|NCT00532883|464055459|FG003|Overall Study|Early Study Termination|4|||
128936695|NCT01797783|464055460|FG000|Overall Study|Adverse Event|1|||
128936696|NCT01797783|464055461|FG001|Overall Study|Adverse Event|1|||
128936697|NCT01797783|464055460|FG000|Overall Study|Withdrawal by Subject|1|||
129217073|NCT04922216|465094904|FG029|Overall Study|Lost to Follow-up|0|||
129217074|NCT04922216|465094905|FG030|Overall Study|Lost to Follow-up|2|||
129217075|NCT04922216|465094906|FG031|Overall Study|Lost to Follow-up|1|||
129031425|NCT04556734|464406456|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129031426|NCT04556734|464406457|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129031427|NCT04556734|464406458|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129031428|NCT04556734|464406459|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129031429|NCT04556734|464406460|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129217076|NCT03926611|465096870|FG000|Overall Study|Adverse Event|0|||
129217077|NCT03926611|465096871|FG001|Overall Study|Adverse Event|0|||
129217078|NCT03926611|465096872|FG002|Overall Study|Adverse Event|0|||
129217079|NCT03926611|465096873|FG003|Overall Study|Adverse Event|3|||
129217080|NCT03926611|465096874|FG004|Overall Study|Adverse Event|1|||
129217081|NCT03926611|465096875|FG005|Overall Study|Adverse Event|3|||
129217082|NCT03926611|465096876|FG006|Overall Study|Adverse Event|0|||
129217083|NCT03926611|465096870|FG000|Overall Study|Lack of Efficacy|1|||
129217084|NCT03926611|465096871|FG001|Overall Study|Lack of Efficacy|2|||
129217085|NCT03926611|465096872|FG002|Overall Study|Lack of Efficacy|0|||
128705966|NCT00420927|463218500|FG001|Period 2|Physician Decision|0|||
128705967|NCT00420927|463218501|FG002|Period 2|Physician Decision|0|||
128705968|NCT00420927|463218502|FG003|Period 2|Physician Decision|0|||
128705969|NCT00420927|463218503|FG004|Period 2|Physician Decision|1|||
128705970|NCT00420927|463218504|FG005|Period 2|Physician Decision|1|||
128705971|NCT00420927|463218505|FG006|Period 2|Physician Decision|0|||
128705972|NCT00420927|463218499|FG000|Period 2|Sponsor decision|0|||
128705973|NCT00420927|463218500|FG001|Period 2|Sponsor decision|0|||
128705974|NCT00420927|463218501|FG002|Period 2|Sponsor decision|1|||
128705975|NCT00420927|463218502|FG003|Period 2|Sponsor decision|0|||
128705976|NCT00420927|463218503|FG004|Period 2|Sponsor decision|0|||
128705977|NCT00420927|463218504|FG005|Period 2|Sponsor decision|0|||
128705978|NCT00420927|463218505|FG006|Period 2|Sponsor decision|1|||
128705979|NCT00420927|463218499|FG000|Period 2|Randomization error|0|||
128705980|NCT00420927|463218500|FG001|Period 2|Randomization error|0|||
128705981|NCT00420927|463218501|FG002|Period 2|Randomization error|0|||
128705982|NCT00420927|463218502|FG003|Period 2|Randomization error|0|||
128705983|NCT00420927|463218503|FG004|Period 2|Randomization error|1|||
128705984|NCT00420927|463218504|FG005|Period 2|Randomization error|1|||
128705985|NCT00420927|463218505|FG006|Period 2|Randomization error|0|||
128705986|NCT00420927|463218499|FG000|Period 2|Noncompliant with study drug|0|||
129031430|NCT04556734|464406453|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129217086|NCT03926611|465096873|FG003|Overall Study|Lack of Efficacy|0|||
128705987|NCT00420927|463218500|FG001|Period 2|Noncompliant with study drug|0|||
128705988|NCT00420927|463218501|FG002|Period 2|Noncompliant with study drug|0|||
128705989|NCT00420927|463218502|FG003|Period 2|Noncompliant with study drug|1|||
128705990|NCT00420927|463218503|FG004|Period 2|Noncompliant with study drug|0|||
128705991|NCT00420927|463218504|FG005|Period 2|Noncompliant with study drug|0|||
128705992|NCT00420927|463218505|FG006|Period 2|Noncompliant with study drug|2|||
128705993|NCT00420927|463218499|FG000|Period 2|Methotrexate intolerance|0|||
128705994|NCT00420927|463218500|FG001|Period 2|Methotrexate intolerance|0|||
128936698|NCT01797783|464055461|FG001|Overall Study|Withdrawal by Subject|0|||
128936699|NCT05232097|464055464|FG000|Overall Study|Physician Decision|1|||
128936700|NCT01172288|464055465|FG000|Overall Study|Adverse Event|1|||
129217087|NCT03926611|465096874|FG004|Overall Study|Lack of Efficacy|1|||
129217088|NCT03926611|465096875|FG005|Overall Study|Lack of Efficacy|0|||
128936701|NCT01172288|464055466|FG001|Overall Study|Adverse Event|0|||
128936702|NCT01172288|464055465|FG000|Overall Study|Protocol Violation|0|||
128936703|NCT01172288|464055466|FG001|Overall Study|Protocol Violation|1|||
128936704|NCT00871858|464055469|FG000|Overall Study|Protocol Violation|3|||
128936705|NCT00871858|464055470|FG001|Overall Study|Protocol Violation|4|||
128936706|NCT00871858|464055469|FG000|Overall Study|Adverse Event|1|||
128936707|NCT00871858|464055470|FG001|Overall Study|Adverse Event|1|||
128936708|NCT00871858|464055469|FG000|Overall Study|Withdrawal by Subject|1|||
128936709|NCT00871858|464055470|FG001|Overall Study|Withdrawal by Subject|1|||
128936710|NCT00871858|464055469|FG000|Overall Study|Lost to Follow-up|0|||
128936711|NCT00871858|464055470|FG001|Overall Study|Lost to Follow-up|1|||
128936712|NCT03662334|464055471|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
128936713|NCT03662334|464055472|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
128936714|NCT02853331|464055483|FG000|Overall Study|Death|59|||
128936715|NCT02853331|464055484|FG001|Overall Study|Death|95|||
128936716|NCT02853331|464055483|FG000|Overall Study|Withdrawal by Subject|5|||
128936717|NCT02853331|464055484|FG001|Overall Study|Withdrawal by Subject|9|||
128936718|NCT02853331|464055483|FG000|Overall Study|Ongoing in study|368|||
128936719|NCT02853331|464055484|FG001|Overall Study|Ongoing in study|325|||
128936720|NCT03290300|464055487|FG000|Overall Study|Lost to Follow-up|3|||
128936721|NCT02746679|464055491|FG000|Overall Study|Lost to Follow-up|4|||
128936722|NCT02746679|464055492|FG001|Overall Study|Lost to Follow-up|6|||
128936723|NCT00487279|464055493|FG000|Overall Study|Death|1|||
128936724|NCT00487279|464055494|FG001|Overall Study|Death|0|||
128936725|NCT00487279|464055493|FG000|Overall Study|Withdrawal by Subject|0|||
128936726|NCT00487279|464055494|FG001|Overall Study|Withdrawal by Subject|2|||
128936727|NCT01520922|464055495|FG000|Treatment Phase|Physician Decision|2|||
128936728|NCT01520922|464055496|FG001|Treatment Phase|Physician Decision|1|||
128936729|NCT01520922|464055495|FG000|Treatment Phase|Progression|0|||
128936730|NCT01520922|464055496|FG001|Treatment Phase|Progression|2|||
128936731|NCT01520922|464055495|FG000|Treatment Phase|Adverse Event|3|||
128936732|NCT01520922|464055496|FG001|Treatment Phase|Adverse Event|5|||
128936733|NCT01520922|464055495|FG000|Follow up|Lost to Follow-up|0|||
128936734|NCT01520922|464055496|FG001|Follow up|Lost to Follow-up|1|||
128936735|NCT01520922|464055495|FG000|Survival Follow-up|Withdrawal by Subject|1|||
128936736|NCT01520922|464055496|FG001|Survival Follow-up|Withdrawal by Subject|0|||
128936737|NCT01618656|464055498|FG000|Overall Study|Withdrawal by Subject|7|||
128936738|NCT01618656|464055499|FG001|Overall Study|Withdrawal by Subject|3|||
128936739|NCT01618656|464055498|FG000|Overall Study|Physician Decision|1|||
128936740|NCT01618656|464055499|FG001|Overall Study|Physician Decision|1|||
128936741|NCT04770155|464055504|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129122497|NCT01799889|464744037|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
129122498|NCT01799889|464744038|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
129122499|NCT01799889|464744039|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
129122500|NCT01799889|464744040|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
129122501|NCT01799889|464744041|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
129122502|NCT01799889|464744042|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
128705995|NCT00420927|463218501|FG002|Period 2|Methotrexate intolerance|0|||
128705996|NCT00420927|463218502|FG003|Period 2|Methotrexate intolerance|0|||
128705997|NCT00420927|463218503|FG004|Period 2|Methotrexate intolerance|0|||
128705998|NCT00420927|463218504|FG005|Period 2|Methotrexate intolerance|0|||
128705999|NCT00420927|463218505|FG006|Period 2|Methotrexate intolerance|1|||
128706000|NCT00420927|463218499|FG000|Period 2|Took prohibited medication|0|||
128706001|NCT00420927|463218500|FG001|Period 2|Took prohibited medication|0|||
128706002|NCT00420927|463218501|FG002|Period 2|Took prohibited medication|0|||
128706003|NCT00420927|463218502|FG003|Period 2|Took prohibited medication|0|||
128706004|NCT00420927|463218503|FG004|Period 2|Took prohibited medication|1|||
128706005|NCT00420927|463218504|FG005|Period 2|Took prohibited medication|0|||
128706006|NCT00420927|463218505|FG006|Period 2|Took prohibited medication|0|||
128706007|NCT02246660|463218506|FG000|Overall Study|Withdrawal by Subject|0|||
128706008|NCT02246660|463218507|FG001|Overall Study|Withdrawal by Subject|1|||
128706009|NCT02246660|463218508|FG002|Overall Study|Withdrawal by Subject|0|||
129122503|NCT01799889|464744043|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
129122504|NCT01799889|464744044|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
128936742|NCT04770155|464055505|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
128936743|NCT04770155|464055506|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
128936744|NCT04770155|464055507|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
128936745|NCT04770155|464055508|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
128936746|NCT04770155|464055509|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
128706010|NCT02246660|463218506|FG000|Overall Study|Death|0|||
128706011|NCT02246660|463218507|FG001|Overall Study|Death|0|||
128706012|NCT02246660|463218508|FG002|Overall Study|Death|1|||
128706013|NCT03018704|463218509|FG000|Overall Study|Lost to Follow-up|1|||
129031431|NCT04556734|464406454|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129031432|NCT04556734|464406455|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129031433|NCT04556734|464406456|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129031434|NCT04556734|464406457|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129031435|NCT04556734|464406458|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129031436|NCT04556734|464406459|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129031437|NCT04556734|464406460|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129031438|NCT04556734|464406453|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
129031439|NCT04556734|464406454|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129122505|NCT01799889|464744045|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
129122506|NCT01799889|464744046|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
129122507|NCT01799889|464744047|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
128768420|NCT03813147|463442139|FG001|Overall Study|Lack of Efficacy|4|||
128768421|NCT03813147|463442138|FG000|Overall Study|Physician Decision|2|||
128768422|NCT03813147|463442139|FG001|Overall Study|Physician Decision|1|||
128768423|NCT01693692|463442140|FG000|Overall Study|Withdrawal by Subject|12|||
128768424|NCT01693692|463442141|FG001|Overall Study|Withdrawal by Subject|10|||
128768425|NCT01693692|463442142|FG002|Overall Study|Withdrawal by Subject|11|||
128768426|NCT01693692|463442140|FG000|Overall Study|Adverse Event|7|||
128768427|NCT01693692|463442141|FG001|Overall Study|Adverse Event|14|||
128768428|NCT01693692|463442142|FG002|Overall Study|Adverse Event|9|||
128768429|NCT01693692|463442140|FG000|Overall Study|Physician Decision|0|||
128768430|NCT01693692|463442141|FG001|Overall Study|Physician Decision|0|||
128768431|NCT01693692|463442142|FG002|Overall Study|Physician Decision|1|||
128768432|NCT01693692|463442140|FG000|Overall Study|Protocol Violation|5|||
128768433|NCT01693692|463442141|FG001|Overall Study|Protocol Violation|4|||
128768434|NCT01693692|463442142|FG002|Overall Study|Protocol Violation|6|||
128768435|NCT01693692|463442140|FG000|Overall Study|Lost to Follow-up|2|||
128768436|NCT01693692|463442141|FG001|Overall Study|Lost to Follow-up|2|||
128768437|NCT01693692|463442142|FG002|Overall Study|Lost to Follow-up|3|||
128768438|NCT01693692|463442140|FG000|Overall Study|Other|4|||
128768439|NCT01693692|463442141|FG001|Overall Study|Other|4|||
128768440|NCT01693692|463442142|FG002|Overall Study|Other|6|||
128768441|NCT04567693|463443981|FG000|Overall Study|Death|0|||
128768442|NCT04567693|463443982|FG001|Overall Study|Death|0|||
128768443|NCT04567693|463443983|FG002|Overall Study|Death|2|||
128768444|NCT04567693|463443981|FG000|Overall Study|Lost to Follow-up|1|||
128768445|NCT04567693|463443982|FG001|Overall Study|Lost to Follow-up|0|||
128768446|NCT04567693|463443983|FG002|Overall Study|Lost to Follow-up|2|||
128768447|NCT04567693|463443981|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
128768448|NCT04567693|463443982|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
128768449|NCT04567693|463443983|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
128768450|NCT03462706|463443986|FG000|Overall Study|Polyp was pedunculated|1|||
128768451|NCT03462706|463443987|FG001|Overall Study|Polyp was pedunculated|0|||
128768452|NCT03462706|463443988|FG002|Overall Study|Polyp was pedunculated|1|||
128768453|NCT03462706|463443989|FG003|Overall Study|Polyp was pedunculated|0|||
128768454|NCT03462706|463443986|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
128768455|NCT03462706|463443987|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
128768456|NCT03462706|463443988|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
128768457|NCT03462706|463443989|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
128768458|NCT04105972|463443994|FG000|Overall Study|Adverse Event|2|||
128768459|NCT04105972|463443995|FG001|Overall Study|Adverse Event|1|||
128768460|NCT00553202|463443996|FG000|Overall Study|Death|16|||
128768461|NCT00553202|463443996|FG000|Overall Study|Lost to Follow-up|1|||
128768462|NCT00553202|463443996|FG000|Overall Study|Physician Decision|28|||
129122508|NCT01799889|464744036|FG000|Overall Study|Study Terminated By Sponsor|1|||
129122509|NCT01799889|464744037|FG001|Overall Study|Study Terminated By Sponsor|0|||
129122510|NCT01799889|464744038|FG002|Overall Study|Study Terminated By Sponsor|0|||
129122511|NCT01799889|464744039|FG003|Overall Study|Study Terminated By Sponsor|0|||
129122512|NCT01799889|464744040|FG004|Overall Study|Study Terminated By Sponsor|2|||
129122513|NCT01799889|464744041|FG005|Overall Study|Study Terminated By Sponsor|1|||
128768463|NCT00553202|463443996|FG000|Overall Study|Withdrawal by Subject|1|||
128768464|NCT00553202|463443996|FG000|Overall Study|No donor identified|16|||
128768465|NCT00553202|463443996|FG000|Overall Study|Fails to meet organ function|6|||
129031440|NCT04556734|464406455|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129031441|NCT04556734|464406456|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129031442|NCT04556734|464406457|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129122514|NCT01799889|464744042|FG006|Overall Study|Study Terminated By Sponsor|0|||
128768466|NCT02593305|463443997|FG000|Post 1|Comparison only group. No intervention.|0|||
128768467|NCT02593305|463443998|FG001|Post 1|Comparison only group. No intervention.|0|||
128768468|NCT02593305|463443999|FG002|Post 1|Comparison only group. No intervention.|10|||
128768469|NCT01161472|463444000|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
128768470|NCT01161472|463444001|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
129122515|NCT01799889|464744043|FG007|Overall Study|Study Terminated By Sponsor|2|||
128936747|NCT04770155|464055510|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
128936748|NCT04770155|464055511|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
128936749|NCT00864227|464055515|FG000|Overall Study|Withdrawal by Subject|1|||
128936750|NCT00864227|464055515|FG000|Overall Study|Disease Relapse/Progression|3|||
128936751|NCT03461289|464055518|FG000|Overall Study|Death|1|||
128936752|NCT03242759|464055522|FG000|Overall Study|Adverse Event|5|||
128936753|NCT03242759|464055523|FG001|Overall Study|Adverse Event|1|||
128936754|NCT03242759|464055522|FG000|Overall Study|Withdrawal by Subject|4|||
128936755|NCT03242759|464055523|FG001|Overall Study|Withdrawal by Subject|3|||
128936756|NCT03242759|464055522|FG000|Overall Study|Lost to Follow-up|3|||
128936757|NCT03242759|464055523|FG001|Overall Study|Lost to Follow-up|1|||
128936758|NCT03242759|464055522|FG000|Overall Study|Administrative problems|1|||
128936759|NCT03242759|464055523|FG001|Overall Study|Administrative problems|1|||
128936760|NCT03242759|464055522|FG000|Overall Study|Death|22|||
128936761|NCT03242759|464055523|FG001|Overall Study|Death|0|||
128936762|NCT03242759|464055522|FG000|Overall Study|Change visit schedule|0|||
128936763|NCT03242759|464055523|FG001|Overall Study|Change visit schedule|1|||
128936764|NCT00336492|464055530|FG000|Overall Study|Adverse Event|4|||
128936765|NCT00336492|464055531|FG001|Overall Study|Adverse Event|3|||
128936766|NCT00336492|464055532|FG002|Overall Study|Adverse Event|6|||
128936767|NCT00336492|464055530|FG000|Overall Study|Lack of Efficacy|6|||
128936768|NCT00336492|464055531|FG001|Overall Study|Lack of Efficacy|1|||
128936769|NCT00336492|464055532|FG002|Overall Study|Lack of Efficacy|4|||
128936770|NCT00336492|464055530|FG000|Overall Study|Other|5|||
128936771|NCT00336492|464055531|FG001|Overall Study|Other|0|||
128936772|NCT00336492|464055532|FG002|Overall Study|Other|1|||
128936773|NCT04773041|464055537|FG000|Overall Study|Unable to data match|1|||
128936774|NCT04773041|464055538|FG001|Overall Study|Unable to data match|0|||
128706014|NCT03018704|463218510|FG001|Overall Study|Lost to Follow-up|1|||
128936775|NCT04773041|464055539|FG002|Overall Study|Unable to data match|0|||
128936776|NCT01522651|464055540|FG000|Overall Study|Adverse Event|3|||
128936777|NCT01522651|464055541|FG001|Overall Study|Adverse Event|4|||
128936778|NCT01522651|464055542|FG002|Overall Study|Adverse Event|4|||
128936779|NCT01522651|464055543|FG003|Overall Study|Adverse Event|5|||
128936780|NCT01522651|464055544|FG004|Overall Study|Adverse Event|4|||
128936781|NCT01522651|464055540|FG000|Overall Study|Cardioversion|1|||
128936782|NCT01522651|464055541|FG001|Overall Study|Cardioversion|0|||
128936783|NCT01522651|464055542|FG002|Overall Study|Cardioversion|0|||
128936784|NCT01522651|464055543|FG003|Overall Study|Cardioversion|0|||
128936785|NCT01522651|464055544|FG004|Overall Study|Cardioversion|0|||
128936786|NCT01522651|464055540|FG000|Overall Study|Device Malfunction|0|||
128936787|NCT01522651|464055541|FG001|Overall Study|Device Malfunction|1|||
128936788|NCT01522651|464055542|FG002|Overall Study|Device Malfunction|0|||
128936789|NCT01522651|464055543|FG003|Overall Study|Device Malfunction|0|||
128936790|NCT01522651|464055544|FG004|Overall Study|Device Malfunction|0|||
128936791|NCT01522651|464055540|FG000|Overall Study|Investigator's Discretion|0|||
128936792|NCT01522651|464055541|FG001|Overall Study|Investigator's Discretion|1|||
129031443|NCT04556734|464406458|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129031444|NCT04556734|464406459|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129031445|NCT04556734|464406460|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129031446|NCT04556734|464406453|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129031447|NCT04556734|464406454|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129031448|NCT04556734|464406455|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
129031449|NCT04556734|464406456|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129031450|NCT04556734|464406457|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129031451|NCT04556734|464406458|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129031452|NCT04556734|464406459|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129031453|NCT04556734|464406460|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129031454|NCT04556734|464406453|FG000|OLE Period (28 Weeks)|Not reported|0|||
129031455|NCT04556734|464406454|FG001|OLE Period (28 Weeks)|Not reported|0|||
129031456|NCT04556734|464406455|FG002|OLE Period (28 Weeks)|Not reported|0|||
129031457|NCT04556734|464406456|FG003|OLE Period (28 Weeks)|Not reported|0|||
129031458|NCT04556734|464406457|FG004|OLE Period (28 Weeks)|Not reported|0|||
129031459|NCT04556734|464406458|FG005|OLE Period (28 Weeks)|Not reported|1|||
129031460|NCT04556734|464406459|FG006|OLE Period (28 Weeks)|Not reported|0|||
129031461|NCT04556734|464406460|FG007|OLE Period (28 Weeks)|Not reported|0|||
129031462|NCT04556734|464406453|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129031463|NCT04556734|464406454|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129031464|NCT04556734|464406455|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129031465|NCT04556734|464406456|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129031466|NCT04556734|464406457|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129031467|NCT04556734|464406458|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
128936793|NCT01522651|464055542|FG002|Overall Study|Investigator's Discretion|0|||
128936794|NCT01522651|464055543|FG003|Overall Study|Investigator's Discretion|0|||
128936795|NCT01522651|464055544|FG004|Overall Study|Investigator's Discretion|0|||
128936796|NCT01522651|464055540|FG000|Overall Study|Protocol Violation|3|||
128936797|NCT01522651|464055541|FG001|Overall Study|Protocol Violation|0|||
128936798|NCT01522651|464055542|FG002|Overall Study|Protocol Violation|0|||
128936799|NCT01522651|464055543|FG003|Overall Study|Protocol Violation|0|||
128936800|NCT01522651|464055544|FG004|Overall Study|Protocol Violation|0|||
128936801|NCT01522651|464055540|FG000|Overall Study|Reason Not Specified|0|||
128936802|NCT01522651|464055541|FG001|Overall Study|Reason Not Specified|0|||
128936803|NCT01522651|464055542|FG002|Overall Study|Reason Not Specified|0|||
128936804|NCT01522651|464055543|FG003|Overall Study|Reason Not Specified|1|||
128936805|NCT01522651|464055544|FG004|Overall Study|Reason Not Specified|0|||
128936806|NCT01522651|464055540|FG000|Overall Study|Participant Non-Compliance|1|||
128936807|NCT01522651|464055541|FG001|Overall Study|Participant Non-Compliance|0|||
128936808|NCT01522651|464055542|FG002|Overall Study|Participant Non-Compliance|0|||
128936809|NCT01522651|464055543|FG003|Overall Study|Participant Non-Compliance|0|||
128936810|NCT01522651|464055544|FG004|Overall Study|Participant Non-Compliance|0|||
128936811|NCT01522651|464055540|FG000|Overall Study|Withdrew Consent|1|||
128936812|NCT01522651|464055541|FG001|Overall Study|Withdrew Consent|1|||
128936813|NCT01522651|464055542|FG002|Overall Study|Withdrew Consent|0|||
128936814|NCT01522651|464055543|FG003|Overall Study|Withdrew Consent|1|||
128936815|NCT01522651|464055544|FG004|Overall Study|Withdrew Consent|1|||
128936816|NCT01522651|464055540|FG000|Overall Study|Randomized but Never Treated|0|||
129122516|NCT01799889|464744044|FG008|Overall Study|Study Terminated By Sponsor|1|||
129122517|NCT01799889|464744045|FG009|Overall Study|Study Terminated By Sponsor|1|||
129122518|NCT01799889|464744046|FG010|Overall Study|Study Terminated By Sponsor|0|||
129122519|NCT01799889|464744047|FG011|Overall Study|Study Terminated By Sponsor|0|||
128706015|NCT02557646|463218514|FG000|Overall Study|Adverse Event|40|||
128706016|NCT02557646|463218514|FG000|Overall Study|Death|1|||
128706017|NCT02557646|463218514|FG000|Overall Study|Lack of Efficacy|186|||
128706018|NCT02557646|463218514|FG000|Overall Study|Withdrawal by Subject|18|||
128706019|NCT02557646|463218514|FG000|Overall Study|Lost to Follow-up|17|||
128706020|NCT02557646|463218514|FG000|Overall Study|Other|14|||
128706021|NCT04448171|463218515|FG000|Overall Study|Procedure Cancelled|1|||
128706022|NCT04448171|463218516|FG001|Overall Study|Procedure Cancelled|0|||
128706023|NCT04448171|463218515|FG000|Overall Study|Protocol Violation|1|||
128706024|NCT04448171|463218516|FG001|Overall Study|Protocol Violation|0|||
128706025|NCT00660309|463218519|FG000|Overall Study|Adverse Event|2|||
128706026|NCT00660309|463218520|FG001|Overall Study|Adverse Event|0|||
128706027|NCT00660309|463218519|FG000|Overall Study|Withdrawal by Subject|0|||
128706028|NCT00660309|463218520|FG001|Overall Study|Withdrawal by Subject|3|||
128706029|NCT02573311|463218521|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
128706030|NCT02573311|463218522|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
128706031|NCT02573311|463218521|FG000|Disposition for Part 2|Physician Decision|25|||
128706032|NCT02573311|463218522|FG001|Disposition for Part 2|Physician Decision|7|||
128706033|NCT02573311|463218521|FG000|Disposition for Part 2|Adverse Event|36|||
128706034|NCT02573311|463218522|FG001|Disposition for Part 2|Adverse Event|5|||
128706035|NCT02573311|463218521|FG000|Disposition for Part 2|Lost to Follow-up|76|||
128706036|NCT02573311|463218522|FG001|Disposition for Part 2|Lost to Follow-up|7|||
128706037|NCT02573311|463218521|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
128706038|NCT02573311|463218522|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
128706039|NCT02573311|463218521|FG000|Disposition for Part 2|Investigator decision|0|||
128706040|NCT02573311|463218522|FG001|Disposition for Part 2|Investigator decision|1|||
128706041|NCT02573311|463218521|FG000|Disposition for Part 2|Other than specified above|13|||
128706042|NCT02573311|463218522|FG001|Disposition for Part 2|Other than specified above|3|||
128706043|NCT04171531|463218524|FG000|Overall Study|Lost to Follow-up|4|||
128706044|NCT04171531|463218525|FG001|Overall Study|Lost to Follow-up|5|||
128706045|NCT04171531|463218524|FG000|Overall Study|Consent only through 6 months|1|||
128706046|NCT04171531|463218525|FG001|Overall Study|Consent only through 6 months|1|||
128706047|NCT04171531|463218524|FG000|Overall Study|Insurance did not cover procedure|0|||
128706048|NCT04171531|463218525|FG001|Overall Study|Insurance did not cover procedure|1|||
128706049|NCT04171531|463218524|FG000|Overall Study|Physician Decision|0|||
128706050|NCT04171531|463218525|FG001|Overall Study|Physician Decision|3|||
128706051|NCT04171531|463218524|FG000|Overall Study|Withdrawal by Subject|1|||
128706052|NCT04171531|463218525|FG001|Overall Study|Withdrawal by Subject|5|||
128706053|NCT03366337|463218529|FG000|Overall Study|Lost to Follow-up|1|||
128706054|NCT03366337|463218530|FG001|Overall Study|Lost to Follow-up|0|||
128706055|NCT03366337|463218531|FG002|Overall Study|Lost to Follow-up|1|||
128936817|NCT01522651|464055541|FG001|Overall Study|Randomized but Never Treated|1|||
128936818|NCT01522651|464055542|FG002|Overall Study|Randomized but Never Treated|0|||
128936819|NCT01522651|464055543|FG003|Overall Study|Randomized but Never Treated|1|||
129122520|NCT01799889|464744036|FG000|Overall Study|Withdrawal by Subject|1|||
129122521|NCT01799889|464744037|FG001|Overall Study|Withdrawal by Subject|6|||
128706056|NCT03366337|463218532|FG003|Overall Study|Lost to Follow-up|0|||
128706057|NCT03366337|463218529|FG000|Overall Study|Withdrawal by Subject|2|||
128706058|NCT03366337|463218530|FG001|Overall Study|Withdrawal by Subject|0|||
128706059|NCT03366337|463218531|FG002|Overall Study|Withdrawal by Subject|1|||
128706060|NCT03366337|463218532|FG003|Overall Study|Withdrawal by Subject|1|||
128706061|NCT05288062|463218534|FG000|Overall Study|Ineligible|0|||
128706062|NCT05288062|463218535|FG001|Overall Study|Ineligible|0|||
128706063|NCT05288062|463218536|FG002|Overall Study|Ineligible|1|||
128706064|NCT05288062|463218537|FG003|Overall Study|Ineligible|0|||
128706065|NCT05288062|463218534|FG000|Overall Study|Withdrawal by Subject|0|||
128706066|NCT05288062|463218535|FG001|Overall Study|Withdrawal by Subject|0|||
128706067|NCT05288062|463218536|FG002|Overall Study|Withdrawal by Subject|1|||
128706068|NCT05288062|463218537|FG003|Overall Study|Withdrawal by Subject|0|||
128706069|NCT00843024|463218538|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
128706070|NCT00843024|463218539|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
128706071|NCT00843024|463218540|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
128706072|NCT00843024|463218541|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
128706073|NCT00843024|463218542|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
128706074|NCT00843024|463218543|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
128706075|NCT00843024|463218538|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
128706076|NCT00843024|463218539|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
128706077|NCT00843024|463218540|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
128706078|NCT00843024|463218541|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
128706079|NCT00843024|463218542|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
128706080|NCT00843024|463218543|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
128706081|NCT00843024|463218538|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
128706082|NCT00843024|463218539|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
128706083|NCT00843024|463218540|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
128706084|NCT00843024|463218541|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
128706085|NCT00843024|463218542|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
128706086|NCT00843024|463218543|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
128706087|NCT00843024|463218538|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
128706088|NCT00843024|463218539|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
128706089|NCT00843024|463218540|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
128706090|NCT00843024|463218541|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
128706091|NCT00843024|463218542|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
128706092|NCT00843024|463218543|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
128706093|NCT00843024|463218538|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
128706094|NCT00843024|463218539|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
128706095|NCT00843024|463218540|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
128706096|NCT00843024|463218541|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
128706097|NCT00843024|463218542|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
128706098|NCT00843024|463218543|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
128706099|NCT00843024|463218538|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
128706100|NCT00843024|463218539|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
128706101|NCT00843024|463218540|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
128706102|NCT00843024|463218541|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
128706103|NCT00843024|463218542|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
128706104|NCT00843024|463218543|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
128706105|NCT00843024|463218538|FG000|Single-blind Placebo Run-In Phase|Other|0|||
128706106|NCT00843024|463218539|FG001|Single-blind Placebo Run-In Phase|Other|1|||
128706107|NCT00843024|463218540|FG002|Single-blind Placebo Run-In Phase|Other|0|||
128706108|NCT00843024|463218541|FG003|Single-blind Placebo Run-In Phase|Other|0|||
128706109|NCT00843024|463218542|FG004|Single-blind Placebo Run-In Phase|Other|0|||
128706110|NCT00843024|463218543|FG005|Single-blind Placebo Run-In Phase|Other|0|||
128706111|NCT00843024|463218538|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
128706112|NCT00843024|463218539|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
128706113|NCT00843024|463218540|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
128706114|NCT00843024|463218541|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
129031468|NCT04556734|464406459|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129031469|NCT04556734|464406460|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
129031470|NCT04556734|464406453|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
129031471|NCT04556734|464406454|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
129031472|NCT04556734|464406455|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
129031473|NCT04556734|464406456|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
129031474|NCT04556734|464406457|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
129031475|NCT04556734|464406458|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
129031476|NCT04556734|464406459|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
129122522|NCT01799889|464744038|FG002|Overall Study|Withdrawal by Subject|4|||
129122523|NCT01799889|464744039|FG003|Overall Study|Withdrawal by Subject|0|||
129122524|NCT01799889|464744040|FG004|Overall Study|Withdrawal by Subject|5|||
129031477|NCT04556734|464406460|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
129031478|NCT04556734|464406453|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129031479|NCT04556734|464406454|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
128768471|NCT01161472|463444002|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
128768472|NCT01161472|463444003|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
128768473|NCT00768430|463444026|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
128768474|NCT00768430|463444027|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
128768475|NCT00041756|463444029|FG000|Overall Study|Adverse Event|4|||
128768476|NCT00041756|463444030|FG001|Overall Study|Adverse Event|10|||
128768477|NCT00041756|463444031|FG002|Overall Study|Adverse Event|6|||
128768478|NCT00041756|463444032|FG003|Overall Study|Adverse Event|11|||
128768479|NCT00041756|463444033|FG004|Overall Study|Adverse Event|34|||
128768480|NCT00041756|463444029|FG000|Overall Study|Protocol Violation|1|||
128768481|NCT00041756|463444030|FG001|Overall Study|Protocol Violation|1|||
128768482|NCT00041756|463444031|FG002|Overall Study|Protocol Violation|2|||
128768483|NCT00041756|463444032|FG003|Overall Study|Protocol Violation|2|||
128768484|NCT00041756|463444033|FG004|Overall Study|Protocol Violation|1|||
128768485|NCT00041756|463444029|FG000|Overall Study|Withdrawal by Subject|3|||
128768486|NCT00041756|463444030|FG001|Overall Study|Withdrawal by Subject|3|||
128768487|NCT00041756|463444031|FG002|Overall Study|Withdrawal by Subject|4|||
128768488|NCT00041756|463444032|FG003|Overall Study|Withdrawal by Subject|2|||
128768489|NCT00041756|463444033|FG004|Overall Study|Withdrawal by Subject|3|||
128768490|NCT00041756|463444029|FG000|Overall Study|Lost to Follow-up|0|||
128768491|NCT00041756|463444030|FG001|Overall Study|Lost to Follow-up|1|||
128768492|NCT00041756|463444031|FG002|Overall Study|Lost to Follow-up|0|||
128768493|NCT00041756|463444032|FG003|Overall Study|Lost to Follow-up|1|||
128768494|NCT00041756|463444033|FG004|Overall Study|Lost to Follow-up|0|||
128768495|NCT00041756|463444029|FG000|Overall Study|Unable to meet protocol criteria|0|||
128768496|NCT00041756|463444030|FG001|Overall Study|Unable to meet protocol criteria|0|||
128768497|NCT00041756|463444031|FG002|Overall Study|Unable to meet protocol criteria|1|||
128768498|NCT00041756|463444032|FG003|Overall Study|Unable to meet protocol criteria|0|||
128768499|NCT00041756|463444033|FG004|Overall Study|Unable to meet protocol criteria|1|||
128768500|NCT00041756|463444029|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
128768501|NCT00041756|463444030|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
128768502|NCT00041756|463444031|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
128768503|NCT00041756|463444032|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
128768504|NCT00041756|463444033|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
128768505|NCT03980184|463444034|FG000|Overall Study|Dropped out before treatment|2|||
128768506|NCT03980184|463444035|FG001|Overall Study|Dropped out before treatment|2|||
128768507|NCT03980184|463444034|FG000|Overall Study|Lost to Follow-up|11|||
128768508|NCT03980184|463444035|FG001|Overall Study|Lost to Follow-up|13|||
128768509|NCT00603265|463444036|FG000|Overall Study|Adverse Event|2|||
128768510|NCT00603265|463444037|FG001|Overall Study|Adverse Event|11|||
128768511|NCT00603265|463444038|FG002|Overall Study|Adverse Event|1|||
128768512|NCT00603265|463444036|FG000|Overall Study|Withdrawal by Subject|1|||
128768513|NCT00603265|463444037|FG001|Overall Study|Withdrawal by Subject|2|||
128768514|NCT00603265|463444038|FG002|Overall Study|Withdrawal by Subject|1|||
128768515|NCT00603265|463444036|FG000|Overall Study|Lack of Efficacy|3|||
128768516|NCT00603265|463444037|FG001|Overall Study|Lack of Efficacy|0|||
128768517|NCT00603265|463444038|FG002|Overall Study|Lack of Efficacy|3|||
128768518|NCT00603265|463444036|FG000|Overall Study|Lost to Follow-up|0|||
128768519|NCT00603265|463444037|FG001|Overall Study|Lost to Follow-up|1|||
128768520|NCT00603265|463444038|FG002|Overall Study|Lost to Follow-up|0|||
128768521|NCT00603265|463444036|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
128768522|NCT00603265|463444037|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
128768523|NCT00603265|463444038|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
128768524|NCT00603265|463444036|FG000|Overall Study|Participant Left Country, No Responses|0|||
128768525|NCT00603265|463444037|FG001|Overall Study|Participant Left Country, No Responses|1|||
128768526|NCT00603265|463444038|FG002|Overall Study|Participant Left Country, No Responses|0|||
128768527|NCT00603265|463444036|FG000|Overall Study|Protocol Violation|1|||
128768528|NCT00603265|463444037|FG001|Overall Study|Protocol Violation|0|||
128768529|NCT00603265|463444038|FG002|Overall Study|Protocol Violation|0|||
128768530|NCT02002884|463444039|FG000|Main Period (MP)|Other|0|||
128768531|NCT02002884|463444040|FG001|Main Period (MP)|Other|3|||
128768532|NCT02002884|463444041|FG002|Main Period (MP)|Other|3|||
128768533|NCT02002884|463444042|FG003|Main Period (MP)|Other|0|||
128768534|NCT02002884|463444039|FG000|Main Period (MP)|Adverse Event|0|||
128768535|NCT02002884|463444040|FG001|Main Period (MP)|Adverse Event|1|||
129217089|NCT03926611|465096876|FG006|Overall Study|Lack of Efficacy|1|||
128768536|NCT02002884|463444041|FG002|Main Period (MP)|Adverse Event|1|||
128768537|NCT02002884|463444042|FG003|Main Period (MP)|Adverse Event|0|||
128768538|NCT02002884|463444039|FG000|Main Period (MP)|Withdrawal by Subject|6|||
128768539|NCT02002884|463444040|FG001|Main Period (MP)|Withdrawal by Subject|2|||
128768540|NCT02002884|463444041|FG002|Main Period (MP)|Withdrawal by Subject|2|||
128768541|NCT02002884|463444042|FG003|Main Period (MP)|Withdrawal by Subject|0|||
128768542|NCT02002884|463444039|FG000|Main Period (MP)|Lost to Follow-up|0|||
128768543|NCT02002884|463444040|FG001|Main Period (MP)|Lost to Follow-up|0|||
128768544|NCT02002884|463444041|FG002|Main Period (MP)|Lost to Follow-up|2|||
128936820|NCT01522651|464055544|FG004|Overall Study|Randomized but Never Treated|1|||
128768545|NCT02002884|463444042|FG003|Main Period (MP)|Lost to Follow-up|0|||
128768546|NCT02002884|463444039|FG000|Open-Label Extension Period (OLEX)|Other|0|||
128768547|NCT02002884|463444040|FG001|Open-Label Extension Period (OLEX)|Other|0|||
128768548|NCT02002884|463444041|FG002|Open-Label Extension Period (OLEX)|Other|0|||
128768549|NCT02002884|463444042|FG003|Open-Label Extension Period (OLEX)|Other|24|||
128936821|NCT02658656|464055545|FG000|Screening|Failed eligibility criteria|0|||
128936822|NCT02658656|464055546|FG001|Screening|Failed eligibility criteria|0|||
128936823|NCT02658656|464055547|FG002|Screening|Failed eligibility criteria|263|||
128936824|NCT02658656|464055545|FG000|Randomization|Withdrawal by Subject|8|||
128936825|NCT02658656|464055546|FG001|Randomization|Withdrawal by Subject|7|||
128936826|NCT02658656|464055547|FG002|Randomization|Withdrawal by Subject|0|||
128936827|NCT02658656|464055545|FG000|Randomization|Lost to Follow-up|1|||
128936828|NCT02658656|464055546|FG001|Randomization|Lost to Follow-up|3|||
128936829|NCT02658656|464055547|FG002|Randomization|Lost to Follow-up|0|||
128936830|NCT02658656|464055545|FG000|Randomization|Adverse Event|4|||
128936831|NCT02658656|464055546|FG001|Randomization|Adverse Event|0|||
128936832|NCT02658656|464055547|FG002|Randomization|Adverse Event|0|||
128936833|NCT02658656|464055545|FG000|Randomization|Administrative Termination|3|||
128936834|NCT02658656|464055546|FG001|Randomization|Administrative Termination|1|||
128936835|NCT02658656|464055547|FG002|Randomization|Administrative Termination|0|||
128936836|NCT02658656|464055545|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
128936837|NCT02658656|464055546|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
128936838|NCT02658656|464055547|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
128936839|NCT02658656|464055545|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
128936840|NCT02658656|464055546|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
128936841|NCT02658656|464055547|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
128936842|NCT02658656|464055545|FG000|Randomization|Not eligible for Randomization|1|||
128936843|NCT02658656|464055546|FG001|Randomization|Not eligible for Randomization|0|||
128936844|NCT02658656|464055547|FG002|Randomization|Not eligible for Randomization|0|||
128936845|NCT02658656|464055545|FG000|Randomization|Protocol Violation|1|||
128936846|NCT02658656|464055546|FG001|Randomization|Protocol Violation|0|||
128936847|NCT02658656|464055547|FG002|Randomization|Protocol Violation|0|||
128936848|NCT02322892|464056897|FG000|Overall Study|Surgery cancelled|1|||
128936849|NCT02322892|464056898|FG001|Overall Study|Surgery cancelled|2|||
128936850|NCT02322892|464056897|FG000|Overall Study|Met exclusion criteria|0|||
128936851|NCT02322892|464056898|FG001|Overall Study|Met exclusion criteria|1|||
128936852|NCT02322892|464056897|FG000|Overall Study|Protocol Violation|1|||
128936853|NCT02322892|464056898|FG001|Overall Study|Protocol Violation|0|||
128936854|NCT02125331|464056901|FG000|Overall Study|Protocol Violation|1|||
128936855|NCT02125331|464056902|FG001|Overall Study|Protocol Violation|0|||
128936856|NCT02125331|464056901|FG000|Overall Study|technical problem|2|||
128936857|NCT02125331|464056902|FG001|Overall Study|technical problem|0|||
128936858|NCT02125331|464056901|FG000|Overall Study|screen failure|2|||
128936859|NCT02125331|464056902|FG001|Overall Study|screen failure|0|||
128936860|NCT03504774|464056903|FG000|Overall Study|Adverse Event|2|||
128936861|NCT03504774|464056904|FG001|Overall Study|Adverse Event|0|||
128936862|NCT03504774|464056903|FG000|Overall Study|Lost to Follow-up|0|||
128936863|NCT03504774|464056904|FG001|Overall Study|Lost to Follow-up|1|||
128936864|NCT03504774|464056903|FG000|Overall Study|Protocol Violation|11|||
128936865|NCT03504774|464056904|FG001|Overall Study|Protocol Violation|3|||
128936866|NCT03504774|464056903|FG000|Overall Study|failed wk 52 DBPCFC|1|||
128936867|NCT03504774|464056904|FG001|Overall Study|failed wk 52 DBPCFC|0|||
128936868|NCT00915005|464056910|FG000|Overall Study|Withdrawal by Subject|4|||
128936869|NCT00915005|464056911|FG001|Overall Study|Withdrawal by Subject|4|||
128936870|NCT00915005|464056910|FG000|Overall Study|Patient preferred protons therapy|6|||
128936871|NCT00915005|464056911|FG001|Overall Study|Patient preferred protons therapy|0|||
128936872|NCT00915005|464056910|FG000|Overall Study|Insurance denial|3|||
128936873|NCT00915005|464056911|FG001|Overall Study|Insurance denial|15|||
128936874|NCT03554005|464056914|FG000|Overall Study|Not in participant's best interest|0|||
128936875|NCT03554005|464056915|FG001|Overall Study|Not in participant's best interest|0|||
128936876|NCT03554005|464056916|FG002|Overall Study|Not in participant's best interest|0|||
128936877|NCT03554005|464056917|FG003|Overall Study|Not in participant's best interest|0|||
128936878|NCT03554005|464056918|FG004|Overall Study|Not in participant's best interest|0|||
128936879|NCT03554005|464056919|FG005|Overall Study|Not in participant's best interest|1|||
128936880|NCT03554005|464056914|FG000|Overall Study|Disease Progression|1|||
128936881|NCT03554005|464056915|FG001|Overall Study|Disease Progression|1|||
128936882|NCT03554005|464056916|FG002|Overall Study|Disease Progression|1|||
128936883|NCT03554005|464056917|FG003|Overall Study|Disease Progression|1|||
128936884|NCT03554005|464056918|FG004|Overall Study|Disease Progression|5|||
128936885|NCT03554005|464056919|FG005|Overall Study|Disease Progression|6|||
128936886|NCT03554005|464056914|FG000|Overall Study|Adverse Event|0|||
128936887|NCT03554005|464056915|FG001|Overall Study|Adverse Event|0|||
129122525|NCT01799889|464744041|FG005|Overall Study|Withdrawal by Subject|1|||
128768550|NCT02002884|463444039|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
128936888|NCT03554005|464056916|FG002|Overall Study|Adverse Event|0|||
128706115|NCT00843024|463218542|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
128706116|NCT00843024|463218543|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
128706117|NCT00843024|463218538|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
128706118|NCT00843024|463218539|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
128706119|NCT00843024|463218540|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
128706120|NCT00843024|463218541|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
128706121|NCT00843024|463218542|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
128706122|NCT00843024|463218543|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
129031480|NCT04556734|464406455|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
128706123|NCT00843024|463218538|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
128706124|NCT00843024|463218539|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
128706125|NCT00843024|463218540|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
128706126|NCT00843024|463218541|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
128706127|NCT00843024|463218542|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
128706128|NCT00843024|463218543|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
128706129|NCT00843024|463218538|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
128706130|NCT00843024|463218539|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
128706131|NCT00843024|463218540|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
128706132|NCT00843024|463218541|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
128706133|NCT00843024|463218542|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
128706134|NCT00843024|463218543|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
128706135|NCT00843024|463218538|FG000|Double-blind Treatment Phase|Physician Decision|0|||
128706136|NCT00843024|463218539|FG001|Double-blind Treatment Phase|Physician Decision|0|||
128706137|NCT00843024|463218540|FG002|Double-blind Treatment Phase|Physician Decision|0|||
128706138|NCT00843024|463218541|FG003|Double-blind Treatment Phase|Physician Decision|3|||
128706139|NCT00843024|463218542|FG004|Double-blind Treatment Phase|Physician Decision|1|||
128706140|NCT00843024|463218543|FG005|Double-blind Treatment Phase|Physician Decision|1|||
128706141|NCT00843024|463218538|FG000|Double-blind Treatment Phase|Adverse Event|0|||
128706142|NCT00843024|463218539|FG001|Double-blind Treatment Phase|Adverse Event|0|||
129031481|NCT04556734|464406456|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
129031482|NCT04556734|464406457|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
129031483|NCT04556734|464406458|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
129031484|NCT04556734|464406459|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
129031485|NCT04556734|464406460|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129031486|NCT01680016|464406461|FG000|Overall Study|Adverse Event|0|||
129031487|NCT01680016|464406462|FG001|Overall Study|Adverse Event|0|||
129031488|NCT01680016|464406463|FG002|Overall Study|Adverse Event|1|||
129031489|NCT01680016|464406464|FG003|Overall Study|Adverse Event|4|||
129031490|NCT01680016|464406461|FG000|Overall Study|The Subject went out of The Trial|1|||
129031491|NCT01680016|464406462|FG001|Overall Study|The Subject went out of The Trial|0|||
129031492|NCT01680016|464406463|FG002|Overall Study|The Subject went out of The Trial|3|||
129031493|NCT01680016|464406464|FG003|Overall Study|The Subject went out of The Trial|0|||
129031494|NCT01680016|464406461|FG000|Overall Study|Protocol Violation|0|||
129031495|NCT01680016|464406462|FG001|Overall Study|Protocol Violation|1|||
129031496|NCT01680016|464406463|FG002|Overall Study|Protocol Violation|0|||
129031497|NCT01680016|464406464|FG003|Overall Study|Protocol Violation|0|||
129031498|NCT01680016|464406461|FG000|Overall Study|Withdrawal by Subject|5|||
129031499|NCT01680016|464406462|FG001|Overall Study|Withdrawal by Subject|7|||
129031500|NCT01680016|464406463|FG002|Overall Study|Withdrawal by Subject|1|||
129031501|NCT01680016|464406464|FG003|Overall Study|Withdrawal by Subject|1|||
129031502|NCT02485158|464406465|FG000|Overall Study|Withdrawal by Subject|3|||
129031503|NCT02485158|464406465|FG000|Overall Study|expected drug side effect|1|||
129031504|NCT01098851|464406468|FG000|Overall Study|Equipment failure|1|||
129031505|NCT01098851|464406469|FG001|Overall Study|Equipment failure|0|||
129031506|NCT03035890|464406470|FG000|Overall Study|Death|1|||
129031507|NCT00377156|464406472|FG000|Overall Study|Death|23|||
129031508|NCT00377156|464406473|FG001|Overall Study|Death|19|||
129031509|NCT00377156|464406472|FG000|Overall Study|Withdrawal by Subject|16|||
129031510|NCT00377156|464406473|FG001|Overall Study|Withdrawal by Subject|24|||
129031511|NCT00377156|464406472|FG000|Overall Study|Had follow-up <90 d|3|||
129031512|NCT00377156|464406473|FG001|Overall Study|Had follow-up <90 d|6|||
129031513|NCT00377156|464406472|FG000|Overall Study|Cancellation|1|||
129031514|NCT00377156|464406473|FG001|Overall Study|Cancellation|0|||
129031515|NCT00377156|464406472|FG000|Overall Study|Refused testing|0|||
129031516|NCT00377156|464406473|FG001|Overall Study|Refused testing|1|||
129031517|NCT00377156|464406472|FG000|Overall Study|Ineligible|0|||
129031518|NCT00377156|464406473|FG001|Overall Study|Ineligible|1|||
129031519|NCT00377156|464406472|FG000|Overall Study|Disability or language problem|0|||
129031520|NCT00377156|464406473|FG001|Overall Study|Disability or language problem|1|||
129031521|NCT00377156|464406472|FG000|Overall Study|Other|5|||
129031522|NCT00377156|464406473|FG001|Overall Study|Other|2|||
129031523|NCT00288704|464406474|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
128706143|NCT00843024|463218540|FG002|Double-blind Treatment Phase|Adverse Event|0|||
129132950|NCT04433975|464778575|FG001|9-month Follow Up|Death|1|||
128768551|NCT02002884|463444040|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
128768552|NCT02002884|463444041|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
128768553|NCT02002884|463444042|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
128768554|NCT02002884|463444039|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
128768555|NCT02002884|463444040|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
128768556|NCT02002884|463444041|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
128768557|NCT02002884|463444042|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
128768558|NCT02002884|463444039|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
128768559|NCT02002884|463444040|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
128768560|NCT02002884|463444041|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
128768561|NCT02002884|463444042|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
128768562|NCT02002884|463444039|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
128768563|NCT02002884|463444040|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
128768564|NCT02002884|463444041|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
128768565|NCT02002884|463444042|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
128768566|NCT02966002|463444043|FG000|Overall Study|Withdrawal by Subject|2|||
128768567|NCT02966002|463444043|FG000|Overall Study|Adverse Event|1|||
128768568|NCT02966002|463444043|FG000|Overall Study|Lost to Follow-up|1|||
128768569|NCT03377790|463444044|FG000|Overall Study|Withdrawal by Subject|1|||
128768570|NCT03377790|463444045|FG001|Overall Study|Withdrawal by Subject|0|||
128768571|NCT03377790|463444044|FG000|Overall Study|Adverse Event|1|||
128768572|NCT03377790|463444045|FG001|Overall Study|Adverse Event|0|||
128768573|NCT03377790|463444044|FG000|Overall Study|Lost to Follow-up|0|||
128768574|NCT03377790|463444045|FG001|Overall Study|Lost to Follow-up|2|||
128768575|NCT03377790|463444044|FG000|Overall Study|Randomized but not treated|1|||
128768576|NCT03377790|463444045|FG001|Overall Study|Randomized but not treated|0|||
128768577|NCT03377790|463444044|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
128768578|NCT03377790|463444045|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
128768579|NCT02632786|463444049|FG000|Overall Study|Adverse Event|2|||
128768580|NCT02632786|463444050|FG001|Overall Study|Adverse Event|1|||
128768581|NCT02632786|463444049|FG000|Overall Study|Death|3|||
128768582|NCT02632786|463444050|FG001|Overall Study|Death|2|||
128768583|NCT02632786|463444049|FG000|Overall Study|Physician Decision|5|||
128768584|NCT02632786|463444050|FG001|Overall Study|Physician Decision|4|||
128768585|NCT02632786|463444049|FG000|Overall Study|Withdrawal by Subject|1|||
128768586|NCT02632786|463444050|FG001|Overall Study|Withdrawal by Subject|0|||
128768587|NCT01235975|463444053|FG000|Overall Study|Serious Adverse Event|0|||
128768588|NCT01235975|463444054|FG001|Overall Study|Serious Adverse Event|1|||
128768589|NCT01235975|463444053|FG000|Overall Study|Withdrawal by Subject|8|||
128768590|NCT01235975|463444054|FG001|Overall Study|Withdrawal by Subject|2|||
128768591|NCT01235975|463444053|FG000|Overall Study|Migrated/moved from study area|2|||
128768592|NCT01235975|463444054|FG001|Overall Study|Migrated/moved from study area|1|||
128768593|NCT01235975|463444053|FG000|Overall Study|Lost to Follow-up|7|||
128768594|NCT01235975|463444054|FG001|Overall Study|Lost to Follow-up|3|||
128768595|NCT00422799|463444055|FG000|Overall Study|Withdrawal by Subject|6|||
128768596|NCT00422799|463444055|FG000|Overall Study|Adverse Event|7|||
128768597|NCT03560258|463444057|FG000|Overall Study|Lost to Follow-up|3|||
128768598|NCT03560258|463444058|FG001|Overall Study|Lost to Follow-up|0|||
128768599|NCT03560258|463444059|FG002|Overall Study|Lost to Follow-up|0|||
128768600|NCT03560258|463444057|FG000|Overall Study|Protocol Violation|0|||
128768601|NCT03560258|463444058|FG001|Overall Study|Protocol Violation|1|||
128768602|NCT03560258|463444059|FG002|Overall Study|Protocol Violation|0|||
128768603|NCT03560258|463444057|FG000|Overall Study|Withdrawal by Subject|0|||
128768604|NCT03560258|463444058|FG001|Overall Study|Withdrawal by Subject|0|||
128768605|NCT03560258|463444059|FG002|Overall Study|Withdrawal by Subject|1|||
128768606|NCT00192023|463444061|FG000|Period III - Double-Blind|Adverse Event|3|||
128936889|NCT03554005|464056917|FG003|Overall Study|Adverse Event|0|||
128936890|NCT03554005|464056918|FG004|Overall Study|Adverse Event|0|||
128936891|NCT03554005|464056919|FG005|Overall Study|Adverse Event|3|||
128936892|NCT03554005|464056914|FG000|Overall Study|Physician Decision|0|||
128936893|NCT03554005|464056915|FG001|Overall Study|Physician Decision|0|||
128936894|NCT03554005|464056916|FG002|Overall Study|Physician Decision|0|||
128936895|NCT03554005|464056917|FG003|Overall Study|Physician Decision|0|||
128936896|NCT03554005|464056918|FG004|Overall Study|Physician Decision|1|||
128936897|NCT03554005|464056919|FG005|Overall Study|Physician Decision|0|||
128936898|NCT03554005|464056914|FG000|Overall Study|Other|0|||
129122526|NCT01799889|464744042|FG006|Overall Study|Withdrawal by Subject|3|||
128768607|NCT00192023|463444062|FG001|Period III - Double-Blind|Adverse Event|0|||
128768608|NCT00192023|463444061|FG000|Period III - Double-Blind|Physician Decision|2|||
128768609|NCT00192023|463444062|FG001|Period III - Double-Blind|Physician Decision|0|||
128768610|NCT00192023|463444061|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
128768611|NCT00192023|463444062|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
128936899|NCT03554005|464056915|FG001|Overall Study|Other|0|||
128936900|NCT03554005|464056916|FG002|Overall Study|Other|0|||
128936901|NCT03554005|464056917|FG003|Overall Study|Other|0|||
128936902|NCT03554005|464056918|FG004|Overall Study|Other|0|||
128706144|NCT00843024|463218541|FG003|Double-blind Treatment Phase|Adverse Event|0|||
128706145|NCT00843024|463218542|FG004|Double-blind Treatment Phase|Adverse Event|1|||
128706146|NCT00843024|463218543|FG005|Double-blind Treatment Phase|Adverse Event|1|||
128706147|NCT00843024|463218538|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
128706148|NCT00843024|463218539|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
128706149|NCT00843024|463218540|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
128706150|NCT00843024|463218541|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
128706151|NCT00843024|463218542|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
128706152|NCT00843024|463218543|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
128706153|NCT02521870|463218549|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706154|NCT02521870|463218550|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
128706155|NCT02521870|463218551|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706156|NCT02521870|463218552|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706157|NCT02521870|463218553|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706158|NCT02521870|463218554|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706159|NCT02521870|463218555|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706160|NCT02521870|463218556|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706161|NCT02521870|463218557|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706162|NCT02521870|463218558|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706163|NCT02521870|463218559|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706164|NCT02521870|463218560|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128706165|NCT02521870|463218549|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
128706166|NCT02521870|463218550|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
128706167|NCT02521870|463218551|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
128706168|NCT02521870|463218552|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
128706169|NCT02521870|463218553|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
128706170|NCT02521870|463218554|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
128706171|NCT02521870|463218555|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
128706172|NCT02521870|463218556|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
128706173|NCT02521870|463218557|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
128706174|NCT02521870|463218558|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
128706175|NCT02521870|463218559|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
128706176|NCT02521870|463218560|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
128706177|NCT02521870|463218549|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
128706178|NCT02521870|463218550|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
128706179|NCT02521870|463218551|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
128706180|NCT02521870|463218552|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
128706181|NCT02521870|463218553|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
128706182|NCT02521870|463218554|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
128706183|NCT02521870|463218555|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
128706184|NCT02521870|463218556|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
128706185|NCT02521870|463218557|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
128706186|NCT02521870|463218558|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
128706187|NCT02521870|463218559|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
128706188|NCT02521870|463218560|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
128706189|NCT02521870|463218549|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128706190|NCT02521870|463218550|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128706191|NCT02521870|463218551|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128706192|NCT02521870|463218552|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128706193|NCT02521870|463218553|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
128706194|NCT02521870|463218554|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
128706195|NCT02521870|463218555|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
128706196|NCT02521870|463218556|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128706197|NCT02521870|463218557|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
128706198|NCT02521870|463218558|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
128706199|NCT02521870|463218559|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
128706200|NCT02521870|463218560|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128706201|NCT02521870|463218549|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
128706202|NCT02521870|463218550|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
128706203|NCT02521870|463218551|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
128706204|NCT02521870|463218552|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
128706205|NCT02521870|463218553|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
128706206|NCT02521870|463218554|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
128706207|NCT02521870|463218555|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
128706208|NCT02521870|463218556|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
128706209|NCT02521870|463218557|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
128706210|NCT02521870|463218558|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
128706211|NCT02521870|463218559|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
128706212|NCT02521870|463218560|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
128706213|NCT02521870|463218549|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
129122527|NCT01799889|464744043|FG007|Overall Study|Withdrawal by Subject|1|||
128706214|NCT02521870|463218550|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
128706215|NCT02521870|463218551|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
128706216|NCT02521870|463218552|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
128706217|NCT02521870|463218553|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
128706218|NCT02521870|463218554|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
128706219|NCT02521870|463218555|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
128706220|NCT02521870|463218556|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
128706221|NCT02521870|463218557|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
128706222|NCT02521870|463218558|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
128706223|NCT02521870|463218559|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
128706224|NCT02521870|463218560|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
128706225|NCT02521870|463218549|FG000|Phase 2: Dose Expansion|Death|0|||
128768612|NCT00192023|463444061|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
128768613|NCT00192023|463444062|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
128768614|NCT00192023|463444061|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
128768615|NCT00192023|463444062|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
128768616|NCT00192023|463444061|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
128768617|NCT00192023|463444062|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
128768618|NCT00192023|463444061|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
128768619|NCT00192023|463444062|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
128768620|NCT00192023|463444061|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
128768621|NCT00192023|463444062|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
128768622|NCT00192023|463444061|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
128768623|NCT00192023|463444062|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
128768624|NCT00192023|463444061|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
128768625|NCT00192023|463444062|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
128768626|NCT02086162|463444063|FG000|Overall Study|Withdrawal by Subject|4|||
128768627|NCT02086162|463444064|FG001|Overall Study|Withdrawal by Subject|4|||
128768628|NCT02086162|463444063|FG000|Overall Study|moved|1|||
128768629|NCT02086162|463444064|FG001|Overall Study|moved|1|||
128768630|NCT02086162|463444063|FG000|Overall Study|Lost to Follow-up|4|||
128768631|NCT02086162|463444064|FG001|Overall Study|Lost to Follow-up|2|||
128768632|NCT02086162|463444063|FG000|Overall Study|Death|1|||
128768633|NCT02086162|463444064|FG001|Overall Study|Death|0|||
128768634|NCT01027364|463444065|FG000|Overall Study|Adverse Event|1|||
128768635|NCT01027364|463444066|FG001|Overall Study|Adverse Event|0|||
128768636|NCT01027364|463444067|FG002|Overall Study|Adverse Event|1|||
128768637|NCT01027364|463444068|FG003|Overall Study|Adverse Event|0|||
128768638|NCT01027364|463444065|FG000|Overall Study|Lost to Follow-up|1|||
128768639|NCT01027364|463444066|FG001|Overall Study|Lost to Follow-up|0|||
128768640|NCT01027364|463444067|FG002|Overall Study|Lost to Follow-up|0|||
128768641|NCT01027364|463444068|FG003|Overall Study|Lost to Follow-up|0|||
128768642|NCT01027364|463444065|FG000|Overall Study|Protocol Violation|1|||
128768643|NCT01027364|463444066|FG001|Overall Study|Protocol Violation|0|||
128768644|NCT01027364|463444067|FG002|Overall Study|Protocol Violation|0|||
128768645|NCT01027364|463444068|FG003|Overall Study|Protocol Violation|1|||
128768646|NCT01027364|463444065|FG000|Overall Study|Withdrawal by Subject|1|||
128768647|NCT01027364|463444066|FG001|Overall Study|Withdrawal by Subject|2|||
128768648|NCT01027364|463444067|FG002|Overall Study|Withdrawal by Subject|0|||
128768649|NCT01027364|463444068|FG003|Overall Study|Withdrawal by Subject|0|||
128768650|NCT01003184|463444069|FG000|Overall Study|Adverse Event|12|||
128768651|NCT01003184|463444070|FG001|Overall Study|Adverse Event|5|||
128768652|NCT01003184|463444069|FG000|Overall Study|Lost to Follow-up|1|||
128768653|NCT01003184|463444070|FG001|Overall Study|Lost to Follow-up|0|||
129031524|NCT00288704|464406475|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
129031525|NCT00288704|464406476|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
129031526|NCT00288704|464406474|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
129031527|NCT00288704|464406475|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
129031528|NCT00288704|464406476|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
129031529|NCT00288704|464406474|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
129031530|NCT00288704|464406475|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
129031531|NCT00288704|464406476|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
129031532|NCT00288704|464406474|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
129031533|NCT00288704|464406475|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
129031534|NCT00288704|464406476|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
129031535|NCT00288704|464406474|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
129031536|NCT00288704|464406475|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
128706226|NCT02521870|463218550|FG001|Phase 2: Dose Expansion|Death|0|||
128768654|NCT01003184|463444069|FG000|Overall Study|Loss of glucose control|1|||
128768655|NCT01003184|463444070|FG001|Overall Study|Loss of glucose control|1|||
128768656|NCT01003184|463444069|FG000|Overall Study|Protocol Violation|3|||
128768657|NCT01003184|463444070|FG001|Overall Study|Protocol Violation|0|||
129031537|NCT00288704|464406476|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
128936903|NCT03554005|464056919|FG005|Overall Study|Other|1|||
128706227|NCT02521870|463218551|FG002|Phase 2: Dose Expansion|Death|0|||
128706228|NCT02521870|463218552|FG003|Phase 2: Dose Expansion|Death|0|||
128706229|NCT02521870|463218553|FG004|Phase 2: Dose Expansion|Death|1|||
128706230|NCT02521870|463218554|FG005|Phase 2: Dose Expansion|Death|1|||
128706231|NCT02521870|463218555|FG006|Phase 2: Dose Expansion|Death|3|||
128706232|NCT02521870|463218556|FG007|Phase 2: Dose Expansion|Death|1|||
128706233|NCT02521870|463218557|FG008|Phase 2: Dose Expansion|Death|1|||
128936904|NCT00631488|464056920|FG000|Overall Study|Adverse Event|1|||
129122528|NCT01799889|464744044|FG008|Overall Study|Withdrawal by Subject|2|||
129122529|NCT01799889|464744045|FG009|Overall Study|Withdrawal by Subject|1|||
129122530|NCT01799889|464744046|FG010|Overall Study|Withdrawal by Subject|1|||
129122531|NCT01799889|464744047|FG011|Overall Study|Withdrawal by Subject|1|||
129122532|NCT01799889|464744036|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129122533|NCT01799889|464744037|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129122534|NCT01799889|464744038|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129122535|NCT01799889|464744039|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129122536|NCT01799889|464744040|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129122537|NCT01799889|464744041|FG005|Overall Study|Non-Compliance With Study Drug|1|||
129122538|NCT01799889|464744042|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129122539|NCT01799889|464744043|FG007|Overall Study|Non-Compliance With Study Drug|0|||
129122540|NCT01799889|464744044|FG008|Overall Study|Non-Compliance With Study Drug|0|||
129122541|NCT01799889|464744045|FG009|Overall Study|Non-Compliance With Study Drug|0|||
129122542|NCT01799889|464744046|FG010|Overall Study|Non-Compliance With Study Drug|0|||
128706234|NCT02521870|463218558|FG009|Phase 2: Dose Expansion|Death|5|||
128706235|NCT02521870|463218559|FG010|Phase 2: Dose Expansion|Death|2|||
128706236|NCT02521870|463218560|FG011|Phase 2: Dose Expansion|Death|2|||
128706237|NCT02521870|463218549|FG000|Phase 2: Dose Expansion|Other|0|||
128706238|NCT02521870|463218550|FG001|Phase 2: Dose Expansion|Other|0|||
128706239|NCT02521870|463218551|FG002|Phase 2: Dose Expansion|Other|0|||
128706240|NCT02521870|463218552|FG003|Phase 2: Dose Expansion|Other|0|||
128706241|NCT02521870|463218553|FG004|Phase 2: Dose Expansion|Other|10|||
128706242|NCT02521870|463218554|FG005|Phase 2: Dose Expansion|Other|3|||
128706243|NCT02521870|463218555|FG006|Phase 2: Dose Expansion|Other|2|||
128706244|NCT02521870|463218556|FG007|Phase 2: Dose Expansion|Other|0|||
128706245|NCT02521870|463218557|FG008|Phase 2: Dose Expansion|Other|10|||
128706246|NCT02521870|463218558|FG009|Phase 2: Dose Expansion|Other|5|||
128706247|NCT02521870|463218559|FG010|Phase 2: Dose Expansion|Other|1|||
128706248|NCT02521870|463218560|FG011|Phase 2: Dose Expansion|Other|7|||
128706249|NCT02521870|463218549|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706250|NCT02521870|463218550|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706251|NCT02521870|463218551|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706252|NCT02521870|463218552|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706253|NCT02521870|463218553|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
128706254|NCT02521870|463218554|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706255|NCT02521870|463218555|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706256|NCT02521870|463218556|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706257|NCT02521870|463218557|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706258|NCT02521870|463218558|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706259|NCT02521870|463218559|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706260|NCT02521870|463218560|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128706261|NCT02521870|463218549|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706262|NCT02521870|463218550|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706263|NCT02521870|463218551|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706264|NCT02521870|463218552|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706265|NCT02521870|463218553|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
128706266|NCT02521870|463218554|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706267|NCT02521870|463218555|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706268|NCT02521870|463218556|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706269|NCT02521870|463218557|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706270|NCT02521870|463218558|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706271|NCT02521870|463218559|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706272|NCT02521870|463218560|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
128706273|NCT00519831|463218561|FG000|Overall Study|Adverse Event|3|||
128706274|NCT02854631|463218562|FG000|Overall Study|Adverse Event|1|||
128706275|NCT02854631|463218563|FG001|Overall Study|Adverse Event|2|||
128706276|NCT02854631|463218562|FG000|Overall Study|Withdrew Consent|3|||
128706277|NCT02854631|463218563|FG001|Overall Study|Withdrew Consent|2|||
129122543|NCT01799889|464744047|FG011|Overall Study|Non-Compliance With Study Drug|0|||
128706278|NCT02854631|463218562|FG000|Overall Study|Investigator's Discretion|2|||
128706279|NCT02854631|463218563|FG001|Overall Study|Investigator's Discretion|0|||
128706280|NCT02854631|463218562|FG000|Overall Study|Death|12|||
129122544|NCT02194465|464744052|FG000|Overall Study|Adverse Event|6|||
129122545|NCT02194465|464744053|FG001|Overall Study|Adverse Event|1|||
129122546|NCT02194465|464744054|FG002|Overall Study|Adverse Event|4|||
129122547|NCT02194465|464744055|FG003|Overall Study|Adverse Event|4|||
129122548|NCT02194465|464744056|FG004|Overall Study|Adverse Event|4|||
129122549|NCT02194465|464744057|FG005|Overall Study|Adverse Event|2|||
129122550|NCT02194465|464744058|FG006|Overall Study|Adverse Event|0|||
129122551|NCT02194465|464744052|FG000|Overall Study|Lost to Follow-up|0|||
129122552|NCT02194465|464744053|FG001|Overall Study|Lost to Follow-up|0|||
129122553|NCT02194465|464744054|FG002|Overall Study|Lost to Follow-up|0|||
129122554|NCT02194465|464744055|FG003|Overall Study|Lost to Follow-up|1|||
129122555|NCT02194465|464744056|FG004|Overall Study|Lost to Follow-up|0|||
129122556|NCT02194465|464744057|FG005|Overall Study|Lost to Follow-up|1|||
129122557|NCT02194465|464744058|FG006|Overall Study|Lost to Follow-up|0|||
129122558|NCT02194465|464744052|FG000|Overall Study|Physician Decision|1|||
129122559|NCT02194465|464744053|FG001|Overall Study|Physician Decision|0|||
129122560|NCT02194465|464744054|FG002|Overall Study|Physician Decision|0|||
129122561|NCT02194465|464744055|FG003|Overall Study|Physician Decision|0|||
129122562|NCT02194465|464744056|FG004|Overall Study|Physician Decision|0|||
129122563|NCT02194465|464744057|FG005|Overall Study|Physician Decision|0|||
129122564|NCT02194465|464744058|FG006|Overall Study|Physician Decision|0|||
129122565|NCT02194465|464744052|FG000|Overall Study|Protocol Violation|1|||
129122566|NCT02194465|464744053|FG001|Overall Study|Protocol Violation|1|||
129122567|NCT02194465|464744054|FG002|Overall Study|Protocol Violation|2|||
129122568|NCT02194465|464744055|FG003|Overall Study|Protocol Violation|1|||
129122569|NCT02194465|464744056|FG004|Overall Study|Protocol Violation|1|||
129122570|NCT02194465|464744057|FG005|Overall Study|Protocol Violation|0|||
129122571|NCT02194465|464744058|FG006|Overall Study|Protocol Violation|0|||
129122572|NCT02194465|464744052|FG000|Overall Study|Withdrawal by Subject|1|||
129122573|NCT02194465|464744053|FG001|Overall Study|Withdrawal by Subject|3|||
129122574|NCT02194465|464744054|FG002|Overall Study|Withdrawal by Subject|1|||
129122575|NCT02194465|464744055|FG003|Overall Study|Withdrawal by Subject|2|||
128706281|NCT02854631|463218563|FG001|Overall Study|Death|8|||
128706282|NCT02854631|463218562|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
128706283|NCT02854631|463218563|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
128706284|NCT02854631|463218562|FG000|Overall Study|Protocol Violation|0|||
128706285|NCT02854631|463218563|FG001|Overall Study|Protocol Violation|1|||
128706286|NCT02854631|463218562|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
128706287|NCT02854631|463218563|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
128706288|NCT02854631|463218562|FG000|Overall Study|Lost to Follow-up|4|||
128706289|NCT02854631|463218563|FG001|Overall Study|Lost to Follow-up|2|||
128706290|NCT00844896|463218564|FG000|Overall Study|Lost to Follow-up|12|||
128706291|NCT00844896|463218565|FG001|Overall Study|Lost to Follow-up|16|||
128706292|NCT00844896|463218564|FG000|Overall Study|Parents did not have time to complete|0|||
128706293|NCT00844896|463218565|FG001|Overall Study|Parents did not have time to complete|1|||
128706294|NCT02233647|463218566|FG000|Overall Study|Adverse Event|1|||
128706295|NCT04342897|463218567|FG000|Overall Study|Death|7|||
128706296|NCT04342897|463218568|FG001|Overall Study|Death|4|||
128706297|NCT04342897|463218567|FG000|Overall Study|Lost to Follow-up|6|||
128706298|NCT04342897|463218568|FG001|Overall Study|Lost to Follow-up|6|||
128706299|NCT04342897|463218567|FG000|Overall Study|Withdrawal by Subject|1|||
128706300|NCT04342897|463218568|FG001|Overall Study|Withdrawal by Subject|2|||
128706301|NCT02634320|463218570|FG000|Overall Study|Adverse Event|2|||
128706302|NCT02634320|463218570|FG000|Overall Study|Lost to Follow-up|3|||
128706303|NCT02634320|463218570|FG000|Overall Study|Moved out of area|2|||
128706304|NCT02634320|463218570|FG000|Overall Study|Out of window for study visits|1|||
128706305|NCT02634320|463218570|FG000|Overall Study|Protocol Violation|1|||
128706306|NCT02634320|463218570|FG000|Overall Study|Withdrawal by Subject|5|||
128706307|NCT02634320|463218570|FG000|Overall Study|Lack of Efficacy|2|||
128706308|NCT04656691|463218577|FG000|Overall Study|Adverse Event|1|||
128706309|NCT03199274|463218578|FG000|Overall Study|Withdrawal by Subject|4|||
128706310|NCT03199274|463218579|FG001|Overall Study|Withdrawal by Subject|0|||
128706311|NCT03199274|463218578|FG000|Overall Study|Lost to Follow-up|0|||
128706312|NCT03199274|463218579|FG001|Overall Study|Lost to Follow-up|1|||
128706313|NCT03199274|463218578|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
128706314|NCT03199274|463218579|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
128706315|NCT05980182|463218585|FG000|Overall Study|Lost to Follow-up|10|||
128706316|NCT02324569|463220442|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
128706317|NCT02324569|463220443|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
128706318|NCT02324569|463220442|FG000|Overall Study|Voluntary Withdrawal|3|||
128706319|NCT02324569|463220443|FG001|Overall Study|Voluntary Withdrawal|6|||
128706320|NCT02324569|463220442|FG000|Overall Study|Lack of Efficacy|2|||
128706321|NCT02324569|463220443|FG001|Overall Study|Lack of Efficacy|3|||
128706322|NCT02324569|463220442|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
128706323|NCT02324569|463220443|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
128706324|NCT02324569|463220442|FG000|Overall Study|Inconvenient Schedule|2|||
128706325|NCT02324569|463220443|FG001|Overall Study|Inconvenient Schedule|0|||
128706326|NCT01943292|463220450|FG000|Overall Study|Withdrawal by Subject|1|||
129122576|NCT02194465|464744056|FG004|Overall Study|Withdrawal by Subject|2|||
129122577|NCT02194465|464744057|FG005|Overall Study|Withdrawal by Subject|1|||
128706327|NCT01943292|463220451|FG001|Overall Study|Withdrawal by Subject|0|||
128706328|NCT01943292|463220452|FG002|Overall Study|Withdrawal by Subject|0|||
128706329|NCT00911820|463220453|FG000|Overall Study|RECIST progression|12|||
128706330|NCT00911820|463220454|FG001|Overall Study|RECIST progression|8|||
128706331|NCT00911820|463220453|FG000|Overall Study|Adverse Event|8|||
128706332|NCT00911820|463220454|FG001|Overall Study|Adverse Event|8|||
128706333|NCT00911820|463220453|FG000|Overall Study|Clinical Progression|7|||
128706334|NCT00911820|463220454|FG001|Overall Study|Clinical Progression|5|||
128706335|NCT00911820|463220453|FG000|Overall Study|Physician Decision|5|||
128706336|NCT00911820|463220454|FG001|Overall Study|Physician Decision|9|||
128706337|NCT00911820|463220453|FG000|Overall Study|Decline in Performance Status|4|||
128706338|NCT00911820|463220454|FG001|Overall Study|Decline in Performance Status|2|||
128706339|NCT00911820|463220453|FG000|Overall Study|Withdrawal by Subject|3|||
128706340|NCT00911820|463220454|FG001|Overall Study|Withdrawal by Subject|4|||
128706341|NCT00911820|463220453|FG000|Overall Study|Death|1|||
128706342|NCT00911820|463220454|FG001|Overall Study|Death|2|||
128706343|NCT00911820|463220453|FG000|Overall Study|Pursue surgery|1|||
128706344|NCT00911820|463220454|FG001|Overall Study|Pursue surgery|1|||
128706345|NCT00911820|463220453|FG000|Overall Study|Pursue Radiation|1|||
128706346|NCT00911820|463220454|FG001|Overall Study|Pursue Radiation|0|||
128706347|NCT00911820|463220453|FG000|Overall Study|Still on Therapy|2|||
128706348|NCT00911820|463220454|FG001|Overall Study|Still on Therapy|2|||
128706349|NCT00911820|463220453|FG000|Overall Study|Pathology Not Confirmed|1|||
128706350|NCT00911820|463220454|FG001|Overall Study|Pathology Not Confirmed|0|||
128706351|NCT00911820|463220453|FG000|Overall Study|Withdraw before Receive Treatment|0|||
128706352|NCT00911820|463220454|FG001|Overall Study|Withdraw before Receive Treatment|2|||
128706353|NCT01852110|463220455|FG000|Overall Study|Adverse Event|12|||
128706354|NCT01852110|463220456|FG001|Overall Study|Adverse Event|5|||
128706355|NCT01852110|463220457|FG002|Overall Study|Adverse Event|0|||
128706356|NCT01852110|463220458|FG003|Overall Study|Adverse Event|0|||
128706357|NCT01852110|463220459|FG004|Overall Study|Adverse Event|0|||
128706358|NCT01852110|463220460|FG005|Overall Study|Adverse Event|0|||
128706359|NCT01852110|463220455|FG000|Overall Study|Lost to Follow-up|1|||
128706360|NCT01852110|463220456|FG001|Overall Study|Lost to Follow-up|3|||
128706361|NCT01852110|463220457|FG002|Overall Study|Lost to Follow-up|0|||
128706362|NCT01852110|463220458|FG003|Overall Study|Lost to Follow-up|0|||
128706363|NCT01852110|463220459|FG004|Overall Study|Lost to Follow-up|0|||
128706364|NCT01852110|463220460|FG005|Overall Study|Lost to Follow-up|0|||
128706365|NCT01852110|463220455|FG000|Overall Study|Non-compliance with Study Drug|2|||
128706366|NCT01852110|463220456|FG001|Overall Study|Non-compliance with Study Drug|1|||
128706367|NCT01852110|463220457|FG002|Overall Study|Non-compliance with Study Drug|0|||
128706368|NCT01852110|463220458|FG003|Overall Study|Non-compliance with Study Drug|0|||
128706369|NCT01852110|463220459|FG004|Overall Study|Non-compliance with Study Drug|0|||
128706370|NCT01852110|463220460|FG005|Overall Study|Non-compliance with Study Drug|0|||
128706371|NCT01852110|463220455|FG000|Overall Study|Physician Decision|1|||
128706372|NCT01852110|463220456|FG001|Overall Study|Physician Decision|0|||
128706373|NCT01852110|463220457|FG002|Overall Study|Physician Decision|0|||
129031538|NCT00288704|464406474|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
129031539|NCT00288704|464406475|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
129031540|NCT00288704|464406476|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
129031541|NCT00288704|464406474|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
129031542|NCT00288704|464406475|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
129031543|NCT00288704|464406476|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
129031544|NCT01579006|464406477|FG000|Overall Study|Lack of Efficacy|10|||
129031545|NCT01579006|464406477|FG000|Overall Study|Adverse Event|13|||
129031546|NCT01579006|464406477|FG000|Overall Study|Withdrawal by Subject|5|||
129031547|NCT01579006|464406477|FG000|Overall Study|Non-compliance|3|||
129031548|NCT01579006|464406477|FG000|Overall Study|Due to participant's health fund|1|||
129031549|NCT01579006|464406477|FG000|Overall Study|Scheduled surgery|1|||
129031550|NCT03343639|464406480|FG000|Overall Study|Withdrawal by Subject|10|||
129031551|NCT03343639|464406481|FG001|Overall Study|Withdrawal by Subject|6|||
129031552|NCT03343639|464406480|FG000|Overall Study|Lost to Follow-up|4|||
129031553|NCT03343639|464406481|FG001|Overall Study|Lost to Follow-up|5|||
129031554|NCT03343639|464406480|FG000|Overall Study|Protocol Violation|0|||
129031555|NCT03343639|464406481|FG001|Overall Study|Protocol Violation|1|||
129031556|NCT05061992|464406482|FG000|Overall Study|Excess bowel movements|1|||
129031557|NCT05061992|464406483|FG001|Overall Study|Excess bowel movements|0|||
129031558|NCT05061992|464406482|FG000|Overall Study|Complications of Medical Care|1|||
129031559|NCT05061992|464406483|FG001|Overall Study|Complications of Medical Care|0|||
128706374|NCT01852110|463220458|FG003|Overall Study|Physician Decision|0|||
128706375|NCT01852110|463220459|FG004|Overall Study|Physician Decision|0|||
129031560|NCT05061992|464406482|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
129031561|NCT05061992|464406483|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
129031562|NCT05061992|464406482|FG000|Overall Study|Withdrawal by Subject|0|||
129217090|NCT03926611|465096870|FG000|Overall Study|Physician Decision|0|||
128706376|NCT01852110|463220460|FG005|Overall Study|Physician Decision|0|||
128706377|NCT01852110|463220455|FG000|Overall Study|Protocol Violation|0|||
129217091|NCT03926611|465096871|FG001|Overall Study|Physician Decision|0|||
128768658|NCT01003184|463444069|FG000|Overall Study|Withdrawal by Subject|1|||
128768659|NCT01003184|463444070|FG001|Overall Study|Withdrawal by Subject|6|||
128768660|NCT01003184|463444069|FG000|Overall Study|Physician Decision|1|||
128768661|NCT01003184|463444070|FG001|Overall Study|Physician Decision|0|||
128768662|NCT03662997|463444071|FG000|Overall Study|Adverse Event|0|||
128768663|NCT03662997|463444072|FG001|Overall Study|Adverse Event|2|||
128768664|NCT03662997|463444073|FG002|Overall Study|Adverse Event|0|||
128768665|NCT03662997|463444074|FG003|Overall Study|Adverse Event|0|||
128768666|NCT01719224|463444075|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
128768667|NCT01719224|463444076|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
128768668|NCT03000673|463444077|FG000|Overall Study|Withdrawal by Subject|1|||
128768669|NCT03000673|463444078|FG001|Overall Study|Withdrawal by Subject|0|||
128768670|NCT03000673|463444079|FG002|Overall Study|Withdrawal by Subject|0|||
128768671|NCT03000673|463444080|FG003|Overall Study|Withdrawal by Subject|0|||
128768672|NCT01121484|463444081|FG000|Overall Study|Adverse Event|12|||
128768673|NCT01121484|463444082|FG001|Overall Study|Adverse Event|5|||
128768674|NCT01121484|463444081|FG000|Overall Study|Lack of Efficacy|3|||
128768675|NCT01121484|463444082|FG001|Overall Study|Lack of Efficacy|11|||
128768676|NCT01121484|463444081|FG000|Overall Study|Lost to Follow-up|5|||
128768677|NCT01121484|463444082|FG001|Overall Study|Lost to Follow-up|9|||
128768678|NCT01121484|463444081|FG000|Overall Study|Physician Decision|0|||
128768679|NCT01121484|463444082|FG001|Overall Study|Physician Decision|3|||
128768680|NCT01121484|463444081|FG000|Overall Study|Protocol Violation|1|||
128768681|NCT01121484|463444082|FG001|Overall Study|Protocol Violation|0|||
128768682|NCT01121484|463444081|FG000|Overall Study|Withdrawal by Subject|8|||
128768683|NCT01121484|463444082|FG001|Overall Study|Withdrawal by Subject|7|||
128768684|NCT01121484|463444081|FG000|Overall Study|Discontinuation of study by sponsor|0|||
128768685|NCT01121484|463444082|FG001|Overall Study|Discontinuation of study by sponsor|1|||
128768686|NCT01121484|463444081|FG000|Overall Study|Other|3|||
128768687|NCT01121484|463444082|FG001|Overall Study|Other|3|||
128768688|NCT01121484|463444081|FG000|Overall Study|Randomized, not treated|1|||
128768689|NCT01121484|463444082|FG001|Overall Study|Randomized, not treated|4|||
128768690|NCT00675506|463444086|FG000|Overall Study|Lost to Follow-up|1|||
128768691|NCT00675506|463444087|FG001|Overall Study|Lost to Follow-up|5|||
128768692|NCT00675506|463444086|FG000|Overall Study|Lost interest|3|||
128768693|NCT00675506|463444087|FG001|Overall Study|Lost interest|5|||
128768694|NCT00675506|463444086|FG000|Overall Study|Elevated fasting glucose|2|||
128768695|NCT00675506|463444087|FG001|Overall Study|Elevated fasting glucose|1|||
128768696|NCT00675506|463444086|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
128768697|NCT00675506|463444087|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
128768698|NCT00675506|463444086|FG000|Overall Study|Elevated IGF-1|2|||
128768699|NCT00675506|463444087|FG001|Overall Study|Elevated IGF-1|0|||
128768700|NCT00675506|463444086|FG000|Overall Study|Hypersensitivity Reaction|1|||
128768701|NCT00675506|463444087|FG001|Overall Study|Hypersensitivity Reaction|0|||
128768702|NCT00675506|463444086|FG000|Overall Study|Disclosed history of cancer|1|||
128768703|NCT00675506|463444087|FG001|Overall Study|Disclosed history of cancer|0|||
128768704|NCT00675506|463444086|FG000|Overall Study|Declined participation|1|||
128768705|NCT00675506|463444087|FG001|Overall Study|Declined participation|0|||
128768706|NCT00675506|463444086|FG000|Overall Study|Schedule conflict|0|||
128768707|NCT00675506|463444087|FG001|Overall Study|Schedule conflict|1|||
129217092|NCT03926611|465096872|FG002|Overall Study|Physician Decision|0|||
128768708|NCT03820323|463444088|FG000|Overall Study|Lost to Follow-up|2|||
128768709|NCT03820323|463444089|FG001|Overall Study|Lost to Follow-up|1|||
129031563|NCT05061992|464406483|FG001|Overall Study|Withdrawal by Subject|1|||
129031564|NCT02473393|464406484|FG000|Overall Study|Adverse Event|0|||
129031565|NCT02473393|464406485|FG001|Overall Study|Adverse Event|0|||
129031566|NCT02473393|464406486|FG002|Overall Study|Adverse Event|1|||
129031567|NCT02473393|464406487|FG003|Overall Study|Adverse Event|0|||
129031568|NCT02473393|464406484|FG000|Overall Study|Withdrawal by Subject|0|||
129031569|NCT02473393|464406485|FG001|Overall Study|Withdrawal by Subject|0|||
129031570|NCT02473393|464406486|FG002|Overall Study|Withdrawal by Subject|1|||
129031571|NCT02473393|464406487|FG003|Overall Study|Withdrawal by Subject|1|||
129031572|NCT04968925|464406491|FG000|Phase I- Period 1|COVID-19 related|0|||
129031573|NCT04968925|464406492|FG001|Phase I- Period 1|COVID-19 related|1|||
129031574|NCT04968925|464406493|FG002|Phase I- Period 1|COVID-19 related|0|||
129217093|NCT03926611|465096873|FG003|Overall Study|Physician Decision|0|||
129031575|NCT04968925|464406494|FG003|Phase I- Period 1|COVID-19 related|0|||
128768710|NCT03820323|463444088|FG000|Overall Study|Missed 12-month visit|22|||
128768711|NCT03820323|463444089|FG001|Overall Study|Missed 12-month visit|14|||
128768712|NCT03820323|463444088|FG000|Overall Study|Death|2|||
128768713|NCT03820323|463444089|FG001|Overall Study|Death|1|||
128768714|NCT03820323|463444088|FG000|Overall Study|Transferred out|13|||
128768715|NCT03820323|463444089|FG001|Overall Study|Transferred out|11|||
128768716|NCT03820323|463444088|FG000|Overall Study|Terminated|0|||
128768717|NCT03820323|463444089|FG001|Overall Study|Terminated|3|||
128768718|NCT03820323|463444088|FG000|Overall Study|Withdrawal by Subject|1|||
128768719|NCT03820323|463444089|FG001|Overall Study|Withdrawal by Subject|6|||
128706378|NCT01852110|463220456|FG001|Overall Study|Protocol Violation|1|||
128706379|NCT01852110|463220457|FG002|Overall Study|Protocol Violation|0|||
128706380|NCT01852110|463220458|FG003|Overall Study|Protocol Violation|0|||
128706381|NCT01852110|463220459|FG004|Overall Study|Protocol Violation|0|||
128706382|NCT01852110|463220460|FG005|Overall Study|Protocol Violation|0|||
128706383|NCT01852110|463220455|FG000|Overall Study|Study Terminated by Sponsor|30|||
128706384|NCT01852110|463220456|FG001|Overall Study|Study Terminated by Sponsor|32|||
128706385|NCT01852110|463220457|FG002|Overall Study|Study Terminated by Sponsor|0|||
128706386|NCT01852110|463220458|FG003|Overall Study|Study Terminated by Sponsor|0|||
128706387|NCT01852110|463220459|FG004|Overall Study|Study Terminated by Sponsor|0|||
128706388|NCT01852110|463220460|FG005|Overall Study|Study Terminated by Sponsor|0|||
128706389|NCT01852110|463220455|FG000|Overall Study|Withdrawal by Subject|4|||
128706390|NCT01852110|463220456|FG001|Overall Study|Withdrawal by Subject|4|||
128706391|NCT01852110|463220457|FG002|Overall Study|Withdrawal by Subject|0|||
128706392|NCT01852110|463220458|FG003|Overall Study|Withdrawal by Subject|0|||
128706393|NCT01852110|463220459|FG004|Overall Study|Withdrawal by Subject|0|||
128706394|NCT01852110|463220460|FG005|Overall Study|Withdrawal by Subject|0|||
128706395|NCT00309387|463220465|FG000|Overall Study|Death|72|||
128706396|NCT00309387|463220466|FG001|Overall Study|Death|73|||
128706397|NCT00309387|463220465|FG000|Overall Study|Lost to Follow-up|70|||
128706398|NCT00309387|463220466|FG001|Overall Study|Lost to Follow-up|86|||
128706399|NCT02483520|463220467|FG000|Overall Study|Lost to Follow-up|3|||
128706400|NCT02483520|463220468|FG001|Overall Study|Lost to Follow-up|4|||
128936905|NCT00631488|464056921|FG001|Overall Study|Adverse Event|0|||
128936906|NCT00631488|464056922|FG002|Overall Study|Adverse Event|0|||
128706401|NCT02483520|463220467|FG000|Overall Study|Withdrawal by Subject|4|||
128706402|NCT02483520|463220468|FG001|Overall Study|Withdrawal by Subject|14|||
128706403|NCT02483520|463220467|FG000|Overall Study|Hospitalized|2|||
128706404|NCT02483520|463220468|FG001|Overall Study|Hospitalized|3|||
128706405|NCT02483520|463220467|FG000|Overall Study|Moved to LTC|2|||
128706406|NCT02483520|463220468|FG001|Overall Study|Moved to LTC|3|||
128706407|NCT03902574|463220478|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
128706408|NCT03902574|463220479|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
128706409|NCT03902574|463220480|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
128706410|NCT04492618|463220482|FG000|Overall Study|Withdrawal by Subject|1|||
128706411|NCT02485301|463220483|FG000|Overall Study|Serious Adverse Events|2|||
128706412|NCT02485301|463220484|FG001|Overall Study|Serious Adverse Events|1|||
128706413|NCT02485301|463220483|FG000|Overall Study|Protocol Violation|0|||
128706414|NCT02485301|463220484|FG001|Overall Study|Protocol Violation|1|||
128706415|NCT02485301|463220483|FG000|Overall Study|Withdrawal by Subject|6|||
128706416|NCT02485301|463220484|FG001|Overall Study|Withdrawal by Subject|7|||
128706417|NCT02485301|463220483|FG000|Overall Study|Migrated/moved from study area|10|||
128706418|NCT02485301|463220484|FG001|Overall Study|Migrated/moved from study area|19|||
128706419|NCT02485301|463220483|FG000|Overall Study|Lost to Follow-up|17|||
128706420|NCT02485301|463220484|FG001|Overall Study|Lost to Follow-up|17|||
128706421|NCT02485301|463220483|FG000|Overall Study|Other|3|||
128706422|NCT02485301|463220484|FG001|Overall Study|Other|4|||
128706423|NCT01059825|463220488|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
128706424|NCT01059825|463220489|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
128706425|NCT01059825|463220490|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
128706426|NCT01059825|463220491|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
128706427|NCT01059825|463220492|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
128706428|NCT01059825|463220493|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
128706429|NCT01059825|463220494|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
128706430|NCT01059825|463220488|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
128706431|NCT01059825|463220489|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
128706432|NCT01059825|463220490|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
128706433|NCT01059825|463220491|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
128706434|NCT01059825|463220492|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
128706435|NCT01059825|463220493|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
128706436|NCT01059825|463220494|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
128706437|NCT01059825|463220488|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
128936907|NCT00631488|464056920|FG000|Overall Study|Lost to Follow-up|2|||
128936908|NCT00631488|464056921|FG001|Overall Study|Lost to Follow-up|2|||
128706438|NCT01059825|463220489|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
128706439|NCT01059825|463220490|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
128706440|NCT01059825|463220491|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
128706441|NCT01059825|463220492|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
128706442|NCT01059825|463220493|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
128936909|NCT00631488|464056922|FG002|Overall Study|Lost to Follow-up|0|||
128936910|NCT00631488|464056920|FG000|Overall Study|Physician Decision|1|||
128936911|NCT00631488|464056921|FG001|Overall Study|Physician Decision|0|||
128936912|NCT00631488|464056922|FG002|Overall Study|Physician Decision|1|||
128936913|NCT00631488|464056920|FG000|Overall Study|Protocol Violation|0|||
128936914|NCT00631488|464056921|FG001|Overall Study|Protocol Violation|0|||
129122578|NCT02194465|464744058|FG006|Overall Study|Withdrawal by Subject|2|||
129122579|NCT02194465|464744052|FG000|Overall Study|Discontinued follow-up period|0|||
129122580|NCT02194465|464744053|FG001|Overall Study|Discontinued follow-up period|2|||
129122581|NCT02194465|464744054|FG002|Overall Study|Discontinued follow-up period|1|||
129122582|NCT02194465|464744055|FG003|Overall Study|Discontinued follow-up period|0|||
129122583|NCT02194465|464744056|FG004|Overall Study|Discontinued follow-up period|2|||
129122584|NCT02194465|464744057|FG005|Overall Study|Discontinued follow-up period|0|||
129122585|NCT02194465|464744058|FG006|Overall Study|Discontinued follow-up period|0|||
129122586|NCT01408641|464744059|FG000|Overall Study|Physician Decision|1|||
129122587|NCT01408641|464744060|FG001|Overall Study|Physician Decision|0|||
129122588|NCT00089648|464744061|FG000|Overall Study|Adverse Event|7|||
129122589|NCT00089648|464744061|FG000|Overall Study|Withdrawal by Subject|1|||
129217094|NCT03926611|465096874|FG004|Overall Study|Physician Decision|0|||
128706443|NCT01059825|463220494|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
128706444|NCT01059825|463220488|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
128706445|NCT01059825|463220489|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
128706446|NCT01059825|463220490|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
128706447|NCT01059825|463220491|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
128706448|NCT01059825|463220492|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
128706449|NCT01059825|463220493|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
128706450|NCT01059825|463220494|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
128706451|NCT01059825|463220488|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
128706452|NCT01059825|463220489|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
128706453|NCT01059825|463220490|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
128706454|NCT01059825|463220491|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
128706455|NCT01059825|463220492|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
128706456|NCT01059825|463220493|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
128706457|NCT01059825|463220494|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
128706458|NCT01059825|463220488|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
128706459|NCT01059825|463220489|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
128706460|NCT01059825|463220490|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
128706461|NCT01059825|463220491|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
128706462|NCT01059825|463220492|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
128706463|NCT01059825|463220493|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
128706464|NCT01059825|463220494|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
128706465|NCT01059825|463220488|FG000|Treatment Period|Lost to Follow-up|2|||
128706466|NCT01059825|463220489|FG001|Treatment Period|Lost to Follow-up|1|||
128706467|NCT01059825|463220490|FG002|Treatment Period|Lost to Follow-up|0|||
128706468|NCT01059825|463220491|FG003|Treatment Period|Lost to Follow-up|1|||
128706469|NCT01059825|463220492|FG004|Treatment Period|Lost to Follow-up|2|||
128706470|NCT01059825|463220493|FG005|Treatment Period|Lost to Follow-up|0|||
128706471|NCT01059825|463220494|FG006|Treatment Period|Lost to Follow-up|0|||
128706472|NCT01059825|463220488|FG000|Treatment Period|Withdrawal by Subject|3|||
128706473|NCT01059825|463220489|FG001|Treatment Period|Withdrawal by Subject|0|||
128706474|NCT01059825|463220490|FG002|Treatment Period|Withdrawal by Subject|1|||
128706475|NCT01059825|463220491|FG003|Treatment Period|Withdrawal by Subject|5|||
128706476|NCT01059825|463220492|FG004|Treatment Period|Withdrawal by Subject|4|||
128706477|NCT01059825|463220493|FG005|Treatment Period|Withdrawal by Subject|1|||
128706478|NCT01059825|463220494|FG006|Treatment Period|Withdrawal by Subject|0|||
128706479|NCT01059825|463220488|FG000|Treatment Period|Other reason not specified|1|||
128706480|NCT01059825|463220489|FG001|Treatment Period|Other reason not specified|2|||
128706481|NCT01059825|463220490|FG002|Treatment Period|Other reason not specified|1|||
128706482|NCT01059825|463220491|FG003|Treatment Period|Other reason not specified|2|||
128706483|NCT01059825|463220492|FG004|Treatment Period|Other reason not specified|0|||
128706484|NCT01059825|463220493|FG005|Treatment Period|Other reason not specified|0|||
128706485|NCT01059825|463220494|FG006|Treatment Period|Other reason not specified|0|||
128706486|NCT01059825|463220488|FG000|Treatment Period|Protocol Violation|0|||
128706487|NCT01059825|463220489|FG001|Treatment Period|Protocol Violation|0|||
128706488|NCT01059825|463220490|FG002|Treatment Period|Protocol Violation|1|||
128706489|NCT01059825|463220491|FG003|Treatment Period|Protocol Violation|1|||
128706490|NCT01059825|463220492|FG004|Treatment Period|Protocol Violation|1|||
128706491|NCT01059825|463220493|FG005|Treatment Period|Protocol Violation|1|||
128706492|NCT01059825|463220494|FG006|Treatment Period|Protocol Violation|0|||
128706493|NCT01059825|463220488|FG000|Treatment Period|Adverse event related to study drug|1|||
129217095|NCT03926611|465096875|FG005|Overall Study|Physician Decision|1|||
128706494|NCT01059825|463220489|FG001|Treatment Period|Adverse event related to study drug|0|||
128706495|NCT01059825|463220490|FG002|Treatment Period|Adverse event related to study drug|1|||
128706496|NCT01059825|463220491|FG003|Treatment Period|Adverse event related to study drug|1|||
128706497|NCT01059825|463220492|FG004|Treatment Period|Adverse event related to study drug|0|||
128706498|NCT01059825|463220493|FG005|Treatment Period|Adverse event related to study drug|0|||
129122590|NCT00089648|464744061|FG000|Overall Study|Lack of Efficacy|33|||
128768720|NCT02912468|463444094|FG000|Overall Study|Adverse Event|3|||
128706499|NCT01059825|463220494|FG006|Treatment Period|Adverse event related to study drug|0|||
128706500|NCT01059825|463220488|FG000|Treatment Period|Insufficient clinical response|3|||
128706501|NCT01059825|463220489|FG001|Treatment Period|Insufficient clinical response|0|||
128706502|NCT01059825|463220490|FG002|Treatment Period|Insufficient clinical response|0|||
128706503|NCT01059825|463220491|FG003|Treatment Period|Insufficient clinical response|0|||
128706504|NCT01059825|463220492|FG004|Treatment Period|Insufficient clinical response|0|||
128706505|NCT01059825|463220493|FG005|Treatment Period|Insufficient clinical response|0|||
128706506|NCT01059825|463220494|FG006|Treatment Period|Insufficient clinical response|0|||
128706507|NCT01059825|463220488|FG000|Treatment Period|Adverse event not related to study drug|0|||
128706508|NCT01059825|463220489|FG001|Treatment Period|Adverse event not related to study drug|1|||
128706509|NCT01059825|463220490|FG002|Treatment Period|Adverse event not related to study drug|2|||
128706510|NCT01059825|463220491|FG003|Treatment Period|Adverse event not related to study drug|1|||
128706511|NCT01059825|463220492|FG004|Treatment Period|Adverse event not related to study drug|1|||
128706512|NCT01059825|463220493|FG005|Treatment Period|Adverse event not related to study drug|1|||
128706513|NCT01059825|463220494|FG006|Treatment Period|Adverse event not related to study drug|0|||
128768721|NCT02912468|463444095|FG001|Overall Study|Adverse Event|2|||
128768722|NCT02912468|463444094|FG000|Overall Study|Withdrawal by Subject|6|||
128768723|NCT02912468|463444095|FG001|Overall Study|Withdrawal by Subject|2|||
128768724|NCT02912468|463444094|FG000|Overall Study|Randomized and not treated|0|||
128768725|NCT02912468|463444095|FG001|Overall Study|Randomized and not treated|1|||
128768726|NCT01320735|463444100|FG000|Overall Study|Adverse Event|3|||
128768727|NCT01320735|463444100|FG000|Overall Study|Withdrawal by Subject|3|||
128936915|NCT00631488|464056922|FG002|Overall Study|Protocol Violation|1|||
128936916|NCT03648476|464056923|FG000|Overall Study|Withdrawal by Subject|2|||
128936917|NCT03648476|464056924|FG001|Overall Study|Withdrawal by Subject|1|||
128936918|NCT02855411|464056926|FG000|Overall Study|Study terminated by sponsor|21|||
128936919|NCT02855411|464056926|FG000|Overall Study|Does not meet entrance criteria|14|||
128936920|NCT01996319|464056929|FG000|Overall Study|Protocol Violation|1|||
128936921|NCT01996319|464056930|FG001|Overall Study|Protocol Violation|0|||
128936922|NCT01996319|464056929|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
128936923|NCT01996319|464056930|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
128936924|NCT01996319|464056929|FG000|Overall Study|Adverse Event|2|||
128936925|NCT01996319|464056930|FG001|Overall Study|Adverse Event|2|||
128936926|NCT01671085|464056931|FG000|Overall Study|Withdrawal by Subject|1|||
128936927|NCT01671085|464056932|FG001|Overall Study|Withdrawal by Subject|0|||
128936928|NCT00637273|464056933|FG000|Overall Study|Adverse Event|11|||
128936929|NCT00637273|464056934|FG001|Overall Study|Adverse Event|5|||
128936930|NCT00637273|464056935|FG002|Overall Study|Adverse Event|7|||
128936931|NCT00637273|464056933|FG000|Overall Study|Lost to Follow-up|8|||
128936932|NCT00637273|464056934|FG001|Overall Study|Lost to Follow-up|9|||
128936933|NCT00637273|464056935|FG002|Overall Study|Lost to Follow-up|13|||
128936934|NCT00637273|464056933|FG000|Overall Study|Protocol Violation|2|||
128936935|NCT00637273|464056934|FG001|Overall Study|Protocol Violation|4|||
128936936|NCT00637273|464056935|FG002|Overall Study|Protocol Violation|1|||
128936937|NCT00637273|464056933|FG000|Overall Study|Withdrawal of Consent|18|||
128936938|NCT00637273|464056934|FG001|Overall Study|Withdrawal of Consent|6|||
128936939|NCT00637273|464056935|FG002|Overall Study|Withdrawal of Consent|18|||
128936940|NCT00637273|464056933|FG000|Overall Study|Investigator Decision|1|||
128936941|NCT00637273|464056934|FG001|Overall Study|Investigator Decision|3|||
128936942|NCT00637273|464056935|FG002|Overall Study|Investigator Decision|1|||
129031576|NCT04968925|464406491|FG000|Phase I- Period 1|Subject enrolled in error|1|||
129031577|NCT04968925|464406492|FG001|Phase I- Period 1|Subject enrolled in error|1|||
129031578|NCT04968925|464406493|FG002|Phase I- Period 1|Subject enrolled in error|0|||
129031579|NCT04968925|464406494|FG003|Phase I- Period 1|Subject enrolled in error|0|||
129031580|NCT04968925|464406491|FG000|Phase II- Period 1|COVID-19 Related|0|||
129031581|NCT04968925|464406492|FG001|Phase II- Period 1|COVID-19 Related|0|||
129031582|NCT04968925|464406493|FG002|Phase II- Period 1|COVID-19 Related|6|||
129031583|NCT04968925|464406494|FG003|Phase II- Period 1|COVID-19 Related|6|||
129031584|NCT04968925|464406491|FG000|Phase II- Period 1|Subject enrolled in error|0|||
129031585|NCT04968925|464406492|FG001|Phase II- Period 1|Subject enrolled in error|0|||
129031586|NCT04968925|464406493|FG002|Phase II- Period 1|Subject enrolled in error|1|||
129031587|NCT04968925|464406494|FG003|Phase II- Period 1|Subject enrolled in error|0|||
129031588|NCT04968925|464406491|FG000|Phase II -Period 2|COVID-19 related|0|||
129031589|NCT04968925|464406492|FG001|Phase II -Period 2|COVID-19 related|0|||
129031590|NCT04968925|464406493|FG002|Phase II -Period 2|COVID-19 related|4|||
129031591|NCT04968925|464406494|FG003|Phase II -Period 2|COVID-19 related|3|||
129031592|NCT04968925|464406491|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
129031593|NCT04968925|464406492|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
129031594|NCT04968925|464406493|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
128768728|NCT01320735|463444100|FG000|Overall Study|Lost to Follow-up|13|||
128936943|NCT00637273|464056933|FG000|Overall Study|Administrative|2|||
128936944|NCT00637273|464056934|FG001|Overall Study|Administrative|0|||
129031595|NCT04968925|464406494|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
128936945|NCT00637273|464056935|FG002|Overall Study|Administrative|0|||
128768729|NCT01320735|463444100|FG000|Overall Study|Administrative Reason|6|||
128768730|NCT01320735|463444100|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
128768731|NCT01320735|463444100|FG000|Overall Study|Protocol Violation|1|||
128768732|NCT01320735|463444100|FG000|Overall Study|Other|1|||
128768733|NCT01320735|463444100|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
128768734|NCT01320735|463444100|FG000|Overall Study|Investigator Unable to be Contacted|17|||
128768735|NCT01107743|463444105|FG000|Overall Study|Protocol Violation|46|||
128768736|NCT00308737|463444106|FG000|Overall Study|Adverse Event|104|||
128768737|NCT00308737|463444107|FG001|Overall Study|Adverse Event|9|||
128768738|NCT00308737|463444108|FG002|Overall Study|Adverse Event|0|||
128768739|NCT00308737|463444106|FG000|Overall Study|Death|4|||
128768740|NCT00308737|463444107|FG001|Overall Study|Death|3|||
128768741|NCT00308737|463444108|FG002|Overall Study|Death|0|||
128768742|NCT00308737|463444106|FG000|Overall Study|Lost to Follow-up|56|||
128768743|NCT00308737|463444107|FG001|Overall Study|Lost to Follow-up|80|||
128768744|NCT00308737|463444108|FG002|Overall Study|Lost to Follow-up|5|||
128768745|NCT00308737|463444106|FG000|Overall Study|Physician Decision|15|||
128768746|NCT00308737|463444107|FG001|Overall Study|Physician Decision|2|||
128768747|NCT00308737|463444108|FG002|Overall Study|Physician Decision|1|||
128768748|NCT00308737|463444106|FG000|Overall Study|Protocol Violation|34|||
128768749|NCT00308737|463444107|FG001|Overall Study|Protocol Violation|9|||
128768750|NCT00308737|463444108|FG002|Overall Study|Protocol Violation|5|||
128768751|NCT00308737|463444106|FG000|Overall Study|Withdrawal by Subject|218|||
128768752|NCT00308737|463444107|FG001|Overall Study|Withdrawal by Subject|166|||
128768753|NCT00308737|463444108|FG002|Overall Study|Withdrawal by Subject|18|||
128768754|NCT00308737|463444106|FG000|Overall Study|Various|32|||
128768755|NCT00308737|463444107|FG001|Overall Study|Various|20|||
128768756|NCT00308737|463444108|FG002|Overall Study|Various|8|||
128768757|NCT01913639|463444109|FG000|Overall Study|Not Eligible|3|||
128768758|NCT01290822|463444110|FG000|Overall Study|Withdrawal by Subject|1|||
128768759|NCT01290822|463444110|FG000|Overall Study|Physician Decision|10|||
128768760|NCT00089895|463444113|FG000|Overall Study|Consent Withdrawn|11|||
128768761|NCT00089895|463444114|FG001|Overall Study|Consent Withdrawn|14|||
128768762|NCT00089895|463444113|FG000|Overall Study|Technical reason|7|||
128768763|NCT00089895|463444114|FG001|Overall Study|Technical reason|2|||
128768764|NCT00089895|463444113|FG000|Overall Study|Surgery|0|||
128768765|NCT00089895|463444114|FG001|Overall Study|Surgery|1|||
128768766|NCT00089895|463444113|FG000|Overall Study|Bleeding|0|||
129122591|NCT03979313|464744062|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
128768767|NCT00089895|463444114|FG001|Overall Study|Bleeding|2|||
129122592|NCT03979313|464744063|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
129122593|NCT03979313|464744062|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
129122594|NCT03979313|464744063|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
129122595|NCT03979313|464744062|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
129122596|NCT03979313|464744063|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
129122597|NCT03979313|464744062|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
129122598|NCT03979313|464744063|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
129122599|NCT03979313|464744062|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
129122600|NCT03979313|464744063|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
129122601|NCT03979313|464744062|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
129122602|NCT03979313|464744063|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
129217096|NCT03926611|465096876|FG006|Overall Study|Physician Decision|0|||
129217097|NCT03926611|465096870|FG000|Overall Study|Protocol Violation|1|||
129217098|NCT03926611|465096871|FG001|Overall Study|Protocol Violation|0|||
128768768|NCT00089895|463444113|FG000|Overall Study|Physician Decision|3|||
128768769|NCT00089895|463444114|FG001|Overall Study|Physician Decision|7|||
128768770|NCT00089895|463444113|FG000|Overall Study|Exclusion criteria met|6|||
128768771|NCT00089895|463444114|FG001|Overall Study|Exclusion criteria met|6|||
128768772|NCT00089895|463444113|FG000|Overall Study|Not otherwise specified|4|||
128768773|NCT00089895|463444114|FG001|Overall Study|Not otherwise specified|8|||
128768774|NCT00089895|463444113|FG000|Overall Study|Missing|4|||
128768775|NCT00089895|463444114|FG001|Overall Study|Missing|2|||
128768776|NCT05644353|463444116|FG000|Overall Study|Physician Decision|1|||
128768777|NCT05644353|463444117|FG001|Overall Study|Physician Decision|0|||
128768778|NCT05644353|463444118|FG002|Overall Study|Physician Decision|0|||
129217099|NCT03926611|465096872|FG002|Overall Study|Protocol Violation|0|||
129217100|NCT03926611|465096873|FG003|Overall Study|Protocol Violation|1|||
129217101|NCT03926611|465096874|FG004|Overall Study|Protocol Violation|1|||
128768779|NCT05644353|463444119|FG003|Overall Study|Physician Decision|0|||
128768780|NCT05644353|463444120|FG004|Overall Study|Physician Decision|0|||
128768781|NCT05644353|463444121|FG005|Overall Study|Physician Decision|0|||
128768782|NCT05644353|463444116|FG000|Overall Study|Protocol Violation|1|||
128768783|NCT05644353|463444117|FG001|Overall Study|Protocol Violation|0|||
128768784|NCT05644353|463444118|FG002|Overall Study|Protocol Violation|0|||
128768785|NCT05644353|463444119|FG003|Overall Study|Protocol Violation|0|||
128768786|NCT05644353|463444120|FG004|Overall Study|Protocol Violation|0|||
128768787|NCT05644353|463444121|FG005|Overall Study|Protocol Violation|0|||
128768788|NCT05644353|463444116|FG000|Overall Study|Withdrawal by Subject|0|||
128706514|NCT02495168|463220495|FG000|Overall Study|Other than Specified|18|||
128706515|NCT02495168|463220496|FG001|Overall Study|Other than Specified|22|||
128706516|NCT02495168|463220497|FG002|Overall Study|Other than Specified|5|||
128706517|NCT02495168|463220495|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
128706518|NCT02495168|463220496|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
128706519|NCT02495168|463220497|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
128706520|NCT02495168|463220495|FG000|Overall Study|Physician Decision|1|||
128706521|NCT02495168|463220496|FG001|Overall Study|Physician Decision|1|||
128706522|NCT02495168|463220497|FG002|Overall Study|Physician Decision|0|||
128706523|NCT02495168|463220495|FG000|Overall Study|Lost to Follow-up|10|||
128706524|NCT02495168|463220496|FG001|Overall Study|Lost to Follow-up|6|||
128706525|NCT02495168|463220497|FG002|Overall Study|Lost to Follow-up|1|||
128706526|NCT02495168|463220495|FG000|Overall Study|Withdrawal by Subject|1|||
128706527|NCT02495168|463220496|FG001|Overall Study|Withdrawal by Subject|4|||
128706528|NCT02495168|463220497|FG002|Overall Study|Withdrawal by Subject|2|||
128706529|NCT02495168|463220495|FG000|Overall Study|Protocol Violation|0|||
128706530|NCT02495168|463220496|FG001|Overall Study|Protocol Violation|10|||
128706531|NCT02495168|463220497|FG002|Overall Study|Protocol Violation|1|||
128706532|NCT02495168|463220495|FG000|Overall Study|Adverse Event|4|||
128706533|NCT02495168|463220496|FG001|Overall Study|Adverse Event|8|||
128706534|NCT02495168|463220497|FG002|Overall Study|Adverse Event|3|||
128706535|NCT02495168|463220495|FG000|Overall Study|Lack of Efficacy|0|||
128706536|NCT02495168|463220496|FG001|Overall Study|Lack of Efficacy|0|||
128706537|NCT02495168|463220497|FG002|Overall Study|Lack of Efficacy|3|||
128706538|NCT02101060|463220500|FG000|Overall Study|Adverse Event|1|||
128706539|NCT02101060|463220501|FG001|Overall Study|Adverse Event|0|||
128706540|NCT02101060|463220500|FG000|Overall Study|Withdrawal by Subject|1|||
128706541|NCT02101060|463220501|FG001|Overall Study|Withdrawal by Subject|1|||
128706542|NCT02101060|463220500|FG000|Overall Study|Lost to Follow-up|3|||
128706543|NCT02101060|463220501|FG001|Overall Study|Lost to Follow-up|3|||
128706544|NCT03462082|463220502|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
128706545|NCT03462082|463220503|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
128706546|NCT03462082|463220504|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
128706547|NCT03462082|463220505|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
128706548|NCT03462082|463220506|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
128706549|NCT03462082|463220507|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
128706550|NCT03462082|463220508|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
128706551|NCT03462082|463220509|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
128706552|NCT00743340|463220515|FG000|Overall Study|Study medication non-compliance|1|||
128706553|NCT00743340|463220515|FG000|Overall Study|Lost to Follow-up|1|||
128706554|NCT00743340|463220515|FG000|Overall Study|Withdrawal from the Study|5|||
128706555|NCT00743340|463220515|FG000|Overall Study|Protocol Violation|1|||
128706556|NCT00743340|463220515|FG000|Overall Study|Virologic failure|8|||
128706557|NCT00743340|463220515|FG000|Overall Study|Pregnancy|1|||
128768789|NCT05644353|463444117|FG001|Overall Study|Withdrawal by Subject|2|||
128768790|NCT05644353|463444118|FG002|Overall Study|Withdrawal by Subject|0|||
128768791|NCT05644353|463444119|FG003|Overall Study|Withdrawal by Subject|0|||
128768792|NCT05644353|463444120|FG004|Overall Study|Withdrawal by Subject|1|||
128768793|NCT05644353|463444121|FG005|Overall Study|Withdrawal by Subject|0|||
128768794|NCT05644353|463444116|FG000|Overall Study|Lost to Follow-up|0|||
128768795|NCT05644353|463444117|FG001|Overall Study|Lost to Follow-up|0|||
128768796|NCT05644353|463444118|FG002|Overall Study|Lost to Follow-up|1|||
128768797|NCT05644353|463444119|FG003|Overall Study|Lost to Follow-up|0|||
128768798|NCT05644353|463444120|FG004|Overall Study|Lost to Follow-up|0|||
128768799|NCT05644353|463444121|FG005|Overall Study|Lost to Follow-up|0|||
128768800|NCT01535274|463444122|FG000|Overall Study|Determined to be ineligible|0|||
128768801|NCT01535274|463444123|FG001|Overall Study|Determined to be ineligible|1|||
128936946|NCT00637273|464056933|FG000|Overall Study|Loss of Glucose Control|1|||
128936947|NCT00637273|464056934|FG001|Overall Study|Loss of Glucose Control|1|||
128936948|NCT00637273|464056935|FG002|Overall Study|Loss of Glucose Control|1|||
128936949|NCT00986258|464056936|FG000|Observation Period|Not eligible to be dosed|11|||
128706558|NCT00743340|463220515|FG000|Overall Study|Rolled over to other Gilead Study|23|||
128706559|NCT00743340|463220515|FG000|Overall Study|Participant Relocated|1|||
128706560|NCT01425281|463220516|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
128768802|NCT01535274|463444122|FG000|Overall Study|Misallocated to propofol intervention|0|||
128768803|NCT01535274|463444123|FG001|Overall Study|Misallocated to propofol intervention|1|||
128768804|NCT02204579|463444125|FG000|Overall Study|Screen failures|2|||
128768805|NCT02778399|463444126|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
128768806|NCT02778399|463444127|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
129122603|NCT03979313|464744062|FG000|All Subjects|Any Other Reason|16|||
128706561|NCT01425281|463220517|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
128706562|NCT01425281|463220516|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
128706563|NCT01425281|463220517|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
128706564|NCT01425281|463220516|FG000|At 180-day Clinical Follow-up|Death|0|||
128706565|NCT01425281|463220517|FG001|At 180-day Clinical Follow-up|Death|1|||
128936950|NCT00986258|464056936|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
128936951|NCT00986258|464056936|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
128936952|NCT00986258|464056936|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
128936953|NCT00986258|464056936|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
128936954|NCT00986258|464056936|FG000|Titration and Optimal Dose Period|Other|1|||
128936955|NCT00986258|464056936|FG000|Maintenance Period|Adverse Event|5|||
128936956|NCT00986258|464056936|FG000|Maintenance Period|Lack of Efficacy|2|||
128936957|NCT00986258|464056936|FG000|Maintenance Period|Withdrawal by Subject|2|||
128936958|NCT04230486|464056945|FG000|Overall Study|Screen Failure|1|||
128936959|NCT03215264|464056946|FG000|Dose Level 2|Adverse Event|0|||
128936960|NCT03215264|464056947|FG001|Dose Level 2|Adverse Event|1|||
128936961|NCT03215264|464056948|FG002|Dose Level 2|Adverse Event|0|||
128936962|NCT03215264|464056946|FG000|Dose Level 3|Withdrawal by Subject|0|||
128936963|NCT03215264|464056947|FG001|Dose Level 3|Withdrawal by Subject|0|||
128936964|NCT03215264|464056948|FG002|Dose Level 3|Withdrawal by Subject|1|||
128936965|NCT02234583|464056951|FG000|Overall Study|Adverse Event|172|||
128936966|NCT02234583|464056952|FG001|Overall Study|Adverse Event|156|||
128936967|NCT02234583|464056951|FG000|Overall Study|Withdrawal by Subject|109|||
128936968|NCT02234583|464056952|FG001|Overall Study|Withdrawal by Subject|157|||
128936969|NCT02234583|464056951|FG000|Overall Study|Lost to Follow-up|0|||
128936970|NCT02234583|464056952|FG001|Overall Study|Lost to Follow-up|1|||
128936971|NCT02234583|464056951|FG000|Overall Study|Lack of Efficacy|58|||
128936972|NCT02234583|464056952|FG001|Overall Study|Lack of Efficacy|103|||
128936973|NCT02234583|464056951|FG000|Overall Study|Protocol Violation|35|||
128936974|NCT02234583|464056952|FG001|Overall Study|Protocol Violation|42|||
128706566|NCT01425281|463220516|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
128706567|NCT01425281|463220517|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
128706568|NCT01425281|463220516|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
128706569|NCT01425281|463220517|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
128706570|NCT01425281|463220516|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
128706571|NCT01425281|463220517|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
128706572|NCT01425281|463220516|FG000|At 2-year Clinical Follow-up|Death|2|||
128706573|NCT01425281|463220517|FG001|At 2-year Clinical Follow-up|Death|0|||
128706574|NCT01425281|463220516|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
128706575|NCT01425281|463220517|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
128706576|NCT01425281|463220516|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
128706577|NCT01425281|463220517|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
128706578|NCT01425281|463220516|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
128706579|NCT01425281|463220517|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
128706580|NCT01425281|463220516|FG000|At 3-year Clinical Follow-up|Death|2|||
128706581|NCT01425281|463220517|FG001|At 3-year Clinical Follow-up|Death|3|||
128706582|NCT01425281|463220516|FG000|At 4-year Clinical Follow-up|Death|7|||
128706583|NCT01425281|463220517|FG001|At 4-year Clinical Follow-up|Death|3|||
128706584|NCT01425281|463220516|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
128706585|NCT01425281|463220517|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
128706586|NCT01425281|463220516|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
128706587|NCT01425281|463220517|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
128706588|NCT01425281|463220516|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
128706589|NCT01425281|463220517|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
128706590|NCT01425281|463220516|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
128936975|NCT02234583|464056951|FG000|Overall Study|Other|39|||
128936976|NCT02234583|464056952|FG001|Overall Study|Other|97|||
128936977|NCT02805907|464056953|FG000|Overall Study|Lost to Follow-up|3|||
128936978|NCT02805907|464056954|FG001|Overall Study|Lost to Follow-up|3|||
128936979|NCT01264965|464056955|FG000|Overall Study|Withdrawal by Subject|10|||
128936980|NCT02202031|464056956|FG000|Overall Study|Lost to Follow-up|1|||
128936981|NCT02202031|464056957|FG001|Overall Study|Lost to Follow-up|0|||
128936982|NCT02202031|464056956|FG000|Overall Study|Too Busy|1|||
128936983|NCT02202031|464056957|FG001|Overall Study|Too Busy|3|||
128936984|NCT02202031|464056956|FG000|Overall Study|Illness/Medical Reason|0|||
128936985|NCT02202031|464056957|FG001|Overall Study|Illness/Medical Reason|2|||
128936986|NCT02202031|464056956|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
128936987|NCT02202031|464056957|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
128936988|NCT01188798|464056960|FG000|Overall Study|Death|0|||
128936989|NCT01188798|464056961|FG001|Overall Study|Death|1|||
128936990|NCT01188798|464056960|FG000|Overall Study|Required additional transplant|1|||
128936991|NCT01188798|464056961|FG001|Overall Study|Required additional transplant|1|||
128936992|NCT01188798|464056960|FG000|Overall Study|Protocol closure|1|||
128936993|NCT01188798|464056961|FG001|Overall Study|Protocol closure|1|||
128936994|NCT02795767|464056962|FG000|Overall Study|Received Commercial Emicizumab|1|||
128936995|NCT02795767|464056963|FG001|Overall Study|Received Commercial Emicizumab|0|||
128936996|NCT02795767|464056964|FG002|Overall Study|Received Commercial Emicizumab|0|||
128936997|NCT01899144|464056974|FG000|Treatment Period 2|Other|1|||
128706591|NCT01425281|463220517|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
128706592|NCT01425281|463220516|FG000|At 5-year Clinical Follow-up|Death|2|||
128706593|NCT01425281|463220517|FG001|At 5-year Clinical Follow-up|Death|0|||
128706594|NCT01425281|463220516|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
128706595|NCT01425281|463220517|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
128706596|NCT01425281|463220516|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
128706597|NCT01425281|463220517|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
128706598|NCT01425281|463220516|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
128706599|NCT01425281|463220517|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
128706600|NCT03454997|463220518|FG000|Overall Study|Staff Coach - Left Oranization|1|||
128706601|NCT03454997|463220519|FG001|Overall Study|Staff Coach - Left Oranization|1|||
128706602|NCT03454997|463220518|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
128706603|NCT03454997|463220519|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
128706604|NCT03454997|463220518|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
128706605|NCT03454997|463220519|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
128706606|NCT03454997|463220518|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
128706607|NCT03454997|463220519|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
128706608|NCT03454997|463220518|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
128706609|NCT03454997|463220519|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
128706610|NCT03454997|463220518|FG000|Overall Study|Client with SMI - Left organization|0|||
128706611|NCT03454997|463220519|FG001|Overall Study|Client with SMI - Left organization|1|||
128936998|NCT01899144|464056974|FG000|Treatment Period 3|Other|2|||
128936999|NCT01899144|464056974|FG000|Treatment Period 5|Other|1|||
128937000|NCT00751881|464056975|FG000|Core Treatment Period|Not treated|1|||
128937001|NCT00751881|464056976|FG001|Core Treatment Period|Not treated|1|||
128937002|NCT00751881|464056977|FG002|Core Treatment Period|Not treated|2|||
128937003|NCT00751881|464056975|FG000|Core Treatment Period|Adverse Event|26|||
128937004|NCT00751881|464056976|FG001|Core Treatment Period|Adverse Event|54|||
128937005|NCT00751881|464056977|FG002|Core Treatment Period|Adverse Event|58|||
128937006|NCT00751881|464056975|FG000|Core Treatment Period|Lack of Efficacy|37|||
128937007|NCT00751881|464056976|FG001|Core Treatment Period|Lack of Efficacy|30|||
128937008|NCT00751881|464056977|FG002|Core Treatment Period|Lack of Efficacy|20|||
128937009|NCT00751881|464056975|FG000|Core Treatment Period|Poor compliance to protocol|15|||
128937010|NCT00751881|464056976|FG001|Core Treatment Period|Poor compliance to protocol|3|||
128937011|NCT00751881|464056977|FG002|Core Treatment Period|Poor compliance to protocol|4|||
128937012|NCT00751881|464056975|FG000|Core Treatment Period|Lost to Follow-up|6|||
128937013|NCT00751881|464056976|FG001|Core Treatment Period|Lost to Follow-up|4|||
128937014|NCT00751881|464056977|FG002|Core Treatment Period|Lost to Follow-up|3|||
128937015|NCT00751881|464056975|FG000|Core Treatment Period|Other: protocol deviation|3|||
128937016|NCT00751881|464056976|FG001|Core Treatment Period|Other: protocol deviation|3|||
128937017|NCT00751881|464056977|FG002|Core Treatment Period|Other: protocol deviation|7|||
128937018|NCT00751881|464056975|FG000|Core Treatment Period|Other: wish to parent|5|||
128937019|NCT00751881|464056976|FG001|Core Treatment Period|Other: wish to parent|7|||
128937020|NCT00751881|464056977|FG002|Core Treatment Period|Other: wish to parent|4|||
128937021|NCT00751881|464056975|FG000|Core Treatment Period|Other: personal/family constraints|6|||
128706612|NCT03454997|463220518|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
128706613|NCT03454997|463220519|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
128706614|NCT01402492|463220525|FG000|Overall Study|Withdrawal by Subject|17|||
128706615|NCT01402492|463220526|FG001|Overall Study|Withdrawal by Subject|11|||
128706616|NCT01402492|463220527|FG002|Overall Study|Withdrawal by Subject|11|||
128706617|NCT01402492|463220525|FG000|Overall Study|Adverse Event|2|||
128706618|NCT01402492|463220526|FG001|Overall Study|Adverse Event|3|||
128706619|NCT01402492|463220527|FG002|Overall Study|Adverse Event|4|||
128706620|NCT01402492|463220525|FG000|Overall Study|Physician Decision|0|||
128937022|NCT00751881|464056976|FG001|Core Treatment Period|Other: personal/family constraints|7|||
128937023|NCT00751881|464056977|FG002|Core Treatment Period|Other: personal/family constraints|10|||
128937024|NCT00751881|464056975|FG000|Core Treatment Period|Other: MS treatment change|6|||
128937025|NCT00751881|464056976|FG001|Core Treatment Period|Other: MS treatment change|4|||
128768807|NCT02778399|463444128|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
128937026|NCT00751881|464056977|FG002|Core Treatment Period|Other: MS treatment change|4|||
128937027|NCT00751881|464056975|FG000|Core Treatment Period|Other: tolerability complaints|2|||
128937028|NCT00751881|464056976|FG001|Core Treatment Period|Other: tolerability complaints|0|||
128937029|NCT00751881|464056977|FG002|Core Treatment Period|Other: tolerability complaints|0|||
128937030|NCT00751881|464056975|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
128937031|NCT00751881|464056976|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
128937032|NCT00751881|464056977|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
128937033|NCT00751881|464056975|FG000|Extension Study Period|Adverse Event|18|||
128706621|NCT01402492|463220526|FG001|Overall Study|Physician Decision|3|||
128706622|NCT01402492|463220527|FG002|Overall Study|Physician Decision|0|||
128706623|NCT01402492|463220525|FG000|Overall Study|Incarcerated (N=3)|2|||
128706624|NCT01402492|463220526|FG001|Overall Study|Incarcerated (N=3)|0|||
128706625|NCT01402492|463220527|FG002|Overall Study|Incarcerated (N=3)|1|||
128706626|NCT00982878|463220528|FG000|Overall Study|Physician Decision|1|||
128706627|NCT03167411|463220529|FG000|Overall Study|Adverse Event|0|||
128706628|NCT03167411|463220530|FG001|Overall Study|Adverse Event|1|||
128706629|NCT01906008|463220537|FG000|Overall Study|Lost to Follow-up|2|||
128706630|NCT01906008|463220538|FG001|Overall Study|Lost to Follow-up|0|||
128706631|NCT01906008|463220537|FG000|Overall Study|Oxaliplatin toxicity|2|||
128706632|NCT01906008|463220538|FG001|Overall Study|Oxaliplatin toxicity|0|||
128768808|NCT02778399|463444129|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
128768809|NCT02778399|463444130|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
128768810|NCT02778399|463444131|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
128768811|NCT02778399|463444126|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
128768812|NCT02778399|463444127|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
128768813|NCT02778399|463444128|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
128768814|NCT02778399|463444129|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
128768815|NCT02778399|463444130|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
128768816|NCT02778399|463444131|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
128768817|NCT02778399|463444126|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
128768818|NCT02778399|463444127|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
128768819|NCT02778399|463444128|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
128768820|NCT02778399|463444129|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
128768821|NCT02778399|463444130|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
128768822|NCT02778399|463444131|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
128768823|NCT02778399|463444126|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
128768824|NCT02778399|463444127|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
128768825|NCT02778399|463444128|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
128768826|NCT02778399|463444129|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
128768827|NCT02778399|463444130|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
128937034|NCT00751881|464056976|FG001|Extension Study Period|Adverse Event|20|||
128937035|NCT00751881|464056977|FG002|Extension Study Period|Adverse Event|21|||
128768828|NCT02778399|463444131|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
128768829|NCT02778399|463444126|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
128768830|NCT02778399|463444127|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
128768831|NCT02778399|463444128|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
128768832|NCT02778399|463444129|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
128768833|NCT02778399|463444130|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
128768834|NCT02778399|463444131|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
128768835|NCT02778399|463444126|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
128768836|NCT02778399|463444127|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
128768837|NCT02778399|463444128|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
128768838|NCT02778399|463444129|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
128768839|NCT02778399|463444130|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
128768840|NCT02778399|463444131|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
128768841|NCT02778399|463444126|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
128768842|NCT02778399|463444127|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
128768843|NCT02778399|463444128|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
128937036|NCT00751881|464056975|FG000|Extension Study Period|Lack of Efficacy|14|||
128937037|NCT00751881|464056976|FG001|Extension Study Period|Lack of Efficacy|10|||
128937038|NCT00751881|464056977|FG002|Extension Study Period|Lack of Efficacy|20|||
128937039|NCT00751881|464056975|FG000|Extension Study Period|Lost to Follow-up|4|||
128937040|NCT00751881|464056976|FG001|Extension Study Period|Lost to Follow-up|9|||
128937041|NCT00751881|464056977|FG002|Extension Study Period|Lost to Follow-up|6|||
128937042|NCT00751881|464056975|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
128768844|NCT02778399|463444129|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
129031596|NCT00876265|464406495|FG000|Overall Study|Miscellaneous reasons|4|||
128937043|NCT00751881|464056976|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
129031597|NCT00876265|464406495|FG000|Overall Study|Lost to Follow-up|6|||
129031598|NCT00876265|464406495|FG000|Overall Study|Withdrawal by Subject|2|||
129031599|NCT00487695|464406496|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
129031600|NCT00487695|464406497|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
129031601|NCT00487695|464406496|FG000|First Procedure|active wheezing (did not have procedure)|1|||
129031602|NCT00487695|464406497|FG001|First Procedure|active wheezing (did not have procedure)|0|||
129031603|NCT00487695|464406496|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
129031604|NCT00487695|464406497|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
129031605|NCT00487695|464406496|FG000|Second Procedure|active wheezing|0|||
129031606|NCT00487695|464406497|FG001|Second Procedure|active wheezing|1|||
129031607|NCT00487695|464406496|FG000|Second Procedure|Withdrawal by Subject|1|||
129031608|NCT00487695|464406497|FG001|Second Procedure|Withdrawal by Subject|2|||
129031609|NCT01698554|464406500|FG000|Overall Study|Adverse Event|2|||
128706633|NCT01906008|463220537|FG000|Overall Study|Protocol Violation|0|||
128706634|NCT01906008|463220538|FG001|Overall Study|Protocol Violation|1|||
128706635|NCT01906008|463220537|FG000|Overall Study|Withdrawal by Subject|1|||
128937044|NCT00751881|464056977|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
128937045|NCT00751881|464056975|FG000|Extension Study Period|Other than specified above|26|||
128937046|NCT00751881|464056976|FG001|Extension Study Period|Other than specified above|30|||
128937047|NCT00751881|464056977|FG002|Extension Study Period|Other than specified above|18|||
128937048|NCT03321929|464056978|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
128937049|NCT01765764|464056979|FG000|Treatment Period|Adverse Event|1|||
128937050|NCT01765764|464056980|FG001|Treatment Period|Adverse Event|2|||
128937051|NCT01765764|464056981|FG002|Treatment Period|Adverse Event|1|||
128937052|NCT01765764|464056979|FG000|Treatment Period|Lost to Follow-up|0|||
128937053|NCT01765764|464056980|FG001|Treatment Period|Lost to Follow-up|3|||
128937054|NCT01765764|464056981|FG002|Treatment Period|Lost to Follow-up|2|||
128937055|NCT01765764|464056979|FG000|Treatment Period|Personal Reasons|1|||
128937056|NCT01765764|464056980|FG001|Treatment Period|Personal Reasons|2|||
128937057|NCT01765764|464056981|FG002|Treatment Period|Personal Reasons|1|||
128937058|NCT01765764|464056979|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
128937059|NCT01765764|464056980|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
128937060|NCT01765764|464056981|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
128706636|NCT01906008|463220538|FG001|Overall Study|Withdrawal by Subject|5|||
128706637|NCT01906008|463220537|FG000|Overall Study|Did not start study med|3|||
128706638|NCT01906008|463220538|FG001|Overall Study|Did not start study med|4|||
128706639|NCT01906008|463220537|FG000|Overall Study|Oxaliplatin stops|10|||
128706640|NCT01906008|463220538|FG001|Overall Study|Oxaliplatin stops|8|||
128706641|NCT01906008|463220537|FG000|Overall Study|Hospice|1|||
128706642|NCT01906008|463220538|FG001|Overall Study|Hospice|0|||
128706643|NCT01906008|463220537|FG000|Overall Study|Physician Decision|3|||
128706644|NCT01906008|463220538|FG001|Overall Study|Physician Decision|3|||
128706645|NCT01906008|463220537|FG000|Overall Study|Lack of compliance of study med|5|||
128706646|NCT01906008|463220538|FG001|Overall Study|Lack of compliance of study med|3|||
128706647|NCT01906008|463220537|FG000|Overall Study|Adverse Event|0|||
128706648|NCT01906008|463220538|FG001|Overall Study|Adverse Event|3|||
128706649|NCT02651922|463220540|FG000|Overall Study|due to exclusion criteria|2|||
128706650|NCT00171730|463220542|FG000|Overall Study|Adverse Event|3|||
128706651|NCT00171730|463220542|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
128706652|NCT00171730|463220542|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
128706653|NCT00171730|463220542|FG000|Overall Study|Withdrawal by Subject|3|||
128706654|NCT02266225|463220543|FG000|Overall Study|Lost to Follow-up|2|||
128706655|NCT02266225|463220543|FG000|Overall Study|Death|1|||
128706656|NCT02266225|463220543|FG000|Overall Study|Withdrawal by Subject|13|||
128706657|NCT01465997|463220544|FG000|Overall Study|Adverse Event|12|||
128706658|NCT01465997|463220545|FG001|Overall Study|Adverse Event|22|||
128706659|NCT01465997|463220544|FG000|Overall Study|Lack of Efficacy|13|||
128706660|NCT01465997|463220545|FG001|Overall Study|Lack of Efficacy|1|||
128706661|NCT01465997|463220544|FG000|Overall Study|Protocol Violation|1|||
128706662|NCT01465997|463220545|FG001|Overall Study|Protocol Violation|4|||
128706663|NCT01465997|463220544|FG000|Overall Study|Lost to Follow-up|6|||
128706664|NCT01465997|463220545|FG001|Overall Study|Lost to Follow-up|9|||
128706665|NCT01465997|463220544|FG000|Overall Study|Withdrawal by Subject|32|||
128706666|NCT01465997|463220545|FG001|Overall Study|Withdrawal by Subject|35|||
128706667|NCT01465997|463220544|FG000|Overall Study|investigator's decision|1|||
128706668|NCT01465997|463220545|FG001|Overall Study|investigator's decision|1|||
128706669|NCT01465997|463220544|FG000|Overall Study|Death|0|||
128706670|NCT01465997|463220545|FG001|Overall Study|Death|1|||
128706671|NCT01465997|463220544|FG000|Overall Study|sponsor's decision|1|||
128706672|NCT01465997|463220545|FG001|Overall Study|sponsor's decision|1|||
128706673|NCT01465997|463220544|FG000|Overall Study|subject withdrew consent|1|||
128706674|NCT01465997|463220545|FG001|Overall Study|subject withdrew consent|0|||
128706675|NCT01465997|463220544|FG000|Overall Study|local lab unblinded site|1|||
128706676|NCT01465997|463220545|FG001|Overall Study|local lab unblinded site|0|||
128937061|NCT00530712|464056987|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
128937062|NCT00530712|464056987|FG000|30 Day Follow-up Visit|Missed Visit|5|||
128937063|NCT00530712|464056987|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
129217102|NCT03926611|465096875|FG005|Overall Study|Protocol Violation|1|||
128706677|NCT01465997|463220544|FG000|Overall Study|withdrew before follow-up|0|||
128706678|NCT01465997|463220545|FG001|Overall Study|withdrew before follow-up|13|||
128706679|NCT01465997|463220544|FG000|Overall Study|decision by site staff|0|||
128706680|NCT01465997|463220545|FG001|Overall Study|decision by site staff|1|||
128706681|NCT01465997|463220544|FG000|Overall Study|subject left participation SP0993|0|||
128706682|NCT01465997|463220545|FG001|Overall Study|subject left participation SP0993|1|||
128706683|NCT00642460|463220546|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
128706684|NCT00642460|463220547|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
128706685|NCT00642460|463220548|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
128706686|NCT00642460|463220549|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
128706687|NCT00642460|463220550|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
128706688|NCT00642460|463220551|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
128937064|NCT00530712|464056987|FG000|6 Month Follow-up Visit|Missed Visit|3|||
128937065|NCT00530712|464056987|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
128706689|NCT00642460|463220546|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
128706690|NCT00642460|463220547|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
128706691|NCT00642460|463220548|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
128768845|NCT02778399|463444130|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
128768846|NCT02778399|463444131|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
128768847|NCT02778399|463444126|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
128768848|NCT02778399|463444127|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
128768849|NCT02778399|463444128|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
128768850|NCT02778399|463444129|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
128768851|NCT02778399|463444130|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
128768852|NCT02778399|463444131|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
128768853|NCT02778399|463444126|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
128768854|NCT02778399|463444127|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
128768855|NCT02778399|463444128|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
128768856|NCT02778399|463444129|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
128768857|NCT02778399|463444130|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
128768858|NCT02778399|463444131|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
128768859|NCT02778399|463444126|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
128768860|NCT02778399|463444127|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
128768861|NCT02778399|463444128|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
128768862|NCT02778399|463444129|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
128768863|NCT02778399|463444130|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
128768864|NCT02778399|463444131|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
128768865|NCT02778399|463444126|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
128768866|NCT02778399|463444127|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
128768867|NCT02778399|463444128|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
128768868|NCT02778399|463444129|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
128768869|NCT02778399|463444130|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
128768870|NCT02778399|463444131|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
128768871|NCT00447954|463444138|FG000|Overall Study|Adverse Event|0|||
128768872|NCT00447954|463444139|FG001|Overall Study|Adverse Event|2|||
128768873|NCT00447954|463444140|FG002|Overall Study|Adverse Event|0|||
128768874|NCT00447954|463444138|FG000|Overall Study|Withdrawal by Subject|0|||
128768875|NCT00447954|463444139|FG001|Overall Study|Withdrawal by Subject|1|||
128768876|NCT00447954|463444140|FG002|Overall Study|Withdrawal by Subject|1|||
128768877|NCT00447954|463444138|FG000|Overall Study|Lost to Follow-up|0|||
128768878|NCT00447954|463444139|FG001|Overall Study|Lost to Follow-up|1|||
128768879|NCT00447954|463444140|FG002|Overall Study|Lost to Follow-up|0|||
128768880|NCT00447954|463444138|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
128768881|NCT00447954|463444139|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
128768882|NCT00447954|463444140|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
128768883|NCT00856661|463444141|FG000|Overall Study|Death|15|||
128768884|NCT00856661|463444142|FG001|Overall Study|Death|18|||
128768885|NCT00856661|463444141|FG000|Overall Study|Protocol Violation|2|||
128768886|NCT00856661|463444142|FG001|Overall Study|Protocol Violation|1|||
128768887|NCT00856661|463444141|FG000|Overall Study|Withdrawal by Subject|1|||
128768888|NCT00856661|463444142|FG001|Overall Study|Withdrawal by Subject|2|||
128768889|NCT00856661|463444141|FG000|Overall Study|Lost to Follow-up|1|||
128768890|NCT00856661|463444142|FG001|Overall Study|Lost to Follow-up|3|||
128768891|NCT00856661|463444141|FG000|Overall Study|Physician Judgement|8|||
128768892|NCT00856661|463444142|FG001|Overall Study|Physician Judgement|5|||
128706692|NCT00642460|463220549|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
128706693|NCT00642460|463220550|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
128706694|NCT00642460|463220551|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
128706695|NCT00642460|463220546|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
128706696|NCT00642460|463220547|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
128706697|NCT00642460|463220548|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
128706698|NCT00642460|463220549|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
128706699|NCT00642460|463220550|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
128706700|NCT00642460|463220551|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
128768893|NCT02120664|463444143|FG000|Overall Study|Withdrawal by Subject|0|||
128768894|NCT02120664|463444144|FG001|Overall Study|Withdrawal by Subject|0|||
128768895|NCT02120664|463444145|FG002|Overall Study|Withdrawal by Subject|0|||
128768896|NCT02120664|463444146|FG003|Overall Study|Withdrawal by Subject|1|||
129122604|NCT03979313|464744063|FG001|All Subjects|Any Other Reason|23|||
129122605|NCT03979313|464744062|FG000|All Subjects|Covid-19|1|||
128768897|NCT02120664|463444147|FG004|Overall Study|Withdrawal by Subject|0|||
128768898|NCT03916744|463444148|FG000|Overall Study|Withdrawal by Subject|0|||
128706701|NCT00642460|463220546|FG000|Part II: Open-Label Up to Week 92|Death|0|||
128706702|NCT00642460|463220547|FG001|Part II: Open-Label Up to Week 92|Death|1|||
128706703|NCT00642460|463220548|FG002|Part II: Open-Label Up to Week 92|Death|0|||
129122606|NCT03979313|464744063|FG001|All Subjects|Covid-19|3|||
129122607|NCT03979313|464744062|FG000|All Subjects|Withdrawal by Subject|35|||
129122608|NCT03979313|464744063|FG001|All Subjects|Withdrawal by Subject|44|||
129122609|NCT03979313|464744062|FG000|All Subjects|Death|0|||
129122610|NCT03979313|464744063|FG001|All Subjects|Death|5|||
129122611|NCT03979313|464744062|FG000|All Subjects|Lost to Follow-up|28|||
129122612|NCT03979313|464744063|FG001|All Subjects|Lost to Follow-up|61|||
129122613|NCT00300053|464744064|FG000|Overall Study|Patient/Caregiver Preference|2|||
128706704|NCT00642460|463220549|FG003|Part II: Open-Label Up to Week 92|Death|2|||
128706705|NCT00642460|463220550|FG004|Part II: Open-Label Up to Week 92|Death|0|||
128706706|NCT00642460|463220551|FG005|Part II: Open-Label Up to Week 92|Death|0|||
128706707|NCT00642460|463220546|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
128706708|NCT00642460|463220547|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
128706709|NCT00642460|463220548|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
128706710|NCT00642460|463220549|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
128706711|NCT00642460|463220550|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
128706712|NCT00642460|463220551|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
128706713|NCT00642460|463220546|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
128706714|NCT00642460|463220547|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
128706715|NCT00642460|463220548|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
128706716|NCT00642460|463220549|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
128706717|NCT00642460|463220550|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
128706718|NCT00642460|463220551|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
128706719|NCT00642460|463220546|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
128706720|NCT00642460|463220547|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
128706721|NCT00642460|463220548|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
128706722|NCT00642460|463220549|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
128706723|NCT00642460|463220550|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
128706724|NCT00642460|463220551|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
128706725|NCT00642460|463220546|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
128706726|NCT00642460|463220547|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
128706727|NCT00642460|463220548|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
128706728|NCT00642460|463220549|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
128706729|NCT00642460|463220550|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
128706730|NCT00642460|463220551|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
128706731|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
128706732|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
128706733|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
128706734|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
128706735|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
128706736|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
128706737|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
128706738|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
128706739|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
128706740|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
128706741|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
128706742|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
128706743|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
128706744|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
128706745|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
128706746|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
128706747|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
128706748|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
128706749|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
128706750|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
128706751|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
128706752|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
128706753|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
128706754|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
128706755|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Other|0|||
128706756|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Other|0|||
128706757|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Other|0|||
128706758|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Other|0|||
129122614|NCT00300053|464744065|FG001|Overall Study|Patient/Caregiver Preference|2|||
129122615|NCT00300053|464744066|FG002|Overall Study|Patient/Caregiver Preference|3|||
129122616|NCT00300053|464744064|FG000|Overall Study|Death|0|||
129122617|NCT00300053|464744065|FG001|Overall Study|Death|0|||
129122618|NCT00300053|464744066|FG002|Overall Study|Death|3|||
128937066|NCT00530712|464056987|FG000|6 Month Follow-up Visit|Death|2|||
129122619|NCT00300053|464744064|FG000|Overall Study|Lost to Follow-up|0|||
129122620|NCT00300053|464744065|FG001|Overall Study|Lost to Follow-up|1|||
129122621|NCT00300053|464744066|FG002|Overall Study|Lost to Follow-up|0|||
129122622|NCT00423605|464744067|FG000|Overall Study|Adverse Event|129|||
129122623|NCT00423605|464744067|FG000|Overall Study|Withdrawal by Subject|36|||
129122624|NCT00423605|464744067|FG000|Overall Study|Lost to Follow-up|15|||
129122625|NCT00423605|464744067|FG000|Overall Study|Lack of Efficacy|38|||
129122626|NCT00423605|464744067|FG000|Overall Study|Sponsor Decision|3|||
129122627|NCT00423605|464744067|FG000|Overall Study|Physician Decision|8|||
129122628|NCT00423605|464744067|FG000|Overall Study|Protocol Violation|7|||
129122629|NCT00423605|464744067|FG000|Overall Study|Not one of the pre-specified options|5|||
129122630|NCT03183908|464744070|FG000|Overall Study|Missing Symptom Diary Data|0|||
129122631|NCT03183908|464744071|FG001|Overall Study|Missing Symptom Diary Data|2|||
129122632|NCT02472405|464744075|FG000|Overall Study|Lost to Follow-up|9|||
129122633|NCT02472405|464744075|FG000|Overall Study|Adverse Event|1|||
129122634|NCT03617588|464744076|FG000|Overall Study|Withdrawal by Subject|1|||
129122635|NCT03617588|464744077|FG001|Overall Study|Withdrawal by Subject|0|||
129122636|NCT01294514|464744078|FG000|Overall Study|Excluded due to Arrhythmia|1|||
129122637|NCT02911116|464744079|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129122638|NCT02911116|464744080|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129122639|NCT02911116|464744079|FG000|Overall Study|Lost to Follow-up|0|||
129122640|NCT02911116|464744080|FG001|Overall Study|Lost to Follow-up|1|||
129122641|NCT04796415|464744081|FG000|Overall Study|not interested|12|||
129122642|NCT04796415|464744081|FG000|Overall Study|health issue|8|||
129122643|NCT04796415|464744081|FG000|Overall Study|Other|4|||
129122644|NCT04796415|464744081|FG000|Overall Study|discharged from home health service|3|||
129122645|NCT04796415|464744081|FG000|Overall Study|re-hospitalization|2|||
128706759|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Other|2|||
128706760|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Other|2|||
128706761|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Death|0|||
128706762|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Death|0|||
128706763|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Death|0|||
128706764|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Death|0|||
128706765|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Death|0|||
128706766|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Death|3|||
128706767|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
128706768|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
128706769|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
128706770|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
128706771|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
128706772|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
128706773|NCT00642460|463220546|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
128706774|NCT00642460|463220547|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
128706775|NCT00642460|463220548|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
128706776|NCT00642460|463220549|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
128706777|NCT00642460|463220550|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
128706778|NCT00642460|463220551|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
128706779|NCT02088047|463220554|FG000|Overall Study|Withdrawal by Subject|1|||
128706780|NCT02088047|463220555|FG001|Overall Study|Withdrawal by Subject|0|||
128768899|NCT03916744|463444149|FG001|Overall Study|Withdrawal by Subject|1|||
128768900|NCT03916744|463444150|FG002|Overall Study|Withdrawal by Subject|2|||
128768901|NCT04524598|463444151|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
128937067|NCT00530712|464056987|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
128937068|NCT00530712|464056987|FG000|12 Month Follow-up Visit|Missed Visit|3|||
128937069|NCT00530712|464056987|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
128937070|NCT00530712|464056987|FG000|12 Month Follow-up Visit|Death|9|||
128937071|NCT03117049|464056995|FG000|Overall Study|Continued the follow-up period|109|||
128937072|NCT03117049|464056996|FG001|Overall Study|Continued the follow-up period|129|||
128937073|NCT03117049|464056995|FG000|Overall Study|Died|82|||
128937074|NCT03117049|464056996|FG001|Overall Study|Died|93|||
129031610|NCT01698554|464406501|FG001|Overall Study|Adverse Event|5|||
129031611|NCT01698554|464406502|FG002|Overall Study|Adverse Event|0|||
129031612|NCT01698554|464406503|FG003|Overall Study|Adverse Event|1|||
128937075|NCT03117049|464056995|FG000|Overall Study|Consent withdrawal|7|||
128937076|NCT03117049|464056996|FG001|Overall Study|Consent withdrawal|6|||
129031613|NCT01698554|464406500|FG000|Overall Study|Lost to Follow-up|1|||
129031614|NCT01698554|464406501|FG001|Overall Study|Lost to Follow-up|0|||
129031615|NCT01698554|464406502|FG002|Overall Study|Lost to Follow-up|0|||
129031616|NCT01698554|464406503|FG003|Overall Study|Lost to Follow-up|0|||
129031617|NCT01698554|464406500|FG000|Overall Study|Personal Reasons|0|||
128937077|NCT03117049|464056995|FG000|Overall Study|Missing contact|3|||
129031618|NCT01698554|464406501|FG001|Overall Study|Personal Reasons|5|||
129122646|NCT04796415|464744081|FG000|Overall Study|moving to nursing home|1|||
129122647|NCT04796415|464744081|FG000|Overall Study|lost contact|1|||
129122648|NCT02469857|464744082|FG000|Overall Study|Death|24|||
128768902|NCT04524598|463444152|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
128768903|NCT04524598|463444153|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
128768904|NCT04524598|463444154|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
128768905|NCT04524598|463444155|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
128768906|NCT04524598|463444151|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
128768907|NCT04524598|463444152|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
128768908|NCT04524598|463444153|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768909|NCT04524598|463444154|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768910|NCT04524598|463444155|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768911|NCT04524598|463444151|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
128768912|NCT04524598|463444152|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
128768913|NCT04524598|463444153|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
128768914|NCT04524598|463444154|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
128768915|NCT04524598|463444155|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
128768916|NCT04524598|463444151|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
128768917|NCT04524598|463444152|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
128768918|NCT04524598|463444153|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
128768919|NCT04524598|463444154|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
128768920|NCT04524598|463444155|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
129031619|NCT01698554|464406502|FG002|Overall Study|Personal Reasons|1|||
129031620|NCT01698554|464406503|FG003|Overall Study|Personal Reasons|1|||
129031621|NCT01698554|464406500|FG000|Overall Study|Protocol Violation|2|||
129031622|NCT01698554|464406501|FG001|Overall Study|Protocol Violation|0|||
129122649|NCT02469857|464744083|FG001|Overall Study|Death|29|||
129122650|NCT02469857|464744082|FG000|Overall Study|Discontinuation|1|||
129122651|NCT02469857|464744083|FG001|Overall Study|Discontinuation|3|||
129122652|NCT02110693|464744084|FG000|Overall Study|Withdrawal by Subject|6|||
129122653|NCT02110693|464744085|FG001|Overall Study|Withdrawal by Subject|7|||
128706781|NCT04605484|463220558|FG000|Overall Study|Lost to Follow-up|0|||
128706782|NCT04605484|463220559|FG001|Overall Study|Lost to Follow-up|1|||
128706783|NCT04605484|463220560|FG002|Overall Study|Lost to Follow-up|1|||
129122654|NCT02110693|464744084|FG000|Overall Study|skipped assessment|15|||
129122655|NCT02110693|464744085|FG001|Overall Study|skipped assessment|18|||
129122656|NCT02110693|464744084|FG000|Overall Study|technical difficulties|6|||
129122657|NCT02110693|464744085|FG001|Overall Study|technical difficulties|4|||
129122658|NCT02110693|464744084|FG000|Overall Study|Other|1|||
128706784|NCT04605484|463220558|FG000|Overall Study|Other|0|||
128706785|NCT04605484|463220559|FG001|Overall Study|Other|1|||
128706786|NCT04605484|463220560|FG002|Overall Study|Other|0|||
128706787|NCT04862585|463220563|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
128706788|NCT04862585|463220564|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
128706789|NCT04862585|463220563|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
128706790|NCT04862585|463220564|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
128706791|NCT04862585|463220563|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
128706792|NCT04862585|463220564|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
128768921|NCT04524598|463444151|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768922|NCT04524598|463444152|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
129031623|NCT01698554|464406502|FG002|Overall Study|Protocol Violation|1|||
129031624|NCT01698554|464406503|FG003|Overall Study|Protocol Violation|0|||
129031625|NCT01698554|464406500|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129031626|NCT01698554|464406501|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129031627|NCT01698554|464406502|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129031628|NCT01698554|464406503|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129031629|NCT02229084|464406504|FG000|Overall Study|Adverse Event|1|||
129031630|NCT02229084|464406505|FG001|Overall Study|Adverse Event|0|||
129031631|NCT02229084|464406506|FG002|Overall Study|Adverse Event|0|||
129031632|NCT02229084|464406507|FG003|Overall Study|Adverse Event|0|||
129031633|NCT02229084|464406508|FG004|Overall Study|Adverse Event|0|||
129031634|NCT02229084|464406509|FG005|Overall Study|Adverse Event|0|||
129031635|NCT02229084|464406510|FG006|Overall Study|Adverse Event|0|||
129031636|NCT02229084|464406504|FG000|Overall Study|Lost to Follow-up|0|||
129031637|NCT02229084|464406505|FG001|Overall Study|Lost to Follow-up|0|||
129031638|NCT02229084|464406506|FG002|Overall Study|Lost to Follow-up|1|||
129031639|NCT02229084|464406507|FG003|Overall Study|Lost to Follow-up|1|||
129031640|NCT02229084|464406508|FG004|Overall Study|Lost to Follow-up|0|||
129122659|NCT02110693|464744085|FG001|Overall Study|Other|0|||
129122660|NCT04810962|464744086|FG000|Overall Study|Adverse Event|0|||
128706793|NCT04862585|463220563|FG000|Overall Study|one withdrew without providing a reason|0|||
129031641|NCT02229084|464406509|FG005|Overall Study|Lost to Follow-up|0|||
129031642|NCT02229084|464406510|FG006|Overall Study|Lost to Follow-up|1|||
129122661|NCT04810962|464744087|FG001|Overall Study|Adverse Event|1|||
129031643|NCT02229084|464406504|FG000|Overall Study|Physician Decision|0|||
129031644|NCT02229084|464406505|FG001|Overall Study|Physician Decision|0|||
128706794|NCT04862585|463220564|FG001|Overall Study|one withdrew without providing a reason|1|||
129122662|NCT04810962|464744086|FG000|Overall Study|Lost to Follow-up|2|||
128706795|NCT00496470|463220565|FG000|Overall Study|Adverse Event|8|||
128706796|NCT00496470|463220566|FG001|Overall Study|Adverse Event|10|||
128706797|NCT00496470|463220565|FG000|Overall Study|Withdrawal by Subject|5|||
128706798|NCT00496470|463220566|FG001|Overall Study|Withdrawal by Subject|12|||
128706799|NCT00496470|463220565|FG000|Overall Study|Incorrectly enrolled|13|||
128706800|NCT00496470|463220566|FG001|Overall Study|Incorrectly enrolled|5|||
128706801|NCT00496470|463220565|FG000|Overall Study|Other reason|0|||
128706802|NCT00496470|463220566|FG001|Overall Study|Other reason|2|||
128706803|NCT01217814|463220567|FG000|Overall Study|Adverse Event|1|||
128706804|NCT01217814|463220568|FG001|Overall Study|Adverse Event|1|||
128706805|NCT01217814|463220569|FG002|Overall Study|Adverse Event|0|||
128706806|NCT01217814|463220567|FG000|Overall Study|Lack of Efficacy|0|||
128706807|NCT01217814|463220568|FG001|Overall Study|Lack of Efficacy|0|||
128706808|NCT01217814|463220569|FG002|Overall Study|Lack of Efficacy|1|||
128706809|NCT01370356|463220570|FG000|Overall Study|Death|1|||
128706810|NCT01370356|463220571|FG001|Overall Study|Death|0|||
128706811|NCT01370356|463220570|FG000|Overall Study|Lack of Efficacy|6|||
128706812|NCT01370356|463220571|FG001|Overall Study|Lack of Efficacy|28|||
128706813|NCT01370356|463220570|FG000|Overall Study|Lost to Follow-up|76|||
128706814|NCT01370356|463220571|FG001|Overall Study|Lost to Follow-up|81|||
128706815|NCT01370356|463220570|FG000|Overall Study|Withdrawal by Subject|54|||
128706816|NCT01370356|463220571|FG001|Overall Study|Withdrawal by Subject|59|||
128706817|NCT01370356|463220570|FG000|Overall Study|Reason not specified|39|||
128706818|NCT01370356|463220571|FG001|Overall Study|Reason not specified|43|||
128706819|NCT01370356|463220570|FG000|Overall Study|Protocol Violation|3|||
128706820|NCT01370356|463220571|FG001|Overall Study|Protocol Violation|3|||
128706821|NCT01370356|463220570|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
128706822|NCT01370356|463220571|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
128706823|NCT01370356|463220570|FG000|Overall Study|AE Not Related to Study Drug|1|||
128706824|NCT01370356|463220571|FG001|Overall Study|AE Not Related to Study Drug|4|||
128706825|NCT00040664|463220572|FG000|Overall Study|Adverse Event|12|||
128706826|NCT00040664|463220573|FG001|Overall Study|Adverse Event|3|||
128706827|NCT00040664|463220574|FG002|Overall Study|Adverse Event|2|||
128706828|NCT00040664|463220575|FG003|Overall Study|Adverse Event|7|||
128706829|NCT00040664|463220572|FG000|Overall Study|Lack of Efficacy|9|||
128706830|NCT00040664|463220573|FG001|Overall Study|Lack of Efficacy|2|||
128706831|NCT00040664|463220574|FG002|Overall Study|Lack of Efficacy|3|||
128706832|NCT00040664|463220575|FG003|Overall Study|Lack of Efficacy|4|||
128706833|NCT00040664|463220572|FG000|Overall Study|Insufficient CD4 response|1|||
128706834|NCT00040664|463220573|FG001|Overall Study|Insufficient CD4 response|0|||
128706835|NCT00040664|463220574|FG002|Overall Study|Insufficient CD4 response|1|||
128706836|NCT00040664|463220575|FG003|Overall Study|Insufficient CD4 response|0|||
128706837|NCT00040664|463220572|FG000|Overall Study|Lost to Follow-up|4|||
128706838|NCT00040664|463220573|FG001|Overall Study|Lost to Follow-up|2|||
128706839|NCT00040664|463220574|FG002|Overall Study|Lost to Follow-up|0|||
128706840|NCT00040664|463220575|FG003|Overall Study|Lost to Follow-up|2|||
128706841|NCT00040664|463220572|FG000|Overall Study|Protocol Violation|2|||
128706842|NCT00040664|463220573|FG001|Overall Study|Protocol Violation|1|||
128706843|NCT00040664|463220574|FG002|Overall Study|Protocol Violation|0|||
128706844|NCT00040664|463220575|FG003|Overall Study|Protocol Violation|1|||
128706845|NCT00040664|463220572|FG000|Overall Study|Withdrawal by Subject|7|||
128706846|NCT00040664|463220573|FG001|Overall Study|Withdrawal by Subject|0|||
128937078|NCT03117049|464056996|FG001|Overall Study|Missing contact|3|||
128937079|NCT00651118|464056997|FG000|Overall Study|Adverse Event|4|||
128937080|NCT00651118|464056998|FG001|Overall Study|Adverse Event|0|||
128937081|NCT00651118|464056999|FG002|Overall Study|Adverse Event|1|||
128937082|NCT00651118|464057000|FG003|Overall Study|Adverse Event|1|||
128937083|NCT00651118|464056997|FG000|Overall Study|Protocol Violation|2|||
128937084|NCT00651118|464056998|FG001|Overall Study|Protocol Violation|2|||
128937085|NCT00651118|464056999|FG002|Overall Study|Protocol Violation|6|||
128937086|NCT00651118|464057000|FG003|Overall Study|Protocol Violation|2|||
128937087|NCT00651118|464056997|FG000|Overall Study|Lost to Follow-up|2|||
129122663|NCT04810962|464744087|FG001|Overall Study|Lost to Follow-up|1|||
128706847|NCT00040664|463220574|FG002|Overall Study|Withdrawal by Subject|3|||
128706848|NCT00040664|463220575|FG003|Overall Study|Withdrawal by Subject|4|||
128706849|NCT00040664|463220572|FG000|Overall Study|Pregnancy|3|||
128706850|NCT00040664|463220573|FG001|Overall Study|Pregnancy|0|||
128706851|NCT00040664|463220574|FG002|Overall Study|Pregnancy|0|||
128706852|NCT00040664|463220575|FG003|Overall Study|Pregnancy|3|||
128706853|NCT00040664|463220572|FG000|Overall Study|Medication adherence/compliance problems|8|||
128937088|NCT00651118|464056998|FG001|Overall Study|Lost to Follow-up|0|||
128937089|NCT00651118|464056999|FG002|Overall Study|Lost to Follow-up|1|||
128706854|NCT00040664|463220573|FG001|Overall Study|Medication adherence/compliance problems|2|||
128706855|NCT00040664|463220574|FG002|Overall Study|Medication adherence/compliance problems|1|||
128937090|NCT00651118|464057000|FG003|Overall Study|Lost to Follow-up|2|||
128937091|NCT00651118|464056997|FG000|Overall Study|administrative|1|||
129122664|NCT04810962|464744086|FG000|Overall Study|Physician Decision|1|||
128706856|NCT00040664|463220575|FG003|Overall Study|Medication adherence/compliance problems|5|||
128706857|NCT00040664|463220572|FG000|Overall Study|Poor taste|2|||
128706858|NCT00040664|463220573|FG001|Overall Study|Poor taste|0|||
128706859|NCT00040664|463220574|FG002|Overall Study|Poor taste|2|||
128706860|NCT00040664|463220575|FG003|Overall Study|Poor taste|0|||
128706861|NCT00040664|463220572|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
128706862|NCT00040664|463220573|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
128706863|NCT00040664|463220574|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
128706864|NCT00040664|463220575|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
128706865|NCT00040664|463220572|FG000|Overall Study|Change of formulation|2|||
128706866|NCT00040664|463220573|FG001|Overall Study|Change of formulation|2|||
128706867|NCT00040664|463220574|FG002|Overall Study|Change of formulation|0|||
128706868|NCT00040664|463220575|FG003|Overall Study|Change of formulation|0|||
128706869|NCT00040664|463220572|FG000|Overall Study|Non-viability of oral suspension|1|||
128706870|NCT00040664|463220573|FG001|Overall Study|Non-viability of oral suspension|0|||
128706871|NCT00040664|463220574|FG002|Overall Study|Non-viability of oral suspension|1|||
128706872|NCT00040664|463220575|FG003|Overall Study|Non-viability of oral suspension|0|||
128706873|NCT00729651|463220576|FG000|Overall Study|Withdrawal by Subject|5|||
128706874|NCT00729651|463220577|FG001|Overall Study|Withdrawal by Subject|6|||
128706875|NCT00729651|463220576|FG000|Overall Study|Lost to Follow-up|5|||
128706876|NCT00729651|463220577|FG001|Overall Study|Lost to Follow-up|4|||
128706877|NCT00729651|463220576|FG000|Overall Study|Protocol Violation|0|||
128706878|NCT00729651|463220577|FG001|Overall Study|Protocol Violation|1|||
128706879|NCT00729651|463220576|FG000|Overall Study|Adverse Event|7|||
128706880|NCT00729651|463220577|FG001|Overall Study|Adverse Event|3|||
128706881|NCT00729651|463220576|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
128706882|NCT00729651|463220577|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
128706883|NCT00729651|463220576|FG000|Overall Study|Subject's private reason|2|||
128706884|NCT00729651|463220577|FG001|Overall Study|Subject's private reason|0|||
128706885|NCT01218243|463220578|FG000|Overall Study|Lack of Efficacy|1|||
128706886|NCT01218243|463220579|FG001|Overall Study|Lack of Efficacy|1|||
128706887|NCT01218243|463220578|FG000|Overall Study|Lost to Follow-up|3|||
128706888|NCT01218243|463220579|FG001|Overall Study|Lost to Follow-up|3|||
128706889|NCT01218243|463220578|FG000|Overall Study|Protocol Violation|5|||
128706890|NCT01218243|463220579|FG001|Overall Study|Protocol Violation|10|||
128706891|NCT01950741|463220590|FG000|Overall Study|Lost to Follow-up|1|||
128706892|NCT01950741|463220590|FG000|Overall Study|Death|1|||
128706893|NCT01950741|463220590|FG000|Overall Study|Withdrawal by Subject|1|||
128706894|NCT01835587|463220594|FG000|Overall Study|Disease Recurrence or Relapse|0|||
128706895|NCT01835587|463220595|FG001|Overall Study|Disease Recurrence or Relapse|3|||
128706896|NCT01835587|463220596|FG002|Overall Study|Disease Recurrence or Relapse|0|||
128706897|NCT01835587|463220597|FG003|Overall Study|Disease Recurrence or Relapse|3|||
128706898|NCT01835587|463220594|FG000|Overall Study|Withdrawal by Subject|2|||
128706899|NCT01835587|463220595|FG001|Overall Study|Withdrawal by Subject|0|||
128706900|NCT01835587|463220596|FG002|Overall Study|Withdrawal by Subject|0|||
128706901|NCT01835587|463220597|FG003|Overall Study|Withdrawal by Subject|3|||
128706902|NCT01835587|463220594|FG000|Overall Study|Adverse Event|0|||
128706903|NCT01835587|463220595|FG001|Overall Study|Adverse Event|0|||
128706904|NCT01835587|463220596|FG002|Overall Study|Adverse Event|2|||
128706905|NCT01835587|463220597|FG003|Overall Study|Adverse Event|2|||
128706906|NCT01835587|463220594|FG000|Overall Study|Death|0|||
128706907|NCT01835587|463220595|FG001|Overall Study|Death|0|||
128706908|NCT01835587|463220596|FG002|Overall Study|Death|0|||
128706909|NCT01835587|463220597|FG003|Overall Study|Death|1|||
128706910|NCT01835587|463220594|FG000|Overall Study|Miscellaneous|0|||
128706911|NCT01835587|463220595|FG001|Overall Study|Miscellaneous|1|||
128706912|NCT01835587|463220596|FG002|Overall Study|Miscellaneous|0|||
128706913|NCT01835587|463220597|FG003|Overall Study|Miscellaneous|0|||
128706914|NCT00357968|463220598|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
128706915|NCT00357968|463220599|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
128706916|NCT00357968|463220598|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
128706917|NCT00357968|463220599|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
128706918|NCT02846779|463220614|FG000|Overall Study|Lost Enrollment|83|||
128706919|NCT02846779|463220615|FG001|Overall Study|Lost Enrollment|82|||
128706920|NCT02846779|463220616|FG002|Overall Study|Lost Enrollment|86|||
128706921|NCT02846779|463220614|FG000|Overall Study|Less than 31 days of follow-up|56|||
128706922|NCT02846779|463220615|FG001|Overall Study|Less than 31 days of follow-up|45|||
128706923|NCT02846779|463220616|FG002|Overall Study|Less than 31 days of follow-up|52|||
128706924|NCT02239978|463222089|FG000|Overall Study|Withdrawal by Subject|2|||
128706925|NCT02239978|463222090|FG001|Overall Study|Withdrawal by Subject|0|||
128706926|NCT00996216|463222096|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
128706927|NCT00996216|463222096|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
128706928|NCT00996216|463222096|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
128706929|NCT00410046|463222097|FG000|Overall Study|Adverse Event|3|||
128706930|NCT00410046|463222097|FG000|Overall Study|Withdrawal by Subject|1|||
128706931|NCT00410046|463222097|FG000|Overall Study|Lost to Follow-up|1|||
128706932|NCT03098550|463222098|FG000|Overall Study|Disease Progression|30|||
128706933|NCT03098550|463222099|FG001|Overall Study|Disease Progression|19|||
128706934|NCT03098550|463222100|FG002|Overall Study|Disease Progression|41|||
128706935|NCT03098550|463222098|FG000|Overall Study|Study Drug Toxicity|2|||
128706936|NCT03098550|463222099|FG001|Overall Study|Study Drug Toxicity|1|||
128706937|NCT03098550|463222100|FG002|Overall Study|Study Drug Toxicity|0|||
128706938|NCT03098550|463222098|FG000|Overall Study|Death|1|||
128706939|NCT03098550|463222099|FG001|Overall Study|Death|0|||
128706940|NCT03098550|463222100|FG002|Overall Study|Death|0|||
128706941|NCT03098550|463222098|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
128706942|NCT03098550|463222099|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
129031645|NCT02229084|464406506|FG002|Overall Study|Physician Decision|0|||
128706943|NCT03098550|463222100|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
128706944|NCT03098550|463222098|FG000|Overall Study|Administrative reason by sponsor|0|||
128706945|NCT03098550|463222099|FG001|Overall Study|Administrative reason by sponsor|0|||
128706946|NCT03098550|463222100|FG002|Overall Study|Administrative reason by sponsor|1|||
128706947|NCT03098550|463222098|FG000|Overall Study|Other reasons|2|||
128706948|NCT03098550|463222099|FG001|Overall Study|Other reasons|0|||
128706949|NCT03098550|463222100|FG002|Overall Study|Other reasons|0|||
128706950|NCT00759031|463222107|FG000|First Intervention (1 Day)|Physician Decision|1|||
128706951|NCT00759031|463222108|FG001|First Intervention (1 Day)|Physician Decision|0|||
128706952|NCT00759031|463222107|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
128706953|NCT00759031|463222108|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
128706954|NCT00759031|463222107|FG000|First Intervention (1 Day)|Screening failure|1|||
128706955|NCT00759031|463222108|FG001|First Intervention (1 Day)|Screening failure|0|||
128706956|NCT02430311|463222109|FG000|Part A|Adverse Event|0|||
128706957|NCT02430311|463222110|FG001|Part A|Adverse Event|1|||
128706958|NCT02430311|463222109|FG000|Part A|Withdrawal by Subject|1|||
128706959|NCT02430311|463222110|FG001|Part A|Withdrawal by Subject|0|||
128706960|NCT02430311|463222109|FG000|Part B|Meet study-specific withdrawal criteria|6|||
128706961|NCT02430311|463222110|FG001|Part B|Meet study-specific withdrawal criteria|6|||
128706962|NCT02430311|463222109|FG000|Part B|Withdrawal by Subject|2|||
128706963|NCT02430311|463222110|FG001|Part B|Withdrawal by Subject|2|||
128706964|NCT02430311|463222109|FG000|Part B|Adverse Event|1|||
129031646|NCT02229084|464406507|FG003|Overall Study|Physician Decision|1|||
129217103|NCT03926611|465096876|FG006|Overall Study|Protocol Violation|1|||
129217104|NCT03926611|465096870|FG000|Overall Study|Technical problems|0|||
129217105|NCT03926611|465096871|FG001|Overall Study|Technical problems|0|||
129217106|NCT03926611|465096872|FG002|Overall Study|Technical problems|0|||
129217107|NCT03926611|465096873|FG003|Overall Study|Technical problems|0|||
129217108|NCT03926611|465096874|FG004|Overall Study|Technical problems|0|||
129217109|NCT03926611|465096875|FG005|Overall Study|Technical problems|1|||
129217110|NCT03926611|465096876|FG006|Overall Study|Technical problems|0|||
129217111|NCT03926611|465096870|FG000|Overall Study|Withdrawal by Subject|1|||
129217112|NCT03926611|465096871|FG001|Overall Study|Withdrawal by Subject|1|||
129217113|NCT03926611|465096872|FG002|Overall Study|Withdrawal by Subject|1|||
129217114|NCT03926611|465096873|FG003|Overall Study|Withdrawal by Subject|0|||
129217115|NCT03926611|465096874|FG004|Overall Study|Withdrawal by Subject|0|||
129217116|NCT03926611|465096875|FG005|Overall Study|Withdrawal by Subject|1|||
129217117|NCT03926611|465096876|FG006|Overall Study|Withdrawal by Subject|3|||
129217118|NCT03926611|465096870|FG000|Overall Study|Covid-19 pandemic|0|||
129217119|NCT03926611|465096871|FG001|Overall Study|Covid-19 pandemic|0|||
129217120|NCT03926611|465096872|FG002|Overall Study|Covid-19 pandemic|1|||
129217121|NCT03926611|465096873|FG003|Overall Study|Covid-19 pandemic|0|||
129217122|NCT03926611|465096874|FG004|Overall Study|Covid-19 pandemic|1|||
129217123|NCT03926611|465096875|FG005|Overall Study|Covid-19 pandemic|2|||
129217124|NCT03926611|465096876|FG006|Overall Study|Covid-19 pandemic|0|||
129217125|NCT00084136|465096879|FG000|PI Comparison|Death|10|||
129217126|NCT00084136|465096880|FG001|PI Comparison|Death|9|||
129217127|NCT00084136|465096881|FG002|PI Comparison|Death|0|||
129217128|NCT00084136|465096879|FG000|PI Comparison|Lost to Follow-up|11|||
129217129|NCT00084136|465096880|FG001|PI Comparison|Lost to Follow-up|8|||
129217130|NCT00084136|465096881|FG002|PI Comparison|Lost to Follow-up|0|||
129217131|NCT00084136|465096879|FG000|PI Comparison|Withdrawal by Subject|33|||
129217132|NCT00084136|465096880|FG001|PI Comparison|Withdrawal by Subject|30|||
129217133|NCT00084136|465096881|FG002|PI Comparison|Withdrawal by Subject|0|||
129217134|NCT00084136|465096879|FG000|PI Comparison|Clinic site closed|1|||
129217135|NCT00084136|465096880|FG001|PI Comparison|Clinic site closed|0|||
129217136|NCT00084136|465096881|FG002|PI Comparison|Clinic site closed|0|||
129031647|NCT02229084|464406508|FG004|Overall Study|Physician Decision|3|||
129217137|NCT00084136|465096879|FG000|NRTI Comparison|Death|20|||
129217138|NCT00084136|465096880|FG001|NRTI Comparison|Death|0|||
129217139|NCT00084136|465096881|FG002|NRTI Comparison|Death|18|||
129217140|NCT00084136|465096879|FG000|NRTI Comparison|Lost to Follow-up|14|||
129217141|NCT00084136|465096880|FG001|NRTI Comparison|Lost to Follow-up|0|||
129217142|NCT00084136|465096881|FG002|NRTI Comparison|Lost to Follow-up|12|||
129217143|NCT00084136|465096879|FG000|NRTI Comparison|Withdrawal by Subject|54|||
129217144|NCT00084136|465096880|FG001|NRTI Comparison|Withdrawal by Subject|0|||
129217145|NCT00084136|465096881|FG002|NRTI Comparison|Withdrawal by Subject|38|||
128768923|NCT04524598|463444153|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
128768924|NCT04524598|463444154|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
128768925|NCT04524598|463444155|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768926|NCT04524598|463444151|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
128768927|NCT04524598|463444152|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
128768928|NCT04524598|463444153|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
128768929|NCT04524598|463444154|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
128768930|NCT04524598|463444155|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
128768931|NCT04524598|463444151|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768932|NCT04524598|463444152|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768933|NCT04524598|463444153|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768934|NCT04524598|463444154|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
128768935|NCT04524598|463444155|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
128768936|NCT04152343|463444156|FG000|Overall Study|Transplanted|5|||
128768937|NCT04152343|463444156|FG000|Overall Study|Death|20|||
128768938|NCT04152343|463444156|FG000|Overall Study|Lost to Follow-up|3|||
128768939|NCT01164228|463444161|FG000|Overall Study|Progression|24|||
128768940|NCT01164228|463444162|FG001|Overall Study|Progression|25|||
128768941|NCT01164228|463444161|FG000|Overall Study|Adverse Event|13|||
128768942|NCT01164228|463444162|FG001|Overall Study|Adverse Event|7|||
128768943|NCT01164228|463444161|FG000|Overall Study|Death|1|||
128768944|NCT01164228|463444162|FG001|Overall Study|Death|1|||
128768945|NCT01164228|463444161|FG000|Overall Study|Withdrawal by Subject|2|||
128768946|NCT01164228|463444162|FG001|Overall Study|Withdrawal by Subject|0|||
128768947|NCT01164228|463444161|FG000|Overall Study|Physician Decision|1|||
128768948|NCT01164228|463444162|FG001|Overall Study|Physician Decision|2|||
128768949|NCT01164228|463444161|FG000|Overall Study|Symptomatic deterioration|1|||
128768950|NCT01164228|463444162|FG001|Overall Study|Symptomatic deterioration|0|||
128768951|NCT01164228|463444161|FG000|Overall Study|Never started treatment|1|||
128768952|NCT01164228|463444162|FG001|Overall Study|Never started treatment|3|||
128768953|NCT01164228|463444161|FG000|Overall Study|Ineligible|1|||
128768954|NCT01164228|463444162|FG001|Overall Study|Ineligible|0|||
128768955|NCT01965938|463444163|FG000|Overall Study|Withdrawal by Subject|1|||
128768956|NCT01965938|463444164|FG001|Overall Study|Withdrawal by Subject|0|||
128768957|NCT03757234|463444165|FG000|Overall Study|Adverse Event|0|||
128768958|NCT03757234|463444166|FG001|Overall Study|Adverse Event|0|||
128768959|NCT03757234|463444167|FG002|Overall Study|Adverse Event|0|||
128768960|NCT03757234|463444168|FG003|Overall Study|Adverse Event|0|||
128768961|NCT03757234|463444169|FG004|Overall Study|Adverse Event|1|||
128768962|NCT03757234|463444165|FG000|Overall Study|Lost to Follow-up|1|||
128768963|NCT03757234|463444166|FG001|Overall Study|Lost to Follow-up|0|||
128768964|NCT03757234|463444167|FG002|Overall Study|Lost to Follow-up|0|||
128768965|NCT03757234|463444168|FG003|Overall Study|Lost to Follow-up|0|||
128768966|NCT03757234|463444169|FG004|Overall Study|Lost to Follow-up|1|||
128768967|NCT03757234|463444165|FG000|Overall Study|Withdrawal by Subject|1|||
128768968|NCT03757234|463444166|FG001|Overall Study|Withdrawal by Subject|1|||
128768969|NCT03757234|463444167|FG002|Overall Study|Withdrawal by Subject|0|||
128768970|NCT03757234|463444168|FG003|Overall Study|Withdrawal by Subject|1|||
128768971|NCT03757234|463444169|FG004|Overall Study|Withdrawal by Subject|2|||
128768972|NCT03757234|463444165|FG000|Overall Study|Other|1|||
128937092|NCT00651118|464056998|FG001|Overall Study|administrative|4|||
128937093|NCT00651118|464056999|FG002|Overall Study|administrative|2|||
128937094|NCT00651118|464057000|FG003|Overall Study|administrative|1|||
128937095|NCT00651118|464056997|FG000|Overall Study|Withdrawal by Subject|0|||
128937096|NCT00651118|464056998|FG001|Overall Study|Withdrawal by Subject|1|||
128937097|NCT00651118|464056999|FG002|Overall Study|Withdrawal by Subject|1|||
128937098|NCT00651118|464057000|FG003|Overall Study|Withdrawal by Subject|1|||
128937099|NCT00839098|464057001|FG000|Overall Study|Withdrawal by Subject|2|||
128937100|NCT00839098|464057002|FG001|Overall Study|Withdrawal by Subject|1|||
128768973|NCT03757234|463444166|FG001|Overall Study|Other|1|||
128937101|NCT00839098|464057003|FG002|Overall Study|Withdrawal by Subject|7|||
128768974|NCT03757234|463444167|FG002|Overall Study|Other|0|||
128768975|NCT03757234|463444168|FG003|Overall Study|Other|0|||
128768976|NCT03757234|463444169|FG004|Overall Study|Other|0|||
128768977|NCT04287868|463444174|FG000|Overall Study|Screening fail|1|||
128768978|NCT04287868|463444175|FG001|Overall Study|Screening fail|0|||
128768979|NCT02936037|463445932|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
128937102|NCT00365976|464057006|FG000|Overall Study|Withdrawal by Subject|1|||
128937103|NCT00365976|464057007|FG001|Overall Study|Withdrawal by Subject|5|||
128937104|NCT00935220|464057008|FG000|Overall Study|Adverse Event|1|||
128937105|NCT00935220|464057008|FG000|Overall Study|Other reason (not specified)|1|||
129122665|NCT04810962|464744087|FG001|Overall Study|Physician Decision|0|||
128937106|NCT00798967|464057009|FG000|Overall Study|Adverse Event|2|||
128937107|NCT00798967|464057010|FG001|Overall Study|Adverse Event|3|||
128937108|NCT00798967|464057009|FG000|Overall Study|Withdrawal by Subject|0|||
128937109|NCT00798967|464057010|FG001|Overall Study|Withdrawal by Subject|1|||
128937110|NCT00798967|464057009|FG000|Overall Study|Physician Decision|1|||
128937111|NCT00798967|464057010|FG001|Overall Study|Physician Decision|0|||
128937112|NCT00798967|464057009|FG000|Overall Study|Randomized in error by site|1|||
128937113|NCT00798967|464057010|FG001|Overall Study|Randomized in error by site|0|||
128937114|NCT01415440|464057013|FG000|Overall Study|Lost to Follow-up|0|||
128937115|NCT01415440|464057014|FG001|Overall Study|Lost to Follow-up|1|||
128937116|NCT01415440|464057015|FG002|Overall Study|Lost to Follow-up|2|||
128937117|NCT01415440|464057013|FG000|Overall Study|Physician Decision|3|||
128937118|NCT01415440|464057014|FG001|Overall Study|Physician Decision|0|||
128937119|NCT01415440|464057015|FG002|Overall Study|Physician Decision|0|||
128937120|NCT01415440|464057013|FG000|Overall Study|Withdrawal by Subject|1|||
128937121|NCT01415440|464057014|FG001|Overall Study|Withdrawal by Subject|0|||
128937122|NCT01415440|464057015|FG002|Overall Study|Withdrawal by Subject|0|||
128937123|NCT00633139|464057018|FG000|Overall Study|Non compliance|0|||
128937124|NCT00633139|464057019|FG001|Overall Study|Non compliance|0|||
128937125|NCT00633139|464057020|FG002|Overall Study|Non compliance|1|||
128937126|NCT00633139|464057018|FG000|Overall Study|Withdrawal by Subject|0|||
128937127|NCT00633139|464057019|FG001|Overall Study|Withdrawal by Subject|1|||
128937128|NCT00633139|464057020|FG002|Overall Study|Withdrawal by Subject|0|||
128937129|NCT02160977|464057021|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
128937130|NCT02160977|464057022|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
129217146|NCT00084136|465096879|FG000|NRTI Comparison|Clinic site closed|12|||
129217147|NCT00084136|465096880|FG001|NRTI Comparison|Clinic site closed|0|||
129217148|NCT00084136|465096881|FG002|NRTI Comparison|Clinic site closed|14|||
129217149|NCT00084136|465096879|FG000|NRTI Comparison|Not reason above|1|||
129217150|NCT00084136|465096880|FG001|NRTI Comparison|Not reason above|0|||
129217151|NCT00084136|465096881|FG002|NRTI Comparison|Not reason above|0|||
129217152|NCT02230670|465096882|FG000|Overall Study|Adverse Event|1|||
129217153|NCT02230670|465096883|FG001|Overall Study|Adverse Event|2|||
129217154|NCT02230670|465096882|FG000|Overall Study|Withdrawal by Subject|2|||
129217155|NCT02230670|465096883|FG001|Overall Study|Withdrawal by Subject|2|||
129217156|NCT02230670|465096882|FG000|Overall Study|Physician Decision|0|||
129217157|NCT02230670|465096883|FG001|Overall Study|Physician Decision|1|||
129217158|NCT02230670|465096882|FG000|Overall Study|Protocol Violation|0|||
129217159|NCT02230670|465096883|FG001|Overall Study|Protocol Violation|1|||
129217160|NCT02230670|465096882|FG000|Overall Study|Progression to Child-Pugh C|1|||
129217161|NCT02230670|465096883|FG001|Overall Study|Progression to Child-Pugh C|2|||
129217162|NCT00836693|465096884|FG000|Overall Study|Adverse Event|4|||
129217163|NCT00836693|465096885|FG001|Overall Study|Adverse Event|1|||
129217164|NCT00836693|465096884|FG000|Overall Study|Sponsor Decision|0|||
129217165|NCT00836693|465096885|FG001|Overall Study|Sponsor Decision|1|||
129217166|NCT00836693|465096884|FG000|Overall Study|Physician Decision|2|||
129217167|NCT00836693|465096885|FG001|Overall Study|Physician Decision|0|||
129217168|NCT00836693|465096884|FG000|Overall Study|Withdrawal by Subject|9|||
129217169|NCT00836693|465096885|FG001|Overall Study|Withdrawal by Subject|4|||
129217170|NCT00836693|465096884|FG000|Overall Study|Protocol Violation|1|||
129217171|NCT00836693|465096885|FG001|Overall Study|Protocol Violation|0|||
129217172|NCT00836693|465096884|FG000|Overall Study|Lost to Follow-up|1|||
129217173|NCT00836693|465096885|FG001|Overall Study|Lost to Follow-up|0|||
129217174|NCT01657019|465096886|FG000|Overall Study|Withdrawal by Subject|65|||
129217175|NCT01657019|465096886|FG000|Overall Study|Adverse Event|55|||
129217176|NCT01657019|465096886|FG000|Overall Study|Lost to Follow-up|48|||
129217177|NCT01657019|465096886|FG000|Overall Study|Protocol Violation|6|||
129217178|NCT01657019|465096886|FG000|Overall Study|Lack of Efficacy|3|||
129217179|NCT01657019|465096886|FG000|Overall Study|Other|58|||
129217180|NCT01750229|465096889|FG000|Randomized Crossover Phase|Adverse Event|1|||
129217181|NCT01750229|465096889|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
129217182|NCT01750229|465096889|FG000|Long-term Follow-up Phase|Adverse Event|2|||
129217183|NCT01750229|465096889|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
129217184|NCT02346721|465096890|FG000|Overall Study|Withdrew Consent|3|||
129217185|NCT02346721|465096890|FG000|Overall Study|Lack of Efficacy|1|||
129217186|NCT03722238|465096891|FG000|Overall Study|Protocol Violation|1|||
129217187|NCT03722238|465096892|FG001|Overall Study|Protocol Violation|0|||
129217188|NCT03722238|465096891|FG000|Overall Study|Physician Decision|1|||
129217189|NCT03722238|465096892|FG001|Overall Study|Physician Decision|0|||
129217190|NCT03722238|465096891|FG000|Overall Study|Death|1|||
129217191|NCT03722238|465096892|FG001|Overall Study|Death|0|||
129217192|NCT03722238|465096891|FG000|Overall Study|Lost to Follow-up|6|||
129217193|NCT03722238|465096892|FG001|Overall Study|Lost to Follow-up|0|||
128937131|NCT02160977|464057021|FG000|Three Months After Surgery|Lost to Follow-up|0|||
128937132|NCT02160977|464057022|FG001|Three Months After Surgery|Lost to Follow-up|2|||
128937133|NCT02160977|464057021|FG000|Six Months After Surgery|Lost to Follow-up|2|||
128937134|NCT02160977|464057022|FG001|Six Months After Surgery|Lost to Follow-up|1|||
128937135|NCT04359823|464058766|FG000|Overall Study|Lost to Follow-up|0|||
128937136|NCT04359823|464058767|FG001|Overall Study|Lost to Follow-up|1|||
129217194|NCT03722238|465096891|FG000|Overall Study|Partial missing data|44|||
129217195|NCT03722238|465096892|FG001|Overall Study|Partial missing data|1|||
129122666|NCT04810962|464744086|FG000|Overall Study|Withdrawal by Subject|1|||
129122667|NCT04810962|464744087|FG001|Overall Study|Withdrawal by Subject|3|||
129122668|NCT04810962|464744086|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
129122669|NCT04810962|464744087|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
129122670|NCT00297167|464744088|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
129122671|NCT00297167|464744089|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
129122672|NCT00297167|464744090|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
129122673|NCT00297167|464744088|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
129122674|NCT00297167|464744089|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
129122675|NCT00297167|464744090|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
129122676|NCT02410629|464744092|FG000|Overall Study|Family cannot commit to the study|2|||
129122677|NCT02410629|464744093|FG001|Overall Study|Family cannot commit to the study|1|||
129217196|NCT03722238|465096891|FG000|Overall Study|Withdrawal by Subject|2|||
128768980|NCT02936037|463445933|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
128768981|NCT02936037|463445932|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
128937137|NCT04359823|464058766|FG000|Overall Study|Withdrawal by Subject|0|||
128937138|NCT04359823|464058767|FG001|Overall Study|Withdrawal by Subject|1|||
128937139|NCT01850563|464058768|FG000|Overall Study|Not eligible|3|||
128937140|NCT01850563|464058769|FG001|Overall Study|Not eligible|0|||
128937141|NCT00408421|464058775|FG000|Treatment Initial Randomization|Adverse Event|5|||
128937142|NCT00408421|464058776|FG001|Treatment Initial Randomization|Adverse Event|9|||
128937143|NCT00408421|464058777|FG002|Treatment Initial Randomization|Adverse Event|0|||
128937144|NCT00408421|464058775|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
128937145|NCT00408421|464058776|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
128937146|NCT00408421|464058777|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
128937147|NCT00408421|464058775|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
128937148|NCT00408421|464058776|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
128937149|NCT00408421|464058777|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
128937150|NCT00408421|464058775|FG000|Treatment Initial Randomization|Physician Decision|1|||
128937151|NCT00408421|464058776|FG001|Treatment Initial Randomization|Physician Decision|0|||
128937152|NCT00408421|464058777|FG002|Treatment Initial Randomization|Physician Decision|0|||
128937153|NCT00408421|464058775|FG000|Treatment Initial Randomization|Protocol Violation|0|||
128937154|NCT00408421|464058776|FG001|Treatment Initial Randomization|Protocol Violation|1|||
128937155|NCT00408421|464058777|FG002|Treatment Initial Randomization|Protocol Violation|0|||
128937156|NCT00408421|464058775|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
128937157|NCT00408421|464058776|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
128937158|NCT00408421|464058777|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
128937159|NCT00408421|464058775|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
128937160|NCT00408421|464058776|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
128937161|NCT00408421|464058777|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
128937162|NCT00408421|464058775|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
128937163|NCT00408421|464058776|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
128937164|NCT00408421|464058777|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
128937165|NCT00408421|464058775|FG000|Treatment Re-Randomization|Adverse Event|2|||
128937166|NCT00408421|464058776|FG001|Treatment Re-Randomization|Adverse Event|2|||
128937167|NCT00408421|464058777|FG002|Treatment Re-Randomization|Adverse Event|4|||
129217197|NCT03722238|465096892|FG001|Overall Study|Withdrawal by Subject|0|||
129217198|NCT03722238|465096891|FG000|Overall Study|Other|4|||
129217199|NCT03722238|465096892|FG001|Overall Study|Other|0|||
129217200|NCT03722238|465096891|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
129217201|NCT03722238|465096892|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
129217202|NCT03722238|465096891|FG000|Overall Study|Did not meet risk classification group criteria|90|||
129217203|NCT03722238|465096892|FG001|Overall Study|Did not meet risk classification group criteria|0|||
129217204|NCT03722238|465096891|FG000|Overall Study|Did not sign consent|17|||
129217205|NCT03722238|465096892|FG001|Overall Study|Did not sign consent|0|||
129217206|NCT03722238|465096891|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
129217207|NCT03722238|465096892|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
129217208|NCT03722238|465096891|FG000|Overall Study|Not willing to purchase study medication|142|||
129217209|NCT03722238|465096892|FG001|Overall Study|Not willing to purchase study medication|0|||
129217210|NCT03722238|465096891|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
129217211|NCT03722238|465096892|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
128768982|NCT02936037|463445933|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
128937168|NCT00408421|464058775|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
128937169|NCT00408421|464058776|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
128937170|NCT00408421|464058777|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
128937171|NCT00408421|464058775|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
129217212|NCT01411891|465096893|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
129217213|NCT01411891|465096894|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
129217214|NCT02004093|465096895|FG000|Overall Study|Death|2|||
129217215|NCT02004093|465096896|FG001|Overall Study|Death|1|||
129217216|NCT02004093|465096895|FG000|Overall Study|Lack of Efficacy|66|||
129217217|NCT02004093|465096896|FG001|Overall Study|Lack of Efficacy|62|||
129217218|NCT02004093|465096895|FG000|Overall Study|Protocol Violation|0|||
129217219|NCT02004093|465096896|FG001|Overall Study|Protocol Violation|1|||
129217220|NCT02004093|465096895|FG000|Overall Study|Lost to Follow-up|0|||
129217221|NCT02004093|465096896|FG001|Overall Study|Lost to Follow-up|1|||
129217222|NCT02004093|465096895|FG000|Overall Study|Withdrawal by Subject|3|||
129217223|NCT02004093|465096896|FG001|Overall Study|Withdrawal by Subject|7|||
129217224|NCT02004093|465096895|FG000|Overall Study|Other|3|||
129217225|NCT02004093|465096896|FG001|Overall Study|Other|1|||
129217226|NCT00414596|465096897|FG000|Overall Study|Protocol Violation|2|||
129217227|NCT02558296|465096898|FG000|Completed the Study Through Week 24|Adverse Event|9|||
129217228|NCT02558296|465096899|FG001|Completed the Study Through Week 24|Adverse Event|3|||
129217229|NCT02558296|465096898|FG000|Completed the Study Through Week 24|Death|7|||
129217230|NCT02558296|465096899|FG001|Completed the Study Through Week 24|Death|7|||
129217231|NCT02558296|465096898|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
129217232|NCT02558296|465096899|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
129217233|NCT02558296|465096898|FG000|Completed the Study Through Week 24|Physician Decision|1|||
129217234|NCT02558296|465096899|FG001|Completed the Study Through Week 24|Physician Decision|0|||
129217235|NCT02558296|465096898|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
129217236|NCT02558296|465096899|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
129217237|NCT02558296|465096898|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
129217238|NCT02558296|465096899|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
129217239|NCT02558296|465096898|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
129217240|NCT02558296|465096899|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
129217241|NCT02558296|465096898|FG000|Completed the Study|Adverse Event|14|||
129217242|NCT02558296|465096899|FG001|Completed the Study|Adverse Event|5|||
129217243|NCT02558296|465096898|FG000|Completed the Study|Death|39|||
129217244|NCT02558296|465096899|FG001|Completed the Study|Death|25|||
129217245|NCT02558296|465096898|FG000|Completed the Study|Lost to Follow-up|31|||
129217246|NCT02558296|465096899|FG001|Completed the Study|Lost to Follow-up|23|||
129217247|NCT02558296|465096898|FG000|Completed the Study|Physician Decision|6|||
129217248|NCT02558296|465096899|FG001|Completed the Study|Physician Decision|0|||
129217249|NCT02558296|465096898|FG000|Completed the Study|Protocol Violation|2|||
129217250|NCT02558296|465096899|FG001|Completed the Study|Protocol Violation|1|||
129217251|NCT02558296|465096898|FG000|Completed the Study|Withdrawal by Subject|53|||
129217252|NCT02558296|465096899|FG001|Completed the Study|Withdrawal by Subject|31|||
129217253|NCT02558296|465096898|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
129217254|NCT02558296|465096899|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
129217255|NCT00297258|465096900|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
129217256|NCT00297258|465096900|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
129217257|NCT00297258|465096900|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
129217258|NCT00297258|465096900|FG000|Overall Study|Intercurrent Illness|3|||
129217259|NCT00297258|465096900|FG000|Overall Study|Intercurrent Death|2|||
129217260|NCT00297258|465096900|FG000|Overall Study|Deteriorization of General Condition|1|||
129217261|NCT00297258|465096900|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
129217262|NCT00297258|465096900|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
129217263|NCT00297258|465096900|FG000|Overall Study|Switch to Commercial Treatment|1|||
128937172|NCT00408421|464058776|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
128937173|NCT00408421|464058777|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
128937174|NCT00408421|464058775|FG000|Treatment Re-Randomization|Physician Decision|1|||
128937175|NCT00408421|464058776|FG001|Treatment Re-Randomization|Physician Decision|3|||
128937176|NCT00408421|464058777|FG002|Treatment Re-Randomization|Physician Decision|0|||
128937177|NCT00408421|464058775|FG000|Treatment Re-Randomization|Protocol Violation|1|||
128937178|NCT00408421|464058776|FG001|Treatment Re-Randomization|Protocol Violation|1|||
128937179|NCT00408421|464058777|FG002|Treatment Re-Randomization|Protocol Violation|0|||
128937180|NCT00408421|464058775|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
128937181|NCT00408421|464058776|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
129217264|NCT00297258|465096900|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
129217265|NCT00346697|465096903|FG000|Overall Study|Lost to Follow-up|0|||
129217266|NCT00346697|465096904|FG001|Overall Study|Lost to Follow-up|1|||
129217267|NCT00734539|465096905|FG000|Main Study|Death|33|||
128937182|NCT00408421|464058777|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
128937183|NCT03009539|464058778|FG000|Overall Study|Lost to Follow-up|132|||
129217268|NCT00734539|465096906|FG001|Main Study|Death|32|||
129217269|NCT00734539|465096905|FG000|Main Study|Physician Decision|2|||
129217270|NCT00734539|465096906|FG001|Main Study|Physician Decision|0|||
129217271|NCT00734539|465096905|FG000|Main Study|Withdrawal by Subject|1|||
129217272|NCT00734539|465096906|FG001|Main Study|Withdrawal by Subject|3|||
128937184|NCT03009539|464058779|FG001|Overall Study|Lost to Follow-up|113|||
129217273|NCT00734539|465096905|FG000|Main Study|Enrolled in error; ineligible|1|||
128937185|NCT03009539|464058780|FG002|Overall Study|Lost to Follow-up|132|||
128937186|NCT03009539|464058781|FG003|Overall Study|Lost to Follow-up|113|||
128937187|NCT00710034|464058782|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
128937188|NCT00710034|464058783|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
128937189|NCT00710034|464058782|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
128937190|NCT00710034|464058783|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
128937191|NCT00710034|464058782|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
128937192|NCT00710034|464058783|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
128937193|NCT00710034|464058782|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
128937194|NCT00710034|464058783|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
128937195|NCT00710034|464058782|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
128937196|NCT00710034|464058783|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
128937197|NCT00710034|464058782|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
128937198|NCT00710034|464058783|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
128937199|NCT00710034|464058782|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
128937200|NCT00710034|464058783|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
128937201|NCT00710034|464058782|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
128937202|NCT00710034|464058783|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
128937203|NCT00710034|464058782|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
128937204|NCT00710034|464058783|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
128937205|NCT00710034|464058782|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
128937206|NCT00710034|464058783|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
128937207|NCT00710034|464058782|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
128937208|NCT00710034|464058783|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
128937209|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
128937210|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
128937211|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
128937212|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
128937213|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Death|8|||
128937214|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Death|3|||
128937215|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
128937216|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
128937217|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
128937218|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
128937219|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
128937220|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
128937221|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
128937222|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
128937223|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
128937224|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
128937225|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
128937226|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
128937227|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
128937228|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
128937229|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
128937230|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
128937231|NCT00494871|464058784|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
128937232|NCT00494871|464058785|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
128937233|NCT00494871|464058784|FG000|Follow-up (FU) Period|Adverse Event|1|||
128937234|NCT00494871|464058785|FG001|Follow-up (FU) Period|Adverse Event|1|||
128937235|NCT00494871|464058784|FG000|Follow-up (FU) Period|Death|13|||
128937236|NCT00494871|464058785|FG001|Follow-up (FU) Period|Death|12|||
128937237|NCT00494871|464058784|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
129217274|NCT00734539|465096906|FG001|Main Study|Enrolled in error; ineligible|0|||
129217275|NCT02504151|465096911|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
129217276|NCT02504151|465096912|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
129217277|NCT02504151|465096911|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
129217278|NCT02504151|465096912|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
129217279|NCT02504151|465096911|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129217280|NCT02504151|465096912|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
128937238|NCT00494871|464058785|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
128937239|NCT00494871|464058784|FG000|Follow-up (FU) Period|Physician Decision|0|||
128937240|NCT00494871|464058785|FG001|Follow-up (FU) Period|Physician Decision|1|||
128937241|NCT00494871|464058784|FG000|Follow-up (FU) Period|Protocol Violation|1|||
129217281|NCT02504151|465096911|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
129217282|NCT02504151|465096912|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
129031648|NCT02229084|464406509|FG005|Overall Study|Physician Decision|0|||
129031649|NCT02229084|464406510|FG006|Overall Study|Physician Decision|1|||
129031650|NCT02229084|464406504|FG000|Overall Study|Withdrawal by Subject|0|||
129217283|NCT05038982|465096913|FG000|Overall Study|Withdrawal by Subject|0|||
128768983|NCT02936037|463445932|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
128768984|NCT02936037|463445933|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
128768985|NCT02936037|463445932|FG000|Double-Blind Treatment Period|Death|0|||
128768986|NCT02936037|463445933|FG001|Double-Blind Treatment Period|Death|1|||
128768987|NCT02936037|463445932|FG000|Double-Blind Treatment Period|Adverse Event|11|||
128768988|NCT02936037|463445933|FG001|Double-Blind Treatment Period|Adverse Event|11|||
128768989|NCT02936037|463445932|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
128768990|NCT02936037|463445933|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
128768991|NCT02936037|463445932|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128768992|NCT02936037|463445933|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
128768993|NCT02936037|463445932|FG000|Open Label Extension|Adverse Event|0|||
128768994|NCT02936037|463445933|FG001|Open Label Extension|Adverse Event|3|||
128768995|NCT02936037|463445932|FG000|Open Label Extension|Other|0|||
128768996|NCT02936037|463445933|FG001|Open Label Extension|Other|3|||
128768997|NCT02936037|463445932|FG000|Open Label Extension|Withdrawal by Subject|0|||
128768998|NCT02936037|463445933|FG001|Open Label Extension|Withdrawal by Subject|4|||
128768999|NCT04666922|463445934|FG000|Overall Study|Withdrawal by Subject|1|||
128769000|NCT04666922|463445935|FG001|Overall Study|Withdrawal by Subject|0|||
128769001|NCT04666922|463445936|FG002|Overall Study|Withdrawal by Subject|0|||
128769002|NCT04666922|463445937|FG003|Overall Study|Withdrawal by Subject|0|||
128769003|NCT04666922|463445938|FG004|Overall Study|Withdrawal by Subject|0|||
128769004|NCT04666922|463445939|FG005|Overall Study|Withdrawal by Subject|0|||
128769005|NCT04666922|463445940|FG006|Overall Study|Withdrawal by Subject|0|||
128769006|NCT00244374|463445941|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
128769007|NCT00244374|463445942|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
128769008|NCT00244374|463445943|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
128769009|NCT00244374|463445944|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
128769010|NCT00244374|463445945|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
128769011|NCT00244374|463445941|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
128769012|NCT00244374|463445942|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
128769013|NCT00244374|463445943|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
128769014|NCT00244374|463445944|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
128769015|NCT00244374|463445945|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
128769016|NCT00244374|463445941|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
128769017|NCT00244374|463445942|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
128769018|NCT00244374|463445943|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
128769019|NCT00244374|463445944|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
128769020|NCT00244374|463445945|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
128769021|NCT00244374|463445941|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
128769022|NCT00244374|463445942|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
128769023|NCT00244374|463445943|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
128769024|NCT00244374|463445944|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
128769025|NCT00244374|463445945|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
128769026|NCT00244374|463445941|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
129031651|NCT02229084|464406505|FG001|Overall Study|Withdrawal by Subject|0|||
129031652|NCT02229084|464406506|FG002|Overall Study|Withdrawal by Subject|1|||
129031653|NCT02229084|464406507|FG003|Overall Study|Withdrawal by Subject|0|||
129031654|NCT02229084|464406508|FG004|Overall Study|Withdrawal by Subject|1|||
129031655|NCT02229084|464406509|FG005|Overall Study|Withdrawal by Subject|1|||
129031656|NCT02229084|464406510|FG006|Overall Study|Withdrawal by Subject|1|||
129031657|NCT02229084|464406504|FG000|Overall Study|Death|0|||
129031658|NCT02229084|464406505|FG001|Overall Study|Death|0|||
129031659|NCT02229084|464406506|FG002|Overall Study|Death|0|||
129217284|NCT05038982|465096914|FG001|Overall Study|Withdrawal by Subject|2|||
129217285|NCT02557139|465096920|FG000|Overall Study|Significant liver elevation|1|||
129217286|NCT02557139|465096921|FG001|Overall Study|Significant liver elevation|0|||
129217287|NCT02557139|465096922|FG002|Overall Study|Significant liver elevation|1|||
129217288|NCT02557139|465096920|FG000|Overall Study|Withdrawal by Subject|1|||
129217289|NCT02557139|465096921|FG001|Overall Study|Withdrawal by Subject|0|||
129217290|NCT02557139|465096922|FG002|Overall Study|Withdrawal by Subject|0|||
129217291|NCT02557139|465096920|FG000|Overall Study|Illness of prohibited medication|0|||
129217292|NCT02557139|465096921|FG001|Overall Study|Illness of prohibited medication|0|||
129217293|NCT02557139|465096922|FG002|Overall Study|Illness of prohibited medication|1|||
128937242|NCT00494871|464058785|FG001|Follow-up (FU) Period|Protocol Violation|0|||
128937243|NCT00494871|464058784|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
128937244|NCT00494871|464058785|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
128937245|NCT00494871|464058784|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
128937246|NCT00494871|464058785|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
128937247|NCT02601001|464058786|FG000|Dosing Period 2|Adverse Event|0|||
128937248|NCT02601001|464058787|FG001|Dosing Period 2|Adverse Event|0|||
128937249|NCT02601001|464058788|FG002|Dosing Period 2|Adverse Event|0|||
128937250|NCT02601001|464058789|FG003|Dosing Period 2|Adverse Event|0|||
128937251|NCT02601001|464058790|FG004|Dosing Period 2|Adverse Event|0|||
128937252|NCT02601001|464058791|FG005|Dosing Period 2|Adverse Event|0|||
128937253|NCT02601001|464058792|FG006|Dosing Period 2|Adverse Event|1|||
128937254|NCT01614769|464058796|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
128937255|NCT01614769|464058797|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
128937256|NCT01614769|464058798|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
128937257|NCT01614769|464058799|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
128937258|NCT01614769|464058800|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
128937259|NCT01614769|464058801|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
128937260|NCT01614769|464058796|FG000|Period 1|Protocol Violation|0|||
129217294|NCT01454102|465096923|FG000|Overall Study|Continuing in the treatment period|0|||
129217295|NCT01454102|465096924|FG001|Overall Study|Continuing in the treatment period|0|||
129217296|NCT01454102|465096925|FG002|Overall Study|Continuing in the treatment period|0|||
129217297|NCT01454102|465096926|FG003|Overall Study|Continuing in the treatment period|0|||
129217298|NCT01454102|465096927|FG004|Overall Study|Continuing in the treatment period|3|||
129217299|NCT01454102|465096928|FG005|Overall Study|Continuing in the treatment period|3|||
129217300|NCT01454102|465096929|FG006|Overall Study|Continuing in the treatment period|2|||
129217301|NCT01454102|465096930|FG007|Overall Study|Continuing in the treatment period|0|||
129217302|NCT01454102|465096931|FG008|Overall Study|Continuing in the treatment period|1|||
129217303|NCT01454102|465096932|FG009|Overall Study|Continuing in the treatment period|0|||
129217304|NCT01454102|465096933|FG010|Overall Study|Continuing in the treatment period|0|||
129217305|NCT01454102|465096934|FG011|Overall Study|Continuing in the treatment period|4|||
129217306|NCT01454102|465096935|FG012|Overall Study|Continuing in the treatment period|7|||
129217307|NCT01454102|465096936|FG013|Overall Study|Continuing in the treatment period|4|||
129217308|NCT01454102|465096937|FG014|Overall Study|Continuing in the treatment period|3|||
129217309|NCT01454102|465096938|FG015|Overall Study|Continuing in the treatment period|1|||
129217310|NCT02592798|465096944|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
129217311|NCT02592798|465096945|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
129217312|NCT02592798|465096944|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
129217313|NCT02592798|465096945|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
129217314|NCT02592798|465096944|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
129217315|NCT02592798|465096945|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
129217316|NCT02592798|465096944|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
129217317|NCT02592798|465096945|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
129217318|NCT02592798|465096944|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
129217319|NCT02592798|465096945|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
129217320|NCT02592798|465096944|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
129217321|NCT02592798|465096945|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
129217322|NCT02592798|465096944|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
129217323|NCT02592798|465096945|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
129217324|NCT02592798|465096944|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
129217325|NCT02592798|465096945|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
129217326|NCT02592798|465096944|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
129217327|NCT02592798|465096945|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
129217328|NCT02592798|465096944|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
129217329|NCT02592798|465096945|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
129217330|NCT02592798|465096944|FG000|Transition From DB2 to OLE|Other reasons|1|||
129217331|NCT02592798|465096945|FG001|Transition From DB2 to OLE|Other reasons|0|||
129217332|NCT02592798|465096944|FG000|Open Label Period (OLE)|Other reasons|0|||
129217333|NCT02592798|465096945|FG001|Open Label Period (OLE)|Other reasons|2|||
129217334|NCT02592798|465096944|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
129217335|NCT02592798|465096945|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
129217336|NCT02592798|465096944|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
129217337|NCT02592798|465096945|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
129217338|NCT02592798|465096944|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
129217339|NCT02592798|465096945|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
129217340|NCT02592798|465096944|FG000|Open Label Period (OLE)|Adverse Event|0|||
129217341|NCT02592798|465096945|FG001|Open Label Period (OLE)|Adverse Event|1|||
128937261|NCT01614769|464058797|FG001|Period 1|Protocol Violation|0|||
128937262|NCT01614769|464058798|FG002|Period 1|Protocol Violation|0|||
128937263|NCT01614769|464058799|FG003|Period 1|Protocol Violation|1|||
128937264|NCT01614769|464058800|FG004|Period 1|Protocol Violation|0|||
129217342|NCT00705016|465096946|FG000|Overall Study|Adverse Event|6|||
128769027|NCT00244374|463445942|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
128769028|NCT00244374|463445943|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
128769029|NCT00244374|463445944|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
128769030|NCT00244374|463445945|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
128769031|NCT00244374|463445941|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
128769032|NCT00244374|463445942|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
128769033|NCT00244374|463445943|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
128769034|NCT00244374|463445944|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
128769035|NCT00244374|463445945|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
128769036|NCT00244374|463445941|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
128769037|NCT00244374|463445942|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
128769038|NCT00244374|463445943|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
128769039|NCT00244374|463445944|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
128769040|NCT00244374|463445945|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
128769041|NCT00244374|463445941|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
128769042|NCT00244374|463445942|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
128769043|NCT00244374|463445943|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
128769044|NCT00244374|463445944|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
128769045|NCT00244374|463445945|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
128769046|NCT00244374|463445941|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
128769047|NCT00244374|463445942|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
128769048|NCT00244374|463445943|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
128769049|NCT00244374|463445944|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
128769050|NCT00244374|463445945|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129122678|NCT02410629|464744092|FG000|Overall Study|Subject returned to work|1|||
129122679|NCT02410629|464744093|FG001|Overall Study|Subject returned to work|0|||
129122680|NCT02410629|464744092|FG000|Overall Study|Subject moved back to home country|0|||
129122681|NCT02410629|464744093|FG001|Overall Study|Subject moved back to home country|1|||
129122682|NCT02410629|464744092|FG000|Overall Study|Subject underwent heart surgery|0|||
129122683|NCT02410629|464744093|FG001|Overall Study|Subject underwent heart surgery|1|||
129122684|NCT02701634|464744094|FG000|Overall Study|Adverse Event|2|||
129122685|NCT02701634|464744095|FG001|Overall Study|Adverse Event|3|||
129122686|NCT02701634|464744094|FG000|Overall Study|Death|1|||
129122687|NCT02701634|464744095|FG001|Overall Study|Death|0|||
129122688|NCT02701634|464744094|FG000|Overall Study|Investigator's Discretion|7|||
129122689|NCT02701634|464744095|FG001|Overall Study|Investigator's Discretion|4|||
129122690|NCT02701634|464744094|FG000|Overall Study|Study terminated by Sponsor|15|||
129122691|NCT02701634|464744095|FG001|Overall Study|Study terminated by Sponsor|17|||
129122692|NCT02701634|464744094|FG000|Overall Study|Withdrew Consent|6|||
129122693|NCT02701634|464744095|FG001|Overall Study|Withdrew Consent|7|||
129122694|NCT02701634|464744094|FG000|Overall Study|Randomized but not treated|1|||
129122695|NCT02701634|464744095|FG001|Overall Study|Randomized but not treated|0|||
129122696|NCT01186770|464744096|FG000|Overall Study|Ineligibility|0|||
129122697|NCT01186770|464744097|FG001|Overall Study|Ineligibility|0|||
129122698|NCT01186770|464744098|FG002|Overall Study|Ineligibility|2|||
129122699|NCT01186770|464744099|FG003|Overall Study|Ineligibility|0|||
129122700|NCT01186770|464744096|FG000|Overall Study|Protocol Violation|7|||
129122701|NCT01186770|464744097|FG001|Overall Study|Protocol Violation|9|||
129122702|NCT01186770|464744098|FG002|Overall Study|Protocol Violation|12|||
129122703|NCT01186770|464744099|FG003|Overall Study|Protocol Violation|14|||
129122704|NCT01186770|464744096|FG000|Overall Study|Adverse Event|2|||
129122705|NCT01186770|464744097|FG001|Overall Study|Adverse Event|9|||
129122706|NCT01186770|464744098|FG002|Overall Study|Adverse Event|7|||
129122707|NCT01186770|464744099|FG003|Overall Study|Adverse Event|9|||
129122708|NCT01186770|464744096|FG000|Overall Study|Withdrawal by Subject|15|||
129122709|NCT01186770|464744097|FG001|Overall Study|Withdrawal by Subject|13|||
129122710|NCT01186770|464744098|FG002|Overall Study|Withdrawal by Subject|11|||
129122711|NCT01186770|464744099|FG003|Overall Study|Withdrawal by Subject|17|||
129122712|NCT01186770|464744096|FG000|Overall Study|Lost to Follow-up|10|||
129122713|NCT01186770|464744097|FG001|Overall Study|Lost to Follow-up|6|||
129122714|NCT01186770|464744098|FG002|Overall Study|Lost to Follow-up|14|||
129122715|NCT01186770|464744099|FG003|Overall Study|Lost to Follow-up|9|||
129122716|NCT01186770|464744096|FG000|Overall Study|Insufficient response to treatment|7|||
129122717|NCT01186770|464744097|FG001|Overall Study|Insufficient response to treatment|8|||
129122718|NCT01186770|464744098|FG002|Overall Study|Insufficient response to treatment|5|||
129122719|NCT01186770|464744099|FG003|Overall Study|Insufficient response to treatment|7|||
129122720|NCT01186770|464744096|FG000|Overall Study|Other than specified|0|||
129122721|NCT01186770|464744097|FG001|Overall Study|Other than specified|1|||
128769051|NCT03722264|463445946|FG000|Overall Study|Physician Decision|3|||
128769052|NCT02959671|463445947|FG000|Overall Study|Adverse Event|2|||
128769053|NCT02959671|463445947|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
128769054|NCT04651114|463445954|FG000|Overall Study|Withdrawal by Subject|8|||
128769055|NCT01923896|463445959|FG000|Overall Study|Adverse Event|1|||
128769056|NCT01923896|463445960|FG001|Overall Study|Adverse Event|0|||
128769057|NCT00474929|463445965|FG000|Overall Study|Withdrawal by Subject|0|||
128769058|NCT00474929|463445966|FG001|Overall Study|Withdrawal by Subject|1|||
128769059|NCT00474929|463445967|FG002|Overall Study|Withdrawal by Subject|0|||
128769060|NCT00474929|463445968|FG003|Overall Study|Withdrawal by Subject|0|||
128769061|NCT00474929|463445969|FG004|Overall Study|Withdrawal by Subject|0|||
128769062|NCT00474929|463445965|FG000|Overall Study|Unrelated medical condition|0|||
128769063|NCT00474929|463445966|FG001|Overall Study|Unrelated medical condition|0|||
128937265|NCT01614769|464058801|FG005|Period 1|Protocol Violation|0|||
128937266|NCT01614769|464058796|FG000|Period 1|Withdrawal by Subject|1|||
128937267|NCT01614769|464058797|FG001|Period 1|Withdrawal by Subject|0|||
128937268|NCT01614769|464058798|FG002|Period 1|Withdrawal by Subject|0|||
128937269|NCT01614769|464058799|FG003|Period 1|Withdrawal by Subject|0|||
128937270|NCT01614769|464058800|FG004|Period 1|Withdrawal by Subject|0|||
128937271|NCT01614769|464058801|FG005|Period 1|Withdrawal by Subject|0|||
128937272|NCT01614769|464058796|FG000|Period 3|Withdrawal by Subject|0|||
128937273|NCT01614769|464058797|FG001|Period 3|Withdrawal by Subject|0|||
128937274|NCT01614769|464058798|FG002|Period 3|Withdrawal by Subject|1|||
128937275|NCT01614769|464058799|FG003|Period 3|Withdrawal by Subject|0|||
128937276|NCT01614769|464058800|FG004|Period 3|Withdrawal by Subject|0|||
128937277|NCT01614769|464058801|FG005|Period 3|Withdrawal by Subject|0|||
128937278|NCT03123354|464058802|FG000|Overall Study|Physician Decision|6|||
128937279|NCT00960440|464058805|FG000|Overall Study|Death|0|||
128937280|NCT00960440|464058806|FG001|Overall Study|Death|0|||
128937281|NCT00960440|464058807|FG002|Overall Study|Death|0|||
128937282|NCT00960440|464058808|FG003|Overall Study|Death|1|||
128937283|NCT00960440|464058805|FG000|Overall Study|Adverse Event|12|||
128937284|NCT00960440|464058806|FG001|Overall Study|Adverse Event|12|||
128937285|NCT00960440|464058807|FG002|Overall Study|Adverse Event|4|||
128937286|NCT00960440|464058808|FG003|Overall Study|Adverse Event|4|||
128937287|NCT00960440|464058805|FG000|Overall Study|Lack of Efficacy|2|||
128937288|NCT00960440|464058806|FG001|Overall Study|Lack of Efficacy|5|||
128937289|NCT00960440|464058807|FG002|Overall Study|Lack of Efficacy|3|||
128937290|NCT00960440|464058808|FG003|Overall Study|Lack of Efficacy|8|||
128937291|NCT00960440|464058805|FG000|Overall Study|Protocol Violation|2|||
128937292|NCT00960440|464058806|FG001|Overall Study|Protocol Violation|8|||
128937293|NCT00960440|464058807|FG002|Overall Study|Protocol Violation|3|||
128937294|NCT00960440|464058808|FG003|Overall Study|Protocol Violation|4|||
128937295|NCT00960440|464058805|FG000|Overall Study|Withdrawal by Subject|9|||
128937296|NCT00960440|464058806|FG001|Overall Study|Withdrawal by Subject|5|||
128937297|NCT00960440|464058807|FG002|Overall Study|Withdrawal by Subject|2|||
128937298|NCT00960440|464058808|FG003|Overall Study|Withdrawal by Subject|1|||
128937299|NCT00960440|464058805|FG000|Overall Study|Other|1|||
128937300|NCT00960440|464058806|FG001|Overall Study|Other|1|||
128937301|NCT00960440|464058807|FG002|Overall Study|Other|1|||
128937302|NCT00960440|464058808|FG003|Overall Study|Other|0|||
128937303|NCT02421120|464058809|FG000|Overall Study|Adverse Event|1|||
128937304|NCT02345161|464058810|FG000|Overall Study|Withdrawal by Subject|25|||
128937305|NCT02345161|464058811|FG001|Overall Study|Withdrawal by Subject|33|||
128937306|NCT02345161|464058810|FG000|Overall Study|Adverse Event|16|||
128937307|NCT02345161|464058811|FG001|Overall Study|Adverse Event|19|||
128937308|NCT02345161|464058810|FG000|Overall Study|Physician Decision|4|||
128937309|NCT02345161|464058811|FG001|Overall Study|Physician Decision|4|||
128937310|NCT02345161|464058810|FG000|Overall Study|Lost to Follow-up|0|||
128937311|NCT02345161|464058811|FG001|Overall Study|Lost to Follow-up|1|||
128937312|NCT00305006|464058814|FG000|Overall Study|Withdrawal by Subject|1|||
128937313|NCT00305006|464058815|FG001|Overall Study|Withdrawal by Subject|0|||
128937314|NCT00305006|464058814|FG000|Overall Study|Failure to complete pretest|0|||
128937315|NCT00305006|464058815|FG001|Overall Study|Failure to complete pretest|1|||
128937316|NCT02606045|464058819|FG000|Overall Study|Study closed before treament could begin|1|||
128769064|NCT00474929|463445967|FG002|Overall Study|Unrelated medical condition|1|||
128769065|NCT00474929|463445968|FG003|Overall Study|Unrelated medical condition|0|||
128769066|NCT00474929|463445969|FG004|Overall Study|Unrelated medical condition|0|||
128937317|NCT02606045|464058820|FG001|Overall Study|Study closed before treament could begin|2|||
128937318|NCT00907881|464058821|FG000|Overall Study|Lost to Follow-up|59|||
128937319|NCT00907881|464058821|FG000|Overall Study|Noncompliance|5|||
128937320|NCT00907881|464058821|FG000|Overall Study|Withdrawal by Subject|5|||
129031660|NCT02229084|464406507|FG003|Overall Study|Death|0|||
128769067|NCT00474929|463445965|FG000|Overall Study|Physician Decision|0|||
128937321|NCT00907881|464058821|FG000|Overall Study|Protocol Violation|1|||
128937322|NCT00907881|464058821|FG000|Overall Study|Missing discontinuation information|15|||
128937323|NCT02616029|464058822|FG000|Overall Study|Adverse Event|1|||
128937324|NCT02616029|464058823|FG001|Overall Study|Adverse Event|0|||
128937325|NCT02616029|464058822|FG000|Overall Study|Death|0|||
128769068|NCT00474929|463445966|FG001|Overall Study|Physician Decision|0|||
128769069|NCT00474929|463445967|FG002|Overall Study|Physician Decision|1|||
128769070|NCT00474929|463445968|FG003|Overall Study|Physician Decision|2|||
128769071|NCT00474929|463445969|FG004|Overall Study|Physician Decision|0|||
128769072|NCT03661996|463445972|FG000|Overall Study|Adverse Event|0|||
128769073|NCT03661996|463445973|FG001|Overall Study|Adverse Event|0|||
128769074|NCT03661996|463445974|FG002|Overall Study|Adverse Event|1|||
128769075|NCT03661996|463445975|FG003|Overall Study|Adverse Event|1|||
128769076|NCT03661996|463445976|FG004|Overall Study|Adverse Event|0|||
128769077|NCT03661996|463445972|FG000|Overall Study|Lost to Follow-up|5|||
128769078|NCT03661996|463445973|FG001|Overall Study|Lost to Follow-up|1|||
128769079|NCT03661996|463445974|FG002|Overall Study|Lost to Follow-up|2|||
128769080|NCT03661996|463445975|FG003|Overall Study|Lost to Follow-up|2|||
128769081|NCT03661996|463445976|FG004|Overall Study|Lost to Follow-up|6|||
128769082|NCT03661996|463445972|FG000|Overall Study|Physician Decision|1|||
128769083|NCT03661996|463445973|FG001|Overall Study|Physician Decision|1|||
128769084|NCT03661996|463445974|FG002|Overall Study|Physician Decision|1|||
128769085|NCT03661996|463445975|FG003|Overall Study|Physician Decision|2|||
128769086|NCT03661996|463445976|FG004|Overall Study|Physician Decision|0|||
128769087|NCT03661996|463445972|FG000|Overall Study|Protocol Violation|0|||
129217343|NCT00705016|465096947|FG001|Overall Study|Adverse Event|11|||
129217344|NCT00705016|465096948|FG002|Overall Study|Adverse Event|10|||
129217345|NCT00705016|465096946|FG000|Overall Study|Death|5|||
128769088|NCT03661996|463445973|FG001|Overall Study|Protocol Violation|0|||
128769089|NCT03661996|463445974|FG002|Overall Study|Protocol Violation|0|||
128769090|NCT03661996|463445975|FG003|Overall Study|Protocol Violation|0|||
128769091|NCT03661996|463445976|FG004|Overall Study|Protocol Violation|1|||
128769092|NCT03661996|463445972|FG000|Overall Study|Withdrawal by Subject|3|||
128769093|NCT03661996|463445973|FG001|Overall Study|Withdrawal by Subject|5|||
128769094|NCT03661996|463445974|FG002|Overall Study|Withdrawal by Subject|1|||
128769095|NCT03661996|463445975|FG003|Overall Study|Withdrawal by Subject|7|||
128769096|NCT03661996|463445976|FG004|Overall Study|Withdrawal by Subject|7|||
128769097|NCT03661996|463445972|FG000|Overall Study|Sponsors Decision|2|||
128769098|NCT03661996|463445973|FG001|Overall Study|Sponsors Decision|0|||
128769099|NCT03661996|463445974|FG002|Overall Study|Sponsors Decision|0|||
128769100|NCT03661996|463445975|FG003|Overall Study|Sponsors Decision|0|||
128769101|NCT03661996|463445976|FG004|Overall Study|Sponsors Decision|0|||
128769102|NCT03661996|463445972|FG000|Overall Study|Other|1|||
128769103|NCT03661996|463445973|FG001|Overall Study|Other|1|||
128937326|NCT02616029|464058823|FG001|Overall Study|Death|1|||
128937327|NCT02616029|464058822|FG000|Overall Study|Protocol Violation|1|||
128937328|NCT02616029|464058823|FG001|Overall Study|Protocol Violation|0|||
128937329|NCT02616029|464058822|FG000|Overall Study|Withdrew Consent|1|||
128937330|NCT02616029|464058823|FG001|Overall Study|Withdrew Consent|0|||
128937331|NCT02616029|464058822|FG000|Overall Study|Enrolled and Never Treated|1|||
128937332|NCT02616029|464058823|FG001|Overall Study|Enrolled and Never Treated|1|||
128937333|NCT01740440|464058824|FG000|Overall Study|Lost to Follow-up|3|||
128937334|NCT03408873|464058830|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
128937335|NCT03408873|464058830|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
128937336|NCT03408873|464058830|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
128937337|NCT03408873|464058830|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
128937338|NCT03408873|464058830|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
128937339|NCT03408873|464058830|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
128937340|NCT03799718|464058831|FG000|Overall Study|Adverse Event|2|||
128937341|NCT01651052|464058833|FG000|Overall Study|Death|21|||
128937342|NCT01651052|464058833|FG000|Overall Study|Explant|1|||
128937343|NCT01651052|464058833|FG000|Overall Study|Withdrawal by Subject|1|||
128937344|NCT01651052|464058833|FG000|Overall Study|Lost to Follow-up|3|||
128937345|NCT01024465|464058844|FG000|Overall Study|Adverse Event|2|||
128937346|NCT01024465|464058844|FG000|Overall Study|Physician Decision|1|||
128937347|NCT03078608|464058845|FG000|Overall Study|Death|1|||
128937348|NCT03078608|464058846|FG001|Overall Study|Death|2|||
128937349|NCT03078608|464058847|FG002|Overall Study|Death|0|||
128937350|NCT03078608|464058848|FG003|Overall Study|Death|0|||
128937351|NCT03078608|464058845|FG000|Overall Study|Withdrawal by Subject|8|||
128937352|NCT03078608|464058846|FG001|Overall Study|Withdrawal by Subject|1|||
128937353|NCT03078608|464058847|FG002|Overall Study|Withdrawal by Subject|0|||
128937354|NCT03078608|464058848|FG003|Overall Study|Withdrawal by Subject|0|||
128937355|NCT03078608|464058845|FG000|Overall Study|Lost to Follow-up|5|||
128937356|NCT03078608|464058846|FG001|Overall Study|Lost to Follow-up|8|||
128769104|NCT03661996|463445974|FG002|Overall Study|Other|1|||
128769105|NCT03661996|463445975|FG003|Overall Study|Other|1|||
128769106|NCT03661996|463445976|FG004|Overall Study|Other|0|||
128769107|NCT00068380|463445977|FG000|Overall Study|Withdrawal by Subject|3|||
128769108|NCT00068380|463445977|FG000|Overall Study|Adverse Event|2|||
128937357|NCT03078608|464058847|FG002|Overall Study|Lost to Follow-up|4|||
128937358|NCT03078608|464058848|FG003|Overall Study|Lost to Follow-up|1|||
128769109|NCT01190215|463445978|FG000|Up to Month 6|Lost to Follow-up|2|||
128937359|NCT00723840|464058849|FG000|Overall Study|Lost to Follow-up|2|||
128937360|NCT00723840|464058849|FG000|Overall Study|Failure to return|18|||
129217346|NCT00705016|465096947|FG001|Overall Study|Death|7|||
128769110|NCT01190215|463445979|FG001|Up to Month 6|Lost to Follow-up|0|||
128769111|NCT00067990|463445996|FG000|Overall Study|Death|5|||
128769112|NCT00067990|463445997|FG001|Overall Study|Death|7|||
128769113|NCT00067990|463445996|FG000|Overall Study|ESRD, Non IF/TA|1|||
128769114|NCT00067990|463445997|FG001|Overall Study|ESRD, Non IF/TA|3|||
128769115|NCT00067990|463445996|FG000|Overall Study|Withdrawal by Subject|4|||
128769116|NCT00067990|463445997|FG001|Overall Study|Withdrawal by Subject|12|||
128769117|NCT01973491|463445998|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
128769118|NCT01973491|463445998|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
128769119|NCT01973491|463445998|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
128769120|NCT01928225|463446006|FG000|Overall Study|Pregnancy|1|||
128769121|NCT01928225|463446007|FG001|Overall Study|Pregnancy|0|||
128769122|NCT01928225|463446006|FG000|Overall Study|basaloid cervical cancer|1|||
128769123|NCT01928225|463446007|FG001|Overall Study|basaloid cervical cancer|0|||
128769124|NCT01928225|463446006|FG000|Overall Study|Lost to Follow-up|1|||
128769125|NCT01928225|463446007|FG001|Overall Study|Lost to Follow-up|3|||
128769126|NCT01454830|463446011|FG000|Overall Study|Withdrawal by Subject|4|||
128769127|NCT01454830|463446012|FG001|Overall Study|Withdrawal by Subject|4|||
128769128|NCT01454830|463446011|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
128769129|NCT01454830|463446012|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
128769130|NCT01454830|463446011|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
128769131|NCT01454830|463446012|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
128769132|NCT01454830|463446011|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
128769133|NCT01454830|463446012|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
128769134|NCT01454830|463446011|FG000|Overall Study|Withdrawal - no polysomnography|3|||
128769135|NCT01454830|463446012|FG001|Overall Study|Withdrawal - no polysomnography|2|||
128769136|NCT00152763|463446013|FG000|Overall Study|Death|4|||
128769137|NCT00152763|463446014|FG001|Overall Study|Death|1|||
128769138|NCT00152763|463446015|FG002|Overall Study|Death|2|||
128769139|NCT00152763|463446016|FG003|Overall Study|Death|1|||
128769140|NCT00152763|463446013|FG000|Overall Study|Lost to Follow-up|6|||
128769141|NCT00152763|463446014|FG001|Overall Study|Lost to Follow-up|4|||
128769142|NCT00152763|463446015|FG002|Overall Study|Lost to Follow-up|2|||
128769143|NCT00152763|463446016|FG003|Overall Study|Lost to Follow-up|13|||
128769144|NCT00569803|463446017|FG000|Overall Study|Lost to Follow-up|1|||
128769145|NCT00569803|463446018|FG001|Overall Study|Lost to Follow-up|0|||
128769146|NCT00569803|463446019|FG002|Overall Study|Lost to Follow-up|0|||
128769147|NCT00569803|463446020|FG003|Overall Study|Lost to Follow-up|0|||
128769148|NCT00569803|463446021|FG004|Overall Study|Lost to Follow-up|0|||
128769149|NCT00569803|463446022|FG005|Overall Study|Lost to Follow-up|0|||
128769150|NCT00569803|463446023|FG006|Overall Study|Lost to Follow-up|0|||
128769151|NCT00569803|463446024|FG007|Overall Study|Lost to Follow-up|0|||
128769152|NCT00569803|463446017|FG000|Overall Study|injection syringe leaked during dosing|0|||
128769153|NCT00569803|463446018|FG001|Overall Study|injection syringe leaked during dosing|0|||
128769154|NCT00569803|463446019|FG002|Overall Study|injection syringe leaked during dosing|0|||
128769155|NCT00569803|463446020|FG003|Overall Study|injection syringe leaked during dosing|1|||
128769156|NCT00569803|463446021|FG004|Overall Study|injection syringe leaked during dosing|0|||
128769157|NCT00569803|463446022|FG005|Overall Study|injection syringe leaked during dosing|0|||
128769158|NCT00569803|463446023|FG006|Overall Study|injection syringe leaked during dosing|0|||
128769159|NCT00569803|463446024|FG007|Overall Study|injection syringe leaked during dosing|0|||
128769160|NCT00569803|463446017|FG000|Overall Study|Withdrawal by Subject|0|||
128769161|NCT00569803|463446018|FG001|Overall Study|Withdrawal by Subject|0|||
128937361|NCT00723840|464058849|FG000|Overall Study|Withdrawal by Subject|55|||
128937362|NCT00723840|464058849|FG000|Overall Study|Serious Adverse Events|3|||
128937363|NCT00723840|464058849|FG000|Overall Study|Other Medical Event|2|||
128937364|NCT00723840|464058849|FG000|Overall Study|Unspecified reason|2|||
128937365|NCT04156646|464058850|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
128937366|NCT04156646|464058851|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
128937367|NCT02086565|464058855|FG000|Overall Study|Lost to Follow-up|9|||
128937368|NCT02086565|464058856|FG001|Overall Study|Lost to Follow-up|7|||
128937369|NCT02086565|464058855|FG000|Overall Study|Withdrawal by Subject|2|||
128937370|NCT02086565|464058856|FG001|Overall Study|Withdrawal by Subject|1|||
128937371|NCT02086565|464058855|FG000|Overall Study|Death|3|||
128937372|NCT02086565|464058856|FG001|Overall Study|Death|2|||
128937373|NCT02086565|464058855|FG000|Overall Study|withdrawn by research team|2|||
128769162|NCT00569803|463446019|FG002|Overall Study|Withdrawal by Subject|0|||
128769163|NCT00569803|463446020|FG003|Overall Study|Withdrawal by Subject|0|||
128937374|NCT02086565|464058856|FG001|Overall Study|withdrawn by research team|2|||
128937375|NCT02116972|464058857|FG000|Overall Study|Adverse Event|4|||
128937376|NCT02116972|464058858|FG001|Overall Study|Adverse Event|4|||
128769164|NCT00569803|463446021|FG004|Overall Study|Withdrawal by Subject|0|||
128769165|NCT00569803|463446022|FG005|Overall Study|Withdrawal by Subject|0|||
128769166|NCT00569803|463446023|FG006|Overall Study|Withdrawal by Subject|0|||
128769167|NCT00569803|463446024|FG007|Overall Study|Withdrawal by Subject|1|||
128937377|NCT02116972|464058859|FG002|Overall Study|Adverse Event|1|||
128769168|NCT00791921|463446027|FG000|Overall Study|Protocol planed|24|||
128937378|NCT02116972|464058857|FG000|Overall Study|Withdrawal by Subject|1|||
128937379|NCT02116972|464058858|FG001|Overall Study|Withdrawal by Subject|1|||
128937380|NCT02116972|464058859|FG002|Overall Study|Withdrawal by Subject|5|||
128937381|NCT02116972|464058857|FG000|Overall Study|Protocol Violation|1|||
128937382|NCT02116972|464058858|FG001|Overall Study|Protocol Violation|0|||
128937383|NCT02116972|464058859|FG002|Overall Study|Protocol Violation|1|||
128937384|NCT02116972|464058857|FG000|Overall Study|Lost to Follow-up|4|||
128937385|NCT02116972|464058858|FG001|Overall Study|Lost to Follow-up|3|||
128937386|NCT02116972|464058859|FG002|Overall Study|Lost to Follow-up|1|||
128937387|NCT02116972|464058857|FG000|Overall Study|Lack of Efficacy|6|||
128937388|NCT02116972|464058858|FG001|Overall Study|Lack of Efficacy|6|||
128937389|NCT02116972|464058859|FG002|Overall Study|Lack of Efficacy|5|||
128937390|NCT02116972|464058857|FG000|Overall Study|scheduling conflicts and relocation|3|||
128937391|NCT02116972|464058858|FG001|Overall Study|scheduling conflicts and relocation|3|||
128937392|NCT02116972|464058859|FG002|Overall Study|scheduling conflicts and relocation|6|||
128937393|NCT00784784|464058860|FG000|Overall Study|Withdrawal by Subject|2|||
128937394|NCT00784784|464058861|FG001|Overall Study|Withdrawal by Subject|2|||
128937395|NCT01400971|464058862|FG000|Overall Study|Death|82|||
128937396|NCT01400971|464058862|FG000|Overall Study|Lost to Follow-up|196|||
128937397|NCT01400971|464058862|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
128937398|NCT01400971|464058862|FG000|Overall Study|Physician Decision|57|||
128937399|NCT01400971|464058862|FG000|Overall Study|Withdrawal by Subject|158|||
128937400|NCT01400971|464058862|FG000|Overall Study|Other|422|||
128937401|NCT00863928|464058865|FG000|Overall Study|Protocol Violation|26|||
128937402|NCT00863928|464058866|FG001|Overall Study|Protocol Violation|0|||
128937403|NCT00863928|464058865|FG000|Overall Study|Withdrawal by Subject|3|||
128937404|NCT00863928|464058866|FG001|Overall Study|Withdrawal by Subject|0|||
128937405|NCT00863928|464058865|FG000|Overall Study|surgery cancellation|4|||
128937406|NCT00863928|464058866|FG001|Overall Study|surgery cancellation|0|||
128937407|NCT00863928|464058865|FG000|Overall Study|medication allergy|3|||
128937408|NCT00863928|464058866|FG001|Overall Study|medication allergy|0|||
128937409|NCT04172831|464058869|FG000|Overall Study|Adverse Event|21|||
128937410|NCT04172831|464058870|FG001|Overall Study|Adverse Event|9|||
128937411|NCT04172831|464058869|FG000|Overall Study|Lack of Efficacy|2|||
128937412|NCT04172831|464058870|FG001|Overall Study|Lack of Efficacy|8|||
128937413|NCT04172831|464058869|FG000|Overall Study|Physician Decision|0|||
128937414|NCT04172831|464058870|FG001|Overall Study|Physician Decision|1|||
128937415|NCT04172831|464058869|FG000|Overall Study|Withdrawal by Subject|12|||
128937416|NCT04172831|464058870|FG001|Overall Study|Withdrawal by Subject|11|||
128937417|NCT04172831|464058869|FG000|Overall Study|Lost to Follow-up|4|||
128937418|NCT04172831|464058870|FG001|Overall Study|Lost to Follow-up|9|||
128937419|NCT04172831|464058869|FG000|Overall Study|COVID-19 related crisis|3|||
128769169|NCT00791921|463446028|FG001|Overall Study|Protocol planed|88|||
128769170|NCT00791921|463446027|FG000|Overall Study|Withdrawal by Subject|1|||
128769171|NCT00791921|463446028|FG001|Overall Study|Withdrawal by Subject|2|||
128769172|NCT00791921|463446027|FG000|Overall Study|Adverse Event|8|||
128769173|NCT00791921|463446028|FG001|Overall Study|Adverse Event|2|||
128769174|NCT00791921|463446027|FG000|Overall Study|Lack of Efficacy|0|||
128769175|NCT00791921|463446028|FG001|Overall Study|Lack of Efficacy|2|||
128769176|NCT00791921|463446027|FG000|Overall Study|Lack of study drug administration|1|||
128769177|NCT00791921|463446028|FG001|Overall Study|Lack of study drug administration|1|||
128769178|NCT00791921|463446027|FG000|Overall Study|Reason other than those above|0|||
128769179|NCT00791921|463446028|FG001|Overall Study|Reason other than those above|1|||
128769180|NCT01965158|463446030|FG000|Overall Study|Adverse Event|14|||
128769181|NCT01965158|463446031|FG001|Overall Study|Adverse Event|5|||
128769182|NCT01965158|463446030|FG000|Overall Study|Withdrawal by Subject|16|||
128769183|NCT01965158|463446031|FG001|Overall Study|Withdrawal by Subject|24|||
128769184|NCT01965158|463446030|FG000|Overall Study|Lost to Follow-up|7|||
128769185|NCT01965158|463446031|FG001|Overall Study|Lost to Follow-up|5|||
128769186|NCT01965158|463446030|FG000|Overall Study|Protocol Violation|1|||
128937420|NCT04172831|464058870|FG001|Overall Study|COVID-19 related crisis|3|||
128937421|NCT04172831|464058869|FG000|Overall Study|Subject non-compliance|1|||
128937422|NCT04172831|464058870|FG001|Overall Study|Subject non-compliance|1|||
128937423|NCT04172831|464058869|FG000|Overall Study|Family emergency|1|||
129031661|NCT02229084|464406508|FG004|Overall Study|Death|0|||
129031662|NCT02229084|464406509|FG005|Overall Study|Death|0|||
128769187|NCT01965158|463446031|FG001|Overall Study|Protocol Violation|1|||
128769188|NCT01965158|463446030|FG000|Overall Study|Other - Miscellaneous|3|||
128769189|NCT01965158|463446031|FG001|Overall Study|Other - Miscellaneous|0|||
128937424|NCT04172831|464058870|FG001|Overall Study|Family emergency|0|||
128937425|NCT01041573|464058871|FG000|Overall Study|Withdrawal by Subject|2|||
128937426|NCT01041573|464058872|FG001|Overall Study|Withdrawal by Subject|5|||
128937427|NCT01041573|464058873|FG002|Overall Study|Withdrawal by Subject|2|||
128937428|NCT01041573|464058874|FG003|Overall Study|Withdrawal by Subject|0|||
128937429|NCT01041573|464058871|FG000|Overall Study|Death|1|||
128937430|NCT01041573|464058872|FG001|Overall Study|Death|0|||
128937431|NCT01041573|464058873|FG002|Overall Study|Death|0|||
128937432|NCT01041573|464058874|FG003|Overall Study|Death|0|||
128937433|NCT01041573|464058871|FG000|Overall Study|Lost to Follow-up|0|||
128937434|NCT01041573|464058872|FG001|Overall Study|Lost to Follow-up|1|||
128937435|NCT01041573|464058873|FG002|Overall Study|Lost to Follow-up|2|||
128937436|NCT01041573|464058874|FG003|Overall Study|Lost to Follow-up|1|||
128937437|NCT01041573|464058871|FG000|Overall Study|Adverse Event|0|||
128937438|NCT01041573|464058872|FG001|Overall Study|Adverse Event|2|||
128937439|NCT01041573|464058873|FG002|Overall Study|Adverse Event|0|||
128937440|NCT01041573|464058874|FG003|Overall Study|Adverse Event|0|||
128937441|NCT01041573|464058871|FG000|Overall Study|relocation|1|||
128769190|NCT00474175|463446032|FG000|Overall Study|Lack of Efficacy|0|||
128769191|NCT00474175|463446033|FG001|Overall Study|Lack of Efficacy|0|||
128769192|NCT00474175|463446034|FG002|Overall Study|Lack of Efficacy|1|||
128769193|NCT00474175|463446032|FG000|Overall Study|Withdrawal by Subject|0|||
128769194|NCT00474175|463446033|FG001|Overall Study|Withdrawal by Subject|1|||
128769195|NCT00474175|463446034|FG002|Overall Study|Withdrawal by Subject|1|||
128769196|NCT00474175|463446032|FG000|Overall Study|Ineligible|1|||
128769197|NCT00474175|463446033|FG001|Overall Study|Ineligible|3|||
128769198|NCT00474175|463446034|FG002|Overall Study|Ineligible|1|||
128769199|NCT00474175|463446032|FG000|Overall Study|Protocol Violation|0|||
128769200|NCT00474175|463446033|FG001|Overall Study|Protocol Violation|2|||
128769201|NCT00474175|463446034|FG002|Overall Study|Protocol Violation|1|||
128769202|NCT00474175|463446032|FG000|Overall Study|Administrative|0|||
128769203|NCT00474175|463446033|FG001|Overall Study|Administrative|1|||
128769204|NCT00474175|463446034|FG002|Overall Study|Administrative|0|||
128769205|NCT01619787|463446037|FG000|Overall Study|Lost to Follow-up|5|||
128769206|NCT02006121|463446040|FG000|Double Blind Phase|Adverse Event|6|||
128937442|NCT01041573|464058872|FG001|Overall Study|relocation|4|||
128937443|NCT01041573|464058873|FG002|Overall Study|relocation|3|||
128937444|NCT01041573|464058874|FG003|Overall Study|relocation|1|||
128937445|NCT01041573|464058871|FG000|Overall Study|further blood extraction|0|||
128937446|NCT01041573|464058872|FG001|Overall Study|further blood extraction|1|||
128937447|NCT01041573|464058873|FG002|Overall Study|further blood extraction|0|||
128937448|NCT01041573|464058874|FG003|Overall Study|further blood extraction|0|||
128937449|NCT01041573|464058871|FG000|Overall Study|positive to anti-HCV|1|||
128937450|NCT01041573|464058872|FG001|Overall Study|positive to anti-HCV|0|||
128937451|NCT01041573|464058873|FG002|Overall Study|positive to anti-HCV|0|||
128937452|NCT01041573|464058874|FG003|Overall Study|positive to anti-HCV|0|||
128937453|NCT01276847|464058876|FG000|Overall Study|Withdrawal by Subject|1|||
128937454|NCT01276847|464058877|FG001|Overall Study|Withdrawal by Subject|0|||
128937455|NCT01276847|464058878|FG002|Overall Study|Withdrawal by Subject|0|||
128937456|NCT02119104|464058881|FG000|Overall Study|Protocol Violation|16|||
128769207|NCT02006121|463446041|FG001|Double Blind Phase|Adverse Event|0|||
128769208|NCT02006121|463446040|FG000|Double Blind Phase|Lack of Efficacy|1|||
128769209|NCT02006121|463446041|FG001|Double Blind Phase|Lack of Efficacy|16|||
128769210|NCT02006121|463446040|FG000|Double Blind Phase|Withdrawal by Subject|3|||
128769211|NCT02006121|463446041|FG001|Double Blind Phase|Withdrawal by Subject|4|||
128769212|NCT02006121|463446040|FG000|Double Blind Phase|Non-compliance with study drug|1|||
128769213|NCT02006121|463446041|FG001|Double Blind Phase|Non-compliance with study drug|3|||
128769214|NCT02006121|463446040|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
128769215|NCT02006121|463446041|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
128769216|NCT02006121|463446040|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
128769217|NCT02006121|463446041|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
128769218|NCT02006121|463446040|FG000|Open Label Phase|Adverse Event|15|||
128769219|NCT02006121|463446041|FG001|Open Label Phase|Adverse Event|0|||
128769220|NCT02006121|463446040|FG000|Open Label Phase|Lack of Efficacy|2|||
128769221|NCT02006121|463446041|FG001|Open Label Phase|Lack of Efficacy|0|||
128769222|NCT02006121|463446040|FG000|Open Label Phase|Protocol Violation|2|||
128769223|NCT02006121|463446041|FG001|Open Label Phase|Protocol Violation|0|||
128769224|NCT02006121|463446040|FG000|Open Label Phase|Withdrawal by Subject|3|||
128769225|NCT02006121|463446041|FG001|Open Label Phase|Withdrawal by Subject|0|||
128769226|NCT02006121|463446040|FG000|Open Label Phase|Non-compliance with study drug|3|||
128769227|NCT02006121|463446041|FG001|Open Label Phase|Non-compliance with study drug|0|||
128769228|NCT00245856|463446053|FG000|Period Two|Withdrawal by Subject|0|||
128769229|NCT00245856|463446054|FG001|Period Two|Withdrawal by Subject|1|||
128769230|NCT02693834|463446056|FG000|Baseline Measurement|Withdrawal by Subject|1|||
128769231|NCT02693834|463446057|FG001|Baseline Measurement|Withdrawal by Subject|0|||
129031663|NCT02229084|464406510|FG006|Overall Study|Death|1|||
129031664|NCT01745094|464406521|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
128769232|NCT02693834|463446056|FG000|Baseline Measurement|Adverse Event|1|||
128769233|NCT02693834|463446057|FG001|Baseline Measurement|Adverse Event|0|||
128769234|NCT02693834|463446056|FG000|Week 2 Practice|Adverse Event|0|||
128769235|NCT02693834|463446057|FG001|Week 2 Practice|Adverse Event|1|||
128937457|NCT02239094|464058883|FG000|Overall Study|Withdrawal by Subject|1|||
128937458|NCT02239094|464058883|FG000|Overall Study|Remitted before started|1|||
128937459|NCT03184701|464058884|FG000|Overall Study|Death|3|||
128937460|NCT03184701|464058884|FG000|Overall Study|Physician Decision|3|||
128937461|NCT03184701|464058884|FG000|Overall Study|Withdrawal by Subject|6|||
128937462|NCT03184701|464058884|FG000|Overall Study|Lost to Follow-up|5|||
129031665|NCT01745094|464406522|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
129031666|NCT01745094|464406523|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
129031667|NCT01745094|464406524|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
129031668|NCT01745094|464406521|FG000|Overall Study|Adverse Event|0|||
129031669|NCT01745094|464406522|FG001|Overall Study|Adverse Event|0|||
129031670|NCT01745094|464406523|FG002|Overall Study|Adverse Event|3|||
129031671|NCT01745094|464406524|FG003|Overall Study|Adverse Event|0|||
128937463|NCT02399475|464058890|FG000|Overall Study|Physician Decision|1|||
128937464|NCT02399475|464058891|FG001|Overall Study|Physician Decision|0|||
128937465|NCT02260193|464058892|FG000|Overall Study|Lack of Efficacy|0|||
128937466|NCT02260193|464058893|FG001|Overall Study|Lack of Efficacy|1|||
128937467|NCT02260193|464058894|FG002|Overall Study|Lack of Efficacy|6|||
128937468|NCT02260193|464058892|FG000|Overall Study|Adverse Event|3|||
128937469|NCT02260193|464058893|FG001|Overall Study|Adverse Event|4|||
128937470|NCT02260193|464058894|FG002|Overall Study|Adverse Event|1|||
128937471|NCT02260193|464058892|FG000|Overall Study|Protocol Violation|0|||
128937472|NCT02260193|464058893|FG001|Overall Study|Protocol Violation|4|||
128937473|NCT02260193|464058894|FG002|Overall Study|Protocol Violation|0|||
128937474|NCT02260193|464058892|FG000|Overall Study|Withdrawal by Subject|3|||
128937475|NCT02260193|464058893|FG001|Overall Study|Withdrawal by Subject|0|||
128937476|NCT02260193|464058894|FG002|Overall Study|Withdrawal by Subject|2|||
128937477|NCT02260193|464058892|FG000|Overall Study|Kidney Transplantation|0|||
128937478|NCT02260193|464058893|FG001|Overall Study|Kidney Transplantation|0|||
128937479|NCT02260193|464058894|FG002|Overall Study|Kidney Transplantation|1|||
128937480|NCT01963117|464058902|FG000|Overall Study|Death|1|||
128937481|NCT01000064|464058903|FG000|Overall Study|Withdrawal by Subject|1|||
129031672|NCT01745094|464406521|FG000|Overall Study|Withdrawal by Subject|2|||
129031673|NCT01745094|464406522|FG001|Overall Study|Withdrawal by Subject|0|||
129031674|NCT01745094|464406523|FG002|Overall Study|Withdrawal by Subject|1|||
129031675|NCT01745094|464406524|FG003|Overall Study|Withdrawal by Subject|2|||
129031676|NCT01745094|464406521|FG000|Overall Study|Protocol Violation|1|||
129031677|NCT01745094|464406522|FG001|Overall Study|Protocol Violation|0|||
129031678|NCT01745094|464406523|FG002|Overall Study|Protocol Violation|3|||
129031679|NCT01745094|464406524|FG003|Overall Study|Protocol Violation|1|||
129031680|NCT01745094|464406521|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
129217347|NCT00705016|465096948|FG002|Overall Study|Death|5|||
129217348|NCT00705016|465096946|FG000|Overall Study|Protocol Violation|0|||
129217349|NCT00705016|465096947|FG001|Overall Study|Protocol Violation|1|||
129217350|NCT00705016|465096948|FG002|Overall Study|Protocol Violation|1|||
129217351|NCT00705016|465096946|FG000|Overall Study|Withdrawal by Subject|4|||
129217352|NCT00705016|465096947|FG001|Overall Study|Withdrawal by Subject|3|||
129217353|NCT00705016|465096948|FG002|Overall Study|Withdrawal by Subject|2|||
129217354|NCT00705016|465096946|FG000|Overall Study|Progressive Disease|33|||
129217355|NCT00705016|465096947|FG001|Overall Study|Progressive Disease|29|||
129217356|NCT00705016|465096948|FG002|Overall Study|Progressive Disease|33|||
129217357|NCT00705016|465096946|FG000|Overall Study|Symptomatic Deterioration|3|||
129217358|NCT00705016|465096947|FG001|Overall Study|Symptomatic Deterioration|1|||
129217359|NCT00705016|465096948|FG002|Overall Study|Symptomatic Deterioration|1|||
129217360|NCT00705016|465096946|FG000|Overall Study|Other|9|||
129217361|NCT00705016|465096947|FG001|Overall Study|Other|6|||
129217362|NCT00705016|465096948|FG002|Overall Study|Other|6|||
129217363|NCT03853109|465096951|FG000|Overall Study|Withdrawal by Subject|0|||
129217364|NCT03853109|465096952|FG001|Overall Study|Withdrawal by Subject|0|||
129217365|NCT03853109|465096953|FG002|Overall Study|Withdrawal by Subject|1|||
129217366|NCT03853109|465096954|FG003|Overall Study|Withdrawal by Subject|2|||
129217367|NCT03853109|465096955|FG004|Overall Study|Withdrawal by Subject|1|||
129217368|NCT03853109|465096956|FG005|Overall Study|Withdrawal by Subject|4|||
129217369|NCT03853109|465096957|FG006|Overall Study|Withdrawal by Subject|5|||
129217370|NCT03853109|465096958|FG007|Overall Study|Withdrawal by Subject|3|||
128937482|NCT01000064|464058904|FG001|Overall Study|Withdrawal by Subject|1|||
128937483|NCT01518192|464058905|FG000|Overall Study|Lost to Follow-up|29|||
128937484|NCT01518192|464058906|FG001|Overall Study|Lost to Follow-up|26|||
129031681|NCT01745094|464406522|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
129217371|NCT03853109|465096951|FG000|Overall Study|Decision by Sponsor|0|||
129217372|NCT03853109|465096952|FG001|Overall Study|Decision by Sponsor|0|||
129217373|NCT03853109|465096953|FG002|Overall Study|Decision by Sponsor|1|||
129217374|NCT03853109|465096954|FG003|Overall Study|Decision by Sponsor|0|||
128937485|NCT01518192|464058907|FG002|Overall Study|Lost to Follow-up|35|||
128937486|NCT03090737|464058910|FG000|Overall Study|Other reasons|1|||
128937487|NCT03090737|464058910|FG000|Overall Study|Completed treatment as per protocol|17|||
128937488|NCT03090737|464058910|FG000|Overall Study|Maximum clinical benefit|2|||
128937489|NCT03090737|464058910|FG000|Overall Study|Adverse event unrelated to study drug|7|||
129031682|NCT01745094|464406523|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
129031683|NCT01745094|464406524|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
129217375|NCT03853109|465096955|FG004|Overall Study|Decision by Sponsor|1|||
129217376|NCT03853109|465096956|FG005|Overall Study|Decision by Sponsor|1|||
129217377|NCT03853109|465096957|FG006|Overall Study|Decision by Sponsor|10|||
128769236|NCT04848662|463446058|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
128769237|NCT04848662|463446059|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
128769238|NCT00562978|463446060|FG000|Overall Study|Patient had imaging dose only|1|||
128769239|NCT00562978|463446061|FG001|Overall Study|Patient had imaging dose only|11|||
128769240|NCT00152971|463446063|FG000|Overall Study|Adverse Event|12|||
128937490|NCT03090737|464058910|FG000|Overall Study|Study drug toxicity|4|||
128937491|NCT03090737|464058910|FG000|Overall Study|Disease progression|98|||
128937492|NCT03141307|464058911|FG000|In-Hospital|Withdrawal by Subject|0|||
128937493|NCT03141307|464058912|FG001|In-Hospital|Withdrawal by Subject|2|||
128937494|NCT03141307|464058911|FG000|In-Hospital|Protocol Violation|4|||
128937495|NCT03141307|464058912|FG001|In-Hospital|Protocol Violation|0|||
128937496|NCT03141307|464058911|FG000|Follow-Up|Lost to Follow-up|97|||
128937497|NCT03141307|464058912|FG001|Follow-Up|Lost to Follow-up|54|||
128937498|NCT04430582|464058915|FG000|Overall Study|Found to meet exclusionary criteria|1|||
128937499|NCT04430582|464058916|FG001|Overall Study|Found to meet exclusionary criteria|0|||
128937500|NCT04430582|464058915|FG000|Overall Study|Withdrawal by Subject|0|||
128937501|NCT04430582|464058916|FG001|Overall Study|Withdrawal by Subject|1|||
128937502|NCT03151148|464060623|FG000|Overall Study|Lost to Follow-up|1|||
128937503|NCT03151148|464060624|FG001|Overall Study|Lost to Follow-up|0|||
128937504|NCT03151148|464060623|FG000|Overall Study|Withdrawal by Subject|1|||
128937505|NCT03151148|464060624|FG001|Overall Study|Withdrawal by Subject|0|||
128937506|NCT04543955|464060625|FG000|Overall Study|Company cancelled study|1|||
128937507|NCT04543955|464060626|FG001|Overall Study|Company cancelled study|0|||
128937508|NCT02433210|464060631|FG000|Overall Study|Physician Decision|1|||
128937509|NCT02433210|464060632|FG001|Overall Study|Physician Decision|0|||
128937510|NCT02433210|464060633|FG002|Overall Study|Physician Decision|0|||
128937511|NCT01958671|464060638|FG000|Overall Study|Adverse Event|1|||
128937512|NCT01958671|464060639|FG001|Overall Study|Adverse Event|1|||
128937513|NCT01958671|464060640|FG002|Overall Study|Adverse Event|5|||
128937514|NCT01958671|464060638|FG000|Overall Study|Death|1|||
128937515|NCT01958671|464060639|FG001|Overall Study|Death|0|||
128937516|NCT01958671|464060640|FG002|Overall Study|Death|0|||
128937517|NCT01958671|464060638|FG000|Overall Study|Excluded medication|0|||
128937518|NCT01958671|464060639|FG001|Overall Study|Excluded medication|0|||
128937519|NCT01958671|464060640|FG002|Overall Study|Excluded medication|1|||
128937520|NCT01958671|464060638|FG000|Overall Study|Hyperglycemia|0|||
128937521|NCT01958671|464060639|FG001|Overall Study|Hyperglycemia|0|||
128937522|NCT01958671|464060640|FG002|Overall Study|Hyperglycemia|2|||
128937523|NCT01958671|464060638|FG000|Overall Study|Lost to Follow-up|7|||
128937524|NCT01958671|464060639|FG001|Overall Study|Lost to Follow-up|11|||
128937525|NCT01958671|464060640|FG002|Overall Study|Lost to Follow-up|7|||
128937526|NCT01958671|464060638|FG000|Overall Study|Non-compliance with study drug|1|||
128937527|NCT01958671|464060639|FG001|Overall Study|Non-compliance with study drug|1|||
128937528|NCT01958671|464060640|FG002|Overall Study|Non-compliance with study drug|1|||
128937529|NCT01958671|464060638|FG000|Overall Study|Pregnancy|0|||
128937530|NCT01958671|464060639|FG001|Overall Study|Pregnancy|0|||
128937531|NCT01958671|464060640|FG002|Overall Study|Pregnancy|1|||
128937532|NCT01958671|464060638|FG000|Overall Study|Protocol Violation|0|||
128937533|NCT01958671|464060639|FG001|Overall Study|Protocol Violation|1|||
128937534|NCT01958671|464060640|FG002|Overall Study|Protocol Violation|0|||
128937535|NCT01958671|464060638|FG000|Overall Study|Study site terminated by sponsor|1|||
128937536|NCT01958671|464060639|FG001|Overall Study|Study site terminated by sponsor|0|||
128937537|NCT01958671|464060640|FG002|Overall Study|Study site terminated by sponsor|1|||
128937538|NCT01958671|464060638|FG000|Overall Study|Participant moved|0|||
128937539|NCT01958671|464060639|FG001|Overall Study|Participant moved|0|||
128937540|NCT01958671|464060640|FG002|Overall Study|Participant moved|1|||
128937541|NCT01958671|464060638|FG000|Overall Study|Withdrawal by Subject|8|||
128937542|NCT01958671|464060639|FG001|Overall Study|Withdrawal by Subject|10|||
128937543|NCT01958671|464060640|FG002|Overall Study|Withdrawal by Subject|13|||
128937544|NCT04760314|464060641|FG000|Induction Period|Withdrawal by Subject|0|||
128937545|NCT04760314|464060642|FG001|Induction Period|Withdrawal by Subject|1|||
128937546|NCT04760314|464060643|FG002|Induction Period|Withdrawal by Subject|1|||
128937547|NCT04760314|464060644|FG003|Induction Period|Withdrawal by Subject|0|||
128769241|NCT00152971|463446064|FG001|Overall Study|Adverse Event|10|||
128769242|NCT00152971|463446065|FG002|Overall Study|Adverse Event|9|||
128769243|NCT00152971|463446063|FG000|Overall Study|Protocol Violation|10|||
128937548|NCT04760314|464060645|FG004|Induction Period|Withdrawal by Subject|0|||
128937549|NCT04760314|464060646|FG005|Induction Period|Withdrawal by Subject|0|||
128937550|NCT04760314|464060647|FG006|Induction Period|Withdrawal by Subject|0|||
128937551|NCT04760314|464060648|FG007|Induction Period|Withdrawal by Subject|0|||
128937552|NCT04760314|464060649|FG008|Induction Period|Withdrawal by Subject|0|||
128937553|NCT04760314|464060650|FG009|Induction Period|Withdrawal by Subject|0|||
128937554|NCT04760314|464060651|FG010|Induction Period|Withdrawal by Subject|0|||
128937555|NCT04760314|464060641|FG000|Induction Period|Adverse Event|0|||
128769244|NCT00152971|463446064|FG001|Overall Study|Protocol Violation|11|||
128937556|NCT04760314|464060642|FG001|Induction Period|Adverse Event|0|||
128937557|NCT04760314|464060643|FG002|Induction Period|Adverse Event|2|||
128937558|NCT04760314|464060644|FG003|Induction Period|Adverse Event|0|||
128937559|NCT04760314|464060645|FG004|Induction Period|Adverse Event|0|||
128937560|NCT04760314|464060646|FG005|Induction Period|Adverse Event|0|||
128937561|NCT04760314|464060647|FG006|Induction Period|Adverse Event|0|||
128937562|NCT04760314|464060648|FG007|Induction Period|Adverse Event|0|||
128937563|NCT04760314|464060649|FG008|Induction Period|Adverse Event|0|||
128937564|NCT04760314|464060650|FG009|Induction Period|Adverse Event|0|||
129217378|NCT03853109|465096958|FG007|Overall Study|Decision by Sponsor|2|||
129217379|NCT03853109|465096951|FG000|Overall Study|Lost to Follow-up|0|||
129217380|NCT03853109|465096952|FG001|Overall Study|Lost to Follow-up|0|||
129217381|NCT03853109|465096953|FG002|Overall Study|Lost to Follow-up|0|||
129217382|NCT03853109|465096954|FG003|Overall Study|Lost to Follow-up|0|||
129217383|NCT03853109|465096955|FG004|Overall Study|Lost to Follow-up|1|||
129217384|NCT03853109|465096956|FG005|Overall Study|Lost to Follow-up|3|||
129217385|NCT03853109|465096957|FG006|Overall Study|Lost to Follow-up|0|||
129217386|NCT03853109|465096958|FG007|Overall Study|Lost to Follow-up|0|||
129217387|NCT03853109|465096951|FG000|Overall Study|Death|2|||
129217388|NCT03853109|465096952|FG001|Overall Study|Death|5|||
129217389|NCT03853109|465096953|FG002|Overall Study|Death|8|||
129217390|NCT03853109|465096954|FG003|Overall Study|Death|10|||
129217391|NCT03853109|465096955|FG004|Overall Study|Death|3|||
129217392|NCT03853109|465096956|FG005|Overall Study|Death|20|||
129217393|NCT03853109|465096957|FG006|Overall Study|Death|10|||
129217394|NCT03853109|465096958|FG007|Overall Study|Death|5|||
129217395|NCT01721044|465096963|FG000|Treatment Period|Adverse Event|7|||
129217396|NCT01721044|465096964|FG001|Treatment Period|Adverse Event|7|||
129217397|NCT01721044|465096965|FG002|Treatment Period|Adverse Event|10|||
129217398|NCT01721044|465096963|FG000|Treatment Period|Death|0|||
129217399|NCT01721044|465096964|FG001|Treatment Period|Death|0|||
129217400|NCT01721044|465096965|FG002|Treatment Period|Death|1|||
129217401|NCT01721044|465096963|FG000|Treatment Period|Lack of Efficacy|16|||
129217402|NCT01721044|465096964|FG001|Treatment Period|Lack of Efficacy|4|||
129217403|NCT01721044|465096965|FG002|Treatment Period|Lack of Efficacy|4|||
129217404|NCT01721044|465096963|FG000|Treatment Period|Lost to Follow-up|0|||
129217405|NCT01721044|465096964|FG001|Treatment Period|Lost to Follow-up|0|||
129217406|NCT01721044|465096965|FG002|Treatment Period|Lost to Follow-up|1|||
129217407|NCT01721044|465096963|FG000|Treatment Period|Physician Decision|1|||
129217408|NCT01721044|465096964|FG001|Treatment Period|Physician Decision|0|||
129217409|NCT01721044|465096965|FG002|Treatment Period|Physician Decision|2|||
129217410|NCT01721044|465096963|FG000|Treatment Period|Protocol Violation|1|||
129217411|NCT01721044|465096964|FG001|Treatment Period|Protocol Violation|0|||
129217412|NCT01721044|465096965|FG002|Treatment Period|Protocol Violation|0|||
129217413|NCT01721044|465096963|FG000|Treatment Period|Withdrawal by Subject|7|||
129217414|NCT01721044|465096964|FG001|Treatment Period|Withdrawal by Subject|6|||
129217415|NCT01721044|465096965|FG002|Treatment Period|Withdrawal by Subject|1|||
129217416|NCT04032093|465096968|FG000|Overall Study|Lost to Follow-up|7|||
129217417|NCT04032093|465096969|FG001|Overall Study|Lost to Follow-up|7|||
129217418|NCT04032093|465096970|FG002|Overall Study|Lost to Follow-up|6|||
129217419|NCT04032093|465096971|FG003|Overall Study|Lost to Follow-up|10|||
129217420|NCT04032093|465096972|FG004|Overall Study|Lost to Follow-up|13|||
129217421|NCT04032093|465096973|FG005|Overall Study|Lost to Follow-up|7|||
129217422|NCT04032093|465096974|FG006|Overall Study|Lost to Follow-up|7|||
129217423|NCT04032093|465096975|FG007|Overall Study|Lost to Follow-up|5|||
129217424|NCT04032093|465096976|FG008|Overall Study|Lost to Follow-up|9|||
129217425|NCT04032093|465096977|FG009|Overall Study|Lost to Follow-up|12|||
129217426|NCT04032093|465096968|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129217427|NCT04032093|465096969|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129217428|NCT04032093|465096970|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129217429|NCT04032093|465096971|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
129217430|NCT04032093|465096972|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
129217431|NCT04032093|465096973|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129217432|NCT04032093|465096974|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
129217433|NCT04032093|465096975|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129217434|NCT04032093|465096976|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
129217435|NCT04032093|465096977|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
129217436|NCT04032093|465096968|FG000|Overall Study|Other|1|||
129217437|NCT04032093|465096969|FG001|Overall Study|Other|0|||
129217438|NCT04032093|465096970|FG002|Overall Study|Other|0|||
129217439|NCT04032093|465096971|FG003|Overall Study|Other|1|||
129217440|NCT04032093|465096972|FG004|Overall Study|Other|1|||
129217441|NCT04032093|465096973|FG005|Overall Study|Other|0|||
129217442|NCT04032093|465096974|FG006|Overall Study|Other|0|||
129217443|NCT04032093|465096975|FG007|Overall Study|Other|0|||
129217444|NCT04032093|465096976|FG008|Overall Study|Other|0|||
128937565|NCT04760314|464060651|FG010|Induction Period|Adverse Event|0|||
129217445|NCT04032093|465096977|FG009|Overall Study|Other|1|||
129217446|NCT04032093|465096968|FG000|Overall Study|Withdrawal by Subject|1|||
129217447|NCT04032093|465096969|FG001|Overall Study|Withdrawal by Subject|3|||
129217448|NCT04032093|465096970|FG002|Overall Study|Withdrawal by Subject|2|||
129217449|NCT04032093|465096971|FG003|Overall Study|Withdrawal by Subject|2|||
129031684|NCT01745094|464406521|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
128769245|NCT00152971|463446065|FG002|Overall Study|Protocol Violation|8|||
128769246|NCT00152971|463446063|FG000|Overall Study|Lost to Follow-up|17|||
128769247|NCT00152971|463446064|FG001|Overall Study|Lost to Follow-up|14|||
128769248|NCT00152971|463446065|FG002|Overall Study|Lost to Follow-up|13|||
128769249|NCT00152971|463446063|FG000|Overall Study|Withdrawal by Subject|9|||
128769250|NCT00152971|463446064|FG001|Overall Study|Withdrawal by Subject|8|||
128769251|NCT00152971|463446065|FG002|Overall Study|Withdrawal by Subject|14|||
128769252|NCT00152971|463446063|FG000|Overall Study|Other|3|||
128769253|NCT00152971|463446064|FG001|Overall Study|Other|5|||
128769254|NCT00152971|463446065|FG002|Overall Study|Other|5|||
128769255|NCT00152971|463446063|FG000|Treatment|Adverse Event|49|||
128769256|NCT00152971|463446064|FG001|Treatment|Adverse Event|40|||
128769257|NCT00152971|463446065|FG002|Treatment|Adverse Event|54|||
128769258|NCT00152971|463446063|FG000|Treatment|Protocol Violation|8|||
128769259|NCT00152971|463446064|FG001|Treatment|Protocol Violation|6|||
128769260|NCT00152971|463446065|FG002|Treatment|Protocol Violation|10|||
128769261|NCT00152971|463446063|FG000|Treatment|Lost to Follow-up|1|||
128769262|NCT00152971|463446064|FG001|Treatment|Lost to Follow-up|2|||
128769263|NCT00152971|463446065|FG002|Treatment|Lost to Follow-up|1|||
128769264|NCT00152971|463446063|FG000|Treatment|Withdrawal by Subject|4|||
128769265|NCT00152971|463446064|FG001|Treatment|Withdrawal by Subject|4|||
128769266|NCT00152971|463446065|FG002|Treatment|Withdrawal by Subject|5|||
128769267|NCT00152971|463446063|FG000|Treatment|Other|9|||
128769268|NCT00152971|463446064|FG001|Treatment|Other|11|||
128769269|NCT00152971|463446065|FG002|Treatment|Other|10|||
128769270|NCT03853317|463446066|FG000|Overall Study|Progressive Disease|5|||
128769271|NCT03853317|463446066|FG000|Overall Study|Adverse Event|1|||
128769272|NCT03853317|463446066|FG000|Overall Study|Death|1|||
128769273|NCT03853317|463446066|FG000|Overall Study|other event|2|||
128769274|NCT00406419|463446067|FG000|Overall Study|Death|3|||
128769275|NCT00406419|463446068|FG001|Overall Study|Death|1|||
128769276|NCT00406419|463446069|FG002|Overall Study|Death|4|||
128769277|NCT00406419|463446067|FG000|Overall Study|Protocol Violation|6|||
128769278|NCT00406419|463446068|FG001|Overall Study|Protocol Violation|2|||
129031685|NCT01745094|464406522|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
129031686|NCT01745094|464406523|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
129031687|NCT01745094|464406524|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
129031688|NCT01745094|464406521|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
129031689|NCT01745094|464406522|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
129031690|NCT01745094|464406523|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
129031691|NCT01745094|464406524|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
129031692|NCT00881569|464406525|FG000|Overall Study|Disease progression|1|||
129031693|NCT00881569|464406526|FG001|Overall Study|Disease progression|1|||
129031694|NCT02623218|464406537|FG000|Overall Study|Lost to Follow-up|0|||
128769279|NCT00406419|463446069|FG002|Overall Study|Protocol Violation|5|||
128769280|NCT00406419|463446067|FG000|Overall Study|Study Terminated by Sponsor|260|||
128769281|NCT00406419|463446068|FG001|Overall Study|Study Terminated by Sponsor|288|||
128769282|NCT00406419|463446069|FG002|Overall Study|Study Terminated by Sponsor|282|||
128769283|NCT00406419|463446067|FG000|Overall Study|Withdrawal by Subject|17|||
128769284|NCT00406419|463446068|FG001|Overall Study|Withdrawal by Subject|24|||
128769285|NCT00406419|463446069|FG002|Overall Study|Withdrawal by Subject|26|||
128769286|NCT00406419|463446067|FG000|Overall Study|Lack of Efficacy|12|||
128769287|NCT00406419|463446068|FG001|Overall Study|Lack of Efficacy|1|||
128769288|NCT00406419|463446069|FG002|Overall Study|Lack of Efficacy|6|||
128769289|NCT00406419|463446067|FG000|Overall Study|Non-Compliance with Study Drug|5|||
128769290|NCT00406419|463446068|FG001|Overall Study|Non-Compliance with Study Drug|6|||
128769291|NCT00406419|463446069|FG002|Overall Study|Non-Compliance with Study Drug|3|||
128769292|NCT00406419|463446067|FG000|Overall Study|Adverse Event|10|||
128769293|NCT00406419|463446068|FG001|Overall Study|Adverse Event|12|||
128769294|NCT00406419|463446069|FG002|Overall Study|Adverse Event|16|||
128769295|NCT00406419|463446067|FG000|Overall Study|Lost to Follow-up|11|||
128769296|NCT00406419|463446068|FG001|Overall Study|Lost to Follow-up|10|||
128769297|NCT00406419|463446069|FG002|Overall Study|Lost to Follow-up|5|||
128769298|NCT02009696|463446075|FG000|Overall Study|Withdrawal by Subject|2|||
128769299|NCT02460263|463446076|FG000|Transition Period|Withdrawal by Subject|1|||
129031695|NCT02623218|464406538|FG001|Overall Study|Lost to Follow-up|1|||
129031696|NCT02623218|464406539|FG002|Overall Study|Lost to Follow-up|0|||
129031697|NCT02623218|464406540|FG003|Overall Study|Lost to Follow-up|0|||
129031698|NCT02623218|464406541|FG004|Overall Study|Lost to Follow-up|0|||
128769300|NCT02460263|463446076|FG000|Transition Period|Death|1|||
128769301|NCT02301156|463446077|FG000|Overall Study|Adverse Event|13|||
128769302|NCT02301156|463446078|FG001|Overall Study|Adverse Event|14|||
128769303|NCT02301156|463446077|FG000|Overall Study|Death|1|||
128769304|NCT02301156|463446078|FG001|Overall Study|Death|5|||
128769305|NCT02301156|463446077|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
128769306|NCT02301156|463446078|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
128769307|NCT02301156|463446077|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
128937566|NCT04760314|464060641|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
128937567|NCT04760314|464060642|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
128937568|NCT04760314|464060643|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
129031699|NCT01726803|464406542|FG000|Overall Study|Lost to Follow-up|6|||
129031700|NCT01726803|464406543|FG001|Overall Study|Lost to Follow-up|1|||
129217450|NCT04032093|465096972|FG004|Overall Study|Withdrawal by Subject|3|||
129217451|NCT04032093|465096973|FG005|Overall Study|Withdrawal by Subject|0|||
128937569|NCT04760314|464060644|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
128937570|NCT04760314|464060645|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
128937571|NCT04760314|464060646|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
128937572|NCT04760314|464060647|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
128937573|NCT04760314|464060648|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
128937574|NCT04760314|464060649|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
128937575|NCT04760314|464060650|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
128937576|NCT04760314|464060651|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
128937577|NCT04760314|464060641|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937578|NCT04760314|464060642|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937579|NCT04760314|464060643|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937580|NCT04760314|464060644|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
128937581|NCT04760314|464060645|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937582|NCT04760314|464060646|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
128937583|NCT04760314|464060647|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
128937584|NCT04760314|464060648|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937585|NCT04760314|464060649|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937586|NCT04760314|464060650|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937587|NCT04760314|464060651|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
128937588|NCT04760314|464060641|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937589|NCT04760314|464060642|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937590|NCT04760314|464060643|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937591|NCT04760314|464060644|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937592|NCT04760314|464060645|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
128937593|NCT04760314|464060646|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937594|NCT04760314|464060647|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937595|NCT04760314|464060648|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937596|NCT04760314|464060649|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937597|NCT04760314|464060650|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937598|NCT04760314|464060651|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
128937599|NCT04760314|464060641|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
128937600|NCT04760314|464060642|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
128937601|NCT04760314|464060643|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
128937602|NCT04760314|464060644|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
128937603|NCT04760314|464060645|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
128937604|NCT04760314|464060646|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
128937605|NCT04760314|464060647|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
128937606|NCT04760314|464060648|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
128937607|NCT04760314|464060649|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
128937608|NCT04760314|464060650|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
128937609|NCT04760314|464060651|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
128937610|NCT04760314|464060641|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129217452|NCT04032093|465096974|FG006|Overall Study|Withdrawal by Subject|0|||
129217453|NCT04032093|465096975|FG007|Overall Study|Withdrawal by Subject|0|||
129217454|NCT04032093|465096976|FG008|Overall Study|Withdrawal by Subject|0|||
129217455|NCT04032093|465096977|FG009|Overall Study|Withdrawal by Subject|0|||
129217456|NCT04032093|465096968|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129217457|NCT04032093|465096969|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129217458|NCT04032093|465096970|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129217459|NCT04032093|465096971|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129217460|NCT04032093|465096972|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129217461|NCT04032093|465096973|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129217462|NCT04032093|465096974|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
129217463|NCT04032093|465096975|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
129217464|NCT04032093|465096976|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
129217465|NCT04032093|465096977|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
129217466|NCT04032093|465096968|FG000|Overall Study|Adverse Event|0|||
128937611|NCT04760314|464060642|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128937612|NCT04760314|464060643|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128937613|NCT04760314|464060644|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129217467|NCT04032093|465096969|FG001|Overall Study|Adverse Event|0|||
129217468|NCT04032093|465096970|FG002|Overall Study|Adverse Event|0|||
129217469|NCT04032093|465096971|FG003|Overall Study|Adverse Event|0|||
128769308|NCT02301156|463446078|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
128769309|NCT02301156|463446077|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
128769310|NCT02301156|463446078|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
128769311|NCT02301156|463446077|FG000|Overall Study|Reason not Specified|6|||
128769312|NCT02301156|463446078|FG001|Overall Study|Reason not Specified|3|||
128769313|NCT03203694|463446079|FG000|Overall Study|Withdrawal by Subject|2|||
128769314|NCT03203694|463446080|FG001|Overall Study|Withdrawal by Subject|0|||
128769315|NCT03203694|463446081|FG002|Overall Study|Withdrawal by Subject|0|||
128769316|NCT03203694|463446082|FG003|Overall Study|Withdrawal by Subject|0|||
128769317|NCT03203694|463446083|FG004|Overall Study|Withdrawal by Subject|0|||
128769318|NCT03203694|463446084|FG005|Overall Study|Withdrawal by Subject|0|||
128769319|NCT01103960|463446085|FG000|Overall Study|Adverse Event|2|||
128769320|NCT01103960|463446086|FG001|Overall Study|Adverse Event|1|||
128769321|NCT01103960|463446085|FG000|Overall Study|Withdrawal by Subject|2|||
128769322|NCT01103960|463446086|FG001|Overall Study|Withdrawal by Subject|1|||
128769323|NCT01103960|463446085|FG000|Overall Study|Other|1|||
128769324|NCT01103960|463446086|FG001|Overall Study|Other|0|||
128769325|NCT02875834|463446089|FG000|Open-label Phase|Withdrawal by Subject|3|||
128769326|NCT02875834|463446090|FG001|Open-label Phase|Withdrawal by Subject|0|||
128769327|NCT02875834|463446091|FG002|Open-label Phase|Withdrawal by Subject|0|||
128769328|NCT02875834|463446092|FG003|Open-label Phase|Withdrawal by Subject|0|||
128769329|NCT02875834|463446089|FG000|Open-label Phase|(Not collected)|4|||
128769330|NCT02875834|463446090|FG001|Open-label Phase|(Not collected)|0|||
128769331|NCT02875834|463446091|FG002|Open-label Phase|(Not collected)|0|||
128769332|NCT02875834|463446092|FG003|Open-label Phase|(Not collected)|0|||
128769333|NCT02875834|463446089|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
128769334|NCT02875834|463446090|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
128769335|NCT02875834|463446091|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
128769336|NCT02875834|463446092|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
128769337|NCT02875834|463446089|FG000|Randomized Treatment Phase|Protocol Violation|0|||
128769338|NCT02875834|463446090|FG001|Randomized Treatment Phase|Protocol Violation|2|||
128769339|NCT02875834|463446091|FG002|Randomized Treatment Phase|Protocol Violation|0|||
128769340|NCT02875834|463446092|FG003|Randomized Treatment Phase|Protocol Violation|0|||
128769341|NCT02875834|463446089|FG000|Randomized Treatment Phase|(Not collected)|0|||
128769342|NCT02875834|463446090|FG001|Randomized Treatment Phase|(Not collected)|9|||
128769343|NCT02875834|463446091|FG002|Randomized Treatment Phase|(Not collected)|10|||
128769344|NCT02875834|463446092|FG003|Randomized Treatment Phase|(Not collected)|9|||
128769345|NCT03311230|463446093|FG000|Overall Study|Withdrawal by Subject|1|||
128769346|NCT03311230|463446094|FG001|Overall Study|Withdrawal by Subject|4|||
128769347|NCT03311230|463446095|FG002|Overall Study|Withdrawal by Subject|2|||
128769348|NCT03311230|463446096|FG003|Overall Study|Withdrawal by Subject|7|||
128769349|NCT03311230|463446093|FG000|Overall Study|Unrelated injury|0|||
128937614|NCT04760314|464060645|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128937615|NCT04760314|464060646|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128937616|NCT04760314|464060647|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128937617|NCT04760314|464060648|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
128937618|NCT04760314|464060649|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
128937619|NCT04760314|464060650|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
128937620|NCT04760314|464060651|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
128937621|NCT04760314|464060641|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937622|NCT04760314|464060642|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937623|NCT04760314|464060643|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937624|NCT04760314|464060644|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937625|NCT04760314|464060645|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937626|NCT04760314|464060646|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937627|NCT04760314|464060647|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937628|NCT04760314|464060648|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
128937629|NCT04760314|464060649|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
128937630|NCT04760314|464060650|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
128937631|NCT04760314|464060651|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
128937632|NCT04760314|464060641|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128937633|NCT04760314|464060642|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128937634|NCT04760314|464060643|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128937635|NCT04760314|464060644|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128769350|NCT03311230|463446094|FG001|Overall Study|Unrelated injury|1|||
128769351|NCT03311230|463446095|FG002|Overall Study|Unrelated injury|0|||
128769352|NCT03311230|463446096|FG003|Overall Study|Unrelated injury|0|||
128769353|NCT03342053|463446097|FG000|Overall Study|Adverse Event|2|||
128769354|NCT03342053|463446098|FG001|Overall Study|Adverse Event|0|||
128769355|NCT03342053|463446097|FG000|Overall Study|Withdrawal by Subject|0|||
128769356|NCT03342053|463446098|FG001|Overall Study|Withdrawal by Subject|1|||
128769357|NCT01302938|463446099|FG000|Overall Study|Withdrawal by Subject|1|||
128937636|NCT04760314|464060645|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128937637|NCT04760314|464060646|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128937638|NCT04760314|464060647|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128937639|NCT04760314|464060648|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
128937640|NCT04760314|464060649|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128937641|NCT04760314|464060650|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129217470|NCT04032093|465096972|FG004|Overall Study|Adverse Event|0|||
129217471|NCT04032093|465096973|FG005|Overall Study|Adverse Event|0|||
129217472|NCT04032093|465096974|FG006|Overall Study|Adverse Event|0|||
129217473|NCT04032093|465096975|FG007|Overall Study|Adverse Event|0|||
129217474|NCT04032093|465096976|FG008|Overall Study|Adverse Event|0|||
129217475|NCT04032093|465096977|FG009|Overall Study|Adverse Event|1|||
129217476|NCT04032093|465096968|FG000|Overall Study|Physician Decision|0|||
129217477|NCT04032093|465096969|FG001|Overall Study|Physician Decision|0|||
129217478|NCT04032093|465096970|FG002|Overall Study|Physician Decision|0|||
129217479|NCT04032093|465096971|FG003|Overall Study|Physician Decision|0|||
129217480|NCT04032093|465096972|FG004|Overall Study|Physician Decision|0|||
129217481|NCT04032093|465096973|FG005|Overall Study|Physician Decision|1|||
129217482|NCT04032093|465096974|FG006|Overall Study|Physician Decision|0|||
129217483|NCT04032093|465096975|FG007|Overall Study|Physician Decision|0|||
129217484|NCT04032093|465096976|FG008|Overall Study|Physician Decision|0|||
129217485|NCT04032093|465096977|FG009|Overall Study|Physician Decision|0|||
129217486|NCT01654302|465096984|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
129217487|NCT01654302|465096985|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
129217488|NCT03133793|465096989|FG000|Overall Study|Withdrawal by Subject|0|||
129217489|NCT03133793|465096990|FG001|Overall Study|Withdrawal by Subject|4|||
129217490|NCT03133793|465096991|FG002|Overall Study|Withdrawal by Subject|2|||
129217491|NCT03133793|465096992|FG003|Overall Study|Withdrawal by Subject|4|||
129217492|NCT03133793|465096989|FG000|Overall Study|Lost to Follow-up|1|||
129217493|NCT03133793|465096990|FG001|Overall Study|Lost to Follow-up|0|||
129217494|NCT03133793|465096991|FG002|Overall Study|Lost to Follow-up|2|||
129217495|NCT03133793|465096992|FG003|Overall Study|Lost to Follow-up|0|||
129217496|NCT03133793|465096989|FG000|Overall Study|Death|0|||
129217497|NCT03133793|465096990|FG001|Overall Study|Death|0|||
129217498|NCT03133793|465096991|FG002|Overall Study|Death|0|||
129217499|NCT03133793|465096992|FG003|Overall Study|Death|1|||
129217500|NCT02839200|465096993|FG000|Overall Study|Withdrawal by Subject|2|||
129217501|NCT02839200|465096994|FG001|Overall Study|Withdrawal by Subject|0|||
129217502|NCT02839200|465096995|FG002|Overall Study|Withdrawal by Subject|1|||
129217503|NCT02839200|465096996|FG003|Overall Study|Withdrawal by Subject|0|||
129217504|NCT02839200|465096997|FG004|Overall Study|Withdrawal by Subject|0|||
129217505|NCT02839200|465096998|FG005|Overall Study|Withdrawal by Subject|1|||
129217506|NCT02839200|465096993|FG000|Overall Study|Lost to Follow-up|2|||
129217507|NCT02839200|465096994|FG001|Overall Study|Lost to Follow-up|0|||
129217508|NCT02839200|465096995|FG002|Overall Study|Lost to Follow-up|0|||
129217509|NCT02839200|465096996|FG003|Overall Study|Lost to Follow-up|0|||
129217510|NCT02839200|465096997|FG004|Overall Study|Lost to Follow-up|1|||
129217511|NCT02839200|465096998|FG005|Overall Study|Lost to Follow-up|0|||
129217512|NCT02839200|465096993|FG000|Overall Study|Adverse Event|0|||
129217513|NCT02839200|465096994|FG001|Overall Study|Adverse Event|0|||
129217514|NCT02839200|465096995|FG002|Overall Study|Adverse Event|0|||
129217515|NCT02839200|465096996|FG003|Overall Study|Adverse Event|0|||
129217516|NCT02839200|465096997|FG004|Overall Study|Adverse Event|1|||
129217517|NCT02839200|465096998|FG005|Overall Study|Adverse Event|0|||
129217518|NCT02839200|465096993|FG000|Overall Study|Randomized in error|0|||
129217519|NCT02839200|465096994|FG001|Overall Study|Randomized in error|1|||
129217520|NCT02839200|465096995|FG002|Overall Study|Randomized in error|0|||
129217521|NCT02839200|465096996|FG003|Overall Study|Randomized in error|0|||
129217522|NCT02839200|465096997|FG004|Overall Study|Randomized in error|0|||
129217523|NCT02839200|465096998|FG005|Overall Study|Randomized in error|0|||
129217524|NCT02952820|465096999|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
129217525|NCT02952820|465097000|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
129217526|NCT02952820|465097001|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
129217527|NCT02952820|465096999|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
129217528|NCT02952820|465097000|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
129217529|NCT02952820|465097001|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
129217530|NCT02952820|465096999|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
129217531|NCT02952820|465097000|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
129217532|NCT02952820|465097001|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
129217533|NCT02952820|465096999|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
129217534|NCT02952820|465097000|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
129217535|NCT02952820|465097001|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
129217536|NCT02952820|465096999|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
129217537|NCT02952820|465097000|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
128937642|NCT04760314|464060651|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
128769358|NCT01302938|463446100|FG001|Overall Study|Withdrawal by Subject|0|||
128769359|NCT01302938|463446099|FG000|Overall Study|Adverse Event|1|||
128769360|NCT01302938|463446100|FG001|Overall Study|Adverse Event|0|||
128769361|NCT01233609|463446101|FG000|Overall Study|Death|1|||
128769362|NCT01233609|463446102|FG001|Overall Study|Death|0|||
128769363|NCT01233609|463446101|FG000|Overall Study|Lost to Follow-up|3|||
128769364|NCT01233609|463446102|FG001|Overall Study|Lost to Follow-up|1|||
128769365|NCT01233609|463446101|FG000|Overall Study|Adverse Event|2|||
128769366|NCT01233609|463446102|FG001|Overall Study|Adverse Event|1|||
128769367|NCT01233609|463446101|FG000|Overall Study|Withdrawal by Subject|3|||
128769368|NCT01233609|463446102|FG001|Overall Study|Withdrawal by Subject|0|||
128769369|NCT02961374|463446103|FG000|Overall Study|Adverse Event|4|||
128769370|NCT00735644|463446104|FG000|Overall Study|Did not receive study vaccine|0|||
128769371|NCT00735644|463446105|FG001|Overall Study|Did not receive study vaccine|1|||
128769372|NCT00735644|463446106|FG002|Overall Study|Did not receive study vaccine|0|||
128769373|NCT00735644|463446107|FG003|Overall Study|Did not receive study vaccine|0|||
128769374|NCT00735644|463446108|FG004|Overall Study|Did not receive study vaccine|0|||
128769375|NCT00735644|463446104|FG000|Overall Study|Withdrawal by Subject|0|||
128769376|NCT00735644|463446105|FG001|Overall Study|Withdrawal by Subject|1|||
128769377|NCT00735644|463446106|FG002|Overall Study|Withdrawal by Subject|1|||
128769378|NCT00735644|463446107|FG003|Overall Study|Withdrawal by Subject|1|||
128769379|NCT00735644|463446108|FG004|Overall Study|Withdrawal by Subject|0|||
128769380|NCT01518946|463446117|FG000|Open-label Phase|Other|4|||
128769381|NCT01518946|463446118|FG001|Open-label Phase|Other|0|||
128769382|NCT01518946|463446119|FG002|Open-label Phase|Other|0|||
128769383|NCT01518946|463446117|FG000|Randomized Phase (First Intervention)|Other|0|||
128769384|NCT01518946|463446118|FG001|Randomized Phase (First Intervention)|Other|1|||
128769385|NCT01518946|463446119|FG002|Randomized Phase (First Intervention)|Other|0|||
128769386|NCT00384059|463446120|FG000|Infant Series|Not consented|2|||
128769387|NCT00384059|463446121|FG001|Infant Series|Not consented|6|||
128769388|NCT00384059|463446120|FG000|Infant Series|Withdrawal by Subject|2|||
128769389|NCT00384059|463446121|FG001|Infant Series|Withdrawal by Subject|2|||
128769390|NCT00384059|463446120|FG000|Infant Series|Adverse Event|1|||
128769391|NCT00384059|463446121|FG001|Infant Series|Adverse Event|2|||
128769392|NCT00384059|463446120|FG000|Infant Series|Protocol Violation|1|||
128769393|NCT00384059|463446121|FG001|Infant Series|Protocol Violation|2|||
128769394|NCT00384059|463446120|FG000|Infant Series|Lost to Follow-up|0|||
128769395|NCT00384059|463446121|FG001|Infant Series|Lost to Follow-up|1|||
128769396|NCT00384059|463446120|FG000|After Infant Series|Protocol Violation|2|||
128769397|NCT00384059|463446121|FG001|After Infant Series|Protocol Violation|3|||
128769398|NCT00384059|463446120|FG000|After Infant Series|Withdrawal by Subject|2|||
128769399|NCT00384059|463446121|FG001|After Infant Series|Withdrawal by Subject|2|||
128769400|NCT00384059|463446120|FG000|After Infant Series|Failed to Return|0|||
128769401|NCT00384059|463446121|FG001|After Infant Series|Failed to Return|2|||
128769402|NCT00384059|463446120|FG000|After Infant Series|Adverse Event|0|||
128769403|NCT00384059|463446121|FG001|After Infant Series|Adverse Event|1|||
128769404|NCT00384059|463446120|FG000|After Infant Series|Physician Decision|0|||
128769405|NCT00384059|463446121|FG001|After Infant Series|Physician Decision|1|||
128769406|NCT00384059|463446120|FG000|After Infant Series|Lost to Follow-up|0|||
128769407|NCT00384059|463446121|FG001|After Infant Series|Lost to Follow-up|1|||
128769408|NCT00384059|463446120|FG000|Toddler Dose|Lost to Follow-up|1|||
128769409|NCT00384059|463446121|FG001|Toddler Dose|Lost to Follow-up|1|||
128769410|NCT00384059|463446120|FG000|Toddler Dose|Failed to return|0|||
128769411|NCT00384059|463446121|FG001|Toddler Dose|Failed to return|1|||
128769412|NCT00235443|463448138|FG000|Overall Study|Adverse Event|4|||
128769413|NCT00235443|463448139|FG001|Overall Study|Adverse Event|12|||
128769414|NCT00235443|463448140|FG002|Overall Study|Adverse Event|17|||
128937643|NCT04760314|464060641|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937644|NCT04760314|464060642|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937645|NCT04760314|464060643|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937646|NCT04760314|464060644|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937647|NCT04760314|464060645|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937648|NCT04760314|464060646|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937649|NCT04760314|464060647|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937650|NCT04760314|464060648|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
128769415|NCT00235443|463448141|FG003|Overall Study|Adverse Event|44|||
128769416|NCT00235443|463448142|FG004|Overall Study|Adverse Event|10|||
128769417|NCT00235443|463448143|FG005|Overall Study|Adverse Event|15|||
128769418|NCT00235443|463448138|FG000|Overall Study|Lack of Efficacy|0|||
128769419|NCT00235443|463448139|FG001|Overall Study|Lack of Efficacy|1|||
128769420|NCT00235443|463448140|FG002|Overall Study|Lack of Efficacy|5|||
128769421|NCT00235443|463448141|FG003|Overall Study|Lack of Efficacy|12|||
128769422|NCT00235443|463448142|FG004|Overall Study|Lack of Efficacy|2|||
128937651|NCT04760314|464060649|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
128937652|NCT04760314|464060650|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
128769423|NCT00235443|463448143|FG005|Overall Study|Lack of Efficacy|9|||
128769424|NCT00235443|463448138|FG000|Overall Study|Withdrawal by Subject|3|||
129122722|NCT01186770|464744098|FG002|Overall Study|Other than specified|1|||
129122723|NCT01186770|464744099|FG003|Overall Study|Other than specified|2|||
129122724|NCT01033136|464744102|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
129122725|NCT01033136|464744103|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
128937653|NCT04760314|464060651|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
128937654|NCT02207530|464060653|FG000|Overall Study|Worsening condition under investigation|78|||
128937655|NCT02207530|464060653|FG000|Overall Study|Patient decision to stop study treatment|5|||
128937656|NCT02207530|464060653|FG000|Overall Study|Adverse Event|8|||
128937657|NCT01505491|464060660|FG000|Overall Study|Other reason not listed|1|||
128937658|NCT01505491|464060661|FG001|Overall Study|Other reason not listed|0|||
128937659|NCT01505491|464060662|FG002|Overall Study|Other reason not listed|0|||
128937660|NCT01505491|464060660|FG000|Overall Study|Withdrawal by Subject|1|||
129122726|NCT00630292|464744104|FG000|Overall Study|Withdrawal by Subject|1|||
128937661|NCT01505491|464060661|FG001|Overall Study|Withdrawal by Subject|1|||
128937662|NCT01505491|464060662|FG002|Overall Study|Withdrawal by Subject|4|||
128937663|NCT01505491|464060660|FG000|Overall Study|Lost to Follow-up|0|||
128937664|NCT01505491|464060661|FG001|Overall Study|Lost to Follow-up|0|||
128937665|NCT01505491|464060662|FG002|Overall Study|Lost to Follow-up|1|||
128937666|NCT00367640|464060671|FG000|Overall Study|Adverse Event|3|||
128937667|NCT00367640|464060672|FG001|Overall Study|Adverse Event|6|||
128937668|NCT00367640|464060673|FG002|Overall Study|Adverse Event|8|||
129122727|NCT04009837|464744109|FG000|Overall Study|Withdrawal by Subject|5|||
129122728|NCT04009837|464744110|FG001|Overall Study|Withdrawal by Subject|4|||
129122729|NCT04009837|464744109|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
129122730|NCT04009837|464744110|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
129122731|NCT03530696|464744113|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
129122732|NCT03530696|464744114|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
129122733|NCT02472353|464744115|FG000|Overall Study|Lost to Follow-up|1|||
129122734|NCT02472353|464744116|FG001|Overall Study|Lost to Follow-up|1|||
129122735|NCT02472353|464744115|FG000|Overall Study|Withdrawal by Subject|2|||
129122736|NCT02472353|464744116|FG001|Overall Study|Withdrawal by Subject|1|||
129122737|NCT02472353|464744115|FG000|Overall Study|Study Termination|1|||
129122738|NCT02472353|464744116|FG001|Overall Study|Study Termination|4|||
129122739|NCT03416179|464744117|FG000|Overall Study|Death|90|||
129122740|NCT03416179|464744118|FG001|Overall Study|Death|87|||
129122741|NCT03416179|464744119|FG002|Overall Study|Death|117|||
129122742|NCT03416179|464744120|FG003|Overall Study|Death|113|||
129122743|NCT03416179|464744117|FG000|Overall Study|Withdrawal by Subject|15|||
129122744|NCT03416179|464744118|FG001|Overall Study|Withdrawal by Subject|20|||
129122745|NCT03416179|464744119|FG002|Overall Study|Withdrawal by Subject|6|||
129122746|NCT03416179|464744120|FG003|Overall Study|Withdrawal by Subject|9|||
129122747|NCT03416179|464744117|FG000|Overall Study|Lost to Follow-up|1|||
129122748|NCT03416179|464744118|FG001|Overall Study|Lost to Follow-up|1|||
129122749|NCT03416179|464744119|FG002|Overall Study|Lost to Follow-up|0|||
129122750|NCT03416179|464744120|FG003|Overall Study|Lost to Follow-up|3|||
129122751|NCT03416179|464744117|FG000|Overall Study|Study participation terminated by Sponsor|93|||
129122752|NCT03416179|464744118|FG001|Overall Study|Study participation terminated by Sponsor|91|||
129122753|NCT03416179|464744119|FG002|Overall Study|Study participation terminated by Sponsor|26|||
129122754|NCT03416179|464744120|FG003|Overall Study|Study participation terminated by Sponsor|31|||
129122755|NCT03416179|464744117|FG000|Overall Study|Other|2|||
129122756|NCT03416179|464744118|FG001|Overall Study|Other|3|||
129122757|NCT03416179|464744119|FG002|Overall Study|Other|1|||
129122758|NCT03416179|464744120|FG003|Overall Study|Other|0|||
129122759|NCT02657551|464744138|FG000|Overall Study|Adverse Event|2|||
129122760|NCT02657551|464744138|FG000|Overall Study|Withdrawal by Subject|1|||
129122761|NCT02657551|464744138|FG000|Overall Study|Non-Compliance|1|||
129122762|NCT02657551|464744138|FG000|Overall Study|Progression / Relapse|4|||
129122763|NCT01035138|464744139|FG000|Overall Study|Adverse Event|4|||
129122764|NCT01035138|464744140|FG001|Overall Study|Adverse Event|0|||
129122765|NCT01035138|464744141|FG002|Overall Study|Adverse Event|2|||
129122766|NCT01035138|464744139|FG000|Overall Study|Caregiver Decision|2|||
129122767|NCT01035138|464744140|FG001|Overall Study|Caregiver Decision|0|||
129122768|NCT01035138|464744141|FG002|Overall Study|Caregiver Decision|1|||
129122769|NCT01035138|464744139|FG000|Overall Study|Withdrawal by Subject|1|||
129122770|NCT01035138|464744140|FG001|Overall Study|Withdrawal by Subject|0|||
129122771|NCT01035138|464744141|FG002|Overall Study|Withdrawal by Subject|0|||
129122772|NCT01035138|464744139|FG000|Overall Study|Physician Decision|0|||
129122773|NCT01035138|464744140|FG001|Overall Study|Physician Decision|0|||
129122774|NCT01035138|464744141|FG002|Overall Study|Physician Decision|1|||
129122775|NCT01035138|464744139|FG000|Overall Study|Sponsor Decision|66|||
129122776|NCT01035138|464744140|FG001|Overall Study|Sponsor Decision|60|||
129122777|NCT01035138|464744141|FG002|Overall Study|Sponsor Decision|42|||
129122778|NCT01035138|464744139|FG000|Overall Study|Lost to Follow-up|0|||
129122779|NCT01035138|464744140|FG001|Overall Study|Lost to Follow-up|0|||
129122780|NCT01035138|464744141|FG002|Overall Study|Lost to Follow-up|1|||
129122781|NCT02916927|464744142|FG000|Overall Study|Discharged prior to study drug receipt|0|||
128937669|NCT00367640|464060674|FG003|Overall Study|Adverse Event|0|||
128937670|NCT00367640|464060671|FG000|Overall Study|Withdrawal by Subject|8|||
128937671|NCT00367640|464060672|FG001|Overall Study|Withdrawal by Subject|11|||
128937672|NCT00367640|464060673|FG002|Overall Study|Withdrawal by Subject|8|||
128937673|NCT00367640|464060674|FG003|Overall Study|Withdrawal by Subject|6|||
128937674|NCT00367640|464060671|FG000|Overall Study|Any other reason not above-mentioned|7|||
128937675|NCT00367640|464060672|FG001|Overall Study|Any other reason not above-mentioned|5|||
128937676|NCT00367640|464060673|FG002|Overall Study|Any other reason not above-mentioned|3|||
128937677|NCT00367640|464060674|FG003|Overall Study|Any other reason not above-mentioned|4|||
128937678|NCT01312428|464060677|FG000|Overall Study|Study Termination|3|||
128937679|NCT01312428|464060678|FG001|Overall Study|Study Termination|4|||
128937680|NCT02214186|464060682|FG000|Overall Study|Lost to Follow-up|1|||
128937681|NCT02214186|464060683|FG001|Overall Study|Lost to Follow-up|1|||
128937682|NCT02214186|464060682|FG000|Overall Study|Protocol Violation|1|||
128937683|NCT02214186|464060683|FG001|Overall Study|Protocol Violation|1|||
128937684|NCT00339183|464060684|FG000|Overall Study|Adverse Event|5|||
128937685|NCT00339183|464060685|FG001|Overall Study|Adverse Event|3|||
128937686|NCT00339183|464060684|FG000|Overall Study|Withdrawal by Subject|16|||
128937687|NCT00339183|464060685|FG001|Overall Study|Withdrawal by Subject|19|||
128937688|NCT00339183|464060684|FG000|Overall Study|Physician Decision|2|||
128937689|NCT00339183|464060685|FG001|Overall Study|Physician Decision|4|||
128937690|NCT00339183|464060684|FG000|Overall Study|Lost to Follow-up|17|||
128937691|NCT00339183|464060685|FG001|Overall Study|Lost to Follow-up|17|||
128937692|NCT00339183|464060684|FG000|Overall Study|Protocol-specified criteria|12|||
128937693|NCT00339183|464060685|FG001|Overall Study|Protocol-specified criteria|8|||
128937694|NCT00339183|464060684|FG000|Overall Study|Missing reason|3|||
128937695|NCT00339183|464060685|FG001|Overall Study|Missing reason|1|||
128937696|NCT00339183|464060684|FG000|Overall Study|Other|46|||
128937697|NCT00339183|464060685|FG001|Overall Study|Other|40|||
128937698|NCT00339183|464060684|FG000|Overall Study|Ongoing|20|||
128937699|NCT00339183|464060685|FG001|Overall Study|Ongoing|13|||
128937700|NCT00611130|464060688|FG000|Overall Study|Lost to Follow-up|25|||
129217538|NCT02952820|465097001|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
129217539|NCT02952820|465096999|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
129217540|NCT02952820|465097000|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
129217541|NCT02952820|465097001|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
129217542|NCT02952820|465096999|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
129217543|NCT02952820|465097000|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
129217544|NCT02952820|465097001|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
129217545|NCT02952820|465096999|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
129217546|NCT02952820|465097000|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
129217547|NCT02952820|465097001|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
129217548|NCT02952820|465096999|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
128937701|NCT00611130|464060689|FG001|Overall Study|Lost to Follow-up|29|||
128937702|NCT00611130|464060688|FG000|Overall Study|Protocol noncompliance|7|||
128937703|NCT00611130|464060689|FG001|Overall Study|Protocol noncompliance|6|||
128937704|NCT00611130|464060688|FG000|Overall Study|Withdrawal by Subject|6|||
128937705|NCT00611130|464060689|FG001|Overall Study|Withdrawal by Subject|5|||
128937706|NCT00611130|464060688|FG000|Overall Study|Other|5|||
128937707|NCT00611130|464060689|FG001|Overall Study|Other|4|||
129217549|NCT02952820|465097000|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
129217550|NCT02952820|465097001|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
129217551|NCT02952820|465096999|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
129217552|NCT02952820|465097000|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
129217553|NCT02952820|465097001|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
129217554|NCT02952820|465096999|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
129217555|NCT02952820|465097000|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
128937708|NCT00611130|464060688|FG000|Overall Study|Incarceration|3|||
128937709|NCT00611130|464060689|FG001|Overall Study|Incarceration|2|||
128937710|NCT00611130|464060688|FG000|Overall Study|Administrative|1|||
128937711|NCT00611130|464060689|FG001|Overall Study|Administrative|1|||
128937712|NCT00611130|464060688|FG000|Overall Study|Adverse Event|1|||
128937713|NCT00611130|464060689|FG001|Overall Study|Adverse Event|0|||
129031701|NCT01726803|464406542|FG000|Overall Study|Withdrawal by Subject|1|||
129031702|NCT01726803|464406543|FG001|Overall Study|Withdrawal by Subject|0|||
129031703|NCT01320722|464406545|FG000|Overall Study|Did not Receive Intervention|3|||
129031704|NCT01320722|464406546|FG001|Overall Study|Did not Receive Intervention|2|||
129217556|NCT02952820|465097001|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
128937714|NCT00611130|464060688|FG000|Overall Study|Death|1|||
128937715|NCT00611130|464060689|FG001|Overall Study|Death|0|||
128937716|NCT03964415|464060691|FG000|Overall Study|Sponsor's decision|1563|||
128937717|NCT03964415|464060692|FG001|Overall Study|Sponsor's decision|1528|||
128937718|NCT03964415|464060691|FG000|Overall Study|Lost to Follow-up|139|||
129217557|NCT02952820|465096999|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
128937719|NCT03964415|464060692|FG001|Overall Study|Lost to Follow-up|146|||
128937720|NCT03964415|464060691|FG000|Overall Study|Withdrawal by Subject|68|||
128937721|NCT03964415|464060692|FG001|Overall Study|Withdrawal by Subject|72|||
128937722|NCT03964415|464060691|FG000|Overall Study|Physician Decision|34|||
128937723|NCT03964415|464060692|FG001|Overall Study|Physician Decision|48|||
128937724|NCT03964415|464060691|FG000|Overall Study|Adverse Event|3|||
128937725|NCT03964415|464060692|FG001|Overall Study|Adverse Event|0|||
128937726|NCT03964415|464060691|FG000|Overall Study|Death|4|||
128937727|NCT03964415|464060692|FG001|Overall Study|Death|6|||
128937728|NCT03964415|464060691|FG000|Overall Study|Protocol Violation|1|||
128769425|NCT00235443|463448139|FG001|Overall Study|Withdrawal by Subject|9|||
128769426|NCT00235443|463448140|FG002|Overall Study|Withdrawal by Subject|25|||
128769427|NCT00235443|463448141|FG003|Overall Study|Withdrawal by Subject|24|||
128769428|NCT00235443|463448142|FG004|Overall Study|Withdrawal by Subject|10|||
128769429|NCT00235443|463448143|FG005|Overall Study|Withdrawal by Subject|12|||
128769430|NCT00235443|463448138|FG000|Overall Study|Lost to Follow-up|0|||
128769431|NCT00235443|463448139|FG001|Overall Study|Lost to Follow-up|8|||
128769432|NCT00235443|463448140|FG002|Overall Study|Lost to Follow-up|6|||
128769433|NCT00235443|463448141|FG003|Overall Study|Lost to Follow-up|6|||
128769434|NCT00235443|463448142|FG004|Overall Study|Lost to Follow-up|4|||
128769435|NCT00235443|463448143|FG005|Overall Study|Lost to Follow-up|3|||
128769436|NCT00235443|463448138|FG000|Overall Study|Unsatisfactory compliance|0|||
128769437|NCT00235443|463448139|FG001|Overall Study|Unsatisfactory compliance|2|||
128769438|NCT00235443|463448140|FG002|Overall Study|Unsatisfactory compliance|3|||
128769439|NCT00235443|463448141|FG003|Overall Study|Unsatisfactory compliance|4|||
128769440|NCT00235443|463448142|FG004|Overall Study|Unsatisfactory compliance|1|||
128769441|NCT00235443|463448143|FG005|Overall Study|Unsatisfactory compliance|0|||
128769442|NCT00235443|463448138|FG000|Overall Study|Other reasons for premature termination|1|||
128769443|NCT00235443|463448139|FG001|Overall Study|Other reasons for premature termination|6|||
128769444|NCT00235443|463448140|FG002|Overall Study|Other reasons for premature termination|6|||
128769445|NCT00235443|463448141|FG003|Overall Study|Other reasons for premature termination|7|||
128769446|NCT00235443|463448142|FG004|Overall Study|Other reasons for premature termination|3|||
128769447|NCT00235443|463448143|FG005|Overall Study|Other reasons for premature termination|6|||
128769448|NCT03029247|463448144|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
128769449|NCT03029247|463448145|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
128769450|NCT03029247|463448144|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
128769451|NCT03029247|463448145|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
128769452|NCT03029247|463448144|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
128769453|NCT03029247|463448145|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
128769454|NCT03029247|463448144|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
128769455|NCT03029247|463448145|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
128769456|NCT01976364|463448148|FG000|Main Study (36 Months)|Adverse Event|63|||
128769457|NCT01976364|463448149|FG001|Main Study (36 Months)|Adverse Event|0|||
128769458|NCT01976364|463448150|FG002|Main Study (36 Months)|Adverse Event|0|||
128937729|NCT03964415|464060692|FG001|Overall Study|Protocol Violation|4|||
128937730|NCT03964415|464060691|FG000|Overall Study|Other|35|||
128937731|NCT03964415|464060692|FG001|Overall Study|Other|38|||
128937732|NCT03964415|464060691|FG000|Overall Study|Randomized but not treated|6|||
128937733|NCT03964415|464060692|FG001|Overall Study|Randomized but not treated|7|||
128937734|NCT01734993|464060693|FG000|Overall Study|Adverse Event|1|||
128937735|NCT01734993|464060693|FG000|Overall Study|Lack of Efficacy|1|||
128937736|NCT01455428|464060697|FG000|Overall Study|Protocol Violation|2|||
128769459|NCT01976364|463448148|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
128769460|NCT01976364|463448149|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
128769461|NCT01976364|463448150|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
128769462|NCT01976364|463448148|FG000|Main Study (36 Months)|Other|13|||
128769463|NCT01976364|463448149|FG001|Main Study (36 Months)|Other|0|||
128769464|NCT01976364|463448150|FG002|Main Study (36 Months)|Other|0|||
128769465|NCT01976364|463448148|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
128769466|NCT01976364|463448149|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
128937737|NCT01455428|464060698|FG001|Overall Study|Protocol Violation|1|||
128937738|NCT01455428|464060697|FG000|Overall Study|Adverse Event|6|||
128937739|NCT01455428|464060698|FG001|Overall Study|Adverse Event|2|||
128937740|NCT01455428|464060697|FG000|Overall Study|Lost to Follow-up|1|||
128937741|NCT01455428|464060698|FG001|Overall Study|Lost to Follow-up|1|||
128769467|NCT01976364|463448150|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
128769468|NCT01976364|463448148|FG000|Main Study (36 Months)|Medication error|1|||
128769469|NCT01976364|463448149|FG001|Main Study (36 Months)|Medication error|0|||
128937742|NCT01455428|464060697|FG000|Overall Study|Withdrawal by Subject|2|||
128937743|NCT01455428|464060698|FG001|Overall Study|Withdrawal by Subject|5|||
128769470|NCT01976364|463448150|FG002|Main Study (36 Months)|Medication error|0|||
128769471|NCT01976364|463448148|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
128937744|NCT01455428|464060697|FG000|Overall Study|Did not meet entrance criteria|0|||
128937745|NCT01455428|464060698|FG001|Overall Study|Did not meet entrance criteria|2|||
128769472|NCT01976364|463448149|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
128769473|NCT01976364|463448150|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
128769474|NCT01976364|463448148|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
128769475|NCT01976364|463448149|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
128769476|NCT01976364|463448150|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
128769477|NCT01976364|463448148|FG000|Main Study (36 Months)|Protocol Violation|13|||
128769478|NCT01976364|463448149|FG001|Main Study (36 Months)|Protocol Violation|0|||
128769479|NCT01976364|463448150|FG002|Main Study (36 Months)|Protocol Violation|0|||
128769480|NCT01976364|463448148|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
128769481|NCT01976364|463448149|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
128769482|NCT01976364|463448150|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
128769483|NCT01976364|463448148|FG000|Main Study (36 Months)|Death|5|||
128769484|NCT01976364|463448149|FG001|Main Study (36 Months)|Death|0|||
128769485|NCT01976364|463448150|FG002|Main Study (36 Months)|Death|0|||
128769486|NCT01976364|463448148|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
128769487|NCT01976364|463448149|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
128937746|NCT01455428|464060697|FG000|Overall Study|Insufficient clinical response|0|||
128937747|NCT01455428|464060698|FG001|Overall Study|Insufficient clinical response|2|||
128937748|NCT01455428|464060697|FG000|Overall Study|Did not receive treatment|1|||
128937749|NCT01455428|464060698|FG001|Overall Study|Did not receive treatment|1|||
128937750|NCT01455428|464060697|FG000|Overall Study|Other|2|||
128937751|NCT01455428|464060698|FG001|Overall Study|Other|4|||
128937752|NCT03303339|464060699|FG000|Overall Study|Death|2|||
128937753|NCT03303339|464060700|FG001|Overall Study|Death|2|||
128937754|NCT03303339|464060701|FG002|Overall Study|Death|2|||
128937755|NCT03303339|464060702|FG003|Overall Study|Death|1|||
128937756|NCT03303339|464060703|FG004|Overall Study|Death|4|||
128937757|NCT03303339|464060704|FG005|Overall Study|Death|2|||
128937758|NCT03303339|464060705|FG006|Overall Study|Death|2|||
128937759|NCT03303339|464060706|FG007|Overall Study|Death|2|||
128937760|NCT03303339|464060707|FG008|Overall Study|Death|3|||
128937761|NCT03303339|464060708|FG009|Overall Study|Death|3|||
128937762|NCT03303339|464060709|FG010|Overall Study|Death|4|||
128937763|NCT03303339|464060710|FG011|Overall Study|Death|24|||
128937764|NCT03303339|464060699|FG000|Overall Study|Study Terminated by Sponsor|0|||
128937765|NCT03303339|464060700|FG001|Overall Study|Study Terminated by Sponsor|0|||
128937766|NCT03303339|464060701|FG002|Overall Study|Study Terminated by Sponsor|0|||
128937767|NCT03303339|464060702|FG003|Overall Study|Study Terminated by Sponsor|0|||
128937768|NCT03303339|464060703|FG004|Overall Study|Study Terminated by Sponsor|0|||
128937769|NCT03303339|464060704|FG005|Overall Study|Study Terminated by Sponsor|0|||
128937770|NCT03303339|464060705|FG006|Overall Study|Study Terminated by Sponsor|0|||
128937771|NCT03303339|464060706|FG007|Overall Study|Study Terminated by Sponsor|0|||
128937772|NCT03303339|464060707|FG008|Overall Study|Study Terminated by Sponsor|1|||
128937773|NCT03303339|464060708|FG009|Overall Study|Study Terminated by Sponsor|0|||
128937774|NCT03303339|464060709|FG010|Overall Study|Study Terminated by Sponsor|1|||
128937775|NCT03303339|464060710|FG011|Overall Study|Study Terminated by Sponsor|1|||
128937776|NCT03303339|464060699|FG000|Overall Study|Withdrawal by Subject|1|||
129122782|NCT02916927|464744143|FG001|Overall Study|Discharged prior to study drug receipt|2|||
129122783|NCT02916927|464744142|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
129122784|NCT02916927|464744143|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
128937777|NCT03303339|464060700|FG001|Overall Study|Withdrawal by Subject|0|||
128937778|NCT03303339|464060701|FG002|Overall Study|Withdrawal by Subject|0|||
128937779|NCT03303339|464060702|FG003|Overall Study|Withdrawal by Subject|0|||
128937780|NCT03303339|464060703|FG004|Overall Study|Withdrawal by Subject|0|||
128937781|NCT03303339|464060704|FG005|Overall Study|Withdrawal by Subject|1|||
128937782|NCT03303339|464060705|FG006|Overall Study|Withdrawal by Subject|1|||
128937783|NCT03303339|464060706|FG007|Overall Study|Withdrawal by Subject|0|||
128937784|NCT03303339|464060707|FG008|Overall Study|Withdrawal by Subject|0|||
128937785|NCT03303339|464060708|FG009|Overall Study|Withdrawal by Subject|0|||
128937786|NCT03303339|464060709|FG010|Overall Study|Withdrawal by Subject|0|||
129122785|NCT02916927|464744142|FG000|Overall Study|Withdrawal before first time point|1|||
128937787|NCT03303339|464060710|FG011|Overall Study|Withdrawal by Subject|2|||
128937788|NCT03303339|464060699|FG000|Overall Study|Physician Decision|0|||
128937789|NCT03303339|464060700|FG001|Overall Study|Physician Decision|0|||
128937790|NCT03303339|464060701|FG002|Overall Study|Physician Decision|0|||
128937791|NCT03303339|464060702|FG003|Overall Study|Physician Decision|0|||
128937792|NCT03303339|464060703|FG004|Overall Study|Physician Decision|1|||
128937793|NCT03303339|464060704|FG005|Overall Study|Physician Decision|0|||
128937794|NCT03303339|464060705|FG006|Overall Study|Physician Decision|0|||
128769488|NCT01976364|463448150|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
128769489|NCT01976364|463448148|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
128769490|NCT01976364|463448149|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
128937795|NCT03303339|464060706|FG007|Overall Study|Physician Decision|0|||
128937796|NCT03303339|464060707|FG008|Overall Study|Physician Decision|0|||
128937797|NCT03303339|464060708|FG009|Overall Study|Physician Decision|0|||
128937798|NCT03303339|464060709|FG010|Overall Study|Physician Decision|0|||
128937799|NCT03303339|464060710|FG011|Overall Study|Physician Decision|0|||
128937800|NCT03303339|464060699|FG000|Overall Study|Safety/Non-compliance|0|||
128937801|NCT03303339|464060700|FG001|Overall Study|Safety/Non-compliance|0|||
128937802|NCT03303339|464060701|FG002|Overall Study|Safety/Non-compliance|0|||
128937803|NCT03303339|464060702|FG003|Overall Study|Safety/Non-compliance|0|||
128937804|NCT03303339|464060703|FG004|Overall Study|Safety/Non-compliance|0|||
128937805|NCT03303339|464060704|FG005|Overall Study|Safety/Non-compliance|0|||
128937806|NCT03303339|464060705|FG006|Overall Study|Safety/Non-compliance|0|||
128937807|NCT03303339|464060706|FG007|Overall Study|Safety/Non-compliance|0|||
129031705|NCT01320722|464406547|FG002|Overall Study|Did not Receive Intervention|1|||
129031706|NCT01320722|464406548|FG003|Overall Study|Did not Receive Intervention|1|||
129031707|NCT01320722|464406549|FG004|Overall Study|Did not Receive Intervention|2|||
129031708|NCT01320722|464406545|FG000|Overall Study|Lost to Follow-up|0|||
129031709|NCT01320722|464406546|FG001|Overall Study|Lost to Follow-up|1|||
129031710|NCT01320722|464406547|FG002|Overall Study|Lost to Follow-up|0|||
129031711|NCT01320722|464406548|FG003|Overall Study|Lost to Follow-up|1|||
129031712|NCT01320722|464406549|FG004|Overall Study|Lost to Follow-up|3|||
129031713|NCT01320722|464406545|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
129031714|NCT01320722|464406546|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
129031715|NCT01320722|464406547|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
129031716|NCT01320722|464406548|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
129031717|NCT01320722|464406549|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
129031718|NCT01320722|464406545|FG000|Overall Study|Participant Developed a Rash|0|||
129031719|NCT01320722|464406546|FG001|Overall Study|Participant Developed a Rash|0|||
129031720|NCT01320722|464406547|FG002|Overall Study|Participant Developed a Rash|2|||
129031721|NCT01320722|464406548|FG003|Overall Study|Participant Developed a Rash|1|||
129031722|NCT01320722|464406549|FG004|Overall Study|Participant Developed a Rash|1|||
129031723|NCT01320722|464406545|FG000|Overall Study|Non-compliant with Medication|0|||
129031724|NCT01320722|464406546|FG001|Overall Study|Non-compliant with Medication|0|||
129031725|NCT01320722|464406547|FG002|Overall Study|Non-compliant with Medication|1|||
129031726|NCT01320722|464406548|FG003|Overall Study|Non-compliant with Medication|0|||
129031727|NCT01320722|464406549|FG004|Overall Study|Non-compliant with Medication|0|||
129031728|NCT01320722|464406545|FG000|Overall Study|Adverse Event|0|||
129031729|NCT01320722|464406546|FG001|Overall Study|Adverse Event|0|||
129031730|NCT01320722|464406547|FG002|Overall Study|Adverse Event|3|||
129031731|NCT01320722|464406548|FG003|Overall Study|Adverse Event|6|||
129031732|NCT01320722|464406549|FG004|Overall Study|Adverse Event|0|||
129031733|NCT01320722|464406545|FG000|Overall Study|Not Compliant with Study Procedures|0|||
129031734|NCT01320722|464406546|FG001|Overall Study|Not Compliant with Study Procedures|0|||
129031735|NCT01320722|464406547|FG002|Overall Study|Not Compliant with Study Procedures|0|||
129031736|NCT01320722|464406548|FG003|Overall Study|Not Compliant with Study Procedures|4|||
129031737|NCT01320722|464406549|FG004|Overall Study|Not Compliant with Study Procedures|0|||
129031738|NCT01320722|464406545|FG000|Overall Study|Pregnancy|0|||
129031739|NCT01320722|464406546|FG001|Overall Study|Pregnancy|0|||
129031740|NCT01320722|464406547|FG002|Overall Study|Pregnancy|0|||
129031741|NCT01320722|464406548|FG003|Overall Study|Pregnancy|1|||
129031742|NCT01320722|464406549|FG004|Overall Study|Pregnancy|0|||
129031743|NCT01320722|464406545|FG000|Overall Study|Started an Exclusionary Medication|0|||
129031744|NCT01320722|464406546|FG001|Overall Study|Started an Exclusionary Medication|0|||
129031745|NCT01320722|464406547|FG002|Overall Study|Started an Exclusionary Medication|0|||
129031746|NCT01320722|464406548|FG003|Overall Study|Started an Exclusionary Medication|0|||
129031747|NCT01320722|464406549|FG004|Overall Study|Started an Exclusionary Medication|1|||
129031748|NCT01320722|464406545|FG000|Overall Study|Withdrew due to Health Condition|0|||
129031749|NCT01320722|464406546|FG001|Overall Study|Withdrew due to Health Condition|0|||
129031750|NCT01320722|464406547|FG002|Overall Study|Withdrew due to Health Condition|0|||
129031751|NCT01320722|464406548|FG003|Overall Study|Withdrew due to Health Condition|0|||
129031752|NCT01320722|464406549|FG004|Overall Study|Withdrew due to Health Condition|1|||
129031753|NCT02616380|464406562|FG000|Overall Study|Lost to Follow-up|1|||
129031754|NCT02616380|464406562|FG000|Overall Study|Other|2|||
129031755|NCT00057941|464406563|FG000|Overall Study|Death|1|||
129031756|NCT00057941|464406564|FG001|Overall Study|Death|2|||
129031757|NCT00057941|464406563|FG000|Overall Study|Adverse Event|7|||
129031758|NCT00057941|464406564|FG001|Overall Study|Adverse Event|9|||
129031759|NCT00057941|464406563|FG000|Overall Study|Lack of Efficacy|54|||
129031760|NCT00057941|464406564|FG001|Overall Study|Lack of Efficacy|53|||
129031761|NCT00057941|464406563|FG000|Overall Study|Withdrawal by Subject|6|||
129031762|NCT00057941|464406564|FG001|Overall Study|Withdrawal by Subject|1|||
129031763|NCT00057941|464406563|FG000|Overall Study|still on treatment|3|||
129031764|NCT00057941|464406564|FG001|Overall Study|still on treatment|1|||
129031765|NCT00057941|464406563|FG000|Overall Study|insurance, symptomatic deterioration|1|||
129031766|NCT00057941|464406564|FG001|Overall Study|insurance, symptomatic deterioration|3|||
129031767|NCT00057941|464406563|FG000|Overall Study|Ineligible|2|||
129031768|NCT00057941|464406564|FG001|Overall Study|Ineligible|5|||
129031769|NCT03407729|464406565|FG000|Overall Study|Lost to Follow-up|2|||
129122786|NCT02916927|464744143|FG001|Overall Study|Withdrawal before first time point|0|||
129122787|NCT00655889|464744144|FG000|Overall Study|Inadequate cell growth|1|||
129217558|NCT02952820|465097000|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
129217559|NCT02952820|465097001|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
129217560|NCT02952820|465096999|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
129217561|NCT02952820|465097000|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
129217562|NCT02952820|465097001|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
129217563|NCT02952820|465096999|FG000|Active Treatment Period (6 Months)|Not treated|0|||
129217564|NCT02952820|465097000|FG001|Active Treatment Period (6 Months)|Not treated|0|||
129217565|NCT02952820|465097001|FG002|Active Treatment Period (6 Months)|Not treated|1|||
129217566|NCT04139018|465097002|FG000|Overall Study|Screen fail|1|||
129217567|NCT04139018|465097003|FG001|Overall Study|Screen fail|0|||
129217568|NCT04139018|465097002|FG000|Overall Study|Withdrawal by Subject|2|||
129217569|NCT04139018|465097003|FG001|Overall Study|Withdrawal by Subject|0|||
129217570|NCT04139018|465097002|FG000|Overall Study|Lost to Follow-up|0|||
129217571|NCT04139018|465097003|FG001|Overall Study|Lost to Follow-up|1|||
129217572|NCT04476797|465097005|FG000|Overall Study|Withdrawal by Subject|1|||
129217573|NCT04476797|465097006|FG001|Overall Study|Withdrawal by Subject|0|||
129217574|NCT04476797|465097007|FG002|Overall Study|Withdrawal by Subject|0|||
129217575|NCT04476797|465097005|FG000|Overall Study|Death|0|||
129217576|NCT04476797|465097006|FG001|Overall Study|Death|1|||
129217577|NCT04476797|465097007|FG002|Overall Study|Death|2|||
129217578|NCT04476797|465097005|FG000|Overall Study|Sponsor Terminated Study|0|||
129217579|NCT04476797|465097006|FG001|Overall Study|Sponsor Terminated Study|18|||
129217580|NCT04476797|465097007|FG002|Overall Study|Sponsor Terminated Study|17|||
129217581|NCT03486834|465097008|FG000|Overall Study|Withdrawal by Subject|46|||
129217582|NCT03486834|465097009|FG001|Overall Study|Withdrawal by Subject|46|||
129217583|NCT03486834|465097010|FG002|Overall Study|Withdrawal by Subject|52|||
129217584|NCT03486834|465097008|FG000|Overall Study|Adverse Event|8|||
129217585|NCT03486834|465097009|FG001|Overall Study|Adverse Event|7|||
129217586|NCT03486834|465097010|FG002|Overall Study|Adverse Event|0|||
129217587|NCT03486834|465097008|FG000|Overall Study|Lost to Follow-up|41|||
129217588|NCT03486834|465097009|FG001|Overall Study|Lost to Follow-up|24|||
129217589|NCT03486834|465097010|FG002|Overall Study|Lost to Follow-up|39|||
129217590|NCT03486834|465097008|FG000|Overall Study|Non-compliance with Study Drug|2|||
129217591|NCT03486834|465097009|FG001|Overall Study|Non-compliance with Study Drug|2|||
129217592|NCT03486834|465097010|FG002|Overall Study|Non-compliance with Study Drug|0|||
129217593|NCT03486834|465097008|FG000|Overall Study|Physician Decision|5|||
129217594|NCT03486834|465097009|FG001|Overall Study|Physician Decision|2|||
129217595|NCT03486834|465097010|FG002|Overall Study|Physician Decision|3|||
129217596|NCT03486834|465097008|FG000|Overall Study|Pregnancy|10|||
129217597|NCT03486834|465097009|FG001|Overall Study|Pregnancy|12|||
129217598|NCT03486834|465097010|FG002|Overall Study|Pregnancy|12|||
129217599|NCT03486834|465097008|FG000|Overall Study|Protocol Deviation|2|||
129217600|NCT03486834|465097009|FG001|Overall Study|Protocol Deviation|3|||
129217601|NCT03486834|465097010|FG002|Overall Study|Protocol Deviation|3|||
129217602|NCT03486834|465097008|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129217603|NCT03486834|465097009|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129217604|NCT03486834|465097010|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129217605|NCT03486834|465097008|FG000|Overall Study|Randomized but not treated|4|||
129217606|NCT03486834|465097009|FG001|Overall Study|Randomized but not treated|4|||
129217607|NCT03486834|465097010|FG002|Overall Study|Randomized but not treated|1|||
129217608|NCT03614156|465097027|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
129217609|NCT03614156|465097028|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
129217610|NCT03614156|465097029|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
129217611|NCT03614156|465097030|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
129217612|NCT03614156|465097027|FG000|Open-Label Treatment Period|Adverse Event|7|||
129217613|NCT03614156|465097028|FG001|Open-Label Treatment Period|Adverse Event|0|||
129217614|NCT03614156|465097029|FG002|Open-Label Treatment Period|Adverse Event|0|||
129217615|NCT03614156|465097030|FG003|Open-Label Treatment Period|Adverse Event|0|||
129217616|NCT03614156|465097027|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
129217617|NCT03614156|465097028|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
129217618|NCT03614156|465097029|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129217619|NCT03614156|465097030|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
129217620|NCT03614156|465097027|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
129217621|NCT03614156|465097028|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
128937808|NCT03303339|464060707|FG008|Overall Study|Safety/Non-compliance|0|||
128937809|NCT03303339|464060708|FG009|Overall Study|Safety/Non-compliance|0|||
129217622|NCT03614156|465097029|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
129217623|NCT03614156|465097030|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
129217624|NCT03614156|465097027|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
129217625|NCT03614156|465097028|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
129217626|NCT03614156|465097029|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
129217627|NCT03614156|465097030|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
129217628|NCT03614156|465097027|FG000|Open-Label Treatment Period|Protocol Violation|2|||
128937810|NCT03303339|464060709|FG010|Overall Study|Safety/Non-compliance|0|||
128937811|NCT03303339|464060710|FG011|Overall Study|Safety/Non-compliance|1|||
128937812|NCT00751101|464060715|FG000|Overall Study|Withdrawal by Subject|1|||
128937813|NCT00751101|464060716|FG001|Overall Study|Withdrawal by Subject|0|||
128769491|NCT01976364|463448150|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
128769492|NCT01976364|463448148|FG000|Sub-study (12 Months)|Protocol Violation|0|||
128769493|NCT01976364|463448149|FG001|Sub-study (12 Months)|Protocol Violation|1|||
128769494|NCT01976364|463448150|FG002|Sub-study (12 Months)|Protocol Violation|1|||
128769495|NCT01976364|463448148|FG000|Sub-study (12 Months)|Adverse Event|0|||
128769496|NCT01976364|463448149|FG001|Sub-study (12 Months)|Adverse Event|4|||
128769497|NCT01976364|463448150|FG002|Sub-study (12 Months)|Adverse Event|3|||
128769498|NCT02757521|463448151|FG000|Overall Study|Adverse Event|1|||
128769499|NCT02757521|463448152|FG001|Overall Study|Adverse Event|0|||
128769500|NCT02318719|463448160|FG000|Double-blind Phase|Adverse Event|7|||
128769501|NCT02318719|463448161|FG001|Double-blind Phase|Adverse Event|6|||
128769502|NCT02318719|463448162|FG002|Double-blind Phase|Adverse Event|12|||
128937814|NCT00751101|464060715|FG000|Overall Study|No HFS / Never Started Patch/|0|||
128937815|NCT00751101|464060716|FG001|Overall Study|No HFS / Never Started Patch/|4|||
128937816|NCT00751101|464060715|FG000|Overall Study|Never began capecitabine|1|||
128937817|NCT00751101|464060716|FG001|Overall Study|Never began capecitabine|0|||
128937818|NCT00751101|464060715|FG000|Overall Study|Physician Decision|0|||
128769503|NCT02318719|463448163|FG003|Double-blind Phase|Adverse Event|4|||
128769504|NCT02318719|463448164|FG004|Double-blind Phase|Adverse Event|0|||
128769505|NCT02318719|463448160|FG000|Double-blind Phase|Lack of Efficacy|5|||
128769506|NCT02318719|463448161|FG001|Double-blind Phase|Lack of Efficacy|0|||
128769507|NCT02318719|463448162|FG002|Double-blind Phase|Lack of Efficacy|1|||
128769508|NCT02318719|463448163|FG003|Double-blind Phase|Lack of Efficacy|1|||
128769509|NCT02318719|463448164|FG004|Double-blind Phase|Lack of Efficacy|0|||
128769510|NCT02318719|463448160|FG000|Double-blind Phase|Protocol Violation|0|||
128769511|NCT02318719|463448161|FG001|Double-blind Phase|Protocol Violation|1|||
128769512|NCT02318719|463448162|FG002|Double-blind Phase|Protocol Violation|3|||
128769513|NCT02318719|463448163|FG003|Double-blind Phase|Protocol Violation|0|||
128769514|NCT02318719|463448164|FG004|Double-blind Phase|Protocol Violation|0|||
128769515|NCT02318719|463448160|FG000|Double-blind Phase|Withdrawal by Subject|25|||
128769516|NCT02318719|463448161|FG001|Double-blind Phase|Withdrawal by Subject|7|||
128769517|NCT02318719|463448162|FG002|Double-blind Phase|Withdrawal by Subject|9|||
128769518|NCT02318719|463448163|FG003|Double-blind Phase|Withdrawal by Subject|10|||
128769519|NCT02318719|463448164|FG004|Double-blind Phase|Withdrawal by Subject|0|||
128769520|NCT02318719|463448160|FG000|Double-blind Phase|Other|1|||
128769521|NCT02318719|463448161|FG001|Double-blind Phase|Other|2|||
128769522|NCT02318719|463448162|FG002|Double-blind Phase|Other|0|||
128769523|NCT02318719|463448163|FG003|Double-blind Phase|Other|0|||
128769524|NCT02318719|463448164|FG004|Double-blind Phase|Other|0|||
128769525|NCT02318719|463448160|FG000|Open-label Extension Phase|Adverse Event|0|||
128769526|NCT02318719|463448161|FG001|Open-label Extension Phase|Adverse Event|0|||
128769527|NCT02318719|463448162|FG002|Open-label Extension Phase|Adverse Event|0|||
128769528|NCT02318719|463448163|FG003|Open-label Extension Phase|Adverse Event|0|||
128769529|NCT02318719|463448164|FG004|Open-label Extension Phase|Adverse Event|15|||
128769530|NCT02318719|463448160|FG000|Open-label Extension Phase|Death|0|||
128769531|NCT02318719|463448161|FG001|Open-label Extension Phase|Death|0|||
128769532|NCT02318719|463448162|FG002|Open-label Extension Phase|Death|0|||
128937819|NCT00751101|464060716|FG001|Overall Study|Physician Decision|1|||
128937820|NCT01905397|464060717|FG000|Overall Study|Death|0|||
128937821|NCT01905397|464060718|FG001|Overall Study|Death|1|||
128937822|NCT01905397|464060717|FG000|Overall Study|Withdrawal by Subject|2|||
128937823|NCT01905397|464060718|FG001|Overall Study|Withdrawal by Subject|0|||
129031770|NCT03407729|464406566|FG001|Overall Study|Lost to Follow-up|0|||
129031771|NCT03407729|464406565|FG000|Overall Study|Unable to schedule|0|||
129031772|NCT03407729|464406566|FG001|Overall Study|Unable to schedule|3|||
129031773|NCT03950674|464406567|FG000|Overall Study|Death|16|||
128769533|NCT02318719|463448163|FG003|Open-label Extension Phase|Death|0|||
128769534|NCT02318719|463448164|FG004|Open-label Extension Phase|Death|1|||
128769535|NCT02318719|463448160|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
128937824|NCT01905397|464060717|FG000|Overall Study|Surgery canceled/aborted|9|||
129031774|NCT03950674|464406568|FG001|Overall Study|Death|15|||
129031775|NCT03950674|464406567|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
129031776|NCT03950674|464406568|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
129031777|NCT00830167|464406571|FG000|Overall Study|Lack of Efficacy|26|||
129031778|NCT00830167|464406572|FG001|Overall Study|Lack of Efficacy|10|||
129031779|NCT00830167|464406571|FG000|Overall Study|Adverse Event|8|||
129031780|NCT00830167|464406572|FG001|Overall Study|Adverse Event|24|||
129031781|NCT00830167|464406571|FG000|Overall Study|Not meeting entrance criteria|2|||
128937825|NCT01905397|464060718|FG001|Overall Study|Surgery canceled/aborted|5|||
129122788|NCT00655889|464744144|FG000|Overall Study|Protocol Violation|1|||
128769536|NCT02318719|463448161|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
128769537|NCT02318719|463448162|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
128769538|NCT02318719|463448163|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
129031782|NCT00830167|464406572|FG001|Overall Study|Not meeting entrance criteria|5|||
128769539|NCT02318719|463448164|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
128769540|NCT02318719|463448160|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
128769541|NCT02318719|463448161|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
128769542|NCT02318719|463448162|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
128769543|NCT02318719|463448163|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
128769544|NCT02318719|463448164|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
128769545|NCT02318719|463448160|FG000|Open-label Extension Phase|Other|0|||
128769546|NCT02318719|463448161|FG001|Open-label Extension Phase|Other|0|||
128769547|NCT02318719|463448162|FG002|Open-label Extension Phase|Other|0|||
128769548|NCT02318719|463448163|FG003|Open-label Extension Phase|Other|0|||
128769549|NCT02318719|463448164|FG004|Open-label Extension Phase|Other|7|||
128769550|NCT01868035|463448165|FG000|Overall Study|Lost to Follow-up|3|||
128769551|NCT01868035|463448165|FG000|Overall Study|Withdrawal by Subject|1|||
128769552|NCT01868035|463448165|FG000|Overall Study|Progressive Disease|2|||
128769553|NCT01868035|463448165|FG000|Overall Study|Non-compliance|1|||
128769554|NCT00432835|463448166|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
128769555|NCT00432835|463448167|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
128769556|NCT00423293|463448168|FG000|Overall Study|Ineligible / No protocol treatment|11|||
128769557|NCT01912222|463448169|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
128769558|NCT01912222|463448170|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
128769559|NCT01912222|463448171|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
128769560|NCT01912222|463448169|FG000|Part B: Treatment Period|Progressive disease|10|||
128769561|NCT01912222|463448170|FG001|Part B: Treatment Period|Progressive disease|12|||
128769562|NCT01912222|463448171|FG002|Part B: Treatment Period|Progressive disease|15|||
128769563|NCT01912222|463448169|FG000|Part B: Treatment Period|Adverse Event|1|||
128769564|NCT01912222|463448170|FG001|Part B: Treatment Period|Adverse Event|2|||
128769565|NCT01912222|463448171|FG002|Part B: Treatment Period|Adverse Event|3|||
128769566|NCT01912222|463448169|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
128769567|NCT01912222|463448170|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
128769568|NCT01912222|463448171|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
128769569|NCT01014975|463448172|FG000|Overall Study|Withdrawal by Subject|1|||
128769570|NCT01014975|463448173|FG001|Overall Study|Withdrawal by Subject|0|||
128769571|NCT01014975|463448174|FG002|Overall Study|Withdrawal by Subject|1|||
128769572|NCT01014975|463448172|FG000|Overall Study|Death|3|||
128769573|NCT01014975|463448173|FG001|Overall Study|Death|3|||
128769574|NCT01014975|463448174|FG002|Overall Study|Death|4|||
128769575|NCT01014975|463448172|FG000|Overall Study|Lost to Follow-up|0|||
128769576|NCT01014975|463448173|FG001|Overall Study|Lost to Follow-up|0|||
128769577|NCT01014975|463448174|FG002|Overall Study|Lost to Follow-up|1|||
128769578|NCT02961881|463448177|FG000|Overall Study|Adverse Event|1|||
128769579|NCT02961881|463448178|FG001|Overall Study|Adverse Event|2|||
128769580|NCT02961881|463448179|FG002|Overall Study|Adverse Event|2|||
128769581|NCT02961881|463448180|FG003|Overall Study|Adverse Event|0|||
128769582|NCT02961881|463448181|FG004|Overall Study|Adverse Event|1|||
128769583|NCT02961881|463448177|FG000|Overall Study|Participant request|0|||
128769584|NCT02961881|463448178|FG001|Overall Study|Participant request|2|||
128769585|NCT02961881|463448179|FG002|Overall Study|Participant request|0|||
128769586|NCT02961881|463448180|FG003|Overall Study|Participant request|0|||
128769587|NCT02961881|463448181|FG004|Overall Study|Participant request|0|||
128769588|NCT02961881|463448177|FG000|Overall Study|Disease progression|1|||
128769589|NCT02961881|463448178|FG001|Overall Study|Disease progression|0|||
128769590|NCT02961881|463448179|FG002|Overall Study|Disease progression|1|||
128769591|NCT02961881|463448180|FG003|Overall Study|Disease progression|0|||
128769592|NCT02961881|463448181|FG004|Overall Study|Disease progression|0|||
128769593|NCT01912781|463448182|FG000|Overall Study|Withdrawal by Subject|2|||
128769594|NCT01912781|463448183|FG001|Overall Study|Withdrawal by Subject|0|||
128769595|NCT00854295|463448186|FG000|Overall Study|Death|7|||
128769596|NCT00854295|463448187|FG001|Overall Study|Death|0|||
128769597|NCT00854295|463448188|FG002|Overall Study|Death|1|||
128769598|NCT00854295|463448189|FG003|Overall Study|Death|1|||
128769599|NCT00854295|463448186|FG000|Overall Study|Adverse Event|6|||
128769600|NCT00854295|463448187|FG001|Overall Study|Adverse Event|1|||
128769601|NCT00854295|463448188|FG002|Overall Study|Adverse Event|1|||
128769602|NCT00854295|463448189|FG003|Overall Study|Adverse Event|3|||
128769603|NCT00854295|463448186|FG000|Overall Study|Lost to Follow-up|18|||
128769604|NCT00854295|463448187|FG001|Overall Study|Lost to Follow-up|5|||
128769605|NCT00854295|463448188|FG002|Overall Study|Lost to Follow-up|21|||
129031783|NCT00830167|464406571|FG000|Overall Study|Withdrawal by Subject|2|||
129031784|NCT00830167|464406572|FG001|Overall Study|Withdrawal by Subject|0|||
129031785|NCT00830167|464406571|FG000|Overall Study|Lost to Follow-up|0|||
129031786|NCT00830167|464406572|FG001|Overall Study|Lost to Follow-up|1|||
129031787|NCT00830167|464406571|FG000|Overall Study|Protocol Violation|0|||
128769606|NCT00854295|463448189|FG003|Overall Study|Lost to Follow-up|21|||
128769607|NCT00854295|463448186|FG000|Overall Study|Physician Decision|10|||
128769608|NCT00854295|463448187|FG001|Overall Study|Physician Decision|0|||
128769609|NCT00854295|463448188|FG002|Overall Study|Physician Decision|0|||
129031788|NCT00830167|464406572|FG001|Overall Study|Protocol Violation|1|||
129031789|NCT00830167|464406571|FG000|Overall Study|Other|2|||
128937826|NCT01905397|464060717|FG000|Overall Study|Incision < 7 cm|2|||
128937827|NCT01905397|464060718|FG001|Overall Study|Incision < 7 cm|0|||
128937828|NCT01905397|464060717|FG000|Overall Study|Wrong treatment|1|||
128937829|NCT01905397|464060718|FG001|Overall Study|Wrong treatment|1|||
128937830|NCT01905397|464060717|FG000|Overall Study|Device not applied|3|||
128937831|NCT01905397|464060718|FG001|Overall Study|Device not applied|0|||
128937832|NCT01905397|464060717|FG000|Overall Study|Dressing not applied in operating room|1|||
128937833|NCT01905397|464060718|FG001|Overall Study|Dressing not applied in operating room|0|||
128937834|NCT01905397|464060717|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
128937835|NCT01905397|464060718|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
128937836|NCT01921270|464060722|FG000|Overall Study|Withdrawal by Subject|1|||
128937837|NCT00844428|464060723|FG000|Screening Period|Screen Failure|3|||
128937838|NCT00844428|464060723|FG000|Extension Treatment Period|Death|1|||
128937839|NCT00844428|464060723|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
129122789|NCT04585893|464744147|FG000|Overall Study|Death|1|||
128769610|NCT00854295|463448189|FG003|Overall Study|Physician Decision|0|||
128769611|NCT03154359|463448190|FG000|Overall Study|Adverse Event|1|||
128769612|NCT03154359|463448190|FG000|Overall Study|Lack of Efficacy|2|||
128937840|NCT00789477|464060724|FG000|Overall Study|Withdrawal by Subject|2|||
129122790|NCT04585893|464744148|FG001|Overall Study|Death|0|||
129122791|NCT01366092|464744149|FG000|Overall Study|Progressive cGVHD|2|||
129122792|NCT01366092|464744149|FG000|Overall Study|Physician Decision|1|||
129122793|NCT01366092|464744149|FG000|Overall Study|Withdrawal by Subject|1|||
129122794|NCT03608163|464744150|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
129122795|NCT03608163|464744151|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
129122796|NCT05399680|464745462|FG000|Overall Study|Lost to Follow-up|1|||
129122797|NCT05399680|464745463|FG001|Overall Study|Lost to Follow-up|0|||
129122798|NCT05399680|464745462|FG000|Overall Study|Death|0|||
129122799|NCT05399680|464745463|FG001|Overall Study|Death|1|||
129122800|NCT02659865|464745464|FG000|Period 1|Withdrawal by Subject|1|||
129122801|NCT02659865|464745465|FG001|Period 1|Withdrawal by Subject|0|||
129122802|NCT02659865|464745466|FG002|Period 1|Withdrawal by Subject|0|||
129122803|NCT02659865|464745467|FG003|Period 1|Withdrawal by Subject|0|||
129122804|NCT02659865|464745468|FG004|Period 1|Withdrawal by Subject|0|||
129122805|NCT02659865|464745464|FG000|Period 1|Adverse Event|0|||
129122806|NCT02659865|464745465|FG001|Period 1|Adverse Event|0|||
129122807|NCT02659865|464745466|FG002|Period 1|Adverse Event|0|||
129122808|NCT02659865|464745467|FG003|Period 1|Adverse Event|0|||
129122809|NCT02659865|464745468|FG004|Period 1|Adverse Event|1|||
129122810|NCT01288430|464745470|FG000|Part 1|Progressive disease|2|||
129122811|NCT01288430|464745471|FG001|Part 1|Progressive disease|1|||
129122812|NCT01288430|464745472|FG002|Part 1|Progressive disease|1|||
129122813|NCT01288430|464745473|FG003|Part 1|Progressive disease|6|||
129122814|NCT01288430|464745474|FG004|Part 1|Progressive disease|2|||
129122815|NCT01288430|464745475|FG005|Part 1|Progressive disease|4|||
129122816|NCT01288430|464745476|FG006|Part 1|Progressive disease|2|||
129122817|NCT01288430|464745477|FG007|Part 1|Progressive disease|0|||
129122818|NCT01288430|464745478|FG008|Part 1|Progressive disease|0|||
129122819|NCT01288430|464745479|FG009|Part 1|Progressive disease|0|||
129122820|NCT01288430|464745470|FG000|Part 1|Clinical disease progression|0|||
129122821|NCT01288430|464745471|FG001|Part 1|Clinical disease progression|0|||
129122822|NCT01288430|464745472|FG002|Part 1|Clinical disease progression|1|||
129122823|NCT01288430|464745473|FG003|Part 1|Clinical disease progression|0|||
129122824|NCT01288430|464745474|FG004|Part 1|Clinical disease progression|0|||
129122825|NCT01288430|464745475|FG005|Part 1|Clinical disease progression|2|||
129122826|NCT01288430|464745476|FG006|Part 1|Clinical disease progression|2|||
129122827|NCT01288430|464745477|FG007|Part 1|Clinical disease progression|0|||
129122828|NCT01288430|464745478|FG008|Part 1|Clinical disease progression|0|||
129122829|NCT01288430|464745479|FG009|Part 1|Clinical disease progression|0|||
129122830|NCT01288430|464745470|FG000|Part 1|Death due to disease progression|0|||
129122831|NCT01288430|464745471|FG001|Part 1|Death due to disease progression|0|||
129122832|NCT01288430|464745472|FG002|Part 1|Death due to disease progression|0|||
129122833|NCT01288430|464745473|FG003|Part 1|Death due to disease progression|0|||
129122834|NCT01288430|464745474|FG004|Part 1|Death due to disease progression|1|||
129122835|NCT01288430|464745475|FG005|Part 1|Death due to disease progression|0|||
129122836|NCT01288430|464745476|FG006|Part 1|Death due to disease progression|0|||
129122837|NCT01288430|464745477|FG007|Part 1|Death due to disease progression|0|||
129122838|NCT01288430|464745478|FG008|Part 1|Death due to disease progression|0|||
129122839|NCT01288430|464745479|FG009|Part 1|Death due to disease progression|0|||
129122840|NCT01288430|464745470|FG000|Part 1|Adverse Event|0|||
129122841|NCT01288430|464745471|FG001|Part 1|Adverse Event|0|||
129122842|NCT01288430|464745472|FG002|Part 1|Adverse Event|3|||
129122843|NCT01288430|464745473|FG003|Part 1|Adverse Event|1|||
129122844|NCT01288430|464745474|FG004|Part 1|Adverse Event|0|||
129122845|NCT01288430|464745475|FG005|Part 1|Adverse Event|0|||
129122846|NCT01288430|464745476|FG006|Part 1|Adverse Event|2|||
129122847|NCT01288430|464745477|FG007|Part 1|Adverse Event|0|||
129122848|NCT01288430|464745478|FG008|Part 1|Adverse Event|0|||
129122849|NCT01288430|464745479|FG009|Part 1|Adverse Event|0|||
129122850|NCT01288430|464745470|FG000|Part 1|Other|0|||
129122851|NCT01288430|464745471|FG001|Part 1|Other|2|||
129122852|NCT01288430|464745472|FG002|Part 1|Other|0|||
129122853|NCT01288430|464745473|FG003|Part 1|Other|0|||
128769613|NCT03154359|463448190|FG000|Overall Study|Lost to Follow-up|3|||
128769614|NCT03154359|463448190|FG000|Overall Study|Physician Decision|3|||
128769615|NCT03154359|463448190|FG000|Overall Study|Protocol Violation|4|||
128769616|NCT03154359|463448190|FG000|Overall Study|Withdrawal by Subject|5|||
128769617|NCT03154359|463448190|FG000|Overall Study|Disruption of study due to COVID-19|4|||
128769618|NCT04250337|463448191|FG000|Overall Study|Adverse Event|0|||
128769619|NCT04250337|463448192|FG001|Overall Study|Adverse Event|3|||
128769620|NCT04250337|463448191|FG000|Overall Study|Lack of Efficacy|1|||
128769621|NCT04250337|463448192|FG001|Overall Study|Lack of Efficacy|3|||
128769622|NCT04250337|463448191|FG000|Overall Study|Physician Decision|1|||
128769623|NCT04250337|463448192|FG001|Overall Study|Physician Decision|0|||
128769624|NCT04250337|463448191|FG000|Overall Study|Protocol Deviation|2|||
128769625|NCT04250337|463448192|FG001|Overall Study|Protocol Deviation|2|||
128769626|NCT04250337|463448191|FG000|Overall Study|Withdrawal by Subject|4|||
128769627|NCT04250337|463448192|FG001|Overall Study|Withdrawal by Subject|3|||
128769628|NCT05033743|463448198|FG000|Overall Study|Lost to Follow-up|1|||
128769629|NCT05033743|463448198|FG000|Overall Study|Protocol Violation|2|||
128769630|NCT05033743|463448198|FG000|Overall Study|Withdrawal by Subject|1|||
128769631|NCT03321006|463448199|FG000|Overall Study|Death|1|||
128769632|NCT03321006|463448200|FG001|Overall Study|Death|0|||
128769633|NCT03321006|463448199|FG000|Overall Study|Lack of Efficacy|1|||
128769634|NCT03321006|463448200|FG001|Overall Study|Lack of Efficacy|0|||
128769635|NCT00365378|463448201|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
128769636|NCT00365378|463448202|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
128769637|NCT00365378|463448203|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
128769638|NCT00365378|463448201|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
128769639|NCT00365378|463448202|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
128769640|NCT00365378|463448203|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
128769641|NCT00365378|463448201|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
128769642|NCT00365378|463448202|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
128769643|NCT00365378|463448203|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
128769644|NCT00365378|463448201|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
128769645|NCT00365378|463448202|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
128769646|NCT00365378|463448203|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
128769647|NCT00365378|463448201|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
128769648|NCT00365378|463448202|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
128769649|NCT00365378|463448203|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
128769650|NCT00365378|463448201|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
128769651|NCT00365378|463448202|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
128769652|NCT00365378|463448203|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
128769653|NCT00365378|463448201|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
128769654|NCT00365378|463448202|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
128769655|NCT00365378|463448203|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
128769656|NCT00365378|463448201|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
128769657|NCT00365378|463448202|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
128769658|NCT00365378|463448203|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
128769659|NCT00365378|463448201|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
128769660|NCT00365378|463448202|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
128769661|NCT00365378|463448203|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
128769662|NCT00365378|463448201|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
128769663|NCT00365378|463448202|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
128769664|NCT00365378|463448203|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
128769665|NCT00365378|463448201|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
128937841|NCT00789477|464060725|FG001|Overall Study|Withdrawal by Subject|1|||
128937842|NCT00789477|464060726|FG002|Overall Study|Withdrawal by Subject|3|||
128937843|NCT00789477|464060727|FG003|Overall Study|Withdrawal by Subject|2|||
129122854|NCT01288430|464745474|FG004|Part 1|Other|0|||
129122855|NCT01288430|464745475|FG005|Part 1|Other|0|||
128769666|NCT00365378|463448202|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
128937844|NCT00789477|464060728|FG004|Overall Study|Withdrawal by Subject|3|||
128769667|NCT00365378|463448203|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
128769668|NCT00365378|463448201|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
128769669|NCT00365378|463448202|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
128769670|NCT00365378|463448203|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
128769671|NCT00365378|463448201|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
128769672|NCT00365378|463448202|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
128769673|NCT00365378|463448203|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
128769674|NCT00365378|463448201|FG000|Extension|Adverse Event|0|||
128769675|NCT00365378|463448202|FG001|Extension|Adverse Event|0|||
128769676|NCT00365378|463448203|FG002|Extension|Adverse Event|1|||
128937845|NCT00789477|464060724|FG000|Overall Study|Protocol Violation|1|||
129122856|NCT01288430|464745476|FG006|Part 1|Other|1|||
128769677|NCT00365378|463448201|FG000|Extension|Moved|0|||
128937846|NCT00789477|464060725|FG001|Overall Study|Protocol Violation|0|||
128937847|NCT00789477|464060726|FG002|Overall Study|Protocol Violation|0|||
128937848|NCT00789477|464060727|FG003|Overall Study|Protocol Violation|1|||
128937849|NCT00789477|464060728|FG004|Overall Study|Protocol Violation|0|||
128937850|NCT00789477|464060724|FG000|Overall Study|Adverse Event|3|||
128937851|NCT00789477|464060725|FG001|Overall Study|Adverse Event|3|||
128937852|NCT00789477|464060726|FG002|Overall Study|Adverse Event|1|||
128937853|NCT00789477|464060727|FG003|Overall Study|Adverse Event|0|||
128937854|NCT00789477|464060728|FG004|Overall Study|Adverse Event|0|||
128937855|NCT00789477|464060724|FG000|Overall Study|Death|1|||
128937856|NCT00789477|464060725|FG001|Overall Study|Death|1|||
128937857|NCT00789477|464060726|FG002|Overall Study|Death|2|||
128937858|NCT00789477|464060727|FG003|Overall Study|Death|2|||
128937859|NCT00789477|464060728|FG004|Overall Study|Death|0|||
128937860|NCT00789477|464060724|FG000|Overall Study|Lost to Follow-up|0|||
128937861|NCT00789477|464060725|FG001|Overall Study|Lost to Follow-up|1|||
128937862|NCT00789477|464060726|FG002|Overall Study|Lost to Follow-up|4|||
128937863|NCT00789477|464060727|FG003|Overall Study|Lost to Follow-up|2|||
128937864|NCT00789477|464060728|FG004|Overall Study|Lost to Follow-up|4|||
128937865|NCT00789477|464060724|FG000|Overall Study|Lack of Efficacy|2|||
128937866|NCT00789477|464060725|FG001|Overall Study|Lack of Efficacy|0|||
128937867|NCT00789477|464060726|FG002|Overall Study|Lack of Efficacy|0|||
129122857|NCT01288430|464745477|FG007|Part 1|Other|0|||
129122858|NCT01288430|464745478|FG008|Part 1|Other|0|||
129122859|NCT01288430|464745479|FG009|Part 1|Other|0|||
129122860|NCT01288430|464745470|FG000|Part 2|Progressive disease|0|||
129122861|NCT01288430|464745471|FG001|Part 2|Progressive disease|0|||
129122862|NCT01288430|464745472|FG002|Part 2|Progressive disease|0|||
129122863|NCT01288430|464745473|FG003|Part 2|Progressive disease|0|||
129122864|NCT01288430|464745474|FG004|Part 2|Progressive disease|0|||
129122865|NCT01288430|464745475|FG005|Part 2|Progressive disease|0|||
129122866|NCT01288430|464745476|FG006|Part 2|Progressive disease|0|||
129217629|NCT03614156|465097028|FG001|Open-Label Treatment Period|Protocol Violation|0|||
128937868|NCT00789477|464060727|FG003|Overall Study|Lack of Efficacy|0|||
128937869|NCT00789477|464060728|FG004|Overall Study|Lack of Efficacy|0|||
128937870|NCT00789477|464060724|FG000|Overall Study|Other|2|||
128937871|NCT00789477|464060725|FG001|Overall Study|Other|0|||
128937872|NCT00789477|464060726|FG002|Overall Study|Other|1|||
128937873|NCT00789477|464060727|FG003|Overall Study|Other|3|||
128937874|NCT00789477|464060728|FG004|Overall Study|Other|0|||
128937875|NCT00455858|464060729|FG000|Overall Study|Lost to Follow-up|2|||
129122867|NCT01288430|464745477|FG007|Part 2|Progressive disease|8|||
129122868|NCT01288430|464745478|FG008|Part 2|Progressive disease|7|||
129217630|NCT03614156|465097029|FG002|Open-Label Treatment Period|Protocol Violation|0|||
129217631|NCT03614156|465097030|FG003|Open-Label Treatment Period|Protocol Violation|0|||
129217632|NCT03614156|465097027|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
129217633|NCT03614156|465097028|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
129217634|NCT03614156|465097029|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
129217635|NCT03614156|465097030|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
129217636|NCT03614156|465097027|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
129217637|NCT03614156|465097028|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
129217638|NCT03614156|465097029|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
129217639|NCT03614156|465097030|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
129217640|NCT03614156|465097027|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
129217641|NCT03614156|465097028|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
129217642|NCT03614156|465097029|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
129217643|NCT03614156|465097030|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
129217644|NCT03614156|465097027|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129217645|NCT03614156|465097028|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
128769678|NCT00365378|463448202|FG001|Extension|Moved|0|||
128769679|NCT00365378|463448203|FG002|Extension|Moved|8|||
128769680|NCT00365378|463448201|FG000|Extension|Lost to Follow-up|0|||
128769681|NCT00365378|463448202|FG001|Extension|Lost to Follow-up|0|||
129122869|NCT01288430|464745479|FG009|Part 2|Progressive disease|2|||
128769682|NCT00365378|463448203|FG002|Extension|Lost to Follow-up|57|||
129122870|NCT01288430|464745470|FG000|Part 2|Clinical disease progression|0|||
129122871|NCT01288430|464745471|FG001|Part 2|Clinical disease progression|0|||
128937876|NCT00455858|464060729|FG000|Overall Study|Protocol Violation|1|||
128937877|NCT00455858|464060729|FG000|Overall Study|Lack of Efficacy|1|||
128937878|NCT00455858|464060729|FG000|Overall Study|Well controlled FPG without insulin|1|||
128937879|NCT00455858|464060729|FG000|Overall Study|Withdrawal|1|||
128937880|NCT02092389|464060731|FG000|Overall Study|Adverse Event|1|||
128937881|NCT02092389|464060731|FG000|Overall Study|Other|5|||
128937882|NCT01242020|464060732|FG000|Overall Study|Withdrawal by Subject|2|||
128937883|NCT01242020|464060733|FG001|Overall Study|Withdrawal by Subject|0|||
129122872|NCT01288430|464745472|FG002|Part 2|Clinical disease progression|0|||
129122873|NCT01288430|464745473|FG003|Part 2|Clinical disease progression|0|||
129122874|NCT01288430|464745474|FG004|Part 2|Clinical disease progression|0|||
129122875|NCT01288430|464745475|FG005|Part 2|Clinical disease progression|0|||
129217646|NCT03614156|465097029|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129217647|NCT03614156|465097030|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129217648|NCT03614156|465097027|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129217649|NCT03614156|465097028|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129217650|NCT03614156|465097029|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
129217651|NCT03614156|465097030|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
129217652|NCT03614156|465097027|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
129217653|NCT03614156|465097028|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
129217654|NCT03614156|465097029|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
129217655|NCT03614156|465097030|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
129217656|NCT03614156|465097027|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
129217657|NCT03614156|465097028|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
129217658|NCT03614156|465097029|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
129217659|NCT03614156|465097030|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
129217660|NCT03614156|465097027|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
129217661|NCT03614156|465097028|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
129217662|NCT03614156|465097029|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
129217663|NCT03614156|465097030|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
129217664|NCT03614156|465097027|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
129217665|NCT03614156|465097028|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
129217666|NCT03614156|465097029|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
129217667|NCT03614156|465097030|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
129217668|NCT03614156|465097027|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
129217669|NCT03614156|465097028|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
129217670|NCT03614156|465097029|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
129217671|NCT03614156|465097030|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
129217672|NCT03614156|465097027|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
129217673|NCT03614156|465097028|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
129217674|NCT03614156|465097029|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
129217675|NCT03614156|465097030|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
129217676|NCT04287517|465097035|FG000|Overall Study|Withdrawal by Subject|1|||
129217677|NCT04287517|465097036|FG001|Overall Study|Withdrawal by Subject|1|||
129122876|NCT01288430|464745476|FG006|Part 2|Clinical disease progression|0|||
129122877|NCT01288430|464745477|FG007|Part 2|Clinical disease progression|2|||
129122878|NCT01288430|464745478|FG008|Part 2|Clinical disease progression|0|||
129122879|NCT01288430|464745479|FG009|Part 2|Clinical disease progression|0|||
129122880|NCT01288430|464745470|FG000|Part 2|Withdrawal by Subject|0|||
129122881|NCT01288430|464745471|FG001|Part 2|Withdrawal by Subject|0|||
129122882|NCT01288430|464745472|FG002|Part 2|Withdrawal by Subject|0|||
129122883|NCT01288430|464745473|FG003|Part 2|Withdrawal by Subject|0|||
129122884|NCT01288430|464745474|FG004|Part 2|Withdrawal by Subject|0|||
129122885|NCT01288430|464745475|FG005|Part 2|Withdrawal by Subject|0|||
129122886|NCT01288430|464745476|FG006|Part 2|Withdrawal by Subject|0|||
129122887|NCT01288430|464745477|FG007|Part 2|Withdrawal by Subject|1|||
129122888|NCT01288430|464745478|FG008|Part 2|Withdrawal by Subject|4|||
129122889|NCT01288430|464745479|FG009|Part 2|Withdrawal by Subject|0|||
129122890|NCT01288430|464745470|FG000|Part 2|Adverse Event|0|||
129122891|NCT01288430|464745471|FG001|Part 2|Adverse Event|0|||
129122892|NCT01288430|464745472|FG002|Part 2|Adverse Event|0|||
129122893|NCT01288430|464745473|FG003|Part 2|Adverse Event|0|||
129122894|NCT01288430|464745474|FG004|Part 2|Adverse Event|0|||
129122895|NCT01288430|464745475|FG005|Part 2|Adverse Event|0|||
129122896|NCT01288430|464745476|FG006|Part 2|Adverse Event|0|||
129122897|NCT01288430|464745477|FG007|Part 2|Adverse Event|1|||
129122898|NCT01288430|464745478|FG008|Part 2|Adverse Event|1|||
129122899|NCT01288430|464745479|FG009|Part 2|Adverse Event|0|||
129122900|NCT01288430|464745470|FG000|Part 2|Other|0|||
129122901|NCT01288430|464745471|FG001|Part 2|Other|0|||
129122902|NCT01288430|464745472|FG002|Part 2|Other|0|||
129122903|NCT01288430|464745473|FG003|Part 2|Other|0|||
129122904|NCT01288430|464745474|FG004|Part 2|Other|0|||
129122905|NCT01288430|464745475|FG005|Part 2|Other|0|||
129122906|NCT01288430|464745476|FG006|Part 2|Other|0|||
129122907|NCT01288430|464745477|FG007|Part 2|Other|0|||
129122908|NCT01288430|464745478|FG008|Part 2|Other|0|||
129122909|NCT01288430|464745479|FG009|Part 2|Other|1|||
129122910|NCT03836053|464745485|FG000|Overall Study|Protocol-specified criteria|0|||
129122911|NCT03836053|464745486|FG001|Overall Study|Protocol-specified criteria|2|||
129122912|NCT03836053|464745487|FG002|Overall Study|Protocol-specified criteria|1|||
129122913|NCT03836053|464745485|FG000|Overall Study|Death|1|||
129122914|NCT03836053|464745486|FG001|Overall Study|Death|6|||
129122915|NCT03836053|464745487|FG002|Overall Study|Death|4|||
129122916|NCT03836053|464745485|FG000|Overall Study|Withdrawal of consent from study|0|||
129122917|NCT03836053|464745486|FG001|Overall Study|Withdrawal of consent from study|0|||
129122918|NCT03836053|464745487|FG002|Overall Study|Withdrawal of consent from study|1|||
129122919|NCT03836053|464745485|FG000|Overall Study|Decision by sponsor|0|||
129122920|NCT03836053|464745486|FG001|Overall Study|Decision by sponsor|2|||
129122921|NCT03836053|464745487|FG002|Overall Study|Decision by sponsor|4|||
129122922|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
129122923|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
129122924|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
129122925|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Death|1|||
129122926|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Death|1|||
129122927|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Death|0|||
129122928|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
129122929|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
129122930|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
129122931|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
129122932|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
129122933|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
129122934|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
129122935|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
129122936|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
129122937|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
129122938|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
129122939|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
129122940|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
129122941|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
129122942|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
129122943|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
129122944|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
129122945|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
129122946|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
129122947|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
129122948|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
129122949|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
129122950|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
129122951|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
129122952|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Other|10|||
129122953|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Other|4|||
129122954|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Other|0|||
129122955|NCT04006457|464745488|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
129122956|NCT04006457|464745489|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
129122957|NCT04006457|464745490|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
129122958|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
129217678|NCT03070964|465097037|FG000|Overall Study|Progressive disease|8|||
129217679|NCT03070964|465097037|FG000|Overall Study|Treatment-unrelated adverse event|2|||
129217680|NCT03070964|465097037|FG000|Overall Study|Never treated|1|||
129217681|NCT03070964|465097037|FG000|Overall Study|Physician Decision|1|||
129217682|NCT03070964|465097037|FG000|Overall Study|Withdrawal by Subject|1|||
129217683|NCT03070964|465097037|FG000|Overall Study|Adverse Event|1|||
129217684|NCT01094119|465097038|FG000|Overall Study|Lack of Efficacy|2|||
129217685|NCT01094119|465097039|FG001|Overall Study|Lack of Efficacy|4|||
129217686|NCT00834093|465097042|FG000|Overall Study|Progressive Disease|3|||
129217687|NCT00834093|465097042|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
129217688|NCT02745119|465097043|FG000|Overall Study|Adverse Event|1|||
129217689|NCT02745119|465097044|FG001|Overall Study|Adverse Event|0|||
128706965|NCT02430311|463222110|FG001|Part B|Adverse Event|0|||
128706966|NCT02430311|463222109|FG000|Part B|Death|1|||
128706967|NCT02430311|463222110|FG001|Part B|Death|0|||
128706968|NCT01342796|463222114|FG000|Overall Study|Withdrawal by Subject|2|||
128706969|NCT01342796|463222115|FG001|Overall Study|Withdrawal by Subject|0|||
128706970|NCT01342796|463222114|FG000|Overall Study|Lost to Follow-up|0|||
128706971|NCT01342796|463222115|FG001|Overall Study|Lost to Follow-up|3|||
128706972|NCT01342796|463222114|FG000|Overall Study|Inappropriate enrollment|1|||
128706973|NCT01342796|463222115|FG001|Overall Study|Inappropriate enrollment|0|||
128706974|NCT01599234|463222116|FG000|Overall Study|Adverse Event|9|||
128706975|NCT01599234|463222117|FG001|Overall Study|Adverse Event|5|||
129122959|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
129122960|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
129122961|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
128706976|NCT01599234|463222116|FG000|Overall Study|Withdrawal by Subject|2|||
128706977|NCT01599234|463222117|FG001|Overall Study|Withdrawal by Subject|1|||
128706978|NCT01599234|463222116|FG000|Overall Study|Lost to Follow-up|1|||
128706979|NCT01599234|463222117|FG001|Overall Study|Lost to Follow-up|2|||
128706980|NCT01599234|463222116|FG000|Overall Study|Lack of Efficacy|2|||
128706981|NCT01599234|463222117|FG001|Overall Study|Lack of Efficacy|4|||
128706982|NCT01599234|463222116|FG000|Overall Study|Unable to operate spray|1|||
128706983|NCT01599234|463222117|FG001|Overall Study|Unable to operate spray|0|||
128706984|NCT01599234|463222116|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
128706985|NCT01599234|463222117|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
128706986|NCT01599234|463222116|FG000|Overall Study|Death|1|||
128706987|NCT01599234|463222117|FG001|Overall Study|Death|0|||
128706988|NCT01599234|463222116|FG000|Overall Study|Patient would not stop driving|1|||
128706989|NCT01599234|463222117|FG001|Overall Study|Patient would not stop driving|0|||
128706990|NCT01599234|463222116|FG000|Overall Study|Contra-indication discovered|0|||
128706991|NCT01599234|463222117|FG001|Overall Study|Contra-indication discovered|1|||
128706992|NCT01599234|463222116|FG000|Overall Study|Pregnancy|0|||
128706993|NCT01599234|463222117|FG001|Overall Study|Pregnancy|1|||
128706994|NCT02899988|463222127|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
128706995|NCT02899988|463222128|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
128706996|NCT02899988|463222129|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128706997|NCT02899988|463222130|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128706998|NCT02899988|463222131|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128706999|NCT02899988|463222132|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128707000|NCT02899988|463222133|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128707001|NCT02899988|463222134|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128707002|NCT02899988|463222135|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128707003|NCT02899988|463222136|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128707004|NCT02899988|463222137|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128707005|NCT02899988|463222127|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
128707006|NCT02899988|463222128|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
128707007|NCT02899988|463222129|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
128707008|NCT02899988|463222130|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
128707009|NCT02899988|463222131|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
128707010|NCT02899988|463222132|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
128707011|NCT02899988|463222133|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
128707012|NCT02899988|463222134|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
128707013|NCT02899988|463222135|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
128707014|NCT02899988|463222136|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
128707015|NCT02899988|463222137|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
128707016|NCT02899988|463222127|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
128707017|NCT02899988|463222128|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
128707018|NCT02899988|463222129|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
129031790|NCT00830167|464406572|FG001|Overall Study|Other|2|||
129031791|NCT00860262|464406575|FG000|Overall Study|Adverse Event|9|||
129031792|NCT00860262|464406576|FG001|Overall Study|Adverse Event|6|||
129031793|NCT00860262|464406577|FG002|Overall Study|Adverse Event|7|||
129031794|NCT00860262|464406575|FG000|Overall Study|Protocol Violation|0|||
129031795|NCT00860262|464406576|FG001|Overall Study|Protocol Violation|1|||
129031796|NCT00860262|464406577|FG002|Overall Study|Protocol Violation|0|||
129031797|NCT00860262|464406575|FG000|Overall Study|Lost to Follow-up|2|||
129031798|NCT00860262|464406576|FG001|Overall Study|Lost to Follow-up|0|||
129122962|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
128707019|NCT02899988|463222130|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
128707020|NCT02899988|463222131|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
128707021|NCT02899988|463222132|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
128707022|NCT02899988|463222133|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
128707023|NCT02899988|463222134|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
128707024|NCT02899988|463222135|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
128707025|NCT02899988|463222136|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
128707026|NCT02899988|463222137|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
128707027|NCT02899988|463222127|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
128707028|NCT02899988|463222128|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
128707029|NCT02899988|463222129|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
128707030|NCT02899988|463222130|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
128707031|NCT02899988|463222131|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
128707032|NCT02899988|463222132|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
128707033|NCT02899988|463222133|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
129122963|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
129031799|NCT00860262|464406577|FG002|Overall Study|Lost to Follow-up|1|||
129031800|NCT00860262|464406575|FG000|Overall Study|Withdrawal by Subject|4|||
129031801|NCT00860262|464406576|FG001|Overall Study|Withdrawal by Subject|8|||
128707034|NCT02899988|463222134|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
128707035|NCT02899988|463222135|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
129031802|NCT00860262|464406577|FG002|Overall Study|Withdrawal by Subject|6|||
129031803|NCT00860262|464406575|FG000|Overall Study|Lack of Efficacy|0|||
129031804|NCT00860262|464406576|FG001|Overall Study|Lack of Efficacy|4|||
129031805|NCT00860262|464406577|FG002|Overall Study|Lack of Efficacy|3|||
128707036|NCT02899988|463222136|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
128707037|NCT02899988|463222137|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
128707038|NCT02899988|463222127|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707039|NCT02899988|463222128|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707040|NCT02899988|463222129|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707041|NCT02899988|463222130|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128769683|NCT00365378|463448201|FG000|Extension|Protocol Violation|0|||
128769684|NCT00365378|463448202|FG001|Extension|Protocol Violation|0|||
128769685|NCT00365378|463448203|FG002|Extension|Protocol Violation|2|||
128769686|NCT00365378|463448201|FG000|Extension|Withdrawal by Subject|0|||
128769687|NCT00365378|463448202|FG001|Extension|Withdrawal by Subject|0|||
128769688|NCT00365378|463448203|FG002|Extension|Withdrawal by Subject|98|||
128769689|NCT00365378|463448201|FG000|Extension|Other|0|||
128769690|NCT00365378|463448202|FG001|Extension|Other|0|||
128769691|NCT00365378|463448203|FG002|Extension|Other|31|||
128769692|NCT00669903|463448204|FG000|Overall Study|Adverse Event|0|||
128769693|NCT00669903|463448205|FG001|Overall Study|Adverse Event|1|||
128769694|NCT00669903|463448206|FG002|Overall Study|Adverse Event|3|||
128769695|NCT00669903|463448207|FG003|Overall Study|Adverse Event|1|||
128769696|NCT00669903|463448204|FG000|Overall Study|Withdrawal by Subject|0|||
128769697|NCT00669903|463448205|FG001|Overall Study|Withdrawal by Subject|2|||
128769698|NCT00669903|463448206|FG002|Overall Study|Withdrawal by Subject|2|||
128769699|NCT00669903|463448207|FG003|Overall Study|Withdrawal by Subject|2|||
128769700|NCT00669903|463448204|FG000|Overall Study|Lost to Follow-up|1|||
128769701|NCT00669903|463448205|FG001|Overall Study|Lost to Follow-up|1|||
129217690|NCT02745119|465097045|FG002|Overall Study|Adverse Event|1|||
129217691|NCT02745119|465097046|FG003|Overall Study|Adverse Event|3|||
129217692|NCT02745119|465097043|FG000|Overall Study|Death|3|||
129217693|NCT02745119|465097044|FG001|Overall Study|Death|3|||
129217694|NCT02745119|465097045|FG002|Overall Study|Death|0|||
129217695|NCT02745119|465097046|FG003|Overall Study|Death|4|||
129217696|NCT02745119|465097043|FG000|Overall Study|Lost to Follow-up|0|||
129217697|NCT02745119|465097044|FG001|Overall Study|Lost to Follow-up|0|||
128707042|NCT02899988|463222131|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707043|NCT02899988|463222132|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
128707044|NCT02899988|463222133|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707045|NCT02899988|463222134|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
128769702|NCT00669903|463448206|FG002|Overall Study|Lost to Follow-up|0|||
128769703|NCT00669903|463448207|FG003|Overall Study|Lost to Follow-up|1|||
128769704|NCT00669903|463448204|FG000|Overall Study|Protocol Violation|0|||
128769705|NCT00669903|463448205|FG001|Overall Study|Protocol Violation|1|||
128769706|NCT00669903|463448206|FG002|Overall Study|Protocol Violation|0|||
128769707|NCT00669903|463448207|FG003|Overall Study|Protocol Violation|0|||
128769708|NCT04789577|463448210|FG000|Overall Study|Withdrawal by Subject|1|||
128769709|NCT04789577|463448211|FG001|Overall Study|Withdrawal by Subject|1|||
128769710|NCT04789577|463448212|FG002|Overall Study|Withdrawal by Subject|1|||
128769711|NCT04789577|463448213|FG003|Overall Study|Withdrawal by Subject|3|||
128769712|NCT04789577|463448214|FG004|Overall Study|Withdrawal by Subject|1|||
128707046|NCT02899988|463222135|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707047|NCT02899988|463222136|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707048|NCT02899988|463222137|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
128707049|NCT02899988|463222127|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
128769713|NCT04789577|463448215|FG005|Overall Study|Withdrawal by Subject|7|||
128769714|NCT04789577|463448216|FG006|Overall Study|Withdrawal by Subject|1|||
128769715|NCT04789577|463448210|FG000|Overall Study|Lost to Follow-up|7|||
128769716|NCT04789577|463448211|FG001|Overall Study|Lost to Follow-up|12|||
128769717|NCT04789577|463448212|FG002|Overall Study|Lost to Follow-up|7|||
128769718|NCT04789577|463448213|FG003|Overall Study|Lost to Follow-up|10|||
128769719|NCT04789577|463448214|FG004|Overall Study|Lost to Follow-up|8|||
128769720|NCT04789577|463448215|FG005|Overall Study|Lost to Follow-up|6|||
128769721|NCT04789577|463448216|FG006|Overall Study|Lost to Follow-up|10|||
128769722|NCT04789577|463448210|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
128937884|NCT01242020|464060732|FG000|Overall Study|Failed screening|1|||
128769723|NCT04789577|463448211|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
128769724|NCT04789577|463448212|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
128769725|NCT04789577|463448213|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
128769726|NCT04789577|463448214|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
128769727|NCT04789577|463448215|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
128769728|NCT04789577|463448216|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
129217698|NCT02745119|465097045|FG002|Overall Study|Lost to Follow-up|0|||
129217699|NCT02745119|465097046|FG003|Overall Study|Lost to Follow-up|1|||
128769729|NCT04789577|463448210|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
128769730|NCT04789577|463448211|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
128769731|NCT04789577|463448212|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
129217700|NCT02745119|465097043|FG000|Overall Study|Protocol Deviation|0|||
128769732|NCT04789577|463448213|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
128937885|NCT01242020|464060733|FG001|Overall Study|Failed screening|0|||
128937886|NCT00772967|464060734|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
128937887|NCT00772967|464060735|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
128937888|NCT00772967|464060736|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
128937889|NCT00772967|464060737|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
128937890|NCT00772967|464060738|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
128937891|NCT00772967|464060739|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
128937892|NCT00772967|464060734|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
128937893|NCT00772967|464060735|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
128937894|NCT00772967|464060736|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
128937895|NCT00772967|464060737|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
128937896|NCT00772967|464060738|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
128937897|NCT00772967|464060739|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
128937898|NCT00772967|464060734|FG000|Crossover Treatment 3|Adverse Event|0|||
128937899|NCT00772967|464060735|FG001|Crossover Treatment 3|Adverse Event|0|||
128707050|NCT02899988|463222128|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
128707051|NCT02899988|463222129|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
128707052|NCT02899988|463222130|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
128707053|NCT02899988|463222131|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
128769733|NCT04789577|463448214|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
128707054|NCT02899988|463222132|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
128707055|NCT02899988|463222133|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
128707056|NCT02899988|463222134|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
128707057|NCT02899988|463222135|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
128707058|NCT02899988|463222136|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
128707059|NCT02899988|463222137|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
128707060|NCT01401283|463222138|FG000|Overall Study|surgery cancelled|5|||
128707061|NCT01401283|463222139|FG001|Overall Study|surgery cancelled|8|||
128707062|NCT01401283|463222138|FG000|Overall Study|preoperative arrhythmia|5|||
128707063|NCT01401283|463222139|FG001|Overall Study|preoperative arrhythmia|0|||
128707064|NCT01401283|463222138|FG000|Overall Study|no central venous access|0|||
128707065|NCT01401283|463222139|FG001|Overall Study|no central venous access|1|||
128707066|NCT01401283|463222138|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
128707067|NCT01401283|463222139|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
128707068|NCT02433483|463222140|FG000|Overall Study|Unacceptable toxicity|1|||
128707069|NCT02433483|463222140|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
128707070|NCT04271605|463222144|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
128707071|NCT03342690|463222145|FG000|Overall Study|Missing Information|9|||
128707072|NCT03342690|463222145|FG000|Overall Study|Protocol Violation|16|||
128707073|NCT01513473|463222146|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
128707074|NCT01513473|463222147|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
128707075|NCT01513473|463222146|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
128707076|NCT01513473|463222147|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
128707077|NCT01513473|463222146|FG000|Main Trial (26 Weeks)|Unclassified|0|||
128707078|NCT01513473|463222147|FG001|Main Trial (26 Weeks)|Unclassified|2|||
128707079|NCT01513473|463222146|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
128707080|NCT01513473|463222147|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
128707081|NCT01513473|463222146|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
128707082|NCT01513473|463222147|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
128707083|NCT00299975|463222155|FG000|Overall Study|Adverse Event|1|||
128707084|NCT00299975|463222156|FG001|Overall Study|Adverse Event|0|||
128707085|NCT00299975|463222157|FG002|Overall Study|Adverse Event|2|||
128707086|NCT00299975|463222155|FG000|Overall Study|Pregnancy|0|||
128707087|NCT00299975|463222156|FG001|Overall Study|Pregnancy|0|||
128707088|NCT00299975|463222157|FG002|Overall Study|Pregnancy|1|||
128707089|NCT00299975|463222155|FG000|Overall Study|Lack of Efficacy|1|||
128707090|NCT00299975|463222156|FG001|Overall Study|Lack of Efficacy|0|||
128707091|NCT00299975|463222157|FG002|Overall Study|Lack of Efficacy|1|||
128707092|NCT00299975|463222155|FG000|Overall Study|Lost to Follow-up|1|||
128707093|NCT00299975|463222156|FG001|Overall Study|Lost to Follow-up|0|||
128707094|NCT00299975|463222157|FG002|Overall Study|Lost to Follow-up|0|||
128707095|NCT00299975|463222155|FG000|Overall Study|Withdrawal by Subject|0|||
128707096|NCT00299975|463222156|FG001|Overall Study|Withdrawal by Subject|1|||
128707097|NCT00299975|463222157|FG002|Overall Study|Withdrawal by Subject|3|||
128937900|NCT00772967|464060736|FG002|Crossover Treatment 3|Adverse Event|0|||
128707098|NCT00299975|463222155|FG000|Overall Study|Physician Decision|0|||
128707099|NCT00299975|463222156|FG001|Overall Study|Physician Decision|0|||
128769734|NCT04789577|463448215|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
128937901|NCT00772967|464060737|FG003|Crossover Treatment 3|Adverse Event|0|||
128937902|NCT00772967|464060738|FG004|Crossover Treatment 3|Adverse Event|1|||
128707100|NCT00299975|463222157|FG002|Overall Study|Physician Decision|1|||
128937903|NCT00772967|464060739|FG005|Crossover Treatment 3|Adverse Event|0|||
128937904|NCT01595646|464060740|FG000|Overall Study|Withdrawal by Subject|1|||
128937905|NCT01595646|464060741|FG001|Overall Study|Withdrawal by Subject|0|||
128937906|NCT01595646|464060742|FG002|Overall Study|Withdrawal by Subject|0|||
128937907|NCT01161524|464060745|FG000|Core Study (23 Weeks)|Adverse Event|3|||
128937908|NCT01161524|464060746|FG001|Core Study (23 Weeks)|Adverse Event|0|||
128937909|NCT01161524|464060747|FG002|Core Study (23 Weeks)|Adverse Event|0|||
128937910|NCT01161524|464060745|FG000|Core Study (23 Weeks)|Other|1|||
128937911|NCT01161524|464060746|FG001|Core Study (23 Weeks)|Other|0|||
128937912|NCT01161524|464060747|FG002|Core Study (23 Weeks)|Other|0|||
128937913|NCT01161524|464060745|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
128937914|NCT01161524|464060746|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
128937915|NCT01161524|464060747|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
128937916|NCT01161524|464060745|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
128937917|NCT01161524|464060746|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
128937918|NCT01161524|464060747|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
128937919|NCT01161524|464060745|FG000|Core Study (23 Weeks)|Subject Choice|3|||
128937920|NCT01161524|464060746|FG001|Core Study (23 Weeks)|Subject Choice|2|||
128937921|NCT01161524|464060747|FG002|Core Study (23 Weeks)|Subject Choice|0|||
128937922|NCT01161524|464060745|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
128937923|NCT01161524|464060746|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
128937924|NCT01161524|464060747|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
128937925|NCT01161524|464060745|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
128937926|NCT01161524|464060746|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
128937927|NCT01161524|464060747|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
128937928|NCT01161524|464060745|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
128937929|NCT01161524|464060746|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
128937930|NCT01161524|464060747|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
128937931|NCT01161524|464060745|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
128937932|NCT01161524|464060746|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
128937933|NCT01161524|464060747|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
128937934|NCT01161524|464060745|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
128937935|NCT01161524|464060746|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
128937936|NCT01161524|464060747|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
128937937|NCT00231062|464060754|FG000|Overall Study|Physician Decision|6|||
128937938|NCT01052012|464060755|FG000|Overall Study|Not treated|2|||
128937939|NCT01052012|464060756|FG001|Overall Study|Not treated|5|||
128937940|NCT01052012|464060757|FG002|Overall Study|Not treated|0|||
128937941|NCT01052012|464060758|FG003|Overall Study|Not treated|0|||
128937942|NCT01052012|464060759|FG004|Overall Study|Not treated|11|||
128937943|NCT01052012|464060760|FG005|Overall Study|Not treated|8|||
128937944|NCT01052012|464060755|FG000|Overall Study|Adverse Event|1|||
128937945|NCT01052012|464060756|FG001|Overall Study|Adverse Event|0|||
128937946|NCT01052012|464060757|FG002|Overall Study|Adverse Event|0|||
128937947|NCT01052012|464060758|FG003|Overall Study|Adverse Event|1|||
128937948|NCT01052012|464060759|FG004|Overall Study|Adverse Event|0|||
128937949|NCT01052012|464060760|FG005|Overall Study|Adverse Event|0|||
128937950|NCT01052012|464060755|FG000|Overall Study|Lost to Follow-up|0|||
128937951|NCT01052012|464060756|FG001|Overall Study|Lost to Follow-up|0|||
128937952|NCT01052012|464060757|FG002|Overall Study|Lost to Follow-up|0|||
128937953|NCT01052012|464060758|FG003|Overall Study|Lost to Follow-up|0|||
128937954|NCT01052012|464060759|FG004|Overall Study|Lost to Follow-up|1|||
128937955|NCT01052012|464060760|FG005|Overall Study|Lost to Follow-up|0|||
128937956|NCT01052012|464060755|FG000|Overall Study|Withdrawal by Subject|1|||
128937957|NCT01052012|464060756|FG001|Overall Study|Withdrawal by Subject|1|||
128937958|NCT01052012|464060757|FG002|Overall Study|Withdrawal by Subject|0|||
128937959|NCT01052012|464060758|FG003|Overall Study|Withdrawal by Subject|0|||
128937960|NCT01052012|464060759|FG004|Overall Study|Withdrawal by Subject|3|||
128937961|NCT01052012|464060760|FG005|Overall Study|Withdrawal by Subject|1|||
128707101|NCT02627144|463222160|FG000|Overall Study|Serious adverse event|32|||
128707102|NCT02627144|463222160|FG000|Overall Study|Cancer progression|171|||
128707103|NCT02627144|463222160|FG000|Overall Study|Death from cancer|20|||
128707104|NCT02627144|463222160|FG000|Overall Study|Death from other cause|8|||
128707105|NCT02627144|463222160|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
128707106|NCT02627144|463222160|FG000|Overall Study|Administrative reasons|65|||
128937962|NCT01052012|464060755|FG000|Overall Study|Physician Decision|0|||
128937963|NCT01052012|464060756|FG001|Overall Study|Physician Decision|0|||
128937964|NCT01052012|464060757|FG002|Overall Study|Physician Decision|0|||
128937965|NCT01052012|464060758|FG003|Overall Study|Physician Decision|0|||
128937966|NCT01052012|464060759|FG004|Overall Study|Physician Decision|0|||
128937967|NCT01052012|464060760|FG005|Overall Study|Physician Decision|1|||
129122964|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
128937968|NCT01052012|464060755|FG000|Overall Study|Other|0|||
128937969|NCT01052012|464060756|FG001|Overall Study|Other|0|||
128937970|NCT01052012|464060757|FG002|Overall Study|Other|0|||
128937971|NCT01052012|464060758|FG003|Overall Study|Other|0|||
129122965|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
128707107|NCT02627144|463222160|FG000|Overall Study|Lost to Follow-up|8|||
128707108|NCT02627144|463222160|FG000|Overall Study|Enrolled, not treated|6|||
128707109|NCT02627144|463222160|FG000|Overall Study|Other|17|||
128707110|NCT02220205|463222161|FG000|Overall Study|Withdrawal by Subject|1|||
128937972|NCT01052012|464060759|FG004|Overall Study|Other|1|||
128937973|NCT01052012|464060760|FG005|Overall Study|Other|0|||
128937974|NCT02698423|464060767|FG000|Overall Study|Lost to Follow-up|19|||
128937975|NCT02698423|464060768|FG001|Overall Study|Lost to Follow-up|24|||
128937976|NCT01651260|464060769|FG000|Overall Study|unable to apply product|3|||
128937977|NCT01952015|464060772|FG000|Induction|Protocol Violation|1|||
128937978|NCT01952015|464060772|FG000|Maintenance|Adverse Event|2|||
128937979|NCT01952015|464060772|FG000|Treatment Period 3|Physician Decision|9|||
128937980|NCT01597193|464060773|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
128937981|NCT01597193|464060774|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
128937982|NCT01597193|464060775|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
128937983|NCT01597193|464060776|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
128937984|NCT01597193|464060777|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
128937985|NCT01597193|464060778|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
128937986|NCT01597193|464060779|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
128937987|NCT01597193|464060773|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
128937988|NCT01597193|464060774|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
128937989|NCT01597193|464060775|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
128937990|NCT01597193|464060776|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
128937991|NCT01597193|464060777|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
128937992|NCT01597193|464060778|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
128937993|NCT01597193|464060779|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
128937994|NCT01597193|464060773|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
128937995|NCT01597193|464060774|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
128937996|NCT01597193|464060775|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
128937997|NCT01597193|464060776|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
128937998|NCT01597193|464060777|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
128937999|NCT01597193|464060778|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
128938000|NCT01597193|464060779|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
128938001|NCT01597193|464060773|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
128938002|NCT01597193|464060774|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
128938003|NCT01597193|464060775|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
128938004|NCT01597193|464060776|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
128938005|NCT01597193|464060777|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
128938006|NCT01597193|464060778|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
128938007|NCT01597193|464060779|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
128938008|NCT01597193|464060773|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
128938009|NCT01597193|464060774|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
128938010|NCT01597193|464060775|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
128938011|NCT01597193|464060776|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
128938012|NCT01597193|464060777|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
128938013|NCT01597193|464060778|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
128938014|NCT01597193|464060779|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
128938015|NCT02508701|464060780|FG000|Overall Study|Lost to Follow-up|9|||
128938016|NCT02508701|464060781|FG001|Overall Study|Lost to Follow-up|5|||
128938017|NCT02508701|464060782|FG002|Overall Study|Lost to Follow-up|5|||
128938018|NCT02508701|464060783|FG003|Overall Study|Lost to Follow-up|3|||
128938019|NCT01259297|464060784|FG000|Double Blind Randomized Period|Death|1|||
128938020|NCT01259297|464060785|FG001|Double Blind Randomized Period|Death|1|||
128938021|NCT01259297|464060786|FG002|Double Blind Randomized Period|Death|1|||
128938022|NCT01259297|464060787|FG003|Double Blind Randomized Period|Death|2|||
128938023|NCT01259297|464060788|FG004|Double Blind Randomized Period|Death|1|||
128938024|NCT01259297|464060789|FG005|Double Blind Randomized Period|Death|5|||
128938025|NCT01259297|464060790|FG006|Double Blind Randomized Period|Death|2|||
128938026|NCT01259297|464060791|FG007|Double Blind Randomized Period|Death|1|||
128938027|NCT01259297|464060784|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
128938028|NCT01259297|464060785|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
128938029|NCT01259297|464060786|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
128938030|NCT01259297|464060787|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
128707111|NCT02220205|463222162|FG001|Overall Study|Withdrawal by Subject|0|||
128707112|NCT00211809|463222165|FG000|Overall Study|Lack of Efficacy|1|||
128938031|NCT01259297|464060788|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
128938032|NCT01259297|464060789|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
128707113|NCT00211809|463222165|FG000|Overall Study|Lost to Follow-up|2|||
128938033|NCT01259297|464060790|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
128938034|NCT01259297|464060791|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
128707114|NCT00211809|463222165|FG000|Overall Study|Pregnancy|1|||
128707115|NCT00211809|463222165|FG000|Overall Study|side effects|2|||
128707116|NCT04294472|463222166|FG000|Overall Study|Adverse Event|0|||
128707117|NCT04294472|463222167|FG001|Overall Study|Adverse Event|1|||
128707118|NCT04294472|463222168|FG002|Overall Study|Adverse Event|1|||
128707119|NCT04294472|463222166|FG000|Overall Study|Randomized but not treated|0|||
128707120|NCT04294472|463222167|FG001|Overall Study|Randomized but not treated|1|||
128707121|NCT04294472|463222168|FG002|Overall Study|Randomized but not treated|1|||
128707122|NCT02925494|463222172|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
128938035|NCT01259297|464060784|FG000|Double Blind Randomized Period|Other reasons|0|||
128938036|NCT01259297|464060785|FG001|Double Blind Randomized Period|Other reasons|1|||
128938037|NCT01259297|464060786|FG002|Double Blind Randomized Period|Other reasons|0|||
128938038|NCT01259297|464060787|FG003|Double Blind Randomized Period|Other reasons|0|||
128938039|NCT01259297|464060788|FG004|Double Blind Randomized Period|Other reasons|1|||
128938040|NCT01259297|464060789|FG005|Double Blind Randomized Period|Other reasons|2|||
128938041|NCT01259297|464060790|FG006|Double Blind Randomized Period|Other reasons|3|||
128938042|NCT01259297|464060791|FG007|Double Blind Randomized Period|Other reasons|1|||
128938043|NCT00592501|464060792|FG000|Overall Study|Withdrawal by Subject|1|||
128938044|NCT00592501|464060792|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
128938045|NCT03880227|464060796|FG000|First Visit|Withdrawal by Subject|1|||
128938046|NCT03880227|464060797|FG001|First Visit|Withdrawal by Subject|0|||
128938047|NCT03880227|464060798|FG002|First Visit|Withdrawal by Subject|0|||
128938048|NCT03880227|464060799|FG003|First Visit|Withdrawal by Subject|0|||
128938049|NCT03880227|464060796|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
128938050|NCT03880227|464060797|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
128938051|NCT03880227|464060798|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
128938052|NCT03880227|464060799|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
128938053|NCT03880227|464060796|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
128938054|NCT03880227|464060797|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
128938055|NCT03880227|464060798|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
128938056|NCT03880227|464060799|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
128938057|NCT03880227|464060796|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
128938058|NCT03880227|464060797|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
128938059|NCT03880227|464060798|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
128938060|NCT03880227|464060799|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
128938061|NCT01070784|464060800|FG000|Overall Study|Withdrawal by Subject|6|||
128938062|NCT01070784|464060801|FG001|Overall Study|Withdrawal by Subject|9|||
128938063|NCT01070784|464060800|FG000|Overall Study|Adverse Event|14|||
128938064|NCT01070784|464060801|FG001|Overall Study|Adverse Event|9|||
128938065|NCT02815397|464060803|FG000|Overall Study|Physician Decision|2|||
128938066|NCT02518620|464060804|FG000|Overall Study|Adverse Event|23|||
128938067|NCT02518620|464060805|FG001|Overall Study|Adverse Event|11|||
128938068|NCT02518620|464060804|FG000|Overall Study|Lack of Efficacy|2|||
128938069|NCT02518620|464060805|FG001|Overall Study|Lack of Efficacy|0|||
128938070|NCT02518620|464060804|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128938071|NCT02518620|464060805|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128938072|NCT02518620|464060804|FG000|Overall Study|Physician Decision|1|||
128938073|NCT02518620|464060805|FG001|Overall Study|Physician Decision|1|||
128938074|NCT02518620|464060804|FG000|Overall Study|Sponsor's Decision|0|||
128938075|NCT02518620|464060805|FG001|Overall Study|Sponsor's Decision|3|||
128938076|NCT02518620|464060804|FG000|Overall Study|Lost to Follow-up|1|||
128938077|NCT02518620|464060805|FG001|Overall Study|Lost to Follow-up|1|||
128938078|NCT02518620|464060804|FG000|Overall Study|Withdrawal by Subject|17|||
128938079|NCT02518620|464060805|FG001|Overall Study|Withdrawal by Subject|9|||
128938080|NCT02518620|464060804|FG000|Overall Study|Death|1|||
128769735|NCT04789577|463448216|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
128769736|NCT01827254|463448218|FG000|Overall Study|Death|10|||
128769737|NCT01827254|463448218|FG000|Overall Study|Case report form not completed|4|||
128707123|NCT02925494|463222173|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
128707124|NCT02925494|463222174|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
128769738|NCT01827254|463448218|FG000|Overall Study|Invalidated centre|3|||
128707125|NCT02925494|463222175|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
128707126|NCT02925494|463222172|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
128769739|NCT01827254|463448218|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
128769740|NCT01827254|463448218|FG000|Overall Study|Did not complete re-challenge|1|||
128769741|NCT01827254|463448218|FG000|Overall Study|Disease progression|36|||
128938081|NCT02518620|464060805|FG001|Overall Study|Death|0|||
128707127|NCT02925494|463222173|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
128769742|NCT01827254|463448218|FG000|Overall Study|Intolerance to treatment|4|||
128769743|NCT01923389|463448228|FG000|Overall Study|Protocol Violation|1|||
128769744|NCT01923389|463448229|FG001|Overall Study|Protocol Violation|0|||
128769745|NCT00366301|463448233|FG000|Overall Study|Lost to Follow-up|4|||
128938082|NCT02518620|464060804|FG000|Overall Study|Pregnancy Wish|3|||
128938083|NCT02518620|464060805|FG001|Overall Study|Pregnancy Wish|0|||
128938084|NCT02518620|464060804|FG000|Overall Study|Pregnancy|1|||
128938085|NCT02518620|464060805|FG001|Overall Study|Pregnancy|0|||
128938086|NCT02518620|464060804|FG000|Overall Study|Relocation|2|||
128938087|NCT02518620|464060805|FG001|Overall Study|Relocation|1|||
128938088|NCT00085540|464060806|FG000|Overall Study|Withdrawal by Subject|0|||
128938089|NCT00085540|464060807|FG001|Overall Study|Withdrawal by Subject|1|||
128707128|NCT02925494|463222174|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
128707129|NCT02925494|463222175|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
128707130|NCT02925494|463222172|FG000|Post-Treatment Follow-Up Period|Other|1|||
128707131|NCT02925494|463222173|FG001|Post-Treatment Follow-Up Period|Other|4|||
128707132|NCT02925494|463222174|FG002|Post-Treatment Follow-Up Period|Other|3|||
128707133|NCT02925494|463222175|FG003|Post-Treatment Follow-Up Period|Other|6|||
128707134|NCT02925494|463222172|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
128707135|NCT02925494|463222173|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
128707136|NCT02925494|463222174|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
128707137|NCT02925494|463222175|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
128707138|NCT02925494|463222172|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
128707139|NCT02925494|463222173|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
128707140|NCT02925494|463222174|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
128707141|NCT02925494|463222175|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
128707142|NCT02925494|463222172|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
128707143|NCT02925494|463222173|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
128938090|NCT00085540|464060806|FG000|Overall Study|Protocol Violation|0|||
128938091|NCT00085540|464060807|FG001|Overall Study|Protocol Violation|1|||
128938092|NCT01605396|464060808|FG000|Overall Study|Adverse Event|5|||
128938093|NCT01605396|464060809|FG001|Overall Study|Adverse Event|3|||
128938094|NCT01605396|464060808|FG000|Overall Study|Lost to Follow-up|1|||
128938095|NCT01605396|464060809|FG001|Overall Study|Lost to Follow-up|0|||
128938096|NCT01605396|464060808|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128938097|NCT01605396|464060809|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128938098|NCT01605396|464060808|FG000|Overall Study|Physician Decision|2|||
128938099|NCT01605396|464060809|FG001|Overall Study|Physician Decision|2|||
128938100|NCT01605396|464060808|FG000|Overall Study|Progressive Disease|23|||
128938101|NCT01605396|464060809|FG001|Overall Study|Progressive Disease|27|||
128938102|NCT01605396|464060808|FG000|Overall Study|Withdrawal by Subject|4|||
128938103|NCT01605396|464060809|FG001|Overall Study|Withdrawal by Subject|2|||
128938104|NCT01605396|464060808|FG000|Overall Study|Transfer Off Study|4|||
128938105|NCT01605396|464060809|FG001|Overall Study|Transfer Off Study|5|||
128938106|NCT03607682|464060812|FG000|Overall Study|Withdrawal by Subject|1|||
128938107|NCT03607682|464060812|FG000|Overall Study|Disease progression|1|||
128938108|NCT00376688|464060813|FG000|Overall Study|Adverse Event|3|||
128938109|NCT00376688|464060813|FG000|Overall Study|Death|1|||
128938110|NCT01770353|464060814|FG000|Overall Study|Progressive disease|2|||
128938111|NCT01770353|464060815|FG001|Overall Study|Progressive disease|1|||
128938112|NCT01770353|464060814|FG000|Overall Study|Adverse Event|0|||
128938113|NCT01770353|464060815|FG001|Overall Study|Adverse Event|1|||
128938114|NCT01770353|464060814|FG000|Overall Study|Protocol Violation|1|||
128938115|NCT01770353|464060815|FG001|Overall Study|Protocol Violation|0|||
128938116|NCT01770353|464060814|FG000|Overall Study|Physician Decision|0|||
128938117|NCT01770353|464060815|FG001|Overall Study|Physician Decision|3|||
128938118|NCT01770353|464060814|FG000|Overall Study|Clinical deterioration|3|||
128938119|NCT01770353|464060815|FG001|Overall Study|Clinical deterioration|6|||
128938120|NCT01770353|464060814|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
128938121|NCT01770353|464060815|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
128938122|NCT02574312|464060816|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
128938123|NCT02574312|464060817|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
128938124|NCT04267562|464062703|FG000|Assessed for Eligibility|Screen Failure|64|||
128938125|NCT04267562|464062703|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
129122966|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
128707144|NCT02925494|463222174|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
128707145|NCT02925494|463222175|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
128707146|NCT02925494|463222172|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
128707147|NCT02925494|463222173|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
128707148|NCT02925494|463222174|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
128707149|NCT02925494|463222175|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
128707150|NCT06149247|463222180|FG000|Overall Study|Adverse Event|0|||
128707151|NCT06149247|463222181|FG001|Overall Study|Adverse Event|1|||
128707152|NCT01756898|463222182|FG000|Overall Study|Adverse Event|7|||
128707153|NCT01756898|463222183|FG001|Overall Study|Adverse Event|1|||
128707154|NCT01756898|463222184|FG002|Overall Study|Adverse Event|0|||
128707155|NCT01756898|463222185|FG003|Overall Study|Adverse Event|0|||
128938126|NCT04267562|464062703|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
128938127|NCT04267562|464062703|FG000|Assessed for Eligibility|Site closure|6|||
128938128|NCT04267562|464062703|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
128938129|NCT04267562|464062703|FG000|Assessed for Eligibility|Physician Decision|1|||
128938130|NCT04267562|464062703|FG000|Month 24|Elective hysterectomy|1|||
128938131|NCT04267562|464062703|FG000|Month 24|Lost to Follow-up|1|||
128938132|NCT04267562|464062703|FG000|Month 36|Elective hysterectomy|2|||
128938133|NCT04267562|464062703|FG000|Month 36|Lost to Follow-up|3|||
128938134|NCT02078713|464062704|FG000|Overall Study|Lost to Follow-up|49|||
128938135|NCT02078713|464062705|FG001|Overall Study|Lost to Follow-up|55|||
128938136|NCT02078713|464062706|FG002|Overall Study|Lost to Follow-up|0|||
128938137|NCT02078713|464062707|FG003|Overall Study|Lost to Follow-up|0|||
128938138|NCT02078713|464062704|FG000|Overall Study|Pregnant at baseline|3|||
128938139|NCT02078713|464062705|FG001|Overall Study|Pregnant at baseline|5|||
128938140|NCT02078713|464062706|FG002|Overall Study|Pregnant at baseline|0|||
128938141|NCT02078713|464062707|FG003|Overall Study|Pregnant at baseline|0|||
128938142|NCT02078713|464062704|FG000|Overall Study|Enrolled twice|0|||
128938143|NCT02078713|464062705|FG001|Overall Study|Enrolled twice|1|||
128938144|NCT02078713|464062706|FG002|Overall Study|Enrolled twice|0|||
128938145|NCT02078713|464062707|FG003|Overall Study|Enrolled twice|0|||
128938146|NCT00696657|464062712|FG000|Overall Study|Protocol Violation|0|||
128938147|NCT00696657|464062713|FG001|Overall Study|Protocol Violation|0|||
128938148|NCT00696657|464062714|FG002|Overall Study|Protocol Violation|0|||
128938149|NCT00696657|464062715|FG003|Overall Study|Protocol Violation|0|||
128938150|NCT00696657|464062716|FG004|Overall Study|Protocol Violation|0|||
128938151|NCT00696657|464062717|FG005|Overall Study|Protocol Violation|1|||
128938152|NCT00696657|464062718|FG006|Overall Study|Protocol Violation|0|||
128938153|NCT00696657|464062719|FG007|Overall Study|Protocol Violation|0|||
128938154|NCT00696657|464062720|FG008|Overall Study|Protocol Violation|1|||
128938155|NCT00696657|464062712|FG000|Overall Study|Lack of Efficacy|0|||
128938156|NCT00696657|464062713|FG001|Overall Study|Lack of Efficacy|1|||
128938157|NCT00696657|464062714|FG002|Overall Study|Lack of Efficacy|0|||
128938158|NCT00696657|464062715|FG003|Overall Study|Lack of Efficacy|0|||
128938159|NCT00696657|464062716|FG004|Overall Study|Lack of Efficacy|0|||
128938160|NCT00696657|464062717|FG005|Overall Study|Lack of Efficacy|0|||
128938161|NCT00696657|464062718|FG006|Overall Study|Lack of Efficacy|0|||
128938162|NCT00696657|464062719|FG007|Overall Study|Lack of Efficacy|0|||
128938163|NCT00696657|464062720|FG008|Overall Study|Lack of Efficacy|0|||
128938164|NCT00696657|464062712|FG000|Overall Study|Withdrawal criteria|1|||
128938165|NCT00696657|464062713|FG001|Overall Study|Withdrawal criteria|3|||
128938166|NCT00696657|464062714|FG002|Overall Study|Withdrawal criteria|2|||
128938167|NCT00696657|464062715|FG003|Overall Study|Withdrawal criteria|2|||
128938168|NCT00696657|464062716|FG004|Overall Study|Withdrawal criteria|0|||
128938169|NCT00696657|464062717|FG005|Overall Study|Withdrawal criteria|0|||
128938170|NCT00696657|464062718|FG006|Overall Study|Withdrawal criteria|1|||
128938171|NCT00696657|464062719|FG007|Overall Study|Withdrawal criteria|1|||
128938172|NCT00696657|464062720|FG008|Overall Study|Withdrawal criteria|2|||
128938173|NCT00696657|464062712|FG000|Overall Study|Unclassified|0|||
128938174|NCT00696657|464062713|FG001|Overall Study|Unclassified|1|||
128938175|NCT00696657|464062714|FG002|Overall Study|Unclassified|3|||
128938176|NCT00696657|464062715|FG003|Overall Study|Unclassified|2|||
128938177|NCT00696657|464062716|FG004|Overall Study|Unclassified|4|||
128938178|NCT00696657|464062717|FG005|Overall Study|Unclassified|2|||
128938179|NCT00696657|464062718|FG006|Overall Study|Unclassified|0|||
128938180|NCT00696657|464062719|FG007|Overall Study|Unclassified|0|||
128938181|NCT00696657|464062720|FG008|Overall Study|Unclassified|1|||
128938182|NCT00696657|464062712|FG000|Overall Study|Adverse Event|0|||
128938183|NCT00696657|464062713|FG001|Overall Study|Adverse Event|0|||
128938184|NCT00696657|464062714|FG002|Overall Study|Adverse Event|3|||
128938185|NCT00696657|464062715|FG003|Overall Study|Adverse Event|7|||
128938186|NCT00696657|464062716|FG004|Overall Study|Adverse Event|6|||
128938187|NCT00696657|464062717|FG005|Overall Study|Adverse Event|9|||
128938188|NCT00696657|464062718|FG006|Overall Study|Adverse Event|14|||
128938189|NCT00696657|464062719|FG007|Overall Study|Adverse Event|2|||
128938190|NCT00696657|464062720|FG008|Overall Study|Adverse Event|5|||
128938191|NCT01790438|464062721|FG000|Overall Study|Adverse Event|3|||
128707156|NCT01756898|463222182|FG000|Overall Study|Lack of Efficacy|4|||
128938192|NCT01790438|464062722|FG001|Overall Study|Adverse Event|2|||
128938193|NCT01790438|464062721|FG000|Overall Study|Death|4|||
128938194|NCT01790438|464062722|FG001|Overall Study|Death|0|||
128938195|NCT01790438|464062721|FG000|Overall Study|Lost to Follow-up|5|||
128938196|NCT01790438|464062722|FG001|Overall Study|Lost to Follow-up|2|||
129122967|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
128707157|NCT01756898|463222183|FG001|Overall Study|Lack of Efficacy|7|||
128938197|NCT01790438|464062721|FG000|Overall Study|Withdrawal by Subject|13|||
128938198|NCT01790438|464062722|FG001|Overall Study|Withdrawal by Subject|2|||
128938199|NCT01790438|464062721|FG000|Overall Study|Physician Decision|3|||
128938200|NCT01790438|464062722|FG001|Overall Study|Physician Decision|1|||
128938201|NCT01790438|464062721|FG000|Overall Study|Sponsor Decision|0|||
128938202|NCT01790438|464062722|FG001|Overall Study|Sponsor Decision|3|||
128938203|NCT01790438|464062721|FG000|Overall Study|Protocol Required Discontinuation|7|||
128938204|NCT01790438|464062722|FG001|Overall Study|Protocol Required Discontinuation|1|||
128938205|NCT02090114|464062726|FG000|Overall Study|Withdrawal by Subject|3|||
128938206|NCT02090114|464062727|FG001|Overall Study|Withdrawal by Subject|6|||
128938207|NCT02090114|464062728|FG002|Overall Study|Withdrawal by Subject|2|||
129122968|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
129122969|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
129122970|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
129122971|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
129122972|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
129122973|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Other|2|||
128938208|NCT02090114|464062729|FG003|Overall Study|Withdrawal by Subject|1|||
128938209|NCT02090114|464062726|FG000|Overall Study|Physician Decision|5|||
128938210|NCT02090114|464062727|FG001|Overall Study|Physician Decision|0|||
128938211|NCT02090114|464062728|FG002|Overall Study|Physician Decision|1|||
128938212|NCT02090114|464062729|FG003|Overall Study|Physician Decision|1|||
128938213|NCT02090114|464062726|FG000|Overall Study|Adverse Event|1|||
128938214|NCT02090114|464062727|FG001|Overall Study|Adverse Event|2|||
128938215|NCT02090114|464062728|FG002|Overall Study|Adverse Event|2|||
128938216|NCT02090114|464062729|FG003|Overall Study|Adverse Event|0|||
128938217|NCT02090114|464062726|FG000|Overall Study|Progressive Disease|20|||
128938218|NCT02090114|464062727|FG001|Overall Study|Progressive Disease|21|||
128938219|NCT02090114|464062728|FG002|Overall Study|Progressive Disease|23|||
128938220|NCT02090114|464062729|FG003|Overall Study|Progressive Disease|6|||
128938221|NCT02090114|464062726|FG000|Overall Study|Death|1|||
128938222|NCT02090114|464062727|FG001|Overall Study|Death|0|||
128938223|NCT02090114|464062728|FG002|Overall Study|Death|1|||
128938224|NCT02090114|464062729|FG003|Overall Study|Death|0|||
128938225|NCT04439838|464062732|FG000|Overall Study|Withdrawal by Subject|0|||
128938226|NCT04439838|464062733|FG001|Overall Study|Withdrawal by Subject|0|||
128938227|NCT04439838|464062734|FG002|Overall Study|Withdrawal by Subject|0|||
128938228|NCT04439838|464062735|FG003|Overall Study|Withdrawal by Subject|0|||
128938229|NCT04439838|464062736|FG004|Overall Study|Withdrawal by Subject|0|||
128938230|NCT04439838|464062737|FG005|Overall Study|Withdrawal by Subject|0|||
128938231|NCT04439838|464062738|FG006|Overall Study|Withdrawal by Subject|0|||
128938232|NCT04439838|464062739|FG007|Overall Study|Withdrawal by Subject|0|||
128938233|NCT04439838|464062740|FG008|Overall Study|Withdrawal by Subject|1|||
128938234|NCT04494633|464062741|FG000|Overall Study|Lost to Follow-up|5|||
128938235|NCT04494633|464062742|FG001|Overall Study|Lost to Follow-up|3|||
128938236|NCT04494633|464062741|FG000|Overall Study|Protocol Violation|1|||
128938237|NCT04494633|464062742|FG001|Overall Study|Protocol Violation|1|||
128938238|NCT02948777|464062743|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
128938239|NCT02311478|464062744|FG000|Overall Study|Withdrawal by Subject|1|||
128938240|NCT02311478|464062744|FG000|Overall Study|Lost to Follow-up|5|||
128938241|NCT02311478|464062744|FG000|Overall Study|Failed IUD Insertion|1|||
128938242|NCT03242928|464062745|FG000|Overall Study|Adverse Event|2|||
128938243|NCT03242928|464062746|FG001|Overall Study|Adverse Event|1|||
128938244|NCT03242928|464062745|FG000|Overall Study|Lost to Follow-up|2|||
128938245|NCT03242928|464062746|FG001|Overall Study|Lost to Follow-up|0|||
128938246|NCT03242928|464062745|FG000|Overall Study|Physician Decision|0|||
128938247|NCT03242928|464062746|FG001|Overall Study|Physician Decision|1|||
128938248|NCT03242928|464062745|FG000|Overall Study|Withdrawal by Subject|5|||
128938249|NCT03242928|464062746|FG001|Overall Study|Withdrawal by Subject|3|||
128938250|NCT00390780|464062747|FG000|Overall Study|Not completed|10|||
128938251|NCT00390780|464062748|FG001|Overall Study|Not completed|4|||
128938252|NCT00390780|464062747|FG000|Overall Study|Protocol Violation|6|||
128938253|NCT00390780|464062748|FG001|Overall Study|Protocol Violation|4|||
128938254|NCT00390780|464062747|FG000|Overall Study|Lost to Follow-up|3|||
128938255|NCT00390780|464062748|FG001|Overall Study|Lost to Follow-up|6|||
128938256|NCT00390780|464062747|FG000|Overall Study|Adverse Event|2|||
128938257|NCT00390780|464062748|FG001|Overall Study|Adverse Event|3|||
128938258|NCT00390780|464062747|FG000|Overall Study|Death|1|||
128938259|NCT00390780|464062748|FG001|Overall Study|Death|3|||
128938260|NCT00390780|464062747|FG000|Overall Study|Withdrawal by Subject|1|||
128938261|NCT00390780|464062748|FG001|Overall Study|Withdrawal by Subject|2|||
128938262|NCT00390780|464062747|FG000|Overall Study|Inclusion criteria not satisfied|0|||
128938263|NCT00390780|464062748|FG001|Overall Study|Inclusion criteria not satisfied|2|||
128938264|NCT00390780|464062747|FG000|Overall Study|Lost to follow up and other reasons|0|||
128938265|NCT00390780|464062748|FG001|Overall Study|Lost to follow up and other reasons|1|||
128938266|NCT00390780|464062747|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
128938267|NCT00390780|464062748|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
128938268|NCT00390780|464062747|FG000|Overall Study|SAE, death|0|||
128938269|NCT00390780|464062748|FG001|Overall Study|SAE, death|1|||
128938270|NCT00109733|464062749|FG000|Overall Study|Protocol Violation|0|||
128938271|NCT00109733|464062750|FG001|Overall Study|Protocol Violation|1|||
128938272|NCT00109733|464062749|FG000|Overall Study|Stopped taking study drug|1|||
128938273|NCT00109733|464062750|FG001|Overall Study|Stopped taking study drug|1|||
128938274|NCT00109733|464062749|FG000|Overall Study|Non-compliant|0|||
129122974|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Other|3|||
129122975|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Other|0|||
128938275|NCT00109733|464062750|FG001|Overall Study|Non-compliant|1|||
128938276|NCT00109733|464062749|FG000|Overall Study|Could not commit time for study|1|||
128938277|NCT00109733|464062750|FG001|Overall Study|Could not commit time for study|1|||
128938278|NCT03332667|464062755|FG000|Overall Study|Adverse Event|0|||
128938279|NCT03332667|464062756|FG001|Overall Study|Adverse Event|0|||
128938280|NCT03332667|464062757|FG002|Overall Study|Adverse Event|2|||
128938281|NCT03332667|464062758|FG003|Overall Study|Adverse Event|1|||
128938282|NCT03332667|464062755|FG000|Overall Study|Withdrawal by Subject|2|||
128938283|NCT03332667|464062756|FG001|Overall Study|Withdrawal by Subject|1|||
128938284|NCT03332667|464062757|FG002|Overall Study|Withdrawal by Subject|5|||
128938285|NCT03332667|464062758|FG003|Overall Study|Withdrawal by Subject|1|||
128938286|NCT03332667|464062755|FG000|Overall Study|Disease Progression or Relapse|2|||
128938287|NCT03332667|464062756|FG001|Overall Study|Disease Progression or Relapse|1|||
128938288|NCT03332667|464062757|FG002|Overall Study|Disease Progression or Relapse|3|||
128938289|NCT03332667|464062758|FG003|Overall Study|Disease Progression or Relapse|0|||
128938290|NCT03332667|464062755|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
128938291|NCT03332667|464062756|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
128938292|NCT03332667|464062757|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
128938293|NCT03332667|464062758|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
128938294|NCT03332667|464062755|FG000|Overall Study|No Treatment Received|0|||
128938295|NCT03332667|464062756|FG001|Overall Study|No Treatment Received|0|||
128938296|NCT03332667|464062757|FG002|Overall Study|No Treatment Received|1|||
128938297|NCT03332667|464062758|FG003|Overall Study|No Treatment Received|0|||
128938298|NCT04964063|464062759|FG000|Overall Study|Adverse Event|4|||
128938299|NCT04964063|464062759|FG000|Overall Study|Lost to Follow-up|47|||
128938300|NCT04964063|464062759|FG000|Overall Study|Withdrawal by Subject|5|||
128938301|NCT04964063|464062759|FG000|Overall Study|Baseline Tasks Expired|41|||
128938302|NCT04964063|464062759|FG000|Overall Study|Participant withdrawn in error|1|||
128938303|NCT01035606|464062760|FG000|Overall Study|change in health, job demands,family|3|||
128938304|NCT01035606|464062761|FG001|Overall Study|change in health, job demands,family|3|||
128938305|NCT01035606|464062762|FG002|Overall Study|change in health, job demands,family|4|||
128938306|NCT03350750|464062763|FG000|Overall Study|Death|1|||
128938307|NCT03350750|464062764|FG001|Overall Study|Death|1|||
128938308|NCT02433288|464062765|FG000|Overall Study|Severe non-compliance to protocol|13|||
128938309|NCT02433288|464062766|FG001|Overall Study|Severe non-compliance to protocol|7|||
128938310|NCT02433288|464062765|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
128938311|NCT02433288|464062766|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
128938312|NCT02433288|464062765|FG000|Overall Study|Withdrawal by Subject|101|||
128938313|NCT02433288|464062766|FG001|Overall Study|Withdrawal by Subject|99|||
128938314|NCT02433288|464062765|FG000|Overall Study|Lost to Follow-up|2|||
128938315|NCT02433288|464062766|FG001|Overall Study|Lost to Follow-up|14|||
128938316|NCT02433288|464062765|FG000|Overall Study|Death|0|||
128938317|NCT02433288|464062766|FG001|Overall Study|Death|3|||
128938318|NCT01849250|464062767|FG000|Overall Study|Withdrawal by Subject|1|||
128938319|NCT01849250|464062768|FG001|Overall Study|Withdrawal by Subject|0|||
128938320|NCT01849250|464062767|FG000|Overall Study|Not Evaluable|5|||
128938321|NCT01849250|464062768|FG001|Overall Study|Not Evaluable|3|||
128938322|NCT01849250|464062767|FG000|Overall Study|Screen Failure|1|||
128938323|NCT01849250|464062768|FG001|Overall Study|Screen Failure|0|||
128938324|NCT01063751|464062771|FG000|Overall Study|Censored from analyses|42|||
128938325|NCT01063751|464062771|FG000|Overall Study|Withdrawal by Subject|34|||
128938326|NCT01063751|464062771|FG000|Overall Study|Lost to Follow-up|30|||
128938327|NCT01063751|464062771|FG000|Overall Study|Death|13|||
128938328|NCT01063751|464062771|FG000|Overall Study|Sponsored Terminated Study|60|||
128938329|NCT01063751|464062771|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
128938330|NCT01063751|464062771|FG000|Overall Study|Investigator site closed|10|||
129122976|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
129122977|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
129122978|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
129122979|NCT04006457|464745488|FG000|Main Study: Treatment Period 2|Ongoing|86|||
128707158|NCT01756898|463222184|FG002|Overall Study|Lack of Efficacy|6|||
128707159|NCT01756898|463222185|FG003|Overall Study|Lack of Efficacy|6|||
128707160|NCT01756898|463222182|FG000|Overall Study|Lost to Follow-up|2|||
128707161|NCT01756898|463222183|FG001|Overall Study|Lost to Follow-up|4|||
128938331|NCT01063751|464062771|FG000|Overall Study|Revision|6|||
128938332|NCT01063751|464062771|FG000|Overall Study|Physician Decision|4|||
128938333|NCT00406315|464062773|FG000|Overall Study|Death|1|||
128938334|NCT00406315|464062773|FG000|Overall Study|Adverse Event|39|||
128938335|NCT00406315|464062773|FG000|Overall Study|Laboratory Abnormality|4|||
128938336|NCT00406315|464062773|FG000|Overall Study|Lack of Efficacy|13|||
128938337|NCT00406315|464062773|FG000|Overall Study|Other|33|||
128938338|NCT00406315|464062773|FG000|Overall Study|Lost to Follow-up|21|||
128938339|NCT00406315|464062773|FG000|Overall Study|Withdrawal by Subject|30|||
128938340|NCT01525849|464062776|FG000|Overall Study|Lost to Follow-up|3|||
128938341|NCT01525849|464062777|FG001|Overall Study|Lost to Follow-up|2|||
129122980|NCT04006457|464745489|FG001|Main Study: Treatment Period 2|Ongoing|96|||
129122981|NCT04006457|464745490|FG002|Main Study: Treatment Period 2|Ongoing|0|||
128938342|NCT01525849|464062776|FG000|Overall Study|Withdrawal by Subject|1|||
128938343|NCT01525849|464062777|FG001|Overall Study|Withdrawal by Subject|9|||
128938344|NCT01525849|464062776|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
128938345|NCT01525849|464062777|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
128938346|NCT01525849|464062776|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
128938347|NCT01525849|464062777|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
128938348|NCT00793819|464062778|FG000|Overall Study|Adverse Event|8|||
128938349|NCT00793819|464062779|FG001|Overall Study|Adverse Event|4|||
128938350|NCT00793819|464062778|FG000|Overall Study|Lack of Efficacy|1|||
128938351|NCT00793819|464062779|FG001|Overall Study|Lack of Efficacy|1|||
128938352|NCT00793819|464062778|FG000|Overall Study|Withdrawal by Subject|4|||
128938353|NCT00793819|464062779|FG001|Overall Study|Withdrawal by Subject|3|||
128938354|NCT00793819|464062778|FG000|Overall Study|Lost to Follow-up|1|||
128938355|NCT00793819|464062779|FG001|Overall Study|Lost to Follow-up|1|||
128938356|NCT00446446|464062780|FG000|Overall Study|Death|10|||
128938357|NCT00446446|464062780|FG000|Overall Study|Withdrawal by Subject|6|||
128938358|NCT00446446|464062780|FG000|Overall Study|Other|4|||
128938359|NCT00446446|464062780|FG000|Overall Study|Disease Progession|2|||
128938360|NCT00446446|464062780|FG000|Overall Study|Adverse Event|1|||
128938361|NCT00446446|464062780|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
128938362|NCT00257192|464062781|FG000|Overall Study|Adverse Event|21|||
128938363|NCT00257192|464062782|FG001|Overall Study|Adverse Event|10|||
128938364|NCT00257192|464062781|FG000|Overall Study|Laboratory abnormality|1|||
128938365|NCT00257192|464062782|FG001|Overall Study|Laboratory abnormality|1|||
128938366|NCT00257192|464062781|FG000|Overall Study|Lost to Follow-up|3|||
128938367|NCT00257192|464062782|FG001|Overall Study|Lost to Follow-up|3|||
128938368|NCT00257192|464062781|FG000|Overall Study|Insufficient clinical response|18|||
128938369|NCT00257192|464062782|FG001|Overall Study|Insufficient clinical response|18|||
128938370|NCT00257192|464062781|FG000|Overall Study|Withdrawal by Subject|14|||
128938371|NCT00257192|464062782|FG001|Overall Study|Withdrawal by Subject|2|||
128938372|NCT00257192|464062781|FG000|Overall Study|Randomized but not treated|0|||
128938373|NCT00257192|464062782|FG001|Overall Study|Randomized but not treated|1|||
128938374|NCT00257192|464062781|FG000|Overall Study|Study terminated by sponsor|1|||
128938375|NCT00257192|464062782|FG001|Overall Study|Study terminated by sponsor|0|||
128938376|NCT00257192|464062781|FG000|Overall Study|Miscellaneous|0|||
128938377|NCT00257192|464062782|FG001|Overall Study|Miscellaneous|4|||
128938378|NCT02062151|464062783|FG000|Overall Study|screen failure|1|||
128938379|NCT01844700|464062792|FG000|Overall Study|Lack of Efficacy|1|||
128938380|NCT01844700|464062793|FG001|Overall Study|Lack of Efficacy|0|||
128938381|NCT01844700|464062792|FG000|Overall Study|refused medication switch|1|||
128938382|NCT01844700|464062793|FG001|Overall Study|refused medication switch|0|||
128938383|NCT01844700|464062792|FG000|Overall Study|Withdrawal by Subject|1|||
128938384|NCT01844700|464062793|FG001|Overall Study|Withdrawal by Subject|0|||
128938385|NCT01844700|464062792|FG000|Overall Study|stopped taking meds|0|||
128938386|NCT01844700|464062793|FG001|Overall Study|stopped taking meds|1|||
128938387|NCT02375698|464062794|FG000|Overall Study|Withdrawal by Subject|0|||
128938388|NCT02375698|464062795|FG001|Overall Study|Withdrawal by Subject|2|||
128938389|NCT02375698|464062794|FG000|Overall Study|Physician Decision|2|||
128938390|NCT02375698|464062795|FG001|Overall Study|Physician Decision|0|||
128938391|NCT02680847|464062796|FG000|Overall Study|Other|2|||
128938392|NCT02680847|464062797|FG001|Overall Study|Other|0|||
128938393|NCT02680847|464062798|FG002|Overall Study|Other|0|||
128938394|NCT02680847|464062796|FG000|Overall Study|No longer met eligibility criteria|2|||
128938395|NCT02680847|464062797|FG001|Overall Study|No longer met eligibility criteria|2|||
128938396|NCT02680847|464062798|FG002|Overall Study|No longer met eligibility criteria|0|||
128938397|NCT02680847|464062796|FG000|Overall Study|Unwilling to participate in study|1|||
129031806|NCT00860262|464406575|FG000|Overall Study|Other|5|||
129031807|NCT00860262|464406576|FG001|Overall Study|Other|3|||
129031808|NCT00860262|464406577|FG002|Overall Study|Other|1|||
129031809|NCT00124618|464406578|FG000|Overall Study|Ineligible|1|||
129031810|NCT01596127|464406579|FG000|Overall Study|Patient Ineligible|1|||
129031811|NCT01675596|464406580|FG000|Overall Study|Death|6|||
129031812|NCT01675596|464406580|FG000|Overall Study|Exit with other reason|1|||
129031813|NCT01675596|464406580|FG000|Overall Study|Missed Visit|1|||
128938398|NCT02680847|464062797|FG001|Overall Study|Unwilling to participate in study|1|||
128938399|NCT02680847|464062798|FG002|Overall Study|Unwilling to participate in study|0|||
128938400|NCT02680847|464062796|FG000|Overall Study|Lack of Efficacy|0|||
128938401|NCT02680847|464062797|FG001|Overall Study|Lack of Efficacy|0|||
128938402|NCT02680847|464062798|FG002|Overall Study|Lack of Efficacy|2|||
128938403|NCT02680847|464062796|FG000|Overall Study|Adverse Event|0|||
128938404|NCT02680847|464062797|FG001|Overall Study|Adverse Event|0|||
128938405|NCT02680847|464062798|FG002|Overall Study|Adverse Event|1|||
128938406|NCT00803244|464062801|FG000|Overall Study|Adverse Event|1|||
128938407|NCT00803244|464062802|FG001|Overall Study|Adverse Event|2|||
129031814|NCT00633022|464406581|FG000|Overall Study|Adverse Event|1|||
129031815|NCT00633022|464406582|FG001|Overall Study|Adverse Event|0|||
129031816|NCT00633022|464406583|FG002|Overall Study|Adverse Event|5|||
129031817|NCT00633022|464406581|FG000|Overall Study|Physician Decision|0|||
129122982|NCT04006457|464745488|FG000|Main Study Observation Period|Adverse Event|1|||
129122983|NCT04006457|464745489|FG001|Main Study Observation Period|Adverse Event|1|||
129122984|NCT04006457|464745490|FG002|Main Study Observation Period|Adverse Event|0|||
129122985|NCT04006457|464745488|FG000|Main Study Observation Period|Lost to Follow-up|0|||
129122986|NCT04006457|464745489|FG001|Main Study Observation Period|Lost to Follow-up|1|||
128938408|NCT00803244|464062801|FG000|Overall Study|Withdrawal by Subject|2|||
128938409|NCT00803244|464062802|FG001|Overall Study|Withdrawal by Subject|3|||
128938410|NCT00803244|464062801|FG000|Overall Study|Any other reason not above-mentioned|4|||
129122987|NCT04006457|464745490|FG002|Main Study Observation Period|Lost to Follow-up|0|||
129122988|NCT04006457|464745488|FG000|Main Study Observation Period|Pregnancy|1|||
129122989|NCT04006457|464745489|FG001|Main Study Observation Period|Pregnancy|0|||
129122990|NCT04006457|464745490|FG002|Main Study Observation Period|Pregnancy|0|||
129122991|NCT04006457|464745488|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
129122992|NCT04006457|464745489|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
129122993|NCT04006457|464745490|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
129122994|NCT04006457|464745488|FG000|Main Study Observation Period|Other|8|||
129122995|NCT04006457|464745489|FG001|Main Study Observation Period|Other|16|||
129122996|NCT04006457|464745490|FG002|Main Study Observation Period|Other|0|||
128938411|NCT00803244|464062802|FG001|Overall Study|Any other reason not above-mentioned|10|||
128938412|NCT02873715|464062803|FG000|Overall Study|Lost to Follow-up|84|||
128938413|NCT02873715|464062804|FG001|Overall Study|Lost to Follow-up|94|||
128938414|NCT02873715|464062803|FG000|Overall Study|Withdrawal by Subject|7|||
128938415|NCT02873715|464062804|FG001|Overall Study|Withdrawal by Subject|26|||
128938416|NCT02021812|464062808|FG000|Overall Study|Death|8|||
128938417|NCT02021812|464062808|FG000|Overall Study|Withdrawal by Subject|3|||
128938418|NCT02021812|464062808|FG000|Overall Study|Lost to Follow-up|2|||
128938419|NCT02021812|464062808|FG000|Overall Study|Refuse to return, COVD 19|2|||
128938420|NCT00564629|464062809|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
128938421|NCT00564629|464062810|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
128938422|NCT03241173|464062811|FG000|Overall Study|Death|3|||
128938423|NCT03241173|464062812|FG001|Overall Study|Death|2|||
128938424|NCT03241173|464062813|FG002|Overall Study|Death|4|||
128938425|NCT03241173|464062814|FG003|Overall Study|Death|4|||
128938426|NCT03241173|464062815|FG004|Overall Study|Death|2|||
128938427|NCT03241173|464062816|FG005|Overall Study|Death|2|||
128938428|NCT03241173|464062817|FG006|Overall Study|Death|3|||
128938429|NCT03241173|464062818|FG007|Overall Study|Death|1|||
128938430|NCT03241173|464062819|FG008|Overall Study|Death|0|||
128938431|NCT03241173|464062820|FG009|Overall Study|Death|5|||
128938432|NCT03241173|464062821|FG010|Overall Study|Death|4|||
128938433|NCT03241173|464062822|FG011|Overall Study|Death|3|||
128938434|NCT03241173|464062823|FG012|Overall Study|Death|0|||
128938435|NCT03241173|464062824|FG013|Overall Study|Death|0|||
128938436|NCT03241173|464062825|FG014|Overall Study|Death|0|||
128938437|NCT03241173|464062811|FG000|Overall Study|Withdrawal by Subject|0|||
128938438|NCT03241173|464062812|FG001|Overall Study|Withdrawal by Subject|0|||
128938439|NCT03241173|464062813|FG002|Overall Study|Withdrawal by Subject|1|||
128938440|NCT03241173|464062814|FG003|Overall Study|Withdrawal by Subject|0|||
128938441|NCT03241173|464062815|FG004|Overall Study|Withdrawal by Subject|0|||
128938442|NCT03241173|464062816|FG005|Overall Study|Withdrawal by Subject|1|||
128938443|NCT03241173|464062817|FG006|Overall Study|Withdrawal by Subject|0|||
128938444|NCT03241173|464062818|FG007|Overall Study|Withdrawal by Subject|0|||
128938445|NCT03241173|464062819|FG008|Overall Study|Withdrawal by Subject|0|||
128938446|NCT03241173|464062820|FG009|Overall Study|Withdrawal by Subject|0|||
128938447|NCT03241173|464062821|FG010|Overall Study|Withdrawal by Subject|0|||
128938448|NCT03241173|464062822|FG011|Overall Study|Withdrawal by Subject|0|||
128938449|NCT03241173|464062823|FG012|Overall Study|Withdrawal by Subject|0|||
128938450|NCT03241173|464062824|FG013|Overall Study|Withdrawal by Subject|0|||
128938451|NCT03241173|464062825|FG014|Overall Study|Withdrawal by Subject|0|||
128938452|NCT03241173|464062811|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
129122997|NCT04006457|464745488|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
129122998|NCT04006457|464745489|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
129122999|NCT04006457|464745490|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
129123000|NCT04006457|464745488|FG000|Main Study Observation Period|Ongoing|2|||
129123001|NCT04006457|464745489|FG001|Main Study Observation Period|Ongoing|1|||
129123002|NCT04006457|464745490|FG002|Main Study Observation Period|Ongoing|0|||
129123003|NCT04006457|464745488|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
128938453|NCT03241173|464062812|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
128938454|NCT03241173|464062813|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
128938455|NCT03241173|464062814|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
128938456|NCT03241173|464062815|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
128938457|NCT03241173|464062816|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
128938458|NCT03241173|464062817|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
128938459|NCT03241173|464062818|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
128938460|NCT03241173|464062819|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
128938461|NCT03241173|464062820|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
128938462|NCT03241173|464062821|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
128938463|NCT03241173|464062822|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
128938464|NCT03241173|464062823|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
128938465|NCT03241173|464062824|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
128938466|NCT03241173|464062825|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
128938467|NCT03241173|464062811|FG000|Overall Study|Lost to Follow-up|0|||
128938468|NCT03241173|464062812|FG001|Overall Study|Lost to Follow-up|0|||
128938469|NCT03241173|464062813|FG002|Overall Study|Lost to Follow-up|0|||
128938470|NCT03241173|464062814|FG003|Overall Study|Lost to Follow-up|0|||
128938471|NCT03241173|464062815|FG004|Overall Study|Lost to Follow-up|1|||
128938472|NCT03241173|464062816|FG005|Overall Study|Lost to Follow-up|0|||
128938473|NCT03241173|464062817|FG006|Overall Study|Lost to Follow-up|0|||
128938474|NCT03241173|464062818|FG007|Overall Study|Lost to Follow-up|0|||
128938475|NCT03241173|464062819|FG008|Overall Study|Lost to Follow-up|0|||
128938476|NCT03241173|464062820|FG009|Overall Study|Lost to Follow-up|1|||
128938477|NCT03241173|464062821|FG010|Overall Study|Lost to Follow-up|0|||
128938478|NCT03241173|464062822|FG011|Overall Study|Lost to Follow-up|0|||
128938479|NCT03241173|464062823|FG012|Overall Study|Lost to Follow-up|0|||
128938480|NCT03241173|464062824|FG013|Overall Study|Lost to Follow-up|0|||
128938481|NCT03241173|464062825|FG014|Overall Study|Lost to Follow-up|0|||
128938482|NCT03634072|464062826|FG000|Overall Study|Early termination of overall study|1|||
128938483|NCT03634072|464062827|FG001|Overall Study|Early termination of overall study|0|||
128938484|NCT00590681|464062828|FG000|Overall Study|Withdrawal by Subject|7|||
128938485|NCT00590681|464062828|FG000|Overall Study|Adverse Event|8|||
128938486|NCT00590681|464062828|FG000|Overall Study|Death|3|||
128938487|NCT00590681|464062828|FG000|Overall Study|Lost to Follow-up|1|||
128938488|NCT00590681|464062828|FG000|Overall Study|disease progression|1|||
128938489|NCT00053846|464062831|FG000|Overall Study|Changed mind|8|||
128938490|NCT00053846|464062832|FG001|Overall Study|Changed mind|13|||
128938491|NCT00053846|464062831|FG000|Overall Study|Became too ill|8|||
128938492|NCT00053846|464062832|FG001|Overall Study|Became too ill|7|||
128938493|NCT00053846|464062831|FG000|Overall Study|Expired|5|||
128938494|NCT00053846|464062832|FG001|Overall Study|Expired|0|||
128938495|NCT00053846|464062831|FG000|Overall Study|Became ineligible|3|||
128938496|NCT00053846|464062832|FG001|Overall Study|Became ineligible|1|||
128938497|NCT00053846|464062831|FG000|Overall Study|Did not return data|1|||
128938498|NCT00053846|464062832|FG001|Overall Study|Did not return data|2|||
128938499|NCT00053846|464062831|FG000|Overall Study|Quit due to side effects|1|||
128938500|NCT00053846|464062832|FG001|Overall Study|Quit due to side effects|3|||
128938501|NCT00053846|464062831|FG000|Overall Study|Pills too large|0|||
128938502|NCT00053846|464062832|FG001|Overall Study|Pills too large|1|||
128938503|NCT00064662|464062833|FG000|Overall Study|Death|1|||
128938504|NCT00064662|464062834|FG001|Overall Study|Death|1|||
128938505|NCT00064662|464062833|FG000|Overall Study|Lost to Follow-up|57|||
128938506|NCT00064662|464062834|FG001|Overall Study|Lost to Follow-up|44|||
128938507|NCT00064662|464062833|FG000|Overall Study|Withdrawal by Subject|14|||
128938508|NCT00064662|464062834|FG001|Overall Study|Withdrawal by Subject|14|||
128938509|NCT00064662|464062833|FG000|Overall Study|Administratively withdrawn|2|||
128938510|NCT00064662|464062834|FG001|Overall Study|Administratively withdrawn|2|||
128938511|NCT01345786|464062842|FG000|Overall Study|Adverse Event|0|||
128938512|NCT01345786|464062843|FG001|Overall Study|Adverse Event|1|||
128938513|NCT01345786|464062844|FG002|Overall Study|Adverse Event|3|||
128938514|NCT01345786|464062845|FG003|Overall Study|Adverse Event|1|||
128938515|NCT01345786|464062842|FG000|Overall Study|Subject withdrew consent|2|||
128938516|NCT01345786|464062843|FG001|Overall Study|Subject withdrew consent|2|||
128938517|NCT01345786|464062844|FG002|Overall Study|Subject withdrew consent|1|||
128938518|NCT01345786|464062845|FG003|Overall Study|Subject withdrew consent|0|||
128938519|NCT01345786|464062842|FG000|Overall Study|Noncompliance with protocol|1|||
128938520|NCT01345786|464062843|FG001|Overall Study|Noncompliance with protocol|0|||
128938521|NCT01345786|464062844|FG002|Overall Study|Noncompliance with protocol|1|||
128938522|NCT01345786|464062845|FG003|Overall Study|Noncompliance with protocol|0|||
128938523|NCT01345786|464062842|FG000|Overall Study|Administrative|3|||
128938524|NCT01345786|464062843|FG001|Overall Study|Administrative|5|||
128938525|NCT01345786|464062844|FG002|Overall Study|Administrative|0|||
128938526|NCT01345786|464062845|FG003|Overall Study|Administrative|0|||
128938527|NCT01345786|464062842|FG000|Overall Study|Lost to Follow-up|0|||
128938528|NCT01345786|464062843|FG001|Overall Study|Lost to Follow-up|0|||
128938529|NCT01345786|464062844|FG002|Overall Study|Lost to Follow-up|0|||
128938530|NCT01345786|464062845|FG003|Overall Study|Lost to Follow-up|2|||
128938531|NCT01929044|464062846|FG000|Overall Study|Adverse Event|1|||
128938532|NCT01929044|464062847|FG001|Overall Study|Adverse Event|0|||
128938533|NCT01929044|464062846|FG000|Overall Study|Protocol Violation|9|||
128938534|NCT01929044|464062847|FG001|Overall Study|Protocol Violation|14|||
128938535|NCT01929044|464062846|FG000|Overall Study|Not Treated|1|||
128938536|NCT01929044|464062847|FG001|Overall Study|Not Treated|3|||
128938537|NCT02807454|464062850|FG000|Overall Study|Adverse Event|1|||
128938538|NCT02807454|464062851|FG001|Overall Study|Adverse Event|0|||
128938539|NCT02807454|464062850|FG000|Overall Study|Withdrawal by Subject|0|||
128938540|NCT02807454|464062851|FG001|Overall Study|Withdrawal by Subject|1|||
128938541|NCT02807454|464062850|FG000|Overall Study|Progressive Disease|30|||
128938542|NCT02807454|464062851|FG001|Overall Study|Progressive Disease|3|||
128938543|NCT02807454|464062850|FG000|Overall Study|Other Reasons|1|||
128938544|NCT02807454|464062851|FG001|Overall Study|Other Reasons|1|||
128938545|NCT02582749|464062852|FG000|Overall Study|Study terminated by funder|5|||
128938546|NCT02582749|464062853|FG001|Overall Study|Study terminated by funder|10|||
128938547|NCT02582749|464062852|FG000|Overall Study|Withdrawal by Subject|0|||
128938548|NCT02582749|464062853|FG001|Overall Study|Withdrawal by Subject|1|||
128938549|NCT02566525|464062854|FG000|Overall Study|Protocol Violation|3|||
129123004|NCT04006457|464745489|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
129123005|NCT04006457|464745490|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
129123006|NCT04486716|464745491|FG000|Core Phase|Subject decision|6|||
129123007|NCT04486716|464745491|FG000|Core Phase|Adverse Event|5|||
129123008|NCT04486716|464745491|FG000|Core Phase|Lost to Follow-up|1|||
129123009|NCT04486716|464745491|FG000|Core Phase|Physician Decision|1|||
129123010|NCT04486716|464745491|FG000|Core Phase|Enrolled subjects not treated|9|||
129123011|NCT02332707|464745492|FG000|Overall Study|Adverse Event|0|||
129123012|NCT02332707|464745493|FG001|Overall Study|Adverse Event|0|||
129123013|NCT02332707|464745494|FG002|Overall Study|Adverse Event|0|||
129123014|NCT02332707|464745495|FG003|Overall Study|Adverse Event|0|||
129123015|NCT02332707|464745496|FG004|Overall Study|Adverse Event|0|||
129123016|NCT02332707|464745497|FG005|Overall Study|Adverse Event|0|||
129123017|NCT02332707|464745498|FG006|Overall Study|Adverse Event|0|||
129123018|NCT02332707|464745499|FG007|Overall Study|Adverse Event|0|||
129123019|NCT02332707|464745500|FG008|Overall Study|Adverse Event|0|||
129123020|NCT02332707|464745501|FG009|Overall Study|Adverse Event|0|||
129123021|NCT02332707|464745502|FG010|Overall Study|Adverse Event|0|||
129123022|NCT02332707|464745503|FG011|Overall Study|Adverse Event|0|||
129123023|NCT02332707|464745504|FG012|Overall Study|Adverse Event|1|||
129123024|NCT02332707|464745505|FG013|Overall Study|Adverse Event|0|||
129123025|NCT02332707|464745506|FG014|Overall Study|Adverse Event|0|||
129123026|NCT02332707|464745507|FG015|Overall Study|Adverse Event|0|||
129123027|NCT02332707|464745508|FG016|Overall Study|Adverse Event|0|||
129123028|NCT02332707|464745509|FG017|Overall Study|Adverse Event|0|||
129123029|NCT02332707|464745492|FG000|Overall Study|Lost to Follow-up|0|||
129123030|NCT02332707|464745493|FG001|Overall Study|Lost to Follow-up|0|||
129123031|NCT02332707|464745494|FG002|Overall Study|Lost to Follow-up|0|||
129123032|NCT02332707|464745495|FG003|Overall Study|Lost to Follow-up|0|||
129123033|NCT02332707|464745496|FG004|Overall Study|Lost to Follow-up|0|||
129123034|NCT02332707|464745497|FG005|Overall Study|Lost to Follow-up|1|||
129123035|NCT02332707|464745498|FG006|Overall Study|Lost to Follow-up|0|||
129123036|NCT02332707|464745499|FG007|Overall Study|Lost to Follow-up|0|||
129123037|NCT02332707|464745500|FG008|Overall Study|Lost to Follow-up|0|||
129123038|NCT02332707|464745501|FG009|Overall Study|Lost to Follow-up|0|||
129123039|NCT02332707|464745502|FG010|Overall Study|Lost to Follow-up|2|||
129123040|NCT02332707|464745503|FG011|Overall Study|Lost to Follow-up|0|||
129123041|NCT02332707|464745504|FG012|Overall Study|Lost to Follow-up|3|||
129123042|NCT02332707|464745505|FG013|Overall Study|Lost to Follow-up|0|||
129123043|NCT02332707|464745506|FG014|Overall Study|Lost to Follow-up|0|||
129123044|NCT02332707|464745507|FG015|Overall Study|Lost to Follow-up|0|||
129123045|NCT02332707|464745508|FG016|Overall Study|Lost to Follow-up|0|||
129123046|NCT02332707|464745509|FG017|Overall Study|Lost to Follow-up|0|||
129123047|NCT02332707|464745492|FG000|Overall Study|Physician Decision|0|||
129123048|NCT02332707|464745493|FG001|Overall Study|Physician Decision|0|||
129123049|NCT02332707|464745494|FG002|Overall Study|Physician Decision|0|||
129123050|NCT02332707|464745495|FG003|Overall Study|Physician Decision|1|||
128938550|NCT02566525|464062855|FG001|Overall Study|Protocol Violation|5|||
128938551|NCT01663740|464062856|FG000|Overall Study|Lost to Follow-up|1|||
129123051|NCT02332707|464745496|FG004|Overall Study|Physician Decision|0|||
129123052|NCT02332707|464745497|FG005|Overall Study|Physician Decision|0|||
129123053|NCT02332707|464745498|FG006|Overall Study|Physician Decision|0|||
129123054|NCT02332707|464745499|FG007|Overall Study|Physician Decision|0|||
129123055|NCT02332707|464745500|FG008|Overall Study|Physician Decision|0|||
129123056|NCT02332707|464745501|FG009|Overall Study|Physician Decision|0|||
129123057|NCT02332707|464745502|FG010|Overall Study|Physician Decision|0|||
129123058|NCT02332707|464745503|FG011|Overall Study|Physician Decision|0|||
129123059|NCT02332707|464745504|FG012|Overall Study|Physician Decision|1|||
129123060|NCT02332707|464745505|FG013|Overall Study|Physician Decision|0|||
129123061|NCT02332707|464745506|FG014|Overall Study|Physician Decision|0|||
129123062|NCT02332707|464745507|FG015|Overall Study|Physician Decision|0|||
129123063|NCT02332707|464745508|FG016|Overall Study|Physician Decision|0|||
129123064|NCT02332707|464745509|FG017|Overall Study|Physician Decision|0|||
129123065|NCT02332707|464745492|FG000|Overall Study|Withdrawal by Subject|0|||
129123066|NCT02332707|464745493|FG001|Overall Study|Withdrawal by Subject|0|||
129217701|NCT02745119|465097044|FG001|Overall Study|Protocol Deviation|0|||
128769746|NCT00366301|463448234|FG001|Overall Study|Lost to Follow-up|4|||
128769747|NCT00366301|463448235|FG002|Overall Study|Lost to Follow-up|3|||
128769748|NCT00366301|463448236|FG003|Overall Study|Lost to Follow-up|7|||
128769749|NCT00366301|463448233|FG000|Overall Study|Withdrawal by Subject|4|||
128769750|NCT00366301|463448234|FG001|Overall Study|Withdrawal by Subject|2|||
128769751|NCT00366301|463448235|FG002|Overall Study|Withdrawal by Subject|1|||
128769752|NCT00366301|463448236|FG003|Overall Study|Withdrawal by Subject|1|||
128769753|NCT01348776|463448241|FG000|Overall Study|Lost to Follow-up|3|||
128769754|NCT01463293|463448242|FG000|Overall Study|Lost to Follow-up|1|||
128769755|NCT01463293|463448243|FG001|Overall Study|Lost to Follow-up|4|||
128769756|NCT01463293|463448244|FG002|Overall Study|Lost to Follow-up|5|||
128769757|NCT01463293|463448242|FG000|Overall Study|Adverse Event|1|||
128769758|NCT01463293|463448243|FG001|Overall Study|Adverse Event|2|||
128769759|NCT01463293|463448244|FG002|Overall Study|Adverse Event|0|||
128769760|NCT01463293|463448242|FG000|Overall Study|Withdrawal by Subject|4|||
128769761|NCT01463293|463448243|FG001|Overall Study|Withdrawal by Subject|10|||
128769762|NCT01463293|463448244|FG002|Overall Study|Withdrawal by Subject|5|||
129123067|NCT02332707|464745494|FG002|Overall Study|Withdrawal by Subject|1|||
129123068|NCT02332707|464745495|FG003|Overall Study|Withdrawal by Subject|0|||
129123069|NCT02332707|464745496|FG004|Overall Study|Withdrawal by Subject|0|||
129123070|NCT02332707|464745497|FG005|Overall Study|Withdrawal by Subject|0|||
129123071|NCT02332707|464745498|FG006|Overall Study|Withdrawal by Subject|0|||
129123072|NCT02332707|464745499|FG007|Overall Study|Withdrawal by Subject|0|||
129123073|NCT02332707|464745500|FG008|Overall Study|Withdrawal by Subject|0|||
129123074|NCT02332707|464745501|FG009|Overall Study|Withdrawal by Subject|3|||
129123075|NCT02332707|464745502|FG010|Overall Study|Withdrawal by Subject|0|||
129123076|NCT02332707|464745503|FG011|Overall Study|Withdrawal by Subject|0|||
129123077|NCT02332707|464745504|FG012|Overall Study|Withdrawal by Subject|0|||
129123078|NCT02332707|464745505|FG013|Overall Study|Withdrawal by Subject|0|||
129123079|NCT02332707|464745506|FG014|Overall Study|Withdrawal by Subject|0|||
129123080|NCT02332707|464745507|FG015|Overall Study|Withdrawal by Subject|0|||
129123081|NCT02332707|464745508|FG016|Overall Study|Withdrawal by Subject|0|||
129123082|NCT02332707|464745509|FG017|Overall Study|Withdrawal by Subject|0|||
129123083|NCT00947544|464745514|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
129123084|NCT00947544|464745515|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
129123085|NCT01240746|464745516|FG000|Overall Study|Adverse Event|2|||
129123086|NCT01240746|464745517|FG001|Overall Study|Adverse Event|0|||
129123087|NCT01240746|464745518|FG002|Overall Study|Adverse Event|10|||
129123088|NCT01240746|464745516|FG000|Overall Study|Lost to Follow-up|23|||
128938552|NCT01663740|464062857|FG001|Overall Study|Lost to Follow-up|4|||
128938553|NCT01663740|464062856|FG000|Overall Study|Other|9|||
128938554|NCT01663740|464062857|FG001|Overall Study|Other|2|||
128938555|NCT01663740|464062856|FG000|Overall Study|Inclusion/Exclusion not met|1|||
128938556|NCT01663740|464062857|FG001|Overall Study|Inclusion/Exclusion not met|0|||
128938557|NCT01663740|464062856|FG000|Overall Study|Death|0|||
128938558|NCT01663740|464062857|FG001|Overall Study|Death|1|||
128938559|NCT01663740|464062856|FG000|Overall Study|Withdrawal by Subject|2|||
128938560|NCT01663740|464062857|FG001|Overall Study|Withdrawal by Subject|1|||
128938561|NCT01663740|464062856|FG000|Overall Study|No end of study status|3|||
128938562|NCT01663740|464062857|FG001|Overall Study|No end of study status|0|||
128938563|NCT01989546|464064960|FG000|Overall Study|Clinical Progression|1|||
128938564|NCT01989546|464064960|FG000|Overall Study|Disease progression on study|8|||
128938565|NCT00059215|464064961|FG000|Overall Study|Adverse Event|5|||
128938566|NCT00059215|464064962|FG001|Overall Study|Adverse Event|5|||
128938567|NCT00059215|464064963|FG002|Overall Study|Adverse Event|9|||
128938568|NCT00059215|464064964|FG003|Overall Study|Adverse Event|9|||
128938569|NCT00059215|464064961|FG000|Overall Study|Death|0|||
128938570|NCT00059215|464064962|FG001|Overall Study|Death|0|||
129123089|NCT01240746|464745517|FG001|Overall Study|Lost to Follow-up|20|||
128938571|NCT00059215|464064963|FG002|Overall Study|Death|3|||
129123090|NCT01240746|464745518|FG002|Overall Study|Lost to Follow-up|102|||
129217702|NCT02745119|465097045|FG002|Overall Study|Protocol Deviation|0|||
129217703|NCT02745119|465097046|FG003|Overall Study|Protocol Deviation|1|||
128769763|NCT01463293|463448242|FG000|Overall Study|Other|0|||
128769764|NCT01463293|463448243|FG001|Overall Study|Other|0|||
128938572|NCT00059215|464064964|FG003|Overall Study|Death|0|||
128938573|NCT00059215|464064961|FG000|Overall Study|Lost to Follow-up|1|||
128938574|NCT00059215|464064962|FG001|Overall Study|Lost to Follow-up|2|||
128938575|NCT00059215|464064963|FG002|Overall Study|Lost to Follow-up|0|||
129123091|NCT01240746|464745516|FG000|Overall Study|Protocol Violation|24|||
129123092|NCT01240746|464745517|FG001|Overall Study|Protocol Violation|15|||
129123093|NCT01240746|464745518|FG002|Overall Study|Protocol Violation|72|||
129123094|NCT01240746|464745516|FG000|Overall Study|Withdrawal by Subject|10|||
129123095|NCT01240746|464745517|FG001|Overall Study|Withdrawal by Subject|13|||
129217704|NCT02745119|465097043|FG000|Overall Study|Withdrawal by Subject|7|||
128769765|NCT01463293|463448244|FG002|Overall Study|Other|2|||
128938576|NCT00059215|464064964|FG003|Overall Study|Lost to Follow-up|0|||
128938577|NCT00059215|464064961|FG000|Overall Study|Withdrawal by Subject|4|||
128938578|NCT00059215|464064962|FG001|Overall Study|Withdrawal by Subject|4|||
129031818|NCT00633022|464406582|FG001|Overall Study|Physician Decision|1|||
129031819|NCT00633022|464406583|FG002|Overall Study|Physician Decision|0|||
129031820|NCT04388787|464406585|FG000|Blinded Period|Patient could not follow instructions|1|||
129031821|NCT04388787|464406585|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
129031822|NCT00688844|464406586|FG000|Overall Study|Lost to Follow-up|10|||
129031823|NCT01374451|464406587|FG000|Overall Study|Administrative problems|1|||
129031824|NCT01374451|464406588|FG001|Overall Study|Administrative problems|0|||
129031825|NCT01223027|464406589|FG000|Overall Study|Adverse Event|20|||
129031826|NCT01223027|464406590|FG001|Overall Study|Adverse Event|10|||
129031827|NCT01223027|464406589|FG000|Overall Study|Death|42|||
129031828|NCT01223027|464406590|FG001|Overall Study|Death|42|||
129031829|NCT01223027|464406589|FG000|Overall Study|Lost to Follow-up|2|||
129123096|NCT01240746|464745518|FG002|Overall Study|Withdrawal by Subject|59|||
129123097|NCT02471183|464745522|FG000|Main Treatment Period|Adverse Event|1|||
129123098|NCT02471183|464745522|FG000|Main Treatment Period|Withdrawal by Subject|1|||
129123099|NCT02471183|464745522|FG000|Extended Treatment Period|Lack of Efficacy|1|||
129123100|NCT02690727|464745523|FG000|Overall Study|Adverse Event|2|||
129123101|NCT02690727|464745524|FG001|Overall Study|Adverse Event|2|||
129123102|NCT01461551|464745532|FG000|Overall Study|Physician Decision|2|||
129123103|NCT01461551|464745533|FG001|Overall Study|Physician Decision|1|||
128707162|NCT01756898|463222184|FG002|Overall Study|Lost to Follow-up|2|||
128707163|NCT01756898|463222185|FG003|Overall Study|Lost to Follow-up|3|||
128707164|NCT01756898|463222182|FG000|Overall Study|Protocol Violation|1|||
128707165|NCT01756898|463222183|FG001|Overall Study|Protocol Violation|2|||
128707166|NCT01756898|463222184|FG002|Overall Study|Protocol Violation|2|||
128707167|NCT01756898|463222185|FG003|Overall Study|Protocol Violation|1|||
128707168|NCT01756898|463222182|FG000|Overall Study|Withdrew Consent|5|||
128707169|NCT01756898|463222183|FG001|Overall Study|Withdrew Consent|3|||
128707170|NCT01756898|463222184|FG002|Overall Study|Withdrew Consent|5|||
128707171|NCT01756898|463222185|FG003|Overall Study|Withdrew Consent|6|||
128707172|NCT01756898|463222182|FG000|Overall Study|Other|0|||
128707173|NCT01756898|463222183|FG001|Overall Study|Other|2|||
128707174|NCT01756898|463222184|FG002|Overall Study|Other|2|||
128707175|NCT01756898|463222185|FG003|Overall Study|Other|0|||
128707176|NCT00496054|463222186|FG000|Overall Study|Adverse Event|1|||
128707177|NCT00496054|463222186|FG000|Overall Study|Lost to Follow-up|7|||
128707178|NCT00471328|463222189|FG000|Core Phase|Adverse Event|18|||
128707179|NCT00471328|463222190|FG001|Core Phase|Adverse Event|6|||
128707180|NCT00471328|463222189|FG000|Core Phase|Death|8|||
128707181|NCT00471328|463222190|FG001|Core Phase|Death|4|||
128707182|NCT00471328|463222189|FG000|Core Phase|Withdrawal by Subject|2|||
128707183|NCT00471328|463222190|FG001|Core Phase|Withdrawal by Subject|2|||
128707184|NCT00471328|463222189|FG000|Core Phase|Abnormal laboratory value|1|||
128707185|NCT00471328|463222190|FG001|Core Phase|Abnormal laboratory value|0|||
128707186|NCT00471328|463222189|FG000|Core Phase|Disease Progression|78|||
128707187|NCT00471328|463222190|FG001|Core Phase|Disease Progression|53|||
128707188|NCT00471328|463222189|FG000|Core Phase|Administrative Problem|0|||
128707189|NCT00471328|463222190|FG001|Core Phase|Administrative Problem|1|||
128707190|NCT00471328|463222189|FG000|Core Phase|Protocol Deviation|0|||
128707191|NCT00471328|463222190|FG001|Core Phase|Protocol Deviation|1|||
128707192|NCT00471328|463222189|FG000|Extension Phase|Adverse Event|3|||
128707193|NCT00471328|463222190|FG001|Extension Phase|Adverse Event|12|||
128707194|NCT00471328|463222189|FG000|Extension Phase|Withdrawal by Subject|0|||
128707195|NCT00471328|463222190|FG001|Extension Phase|Withdrawal by Subject|2|||
128707196|NCT00471328|463222189|FG000|Extension Phase|Death|1|||
128707197|NCT00471328|463222190|FG001|Extension Phase|Death|7|||
128707198|NCT00471328|463222189|FG000|Extension Phase|Protocol Deviation|3|||
128707199|NCT00471328|463222190|FG001|Extension Phase|Protocol Deviation|1|||
128707200|NCT00471328|463222189|FG000|Extension Phase|Treatment duration as per protocol|0|||
128707201|NCT00471328|463222190|FG001|Extension Phase|Treatment duration as per protocol|1|||
128707202|NCT00471328|463222189|FG000|Extension Phase|Disease Progression|32|||
128707203|NCT00471328|463222190|FG001|Extension Phase|Disease Progression|44|||
128707204|NCT00471328|463222189|FG000|Extension Phase|New cancer Therapy|1|||
129217705|NCT02745119|465097044|FG001|Overall Study|Withdrawal by Subject|15|||
129217706|NCT02745119|465097045|FG002|Overall Study|Withdrawal by Subject|8|||
128707205|NCT00471328|463222190|FG001|Extension Phase|New cancer Therapy|0|||
128707206|NCT00471328|463222189|FG000|Extension Phase|Administrative Problem|1|||
128707207|NCT00471328|463222190|FG001|Extension Phase|Administrative Problem|0|||
128707208|NCT04051008|463222191|FG000|Overall Study|Withdrawal by Subject|2|||
128707209|NCT04051008|463222192|FG001|Overall Study|Withdrawal by Subject|0|||
128707210|NCT04051008|463222193|FG002|Overall Study|Withdrawal by Subject|1|||
128707211|NCT02132130|463222196|FG000|Overall Study|Lost to Follow-up|0|||
128707212|NCT02132130|463222197|FG001|Overall Study|Lost to Follow-up|2|||
128707213|NCT02132130|463222198|FG002|Overall Study|Lost to Follow-up|0|||
129031830|NCT01223027|464406590|FG001|Overall Study|Lost to Follow-up|1|||
129031831|NCT01223027|464406589|FG000|Overall Study|Physician Decision|4|||
129031832|NCT01223027|464406590|FG001|Overall Study|Physician Decision|8|||
129031833|NCT01223027|464406589|FG000|Overall Study|Progressive Disease|167|||
129031834|NCT01223027|464406590|FG001|Overall Study|Progressive Disease|183|||
128938579|NCT00059215|464064963|FG002|Overall Study|Withdrawal by Subject|1|||
128938580|NCT00059215|464064964|FG003|Overall Study|Withdrawal by Subject|3|||
128938581|NCT00059215|464064961|FG000|Overall Study|Protocol Violation|1|||
128938582|NCT00059215|464064962|FG001|Overall Study|Protocol Violation|0|||
128938583|NCT00059215|464064963|FG002|Overall Study|Protocol Violation|1|||
128938584|NCT00059215|464064964|FG003|Overall Study|Protocol Violation|0|||
128938585|NCT00059215|464064961|FG000|Overall Study|Protocol entry criteria not met|1|||
128938586|NCT00059215|464064962|FG001|Overall Study|Protocol entry criteria not met|1|||
128938587|NCT00059215|464064963|FG002|Overall Study|Protocol entry criteria not met|0|||
128938588|NCT00059215|464064964|FG003|Overall Study|Protocol entry criteria not met|2|||
128938589|NCT00059215|464064961|FG000|Overall Study|Physician Decision|1|||
128938590|NCT00059215|464064962|FG001|Overall Study|Physician Decision|2|||
128938591|NCT00059215|464064963|FG002|Overall Study|Physician Decision|1|||
128938592|NCT00059215|464064964|FG003|Overall Study|Physician Decision|1|||
128938593|NCT00414310|464064965|FG000|Overall Study|Not treated|1|||
128938594|NCT00414310|464064966|FG001|Overall Study|Not treated|0|||
128938595|NCT01254604|464064967|FG000|Overall Study|Lost to Follow-up|1|||
128938596|NCT01254604|464064968|FG001|Overall Study|Lost to Follow-up|1|||
128938597|NCT01254604|464064967|FG000|Overall Study|Protocol Violation|2|||
128938598|NCT01254604|464064968|FG001|Overall Study|Protocol Violation|2|||
128938599|NCT01254604|464064967|FG000|Overall Study|Withdrawal by Subject|2|||
128938600|NCT01254604|464064968|FG001|Overall Study|Withdrawal by Subject|4|||
128938601|NCT01254604|464064967|FG000|Overall Study|Adverse Event|3|||
128938602|NCT01254604|464064968|FG001|Overall Study|Adverse Event|2|||
128938603|NCT03074162|464064969|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
128938604|NCT03074162|464064970|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
128938605|NCT03074162|464064971|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
128938606|NCT03074162|464064972|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
128938607|NCT03074162|464064973|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
128938608|NCT03074162|464064974|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
128938609|NCT03074162|464064969|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
128938610|NCT03074162|464064970|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
128938611|NCT03074162|464064971|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
128938612|NCT03074162|464064972|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
128938613|NCT03074162|464064973|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
128938614|NCT03074162|464064974|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
128938615|NCT03074162|464064969|FG000|Period 3|Withdrawal by Subject|1|||
128938616|NCT03074162|464064970|FG001|Period 3|Withdrawal by Subject|0|||
128938617|NCT03074162|464064971|FG002|Period 3|Withdrawal by Subject|0|||
128938618|NCT03074162|464064972|FG003|Period 3|Withdrawal by Subject|0|||
128938619|NCT03074162|464064973|FG004|Period 3|Withdrawal by Subject|1|||
128938620|NCT03074162|464064974|FG005|Period 3|Withdrawal by Subject|0|||
128938621|NCT01993329|464064975|FG000|Period 2|Adverse Event|0|||
128938622|NCT01993329|464064976|FG001|Period 2|Adverse Event|0|||
128938623|NCT01993329|464064977|FG002|Period 2|Adverse Event|0|||
128938624|NCT01993329|464064978|FG003|Period 2|Adverse Event|0|||
128938625|NCT01993329|464064979|FG004|Period 2|Adverse Event|0|||
128938626|NCT01993329|464064980|FG005|Period 2|Adverse Event|1|||
128938627|NCT01993329|464064975|FG000|Wash-out|Personal reasons|0|||
128938628|NCT01993329|464064976|FG001|Wash-out|Personal reasons|1|||
128938629|NCT01993329|464064977|FG002|Wash-out|Personal reasons|0|||
128938630|NCT01993329|464064978|FG003|Wash-out|Personal reasons|0|||
128938631|NCT01993329|464064979|FG004|Wash-out|Personal reasons|0|||
128938632|NCT01993329|464064980|FG005|Wash-out|Personal reasons|0|||
128938633|NCT03041116|464064981|FG000|Double-blind|Death|0|||
128938634|NCT03041116|464064982|FG001|Double-blind|Death|2|||
128938635|NCT03041116|464064981|FG000|Double-blind|Withdrawal by Subject|0|||
129031835|NCT01223027|464406589|FG000|Overall Study|Protocol Violation|2|||
129031836|NCT01223027|464406590|FG001|Overall Study|Protocol Violation|1|||
129031837|NCT01223027|464406589|FG000|Overall Study|Subject/guardian decicion|18|||
129031838|NCT01223027|464406590|FG001|Overall Study|Subject/guardian decicion|16|||
129031839|NCT01223027|464406589|FG000|Overall Study|New therapy for study indication|17|||
129031840|NCT01223027|464406590|FG001|Overall Study|New therapy for study indication|8|||
129031841|NCT01223027|464406589|FG000|Overall Study|Study terminated by sponsor|2|||
129031842|NCT01223027|464406590|FG001|Overall Study|Study terminated by sponsor|8|||
129031843|NCT02061280|464406591|FG000|Overall Study|Protocol Violation|12|||
129031844|NCT02061280|464406592|FG001|Overall Study|Protocol Violation|8|||
129031845|NCT02061280|464406591|FG000|Overall Study|moved out of state|0|||
129123104|NCT01461551|464745534|FG002|Overall Study|Physician Decision|2|||
129123105|NCT00827567|464745535|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
128707214|NCT02132130|463222199|FG003|Overall Study|Lost to Follow-up|0|||
128938636|NCT03041116|464064982|FG001|Double-blind|Withdrawal by Subject|4|||
128938637|NCT03041116|464064981|FG000|Open-label|Death|1|||
128938638|NCT03041116|464064982|FG001|Open-label|Death|0|||
129031846|NCT02061280|464406592|FG001|Overall Study|moved out of state|1|||
129031847|NCT02061280|464406591|FG000|Overall Study|Withdrawal by Subject|1|||
129031848|NCT02061280|464406592|FG001|Overall Study|Withdrawal by Subject|2|||
129031849|NCT02061280|464406591|FG000|Overall Study|Lost to Follow-up|5|||
129123106|NCT01155141|464745536|FG000|Overall Study|Withdrawal by Subject|1|||
128938639|NCT03041116|464064981|FG000|Open-label|Termination of the study by Sponsor|39|||
128938640|NCT03041116|464064982|FG001|Open-label|Termination of the study by Sponsor|37|||
128938641|NCT03041116|464064981|FG000|Open-label|Withdrawal by Subject|1|||
128938642|NCT03041116|464064982|FG001|Open-label|Withdrawal by Subject|0|||
128938643|NCT01781429|464064986|FG000|Overall Study|Death|0|||
128938644|NCT01781429|464064987|FG001|Overall Study|Death|0|||
128938645|NCT01781429|464064988|FG002|Overall Study|Death|0|||
128938646|NCT01781429|464064989|FG003|Overall Study|Death|0|||
128938647|NCT01781429|464064990|FG004|Overall Study|Death|0|||
128938648|NCT01781429|464064991|FG005|Overall Study|Death|0|||
128938649|NCT01781429|464064992|FG006|Overall Study|Death|0|||
128938650|NCT01781429|464064993|FG007|Overall Study|Death|0|||
128938651|NCT01781429|464064994|FG008|Overall Study|Death|0|||
128938652|NCT01781429|464064995|FG009|Overall Study|Death|1|||
128938653|NCT01781429|464064996|FG010|Overall Study|Death|0|||
128938654|NCT01781429|464064997|FG011|Overall Study|Death|0|||
128938655|NCT01781429|464064998|FG012|Overall Study|Death|1|||
128938656|NCT01781429|464064999|FG013|Overall Study|Death|0|||
128938657|NCT01781429|464065000|FG014|Overall Study|Death|1|||
128938658|NCT01781429|464065001|FG015|Overall Study|Death|0|||
128938659|NCT01781429|464064986|FG000|Overall Study|Withdrawal by Subject|0|||
128938660|NCT01781429|464064987|FG001|Overall Study|Withdrawal by Subject|0|||
128938661|NCT01781429|464064988|FG002|Overall Study|Withdrawal by Subject|0|||
128938662|NCT01781429|464064989|FG003|Overall Study|Withdrawal by Subject|0|||
128938663|NCT01781429|464064990|FG004|Overall Study|Withdrawal by Subject|0|||
128938664|NCT01781429|464064991|FG005|Overall Study|Withdrawal by Subject|0|||
128938665|NCT01781429|464064992|FG006|Overall Study|Withdrawal by Subject|0|||
128938666|NCT01781429|464064993|FG007|Overall Study|Withdrawal by Subject|0|||
128938667|NCT01781429|464064994|FG008|Overall Study|Withdrawal by Subject|1|||
128938668|NCT01781429|464064995|FG009|Overall Study|Withdrawal by Subject|3|||
128938669|NCT01781429|464064996|FG010|Overall Study|Withdrawal by Subject|1|||
128938670|NCT01781429|464064997|FG011|Overall Study|Withdrawal by Subject|1|||
128938671|NCT01781429|464064998|FG012|Overall Study|Withdrawal by Subject|5|||
128938672|NCT01781429|464064999|FG013|Overall Study|Withdrawal by Subject|2|||
128938673|NCT01781429|464065000|FG014|Overall Study|Withdrawal by Subject|3|||
128938674|NCT01781429|464065001|FG015|Overall Study|Withdrawal by Subject|0|||
128938675|NCT01781429|464064986|FG000|Overall Study|Disease Progression|1|||
128938676|NCT01781429|464064987|FG001|Overall Study|Disease Progression|0|||
128938677|NCT01781429|464064988|FG002|Overall Study|Disease Progression|1|||
128938678|NCT01781429|464064989|FG003|Overall Study|Disease Progression|1|||
128938679|NCT01781429|464064990|FG004|Overall Study|Disease Progression|1|||
128938680|NCT01781429|464064991|FG005|Overall Study|Disease Progression|4|||
128938681|NCT01781429|464064992|FG006|Overall Study|Disease Progression|7|||
128938682|NCT01781429|464064993|FG007|Overall Study|Disease Progression|4|||
128938683|NCT01781429|464064994|FG008|Overall Study|Disease Progression|6|||
128938684|NCT01781429|464064995|FG009|Overall Study|Disease Progression|15|||
128938685|NCT01781429|464064996|FG010|Overall Study|Disease Progression|15|||
128938686|NCT01781429|464064997|FG011|Overall Study|Disease Progression|15|||
128938687|NCT01781429|464064998|FG012|Overall Study|Disease Progression|15|||
128938688|NCT01781429|464064999|FG013|Overall Study|Disease Progression|4|||
128938689|NCT01781429|464065000|FG014|Overall Study|Disease Progression|11|||
128938690|NCT01781429|464065001|FG015|Overall Study|Disease Progression|0|||
128938691|NCT01781429|464064986|FG000|Overall Study|Unacceptable Toxicity|0|||
128938692|NCT01781429|464064987|FG001|Overall Study|Unacceptable Toxicity|0|||
128938693|NCT01781429|464064988|FG002|Overall Study|Unacceptable Toxicity|0|||
128938694|NCT01781429|464064989|FG003|Overall Study|Unacceptable Toxicity|0|||
128938695|NCT01781429|464064990|FG004|Overall Study|Unacceptable Toxicity|0|||
128938696|NCT01781429|464064991|FG005|Overall Study|Unacceptable Toxicity|0|||
128938697|NCT01781429|464064992|FG006|Overall Study|Unacceptable Toxicity|0|||
128938698|NCT01781429|464064993|FG007|Overall Study|Unacceptable Toxicity|0|||
128938699|NCT01781429|464064994|FG008|Overall Study|Unacceptable Toxicity|0|||
129123107|NCT01155141|464745536|FG000|Overall Study|Screen Failure|1|||
128938700|NCT01781429|464064995|FG009|Overall Study|Unacceptable Toxicity|0|||
128938701|NCT01781429|464064996|FG010|Overall Study|Unacceptable Toxicity|0|||
128938702|NCT01781429|464064997|FG011|Overall Study|Unacceptable Toxicity|2|||
128938703|NCT01781429|464064998|FG012|Overall Study|Unacceptable Toxicity|0|||
128938704|NCT01781429|464064999|FG013|Overall Study|Unacceptable Toxicity|0|||
128938705|NCT01781429|464065000|FG014|Overall Study|Unacceptable Toxicity|0|||
128938706|NCT01781429|464065001|FG015|Overall Study|Unacceptable Toxicity|0|||
128938707|NCT01781429|464064986|FG000|Overall Study|Patient Condition Changed|0|||
128938708|NCT01781429|464064987|FG001|Overall Study|Patient Condition Changed|0|||
128938709|NCT01781429|464064988|FG002|Overall Study|Patient Condition Changed|0|||
128938710|NCT01781429|464064989|FG003|Overall Study|Patient Condition Changed|0|||
129123108|NCT03473197|464745537|FG000|Overall Study|Adverse Event|4|||
128938711|NCT01781429|464064990|FG004|Overall Study|Patient Condition Changed|0|||
128938712|NCT01781429|464064991|FG005|Overall Study|Patient Condition Changed|0|||
128938713|NCT01781429|464064992|FG006|Overall Study|Patient Condition Changed|0|||
129123109|NCT03473197|464745537|FG000|Overall Study|Lost to Follow-up|1|||
128938714|NCT01781429|464064993|FG007|Overall Study|Patient Condition Changed|0|||
128938715|NCT01781429|464064994|FG008|Overall Study|Patient Condition Changed|0|||
128938716|NCT01781429|464064995|FG009|Overall Study|Patient Condition Changed|4|||
128938717|NCT01781429|464064996|FG010|Overall Study|Patient Condition Changed|0|||
128938718|NCT01781429|464064997|FG011|Overall Study|Patient Condition Changed|1|||
128938719|NCT01781429|464064998|FG012|Overall Study|Patient Condition Changed|0|||
128938720|NCT01781429|464064999|FG013|Overall Study|Patient Condition Changed|1|||
128938721|NCT01781429|464065000|FG014|Overall Study|Patient Condition Changed|0|||
128938722|NCT01781429|464065001|FG015|Overall Study|Patient Condition Changed|0|||
128938723|NCT01781429|464064986|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
128938724|NCT01781429|464064987|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
128938725|NCT01781429|464064988|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
128938726|NCT01781429|464064989|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
128938727|NCT01781429|464064990|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
128938728|NCT01781429|464064991|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
128938729|NCT01781429|464064992|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
128938730|NCT01781429|464064993|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
128938731|NCT01781429|464064994|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
128938732|NCT01781429|464064995|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
128938733|NCT01781429|464064996|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
128938734|NCT01781429|464064997|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
128938735|NCT01781429|464064998|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
128938736|NCT01781429|464064999|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
128938737|NCT01781429|464065000|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
128938738|NCT01781429|464065001|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
128938739|NCT01781429|464064986|FG000|Overall Study|Enrolled, but not treated|0|||
128938740|NCT01781429|464064987|FG001|Overall Study|Enrolled, but not treated|0|||
128938741|NCT01781429|464064988|FG002|Overall Study|Enrolled, but not treated|0|||
128938742|NCT01781429|464064989|FG003|Overall Study|Enrolled, but not treated|0|||
128938743|NCT01781429|464064990|FG004|Overall Study|Enrolled, but not treated|0|||
128938744|NCT01781429|464064991|FG005|Overall Study|Enrolled, but not treated|0|||
128938745|NCT01781429|464064992|FG006|Overall Study|Enrolled, but not treated|0|||
128938746|NCT01781429|464064993|FG007|Overall Study|Enrolled, but not treated|0|||
128938747|NCT01781429|464064994|FG008|Overall Study|Enrolled, but not treated|0|||
128938748|NCT01781429|464064995|FG009|Overall Study|Enrolled, but not treated|0|||
128938749|NCT01781429|464064996|FG010|Overall Study|Enrolled, but not treated|1|||
128938750|NCT01781429|464064997|FG011|Overall Study|Enrolled, but not treated|0|||
128938751|NCT01781429|464064998|FG012|Overall Study|Enrolled, but not treated|0|||
128938752|NCT01781429|464064999|FG013|Overall Study|Enrolled, but not treated|0|||
128938753|NCT01781429|464065000|FG014|Overall Study|Enrolled, but not treated|0|||
128938754|NCT01781429|464065001|FG015|Overall Study|Enrolled, but not treated|0|||
128938755|NCT02678741|464065002|FG000|Overall Study|Death|4|||
128938756|NCT02678741|464065002|FG000|Overall Study|Withdrawal by Subject|1|||
128938757|NCT02678741|464065002|FG000|Overall Study|ineligible|3|||
128938758|NCT02678741|464065002|FG000|Overall Study|Not RECIST Measurable|2|||
128938759|NCT02678741|464065002|FG000|Overall Study|Lack of Efficacy|10|||
128938760|NCT00903032|464065003|FG000|Overall Study|Withdrawal by Subject|5|||
128938761|NCT00903032|464065004|FG001|Overall Study|Withdrawal by Subject|3|||
128938762|NCT00903032|464065003|FG000|Overall Study|Lost to Follow-up|2|||
128938763|NCT00903032|464065004|FG001|Overall Study|Lost to Follow-up|2|||
128938764|NCT00931892|464065018|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
128938765|NCT00931892|464065019|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
128938766|NCT01876732|464065020|FG000|Overall Study|MMA was not over 800mg/dL|75|||
128938767|NCT01675531|464065021|FG000|Overall Study|Adverse Event|9|||
128938768|NCT01675531|464065021|FG000|Overall Study|Withdrawal by Subject|7|||
128938769|NCT01675531|464065021|FG000|Overall Study|Lack of Efficacy|1|||
129123110|NCT03473197|464745537|FG000|Overall Study|Withdrawal by Subject|5|||
129123111|NCT00785629|464745538|FG000|Overall Study|Adverse Event|2|||
129123112|NCT00785629|464745539|FG001|Overall Study|Adverse Event|1|||
129123113|NCT00785629|464745540|FG002|Overall Study|Adverse Event|1|||
129123114|NCT00785629|464745541|FG003|Overall Study|Adverse Event|5|||
129123115|NCT00785629|464745538|FG000|Overall Study|Protocol Violation|1|||
128938770|NCT01675531|464065021|FG000|Overall Study|Protocol Violation|8|||
128938771|NCT00623467|464065022|FG000|Overall Study|Lost to Follow-up|1|||
128938772|NCT00623467|464065022|FG000|Overall Study|Protocol Violation|4|||
128938773|NCT00623467|464065022|FG000|Overall Study|Withdrawal by Subject|2|||
128938774|NCT02795988|464065031|FG000|Phase 1b|Withdrawal by Subject|0|||
128938775|NCT02795988|464065032|FG001|Phase 1b|Withdrawal by Subject|1|||
128938776|NCT02795988|464065033|FG002|Phase 1b|Withdrawal by Subject|0|||
128938777|NCT02795988|464065034|FG003|Phase 1b|Withdrawal by Subject|0|||
128938778|NCT02795988|464065035|FG004|Phase 1b|Withdrawal by Subject|0|||
128938779|NCT02795988|464065036|FG005|Phase 1b|Withdrawal by Subject|0|||
128938780|NCT02795988|464065037|FG006|Phase 1b|Withdrawal by Subject|0|||
128938781|NCT02795988|464065031|FG000|Phase 1b|Death|1|||
128938782|NCT02795988|464065032|FG001|Phase 1b|Death|2|||
128938783|NCT02795988|464065033|FG002|Phase 1b|Death|1|||
128938784|NCT02795988|464065034|FG003|Phase 1b|Death|0|||
128938785|NCT02795988|464065035|FG004|Phase 1b|Death|0|||
128938786|NCT02795988|464065036|FG005|Phase 1b|Death|0|||
128938787|NCT02795988|464065037|FG006|Phase 1b|Death|0|||
128938788|NCT02795988|464065031|FG000|Phase 1b|Physician Decision|0|||
128938789|NCT02795988|464065032|FG001|Phase 1b|Physician Decision|0|||
128938790|NCT02795988|464065033|FG002|Phase 1b|Physician Decision|1|||
128938791|NCT02795988|464065034|FG003|Phase 1b|Physician Decision|0|||
128938792|NCT02795988|464065035|FG004|Phase 1b|Physician Decision|0|||
128938793|NCT02795988|464065036|FG005|Phase 1b|Physician Decision|0|||
128938794|NCT02795988|464065037|FG006|Phase 1b|Physician Decision|0|||
128769766|NCT03125941|463448251|FG000|Overall Study|did not receive intervention|1|||
128769767|NCT03125941|463448252|FG001|Overall Study|did not receive intervention|2|||
128769768|NCT00779584|463448253|FG000|Overall Study|Protocol Violation|0|||
128938795|NCT02795988|464065031|FG000|Phase 1b|Progressive Disease|2|||
128938796|NCT02795988|464065032|FG001|Phase 1b|Progressive Disease|2|||
128938797|NCT02795988|464065033|FG002|Phase 1b|Progressive Disease|0|||
128938798|NCT02795988|464065034|FG003|Phase 1b|Progressive Disease|0|||
128938799|NCT02795988|464065035|FG004|Phase 1b|Progressive Disease|0|||
128938800|NCT02795988|464065036|FG005|Phase 1b|Progressive Disease|0|||
128938801|NCT02795988|464065037|FG006|Phase 1b|Progressive Disease|0|||
128938802|NCT02795988|464065031|FG000|Phase 2|Withdrawal by Subject|0|||
128938803|NCT02795988|464065032|FG001|Phase 2|Withdrawal by Subject|0|||
128938804|NCT02795988|464065033|FG002|Phase 2|Withdrawal by Subject|0|||
128938805|NCT02795988|464065034|FG003|Phase 2|Withdrawal by Subject|1|||
128938806|NCT02795988|464065035|FG004|Phase 2|Withdrawal by Subject|0|||
128938807|NCT02795988|464065036|FG005|Phase 2|Withdrawal by Subject|0|||
128938808|NCT02795988|464065037|FG006|Phase 2|Withdrawal by Subject|0|||
128938809|NCT02795988|464065031|FG000|Phase 2|Death|0|||
128938810|NCT02795988|464065032|FG001|Phase 2|Death|0|||
128938811|NCT02795988|464065033|FG002|Phase 2|Death|0|||
128938812|NCT02795988|464065034|FG003|Phase 2|Death|17|||
128938813|NCT02795988|464065035|FG004|Phase 2|Death|17|||
128938814|NCT02795988|464065036|FG005|Phase 2|Death|0|||
128938815|NCT02795988|464065037|FG006|Phase 2|Death|0|||
128938816|NCT02795988|464065031|FG000|Phase 2|Other|0|||
128938817|NCT02795988|464065032|FG001|Phase 2|Other|0|||
128938818|NCT02795988|464065033|FG002|Phase 2|Other|0|||
128938819|NCT02795988|464065034|FG003|Phase 2|Other|1|||
128938820|NCT02795988|464065035|FG004|Phase 2|Other|0|||
128938821|NCT02795988|464065036|FG005|Phase 2|Other|0|||
128938822|NCT02795988|464065037|FG006|Phase 2|Other|0|||
128938823|NCT02795988|464065031|FG000|Phase 2 Extension|Death|0|||
128938824|NCT02795988|464065032|FG001|Phase 2 Extension|Death|0|||
128938825|NCT02795988|464065033|FG002|Phase 2 Extension|Death|0|||
128938826|NCT02795988|464065034|FG003|Phase 2 Extension|Death|0|||
128938827|NCT02795988|464065035|FG004|Phase 2 Extension|Death|0|||
128938828|NCT02795988|464065036|FG005|Phase 2 Extension|Death|5|||
128938829|NCT02795988|464065037|FG006|Phase 2 Extension|Death|6|||
128938830|NCT02795988|464065031|FG000|Phase 2 Extension|Other reasons|0|||
128938831|NCT02795988|464065032|FG001|Phase 2 Extension|Other reasons|0|||
128938832|NCT02795988|464065033|FG002|Phase 2 Extension|Other reasons|0|||
128938833|NCT02795988|464065034|FG003|Phase 2 Extension|Other reasons|0|||
128938834|NCT02795988|464065035|FG004|Phase 2 Extension|Other reasons|0|||
128938835|NCT02795988|464065036|FG005|Phase 2 Extension|Other reasons|2|||
128938836|NCT02795988|464065037|FG006|Phase 2 Extension|Other reasons|1|||
128938837|NCT02834403|464065038|FG000|Overall Study|Physician Decision|2|||
128938838|NCT02834403|464065039|FG001|Overall Study|Physician Decision|1|||
128938839|NCT02834403|464065040|FG002|Overall Study|Physician Decision|2|||
128938840|NCT02834403|464065041|FG003|Overall Study|Physician Decision|1|||
128938841|NCT02834403|464065042|FG004|Overall Study|Physician Decision|1|||
129031850|NCT02061280|464406592|FG001|Overall Study|Lost to Follow-up|1|||
128769769|NCT00779584|463448254|FG001|Overall Study|Protocol Violation|0|||
128938842|NCT02834403|464065043|FG005|Overall Study|Physician Decision|2|||
128938843|NCT02834403|464065044|FG006|Overall Study|Physician Decision|12|||
128938844|NCT02834403|464065038|FG000|Overall Study|Adverse Event|0|||
128938845|NCT02834403|464065039|FG001|Overall Study|Adverse Event|0|||
128938846|NCT02834403|464065040|FG002|Overall Study|Adverse Event|0|||
128938847|NCT02834403|464065041|FG003|Overall Study|Adverse Event|0|||
128938848|NCT02834403|464065042|FG004|Overall Study|Adverse Event|1|||
128938849|NCT02834403|464065043|FG005|Overall Study|Adverse Event|1|||
129031851|NCT00724958|464406593|FG000|Overall Study|Adverse Event|28|||
128938850|NCT02834403|464065044|FG006|Overall Study|Adverse Event|3|||
128938851|NCT02834403|464065038|FG000|Overall Study|Withdrawal by Subject|0|||
128938852|NCT02834403|464065039|FG001|Overall Study|Withdrawal by Subject|1|||
128938853|NCT02834403|464065040|FG002|Overall Study|Withdrawal by Subject|0|||
128938854|NCT02834403|464065041|FG003|Overall Study|Withdrawal by Subject|0|||
128938855|NCT02834403|464065042|FG004|Overall Study|Withdrawal by Subject|1|||
128938856|NCT02834403|464065043|FG005|Overall Study|Withdrawal by Subject|0|||
128938857|NCT02834403|464065044|FG006|Overall Study|Withdrawal by Subject|0|||
128938858|NCT02834403|464065038|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
128938859|NCT02834403|464065039|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
129031852|NCT00724958|464406593|FG000|Overall Study|Loss of Response|40|||
128938860|NCT02834403|464065040|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
128938861|NCT02834403|464065041|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
128938862|NCT02834403|464065042|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
128938863|NCT02834403|464065043|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
128938864|NCT02834403|464065044|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
128938865|NCT02341014|464065045|FG000|Overall Study|Adverse Event|0|||
128938866|NCT02341014|464065046|FG001|Overall Study|Adverse Event|1|||
128938867|NCT02341014|464065047|FG002|Overall Study|Adverse Event|0|||
128938868|NCT02341014|464065048|FG003|Overall Study|Adverse Event|0|||
128938869|NCT02341014|464065049|FG004|Overall Study|Adverse Event|2|||
128938870|NCT04705597|464065050|FG000|Overall Study|Death|16|||
128938871|NCT04705597|464065051|FG001|Overall Study|Death|9|||
128938872|NCT04705597|464065050|FG000|Overall Study|Lost to Follow-up|1|||
128938873|NCT04705597|464065051|FG001|Overall Study|Lost to Follow-up|0|||
128938874|NCT04705597|464065050|FG000|Overall Study|Withdrawal by Subject|1|||
128938875|NCT04705597|464065051|FG001|Overall Study|Withdrawal by Subject|2|||
128938876|NCT00273858|464065063|FG000|Overall Study|Not completed 24 month observation time|334|||
128938877|NCT00273858|464065063|FG000|Overall Study|Lost to Follow-up|101|||
128938878|NCT00273858|464065063|FG000|Overall Study|Withdrawal by Subject|21|||
128938879|NCT00273858|464065063|FG000|Overall Study|Adverse Event|81|||
128938880|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
128938881|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
128938882|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
128938883|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
128938884|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
128938885|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
128938886|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
128938887|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
128938888|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
128938889|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
128938890|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
128938891|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
128938892|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
128938893|NCT02232516|464065064|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
128938894|NCT02232516|464065064|FG000|Survival Follow-up|Death|15|||
128938895|NCT02232516|464065064|FG000|Survival Follow-up|Withdrawal by Subject|3|||
128938896|NCT02232516|464065064|FG000|Survival Follow-up|Lost to Follow-up|1|||
128938897|NCT02232516|464065064|FG000|Survival Follow-up|Still in follow-up|5|||
128938898|NCT01070550|464065065|FG000|Overall Study|Adverse Event|43|||
128938899|NCT01070550|464065066|FG001|Overall Study|Adverse Event|1|||
128938900|NCT01070550|464065067|FG002|Overall Study|Adverse Event|3|||
128938901|NCT01070550|464065068|FG003|Overall Study|Adverse Event|0|||
128938902|NCT01070550|464065069|FG004|Overall Study|Adverse Event|0|||
128938903|NCT01070550|464065070|FG005|Overall Study|Adverse Event|0|||
128938904|NCT01070550|464065065|FG000|Overall Study|Death|20|||
128938905|NCT01070550|464065066|FG001|Overall Study|Death|4|||
128938906|NCT01070550|464065067|FG002|Overall Study|Death|3|||
128938907|NCT01070550|464065068|FG003|Overall Study|Death|0|||
128938908|NCT01070550|464065069|FG004|Overall Study|Death|0|||
128938909|NCT01070550|464065070|FG005|Overall Study|Death|0|||
128938910|NCT01070550|464065065|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
128938911|NCT01070550|464065066|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
128938912|NCT01070550|464065067|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
128938913|NCT01070550|464065068|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
128938914|NCT01070550|464065069|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
128938915|NCT01070550|464065070|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
128938916|NCT01070550|464065065|FG000|Overall Study|Early termination|3|||
128938917|NCT01070550|464065066|FG001|Overall Study|Early termination|0|||
128938918|NCT01070550|464065067|FG002|Overall Study|Early termination|0|||
128938919|NCT01070550|464065068|FG003|Overall Study|Early termination|0|||
128938920|NCT01070550|464065069|FG004|Overall Study|Early termination|0|||
128938921|NCT01070550|464065070|FG005|Overall Study|Early termination|0|||
128938922|NCT01070550|464065065|FG000|Overall Study|Failed to return|450|||
128938923|NCT01070550|464065066|FG001|Overall Study|Failed to return|33|||
128938924|NCT01070550|464065067|FG002|Overall Study|Failed to return|144|||
128938925|NCT01070550|464065068|FG003|Overall Study|Failed to return|40|||
128938926|NCT01070550|464065069|FG004|Overall Study|Failed to return|1|||
128938927|NCT01070550|464065070|FG005|Overall Study|Failed to return|2|||
128938928|NCT01070550|464065065|FG000|Overall Study|Incomplete treatment|2|||
128938929|NCT01070550|464065066|FG001|Overall Study|Incomplete treatment|0|||
128938930|NCT01070550|464065067|FG002|Overall Study|Incomplete treatment|0|||
128938931|NCT01070550|464065068|FG003|Overall Study|Incomplete treatment|0|||
129123116|NCT00785629|464745539|FG001|Overall Study|Protocol Violation|2|||
128938932|NCT01070550|464065069|FG004|Overall Study|Incomplete treatment|0|||
128938933|NCT01070550|464065070|FG005|Overall Study|Incomplete treatment|0|||
129031853|NCT00724958|464406593|FG000|Overall Study|No Response|18|||
129031854|NCT00724958|464406593|FG000|Overall Study|Remission|7|||
129031855|NCT00724958|464406593|FG000|Overall Study|Other Reason|76|||
129031856|NCT00724958|464406593|FG000|Overall Study|No documentation for end of therapy|13|||
129031857|NCT01520987|464408137|FG000|Overall Study|Withdrawal by Subject|1|||
129031858|NCT01520987|464408138|FG001|Overall Study|Withdrawal by Subject|0|||
129031859|NCT01520987|464408139|FG002|Overall Study|Withdrawal by Subject|0|||
129031860|NCT01520987|464408140|FG003|Overall Study|Withdrawal by Subject|0|||
129031861|NCT01520987|464408141|FG004|Overall Study|Withdrawal by Subject|0|||
129031862|NCT01520987|464408142|FG005|Overall Study|Withdrawal by Subject|1|||
129031863|NCT01520987|464408143|FG006|Overall Study|Withdrawal by Subject|0|||
129031864|NCT01520987|464408144|FG007|Overall Study|Withdrawal by Subject|0|||
129031865|NCT02005562|464408145|FG000|Overall Study|Death|2|||
129031866|NCT02005562|464408146|FG001|Overall Study|Death|2|||
129031867|NCT02005562|464408145|FG000|Overall Study|Graft loss|7|||
129031868|NCT02005562|464408146|FG001|Overall Study|Graft loss|6|||
129031869|NCT02005562|464408145|FG000|Overall Study|Withdrawal by Subject|2|||
128938934|NCT01070550|464065065|FG000|Overall Study|Lab test not done|22|||
128938935|NCT01070550|464065066|FG001|Overall Study|Lab test not done|3|||
128938936|NCT01070550|464065067|FG002|Overall Study|Lab test not done|4|||
128938937|NCT01070550|464065068|FG003|Overall Study|Lab test not done|1|||
128938938|NCT01070550|464065069|FG004|Overall Study|Lab test not done|0|||
128938939|NCT01070550|464065070|FG005|Overall Study|Lab test not done|1|||
128938940|NCT01070550|464065065|FG000|Overall Study|Lack of Efficacy|65|||
128938941|NCT01070550|464065066|FG001|Overall Study|Lack of Efficacy|1|||
128938942|NCT01070550|464065067|FG002|Overall Study|Lack of Efficacy|5|||
128938943|NCT01070550|464065068|FG003|Overall Study|Lack of Efficacy|5|||
128938944|NCT01070550|464065069|FG004|Overall Study|Lack of Efficacy|0|||
128938945|NCT01070550|464065070|FG005|Overall Study|Lack of Efficacy|1|||
128938946|NCT01070550|464065065|FG000|Overall Study|Miscellaneous|12|||
128938947|NCT01070550|464065066|FG001|Overall Study|Miscellaneous|2|||
128938948|NCT01070550|464065067|FG002|Overall Study|Miscellaneous|3|||
128938949|NCT01070550|464065068|FG003|Overall Study|Miscellaneous|1|||
128938950|NCT01070550|464065069|FG004|Overall Study|Miscellaneous|0|||
128938951|NCT01070550|464065070|FG005|Overall Study|Miscellaneous|0|||
128938952|NCT01070550|464065065|FG000|Overall Study|New treatment started|3|||
128938953|NCT01070550|464065066|FG001|Overall Study|New treatment started|1|||
128938954|NCT01070550|464065067|FG002|Overall Study|New treatment started|0|||
128938955|NCT01070550|464065068|FG003|Overall Study|New treatment started|2|||
128938956|NCT01070550|464065069|FG004|Overall Study|New treatment started|0|||
128938957|NCT01070550|464065070|FG005|Overall Study|New treatment started|0|||
128938958|NCT01070550|464065065|FG000|Overall Study|Non-responders|493|||
128938959|NCT01070550|464065066|FG001|Overall Study|Non-responders|4|||
128938960|NCT01070550|464065067|FG002|Overall Study|Non-responders|21|||
128938961|NCT01070550|464065068|FG003|Overall Study|Non-responders|20|||
128938962|NCT01070550|464065069|FG004|Overall Study|Non-responders|0|||
128938963|NCT01070550|464065070|FG005|Overall Study|Non-responders|2|||
128938964|NCT01070550|464065065|FG000|Overall Study|Not categorized|33|||
128938965|NCT01070550|464065066|FG001|Overall Study|Not categorized|2|||
128938966|NCT01070550|464065067|FG002|Overall Study|Not categorized|6|||
128938967|NCT01070550|464065068|FG003|Overall Study|Not categorized|1|||
128938968|NCT01070550|464065069|FG004|Overall Study|Not categorized|0|||
128938969|NCT01070550|464065070|FG005|Overall Study|Not categorized|1|||
128938970|NCT01070550|464065065|FG000|Overall Study|Protocol Violation|15|||
128938971|NCT01070550|464065066|FG001|Overall Study|Protocol Violation|1|||
128938972|NCT01070550|464065067|FG002|Overall Study|Protocol Violation|1|||
128938973|NCT01070550|464065068|FG003|Overall Study|Protocol Violation|1|||
128938974|NCT01070550|464065069|FG004|Overall Study|Protocol Violation|0|||
128938975|NCT01070550|464065070|FG005|Overall Study|Protocol Violation|0|||
129031870|NCT02005562|464408146|FG001|Overall Study|Withdrawal by Subject|2|||
129031871|NCT02005562|464408145|FG000|Overall Study|No transplant|1|||
129031872|NCT02005562|464408146|FG001|Overall Study|No transplant|4|||
128938976|NCT01070550|464065065|FG000|Overall Study|Relapse|44|||
129031873|NCT02005562|464408145|FG000|Overall Study|Physician Decision|0|||
128938977|NCT01070550|464065066|FG001|Overall Study|Relapse|5|||
129031874|NCT02005562|464408146|FG001|Overall Study|Physician Decision|1|||
128938978|NCT01070550|464065067|FG002|Overall Study|Relapse|14|||
128938979|NCT01070550|464065068|FG003|Overall Study|Relapse|4|||
128938980|NCT01070550|464065069|FG004|Overall Study|Relapse|0|||
128938981|NCT01070550|464065070|FG005|Overall Study|Relapse|0|||
128938982|NCT01070550|464065065|FG000|Overall Study|Result not available|3|||
128938983|NCT01070550|464065066|FG001|Overall Study|Result not available|1|||
128938984|NCT01070550|464065067|FG002|Overall Study|Result not available|3|||
128938985|NCT01070550|464065068|FG003|Overall Study|Result not available|0|||
129031875|NCT04729101|464408147|FG000|Overall Study|Adverse Event|1|||
129031876|NCT04729101|464408148|FG001|Overall Study|Adverse Event|0|||
129031877|NCT04729101|464408147|FG000|Overall Study|Physician Decision|1|||
129031878|NCT04729101|464408148|FG001|Overall Study|Physician Decision|0|||
129031879|NCT04729101|464408147|FG000|Overall Study|Withdrawal by Subject|1|||
129031880|NCT04729101|464408148|FG001|Overall Study|Withdrawal by Subject|0|||
128938986|NCT01070550|464065069|FG004|Overall Study|Result not available|0|||
128938987|NCT01070550|464065070|FG005|Overall Study|Result not available|0|||
128938988|NCT01070550|464065065|FG000|Overall Study|Screen failure|1|||
128938989|NCT01070550|464065066|FG001|Overall Study|Screen failure|0|||
128938990|NCT01070550|464065067|FG002|Overall Study|Screen failure|0|||
128938991|NCT01070550|464065068|FG003|Overall Study|Screen failure|0|||
128938992|NCT01070550|464065069|FG004|Overall Study|Screen failure|0|||
128938993|NCT01070550|464065070|FG005|Overall Study|Screen failure|0|||
128938994|NCT01070550|464065065|FG000|Overall Study|Sponsor decision|1|||
128938995|NCT01070550|464065066|FG001|Overall Study|Sponsor decision|0|||
128938996|NCT01070550|464065067|FG002|Overall Study|Sponsor decision|0|||
128938997|NCT01070550|464065068|FG003|Overall Study|Sponsor decision|0|||
128938998|NCT01070550|464065069|FG004|Overall Study|Sponsor decision|0|||
128938999|NCT01070550|464065070|FG005|Overall Study|Sponsor decision|0|||
128939000|NCT01070550|464065065|FG000|Overall Study|Treatment duration shortened|1|||
128939001|NCT01070550|464065066|FG001|Overall Study|Treatment duration shortened|0|||
128939002|NCT01070550|464065067|FG002|Overall Study|Treatment duration shortened|0|||
128939003|NCT01070550|464065068|FG003|Overall Study|Treatment duration shortened|0|||
128939004|NCT01070550|464065069|FG004|Overall Study|Treatment duration shortened|0|||
128939005|NCT01070550|464065070|FG005|Overall Study|Treatment duration shortened|0|||
128939006|NCT01070550|464065065|FG000|Overall Study|Treatment interrupted|7|||
128939007|NCT01070550|464065066|FG001|Overall Study|Treatment interrupted|0|||
128939008|NCT01070550|464065067|FG002|Overall Study|Treatment interrupted|1|||
128939009|NCT01070550|464065068|FG003|Overall Study|Treatment interrupted|1|||
128939010|NCT01070550|464065069|FG004|Overall Study|Treatment interrupted|0|||
128939011|NCT01070550|464065070|FG005|Overall Study|Treatment interrupted|0|||
128939012|NCT01070550|464065065|FG000|Overall Study|Treatment not started|14|||
128939013|NCT01070550|464065066|FG001|Overall Study|Treatment not started|2|||
128939014|NCT01070550|464065067|FG002|Overall Study|Treatment not started|4|||
128939015|NCT01070550|464065068|FG003|Overall Study|Treatment not started|0|||
128939016|NCT01070550|464065069|FG004|Overall Study|Treatment not started|0|||
128939017|NCT01070550|464065070|FG005|Overall Study|Treatment not started|0|||
128939018|NCT01070550|464065065|FG000|Overall Study|Treatment restarted|0|||
128939019|NCT01070550|464065066|FG001|Overall Study|Treatment restarted|1|||
128939020|NCT01070550|464065067|FG002|Overall Study|Treatment restarted|0|||
128939021|NCT01070550|464065068|FG003|Overall Study|Treatment restarted|0|||
128939022|NCT01070550|464065069|FG004|Overall Study|Treatment restarted|0|||
128939023|NCT01070550|464065070|FG005|Overall Study|Treatment restarted|0|||
128939024|NCT01070550|464065065|FG000|Overall Study|Treatment stopped|3|||
128939025|NCT01070550|464065066|FG001|Overall Study|Treatment stopped|0|||
128939026|NCT01070550|464065067|FG002|Overall Study|Treatment stopped|0|||
128939027|NCT01070550|464065068|FG003|Overall Study|Treatment stopped|0|||
128939028|NCT01070550|464065069|FG004|Overall Study|Treatment stopped|0|||
128939029|NCT01070550|464065070|FG005|Overall Study|Treatment stopped|0|||
128939030|NCT01070550|464065065|FG000|Overall Study|Treatment unavailable|1|||
128939031|NCT01070550|464065066|FG001|Overall Study|Treatment unavailable|0|||
128939032|NCT01070550|464065067|FG002|Overall Study|Treatment unavailable|0|||
128939033|NCT01070550|464065068|FG003|Overall Study|Treatment unavailable|0|||
128939034|NCT01070550|464065069|FG004|Overall Study|Treatment unavailable|0|||
128939035|NCT01070550|464065070|FG005|Overall Study|Treatment unavailable|0|||
129031881|NCT00274625|464408149|FG000|Overall Study|Lost to Follow-up|46|||
129031882|NCT00274625|464408150|FG001|Overall Study|Lost to Follow-up|54|||
129031883|NCT00274625|464408149|FG000|Overall Study|Excluded from analysis|14|||
129031884|NCT00274625|464408150|FG001|Overall Study|Excluded from analysis|8|||
129031885|NCT02940522|464408151|FG000|Overall Study|Lost to Follow-up|1|||
129031886|NCT02940522|464408152|FG001|Overall Study|Lost to Follow-up|2|||
129031887|NCT02940522|464408151|FG000|Overall Study|Withdrawal by Subject|1|||
129031888|NCT02940522|464408152|FG001|Overall Study|Withdrawal by Subject|0|||
129031889|NCT01754376|464408156|FG000|Overall Study|Adverse Event|1|||
129031890|NCT01754376|464408156|FG000|Overall Study|Lack of Efficacy|2|||
129031891|NCT04590781|464408157|FG000|Overall Study|Death|0|||
129031892|NCT04590781|464408158|FG001|Overall Study|Death|2|||
129031893|NCT04590781|464408157|FG000|Overall Study|Withdrawal by Subject|2|||
129031894|NCT04590781|464408158|FG001|Overall Study|Withdrawal by Subject|0|||
129031895|NCT04264819|464408160|FG000|Overall Study|Physician Decision|19|||
129031896|NCT04264819|464408160|FG000|Overall Study|Adverse Event|12|||
129031897|NCT04264819|464408160|FG000|Overall Study|Withdrawal by Subject|11|||
129031898|NCT04264819|464408160|FG000|Overall Study|Lost to Follow-up|2|||
128939036|NCT01070550|464065065|FG000|Overall Study|Treatment was stopped early|7|||
128939037|NCT01070550|464065066|FG001|Overall Study|Treatment was stopped early|0|||
129031899|NCT04264819|464408160|FG000|Overall Study|Death|2|||
129031900|NCT02846883|464408162|FG000|Overall Study|Death|0|||
129031901|NCT02846883|464408163|FG001|Overall Study|Death|1|||
129031902|NCT02846883|464408164|FG002|Overall Study|Death|1|||
129031903|NCT02846883|464408162|FG000|Overall Study|Lost to Follow-up|0|||
129031904|NCT02846883|464408163|FG001|Overall Study|Lost to Follow-up|0|||
129031905|NCT02846883|464408164|FG002|Overall Study|Lost to Follow-up|1|||
129031906|NCT02846883|464408162|FG000|Overall Study|Withdrawal by Subject|1|||
128939038|NCT01070550|464065067|FG002|Overall Study|Treatment was stopped early|0|||
128939039|NCT01070550|464065068|FG003|Overall Study|Treatment was stopped early|0|||
128939040|NCT01070550|464065069|FG004|Overall Study|Treatment was stopped early|0|||
128939041|NCT01070550|464065070|FG005|Overall Study|Treatment was stopped early|0|||
128939042|NCT01070550|464065065|FG000|Overall Study|Other|5|||
128939043|NCT01070550|464065066|FG001|Overall Study|Other|0|||
128939044|NCT01070550|464065067|FG002|Overall Study|Other|0|||
128939045|NCT01070550|464065068|FG003|Overall Study|Other|1|||
128939046|NCT01070550|464065069|FG004|Overall Study|Other|0|||
128939047|NCT01070550|464065070|FG005|Overall Study|Other|0|||
128939048|NCT01070550|464065065|FG000|Overall Study|Withdrawal by Subject|35|||
128939049|NCT01070550|464065066|FG001|Overall Study|Withdrawal by Subject|0|||
128939050|NCT01070550|464065067|FG002|Overall Study|Withdrawal by Subject|3|||
128939051|NCT01070550|464065068|FG003|Overall Study|Withdrawal by Subject|0|||
128939052|NCT01070550|464065069|FG004|Overall Study|Withdrawal by Subject|0|||
128939053|NCT01070550|464065070|FG005|Overall Study|Withdrawal by Subject|0|||
128939054|NCT01585961|464065071|FG000|Overall Study|Death|6|||
128939055|NCT01585961|464065071|FG000|Overall Study|Physician Decision|1|||
128939056|NCT01585961|464065071|FG000|Overall Study|Decision to use non-study catheter|1|||
128939057|NCT01585961|464065071|FG000|Overall Study|Withdrawal by Subject|1|||
128939058|NCT01585961|464065071|FG000|Overall Study|Lost to Follow-up|23|||
128939059|NCT01585961|464065071|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
128939060|NCT01258348|464065072|FG000|Overall Study|Adverse Event|1|||
128939061|NCT01258348|464065073|FG001|Overall Study|Adverse Event|1|||
128939062|NCT01258348|464065074|FG002|Overall Study|Adverse Event|3|||
128939063|NCT01258348|464065075|FG003|Overall Study|Adverse Event|2|||
128939064|NCT01258348|464065076|FG004|Overall Study|Adverse Event|4|||
128939065|NCT01258348|464065072|FG000|Overall Study|Progressive Disease|0|||
128939066|NCT01258348|464065073|FG001|Overall Study|Progressive Disease|3|||
128939067|NCT01258348|464065074|FG002|Overall Study|Progressive Disease|0|||
128939068|NCT01258348|464065075|FG003|Overall Study|Progressive Disease|2|||
129031907|NCT02846883|464408163|FG001|Overall Study|Withdrawal by Subject|0|||
129031908|NCT02846883|464408164|FG002|Overall Study|Withdrawal by Subject|0|||
129031909|NCT02846883|464408162|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
129031910|NCT02846883|464408163|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
129031911|NCT02846883|464408164|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
129031912|NCT02846883|464408162|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
129031913|NCT02846883|464408163|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
129031914|NCT02846883|464408164|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
129031915|NCT00927251|464408165|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
129031916|NCT04768296|464408166|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
129031917|NCT04768296|464408167|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
129031918|NCT03087786|464408170|FG000|Overall Study|Withdrawal by Subject|2|||
129031919|NCT03087786|464408171|FG001|Overall Study|Withdrawal by Subject|0|||
129031920|NCT01453153|464408176|FG000|Overall Study|Physician Decision|0|||
129031921|NCT01453153|464408177|FG001|Overall Study|Physician Decision|0|||
129031922|NCT01453153|464408178|FG002|Overall Study|Physician Decision|1|||
129031923|NCT01453153|464408176|FG000|Overall Study|Progressive Disease|3|||
129031924|NCT01453153|464408177|FG001|Overall Study|Progressive Disease|2|||
129031925|NCT01453153|464408178|FG002|Overall Study|Progressive Disease|16|||
129031926|NCT01453153|464408176|FG000|Overall Study|Withdrawal by Subject|0|||
129031927|NCT01453153|464408177|FG001|Overall Study|Withdrawal by Subject|1|||
129031928|NCT01453153|464408178|FG002|Overall Study|Withdrawal by Subject|2|||
129031929|NCT01453153|464408176|FG000|Overall Study|Adverse Event|1|||
129031930|NCT01453153|464408177|FG001|Overall Study|Adverse Event|1|||
129031931|NCT01453153|464408178|FG002|Overall Study|Adverse Event|1|||
129031932|NCT01802216|464408180|FG000|4 Month Visit|Participant did not show to visit|3|||
129031933|NCT01802216|464408181|FG001|4 Month Visit|Participant did not show to visit|4|||
129031934|NCT01802216|464408180|FG000|8 Month Visit|Participant did not show to visit|3|||
129031935|NCT01802216|464408181|FG001|8 Month Visit|Participant did not show to visit|5|||
129031936|NCT01802216|464408180|FG000|12 Month Visit|Participant did not show to visit|3|||
129031937|NCT01802216|464408181|FG001|12 Month Visit|Participant did not show to visit|4|||
129031938|NCT00799708|464408182|FG000|Overall Study|non-compliance|1|||
129031939|NCT00799708|464408183|FG001|Overall Study|non-compliance|0|||
129031940|NCT00799708|464408184|FG002|Overall Study|non-compliance|0|||
129031941|NCT00880334|464408185|FG000|Randomized Phase|Physician Decision|1|||
129031942|NCT00880334|464408186|FG001|Randomized Phase|Physician Decision|0|||
129031943|NCT00880334|464408185|FG000|Randomized Phase|Withdrawal by Subject|2|||
129031944|NCT00880334|464408186|FG001|Randomized Phase|Withdrawal by Subject|1|||
129031945|NCT00880334|464408185|FG000|Randomized Phase|Inadequate Labs|1|||
129031946|NCT00880334|464408186|FG001|Randomized Phase|Inadequate Labs|1|||
128939069|NCT01258348|464065076|FG004|Overall Study|Progressive Disease|2|||
129031947|NCT00880334|464408185|FG000|Randomized Phase|Brain Metastasis|0|||
128939070|NCT01258348|464065072|FG000|Overall Study|Physician Decision|0|||
128939071|NCT01258348|464065073|FG001|Overall Study|Physician Decision|0|||
129031948|NCT00880334|464408186|FG001|Randomized Phase|Brain Metastasis|1|||
129031949|NCT00880334|464408185|FG000|Randomized Phase|Crossover Participants|0|||
129031950|NCT00880334|464408186|FG001|Randomized Phase|Crossover Participants|37|||
129031951|NCT02274558|464408191|FG000|Overall Study|Adverse Event|2|||
129031952|NCT02274558|464408192|FG001|Overall Study|Adverse Event|4|||
129031953|NCT02274558|464408193|FG002|Overall Study|Adverse Event|2|||
129031954|NCT02274558|464408191|FG000|Overall Study|Non-compliance|2|||
129031955|NCT02274558|464408192|FG001|Overall Study|Non-compliance|1|||
129031956|NCT02274558|464408193|FG002|Overall Study|Non-compliance|0|||
129031957|NCT02274558|464408191|FG000|Overall Study|Withdrawal by Subject|1|||
129031958|NCT02274558|464408192|FG001|Overall Study|Withdrawal by Subject|5|||
129031959|NCT02274558|464408193|FG002|Overall Study|Withdrawal by Subject|4|||
129031960|NCT02274558|464408191|FG000|Overall Study|Death|0|||
129031961|NCT02274558|464408192|FG001|Overall Study|Death|0|||
129031962|NCT02274558|464408193|FG002|Overall Study|Death|1|||
129031963|NCT02274558|464408191|FG000|Overall Study|Lost to Follow-up|2|||
129031964|NCT02274558|464408192|FG001|Overall Study|Lost to Follow-up|1|||
129031965|NCT02274558|464408193|FG002|Overall Study|Lost to Follow-up|1|||
128939072|NCT01258348|464065074|FG002|Overall Study|Physician Decision|0|||
128939073|NCT01258348|464065075|FG003|Overall Study|Physician Decision|2|||
128939074|NCT01258348|464065076|FG004|Overall Study|Physician Decision|0|||
128939075|NCT01258348|464065072|FG000|Overall Study|Withdrawal by Subject|0|||
128939076|NCT01258348|464065073|FG001|Overall Study|Withdrawal by Subject|1|||
128939077|NCT01258348|464065074|FG002|Overall Study|Withdrawal by Subject|0|||
128939078|NCT01258348|464065075|FG003|Overall Study|Withdrawal by Subject|0|||
128939079|NCT01258348|464065076|FG004|Overall Study|Withdrawal by Subject|0|||
128939080|NCT06094296|464065077|FG000|Overall Study|Progressive Disease|1|||
128939081|NCT06094296|464065078|FG001|Overall Study|Progressive Disease|0|||
128939082|NCT06094296|464065079|FG002|Overall Study|Progressive Disease|0|||
128939083|NCT06094296|464065080|FG003|Overall Study|Progressive Disease|0|||
128939084|NCT01809262|464065081|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939085|NCT01809262|464065082|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939086|NCT01809262|464065083|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939087|NCT01809262|464065084|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939088|NCT01809262|464065085|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
128939089|NCT01809262|464065086|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939090|NCT01809262|464065087|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939091|NCT01809262|464065088|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939092|NCT01809262|464065089|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939093|NCT01809262|464065090|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
128939094|NCT01809262|464065081|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939095|NCT01809262|464065082|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
128939096|NCT01809262|464065083|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939097|NCT01809262|464065084|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939098|NCT01809262|464065085|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939099|NCT01809262|464065086|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939100|NCT01809262|464065087|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939101|NCT01809262|464065088|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939102|NCT01809262|464065089|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939103|NCT01809262|464065090|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
128939104|NCT02064439|464065092|FG000|Overall Study|Adverse Event|51|||
128939105|NCT02064439|464065093|FG001|Overall Study|Adverse Event|47|||
128939106|NCT02064439|464065094|FG002|Overall Study|Adverse Event|46|||
128939107|NCT02064439|464065092|FG000|Overall Study|Death|0|||
128939108|NCT02064439|464065093|FG001|Overall Study|Death|2|||
129031966|NCT02274558|464408191|FG000|Overall Study|Physician Decision|0|||
129031967|NCT02274558|464408192|FG001|Overall Study|Physician Decision|2|||
129031968|NCT02274558|464408193|FG002|Overall Study|Physician Decision|1|||
129031969|NCT05393271|464408203|FG000|Overall Study|Physician Decision|0|||
129031970|NCT05393271|464408204|FG001|Overall Study|Physician Decision|0|||
129031971|NCT05393271|464408205|FG002|Overall Study|Physician Decision|0|||
129031972|NCT05393271|464408206|FG003|Overall Study|Physician Decision|0|||
129031973|NCT05393271|464408207|FG004|Overall Study|Physician Decision|0|||
129031974|NCT05393271|464408208|FG005|Overall Study|Physician Decision|0|||
129123117|NCT00785629|464745540|FG002|Overall Study|Protocol Violation|4|||
128707215|NCT02132130|463222196|FG000|Overall Study|Withdrawal by Subject|0|||
128939109|NCT02064439|464065094|FG002|Overall Study|Death|3|||
128939110|NCT02064439|464065092|FG000|Overall Study|Withdrawal by Subject|29|||
128939111|NCT02064439|464065093|FG001|Overall Study|Withdrawal by Subject|18|||
128939112|NCT02064439|464065094|FG002|Overall Study|Withdrawal by Subject|26|||
128939113|NCT02064439|464065092|FG000|Overall Study|Protocol Violation|3|||
128939114|NCT02064439|464065093|FG001|Overall Study|Protocol Violation|5|||
128939115|NCT02064439|464065094|FG002|Overall Study|Protocol Violation|3|||
128939116|NCT02064439|464065092|FG000|Overall Study|Lost to Follow-up|1|||
129031975|NCT05393271|464408209|FG006|Overall Study|Physician Decision|1|||
129031976|NCT05393271|464408210|FG007|Overall Study|Physician Decision|0|||
129031977|NCT05393271|464408211|FG008|Overall Study|Physician Decision|0|||
129031978|NCT05393271|464408212|FG009|Overall Study|Physician Decision|0|||
128939117|NCT02064439|464065093|FG001|Overall Study|Lost to Follow-up|3|||
128939118|NCT02064439|464065094|FG002|Overall Study|Lost to Follow-up|4|||
128939119|NCT02064439|464065092|FG000|Overall Study|Non-compliance with study medication|21|||
128939120|NCT02064439|464065093|FG001|Overall Study|Non-compliance with study medication|19|||
128939121|NCT02064439|464065094|FG002|Overall Study|Non-compliance with study medication|23|||
128939122|NCT02064439|464065092|FG000|Overall Study|Physician Decision|0|||
128939123|NCT02064439|464065093|FG001|Overall Study|Physician Decision|1|||
128939124|NCT02064439|464065094|FG002|Overall Study|Physician Decision|1|||
128939125|NCT02064439|464065092|FG000|Overall Study|Logistical difficulties|6|||
128939126|NCT02064439|464065093|FG001|Overall Study|Logistical difficulties|5|||
128939127|NCT02064439|464065094|FG002|Overall Study|Logistical difficulties|2|||
128939128|NCT02064439|464065092|FG000|Overall Study|Efficacy outcome reached|18|||
128939129|NCT02064439|464065093|FG001|Overall Study|Efficacy outcome reached|16|||
128939130|NCT02064439|464065094|FG002|Overall Study|Efficacy outcome reached|57|||
128939131|NCT02064439|464065092|FG000|Overall Study|Safety outcome reached|12|||
128939132|NCT02064439|464065093|FG001|Overall Study|Safety outcome reached|20|||
128939133|NCT02064439|464065094|FG002|Overall Study|Safety outcome reached|10|||
128939134|NCT02064439|464065092|FG000|Overall Study|Other|2|||
128939135|NCT02064439|464065093|FG001|Overall Study|Other|2|||
128939136|NCT02064439|464065094|FG002|Overall Study|Other|7|||
128939137|NCT01120093|464065099|FG000|Treatment Period 1|Adverse Event|0|||
128939138|NCT01120093|464065100|FG001|Treatment Period 1|Adverse Event|0|||
129123118|NCT00785629|464745541|FG003|Overall Study|Protocol Violation|5|||
129123119|NCT00785629|464745538|FG000|Overall Study|administrative decision|5|||
129123120|NCT00785629|464745539|FG001|Overall Study|administrative decision|1|||
129123121|NCT00785629|464745540|FG002|Overall Study|administrative decision|3|||
129123122|NCT00785629|464745541|FG003|Overall Study|administrative decision|4|||
129123123|NCT00785629|464745538|FG000|Overall Study|Withdrawal by Subject|0|||
129123124|NCT00785629|464745539|FG001|Overall Study|Withdrawal by Subject|1|||
129123125|NCT00785629|464745540|FG002|Overall Study|Withdrawal by Subject|2|||
129123126|NCT00785629|464745541|FG003|Overall Study|Withdrawal by Subject|2|||
128939139|NCT01120093|464065101|FG002|Treatment Period 1|Adverse Event|1|||
128939140|NCT01120093|464065102|FG003|Treatment Period 1|Adverse Event|0|||
128939141|NCT01120093|464065103|FG004|Treatment Period 1|Adverse Event|1|||
128939142|NCT01120093|464065099|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128939143|NCT01120093|464065100|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128939144|NCT01120093|464065101|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128939145|NCT01120093|464065102|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128939146|NCT01120093|464065103|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128939147|NCT01120093|464065099|FG000|Treatment Period 2|Adverse Event|0|||
128939148|NCT01120093|464065100|FG001|Treatment Period 2|Adverse Event|0|||
128939149|NCT01120093|464065101|FG002|Treatment Period 2|Adverse Event|0|||
128939150|NCT01120093|464065102|FG003|Treatment Period 2|Adverse Event|1|||
128939151|NCT01120093|464065103|FG004|Treatment Period 2|Adverse Event|0|||
128939152|NCT01120093|464065099|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128939153|NCT01120093|464065100|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128939154|NCT01120093|464065101|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128939155|NCT01120093|464065102|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128939156|NCT01120093|464065103|FG004|Treatment Period 2|Withdrawal by Subject|1|||
128939157|NCT01120093|464065099|FG000|Treatment Period 3|Lack of Efficacy|0|||
128939158|NCT01120093|464065100|FG001|Treatment Period 3|Lack of Efficacy|0|||
128939159|NCT01120093|464065101|FG002|Treatment Period 3|Lack of Efficacy|0|||
128939160|NCT01120093|464065102|FG003|Treatment Period 3|Lack of Efficacy|1|||
128939161|NCT01120093|464065103|FG004|Treatment Period 3|Lack of Efficacy|0|||
128939162|NCT01120093|464065099|FG000|Treatment Period 3|Adverse Event|0|||
128939163|NCT01120093|464065100|FG001|Treatment Period 3|Adverse Event|0|||
128939164|NCT01120093|464065101|FG002|Treatment Period 3|Adverse Event|0|||
128939165|NCT01120093|464065102|FG003|Treatment Period 3|Adverse Event|0|||
128939166|NCT01120093|464065103|FG004|Treatment Period 3|Adverse Event|1|||
128939167|NCT01120093|464065099|FG000|Treatment Period 3|Withdrawal by Subject|0|||
128939168|NCT01120093|464065100|FG001|Treatment Period 3|Withdrawal by Subject|0|||
128939169|NCT01120093|464065101|FG002|Treatment Period 3|Withdrawal by Subject|1|||
128939170|NCT01120093|464065102|FG003|Treatment Period 3|Withdrawal by Subject|0|||
128939171|NCT01120093|464065103|FG004|Treatment Period 3|Withdrawal by Subject|0|||
128939172|NCT01120093|464065099|FG000|Treatment Period 4|Adverse Event|1|||
128939173|NCT01120093|464065100|FG001|Treatment Period 4|Adverse Event|0|||
128939174|NCT01120093|464065101|FG002|Treatment Period 4|Adverse Event|0|||
128939175|NCT01120093|464065102|FG003|Treatment Period 4|Adverse Event|0|||
128939176|NCT01120093|464065103|FG004|Treatment Period 4|Adverse Event|0|||
128769770|NCT00779584|463448255|FG002|Overall Study|Protocol Violation|0|||
128769771|NCT00779584|463448256|FG003|Overall Study|Protocol Violation|0|||
129123127|NCT00851591|464745544|FG000|Overall Study|Withdrawal by Subject|2|||
128939177|NCT01120093|464065099|FG000|Treatment Period 5|Adverse Event|0|||
128939178|NCT01120093|464065100|FG001|Treatment Period 5|Adverse Event|1|||
128939179|NCT01120093|464065101|FG002|Treatment Period 5|Adverse Event|0|||
128939180|NCT01120093|464065102|FG003|Treatment Period 5|Adverse Event|1|||
128939181|NCT01120093|464065103|FG004|Treatment Period 5|Adverse Event|0|||
128939182|NCT03649321|464065106|FG000|Overall Study|Withdrawal by Subject|1|||
129031979|NCT05393271|464408213|FG010|Overall Study|Physician Decision|0|||
129031980|NCT02483416|464408214|FG000|Overall Study|Other reason|0|||
129031981|NCT02483416|464408215|FG001|Overall Study|Other reason|1|||
129031982|NCT02483416|464408214|FG000|Overall Study|Treatment stop|3|||
129031983|NCT02483416|464408215|FG001|Overall Study|Treatment stop|0|||
128939183|NCT03649321|464065107|FG001|Overall Study|Withdrawal by Subject|0|||
128939184|NCT03649321|464065106|FG000|Overall Study|Death|1|||
128939185|NCT03649321|464065107|FG001|Overall Study|Death|0|||
128939186|NCT01702363|464065108|FG000|Overall Study|Adverse Event|14|||
128939187|NCT01702363|464065108|FG000|Overall Study|Lack of Efficacy|4|||
128939188|NCT01702363|464065108|FG000|Overall Study|Withdrawal by Subject|2|||
128939189|NCT02184143|464065115|FG000|Overall Study|Withdrawal by Subject|4|||
128939190|NCT02184143|464065116|FG001|Overall Study|Withdrawal by Subject|4|||
128939191|NCT02184143|464065115|FG000|Overall Study|Lost to Follow-up|5|||
128939192|NCT02184143|464065116|FG001|Overall Study|Lost to Follow-up|3|||
128939193|NCT02184143|464065115|FG000|Overall Study|Death|1|||
128939194|NCT02184143|464065116|FG001|Overall Study|Death|0|||
128939195|NCT00321984|464065117|FG000|Overall Study|Adverse Event|9|||
128939196|NCT00321984|464065118|FG001|Overall Study|Adverse Event|6|||
128939197|NCT00321984|464065119|FG002|Overall Study|Adverse Event|8|||
128939198|NCT00321984|464065117|FG000|Overall Study|Protocol Violation|0|||
128939199|NCT00321984|464065118|FG001|Overall Study|Protocol Violation|1|||
128939200|NCT00321984|464065119|FG002|Overall Study|Protocol Violation|1|||
128939201|NCT00321984|464065117|FG000|Overall Study|Lost to Follow-up|2|||
128939202|NCT00321984|464065118|FG001|Overall Study|Lost to Follow-up|4|||
128939203|NCT00321984|464065119|FG002|Overall Study|Lost to Follow-up|2|||
128939204|NCT00321984|464065117|FG000|Overall Study|Withdrawal by Subject|8|||
128939205|NCT00321984|464065118|FG001|Overall Study|Withdrawal by Subject|6|||
128939206|NCT00321984|464065119|FG002|Overall Study|Withdrawal by Subject|5|||
128939207|NCT00321984|464065117|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
128939208|NCT00321984|464065118|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
128939209|NCT00321984|464065119|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
128939210|NCT00321984|464065117|FG000|Overall Study|Lack of Efficacy|3|||
128939211|NCT00321984|464065118|FG001|Overall Study|Lack of Efficacy|1|||
128939212|NCT00321984|464065119|FG002|Overall Study|Lack of Efficacy|3|||
128939213|NCT00321984|464065117|FG000|Overall Study|Noncompliant|0|||
128939214|NCT00321984|464065118|FG001|Overall Study|Noncompliant|0|||
128939215|NCT00321984|464065119|FG002|Overall Study|Noncompliant|2|||
128939216|NCT00321984|464065117|FG000|Overall Study|Pregnancy|0|||
128939217|NCT00321984|464065118|FG001|Overall Study|Pregnancy|1|||
128939218|NCT00321984|464065119|FG002|Overall Study|Pregnancy|0|||
128939219|NCT00321984|464065117|FG000|Overall Study|Per Subject Request|1|||
128939220|NCT00321984|464065118|FG001|Overall Study|Per Subject Request|0|||
128939221|NCT00321984|464065119|FG002|Overall Study|Per Subject Request|0|||
128939222|NCT00321984|464065117|FG000|Overall Study|Per Investigator Request|1|||
128939223|NCT00321984|464065118|FG001|Overall Study|Per Investigator Request|0|||
128939224|NCT00321984|464065119|FG002|Overall Study|Per Investigator Request|0|||
128939225|NCT00321984|464065117|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
128939226|NCT00321984|464065118|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
128939227|NCT00321984|464065119|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
128939228|NCT02142894|464065120|FG000|Overall Study|Protocol Violation|8|||
128939229|NCT00570739|464065122|FG000|Overall Study|Adverse Event|8|||
128939230|NCT00570739|464065123|FG001|Overall Study|Adverse Event|6|||
128939231|NCT00570739|464065124|FG002|Overall Study|Adverse Event|2|||
128939232|NCT00570739|464065125|FG003|Overall Study|Adverse Event|2|||
128939233|NCT00570739|464065122|FG000|Overall Study|Lost to Follow-up|4|||
128939234|NCT00570739|464065123|FG001|Overall Study|Lost to Follow-up|5|||
128939235|NCT00570739|464065124|FG002|Overall Study|Lost to Follow-up|4|||
128939236|NCT00570739|464065125|FG003|Overall Study|Lost to Follow-up|1|||
128939237|NCT00570739|464065122|FG000|Overall Study|Physician Decision|1|||
128939238|NCT00570739|464065123|FG001|Overall Study|Physician Decision|1|||
128939239|NCT00570739|464065124|FG002|Overall Study|Physician Decision|0|||
128939240|NCT00570739|464065125|FG003|Overall Study|Physician Decision|0|||
129031984|NCT03433703|464408222|FG000|Overall Study|Study terminated by Sponsor|2|||
129031985|NCT01957150|464408223|FG000|Overall Study|Adverse Event|23|||
129031986|NCT01957150|464408224|FG001|Overall Study|Adverse Event|20|||
129031987|NCT01957150|464408223|FG000|Overall Study|Withdrawal by Subject|13|||
129031988|NCT01957150|464408224|FG001|Overall Study|Withdrawal by Subject|17|||
129031989|NCT01957150|464408223|FG000|Overall Study|Physician Decision|3|||
129031990|NCT01957150|464408224|FG001|Overall Study|Physician Decision|6|||
129031991|NCT01957150|464408223|FG000|Overall Study|Lost to Follow-up|4|||
128939241|NCT00570739|464065122|FG000|Overall Study|Withdrawal by Subject|7|||
128939242|NCT00570739|464065123|FG001|Overall Study|Withdrawal by Subject|7|||
128939243|NCT00570739|464065124|FG002|Overall Study|Withdrawal by Subject|3|||
129031992|NCT01957150|464408224|FG001|Overall Study|Lost to Follow-up|4|||
129031993|NCT01957150|464408223|FG000|Overall Study|Protocol Violation|1|||
129031994|NCT01957150|464408224|FG001|Overall Study|Protocol Violation|0|||
128939244|NCT00570739|464065125|FG003|Overall Study|Withdrawal by Subject|5|||
129031995|NCT01957150|464408223|FG000|Overall Study|Lack of Efficacy|11|||
128769772|NCT00779584|463448257|FG004|Overall Study|Protocol Violation|0|||
128769773|NCT00779584|463448258|FG005|Overall Study|Protocol Violation|1|||
128769774|NCT00779584|463448259|FG006|Overall Study|Protocol Violation|0|||
128769775|NCT00779584|463448260|FG007|Overall Study|Protocol Violation|0|||
128769776|NCT00779584|463448261|FG008|Overall Study|Protocol Violation|0|||
128769777|NCT00779584|463448253|FG000|Overall Study|Withdrawal by Subject|1|||
128769778|NCT00779584|463448254|FG001|Overall Study|Withdrawal by Subject|1|||
128769779|NCT00779584|463448255|FG002|Overall Study|Withdrawal by Subject|2|||
128769780|NCT00779584|463448256|FG003|Overall Study|Withdrawal by Subject|0|||
128769781|NCT00779584|463448257|FG004|Overall Study|Withdrawal by Subject|0|||
128769782|NCT00779584|463448258|FG005|Overall Study|Withdrawal by Subject|2|||
128769783|NCT00779584|463448259|FG006|Overall Study|Withdrawal by Subject|1|||
128769784|NCT00779584|463448260|FG007|Overall Study|Withdrawal by Subject|0|||
128769785|NCT00779584|463448261|FG008|Overall Study|Withdrawal by Subject|0|||
128769786|NCT00779584|463448253|FG000|Overall Study|Lost to Follow-up|0|||
128769787|NCT00779584|463448254|FG001|Overall Study|Lost to Follow-up|0|||
128769788|NCT00779584|463448255|FG002|Overall Study|Lost to Follow-up|0|||
128769789|NCT00779584|463448256|FG003|Overall Study|Lost to Follow-up|0|||
128769790|NCT00779584|463448257|FG004|Overall Study|Lost to Follow-up|1|||
128769791|NCT00779584|463448258|FG005|Overall Study|Lost to Follow-up|0|||
128769792|NCT00779584|463448259|FG006|Overall Study|Lost to Follow-up|0|||
128939245|NCT00570739|464065122|FG000|Overall Study|Required restricted medication|0|||
128939246|NCT00570739|464065123|FG001|Overall Study|Required restricted medication|0|||
128939247|NCT00570739|464065124|FG002|Overall Study|Required restricted medication|1|||
128939248|NCT00570739|464065125|FG003|Overall Study|Required restricted medication|0|||
128939249|NCT00570739|464065122|FG000|Overall Study|Met discontinuation criteria|1|||
128939250|NCT00570739|464065123|FG001|Overall Study|Met discontinuation criteria|0|||
128939251|NCT00570739|464065124|FG002|Overall Study|Met discontinuation criteria|1|||
128939252|NCT00570739|464065125|FG003|Overall Study|Met discontinuation criteria|1|||
128939253|NCT00570739|464065122|FG000|Overall Study|Other|0|||
128939254|NCT00570739|464065123|FG001|Overall Study|Other|2|||
128939255|NCT00570739|464065124|FG002|Overall Study|Other|5|||
128939256|NCT00570739|464065125|FG003|Overall Study|Other|3|||
128939257|NCT00616239|464065127|FG000|Overall Study|Withdrawal by Subject|2|||
128939258|NCT02144220|464065129|FG000|Overall Study|technology incompatibility|9|||
128939259|NCT02144220|464065129|FG000|Overall Study|Lack of Efficacy|4|||
128939260|NCT02144220|464065129|FG000|Overall Study|Physician Decision|3|||
128939261|NCT02144220|464065129|FG000|Overall Study|Withdrawal by Subject|2|||
128939262|NCT02144220|464065129|FG000|Overall Study|Protocol Violation|1|||
128939263|NCT03648996|464065130|FG000|Overall Study|Withdrawal by Subject|0|||
128939264|NCT03648996|464065131|FG001|Overall Study|Withdrawal by Subject|2|||
128939265|NCT03648996|464065132|FG002|Overall Study|Withdrawal by Subject|2|||
128939266|NCT03648996|464065130|FG000|Overall Study|Physician Decision|2|||
128939267|NCT03648996|464065131|FG001|Overall Study|Physician Decision|0|||
128939268|NCT03648996|464065132|FG002|Overall Study|Physician Decision|0|||
128939269|NCT00443430|464065136|FG000|Overall Study|Lack of Efficacy|3|||
128939270|NCT00443430|464065137|FG001|Overall Study|Lack of Efficacy|3|||
128939271|NCT00443430|464065136|FG000|Overall Study|Adverse Event|1|||
128939272|NCT00443430|464065137|FG001|Overall Study|Adverse Event|1|||
128939273|NCT00504166|464065139|FG000|Overall Study|Adverse Event|1|||
128939274|NCT00504166|464065140|FG001|Overall Study|Adverse Event|4|||
128939275|NCT00504166|464065139|FG000|Overall Study|Withdrawal by Subject|3|||
128939276|NCT00504166|464065140|FG001|Overall Study|Withdrawal by Subject|6|||
128939277|NCT00504166|464065139|FG000|Overall Study|Physician Decision|1|||
128939278|NCT00504166|464065140|FG001|Overall Study|Physician Decision|1|||
128939279|NCT00504166|464065139|FG000|Overall Study|Lost to Follow-up|1|||
128939280|NCT00504166|464065140|FG001|Overall Study|Lost to Follow-up|3|||
128939281|NCT02229864|464065141|FG000|Overall Study|Death|2|||
128939282|NCT02229864|464065141|FG000|Overall Study|Lost to Follow-up|1|||
129031996|NCT01957150|464408224|FG001|Overall Study|Lack of Efficacy|11|||
129031997|NCT02786953|464408227|FG000|Overall Study|Withdrawal by Subject|3|||
129031998|NCT02786953|464408228|FG001|Overall Study|Withdrawal by Subject|0|||
129031999|NCT02786953|464408227|FG000|Overall Study|Physician Decision|0|||
129032000|NCT02786953|464408228|FG001|Overall Study|Physician Decision|1|||
128769793|NCT00779584|463448260|FG007|Overall Study|Lost to Follow-up|0|||
128769794|NCT00779584|463448261|FG008|Overall Study|Lost to Follow-up|0|||
128769795|NCT00779584|463448253|FG000|Overall Study|Progression of Disease|0|||
128939283|NCT02650284|464065146|FG000|Overall Study|Lost to Follow-up|3|||
128939284|NCT02650284|464065147|FG001|Overall Study|Lost to Follow-up|3|||
128939285|NCT02650284|464065146|FG000|Overall Study|Consent incorrectly taken|0|||
128939286|NCT02650284|464065147|FG001|Overall Study|Consent incorrectly taken|1|||
129032001|NCT00252564|464408229|FG000|Overall Study|Adverse Event|17|||
128769796|NCT00779584|463448254|FG001|Overall Study|Progression of Disease|1|||
128769797|NCT00779584|463448255|FG002|Overall Study|Progression of Disease|2|||
128769798|NCT00779584|463448256|FG003|Overall Study|Progression of Disease|6|||
128939287|NCT01165203|464065150|FG000|Active Phase|Serious Adverse Event|1|||
128939288|NCT01165203|464065151|FG001|Active Phase|Serious Adverse Event|0|||
128769799|NCT00779584|463448257|FG004|Overall Study|Progression of Disease|5|||
128939289|NCT01165203|464065150|FG000|Active Phase|Withdrawal by Subject|2|||
129123128|NCT00851591|464745545|FG001|Overall Study|Withdrawal by Subject|0|||
128939290|NCT01165203|464065151|FG001|Active Phase|Withdrawal by Subject|1|||
128939291|NCT01165203|464065150|FG000|Active Phase|Migrated/moved from study area|0|||
128939292|NCT01165203|464065151|FG001|Active Phase|Migrated/moved from study area|1|||
128939293|NCT01165203|464065150|FG000|Active Phase|Lost to Follow-up|2|||
128939294|NCT01165203|464065151|FG001|Active Phase|Lost to Follow-up|0|||
128939295|NCT01165203|464065150|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
128939296|NCT01165203|464065151|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
128939297|NCT01165203|464065150|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
128939298|NCT01165203|464065151|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
128939299|NCT01165203|464065150|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
128939300|NCT01165203|464065151|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
128939301|NCT01165203|464065150|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
128939302|NCT01165203|464065151|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
128939303|NCT01165203|464065150|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
128939304|NCT01165203|464065151|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
128939305|NCT01780389|464065153|FG000|Overall Study|Adverse Event|1|||
128939306|NCT00337467|464065157|FG000|Overall Study|Adverse Event|3|||
128939307|NCT00337467|464065157|FG000|Overall Study|Subject Withdrew Consent|2|||
128939308|NCT00337467|464065157|FG000|Overall Study|Pregnancy|1|||
128939309|NCT00337467|464065157|FG000|Overall Study|Lost to Follow-up|2|||
128939310|NCT00337467|464065157|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
128939311|NCT04083222|464065158|FG000|Overall Study|Voluntary Withdrawal|0|||
128939312|NCT04083222|464065159|FG001|Overall Study|Voluntary Withdrawal|1|||
128939313|NCT04083222|464065158|FG000|Overall Study|Reason not Specified|0|||
128939314|NCT04083222|464065159|FG001|Overall Study|Reason not Specified|1|||
128939315|NCT03103750|464065160|FG000|Overall Study|Adverse Event|1|||
128939316|NCT03103750|464065161|FG001|Overall Study|Adverse Event|0|||
128939317|NCT03103750|464065160|FG000|Overall Study|Lost to Follow-up|1|||
128939318|NCT03103750|464065161|FG001|Overall Study|Lost to Follow-up|0|||
128939319|NCT03103750|464065160|FG000|Overall Study|PET Equipment Related|2|||
128939320|NCT03103750|464065161|FG001|Overall Study|PET Equipment Related|2|||
128939321|NCT04400318|464066521|FG000|Overall Study|Adverse Event|1|||
128939322|NCT04400318|464066522|FG001|Overall Study|Adverse Event|0|||
128939323|NCT04400318|464066521|FG000|Overall Study|Withdrawal by Subject|1|||
128939324|NCT04400318|464066522|FG001|Overall Study|Withdrawal by Subject|1|||
128939325|NCT04400318|464066521|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
128939326|NCT04400318|464066522|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
128939327|NCT01096446|464066523|FG000|Overall Study|Death|1|||
128939328|NCT01096446|464066524|FG001|Overall Study|Death|0|||
128939329|NCT01096446|464066523|FG000|Overall Study|Protocol Violation|2|||
128939330|NCT01096446|464066524|FG001|Overall Study|Protocol Violation|0|||
128939331|NCT00747617|464066525|FG000|Overall Study|Lost to Follow-up|3|||
128939332|NCT00747617|464066526|FG001|Overall Study|Lost to Follow-up|1|||
128939333|NCT02279524|464066527|FG000|Overall Study|Withdrawal by Subject|3|||
128939334|NCT02279524|464066528|FG001|Overall Study|Withdrawal by Subject|6|||
128939335|NCT02279524|464066529|FG002|Overall Study|Withdrawal by Subject|3|||
128939336|NCT02279524|464066527|FG000|Overall Study|Adverse Event|4|||
128939337|NCT02279524|464066528|FG001|Overall Study|Adverse Event|3|||
128939338|NCT02279524|464066529|FG002|Overall Study|Adverse Event|2|||
128939339|NCT02279524|464066527|FG000|Overall Study|Lost to Follow-up|1|||
128939340|NCT02279524|464066528|FG001|Overall Study|Lost to Follow-up|1|||
128939341|NCT02279524|464066529|FG002|Overall Study|Lost to Follow-up|0|||
128939342|NCT02279524|464066527|FG000|Overall Study|Disallowed medication|1|||
128939343|NCT02279524|464066528|FG001|Overall Study|Disallowed medication|1|||
128939344|NCT02279524|464066529|FG002|Overall Study|Disallowed medication|2|||
128939345|NCT02279524|464066527|FG000|Overall Study|Bariatric surgery|1|||
128939346|NCT02279524|464066528|FG001|Overall Study|Bariatric surgery|0|||
128939347|NCT02279524|464066529|FG002|Overall Study|Bariatric surgery|0|||
128939348|NCT01746732|464066530|FG000|Lead-In Period|Withdrawal by Subject|1|||
128939349|NCT01746732|464066531|FG001|Lead-In Period|Withdrawal by Subject|0|||
128939350|NCT01746732|464066532|FG002|Lead-In Period|Withdrawal by Subject|0|||
128939351|NCT01746732|464066530|FG000|Period 1|Physician Decision|0|||
128939352|NCT01746732|464066531|FG001|Period 1|Physician Decision|1|||
128939353|NCT01746732|464066532|FG002|Period 1|Physician Decision|0|||
128939354|NCT01746732|464066530|FG000|Period 2|Withdrawal by Subject|0|||
128939355|NCT01746732|464066531|FG001|Period 2|Withdrawal by Subject|0|||
128939356|NCT01746732|464066532|FG002|Period 2|Withdrawal by Subject|2|||
128939357|NCT01746732|464066530|FG000|Period 2|Adverse Event|0|||
128939358|NCT01746732|464066531|FG001|Period 2|Adverse Event|0|||
128939359|NCT01746732|464066532|FG002|Period 2|Adverse Event|1|||
128939360|NCT01746732|464066530|FG000|Period 2|Lost to Follow-up|0|||
128939361|NCT01746732|464066531|FG001|Period 2|Lost to Follow-up|0|||
128939362|NCT01746732|464066532|FG002|Period 2|Lost to Follow-up|1|||
129132951|NCT04433975|464778574|FG000|12-month Follow Up|Lost to Follow-up|27|||
128939363|NCT03509207|464066533|FG000|Overall Study|Death|2|||
128939364|NCT02817555|464066534|FG000|Overall Study|Death|1|||
128939365|NCT02817555|464066535|FG001|Overall Study|Death|3|||
128939366|NCT02817555|464066534|FG000|Overall Study|moved away|1|||
128939367|NCT02817555|464066535|FG001|Overall Study|moved away|0|||
128939368|NCT02817555|464066534|FG000|Overall Study|transplant|1|||
128939369|NCT02817555|464066535|FG001|Overall Study|transplant|1|||
128939370|NCT02817555|464066534|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
128939371|NCT02817555|464066535|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
128939372|NCT00137436|464066536|FG000|Overall Study|Adverse Event|13|||
128939373|NCT00137436|464066536|FG000|Overall Study|Death|2|||
128939374|NCT00137436|464066536|FG000|Overall Study|Lack of Efficacy|17|||
128939375|NCT00137436|464066536|FG000|Overall Study|Withdrawal by Subject|6|||
128939376|NCT00137436|464066536|FG000|Overall Study|Other|5|||
128939377|NCT00912015|464066540|FG000|Overall Study|Lack of Efficacy|1|||
128939378|NCT00912015|464066541|FG001|Overall Study|Lack of Efficacy|0|||
128939379|NCT00912015|464066542|FG002|Overall Study|Lack of Efficacy|0|||
128939380|NCT00912015|464066543|FG003|Overall Study|Lack of Efficacy|0|||
129123129|NCT02326883|464745547|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
129123130|NCT02326883|464745548|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
129123131|NCT02326883|464745549|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
128939381|NCT00912015|464066540|FG000|Overall Study|Withdrawal by Subject|8|||
128939382|NCT00912015|464066541|FG001|Overall Study|Withdrawal by Subject|8|||
128939383|NCT00912015|464066542|FG002|Overall Study|Withdrawal by Subject|3|||
128939384|NCT00912015|464066543|FG003|Overall Study|Withdrawal by Subject|0|||
128939385|NCT00912015|464066540|FG000|Overall Study|Protocol Violation|1|||
128939386|NCT00912015|464066541|FG001|Overall Study|Protocol Violation|0|||
128939387|NCT00912015|464066542|FG002|Overall Study|Protocol Violation|0|||
128939388|NCT00912015|464066543|FG003|Overall Study|Protocol Violation|1|||
128939389|NCT00912015|464066540|FG000|Overall Study|Adverse Event|6|||
128939390|NCT00912015|464066541|FG001|Overall Study|Adverse Event|0|||
128939391|NCT00912015|464066542|FG002|Overall Study|Adverse Event|0|||
128939392|NCT00912015|464066543|FG003|Overall Study|Adverse Event|1|||
128939393|NCT01356602|464066544|FG000|Overall Study|Protocol Deviation|0|||
128939394|NCT01356602|464066545|FG001|Overall Study|Protocol Deviation|1|||
128939395|NCT01356602|464066546|FG002|Overall Study|Protocol Deviation|1|||
128939396|NCT01356602|464066544|FG000|Overall Study|Administrative Problems|1|||
128939397|NCT01356602|464066545|FG001|Overall Study|Administrative Problems|4|||
128939398|NCT01356602|464066546|FG002|Overall Study|Administrative Problems|5|||
128939399|NCT01356602|464066544|FG000|Overall Study|Lost to Follow-up|4|||
128939400|NCT01356602|464066545|FG001|Overall Study|Lost to Follow-up|5|||
128939401|NCT01356602|464066546|FG002|Overall Study|Lost to Follow-up|6|||
128939402|NCT01356602|464066544|FG000|Overall Study|Withdrawal by Subject|4|||
128939403|NCT01356602|464066545|FG001|Overall Study|Withdrawal by Subject|3|||
128939404|NCT01356602|464066546|FG002|Overall Study|Withdrawal by Subject|7|||
128939405|NCT01356602|464066544|FG000|Overall Study|Lack of Efficacy|0|||
128939406|NCT01356602|464066545|FG001|Overall Study|Lack of Efficacy|1|||
128939407|NCT01356602|464066546|FG002|Overall Study|Lack of Efficacy|4|||
128939408|NCT01356602|464066544|FG000|Overall Study|Adverse Event|0|||
128939409|NCT01356602|464066545|FG001|Overall Study|Adverse Event|1|||
128939410|NCT01356602|464066546|FG002|Overall Study|Adverse Event|1|||
128939411|NCT01115569|464066547|FG000|Conversion/Titration Phase|Adverse Event|59|||
128939412|NCT01115569|464066548|FG001|Conversion/Titration Phase|Adverse Event|0|||
128939413|NCT01115569|464066547|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
128939414|NCT01115569|464066548|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
128939415|NCT01115569|464066547|FG000|Conversion/Titration Phase|Physician Decision|5|||
128939416|NCT01115569|464066548|FG001|Conversion/Titration Phase|Physician Decision|0|||
128939417|NCT01115569|464066547|FG000|Conversion/Titration Phase|Protocol Violation|68|||
128939418|NCT01115569|464066548|FG001|Conversion/Titration Phase|Protocol Violation|0|||
128939419|NCT01115569|464066547|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
128939420|NCT01115569|464066548|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
128939421|NCT01115569|464066547|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
128939422|NCT01115569|464066548|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
128939423|NCT01115569|464066547|FG000|Maintenance Phase|Adverse Event|0|||
128939424|NCT01115569|464066548|FG001|Maintenance Phase|Adverse Event|43|||
128939425|NCT01115569|464066547|FG000|Maintenance Phase|Lost to Follow-up|0|||
128939426|NCT01115569|464066548|FG001|Maintenance Phase|Lost to Follow-up|8|||
128939427|NCT01115569|464066547|FG000|Maintenance Phase|Physician Decision|0|||
128939428|NCT01115569|464066548|FG001|Maintenance Phase|Physician Decision|3|||
128939429|NCT01115569|464066547|FG000|Maintenance Phase|Protocol Violation|0|||
128939430|NCT01115569|464066548|FG001|Maintenance Phase|Protocol Violation|9|||
128939431|NCT01115569|464066547|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128939432|NCT01115569|464066548|FG001|Maintenance Phase|Withdrawal by Subject|27|||
128939433|NCT01115569|464066547|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
128939434|NCT01115569|464066548|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
128707216|NCT02132130|463222197|FG001|Overall Study|Withdrawal by Subject|0|||
128707217|NCT02132130|463222198|FG002|Overall Study|Withdrawal by Subject|0|||
128707218|NCT02132130|463222199|FG003|Overall Study|Withdrawal by Subject|1|||
128939435|NCT01115569|464066547|FG000|Maintenance Phase|Administrative|0|||
128939436|NCT01115569|464066548|FG001|Maintenance Phase|Administrative|1|||
128939437|NCT01931462|464066549|FG000|Overall Study|Withdrawal by Subject|1|||
128939438|NCT02361762|464066550|FG000|Overall Study|Withdrawal by Subject|0|||
128939439|NCT02361762|464066551|FG001|Overall Study|Withdrawal by Subject|1|||
128939440|NCT02361762|464066550|FG000|Overall Study|Lost to Follow-up|0|||
128939441|NCT02361762|464066551|FG001|Overall Study|Lost to Follow-up|1|||
128939442|NCT02819310|464066552|FG000|Overall Study|Withdrawal by Subject|37|||
128939443|NCT02819310|464066552|FG000|Overall Study|Lost to Follow-up|16|||
128939444|NCT02819310|464066552|FG000|Overall Study|Adverse Event|13|||
128939445|NCT02819310|464066552|FG000|Overall Study|Lack of Efficacy|5|||
128939446|NCT02819310|464066552|FG000|Overall Study|Physician Decision|8|||
128939447|NCT02819310|464066552|FG000|Overall Study|Protocol Violation|30|||
128939448|NCT05070429|464066560|FG000|Overall Study|Death|0|||
128939449|NCT05070429|464066561|FG001|Overall Study|Death|4|||
128939450|NCT05070429|464066560|FG000|Overall Study|Withdrawal by Subject|2|||
128939451|NCT05070429|464066561|FG001|Overall Study|Withdrawal by Subject|1|||
128939452|NCT05070429|464066560|FG000|Overall Study|Other|15|||
128939453|NCT05070429|464066561|FG001|Overall Study|Other|5|||
128939454|NCT03276936|464066562|FG000|Overall Study|Adverse Event|4|||
128939455|NCT03276936|464066563|FG001|Overall Study|Adverse Event|2|||
128939456|NCT03276936|464066562|FG000|Overall Study|Lost to Follow-up|16|||
128939457|NCT03276936|464066563|FG001|Overall Study|Lost to Follow-up|13|||
128939458|NCT03276936|464066562|FG000|Overall Study|Withdrawal by Subject|30|||
128939459|NCT03276936|464066563|FG001|Overall Study|Withdrawal by Subject|20|||
128939460|NCT03276936|464066562|FG000|Overall Study|Not mentioned|6|||
128939461|NCT03276936|464066563|FG001|Overall Study|Not mentioned|3|||
128939462|NCT00943319|464066564|FG000|Overall Study|Death|1|||
128939463|NCT02043301|464066565|FG000|Overall Study|Discontinued|0|||
128939464|NCT02043301|464066566|FG001|Overall Study|Discontinued|1|||
128939465|NCT02043301|464066567|FG002|Overall Study|Discontinued|0|||
128939466|NCT03097328|464066568|FG000|Overall Study|Still on Therapy|2|||
128939467|NCT03097328|464066568|FG000|Overall Study|Progressive Disease|29|||
128939468|NCT03097328|464066568|FG000|Overall Study|Adverse Event|4|||
128939469|NCT03097328|464066568|FG000|Overall Study|Withdrawal by Subject|1|||
128939470|NCT03097328|464066568|FG000|Overall Study|Physician Decision|1|||
128939471|NCT03097328|464066568|FG000|Overall Study|Patient Decision|1|||
128939472|NCT03097328|464066568|FG000|Overall Study|Ineligible for Study Drug|1|||
128939473|NCT01798134|464066569|FG000|Overall Study|Lost to Follow-up|1|||
128939474|NCT01798134|464066569|FG000|Overall Study|Withdrawal by Subject|3|||
128939475|NCT01798134|464066569|FG000|Overall Study|Death|2|||
128939476|NCT01798134|464066569|FG000|Overall Study|Adverse Event|3|||
128939477|NCT01798134|464066569|FG000|Overall Study|Physician Decision|3|||
128939478|NCT01798134|464066569|FG000|Overall Study|Liver transplant/surgery|4|||
128939479|NCT02023164|464066570|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
128939480|NCT02023164|464066571|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
128939481|NCT02653976|464066572|FG000|Overall Study|Withdrawal by Subject|5|||
128939482|NCT02653976|464066572|FG000|Overall Study|Death|4|||
128939483|NCT00883558|464066573|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
128939484|NCT00883558|464066574|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
128939485|NCT00883558|464066575|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
128939486|NCT00883558|464066573|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
128939487|NCT00883558|464066574|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
128939488|NCT00883558|464066575|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
128939489|NCT00883558|464066573|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
128939490|NCT00883558|464066574|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
128939491|NCT00883558|464066575|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
128939492|NCT00883558|464066573|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
128707219|NCT00838578|463222200|FG000|Overall Study|Protocol Violation|2|||
128707220|NCT00600483|463222201|FG000|Overall Study|Lost to Follow-up|26|||
128707221|NCT00600483|463222202|FG001|Overall Study|Lost to Follow-up|47|||
128939493|NCT00883558|464066574|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
128939494|NCT00883558|464066575|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
128939495|NCT00883558|464066573|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
128939496|NCT00883558|464066574|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
128939497|NCT00883558|464066575|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
128939498|NCT02436577|464066576|FG000|Overall Study|Protocol Deviation|0|||
128939499|NCT02436577|464066577|FG001|Overall Study|Protocol Deviation|1|||
128939500|NCT02436577|464066578|FG002|Overall Study|Protocol Deviation|0|||
128939501|NCT02436577|464066579|FG003|Overall Study|Protocol Deviation|0|||
128939502|NCT02436577|464066580|FG004|Overall Study|Protocol Deviation|0|||
128939503|NCT02436577|464066581|FG005|Overall Study|Protocol Deviation|0|||
128939504|NCT03703375|464066582|FG000|Randomization Period|Withdrawal by Subject|0|||
128939505|NCT03703375|464066583|FG001|Randomization Period|Withdrawal by Subject|0|||
128939506|NCT03703375|464066584|FG002|Randomization Period|Withdrawal by Subject|0|||
128939507|NCT03703375|464066585|FG003|Randomization Period|Withdrawal by Subject|1|||
128939508|NCT03703375|464066582|FG000|Randomization Period|Completed safety run-in treatment|7|||
128939509|NCT03703375|464066583|FG001|Randomization Period|Completed safety run-in treatment|0|||
128939510|NCT03703375|464066584|FG002|Randomization Period|Completed safety run-in treatment|0|||
128939511|NCT03703375|464066585|FG003|Randomization Period|Completed safety run-in treatment|0|||
128939512|NCT03703375|464066582|FG000|Treatment Period|Other Reasons|0|||
128939513|NCT03703375|464066583|FG001|Treatment Period|Other Reasons|1|||
128939514|NCT03703375|464066584|FG002|Treatment Period|Other Reasons|0|||
128939515|NCT03703375|464066585|FG003|Treatment Period|Other Reasons|3|||
128939516|NCT03703375|464066582|FG000|Treatment Period|Consent Withdrawal|0|||
128939517|NCT03703375|464066583|FG001|Treatment Period|Consent Withdrawal|0|||
128939518|NCT03703375|464066584|FG002|Treatment Period|Consent Withdrawal|0|||
128939519|NCT03703375|464066585|FG003|Treatment Period|Consent Withdrawal|1|||
128939520|NCT03703375|464066582|FG000|Treatment Period|Death|1|||
128939521|NCT03703375|464066583|FG001|Treatment Period|Death|0|||
128939522|NCT03703375|464066584|FG002|Treatment Period|Death|1|||
129217707|NCT02745119|465097046|FG003|Overall Study|Withdrawal by Subject|14|||
129217708|NCT02745119|465097043|FG000|Overall Study|Study Terminated by Sponsor|134|||
128769800|NCT00779584|463448258|FG005|Overall Study|Progression of Disease|1|||
128769801|NCT00779584|463448259|FG006|Overall Study|Progression of Disease|4|||
128939523|NCT03703375|464066585|FG003|Treatment Period|Death|2|||
128939524|NCT03703375|464066582|FG000|Treatment Period|Toxicity of Study Treatment|2|||
128939525|NCT03703375|464066583|FG001|Treatment Period|Toxicity of Study Treatment|0|||
128939526|NCT03703375|464066584|FG002|Treatment Period|Toxicity of Study Treatment|4|||
128939527|NCT03703375|464066585|FG003|Treatment Period|Toxicity of Study Treatment|1|||
128939528|NCT03703375|464066582|FG000|Treatment Period|Progression|32|||
128939529|NCT03703375|464066583|FG001|Treatment Period|Progression|1|||
128939530|NCT03703375|464066584|FG002|Treatment Period|Progression|7|||
128939531|NCT03703375|464066585|FG003|Treatment Period|Progression|11|||
128939532|NCT03703375|464066582|FG000|Treatment Period|Completed treatment|7|||
128939533|NCT03703375|464066583|FG001|Treatment Period|Completed treatment|2|||
128939534|NCT03703375|464066584|FG002|Treatment Period|Completed treatment|0|||
128939535|NCT03703375|464066585|FG003|Treatment Period|Completed treatment|0|||
128939536|NCT00625365|464066587|FG000|Overall Study|Withdrawal by Subject|1|||
128939537|NCT00625365|464066587|FG000|Overall Study|No IV access|5|||
128939538|NCT00625365|464066587|FG000|Overall Study|VSD|1|||
128939539|NCT02531373|464066591|FG000|Overall Study|Lack of Efficacy|0|||
128939540|NCT02531373|464066592|FG001|Overall Study|Lack of Efficacy|0|||
128939541|NCT02531373|464066593|FG002|Overall Study|Lack of Efficacy|0|||
128939542|NCT02531373|464066594|FG003|Overall Study|Lack of Efficacy|0|||
128939543|NCT02531373|464066595|FG004|Overall Study|Lack of Efficacy|3|||
128939544|NCT02531373|464066596|FG005|Overall Study|Lack of Efficacy|2|||
128939545|NCT02531373|464066597|FG006|Overall Study|Lack of Efficacy|4|||
128939546|NCT02531373|464066598|FG007|Overall Study|Lack of Efficacy|8|||
128939547|NCT02531373|464066599|FG008|Overall Study|Lack of Efficacy|5|||
128939548|NCT02531373|464066591|FG000|Overall Study|Lost to Follow-up|0|||
128939549|NCT02531373|464066592|FG001|Overall Study|Lost to Follow-up|0|||
128939550|NCT02531373|464066593|FG002|Overall Study|Lost to Follow-up|0|||
128939551|NCT02531373|464066594|FG003|Overall Study|Lost to Follow-up|0|||
128939552|NCT02531373|464066595|FG004|Overall Study|Lost to Follow-up|0|||
128939553|NCT02531373|464066596|FG005|Overall Study|Lost to Follow-up|2|||
128939554|NCT02531373|464066597|FG006|Overall Study|Lost to Follow-up|2|||
128939555|NCT02531373|464066598|FG007|Overall Study|Lost to Follow-up|0|||
128939556|NCT02531373|464066599|FG008|Overall Study|Lost to Follow-up|0|||
128939557|NCT02531373|464066591|FG000|Overall Study|Physician Decision|0|||
128939558|NCT02531373|464066592|FG001|Overall Study|Physician Decision|0|||
128769802|NCT00779584|463448260|FG007|Overall Study|Progression of Disease|2|||
128769803|NCT00779584|463448261|FG008|Overall Study|Progression of Disease|1|||
128769804|NCT00779584|463448253|FG000|Overall Study|Adverse Event|1|||
128769805|NCT00779584|463448254|FG001|Overall Study|Adverse Event|0|||
128769806|NCT00779584|463448255|FG002|Overall Study|Adverse Event|2|||
128769807|NCT00779584|463448256|FG003|Overall Study|Adverse Event|0|||
128769808|NCT00779584|463448257|FG004|Overall Study|Adverse Event|0|||
128939559|NCT02531373|464066593|FG002|Overall Study|Physician Decision|0|||
128939560|NCT02531373|464066594|FG003|Overall Study|Physician Decision|0|||
128939561|NCT02531373|464066595|FG004|Overall Study|Physician Decision|2|||
128939562|NCT02531373|464066596|FG005|Overall Study|Physician Decision|1|||
128939563|NCT02531373|464066597|FG006|Overall Study|Physician Decision|0|||
129032002|NCT00252564|464408230|FG001|Overall Study|Adverse Event|13|||
128939564|NCT02531373|464066598|FG007|Overall Study|Physician Decision|0|||
128939565|NCT02531373|464066599|FG008|Overall Study|Physician Decision|0|||
128939566|NCT02531373|464066591|FG000|Overall Study|Protocol Violation|0|||
128939567|NCT02531373|464066592|FG001|Overall Study|Protocol Violation|0|||
128939568|NCT02531373|464066593|FG002|Overall Study|Protocol Violation|0|||
128939569|NCT02531373|464066594|FG003|Overall Study|Protocol Violation|0|||
128939570|NCT02531373|464066595|FG004|Overall Study|Protocol Violation|0|||
129123132|NCT02736617|464745550|FG000|Treatment|Adverse Event|1|||
129123133|NCT02736617|464745550|FG000|Treatment|Lack of Efficacy|1|||
129123134|NCT02736617|464745550|FG000|Treatment|Withdrawal by Subject|1|||
129123135|NCT02736617|464745550|FG000|Maintenance|Lack of Efficacy|4|||
129123136|NCT02736617|464745550|FG000|Maintenance|Physician Decision|1|||
129123137|NCT04154956|464745555|FG000|Overall Study|Death|109|||
129123138|NCT04154956|464745556|FG001|Overall Study|Death|110|||
129123139|NCT04154956|464745555|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
129123140|NCT04154956|464745556|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
128769809|NCT00779584|463448258|FG005|Overall Study|Adverse Event|0|||
128769810|NCT00779584|463448259|FG006|Overall Study|Adverse Event|2|||
128769811|NCT00779584|463448260|FG007|Overall Study|Adverse Event|1|||
128769812|NCT00779584|463448261|FG008|Overall Study|Adverse Event|1|||
128769813|NCT00779584|463448253|FG000|Overall Study|Symptomatic Deterioration|1|||
128769814|NCT00779584|463448254|FG001|Overall Study|Symptomatic Deterioration|1|||
128769815|NCT00779584|463448255|FG002|Overall Study|Symptomatic Deterioration|1|||
128939571|NCT02531373|464066596|FG005|Overall Study|Protocol Violation|1|||
128939572|NCT02531373|464066597|FG006|Overall Study|Protocol Violation|1|||
128939573|NCT02531373|464066598|FG007|Overall Study|Protocol Violation|0|||
128939574|NCT02531373|464066599|FG008|Overall Study|Protocol Violation|1|||
128939575|NCT02531373|464066591|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128939576|NCT02531373|464066592|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128939577|NCT02531373|464066593|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128939578|NCT02531373|464066594|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128939579|NCT02531373|464066595|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
128939580|NCT02531373|464066596|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
128939581|NCT02531373|464066597|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
128939582|NCT02531373|464066598|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
128939583|NCT02531373|464066599|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
128939584|NCT02531373|464066591|FG000|Overall Study|Withdrawal by Subject|0|||
128939585|NCT02531373|464066592|FG001|Overall Study|Withdrawal by Subject|0|||
128939586|NCT02531373|464066593|FG002|Overall Study|Withdrawal by Subject|0|||
128939587|NCT02531373|464066594|FG003|Overall Study|Withdrawal by Subject|0|||
128939588|NCT02531373|464066595|FG004|Overall Study|Withdrawal by Subject|3|||
128939589|NCT02531373|464066596|FG005|Overall Study|Withdrawal by Subject|0|||
128939590|NCT02531373|464066597|FG006|Overall Study|Withdrawal by Subject|0|||
128939591|NCT02531373|464066598|FG007|Overall Study|Withdrawal by Subject|0|||
128939592|NCT02531373|464066599|FG008|Overall Study|Withdrawal by Subject|0|||
128939593|NCT00536731|464066600|FG000|Overall Study|Adverse Event|3|||
129032003|NCT00252564|464408229|FG000|Overall Study|Unrelated Complication|2|||
129032004|NCT00252564|464408230|FG001|Overall Study|Unrelated Complication|1|||
129032005|NCT00252564|464408229|FG000|Overall Study|Disease Progression|14|||
129032006|NCT00252564|464408230|FG001|Overall Study|Disease Progression|20|||
129032007|NCT00252564|464408229|FG000|Overall Study|Death|0|||
129032008|NCT00252564|464408230|FG001|Overall Study|Death|3|||
129032009|NCT00252564|464408229|FG000|Overall Study|Physician Decision|1|||
129032010|NCT00252564|464408230|FG001|Overall Study|Physician Decision|0|||
129032011|NCT00252564|464408229|FG000|Overall Study|Lost to Follow-up|1|||
129032012|NCT00252564|464408230|FG001|Overall Study|Lost to Follow-up|0|||
129032013|NCT00252564|464408229|FG000|Overall Study|Patient Request|4|||
129032014|NCT00252564|464408230|FG001|Overall Study|Patient Request|5|||
129032015|NCT00252564|464408229|FG000|Overall Study|Withdrawal by Subject|0|||
129032016|NCT00252564|464408230|FG001|Overall Study|Withdrawal by Subject|2|||
129032017|NCT04561115|464408231|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
129032018|NCT04561115|464408232|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
129032019|NCT04561115|464408231|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
129032020|NCT04561115|464408232|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
129032021|NCT04561115|464408231|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
129032022|NCT04561115|464408232|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
129032023|NCT00743145|464408233|FG000|Overall Study|Withdrawal by Subject|1|||
129032024|NCT00743145|464408233|FG000|Overall Study|Adverse Event|2|||
129032025|NCT00743145|464408233|FG000|Overall Study|Pregnancy|1|||
129032026|NCT02416180|464408234|FG000|Overall Study|Withdrawal by Subject|1|||
129123141|NCT04154956|464745555|FG000|Overall Study|Withdrawal by Subject|1|||
129123142|NCT04154956|464745556|FG001|Overall Study|Withdrawal by Subject|7|||
128939594|NCT00536731|464066601|FG001|Overall Study|Adverse Event|2|||
129123143|NCT04154956|464745555|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
128939595|NCT00536731|464066602|FG002|Overall Study|Adverse Event|3|||
128939596|NCT00536731|464066600|FG000|Overall Study|Withdrawal by Subject|0|||
128939597|NCT00536731|464066601|FG001|Overall Study|Withdrawal by Subject|2|||
128939598|NCT00536731|464066602|FG002|Overall Study|Withdrawal by Subject|0|||
129032027|NCT03414034|464408237|FG000|Overall Study|Adverse Event|6|||
129032028|NCT03414034|464408238|FG001|Overall Study|Adverse Event|1|||
129032029|NCT03414034|464408239|FG002|Overall Study|Adverse Event|1|||
129032030|NCT03414034|464408237|FG000|Overall Study|Death|0|||
129032031|NCT03414034|464408238|FG001|Overall Study|Death|0|||
129032032|NCT03414034|464408239|FG002|Overall Study|Death|1|||
129032033|NCT03414034|464408237|FG000|Overall Study|Non-compliance With Study Drug|0|||
129032034|NCT03414034|464408238|FG001|Overall Study|Non-compliance With Study Drug|0|||
129032035|NCT03414034|464408239|FG002|Overall Study|Non-compliance With Study Drug|1|||
129032036|NCT03414034|464408237|FG000|Overall Study|Physician Decision|1|||
129032037|NCT03414034|464408238|FG001|Overall Study|Physician Decision|3|||
129032038|NCT03414034|464408239|FG002|Overall Study|Physician Decision|2|||
129032039|NCT03414034|464408237|FG000|Overall Study|Withdrawal of Informed Consent|2|||
129032040|NCT03414034|464408238|FG001|Overall Study|Withdrawal of Informed Consent|1|||
129032041|NCT03414034|464408239|FG002|Overall Study|Withdrawal of Informed Consent|4|||
129032042|NCT03414034|464408237|FG000|Overall Study|Progressive Disease|15|||
129032043|NCT03414034|464408238|FG001|Overall Study|Progressive Disease|15|||
129032044|NCT03414034|464408239|FG002|Overall Study|Progressive Disease|17|||
129032045|NCT03414034|464408237|FG000|Overall Study|Miscellaneous|0|||
129032046|NCT03414034|464408238|FG001|Overall Study|Miscellaneous|0|||
129032047|NCT03414034|464408239|FG002|Overall Study|Miscellaneous|2|||
129032048|NCT04010227|464408241|FG000|Overall Study|Death|1|||
129032049|NCT04010227|464408242|FG001|Overall Study|Death|2|||
129032050|NCT04010227|464408241|FG000|Overall Study|Medical Reasons|4|||
129032051|NCT04010227|464408242|FG001|Overall Study|Medical Reasons|3|||
129032052|NCT04010227|464408241|FG000|Overall Study|Withdrawal by Subject|2|||
129032053|NCT04010227|464408242|FG001|Overall Study|Withdrawal by Subject|0|||
129032054|NCT04010227|464408241|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
129032055|NCT04010227|464408242|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
129032056|NCT01841073|464408243|FG000|Overall Study|Adverse Event|1|||
129032057|NCT01841073|464408244|FG001|Overall Study|Adverse Event|1|||
129032058|NCT01841073|464408243|FG000|Overall Study|Physician Decision|1|||
129032059|NCT01841073|464408244|FG001|Overall Study|Physician Decision|0|||
129032060|NCT01841073|464408243|FG000|Overall Study|Lost to Follow-up|0|||
129032061|NCT01841073|464408244|FG001|Overall Study|Lost to Follow-up|2|||
129032062|NCT01670097|464408245|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
129032063|NCT01670097|464408246|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
129032064|NCT01670097|464408245|FG000|Overall Study|Study burden|1|||
129032065|NCT01670097|464408246|FG001|Overall Study|Study burden|0|||
129032066|NCT01670097|464408245|FG000|Overall Study|COPD exacerbation|0|||
129032067|NCT01670097|464408246|FG001|Overall Study|COPD exacerbation|1|||
129032068|NCT01670097|464408245|FG000|Overall Study|Neutropenia|0|||
129032069|NCT01670097|464408246|FG001|Overall Study|Neutropenia|1|||
129032070|NCT01670097|464408245|FG000|Overall Study|Clinical deterioration|0|||
129032071|NCT01670097|464408246|FG001|Overall Study|Clinical deterioration|1|||
129032072|NCT01670097|464408245|FG000|Overall Study|Disease progression|0|||
129032073|NCT01670097|464408246|FG001|Overall Study|Disease progression|1|||
129032074|NCT00550147|464408249|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
129032075|NCT00550147|464408249|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
129032076|NCT00550147|464408249|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
129032077|NCT00550147|464408249|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
129032078|NCT00550147|464408249|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
129032079|NCT04320745|464408250|FG000|Overall Study|Adverse Event|26|||
129032080|NCT04320745|464408250|FG000|Overall Study|Withdrawal by Subject|4|||
129032081|NCT04320745|464408250|FG000|Overall Study|Lost to Follow-up|12|||
129032082|NCT04320745|464408250|FG000|Overall Study|Protocol Deviation|2|||
129032083|NCT04320745|464408250|FG000|Overall Study|Non-compliance With Study Drug|2|||
129032084|NCT04320745|464408250|FG000|Overall Study|Reason Not Specified|1|||
129032085|NCT01824498|464408251|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
129032086|NCT01824498|464408252|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
129032087|NCT01824498|464408253|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
129032088|NCT01824498|464408254|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
129032089|NCT01824498|464408255|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
129032090|NCT01824498|464408256|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
129032091|NCT01277510|464408257|FG000|Double-blind Phase|Non-compliance|0|||
129032092|NCT01277510|464408258|FG001|Double-blind Phase|Non-compliance|1|||
129032093|NCT01277510|464408257|FG000|Double-blind Phase|Adverse Event|1|||
129032094|NCT01277510|464408258|FG001|Double-blind Phase|Adverse Event|0|||
129032095|NCT01277510|464408257|FG000|Double-blind Phase|Withdrawal by Subject|2|||
129032096|NCT01277510|464408258|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129032097|NCT01277510|464408257|FG000|Double-blind Phase|Administrative decision|7|||
129032098|NCT01277510|464408258|FG001|Double-blind Phase|Administrative decision|9|||
129032099|NCT01277510|464408257|FG000|Double-blind Phase|Death|0|||
129032100|NCT01277510|464408258|FG001|Double-blind Phase|Death|1|||
129032101|NCT01277510|464408257|FG000|Double-blind Phase|Protocol-specified criteria|2|||
129032102|NCT01277510|464408258|FG001|Double-blind Phase|Protocol-specified criteria|6|||
129032103|NCT01277510|464408257|FG000|Double-blind Phase|Other|1|||
129032104|NCT01277510|464408258|FG001|Double-blind Phase|Other|1|||
129032105|NCT01277510|464408257|FG000|Open-label Phase|Administrative decision|4|||
129032106|NCT01277510|464408258|FG001|Open-label Phase|Administrative decision|3|||
129032107|NCT01277510|464408257|FG000|Open-label Phase|Protocol-specified criteria|1|||
129032108|NCT01277510|464408258|FG001|Open-label Phase|Protocol-specified criteria|0|||
129032109|NCT01277510|464408257|FG000|Open-label Phase|Never received investigational product|2|||
129032110|NCT01277510|464408258|FG001|Open-label Phase|Never received investigational product|0|||
128939599|NCT00536731|464066600|FG000|Overall Study|Intake of prohibited conc. medication|0|||
128939600|NCT00536731|464066601|FG001|Overall Study|Intake of prohibited conc. medication|0|||
128939601|NCT00536731|464066602|FG002|Overall Study|Intake of prohibited conc. medication|1|||
128939602|NCT00536731|464066600|FG000|Overall Study|Safety reasons|0|||
128939603|NCT00536731|464066601|FG001|Overall Study|Safety reasons|0|||
128939604|NCT00536731|464066602|FG002|Overall Study|Safety reasons|1|||
128939605|NCT00536731|464066600|FG000|Overall Study|Other|1|||
128939606|NCT00536731|464066601|FG001|Overall Study|Other|1|||
128939607|NCT00536731|464066602|FG002|Overall Study|Other|0|||
128939608|NCT01234402|464066603|FG000|Overall Study|Lost to Follow-up|0|||
128939609|NCT01234402|464066604|FG001|Overall Study|Lost to Follow-up|1|||
128939610|NCT01234402|464066605|FG002|Overall Study|Lost to Follow-up|3|||
128939611|NCT01234402|464066603|FG000|Overall Study|Withdrawal by Subject|1|||
128939612|NCT01234402|464066604|FG001|Overall Study|Withdrawal by Subject|3|||
128939613|NCT01234402|464066605|FG002|Overall Study|Withdrawal by Subject|4|||
128939614|NCT01234402|464066603|FG000|Overall Study|Never treated: Death|0|||
128939615|NCT01234402|464066604|FG001|Overall Study|Never treated: Death|0|||
128939616|NCT01234402|464066605|FG002|Overall Study|Never treated: Death|1|||
128939617|NCT01234402|464066603|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
128939618|NCT01234402|464066604|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
128939619|NCT01234402|464066605|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
128939620|NCT01234402|464066603|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
129032111|NCT01685008|464408259|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
129032112|NCT01685008|464408260|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
129032113|NCT01685008|464408261|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
129032114|NCT01685008|464408262|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
129032115|NCT01685008|464408259|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
129032116|NCT01685008|464408260|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
129123144|NCT04154956|464745556|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
129123145|NCT00805532|464745557|FG000|Overall Study|invalid data|0|||
129123146|NCT00805532|464745558|FG001|Overall Study|invalid data|1|||
129123147|NCT01859741|464745559|FG000|Overall Study|Death|3|||
129032117|NCT01685008|464408261|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
129032118|NCT01685008|464408262|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
129032119|NCT01685008|464408259|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
129032120|NCT01685008|464408260|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
129032121|NCT01685008|464408261|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
129032122|NCT01685008|464408262|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
129032123|NCT01685008|464408259|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
129032124|NCT01685008|464408260|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
129032125|NCT01685008|464408261|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
129032126|NCT01685008|464408262|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
129032127|NCT01685008|464408259|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
129032128|NCT01685008|464408260|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
129123148|NCT01859741|464745560|FG001|Overall Study|Death|2|||
129123149|NCT01859741|464745561|FG002|Overall Study|Death|4|||
129123150|NCT01859741|464745562|FG003|Overall Study|Death|3|||
129123151|NCT01859741|464745563|FG004|Overall Study|Death|5|||
129123152|NCT01859741|464745564|FG005|Overall Study|Death|4|||
128769816|NCT00779584|463448256|FG003|Overall Study|Symptomatic Deterioration|0|||
128769817|NCT00779584|463448257|FG004|Overall Study|Symptomatic Deterioration|0|||
128769818|NCT00779584|463448258|FG005|Overall Study|Symptomatic Deterioration|1|||
128769819|NCT00779584|463448259|FG006|Overall Study|Symptomatic Deterioration|1|||
128939621|NCT01234402|464066604|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
129032129|NCT01685008|464408261|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
129032130|NCT01685008|464408262|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
129032131|NCT01970592|464408263|FG000|Overall Study|Withdrawal by Subject|4|||
129032132|NCT01970592|464408263|FG000|Overall Study|Physician Decision|1|||
129032133|NCT01970592|464408263|FG000|Overall Study|Adverse Event|1|||
129032134|NCT00160524|464408266|FG000|Overall Study|Adverse Event|119|||
129032135|NCT00160524|464408266|FG000|Overall Study|Adverse Event and Other|94|||
129032136|NCT00160524|464408266|FG000|Overall Study|Protocol Violation|16|||
128769820|NCT00779584|463448260|FG007|Overall Study|Symptomatic Deterioration|0|||
128939622|NCT01234402|464066605|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
128939623|NCT02389816|464066606|FG000|Overall Study|Randomized but Not Treated|1|||
128939624|NCT02389816|464066607|FG001|Overall Study|Randomized but Not Treated|0|||
129032137|NCT00160524|464408266|FG000|Overall Study|Protocol Violation and Other|2|||
128707222|NCT00600483|463222201|FG000|Overall Study|Randomized but not treated|10|||
128707223|NCT00600483|463222202|FG001|Overall Study|Randomized but not treated|0|||
128939625|NCT02389816|464066608|FG002|Overall Study|Randomized but Not Treated|0|||
128939626|NCT02389816|464066606|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
128939627|NCT02389816|464066607|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
128939628|NCT02389816|464066608|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
128939629|NCT02389816|464066606|FG000|Overall Study|Major Protocol Deviation|1|||
128939630|NCT02389816|464066607|FG001|Overall Study|Major Protocol Deviation|0|||
128939631|NCT02389816|464066608|FG002|Overall Study|Major Protocol Deviation|0|||
128939632|NCT02389816|464066606|FG000|Overall Study|Lost to Follow-up|1|||
128939633|NCT02389816|464066607|FG001|Overall Study|Lost to Follow-up|0|||
128939634|NCT02389816|464066608|FG002|Overall Study|Lost to Follow-up|0|||
128939635|NCT02389816|464066606|FG000|Overall Study|Withdrawal of Consent|6|||
128939636|NCT02389816|464066607|FG001|Overall Study|Withdrawal of Consent|4|||
128939637|NCT02389816|464066608|FG002|Overall Study|Withdrawal of Consent|4|||
128939638|NCT02389816|464066606|FG000|Overall Study|Lack of Efficacy|1|||
128939639|NCT02389816|464066607|FG001|Overall Study|Lack of Efficacy|0|||
128939640|NCT02389816|464066608|FG002|Overall Study|Lack of Efficacy|0|||
128939641|NCT02389816|464066606|FG000|Overall Study|Non Compliance with Study Drug|1|||
128939642|NCT02389816|464066607|FG001|Overall Study|Non Compliance with Study Drug|1|||
128939643|NCT02389816|464066608|FG002|Overall Study|Non Compliance with Study Drug|1|||
128939644|NCT02389816|464066606|FG000|Overall Study|Reason not Specified|0|||
128939645|NCT02389816|464066607|FG001|Overall Study|Reason not Specified|2|||
128939646|NCT02389816|464066608|FG002|Overall Study|Reason not Specified|0|||
128939647|NCT02417233|464066609|FG000|Overall Study|Death|4|||
128939648|NCT02417233|464066610|FG001|Overall Study|Death|10|||
128939649|NCT02417233|464066611|FG002|Overall Study|Death|14|||
128939650|NCT02417233|464066609|FG000|Overall Study|Lost to Follow-up|27|||
128939651|NCT02417233|464066610|FG001|Overall Study|Lost to Follow-up|39|||
128939652|NCT02417233|464066611|FG002|Overall Study|Lost to Follow-up|34|||
128707224|NCT01482884|463222205|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
128707225|NCT01482884|463222206|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
128939653|NCT02417233|464066609|FG000|Overall Study|Protocol Violation|2|||
128939654|NCT02417233|464066610|FG001|Overall Study|Protocol Violation|0|||
128939655|NCT02417233|464066611|FG002|Overall Study|Protocol Violation|2|||
128939656|NCT02417233|464066609|FG000|Overall Study|Withdrawal by Subject|2|||
128939657|NCT02417233|464066610|FG001|Overall Study|Withdrawal by Subject|1|||
128939658|NCT02417233|464066611|FG002|Overall Study|Withdrawal by Subject|8|||
128939659|NCT02417233|464066609|FG000|Overall Study|Relocation out of study area|1|||
128939660|NCT02417233|464066610|FG001|Overall Study|Relocation out of study area|0|||
128939661|NCT02417233|464066611|FG002|Overall Study|Relocation out of study area|1|||
128939662|NCT02417233|464066609|FG000|Overall Study|Mentally unstable|0|||
128939663|NCT02417233|464066610|FG001|Overall Study|Mentally unstable|1|||
128939664|NCT02417233|464066611|FG002|Overall Study|Mentally unstable|0|||
128939665|NCT01594476|464066612|FG000|Overall Study|Protocol Violation|1|||
128939666|NCT01594476|464066613|FG001|Overall Study|Protocol Violation|3|||
128939667|NCT01469013|464066616|FG000|Part A (Treatment Period)|Adverse Event|1|||
128939668|NCT01469013|464066617|FG001|Part A (Treatment Period)|Adverse Event|0|||
128939669|NCT01469013|464066618|FG002|Part A (Treatment Period)|Adverse Event|0|||
128939670|NCT01469013|464066619|FG003|Part A (Treatment Period)|Adverse Event|0|||
129032138|NCT00160524|464408266|FG000|Overall Study|Withdrawal by Subject|141|||
129032139|NCT00160524|464408266|FG000|Overall Study|Withdrawal by Subject and Other|17|||
129032140|NCT00160524|464408266|FG000|Overall Study|Physician Decision|27|||
129032141|NCT00160524|464408266|FG000|Overall Study|Physician Decision and Other|6|||
129032142|NCT00160524|464408266|FG000|Overall Study|Lost to Follow-up|13|||
129032143|NCT00160524|464408266|FG000|Overall Study|Lost to Follow-up and Other|1|||
129032144|NCT00160524|464408266|FG000|Overall Study|Lack of Efficacy|21|||
129032145|NCT00160524|464408266|FG000|Overall Study|Lack of Efficacy and Other|1|||
129032146|NCT00160524|464408266|FG000|Overall Study|Other|20|||
129032147|NCT05263505|464408267|FG000|Overall Study|Adverse Event|0|||
129032148|NCT05263505|464408268|FG001|Overall Study|Adverse Event|1|||
129217709|NCT02745119|465097044|FG001|Overall Study|Study Terminated by Sponsor|252|||
128707226|NCT01482884|463222205|FG000|Overall Study|Protocol Violation|1|||
128707227|NCT01482884|463222206|FG001|Overall Study|Protocol Violation|0|||
128939671|NCT01469013|464066620|FG004|Part A (Treatment Period)|Adverse Event|1|||
128939672|NCT01469013|464066621|FG005|Part A (Treatment Period)|Adverse Event|0|||
128939673|NCT01469013|464066622|FG006|Part A (Treatment Period)|Adverse Event|0|||
128939674|NCT01469013|464066623|FG007|Part A (Treatment Period)|Adverse Event|0|||
128939675|NCT01469013|464066624|FG008|Part A (Treatment Period)|Adverse Event|0|||
129032149|NCT00609154|464408270|FG000|Overall Study|Protocol Violation|1|||
128939676|NCT01469013|464066625|FG009|Part A (Treatment Period)|Adverse Event|0|||
128939677|NCT01469013|464066626|FG010|Part A (Treatment Period)|Adverse Event|0|||
128939678|NCT01469013|464066627|FG011|Part A (Treatment Period)|Adverse Event|0|||
128939679|NCT01469013|464066628|FG012|Part A (Treatment Period)|Adverse Event|0|||
128939680|NCT01469013|464066616|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939681|NCT01469013|464066617|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
128769821|NCT00779584|463448261|FG008|Overall Study|Symptomatic Deterioration|0|||
128939682|NCT01469013|464066618|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
128939683|NCT01469013|464066619|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939684|NCT01469013|464066620|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939685|NCT01469013|464066621|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939686|NCT01469013|464066622|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939687|NCT01469013|464066623|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939688|NCT01469013|464066624|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939689|NCT01469013|464066625|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939690|NCT01469013|464066626|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939691|NCT01469013|464066627|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939692|NCT01469013|464066628|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
128939693|NCT01469013|464066616|FG000|Part B (Extension Period)|Adverse Event|0|||
129032150|NCT00609154|464408271|FG001|Overall Study|Protocol Violation|2|||
129032151|NCT00609154|464408270|FG000|Overall Study|Unable to establish IV access|0|||
129032152|NCT00609154|464408271|FG001|Overall Study|Unable to establish IV access|4|||
129032153|NCT00609154|464408270|FG000|Overall Study|Adverse Event|0|||
129032154|NCT00609154|464408271|FG001|Overall Study|Adverse Event|2|||
129032155|NCT02224053|464408272|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
129032156|NCT02224053|464408272|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
129032157|NCT02224053|464408272|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
129032158|NCT02224053|464408272|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
129032159|NCT02224053|464408272|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
129032160|NCT01898598|464408276|FG000|Overall Study|Adverse Event|1|||
129032161|NCT01898598|464408277|FG001|Overall Study|Adverse Event|0|||
129032162|NCT01898598|464408276|FG000|Overall Study|Withdrawal by Subject|3|||
129032163|NCT01898598|464408277|FG001|Overall Study|Withdrawal by Subject|0|||
129032164|NCT01898598|464408276|FG000|Overall Study|Lost to Follow-up|0|||
129032165|NCT01898598|464408277|FG001|Overall Study|Lost to Follow-up|1|||
129032166|NCT01898598|464408276|FG000|Overall Study|Other|0|||
129032167|NCT01898598|464408277|FG001|Overall Study|Other|1|||
129032168|NCT03833427|464408278|FG000|Overall Study|Death|4|||
129032169|NCT03833427|464408279|FG001|Overall Study|Death|2|||
129032170|NCT03833427|464408280|FG002|Overall Study|Death|9|||
129032171|NCT03833427|464408281|FG003|Overall Study|Death|11|||
129032172|NCT03833427|464408282|FG004|Overall Study|Death|0|||
129032173|NCT03833427|464408283|FG005|Overall Study|Death|0|||
129032174|NCT03833427|464408284|FG006|Overall Study|Death|0|||
129032175|NCT03833427|464408278|FG000|Overall Study|Withdrawal by Subject|0|||
129032176|NCT03833427|464408279|FG001|Overall Study|Withdrawal by Subject|1|||
129032177|NCT03833427|464408280|FG002|Overall Study|Withdrawal by Subject|1|||
129032178|NCT03833427|464408281|FG003|Overall Study|Withdrawal by Subject|0|||
129032179|NCT03833427|464408282|FG004|Overall Study|Withdrawal by Subject|0|||
129032180|NCT03833427|464408283|FG005|Overall Study|Withdrawal by Subject|0|||
129032181|NCT03833427|464408284|FG006|Overall Study|Withdrawal by Subject|0|||
129032182|NCT03833427|464408278|FG000|Overall Study|Sponsor Decision|0|||
129032183|NCT03833427|464408279|FG001|Overall Study|Sponsor Decision|0|||
129032184|NCT03833427|464408280|FG002|Overall Study|Sponsor Decision|1|||
129032185|NCT03833427|464408281|FG003|Overall Study|Sponsor Decision|3|||
129032186|NCT03833427|464408282|FG004|Overall Study|Sponsor Decision|0|||
129032187|NCT03833427|464408283|FG005|Overall Study|Sponsor Decision|0|||
129032188|NCT03833427|464408284|FG006|Overall Study|Sponsor Decision|0|||
129032189|NCT01499160|464408289|FG000|Overall Study|Adverse Event|1|||
129032190|NCT01499160|464408289|FG000|Overall Study|Withdrawal by Subject|1|||
129032191|NCT03448692|464408290|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
129032192|NCT03448692|464408291|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
129032193|NCT03448692|464408290|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
129032194|NCT03448692|464408291|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
129032195|NCT03448692|464408290|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
129032196|NCT03448692|464408291|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
129032197|NCT03448692|464408290|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
129032198|NCT03448692|464408291|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
129032199|NCT03448692|464408290|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
129032200|NCT03448692|464408291|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
129032201|NCT00593827|464408293|FG000|Overall Study|On Active Treatment/Pending|0|||
129032202|NCT00593827|464408294|FG001|Overall Study|On Active Treatment/Pending|2|||
129032203|NCT02710214|464410178|FG000|Overall Study|Lost to Follow-up|1|||
129032204|NCT02710214|464410179|FG001|Overall Study|Lost to Follow-up|0|||
128769822|NCT00779584|463448253|FG000|Overall Study|Ongoing in Study|0|||
128769823|NCT00779584|463448254|FG001|Overall Study|Ongoing in Study|0|||
128939694|NCT01469013|464066617|FG001|Part B (Extension Period)|Adverse Event|0|||
128939695|NCT01469013|464066618|FG002|Part B (Extension Period)|Adverse Event|0|||
128939696|NCT01469013|464066619|FG003|Part B (Extension Period)|Adverse Event|0|||
129032205|NCT02710214|464410178|FG000|Overall Study|Lack of Efficacy|0|||
128939697|NCT01469013|464066620|FG004|Part B (Extension Period)|Adverse Event|0|||
128939698|NCT01469013|464066621|FG005|Part B (Extension Period)|Adverse Event|2|||
128939699|NCT01469013|464066622|FG006|Part B (Extension Period)|Adverse Event|5|||
128939700|NCT01469013|464066623|FG007|Part B (Extension Period)|Adverse Event|5|||
128939701|NCT01469013|464066624|FG008|Part B (Extension Period)|Adverse Event|3|||
128939702|NCT01469013|464066625|FG009|Part B (Extension Period)|Adverse Event|3|||
128939703|NCT01469013|464066626|FG010|Part B (Extension Period)|Adverse Event|1|||
128939704|NCT01469013|464066627|FG011|Part B (Extension Period)|Adverse Event|6|||
128939705|NCT01469013|464066628|FG012|Part B (Extension Period)|Adverse Event|3|||
128939706|NCT01469013|464066616|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
128939707|NCT01469013|464066617|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
128939708|NCT01469013|464066618|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
128939709|NCT01469013|464066619|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
128939710|NCT01469013|464066620|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
128939711|NCT01469013|464066621|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
128939712|NCT01469013|464066622|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
128939713|NCT01469013|464066623|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
128939714|NCT01469013|464066624|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
128939715|NCT01469013|464066625|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
128939716|NCT01469013|464066626|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
128939717|NCT01469013|464066627|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
128939718|NCT01469013|464066628|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
128939719|NCT00002663|464066629|FG000|Overall Study|Death|4|||
128939720|NCT00002663|464066630|FG001|Overall Study|Death|1|||
128939721|NCT00002663|464066631|FG002|Overall Study|Death|1|||
128939722|NCT00002663|464066632|FG003|Overall Study|Death|0|||
128939723|NCT00002663|464066633|FG004|Overall Study|Death|0|||
128939724|NCT00002663|464066634|FG005|Overall Study|Death|13|||
128939725|NCT00002663|464066635|FG006|Overall Study|Death|0|||
128939726|NCT00002663|464066636|FG007|Overall Study|Death|1|||
128939727|NCT00002663|464066637|FG008|Overall Study|Death|1|||
128939728|NCT00002663|464066638|FG009|Overall Study|Death|1|||
128939729|NCT00002663|464066629|FG000|Overall Study|Lost to Follow-up|3|||
128939730|NCT00002663|464066630|FG001|Overall Study|Lost to Follow-up|0|||
128939731|NCT00002663|464066631|FG002|Overall Study|Lost to Follow-up|0|||
128939732|NCT00002663|464066632|FG003|Overall Study|Lost to Follow-up|1|||
128939733|NCT00002663|464066633|FG004|Overall Study|Lost to Follow-up|0|||
128939734|NCT00002663|464066634|FG005|Overall Study|Lost to Follow-up|1|||
128939735|NCT00002663|464066635|FG006|Overall Study|Lost to Follow-up|0|||
128939736|NCT00002663|464066636|FG007|Overall Study|Lost to Follow-up|0|||
128939737|NCT00002663|464066637|FG008|Overall Study|Lost to Follow-up|0|||
128939738|NCT00002663|464066638|FG009|Overall Study|Lost to Follow-up|0|||
128939739|NCT00002663|464066629|FG000|Overall Study|Other|0|||
128939740|NCT00002663|464066630|FG001|Overall Study|Other|1|||
128939741|NCT00002663|464066631|FG002|Overall Study|Other|0|||
128939742|NCT00002663|464066632|FG003|Overall Study|Other|0|||
128939743|NCT00002663|464066633|FG004|Overall Study|Other|0|||
128939744|NCT00002663|464066634|FG005|Overall Study|Other|1|||
128939745|NCT00002663|464066635|FG006|Overall Study|Other|1|||
128939746|NCT00002663|464066636|FG007|Overall Study|Other|0|||
128939747|NCT00002663|464066637|FG008|Overall Study|Other|0|||
128939748|NCT00002663|464066638|FG009|Overall Study|Other|0|||
128939749|NCT00002663|464066629|FG000|Overall Study|Physician Decision|0|||
128939750|NCT00002663|464066630|FG001|Overall Study|Physician Decision|0|||
129032206|NCT02710214|464410179|FG001|Overall Study|Lack of Efficacy|1|||
129032207|NCT02710214|464410178|FG000|Overall Study|Death|0|||
129032208|NCT02710214|464410179|FG001|Overall Study|Death|1|||
129032209|NCT01188226|464410183|FG000|Overall Study|Withdrawal by Subject|4|||
129032210|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
129032211|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
129032212|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
129032213|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
129032214|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
128939751|NCT00002663|464066631|FG002|Overall Study|Physician Decision|0|||
128939752|NCT00002663|464066632|FG003|Overall Study|Physician Decision|0|||
128939753|NCT00002663|464066633|FG004|Overall Study|Physician Decision|1|||
128939754|NCT00002663|464066634|FG005|Overall Study|Physician Decision|0|||
128939755|NCT00002663|464066635|FG006|Overall Study|Physician Decision|0|||
129032215|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
129123153|NCT01859741|464745565|FG006|Overall Study|Death|51|||
128939756|NCT00002663|464066636|FG007|Overall Study|Physician Decision|0|||
128939757|NCT00002663|464066637|FG008|Overall Study|Physician Decision|1|||
128939758|NCT00002663|464066638|FG009|Overall Study|Physician Decision|1|||
128939759|NCT00002663|464066629|FG000|Overall Study|Adverse Event|0|||
128939760|NCT00002663|464066630|FG001|Overall Study|Adverse Event|0|||
128939761|NCT00002663|464066631|FG002|Overall Study|Adverse Event|0|||
128939762|NCT00002663|464066632|FG003|Overall Study|Adverse Event|1|||
128939763|NCT00002663|464066633|FG004|Overall Study|Adverse Event|0|||
128939764|NCT00002663|464066634|FG005|Overall Study|Adverse Event|0|||
128939765|NCT00002663|464066635|FG006|Overall Study|Adverse Event|0|||
128939766|NCT00002663|464066636|FG007|Overall Study|Adverse Event|1|||
128939767|NCT00002663|464066637|FG008|Overall Study|Adverse Event|0|||
128939768|NCT00002663|464066638|FG009|Overall Study|Adverse Event|0|||
128939769|NCT01603641|464066640|FG000|Overall Study|Did not Receive Treatment|3|||
128939770|NCT01603641|464066640|FG000|Overall Study|Adverse Event|1|||
128939771|NCT01603641|464066640|FG000|Overall Study|Lack of Efficacy|1|||
128939772|NCT01603641|464066640|FG000|Overall Study|Lost to Follow-up|6|||
128939773|NCT01603641|464066640|FG000|Overall Study|Personal Reasons|18|||
128939774|NCT01603641|464066640|FG000|Overall Study|Other Miscellaneous Reasons|6|||
128939775|NCT03161678|464066641|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
128939776|NCT03161678|464066642|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
128939777|NCT03161678|464066643|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
128939778|NCT03161678|464066644|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
128939779|NCT03161678|464066645|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
128939780|NCT03161678|464066646|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
128939781|NCT03161678|464066641|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
128939782|NCT03161678|464066642|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
128939783|NCT03161678|464066643|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
128939784|NCT03161678|464066644|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
128939785|NCT03161678|464066645|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
128939786|NCT03161678|464066646|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
128939787|NCT03161678|464066641|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
128939788|NCT03161678|464066642|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
128939789|NCT03161678|464066643|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
128939790|NCT03161678|464066644|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
128939791|NCT03161678|464066645|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
128939792|NCT03161678|464066646|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
128939793|NCT03161678|464066641|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
128939794|NCT03161678|464066642|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
128939795|NCT03161678|464066643|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
128939796|NCT03161678|464066644|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
128939797|NCT03161678|464066645|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
128939798|NCT03161678|464066646|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
128939799|NCT00739297|464066647|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
128939800|NCT00739297|464066648|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
128939801|NCT00739297|464066649|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
128939802|NCT00739297|464066650|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
128939803|NCT00739297|464066651|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
128939804|NCT00739297|464066652|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
128939805|NCT00739297|464066653|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
128939806|NCT00739297|464066647|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
128939807|NCT00739297|464066648|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
128939808|NCT00739297|464066649|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
128939809|NCT00739297|464066650|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
128939810|NCT00739297|464066651|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
128939811|NCT00739297|464066652|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
128939812|NCT00739297|464066653|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
128939813|NCT01757704|464066654|FG000|Overall Study|Protocol Violation|1|||
128939814|NCT01757704|464066655|FG001|Overall Study|Protocol Violation|3|||
128939815|NCT02890329|464066658|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
128939816|NCT02890329|464066659|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
128939817|NCT02890329|464066660|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
128939818|NCT02890329|464066661|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
128939819|NCT02890329|464066662|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
128939820|NCT02890329|464066663|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
128939821|NCT02890329|464066658|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
128939822|NCT02890329|464066659|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
128939823|NCT02890329|464066660|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
128939824|NCT02890329|464066661|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
128939825|NCT02890329|464066662|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
128939826|NCT02890329|464066663|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
128939827|NCT02890329|464066658|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
128939828|NCT02890329|464066659|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
128939829|NCT02890329|464066660|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
128939830|NCT02890329|464066661|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
128939831|NCT02890329|464066662|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
128939832|NCT02890329|464066663|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
128939833|NCT02890329|464066658|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
128939834|NCT02890329|464066659|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
128939835|NCT02890329|464066660|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
128939836|NCT02890329|464066661|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
128939837|NCT02890329|464066662|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
128769824|NCT00779584|463448255|FG002|Overall Study|Ongoing in Study|0|||
128769825|NCT00779584|463448256|FG003|Overall Study|Ongoing in Study|0|||
128769826|NCT00779584|463448257|FG004|Overall Study|Ongoing in Study|1|||
128769827|NCT00779584|463448258|FG005|Overall Study|Ongoing in Study|1|||
128769828|NCT00779584|463448259|FG006|Overall Study|Ongoing in Study|0|||
128769829|NCT00779584|463448260|FG007|Overall Study|Ongoing in Study|0|||
128769830|NCT00779584|463448261|FG008|Overall Study|Ongoing in Study|0|||
128769831|NCT02878213|463448264|FG000|Overall Study|Withdrawal by Subject|2|||
128769832|NCT02878213|463448264|FG000|Overall Study|Adverse Event|1|||
128769833|NCT02494206|463448280|FG000|Overall Study|Adverse Event|1|||
128769834|NCT02494206|463448280|FG000|Overall Study|Disease Progression|1|||
128769835|NCT04986982|463448281|FG000|Overall Study|Withdrawal by Subject|3|||
128769836|NCT04986982|463448282|FG001|Overall Study|Withdrawal by Subject|1|||
128769837|NCT04986982|463448281|FG000|Overall Study|Lack of Efficacy|0|||
128769838|NCT04986982|463448282|FG001|Overall Study|Lack of Efficacy|2|||
128769839|NCT04986982|463448281|FG000|Overall Study|Ineligibility|3|||
128769840|NCT04986982|463448282|FG001|Overall Study|Ineligibility|0|||
128769841|NCT04986982|463448281|FG000|Overall Study|Adverse Event|4|||
128769842|NCT04986982|463448282|FG001|Overall Study|Adverse Event|4|||
128769843|NCT04986982|463448281|FG000|Overall Study|Lost to Follow-up|0|||
128769844|NCT04986982|463448282|FG001|Overall Study|Lost to Follow-up|1|||
129032216|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
129032217|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
129032218|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
129032219|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
129032220|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
129032221|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
129032222|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
129032223|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
129123154|NCT01859741|464745566|FG007|Overall Study|Death|51|||
129123155|NCT01859741|464745559|FG000|Overall Study|Lost to Follow-up|0|||
129123156|NCT01859741|464745560|FG001|Overall Study|Lost to Follow-up|0|||
129123157|NCT01859741|464745561|FG002|Overall Study|Lost to Follow-up|0|||
129123158|NCT01859741|464745562|FG003|Overall Study|Lost to Follow-up|0|||
129123159|NCT01859741|464745563|FG004|Overall Study|Lost to Follow-up|0|||
129123160|NCT01859741|464745564|FG005|Overall Study|Lost to Follow-up|1|||
129123161|NCT01859741|464745565|FG006|Overall Study|Lost to Follow-up|0|||
128769845|NCT04986982|463448281|FG000|Overall Study|Sponsor's discretion|1|||
128769846|NCT04986982|463448282|FG001|Overall Study|Sponsor's discretion|0|||
128769847|NCT01155661|463448283|FG000|Overall Study|Adverse Event|101|||
128769848|NCT01155661|463448283|FG000|Overall Study|Death|1|||
128769849|NCT01155661|463448283|FG000|Overall Study|Lack of Efficacy|32|||
128769850|NCT01155661|463448283|FG000|Overall Study|Lost to Follow-up|22|||
128769851|NCT01155661|463448283|FG000|Overall Study|Physician Decision|3|||
128769852|NCT01155661|463448283|FG000|Overall Study|Protocol Violation|35|||
128769853|NCT01155661|463448283|FG000|Overall Study|Withdrawal by Subject|73|||
128769854|NCT01155661|463448283|FG000|Overall Study|Sponsor Decision|13|||
128769855|NCT01396395|463448284|FG000|Overall Study|Withdrawal by Subject|10|||
128769856|NCT01396395|463448285|FG001|Overall Study|Withdrawal by Subject|12|||
128939838|NCT02890329|464066663|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
128939839|NCT02749721|464066667|FG000|Screening|Withdrawal by Subject|1|||
128939840|NCT02749721|464066667|FG000|Screening|Lost to Follow-up|2|||
128939841|NCT02749721|464066667|FG000|Screening|Protocol Violation|3|||
128939842|NCT02749721|464066667|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
128939843|NCT02749721|464066667|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
128939844|NCT02137772|464066668|FG000|Overall Study|Adverse Event|6|||
128939845|NCT02137772|464066669|FG001|Overall Study|Adverse Event|3|||
128939846|NCT02137772|464066668|FG000|Overall Study|Death|71|||
128939847|NCT02137772|464066669|FG001|Overall Study|Death|44|||
128939848|NCT02137772|464066668|FG000|Overall Study|Lost to Follow-up|8|||
128939849|NCT02137772|464066669|FG001|Overall Study|Lost to Follow-up|4|||
128939850|NCT02137772|464066668|FG000|Overall Study|Physician Decision|15|||
128939851|NCT02137772|464066669|FG001|Overall Study|Physician Decision|5|||
128939852|NCT02137772|464066668|FG000|Overall Study|Withdrawal by Subject|28|||
128939853|NCT02137772|464066669|FG001|Overall Study|Withdrawal by Subject|17|||
128939854|NCT02137772|464066668|FG000|Overall Study|Non-compliance with study drug|1|||
128939855|NCT02137772|464066669|FG001|Overall Study|Non-compliance with study drug|0|||
128939856|NCT02137772|464066668|FG000|Overall Study|Not treated|3|||
128939857|NCT02137772|464066669|FG001|Overall Study|Not treated|2|||
128939858|NCT02084134|464066672|FG000|Overall Study|Protocol Violation|4|||
128939859|NCT02084134|464066673|FG001|Overall Study|Protocol Violation|2|||
128707228|NCT01482884|463222205|FG000|Overall Study|Lost to Follow-up|2|||
128707229|NCT01482884|463222206|FG001|Overall Study|Lost to Follow-up|2|||
128707230|NCT01482884|463222205|FG000|Overall Study|Lack of Efficacy|0|||
128707231|NCT01482884|463222206|FG001|Overall Study|Lack of Efficacy|1|||
128707232|NCT01482884|463222205|FG000|Overall Study|Adverse Event|2|||
128707233|NCT01482884|463222206|FG001|Overall Study|Adverse Event|1|||
128707234|NCT01482884|463222205|FG000|Overall Study|Withdrawal by Subject|8|||
128707235|NCT01482884|463222206|FG001|Overall Study|Withdrawal by Subject|13|||
128707236|NCT00580606|463222207|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
128769857|NCT01396395|463448284|FG000|Overall Study|Protocol Violation|3|||
128769858|NCT01396395|463448285|FG001|Overall Study|Protocol Violation|1|||
128769859|NCT01396395|463448284|FG000|Overall Study|Adverse Event|10|||
128769860|NCT01396395|463448285|FG001|Overall Study|Adverse Event|2|||
128769861|NCT01396395|463448284|FG000|Overall Study|Lost to Follow-up|17|||
128769862|NCT01396395|463448285|FG001|Overall Study|Lost to Follow-up|11|||
128707237|NCT00580606|463222208|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
128769863|NCT01396395|463448284|FG000|Overall Study|Other|0|||
128769864|NCT01396395|463448285|FG001|Overall Study|Other|1|||
128769865|NCT00882921|463448287|FG000|Overall Study|Death|2|||
128769866|NCT00882921|463448287|FG000|Overall Study|Other|3|||
128769867|NCT00882921|463448287|FG000|Overall Study|Lost to Follow-up|2|||
128769868|NCT00882921|463448287|FG000|Overall Study|Termination By Investigator|3|||
128769869|NCT00882921|463448287|FG000|Overall Study|Withdrawal Of Consent|1|||
128769870|NCT01370005|463448288|FG000|Overall Study|Not treated|1|||
128769871|NCT01370005|463448289|FG001|Overall Study|Not treated|0|||
128769872|NCT01370005|463448290|FG002|Overall Study|Not treated|0|||
128769873|NCT01370005|463448288|FG000|Overall Study|Adverse Event|5|||
128769874|NCT01370005|463448289|FG001|Overall Study|Adverse Event|5|||
128769875|NCT01370005|463448290|FG002|Overall Study|Adverse Event|6|||
128769876|NCT01370005|463448288|FG000|Overall Study|Lack of Efficacy|1|||
128769877|NCT01370005|463448289|FG001|Overall Study|Lack of Efficacy|0|||
128939860|NCT02084134|464066672|FG000|Overall Study|Death|0|||
128939861|NCT02084134|464066673|FG001|Overall Study|Death|1|||
128769878|NCT01370005|463448290|FG002|Overall Study|Lack of Efficacy|0|||
128769879|NCT01370005|463448288|FG000|Overall Study|Non compliant with protocol|0|||
128769880|NCT01370005|463448289|FG001|Overall Study|Non compliant with protocol|1|||
128769881|NCT01370005|463448290|FG002|Overall Study|Non compliant with protocol|2|||
128769882|NCT01370005|463448288|FG000|Overall Study|Lost to Follow-up|1|||
128769883|NCT01370005|463448289|FG001|Overall Study|Lost to Follow-up|1|||
128769884|NCT01370005|463448290|FG002|Overall Study|Lost to Follow-up|1|||
128707238|NCT00580606|463222207|FG000|Open Label (OL)|Withdrawal by Subject|4|||
128707239|NCT00580606|463222208|FG001|Open Label (OL)|Withdrawal by Subject|6|||
128707240|NCT00580606|463222207|FG000|Open Label (OL)|Dosing Symptoms|0|||
128707241|NCT00580606|463222208|FG001|Open Label (OL)|Dosing Symptoms|1|||
128769885|NCT01370005|463448288|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
128769886|NCT01370005|463448289|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
128769887|NCT01370005|463448290|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
128769888|NCT01370005|463448288|FG000|Overall Study|Other reason not defined above|3|||
128769889|NCT01370005|463448289|FG001|Overall Study|Other reason not defined above|0|||
128769890|NCT01370005|463448290|FG002|Overall Study|Other reason not defined above|2|||
128769891|NCT02302066|463448291|FG000|Overall Study|Adverse Event|1|||
128769892|NCT02302066|463448292|FG001|Overall Study|Adverse Event|1|||
128769893|NCT02302066|463448293|FG002|Overall Study|Adverse Event|3|||
128769894|NCT02302066|463448294|FG003|Overall Study|Adverse Event|0|||
128769895|NCT02302066|463448291|FG000|Overall Study|Lost to Follow-up|4|||
128769896|NCT02302066|463448292|FG001|Overall Study|Lost to Follow-up|5|||
128939862|NCT00374907|464066674|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
128939863|NCT00374907|464066675|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
128939864|NCT00374907|464066674|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
128939865|NCT00374907|464066675|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
128939866|NCT00374907|464066674|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
128939867|NCT00374907|464066675|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
128939868|NCT00374907|464066674|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
128939869|NCT00374907|464066675|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
128939870|NCT00374907|464066674|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
128939871|NCT00374907|464066675|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
128939872|NCT01323673|464066679|FG000|Overall Study|Adverse Event|0|||
128939873|NCT01323673|464066680|FG001|Overall Study|Adverse Event|1|||
128939874|NCT01323673|464066679|FG000|Overall Study|Lost to Follow-up|0|||
128939875|NCT01323673|464066680|FG001|Overall Study|Lost to Follow-up|1|||
128939876|NCT01323673|464066679|FG000|Overall Study|Protocol Violation|1|||
128939877|NCT01323673|464066680|FG001|Overall Study|Protocol Violation|0|||
128939878|NCT01323673|464066679|FG000|Overall Study|Withdrawal by Subject|2|||
128939879|NCT01323673|464066680|FG001|Overall Study|Withdrawal by Subject|3|||
128939880|NCT04598165|464066681|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
128939881|NCT04598165|464066682|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
128939882|NCT04598165|464066681|FG000|Completed 6-week Follow-up|Death|2|||
128939883|NCT04598165|464066682|FG001|Completed 6-week Follow-up|Death|1|||
128939884|NCT04598165|464066681|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
128939885|NCT04598165|464066682|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
128939886|NCT04598165|464066681|FG000|Completed 6-week Follow-up|Ineligible|4|||
128939887|NCT04598165|464066682|FG001|Completed 6-week Follow-up|Ineligible|3|||
128939888|NCT04598165|464066681|FG000|Completed 6-week Follow-up|Partner refusal|0|||
128939889|NCT04598165|464066682|FG001|Completed 6-week Follow-up|Partner refusal|1|||
128939890|NCT04598165|464066681|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
128939891|NCT04598165|464066682|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
128939892|NCT02379923|464066683|FG000|Overall Study|Death|5|||
128939893|NCT00426751|464066684|FG000|Overall Study|Adverse Event|8|||
128939894|NCT00426751|464066685|FG001|Overall Study|Adverse Event|1|||
128939895|NCT00426751|464066684|FG000|Overall Study|Lost to Follow-up|7|||
128939896|NCT00426751|464066685|FG001|Overall Study|Lost to Follow-up|6|||
128939897|NCT00426751|464066684|FG000|Overall Study|Consent Withdrawn|0|||
128939898|NCT00426751|464066685|FG001|Overall Study|Consent Withdrawn|1|||
128939899|NCT00426751|464066684|FG000|Overall Study|Other Reasons|7|||
128939900|NCT00426751|464066685|FG001|Overall Study|Other Reasons|12|||
128939901|NCT01200511|464066686|FG000|Overall Study|Lost to Follow-up|3|||
128939902|NCT01200511|464066686|FG000|Overall Study|Withdrawal by Subject|1|||
128939903|NCT01200511|464066686|FG000|Overall Study|Adverse Event|1|||
128939904|NCT02429427|464066690|FG000|Overall Study|Adverse Event|220|||
128939905|NCT02429427|464066691|FG001|Overall Study|Adverse Event|92|||
128939906|NCT02429427|464066690|FG000|Overall Study|Protocol Violation|10|||
128939907|NCT02429427|464066691|FG001|Overall Study|Protocol Violation|6|||
128939908|NCT02429427|464066690|FG000|Overall Study|Lost to Follow-up|15|||
128939909|NCT02429427|464066691|FG001|Overall Study|Lost to Follow-up|6|||
128939910|NCT02429427|464066690|FG000|Overall Study|Withdrawal by Subject|64|||
128939911|NCT02429427|464066691|FG001|Overall Study|Withdrawal by Subject|34|||
129123162|NCT01859741|464745566|FG007|Overall Study|Lost to Follow-up|4|||
128707242|NCT00580606|463222207|FG000|Open Label (OL)|Lost to Follow-up|0|||
128707243|NCT00580606|463222208|FG001|Open Label (OL)|Lost to Follow-up|1|||
128707244|NCT00580606|463222207|FG000|Open Label (OL)|Pregnancy|0|||
128707245|NCT00580606|463222208|FG001|Open Label (OL)|Pregnancy|1|||
128707246|NCT00580606|463222207|FG000|Open Label (OL)|Non-compliance|2|||
128707247|NCT00580606|463222208|FG001|Open Label (OL)|Non-compliance|0|||
128707248|NCT00580606|463222207|FG000|Open Label (OL)|Physician Decision|1|||
128707249|NCT00580606|463222208|FG001|Open Label (OL)|Physician Decision|1|||
128707250|NCT00580606|463222207|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
128707251|NCT00580606|463222208|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
128707252|NCT00439244|463222211|FG000|Overall Study|Adverse Event|5|||
128707253|NCT00439244|463222212|FG001|Overall Study|Adverse Event|2|||
128707254|NCT00439244|463222213|FG002|Overall Study|Adverse Event|3|||
128707255|NCT00439244|463222211|FG000|Overall Study|Withdrawal by Subject|3|||
128707256|NCT00439244|463222212|FG001|Overall Study|Withdrawal by Subject|1|||
128707257|NCT00439244|463222213|FG002|Overall Study|Withdrawal by Subject|2|||
128707258|NCT00439244|463222211|FG000|Overall Study|Lost to Follow-up|2|||
128707259|NCT00439244|463222212|FG001|Overall Study|Lost to Follow-up|1|||
128707260|NCT00439244|463222213|FG002|Overall Study|Lost to Follow-up|2|||
128707261|NCT00439244|463222211|FG000|Overall Study|Death|0|||
128707262|NCT00439244|463222212|FG001|Overall Study|Death|1|||
128707263|NCT00439244|463222213|FG002|Overall Study|Death|0|||
128707264|NCT00439244|463222211|FG000|Overall Study|Protocol Violation|0|||
128707265|NCT00439244|463222212|FG001|Overall Study|Protocol Violation|1|||
128707266|NCT00439244|463222213|FG002|Overall Study|Protocol Violation|0|||
128707267|NCT00439244|463222211|FG000|Overall Study|Administrative problems|1|||
128707268|NCT00439244|463222212|FG001|Overall Study|Administrative problems|0|||
128707269|NCT00439244|463222213|FG002|Overall Study|Administrative problems|0|||
128707270|NCT03655691|463222214|FG000|Overall Study|Adverse Event|0|||
128707271|NCT03655691|463222215|FG001|Overall Study|Adverse Event|0|||
128707272|NCT03655691|463222216|FG002|Overall Study|Adverse Event|1|||
128707273|NCT03655691|463222214|FG000|Overall Study|Lost to Follow-up|1|||
128707274|NCT03655691|463222215|FG001|Overall Study|Lost to Follow-up|1|||
128707275|NCT03655691|463222216|FG002|Overall Study|Lost to Follow-up|2|||
128707276|NCT03655691|463222214|FG000|Overall Study|Protocol Violation|0|||
128707277|NCT03655691|463222215|FG001|Overall Study|Protocol Violation|1|||
128707278|NCT03655691|463222216|FG002|Overall Study|Protocol Violation|0|||
128707279|NCT03655691|463222214|FG000|Overall Study|Withdrawal by Subject|1|||
128707280|NCT03655691|463222215|FG001|Overall Study|Withdrawal by Subject|1|||
128707281|NCT03655691|463222216|FG002|Overall Study|Withdrawal by Subject|0|||
128707282|NCT01325584|463222219|FG000|Overall Study|Death|1|||
128707283|NCT00887978|463222220|FG000|Overall Study|Adverse Event|18|||
128707284|NCT00887978|463222221|FG001|Overall Study|Adverse Event|5|||
128707285|NCT00887978|463222220|FG000|Overall Study|Clinical Worsening|4|||
128707286|NCT00887978|463222221|FG001|Overall Study|Clinical Worsening|4|||
128707287|NCT00887978|463222220|FG000|Overall Study|Death|2|||
128707288|NCT00887978|463222221|FG001|Overall Study|Death|3|||
128707289|NCT00887978|463222220|FG000|Overall Study|Withdrawal by Subject|1|||
128939912|NCT02429427|464066690|FG000|Overall Study|Other|62|||
128939913|NCT02429427|464066691|FG001|Overall Study|Other|41|||
128939914|NCT00165646|464067721|FG000|Overall Study|Adverse Event|1|||
128939915|NCT00165646|464067722|FG001|Overall Study|Adverse Event|1|||
128939916|NCT00165646|464067723|FG002|Overall Study|Adverse Event|1|||
128939917|NCT00165646|464067721|FG000|Overall Study|Lack of Efficacy|1|||
128939918|NCT00165646|464067722|FG001|Overall Study|Lack of Efficacy|2|||
128939919|NCT00165646|464067723|FG002|Overall Study|Lack of Efficacy|0|||
128939920|NCT00165646|464067721|FG000|Overall Study|Withdrawal by Subject|0|||
128707290|NCT00887978|463222221|FG001|Overall Study|Withdrawal by Subject|2|||
128707291|NCT00887978|463222220|FG000|Overall Study|Lost to Follow-up|0|||
128707292|NCT00887978|463222221|FG001|Overall Study|Lost to Follow-up|1|||
128707293|NCT04102020|463222222|FG000|Overall Study|Adverse Event|1|||
128707294|NCT04102020|463222223|FG001|Overall Study|Adverse Event|0|||
128707295|NCT04102020|463222224|FG002|Overall Study|Adverse Event|0|||
128707296|NCT04102020|463222225|FG003|Overall Study|Adverse Event|1|||
128707297|NCT04102020|463222226|FG004|Overall Study|Adverse Event|0|||
128707298|NCT04102020|463222222|FG000|Overall Study|Withdrawal by Subject|0|||
128707299|NCT04102020|463222223|FG001|Overall Study|Withdrawal by Subject|1|||
128707300|NCT04102020|463222224|FG002|Overall Study|Withdrawal by Subject|1|||
128707301|NCT04102020|463222225|FG003|Overall Study|Withdrawal by Subject|1|||
128707302|NCT04102020|463222226|FG004|Overall Study|Withdrawal by Subject|1|||
128707303|NCT04102020|463222222|FG000|Overall Study|Death|1|||
128707304|NCT04102020|463222223|FG001|Overall Study|Death|4|||
128707305|NCT04102020|463222224|FG002|Overall Study|Death|1|||
128707306|NCT04102020|463222225|FG003|Overall Study|Death|1|||
128707307|NCT04102020|463222226|FG004|Overall Study|Death|0|||
128707308|NCT04102020|463222222|FG000|Overall Study|Physician Decision|1|||
128707309|NCT04102020|463222223|FG001|Overall Study|Physician Decision|2|||
128707310|NCT04102020|463222224|FG002|Overall Study|Physician Decision|2|||
128707311|NCT04102020|463222225|FG003|Overall Study|Physician Decision|0|||
128707312|NCT04102020|463222226|FG004|Overall Study|Physician Decision|1|||
128707313|NCT04102020|463222222|FG000|Overall Study|COVID-19 Infection|1|||
128707314|NCT04102020|463222223|FG001|Overall Study|COVID-19 Infection|0|||
128707315|NCT04102020|463222224|FG002|Overall Study|COVID-19 Infection|0|||
128707316|NCT04102020|463222225|FG003|Overall Study|COVID-19 Infection|0|||
128707317|NCT04102020|463222226|FG004|Overall Study|COVID-19 Infection|0|||
128707318|NCT04102020|463222222|FG000|Overall Study|Not disclosed|5|||
128707319|NCT04102020|463222223|FG001|Overall Study|Not disclosed|3|||
128707320|NCT04102020|463222224|FG002|Overall Study|Not disclosed|8|||
128707321|NCT04102020|463222225|FG003|Overall Study|Not disclosed|0|||
128707322|NCT04102020|463222226|FG004|Overall Study|Not disclosed|1|||
128707323|NCT04102020|463222222|FG000|Overall Study|MIssing|1|||
128707324|NCT04102020|463222223|FG001|Overall Study|MIssing|0|||
128707325|NCT04102020|463222224|FG002|Overall Study|MIssing|1|||
128707326|NCT04102020|463222225|FG003|Overall Study|MIssing|1|||
128707327|NCT04102020|463222226|FG004|Overall Study|MIssing|1|||
128707328|NCT04102020|463222222|FG000|Overall Study|Continuing in ongoing study|13|||
128707329|NCT04102020|463222223|FG001|Overall Study|Continuing in ongoing study|13|||
128707330|NCT04102020|463222224|FG002|Overall Study|Continuing in ongoing study|7|||
128707331|NCT04102020|463222225|FG003|Overall Study|Continuing in ongoing study|26|||
128707332|NCT04102020|463222226|FG004|Overall Study|Continuing in ongoing study|12|||
128707333|NCT05353985|463222235|FG000|Overall Study|Adverse Event|5|||
128707334|NCT05353985|463222236|FG001|Overall Study|Adverse Event|7|||
128707335|NCT05353985|463222235|FG000|Overall Study|Lost to Follow-up|1|||
128707336|NCT05353985|463222236|FG001|Overall Study|Lost to Follow-up|1|||
128707337|NCT05353985|463222235|FG000|Overall Study|Protocol Violation|1|||
128707338|NCT05353985|463222236|FG001|Overall Study|Protocol Violation|0|||
128707339|NCT05353985|463222235|FG000|Overall Study|Withdrawal by Subject|13|||
128707340|NCT05353985|463222236|FG001|Overall Study|Withdrawal by Subject|17|||
128707341|NCT05353985|463222235|FG000|Overall Study|Reason Not Specified|1|||
128707342|NCT05353985|463222236|FG001|Overall Study|Reason Not Specified|0|||
128707343|NCT05353985|463222235|FG000|Overall Study|Randomized in Error & Not Treated|0|||
128707344|NCT05353985|463222236|FG001|Overall Study|Randomized in Error & Not Treated|1|||
128707345|NCT04600921|463222237|FG000|Overall Study|Withdrawal by Subject|3|||
128707346|NCT04600921|463222238|FG001|Overall Study|Withdrawal by Subject|5|||
128707347|NCT04600921|463222237|FG000|Overall Study|Death|0|||
128707348|NCT04600921|463222238|FG001|Overall Study|Death|1|||
128707349|NCT00793403|463223830|FG000|Overall Study|Other|73|||
128707350|NCT00842712|463223831|FG000|Safety Run-in Part|Adverse Event|0|||
128707351|NCT00842712|463223832|FG001|Safety Run-in Part|Adverse Event|1|||
128707352|NCT00842712|463223833|FG002|Safety Run-in Part|Adverse Event|0|||
128707353|NCT00842712|463223834|FG003|Safety Run-in Part|Adverse Event|0|||
128707354|NCT00842712|463223835|FG004|Safety Run-in Part|Adverse Event|0|||
128707355|NCT00842712|463223836|FG005|Safety Run-in Part|Adverse Event|0|||
128707356|NCT00842712|463223837|FG006|Safety Run-in Part|Adverse Event|0|||
128707357|NCT00842712|463223831|FG000|Safety Run-in Part|Progressive disease|3|||
128707358|NCT00842712|463223832|FG001|Safety Run-in Part|Progressive disease|1|||
128707359|NCT00842712|463223833|FG002|Safety Run-in Part|Progressive disease|0|||
128707360|NCT00842712|463223834|FG003|Safety Run-in Part|Progressive disease|1|||
128707361|NCT00842712|463223835|FG004|Safety Run-in Part|Progressive disease|0|||
128939921|NCT00165646|464067722|FG001|Overall Study|Withdrawal by Subject|2|||
128939922|NCT00165646|464067723|FG002|Overall Study|Withdrawal by Subject|1|||
128939923|NCT00165646|464067721|FG000|Overall Study|Physician Decision|2|||
128939924|NCT00165646|464067722|FG001|Overall Study|Physician Decision|0|||
128939925|NCT00165646|464067723|FG002|Overall Study|Physician Decision|2|||
128939926|NCT00165646|464067721|FG000|Overall Study|Protocol Violation|1|||
128939927|NCT00165646|464067722|FG001|Overall Study|Protocol Violation|0|||
128939928|NCT00165646|464067723|FG002|Overall Study|Protocol Violation|0|||
128939929|NCT04657016|464067724|FG000|Overall Study|Adverse Event|2|||
128939930|NCT04657016|464067725|FG001|Overall Study|Adverse Event|4|||
128939931|NCT04657016|464067724|FG000|Overall Study|Death|1|||
128939932|NCT04657016|464067725|FG001|Overall Study|Death|1|||
128939933|NCT04657016|464067724|FG000|Overall Study|Lost to Follow-up|24|||
128939934|NCT04657016|464067725|FG001|Overall Study|Lost to Follow-up|12|||
128939935|NCT04657016|464067724|FG000|Overall Study|Physician Decision|1|||
128939936|NCT04657016|464067725|FG001|Overall Study|Physician Decision|2|||
128939937|NCT04657016|464067724|FG000|Overall Study|Pregnancy|2|||
128939938|NCT04657016|464067725|FG001|Overall Study|Pregnancy|2|||
128939939|NCT04657016|464067724|FG000|Overall Study|Protocol Deviation|1|||
128939940|NCT04657016|464067725|FG001|Overall Study|Protocol Deviation|0|||
128939941|NCT04657016|464067724|FG000|Overall Study|Withdrawal by Subject|28|||
128939942|NCT04657016|464067725|FG001|Overall Study|Withdrawal by Subject|14|||
128939943|NCT04657016|464067724|FG000|Overall Study|Other - as reported by the investigator|6|||
128939944|NCT04657016|464067725|FG001|Overall Study|Other - as reported by the investigator|0|||
128939945|NCT01755195|464067726|FG000|Overall Study|Participant noncompliance|2|||
128939946|NCT01755195|464067726|FG000|Overall Study|Switched to alternative treatment|4|||
128939947|NCT01755195|464067726|FG000|Overall Study|Withdrawal by Subject|1|||
128939948|NCT01755195|464067726|FG000|Overall Study|Participant refused to start treatment|1|||
128939949|NCT01755195|464067726|FG000|Overall Study|Participant has been consented for another trial|1|||
128939950|NCT01755195|464067726|FG000|Overall Study|Refused further treatment|3|||
128939951|NCT01755195|464067726|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
128939952|NCT03470922|464067727|FG000|Overall Study|Death|107|||
128939953|NCT03470922|464067728|FG001|Overall Study|Death|118|||
128939954|NCT03470922|464067727|FG000|Overall Study|Lost to Follow-up|5|||
128939955|NCT03470922|464067728|FG001|Overall Study|Lost to Follow-up|5|||
128939956|NCT03470922|464067727|FG000|Overall Study|Participant Withdrew Consent|4|||
128939957|NCT03470922|464067728|FG001|Overall Study|Participant Withdrew Consent|9|||
129032224|NCT04592419|464410187|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
129032225|NCT04592419|464410188|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
129032226|NCT04592419|464410187|FG000|Open-Label Extension Period|Adverse Event|1|||
129032227|NCT04592419|464410188|FG001|Open-Label Extension Period|Adverse Event|2|||
128707362|NCT00842712|463223836|FG005|Safety Run-in Part|Progressive disease|0|||
128707363|NCT00842712|463223837|FG006|Safety Run-in Part|Progressive disease|0|||
128707364|NCT00842712|463223831|FG000|Randomized Part|Randomized but not treated|0|||
128707365|NCT00842712|463223832|FG001|Randomized Part|Randomized but not treated|0|||
128707366|NCT00842712|463223833|FG002|Randomized Part|Randomized but not treated|0|||
128707367|NCT00842712|463223834|FG003|Randomized Part|Randomized but not treated|0|||
128707368|NCT00842712|463223835|FG004|Randomized Part|Randomized but not treated|0|||
128707369|NCT00842712|463223836|FG005|Randomized Part|Randomized but not treated|1|||
128707370|NCT00842712|463223837|FG006|Randomized Part|Randomized but not treated|4|||
128707371|NCT00842712|463223831|FG000|Randomized Part|Ongoing at cut-off date|0|||
128707372|NCT00842712|463223832|FG001|Randomized Part|Ongoing at cut-off date|0|||
128707373|NCT00842712|463223833|FG002|Randomized Part|Ongoing at cut-off date|0|||
128707374|NCT00842712|463223834|FG003|Randomized Part|Ongoing at cut-off date|0|||
128707375|NCT00842712|463223835|FG004|Randomized Part|Ongoing at cut-off date|0|||
128707376|NCT00842712|463223836|FG005|Randomized Part|Ongoing at cut-off date|0|||
128707377|NCT00842712|463223837|FG006|Randomized Part|Ongoing at cut-off date|2|||
128707378|NCT01384760|463223839|FG000|Overall Study|Lost to Follow-up|0|||
128707379|NCT01384760|463223840|FG001|Overall Study|Lost to Follow-up|6|||
128707380|NCT01384760|463223839|FG000|Overall Study|Protocol Violation|16|||
128707381|NCT01384760|463223840|FG001|Overall Study|Protocol Violation|0|||
128707382|NCT00963547|463223841|FG000|Overall Study|Adverse Event|0|||
128707383|NCT00963547|463223842|FG001|Overall Study|Adverse Event|1|||
128707384|NCT00963547|463223843|FG002|Overall Study|Adverse Event|0|||
128707385|NCT00963547|463223844|FG003|Overall Study|Adverse Event|1|||
128707386|NCT00963547|463223845|FG004|Overall Study|Adverse Event|0|||
128707387|NCT00963547|463223846|FG005|Overall Study|Adverse Event|0|||
128707388|NCT00963547|463223847|FG006|Overall Study|Adverse Event|0|||
128707389|NCT00963547|463223841|FG000|Overall Study|Physician Decision|1|||
128707390|NCT00963547|463223842|FG001|Overall Study|Physician Decision|1|||
128707391|NCT00963547|463223843|FG002|Overall Study|Physician Decision|0|||
128707392|NCT00963547|463223844|FG003|Overall Study|Physician Decision|0|||
128707393|NCT00963547|463223845|FG004|Overall Study|Physician Decision|0|||
128707394|NCT00963547|463223846|FG005|Overall Study|Physician Decision|0|||
128707395|NCT00963547|463223847|FG006|Overall Study|Physician Decision|0|||
128939958|NCT03470922|464067727|FG000|Overall Study|Other reasons|1|||
128769897|NCT02302066|463448293|FG002|Overall Study|Lost to Follow-up|24|||
128769898|NCT02302066|463448294|FG003|Overall Study|Lost to Follow-up|7|||
128769899|NCT02302066|463448291|FG000|Overall Study|Withdrawal by Subject|25|||
128769900|NCT02302066|463448292|FG001|Overall Study|Withdrawal by Subject|58|||
128769901|NCT02302066|463448293|FG002|Overall Study|Withdrawal by Subject|124|||
128769902|NCT02302066|463448294|FG003|Overall Study|Withdrawal by Subject|33|||
128769903|NCT02302066|463448291|FG000|Overall Study|Pregnancy|2|||
128769904|NCT02302066|463448292|FG001|Overall Study|Pregnancy|10|||
128769905|NCT02302066|463448293|FG002|Overall Study|Pregnancy|12|||
128769906|NCT02302066|463448294|FG003|Overall Study|Pregnancy|0|||
128769907|NCT02302066|463448291|FG000|Overall Study|Reason Not Specified|1|||
128769908|NCT02302066|463448292|FG001|Overall Study|Reason Not Specified|1|||
128769909|NCT02302066|463448293|FG002|Overall Study|Reason Not Specified|9|||
128769910|NCT02302066|463448294|FG003|Overall Study|Reason Not Specified|1|||
128769911|NCT05490329|463448295|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
128769912|NCT05490329|463448296|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
128769913|NCT05490329|463448295|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
128769914|NCT05490329|463448296|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
128769915|NCT05490329|463448295|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
128769916|NCT05490329|463448296|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
128939959|NCT03470922|464067728|FG001|Overall Study|Other reasons|0|||
128939960|NCT03470922|464067727|FG000|Overall Study|Not reported|1|||
128939961|NCT03470922|464067728|FG001|Overall Study|Not reported|0|||
128939962|NCT02340819|464067729|FG000|Overall Study|Adverse Event|1|||
128939963|NCT02340819|464067729|FG000|Overall Study|Withdrawal by Subject|2|||
128939964|NCT02340819|464067729|FG000|Overall Study|Discontinued with other reason|1|||
128939965|NCT01793051|464067730|FG000|Overall Study|Withdrawal by Subject|6|||
128939966|NCT01793051|464067731|FG001|Overall Study|Withdrawal by Subject|4|||
128939967|NCT01793051|464067730|FG000|Overall Study|Adverse Event|0|||
128939968|NCT01793051|464067731|FG001|Overall Study|Adverse Event|2|||
128939969|NCT01793051|464067730|FG000|Overall Study|Too ill to continue|1|||
128939970|NCT01793051|464067731|FG001|Overall Study|Too ill to continue|0|||
128939971|NCT01793051|464067730|FG000|Overall Study|Switched chemo|1|||
128939972|NCT01793051|464067731|FG001|Overall Study|Switched chemo|1|||
128939973|NCT01793051|464067730|FG000|Overall Study|Lack of compliance|1|||
128939974|NCT01793051|464067731|FG001|Overall Study|Lack of compliance|0|||
128939975|NCT01793051|464067730|FG000|Overall Study|Requested to be removed from the study|1|||
128939976|NCT01793051|464067731|FG001|Overall Study|Requested to be removed from the study|1|||
128939977|NCT04467164|464067736|FG000|Washout (1 Week)|Lost to Follow-up|2|||
128939978|NCT04467164|464067737|FG001|Washout (1 Week)|Lost to Follow-up|0|||
128939979|NCT01675011|464067740|FG000|Overall Study|Trial terminated by Sponsor|3|||
128939980|NCT01675011|464067741|FG001|Overall Study|Trial terminated by Sponsor|1|||
128939981|NCT01703286|464067743|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
128939982|NCT01703286|464067744|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
128939983|NCT01703286|464067745|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
128939984|NCT01703286|464067746|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
128939985|NCT01703286|464067747|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
128939986|NCT01703286|464067748|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
128939987|NCT01703286|464067743|FG000|Period 2 Including Washout|Adverse Event|0|||
128939988|NCT01703286|464067744|FG001|Period 2 Including Washout|Adverse Event|0|||
128939989|NCT01703286|464067745|FG002|Period 2 Including Washout|Adverse Event|0|||
128939990|NCT01703286|464067746|FG003|Period 2 Including Washout|Adverse Event|1|||
128939991|NCT01703286|464067747|FG004|Period 2 Including Washout|Adverse Event|0|||
128939992|NCT01703286|464067748|FG005|Period 2 Including Washout|Adverse Event|0|||
128939993|NCT01984346|464067749|FG000|Overall Study|Physician Decision|4|||
128939994|NCT01984346|464067750|FG001|Overall Study|Physician Decision|2|||
128939995|NCT01984346|464067749|FG000|Overall Study|Withdrawal by Subject|2|||
128939996|NCT01984346|464067750|FG001|Overall Study|Withdrawal by Subject|2|||
128939997|NCT01984346|464067749|FG000|Overall Study|Enrollment Closed|8|||
128939998|NCT01984346|464067750|FG001|Overall Study|Enrollment Closed|1|||
128939999|NCT01984346|464067749|FG000|Overall Study|Insurance Coverage|1|||
128940000|NCT01984346|464067750|FG001|Overall Study|Insurance Coverage|0|||
128940001|NCT01984346|464067749|FG000|Overall Study|Intra-operative Exclusion|2|||
128940002|NCT01984346|464067750|FG001|Overall Study|Intra-operative Exclusion|0|||
128940003|NCT05058664|464067757|FG000|Overall Study|No follow-up data provided|4|||
128940004|NCT05058664|464067758|FG001|Overall Study|No follow-up data provided|0|||
128940005|NCT05058664|464067759|FG002|Overall Study|No follow-up data provided|2|||
128940006|NCT05058664|464067757|FG000|Overall Study|Withdrawal by Subject|0|||
128940007|NCT05058664|464067758|FG001|Overall Study|Withdrawal by Subject|0|||
128940008|NCT05058664|464067759|FG002|Overall Study|Withdrawal by Subject|1|||
128940009|NCT00972244|464067760|FG000|Overall Study|Incorrect Enrolment|1|||
128940010|NCT00972244|464067761|FG001|Overall Study|Incorrect Enrolment|0|||
128940011|NCT00972244|464067762|FG002|Overall Study|Incorrect Enrolment|0|||
128940012|NCT00972244|464067763|FG003|Overall Study|Incorrect Enrolment|0|||
128940013|NCT00972244|464067764|FG004|Overall Study|Incorrect Enrolment|0|||
128940014|NCT00972244|464067760|FG000|Overall Study|Adverse Event|0|||
128707396|NCT00963547|463223841|FG000|Overall Study|Progressive Disease|3|||
129123163|NCT01859741|464745559|FG000|Overall Study|Withdrawal by Subject|0|||
129123164|NCT01859741|464745560|FG001|Overall Study|Withdrawal by Subject|1|||
129123165|NCT01859741|464745561|FG002|Overall Study|Withdrawal by Subject|2|||
129123166|NCT01859741|464745562|FG003|Overall Study|Withdrawal by Subject|0|||
129123167|NCT01859741|464745563|FG004|Overall Study|Withdrawal by Subject|0|||
129123168|NCT01859741|464745564|FG005|Overall Study|Withdrawal by Subject|1|||
129123169|NCT01859741|464745565|FG006|Overall Study|Withdrawal by Subject|1|||
129123170|NCT01859741|464745566|FG007|Overall Study|Withdrawal by Subject|1|||
129123171|NCT01859741|464745559|FG000|Overall Study|Study Terminated by Sponsor|0|||
129123172|NCT01859741|464745560|FG001|Overall Study|Study Terminated by Sponsor|0|||
129123173|NCT01859741|464745561|FG002|Overall Study|Study Terminated by Sponsor|0|||
129123174|NCT01859741|464745562|FG003|Overall Study|Study Terminated by Sponsor|0|||
129123175|NCT01859741|464745563|FG004|Overall Study|Study Terminated by Sponsor|1|||
129123176|NCT01859741|464745564|FG005|Overall Study|Study Terminated by Sponsor|0|||
129123177|NCT01859741|464745565|FG006|Overall Study|Study Terminated by Sponsor|16|||
129123178|NCT01859741|464745566|FG007|Overall Study|Study Terminated by Sponsor|14|||
129123179|NCT01859741|464745559|FG000|Overall Study|Other|0|||
129123180|NCT01859741|464745560|FG001|Overall Study|Other|0|||
129123181|NCT01859741|464745561|FG002|Overall Study|Other|0|||
129123182|NCT01859741|464745562|FG003|Overall Study|Other|0|||
129123183|NCT01859741|464745563|FG004|Overall Study|Other|0|||
129123184|NCT01859741|464745564|FG005|Overall Study|Other|0|||
129123185|NCT01859741|464745565|FG006|Overall Study|Other|2|||
129123186|NCT01859741|464745566|FG007|Overall Study|Other|0|||
129123187|NCT02412657|464745570|FG000|Overall Study|Lost to Follow-up|1|||
129123188|NCT02412657|464745571|FG001|Overall Study|Lost to Follow-up|0|||
129123189|NCT02412657|464745572|FG002|Overall Study|Lost to Follow-up|0|||
129123190|NCT02412657|464745570|FG000|Overall Study|Protocol Violation|0|||
129123191|NCT02412657|464745571|FG001|Overall Study|Protocol Violation|2|||
129123192|NCT02412657|464745572|FG002|Overall Study|Protocol Violation|3|||
129123193|NCT00142415|464745576|FG000|Overall Study|Physician Decision|0|||
129123194|NCT00142415|464745577|FG001|Overall Study|Physician Decision|0|||
129123195|NCT00142415|464745578|FG002|Overall Study|Physician Decision|0|||
129123196|NCT00142415|464745579|FG003|Overall Study|Physician Decision|0|||
129123197|NCT00142415|464745580|FG004|Overall Study|Physician Decision|1|||
129123198|NCT00142415|464745581|FG005|Overall Study|Physician Decision|2|||
129123199|NCT01189266|464745582|FG000|Overall Study|Adverse Event|1|||
129123200|NCT01189266|464745583|FG001|Overall Study|Adverse Event|0|||
129123201|NCT01189266|464745584|FG002|Overall Study|Adverse Event|5|||
129123202|NCT01189266|464745582|FG000|Overall Study|Death|0|||
129123203|NCT01189266|464745583|FG001|Overall Study|Death|0|||
128707397|NCT00963547|463223842|FG001|Overall Study|Progressive Disease|8|||
128707398|NCT00963547|463223843|FG002|Overall Study|Progressive Disease|9|||
128707399|NCT00963547|463223844|FG003|Overall Study|Progressive Disease|5|||
128940015|NCT00972244|464067761|FG001|Overall Study|Adverse Event|1|||
128940016|NCT00972244|464067762|FG002|Overall Study|Adverse Event|1|||
128940017|NCT00972244|464067763|FG003|Overall Study|Adverse Event|0|||
128940018|NCT00972244|464067764|FG004|Overall Study|Adverse Event|0|||
128940019|NCT00972244|464067760|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
128940020|NCT00972244|464067761|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
128940021|NCT00972244|464067762|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
128940022|NCT00972244|464067763|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
128940023|NCT00972244|464067764|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
128940024|NCT00972244|464067760|FG000|Overall Study|Withdrawal by Subject|1|||
128940025|NCT00972244|464067761|FG001|Overall Study|Withdrawal by Subject|2|||
128940026|NCT00972244|464067762|FG002|Overall Study|Withdrawal by Subject|1|||
128940027|NCT00972244|464067763|FG003|Overall Study|Withdrawal by Subject|0|||
128940028|NCT00972244|464067764|FG004|Overall Study|Withdrawal by Subject|1|||
128940029|NCT00972244|464067760|FG000|Overall Study|Safety|0|||
128940030|NCT00972244|464067761|FG001|Overall Study|Safety|0|||
128940031|NCT00972244|464067762|FG002|Overall Study|Safety|0|||
128940032|NCT00972244|464067763|FG003|Overall Study|Safety|0|||
128940033|NCT00972244|464067764|FG004|Overall Study|Safety|1|||
128940034|NCT00972244|464067760|FG000|Overall Study|Death|1|||
128940035|NCT00972244|464067761|FG001|Overall Study|Death|0|||
128940036|NCT00972244|464067762|FG002|Overall Study|Death|0|||
128940037|NCT00972244|464067763|FG003|Overall Study|Death|0|||
128940038|NCT00972244|464067764|FG004|Overall Study|Death|0|||
128940039|NCT00972244|464067760|FG000|Overall Study|Various|0|||
129123204|NCT01189266|464745584|FG002|Overall Study|Death|5|||
129123205|NCT01189266|464745582|FG000|Overall Study|Lack of Efficacy|4|||
129123206|NCT01189266|464745583|FG001|Overall Study|Lack of Efficacy|5|||
129123207|NCT01189266|464745584|FG002|Overall Study|Lack of Efficacy|44|||
129123208|NCT01189266|464745582|FG000|Overall Study|Physician Decision|0|||
128940040|NCT00972244|464067761|FG001|Overall Study|Various|0|||
128940041|NCT00972244|464067762|FG002|Overall Study|Various|0|||
128940042|NCT00972244|464067763|FG003|Overall Study|Various|0|||
129123209|NCT01189266|464745583|FG001|Overall Study|Physician Decision|0|||
129123210|NCT01189266|464745584|FG002|Overall Study|Physician Decision|1|||
129123211|NCT01189266|464745582|FG000|Overall Study|Protocol Violation|0|||
129123212|NCT01189266|464745583|FG001|Overall Study|Protocol Violation|1|||
129123213|NCT01189266|464745584|FG002|Overall Study|Protocol Violation|1|||
128707400|NCT00963547|463223845|FG004|Overall Study|Progressive Disease|0|||
128707401|NCT00963547|463223846|FG005|Overall Study|Progressive Disease|0|||
128707402|NCT00963547|463223847|FG006|Overall Study|Progressive Disease|0|||
128707403|NCT00963547|463223841|FG000|Overall Study|Withdrawal by Subject|0|||
128707404|NCT00963547|463223842|FG001|Overall Study|Withdrawal by Subject|0|||
128707405|NCT00963547|463223843|FG002|Overall Study|Withdrawal by Subject|3|||
128707406|NCT00963547|463223844|FG003|Overall Study|Withdrawal by Subject|0|||
128940043|NCT00972244|464067764|FG004|Overall Study|Various|2|||
128940044|NCT01597557|464067765|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
128940045|NCT01597557|464067766|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
128940046|NCT01293032|464067775|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
128940047|NCT01293032|464067776|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
128940048|NCT01293032|464067777|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
128940049|NCT01293032|464067778|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
128940050|NCT01293032|464067775|FG000|Treatment|Adverse Event|0|||
128940051|NCT01293032|464067776|FG001|Treatment|Adverse Event|0|||
128940052|NCT01293032|464067777|FG002|Treatment|Adverse Event|1|||
128940053|NCT01293032|464067778|FG003|Treatment|Adverse Event|1|||
128940054|NCT01293032|464067775|FG000|Treatment|Withdrawal by Subject|2|||
128940055|NCT01293032|464067776|FG001|Treatment|Withdrawal by Subject|4|||
128940056|NCT01293032|464067777|FG002|Treatment|Withdrawal by Subject|0|||
128940057|NCT01293032|464067778|FG003|Treatment|Withdrawal by Subject|0|||
128940058|NCT01293032|464067775|FG000|Treatment|Disease Progression, relapse|0|||
128940059|NCT01293032|464067776|FG001|Treatment|Disease Progression, relapse|1|||
128940060|NCT01293032|464067777|FG002|Treatment|Disease Progression, relapse|0|||
128940061|NCT01293032|464067778|FG003|Treatment|Disease Progression, relapse|0|||
128940062|NCT02985450|464067782|FG000|Overall Study|Lost to Follow-up|7|||
128940063|NCT00431847|464067783|FG000|Overall Study|completion of less than two study visits|6|||
128940064|NCT00431847|464067784|FG001|Overall Study|completion of less than two study visits|3|||
128940065|NCT00431847|464067785|FG002|Overall Study|completion of less than two study visits|4|||
128940066|NCT00431847|464067786|FG003|Overall Study|completion of less than two study visits|14|||
128940067|NCT00431847|464067787|FG004|Overall Study|completion of less than two study visits|0|||
128940068|NCT00431847|464067783|FG000|Overall Study|Protocol Violation|0|||
128940069|NCT00431847|464067784|FG001|Overall Study|Protocol Violation|0|||
128940070|NCT00431847|464067785|FG002|Overall Study|Protocol Violation|0|||
128940071|NCT00431847|464067786|FG003|Overall Study|Protocol Violation|0|||
128940072|NCT00431847|464067787|FG004|Overall Study|Protocol Violation|1|||
128940073|NCT01095250|464067796|FG000|Overall Study|administrative reasons|8|||
128940074|NCT01095250|464067797|FG001|Overall Study|administrative reasons|10|||
128940075|NCT01095250|464067798|FG002|Overall Study|administrative reasons|7|||
128940076|NCT01095250|464067799|FG003|Overall Study|administrative reasons|5|||
128940077|NCT01095250|464067796|FG000|Overall Study|Withdrawal by Subject|0|||
128769917|NCT03176238|463448297|FG000|Overall Study|Unacceptable AEs|15|||
128769918|NCT03176238|463448298|FG001|Overall Study|Unacceptable AEs|8|||
128769919|NCT03176238|463448297|FG000|Overall Study|Abnormal lab value(s)|2|||
128940078|NCT01095250|464067797|FG001|Overall Study|Withdrawal by Subject|0|||
128940079|NCT01095250|464067798|FG002|Overall Study|Withdrawal by Subject|1|||
128940080|NCT01095250|464067799|FG003|Overall Study|Withdrawal by Subject|0|||
128940081|NCT04229446|464067800|FG000|Overall Study|Death|12|||
128940082|NCT04229446|464067801|FG001|Overall Study|Death|10|||
128940083|NCT04229446|464067800|FG000|Overall Study|Lost to Follow-up|5|||
128940084|NCT04229446|464067801|FG001|Overall Study|Lost to Follow-up|8|||
128940085|NCT00705224|464067802|FG000|Overall Study|Adverse Event|1|||
128940086|NCT00705224|464067802|FG000|Overall Study|Lack of Efficacy|2|||
128940087|NCT00705224|464067802|FG000|Overall Study|Withdrawal by Subject|3|||
128940088|NCT00705224|464067802|FG000|Overall Study|Lost to Follow-up|5|||
128940089|NCT00968253|464067803|FG000|Overall Study|Death|0|||
128940090|NCT00968253|464067804|FG001|Overall Study|Death|0|||
128940091|NCT00968253|464067805|FG002|Overall Study|Death|2|||
128940092|NCT00968253|464067803|FG000|Overall Study|Withdrawal by Subject|0|||
128940093|NCT00968253|464067804|FG001|Overall Study|Withdrawal by Subject|0|||
128940094|NCT00968253|464067805|FG002|Overall Study|Withdrawal by Subject|1|||
128940095|NCT00968253|464067803|FG000|Overall Study|Disease Progression|0|||
128707407|NCT00963547|463223845|FG004|Overall Study|Withdrawal by Subject|0|||
128707408|NCT00963547|463223846|FG005|Overall Study|Withdrawal by Subject|0|||
128940096|NCT00968253|464067804|FG001|Overall Study|Disease Progression|3|||
128940097|NCT00968253|464067805|FG002|Overall Study|Disease Progression|3|||
128940098|NCT00968253|464067803|FG000|Overall Study|Adverse Event|0|||
128940099|NCT00968253|464067804|FG001|Overall Study|Adverse Event|0|||
129123214|NCT01189266|464745582|FG000|Overall Study|Withdrawal by Subject|0|||
128940100|NCT00968253|464067805|FG002|Overall Study|Adverse Event|1|||
128940101|NCT03596177|464067807|FG000|Single Blind Period|Withdrawal by Subject|1|||
128940102|NCT03596177|464067808|FG001|Single Blind Period|Withdrawal by Subject|1|||
128940103|NCT03596177|464067807|FG000|Single Blind Period|Other|1|||
128940104|NCT03596177|464067808|FG001|Single Blind Period|Other|0|||
128940105|NCT03596177|464067807|FG000|Double Blind Period|Withdrawal by Subject|0|||
128940106|NCT03596177|464067808|FG001|Double Blind Period|Withdrawal by Subject|1|||
128940107|NCT03596177|464067807|FG000|Double Blind Period|Other|0|||
128940108|NCT03596177|464067808|FG001|Double Blind Period|Other|4|||
128940109|NCT03596177|464067807|FG000|Double Blind Period|Death during safety follow-up|0|||
128940110|NCT03596177|464067808|FG001|Double Blind Period|Death during safety follow-up|1|||
128940111|NCT03141086|464067811|FG000|Overall Study|Study Terminated By Sponsor|1|||
128940112|NCT03141086|464067812|FG001|Overall Study|Study Terminated By Sponsor|1|||
128940113|NCT03141086|464067811|FG000|Overall Study|Withdrawal by Subject|0|||
128940114|NCT03141086|464067812|FG001|Overall Study|Withdrawal by Subject|1|||
128940115|NCT03141086|464067811|FG000|Overall Study|Protocol Violation|0|||
128940116|NCT03141086|464067812|FG001|Overall Study|Protocol Violation|1|||
128940117|NCT03141086|464067811|FG000|Overall Study|Adverse Event|0|||
128940118|NCT03141086|464067812|FG001|Overall Study|Adverse Event|2|||
128940119|NCT02488759|464067815|FG000|Overall Study|Disease progression|73|||
128940120|NCT02488759|464067816|FG001|Overall Study|Disease progression|111|||
128940121|NCT02488759|464067817|FG002|Overall Study|Disease progression|62|||
128940122|NCT02488759|464067818|FG003|Overall Study|Disease progression|7|||
128940123|NCT02488759|464067819|FG004|Overall Study|Disease progression|4|||
128940124|NCT02488759|464067820|FG005|Overall Study|Disease progression|2|||
128940125|NCT02488759|464067815|FG000|Overall Study|Study drug toxicity|11|||
128940126|NCT02488759|464067816|FG001|Overall Study|Study drug toxicity|33|||
128940127|NCT02488759|464067817|FG002|Overall Study|Study drug toxicity|31|||
128940128|NCT02488759|464067818|FG003|Overall Study|Study drug toxicity|0|||
128940129|NCT02488759|464067819|FG004|Overall Study|Study drug toxicity|0|||
128940130|NCT02488759|464067820|FG005|Overall Study|Study drug toxicity|2|||
128769920|NCT03176238|463448298|FG001|Overall Study|Abnormal lab value(s)|0|||
128769921|NCT03176238|463448297|FG000|Overall Study|Inter-current illness|0|||
128769922|NCT03176238|463448298|FG001|Overall Study|Inter-current illness|1|||
128769923|NCT03176238|463448297|FG000|Overall Study|Consent withdrawal|14|||
128769924|NCT03176238|463448298|FG001|Overall Study|Consent withdrawal|2|||
128769925|NCT03176238|463448297|FG000|Overall Study|Lost to Follow-up|3|||
128769926|NCT03176238|463448298|FG001|Overall Study|Lost to Follow-up|0|||
128769927|NCT03176238|463448297|FG000|Overall Study|Administrative problems|1|||
128769928|NCT03176238|463448298|FG001|Overall Study|Administrative problems|0|||
128769929|NCT03176238|463448297|FG000|Overall Study|Death|3|||
128769930|NCT03176238|463448298|FG001|Overall Study|Death|0|||
128769931|NCT03176238|463448297|FG000|Overall Study|Disease Progression|133|||
128769932|NCT03176238|463448298|FG001|Overall Study|Disease Progression|22|||
128769933|NCT03176238|463448297|FG000|Overall Study|Tx duration completed per EAP|0|||
128769934|NCT03176238|463448298|FG001|Overall Study|Tx duration completed per EAP|1|||
128769935|NCT03176238|463448297|FG000|Overall Study|Patient is switched to commercial drug|16|||
128769936|NCT03176238|463448298|FG001|Overall Study|Patient is switched to commercial drug|1|||
128940131|NCT02488759|464067815|FG000|Overall Study|Adverse event unrelated to study drug|9|||
128940132|NCT02488759|464067816|FG001|Overall Study|Adverse event unrelated to study drug|11|||
128940133|NCT02488759|464067817|FG002|Overall Study|Adverse event unrelated to study drug|7|||
128940134|NCT02488759|464067818|FG003|Overall Study|Adverse event unrelated to study drug|0|||
128940135|NCT02488759|464067819|FG004|Overall Study|Adverse event unrelated to study drug|1|||
128940136|NCT02488759|464067820|FG005|Overall Study|Adverse event unrelated to study drug|0|||
128940137|NCT02488759|464067815|FG000|Overall Study|Participant request to discontinue study treatment|6|||
128940138|NCT02488759|464067816|FG001|Overall Study|Participant request to discontinue study treatment|8|||
128940139|NCT02488759|464067817|FG002|Overall Study|Participant request to discontinue study treatment|4|||
128940140|NCT02488759|464067818|FG003|Overall Study|Participant request to discontinue study treatment|0|||
128940141|NCT02488759|464067819|FG004|Overall Study|Participant request to discontinue study treatment|0|||
128940142|NCT02488759|464067820|FG005|Overall Study|Participant request to discontinue study treatment|0|||
129123215|NCT01189266|464745583|FG001|Overall Study|Withdrawal by Subject|0|||
129123216|NCT01189266|464745584|FG002|Overall Study|Withdrawal by Subject|1|||
129123217|NCT01189266|464745582|FG000|Overall Study|Patient refuses further therapy|1|||
129123218|NCT01189266|464745583|FG001|Overall Study|Patient refuses further therapy|0|||
128940143|NCT02488759|464067815|FG000|Overall Study|Withdrawal by Subject|4|||
128940144|NCT02488759|464067816|FG001|Overall Study|Withdrawal by Subject|0|||
128940145|NCT02488759|464067817|FG002|Overall Study|Withdrawal by Subject|3|||
128940146|NCT02488759|464067818|FG003|Overall Study|Withdrawal by Subject|0|||
128940147|NCT02488759|464067819|FG004|Overall Study|Withdrawal by Subject|0|||
128940148|NCT02488759|464067820|FG005|Overall Study|Withdrawal by Subject|2|||
128940149|NCT02488759|464067815|FG000|Overall Study|Lost to Follow-up|0|||
129123219|NCT01189266|464745584|FG002|Overall Study|Patient refuses further therapy|7|||
128940150|NCT02488759|464067816|FG001|Overall Study|Lost to Follow-up|0|||
128940151|NCT02488759|464067817|FG002|Overall Study|Lost to Follow-up|2|||
128940152|NCT02488759|464067818|FG003|Overall Study|Lost to Follow-up|0|||
128940153|NCT02488759|464067819|FG004|Overall Study|Lost to Follow-up|0|||
129123220|NCT01189266|464745582|FG000|Overall Study|No treatment|0|||
128940154|NCT02488759|464067820|FG005|Overall Study|Lost to Follow-up|0|||
128940155|NCT02488759|464067815|FG000|Overall Study|Maximum clinical benefit|3|||
128940156|NCT02488759|464067816|FG001|Overall Study|Maximum clinical benefit|0|||
128940157|NCT02488759|464067817|FG002|Overall Study|Maximum clinical benefit|1|||
128940158|NCT02488759|464067818|FG003|Overall Study|Maximum clinical benefit|0|||
128940159|NCT02488759|464067819|FG004|Overall Study|Maximum clinical benefit|0|||
128940160|NCT02488759|464067820|FG005|Overall Study|Maximum clinical benefit|0|||
128940161|NCT02488759|464067815|FG000|Overall Study|Other reasons|7|||
128940162|NCT02488759|464067816|FG001|Overall Study|Other reasons|32|||
128940163|NCT02488759|464067817|FG002|Overall Study|Other reasons|23|||
128940164|NCT02488759|464067818|FG003|Overall Study|Other reasons|1|||
128940165|NCT02488759|464067819|FG004|Overall Study|Other reasons|1|||
128940166|NCT02488759|464067820|FG005|Overall Study|Other reasons|1|||
128940167|NCT03860844|464067821|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
128940168|NCT03860844|464067822|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
128940169|NCT03860844|464067823|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
128940170|NCT03860844|464067821|FG000|Overall Study|Progressive disease|5|||
128940171|NCT03860844|464067822|FG001|Overall Study|Progressive disease|3|||
128940172|NCT03860844|464067823|FG002|Overall Study|Progressive disease|4|||
128940173|NCT03860844|464067821|FG000|Overall Study|Other, Not related to COVID-19|0|||
128940174|NCT03860844|464067822|FG001|Overall Study|Other, Not related to COVID-19|1|||
128940175|NCT03860844|464067823|FG002|Overall Study|Other, Not related to COVID-19|0|||
128940176|NCT01678807|464067824|FG000|Overall Study|Adverse Event|4|||
128940177|NCT01678807|464067825|FG001|Overall Study|Adverse Event|4|||
128940178|NCT01678807|464067826|FG002|Overall Study|Adverse Event|0|||
128707409|NCT00963547|463223847|FG006|Overall Study|Withdrawal by Subject|0|||
128707410|NCT00963547|463223841|FG000|Overall Study|Reason Unknown|0|||
128707411|NCT00963547|463223842|FG001|Overall Study|Reason Unknown|1|||
128707412|NCT00963547|463223843|FG002|Overall Study|Reason Unknown|0|||
128707413|NCT00963547|463223844|FG003|Overall Study|Reason Unknown|0|||
128707414|NCT00963547|463223845|FG004|Overall Study|Reason Unknown|0|||
128707415|NCT00963547|463223846|FG005|Overall Study|Reason Unknown|0|||
128707416|NCT00963547|463223847|FG006|Overall Study|Reason Unknown|0|||
128707417|NCT00482612|463223854|FG000|In-treatment Period|No study medication administered|0|||
128707418|NCT00482612|463223855|FG001|In-treatment Period|No study medication administered|0|||
128707419|NCT00482612|463223856|FG002|In-treatment Period|No study medication administered|1|||
128707420|NCT00482612|463223857|FG003|In-treatment Period|No study medication administered|0|||
128707421|NCT00482612|463223854|FG000|Follow-up Period|Other|4|||
128707422|NCT00482612|463223855|FG001|Follow-up Period|Other|2|||
128707423|NCT00482612|463223856|FG002|Follow-up Period|Other|1|||
128940179|NCT01678807|464067824|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
128940180|NCT01678807|464067825|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
128940181|NCT01678807|464067826|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
128940182|NCT00370149|464067827|FG000|Overall Study|Physician Decision|16|||
128940183|NCT00370149|464067828|FG001|Overall Study|Physician Decision|16|||
128940184|NCT00370149|464067827|FG000|Overall Study|Protocol Violation|1|||
128940185|NCT00370149|464067828|FG001|Overall Study|Protocol Violation|0|||
128940186|NCT00370149|464067827|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
128940187|NCT00370149|464067828|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
128940188|NCT00370149|464067827|FG000|Overall Study|Pre-existing infection|0|||
128940189|NCT00370149|464067828|FG001|Overall Study|Pre-existing infection|1|||
128940190|NCT00370149|464067827|FG000|Overall Study|Antibiotic coated dressing placed|0|||
128940191|NCT00370149|464067828|FG001|Overall Study|Antibiotic coated dressing placed|1|||
128940192|NCT00719732|464067829|FG000|Overall Study|Lost to Follow-up|20|||
128940193|NCT00719732|464067829|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
128940194|NCT00719732|464067829|FG000|Overall Study|Illness not associated with device|1|||
128940195|NCT03625986|464069502|FG000|Randomization Period|Lost to Follow-up|7|||
128940196|NCT03625986|464069503|FG001|Randomization Period|Lost to Follow-up|12|||
128940197|NCT03625986|464069502|FG000|Randomization Period|Withdrawal by Subject|10|||
128940198|NCT03625986|464069503|FG001|Randomization Period|Withdrawal by Subject|6|||
128940199|NCT04920084|464069505|FG000|Overall Study|Adverse Event|1|||
128940200|NCT04920084|464069505|FG000|Overall Study|Lost to Follow-up|2|||
128940201|NCT04920084|464069505|FG000|Overall Study|Withdrawal by Subject|2|||
128940202|NCT00620321|464069506|FG000|Overall Study|Adverse Event|1|||
128940203|NCT00620321|464069507|FG001|Overall Study|Adverse Event|1|||
129032228|NCT04592419|464410187|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
129032229|NCT04592419|464410188|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
129032230|NCT04592419|464410187|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
129032231|NCT04592419|464410188|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
129032232|NCT04592419|464410187|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
129032233|NCT04592419|464410188|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
129032234|NCT04592419|464410187|FG000|Open-Label Extension Period|Sponsor Request|73|||
129032235|NCT04592419|464410188|FG001|Open-Label Extension Period|Sponsor Request|84|||
129032236|NCT02943993|464410205|FG000|Overall Study|Withdrawal by Subject|52|||
128940204|NCT00620321|464069506|FG000|Overall Study|Death|1|||
128940205|NCT00620321|464069507|FG001|Overall Study|Death|1|||
128940206|NCT00620321|464069506|FG000|Overall Study|Physician Decision|0|||
128940207|NCT00620321|464069507|FG001|Overall Study|Physician Decision|7|||
128940208|NCT00620321|464069506|FG000|Overall Study|Progressive Disease|5|||
128940209|NCT00620321|464069507|FG001|Overall Study|Progressive Disease|5|||
128940210|NCT00620321|464069506|FG000|Overall Study|Sponsor Decision|0|||
128940211|NCT00620321|464069507|FG001|Overall Study|Sponsor Decision|1|||
128940212|NCT00620321|464069506|FG000|Overall Study|Withdrawal by Subject|1|||
128940213|NCT00620321|464069507|FG001|Overall Study|Withdrawal by Subject|1|||
128940214|NCT04191967|464069508|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
128940215|NCT04191967|464069508|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
128940216|NCT01431144|464069509|FG000|Overall Study|Implant mobility and removal|2|||
128940217|NCT01431144|464069510|FG001|Overall Study|Implant mobility and removal|0|||
128940218|NCT02410902|464069519|FG000|Overall Study|Adverse Event|2|||
128940219|NCT02410902|464069520|FG001|Overall Study|Adverse Event|3|||
128940220|NCT02410902|464069519|FG000|Overall Study|Lost to Follow-up|4|||
128940221|NCT02410902|464069520|FG001|Overall Study|Lost to Follow-up|1|||
128940222|NCT02410902|464069519|FG000|Overall Study|Protocol Violation|1|||
128940223|NCT02410902|464069520|FG001|Overall Study|Protocol Violation|4|||
129123221|NCT01189266|464745583|FG001|Overall Study|No treatment|0|||
129123222|NCT01189266|464745584|FG002|Overall Study|No treatment|1|||
129123223|NCT03620162|464745585|FG000|Overall Study|Physician Decision|4|||
129123224|NCT03620162|464745586|FG001|Overall Study|Physician Decision|0|||
129123225|NCT03620162|464745587|FG002|Overall Study|Physician Decision|1|||
129123226|NCT03620162|464745588|FG003|Overall Study|Physician Decision|0|||
129123227|NCT03620162|464745589|FG004|Overall Study|Physician Decision|2|||
129123228|NCT03620162|464745585|FG000|Overall Study|Lost to Follow-up|2|||
129123229|NCT03620162|464745586|FG001|Overall Study|Lost to Follow-up|6|||
129123230|NCT03620162|464745587|FG002|Overall Study|Lost to Follow-up|7|||
129123231|NCT03620162|464745588|FG003|Overall Study|Lost to Follow-up|3|||
129123232|NCT03620162|464745589|FG004|Overall Study|Lost to Follow-up|2|||
129123233|NCT03620162|464745585|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
129123234|NCT03620162|464745586|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
128940224|NCT02410902|464069519|FG000|Overall Study|Withdrawal by Subject|6|||
128940225|NCT02410902|464069520|FG001|Overall Study|Withdrawal by Subject|8|||
128940226|NCT02410902|464069519|FG000|Overall Study|Non-Compliance|8|||
128940227|NCT02410902|464069520|FG001|Overall Study|Non-Compliance|2|||
128940228|NCT00953043|464069521|FG000|Overall Study|Withdrawal by Subject|4|||
128940229|NCT00953043|464069522|FG001|Overall Study|Withdrawal by Subject|0|||
128940230|NCT00953043|464069521|FG000|Overall Study|Physician Decision|0|||
128940231|NCT00953043|464069522|FG001|Overall Study|Physician Decision|2|||
128940232|NCT01043185|464069524|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
128940233|NCT01043185|464069525|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
128940234|NCT01043185|464069526|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
128940235|NCT01043185|464069527|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
128940236|NCT01043185|464069528|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
128940237|NCT01043185|464069529|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
128940238|NCT01043185|464069530|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
128940239|NCT01043185|464069531|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
128940240|NCT01043185|464069532|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
128940241|NCT01043185|464069533|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
128940242|NCT01432262|464069534|FG000|Overall Study|Withdrawal by Subject|2|||
128940243|NCT01432262|464069535|FG001|Overall Study|Withdrawal by Subject|1|||
128940244|NCT01104558|464069536|FG000|Overall Study|Protocol Violation|6|||
128940245|NCT01104558|464069536|FG000|Overall Study|Missing of primary efficacy assessment|10|||
128940246|NCT01104558|464069536|FG000|Overall Study|Missing of genetic analysis results|1|||
128940247|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
128940248|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
128940249|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
128940250|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
128940251|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
128940252|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
128940253|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
128940254|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
128940255|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
128940256|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
128940257|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
128940258|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
128940259|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
128978104|NCT01854918|464205317|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
129123235|NCT03620162|464745587|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
129123236|NCT03620162|464745588|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
129123237|NCT03620162|464745589|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
128769937|NCT03176238|463448297|FG000|Overall Study|Protocol Violation|1|||
128769938|NCT03176238|463448298|FG001|Overall Study|Protocol Violation|0|||
128769939|NCT03176238|463448297|FG000|Overall Study|Changes in the patient's condition|2|||
128769940|NCT03176238|463448298|FG001|Overall Study|Changes in the patient's condition|1|||
128769941|NCT03176238|463448297|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
128769942|NCT03176238|463448298|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
128769943|NCT02638623|463448300|FG000|Overall Study|Surgery timing|5|||
128769944|NCT02638623|463448301|FG001|Overall Study|Surgery timing|6|||
128769945|NCT02638623|463448300|FG000|Overall Study|Not given intervention|2|||
128769946|NCT02638623|463448301|FG001|Overall Study|Not given intervention|0|||
128769947|NCT02090634|463448302|FG000|Overall Study|Lost to Follow-up|0|||
128769948|NCT02090634|463448303|FG001|Overall Study|Lost to Follow-up|1|||
128769949|NCT02090634|463448302|FG000|Overall Study|Death|0|||
128769950|NCT02090634|463448303|FG001|Overall Study|Death|1|||
128769951|NCT02090634|463448302|FG000|Overall Study|Protocol Violation|3|||
128769952|NCT02090634|463448303|FG001|Overall Study|Protocol Violation|1|||
128769953|NCT02090634|463448302|FG000|Overall Study|Adverse Event|2|||
128769954|NCT02090634|463448303|FG001|Overall Study|Adverse Event|0|||
128769955|NCT00886639|463448306|FG000|Overall Study|acute exacerbation|14|||
128769956|NCT00886639|463448306|FG000|Overall Study|non-compliance|2|||
128769957|NCT01871558|463448307|FG000|Overall Study|Other reason|0|||
128940260|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
128940261|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
128940262|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
128940263|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
128940264|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
128940265|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
128940266|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
128940267|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
128940268|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
128940269|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
128940270|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
128940271|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
128940272|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
128940273|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
128940274|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
128940275|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
128940276|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
128940277|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
128940278|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
128940279|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
128940280|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
128940281|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
128940282|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
128940283|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
128940284|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
128940285|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
128940286|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
128940287|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
128940288|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
129217710|NCT02745119|465097045|FG002|Overall Study|Study Terminated by Sponsor|135|||
129217711|NCT02745119|465097046|FG003|Overall Study|Study Terminated by Sponsor|251|||
128769958|NCT01871558|463448308|FG001|Overall Study|Other reason|1|||
128769959|NCT01871558|463448307|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
128769960|NCT01871558|463448308|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
128769961|NCT01871558|463448307|FG000|Overall Study|Withdrawal by Subject|2|||
128769962|NCT01871558|463448308|FG001|Overall Study|Withdrawal by Subject|0|||
128769963|NCT01032044|463448314|FG000|Overall Study|Protocol Violation|14|||
128769964|NCT01032044|463448315|FG001|Overall Study|Protocol Violation|8|||
128769965|NCT01032044|463448314|FG000|Overall Study|Adverse Event|0|||
128769966|NCT01032044|463448315|FG001|Overall Study|Adverse Event|1|||
128769967|NCT01032044|463448314|FG000|Overall Study|Lost to Follow-up|11|||
128769968|NCT01032044|463448315|FG001|Overall Study|Lost to Follow-up|11|||
128769969|NCT02041923|463448316|FG000|Overall Study|Lost to Follow-up|26|||
128769970|NCT02041923|463448317|FG001|Overall Study|Lost to Follow-up|30|||
128769971|NCT00874432|463448319|FG000|Overall Study|Withdrawal by Subject|1|||
128769972|NCT00874432|463448320|FG001|Overall Study|Withdrawal by Subject|0|||
128769973|NCT00874432|463448321|FG002|Overall Study|Withdrawal by Subject|0|||
128769974|NCT00874432|463448322|FG003|Overall Study|Withdrawal by Subject|0|||
128707424|NCT00482612|463223857|FG003|Follow-up Period|Other|2|||
128707425|NCT00482612|463223854|FG000|Follow-up Period|Lack of compliance|0|||
128707426|NCT00482612|463223855|FG001|Follow-up Period|Lack of compliance|0|||
129032237|NCT02943993|464410205|FG000|Overall Study|Transfer to another institution|6|||
129032238|NCT02943993|464410205|FG000|Overall Study|Lost to Follow-up|135|||
129032239|NCT02943993|464410205|FG000|Overall Study|Death|98|||
129032240|NCT02943993|464410205|FG000|Overall Study|Other reason for premature termination|32|||
129032241|NCT02943993|464410205|FG000|Overall Study|Missing reason for termination|7|||
129032242|NCT01408888|464410209|FG000|First Intervention|Adverse Event|0|||
129032243|NCT01408888|464410210|FG001|First Intervention|Adverse Event|1|||
129032244|NCT01408888|464410209|FG000|First Intervention|Withdrawal by Subject|0|||
129032245|NCT01408888|464410210|FG001|First Intervention|Withdrawal by Subject|2|||
129032246|NCT01408888|464410209|FG000|Second Intervention|Withdrawal by Subject|1|||
129032247|NCT01408888|464410210|FG001|Second Intervention|Withdrawal by Subject|0|||
129032248|NCT01408888|464410209|FG000|Second Intervention|Adverse Event|1|||
129032249|NCT01408888|464410210|FG001|Second Intervention|Adverse Event|0|||
129032250|NCT00695110|464410213|FG000|Treatment Period 1|Adverse Event|1|||
128707427|NCT00482612|463223856|FG002|Follow-up Period|Lack of compliance|1|||
128707428|NCT00482612|463223857|FG003|Follow-up Period|Lack of compliance|0|||
128707429|NCT00482612|463223854|FG000|Follow-up Period|Lost to Follow-up|0|||
129032251|NCT00695110|464410213|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129032252|NCT00695110|464410213|FG000|Treatment Period 3|Withdrawal by Subject|1|||
129123238|NCT01682031|464745594|FG000|Overall Study|Withdrawal by Subject|0|||
129123239|NCT01682031|464745595|FG001|Overall Study|Withdrawal by Subject|1|||
129123240|NCT01682031|464745594|FG000|Overall Study|Adverse Event|0|||
129123241|NCT01682031|464745595|FG001|Overall Study|Adverse Event|2|||
129123242|NCT01682031|464745594|FG000|Overall Study|MRI results indicate increased nodul|0|||
129123243|NCT01682031|464745595|FG001|Overall Study|MRI results indicate increased nodul|1|||
129123244|NCT01682031|464745594|FG000|Overall Study|Patient could not swallow tablets|1|||
129123245|NCT01682031|464745595|FG001|Overall Study|Patient could not swallow tablets|0|||
129123246|NCT01682031|464745594|FG000|Overall Study|Patient stopped selenium on his own|0|||
129123247|NCT01682031|464745595|FG001|Overall Study|Patient stopped selenium on his own|1|||
129123248|NCT01056536|464745597|FG000|Overall Study|Lost to Follow-up|202|||
129123249|NCT01056536|464745598|FG001|Overall Study|Lost to Follow-up|116|||
129123250|NCT01056536|464745599|FG002|Overall Study|Lost to Follow-up|248|||
129123251|NCT02763566|464745600|FG000|Overall Study|Lost to Follow-up|1|||
129123252|NCT02763566|464745601|FG001|Overall Study|Lost to Follow-up|4|||
129123253|NCT02763566|464745602|FG002|Overall Study|Lost to Follow-up|0|||
129123254|NCT02763566|464745603|FG003|Overall Study|Lost to Follow-up|1|||
129123255|NCT02763566|464745600|FG000|Overall Study|On study treatment at study conclusion|114|||
129123256|NCT02763566|464745601|FG001|Overall Study|On study treatment at study conclusion|34|||
129123257|NCT02763566|464745602|FG002|Overall Study|On study treatment at study conclusion|54|||
129123258|NCT02763566|464745603|FG003|Overall Study|On study treatment at study conclusion|13|||
129123259|NCT02763566|464745600|FG000|Overall Study|Withdrawal by Subject|3|||
129123260|NCT02763566|464745601|FG001|Overall Study|Withdrawal by Subject|1|||
129123261|NCT02763566|464745602|FG002|Overall Study|Withdrawal by Subject|0|||
129123262|NCT02763566|464745603|FG003|Overall Study|Withdrawal by Subject|0|||
129123263|NCT00315445|464745604|FG000|Overall Study|Adverse Event|7|||
129123264|NCT00315445|464745605|FG001|Overall Study|Adverse Event|12|||
129123265|NCT00315445|464745606|FG002|Overall Study|Adverse Event|15|||
128707430|NCT00482612|463223855|FG001|Follow-up Period|Lost to Follow-up|4|||
128707431|NCT00482612|463223856|FG002|Follow-up Period|Lost to Follow-up|2|||
128707432|NCT00482612|463223857|FG003|Follow-up Period|Lost to Follow-up|1|||
128707433|NCT00482612|463223854|FG000|Follow-up Period|Adverse Event|4|||
128707434|NCT00482612|463223855|FG001|Follow-up Period|Adverse Event|7|||
128707435|NCT00482612|463223856|FG002|Follow-up Period|Adverse Event|9|||
129123266|NCT00315445|464745604|FG000|Overall Study|Lack of Efficacy|16|||
129123267|NCT00315445|464745605|FG001|Overall Study|Lack of Efficacy|1|||
129123268|NCT00315445|464745606|FG002|Overall Study|Lack of Efficacy|7|||
129123269|NCT00315445|464745604|FG000|Overall Study|Lost to Follow-up|1|||
129123270|NCT00315445|464745605|FG001|Overall Study|Lost to Follow-up|0|||
129123271|NCT00315445|464745606|FG002|Overall Study|Lost to Follow-up|1|||
129123272|NCT00315445|464745604|FG000|Overall Study|Protocol Violation|2|||
129123273|NCT00315445|464745605|FG001|Overall Study|Protocol Violation|0|||
129032253|NCT00695110|464410213|FG000|Treatment Period 4|Adverse Event|1|||
129032254|NCT04542694|464410214|FG000|Overall Study|The need for prohibited therapy|2|||
129032255|NCT04542694|464410215|FG001|Overall Study|The need for prohibited therapy|0|||
129032256|NCT04542694|464410214|FG000|Overall Study|Adverse Event|1|||
129123274|NCT00315445|464745606|FG002|Overall Study|Protocol Violation|1|||
128707436|NCT00482612|463223857|FG003|Follow-up Period|Adverse Event|0|||
128707437|NCT00482612|463223854|FG000|Follow-up Period|Lack of Efficacy|2|||
128707438|NCT00482612|463223855|FG001|Follow-up Period|Lack of Efficacy|0|||
129032257|NCT04542694|464410215|FG001|Overall Study|Adverse Event|0|||
129123275|NCT00315445|464745604|FG000|Overall Study|Other|1|||
129123276|NCT00315445|464745605|FG001|Overall Study|Other|3|||
129123277|NCT00315445|464745606|FG002|Overall Study|Other|0|||
129032258|NCT04542694|464410214|FG000|Overall Study|Protocol Violation|1|||
128707439|NCT00482612|463223856|FG002|Follow-up Period|Lack of Efficacy|1|||
128707440|NCT00482612|463223857|FG003|Follow-up Period|Lack of Efficacy|0|||
128707441|NCT00482612|463223854|FG000|Follow-up Period|Withdrawal by Subject|3|||
128707442|NCT00482612|463223855|FG001|Follow-up Period|Withdrawal by Subject|5|||
128707443|NCT00482612|463223856|FG002|Follow-up Period|Withdrawal by Subject|7|||
128707444|NCT00482612|463223857|FG003|Follow-up Period|Withdrawal by Subject|2|||
128707445|NCT00482612|463223854|FG000|Follow-up Period|Reasons not related to trial|1|||
128769975|NCT00874432|463448319|FG000|Overall Study|Physician Decision|1|||
128769976|NCT00874432|463448320|FG001|Overall Study|Physician Decision|0|||
128769977|NCT00874432|463448321|FG002|Overall Study|Physician Decision|0|||
128769978|NCT00874432|463448322|FG003|Overall Study|Physician Decision|0|||
128769979|NCT00874432|463448319|FG000|Overall Study|Other|1|||
128769980|NCT00874432|463448320|FG001|Overall Study|Other|2|||
128769981|NCT00874432|463448321|FG002|Overall Study|Other|8|||
128769982|NCT00874432|463448322|FG003|Overall Study|Other|3|||
128769983|NCT01167179|463450061|FG000|Overall Study|disease recurrence|4|||
128769984|NCT01167179|463450062|FG001|Overall Study|disease recurrence|4|||
128769985|NCT01167179|463450061|FG000|Overall Study|Death|4|||
128769986|NCT01167179|463450062|FG001|Overall Study|Death|10|||
128769987|NCT01167179|463450061|FG000|Overall Study|Withdrawal by Subject|1|||
128769988|NCT01167179|463450062|FG001|Overall Study|Withdrawal by Subject|2|||
128769989|NCT01167179|463450061|FG000|Overall Study|diverse|6|||
128769990|NCT01167179|463450062|FG001|Overall Study|diverse|5|||
128769991|NCT02781506|463450063|FG000|Overall Study|Adverse Event|5|||
128769992|NCT01158378|463450064|FG000|Overall Study|Death|4|||
128769993|NCT01158378|463450065|FG001|Overall Study|Death|5|||
128769994|NCT01158378|463450064|FG000|Overall Study|Lost to Follow-up|2|||
128769995|NCT01158378|463450065|FG001|Overall Study|Lost to Follow-up|4|||
128769996|NCT01158378|463450064|FG000|Overall Study|Withdrawal by Subject|4|||
128769997|NCT01158378|463450065|FG001|Overall Study|Withdrawal by Subject|0|||
128769998|NCT03017235|463450066|FG000|Overall Study|Withdrawal by Subject|4|||
128769999|NCT03017235|463450067|FG001|Overall Study|Withdrawal by Subject|3|||
128770000|NCT03017235|463450066|FG000|Overall Study|Lost to Follow-up|2|||
128770001|NCT03017235|463450067|FG001|Overall Study|Lost to Follow-up|7|||
128770002|NCT03017235|463450066|FG000|Overall Study|Adverse Event|0|||
128770003|NCT03017235|463450067|FG001|Overall Study|Adverse Event|1|||
128770004|NCT03017235|463450066|FG000|Overall Study|Protocol Violation|2|||
128770005|NCT03017235|463450067|FG001|Overall Study|Protocol Violation|1|||
128770006|NCT03017235|463450066|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
128770007|NCT03017235|463450067|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
128770008|NCT02593539|463450071|FG000|Overall Study|Adverse Event|1|||
128770009|NCT00649389|463450072|FG000|Overall Study|Adverse Event|22|||
128770010|NCT00649389|463450073|FG001|Overall Study|Adverse Event|46|||
128770011|NCT00649389|463450074|FG002|Overall Study|Adverse Event|38|||
128770012|NCT00649389|463450075|FG003|Overall Study|Adverse Event|48|||
128770013|NCT00649389|463450072|FG000|Overall Study|Lost to Follow-up|15|||
128770014|NCT00649389|463450073|FG001|Overall Study|Lost to Follow-up|17|||
128770015|NCT00649389|463450074|FG002|Overall Study|Lost to Follow-up|21|||
128770016|NCT00649389|463450075|FG003|Overall Study|Lost to Follow-up|26|||
128770017|NCT00649389|463450072|FG000|Overall Study|Protocol Violation|11|||
128770018|NCT00649389|463450073|FG001|Overall Study|Protocol Violation|13|||
128770019|NCT00649389|463450074|FG002|Overall Study|Protocol Violation|9|||
128770020|NCT00649389|463450075|FG003|Overall Study|Protocol Violation|8|||
128770021|NCT00649389|463450072|FG000|Overall Study|Withdrawal by Subject|20|||
128770022|NCT00649389|463450073|FG001|Overall Study|Withdrawal by Subject|21|||
128770023|NCT00649389|463450074|FG002|Overall Study|Withdrawal by Subject|19|||
128770024|NCT00649389|463450075|FG003|Overall Study|Withdrawal by Subject|23|||
128770025|NCT00649389|463450072|FG000|Overall Study|Other|3|||
128770026|NCT00649389|463450073|FG001|Overall Study|Other|9|||
128770027|NCT00649389|463450074|FG002|Overall Study|Other|1|||
128770028|NCT00649389|463450075|FG003|Overall Study|Other|6|||
128770029|NCT01806740|463450076|FG000|Overall Study|Withdrawal by Subject|4|||
128707446|NCT00482612|463223855|FG001|Follow-up Period|Reasons not related to trial|0|||
128770030|NCT01806740|463450076|FG000|Overall Study|Physician Decision|1|||
128707447|NCT00482612|463223856|FG002|Follow-up Period|Reasons not related to trial|1|||
128707448|NCT00482612|463223857|FG003|Follow-up Period|Reasons not related to trial|3|||
128770031|NCT01806740|463450076|FG000|Overall Study|Patient's refusal of treatment|1|||
128770032|NCT02105636|463450083|FG000|Pre-Treatment|Disease Progression|1|||
128770033|NCT02105636|463450084|FG001|Pre-Treatment|Disease Progression|0|||
128770034|NCT02105636|463450083|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
128770035|NCT02105636|463450084|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
128770036|NCT02105636|463450083|FG000|Pre-Treatment|Participant withdrew consent|0|||
128770037|NCT02105636|463450084|FG001|Pre-Treatment|Participant withdrew consent|6|||
128770038|NCT02105636|463450083|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
128770039|NCT02105636|463450084|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
128770040|NCT02105636|463450083|FG000|Treatment|Study Drug Toxicity|14|||
128770041|NCT02105636|463450084|FG001|Treatment|Study Drug Toxicity|10|||
128770042|NCT02105636|463450083|FG000|Treatment|Adverse event unrelated to study drug|19|||
128770043|NCT02105636|463450084|FG001|Treatment|Adverse event unrelated to study drug|3|||
128770044|NCT02105636|463450083|FG000|Treatment|Participant request to discontinue study treatment|8|||
128770045|NCT02105636|463450084|FG001|Treatment|Participant request to discontinue study treatment|6|||
128770046|NCT02105636|463450083|FG000|Treatment|Participant withdrew consent|5|||
128770047|NCT02105636|463450084|FG001|Treatment|Participant withdrew consent|1|||
128770048|NCT02105636|463450083|FG000|Treatment|Lost to Follow-up|1|||
128940289|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
128940290|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
128940291|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
128940292|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
128940293|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
128940294|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
128940295|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
128940296|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
128940297|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
128940298|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
128940299|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
128940300|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
128940301|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
128940302|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
128940303|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
128940304|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
128940305|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
128940306|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
128940307|NCT03395197|464069539|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
128940308|NCT03395197|464069540|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
128940309|NCT03395197|464069541|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
129032259|NCT04542694|464410215|FG001|Overall Study|Protocol Violation|0|||
129032260|NCT00969124|464410218|FG000|Overall Study|Protocol Violation|2|||
129032261|NCT00969124|464410218|FG000|Overall Study|Inadequate bowel preparation|15|||
128770049|NCT02105636|463450084|FG001|Treatment|Lost to Follow-up|0|||
128770050|NCT02105636|463450083|FG000|Treatment|Maximum Clinical Benefit|1|||
128770051|NCT02105636|463450084|FG001|Treatment|Maximum Clinical Benefit|3|||
128770052|NCT02105636|463450083|FG000|Treatment|Poor/Non-compliance|0|||
128770053|NCT02105636|463450084|FG001|Treatment|Poor/Non-compliance|1|||
128770054|NCT02105636|463450083|FG000|Treatment|Participant no longer meets study criteria|1|||
128770055|NCT02105636|463450084|FG001|Treatment|Participant no longer meets study criteria|0|||
128770056|NCT02105636|463450083|FG000|Treatment|Other reasons|1|||
128770057|NCT02105636|463450084|FG001|Treatment|Other reasons|0|||
129032262|NCT00969124|464410218|FG000|Overall Study|Inability to reach cecum|9|||
128770058|NCT02105636|463450083|FG000|Treatment|Disease Progression|185|||
128770059|NCT02105636|463450084|FG001|Treatment|Disease Progression|87|||
129032263|NCT00969124|464410218|FG000|Overall Study|Previously unrecognized disease|3|||
128770060|NCT00592319|463450086|FG000|Overall Study|Lost to Follow-up|0|||
128770061|NCT00592319|463450087|FG001|Overall Study|Lost to Follow-up|3|||
128770062|NCT00003511|463450091|FG000|Overall Study|Not evaluable|4|||
128770063|NCT00312858|463450093|FG000|Overall Study|Adverse Event|0|||
128770064|NCT00312858|463450094|FG001|Overall Study|Adverse Event|1|||
128770065|NCT00312858|463450093|FG000|Overall Study|Lost to Follow-up|25|||
128770066|NCT00312858|463450094|FG001|Overall Study|Lost to Follow-up|42|||
128770067|NCT00312858|463450093|FG000|Overall Study|Protocol Violation|3|||
128770068|NCT00312858|463450094|FG001|Overall Study|Protocol Violation|8|||
129032264|NCT00969124|464410218|FG000|Overall Study|Technical error|1|||
129032265|NCT02167594|464410219|FG000|Overall Study|Withdrawal by Subject|2|||
129032266|NCT02167594|464410220|FG001|Overall Study|Withdrawal by Subject|0|||
128770069|NCT00312858|463450093|FG000|Overall Study|Withdraw by Participant|20|||
128770070|NCT00312858|463450094|FG001|Overall Study|Withdraw by Participant|20|||
128770071|NCT00312858|463450093|FG000|Overall Study|Participant Moved|11|||
128770072|NCT00312858|463450094|FG001|Overall Study|Participant Moved|10|||
128770073|NCT00312858|463450093|FG000|Overall Study|Other|9|||
128770074|NCT00312858|463450094|FG001|Overall Study|Other|12|||
128770075|NCT00802659|463450095|FG000|Overall Study|Physician Decision|0|||
128770076|NCT00802659|463450096|FG001|Overall Study|Physician Decision|1|||
128770077|NCT00802659|463450097|FG002|Overall Study|Physician Decision|0|||
128770078|NCT00802659|463450098|FG003|Overall Study|Physician Decision|0|||
128770079|NCT05340751|463450101|FG000|Overall Study|Physician Decision|3|||
128770080|NCT04399551|463450102|FG000|Overall Study|Adverse Event|15|||
128770081|NCT04399551|463450102|FG000|Overall Study|Withdrawal by Subject|6|||
128770082|NCT04399551|463450102|FG000|Overall Study|Physician Decision|3|||
128770083|NCT04399551|463450102|FG000|Overall Study|Lost to Follow-up|2|||
128770084|NCT04399551|463450102|FG000|Overall Study|Protocol Deviation|2|||
128770085|NCT01336634|463450103|FG000|Overall Study|Study closed/terminated|5|||
128770086|NCT01336634|463450104|FG001|Overall Study|Study closed/terminated|6|||
129032267|NCT02167594|464410221|FG002|Overall Study|Withdrawal by Subject|0|||
129032268|NCT02167594|464410219|FG000|Overall Study|Death|0|||
129032269|NCT02167594|464410220|FG001|Overall Study|Death|1|||
129032270|NCT02167594|464410221|FG002|Overall Study|Death|0|||
129032271|NCT01583530|464410224|FG000|Overall Study|Adverse Event|0|||
129032272|NCT01583530|464410225|FG001|Overall Study|Adverse Event|0|||
129032273|NCT01583530|464410226|FG002|Overall Study|Adverse Event|0|||
129032274|NCT01583530|464410227|FG003|Overall Study|Adverse Event|0|||
129032275|NCT01583530|464410228|FG004|Overall Study|Adverse Event|0|||
129032276|NCT01583530|464410229|FG005|Overall Study|Adverse Event|1|||
129032277|NCT01583530|464410224|FG000|Overall Study|Withdrawal by Subject|0|||
129032278|NCT01583530|464410225|FG001|Overall Study|Withdrawal by Subject|3|||
129032279|NCT01583530|464410226|FG002|Overall Study|Withdrawal by Subject|0|||
129032280|NCT01583530|464410227|FG003|Overall Study|Withdrawal by Subject|1|||
129032281|NCT01583530|464410228|FG004|Overall Study|Withdrawal by Subject|1|||
129032282|NCT01583530|464410229|FG005|Overall Study|Withdrawal by Subject|2|||
129032283|NCT01583530|464410224|FG000|Overall Study|Lost to Follow-up|0|||
129032284|NCT01583530|464410225|FG001|Overall Study|Lost to Follow-up|0|||
129032285|NCT01583530|464410226|FG002|Overall Study|Lost to Follow-up|0|||
129032286|NCT01583530|464410227|FG003|Overall Study|Lost to Follow-up|0|||
129032287|NCT01583530|464410228|FG004|Overall Study|Lost to Follow-up|3|||
129032288|NCT01583530|464410229|FG005|Overall Study|Lost to Follow-up|0|||
129032289|NCT01583530|464410224|FG000|Overall Study|Lack of compliance|0|||
129032290|NCT01583530|464410225|FG001|Overall Study|Lack of compliance|0|||
129032291|NCT01583530|464410226|FG002|Overall Study|Lack of compliance|0|||
129032292|NCT01583530|464410227|FG003|Overall Study|Lack of compliance|0|||
129032293|NCT01583530|464410228|FG004|Overall Study|Lack of compliance|1|||
129032294|NCT01583530|464410229|FG005|Overall Study|Lack of compliance|0|||
129032295|NCT01332968|464410232|FG000|Induction Period|Adverse Event|23|||
129032296|NCT01332968|464410233|FG001|Induction Period|Adverse Event|26|||
129032297|NCT01332968|464410234|FG002|Induction Period|Adverse Event|0|||
129032298|NCT01332968|464410235|FG003|Induction Period|Adverse Event|0|||
129032299|NCT01332968|464410236|FG004|Induction Period|Adverse Event|0|||
129032300|NCT01332968|464410237|FG005|Induction Period|Adverse Event|0|||
129032301|NCT01332968|464410238|FG006|Induction Period|Adverse Event|0|||
129032302|NCT01332968|464410239|FG007|Induction Period|Adverse Event|0|||
129032303|NCT01332968|464410232|FG000|Induction Period|Death|1|||
129032304|NCT01332968|464410233|FG001|Induction Period|Death|4|||
129032305|NCT01332968|464410234|FG002|Induction Period|Death|0|||
129032306|NCT01332968|464410235|FG003|Induction Period|Death|0|||
129032307|NCT01332968|464410236|FG004|Induction Period|Death|0|||
129032308|NCT01332968|464410237|FG005|Induction Period|Death|0|||
129032309|NCT01332968|464410238|FG006|Induction Period|Death|0|||
129032310|NCT01332968|464410239|FG007|Induction Period|Death|0|||
129032311|NCT01332968|464410232|FG000|Induction Period|Non-compliance|1|||
129032312|NCT01332968|464410233|FG001|Induction Period|Non-compliance|0|||
129032313|NCT01332968|464410234|FG002|Induction Period|Non-compliance|0|||
129032314|NCT01332968|464410235|FG003|Induction Period|Non-compliance|0|||
129032315|NCT01332968|464410236|FG004|Induction Period|Non-compliance|0|||
129032316|NCT01332968|464410237|FG005|Induction Period|Non-compliance|0|||
129032317|NCT01332968|464410238|FG006|Induction Period|Non-compliance|0|||
129032318|NCT01332968|464410239|FG007|Induction Period|Non-compliance|0|||
129032319|NCT01332968|464410232|FG000|Induction Period|Other|2|||
129032320|NCT01332968|464410233|FG001|Induction Period|Other|2|||
129032321|NCT01332968|464410234|FG002|Induction Period|Other|0|||
129032322|NCT01332968|464410235|FG003|Induction Period|Other|0|||
129032323|NCT01332968|464410236|FG004|Induction Period|Other|0|||
129032324|NCT01332968|464410237|FG005|Induction Period|Other|0|||
129032325|NCT01332968|464410238|FG006|Induction Period|Other|0|||
129032326|NCT01332968|464410239|FG007|Induction Period|Other|0|||
129032327|NCT01332968|464410232|FG000|Induction Period|Physician Decision|6|||
129032328|NCT01332968|464410233|FG001|Induction Period|Physician Decision|1|||
129032329|NCT01332968|464410234|FG002|Induction Period|Physician Decision|0|||
129032330|NCT01332968|464410235|FG003|Induction Period|Physician Decision|0|||
129032331|NCT01332968|464410236|FG004|Induction Period|Physician Decision|0|||
129032332|NCT01332968|464410237|FG005|Induction Period|Physician Decision|0|||
129032333|NCT01332968|464410238|FG006|Induction Period|Physician Decision|0|||
129032334|NCT01332968|464410239|FG007|Induction Period|Physician Decision|0|||
129032335|NCT01332968|464410232|FG000|Induction Period|Progressive Disease|15|||
129032336|NCT01332968|464410233|FG001|Induction Period|Progressive Disease|7|||
129032337|NCT01332968|464410234|FG002|Induction Period|Progressive Disease|0|||
129032338|NCT01332968|464410235|FG003|Induction Period|Progressive Disease|0|||
129032339|NCT01332968|464410236|FG004|Induction Period|Progressive Disease|0|||
129032340|NCT01332968|464410237|FG005|Induction Period|Progressive Disease|0|||
129032341|NCT01332968|464410238|FG006|Induction Period|Progressive Disease|0|||
129032342|NCT01332968|464410239|FG007|Induction Period|Progressive Disease|0|||
129032343|NCT01332968|464410232|FG000|Induction Period|Protocol Violation|3|||
129032344|NCT01332968|464410233|FG001|Induction Period|Protocol Violation|4|||
129032345|NCT01332968|464410234|FG002|Induction Period|Protocol Violation|0|||
129032346|NCT01332968|464410235|FG003|Induction Period|Protocol Violation|0|||
129123278|NCT01101178|464745609|FG000|Period 1|Withdrawal by Subject|1|||
128707449|NCT01366521|463223858|FG000|Overall Study|Adverse Event|1|||
128770087|NCT01336634|463450105|FG002|Overall Study|Study closed/terminated|6|||
128770088|NCT01336634|463450103|FG000|Overall Study|Lost to Follow-up|2|||
128770089|NCT01336634|463450104|FG001|Overall Study|Lost to Follow-up|1|||
128770090|NCT01336634|463450105|FG002|Overall Study|Lost to Follow-up|1|||
128707450|NCT01366521|463223859|FG001|Overall Study|Adverse Event|0|||
128707451|NCT01366521|463223860|FG002|Overall Study|Adverse Event|0|||
128707452|NCT01366521|463223861|FG003|Overall Study|Adverse Event|0|||
128707453|NCT01366521|463223858|FG000|Overall Study|Protocol Violation|0|||
128707454|NCT01366521|463223859|FG001|Overall Study|Protocol Violation|0|||
128707455|NCT01366521|463223860|FG002|Overall Study|Protocol Violation|1|||
128707456|NCT01366521|463223861|FG003|Overall Study|Protocol Violation|0|||
128707457|NCT01366521|463223858|FG000|Overall Study|Physician Decision|0|||
128707458|NCT01366521|463223859|FG001|Overall Study|Physician Decision|0|||
128707459|NCT01366521|463223860|FG002|Overall Study|Physician Decision|1|||
128707460|NCT01366521|463223861|FG003|Overall Study|Physician Decision|0|||
128707461|NCT01366521|463223858|FG000|Overall Study|Withdrawal by Subject|0|||
128707462|NCT01366521|463223859|FG001|Overall Study|Withdrawal by Subject|1|||
128707463|NCT01366521|463223860|FG002|Overall Study|Withdrawal by Subject|0|||
128707464|NCT01366521|463223861|FG003|Overall Study|Withdrawal by Subject|0|||
128707465|NCT00660023|463223862|FG000|Overall Study|Adverse Event|2|||
128707466|NCT00660023|463223862|FG000|Overall Study|Death|8|||
128707467|NCT00660023|463223862|FG000|Overall Study|Blood Transfusion|5|||
128707468|NCT00660023|463223862|FG000|Overall Study|Renal Transplantation|3|||
128707469|NCT00660023|463223862|FG000|Overall Study|Withdrawal by Subject|1|||
128707470|NCT00660023|463223862|FG000|Overall Study|Missed Pregnancy Test|1|||
128707471|NCT00660023|463223862|FG000|Overall Study|Other Screening Failure|9|||
128707472|NCT00684307|463223863|FG000|Overall Study|Adverse Event|11|||
128707473|NCT00684307|463223864|FG001|Overall Study|Adverse Event|6|||
128707474|NCT00684307|463223865|FG002|Overall Study|Adverse Event|15|||
128770091|NCT01336634|463450103|FG000|Overall Study|Physician Decision|1|||
128770092|NCT01336634|463450104|FG001|Overall Study|Physician Decision|1|||
128770093|NCT01336634|463450105|FG002|Overall Study|Physician Decision|0|||
128770094|NCT01336634|463450103|FG000|Overall Study|Withdrawal by Subject|6|||
128770095|NCT01336634|463450104|FG001|Overall Study|Withdrawal by Subject|0|||
128770096|NCT01336634|463450105|FG002|Overall Study|Withdrawal by Subject|2|||
128770097|NCT01863043|463450106|FG000|Overall Study|Death|6|||
128770098|NCT01863043|463450107|FG001|Overall Study|Death|1|||
128770099|NCT01863043|463450106|FG000|Overall Study|Withdrawal by Subject|0|||
128770100|NCT01863043|463450107|FG001|Overall Study|Withdrawal by Subject|2|||
128770101|NCT01863043|463450106|FG000|Overall Study|Adverse Event|7|||
128770102|NCT01863043|463450107|FG001|Overall Study|Adverse Event|8|||
128770103|NCT01863043|463450106|FG000|Overall Study|exclusion criteria found after enrollment|0|||
128770104|NCT01863043|463450107|FG001|Overall Study|exclusion criteria found after enrollment|1|||
128770105|NCT04537897|463450108|FG000|Overall Study|Other than listed|0|||
128770106|NCT04537897|463450109|FG001|Overall Study|Other than listed|0|||
128770107|NCT04537897|463450110|FG002|Overall Study|Other than listed|0|||
128770108|NCT04537897|463450111|FG003|Overall Study|Other than listed|0|||
128770109|NCT04537897|463450112|FG004|Overall Study|Other than listed|0|||
128770110|NCT04537897|463450113|FG005|Overall Study|Other than listed|0|||
128770111|NCT04537897|463450114|FG006|Overall Study|Other than listed|1|||
128770112|NCT04537897|463450115|FG007|Overall Study|Other than listed|0|||
128770113|NCT04537897|463450116|FG008|Overall Study|Other than listed|0|||
128770114|NCT04537897|463450108|FG000|Overall Study|Adverse Event|0|||
128770115|NCT04537897|463450109|FG001|Overall Study|Adverse Event|0|||
128770116|NCT04537897|463450110|FG002|Overall Study|Adverse Event|0|||
128770117|NCT04537897|463450111|FG003|Overall Study|Adverse Event|1|||
128770118|NCT04537897|463450112|FG004|Overall Study|Adverse Event|0|||
128770119|NCT04537897|463450113|FG005|Overall Study|Adverse Event|0|||
128770120|NCT04537897|463450114|FG006|Overall Study|Adverse Event|0|||
128770121|NCT04537897|463450115|FG007|Overall Study|Adverse Event|0|||
129032347|NCT01332968|464410236|FG004|Induction Period|Protocol Violation|0|||
129032348|NCT01332968|464410237|FG005|Induction Period|Protocol Violation|0|||
129032349|NCT01332968|464410238|FG006|Induction Period|Protocol Violation|0|||
129032350|NCT01332968|464410239|FG007|Induction Period|Protocol Violation|0|||
129032351|NCT01332968|464410232|FG000|Induction Period|Withdrawal by Subject|3|||
128707475|NCT00684307|463223866|FG003|Overall Study|Adverse Event|16|||
128707476|NCT00684307|463223867|FG004|Overall Study|Adverse Event|8|||
128707477|NCT00684307|463223863|FG000|Overall Study|Development of increasing Liver Function|0|||
128707478|NCT00684307|463223864|FG001|Overall Study|Development of increasing Liver Function|2|||
128707479|NCT00684307|463223865|FG002|Overall Study|Development of increasing Liver Function|0|||
128770122|NCT04537897|463450116|FG008|Overall Study|Adverse Event|0|||
128770123|NCT04537897|463450108|FG000|Overall Study|Withdrawal by Subject|0|||
128770124|NCT04537897|463450109|FG001|Overall Study|Withdrawal by Subject|1|||
128770125|NCT04537897|463450110|FG002|Overall Study|Withdrawal by Subject|0|||
128770126|NCT04537897|463450111|FG003|Overall Study|Withdrawal by Subject|0|||
128770127|NCT04537897|463450112|FG004|Overall Study|Withdrawal by Subject|0|||
128707480|NCT00684307|463223866|FG003|Overall Study|Development of increasing Liver Function|1|||
129032352|NCT01332968|464410233|FG001|Induction Period|Withdrawal by Subject|5|||
129032353|NCT01332968|464410234|FG002|Induction Period|Withdrawal by Subject|0|||
129032354|NCT01332968|464410235|FG003|Induction Period|Withdrawal by Subject|0|||
129032355|NCT01332968|464410236|FG004|Induction Period|Withdrawal by Subject|0|||
129032356|NCT01332968|464410237|FG005|Induction Period|Withdrawal by Subject|0|||
129032357|NCT01332968|464410238|FG006|Induction Period|Withdrawal by Subject|0|||
129032358|NCT01332968|464410239|FG007|Induction Period|Withdrawal by Subject|0|||
129032359|NCT01332968|464410232|FG000|Induction Period|Randomised but not treated|4|||
129032360|NCT01332968|464410233|FG001|Induction Period|Randomised but not treated|7|||
129032361|NCT01332968|464410234|FG002|Induction Period|Randomised but not treated|0|||
129032362|NCT01332968|464410235|FG003|Induction Period|Randomised but not treated|0|||
129032363|NCT01332968|464410236|FG004|Induction Period|Randomised but not treated|0|||
129032364|NCT01332968|464410237|FG005|Induction Period|Randomised but not treated|0|||
129032365|NCT01332968|464410238|FG006|Induction Period|Randomised but not treated|0|||
129032366|NCT01332968|464410239|FG007|Induction Period|Randomised but not treated|0|||
129032367|NCT01332968|464410232|FG000|Maintenance/Observation Period|Adverse Event|0|||
129032368|NCT01332968|464410233|FG001|Maintenance/Observation Period|Adverse Event|0|||
129032369|NCT01332968|464410234|FG002|Maintenance/Observation Period|Adverse Event|53|||
129032370|NCT01332968|464410235|FG003|Maintenance/Observation Period|Adverse Event|66|||
129032371|NCT01332968|464410236|FG004|Maintenance/Observation Period|Adverse Event|0|||
129032372|NCT01332968|464410237|FG005|Maintenance/Observation Period|Adverse Event|0|||
129032373|NCT01332968|464410238|FG006|Maintenance/Observation Period|Adverse Event|0|||
129032374|NCT01332968|464410239|FG007|Maintenance/Observation Period|Adverse Event|0|||
129032375|NCT01332968|464410232|FG000|Maintenance/Observation Period|Death|0|||
129032376|NCT01332968|464410233|FG001|Maintenance/Observation Period|Death|0|||
129032377|NCT01332968|464410234|FG002|Maintenance/Observation Period|Death|5|||
129032378|NCT01332968|464410235|FG003|Maintenance/Observation Period|Death|6|||
129032379|NCT01332968|464410236|FG004|Maintenance/Observation Period|Death|0|||
129032380|NCT01332968|464410237|FG005|Maintenance/Observation Period|Death|0|||
129032381|NCT01332968|464410238|FG006|Maintenance/Observation Period|Death|0|||
129032382|NCT01332968|464410239|FG007|Maintenance/Observation Period|Death|0|||
129032383|NCT01332968|464410232|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
128707481|NCT00684307|463223867|FG004|Overall Study|Development of increasing Liver Function|0|||
128707482|NCT00684307|463223863|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
128707483|NCT00684307|463223864|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
128707484|NCT00684307|463223865|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
128707485|NCT00684307|463223866|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
128707486|NCT00684307|463223867|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
128707487|NCT00684307|463223863|FG000|Overall Study|Incorrect enrolment or randomization|4|||
129032384|NCT01332968|464410233|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
129032385|NCT01332968|464410234|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
129032386|NCT01332968|464410235|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
129032387|NCT01332968|464410236|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
129032388|NCT01332968|464410237|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
129032389|NCT01332968|464410238|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
129032390|NCT01332968|464410239|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
129032391|NCT01332968|464410232|FG000|Maintenance/Observation Period|Non-compliance|0|||
129032392|NCT01332968|464410233|FG001|Maintenance/Observation Period|Non-compliance|0|||
129032393|NCT01332968|464410234|FG002|Maintenance/Observation Period|Non-compliance|4|||
129032394|NCT01332968|464410235|FG003|Maintenance/Observation Period|Non-compliance|3|||
129032395|NCT01332968|464410236|FG004|Maintenance/Observation Period|Non-compliance|0|||
129032396|NCT01332968|464410237|FG005|Maintenance/Observation Period|Non-compliance|0|||
129032397|NCT01332968|464410238|FG006|Maintenance/Observation Period|Non-compliance|0|||
129032398|NCT01332968|464410239|FG007|Maintenance/Observation Period|Non-compliance|0|||
129032399|NCT01332968|464410232|FG000|Maintenance/Observation Period|Other|0|||
129032400|NCT01332968|464410233|FG001|Maintenance/Observation Period|Other|0|||
129032401|NCT01332968|464410234|FG002|Maintenance/Observation Period|Other|4|||
129032402|NCT01332968|464410235|FG003|Maintenance/Observation Period|Other|7|||
129032403|NCT01332968|464410236|FG004|Maintenance/Observation Period|Other|0|||
129032404|NCT01332968|464410237|FG005|Maintenance/Observation Period|Other|0|||
129032405|NCT01332968|464410238|FG006|Maintenance/Observation Period|Other|0|||
129032406|NCT01332968|464410239|FG007|Maintenance/Observation Period|Other|0|||
129032407|NCT01332968|464410232|FG000|Maintenance/Observation Period|Physician Decision|0|||
129032408|NCT01332968|464410233|FG001|Maintenance/Observation Period|Physician Decision|0|||
129032409|NCT01332968|464410234|FG002|Maintenance/Observation Period|Physician Decision|14|||
129032410|NCT01332968|464410235|FG003|Maintenance/Observation Period|Physician Decision|19|||
129032411|NCT01332968|464410236|FG004|Maintenance/Observation Period|Physician Decision|0|||
129032412|NCT01332968|464410237|FG005|Maintenance/Observation Period|Physician Decision|1|||
129032413|NCT01332968|464410238|FG006|Maintenance/Observation Period|Physician Decision|0|||
129032414|NCT01332968|464410239|FG007|Maintenance/Observation Period|Physician Decision|0|||
129032415|NCT01332968|464410232|FG000|Maintenance/Observation Period|Progressive Disease|0|||
128770128|NCT04537897|463450113|FG005|Overall Study|Withdrawal by Subject|0|||
128770129|NCT04537897|463450114|FG006|Overall Study|Withdrawal by Subject|0|||
128770130|NCT04537897|463450115|FG007|Overall Study|Withdrawal by Subject|0|||
128770131|NCT04537897|463450116|FG008|Overall Study|Withdrawal by Subject|0|||
128770132|NCT00197028|463450120|FG000|Overall Study|Adverse Event|2|||
128770133|NCT00197028|463450121|FG001|Overall Study|Adverse Event|2|||
128770134|NCT00197028|463450120|FG000|Overall Study|Protocol Violation|2|||
128770135|NCT00197028|463450121|FG001|Overall Study|Protocol Violation|1|||
128770136|NCT00197028|463450120|FG000|Overall Study|Withdrawal by Subject|8|||
128770137|NCT00197028|463450121|FG001|Overall Study|Withdrawal by Subject|12|||
128770138|NCT00197028|463450120|FG000|Overall Study|Lost to Follow-up|1|||
128770139|NCT00197028|463450121|FG001|Overall Study|Lost to Follow-up|0|||
128770140|NCT00197028|463450120|FG000|Overall Study|Other|3|||
128770141|NCT00197028|463450121|FG001|Overall Study|Other|6|||
128770142|NCT00885352|463450126|FG000|Overall Study|Adverse Event|2|||
128770143|NCT00885352|463450127|FG001|Overall Study|Adverse Event|3|||
128770144|NCT00885352|463450126|FG000|Overall Study|Lost to Follow-up|2|||
128770145|NCT00885352|463450127|FG001|Overall Study|Lost to Follow-up|2|||
128770146|NCT00885352|463450126|FG000|Overall Study|Physician Decision|0|||
128770147|NCT00885352|463450127|FG001|Overall Study|Physician Decision|3|||
128770148|NCT00885352|463450126|FG000|Overall Study|Protocol Violation|0|||
128770149|NCT00885352|463450127|FG001|Overall Study|Protocol Violation|2|||
128770150|NCT00885352|463450126|FG000|Overall Study|Withdrawal by Subject|1|||
128770151|NCT00885352|463450127|FG001|Overall Study|Withdrawal by Subject|5|||
128770152|NCT00885352|463450126|FG000|Overall Study|Contradiction to study medication|0|||
128770153|NCT00885352|463450127|FG001|Overall Study|Contradiction to study medication|2|||
128770154|NCT00885352|463450126|FG000|Overall Study|Excluded medication|2|||
128770155|NCT00885352|463450127|FG001|Overall Study|Excluded medication|2|||
128770156|NCT00885352|463450126|FG000|Overall Study|Lab abnormalities|1|||
128770157|NCT00885352|463450127|FG001|Overall Study|Lab abnormalities|1|||
128770158|NCT04161807|463450133|FG000|Overall Study|Withdrawal by Subject|2|||
128770159|NCT04161807|463450133|FG000|Overall Study|Performed only 1 treatment|2|||
128770160|NCT03292146|463450138|FG000|Baseline to 12 Months|Relocation|1|||
128770161|NCT03292146|463450139|FG001|Baseline to 12 Months|Relocation|0|||
128770162|NCT03292146|463450138|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
128770163|NCT03292146|463450139|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
128770164|NCT03292146|463450138|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
128770165|NCT03292146|463450139|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
128770166|NCT03292146|463450138|FG000|12 Months to 24 Months|Planning pregnancy|2|||
128770167|NCT03292146|463450139|FG001|12 Months to 24 Months|Planning pregnancy|2|||
128770168|NCT03292146|463450138|FG000|12 Months to 24 Months|Personal reasons|1|||
128770169|NCT03292146|463450139|FG001|12 Months to 24 Months|Personal reasons|0|||
128770170|NCT03292146|463450138|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
128770171|NCT03292146|463450139|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
128770172|NCT00545363|463450142|FG000|Overall Study|Adverse Event|6|||
128770173|NCT00545363|463450143|FG001|Overall Study|Adverse Event|7|||
128770174|NCT00545363|463450142|FG000|Overall Study|Withdrawal by Subject|6|||
128770175|NCT00545363|463450143|FG001|Overall Study|Withdrawal by Subject|5|||
128770176|NCT00545363|463450142|FG000|Overall Study|Non-compliance|3|||
128770177|NCT00545363|463450143|FG001|Overall Study|Non-compliance|1|||
128770178|NCT00545363|463450142|FG000|Overall Study|Did not meet entry criteria|1|||
128770179|NCT00545363|463450143|FG001|Overall Study|Did not meet entry criteria|1|||
128770180|NCT00545363|463450142|FG000|Overall Study|Lost to Follow-up|2|||
128770181|NCT00545363|463450143|FG001|Overall Study|Lost to Follow-up|0|||
128770182|NCT00545363|463450142|FG000|Overall Study|Other|1|||
128770183|NCT00545363|463450143|FG001|Overall Study|Other|1|||
128770184|NCT01372605|463450144|FG000|Overall Study|Death|1|||
128770185|NCT01372605|463450145|FG001|Overall Study|Death|2|||
128770186|NCT01372605|463450144|FG000|Overall Study|Lost to Follow-up|2|||
128770187|NCT01372605|463450145|FG001|Overall Study|Lost to Follow-up|1|||
128770188|NCT01372605|463450144|FG000|Overall Study|Withdrawal by Subject|4|||
129032416|NCT01332968|464410233|FG001|Maintenance/Observation Period|Progressive Disease|0|||
129032417|NCT01332968|464410234|FG002|Maintenance/Observation Period|Progressive Disease|72|||
129123279|NCT01101178|464745610|FG001|Period 1|Withdrawal by Subject|2|||
128770189|NCT01372605|463450145|FG001|Overall Study|Withdrawal by Subject|7|||
128770190|NCT01372605|463450144|FG000|Overall Study|Moved|3|||
128770191|NCT01372605|463450145|FG001|Overall Study|Moved|0|||
128770192|NCT01372605|463450144|FG000|Overall Study|Changed medical home|2|||
128770193|NCT01372605|463450145|FG001|Overall Study|Changed medical home|0|||
128770194|NCT00951509|463450146|FG000|Overall Study|Withdrawal by Subject|2|||
128770195|NCT04362137|463450149|FG000|Overall Study|Death|9|||
128770196|NCT04362137|463450150|FG001|Overall Study|Death|3|||
128770197|NCT04362137|463450149|FG000|Overall Study|Patient decision|6|||
128770198|NCT04362137|463450150|FG001|Overall Study|Patient decision|3|||
128770199|NCT04362137|463450149|FG000|Overall Study|Adverse Event|1|||
128770200|NCT04362137|463450150|FG001|Overall Study|Adverse Event|0|||
128770201|NCT04362137|463450149|FG000|Overall Study|Lost to Follow-up|1|||
128770202|NCT04362137|463450150|FG001|Overall Study|Lost to Follow-up|0|||
128707488|NCT00684307|463223864|FG001|Overall Study|Incorrect enrolment or randomization|0|||
128707489|NCT00684307|463223865|FG002|Overall Study|Incorrect enrolment or randomization|0|||
128940310|NCT03395197|464069542|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
128940311|NCT03395197|464069543|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
128940312|NCT03395197|464069544|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
128940313|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Death|0|||
128940314|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Death|0|||
128940315|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Death|0|||
128940316|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Death|0|||
128940317|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Death|1|||
128940318|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Death|4|||
128940319|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
128940320|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
128940321|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
128940322|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
128940323|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
128940324|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
128940325|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
128940326|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
128940327|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
128940328|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
128940329|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
128940330|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
128940331|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
129217712|NCT02745119|465097043|FG000|Overall Study|Physician Decision|0|||
129217713|NCT02745119|465097044|FG001|Overall Study|Physician Decision|2|||
128707490|NCT00684307|463223866|FG003|Overall Study|Incorrect enrolment or randomization|0|||
128707491|NCT00684307|463223867|FG004|Overall Study|Incorrect enrolment or randomization|0|||
128707492|NCT00684307|463223863|FG000|Overall Study|Interupted IP for more than 7 days|0|||
128707493|NCT00684307|463223864|FG001|Overall Study|Interupted IP for more than 7 days|4|||
128707494|NCT00684307|463223865|FG002|Overall Study|Interupted IP for more than 7 days|1|||
128707495|NCT00684307|463223866|FG003|Overall Study|Interupted IP for more than 7 days|3|||
128707496|NCT00684307|463223867|FG004|Overall Study|Interupted IP for more than 7 days|3|||
128707497|NCT00684307|463223863|FG000|Overall Study|Severe non compliance to protocol|1|||
128707498|NCT00684307|463223864|FG001|Overall Study|Severe non compliance to protocol|0|||
128707499|NCT00684307|463223865|FG002|Overall Study|Severe non compliance to protocol|0|||
128707500|NCT00684307|463223866|FG003|Overall Study|Severe non compliance to protocol|1|||
128707501|NCT00684307|463223867|FG004|Overall Study|Severe non compliance to protocol|2|||
128707502|NCT00684307|463223863|FG000|Overall Study|Participant not willing to continue|7|||
128707503|NCT00684307|463223864|FG001|Overall Study|Participant not willing to continue|10|||
128707504|NCT00684307|463223865|FG002|Overall Study|Participant not willing to continue|11|||
128707505|NCT00684307|463223866|FG003|Overall Study|Participant not willing to continue|5|||
128707506|NCT00684307|463223867|FG004|Overall Study|Participant not willing to continue|8|||
128707507|NCT00684307|463223863|FG000|Overall Study|Criteria from the CSR|0|||
128707508|NCT00684307|463223864|FG001|Overall Study|Criteria from the CSR|0|||
128707509|NCT00684307|463223865|FG002|Overall Study|Criteria from the CSR|1|||
128707510|NCT00684307|463223866|FG003|Overall Study|Criteria from the CSR|3|||
128707511|NCT00684307|463223867|FG004|Overall Study|Criteria from the CSR|3|||
128707512|NCT04180488|463223868|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
128707513|NCT04180488|463223869|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
128707514|NCT04180488|463223870|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
128707515|NCT04180488|463223871|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
128707516|NCT04180488|463223872|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
128707517|NCT04180488|463223873|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
128707518|NCT04180488|463223868|FG000|Overall Study|Withdrawal by Subject|8|||
128707519|NCT04180488|463223869|FG001|Overall Study|Withdrawal by Subject|4|||
128707520|NCT04180488|463223870|FG002|Overall Study|Withdrawal by Subject|5|||
128707521|NCT04180488|463223871|FG003|Overall Study|Withdrawal by Subject|2|||
128707522|NCT04180488|463223872|FG004|Overall Study|Withdrawal by Subject|8|||
128707523|NCT04180488|463223873|FG005|Overall Study|Withdrawal by Subject|6|||
128707524|NCT04180488|463223868|FG000|Overall Study|Adverse Event|3|||
128707525|NCT04180488|463223869|FG001|Overall Study|Adverse Event|2|||
128707526|NCT04180488|463223870|FG002|Overall Study|Adverse Event|0|||
128707527|NCT04180488|463223871|FG003|Overall Study|Adverse Event|0|||
128707528|NCT04180488|463223872|FG004|Overall Study|Adverse Event|0|||
128707529|NCT04180488|463223873|FG005|Overall Study|Adverse Event|0|||
128707530|NCT04180488|463223868|FG000|Overall Study|Poor compliance to protocol|0|||
128707531|NCT04180488|463223869|FG001|Overall Study|Poor compliance to protocol|0|||
128940332|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
128940333|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
128940334|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
128940335|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
128940336|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
128940337|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
128940338|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
128940339|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
128940340|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
128940341|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
128940342|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
128940343|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
128940344|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
128940345|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
128940346|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
128940347|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
128940348|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
128940349|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
128940350|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
129123280|NCT01101178|464745609|FG000|Period 1|Positive drug screen|1|||
129123281|NCT01101178|464745610|FG001|Period 1|Positive drug screen|1|||
129123282|NCT01101178|464745609|FG000|Period 1|Adverse Event|2|||
129123283|NCT01101178|464745610|FG001|Period 1|Adverse Event|1|||
129123284|NCT01101178|464745609|FG000|Period 2|Withdrawal by Subject|0|||
129123285|NCT01101178|464745610|FG001|Period 2|Withdrawal by Subject|1|||
129123286|NCT01850641|464745611|FG000|Overall Study|Physician Decision|1|||
128707532|NCT04180488|463223870|FG002|Overall Study|Poor compliance to protocol|1|||
128707533|NCT04180488|463223871|FG003|Overall Study|Poor compliance to protocol|0|||
128707534|NCT04180488|463223872|FG004|Overall Study|Poor compliance to protocol|0|||
128707535|NCT04180488|463223873|FG005|Overall Study|Poor compliance to protocol|0|||
128707536|NCT03506815|463223874|FG000|Overall Study|Adverse Event|8|||
128707537|NCT03506815|463223875|FG001|Overall Study|Adverse Event|0|||
128707538|NCT03506815|463223874|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
128707539|NCT03506815|463223875|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
128707540|NCT03506815|463223874|FG000|Overall Study|Protocol Violation|1|||
128707541|NCT03506815|463223875|FG001|Overall Study|Protocol Violation|0|||
128707542|NCT03506815|463223874|FG000|Overall Study|Elective Surgery|1|||
128707543|NCT03506815|463223875|FG001|Overall Study|Elective Surgery|0|||
128707544|NCT04160091|463223876|FG000|Overall Study|Terminated by Sponsor|7|||
128707545|NCT04160091|463223877|FG001|Overall Study|Terminated by Sponsor|3|||
128707546|NCT04160091|463223878|FG002|Overall Study|Terminated by Sponsor|5|||
128707547|NCT04160091|463223879|FG003|Overall Study|Terminated by Sponsor|2|||
128707548|NCT04160091|463223876|FG000|Overall Study|Noncompliance|0|||
128707549|NCT04160091|463223877|FG001|Overall Study|Noncompliance|0|||
128707550|NCT04160091|463223878|FG002|Overall Study|Noncompliance|0|||
128707551|NCT04160091|463223879|FG003|Overall Study|Noncompliance|1|||
128707552|NCT04160091|463223876|FG000|Overall Study|Withdrawal by Subject|0|||
128707553|NCT04160091|463223877|FG001|Overall Study|Withdrawal by Subject|0|||
128707554|NCT04160091|463223878|FG002|Overall Study|Withdrawal by Subject|0|||
128707555|NCT04160091|463223879|FG003|Overall Study|Withdrawal by Subject|1|||
128707556|NCT00381095|463223886|FG000|Overall Study|Death|3|||
128707557|NCT00381095|463223887|FG001|Overall Study|Death|4|||
128707558|NCT00381095|463223886|FG000|Overall Study|Lack of Efficacy|2|||
128707559|NCT00381095|463223887|FG001|Overall Study|Lack of Efficacy|4|||
128707560|NCT00381095|463223886|FG000|Overall Study|Other|2|||
128707561|NCT00381095|463223887|FG001|Overall Study|Other|2|||
128707562|NCT00381095|463223886|FG000|Overall Study|Protocol Violation|1|||
128707563|NCT00381095|463223887|FG001|Overall Study|Protocol Violation|1|||
128707564|NCT00381095|463223886|FG000|Overall Study|Withdrawal by Subject|3|||
128707565|NCT00381095|463223887|FG001|Overall Study|Withdrawal by Subject|3|||
128707566|NCT00381095|463223886|FG000|Overall Study|Adverse Event|2|||
128707567|NCT00381095|463223887|FG001|Overall Study|Adverse Event|7|||
128707568|NCT01104493|463223888|FG000|Overall Study|Lost to Follow-up|0|||
128707569|NCT01104493|463223889|FG001|Overall Study|Lost to Follow-up|2|||
128707570|NCT00549302|463223892|FG000|Double-Blind|Death|2|||
128707571|NCT00549302|463223893|FG001|Double-Blind|Death|9|||
128707572|NCT00549302|463223894|FG002|Double-Blind|Death|0|||
128707573|NCT00549302|463223892|FG000|Double-Blind|Adverse Event|3|||
128707574|NCT00549302|463223893|FG001|Double-Blind|Adverse Event|16|||
128707575|NCT00549302|463223894|FG002|Double-Blind|Adverse Event|0|||
128707576|NCT00549302|463223892|FG000|Double-Blind|Withdrawal by Subject|3|||
128707577|NCT00549302|463223893|FG001|Double-Blind|Withdrawal by Subject|8|||
128707578|NCT00549302|463223894|FG002|Double-Blind|Withdrawal by Subject|0|||
128940351|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
128940352|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
128940353|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
128940354|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
128940355|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Other|0|||
128940356|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Other|0|||
128940357|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Other|0|||
128940358|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Other|0|||
128940359|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Other|3|||
128940360|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Other|3|||
128940361|NCT03395197|464069539|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
128940362|NCT03395197|464069540|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
128940363|NCT03395197|464069541|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
128940364|NCT03395197|464069542|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
128940365|NCT03395197|464069543|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
128940366|NCT03395197|464069544|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
128940367|NCT01605071|464069545|FG000|Overall Study|Withdrawal by Subject|3|||
128940368|NCT01605071|464069546|FG001|Overall Study|Withdrawal by Subject|2|||
128940369|NCT00392171|464069547|FG000|Overall Study|Did not meet inclusion criteria|4|||
128940370|NCT00392171|464069547|FG000|Overall Study|Disease progression|101|||
128940371|NCT00028002|464069551|FG000|Overall Study|Withdrawal by Subject|3|||
128940372|NCT00028002|464069551|FG000|Overall Study|Ineligible|8|||
128940373|NCT01881620|464069554|FG000|Overall Study|Protocol Violation|4|||
128940374|NCT01808118|464069557|FG000|Period 1|Adverse Event|15|||
128940375|NCT01808118|464069558|FG001|Period 1|Adverse Event|0|||
128940376|NCT01808118|464069559|FG002|Period 1|Adverse Event|0|||
128940377|NCT01808118|464069557|FG000|Period 1|Withdrew consent|24|||
128940378|NCT01808118|464069558|FG001|Period 1|Withdrew consent|0|||
128940379|NCT01808118|464069559|FG002|Period 1|Withdrew consent|0|||
128940380|NCT01808118|464069557|FG000|Period 1|Lost to Follow-up|9|||
128940381|NCT01808118|464069558|FG001|Period 1|Lost to Follow-up|0|||
128940382|NCT01808118|464069559|FG002|Period 1|Lost to Follow-up|0|||
128940383|NCT01808118|464069557|FG000|Period 1|Did not meet criteria for remission|303|||
128940384|NCT01808118|464069558|FG001|Period 1|Did not meet criteria for remission|0|||
128940385|NCT01808118|464069559|FG002|Period 1|Did not meet criteria for remission|0|||
128940386|NCT01808118|464069557|FG000|Period 1|Enrolled in error|7|||
128940387|NCT01808118|464069558|FG001|Period 1|Enrolled in error|0|||
128940388|NCT01808118|464069559|FG002|Period 1|Enrolled in error|0|||
128940389|NCT01808118|464069557|FG000|Period 1|Did not meet inclusion criteria|3|||
128940390|NCT01808118|464069558|FG001|Period 1|Did not meet inclusion criteria|0|||
128940391|NCT01808118|464069559|FG002|Period 1|Did not meet inclusion criteria|0|||
128940392|NCT01808118|464069557|FG000|Period 1|Non-conformance with inclusion criteria|3|||
128940393|NCT01808118|464069558|FG001|Period 1|Non-conformance with inclusion criteria|0|||
128940394|NCT01808118|464069559|FG002|Period 1|Non-conformance with inclusion criteria|0|||
128940395|NCT01808118|464069557|FG000|Period 1|Investigator decision: site closure|2|||
128940396|NCT01808118|464069558|FG001|Period 1|Investigator decision: site closure|0|||
128940397|NCT01808118|464069559|FG002|Period 1|Investigator decision: site closure|0|||
128940398|NCT01808118|464069557|FG000|Period 1|Non-compliance per sponsor|1|||
128940399|NCT01808118|464069558|FG001|Period 1|Non-compliance per sponsor|0|||
128940400|NCT01808118|464069559|FG002|Period 1|Non-compliance per sponsor|0|||
128940401|NCT01808118|464069557|FG000|Period 1|Lack of Efficacy|1|||
128940402|NCT01808118|464069558|FG001|Period 1|Lack of Efficacy|0|||
128940403|NCT01808118|464069559|FG002|Period 1|Lack of Efficacy|0|||
128940404|NCT01808118|464069557|FG000|Period 2|Adverse Event|0|||
129032418|NCT01332968|464410235|FG003|Maintenance/Observation Period|Progressive Disease|40|||
128707579|NCT00549302|463223892|FG000|Double-Blind|Investigator Decision|1|||
128707580|NCT00549302|463223893|FG001|Double-Blind|Investigator Decision|5|||
128707581|NCT00549302|463223894|FG002|Double-Blind|Investigator Decision|0|||
128707582|NCT00549302|463223892|FG000|Double-Blind|Sponsor Decision|0|||
128707583|NCT00549302|463223893|FG001|Double-Blind|Sponsor Decision|1|||
128940405|NCT01808118|464069558|FG001|Period 2|Adverse Event|4|||
128940406|NCT01808118|464069559|FG002|Period 2|Adverse Event|0|||
128940407|NCT01808118|464069557|FG000|Period 2|Withdrew consent|0|||
128940408|NCT01808118|464069558|FG001|Period 2|Withdrew consent|7|||
128940409|NCT01808118|464069559|FG002|Period 2|Withdrew consent|6|||
128940410|NCT01808118|464069557|FG000|Period 2|Lost to Follow-up|0|||
128940411|NCT01808118|464069558|FG001|Period 2|Lost to Follow-up|0|||
128940412|NCT01808118|464069559|FG002|Period 2|Lost to Follow-up|2|||
128940413|NCT01808118|464069557|FG000|Period 2|Investigator no longer conducting trials|0|||
128940414|NCT01808118|464069558|FG001|Period 2|Investigator no longer conducting trials|1|||
128940415|NCT01808118|464069559|FG002|Period 2|Investigator no longer conducting trials|0|||
128940416|NCT01808118|464069557|FG000|Period 2|Switched to other therapy|0|||
129032419|NCT01332968|464410236|FG004|Maintenance/Observation Period|Progressive Disease|0|||
128707584|NCT00549302|463223894|FG002|Double-Blind|Sponsor Decision|0|||
128707585|NCT00549302|463223892|FG000|Double-Blind|Lost to Follow-up|1|||
128940417|NCT01808118|464069558|FG001|Period 2|Switched to other therapy|1|||
128940418|NCT01808118|464069559|FG002|Period 2|Switched to other therapy|0|||
128940419|NCT00615290|464069565|FG000|Overall Study|Adverse Event|2|||
128940420|NCT00615290|464069565|FG000|Overall Study|Lost to Follow-up|3|||
128940421|NCT00615290|464069565|FG000|Overall Study|Withdrawal by Subject|1|||
128940422|NCT00615290|464069565|FG000|Overall Study|Other|2|||
128940423|NCT01252134|464069566|FG000|Period 1, 8 Hours|Personal Reasons|0|||
128940424|NCT01252134|464069567|FG001|Period 1, 8 Hours|Personal Reasons|1|||
128940425|NCT01252134|464069568|FG002|Period 1, 8 Hours|Personal Reasons|1|||
128940426|NCT01252134|464069569|FG003|Period 1, 8 Hours|Personal Reasons|0|||
128940427|NCT01252134|464069570|FG004|Period 1, 8 Hours|Personal Reasons|0|||
128940428|NCT01252134|464069571|FG005|Period 1, 8 Hours|Personal Reasons|0|||
128940429|NCT03650452|464069572|FG000|Overall Study|Physician Decision|1|||
128940430|NCT03650452|464069573|FG001|Overall Study|Physician Decision|0|||
128940431|NCT03650452|464069572|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
128940432|NCT03650452|464069573|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
128940433|NCT03650452|464069572|FG000|Overall Study|Adverse Event|3|||
128940434|NCT03650452|464069573|FG001|Overall Study|Adverse Event|4|||
128940435|NCT03650452|464069572|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
128940436|NCT03650452|464069573|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
128940437|NCT00718419|464069574|FG000|Overall Study|Adverse Event|2|||
128940438|NCT00718419|464069575|FG001|Overall Study|Adverse Event|1|||
128940439|NCT00718419|464069574|FG000|Overall Study|Physician Decision|1|||
128940440|NCT00718419|464069575|FG001|Overall Study|Physician Decision|6|||
128940441|NCT00718419|464069574|FG000|Overall Study|Sponsor decision|0|||
128940442|NCT00718419|464069575|FG001|Overall Study|Sponsor decision|1|||
128940443|NCT00718419|464069574|FG000|Overall Study|Withdrawal by Subject|0|||
128940444|NCT00718419|464069575|FG001|Overall Study|Withdrawal by Subject|5|||
128940445|NCT00718419|464069574|FG000|Overall Study|Progressive Disease|7|||
128940446|NCT00718419|464069575|FG001|Overall Study|Progressive Disease|25|||
128940447|NCT00718419|464069574|FG000|Overall Study|Death Due to Progressive Disease|2|||
128940448|NCT00718419|464069575|FG001|Overall Study|Death Due to Progressive Disease|0|||
128940449|NCT00718419|464069574|FG000|Overall Study|Death Due to Study Drug Related|0|||
128940450|NCT00718419|464069575|FG001|Overall Study|Death Due to Study Drug Related|1|||
128940451|NCT00718419|464069574|FG000|Overall Study|Death Due to Adverse Events|1|||
128940452|NCT00718419|464069575|FG001|Overall Study|Death Due to Adverse Events|0|||
128940453|NCT03952468|464069583|FG000|Overall Study|Death|0|||
128940454|NCT03952468|464069584|FG001|Overall Study|Death|1|||
128940455|NCT03952468|464069583|FG000|Overall Study|Adverse Event|0|||
128940456|NCT03952468|464069584|FG001|Overall Study|Adverse Event|1|||
128940457|NCT03952468|464069583|FG000|Overall Study|Physician Decision|1|||
128940458|NCT03952468|464069584|FG001|Overall Study|Physician Decision|0|||
128940459|NCT03952468|464069583|FG000|Overall Study|Lost to Follow-up|3|||
128940460|NCT03952468|464069584|FG001|Overall Study|Lost to Follow-up|4|||
128940461|NCT03952468|464069583|FG000|Overall Study|Withdrawal by Subject|2|||
128940462|NCT03952468|464069584|FG001|Overall Study|Withdrawal by Subject|1|||
128940463|NCT05761444|464069585|FG000|Overall Study|Protocol Violation|2|||
128940464|NCT05761444|464069586|FG001|Overall Study|Protocol Violation|1|||
128940465|NCT05761444|464069585|FG000|Overall Study|Adverse Event|2|||
128940466|NCT05761444|464069586|FG001|Overall Study|Adverse Event|2|||
128940467|NCT05761444|464069585|FG000|Overall Study|Withdrawal by Subject|3|||
128940468|NCT05761444|464069586|FG001|Overall Study|Withdrawal by Subject|2|||
128940469|NCT05761444|464069585|FG000|Overall Study|Other|1|||
128940470|NCT05761444|464069586|FG001|Overall Study|Other|0|||
128940471|NCT01106534|464069587|FG000|Overall Study|Withdrawal by Subject|18|||
128940472|NCT01106534|464069587|FG000|Overall Study|Lost to Follow-up|2|||
128940473|NCT01106534|464069587|FG000|Overall Study|Death|16|||
128940474|NCT01106534|464069587|FG000|Overall Study|Physician Decision|1|||
128940475|NCT05187013|464069591|FG000|Overall Study|Withdrawal by Subject|1|||
128940476|NCT05187013|464069592|FG001|Overall Study|Withdrawal by Subject|1|||
128940477|NCT05187013|464069593|FG002|Overall Study|Withdrawal by Subject|0|||
128940478|NCT05187013|464069591|FG000|Overall Study|Death|0|||
128940479|NCT05187013|464069592|FG001|Overall Study|Death|1|||
128940480|NCT05187013|464069593|FG002|Overall Study|Death|0|||
128940481|NCT05187013|464069591|FG000|Overall Study|Lost to Follow-up|20|||
128940482|NCT05187013|464069592|FG001|Overall Study|Lost to Follow-up|17|||
128940483|NCT05187013|464069593|FG002|Overall Study|Lost to Follow-up|0|||
128940484|NCT05187013|464069591|FG000|Overall Study|Ongoing Participants|3|||
128940485|NCT05187013|464069592|FG001|Overall Study|Ongoing Participants|5|||
128940486|NCT05187013|464069593|FG002|Overall Study|Ongoing Participants|0|||
128940487|NCT04488822|464069594|FG000|Overall Study|Adverse Event|8|||
128940488|NCT04488822|464069594|FG000|Overall Study|Withdrawal by Subject|1|||
128940489|NCT03838367|464069595|FG000|Overall Study|Early termination of study|3|||
128940490|NCT03838367|464069596|FG001|Overall Study|Early termination of study|4|||
128940491|NCT03838367|464069597|FG002|Overall Study|Early termination of study|3|||
128940492|NCT03838367|464069598|FG003|Overall Study|Early termination of study|0|||
128940493|NCT03406104|464069599|FG000|Overall Study|Lost to Follow-up|2|||
128940494|NCT03406104|464069599|FG000|Overall Study|Withdrawal by Subject|2|||
128707586|NCT00549302|463223893|FG001|Double-Blind|Lost to Follow-up|2|||
128707587|NCT00549302|463223894|FG002|Double-Blind|Lost to Follow-up|0|||
128707588|NCT00549302|463223892|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
128707589|NCT00549302|463223893|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
128707590|NCT00549302|463223894|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
128707591|NCT00549302|463223892|FG000|Double-Blind|New condition or starts new therapy|0|||
128707592|NCT00549302|463223893|FG001|Double-Blind|New condition or starts new therapy|2|||
128707593|NCT00549302|463223894|FG002|Double-Blind|New condition or starts new therapy|0|||
128707594|NCT00549302|463223892|FG000|Open-Label|Adverse Event|0|||
128940495|NCT03406104|464069599|FG000|Overall Study|due to Covid patient did not want to travel|1|||
128940496|NCT03406104|464069599|FG000|Overall Study|Death|2|||
128940497|NCT02499146|464069608|FG000|Overall Study|Lost to Follow-up|1|||
128940498|NCT02499146|464069608|FG000|Overall Study|Withdrawal by Subject|1|||
128940499|NCT02499146|464069608|FG000|Overall Study|Other|2|||
128940500|NCT02499146|464069608|FG000|Overall Study|Ongoing at date of cut-off|9|||
128940501|NCT02499146|464069608|FG000|Overall Study|Began other treatment/therapy|13|||
128940502|NCT05692154|464069609|FG000|Overall Study|Adverse Event|0|||
128940503|NCT05692154|464069610|FG001|Overall Study|Adverse Event|1|||
128940504|NCT01879618|464069611|FG000|Overall Study|Does not meet entrance criteria|1|||
128940505|NCT01879618|464069611|FG000|Overall Study|Withdrawal by Subject|1|||
128940506|NCT01879618|464069611|FG000|Overall Study|Surgery;changed schedule; not available|8|||
128940507|NCT01879618|464069611|FG000|Overall Study|Protocol Violation|6|||
128940508|NCT01879618|464069611|FG000|Overall Study|Adverse Event|5|||
128940509|NCT00938327|464069612|FG000|Overall Study|Adverse Event|2|||
128940510|NCT00938327|464069612|FG000|Overall Study|Protocol Violation|1|||
128940511|NCT00938327|464069612|FG000|Overall Study|Withdrawal by Subject|4|||
128940512|NCT00938327|464069612|FG000|Overall Study|Lost to Follow-up|37|||
128940513|NCT00938327|464069612|FG000|Overall Study|2nd dose received outside of the study|7|||
128940514|NCT00938327|464069612|FG000|Overall Study|Vaccine not received as out of stock|9|||
128940515|NCT02691247|464069613|FG000|Overall Study|Withdrawal by Subject|1|||
128940516|NCT02691247|464069614|FG001|Overall Study|Withdrawal by Subject|2|||
128940517|NCT02691247|464069615|FG002|Overall Study|Withdrawal by Subject|2|||
128940518|NCT02691247|464069613|FG000|Overall Study|Lost to Follow-up|2|||
128940519|NCT02691247|464069614|FG001|Overall Study|Lost to Follow-up|0|||
128940520|NCT02691247|464069615|FG002|Overall Study|Lost to Follow-up|1|||
128940521|NCT02552355|464069616|FG000|Overall Study|Adverse Event|0|||
128940522|NCT02552355|464069617|FG001|Overall Study|Adverse Event|2|||
128940523|NCT02552355|464069618|FG002|Overall Study|Adverse Event|2|||
128940524|NCT02552355|464069619|FG003|Overall Study|Adverse Event|0|||
128940525|NCT02552355|464069616|FG000|Overall Study|Withdrawal by Subject|0|||
128940526|NCT02552355|464069617|FG001|Overall Study|Withdrawal by Subject|0|||
128940527|NCT02552355|464069618|FG002|Overall Study|Withdrawal by Subject|0|||
128940528|NCT02552355|464069619|FG003|Overall Study|Withdrawal by Subject|1|||
128940529|NCT01519245|464069620|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
128940530|NCT01519245|464069621|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
128940531|NCT00933335|464069622|FG000|Overall Study|Lost to Follow-up|1|||
128940532|NCT00933335|464069623|FG001|Overall Study|Lost to Follow-up|3|||
128940533|NCT00933335|464069622|FG000|Overall Study|Withdrawal by Subject|0|||
128940534|NCT00933335|464069623|FG001|Overall Study|Withdrawal by Subject|1|||
129032420|NCT01332968|464410237|FG005|Maintenance/Observation Period|Progressive Disease|0|||
129032421|NCT01332968|464410238|FG006|Maintenance/Observation Period|Progressive Disease|0|||
129032422|NCT01332968|464410239|FG007|Maintenance/Observation Period|Progressive Disease|0|||
129032423|NCT01332968|464410232|FG000|Maintenance/Observation Period|Protocol Violation|0|||
129032424|NCT01332968|464410233|FG001|Maintenance/Observation Period|Protocol Violation|0|||
129032425|NCT01332968|464410234|FG002|Maintenance/Observation Period|Protocol Violation|1|||
129032426|NCT01332968|464410235|FG003|Maintenance/Observation Period|Protocol Violation|1|||
129032427|NCT01332968|464410236|FG004|Maintenance/Observation Period|Protocol Violation|0|||
128770203|NCT04362137|463450149|FG000|Overall Study|Protocol deviation|1|||
128940535|NCT00933335|464069622|FG000|Overall Study|Progressive Disease|0|||
128940536|NCT00933335|464069623|FG001|Overall Study|Progressive Disease|11|||
128940537|NCT00933335|464069622|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
128940538|NCT00933335|464069623|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
128940539|NCT00933335|464069622|FG000|Overall Study|Co-morbid Illness|1|||
128940540|NCT00933335|464069623|FG001|Overall Study|Co-morbid Illness|0|||
128940541|NCT02275026|464069626|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
128940542|NCT02275026|464069626|FG000|Overall Study|Withdrawal by Subject|4|||
128940543|NCT02275026|464069626|FG000|Overall Study|Ineligible due to medical history|13|||
129032428|NCT01332968|464410237|FG005|Maintenance/Observation Period|Protocol Violation|0|||
128940544|NCT02275026|464069626|FG000|Overall Study|MRI malfunction precluded testing|1|||
128940545|NCT02275026|464069626|FG000|Overall Study|Ineligible after MRI findings|1|||
129032429|NCT01332968|464410238|FG006|Maintenance/Observation Period|Protocol Violation|0|||
129032430|NCT01332968|464410239|FG007|Maintenance/Observation Period|Protocol Violation|0|||
128770204|NCT04362137|463450150|FG001|Overall Study|Protocol deviation|0|||
128770205|NCT03306043|463450154|FG000|Overall Study|Adverse Event|1|||
128940546|NCT02275026|464069626|FG000|Overall Study|Lost to Follow-up|2|||
128940547|NCT02275026|464069626|FG000|Overall Study|Scanner failure|1|||
128940548|NCT05468086|464069627|FG000|Overall Study|Withdrawal by Subject|3|||
128940549|NCT05468086|464069627|FG000|Overall Study|Subject was found ineligible after consent|1|||
128940550|NCT01108809|464069628|FG000|Overall Study|Adverse Event|3|||
128940551|NCT01108809|464069628|FG000|Overall Study|Lost to Follow-up|1|||
128940552|NCT00783705|464069630|FG000|Overall Study|Adverse Event|2|||
128940553|NCT00783705|464069631|FG001|Overall Study|Adverse Event|0|||
128940554|NCT00783705|464069630|FG000|Overall Study|Withdrawal by Subject|3|||
128940555|NCT00783705|464069631|FG001|Overall Study|Withdrawal by Subject|2|||
128940556|NCT00783705|464069630|FG000|Overall Study|Lost to Follow-up|1|||
128940557|NCT00783705|464069631|FG001|Overall Study|Lost to Follow-up|3|||
128940558|NCT01954121|464069632|FG000|Overall Study|Lack of Efficacy|94|||
128940559|NCT01954121|464069633|FG001|Overall Study|Lack of Efficacy|41|||
128940560|NCT01954121|464069632|FG000|Overall Study|Protocol Violation|0|||
128940561|NCT01954121|464069633|FG001|Overall Study|Protocol Violation|2|||
128940562|NCT01954121|464069632|FG000|Overall Study|Lost to Follow-up|5|||
128940563|NCT01954121|464069633|FG001|Overall Study|Lost to Follow-up|6|||
128940564|NCT01954121|464069632|FG000|Overall Study|Withdrawal by Subject|18|||
128940565|NCT01954121|464069633|FG001|Overall Study|Withdrawal by Subject|12|||
128940566|NCT01954121|464069632|FG000|Overall Study|Pregnancy|1|||
128940567|NCT01954121|464069633|FG001|Overall Study|Pregnancy|1|||
128940568|NCT01954121|464069632|FG000|Overall Study|AE, serious fatal|1|||
128940569|NCT01954121|464069633|FG001|Overall Study|AE, serious fatal|0|||
128940570|NCT01954121|464069632|FG000|Overall Study|AE, non-serious non-fatal|5|||
128940571|NCT01954121|464069633|FG001|Overall Study|AE, non-serious non-fatal|22|||
128940572|NCT01954121|464069632|FG000|Overall Study|SAE, non-fatal|1|||
128940573|NCT01954121|464069633|FG001|Overall Study|SAE, non-fatal|4|||
128940574|NCT01954121|464069632|FG000|Overall Study|Non-compliant with study procedures|1|||
128940575|NCT01954121|464069633|FG001|Overall Study|Non-compliant with study procedures|0|||
128940576|NCT01954121|464069632|FG000|Overall Study|Non-compliant patient|1|||
128940577|NCT01954121|464069633|FG001|Overall Study|Non-compliant patient|1|||
128940578|NCT01954121|464069632|FG000|Overall Study|Subject did not follow instructions|0|||
128940579|NCT01954121|464069633|FG001|Overall Study|Subject did not follow instructions|2|||
128940580|NCT02504892|464069639|FG000|Overall Study|Adverse event-pneumonitis|2|||
128940581|NCT00576693|464069640|FG000|Overall Study|Lost to Follow-up|7|||
128940582|NCT00576693|464069641|FG001|Overall Study|Lost to Follow-up|11|||
128940583|NCT00576693|464069640|FG000|Overall Study|Withdrawal by Subject|3|||
128940584|NCT00576693|464069641|FG001|Overall Study|Withdrawal by Subject|13|||
128940585|NCT01413178|464069642|FG000|Overall Study|Toxicity|1|||
128940586|NCT01413178|464069643|FG001|Overall Study|Toxicity|0|||
128940587|NCT01413178|464069642|FG000|Overall Study|Ineligible|0|||
128940588|NCT01413178|464069643|FG001|Overall Study|Ineligible|2|||
128940589|NCT03643432|464069644|FG000|Overall Study|Lost to Follow-up|1|||
128940590|NCT03643432|464069645|FG001|Overall Study|Lost to Follow-up|0|||
128940591|NCT00804193|464069646|FG000|Overall Study|Lack of baseline fungus|32|||
128940592|NCT00804193|464069647|FG001|Overall Study|Lack of baseline fungus|31|||
128940593|NCT00804193|464069648|FG002|Overall Study|Lack of baseline fungus|19|||
128940594|NCT00804193|464069646|FG000|Overall Study|Adverse Event|0|||
128940595|NCT00804193|464069647|FG001|Overall Study|Adverse Event|0|||
128940596|NCT00804193|464069648|FG002|Overall Study|Adverse Event|2|||
128940597|NCT00804193|464069646|FG000|Overall Study|Lack of Efficacy|1|||
128940598|NCT00804193|464069647|FG001|Overall Study|Lack of Efficacy|1|||
128940599|NCT00804193|464069648|FG002|Overall Study|Lack of Efficacy|3|||
128940600|NCT00804193|464069646|FG000|Overall Study|Protocol Violation|0|||
128940601|NCT00804193|464069647|FG001|Overall Study|Protocol Violation|8|||
128940602|NCT00804193|464069648|FG002|Overall Study|Protocol Violation|2|||
128940603|NCT00804193|464069646|FG000|Overall Study|Lost to Follow-up|3|||
129032431|NCT01332968|464410232|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
129032432|NCT01332968|464410233|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
129032433|NCT01332968|464410234|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
129032434|NCT01332968|464410235|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
129032435|NCT01332968|464410236|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
129032436|NCT01332968|464410237|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
129032437|NCT01332968|464410238|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
129032438|NCT01332968|464410239|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
129032439|NCT01332968|464410232|FG000|Follow-Up Period|Adverse Event|0|||
128940604|NCT00804193|464069647|FG001|Overall Study|Lost to Follow-up|3|||
128940605|NCT00804193|464069648|FG002|Overall Study|Lost to Follow-up|4|||
128940606|NCT00804193|464069646|FG000|Overall Study|Withdrawal by Subject|3|||
128940607|NCT00804193|464069647|FG001|Overall Study|Withdrawal by Subject|1|||
128940608|NCT00804193|464069648|FG002|Overall Study|Withdrawal by Subject|2|||
128940609|NCT04072146|464069649|FG000|Overall Study|Adverse Event|0|||
128940610|NCT04072146|464069650|FG001|Overall Study|Adverse Event|1|||
128940611|NCT01617434|464069651|FG000|Overall Study|Adverse Event|12|||
128940612|NCT01617434|464069652|FG001|Overall Study|Adverse Event|3|||
128940613|NCT01617434|464069651|FG000|Overall Study|Protocol Violation|8|||
128707595|NCT00549302|463223893|FG001|Open-Label|Adverse Event|0|||
128707596|NCT00549302|463223894|FG002|Open-Label|Adverse Event|11|||
128707597|NCT00549302|463223892|FG000|Open-Label|Death|0|||
128707598|NCT00549302|463223893|FG001|Open-Label|Death|0|||
128707599|NCT00549302|463223894|FG002|Open-Label|Death|40|||
128940614|NCT01617434|464069652|FG001|Overall Study|Protocol Violation|7|||
128940615|NCT01617434|464069651|FG000|Overall Study|Withdrawal Criteria|12|||
128940616|NCT01617434|464069652|FG001|Overall Study|Withdrawal Criteria|37|||
128940617|NCT01617434|464069651|FG000|Overall Study|Unclassified|3|||
128940618|NCT01617434|464069652|FG001|Overall Study|Unclassified|4|||
128940619|NCT01987986|464069653|FG000|Overall Study|Lost to Follow-up|1|||
128940620|NCT01987986|464069654|FG001|Overall Study|Lost to Follow-up|0|||
128940621|NCT01987986|464069655|FG002|Overall Study|Lost to Follow-up|0|||
128940622|NCT01987986|464069656|FG003|Overall Study|Lost to Follow-up|0|||
128940623|NCT01987986|464069653|FG000|Overall Study|Adverse Event|1|||
128940624|NCT01987986|464069654|FG001|Overall Study|Adverse Event|0|||
128940625|NCT01987986|464069655|FG002|Overall Study|Adverse Event|2|||
128940626|NCT01987986|464069656|FG003|Overall Study|Adverse Event|0|||
128940627|NCT03283163|464069659|FG000|Overall Study|Lost to Follow-up|1|||
128940628|NCT03283163|464069659|FG000|Overall Study|other life commitments|6|||
128940629|NCT03283163|464069659|FG000|Overall Study|COVID-19 institution wide halting|1|||
128940630|NCT03283163|464069659|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
128940631|NCT03283163|464069659|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
128940632|NCT00237796|464069660|FG000|Overall Study|Baseline and one other ILSS required|10|||
128940633|NCT00237796|464069661|FG001|Overall Study|Baseline and one other ILSS required|5|||
128940634|NCT04238663|464069665|FG000|Overall Study|Lost to Follow-up|0|||
128940635|NCT04238663|464069666|FG001|Overall Study|Lost to Follow-up|1|||
128940636|NCT04238663|464069667|FG002|Overall Study|Lost to Follow-up|0|||
128940637|NCT01193348|464069668|FG000|Screening Period|Screen Failure|5|||
128940638|NCT01193348|464069668|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
128940639|NCT01193348|464069668|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
128940640|NCT01193348|464069668|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
128940641|NCT01193348|464069668|FG000|Extension Treatment Period|Physician Decision|1|||
128940642|NCT01193348|464069668|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
128940643|NCT04070378|464069669|FG000|Overall Study|Withdrawal by Subject|2|||
128940644|NCT04070378|464069669|FG000|Overall Study|Screen Failure|6|||
128940645|NCT04070378|464069669|FG000|Overall Study|Physician Decision|1|||
128940646|NCT04070378|464069669|FG000|Overall Study|Adverse Event|1|||
128940647|NCT03259334|464069670|FG000|Overall Study|Adverse Event|3|||
128940648|NCT03259334|464069671|FG001|Overall Study|Adverse Event|8|||
128940649|NCT03259334|464069672|FG002|Overall Study|Adverse Event|5|||
128940650|NCT03259334|464069670|FG000|Overall Study|Withdrawal by Subject|4|||
128940651|NCT03259334|464069671|FG001|Overall Study|Withdrawal by Subject|2|||
128940652|NCT03259334|464069672|FG002|Overall Study|Withdrawal by Subject|4|||
128940653|NCT03259334|464069670|FG000|Overall Study|Physician Decision|1|||
128940654|NCT03259334|464069671|FG001|Overall Study|Physician Decision|0|||
128940655|NCT03259334|464069672|FG002|Overall Study|Physician Decision|0|||
128940656|NCT03259334|464069670|FG000|Overall Study|Lost to Follow-up|0|||
128940657|NCT03259334|464069671|FG001|Overall Study|Lost to Follow-up|2|||
128940658|NCT03259334|464069672|FG002|Overall Study|Lost to Follow-up|1|||
128940659|NCT03259334|464069670|FG000|Overall Study|Protocol Deviation|0|||
128940660|NCT03259334|464069671|FG001|Overall Study|Protocol Deviation|3|||
128940661|NCT03259334|464069672|FG002|Overall Study|Protocol Deviation|2|||
128940662|NCT03259334|464069670|FG000|Overall Study|Lack of Efficacy|2|||
128940663|NCT03259334|464069671|FG001|Overall Study|Lack of Efficacy|0|||
128940664|NCT03259334|464069672|FG002|Overall Study|Lack of Efficacy|1|||
128940665|NCT03259334|464069670|FG000|Overall Study|Randomized but never treated|0|||
128940666|NCT03259334|464069671|FG001|Overall Study|Randomized but never treated|2|||
128940667|NCT03259334|464069672|FG002|Overall Study|Randomized but never treated|0|||
128940668|NCT00701727|464070974|FG000|First Treatment Period|Adverse Event|0|||
128940669|NCT00701727|464070975|FG001|First Treatment Period|Adverse Event|0|||
128940670|NCT00701727|464070974|FG000|First Treatment Period|Withdrawal by Subject|1|||
128940671|NCT00701727|464070975|FG001|First Treatment Period|Withdrawal by Subject|0|||
128940672|NCT00701727|464070974|FG000|First Treatment Period|sponsor decision|0|||
128940673|NCT00701727|464070975|FG001|First Treatment Period|sponsor decision|1|||
129032440|NCT01332968|464410233|FG001|Follow-Up Period|Adverse Event|0|||
129032441|NCT01332968|464410234|FG002|Follow-Up Period|Adverse Event|0|||
129032442|NCT01332968|464410235|FG003|Follow-Up Period|Adverse Event|0|||
129032443|NCT01332968|464410236|FG004|Follow-Up Period|Adverse Event|0|||
128940674|NCT00701727|464070974|FG000|First Treatment Period|Lost to Follow-up|0|||
128940675|NCT00701727|464070975|FG001|First Treatment Period|Lost to Follow-up|1|||
128940676|NCT00701727|464070974|FG000|Second Treatment Period|Withdrawal by Subject|2|||
128707600|NCT00549302|463223892|FG000|Open-Label|Investigator Decision|0|||
128707601|NCT00549302|463223893|FG001|Open-Label|Investigator Decision|0|||
128940677|NCT00701727|464070975|FG001|Second Treatment Period|Withdrawal by Subject|0|||
128940678|NCT05113953|464070978|FG000|Overall Study|Adverse Event|5|||
128940679|NCT05113953|464070979|FG001|Overall Study|Adverse Event|0|||
128940680|NCT05113953|464070980|FG002|Overall Study|Adverse Event|3|||
128940681|NCT05113953|464070978|FG000|Overall Study|Lost to Follow-up|3|||
128940682|NCT05113953|464070979|FG001|Overall Study|Lost to Follow-up|4|||
128940683|NCT05113953|464070980|FG002|Overall Study|Lost to Follow-up|2|||
128940684|NCT05113953|464070978|FG000|Overall Study|Non-compliance with Study Drug|1|||
128940685|NCT05113953|464070979|FG001|Overall Study|Non-compliance with Study Drug|0|||
128940686|NCT05113953|464070980|FG002|Overall Study|Non-compliance with Study Drug|0|||
128940687|NCT05113953|464070978|FG000|Overall Study|Withdrawal by Subject|2|||
128940688|NCT05113953|464070979|FG001|Overall Study|Withdrawal by Subject|6|||
128940689|NCT05113953|464070980|FG002|Overall Study|Withdrawal by Subject|4|||
128940690|NCT05113953|464070978|FG000|Overall Study|Reason not Specified|2|||
128940691|NCT05113953|464070979|FG001|Overall Study|Reason not Specified|0|||
128940692|NCT05113953|464070980|FG002|Overall Study|Reason not Specified|0|||
128940693|NCT00523341|464070981|FG000|Overall Study|Withdrawal by Subject|399|||
128940694|NCT00523341|464070982|FG001|Overall Study|Withdrawal by Subject|427|||
128940695|NCT00523341|464070981|FG000|Overall Study|Other|181|||
128940696|NCT00523341|464070982|FG001|Overall Study|Other|198|||
128940697|NCT00523341|464070981|FG000|Overall Study|Adverse Event|122|||
128940698|NCT00523341|464070982|FG001|Overall Study|Adverse Event|155|||
128940699|NCT00523341|464070981|FG000|Overall Study|Death|101|||
128940700|NCT00523341|464070982|FG001|Overall Study|Death|110|||
128940701|NCT00523341|464070981|FG000|Overall Study|Lost to Follow-up|73|||
128940702|NCT00523341|464070982|FG001|Overall Study|Lost to Follow-up|61|||
128940703|NCT00523341|464070981|FG000|Overall Study|Non-compliance|20|||
128940704|NCT00523341|464070982|FG001|Overall Study|Non-compliance|13|||
128940705|NCT00523341|464070981|FG000|Overall Study|Physician Decision|14|||
128770206|NCT03306043|463450154|FG000|Overall Study|Lost to Follow-up|1|||
128770207|NCT03306043|463450154|FG000|Overall Study|Withdrawal by Subject|2|||
128770208|NCT00785538|463450155|FG000|Treatment Period|Adverse Event|1|||
128770209|NCT00785538|463450156|FG001|Treatment Period|Adverse Event|2|||
128770210|NCT00785538|463450157|FG002|Treatment Period|Adverse Event|2|||
128770211|NCT00785538|463450158|FG003|Treatment Period|Adverse Event|0|||
128770212|NCT00785538|463450155|FG000|Treatment Period|Withdrawal by Subject|0|||
128770213|NCT00785538|463450156|FG001|Treatment Period|Withdrawal by Subject|0|||
128770214|NCT00785538|463450157|FG002|Treatment Period|Withdrawal by Subject|0|||
128940706|NCT00523341|464070982|FG001|Overall Study|Physician Decision|13|||
128940707|NCT00523341|464070981|FG000|Overall Study|Requirement for Alternative Therapy|4|||
128940708|NCT00523341|464070982|FG001|Overall Study|Requirement for Alternative Therapy|14|||
128940709|NCT00523341|464070981|FG000|Overall Study|Protocol Deviation|6|||
128940710|NCT00523341|464070982|FG001|Overall Study|Protocol Deviation|5|||
128940711|NCT00523341|464070981|FG000|Overall Study|Ineligibility Determined|3|||
128940712|NCT00523341|464070982|FG001|Overall Study|Ineligibility Determined|4|||
128940713|NCT00523341|464070981|FG000|Overall Study|Disease Progression|1|||
128940714|NCT00523341|464070982|FG001|Overall Study|Disease Progression|0|||
128940715|NCT05137041|464070983|FG000|Overall Study|Lost to Follow-up|1|||
128940716|NCT05137041|464070984|FG001|Overall Study|Lost to Follow-up|1|||
128940717|NCT05137041|464070983|FG000|Overall Study|Withdrawal by Subject|0|||
128940718|NCT05137041|464070984|FG001|Overall Study|Withdrawal by Subject|2|||
128940719|NCT05137041|464070983|FG000|Overall Study|Reason not Specified|0|||
128940720|NCT05137041|464070984|FG001|Overall Study|Reason not Specified|1|||
128940721|NCT00502307|464070987|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
128940722|NCT00502307|464070988|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
128940723|NCT00502307|464070989|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
128940724|NCT00502307|464070987|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
128940725|NCT00502307|464070988|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
128940726|NCT00502307|464070989|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
128940727|NCT00502307|464070987|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
128940728|NCT00502307|464070988|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
128940729|NCT00502307|464070989|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
129123287|NCT01850641|464745611|FG000|Overall Study|Decrease in serum phosphorus|1|||
129123288|NCT01850641|464745611|FG000|Overall Study|Decrease in serum calcium|2|||
128940730|NCT00502307|464070987|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
128940731|NCT00502307|464070988|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
129123289|NCT01850641|464745611|FG000|Overall Study|Increase in serum ferritin|1|||
129123290|NCT00141817|464745612|FG000|Overall Study|Protocol Violation|0|||
129123291|NCT00141817|464745613|FG001|Overall Study|Protocol Violation|0|||
128770215|NCT00785538|463450158|FG003|Treatment Period|Withdrawal by Subject|1|||
128770216|NCT01799720|463450159|FG000|Overall Study|Withdrawal by Subject|3|||
128770217|NCT01799720|463450160|FG001|Overall Study|Withdrawal by Subject|0|||
128940732|NCT00502307|464070989|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
128940733|NCT00502307|464070987|FG000|Maintenance Period|Progressive disease|80|||
128940734|NCT00502307|464070988|FG001|Maintenance Period|Progressive disease|0|||
128940735|NCT00502307|464070989|FG002|Maintenance Period|Progressive disease|0|||
128940736|NCT00502307|464070987|FG000|Maintenance Period|Discontinued due to other reasons|68|||
129032444|NCT01332968|464410237|FG005|Follow-Up Period|Adverse Event|0|||
129032445|NCT01332968|464410238|FG006|Follow-Up Period|Adverse Event|0|||
129032446|NCT01332968|464410239|FG007|Follow-Up Period|Adverse Event|4|||
129032447|NCT01332968|464410232|FG000|Follow-Up Period|Death|0|||
129032448|NCT01332968|464410233|FG001|Follow-Up Period|Death|0|||
129032449|NCT01332968|464410234|FG002|Follow-Up Period|Death|0|||
129032450|NCT01332968|464410235|FG003|Follow-Up Period|Death|0|||
129032451|NCT01332968|464410236|FG004|Follow-Up Period|Death|0|||
129032452|NCT01332968|464410237|FG005|Follow-Up Period|Death|0|||
129032453|NCT01332968|464410238|FG006|Follow-Up Period|Death|27|||
129032454|NCT01332968|464410239|FG007|Follow-Up Period|Death|30|||
129032455|NCT01332968|464410232|FG000|Follow-Up Period|Lost to Follow-up|0|||
129032456|NCT01332968|464410233|FG001|Follow-Up Period|Lost to Follow-up|0|||
129032457|NCT01332968|464410234|FG002|Follow-Up Period|Lost to Follow-up|0|||
129032458|NCT01332968|464410235|FG003|Follow-Up Period|Lost to Follow-up|0|||
129032459|NCT01332968|464410236|FG004|Follow-Up Period|Lost to Follow-up|0|||
129032460|NCT01332968|464410237|FG005|Follow-Up Period|Lost to Follow-up|0|||
129032461|NCT01332968|464410238|FG006|Follow-Up Period|Lost to Follow-up|11|||
129032462|NCT01332968|464410239|FG007|Follow-Up Period|Lost to Follow-up|15|||
129032463|NCT01332968|464410232|FG000|Follow-Up Period|Non-compliance|0|||
129032464|NCT01332968|464410233|FG001|Follow-Up Period|Non-compliance|0|||
129032465|NCT01332968|464410234|FG002|Follow-Up Period|Non-compliance|0|||
129032466|NCT01332968|464410235|FG003|Follow-Up Period|Non-compliance|0|||
129032467|NCT01332968|464410236|FG004|Follow-Up Period|Non-compliance|0|||
129032468|NCT01332968|464410237|FG005|Follow-Up Period|Non-compliance|0|||
129032469|NCT01332968|464410238|FG006|Follow-Up Period|Non-compliance|4|||
129032470|NCT01332968|464410239|FG007|Follow-Up Period|Non-compliance|9|||
129032471|NCT01332968|464410232|FG000|Follow-Up Period|Other|0|||
129032472|NCT01332968|464410233|FG001|Follow-Up Period|Other|0|||
129032473|NCT01332968|464410234|FG002|Follow-Up Period|Other|0|||
129032474|NCT01332968|464410235|FG003|Follow-Up Period|Other|0|||
129032475|NCT01332968|464410236|FG004|Follow-Up Period|Other|0|||
129032476|NCT01332968|464410237|FG005|Follow-Up Period|Other|0|||
129032477|NCT01332968|464410238|FG006|Follow-Up Period|Other|18|||
129032478|NCT01332968|464410239|FG007|Follow-Up Period|Other|21|||
129032479|NCT01332968|464410232|FG000|Follow-Up Period|Physician Decision|0|||
129032480|NCT01332968|464410233|FG001|Follow-Up Period|Physician Decision|0|||
129032481|NCT01332968|464410234|FG002|Follow-Up Period|Physician Decision|0|||
129032482|NCT01332968|464410235|FG003|Follow-Up Period|Physician Decision|0|||
129032483|NCT01332968|464410236|FG004|Follow-Up Period|Physician Decision|0|||
129032484|NCT01332968|464410237|FG005|Follow-Up Period|Physician Decision|0|||
129032485|NCT01332968|464410238|FG006|Follow-Up Period|Physician Decision|12|||
129032486|NCT01332968|464410239|FG007|Follow-Up Period|Physician Decision|15|||
129032487|NCT01332968|464410232|FG000|Follow-Up Period|Progressive Disease|0|||
129032488|NCT01332968|464410233|FG001|Follow-Up Period|Progressive Disease|0|||
129032489|NCT01332968|464410234|FG002|Follow-Up Period|Progressive Disease|0|||
129032490|NCT01332968|464410235|FG003|Follow-Up Period|Progressive Disease|0|||
129032491|NCT01332968|464410236|FG004|Follow-Up Period|Progressive Disease|0|||
129032492|NCT01332968|464410237|FG005|Follow-Up Period|Progressive Disease|0|||
129032493|NCT01332968|464410238|FG006|Follow-Up Period|Progressive Disease|126|||
129032494|NCT01332968|464410239|FG007|Follow-Up Period|Progressive Disease|106|||
129032495|NCT01332968|464410232|FG000|Follow-Up Period|Protocol Violation|0|||
129032496|NCT01332968|464410233|FG001|Follow-Up Period|Protocol Violation|0|||
129032497|NCT01332968|464410234|FG002|Follow-Up Period|Protocol Violation|0|||
129032498|NCT01332968|464410235|FG003|Follow-Up Period|Protocol Violation|0|||
129032499|NCT01332968|464410236|FG004|Follow-Up Period|Protocol Violation|0|||
129032500|NCT01332968|464410237|FG005|Follow-Up Period|Protocol Violation|0|||
129032501|NCT01332968|464410238|FG006|Follow-Up Period|Protocol Violation|1|||
128707602|NCT00549302|463223894|FG002|Open-Label|Investigator Decision|5|||
128707603|NCT00549302|463223892|FG000|Open-Label|Lost to Follow-up|0|||
129032502|NCT01332968|464410239|FG007|Follow-Up Period|Protocol Violation|0|||
129032503|NCT01332968|464410232|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129032504|NCT01332968|464410233|FG001|Follow-Up Period|Withdrawal by Subject|0|||
129032505|NCT01332968|464410234|FG002|Follow-Up Period|Withdrawal by Subject|0|||
129032506|NCT01332968|464410235|FG003|Follow-Up Period|Withdrawal by Subject|0|||
129032507|NCT01332968|464410236|FG004|Follow-Up Period|Withdrawal by Subject|0|||
129032508|NCT01332968|464410237|FG005|Follow-Up Period|Withdrawal by Subject|0|||
129032509|NCT01332968|464410238|FG006|Follow-Up Period|Withdrawal by Subject|29|||
129032510|NCT01332968|464410239|FG007|Follow-Up Period|Withdrawal by Subject|32|||
129032511|NCT01332968|464410232|FG000|Follow-Up Period|No reason provided|0|||
128707604|NCT00549302|463223893|FG001|Open-Label|Lost to Follow-up|0|||
129032512|NCT01332968|464410233|FG001|Follow-Up Period|No reason provided|0|||
129032513|NCT01332968|464410234|FG002|Follow-Up Period|No reason provided|0|||
129032514|NCT01332968|464410235|FG003|Follow-Up Period|No reason provided|0|||
129032515|NCT01332968|464410236|FG004|Follow-Up Period|No reason provided|0|||
129032516|NCT01332968|464410237|FG005|Follow-Up Period|No reason provided|0|||
129032517|NCT01332968|464410238|FG006|Follow-Up Period|No reason provided|2|||
128707605|NCT00549302|463223894|FG002|Open-Label|Lost to Follow-up|2|||
129032518|NCT01332968|464410239|FG007|Follow-Up Period|No reason provided|3|||
128940737|NCT00502307|464070988|FG001|Maintenance Period|Discontinued due to other reasons|0|||
128940738|NCT00502307|464070989|FG002|Maintenance Period|Discontinued due to other reasons|0|||
128940739|NCT04907539|464070990|FG000|Overall Study|Consent withdrawn|1|||
128940740|NCT04907539|464070991|FG001|Overall Study|Consent withdrawn|0|||
128940741|NCT04907539|464070990|FG000|Overall Study|Death|14|||
128940742|NCT04907539|464070991|FG001|Overall Study|Death|3|||
128940743|NCT00051558|464070993|FG000|Overall Study|Adverse Event|30|||
128940744|NCT00051558|464070994|FG001|Overall Study|Adverse Event|18|||
128940745|NCT00051558|464070993|FG000|Overall Study|Withdrawal by Subject|29|||
128940746|NCT00051558|464070994|FG001|Overall Study|Withdrawal by Subject|42|||
128940747|NCT00051558|464070993|FG000|Overall Study|Death|9|||
128940748|NCT00051558|464070994|FG001|Overall Study|Death|15|||
128940749|NCT00051558|464070993|FG000|Overall Study|Lost to Follow-up|4|||
128940750|NCT00051558|464070994|FG001|Overall Study|Lost to Follow-up|13|||
128940751|NCT00051558|464070993|FG000|Overall Study|Protocol Violation|3|||
128940752|NCT00051558|464070994|FG001|Overall Study|Protocol Violation|4|||
128940753|NCT00051558|464070993|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
128940754|NCT00051558|464070994|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
128940755|NCT00051558|464070993|FG000|Overall Study|Sponsor Decision|6|||
128940756|NCT00051558|464070994|FG001|Overall Study|Sponsor Decision|1|||
128940757|NCT00051558|464070993|FG000|Overall Study|Other|2|||
128940758|NCT00051558|464070994|FG001|Overall Study|Other|1|||
128940759|NCT00051558|464070993|FG000|Overall Study|Significant Lab Value|2|||
128940760|NCT00051558|464070994|FG001|Overall Study|Significant Lab Value|0|||
128940761|NCT00051558|464070993|FG000|Overall Study|Physician Decision|5|||
128940762|NCT00051558|464070994|FG001|Overall Study|Physician Decision|0|||
128940763|NCT02273050|464070997|FG000|Overall Study|Adverse Event|4|||
128940764|NCT02273050|464070998|FG001|Overall Study|Adverse Event|3|||
128940765|NCT02273050|464070999|FG002|Overall Study|Adverse Event|3|||
128940766|NCT02273050|464070997|FG000|Overall Study|Death|0|||
128940767|NCT02273050|464070998|FG001|Overall Study|Death|0|||
128940768|NCT02273050|464070999|FG002|Overall Study|Death|1|||
128940769|NCT02273050|464070997|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
128940770|NCT02273050|464070998|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
128940771|NCT02273050|464070999|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
128940772|NCT02273050|464070997|FG000|Overall Study|Lack of Efficacy|0|||
128940773|NCT02273050|464070998|FG001|Overall Study|Lack of Efficacy|1|||
128940774|NCT02273050|464070999|FG002|Overall Study|Lack of Efficacy|1|||
128940775|NCT02273050|464070997|FG000|Overall Study|Withdrawal by Subject|17|||
128940776|NCT02273050|464070998|FG001|Overall Study|Withdrawal by Subject|14|||
128940777|NCT02273050|464070999|FG002|Overall Study|Withdrawal by Subject|16|||
128940778|NCT02273050|464070997|FG000|Overall Study|Lost to Follow-up|0|||
128940779|NCT02273050|464070998|FG001|Overall Study|Lost to Follow-up|2|||
128940780|NCT02273050|464070999|FG002|Overall Study|Lost to Follow-up|3|||
128940781|NCT02273050|464070997|FG000|Overall Study|Protocol Violation|3|||
128940782|NCT02273050|464070998|FG001|Overall Study|Protocol Violation|1|||
128940783|NCT02273050|464070999|FG002|Overall Study|Protocol Violation|4|||
128940784|NCT01795898|464071001|FG000|Overall Study|Adverse Event|27|||
128940785|NCT01795898|464071001|FG000|Overall Study|Lost to Follow-up|20|||
128940786|NCT01795898|464071001|FG000|Overall Study|Withdrawal of consent|6|||
128940787|NCT01795898|464071001|FG000|Overall Study|Diagnosed with metastasis|1|||
128940788|NCT01795898|464071001|FG000|Overall Study|No pain|1|||
128940789|NCT01795898|464071001|FG000|Overall Study|Death|1|||
128940790|NCT01795898|464071001|FG000|Overall Study|Withdrew consent & had adverse events|3|||
128940791|NCT01795898|464071001|FG000|Overall Study|Physician Decision|1|||
128940792|NCT03539458|464071002|FG000|Overall Study|Death|1|||
128940793|NCT02297438|464071003|FG000|Overall Study|Death|79|||
128940794|NCT02297438|464071004|FG001|Overall Study|Death|86|||
128940795|NCT02297438|464071003|FG000|Overall Study|Lost to Follow-up|9|||
129032519|NCT03480022|464410240|FG000|Overall Study|Pregnancy|2|||
129032520|NCT03480022|464410241|FG001|Overall Study|Pregnancy|0|||
129032521|NCT03480022|464410240|FG000|Overall Study|Adverse Event|6|||
129032522|NCT03480022|464410241|FG001|Overall Study|Adverse Event|0|||
128940796|NCT02297438|464071004|FG001|Overall Study|Lost to Follow-up|7|||
128940797|NCT02297438|464071003|FG000|Overall Study|Withdrawal by Subject|7|||
128940798|NCT02297438|464071004|FG001|Overall Study|Withdrawal by Subject|0|||
128940799|NCT02297438|464071003|FG000|Overall Study|Other|9|||
128940800|NCT02297438|464071004|FG001|Overall Study|Other|5|||
129032523|NCT03480022|464410240|FG000|Overall Study|Lack of Efficacy|0|||
128940801|NCT02297438|464071003|FG000|Overall Study|Ongoing|65|||
128940802|NCT02297438|464071004|FG001|Overall Study|Ongoing|73|||
128940803|NCT02042404|464071005|FG000|Overall Study|Death|1|||
128940804|NCT02042404|464071006|FG001|Overall Study|Death|0|||
129032524|NCT03480022|464410241|FG001|Overall Study|Lack of Efficacy|2|||
128940805|NCT02042404|464071005|FG000|Overall Study|Unrelated Adverse Event|3|||
128940806|NCT02042404|464071006|FG001|Overall Study|Unrelated Adverse Event|0|||
128940807|NCT02042404|464071005|FG000|Overall Study|Inability to meet time requirements|1|||
128940808|NCT02042404|464071006|FG001|Overall Study|Inability to meet time requirements|0|||
128940809|NCT00726323|464071007|FG000|Overall Study|Withdrawal by Subject|3|||
129032525|NCT03480022|464410240|FG000|Overall Study|Physician Decision|0|||
129032526|NCT03480022|464410241|FG001|Overall Study|Physician Decision|1|||
129032527|NCT03480022|464410240|FG000|Overall Study|Withdrawal by Subject|2|||
129032528|NCT03480022|464410241|FG001|Overall Study|Withdrawal by Subject|0|||
129032529|NCT03480022|464410240|FG000|Overall Study|Medication concerns|1|||
129032530|NCT03480022|464410241|FG001|Overall Study|Medication concerns|0|||
129032531|NCT03480022|464410240|FG000|Overall Study|Family member COVID exposure|0|||
129032532|NCT03480022|464410241|FG001|Overall Study|Family member COVID exposure|1|||
129032533|NCT00640926|464410242|FG000|Overall Study|Adverse Event|2|||
129032534|NCT00640926|464410243|FG001|Overall Study|Adverse Event|3|||
129032535|NCT00640926|464410244|FG002|Overall Study|Adverse Event|2|||
129032536|NCT00640926|464410242|FG000|Overall Study|Lack of Efficacy|0|||
129032537|NCT00640926|464410243|FG001|Overall Study|Lack of Efficacy|2|||
129032538|NCT00640926|464410244|FG002|Overall Study|Lack of Efficacy|1|||
129032539|NCT00640926|464410242|FG000|Overall Study|Protocol Violation|2|||
129032540|NCT00640926|464410243|FG001|Overall Study|Protocol Violation|0|||
129032541|NCT00640926|464410244|FG002|Overall Study|Protocol Violation|2|||
129032542|NCT00640926|464410242|FG000|Overall Study|Lost to Follow-up|3|||
129032543|NCT00640926|464410243|FG001|Overall Study|Lost to Follow-up|1|||
129032544|NCT00640926|464410244|FG002|Overall Study|Lost to Follow-up|2|||
129032545|NCT00640926|464410242|FG000|Overall Study|Withdrawal by Subject|1|||
129032546|NCT00640926|464410243|FG001|Overall Study|Withdrawal by Subject|0|||
129032547|NCT00640926|464410244|FG002|Overall Study|Withdrawal by Subject|1|||
129032548|NCT03922750|464410245|FG000|Overall Study|Unclassified|0|||
129032549|NCT03922750|464410246|FG001|Overall Study|Unclassified|0|||
129032550|NCT03922750|464410247|FG002|Overall Study|Unclassified|1|||
129032551|NCT03922750|464410245|FG000|Overall Study|Adverse Event|0|||
129032552|NCT03922750|464410246|FG001|Overall Study|Adverse Event|1|||
129032553|NCT03922750|464410247|FG002|Overall Study|Adverse Event|0|||
129032554|NCT02985398|464410248|FG000|Overall Study|Adverse Event|1|||
129032555|NCT02985398|464410248|FG000|Overall Study|Lost to Follow-up|4|||
129032556|NCT02985398|464410248|FG000|Overall Study|Withdrawal by Subject|8|||
129032557|NCT02985398|464410248|FG000|Overall Study|Study Burden|9|||
129032558|NCT04164758|464410249|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
129032559|NCT04164758|464410250|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
129032560|NCT04164758|464410251|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
129032561|NCT04164758|464410249|FG000|Overall Study|Adverse Event|0|||
129032562|NCT04164758|464410250|FG001|Overall Study|Adverse Event|1|||
129032563|NCT04164758|464410251|FG002|Overall Study|Adverse Event|0|||
129032564|NCT00697827|464410256|FG000|Overall Study|enrolled but not treated|2|||
129032565|NCT00697827|464410257|FG001|Overall Study|enrolled but not treated|1|||
129032566|NCT00283842|464410258|FG000|Overall Study|Adverse Event|8|||
129032567|NCT00283842|464410259|FG001|Overall Study|Adverse Event|7|||
129032568|NCT00283842|464410260|FG002|Overall Study|Adverse Event|21|||
129032569|NCT00283842|464410261|FG003|Overall Study|Adverse Event|21|||
129032570|NCT00283842|464410262|FG004|Overall Study|Adverse Event|5|||
129032571|NCT00283842|464410258|FG000|Overall Study|Protocol Violation|1|||
129032572|NCT00283842|464410259|FG001|Overall Study|Protocol Violation|5|||
129032573|NCT00283842|464410260|FG002|Overall Study|Protocol Violation|4|||
129032574|NCT00283842|464410261|FG003|Overall Study|Protocol Violation|0|||
129032575|NCT00283842|464410262|FG004|Overall Study|Protocol Violation|0|||
129032576|NCT00283842|464410258|FG000|Overall Study|Protocol deviation|0|||
129032577|NCT00283842|464410259|FG001|Overall Study|Protocol deviation|0|||
129032578|NCT00283842|464410260|FG002|Overall Study|Protocol deviation|0|||
129032579|NCT00283842|464410261|FG003|Overall Study|Protocol deviation|0|||
129032580|NCT00283842|464410262|FG004|Overall Study|Protocol deviation|2|||
129032581|NCT00283842|464410258|FG000|Overall Study|Withdrawal by Subject|2|||
129032582|NCT00283842|464410259|FG001|Overall Study|Withdrawal by Subject|1|||
129032583|NCT00283842|464410260|FG002|Overall Study|Withdrawal by Subject|1|||
128707606|NCT00549302|463223892|FG000|Open-Label|Other|0|||
128707607|NCT00549302|463223893|FG001|Open-Label|Other|0|||
128707608|NCT00549302|463223894|FG002|Open-Label|Other|3|||
128707609|NCT00549302|463223892|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
129032584|NCT00283842|464410261|FG003|Overall Study|Withdrawal by Subject|5|||
129032585|NCT00283842|464410262|FG004|Overall Study|Withdrawal by Subject|4|||
129032586|NCT00283842|464410258|FG000|Overall Study|Lack of Efficacy|1|||
129032587|NCT00283842|464410259|FG001|Overall Study|Lack of Efficacy|3|||
128707610|NCT00549302|463223893|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
129032588|NCT00283842|464410260|FG002|Overall Study|Lack of Efficacy|1|||
129032589|NCT00283842|464410261|FG003|Overall Study|Lack of Efficacy|0|||
128707611|NCT00549302|463223894|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
129032590|NCT00283842|464410262|FG004|Overall Study|Lack of Efficacy|3|||
129032591|NCT00283842|464410258|FG000|Overall Study|Lost to Follow-up|0|||
129032592|NCT00283842|464410259|FG001|Overall Study|Lost to Follow-up|2|||
129032593|NCT00283842|464410260|FG002|Overall Study|Lost to Follow-up|4|||
129032594|NCT00283842|464410261|FG003|Overall Study|Lost to Follow-up|1|||
129032595|NCT00283842|464410262|FG004|Overall Study|Lost to Follow-up|1|||
129032596|NCT05665387|464410263|FG000|Overall Study|Withdrawal by Subject|1|||
128707612|NCT00549302|463223892|FG000|Open-Label|Withdrawal by Subject|0|||
129032597|NCT05665387|464410264|FG001|Overall Study|Withdrawal by Subject|0|||
128940810|NCT00726323|464071008|FG001|Overall Study|Withdrawal by Subject|1|||
128940811|NCT00726323|464071007|FG000|Overall Study|Physician Decision|1|||
128940812|NCT00726323|464071008|FG001|Overall Study|Physician Decision|0|||
128940813|NCT00726323|464071007|FG000|Overall Study|Progressive disease|23|||
128940814|NCT00726323|464071008|FG001|Overall Study|Progressive disease|16|||
128940815|NCT00726323|464071007|FG000|Overall Study|Clinical progression|0|||
128940816|NCT00726323|464071008|FG001|Overall Study|Clinical progression|3|||
128940817|NCT00726323|464071007|FG000|Overall Study|Adverse Event|9|||
128940818|NCT00726323|464071008|FG001|Overall Study|Adverse Event|9|||
128940819|NCT00726323|464071007|FG000|Overall Study|Death|1|||
128940820|NCT00726323|464071008|FG001|Overall Study|Death|0|||
128940821|NCT00726323|464071007|FG000|Overall Study|Participant wished to discontinue|0|||
128940822|NCT00726323|464071008|FG001|Overall Study|Participant wished to discontinue|1|||
128940823|NCT00726323|464071007|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
128940824|NCT00726323|464071008|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
128940825|NCT03521154|464071010|FG000|Overall Study|Ongoing study at data cut-off|111|||
128940826|NCT03521154|464071011|FG001|Overall Study|Ongoing study at data cut-off|52|||
128940827|NCT00972478|464071013|FG000|Overall Study|Adverse Event|3|||
128940828|NCT00972478|464071014|FG001|Overall Study|Adverse Event|16|||
128940829|NCT00972478|464071013|FG000|Overall Study|Withdrawal by Subject|1|||
128940830|NCT00972478|464071014|FG001|Overall Study|Withdrawal by Subject|8|||
128940831|NCT00972478|464071013|FG000|Overall Study|Progression/Relapse|0|||
128940832|NCT00972478|464071014|FG001|Overall Study|Progression/Relapse|2|||
128940833|NCT00972478|464071013|FG000|Overall Study|Death|0|||
128940834|NCT00972478|464071014|FG001|Overall Study|Death|2|||
128940835|NCT00972478|464071013|FG000|Overall Study|Not protocol specified|1|||
128940836|NCT00972478|464071014|FG001|Overall Study|Not protocol specified|1|||
128940837|NCT00972478|464071013|FG000|Overall Study|Ineligible|1|||
128940838|NCT00972478|464071014|FG001|Overall Study|Ineligible|7|||
128940839|NCT00972478|464071013|FG000|Overall Study|Not start protocol treatment|1|||
128940840|NCT00972478|464071014|FG001|Overall Study|Not start protocol treatment|2|||
128940841|NCT02561000|464071015|FG000|Overall Study|Withdrawal by Subject|2|||
128940842|NCT02561000|464071016|FG001|Overall Study|Withdrawal by Subject|3|||
128940843|NCT02561000|464071017|FG002|Overall Study|Withdrawal by Subject|0|||
128940844|NCT02561000|464071015|FG000|Overall Study|Adverse Event|0|||
128940845|NCT02561000|464071016|FG001|Overall Study|Adverse Event|1|||
128940846|NCT02561000|464071017|FG002|Overall Study|Adverse Event|0|||
128940847|NCT01522976|464071018|FG000|Overall Study|Ineligible|4|||
128940848|NCT01522976|464071019|FG001|Overall Study|Ineligible|0|||
128940849|NCT01522976|464071020|FG002|Overall Study|Ineligible|1|||
128940850|NCT01522976|464071018|FG000|Overall Study|Death|7|||
128940851|NCT01522976|464071019|FG001|Overall Study|Death|6|||
128940852|NCT01522976|464071020|FG002|Overall Study|Death|2|||
128940853|NCT01522976|464071018|FG000|Overall Study|Still on treatment|9|||
128940854|NCT01522976|464071019|FG001|Overall Study|Still on treatment|9|||
128940855|NCT01522976|464071020|FG002|Overall Study|Still on treatment|6|||
128940856|NCT01522976|464071018|FG000|Overall Study|Disease progression|28|||
128940857|NCT01522976|464071019|FG001|Overall Study|Disease progression|30|||
128940858|NCT01522976|464071020|FG002|Overall Study|Disease progression|25|||
128940859|NCT01522976|464071018|FG000|Overall Study|Adverse Event|17|||
128940860|NCT01522976|464071019|FG001|Overall Study|Adverse Event|7|||
129032598|NCT05665387|464410265|FG002|Overall Study|Withdrawal by Subject|1|||
129032599|NCT03732833|464410266|FG000|Overall Study|Adverse Event|0|||
129032600|NCT03732833|464410267|FG001|Overall Study|Adverse Event|3|||
129032601|NCT03732833|464410268|FG002|Overall Study|Adverse Event|1|||
129032602|NCT03732833|464410266|FG000|Overall Study|Withdrawal by Subject|11|||
129032603|NCT03732833|464410267|FG001|Overall Study|Withdrawal by Subject|13|||
129032604|NCT03732833|464410268|FG002|Overall Study|Withdrawal by Subject|8|||
129032605|NCT03732833|464410266|FG000|Overall Study|Lost to Follow-up|3|||
129032606|NCT03732833|464410267|FG001|Overall Study|Lost to Follow-up|5|||
129032607|NCT03732833|464410268|FG002|Overall Study|Lost to Follow-up|4|||
129032608|NCT03732833|464410266|FG000|Overall Study|Pregnancy|0|||
129032609|NCT03732833|464410267|FG001|Overall Study|Pregnancy|2|||
129032610|NCT03732833|464410268|FG002|Overall Study|Pregnancy|0|||
129032611|NCT03732833|464410266|FG000|Overall Study|Physician Decision|2|||
129032612|NCT03732833|464410267|FG001|Overall Study|Physician Decision|3|||
129032613|NCT03732833|464410268|FG002|Overall Study|Physician Decision|1|||
129032614|NCT03732833|464410266|FG000|Overall Study|Covid-19 related and other reasons|2|||
129032615|NCT03732833|464410267|FG001|Overall Study|Covid-19 related and other reasons|7|||
129032616|NCT03732833|464410268|FG002|Overall Study|Covid-19 related and other reasons|3|||
128940861|NCT01522976|464071020|FG002|Overall Study|Adverse Event|18|||
128940862|NCT01522976|464071018|FG000|Overall Study|Refusal unrelated to adverse event|10|||
128940863|NCT01522976|464071019|FG001|Overall Study|Refusal unrelated to adverse event|13|||
128940864|NCT01522976|464071020|FG002|Overall Study|Refusal unrelated to adverse event|14|||
128940865|NCT01522976|464071018|FG000|Overall Study|Not protocol specified|22|||
128940866|NCT01522976|464071019|FG001|Overall Study|Not protocol specified|27|||
128940867|NCT01522976|464071020|FG002|Overall Study|Not protocol specified|27|||
129032617|NCT02311894|464410272|FG000|Overall Study|Discontinued in error|1|||
129032618|NCT02311894|464410272|FG000|Overall Study|Lost to Follow-up|1|||
128940868|NCT04075266|464071023|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
128940869|NCT04075266|464071024|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
128940870|NCT04075266|464071023|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
128940871|NCT04075266|464071024|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
128940872|NCT05132569|464071025|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
128940873|NCT05132569|464071026|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
128940874|NCT05132569|464071025|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
128940875|NCT05132569|464071026|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
128940876|NCT05132569|464071025|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
128940877|NCT05132569|464071026|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
128940878|NCT04102098|464071027|FG000|Main Study Period|Ongoing in study|302|||
128940879|NCT04102098|464071028|FG001|Main Study Period|Ongoing in study|291|||
128940880|NCT04102098|464071027|FG000|Main Study Period|Death|20|||
128940881|NCT04102098|464071028|FG001|Main Study Period|Death|27|||
128940882|NCT04102098|464071027|FG000|Main Study Period|Lost to Follow-up|1|||
128940883|NCT04102098|464071028|FG001|Main Study Period|Lost to Follow-up|1|||
128940884|NCT04102098|464071027|FG000|Main Study Period|Physician Decision|0|||
128940885|NCT04102098|464071028|FG001|Main Study Period|Physician Decision|1|||
128940886|NCT04102098|464071027|FG000|Main Study Period|Withdrawal by Subject|11|||
128940887|NCT04102098|464071028|FG001|Main Study Period|Withdrawal by Subject|14|||
128940888|NCT04102098|464071027|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
128940889|NCT04102098|464071028|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
128940890|NCT04102098|464071027|FG000|Crossover: AS Who Crossed Over|Death|11|||
128940891|NCT04102098|464071028|FG001|Crossover: AS Who Crossed Over|Death|0|||
128940892|NCT04102098|464071027|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
128940893|NCT04102098|464071028|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
128940894|NCT04742907|464071029|FG000|Overall Study|Adverse Event|1|||
128940895|NCT04742907|464071030|FG001|Overall Study|Adverse Event|0|||
128940896|NCT04742907|464071031|FG002|Overall Study|Adverse Event|1|||
128940897|NCT04742907|464071029|FG000|Overall Study|Lost to Follow-up|3|||
128940898|NCT04742907|464071030|FG001|Overall Study|Lost to Follow-up|3|||
128940899|NCT04742907|464071031|FG002|Overall Study|Lost to Follow-up|2|||
128940900|NCT04742907|464071029|FG000|Overall Study|Physician Decision|0|||
128940901|NCT04742907|464071030|FG001|Overall Study|Physician Decision|1|||
128940902|NCT04742907|464071031|FG002|Overall Study|Physician Decision|0|||
128940903|NCT04742907|464071029|FG000|Overall Study|Protocol Violation|1|||
128940904|NCT04742907|464071030|FG001|Overall Study|Protocol Violation|1|||
128940905|NCT04742907|464071031|FG002|Overall Study|Protocol Violation|1|||
128940906|NCT04742907|464071029|FG000|Overall Study|Withdrawal by Subject|5|||
128940907|NCT04742907|464071030|FG001|Overall Study|Withdrawal by Subject|6|||
128940908|NCT04742907|464071031|FG002|Overall Study|Withdrawal by Subject|4|||
128940909|NCT04742907|464071029|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
128940910|NCT04742907|464071030|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
128940911|NCT04742907|464071031|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
128940912|NCT04742907|464071029|FG000|Overall Study|Did Not Receive the Study Drug|2|||
128940913|NCT04742907|464071030|FG001|Overall Study|Did Not Receive the Study Drug|4|||
128940914|NCT04742907|464071031|FG002|Overall Study|Did Not Receive the Study Drug|4|||
128940915|NCT00365716|464071032|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
128940916|NCT00365716|464071033|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
128940917|NCT00365716|464071034|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
128940918|NCT00365716|464071035|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
128940919|NCT00365716|464071036|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
128940920|NCT00365716|464071037|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
128940921|NCT00365716|464071038|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
128940922|NCT00365716|464071032|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
128940923|NCT00365716|464071033|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
128940924|NCT00365716|464071034|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
128940925|NCT00365716|464071035|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
128940926|NCT00365716|464071036|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
128940927|NCT00365716|464071037|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
129032619|NCT02311894|464410272|FG000|Overall Study|Adverse Event|1|||
129032620|NCT02311894|464410272|FG000|Overall Study|Withdrawal by Subject|1|||
129032621|NCT02472639|464410274|FG000|Overall Study|Physician Decision|4|||
129032622|NCT02472639|464410275|FG001|Overall Study|Physician Decision|3|||
129032623|NCT00751023|464410277|FG000|Overall Study|Lost to Follow-up|11|||
128940928|NCT00365716|464071038|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
128940929|NCT00365716|464071032|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
128940930|NCT00365716|464071033|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
128940931|NCT00365716|464071034|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
128940932|NCT00365716|464071035|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
128940933|NCT00365716|464071036|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
128940934|NCT00365716|464071037|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
128940935|NCT00365716|464071038|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
128940936|NCT00365716|464071032|FG000|Base Study (Day 1 to Month 7)|Other|0|||
128940937|NCT00365716|464071033|FG001|Base Study (Day 1 to Month 7)|Other|1|||
128940938|NCT00365716|464071034|FG002|Base Study (Day 1 to Month 7)|Other|0|||
128940939|NCT00365716|464071035|FG003|Base Study (Day 1 to Month 7)|Other|0|||
128940940|NCT00365716|464071036|FG004|Base Study (Day 1 to Month 7)|Other|0|||
128940941|NCT00365716|464071037|FG005|Base Study (Day 1 to Month 7)|Other|0|||
128940942|NCT00365716|464071038|FG006|Base Study (Day 1 to Month 7)|Other|0|||
128940943|NCT00365716|464071032|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
128940944|NCT00365716|464071033|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
128940945|NCT00365716|464071034|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
128940946|NCT00365716|464071035|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
128940947|NCT00365716|464071036|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
129217714|NCT02745119|465097045|FG002|Overall Study|Physician Decision|2|||
128940948|NCT00365716|464071037|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
128940949|NCT00365716|464071038|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
128940950|NCT00365716|464071032|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
128940951|NCT00365716|464071033|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
129217715|NCT02745119|465097046|FG003|Overall Study|Physician Decision|2|||
129217716|NCT02745119|465097043|FG000|Overall Study|Reason Not Specified|0|||
129217717|NCT02745119|465097044|FG001|Overall Study|Reason Not Specified|2|||
129217718|NCT02745119|465097045|FG002|Overall Study|Reason Not Specified|0|||
129217719|NCT02745119|465097046|FG003|Overall Study|Reason Not Specified|1|||
129217720|NCT01587924|465097047|FG000|Overall Study|Adverse Event|0|||
129217721|NCT01587924|465097048|FG001|Overall Study|Adverse Event|2|||
129217722|NCT01587924|465097049|FG002|Overall Study|Adverse Event|0|||
129217723|NCT01587924|465097050|FG003|Overall Study|Adverse Event|0|||
129217724|NCT01587924|465097047|FG000|Overall Study|Protocol Violation|2|||
129217725|NCT01587924|465097048|FG001|Overall Study|Protocol Violation|1|||
129217726|NCT01587924|465097049|FG002|Overall Study|Protocol Violation|2|||
129217727|NCT01587924|465097050|FG003|Overall Study|Protocol Violation|1|||
129217728|NCT01587924|465097047|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
129217729|NCT01587924|465097048|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
129217730|NCT01587924|465097049|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
129217731|NCT01587924|465097050|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
129217732|NCT01587924|465097047|FG000|Overall Study|Withdrawal by Subject|0|||
129217733|NCT01587924|465097048|FG001|Overall Study|Withdrawal by Subject|1|||
129217734|NCT01587924|465097049|FG002|Overall Study|Withdrawal by Subject|1|||
129217735|NCT01587924|465097050|FG003|Overall Study|Withdrawal by Subject|0|||
129217736|NCT00432172|465097051|FG000|Overall Study|Physician Decision|0|||
129217737|NCT00432172|465097052|FG001|Overall Study|Physician Decision|0|||
129217738|NCT00432172|465097053|FG002|Overall Study|Physician Decision|2|||
129217739|NCT00432172|465097054|FG003|Overall Study|Physician Decision|0|||
129217740|NCT00432172|465097051|FG000|Overall Study|Adverse Event|4|||
129217741|NCT00432172|465097052|FG001|Overall Study|Adverse Event|2|||
129217742|NCT00432172|465097053|FG002|Overall Study|Adverse Event|4|||
129217743|NCT00432172|465097054|FG003|Overall Study|Adverse Event|3|||
129217744|NCT00432172|465097051|FG000|Overall Study|Disease progression|0|||
129217745|NCT00432172|465097052|FG001|Overall Study|Disease progression|2|||
129217746|NCT00432172|465097053|FG002|Overall Study|Disease progression|5|||
128940952|NCT00365716|464071034|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
128940953|NCT00365716|464071035|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
128940954|NCT00365716|464071036|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
128940955|NCT00365716|464071037|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
128940956|NCT00365716|464071038|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
128940957|NCT00365716|464071032|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
128940958|NCT00365716|464071033|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
128940959|NCT00365716|464071034|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
128940960|NCT00365716|464071035|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
128940961|NCT00365716|464071036|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
129217747|NCT00432172|465097054|FG003|Overall Study|Disease progression|1|||
129217748|NCT00432172|465097051|FG000|Overall Study|Withdrawal by Subject|0|||
129217749|NCT00432172|465097052|FG001|Overall Study|Withdrawal by Subject|1|||
129217750|NCT00432172|465097053|FG002|Overall Study|Withdrawal by Subject|0|||
129217751|NCT00432172|465097054|FG003|Overall Study|Withdrawal by Subject|2|||
129217752|NCT00432172|465097051|FG000|Overall Study|No treatment received|2|||
129217753|NCT00432172|465097052|FG001|Overall Study|No treatment received|2|||
129217754|NCT00432172|465097053|FG002|Overall Study|No treatment received|0|||
129217755|NCT00432172|465097054|FG003|Overall Study|No treatment received|1|||
128940962|NCT00365716|464071037|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
128940963|NCT00365716|464071038|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
128940964|NCT00365716|464071032|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
128940965|NCT00365716|464071033|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
129032624|NCT00751023|464410278|FG001|Overall Study|Lost to Follow-up|7|||
129032625|NCT00702507|464410281|FG000|Initial Treatment Phase|Adverse Event|2|||
129032626|NCT00702507|464410281|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
129032627|NCT00702507|464410281|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
129032628|NCT00702507|464410281|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
129032629|NCT00702507|464410281|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
129032630|NCT00702507|464410281|FG000|Follow-up Phase|Protocol Violation|2|||
129032631|NCT00702507|464410281|FG000|Follow-up Phase|Lost to Follow-up|23|||
129032632|NCT00702507|464410281|FG000|Follow-up Phase|Late Enrollment|1|||
129032633|NCT02308696|464410283|FG000|Overall Study|Lost to Follow-up|28|||
129032634|NCT02308696|464410284|FG001|Overall Study|Lost to Follow-up|21|||
129032635|NCT02308696|464410283|FG000|Overall Study|Death|8|||
129123292|NCT00141817|464745614|FG002|Overall Study|Protocol Violation|1|||
129123293|NCT00141817|464745615|FG003|Overall Study|Protocol Violation|0|||
129123294|NCT00141817|464745612|FG000|Overall Study|Parent request|1|||
129123295|NCT00141817|464745613|FG001|Overall Study|Parent request|0|||
129123296|NCT00141817|464745614|FG002|Overall Study|Parent request|0|||
128940966|NCT00365716|464071034|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
128940967|NCT00365716|464071035|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
128940968|NCT00365716|464071036|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
128940969|NCT00365716|464071037|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
128940970|NCT00365716|464071038|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
128940971|NCT00365716|464071032|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
128940972|NCT00365716|464071033|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
128940973|NCT00365716|464071034|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
128940974|NCT00365716|464071035|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
128940975|NCT00365716|464071036|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
128940976|NCT00365716|464071037|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
128940977|NCT00365716|464071038|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
128940978|NCT00365716|464071032|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
128940979|NCT00365716|464071033|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
128940980|NCT00365716|464071034|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
128940981|NCT00365716|464071035|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
128940982|NCT00365716|464071036|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
128940983|NCT00365716|464071037|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
128940984|NCT00365716|464071038|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
128940985|NCT00365716|464071032|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
128940986|NCT00365716|464071033|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
128940987|NCT00365716|464071034|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
128940988|NCT00365716|464071035|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
128940989|NCT00365716|464071036|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
128940990|NCT00365716|464071037|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
128940991|NCT00365716|464071038|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
128940992|NCT00365716|464071032|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
128940993|NCT00365716|464071033|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
128940994|NCT00365716|464071034|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
128940995|NCT00365716|464071035|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
128940996|NCT00365716|464071036|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
128940997|NCT00365716|464071037|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
128940998|NCT00365716|464071038|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
128940999|NCT00365716|464071032|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
128941000|NCT00365716|464071033|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
128941001|NCT00365716|464071034|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
128941002|NCT00365716|464071035|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
128941003|NCT00365716|464071036|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
128941004|NCT00365716|464071037|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
128941005|NCT00365716|464071038|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
128941006|NCT00365716|464071032|FG000|Extension 1|Lost to Follow-up|0|||
128941007|NCT00365716|464071033|FG001|Extension 1|Lost to Follow-up|0|||
128941008|NCT00365716|464071034|FG002|Extension 1|Lost to Follow-up|0|||
128941009|NCT00365716|464071035|FG003|Extension 1|Lost to Follow-up|0|||
128941010|NCT00365716|464071036|FG004|Extension 1|Lost to Follow-up|0|||
129032636|NCT02308696|464410284|FG001|Overall Study|Death|4|||
129123297|NCT00141817|464745615|FG003|Overall Study|Parent request|0|||
129123298|NCT00846365|464745622|FG000|Overall Study|Adverse Event|20|||
128941011|NCT00365716|464071037|FG005|Extension 1|Lost to Follow-up|1|||
129123299|NCT00846365|464745623|FG001|Overall Study|Adverse Event|30|||
129032637|NCT02308696|464410283|FG000|Overall Study|Moved to a Higher Level of Care|17|||
129032638|NCT02308696|464410284|FG001|Overall Study|Moved to a Higher Level of Care|6|||
129123300|NCT00846365|464745624|FG002|Overall Study|Adverse Event|11|||
129123301|NCT00846365|464745622|FG000|Overall Study|Protocol Violation|5|||
128941012|NCT00365716|464071038|FG006|Extension 1|Lost to Follow-up|0|||
128941013|NCT00365716|464071032|FG000|Extension 1|Other|0|||
128941014|NCT00365716|464071033|FG001|Extension 1|Other|0|||
128941015|NCT00365716|464071034|FG002|Extension 1|Other|0|||
128941016|NCT00365716|464071035|FG003|Extension 1|Other|0|||
128941017|NCT00365716|464071036|FG004|Extension 1|Other|0|||
128941018|NCT00365716|464071037|FG005|Extension 1|Other|9|||
128941019|NCT00365716|464071038|FG006|Extension 1|Other|0|||
128941020|NCT00365716|464071032|FG000|Extension 1|Moved|0|||
128941021|NCT00365716|464071033|FG001|Extension 1|Moved|0|||
128941022|NCT00365716|464071034|FG002|Extension 1|Moved|0|||
128941023|NCT00365716|464071035|FG003|Extension 1|Moved|0|||
128941024|NCT00365716|464071036|FG004|Extension 1|Moved|0|||
128941025|NCT00365716|464071037|FG005|Extension 1|Moved|4|||
128941026|NCT00365716|464071038|FG006|Extension 1|Moved|0|||
128941027|NCT00365716|464071032|FG000|Extension 1|Withdrawal by Subject|0|||
128941028|NCT00365716|464071033|FG001|Extension 1|Withdrawal by Subject|0|||
128941029|NCT00365716|464071034|FG002|Extension 1|Withdrawal by Subject|0|||
128941030|NCT00365716|464071035|FG003|Extension 1|Withdrawal by Subject|0|||
128941031|NCT00365716|464071036|FG004|Extension 1|Withdrawal by Subject|0|||
128941032|NCT00365716|464071037|FG005|Extension 1|Withdrawal by Subject|3|||
128941033|NCT00365716|464071038|FG006|Extension 1|Withdrawal by Subject|0|||
128941034|NCT00365716|464071032|FG000|Extension 1|Pregnancy|0|||
128941035|NCT00365716|464071033|FG001|Extension 1|Pregnancy|0|||
128941036|NCT00365716|464071034|FG002|Extension 1|Pregnancy|0|||
128941037|NCT00365716|464071035|FG003|Extension 1|Pregnancy|0|||
128941038|NCT00365716|464071036|FG004|Extension 1|Pregnancy|0|||
128941039|NCT00365716|464071037|FG005|Extension 1|Pregnancy|4|||
128941040|NCT00365716|464071038|FG006|Extension 1|Pregnancy|0|||
128941041|NCT00365716|464071032|FG000|Extension 1|Protocol Violation|0|||
128941042|NCT00365716|464071033|FG001|Extension 1|Protocol Violation|0|||
128941043|NCT00365716|464071034|FG002|Extension 1|Protocol Violation|0|||
128941044|NCT00365716|464071035|FG003|Extension 1|Protocol Violation|0|||
128941045|NCT00365716|464071036|FG004|Extension 1|Protocol Violation|0|||
128941046|NCT00365716|464071037|FG005|Extension 1|Protocol Violation|1|||
128941047|NCT00365716|464071038|FG006|Extension 1|Protocol Violation|0|||
128941048|NCT00365716|464071032|FG000|Extension 2|Lost to Follow-up|0|||
128941049|NCT00365716|464071033|FG001|Extension 2|Lost to Follow-up|0|||
128941050|NCT00365716|464071034|FG002|Extension 2|Lost to Follow-up|0|||
128941051|NCT00365716|464071035|FG003|Extension 2|Lost to Follow-up|0|||
128941052|NCT00365716|464071036|FG004|Extension 2|Lost to Follow-up|0|||
128941053|NCT00365716|464071037|FG005|Extension 2|Lost to Follow-up|0|||
129123302|NCT00846365|464745623|FG001|Overall Study|Protocol Violation|4|||
129123303|NCT00846365|464745624|FG002|Overall Study|Protocol Violation|0|||
129123304|NCT00846365|464745622|FG000|Overall Study|Lost to Follow-up|8|||
129123305|NCT00846365|464745623|FG001|Overall Study|Lost to Follow-up|2|||
129123306|NCT00846365|464745624|FG002|Overall Study|Lost to Follow-up|5|||
129123307|NCT00846365|464745622|FG000|Overall Study|Withdrawal by Subject|11|||
129123308|NCT00846365|464745623|FG001|Overall Study|Withdrawal by Subject|11|||
129123309|NCT00846365|464745624|FG002|Overall Study|Withdrawal by Subject|9|||
129123310|NCT00846365|464745622|FG000|Overall Study|Pregnancy|1|||
129123311|NCT00846365|464745623|FG001|Overall Study|Pregnancy|0|||
129123312|NCT00846365|464745624|FG002|Overall Study|Pregnancy|0|||
129123313|NCT00846365|464745622|FG000|Overall Study|Lack of Efficacy|1|||
129123314|NCT00846365|464745623|FG001|Overall Study|Lack of Efficacy|1|||
129123315|NCT00846365|464745624|FG002|Overall Study|Lack of Efficacy|2|||
129123316|NCT00846365|464745622|FG000|Overall Study|Other|9|||
129123317|NCT00846365|464745623|FG001|Overall Study|Other|1|||
129123318|NCT00846365|464745624|FG002|Overall Study|Other|6|||
129123319|NCT01157845|464745625|FG000|Overall Study|Lost to Follow-up|5|||
129123320|NCT01157845|464745625|FG000|Overall Study|Withdrawal by Subject|12|||
128941054|NCT00365716|464071038|FG006|Extension 2|Lost to Follow-up|2|||
128941055|NCT00365716|464071032|FG000|Extension 2|Other|0|||
128941056|NCT00365716|464071033|FG001|Extension 2|Other|0|||
128941057|NCT00365716|464071034|FG002|Extension 2|Other|0|||
128941058|NCT00365716|464071035|FG003|Extension 2|Other|0|||
128941059|NCT00365716|464071036|FG004|Extension 2|Other|0|||
128941060|NCT00365716|464071037|FG005|Extension 2|Other|0|||
129123321|NCT01157845|464745625|FG000|Overall Study|Physician Decision|3|||
128941061|NCT00365716|464071038|FG006|Extension 2|Other|3|||
129123322|NCT01157845|464745625|FG000|Overall Study|Protocol Violation|13|||
129123323|NCT01157845|464745625|FG000|Overall Study|Study was ended|1|||
129123324|NCT01157845|464745625|FG000|Overall Study|Device malfunction|1|||
129123325|NCT04530630|464746926|FG000|Overall Study|Physician Decision|1|||
128941062|NCT00365716|464071032|FG000|Extension 2|Withdrawal by Subject|0|||
128941063|NCT00365716|464071033|FG001|Extension 2|Withdrawal by Subject|0|||
128941064|NCT00365716|464071034|FG002|Extension 2|Withdrawal by Subject|0|||
128941065|NCT00365716|464071035|FG003|Extension 2|Withdrawal by Subject|0|||
128941066|NCT00365716|464071036|FG004|Extension 2|Withdrawal by Subject|0|||
128941067|NCT00365716|464071037|FG005|Extension 2|Withdrawal by Subject|0|||
128941068|NCT00365716|464071038|FG006|Extension 2|Withdrawal by Subject|5|||
128941069|NCT02280291|464071039|FG000|Overall Study|Lost to Follow-up|2|||
128941070|NCT02280291|464071040|FG001|Overall Study|Lost to Follow-up|1|||
128941071|NCT02280291|464071041|FG002|Overall Study|Lost to Follow-up|3|||
129123326|NCT03675308|464746929|FG000|Overall Study|Adverse Event|3|||
128941072|NCT02280291|464071042|FG003|Overall Study|Lost to Follow-up|8|||
128941073|NCT02280291|464071039|FG000|Overall Study|Protocol Violation|1|||
128941074|NCT02280291|464071040|FG001|Overall Study|Protocol Violation|0|||
128941075|NCT02280291|464071041|FG002|Overall Study|Protocol Violation|0|||
128941076|NCT02280291|464071042|FG003|Overall Study|Protocol Violation|0|||
128941077|NCT02280291|464071039|FG000|Overall Study|Other|1|||
128941078|NCT02280291|464071040|FG001|Overall Study|Other|1|||
128941079|NCT02280291|464071041|FG002|Overall Study|Other|0|||
128941080|NCT02280291|464071042|FG003|Overall Study|Other|0|||
128941081|NCT06150573|464071043|FG000|Overall Study|Did not meet study criteria|1|||
128941082|NCT06150573|464071044|FG001|Overall Study|Did not meet study criteria|0|||
128941083|NCT06150573|464071043|FG000|Overall Study|Adverse Event|1|||
128941084|NCT06150573|464071044|FG001|Overall Study|Adverse Event|0|||
128941085|NCT06150573|464071043|FG000|Overall Study|Lost to Follow-up|0|||
128941086|NCT06150573|464071044|FG001|Overall Study|Lost to Follow-up|1|||
128941087|NCT06150573|464071043|FG000|Overall Study|Protocol Violation|0|||
128941088|NCT06150573|464071044|FG001|Overall Study|Protocol Violation|1|||
128941089|NCT06150573|464071043|FG000|Overall Study|Withdrawal by Subject|2|||
128941090|NCT06150573|464071044|FG001|Overall Study|Withdrawal by Subject|0|||
128941091|NCT00069095|464071045|FG000|Primary Treatment Phase|Ongoing|0|||
128941092|NCT00069095|464071046|FG001|Primary Treatment Phase|Ongoing|0|||
128941093|NCT00069095|464071047|FG002|Primary Treatment Phase|Ongoing|5|||
128941094|NCT00069095|464071048|FG003|Primary Treatment Phase|Ongoing|7|||
128941095|NCT00069095|464071049|FG004|Primary Treatment Phase|Ongoing|7|||
128941096|NCT00069095|464071050|FG005|Primary Treatment Phase|Ongoing|4|||
128941097|NCT00069095|464071045|FG000|Primary Treatment Phase|Admin/Other|29|||
128941098|NCT00069095|464071046|FG001|Primary Treatment Phase|Admin/Other|38|||
128941099|NCT00069095|464071047|FG002|Primary Treatment Phase|Admin/Other|31|||
128941100|NCT00069095|464071048|FG003|Primary Treatment Phase|Admin/Other|45|||
128941101|NCT00069095|464071049|FG004|Primary Treatment Phase|Admin/Other|48|||
128941102|NCT00069095|464071050|FG005|Primary Treatment Phase|Admin/Other|42|||
128941103|NCT00069095|464071045|FG000|Primary Treatment Phase|Adverse Event|99|||
128941104|NCT00069095|464071046|FG001|Primary Treatment Phase|Adverse Event|92|||
128941105|NCT00069095|464071047|FG002|Primary Treatment Phase|Adverse Event|71|||
128941106|NCT00069095|464071048|FG003|Primary Treatment Phase|Adverse Event|72|||
128941107|NCT00069095|464071049|FG004|Primary Treatment Phase|Adverse Event|109|||
128941108|NCT00069095|464071050|FG005|Primary Treatment Phase|Adverse Event|101|||
128941109|NCT00069095|464071045|FG000|Primary Treatment Phase|Death|14|||
128941110|NCT00069095|464071046|FG001|Primary Treatment Phase|Death|8|||
128941111|NCT00069095|464071047|FG002|Primary Treatment Phase|Death|2|||
128941112|NCT00069095|464071048|FG003|Primary Treatment Phase|Death|5|||
128941113|NCT00069095|464071049|FG004|Primary Treatment Phase|Death|8|||
128941114|NCT00069095|464071050|FG005|Primary Treatment Phase|Death|8|||
128941115|NCT00069095|464071045|FG000|Primary Treatment Phase|Failure to return|5|||
128941116|NCT00069095|464071046|FG001|Primary Treatment Phase|Failure to return|5|||
128941117|NCT00069095|464071047|FG002|Primary Treatment Phase|Failure to return|0|||
128941118|NCT00069095|464071048|FG003|Primary Treatment Phase|Failure to return|0|||
128941119|NCT00069095|464071049|FG004|Primary Treatment Phase|Failure to return|0|||
128941120|NCT00069095|464071050|FG005|Primary Treatment Phase|Failure to return|2|||
128941121|NCT00069095|464071045|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
128941122|NCT00069095|464071046|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
128941123|NCT00069095|464071047|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
128941124|NCT00069095|464071048|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
128941125|NCT00069095|464071049|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
128941126|NCT00069095|464071050|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
128941127|NCT00069095|464071045|FG000|Primary Treatment Phase|Refused treatment|15|||
128941128|NCT00069095|464071046|FG001|Primary Treatment Phase|Refused treatment|26|||
128941129|NCT00069095|464071047|FG002|Primary Treatment Phase|Refused treatment|17|||
128941130|NCT00069095|464071048|FG003|Primary Treatment Phase|Refused treatment|31|||
128941131|NCT00069095|464071049|FG004|Primary Treatment Phase|Refused treatment|24|||
128941132|NCT00069095|464071050|FG005|Primary Treatment Phase|Refused treatment|27|||
128941133|NCT00069095|464071045|FG000|Primary Treatment Phase|Withdrew|2|||
128941134|NCT00069095|464071046|FG001|Primary Treatment Phase|Withdrew|3|||
128941135|NCT00069095|464071047|FG002|Primary Treatment Phase|Withdrew|8|||
128941136|NCT00069095|464071048|FG003|Primary Treatment Phase|Withdrew|2|||
128941137|NCT00069095|464071049|FG004|Primary Treatment Phase|Withdrew|4|||
128941138|NCT00069095|464071050|FG005|Primary Treatment Phase|Withdrew|9|||
128941139|NCT00069095|464071045|FG000|Primary Treatment Phase|Other Violation|0|||
128941140|NCT00069095|464071046|FG001|Primary Treatment Phase|Other Violation|1|||
128941141|NCT00069095|464071047|FG002|Primary Treatment Phase|Other Violation|1|||
129032639|NCT01211262|464410288|FG000|Overall Study|Progressive Disease|18|||
129032640|NCT01211262|464410289|FG001|Overall Study|Progressive Disease|9|||
128941142|NCT00069095|464071048|FG003|Primary Treatment Phase|Other Violation|1|||
128941143|NCT00069095|464071049|FG004|Primary Treatment Phase|Other Violation|0|||
128941144|NCT00069095|464071050|FG005|Primary Treatment Phase|Other Violation|1|||
128941145|NCT00069095|464071045|FG000|Primary Treatment Phase|Violation criteria|0|||
128941146|NCT00069095|464071046|FG001|Primary Treatment Phase|Violation criteria|2|||
129032641|NCT01211262|464410288|FG000|Overall Study|Adverse Event|4|||
129032642|NCT01211262|464410289|FG001|Overall Study|Adverse Event|0|||
129032643|NCT01211262|464410288|FG000|Overall Study|Withdrawal of Consent|1|||
129032644|NCT01211262|464410289|FG001|Overall Study|Withdrawal of Consent|0|||
129032645|NCT01211262|464410288|FG000|Overall Study|Other|0|||
129032646|NCT01211262|464410289|FG001|Overall Study|Other|1|||
129032647|NCT04049097|464410290|FG000|Overall Study|Adverse Event|18|||
129032648|NCT04049097|464410290|FG000|Overall Study|Death|2|||
129032649|NCT04049097|464410290|FG000|Overall Study|Lost to Follow-up|1|||
129032650|NCT04049097|464410290|FG000|Overall Study|Physician Decision|2|||
129032651|NCT04049097|464410290|FG000|Overall Study|Withdrawal by Subject|9|||
129032652|NCT04049097|464410290|FG000|Overall Study|Protocol Violation|2|||
129032653|NCT04049097|464410290|FG000|Overall Study|Other|1|||
129032654|NCT04049097|464410290|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
129032655|NCT03980522|464410298|FG000|Treatment Period|Adverse Event|1|||
129032656|NCT03980522|464410299|FG001|Treatment Period|Adverse Event|0|||
129032657|NCT03980522|464410300|FG002|Treatment Period|Adverse Event|0|||
128707613|NCT00549302|463223893|FG001|Open-Label|Withdrawal by Subject|0|||
128707614|NCT00549302|463223894|FG002|Open-Label|Withdrawal by Subject|6|||
128707615|NCT03585504|463223895|FG000|Overall Study|Lost to Follow-up|26|||
128707616|NCT03585504|463223896|FG001|Overall Study|Lost to Follow-up|29|||
128941147|NCT00069095|464071047|FG002|Primary Treatment Phase|Violation criteria|4|||
128941148|NCT00069095|464071048|FG003|Primary Treatment Phase|Violation criteria|3|||
128941149|NCT00069095|464071049|FG004|Primary Treatment Phase|Violation criteria|1|||
128941150|NCT00069095|464071050|FG005|Primary Treatment Phase|Violation criteria|5|||
128941151|NCT00069095|464071045|FG000|Post-study Treatment Phase|Missing reason|1|||
128941152|NCT00069095|464071046|FG001|Post-study Treatment Phase|Missing reason|3|||
128941153|NCT00069095|464071047|FG002|Post-study Treatment Phase|Missing reason|12|||
128941154|NCT00069095|464071048|FG003|Post-study Treatment Phase|Missing reason|8|||
128941155|NCT00069095|464071049|FG004|Post-study Treatment Phase|Missing reason|18|||
128941156|NCT00069095|464071050|FG005|Post-study Treatment Phase|Missing reason|17|||
128941157|NCT00069095|464071045|FG000|Post-study Treatment Phase|Adverse Event|2|||
128941158|NCT00069095|464071046|FG001|Post-study Treatment Phase|Adverse Event|3|||
128941159|NCT00069095|464071047|FG002|Post-study Treatment Phase|Adverse Event|1|||
128941160|NCT00069095|464071048|FG003|Post-study Treatment Phase|Adverse Event|0|||
128941161|NCT00069095|464071049|FG004|Post-study Treatment Phase|Adverse Event|5|||
128941162|NCT00069095|464071050|FG005|Post-study Treatment Phase|Adverse Event|1|||
128941163|NCT00069095|464071045|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
128941164|NCT00069095|464071046|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
128941165|NCT00069095|464071047|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
128941166|NCT00069095|464071048|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
128941167|NCT00069095|464071049|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
128941168|NCT00069095|464071050|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
128941169|NCT00069095|464071045|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
128941170|NCT00069095|464071046|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
128941171|NCT00069095|464071047|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
128941172|NCT00069095|464071048|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
128941173|NCT00069095|464071049|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
128941174|NCT00069095|464071050|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
128941175|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
128941176|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
128941177|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
128941178|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
128941179|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
128941180|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
128941181|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant had complete response|1|||
128941182|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant had complete response|1|||
128941183|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant had complete response|0|||
128941184|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant had complete response|0|||
128941185|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant had complete response|0|||
128941186|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant had complete response|0|||
128941187|NCT00069095|464071045|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
128941188|NCT00069095|464071046|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
128941189|NCT00069095|464071047|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
128941190|NCT00069095|464071048|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
128941191|NCT00069095|464071049|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
129032658|NCT03980522|464410301|FG003|Treatment Period|Adverse Event|0|||
129032659|NCT03980522|464410302|FG004|Treatment Period|Adverse Event|0|||
129032660|NCT04892147|464410303|FG000|Overall Study|Withdrawal by Subject|2|||
129032661|NCT04892147|464410304|FG001|Overall Study|Withdrawal by Subject|0|||
128707617|NCT01414114|463223897|FG000|Overall Study|Adverse Event|2|||
128770218|NCT01799720|463450161|FG002|Overall Study|Withdrawal by Subject|0|||
128770219|NCT01799720|463450159|FG000|Overall Study|Protocol Violation|0|||
128941192|NCT00069095|464071050|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
128941193|NCT00069095|464071045|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
128941194|NCT00069095|464071046|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
128941195|NCT00069095|464071047|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
128941196|NCT00069095|464071048|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
128941197|NCT00069095|464071049|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
128941198|NCT00069095|464071050|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
128941199|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
128941200|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
128941201|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
128941202|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
128941203|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
128941204|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
128941205|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
128941206|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
128941207|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
128941208|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
128941209|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
128941210|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
128941211|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
128941212|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
128941213|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
128941214|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
128941215|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
128941216|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
128941217|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
128941218|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
128941219|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
128941220|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
128941221|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
128941222|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
128941223|NCT00069095|464071045|FG000|Post-study Treatment Phase|Surgery|0|||
128941224|NCT00069095|464071046|FG001|Post-study Treatment Phase|Surgery|0|||
128941225|NCT00069095|464071047|FG002|Post-study Treatment Phase|Surgery|0|||
128941226|NCT00069095|464071048|FG003|Post-study Treatment Phase|Surgery|1|||
128941227|NCT00069095|464071049|FG004|Post-study Treatment Phase|Surgery|1|||
128941228|NCT00069095|464071050|FG005|Post-study Treatment Phase|Surgery|0|||
128941229|NCT00069095|464071045|FG000|Post-study Treatment Phase|Death|0|||
128941230|NCT00069095|464071046|FG001|Post-study Treatment Phase|Death|0|||
128941231|NCT00069095|464071047|FG002|Post-study Treatment Phase|Death|0|||
128941232|NCT00069095|464071048|FG003|Post-study Treatment Phase|Death|0|||
128941233|NCT00069095|464071049|FG004|Post-study Treatment Phase|Death|1|||
128941234|NCT00069095|464071050|FG005|Post-study Treatment Phase|Death|0|||
128941235|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
128941236|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
128941237|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
128941238|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
128941239|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
128941240|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
128941241|NCT00069095|464071045|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
128941242|NCT00069095|464071046|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
128941243|NCT00069095|464071047|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
128941244|NCT00069095|464071048|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
128941245|NCT00069095|464071049|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
128941246|NCT00069095|464071050|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
128941247|NCT00069095|464071045|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
128941248|NCT00069095|464071046|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
128941249|NCT00069095|464071047|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
128941250|NCT00069095|464071048|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
128941251|NCT00069095|464071049|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
128941252|NCT00069095|464071050|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
128770220|NCT01799720|463450160|FG001|Overall Study|Protocol Violation|1|||
129032662|NCT02661022|464410305|FG000|Overall Study|Withdrawal by Subject|3|||
129032663|NCT02661022|464410306|FG001|Overall Study|Withdrawal by Subject|0|||
129032664|NCT02661022|464410305|FG000|Overall Study|Adverse Event|1|||
129032665|NCT02661022|464410306|FG001|Overall Study|Adverse Event|1|||
129032666|NCT02661022|464410305|FG000|Overall Study|Physician Decision|1|||
129032667|NCT02661022|464410306|FG001|Overall Study|Physician Decision|0|||
129032668|NCT02661022|464410305|FG000|Overall Study|Progressive Disease|2|||
129032669|NCT02661022|464410306|FG001|Overall Study|Progressive Disease|1|||
129032670|NCT01785615|464410314|FG000|Dietary Phase|Lost to Follow-up|0|||
129032671|NCT01785615|464410315|FG001|Dietary Phase|Lost to Follow-up|0|||
129032672|NCT01785615|464410316|FG002|Dietary Phase|Lost to Follow-up|0|||
129032673|NCT01785615|464410317|FG003|Dietary Phase|Lost to Follow-up|24|||
129032674|NCT03428945|464410318|FG000|Overall Study|Lost to Follow-up|5|||
129032675|NCT03428945|464410319|FG001|Overall Study|Lost to Follow-up|3|||
129032676|NCT03428945|464410318|FG000|Overall Study|Withdrawal by Subject|10|||
129032677|NCT03428945|464410319|FG001|Overall Study|Withdrawal by Subject|10|||
129123327|NCT03675308|464746930|FG001|Overall Study|Adverse Event|2|||
129123328|NCT03675308|464746929|FG000|Overall Study|Withdrawal by Subject|6|||
129123329|NCT03675308|464746930|FG001|Overall Study|Withdrawal by Subject|4|||
129123330|NCT03675308|464746929|FG000|Overall Study|Lost to Follow-up|3|||
128941253|NCT00069095|464071045|FG000|Post-study Treatment Phase|Investigator decision|0|||
128941254|NCT00069095|464071046|FG001|Post-study Treatment Phase|Investigator decision|0|||
128941255|NCT00069095|464071047|FG002|Post-study Treatment Phase|Investigator decision|0|||
128941256|NCT00069095|464071048|FG003|Post-study Treatment Phase|Investigator decision|0|||
128941257|NCT00069095|464071049|FG004|Post-study Treatment Phase|Investigator decision|0|||
128941258|NCT00069095|464071050|FG005|Post-study Treatment Phase|Investigator decision|1|||
128941259|NCT00069095|464071045|FG000|Follow-up Phase|Death|174|||
128941260|NCT00069095|464071046|FG001|Follow-up Phase|Death|206|||
128941261|NCT00069095|464071047|FG002|Follow-up Phase|Death|120|||
128941262|NCT00069095|464071048|FG003|Follow-up Phase|Death|112|||
128941263|NCT00069095|464071049|FG004|Follow-up Phase|Death|92|||
128941264|NCT00069095|464071050|FG005|Follow-up Phase|Death|101|||
128941265|NCT03508622|464071051|FG000|Overall Study|Protocol Violation|1|||
128941266|NCT03508622|464071052|FG001|Overall Study|Protocol Violation|0|||
128941267|NCT03508622|464071051|FG000|Overall Study|Withdrawal by Subject|1|||
128941268|NCT03508622|464071052|FG001|Overall Study|Withdrawal by Subject|0|||
128941269|NCT03508622|464071051|FG000|Overall Study|Lost to Follow-up|16|||
128941270|NCT03508622|464071052|FG001|Overall Study|Lost to Follow-up|0|||
128941271|NCT03508622|464071051|FG000|Overall Study|Incomplete data|0|||
128941272|NCT03508622|464071052|FG001|Overall Study|Incomplete data|24|||
128941273|NCT00210158|464071054|FG000|Overall Study|Protocol Violation|0|||
128941274|NCT00210158|464071055|FG001|Overall Study|Protocol Violation|2|||
128941275|NCT04716933|464071056|FG000|Overall Study|Sponsor Decision|36|||
128941276|NCT04716933|464071057|FG001|Overall Study|Sponsor Decision|33|||
128941277|NCT04716933|464071056|FG000|Overall Study|Death|65|||
128941278|NCT04716933|464071057|FG001|Overall Study|Death|67|||
128941279|NCT03196505|464071060|FG000|Overall Study|Physician Decision|26|||
128941280|NCT03196505|464071061|FG001|Overall Study|Physician Decision|26|||
128941281|NCT01005719|464071062|FG000|Period 1|Adverse Event|0|||
128941282|NCT01005719|464071063|FG001|Period 1|Adverse Event|0|||
128941283|NCT01005719|464071064|FG002|Period 1|Adverse Event|0|||
128941284|NCT01005719|464071065|FG003|Period 1|Adverse Event|1|||
128941285|NCT01005719|464071066|FG004|Period 1|Adverse Event|0|||
128941286|NCT01005719|464071067|FG005|Period 1|Adverse Event|0|||
128941287|NCT01005719|464071062|FG000|Period 1|Delay in completing study procedures|0|||
128941288|NCT01005719|464071063|FG001|Period 1|Delay in completing study procedures|0|||
128941289|NCT01005719|464071064|FG002|Period 1|Delay in completing study procedures|0|||
128941290|NCT01005719|464071065|FG003|Period 1|Delay in completing study procedures|0|||
128941291|NCT01005719|464071066|FG004|Period 1|Delay in completing study procedures|0|||
128941292|NCT01005719|464071067|FG005|Period 1|Delay in completing study procedures|1|||
128941293|NCT01005719|464071062|FG000|Period 2|Adverse Event|0|||
129123331|NCT03675308|464746930|FG001|Overall Study|Lost to Follow-up|0|||
129123332|NCT03675308|464746929|FG000|Overall Study|Lack of Efficacy|1|||
129032678|NCT01266603|464410321|FG000|Overall Study|Adverse Event|1|||
129123333|NCT03675308|464746930|FG001|Overall Study|Lack of Efficacy|1|||
128941294|NCT01005719|464071063|FG001|Period 2|Adverse Event|0|||
129032679|NCT01266603|464410321|FG000|Overall Study|Lack of Efficacy|14|||
129032680|NCT01266603|464410321|FG000|Overall Study|Withdrawal by Subject|1|||
128941295|NCT01005719|464071064|FG002|Period 2|Adverse Event|0|||
128941296|NCT01005719|464071065|FG003|Period 2|Adverse Event|0|||
128941297|NCT01005719|464071066|FG004|Period 2|Adverse Event|1|||
128941298|NCT01005719|464071067|FG005|Period 2|Adverse Event|1|||
129123334|NCT03675308|464746929|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
129217756|NCT02425943|465097055|FG000|Overall Study|Adverse Event|3|||
128941299|NCT00069576|464071068|FG000|Original Trial|Lost to Follow-up|25|||
128941300|NCT00069576|464071069|FG001|Original Trial|Lost to Follow-up|33|||
128941301|NCT00069576|464071068|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
129032681|NCT01266603|464410321|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
129032682|NCT01598896|464410323|FG000|Overall Study|Withdrawal by Subject|0|||
128941302|NCT00069576|464071069|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
128941303|NCT05590793|464071070|FG000|Overall Study|Withdrawal by Subject|6|||
128941304|NCT05590793|464071070|FG000|Overall Study|Physician Decision|1|||
128941305|NCT03015610|464071071|FG000|Overall Study|Lost to Follow-up|1|||
128941306|NCT03015610|464071072|FG001|Overall Study|Lost to Follow-up|5|||
128941307|NCT05100199|464071073|FG000|Overall Study|Lost to Follow-up|5|||
128941308|NCT05100199|464071074|FG001|Overall Study|Lost to Follow-up|8|||
128941309|NCT05100199|464071075|FG002|Overall Study|Lost to Follow-up|3|||
128941310|NCT05100199|464071076|FG003|Overall Study|Lost to Follow-up|6|||
128941311|NCT05100199|464071073|FG000|Overall Study|Withdrawal by Subject|3|||
128941312|NCT05100199|464071074|FG001|Overall Study|Withdrawal by Subject|3|||
128941313|NCT05100199|464071075|FG002|Overall Study|Withdrawal by Subject|9|||
128941314|NCT05100199|464071076|FG003|Overall Study|Withdrawal by Subject|7|||
128941315|NCT05100199|464071073|FG000|Overall Study|Other|0|||
128941316|NCT05100199|464071074|FG001|Overall Study|Other|0|||
128941317|NCT05100199|464071075|FG002|Overall Study|Other|1|||
128941318|NCT05100199|464071076|FG003|Overall Study|Other|1|||
128941319|NCT00001262|464071080|FG000|Overall Study|Death|10|||
128941320|NCT00001262|464071081|FG001|Overall Study|Death|11|||
128941321|NCT00001262|464071082|FG002|Overall Study|Death|0|||
128941322|NCT00001262|464071080|FG000|Overall Study|Withdrawal by Subject|0|||
128941323|NCT00001262|464071081|FG001|Overall Study|Withdrawal by Subject|3|||
128941324|NCT00001262|464071082|FG002|Overall Study|Withdrawal by Subject|0|||
128941325|NCT00878072|464071084|FG000|Overall Study|Withdrew consent|2|||
128941326|NCT03844633|464071088|FG000|1 Week FU|Lost to Follow-up|0|||
128941327|NCT03844633|464071089|FG001|1 Week FU|Lost to Follow-up|1|||
128941328|NCT03844633|464071090|FG002|1 Week FU|Lost to Follow-up|4|||
128941329|NCT03844633|464071088|FG000|12-month Follow-up|Lost to Follow-up|7|||
128941330|NCT03844633|464071089|FG001|12-month Follow-up|Lost to Follow-up|5|||
128941331|NCT03844633|464071090|FG002|12-month Follow-up|Lost to Follow-up|8|||
128941332|NCT02588248|464071095|FG000|Overall Study|Physician Decision|4|||
128941333|NCT02588248|464071096|FG001|Overall Study|Physician Decision|3|||
128941334|NCT05306873|464072393|FG000|Stage 2|Study stopped|1|||
128941335|NCT05306873|464072394|FG001|Stage 2|Study stopped|1|||
128941336|NCT05306873|464072395|FG002|Stage 2|Study stopped|0|||
128941337|NCT05306873|464072396|FG003|Stage 2|Study stopped|0|||
128941338|NCT05306873|464072393|FG000|Stage 2|Stage 2 Treatment Failure|2|||
128941339|NCT05306873|464072394|FG001|Stage 2|Stage 2 Treatment Failure|3|||
128941340|NCT05306873|464072395|FG002|Stage 2|Stage 2 Treatment Failure|0|||
128941341|NCT05306873|464072396|FG003|Stage 2|Stage 2 Treatment Failure|0|||
128941342|NCT05306873|464072393|FG000|Stage 2|Logistical issues due to participant moving|1|||
128941343|NCT05306873|464072394|FG001|Stage 2|Logistical issues due to participant moving|0|||
128941344|NCT05306873|464072395|FG002|Stage 2|Logistical issues due to participant moving|0|||
128941345|NCT05306873|464072396|FG003|Stage 2|Logistical issues due to participant moving|0|||
128941346|NCT05306873|464072393|FG000|Stage 3|Stage 3 Treatment Failure|0|||
128941347|NCT05306873|464072394|FG001|Stage 3|Stage 3 Treatment Failure|0|||
128941348|NCT05306873|464072395|FG002|Stage 3|Stage 3 Treatment Failure|0|||
128941349|NCT05306873|464072396|FG003|Stage 3|Stage 3 Treatment Failure|1|||
128941350|NCT05306873|464072393|FG000|Stage 3|Study Stopped|0|||
128941351|NCT05306873|464072394|FG001|Stage 3|Study Stopped|0|||
128941352|NCT05306873|464072395|FG002|Stage 3|Study Stopped|1|||
128941353|NCT05306873|464072396|FG003|Stage 3|Study Stopped|0|||
128941354|NCT02626819|464072397|FG000|Overall Study|Lost to Follow-up|3|||
128941355|NCT02626819|464072398|FG001|Overall Study|Lost to Follow-up|2|||
128941356|NCT02626819|464072397|FG000|Overall Study|Withdrawal by Subject|1|||
128941357|NCT02626819|464072398|FG001|Overall Study|Withdrawal by Subject|0|||
128941358|NCT02626819|464072397|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
128941359|NCT02626819|464072398|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
128941360|NCT01701583|464072402|FG000|Overall Study|Withdrawal by Subject|2|||
129032683|NCT01598896|464410324|FG001|Overall Study|Withdrawal by Subject|1|||
128941361|NCT01701583|464072403|FG001|Overall Study|Withdrawal by Subject|0|||
128941362|NCT01441440|464072404|FG000|Overall Study|Death|1|||
128941363|NCT01441440|464072405|FG001|Overall Study|Death|0|||
128941364|NCT01441440|464072406|FG002|Overall Study|Death|1|||
128941365|NCT01441440|464072404|FG000|Overall Study|Adverse Event|2|||
128941366|NCT01441440|464072405|FG001|Overall Study|Adverse Event|9|||
128941367|NCT01441440|464072406|FG002|Overall Study|Adverse Event|9|||
129032684|NCT01598896|464410323|FG000|Overall Study|Lack of Efficacy|0|||
129032685|NCT01598896|464410324|FG001|Overall Study|Lack of Efficacy|1|||
128941368|NCT01441440|464072404|FG000|Overall Study|Lost to Follow-up|0|||
128941369|NCT01441440|464072405|FG001|Overall Study|Lost to Follow-up|2|||
128941370|NCT01441440|464072406|FG002|Overall Study|Lost to Follow-up|1|||
128941371|NCT01441440|464072404|FG000|Overall Study|Withdrawal by Subject|11|||
128941372|NCT01441440|464072405|FG001|Overall Study|Withdrawal by Subject|9|||
128941373|NCT01441440|464072406|FG002|Overall Study|Withdrawal by Subject|9|||
128941374|NCT01441440|464072404|FG000|Overall Study|Pregnancy|1|||
128941375|NCT01441440|464072405|FG001|Overall Study|Pregnancy|0|||
128941376|NCT01441440|464072406|FG002|Overall Study|Pregnancy|0|||
128941377|NCT01441440|464072404|FG000|Overall Study|Lack of Efficacy|1|||
128941378|NCT01441440|464072405|FG001|Overall Study|Lack of Efficacy|0|||
128941379|NCT01441440|464072406|FG002|Overall Study|Lack of Efficacy|1|||
128941380|NCT01441440|464072404|FG000|Overall Study|Moving|0|||
128941381|NCT01441440|464072405|FG001|Overall Study|Moving|1|||
128941382|NCT01441440|464072406|FG002|Overall Study|Moving|1|||
128941383|NCT01441440|464072404|FG000|Overall Study|Work-related matter|0|||
128941384|NCT01441440|464072405|FG001|Overall Study|Work-related matter|1|||
128941385|NCT01441440|464072406|FG002|Overall Study|Work-related matter|0|||
128941386|NCT01441440|464072404|FG000|Overall Study|Difficllty in keeping the schedule|1|||
128941387|NCT01441440|464072405|FG001|Overall Study|Difficllty in keeping the schedule|1|||
128941388|NCT01441440|464072406|FG002|Overall Study|Difficllty in keeping the schedule|0|||
128941389|NCT02750813|464072407|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
128941390|NCT02750813|464072408|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
128941391|NCT02750813|464072407|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
128941392|NCT02750813|464072408|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
128941393|NCT02245568|464072409|FG000|Overall Study|Study terminated by Sponsor|346|||
128941394|NCT02245568|464072409|FG000|Overall Study|Adverse Event|144|||
128941395|NCT02245568|464072409|FG000|Overall Study|Lack of Efficacy|98|||
128941396|NCT02245568|464072409|FG000|Overall Study|Withdrawal by Caregiver|85|||
128941397|NCT02245568|464072409|FG000|Overall Study|Withdrawal by Subject|77|||
128941398|NCT02245568|464072409|FG000|Overall Study|Withdrawal by Legal Representative|31|||
128941399|NCT02245568|464072409|FG000|Overall Study|Missing (Site closure)|16|||
128941400|NCT02245568|464072409|FG000|Overall Study|Physician Decision|14|||
128941401|NCT02245568|464072409|FG000|Overall Study|Non-compliance with study drug|11|||
128941402|NCT02245568|464072409|FG000|Overall Study|Death|9|||
128941403|NCT02245568|464072409|FG000|Overall Study|Blue staining|6|||
128941404|NCT02245568|464072409|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
128941405|NCT02245568|464072409|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
128941406|NCT02245568|464072409|FG000|Overall Study|Lost to Follow-up|5|||
128941407|NCT00366548|464072410|FG000|Infant Series|Adverse Event|1|||
128941408|NCT00366548|464072411|FG001|Infant Series|Adverse Event|3|||
128941409|NCT00366548|464072410|FG000|Infant Series|Protocol Violation|0|||
128941410|NCT00366548|464072411|FG001|Infant Series|Protocol Violation|1|||
128941411|NCT00366548|464072410|FG000|Infant Series|Withdrawal by Subject|3|||
128941412|NCT00366548|464072411|FG001|Infant Series|Withdrawal by Subject|1|||
128941413|NCT00366548|464072410|FG000|After Infant Series|Withdrawal by Subject|3|||
128941414|NCT00366548|464072411|FG001|After Infant Series|Withdrawal by Subject|1|||
128941415|NCT00366548|464072410|FG000|After Infant Series|Adverse Event|2|||
128941416|NCT00366548|464072411|FG001|After Infant Series|Adverse Event|0|||
128941417|NCT00366548|464072410|FG000|After Infant Series|Lost to Follow-up|1|||
128941418|NCT00366548|464072411|FG001|After Infant Series|Lost to Follow-up|0|||
128941419|NCT02849990|464072412|FG000|Overall Study|Adverse Event|1|||
128941420|NCT02849990|464072412|FG000|Overall Study|Withdrawal by Subject|1|||
128941421|NCT01051986|464072414|FG000|Overall Study|Death|1|||
128941422|NCT01051986|464072415|FG001|Overall Study|Death|0|||
128941423|NCT01051986|464072414|FG000|Overall Study|Withdrawal by Subject|2|||
128941424|NCT01051986|464072415|FG001|Overall Study|Withdrawal by Subject|1|||
128941425|NCT01051986|464072414|FG000|Overall Study|Protocol Violation|2|||
128941426|NCT01051986|464072415|FG001|Overall Study|Protocol Violation|3|||
128941427|NCT01725152|464072417|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
128941428|NCT01725152|464072418|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
128941429|NCT01725152|464072417|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
128941430|NCT01725152|464072418|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
128941431|NCT01725152|464072417|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
128941432|NCT01725152|464072418|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
128941433|NCT01725152|464072417|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
128941434|NCT01725152|464072418|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
128941435|NCT02044159|464072419|FG000|Overall Study|Consent declined (deferred consent)|2|||
128941436|NCT02044159|464072420|FG001|Overall Study|Consent declined (deferred consent)|4|||
128941437|NCT02044159|464072419|FG000|Overall Study|No longer eligible, drug not given|1|||
128941438|NCT02044159|464072420|FG001|Overall Study|No longer eligible, drug not given|0|||
128941439|NCT02044159|464072419|FG000|Overall Study|Nurse declined to give study drug|1|||
128941440|NCT02044159|464072420|FG001|Overall Study|Nurse declined to give study drug|0|||
128941441|NCT01111539|464072421|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
128941442|NCT01111539|464072422|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128941443|NCT01111539|464072423|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128941444|NCT01111539|464072424|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128941445|NCT01111539|464072425|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
128941446|NCT01111539|464072421|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
128941447|NCT01111539|464072422|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128941448|NCT01111539|464072423|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128941449|NCT01111539|464072424|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128941450|NCT01111539|464072425|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
128941451|NCT01111539|464072421|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
128941452|NCT01111539|464072422|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128941453|NCT01111539|464072423|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128941454|NCT01111539|464072424|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128941455|NCT01111539|464072425|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128941456|NCT01111539|464072421|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
128941457|NCT01111539|464072422|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
128941458|NCT01111539|464072423|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
128941459|NCT01111539|464072424|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
128941460|NCT01111539|464072425|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
128941461|NCT01111539|464072421|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
128941462|NCT01111539|464072422|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
128941463|NCT01111539|464072423|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
128941464|NCT01111539|464072424|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
128941465|NCT01111539|464072425|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
128941466|NCT01111539|464072421|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
128941467|NCT01111539|464072422|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128941468|NCT01111539|464072423|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128941469|NCT01111539|464072424|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128941470|NCT01111539|464072425|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
128941471|NCT01111539|464072421|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
128941472|NCT01111539|464072422|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
128941473|NCT01111539|464072423|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
128941474|NCT01111539|464072424|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
128941475|NCT01111539|464072425|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
128941476|NCT01111539|464072421|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
128941477|NCT01111539|464072422|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
128941478|NCT01111539|464072423|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
128941479|NCT01111539|464072424|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
128941480|NCT01111539|464072425|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
128941481|NCT01111539|464072421|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
128941482|NCT01111539|464072422|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
128941483|NCT01111539|464072423|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
128941484|NCT01111539|464072424|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
128941485|NCT01111539|464072425|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
128941486|NCT01111539|464072421|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
128941487|NCT01111539|464072422|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
128941488|NCT01111539|464072423|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
128941489|NCT01111539|464072424|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
128941490|NCT01111539|464072425|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
128941491|NCT01111539|464072421|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
128941492|NCT01111539|464072422|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
128941493|NCT01111539|464072423|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
128941494|NCT01111539|464072424|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
128941495|NCT01111539|464072425|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
128941496|NCT01111539|464072421|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
128941497|NCT01111539|464072422|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
128941498|NCT01111539|464072423|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
128941499|NCT01111539|464072424|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
128941500|NCT01111539|464072425|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
128941501|NCT01111539|464072421|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
128941502|NCT01111539|464072422|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
128941503|NCT01111539|464072423|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
128941504|NCT01111539|464072424|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
128941505|NCT01111539|464072425|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
128941506|NCT01111539|464072421|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128941507|NCT01111539|464072422|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128941508|NCT01111539|464072423|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128941509|NCT01111539|464072424|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
128941510|NCT01111539|464072425|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
128941511|NCT03628417|464072426|FG000|Overall Study|Death|1|||
128941512|NCT03628417|464072427|FG001|Overall Study|Death|1|||
128707618|NCT01414114|463223897|FG000|Overall Study|Withdrawal by Subject|1|||
128707619|NCT01414114|463223897|FG000|Overall Study|Other|2|||
128941513|NCT00372190|464072428|FG000|Overall Study|Lost to Follow-up|3|||
128941514|NCT00372190|464072429|FG001|Overall Study|Lost to Follow-up|1|||
129217757|NCT02425943|465097056|FG001|Overall Study|Adverse Event|1|||
128941515|NCT04430738|464072441|FG000|Phase 1: Dose Escalation|Death|1|||
128941516|NCT04430738|464072442|FG001|Phase 1: Dose Escalation|Death|4|||
128941517|NCT04430738|464072443|FG002|Phase 1: Dose Escalation|Death|4|||
128941518|NCT04430738|464072444|FG003|Phase 1: Dose Escalation|Death|1|||
128941519|NCT04430738|464072445|FG004|Phase 1: Dose Escalation|Death|6|||
128941520|NCT04430738|464072446|FG005|Phase 1: Dose Escalation|Death|0|||
128941521|NCT04430738|464072441|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
128941522|NCT04430738|464072442|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
128941523|NCT04430738|464072443|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
128941524|NCT04430738|464072444|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
128941525|NCT04430738|464072445|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
128941526|NCT04430738|464072446|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
128941527|NCT04430738|464072441|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
128941528|NCT04430738|464072442|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
128941529|NCT04430738|464072443|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
128941530|NCT04430738|464072444|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
128941531|NCT04430738|464072445|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
128941532|NCT04430738|464072446|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
128941533|NCT04430738|464072441|FG000|Phase 1: Dose Escalation|Other|1|||
128941534|NCT04430738|464072442|FG001|Phase 1: Dose Escalation|Other|0|||
128941535|NCT04430738|464072443|FG002|Phase 1: Dose Escalation|Other|0|||
128941536|NCT04430738|464072444|FG003|Phase 1: Dose Escalation|Other|0|||
128941537|NCT04430738|464072445|FG004|Phase 1: Dose Escalation|Other|0|||
128941538|NCT04430738|464072446|FG005|Phase 1: Dose Escalation|Other|0|||
128941539|NCT04430738|464072441|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
128941540|NCT04430738|464072442|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
128941541|NCT04430738|464072443|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
128941542|NCT04430738|464072444|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
128941543|NCT04430738|464072445|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
128941544|NCT04430738|464072446|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
128941545|NCT04430738|464072441|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
128941546|NCT04430738|464072442|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
128941547|NCT04430738|464072443|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
128941548|NCT04430738|464072444|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
128941549|NCT04430738|464072445|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
128941550|NCT04430738|464072446|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
128941551|NCT00752609|464072457|FG000|Overall Study|Adverse Event|2|||
128941552|NCT00752609|464072458|FG001|Overall Study|Adverse Event|2|||
128941553|NCT00752609|464072457|FG000|Overall Study|Withdrawal by Subject|3|||
128941554|NCT00752609|464072458|FG001|Overall Study|Withdrawal by Subject|0|||
128941555|NCT00752609|464072457|FG000|Overall Study|Physician Decision|1|||
128941556|NCT00752609|464072458|FG001|Overall Study|Physician Decision|0|||
128941557|NCT00752609|464072457|FG000|Overall Study|Death|1|||
128941558|NCT00752609|464072458|FG001|Overall Study|Death|0|||
128941559|NCT00752609|464072457|FG000|Overall Study|Met exclusion criteria|1|||
128941560|NCT00752609|464072458|FG001|Overall Study|Met exclusion criteria|0|||
128941561|NCT00752609|464072457|FG000|Overall Study|Received Aranesp in error|1|||
128941562|NCT00752609|464072458|FG001|Overall Study|Received Aranesp in error|0|||
128941563|NCT05114590|464072459|FG000|Overall Study|Adverse Event|1|||
128941564|NCT05114590|464072459|FG000|Overall Study|Investigator decision|1|||
128941565|NCT05114590|464072459|FG000|Overall Study|Lost to Follow-up|5|||
128941566|NCT05114590|464072459|FG000|Overall Study|Withdrawal by Subject|5|||
128941567|NCT05114590|464072459|FG000|Overall Study|Other|2|||
128941568|NCT00358917|464072462|FG000|Overall Study|Adverse Event|14|||
128941569|NCT00358917|464072463|FG001|Overall Study|Adverse Event|21|||
128941570|NCT00358917|464072462|FG000|Overall Study|Withdrawal by Subject|5|||
128941571|NCT00358917|464072463|FG001|Overall Study|Withdrawal by Subject|7|||
128941572|NCT00358917|464072462|FG000|Overall Study|Lost to Follow-up|20|||
128941573|NCT00358917|464072463|FG001|Overall Study|Lost to Follow-up|17|||
129217758|NCT02425943|465097055|FG000|Overall Study|Lost to Follow-up|59|||
129217759|NCT02425943|465097056|FG001|Overall Study|Lost to Follow-up|37|||
128941574|NCT00358917|464072462|FG000|Overall Study|Noncompliance|12|||
128941575|NCT00358917|464072463|FG001|Overall Study|Noncompliance|11|||
128941576|NCT00358917|464072462|FG000|Overall Study|Death|2|||
128941577|NCT00358917|464072463|FG001|Overall Study|Death|3|||
128941578|NCT00358917|464072462|FG000|Overall Study|Virologic failure|11|||
128941579|NCT00358917|464072463|FG001|Overall Study|Virologic failure|8|||
128941580|NCT00358917|464072462|FG000|Overall Study|Unable to Continue Participation|2|||
128941581|NCT00358917|464072463|FG001|Overall Study|Unable to Continue Participation|2|||
129032686|NCT01120691|464410327|FG000|Overall Study|Adverse Event|59|||
129217760|NCT02425943|465097055|FG000|Overall Study|Protocol Violation|4|||
129217761|NCT02425943|465097056|FG001|Overall Study|Protocol Violation|1|||
129032687|NCT01120691|464410328|FG001|Overall Study|Adverse Event|67|||
129032688|NCT01120691|464410329|FG002|Overall Study|Adverse Event|47|||
129032689|NCT01120691|464410327|FG000|Overall Study|Subject withdrew consent|33|||
129032690|NCT01120691|464410328|FG001|Overall Study|Subject withdrew consent|50|||
129032691|NCT01120691|464410329|FG002|Overall Study|Subject withdrew consent|44|||
129032692|NCT01120691|464410327|FG000|Overall Study|Death|21|||
129032693|NCT01120691|464410328|FG001|Overall Study|Death|22|||
129032694|NCT01120691|464410329|FG002|Overall Study|Death|24|||
129032695|NCT01120691|464410327|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
129032696|NCT01120691|464410328|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
129032697|NCT01120691|464410329|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
129032698|NCT01120691|464410327|FG000|Overall Study|Administrative problems|15|||
129032699|NCT01120691|464410328|FG001|Overall Study|Administrative problems|8|||
129032700|NCT01120691|464410329|FG002|Overall Study|Administrative problems|9|||
129032701|NCT01120691|464410327|FG000|Overall Study|Protocol deviation|13|||
129032702|NCT01120691|464410328|FG001|Overall Study|Protocol deviation|12|||
129032703|NCT01120691|464410329|FG002|Overall Study|Protocol deviation|12|||
129032704|NCT01120691|464410327|FG000|Overall Study|Lost to Follow-up|5|||
129032705|NCT01120691|464410328|FG001|Overall Study|Lost to Follow-up|6|||
129032706|NCT01120691|464410329|FG002|Overall Study|Lost to Follow-up|4|||
129032707|NCT01120691|464410327|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129032708|NCT01120691|464410328|FG001|Overall Study|Abnormal test procedure result(s)|2|||
129032709|NCT01120691|464410329|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129032710|NCT01120691|464410327|FG000|Overall Study|Patient's inability to use the device|3|||
129032711|NCT01120691|464410328|FG001|Overall Study|Patient's inability to use the device|1|||
129032712|NCT01120691|464410329|FG002|Overall Study|Patient's inability to use the device|0|||
129032713|NCT01120691|464410327|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129032714|NCT01120691|464410328|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129032715|NCT01120691|464410329|FG002|Overall Study|Abnormal laboratory value(s)|4|||
129032716|NCT04553406|464410330|FG000|Overall Study|Study Discontinuation|0|||
129032717|NCT04553406|464410331|FG001|Overall Study|Study Discontinuation|1|||
129032718|NCT03370510|464410332|FG000|Overall Study|COVID-19|2|||
129032719|NCT03370510|464410333|FG001|Overall Study|COVID-19|0|||
129032720|NCT00772148|464410334|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
129032721|NCT00772148|464410335|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
129032722|NCT00772148|464410334|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
129032723|NCT00772148|464410335|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
129032724|NCT00772148|464410334|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
129032725|NCT00772148|464410335|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
129032726|NCT00772148|464410334|FG000|Maintenance Phase (Week 52)|Death|2|||
129032727|NCT00772148|464410335|FG001|Maintenance Phase (Week 52)|Death|2|||
129032728|NCT00772148|464410334|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
129032729|NCT00772148|464410335|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
129032730|NCT00772148|464410334|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
129032731|NCT00772148|464410335|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
129032732|NCT00772148|464410334|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
129032733|NCT00772148|464410335|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
129032734|NCT01562613|464410336|FG000|Overall Study|Lost to Follow-up|2|||
129032735|NCT01562613|464410336|FG000|Overall Study|Withdrawal by Subject|2|||
129032736|NCT03573336|464410341|FG000|Overall Study|Study terminated|2|||
129032737|NCT03573336|464410342|FG001|Overall Study|Study terminated|4|||
128707620|NCT00105482|463223898|FG000|Overall Study|Adverse Event|1|||
128707621|NCT00105482|463223899|FG001|Overall Study|Adverse Event|1|||
128707622|NCT00105482|463223898|FG000|Overall Study|Lost to Follow-up|26|||
128941582|NCT01379534|464072472|FG000|Treatment Phase|Withdrawal by Subject|2|||
128941583|NCT01379534|464072473|FG001|Treatment Phase|Withdrawal by Subject|2|||
128941584|NCT01379534|464072472|FG000|Treatment Phase|Progressive disease|13|||
128941585|NCT01379534|464072473|FG001|Treatment Phase|Progressive disease|22|||
128941586|NCT01379534|464072472|FG000|Treatment Phase|Adverse Event|7|||
128941587|NCT01379534|464072473|FG001|Treatment Phase|Adverse Event|7|||
128941588|NCT01379534|464072472|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
128941589|NCT01379534|464072473|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
128941590|NCT01379534|464072472|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
129032738|NCT03573336|464410343|FG002|Overall Study|Study terminated|2|||
129032739|NCT01525628|464410344|FG000|Overall Study|Adverse Event|1|||
129032740|NCT01525628|464410345|FG001|Overall Study|Adverse Event|1|||
129032741|NCT01525628|464410346|FG002|Overall Study|Adverse Event|2|||
129032742|NCT01525628|464410347|FG003|Overall Study|Adverse Event|0|||
129032743|NCT01525628|464410348|FG004|Overall Study|Adverse Event|1|||
129032744|NCT01525628|464410344|FG000|Overall Study|Lack of Efficacy|0|||
129032745|NCT01525628|464410345|FG001|Overall Study|Lack of Efficacy|2|||
129032746|NCT01525628|464410346|FG002|Overall Study|Lack of Efficacy|2|||
129032747|NCT01525628|464410347|FG003|Overall Study|Lack of Efficacy|1|||
129032748|NCT01525628|464410348|FG004|Overall Study|Lack of Efficacy|2|||
128707623|NCT00105482|463223899|FG001|Overall Study|Lost to Follow-up|17|||
128941591|NCT01379534|464072473|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
128941592|NCT01379534|464072472|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
128941593|NCT01379534|464072473|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
128941594|NCT01379534|464072472|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
128941595|NCT01379534|464072473|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
128941596|NCT05372575|464072480|FG000|Overall Study|Protocol Violation|7|||
128941597|NCT05372575|464072481|FG001|Overall Study|Protocol Violation|16|||
128941598|NCT01096550|464072482|FG000|Overall Study|discontinued site|10|||
128941599|NCT01096550|464072483|FG001|Overall Study|discontinued site|11|||
128941600|NCT01096550|464072482|FG000|Overall Study|non-regular treatment track at clinic|1|||
128941601|NCT01096550|464072483|FG001|Overall Study|non-regular treatment track at clinic|1|||
128941602|NCT01096550|464072482|FG000|Overall Study|clinic readmission|1|||
128941603|NCT01096550|464072483|FG001|Overall Study|clinic readmission|1|||
128941604|NCT01096550|464072482|FG000|Overall Study|Withdrawal by Subject|0|||
128941605|NCT01096550|464072483|FG001|Overall Study|Withdrawal by Subject|1|||
128941606|NCT01096550|464072482|FG000|Overall Study|non-African American participant|13|||
128941607|NCT01096550|464072483|FG001|Overall Study|non-African American participant|6|||
128941608|NCT01096550|464072482|FG000|Overall Study|Lost to Follow-up|12|||
128941609|NCT01096550|464072483|FG001|Overall Study|Lost to Follow-up|9|||
128941610|NCT01544595|464072486|FG000|Status at Week 68|Adverse Event|3|||
128941611|NCT01544595|464072487|FG001|Status at Week 68|Adverse Event|2|||
128941612|NCT01544595|464072488|FG002|Status at Week 68|Adverse Event|1|||
128941613|NCT01544595|464072489|FG003|Status at Week 68|Adverse Event|0|||
128941614|NCT01544595|464072490|FG004|Status at Week 68|Adverse Event|0|||
128941615|NCT01544595|464072491|FG005|Status at Week 68|Adverse Event|0|||
128941616|NCT01544595|464072486|FG000|Status at Week 68|Lack of Efficacy|1|||
128941617|NCT01544595|464072487|FG001|Status at Week 68|Lack of Efficacy|0|||
128941618|NCT01544595|464072488|FG002|Status at Week 68|Lack of Efficacy|0|||
128941619|NCT01544595|464072489|FG003|Status at Week 68|Lack of Efficacy|0|||
128941620|NCT01544595|464072490|FG004|Status at Week 68|Lack of Efficacy|0|||
128941621|NCT01544595|464072491|FG005|Status at Week 68|Lack of Efficacy|0|||
128941622|NCT01544595|464072486|FG000|Status at Week 68|Lost to Follow-up|1|||
128941623|NCT01544595|464072487|FG001|Status at Week 68|Lost to Follow-up|1|||
128941624|NCT01544595|464072488|FG002|Status at Week 68|Lost to Follow-up|0|||
128941625|NCT01544595|464072489|FG003|Status at Week 68|Lost to Follow-up|0|||
128941626|NCT01544595|464072490|FG004|Status at Week 68|Lost to Follow-up|0|||
128941627|NCT01544595|464072491|FG005|Status at Week 68|Lost to Follow-up|0|||
128941628|NCT01544595|464072486|FG000|Status at Week 68|Non-compliance with study treatment|1|||
128941629|NCT01544595|464072487|FG001|Status at Week 68|Non-compliance with study treatment|0|||
128941630|NCT01544595|464072488|FG002|Status at Week 68|Non-compliance with study treatment|0|||
128941631|NCT01544595|464072489|FG003|Status at Week 68|Non-compliance with study treatment|1|||
128941632|NCT01544595|464072490|FG004|Status at Week 68|Non-compliance with study treatment|0|||
128941633|NCT01544595|464072491|FG005|Status at Week 68|Non-compliance with study treatment|0|||
128941634|NCT01544595|464072486|FG000|Status at Week 68|Protocol Violation|2|||
128941635|NCT01544595|464072487|FG001|Status at Week 68|Protocol Violation|0|||
128941636|NCT01544595|464072488|FG002|Status at Week 68|Protocol Violation|1|||
128941637|NCT01544595|464072489|FG003|Status at Week 68|Protocol Violation|1|||
128941638|NCT01544595|464072490|FG004|Status at Week 68|Protocol Violation|0|||
128941639|NCT01544595|464072491|FG005|Status at Week 68|Protocol Violation|0|||
128941640|NCT01544595|464072486|FG000|Status at Week 68|Technical problems|1|||
128941641|NCT01544595|464072487|FG001|Status at Week 68|Technical problems|0|||
128941642|NCT01544595|464072488|FG002|Status at Week 68|Technical problems|0|||
128941643|NCT01544595|464072489|FG003|Status at Week 68|Technical problems|1|||
128941644|NCT01544595|464072490|FG004|Status at Week 68|Technical problems|0|||
128941645|NCT01544595|464072491|FG005|Status at Week 68|Technical problems|0|||
128941646|NCT01544595|464072486|FG000|Status at Week 68|Withdrawal by Subject|0|||
128941647|NCT01544595|464072487|FG001|Status at Week 68|Withdrawal by Subject|1|||
128941648|NCT01544595|464072488|FG002|Status at Week 68|Withdrawal by Subject|1|||
128941649|NCT01544595|464072489|FG003|Status at Week 68|Withdrawal by Subject|2|||
128941650|NCT01544595|464072490|FG004|Status at Week 68|Withdrawal by Subject|0|||
128941651|NCT01544595|464072491|FG005|Status at Week 68|Withdrawal by Subject|0|||
128941652|NCT01544595|464072486|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
128707624|NCT00105482|463223898|FG000|Overall Study|Withdrawal by Subject|0|||
128941653|NCT01544595|464072487|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
128941654|NCT01544595|464072488|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
128941655|NCT01544595|464072489|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
128941656|NCT01544595|464072490|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
128941657|NCT01544595|464072491|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
128941658|NCT01544595|464072486|FG000|Status at Week 156|Withdrawal by Subject|9|||
128707625|NCT00105482|463223899|FG001|Overall Study|Withdrawal by Subject|1|||
128941659|NCT01544595|464072487|FG001|Status at Week 156|Withdrawal by Subject|10|||
128941660|NCT01544595|464072488|FG002|Status at Week 156|Withdrawal by Subject|4|||
128941661|NCT01544595|464072489|FG003|Status at Week 156|Withdrawal by Subject|9|||
128941662|NCT01544595|464072490|FG004|Status at Week 156|Withdrawal by Subject|20|||
128941663|NCT01544595|464072491|FG005|Status at Week 156|Withdrawal by Subject|6|||
128941664|NCT01544595|464072486|FG000|Status at Week 156|Adverse Event|9|||
128941665|NCT01544595|464072487|FG001|Status at Week 156|Adverse Event|11|||
128941666|NCT01544595|464072488|FG002|Status at Week 156|Adverse Event|1|||
128941667|NCT01544595|464072489|FG003|Status at Week 156|Adverse Event|3|||
128941668|NCT01544595|464072490|FG004|Status at Week 156|Adverse Event|4|||
128941669|NCT01544595|464072491|FG005|Status at Week 156|Adverse Event|2|||
128941670|NCT01544595|464072486|FG000|Status at Week 156|Lost to Follow-up|4|||
128941671|NCT01544595|464072487|FG001|Status at Week 156|Lost to Follow-up|4|||
128941672|NCT01544595|464072488|FG002|Status at Week 156|Lost to Follow-up|0|||
128941673|NCT01544595|464072489|FG003|Status at Week 156|Lost to Follow-up|1|||
128941674|NCT01544595|464072490|FG004|Status at Week 156|Lost to Follow-up|4|||
128941675|NCT01544595|464072491|FG005|Status at Week 156|Lost to Follow-up|1|||
128941676|NCT01544595|464072486|FG000|Status at Week 156|Non-compliance with study treatement|0|||
128941677|NCT01544595|464072487|FG001|Status at Week 156|Non-compliance with study treatement|1|||
128941678|NCT01544595|464072488|FG002|Status at Week 156|Non-compliance with study treatement|0|||
128941679|NCT01544595|464072489|FG003|Status at Week 156|Non-compliance with study treatement|1|||
128941680|NCT01544595|464072490|FG004|Status at Week 156|Non-compliance with study treatement|0|||
128941681|NCT01544595|464072491|FG005|Status at Week 156|Non-compliance with study treatement|1|||
128941682|NCT01544595|464072486|FG000|Status at Week 156|Physician Decision|0|||
128941683|NCT01544595|464072487|FG001|Status at Week 156|Physician Decision|3|||
128941684|NCT01544595|464072488|FG002|Status at Week 156|Physician Decision|1|||
128941685|NCT01544595|464072489|FG003|Status at Week 156|Physician Decision|0|||
128941686|NCT01544595|464072490|FG004|Status at Week 156|Physician Decision|0|||
128941687|NCT01544595|464072491|FG005|Status at Week 156|Physician Decision|0|||
128941688|NCT01544595|464072486|FG000|Status at Week 156|Pregnancy|2|||
128941689|NCT01544595|464072487|FG001|Status at Week 156|Pregnancy|3|||
128941690|NCT01544595|464072488|FG002|Status at Week 156|Pregnancy|0|||
128941691|NCT01544595|464072489|FG003|Status at Week 156|Pregnancy|0|||
128941692|NCT01544595|464072490|FG004|Status at Week 156|Pregnancy|0|||
128941693|NCT01544595|464072491|FG005|Status at Week 156|Pregnancy|0|||
128941694|NCT01544595|464072486|FG000|Status at Week 156|Protocol Violation|3|||
128941695|NCT01544595|464072487|FG001|Status at Week 156|Protocol Violation|1|||
128941696|NCT01544595|464072488|FG002|Status at Week 156|Protocol Violation|2|||
128941697|NCT01544595|464072489|FG003|Status at Week 156|Protocol Violation|2|||
128941698|NCT01544595|464072490|FG004|Status at Week 156|Protocol Violation|0|||
128941699|NCT01544595|464072491|FG005|Status at Week 156|Protocol Violation|0|||
128941700|NCT01544595|464072486|FG000|Status at Week 156|Technical problems|3|||
128941701|NCT01544595|464072487|FG001|Status at Week 156|Technical problems|1|||
128941702|NCT01544595|464072488|FG002|Status at Week 156|Technical problems|0|||
128941703|NCT01544595|464072489|FG003|Status at Week 156|Technical problems|1|||
128941704|NCT01544595|464072490|FG004|Status at Week 156|Technical problems|0|||
128941705|NCT01544595|464072491|FG005|Status at Week 156|Technical problems|0|||
128941706|NCT01544595|464072486|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
128941707|NCT01544595|464072487|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
128941708|NCT01544595|464072488|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
128941709|NCT01544595|464072489|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
128941710|NCT01544595|464072490|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
128941711|NCT01544595|464072491|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
128941712|NCT01544595|464072486|FG000|Status at Week 156|Lack of Efficacy|1|||
128941713|NCT01544595|464072487|FG001|Status at Week 156|Lack of Efficacy|0|||
128941714|NCT01544595|464072488|FG002|Status at Week 156|Lack of Efficacy|1|||
128941715|NCT01544595|464072489|FG003|Status at Week 156|Lack of Efficacy|4|||
128941716|NCT01544595|464072490|FG004|Status at Week 156|Lack of Efficacy|10|||
128941717|NCT01544595|464072491|FG005|Status at Week 156|Lack of Efficacy|5|||
128941718|NCT04333433|464072496|FG000|Overall Study|Withdrawal by Subject|6|||
128941719|NCT04333433|464072497|FG001|Overall Study|Withdrawal by Subject|3|||
128941720|NCT04333433|464072496|FG000|Overall Study|Death|3|||
128941721|NCT04333433|464072497|FG001|Overall Study|Death|0|||
128941722|NCT04333433|464072496|FG000|Overall Study|Lost to Follow-up|6|||
128941723|NCT04333433|464072497|FG001|Overall Study|Lost to Follow-up|1|||
128941724|NCT04333433|464072496|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
128941725|NCT04333433|464072497|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
128941726|NCT00320385|464072498|FG000|Overall Study|Lost to Follow-up|7|||
128941727|NCT00320385|464072499|FG001|Overall Study|Lost to Follow-up|10|||
128941728|NCT00320385|464072498|FG000|Overall Study|Withdrawal by Subject|6|||
128941729|NCT00320385|464072499|FG001|Overall Study|Withdrawal by Subject|7|||
128941730|NCT00320385|464072498|FG000|Overall Study|Sponsor Terminated Study|2|||
128941731|NCT00320385|464072499|FG001|Overall Study|Sponsor Terminated Study|1|||
128941732|NCT00320385|464072498|FG000|Overall Study|Investigator Decision|0|||
129032749|NCT01525628|464410344|FG000|Overall Study|Protocol Violation|0|||
129032750|NCT01525628|464410345|FG001|Overall Study|Protocol Violation|0|||
129032751|NCT01525628|464410346|FG002|Overall Study|Protocol Violation|1|||
128941733|NCT00320385|464072499|FG001|Overall Study|Investigator Decision|1|||
128941734|NCT00320385|464072498|FG000|Overall Study|Death|1|||
128941735|NCT00320385|464072499|FG001|Overall Study|Death|2|||
128941736|NCT00320385|464072498|FG000|Overall Study|Serious Adverse Event|1|||
128941737|NCT00320385|464072499|FG001|Overall Study|Serious Adverse Event|0|||
128941738|NCT00320385|464072498|FG000|Overall Study|Withdrew Consent|1|||
128941739|NCT00320385|464072499|FG001|Overall Study|Withdrew Consent|0|||
128941740|NCT00320385|464072498|FG000|Overall Study|Adverse Event|0|||
128941741|NCT00320385|464072499|FG001|Overall Study|Adverse Event|1|||
128941742|NCT03288779|464072505|FG000|Overall Study|Withdrawal by Subject|3|||
128941743|NCT01355068|464072506|FG000|First Intervention Period|Adverse Event|0|||
128941744|NCT01355068|464072507|FG001|First Intervention Period|Adverse Event|1|||
128941745|NCT01355068|464072506|FG000|First Intervention Period|Withdrawal by Subject|0|||
128941746|NCT01355068|464072507|FG001|First Intervention Period|Withdrawal by Subject|1|||
128941747|NCT00524745|464072508|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
128941748|NCT00524745|464072509|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
128941749|NCT00524745|464072510|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
128941750|NCT00524745|464072511|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
128941751|NCT00872170|464072512|FG000|Overall Study|Adverse Event|1|||
128941752|NCT00872170|464072513|FG001|Overall Study|Adverse Event|0|||
128941753|NCT00601523|464072514|FG000|Overall Study|Adverse Event|42|||
128941754|NCT00601523|464072515|FG001|Overall Study|Adverse Event|14|||
128941755|NCT00601523|464072514|FG000|Overall Study|Lack of Efficacy|3|||
128941756|NCT00601523|464072515|FG001|Overall Study|Lack of Efficacy|0|||
128941757|NCT00601523|464072514|FG000|Overall Study|Protocol Violation|5|||
128941758|NCT00601523|464072515|FG001|Overall Study|Protocol Violation|1|||
128941759|NCT00601523|464072514|FG000|Overall Study|Lost to Follow-up|0|||
128941760|NCT00601523|464072515|FG001|Overall Study|Lost to Follow-up|1|||
128941761|NCT00601523|464072514|FG000|Overall Study|Withdrawal by Subject|18|||
128941762|NCT00601523|464072515|FG001|Overall Study|Withdrawal by Subject|9|||
128941763|NCT00601523|464072514|FG000|Overall Study|Other|9|||
128941764|NCT00601523|464072515|FG001|Overall Study|Other|1|||
128941765|NCT01721408|464072516|FG000|Overall Study|Adverse Event|6|||
128941766|NCT01721408|464072517|FG001|Overall Study|Adverse Event|1|||
128941767|NCT01721408|464072516|FG000|Overall Study|Death|1|||
128941768|NCT01721408|464072517|FG001|Overall Study|Death|0|||
128941769|NCT01721408|464072516|FG000|Overall Study|Insufficient clinical response|15|||
128941770|NCT01721408|464072517|FG001|Overall Study|Insufficient clinical response|6|||
128941771|NCT01721408|464072516|FG000|Overall Study|No longer willing to participate study|9|||
128941772|NCT01721408|464072517|FG001|Overall Study|No longer willing to participate study|10|||
128941773|NCT01721408|464072516|FG000|Overall Study|Protocol Violation|0|||
128941774|NCT01721408|464072517|FG001|Overall Study|Protocol Violation|2|||
128941775|NCT01721408|464072516|FG000|Overall Study|Other|3|||
128941776|NCT01721408|464072517|FG001|Overall Study|Other|3|||
128941777|NCT01721408|464072516|FG000|Overall Study|Lost to Follow-up|1|||
128941778|NCT01721408|464072517|FG001|Overall Study|Lost to Follow-up|2|||
128941779|NCT01721408|464072516|FG000|Overall Study|Does not meet entrance criteria|1|||
128941780|NCT01721408|464072517|FG001|Overall Study|Does not meet entrance criteria|0|||
128941781|NCT03987620|464072520|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
128941782|NCT03987620|464072521|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
128941783|NCT03987620|464072520|FG000|Overall Study|Adverse Event|3|||
128941784|NCT03987620|464072521|FG001|Overall Study|Adverse Event|0|||
128941785|NCT03987620|464072520|FG000|Overall Study|Lost to Follow-up|1|||
128941786|NCT03987620|464072521|FG001|Overall Study|Lost to Follow-up|2|||
128941787|NCT03987620|464072520|FG000|Overall Study|Physician Decision|0|||
128941788|NCT03987620|464072521|FG001|Overall Study|Physician Decision|1|||
128941789|NCT03987620|464072520|FG000|Overall Study|Pregnancy|1|||
128941790|NCT03987620|464072521|FG001|Overall Study|Pregnancy|0|||
128941791|NCT03987620|464072520|FG000|Overall Study|Withdrawal by Subject|7|||
128941792|NCT03987620|464072521|FG001|Overall Study|Withdrawal by Subject|1|||
128941793|NCT03987620|464072520|FG000|Overall Study|Other|2|||
129032752|NCT01525628|464410347|FG003|Overall Study|Protocol Violation|0|||
128941794|NCT03987620|464072521|FG001|Overall Study|Other|5|||
128941795|NCT02149836|464072522|FG000|Overall Study|Withdrawal by Subject|1|||
128941796|NCT01204658|464072523|FG000|Primary Phase|Adverse Event|0|||
128941797|NCT01204658|464072524|FG001|Primary Phase|Adverse Event|0|||
128941798|NCT01204658|464072525|FG002|Primary Phase|Adverse Event|1|||
128941799|NCT01204658|464072526|FG003|Primary Phase|Adverse Event|0|||
128941800|NCT01064648|464072531|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
128941801|NCT01064648|464072532|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
128941802|NCT01064648|464072533|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
129032753|NCT01525628|464410348|FG004|Overall Study|Protocol Violation|0|||
128941803|NCT01064648|464072534|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
128941804|NCT01064648|464072531|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
128941805|NCT01064648|464072532|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
128941806|NCT01064648|464072533|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
128941807|NCT01064648|464072534|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
129032754|NCT01525628|464410344|FG000|Overall Study|Lost to Follow-up|1|||
129032755|NCT01525628|464410345|FG001|Overall Study|Lost to Follow-up|1|||
129032756|NCT01525628|464410346|FG002|Overall Study|Lost to Follow-up|0|||
129032757|NCT01525628|464410347|FG003|Overall Study|Lost to Follow-up|0|||
129032758|NCT01525628|464410348|FG004|Overall Study|Lost to Follow-up|0|||
129032759|NCT01525628|464410344|FG000|Overall Study|Withdrawal by Subject|0|||
129032760|NCT01525628|464410345|FG001|Overall Study|Withdrawal by Subject|1|||
129032761|NCT01525628|464410346|FG002|Overall Study|Withdrawal by Subject|0|||
129032762|NCT01525628|464410347|FG003|Overall Study|Withdrawal by Subject|0|||
129032763|NCT01525628|464410348|FG004|Overall Study|Withdrawal by Subject|0|||
129032764|NCT01525628|464410344|FG000|Overall Study|Other reason not defined above|0|||
129032765|NCT01525628|464410345|FG001|Overall Study|Other reason not defined above|0|||
129032766|NCT01525628|464410346|FG002|Overall Study|Other reason not defined above|0|||
129032767|NCT01525628|464410347|FG003|Overall Study|Other reason not defined above|3|||
129032768|NCT01525628|464410348|FG004|Overall Study|Other reason not defined above|0|||
129032769|NCT03493919|464410350|FG000|Overall Study|Other|2|||
129032770|NCT03493919|464410351|FG001|Overall Study|Other|0|||
129032771|NCT03493919|464410352|FG002|Overall Study|Other|1|||
129032772|NCT03493919|464410353|FG003|Overall Study|Other|0|||
129032773|NCT03493919|464410350|FG000|Overall Study|Withdrawal by Subject|9|||
129032774|NCT03493919|464410351|FG001|Overall Study|Withdrawal by Subject|3|||
129032775|NCT03493919|464410352|FG002|Overall Study|Withdrawal by Subject|1|||
129032776|NCT03493919|464410353|FG003|Overall Study|Withdrawal by Subject|1|||
129032777|NCT03493919|464410350|FG000|Overall Study|Lost to Follow-up|5|||
129032778|NCT03493919|464410351|FG001|Overall Study|Lost to Follow-up|0|||
129032779|NCT03493919|464410352|FG002|Overall Study|Lost to Follow-up|0|||
129032780|NCT03493919|464410353|FG003|Overall Study|Lost to Follow-up|3|||
129032781|NCT03493919|464410350|FG000|Overall Study|Adverse Event|0|||
129032782|NCT03493919|464410351|FG001|Overall Study|Adverse Event|1|||
129032783|NCT03493919|464410352|FG002|Overall Study|Adverse Event|0|||
129032784|NCT03493919|464410353|FG003|Overall Study|Adverse Event|0|||
129032785|NCT04640194|464410354|FG000|Overall Study|Adverse Event|3|||
129032786|NCT04640194|464410355|FG001|Overall Study|Adverse Event|7|||
128941808|NCT01064648|464072531|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
128941809|NCT01064648|464072532|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
128941810|NCT01064648|464072533|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
128941811|NCT01064648|464072534|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
128941812|NCT01064648|464072531|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
128941813|NCT01064648|464072532|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
128941814|NCT01064648|464072533|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
128941815|NCT01064648|464072534|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
128941816|NCT01064648|464072531|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
128941817|NCT01064648|464072532|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
128941818|NCT01064648|464072533|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
128941819|NCT01064648|464072534|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
128941820|NCT01064648|464072531|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
128941821|NCT01064648|464072532|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
129032787|NCT04640194|464410356|FG002|Overall Study|Adverse Event|0|||
129032788|NCT04640194|464410357|FG003|Overall Study|Adverse Event|5|||
129032789|NCT04640194|464410358|FG004|Overall Study|Adverse Event|0|||
129032790|NCT04640194|464410359|FG005|Overall Study|Adverse Event|4|||
129032791|NCT04640194|464410360|FG006|Overall Study|Adverse Event|0|||
129032792|NCT04640194|464410354|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
129032793|NCT04640194|464410355|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
129032794|NCT04640194|464410356|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
129032795|NCT04640194|464410357|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
129032796|NCT04640194|464410358|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
129032797|NCT04640194|464410359|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
129032798|NCT04640194|464410360|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
129032799|NCT04640194|464410354|FG000|Overall Study|fibrinogen level too low|0|||
129032800|NCT04640194|464410355|FG001|Overall Study|fibrinogen level too low|0|||
129032801|NCT04640194|464410356|FG002|Overall Study|fibrinogen level too low|0|||
129032802|NCT04640194|464410357|FG003|Overall Study|fibrinogen level too low|1|||
129032803|NCT04640194|464410358|FG004|Overall Study|fibrinogen level too low|0|||
129032804|NCT04640194|464410359|FG005|Overall Study|fibrinogen level too low|0|||
129032805|NCT04640194|464410360|FG006|Overall Study|fibrinogen level too low|0|||
129032806|NCT04640194|464410354|FG000|Overall Study|mild bleeding|0|||
129032807|NCT04640194|464410355|FG001|Overall Study|mild bleeding|0|||
128941822|NCT01064648|464072533|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
128941823|NCT01064648|464072534|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
128941824|NCT01064648|464072531|FG000|Phase II|Adverse Event|0|||
128941825|NCT01064648|464072532|FG001|Phase II|Adverse Event|0|||
129032808|NCT04640194|464410356|FG002|Overall Study|mild bleeding|0|||
129032809|NCT04640194|464410357|FG003|Overall Study|mild bleeding|1|||
129032810|NCT04640194|464410358|FG004|Overall Study|mild bleeding|0|||
129032811|NCT04640194|464410359|FG005|Overall Study|mild bleeding|0|||
128941826|NCT01064648|464072533|FG002|Phase II|Adverse Event|15|||
128941827|NCT01064648|464072534|FG003|Phase II|Adverse Event|8|||
128941828|NCT01064648|464072531|FG000|Phase II|Death|0|||
128941829|NCT01064648|464072532|FG001|Phase II|Death|0|||
128941830|NCT01064648|464072533|FG002|Phase II|Death|4|||
128941831|NCT01064648|464072534|FG003|Phase II|Death|5|||
128941832|NCT01064648|464072531|FG000|Phase II|Withdrawal by Subject|0|||
128941833|NCT01064648|464072532|FG001|Phase II|Withdrawal by Subject|0|||
128941834|NCT01064648|464072533|FG002|Phase II|Withdrawal by Subject|2|||
128941835|NCT01064648|464072534|FG003|Phase II|Withdrawal by Subject|5|||
128941836|NCT01064648|464072531|FG000|Phase II|Progression|0|||
128941837|NCT01064648|464072532|FG001|Phase II|Progression|0|||
128941838|NCT01064648|464072533|FG002|Phase II|Progression|21|||
128941839|NCT01064648|464072534|FG003|Phase II|Progression|27|||
128941840|NCT01064648|464072531|FG000|Phase II|Non-protocol specified|0|||
128941841|NCT01064648|464072532|FG001|Phase II|Non-protocol specified|0|||
128941842|NCT01064648|464072533|FG002|Phase II|Non-protocol specified|5|||
128941843|NCT01064648|464072534|FG003|Phase II|Non-protocol specified|3|||
128941844|NCT01064648|464072531|FG000|Phase II|Under Review|0|||
128941845|NCT01064648|464072532|FG001|Phase II|Under Review|0|||
128941846|NCT01064648|464072533|FG002|Phase II|Under Review|2|||
128941847|NCT01064648|464072534|FG003|Phase II|Under Review|0|||
128941848|NCT00977574|464072535|FG000|Overall Study|Never Treated|4|||
128941849|NCT00977574|464072536|FG001|Overall Study|Never Treated|2|||
128941850|NCT00977574|464072537|FG002|Overall Study|Never Treated|4|||
128941851|NCT05128162|464072538|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
128941852|NCT05128162|464072538|FG000|Overall Study|Physician Decision|1|||
128941853|NCT04491877|464074936|FG000|Overall Study|Protocol Deviation|1|||
128941854|NCT04491877|464074937|FG001|Overall Study|Protocol Deviation|0|||
128941855|NCT04491877|464074938|FG002|Overall Study|Protocol Deviation|2|||
128941856|NCT04491877|464074939|FG003|Overall Study|Protocol Deviation|0|||
128941857|NCT04491877|464074940|FG004|Overall Study|Protocol Deviation|0|||
128941858|NCT04491877|464074941|FG005|Overall Study|Protocol Deviation|0|||
128941859|NCT04491877|464074942|FG006|Overall Study|Protocol Deviation|1|||
128941860|NCT04491877|464074943|FG007|Overall Study|Protocol Deviation|1|||
128941861|NCT04491877|464074944|FG008|Overall Study|Protocol Deviation|0|||
128941862|NCT04491877|464074936|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128941863|NCT04491877|464074937|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128941864|NCT04491877|464074938|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128941865|NCT04491877|464074939|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
128941866|NCT04491877|464074940|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
128941867|NCT04491877|464074941|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
128941868|NCT04491877|464074942|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
128941869|NCT04491877|464074943|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
128941870|NCT04491877|464074944|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
128941871|NCT04491877|464074936|FG000|Overall Study|Lost to Follow-up|0|||
128941872|NCT04491877|464074937|FG001|Overall Study|Lost to Follow-up|2|||
128941873|NCT04491877|464074938|FG002|Overall Study|Lost to Follow-up|0|||
128941874|NCT04491877|464074939|FG003|Overall Study|Lost to Follow-up|0|||
128941875|NCT04491877|464074940|FG004|Overall Study|Lost to Follow-up|0|||
128941876|NCT04491877|464074941|FG005|Overall Study|Lost to Follow-up|0|||
128941877|NCT04491877|464074942|FG006|Overall Study|Lost to Follow-up|2|||
128941878|NCT04491877|464074943|FG007|Overall Study|Lost to Follow-up|1|||
128941879|NCT04491877|464074944|FG008|Overall Study|Lost to Follow-up|1|||
128941880|NCT01286272|464074945|FG000|Overall Study|Ineligible after beginning treatment|1|||
128941881|NCT01286272|464074946|FG001|Overall Study|Ineligible after beginning treatment|3|||
128941882|NCT00074412|464074947|FG000|Overall Study|Death|30|||
128941883|NCT00074412|464074948|FG001|Overall Study|Death|26|||
128941884|NCT00074412|464074947|FG000|Overall Study|Lost to Follow-up|52|||
128941885|NCT00074412|464074948|FG001|Overall Study|Lost to Follow-up|58|||
128941886|NCT00418834|464074953|FG000|Overall Study|Adverse Event|16|||
128941887|NCT00418834|464074954|FG001|Overall Study|Adverse Event|9|||
128941888|NCT00418834|464074953|FG000|Overall Study|Lost to Follow-up|0|||
128941889|NCT00418834|464074954|FG001|Overall Study|Lost to Follow-up|1|||
128941890|NCT00418834|464074953|FG000|Overall Study|Protocol Violation|4|||
128941891|NCT00418834|464074954|FG001|Overall Study|Protocol Violation|3|||
128941892|NCT00418834|464074953|FG000|Overall Study|Withdrawal by Subject|3|||
128941893|NCT00418834|464074954|FG001|Overall Study|Withdrawal by Subject|7|||
128941894|NCT01953328|464074955|FG000|Overall Study|Withdrawal by Subject|0|||
128941895|NCT01953328|464074956|FG001|Overall Study|Withdrawal by Subject|0|||
128941896|NCT01953328|464074957|FG002|Overall Study|Withdrawal by Subject|0|||
128941897|NCT01953328|464074958|FG003|Overall Study|Withdrawal by Subject|0|||
128941898|NCT01953328|464074959|FG004|Overall Study|Withdrawal by Subject|1|||
128941899|NCT01953328|464074960|FG005|Overall Study|Withdrawal by Subject|0|||
128941900|NCT01953328|464074961|FG006|Overall Study|Withdrawal by Subject|0|||
128941901|NCT01953328|464074962|FG007|Overall Study|Withdrawal by Subject|0|||
128941902|NCT01953328|464074955|FG000|Overall Study|Lost to Follow-up|0|||
128941903|NCT01953328|464074956|FG001|Overall Study|Lost to Follow-up|0|||
128941904|NCT01953328|464074957|FG002|Overall Study|Lost to Follow-up|0|||
128941905|NCT01953328|464074958|FG003|Overall Study|Lost to Follow-up|0|||
128941906|NCT01953328|464074959|FG004|Overall Study|Lost to Follow-up|1|||
128941907|NCT01953328|464074960|FG005|Overall Study|Lost to Follow-up|0|||
128941908|NCT01953328|464074961|FG006|Overall Study|Lost to Follow-up|0|||
128941909|NCT01953328|464074962|FG007|Overall Study|Lost to Follow-up|0|||
128941910|NCT02364947|464074971|FG000|Overall Study|Withdrawal by Subject|10|||
128941911|NCT02364947|464074972|FG001|Overall Study|Withdrawal by Subject|8|||
128941912|NCT02364947|464074973|FG002|Overall Study|Withdrawal by Subject|9|||
128941913|NCT02364947|464074971|FG000|Overall Study|Adverse Event|45|||
128941914|NCT02364947|464074972|FG001|Overall Study|Adverse Event|33|||
128941915|NCT02364947|464074973|FG002|Overall Study|Adverse Event|11|||
128941916|NCT02364947|464074971|FG000|Overall Study|Protocol Violation|1|||
128941917|NCT02364947|464074972|FG001|Overall Study|Protocol Violation|1|||
128941918|NCT02364947|464074973|FG002|Overall Study|Protocol Violation|1|||
128941919|NCT02364947|464074971|FG000|Overall Study|Physician Decision|3|||
128941920|NCT02364947|464074972|FG001|Overall Study|Physician Decision|2|||
128941921|NCT02364947|464074973|FG002|Overall Study|Physician Decision|5|||
128941922|NCT02364947|464074971|FG000|Overall Study|Death|0|||
128941923|NCT02364947|464074972|FG001|Overall Study|Death|1|||
128941924|NCT02364947|464074973|FG002|Overall Study|Death|0|||
128941925|NCT00423085|464074974|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
128941926|NCT00423085|464074975|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
128941927|NCT00423085|464074976|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
128941928|NCT00423085|464074977|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
128941929|NCT00423085|464074974|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
128941930|NCT00423085|464074975|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
128941931|NCT00423085|464074976|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
128941932|NCT00423085|464074977|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
128941933|NCT00423085|464074974|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
128941934|NCT00423085|464074975|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
128941935|NCT00423085|464074976|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
128941936|NCT00423085|464074977|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
128941937|NCT00423085|464074974|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
128941938|NCT00423085|464074975|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
128941939|NCT00423085|464074976|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
128941940|NCT00423085|464074977|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
128941941|NCT00423085|464074974|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
128941942|NCT00423085|464074975|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
128941943|NCT00423085|464074976|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
128941944|NCT00423085|464074977|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
128941945|NCT00423085|464074974|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
128941946|NCT00423085|464074975|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
128941947|NCT00423085|464074976|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
128941948|NCT00423085|464074977|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
128941949|NCT00423085|464074974|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
128941950|NCT00423085|464074975|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
128941951|NCT00423085|464074976|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
128941952|NCT00423085|464074977|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
128941953|NCT00423085|464074974|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
128941954|NCT00423085|464074975|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
128941955|NCT00423085|464074976|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
128941956|NCT00423085|464074977|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
128941957|NCT00423085|464074974|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
128941958|NCT00423085|464074975|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
128941959|NCT00423085|464074976|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
128941960|NCT00423085|464074977|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
128941961|NCT00423085|464074974|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
128941962|NCT00423085|464074975|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
128941963|NCT00423085|464074976|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
128941964|NCT00423085|464074977|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
128941965|NCT00423085|464074974|FG000|52-Week Open-Label Extension Phase|Death|0|||
128941966|NCT00423085|464074975|FG001|52-Week Open-Label Extension Phase|Death|0|||
128941967|NCT00423085|464074976|FG002|52-Week Open-Label Extension Phase|Death|0|||
128941968|NCT00423085|464074977|FG003|52-Week Open-Label Extension Phase|Death|2|||
128941969|NCT02163993|464074978|FG000|Treatment Period|Adverse Event|0|||
128941970|NCT02163993|464074979|FG001|Treatment Period|Adverse Event|1|||
128941971|NCT02163993|464074980|FG002|Treatment Period|Adverse Event|0|||
129123335|NCT03675308|464746930|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
129123336|NCT03675308|464746929|FG000|Overall Study|Other|0|||
128941972|NCT02163993|464074981|FG003|Treatment Period|Adverse Event|0|||
128941973|NCT02163993|464074982|FG004|Treatment Period|Adverse Event|1|||
129032812|NCT04640194|464410360|FG006|Overall Study|mild bleeding|0|||
129032813|NCT04640194|464410354|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129032814|NCT04640194|464410355|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
129032815|NCT04640194|464410356|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129032816|NCT04640194|464410357|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129032817|NCT04640194|464410358|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129032818|NCT04640194|464410359|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129032819|NCT04640194|464410360|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129032820|NCT00663234|464410361|FG000|Overall Study|Not willing to adhere to requirements|1|||
129032821|NCT01709903|464410364|FG000|Overall Study|administrative problems|2|||
129032822|NCT01709903|464410365|FG001|Overall Study|administrative problems|6|||
129032823|NCT01709903|464410364|FG000|Overall Study|Abnormal test procedure results|1|||
129032824|NCT01709903|464410365|FG001|Overall Study|Abnormal test procedure results|0|||
129032825|NCT01709903|464410364|FG000|Overall Study|In ability to use device|1|||
129032826|NCT01709903|464410365|FG001|Overall Study|In ability to use device|1|||
129032827|NCT01709903|464410364|FG000|Overall Study|no longer needed study drug|0|||
129032828|NCT01709903|464410365|FG001|Overall Study|no longer needed study drug|1|||
129032829|NCT01709903|464410364|FG000|Overall Study|Lost to Follow-up|0|||
129032830|NCT01709903|464410365|FG001|Overall Study|Lost to Follow-up|2|||
129032831|NCT01709903|464410364|FG000|Overall Study|Death|2|||
129032832|NCT01709903|464410365|FG001|Overall Study|Death|0|||
129032833|NCT01709903|464410364|FG000|Overall Study|Protocol Violation|3|||
129032834|NCT01709903|464410365|FG001|Overall Study|Protocol Violation|2|||
129032835|NCT01709903|464410364|FG000|Overall Study|Lack of Efficacy|3|||
129032836|NCT01709903|464410365|FG001|Overall Study|Lack of Efficacy|3|||
129032837|NCT01709903|464410364|FG000|Overall Study|Withdrawal by Subject|6|||
129032838|NCT01709903|464410365|FG001|Overall Study|Withdrawal by Subject|6|||
129032839|NCT01709903|464410364|FG000|Overall Study|Adverse Event|11|||
129032840|NCT01709903|464410365|FG001|Overall Study|Adverse Event|18|||
129032841|NCT04773600|464410380|FG000|Overall Study|Withdrawal by Subject|15|||
129032842|NCT04773600|464410381|FG001|Overall Study|Withdrawal by Subject|9|||
129032843|NCT04773600|464410380|FG000|Overall Study|Lost to Follow-up|10|||
129032844|NCT04773600|464410381|FG001|Overall Study|Lost to Follow-up|6|||
129032845|NCT04773600|464410380|FG000|Overall Study|Adverse Event|8|||
129032846|NCT04773600|464410381|FG001|Overall Study|Adverse Event|2|||
129032847|NCT04773600|464410380|FG000|Overall Study|Lack of Efficacy|2|||
129032848|NCT04773600|464410381|FG001|Overall Study|Lack of Efficacy|3|||
129032849|NCT04773600|464410380|FG000|Overall Study|Noncompliance|2|||
129032850|NCT04773600|464410381|FG001|Overall Study|Noncompliance|0|||
129032851|NCT04773600|464410380|FG000|Overall Study|Protocol Violation|2|||
129032852|NCT04773600|464410381|FG001|Overall Study|Protocol Violation|0|||
129032853|NCT04773600|464410380|FG000|Overall Study|Physician Decision|0|||
129032854|NCT04773600|464410381|FG001|Overall Study|Physician Decision|1|||
129032855|NCT04773600|464410380|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
129032856|NCT04773600|464410381|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
129032857|NCT04773600|464410380|FG000|Overall Study|Emergency Travel Out of Country|1|||
129032858|NCT04773600|464410381|FG001|Overall Study|Emergency Travel Out of Country|0|||
129032859|NCT05135273|464411990|FG000|Overall Study|Recruited into the army|0|||
129032860|NCT05135273|464411991|FG001|Overall Study|Recruited into the army|0|||
129032861|NCT05135273|464411992|FG002|Overall Study|Recruited into the army|0|||
129032862|NCT05135273|464411993|FG003|Overall Study|Recruited into the army|0|||
129032863|NCT05135273|464411994|FG004|Overall Study|Recruited into the army|1|||
129032864|NCT05135273|464411995|FG005|Overall Study|Recruited into the army|0|||
129032865|NCT05135273|464411996|FG006|Overall Study|Recruited into the army|0|||
129032866|NCT05135273|464411997|FG007|Overall Study|Recruited into the army|0|||
129032867|NCT05135273|464411990|FG000|Overall Study|Moved away from study site|0|||
129032868|NCT05135273|464411991|FG001|Overall Study|Moved away from study site|0|||
129032869|NCT05135273|464411992|FG002|Overall Study|Moved away from study site|0|||
129032870|NCT05135273|464411993|FG003|Overall Study|Moved away from study site|0|||
129032871|NCT05135273|464411994|FG004|Overall Study|Moved away from study site|0|||
129032872|NCT05135273|464411995|FG005|Overall Study|Moved away from study site|1|||
129032873|NCT05135273|464411996|FG006|Overall Study|Moved away from study site|1|||
129032874|NCT05135273|464411997|FG007|Overall Study|Moved away from study site|0|||
129032875|NCT05135273|464411990|FG000|Overall Study|Travel|0|||
129032876|NCT05135273|464411991|FG001|Overall Study|Travel|0|||
129032877|NCT05135273|464411992|FG002|Overall Study|Travel|0|||
129032878|NCT05135273|464411993|FG003|Overall Study|Travel|0|||
129032879|NCT05135273|464411994|FG004|Overall Study|Travel|0|||
129032880|NCT05135273|464411995|FG005|Overall Study|Travel|0|||
129032881|NCT05135273|464411996|FG006|Overall Study|Travel|0|||
129032882|NCT05135273|464411997|FG007|Overall Study|Travel|1|||
129032883|NCT01705717|464412005|FG000|Overall Study|Adverse Event|2|||
129032884|NCT01705717|464412006|FG001|Overall Study|Adverse Event|2|||
129032885|NCT01705717|464412005|FG000|Overall Study|Lack of Efficacy|0|||
129032886|NCT01705717|464412006|FG001|Overall Study|Lack of Efficacy|1|||
129032887|NCT01705717|464412005|FG000|Overall Study|Other|0|||
129032888|NCT01705717|464412006|FG001|Overall Study|Other|2|||
129032889|NCT01662024|464412011|FG000|Overall Study|Pregnancy|2|||
129032890|NCT01662024|464412011|FG000|Overall Study|Withdrawal by Subject|3|||
129032891|NCT04980456|464412012|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
129032892|NCT04980456|464412013|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
129032893|NCT04980456|464412012|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
129032894|NCT04980456|464412013|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
129032895|NCT04980456|464412012|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
129032896|NCT04980456|464412013|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
129032897|NCT04980456|464412012|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
129032898|NCT04980456|464412013|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
129032899|NCT04832971|464412014|FG000|Overall Study|Death|1|||
129032900|NCT04832971|464412015|FG001|Overall Study|Death|0|||
129032901|NCT04832971|464412016|FG002|Overall Study|Death|0|||
129032902|NCT04832971|464412017|FG003|Overall Study|Death|0|||
129032903|NCT04832971|464412014|FG000|Overall Study|Lost to Follow-up|1|||
129032904|NCT04832971|464412015|FG001|Overall Study|Lost to Follow-up|1|||
129032905|NCT04832971|464412016|FG002|Overall Study|Lost to Follow-up|1|||
129032906|NCT04832971|464412017|FG003|Overall Study|Lost to Follow-up|0|||
129032907|NCT04832971|464412014|FG000|Overall Study|Withdrawal by Subject|1|||
129032908|NCT04832971|464412015|FG001|Overall Study|Withdrawal by Subject|3|||
129032909|NCT04832971|464412016|FG002|Overall Study|Withdrawal by Subject|2|||
129032910|NCT04832971|464412017|FG003|Overall Study|Withdrawal by Subject|2|||
129032911|NCT04832971|464412014|FG000|Overall Study|Other, Not Specified|0|||
129032912|NCT04832971|464412015|FG001|Overall Study|Other, Not Specified|0|||
129032913|NCT04832971|464412016|FG002|Overall Study|Other, Not Specified|1|||
129032914|NCT04832971|464412017|FG003|Overall Study|Other, Not Specified|0|||
129032915|NCT00500318|464412019|FG000|Overall Study|Adverse Event|3|||
129032916|NCT00500318|464412020|FG001|Overall Study|Adverse Event|8|||
129032917|NCT00500318|464412019|FG000|Overall Study|Protocol Violation|1|||
129032918|NCT00500318|464412020|FG001|Overall Study|Protocol Violation|3|||
129032919|NCT00500318|464412019|FG000|Overall Study|Withdrawal by Subject|1|||
129032920|NCT00500318|464412020|FG001|Overall Study|Withdrawal by Subject|2|||
129032921|NCT00500318|464412019|FG000|Overall Study|Lack of Efficacy|0|||
129032922|NCT00500318|464412020|FG001|Overall Study|Lack of Efficacy|3|||
129032923|NCT00500318|464412019|FG000|Overall Study|Other Reason|0|||
129032924|NCT00500318|464412020|FG001|Overall Study|Other Reason|1|||
129032925|NCT03243396|464412021|FG000|Overall Study|Lost to Follow-up|2|||
129032926|NCT03243396|464412022|FG001|Overall Study|Lost to Follow-up|3|||
129032927|NCT03243396|464412023|FG002|Overall Study|Lost to Follow-up|15|||
129032928|NCT03243396|464412024|FG003|Overall Study|Lost to Follow-up|8|||
129032929|NCT03243396|464412025|FG004|Overall Study|Lost to Follow-up|1|||
129032930|NCT03243396|464412026|FG005|Overall Study|Lost to Follow-up|4|||
129032931|NCT03243396|464412027|FG006|Overall Study|Lost to Follow-up|9|||
129032932|NCT03687242|464412028|FG000|Overall Study|Adverse Event|1|||
129032933|NCT01257581|464412029|FG000|Overall Study|Early Termination|3|||
129032934|NCT01257581|464412030|FG001|Overall Study|Early Termination|1|||
129032935|NCT01257581|464412031|FG002|Overall Study|Early Termination|2|||
129032936|NCT01257581|464412029|FG000|Overall Study|Death|2|||
129032937|NCT01257581|464412030|FG001|Overall Study|Death|2|||
129032938|NCT01257581|464412031|FG002|Overall Study|Death|4|||
129032939|NCT02655224|464412032|FG000|Overall Study|Adverse Event|1|||
129032940|NCT02655224|464412033|FG001|Overall Study|Adverse Event|1|||
129032941|NCT02419573|464412037|FG000|Overall Study|Lost to Follow-up|3|||
129032942|NCT02419573|464412038|FG001|Overall Study|Lost to Follow-up|0|||
129123337|NCT03675308|464746930|FG001|Overall Study|Other|1|||
129123338|NCT00788671|464746934|FG000|Overall Study|Death|2|||
129123339|NCT00788671|464746934|FG000|Overall Study|Unable to biopsy|1|||
129123340|NCT00788671|464746934|FG000|Overall Study|Withdrawal by Subject|4|||
129032943|NCT02419573|464412037|FG000|Overall Study|Withdrawal by Subject|1|||
129032944|NCT02419573|464412038|FG001|Overall Study|Withdrawal by Subject|0|||
129032945|NCT02246764|464412039|FG000|Overall Study|Adverse Event|15|||
129032946|NCT02246764|464412040|FG001|Overall Study|Adverse Event|29|||
129032947|NCT02246764|464412041|FG002|Overall Study|Adverse Event|1|||
129032948|NCT02246764|464412039|FG000|Overall Study|Withdrawal by Subject|0|||
129123341|NCT00788671|464746934|FG000|Overall Study|IUD expulsed|1|||
129123342|NCT00788671|464746934|FG000|Overall Study|Lost to follow up|2|||
129123343|NCT04761822|464746935|FG000|Overall Study|Adverse Event|3|||
129123344|NCT04761822|464746936|FG001|Overall Study|Adverse Event|1|||
129032949|NCT02246764|464412040|FG001|Overall Study|Withdrawal by Subject|0|||
129032950|NCT02246764|464412041|FG002|Overall Study|Withdrawal by Subject|1|||
129032951|NCT02246764|464412039|FG000|Overall Study|Disallowed Concomitant Medication|1|||
129032952|NCT02246764|464412040|FG001|Overall Study|Disallowed Concomitant Medication|0|||
129032953|NCT02246764|464412041|FG002|Overall Study|Disallowed Concomitant Medication|0|||
129032954|NCT02246764|464412039|FG000|Overall Study|Physician Decision|0|||
129032955|NCT02246764|464412040|FG001|Overall Study|Physician Decision|2|||
129032956|NCT02246764|464412041|FG002|Overall Study|Physician Decision|1|||
129123345|NCT04761822|464746937|FG002|Overall Study|Adverse Event|1|||
129123346|NCT04761822|464746938|FG003|Overall Study|Adverse Event|3|||
128941974|NCT02163993|464074978|FG000|Treatment Period|Lost to Follow-up|2|||
128941975|NCT02163993|464074979|FG001|Treatment Period|Lost to Follow-up|3|||
128941976|NCT02163993|464074980|FG002|Treatment Period|Lost to Follow-up|1|||
128941977|NCT02163993|464074981|FG003|Treatment Period|Lost to Follow-up|3|||
128941978|NCT02163993|464074982|FG004|Treatment Period|Lost to Follow-up|1|||
128941979|NCT02163993|464074978|FG000|Treatment Period|Physician Decision|1|||
128941980|NCT02163993|464074979|FG001|Treatment Period|Physician Decision|0|||
128941981|NCT02163993|464074980|FG002|Treatment Period|Physician Decision|0|||
128941982|NCT02163993|464074981|FG003|Treatment Period|Physician Decision|0|||
128941983|NCT02163993|464074982|FG004|Treatment Period|Physician Decision|0|||
128941984|NCT02163993|464074978|FG000|Treatment Period|Protocol Violation|2|||
128941985|NCT02163993|464074979|FG001|Treatment Period|Protocol Violation|1|||
128941986|NCT02163993|464074980|FG002|Treatment Period|Protocol Violation|0|||
128941987|NCT02163993|464074981|FG003|Treatment Period|Protocol Violation|1|||
128941988|NCT02163993|464074982|FG004|Treatment Period|Protocol Violation|2|||
128941989|NCT02163993|464074978|FG000|Treatment Period|Withdrawal by Subject|6|||
128941990|NCT02163993|464074979|FG001|Treatment Period|Withdrawal by Subject|4|||
128941991|NCT02163993|464074980|FG002|Treatment Period|Withdrawal by Subject|1|||
128941992|NCT02163993|464074981|FG003|Treatment Period|Withdrawal by Subject|4|||
128941993|NCT02163993|464074982|FG004|Treatment Period|Withdrawal by Subject|1|||
128941994|NCT02163993|464074978|FG000|Treatment Period|Not treated|1|||
128941995|NCT02163993|464074979|FG001|Treatment Period|Not treated|0|||
128941996|NCT02163993|464074980|FG002|Treatment Period|Not treated|0|||
128941997|NCT02163993|464074981|FG003|Treatment Period|Not treated|1|||
128941998|NCT02163993|464074982|FG004|Treatment Period|Not treated|2|||
128941999|NCT02163993|464074978|FG000|Post-treatment Period|Adverse Event|0|||
128942000|NCT02163993|464074979|FG001|Post-treatment Period|Adverse Event|0|||
128942001|NCT02163993|464074980|FG002|Post-treatment Period|Adverse Event|1|||
128942002|NCT02163993|464074981|FG003|Post-treatment Period|Adverse Event|0|||
128942003|NCT02163993|464074982|FG004|Post-treatment Period|Adverse Event|0|||
128942004|NCT02163993|464074978|FG000|Post-treatment Period|Lost to Follow-up|2|||
128942005|NCT02163993|464074979|FG001|Post-treatment Period|Lost to Follow-up|2|||
128942006|NCT02163993|464074980|FG002|Post-treatment Period|Lost to Follow-up|3|||
128942007|NCT02163993|464074981|FG003|Post-treatment Period|Lost to Follow-up|1|||
128942008|NCT02163993|464074982|FG004|Post-treatment Period|Lost to Follow-up|0|||
128942009|NCT02163993|464074978|FG000|Post-treatment Period|Protocol Violation|0|||
128942010|NCT02163993|464074979|FG001|Post-treatment Period|Protocol Violation|0|||
128942011|NCT02163993|464074980|FG002|Post-treatment Period|Protocol Violation|0|||
128942012|NCT02163993|464074981|FG003|Post-treatment Period|Protocol Violation|0|||
128942013|NCT02163993|464074982|FG004|Post-treatment Period|Protocol Violation|1|||
128942014|NCT02163993|464074978|FG000|Post-treatment Period|Withdrawal by Subject|2|||
128942015|NCT02163993|464074979|FG001|Post-treatment Period|Withdrawal by Subject|4|||
128942016|NCT02163993|464074980|FG002|Post-treatment Period|Withdrawal by Subject|0|||
128942017|NCT02163993|464074981|FG003|Post-treatment Period|Withdrawal by Subject|1|||
128942018|NCT02163993|464074982|FG004|Post-treatment Period|Withdrawal by Subject|2|||
128942019|NCT00853489|464074983|FG000|Overall Study|Lost to Follow-up|5|||
128942020|NCT00853489|464074984|FG001|Overall Study|Lost to Follow-up|2|||
128942021|NCT05525975|464074985|FG000|Overall Study|Surgery cancellation|4|||
128942022|NCT05525975|464074986|FG001|Overall Study|Surgery cancellation|5|||
128942023|NCT05525975|464074985|FG000|Overall Study|didn't fill prescription|1|||
128942024|NCT05525975|464074986|FG001|Overall Study|didn't fill prescription|0|||
128942025|NCT05525975|464074985|FG000|Overall Study|Withdrawal by Subject|0|||
128942026|NCT05525975|464074986|FG001|Overall Study|Withdrawal by Subject|3|||
128942027|NCT01345123|464074988|FG000|Overall Study|participants no longer with health plan|79|||
128942028|NCT01345123|464074989|FG001|Overall Study|participants no longer with health plan|85|||
128942029|NCT01345123|464074990|FG002|Overall Study|participants no longer with health plan|88|||
128942030|NCT02273752|464074991|FG000|Overall Study|Trial was terminated early|2|||
128942031|NCT02808312|464074992|FG000|Overall Study|Enrolled but Never Treated|0|||
128942032|NCT02808312|464074993|FG001|Overall Study|Enrolled but Never Treated|0|||
128942033|NCT02808312|464074994|FG002|Overall Study|Enrolled but Never Treated|1|||
128942034|NCT02808312|464074995|FG003|Overall Study|Enrolled but Never Treated|0|||
128942035|NCT02808312|464074996|FG004|Overall Study|Enrolled but Never Treated|0|||
128942036|NCT01623531|464075002|FG000|Overall Study|Death|1|||
128942037|NCT01623531|464075003|FG001|Overall Study|Death|0|||
129032957|NCT02246764|464412039|FG000|Overall Study|Protocol Violation|2|||
128942038|NCT01623531|464075002|FG000|Overall Study|Protocol Violation|2|||
129032958|NCT02246764|464412040|FG001|Overall Study|Protocol Violation|1|||
128942039|NCT01623531|464075003|FG001|Overall Study|Protocol Violation|1|||
128942040|NCT01623531|464075002|FG000|Overall Study|Missing data at primary outcome time poi|1|||
128942041|NCT01623531|464075003|FG001|Overall Study|Missing data at primary outcome time poi|1|||
128942042|NCT01429792|464075004|FG000|Overall Study|Other Reasons|67|||
128942043|NCT01429792|464075004|FG000|Overall Study|Unknown Disposition|94|||
128942044|NCT01429792|464075004|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
128942045|NCT01429792|464075004|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
128942046|NCT01429792|464075004|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
128942047|NCT01429792|464075004|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
128942048|NCT01429792|464075004|FG000|Overall Study|Withdrawal by Subject|70|||
128942049|NCT01429792|464075004|FG000|Overall Study|Lost to Follow-up|88|||
128942050|NCT04184622|464075006|FG000|Primary Treatment Period|Adverse Event|6|||
128942051|NCT04184622|464075007|FG001|Primary Treatment Period|Adverse Event|4|||
128942052|NCT04184622|464075008|FG002|Primary Treatment Period|Adverse Event|8|||
128942053|NCT04184622|464075009|FG003|Primary Treatment Period|Adverse Event|6|||
128942054|NCT04184622|464075006|FG000|Primary Treatment Period|Death|4|||
128942055|NCT04184622|464075007|FG001|Primary Treatment Period|Death|4|||
128942056|NCT04184622|464075008|FG002|Primary Treatment Period|Death|2|||
128942057|NCT04184622|464075009|FG003|Primary Treatment Period|Death|1|||
128942058|NCT04184622|464075006|FG000|Primary Treatment Period|Lost to Follow-up|41|||
128942059|NCT04184622|464075007|FG001|Primary Treatment Period|Lost to Follow-up|17|||
128942060|NCT04184622|464075008|FG002|Primary Treatment Period|Lost to Follow-up|15|||
128942061|NCT04184622|464075009|FG003|Primary Treatment Period|Lost to Follow-up|13|||
128942062|NCT04184622|464075006|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
128942063|NCT04184622|464075007|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
128942064|NCT04184622|464075008|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
128942065|NCT04184622|464075009|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
128942066|NCT04184622|464075006|FG000|Primary Treatment Period|Physician Decision|0|||
128942067|NCT04184622|464075007|FG001|Primary Treatment Period|Physician Decision|0|||
128942068|NCT04184622|464075008|FG002|Primary Treatment Period|Physician Decision|3|||
128942069|NCT04184622|464075009|FG003|Primary Treatment Period|Physician Decision|1|||
128942070|NCT04184622|464075006|FG000|Primary Treatment Period|Pregnancy|4|||
128942071|NCT04184622|464075007|FG001|Primary Treatment Period|Pregnancy|3|||
128942072|NCT04184622|464075008|FG002|Primary Treatment Period|Pregnancy|4|||
128942073|NCT04184622|464075009|FG003|Primary Treatment Period|Pregnancy|1|||
128942074|NCT04184622|464075006|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
128942075|NCT04184622|464075007|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
128942076|NCT04184622|464075008|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
128942077|NCT04184622|464075009|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
128942078|NCT04184622|464075006|FG000|Additional Treatment Period|Adverse Event|1|||
128942079|NCT04184622|464075007|FG001|Additional Treatment Period|Adverse Event|2|||
128942080|NCT04184622|464075008|FG002|Additional Treatment Period|Adverse Event|1|||
128942081|NCT04184622|464075009|FG003|Additional Treatment Period|Adverse Event|0|||
128942082|NCT04184622|464075006|FG000|Additional Treatment Period|Death|0|||
128942083|NCT04184622|464075007|FG001|Additional Treatment Period|Death|0|||
128942084|NCT04184622|464075008|FG002|Additional Treatment Period|Death|1|||
128942085|NCT04184622|464075009|FG003|Additional Treatment Period|Death|1|||
128942086|NCT04184622|464075006|FG000|Additional Treatment Period|Lost to Follow-up|6|||
128942087|NCT04184622|464075007|FG001|Additional Treatment Period|Lost to Follow-up|4|||
128942088|NCT04184622|464075008|FG002|Additional Treatment Period|Lost to Follow-up|8|||
128942089|NCT04184622|464075009|FG003|Additional Treatment Period|Lost to Follow-up|6|||
128942090|NCT04184622|464075006|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
128942091|NCT04184622|464075007|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
128942092|NCT04184622|464075008|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
128942093|NCT04184622|464075009|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
128942094|NCT04184622|464075006|FG000|Additional Treatment Period|Physician Decision|0|||
128942095|NCT04184622|464075007|FG001|Additional Treatment Period|Physician Decision|0|||
128942096|NCT04184622|464075008|FG002|Additional Treatment Period|Physician Decision|1|||
128942097|NCT04184622|464075009|FG003|Additional Treatment Period|Physician Decision|0|||
128942098|NCT04184622|464075006|FG000|Additional Treatment Period|Pregnancy|0|||
128942099|NCT04184622|464075007|FG001|Additional Treatment Period|Pregnancy|0|||
128942100|NCT04184622|464075008|FG002|Additional Treatment Period|Pregnancy|0|||
128942101|NCT04184622|464075009|FG003|Additional Treatment Period|Pregnancy|1|||
128942102|NCT04184622|464075006|FG000|Additional Treatment Period|Protocol deviation|0|||
128942103|NCT04184622|464075007|FG001|Additional Treatment Period|Protocol deviation|0|||
128942104|NCT04184622|464075008|FG002|Additional Treatment Period|Protocol deviation|1|||
128942105|NCT04184622|464075009|FG003|Additional Treatment Period|Protocol deviation|0|||
128942106|NCT04184622|464075006|FG000|Additional Treatment Period|Site closed|1|||
128942107|NCT04184622|464075007|FG001|Additional Treatment Period|Site closed|0|||
128942108|NCT04184622|464075008|FG002|Additional Treatment Period|Site closed|1|||
128942109|NCT04184622|464075009|FG003|Additional Treatment Period|Site closed|0|||
128942110|NCT04184622|464075006|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
128942111|NCT04184622|464075007|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
128942112|NCT04184622|464075008|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
128942113|NCT04184622|464075009|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
128942114|NCT04184622|464075006|FG000|Safety Follow-up Period|Adverse Event|6|||
128942115|NCT04184622|464075007|FG001|Safety Follow-up Period|Adverse Event|8|||
128942116|NCT04184622|464075008|FG002|Safety Follow-up Period|Adverse Event|9|||
128942117|NCT04184622|464075009|FG003|Safety Follow-up Period|Adverse Event|16|||
128942118|NCT04184622|464075006|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
128942119|NCT04184622|464075007|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
128942120|NCT04184622|464075008|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
128942121|NCT04184622|464075009|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
128942122|NCT04184622|464075006|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
128942123|NCT04184622|464075007|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
128942124|NCT04184622|464075008|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
128942125|NCT04184622|464075009|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
128942126|NCT04184622|464075006|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
128942127|NCT04184622|464075007|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
128942128|NCT04184622|464075008|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
128942129|NCT04184622|464075009|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
128942130|NCT04184622|464075006|FG000|Safety Follow-up Period|Physician Decision|1|||
128942131|NCT04184622|464075007|FG001|Safety Follow-up Period|Physician Decision|0|||
128942132|NCT04184622|464075008|FG002|Safety Follow-up Period|Physician Decision|0|||
128942133|NCT04184622|464075009|FG003|Safety Follow-up Period|Physician Decision|1|||
128942134|NCT04184622|464075006|FG000|Safety Follow-up Period|Pregnancy|1|||
128942135|NCT04184622|464075007|FG001|Safety Follow-up Period|Pregnancy|3|||
128942136|NCT04184622|464075008|FG002|Safety Follow-up Period|Pregnancy|0|||
128942137|NCT04184622|464075009|FG003|Safety Follow-up Period|Pregnancy|6|||
128942138|NCT04184622|464075006|FG000|Safety Follow-up Period|Protocol deviation|1|||
128942139|NCT04184622|464075007|FG001|Safety Follow-up Period|Protocol deviation|0|||
128942140|NCT04184622|464075008|FG002|Safety Follow-up Period|Protocol deviation|0|||
128942141|NCT04184622|464075009|FG003|Safety Follow-up Period|Protocol deviation|0|||
128942142|NCT04184622|464075006|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
128942143|NCT04184622|464075007|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
128942144|NCT04184622|464075008|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
128942145|NCT04184622|464075009|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
128942146|NCT01617681|464075010|FG000|Period 1 Double Blind|Adverse Event|2|||
128942147|NCT01617681|464075011|FG001|Period 1 Double Blind|Adverse Event|0|||
128942148|NCT01617681|464075012|FG002|Period 1 Double Blind|Adverse Event|0|||
128942149|NCT01617681|464075013|FG003|Period 1 Double Blind|Adverse Event|2|||
128942150|NCT01617681|464075014|FG004|Period 1 Double Blind|Adverse Event|0|||
128942151|NCT01617681|464075010|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
128942152|NCT01617681|464075011|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
128942153|NCT01617681|464075012|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
128942154|NCT01617681|464075013|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
128942155|NCT01617681|464075014|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
128942156|NCT01617681|464075010|FG000|Period 2 Open Label|Adverse Event|0|||
128942157|NCT01617681|464075011|FG001|Period 2 Open Label|Adverse Event|0|||
128942158|NCT01617681|464075012|FG002|Period 2 Open Label|Adverse Event|0|||
128942159|NCT01617681|464075013|FG003|Period 2 Open Label|Adverse Event|0|||
128942160|NCT01617681|464075014|FG004|Period 2 Open Label|Adverse Event|3|||
128942161|NCT01617681|464075010|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
128942162|NCT01617681|464075011|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
128942163|NCT01617681|464075012|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
128942164|NCT01617681|464075013|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
128942165|NCT01617681|464075014|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
128942166|NCT01856595|464075017|FG000|Overall Study|Withdrawal by Subject|0|||
128942167|NCT01856595|464075018|FG001|Overall Study|Withdrawal by Subject|1|||
128942168|NCT01856595|464075019|FG002|Overall Study|Withdrawal by Subject|0|||
128942169|NCT01856595|464075020|FG003|Overall Study|Withdrawal by Subject|0|||
128942170|NCT01856595|464075021|FG004|Overall Study|Withdrawal by Subject|0|||
128942171|NCT01856595|464075022|FG005|Overall Study|Withdrawal by Subject|0|||
128707626|NCT00105482|463223898|FG000|Overall Study|Lost Interest|29|||
128707627|NCT00105482|463223899|FG001|Overall Study|Lost Interest|32|||
128707628|NCT00105482|463223898|FG000|Overall Study|Scheduling Conflict|2|||
128707629|NCT00105482|463223899|FG001|Overall Study|Scheduling Conflict|3|||
128707630|NCT00105482|463223898|FG000|Overall Study|Withdrawn by PI|1|||
128707631|NCT00105482|463223899|FG001|Overall Study|Withdrawn by PI|1|||
128707632|NCT05620563|463223900|FG000|Overall Study|Adverse Event|3|||
128707633|NCT05620563|463223901|FG001|Overall Study|Adverse Event|1|||
128707634|NCT05620563|463223900|FG000|Overall Study|Lost to Follow-up|0|||
128707635|NCT05620563|463223901|FG001|Overall Study|Lost to Follow-up|2|||
128707636|NCT05620563|463223900|FG000|Overall Study|Protocol Deviation|1|||
128707637|NCT05620563|463223901|FG001|Overall Study|Protocol Deviation|2|||
128707638|NCT05620563|463223900|FG000|Overall Study|Withdrawal by Subject|3|||
128707639|NCT05620563|463223901|FG001|Overall Study|Withdrawal by Subject|3|||
128942172|NCT01856595|464075023|FG006|Overall Study|Withdrawal by Subject|1|||
128942173|NCT01856595|464075024|FG007|Overall Study|Withdrawal by Subject|0|||
128942174|NCT01856595|464075025|FG008|Overall Study|Withdrawal by Subject|0|||
128707640|NCT05620563|463223900|FG000|Overall Study|Physician Decision|0|||
128707641|NCT05620563|463223901|FG001|Overall Study|Physician Decision|1|||
128707642|NCT00085631|463223902|FG000|Overall Study|Missing Data|4|||
128707643|NCT00085631|463223903|FG001|Overall Study|Missing Data|11|||
128707644|NCT00085631|463223904|FG002|Overall Study|Missing Data|7|||
128707645|NCT00411645|463223905|FG000|Overall Study|Consent Withdrawn|13|||
128707646|NCT00411645|463223906|FG001|Overall Study|Consent Withdrawn|22|||
128942175|NCT04426825|464075026|FG000|Overall Study|Death|17|||
128942176|NCT04426825|464075026|FG000|Overall Study|Lost to Follow-up|1|||
128942177|NCT04426825|464075026|FG000|Overall Study|Study terminated by sponsor|5|||
128942178|NCT01763905|464075031|FG000|Overall Study|Withdrawal by Subject|1|||
128942179|NCT01763905|464075032|FG001|Overall Study|Withdrawal by Subject|1|||
128942180|NCT01763905|464075033|FG002|Overall Study|Withdrawal by Subject|0|||
128942181|NCT01763905|464075034|FG003|Overall Study|Withdrawal by Subject|1|||
128942182|NCT01763905|464075031|FG000|Overall Study|Decision by sponsor|5|||
128942183|NCT01763905|464075032|FG001|Overall Study|Decision by sponsor|0|||
128942184|NCT01763905|464075033|FG002|Overall Study|Decision by sponsor|8|||
128942185|NCT01763905|464075034|FG003|Overall Study|Decision by sponsor|0|||
128942186|NCT01763905|464075031|FG000|Overall Study|Lost to Follow-up|0|||
128942187|NCT01763905|464075032|FG001|Overall Study|Lost to Follow-up|0|||
128942188|NCT01763905|464075033|FG002|Overall Study|Lost to Follow-up|1|||
128942189|NCT01763905|464075034|FG003|Overall Study|Lost to Follow-up|0|||
128942190|NCT01028651|464075037|FG000|Overall Study|Death|2|||
128942191|NCT01028651|464075037|FG000|Overall Study|Adverse Event|1|||
128942192|NCT01554956|464075038|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
128942193|NCT01554956|464075039|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
128942194|NCT01554956|464075040|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
128942195|NCT01554956|464075038|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
128942196|NCT01554956|464075039|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
128942197|NCT01554956|464075040|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
128942198|NCT01554956|464075038|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
128942199|NCT01554956|464075039|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
128942200|NCT01554956|464075040|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
128942201|NCT00913978|464075041|FG000|Overall Study|Surgeon choice|1|||
128942202|NCT00913978|464075042|FG001|Overall Study|Surgeon choice|3|||
128942203|NCT01327651|464075046|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
128942204|NCT01327651|464075047|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
128942205|NCT01327651|464075048|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
128942206|NCT01327651|464075049|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
128942207|NCT01327651|464075050|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
128942208|NCT01327651|464075051|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
128942209|NCT01327651|464075052|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
128942210|NCT01327651|464075053|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
128942211|NCT01327651|464075054|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
128942212|NCT01327651|464075046|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
128942213|NCT01327651|464075047|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942214|NCT01327651|464075048|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942215|NCT01327651|464075049|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942216|NCT01327651|464075050|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942217|NCT01327651|464075051|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942218|NCT01327651|464075052|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942219|NCT01327651|464075053|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942220|NCT01327651|464075054|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
128942221|NCT01327651|464075046|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
128942222|NCT01327651|464075047|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
128942223|NCT01327651|464075048|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
128942224|NCT01327651|464075049|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
128942225|NCT01327651|464075050|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
128942226|NCT01327651|464075051|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
128942227|NCT01327651|464075052|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
128942228|NCT01327651|464075053|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
128942229|NCT01327651|464075054|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
128942230|NCT01327651|464075046|FG000|Post Study Follow-up|Lost to Follow-up|0|||
128707647|NCT00411645|463223905|FG000|Overall Study|Death|56|||
128707648|NCT00411645|463223906|FG001|Overall Study|Death|135|||
128707649|NCT00411645|463223905|FG000|Overall Study|Investigator/Sponsor Decision|10|||
128942231|NCT01327651|464075047|FG001|Post Study Follow-up|Lost to Follow-up|1|||
128942232|NCT01327651|464075048|FG002|Post Study Follow-up|Lost to Follow-up|1|||
128942233|NCT01327651|464075049|FG003|Post Study Follow-up|Lost to Follow-up|0|||
128707650|NCT00411645|463223906|FG001|Overall Study|Investigator/Sponsor Decision|7|||
128942234|NCT01327651|464075050|FG004|Post Study Follow-up|Lost to Follow-up|0|||
128942235|NCT01327651|464075051|FG005|Post Study Follow-up|Lost to Follow-up|0|||
128707651|NCT00411645|463223905|FG000|Overall Study|Lost to Follow-up|2|||
128707652|NCT00411645|463223906|FG001|Overall Study|Lost to Follow-up|0|||
128942236|NCT01327651|464075052|FG006|Post Study Follow-up|Lost to Follow-up|4|||
128942237|NCT01327651|464075053|FG007|Post Study Follow-up|Lost to Follow-up|1|||
128942238|NCT01327651|464075054|FG008|Post Study Follow-up|Lost to Follow-up|2|||
128942239|NCT03249792|464075059|FG000|Arms 1, 2, and 4|Death|1|||
128942240|NCT03249792|464075060|FG001|Arms 1, 2, and 4|Death|1|||
128942241|NCT03249792|464075061|FG002|Arms 1, 2, and 4|Death|0|||
128942242|NCT03249792|464075062|FG003|Arms 1, 2, and 4|Death|2|||
128942243|NCT03249792|464075063|FG004|Arms 1, 2, and 4|Death|3|||
128942244|NCT03249792|464075064|FG005|Arms 1, 2, and 4|Death|2|||
128942245|NCT03249792|464075065|FG006|Arms 1, 2, and 4|Death|2|||
128942246|NCT03249792|464075066|FG007|Arms 1, 2, and 4|Death|4|||
128942247|NCT03249792|464075067|FG008|Arms 1, 2, and 4|Death|2|||
128942248|NCT03249792|464075068|FG009|Arms 1, 2, and 4|Death|1|||
128942249|NCT03249792|464075069|FG010|Arms 1, 2, and 4|Death|7|||
128942250|NCT03249792|464075070|FG011|Arms 1, 2, and 4|Death|7|||
128942251|NCT03249792|464075071|FG012|Arms 1, 2, and 4|Death|12|||
128942252|NCT03249792|464075072|FG013|Arms 1, 2, and 4|Death|7|||
128942253|NCT03249792|464075073|FG014|Arms 1, 2, and 4|Death|0|||
128942254|NCT03249792|464075074|FG015|Arms 1, 2, and 4|Death|4|||
128942255|NCT03249792|464075075|FG016|Arms 1, 2, and 4|Death|4|||
128942256|NCT03249792|464075076|FG017|Arms 1, 2, and 4|Death|12|||
128942257|NCT03249792|464075077|FG018|Arms 1, 2, and 4|Death|6|||
128942258|NCT03249792|464075078|FG019|Arms 1, 2, and 4|Death|4|||
128942259|NCT03249792|464075079|FG020|Arms 1, 2, and 4|Death|2|||
128942260|NCT03249792|464075080|FG021|Arms 1, 2, and 4|Death|3|||
128942261|NCT03249792|464075081|FG022|Arms 1, 2, and 4|Death|1|||
128942262|NCT03249792|464075082|FG023|Arms 1, 2, and 4|Death|1|||
128942263|NCT03249792|464075083|FG024|Arms 1, 2, and 4|Death|4|||
128942264|NCT03249792|464075084|FG025|Arms 1, 2, and 4|Death|0|||
128942265|NCT03249792|464075085|FG026|Arms 1, 2, and 4|Death|0|||
128942266|NCT03249792|464075086|FG027|Arms 1, 2, and 4|Death|0|||
128942267|NCT03249792|464075087|FG028|Arms 1, 2, and 4|Death|0|||
128942268|NCT03249792|464075088|FG029|Arms 1, 2, and 4|Death|0|||
128942269|NCT03249792|464075089|FG030|Arms 1, 2, and 4|Death|0|||
128942270|NCT03249792|464075090|FG031|Arms 1, 2, and 4|Death|0|||
128942271|NCT03249792|464075091|FG032|Arms 1, 2, and 4|Death|0|||
128942272|NCT03249792|464075059|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942273|NCT03249792|464075060|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942274|NCT03249792|464075061|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
128942275|NCT03249792|464075062|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942276|NCT03249792|464075063|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942277|NCT03249792|464075064|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
128942278|NCT03249792|464075065|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
128942279|NCT03249792|464075066|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942280|NCT03249792|464075067|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
128942281|NCT03249792|464075068|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
128942282|NCT03249792|464075069|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
128942283|NCT03249792|464075070|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
128942284|NCT03249792|464075071|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
128942285|NCT03249792|464075072|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
128942286|NCT03249792|464075073|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942287|NCT03249792|464075074|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942288|NCT03249792|464075075|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
128942289|NCT03249792|464075076|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942290|NCT03249792|464075077|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
128942291|NCT03249792|464075078|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942292|NCT03249792|464075079|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942293|NCT03249792|464075080|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942294|NCT03249792|464075081|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
128942295|NCT03249792|464075082|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
128942296|NCT03249792|464075083|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942297|NCT03249792|464075084|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942298|NCT03249792|464075085|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942299|NCT03249792|464075086|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942300|NCT03249792|464075087|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942301|NCT03249792|464075088|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128707653|NCT04626297|463223909|FG000|Overall Study|Adverse Event|5|||
128707654|NCT04626297|463223910|FG001|Overall Study|Adverse Event|3|||
128942302|NCT03249792|464075089|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942303|NCT03249792|464075090|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942304|NCT03249792|464075091|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
128942305|NCT03249792|464075059|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
128942306|NCT03249792|464075060|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
128942307|NCT03249792|464075061|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
128942308|NCT03249792|464075062|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
128942309|NCT03249792|464075063|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
128942310|NCT03249792|464075064|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
128942311|NCT03249792|464075065|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
128942312|NCT03249792|464075066|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
128942313|NCT03249792|464075067|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
128942314|NCT03249792|464075068|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
128942315|NCT03249792|464075069|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
128942316|NCT03249792|464075070|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
128942317|NCT03249792|464075071|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
128942318|NCT03249792|464075072|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
128942319|NCT03249792|464075073|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
128942320|NCT03249792|464075074|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
128942321|NCT03249792|464075075|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
128942322|NCT03249792|464075076|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
128942323|NCT03249792|464075077|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
128942324|NCT03249792|464075078|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
128942325|NCT03249792|464075079|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
128942326|NCT03249792|464075080|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
128942327|NCT03249792|464075081|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
128942328|NCT03249792|464075082|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
128942329|NCT03249792|464075083|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
128942330|NCT03249792|464075084|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
128942331|NCT03249792|464075085|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
128942332|NCT03249792|464075086|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
128942333|NCT03249792|464075087|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
128942334|NCT03249792|464075088|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
128942335|NCT03249792|464075089|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
128942336|NCT03249792|464075090|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
128942337|NCT03249792|464075091|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
128942338|NCT03249792|464075059|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942339|NCT03249792|464075060|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942340|NCT03249792|464075061|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942341|NCT03249792|464075062|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942342|NCT03249792|464075063|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942343|NCT03249792|464075064|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942344|NCT03249792|464075065|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942345|NCT03249792|464075066|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942346|NCT03249792|464075067|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
128942347|NCT03249792|464075068|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942348|NCT03249792|464075069|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942349|NCT03249792|464075070|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942350|NCT03249792|464075071|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942351|NCT03249792|464075072|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942352|NCT03249792|464075073|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942353|NCT03249792|464075074|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942354|NCT03249792|464075075|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
128942355|NCT03249792|464075076|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
128942356|NCT03249792|464075077|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942357|NCT03249792|464075078|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
128942358|NCT03249792|464075079|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942359|NCT03249792|464075080|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942360|NCT03249792|464075081|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942361|NCT03249792|464075082|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942362|NCT03249792|464075083|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942363|NCT03249792|464075084|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942364|NCT03249792|464075085|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942365|NCT03249792|464075086|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942366|NCT03249792|464075087|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942367|NCT03249792|464075088|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942368|NCT03249792|464075089|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942369|NCT03249792|464075090|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942370|NCT03249792|464075091|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
128942371|NCT03249792|464075059|FG000|Switch Over Period|Withdrawal by Subject|0|||
128942372|NCT03249792|464075060|FG001|Switch Over Period|Withdrawal by Subject|0|||
128942373|NCT03249792|464075061|FG002|Switch Over Period|Withdrawal by Subject|0|||
128942374|NCT03249792|464075062|FG003|Switch Over Period|Withdrawal by Subject|0|||
128942375|NCT03249792|464075063|FG004|Switch Over Period|Withdrawal by Subject|0|||
128942376|NCT03249792|464075064|FG005|Switch Over Period|Withdrawal by Subject|0|||
128942377|NCT03249792|464075065|FG006|Switch Over Period|Withdrawal by Subject|0|||
128942378|NCT03249792|464075066|FG007|Switch Over Period|Withdrawal by Subject|0|||
128942379|NCT03249792|464075067|FG008|Switch Over Period|Withdrawal by Subject|0|||
128942380|NCT03249792|464075068|FG009|Switch Over Period|Withdrawal by Subject|0|||
128942381|NCT03249792|464075069|FG010|Switch Over Period|Withdrawal by Subject|0|||
128942382|NCT03249792|464075070|FG011|Switch Over Period|Withdrawal by Subject|0|||
128942383|NCT03249792|464075071|FG012|Switch Over Period|Withdrawal by Subject|0|||
129123347|NCT04761822|464746935|FG000|Overall Study|Lost to Follow-up|1|||
128942384|NCT03249792|464075072|FG013|Switch Over Period|Withdrawal by Subject|0|||
128942385|NCT03249792|464075073|FG014|Switch Over Period|Withdrawal by Subject|0|||
128942386|NCT03249792|464075074|FG015|Switch Over Period|Withdrawal by Subject|0|||
128942387|NCT03249792|464075075|FG016|Switch Over Period|Withdrawal by Subject|0|||
128942388|NCT03249792|464075076|FG017|Switch Over Period|Withdrawal by Subject|0|||
128942389|NCT03249792|464075077|FG018|Switch Over Period|Withdrawal by Subject|0|||
128942390|NCT03249792|464075078|FG019|Switch Over Period|Withdrawal by Subject|0|||
128942391|NCT03249792|464075079|FG020|Switch Over Period|Withdrawal by Subject|0|||
128942392|NCT03249792|464075080|FG021|Switch Over Period|Withdrawal by Subject|0|||
128942393|NCT03249792|464075081|FG022|Switch Over Period|Withdrawal by Subject|0|||
128942394|NCT03249792|464075082|FG023|Switch Over Period|Withdrawal by Subject|0|||
128942395|NCT03249792|464075083|FG024|Switch Over Period|Withdrawal by Subject|0|||
128942396|NCT03249792|464075084|FG025|Switch Over Period|Withdrawal by Subject|0|||
128942397|NCT03249792|464075085|FG026|Switch Over Period|Withdrawal by Subject|0|||
128942398|NCT03249792|464075086|FG027|Switch Over Period|Withdrawal by Subject|0|||
128942399|NCT03249792|464075087|FG028|Switch Over Period|Withdrawal by Subject|0|||
128942400|NCT03249792|464075088|FG029|Switch Over Period|Withdrawal by Subject|0|||
128942401|NCT03249792|464075089|FG030|Switch Over Period|Withdrawal by Subject|0|||
128942402|NCT03249792|464075090|FG031|Switch Over Period|Withdrawal by Subject|1|||
128942403|NCT03249792|464075091|FG032|Switch Over Period|Withdrawal by Subject|0|||
128942404|NCT03249792|464075059|FG000|Switch Over Period|Progressive Disease|0|||
128942405|NCT03249792|464075060|FG001|Switch Over Period|Progressive Disease|0|||
128942406|NCT03249792|464075061|FG002|Switch Over Period|Progressive Disease|0|||
128942407|NCT03249792|464075062|FG003|Switch Over Period|Progressive Disease|0|||
128942408|NCT03249792|464075063|FG004|Switch Over Period|Progressive Disease|0|||
128942409|NCT03249792|464075064|FG005|Switch Over Period|Progressive Disease|0|||
128942410|NCT03249792|464075065|FG006|Switch Over Period|Progressive Disease|0|||
128942411|NCT03249792|464075066|FG007|Switch Over Period|Progressive Disease|0|||
128942412|NCT03249792|464075067|FG008|Switch Over Period|Progressive Disease|0|||
128942413|NCT03249792|464075068|FG009|Switch Over Period|Progressive Disease|0|||
128942414|NCT03249792|464075069|FG010|Switch Over Period|Progressive Disease|0|||
128942415|NCT03249792|464075070|FG011|Switch Over Period|Progressive Disease|0|||
128942416|NCT03249792|464075071|FG012|Switch Over Period|Progressive Disease|0|||
128942417|NCT03249792|464075072|FG013|Switch Over Period|Progressive Disease|0|||
128942418|NCT03249792|464075073|FG014|Switch Over Period|Progressive Disease|0|||
128942419|NCT03249792|464075074|FG015|Switch Over Period|Progressive Disease|0|||
128942420|NCT03249792|464075075|FG016|Switch Over Period|Progressive Disease|0|||
128942421|NCT03249792|464075076|FG017|Switch Over Period|Progressive Disease|0|||
128942422|NCT03249792|464075077|FG018|Switch Over Period|Progressive Disease|0|||
128942423|NCT03249792|464075078|FG019|Switch Over Period|Progressive Disease|0|||
128942424|NCT03249792|464075079|FG020|Switch Over Period|Progressive Disease|0|||
128942425|NCT03249792|464075080|FG021|Switch Over Period|Progressive Disease|0|||
128942426|NCT03249792|464075081|FG022|Switch Over Period|Progressive Disease|0|||
128942427|NCT03249792|464075082|FG023|Switch Over Period|Progressive Disease|0|||
128942428|NCT03249792|464075083|FG024|Switch Over Period|Progressive Disease|0|||
128942429|NCT03249792|464075084|FG025|Switch Over Period|Progressive Disease|0|||
128942430|NCT03249792|464075085|FG026|Switch Over Period|Progressive Disease|1|||
128942431|NCT03249792|464075086|FG027|Switch Over Period|Progressive Disease|0|||
128942432|NCT03249792|464075087|FG028|Switch Over Period|Progressive Disease|1|||
128942433|NCT03249792|464075088|FG029|Switch Over Period|Progressive Disease|2|||
128942434|NCT03249792|464075089|FG030|Switch Over Period|Progressive Disease|1|||
128942435|NCT03249792|464075090|FG031|Switch Over Period|Progressive Disease|0|||
128942436|NCT03249792|464075091|FG032|Switch Over Period|Progressive Disease|1|||
128942437|NCT03249792|464075059|FG000|Switch Over Period|Adverse Event|0|||
128942438|NCT03249792|464075060|FG001|Switch Over Period|Adverse Event|0|||
128942439|NCT03249792|464075061|FG002|Switch Over Period|Adverse Event|0|||
128942440|NCT03249792|464075062|FG003|Switch Over Period|Adverse Event|0|||
128942441|NCT03249792|464075063|FG004|Switch Over Period|Adverse Event|0|||
128942442|NCT03249792|464075064|FG005|Switch Over Period|Adverse Event|0|||
128942443|NCT03249792|464075065|FG006|Switch Over Period|Adverse Event|0|||
128942444|NCT03249792|464075066|FG007|Switch Over Period|Adverse Event|0|||
128942445|NCT03249792|464075067|FG008|Switch Over Period|Adverse Event|0|||
128942446|NCT03249792|464075068|FG009|Switch Over Period|Adverse Event|0|||
128942447|NCT03249792|464075069|FG010|Switch Over Period|Adverse Event|0|||
128942448|NCT03249792|464075070|FG011|Switch Over Period|Adverse Event|0|||
128942449|NCT03249792|464075071|FG012|Switch Over Period|Adverse Event|0|||
128707655|NCT04626297|463223909|FG000|Overall Study|Lost to Follow-up|7|||
128707656|NCT04626297|463223910|FG001|Overall Study|Lost to Follow-up|3|||
128707657|NCT04626297|463223909|FG000|Overall Study|Protocol Violation|5|||
128707658|NCT04626297|463223910|FG001|Overall Study|Protocol Violation|1|||
128707659|NCT04626297|463223909|FG000|Overall Study|Withdrawal by Subject|20|||
128942450|NCT03249792|464075072|FG013|Switch Over Period|Adverse Event|0|||
128942451|NCT03249792|464075073|FG014|Switch Over Period|Adverse Event|0|||
128942452|NCT03249792|464075074|FG015|Switch Over Period|Adverse Event|0|||
128942453|NCT03249792|464075075|FG016|Switch Over Period|Adverse Event|0|||
129032959|NCT02246764|464412041|FG002|Overall Study|Protocol Violation|1|||
128707660|NCT04626297|463223910|FG001|Overall Study|Withdrawal by Subject|6|||
128942454|NCT03249792|464075076|FG017|Switch Over Period|Adverse Event|0|||
128942455|NCT03249792|464075077|FG018|Switch Over Period|Adverse Event|0|||
128942456|NCT03249792|464075078|FG019|Switch Over Period|Adverse Event|0|||
128942457|NCT03249792|464075079|FG020|Switch Over Period|Adverse Event|0|||
128942458|NCT03249792|464075080|FG021|Switch Over Period|Adverse Event|0|||
128942459|NCT03249792|464075081|FG022|Switch Over Period|Adverse Event|0|||
128707661|NCT04626297|463223909|FG000|Overall Study|Sponsor decision|2|||
128942460|NCT03249792|464075082|FG023|Switch Over Period|Adverse Event|0|||
128942461|NCT03249792|464075083|FG024|Switch Over Period|Adverse Event|0|||
128942462|NCT03249792|464075084|FG025|Switch Over Period|Adverse Event|1|||
128942463|NCT03249792|464075085|FG026|Switch Over Period|Adverse Event|0|||
128942464|NCT03249792|464075086|FG027|Switch Over Period|Adverse Event|1|||
128942465|NCT03249792|464075087|FG028|Switch Over Period|Adverse Event|0|||
128942466|NCT03249792|464075088|FG029|Switch Over Period|Adverse Event|0|||
128942467|NCT03249792|464075089|FG030|Switch Over Period|Adverse Event|0|||
128942468|NCT03249792|464075090|FG031|Switch Over Period|Adverse Event|0|||
128942469|NCT03249792|464075091|FG032|Switch Over Period|Adverse Event|0|||
128942470|NCT01201798|464075095|FG000|Overall Study|Adverse Event|2|||
128942471|NCT01201798|464075096|FG001|Overall Study|Adverse Event|0|||
128942472|NCT01201798|464075095|FG000|Overall Study|Lost to Follow-up|3|||
128942473|NCT01201798|464075096|FG001|Overall Study|Lost to Follow-up|5|||
128942474|NCT01201798|464075095|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
128942475|NCT01201798|464075096|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
128942476|NCT01201798|464075095|FG000|Overall Study|Noncompliance|1|||
128942477|NCT01201798|464075096|FG001|Overall Study|Noncompliance|0|||
128942478|NCT01201798|464075095|FG000|Overall Study|Protocol Violation|1|||
128942479|NCT01201798|464075096|FG001|Overall Study|Protocol Violation|1|||
128942480|NCT01201798|464075095|FG000|Overall Study|Treatment Failure|1|||
128942481|NCT01201798|464075096|FG001|Overall Study|Treatment Failure|8|||
128942482|NCT00525148|464075097|FG000|Overall Study|Other Adverse Event|3|||
128942483|NCT00525148|464075098|FG001|Overall Study|Other Adverse Event|5|||
128942484|NCT00525148|464075099|FG002|Overall Study|Other Adverse Event|1|||
128942485|NCT00525148|464075100|FG003|Overall Study|Other Adverse Event|8|||
128942486|NCT00525148|464075097|FG000|Overall Study|Progressive disease|18|||
128942487|NCT00525148|464075098|FG001|Overall Study|Progressive disease|30|||
128942488|NCT00525148|464075099|FG002|Overall Study|Progressive disease|6|||
128942489|NCT00525148|464075100|FG003|Overall Study|Progressive disease|49|||
128942490|NCT00525148|464075097|FG000|Overall Study|Refused continuation of study medication|0|||
128942491|NCT00525148|464075098|FG001|Overall Study|Refused continuation of study medication|2|||
128942492|NCT00525148|464075099|FG002|Overall Study|Refused continuation of study medication|0|||
128942493|NCT00525148|464075100|FG003|Overall Study|Refused continuation of study medication|1|||
128942494|NCT00525148|464075097|FG000|Overall Study|Other than stated|2|||
128942495|NCT00525148|464075098|FG001|Overall Study|Other than stated|1|||
128942496|NCT00525148|464075099|FG002|Overall Study|Other than stated|0|||
128942497|NCT00525148|464075100|FG003|Overall Study|Other than stated|3|||
128942498|NCT00114972|464075101|FG000|Overall Study|Withdrawal by Subject|40|||
128942499|NCT00114972|464075102|FG001|Overall Study|Withdrawal by Subject|7|||
128942500|NCT00114972|464075101|FG000|Overall Study|Lost to Follow-up|8|||
128942501|NCT00114972|464075102|FG001|Overall Study|Lost to Follow-up|5|||
128942502|NCT00830037|464075103|FG000|Overall Study|Withdrawal by Subject|2|||
128942503|NCT00830037|464075104|FG001|Overall Study|Withdrawal by Subject|3|||
128942504|NCT00830037|464075103|FG000|Overall Study|Lost to Follow-up|1|||
128942505|NCT00830037|464075104|FG001|Overall Study|Lost to Follow-up|2|||
128942506|NCT00830037|464075103|FG000|Overall Study|Active when terminated by DSMB|15|||
128942507|NCT00830037|464075104|FG001|Overall Study|Active when terminated by DSMB|14|||
128942508|NCT01425190|464075105|FG000|Overall Study|Full dose not consumed.|1|||
128942509|NCT01425190|464075106|FG001|Overall Study|Full dose not consumed.|0|||
128942510|NCT01425190|464075107|FG002|Overall Study|Full dose not consumed.|0|||
128942511|NCT02538666|464075111|FG000|Pre-Treatment|Disease progression|1|||
128942512|NCT02538666|464075112|FG001|Pre-Treatment|Disease progression|0|||
128942513|NCT02538666|464075113|FG002|Pre-Treatment|Disease progression|0|||
128942514|NCT02538666|464075111|FG000|Pre-Treatment|no longer meets study criteria|1|||
128942515|NCT02538666|464075112|FG001|Pre-Treatment|no longer meets study criteria|0|||
128942516|NCT02538666|464075113|FG002|Pre-Treatment|no longer meets study criteria|0|||
129032960|NCT02754492|464412044|FG000|Overall Study|Protocol Violation|2|||
129032961|NCT02754492|464412045|FG001|Overall Study|Protocol Violation|2|||
129032962|NCT02754492|464412046|FG002|Overall Study|Protocol Violation|0|||
129032963|NCT02754492|464412047|FG003|Overall Study|Protocol Violation|1|||
129032964|NCT02754492|464412044|FG000|Overall Study|Withdrawal by Subject|2|||
129032965|NCT02754492|464412045|FG001|Overall Study|Withdrawal by Subject|0|||
129032966|NCT02754492|464412046|FG002|Overall Study|Withdrawal by Subject|0|||
129032967|NCT02754492|464412047|FG003|Overall Study|Withdrawal by Subject|0|||
129032968|NCT02754492|464412044|FG000|Overall Study|Equipment malfuntion|0|||
129032969|NCT02754492|464412045|FG001|Overall Study|Equipment malfuntion|0|||
129032970|NCT02754492|464412046|FG002|Overall Study|Equipment malfuntion|2|||
129032971|NCT02754492|464412047|FG003|Overall Study|Equipment malfuntion|5|||
129032972|NCT02754492|464412044|FG000|Overall Study|Adverse Event|0|||
129032973|NCT02754492|464412045|FG001|Overall Study|Adverse Event|0|||
129032974|NCT02754492|464412046|FG002|Overall Study|Adverse Event|0|||
129032975|NCT02754492|464412047|FG003|Overall Study|Adverse Event|13|||
129032976|NCT02754492|464412044|FG000|Overall Study|Venous access issues not resulting in AE|0|||
129032977|NCT02754492|464412045|FG001|Overall Study|Venous access issues not resulting in AE|0|||
129032978|NCT02754492|464412046|FG002|Overall Study|Venous access issues not resulting in AE|0|||
129032979|NCT02754492|464412047|FG003|Overall Study|Venous access issues not resulting in AE|4|||
128707662|NCT04626297|463223910|FG001|Overall Study|Sponsor decision|1|||
128707663|NCT05048784|463223917|FG000|Period 1|Adverse Event|3|||
128707664|NCT05048784|463223918|FG001|Period 1|Adverse Event|1|||
128707665|NCT05048784|463223919|FG002|Period 1|Adverse Event|0|||
128707666|NCT05048784|463223920|FG003|Period 1|Adverse Event|0|||
128707667|NCT05048784|463223917|FG000|Period 2|Lost to Follow-up|0|||
128707668|NCT05048784|463223918|FG001|Period 2|Lost to Follow-up|1|||
128707669|NCT05048784|463223919|FG002|Period 2|Lost to Follow-up|0|||
128707670|NCT05048784|463223920|FG003|Period 2|Lost to Follow-up|0|||
128707671|NCT03521934|463223921|FG000|Overall Study|Death|65|||
128707672|NCT03521934|463223922|FG001|Overall Study|Death|73|||
128707673|NCT03521934|463223921|FG000|Overall Study|Withdrawal by Subject|18|||
128707674|NCT03521934|463223922|FG001|Overall Study|Withdrawal by Subject|23|||
128707675|NCT03521934|463223921|FG000|Overall Study|Site Terminated by Sponsor|39|||
128707676|NCT03521934|463223922|FG001|Overall Study|Site Terminated by Sponsor|35|||
128707677|NCT03521934|463223921|FG000|Overall Study|Study Terminated by Sponsor|483|||
128707678|NCT03521934|463223922|FG001|Overall Study|Study Terminated by Sponsor|477|||
128707679|NCT03521934|463223921|FG000|Overall Study|Reason not Specified|3|||
128707680|NCT03521934|463223922|FG001|Overall Study|Reason not Specified|6|||
128707681|NCT03020160|463223925|FG000|Overall Study|Withdrawal by Subject|1|||
128707682|NCT03020160|463223926|FG001|Overall Study|Withdrawal by Subject|0|||
128707683|NCT00284050|463223927|FG000|Overall Study|Adverse Event|1|||
128707684|NCT00284050|463223928|FG001|Overall Study|Adverse Event|1|||
128707685|NCT00284050|463223929|FG002|Overall Study|Adverse Event|1|||
128942517|NCT02538666|464075111|FG000|Pre-Treatment|Withdrew Consent|0|||
128942518|NCT02538666|464075112|FG001|Pre-Treatment|Withdrew Consent|1|||
128942519|NCT02538666|464075113|FG002|Pre-Treatment|Withdrew Consent|1|||
128942520|NCT02538666|464075111|FG000|Treatment|Disease progression|270|||
128942521|NCT02538666|464075112|FG001|Treatment|Disease progression|227|||
128942522|NCT02538666|464075113|FG002|Treatment|Disease progression|165|||
128942523|NCT02538666|464075111|FG000|Treatment|Study drug toxicity|1|||
128942524|NCT02538666|464075112|FG001|Treatment|Study drug toxicity|29|||
128942525|NCT02538666|464075113|FG002|Treatment|Study drug toxicity|92|||
128942526|NCT02538666|464075111|FG000|Treatment|Death|0|||
128942527|NCT02538666|464075112|FG001|Treatment|Death|2|||
128942528|NCT02538666|464075113|FG002|Treatment|Death|3|||
128942529|NCT02538666|464075111|FG000|Treatment|Adverse event unrelated to study drug|8|||
128942530|NCT02538666|464075112|FG001|Treatment|Adverse event unrelated to study drug|10|||
128942531|NCT02538666|464075113|FG002|Treatment|Adverse event unrelated to study drug|15|||
128942532|NCT02538666|464075111|FG000|Treatment|Participant request to discontinue study treatment|3|||
128942533|NCT02538666|464075112|FG001|Treatment|Participant request to discontinue study treatment|6|||
128942534|NCT02538666|464075113|FG002|Treatment|Participant request to discontinue study treatment|11|||
128942535|NCT02538666|464075111|FG000|Treatment|Participant withdrew consent|2|||
128942536|NCT02538666|464075112|FG001|Treatment|Participant withdrew consent|5|||
128942537|NCT02538666|464075113|FG002|Treatment|Participant withdrew consent|3|||
128942538|NCT02538666|464075111|FG000|Treatment|Lost to Follow-up|0|||
128942539|NCT02538666|464075112|FG001|Treatment|Lost to Follow-up|1|||
128942540|NCT02538666|464075113|FG002|Treatment|Lost to Follow-up|1|||
128942541|NCT02538666|464075111|FG000|Treatment|Maximum clinical benefit|4|||
128942542|NCT02538666|464075112|FG001|Treatment|Maximum clinical benefit|3|||
128942543|NCT02538666|464075113|FG002|Treatment|Maximum clinical benefit|4|||
128942544|NCT02538666|464075111|FG000|Treatment|Poor/non-compliance|0|||
128942545|NCT02538666|464075112|FG001|Treatment|Poor/non-compliance|1|||
128942546|NCT02538666|464075113|FG002|Treatment|Poor/non-compliance|0|||
128942547|NCT02538666|464075111|FG000|Treatment|Participant no longer meets study criteria|0|||
128707686|NCT00284050|463223927|FG000|Overall Study|Lack of Efficacy|0|||
128707687|NCT00284050|463223928|FG001|Overall Study|Lack of Efficacy|1|||
128707688|NCT00284050|463223929|FG002|Overall Study|Lack of Efficacy|3|||
128707689|NCT00284050|463223927|FG000|Overall Study|Protocol Violation|0|||
128707690|NCT00284050|463223928|FG001|Overall Study|Protocol Violation|1|||
128707691|NCT00284050|463223929|FG002|Overall Study|Protocol Violation|2|||
128707692|NCT00284050|463223927|FG000|Overall Study|Withdrawal by Subject|2|||
128707693|NCT00284050|463223928|FG001|Overall Study|Withdrawal by Subject|2|||
128707694|NCT00284050|463223929|FG002|Overall Study|Withdrawal by Subject|2|||
128707695|NCT00284050|463223927|FG000|Overall Study|Lost to Follow-up|1|||
128707696|NCT00284050|463223928|FG001|Overall Study|Lost to Follow-up|0|||
128707697|NCT00284050|463223929|FG002|Overall Study|Lost to Follow-up|1|||
128942548|NCT02538666|464075112|FG001|Treatment|Participant no longer meets study criteria|2|||
129032980|NCT02104817|464412048|FG000|Overall Study|Death|363|||
128707698|NCT00284050|463223927|FG000|Overall Study|Death|1|||
128707699|NCT00284050|463223928|FG001|Overall Study|Death|0|||
128707700|NCT00284050|463223929|FG002|Overall Study|Death|0|||
128707701|NCT02547649|463223932|FG000|Overall Study|Lost to Follow-up|3|||
128707702|NCT02547649|463223933|FG001|Overall Study|Lost to Follow-up|1|||
128942549|NCT02538666|464075113|FG002|Treatment|Participant no longer meets study criteria|0|||
129032981|NCT02104817|464412049|FG001|Overall Study|Death|330|||
128707703|NCT02547649|463223934|FG002|Overall Study|Lost to Follow-up|1|||
128707704|NCT02547649|463223932|FG000|Overall Study|Not vaccinated|0|||
128707705|NCT02547649|463223933|FG001|Overall Study|Not vaccinated|0|||
128707706|NCT02547649|463223934|FG002|Overall Study|Not vaccinated|1|||
128707707|NCT02547649|463223932|FG000|Overall Study|Withdrawal by Subject|0|||
128707708|NCT02547649|463223933|FG001|Overall Study|Withdrawal by Subject|4|||
128707709|NCT02547649|463223934|FG002|Overall Study|Withdrawal by Subject|2|||
128707710|NCT01750242|463223937|FG000|Overall Study|Unreadable Images|3|||
128707711|NCT01484197|463223940|FG000|Treatment Period 1|Adverse Event|1|||
128707712|NCT01484197|463223941|FG001|Treatment Period 1|Adverse Event|0|||
128942550|NCT02538666|464075111|FG000|Treatment|Administrative reason by sponsor|0|||
128942551|NCT02538666|464075112|FG001|Treatment|Administrative reason by sponsor|0|||
128942552|NCT02538666|464075113|FG002|Treatment|Administrative reason by sponsor|1|||
128942553|NCT02538666|464075111|FG000|Treatment|Other reasons|8|||
128942554|NCT02538666|464075112|FG001|Treatment|Other reasons|15|||
128942555|NCT02538666|464075113|FG002|Treatment|Other reasons|5|||
128942556|NCT02538666|464075111|FG000|Treatment|Not reported|2|||
128942557|NCT02538666|464075112|FG001|Treatment|Not reported|2|||
128942558|NCT02538666|464075113|FG002|Treatment|Not reported|2|||
128942559|NCT04590937|464075114|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
128942560|NCT01555463|464075119|FG000|Treatment|Adverse Event|6|||
128942561|NCT01555463|464075120|FG001|Treatment|Adverse Event|12|||
128942562|NCT01555463|464075119|FG000|Treatment|Withdrawal by Subject|24|||
128942563|NCT01555463|464075120|FG001|Treatment|Withdrawal by Subject|36|||
128942564|NCT01555463|464075119|FG000|Treatment|Lost to Follow-up|28|||
128942565|NCT01555463|464075120|FG001|Treatment|Lost to Follow-up|23|||
128942566|NCT01555463|464075119|FG000|Treatment|Protocol Violation|4|||
128942567|NCT01555463|464075120|FG001|Treatment|Protocol Violation|5|||
128942568|NCT01555463|464075119|FG000|Treatment|Other reason|2|||
128942569|NCT01555463|464075120|FG001|Treatment|Other reason|3|||
128942570|NCT01555463|464075119|FG000|Follow up|Adverse Event|2|||
128942571|NCT01555463|464075120|FG001|Follow up|Adverse Event|5|||
128942572|NCT01555463|464075119|FG000|Follow up|Death|0|||
128942573|NCT01555463|464075120|FG001|Follow up|Death|1|||
128942574|NCT01555463|464075119|FG000|Follow up|Withdrawal by Subject|22|||
128942575|NCT01555463|464075120|FG001|Follow up|Withdrawal by Subject|22|||
128942576|NCT01555463|464075119|FG000|Follow up|Lost to Follow-up|9|||
128942577|NCT01555463|464075120|FG001|Follow up|Lost to Follow-up|10|||
128942578|NCT01555463|464075119|FG000|Follow up|Protocol Violation|2|||
128942579|NCT01555463|464075120|FG001|Follow up|Protocol Violation|4|||
128942580|NCT01555463|464075119|FG000|Follow up|Other reason|3|||
128942581|NCT01555463|464075120|FG001|Follow up|Other reason|3|||
128942582|NCT02026271|464075121|FG000|Overall Study|Adverse Event|2|||
128942583|NCT02026271|464075122|FG001|Overall Study|Adverse Event|3|||
128942584|NCT02026271|464075123|FG002|Overall Study|Adverse Event|2|||
128942585|NCT02026271|464075124|FG003|Overall Study|Adverse Event|3|||
128942586|NCT02026271|464075125|FG004|Overall Study|Adverse Event|0|||
128770221|NCT01799720|463450161|FG002|Overall Study|Protocol Violation|0|||
128770222|NCT01799720|463450159|FG000|Overall Study|Pregnancy|0|||
128770223|NCT01799720|463450160|FG001|Overall Study|Pregnancy|0|||
128770224|NCT01799720|463450161|FG002|Overall Study|Pregnancy|1|||
128942587|NCT02026271|464075121|FG000|Overall Study|Withdrawal by Subject|0|||
128942588|NCT02026271|464075122|FG001|Overall Study|Withdrawal by Subject|0|||
128942589|NCT02026271|464075123|FG002|Overall Study|Withdrawal by Subject|0|||
128942590|NCT02026271|464075124|FG003|Overall Study|Withdrawal by Subject|0|||
128942591|NCT02026271|464075125|FG004|Overall Study|Withdrawal by Subject|1|||
128942592|NCT04370028|464075126|FG000|Overall Study|Withdrawal by Subject|695|||
128942593|NCT04370028|464075126|FG000|Overall Study|Protocol Violation|9|||
129032982|NCT02104817|464412048|FG000|Overall Study|Lost to Follow-up|3|||
128707713|NCT01484197|463223942|FG002|Treatment Period 1|Adverse Event|0|||
128707714|NCT01484197|463223943|FG003|Treatment Period 1|Adverse Event|0|||
128770225|NCT04276090|463450162|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
128942594|NCT04370028|464075126|FG000|Overall Study|Adverse Event|3|||
128942595|NCT04743635|464075127|FG000|Overall Study|Lost to Follow-up|2|||
128942596|NCT04743635|464075128|FG001|Overall Study|Lost to Follow-up|0|||
128942597|NCT02426658|464075129|FG000|Overall Study|Withdrawal by Subject|1|||
128770226|NCT04276090|463450163|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
128707715|NCT01484197|463223940|FG000|Treatment Period 2|Subject withdrew consent|0|||
128707716|NCT01484197|463223941|FG001|Treatment Period 2|Subject withdrew consent|0|||
128707717|NCT01484197|463223942|FG002|Treatment Period 2|Subject withdrew consent|0|||
128942598|NCT02426658|464075129|FG000|Overall Study|Patient expired before treatment|2|||
128942599|NCT01199263|464075130|FG000|Overall Study|Ineligible|0|||
128942600|NCT01199263|464075131|FG001|Overall Study|Ineligible|2|||
128942601|NCT01199263|464075130|FG000|Overall Study|Never Treated|6|||
128942602|NCT01199263|464075131|FG001|Overall Study|Never Treated|0|||
128942603|NCT01402284|464075132|FG000|Overall Study|Withdrawal consent|2|||
128942604|NCT01402284|464075132|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
128942605|NCT01402284|464075132|FG000|Overall Study|Physician Decision|1|||
128707718|NCT01484197|463223943|FG003|Treatment Period 2|Subject withdrew consent|1|||
128770227|NCT01234649|463450164|FG000|Overall Study|Withdrawal by Subject|32|||
128942606|NCT01402284|464075132|FG000|Overall Study|Disease progression on study|10|||
128942607|NCT02928406|464075133|FG000|Overall Study|Death|780|||
128707719|NCT02706691|463223945|FG000|Overall Study|Adverse Event|1|||
128707720|NCT05025241|463223949|FG000|Screening|Failed Screening|5|||
128707721|NCT05025241|463223949|FG000|Treatment and Follow Up|Adverse Event|3|||
128707722|NCT02007109|463223952|FG000|Overall Study|Diary not returned or excluded|102|||
128707723|NCT02007109|463223952|FG000|Overall Study|Excluded - Age<7yo|9|||
128707724|NCT03572062|463223953|FG000|Overall Study|Adverse Event|0|||
128707725|NCT03572062|463223954|FG001|Overall Study|Adverse Event|0|||
128707726|NCT03572062|463223955|FG002|Overall Study|Adverse Event|0|||
128707727|NCT03572062|463223956|FG003|Overall Study|Adverse Event|0|||
128707728|NCT03572062|463223957|FG004|Overall Study|Adverse Event|0|||
128707729|NCT03572062|463223958|FG005|Overall Study|Adverse Event|0|||
128707730|NCT03572062|463223959|FG006|Overall Study|Adverse Event|0|||
128707731|NCT03572062|463223960|FG007|Overall Study|Adverse Event|0|||
128707732|NCT03572062|463223961|FG008|Overall Study|Adverse Event|1|||
128707733|NCT03572062|463223962|FG009|Overall Study|Adverse Event|3|||
128707734|NCT03572062|463223953|FG000|Overall Study|Death|0|||
128707735|NCT03572062|463223954|FG001|Overall Study|Death|0|||
128942608|NCT02928406|464075133|FG000|Overall Study|Progressive disease|3|||
128942609|NCT02928406|464075133|FG000|Overall Study|Lost to Follow-up|49|||
128942610|NCT02928406|464075133|FG000|Overall Study|Non-compliance|2|||
128942611|NCT02928406|464075133|FG000|Overall Study|Withdrawal by Subject|40|||
128942612|NCT02928406|464075133|FG000|Overall Study|Study terminated by sponsor|57|||
128942613|NCT02928406|464075133|FG000|Overall Study|Physician Decision|1|||
128942614|NCT02928406|464075133|FG000|Overall Study|Various reasons|72|||
128942615|NCT05281523|464075137|FG000|Overall Study|Adverse Event|1|||
128942616|NCT05281523|464075138|FG001|Overall Study|Adverse Event|1|||
128942617|NCT05281523|464075137|FG000|Overall Study|Physician Decision|1|||
128942618|NCT05281523|464075138|FG001|Overall Study|Physician Decision|1|||
128942619|NCT05281523|464075137|FG000|Overall Study|Withdrawal by Subject|5|||
128942620|NCT05281523|464075138|FG001|Overall Study|Withdrawal by Subject|15|||
128942621|NCT05281523|464075137|FG000|Overall Study|GCP violations|3|||
128942622|NCT05281523|464075138|FG001|Overall Study|GCP violations|4|||
128942623|NCT05513391|464075139|FG000|Overall Study|Adverse Event|1|||
128942624|NCT05513391|464075140|FG001|Overall Study|Adverse Event|0|||
128942625|NCT05513391|464075139|FG000|Overall Study|Protocol Deviation|0|||
128942626|NCT05513391|464075140|FG001|Overall Study|Protocol Deviation|1|||
128942627|NCT05513391|464075139|FG000|Overall Study|Withdrawal by Subject|3|||
128942628|NCT05513391|464075140|FG001|Overall Study|Withdrawal by Subject|1|||
128942629|NCT05513391|464075139|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
128942630|NCT05513391|464075140|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
128942631|NCT05513391|464075139|FG000|Overall Study|Lost to Follow-up|0|||
128942632|NCT05513391|464075140|FG001|Overall Study|Lost to Follow-up|2|||
128942633|NCT04038255|464077064|FG000|Overall Study|Lost to Follow-up|0|||
128942634|NCT04038255|464077065|FG001|Overall Study|Lost to Follow-up|9|||
128942635|NCT04038255|464077066|FG002|Overall Study|Lost to Follow-up|5|||
128942636|NCT04038255|464077064|FG000|Overall Study|Withdrawal by Subject|0|||
128942637|NCT04038255|464077065|FG001|Overall Study|Withdrawal by Subject|0|||
128942638|NCT04038255|464077066|FG002|Overall Study|Withdrawal by Subject|1|||
128942639|NCT05183867|464077069|FG000|Overall Study|Withdrawal by Subject|3|||
128942640|NCT05183867|464077070|FG001|Overall Study|Withdrawal by Subject|2|||
128942641|NCT05183867|464077071|FG002|Overall Study|Withdrawal by Subject|0|||
128942642|NCT00492856|464077076|FG000|Induction|Adverse Event|2|||
128942643|NCT00492856|464077077|FG001|Induction|Adverse Event|0|||
128942644|NCT00492856|464077078|FG002|Induction|Adverse Event|0|||
128942645|NCT00492856|464077079|FG003|Induction|Adverse Event|0|||
128942646|NCT00492856|464077076|FG000|Induction|Withdrawal by Subject|1|||
128942647|NCT00492856|464077077|FG001|Induction|Withdrawal by Subject|0|||
128942648|NCT00492856|464077078|FG002|Induction|Withdrawal by Subject|0|||
128707736|NCT03572062|463223955|FG002|Overall Study|Death|0|||
128707737|NCT03572062|463223956|FG003|Overall Study|Death|0|||
128707738|NCT03572062|463223957|FG004|Overall Study|Death|0|||
128707739|NCT03572062|463223958|FG005|Overall Study|Death|1|||
128707740|NCT03572062|463223959|FG006|Overall Study|Death|0|||
128707741|NCT03572062|463223960|FG007|Overall Study|Death|0|||
128707742|NCT03572062|463223961|FG008|Overall Study|Death|0|||
128942649|NCT00492856|464077079|FG003|Induction|Withdrawal by Subject|0|||
128942650|NCT00492856|464077076|FG000|Induction|Death|3|||
128942651|NCT00492856|464077077|FG001|Induction|Death|0|||
128942652|NCT00492856|464077078|FG002|Induction|Death|0|||
128942653|NCT00492856|464077079|FG003|Induction|Death|0|||
128942654|NCT00492856|464077076|FG000|Consolidation|Adverse Event|6|||
128942655|NCT00492856|464077077|FG001|Consolidation|Adverse Event|0|||
128942656|NCT00492856|464077078|FG002|Consolidation|Adverse Event|0|||
128942657|NCT00492856|464077079|FG003|Consolidation|Adverse Event|0|||
128942658|NCT00492856|464077076|FG000|Consolidation|Not protocol specified|2|||
128942659|NCT00492856|464077077|FG001|Consolidation|Not protocol specified|0|||
128707743|NCT03572062|463223962|FG009|Overall Study|Death|0|||
128707744|NCT03572062|463223953|FG000|Overall Study|Lost to Follow-up|0|||
128707745|NCT03572062|463223954|FG001|Overall Study|Lost to Follow-up|0|||
128707746|NCT03572062|463223955|FG002|Overall Study|Lost to Follow-up|0|||
128942660|NCT00492856|464077078|FG002|Consolidation|Not protocol specified|0|||
128707747|NCT03572062|463223956|FG003|Overall Study|Lost to Follow-up|0|||
128707748|NCT03572062|463223957|FG004|Overall Study|Lost to Follow-up|0|||
128707749|NCT03572062|463223958|FG005|Overall Study|Lost to Follow-up|1|||
128707750|NCT03572062|463223959|FG006|Overall Study|Lost to Follow-up|1|||
128707751|NCT03572062|463223960|FG007|Overall Study|Lost to Follow-up|0|||
128707752|NCT03572062|463223961|FG008|Overall Study|Lost to Follow-up|0|||
128707753|NCT03572062|463223962|FG009|Overall Study|Lost to Follow-up|0|||
128707754|NCT03572062|463223953|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707755|NCT03572062|463223954|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707756|NCT03572062|463223955|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707757|NCT03572062|463223956|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707758|NCT03572062|463223957|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707759|NCT03572062|463223958|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707760|NCT03572062|463223959|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707761|NCT03572062|463223960|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707762|NCT03572062|463223961|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
128707763|NCT03572062|463223962|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
128707764|NCT03572062|463223953|FG000|Overall Study|Study Terminated By Sponsor|0|||
128707765|NCT03572062|463223954|FG001|Overall Study|Study Terminated By Sponsor|0|||
128707766|NCT03572062|463223955|FG002|Overall Study|Study Terminated By Sponsor|0|||
128707767|NCT03572062|463223956|FG003|Overall Study|Study Terminated By Sponsor|0|||
128707768|NCT03572062|463223957|FG004|Overall Study|Study Terminated By Sponsor|0|||
128707769|NCT03572062|463223958|FG005|Overall Study|Study Terminated By Sponsor|0|||
128707770|NCT03572062|463223959|FG006|Overall Study|Study Terminated By Sponsor|0|||
128707771|NCT03572062|463223960|FG007|Overall Study|Study Terminated By Sponsor|0|||
128707772|NCT03572062|463223961|FG008|Overall Study|Study Terminated By Sponsor|29|||
128707773|NCT03572062|463223962|FG009|Overall Study|Study Terminated By Sponsor|27|||
128707774|NCT03572062|463223953|FG000|Overall Study|Physician Decision|0|||
128707775|NCT03572062|463223954|FG001|Overall Study|Physician Decision|0|||
128707776|NCT03572062|463223955|FG002|Overall Study|Physician Decision|0|||
128707777|NCT03572062|463223956|FG003|Overall Study|Physician Decision|0|||
128707778|NCT03572062|463223957|FG004|Overall Study|Physician Decision|0|||
128707779|NCT03572062|463223958|FG005|Overall Study|Physician Decision|0|||
128707780|NCT03572062|463223959|FG006|Overall Study|Physician Decision|0|||
128707781|NCT03572062|463223960|FG007|Overall Study|Physician Decision|0|||
128707782|NCT03572062|463223961|FG008|Overall Study|Physician Decision|1|||
128707783|NCT03572062|463223962|FG009|Overall Study|Physician Decision|0|||
128707784|NCT03572062|463223953|FG000|Overall Study|Withdrawal by Subject|0|||
128707785|NCT03572062|463223954|FG001|Overall Study|Withdrawal by Subject|0|||
128707786|NCT03572062|463223955|FG002|Overall Study|Withdrawal by Subject|0|||
128707787|NCT03572062|463223956|FG003|Overall Study|Withdrawal by Subject|0|||
128707788|NCT03572062|463223957|FG004|Overall Study|Withdrawal by Subject|0|||
128707789|NCT03572062|463223958|FG005|Overall Study|Withdrawal by Subject|0|||
128707790|NCT03572062|463223959|FG006|Overall Study|Withdrawal by Subject|0|||
128707791|NCT03572062|463223960|FG007|Overall Study|Withdrawal by Subject|0|||
128707792|NCT03572062|463223961|FG008|Overall Study|Withdrawal by Subject|0|||
128707793|NCT03572062|463223962|FG009|Overall Study|Withdrawal by Subject|1|||
128707794|NCT03572062|463223953|FG000|Overall Study|Randomized But Not Treated|0|||
128707795|NCT03572062|463223954|FG001|Overall Study|Randomized But Not Treated|0|||
128707796|NCT03572062|463223955|FG002|Overall Study|Randomized But Not Treated|0|||
128707797|NCT03572062|463223956|FG003|Overall Study|Randomized But Not Treated|0|||
128707798|NCT03572062|463223957|FG004|Overall Study|Randomized But Not Treated|1|||
128707799|NCT03572062|463223958|FG005|Overall Study|Randomized But Not Treated|2|||
128942661|NCT00492856|464077079|FG003|Consolidation|Not protocol specified|0|||
128942662|NCT00492856|464077076|FG000|Consolidation|Lost to Follow-up|1|||
128942663|NCT00492856|464077077|FG001|Consolidation|Lost to Follow-up|0|||
128942664|NCT00492856|464077078|FG002|Consolidation|Lost to Follow-up|0|||
128942665|NCT00492856|464077079|FG003|Consolidation|Lost to Follow-up|0|||
128942666|NCT00492856|464077076|FG000|Post-consolidation|Adverse Event|0|||
128942667|NCT00492856|464077077|FG001|Post-consolidation|Adverse Event|4|||
128942668|NCT00492856|464077078|FG002|Post-consolidation|Adverse Event|0|||
128942669|NCT00492856|464077079|FG003|Post-consolidation|Adverse Event|1|||
128942670|NCT00492856|464077076|FG000|Post-consolidation|Withdrawal by Subject|0|||
129032983|NCT02104817|464412049|FG001|Overall Study|Lost to Follow-up|2|||
128707800|NCT03572062|463223959|FG006|Overall Study|Randomized But Not Treated|0|||
128707801|NCT03572062|463223960|FG007|Overall Study|Randomized But Not Treated|1|||
128707802|NCT03572062|463223961|FG008|Overall Study|Randomized But Not Treated|0|||
128707803|NCT03572062|463223962|FG009|Overall Study|Randomized But Not Treated|0|||
128707804|NCT00458211|463223963|FG000|Overall Study|Lack of Efficacy|12|||
128707805|NCT00458211|463223963|FG000|Overall Study|Withdrawal by Subject|2|||
128707806|NCT00458211|463223963|FG000|Overall Study|Protocol Violation|2|||
128707807|NCT03310775|463223971|FG000|Overall Study|Lost to Follow-up|2|||
128707808|NCT03310775|463223972|FG001|Overall Study|Lost to Follow-up|3|||
128707809|NCT03310775|463223971|FG000|Overall Study|aggravation of depression|0|||
128707810|NCT03310775|463223972|FG001|Overall Study|aggravation of depression|1|||
128942671|NCT00492856|464077077|FG001|Post-consolidation|Withdrawal by Subject|4|||
128707811|NCT00646776|463223973|FG000|Overall Study|Adverse Event|1|||
128707812|NCT00646776|463223974|FG001|Overall Study|Adverse Event|9|||
128707813|NCT00646776|463223973|FG000|Overall Study|Investigator discretion|0|||
128707814|NCT00646776|463223974|FG001|Overall Study|Investigator discretion|4|||
128707815|NCT00126568|463223975|FG000|Overall Study|Death|2|||
128707816|NCT03031678|463223977|FG000|Overall Study|Study closed prior to completion|1|||
128707817|NCT01753856|463223978|FG000|Overall Study|Adverse Event|1|||
128707818|NCT01753856|463223979|FG001|Overall Study|Adverse Event|0|||
128707819|NCT01753856|463223978|FG000|Overall Study|Withdrawal by Subject|0|||
128707820|NCT01753856|463223979|FG001|Overall Study|Withdrawal by Subject|2|||
128707821|NCT01753856|463223978|FG000|Overall Study|Sponsor Decision|2|||
128707822|NCT01753856|463223979|FG001|Overall Study|Sponsor Decision|0|||
128707823|NCT00434330|463223984|FG000|Overall Study|Adverse Event|0|||
128707824|NCT00434330|463223985|FG001|Overall Study|Adverse Event|0|||
128707825|NCT00434330|463223986|FG002|Overall Study|Adverse Event|1|||
128707826|NCT00434330|463223987|FG003|Overall Study|Adverse Event|0|||
128707827|NCT00434330|463223988|FG004|Overall Study|Adverse Event|0|||
128707828|NCT00434330|463223989|FG005|Overall Study|Adverse Event|0|||
128707829|NCT00434330|463223984|FG000|Overall Study|Death|1|||
128707830|NCT00434330|463223985|FG001|Overall Study|Death|0|||
128707831|NCT00434330|463223986|FG002|Overall Study|Death|0|||
128707832|NCT00434330|463223987|FG003|Overall Study|Death|0|||
128707833|NCT00434330|463223988|FG004|Overall Study|Death|1|||
128707834|NCT00434330|463223989|FG005|Overall Study|Death|1|||
128707835|NCT00434330|463223984|FG000|Overall Study|Withdrawal by Subject|0|||
128707836|NCT00434330|463223985|FG001|Overall Study|Withdrawal by Subject|0|||
128707837|NCT00434330|463223986|FG002|Overall Study|Withdrawal by Subject|1|||
128707838|NCT00434330|463223987|FG003|Overall Study|Withdrawal by Subject|1|||
128707839|NCT00434330|463223988|FG004|Overall Study|Withdrawal by Subject|0|||
128707840|NCT00434330|463223989|FG005|Overall Study|Withdrawal by Subject|0|||
128707841|NCT00434330|463223984|FG000|Overall Study|Renal transplant|0|||
128707842|NCT00434330|463223985|FG001|Overall Study|Renal transplant|0|||
128707843|NCT00434330|463223986|FG002|Overall Study|Renal transplant|0|||
128707844|NCT00434330|463223987|FG003|Overall Study|Renal transplant|1|||
128707845|NCT00434330|463223988|FG004|Overall Study|Renal transplant|0|||
128707846|NCT00434330|463223989|FG005|Overall Study|Renal transplant|0|||
128707847|NCT00434330|463223984|FG000|Overall Study|Subject Not Compliant With Study|0|||
128707848|NCT00434330|463223985|FG001|Overall Study|Subject Not Compliant With Study|0|||
128707849|NCT00434330|463223986|FG002|Overall Study|Subject Not Compliant With Study|1|||
128707850|NCT00434330|463223987|FG003|Overall Study|Subject Not Compliant With Study|0|||
128707851|NCT00434330|463223988|FG004|Overall Study|Subject Not Compliant With Study|0|||
128707852|NCT00434330|463223989|FG005|Overall Study|Subject Not Compliant With Study|0|||
128707853|NCT04847557|463223990|FG000|Overall Study|Adverse Event|1|||
128707854|NCT04847557|463223991|FG001|Overall Study|Adverse Event|0|||
128707855|NCT04847557|463223990|FG000|Overall Study|Death|19|||
128707856|NCT04847557|463223991|FG001|Overall Study|Death|15|||
128707857|NCT04847557|463223990|FG000|Overall Study|Lost to Follow-up|3|||
128942672|NCT00492856|464077078|FG002|Post-consolidation|Withdrawal by Subject|0|||
128942673|NCT00492856|464077079|FG003|Post-consolidation|Withdrawal by Subject|0|||
128942674|NCT00492856|464077076|FG000|Post-consolidation|Death|0|||
128942675|NCT00492856|464077077|FG001|Post-consolidation|Death|1|||
128942676|NCT00492856|464077078|FG002|Post-consolidation|Death|0|||
128942677|NCT00492856|464077079|FG003|Post-consolidation|Death|0|||
128942678|NCT00492856|464077076|FG000|Post-consolidation|Not protocol specified|0|||
128942679|NCT00492856|464077077|FG001|Post-consolidation|Not protocol specified|1|||
128942680|NCT00492856|464077078|FG002|Post-consolidation|Not protocol specified|0|||
128942681|NCT00492856|464077079|FG003|Post-consolidation|Not protocol specified|0|||
128942682|NCT00492856|464077076|FG000|Post-consolidation|Lost to Follow-up|0|||
128942683|NCT00492856|464077077|FG001|Post-consolidation|Lost to Follow-up|2|||
128707858|NCT04847557|463223991|FG001|Overall Study|Lost to Follow-up|6|||
128942684|NCT00492856|464077078|FG002|Post-consolidation|Lost to Follow-up|0|||
128942685|NCT00492856|464077079|FG003|Post-consolidation|Lost to Follow-up|0|||
128942686|NCT00492856|464077076|FG000|Post-consolidation|Observation Arm|0|||
128942687|NCT00492856|464077077|FG001|Post-consolidation|Observation Arm|0|||
129032984|NCT02104817|464412048|FG000|Overall Study|Protocol Violation|0|||
128707859|NCT04847557|463223990|FG000|Overall Study|Physician Decision|1|||
128707860|NCT04847557|463223991|FG001|Overall Study|Physician Decision|0|||
128707861|NCT04847557|463223990|FG000|Overall Study|Protocol Violation|0|||
128707862|NCT04847557|463223991|FG001|Overall Study|Protocol Violation|1|||
128707863|NCT04847557|463223990|FG000|Overall Study|Withdrawal by Subject|8|||
128707864|NCT04847557|463223991|FG001|Overall Study|Withdrawal by Subject|14|||
128707865|NCT02310568|463226278|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
128707866|NCT02310568|463226279|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
128707867|NCT02310568|463226280|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
128707868|NCT02310568|463226281|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
128707869|NCT02310568|463226282|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
128707870|NCT02310568|463226278|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
128707871|NCT02310568|463226279|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129032985|NCT02104817|464412049|FG001|Overall Study|Protocol Violation|1|||
129032986|NCT02104817|464412048|FG000|Overall Study|Study terminated by sponsor|5854|||
129032987|NCT02104817|464412049|FG001|Overall Study|Study terminated by sponsor|5901|||
129032988|NCT02104817|464412048|FG000|Overall Study|Withdrawal by Subject|111|||
129032989|NCT02104817|464412049|FG001|Overall Study|Withdrawal by Subject|78|||
129032990|NCT02104817|464412048|FG000|Overall Study|Other reasons|128|||
129032991|NCT02104817|464412049|FG001|Overall Study|Other reasons|135|||
129032992|NCT02575339|464412056|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
129032993|NCT02575339|464412057|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
129032994|NCT02575339|464412058|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
129032995|NCT02575339|464412056|FG000|Study Treatment|Disease Progression|5|||
129032996|NCT02575339|464412057|FG001|Study Treatment|Disease Progression|2|||
128707872|NCT02310568|463226280|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
128707873|NCT02310568|463226281|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
128707874|NCT02310568|463226282|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
128707875|NCT02310568|463226278|FG000|Stage 1 ( 4 Weeks)|Other|1|||
128707876|NCT02310568|463226279|FG001|Stage 1 ( 4 Weeks)|Other|1|||
128707877|NCT02310568|463226280|FG002|Stage 1 ( 4 Weeks)|Other|0|||
128707878|NCT02310568|463226281|FG003|Stage 1 ( 4 Weeks)|Other|0|||
128707879|NCT02310568|463226282|FG004|Stage 1 ( 4 Weeks)|Other|0|||
128942688|NCT00492856|464077078|FG002|Post-consolidation|Observation Arm|27|||
128942689|NCT00492856|464077079|FG003|Post-consolidation|Observation Arm|0|||
128942690|NCT01520324|464077080|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
128942691|NCT03488472|464077081|FG000|Overall Study|disease progression additional mets|1|||
128942692|NCT01998581|464077082|FG000|Overall Study|Refused repeat treatment|20|||
128942693|NCT01998581|464077083|FG001|Overall Study|Refused repeat treatment|4|||
128942694|NCT01998581|464077082|FG000|Overall Study|Protocol Violation|1|||
128942695|NCT01998581|464077083|FG001|Overall Study|Protocol Violation|0|||
128942696|NCT01998581|464077082|FG000|Overall Study|Withdrawal by Subject|8|||
128942697|NCT01998581|464077083|FG001|Overall Study|Withdrawal by Subject|1|||
128942698|NCT01998581|464077082|FG000|Overall Study|Lost to Follow-up|12|||
128942699|NCT01998581|464077083|FG001|Overall Study|Lost to Follow-up|4|||
128942700|NCT01998581|464077082|FG000|Overall Study|Adverse Event|1|||
128942701|NCT01998581|464077083|FG001|Overall Study|Adverse Event|1|||
128942702|NCT01998581|464077082|FG000|Overall Study|Other reasons|3|||
128942703|NCT01998581|464077083|FG001|Overall Study|Other reasons|2|||
128942704|NCT01998581|464077082|FG000|Overall Study|Randomized but withdrew before treatment|1|||
128942705|NCT01998581|464077083|FG001|Overall Study|Randomized but withdrew before treatment|0|||
128942706|NCT01251276|464077084|FG000|Overall Study|Protocol Violation|1|||
128942707|NCT01251276|464077085|FG001|Overall Study|Protocol Violation|0|||
128942708|NCT01251276|464077084|FG000|Overall Study|Lost to Follow-up|0|||
128942709|NCT01251276|464077085|FG001|Overall Study|Lost to Follow-up|1|||
128942710|NCT00441441|464077089|FG000|Overall Study|Adverse Event|2|||
128942711|NCT00441441|464077090|FG001|Overall Study|Adverse Event|1|||
128942712|NCT00441441|464077089|FG000|Overall Study|Protocol Violation|4|||
128942713|NCT00441441|464077090|FG001|Overall Study|Protocol Violation|6|||
128942714|NCT00441441|464077089|FG000|Overall Study|Exacerbation of asthma|1|||
128942715|NCT00441441|464077090|FG001|Overall Study|Exacerbation of asthma|2|||
128942716|NCT00441441|464077089|FG000|Overall Study|Withdrawal by Subject|1|||
128942717|NCT00441441|464077090|FG001|Overall Study|Withdrawal by Subject|2|||
128942718|NCT00441441|464077089|FG000|Overall Study|Other|3|||
128942719|NCT00441441|464077090|FG001|Overall Study|Other|3|||
128942720|NCT00262080|464077091|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
128942721|NCT00262080|464077092|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
128942722|NCT00262080|464077093|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
128942723|NCT00262080|464077091|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
128942724|NCT00262080|464077092|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
128942725|NCT00262080|464077093|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
128942726|NCT00262080|464077091|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
128942727|NCT00262080|464077092|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
128942728|NCT00262080|464077093|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
129032997|NCT02575339|464412058|FG002|Study Treatment|Disease Progression|0|||
129032998|NCT02575339|464412056|FG000|Study Treatment|Adverse Event|1|||
128707880|NCT02310568|463226278|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
128707881|NCT02310568|463226279|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
128942729|NCT00262080|464077091|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
128942730|NCT00262080|464077092|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
128942731|NCT00262080|464077093|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
128942732|NCT00262080|464077091|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
128942733|NCT00262080|464077092|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
128942734|NCT00262080|464077093|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
128942735|NCT00262080|464077091|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
128707882|NCT02310568|463226280|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
128707883|NCT02310568|463226281|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
128707884|NCT02310568|463226282|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
128707885|NCT02310568|463226278|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
128707886|NCT02310568|463226279|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
128707887|NCT02310568|463226280|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
128707888|NCT02310568|463226281|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
128707889|NCT02310568|463226282|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
128707890|NCT02310568|463226278|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
128707891|NCT02310568|463226279|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
128942736|NCT00262080|464077092|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
128942737|NCT00262080|464077093|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
128942738|NCT03100942|464077094|FG000|Randomized Treatment Period|Withdrew Consent|4|||
128942739|NCT03100942|464077095|FG001|Randomized Treatment Period|Withdrew Consent|5|||
128942740|NCT03100942|464077096|FG002|Randomized Treatment Period|Withdrew Consent|3|||
128942741|NCT03100942|464077097|FG003|Randomized Treatment Period|Withdrew Consent|3|||
128942742|NCT03100942|464077098|FG004|Randomized Treatment Period|Withdrew Consent|0|||
128942743|NCT03100942|464077099|FG005|Randomized Treatment Period|Withdrew Consent|0|||
128942744|NCT03100942|464077100|FG006|Randomized Treatment Period|Withdrew Consent|0|||
128942745|NCT03100942|464077094|FG000|Randomized Treatment Period|Adverse Event|5|||
128942746|NCT03100942|464077095|FG001|Randomized Treatment Period|Adverse Event|2|||
128942747|NCT03100942|464077096|FG002|Randomized Treatment Period|Adverse Event|1|||
128942748|NCT03100942|464077097|FG003|Randomized Treatment Period|Adverse Event|0|||
128942749|NCT03100942|464077098|FG004|Randomized Treatment Period|Adverse Event|0|||
128942750|NCT03100942|464077099|FG005|Randomized Treatment Period|Adverse Event|0|||
128942751|NCT03100942|464077100|FG006|Randomized Treatment Period|Adverse Event|0|||
128942752|NCT03100942|464077094|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
128942753|NCT03100942|464077095|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
128942754|NCT03100942|464077096|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
128942755|NCT03100942|464077097|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
128942756|NCT03100942|464077098|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
128942757|NCT03100942|464077099|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
128942758|NCT03100942|464077100|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
128942759|NCT03100942|464077094|FG000|Randomized Treatment Period|Protocol Violation|0|||
128942760|NCT03100942|464077095|FG001|Randomized Treatment Period|Protocol Violation|1|||
128942761|NCT03100942|464077096|FG002|Randomized Treatment Period|Protocol Violation|1|||
128942762|NCT03100942|464077097|FG003|Randomized Treatment Period|Protocol Violation|1|||
128942763|NCT03100942|464077098|FG004|Randomized Treatment Period|Protocol Violation|0|||
128942764|NCT03100942|464077099|FG005|Randomized Treatment Period|Protocol Violation|0|||
128942765|NCT03100942|464077100|FG006|Randomized Treatment Period|Protocol Violation|0|||
128942766|NCT03100942|464077094|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
128942767|NCT03100942|464077095|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
128942768|NCT03100942|464077096|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
128942769|NCT03100942|464077097|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
128942770|NCT03100942|464077098|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
128942771|NCT03100942|464077099|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
128942772|NCT03100942|464077100|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
128942773|NCT03100942|464077094|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
128942774|NCT03100942|464077095|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
128942775|NCT03100942|464077096|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
128942776|NCT03100942|464077097|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
128942777|NCT03100942|464077098|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
128942778|NCT03100942|464077099|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
128942779|NCT03100942|464077100|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
128942780|NCT03100942|464077094|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
128942781|NCT03100942|464077095|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
128942782|NCT03100942|464077096|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
128942783|NCT03100942|464077097|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
128942784|NCT03100942|464077098|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
128942785|NCT03100942|464077099|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
128942786|NCT03100942|464077100|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
128942787|NCT04009096|464077101|FG000|Overall Study|Withdrawal by Subject|0|||
128942788|NCT04009096|464077102|FG001|Overall Study|Withdrawal by Subject|7|||
128707892|NCT02310568|463226280|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
128707893|NCT02310568|463226281|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
128707894|NCT02310568|463226282|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
128707895|NCT02310568|463226278|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
128942789|NCT04009096|464077103|FG002|Overall Study|Withdrawal by Subject|0|||
128942790|NCT04009096|464077101|FG000|Overall Study|Physician Decision|0|||
128942791|NCT04009096|464077102|FG001|Overall Study|Physician Decision|1|||
128942792|NCT04009096|464077103|FG002|Overall Study|Physician Decision|0|||
128942793|NCT05151471|464077104|FG000|Overall Study|Adverse Event|21|||
128707896|NCT02310568|463226279|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
128942794|NCT05151471|464077105|FG001|Overall Study|Adverse Event|16|||
128942795|NCT05151471|464077104|FG000|Overall Study|Death|1|||
128942796|NCT05151471|464077105|FG001|Overall Study|Death|0|||
128942797|NCT05151471|464077104|FG000|Overall Study|Lost to Follow-up|0|||
128942798|NCT05151471|464077105|FG001|Overall Study|Lost to Follow-up|1|||
128942799|NCT05151471|464077104|FG000|Overall Study|Withdrawal by Subject|7|||
128942800|NCT05151471|464077105|FG001|Overall Study|Withdrawal by Subject|9|||
128942801|NCT05151471|464077104|FG000|Overall Study|Study terminated by sponsor|49|||
128942802|NCT05151471|464077105|FG001|Overall Study|Study terminated by sponsor|47|||
128942803|NCT05151471|464077104|FG000|Overall Study|Other|2|||
128942804|NCT05151471|464077105|FG001|Overall Study|Other|1|||
128942805|NCT04263142|464077106|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
128942806|NCT04263142|464077107|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
128942807|NCT04263142|464077108|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
128942808|NCT04263142|464077109|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
128942809|NCT04263142|464077110|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
128942810|NCT04263142|464077106|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
128942811|NCT04263142|464077107|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
128942812|NCT04263142|464077108|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
128942813|NCT04263142|464077109|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
128942814|NCT04263142|464077110|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
128942815|NCT00769704|464077111|FG000|Overall Study|Lost to Follow-up|3|||
128942816|NCT00769704|464077112|FG001|Overall Study|Lost to Follow-up|2|||
128942817|NCT00769704|464077111|FG000|Overall Study|Death|95|||
128942818|NCT00769704|464077112|FG001|Overall Study|Death|190|||
128942819|NCT00769704|464077111|FG000|Overall Study|Withdrawal by Subject|12|||
128942820|NCT00769704|464077112|FG001|Overall Study|Withdrawal by Subject|5|||
128942821|NCT00769704|464077111|FG000|Overall Study|Other|1|||
128942822|NCT00769704|464077112|FG001|Overall Study|Other|2|||
128942823|NCT04346628|464077117|FG000|Overall Study|Lost to Follow-up|4|||
128942824|NCT04346628|464077118|FG001|Overall Study|Lost to Follow-up|4|||
128942825|NCT04346628|464077117|FG000|Overall Study|Withdrew (had personal reasons)|2|||
128942826|NCT04346628|464077118|FG001|Overall Study|Withdrew (had personal reasons)|5|||
128942827|NCT04346628|464077117|FG000|Overall Study|Withdrew (medication intolerant)|0|||
128942828|NCT04346628|464077118|FG001|Overall Study|Withdrew (medication intolerant)|3|||
128942829|NCT04346628|464077117|FG000|Overall Study|Withdrew (declined intervention)|0|||
128942830|NCT04346628|464077118|FG001|Overall Study|Withdrew (declined intervention)|1|||
128942831|NCT03456713|464077122|FG000|Overall Study|Lost to Follow-up|1|||
128942832|NCT03456713|464077123|FG001|Overall Study|Lost to Follow-up|0|||
128942833|NCT03456713|464077124|FG002|Overall Study|Lost to Follow-up|0|||
128942834|NCT03456713|464077125|FG003|Overall Study|Lost to Follow-up|0|||
128942835|NCT01263691|464077129|FG000|Overall Study|Lost to Follow-up|1|||
128942836|NCT01263691|464077130|FG001|Overall Study|Lost to Follow-up|0|||
128942837|NCT01263691|464077131|FG002|Overall Study|Lost to Follow-up|1|||
128942838|NCT01263691|464077132|FG003|Overall Study|Lost to Follow-up|1|||
128942839|NCT01263691|464077133|FG004|Overall Study|Lost to Follow-up|0|||
128942840|NCT01263691|464077134|FG005|Overall Study|Lost to Follow-up|0|||
128942841|NCT01263691|464077129|FG000|Overall Study|Withdrawal by Subject|1|||
128942842|NCT01263691|464077130|FG001|Overall Study|Withdrawal by Subject|0|||
128942843|NCT01263691|464077131|FG002|Overall Study|Withdrawal by Subject|0|||
128942844|NCT01263691|464077132|FG003|Overall Study|Withdrawal by Subject|0|||
128942845|NCT01263691|464077133|FG004|Overall Study|Withdrawal by Subject|0|||
128942846|NCT01263691|464077134|FG005|Overall Study|Withdrawal by Subject|0|||
128942847|NCT01263691|464077129|FG000|Overall Study|Adverse Event|1|||
128942848|NCT01263691|464077130|FG001|Overall Study|Adverse Event|0|||
128942849|NCT01263691|464077131|FG002|Overall Study|Adverse Event|0|||
128942850|NCT01263691|464077132|FG003|Overall Study|Adverse Event|0|||
128942851|NCT01263691|464077133|FG004|Overall Study|Adverse Event|0|||
128942852|NCT01263691|464077134|FG005|Overall Study|Adverse Event|0|||
128942853|NCT01428063|464077136|FG000|Overall Study|Lack of Efficacy|8|||
128942854|NCT01428063|464077137|FG001|Overall Study|Lack of Efficacy|4|||
128942855|NCT01428063|464077138|FG002|Overall Study|Lack of Efficacy|1|||
128942856|NCT01428063|464077136|FG000|Overall Study|Adverse Event|2|||
128942857|NCT01428063|464077137|FG001|Overall Study|Adverse Event|3|||
128942858|NCT01428063|464077138|FG002|Overall Study|Adverse Event|0|||
128942859|NCT01428063|464077136|FG000|Overall Study|Lost to Follow-up|0|||
128942860|NCT01428063|464077137|FG001|Overall Study|Lost to Follow-up|2|||
128942861|NCT01428063|464077138|FG002|Overall Study|Lost to Follow-up|0|||
128942862|NCT01428063|464077136|FG000|Overall Study|No longer meets study criteria|0|||
128942863|NCT01428063|464077137|FG001|Overall Study|No longer meets study criteria|1|||
128942864|NCT01428063|464077138|FG002|Overall Study|No longer meets study criteria|0|||
128942865|NCT02284906|464077139|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
128942866|NCT02284906|464077140|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
128942867|NCT02284906|464077141|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
128942868|NCT02284906|464077139|FG000|Overall Study|Major Protocol Deviation|0|||
128942869|NCT02284906|464077140|FG001|Overall Study|Major Protocol Deviation|1|||
128707897|NCT02310568|463226280|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
128707898|NCT02310568|463226281|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
128707899|NCT02310568|463226282|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
128707900|NCT02310568|463226278|FG000|Stage 2 (4 Weeks)|Other|0|||
128707901|NCT02310568|463226279|FG001|Stage 2 (4 Weeks)|Other|1|||
128707902|NCT02310568|463226280|FG002|Stage 2 (4 Weeks)|Other|1|||
128707903|NCT02310568|463226281|FG003|Stage 2 (4 Weeks)|Other|0|||
128707904|NCT02310568|463226282|FG004|Stage 2 (4 Weeks)|Other|0|||
128707905|NCT02310568|463226278|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
128707906|NCT02310568|463226279|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
128707907|NCT02310568|463226280|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
128707908|NCT02310568|463226281|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
128707909|NCT02310568|463226282|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
128942870|NCT02284906|464077141|FG002|Overall Study|Major Protocol Deviation|0|||
128942871|NCT02284906|464077139|FG000|Overall Study|Voluntary Withdrawal|2|||
128942872|NCT02284906|464077140|FG001|Overall Study|Voluntary Withdrawal|4|||
128942873|NCT02284906|464077141|FG002|Overall Study|Voluntary Withdrawal|5|||
128942874|NCT02284906|464077139|FG000|Overall Study|Study Termination|0|||
128942875|NCT02284906|464077140|FG001|Overall Study|Study Termination|11|||
128942876|NCT02284906|464077141|FG002|Overall Study|Study Termination|14|||
128942877|NCT02284906|464077139|FG000|Overall Study|Reason not Specified|1|||
128942878|NCT02284906|464077140|FG001|Overall Study|Reason not Specified|1|||
128942879|NCT02284906|464077141|FG002|Overall Study|Reason not Specified|0|||
128942880|NCT00850759|464077142|FG000|Overall Study|Lost to Follow-up|7|||
128942881|NCT00850759|464077143|FG001|Overall Study|Lost to Follow-up|5|||
128942882|NCT00850759|464077144|FG002|Overall Study|Lost to Follow-up|5|||
128942883|NCT00850759|464077145|FG003|Overall Study|Lost to Follow-up|3|||
128942884|NCT00532948|464077146|FG000|Overall Study|Protocol Violation|1|||
128942885|NCT00532948|464077147|FG001|Overall Study|Protocol Violation|0|||
128942886|NCT00532948|464077148|FG002|Overall Study|Protocol Violation|0|||
128942887|NCT00532948|464077146|FG000|Overall Study|Death|3|||
128942888|NCT00532948|464077147|FG001|Overall Study|Death|3|||
128942889|NCT00532948|464077148|FG002|Overall Study|Death|4|||
128942890|NCT00532948|464077146|FG000|Overall Study|Violation of selection criteria at entry|0|||
128942891|NCT00532948|464077147|FG001|Overall Study|Violation of selection criteria at entry|1|||
128942892|NCT00532948|464077148|FG002|Overall Study|Violation of selection criteria at entry|0|||
128942893|NCT00532948|464077146|FG000|Overall Study|Failure to return|0|||
128942894|NCT00532948|464077147|FG001|Overall Study|Failure to return|1|||
128942895|NCT00532948|464077148|FG002|Overall Study|Failure to return|0|||
128942896|NCT01753076|464077149|FG000|Overall Study|Adverse Event|17|||
128942897|NCT01753076|464077150|FG001|Overall Study|Adverse Event|18|||
128942898|NCT01753076|464077149|FG000|Overall Study|Lack of Efficacy|3|||
128942899|NCT01753076|464077150|FG001|Overall Study|Lack of Efficacy|1|||
128942900|NCT01753076|464077149|FG000|Overall Study|Lost to Follow-up|2|||
128942901|NCT01753076|464077150|FG001|Overall Study|Lost to Follow-up|1|||
128942902|NCT01753076|464077149|FG000|Overall Study|Physician Decision|4|||
128942903|NCT01753076|464077150|FG001|Overall Study|Physician Decision|2|||
128942904|NCT01753076|464077149|FG000|Overall Study|Withdrawal by Subject|14|||
128942905|NCT01753076|464077150|FG001|Overall Study|Withdrawal by Subject|24|||
128942906|NCT01753076|464077149|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
128942907|NCT01753076|464077150|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
128942908|NCT02575079|464077151|FG000|Overall Study|Death|3|||
128942909|NCT02575079|464077152|FG001|Overall Study|Death|0|||
128942910|NCT02575079|464077151|FG000|Overall Study|Withdrawal by Subject|3|||
128942911|NCT02575079|464077152|FG001|Overall Study|Withdrawal by Subject|0|||
128707910|NCT02310568|463226278|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
128707911|NCT02310568|463226279|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
128707912|NCT02310568|463226280|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
128770228|NCT01234649|463450165|FG001|Overall Study|Withdrawal by Subject|26|||
128770229|NCT01234649|463450164|FG000|Overall Study|Pregnancy|6|||
128770230|NCT01234649|463450165|FG001|Overall Study|Pregnancy|6|||
128770231|NCT01234649|463450164|FG000|Overall Study|intolerant to side effects|4|||
128942912|NCT02918266|464077153|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
128942913|NCT02918266|464077154|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128942914|NCT02918266|464077155|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128942915|NCT02918266|464077156|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128942916|NCT02918266|464077157|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128942917|NCT02918266|464077158|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128942918|NCT02918266|464077159|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
128942919|NCT02918266|464077160|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128942920|NCT02918266|464077161|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
128942921|NCT02918266|464077162|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128942922|NCT02918266|464077163|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
128707913|NCT02310568|463226281|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
128770232|NCT01234649|463450165|FG001|Overall Study|intolerant to side effects|3|||
128770233|NCT01234649|463450164|FG000|Overall Study|Allergic reaction|1|||
128942923|NCT01259856|464077170|FG000|Overall Study|Adverse Event|12|||
128942924|NCT01259856|464077171|FG001|Overall Study|Adverse Event|9|||
128942925|NCT01259856|464077170|FG000|Overall Study|Death|0|||
128942926|NCT01259856|464077171|FG001|Overall Study|Death|1|||
128942927|NCT01259856|464077170|FG000|Overall Study|Lack of Efficacy|3|||
128942928|NCT01259856|464077171|FG001|Overall Study|Lack of Efficacy|1|||
128942929|NCT01259856|464077170|FG000|Overall Study|Lost to Follow-up|1|||
128942930|NCT01259856|464077171|FG001|Overall Study|Lost to Follow-up|1|||
128942931|NCT01259856|464077170|FG000|Overall Study|Physician Decision|2|||
128942932|NCT01259856|464077171|FG001|Overall Study|Physician Decision|1|||
128942933|NCT01259856|464077170|FG000|Overall Study|Withdrawal by Subject|9|||
128942934|NCT01259856|464077171|FG001|Overall Study|Withdrawal by Subject|10|||
128942935|NCT01259856|464077170|FG000|Overall Study|Treatment never started|0|||
128942936|NCT01259856|464077171|FG001|Overall Study|Treatment never started|6|||
128942937|NCT01259856|464077170|FG000|Overall Study|Study closure by sponsor|40|||
128942938|NCT01259856|464077171|FG001|Overall Study|Study closure by sponsor|41|||
128942939|NCT01259856|464077170|FG000|Overall Study|Patient developed other disease|0|||
128942940|NCT01259856|464077171|FG001|Overall Study|Patient developed other disease|1|||
128942941|NCT01259856|464077170|FG000|Overall Study|Transfer to another study|0|||
128942942|NCT01259856|464077171|FG001|Overall Study|Transfer to another study|1|||
128942943|NCT01259856|464077170|FG000|Overall Study|Unknown/missing|2|||
128942944|NCT01259856|464077171|FG001|Overall Study|Unknown/missing|2|||
128942945|NCT00788775|464077172|FG000|Overall Study|Progressive Disease|8|||
128942946|NCT00788775|464077173|FG001|Overall Study|Progressive Disease|6|||
128942947|NCT00788775|464077172|FG000|Overall Study|Withdrawal by Subject|0|||
128942948|NCT00788775|464077173|FG001|Overall Study|Withdrawal by Subject|2|||
128942949|NCT00788775|464077172|FG000|Overall Study|Patient Non-Compliance|1|||
128942950|NCT00788775|464077173|FG001|Overall Study|Patient Non-Compliance|0|||
128942951|NCT00788775|464077172|FG000|Overall Study|Patient's measurable disease resected.|1|||
128942952|NCT00788775|464077173|FG001|Overall Study|Patient's measurable disease resected.|0|||
128942953|NCT00578864|464077174|FG000|Overall Study|Death|1|||
128942954|NCT00578864|464077175|FG001|Overall Study|Death|0|||
128942955|NCT01253044|464077180|FG000|Overall Study|Lost to Follow-up|38|||
128942956|NCT01253044|464077181|FG001|Overall Study|Lost to Follow-up|29|||
128942957|NCT02702193|464077182|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
128942958|NCT02702193|464077183|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
128942959|NCT02702193|464077182|FG000|4 Month Follow up|Withdrawal by Subject|1|||
128942960|NCT02702193|464077183|FG001|4 Month Follow up|Withdrawal by Subject|0|||
128942961|NCT02702193|464077182|FG000|4 Month Follow up|Lost to Follow-up|17|||
128942962|NCT02702193|464077183|FG001|4 Month Follow up|Lost to Follow-up|18|||
128942963|NCT02702193|464077182|FG000|8 Month Follow up|Withdrawal by Subject|1|||
128942964|NCT02702193|464077183|FG001|8 Month Follow up|Withdrawal by Subject|0|||
128942965|NCT02702193|464077182|FG000|8 Month Follow up|Lost to Follow-up|14|||
128942966|NCT02702193|464077183|FG001|8 Month Follow up|Lost to Follow-up|18|||
128942967|NCT02702193|464077182|FG000|12 Month Follow up|Withdrawal by Subject|1|||
128942968|NCT02702193|464077183|FG001|12 Month Follow up|Withdrawal by Subject|0|||
128942969|NCT02702193|464077182|FG000|12 Month Follow up|Lost to Follow-up|16|||
128942970|NCT02702193|464077183|FG001|12 Month Follow up|Lost to Follow-up|18|||
128942971|NCT01035255|464077188|FG000|Overall Study|Death|724|||
128942972|NCT01035255|464077189|FG001|Overall Study|Death|844|||
128942973|NCT01035255|464077188|FG000|Overall Study|Lost to Follow-up|2|||
128942974|NCT01035255|464077189|FG001|Overall Study|Lost to Follow-up|5|||
128942975|NCT01035255|464077188|FG000|Overall Study|patient's request|15|||
128942976|NCT01035255|464077189|FG001|Overall Study|patient's request|13|||
128942977|NCT03196297|464077190|FG000|Main Period|Withdrawal by Subject|4|||
128942978|NCT03196297|464077190|FG000|Extension Period|Withdrawal by Subject|1|||
128942979|NCT03196297|464077190|FG000|Extension Period|Lack of Efficacy|2|||
128942980|NCT00829166|464077191|FG000|Overall Study|Death|305|||
128942981|NCT00829166|464077192|FG001|Overall Study|Death|333|||
128942982|NCT00829166|464077191|FG000|Overall Study|Lost to Follow-up|5|||
129032999|NCT02575339|464412057|FG001|Study Treatment|Adverse Event|2|||
129033000|NCT02575339|464412058|FG002|Study Treatment|Adverse Event|0|||
129033001|NCT02575339|464412056|FG000|Follow up|Death|6|||
128770234|NCT01234649|463450165|FG001|Overall Study|Allergic reaction|0|||
128942983|NCT00829166|464077192|FG001|Overall Study|Lost to Follow-up|4|||
128942984|NCT00829166|464077191|FG000|Overall Study|Physician's Decision|4|||
128942985|NCT00829166|464077192|FG001|Overall Study|Physician's Decision|3|||
128942986|NCT00829166|464077191|FG000|Overall Study|Subject's Decision|41|||
128942987|NCT00829166|464077192|FG001|Overall Study|Subject's Decision|55|||
128942988|NCT00829166|464077191|FG000|Overall Study|Sponsor's Decision|137|||
128942989|NCT00829166|464077192|FG001|Overall Study|Sponsor's Decision|98|||
128942990|NCT00829166|464077191|FG000|Overall Study|Reason Not Specified|3|||
128942991|NCT00829166|464077192|FG001|Overall Study|Reason Not Specified|3|||
128942992|NCT03345836|464077193|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
128942993|NCT03345836|464077194|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
128942994|NCT03345836|464077195|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
128942995|NCT03345836|464077196|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
129033002|NCT02575339|464412057|FG001|Follow up|Death|2|||
128707914|NCT02310568|463226282|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
128707915|NCT02310568|463226278|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
128707916|NCT02310568|463226279|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
128707917|NCT02310568|463226280|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
128942996|NCT03345836|464077197|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
128942997|NCT03345836|464077198|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
128942998|NCT03345836|464077193|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
128942999|NCT03345836|464077194|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
128943000|NCT03345836|464077195|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
128943001|NCT03345836|464077196|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
128943002|NCT03345836|464077197|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
128943003|NCT03345836|464077198|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
128943004|NCT03345836|464077193|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
128943005|NCT03345836|464077194|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
128943006|NCT03345836|464077195|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
128943007|NCT03345836|464077196|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
128943008|NCT03345836|464077197|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
128943009|NCT03345836|464077198|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
128943010|NCT03345836|464077193|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
128943011|NCT03345836|464077194|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
128943012|NCT03345836|464077195|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
128943013|NCT03345836|464077196|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
128943014|NCT03345836|464077197|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
128943015|NCT03345836|464077198|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
128943016|NCT03345836|464077193|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
128943017|NCT03345836|464077194|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
128943018|NCT03345836|464077195|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
128943019|NCT03345836|464077196|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
128943020|NCT03345836|464077197|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
128943021|NCT03345836|464077198|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
128943022|NCT03345836|464077193|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
128943023|NCT03345836|464077194|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
128943024|NCT03345836|464077195|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
128943025|NCT03345836|464077196|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
128943026|NCT03345836|464077197|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
128943027|NCT03345836|464077198|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
128943028|NCT03345836|464077193|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
128943029|NCT03345836|464077194|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
128943030|NCT03345836|464077195|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
128943031|NCT03345836|464077196|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
128943032|NCT03345836|464077197|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
128943033|NCT03345836|464077198|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
128943034|NCT03345836|464077193|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
128943035|NCT03345836|464077194|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
128943036|NCT03345836|464077195|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
128943037|NCT03345836|464077196|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
128943038|NCT03345836|464077197|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
128943039|NCT03345836|464077198|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
128943040|NCT03345836|464077193|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
128943041|NCT03345836|464077194|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
128943042|NCT03345836|464077195|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
128943043|NCT03345836|464077196|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
128943044|NCT03345836|464077197|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
128943045|NCT03345836|464077198|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
128943046|NCT03345836|464077193|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
128943047|NCT03345836|464077194|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
128943048|NCT03345836|464077195|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
128943049|NCT03345836|464077196|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
128943050|NCT03345836|464077197|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
128978105|NCT01854918|464205318|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
128978106|NCT01854918|464205317|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
128978107|NCT01854918|464205318|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
128707918|NCT02310568|463226281|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
128707919|NCT02310568|463226282|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
128943051|NCT03345836|464077198|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
128943052|NCT03345836|464077193|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
128943053|NCT03345836|464077194|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
128943054|NCT03345836|464077195|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
128943055|NCT03345836|464077196|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
128943056|NCT03345836|464077197|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
128943057|NCT03345836|464077198|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
128943058|NCT01635933|464077201|FG000|Overall Study|Adverse Event|1|||
128943059|NCT01635933|464077202|FG001|Overall Study|Adverse Event|0|||
128943060|NCT01635933|464077201|FG000|Overall Study|Lost to Follow-up|0|||
128943061|NCT01635933|464077202|FG001|Overall Study|Lost to Follow-up|5|||
128943062|NCT01635933|464077201|FG000|Overall Study|Subject decision|1|||
128943063|NCT01635933|464077202|FG001|Overall Study|Subject decision|1|||
128943064|NCT01635933|464077201|FG000|Overall Study|Noncompliance|0|||
128943065|NCT01635933|464077202|FG001|Overall Study|Noncompliance|1|||
128943066|NCT01635933|464077201|FG000|Overall Study|No longer had transportation|0|||
128943067|NCT01635933|464077202|FG001|Overall Study|No longer had transportation|1|||
128943068|NCT03510663|464077203|FG000|Overall Study|Withdrawal by Subject|0|||
128943069|NCT03510663|464077204|FG001|Overall Study|Withdrawal by Subject|1|||
128943070|NCT03510663|464077205|FG002|Overall Study|Withdrawal by Subject|0|||
128943071|NCT03510663|464077206|FG003|Overall Study|Withdrawal by Subject|0|||
128943072|NCT03510663|464077207|FG004|Overall Study|Withdrawal by Subject|0|||
128943073|NCT03510663|464077208|FG005|Overall Study|Withdrawal by Subject|0|||
128943074|NCT03510663|464077209|FG006|Overall Study|Withdrawal by Subject|0|||
128943075|NCT03510663|464077210|FG007|Overall Study|Withdrawal by Subject|0|||
128943076|NCT02213198|464077213|FG000|Baseline|No show for intake|7|||
128943077|NCT02213198|464077214|FG001|Baseline|No show for intake|9|||
128943078|NCT02213198|464077213|FG000|Baseline|Withdrawal by Subject|34|||
128943079|NCT02213198|464077214|FG001|Baseline|Withdrawal by Subject|11|||
128943080|NCT02213198|464077213|FG000|Baseline|transferred out of clinic|7|||
128943081|NCT02213198|464077214|FG001|Baseline|transferred out of clinic|9|||
128943082|NCT02213198|464077213|FG000|Baseline|Lost to Follow-up|40|||
128943083|NCT02213198|464077214|FG001|Baseline|Lost to Follow-up|21|||
128943084|NCT02213198|464077213|FG000|Baseline|incarcerated,violent|0|||
128943085|NCT02213198|464077214|FG001|Baseline|incarcerated,violent|1|||
128943086|NCT02213198|464077213|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
128943087|NCT02213198|464077214|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
128943088|NCT02213198|464077213|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
128943089|NCT02213198|464077214|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
128943090|NCT02213198|464077213|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
128943091|NCT02213198|464077214|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
128943092|NCT02213198|464077213|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
129033003|NCT02575339|464412058|FG002|Follow up|Death|0|||
129033004|NCT02575339|464412056|FG000|Follow up|Study Terminated|0|||
128943093|NCT02213198|464077214|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
129033005|NCT02575339|464412057|FG001|Follow up|Study Terminated|2|||
129033006|NCT02575339|464412058|FG002|Follow up|Study Terminated|0|||
129033007|NCT02575339|464412056|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
129033008|NCT02575339|464412057|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
129033009|NCT02575339|464412058|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
129033010|NCT04675775|464412059|FG000|Overall Study|Withdrawal by Subject|7|||
129033011|NCT04633642|464412060|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
129033012|NCT04633642|464412061|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
129033013|NCT00611884|464412062|FG000|Overall Study|Adverse Event|1|||
129033014|NCT00611884|464412063|FG001|Overall Study|Adverse Event|0|||
129033015|NCT00611884|464412064|FG002|Overall Study|Adverse Event|0|||
129033016|NCT00611884|464412065|FG003|Overall Study|Adverse Event|1|||
129033017|NCT00611884|464412062|FG000|Overall Study|Non-Compliance|1|||
129033018|NCT00611884|464412063|FG001|Overall Study|Non-Compliance|4|||
129033019|NCT00611884|464412064|FG002|Overall Study|Non-Compliance|2|||
129033020|NCT00611884|464412065|FG003|Overall Study|Non-Compliance|2|||
129033021|NCT00611884|464412062|FG000|Overall Study|Lack of Efficacy|0|||
129033022|NCT00611884|464412063|FG001|Overall Study|Lack of Efficacy|1|||
128943094|NCT02213198|464077213|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
128943095|NCT02213198|464077214|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
128943096|NCT02213198|464077213|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
129033023|NCT00611884|464412064|FG002|Overall Study|Lack of Efficacy|0|||
129033024|NCT00611884|464412065|FG003|Overall Study|Lack of Efficacy|0|||
129033025|NCT00611884|464412062|FG000|Overall Study|Unclassified|7|||
129033026|NCT00611884|464412063|FG001|Overall Study|Unclassified|4|||
129033027|NCT00611884|464412064|FG002|Overall Study|Unclassified|2|||
129123348|NCT04761822|464746936|FG001|Overall Study|Lost to Follow-up|0|||
129033028|NCT00611884|464412065|FG003|Overall Study|Unclassified|3|||
129033029|NCT00981799|464412066|FG000|Overall Study|Adverse Event|1|||
129033030|NCT00981799|464412067|FG001|Overall Study|Adverse Event|1|||
129033031|NCT00981799|464412068|FG002|Overall Study|Adverse Event|0|||
129033032|NCT00981799|464412069|FG003|Overall Study|Adverse Event|0|||
129033033|NCT00687739|464412070|FG000|Overall Study|Lost to Follow-up|2|||
129123349|NCT04761822|464746937|FG002|Overall Study|Lost to Follow-up|2|||
129123350|NCT04761822|464746938|FG003|Overall Study|Lost to Follow-up|3|||
129123351|NCT04761822|464746935|FG000|Overall Study|Physician Decision|0|||
129123352|NCT04761822|464746936|FG001|Overall Study|Physician Decision|1|||
129123353|NCT04761822|464746937|FG002|Overall Study|Physician Decision|0|||
129123354|NCT04761822|464746938|FG003|Overall Study|Physician Decision|0|||
129123355|NCT04761822|464746935|FG000|Overall Study|Withdrawal by Subject|3|||
129123356|NCT04761822|464746936|FG001|Overall Study|Withdrawal by Subject|8|||
129123357|NCT04761822|464746937|FG002|Overall Study|Withdrawal by Subject|1|||
129123358|NCT04761822|464746938|FG003|Overall Study|Withdrawal by Subject|11|||
129123359|NCT04761822|464746935|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
129123360|NCT04761822|464746936|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
129123361|NCT04761822|464746937|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
129123362|NCT04761822|464746938|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
129123363|NCT04761822|464746935|FG000|Overall Study|Participant requested unblinding|0|||
129123364|NCT04761822|464746936|FG001|Overall Study|Participant requested unblinding|0|||
129123365|NCT04761822|464746937|FG002|Overall Study|Participant requested unblinding|0|||
129123366|NCT04761822|464746938|FG003|Overall Study|Participant requested unblinding|1|||
129123367|NCT06633965|464746941|FG000|Overall Study|Withdrawal by Subject|0|||
129123368|NCT06633965|464746942|FG001|Overall Study|Withdrawal by Subject|1|||
129123369|NCT01963611|464746949|FG000|Overall Study|Adverse Event|1|||
129123370|NCT01963611|464746950|FG001|Overall Study|Adverse Event|1|||
129123371|NCT01963611|464746951|FG002|Overall Study|Adverse Event|3|||
128707920|NCT02989194|463226292|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
128707921|NCT02989194|463226293|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
128707922|NCT02989194|463226294|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
128707923|NCT02989194|463226292|FG000|Overall Study|Lost to Follow-up|0|||
128707924|NCT02989194|463226293|FG001|Overall Study|Lost to Follow-up|1|||
128707925|NCT02989194|463226294|FG002|Overall Study|Lost to Follow-up|0|||
128707926|NCT02989194|463226292|FG000|Overall Study|Withdrawal by Subject|0|||
129033034|NCT00687739|464412071|FG001|Overall Study|Lost to Follow-up|2|||
129033035|NCT00687739|464412072|FG002|Overall Study|Lost to Follow-up|1|||
129033036|NCT00687739|464412073|FG003|Overall Study|Lost to Follow-up|2|||
129033037|NCT00687739|464412070|FG000|Overall Study|Adverse Event|0|||
129033038|NCT00687739|464412071|FG001|Overall Study|Adverse Event|1|||
129033039|NCT00687739|464412072|FG002|Overall Study|Adverse Event|1|||
129033040|NCT00687739|464412073|FG003|Overall Study|Adverse Event|0|||
129033041|NCT01190930|464412075|FG000|Induction|Adverse Event|17|||
129033042|NCT01190930|464412076|FG001|Induction|Adverse Event|0|||
129033043|NCT01190930|464412077|FG002|Induction|Adverse Event|0|||
129033044|NCT01190930|464412078|FG003|Induction|Adverse Event|0|||
129033045|NCT01190930|464412079|FG004|Induction|Adverse Event|0|||
129033046|NCT01190930|464412080|FG005|Induction|Adverse Event|0|||
129033047|NCT01190930|464412081|FG006|Induction|Adverse Event|0|||
129033048|NCT01190930|464412082|FG007|Induction|Adverse Event|0|||
129033049|NCT01190930|464412083|FG008|Induction|Adverse Event|0|||
129033050|NCT01190930|464412084|FG009|Induction|Adverse Event|0|||
129033051|NCT01190930|464412075|FG000|Induction|Death|34|||
129033052|NCT01190930|464412076|FG001|Induction|Death|0|||
129033053|NCT01190930|464412077|FG002|Induction|Death|0|||
129033054|NCT01190930|464412078|FG003|Induction|Death|0|||
129033055|NCT01190930|464412079|FG004|Induction|Death|0|||
129033056|NCT01190930|464412080|FG005|Induction|Death|0|||
129033057|NCT01190930|464412081|FG006|Induction|Death|0|||
129033058|NCT01190930|464412082|FG007|Induction|Death|0|||
129033059|NCT01190930|464412083|FG008|Induction|Death|0|||
129033060|NCT01190930|464412084|FG009|Induction|Death|0|||
129033061|NCT01190930|464412075|FG000|Induction|Lost to Follow-up|1|||
129033062|NCT01190930|464412076|FG001|Induction|Lost to Follow-up|0|||
129033063|NCT01190930|464412077|FG002|Induction|Lost to Follow-up|0|||
129033064|NCT01190930|464412078|FG003|Induction|Lost to Follow-up|0|||
129033065|NCT01190930|464412079|FG004|Induction|Lost to Follow-up|0|||
129033066|NCT01190930|464412080|FG005|Induction|Lost to Follow-up|0|||
129033067|NCT01190930|464412081|FG006|Induction|Lost to Follow-up|0|||
129033068|NCT01190930|464412082|FG007|Induction|Lost to Follow-up|0|||
129033069|NCT01190930|464412083|FG008|Induction|Lost to Follow-up|0|||
129033070|NCT01190930|464412084|FG009|Induction|Lost to Follow-up|0|||
129033071|NCT01190930|464412075|FG000|Induction|Physician Decision|125|||
129033072|NCT01190930|464412076|FG001|Induction|Physician Decision|3|||
129033073|NCT01190930|464412077|FG002|Induction|Physician Decision|0|||
129033074|NCT01190930|464412078|FG003|Induction|Physician Decision|0|||
129033075|NCT01190930|464412079|FG004|Induction|Physician Decision|0|||
129033076|NCT01190930|464412080|FG005|Induction|Physician Decision|0|||
128707927|NCT02989194|463226293|FG001|Overall Study|Withdrawal by Subject|1|||
128707928|NCT02989194|463226294|FG002|Overall Study|Withdrawal by Subject|0|||
128707929|NCT01549860|463226295|FG000|Overall Study|Withdrawal by Subject|1|||
128707930|NCT01549860|463226296|FG001|Overall Study|Withdrawal by Subject|0|||
128707931|NCT01549860|463226295|FG000|Overall Study|Physician Decision|1|||
128707932|NCT01549860|463226296|FG001|Overall Study|Physician Decision|1|||
128707933|NCT01224431|463226299|FG000|Overall Study|not randomized|0|||
128707934|NCT01224431|463226300|FG001|Overall Study|not randomized|4|||
128707935|NCT01224431|463226299|FG000|Overall Study|no video record|0|||
128707936|NCT01224431|463226300|FG001|Overall Study|no video record|1|||
128707937|NCT01327885|463226306|FG000|Overall Study|Disease progression-according to RECIST|173|||
128707938|NCT01327885|463226307|FG001|Overall Study|Disease progression-according to RECIST|165|||
128707939|NCT01327885|463226306|FG000|Overall Study|Clinical progression|24|||
128707940|NCT01327885|463226307|FG001|Overall Study|Clinical progression|27|||
128707941|NCT01327885|463226306|FG000|Overall Study|Adverse Event|14|||
128707942|NCT01327885|463226307|FG001|Overall Study|Adverse Event|10|||
128707943|NCT01327885|463226306|FG000|Overall Study|Subject choice|5|||
128707944|NCT01327885|463226307|FG001|Overall Study|Subject choice|10|||
128707945|NCT01327885|463226306|FG000|Overall Study|Other|8|||
128707946|NCT01327885|463226307|FG001|Overall Study|Other|6|||
128707947|NCT01327885|463226306|FG000|Overall Study|Withdrawal of consent from study|3|||
128707948|NCT01327885|463226307|FG001|Overall Study|Withdrawal of consent from study|4|||
128707949|NCT01327885|463226306|FG000|Overall Study|Not treated|1|||
128707950|NCT01327885|463226307|FG001|Overall Study|Not treated|1|||
128707951|NCT01327885|463226306|FG000|Overall Study|Administrative decision|0|||
128707952|NCT01327885|463226307|FG001|Overall Study|Administrative decision|1|||
128707953|NCT03824912|463226310|FG000|Overall Study|Lost to Follow-up|18|||
128707954|NCT03824912|463226311|FG001|Overall Study|Lost to Follow-up|15|||
128707955|NCT03824912|463226312|FG002|Overall Study|Lost to Follow-up|8|||
128707956|NCT03824912|463226310|FG000|Overall Study|Negative Baseline Culture Result|118|||
128707957|NCT03824912|463226311|FG001|Overall Study|Negative Baseline Culture Result|112|||
128707958|NCT03824912|463226312|FG002|Overall Study|Negative Baseline Culture Result|57|||
128707959|NCT03824912|463226310|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128707960|NCT03824912|463226311|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128707961|NCT03824912|463226312|FG002|Overall Study|Non-Compliance with Study Drug|1|||
128707962|NCT03824912|463226310|FG000|Overall Study|Protocol Violation|1|||
128707963|NCT03824912|463226311|FG001|Overall Study|Protocol Violation|4|||
128707964|NCT03824912|463226312|FG002|Overall Study|Protocol Violation|1|||
128707965|NCT03824912|463226310|FG000|Overall Study|Withdrawal by Subject|3|||
128707966|NCT03824912|463226311|FG001|Overall Study|Withdrawal by Subject|2|||
128707967|NCT03824912|463226312|FG002|Overall Study|Withdrawal by Subject|1|||
128707968|NCT03824912|463226310|FG000|Overall Study|Participation in another study|0|||
128707969|NCT03824912|463226311|FG001|Overall Study|Participation in another study|1|||
128707970|NCT03824912|463226312|FG002|Overall Study|Participation in another study|0|||
128707971|NCT02511184|463226313|FG000|Overall Study|Death|1|||
128707972|NCT02511184|463226314|FG001|Overall Study|Death|0|||
128707973|NCT02511184|463226313|FG000|Overall Study|Lost to Follow-up|0|||
128707974|NCT02511184|463226314|FG001|Overall Study|Lost to Follow-up|1|||
128707975|NCT02511184|463226313|FG000|Overall Study|Study terminated by sponsor|1|||
128707976|NCT02511184|463226314|FG001|Overall Study|Study terminated by sponsor|5|||
128707977|NCT02511184|463226313|FG000|Overall Study|Withdrawal by Subject|0|||
128707978|NCT02511184|463226314|FG001|Overall Study|Withdrawal by Subject|1|||
128707979|NCT02041286|463226315|FG000|Overall Study|Adverse Event|1|||
128707980|NCT01963403|463226322|FG000|Overall Study|Lost to Follow-up|2|||
128707981|NCT01963403|463226323|FG001|Overall Study|Lost to Follow-up|3|||
128707982|NCT01963403|463226322|FG000|Overall Study|Implant removal|0|||
129123372|NCT01963611|464746952|FG003|Overall Study|Adverse Event|4|||
129123373|NCT01963611|464746953|FG004|Overall Study|Adverse Event|3|||
128707983|NCT01963403|463226323|FG001|Overall Study|Implant removal|1|||
128707984|NCT01349790|463226331|FG000|Overall Study|Investigator Judgement|3|||
128707985|NCT01349790|463226331|FG000|Overall Study|Death|2|||
129123374|NCT01963611|464746949|FG000|Overall Study|Protocol Violation|0|||
128707986|NCT01349790|463226331|FG000|Overall Study|Withdrawal by Patient|2|||
128707987|NCT01349790|463226331|FG000|Overall Study|Adverse Event|1|||
128707988|NCT01349790|463226331|FG000|Overall Study|Lost to Follow-up|1|||
128707989|NCT02085785|463226336|FG000|Overall Study|Withdrawal by Subject|2|||
128707990|NCT02085785|463226337|FG001|Overall Study|Withdrawal by Subject|1|||
128707991|NCT02085785|463226336|FG000|Overall Study|Lost to Follow-up|0|||
128707992|NCT02085785|463226337|FG001|Overall Study|Lost to Follow-up|1|||
128707993|NCT00779467|463226338|FG000|Overall Study|Lack of Efficacy|11|||
128943097|NCT02213198|464077214|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
128707994|NCT00779467|463226339|FG001|Overall Study|Lack of Efficacy|2|||
128707995|NCT00779467|463226340|FG002|Overall Study|Lack of Efficacy|6|||
129123375|NCT01963611|464746950|FG001|Overall Study|Protocol Violation|0|||
129123376|NCT01963611|464746951|FG002|Overall Study|Protocol Violation|0|||
128770235|NCT01234649|463450164|FG000|Overall Study|Lack of Efficacy|0|||
128707996|NCT00779467|463226341|FG003|Overall Study|Lack of Efficacy|11|||
128707997|NCT00779467|463226338|FG000|Overall Study|failed inclusion criteria|3|||
128943098|NCT03382899|464077215|FG000|Overall Study|Ineligibility Determined|0|||
128943099|NCT03382899|464077216|FG001|Overall Study|Ineligibility Determined|1|||
128943100|NCT03382899|464077215|FG000|Overall Study|Lost to Follow-up|0|||
128943101|NCT03382899|464077216|FG001|Overall Study|Lost to Follow-up|1|||
128943102|NCT03382899|464077215|FG000|Overall Study|Sponsor's decision|31|||
128943103|NCT03382899|464077216|FG001|Overall Study|Sponsor's decision|28|||
128943104|NCT03382899|464077215|FG000|Overall Study|Withdrawal by Subject|0|||
128943105|NCT03382899|464077216|FG001|Overall Study|Withdrawal by Subject|5|||
128943106|NCT00540449|464077217|FG000|Overall Study|Adverse Event|12|||
128943107|NCT00540449|464077218|FG001|Overall Study|Adverse Event|32|||
128943108|NCT00540449|464077217|FG000|Overall Study|Sponsor's Decision|1|||
128943109|NCT00540449|464077218|FG001|Overall Study|Sponsor's Decision|1|||
128943110|NCT00540449|464077217|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
128943111|NCT00540449|464077218|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
128943112|NCT00540449|464077217|FG000|Overall Study|Lost to Follow-up|19|||
128943113|NCT00540449|464077218|FG001|Overall Study|Lost to Follow-up|17|||
128943114|NCT00540449|464077217|FG000|Overall Study|Subject Non-Compliant|7|||
128943115|NCT00540449|464077218|FG001|Overall Study|Subject Non-Compliant|5|||
128943116|NCT00540449|464077217|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
128943117|NCT00540449|464077218|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
128943118|NCT00540449|464077217|FG000|Overall Study|Withdrawal by Subject|10|||
128943119|NCT00540449|464077218|FG001|Overall Study|Withdrawal by Subject|10|||
128943120|NCT00540449|464077217|FG000|Overall Study|Other|1|||
128943121|NCT00540449|464077218|FG001|Overall Study|Other|4|||
128943122|NCT00524316|464077219|FG000|Overall Study|Withdrawal by Subject|2|||
128943123|NCT00524316|464077219|FG000|Overall Study|Adverse Event|7|||
128943124|NCT00524316|464077219|FG000|Overall Study|Disease Progression|7|||
128943125|NCT00905021|464077221|FG000|Overall Study|Adverse Event|2|||
128943126|NCT04937816|464077222|FG000|Overall Study|Study drug stopped, reason missing|5|||
128943127|NCT04937816|464077223|FG001|Overall Study|Study drug stopped, reason missing|3|||
128943128|NCT04937816|464077224|FG002|Overall Study|Study drug stopped, reason missing|4|||
128943129|NCT04937816|464077225|FG003|Overall Study|Study drug stopped, reason missing|6|||
128943130|NCT04937816|464077226|FG004|Overall Study|Study drug stopped, reason missing|1|||
128943131|NCT04937816|464077227|FG005|Overall Study|Study drug stopped, reason missing|0|||
128943132|NCT04937816|464077228|FG006|Overall Study|Study drug stopped, reason missing|0|||
129033077|NCT01190930|464412081|FG006|Induction|Physician Decision|0|||
129033078|NCT01190930|464412082|FG007|Induction|Physician Decision|0|||
129033079|NCT01190930|464412083|FG008|Induction|Physician Decision|0|||
129033080|NCT01190930|464412084|FG009|Induction|Physician Decision|0|||
129033081|NCT01190930|464412075|FG000|Induction|Withdrawal by Subject|9|||
129033082|NCT01190930|464412076|FG001|Induction|Withdrawal by Subject|0|||
128943133|NCT04937816|464077222|FG000|Overall Study|Other than stated below|173|||
128943134|NCT04937816|464077223|FG001|Overall Study|Other than stated below|143|||
128943135|NCT04937816|464077224|FG002|Overall Study|Other than stated below|125|||
128943136|NCT04937816|464077225|FG003|Overall Study|Other than stated below|44|||
128943137|NCT04937816|464077226|FG004|Overall Study|Other than stated below|45|||
128943138|NCT04937816|464077227|FG005|Overall Study|Other than stated below|28|||
128943139|NCT04937816|464077228|FG006|Overall Study|Other than stated below|31|||
128943140|NCT04937816|464077222|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
128943141|NCT04937816|464077223|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
128943142|NCT04937816|464077224|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
128943143|NCT04937816|464077225|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
128943144|NCT04937816|464077226|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
128943145|NCT04937816|464077227|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
128943146|NCT04937816|464077228|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
128943147|NCT04937816|464077222|FG000|Overall Study|Lost to Follow-up|15|||
128943148|NCT04937816|464077223|FG001|Overall Study|Lost to Follow-up|9|||
128943149|NCT04937816|464077224|FG002|Overall Study|Lost to Follow-up|6|||
128943150|NCT04937816|464077225|FG003|Overall Study|Lost to Follow-up|6|||
128943151|NCT04937816|464077226|FG004|Overall Study|Lost to Follow-up|16|||
128943152|NCT04937816|464077227|FG005|Overall Study|Lost to Follow-up|11|||
128943153|NCT04937816|464077228|FG006|Overall Study|Lost to Follow-up|17|||
128943154|NCT04937816|464077222|FG000|Overall Study|Protocol Violation|15|||
128943155|NCT04937816|464077223|FG001|Overall Study|Protocol Violation|15|||
129033083|NCT01190930|464412077|FG002|Induction|Withdrawal by Subject|0|||
129033084|NCT01190930|464412078|FG003|Induction|Withdrawal by Subject|0|||
128943156|NCT04937816|464077224|FG002|Overall Study|Protocol Violation|12|||
128943157|NCT04937816|464077225|FG003|Overall Study|Protocol Violation|30|||
128943158|NCT04937816|464077226|FG004|Overall Study|Protocol Violation|24|||
128943159|NCT04937816|464077227|FG005|Overall Study|Protocol Violation|5|||
128943160|NCT04937816|464077228|FG006|Overall Study|Protocol Violation|5|||
129033085|NCT01190930|464412079|FG004|Induction|Withdrawal by Subject|0|||
129033086|NCT01190930|464412080|FG005|Induction|Withdrawal by Subject|0|||
128943161|NCT04937816|464077222|FG000|Overall Study|Adverse Event|303|||
128943162|NCT04937816|464077223|FG001|Overall Study|Adverse Event|267|||
128943163|NCT04937816|464077224|FG002|Overall Study|Adverse Event|273|||
128707998|NCT00779467|463226339|FG001|Overall Study|failed inclusion criteria|3|||
128707999|NCT00779467|463226340|FG002|Overall Study|failed inclusion criteria|1|||
128708000|NCT00779467|463226341|FG003|Overall Study|failed inclusion criteria|2|||
128708001|NCT00779467|463226338|FG000|Overall Study|missing data|1|||
128708002|NCT00779467|463226339|FG001|Overall Study|missing data|0|||
128708003|NCT00779467|463226340|FG002|Overall Study|missing data|1|||
128708004|NCT00779467|463226341|FG003|Overall Study|missing data|4|||
128708005|NCT00779467|463226338|FG000|Overall Study|technical issue|0|||
128708006|NCT00779467|463226339|FG001|Overall Study|technical issue|0|||
128708007|NCT00779467|463226340|FG002|Overall Study|technical issue|2|||
128708008|NCT00779467|463226341|FG003|Overall Study|technical issue|1|||
128708009|NCT00779467|463226338|FG000|Overall Study|unavailable research staff|0|||
128708010|NCT00779467|463226339|FG001|Overall Study|unavailable research staff|0|||
128708011|NCT00779467|463226340|FG002|Overall Study|unavailable research staff|0|||
128708012|NCT00779467|463226341|FG003|Overall Study|unavailable research staff|1|||
128770236|NCT01234649|463450165|FG001|Overall Study|Lack of Efficacy|3|||
128770237|NCT00318149|463450168|FG000|Overall Study|Adverse Event|0|||
128943164|NCT04937816|464077225|FG003|Overall Study|Adverse Event|553|||
128943165|NCT04937816|464077226|FG004|Overall Study|Adverse Event|575|||
128943166|NCT04937816|464077227|FG005|Overall Study|Adverse Event|343|||
128943167|NCT04937816|464077228|FG006|Overall Study|Adverse Event|337|||
128943168|NCT04937816|464077222|FG000|Overall Study|Not treated|4|||
128943169|NCT04937816|464077223|FG001|Overall Study|Not treated|2|||
128943170|NCT04937816|464077224|FG002|Overall Study|Not treated|2|||
128943171|NCT04937816|464077225|FG003|Overall Study|Not treated|2|||
128943172|NCT04937816|464077226|FG004|Overall Study|Not treated|1|||
128943173|NCT04937816|464077227|FG005|Overall Study|Not treated|4|||
128943174|NCT04937816|464077228|FG006|Overall Study|Not treated|0|||
128943175|NCT05513053|464077229|FG000|Overall Study|Lost to Follow-up|9|||
128943176|NCT05513053|464077230|FG001|Overall Study|Lost to Follow-up|11|||
128943177|NCT05513053|464077229|FG000|Overall Study|Withdrawal by parent/guardian|2|||
128943178|NCT05513053|464077230|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128943179|NCT05513053|464077229|FG000|Overall Study|Withdrawal by Subject|2|||
128943180|NCT05513053|464077230|FG001|Overall Study|Withdrawal by Subject|9|||
128943181|NCT05513053|464077229|FG000|Overall Study|Protocol Violation|6|||
128943182|NCT05513053|464077230|FG001|Overall Study|Protocol Violation|3|||
128943183|NCT05513053|464077229|FG000|Overall Study|Adverse Event|0|||
128943184|NCT05513053|464077230|FG001|Overall Study|Adverse Event|2|||
128943185|NCT00450372|464078681|FG000|Overall Study|Physician Decision|1|||
128943186|NCT03484923|464078682|FG000|Overall Study|Adverse Event|3|||
128943187|NCT03484923|464078683|FG001|Overall Study|Adverse Event|3|||
128943188|NCT03484923|464078684|FG002|Overall Study|Adverse Event|5|||
128943189|NCT03484923|464078685|FG003|Overall Study|Adverse Event|11|||
128943190|NCT03484923|464078686|FG004|Overall Study|Adverse Event|1|||
128943191|NCT03484923|464078682|FG000|Overall Study|Death|2|||
128943192|NCT03484923|464078683|FG001|Overall Study|Death|2|||
128943193|NCT03484923|464078684|FG002|Overall Study|Death|3|||
128943194|NCT03484923|464078685|FG003|Overall Study|Death|0|||
128943195|NCT03484923|464078686|FG004|Overall Study|Death|1|||
128943196|NCT03484923|464078682|FG000|Overall Study|Physician Decision|6|||
128943197|NCT03484923|464078683|FG001|Overall Study|Physician Decision|7|||
128943198|NCT03484923|464078684|FG002|Overall Study|Physician Decision|6|||
128943199|NCT03484923|464078685|FG003|Overall Study|Physician Decision|3|||
128943200|NCT03484923|464078686|FG004|Overall Study|Physician Decision|2|||
128943201|NCT03484923|464078682|FG000|Overall Study|Progressive disease|33|||
128943202|NCT03484923|464078683|FG001|Overall Study|Progressive disease|28|||
128708013|NCT02692703|463226342|FG000|Overall Study|Lost to Follow-up|1|||
128708014|NCT02692703|463226342|FG000|Overall Study|Other|1|||
128708015|NCT04118166|463226343|FG000|Overall Study|Adverse Event|1|||
128708016|NCT00885105|463226344|FG000|Overall Study|Withdrawal by Subject|0|||
128708017|NCT00885105|463226345|FG001|Overall Study|Withdrawal by Subject|8|||
128770238|NCT00318149|463450169|FG001|Overall Study|Adverse Event|0|||
128943203|NCT03484923|464078684|FG002|Overall Study|Progressive disease|26|||
128943204|NCT03484923|464078685|FG003|Overall Study|Progressive disease|30|||
128943205|NCT03484923|464078686|FG004|Overall Study|Progressive disease|16|||
129033087|NCT01190930|464412081|FG006|Induction|Withdrawal by Subject|0|||
128708018|NCT00885105|463226344|FG000|Overall Study|Adverse Event|1|||
128708019|NCT00885105|463226345|FG001|Overall Study|Adverse Event|0|||
128708020|NCT00885105|463226344|FG000|Overall Study|Protocol Violation|0|||
128770239|NCT00318149|463450170|FG002|Overall Study|Adverse Event|0|||
128943206|NCT03484923|464078682|FG000|Overall Study|Subject Decision|1|||
128943207|NCT03484923|464078683|FG001|Overall Study|Subject Decision|3|||
128943208|NCT03484923|464078684|FG002|Overall Study|Subject Decision|3|||
128943209|NCT03484923|464078685|FG003|Overall Study|Subject Decision|0|||
128943210|NCT03484923|464078686|FG004|Overall Study|Subject Decision|1|||
128943211|NCT03165721|464078687|FG000|Overall Study|Refused further treatment|3|||
128943212|NCT03165721|464078688|FG001|Overall Study|Refused further treatment|0|||
128943213|NCT03165721|464078689|FG002|Overall Study|Refused further treatment|0|||
128943214|NCT03165721|464078687|FG000|Overall Study|Physician Decision|1|||
128943215|NCT03165721|464078688|FG001|Overall Study|Physician Decision|0|||
128943216|NCT03165721|464078689|FG002|Overall Study|Physician Decision|0|||
128708021|NCT00885105|463226345|FG001|Overall Study|Protocol Violation|2|||
128708022|NCT03519932|463226346|FG000|First Intervention|Adverse Event|1|||
128708023|NCT03519932|463226347|FG001|First Intervention|Adverse Event|3|||
128708024|NCT02254486|463226348|FG000|Overall Study|Adverse Event|1|||
128708025|NCT02254486|463226349|FG001|Overall Study|Adverse Event|1|||
128708026|NCT02254486|463226348|FG000|Overall Study|Lack of Efficacy|1|||
128708027|NCT02254486|463226349|FG001|Overall Study|Lack of Efficacy|0|||
128708028|NCT02254486|463226348|FG000|Overall Study|Lost to Follow-up|2|||
128708029|NCT02254486|463226349|FG001|Overall Study|Lost to Follow-up|4|||
128708030|NCT02254486|463226348|FG000|Overall Study|Protocol Violation|1|||
128708031|NCT02254486|463226349|FG001|Overall Study|Protocol Violation|2|||
128708032|NCT02254486|463226348|FG000|Overall Study|Withdrawal by Subject|17|||
128708033|NCT02254486|463226349|FG001|Overall Study|Withdrawal by Subject|15|||
128708034|NCT02254486|463226348|FG000|Overall Study|GFR<60mL/min|16|||
128708035|NCT02254486|463226349|FG001|Overall Study|GFR<60mL/min|21|||
128708036|NCT02254486|463226348|FG000|Overall Study|Various|12|||
128708037|NCT02254486|463226349|FG001|Overall Study|Various|12|||
128708038|NCT01350414|463226350|FG000|Overall Study|Lost to Follow-up|13|||
128708039|NCT01350414|463226350|FG000|Overall Study|Withdrawal by Subject|4|||
128708040|NCT01350414|463226350|FG000|Overall Study|Physician Decision|2|||
128708041|NCT04016285|463226351|FG000|Overall Study|Did not progress to surgery|2|||
128708042|NCT04016285|463226352|FG001|Overall Study|Did not progress to surgery|5|||
128708043|NCT04016285|463226351|FG000|Overall Study|Failed to collect outcome data|5|||
128708044|NCT04016285|463226352|FG001|Overall Study|Failed to collect outcome data|3|||
128708045|NCT02573350|463226355|FG000|Overall Study|Lost to Follow-up|2|||
128708046|NCT02573350|463226356|FG001|Overall Study|Lost to Follow-up|1|||
128708047|NCT02573350|463226355|FG000|Overall Study|Adverse Event|3|||
128708048|NCT02573350|463226356|FG001|Overall Study|Adverse Event|4|||
128708049|NCT02573350|463226355|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
128708050|NCT02573350|463226356|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
128708051|NCT02573350|463226355|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
128708052|NCT02573350|463226356|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
128708053|NCT02573350|463226355|FG000|Overall Study|Subject withdrew consent to participate|6|||
128708054|NCT02573350|463226356|FG001|Overall Study|Subject withdrew consent to participate|1|||
128708055|NCT02573350|463226355|FG000|Overall Study|Protocol Deviation|1|||
128943217|NCT01863849|464078690|FG000|Overall Study|Lost to Follow-up|1|||
128943218|NCT01863849|464078691|FG001|Overall Study|Lost to Follow-up|0|||
128943219|NCT01457118|464078692|FG000|Overall Study|Adverse Event|1|||
128943220|NCT01457118|464078693|FG001|Overall Study|Adverse Event|0|||
128943221|NCT01457118|464078694|FG002|Overall Study|Adverse Event|0|||
128943222|NCT01457118|464078695|FG003|Overall Study|Adverse Event|1|||
128943223|NCT01457118|464078692|FG000|Overall Study|Clinical Progression|0|||
128943224|NCT01457118|464078693|FG001|Overall Study|Clinical Progression|1|||
128943225|NCT01457118|464078694|FG002|Overall Study|Clinical Progression|0|||
128943226|NCT01457118|464078695|FG003|Overall Study|Clinical Progression|1|||
128943227|NCT01457118|464078692|FG000|Overall Study|Physician Decision|2|||
128943228|NCT01457118|464078693|FG001|Overall Study|Physician Decision|0|||
128943229|NCT01457118|464078694|FG002|Overall Study|Physician Decision|0|||
128943230|NCT01457118|464078695|FG003|Overall Study|Physician Decision|0|||
128943231|NCT01457118|464078692|FG000|Overall Study|Progressive Disease by RECIST|12|||
128943232|NCT01457118|464078693|FG001|Overall Study|Progressive Disease by RECIST|3|||
128943233|NCT01457118|464078694|FG002|Overall Study|Progressive Disease by RECIST|1|||
128943234|NCT01457118|464078695|FG003|Overall Study|Progressive Disease by RECIST|0|||
128943235|NCT01457118|464078692|FG000|Overall Study|Withdrawal by Subject|5|||
128943236|NCT01457118|464078693|FG001|Overall Study|Withdrawal by Subject|0|||
129033088|NCT01190930|464412082|FG007|Induction|Withdrawal by Subject|0|||
129033089|NCT01190930|464412083|FG008|Induction|Withdrawal by Subject|0|||
129033090|NCT01190930|464412084|FG009|Induction|Withdrawal by Subject|0|||
128708056|NCT02573350|463226356|FG001|Overall Study|Protocol Deviation|1|||
128708057|NCT02708121|463226359|FG000|Overall Study|Withdrawn by Study Team|1|||
128708058|NCT02708121|463226360|FG001|Overall Study|Withdrawn by Study Team|1|||
128708059|NCT02708121|463226359|FG000|Overall Study|Withdrawal by Subject|0|||
128708060|NCT02708121|463226360|FG001|Overall Study|Withdrawal by Subject|4|||
128708061|NCT01833520|463226361|FG000|Overall Study|Lack of Efficacy|3|||
128708062|NCT01833520|463226362|FG001|Overall Study|Lack of Efficacy|3|||
128708063|NCT01833520|463226363|FG002|Overall Study|Lack of Efficacy|8|||
128708064|NCT01833520|463226364|FG003|Overall Study|Lack of Efficacy|3|||
128708065|NCT02743520|463226365|FG000|Overall Study|Withdrawal by Subject|1|||
128708066|NCT01749514|463226366|FG000|Overall Study|Lost to Follow-up|0|||
128708067|NCT01749514|463226367|FG001|Overall Study|Lost to Follow-up|0|||
128708068|NCT01749514|463226368|FG002|Overall Study|Lost to Follow-up|0|||
128708069|NCT01749514|463226369|FG003|Overall Study|Lost to Follow-up|0|||
128943237|NCT01457118|464078694|FG002|Overall Study|Withdrawal by Subject|0|||
128943238|NCT01457118|464078695|FG003|Overall Study|Withdrawal by Subject|0|||
128943239|NCT01202227|464078700|FG000|Overall Study|Adverse Event|16|||
128943240|NCT01202227|464078700|FG000|Overall Study|Withdrawal by Subject|2|||
128943241|NCT01202227|464078700|FG000|Overall Study|Lack of Efficacy|1|||
128943242|NCT00643487|464078701|FG000|Overall Study|Technical difficulty|3|||
128943243|NCT04402008|464078702|FG000|Overall Study|Adverse Event|0|||
128943244|NCT04402008|464078703|FG001|Overall Study|Adverse Event|0|||
128943245|NCT04402008|464078704|FG002|Overall Study|Adverse Event|0|||
128943246|NCT04402008|464078705|FG003|Overall Study|Adverse Event|1|||
128943247|NCT04402008|464078706|FG004|Overall Study|Adverse Event|0|||
128943248|NCT04402008|464078707|FG005|Overall Study|Adverse Event|0|||
128943249|NCT04402008|464078708|FG006|Overall Study|Adverse Event|0|||
129123377|NCT01963611|464746952|FG003|Overall Study|Protocol Violation|1|||
128943250|NCT04402008|464078702|FG000|Overall Study|Disease Progression|3|||
128943251|NCT04402008|464078703|FG001|Overall Study|Disease Progression|2|||
128943252|NCT04402008|464078704|FG002|Overall Study|Disease Progression|3|||
128943253|NCT04402008|464078705|FG003|Overall Study|Disease Progression|3|||
128943254|NCT04402008|464078706|FG004|Overall Study|Disease Progression|4|||
128943255|NCT04402008|464078707|FG005|Overall Study|Disease Progression|3|||
128943256|NCT04402008|464078708|FG006|Overall Study|Disease Progression|10|||
128943257|NCT04402008|464078702|FG000|Overall Study|Withdrawal by Subject|0|||
128943258|NCT04402008|464078703|FG001|Overall Study|Withdrawal by Subject|1|||
128943259|NCT04402008|464078704|FG002|Overall Study|Withdrawal by Subject|0|||
128943260|NCT04402008|464078705|FG003|Overall Study|Withdrawal by Subject|0|||
128943261|NCT04402008|464078706|FG004|Overall Study|Withdrawal by Subject|1|||
128943262|NCT04402008|464078707|FG005|Overall Study|Withdrawal by Subject|0|||
128943263|NCT04402008|464078708|FG006|Overall Study|Withdrawal by Subject|0|||
128943264|NCT04402008|464078702|FG000|Overall Study|Sponsor Decision|0|||
128943265|NCT04402008|464078703|FG001|Overall Study|Sponsor Decision|0|||
128943266|NCT04402008|464078704|FG002|Overall Study|Sponsor Decision|0|||
128943267|NCT04402008|464078705|FG003|Overall Study|Sponsor Decision|0|||
128943268|NCT04402008|464078706|FG004|Overall Study|Sponsor Decision|0|||
128943269|NCT04402008|464078707|FG005|Overall Study|Sponsor Decision|0|||
128943270|NCT04402008|464078708|FG006|Overall Study|Sponsor Decision|3|||
128943271|NCT04402008|464078702|FG000|Overall Study|Death|0|||
128943272|NCT04402008|464078703|FG001|Overall Study|Death|0|||
128943273|NCT04402008|464078704|FG002|Overall Study|Death|0|||
128943274|NCT04402008|464078705|FG003|Overall Study|Death|0|||
128943275|NCT04402008|464078706|FG004|Overall Study|Death|1|||
128943276|NCT04402008|464078707|FG005|Overall Study|Death|0|||
128943277|NCT04402008|464078708|FG006|Overall Study|Death|2|||
128943278|NCT04402008|464078702|FG000|Overall Study|Other|0|||
128943279|NCT04402008|464078703|FG001|Overall Study|Other|0|||
128943280|NCT04402008|464078704|FG002|Overall Study|Other|0|||
128943281|NCT04402008|464078705|FG003|Overall Study|Other|0|||
128943282|NCT04402008|464078706|FG004|Overall Study|Other|0|||
128943283|NCT04402008|464078707|FG005|Overall Study|Other|0|||
128943284|NCT04402008|464078708|FG006|Overall Study|Other|5|||
128943285|NCT01533935|464078709|FG000|Overall Study|Adverse Event|5|||
128943286|NCT01533935|464078710|FG001|Overall Study|Adverse Event|7|||
128943287|NCT01533935|464078711|FG002|Overall Study|Adverse Event|1|||
128943288|NCT01533935|464078712|FG003|Overall Study|Adverse Event|5|||
129123378|NCT01963611|464746953|FG004|Overall Study|Protocol Violation|0|||
129123379|NCT01963611|464746949|FG000|Overall Study|Lack of Efficacy|0|||
129123380|NCT01963611|464746950|FG001|Overall Study|Lack of Efficacy|0|||
129123381|NCT01963611|464746951|FG002|Overall Study|Lack of Efficacy|0|||
129123382|NCT01963611|464746952|FG003|Overall Study|Lack of Efficacy|1|||
129123383|NCT01963611|464746953|FG004|Overall Study|Lack of Efficacy|0|||
129123384|NCT01963611|464746949|FG000|Overall Study|Withdrawal by Subject|3|||
129123385|NCT01963611|464746950|FG001|Overall Study|Withdrawal by Subject|2|||
129123386|NCT01963611|464746951|FG002|Overall Study|Withdrawal by Subject|1|||
128943289|NCT01533935|464078713|FG004|Overall Study|Adverse Event|3|||
128943290|NCT01533935|464078709|FG000|Overall Study|Protocol Violation|0|||
129123387|NCT01963611|464746952|FG003|Overall Study|Withdrawal by Subject|1|||
129123388|NCT01963611|464746953|FG004|Overall Study|Withdrawal by Subject|3|||
129123389|NCT01963611|464746949|FG000|Overall Study|Other|47|||
129123390|NCT01963611|464746950|FG001|Overall Study|Other|46|||
129123391|NCT01963611|464746951|FG002|Overall Study|Other|48|||
129123392|NCT01963611|464746952|FG003|Overall Study|Other|45|||
129123393|NCT01963611|464746953|FG004|Overall Study|Other|45|||
129123394|NCT01126424|464746954|FG000|Overall Study|Adverse Event|0|||
129123395|NCT01126424|464746955|FG001|Overall Study|Adverse Event|0|||
129123396|NCT01126424|464746956|FG002|Overall Study|Adverse Event|0|||
129123397|NCT01126424|464746957|FG003|Overall Study|Adverse Event|0|||
129217762|NCT02425943|465097055|FG000|Overall Study|Withdrawal by Subject|64|||
129217763|NCT02425943|465097056|FG001|Overall Study|Withdrawal by Subject|31|||
129217764|NCT02425943|465097055|FG000|Overall Study|Other|6|||
128943291|NCT01533935|464078710|FG001|Overall Study|Protocol Violation|2|||
128943292|NCT01533935|464078711|FG002|Overall Study|Protocol Violation|0|||
128943293|NCT01533935|464078712|FG003|Overall Study|Protocol Violation|0|||
128943294|NCT01533935|464078713|FG004|Overall Study|Protocol Violation|0|||
128943295|NCT01533935|464078709|FG000|Overall Study|Lost to Follow-up|0|||
128943296|NCT01533935|464078710|FG001|Overall Study|Lost to Follow-up|0|||
128943297|NCT01533935|464078711|FG002|Overall Study|Lost to Follow-up|1|||
128943298|NCT01533935|464078712|FG003|Overall Study|Lost to Follow-up|0|||
128943299|NCT01533935|464078713|FG004|Overall Study|Lost to Follow-up|0|||
128708070|NCT01749514|463226370|FG004|Overall Study|Lost to Follow-up|0|||
128708071|NCT01749514|463226371|FG005|Overall Study|Lost to Follow-up|0|||
128943300|NCT01533935|464078709|FG000|Overall Study|Withdrawal by Subject|0|||
128943301|NCT01533935|464078710|FG001|Overall Study|Withdrawal by Subject|4|||
128943302|NCT01533935|464078711|FG002|Overall Study|Withdrawal by Subject|5|||
128943303|NCT01533935|464078712|FG003|Overall Study|Withdrawal by Subject|2|||
128943304|NCT01533935|464078713|FG004|Overall Study|Withdrawal by Subject|4|||
128943305|NCT01533935|464078709|FG000|Overall Study|Other reason not defined above|1|||
128943306|NCT01533935|464078710|FG001|Overall Study|Other reason not defined above|0|||
128943307|NCT01533935|464078711|FG002|Overall Study|Other reason not defined above|1|||
128943308|NCT01533935|464078712|FG003|Overall Study|Other reason not defined above|0|||
128943309|NCT01533935|464078713|FG004|Overall Study|Other reason not defined above|1|||
128943310|NCT00879814|464078714|FG000|Overall Study|Adverse Event|0|||
128943311|NCT00879814|464078715|FG001|Overall Study|Adverse Event|1|||
128943312|NCT00879814|464078716|FG002|Overall Study|Adverse Event|0|||
128943313|NCT00879814|464078717|FG003|Overall Study|Adverse Event|0|||
128943314|NCT00879814|464078714|FG000|Overall Study|Lost to Follow-up|1|||
128943315|NCT00879814|464078715|FG001|Overall Study|Lost to Follow-up|0|||
128943316|NCT00879814|464078716|FG002|Overall Study|Lost to Follow-up|0|||
128943317|NCT00879814|464078717|FG003|Overall Study|Lost to Follow-up|2|||
128943318|NCT00879814|464078714|FG000|Overall Study|Participant Failed to Return|0|||
128943319|NCT00879814|464078715|FG001|Overall Study|Participant Failed to Return|0|||
128943320|NCT00879814|464078716|FG002|Overall Study|Participant Failed to Return|0|||
128943321|NCT00879814|464078717|FG003|Overall Study|Participant Failed to Return|1|||
128943322|NCT00879814|464078714|FG000|Overall Study|Withdrawal by Subject|3|||
128943323|NCT00879814|464078715|FG001|Overall Study|Withdrawal by Subject|1|||
128943324|NCT00879814|464078716|FG002|Overall Study|Withdrawal by Subject|1|||
128943325|NCT00879814|464078717|FG003|Overall Study|Withdrawal by Subject|2|||
128943326|NCT00879814|464078714|FG000|Overall Study|Physician Decision|0|||
128943327|NCT00879814|464078715|FG001|Overall Study|Physician Decision|0|||
128943328|NCT00879814|464078716|FG002|Overall Study|Physician Decision|1|||
128943329|NCT00879814|464078717|FG003|Overall Study|Physician Decision|0|||
128943330|NCT00879814|464078714|FG000|Overall Study|Other|0|||
128943331|NCT00879814|464078715|FG001|Overall Study|Other|0|||
128943332|NCT00879814|464078716|FG002|Overall Study|Other|1|||
128943333|NCT00879814|464078717|FG003|Overall Study|Other|0|||
128943334|NCT00630812|464078730|FG000|Randomisation to First Dose|Adverse Event|1|||
128943335|NCT00630812|464078731|FG001|Randomisation to First Dose|Adverse Event|1|||
128943336|NCT00630812|464078730|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
128943337|NCT00630812|464078731|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
128943338|NCT00630812|464078730|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
128943339|NCT00630812|464078731|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
128943340|NCT00630812|464078730|FG000|Randomisation to First Dose|Protocol Violation|4|||
128943341|NCT00630812|464078731|FG001|Randomisation to First Dose|Protocol Violation|1|||
128943342|NCT00630812|464078730|FG000|Double Blind Treatment Period|Adverse Event|13|||
128943343|NCT00630812|464078731|FG001|Double Blind Treatment Period|Adverse Event|5|||
128943344|NCT00630812|464078730|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
128943345|NCT00630812|464078731|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
128943346|NCT00630812|464078730|FG000|Double Blind Treatment Period|Physician Decision|2|||
128943347|NCT00630812|464078731|FG001|Double Blind Treatment Period|Physician Decision|1|||
128943348|NCT00630812|464078730|FG000|Double Blind Treatment Period|Protocol Violation|1|||
128943349|NCT00630812|464078731|FG001|Double Blind Treatment Period|Protocol Violation|0|||
128943350|NCT00630812|464078730|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
128943351|NCT00630812|464078731|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
128943352|NCT00630812|464078730|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
128943353|NCT00630812|464078731|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
128943354|NCT00630812|464078730|FG000|Double Blind Treatment Period|Non-compliance|0|||
128943355|NCT00630812|464078731|FG001|Double Blind Treatment Period|Non-compliance|1|||
128943356|NCT01219959|464078732|FG000|Overall Study|Adverse Event|6|||
128943357|NCT01219959|464078733|FG001|Overall Study|Adverse Event|14|||
128943358|NCT01219959|464078732|FG000|Overall Study|Physician Decision|0|||
129033091|NCT01190930|464412075|FG000|Induction|Refusal|235|||
128708072|NCT01749514|463226372|FG006|Overall Study|Lost to Follow-up|0|||
128708073|NCT01749514|463226373|FG007|Overall Study|Lost to Follow-up|1|||
128708074|NCT01749514|463226366|FG000|Overall Study|Withdrawal by Subject|0|||
128708075|NCT01749514|463226367|FG001|Overall Study|Withdrawal by Subject|0|||
128708076|NCT01749514|463226368|FG002|Overall Study|Withdrawal by Subject|0|||
128708077|NCT01749514|463226369|FG003|Overall Study|Withdrawal by Subject|0|||
128943359|NCT01219959|464078733|FG001|Overall Study|Physician Decision|4|||
129033092|NCT01190930|464412076|FG001|Induction|Refusal|0|||
128708078|NCT01749514|463226370|FG004|Overall Study|Withdrawal by Subject|0|||
128943360|NCT01219959|464078732|FG000|Overall Study|Withdrawal by Subject|0|||
128943361|NCT01219959|464078733|FG001|Overall Study|Withdrawal by Subject|2|||
128943362|NCT01219959|464078732|FG000|Overall Study|Renal Transplantation|0|||
128943363|NCT01219959|464078733|FG001|Overall Study|Renal Transplantation|3|||
129033093|NCT01190930|464412077|FG002|Induction|Refusal|0|||
129033094|NCT01190930|464412078|FG003|Induction|Refusal|0|||
129033095|NCT01190930|464412079|FG004|Induction|Refusal|0|||
129033096|NCT01190930|464412080|FG005|Induction|Refusal|0|||
129033097|NCT01190930|464412081|FG006|Induction|Refusal|0|||
129033098|NCT01190930|464412082|FG007|Induction|Refusal|0|||
129033099|NCT01190930|464412083|FG008|Induction|Refusal|0|||
129033100|NCT01190930|464412084|FG009|Induction|Refusal|0|||
129033101|NCT01190930|464412075|FG000|Induction|Inevaluable|23|||
129033102|NCT01190930|464412076|FG001|Induction|Inevaluable|1|||
129033103|NCT01190930|464412077|FG002|Induction|Inevaluable|0|||
129033104|NCT01190930|464412078|FG003|Induction|Inevaluable|0|||
129033105|NCT01190930|464412079|FG004|Induction|Inevaluable|0|||
129033106|NCT01190930|464412080|FG005|Induction|Inevaluable|0|||
129033107|NCT01190930|464412081|FG006|Induction|Inevaluable|0|||
129033108|NCT01190930|464412082|FG007|Induction|Inevaluable|0|||
129033109|NCT01190930|464412083|FG008|Induction|Inevaluable|0|||
129033110|NCT01190930|464412084|FG009|Induction|Inevaluable|0|||
129033111|NCT01190930|464412075|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
129033112|NCT01190930|464412076|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033113|NCT01190930|464412077|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033114|NCT01190930|464412078|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033115|NCT01190930|464412079|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033116|NCT01190930|464412080|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033117|NCT01190930|464412081|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033118|NCT01190930|464412082|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033119|NCT01190930|464412083|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033120|NCT01190930|464412084|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129033121|NCT01190930|464412075|FG000|Induction|High Risk Downs|80|||
129033122|NCT01190930|464412076|FG001|Induction|High Risk Downs|0|||
129033123|NCT01190930|464412077|FG002|Induction|High Risk Downs|0|||
129033124|NCT01190930|464412078|FG003|Induction|High Risk Downs|0|||
129033125|NCT01190930|464412079|FG004|Induction|High Risk Downs|0|||
129033126|NCT01190930|464412080|FG005|Induction|High Risk Downs|0|||
129033127|NCT01190930|464412081|FG006|Induction|High Risk Downs|0|||
129033128|NCT01190930|464412082|FG007|Induction|High Risk Downs|0|||
129033129|NCT01190930|464412083|FG008|Induction|High Risk Downs|0|||
129033130|NCT01190930|464412084|FG009|Induction|High Risk Downs|0|||
129033131|NCT01190930|464412075|FG000|Induction|Enrollment onto another COG Protocol|1|||
129033132|NCT01190930|464412076|FG001|Induction|Enrollment onto another COG Protocol|0|||
129033133|NCT01190930|464412077|FG002|Induction|Enrollment onto another COG Protocol|0|||
129033134|NCT01190930|464412078|FG003|Induction|Enrollment onto another COG Protocol|0|||
129033135|NCT01190930|464412079|FG004|Induction|Enrollment onto another COG Protocol|0|||
129033136|NCT01190930|464412080|FG005|Induction|Enrollment onto another COG Protocol|0|||
129033137|NCT01190930|464412081|FG006|Induction|Enrollment onto another COG Protocol|0|||
129033138|NCT01190930|464412082|FG007|Induction|Enrollment onto another COG Protocol|0|||
129033139|NCT01190930|464412083|FG008|Induction|Enrollment onto another COG Protocol|0|||
129033140|NCT01190930|464412084|FG009|Induction|Enrollment onto another COG Protocol|0|||
129033141|NCT01190930|464412075|FG000|Induction|Average Risk|1847|||
129033142|NCT01190930|464412076|FG001|Induction|Average Risk|0|||
129033143|NCT01190930|464412077|FG002|Induction|Average Risk|0|||
129033144|NCT01190930|464412078|FG003|Induction|Average Risk|0|||
129033145|NCT01190930|464412079|FG004|Induction|Average Risk|0|||
129033146|NCT01190930|464412080|FG005|Induction|Average Risk|0|||
129033147|NCT01190930|464412081|FG006|Induction|Average Risk|0|||
129033148|NCT01190930|464412082|FG007|Induction|Average Risk|0|||
129033149|NCT01190930|464412083|FG008|Induction|Average Risk|0|||
129033150|NCT01190930|464412084|FG009|Induction|Average Risk|0|||
129033151|NCT01190930|464412075|FG000|Induction|High Risk|1227|||
129033152|NCT01190930|464412076|FG001|Induction|High Risk|0|||
129033153|NCT01190930|464412077|FG002|Induction|High Risk|0|||
129033154|NCT01190930|464412078|FG003|Induction|High Risk|0|||
129033155|NCT01190930|464412079|FG004|Induction|High Risk|0|||
129033156|NCT01190930|464412080|FG005|Induction|High Risk|0|||
129033157|NCT01190930|464412081|FG006|Induction|High Risk|0|||
129033158|NCT01190930|464412082|FG007|Induction|High Risk|0|||
129033159|NCT01190930|464412083|FG008|Induction|High Risk|0|||
129033160|NCT01190930|464412084|FG009|Induction|High Risk|0|||
129033161|NCT01190930|464412075|FG000|Induction|Low Risk|443|||
129033162|NCT01190930|464412076|FG001|Induction|Low Risk|0|||
129033163|NCT01190930|464412077|FG002|Induction|Low Risk|0|||
129033164|NCT01190930|464412078|FG003|Induction|Low Risk|0|||
129033165|NCT01190930|464412079|FG004|Induction|Low Risk|0|||
129033166|NCT01190930|464412080|FG005|Induction|Low Risk|0|||
129033167|NCT01190930|464412081|FG006|Induction|Low Risk|0|||
129033168|NCT01190930|464412082|FG007|Induction|Low Risk|0|||
129033169|NCT01190930|464412083|FG008|Induction|Low Risk|0|||
129033170|NCT01190930|464412084|FG009|Induction|Low Risk|0|||
129033171|NCT01190930|464412075|FG000|Induction|Very High Risk|1012|||
129033172|NCT01190930|464412076|FG001|Induction|Very High Risk|0|||
129033173|NCT01190930|464412077|FG002|Induction|Very High Risk|0|||
129033174|NCT01190930|464412078|FG003|Induction|Very High Risk|0|||
129033175|NCT01190930|464412079|FG004|Induction|Very High Risk|0|||
129033176|NCT01190930|464412080|FG005|Induction|Very High Risk|0|||
129033177|NCT01190930|464412081|FG006|Induction|Very High Risk|0|||
129033178|NCT01190930|464412082|FG007|Induction|Very High Risk|0|||
129033179|NCT01190930|464412083|FG008|Induction|Very High Risk|0|||
129033180|NCT01190930|464412084|FG009|Induction|Very High Risk|0|||
129033181|NCT01190930|464412075|FG000|Induction|Philadelphia chromosome-positive|99|||
129033182|NCT01190930|464412076|FG001|Induction|Philadelphia chromosome-positive|0|||
129033183|NCT01190930|464412077|FG002|Induction|Philadelphia chromosome-positive|0|||
129033184|NCT01190930|464412078|FG003|Induction|Philadelphia chromosome-positive|0|||
129033185|NCT01190930|464412079|FG004|Induction|Philadelphia chromosome-positive|0|||
129033186|NCT01190930|464412080|FG005|Induction|Philadelphia chromosome-positive|0|||
129033187|NCT01190930|464412081|FG006|Induction|Philadelphia chromosome-positive|0|||
129033188|NCT01190930|464412082|FG007|Induction|Philadelphia chromosome-positive|0|||
129033189|NCT01190930|464412083|FG008|Induction|Philadelphia chromosome-positive|0|||
129033190|NCT01190930|464412084|FG009|Induction|Philadelphia chromosome-positive|0|||
129033191|NCT01190930|464412075|FG000|Induction|Incomplete Induction data|63|||
129033192|NCT01190930|464412076|FG001|Induction|Incomplete Induction data|0|||
129033193|NCT01190930|464412077|FG002|Induction|Incomplete Induction data|0|||
129033194|NCT01190930|464412078|FG003|Induction|Incomplete Induction data|0|||
129033195|NCT01190930|464412079|FG004|Induction|Incomplete Induction data|0|||
129033196|NCT01190930|464412080|FG005|Induction|Incomplete Induction data|0|||
128943364|NCT01219959|464078732|FG000|Overall Study|Other|1|||
128943365|NCT01219959|464078733|FG001|Overall Study|Other|0|||
128943366|NCT02935634|464078734|FG000|Randomization|Participant withdrew consent|0|||
128943367|NCT02935634|464078735|FG001|Randomization|Participant withdrew consent|1|||
128943368|NCT02935634|464078736|FG002|Randomization|Participant withdrew consent|0|||
128943369|NCT02935634|464078737|FG003|Randomization|Participant withdrew consent|0|||
128943370|NCT02935634|464078738|FG004|Randomization|Participant withdrew consent|0|||
128943371|NCT02935634|464078739|FG005|Randomization|Participant withdrew consent|0|||
128943372|NCT02935634|464078734|FG000|Randomization|Death|2|||
128943373|NCT02935634|464078735|FG001|Randomization|Death|1|||
128943374|NCT02935634|464078736|FG002|Randomization|Death|1|||
128943375|NCT02935634|464078737|FG003|Randomization|Death|0|||
128943376|NCT02935634|464078738|FG004|Randomization|Death|0|||
128943377|NCT02935634|464078739|FG005|Randomization|Death|0|||
128943378|NCT02935634|464078734|FG000|Randomization|Other reasons|0|||
128943379|NCT02935634|464078735|FG001|Randomization|Other reasons|2|||
128943380|NCT02935634|464078736|FG002|Randomization|Other reasons|2|||
128943381|NCT02935634|464078737|FG003|Randomization|Other reasons|0|||
128943382|NCT02935634|464078738|FG004|Randomization|Other reasons|0|||
128943383|NCT02935634|464078739|FG005|Randomization|Other reasons|0|||
128943384|NCT02935634|464078734|FG000|Treatment: Track 1|Disease progression|15|||
128943385|NCT02935634|464078735|FG001|Treatment: Track 1|Disease progression|17|||
128943386|NCT02935634|464078736|FG002|Treatment: Track 1|Disease progression|28|||
128943387|NCT02935634|464078737|FG003|Treatment: Track 1|Disease progression|4|||
128943388|NCT02935634|464078738|FG004|Treatment: Track 1|Disease progression|6|||
128943389|NCT02935634|464078739|FG005|Treatment: Track 1|Disease progression|2|||
128943390|NCT02935634|464078734|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
128943391|NCT02935634|464078735|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
128943392|NCT02935634|464078736|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
128943393|NCT02935634|464078737|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
128943394|NCT02935634|464078738|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
128943395|NCT02935634|464078739|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
128943396|NCT02935634|464078734|FG000|Treatment: Track 1|Lost to Follow-up|1|||
128943397|NCT02935634|464078735|FG001|Treatment: Track 1|Lost to Follow-up|0|||
128943398|NCT02935634|464078736|FG002|Treatment: Track 1|Lost to Follow-up|0|||
128943399|NCT02935634|464078737|FG003|Treatment: Track 1|Lost to Follow-up|0|||
129033197|NCT01190930|464412081|FG006|Induction|Incomplete Induction data|0|||
129033198|NCT01190930|464412082|FG007|Induction|Incomplete Induction data|0|||
129033199|NCT01190930|464412083|FG008|Induction|Incomplete Induction data|0|||
129033200|NCT01190930|464412084|FG009|Induction|Incomplete Induction data|0|||
129033201|NCT01190930|464412075|FG000|Induction|Progressive disease|0|||
129033202|NCT01190930|464412076|FG001|Induction|Progressive disease|1|||
129033203|NCT01190930|464412077|FG002|Induction|Progressive disease|0|||
128708079|NCT01749514|463226371|FG005|Overall Study|Withdrawal by Subject|1|||
128708080|NCT01749514|463226372|FG006|Overall Study|Withdrawal by Subject|0|||
128708081|NCT01749514|463226373|FG007|Overall Study|Withdrawal by Subject|1|||
128943400|NCT02935634|464078738|FG004|Treatment: Track 1|Lost to Follow-up|0|||
128943401|NCT02935634|464078739|FG005|Treatment: Track 1|Lost to Follow-up|0|||
128943402|NCT02935634|464078734|FG000|Treatment: Track 1|Study drug toxicity|2|||
128943403|NCT02935634|464078735|FG001|Treatment: Track 1|Study drug toxicity|1|||
129033204|NCT01190930|464412078|FG003|Induction|Progressive disease|0|||
129033205|NCT01190930|464412079|FG004|Induction|Progressive disease|0|||
129217765|NCT02425943|465097056|FG001|Overall Study|Other|0|||
128943404|NCT02935634|464078736|FG002|Treatment: Track 1|Study drug toxicity|3|||
128943405|NCT02935634|464078737|FG003|Treatment: Track 1|Study drug toxicity|0|||
128943406|NCT02935634|464078738|FG004|Treatment: Track 1|Study drug toxicity|0|||
128770240|NCT00318149|463450171|FG003|Overall Study|Adverse Event|0|||
128770241|NCT00318149|463450172|FG004|Overall Study|Adverse Event|0|||
128770242|NCT00318149|463450173|FG005|Overall Study|Adverse Event|2|||
128770243|NCT00785707|463450179|FG000|Overall Study|Lost to Follow-up|7|||
128770244|NCT00105586|463450180|FG000|Overall Study|Adverse Event|4|||
128770245|NCT00105586|463450181|FG001|Overall Study|Adverse Event|3|||
128770246|NCT00105586|463450180|FG000|Overall Study|Physician Decision|13|||
128770247|NCT00105586|463450181|FG001|Overall Study|Physician Decision|13|||
128943407|NCT02935634|464078739|FG005|Treatment: Track 1|Study drug toxicity|1|||
128943408|NCT02935634|464078734|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
128943409|NCT02935634|464078735|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
128943410|NCT02935634|464078736|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
128943411|NCT02935634|464078737|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
128943412|NCT02935634|464078738|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
128943413|NCT02935634|464078739|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
128943414|NCT02935634|464078734|FG000|Treatment: Track 1|Participant withdrew consent|2|||
128943415|NCT02935634|464078735|FG001|Treatment: Track 1|Participant withdrew consent|0|||
128943416|NCT02935634|464078736|FG002|Treatment: Track 1|Participant withdrew consent|1|||
128943417|NCT02935634|464078737|FG003|Treatment: Track 1|Participant withdrew consent|0|||
128943418|NCT02935634|464078738|FG004|Treatment: Track 1|Participant withdrew consent|1|||
128943419|NCT02935634|464078739|FG005|Treatment: Track 1|Participant withdrew consent|0|||
128943420|NCT02935634|464078734|FG000|Treatment: Track 1|Other reasons|0|||
128943421|NCT02935634|464078735|FG001|Treatment: Track 1|Other reasons|0|||
128943422|NCT02935634|464078736|FG002|Treatment: Track 1|Other reasons|2|||
128943423|NCT02935634|464078737|FG003|Treatment: Track 1|Other reasons|0|||
128943424|NCT02935634|464078738|FG004|Treatment: Track 1|Other reasons|0|||
128943425|NCT02935634|464078739|FG005|Treatment: Track 1|Other reasons|0|||
128943426|NCT02935634|464078734|FG000|Treatment: Track 2|Disease progression|13|||
128943427|NCT02935634|464078735|FG001|Treatment: Track 2|Disease progression|26|||
128943428|NCT02935634|464078736|FG002|Treatment: Track 2|Disease progression|20|||
128943429|NCT02935634|464078737|FG003|Treatment: Track 2|Disease progression|5|||
128943430|NCT02935634|464078738|FG004|Treatment: Track 2|Disease progression|1|||
128943431|NCT02935634|464078739|FG005|Treatment: Track 2|Disease progression|4|||
128943432|NCT02935634|464078734|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
128943433|NCT02935634|464078735|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
128943434|NCT02935634|464078736|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
128943435|NCT02935634|464078737|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
128943436|NCT02935634|464078738|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
128943437|NCT02935634|464078739|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
128943438|NCT02935634|464078734|FG000|Treatment: Track 2|Study drug toxicity|7|||
128943439|NCT02935634|464078735|FG001|Treatment: Track 2|Study drug toxicity|3|||
128943440|NCT02935634|464078736|FG002|Treatment: Track 2|Study drug toxicity|0|||
128943441|NCT02935634|464078737|FG003|Treatment: Track 2|Study drug toxicity|0|||
128943442|NCT02935634|464078738|FG004|Treatment: Track 2|Study drug toxicity|0|||
128943443|NCT02935634|464078739|FG005|Treatment: Track 2|Study drug toxicity|0|||
128943444|NCT02935634|464078734|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
128943445|NCT02935634|464078735|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
128943446|NCT02935634|464078736|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
128943447|NCT02935634|464078737|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
128943448|NCT02935634|464078738|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
128943449|NCT02935634|464078739|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
128943450|NCT02935634|464078734|FG000|Treatment: Track 2|Participant withdrew consent|0|||
128943451|NCT02935634|464078735|FG001|Treatment: Track 2|Participant withdrew consent|1|||
128943452|NCT02935634|464078736|FG002|Treatment: Track 2|Participant withdrew consent|1|||
128943453|NCT02935634|464078737|FG003|Treatment: Track 2|Participant withdrew consent|0|||
128943454|NCT02935634|464078738|FG004|Treatment: Track 2|Participant withdrew consent|1|||
128943455|NCT02935634|464078739|FG005|Treatment: Track 2|Participant withdrew consent|0|||
128943456|NCT03430245|464078740|FG000|Overall Study|Withdrawal by Subject|6|||
129123398|NCT01126424|464746958|FG004|Overall Study|Adverse Event|1|||
129123399|NCT01126424|464746959|FG005|Overall Study|Adverse Event|0|||
128943457|NCT03430245|464078740|FG000|Overall Study|Lost to Follow-up|1|||
128943458|NCT05628181|464078741|FG000|Overall Study|Death|2|||
128943459|NCT05628181|464078742|FG001|Overall Study|Death|4|||
128943460|NCT05628181|464078743|FG002|Overall Study|Death|0|||
128943461|NCT03656926|464078750|FG000|Overall Study|Adverse Event|5|||
128943462|NCT03656926|464078751|FG001|Overall Study|Adverse Event|4|||
128943463|NCT03656926|464078750|FG000|Overall Study|Withdrawal by Subject|7|||
128943464|NCT03656926|464078751|FG001|Overall Study|Withdrawal by Subject|2|||
128943465|NCT03656926|464078750|FG000|Overall Study|Screen fail after randomization|1|||
128770248|NCT02306122|463450182|FG000|Initial Physician Randomization|Physician Decision|0|||
128770249|NCT02306122|463450183|FG001|Initial Physician Randomization|Physician Decision|0|||
128770250|NCT02306122|463450184|FG002|Initial Physician Randomization|Physician Decision|0|||
129033206|NCT01190930|464412080|FG005|Induction|Progressive disease|0|||
129033207|NCT01190930|464412081|FG006|Induction|Progressive disease|0|||
129033208|NCT01190930|464412082|FG007|Induction|Progressive disease|0|||
129033209|NCT01190930|464412083|FG008|Induction|Progressive disease|0|||
129033210|NCT01190930|464412084|FG009|Induction|Progressive disease|0|||
129033211|NCT01190930|464412075|FG000|Induction|No treatment|3|||
129033212|NCT01190930|464412076|FG001|Induction|No treatment|0|||
129033213|NCT01190930|464412077|FG002|Induction|No treatment|0|||
129033214|NCT01190930|464412078|FG003|Induction|No treatment|0|||
129033215|NCT01190930|464412079|FG004|Induction|No treatment|0|||
129033216|NCT01190930|464412080|FG005|Induction|No treatment|0|||
129033217|NCT01190930|464412081|FG006|Induction|No treatment|0|||
129033218|NCT01190930|464412082|FG007|Induction|No treatment|0|||
129033219|NCT01190930|464412083|FG008|Induction|No treatment|0|||
129033220|NCT01190930|464412084|FG009|Induction|No treatment|0|||
129033221|NCT01190930|464412075|FG000|Induction|Ineligible|69|||
129033222|NCT01190930|464412076|FG001|Induction|Ineligible|4|||
129033223|NCT01190930|464412077|FG002|Induction|Ineligible|0|||
129033224|NCT01190930|464412078|FG003|Induction|Ineligible|0|||
129033225|NCT01190930|464412079|FG004|Induction|Ineligible|0|||
129033226|NCT01190930|464412080|FG005|Induction|Ineligible|0|||
129033227|NCT01190930|464412081|FG006|Induction|Ineligible|0|||
129033228|NCT01190930|464412082|FG007|Induction|Ineligible|0|||
129033229|NCT01190930|464412083|FG008|Induction|Ineligible|0|||
129033230|NCT01190930|464412084|FG009|Induction|Ineligible|0|||
129033231|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
129033232|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
129033233|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
129033234|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
129033235|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
129033236|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
129033237|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
129033238|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
129033239|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
129033240|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
129033241|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Death|0|||
129033242|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Death|0|||
129033243|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Death|8|||
129033244|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Death|4|||
129033245|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Death|0|||
129033246|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Death|0|||
129033247|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Death|0|||
129033248|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Death|0|||
129033249|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Death|0|||
129033250|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Death|0|||
129033251|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
129033252|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
129033253|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
129033254|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
129033255|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
129033256|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
129033257|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
129033258|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
129033259|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
129033260|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
129033261|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129033262|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
129033263|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
129033264|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
129033265|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
128708082|NCT01749514|463226366|FG000|Overall Study|Not Reported|0|||
128708083|NCT01749514|463226367|FG001|Overall Study|Not Reported|0|||
128708084|NCT01749514|463226368|FG002|Overall Study|Not Reported|0|||
129033266|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129033267|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
128708085|NCT01749514|463226369|FG003|Overall Study|Not Reported|0|||
129033268|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129033269|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129033270|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129033271|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Refusal|0|||
129033272|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Refusal|2|||
129033273|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Refusal|694|||
129033274|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Refusal|4|||
129033275|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Refusal|0|||
129033276|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Refusal|3|||
129033277|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Refusal|0|||
128943466|NCT03656926|464078751|FG001|Overall Study|Screen fail after randomization|0|||
128943467|NCT03656926|464078750|FG000|Overall Study|PI decision due to patient condition|1|||
128943468|NCT03656926|464078751|FG001|Overall Study|PI decision due to patient condition|0|||
128943469|NCT03656926|464078750|FG000|Overall Study|Patient unresponsiveness|1|||
128943470|NCT03656926|464078751|FG001|Overall Study|Patient unresponsiveness|0|||
128943471|NCT05610176|464078752|FG000|Overall Study|Death|6|||
128943472|NCT00316303|464078753|FG000|Overall Study|Lost to Follow-up|11|||
128943473|NCT00316303|464078754|FG001|Overall Study|Lost to Follow-up|16|||
128943474|NCT01087528|464078755|FG000|Overall Study|Withdrawal by Subject|1|||
128943475|NCT01087528|464078755|FG000|Overall Study|Incomplete CE procedure|6|||
128943476|NCT00905307|464078762|FG000|Overall Study|Switched to Open Label Rescue|7|||
128943477|NCT00905307|464078763|FG001|Overall Study|Switched to Open Label Rescue|17|||
128943478|NCT00905307|464078764|FG002|Overall Study|Switched to Open Label Rescue|11|||
128943479|NCT00905307|464078765|FG003|Overall Study|Switched to Open Label Rescue|11|||
128943480|NCT00905307|464078766|FG004|Overall Study|Switched to Open Label Rescue|4|||
128943481|NCT00905307|464078767|FG005|Overall Study|Switched to Open Label Rescue|15|||
128943482|NCT00905307|464078762|FG000|Overall Study|Lost to Follow-up|0|||
128943483|NCT00905307|464078763|FG001|Overall Study|Lost to Follow-up|0|||
128943484|NCT00905307|464078764|FG002|Overall Study|Lost to Follow-up|0|||
128943485|NCT00905307|464078765|FG003|Overall Study|Lost to Follow-up|0|||
128943486|NCT00905307|464078766|FG004|Overall Study|Lost to Follow-up|1|||
128943487|NCT00905307|464078767|FG005|Overall Study|Lost to Follow-up|1|||
128943488|NCT00905307|464078762|FG000|Overall Study|Adverse Event|3|||
128943489|NCT00905307|464078763|FG001|Overall Study|Adverse Event|4|||
128943490|NCT00905307|464078764|FG002|Overall Study|Adverse Event|5|||
128943491|NCT00905307|464078765|FG003|Overall Study|Adverse Event|11|||
128943492|NCT00905307|464078766|FG004|Overall Study|Adverse Event|3|||
128943493|NCT00905307|464078767|FG005|Overall Study|Adverse Event|5|||
128943494|NCT00905307|464078762|FG000|Overall Study|Withdrawal by Subject|5|||
128943495|NCT00905307|464078763|FG001|Overall Study|Withdrawal by Subject|13|||
128943496|NCT00905307|464078764|FG002|Overall Study|Withdrawal by Subject|15|||
128943497|NCT00905307|464078765|FG003|Overall Study|Withdrawal by Subject|11|||
128943498|NCT00905307|464078766|FG004|Overall Study|Withdrawal by Subject|4|||
128943499|NCT00905307|464078767|FG005|Overall Study|Withdrawal by Subject|13|||
128943500|NCT00905307|464078762|FG000|Overall Study|Protocol Violation|1|||
128943501|NCT00905307|464078763|FG001|Overall Study|Protocol Violation|0|||
128943502|NCT00905307|464078764|FG002|Overall Study|Protocol Violation|1|||
128943503|NCT00905307|464078765|FG003|Overall Study|Protocol Violation|0|||
128943504|NCT00905307|464078766|FG004|Overall Study|Protocol Violation|0|||
128943505|NCT00905307|464078767|FG005|Overall Study|Protocol Violation|0|||
128943506|NCT00905307|464078762|FG000|Overall Study|Lack of Efficacy|6|||
128943507|NCT00905307|464078763|FG001|Overall Study|Lack of Efficacy|3|||
128943508|NCT00905307|464078764|FG002|Overall Study|Lack of Efficacy|5|||
128943509|NCT00905307|464078765|FG003|Overall Study|Lack of Efficacy|4|||
128943510|NCT00905307|464078766|FG004|Overall Study|Lack of Efficacy|4|||
128943511|NCT00905307|464078767|FG005|Overall Study|Lack of Efficacy|8|||
128943512|NCT04060667|464078768|FG000|Overall Study|Lost to Follow-up|75|||
128943513|NCT04060667|464078769|FG001|Overall Study|Lost to Follow-up|10|||
128943514|NCT01864018|464078772|FG000|Overall Study|Ineligible|3|||
128943515|NCT01864018|464078773|FG001|Overall Study|Ineligible|1|||
128943516|NCT03609359|464078778|FG000|Overall Study|Progression of primary disease (PD)|25|||
128943517|NCT03609359|464078778|FG000|Overall Study|Patient's refusal|1|||
128943518|NCT03609359|464078778|FG000|Overall Study|Physician Decision|1|||
128943519|NCT03609359|464078778|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
128943520|NCT01912729|464078780|FG000|Overall Study|Withdrawal by Subject|0|||
128943521|NCT01912729|464078781|FG001|Overall Study|Withdrawal by Subject|1|||
128943522|NCT01952834|464078782|FG000|Overall Study|Adverse Event|1|||
128943523|NCT04285346|464078783|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
128943524|NCT04285346|464078784|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
128943525|NCT04285346|464078783|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
128943526|NCT04285346|464078784|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
128943527|NCT04285346|464078783|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
128943528|NCT04285346|464078784|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
128943529|NCT00610935|464078785|FG000|Overall Study|Lost to Follow-up|0|||
128943530|NCT00610935|464078786|FG001|Overall Study|Lost to Follow-up|1|||
128943531|NCT00610935|464078785|FG000|Overall Study|Withdrawal by Subject|0|||
128943532|NCT00610935|464078786|FG001|Overall Study|Withdrawal by Subject|2|||
128943533|NCT00610935|464078785|FG000|Overall Study|Sponsor Discontinuation|1|||
128943534|NCT00610935|464078786|FG001|Overall Study|Sponsor Discontinuation|0|||
128943535|NCT00740779|464078787|FG000|Overall Study|Adverse Event|4|||
128943536|NCT00740779|464078788|FG001|Overall Study|Adverse Event|6|||
128943537|NCT00740779|464078789|FG002|Overall Study|Adverse Event|3|||
128943538|NCT00740779|464078787|FG000|Overall Study|Protocol Violation|1|||
128943539|NCT00740779|464078788|FG001|Overall Study|Protocol Violation|1|||
128943540|NCT00740779|464078789|FG002|Overall Study|Protocol Violation|1|||
128943541|NCT00740779|464078787|FG000|Overall Study|Lack of Efficacy|0|||
128708086|NCT01749514|463226370|FG004|Overall Study|Not Reported|0|||
128708087|NCT01749514|463226371|FG005|Overall Study|Not Reported|0|||
128708088|NCT01749514|463226372|FG006|Overall Study|Not Reported|0|||
128708089|NCT01749514|463226373|FG007|Overall Study|Not Reported|5|||
128708090|NCT01979016|463226375|FG000|Overall Study|Withdrawal by Subject|2|||
128943542|NCT00740779|464078788|FG001|Overall Study|Lack of Efficacy|0|||
128943543|NCT00740779|464078789|FG002|Overall Study|Lack of Efficacy|2|||
128943544|NCT00740779|464078787|FG000|Overall Study|Withdrawal by Subject|2|||
128943545|NCT00740779|464078788|FG001|Overall Study|Withdrawal by Subject|4|||
128943546|NCT00740779|464078789|FG002|Overall Study|Withdrawal by Subject|2|||
128943547|NCT00740779|464078787|FG000|Overall Study|Lost to Follow-up|2|||
128943548|NCT00740779|464078788|FG001|Overall Study|Lost to Follow-up|3|||
128943549|NCT00740779|464078789|FG002|Overall Study|Lost to Follow-up|5|||
128943550|NCT00850460|464078790|FG000|Overall Study|Lost to Follow-up|4|||
128943551|NCT00850460|464078791|FG001|Overall Study|Lost to Follow-up|4|||
128943552|NCT02399813|464078794|FG000|Overall Study|Progressive Disease-Radiographic|2|||
128943553|NCT02399813|464078794|FG000|Overall Study|Death|20|||
128943554|NCT02399813|464078794|FG000|Overall Study|Withdrawal by Subject|3|||
128943555|NCT02399813|464078794|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
128943556|NCT02399813|464078794|FG000|Overall Study|Lost to Follow-up|2|||
128943557|NCT02399813|464078794|FG000|Overall Study|Other than specified|5|||
128943558|NCT00988559|464078795|FG000|Overall Study|Withdrawal by Subject|1|||
128943559|NCT00988559|464078796|FG001|Overall Study|Withdrawal by Subject|1|||
128943560|NCT00988559|464078797|FG002|Overall Study|Withdrawal by Subject|0|||
128943561|NCT00988559|464078798|FG003|Overall Study|Withdrawal by Subject|1|||
128943562|NCT00988559|464078795|FG000|Overall Study|Pregnancy|0|||
128943563|NCT00988559|464078796|FG001|Overall Study|Pregnancy|1|||
128943564|NCT00988559|464078797|FG002|Overall Study|Pregnancy|1|||
128943565|NCT00988559|464078798|FG003|Overall Study|Pregnancy|0|||
128943566|NCT00988559|464078795|FG000|Overall Study|Lost to Follow-up|0|||
128943567|NCT00988559|464078796|FG001|Overall Study|Lost to Follow-up|0|||
128943568|NCT00988559|464078797|FG002|Overall Study|Lost to Follow-up|1|||
128943569|NCT00988559|464078798|FG003|Overall Study|Lost to Follow-up|0|||
128943570|NCT03007953|464078799|FG000|Overall Study|Withdrawal by Subject|5|||
128943571|NCT03007953|464078800|FG001|Overall Study|Withdrawal by Subject|2|||
128943572|NCT03007953|464078799|FG000|Overall Study|Death|5|||
128943573|NCT03007953|464078800|FG001|Overall Study|Death|7|||
128943574|NCT03007953|464078799|FG000|Overall Study|Lost to Follow-up|3|||
128943575|NCT03007953|464078800|FG001|Overall Study|Lost to Follow-up|2|||
128943576|NCT03007953|464078799|FG000|Overall Study|Enrolled in Hospice|3|||
128943577|NCT03007953|464078800|FG001|Overall Study|Enrolled in Hospice|2|||
128943578|NCT02224846|464078801|FG000|Period 1 (Month 3)|Adverse Event|2|||
128943579|NCT02224846|464078802|FG001|Period 1 (Month 3)|Adverse Event|1|||
128943580|NCT02224846|464078801|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
128943581|NCT02224846|464078802|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
128943582|NCT02224846|464078801|FG000|Period 1 (Month 3)|Protocol Violation|4|||
128943583|NCT02224846|464078802|FG001|Period 1 (Month 3)|Protocol Violation|8|||
128943584|NCT02224846|464078801|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
128943585|NCT02224846|464078802|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
128943586|NCT02224846|464078801|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
128943587|NCT02224846|464078802|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
128943588|NCT02224846|464078801|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
128943589|NCT02224846|464078802|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
128943590|NCT02224846|464078801|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
128943591|NCT02224846|464078802|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
128943592|NCT02224846|464078801|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
128943593|NCT02224846|464078802|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
128943594|NCT02224846|464078801|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
128943595|NCT02224846|464078802|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
128708091|NCT01979016|463226376|FG001|Overall Study|Withdrawal by Subject|0|||
128708092|NCT01979016|463226375|FG000|Overall Study|Adverse Event|0|||
128943596|NCT02224846|464078801|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
128943597|NCT02224846|464078802|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
128943598|NCT02224846|464078801|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
128943599|NCT02224846|464078802|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
128943600|NCT02224846|464078801|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
128943601|NCT02224846|464078802|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
128708093|NCT01979016|463226376|FG001|Overall Study|Adverse Event|1|||
128708094|NCT00938639|463226377|FG000|Overall Study|Moved away from study area|0|||
128943602|NCT02224846|464078801|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
128943603|NCT02224846|464078802|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
128943604|NCT02224846|464078801|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
128943605|NCT02224846|464078802|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
128943606|NCT02224846|464078801|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
128708095|NCT00938639|463226378|FG001|Overall Study|Moved away from study area|1|||
128943607|NCT02224846|464078802|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
128943608|NCT02224846|464078801|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
128943609|NCT02224846|464078802|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
128943610|NCT02224846|464078801|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
128943611|NCT02224846|464078802|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
128943612|NCT03280550|464078803|FG000|Overall Study|Withdrawal by Subject|2|||
128943613|NCT03280550|464078804|FG001|Overall Study|Withdrawal by Subject|2|||
128943614|NCT03280550|464078803|FG000|Overall Study|Physician Decision|0|||
128943615|NCT03280550|464078804|FG001|Overall Study|Physician Decision|1|||
128943616|NCT02203838|464078807|FG000|Overall Study|Lack of Efficacy|7|||
128943617|NCT02203838|464078808|FG001|Overall Study|Lack of Efficacy|0|||
128943618|NCT02203838|464078809|FG002|Overall Study|Lack of Efficacy|1|||
128943619|NCT02203838|464078810|FG003|Overall Study|Lack of Efficacy|1|||
128943620|NCT02203838|464078807|FG000|Overall Study|Adverse Event|46|||
128943621|NCT02203838|464078808|FG001|Overall Study|Adverse Event|6|||
128943622|NCT02203838|464078809|FG002|Overall Study|Adverse Event|3|||
128943623|NCT02203838|464078810|FG003|Overall Study|Adverse Event|2|||
128943624|NCT02203838|464078807|FG000|Overall Study|Lost to Follow-up|39|||
128943625|NCT02203838|464078808|FG001|Overall Study|Lost to Follow-up|3|||
128943626|NCT02203838|464078809|FG002|Overall Study|Lost to Follow-up|2|||
128943627|NCT02203838|464078810|FG003|Overall Study|Lost to Follow-up|1|||
128943628|NCT02203838|464078807|FG000|Overall Study|Protocol Violation|7|||
128943629|NCT02203838|464078808|FG001|Overall Study|Protocol Violation|3|||
128943630|NCT02203838|464078809|FG002|Overall Study|Protocol Violation|0|||
128943631|NCT02203838|464078810|FG003|Overall Study|Protocol Violation|0|||
128943632|NCT02203838|464078807|FG000|Overall Study|Withdrawal by Subject|83|||
128943633|NCT02203838|464078808|FG001|Overall Study|Withdrawal by Subject|10|||
128943634|NCT02203838|464078809|FG002|Overall Study|Withdrawal by Subject|8|||
128943635|NCT02203838|464078810|FG003|Overall Study|Withdrawal by Subject|11|||
128943636|NCT02203838|464078807|FG000|Overall Study|Physician Decision|27|||
128943637|NCT02203838|464078808|FG001|Overall Study|Physician Decision|0|||
128943638|NCT02203838|464078809|FG002|Overall Study|Physician Decision|2|||
128943639|NCT02203838|464078810|FG003|Overall Study|Physician Decision|3|||
128943640|NCT02203838|464078807|FG000|Overall Study|Other|1|||
128943641|NCT02203838|464078808|FG001|Overall Study|Other|0|||
128943642|NCT02203838|464078809|FG002|Overall Study|Other|0|||
128943643|NCT02203838|464078810|FG003|Overall Study|Other|0|||
128943644|NCT01915849|464078815|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
128943645|NCT01915849|464078816|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
128943646|NCT01915849|464078817|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
128943647|NCT01915849|464078818|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
128943648|NCT01915849|464078815|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
128943649|NCT01915849|464078816|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
128943650|NCT01915849|464078817|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
128943651|NCT01915849|464078818|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
128943652|NCT02689219|464078821|FG000|Overall Study|Death|1|||
128943653|NCT02689219|464078822|FG001|Overall Study|Death|1|||
128943654|NCT02689219|464078821|FG000|Overall Study|Disease Progression|10|||
128943655|NCT02689219|464078822|FG001|Overall Study|Disease Progression|6|||
128943656|NCT01067508|464078823|FG000|Overall Study|Physician Decision|0|||
128943657|NCT01067508|464078824|FG001|Overall Study|Physician Decision|1|||
128943658|NCT01067508|464078823|FG000|Overall Study|Withdrawal by Subject|0|||
128943659|NCT01067508|464078824|FG001|Overall Study|Withdrawal by Subject|1|||
128943660|NCT00444626|464078825|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
128943661|NCT00444626|464078825|FG000|Initial Treatment Period|Adverse Event|1|||
128943662|NCT00444626|464078825|FG000|Initial Treatment Period|Lost to Follow-up|9|||
128943663|NCT00786838|464078826|FG000|Overall Study|Physician Decision|4|||
128943664|NCT00786838|464078826|FG000|Overall Study|Death|4|||
128943665|NCT00786838|464078826|FG000|Overall Study|Adverse Event|6|||
128943666|NCT00786838|464078826|FG000|Overall Study|Progressive disease|31|||
128943667|NCT00786838|464078826|FG000|Overall Study|Withdrawal by Subject|4|||
128943668|NCT00309777|464078827|FG000|Overall Study|Adverse Event|13|||
128943669|NCT00309777|464078828|FG001|Overall Study|Adverse Event|2|||
129033278|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Refusal|0|||
128943670|NCT00309777|464078829|FG002|Overall Study|Adverse Event|8|||
128943671|NCT00309777|464078830|FG003|Overall Study|Adverse Event|1|||
128943672|NCT00309777|464078827|FG000|Overall Study|Protocol Violation|4|||
128943673|NCT00309777|464078828|FG001|Overall Study|Protocol Violation|1|||
128943674|NCT00309777|464078829|FG002|Overall Study|Protocol Violation|3|||
129033279|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Refusal|0|||
128943675|NCT00309777|464078830|FG003|Overall Study|Protocol Violation|1|||
128943676|NCT00309777|464078827|FG000|Overall Study|Withdrawal by Subject|6|||
128943677|NCT00309777|464078828|FG001|Overall Study|Withdrawal by Subject|5|||
128943678|NCT00309777|464078829|FG002|Overall Study|Withdrawal by Subject|7|||
129033280|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Refusal|0|||
128943679|NCT00309777|464078830|FG003|Overall Study|Withdrawal by Subject|2|||
128943680|NCT00309777|464078827|FG000|Overall Study|Lost to Follow-up|0|||
128943681|NCT00309777|464078828|FG001|Overall Study|Lost to Follow-up|0|||
128943682|NCT00309777|464078829|FG002|Overall Study|Lost to Follow-up|1|||
128943683|NCT00309777|464078830|FG003|Overall Study|Lost to Follow-up|0|||
128943684|NCT00309777|464078827|FG000|Overall Study|Death|0|||
128943685|NCT00309777|464078828|FG001|Overall Study|Death|1|||
128943686|NCT00309777|464078829|FG002|Overall Study|Death|0|||
128943687|NCT00309777|464078830|FG003|Overall Study|Death|0|||
128943688|NCT03050359|464080376|FG000|Overall Study|Randomized But Not Treated|2|||
128943689|NCT03050359|464080377|FG001|Overall Study|Randomized But Not Treated|0|||
128943690|NCT03050359|464080376|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
128943691|NCT03050359|464080377|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
128943692|NCT03050359|464080376|FG000|Overall Study|Significant Protocol Deviation|2|||
128943693|NCT03050359|464080377|FG001|Overall Study|Significant Protocol Deviation|3|||
128943694|NCT03050359|464080376|FG000|Overall Study|Lost to Follow-up|2|||
128943695|NCT03050359|464080377|FG001|Overall Study|Lost to Follow-up|1|||
128943696|NCT03050359|464080376|FG000|Overall Study|Voluntary Withdrawal|4|||
128943697|NCT03050359|464080377|FG001|Overall Study|Voluntary Withdrawal|6|||
128943698|NCT03050359|464080376|FG000|Overall Study|Pregnancy|1|||
128943699|NCT03050359|464080377|FG001|Overall Study|Pregnancy|0|||
128943700|NCT03050359|464080376|FG000|Overall Study|Reason Not Specified|1|||
128943701|NCT03050359|464080377|FG001|Overall Study|Reason Not Specified|0|||
128943702|NCT02614287|464080380|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
128943703|NCT02614287|464080381|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
128943704|NCT02614287|464080380|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
128943705|NCT02614287|464080381|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
128943706|NCT02614287|464080380|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
128943707|NCT02614287|464080381|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
128943708|NCT02614287|464080380|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
128943709|NCT02614287|464080381|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
128943710|NCT02614287|464080380|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
128943711|NCT02614287|464080381|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
128943712|NCT02614287|464080380|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
128943713|NCT02614287|464080381|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
128943714|NCT02614287|464080380|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
128943715|NCT02614287|464080381|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
128943716|NCT02614287|464080380|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
128943717|NCT02614287|464080381|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
128943718|NCT03580382|464080385|FG000|Overall Study|Early Termination of Study|0|||
128943719|NCT03580382|464080386|FG001|Overall Study|Early Termination of Study|3|||
128943720|NCT05619172|464080387|FG000|Safety Cohort 1|Death|7|||
128943721|NCT05619172|464080388|FG001|Safety Cohort 1|Death|0|||
128943722|NCT05619172|464080387|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
128943723|NCT05619172|464080388|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
128943724|NCT05619172|464080387|FG000|Safety Cohort 2|Death|0|||
128943725|NCT05619172|464080388|FG001|Safety Cohort 2|Death|1|||
128943726|NCT05619172|464080387|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
128943727|NCT05619172|464080388|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
128943728|NCT03010423|464080389|FG000|Overall Study|Study termination|8|||
128943729|NCT01718509|464080390|FG000|Overall Study|Lost to Follow-up|18|||
128943730|NCT01718509|464080391|FG001|Overall Study|Lost to Follow-up|15|||
128943731|NCT01718509|464080390|FG000|Overall Study|Withdrawal by Subject|7|||
128943732|NCT01718509|464080391|FG001|Overall Study|Withdrawal by Subject|13|||
128943733|NCT01718509|464080390|FG000|Overall Study|Adverse Event|5|||
129123400|NCT01126424|464746954|FG000|Overall Study|Withdrawal by Subject|0|||
129123401|NCT01126424|464746955|FG001|Overall Study|Withdrawal by Subject|0|||
129123402|NCT01126424|464746956|FG002|Overall Study|Withdrawal by Subject|1|||
129123403|NCT01126424|464746957|FG003|Overall Study|Withdrawal by Subject|3|||
129123404|NCT01126424|464746958|FG004|Overall Study|Withdrawal by Subject|1|||
129123405|NCT01126424|464746959|FG005|Overall Study|Withdrawal by Subject|0|||
129123406|NCT03801252|464746961|FG000|Overall Study|Protocol Violation|1|||
129123407|NCT03801252|464746962|FG001|Overall Study|Protocol Violation|2|||
129123408|NCT01134042|464746963|FG000|Overall Study|Adverse Event|3|||
129123409|NCT01134042|464746964|FG001|Overall Study|Adverse Event|7|||
128943734|NCT01718509|464080391|FG001|Overall Study|Adverse Event|7|||
128943735|NCT01718509|464080390|FG000|Overall Study|Other|13|||
128943736|NCT01718509|464080391|FG001|Overall Study|Other|11|||
128943737|NCT01718509|464080390|FG000|Overall Study|Protocol Violation|4|||
128943738|NCT01718509|464080391|FG001|Overall Study|Protocol Violation|2|||
128943739|NCT01718509|464080390|FG000|Overall Study|Lack of Efficacy|1|||
128943740|NCT01718509|464080391|FG001|Overall Study|Lack of Efficacy|0|||
128943741|NCT00411788|464080397|FG000|Overall Study|Protocol Violation|1|||
128943742|NCT00411788|464080397|FG000|Overall Study|Adverse Event|1|||
128943743|NCT01728584|464080398|FG000|Overall Study|Adverse Event|1|||
128943744|NCT01728584|464080399|FG001|Overall Study|Adverse Event|0|||
128943745|NCT01728584|464080400|FG002|Overall Study|Adverse Event|0|||
128943746|NCT01728584|464080401|FG003|Overall Study|Adverse Event|0|||
128943747|NCT01728584|464080398|FG000|Overall Study|Physician Decision|4|||
128943748|NCT01728584|464080399|FG001|Overall Study|Physician Decision|0|||
128943749|NCT01728584|464080400|FG002|Overall Study|Physician Decision|1|||
128943750|NCT01728584|464080401|FG003|Overall Study|Physician Decision|0|||
128943751|NCT01728584|464080398|FG000|Overall Study|Withdrawal by Subject|1|||
128943752|NCT01728584|464080399|FG001|Overall Study|Withdrawal by Subject|0|||
128943753|NCT01728584|464080400|FG002|Overall Study|Withdrawal by Subject|0|||
128943754|NCT01728584|464080401|FG003|Overall Study|Withdrawal by Subject|0|||
128943755|NCT01728584|464080398|FG000|Overall Study|Screen failure|1|||
128943756|NCT01728584|464080399|FG001|Overall Study|Screen failure|0|||
128943757|NCT01728584|464080400|FG002|Overall Study|Screen failure|0|||
128943758|NCT01728584|464080401|FG003|Overall Study|Screen failure|0|||
128943759|NCT01728584|464080398|FG000|Overall Study|Other reason (not specified)|1|||
128943760|NCT01728584|464080399|FG001|Overall Study|Other reason (not specified)|0|||
128943761|NCT01728584|464080400|FG002|Overall Study|Other reason (not specified)|0|||
128943762|NCT01728584|464080401|FG003|Overall Study|Other reason (not specified)|1|||
128943763|NCT05906732|464080402|FG000|Overall Study|Withdrawal by Subject|1|||
128943764|NCT05906732|464080403|FG001|Overall Study|Withdrawal by Subject|0|||
128943765|NCT05906732|464080404|FG002|Overall Study|Withdrawal by Subject|0|||
128943766|NCT05906732|464080405|FG003|Overall Study|Withdrawal by Subject|0|||
128943767|NCT05906732|464080402|FG000|Overall Study|Physician Decision|2|||
128943768|NCT05906732|464080403|FG001|Overall Study|Physician Decision|4|||
128943769|NCT05906732|464080404|FG002|Overall Study|Physician Decision|0|||
128943770|NCT05906732|464080405|FG003|Overall Study|Physician Decision|0|||
128943771|NCT01727713|464080411|FG000|Overall Study|Lost to Follow-up|5|||
128943772|NCT01727713|464080411|FG000|Overall Study|Adverse Event|10|||
128943773|NCT01727713|464080411|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
128943774|NCT01727713|464080411|FG000|Overall Study|Withdrawal by Subject|13|||
128943775|NCT01727713|464080411|FG000|Overall Study|Protocol Deviation|2|||
128943776|NCT00471536|464080416|FG000|Overall Study|Withdrawal by Subject|1|||
128943777|NCT02651194|464080417|FG000|Overall Study|Lost to Follow-up|3|||
128943778|NCT02651194|464080417|FG000|Overall Study|Other|2|||
128943779|NCT03885726|464080420|FG000|Overall Study|Staffing issues/lost interest|1|||
128943780|NCT03885726|464080420|FG000|Overall Study|Early discharge from hospital|3|||
128943781|NCT01217190|464080421|FG000|Second Dosing|Withdrawal by Subject|0|||
128943782|NCT01217190|464080422|FG001|Second Dosing|Withdrawal by Subject|2|||
128943783|NCT03116399|464080423|FG000|Overall Study|Death|8|||
128943784|NCT03116399|464080424|FG001|Overall Study|Death|3|||
128943785|NCT03116399|464080423|FG000|Overall Study|Lost to Follow-up|7|||
128943786|NCT03116399|464080424|FG001|Overall Study|Lost to Follow-up|11|||
128943787|NCT03116399|464080423|FG000|Overall Study|Investigator Decision|1|||
128943788|NCT03116399|464080424|FG001|Overall Study|Investigator Decision|1|||
128943789|NCT03116399|464080423|FG000|Overall Study|Withdrawal by Subject|24|||
128943790|NCT03116399|464080424|FG001|Overall Study|Withdrawal by Subject|9|||
128943791|NCT00195260|464080426|FG000|Part 1: Dose Escalation|Adverse Event|0|||
128943792|NCT00195260|464080427|FG001|Part 1: Dose Escalation|Adverse Event|1|||
128943793|NCT00195260|464080428|FG002|Part 1: Dose Escalation|Adverse Event|0|||
128943794|NCT00195260|464080429|FG003|Part 1: Dose Escalation|Adverse Event|1|||
128943795|NCT00195260|464080430|FG004|Part 1: Dose Escalation|Adverse Event|1|||
128943796|NCT00195260|464080431|FG005|Part 1: Dose Escalation|Adverse Event|0|||
128943797|NCT00195260|464080432|FG006|Part 1: Dose Escalation|Adverse Event|3|||
128943798|NCT00195260|464080433|FG007|Part 1: Dose Escalation|Adverse Event|0|||
128943799|NCT00195260|464080434|FG008|Part 1: Dose Escalation|Adverse Event|0|||
128943800|NCT00195260|464080435|FG009|Part 1: Dose Escalation|Adverse Event|0|||
128943801|NCT00195260|464080436|FG010|Part 1: Dose Escalation|Adverse Event|0|||
128943802|NCT00195260|464080426|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943803|NCT00195260|464080427|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943804|NCT00195260|464080428|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943805|NCT00195260|464080429|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943806|NCT00195260|464080430|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
128943807|NCT00195260|464080431|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943808|NCT00195260|464080432|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943809|NCT00195260|464080433|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
128943810|NCT00195260|464080434|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129033281|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
129033282|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
129033283|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
129033284|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
129033285|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
128943811|NCT00195260|464080435|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943812|NCT00195260|464080436|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128943813|NCT00195260|464080426|FG000|Part 1: Dose Escalation|Death|0|||
129033286|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
128943814|NCT00195260|464080427|FG001|Part 1: Dose Escalation|Death|0|||
128943815|NCT00195260|464080428|FG002|Part 1: Dose Escalation|Death|0|||
128943816|NCT00195260|464080429|FG003|Part 1: Dose Escalation|Death|0|||
128943817|NCT00195260|464080430|FG004|Part 1: Dose Escalation|Death|0|||
128943818|NCT00195260|464080431|FG005|Part 1: Dose Escalation|Death|0|||
128708096|NCT00938639|463226377|FG000|Overall Study|Lost to Follow-up|1|||
128943819|NCT00195260|464080432|FG006|Part 1: Dose Escalation|Death|0|||
128943820|NCT00195260|464080433|FG007|Part 1: Dose Escalation|Death|1|||
128943821|NCT00195260|464080434|FG008|Part 1: Dose Escalation|Death|0|||
128943822|NCT00195260|464080435|FG009|Part 1: Dose Escalation|Death|0|||
128943823|NCT00195260|464080436|FG010|Part 1: Dose Escalation|Death|0|||
128943824|NCT00195260|464080426|FG000|Part 1: Dose Escalation|Disease Progression|3|||
128943825|NCT00195260|464080427|FG001|Part 1: Dose Escalation|Disease Progression|2|||
128943826|NCT00195260|464080428|FG002|Part 1: Dose Escalation|Disease Progression|5|||
128943827|NCT00195260|464080429|FG003|Part 1: Dose Escalation|Disease Progression|6|||
128943828|NCT00195260|464080430|FG004|Part 1: Dose Escalation|Disease Progression|4|||
128943829|NCT00195260|464080431|FG005|Part 1: Dose Escalation|Disease Progression|6|||
128943830|NCT00195260|464080432|FG006|Part 1: Dose Escalation|Disease Progression|7|||
128943831|NCT00195260|464080433|FG007|Part 1: Dose Escalation|Disease Progression|4|||
128943832|NCT00195260|464080434|FG008|Part 1: Dose Escalation|Disease Progression|0|||
128943833|NCT00195260|464080435|FG009|Part 1: Dose Escalation|Disease Progression|0|||
128943834|NCT00195260|464080436|FG010|Part 1: Dose Escalation|Disease Progression|0|||
128943835|NCT00195260|464080426|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
128943836|NCT00195260|464080427|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
128943837|NCT00195260|464080428|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
128943838|NCT00195260|464080429|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
128943839|NCT00195260|464080430|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
128943840|NCT00195260|464080431|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
128943841|NCT00195260|464080432|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
128943842|NCT00195260|464080433|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
128943843|NCT00195260|464080434|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
128943844|NCT00195260|464080435|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
128943845|NCT00195260|464080436|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
128943846|NCT00195260|464080426|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943847|NCT00195260|464080427|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943848|NCT00195260|464080428|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943849|NCT00195260|464080429|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943850|NCT00195260|464080430|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943851|NCT00195260|464080431|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943852|NCT00195260|464080432|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943853|NCT00195260|464080433|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
128943854|NCT00195260|464080434|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
128943855|NCT00195260|464080435|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
128943856|NCT00195260|464080436|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
128943857|NCT00195260|464080426|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943858|NCT00195260|464080427|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943859|NCT00195260|464080428|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943860|NCT00195260|464080429|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943861|NCT00195260|464080430|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943862|NCT00195260|464080431|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943863|NCT00195260|464080432|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943864|NCT00195260|464080433|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
128943865|NCT00195260|464080434|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
128943866|NCT00195260|464080435|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
128943867|NCT00195260|464080436|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
128943868|NCT00195260|464080426|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943869|NCT00195260|464080427|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943870|NCT00195260|464080428|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943871|NCT00195260|464080429|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943872|NCT00195260|464080430|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943873|NCT00195260|464080431|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943874|NCT00195260|464080432|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943875|NCT00195260|464080433|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
128943876|NCT00195260|464080434|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
128943877|NCT00195260|464080435|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
128943878|NCT00195260|464080436|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
128943879|NCT00195260|464080426|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
128943880|NCT00195260|464080427|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
128943881|NCT00195260|464080428|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
128943882|NCT00195260|464080429|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
128943883|NCT00195260|464080430|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
128943884|NCT00195260|464080431|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
128943885|NCT00195260|464080432|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129123410|NCT01134042|464746965|FG002|Overall Study|Adverse Event|2|||
128708097|NCT00938639|463226378|FG001|Overall Study|Lost to Follow-up|2|||
128708098|NCT00938639|463226377|FG000|Overall Study|Family issues|1|||
128708099|NCT00938639|463226378|FG001|Overall Study|Family issues|1|||
128708100|NCT00938639|463226377|FG000|Overall Study|Participant noncompliance|1|||
128708101|NCT00938639|463226378|FG001|Overall Study|Participant noncompliance|0|||
128943886|NCT00195260|464080433|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
128943887|NCT00195260|464080434|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
128943888|NCT00195260|464080435|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
128943889|NCT00195260|464080436|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
128943890|NCT01975272|464080441|FG000|Overall Study|Excluded after protocol amendment|1|||
128943891|NCT01975272|464080442|FG001|Overall Study|Excluded after protocol amendment|1|||
128943892|NCT01975272|464080443|FG002|Overall Study|Excluded after protocol amendment|2|||
128943893|NCT00515008|464080446|FG000|Overall Study|Lost to Follow-up|1|||
128943894|NCT00515008|464080447|FG001|Overall Study|Lost to Follow-up|0|||
128943895|NCT00515008|464080446|FG000|Overall Study|Declined|0|||
128943896|NCT00515008|464080447|FG001|Overall Study|Declined|3|||
128943897|NCT00515008|464080446|FG000|Overall Study|Left the Boston Area|1|||
128943898|NCT00515008|464080447|FG001|Overall Study|Left the Boston Area|1|||
128943899|NCT00515008|464080446|FG000|Overall Study|Scheduling conflict|1|||
128943900|NCT00515008|464080447|FG001|Overall Study|Scheduling conflict|0|||
128943901|NCT02775864|464080448|FG000|Overall Study|Data ended end of 2010|1764|||
128943902|NCT02775864|464080449|FG001|Overall Study|Data ended end of 2010|2880|||
128943903|NCT02775864|464080450|FG002|Overall Study|Data ended end of 2010|1140|||
128943904|NCT02775864|464080451|FG003|Overall Study|Data ended end of 2010|1194|||
128943905|NCT02775864|464080448|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
128943906|NCT02775864|464080449|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
128943907|NCT02775864|464080450|FG002|Overall Study|Medicaid eligibility discontinued|720|||
128943908|NCT02775864|464080451|FG003|Overall Study|Medicaid eligibility discontinued|890|||
128943909|NCT03238235|464080452|FG000|Overall Study|Adverse Event|2|||
128943910|NCT03238235|464080453|FG001|Overall Study|Adverse Event|0|||
128943911|NCT03238235|464080452|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
128943912|NCT03238235|464080453|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
128943913|NCT05896761|464080454|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
128943914|NCT05896761|464080455|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
128943915|NCT05896761|464080454|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
128943916|NCT05896761|464080455|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
128943917|NCT03552549|464080458|FG000|Overall Study|Disease progression|25|||
128943918|NCT03552549|464080459|FG001|Overall Study|Disease progression|17|||
128943919|NCT03552549|464080458|FG000|Overall Study|Adverse event in first 12 months|12|||
128943920|NCT03552549|464080459|FG001|Overall Study|Adverse event in first 12 months|8|||
128943921|NCT03552549|464080458|FG000|Overall Study|Withdrawal by Subject|7|||
128943922|NCT03552549|464080459|FG001|Overall Study|Withdrawal by Subject|7|||
128943923|NCT03552549|464080458|FG000|Overall Study|Unknown (no reason provided)|4|||
128943924|NCT03552549|464080459|FG001|Overall Study|Unknown (no reason provided)|2|||
128943925|NCT03552549|464080458|FG000|Overall Study|Not in participant's best interest|2|||
128943926|NCT03552549|464080459|FG001|Overall Study|Not in participant's best interest|1|||
128943927|NCT03552549|464080458|FG000|Overall Study|Did not complete study treatment|2|||
128943928|NCT03552549|464080459|FG001|Overall Study|Did not complete study treatment|3|||
128943929|NCT03552549|464080458|FG000|Overall Study|Did not meet eligibility criteria|1|||
128943930|NCT03552549|464080459|FG001|Overall Study|Did not meet eligibility criteria|0|||
128943931|NCT03552549|464080458|FG000|Overall Study|Administrative|0|||
128943932|NCT03552549|464080459|FG001|Overall Study|Administrative|14|||
128943933|NCT02739594|464080462|FG000|Overall Study|Undesired Event|3|||
128943934|NCT02739594|464080463|FG001|Overall Study|Undesired Event|4|||
128943935|NCT02739594|464080462|FG000|Overall Study|Violation of Eligibility Criteria|1|||
128943936|NCT02739594|464080463|FG001|Overall Study|Violation of Eligibility Criteria|2|||
128943937|NCT02739594|464080462|FG000|Overall Study|Protocol Violation|5|||
128943938|NCT02739594|464080463|FG001|Overall Study|Protocol Violation|6|||
128943939|NCT02739594|464080462|FG000|Overall Study|Death|4|||
128943940|NCT02739594|464080463|FG001|Overall Study|Death|2|||
128943941|NCT02739594|464080462|FG000|Overall Study|Renal Insufficiency|4|||
128943942|NCT02739594|464080463|FG001|Overall Study|Renal Insufficiency|6|||
128943943|NCT02739594|464080462|FG000|Overall Study|Administrative Reasons|1|||
128708102|NCT02509156|463226379|FG000|Randomized Phase|Death|1|||
128708103|NCT02509156|463226380|FG001|Randomized Phase|Death|0|||
128708104|NCT02509156|463226379|FG000|Randomized Phase|Withdrawal by Subject|1|||
128943944|NCT02739594|464080463|FG001|Overall Study|Administrative Reasons|3|||
129033287|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
129033288|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
129033289|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
128770251|NCT02306122|463450185|FG003|Initial Physician Randomization|Physician Decision|0|||
128770252|NCT02306122|463450186|FG004|Initial Physician Randomization|Physician Decision|0|||
128943945|NCT02739594|464080462|FG000|Overall Study|Withdrawal by Subject|1|||
129033290|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
129033291|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033292|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
129033293|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033294|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033295|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033296|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033297|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033298|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033299|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033300|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129033301|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
129033302|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
129033303|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
129033304|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
129033305|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
129033306|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
129033307|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
129033308|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
129033309|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
129033310|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
129033311|NCT01190930|464412075|FG000|Post Induction Pre-Maintenance|Relapse|0|||
129033312|NCT01190930|464412076|FG001|Post Induction Pre-Maintenance|Relapse|0|||
129033313|NCT01190930|464412077|FG002|Post Induction Pre-Maintenance|Relapse|1|||
129033314|NCT01190930|464412078|FG003|Post Induction Pre-Maintenance|Relapse|0|||
129033315|NCT01190930|464412079|FG004|Post Induction Pre-Maintenance|Relapse|0|||
129033316|NCT01190930|464412080|FG005|Post Induction Pre-Maintenance|Relapse|0|||
129033317|NCT01190930|464412081|FG006|Post Induction Pre-Maintenance|Relapse|0|||
129033318|NCT01190930|464412082|FG007|Post Induction Pre-Maintenance|Relapse|0|||
129033319|NCT01190930|464412083|FG008|Post Induction Pre-Maintenance|Relapse|0|||
129033320|NCT01190930|464412084|FG009|Post Induction Pre-Maintenance|Relapse|0|||
129033321|NCT01190930|464412075|FG000|Maintenance|Adverse Event|0|||
129033322|NCT01190930|464412076|FG001|Maintenance|Adverse Event|0|||
129033323|NCT01190930|464412077|FG002|Maintenance|Adverse Event|0|||
129033324|NCT01190930|464412078|FG003|Maintenance|Adverse Event|0|||
129033325|NCT01190930|464412079|FG004|Maintenance|Adverse Event|0|||
129033326|NCT01190930|464412080|FG005|Maintenance|Adverse Event|1|||
129033327|NCT01190930|464412081|FG006|Maintenance|Adverse Event|1|||
129033328|NCT01190930|464412082|FG007|Maintenance|Adverse Event|3|||
129033329|NCT01190930|464412083|FG008|Maintenance|Adverse Event|3|||
129033330|NCT01190930|464412084|FG009|Maintenance|Adverse Event|0|||
129033331|NCT01190930|464412075|FG000|Maintenance|Death|0|||
129033332|NCT01190930|464412076|FG001|Maintenance|Death|0|||
129033333|NCT01190930|464412077|FG002|Maintenance|Death|0|||
129033334|NCT01190930|464412078|FG003|Maintenance|Death|1|||
129033335|NCT01190930|464412079|FG004|Maintenance|Death|0|||
129033336|NCT01190930|464412080|FG005|Maintenance|Death|0|||
129033337|NCT01190930|464412081|FG006|Maintenance|Death|2|||
129033338|NCT01190930|464412082|FG007|Maintenance|Death|2|||
129033339|NCT01190930|464412083|FG008|Maintenance|Death|2|||
129033340|NCT01190930|464412084|FG009|Maintenance|Death|2|||
129033341|NCT01190930|464412075|FG000|Maintenance|Lost to Follow-up|0|||
129033342|NCT01190930|464412076|FG001|Maintenance|Lost to Follow-up|0|||
129033343|NCT01190930|464412077|FG002|Maintenance|Lost to Follow-up|0|||
129033344|NCT01190930|464412078|FG003|Maintenance|Lost to Follow-up|0|||
129033345|NCT01190930|464412079|FG004|Maintenance|Lost to Follow-up|0|||
129033346|NCT01190930|464412080|FG005|Maintenance|Lost to Follow-up|0|||
129123411|NCT01134042|464746963|FG000|Overall Study|Lack of Efficacy|21|||
129123412|NCT01134042|464746964|FG001|Overall Study|Lack of Efficacy|6|||
129123413|NCT01134042|464746965|FG002|Overall Study|Lack of Efficacy|18|||
129123414|NCT01134042|464746963|FG000|Overall Study|Protocol Violation|5|||
129123415|NCT01134042|464746964|FG001|Overall Study|Protocol Violation|3|||
129033347|NCT01190930|464412081|FG006|Maintenance|Lost to Follow-up|1|||
129033348|NCT01190930|464412082|FG007|Maintenance|Lost to Follow-up|1|||
129033349|NCT01190930|464412083|FG008|Maintenance|Lost to Follow-up|1|||
129033350|NCT01190930|464412084|FG009|Maintenance|Lost to Follow-up|0|||
129033351|NCT01190930|464412075|FG000|Maintenance|Physician Decision|0|||
129033352|NCT01190930|464412076|FG001|Maintenance|Physician Decision|1|||
129033353|NCT01190930|464412077|FG002|Maintenance|Physician Decision|0|||
129033354|NCT01190930|464412078|FG003|Maintenance|Physician Decision|5|||
129033355|NCT01190930|464412079|FG004|Maintenance|Physician Decision|9|||
129033356|NCT01190930|464412080|FG005|Maintenance|Physician Decision|4|||
129033357|NCT01190930|464412081|FG006|Maintenance|Physician Decision|8|||
129033358|NCT01190930|464412082|FG007|Maintenance|Physician Decision|8|||
129033359|NCT01190930|464412083|FG008|Maintenance|Physician Decision|10|||
129123416|NCT01134042|464746965|FG002|Overall Study|Protocol Violation|5|||
129033360|NCT01190930|464412084|FG009|Maintenance|Physician Decision|17|||
128708105|NCT02509156|463226380|FG001|Randomized Phase|Withdrawal by Subject|1|||
128708106|NCT04326231|463226381|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
128708107|NCT00006903|463226384|FG000|Overall Study|Still receiving treatment|0|||
128708108|NCT00006903|463226385|FG001|Overall Study|Still receiving treatment|0|||
128708109|NCT00006903|463226386|FG002|Overall Study|Still receiving treatment|1|||
128708110|NCT00006903|463226384|FG000|Overall Study|Refused further treatment|0|||
128708111|NCT00006903|463226385|FG001|Overall Study|Refused further treatment|2|||
128708112|NCT00006903|463226386|FG002|Overall Study|Refused further treatment|1|||
128708113|NCT00006903|463226384|FG000|Overall Study|Adverse Event|0|||
128708114|NCT00006903|463226385|FG001|Overall Study|Adverse Event|0|||
128708115|NCT00006903|463226386|FG002|Overall Study|Adverse Event|1|||
128708116|NCT00006903|463226384|FG000|Overall Study|Death|0|||
128708117|NCT00006903|463226385|FG001|Overall Study|Death|1|||
128708118|NCT00006903|463226386|FG002|Overall Study|Death|0|||
128708119|NCT00006903|463226384|FG000|Overall Study|Patient never treated|0|||
128708120|NCT00006903|463226385|FG001|Overall Study|Patient never treated|0|||
128708121|NCT00006903|463226386|FG002|Overall Study|Patient never treated|1|||
128708122|NCT00006903|463226384|FG000|Overall Study|Ineligible|10|||
128708123|NCT00006903|463226385|FG001|Overall Study|Ineligible|1|||
128708124|NCT00006903|463226386|FG002|Overall Study|Ineligible|2|||
128708125|NCT01980992|463226389|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
128708126|NCT01980992|463226390|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
128708127|NCT01980992|463226389|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
128708128|NCT01980992|463226390|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
128708129|NCT01980992|463226389|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
128708130|NCT01980992|463226390|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
128708131|NCT01980992|463226389|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
128708132|NCT01980992|463226390|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
128708133|NCT01980992|463226389|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
128708134|NCT01980992|463226390|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
128708135|NCT01980992|463226389|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
128708136|NCT01980992|463226390|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
128708137|NCT01366209|463226393|FG000|Overall Study|Adverse Event|6|||
128708138|NCT01366209|463226394|FG001|Overall Study|Adverse Event|7|||
128708139|NCT01366209|463226393|FG000|Overall Study|Withdrawal by Subject|4|||
128708140|NCT01366209|463226394|FG001|Overall Study|Withdrawal by Subject|4|||
128708141|NCT01366209|463226393|FG000|Overall Study|Death|12|||
128708142|NCT01366209|463226394|FG001|Overall Study|Death|19|||
128708143|NCT01366209|463226393|FG000|Overall Study|Lung transplantation|6|||
128708144|NCT01366209|463226394|FG001|Overall Study|Lung transplantation|1|||
128708145|NCT01366209|463226393|FG000|Overall Study|Lost to Follow-up|2|||
128708146|NCT01366209|463226394|FG001|Overall Study|Lost to Follow-up|1|||
128943946|NCT02739594|464080463|FG001|Overall Study|Withdrawal by Subject|1|||
128943947|NCT02739594|464080462|FG000|Overall Study|Lost to Follow-up|0|||
128943948|NCT02739594|464080463|FG001|Overall Study|Lost to Follow-up|1|||
128943949|NCT02739594|464080462|FG000|Overall Study|Elevated Serum Creatinine|0|||
128943950|NCT02739594|464080463|FG001|Overall Study|Elevated Serum Creatinine|1|||
128943951|NCT02739594|464080462|FG000|Overall Study|Other|6|||
128943952|NCT02739594|464080463|FG001|Overall Study|Other|2|||
128943953|NCT01465178|464080466|FG000|Overall Study|Withdrawal by Subject|1|||
128943954|NCT01465178|464080467|FG001|Overall Study|Withdrawal by Subject|0|||
128943955|NCT00527111|464080468|FG000|Overall Study|Adverse Event|14|||
128943956|NCT00527111|464080469|FG001|Overall Study|Adverse Event|13|||
128943957|NCT00527111|464080468|FG000|Overall Study|Death|0|||
128943958|NCT00527111|464080469|FG001|Overall Study|Death|1|||
128943959|NCT00527111|464080468|FG000|Overall Study|Investigator Request|2|||
128708147|NCT01366209|463226393|FG000|Overall Study|Physician Decision|1|||
128708148|NCT01366209|463226394|FG001|Overall Study|Physician Decision|0|||
128708149|NCT01366209|463226393|FG000|Overall Study|Sponsors decision|0|||
128708150|NCT01366209|463226394|FG001|Overall Study|Sponsors decision|1|||
128943960|NCT00527111|464080469|FG001|Overall Study|Investigator Request|1|||
128943961|NCT00527111|464080468|FG000|Overall Study|Patient Request|2|||
128943962|NCT00527111|464080469|FG001|Overall Study|Patient Request|5|||
128943963|NCT00527111|464080468|FG000|Overall Study|Other|2|||
128943964|NCT00527111|464080469|FG001|Overall Study|Other|2|||
128943965|NCT03827473|464080472|FG000|Overall Study|Withdrawal by Subject|1|||
128708151|NCT01366209|463226393|FG000|Overall Study|Withdrew consent|4|||
128708152|NCT01366209|463226394|FG001|Overall Study|Withdrew consent|3|||
128943966|NCT03827473|464080473|FG001|Overall Study|Withdrawal by Subject|0|||
128943967|NCT01477892|464080474|FG000|Overall Study|Withdrawal by Subject|0|||
128943968|NCT01477892|464080475|FG001|Overall Study|Withdrawal by Subject|2|||
128708153|NCT02670837|463226395|FG000|Overall Study|Death|2|||
128708154|NCT02670837|463226396|FG001|Overall Study|Death|0|||
128708155|NCT02670837|463226397|FG002|Overall Study|Death|0|||
128708156|NCT01053221|463226398|FG000|Overall Study|The study was closed prematurely|5|||
128708157|NCT01053221|463226399|FG001|Overall Study|The study was closed prematurely|9|||
128943969|NCT01921257|464080476|FG000|Overall Study|Adverse Event|1|||
129123417|NCT01134042|464746963|FG000|Overall Study|Lost to Follow-up|2|||
129123418|NCT01134042|464746964|FG001|Overall Study|Lost to Follow-up|0|||
129123419|NCT01134042|464746965|FG002|Overall Study|Lost to Follow-up|1|||
129123420|NCT01134042|464746963|FG000|Overall Study|Physician Decision|4|||
129123421|NCT01134042|464746964|FG001|Overall Study|Physician Decision|8|||
129123422|NCT01134042|464746965|FG002|Overall Study|Physician Decision|1|||
129123423|NCT01134042|464746963|FG000|Overall Study|Withdrawal by Subject|13|||
129123424|NCT01134042|464746964|FG001|Overall Study|Withdrawal by Subject|4|||
129123425|NCT01134042|464746965|FG002|Overall Study|Withdrawal by Subject|7|||
129123426|NCT01983930|464746966|FG000|Overall Study|Withdrawal by Subject|9|||
129123427|NCT01983930|464746967|FG001|Overall Study|Withdrawal by Subject|8|||
129123428|NCT01983930|464746966|FG000|Overall Study|Adverse Event|0|||
129123429|NCT01983930|464746967|FG001|Overall Study|Adverse Event|1|||
129123430|NCT00393367|464746968|FG000|Overall Study|Protocol Violation|2|||
129123431|NCT00393367|464746969|FG001|Overall Study|Protocol Violation|5|||
129123432|NCT00393367|464746968|FG000|Overall Study|Withdrawal by Subject|0|||
129123433|NCT00393367|464746969|FG001|Overall Study|Withdrawal by Subject|2|||
129123434|NCT03286504|464746970|FG000|Overall Study|Lost to Follow-up|19|||
129123435|NCT03286504|464746971|FG001|Overall Study|Lost to Follow-up|16|||
129123436|NCT01432327|464746972|FG000|Posttest 3 Months|depression|3|||
129123437|NCT01432327|464746973|FG001|Posttest 3 Months|depression|0|||
129123438|NCT01432327|464746974|FG002|Posttest 3 Months|depression|0|||
129123439|NCT01432327|464746975|FG003|Posttest 3 Months|depression|0|||
129123440|NCT01432327|464746972|FG000|Posttest 3 Months|Lost to Follow-up|1|||
129123441|NCT01432327|464746973|FG001|Posttest 3 Months|Lost to Follow-up|0|||
129123442|NCT01432327|464746974|FG002|Posttest 3 Months|Lost to Follow-up|2|||
129123443|NCT01432327|464746975|FG003|Posttest 3 Months|Lost to Follow-up|1|||
128708158|NCT00582166|463226400|FG000|Overall Study|Death|1|||
128708159|NCT00582166|463226400|FG000|Overall Study|Ineligible pathology|1|||
128943970|NCT01921257|464080476|FG000|Overall Study|Protocol Violation|1|||
128943971|NCT01921257|464080476|FG000|Overall Study|Withdrawal by Subject|1|||
128943972|NCT05515601|464080480|FG000|Overall Study|Withdrawal by Subject|1|||
128943973|NCT05515601|464080481|FG001|Overall Study|Withdrawal by Subject|3|||
128943974|NCT05515601|464080482|FG002|Overall Study|Withdrawal by Subject|2|||
128943975|NCT05515601|464080483|FG003|Overall Study|Withdrawal by Subject|1|||
128943976|NCT05515601|464080484|FG004|Overall Study|Withdrawal by Subject|1|||
128943977|NCT05515601|464080485|FG005|Overall Study|Withdrawal by Subject|1|||
128943978|NCT05515601|464080480|FG000|Overall Study|Lost to Follow-up|0|||
128943979|NCT05515601|464080481|FG001|Overall Study|Lost to Follow-up|0|||
128943980|NCT05515601|464080482|FG002|Overall Study|Lost to Follow-up|0|||
128943981|NCT05515601|464080483|FG003|Overall Study|Lost to Follow-up|0|||
128943982|NCT05515601|464080484|FG004|Overall Study|Lost to Follow-up|1|||
128943983|NCT05515601|464080485|FG005|Overall Study|Lost to Follow-up|0|||
128943984|NCT00777491|464080486|FG000|Overall Study|Protocol Violation|0|||
128943985|NCT00777491|464080487|FG001|Overall Study|Protocol Violation|2|||
128943986|NCT00777491|464080486|FG000|Overall Study|Did not receive any protocol treatment|2|||
128943987|NCT00777491|464080487|FG001|Overall Study|Did not receive any protocol treatment|0|||
128943988|NCT00540436|464080490|FG000|First 12-Week Treatment Period|Adverse Event|1|||
128943989|NCT00540436|464080490|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
128943990|NCT00540436|464080490|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
128943991|NCT00540436|464080490|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
128943992|NCT03255291|464080491|FG000|Overall Study|Determined to be ineligible|10|||
128943993|NCT03255291|464080492|FG001|Overall Study|Determined to be ineligible|12|||
128943994|NCT03255291|464080493|FG002|Overall Study|Determined to be ineligible|6|||
128943995|NCT03255291|464080494|FG003|Overall Study|Determined to be ineligible|6|||
128943996|NCT03255291|464080495|FG004|Overall Study|Determined to be ineligible|5|||
128943997|NCT03255291|464080496|FG005|Overall Study|Determined to be ineligible|10|||
128943998|NCT03255291|464080491|FG000|Overall Study|Baseline data collection issues|3|||
128943999|NCT03255291|464080492|FG001|Overall Study|Baseline data collection issues|0|||
128944000|NCT03255291|464080493|FG002|Overall Study|Baseline data collection issues|0|||
128944001|NCT03255291|464080494|FG003|Overall Study|Baseline data collection issues|0|||
128944002|NCT03255291|464080495|FG004|Overall Study|Baseline data collection issues|2|||
128944003|NCT03255291|464080496|FG005|Overall Study|Baseline data collection issues|0|||
128944004|NCT01745393|464080497|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
128944005|NCT01745393|464080498|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
128944006|NCT01745393|464080497|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
129123444|NCT01432327|464746972|FG000|Posttest 3 Months|Allergic reaction|0|||
129123445|NCT01432327|464746973|FG001|Posttest 3 Months|Allergic reaction|2|||
129123446|NCT01432327|464746974|FG002|Posttest 3 Months|Allergic reaction|0|||
129123447|NCT01432327|464746975|FG003|Posttest 3 Months|Allergic reaction|0|||
129123448|NCT01432327|464746972|FG000|Posttest 6 Months|Lost to Follow-up|0|||
129123449|NCT01432327|464746973|FG001|Posttest 6 Months|Lost to Follow-up|0|||
129123450|NCT01432327|464746974|FG002|Posttest 6 Months|Lost to Follow-up|3|||
128708160|NCT02532972|463226401|FG000|Overall Study|Withdrawal by Subject|1|||
128708161|NCT01606436|463226402|FG000|Overall Study|Withdrawal by Subject|0|||
128944007|NCT01745393|464080498|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
128944008|NCT01745393|464080497|FG000|12-month Follow-up|Lost to Follow-up|6|||
128944009|NCT01745393|464080498|FG001|12-month Follow-up|Lost to Follow-up|5|||
128944010|NCT00471445|464080500|FG000|Overall Study|Withdrawal by Subject|1|||
128944011|NCT00471445|464080501|FG001|Overall Study|Withdrawal by Subject|1|||
128944012|NCT00471445|464080500|FG000|Overall Study|Ineligible|1|||
128944013|NCT00471445|464080501|FG001|Overall Study|Ineligible|0|||
128944014|NCT00471445|464080500|FG000|Overall Study|Protocol Violation|0|||
128944015|NCT00471445|464080501|FG001|Overall Study|Protocol Violation|1|||
128944016|NCT03591146|464080502|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
128944017|NCT03591146|464080503|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
128944018|NCT03591146|464080504|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
128944019|NCT03591146|464080505|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
128944020|NCT03591146|464080506|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
128944021|NCT03591146|464080502|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
128944022|NCT03591146|464080503|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
128944023|NCT03591146|464080504|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
128944024|NCT03591146|464080505|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
128944025|NCT03591146|464080506|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
128944026|NCT03591146|464080502|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
128944027|NCT03591146|464080503|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
128944028|NCT03591146|464080504|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
128944029|NCT03591146|464080505|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
128944030|NCT03591146|464080506|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
128944031|NCT03591146|464080502|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
128944032|NCT03591146|464080503|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
128944033|NCT03591146|464080504|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
128944034|NCT03591146|464080505|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
128944035|NCT03591146|464080506|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
128944036|NCT04737031|464080509|FG000|Overall Study|Patients who did not have a treatment visit|0|||
128944037|NCT04737031|464080510|FG001|Overall Study|Patients who did not have a treatment visit|31|||
128944038|NCT04737031|464080511|FG002|Overall Study|Patients who did not have a treatment visit|93|||
128944039|NCT04737031|464080512|FG003|Overall Study|Patients who did not have a treatment visit|227|||
128944040|NCT01511419|464080517|FG000|Dose 2|Physician Decision|1|||
128944041|NCT01511419|464080518|FG001|Dose 2|Physician Decision|0|||
128944042|NCT04594239|464080519|FG000|Overall Study|Withdrawal by Subject|3|||
128944043|NCT04594239|464080520|FG001|Overall Study|Withdrawal by Subject|4|||
128944044|NCT04594239|464080521|FG002|Overall Study|Withdrawal by Subject|2|||
128944045|NCT04594239|464080522|FG003|Overall Study|Withdrawal by Subject|4|||
128944046|NCT04594239|464080519|FG000|Overall Study|Lost to Follow-up|8|||
128944047|NCT04594239|464080520|FG001|Overall Study|Lost to Follow-up|5|||
128944048|NCT04594239|464080521|FG002|Overall Study|Lost to Follow-up|4|||
128944049|NCT04594239|464080522|FG003|Overall Study|Lost to Follow-up|6|||
128944050|NCT04594239|464080519|FG000|Overall Study|Subject relocated|0|||
128944051|NCT04594239|464080520|FG001|Overall Study|Subject relocated|0|||
128944052|NCT04594239|464080521|FG002|Overall Study|Subject relocated|0|||
128944053|NCT04594239|464080522|FG003|Overall Study|Subject relocated|1|||
128944054|NCT00091390|464080523|FG000|Overall Study|Protocol Violation|1|||
128944055|NCT00091390|464080523|FG000|Overall Study|No protocol treatment|3|||
128944056|NCT03229759|464080524|FG000|Overall Study|Screen Failure|30|||
128944057|NCT00436215|464080525|FG000|Overall Study|Refused further treatment|3|||
128944058|NCT00436215|464080525|FG000|Overall Study|Small bowel obstruction|1|||
128944059|NCT02326467|464081811|FG000|Overall Study|Withdrawal by Subject|1|||
128944060|NCT00434512|464081812|FG000|Overall Study|Migrated/moved from study area|0|||
128944061|NCT00434512|464081813|FG001|Overall Study|Migrated/moved from study area|0|||
128944062|NCT00434512|464081814|FG002|Overall Study|Migrated/moved from study area|0|||
128944063|NCT00434512|464081815|FG003|Overall Study|Migrated/moved from study area|1|||
128944064|NCT00434512|464081816|FG004|Overall Study|Migrated/moved from study area|1|||
128944065|NCT00434512|464081817|FG005|Overall Study|Migrated/moved from study area|1|||
128944066|NCT00434512|464081812|FG000|Overall Study|Other|0|||
128944067|NCT00434512|464081813|FG001|Overall Study|Other|1|||
128944068|NCT00434512|464081814|FG002|Overall Study|Other|0|||
128944069|NCT00434512|464081815|FG003|Overall Study|Other|0|||
128944070|NCT00434512|464081816|FG004|Overall Study|Other|0|||
128944071|NCT00434512|464081817|FG005|Overall Study|Other|0|||
128944072|NCT00833248|464081820|FG000|Overall Study|Adverse Event|3|||
128944073|NCT00833248|464081821|FG001|Overall Study|Adverse Event|0|||
128944074|NCT00833248|464081820|FG000|Overall Study|Protocol Violation|1|||
128944075|NCT00833248|464081821|FG001|Overall Study|Protocol Violation|2|||
129033361|NCT01190930|464412075|FG000|Maintenance|Withdrawal by Subject|0|||
129033362|NCT01190930|464412076|FG001|Maintenance|Withdrawal by Subject|0|||
129033363|NCT01190930|464412077|FG002|Maintenance|Withdrawal by Subject|0|||
129033364|NCT01190930|464412078|FG003|Maintenance|Withdrawal by Subject|0|||
129033365|NCT01190930|464412079|FG004|Maintenance|Withdrawal by Subject|0|||
129033366|NCT01190930|464412080|FG005|Maintenance|Withdrawal by Subject|0|||
128708162|NCT01606436|463226403|FG001|Overall Study|Withdrawal by Subject|0|||
128944076|NCT00833248|464081820|FG000|Overall Study|Withdrawal by Subject|0|||
128944077|NCT00833248|464081821|FG001|Overall Study|Withdrawal by Subject|1|||
128944078|NCT02006667|464081822|FG000|Overall Study|Adverse Event|3|||
128944079|NCT02006667|464081822|FG000|Overall Study|Death|2|||
128944080|NCT02006667|464081822|FG000|Overall Study|Withdrawal by Subject|1|||
128944081|NCT02939937|464081823|FG000|Overall Study|Adverse Event|5|||
128944082|NCT02939937|464081824|FG001|Overall Study|Adverse Event|0|||
128944083|NCT02939937|464081823|FG000|Overall Study|Lost to Follow-up|1|||
128944084|NCT02939937|464081824|FG001|Overall Study|Lost to Follow-up|3|||
128944085|NCT00520676|464081837|FG000|Overall Study|Death|84|||
128944086|NCT00520676|464081838|FG001|Overall Study|Death|81|||
128944087|NCT00520676|464081837|FG000|Overall Study|Lost to Follow-up|6|||
128944088|NCT00520676|464081838|FG001|Overall Study|Lost to Follow-up|10|||
128944089|NCT00520676|464081837|FG000|Overall Study|Physician Decision|4|||
128944090|NCT00520676|464081838|FG001|Overall Study|Physician Decision|1|||
128944091|NCT00520676|464081837|FG000|Overall Study|Withdrawal by Subject|7|||
128944092|NCT00520676|464081838|FG001|Overall Study|Withdrawal by Subject|11|||
128944093|NCT02179515|464081839|FG000|Overall Study|switched to alternative treatment|0|||
128944094|NCT02179515|464081840|FG001|Overall Study|switched to alternative treatment|1|||
128944095|NCT02179515|464081841|FG002|Overall Study|switched to alternative treatment|1|||
128944096|NCT02179515|464081839|FG000|Overall Study|Death|0|||
128944097|NCT02179515|464081840|FG001|Overall Study|Death|1|||
128944098|NCT02179515|464081841|FG002|Overall Study|Death|1|||
128944099|NCT02179515|464081839|FG000|Overall Study|refused further treatment|0|||
128944100|NCT02179515|464081840|FG001|Overall Study|refused further treatment|3|||
128944101|NCT02179515|464081841|FG002|Overall Study|refused further treatment|4|||
128944102|NCT02179515|464081839|FG000|Overall Study|Disease progression on study|2|||
128944103|NCT02179515|464081840|FG001|Overall Study|Disease progression on study|11|||
128944104|NCT02179515|464081841|FG002|Overall Study|Disease progression on study|8|||
128944105|NCT00115349|464081846|FG000|Overall Study|Study closed due to low enrollment.|11|||
128944106|NCT00115349|464081847|FG001|Overall Study|Study closed due to low enrollment.|9|||
128944107|NCT02116660|464081848|FG000|Overall Study|Deteriorating renal function|0|||
128944108|NCT02116660|464081849|FG001|Overall Study|Deteriorating renal function|1|||
128944109|NCT02116660|464081848|FG000|Overall Study|Adverse Event|1|||
128944110|NCT02116660|464081849|FG001|Overall Study|Adverse Event|1|||
128944111|NCT02116660|464081848|FG000|Overall Study|Withdrawal by Subject|0|||
128944112|NCT02116660|464081849|FG001|Overall Study|Withdrawal by Subject|2|||
128944113|NCT02116660|464081848|FG000|Overall Study|Organization reason|1|||
128944114|NCT02116660|464081849|FG001|Overall Study|Organization reason|0|||
128944115|NCT00390416|464081850|FG000|Overall Study|Withdrawal by Subject|1|||
128944116|NCT00390416|464081850|FG000|Overall Study|Not treated|3|||
128944117|NCT00506077|464081851|FG000|Treatment Period 1|Adverse Event|2|||
128944118|NCT00506077|464081852|FG001|Treatment Period 1|Adverse Event|1|||
128944119|NCT00506077|464081851|FG000|Treatment Period 1|Lost to Follow-up|0|||
128944120|NCT00506077|464081852|FG001|Treatment Period 1|Lost to Follow-up|2|||
128944121|NCT00506077|464081851|FG000|Treatment Period 1|Withdrawal by Subject|2|||
128944122|NCT00506077|464081852|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128944123|NCT00506077|464081851|FG000|Treatment Period 2|Adverse Event|0|||
128944124|NCT00506077|464081852|FG001|Treatment Period 2|Adverse Event|1|||
128944125|NCT00506077|464081851|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128944126|NCT00506077|464081852|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128944127|NCT02868216|464081854|FG000|Overall Study|Death|0|||
128944128|NCT02868216|464081855|FG001|Overall Study|Death|1|||
128944129|NCT02868216|464081854|FG000|Overall Study|coronary artery bypass|1|||
128944130|NCT02868216|464081855|FG001|Overall Study|coronary artery bypass|0|||
128944131|NCT02868216|464081854|FG000|Overall Study|Withdrawal by Subject|7|||
128944132|NCT02868216|464081855|FG001|Overall Study|Withdrawal by Subject|5|||
128944133|NCT02496585|464081856|FG000|Overall Study|Death|3|||
129123451|NCT01432327|464746975|FG003|Posttest 6 Months|Lost to Follow-up|2|||
128708163|NCT01606436|463226404|FG002|Overall Study|Withdrawal by Subject|1|||
128708164|NCT01606436|463226405|FG003|Overall Study|Withdrawal by Subject|1|||
128944134|NCT02496585|464081857|FG001|Overall Study|Death|0|||
128944135|NCT02496585|464081856|FG000|Overall Study|Lost to Follow-up|2|||
128944136|NCT02496585|464081857|FG001|Overall Study|Lost to Follow-up|0|||
128944137|NCT02496585|464081856|FG000|Overall Study|Withdrawal by Subject|1|||
128944138|NCT02496585|464081857|FG001|Overall Study|Withdrawal by Subject|2|||
128944139|NCT02496585|464081856|FG000|Overall Study|Progression of Malignancy|4|||
128944140|NCT02496585|464081857|FG001|Overall Study|Progression of Malignancy|1|||
128944141|NCT04891770|464081858|FG000|Overall Study|Withdrew consent|1|||
129123452|NCT01432327|464746972|FG000|Posttest 6 Months|Allergic reaction|0|||
129123453|NCT01432327|464746973|FG001|Posttest 6 Months|Allergic reaction|0|||
128944142|NCT04891770|464081859|FG001|Overall Study|Withdrew consent|3|||
128944143|NCT04891770|464081860|FG002|Overall Study|Withdrew consent|0|||
128944144|NCT04891770|464081858|FG000|Overall Study|Enrolled but never treated|0|||
128944145|NCT04891770|464081859|FG001|Overall Study|Enrolled but never treated|0|||
129123454|NCT01432327|464746974|FG002|Posttest 6 Months|Allergic reaction|1|||
129123455|NCT01432327|464746975|FG003|Posttest 6 Months|Allergic reaction|0|||
129033367|NCT01190930|464412081|FG006|Maintenance|Withdrawal by Subject|2|||
129033368|NCT01190930|464412082|FG007|Maintenance|Withdrawal by Subject|1|||
129033369|NCT01190930|464412083|FG008|Maintenance|Withdrawal by Subject|4|||
129033370|NCT01190930|464412084|FG009|Maintenance|Withdrawal by Subject|1|||
129033371|NCT01190930|464412075|FG000|Maintenance|Refusal|0|||
129033372|NCT01190930|464412076|FG001|Maintenance|Refusal|1|||
129033373|NCT01190930|464412077|FG002|Maintenance|Refusal|0|||
129033374|NCT01190930|464412078|FG003|Maintenance|Refusal|2|||
129033375|NCT01190930|464412079|FG004|Maintenance|Refusal|0|||
129033376|NCT01190930|464412080|FG005|Maintenance|Refusal|4|||
129033377|NCT01190930|464412081|FG006|Maintenance|Refusal|5|||
129033378|NCT01190930|464412082|FG007|Maintenance|Refusal|17|||
129033379|NCT01190930|464412083|FG008|Maintenance|Refusal|13|||
129033380|NCT01190930|464412084|FG009|Maintenance|Refusal|6|||
129033381|NCT01190930|464412075|FG000|Maintenance|second malignant neoplasm|0|||
129033382|NCT01190930|464412076|FG001|Maintenance|second malignant neoplasm|0|||
129033383|NCT01190930|464412077|FG002|Maintenance|second malignant neoplasm|0|||
129033384|NCT01190930|464412078|FG003|Maintenance|second malignant neoplasm|1|||
129033385|NCT01190930|464412079|FG004|Maintenance|second malignant neoplasm|0|||
129033386|NCT01190930|464412080|FG005|Maintenance|second malignant neoplasm|1|||
129033387|NCT01190930|464412081|FG006|Maintenance|second malignant neoplasm|0|||
129033388|NCT01190930|464412082|FG007|Maintenance|second malignant neoplasm|0|||
129033389|NCT01190930|464412083|FG008|Maintenance|second malignant neoplasm|1|||
129033390|NCT01190930|464412084|FG009|Maintenance|second malignant neoplasm|0|||
129033391|NCT01190930|464412075|FG000|Maintenance|Inevaluable|0|||
129033392|NCT01190930|464412076|FG001|Maintenance|Inevaluable|0|||
129033393|NCT01190930|464412077|FG002|Maintenance|Inevaluable|0|||
129033394|NCT01190930|464412078|FG003|Maintenance|Inevaluable|0|||
129033395|NCT01190930|464412079|FG004|Maintenance|Inevaluable|0|||
129033396|NCT01190930|464412080|FG005|Maintenance|Inevaluable|1|||
129033397|NCT01190930|464412081|FG006|Maintenance|Inevaluable|1|||
129033398|NCT01190930|464412082|FG007|Maintenance|Inevaluable|1|||
129033399|NCT01190930|464412083|FG008|Maintenance|Inevaluable|0|||
129033400|NCT01190930|464412084|FG009|Maintenance|Inevaluable|0|||
129033401|NCT01190930|464412075|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
129033402|NCT01190930|464412076|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
129033403|NCT01190930|464412077|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
129033404|NCT01190930|464412078|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
129033405|NCT01190930|464412079|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
129033406|NCT01190930|464412080|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
129033407|NCT01190930|464412081|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
129033408|NCT01190930|464412082|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
129033409|NCT01190930|464412083|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
129033410|NCT01190930|464412084|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
129033411|NCT01190930|464412075|FG000|Maintenance|Relapse|0|||
129033412|NCT01190930|464412076|FG001|Maintenance|Relapse|0|||
129033413|NCT01190930|464412077|FG002|Maintenance|Relapse|0|||
129033414|NCT01190930|464412078|FG003|Maintenance|Relapse|2|||
129033415|NCT01190930|464412079|FG004|Maintenance|Relapse|0|||
129033416|NCT01190930|464412080|FG005|Maintenance|Relapse|1|||
129033417|NCT01190930|464412081|FG006|Maintenance|Relapse|6|||
129033418|NCT01190930|464412082|FG007|Maintenance|Relapse|13|||
129033419|NCT01190930|464412083|FG008|Maintenance|Relapse|11|||
129033420|NCT01190930|464412084|FG009|Maintenance|Relapse|11|||
129033421|NCT01190930|464412075|FG000|Maintenance|Still on therapy|0|||
129033422|NCT01190930|464412076|FG001|Maintenance|Still on therapy|8|||
129033423|NCT01190930|464412077|FG002|Maintenance|Still on therapy|0|||
129033424|NCT01190930|464412078|FG003|Maintenance|Still on therapy|29|||
129033425|NCT01190930|464412079|FG004|Maintenance|Still on therapy|0|||
129033426|NCT01190930|464412080|FG005|Maintenance|Still on therapy|0|||
129033427|NCT01190930|464412081|FG006|Maintenance|Still on therapy|0|||
129033428|NCT01190930|464412082|FG007|Maintenance|Still on therapy|0|||
129033429|NCT01190930|464412083|FG008|Maintenance|Still on therapy|0|||
129033430|NCT01190930|464412084|FG009|Maintenance|Still on therapy|0|||
129033431|NCT02161549|464412085|FG000|Overall Study|Physician Decision|6|||
129033432|NCT02161549|464412086|FG001|Overall Study|Physician Decision|2|||
129033433|NCT03223909|464412087|FG000|Overall Study|Protocol Violation|48|||
129033434|NCT03223909|464412088|FG001|Overall Study|Protocol Violation|45|||
129033435|NCT03223909|464412089|FG002|Overall Study|Protocol Violation|16|||
129033436|NCT01628549|464412094|FG000|Overall Study|Adverse Event|1|||
129033437|NCT01628549|464412095|FG001|Overall Study|Adverse Event|1|||
129033438|NCT01628549|464412096|FG002|Overall Study|Adverse Event|0|||
129033439|NCT01628549|464412097|FG003|Overall Study|Adverse Event|4|||
129033440|NCT01628549|464412094|FG000|Overall Study|Lost to Follow-up|3|||
129033441|NCT01628549|464412095|FG001|Overall Study|Lost to Follow-up|4|||
129033442|NCT01628549|464412096|FG002|Overall Study|Lost to Follow-up|3|||
129033443|NCT01628549|464412097|FG003|Overall Study|Lost to Follow-up|3|||
129033444|NCT01628549|464412094|FG000|Overall Study|Withdrawal by Subject|3|||
129033445|NCT01628549|464412095|FG001|Overall Study|Withdrawal by Subject|4|||
129033446|NCT01628549|464412096|FG002|Overall Study|Withdrawal by Subject|4|||
129033447|NCT01628549|464412097|FG003|Overall Study|Withdrawal by Subject|1|||
129033448|NCT01628549|464412094|FG000|Overall Study|Protocol Violation|2|||
129033449|NCT01628549|464412095|FG001|Overall Study|Protocol Violation|1|||
129033450|NCT01628549|464412096|FG002|Overall Study|Protocol Violation|1|||
129033451|NCT01628549|464412097|FG003|Overall Study|Protocol Violation|0|||
129033452|NCT01628549|464412094|FG000|Overall Study|withdrawn for noncompliance|0|||
129033453|NCT01628549|464412095|FG001|Overall Study|withdrawn for noncompliance|2|||
129033454|NCT01628549|464412096|FG002|Overall Study|withdrawn for noncompliance|1|||
129033455|NCT01628549|464412097|FG003|Overall Study|withdrawn for noncompliance|0|||
129033456|NCT01628549|464412094|FG000|Overall Study|abnormal laboratory test results|0|||
129033457|NCT01628549|464412095|FG001|Overall Study|abnormal laboratory test results|0|||
129033458|NCT01628549|464412096|FG002|Overall Study|abnormal laboratory test results|1|||
129033459|NCT01628549|464412097|FG003|Overall Study|abnormal laboratory test results|0|||
129033460|NCT01628549|464412094|FG000|Overall Study|positive pregnancy test|0|||
129033461|NCT01628549|464412095|FG001|Overall Study|positive pregnancy test|0|||
129033462|NCT01628549|464412096|FG002|Overall Study|positive pregnancy test|0|||
129033463|NCT01628549|464412097|FG003|Overall Study|positive pregnancy test|1|||
129033464|NCT00177164|464412101|FG000|Overall Study|Protocol Violation|0|||
129033465|NCT00177164|464412102|FG001|Overall Study|Protocol Violation|7|||
129033466|NCT00177164|464412101|FG000|Overall Study|Lost to Follow-up|4|||
129033467|NCT00177164|464412102|FG001|Overall Study|Lost to Follow-up|5|||
129033468|NCT00177164|464412101|FG000|Overall Study|increase in alcohol and drug use|1|||
129033469|NCT00177164|464412102|FG001|Overall Study|increase in alcohol and drug use|2|||
129033470|NCT00177164|464412101|FG000|Overall Study|Adverse Event|1|||
129033471|NCT00177164|464412102|FG001|Overall Study|Adverse Event|0|||
129033472|NCT00177164|464412101|FG000|Overall Study|discharge from hospital|1|||
129033473|NCT00177164|464412102|FG001|Overall Study|discharge from hospital|0|||
129033474|NCT00177164|464412101|FG000|Overall Study|Lack of Efficacy|2|||
129033475|NCT00177164|464412102|FG001|Overall Study|Lack of Efficacy|1|||
128708165|NCT01606436|463226406|FG004|Overall Study|Withdrawal by Subject|1|||
128708166|NCT01606436|463226407|FG005|Overall Study|Withdrawal by Subject|0|||
128708167|NCT01606436|463226402|FG000|Overall Study|Adverse Event|0|||
128708168|NCT01606436|463226403|FG001|Overall Study|Adverse Event|0|||
128708169|NCT01606436|463226404|FG002|Overall Study|Adverse Event|1|||
128708170|NCT01606436|463226405|FG003|Overall Study|Adverse Event|0|||
128770253|NCT02306122|463450187|FG005|Initial Physician Randomization|Physician Decision|0|||
128770254|NCT02306122|463450188|FG006|Initial Physician Randomization|Physician Decision|0|||
128770255|NCT02306122|463450189|FG007|Initial Physician Randomization|Physician Decision|0|||
129033476|NCT00177164|464412101|FG000|Overall Study|Pregnancy|0|||
129033477|NCT00177164|464412102|FG001|Overall Study|Pregnancy|1|||
128708171|NCT01606436|463226406|FG004|Overall Study|Adverse Event|0|||
128708172|NCT01606436|463226407|FG005|Overall Study|Adverse Event|0|||
128708173|NCT01606436|463226402|FG000|Overall Study|Sponsor Decision|0|||
128708174|NCT01606436|463226403|FG001|Overall Study|Sponsor Decision|0|||
128708175|NCT01606436|463226404|FG002|Overall Study|Sponsor Decision|0|||
128708176|NCT01606436|463226405|FG003|Overall Study|Sponsor Decision|1|||
128708177|NCT01606436|463226406|FG004|Overall Study|Sponsor Decision|0|||
128708178|NCT01606436|463226407|FG005|Overall Study|Sponsor Decision|0|||
128708179|NCT02859454|463226408|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
128708180|NCT01025752|463226409|FG000|Overall Study|Lost to Follow-up|7|||
128708181|NCT01025752|463226410|FG001|Overall Study|Lost to Follow-up|10|||
128708182|NCT01025752|463226409|FG000|Overall Study|Physician Decision|1|||
128708183|NCT01025752|463226410|FG001|Overall Study|Physician Decision|3|||
128708184|NCT01417234|463226413|FG000|Overall Study|Subject non-compliant|3|||
128708185|NCT00023764|463226414|FG000|Overall Study|Other|1|||
128770256|NCT02306122|463450190|FG008|Initial Physician Randomization|Physician Decision|1|||
129033478|NCT00965757|464412103|FG000|Double-blind Phase|Progression of concomitant disease|1|||
129033479|NCT00965757|464412104|FG001|Double-blind Phase|Progression of concomitant disease|2|||
129033480|NCT00965757|464412105|FG002|Double-blind Phase|Progression of concomitant disease|0|||
129033481|NCT00965757|464412106|FG003|Double-blind Phase|Progression of concomitant disease|0|||
128770257|NCT02306122|463450191|FG009|Initial Physician Randomization|Physician Decision|0|||
129033482|NCT00965757|464412103|FG000|Double-blind Phase|Adverse drug reaction|2|||
129033483|NCT00965757|464412104|FG001|Double-blind Phase|Adverse drug reaction|1|||
129033484|NCT00965757|464412105|FG002|Double-blind Phase|Adverse drug reaction|0|||
128708186|NCT00023764|463226414|FG000|Overall Study|Adverse Event|4|||
128770258|NCT02306122|463450192|FG010|Initial Physician Randomization|Physician Decision|0|||
128708187|NCT00023764|463226414|FG000|Overall Study|Withdrawal by Subject|1|||
128708188|NCT00023764|463226414|FG000|Overall Study|Progression of disease|6|||
129033485|NCT00965757|464412106|FG003|Double-blind Phase|Adverse drug reaction|0|||
129033486|NCT00965757|464412103|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
129033487|NCT00965757|464412104|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
129033488|NCT00965757|464412105|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
129033489|NCT00965757|464412106|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
129033490|NCT00965757|464412103|FG000|Double-blind Phase|Lack of Efficacy|7|||
129033491|NCT00965757|464412104|FG001|Double-blind Phase|Lack of Efficacy|11|||
128708189|NCT00023764|463226414|FG000|Overall Study|patient received other treatment|1|||
128708190|NCT00023764|463226414|FG000|Overall Study|delay in obtaining staging images|1|||
128708191|NCT02603419|463226419|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
128708192|NCT02603419|463226420|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
128708193|NCT02603419|463226421|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
128708194|NCT02603419|463226422|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
128708195|NCT02603419|463226423|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
128708196|NCT02603419|463226424|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
128944146|NCT04891770|464081860|FG002|Overall Study|Enrolled but never treated|1|||
128944147|NCT04891770|464081858|FG000|Overall Study|Investigator's discretion|0|||
128944148|NCT04891770|464081859|FG001|Overall Study|Investigator's discretion|1|||
128944149|NCT04891770|464081860|FG002|Overall Study|Investigator's discretion|0|||
128708197|NCT02603419|463226419|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
128944150|NCT00222729|464081869|FG000|Overall Study|Adverse Event|3|||
128944151|NCT05091060|464081870|FG000|Overall Study|Lost to Follow-up|1|||
128944152|NCT01798706|464081871|FG000|Overall Study|Adverse Event|15|||
128944153|NCT01798706|464081872|FG001|Overall Study|Adverse Event|10|||
128944154|NCT01798706|464081871|FG000|Overall Study|Lack of Efficacy|0|||
128944155|NCT01798706|464081872|FG001|Overall Study|Lack of Efficacy|2|||
128944156|NCT01798706|464081871|FG000|Overall Study|Poor compliance to protocol|1|||
128944157|NCT01798706|464081872|FG001|Overall Study|Poor compliance to protocol|0|||
128944158|NCT01798706|464081871|FG000|Overall Study|Other than specified above|5|||
128944159|NCT01798706|464081872|FG001|Overall Study|Other than specified above|9|||
128944160|NCT00496873|464081873|FG000|Overall Study|Ineligible|2|||
128944161|NCT00496873|464081873|FG000|Overall Study|Death|2|||
128944162|NCT00496873|464081873|FG000|Overall Study|Withdrawal by Subject|3|||
128944163|NCT01318083|464081876|FG000|Overall Study|Adverse Event|4|||
128944164|NCT01318083|464081877|FG001|Overall Study|Adverse Event|1|||
128944165|NCT01318083|464081878|FG002|Overall Study|Adverse Event|2|||
128944166|NCT01318083|464081876|FG000|Overall Study|Withdrawal by Subject|1|||
128944167|NCT01318083|464081877|FG001|Overall Study|Withdrawal by Subject|0|||
128944168|NCT01318083|464081878|FG002|Overall Study|Withdrawal by Subject|2|||
128944169|NCT01318083|464081876|FG000|Overall Study|Lack of Efficacy|0|||
128944170|NCT01318083|464081877|FG001|Overall Study|Lack of Efficacy|0|||
128944171|NCT01318083|464081878|FG002|Overall Study|Lack of Efficacy|1|||
128944172|NCT01318083|464081876|FG000|Overall Study|Treatment Complications|1|||
128944173|NCT01318083|464081877|FG001|Overall Study|Treatment Complications|0|||
128944174|NCT01318083|464081878|FG002|Overall Study|Treatment Complications|0|||
128944175|NCT01318083|464081876|FG000|Overall Study|Lack of Study Medication Compliance|0|||
128944176|NCT01318083|464081877|FG001|Overall Study|Lack of Study Medication Compliance|1|||
128944177|NCT01318083|464081878|FG002|Overall Study|Lack of Study Medication Compliance|0|||
128944178|NCT02028338|464081879|FG000|Overall Study|Withdrawal by Subject|3|||
128944179|NCT02028338|464081880|FG001|Overall Study|Withdrawal by Subject|1|||
128944180|NCT02028338|464081879|FG000|Overall Study|Unable to contact participant|1|||
128944181|NCT02028338|464081880|FG001|Overall Study|Unable to contact participant|0|||
128944182|NCT02761993|464081890|FG000|Overall Study|Adverse Event|0|||
128944183|NCT02761993|464081891|FG001|Overall Study|Adverse Event|2|||
128944184|NCT02761993|464081892|FG002|Overall Study|Adverse Event|0|||
128944185|NCT02761993|464081890|FG000|Overall Study|Lost to Follow-up|1|||
128944186|NCT02761993|464081891|FG001|Overall Study|Lost to Follow-up|3|||
128944187|NCT02761993|464081892|FG002|Overall Study|Lost to Follow-up|2|||
128944188|NCT02761993|464081890|FG000|Overall Study|Withdrawal by Subject|1|||
128944189|NCT02761993|464081891|FG001|Overall Study|Withdrawal by Subject|1|||
128944190|NCT02761993|464081892|FG002|Overall Study|Withdrawal by Subject|2|||
128944191|NCT01842620|464081893|FG000|Period 1|Withdrawal by Subject|1|||
128944192|NCT01842620|464081894|FG001|Period 1|Withdrawal by Subject|0|||
128944193|NCT00256867|464081895|FG000|Overall Study|Adverse Event|0|||
128944194|NCT00256867|464081896|FG001|Overall Study|Adverse Event|1|||
128944195|NCT00256867|464081897|FG002|Overall Study|Adverse Event|1|||
128944196|NCT00256867|464081898|FG003|Overall Study|Adverse Event|1|||
128944197|NCT00256867|464081899|FG004|Overall Study|Adverse Event|2|||
128944198|NCT00256867|464081900|FG005|Overall Study|Adverse Event|2|||
128944199|NCT00256867|464081901|FG006|Overall Study|Adverse Event|1|||
129033492|NCT00965757|464412105|FG002|Double-blind Phase|Lack of Efficacy|0|||
129033493|NCT00965757|464412106|FG003|Double-blind Phase|Lack of Efficacy|0|||
129033494|NCT00965757|464412103|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
129033495|NCT00965757|464412104|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
129033496|NCT00965757|464412105|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
128708198|NCT02603419|463226420|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
128944200|NCT00256867|464081902|FG007|Overall Study|Adverse Event|4|||
128944201|NCT00256867|464081895|FG000|Overall Study|Lost to Follow-up|2|||
128944202|NCT00256867|464081896|FG001|Overall Study|Lost to Follow-up|2|||
129033497|NCT00965757|464412106|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
128944203|NCT00256867|464081897|FG002|Overall Study|Lost to Follow-up|2|||
128944204|NCT00256867|464081898|FG003|Overall Study|Lost to Follow-up|3|||
128944205|NCT00256867|464081899|FG004|Overall Study|Lost to Follow-up|2|||
128944206|NCT00256867|464081900|FG005|Overall Study|Lost to Follow-up|0|||
129033498|NCT00965757|464412103|FG000|Double-blind Phase|Lost to Follow-up|0|||
129033499|NCT00965757|464412104|FG001|Double-blind Phase|Lost to Follow-up|1|||
129033500|NCT00965757|464412105|FG002|Double-blind Phase|Lost to Follow-up|0|||
129033501|NCT00965757|464412106|FG003|Double-blind Phase|Lost to Follow-up|0|||
129033502|NCT00965757|464412103|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
129033503|NCT00965757|464412104|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
129033504|NCT00965757|464412105|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
129033505|NCT00965757|464412106|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
129033506|NCT00965757|464412103|FG000|Double-blind Phase|Other|1|||
129033507|NCT00965757|464412104|FG001|Double-blind Phase|Other|0|||
128708199|NCT02603419|463226421|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
128708200|NCT02603419|463226422|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
128708201|NCT02603419|463226423|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
128708202|NCT02603419|463226424|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
129033508|NCT00965757|464412105|FG002|Double-blind Phase|Other|0|||
129033509|NCT00965757|464412106|FG003|Double-blind Phase|Other|0|||
129033510|NCT00965757|464412103|FG000|Extension Phase|Progression of concomitant disease|0|||
129033511|NCT00965757|464412104|FG001|Extension Phase|Progression of concomitant disease|0|||
129033512|NCT00965757|464412105|FG002|Extension Phase|Progression of concomitant disease|4|||
129033513|NCT00965757|464412106|FG003|Extension Phase|Progression of concomitant disease|2|||
129033514|NCT00965757|464412103|FG000|Extension Phase|Adverse drug reaction|0|||
129033515|NCT00965757|464412104|FG001|Extension Phase|Adverse drug reaction|0|||
129033516|NCT00965757|464412105|FG002|Extension Phase|Adverse drug reaction|6|||
129033517|NCT00965757|464412106|FG003|Extension Phase|Adverse drug reaction|3|||
129033518|NCT00965757|464412103|FG000|Extension Phase|Abnormal Laboratory Value|0|||
129033519|NCT00965757|464412104|FG001|Extension Phase|Abnormal Laboratory Value|0|||
129033520|NCT00965757|464412105|FG002|Extension Phase|Abnormal Laboratory Value|6|||
129033521|NCT00965757|464412106|FG003|Extension Phase|Abnormal Laboratory Value|1|||
129033522|NCT00965757|464412103|FG000|Extension Phase|Lack of Efficacy|0|||
129033523|NCT00965757|464412104|FG001|Extension Phase|Lack of Efficacy|0|||
129033524|NCT00965757|464412105|FG002|Extension Phase|Lack of Efficacy|8|||
129033525|NCT00965757|464412106|FG003|Extension Phase|Lack of Efficacy|12|||
129033526|NCT00965757|464412103|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
129033527|NCT00965757|464412104|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
129033528|NCT00965757|464412105|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
129033529|NCT00965757|464412106|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
129033530|NCT00965757|464412103|FG000|Extension Phase|Lost to Follow-up|0|||
129033531|NCT00965757|464412104|FG001|Extension Phase|Lost to Follow-up|0|||
129033532|NCT00965757|464412105|FG002|Extension Phase|Lost to Follow-up|0|||
129033533|NCT00965757|464412106|FG003|Extension Phase|Lost to Follow-up|1|||
129033534|NCT00965757|464412103|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
129033535|NCT00965757|464412104|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
129033536|NCT00965757|464412105|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
128708203|NCT02603419|463226419|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
128944207|NCT00256867|464081901|FG006|Overall Study|Lost to Follow-up|1|||
128944208|NCT00256867|464081902|FG007|Overall Study|Lost to Follow-up|2|||
128944209|NCT00256867|464081895|FG000|Overall Study|Protocol Violation|0|||
128944210|NCT00256867|464081896|FG001|Overall Study|Protocol Violation|0|||
128944211|NCT00256867|464081897|FG002|Overall Study|Protocol Violation|0|||
128944212|NCT00256867|464081898|FG003|Overall Study|Protocol Violation|1|||
128944213|NCT00256867|464081899|FG004|Overall Study|Protocol Violation|0|||
128944214|NCT00256867|464081900|FG005|Overall Study|Protocol Violation|1|||
128944215|NCT00256867|464081901|FG006|Overall Study|Protocol Violation|0|||
128944216|NCT00256867|464081902|FG007|Overall Study|Protocol Violation|1|||
128944217|NCT00256867|464081895|FG000|Overall Study|Withdrawal by Subject|0|||
128944218|NCT00256867|464081896|FG001|Overall Study|Withdrawal by Subject|0|||
128944219|NCT00256867|464081897|FG002|Overall Study|Withdrawal by Subject|1|||
128944220|NCT00256867|464081898|FG003|Overall Study|Withdrawal by Subject|1|||
129033537|NCT00965757|464412106|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
129033538|NCT00965757|464412103|FG000|Extension Phase|Protocol Violation|0|||
129033539|NCT00965757|464412104|FG001|Extension Phase|Protocol Violation|0|||
129033540|NCT00965757|464412105|FG002|Extension Phase|Protocol Violation|0|||
129033541|NCT00965757|464412106|FG003|Extension Phase|Protocol Violation|1|||
129033542|NCT00965757|464412103|FG000|Extension Phase|Other|0|||
128770259|NCT02262260|463450195|FG000|Overall Study|Adverse Event|4|||
128944221|NCT00256867|464081899|FG004|Overall Study|Withdrawal by Subject|2|||
128944222|NCT00256867|464081900|FG005|Overall Study|Withdrawal by Subject|2|||
129033543|NCT00965757|464412104|FG001|Extension Phase|Other|0|||
129033544|NCT00965757|464412105|FG002|Extension Phase|Other|2|||
129123456|NCT01432327|464746972|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
129123457|NCT01432327|464746973|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
129033545|NCT00965757|464412106|FG003|Extension Phase|Other|1|||
129033546|NCT02451358|464412107|FG000|Overall Study|Withdrawal by Subject|1|||
129033547|NCT02451358|464412108|FG001|Overall Study|Withdrawal by Subject|1|||
129033548|NCT02451358|464412109|FG002|Overall Study|Withdrawal by Subject|0|||
129123458|NCT01432327|464746974|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
129123459|NCT01432327|464746975|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
128944223|NCT00256867|464081901|FG006|Overall Study|Withdrawal by Subject|3|||
128944224|NCT00256867|464081902|FG007|Overall Study|Withdrawal by Subject|2|||
128944225|NCT00256867|464081895|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
128944226|NCT00256867|464081896|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
128944227|NCT00256867|464081897|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
128944228|NCT00256867|464081898|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
128944229|NCT00256867|464081899|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
128944230|NCT00256867|464081900|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
128944231|NCT00256867|464081901|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
128944232|NCT00256867|464081902|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
128944233|NCT00256867|464081895|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
128944234|NCT00256867|464081896|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
128944235|NCT00256867|464081897|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
128944236|NCT00256867|464081898|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
128944237|NCT00256867|464081899|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
128944238|NCT00256867|464081900|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
128944239|NCT00256867|464081901|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
128944240|NCT00256867|464081902|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
128944241|NCT00256867|464081895|FG000|Overall Study|Investigator's Decision|0|||
128944242|NCT00256867|464081896|FG001|Overall Study|Investigator's Decision|0|||
128944243|NCT00256867|464081897|FG002|Overall Study|Investigator's Decision|0|||
128944244|NCT00256867|464081898|FG003|Overall Study|Investigator's Decision|0|||
128944245|NCT00256867|464081899|FG004|Overall Study|Investigator's Decision|1|||
128944246|NCT00256867|464081900|FG005|Overall Study|Investigator's Decision|0|||
128944247|NCT00256867|464081901|FG006|Overall Study|Investigator's Decision|0|||
128944248|NCT00256867|464081902|FG007|Overall Study|Investigator's Decision|0|||
128944249|NCT00256867|464081895|FG000|Overall Study|Non-compliance with study medication|0|||
128944250|NCT00256867|464081896|FG001|Overall Study|Non-compliance with study medication|0|||
128944251|NCT00256867|464081897|FG002|Overall Study|Non-compliance with study medication|0|||
128944252|NCT00256867|464081898|FG003|Overall Study|Non-compliance with study medication|0|||
128944253|NCT00256867|464081899|FG004|Overall Study|Non-compliance with study medication|0|||
128944254|NCT00256867|464081900|FG005|Overall Study|Non-compliance with study medication|0|||
128944255|NCT00256867|464081901|FG006|Overall Study|Non-compliance with study medication|0|||
128944256|NCT00256867|464081902|FG007|Overall Study|Non-compliance with study medication|1|||
128944257|NCT00256867|464081895|FG000|Overall Study|Participant travelled Overseas|0|||
128944258|NCT00256867|464081896|FG001|Overall Study|Participant travelled Overseas|1|||
128944259|NCT00256867|464081897|FG002|Overall Study|Participant travelled Overseas|0|||
128944260|NCT00256867|464081898|FG003|Overall Study|Participant travelled Overseas|0|||
128944261|NCT00256867|464081899|FG004|Overall Study|Participant travelled Overseas|0|||
128944262|NCT00256867|464081900|FG005|Overall Study|Participant travelled Overseas|0|||
128944263|NCT00256867|464081901|FG006|Overall Study|Participant travelled Overseas|0|||
128944264|NCT00256867|464081902|FG007|Overall Study|Participant travelled Overseas|0|||
128944265|NCT00256867|464081895|FG000|Overall Study|Participant out of assessment window|0|||
128944266|NCT00256867|464081896|FG001|Overall Study|Participant out of assessment window|0|||
128944267|NCT00256867|464081897|FG002|Overall Study|Participant out of assessment window|1|||
128944268|NCT00256867|464081898|FG003|Overall Study|Participant out of assessment window|0|||
128944269|NCT00256867|464081899|FG004|Overall Study|Participant out of assessment window|0|||
128944270|NCT00256867|464081900|FG005|Overall Study|Participant out of assessment window|0|||
128944271|NCT00256867|464081901|FG006|Overall Study|Participant out of assessment window|0|||
128944272|NCT00256867|464081902|FG007|Overall Study|Participant out of assessment window|0|||
128944273|NCT00256867|464081895|FG000|Overall Study|Withdrawal by participant|0|||
128944274|NCT00256867|464081896|FG001|Overall Study|Withdrawal by participant|0|||
128944275|NCT00256867|464081897|FG002|Overall Study|Withdrawal by participant|0|||
128944276|NCT00256867|464081898|FG003|Overall Study|Withdrawal by participant|0|||
128944277|NCT00256867|464081899|FG004|Overall Study|Withdrawal by participant|0|||
128944278|NCT00256867|464081900|FG005|Overall Study|Withdrawal by participant|1|||
128944279|NCT00256867|464081901|FG006|Overall Study|Withdrawal by participant|0|||
128944280|NCT00256867|464081902|FG007|Overall Study|Withdrawal by participant|0|||
128944281|NCT02993224|464081903|FG000|Core Phase - Period 1|Adverse Event|4|||
129123460|NCT01432327|464746972|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
128944282|NCT02993224|464081903|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
128944283|NCT02993224|464081903|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
128944284|NCT02993224|464081903|FG000|Core Phase- Period 2|Adverse Event|1|||
128944285|NCT02993224|464081903|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
128944286|NCT02993224|464081903|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
129123461|NCT01432327|464746973|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
129123462|NCT01432327|464746974|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
128708204|NCT02603419|463226420|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
128708205|NCT02603419|463226421|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
128944287|NCT02993224|464081903|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
128944288|NCT02993224|464081903|FG000|Extension Phase|Adverse Event|3|||
128944289|NCT02993224|464081903|FG000|Extension Phase|Withdrawal by Subject|3|||
128944290|NCT02993224|464081903|FG000|Extension Phase|Lost to Follow-up|2|||
128944291|NCT02993224|464081903|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
128944292|NCT01930799|464081905|FG000|Overall Study|Withdrawal by Subject|3|||
128944293|NCT01930799|464081905|FG000|Overall Study|Lost to Follow-up|5|||
128944294|NCT00952289|464081906|FG000|All Participants|Death|9|||
128944295|NCT00952289|464081907|FG001|All Participants|Death|9|||
128944296|NCT00952289|464081906|FG000|All Participants|Adverse Event|8|||
128944297|NCT00952289|464081907|FG001|All Participants|Adverse Event|8|||
128944298|NCT00952289|464081906|FG000|All Participants|Disease progression|3|||
128944299|NCT00952289|464081907|FG001|All Participants|Disease progression|12|||
128944300|NCT00952289|464081906|FG000|All Participants|Withdrawal by Subject|1|||
128944301|NCT00952289|464081907|FG001|All Participants|Withdrawal by Subject|10|||
128944302|NCT00952289|464081906|FG000|All Participants|Data lost during site relocation|0|||
128944303|NCT00952289|464081907|FG001|All Participants|Data lost during site relocation|1|||
128944304|NCT00952289|464081906|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
128944305|NCT00952289|464081907|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
128944306|NCT00952289|464081906|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
128944307|NCT00952289|464081907|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
128944308|NCT00952289|464081906|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
128944309|NCT00952289|464081907|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
128944310|NCT00952289|464081906|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
128944311|NCT00952289|464081907|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
128944312|NCT00952289|464081906|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
128944313|NCT00952289|464081907|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
128944314|NCT00875017|464081908|FG000|First Intervention|Withdrawal by Subject|1|||
128944315|NCT00875017|464081909|FG001|First Intervention|Withdrawal by Subject|0|||
128944316|NCT00875017|464081910|FG002|First Intervention|Withdrawal by Subject|1|||
128944317|NCT00875017|464081911|FG003|First Intervention|Withdrawal by Subject|0|||
128944318|NCT00875017|464081912|FG004|First Intervention|Withdrawal by Subject|0|||
128944319|NCT00875017|464081913|FG005|First Intervention|Withdrawal by Subject|0|||
128944320|NCT00875017|464081908|FG000|First Intervention|Adverse Event|0|||
128944321|NCT00875017|464081909|FG001|First Intervention|Adverse Event|0|||
128944322|NCT00875017|464081910|FG002|First Intervention|Adverse Event|0|||
128944323|NCT00875017|464081911|FG003|First Intervention|Adverse Event|1|||
128944324|NCT00875017|464081912|FG004|First Intervention|Adverse Event|0|||
128944325|NCT00875017|464081913|FG005|First Intervention|Adverse Event|0|||
128944326|NCT00875017|464081908|FG000|First Intervention|Problems collecting rectal effluent|1|||
128944327|NCT00875017|464081909|FG001|First Intervention|Problems collecting rectal effluent|0|||
128944328|NCT00875017|464081910|FG002|First Intervention|Problems collecting rectal effluent|0|||
128944329|NCT00875017|464081911|FG003|First Intervention|Problems collecting rectal effluent|0|||
128944330|NCT00875017|464081912|FG004|First Intervention|Problems collecting rectal effluent|0|||
128944331|NCT00875017|464081913|FG005|First Intervention|Problems collecting rectal effluent|0|||
128944332|NCT00875017|464081908|FG000|First Intervention|Intolerance to nasogastric tube|0|||
128944333|NCT00875017|464081909|FG001|First Intervention|Intolerance to nasogastric tube|0|||
128944334|NCT00875017|464081910|FG002|First Intervention|Intolerance to nasogastric tube|0|||
128944335|NCT00875017|464081911|FG003|First Intervention|Intolerance to nasogastric tube|0|||
128944336|NCT00875017|464081912|FG004|First Intervention|Intolerance to nasogastric tube|1|||
129217766|NCT03313037|465097063|FG000|Overall Study|Protocol Violation|4|||
128708206|NCT02603419|463226422|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
128708207|NCT02603419|463226423|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
128708208|NCT02603419|463226424|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
128708209|NCT02603419|463226419|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
128770260|NCT02262260|463450196|FG001|Overall Study|Adverse Event|1|||
128944337|NCT00875017|464081913|FG005|First Intervention|Intolerance to nasogastric tube|0|||
128944338|NCT00875017|464081908|FG000|Washout|Problem collecting rectal effluent|0|||
128944339|NCT00875017|464081909|FG001|Washout|Problem collecting rectal effluent|0|||
128944340|NCT00875017|464081910|FG002|Washout|Problem collecting rectal effluent|1|||
128944341|NCT00875017|464081911|FG003|Washout|Problem collecting rectal effluent|0|||
128944342|NCT00875017|464081912|FG004|Washout|Problem collecting rectal effluent|0|||
128944343|NCT00875017|464081913|FG005|Washout|Problem collecting rectal effluent|0|||
128944344|NCT00875017|464081908|FG000|Second Intervention|Adverse Event|0|||
128944345|NCT00875017|464081909|FG001|Second Intervention|Adverse Event|0|||
128944346|NCT00875017|464081910|FG002|Second Intervention|Adverse Event|0|||
129217767|NCT03313037|465097064|FG001|Overall Study|Protocol Violation|1|||
129217768|NCT03313037|465097063|FG000|Overall Study|Other|1|||
129217769|NCT03313037|465097064|FG001|Overall Study|Other|1|||
128770261|NCT02262260|463450195|FG000|Overall Study|Withdrawal of consent|4|||
128770262|NCT02262260|463450196|FG001|Overall Study|Withdrawal of consent|2|||
128944347|NCT00875017|464081911|FG003|Second Intervention|Adverse Event|1|||
128944348|NCT00875017|464081912|FG004|Second Intervention|Adverse Event|0|||
128944349|NCT00875017|464081913|FG005|Second Intervention|Adverse Event|0|||
128944350|NCT00875017|464081908|FG000|Washout|Problems collecting rectal effluent|0|||
128944351|NCT00875017|464081909|FG001|Washout|Problems collecting rectal effluent|1|||
128944352|NCT00875017|464081910|FG002|Washout|Problems collecting rectal effluent|0|||
128944353|NCT00875017|464081911|FG003|Washout|Problems collecting rectal effluent|0|||
128944354|NCT00875017|464081912|FG004|Washout|Problems collecting rectal effluent|0|||
128944355|NCT00875017|464081913|FG005|Washout|Problems collecting rectal effluent|0|||
128944356|NCT00875017|464081908|FG000|Third Intervention|Adverse Event|0|||
128944357|NCT00875017|464081909|FG001|Third Intervention|Adverse Event|1|||
128944358|NCT00875017|464081910|FG002|Third Intervention|Adverse Event|1|||
128944359|NCT00875017|464081911|FG003|Third Intervention|Adverse Event|0|||
128944360|NCT00875017|464081912|FG004|Third Intervention|Adverse Event|0|||
128944361|NCT00875017|464081913|FG005|Third Intervention|Adverse Event|0|||
128944362|NCT00875017|464081908|FG000|Washout|Withdrawal by Subject|0|||
128944363|NCT00875017|464081909|FG001|Washout|Withdrawal by Subject|0|||
128944364|NCT00875017|464081910|FG002|Washout|Withdrawal by Subject|0|||
128944365|NCT00875017|464081911|FG003|Washout|Withdrawal by Subject|0|||
128944366|NCT00875017|464081912|FG004|Washout|Withdrawal by Subject|1|||
128944367|NCT00875017|464081913|FG005|Washout|Withdrawal by Subject|0|||
128944368|NCT00875017|464081908|FG000|Fourth Intervention|Inability to comply with fasting|0|||
128944369|NCT00875017|464081909|FG001|Fourth Intervention|Inability to comply with fasting|0|||
128944370|NCT00875017|464081910|FG002|Fourth Intervention|Inability to comply with fasting|0|||
128944371|NCT00875017|464081911|FG003|Fourth Intervention|Inability to comply with fasting|0|||
128944372|NCT00875017|464081912|FG004|Fourth Intervention|Inability to comply with fasting|0|||
128944373|NCT00875017|464081913|FG005|Fourth Intervention|Inability to comply with fasting|1|||
128944374|NCT03342469|464081914|FG000|Overall Study|Withdrawal by Subject|0|||
128944375|NCT03342469|464081915|FG001|Overall Study|Withdrawal by Subject|1|||
128944376|NCT03342469|464081916|FG002|Overall Study|Withdrawal by Subject|0|||
128944377|NCT03342469|464081917|FG003|Overall Study|Withdrawal by Subject|0|||
128944378|NCT03136185|464081925|FG000|Overall Study|Adverse Event|0|||
128944379|NCT03136185|464081926|FG001|Overall Study|Adverse Event|1|||
128944380|NCT03136185|464081927|FG002|Overall Study|Adverse Event|3|||
128944381|NCT03136185|464081928|FG003|Overall Study|Adverse Event|1|||
128944382|NCT03136185|464081929|FG004|Overall Study|Adverse Event|2|||
128944383|NCT03136185|464081930|FG005|Overall Study|Adverse Event|2|||
128944384|NCT03136185|464081931|FG006|Overall Study|Adverse Event|5|||
128944385|NCT03136185|464081932|FG007|Overall Study|Adverse Event|1|||
128944386|NCT03136185|464081933|FG008|Overall Study|Adverse Event|1|||
128944387|NCT03136185|464081925|FG000|Overall Study|Death|0|||
128944388|NCT03136185|464081926|FG001|Overall Study|Death|0|||
128944389|NCT03136185|464081927|FG002|Overall Study|Death|0|||
128944390|NCT03136185|464081928|FG003|Overall Study|Death|1|||
128944391|NCT03136185|464081929|FG004|Overall Study|Death|1|||
128944392|NCT03136185|464081930|FG005|Overall Study|Death|0|||
128944393|NCT03136185|464081931|FG006|Overall Study|Death|1|||
128944394|NCT03136185|464081932|FG007|Overall Study|Death|0|||
128944395|NCT03136185|464081933|FG008|Overall Study|Death|0|||
128944396|NCT03136185|464081925|FG000|Overall Study|Physician Decision|3|||
129123463|NCT01432327|464746975|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
129123464|NCT01432327|464746972|FG000|Posttest 1 Year|Lost to Follow-up|0|||
129123465|NCT01432327|464746973|FG001|Posttest 1 Year|Lost to Follow-up|0|||
129123466|NCT01432327|464746974|FG002|Posttest 1 Year|Lost to Follow-up|4|||
128944397|NCT03136185|464081926|FG001|Overall Study|Physician Decision|1|||
128944398|NCT03136185|464081927|FG002|Overall Study|Physician Decision|1|||
128944399|NCT03136185|464081928|FG003|Overall Study|Physician Decision|2|||
128944400|NCT03136185|464081929|FG004|Overall Study|Physician Decision|1|||
128944401|NCT03136185|464081930|FG005|Overall Study|Physician Decision|2|||
128944402|NCT03136185|464081931|FG006|Overall Study|Physician Decision|1|||
128944403|NCT03136185|464081932|FG007|Overall Study|Physician Decision|0|||
128944404|NCT03136185|464081933|FG008|Overall Study|Physician Decision|1|||
128944405|NCT03136185|464081925|FG000|Overall Study|Protocol Defined Disease Progression|0|||
128944406|NCT03136185|464081926|FG001|Overall Study|Protocol Defined Disease Progression|0|||
128944407|NCT03136185|464081927|FG002|Overall Study|Protocol Defined Disease Progression|1|||
129123467|NCT01432327|464746975|FG003|Posttest 1 Year|Lost to Follow-up|2|||
128944408|NCT03136185|464081928|FG003|Overall Study|Protocol Defined Disease Progression|0|||
128944409|NCT03136185|464081929|FG004|Overall Study|Protocol Defined Disease Progression|0|||
128944410|NCT03136185|464081930|FG005|Overall Study|Protocol Defined Disease Progression|1|||
128944411|NCT03136185|464081931|FG006|Overall Study|Protocol Defined Disease Progression|0|||
128944412|NCT03136185|464081932|FG007|Overall Study|Protocol Defined Disease Progression|1|||
128944413|NCT03136185|464081933|FG008|Overall Study|Protocol Defined Disease Progression|1|||
128944414|NCT03136185|464081925|FG000|Overall Study|Withdrawal by Subject|1|||
128770263|NCT02262260|463450195|FG000|Overall Study|Lost to Follow-up|1|||
128944415|NCT03136185|464081926|FG001|Overall Study|Withdrawal by Subject|0|||
128944416|NCT03136185|464081927|FG002|Overall Study|Withdrawal by Subject|1|||
128944417|NCT03136185|464081928|FG003|Overall Study|Withdrawal by Subject|1|||
128944418|NCT03136185|464081929|FG004|Overall Study|Withdrawal by Subject|1|||
128944419|NCT03136185|464081930|FG005|Overall Study|Withdrawal by Subject|1|||
128944420|NCT03136185|464081931|FG006|Overall Study|Withdrawal by Subject|2|||
128944421|NCT03136185|464081932|FG007|Overall Study|Withdrawal by Subject|3|||
128944422|NCT03136185|464081933|FG008|Overall Study|Withdrawal by Subject|3|||
128944423|NCT03136185|464081925|FG000|Overall Study|Not Reported|4|||
128944424|NCT03136185|464081926|FG001|Overall Study|Not Reported|1|||
128944425|NCT03136185|464081927|FG002|Overall Study|Not Reported|0|||
128944426|NCT03136185|464081928|FG003|Overall Study|Not Reported|1|||
128944427|NCT03136185|464081929|FG004|Overall Study|Not Reported|0|||
128944428|NCT03136185|464081930|FG005|Overall Study|Not Reported|2|||
128944429|NCT03136185|464081931|FG006|Overall Study|Not Reported|1|||
128944430|NCT03136185|464081932|FG007|Overall Study|Not Reported|1|||
128944431|NCT03136185|464081933|FG008|Overall Study|Not Reported|0|||
128944432|NCT00364845|464081939|FG000|Overall Study|Adverse Event|1|||
128944433|NCT00364845|464081940|FG001|Overall Study|Adverse Event|0|||
128944434|NCT00364845|464081939|FG000|Overall Study|Withdrawal by Subject|2|||
128944435|NCT00364845|464081940|FG001|Overall Study|Withdrawal by Subject|1|||
128944436|NCT00364845|464081939|FG000|Overall Study|Physician Decision|8|||
128944437|NCT00364845|464081940|FG001|Overall Study|Physician Decision|8|||
128944438|NCT00364845|464081939|FG000|Overall Study|Lost to Follow-up|0|||
128944439|NCT00364845|464081940|FG001|Overall Study|Lost to Follow-up|1|||
128944440|NCT00364845|464081939|FG000|Overall Study|Death|0|||
128944441|NCT00364845|464081940|FG001|Overall Study|Death|1|||
128944442|NCT04160468|464081941|FG000|Overall Study|Lost to Follow-up|19|||
128944443|NCT04160468|464081942|FG001|Overall Study|Lost to Follow-up|4|||
128944444|NCT04160468|464081941|FG000|Overall Study|Randomized but not dosed|6|||
128944445|NCT04160468|464081942|FG001|Overall Study|Randomized but not dosed|0|||
128944446|NCT04160468|464081941|FG000|Overall Study|Withdrawal by Subject|4|||
128944447|NCT04160468|464081942|FG001|Overall Study|Withdrawal by Subject|1|||
128944448|NCT04160468|464081941|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
128944449|NCT04160468|464081942|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
128944450|NCT04160468|464081941|FG000|Overall Study|Participant incarcerated|1|||
128944451|NCT04160468|464081942|FG001|Overall Study|Participant incarcerated|0|||
128944452|NCT01187901|464081943|FG000|Overall Study|Protocol Violation|1|||
128944453|NCT01187901|464081944|FG001|Overall Study|Protocol Violation|0|||
128944454|NCT01187901|464081943|FG000|Overall Study|Lost to Follow-up|1|||
128944455|NCT01187901|464081944|FG001|Overall Study|Lost to Follow-up|2|||
128944456|NCT01187901|464081943|FG000|Overall Study|Unrelated Health Reasons|1|||
128944457|NCT01187901|464081944|FG001|Overall Study|Unrelated Health Reasons|2|||
128944458|NCT01187901|464081943|FG000|Overall Study|Suspected Allergic Reaction|1|||
128944459|NCT01187901|464081944|FG001|Overall Study|Suspected Allergic Reaction|1|||
128944460|NCT01187901|464081943|FG000|Overall Study|Adverse Event|3|||
128944461|NCT01187901|464081944|FG001|Overall Study|Adverse Event|0|||
128944462|NCT01187901|464081943|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
128944463|NCT01187901|464081944|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
128944464|NCT01187901|464081943|FG000|Overall Study|Pregnancy|0|||
128944465|NCT01187901|464081944|FG001|Overall Study|Pregnancy|2|||
128944466|NCT01912768|464081945|FG000|Overall Study|Adverse Event|2|||
128944467|NCT01912768|464081946|FG001|Overall Study|Adverse Event|0|||
128944468|NCT01912768|464081945|FG000|Overall Study|Lost to Follow-up|2|||
128944469|NCT01912768|464081946|FG001|Overall Study|Lost to Follow-up|1|||
128944470|NCT01912768|464081945|FG000|Overall Study|Withdrawal by Subject|5|||
128944471|NCT01912768|464081946|FG001|Overall Study|Withdrawal by Subject|3|||
128944472|NCT01912768|464081945|FG000|Overall Study|Randomized in error|1|||
129033549|NCT02451358|464412110|FG003|Overall Study|Withdrawal by Subject|0|||
129033550|NCT02451358|464412107|FG000|Overall Study|Protocol Violation|0|||
129033551|NCT02451358|464412108|FG001|Overall Study|Protocol Violation|1|||
128944473|NCT01912768|464081946|FG001|Overall Study|Randomized in error|0|||
128944474|NCT00488033|464081947|FG000|Overall Study|Withdrawal by Subject|1|||
128944475|NCT00488033|464081948|FG001|Overall Study|Withdrawal by Subject|0|||
128944476|NCT04715230|464081955|FG000|Overall Study|Withdrawal by Subject|1|||
128944477|NCT04715230|464081956|FG001|Overall Study|Withdrawal by Subject|0|||
128944478|NCT04715230|464081957|FG002|Overall Study|Withdrawal by Subject|0|||
128944479|NCT04715230|464081955|FG000|Overall Study|Lost to Follow-up|0|||
128944480|NCT04715230|464081956|FG001|Overall Study|Lost to Follow-up|5|||
128944481|NCT04715230|464081957|FG002|Overall Study|Lost to Follow-up|1|||
129033552|NCT02451358|464412109|FG002|Overall Study|Protocol Violation|1|||
128944482|NCT03453151|464081958|FG000|Overall Study|Withdrawal by Subject|1|||
128944483|NCT03453151|464081958|FG000|Overall Study|Physician Decision|3|||
128944484|NCT00488618|464081963|FG000|Overall Study|Adverse Event|13|||
128944485|NCT00488618|464081964|FG001|Overall Study|Adverse Event|17|||
128944486|NCT00488618|464081963|FG000|Overall Study|Insufficient Therapeutic Response|18|||
128944487|NCT00488618|464081964|FG001|Overall Study|Insufficient Therapeutic Response|11|||
128944488|NCT00488618|464081963|FG000|Overall Study|Protocol Violation|0|||
128944489|NCT00488618|464081964|FG001|Overall Study|Protocol Violation|2|||
128944490|NCT00488618|464081963|FG000|Overall Study|Withdrawal of Consent|15|||
128944491|NCT00488618|464081964|FG001|Overall Study|Withdrawal of Consent|13|||
128944492|NCT00488618|464081963|FG000|Overall Study|Lost to Follow-up|1|||
128944493|NCT00488618|464081964|FG001|Overall Study|Lost to Follow-up|0|||
128944494|NCT01575197|464083343|FG000|Overall Study|Migration out of study area|1|||
128944495|NCT01575197|464083344|FG001|Overall Study|Migration out of study area|5|||
128944496|NCT01575197|464083345|FG002|Overall Study|Migration out of study area|4|||
128944497|NCT01575197|464083343|FG000|Overall Study|SAE|0|||
128944498|NCT01575197|464083344|FG001|Overall Study|SAE|1|||
128944499|NCT01575197|464083345|FG002|Overall Study|SAE|0|||
128944500|NCT01575197|464083343|FG000|Overall Study|Lost to Follow-up|0|||
128944501|NCT01575197|464083344|FG001|Overall Study|Lost to Follow-up|1|||
128944502|NCT01575197|464083345|FG002|Overall Study|Lost to Follow-up|0|||
128944503|NCT01575197|464083343|FG000|Overall Study|Withdrawal by Subject|0|||
128944504|NCT01575197|464083344|FG001|Overall Study|Withdrawal by Subject|1|||
128944505|NCT01575197|464083345|FG002|Overall Study|Withdrawal by Subject|1|||
128944506|NCT01575197|464083343|FG000|Overall Study|Protocol Violation|2|||
128944507|NCT01575197|464083344|FG001|Overall Study|Protocol Violation|1|||
128944508|NCT01575197|464083345|FG002|Overall Study|Protocol Violation|1|||
128944509|NCT00111475|464083349|FG000|Overall Study|Lost to Follow-up|0|||
128944510|NCT00111475|464083350|FG001|Overall Study|Lost to Follow-up|0|||
128944511|NCT00111475|464083351|FG002|Overall Study|Lost to Follow-up|0|||
128944512|NCT00111475|464083352|FG003|Overall Study|Lost to Follow-up|0|||
128944513|NCT00111475|464083353|FG004|Overall Study|Lost to Follow-up|0|||
128944514|NCT00111475|464083354|FG005|Overall Study|Lost to Follow-up|1|||
128944515|NCT00111475|464083355|FG006|Overall Study|Lost to Follow-up|0|||
128944516|NCT00111475|464083356|FG007|Overall Study|Lost to Follow-up|0|||
128944517|NCT00111475|464083357|FG008|Overall Study|Lost to Follow-up|0|||
128944518|NCT00111475|464083358|FG009|Overall Study|Lost to Follow-up|0|||
128944519|NCT03303092|464083359|FG000|Overall Study|Adverse Event|1|||
128944520|NCT03303092|464083360|FG001|Overall Study|Adverse Event|0|||
128944521|NCT03303092|464083361|FG002|Overall Study|Adverse Event|1|||
128944522|NCT03303092|464083359|FG000|Overall Study|Protocol Violation|1|||
128944523|NCT03303092|464083360|FG001|Overall Study|Protocol Violation|5|||
128944524|NCT03303092|464083361|FG002|Overall Study|Protocol Violation|1|||
128944525|NCT03303092|464083359|FG000|Overall Study|Withdrawal by Subject|1|||
128944526|NCT03303092|464083360|FG001|Overall Study|Withdrawal by Subject|1|||
128944527|NCT03303092|464083361|FG002|Overall Study|Withdrawal by Subject|3|||
128944528|NCT04281030|464083367|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
128944529|NCT04281030|464083368|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
128944530|NCT04281030|464083367|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
128944531|NCT04281030|464083368|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
128944532|NCT01361009|464083369|FG000|Overall Study|Protocol Violation|116|||
128944533|NCT01826422|464083370|FG000|Overall Study|Withdrawal by Subject|1|||
128944534|NCT01826422|464083371|FG001|Overall Study|Withdrawal by Subject|3|||
128944535|NCT03439748|464083374|FG000|Overall Study|Withdrawal by Subject|11|||
128944536|NCT03439748|464083375|FG001|Overall Study|Withdrawal by Subject|17|||
128944537|NCT05131451|464083376|FG000|Overall Study|Protocol Violation|1|||
128944538|NCT05131451|464083377|FG001|Overall Study|Protocol Violation|0|||
128944539|NCT00782418|464083384|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
128944540|NCT00782418|464083385|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
128944541|NCT00782418|464083386|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
128944542|NCT00782418|464083387|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
128944543|NCT00782418|464083388|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
128944544|NCT00782418|464083389|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
128944545|NCT00782418|464083390|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
128944546|NCT00782418|464083384|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
128944547|NCT00782418|464083385|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
128944548|NCT00782418|464083386|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
128944549|NCT00782418|464083387|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
128944550|NCT00782418|464083388|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
128944551|NCT00782418|464083389|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
128944552|NCT00782418|464083390|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
128944553|NCT02324842|464083391|FG000|Overall Study|Lost to Follow-up|1|||
128944554|NCT02324842|464083392|FG001|Overall Study|Lost to Follow-up|1|||
128944555|NCT02324842|464083393|FG002|Overall Study|Lost to Follow-up|2|||
128944556|NCT02750800|464083394|FG000|Overall Study|Adverse Event|18|||
128944557|NCT02750800|464083394|FG000|Overall Study|Lost to Follow-up|12|||
128944558|NCT02750800|464083394|FG000|Overall Study|Investigator decision|53|||
128944559|NCT02750800|464083394|FG000|Overall Study|Patient request|12|||
128944560|NCT02750800|464083394|FG000|Overall Study|Other, not specified|3|||
128944561|NCT03298412|464083395|FG000|Run-in Period|Other, Not Specified|1|||
128944562|NCT03298412|464083395|FG000|Run-in Period|Disease Progression|1|||
128708210|NCT02603419|463226420|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
128708211|NCT02603419|463226421|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
128708212|NCT02603419|463226422|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
128708213|NCT02603419|463226423|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
128708214|NCT02603419|463226424|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
128708215|NCT02603419|463226419|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
128708216|NCT02603419|463226420|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
128708217|NCT02603419|463226421|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
128708218|NCT02603419|463226422|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
128708219|NCT02603419|463226423|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
128708220|NCT02603419|463226424|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
128708221|NCT02603419|463226419|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
128708222|NCT02603419|463226420|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
128708223|NCT02603419|463226421|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
128708224|NCT02603419|463226422|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
128708225|NCT02603419|463226423|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
128708226|NCT02603419|463226424|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
129123468|NCT01432327|464746972|FG000|Posttest 1 Year|Allergic reaction|0|||
129123469|NCT01432327|464746973|FG001|Posttest 1 Year|Allergic reaction|0|||
128708227|NCT02603419|463226419|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
128708228|NCT02603419|463226420|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
128708229|NCT02603419|463226421|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
128708230|NCT02603419|463226422|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
128708231|NCT02603419|463226423|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
128944563|NCT03298412|464083395|FG000|Run-in Period|Ineligibility Determined|1|||
129123470|NCT01432327|464746974|FG002|Posttest 1 Year|Allergic reaction|1|||
129123471|NCT01432327|464746975|FG003|Posttest 1 Year|Allergic reaction|1|||
129123472|NCT00141921|464746978|FG000|Overall Study|Remain on Study|28|||
129123473|NCT00141921|464746978|FG000|Overall Study|Withdrawal by Subject|42|||
129123474|NCT00141921|464746978|FG000|Overall Study|Lost to Follow-up|19|||
129123475|NCT00141921|464746978|FG000|Overall Study|Noncompliance|17|||
129123476|NCT00141921|464746978|FG000|Overall Study|Disease Progression|7|||
129123477|NCT00141921|464746978|FG000|Overall Study|Protocol Deviation|7|||
129123478|NCT00141921|464746978|FG000|Overall Study|Adverse Event|5|||
129217770|NCT03313037|465097063|FG000|Overall Study|Withdrawal by Subject|4|||
128708232|NCT02603419|463226424|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
128708233|NCT02603419|463226419|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
128708234|NCT02603419|463226420|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
128708235|NCT02603419|463226421|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
128944564|NCT03298412|464083395|FG000|Run-in Period|Decision by Sponsor|6|||
128944565|NCT01894477|464083396|FG000|Overall Study|Protocol Violation|0|||
128944566|NCT01894477|464083397|FG001|Overall Study|Protocol Violation|1|||
128944567|NCT01894477|464083396|FG000|Overall Study|protocol changed due SC changed to cord|0|||
128944568|NCT01894477|464083397|FG001|Overall Study|protocol changed due SC changed to cord|1|||
128944569|NCT00995345|464083400|FG000|Overall Study|Withdrawal by Subject|4|||
128944570|NCT00995345|464083401|FG001|Overall Study|Withdrawal by Subject|2|||
128944571|NCT00995345|464083402|FG002|Overall Study|Withdrawal by Subject|1|||
128944572|NCT00995345|464083403|FG003|Overall Study|Withdrawal by Subject|3|||
128944573|NCT00995345|464083404|FG004|Overall Study|Withdrawal by Subject|1|||
128944574|NCT00995345|464083400|FG000|Overall Study|Adverse Event|3|||
128944575|NCT00995345|464083401|FG001|Overall Study|Adverse Event|1|||
128944576|NCT00995345|464083402|FG002|Overall Study|Adverse Event|2|||
128944577|NCT00995345|464083403|FG003|Overall Study|Adverse Event|0|||
128944578|NCT00995345|464083404|FG004|Overall Study|Adverse Event|1|||
128944579|NCT00995345|464083400|FG000|Overall Study|Lost to Follow-up|2|||
128944580|NCT00995345|464083401|FG001|Overall Study|Lost to Follow-up|2|||
128944581|NCT00995345|464083402|FG002|Overall Study|Lost to Follow-up|2|||
128944582|NCT00995345|464083403|FG003|Overall Study|Lost to Follow-up|1|||
128944583|NCT00995345|464083404|FG004|Overall Study|Lost to Follow-up|0|||
128944584|NCT00995345|464083400|FG000|Overall Study|all other reasons combined|2|||
128944585|NCT00995345|464083401|FG001|Overall Study|all other reasons combined|2|||
128944586|NCT00995345|464083402|FG002|Overall Study|all other reasons combined|2|||
128944587|NCT00995345|464083403|FG003|Overall Study|all other reasons combined|1|||
128944588|NCT00995345|464083404|FG004|Overall Study|all other reasons combined|3|||
128944589|NCT01860534|464083405|FG000|ROP #1|Needed treatment for ROP|0|||
128944590|NCT01860534|464083406|FG001|ROP #1|Needed treatment for ROP|1|||
128944591|NCT01860534|464083405|FG000|ROP #2|discharged prior to ROP #2|1|||
128944592|NCT01860534|464083406|FG001|ROP #2|discharged prior to ROP #2|0|||
128944593|NCT05122650|464083412|FG000|Overall Study|Adverse Event|4|||
129123479|NCT00141921|464746978|FG000|Overall Study|Administrative Decision|2|||
129123480|NCT00141921|464746978|FG000|Overall Study|Pregnancy|4|||
128944594|NCT05122650|464083413|FG001|Overall Study|Adverse Event|16|||
128944595|NCT05122650|464083414|FG002|Overall Study|Adverse Event|11|||
128944596|NCT05122650|464083415|FG003|Overall Study|Adverse Event|12|||
128944597|NCT05122650|464083412|FG000|Overall Study|Lack of Efficacy|0|||
128944598|NCT05122650|464083413|FG001|Overall Study|Lack of Efficacy|1|||
128944599|NCT05122650|464083414|FG002|Overall Study|Lack of Efficacy|1|||
128944600|NCT05122650|464083415|FG003|Overall Study|Lack of Efficacy|2|||
128944601|NCT05122650|464083412|FG000|Overall Study|Lost to Follow-up|1|||
128944602|NCT05122650|464083413|FG001|Overall Study|Lost to Follow-up|1|||
128944603|NCT05122650|464083414|FG002|Overall Study|Lost to Follow-up|3|||
128944604|NCT05122650|464083415|FG003|Overall Study|Lost to Follow-up|0|||
128944605|NCT05122650|464083412|FG000|Overall Study|Non-compliance with study intervention|0|||
128944606|NCT05122650|464083413|FG001|Overall Study|Non-compliance with study intervention|0|||
128944607|NCT05122650|464083414|FG002|Overall Study|Non-compliance with study intervention|0|||
128944608|NCT05122650|464083415|FG003|Overall Study|Non-compliance with study intervention|2|||
128944609|NCT05122650|464083412|FG000|Overall Study|Protocol Violation|0|||
128944610|NCT05122650|464083413|FG001|Overall Study|Protocol Violation|1|||
128944611|NCT05122650|464083414|FG002|Overall Study|Protocol Violation|0|||
128944612|NCT05122650|464083415|FG003|Overall Study|Protocol Violation|1|||
128944613|NCT05122650|464083412|FG000|Overall Study|Randomized by mistake|0|||
128944614|NCT05122650|464083413|FG001|Overall Study|Randomized by mistake|0|||
128944615|NCT05122650|464083414|FG002|Overall Study|Randomized by mistake|3|||
128944616|NCT05122650|464083415|FG003|Overall Study|Randomized by mistake|2|||
128944617|NCT05122650|464083412|FG000|Overall Study|Sponsor request|0|||
128944618|NCT05122650|464083413|FG001|Overall Study|Sponsor request|1|||
128944619|NCT05122650|464083414|FG002|Overall Study|Sponsor request|1|||
128944620|NCT05122650|464083415|FG003|Overall Study|Sponsor request|2|||
128944621|NCT05122650|464083412|FG000|Overall Study|Withdrawal by Subject|3|||
128944622|NCT05122650|464083413|FG001|Overall Study|Withdrawal by Subject|7|||
128944623|NCT05122650|464083414|FG002|Overall Study|Withdrawal by Subject|4|||
128944624|NCT05122650|464083415|FG003|Overall Study|Withdrawal by Subject|8|||
128944625|NCT05122650|464083412|FG000|Overall Study|Other|5|||
128944626|NCT05122650|464083413|FG001|Overall Study|Other|0|||
128944627|NCT05122650|464083414|FG002|Overall Study|Other|0|||
128944628|NCT05122650|464083415|FG003|Overall Study|Other|0|||
128944629|NCT01401010|464083416|FG000|Overall Study|Could not interpret assay results|1|||
128944630|NCT01401010|464083417|FG001|Overall Study|Could not interpret assay results|0|||
128944631|NCT04360187|464083428|FG000|Double-Blind Treatment|Adverse Event|9|||
128944632|NCT04360187|464083429|FG001|Double-Blind Treatment|Adverse Event|11|||
128944633|NCT04360187|464083428|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
128944634|NCT04360187|464083429|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
128944635|NCT04360187|464083428|FG000|Double-Blind Treatment|Physician Decision|1|||
128944636|NCT04360187|464083429|FG001|Double-Blind Treatment|Physician Decision|0|||
128944637|NCT04360187|464083428|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
128944638|NCT04360187|464083429|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
128944639|NCT04360187|464083428|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
128944640|NCT04360187|464083429|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
128944641|NCT04360187|464083428|FG000|Follow-Up|Lost to Follow-up|1|||
128944642|NCT04360187|464083429|FG001|Follow-Up|Lost to Follow-up|0|||
128944643|NCT01423617|464083437|FG000|Overall Study|Lost to Follow-up|0|||
128944644|NCT01423617|464083438|FG001|Overall Study|Lost to Follow-up|1|||
128944645|NCT01515306|464083439|FG000|Overall Study|Adverse Event|3|||
128944646|NCT01515306|464083440|FG001|Overall Study|Adverse Event|2|||
128944647|NCT01515306|464083439|FG000|Overall Study|Progressive Disease|19|||
128944648|NCT01515306|464083440|FG001|Overall Study|Progressive Disease|9|||
128944649|NCT01515306|464083439|FG000|Overall Study|Withdrawal by Subject|1|||
128944650|NCT01515306|464083440|FG001|Overall Study|Withdrawal by Subject|2|||
128944651|NCT01515306|464083439|FG000|Overall Study|Physician Decision|1|||
128944652|NCT01515306|464083440|FG001|Overall Study|Physician Decision|1|||
128944653|NCT00634244|464083444|FG000|Overall Study|Never started treatment|0|||
128944654|NCT00634244|464083445|FG001|Overall Study|Never started treatment|1|||
128944655|NCT00634244|464083446|FG002|Overall Study|Never started treatment|0|||
128944656|NCT00634244|464083444|FG000|Overall Study|Death|1|||
129217771|NCT03313037|465097064|FG001|Overall Study|Withdrawal by Subject|3|||
128944657|NCT00634244|464083445|FG001|Overall Study|Death|6|||
128944658|NCT00634244|464083446|FG002|Overall Study|Death|0|||
128944659|NCT00634244|464083444|FG000|Overall Study|Adverse Event|0|||
128944660|NCT00634244|464083445|FG001|Overall Study|Adverse Event|2|||
128944661|NCT00634244|464083446|FG002|Overall Study|Adverse Event|0|||
128944662|NCT00634244|464083444|FG000|Overall Study|Withdrawal by Subject|0|||
128708236|NCT02603419|463226422|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
128708237|NCT02603419|463226423|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
128944663|NCT00634244|464083445|FG001|Overall Study|Withdrawal by Subject|1|||
128944664|NCT00634244|464083446|FG002|Overall Study|Withdrawal by Subject|0|||
128944665|NCT00634244|464083444|FG000|Overall Study|Physician Decision|0|||
128944666|NCT00634244|464083445|FG001|Overall Study|Physician Decision|1|||
128944667|NCT00634244|464083446|FG002|Overall Study|Physician Decision|0|||
129217772|NCT03313037|465097063|FG000|Overall Study|No longer meets eligibility criteria|1|||
128708238|NCT02603419|463226424|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
128708239|NCT02603419|463226419|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
128708240|NCT02603419|463226420|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
128708241|NCT02603419|463226421|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
128708242|NCT02603419|463226422|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
128708243|NCT02603419|463226423|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
128708244|NCT02603419|463226424|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
128708245|NCT02603419|463226419|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
128944668|NCT00634244|464083444|FG000|Overall Study|Disease progression/relapse|0|||
128944669|NCT00634244|464083445|FG001|Overall Study|Disease progression/relapse|1|||
128944670|NCT00634244|464083446|FG002|Overall Study|Disease progression/relapse|0|||
128944671|NCT00634244|464083444|FG000|Overall Study|Other complicating disease|0|||
128944672|NCT00634244|464083445|FG001|Overall Study|Other complicating disease|1|||
128944673|NCT00634244|464083446|FG002|Overall Study|Other complicating disease|0|||
128944674|NCT02435277|464083449|FG000|Overall Study|Adverse Event|1|||
128944675|NCT02435277|464083450|FG001|Overall Study|Adverse Event|1|||
128944676|NCT02435277|464083451|FG002|Overall Study|Adverse Event|0|||
128944677|NCT02435277|464083452|FG003|Overall Study|Adverse Event|0|||
128944678|NCT02435277|464083449|FG000|Overall Study|Withdrawal by Subject|1|||
128944679|NCT02435277|464083450|FG001|Overall Study|Withdrawal by Subject|0|||
128944680|NCT02435277|464083451|FG002|Overall Study|Withdrawal by Subject|0|||
128944681|NCT02435277|464083452|FG003|Overall Study|Withdrawal by Subject|0|||
128944682|NCT01468909|464083460|FG000|Overall Study|Never Treated|2|||
128944683|NCT01468909|464083461|FG001|Overall Study|Never Treated|2|||
128944684|NCT02635737|464083464|FG000|Overall Study|Protocol Violation|1|||
128944685|NCT00937768|464083465|FG000|Overall Study|Refused Further Treatment|3|||
128944686|NCT00937768|464083466|FG001|Overall Study|Refused Further Treatment|2|||
128944687|NCT00937768|464083465|FG000|Overall Study|Disease Progression|1|||
128944688|NCT00937768|464083466|FG001|Overall Study|Disease Progression|1|||
128944689|NCT00937768|464083465|FG000|Overall Study|Alternate Treatment|0|||
128944690|NCT00937768|464083466|FG001|Overall Study|Alternate Treatment|1|||
128944691|NCT00937768|464083465|FG000|Overall Study|No Further Funding|4|||
128944692|NCT00937768|464083466|FG001|Overall Study|No Further Funding|4|||
128944693|NCT01687413|464083467|FG000|Overall Study|Withdrawal by Subject|0|||
128944694|NCT01687413|464083468|FG001|Overall Study|Withdrawal by Subject|2|||
128944695|NCT01687413|464083467|FG000|Overall Study|Not eligible|0|||
128944696|NCT01687413|464083468|FG001|Overall Study|Not eligible|2|||
128944697|NCT01687413|464083467|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
128944698|NCT01687413|464083468|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
128944699|NCT00992446|464083488|FG000|Overall Study|Disease Progression|1|||
128944700|NCT00992446|464083488|FG000|Overall Study|Withdrawal by Subject|2|||
128944701|NCT00992446|464083488|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
128944702|NCT03675737|464083490|FG000|Overall Study|Death|593|||
128944703|NCT03675737|464083491|FG001|Overall Study|Death|660|||
128944704|NCT03675737|464083490|FG000|Overall Study|Lost to Follow-up|1|||
128944705|NCT03675737|464083491|FG001|Overall Study|Lost to Follow-up|5|||
128944706|NCT03675737|464083490|FG000|Overall Study|Physician Decision|1|||
128944707|NCT03675737|464083491|FG001|Overall Study|Physician Decision|0|||
128944708|NCT03675737|464083490|FG000|Overall Study|Withdrawal by Subject|14|||
128944709|NCT03675737|464083491|FG001|Overall Study|Withdrawal by Subject|12|||
128944710|NCT03675737|464083490|FG000|Overall Study|Ongoing in Study|181|||
128944711|NCT03675737|464083491|FG001|Overall Study|Ongoing in Study|112|||
128944712|NCT02349789|464084823|FG000|Overall Study|Withdrawal by Subject|2|||
128944713|NCT00683475|464084824|FG000|Overall Study|Withdrawal by Subject|1|||
128944714|NCT00683475|464084825|FG001|Overall Study|Withdrawal by Subject|0|||
128944715|NCT00683475|464084824|FG000|Overall Study|Never Treated: Adverse Event|2|||
128944716|NCT00683475|464084825|FG001|Overall Study|Never Treated: Adverse Event|3|||
128944717|NCT00683475|464084824|FG000|Overall Study|Never Treated: Progressive Disease|1|||
128944718|NCT00683475|464084825|FG001|Overall Study|Never Treated: Progressive Disease|0|||
128944719|NCT02922634|464084826|FG000|Overall Study|Withdrawal by Subject|5|||
128944720|NCT02922634|464084826|FG000|Overall Study|Did not have their surgery|5|||
128944721|NCT02723604|464084827|FG000|Overall Study|ineligible|1|||
128944722|NCT02723604|464084827|FG000|Overall Study|never received treatment|1|||
128944723|NCT00352755|464084828|FG000|Overall Study|Physician Decision|1|||
128944724|NCT00352755|464084828|FG000|Overall Study|Adverse Event|1|||
128944725|NCT01694420|464084830|FG000|Overall Study|Lost to Follow-up|3|||
128944726|NCT03987919|464084831|FG000|Overall Study|Adverse Event|1|||
128944727|NCT03987919|464084832|FG001|Overall Study|Adverse Event|4|||
128944728|NCT03987919|464084833|FG002|Overall Study|Adverse Event|1|||
128770264|NCT02262260|463450196|FG001|Overall Study|Lost to Follow-up|2|||
128944729|NCT03987919|464084834|FG003|Overall Study|Adverse Event|3|||
128944730|NCT03987919|464084831|FG000|Overall Study|Death|4|||
128944731|NCT03987919|464084832|FG001|Overall Study|Death|4|||
128944732|NCT03987919|464084833|FG002|Overall Study|Death|4|||
128944733|NCT03987919|464084834|FG003|Overall Study|Death|1|||
128944734|NCT03987919|464084831|FG000|Overall Study|Lost to Follow-up|5|||
128944735|NCT03987919|464084832|FG001|Overall Study|Lost to Follow-up|6|||
128944736|NCT03987919|464084833|FG002|Overall Study|Lost to Follow-up|8|||
128944737|NCT03987919|464084834|FG003|Overall Study|Lost to Follow-up|12|||
128944738|NCT03987919|464084831|FG000|Overall Study|Physician Decision|0|||
128944739|NCT03987919|464084832|FG001|Overall Study|Physician Decision|2|||
128944740|NCT03987919|464084833|FG002|Overall Study|Physician Decision|0|||
128944741|NCT03987919|464084834|FG003|Overall Study|Physician Decision|4|||
128944742|NCT03987919|464084831|FG000|Overall Study|Pregnancy|1|||
128944743|NCT03987919|464084832|FG001|Overall Study|Pregnancy|0|||
128944744|NCT03987919|464084833|FG002|Overall Study|Pregnancy|1|||
128944745|NCT03987919|464084834|FG003|Overall Study|Pregnancy|1|||
128944746|NCT03987919|464084831|FG000|Overall Study|Protocol Violation|0|||
128944747|NCT03987919|464084832|FG001|Overall Study|Protocol Violation|1|||
128944748|NCT03987919|464084833|FG002|Overall Study|Protocol Violation|0|||
128944749|NCT03987919|464084834|FG003|Overall Study|Protocol Violation|0|||
128944750|NCT03987919|464084831|FG000|Overall Study|Site terminated by Sponsor|0|||
128944751|NCT03987919|464084832|FG001|Overall Study|Site terminated by Sponsor|0|||
128944752|NCT03987919|464084833|FG002|Overall Study|Site terminated by Sponsor|0|||
128944753|NCT03987919|464084834|FG003|Overall Study|Site terminated by Sponsor|1|||
128944754|NCT03987919|464084831|FG000|Overall Study|Withdrawal by Subject|7|||
128944755|NCT03987919|464084832|FG001|Overall Study|Withdrawal by Subject|7|||
128944756|NCT03987919|464084833|FG002|Overall Study|Withdrawal by Subject|8|||
128944757|NCT03987919|464084834|FG003|Overall Study|Withdrawal by Subject|4|||
128944758|NCT03987919|464084831|FG000|Overall Study|Other - as reported by the investigator|1|||
128944759|NCT03987919|464084832|FG001|Overall Study|Other - as reported by the investigator|3|||
128944760|NCT03987919|464084833|FG002|Overall Study|Other - as reported by the investigator|2|||
128944761|NCT03987919|464084834|FG003|Overall Study|Other - as reported by the investigator|0|||
128944762|NCT01194804|464084835|FG000|Overall Study|Withdrawal by Subject|1|||
128944763|NCT03621943|464084836|FG000|First Randomized Intervention|Lost to Follow-up|51|||
128944764|NCT03621943|464084837|FG001|First Randomized Intervention|Lost to Follow-up|54|||
128944765|NCT03621943|464084836|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
128944766|NCT03621943|464084837|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
128944767|NCT03621943|464084836|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
128944768|NCT03621943|464084837|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
128944769|NCT03621943|464084836|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
128944770|NCT03621943|464084837|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
128944771|NCT00315705|464084838|FG000|Phase 1|Refused further treatment|1|||
128944772|NCT00315705|464084838|FG000|Phase 1|Failure to achieve response|8|||
128944773|NCT00315705|464084838|FG000|Phase 1|Disease relapse|4|||
128944774|NCT00315705|464084838|FG000|Phase 1|Scheduled for transplant|9|||
128944775|NCT00315705|464084838|FG000|Phase 1|Death|3|||
128944776|NCT00315705|464084838|FG000|Phase 2|Physician Decision|4|||
128944777|NCT00315705|464084838|FG000|Phase 2|Adverse Event|1|||
128944778|NCT00315705|464084838|FG000|Phase 2|Failure to achieve response|3|||
128944779|NCT00315705|464084838|FG000|Phase 2|Disease relapse|1|||
128944780|NCT00315705|464084838|FG000|Phase 2|Scheduled for transplant|8|||
128944781|NCT00315705|464084838|FG000|Phase 2|Other|1|||
128944782|NCT00315705|464084838|FG000|Phase 2|Death|7|||
128944783|NCT00748553|464084839|FG000|Overall Study|Adverse Event|0|||
128944784|NCT00748553|464084840|FG001|Overall Study|Adverse Event|1|||
128944785|NCT00748553|464084839|FG000|Overall Study|disease progression|2|||
129033553|NCT02451358|464412110|FG003|Overall Study|Protocol Violation|0|||
129033554|NCT01344018|464412120|FG000|Overall Study|Death|22|||
129033555|NCT01344018|464412121|FG001|Overall Study|Death|25|||
129033556|NCT01344018|464412120|FG000|Overall Study|Lost to Follow-up|4|||
129033557|NCT01344018|464412121|FG001|Overall Study|Lost to Follow-up|7|||
129033558|NCT05070754|464412122|FG000|Overall Study|Withdrawal by Subject|0|||
129033559|NCT05070754|464412123|FG001|Overall Study|Withdrawal by Subject|0|||
129033560|NCT05070754|464412124|FG002|Overall Study|Withdrawal by Subject|0|||
129033561|NCT05070754|464412125|FG003|Overall Study|Withdrawal by Subject|1|||
129033562|NCT05070754|464412122|FG000|Overall Study|Protocol Violation|0|||
129033563|NCT05070754|464412123|FG001|Overall Study|Protocol Violation|0|||
129033564|NCT05070754|464412124|FG002|Overall Study|Protocol Violation|0|||
129033565|NCT05070754|464412125|FG003|Overall Study|Protocol Violation|1|||
129033566|NCT01398787|464412126|FG000|Overall Study|Adverse Event|1|||
128944786|NCT00748553|464084840|FG001|Overall Study|disease progression|0|||
129033567|NCT02351167|464412127|FG000|Overall Study|Withdrawal by Subject|19|||
129033568|NCT02351167|464412128|FG001|Overall Study|Withdrawal by Subject|18|||
129033569|NCT02351167|464412129|FG002|Overall Study|Withdrawal by Subject|21|||
129033570|NCT00668395|464412132|FG000|Overall Study|Withdrawal by Subject|4|||
129033571|NCT00668395|464412133|FG001|Overall Study|Withdrawal by Subject|4|||
129217773|NCT03313037|465097064|FG001|Overall Study|No longer meets eligibility criteria|7|||
128944787|NCT00748553|464084839|FG000|Overall Study|noncompliance|1|||
128944788|NCT00748553|464084840|FG001|Overall Study|noncompliance|0|||
128944789|NCT00948818|464084842|FG000|Overall Study|Adverse Event|10|||
128944790|NCT00948818|464084843|FG001|Overall Study|Adverse Event|32|||
128944791|NCT00948818|464084842|FG000|Overall Study|Protocol Violation|9|||
128944792|NCT00948818|464084843|FG001|Overall Study|Protocol Violation|10|||
129033572|NCT00668395|464412134|FG002|Overall Study|Withdrawal by Subject|1|||
129033573|NCT00668395|464412132|FG000|Overall Study|Adverse Event|1|||
129033574|NCT00668395|464412133|FG001|Overall Study|Adverse Event|1|||
129033575|NCT00668395|464412134|FG002|Overall Study|Adverse Event|0|||
129033576|NCT00668395|464412132|FG000|Overall Study|Physician Decision|1|||
129033577|NCT00668395|464412133|FG001|Overall Study|Physician Decision|1|||
129033578|NCT00668395|464412134|FG002|Overall Study|Physician Decision|0|||
129033579|NCT02858037|464412137|FG000|Overall Study|Death|1|||
129033580|NCT02858037|464412137|FG000|Overall Study|Withdrawal by Subject|18|||
129033581|NCT02858037|464412137|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
129033582|NCT02858037|464412137|FG000|Overall Study|Lost to Follow-up|3|||
129033583|NCT02858037|464412137|FG000|Overall Study|Other|4|||
129033584|NCT00046839|464412144|FG000|Overall Study|Ineligible / No protocol treatment|0|||
129033585|NCT00046839|464412145|FG001|Overall Study|Ineligible / No protocol treatment|2|||
129033586|NCT00046839|464412144|FG000|Overall Study|Withdrawal of consent|1|||
129033587|NCT00046839|464412145|FG001|Overall Study|Withdrawal of consent|0|||
129033588|NCT04768114|464412146|FG000|Overall Study|Lost to Follow-up|5|||
129033589|NCT04768114|464412147|FG001|Overall Study|Lost to Follow-up|10|||
129033590|NCT04768114|464412146|FG000|Overall Study|Withdrawal by Subject|0|||
129033591|NCT04768114|464412147|FG001|Overall Study|Withdrawal by Subject|1|||
129033592|NCT00715676|464412152|FG000|Overall Study|Adverse Event|3|||
129033593|NCT00715676|464412153|FG001|Overall Study|Adverse Event|5|||
129033594|NCT00715676|464412154|FG002|Overall Study|Adverse Event|21|||
129033595|NCT00715676|464412152|FG000|Overall Study|Withdrawal by Subject|1|||
129033596|NCT00715676|464412153|FG001|Overall Study|Withdrawal by Subject|3|||
129033597|NCT00715676|464412154|FG002|Overall Study|Withdrawal by Subject|8|||
129033598|NCT00715676|464412152|FG000|Overall Study|Lost to Follow-up|1|||
129033599|NCT00715676|464412153|FG001|Overall Study|Lost to Follow-up|2|||
129033600|NCT00715676|464412154|FG002|Overall Study|Lost to Follow-up|1|||
129033601|NCT00715676|464412152|FG000|Overall Study|Terminated by Sponsor|1|||
129033602|NCT00715676|464412153|FG001|Overall Study|Terminated by Sponsor|0|||
129033603|NCT00715676|464412154|FG002|Overall Study|Terminated by Sponsor|0|||
129033604|NCT00715676|464412152|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
129033605|NCT00715676|464412153|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
129033606|NCT00715676|464412154|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
129033607|NCT00715676|464412152|FG000|Overall Study|Use of Exclusionary Medication|0|||
129033608|NCT00715676|464412153|FG001|Overall Study|Use of Exclusionary Medication|0|||
129033609|NCT00715676|464412154|FG002|Overall Study|Use of Exclusionary Medication|1|||
129033610|NCT00715676|464412152|FG000|Overall Study|Elevated Blood Glucose|0|||
129033611|NCT00715676|464412153|FG001|Overall Study|Elevated Blood Glucose|1|||
129033612|NCT00715676|464412154|FG002|Overall Study|Elevated Blood Glucose|0|||
129033613|NCT01091363|464412155|FG000|Overall Study|Withdrawal by Subject|11|||
129033614|NCT01091363|464412156|FG001|Overall Study|Withdrawal by Subject|15|||
129033615|NCT01091363|464412155|FG000|Overall Study|Lost to Follow-up|2|||
129033616|NCT01091363|464412156|FG001|Overall Study|Lost to Follow-up|2|||
129033617|NCT00360490|464412161|FG000|Overall Study|Adverse Event|4|||
129033618|NCT00360490|464412162|FG001|Overall Study|Adverse Event|2|||
129033619|NCT00360490|464412161|FG000|Overall Study|Lost to Follow-up|2|||
129033620|NCT00360490|464412162|FG001|Overall Study|Lost to Follow-up|1|||
129033621|NCT00360490|464412161|FG000|Overall Study|Physician Decision|2|||
129033622|NCT00360490|464412162|FG001|Overall Study|Physician Decision|1|||
129033623|NCT00360490|464412161|FG000|Overall Study|Protocol Violation|0|||
129033624|NCT00360490|464412162|FG001|Overall Study|Protocol Violation|4|||
129033625|NCT00360490|464412161|FG000|Overall Study|Withdrawal by Subject|1|||
129033626|NCT00360490|464412162|FG001|Overall Study|Withdrawal by Subject|3|||
129033627|NCT01517867|464412163|FG000|Overall Study|never started treatment|29|||
129033628|NCT01517867|464412164|FG001|Overall Study|never started treatment|32|||
129033629|NCT01517867|464412163|FG000|Overall Study|Withdrawal by Subject|34|||
129033630|NCT01517867|464412164|FG001|Overall Study|Withdrawal by Subject|30|||
129033631|NCT01517867|464412163|FG000|Overall Study|Still in treatment at study end|0|||
129123481|NCT00141921|464746978|FG000|Overall Study|Ineligibility Determined|2|||
128708246|NCT02603419|463226420|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
128708247|NCT02603419|463226421|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
128708248|NCT02603419|463226422|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129123482|NCT00141921|464746978|FG000|Overall Study|Other|8|||
129123483|NCT02030600|464746981|FG000|Treatment Period 1|Adverse Event|5|||
128708249|NCT02603419|463226423|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
128708250|NCT02603419|463226424|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
129033632|NCT01517867|464412164|FG001|Overall Study|Still in treatment at study end|3|||
129033633|NCT03294317|464412166|FG000|Overall Study|Physician Decision|1|||
129123484|NCT02030600|464746982|FG001|Treatment Period 1|Adverse Event|7|||
129033634|NCT03294317|464412166|FG000|Overall Study|Withdrawal by Subject|6|||
129033635|NCT03294317|464412166|FG000|Overall Study|Lost to Follow-up|1|||
129033636|NCT03294317|464412166|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
129033637|NCT03294317|464412166|FG000|Overall Study|Failed HB lead implant|8|||
129033638|NCT03294317|464412166|FG000|Overall Study|Received CRT instead|1|||
129033639|NCT03294317|464412166|FG000|Overall Study|Exited after lead revision|2|||
129033640|NCT02387762|464412167|FG000|Overall Study|Withdrawal by Subject|1|||
129033641|NCT02387762|464412168|FG001|Overall Study|Withdrawal by Subject|0|||
129033642|NCT02614898|464412178|FG000|Overall Study|Participated until study termination|10|||
129033643|NCT02614898|464412179|FG001|Overall Study|Participated until study termination|26|||
129033644|NCT02614898|464412178|FG000|Overall Study|Lost to Follow-up|0|||
129033645|NCT02614898|464412179|FG001|Overall Study|Lost to Follow-up|2|||
129033646|NCT02614898|464412178|FG000|Overall Study|Physician Decision|1|||
129033647|NCT02614898|464412179|FG001|Overall Study|Physician Decision|8|||
129033648|NCT02614898|464412178|FG000|Overall Study|Study Terminated by Sponsor|3|||
129033649|NCT02614898|464412179|FG001|Overall Study|Study Terminated by Sponsor|0|||
129033650|NCT02614898|464412178|FG000|Overall Study|Withdrawal by Subject|0|||
129033651|NCT02614898|464412179|FG001|Overall Study|Withdrawal by Subject|2|||
129033652|NCT02614898|464412178|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129033653|NCT02614898|464412179|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129033654|NCT02614898|464412178|FG000|Overall Study|Other-Additional Information Unavailable|0|||
129033655|NCT02614898|464412179|FG001|Overall Study|Other-Additional Information Unavailable|11|||
129033656|NCT02614898|464412178|FG000|Overall Study|Missing|0|||
129033657|NCT02614898|464412179|FG001|Overall Study|Missing|1|||
129033658|NCT00239005|464412180|FG000|Overall Study|Adverse Event|6|||
129033659|NCT00239005|464412181|FG001|Overall Study|Adverse Event|6|||
129033660|NCT00239005|464412180|FG000|Overall Study|Withdrawal by Subject|3|||
129033661|NCT00239005|464412181|FG001|Overall Study|Withdrawal by Subject|4|||
129033662|NCT00239005|464412180|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
129033663|NCT00239005|464412181|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
129033664|NCT00239005|464412180|FG000|Overall Study|Protocol Violation|1|||
129033665|NCT00239005|464412181|FG001|Overall Study|Protocol Violation|0|||
129033666|NCT00239005|464412180|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
129033667|NCT00239005|464412181|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
129033668|NCT00239005|464412180|FG000|Overall Study|Lost to Follow-up|0|||
129033669|NCT00239005|464412181|FG001|Overall Study|Lost to Follow-up|1|||
129033670|NCT00787605|464412182|FG000|Overall Study|Administrative Problems|3|||
129033671|NCT00787605|464412183|FG001|Overall Study|Administrative Problems|0|||
129033672|NCT00787605|464412182|FG000|Overall Study|Adverse Event|14|||
129033673|NCT00787605|464412183|FG001|Overall Study|Adverse Event|25|||
129033674|NCT00787605|464412182|FG000|Overall Study|Lost to Follow-up|3|||
128944793|NCT00948818|464084842|FG000|Overall Study|Withdrawal by Subject|25|||
128944794|NCT00948818|464084843|FG001|Overall Study|Withdrawal by Subject|25|||
128944795|NCT00948818|464084842|FG000|Overall Study|Lost to Follow-up|10|||
128944796|NCT00948818|464084843|FG001|Overall Study|Lost to Follow-up|17|||
128944797|NCT00948818|464084842|FG000|Overall Study|Lack of Efficacy|4|||
128944798|NCT00948818|464084843|FG001|Overall Study|Lack of Efficacy|5|||
128944799|NCT00948818|464084842|FG000|Overall Study|Other Reason|4|||
128944800|NCT00948818|464084843|FG001|Overall Study|Other Reason|5|||
128944801|NCT00745368|464084844|FG000|Overall Study|Unable to provide sample|3|||
128944802|NCT03446651|464084848|FG000|Overall Study|Lost to Follow-up|4|||
128944803|NCT03446651|464084849|FG001|Overall Study|Lost to Follow-up|0|||
128944804|NCT03446651|464084848|FG000|Overall Study|Open Label Participants|5|||
128944805|NCT03446651|464084849|FG001|Overall Study|Open Label Participants|0|||
128944806|NCT05631548|464084851|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
128944807|NCT05631548|464084852|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
128944808|NCT01592409|464084853|FG000|Overall Study|Withdrawal by Subject|0|||
128944809|NCT01592409|464084854|FG001|Overall Study|Withdrawal by Subject|1|||
128944810|NCT01409031|464084858|FG000|Overall Study|transferred to other hosp|1|||
128944811|NCT01409031|464084859|FG001|Overall Study|transferred to other hosp|0|||
128944812|NCT03135028|464084862|FG000|Overall Study|Death|6|||
128944813|NCT03135028|464084862|FG000|Overall Study|Study Terminated by Sponsor|2|||
128944814|NCT03135028|464084862|FG000|Overall Study|Withdrew Consent|1|||
128944815|NCT00748540|464084863|FG000|Overall Study|Physician Decision|1|||
128944816|NCT01814800|464084865|FG000|Overall Study|Adverse Event|2|||
128944817|NCT01814800|464084865|FG000|Overall Study|Pregnancy|1|||
128944818|NCT01814800|464084865|FG000|Overall Study|Sponsor decision|1|||
129033675|NCT00787605|464412183|FG001|Overall Study|Lost to Follow-up|6|||
129033676|NCT00787605|464412182|FG000|Overall Study|Protocol Violation|7|||
129033677|NCT00787605|464412183|FG001|Overall Study|Protocol Violation|3|||
129123485|NCT02030600|464746981|FG000|Treatment Period 1|Lack of Efficacy|0|||
129123486|NCT02030600|464746982|FG001|Treatment Period 1|Lack of Efficacy|1|||
128944819|NCT01814800|464084865|FG000|Overall Study|Subject relocation|1|||
128944820|NCT02371759|464084868|FG000|Overall Study|Protocol Violation|3|||
129033678|NCT00787605|464412182|FG000|Overall Study|Withdrawal by Subject|6|||
129033679|NCT00787605|464412183|FG001|Overall Study|Withdrawal by Subject|13|||
129033680|NCT00787605|464412182|FG000|Overall Study|Lack of Efficacy|13|||
129033681|NCT00787605|464412183|FG001|Overall Study|Lack of Efficacy|9|||
129123487|NCT02030600|464746981|FG000|Treatment Period 1|Lost to Follow-up|11|||
128944821|NCT02371759|464084869|FG001|Overall Study|Protocol Violation|1|||
128944822|NCT02371759|464084870|FG002|Overall Study|Protocol Violation|1|||
128944823|NCT02371759|464084871|FG003|Overall Study|Protocol Violation|0|||
128944824|NCT02371759|464084872|FG004|Overall Study|Protocol Violation|3|||
128944825|NCT02371759|464084873|FG005|Overall Study|Protocol Violation|1|||
128944826|NCT02371759|464084874|FG006|Overall Study|Protocol Violation|0|||
128944827|NCT02371759|464084875|FG007|Overall Study|Protocol Violation|3|||
128944828|NCT02371759|464084868|FG000|Overall Study|Withdrawal by Subject|0|||
128944829|NCT02371759|464084869|FG001|Overall Study|Withdrawal by Subject|0|||
128944830|NCT02371759|464084870|FG002|Overall Study|Withdrawal by Subject|0|||
128944831|NCT02371759|464084871|FG003|Overall Study|Withdrawal by Subject|0|||
128944832|NCT02371759|464084872|FG004|Overall Study|Withdrawal by Subject|0|||
128944833|NCT02371759|464084873|FG005|Overall Study|Withdrawal by Subject|0|||
128944834|NCT02371759|464084874|FG006|Overall Study|Withdrawal by Subject|0|||
128944835|NCT02371759|464084875|FG007|Overall Study|Withdrawal by Subject|1|||
128944836|NCT00243230|464084878|FG000|Double-Blind Period|Adverse Event|0|||
128944837|NCT00243230|464084879|FG001|Double-Blind Period|Adverse Event|2|||
128944838|NCT00243230|464084880|FG002|Double-Blind Period|Adverse Event|2|||
128944839|NCT00243230|464084881|FG003|Double-Blind Period|Adverse Event|0|||
128944840|NCT00243230|464084878|FG000|Double-Blind Period|Withdrawal by Subject|1|||
128944841|NCT00243230|464084879|FG001|Double-Blind Period|Withdrawal by Subject|0|||
128944842|NCT00243230|464084880|FG002|Double-Blind Period|Withdrawal by Subject|0|||
128944843|NCT00243230|464084881|FG003|Double-Blind Period|Withdrawal by Subject|0|||
128944844|NCT00243230|464084878|FG000|Double-Blind Period|Protocol Violation|0|||
128944845|NCT00243230|464084879|FG001|Double-Blind Period|Protocol Violation|0|||
128944846|NCT00243230|464084880|FG002|Double-Blind Period|Protocol Violation|1|||
128944847|NCT00243230|464084881|FG003|Double-Blind Period|Protocol Violation|0|||
128944848|NCT00243230|464084878|FG000|Double-Blind Period|Randomized but Not Treated|0|||
128944849|NCT00243230|464084879|FG001|Double-Blind Period|Randomized but Not Treated|0|||
128944850|NCT00243230|464084880|FG002|Double-Blind Period|Randomized but Not Treated|2|||
128944851|NCT00243230|464084881|FG003|Double-Blind Period|Randomized but Not Treated|0|||
128944852|NCT00243230|464084878|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
128944853|NCT00243230|464084879|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
128944854|NCT00243230|464084880|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
128944855|NCT00243230|464084881|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
128944856|NCT00243230|464084878|FG000|Open Label Period|Adverse Event|0|||
128944857|NCT00243230|464084879|FG001|Open Label Period|Adverse Event|0|||
128944858|NCT00243230|464084880|FG002|Open Label Period|Adverse Event|0|||
128944859|NCT00243230|464084881|FG003|Open Label Period|Adverse Event|2|||
128944860|NCT00243230|464084878|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
128944861|NCT00243230|464084879|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
128944862|NCT00243230|464084880|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
128944863|NCT00243230|464084881|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
128944864|NCT00243230|464084878|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
128944865|NCT00243230|464084879|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
128944866|NCT00243230|464084880|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
128944867|NCT00243230|464084881|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
128944868|NCT00243230|464084878|FG000|Open Label Period|Lost to Follow-up|0|||
128944869|NCT00243230|464084879|FG001|Open Label Period|Lost to Follow-up|0|||
128944870|NCT00243230|464084880|FG002|Open Label Period|Lost to Follow-up|0|||
128944871|NCT00243230|464084881|FG003|Open Label Period|Lost to Follow-up|2|||
128944872|NCT00243230|464084878|FG000|Open Label Period|Withdrawal by Subject|0|||
128944873|NCT00243230|464084879|FG001|Open Label Period|Withdrawal by Subject|0|||
128944874|NCT00243230|464084880|FG002|Open Label Period|Withdrawal by Subject|0|||
128944875|NCT00243230|464084881|FG003|Open Label Period|Withdrawal by Subject|2|||
128944876|NCT00243230|464084878|FG000|Open Label Period|Protocol Violation|0|||
128944877|NCT00243230|464084879|FG001|Open Label Period|Protocol Violation|0|||
128944878|NCT00243230|464084880|FG002|Open Label Period|Protocol Violation|0|||
128944879|NCT00243230|464084881|FG003|Open Label Period|Protocol Violation|2|||
128944880|NCT00243230|464084878|FG000|Open Label Period|Administrative Reason|0|||
128944881|NCT00243230|464084879|FG001|Open Label Period|Administrative Reason|0|||
128944882|NCT00243230|464084880|FG002|Open Label Period|Administrative Reason|0|||
128944883|NCT00243230|464084881|FG003|Open Label Period|Administrative Reason|63|||
128944884|NCT01689207|464084882|FG000|Overall Study|Adverse Event|0|||
128944885|NCT01689207|464084883|FG001|Overall Study|Adverse Event|1|||
128944886|NCT01689207|464084884|FG002|Overall Study|Adverse Event|0|||
128944887|NCT01689207|464084885|FG003|Overall Study|Adverse Event|0|||
128944888|NCT01689207|464084886|FG004|Overall Study|Adverse Event|2|||
128944889|NCT01689207|464084887|FG005|Overall Study|Adverse Event|1|||
128944890|NCT01689207|464084888|FG006|Overall Study|Adverse Event|0|||
128944891|NCT01689207|464084889|FG007|Overall Study|Adverse Event|0|||
128944892|NCT01689207|464084890|FG008|Overall Study|Adverse Event|1|||
128944893|NCT01689207|464084891|FG009|Overall Study|Adverse Event|0|||
128944894|NCT01689207|464084892|FG010|Overall Study|Adverse Event|0|||
128944895|NCT03855137|464084893|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
128708251|NCT02850965|463226425|FG000|Overall Study|Other than listed|3|||
128944896|NCT03855137|464084894|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
128944897|NCT03855137|464084895|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
128944898|NCT03855137|464084893|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
128944899|NCT03855137|464084894|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
128944900|NCT03855137|464084895|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
128944901|NCT03855137|464084893|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
128944902|NCT03855137|464084894|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
128944903|NCT03855137|464084895|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
128944904|NCT03855137|464084893|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
128944905|NCT03855137|464084894|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
128944906|NCT03855137|464084895|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
128944907|NCT03855137|464084893|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
128944908|NCT03855137|464084894|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
128944909|NCT03855137|464084895|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
128944910|NCT03855137|464084893|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
128944911|NCT03855137|464084894|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
128944912|NCT03855137|464084895|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
128944913|NCT03855137|464084893|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
128944914|NCT03855137|464084894|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
128944915|NCT03855137|464084895|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
128944916|NCT03855137|464084893|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
128944917|NCT03855137|464084894|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
128944918|NCT03855137|464084895|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
128944919|NCT03855137|464084893|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
128944920|NCT03855137|464084894|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
128944921|NCT03855137|464084895|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
129123488|NCT02030600|464746982|FG001|Treatment Period 1|Lost to Follow-up|3|||
129123489|NCT02030600|464746981|FG000|Treatment Period 1|Protocol Violation|22|||
129123490|NCT02030600|464746982|FG001|Treatment Period 1|Protocol Violation|17|||
129123491|NCT02030600|464746981|FG000|Treatment Period 1|Withdrawal by Subject|13|||
129123492|NCT02030600|464746982|FG001|Treatment Period 1|Withdrawal by Subject|17|||
129123493|NCT02030600|464746981|FG000|Treatment Period 1|Casebook Unsigned|1|||
129123494|NCT02030600|464746982|FG001|Treatment Period 1|Casebook Unsigned|0|||
129123495|NCT02030600|464746981|FG000|Treatment Period 1|Unclassified|1|||
129123496|NCT02030600|464746982|FG001|Treatment Period 1|Unclassified|0|||
129123497|NCT02030600|464746981|FG000|Treatment Period 2|Adverse Event|4|||
129123498|NCT02030600|464746982|FG001|Treatment Period 2|Adverse Event|4|||
129123499|NCT02030600|464746981|FG000|Treatment Period 2|Lack of Efficacy|2|||
129123500|NCT02030600|464746982|FG001|Treatment Period 2|Lack of Efficacy|1|||
129123501|NCT02030600|464746981|FG000|Treatment Period 2|Lost to Follow-up|4|||
129123502|NCT02030600|464746982|FG001|Treatment Period 2|Lost to Follow-up|2|||
129123503|NCT02030600|464746981|FG000|Treatment Period 2|Protocol Violation|1|||
129123504|NCT02030600|464746982|FG001|Treatment Period 2|Protocol Violation|2|||
129123505|NCT02030600|464746981|FG000|Treatment Period 2|Withdrawal by Subject|13|||
129123506|NCT02030600|464746982|FG001|Treatment Period 2|Withdrawal by Subject|9|||
129123507|NCT02030600|464746981|FG000|Treatment Period 2|Unclassified|1|||
129123508|NCT02030600|464746982|FG001|Treatment Period 2|Unclassified|0|||
129123509|NCT01155323|464746983|FG000|First Intervention|exclusion criteria|1|||
128708252|NCT02850965|463226426|FG001|Overall Study|Other than listed|4|||
128708253|NCT02850965|463226425|FG000|Overall Study|Protocol Violation|0|||
128708254|NCT02850965|463226426|FG001|Overall Study|Protocol Violation|2|||
128708255|NCT02850965|463226425|FG000|Overall Study|Lost to Follow-up|5|||
128944922|NCT03855137|464084893|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
128944923|NCT03855137|464084894|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
128944924|NCT03855137|464084895|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
129123510|NCT01155323|464746984|FG001|First Intervention|exclusion criteria|1|||
129123511|NCT01155323|464746983|FG000|Second Intervention|Lost to Follow-up|1|||
129123512|NCT01155323|464746984|FG001|Second Intervention|Lost to Follow-up|1|||
129123513|NCT02471339|464746988|FG000|Overall Study|Did not provide follow-up data|2|||
129123514|NCT02471339|464746989|FG001|Overall Study|Did not provide follow-up data|0|||
129123515|NCT00626639|464746997|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
129123516|NCT00626639|464746998|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
128944925|NCT04369430|464084900|FG000|Overall Study|Adverse Event|2|||
128944926|NCT04369430|464084901|FG001|Overall Study|Adverse Event|3|||
129123517|NCT00303186|464746999|FG000|Overall Study|Other|52|||
128708256|NCT02850965|463226426|FG001|Overall Study|Lost to Follow-up|3|||
129123518|NCT00937950|464747001|FG000|Overall Study|Withdrawal by Subject|23|||
129123519|NCT00937950|464747001|FG000|Overall Study|Migrated/moved from study area|27|||
129123520|NCT00937950|464747001|FG000|Overall Study|Lost to Follow-up|144|||
129123521|NCT00937950|464747001|FG000|Overall Study|Missing confirmed|4|||
129123522|NCT00937950|464747001|FG000|Overall Study|Other|18|||
129123523|NCT00460798|464747003|FG000|Overall Study|Death|59|||
128944927|NCT04369430|464084900|FG000|Overall Study|Death|1|||
128944928|NCT04369430|464084901|FG001|Overall Study|Death|0|||
128944929|NCT04369430|464084900|FG000|Overall Study|Withdrawal by Subject|4|||
128944930|NCT04369430|464084901|FG001|Overall Study|Withdrawal by Subject|3|||
128944931|NCT04369430|464084900|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
128944932|NCT04369430|464084901|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
128944933|NCT04369430|464084900|FG000|Overall Study|Lost to Follow-up|0|||
128944934|NCT04369430|464084901|FG001|Overall Study|Lost to Follow-up|1|||
128944935|NCT00008138|464084902|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
128944936|NCT00008138|464084902|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
128944937|NCT00008138|464084902|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
128944938|NCT00008138|464084902|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
128944939|NCT00008138|464084902|FG000|Interval Debulking|Withdrawal by Subject|2|||
128944940|NCT00008138|464084902|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
128944941|NCT00008138|464084902|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
128944942|NCT00008138|464084902|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
128944943|NCT02065622|464084903|FG000|Induction Study|Adverse Event|13|||
128944944|NCT02065622|464084904|FG001|Induction Study|Adverse Event|19|||
128944945|NCT02065622|464084905|FG002|Induction Study|Adverse Event|0|||
128944946|NCT02065622|464084906|FG003|Induction Study|Adverse Event|0|||
128944947|NCT02065622|464084907|FG004|Induction Study|Adverse Event|0|||
128944948|NCT02065622|464084903|FG000|Induction Study|Withdrawal by Subject|3|||
128944949|NCT02065622|464084904|FG001|Induction Study|Withdrawal by Subject|5|||
128944950|NCT02065622|464084905|FG002|Induction Study|Withdrawal by Subject|0|||
128944951|NCT02065622|464084906|FG003|Induction Study|Withdrawal by Subject|0|||
128944952|NCT02065622|464084907|FG004|Induction Study|Withdrawal by Subject|0|||
128944953|NCT02065622|464084903|FG000|Induction Study|Lost to Follow-up|1|||
128944954|NCT02065622|464084904|FG001|Induction Study|Lost to Follow-up|0|||
128944955|NCT02065622|464084905|FG002|Induction Study|Lost to Follow-up|0|||
128944956|NCT02065622|464084906|FG003|Induction Study|Lost to Follow-up|0|||
128944957|NCT02065622|464084907|FG004|Induction Study|Lost to Follow-up|0|||
128944958|NCT02065622|464084903|FG000|Induction Study|Lack of Efficacy|22|||
128944959|NCT02065622|464084904|FG001|Induction Study|Lack of Efficacy|27|||
128944960|NCT02065622|464084905|FG002|Induction Study|Lack of Efficacy|0|||
128944961|NCT02065622|464084906|FG003|Induction Study|Lack of Efficacy|0|||
128944962|NCT02065622|464084907|FG004|Induction Study|Lack of Efficacy|0|||
128944963|NCT02065622|464084903|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
128944964|NCT02065622|464084904|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
128944965|NCT02065622|464084905|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
128944966|NCT02065622|464084906|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
128944967|NCT02065622|464084907|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
128944968|NCT02065622|464084903|FG000|Induction Study|Subject Noncompliance|1|||
128944969|NCT02065622|464084904|FG001|Induction Study|Subject Noncompliance|1|||
128944970|NCT02065622|464084905|FG002|Induction Study|Subject Noncompliance|0|||
128944971|NCT02065622|464084906|FG003|Induction Study|Subject Noncompliance|0|||
128944972|NCT02065622|464084907|FG004|Induction Study|Subject Noncompliance|0|||
128944973|NCT02065622|464084903|FG000|Induction Study|Other, Not Specified|3|||
128944974|NCT02065622|464084904|FG001|Induction Study|Other, Not Specified|2|||
128944975|NCT02065622|464084905|FG002|Induction Study|Other, Not Specified|0|||
128944976|NCT02065622|464084906|FG003|Induction Study|Other, Not Specified|0|||
128944977|NCT02065622|464084907|FG004|Induction Study|Other, Not Specified|0|||
128944978|NCT02065622|464084903|FG000|Maintenance Study|Adverse Event|0|||
128944979|NCT02065622|464084904|FG001|Maintenance Study|Adverse Event|0|||
128944980|NCT02065622|464084905|FG002|Maintenance Study|Adverse Event|25|||
128944981|NCT02065622|464084906|FG003|Maintenance Study|Adverse Event|22|||
128944982|NCT02065622|464084907|FG004|Maintenance Study|Adverse Event|11|||
128944983|NCT02065622|464084903|FG000|Maintenance Study|Withdrawal by Subject|0|||
128944984|NCT02065622|464084904|FG001|Maintenance Study|Withdrawal by Subject|0|||
128944985|NCT02065622|464084905|FG002|Maintenance Study|Withdrawal by Subject|11|||
128944986|NCT02065622|464084906|FG003|Maintenance Study|Withdrawal by Subject|5|||
128944987|NCT02065622|464084907|FG004|Maintenance Study|Withdrawal by Subject|7|||
128944988|NCT02065622|464084903|FG000|Maintenance Study|Lost to Follow-up|0|||
128944989|NCT02065622|464084904|FG001|Maintenance Study|Lost to Follow-up|0|||
128944990|NCT02065622|464084905|FG002|Maintenance Study|Lost to Follow-up|4|||
128944991|NCT02065622|464084906|FG003|Maintenance Study|Lost to Follow-up|1|||
128944992|NCT02065622|464084907|FG004|Maintenance Study|Lost to Follow-up|1|||
128944993|NCT02065622|464084903|FG000|Maintenance Study|Lack of Efficacy|0|||
128944994|NCT02065622|464084904|FG001|Maintenance Study|Lack of Efficacy|0|||
128944995|NCT02065622|464084905|FG002|Maintenance Study|Lack of Efficacy|70|||
128944996|NCT02065622|464084906|FG003|Maintenance Study|Lack of Efficacy|55|||
128944997|NCT02065622|464084907|FG004|Maintenance Study|Lack of Efficacy|19|||
128944998|NCT02065622|464084903|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
128944999|NCT02065622|464084904|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
128945000|NCT02065622|464084905|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
128945001|NCT02065622|464084906|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
128945002|NCT02065622|464084907|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
128945003|NCT02065622|464084903|FG000|Maintenance Study|Subject Non-Compliance|0|||
128945004|NCT02065622|464084904|FG001|Maintenance Study|Subject Non-Compliance|0|||
128945005|NCT02065622|464084905|FG002|Maintenance Study|Subject Non-Compliance|1|||
128945006|NCT02065622|464084906|FG003|Maintenance Study|Subject Non-Compliance|3|||
128945007|NCT02065622|464084907|FG004|Maintenance Study|Subject Non-Compliance|2|||
128945008|NCT02065622|464084903|FG000|Maintenance Study|Other, Not Specified|0|||
128945009|NCT02065622|464084904|FG001|Maintenance Study|Other, Not Specified|0|||
128945010|NCT02065622|464084905|FG002|Maintenance Study|Other, Not Specified|6|||
128945011|NCT02065622|464084906|FG003|Maintenance Study|Other, Not Specified|14|||
128945012|NCT02065622|464084907|FG004|Maintenance Study|Other, Not Specified|2|||
128945013|NCT02065622|464084903|FG000|Maintenance Study|Unknown Reason|0|||
128945014|NCT02065622|464084904|FG001|Maintenance Study|Unknown Reason|0|||
128945015|NCT02065622|464084905|FG002|Maintenance Study|Unknown Reason|0|||
128945016|NCT02065622|464084906|FG003|Maintenance Study|Unknown Reason|1|||
128945017|NCT02065622|464084907|FG004|Maintenance Study|Unknown Reason|0|||
128945018|NCT04973228|464084908|FG000|Overall Study|Adverse Event|2|||
128945019|NCT04973228|464084909|FG001|Overall Study|Adverse Event|3|||
128945020|NCT04973228|464084908|FG000|Overall Study|Lack of Efficacy|1|||
128945021|NCT04973228|464084909|FG001|Overall Study|Lack of Efficacy|3|||
128945022|NCT04973228|464084908|FG000|Overall Study|Lost to Follow-up|12|||
128945023|NCT04973228|464084909|FG001|Overall Study|Lost to Follow-up|4|||
128945024|NCT04973228|464084908|FG000|Overall Study|Withdrawal by Subject|11|||
128945025|NCT04973228|464084909|FG001|Overall Study|Withdrawal by Subject|4|||
128945026|NCT04973228|464084908|FG000|Overall Study|Did not tolerate application|1|||
128945027|NCT04973228|464084909|FG001|Overall Study|Did not tolerate application|0|||
128945028|NCT04973228|464084908|FG000|Overall Study|Wanted to early terminate and use own product|0|||
128945029|NCT04973228|464084909|FG001|Overall Study|Wanted to early terminate and use own product|1|||
128945030|NCT04973228|464084908|FG000|Overall Study|Missed visits due to new work schedule|1|||
128945031|NCT04973228|464084909|FG001|Overall Study|Missed visits due to new work schedule|0|||
128945032|NCT02678780|464084912|FG000|Overall Study|Adverse Event|11|||
128945033|NCT02678780|464084913|FG001|Overall Study|Adverse Event|14|||
128945034|NCT02678780|464084912|FG000|Overall Study|Withdrawal by Subject|2|||
128945035|NCT02678780|464084913|FG001|Overall Study|Withdrawal by Subject|1|||
128945036|NCT02678780|464084912|FG000|Overall Study|Sponsor discontinuation|7|||
128945037|NCT02678780|464084913|FG001|Overall Study|Sponsor discontinuation|4|||
128945038|NCT02678780|464084912|FG000|Overall Study|Death|1|||
128945039|NCT02678780|464084913|FG001|Overall Study|Death|1|||
128945040|NCT02678780|464084912|FG000|Overall Study|Other|6|||
128945041|NCT02678780|464084913|FG001|Overall Study|Other|8|||
128945042|NCT00406640|464084914|FG000|Acute Phase|Adverse Event|18|||
128945043|NCT00406640|464084915|FG001|Acute Phase|Adverse Event|13|||
128945044|NCT00406640|464084914|FG000|Acute Phase|Failed to Return|5|||
128945045|NCT00406640|464084915|FG001|Acute Phase|Failed to Return|1|||
128945046|NCT00406640|464084914|FG000|Acute Phase|Physician Decision|0|||
128945047|NCT00406640|464084915|FG001|Acute Phase|Physician Decision|1|||
128945048|NCT00406640|464084914|FG000|Acute Phase|Lost to Follow-up|7|||
128945049|NCT00406640|464084915|FG001|Acute Phase|Lost to Follow-up|4|||
128945050|NCT00406640|464084914|FG000|Acute Phase|Protocol deviation|4|||
128945051|NCT00406640|464084915|FG001|Acute Phase|Protocol deviation|10|||
128945052|NCT00406640|464084914|FG000|Acute Phase|Protocol Violation|3|||
128945053|NCT00406640|464084915|FG001|Acute Phase|Protocol Violation|2|||
128945054|NCT00406640|464084914|FG000|Acute Phase|Withdrawal by Subject|11|||
128945055|NCT00406640|464084915|FG001|Acute Phase|Withdrawal by Subject|9|||
128945056|NCT00406640|464084914|FG000|Acute Phase|Lack of Efficacy|3|||
128945057|NCT00406640|464084915|FG001|Acute Phase|Lack of Efficacy|3|||
128945058|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
128945059|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
128945060|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Death|1|||
129033682|NCT03382041|464412184|FG000|Overall Study|Consent Form Lost|2|||
128708257|NCT02850965|463226425|FG000|Overall Study|Lack of Efficacy|4|||
128945061|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Death|0|||
128945062|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
128945063|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
128945064|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
128708258|NCT02850965|463226426|FG001|Overall Study|Lack of Efficacy|8|||
128708259|NCT02850965|463226425|FG000|Overall Study|Adverse Event|3|||
128945065|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
128945066|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
128945067|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
128945068|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|non-compliance|7|||
128945069|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|non-compliance|5|||
128945070|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
128945071|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
128945072|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
129033683|NCT03382041|464412185|FG001|Overall Study|Consent Form Lost|1|||
129033684|NCT03382041|464412184|FG000|Overall Study|Withdrawal by Subject|1|||
129033685|NCT03382041|464412185|FG001|Overall Study|Withdrawal by Subject|4|||
129033686|NCT03382041|464412184|FG000|Overall Study|Lost to Follow-up|1|||
129033687|NCT03382041|464412185|FG001|Overall Study|Lost to Follow-up|4|||
129033688|NCT04428645|464412191|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
129033689|NCT02293460|464414070|FG000|Overall Study|Protocol Violation|1|||
129033690|NCT02293460|464414070|FG000|Overall Study|Lack of Efficacy|2|||
129033691|NCT02293460|464414070|FG000|Overall Study|Adverse Event|2|||
129033692|NCT02293460|464414070|FG000|Overall Study|Withdrawal by Subject|1|||
129033693|NCT04129944|464414071|FG000|Overall Study|Death|0|||
129033694|NCT04129944|464414072|FG001|Overall Study|Death|0|||
129033695|NCT04129944|464414073|FG002|Overall Study|Death|0|||
129033696|NCT04129944|464414074|FG003|Overall Study|Death|1|||
129033697|NCT04129944|464414071|FG000|Overall Study|Lost to Follow-up|1|||
129033698|NCT04129944|464414072|FG001|Overall Study|Lost to Follow-up|0|||
129033699|NCT04129944|464414073|FG002|Overall Study|Lost to Follow-up|0|||
129033700|NCT04129944|464414074|FG003|Overall Study|Lost to Follow-up|0|||
129033701|NCT04129944|464414071|FG000|Overall Study|Withdrawal by Subject|1|||
129033702|NCT04129944|464414072|FG001|Overall Study|Withdrawal by Subject|0|||
129033703|NCT04129944|464414073|FG002|Overall Study|Withdrawal by Subject|1|||
129033704|NCT04129944|464414074|FG003|Overall Study|Withdrawal by Subject|2|||
129033705|NCT00493792|464414075|FG000|Overall Study|Death|55|||
129033706|NCT00493792|464414076|FG001|Overall Study|Death|50|||
129033707|NCT00493792|464414075|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
129217774|NCT03313037|465097063|FG000|Overall Study|Lost to Follow-up|9|||
128945073|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
128945074|NCT00406640|464084914|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
128945075|NCT00406640|464084915|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
128945076|NCT00406640|464084914|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
128945077|NCT00406640|464084915|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
128945078|NCT00406640|464084914|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
128945079|NCT00406640|464084915|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
128945080|NCT00406640|464084914|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
128945081|NCT00406640|464084915|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
128945082|NCT00406640|464084914|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
128945083|NCT00406640|464084915|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
128945084|NCT00406640|464084914|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
128945085|NCT00406640|464084915|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
128945086|NCT00406640|464084914|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
128945087|NCT00406640|464084915|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
128945088|NCT00406640|464084914|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
128945089|NCT00406640|464084915|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
128945090|NCT01454401|464084918|FG000|Overall Study|Death|1|||
128945091|NCT01454401|464084918|FG000|Overall Study|hospitalised|1|||
128945092|NCT01454401|464084918|FG000|Overall Study|osteomyelitis|2|||
128945093|NCT01454401|464084918|FG000|Overall Study|non-adherence|1|||
128945094|NCT00755846|464086628|FG000|Overall Study|Adverse Event|0|||
128945095|NCT00755846|464086629|FG001|Overall Study|Adverse Event|0|||
128945096|NCT00755846|464086630|FG002|Overall Study|Adverse Event|0|||
128945097|NCT00755846|464086631|FG003|Overall Study|Adverse Event|1|||
128945098|NCT00755846|464086632|FG004|Overall Study|Adverse Event|3|||
128945099|NCT00755846|464086633|FG005|Overall Study|Adverse Event|2|||
128945100|NCT00755846|464086628|FG000|Overall Study|Protocol Violation|1|||
128945101|NCT00755846|464086629|FG001|Overall Study|Protocol Violation|1|||
128945102|NCT00755846|464086630|FG002|Overall Study|Protocol Violation|1|||
128945103|NCT00755846|464086631|FG003|Overall Study|Protocol Violation|1|||
128945104|NCT00755846|464086632|FG004|Overall Study|Protocol Violation|1|||
128945105|NCT00755846|464086633|FG005|Overall Study|Protocol Violation|1|||
128945106|NCT00755846|464086628|FG000|Overall Study|Lost to Follow-up|0|||
128945107|NCT00755846|464086629|FG001|Overall Study|Lost to Follow-up|2|||
128945108|NCT00755846|464086630|FG002|Overall Study|Lost to Follow-up|1|||
128945109|NCT00755846|464086631|FG003|Overall Study|Lost to Follow-up|0|||
128945110|NCT00755846|464086632|FG004|Overall Study|Lost to Follow-up|4|||
128945111|NCT00755846|464086633|FG005|Overall Study|Lost to Follow-up|2|||
128945112|NCT00755846|464086628|FG000|Overall Study|Withdrawal by Subject|2|||
128945113|NCT00755846|464086629|FG001|Overall Study|Withdrawal by Subject|3|||
128945114|NCT00755846|464086630|FG002|Overall Study|Withdrawal by Subject|5|||
128945115|NCT00755846|464086631|FG003|Overall Study|Withdrawal by Subject|2|||
128945116|NCT00755846|464086632|FG004|Overall Study|Withdrawal by Subject|0|||
128945117|NCT00755846|464086633|FG005|Overall Study|Withdrawal by Subject|1|||
128945118|NCT00755846|464086628|FG000|Overall Study|Hyperglycemic Rescue|21|||
128945119|NCT00755846|464086629|FG001|Overall Study|Hyperglycemic Rescue|7|||
128945120|NCT00755846|464086630|FG002|Overall Study|Hyperglycemic Rescue|5|||
129033708|NCT00493792|464414076|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
128945121|NCT00755846|464086631|FG003|Overall Study|Hyperglycemic Rescue|8|||
128945122|NCT00755846|464086632|FG004|Overall Study|Hyperglycemic Rescue|8|||
128945123|NCT00755846|464086633|FG005|Overall Study|Hyperglycemic Rescue|7|||
128945124|NCT00755846|464086628|FG000|Overall Study|Physician Decision|1|||
128945125|NCT00755846|464086629|FG001|Overall Study|Physician Decision|3|||
128945126|NCT00755846|464086630|FG002|Overall Study|Physician Decision|0|||
128945127|NCT00755846|464086631|FG003|Overall Study|Physician Decision|1|||
128945128|NCT00755846|464086632|FG004|Overall Study|Physician Decision|0|||
128945129|NCT00755846|464086633|FG005|Overall Study|Physician Decision|1|||
128945130|NCT00755846|464086628|FG000|Overall Study|Administrative Error|0|||
128945131|NCT00755846|464086629|FG001|Overall Study|Administrative Error|1|||
128945132|NCT00755846|464086630|FG002|Overall Study|Administrative Error|0|||
128945133|NCT00755846|464086631|FG003|Overall Study|Administrative Error|0|||
128945134|NCT00755846|464086632|FG004|Overall Study|Administrative Error|0|||
128945135|NCT00755846|464086633|FG005|Overall Study|Administrative Error|0|||
128945136|NCT00755846|464086628|FG000|Overall Study|Participant Non-compliance|0|||
128945137|NCT00755846|464086629|FG001|Overall Study|Participant Non-compliance|0|||
128945138|NCT00755846|464086630|FG002|Overall Study|Participant Non-compliance|0|||
128945139|NCT00755846|464086631|FG003|Overall Study|Participant Non-compliance|0|||
128945140|NCT00755846|464086632|FG004|Overall Study|Participant Non-compliance|1|||
128945141|NCT00755846|464086633|FG005|Overall Study|Participant Non-compliance|0|||
128945142|NCT00311181|464086634|FG000|Overall Study|Final DFTs were not obtained|96|||
128945143|NCT02669862|464086635|FG000|Overall Study|Lost to Follow-up|0|||
128945144|NCT02669862|464086636|FG001|Overall Study|Lost to Follow-up|2|||
128945145|NCT02669862|464086637|FG002|Overall Study|Lost to Follow-up|1|||
128945146|NCT02669862|464086635|FG000|Overall Study|Withdrawal by Subject|2|||
128945147|NCT02669862|464086636|FG001|Overall Study|Withdrawal by Subject|2|||
128945148|NCT02669862|464086637|FG002|Overall Study|Withdrawal by Subject|3|||
128945149|NCT02669862|464086635|FG000|Overall Study|moved|0|||
128945150|NCT02669862|464086636|FG001|Overall Study|moved|1|||
128945151|NCT02669862|464086637|FG002|Overall Study|moved|0|||
128945152|NCT02669862|464086635|FG000|Overall Study|Protocol Violation|0|||
128945153|NCT02669862|464086636|FG001|Overall Study|Protocol Violation|0|||
128945154|NCT02669862|464086637|FG002|Overall Study|Protocol Violation|1|||
128945155|NCT02429258|464086640|FG000|Overall Study|Withdrawal by Subject|2|||
128945156|NCT02429258|464086641|FG001|Overall Study|Withdrawal by Subject|0|||
128945157|NCT02429258|464086640|FG000|Overall Study|Protocol Violation|0|||
128945158|NCT02429258|464086641|FG001|Overall Study|Protocol Violation|1|||
128945159|NCT02397694|464086642|FG000|Double-Blinded Phase|Adverse Event|1|||
128945160|NCT02397694|464086643|FG001|Double-Blinded Phase|Adverse Event|0|||
128945161|NCT02397694|464086642|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
128945162|NCT02397694|464086643|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
128945163|NCT02397694|464086642|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
128945164|NCT02397694|464086643|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
128945165|NCT02397694|464086642|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
128945166|NCT02397694|464086643|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
128945167|NCT02397694|464086642|FG000|Open Label Extension Phase|Protocol Violation|1|||
128945168|NCT02397694|464086643|FG001|Open Label Extension Phase|Protocol Violation|0|||
128945169|NCT02397694|464086642|FG000|Open Label Extension Phase|Withdrew Consent|3|||
128945170|NCT02397694|464086643|FG001|Open Label Extension Phase|Withdrew Consent|1|||
128945171|NCT02397694|464086642|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
128945172|NCT02397694|464086643|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
128945173|NCT00762372|464086647|FG000|Overall Study|Adverse Event|1|||
128945174|NCT00762372|464086648|FG001|Overall Study|Adverse Event|0|||
128945175|NCT00762372|464086649|FG002|Overall Study|Adverse Event|0|||
128945176|NCT03364335|464086650|FG000|Overall Study|Adverse Event|3|||
129123524|NCT00460798|464747003|FG000|Overall Study|Adverse Event|27|||
129123525|NCT00460798|464747003|FG000|Overall Study|Lost to Follow-up|19|||
128945177|NCT03364335|464086651|FG001|Overall Study|Adverse Event|4|||
128945178|NCT03364335|464086652|FG002|Overall Study|Adverse Event|1|||
129123526|NCT00460798|464747003|FG000|Overall Study|Progressive Disease|99|||
129123527|NCT00460798|464747003|FG000|Overall Study|Other|27|||
128945179|NCT03364335|464086653|FG003|Overall Study|Adverse Event|2|||
128945180|NCT03364335|464086654|FG004|Overall Study|Adverse Event|0|||
128945181|NCT03364335|464086650|FG000|Overall Study|Lost to Follow-up|7|||
128945182|NCT03364335|464086651|FG001|Overall Study|Lost to Follow-up|7|||
128945183|NCT03364335|464086652|FG002|Overall Study|Lost to Follow-up|10|||
128945184|NCT03364335|464086653|FG003|Overall Study|Lost to Follow-up|11|||
128945185|NCT03364335|464086654|FG004|Overall Study|Lost to Follow-up|11|||
128945186|NCT00818207|464086655|FG000|Overall Study|Adverse Event|6|||
128945187|NCT00818207|464086656|FG001|Overall Study|Adverse Event|0|||
128945188|NCT00818207|464086655|FG000|Overall Study|Lost to Follow-up|160|||
128945189|NCT00818207|464086656|FG001|Overall Study|Lost to Follow-up|146|||
128945190|NCT00818207|464086655|FG000|Overall Study|Multiple reasons|11|||
128945191|NCT00818207|464086656|FG001|Overall Study|Multiple reasons|12|||
129123528|NCT00460798|464747003|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
128945192|NCT00818207|464086655|FG000|Overall Study|Withdrawal by Subject|42|||
129217775|NCT03313037|465097064|FG001|Overall Study|Lost to Follow-up|8|||
128708260|NCT02850965|463226426|FG001|Overall Study|Adverse Event|2|||
128945193|NCT00818207|464086656|FG001|Overall Study|Withdrawal by Subject|104|||
128945194|NCT00818207|464086655|FG000|Overall Study|Death|3|||
128945195|NCT00818207|464086656|FG001|Overall Study|Death|5|||
128945196|NCT02494778|464086657|FG000|Overall Study|Death|3|||
128945197|NCT02494778|464086657|FG000|Overall Study|Other|173|||
128945198|NCT02494778|464086657|FG000|Overall Study|Lack of Efficacy|4|||
128945199|NCT02494778|464086657|FG000|Overall Study|Adverse Event|18|||
128945200|NCT02494778|464086657|FG000|Overall Study|Withdrawal by Subject|20|||
128945201|NCT02494778|464086657|FG000|Overall Study|Lost to Follow-up|2|||
128945202|NCT02494778|464086657|FG000|Overall Study|Noncompliant with study drug admin.|1|||
128945203|NCT02616185|464086658|FG000|Overall Study|Death|0|||
128945204|NCT02616185|464086659|FG001|Overall Study|Death|0|||
128945205|NCT02616185|464086660|FG002|Overall Study|Death|0|||
128945206|NCT02616185|464086661|FG003|Overall Study|Death|1|||
128945207|NCT02616185|464086662|FG004|Overall Study|Death|2|||
128945208|NCT02616185|464086663|FG005|Overall Study|Death|0|||
128945209|NCT02616185|464086664|FG006|Overall Study|Death|0|||
128945210|NCT02616185|464086665|FG007|Overall Study|Death|2|||
128945211|NCT02616185|464086666|FG008|Overall Study|Death|1|||
128945212|NCT02616185|464086658|FG000|Overall Study|Study terminated by sponsor|0|||
128945213|NCT02616185|464086659|FG001|Overall Study|Study terminated by sponsor|0|||
128945214|NCT02616185|464086660|FG002|Overall Study|Study terminated by sponsor|1|||
128945215|NCT02616185|464086661|FG003|Overall Study|Study terminated by sponsor|0|||
128945216|NCT02616185|464086662|FG004|Overall Study|Study terminated by sponsor|0|||
128945217|NCT02616185|464086663|FG005|Overall Study|Study terminated by sponsor|0|||
128945218|NCT02616185|464086664|FG006|Overall Study|Study terminated by sponsor|5|||
128945219|NCT02616185|464086665|FG007|Overall Study|Study terminated by sponsor|2|||
128945220|NCT02616185|464086666|FG008|Overall Study|Study terminated by sponsor|0|||
128945221|NCT02616185|464086658|FG000|Overall Study|Participant refused further follow-up|1|||
128945222|NCT02616185|464086659|FG001|Overall Study|Participant refused further follow-up|1|||
128945223|NCT02616185|464086660|FG002|Overall Study|Participant refused further follow-up|2|||
128945224|NCT02616185|464086661|FG003|Overall Study|Participant refused further follow-up|3|||
128945225|NCT02616185|464086662|FG004|Overall Study|Participant refused further follow-up|4|||
128945226|NCT02616185|464086663|FG005|Overall Study|Participant refused further follow-up|0|||
128945227|NCT02616185|464086664|FG006|Overall Study|Participant refused further follow-up|3|||
128945228|NCT02616185|464086665|FG007|Overall Study|Participant refused further follow-up|4|||
128945229|NCT02616185|464086666|FG008|Overall Study|Participant refused further follow-up|3|||
128945230|NCT02616185|464086658|FG000|Overall Study|Not reported|0|||
128945231|NCT02616185|464086659|FG001|Overall Study|Not reported|0|||
128945232|NCT02616185|464086660|FG002|Overall Study|Not reported|0|||
128945233|NCT02616185|464086661|FG003|Overall Study|Not reported|1|||
128945234|NCT02616185|464086662|FG004|Overall Study|Not reported|3|||
128945235|NCT02616185|464086663|FG005|Overall Study|Not reported|1|||
128945236|NCT02616185|464086664|FG006|Overall Study|Not reported|0|||
128945237|NCT02616185|464086665|FG007|Overall Study|Not reported|5|||
128945238|NCT02616185|464086666|FG008|Overall Study|Not reported|2|||
128945239|NCT01303380|464086667|FG000|Overall Study|Lack of compliance to study procedures|1|||
128945240|NCT03725202|464086668|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
128945241|NCT03725202|464086669|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
128945242|NCT03725202|464086670|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
128945243|NCT03725202|464086671|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
128945244|NCT03725202|464086672|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
128945245|NCT03725202|464086673|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
128945246|NCT03725202|464086674|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
128945247|NCT03725202|464086675|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
128945248|NCT03725202|464086668|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
128945249|NCT03725202|464086669|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
128945250|NCT03725202|464086670|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
128945251|NCT03725202|464086671|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
128945252|NCT03725202|464086672|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
128945253|NCT03725202|464086673|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
128945254|NCT03725202|464086674|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
128708261|NCT02850965|463226425|FG000|Overall Study|Withdrawal by Subject|3|||
128945255|NCT03725202|464086675|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
129123529|NCT00460798|464747003|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
129123530|NCT01898130|464747004|FG000|Treatment|Withdrawal by Subject|2|||
129123531|NCT01898130|464747004|FG000|Treatment|Progressive Disease|4|||
128945256|NCT03725202|464086668|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
128945257|NCT03725202|464086669|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
128945258|NCT03725202|464086670|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
128945259|NCT03725202|464086671|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
128945260|NCT03725202|464086672|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129123532|NCT01898130|464747004|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
128945261|NCT03725202|464086673|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
128945262|NCT03725202|464086674|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
128945263|NCT03725202|464086675|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
128945264|NCT03725202|464086668|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
128945265|NCT03725202|464086669|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
128945266|NCT03725202|464086670|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
128945267|NCT03725202|464086671|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
128945268|NCT03725202|464086672|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
128945269|NCT03725202|464086673|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
128945270|NCT03725202|464086674|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
128945271|NCT03725202|464086675|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
128945272|NCT03725202|464086668|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
128945273|NCT03725202|464086669|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
128945274|NCT03725202|464086670|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
128945275|NCT03725202|464086671|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
128945276|NCT03725202|464086672|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
128945277|NCT03725202|464086673|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
128945278|NCT03725202|464086674|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
128945279|NCT03725202|464086675|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
128945280|NCT03725202|464086668|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
128945281|NCT03725202|464086669|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
128945282|NCT03725202|464086670|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
128945283|NCT03725202|464086671|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
128945284|NCT03725202|464086672|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
128945285|NCT03725202|464086673|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
128945286|NCT03725202|464086674|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
128945287|NCT03725202|464086675|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
128945288|NCT03725202|464086668|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
128945289|NCT03725202|464086669|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
128945290|NCT03725202|464086670|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
128945291|NCT03725202|464086671|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
128945292|NCT03725202|464086672|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
128945293|NCT03725202|464086673|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
128945294|NCT03725202|464086674|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
128945295|NCT03725202|464086675|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
128945296|NCT03725202|464086668|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
128945297|NCT03725202|464086669|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
128945298|NCT03725202|464086670|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
128945299|NCT03725202|464086671|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
128945300|NCT03725202|464086672|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
128945301|NCT03725202|464086673|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
128945302|NCT03725202|464086674|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
128945303|NCT03725202|464086675|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
128945304|NCT03725202|464086668|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
128945305|NCT03725202|464086669|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
128945306|NCT03725202|464086670|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
128945307|NCT03725202|464086671|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
128945308|NCT03725202|464086672|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
128945309|NCT03725202|464086673|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
128945310|NCT03725202|464086674|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
128945311|NCT03725202|464086675|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
128945312|NCT03725202|464086668|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
128945313|NCT03725202|464086669|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
128945314|NCT03725202|464086670|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
128945315|NCT03725202|464086671|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
128945316|NCT03725202|464086672|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
128945317|NCT03725202|464086673|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
128945318|NCT03725202|464086674|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
128945319|NCT03725202|464086675|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
128945320|NCT03725202|464086668|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
128945321|NCT03725202|464086669|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
128945322|NCT03725202|464086670|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
128945323|NCT03725202|464086671|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
128708262|NCT02850965|463226426|FG001|Overall Study|Withdrawal by Subject|4|||
128708263|NCT02850965|463226425|FG000|Overall Study|Physician Decision|0|||
128770265|NCT02262260|463450195|FG000|Overall Study|Protocol deviation|2|||
128770266|NCT02262260|463450196|FG001|Overall Study|Protocol deviation|5|||
128770267|NCT01794117|463450198|FG000|Overall Study|Adverse Event|1|||
128945324|NCT03725202|464086672|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
128945325|NCT03725202|464086673|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
128945326|NCT03725202|464086674|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
128945327|NCT03725202|464086675|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
128945328|NCT03725202|464086668|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
128945329|NCT03725202|464086669|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
128945330|NCT03725202|464086670|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
128945331|NCT03725202|464086671|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
128945332|NCT03725202|464086672|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
128945333|NCT03725202|464086673|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
128945334|NCT03725202|464086674|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
128945335|NCT03725202|464086675|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
128945336|NCT01328249|464086678|FG000|Overall Study|Adverse Event|3|||
128945337|NCT01328249|464086679|FG001|Overall Study|Adverse Event|0|||
128945338|NCT01328249|464086678|FG000|Overall Study|Disease progression|1|||
128945339|NCT01328249|464086679|FG001|Overall Study|Disease progression|0|||
128945340|NCT01328249|464086678|FG000|Overall Study|Withdrawal by Subject|1|||
128945341|NCT01328249|464086679|FG001|Overall Study|Withdrawal by Subject|1|||
128945342|NCT01328249|464086678|FG000|Overall Study|Moved before end of treatment visit|1|||
128945343|NCT01328249|464086679|FG001|Overall Study|Moved before end of treatment visit|0|||
128945344|NCT01328249|464086678|FG000|Overall Study|Subject choice|1|||
128945345|NCT01328249|464086679|FG001|Overall Study|Subject choice|1|||
128945346|NCT01328249|464086678|FG000|Overall Study|Protocol Violation|0|||
128945347|NCT01328249|464086679|FG001|Overall Study|Protocol Violation|1|||
128945348|NCT01215734|464086680|FG000|Overall Study|Death|0|||
128945349|NCT01215734|464086681|FG001|Overall Study|Death|1|||
128945350|NCT01716533|464086682|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
128945351|NCT01716533|464086683|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
128945352|NCT01716533|464086684|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
128945353|NCT01716533|464086685|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
128945354|NCT01716533|464086682|FG000|Overall Study|Withdrawal by Subject|0|||
128945355|NCT01716533|464086683|FG001|Overall Study|Withdrawal by Subject|0|||
128945356|NCT01716533|464086684|FG002|Overall Study|Withdrawal by Subject|0|||
128945357|NCT01716533|464086685|FG003|Overall Study|Withdrawal by Subject|5|||
128945358|NCT01716533|464086682|FG000|Overall Study|Death|0|||
128945359|NCT01716533|464086683|FG001|Overall Study|Death|0|||
128945360|NCT01716533|464086684|FG002|Overall Study|Death|0|||
128945361|NCT01716533|464086685|FG003|Overall Study|Death|2|||
128945362|NCT01716533|464086682|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
128945363|NCT01716533|464086683|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
128945364|NCT01716533|464086684|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
128945365|NCT01716533|464086685|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
128945366|NCT02330549|464086686|FG000|Overall Study|Adverse Event|1|||
128945367|NCT02330549|464086687|FG001|Overall Study|Adverse Event|0|||
128945368|NCT02330549|464086686|FG000|Overall Study|Subject withdrew consent|2|||
128945369|NCT02330549|464086687|FG001|Overall Study|Subject withdrew consent|1|||
128945370|NCT02330549|464086686|FG000|Overall Study|Failure to meet randomization criteria|1|||
128770268|NCT01794117|463450199|FG001|Overall Study|Adverse Event|0|||
128770269|NCT01794117|463450200|FG002|Overall Study|Adverse Event|0|||
128770270|NCT01794117|463450201|FG003|Overall Study|Adverse Event|0|||
128770271|NCT01794117|463450198|FG000|Overall Study|Participant noncompliance|0|||
128770272|NCT01794117|463450199|FG001|Overall Study|Participant noncompliance|1|||
128770273|NCT01794117|463450200|FG002|Overall Study|Participant noncompliance|0|||
128770274|NCT01794117|463450201|FG003|Overall Study|Participant noncompliance|0|||
128770275|NCT01794117|463450198|FG000|Overall Study|Refused further treatment|0|||
128770276|NCT01794117|463450199|FG001|Overall Study|Refused further treatment|2|||
128945371|NCT02330549|464086687|FG001|Overall Study|Failure to meet randomization criteria|0|||
128770277|NCT01794117|463450200|FG002|Overall Study|Refused further treatment|0|||
128770278|NCT01794117|463450201|FG003|Overall Study|Refused further treatment|0|||
128945372|NCT00495495|464086693|FG000|Overall Study|Protocol Violation|99|||
128945373|NCT03331666|464086697|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
128945374|NCT03331666|464086698|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
128945375|NCT01026389|464086701|FG000|Overall Study|Withdrawal by Subject|1|||
128945376|NCT01026389|464086702|FG001|Overall Study|Withdrawal by Subject|3|||
128945377|NCT01026389|464086701|FG000|Overall Study|change of treatment, patient moved|4|||
128945378|NCT01026389|464086702|FG001|Overall Study|change of treatment, patient moved|2|||
128945379|NCT01995136|464086703|FG000|Overall Study|Change in residence|1|||
128770279|NCT03734991|463450202|FG000|Overall Study|Adverse Event|4|||
128770280|NCT03734991|463450203|FG001|Overall Study|Adverse Event|0|||
128945380|NCT04410198|464086704|FG000|Overall Study|Death|10|||
128945381|NCT04410198|464086704|FG000|Overall Study|Withdrawal by Subject|7|||
128945382|NCT04410198|464086704|FG000|Overall Study|Transferred/Relocation|4|||
128945383|NCT04410198|464086704|FG000|Overall Study|Kidney Transplant|9|||
128945384|NCT04410198|464086704|FG000|Overall Study|Adverse Event|4|||
128945385|NCT04410198|464086704|FG000|Overall Study|Physician Decision|2|||
128945386|NCT04410198|464086704|FG000|Overall Study|Other than specified|1|||
128945387|NCT01830543|464086707|FG000|Overall Study|Subject Decision|19|||
128945388|NCT01830543|464086708|FG001|Overall Study|Subject Decision|21|||
128945389|NCT01830543|464086709|FG002|Overall Study|Subject Decision|57|||
128945390|NCT01830543|464086707|FG000|Overall Study|Adverse Event|91|||
128945391|NCT01830543|464086708|FG001|Overall Study|Adverse Event|77|||
128945392|NCT01830543|464086709|FG002|Overall Study|Adverse Event|76|||
128945393|NCT01830543|464086707|FG000|Overall Study|Death|20|||
128945394|NCT01830543|464086708|FG001|Overall Study|Death|22|||
128945395|NCT01830543|464086709|FG002|Overall Study|Death|22|||
128945396|NCT01830543|464086707|FG000|Overall Study|Protocol Violation|3|||
128945397|NCT01830543|464086708|FG001|Overall Study|Protocol Violation|7|||
128945398|NCT01830543|464086709|FG002|Overall Study|Protocol Violation|7|||
128945399|NCT01830543|464086707|FG000|Overall Study|Physician Decision|11|||
128945400|NCT01830543|464086708|FG001|Overall Study|Physician Decision|5|||
128945401|NCT01830543|464086709|FG002|Overall Study|Physician Decision|12|||
128945402|NCT01830543|464086707|FG000|Overall Study|Withdrawal by consent|3|||
128945403|NCT01830543|464086708|FG001|Overall Study|Withdrawal by consent|3|||
128945404|NCT01830543|464086709|FG002|Overall Study|Withdrawal by consent|3|||
128945405|NCT01830543|464086707|FG000|Overall Study|Other|12|||
128945406|NCT01830543|464086708|FG001|Overall Study|Other|17|||
128945407|NCT01830543|464086709|FG002|Overall Study|Other|37|||
128945408|NCT03583372|464086712|FG000|Overall Study|Withdrawal by Subject|6|||
128945409|NCT03583372|464086713|FG001|Overall Study|Withdrawal by Subject|11|||
128945410|NCT03583372|464086714|FG002|Overall Study|Withdrawal by Subject|7|||
128945411|NCT03583372|464086715|FG003|Overall Study|Withdrawal by Subject|8|||
128945412|NCT03583372|464086712|FG000|Overall Study|Lost to Follow-up|4|||
128945413|NCT03583372|464086713|FG001|Overall Study|Lost to Follow-up|6|||
128945414|NCT03583372|464086714|FG002|Overall Study|Lost to Follow-up|3|||
128945415|NCT03583372|464086715|FG003|Overall Study|Lost to Follow-up|2|||
128945416|NCT03583372|464086712|FG000|Overall Study|Adverse Event|1|||
128945417|NCT03583372|464086713|FG001|Overall Study|Adverse Event|3|||
128945418|NCT03583372|464086714|FG002|Overall Study|Adverse Event|4|||
128945419|NCT03583372|464086715|FG003|Overall Study|Adverse Event|4|||
128945420|NCT03583372|464086712|FG000|Overall Study|Physician Decision|0|||
128945421|NCT03583372|464086713|FG001|Overall Study|Physician Decision|1|||
128945422|NCT03583372|464086714|FG002|Overall Study|Physician Decision|1|||
128945423|NCT03583372|464086715|FG003|Overall Study|Physician Decision|1|||
128945424|NCT03583372|464086712|FG000|Overall Study|Lack of Efficacy|0|||
128945425|NCT03583372|464086713|FG001|Overall Study|Lack of Efficacy|1|||
128945426|NCT03583372|464086714|FG002|Overall Study|Lack of Efficacy|0|||
128945427|NCT03583372|464086715|FG003|Overall Study|Lack of Efficacy|1|||
128945428|NCT03583372|464086712|FG000|Overall Study|Death|1|||
128945429|NCT03583372|464086713|FG001|Overall Study|Death|0|||
128945430|NCT03583372|464086714|FG002|Overall Study|Death|0|||
128945431|NCT03583372|464086715|FG003|Overall Study|Death|0|||
128945432|NCT03583372|464086712|FG000|Overall Study|Protocol Violation|0|||
128945433|NCT03583372|464086713|FG001|Overall Study|Protocol Violation|1|||
128945434|NCT03583372|464086714|FG002|Overall Study|Protocol Violation|0|||
128945435|NCT03583372|464086715|FG003|Overall Study|Protocol Violation|0|||
128945436|NCT03583372|464086712|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
128945437|NCT03583372|464086713|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
128945438|NCT03583372|464086714|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
128945439|NCT03583372|464086715|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
128945440|NCT03583372|464086712|FG000|Overall Study|Did Not Receive Study Drug|0|||
128945441|NCT03583372|464086713|FG001|Overall Study|Did Not Receive Study Drug|1|||
128945442|NCT03583372|464086714|FG002|Overall Study|Did Not Receive Study Drug|0|||
128945443|NCT03583372|464086715|FG003|Overall Study|Did Not Receive Study Drug|0|||
128945444|NCT03583372|464086712|FG000|Overall Study|Captured as Other in the Database|1|||
128945445|NCT03583372|464086713|FG001|Overall Study|Captured as Other in the Database|2|||
128945446|NCT03583372|464086714|FG002|Overall Study|Captured as Other in the Database|4|||
128945447|NCT03583372|464086715|FG003|Overall Study|Captured as Other in the Database|1|||
128945448|NCT01030458|464086726|FG000|Overall Study|Lost to Follow-up|9|||
128945449|NCT01030458|464086727|FG001|Overall Study|Lost to Follow-up|10|||
128945450|NCT01030458|464086726|FG000|Overall Study|Withdrawal by Subject|2|||
128945451|NCT01030458|464086727|FG001|Overall Study|Withdrawal by Subject|3|||
128945452|NCT01030458|464086726|FG000|Overall Study|Logistical reasons|9|||
128945453|NCT01030458|464086727|FG001|Overall Study|Logistical reasons|5|||
128945454|NCT01030458|464086726|FG000|Overall Study|Moved or changed job|6|||
128945455|NCT01030458|464086727|FG001|Overall Study|Moved or changed job|13|||
128945456|NCT01030458|464086726|FG000|Overall Study|Side effect of medication|1|||
128945457|NCT01030458|464086727|FG001|Overall Study|Side effect of medication|1|||
128945458|NCT02420223|464086728|FG000|Overall Study|Adverse Event|1|||
128945459|NCT02420223|464086729|FG001|Overall Study|Adverse Event|0|||
128945460|NCT02420223|464086728|FG000|Overall Study|Physician Decision|0|||
128945461|NCT02420223|464086729|FG001|Overall Study|Physician Decision|2|||
128945462|NCT05142332|464086736|FG000|Overall Study|Withdrawal by Subject|0|||
128945463|NCT05142332|464086737|FG001|Overall Study|Withdrawal by Subject|1|||
128945464|NCT05142332|464086738|FG002|Overall Study|Withdrawal by Subject|2|||
128945465|NCT05142332|464086739|FG003|Overall Study|Withdrawal by Subject|0|||
128945466|NCT05142332|464086740|FG004|Overall Study|Withdrawal by Subject|0|||
128945467|NCT05142332|464086741|FG005|Overall Study|Withdrawal by Subject|2|||
128945468|NCT05142332|464086742|FG006|Overall Study|Withdrawal by Subject|6|||
128945469|NCT05142332|464086736|FG000|Overall Study|Left ED|3|||
128945470|NCT05142332|464086737|FG001|Overall Study|Left ED|0|||
128945471|NCT05142332|464086738|FG002|Overall Study|Left ED|4|||
128945472|NCT05142332|464086739|FG003|Overall Study|Left ED|6|||
128945473|NCT05142332|464086740|FG004|Overall Study|Left ED|1|||
128945474|NCT05142332|464086741|FG005|Overall Study|Left ED|2|||
128945475|NCT05142332|464086742|FG006|Overall Study|Left ED|6|||
128945476|NCT05142332|464086736|FG000|Overall Study|Physician Decision|0|||
128945477|NCT05142332|464086737|FG001|Overall Study|Physician Decision|0|||
128945478|NCT05142332|464086738|FG002|Overall Study|Physician Decision|2|||
128945479|NCT05142332|464086739|FG003|Overall Study|Physician Decision|1|||
128945480|NCT05142332|464086740|FG004|Overall Study|Physician Decision|0|||
128945481|NCT05142332|464086741|FG005|Overall Study|Physician Decision|0|||
128945482|NCT05142332|464086742|FG006|Overall Study|Physician Decision|3|||
128945483|NCT05142332|464086736|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
128945484|NCT05142332|464086737|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
128945485|NCT05142332|464086738|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
128945486|NCT05142332|464086739|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
128945487|NCT05142332|464086740|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
128945488|NCT05142332|464086741|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
128945489|NCT05142332|464086742|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
128945490|NCT02052778|464086747|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
128945491|NCT02052778|464086748|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
128945492|NCT02052778|464086749|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
128945493|NCT02052778|464086750|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
128708264|NCT02850965|463226426|FG001|Overall Study|Physician Decision|1|||
128708265|NCT02850965|463226425|FG000|Overall Study|Randomized but not treated|0|||
128708266|NCT02850965|463226426|FG001|Overall Study|Randomized but not treated|1|||
128708267|NCT02289417|463226427|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
128708268|NCT02289417|463226428|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
128708269|NCT02289417|463226429|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
128708270|NCT02289417|463226430|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
128945494|NCT02052778|464086751|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
128945495|NCT02052778|464086752|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
128945496|NCT02052778|464086753|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945497|NCT02052778|464086754|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
128945498|NCT02052778|464086755|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
128945499|NCT02052778|464086756|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
128945500|NCT02052778|464086757|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
128945501|NCT02052778|464086758|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
128945502|NCT02052778|464086759|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
128945503|NCT02052778|464086760|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
128945504|NCT02052778|464086761|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945505|NCT02052778|464086762|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945506|NCT02052778|464086763|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945507|NCT02052778|464086764|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945508|NCT02052778|464086765|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945509|NCT02052778|464086766|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945510|NCT02052778|464086767|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945511|NCT02052778|464086768|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945512|NCT02052778|464086769|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
128945513|NCT02052778|464086747|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
128945514|NCT02052778|464086748|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
128945515|NCT02052778|464086749|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
128945516|NCT02052778|464086750|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
128708271|NCT02289417|463226431|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
128708272|NCT02289417|463226432|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
128708273|NCT02289417|463226433|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
128708274|NCT02289417|463226434|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
128708275|NCT02289417|463226435|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
128708276|NCT02289417|463226427|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
128708277|NCT02289417|463226428|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
128708278|NCT02289417|463226429|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
128708279|NCT02289417|463226430|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
128708280|NCT02289417|463226431|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
128708281|NCT02289417|463226432|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
128708282|NCT02289417|463226433|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
128708283|NCT02289417|463226434|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
128708284|NCT02289417|463226435|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
128708285|NCT02289417|463226427|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128708286|NCT02289417|463226428|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
128708287|NCT02289417|463226429|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128708288|NCT02289417|463226430|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128945517|NCT02052778|464086751|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
128945518|NCT02052778|464086752|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
128945519|NCT02052778|464086753|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
128945520|NCT02052778|464086754|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
128945521|NCT02052778|464086755|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
128945522|NCT02052778|464086756|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945523|NCT02052778|464086757|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945524|NCT02052778|464086758|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
128945525|NCT02052778|464086759|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
128945526|NCT02052778|464086760|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
128945527|NCT02052778|464086761|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945528|NCT02052778|464086762|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945529|NCT02052778|464086763|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945530|NCT02052778|464086764|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945531|NCT02052778|464086765|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945532|NCT02052778|464086766|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945533|NCT02052778|464086767|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945534|NCT02052778|464086768|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945535|NCT02052778|464086769|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
128945536|NCT02052778|464086747|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945537|NCT02052778|464086748|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945538|NCT02052778|464086749|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945539|NCT02052778|464086750|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945540|NCT02052778|464086751|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945541|NCT02052778|464086752|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945542|NCT02052778|464086753|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945543|NCT02052778|464086754|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945544|NCT02052778|464086755|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945545|NCT02052778|464086756|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945546|NCT02052778|464086757|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945547|NCT02052778|464086758|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945548|NCT02052778|464086759|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945549|NCT02052778|464086760|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
128945550|NCT02052778|464086761|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945551|NCT02052778|464086762|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945552|NCT02052778|464086763|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945553|NCT02052778|464086764|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945554|NCT02052778|464086765|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945555|NCT02052778|464086766|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945556|NCT02052778|464086767|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945557|NCT02052778|464086768|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945558|NCT02052778|464086769|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
128945559|NCT02052778|464086747|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
128945560|NCT02052778|464086748|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
128945561|NCT02052778|464086749|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
128945562|NCT02052778|464086750|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
128945563|NCT02052778|464086751|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
128770281|NCT03734991|463450202|FG000|Overall Study|Lost to Follow-up|4|||
128708289|NCT02289417|463226431|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128708290|NCT02289417|463226432|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128708291|NCT02289417|463226433|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128708292|NCT02289417|463226434|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128708293|NCT02289417|463226435|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
128708294|NCT02289417|463226427|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
128708295|NCT02289417|463226428|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708296|NCT02289417|463226429|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708297|NCT02289417|463226430|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708298|NCT02289417|463226431|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708299|NCT02289417|463226432|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708300|NCT02289417|463226433|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708301|NCT02289417|463226434|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708302|NCT02289417|463226435|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
128708303|NCT02289417|463226427|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
128945564|NCT02052778|464086752|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
128945565|NCT02052778|464086753|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
128945566|NCT02052778|464086754|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
128945567|NCT02052778|464086755|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
128945568|NCT02052778|464086756|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
128945569|NCT02052778|464086757|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
128945570|NCT02052778|464086758|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
128945571|NCT02052778|464086759|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
128945572|NCT02052778|464086760|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
128945573|NCT02052778|464086761|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
128945574|NCT02052778|464086762|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
128945575|NCT02052778|464086763|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
128945576|NCT02052778|464086764|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
128945577|NCT02052778|464086765|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
128945578|NCT02052778|464086766|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
128945579|NCT02052778|464086767|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
128945580|NCT02052778|464086768|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
128945581|NCT02052778|464086769|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
128945582|NCT02052778|464086747|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945583|NCT02052778|464086748|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945584|NCT02052778|464086749|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945585|NCT02052778|464086750|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945586|NCT02052778|464086751|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945587|NCT02052778|464086752|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945588|NCT02052778|464086753|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945589|NCT02052778|464086754|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945590|NCT02052778|464086755|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
128945591|NCT02052778|464086756|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945592|NCT02052778|464086757|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945593|NCT02052778|464086758|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945594|NCT02052778|464086759|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945595|NCT02052778|464086760|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
128945596|NCT02052778|464086761|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945597|NCT02052778|464086762|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945598|NCT02052778|464086763|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945599|NCT02052778|464086764|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945600|NCT02052778|464086765|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945601|NCT02052778|464086766|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945602|NCT02052778|464086767|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945603|NCT02052778|464086768|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945604|NCT02052778|464086769|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
128945605|NCT02052778|464086747|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945606|NCT02052778|464086748|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945607|NCT02052778|464086749|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945608|NCT02052778|464086750|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945609|NCT02052778|464086751|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128708304|NCT02289417|463226428|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
128708305|NCT02289417|463226429|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
128945610|NCT02052778|464086752|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
128945611|NCT02052778|464086753|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945612|NCT02052778|464086754|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945613|NCT02052778|464086755|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945614|NCT02052778|464086756|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945615|NCT02052778|464086757|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945616|NCT02052778|464086758|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945617|NCT02052778|464086759|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
128945618|NCT02052778|464086760|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945619|NCT02052778|464086761|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945620|NCT02052778|464086762|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945621|NCT02052778|464086763|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945622|NCT02052778|464086764|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945623|NCT02052778|464086765|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945624|NCT02052778|464086766|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945625|NCT02052778|464086767|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945626|NCT02052778|464086768|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945627|NCT02052778|464086769|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
128945628|NCT02052778|464086747|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945629|NCT02052778|464086748|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945630|NCT02052778|464086749|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945631|NCT02052778|464086750|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945632|NCT02052778|464086751|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945633|NCT02052778|464086752|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945634|NCT02052778|464086753|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945635|NCT02052778|464086754|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945636|NCT02052778|464086755|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945637|NCT02052778|464086756|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945638|NCT02052778|464086757|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945639|NCT02052778|464086758|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945640|NCT02052778|464086759|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945641|NCT02052778|464086760|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945642|NCT02052778|464086761|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
128945643|NCT02052778|464086762|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
128945644|NCT02052778|464086763|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
128945645|NCT02052778|464086764|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
128945646|NCT02052778|464086765|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
128945647|NCT02052778|464086766|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
128945648|NCT02052778|464086767|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
128945649|NCT02052778|464086768|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
128945650|NCT02052778|464086769|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
128945651|NCT02052778|464086747|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945652|NCT02052778|464086748|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945653|NCT02052778|464086749|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945654|NCT02052778|464086750|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945655|NCT02052778|464086751|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945656|NCT02052778|464086752|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129033709|NCT00348816|464414077|FG000|Overall Study|Noncompliance with radiation treatment|1|||
128708306|NCT02289417|463226430|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
128708307|NCT02289417|463226431|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
128708308|NCT02289417|463226432|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
128708309|NCT02289417|463226433|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
128708310|NCT02289417|463226434|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
128708311|NCT02289417|463226435|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
128708312|NCT02289417|463226427|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128708313|NCT02289417|463226428|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128708314|NCT02289417|463226429|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
128708315|NCT02289417|463226430|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128708316|NCT02289417|463226431|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128708317|NCT02289417|463226432|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128708318|NCT02289417|463226433|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128708319|NCT02289417|463226434|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128770282|NCT03734991|463450203|FG001|Overall Study|Lost to Follow-up|0|||
128945657|NCT02052778|464086753|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945658|NCT02052778|464086754|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945659|NCT02052778|464086755|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945660|NCT02052778|464086756|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945661|NCT02052778|464086757|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945662|NCT02052778|464086758|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945663|NCT02052778|464086759|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945664|NCT02052778|464086760|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945665|NCT02052778|464086761|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
128945666|NCT02052778|464086762|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
128945667|NCT02052778|464086763|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945668|NCT02052778|464086764|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
128945669|NCT02052778|464086765|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
128945670|NCT02052778|464086766|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
128945671|NCT02052778|464086767|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
128945672|NCT02052778|464086768|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
128945673|NCT02052778|464086769|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
128945674|NCT02052778|464086747|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945675|NCT02052778|464086748|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945676|NCT02052778|464086749|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945677|NCT02052778|464086750|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945678|NCT02052778|464086751|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945679|NCT02052778|464086752|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945680|NCT02052778|464086753|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945681|NCT02052778|464086754|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945682|NCT02052778|464086755|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945683|NCT02052778|464086756|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945684|NCT02052778|464086757|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945685|NCT02052778|464086758|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945686|NCT02052778|464086759|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945687|NCT02052778|464086760|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945688|NCT02052778|464086761|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
128945689|NCT02052778|464086762|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
128945690|NCT02052778|464086763|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
128945691|NCT02052778|464086764|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945692|NCT02052778|464086765|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
128945693|NCT02052778|464086766|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
128945694|NCT02052778|464086767|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945695|NCT02052778|464086768|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945696|NCT02052778|464086769|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
128945697|NCT02052778|464086747|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945698|NCT02052778|464086748|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945699|NCT02052778|464086749|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945700|NCT02052778|464086750|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945701|NCT02052778|464086751|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945702|NCT02052778|464086752|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945703|NCT02052778|464086753|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945704|NCT02052778|464086754|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945705|NCT02052778|464086755|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945706|NCT02052778|464086756|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945707|NCT02052778|464086757|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945708|NCT02052778|464086758|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945709|NCT02052778|464086759|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129123533|NCT04666298|464747010|FG000|Overall Study|Subject decision|1|||
128708320|NCT02289417|463226435|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
128708321|NCT02289417|463226427|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
128708322|NCT02289417|463226428|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
128708323|NCT02289417|463226429|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
128708324|NCT02289417|463226430|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
128708325|NCT02289417|463226431|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
128708326|NCT02289417|463226432|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
128708327|NCT02289417|463226433|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
128770283|NCT03734991|463450202|FG000|Overall Study|Physician Decision|0|||
128945710|NCT02052778|464086760|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945711|NCT02052778|464086761|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
128945712|NCT02052778|464086762|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
128945713|NCT02052778|464086763|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945714|NCT02052778|464086764|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945715|NCT02052778|464086765|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945716|NCT02052778|464086766|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129123534|NCT04666298|464747011|FG001|Overall Study|Subject decision|0|||
129123535|NCT04666298|464747012|FG002|Overall Study|Subject decision|0|||
129123536|NCT04666298|464747013|FG003|Overall Study|Subject decision|2|||
129123537|NCT04666298|464747010|FG000|Overall Study|Death|1|||
129123538|NCT04666298|464747011|FG001|Overall Study|Death|0|||
129123539|NCT04666298|464747012|FG002|Overall Study|Death|0|||
129123540|NCT04666298|464747013|FG003|Overall Study|Death|0|||
129123541|NCT04666298|464747010|FG000|Overall Study|Lost to Follow-up|0|||
129123542|NCT04666298|464747011|FG001|Overall Study|Lost to Follow-up|0|||
129123543|NCT04666298|464747012|FG002|Overall Study|Lost to Follow-up|0|||
129123544|NCT04666298|464747013|FG003|Overall Study|Lost to Follow-up|1|||
129123545|NCT04666298|464747010|FG000|Overall Study|Physician Decision|0|||
129123546|NCT04666298|464747011|FG001|Overall Study|Physician Decision|0|||
129123547|NCT04666298|464747012|FG002|Overall Study|Physician Decision|0|||
129123548|NCT04666298|464747013|FG003|Overall Study|Physician Decision|1|||
129123549|NCT04666298|464747010|FG000|Overall Study|Protocol deviation|0|||
129123550|NCT04666298|464747011|FG001|Overall Study|Protocol deviation|0|||
129123551|NCT04666298|464747012|FG002|Overall Study|Protocol deviation|1|||
129123552|NCT04666298|464747013|FG003|Overall Study|Protocol deviation|0|||
129123553|NCT00844519|464747014|FG000|Overall Study|Withdrawal by Subject|1|||
129123554|NCT00844519|464747015|FG001|Overall Study|Withdrawal by Subject|1|||
129123555|NCT00844519|464747014|FG000|Overall Study|Adverse Event|1|||
129123556|NCT00844519|464747015|FG001|Overall Study|Adverse Event|0|||
129123557|NCT00226655|464747016|FG000|Overall Study|Death|13|||
129123558|NCT00226655|464747016|FG000|Overall Study|Withdrawal by Subject|15|||
129123559|NCT00226655|464747016|FG000|Overall Study|Adverse Event|35|||
129123560|NCT00226655|464747016|FG000|Overall Study|Physician Decision|6|||
129123561|NCT00226655|464747016|FG000|Overall Study|Clinical deterioration|10|||
129123562|NCT06438601|464747017|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
129123563|NCT06438601|464747018|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
129123564|NCT06438601|464747017|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
129123565|NCT06438601|464747018|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
129123566|NCT03188822|464747021|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
129123567|NCT03188822|464747021|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
129123568|NCT03805841|464747022|FG000|Overall Study|Clinical Progression|2|||
129123569|NCT03805841|464747023|FG001|Overall Study|Clinical Progression|0|||
129123570|NCT03805841|464747024|FG002|Overall Study|Clinical Progression|0|||
129123571|NCT03805841|464747022|FG000|Overall Study|Death|0|||
129123572|NCT03805841|464747023|FG001|Overall Study|Death|3|||
129123573|NCT03805841|464747024|FG002|Overall Study|Death|1|||
129123574|NCT03805841|464747022|FG000|Overall Study|Lost to Follow-up|0|||
129123575|NCT03805841|464747023|FG001|Overall Study|Lost to Follow-up|0|||
129123576|NCT03805841|464747024|FG002|Overall Study|Lost to Follow-up|1|||
129123577|NCT03805841|464747022|FG000|Overall Study|Withdrawal by Subject|2|||
129123578|NCT03805841|464747023|FG001|Overall Study|Withdrawal by Subject|3|||
129123579|NCT03805841|464747024|FG002|Overall Study|Withdrawal by Subject|0|||
129123580|NCT03805841|464747022|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
129123581|NCT03805841|464747023|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
129123582|NCT03805841|464747024|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
129123583|NCT02460289|464747027|FG000|Overall Study|Adverse Event|1|||
129123584|NCT02460289|464747027|FG000|Overall Study|Withdrawal by Subject|8|||
129123585|NCT02460289|464747027|FG000|Overall Study|Lost to Follow-up|1|||
129123586|NCT01977846|464747028|FG000|Total Study - Prospective|Death|0|||
129123587|NCT01977846|464747029|FG001|Total Study - Prospective|Death|1|||
129123588|NCT01977846|464747028|FG000|Total Study - Prospective|Lost to Follow-up|0|||
129123589|NCT01977846|464747029|FG001|Total Study - Prospective|Lost to Follow-up|8|||
129123590|NCT01977846|464747028|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
129123591|NCT01977846|464747029|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
129123592|NCT01977846|464747028|FG000|Total Study - Prospective|Not available at time of visit|0|||
129123593|NCT01977846|464747029|FG001|Total Study - Prospective|Not available at time of visit|5|||
129123594|NCT01977846|464747028|FG000|Total Study - Prospective|No show|0|||
129123595|NCT01977846|464747029|FG001|Total Study - Prospective|No show|1|||
129123596|NCT01977846|464747028|FG000|Total Study - Prospective|Protocol Violation|0|||
129123597|NCT01977846|464747029|FG001|Total Study - Prospective|Protocol Violation|1|||
129123598|NCT02164916|464747030|FG000|Overall Study|Adverse Event|3|||
129123599|NCT02164916|464747031|FG001|Overall Study|Adverse Event|8|||
128770284|NCT03734991|463450203|FG001|Overall Study|Physician Decision|1|||
128770285|NCT03734991|463450202|FG000|Overall Study|Pregnancy|1|||
128770286|NCT03734991|463450203|FG001|Overall Study|Pregnancy|0|||
128770287|NCT03734991|463450202|FG000|Overall Study|Withdrawal by Subject|6|||
128770288|NCT03734991|463450203|FG001|Overall Study|Withdrawal by Subject|3|||
128770289|NCT03734991|463450202|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
128770290|NCT03734991|463450203|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
128770291|NCT03734991|463450202|FG000|Overall Study|Other|2|||
128770292|NCT03734991|463450203|FG001|Overall Study|Other|2|||
128770293|NCT02322814|463450206|FG000|Overall Study|Death|7|||
128770294|NCT02322814|463450207|FG001|Overall Study|Death|29|||
128770295|NCT02322814|463450208|FG002|Overall Study|Death|32|||
128770296|NCT02322814|463450209|FG003|Overall Study|Death|23|||
128770297|NCT02322814|463450210|FG004|Overall Study|Death|14|||
128770298|NCT02322814|463450206|FG000|Overall Study|Lost to Follow-up|1|||
128945717|NCT02052778|464086767|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945718|NCT02052778|464086768|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945719|NCT02052778|464086769|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
128945720|NCT02052778|464086747|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945721|NCT02052778|464086748|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945722|NCT02052778|464086749|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945723|NCT02052778|464086750|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945724|NCT02052778|464086751|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945725|NCT02052778|464086752|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945726|NCT02052778|464086753|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945727|NCT02052778|464086754|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945728|NCT02052778|464086755|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945729|NCT02052778|464086756|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945730|NCT02052778|464086757|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945731|NCT02052778|464086758|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945732|NCT02052778|464086759|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945733|NCT02052778|464086760|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945734|NCT02052778|464086761|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
128945735|NCT02052778|464086762|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
128945736|NCT02052778|464086763|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945737|NCT02052778|464086764|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945738|NCT02052778|464086765|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945739|NCT02052778|464086766|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
128945740|NCT02052778|464086767|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945741|NCT02052778|464086768|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945742|NCT02052778|464086769|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
128945743|NCT02052778|464086747|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
128945744|NCT02052778|464086748|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
128945745|NCT02052778|464086749|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
128945746|NCT02052778|464086750|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
128945747|NCT02052778|464086751|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
128945748|NCT02052778|464086752|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
128945749|NCT02052778|464086753|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
128945750|NCT02052778|464086754|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
128945751|NCT02052778|464086755|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
128945752|NCT02052778|464086756|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
128945753|NCT02052778|464086757|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
128945754|NCT02052778|464086758|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
128945755|NCT02052778|464086759|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
128945756|NCT02052778|464086760|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
128945757|NCT02052778|464086761|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
128945758|NCT02052778|464086762|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
128945759|NCT02052778|464086763|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
128945760|NCT02052778|464086764|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
128945761|NCT02052778|464086765|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
128945762|NCT02052778|464086766|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
128945763|NCT02052778|464086767|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
128945764|NCT02052778|464086768|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
128945765|NCT02052778|464086769|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
128945766|NCT02052778|464086747|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945767|NCT02052778|464086748|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128770299|NCT02322814|463450207|FG001|Overall Study|Lost to Follow-up|3|||
128770300|NCT02322814|463450208|FG002|Overall Study|Lost to Follow-up|3|||
128945768|NCT02052778|464086749|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945769|NCT02052778|464086750|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945770|NCT02052778|464086751|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945771|NCT02052778|464086752|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945772|NCT02052778|464086753|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945773|NCT02052778|464086754|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945774|NCT02052778|464086755|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945775|NCT02052778|464086756|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945776|NCT02052778|464086757|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945777|NCT02052778|464086758|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945778|NCT02052778|464086759|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945779|NCT02052778|464086760|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945780|NCT02052778|464086761|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
128945781|NCT02052778|464086762|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
128945782|NCT02052778|464086763|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
128945783|NCT02052778|464086764|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945784|NCT02052778|464086765|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
128945785|NCT02052778|464086766|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945786|NCT02052778|464086767|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945787|NCT02052778|464086768|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945788|NCT02052778|464086769|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
128945789|NCT02052778|464086747|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945790|NCT02052778|464086748|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945791|NCT02052778|464086749|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945792|NCT02052778|464086750|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945793|NCT02052778|464086751|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945794|NCT02052778|464086752|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945795|NCT02052778|464086753|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945796|NCT02052778|464086754|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945797|NCT02052778|464086755|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945798|NCT02052778|464086756|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945799|NCT02052778|464086757|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945800|NCT02052778|464086758|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945801|NCT02052778|464086759|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945802|NCT02052778|464086760|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945803|NCT02052778|464086761|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945804|NCT02052778|464086762|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945805|NCT02052778|464086763|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945806|NCT02052778|464086764|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945807|NCT02052778|464086765|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945808|NCT02052778|464086766|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945809|NCT02052778|464086767|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945810|NCT02052778|464086768|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
128945811|NCT02052778|464086769|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
128945812|NCT02052778|464086747|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945813|NCT02052778|464086748|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945814|NCT02052778|464086749|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945815|NCT02052778|464086750|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945816|NCT02052778|464086751|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945817|NCT02052778|464086752|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945818|NCT02052778|464086753|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945819|NCT02052778|464086754|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945820|NCT02052778|464086755|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945821|NCT02052778|464086756|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945822|NCT02052778|464086757|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129033710|NCT02050321|464414080|FG000|Overall Study|Withdrawal by Subject|1|||
129033711|NCT02050321|464414080|FG000|Overall Study|Adverse Event|1|||
128945823|NCT02052778|464086758|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945824|NCT02052778|464086759|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945825|NCT02052778|464086760|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128708328|NCT02289417|463226434|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
128708329|NCT02289417|463226435|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
128708330|NCT02289417|463226427|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
128708331|NCT02289417|463226428|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
128708332|NCT02289417|463226429|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
128708333|NCT02289417|463226430|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
128708334|NCT02289417|463226431|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
128945826|NCT02052778|464086761|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945827|NCT02052778|464086762|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945828|NCT02052778|464086763|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945829|NCT02052778|464086764|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945830|NCT02052778|464086765|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945831|NCT02052778|464086766|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945832|NCT02052778|464086767|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945833|NCT02052778|464086768|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
128945834|NCT02052778|464086769|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
128945835|NCT02052778|464086747|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945836|NCT02052778|464086748|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945837|NCT02052778|464086749|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945838|NCT02052778|464086750|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945839|NCT02052778|464086751|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945840|NCT02052778|464086752|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945841|NCT02052778|464086753|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945842|NCT02052778|464086754|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945843|NCT02052778|464086755|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945844|NCT02052778|464086756|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945845|NCT02052778|464086757|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945846|NCT02052778|464086758|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945847|NCT02052778|464086759|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945848|NCT02052778|464086760|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945849|NCT02052778|464086761|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945850|NCT02052778|464086762|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945851|NCT02052778|464086763|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945852|NCT02052778|464086764|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945853|NCT02052778|464086765|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945854|NCT02052778|464086766|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945855|NCT02052778|464086767|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945856|NCT02052778|464086768|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
128945857|NCT02052778|464086769|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
128945858|NCT02052778|464086747|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945859|NCT02052778|464086748|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945860|NCT02052778|464086749|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945861|NCT02052778|464086750|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945862|NCT02052778|464086751|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945863|NCT02052778|464086752|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945864|NCT02052778|464086753|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945865|NCT02052778|464086754|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945866|NCT02052778|464086755|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945867|NCT02052778|464086756|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945868|NCT02052778|464086757|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945869|NCT02052778|464086758|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945870|NCT02052778|464086759|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945871|NCT02052778|464086760|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945872|NCT02052778|464086761|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945873|NCT02052778|464086762|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945874|NCT02052778|464086763|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945875|NCT02052778|464086764|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945876|NCT02052778|464086765|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945877|NCT02052778|464086766|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945878|NCT02052778|464086767|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
128945879|NCT02052778|464086768|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129123600|NCT02164916|464747030|FG000|Overall Study|Death|1|||
129123601|NCT02164916|464747031|FG001|Overall Study|Death|1|||
129123602|NCT02164916|464747030|FG000|Overall Study|Refusal unrelated to adverse event|3|||
128708335|NCT02289417|463226432|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
128708336|NCT02289417|463226433|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
128708337|NCT02289417|463226434|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
128708338|NCT02289417|463226435|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
128708339|NCT02289417|463226427|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128708340|NCT02289417|463226428|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128945880|NCT02052778|464086769|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
128945881|NCT02052778|464086747|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945882|NCT02052778|464086748|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945883|NCT02052778|464086749|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945884|NCT02052778|464086750|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945885|NCT02052778|464086751|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945886|NCT02052778|464086752|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945887|NCT02052778|464086753|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945888|NCT02052778|464086754|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945889|NCT02052778|464086755|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945890|NCT02052778|464086756|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945891|NCT02052778|464086757|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945892|NCT02052778|464086758|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945893|NCT02052778|464086759|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945894|NCT02052778|464086760|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945895|NCT02052778|464086761|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945896|NCT02052778|464086762|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945897|NCT02052778|464086763|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945898|NCT02052778|464086764|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945899|NCT02052778|464086765|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945900|NCT02052778|464086766|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945901|NCT02052778|464086767|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945902|NCT02052778|464086768|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
128945903|NCT02052778|464086769|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
128945904|NCT02052778|464086747|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
128945905|NCT02052778|464086748|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
128945906|NCT02052778|464086749|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
128945907|NCT02052778|464086750|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
128945908|NCT02052778|464086751|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
128945909|NCT02052778|464086752|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
128945910|NCT02052778|464086753|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
128945911|NCT02052778|464086754|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
128945912|NCT02052778|464086755|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
128945913|NCT02052778|464086756|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
128945914|NCT02052778|464086757|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
128945915|NCT02052778|464086758|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
128945916|NCT02052778|464086759|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
128945917|NCT02052778|464086760|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
128945918|NCT02052778|464086761|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
128945919|NCT02052778|464086762|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
128945920|NCT02052778|464086763|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
128945921|NCT02052778|464086764|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
128945922|NCT02052778|464086765|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
128945923|NCT02052778|464086766|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
128945924|NCT02052778|464086767|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
128945925|NCT02052778|464086768|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
128945926|NCT02052778|464086769|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
128945927|NCT02052778|464086747|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945928|NCT02052778|464086748|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945929|NCT02052778|464086749|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945930|NCT02052778|464086750|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945931|NCT02052778|464086751|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945932|NCT02052778|464086752|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945933|NCT02052778|464086753|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945934|NCT02052778|464086754|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945935|NCT02052778|464086755|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945936|NCT02052778|464086756|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945937|NCT02052778|464086757|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945938|NCT02052778|464086758|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945939|NCT02052778|464086759|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945940|NCT02052778|464086760|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945941|NCT02052778|464086761|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945942|NCT02052778|464086762|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945943|NCT02052778|464086763|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945944|NCT02052778|464086764|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945945|NCT02052778|464086765|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945946|NCT02052778|464086766|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945947|NCT02052778|464086767|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945948|NCT02052778|464086768|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
128945949|NCT02052778|464086769|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
128708341|NCT02289417|463226429|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128708342|NCT02289417|463226430|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128945950|NCT01980706|464086774|FG000|Overall Study|Withdrawal by Subject|9|||
128945951|NCT01980706|464086775|FG001|Overall Study|Withdrawal by Subject|6|||
128945952|NCT01980706|464086776|FG002|Overall Study|Withdrawal by Subject|2|||
128945953|NCT01980706|464086774|FG000|Overall Study|Adverse Event|1|||
128945954|NCT01980706|464086775|FG001|Overall Study|Adverse Event|2|||
128945955|NCT01980706|464086776|FG002|Overall Study|Adverse Event|5|||
128945956|NCT01980706|464086774|FG000|Overall Study|Lost to Follow-up|3|||
128945957|NCT01980706|464086775|FG001|Overall Study|Lost to Follow-up|4|||
128945958|NCT01980706|464086776|FG002|Overall Study|Lost to Follow-up|3|||
128945959|NCT01980706|464086774|FG000|Overall Study|miscellaneous|4|||
128945960|NCT01980706|464086775|FG001|Overall Study|miscellaneous|5|||
128945961|NCT01980706|464086776|FG002|Overall Study|miscellaneous|3|||
128945962|NCT01094730|464086779|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
128945963|NCT01094730|464086780|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
128945964|NCT01094730|464086779|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
128945965|NCT01094730|464086780|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
128945966|NCT01094730|464086779|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
129217776|NCT03313037|465097063|FG000|Overall Study|Randomized but not treated|1|||
128945967|NCT01094730|464086780|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
128945968|NCT01094730|464086779|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
128945969|NCT01094730|464086780|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
129217777|NCT03313037|465097064|FG001|Overall Study|Randomized but not treated|0|||
128708343|NCT02289417|463226431|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128708344|NCT02289417|463226432|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128708345|NCT02289417|463226433|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
128708346|NCT02289417|463226434|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128708347|NCT02289417|463226435|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
128708348|NCT02289417|463226427|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
128708349|NCT02289417|463226428|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
128708350|NCT02289417|463226429|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
128708351|NCT02289417|463226430|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
128708352|NCT02289417|463226431|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
128708353|NCT02289417|463226432|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
128708354|NCT02289417|463226433|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
128945970|NCT01094730|464086779|FG000|Period 2 (14 Days)|Protocol Violation|2|||
128945971|NCT01094730|464086780|FG001|Period 2 (14 Days)|Protocol Violation|0|||
128945972|NCT01094730|464086779|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
129033712|NCT00113919|464414081|FG000|Overall Study|Physician Decision|8|||
129033713|NCT00113919|464414081|FG000|Overall Study|Death|6|||
129033714|NCT01963260|464414082|FG000|Overall Study|Withdrawal by Subject|2|||
129033715|NCT01963260|464414083|FG001|Overall Study|Withdrawal by Subject|0|||
129033716|NCT01963260|464414084|FG002|Overall Study|Withdrawal by Subject|0|||
129033717|NCT01963260|464414085|FG003|Overall Study|Withdrawal by Subject|1|||
129033718|NCT01963260|464414086|FG004|Overall Study|Withdrawal by Subject|2|||
129033719|NCT01963260|464414087|FG005|Overall Study|Withdrawal by Subject|0|||
129033720|NCT01963260|464414088|FG006|Overall Study|Withdrawal by Subject|0|||
129033721|NCT01963260|464414089|FG007|Overall Study|Withdrawal by Subject|0|||
129033722|NCT01963260|464414090|FG008|Overall Study|Withdrawal by Subject|0|||
129033723|NCT01963260|464414091|FG009|Overall Study|Withdrawal by Subject|0|||
129033724|NCT00372996|464414092|FG000|Overall Study|Death|11|||
129033725|NCT00372996|464414093|FG001|Overall Study|Death|4|||
129033726|NCT00372996|464414094|FG002|Overall Study|Death|8|||
129033727|NCT00372996|464414095|FG003|Overall Study|Death|7|||
129033728|NCT00372996|464414092|FG000|Overall Study|Lost to Follow-up|0|||
129033729|NCT00372996|464414093|FG001|Overall Study|Lost to Follow-up|2|||
129033730|NCT00372996|464414094|FG002|Overall Study|Lost to Follow-up|0|||
129033731|NCT00372996|464414095|FG003|Overall Study|Lost to Follow-up|1|||
129033732|NCT00372996|464414092|FG000|Overall Study|Withdrawal by Subject|12|||
129033733|NCT00372996|464414093|FG001|Overall Study|Withdrawal by Subject|6|||
129033734|NCT00372996|464414094|FG002|Overall Study|Withdrawal by Subject|9|||
129033735|NCT00372996|464414095|FG003|Overall Study|Withdrawal by Subject|5|||
129033736|NCT00372996|464414092|FG000|Overall Study|Study Terminated by Sponsor|4|||
129033737|NCT00372996|464414093|FG001|Overall Study|Study Terminated by Sponsor|0|||
129033738|NCT00372996|464414094|FG002|Overall Study|Study Terminated by Sponsor|4|||
129033739|NCT00372996|464414095|FG003|Overall Study|Study Terminated by Sponsor|0|||
129033740|NCT00372996|464414092|FG000|Overall Study|Other|10|||
129033741|NCT00372996|464414093|FG001|Overall Study|Other|2|||
129217778|NCT02379091|465097065|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
128770301|NCT02322814|463450209|FG003|Overall Study|Lost to Follow-up|1|||
128945973|NCT01094730|464086780|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
128945974|NCT01094730|464086779|FG000|Period 2 (14 Days)|Adverse Event|0|||
128945975|NCT01094730|464086780|FG001|Period 2 (14 Days)|Adverse Event|1|||
129033742|NCT00372996|464414094|FG002|Overall Study|Other|7|||
128945976|NCT01094730|464086779|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
128945977|NCT01094730|464086780|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
128945978|NCT04171037|464086781|FG000|Overall Study|Lost to Follow-up|1|||
128945979|NCT04171037|464086782|FG001|Overall Study|Lost to Follow-up|0|||
128945980|NCT04171037|464086781|FG000|Overall Study|Physician Decision|3|||
128708355|NCT02289417|463226434|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
128708356|NCT02289417|463226435|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
128708357|NCT02289417|463226427|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
128708358|NCT02289417|463226428|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
128945981|NCT04171037|464086782|FG001|Overall Study|Physician Decision|3|||
128945982|NCT01934894|464086783|FG000|Overall Study|Adverse Event|1|||
128945983|NCT01934894|464086784|FG001|Overall Study|Adverse Event|2|||
128945984|NCT01934894|464086783|FG000|Overall Study|Death|2|||
128945985|NCT01934894|464086784|FG001|Overall Study|Death|0|||
128945986|NCT01934894|464086783|FG000|Overall Study|Withdrawal by Subject|0|||
128945987|NCT01934894|464086784|FG001|Overall Study|Withdrawal by Subject|1|||
128945988|NCT01934894|464086783|FG000|Overall Study|Progressive Disease|3|||
128945989|NCT01934894|464086784|FG001|Overall Study|Progressive Disease|2|||
128945990|NCT01100307|464086786|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
128945991|NCT01100307|464086787|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
128945992|NCT01100307|464086786|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
128945993|NCT01100307|464086787|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
128945994|NCT01100307|464086786|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
128945995|NCT01100307|464086787|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
128945996|NCT01100307|464086786|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
128945997|NCT01100307|464086787|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
128945998|NCT01100307|464086786|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
128945999|NCT01100307|464086787|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
128946000|NCT01100307|464086786|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
128946001|NCT01100307|464086787|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
128946002|NCT04436822|464086788|FG000|Overall Study|Physician Decision|2|||
128946003|NCT04436822|464086789|FG001|Overall Study|Physician Decision|0|||
128946004|NCT04436822|464086788|FG000|Overall Study|Sponsor request|1|||
128946005|NCT04436822|464086789|FG001|Overall Study|Sponsor request|0|||
128946006|NCT04436822|464086788|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128946007|NCT04436822|464086789|FG001|Overall Study|Withdrawal by parent/guardian|3|||
128946008|NCT04436822|464086788|FG000|Overall Study|Unsuccessful procedure|0|||
128946009|NCT04436822|464086789|FG001|Overall Study|Unsuccessful procedure|1|||
128946010|NCT04436822|464086788|FG000|Overall Study|Withdrawal due to Covid-19|8|||
128946011|NCT04436822|464086789|FG001|Overall Study|Withdrawal due to Covid-19|1|||
128946012|NCT04436822|464086788|FG000|Overall Study|Withdrawal by Subject|1|||
128946013|NCT04436822|464086789|FG001|Overall Study|Withdrawal by Subject|0|||
128946014|NCT04436822|464086788|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
128946015|NCT04436822|464086789|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
128946016|NCT03375112|464086790|FG000|Overall Study|Withdrawal by Subject|3|||
128946017|NCT03375112|464086791|FG001|Overall Study|Withdrawal by Subject|0|||
128946018|NCT05118386|464086793|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
128946019|NCT05118386|464086794|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
128946020|NCT05118386|464086795|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
128946021|NCT05118386|464086796|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
128946022|NCT05118386|464086797|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
128946023|NCT05118386|464086798|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
128946024|NCT05118386|464086793|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
128946025|NCT05118386|464086794|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
128946026|NCT05118386|464086795|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
128946027|NCT05118386|464086796|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
128946028|NCT05118386|464086797|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
128946029|NCT05118386|464086798|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
128946030|NCT00303108|464086799|FG000|Overall Study|Adverse Event|5|||
128946031|NCT00303108|464086800|FG001|Overall Study|Adverse Event|6|||
128946032|NCT00303108|464086801|FG002|Overall Study|Adverse Event|7|||
128946033|NCT00303108|464086799|FG000|Overall Study|Patient Request|4|||
128708359|NCT02289417|463226429|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
128708360|NCT02289417|463226430|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
128708361|NCT02289417|463226431|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
128946034|NCT00303108|464086800|FG001|Overall Study|Patient Request|2|||
128946035|NCT00303108|464086801|FG002|Overall Study|Patient Request|8|||
128946036|NCT00303108|464086799|FG000|Overall Study|Failed Entry|1|||
128946037|NCT00303108|464086800|FG001|Overall Study|Failed Entry|0|||
128946038|NCT00303108|464086801|FG002|Overall Study|Failed Entry|1|||
128946039|NCT00303108|464086799|FG000|Overall Study|ineligible|2|||
128946040|NCT00303108|464086800|FG001|Overall Study|ineligible|1|||
128946041|NCT00303108|464086801|FG002|Overall Study|ineligible|0|||
128946042|NCT03201198|464086804|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
128946043|NCT03201198|464086805|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
128946044|NCT03201198|464086804|FG000|Overall Study|Withdrawal by Subject|2|||
128946045|NCT03201198|464086805|FG001|Overall Study|Withdrawal by Subject|3|||
128946046|NCT02427477|464086808|FG000|Period 1|Adverse Event|1|||
128946047|NCT02427477|464086809|FG001|Period 1|Adverse Event|0|||
128946048|NCT03213626|464086810|FG000|Overall Study|Adverse Event|1|||
128946049|NCT03213626|464086810|FG000|Overall Study|Progressive Disease|6|||
128946050|NCT01767194|464086813|FG000|Overall Study|Adverse Event|1|||
128946051|NCT01767194|464086814|FG001|Overall Study|Adverse Event|1|||
128946052|NCT01767194|464086813|FG000|Overall Study|Death|0|||
128946053|NCT01767194|464086814|FG001|Overall Study|Death|1|||
128946054|NCT01767194|464086813|FG000|Overall Study|Lack of Efficacy|12|||
128946055|NCT01767194|464086814|FG001|Overall Study|Lack of Efficacy|11|||
128946056|NCT01767194|464086813|FG000|Overall Study|Physician Decision|2|||
128946057|NCT01767194|464086814|FG001|Overall Study|Physician Decision|23|||
128946058|NCT01767194|464086813|FG000|Overall Study|Withdrawal by Subject|0|||
128946059|NCT01767194|464086814|FG001|Overall Study|Withdrawal by Subject|1|||
128946060|NCT01767194|464086813|FG000|Overall Study|Ineligible|1|||
128946061|NCT01767194|464086814|FG001|Overall Study|Ineligible|1|||
128946062|NCT01767194|464086813|FG000|Overall Study|Refusal by patient/parent|2|||
128946063|NCT01767194|464086814|FG001|Overall Study|Refusal by patient/parent|4|||
128946064|NCT01767194|464086813|FG000|Overall Study|Criteria not met on time for next cycle|0|||
128946065|NCT01767194|464086814|FG001|Overall Study|Criteria not met on time for next cycle|1|||
128946066|NCT00786032|464088330|FG000|Overall Study|Death|4|||
128946067|NCT00786032|464088330|FG000|Overall Study|Withdrawal by Subject|14|||
128946068|NCT00786032|464088330|FG000|Overall Study|Did not complete in the timeframe|6|||
128946069|NCT02457182|464088331|FG000|Overall Study|Lost to Follow-up|1|||
128946070|NCT02457182|464088332|FG001|Overall Study|Lost to Follow-up|0|||
128946071|NCT02294318|464088335|FG000|Overall Study|Worsening of drinking|3|||
128946072|NCT02294318|464088336|FG001|Overall Study|Worsening of drinking|0|||
128946073|NCT02294318|464088335|FG000|Overall Study|Not exposed to intervention|0|||
128946074|NCT02294318|464088336|FG001|Overall Study|Not exposed to intervention|2|||
128946075|NCT02670915|464088337|FG000|Overall Study|Withdrawal by Subject|0|||
128946076|NCT02670915|464088338|FG001|Overall Study|Withdrawal by Subject|1|||
128946077|NCT02670915|464088339|FG002|Overall Study|Withdrawal by Subject|4|||
128946078|NCT02670915|464088337|FG000|Overall Study|Withdrawal by parent/guardian|4|||
128946079|NCT02670915|464088338|FG001|Overall Study|Withdrawal by parent/guardian|4|||
128946080|NCT02670915|464088339|FG002|Overall Study|Withdrawal by parent/guardian|1|||
128946081|NCT02670915|464088337|FG000|Overall Study|Unclassified|0|||
128946082|NCT02670915|464088338|FG001|Overall Study|Unclassified|3|||
128946083|NCT02670915|464088339|FG002|Overall Study|Unclassified|0|||
128946084|NCT01346371|464088344|FG000|Overall Study|Lost to Follow-up|2|||
128946085|NCT01346371|464088345|FG001|Overall Study|Lost to Follow-up|0|||
128946086|NCT01670656|464088347|FG000|Overall Study|Non-compliance with study drug|0|||
128946087|NCT01670656|464088348|FG001|Overall Study|Non-compliance with study drug|0|||
128946088|NCT01670656|464088349|FG002|Overall Study|Non-compliance with study drug|3|||
128946089|NCT01670656|464088350|FG003|Overall Study|Non-compliance with study drug|0|||
128946090|NCT01670656|464088351|FG004|Overall Study|Non-compliance with study drug|1|||
128946091|NCT01670656|464088347|FG000|Overall Study|Pregnancy|0|||
128946092|NCT01670656|464088348|FG001|Overall Study|Pregnancy|0|||
128946093|NCT01670656|464088349|FG002|Overall Study|Pregnancy|0|||
128946094|NCT01670656|464088350|FG003|Overall Study|Pregnancy|0|||
128946095|NCT01670656|464088351|FG004|Overall Study|Pregnancy|1|||
128946096|NCT01670656|464088347|FG000|Overall Study|Withdrawal by Subject|1|||
128946097|NCT01670656|464088348|FG001|Overall Study|Withdrawal by Subject|1|||
128946098|NCT01670656|464088349|FG002|Overall Study|Withdrawal by Subject|0|||
128946099|NCT01670656|464088350|FG003|Overall Study|Withdrawal by Subject|0|||
128708362|NCT02289417|463226432|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
128708363|NCT02289417|463226433|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
128946100|NCT01670656|464088351|FG004|Overall Study|Withdrawal by Subject|0|||
128946101|NCT01670656|464088347|FG000|Overall Study|Non-compliance with protocol|0|||
128708364|NCT02289417|463226434|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
128946102|NCT01670656|464088348|FG001|Overall Study|Non-compliance with protocol|3|||
128946103|NCT01670656|464088349|FG002|Overall Study|Non-compliance with protocol|1|||
128946104|NCT01670656|464088350|FG003|Overall Study|Non-compliance with protocol|1|||
128946105|NCT01670656|464088351|FG004|Overall Study|Non-compliance with protocol|2|||
128946106|NCT01670656|464088347|FG000|Overall Study|Adverse Event|2|||
128946107|NCT01670656|464088348|FG001|Overall Study|Adverse Event|2|||
128946108|NCT01670656|464088349|FG002|Overall Study|Adverse Event|2|||
128946109|NCT01670656|464088350|FG003|Overall Study|Adverse Event|3|||
128946110|NCT01670656|464088351|FG004|Overall Study|Adverse Event|3|||
128946111|NCT01670656|464088347|FG000|Overall Study|Subject withdrew consent|0|||
128946112|NCT01670656|464088348|FG001|Overall Study|Subject withdrew consent|1|||
129033743|NCT00372996|464414095|FG003|Overall Study|Other|7|||
129033744|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
129033745|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
129033746|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
129033747|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
129033748|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
129033749|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
129033750|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
129033751|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
129033752|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
129033753|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
129033754|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
129033755|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
129033756|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
129033757|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
129033758|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
129033759|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
129033760|NCT01067521|464414099|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
129033761|NCT01067521|464414100|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
129033762|NCT01067521|464414099|FG000|Open-Label Period|Death|3|||
129033763|NCT01067521|464414100|FG001|Open-Label Period|Death|1|||
129033764|NCT01067521|464414099|FG000|Open-Label Period|Adverse Event|30|||
129033765|NCT01067521|464414100|FG001|Open-Label Period|Adverse Event|28|||
129033766|NCT01067521|464414099|FG000|Open-Label Period|Withdrawal by Subject|160|||
129033767|NCT01067521|464414100|FG001|Open-Label Period|Withdrawal by Subject|88|||
129033768|NCT01067521|464414099|FG000|Open-Label Period|Physician Decision|13|||
129033769|NCT01067521|464414100|FG001|Open-Label Period|Physician Decision|11|||
129033770|NCT01067521|464414099|FG000|Open-Label Period|Non-compliance with study drug|5|||
129033771|NCT01067521|464414100|FG001|Open-Label Period|Non-compliance with study drug|0|||
129033772|NCT01067521|464414099|FG000|Open-Label Period|Protocol Violation|3|||
129033773|NCT01067521|464414100|FG001|Open-Label Period|Protocol Violation|0|||
129033774|NCT01067521|464414099|FG000|Open-Label Period|Pregnancy|14|||
129033775|NCT01067521|464414100|FG001|Open-Label Period|Pregnancy|8|||
129033776|NCT01067521|464414099|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
129033777|NCT01067521|464414100|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
129033778|NCT01067521|464414099|FG000|Open-Label Period|Lost to Follow-up|21|||
129033779|NCT01067521|464414100|FG001|Open-Label Period|Lost to Follow-up|20|||
129033780|NCT02151149|464414102|FG000|Treatment Period|Death|2|||
129217779|NCT02379091|465097066|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129217780|NCT02379091|465097067|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129217781|NCT02379091|465097068|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129217782|NCT02379091|465097065|FG000|Overall Study|Principal Investigator Discretion|0|||
129217783|NCT02379091|465097066|FG001|Overall Study|Principal Investigator Discretion|1|||
129217784|NCT02379091|465097067|FG002|Overall Study|Principal Investigator Discretion|0|||
129217785|NCT02379091|465097068|FG003|Overall Study|Principal Investigator Discretion|0|||
129033781|NCT02151149|464414103|FG001|Treatment Period|Death|3|||
129033782|NCT02151149|464414102|FG000|Treatment Period|Adverse Event|17|||
129033783|NCT02151149|464414103|FG001|Treatment Period|Adverse Event|14|||
129033784|NCT02151149|464414102|FG000|Treatment Period|Progressive Disease|25|||
129033785|NCT02151149|464414103|FG001|Treatment Period|Progressive Disease|24|||
129033786|NCT02151149|464414102|FG000|Treatment Period|Symptomatic Deterioration|2|||
129033787|NCT02151149|464414103|FG001|Treatment Period|Symptomatic Deterioration|10|||
129033788|NCT02151149|464414102|FG000|Treatment Period|Withdrawal by Subject|13|||
129033789|NCT02151149|464414103|FG001|Treatment Period|Withdrawal by Subject|11|||
129033790|NCT02151149|464414102|FG000|Treatment Period|Miscellaneous|8|||
129033791|NCT02151149|464414103|FG001|Treatment Period|Miscellaneous|7|||
129033792|NCT02151149|464414102|FG000|Treatment Period|Participants randomized but not treated|3|||
129033793|NCT02151149|464414103|FG001|Treatment Period|Participants randomized but not treated|2|||
129033794|NCT02151149|464414102|FG000|Follow-Up Period|Lost to Follow-up|2|||
129033795|NCT02151149|464414103|FG001|Follow-Up Period|Lost to Follow-up|3|||
129033796|NCT02151149|464414102|FG000|Follow-Up Period|Death|37|||
129033797|NCT02151149|464414103|FG001|Follow-Up Period|Death|34|||
129033798|NCT02760433|464414104|FG000|Overall Study|Lost to Follow-up|1|||
129033799|NCT02760433|464414105|FG001|Overall Study|Lost to Follow-up|0|||
129033800|NCT02760433|464414106|FG002|Overall Study|Lost to Follow-up|1|||
129033801|NCT02760433|464414107|FG003|Overall Study|Lost to Follow-up|0|||
129033802|NCT02760433|464414108|FG004|Overall Study|Lost to Follow-up|0|||
129217786|NCT02379091|465097065|FG000|Overall Study|Lost to Follow-up|0|||
129217787|NCT02379091|465097066|FG001|Overall Study|Lost to Follow-up|0|||
129033803|NCT02760433|464414104|FG000|Overall Study|Withdrawal by Subject|23|||
129033804|NCT02760433|464414105|FG001|Overall Study|Withdrawal by Subject|9|||
129033805|NCT02760433|464414106|FG002|Overall Study|Withdrawal by Subject|0|||
129033806|NCT02760433|464414107|FG003|Overall Study|Withdrawal by Subject|2|||
128946113|NCT01670656|464088349|FG002|Overall Study|Subject withdrew consent|2|||
128946114|NCT01670656|464088350|FG003|Overall Study|Subject withdrew consent|1|||
128946115|NCT01670656|464088351|FG004|Overall Study|Subject withdrew consent|1|||
128946116|NCT01670656|464088347|FG000|Overall Study|Lost to Follow-up|0|||
128946117|NCT01670656|464088348|FG001|Overall Study|Lost to Follow-up|0|||
128946118|NCT01670656|464088349|FG002|Overall Study|Lost to Follow-up|0|||
128946119|NCT01670656|464088350|FG003|Overall Study|Lost to Follow-up|0|||
128946120|NCT01670656|464088351|FG004|Overall Study|Lost to Follow-up|3|||
128946121|NCT01670656|464088347|FG000|Overall Study|Subject moved|0|||
129217788|NCT02379091|465097067|FG002|Overall Study|Lost to Follow-up|0|||
129217789|NCT02379091|465097068|FG003|Overall Study|Lost to Follow-up|1|||
129217790|NCT02379091|465097065|FG000|Overall Study|Voluntary Withdrawal|2|||
129217791|NCT02379091|465097066|FG001|Overall Study|Voluntary Withdrawal|5|||
128946122|NCT01670656|464088348|FG001|Overall Study|Subject moved|0|||
128946123|NCT01670656|464088349|FG002|Overall Study|Subject moved|0|||
129217792|NCT02379091|465097067|FG002|Overall Study|Voluntary Withdrawal|2|||
129217793|NCT02379091|465097068|FG003|Overall Study|Voluntary Withdrawal|4|||
129217794|NCT02379091|465097065|FG000|Overall Study|Study Termination|7|||
129217795|NCT02379091|465097066|FG001|Overall Study|Study Termination|2|||
129217796|NCT02379091|465097067|FG002|Overall Study|Study Termination|5|||
129217797|NCT02379091|465097068|FG003|Overall Study|Study Termination|8|||
129217798|NCT02379091|465097065|FG000|Overall Study|Lack of Efficacy|3|||
129217799|NCT02379091|465097066|FG001|Overall Study|Lack of Efficacy|0|||
129217800|NCT02379091|465097067|FG002|Overall Study|Lack of Efficacy|0|||
129217801|NCT02379091|465097068|FG003|Overall Study|Lack of Efficacy|0|||
129217802|NCT03278249|465097069|FG000|Overall Study|Withdrawal by Subject|2|||
129217803|NCT03278249|465097069|FG000|Overall Study|Lost to Follow-up|1|||
128946124|NCT01670656|464088350|FG003|Overall Study|Subject moved|1|||
128946125|NCT01670656|464088351|FG004|Overall Study|Subject moved|0|||
128946126|NCT00789958|464088352|FG000|Overall Study|Adverse Event|3|||
128946127|NCT00789958|464088352|FG000|Overall Study|Withdrawal by Subject|4|||
128946128|NCT00789958|464088352|FG000|Overall Study|Progression|3|||
128946129|NCT00789958|464088352|FG000|Overall Study|not protocol specified|1|||
128946130|NCT00789958|464088352|FG000|Overall Study|Not eligible/not analyzable|26|||
128946131|NCT03137121|464088355|FG000|Overall Study|Withdrawal by Subject|0|||
128946132|NCT03137121|464088356|FG001|Overall Study|Withdrawal by Subject|1|||
128946133|NCT00836277|464088357|FG000|Overall Study|Not evaluable for response|6|||
128946134|NCT01354353|464088363|FG000|Overall Study|Adverse Event|1|||
128946135|NCT01354353|464088364|FG001|Overall Study|Adverse Event|0|||
128946136|NCT01354353|464088365|FG002|Overall Study|Adverse Event|0|||
128946137|NCT01354353|464088366|FG003|Overall Study|Adverse Event|4|||
128946138|NCT01354353|464088367|FG004|Overall Study|Adverse Event|0|||
128946139|NCT01354353|464088368|FG005|Overall Study|Adverse Event|5|||
128946140|NCT01354353|464088363|FG000|Overall Study|Entry Criteria Not Met|0|||
128946141|NCT01354353|464088364|FG001|Overall Study|Entry Criteria Not Met|0|||
128946142|NCT01354353|464088365|FG002|Overall Study|Entry Criteria Not Met|0|||
128946143|NCT01354353|464088366|FG003|Overall Study|Entry Criteria Not Met|1|||
128946144|NCT01354353|464088367|FG004|Overall Study|Entry Criteria Not Met|1|||
128946145|NCT01354353|464088368|FG005|Overall Study|Entry Criteria Not Met|0|||
128946146|NCT01354353|464088363|FG000|Overall Study|Physician Decision|0|||
128946147|NCT01354353|464088364|FG001|Overall Study|Physician Decision|1|||
128946148|NCT01354353|464088365|FG002|Overall Study|Physician Decision|1|||
128946149|NCT01354353|464088366|FG003|Overall Study|Physician Decision|0|||
128946150|NCT01354353|464088367|FG004|Overall Study|Physician Decision|0|||
128946151|NCT01354353|464088368|FG005|Overall Study|Physician Decision|0|||
128946152|NCT01354353|464088363|FG000|Overall Study|Withdrawal by Subject|2|||
128946153|NCT01354353|464088364|FG001|Overall Study|Withdrawal by Subject|0|||
128946154|NCT01354353|464088365|FG002|Overall Study|Withdrawal by Subject|1|||
128946155|NCT01354353|464088366|FG003|Overall Study|Withdrawal by Subject|0|||
128946156|NCT01354353|464088367|FG004|Overall Study|Withdrawal by Subject|0|||
129033807|NCT02760433|464414108|FG004|Overall Study|Withdrawal by Subject|9|||
129033808|NCT02760433|464414104|FG000|Overall Study|Lack of Response At Week 14|0|||
129217804|NCT04801420|465097070|FG000|Overall Study|Other|1|||
129217805|NCT04801420|465097071|FG001|Overall Study|Other|2|||
129217806|NCT04801420|465097072|FG002|Overall Study|Other|1|||
129217807|NCT04801420|465097070|FG000|Overall Study|Lost to Follow-up|7|||
129217808|NCT04801420|465097071|FG001|Overall Study|Lost to Follow-up|9|||
128946157|NCT01354353|464088368|FG005|Overall Study|Withdrawal by Subject|1|||
128946158|NCT04831515|464088371|FG000|First Intervention|Adverse Event|0|||
128946159|NCT04831515|464088372|FG001|First Intervention|Adverse Event|1|||
128946160|NCT01640925|464088375|FG000|Overall Study|Withdrawal by Subject|1|||
128946161|NCT01640925|464088376|FG001|Overall Study|Withdrawal by Subject|0|||
128946162|NCT01640925|464088375|FG000|Overall Study|Previously enrolled in this trial|13|||
129217809|NCT04801420|465097072|FG002|Overall Study|Lost to Follow-up|10|||
129217810|NCT04801420|465097070|FG000|Overall Study|Moved from study area|0|||
129217811|NCT04801420|465097071|FG001|Overall Study|Moved from study area|1|||
128946163|NCT01640925|464088376|FG001|Overall Study|Previously enrolled in this trial|11|||
128946164|NCT01332019|464088387|FG000|Overall Study|Was Not Dosed|1|||
129033809|NCT02760433|464414105|FG001|Overall Study|Lack of Response At Week 14|0|||
128946165|NCT01332019|464088388|FG001|Overall Study|Was Not Dosed|0|||
128946166|NCT01332019|464088387|FG000|Overall Study|Other|16|||
128946167|NCT01332019|464088388|FG001|Overall Study|Other|18|||
128946168|NCT01332019|464088387|FG000|Overall Study|Death|2|||
128946169|NCT01332019|464088388|FG001|Overall Study|Death|1|||
128946170|NCT01332019|464088387|FG000|Overall Study|Physician Decision|4|||
128946171|NCT01332019|464088388|FG001|Overall Study|Physician Decision|3|||
128946172|NCT01332019|464088387|FG000|Overall Study|Withdrawal by Subject|73|||
128946173|NCT01332019|464088388|FG001|Overall Study|Withdrawal by Subject|71|||
128946174|NCT01332019|464088387|FG000|Overall Study|Lost to Follow-up|4|||
128946175|NCT01332019|464088388|FG001|Overall Study|Lost to Follow-up|7|||
128946176|NCT01332019|464088387|FG000|Overall Study|Adverse Event|13|||
128946177|NCT01332019|464088388|FG001|Overall Study|Adverse Event|22|||
128946178|NCT00288860|464088391|FG000|Overall Study|Did not complete intake|4|||
128946179|NCT00288860|464088392|FG001|Overall Study|Did not complete intake|8|||
128946180|NCT00288860|464088391|FG000|Overall Study|Death|4|||
128946181|NCT00288860|464088392|FG001|Overall Study|Death|3|||
128946182|NCT00288860|464088391|FG000|Overall Study|Withdrawal by Subject|20|||
128946183|NCT00288860|464088392|FG001|Overall Study|Withdrawal by Subject|15|||
128946184|NCT00288860|464088391|FG000|Overall Study|Lost to Follow-up|74|||
128946185|NCT00288860|464088392|FG001|Overall Study|Lost to Follow-up|71|||
128946186|NCT01104584|464088394|FG000|Overall Study|Study drug never administered|21|||
128946187|NCT01104584|464088394|FG000|Overall Study|Study prematurely discontinued|2|||
128946188|NCT04017442|464088395|FG000|Overall Study|Withdrawal by Subject|0|||
128946189|NCT04017442|464088396|FG001|Overall Study|Withdrawal by Subject|3|||
128946190|NCT04017442|464088395|FG000|Overall Study|Lost to Follow-up|21|||
128946191|NCT04017442|464088396|FG001|Overall Study|Lost to Follow-up|19|||
128946192|NCT02586233|464088397|FG000|Overall Study|Randomized but did not receive treatment|0|||
128946193|NCT02586233|464088398|FG001|Overall Study|Randomized but did not receive treatment|1|||
128946194|NCT02586233|464088399|FG002|Overall Study|Randomized but did not receive treatment|0|||
128946195|NCT02586233|464088400|FG003|Overall Study|Randomized but did not receive treatment|0|||
128946196|NCT02586233|464088401|FG004|Overall Study|Randomized but did not receive treatment|0|||
129123603|NCT02164916|464747031|FG001|Overall Study|Refusal unrelated to adverse event|7|||
129123604|NCT02164916|464747030|FG000|Overall Study|Progression|37|||
129123605|NCT02164916|464747031|FG001|Overall Study|Progression|26|||
129123606|NCT02164916|464747030|FG000|Overall Study|Not protocol specified|5|||
129123607|NCT02164916|464747031|FG001|Overall Study|Not protocol specified|1|||
129123608|NCT02164916|464747030|FG000|Overall Study|Reason under review|1|||
129123609|NCT02164916|464747031|FG001|Overall Study|Reason under review|6|||
129123610|NCT02164916|464747030|FG000|Overall Study|Not eligible|2|||
129123611|NCT02164916|464747031|FG001|Overall Study|Not eligible|5|||
129123612|NCT00596635|464747037|FG000|Overall Study|Lost to Follow-up|0|||
129123613|NCT00596635|464747038|FG001|Overall Study|Lost to Follow-up|2|||
129123614|NCT00596635|464747039|FG002|Overall Study|Lost to Follow-up|0|||
129123615|NCT00596635|464747037|FG000|Overall Study|Treatment for symptomatic UTI|4|||
129123616|NCT00596635|464747038|FG001|Overall Study|Treatment for symptomatic UTI|6|||
129123617|NCT00596635|464747039|FG002|Overall Study|Treatment for symptomatic UTI|3|||
129123618|NCT00596635|464747037|FG000|Overall Study|Hip fracture|2|||
129123619|NCT00596635|464747038|FG001|Overall Study|Hip fracture|3|||
129123620|NCT00596635|464747039|FG002|Overall Study|Hip fracture|3|||
129123621|NCT00596635|464747037|FG000|Overall Study|Could not provide urine specimen|1|||
129123622|NCT00596635|464747038|FG001|Overall Study|Could not provide urine specimen|2|||
129123623|NCT00596635|464747039|FG002|Overall Study|Could not provide urine specimen|2|||
129123624|NCT00127803|464747040|FG000|Overall Study|Adverse Event|2|||
129123625|NCT00127803|464747041|FG001|Overall Study|Adverse Event|0|||
129123626|NCT00127803|464747042|FG002|Overall Study|Adverse Event|0|||
129123627|NCT00127803|464747043|FG003|Overall Study|Adverse Event|0|||
129123628|NCT00127803|464747040|FG000|Overall Study|Withdrawal by Subject|1|||
129123629|NCT00127803|464747041|FG001|Overall Study|Withdrawal by Subject|0|||
129123630|NCT00127803|464747042|FG002|Overall Study|Withdrawal by Subject|0|||
128770302|NCT02322814|463450210|FG004|Overall Study|Lost to Follow-up|0|||
128946197|NCT02586233|464088402|FG005|Overall Study|Randomized but did not receive treatment|2|||
128946198|NCT02586233|464088403|FG006|Overall Study|Randomized but did not receive treatment|2|||
128946199|NCT02586233|464088397|FG000|Overall Study|Death|0|||
128946200|NCT02586233|464088398|FG001|Overall Study|Death|1|||
128946201|NCT02586233|464088399|FG002|Overall Study|Death|0|||
128946202|NCT02586233|464088400|FG003|Overall Study|Death|0|||
129123631|NCT00127803|464747043|FG003|Overall Study|Withdrawal by Subject|0|||
129123632|NCT00127803|464747040|FG000|Overall Study|Lost to Follow-up|0|||
129123633|NCT00127803|464747041|FG001|Overall Study|Lost to Follow-up|0|||
129123634|NCT00127803|464747042|FG002|Overall Study|Lost to Follow-up|0|||
128946203|NCT02586233|464088401|FG004|Overall Study|Death|2|||
128946204|NCT02586233|464088402|FG005|Overall Study|Death|0|||
128946205|NCT02586233|464088403|FG006|Overall Study|Death|0|||
128946206|NCT01757405|464088404|FG000|Overall Study|Lost to Follow-up|1|||
129123635|NCT00127803|464747043|FG003|Overall Study|Lost to Follow-up|1|||
128946207|NCT01757405|464088405|FG001|Overall Study|Lost to Follow-up|1|||
128946208|NCT01757405|464088404|FG000|Overall Study|Withdrawal by Subject|0|||
129123636|NCT01925417|464747048|FG000|Overall Study|Withdrawal by Subject|2|||
128946209|NCT01757405|464088405|FG001|Overall Study|Withdrawal by Subject|1|||
128946210|NCT00082758|464088407|FG000|Overall Study|Adverse Event|0|||
128946211|NCT00082758|464088408|FG001|Overall Study|Adverse Event|2|||
128946212|NCT00082758|464088409|FG002|Overall Study|Adverse Event|0|||
128946213|NCT00082758|464088407|FG000|Overall Study|Lack of Efficacy|12|||
128946214|NCT00082758|464088408|FG001|Overall Study|Lack of Efficacy|13|||
128946215|NCT00082758|464088409|FG002|Overall Study|Lack of Efficacy|0|||
128946216|NCT00082758|464088407|FG000|Overall Study|Physician Decision|0|||
128946217|NCT00082758|464088408|FG001|Overall Study|Physician Decision|1|||
128946218|NCT00082758|464088409|FG002|Overall Study|Physician Decision|0|||
128946219|NCT00082758|464088407|FG000|Overall Study|Withdrawal by Subject|3|||
128946220|NCT00082758|464088408|FG001|Overall Study|Withdrawal by Subject|0|||
128946221|NCT00082758|464088409|FG002|Overall Study|Withdrawal by Subject|0|||
128946222|NCT00082758|464088407|FG000|Overall Study|Protocol Violation|0|||
128946223|NCT00082758|464088408|FG001|Overall Study|Protocol Violation|1|||
128946224|NCT00082758|464088409|FG002|Overall Study|Protocol Violation|0|||
128946225|NCT00238303|464088410|FG000|Overall Study|Withdrawal by Subject|11|||
128946226|NCT00238303|464088411|FG001|Overall Study|Withdrawal by Subject|1|||
128946227|NCT00238303|464088412|FG002|Overall Study|Withdrawal by Subject|2|||
128946228|NCT00238303|464088410|FG000|Overall Study|Death|1|||
128946229|NCT00238303|464088411|FG001|Overall Study|Death|0|||
128946230|NCT00238303|464088412|FG002|Overall Study|Death|1|||
128946231|NCT00238303|464088410|FG000|Overall Study|Other Medical Problems|2|||
128946232|NCT00238303|464088411|FG001|Overall Study|Other Medical Problems|0|||
128946233|NCT00238303|464088412|FG002|Overall Study|Other Medical Problems|2|||
128946234|NCT00238303|464088410|FG000|Overall Study|Poor tolerance of study treatment|1|||
128946235|NCT00238303|464088411|FG001|Overall Study|Poor tolerance of study treatment|0|||
128946236|NCT00238303|464088412|FG002|Overall Study|Poor tolerance of study treatment|1|||
128946237|NCT00238303|464088410|FG000|Overall Study|Adverse Event|0|||
128946238|NCT00238303|464088411|FG001|Overall Study|Adverse Event|1|||
128946239|NCT00238303|464088412|FG002|Overall Study|Adverse Event|3|||
128946240|NCT02561299|464088416|FG000|Overall Study|Death|2|||
129123637|NCT01925417|464747048|FG000|Overall Study|Death|1|||
129123638|NCT03479905|464747049|FG000|Overall Study|Other airway method used|4|||
129123639|NCT03479905|464747050|FG001|Overall Study|Other airway method used|5|||
129123640|NCT03479905|464747051|FG002|Overall Study|Other airway method used|5|||
129123641|NCT00862992|464747052|FG000|Overall Study|Adverse Event|2|||
129123642|NCT00862992|464747053|FG001|Overall Study|Adverse Event|1|||
129123643|NCT00862992|464747054|FG002|Overall Study|Adverse Event|1|||
129123644|NCT00862992|464747052|FG000|Overall Study|Physician Decision|1|||
129123645|NCT00862992|464747053|FG001|Overall Study|Physician Decision|0|||
129123646|NCT00862992|464747054|FG002|Overall Study|Physician Decision|0|||
129123647|NCT00862992|464747052|FG000|Overall Study|Withdrawal by Subject|0|||
129123648|NCT00862992|464747053|FG001|Overall Study|Withdrawal by Subject|0|||
129123649|NCT00862992|464747054|FG002|Overall Study|Withdrawal by Subject|2|||
129123650|NCT00720759|464747055|FG000|Overall Study|Lost to Follow-up|0|||
129123651|NCT00720759|464747056|FG001|Overall Study|Lost to Follow-up|1|||
129123652|NCT00720759|464747057|FG002|Overall Study|Lost to Follow-up|1|||
129123653|NCT00720759|464747058|FG003|Overall Study|Lost to Follow-up|0|||
129123654|NCT01047319|464747059|FG000|Overall Study|Teva requested participant withdrawal|3|||
129123655|NCT01047319|464747060|FG001|Overall Study|Teva requested participant withdrawal|0|||
129123656|NCT01047319|464747061|FG002|Overall Study|Teva requested participant withdrawal|1|||
129123657|NCT01047319|464747059|FG000|Overall Study|Protocol Violation|3|||
129123658|NCT01047319|464747060|FG001|Overall Study|Protocol Violation|2|||
129123659|NCT01047319|464747061|FG002|Overall Study|Protocol Violation|4|||
129123660|NCT01047319|464747059|FG000|Overall Study|Lack of Efficacy|4|||
129123661|NCT01047319|464747060|FG001|Overall Study|Lack of Efficacy|3|||
129123662|NCT01047319|464747061|FG002|Overall Study|Lack of Efficacy|3|||
129123663|NCT01047319|464747059|FG000|Overall Study|Death|5|||
129123664|NCT01047319|464747060|FG001|Overall Study|Death|1|||
129123665|NCT01047319|464747061|FG002|Overall Study|Death|5|||
128946241|NCT02561299|464088417|FG001|Overall Study|Death|4|||
129123666|NCT01047319|464747059|FG000|Overall Study|Pregnancy|13|||
129123667|NCT01047319|464747060|FG001|Overall Study|Pregnancy|8|||
129217812|NCT04801420|465097072|FG002|Overall Study|Moved from study area|1|||
129217813|NCT04801420|465097070|FG000|Overall Study|Withdrawal by Subject|5|||
129217814|NCT04801420|465097071|FG001|Overall Study|Withdrawal by Subject|1|||
128946242|NCT02561299|464088416|FG000|Overall Study|Lost to Follow-up|1|||
128946243|NCT02561299|464088417|FG001|Overall Study|Lost to Follow-up|0|||
128946244|NCT02561299|464088416|FG000|Overall Study|Withdrawal by Subject|2|||
128946245|NCT02561299|464088417|FG001|Overall Study|Withdrawal by Subject|2|||
128946246|NCT01358877|464088418|FG000|Overall Study|Death|80|||
128946247|NCT01358877|464088419|FG001|Overall Study|Death|89|||
129123668|NCT01047319|464747061|FG002|Overall Study|Pregnancy|8|||
129123669|NCT01047319|464747059|FG000|Overall Study|Physician Decision|12|||
129123670|NCT01047319|464747060|FG001|Overall Study|Physician Decision|9|||
129123671|NCT01047319|464747061|FG002|Overall Study|Physician Decision|10|||
129123672|NCT01047319|464747059|FG000|Overall Study|Lost to Follow-up|14|||
128946248|NCT01358877|464088418|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
128946249|NCT01358877|464088419|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
128946250|NCT01358877|464088418|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
128946251|NCT01358877|464088419|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
128946252|NCT01358877|464088418|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
128946253|NCT01358877|464088419|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
128946254|NCT01358877|464088418|FG000|Overall Study|Other|142|||
128946255|NCT01358877|464088419|FG001|Overall Study|Other|129|||
128946256|NCT01911845|464088424|FG000|Overall Study|Adverse Event|2|||
128946257|NCT01911845|464088424|FG000|Overall Study|Lost to Follow-up|1|||
129123673|NCT01047319|464747060|FG001|Overall Study|Lost to Follow-up|10|||
129123674|NCT01047319|464747061|FG002|Overall Study|Lost to Follow-up|10|||
129123675|NCT01047319|464747059|FG000|Overall Study|Adverse Event|16|||
129123676|NCT01047319|464747060|FG001|Overall Study|Adverse Event|27|||
129123677|NCT01047319|464747061|FG002|Overall Study|Adverse Event|21|||
129123678|NCT01047319|464747059|FG000|Overall Study|Withdrawal by Subject|77|||
129123679|NCT01047319|464747060|FG001|Overall Study|Withdrawal by Subject|75|||
129123680|NCT01047319|464747061|FG002|Overall Study|Withdrawal by Subject|87|||
129123681|NCT01047319|464747059|FG000|Overall Study|Study terminated by Sponsor|198|||
129123682|NCT01047319|464747060|FG001|Overall Study|Study terminated by Sponsor|215|||
129123683|NCT01047319|464747061|FG002|Overall Study|Study terminated by Sponsor|203|||
129123684|NCT02318940|464747062|FG000|Overall Study|lost the record|1|||
129123685|NCT02318940|464747063|FG001|Overall Study|lost the record|0|||
129123686|NCT01277861|464747066|FG000|Overall Study|Physician Decision|2|||
129123687|NCT01277861|464747067|FG001|Overall Study|Physician Decision|2|||
129123688|NCT02696798|464747068|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
129123689|NCT02696798|464747069|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
129123690|NCT02696798|464747070|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
129123691|NCT02696798|464747068|FG000|Blinded Treatment Dosing Period|Death|0|||
129123692|NCT02696798|464747069|FG001|Blinded Treatment Dosing Period|Death|0|||
129123693|NCT02696798|464747070|FG002|Blinded Treatment Dosing Period|Death|1|||
129123694|NCT02696798|464747068|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
129123695|NCT02696798|464747069|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
129123696|NCT02696798|464747070|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
129123697|NCT02696798|464747068|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
129123698|NCT02696798|464747069|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
129123699|NCT02696798|464747070|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
129123700|NCT02696798|464747068|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
129123701|NCT02696798|464747069|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
129123702|NCT02696798|464747070|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
129123703|NCT02696798|464747068|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
129123704|NCT02696798|464747069|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
129123705|NCT02696798|464747070|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
129123706|NCT02696798|464747068|FG000|Extended Treatment Period|Adverse Event|1|||
129123707|NCT02696798|464747069|FG001|Extended Treatment Period|Adverse Event|4|||
129123708|NCT02696798|464747070|FG002|Extended Treatment Period|Adverse Event|5|||
129123709|NCT02696798|464747068|FG000|Extended Treatment Period|Lack of Efficacy|7|||
129123710|NCT02696798|464747069|FG001|Extended Treatment Period|Lack of Efficacy|2|||
129123711|NCT02696798|464747070|FG002|Extended Treatment Period|Lack of Efficacy|2|||
129123712|NCT02696798|464747068|FG000|Extended Treatment Period|Lost to Follow-up|1|||
129123713|NCT02696798|464747069|FG001|Extended Treatment Period|Lost to Follow-up|0|||
129123714|NCT02696798|464747070|FG002|Extended Treatment Period|Lost to Follow-up|0|||
129123715|NCT02696798|464747068|FG000|Extended Treatment Period|Physician Decision|0|||
129123716|NCT02696798|464747069|FG001|Extended Treatment Period|Physician Decision|1|||
129123717|NCT02696798|464747070|FG002|Extended Treatment Period|Physician Decision|0|||
129123718|NCT02696798|464747068|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
129123719|NCT02696798|464747069|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
129123720|NCT02696798|464747070|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
129123721|NCT02696798|464747068|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
129123722|NCT02696798|464747069|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
129123723|NCT02696798|464747070|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
128946258|NCT01911845|464088424|FG000|Overall Study|Other (not specified)|3|||
128946259|NCT01994226|464088425|FG000|Overall Study|Protocol Violation|13|||
128946260|NCT01994226|464088426|FG001|Overall Study|Protocol Violation|10|||
128946261|NCT01994226|464088425|FG000|Overall Study|Early Cessation of treatment|6|||
128946262|NCT01994226|464088426|FG001|Overall Study|Early Cessation of treatment|11|||
129123724|NCT02696798|464747068|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
129123725|NCT02696798|464747069|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
129123726|NCT02696798|464747070|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
129123727|NCT02696798|464747068|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
128946263|NCT00501046|464088431|FG000|Overall Study|Adverse Event|21|||
128946264|NCT00501046|464088432|FG001|Overall Study|Adverse Event|25|||
129217815|NCT04801420|465097072|FG002|Overall Study|Withdrawal by Subject|4|||
129217816|NCT04801420|465097070|FG000|Overall Study|Individual stopping criteria reached|0|||
129217817|NCT04801420|465097071|FG001|Overall Study|Individual stopping criteria reached|1|||
129217818|NCT04801420|465097072|FG002|Overall Study|Individual stopping criteria reached|0|||
129217819|NCT04801420|465097070|FG000|Overall Study|Ongoing in the study|195|||
129217820|NCT04801420|465097071|FG001|Overall Study|Ongoing in the study|195|||
129217821|NCT04801420|465097072|FG002|Overall Study|Ongoing in the study|192|||
129217822|NCT04774094|465097073|FG000|Overall Study|Other|2|||
129217823|NCT04774094|465097073|FG000|Overall Study|Withdrawal by Subject|9|||
129217824|NCT04774094|465097073|FG000|Overall Study|Lost to Follow-up|7|||
129217825|NCT04774094|465097073|FG000|Overall Study|Lack of Efficacy|5|||
129217826|NCT04774094|465097073|FG000|Overall Study|Death|17|||
129217827|NCT04774094|465097073|FG000|Overall Study|Adverse Event|4|||
129217828|NCT04988477|465097075|FG000|Overall Study|Death|1|||
129217829|NCT04988477|465097076|FG001|Overall Study|Death|0|||
129217830|NCT04988477|465097077|FG002|Overall Study|Death|0|||
128946265|NCT00501046|464088431|FG000|Overall Study|Death|23|||
129217831|NCT04988477|465097075|FG000|Overall Study|Lost to Follow-up|5|||
129217832|NCT04988477|465097076|FG001|Overall Study|Lost to Follow-up|2|||
129217833|NCT04988477|465097077|FG002|Overall Study|Lost to Follow-up|0|||
129217834|NCT04988477|465097075|FG000|Overall Study|Withdrawal by Subject|2|||
129217835|NCT04988477|465097076|FG001|Overall Study|Withdrawal by Subject|0|||
129217836|NCT04988477|465097077|FG002|Overall Study|Withdrawal by Subject|0|||
128946266|NCT00501046|464088432|FG001|Overall Study|Death|30|||
128946267|NCT00501046|464088431|FG000|Overall Study|Lost to Follow-up|14|||
128946268|NCT00501046|464088432|FG001|Overall Study|Lost to Follow-up|13|||
128946269|NCT00501046|464088431|FG000|Overall Study|Physician Decision|7|||
128946270|NCT00501046|464088432|FG001|Overall Study|Physician Decision|2|||
128946271|NCT00501046|464088431|FG000|Overall Study|Pregnancy|0|||
128946272|NCT00501046|464088432|FG001|Overall Study|Pregnancy|3|||
128946273|NCT00501046|464088431|FG000|Overall Study|Protocol Violation|2|||
128946274|NCT00501046|464088432|FG001|Overall Study|Protocol Violation|1|||
128946275|NCT00501046|464088431|FG000|Overall Study|Withdrawal by Subject|84|||
128946276|NCT00501046|464088432|FG001|Overall Study|Withdrawal by Subject|83|||
128946277|NCT00501046|464088431|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
128946278|NCT00501046|464088432|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
128946279|NCT02345252|464088438|FG000|Double-Blind Phase|Adverse Event|2|||
128946280|NCT02345252|464088439|FG001|Double-Blind Phase|Adverse Event|3|||
128946281|NCT02345252|464088438|FG000|Double-Blind Phase|Death|1|||
128946282|NCT02345252|464088439|FG001|Double-Blind Phase|Death|2|||
128946283|NCT02345252|464088438|FG000|Double-Blind Phase|Lack of Efficacy|1|||
128946284|NCT02345252|464088439|FG001|Double-Blind Phase|Lack of Efficacy|0|||
128946285|NCT02345252|464088438|FG000|Double-Blind Phase|Investigator's Discretion|4|||
128946286|NCT02345252|464088439|FG001|Double-Blind Phase|Investigator's Discretion|6|||
128946287|NCT02345252|464088438|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
128946288|NCT02345252|464088439|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
128946289|NCT02345252|464088438|FG000|Double-Blind Phase|Protocol Violation|2|||
128946290|NCT02345252|464088439|FG001|Double-Blind Phase|Protocol Violation|1|||
129217837|NCT01646125|465098493|FG000|Overall Study|Untreated|2|||
129217838|NCT01646125|465098494|FG001|Overall Study|Untreated|5|||
129217839|NCT01646125|465098493|FG000|Overall Study|Adverse Event|2|||
128946291|NCT02345252|464088438|FG000|Double-Blind Phase|Withdrew Consent|21|||
128946292|NCT02345252|464088439|FG001|Double-Blind Phase|Withdrew Consent|23|||
129033810|NCT02760433|464414106|FG002|Overall Study|Lack of Response At Week 14|0|||
129033811|NCT02760433|464414107|FG003|Overall Study|Lack of Response At Week 14|0|||
129033812|NCT02760433|464414108|FG004|Overall Study|Lack of Response At Week 14|1|||
129033813|NCT02760433|464414104|FG000|Overall Study|Subject refused to continue the study|1|||
129033814|NCT02760433|464414105|FG001|Overall Study|Subject refused to continue the study|0|||
129033815|NCT02760433|464414106|FG002|Overall Study|Subject refused to continue the study|0|||
129033816|NCT02760433|464414107|FG003|Overall Study|Subject refused to continue the study|0|||
129033817|NCT02760433|464414108|FG004|Overall Study|Subject refused to continue the study|0|||
129033818|NCT02760433|464414104|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
129033819|NCT02760433|464414105|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129033820|NCT02760433|464414106|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129033821|NCT02760433|464414107|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129033822|NCT02760433|464414108|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129033823|NCT02760433|464414104|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129033824|NCT02760433|464414105|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
129033825|NCT02760433|464414106|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129217840|NCT01646125|465098494|FG001|Overall Study|Adverse Event|1|||
129217841|NCT01646125|465098493|FG000|Overall Study|Death|1|||
128946293|NCT02345252|464088438|FG000|Double-Blind Phase|Lost to Follow-up|8|||
128946294|NCT02345252|464088439|FG001|Double-Blind Phase|Lost to Follow-up|10|||
129123728|NCT02696798|464747069|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
129123729|NCT02696798|464747070|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
129123730|NCT02696798|464747068|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
129123731|NCT02696798|464747069|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
129123732|NCT02696798|464747070|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
129123733|NCT02696798|464747068|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
129123734|NCT02696798|464747069|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
128708365|NCT02289417|463226435|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
128708366|NCT02289417|463226427|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
128708367|NCT02289417|463226428|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
128708368|NCT02289417|463226429|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
128708369|NCT02289417|463226430|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
128708370|NCT02289417|463226431|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
128708371|NCT02289417|463226432|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
128708372|NCT02289417|463226433|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
128708373|NCT02289417|463226434|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
128708374|NCT02289417|463226435|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
128708375|NCT02289417|463226427|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
128708376|NCT02289417|463226428|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
128708377|NCT02289417|463226429|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
128708378|NCT02289417|463226430|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
128708379|NCT02289417|463226431|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
128708380|NCT02289417|463226432|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
128708381|NCT02289417|463226433|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
128708382|NCT02289417|463226434|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
128708383|NCT02289417|463226435|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
128708384|NCT02289417|463226427|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708385|NCT02289417|463226428|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708386|NCT02289417|463226429|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708387|NCT02289417|463226430|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708388|NCT02289417|463226431|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708389|NCT02289417|463226432|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708390|NCT02289417|463226433|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708391|NCT02289417|463226434|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
128708392|NCT02289417|463226435|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
128708393|NCT04786990|463226436|FG000|Overall Study|Withdrawal by Subject|1|||
128708394|NCT04786990|463226436|FG000|Overall Study|Adverse Event|1|||
128708395|NCT04786990|463226436|FG000|Overall Study|Lost to Follow-up|1|||
128708396|NCT04786990|463226436|FG000|Overall Study|Noncompliance|1|||
128708397|NCT04786990|463226436|FG000|Overall Study|Unable to complete site visits|1|||
128708398|NCT04786990|463226436|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
128708399|NCT01782222|463226437|FG000|Overall Study|Adverse Event|4|||
128708400|NCT01782222|463226438|FG001|Overall Study|Adverse Event|5|||
128708401|NCT01782222|463226439|FG002|Overall Study|Adverse Event|3|||
128946295|NCT02345252|464088438|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
128946296|NCT02345252|464088439|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
128946297|NCT01842308|464088442|FG000|Overall Study|Withdrawal by Subject|0|||
128946298|NCT01842308|464088443|FG001|Overall Study|Withdrawal by Subject|0|||
129123735|NCT02696798|464747070|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
129123736|NCT02696798|464747068|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
129123737|NCT02696798|464747069|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
129123738|NCT02696798|464747070|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
129123739|NCT00857389|464747071|FG000|Overall Study|Did not proceed to transplant|2|||
129123740|NCT03311555|464747072|FG000|Overall Study|Adverse Event|1|||
129123741|NCT03454555|464749409|FG000|Overall Study|Death|6|||
129123742|NCT03454555|464749410|FG001|Overall Study|Death|6|||
129123743|NCT03454555|464749409|FG000|Overall Study|Lost to Follow-up|31|||
129123744|NCT03454555|464749410|FG001|Overall Study|Lost to Follow-up|12|||
129123745|NCT03454555|464749409|FG000|Overall Study|Physician Decision|2|||
129123746|NCT03454555|464749410|FG001|Overall Study|Physician Decision|6|||
129123747|NCT03454555|464749409|FG000|Overall Study|Withdrawal by Subject|34|||
129123748|NCT03454555|464749410|FG001|Overall Study|Withdrawal by Subject|5|||
129123749|NCT03454555|464749409|FG000|Overall Study|Ineligible|1|||
129123750|NCT03454555|464749410|FG001|Overall Study|Ineligible|5|||
128946299|NCT01842308|464088444|FG002|Overall Study|Withdrawal by Subject|0|||
128946300|NCT01842308|464088445|FG003|Overall Study|Withdrawal by Subject|0|||
128946301|NCT01842308|464088446|FG004|Overall Study|Withdrawal by Subject|1|||
128708402|NCT01782222|463226437|FG000|Overall Study|Lack of Efficacy|2|||
128708403|NCT01782222|463226438|FG001|Overall Study|Lack of Efficacy|1|||
128708404|NCT01782222|463226439|FG002|Overall Study|Lack of Efficacy|0|||
128946302|NCT00779324|464088447|FG000|Overall Study|Lost to Follow-up|2|||
129123751|NCT01386385|464749411|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
128708405|NCT01782222|463226437|FG000|Overall Study|Protocol Violation|1|||
128946303|NCT00779324|464088448|FG001|Overall Study|Lost to Follow-up|1|||
128946304|NCT00779324|464088447|FG000|Overall Study|Withdrawal by Subject|4|||
128946305|NCT00779324|464088448|FG001|Overall Study|Withdrawal by Subject|2|||
128946306|NCT00779324|464088447|FG000|Overall Study|Missed visit|1|||
128946307|NCT00779324|464088448|FG001|Overall Study|Missed visit|1|||
128946308|NCT00617409|464088449|FG000|Overall Study|Withdrawal by Subject|4|||
128946309|NCT00617409|464088450|FG001|Overall Study|Withdrawal by Subject|1|||
128946310|NCT00617409|464088451|FG002|Overall Study|Withdrawal by Subject|2|||
128946311|NCT00617409|464088449|FG000|Overall Study|Adverse Event|0|||
128946312|NCT00617409|464088450|FG001|Overall Study|Adverse Event|2|||
128946313|NCT00617409|464088451|FG002|Overall Study|Adverse Event|3|||
128946314|NCT00617409|464088449|FG000|Overall Study|Disease Progression|8|||
128946315|NCT00617409|464088450|FG001|Overall Study|Disease Progression|8|||
128946316|NCT00617409|464088451|FG002|Overall Study|Disease Progression|18|||
128946317|NCT00617409|464088449|FG000|Overall Study|Death|3|||
128946318|NCT00617409|464088450|FG001|Overall Study|Death|5|||
128946319|NCT00617409|464088451|FG002|Overall Study|Death|4|||
128946320|NCT00617409|464088449|FG000|Overall Study|Alternative Therapy|1|||
128946321|NCT00617409|464088450|FG001|Overall Study|Alternative Therapy|2|||
128946322|NCT00617409|464088451|FG002|Overall Study|Alternative Therapy|0|||
128946323|NCT00987623|464088452|FG000|Overall Study|Lost to Follow-up|2|||
128946324|NCT00987623|464088453|FG001|Overall Study|Lost to Follow-up|1|||
128946325|NCT00987623|464088452|FG000|Overall Study|Time/job conflict|2|||
128946326|NCT00987623|464088453|FG001|Overall Study|Time/job conflict|0|||
128946327|NCT00987623|464088452|FG000|Overall Study|Discomfort|1|||
128946328|NCT00987623|464088453|FG001|Overall Study|Discomfort|0|||
128946329|NCT00987623|464088452|FG000|Overall Study|Biomicroscopy|0|||
128946330|NCT00987623|464088453|FG001|Overall Study|Biomicroscopy|1|||
128946331|NCT00987623|464088452|FG000|Overall Study|Influenza|0|||
128946332|NCT00987623|464088453|FG001|Overall Study|Influenza|1|||
128946333|NCT02509598|464088454|FG000|Overall Study|Withdrawal by Subject|1|||
128946334|NCT04056455|464088455|FG000|Overall Study|Adverse Event|1|||
128946335|NCT04056455|464088456|FG001|Overall Study|Adverse Event|0|||
128946336|NCT02196038|464088457|FG000|Overall Study|Death|16|||
128946337|NCT02196038|464088458|FG001|Overall Study|Death|21|||
128946338|NCT02196038|464088457|FG000|Overall Study|Withdrawal by Subject|0|||
128946339|NCT02196038|464088458|FG001|Overall Study|Withdrawal by Subject|1|||
128946340|NCT02196038|464088457|FG000|Overall Study|Lost to Follow-up|1|||
128946341|NCT02196038|464088458|FG001|Overall Study|Lost to Follow-up|0|||
128946342|NCT02065869|464088464|FG000|Overall Study|Death|7|||
128946343|NCT02065869|464088464|FG000|Overall Study|Disease relapse|16|||
128946344|NCT02065869|464088464|FG000|Overall Study|Lost to Follow-up|4|||
128946345|NCT02065869|464088464|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
128946346|NCT02065869|464088464|FG000|Overall Study|Withdrawal by Subject|1|||
128946347|NCT03807739|464088465|FG000|Overall Study|Adverse Event|1|||
128946348|NCT03807739|464088466|FG001|Overall Study|Adverse Event|0|||
128946349|NCT03807739|464088467|FG002|Overall Study|Adverse Event|0|||
128946350|NCT03807739|464088468|FG003|Overall Study|Adverse Event|0|||
128946351|NCT03807739|464088465|FG000|Overall Study|Withdrawal by Subject|1|||
128946352|NCT03807739|464088466|FG001|Overall Study|Withdrawal by Subject|0|||
128946353|NCT03807739|464088467|FG002|Overall Study|Withdrawal by Subject|0|||
128946354|NCT03807739|464088468|FG003|Overall Study|Withdrawal by Subject|0|||
128946355|NCT00894413|464088471|FG000|Overall Study|Physician Decision|0|||
128946356|NCT00894413|464088472|FG001|Overall Study|Physician Decision|2|||
128946357|NCT00894413|464088471|FG000|Overall Study|Adverse Event|0|||
128946358|NCT00894413|464088472|FG001|Overall Study|Adverse Event|2|||
128946359|NCT00894413|464088471|FG000|Overall Study|Withdrawal by Subject|0|||
128946360|NCT00894413|464088472|FG001|Overall Study|Withdrawal by Subject|4|||
128946361|NCT00789191|464090426|FG000|Overall Study|Adverse Event|2|||
128946362|NCT00789191|464090427|FG001|Overall Study|Adverse Event|4|||
128946363|NCT00789191|464090426|FG000|Overall Study|Lack of Efficacy|0|||
128946364|NCT00789191|464090427|FG001|Overall Study|Lack of Efficacy|5|||
128946365|NCT00789191|464090426|FG000|Overall Study|Protocol Violation|5|||
128946366|NCT00789191|464090427|FG001|Overall Study|Protocol Violation|3|||
128946367|NCT00789191|464090426|FG000|Overall Study|Withdrawal Criteria|2|||
128946368|NCT00789191|464090427|FG001|Overall Study|Withdrawal Criteria|4|||
129033826|NCT02760433|464414107|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129033827|NCT02760433|464414108|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129033828|NCT00766493|464414109|FG000|30 Days Post-Procedure|Discontinued|7|||
129033829|NCT00766493|464414109|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
129033830|NCT00766493|464414109|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
129033831|NCT03419962|464414112|FG000|Overall Study|Change to other medication|1|||
129123752|NCT01386385|464749412|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
128946369|NCT00789191|464090426|FG000|Overall Study|Unclassified|5|||
128946370|NCT00789191|464090427|FG001|Overall Study|Unclassified|3|||
128946371|NCT03497429|464090428|FG000|Overall Study|Progressive disease|3|||
128946372|NCT03497429|464090429|FG001|Overall Study|Progressive disease|4|||
128708406|NCT01782222|463226438|FG001|Overall Study|Protocol Violation|0|||
128708407|NCT01782222|463226439|FG002|Overall Study|Protocol Violation|0|||
128708408|NCT01782222|463226437|FG000|Overall Study|Withdrawal by Subject|1|||
128708409|NCT01782222|463226438|FG001|Overall Study|Withdrawal by Subject|4|||
128708410|NCT01782222|463226439|FG002|Overall Study|Withdrawal by Subject|1|||
128708411|NCT01782222|463226437|FG000|Overall Study|Moved to other state|0|||
128708412|NCT01782222|463226438|FG001|Overall Study|Moved to other state|1|||
128708413|NCT01782222|463226439|FG002|Overall Study|Moved to other state|0|||
128708414|NCT01500694|463226440|FG000|Overall Study|Adverse Event|4|||
128708415|NCT01500694|463226441|FG001|Overall Study|Adverse Event|3|||
128708416|NCT01500694|463226440|FG000|Overall Study|Protocol Violation|0|||
128708417|NCT01500694|463226441|FG001|Overall Study|Protocol Violation|1|||
128708418|NCT01500694|463226440|FG000|Overall Study|Withdrawal by Subject|23|||
128708419|NCT01500694|463226441|FG001|Overall Study|Withdrawal by Subject|14|||
128708420|NCT01500694|463226440|FG000|Overall Study|Lost to Follow-up|2|||
128708421|NCT01500694|463226441|FG001|Overall Study|Lost to Follow-up|3|||
128708422|NCT01500694|463226440|FG000|Overall Study|Lack of Efficacy|14|||
128708423|NCT01500694|463226441|FG001|Overall Study|Lack of Efficacy|5|||
128708424|NCT01500694|463226440|FG000|Overall Study|Other|9|||
128708425|NCT01500694|463226441|FG001|Overall Study|Other|3|||
128708426|NCT00833794|463226442|FG000|Open-label Phase|Adverse Event|225|||
128708427|NCT00833794|463226443|FG001|Open-label Phase|Adverse Event|0|||
128708428|NCT00833794|463226442|FG000|Open-label Phase|Lack of Efficacy|28|||
128708429|NCT00833794|463226443|FG001|Open-label Phase|Lack of Efficacy|0|||
128708430|NCT00833794|463226442|FG000|Open-label Phase|Withdrawal by Subject|48|||
128708431|NCT00833794|463226443|FG001|Open-label Phase|Withdrawal by Subject|0|||
129217842|NCT01646125|465098494|FG001|Overall Study|Death|1|||
129217843|NCT01646125|465098493|FG000|Overall Study|Physician Decision|1|||
129217844|NCT01646125|465098494|FG001|Overall Study|Physician Decision|3|||
129217845|NCT01646125|465098493|FG000|Overall Study|Progressive disease|22|||
128708432|NCT00833794|463226442|FG000|Open-label Phase|Physician Decision|20|||
128708433|NCT00833794|463226443|FG001|Open-label Phase|Physician Decision|0|||
128708434|NCT00833794|463226442|FG000|Open-label Phase|Administrative reason|1|||
128708435|NCT00833794|463226443|FG001|Open-label Phase|Administrative reason|0|||
128708436|NCT00833794|463226442|FG000|Open-label Phase|Protocol Violation|47|||
128770303|NCT02322814|463450206|FG000|Overall Study|Various Reasons|2|||
128770304|NCT02322814|463450207|FG001|Overall Study|Various Reasons|0|||
128770305|NCT02322814|463450208|FG002|Overall Study|Various Reasons|1|||
128770306|NCT02322814|463450209|FG003|Overall Study|Various Reasons|1|||
128770307|NCT02322814|463450210|FG004|Overall Study|Various Reasons|0|||
128770308|NCT02322814|463450206|FG000|Overall Study|Progressive Disease|0|||
128770309|NCT02322814|463450207|FG001|Overall Study|Progressive Disease|0|||
128770310|NCT02322814|463450208|FG002|Overall Study|Progressive Disease|0|||
128770311|NCT02322814|463450209|FG003|Overall Study|Progressive Disease|1|||
128770312|NCT02322814|463450210|FG004|Overall Study|Progressive Disease|1|||
128770313|NCT02322814|463450206|FG000|Overall Study|Protocol Violation|1|||
128770314|NCT02322814|463450207|FG001|Overall Study|Protocol Violation|0|||
128946373|NCT03497429|464090428|FG000|Overall Study|Adverse Event|0|||
128946374|NCT03497429|464090429|FG001|Overall Study|Adverse Event|2|||
128946375|NCT01009983|464090430|FG000|Overall Study|necessary scans not completed|1|||
128946376|NCT00506948|464090431|FG000|Overall Study|Death|4|||
128946377|NCT00506948|464090431|FG000|Overall Study|Adverse Event|5|||
128946378|NCT00506948|464090431|FG000|Overall Study|Physician Decision|1|||
129123753|NCT01386385|464749413|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129123754|NCT01386385|464749414|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129123755|NCT01386385|464749415|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129123756|NCT01386385|464749416|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129123757|NCT01386385|464749417|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129123758|NCT01386385|464749418|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129123759|NCT01386385|464749411|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
129123760|NCT01386385|464749412|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129123761|NCT01386385|464749413|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129123762|NCT01386385|464749414|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129123763|NCT01386385|464749415|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129123764|NCT01386385|464749416|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129217846|NCT01646125|465098494|FG001|Overall Study|Progressive disease|16|||
129217847|NCT01646125|465098493|FG000|Overall Study|Study terminated by sponsor|2|||
128770315|NCT02322814|463450208|FG002|Overall Study|Protocol Violation|0|||
128770316|NCT02322814|463450209|FG003|Overall Study|Protocol Violation|0|||
128770317|NCT02322814|463450210|FG004|Overall Study|Protocol Violation|0|||
128946379|NCT02174861|464090432|FG000|Overall Study|Decision by sponsor|8|||
128946380|NCT02174861|464090432|FG000|Overall Study|Withdrawal by Subject|124|||
128708437|NCT00833794|463226443|FG001|Open-label Phase|Protocol Violation|0|||
128708438|NCT00833794|463226442|FG000|Open-label Phase|Did not complete wash-out period|12|||
128708439|NCT00833794|463226443|FG001|Open-label Phase|Did not complete wash-out period|0|||
128770318|NCT02322814|463450206|FG000|Overall Study|Study Terminated by Sponsor|0|||
129033832|NCT03419962|464414112|FG000|Overall Study|Refusal of continuing with trial drug|1|||
129033833|NCT03419962|464414112|FG000|Overall Study|Lost to Follow-up|3|||
129033834|NCT03419962|464414112|FG000|Overall Study|Difficulty in inhaling the doses|1|||
129033835|NCT03419962|464414112|FG000|Overall Study|Missing completion data|31|||
129033836|NCT01781234|464414116|FG000|Overall Study|Adverse Event|2|||
129033837|NCT01781234|464414117|FG001|Overall Study|Adverse Event|0|||
129033838|NCT01781234|464414116|FG000|Overall Study|Protocol Violation|3|||
129033839|NCT01781234|464414117|FG001|Overall Study|Protocol Violation|0|||
129033840|NCT01781234|464414116|FG000|Overall Study|Withdrawal by Subject|4|||
129033841|NCT01781234|464414117|FG001|Overall Study|Withdrawal by Subject|3|||
129033842|NCT03439085|464414118|FG000|Overall Study|Death|2|||
129033843|NCT03439085|464414118|FG000|Overall Study|Screen Failure|20|||
129033844|NCT01292837|464414119|FG000|Overall Study|Adverse Event|1|||
129033845|NCT01292837|464414119|FG000|Overall Study|Further treatment determined|1|||
129033846|NCT01206439|464414120|FG000|Overall Study|subject did not meet inclusion criteria|1|||
129033847|NCT05889039|464414121|FG000|Overall Study|error in completing survey|0|||
129033848|NCT05889039|464414122|FG001|Overall Study|error in completing survey|2|||
129217848|NCT01646125|465098494|FG001|Overall Study|Study terminated by sponsor|1|||
129217849|NCT01646125|465098493|FG000|Overall Study|Subject/Guardian decision|1|||
129217850|NCT01646125|465098494|FG001|Overall Study|Subject/Guardian decision|1|||
129217851|NCT01376804|465098495|FG000|Treatment Period|Withdrawal by Subject|1|||
129217852|NCT01376804|465098495|FG000|Treatment Period|Adverse Event|6|||
129217853|NCT01376804|465098495|FG000|Treatment Period|Patient did not receive study drug|1|||
129217854|NCT01357850|465098496|FG000|Overall Study|Lost to Follow-up|1|||
129217855|NCT01357850|465098497|FG001|Overall Study|Lost to Follow-up|0|||
129217856|NCT01357850|465098498|FG002|Overall Study|Lost to Follow-up|0|||
129217857|NCT01357850|465098499|FG003|Overall Study|Lost to Follow-up|0|||
129217858|NCT00753506|465098502|FG000|Overall Study|Withdrawal by Subject|4|||
129217859|NCT00753506|465098503|FG001|Overall Study|Withdrawal by Subject|1|||
129217860|NCT00753506|465098502|FG000|Overall Study|Lost to Follow-up|2|||
129217861|NCT00753506|465098503|FG001|Overall Study|Lost to Follow-up|0|||
129217862|NCT00753506|465098502|FG000|Overall Study|Other reason|1|||
129217863|NCT00753506|465098503|FG001|Overall Study|Other reason|1|||
129217864|NCT01600716|465098504|FG000|Overall Study|Other Reasons|3|||
129217865|NCT01600716|465098505|FG001|Overall Study|Other Reasons|1|||
129217866|NCT01600716|465098504|FG000|Overall Study|Personal Reasons|0|||
129217867|NCT01600716|465098505|FG001|Overall Study|Personal Reasons|2|||
129217868|NCT01600716|465098504|FG000|Overall Study|Lost to Follow-up|0|||
129217869|NCT01600716|465098505|FG001|Overall Study|Lost to Follow-up|2|||
129217870|NCT01600716|465098504|FG000|Overall Study|Pregnancy|1|||
129217871|NCT01600716|465098505|FG001|Overall Study|Pregnancy|0|||
129217872|NCT01600716|465098504|FG000|Overall Study|Lack of Efficacy|2|||
128946381|NCT02174861|464090432|FG000|Overall Study|Lost to Follow-up|26|||
128946382|NCT02702518|464090438|FG000|Overall Study|Lost to Follow-up|3|||
128946383|NCT02702518|464090439|FG001|Overall Study|Lost to Follow-up|4|||
128946384|NCT01000727|464090441|FG000|Overall Study|Lost to Follow-up|41|||
128946385|NCT01000727|464090442|FG001|Overall Study|Lost to Follow-up|43|||
128946386|NCT01000727|464090441|FG000|Overall Study|Withdrawal by Subject|111|||
128946387|NCT01000727|464090442|FG001|Overall Study|Withdrawal by Subject|109|||
128946388|NCT01000727|464090441|FG000|Overall Study|Study closed/terminated|23|||
128946389|NCT01000727|464090442|FG001|Overall Study|Study closed/terminated|24|||
128946390|NCT03544268|464090445|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
128946391|NCT03544268|464090446|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
128946392|NCT00568958|464090449|FG000|Allocation|Withdrawal by Subject|7|||
128946393|NCT00568958|464090450|FG001|Allocation|Withdrawal by Subject|3|||
128946394|NCT00568958|464090449|FG000|Allocation|Physician Decision|2|||
128946395|NCT00568958|464090450|FG001|Allocation|Physician Decision|0|||
128946396|NCT00568958|464090449|FG000|Follow-Up|Withdrawal by Subject|6|||
128946397|NCT00568958|464090450|FG001|Follow-Up|Withdrawal by Subject|6|||
128946398|NCT00568958|464090449|FG000|Follow-Up|Physician Decision|1|||
128946399|NCT00568958|464090450|FG001|Follow-Up|Physician Decision|1|||
128946400|NCT00568958|464090449|FG000|Follow-Up|Family Emergency|1|||
128946401|NCT00568958|464090450|FG001|Follow-Up|Family Emergency|0|||
128946402|NCT00568958|464090449|FG000|Follow-Up|Adverse Event|1|||
129033849|NCT05889039|464414123|FG002|Overall Study|error in completing survey|0|||
129217873|NCT01600716|465098505|FG001|Overall Study|Lack of Efficacy|1|||
129217874|NCT01600716|465098504|FG000|Overall Study|Adverse Event|1|||
128946403|NCT00568958|464090450|FG001|Follow-Up|Adverse Event|0|||
128946404|NCT00377611|464090454|FG000|Overall Study|Adverse Event|2|||
128946405|NCT00377611|464090455|FG001|Overall Study|Adverse Event|9|||
129033850|NCT05889039|464414124|FG003|Overall Study|error in completing survey|0|||
129033851|NCT05889039|464414121|FG000|Overall Study|Lost to Follow-up|4|||
129033852|NCT05889039|464414122|FG001|Overall Study|Lost to Follow-up|0|||
129033853|NCT05889039|464414123|FG002|Overall Study|Lost to Follow-up|0|||
129033854|NCT05889039|464414124|FG003|Overall Study|Lost to Follow-up|0|||
129217875|NCT01600716|465098505|FG001|Overall Study|Adverse Event|1|||
129217876|NCT03349034|465098508|FG000|Overall Study|catheters dislodged during transport|2|||
129217877|NCT03349034|465098509|FG001|Overall Study|catheters dislodged during transport|0|||
129217878|NCT03349034|465098508|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
129217879|NCT03349034|465098509|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
129217880|NCT03349034|465098508|FG000|Overall Study|soft tissue flap used|1|||
129217881|NCT03349034|465098509|FG001|Overall Study|soft tissue flap used|0|||
129217882|NCT03349034|465098508|FG000|Overall Study|Other|0|||
129217883|NCT03349034|465098509|FG001|Overall Study|Other|1|||
129217884|NCT00865566|465098510|FG000|Overall Study|Death|1|||
129217885|NCT00865566|465098511|FG001|Overall Study|Death|11|||
129217886|NCT00865566|465098510|FG000|Overall Study|Lost to Follow-up|314|||
129217887|NCT00865566|465098511|FG001|Overall Study|Lost to Follow-up|315|||
129217888|NCT00865566|465098510|FG000|Overall Study|Withdrawal by Subject|45|||
129217889|NCT00865566|465098511|FG001|Overall Study|Withdrawal by Subject|65|||
129217890|NCT00865566|465098510|FG000|Overall Study|Physician Decision|0|||
129217891|NCT00865566|465098511|FG001|Overall Study|Physician Decision|1|||
129217892|NCT00865566|465098510|FG000|Overall Study|Participant relocated|78|||
129217893|NCT00865566|465098511|FG001|Overall Study|Participant relocated|107|||
129217894|NCT00865566|465098510|FG000|Overall Study|Participant unable to adhere|27|||
129217895|NCT00865566|465098511|FG001|Overall Study|Participant unable to adhere|42|||
129217896|NCT00865566|465098510|FG000|Overall Study|Other; N=245 due to early study closure|154|||
129217897|NCT00865566|465098511|FG001|Overall Study|Other; N=245 due to early study closure|139|||
129217898|NCT00865566|465098510|FG000|Overall Study|HIV infection|5|||
129217899|NCT00865566|465098511|FG001|Overall Study|HIV infection|7|||
129217900|NCT00815659|465098512|FG000|Overall Study|Adverse Event|9|||
129217901|NCT00815659|465098512|FG000|Overall Study|Withdrawal by Subject|9|||
129217902|NCT00815659|465098512|FG000|Overall Study|Lost to Follow-up|4|||
129217903|NCT00815659|465098512|FG000|Overall Study|Protocol Violation|1|||
129217904|NCT02395471|465098513|FG000|Overall Study|Lost to Follow-up|2|||
129217905|NCT02395471|465098514|FG001|Overall Study|Lost to Follow-up|0|||
129217906|NCT02395471|465098513|FG000|Overall Study|Withdrawal by Subject|2|||
128770319|NCT02322814|463450207|FG001|Overall Study|Study Terminated by Sponsor|7|||
128770320|NCT02322814|463450208|FG002|Overall Study|Study Terminated by Sponsor|9|||
128770321|NCT02322814|463450209|FG003|Overall Study|Study Terminated by Sponsor|5|||
128946406|NCT00377611|464090454|FG000|Overall Study|Protocol Violation|2|||
128946407|NCT00377611|464090455|FG001|Overall Study|Protocol Violation|0|||
128946408|NCT00377611|464090454|FG000|Overall Study|Withdrawal by Subject|0|||
128946409|NCT00377611|464090455|FG001|Overall Study|Withdrawal by Subject|5|||
128946410|NCT00377611|464090454|FG000|Overall Study|Lost to Follow-up|18|||
128946411|NCT00377611|464090455|FG001|Overall Study|Lost to Follow-up|16|||
128946412|NCT00377611|464090454|FG000|Overall Study|Other|0|||
128946413|NCT00377611|464090455|FG001|Overall Study|Other|3|||
128946414|NCT02156492|464090458|FG000|Period 1|No Reason Given|0|||
128946415|NCT02156492|464090459|FG001|Period 1|No Reason Given|1|||
128946416|NCT02156492|464090460|FG002|Period 1|No Reason Given|0|||
128946417|NCT02156492|464090458|FG000|Period 3|Adverse Event|0|||
128946418|NCT02156492|464090459|FG001|Period 3|Adverse Event|1|||
128946419|NCT02156492|464090460|FG002|Period 3|Adverse Event|0|||
128946420|NCT00871377|464090461|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
128946421|NCT00871377|464090462|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
128946422|NCT00871377|464090463|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
128946423|NCT00871377|464090464|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
128946424|NCT00871377|464090465|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
128946425|NCT00871377|464090466|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
128946426|NCT00871377|464090461|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
128946427|NCT00871377|464090462|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129033855|NCT04531527|464414127|FG000|Overall Study|Found to be Ineligible|3|||
129033856|NCT01881737|464414131|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
129033857|NCT01881737|464414131|FG000|Overall Study|Withdrawal by Subject|1|||
129033858|NCT01881737|464414131|FG000|Overall Study|Worsening of baseline behavior|1|||
129033859|NCT00982228|464414142|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
129033860|NCT00982228|464414143|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
129033861|NCT00982228|464414142|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
129033862|NCT00982228|464414143|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
129033863|NCT00982228|464414142|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
129033864|NCT00982228|464414143|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
129033865|NCT00982228|464414142|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
129033866|NCT00982228|464414143|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
129217907|NCT02395471|465098514|FG001|Overall Study|Withdrawal by Subject|1|||
129217908|NCT02395471|465098513|FG000|Overall Study|Physician Decision|1|||
128946428|NCT00871377|464090463|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129217909|NCT02395471|465098514|FG001|Overall Study|Physician Decision|0|||
129217910|NCT02395471|465098513|FG000|Overall Study|Protocol Violation|0|||
129217911|NCT02395471|465098514|FG001|Overall Study|Protocol Violation|1|||
128946429|NCT00871377|464090464|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129033867|NCT00982228|464414142|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
128946430|NCT00871377|464090465|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129123765|NCT01386385|464749417|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129123766|NCT01386385|464749418|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129123767|NCT01386385|464749411|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129123768|NCT01386385|464749412|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129123769|NCT01386385|464749413|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
129123770|NCT01386385|464749414|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129123771|NCT01386385|464749415|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129123772|NCT01386385|464749416|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129123773|NCT01386385|464749417|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129123774|NCT01386385|464749418|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129123775|NCT01386385|464749411|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129123776|NCT01386385|464749412|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129123777|NCT01386385|464749413|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129123778|NCT01386385|464749414|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129123779|NCT01386385|464749415|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
129123780|NCT01386385|464749416|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129123781|NCT01386385|464749417|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129123782|NCT01386385|464749418|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129123783|NCT01386385|464749411|FG000|Phase II Concurrent CRT|Adverse Event|0|||
129123784|NCT01386385|464749412|FG001|Phase II Concurrent CRT|Adverse Event|0|||
129123785|NCT01386385|464749413|FG002|Phase II Concurrent CRT|Adverse Event|0|||
129123786|NCT01386385|464749414|FG003|Phase II Concurrent CRT|Adverse Event|0|||
129123787|NCT01386385|464749415|FG004|Phase II Concurrent CRT|Adverse Event|0|||
129123788|NCT01386385|464749416|FG005|Phase II Concurrent CRT|Adverse Event|0|||
129123789|NCT01386385|464749417|FG006|Phase II Concurrent CRT|Adverse Event|3|||
129123790|NCT01386385|464749418|FG007|Phase II Concurrent CRT|Adverse Event|3|||
128946431|NCT00871377|464090466|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
128946432|NCT00871377|464090461|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
128946433|NCT00871377|464090462|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946434|NCT00871377|464090463|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946435|NCT00871377|464090464|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946436|NCT00871377|464090465|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946437|NCT00871377|464090466|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946438|NCT00871377|464090461|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946439|NCT00871377|464090462|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946440|NCT00871377|464090463|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946441|NCT00871377|464090464|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946442|NCT00871377|464090465|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
128946443|NCT00871377|464090466|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
128946444|NCT00871377|464090461|FG000|Third Intervention (10 Weeks)|Death|0|||
128946445|NCT00871377|464090462|FG001|Third Intervention (10 Weeks)|Death|0|||
128946446|NCT00871377|464090463|FG002|Third Intervention (10 Weeks)|Death|0|||
128946447|NCT00871377|464090464|FG003|Third Intervention (10 Weeks)|Death|1|||
128946448|NCT00871377|464090465|FG004|Third Intervention (10 Weeks)|Death|0|||
128946449|NCT00871377|464090466|FG005|Third Intervention (10 Weeks)|Death|0|||
128946450|NCT01395368|464090468|FG000|Overall Study|Physician Decision|14|||
128946451|NCT01395368|464090468|FG000|Overall Study|Withdrawal by Subject|2|||
128946452|NCT03072719|464090475|FG000|Overall Study|Adverse Event|1|||
128946453|NCT03072719|464090476|FG001|Overall Study|Adverse Event|1|||
128946454|NCT00882999|464090477|FG000|Overall Study|Adverse Event|0|||
128946455|NCT00882999|464090478|FG001|Overall Study|Adverse Event|0|||
128946456|NCT00882999|464090479|FG002|Overall Study|Adverse Event|0|||
128946457|NCT00882999|464090480|FG003|Overall Study|Adverse Event|0|||
128946458|NCT00882999|464090481|FG004|Overall Study|Adverse Event|1|||
128946459|NCT00882999|464090482|FG005|Overall Study|Adverse Event|0|||
128946460|NCT00882999|464090483|FG006|Overall Study|Adverse Event|0|||
128946461|NCT00882999|464090477|FG000|Overall Study|Death|0|||
128946462|NCT00882999|464090478|FG001|Overall Study|Death|1|||
128946463|NCT00882999|464090479|FG002|Overall Study|Death|0|||
128946464|NCT00882999|464090480|FG003|Overall Study|Death|0|||
128946465|NCT00882999|464090481|FG004|Overall Study|Death|0|||
128946466|NCT00882999|464090482|FG005|Overall Study|Death|0|||
128946467|NCT00882999|464090483|FG006|Overall Study|Death|0|||
128946468|NCT00882999|464090477|FG000|Overall Study|Withdrawal by Subject|7|||
128946469|NCT00882999|464090478|FG001|Overall Study|Withdrawal by Subject|6|||
128946470|NCT00882999|464090479|FG002|Overall Study|Withdrawal by Subject|3|||
128946471|NCT00882999|464090480|FG003|Overall Study|Withdrawal by Subject|3|||
128946472|NCT00882999|464090481|FG004|Overall Study|Withdrawal by Subject|6|||
128946473|NCT00882999|464090482|FG005|Overall Study|Withdrawal by Subject|5|||
128946474|NCT00882999|464090483|FG006|Overall Study|Withdrawal by Subject|5|||
128946475|NCT00882999|464090477|FG000|Overall Study|Lost to Follow-up|0|||
128946476|NCT00882999|464090478|FG001|Overall Study|Lost to Follow-up|1|||
129123791|NCT01386385|464749411|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129123792|NCT01386385|464749412|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129123793|NCT01386385|464749413|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
128946477|NCT00882999|464090479|FG002|Overall Study|Lost to Follow-up|1|||
128946478|NCT00882999|464090480|FG003|Overall Study|Lost to Follow-up|2|||
128946479|NCT00882999|464090481|FG004|Overall Study|Lost to Follow-up|1|||
128946480|NCT00882999|464090482|FG005|Overall Study|Lost to Follow-up|1|||
128946481|NCT00882999|464090483|FG006|Overall Study|Lost to Follow-up|2|||
128946482|NCT00882999|464090477|FG000|Overall Study|Physician Decision|1|||
128946483|NCT00882999|464090478|FG001|Overall Study|Physician Decision|0|||
128946484|NCT00882999|464090479|FG002|Overall Study|Physician Decision|0|||
128946485|NCT00882999|464090480|FG003|Overall Study|Physician Decision|0|||
128946486|NCT00882999|464090481|FG004|Overall Study|Physician Decision|0|||
128946487|NCT00882999|464090482|FG005|Overall Study|Physician Decision|1|||
128946488|NCT00882999|464090483|FG006|Overall Study|Physician Decision|1|||
128946489|NCT01248130|464090487|FG000|Overall Study|Protocol Violation|1|||
128946490|NCT01248130|464090488|FG001|Overall Study|Protocol Violation|0|||
128946491|NCT01248130|464090487|FG000|Overall Study|Ineligible|1|||
128946492|NCT01248130|464090488|FG001|Overall Study|Ineligible|0|||
128946493|NCT04507867|464090491|FG000|Overall Study|Death|7|||
128946494|NCT04507867|464090492|FG001|Overall Study|Death|1|||
128946495|NCT00781599|464090493|FG000|Overall Study|Lost to Follow-up|7|||
128946496|NCT00781599|464090494|FG001|Overall Study|Lost to Follow-up|4|||
128946497|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
128946498|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
128946499|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
128946500|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
128946501|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
128946502|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
128946503|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
128946504|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
128946505|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
128946506|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
128946507|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
128946508|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
128946509|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
128946510|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
128946511|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
128946512|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
128946513|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
128946514|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
128946515|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
128946516|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
128946517|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
128946518|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
128946519|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
128946520|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
128946521|NCT01106625|464090495|FG000|Core Period: Baseline to Week 26|Other|8|||
128946522|NCT01106625|464090496|FG001|Core Period: Baseline to Week 26|Other|7|||
128946523|NCT01106625|464090497|FG002|Core Period: Baseline to Week 26|Other|4|||
128946524|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
128946525|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
128946526|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
128946527|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
128946528|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
128946529|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
128946530|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
128946531|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
128946532|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
128946533|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
128946534|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
128946535|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
128946536|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
128946537|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
128946538|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
128946539|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
128946540|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
128946541|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
128946542|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
128946543|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
128946544|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
129217912|NCT02395471|465098513|FG000|Overall Study|Failure to swollow sponge twice|1|||
129217913|NCT02395471|465098514|FG001|Overall Study|Failure to swollow sponge twice|0|||
129217914|NCT02395471|465098513|FG000|Overall Study|Patient did not return for procedure|0|||
129217915|NCT02395471|465098514|FG001|Overall Study|Patient did not return for procedure|1|||
129217916|NCT02395471|465098513|FG000|Overall Study|Subject not eligible|1|||
129217917|NCT02395471|465098514|FG001|Overall Study|Subject not eligible|0|||
129217918|NCT03847896|465098515|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129217919|NCT03847896|465098516|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129217920|NCT03847896|465098517|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
129217921|NCT03847896|465098518|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129217922|NCT03847896|465098519|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129217923|NCT03847896|465098515|FG000|Overall Study|Withdrawal by Subject|2|||
129217924|NCT03847896|465098516|FG001|Overall Study|Withdrawal by Subject|10|||
129217925|NCT03847896|465098517|FG002|Overall Study|Withdrawal by Subject|5|||
129217926|NCT03847896|465098518|FG003|Overall Study|Withdrawal by Subject|9|||
129217927|NCT03847896|465098519|FG004|Overall Study|Withdrawal by Subject|8|||
129217928|NCT03847896|465098515|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129217929|NCT03847896|465098516|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129217930|NCT03847896|465098517|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129217931|NCT03847896|465098518|FG003|Overall Study|Withdrawal by parent/guardian|0|||
129217932|NCT03847896|465098519|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129217933|NCT03847896|465098515|FG000|Overall Study|Adverse Event|2|||
129217934|NCT03847896|465098516|FG001|Overall Study|Adverse Event|1|||
129217935|NCT03847896|465098517|FG002|Overall Study|Adverse Event|3|||
129217936|NCT03847896|465098518|FG003|Overall Study|Adverse Event|2|||
129217937|NCT03847896|465098519|FG004|Overall Study|Adverse Event|4|||
129217938|NCT03847896|465098515|FG000|Overall Study|A severe exacerbation event|0|||
128946545|NCT01106625|464090495|FG000|Extension Period: Week 26 to Week 52|Other|5|||
128946546|NCT01106625|464090496|FG001|Extension Period: Week 26 to Week 52|Other|5|||
128946547|NCT01106625|464090497|FG002|Extension Period: Week 26 to Week 52|Other|4|||
128946548|NCT01496430|464090503|FG000|Overall Study|Adverse Event|0|||
128946549|NCT01496430|464090504|FG001|Overall Study|Adverse Event|0|||
128946550|NCT01496430|464090505|FG002|Overall Study|Adverse Event|1|||
128946551|NCT01496430|464090503|FG000|Overall Study|Major Protocol Deviation|0|||
128946552|NCT01496430|464090504|FG001|Overall Study|Major Protocol Deviation|0|||
128946553|NCT01496430|464090505|FG002|Overall Study|Major Protocol Deviation|1|||
128946554|NCT01496430|464090503|FG000|Overall Study|Lost to Follow-up|2|||
128946555|NCT01496430|464090504|FG001|Overall Study|Lost to Follow-up|3|||
128946556|NCT01496430|464090505|FG002|Overall Study|Lost to Follow-up|1|||
128946557|NCT01496430|464090503|FG000|Overall Study|Voluntary Withdrawal|2|||
128946558|NCT01496430|464090504|FG001|Overall Study|Voluntary Withdrawal|1|||
128946559|NCT01496430|464090505|FG002|Overall Study|Voluntary Withdrawal|6|||
128946560|NCT01496430|464090503|FG000|Overall Study|Principal Investigator Discretion|0|||
128946561|NCT01496430|464090504|FG001|Overall Study|Principal Investigator Discretion|1|||
128946562|NCT01496430|464090505|FG002|Overall Study|Principal Investigator Discretion|1|||
128946563|NCT01496430|464090503|FG000|Overall Study|Other|2|||
128946564|NCT01496430|464090504|FG001|Overall Study|Other|0|||
128946565|NCT01496430|464090505|FG002|Overall Study|Other|0|||
128946566|NCT00997321|464090506|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
128946567|NCT00997321|464090507|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
128946568|NCT02512068|464090512|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
128946569|NCT02512068|464090513|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
128946570|NCT02512068|464090512|FG000|Overall Study|Major Protocol Deviation|1|||
128946571|NCT02512068|464090513|FG001|Overall Study|Major Protocol Deviation|0|||
128946572|NCT02512068|464090512|FG000|Overall Study|Voluntary Withdrawal|0|||
128946573|NCT02512068|464090513|FG001|Overall Study|Voluntary Withdrawal|1|||
128946574|NCT02512068|464090512|FG000|Overall Study|Lack of Efficacy|0|||
128946575|NCT02512068|464090513|FG001|Overall Study|Lack of Efficacy|1|||
129217939|NCT03847896|465098516|FG001|Overall Study|A severe exacerbation event|0|||
129217940|NCT03847896|465098517|FG002|Overall Study|A severe exacerbation event|0|||
129217941|NCT03847896|465098518|FG003|Overall Study|A severe exacerbation event|0|||
129217942|NCT03847896|465098519|FG004|Overall Study|A severe exacerbation event|3|||
129217943|NCT03847896|465098515|FG000|Overall Study|Protocol Violation|0|||
129217944|NCT03847896|465098516|FG001|Overall Study|Protocol Violation|2|||
128946576|NCT02512068|464090512|FG000|Overall Study|Reason Not Specified|3|||
129217945|NCT03847896|465098517|FG002|Overall Study|Protocol Violation|1|||
129217946|NCT03847896|465098518|FG003|Overall Study|Protocol Violation|0|||
129217947|NCT03847896|465098519|FG004|Overall Study|Protocol Violation|2|||
129217948|NCT03847896|465098515|FG000|Overall Study|Lost to Follow-up|0|||
128946577|NCT02512068|464090513|FG001|Overall Study|Reason Not Specified|5|||
128946578|NCT03521687|464090520|FG000|Overall Study|Adverse Event|4|||
128946579|NCT03521687|464090520|FG000|Overall Study|Physician Decision|1|||
128946580|NCT01151579|464090526|FG000|Overall Study|Physician Decision|3|||
128946581|NCT01151579|464090527|FG001|Overall Study|Physician Decision|1|||
129123794|NCT01386385|464749414|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129123795|NCT01386385|464749415|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129123796|NCT01386385|464749416|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129123797|NCT01386385|464749417|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
129123798|NCT01386385|464749418|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129123799|NCT01386385|464749411|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
129123800|NCT01386385|464749412|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
129123801|NCT01386385|464749413|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
128946582|NCT01151579|464090526|FG000|Overall Study|Withdrawal by Subject|3|||
128946583|NCT01151579|464090527|FG001|Overall Study|Withdrawal by Subject|2|||
128946584|NCT01151579|464090526|FG000|Overall Study|Not meet inclusion criteria|6|||
128946585|NCT01151579|464090527|FG001|Overall Study|Not meet inclusion criteria|4|||
128946586|NCT01276457|464090530|FG000|Core Study|Adverse Event|6|||
128946587|NCT01276457|464090531|FG001|Core Study|Adverse Event|3|||
128946588|NCT01276457|464090530|FG000|Core Study|Lost to Follow-up|1|||
128946589|NCT01276457|464090531|FG001|Core Study|Lost to Follow-up|2|||
128946590|NCT01276457|464090530|FG000|Core Study|Administrative problems|1|||
128946591|NCT01276457|464090531|FG001|Core Study|Administrative problems|1|||
128708440|NCT00833794|463226442|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
128708441|NCT00833794|463226443|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
128946592|NCT01276457|464090530|FG000|Core Study|Death|2|||
128946593|NCT01276457|464090531|FG001|Core Study|Death|2|||
128946594|NCT01276457|464090530|FG000|Core Study|Lack of Efficacy|3|||
128946595|NCT01276457|464090531|FG001|Core Study|Lack of Efficacy|12|||
128946596|NCT01276457|464090530|FG000|Extension Study|Lost to Follow-up|3|||
128946597|NCT01276457|464090531|FG001|Extension Study|Lost to Follow-up|0|||
128946598|NCT01276457|464090530|FG000|Extension Study|Death|0|||
128946599|NCT01276457|464090531|FG001|Extension Study|Death|1|||
128946600|NCT01276457|464090530|FG000|Extension Study|Lack of Efficacy|3|||
128946601|NCT01276457|464090531|FG001|Extension Study|Lack of Efficacy|1|||
128946602|NCT01153763|464090534|FG000|Overall Study|Study Closed|16|||
128946603|NCT01153763|464090534|FG000|Overall Study|Lost to Follow-up|1|||
128946604|NCT01153763|464090534|FG000|Overall Study|Physician Decision|2|||
128946605|NCT01153763|464090534|FG000|Overall Study|Withdrawal by Subject|2|||
128946606|NCT01474746|464090535|FG000|Overall Study|Lost to Follow-up|1|||
128946607|NCT01474746|464090536|FG001|Overall Study|Lost to Follow-up|1|||
128946608|NCT01474746|464090535|FG000|Overall Study|Withdrawal by Subject|2|||
128946609|NCT01474746|464090536|FG001|Overall Study|Withdrawal by Subject|1|||
128946610|NCT01766336|464090538|FG000|Overall Study|Adverse Event|11|||
128946611|NCT01766336|464090539|FG001|Overall Study|Adverse Event|8|||
128946612|NCT01766336|464090538|FG000|Overall Study|Death|4|||
128946613|NCT01766336|464090539|FG001|Overall Study|Death|3|||
128946614|NCT01766336|464090538|FG000|Overall Study|Lost to Follow-up|1|||
128946615|NCT01766336|464090539|FG001|Overall Study|Lost to Follow-up|3|||
128946616|NCT01766336|464090538|FG000|Overall Study|Physician Decision|4|||
128946617|NCT01766336|464090539|FG001|Overall Study|Physician Decision|2|||
128946618|NCT01766336|464090538|FG000|Overall Study|Protocol Violation|0|||
128946619|NCT01766336|464090539|FG001|Overall Study|Protocol Violation|1|||
128946620|NCT01766336|464090538|FG000|Overall Study|Sponsor Decision|52|||
128946621|NCT01766336|464090539|FG001|Overall Study|Sponsor Decision|43|||
128946622|NCT01766336|464090538|FG000|Overall Study|Withdrawal by Subject|18|||
128946623|NCT01766336|464090539|FG001|Overall Study|Withdrawal by Subject|15|||
128946624|NCT02605447|464090540|FG000|Overall Study|Death|66|||
128946625|NCT02605447|464090540|FG000|Overall Study|Physician Decision|1|||
128946626|NCT02605447|464090540|FG000|Overall Study|Lost to Follow-up|24|||
128946627|NCT02605447|464090540|FG000|Overall Study|Withdrawal by Subject|10|||
128946628|NCT02605447|464090540|FG000|Overall Study|Not disclosed|1|||
128946629|NCT04544709|464090544|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
129123802|NCT01386385|464749414|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
129123803|NCT01386385|464749415|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
129123804|NCT01386385|464749416|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
129217949|NCT03847896|465098516|FG001|Overall Study|Lost to Follow-up|0|||
128708442|NCT00833794|463226442|FG000|Double-blind Phase|Adverse Event|44|||
128708443|NCT00833794|463226443|FG001|Double-blind Phase|Adverse Event|11|||
128708444|NCT00833794|463226442|FG000|Double-blind Phase|Lack of Efficacy|34|||
128708445|NCT00833794|463226443|FG001|Double-blind Phase|Lack of Efficacy|22|||
128708446|NCT00833794|463226442|FG000|Double-blind Phase|Withdrawal by Subject|23|||
128708447|NCT00833794|463226443|FG001|Double-blind Phase|Withdrawal by Subject|6|||
128708448|NCT00833794|463226442|FG000|Double-blind Phase|Physician Decision|4|||
128708449|NCT00833794|463226443|FG001|Double-blind Phase|Physician Decision|7|||
128708450|NCT00833794|463226442|FG000|Double-blind Phase|Administrative reason|1|||
128708451|NCT00833794|463226443|FG001|Double-blind Phase|Administrative reason|3|||
128708452|NCT01605877|463226444|FG000|Overall Study|Withdrawal by Subject|1|||
128708453|NCT01918085|463226447|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
128946630|NCT02045212|464090545|FG000|Overall Study|Adverse Event|0|||
128946631|NCT02045212|464090546|FG001|Overall Study|Adverse Event|1|||
128946632|NCT02045212|464090545|FG000|Overall Study|Withdrawal by Subject|1|||
128946633|NCT02045212|464090546|FG001|Overall Study|Withdrawal by Subject|0|||
128946634|NCT02045212|464090545|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
128946635|NCT02045212|464090546|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
128946636|NCT02402218|464090550|FG000|Overall Study|Did not pickup study medication|12|||
128946637|NCT02402218|464090551|FG001|Overall Study|Did not pickup study medication|9|||
128946638|NCT02402218|464090552|FG002|Overall Study|Did not pickup study medication|13|||
128946639|NCT02402218|464090550|FG000|Overall Study|Lack of Efficacy|0|||
128946640|NCT02402218|464090551|FG001|Overall Study|Lack of Efficacy|1|||
128946641|NCT02402218|464090552|FG002|Overall Study|Lack of Efficacy|1|||
128946642|NCT02402218|464090550|FG000|Overall Study|Death|1|||
128946643|NCT02402218|464090551|FG001|Overall Study|Death|0|||
128946644|NCT02402218|464090552|FG002|Overall Study|Death|0|||
128946645|NCT02402218|464090550|FG000|Overall Study|Reinfection|0|||
128946646|NCT02402218|464090551|FG001|Overall Study|Reinfection|0|||
128946647|NCT02402218|464090552|FG002|Overall Study|Reinfection|1|||
128946648|NCT02402218|464090550|FG000|Overall Study|Adverse Event|0|||
128946649|NCT02402218|464090551|FG001|Overall Study|Adverse Event|2|||
128946650|NCT02402218|464090552|FG002|Overall Study|Adverse Event|1|||
128946651|NCT02402218|464090550|FG000|Overall Study|Withdrawal by Subject|1|||
128946652|NCT02402218|464090551|FG001|Overall Study|Withdrawal by Subject|1|||
128946653|NCT02402218|464090552|FG002|Overall Study|Withdrawal by Subject|1|||
128946654|NCT00369668|464090554|FG000|Overall Study|Lack of Efficacy|4|||
128946655|NCT00369668|464090555|FG001|Overall Study|Lack of Efficacy|5|||
128946656|NCT00369668|464090556|FG002|Overall Study|Lack of Efficacy|7|||
128946657|NCT03126539|464090564|FG000|Overall Study|Lost to Follow-up|1|||
128946658|NCT03126539|464090565|FG001|Overall Study|Lost to Follow-up|1|||
128946659|NCT03126539|464090566|FG002|Overall Study|Lost to Follow-up|1|||
128946660|NCT03126539|464090567|FG003|Overall Study|Lost to Follow-up|0|||
128946661|NCT03126539|464090568|FG004|Overall Study|Lost to Follow-up|0|||
128946662|NCT03352414|464090569|FG000|Overall Study|Ineligible by operative criteria|12|||
128946663|NCT03352414|464090570|FG001|Overall Study|Ineligible by operative criteria|10|||
128946664|NCT02632110|464090571|FG000|Overall Study|Withdrawal by Subject|1|||
129123805|NCT01386385|464749417|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
129123806|NCT01386385|464749418|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
129123807|NCT01386385|464749411|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129123808|NCT01386385|464749412|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129123809|NCT01386385|464749413|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129123810|NCT01386385|464749414|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129123811|NCT01386385|464749415|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129123812|NCT01386385|464749416|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129123813|NCT01386385|464749417|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
129123814|NCT01386385|464749418|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129123815|NCT01386385|464749411|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
129123816|NCT01386385|464749412|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
129123817|NCT01386385|464749413|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
129123818|NCT01386385|464749414|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
129123819|NCT01386385|464749415|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
129123820|NCT01386385|464749416|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
129123821|NCT01386385|464749417|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
129123822|NCT01386385|464749418|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
129123823|NCT05399485|464749419|FG000|DBT Phase|Other|6|||
129123824|NCT05399485|464749420|FG001|DBT Phase|Other|5|||
129123825|NCT05399485|464749419|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
129123826|NCT05399485|464749420|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
129123827|NCT05399485|464749419|FG000|DBT Phase|Withdrawal by Subject|3|||
129123828|NCT05399485|464749420|FG001|DBT Phase|Withdrawal by Subject|2|||
129123829|NCT05399485|464749419|FG000|DBT Phase|Protocol Violation|2|||
129123830|NCT05399485|464749420|FG001|DBT Phase|Protocol Violation|1|||
129123831|NCT05399485|464749419|FG000|DBT Phase|Physician Decision|0|||
129123832|NCT05399485|464749420|FG001|DBT Phase|Physician Decision|1|||
129123833|NCT05399485|464749419|FG000|DBT Phase|Adverse Event|2|||
129123834|NCT05399485|464749420|FG001|DBT Phase|Adverse Event|1|||
129123835|NCT05399485|464749419|FG000|OLE Phase|Not reported|0|||
129123836|NCT05399485|464749420|FG001|OLE Phase|Not reported|1|||
129123837|NCT05399485|464749419|FG000|OLE Phase|Other|3|||
128946665|NCT02632110|464090572|FG001|Overall Study|Withdrawal by Subject|1|||
128946666|NCT02632110|464090573|FG002|Overall Study|Withdrawal by Subject|0|||
128946667|NCT02632110|464090574|FG003|Overall Study|Withdrawal by Subject|0|||
129123838|NCT05399485|464749420|FG001|OLE Phase|Other|3|||
129123839|NCT05399485|464749419|FG000|OLE Phase|Withdrawal by Subject|8|||
129123840|NCT05399485|464749420|FG001|OLE Phase|Withdrawal by Subject|5|||
128946668|NCT02632110|464090575|FG004|Overall Study|Withdrawal by Subject|1|||
128946669|NCT02632110|464090576|FG005|Overall Study|Withdrawal by Subject|1|||
128946670|NCT02632110|464090577|FG006|Overall Study|Withdrawal by Subject|3|||
128946671|NCT02632110|464090578|FG007|Overall Study|Withdrawal by Subject|3|||
128946672|NCT02632110|464090579|FG008|Overall Study|Withdrawal by Subject|1|||
128946673|NCT02632110|464090580|FG009|Overall Study|Withdrawal by Subject|1|||
129217950|NCT03847896|465098517|FG002|Overall Study|Lost to Follow-up|0|||
129217951|NCT03847896|465098518|FG003|Overall Study|Lost to Follow-up|1|||
129217952|NCT03847896|465098519|FG004|Overall Study|Lost to Follow-up|0|||
129217953|NCT03847896|465098515|FG000|Overall Study|Condition under investigation worsened|0|||
129217954|NCT03847896|465098516|FG001|Overall Study|Condition under investigation worsened|0|||
129217955|NCT03847896|465098517|FG002|Overall Study|Condition under investigation worsened|0|||
129217956|NCT03847896|465098518|FG003|Overall Study|Condition under investigation worsened|1|||
129217957|NCT03847896|465098519|FG004|Overall Study|Condition under investigation worsened|1|||
129217958|NCT03847896|465098515|FG000|Overall Study|Lack of Efficacy|0|||
129217959|NCT03847896|465098516|FG001|Overall Study|Lack of Efficacy|0|||
129217960|NCT03847896|465098517|FG002|Overall Study|Lack of Efficacy|0|||
129217961|NCT03847896|465098518|FG003|Overall Study|Lack of Efficacy|2|||
129217962|NCT03847896|465098519|FG004|Overall Study|Lack of Efficacy|2|||
129217963|NCT03847896|465098515|FG000|Overall Study|Other reasons|3|||
129217964|NCT03847896|465098516|FG001|Overall Study|Other reasons|3|||
129217965|NCT03847896|465098517|FG002|Overall Study|Other reasons|1|||
129217966|NCT03847896|465098518|FG003|Overall Study|Other reasons|2|||
129217967|NCT03847896|465098519|FG004|Overall Study|Other reasons|1|||
129217968|NCT02978781|465098520|FG000|Part A|Adverse Event|1|||
129217969|NCT02978781|465098521|FG001|Part A|Adverse Event|1|||
129217970|NCT02978781|465098522|FG002|Part A|Adverse Event|0|||
129217971|NCT02978781|465098523|FG003|Part A|Adverse Event|0|||
129217972|NCT02978781|465098524|FG004|Part A|Adverse Event|0|||
129217973|NCT02978781|465098520|FG000|Part A|Withdrawal by Subject|0|||
129217974|NCT02978781|465098521|FG001|Part A|Withdrawal by Subject|1|||
129217975|NCT02978781|465098522|FG002|Part A|Withdrawal by Subject|0|||
129217976|NCT02978781|465098523|FG003|Part A|Withdrawal by Subject|0|||
129217977|NCT02978781|465098524|FG004|Part A|Withdrawal by Subject|0|||
129217978|NCT02978781|465098520|FG000|Part B|Withdrawal by Subject|0|||
129217979|NCT02978781|465098521|FG001|Part B|Withdrawal by Subject|0|||
129217980|NCT02978781|465098522|FG002|Part B|Withdrawal by Subject|0|||
129217981|NCT02978781|465098523|FG003|Part B|Withdrawal by Subject|1|||
129217982|NCT02978781|465098524|FG004|Part B|Withdrawal by Subject|0|||
128946674|NCT00516269|464090583|FG000|Overall Study|Adverse Event|2|||
128946675|NCT00516269|464090584|FG001|Overall Study|Adverse Event|1|||
128946676|NCT00516269|464090583|FG000|Overall Study|Lost to Follow-up|0|||
128946677|NCT00516269|464090584|FG001|Overall Study|Lost to Follow-up|1|||
128946678|NCT00516269|464090583|FG000|Overall Study|Protocol Violation|0|||
128946679|NCT00516269|464090584|FG001|Overall Study|Protocol Violation|1|||
128946680|NCT00142519|464090585|FG000|Overall Study|Not Treated|7|||
128946681|NCT00142519|464090586|FG001|Overall Study|Not Treated|9|||
128946682|NCT00142519|464090585|FG000|Overall Study|Protocol Violation|1|||
128946683|NCT00142519|464090586|FG001|Overall Study|Protocol Violation|0|||
128946684|NCT00142519|464090585|FG000|Overall Study|Withdrawal by Subject|10|||
128946685|NCT00142519|464090586|FG001|Overall Study|Withdrawal by Subject|7|||
128946686|NCT02596711|464090587|FG000|Overall Study|Lost to Follow-up|1|||
128946687|NCT02596711|464090588|FG001|Overall Study|Lost to Follow-up|2|||
128946688|NCT02596711|464090589|FG002|Overall Study|Lost to Follow-up|3|||
129217983|NCT02978781|465098520|FG000|Part C|Adverse Event|0|||
129217984|NCT02978781|465098521|FG001|Part C|Adverse Event|0|||
129217985|NCT02978781|465098522|FG002|Part C|Adverse Event|0|||
129217986|NCT02978781|465098523|FG003|Part C|Adverse Event|0|||
129217987|NCT02978781|465098524|FG004|Part C|Adverse Event|2|||
129217988|NCT02978781|465098520|FG000|Part C|Withdrawal by Subject|0|||
128946689|NCT01005732|464090590|FG000|Overall Study|Lost to Follow-up|10|||
128946690|NCT01005732|464090590|FG000|Overall Study|Death|1|||
128946691|NCT01552928|464090591|FG000|Period 3|Adverse Event|0|||
128946692|NCT01552928|464090592|FG001|Period 3|Adverse Event|0|||
128946693|NCT01552928|464090593|FG002|Period 3|Adverse Event|1|||
128946694|NCT01552928|464090594|FG003|Period 3|Adverse Event|0|||
128946695|NCT01079962|464090596|FG000|Overall Study|Adverse Event|2|||
128946696|NCT01079962|464090597|FG001|Overall Study|Adverse Event|2|||
128946697|NCT01079962|464090596|FG000|Overall Study|Withdrawal by Subject|5|||
128946698|NCT01079962|464090597|FG001|Overall Study|Withdrawal by Subject|7|||
128946699|NCT01079962|464090596|FG000|Overall Study|Protocol Violation|2|||
128946700|NCT01079962|464090597|FG001|Overall Study|Protocol Violation|2|||
128946701|NCT01079962|464090596|FG000|Overall Study|No blood pressure (BP) control|3|||
128946702|NCT01079962|464090597|FG001|Overall Study|No blood pressure (BP) control|0|||
128946703|NCT01079962|464090596|FG000|Overall Study|Inclusion/exclusion criteria|1|||
128946704|NCT01079962|464090597|FG001|Overall Study|Inclusion/exclusion criteria|3|||
129033868|NCT00982228|464414143|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
129217989|NCT02978781|465098521|FG001|Part C|Withdrawal by Subject|0|||
128770322|NCT02322814|463450210|FG004|Overall Study|Study Terminated by Sponsor|13|||
128946705|NCT01079962|464090596|FG000|Overall Study|Participant not returning for next visit|1|||
128946706|NCT01079962|464090597|FG001|Overall Study|Participant not returning for next visit|0|||
128946707|NCT01079962|464090596|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
128946708|NCT01079962|464090597|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
128946709|NCT01331239|464090598|FG000|Part II: Core Study|Adverse Event|0|||
129217990|NCT02978781|465098522|FG002|Part C|Withdrawal by Subject|0|||
129217991|NCT02978781|465098523|FG003|Part C|Withdrawal by Subject|0|||
129217992|NCT02978781|465098524|FG004|Part C|Withdrawal by Subject|1|||
129217993|NCT02978781|465098520|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
129217994|NCT02978781|465098521|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
129217995|NCT02978781|465098522|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
129217996|NCT02978781|465098523|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
129217997|NCT02978781|465098524|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
129217998|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
129217999|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
129218000|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Adverse Event|31|||
128708454|NCT01918085|463226448|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
128708455|NCT00679302|463226457|FG000|Overall Study|Lost to Follow-up|8|||
128708456|NCT00679302|463226458|FG001|Overall Study|Lost to Follow-up|4|||
128708457|NCT05109442|463226459|FG000|Overall Study|Withdrawal by Subject|0|||
128946710|NCT01331239|464090599|FG001|Part II: Core Study|Adverse Event|3|||
128946711|NCT01331239|464090600|FG002|Part II: Core Study|Adverse Event|0|||
128946712|NCT01331239|464090598|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
128946713|NCT01331239|464090599|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
128946714|NCT01331239|464090600|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
128946715|NCT01331239|464090598|FG000|Part II: Core Study|Withdrawal by Subject|0|||
128946716|NCT01331239|464090599|FG001|Part II: Core Study|Withdrawal by Subject|2|||
128946717|NCT01331239|464090600|FG002|Part II: Core Study|Withdrawal by Subject|0|||
128946718|NCT01331239|464090598|FG000|Part II: Core Study|Administrative problems|0|||
128946719|NCT01331239|464090599|FG001|Part II: Core Study|Administrative problems|1|||
128946720|NCT01331239|464090600|FG002|Part II: Core Study|Administrative problems|0|||
128946721|NCT00946530|464090601|FG000|Overall Study|Withdrawal by Subject|0|||
128946722|NCT00946530|464090602|FG001|Overall Study|Withdrawal by Subject|3|||
128946723|NCT00946530|464090603|FG002|Overall Study|Withdrawal by Subject|0|||
128946724|NCT00946530|464090604|FG003|Overall Study|Withdrawal by Subject|3|||
128946725|NCT00946530|464090601|FG000|Overall Study|Physician Decision|1|||
128946726|NCT00946530|464090602|FG001|Overall Study|Physician Decision|1|||
128946727|NCT00946530|464090603|FG002|Overall Study|Physician Decision|1|||
128946728|NCT00946530|464090604|FG003|Overall Study|Physician Decision|1|||
128946729|NCT01008995|464090607|FG000|Controlled Period|Adverse Event|1|||
128946730|NCT01008995|464090608|FG001|Controlled Period|Adverse Event|2|||
128946731|NCT01008995|464090609|FG002|Controlled Period|Adverse Event|0|||
128946732|NCT01008995|464090610|FG003|Controlled Period|Adverse Event|0|||
128946733|NCT01008995|464090607|FG000|Controlled Period|Other|2|||
128946734|NCT01008995|464090608|FG001|Controlled Period|Other|1|||
128946735|NCT01008995|464090609|FG002|Controlled Period|Other|0|||
128946736|NCT01008995|464090610|FG003|Controlled Period|Other|0|||
128946737|NCT01008995|464090607|FG000|After Controlled Period|Adverse Event|0|||
128946738|NCT01008995|464090608|FG001|After Controlled Period|Adverse Event|0|||
128946739|NCT01008995|464090609|FG002|After Controlled Period|Adverse Event|1|||
128946740|NCT01008995|464090610|FG003|After Controlled Period|Adverse Event|1|||
128946741|NCT01008995|464090607|FG000|After Controlled Period|Other|0|||
128946742|NCT01008995|464090608|FG001|After Controlled Period|Other|0|||
128946743|NCT01008995|464090609|FG002|After Controlled Period|Other|1|||
128946744|NCT01008995|464090610|FG003|After Controlled Period|Other|0|||
128946745|NCT02625324|464092184|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
128946746|NCT02625324|464092184|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
128946747|NCT02625324|464092184|FG000|6-Month Follow-up Subject Accountability|Death|5|||
128946748|NCT02625324|464092184|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
128946749|NCT02625324|464092184|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
128946750|NCT02625324|464092184|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
128946751|NCT02625324|464092184|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
128946752|NCT02625324|464092184|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
128946753|NCT02625324|464092184|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
128946754|NCT02625324|464092184|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
128946755|NCT02625324|464092184|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
128946756|NCT02625324|464092184|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
128946757|NCT02625324|464092184|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
128946758|NCT02625324|464092184|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
128708458|NCT05109442|463226460|FG001|Overall Study|Withdrawal by Subject|0|||
128708459|NCT05109442|463226461|FG002|Overall Study|Withdrawal by Subject|1|||
128946759|NCT02625324|464092184|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
128708460|NCT05109442|463226462|FG003|Overall Study|Withdrawal by Subject|0|||
128946760|NCT02625324|464092184|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
128946761|NCT02625324|464092184|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
128946762|NCT01116687|464092189|FG000|Overall Study|Withdrawal by Subject|4|||
128946763|NCT00165841|464092190|FG000|Overall Study|Adverse Event|2|||
128946764|NCT00165841|464092191|FG001|Overall Study|Adverse Event|3|||
129033869|NCT00982228|464414142|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
129033870|NCT00982228|464414143|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
129218001|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Adverse Event|21|||
129033871|NCT00982228|464414142|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
129033872|NCT00982228|464414143|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
129033873|NCT00982228|464414142|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
129033874|NCT00982228|464414143|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
129033875|NCT00982228|464414142|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
129033876|NCT00982228|464414143|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
129033877|NCT00982228|464414142|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
128770323|NCT02322814|463450206|FG000|Overall Study|Withdrawal by Subject|5|||
128770324|NCT02322814|463450207|FG001|Overall Study|Withdrawal by Subject|4|||
128770325|NCT02322814|463450208|FG002|Overall Study|Withdrawal by Subject|2|||
128770326|NCT02322814|463450209|FG003|Overall Study|Withdrawal by Subject|1|||
128770327|NCT02322814|463450210|FG004|Overall Study|Withdrawal by Subject|3|||
128770328|NCT00591864|463450211|FG000|Overall Study|Incomplete Imaging|5|||
128770329|NCT02459093|463450212|FG000|Overall Study|Protocol Violation|6|||
128770330|NCT02459093|463450213|FG001|Overall Study|Protocol Violation|11|||
128770331|NCT02459093|463450212|FG000|Overall Study|Lost to Follow-up|6|||
129033878|NCT00982228|464414143|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
129033879|NCT02250651|464414144|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
129033880|NCT02250651|464414145|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
129033881|NCT02250651|464414146|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
129033882|NCT02250651|464414144|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
129033883|NCT02250651|464414145|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
129033884|NCT02250651|464414146|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
129033885|NCT02250651|464414144|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
129033886|NCT02250651|464414145|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
129033887|NCT02250651|464414146|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
129033888|NCT02250651|464414144|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
129033889|NCT02250651|464414145|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
129033890|NCT02250651|464414146|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
129033891|NCT02250651|464414144|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
129033892|NCT02250651|464414145|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
129033893|NCT02250651|464414146|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
129033894|NCT02250651|464414144|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
129033895|NCT02250651|464414145|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
129033896|NCT02250651|464414146|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
129033897|NCT02250651|464414144|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
129033898|NCT02250651|464414145|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
129033899|NCT02250651|464414146|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
129218002|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
129218003|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
129218004|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
129218005|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
129218006|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
129218007|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
129218008|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
129218009|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
129218010|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Administrative problems|3|||
129218011|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Administrative problems|3|||
129218012|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Death|5|||
129218013|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Death|8|||
129218014|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Disease progression|139|||
129218015|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Disease progression|119|||
129218016|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
129218017|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
129033900|NCT02250651|464414144|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
129218018|NCT00785785|465098525|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
129218019|NCT00785785|465098526|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
129218020|NCT00785785|465098525|FG000|Optional Extension Phase|Adverse Event|4|||
129218021|NCT00785785|465098526|FG001|Optional Extension Phase|Adverse Event|5|||
129218022|NCT00785785|465098525|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
129218023|NCT00785785|465098526|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
129218024|NCT00785785|465098525|FG000|Optional Extension Phase|Lost to Follow-up|1|||
129218025|NCT00785785|465098526|FG001|Optional Extension Phase|Lost to Follow-up|0|||
128770332|NCT02459093|463450213|FG001|Overall Study|Lost to Follow-up|7|||
128770333|NCT00118092|463450214|FG000|Overall Study|Withdrawal by Subject|1|||
128946765|NCT00165841|464092190|FG000|Overall Study|Lack of Efficacy|6|||
128946766|NCT00165841|464092191|FG001|Overall Study|Lack of Efficacy|33|||
128946767|NCT00165841|464092190|FG000|Overall Study|Lost to Follow-up|4|||
128946768|NCT00165841|464092191|FG001|Overall Study|Lost to Follow-up|4|||
128946769|NCT00165841|464092190|FG000|Overall Study|Withdrawal by Subject|7|||
128946770|NCT00165841|464092191|FG001|Overall Study|Withdrawal by Subject|8|||
128946771|NCT00165841|464092190|FG000|Overall Study|Physician Decision|1|||
128946772|NCT00165841|464092191|FG001|Overall Study|Physician Decision|0|||
128946773|NCT00165841|464092190|FG000|Overall Study|Protocol Violation|6|||
128946774|NCT00165841|464092191|FG001|Overall Study|Protocol Violation|8|||
128946775|NCT00165841|464092190|FG000|Overall Study|Other|3|||
128946776|NCT00165841|464092191|FG001|Overall Study|Other|5|||
128946777|NCT00165841|464092190|FG000|Overall Study|Medication Noncompliance|1|||
128946778|NCT00165841|464092191|FG001|Overall Study|Medication Noncompliance|1|||
128946779|NCT03196193|464092198|FG000|Overall Study|Adverse Event|1|||
128946780|NCT03196193|464092199|FG001|Overall Study|Adverse Event|0|||
128946781|NCT03196193|464092198|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
128946782|NCT03196193|464092199|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
128946783|NCT02709083|464092200|FG000|Overall Study|Original PI left institution|7|||
129033901|NCT02250651|464414145|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
129033902|NCT02250651|464414146|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
129033903|NCT02250651|464414144|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
129033904|NCT02250651|464414145|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
129033905|NCT02250651|464414146|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
129033906|NCT02250651|464414144|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
129033907|NCT02250651|464414145|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
129033908|NCT02250651|464414146|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
129033909|NCT02250651|464414144|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
129033910|NCT02250651|464414145|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
129033911|NCT02250651|464414146|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
129033912|NCT02250651|464414144|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
129033913|NCT02250651|464414145|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
129033914|NCT02250651|464414146|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
129033915|NCT02250651|464414144|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
129033916|NCT02250651|464414145|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
129033917|NCT02250651|464414146|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
129033918|NCT02250651|464414144|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
129033919|NCT02250651|464414145|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
129033920|NCT02250651|464414146|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
129033921|NCT02250651|464414144|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
129033922|NCT02250651|464414145|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
129033923|NCT02250651|464414146|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
129033924|NCT03496298|464414147|FG000|Overall Study|Adverse Event|49|||
129033925|NCT03496298|464414148|FG001|Overall Study|Adverse Event|68|||
129033926|NCT03496298|464414149|FG002|Overall Study|Adverse Event|79|||
129033927|NCT03496298|464414147|FG000|Overall Study|Study terminated by Sponsor|1050|||
129033928|NCT03496298|464414148|FG001|Overall Study|Study terminated by Sponsor|1063|||
129033929|NCT03496298|464414149|FG002|Overall Study|Study terminated by Sponsor|1071|||
129033930|NCT03496298|464414147|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
129033931|NCT03496298|464414148|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
129033932|NCT03496298|464414149|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
129033933|NCT03496298|464414147|FG000|Overall Study|Withdrawal by Subject|176|||
129033934|NCT03496298|464414148|FG001|Overall Study|Withdrawal by Subject|154|||
129033935|NCT03496298|464414149|FG002|Overall Study|Withdrawal by Subject|151|||
129033936|NCT03496298|464414147|FG000|Overall Study|Other|29|||
129033937|NCT03496298|464414148|FG001|Overall Study|Other|20|||
129033938|NCT03496298|464414149|FG002|Overall Study|Other|23|||
129033939|NCT03496298|464414147|FG000|Overall Study|Randomized and not treated|1|||
129033940|NCT03496298|464414148|FG001|Overall Study|Randomized and not treated|1|||
129033941|NCT03496298|464414149|FG002|Overall Study|Randomized and not treated|1|||
129033942|NCT01438476|464414152|FG000|Overall Study|Protocol Violation|1|||
129033943|NCT01438476|464414153|FG001|Overall Study|Protocol Violation|0|||
129033944|NCT01438476|464414152|FG000|Overall Study|Withdrawal by Subject|1|||
129033945|NCT01438476|464414153|FG001|Overall Study|Withdrawal by Subject|0|||
129033946|NCT01438476|464414152|FG000|Overall Study|No Surgery- Disease|8|||
129033947|NCT01438476|464414153|FG001|Overall Study|No Surgery- Disease|10|||
129033948|NCT01438476|464414152|FG000|Overall Study|Communication barrier|0|||
128946784|NCT04031404|464092201|FG000|Baseline|Lost to Follow-up|0|||
128946785|NCT04031404|464092202|FG001|Baseline|Lost to Follow-up|1|||
128946786|NCT04031404|464092201|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
128946787|NCT04031404|464092202|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
128946788|NCT04031404|464092201|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
128946789|NCT04031404|464092202|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
128946790|NCT04031404|464092201|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
128946791|NCT04031404|464092202|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
128946792|NCT04031404|464092201|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
128946793|NCT04031404|464092202|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
128946794|NCT02796391|464092205|FG000|Overall Study|Lost to Follow-up|2|||
128946795|NCT02796391|464092206|FG001|Overall Study|Lost to Follow-up|2|||
128946796|NCT02796391|464092207|FG002|Overall Study|Lost to Follow-up|13|||
128946797|NCT02796391|464092208|FG003|Overall Study|Lost to Follow-up|8|||
128946798|NCT02796391|464092209|FG004|Overall Study|Lost to Follow-up|14|||
128946799|NCT02796391|464092210|FG005|Overall Study|Lost to Follow-up|13|||
128946800|NCT02796391|464092205|FG000|Overall Study|COVID|0|||
128946801|NCT02796391|464092206|FG001|Overall Study|COVID|0|||
128946802|NCT02796391|464092207|FG002|Overall Study|COVID|5|||
128946803|NCT02796391|464092208|FG003|Overall Study|COVID|5|||
128946804|NCT02796391|464092209|FG004|Overall Study|COVID|2|||
128946805|NCT02796391|464092210|FG005|Overall Study|COVID|4|||
128946806|NCT02796391|464092205|FG000|Overall Study|Participant did not like study cigarettes|0|||
128946807|NCT02796391|464092206|FG001|Overall Study|Participant did not like study cigarettes|0|||
128946808|NCT02796391|464092207|FG002|Overall Study|Participant did not like study cigarettes|3|||
128946809|NCT02796391|464092208|FG003|Overall Study|Participant did not like study cigarettes|0|||
128946810|NCT02796391|464092209|FG004|Overall Study|Participant did not like study cigarettes|0|||
128946811|NCT02796391|464092210|FG005|Overall Study|Participant did not like study cigarettes|0|||
128946812|NCT02796391|464092205|FG000|Overall Study|Withdrawal by Subject|1|||
128946813|NCT02796391|464092206|FG001|Overall Study|Withdrawal by Subject|1|||
128946814|NCT02796391|464092207|FG002|Overall Study|Withdrawal by Subject|4|||
128946815|NCT02796391|464092208|FG003|Overall Study|Withdrawal by Subject|3|||
128946816|NCT02796391|464092209|FG004|Overall Study|Withdrawal by Subject|4|||
128946817|NCT02796391|464092210|FG005|Overall Study|Withdrawal by Subject|3|||
128946818|NCT02796391|464092205|FG000|Overall Study|Adverse Event|0|||
128946819|NCT02796391|464092206|FG001|Overall Study|Adverse Event|0|||
128946820|NCT02796391|464092207|FG002|Overall Study|Adverse Event|0|||
128946821|NCT02796391|464092208|FG003|Overall Study|Adverse Event|1|||
128946822|NCT02796391|464092209|FG004|Overall Study|Adverse Event|0|||
128946823|NCT02796391|464092210|FG005|Overall Study|Adverse Event|0|||
128946824|NCT02796391|464092205|FG000|Overall Study|Protocol Violation|0|||
128946825|NCT02796391|464092206|FG001|Overall Study|Protocol Violation|0|||
128946826|NCT02796391|464092207|FG002|Overall Study|Protocol Violation|0|||
128946827|NCT02796391|464092208|FG003|Overall Study|Protocol Violation|1|||
128946828|NCT02796391|464092209|FG004|Overall Study|Protocol Violation|0|||
128946829|NCT02796391|464092210|FG005|Overall Study|Protocol Violation|0|||
128946830|NCT02681055|464092211|FG000|Weeks 5-12|Adverse Event|1|||
128946831|NCT02695524|464092212|FG000|Overall Study|Lost to Follow-up|3|||
129033949|NCT01438476|464414153|FG001|Overall Study|Communication barrier|1|||
129123841|NCT05399485|464749419|FG000|OLE Phase|Pregnancy|0|||
129123842|NCT05399485|464749420|FG001|OLE Phase|Pregnancy|1|||
129123843|NCT05399485|464749419|FG000|OLE Phase|Physician Decision|2|||
129123844|NCT05399485|464749420|FG001|OLE Phase|Physician Decision|0|||
129123845|NCT05399485|464749419|FG000|OLE Phase|Adverse Event|0|||
129123846|NCT05399485|464749420|FG001|OLE Phase|Adverse Event|1|||
129123847|NCT05399485|464749419|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
129123848|NCT05399485|464749420|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
129123849|NCT03405870|464749421|FG000|Overall Study|Withdrawal|1|||
129218026|NCT00785785|465098525|FG000|Optional Extension Phase|Administrative problems|2|||
129218027|NCT00785785|465098526|FG001|Optional Extension Phase|Administrative problems|0|||
128708461|NCT05109442|463226463|FG004|Overall Study|Withdrawal by Subject|0|||
128708462|NCT05109442|463226464|FG005|Overall Study|Withdrawal by Subject|0|||
129033950|NCT02522780|464414158|FG000|Overall Study|Consent withdrawn by subject|5|||
129033951|NCT02522780|464414159|FG001|Overall Study|Consent withdrawn by subject|7|||
129033952|NCT02522780|464414158|FG000|Overall Study|Protocol deviation|1|||
129033953|NCT02522780|464414159|FG001|Overall Study|Protocol deviation|3|||
129033954|NCT02522780|464414158|FG000|Overall Study|Subject refused endoscopic procedure|0|||
129033955|NCT02522780|464414159|FG001|Overall Study|Subject refused endoscopic procedure|1|||
129033956|NCT02522780|464414158|FG000|Overall Study|Adverse event, non-fatal|11|||
128946832|NCT02695524|464092213|FG001|Overall Study|Lost to Follow-up|2|||
128946833|NCT02695524|464092212|FG000|Overall Study|Death|0|||
128946834|NCT02695524|464092213|FG001|Overall Study|Death|1|||
128946835|NCT00831441|464092216|FG000|Randomized|Death|82|||
128946836|NCT00831441|464092217|FG001|Randomized|Death|81|||
128946837|NCT00831441|464092216|FG000|Randomized|Adverse Event|248|||
128946838|NCT00831441|464092217|FG001|Randomized|Adverse Event|321|||
128946839|NCT00831441|464092216|FG000|Randomized|Emergency procedure|2|||
128946840|NCT00831441|464092217|FG001|Randomized|Emergency procedure|2|||
128946841|NCT00831441|464092216|FG000|Randomized|Elective procedure|26|||
128946842|NCT00831441|464092217|FG001|Randomized|Elective procedure|25|||
129033957|NCT02522780|464414159|FG001|Overall Study|Adverse event, non-fatal|16|||
129033958|NCT02058160|464414160|FG000|Overall Study|Randomized but not treated|2|||
129123850|NCT03405870|464749422|FG001|Overall Study|Withdrawal|0|||
129033959|NCT02058160|464414161|FG001|Overall Study|Randomized but not treated|4|||
129033960|NCT02058160|464414160|FG000|Overall Study|Poor compliance to protocol|4|||
129033961|NCT02058160|464414161|FG001|Overall Study|Poor compliance to protocol|1|||
129033962|NCT02058160|464414160|FG000|Overall Study|Adverse Event|12|||
129033963|NCT02058160|464414161|FG001|Overall Study|Adverse Event|3|||
129033964|NCT02058160|464414160|FG000|Overall Study|Lost to Follow-up|1|||
128708463|NCT05109442|463226459|FG000|Overall Study|Adverse Event|0|||
128708464|NCT05109442|463226460|FG001|Overall Study|Adverse Event|1|||
128708465|NCT05109442|463226461|FG002|Overall Study|Adverse Event|5|||
128708466|NCT05109442|463226462|FG003|Overall Study|Adverse Event|0|||
128708467|NCT05109442|463226463|FG004|Overall Study|Adverse Event|0|||
128708468|NCT05109442|463226464|FG005|Overall Study|Adverse Event|2|||
128708469|NCT05109442|463226459|FG000|Overall Study|Death|0|||
128708470|NCT05109442|463226460|FG001|Overall Study|Death|0|||
128708471|NCT05109442|463226461|FG002|Overall Study|Death|4|||
128708472|NCT05109442|463226462|FG003|Overall Study|Death|0|||
128708473|NCT05109442|463226463|FG004|Overall Study|Death|0|||
128708474|NCT05109442|463226464|FG005|Overall Study|Death|1|||
129033965|NCT02058160|464414161|FG001|Overall Study|Lost to Follow-up|0|||
129033966|NCT02058160|464414160|FG000|Overall Study|Other than specified above|12|||
129033967|NCT02058160|464414161|FG001|Overall Study|Other than specified above|6|||
129033968|NCT02260635|464414162|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
129033969|NCT02260635|464414163|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
129033970|NCT02260635|464414162|FG000|Open-Label Extension|Study Termination|25|||
129033971|NCT02260635|464414163|FG001|Open-Label Extension|Study Termination|25|||
129033972|NCT02260635|464414162|FG000|Open-Label Extension|Withdrawal by Subject|1|||
129033973|NCT02260635|464414163|FG001|Open-Label Extension|Withdrawal by Subject|0|||
129033974|NCT04106817|464414164|FG000|Overall Study|Lost to Follow-up|1|||
128708475|NCT05109442|463226459|FG000|Overall Study|Physician Decision|1|||
128708476|NCT05109442|463226460|FG001|Overall Study|Physician Decision|0|||
129033975|NCT04106817|464414165|FG001|Overall Study|Lost to Follow-up|0|||
129033976|NCT04106817|464414166|FG002|Overall Study|Lost to Follow-up|0|||
129033977|NCT00152516|464414167|FG000|Overall Study|Adverse Event|18|||
129033978|NCT00152516|464414167|FG000|Overall Study|Lack and Loss of Efficacy|30|||
129033979|NCT00152516|464414167|FG000|Overall Study|Lost to Follow-up|5|||
129033980|NCT00152516|464414167|FG000|Overall Study|Withdrawal by Subject|8|||
129033981|NCT00152516|464414167|FG000|Overall Study|Protocol Violation|3|||
129033982|NCT00152516|464414167|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
129033983|NCT00152516|464414167|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
129033984|NCT00152516|464414167|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
129033985|NCT00152516|464414167|FG000|Overall Study|Other: Non-Compliance|2|||
129033986|NCT00152516|464414167|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
129033987|NCT00152516|464414167|FG000|Overall Study|Other: Moved Out Of State|1|||
129033988|NCT00152516|464414167|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
129033989|NCT00152516|464414167|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
129033990|NCT02289820|464414168|FG000|Overall Study|Withdrawal by Subject|2|||
129033991|NCT02289820|464414169|FG001|Overall Study|Withdrawal by Subject|1|||
129033992|NCT02289820|464414170|FG002|Overall Study|Withdrawal by Subject|2|||
129033993|NCT02289820|464414171|FG003|Overall Study|Withdrawal by Subject|1|||
129033994|NCT02289820|464414172|FG004|Overall Study|Withdrawal by Subject|0|||
129033995|NCT02289820|464414173|FG005|Overall Study|Withdrawal by Subject|0|||
129218028|NCT00785785|465098525|FG000|Optional Extension Phase|Death|1|||
129218029|NCT00785785|465098526|FG001|Optional Extension Phase|Death|5|||
129218030|NCT00785785|465098525|FG000|Optional Extension Phase|Disease progression|22|||
129218031|NCT00785785|465098526|FG001|Optional Extension Phase|Disease progression|70|||
128708477|NCT05109442|463226461|FG002|Overall Study|Physician Decision|1|||
128708478|NCT05109442|463226462|FG003|Overall Study|Physician Decision|0|||
129033996|NCT02289820|464414174|FG006|Overall Study|Withdrawal by Subject|1|||
129033997|NCT02289820|464414168|FG000|Overall Study|Death|0|||
129033998|NCT02289820|464414169|FG001|Overall Study|Death|0|||
129033999|NCT02289820|464414170|FG002|Overall Study|Death|1|||
129034000|NCT02289820|464414171|FG003|Overall Study|Death|0|||
129034001|NCT02289820|464414172|FG004|Overall Study|Death|0|||
129034002|NCT02289820|464414173|FG005|Overall Study|Death|0|||
129034003|NCT02289820|464414174|FG006|Overall Study|Death|0|||
129034004|NCT02289820|464414168|FG000|Overall Study|Lost to Follow-up|0|||
129034005|NCT02289820|464414169|FG001|Overall Study|Lost to Follow-up|0|||
129034006|NCT02289820|464414170|FG002|Overall Study|Lost to Follow-up|3|||
129034007|NCT02289820|464414171|FG003|Overall Study|Lost to Follow-up|1|||
129034008|NCT02289820|464414172|FG004|Overall Study|Lost to Follow-up|0|||
129034009|NCT02289820|464414173|FG005|Overall Study|Lost to Follow-up|1|||
129034010|NCT02289820|464414174|FG006|Overall Study|Lost to Follow-up|1|||
129034011|NCT02289820|464414168|FG000|Overall Study|withdrawal of consent|0|||
129034012|NCT02289820|464414169|FG001|Overall Study|withdrawal of consent|1|||
129034013|NCT02289820|464414170|FG002|Overall Study|withdrawal of consent|0|||
129034014|NCT02289820|464414171|FG003|Overall Study|withdrawal of consent|0|||
128708479|NCT05109442|463226463|FG004|Overall Study|Physician Decision|0|||
129034015|NCT02289820|464414172|FG004|Overall Study|withdrawal of consent|0|||
128708480|NCT05109442|463226464|FG005|Overall Study|Physician Decision|2|||
128708481|NCT05109442|463226459|FG000|Overall Study|Other than listed|0|||
128708482|NCT05109442|463226460|FG001|Overall Study|Other than listed|0|||
128708483|NCT05109442|463226461|FG002|Overall Study|Other than listed|9|||
128708484|NCT05109442|463226462|FG003|Overall Study|Other than listed|2|||
128708485|NCT05109442|463226463|FG004|Overall Study|Other than listed|0|||
128708486|NCT05109442|463226464|FG005|Overall Study|Other than listed|8|||
128708487|NCT05109442|463226459|FG000|Overall Study|Lack of Efficacy|3|||
128708488|NCT05109442|463226460|FG001|Overall Study|Lack of Efficacy|5|||
128708489|NCT05109442|463226461|FG002|Overall Study|Lack of Efficacy|29|||
128708490|NCT05109442|463226462|FG003|Overall Study|Lack of Efficacy|10|||
128708491|NCT05109442|463226463|FG004|Overall Study|Lack of Efficacy|11|||
128708492|NCT05109442|463226464|FG005|Overall Study|Lack of Efficacy|17|||
128708493|NCT04853225|463226465|FG000|Overall Study|Withdrawal by Subject|81|||
128708494|NCT04853225|463226466|FG001|Overall Study|Withdrawal by Subject|4|||
128708495|NCT04853225|463226467|FG002|Overall Study|Withdrawal by Subject|1|||
128708496|NCT04853225|463226465|FG000|Overall Study|Physician Decision|12|||
128708497|NCT04853225|463226466|FG001|Overall Study|Physician Decision|4|||
128708498|NCT04853225|463226467|FG002|Overall Study|Physician Decision|1|||
128708499|NCT04853225|463226465|FG000|Overall Study|Lost to Follow-up|50|||
128708500|NCT04853225|463226466|FG001|Overall Study|Lost to Follow-up|0|||
128946843|NCT00831441|464092216|FG000|Randomized|Physician Decision|26|||
128946844|NCT00831441|464092217|FG001|Randomized|Physician Decision|35|||
128946845|NCT00831441|464092216|FG000|Randomized|No longer met criteria|13|||
128946846|NCT00831441|464092217|FG001|Randomized|No longer met criteria|19|||
128946847|NCT00831441|464092216|FG000|Randomized|Withdrawal by Subject|178|||
128946848|NCT00831441|464092217|FG001|Randomized|Withdrawal by Subject|212|||
128946849|NCT00831441|464092216|FG000|Randomized|Lost to Follow-up|26|||
128946850|NCT00831441|464092217|FG001|Randomized|Lost to Follow-up|35|||
128946851|NCT00831441|464092216|FG000|Randomized|Administrative reason by sponsor|2780|||
128946852|NCT00831441|464092217|FG001|Randomized|Administrative reason by sponsor|2671|||
128946853|NCT00831441|464092216|FG000|Randomized|poor/non-compliance|30|||
128946854|NCT00831441|464092217|FG001|Randomized|poor/non-compliance|38|||
128946855|NCT00831441|464092216|FG000|Randomized|non-specified|276|||
128946856|NCT00831441|464092217|FG001|Randomized|non-specified|266|||
128946857|NCT00831441|464092216|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
128946858|NCT00831441|464092217|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
128946859|NCT00831441|464092216|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
128946860|NCT00831441|464092217|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
128946861|NCT00831441|464092216|FG000|Follow Up (30 Days)|Death|63|||
128946862|NCT00831441|464092217|FG001|Follow Up (30 Days)|Death|86|||
128946863|NCT00831441|464092216|FG000|Follow Up (30 Days)|non-specified|16|||
128946864|NCT00831441|464092217|FG001|Follow Up (30 Days)|non-specified|26|||
128946865|NCT00831441|464092216|FG000|Follow Up (30 Days)|missing end of study status|0|||
128946866|NCT00831441|464092217|FG001|Follow Up (30 Days)|missing end of study status|1|||
128946867|NCT05674344|464092218|FG000|Overall Study|Screen Fail|21|||
128946868|NCT05674344|464092218|FG000|Overall Study|Incomplete study procedures|3|||
128946869|NCT00111917|464092219|FG000|Overall Study|Withdrawal by Subject|1|||
128946870|NCT00111917|464092220|FG001|Overall Study|Withdrawal by Subject|1|||
128946871|NCT00960934|464092221|FG000|Overall Study|Adverse Event|2|||
128946872|NCT00960934|464092222|FG001|Overall Study|Adverse Event|3|||
128946873|NCT00960934|464092223|FG002|Overall Study|Adverse Event|3|||
128946874|NCT00960934|464092224|FG003|Overall Study|Adverse Event|2|||
128946875|NCT00960934|464092225|FG004|Overall Study|Adverse Event|4|||
128946876|NCT00960934|464092226|FG005|Overall Study|Adverse Event|3|||
128946877|NCT00960934|464092221|FG000|Overall Study|Lack of Efficacy|1|||
128946878|NCT00960934|464092222|FG001|Overall Study|Lack of Efficacy|0|||
128708501|NCT04853225|463226467|FG002|Overall Study|Lost to Follow-up|0|||
128708502|NCT04853225|463226465|FG000|Overall Study|Other|102|||
128708503|NCT04853225|463226466|FG001|Overall Study|Other|11|||
128708504|NCT04853225|463226467|FG002|Overall Study|Other|5|||
128708505|NCT04853225|463226465|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
128946879|NCT00960934|464092223|FG002|Overall Study|Lack of Efficacy|0|||
128946880|NCT00960934|464092224|FG003|Overall Study|Lack of Efficacy|0|||
128946881|NCT00960934|464092225|FG004|Overall Study|Lack of Efficacy|0|||
128708506|NCT04853225|463226466|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
128708507|NCT04853225|463226467|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
128946882|NCT00960934|464092226|FG005|Overall Study|Lack of Efficacy|0|||
128946883|NCT00960934|464092221|FG000|Overall Study|Lost to Follow-up|0|||
128946884|NCT00960934|464092222|FG001|Overall Study|Lost to Follow-up|1|||
128946885|NCT00960934|464092223|FG002|Overall Study|Lost to Follow-up|0|||
128708508|NCT04853225|463226465|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
128946886|NCT00960934|464092224|FG003|Overall Study|Lost to Follow-up|0|||
128946887|NCT00960934|464092225|FG004|Overall Study|Lost to Follow-up|0|||
128946888|NCT00960934|464092226|FG005|Overall Study|Lost to Follow-up|0|||
128770334|NCT00118092|463450214|FG000|Overall Study|Protocol Violation|1|||
128946889|NCT00960934|464092221|FG000|Overall Study|Other|2|||
128946890|NCT00960934|464092222|FG001|Overall Study|Other|1|||
128946891|NCT00960934|464092223|FG002|Overall Study|Other|5|||
128946892|NCT00960934|464092224|FG003|Overall Study|Other|4|||
128946893|NCT00960934|464092225|FG004|Overall Study|Other|2|||
128946894|NCT00960934|464092226|FG005|Overall Study|Other|2|||
128946895|NCT00960934|464092221|FG000|Overall Study|Physician Decision|0|||
128946896|NCT00960934|464092222|FG001|Overall Study|Physician Decision|1|||
128946897|NCT00960934|464092223|FG002|Overall Study|Physician Decision|0|||
128946898|NCT00960934|464092224|FG003|Overall Study|Physician Decision|0|||
128946899|NCT00960934|464092225|FG004|Overall Study|Physician Decision|0|||
128946900|NCT00960934|464092226|FG005|Overall Study|Physician Decision|0|||
128946901|NCT00960934|464092221|FG000|Overall Study|Progressive Disease|1|||
128946902|NCT00960934|464092222|FG001|Overall Study|Progressive Disease|1|||
128946903|NCT00960934|464092223|FG002|Overall Study|Progressive Disease|0|||
128946904|NCT00960934|464092224|FG003|Overall Study|Progressive Disease|0|||
128946905|NCT00960934|464092225|FG004|Overall Study|Progressive Disease|1|||
128946906|NCT00960934|464092226|FG005|Overall Study|Progressive Disease|1|||
128946907|NCT00960934|464092221|FG000|Overall Study|Protocol Violation|3|||
128946908|NCT00960934|464092222|FG001|Overall Study|Protocol Violation|4|||
128946909|NCT00960934|464092223|FG002|Overall Study|Protocol Violation|0|||
128946910|NCT00960934|464092224|FG003|Overall Study|Protocol Violation|3|||
128946911|NCT00960934|464092225|FG004|Overall Study|Protocol Violation|3|||
128946912|NCT00960934|464092226|FG005|Overall Study|Protocol Violation|2|||
128946913|NCT00960934|464092221|FG000|Overall Study|Withdrawal by Subject|5|||
128946914|NCT00960934|464092222|FG001|Overall Study|Withdrawal by Subject|6|||
128946915|NCT00960934|464092223|FG002|Overall Study|Withdrawal by Subject|4|||
128946916|NCT00960934|464092224|FG003|Overall Study|Withdrawal by Subject|5|||
128946917|NCT00960934|464092225|FG004|Overall Study|Withdrawal by Subject|5|||
128946918|NCT00960934|464092226|FG005|Overall Study|Withdrawal by Subject|7|||
128946919|NCT00960934|464092221|FG000|Overall Study|Study Terminated by Sponsor|50|||
128946920|NCT00960934|464092222|FG001|Overall Study|Study Terminated by Sponsor|46|||
128946921|NCT00960934|464092223|FG002|Overall Study|Study Terminated by Sponsor|52|||
128946922|NCT00960934|464092224|FG003|Overall Study|Study Terminated by Sponsor|50|||
128946923|NCT00960934|464092225|FG004|Overall Study|Study Terminated by Sponsor|49|||
128946924|NCT00960934|464092226|FG005|Overall Study|Study Terminated by Sponsor|49|||
128946925|NCT05254613|464092232|FG000|Overall Study|Lost to Follow-up|0|||
128946926|NCT05254613|464092233|FG001|Overall Study|Lost to Follow-up|0|||
128946927|NCT05254613|464092234|FG002|Overall Study|Lost to Follow-up|1|||
128946928|NCT00839423|464092237|FG000|Overall Study|Adverse Event|4|||
128946929|NCT00839423|464092238|FG001|Overall Study|Adverse Event|3|||
128946930|NCT00839423|464092239|FG002|Overall Study|Adverse Event|7|||
128946931|NCT00839423|464092240|FG003|Overall Study|Adverse Event|16|||
128946932|NCT00839423|464092237|FG000|Overall Study|Lack of Efficacy|6|||
128946933|NCT00839423|464092238|FG001|Overall Study|Lack of Efficacy|6|||
129034016|NCT02289820|464414173|FG005|Overall Study|withdrawal of consent|0|||
129034017|NCT02289820|464414174|FG006|Overall Study|withdrawal of consent|0|||
129034018|NCT00926367|464414177|FG000|Overall Study|Withdrawal by Subject|0|||
129034019|NCT00926367|464414178|FG001|Overall Study|Withdrawal by Subject|1|||
129034020|NCT00926367|464414177|FG000|Overall Study|Lost to Follow-up|1|||
129034021|NCT00926367|464414178|FG001|Overall Study|Lost to Follow-up|0|||
129034022|NCT00926367|464414177|FG000|Overall Study|Skin Irritation|1|||
129034023|NCT00926367|464414178|FG001|Overall Study|Skin Irritation|2|||
129034024|NCT02725411|464414179|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
129034025|NCT02725411|464414180|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
129034026|NCT02725411|464414181|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
129034027|NCT02725411|464414179|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
129034028|NCT02725411|464414180|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
129034029|NCT02725411|464414181|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
129034030|NCT02725411|464414179|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
129034031|NCT02725411|464414180|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
129034032|NCT02725411|464414181|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
129034033|NCT02725411|464414179|FG000|Treatment Period (56 Weeks)|Other|1|||
129034034|NCT02725411|464414180|FG001|Treatment Period (56 Weeks)|Other|4|||
129034035|NCT02725411|464414181|FG002|Treatment Period (56 Weeks)|Other|5|||
129034036|NCT02725411|464414179|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
129034037|NCT02725411|464414180|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
129034038|NCT02725411|464414181|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
129034039|NCT02725411|464414179|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
129034040|NCT02725411|464414180|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
129034041|NCT02725411|464414181|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
129034042|NCT02725411|464414179|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
129034043|NCT02725411|464414180|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
129034044|NCT02725411|464414181|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
129034045|NCT02725411|464414179|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
129034046|NCT02725411|464414180|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
129034047|NCT02725411|464414181|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
129034048|NCT02725411|464414179|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
129034049|NCT02725411|464414180|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
128946934|NCT00839423|464092239|FG002|Overall Study|Lack of Efficacy|3|||
128946935|NCT00839423|464092240|FG003|Overall Study|Lack of Efficacy|2|||
128946936|NCT00839423|464092237|FG000|Overall Study|Non-compliance|0|||
128946937|NCT00839423|464092238|FG001|Overall Study|Non-compliance|0|||
128946938|NCT00839423|464092239|FG002|Overall Study|Non-compliance|0|||
128946939|NCT00839423|464092240|FG003|Overall Study|Non-compliance|1|||
128946940|NCT00839423|464092237|FG000|Overall Study|Protocol Violation|0|||
128946941|NCT00839423|464092238|FG001|Overall Study|Protocol Violation|1|||
128946942|NCT00839423|464092239|FG002|Overall Study|Protocol Violation|2|||
128946943|NCT00839423|464092240|FG003|Overall Study|Protocol Violation|0|||
128946944|NCT00839423|464092237|FG000|Overall Study|Withdrawal of consent|4|||
128946945|NCT00839423|464092238|FG001|Overall Study|Withdrawal of consent|0|||
128946946|NCT00839423|464092239|FG002|Overall Study|Withdrawal of consent|4|||
128946947|NCT00839423|464092240|FG003|Overall Study|Withdrawal of consent|1|||
128946948|NCT00839423|464092237|FG000|Overall Study|Lost to Follow-up|1|||
128946949|NCT00839423|464092238|FG001|Overall Study|Lost to Follow-up|0|||
128946950|NCT00839423|464092239|FG002|Overall Study|Lost to Follow-up|1|||
128946951|NCT00839423|464092240|FG003|Overall Study|Lost to Follow-up|0|||
128946952|NCT00839423|464092237|FG000|Overall Study|Administrative or other reasons|3|||
128946953|NCT00839423|464092238|FG001|Overall Study|Administrative or other reasons|0|||
128946954|NCT00839423|464092239|FG002|Overall Study|Administrative or other reasons|1|||
128946955|NCT00839423|464092240|FG003|Overall Study|Administrative or other reasons|0|||
128946956|NCT02387372|464092241|FG000|Overall Study|Not Treated|1|||
128946957|NCT02387372|464092242|FG001|Overall Study|Not Treated|0|||
128946958|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
128946959|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
128946960|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
128946961|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
128946962|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
128946963|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
128946964|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
128946965|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
128946966|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
128946967|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
128946968|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
128946969|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
128946970|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
128946971|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
128946972|NCT00848549|464092243|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
128946973|NCT00848549|464092244|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
128946974|NCT00848549|464092243|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
128946975|NCT00848549|464092244|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
128946976|NCT00848549|464092243|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
128946977|NCT00848549|464092244|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
128946978|NCT00848549|464092243|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
128946979|NCT00848549|464092244|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
128946980|NCT00848549|464092243|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
129123851|NCT03405870|464749423|FG002|Overall Study|Withdrawal|1|||
129123852|NCT03405870|464749424|FG003|Overall Study|Withdrawal|0|||
129123853|NCT03405870|464749425|FG004|Overall Study|Withdrawal|0|||
129123854|NCT03405870|464749426|FG005|Overall Study|Withdrawal|0|||
129123855|NCT03405870|464749427|FG006|Overall Study|Withdrawal|1|||
129123856|NCT03405870|464749428|FG007|Overall Study|Withdrawal|0|||
129123857|NCT05172609|464749429|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
129123858|NCT05172609|464749430|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
129123859|NCT05172609|464749429|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
129123860|NCT05172609|464749430|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
129123861|NCT05172609|464749429|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
129123862|NCT05172609|464749430|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
129123863|NCT03737994|464749431|FG000|Overall Study|Withdrawal by Subject|0|||
129123864|NCT03737994|464749432|FG001|Overall Study|Withdrawal by Subject|0|||
129123865|NCT03737994|464749433|FG002|Overall Study|Withdrawal by Subject|0|||
129123866|NCT03737994|464749434|FG003|Overall Study|Withdrawal by Subject|0|||
129123867|NCT03737994|464749435|FG004|Overall Study|Withdrawal by Subject|0|||
129123868|NCT03737994|464749436|FG005|Overall Study|Withdrawal by Subject|0|||
129123869|NCT03737994|464749437|FG006|Overall Study|Withdrawal by Subject|1|||
129123870|NCT03846479|464749438|FG000|Overall Study|Death|8|||
129123871|NCT03846479|464749438|FG000|Overall Study|Lost to Follow-up|1|||
129123872|NCT01473134|464749439|FG000|Overall Study|Lost to Follow-up|21|||
129218032|NCT00785785|465098525|FG000|Optional Extension Phase|Protocol deviation|0|||
128770335|NCT02736968|463450222|FG000|Overall Study|Lost to Follow-up|0|||
129123873|NCT01473134|464749440|FG001|Overall Study|Lost to Follow-up|13|||
128708509|NCT04853225|463226466|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
128708510|NCT04853225|463226467|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
128708511|NCT02700815|463228418|FG000|Overall Study|Adverse Event|0|||
128708512|NCT02700815|463228419|FG001|Overall Study|Adverse Event|6|||
128708513|NCT02700815|463228420|FG002|Overall Study|Adverse Event|2|||
128708514|NCT02700815|463228421|FG003|Overall Study|Adverse Event|3|||
128708515|NCT02700815|463228418|FG000|Overall Study|Lack of Efficacy|0|||
128708516|NCT02700815|463228419|FG001|Overall Study|Lack of Efficacy|0|||
128708517|NCT02700815|463228420|FG002|Overall Study|Lack of Efficacy|1|||
128708518|NCT02700815|463228421|FG003|Overall Study|Lack of Efficacy|2|||
128708519|NCT02700815|463228418|FG000|Overall Study|Lost to Follow-up|1|||
128708520|NCT02700815|463228419|FG001|Overall Study|Lost to Follow-up|0|||
128708521|NCT02700815|463228420|FG002|Overall Study|Lost to Follow-up|0|||
128708522|NCT02700815|463228421|FG003|Overall Study|Lost to Follow-up|1|||
128708523|NCT02700815|463228418|FG000|Overall Study|Refusal to continue medication|0|||
128708524|NCT02700815|463228419|FG001|Overall Study|Refusal to continue medication|1|||
128708525|NCT02700815|463228420|FG002|Overall Study|Refusal to continue medication|0|||
128708526|NCT02700815|463228421|FG003|Overall Study|Refusal to continue medication|1|||
128708527|NCT02700815|463228418|FG000|Overall Study|Withdrawal by Subject|0|||
128708528|NCT02700815|463228419|FG001|Overall Study|Withdrawal by Subject|0|||
128708529|NCT02700815|463228420|FG002|Overall Study|Withdrawal by Subject|1|||
128708530|NCT02700815|463228421|FG003|Overall Study|Withdrawal by Subject|0|||
128708531|NCT04983264|463228430|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
128708532|NCT04983264|463228431|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
128708533|NCT04983264|463228432|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
128708534|NCT04983264|463228430|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
128708535|NCT04983264|463228431|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
128708536|NCT04983264|463228432|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
128708537|NCT02551731|463228439|FG000|Overall Study|Withdrawal by Subject|2|||
128708538|NCT03765918|463228442|FG000|Overall Study|Death|109|||
128946981|NCT00848549|464092244|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
128946982|NCT00848549|464092243|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
128946983|NCT00848549|464092244|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
128946984|NCT00848549|464092243|FG000|E2090-E044-314 (Extension Study)|Other|5|||
128946985|NCT00848549|464092244|FG001|E2090-E044-314 (Extension Study)|Other|6|||
128946986|NCT02106455|464092245|FG000|Overall Study|Case Report Form Uncollected|6|||
128946987|NCT02106455|464092245|FG000|Overall Study|Protocol Deviation|2|||
128946988|NCT01576016|464092249|FG000|Lead Safety|Death|132|||
128946989|NCT01576016|464092250|FG001|Lead Safety|Death|0|||
128946990|NCT01576016|464092249|FG000|Lead Safety|Withdrawal by Subject|81|||
128946991|NCT01576016|464092250|FG001|Lead Safety|Withdrawal by Subject|0|||
128946992|NCT01576016|464092249|FG000|Lead Safety|System Explanted without Replacement|24|||
128946993|NCT01576016|464092250|FG001|Lead Safety|System Explanted without Replacement|0|||
128946994|NCT01576016|464092249|FG000|Lead Safety|Physician Decision|14|||
128946995|NCT01576016|464092250|FG001|Lead Safety|Physician Decision|0|||
128946996|NCT01576016|464092249|FG000|Lead Safety|Lost to Follow-up|13|||
128946997|NCT01576016|464092250|FG001|Lead Safety|Lost to Follow-up|0|||
128946998|NCT01576016|464092249|FG000|Lead Safety|Unsuccessful implant|2|||
128946999|NCT01576016|464092250|FG001|Lead Safety|Unsuccessful implant|0|||
128947000|NCT01576016|464092249|FG000|Lead Safety|Sponsor request|1|||
128947001|NCT01576016|464092250|FG001|Lead Safety|Sponsor request|0|||
128947002|NCT01576016|464092249|FG000|Lead Safety|Device replaced with CRT-D|1|||
128947003|NCT01576016|464092250|FG001|Lead Safety|Device replaced with CRT-D|0|||
128947004|NCT01576016|464092249|FG000|Lead Safety|Patient on Palliative Care|1|||
128947005|NCT01576016|464092250|FG001|Lead Safety|Patient on Palliative Care|0|||
128947006|NCT01576016|464092249|FG000|Lead Safety|Patient noncompliance|1|||
128947007|NCT01576016|464092250|FG001|Lead Safety|Patient noncompliance|0|||
128947008|NCT01576016|464092249|FG000|Lead Safety|Too far from study site|1|||
128947009|NCT01576016|464092250|FG001|Lead Safety|Too far from study site|0|||
128947010|NCT01576016|464092249|FG000|Lead Safety|System deactivated|1|||
129123874|NCT01473134|464749439|FG000|Overall Study|Protocol Violation|32|||
129123875|NCT01473134|464749440|FG001|Overall Study|Protocol Violation|19|||
128708539|NCT03765918|463228443|FG001|Overall Study|Death|127|||
128708540|NCT03765918|463228442|FG000|Overall Study|Lost to Follow-up|2|||
129123876|NCT01473134|464749439|FG000|Overall Study|Withdrawal by Subject|1|||
129123877|NCT01473134|464749440|FG001|Overall Study|Withdrawal by Subject|2|||
128708541|NCT03765918|463228443|FG001|Overall Study|Lost to Follow-up|3|||
128708542|NCT03765918|463228442|FG000|Overall Study|Withdrawal by Subject|12|||
128708543|NCT03765918|463228443|FG001|Overall Study|Withdrawal by Subject|16|||
128708544|NCT03765918|463228442|FG000|Overall Study|Participants Ongoing|240|||
128708545|NCT03765918|463228443|FG001|Overall Study|Participants Ongoing|205|||
128947011|NCT01576016|464092250|FG001|Lead Safety|System deactivated|0|||
128947012|NCT01576016|464092249|FG000|Lead Safety|Patient no longer followed by study PI|1|||
128947013|NCT01576016|464092250|FG001|Lead Safety|Patient no longer followed by study PI|0|||
128947014|NCT01576016|464092249|FG000|MRI Safety|Withdrawal by Subject|0|||
128947015|NCT01576016|464092250|FG001|MRI Safety|Withdrawal by Subject|10|||
129034050|NCT02725411|464414181|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
129034051|NCT02725411|464414179|FG000|Follow-up Period (24 Weeks)|Other|1|||
129034052|NCT02725411|464414180|FG001|Follow-up Period (24 Weeks)|Other|4|||
129034053|NCT02725411|464414181|FG002|Follow-up Period (24 Weeks)|Other|2|||
129034054|NCT02725411|464414179|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
129034055|NCT02725411|464414180|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
129034056|NCT02725411|464414181|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
129034057|NCT03847974|464414188|FG000|Overall Study|relocated out of region|3|||
129034058|NCT03847974|464414188|FG000|Overall Study|Withdrawal by Subject|2|||
129034059|NCT03847974|464414188|FG000|Overall Study|Adverse Event|1|||
129034060|NCT01924364|464414189|FG000|Overall Study|Physician Decision|3|||
129034061|NCT02911935|464414190|FG000|Overall Study|Lost to Follow-up|5|||
129034062|NCT02911935|464414191|FG001|Overall Study|Lost to Follow-up|7|||
129034063|NCT01685216|464414194|FG000|Overall Study|Did not receive study drug|1|||
128947016|NCT01576016|464092249|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
128947017|NCT01576016|464092250|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
128947018|NCT01576016|464092249|FG000|MRI Safety|Has not yet completed MRI scan|0|||
128947019|NCT01576016|464092250|FG001|MRI Safety|Has not yet completed MRI scan|56|||
128947020|NCT01576016|464092249|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
128947021|NCT01576016|464092250|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
128947022|NCT02488551|464092251|FG000|Overall Study|Lost to Follow-up|4|||
128947023|NCT02488551|464092252|FG001|Overall Study|Lost to Follow-up|7|||
128947024|NCT02488551|464092253|FG002|Overall Study|Lost to Follow-up|0|||
128947025|NCT02488551|464092254|FG003|Overall Study|Lost to Follow-up|0|||
128947026|NCT02488551|464092251|FG000|Overall Study|Military Deployment|1|||
128947027|NCT02488551|464092252|FG001|Overall Study|Military Deployment|1|||
128947028|NCT02488551|464092253|FG002|Overall Study|Military Deployment|0|||
128947029|NCT02488551|464092254|FG003|Overall Study|Military Deployment|0|||
128947030|NCT03364608|464092257|FG000|Overall Study|Withdrawal by Subject|4|||
128947031|NCT03364608|464092257|FG000|Overall Study|Protocol Violation|2|||
128947032|NCT03364608|464092257|FG000|Overall Study|Lost to Follow-up|2|||
128947033|NCT00436566|464092264|FG000|Overall Study|Withdrawal by Subject|2|||
128947034|NCT00436566|464092264|FG000|Overall Study|Protocol Violation|1|||
128947035|NCT01188564|464092267|FG000|Double-blind Phase|randomized not treated|1|||
128947036|NCT01188564|464092268|FG001|Double-blind Phase|randomized not treated|0|||
128947037|NCT03888391|464092275|FG000|Overall Study|Lost to Follow-up|15|||
128947038|NCT01954251|464092277|FG000|Overall Study|Adverse Event|5|||
128947039|NCT01954251|464092278|FG001|Overall Study|Adverse Event|7|||
128947040|NCT01954251|464092277|FG000|Overall Study|Lost to Follow-up|6|||
128947041|NCT01954251|464092278|FG001|Overall Study|Lost to Follow-up|6|||
128947042|NCT01954251|464092277|FG000|Overall Study|Withdrawal by Subject|2|||
128947043|NCT01954251|464092278|FG001|Overall Study|Withdrawal by Subject|6|||
128947044|NCT02175771|464092279|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
128947045|NCT02175771|464092280|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128947046|NCT02175771|464092281|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128947047|NCT02175771|464092282|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128947048|NCT02175771|464092283|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128947049|NCT02175771|464092284|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129034064|NCT00685750|464414195|FG000|Overall Study|Tumor sampling failure|0|||
129034065|NCT00685750|464414196|FG001|Overall Study|Tumor sampling failure|0|||
129034066|NCT00685750|464414197|FG002|Overall Study|Tumor sampling failure|1|||
129034067|NCT00685750|464414198|FG003|Overall Study|Tumor sampling failure|0|||
129034068|NCT00685750|464414199|FG004|Overall Study|Tumor sampling failure|0|||
129034069|NCT00685750|464414200|FG005|Overall Study|Tumor sampling failure|0|||
129034070|NCT00685750|464414201|FG006|Overall Study|Tumor sampling failure|0|||
129034071|NCT00685750|464414195|FG000|Overall Study|Patient didn't receive the treatment|0|||
129034072|NCT00685750|464414196|FG001|Overall Study|Patient didn't receive the treatment|0|||
129034073|NCT00685750|464414197|FG002|Overall Study|Patient didn't receive the treatment|0|||
129034074|NCT00685750|464414198|FG003|Overall Study|Patient didn't receive the treatment|0|||
129034075|NCT00685750|464414199|FG004|Overall Study|Patient didn't receive the treatment|0|||
129034076|NCT00685750|464414200|FG005|Overall Study|Patient didn't receive the treatment|0|||
129034077|NCT00685750|464414201|FG006|Overall Study|Patient didn't receive the treatment|1|||
129034078|NCT00685750|464414195|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129034079|NCT00685750|464414196|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129034080|NCT00685750|464414197|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129034081|NCT00685750|464414198|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
129034082|NCT00685750|464414199|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129034083|NCT00685750|464414200|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
129034084|NCT00685750|464414201|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
129034085|NCT00250705|464414202|FG000|Overall Study|Lack of Efficacy|2|||
129034086|NCT02466386|464414203|FG000|Overall Study|Adverse Event|5|||
128947050|NCT02175771|464092285|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128947051|NCT02175771|464092286|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129123878|NCT01473134|464749439|FG000|Overall Study|Death|0|||
129123879|NCT01473134|464749440|FG001|Overall Study|Death|1|||
129123880|NCT01473134|464749439|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
129123881|NCT01473134|464749440|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
129123882|NCT05020015|464749443|FG000|Overall Study|Ongoing on study|1|||
129123883|NCT05020015|464749444|FG001|Overall Study|Ongoing on study|3|||
129123884|NCT05020015|464749445|FG002|Overall Study|Ongoing on study|4|||
129123885|NCT05020015|464749446|FG003|Overall Study|Ongoing on study|7|||
129123886|NCT05020015|464749443|FG000|Overall Study|Death|2|||
129123887|NCT05020015|464749444|FG001|Overall Study|Death|3|||
128770336|NCT02736968|463450223|FG001|Overall Study|Lost to Follow-up|0|||
128770337|NCT02736968|463450224|FG002|Overall Study|Lost to Follow-up|0|||
128770338|NCT02736968|463450225|FG003|Overall Study|Lost to Follow-up|0|||
128947052|NCT02175771|464092287|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128947053|NCT02175771|464092279|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
128947054|NCT02175771|464092280|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947055|NCT02175771|464092281|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947056|NCT02175771|464092282|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947057|NCT02175771|464092283|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947058|NCT02175771|464092284|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947059|NCT02175771|464092285|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947060|NCT02175771|464092286|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947061|NCT02175771|464092287|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128947062|NCT02175771|464092279|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
128947063|NCT02175771|464092280|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947064|NCT02175771|464092281|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947065|NCT02175771|464092282|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947066|NCT02175771|464092283|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947067|NCT02175771|464092284|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947068|NCT02175771|464092285|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947069|NCT02175771|464092286|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947070|NCT02175771|464092287|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128947071|NCT02175771|464092279|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
128947072|NCT02175771|464092280|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947073|NCT02175771|464092281|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947074|NCT02175771|464092282|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947075|NCT02175771|464092283|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947076|NCT02175771|464092284|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947077|NCT02175771|464092285|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947078|NCT02175771|464092286|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947079|NCT02175771|464092287|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
128947080|NCT02175771|464092279|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
128947081|NCT02175771|464092280|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947082|NCT02175771|464092281|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947083|NCT02175771|464092282|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947084|NCT02175771|464092283|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947085|NCT02175771|464092284|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947086|NCT02175771|464092285|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947087|NCT02175771|464092286|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947088|NCT02175771|464092287|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128947089|NCT02175771|464092279|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
128947090|NCT02175771|464092280|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947091|NCT02175771|464092281|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947092|NCT02175771|464092282|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947093|NCT02175771|464092283|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947094|NCT02175771|464092284|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947095|NCT02175771|464092285|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947096|NCT02175771|464092286|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947097|NCT02175771|464092287|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128947098|NCT02175771|464092279|FG000|Run-In Period (Pre-assignment)|Other|8|||
128947099|NCT02175771|464092280|FG001|Run-In Period (Pre-assignment)|Other|0|||
128947100|NCT02175771|464092281|FG002|Run-In Period (Pre-assignment)|Other|0|||
128947101|NCT02175771|464092282|FG003|Run-In Period (Pre-assignment)|Other|0|||
128947102|NCT02175771|464092283|FG004|Run-In Period (Pre-assignment)|Other|0|||
128947103|NCT02175771|464092284|FG005|Run-In Period (Pre-assignment)|Other|0|||
129123888|NCT05020015|464749445|FG002|Overall Study|Death|4|||
129123889|NCT05020015|464749446|FG003|Overall Study|Death|0|||
129123890|NCT05020015|464749443|FG000|Overall Study|Withdrawal by Subject|0|||
129123891|NCT05020015|464749444|FG001|Overall Study|Withdrawal by Subject|0|||
129123892|NCT05020015|464749445|FG002|Overall Study|Withdrawal by Subject|1|||
128947104|NCT02175771|464092285|FG006|Run-In Period (Pre-assignment)|Other|0|||
128947105|NCT02175771|464092286|FG007|Run-In Period (Pre-assignment)|Other|0|||
128947106|NCT02175771|464092287|FG008|Run-In Period (Pre-assignment)|Other|0|||
128947107|NCT02175771|464092279|FG000|Treatment Period|Adverse Event|0|||
128947108|NCT02175771|464092280|FG001|Treatment Period|Adverse Event|2|||
128947109|NCT02175771|464092281|FG002|Treatment Period|Adverse Event|1|||
128947110|NCT02175771|464092282|FG003|Treatment Period|Adverse Event|1|||
128947111|NCT02175771|464092283|FG004|Treatment Period|Adverse Event|1|||
128947112|NCT02175771|464092284|FG005|Treatment Period|Adverse Event|3|||
128947113|NCT02175771|464092285|FG006|Treatment Period|Adverse Event|2|||
128947114|NCT02175771|464092286|FG007|Treatment Period|Adverse Event|0|||
128947115|NCT02175771|464092287|FG008|Treatment Period|Adverse Event|1|||
128947116|NCT02175771|464092279|FG000|Treatment Period|Withdrawal by Subject|0|||
128947117|NCT02175771|464092280|FG001|Treatment Period|Withdrawal by Subject|9|||
128947118|NCT02175771|464092281|FG002|Treatment Period|Withdrawal by Subject|3|||
128947119|NCT02175771|464092282|FG003|Treatment Period|Withdrawal by Subject|6|||
128947120|NCT02175771|464092283|FG004|Treatment Period|Withdrawal by Subject|2|||
128947121|NCT02175771|464092284|FG005|Treatment Period|Withdrawal by Subject|4|||
128947122|NCT02175771|464092285|FG006|Treatment Period|Withdrawal by Subject|2|||
128947123|NCT02175771|464092286|FG007|Treatment Period|Withdrawal by Subject|9|||
128947124|NCT02175771|464092287|FG008|Treatment Period|Withdrawal by Subject|2|||
128947125|NCT02175771|464092279|FG000|Treatment Period|Noncompliance|0|||
128947126|NCT02175771|464092280|FG001|Treatment Period|Noncompliance|1|||
128947127|NCT02175771|464092281|FG002|Treatment Period|Noncompliance|2|||
128947128|NCT02175771|464092282|FG003|Treatment Period|Noncompliance|0|||
128947129|NCT02175771|464092283|FG004|Treatment Period|Noncompliance|0|||
128947130|NCT02175771|464092284|FG005|Treatment Period|Noncompliance|0|||
128947131|NCT02175771|464092285|FG006|Treatment Period|Noncompliance|0|||
128947132|NCT02175771|464092286|FG007|Treatment Period|Noncompliance|0|||
128947133|NCT02175771|464092287|FG008|Treatment Period|Noncompliance|1|||
128947134|NCT02175771|464092279|FG000|Treatment Period|Protocol Violation|0|||
128947135|NCT02175771|464092280|FG001|Treatment Period|Protocol Violation|0|||
128947136|NCT02175771|464092281|FG002|Treatment Period|Protocol Violation|0|||
128947137|NCT02175771|464092282|FG003|Treatment Period|Protocol Violation|0|||
128947138|NCT02175771|464092283|FG004|Treatment Period|Protocol Violation|0|||
128947139|NCT02175771|464092284|FG005|Treatment Period|Protocol Violation|0|||
128947140|NCT02175771|464092285|FG006|Treatment Period|Protocol Violation|0|||
128947141|NCT02175771|464092286|FG007|Treatment Period|Protocol Violation|1|||
129218033|NCT00785785|465098526|FG001|Optional Extension Phase|Protocol deviation|2|||
129218034|NCT00785785|465098525|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
128947142|NCT02175771|464092287|FG008|Treatment Period|Protocol Violation|0|||
128947143|NCT02175771|464092279|FG000|Treatment Period|Disease progression|0|||
128947144|NCT02175771|464092280|FG001|Treatment Period|Disease progression|0|||
128947145|NCT02175771|464092281|FG002|Treatment Period|Disease progression|0|||
128947146|NCT02175771|464092282|FG003|Treatment Period|Disease progression|0|||
128947147|NCT02175771|464092283|FG004|Treatment Period|Disease progression|0|||
128947148|NCT02175771|464092284|FG005|Treatment Period|Disease progression|0|||
128947149|NCT02175771|464092285|FG006|Treatment Period|Disease progression|0|||
128947150|NCT02175771|464092286|FG007|Treatment Period|Disease progression|2|||
128947151|NCT02175771|464092287|FG008|Treatment Period|Disease progression|0|||
128947152|NCT02175771|464092279|FG000|Treatment Period|Lost to Follow-up|0|||
128947153|NCT02175771|464092280|FG001|Treatment Period|Lost to Follow-up|3|||
128947154|NCT02175771|464092281|FG002|Treatment Period|Lost to Follow-up|1|||
128947155|NCT02175771|464092282|FG003|Treatment Period|Lost to Follow-up|3|||
128947156|NCT02175771|464092283|FG004|Treatment Period|Lost to Follow-up|1|||
128947157|NCT02175771|464092284|FG005|Treatment Period|Lost to Follow-up|2|||
128947158|NCT02175771|464092285|FG006|Treatment Period|Lost to Follow-up|1|||
128947159|NCT02175771|464092286|FG007|Treatment Period|Lost to Follow-up|2|||
128708546|NCT04202965|463228444|FG000|Overall Study|Adverse Event|3|||
128947160|NCT02175771|464092287|FG008|Treatment Period|Lost to Follow-up|2|||
128947161|NCT02175771|464092279|FG000|Treatment Period|Lack of Efficacy|0|||
128947162|NCT02175771|464092280|FG001|Treatment Period|Lack of Efficacy|0|||
128708547|NCT04202965|463228444|FG000|Overall Study|Did not meet inclusion criteria|1|||
128708548|NCT01678911|463228445|FG000|Second Intervention|Lost to Follow-up|2|||
128708549|NCT01678911|463228446|FG001|Second Intervention|Lost to Follow-up|0|||
128708550|NCT00356369|463228447|FG000|Active Phase|Withdrawal by Subject|2|||
128708551|NCT00356369|463228448|FG001|Active Phase|Withdrawal by Subject|1|||
128708552|NCT02117648|463228451|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
128708553|NCT02117648|463228451|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
128947163|NCT02175771|464092281|FG002|Treatment Period|Lack of Efficacy|0|||
128947164|NCT02175771|464092282|FG003|Treatment Period|Lack of Efficacy|0|||
128947165|NCT02175771|464092283|FG004|Treatment Period|Lack of Efficacy|0|||
128947166|NCT02175771|464092284|FG005|Treatment Period|Lack of Efficacy|1|||
128947167|NCT02175771|464092285|FG006|Treatment Period|Lack of Efficacy|0|||
128947168|NCT02175771|464092286|FG007|Treatment Period|Lack of Efficacy|1|||
128947169|NCT02175771|464092287|FG008|Treatment Period|Lack of Efficacy|0|||
128947170|NCT02175771|464092279|FG000|Treatment Period|Other|0|||
128947171|NCT02175771|464092280|FG001|Treatment Period|Other|1|||
128947172|NCT02175771|464092281|FG002|Treatment Period|Other|0|||
128947173|NCT02175771|464092282|FG003|Treatment Period|Other|3|||
128947174|NCT02175771|464092283|FG004|Treatment Period|Other|1|||
128947175|NCT02175771|464092284|FG005|Treatment Period|Other|0|||
128947176|NCT02175771|464092285|FG006|Treatment Period|Other|0|||
128947177|NCT02175771|464092286|FG007|Treatment Period|Other|2|||
128947178|NCT02175771|464092287|FG008|Treatment Period|Other|0|||
128947179|NCT02232087|464092288|FG000|Overall Study|Withdrawal by Subject|2|||
128947180|NCT02232087|464092289|FG001|Overall Study|Withdrawal by Subject|0|||
128947181|NCT02232087|464092290|FG002|Overall Study|Withdrawal by Subject|0|||
128947182|NCT02232087|464092291|FG003|Overall Study|Withdrawal by Subject|0|||
128947183|NCT02232087|464092292|FG004|Overall Study|Withdrawal by Subject|0|||
128947184|NCT02232087|464092293|FG005|Overall Study|Withdrawal by Subject|1|||
128947185|NCT02232087|464092288|FG000|Overall Study|poor inhalation technique|0|||
128947186|NCT02232087|464092289|FG001|Overall Study|poor inhalation technique|1|||
128947187|NCT02232087|464092290|FG002|Overall Study|poor inhalation technique|0|||
128947188|NCT02232087|464092291|FG003|Overall Study|poor inhalation technique|0|||
128947189|NCT02232087|464092292|FG004|Overall Study|poor inhalation technique|0|||
128947190|NCT02232087|464092293|FG005|Overall Study|poor inhalation technique|2|||
128947191|NCT02232087|464092288|FG000|Overall Study|protocol stop criteria|0|||
128947192|NCT02232087|464092289|FG001|Overall Study|protocol stop criteria|1|||
128947193|NCT02232087|464092290|FG002|Overall Study|protocol stop criteria|0|||
128947194|NCT02232087|464092291|FG003|Overall Study|protocol stop criteria|1|||
128947195|NCT02232087|464092292|FG004|Overall Study|protocol stop criteria|0|||
128947196|NCT02232087|464092293|FG005|Overall Study|protocol stop criteria|0|||
128947197|NCT02232087|464092288|FG000|Overall Study|Adverse Event|0|||
128947198|NCT02232087|464092289|FG001|Overall Study|Adverse Event|0|||
128947199|NCT02232087|464092290|FG002|Overall Study|Adverse Event|0|||
128947200|NCT02232087|464092291|FG003|Overall Study|Adverse Event|0|||
128947201|NCT02232087|464092292|FG004|Overall Study|Adverse Event|1|||
128947202|NCT02232087|464092293|FG005|Overall Study|Adverse Event|0|||
128947203|NCT04069156|464092294|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
128947204|NCT04069156|464092295|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
128947205|NCT04069156|464092294|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
128947206|NCT04069156|464092295|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
128947207|NCT04069156|464092294|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
128947208|NCT04069156|464092295|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
128947209|NCT04069156|464092294|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
128947210|NCT04069156|464092295|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
128947211|NCT02207556|464092296|FG000|Overall Study|Physician Decision|1|||
128947212|NCT02207556|464092297|FG001|Overall Study|Physician Decision|0|||
128947213|NCT02207556|464092296|FG000|Overall Study|Withdrawal by Subject|1|||
128947214|NCT02207556|464092297|FG001|Overall Study|Withdrawal by Subject|0|||
128947215|NCT02207556|464092296|FG000|Overall Study|Death|0|||
128947216|NCT02207556|464092297|FG001|Overall Study|Death|5|||
128947217|NCT03558555|464092298|FG000|Overall Study|Lost to Follow-up|2|||
128947218|NCT03558555|464092299|FG001|Overall Study|Lost to Follow-up|1|||
128947219|NCT01958125|464092300|FG000|Overall Study|Missing diary data|2|||
128947220|NCT01958125|464092301|FG001|Overall Study|Missing diary data|6|||
128947221|NCT01958125|464092300|FG000|Overall Study|No headache attacks|0|||
128947222|NCT01958125|464092301|FG001|Overall Study|No headache attacks|2|||
128947223|NCT01088438|464092326|FG000|Overall Study|Withdrawal by Subject|11|||
128947224|NCT01088438|464092327|FG001|Overall Study|Withdrawal by Subject|6|||
128708554|NCT02117648|463228451|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
128708555|NCT02117648|463228451|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
128708556|NCT02117648|463228451|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
128708557|NCT02117648|463228451|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
128708558|NCT02117648|463228451|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
128708559|NCT02117648|463228451|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
128708560|NCT02117648|463228451|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
128708561|NCT02117648|463228451|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
128708562|NCT02117648|463228451|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
128708563|NCT01985867|463228452|FG000|Overall Study|Lost to Follow-up|3|||
128708564|NCT01985867|463228453|FG001|Overall Study|Lost to Follow-up|4|||
128947225|NCT01088438|464092326|FG000|Overall Study|Lost to Follow-up|18|||
128947226|NCT01088438|464092327|FG001|Overall Study|Lost to Follow-up|30|||
128947227|NCT00511342|464092328|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
128947228|NCT00511342|464092329|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
128947229|NCT00511342|464092328|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
128947230|NCT00511342|464092329|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
128947231|NCT00511342|464092328|FG000|Overall Study|Pregnancy|0|||
128947232|NCT00511342|464092329|FG001|Overall Study|Pregnancy|1|||
128947233|NCT00511342|464092328|FG000|Overall Study|Pregnancy wish|0|||
128947234|NCT00511342|464092329|FG001|Overall Study|Pregnancy wish|1|||
128947235|NCT00511342|464092328|FG000|Overall Study|Lost to Follow-up|1|||
128947236|NCT00511342|464092329|FG001|Overall Study|Lost to Follow-up|5|||
128947237|NCT00511342|464092328|FG000|Overall Study|Other Reason|2|||
128947238|NCT00511342|464092329|FG001|Overall Study|Other Reason|2|||
128947239|NCT00668200|464092330|FG000|Overall Study|Withdrawal by Subject|2|||
128947240|NCT00668200|464092330|FG000|Overall Study|Lost to Follow-up|1|||
128947241|NCT01098461|464092332|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
128947242|NCT01098461|464092333|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
128947243|NCT01098461|464092334|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
128947244|NCT01098461|464092335|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
129123893|NCT05020015|464749446|FG003|Overall Study|Withdrawal by Subject|0|||
129123894|NCT05020015|464749443|FG000|Overall Study|Reason Not Specified|0|||
129123895|NCT05020015|464749444|FG001|Overall Study|Reason Not Specified|0|||
129123896|NCT05020015|464749445|FG002|Overall Study|Reason Not Specified|2|||
129123897|NCT05020015|464749446|FG003|Overall Study|Reason Not Specified|0|||
129123898|NCT04476043|464749449|FG000|Overall Study|Withdrawal by Subject|1|||
129123899|NCT04476043|464749450|FG001|Overall Study|Withdrawal by Subject|3|||
129123900|NCT04476043|464749451|FG002|Overall Study|Withdrawal by Subject|4|||
129123901|NCT04476043|464749452|FG003|Overall Study|Withdrawal by Subject|1|||
129123902|NCT04476043|464749449|FG000|Overall Study|Lost to Follow-up|1|||
129123903|NCT04476043|464749450|FG001|Overall Study|Lost to Follow-up|1|||
129123904|NCT04476043|464749451|FG002|Overall Study|Lost to Follow-up|2|||
129123905|NCT04476043|464749452|FG003|Overall Study|Lost to Follow-up|1|||
129123906|NCT04476043|464749449|FG000|Overall Study|Adverse Event|2|||
129123907|NCT04476043|464749450|FG001|Overall Study|Adverse Event|0|||
129123908|NCT04476043|464749451|FG002|Overall Study|Adverse Event|1|||
129123909|NCT04476043|464749452|FG003|Overall Study|Adverse Event|0|||
129123910|NCT04476043|464749449|FG000|Overall Study|Protocol Violation|0|||
129123911|NCT04476043|464749450|FG001|Overall Study|Protocol Violation|1|||
129123912|NCT04476043|464749451|FG002|Overall Study|Protocol Violation|0|||
129123913|NCT04476043|464749452|FG003|Overall Study|Protocol Violation|0|||
129123914|NCT06217380|464749453|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
129123915|NCT06217380|464749453|FG000|Overall Study|Physician Decision|1|||
129123916|NCT06217380|464749453|FG000|Overall Study|Withdrawal by Subject|2|||
129123917|NCT00614393|464749458|FG000|Overall Study|Adverse Event|20|||
129123918|NCT00614393|464749459|FG001|Overall Study|Adverse Event|2|||
129123919|NCT00614393|464749460|FG002|Overall Study|Adverse Event|3|||
129123920|NCT00614393|464749461|FG003|Overall Study|Adverse Event|13|||
129123921|NCT00614393|464749462|FG004|Overall Study|Adverse Event|21|||
129123922|NCT00614393|464749458|FG000|Overall Study|Lost to Follow-up|0|||
129123923|NCT00614393|464749459|FG001|Overall Study|Lost to Follow-up|0|||
129123924|NCT00614393|464749460|FG002|Overall Study|Lost to Follow-up|0|||
129123925|NCT00614393|464749461|FG003|Overall Study|Lost to Follow-up|1|||
129123926|NCT00614393|464749462|FG004|Overall Study|Lost to Follow-up|2|||
129123927|NCT00614393|464749458|FG000|Overall Study|Physician Decision|17|||
129123928|NCT00614393|464749459|FG001|Overall Study|Physician Decision|0|||
129123929|NCT00614393|464749460|FG002|Overall Study|Physician Decision|1|||
129123930|NCT00614393|464749461|FG003|Overall Study|Physician Decision|8|||
129123931|NCT00614393|464749462|FG004|Overall Study|Physician Decision|9|||
129123932|NCT00614393|464749458|FG000|Overall Study|Progressive Disease|118|||
128947245|NCT01098461|464092332|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
128947246|NCT01098461|464092333|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
128947247|NCT01098461|464092334|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
128947248|NCT01098461|464092335|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
128947249|NCT01098461|464092332|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
128947250|NCT01098461|464092333|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
128947251|NCT01098461|464092334|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
128947252|NCT01098461|464092335|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
128947253|NCT01098461|464092332|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
128947254|NCT01098461|464092333|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
128947255|NCT01098461|464092334|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
128947256|NCT01098461|464092335|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
128947257|NCT01098461|464092332|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
128947258|NCT01098461|464092333|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
128947259|NCT01098461|464092334|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
129123933|NCT00614393|464749459|FG001|Overall Study|Progressive Disease|5|||
129123934|NCT00614393|464749460|FG002|Overall Study|Progressive Disease|5|||
129123935|NCT00614393|464749461|FG003|Overall Study|Progressive Disease|138|||
129123936|NCT00614393|464749462|FG004|Overall Study|Progressive Disease|130|||
129123937|NCT00614393|464749458|FG000|Overall Study|Protocol Violation|1|||
129123938|NCT00614393|464749459|FG001|Overall Study|Protocol Violation|0|||
129123939|NCT00614393|464749460|FG002|Overall Study|Protocol Violation|0|||
129123940|NCT00614393|464749461|FG003|Overall Study|Protocol Violation|0|||
129123941|NCT00614393|464749462|FG004|Overall Study|Protocol Violation|0|||
129123942|NCT00614393|464749458|FG000|Overall Study|Terminated by Sponsor|0|||
129123943|NCT00614393|464749459|FG001|Overall Study|Terminated by Sponsor|0|||
128708565|NCT01985867|463228452|FG000|Overall Study|Adverse Event|3|||
128708566|NCT01985867|463228453|FG001|Overall Study|Adverse Event|2|||
128708567|NCT01985867|463228452|FG000|Overall Study|Lack of Efficacy|1|||
128708568|NCT01985867|463228453|FG001|Overall Study|Lack of Efficacy|0|||
128947260|NCT01098461|464092335|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
128947261|NCT01098461|464092332|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
128947262|NCT01098461|464092333|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
128947263|NCT01098461|464092334|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
128947264|NCT01098461|464092335|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
128947265|NCT01098461|464092332|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
128947266|NCT01098461|464092333|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
128947267|NCT01098461|464092334|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
128947268|NCT01098461|464092335|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
128947269|NCT03628508|464092336|FG000|Overall Study|Lost to Follow-up|1|||
128947270|NCT04570657|464092338|FG000|Overall Study|Adverse Event|0|||
128947271|NCT04570657|464092339|FG001|Overall Study|Adverse Event|0|||
128947272|NCT04570657|464092340|FG002|Overall Study|Adverse Event|1|||
128947273|NCT04570657|464092338|FG000|Overall Study|Lost to Follow-up|0|||
128947274|NCT04570657|464092339|FG001|Overall Study|Lost to Follow-up|0|||
128947275|NCT04570657|464092340|FG002|Overall Study|Lost to Follow-up|1|||
128947276|NCT04570657|464092338|FG000|Overall Study|Physician Decision|0|||
128947277|NCT04570657|464092339|FG001|Overall Study|Physician Decision|1|||
128947278|NCT04570657|464092340|FG002|Overall Study|Physician Decision|0|||
128947279|NCT04570657|464092338|FG000|Overall Study|Withdrawal by Subject|1|||
128947280|NCT04570657|464092339|FG001|Overall Study|Withdrawal by Subject|2|||
128947281|NCT04570657|464092340|FG002|Overall Study|Withdrawal by Subject|2|||
128947282|NCT01072539|464092341|FG000|Overall Study|Treated prior to the Site Initiation|1|||
128947283|NCT01072539|464092341|FG000|Overall Study|Protocol Violation|2|||
128947284|NCT00115804|464092344|FG000|Overall Study|Adverse Event|2|||
128947285|NCT01752842|464092345|FG000|Overall Study|Adverse Event|3|||
128947286|NCT01752842|464092346|FG001|Overall Study|Adverse Event|0|||
128947287|NCT01752842|464092345|FG000|Overall Study|Withdrawal by Subject|0|||
128947288|NCT01752842|464092346|FG001|Overall Study|Withdrawal by Subject|2|||
128947289|NCT01683071|464092347|FG000|Part 1|Lack of Efficacy|1|||
128947290|NCT01683071|464092348|FG001|Part 1|Lack of Efficacy|0|||
128947291|NCT01683071|464092349|FG002|Part 1|Lack of Efficacy|0|||
128947292|NCT01683071|464092350|FG003|Part 1|Lack of Efficacy|3|||
128947293|NCT01683071|464092351|FG004|Part 1|Lack of Efficacy|0|||
128947294|NCT01683071|464092352|FG005|Part 1|Lack of Efficacy|0|||
128947295|NCT01683071|464092347|FG000|Part 1|Withdrawal by Subject|1|||
128947296|NCT01683071|464092348|FG001|Part 1|Withdrawal by Subject|2|||
128947297|NCT01683071|464092349|FG002|Part 1|Withdrawal by Subject|2|||
128947298|NCT01683071|464092350|FG003|Part 1|Withdrawal by Subject|1|||
128947299|NCT01683071|464092351|FG004|Part 1|Withdrawal by Subject|0|||
128947300|NCT01683071|464092352|FG005|Part 1|Withdrawal by Subject|0|||
128947301|NCT01683071|464092347|FG000|Part 1|Surgery Cancelled|1|||
128947302|NCT01683071|464092348|FG001|Part 1|Surgery Cancelled|0|||
128947303|NCT01683071|464092349|FG002|Part 1|Surgery Cancelled|0|||
128947304|NCT01683071|464092350|FG003|Part 1|Surgery Cancelled|0|||
128947305|NCT01683071|464092351|FG004|Part 1|Surgery Cancelled|0|||
128947306|NCT01683071|464092352|FG005|Part 1|Surgery Cancelled|0|||
128947307|NCT01683071|464092347|FG000|Part 1|Did not receive study drug|1|||
128947308|NCT01683071|464092348|FG001|Part 1|Did not receive study drug|0|||
128947309|NCT01683071|464092349|FG002|Part 1|Did not receive study drug|0|||
128947310|NCT01683071|464092350|FG003|Part 1|Did not receive study drug|1|||
128947311|NCT01683071|464092351|FG004|Part 1|Did not receive study drug|0|||
128947312|NCT01683071|464092352|FG005|Part 1|Did not receive study drug|0|||
128947313|NCT01683071|464092347|FG000|Part 1|Early termination; met exclusion criteria|0|||
128947314|NCT01683071|464092348|FG001|Part 1|Early termination; met exclusion criteria|2|||
128947315|NCT01683071|464092349|FG002|Part 1|Early termination; met exclusion criteria|1|||
129034087|NCT02466386|464414203|FG000|Overall Study|Protocol Violation|2|||
128708569|NCT01442675|463228458|FG000|Overall Study|Protocol Violation|6|||
128708570|NCT01442675|463228458|FG000|Overall Study|Lost to Follow-up|2|||
128708571|NCT01442675|463228458|FG000|Overall Study|Withdrawal by Subject|4|||
128708572|NCT00752232|463228459|FG000|Overall Study|Protocol Violation|0|||
128947316|NCT01683071|464092350|FG003|Part 1|Early termination; met exclusion criteria|0|||
128947317|NCT01683071|464092351|FG004|Part 1|Early termination; met exclusion criteria|0|||
128947318|NCT01683071|464092352|FG005|Part 1|Early termination; met exclusion criteria|0|||
128947319|NCT01683071|464092347|FG000|Part 2|Lack of Efficacy|0|||
128947320|NCT01683071|464092348|FG001|Part 2|Lack of Efficacy|0|||
128947321|NCT01683071|464092349|FG002|Part 2|Lack of Efficacy|0|||
128947322|NCT01683071|464092350|FG003|Part 2|Lack of Efficacy|0|||
128947323|NCT01683071|464092351|FG004|Part 2|Lack of Efficacy|3|||
128947324|NCT01683071|464092352|FG005|Part 2|Lack of Efficacy|4|||
128947325|NCT01683071|464092347|FG000|Part 2|Lost to Follow-up|0|||
128947326|NCT01683071|464092348|FG001|Part 2|Lost to Follow-up|0|||
128947327|NCT01683071|464092349|FG002|Part 2|Lost to Follow-up|0|||
128947328|NCT01683071|464092350|FG003|Part 2|Lost to Follow-up|0|||
129123944|NCT00614393|464749460|FG002|Overall Study|Terminated by Sponsor|0|||
129123945|NCT00614393|464749461|FG003|Overall Study|Terminated by Sponsor|0|||
129123946|NCT00614393|464749462|FG004|Overall Study|Terminated by Sponsor|1|||
128947329|NCT01683071|464092351|FG004|Part 2|Lost to Follow-up|2|||
128947330|NCT01683071|464092352|FG005|Part 2|Lost to Follow-up|0|||
128947331|NCT01683071|464092347|FG000|Part 2|Withdrawal by Subject|0|||
128947332|NCT01683071|464092348|FG001|Part 2|Withdrawal by Subject|0|||
128947333|NCT01683071|464092349|FG002|Part 2|Withdrawal by Subject|0|||
128947334|NCT01683071|464092350|FG003|Part 2|Withdrawal by Subject|0|||
128947335|NCT01683071|464092351|FG004|Part 2|Withdrawal by Subject|3|||
128947336|NCT01683071|464092352|FG005|Part 2|Withdrawal by Subject|3|||
128947337|NCT01683071|464092347|FG000|Part 2|Surgery cancelled|0|||
128947338|NCT01683071|464092348|FG001|Part 2|Surgery cancelled|0|||
128947339|NCT01683071|464092349|FG002|Part 2|Surgery cancelled|0|||
129123947|NCT00614393|464749458|FG000|Overall Study|Withdrawal by Subject|20|||
129123948|NCT00614393|464749459|FG001|Overall Study|Withdrawal by Subject|1|||
129123949|NCT00614393|464749460|FG002|Overall Study|Withdrawal by Subject|1|||
129123950|NCT00614393|464749461|FG003|Overall Study|Withdrawal by Subject|16|||
129123951|NCT00614393|464749462|FG004|Overall Study|Withdrawal by Subject|13|||
129123952|NCT00614393|464749458|FG000|Overall Study|Other|4|||
129123953|NCT00614393|464749459|FG001|Overall Study|Other|0|||
129123954|NCT00614393|464749460|FG002|Overall Study|Other|0|||
129123955|NCT00614393|464749461|FG003|Overall Study|Other|4|||
129123956|NCT00614393|464749462|FG004|Overall Study|Other|2|||
129123957|NCT00614393|464749458|FG000|Overall Study|Not Treated|0|||
129123958|NCT00614393|464749459|FG001|Overall Study|Not Treated|0|||
129123959|NCT00614393|464749460|FG002|Overall Study|Not Treated|0|||
129123960|NCT00614393|464749461|FG003|Overall Study|Not Treated|0|||
129123961|NCT00614393|464749462|FG004|Overall Study|Not Treated|2|||
129123962|NCT02328105|464749463|FG000|Overall Study|Death|6|||
129123963|NCT02328105|464749463|FG000|Overall Study|Withdrawal by Subject|1|||
129123964|NCT02328105|464749463|FG000|Overall Study|Still On Study in Follow-Up|4|||
129123965|NCT01588509|464749464|FG000|Overall Study|Lost to Follow-up|1|||
129123966|NCT01588509|464749465|FG001|Overall Study|Lost to Follow-up|0|||
129123967|NCT00855582|464749469|FG000|Overall Study|Adverse Event|2|||
129123968|NCT00855582|464749470|FG001|Overall Study|Adverse Event|6|||
129123969|NCT00855582|464749471|FG002|Overall Study|Adverse Event|3|||
129123970|NCT00855582|464749469|FG000|Overall Study|Death|1|||
129123971|NCT00855582|464749470|FG001|Overall Study|Death|0|||
129123972|NCT00855582|464749471|FG002|Overall Study|Death|0|||
129123973|NCT00855582|464749469|FG000|Overall Study|Lack of Efficacy|1|||
129123974|NCT00855582|464749470|FG001|Overall Study|Lack of Efficacy|3|||
129123975|NCT00855582|464749471|FG002|Overall Study|Lack of Efficacy|8|||
129123976|NCT00855582|464749469|FG000|Overall Study|Lost to Follow-up|1|||
129123977|NCT00855582|464749470|FG001|Overall Study|Lost to Follow-up|3|||
129123978|NCT00855582|464749471|FG002|Overall Study|Lost to Follow-up|1|||
129123979|NCT00855582|464749469|FG000|Overall Study|Physician Decision|0|||
129123980|NCT00855582|464749470|FG001|Overall Study|Physician Decision|0|||
129123981|NCT00855582|464749471|FG002|Overall Study|Physician Decision|1|||
129123982|NCT00855582|464749469|FG000|Overall Study|Protocol Violation|6|||
129123983|NCT00855582|464749470|FG001|Overall Study|Protocol Violation|2|||
129123984|NCT00855582|464749471|FG002|Overall Study|Protocol Violation|6|||
129123985|NCT00855582|464749469|FG000|Overall Study|Entry Criteria Not Met|8|||
129123986|NCT00855582|464749470|FG001|Overall Study|Entry Criteria Not Met|6|||
129123987|NCT00855582|464749471|FG002|Overall Study|Entry Criteria Not Met|3|||
129123988|NCT00855582|464749469|FG000|Overall Study|Withdrawal by Subject|7|||
129123989|NCT00855582|464749470|FG001|Overall Study|Withdrawal by Subject|4|||
129123990|NCT00855582|464749471|FG002|Overall Study|Withdrawal by Subject|8|||
129123991|NCT03345004|464749472|FG000|Overall Study|Physician Decision|1|||
129123992|NCT03345004|464749473|FG001|Overall Study|Physician Decision|0|||
128947340|NCT01683071|464092350|FG003|Part 2|Surgery cancelled|0|||
128947341|NCT01683071|464092351|FG004|Part 2|Surgery cancelled|4|||
128947342|NCT01683071|464092352|FG005|Part 2|Surgery cancelled|2|||
128947343|NCT01683071|464092347|FG000|Part 2|Did not receive study drug|0|||
128947344|NCT01683071|464092348|FG001|Part 2|Did not receive study drug|0|||
129123993|NCT03345004|464749472|FG000|Overall Study|Withdrawal by Subject|0|||
129123994|NCT03345004|464749473|FG001|Overall Study|Withdrawal by Subject|1|||
129123995|NCT01013753|464749474|FG000|Overall Study|Adverse Event|8|||
128947345|NCT01683071|464092349|FG002|Part 2|Did not receive study drug|0|||
128947346|NCT01683071|464092350|FG003|Part 2|Did not receive study drug|0|||
128947347|NCT01683071|464092351|FG004|Part 2|Did not receive study drug|2|||
128947348|NCT01683071|464092352|FG005|Part 2|Did not receive study drug|1|||
129123996|NCT01013753|464749474|FG000|Overall Study|Protocol Violation|3|||
129123997|NCT01013753|464749474|FG000|Overall Study|Lost to Follow-up|1|||
129123998|NCT01013753|464749474|FG000|Overall Study|Withdrawal by Subject|2|||
129123999|NCT01013753|464749474|FG000|Overall Study|Other|2|||
128947349|NCT01683071|464092347|FG000|Part 2|Met exclusion criterion|0|||
129124000|NCT03320369|464749477|FG000|Overall Study|Adverse Event|1|||
129124001|NCT03320369|464749477|FG000|Overall Study|Withdrawal by Subject|2|||
129124002|NCT01732692|464749478|FG000|Overall Study|Adverse Event|0|||
129124003|NCT01732692|464749479|FG001|Overall Study|Adverse Event|1|||
128708573|NCT00752232|463228460|FG001|Overall Study|Protocol Violation|0|||
128708574|NCT00752232|463228461|FG002|Overall Study|Protocol Violation|0|||
128708575|NCT00752232|463228462|FG003|Overall Study|Protocol Violation|0|||
128708576|NCT00752232|463228463|FG004|Overall Study|Protocol Violation|0|||
128708577|NCT00752232|463228464|FG005|Overall Study|Protocol Violation|1|||
128708578|NCT00752232|463228465|FG006|Overall Study|Protocol Violation|0|||
128708579|NCT00752232|463228459|FG000|Overall Study|Caregiver request|2|||
128708580|NCT00752232|463228460|FG001|Overall Study|Caregiver request|0|||
128708581|NCT00752232|463228461|FG002|Overall Study|Caregiver request|0|||
128708582|NCT00752232|463228462|FG003|Overall Study|Caregiver request|0|||
128708583|NCT00752232|463228463|FG004|Overall Study|Caregiver request|1|||
128708584|NCT00752232|463228464|FG005|Overall Study|Caregiver request|0|||
128708585|NCT00752232|463228465|FG006|Overall Study|Caregiver request|0|||
128708586|NCT00752232|463228459|FG000|Overall Study|Investigator request|0|||
128708587|NCT00752232|463228460|FG001|Overall Study|Investigator request|0|||
128708588|NCT00752232|463228461|FG002|Overall Study|Investigator request|0|||
128708589|NCT00752232|463228462|FG003|Overall Study|Investigator request|0|||
128708590|NCT00752232|463228463|FG004|Overall Study|Investigator request|1|||
128708591|NCT00752232|463228464|FG005|Overall Study|Investigator request|0|||
128708592|NCT00752232|463228465|FG006|Overall Study|Investigator request|0|||
128708593|NCT00752232|463228459|FG000|Overall Study|Subject request|0|||
128708594|NCT00752232|463228460|FG001|Overall Study|Subject request|0|||
128708595|NCT00752232|463228461|FG002|Overall Study|Subject request|1|||
128708596|NCT00752232|463228462|FG003|Overall Study|Subject request|0|||
128708597|NCT00752232|463228463|FG004|Overall Study|Subject request|0|||
128708598|NCT00752232|463228464|FG005|Overall Study|Subject request|0|||
128770339|NCT02736968|463450226|FG004|Overall Study|Lost to Follow-up|0|||
128947350|NCT01683071|464092348|FG001|Part 2|Met exclusion criterion|0|||
128947351|NCT01683071|464092349|FG002|Part 2|Met exclusion criterion|0|||
128947352|NCT01683071|464092350|FG003|Part 2|Met exclusion criterion|0|||
128947353|NCT01683071|464092351|FG004|Part 2|Met exclusion criterion|1|||
128947354|NCT01683071|464092352|FG005|Part 2|Met exclusion criterion|1|||
128947355|NCT01683071|464092347|FG000|Part 2|Protocol deviation|0|||
128947356|NCT01683071|464092348|FG001|Part 2|Protocol deviation|0|||
128947357|NCT01683071|464092349|FG002|Part 2|Protocol deviation|0|||
128947358|NCT01683071|464092350|FG003|Part 2|Protocol deviation|0|||
128947359|NCT01683071|464092351|FG004|Part 2|Protocol deviation|1|||
128947360|NCT01683071|464092352|FG005|Part 2|Protocol deviation|2|||
129124004|NCT01137786|464749480|FG000|Overall Study|Lost to Follow-up|0|||
129124005|NCT01137786|464749481|FG001|Overall Study|Lost to Follow-up|2|||
129124006|NCT01137786|464749480|FG000|Overall Study|Withdrawal by Subject|1|||
129124007|NCT01137786|464749481|FG001|Overall Study|Withdrawal by Subject|1|||
129124008|NCT01281306|464749482|FG000|Overall Study|Lack of Efficacy|0|||
129124009|NCT01281306|464749483|FG001|Overall Study|Lack of Efficacy|1|||
129124010|NCT01281306|464749484|FG002|Overall Study|Lack of Efficacy|3|||
129124011|NCT01281306|464749485|FG003|Overall Study|Lack of Efficacy|0|||
129124012|NCT01281306|464749486|FG004|Overall Study|Lack of Efficacy|2|||
129124013|NCT01281306|464749487|FG005|Overall Study|Lack of Efficacy|0|||
129124014|NCT01281306|464749488|FG006|Overall Study|Lack of Efficacy|1|||
129124015|NCT01281306|464749482|FG000|Overall Study|Withdrawal by Subject|1|||
129124016|NCT01281306|464749483|FG001|Overall Study|Withdrawal by Subject|0|||
129124017|NCT01281306|464749484|FG002|Overall Study|Withdrawal by Subject|2|||
129124018|NCT01281306|464749485|FG003|Overall Study|Withdrawal by Subject|4|||
129124019|NCT01281306|464749486|FG004|Overall Study|Withdrawal by Subject|1|||
129124020|NCT01281306|464749487|FG005|Overall Study|Withdrawal by Subject|3|||
129124021|NCT01281306|464749488|FG006|Overall Study|Withdrawal by Subject|1|||
129124022|NCT01281306|464749482|FG000|Overall Study|Protocol deviation|0|||
129124023|NCT01281306|464749483|FG001|Overall Study|Protocol deviation|1|||
129124024|NCT01281306|464749484|FG002|Overall Study|Protocol deviation|1|||
129124025|NCT01281306|464749485|FG003|Overall Study|Protocol deviation|1|||
129124026|NCT01281306|464749486|FG004|Overall Study|Protocol deviation|1|||
128770340|NCT02736968|463450227|FG005|Overall Study|Lost to Follow-up|0|||
128770341|NCT02736968|463450228|FG006|Overall Study|Lost to Follow-up|5|||
128770342|NCT02736968|463450229|FG007|Overall Study|Lost to Follow-up|2|||
128770343|NCT02736968|463450222|FG000|Overall Study|COVID-19 Pandemic|0|||
129124027|NCT01281306|464749487|FG005|Overall Study|Protocol deviation|0|||
129124028|NCT01281306|464749488|FG006|Overall Study|Protocol deviation|0|||
128947361|NCT01683071|464092347|FG000|Part 2|Withdrawal by investigator decision|0|||
128947362|NCT01683071|464092348|FG001|Part 2|Withdrawal by investigator decision|0|||
129124029|NCT01281306|464749482|FG000|Overall Study|Condition no longer requires study drug|1|||
129124030|NCT01281306|464749483|FG001|Overall Study|Condition no longer requires study drug|0|||
129124031|NCT01281306|464749484|FG002|Overall Study|Condition no longer requires study drug|0|||
128708599|NCT00752232|463228465|FG006|Overall Study|Subject request|0|||
128708600|NCT00752232|463228459|FG000|Overall Study|Group home admission|0|||
128708601|NCT00752232|463228460|FG001|Overall Study|Group home admission|0|||
128708602|NCT00752232|463228461|FG002|Overall Study|Group home admission|0|||
128708603|NCT00752232|463228462|FG003|Overall Study|Group home admission|1|||
128708604|NCT00752232|463228463|FG004|Overall Study|Group home admission|0|||
128947363|NCT01683071|464092349|FG002|Part 2|Withdrawal by investigator decision|0|||
129218035|NCT00785785|465098526|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
129218036|NCT02453321|465098527|FG000|Overall Study|Weakness|1|||
129218037|NCT02453321|465098528|FG001|Overall Study|Weakness|1|||
129218038|NCT02453321|465098529|FG002|Overall Study|Weakness|2|||
129218039|NCT02453321|465098527|FG000|Overall Study|Deep Venous Thrombosis|0|||
129218040|NCT02453321|465098528|FG001|Overall Study|Deep Venous Thrombosis|1|||
129218041|NCT02453321|465098529|FG002|Overall Study|Deep Venous Thrombosis|0|||
129218042|NCT00521404|465098530|FG000|Overall Study|Adverse Event|13|||
129218043|NCT00521404|465098530|FG000|Overall Study|Disease Progression|33|||
129218044|NCT00521404|465098530|FG000|Overall Study|Investigator decision|5|||
129218045|NCT00521404|465098530|FG000|Overall Study|Withdrawal of consent|3|||
129218046|NCT00521404|465098530|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
129218047|NCT00521404|465098530|FG000|Overall Study|Other|7|||
129218048|NCT02282605|465098531|FG000|Overall Study|negative SA result on Day -1|3|||
129218049|NCT02282605|465098532|FG001|Overall Study|negative SA result on Day -1|0|||
129218050|NCT02282605|465098533|FG002|Overall Study|negative SA result on Day -1|0|||
129218051|NCT03584789|465098536|FG000|Overall Study|refused EHR permission|19|||
129218052|NCT03584789|465098537|FG001|Overall Study|refused EHR permission|28|||
129218053|NCT03584789|465098538|FG002|Overall Study|refused EHR permission|23|||
129218054|NCT03584789|465098536|FG000|Overall Study|patients tied to a provider who retired|0|||
129218055|NCT03584789|465098537|FG001|Overall Study|patients tied to a provider who retired|0|||
129218056|NCT03584789|465098538|FG002|Overall Study|patients tied to a provider who retired|3|||
129218057|NCT02035267|465098539|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
129218058|NCT02035267|465098540|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
129218059|NCT02035267|465098541|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
129218060|NCT02035267|465098542|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
129218061|NCT02035267|465098539|FG000|Overall Study|Adverse Event|0|||
129218062|NCT02035267|465098540|FG001|Overall Study|Adverse Event|0|||
129218063|NCT02035267|465098541|FG002|Overall Study|Adverse Event|1|||
129218064|NCT02035267|465098542|FG003|Overall Study|Adverse Event|0|||
129218065|NCT02035267|465098539|FG000|Overall Study|Lost to Follow-up|0|||
129218066|NCT02035267|465098540|FG001|Overall Study|Lost to Follow-up|0|||
129218067|NCT02035267|465098541|FG002|Overall Study|Lost to Follow-up|0|||
129218068|NCT02035267|465098542|FG003|Overall Study|Lost to Follow-up|1|||
129218069|NCT02035267|465098539|FG000|Overall Study|Other unspecified|0|||
129218070|NCT02035267|465098540|FG001|Overall Study|Other unspecified|1|||
129218071|NCT02035267|465098541|FG002|Overall Study|Other unspecified|0|||
129218072|NCT02035267|465098542|FG003|Overall Study|Other unspecified|0|||
129218073|NCT00823615|465098551|FG000|Period 2|Lost to Follow-up|2|||
129218074|NCT00823615|465098552|FG001|Period 2|Lost to Follow-up|0|||
129218075|NCT00823615|465098551|FG000|Period 2|Time/Job Conflict|1|||
129218076|NCT00823615|465098552|FG001|Period 2|Time/Job Conflict|2|||
129218077|NCT00892099|465098554|FG000|Overall Study|Death|1|||
129218078|NCT00892099|465098555|FG001|Overall Study|Death|0|||
129218079|NCT00892099|465098556|FG002|Overall Study|Death|1|||
129218080|NCT00892099|465098554|FG000|Overall Study|Adverse Event|1|||
129218081|NCT00892099|465098555|FG001|Overall Study|Adverse Event|0|||
129218082|NCT00892099|465098556|FG002|Overall Study|Adverse Event|0|||
129218083|NCT00892099|465098554|FG000|Overall Study|replocated|1|||
129218084|NCT00892099|465098555|FG001|Overall Study|replocated|0|||
129218085|NCT00892099|465098556|FG002|Overall Study|replocated|2|||
129218086|NCT00892099|465098554|FG000|Overall Study|Prolonged hospitalization|1|||
129124032|NCT01281306|464749485|FG003|Overall Study|Condition no longer requires study drug|0|||
129124033|NCT01281306|464749486|FG004|Overall Study|Condition no longer requires study drug|0|||
129124034|NCT01281306|464749487|FG005|Overall Study|Condition no longer requires study drug|1|||
129124035|NCT01281306|464749488|FG006|Overall Study|Condition no longer requires study drug|1|||
129124036|NCT01281306|464749482|FG000|Overall Study|Lost to Follow-up|1|||
129124037|NCT01281306|464749483|FG001|Overall Study|Lost to Follow-up|0|||
129124038|NCT01281306|464749484|FG002|Overall Study|Lost to Follow-up|0|||
129124039|NCT01281306|464749485|FG003|Overall Study|Lost to Follow-up|2|||
129124040|NCT01281306|464749486|FG004|Overall Study|Lost to Follow-up|0|||
129124041|NCT01281306|464749487|FG005|Overall Study|Lost to Follow-up|0|||
129218087|NCT00892099|465098555|FG001|Overall Study|Prolonged hospitalization|0|||
129218088|NCT00892099|465098556|FG002|Overall Study|Prolonged hospitalization|1|||
129218089|NCT00892099|465098554|FG000|Overall Study|no further details|1|||
129218090|NCT00892099|465098555|FG001|Overall Study|no further details|0|||
128708605|NCT00752232|463228464|FG005|Overall Study|Group home admission|0|||
129218091|NCT00892099|465098556|FG002|Overall Study|no further details|1|||
129218092|NCT00892099|465098554|FG000|Overall Study|kidney function recovered|0|||
128708606|NCT00752232|463228465|FG006|Overall Study|Group home admission|0|||
128708607|NCT00752232|463228459|FG000|Overall Study|Caregiver could not attend the subject|0|||
128770344|NCT02736968|463450223|FG001|Overall Study|COVID-19 Pandemic|0|||
129124042|NCT01281306|464749488|FG006|Overall Study|Lost to Follow-up|1|||
129218093|NCT00892099|465098555|FG001|Overall Study|kidney function recovered|1|||
129218094|NCT00892099|465098556|FG002|Overall Study|kidney function recovered|0|||
129218095|NCT00892099|465098554|FG000|Overall Study|investigator decision|0|||
129218096|NCT00892099|465098555|FG001|Overall Study|investigator decision|0|||
128947364|NCT01683071|464092350|FG003|Part 2|Withdrawal by investigator decision|0|||
128947365|NCT01683071|464092351|FG004|Part 2|Withdrawal by investigator decision|1|||
128947366|NCT01683071|464092352|FG005|Part 2|Withdrawal by investigator decision|2|||
128947367|NCT01968187|464092355|FG000|Overall Study|Adverse Event|0|||
128947368|NCT01968187|464092356|FG001|Overall Study|Adverse Event|1|||
128947369|NCT01968187|464092355|FG000|Overall Study|Randomized but not treated|1|||
128947370|NCT01968187|464092356|FG001|Overall Study|Randomized but not treated|0|||
128947371|NCT04095286|464092357|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129218097|NCT00892099|465098556|FG002|Overall Study|investigator decision|1|||
129218098|NCT00892099|465098554|FG000|Overall Study|Lost to Follow-up|0|||
129218099|NCT00892099|465098555|FG001|Overall Study|Lost to Follow-up|0|||
129218100|NCT00892099|465098556|FG002|Overall Study|Lost to Follow-up|1|||
129218101|NCT00658359|465098559|FG000|Overall Study|Death|3|||
129218102|NCT00658359|465098560|FG001|Overall Study|Death|1|||
129218103|NCT00658359|465098561|FG002|Overall Study|Death|2|||
129218104|NCT00658359|465098559|FG000|Overall Study|Adverse Event|13|||
129218105|NCT00658359|465098560|FG001|Overall Study|Adverse Event|6|||
129218106|NCT00658359|465098561|FG002|Overall Study|Adverse Event|9|||
129218107|NCT00658359|465098559|FG000|Overall Study|Protocol Violation|1|||
129218108|NCT00658359|465098560|FG001|Overall Study|Protocol Violation|0|||
129218109|NCT00658359|465098561|FG002|Overall Study|Protocol Violation|0|||
129218110|NCT00658359|465098559|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
129218111|NCT00658359|465098560|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
129218112|NCT00658359|465098561|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
129218113|NCT00658359|465098559|FG000|Overall Study|Withdrawal by Subject|7|||
129218114|NCT00658359|465098560|FG001|Overall Study|Withdrawal by Subject|4|||
129218115|NCT00658359|465098561|FG002|Overall Study|Withdrawal by Subject|2|||
129218116|NCT00658359|465098559|FG000|Overall Study|Lost to Follow-up|2|||
129218117|NCT00658359|465098560|FG001|Overall Study|Lost to Follow-up|2|||
129218118|NCT00658359|465098561|FG002|Overall Study|Lost to Follow-up|4|||
129218119|NCT00658359|465098559|FG000|Overall Study|Lack of Efficacy|0|||
129218120|NCT00658359|465098560|FG001|Overall Study|Lack of Efficacy|1|||
129218121|NCT00658359|465098561|FG002|Overall Study|Lack of Efficacy|0|||
129218122|NCT02754440|465098562|FG000|Overall Study|Protocol Violation|3|||
129218123|NCT02754440|465098563|FG001|Overall Study|Protocol Violation|2|||
129218124|NCT02754440|465098564|FG002|Overall Study|Protocol Violation|2|||
129218125|NCT02754440|465098565|FG003|Overall Study|Protocol Violation|6|||
128947372|NCT04095286|464092358|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
128947373|NCT04095286|464092359|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947374|NCT04095286|464092360|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947375|NCT04095286|464092361|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947376|NCT04095286|464092362|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947377|NCT04095286|464092357|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
128947378|NCT04095286|464092358|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
128947379|NCT04095286|464092359|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
128947380|NCT04095286|464092360|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
128947381|NCT04095286|464092361|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
128947382|NCT04095286|464092362|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
128947383|NCT04095286|464092357|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
128947384|NCT04095286|464092358|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
128947385|NCT04095286|464092359|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
128947386|NCT04095286|464092360|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
128947387|NCT04095286|464092361|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
128947388|NCT04095286|464092362|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
128947389|NCT04095286|464092357|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947390|NCT04095286|464092358|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947391|NCT04095286|464092359|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
128978108|NCT01854918|464205317|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
129124043|NCT01281306|464749482|FG000|Overall Study|Death|1|||
129124044|NCT01281306|464749483|FG001|Overall Study|Death|0|||
129124045|NCT01281306|464749484|FG002|Overall Study|Death|0|||
129124046|NCT01281306|464749485|FG003|Overall Study|Death|0|||
129124047|NCT01281306|464749486|FG004|Overall Study|Death|0|||
129124048|NCT01281306|464749487|FG005|Overall Study|Death|0|||
129124049|NCT01281306|464749488|FG006|Overall Study|Death|0|||
129124050|NCT01281306|464749482|FG000|Overall Study|Adverse Event|3|||
129218126|NCT02754440|465098562|FG000|Overall Study|Adverse Event|3|||
129124051|NCT01281306|464749483|FG001|Overall Study|Adverse Event|2|||
129124052|NCT01281306|464749484|FG002|Overall Study|Adverse Event|2|||
129218127|NCT02754440|465098563|FG001|Overall Study|Adverse Event|1|||
129218128|NCT02754440|465098564|FG002|Overall Study|Adverse Event|0|||
129218129|NCT02754440|465098565|FG003|Overall Study|Adverse Event|9|||
129218130|NCT02754440|465098562|FG000|Overall Study|Withdrawal by Subject|0|||
128708608|NCT00752232|463228460|FG001|Overall Study|Caregiver could not attend the subject|0|||
128708609|NCT00752232|463228461|FG002|Overall Study|Caregiver could not attend the subject|0|||
128708610|NCT00752232|463228462|FG003|Overall Study|Caregiver could not attend the subject|0|||
128708611|NCT00752232|463228463|FG004|Overall Study|Caregiver could not attend the subject|1|||
128947392|NCT04095286|464092360|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947393|NCT04095286|464092361|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947394|NCT04095286|464092362|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
128947395|NCT04095286|464092357|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
128947396|NCT04095286|464092358|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
128708612|NCT00752232|463228464|FG005|Overall Study|Caregiver could not attend the subject|0|||
128708613|NCT00752232|463228465|FG006|Overall Study|Caregiver could not attend the subject|0|||
128708614|NCT01919723|463228466|FG000|Overall Study|Blood Samples Hemolyzed|2|||
128708615|NCT01919723|463228467|FG001|Overall Study|Blood Samples Hemolyzed|2|||
128708616|NCT00555321|463228468|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
128708617|NCT00555321|463228469|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
128708618|NCT00555321|463228470|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
128708619|NCT00555321|463228471|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
128708620|NCT00555321|463228472|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
128708621|NCT00555321|463228468|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
128708622|NCT00555321|463228469|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
128708623|NCT00555321|463228470|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
128708624|NCT00555321|463228471|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
128708625|NCT00555321|463228472|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
128947397|NCT04095286|464092359|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
128947398|NCT04095286|464092360|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
128947399|NCT04095286|464092361|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
128947400|NCT04095286|464092362|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
128947401|NCT02020031|464094539|FG000|Overall Study|Physician Decision|1|||
128947402|NCT02020031|464094540|FG001|Overall Study|Physician Decision|1|||
128947403|NCT04092816|464094552|FG000|Overall Study|Lost to Follow-up|1|||
128947404|NCT04092816|464094553|FG001|Overall Study|Lost to Follow-up|2|||
128947405|NCT00424528|464094554|FG000|Overall Study|Adverse Event|2|||
128947406|NCT00424528|464094555|FG001|Overall Study|Adverse Event|1|||
128947407|NCT00424528|464094556|FG002|Overall Study|Adverse Event|2|||
128947408|NCT00424528|464094554|FG000|Overall Study|Protocol Violation|1|||
128947409|NCT00424528|464094555|FG001|Overall Study|Protocol Violation|1|||
128947410|NCT00424528|464094556|FG002|Overall Study|Protocol Violation|0|||
128947411|NCT00424528|464094554|FG000|Overall Study|Lost to Follow-up|0|||
128947412|NCT00424528|464094555|FG001|Overall Study|Lost to Follow-up|1|||
128947413|NCT00424528|464094556|FG002|Overall Study|Lost to Follow-up|0|||
128947414|NCT00424528|464094554|FG000|Overall Study|noncompliance with study requirements|2|||
128947415|NCT00424528|464094555|FG001|Overall Study|noncompliance with study requirements|1|||
128947416|NCT00424528|464094556|FG002|Overall Study|noncompliance with study requirements|2|||
128947417|NCT00254293|464094562|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
128947418|NCT00254293|464094563|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
128947419|NCT00254293|464094564|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
128947420|NCT00254293|464094565|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
128947421|NCT00254293|464094566|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
128947422|NCT00254293|464094567|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
128947423|NCT00254293|464094568|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
128947424|NCT00254293|464094562|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
128947425|NCT00254293|464094563|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
128947426|NCT00254293|464094564|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
128947427|NCT00254293|464094565|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
128947428|NCT00254293|464094566|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
128947429|NCT00254293|464094567|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
128947430|NCT00254293|464094568|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
128947431|NCT00254293|464094562|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
128947432|NCT00254293|464094563|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
128947433|NCT00254293|464094564|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
128947434|NCT00254293|464094565|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
128947435|NCT00254293|464094566|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
128947436|NCT00254293|464094567|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
128947437|NCT00254293|464094568|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
128947438|NCT00254293|464094562|FG000|LTE Open Label Variable SC Dosing|Death|0|||
128708626|NCT00555321|463228468|FG000|Treatment Phase up to 12-months|Death|2|||
128708627|NCT00555321|463228469|FG001|Treatment Phase up to 12-months|Death|1|||
128770345|NCT02736968|463450224|FG002|Overall Study|COVID-19 Pandemic|0|||
128708628|NCT00555321|463228470|FG002|Treatment Phase up to 12-months|Death|4|||
128708629|NCT00555321|463228471|FG003|Treatment Phase up to 12-months|Death|0|||
128708630|NCT00555321|463228472|FG004|Treatment Phase up to 12-months|Death|0|||
128708631|NCT00555321|463228468|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
128708632|NCT00555321|463228469|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
128708633|NCT00555321|463228470|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
128708634|NCT00555321|463228471|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
128708635|NCT00555321|463228472|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
128708636|NCT00555321|463228468|FG000|Treatment Phase up to 12-months|Other Reason|1|||
128708637|NCT00555321|463228469|FG001|Treatment Phase up to 12-months|Other Reason|3|||
128708638|NCT00555321|463228470|FG002|Treatment Phase up to 12-months|Other Reason|2|||
128708639|NCT00555321|463228471|FG003|Treatment Phase up to 12-months|Other Reason|0|||
128708640|NCT00555321|463228472|FG004|Treatment Phase up to 12-months|Other Reason|0|||
128708641|NCT00555321|463228468|FG000|Treatment Phase up to 12-months|Never treated|2|||
128708642|NCT00555321|463228469|FG001|Treatment Phase up to 12-months|Never treated|3|||
128708643|NCT00555321|463228470|FG002|Treatment Phase up to 12-months|Never treated|1|||
128708644|NCT00555321|463228471|FG003|Treatment Phase up to 12-months|Never treated|0|||
128708645|NCT00555321|463228472|FG004|Treatment Phase up to 12-months|Never treated|4|||
128708646|NCT00555321|463228468|FG000|Long-term Extension Phase|Adverse Event|2|||
128708647|NCT00555321|463228469|FG001|Long-term Extension Phase|Adverse Event|5|||
128708648|NCT00555321|463228470|FG002|Long-term Extension Phase|Adverse Event|2|||
128708649|NCT00555321|463228471|FG003|Long-term Extension Phase|Adverse Event|1|||
128708650|NCT00555321|463228472|FG004|Long-term Extension Phase|Adverse Event|0|||
128708651|NCT00555321|463228468|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
128947439|NCT00254293|464094563|FG001|LTE Open Label Variable SC Dosing|Death|0|||
128947440|NCT00254293|464094564|FG002|LTE Open Label Variable SC Dosing|Death|1|||
128947441|NCT00254293|464094565|FG003|LTE Open Label Variable SC Dosing|Death|0|||
128947442|NCT00254293|464094566|FG004|LTE Open Label Variable SC Dosing|Death|0|||
128947443|NCT00254293|464094567|FG005|LTE Open Label Variable SC Dosing|Death|0|||
128947444|NCT00254293|464094568|FG006|LTE Open Label Variable SC Dosing|Death|0|||
128947445|NCT00254293|464094562|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
128947446|NCT00254293|464094563|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
128947447|NCT00254293|464094564|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
128947448|NCT00254293|464094565|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
128947449|NCT00254293|464094566|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
128947450|NCT00254293|464094567|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
128947451|NCT00254293|464094568|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
128947452|NCT00254293|464094562|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
128947453|NCT00254293|464094563|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
128947454|NCT00254293|464094564|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
128947455|NCT00254293|464094565|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
128947456|NCT00254293|464094566|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
128947457|NCT00254293|464094567|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
128947458|NCT00254293|464094568|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
128947459|NCT00254293|464094562|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
128947460|NCT00254293|464094563|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
128947461|NCT00254293|464094564|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
128947462|NCT00254293|464094565|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
128947463|NCT00254293|464094566|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
128947464|NCT00254293|464094567|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
128947465|NCT00254293|464094568|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
128708652|NCT00555321|463228469|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
128708653|NCT00555321|463228470|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
128708654|NCT00555321|463228471|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
128947466|NCT00254293|464094562|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
128947467|NCT00254293|464094563|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
128947468|NCT00254293|464094564|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
128947469|NCT00254293|464094565|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
128708655|NCT00555321|463228472|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
129034088|NCT02466386|464414203|FG000|Overall Study|Withdrawal by Subject|14|||
129034089|NCT02466386|464414203|FG000|Overall Study|Lost to Follow-up|5|||
129034090|NCT02466386|464414203|FG000|Overall Study|Lack of Efficacy|8|||
128708656|NCT00555321|463228468|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
128708657|NCT00555321|463228469|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
129034091|NCT02466386|464414203|FG000|Overall Study|Other|10|||
129034092|NCT05317195|464414204|FG000|Randomization|Withdrawal by Subject|1|||
129034093|NCT05317195|464414204|FG000|Randomization|Discontinued|6|||
129034094|NCT05317195|464414204|FG000|Admission|Withdrawal by Subject|2|||
129034095|NCT01688882|464414205|FG000|Overall Study|Adverse Event|1|||
129034096|NCT01688882|464414206|FG001|Overall Study|Adverse Event|0|||
129034097|NCT01688882|464414205|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128947470|NCT00254293|464094566|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
128708658|NCT00555321|463228470|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
128708659|NCT00555321|463228471|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
128708660|NCT00555321|463228472|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
128708661|NCT00555321|463228468|FG000|Long-term Extension Phase|Death|2|||
128708662|NCT00555321|463228469|FG001|Long-term Extension Phase|Death|0|||
128708663|NCT00555321|463228470|FG002|Long-term Extension Phase|Death|0|||
128708664|NCT00555321|463228471|FG003|Long-term Extension Phase|Death|3|||
128708665|NCT00555321|463228472|FG004|Long-term Extension Phase|Death|0|||
128708666|NCT00555321|463228468|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
128708667|NCT00555321|463228469|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
128708668|NCT00555321|463228470|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
128947471|NCT00254293|464094567|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
128947472|NCT00254293|464094568|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
128947473|NCT00254293|464094562|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
128947474|NCT00254293|464094563|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
128947475|NCT00254293|464094564|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
128947476|NCT00254293|464094565|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
128947477|NCT00254293|464094566|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
128947478|NCT00254293|464094567|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
128947479|NCT00254293|464094568|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
128947480|NCT00254293|464094562|FG000|LTE Open Label Variable SC Dosing|Other|0|||
128947481|NCT00254293|464094563|FG001|LTE Open Label Variable SC Dosing|Other|0|||
128947482|NCT00254293|464094564|FG002|LTE Open Label Variable SC Dosing|Other|2|||
128947483|NCT00254293|464094565|FG003|LTE Open Label Variable SC Dosing|Other|0|||
128947484|NCT00254293|464094566|FG004|LTE Open Label Variable SC Dosing|Other|0|||
128947485|NCT00254293|464094567|FG005|LTE Open Label Variable SC Dosing|Other|0|||
128947486|NCT00254293|464094568|FG006|LTE Open Label Variable SC Dosing|Other|0|||
128947487|NCT00254293|464094562|FG000|LTE Open Label Fixed Dosing|Death|0|||
128947488|NCT00254293|464094563|FG001|LTE Open Label Fixed Dosing|Death|0|||
128947489|NCT00254293|464094564|FG002|LTE Open Label Fixed Dosing|Death|0|||
128947490|NCT00254293|464094565|FG003|LTE Open Label Fixed Dosing|Death|0|||
128947491|NCT00254293|464094566|FG004|LTE Open Label Fixed Dosing|Death|0|||
128947492|NCT00254293|464094567|FG005|LTE Open Label Fixed Dosing|Death|0|||
128947493|NCT00254293|464094568|FG006|LTE Open Label Fixed Dosing|Death|3|||
128947494|NCT00254293|464094562|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
128947495|NCT00254293|464094563|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
128947496|NCT00254293|464094564|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
128947497|NCT00254293|464094565|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
128947498|NCT00254293|464094566|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
128947499|NCT00254293|464094567|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
128947500|NCT00254293|464094568|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
129124053|NCT01281306|464749485|FG003|Overall Study|Adverse Event|3|||
129124054|NCT01281306|464749486|FG004|Overall Study|Adverse Event|5|||
129124055|NCT01281306|464749487|FG005|Overall Study|Adverse Event|3|||
129124056|NCT01281306|464749488|FG006|Overall Study|Adverse Event|3|||
129124057|NCT01281306|464749482|FG000|Overall Study|Randomized in error|1|||
129124058|NCT01281306|464749483|FG001|Overall Study|Randomized in error|0|||
129124059|NCT01281306|464749484|FG002|Overall Study|Randomized in error|0|||
129124060|NCT01281306|464749485|FG003|Overall Study|Randomized in error|1|||
129124061|NCT01281306|464749486|FG004|Overall Study|Randomized in error|0|||
129124062|NCT01281306|464749487|FG005|Overall Study|Randomized in error|0|||
129124063|NCT01281306|464749488|FG006|Overall Study|Randomized in error|0|||
129124064|NCT02320396|464749489|FG000|Overall Study|Adverse Event|2|||
129124065|NCT02320396|464749490|FG001|Overall Study|Adverse Event|2|||
129124066|NCT02320396|464749489|FG000|Overall Study|Pregnancy|0|||
129124067|NCT02320396|464749490|FG001|Overall Study|Pregnancy|1|||
129124068|NCT02320396|464749489|FG000|Overall Study|Protocol Violation|0|||
129124069|NCT02320396|464749490|FG001|Overall Study|Protocol Violation|1|||
129124070|NCT02320396|464749489|FG000|Overall Study|Withdrawal by Subject|2|||
129124071|NCT02320396|464749490|FG001|Overall Study|Withdrawal by Subject|0|||
129124072|NCT03331562|464749491|FG000|Overall Study|Adverse Event|2|||
129124073|NCT03331562|464749492|FG001|Overall Study|Adverse Event|0|||
129124074|NCT03331562|464749491|FG000|Overall Study|Death|1|||
129124075|NCT03331562|464749492|FG001|Overall Study|Death|0|||
129124076|NCT03718000|464749493|FG000|Overall Study|Relocation|2|||
129124077|NCT03718000|464749494|FG001|Overall Study|Relocation|4|||
129124078|NCT03718000|464749493|FG000|Overall Study|Pregnancy|0|||
128947501|NCT00254293|464094562|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
128947502|NCT00254293|464094563|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
128947503|NCT00254293|464094564|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129124079|NCT03718000|464749494|FG001|Overall Study|Pregnancy|1|||
129124080|NCT05522751|464749497|FG000|Overall Study|Adverse Event|1|||
129124081|NCT02475213|464749498|FG000|Overall Study|Adverse Event|2|||
129124082|NCT02475213|464749499|FG001|Overall Study|Adverse Event|0|||
128947504|NCT00254293|464094565|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
128947505|NCT00254293|464094566|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
128947506|NCT00254293|464094567|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
128947507|NCT00254293|464094568|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
128947508|NCT00254293|464094562|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
128947509|NCT00254293|464094563|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
128947510|NCT00254293|464094564|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
128947511|NCT00254293|464094565|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
128947512|NCT00254293|464094566|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
128947513|NCT00254293|464094567|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
128947514|NCT00254293|464094568|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
128947515|NCT00254293|464094562|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
128947516|NCT00254293|464094563|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
128947517|NCT00254293|464094564|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
128947518|NCT00254293|464094565|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
128947519|NCT00254293|464094566|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
128947520|NCT00254293|464094567|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
128947521|NCT00254293|464094568|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
128947522|NCT00254293|464094562|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
128947523|NCT00254293|464094563|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
128947524|NCT00254293|464094564|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
128947525|NCT00254293|464094565|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
128947526|NCT00254293|464094566|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
128947527|NCT00254293|464094567|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
128947528|NCT00254293|464094568|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
128947529|NCT00254293|464094562|FG000|LTE Open Label Fixed Dosing|Other|0|||
128947530|NCT00254293|464094563|FG001|LTE Open Label Fixed Dosing|Other|0|||
128947531|NCT00254293|464094564|FG002|LTE Open Label Fixed Dosing|Other|0|||
128947532|NCT00254293|464094565|FG003|LTE Open Label Fixed Dosing|Other|0|||
128947533|NCT00254293|464094566|FG004|LTE Open Label Fixed Dosing|Other|0|||
128947534|NCT00254293|464094567|FG005|LTE Open Label Fixed Dosing|Other|0|||
128947535|NCT00254293|464094568|FG006|LTE Open Label Fixed Dosing|Other|1|||
128947536|NCT01697267|464094570|FG000|Overall Study|Death|3|||
128947537|NCT01697267|464094571|FG001|Overall Study|Death|1|||
128947538|NCT01697267|464094570|FG000|Overall Study|Withdrawal by Subject|5|||
128947539|NCT01697267|464094571|FG001|Overall Study|Withdrawal by Subject|5|||
128947540|NCT01697267|464094570|FG000|Overall Study|Adverse Event|2|||
129124083|NCT02475213|464749500|FG002|Overall Study|Adverse Event|0|||
129124084|NCT02475213|464749501|FG003|Overall Study|Adverse Event|1|||
129124085|NCT02475213|464749502|FG004|Overall Study|Adverse Event|1|||
129124086|NCT02475213|464749503|FG005|Overall Study|Adverse Event|4|||
129124087|NCT02475213|464749504|FG006|Overall Study|Adverse Event|6|||
129124088|NCT02475213|464749505|FG007|Overall Study|Adverse Event|2|||
129124089|NCT02475213|464749498|FG000|Overall Study|Physician Decision|1|||
129124090|NCT02475213|464749499|FG001|Overall Study|Physician Decision|1|||
129124091|NCT02475213|464749500|FG002|Overall Study|Physician Decision|1|||
129124092|NCT02475213|464749501|FG003|Overall Study|Physician Decision|0|||
129124093|NCT02475213|464749502|FG004|Overall Study|Physician Decision|0|||
129124094|NCT02475213|464749503|FG005|Overall Study|Physician Decision|1|||
129124095|NCT02475213|464749504|FG006|Overall Study|Physician Decision|4|||
129124096|NCT02475213|464749505|FG007|Overall Study|Physician Decision|0|||
129124097|NCT02475213|464749498|FG000|Overall Study|Progressive Disease|3|||
129124098|NCT02475213|464749499|FG001|Overall Study|Progressive Disease|2|||
129124099|NCT02475213|464749500|FG002|Overall Study|Progressive Disease|2|||
129124100|NCT02475213|464749501|FG003|Overall Study|Progressive Disease|13|||
129124101|NCT02475213|464749502|FG004|Overall Study|Progressive Disease|15|||
129124102|NCT02475213|464749503|FG005|Overall Study|Progressive Disease|25|||
129124103|NCT02475213|464749504|FG006|Overall Study|Progressive Disease|30|||
129124104|NCT02475213|464749505|FG007|Overall Study|Progressive Disease|10|||
129124105|NCT02475213|464749498|FG000|Overall Study|Death|0|||
129124106|NCT02475213|464749499|FG001|Overall Study|Death|0|||
129124107|NCT02475213|464749500|FG002|Overall Study|Death|0|||
128947541|NCT01697267|464094571|FG001|Overall Study|Adverse Event|1|||
128947542|NCT01697267|464094570|FG000|Overall Study|Lost to Follow-up|2|||
129124108|NCT02475213|464749501|FG003|Overall Study|Death|0|||
129124109|NCT02475213|464749502|FG004|Overall Study|Death|0|||
129124110|NCT02475213|464749503|FG005|Overall Study|Death|4|||
129124111|NCT02475213|464749504|FG006|Overall Study|Death|1|||
129124112|NCT02475213|464749505|FG007|Overall Study|Death|0|||
129124113|NCT02475213|464749498|FG000|Overall Study|Protocol Violation|0|||
129124114|NCT02475213|464749499|FG001|Overall Study|Protocol Violation|0|||
129218131|NCT02754440|465098563|FG001|Overall Study|Withdrawal by Subject|0|||
128947543|NCT01697267|464094571|FG001|Overall Study|Lost to Follow-up|4|||
128947544|NCT01697267|464094570|FG000|Overall Study|Physician Decision|2|||
129124115|NCT02475213|464749500|FG002|Overall Study|Protocol Violation|0|||
129124116|NCT02475213|464749501|FG003|Overall Study|Protocol Violation|0|||
129218132|NCT02754440|465098564|FG002|Overall Study|Withdrawal by Subject|0|||
128947545|NCT01697267|464094571|FG001|Overall Study|Physician Decision|4|||
128947546|NCT00333619|464094572|FG000|Overall Study|Death|12|||
128947547|NCT00333619|464094573|FG001|Overall Study|Death|6|||
128947548|NCT00333619|464094572|FG000|Overall Study|Withdrawal by Subject|6|||
128947549|NCT00333619|464094573|FG001|Overall Study|Withdrawal by Subject|1|||
128947550|NCT00333619|464094572|FG000|Overall Study|Lost to Follow-up|3|||
128947551|NCT00333619|464094573|FG001|Overall Study|Lost to Follow-up|3|||
128947552|NCT01626352|464094574|FG000|Overall Study|Disease Progression|3|||
128947553|NCT01626352|464094574|FG000|Overall Study|Intercurrent Illness|2|||
128947554|NCT01626352|464094574|FG000|Overall Study|Death|2|||
128947555|NCT01626352|464094574|FG000|Overall Study|Withdrawal by Subject|1|||
129124117|NCT02475213|464749502|FG004|Overall Study|Protocol Violation|1|||
129124118|NCT02475213|464749503|FG005|Overall Study|Protocol Violation|0|||
128708669|NCT00555321|463228471|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
128708670|NCT00555321|463228472|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
128708671|NCT00555321|463228468|FG000|Long-term Extension Phase|Other Reason|1|||
128708672|NCT00555321|463228469|FG001|Long-term Extension Phase|Other Reason|0|||
128708673|NCT00555321|463228470|FG002|Long-term Extension Phase|Other Reason|2|||
128708674|NCT00555321|463228471|FG003|Long-term Extension Phase|Other Reason|0|||
128708675|NCT00555321|463228472|FG004|Long-term Extension Phase|Other Reason|0|||
128708676|NCT03334448|463228478|FG000|Washout|Personal Reason|0|||
128708677|NCT03334448|463228479|FG001|Washout|Personal Reason|1|||
128708678|NCT03334448|463228480|FG002|Washout|Personal Reason|0|||
129124119|NCT02475213|464749504|FG006|Overall Study|Protocol Violation|0|||
128708679|NCT03334448|463228481|FG003|Washout|Personal Reason|0|||
128708680|NCT03334448|463228478|FG000|Washout|Protocol Violation|0|||
128708681|NCT03334448|463228479|FG001|Washout|Protocol Violation|0|||
129124120|NCT02475213|464749505|FG007|Overall Study|Protocol Violation|0|||
129124121|NCT02475213|464749498|FG000|Overall Study|Withdrawal by Subject|0|||
129124122|NCT02475213|464749499|FG001|Overall Study|Withdrawal by Subject|0|||
129124123|NCT02475213|464749500|FG002|Overall Study|Withdrawal by Subject|0|||
129124124|NCT02475213|464749501|FG003|Overall Study|Withdrawal by Subject|1|||
129124125|NCT02475213|464749502|FG004|Overall Study|Withdrawal by Subject|0|||
129124126|NCT02475213|464749503|FG005|Overall Study|Withdrawal by Subject|2|||
129124127|NCT02475213|464749504|FG006|Overall Study|Withdrawal by Subject|2|||
129124128|NCT02475213|464749505|FG007|Overall Study|Withdrawal by Subject|0|||
129124129|NCT02475213|464749498|FG000|Overall Study|Other|0|||
129124130|NCT02475213|464749499|FG001|Overall Study|Other|0|||
129124131|NCT02475213|464749500|FG002|Overall Study|Other|0|||
129124132|NCT02475213|464749501|FG003|Overall Study|Other|1|||
129124133|NCT02475213|464749502|FG004|Overall Study|Other|3|||
129124134|NCT02475213|464749503|FG005|Overall Study|Other|1|||
129124135|NCT02475213|464749504|FG006|Overall Study|Other|0|||
129124136|NCT02475213|464749505|FG007|Overall Study|Other|0|||
129124137|NCT00505921|464749506|FG000|Overall Study|Ineligible|1|||
129124138|NCT00505921|464749506|FG000|Overall Study|Failed to Mobilize|8|||
129124139|NCT02441283|464749507|FG000|Overall Study|Withdrew consent|15|||
129124140|NCT02441283|464749507|FG000|Overall Study|Lost to Follow-up|42|||
129124141|NCT02441283|464749507|FG000|Overall Study|Death|1|||
129124142|NCT02441283|464749507|FG000|Overall Study|Other, not specified|32|||
129124143|NCT02382939|464749513|FG000|Overall Study|Adverse Event|1|||
129124144|NCT02382939|464749514|FG001|Overall Study|Adverse Event|1|||
129124145|NCT02382939|464749513|FG000|Overall Study|Withdrawal by Subject|2|||
129124146|NCT02382939|464749514|FG001|Overall Study|Withdrawal by Subject|2|||
129124147|NCT00537277|464749517|FG000|Overall Study|Adverse Event|1|||
128708682|NCT03334448|463228480|FG002|Washout|Protocol Violation|0|||
128708683|NCT03334448|463228481|FG003|Washout|Protocol Violation|1|||
128708684|NCT01683383|463228483|FG000|Overall Study|Infant was not transported|1|||
128708685|NCT01683383|463228484|FG001|Overall Study|Infant was not transported|0|||
128708686|NCT00855920|463228485|FG000|Overall Study|Protocol Violation|0|||
129124148|NCT00537277|464749517|FG000|Overall Study|Lack of Efficacy|2|||
129124149|NCT00537277|464749517|FG000|Overall Study|Lost to Follow-up|12|||
129124150|NCT00537277|464749517|FG000|Overall Study|Protocol Violation|11|||
129124151|NCT00537277|464749517|FG000|Overall Study|Unclassified|4|||
129124152|NCT00537277|464749517|FG000|Overall Study|Inability to tolerate trial medication|4|||
128708687|NCT00855920|463228486|FG001|Overall Study|Protocol Violation|0|||
128708688|NCT00855920|463228487|FG002|Overall Study|Protocol Violation|2|||
128708689|NCT00855920|463228485|FG000|Overall Study|Adverse Event|2|||
128708690|NCT00855920|463228486|FG001|Overall Study|Adverse Event|1|||
128708691|NCT00855920|463228487|FG002|Overall Study|Adverse Event|1|||
129124153|NCT00537277|464749517|FG000|Overall Study|Non-compliance with trial procedures|15|||
128947556|NCT01626352|464094574|FG000|Overall Study|Non-Compliance|1|||
129124154|NCT01838876|464749518|FG000|Overall Study|Adverse Event|49|||
129124155|NCT01838876|464749518|FG000|Overall Study|Insufficient Therapeutic Response|10|||
129124156|NCT01838876|464749518|FG000|Overall Study|Protocol Violation|34|||
129124157|NCT01838876|464749518|FG000|Overall Study|Withdrawal of Consent|33|||
129124158|NCT01838876|464749518|FG000|Overall Study|Lost to Follow-up|21|||
129124159|NCT01838876|464749518|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
129124160|NCT01838876|464749518|FG000|Overall Study|Reason not Specified|7|||
129124161|NCT01838876|464749518|FG000|Overall Study|Did not meet eligibility criteria|78|||
129124162|NCT02101294|464749519|FG000|Overall Study|Withdrawal by Subject|5|||
129218133|NCT02754440|465098565|FG003|Overall Study|Withdrawal by Subject|1|||
129218134|NCT02754440|465098562|FG000|Overall Study|Equipment failure|0|||
129218135|NCT02754440|465098563|FG001|Overall Study|Equipment failure|5|||
128708692|NCT00855920|463228485|FG000|Overall Study|Lack of Efficacy|2|||
128708693|NCT00855920|463228486|FG001|Overall Study|Lack of Efficacy|2|||
128708694|NCT00855920|463228487|FG002|Overall Study|Lack of Efficacy|2|||
128708695|NCT00855920|463228485|FG000|Overall Study|Withdrawal by Subject|2|||
128708696|NCT00855920|463228486|FG001|Overall Study|Withdrawal by Subject|3|||
128708697|NCT00855920|463228487|FG002|Overall Study|Withdrawal by Subject|2|||
128708698|NCT00855920|463228485|FG000|Overall Study|Lost to Follow-up|1|||
128708699|NCT00855920|463228486|FG001|Overall Study|Lost to Follow-up|0|||
129124163|NCT02101294|464749519|FG000|Overall Study|Lost to Follow-up|6|||
129124164|NCT01311661|464749522|FG000|Overall Study|Adverse Event|2|||
129124165|NCT01311661|464749522|FG000|Overall Study|Protocol Violation|3|||
129124166|NCT01311661|464749522|FG000|Overall Study|Withdrawal by Subject|2|||
129124167|NCT00207740|464749525|FG000|Overall Study|Adverse Event|4|||
129124168|NCT00207740|464749526|FG001|Overall Study|Adverse Event|14|||
129124169|NCT00207740|464749527|FG002|Overall Study|Adverse Event|14|||
129124170|NCT00207740|464749528|FG003|Overall Study|Adverse Event|11|||
129124171|NCT00207740|464749525|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129124172|NCT00207740|464749526|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129124173|NCT00207740|464749527|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129124174|NCT00207740|464749528|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
129124175|NCT00207740|464749525|FG000|Overall Study|Lost to Follow-up|0|||
129124176|NCT00207740|464749526|FG001|Overall Study|Lost to Follow-up|2|||
129124177|NCT00207740|464749527|FG002|Overall Study|Lost to Follow-up|1|||
129124178|NCT00207740|464749528|FG003|Overall Study|Lost to Follow-up|1|||
129124179|NCT00207740|464749525|FG000|Overall Study|Death|0|||
129124180|NCT00207740|464749526|FG001|Overall Study|Death|0|||
129124181|NCT00207740|464749527|FG002|Overall Study|Death|0|||
129124182|NCT00207740|464749528|FG003|Overall Study|Death|1|||
129124183|NCT00207740|464749525|FG000|Overall Study|Sponsor Directive|22|||
129124184|NCT00207740|464749526|FG001|Overall Study|Sponsor Directive|15|||
129124185|NCT00207740|464749527|FG002|Overall Study|Sponsor Directive|16|||
128708700|NCT00855920|463228487|FG002|Overall Study|Lost to Follow-up|2|||
128708701|NCT00855920|463228485|FG000|Overall Study|Death|0|||
128708702|NCT00855920|463228486|FG001|Overall Study|Death|1|||
128708703|NCT00855920|463228487|FG002|Overall Study|Death|0|||
128708704|NCT00855920|463228485|FG000|Overall Study|Decision by the sponsor|0|||
128708705|NCT00855920|463228486|FG001|Overall Study|Decision by the sponsor|1|||
128708706|NCT00855920|463228487|FG002|Overall Study|Decision by the sponsor|1|||
128708707|NCT00855920|463228485|FG000|Overall Study|Other than specified above|1|||
128708708|NCT00855920|463228486|FG001|Overall Study|Other than specified above|1|||
128708709|NCT00855920|463228487|FG002|Overall Study|Other than specified above|1|||
128708710|NCT00996307|463228488|FG000|Overall Study|Adverse Event|0|||
128708711|NCT00996307|463228489|FG001|Overall Study|Adverse Event|1|||
128708712|NCT00996307|463228490|FG002|Overall Study|Adverse Event|0|||
128708713|NCT00996307|463228491|FG003|Overall Study|Adverse Event|0|||
128708714|NCT00996307|463228488|FG000|Overall Study|Withdrawal by Subject|3|||
128708715|NCT00996307|463228489|FG001|Overall Study|Withdrawal by Subject|2|||
128708716|NCT00996307|463228490|FG002|Overall Study|Withdrawal by Subject|5|||
128708717|NCT00996307|463228491|FG003|Overall Study|Withdrawal by Subject|5|||
128708718|NCT00996307|463228488|FG000|Overall Study|Lost to Follow-up|13|||
128947557|NCT01626352|464094574|FG000|Overall Study|Never Treated|1|||
129124186|NCT00207740|464749528|FG003|Overall Study|Sponsor Directive|21|||
129124187|NCT00207740|464749525|FG000|Overall Study|Other|2|||
129124188|NCT00207740|464749526|FG001|Overall Study|Other|10|||
129124189|NCT00207740|464749527|FG002|Overall Study|Other|7|||
129124190|NCT00207740|464749528|FG003|Overall Study|Other|5|||
129124191|NCT00390013|464749529|FG000|Phase 1|tired|0|||
129124192|NCT00390013|464749530|FG001|Phase 1|tired|0|||
129124193|NCT00390013|464749531|FG002|Phase 1|tired|0|||
129218136|NCT02754440|465098564|FG002|Overall Study|Equipment failure|5|||
128708719|NCT00996307|463228489|FG001|Overall Study|Lost to Follow-up|13|||
128708720|NCT00996307|463228490|FG002|Overall Study|Lost to Follow-up|7|||
128708721|NCT00996307|463228491|FG003|Overall Study|Lost to Follow-up|15|||
128708722|NCT00996307|463228488|FG000|Overall Study|Administrative reason|0|||
128708723|NCT00996307|463228489|FG001|Overall Study|Administrative reason|1|||
128708724|NCT00996307|463228490|FG002|Overall Study|Administrative reason|0|||
128708725|NCT00996307|463228491|FG003|Overall Study|Administrative reason|0|||
129124194|NCT00390013|464749532|FG003|Phase 1|tired|1|||
129124195|NCT00390013|464749529|FG000|Phase 2 First Treatment|tired|1|||
129124196|NCT00390013|464749530|FG001|Phase 2 First Treatment|tired|0|||
129124197|NCT00390013|464749531|FG002|Phase 2 First Treatment|tired|0|||
129218137|NCT02754440|465098565|FG003|Overall Study|Equipment failure|7|||
128708726|NCT00996307|463228488|FG000|Overall Study|Unable to classify|4|||
129124198|NCT00390013|464749532|FG003|Phase 2 First Treatment|tired|0|||
129124199|NCT00390013|464749529|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
128708727|NCT00996307|463228489|FG001|Overall Study|Unable to classify|0|||
128708728|NCT00996307|463228490|FG002|Overall Study|Unable to classify|2|||
128947558|NCT00798655|464094575|FG000|Overall Study|Did not receive at least one dose of pan|2|||
128947559|NCT00343291|464094576|FG000|Overall Study|Adverse Event|13|||
128947560|NCT00343291|464094577|FG001|Overall Study|Adverse Event|13|||
128947561|NCT00343291|464094576|FG000|Overall Study|Death|3|||
128947562|NCT00343291|464094577|FG001|Overall Study|Death|2|||
128947563|NCT00343291|464094576|FG000|Overall Study|Progressive disease|33|||
128947564|NCT00343291|464094577|FG001|Overall Study|Progressive disease|34|||
128947565|NCT00343291|464094576|FG000|Overall Study|Withdrawal by Subject|0|||
128947566|NCT00343291|464094577|FG001|Overall Study|Withdrawal by Subject|2|||
128947567|NCT00343291|464094576|FG000|Overall Study|Other|8|||
128947568|NCT00343291|464094577|FG001|Overall Study|Other|5|||
128947569|NCT02338492|464094584|FG000|Overall Study|Death|32|||
128947570|NCT02338492|464094584|FG000|Overall Study|Adverse Event|3|||
128947571|NCT02338492|464094584|FG000|Overall Study|Lost to Follow-up|4|||
128947572|NCT02338492|464094584|FG000|Overall Study|Reason not captured above|6|||
128947573|NCT01071096|464094585|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
128947574|NCT01071096|464094586|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
128947575|NCT04348656|464094587|FG000|Overall Study|Withdrawal by Subject|2|||
128947576|NCT04348656|464094588|FG001|Overall Study|Withdrawal by Subject|0|||
128947577|NCT04348656|464094587|FG000|Overall Study|Lost to Follow-up|11|||
128947578|NCT04348656|464094588|FG001|Overall Study|Lost to Follow-up|6|||
128947579|NCT00937560|464094592|FG000|Initial Treatment|Death|6|||
128947580|NCT00937560|464094592|FG000|Initial Treatment|Withdraw consent|3|||
128947581|NCT00937560|464094592|FG000|Initial Treatment|Adverse Event|1|||
128947582|NCT00937560|464094592|FG000|Initial Treatment|Lost to Follow-up|1|||
128947583|NCT00937560|464094592|FG000|Initial Treatment|No end of study page|10|||
128947584|NCT00937560|464094592|FG000|Maintenance Treatment|Death|12|||
128947585|NCT00937560|464094592|FG000|Maintenance Treatment|Withdraw consent|5|||
128947586|NCT00937560|464094592|FG000|Maintenance Treatment|According to protocol|1|||
128947587|NCT03421964|464094596|FG000|Overall Study|Lost to Follow-up|11|||
128947588|NCT03421964|464094597|FG001|Overall Study|Lost to Follow-up|21|||
128947589|NCT03421964|464094596|FG000|Overall Study|Withdrawal by Subject|9|||
128947590|NCT03421964|464094597|FG001|Overall Study|Withdrawal by Subject|3|||
128947591|NCT03421964|464094596|FG000|Overall Study|Incarcerated|1|||
128947592|NCT03421964|464094597|FG001|Overall Study|Incarcerated|0|||
128947593|NCT03421964|464094596|FG000|Overall Study|Inpt Treatment Facility|1|||
128947594|NCT03421964|464094597|FG001|Overall Study|Inpt Treatment Facility|1|||
128947595|NCT03421964|464094596|FG000|Overall Study|Virtual Platform Issues|1|||
128947596|NCT03421964|464094597|FG001|Overall Study|Virtual Platform Issues|1|||
128947597|NCT00229203|464094600|FG000|Overall Study|Progressive disease|18|||
128947598|NCT00229203|464094601|FG001|Overall Study|Progressive disease|9|||
128947599|NCT00229203|464094600|FG000|Overall Study|Toxicity|6|||
128947600|NCT00229203|464094601|FG001|Overall Study|Toxicity|1|||
128947601|NCT00229203|464094600|FG000|Overall Study|Death|4|||
128947602|NCT00229203|464094601|FG001|Overall Study|Death|2|||
128947603|NCT00229203|464094600|FG000|Overall Study|Other|3|||
128947604|NCT00229203|464094601|FG001|Overall Study|Other|3|||
128947605|NCT00229203|464094600|FG000|Overall Study|Withdrawal by Subject|1|||
128947606|NCT00229203|464094601|FG001|Overall Study|Withdrawal by Subject|4|||
128947607|NCT03607838|464094602|FG000|Overall Study|Lack of Efficacy|14|||
128947608|NCT03607838|464094603|FG001|Overall Study|Lack of Efficacy|20|||
128947609|NCT03607838|464094602|FG000|Overall Study|Withdrawal by Subject|13|||
128947610|NCT03607838|464094603|FG001|Overall Study|Withdrawal by Subject|8|||
129124200|NCT00390013|464749530|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
129124201|NCT00390013|464749531|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
129124202|NCT00390013|464749532|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
129124203|NCT00924898|464749538|FG000|Overall Study|Withdrawal by Subject|2|||
129124204|NCT01285518|464749539|FG000|Overall Study|Lost to Follow-up|0|||
129124205|NCT01285518|464749540|FG001|Overall Study|Lost to Follow-up|0|||
129124206|NCT01285518|464749541|FG002|Overall Study|Lost to Follow-up|0|||
129124207|NCT01285518|464749542|FG003|Overall Study|Lost to Follow-up|0|||
128708729|NCT00996307|463228491|FG003|Overall Study|Unable to classify|1|||
128708730|NCT02496611|463228494|FG000|Overall Study|Lost to Follow-up|2|||
128708731|NCT02496611|463228495|FG001|Overall Study|Lost to Follow-up|1|||
129124208|NCT01285518|464749543|FG004|Overall Study|Lost to Follow-up|0|||
129124209|NCT01285518|464749544|FG005|Overall Study|Lost to Follow-up|1|||
129124210|NCT01285518|464749545|FG006|Overall Study|Lost to Follow-up|0|||
128947611|NCT03607838|464094602|FG000|Overall Study|Lost to Follow-up|6|||
128947612|NCT03607838|464094603|FG001|Overall Study|Lost to Follow-up|11|||
128947613|NCT03607838|464094602|FG000|Overall Study|Adverse Event|2|||
128947614|NCT03607838|464094603|FG001|Overall Study|Adverse Event|2|||
129124211|NCT01285518|464749546|FG007|Overall Study|Lost to Follow-up|0|||
128708732|NCT02496611|463228494|FG000|Overall Study|Withdrawal by Subject|5|||
128947615|NCT03607838|464094602|FG000|Overall Study|Physician Decision|2|||
129124212|NCT00294658|464749547|FG000|Overall Study|Death|0|||
128947616|NCT03607838|464094603|FG001|Overall Study|Physician Decision|0|||
128947617|NCT03607838|464094602|FG000|Overall Study|Failure to meet randomization criteria|1|||
128708733|NCT02496611|463228495|FG001|Overall Study|Withdrawal by Subject|2|||
128708734|NCT02788357|463228499|FG000|Overall Study|Lost to Follow-up|3|||
128708735|NCT02788357|463228500|FG001|Overall Study|Lost to Follow-up|0|||
128708736|NCT01365910|463228501|FG000|Overall Study|Withdrawal by Subject|7|||
128947618|NCT03607838|464094603|FG001|Overall Study|Failure to meet randomization criteria|2|||
128947619|NCT03607838|464094602|FG000|Overall Study|Pregnancy|1|||
128947620|NCT03607838|464094603|FG001|Overall Study|Pregnancy|0|||
128947621|NCT03607838|464094602|FG000|Overall Study|Protocol Violation|1|||
128947622|NCT03607838|464094603|FG001|Overall Study|Protocol Violation|0|||
128947623|NCT03607838|464094602|FG000|Overall Study|Due to work|1|||
128947624|NCT03607838|464094603|FG001|Overall Study|Due to work|0|||
128947625|NCT03607838|464094602|FG000|Overall Study|Litigation|0|||
128947626|NCT03607838|464094603|FG001|Overall Study|Litigation|1|||
128947627|NCT03607838|464094602|FG000|Overall Study|Temperature excursion for study drug|0|||
128947628|NCT03607838|464094603|FG001|Overall Study|Temperature excursion for study drug|1|||
128947629|NCT03607838|464094602|FG000|Overall Study|Change of mind|0|||
128947630|NCT03607838|464094603|FG001|Overall Study|Change of mind|1|||
128947631|NCT02546674|464094606|FG000|Overall Study|Adverse Event|19|||
128947632|NCT02546674|464094606|FG000|Overall Study|Death|1|||
128947633|NCT02546674|464094606|FG000|Overall Study|Lost to Follow-up|1|||
128947634|NCT02546674|464094606|FG000|Overall Study|Physician Decision|13|||
128947635|NCT02546674|464094606|FG000|Overall Study|Pregnancy|1|||
128947636|NCT02546674|464094606|FG000|Overall Study|Progressive Disease|2|||
128947637|NCT02546674|464094606|FG000|Overall Study|Protocol Deviation|2|||
128947638|NCT02546674|464094606|FG000|Overall Study|Subject/Guardian Decision|6|||
128947639|NCT02546674|464094606|FG000|Overall Study|Withdrawal of Informed Consent|3|||
128947640|NCT01163253|464094607|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
128947641|NCT01163253|464094608|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
128947642|NCT01163253|464094607|FG000|Overall Study|Study Terminated by Sponsor|978|||
128947643|NCT01163253|464094608|FG001|Overall Study|Study Terminated by Sponsor|349|||
128947644|NCT01163253|464094607|FG000|Overall Study|Protocol Violation|43|||
129124213|NCT00294658|464749548|FG001|Overall Study|Death|1|||
129124214|NCT00294658|464749547|FG000|Overall Study|Lost to Follow-up|4|||
129124215|NCT00294658|464749548|FG001|Overall Study|Lost to Follow-up|0|||
129124216|NCT00294658|464749547|FG000|Overall Study|Physician Decision|1|||
129124217|NCT00294658|464749548|FG001|Overall Study|Physician Decision|2|||
129124218|NCT00294658|464749547|FG000|Overall Study|Pregnancy|0|||
129124219|NCT00294658|464749548|FG001|Overall Study|Pregnancy|1|||
129124220|NCT00294658|464749547|FG000|Overall Study|Withdrawal by Subject|0|||
129124221|NCT00294658|464749548|FG001|Overall Study|Withdrawal by Subject|4|||
129124222|NCT00294658|464749547|FG000|Overall Study|Found to have invasive thymoma|1|||
129124223|NCT00294658|464749548|FG001|Overall Study|Found to have invasive thymoma|0|||
129124224|NCT00294658|464749547|FG000|Overall Study|Patient and family were not satisfied|0|||
129124225|NCT00294658|464749548|FG001|Overall Study|Patient and family were not satisfied|1|||
129124226|NCT01910441|464749554|FG000|Overall Study|Sponsor decision|0|||
129124227|NCT01910441|464749555|FG001|Overall Study|Sponsor decision|2|||
129124228|NCT01910441|464749554|FG000|Overall Study|Lost to Follow-up|6|||
129124229|NCT01910441|464749555|FG001|Overall Study|Lost to Follow-up|5|||
129124230|NCT01910441|464749554|FG000|Overall Study|Withdrawal by Subject|0|||
129124231|NCT01910441|464749555|FG001|Overall Study|Withdrawal by Subject|1|||
129124232|NCT01910441|464749554|FG000|Overall Study|Non-compliance|0|||
129124233|NCT01910441|464749555|FG001|Overall Study|Non-compliance|1|||
129124234|NCT01910441|464749554|FG000|Overall Study|Adverse Event|1|||
129124235|NCT01910441|464749555|FG001|Overall Study|Adverse Event|0|||
129124236|NCT01910441|464749554|FG000|Overall Study|Physician Decision|0|||
129124237|NCT01910441|464749555|FG001|Overall Study|Physician Decision|1|||
129124238|NCT01811238|464749556|FG000|Overall Study|Withdrawal by Subject|42|||
129124239|NCT01811238|464749556|FG000|Overall Study|Adverse Event|25|||
129124240|NCT01811238|464749556|FG000|Overall Study|Protocol Violation|4|||
129124241|NCT01811238|464749556|FG000|Overall Study|Lack of Efficacy|4|||
129124242|NCT01811238|464749556|FG000|Overall Study|subject refused study medication|6|||
129124243|NCT02340949|464749557|FG000|Overall Study|Adverse Event|4|||
129124244|NCT02340949|464749558|FG001|Overall Study|Adverse Event|2|||
129124245|NCT02340949|464749557|FG000|Overall Study|Withdrawal by Subject|2|||
128708737|NCT01365910|463228501|FG000|Overall Study|disease progression|18|||
128947645|NCT01163253|464094608|FG001|Overall Study|Protocol Violation|12|||
128947646|NCT01163253|464094607|FG000|Overall Study|Withdrawal by Subject|199|||
128947647|NCT01163253|464094608|FG001|Overall Study|Withdrawal by Subject|50|||
128947648|NCT01163253|464094607|FG000|Overall Study|Medication Error|1|||
128947649|NCT01163253|464094608|FG001|Overall Study|Medication Error|0|||
128947650|NCT01163253|464094607|FG000|Overall Study|Lost to Follow-up|125|||
129124246|NCT02340949|464749558|FG001|Overall Study|Withdrawal by Subject|0|||
129124247|NCT02340949|464749557|FG000|Overall Study|Progression disease|6|||
129124248|NCT02340949|464749558|FG001|Overall Study|Progression disease|2|||
129124249|NCT02340949|464749557|FG000|Overall Study|Death|3|||
129218138|NCT02754440|465098562|FG000|Overall Study|Subject issues not resulting in AE|0|||
128708738|NCT01365910|463228501|FG000|Overall Study|Adverse Event|3|||
129124250|NCT02340949|464749558|FG001|Overall Study|Death|0|||
129124251|NCT02340949|464749557|FG000|Overall Study|Physician Decision|1|||
129124252|NCT02340949|464749558|FG001|Overall Study|Physician Decision|0|||
129124253|NCT01192178|464749559|FG000|Overall Study|Withdrawal by Subject|6|||
129124254|NCT01192178|464749560|FG001|Overall Study|Withdrawal by Subject|10|||
129124255|NCT01192178|464749559|FG000|Overall Study|Protocol Violation|10|||
129124256|NCT01192178|464749560|FG001|Overall Study|Protocol Violation|3|||
129124257|NCT01192178|464749559|FG000|Overall Study|Physician Decision|2|||
129124258|NCT01192178|464749560|FG001|Overall Study|Physician Decision|4|||
129124259|NCT01192178|464749559|FG000|Overall Study|Lost to Follow-up|3|||
129124260|NCT01192178|464749560|FG001|Overall Study|Lost to Follow-up|3|||
129124261|NCT01192178|464749559|FG000|Overall Study|Adverse Event|2|||
129124262|NCT01192178|464749560|FG001|Overall Study|Adverse Event|1|||
129124263|NCT01192178|464749559|FG000|Overall Study|Lack of Efficacy|1|||
129124264|NCT01192178|464749560|FG001|Overall Study|Lack of Efficacy|2|||
129124265|NCT00296517|464749561|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
129124266|NCT00296517|464749562|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
129124267|NCT00296517|464749561|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
129124268|NCT00296517|464749562|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
129124269|NCT00296517|464749561|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
129124270|NCT00296517|464749562|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
129124271|NCT00296517|464749561|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
129124272|NCT00296517|464749562|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
128947651|NCT01163253|464094608|FG001|Overall Study|Lost to Follow-up|23|||
128947652|NCT01163253|464094607|FG000|Overall Study|Insufficient Clinical Response|423|||
128947653|NCT01163253|464094608|FG001|Overall Study|Insufficient Clinical Response|29|||
128947654|NCT01163253|464094607|FG000|Overall Study|Adverse Event|300|||
128947655|NCT01163253|464094608|FG001|Overall Study|Adverse Event|78|||
128947656|NCT01163253|464094607|FG000|Overall Study|Death|17|||
128947657|NCT01163253|464094608|FG001|Overall Study|Death|5|||
128947658|NCT01163253|464094607|FG000|Overall Study|Ongoing|13|||
128947659|NCT01163253|464094608|FG001|Overall Study|Ongoing|4|||
128947660|NCT01163253|464094607|FG000|Overall Study|Other Unspecified|170|||
128947661|NCT01163253|464094608|FG001|Overall Study|Other Unspecified|34|||
128947662|NCT02492997|464094609|FG000|Overall Study|Withdrawal by Subject|1|||
128947663|NCT02492997|464094610|FG001|Overall Study|Withdrawal by Subject|0|||
128947664|NCT02492997|464094609|FG000|Overall Study|Gained Weight|1|||
128947665|NCT02492997|464094610|FG001|Overall Study|Gained Weight|0|||
128947666|NCT02492997|464094609|FG000|Overall Study|Lost to Follow-up|0|||
128947667|NCT02492997|464094610|FG001|Overall Study|Lost to Follow-up|1|||
128947668|NCT00423735|464094611|FG000|Overall Study|Ineligible / No protocol treatment|8|||
128947669|NCT00423735|464094612|FG001|Overall Study|Ineligible / No protocol treatment|6|||
128947670|NCT00423735|464094613|FG002|Overall Study|Ineligible / No protocol treatment|0|||
128947671|NCT02864940|464094614|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
128947672|NCT02864940|464094615|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
128947673|NCT00579501|464094620|FG000|Overall Study|Death|1|||
128947674|NCT00579501|464094620|FG000|Overall Study|End of neoadjuvant therapy|25|||
128947675|NCT00579501|464094620|FG000|Overall Study|toxicity|1|||
128947676|NCT00579501|464094620|FG000|Overall Study|Secondary lesion|1|||
128947677|NCT00579501|464094620|FG000|Overall Study|Radiation therapy before surgery|1|||
128947678|NCT03364673|464094621|FG000|Overall Study|Withdrawal by Subject|2|||
128947679|NCT03364673|464094621|FG000|Overall Study|Injury unrelated to study|3|||
128947680|NCT03025217|464094622|FG000|Overall Study|Pregnancy|1|||
128947681|NCT03025217|464094622|FG000|Overall Study|Lost to Follow-up|1|||
128947682|NCT03025217|464094622|FG000|Overall Study|Not eligible, poor English|2|||
128947683|NCT02208024|464094623|FG000|Overall Study|Withdrawal by Subject|1|||
128947684|NCT04096326|464094624|FG000|Overall Study|Withdrawal by Subject|0|||
128947685|NCT04096326|464094625|FG001|Overall Study|Withdrawal by Subject|0|||
128947686|NCT04096326|464094626|FG002|Overall Study|Withdrawal by Subject|0|||
128947687|NCT04096326|464094627|FG003|Overall Study|Withdrawal by Subject|0|||
129124273|NCT00296517|464749561|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
129124274|NCT00296517|464749562|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
129124275|NCT00296517|464749561|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
129124276|NCT00296517|464749562|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
129124277|NCT00296517|464749561|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
129124278|NCT00296517|464749562|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
129124279|NCT00296517|464749561|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
129124280|NCT00296517|464749562|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
129124281|NCT00296517|464749561|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
129218139|NCT02754440|465098563|FG001|Overall Study|Subject issues not resulting in AE|0|||
128947688|NCT04096326|464094628|FG004|Overall Study|Withdrawal by Subject|0|||
128947689|NCT04096326|464094629|FG005|Overall Study|Withdrawal by Subject|0|||
128947690|NCT04096326|464094630|FG006|Overall Study|Withdrawal by Subject|1|||
128947691|NCT04096326|464094631|FG007|Overall Study|Withdrawal by Subject|0|||
128947692|NCT04096326|464094632|FG008|Overall Study|Withdrawal by Subject|0|||
128947693|NCT04096326|464094633|FG009|Overall Study|Withdrawal by Subject|0|||
128947694|NCT04096326|464094624|FG000|Overall Study|Lost to Follow-up|0|||
128947695|NCT04096326|464094625|FG001|Overall Study|Lost to Follow-up|1|||
128947696|NCT04096326|464094626|FG002|Overall Study|Lost to Follow-up|0|||
128947697|NCT04096326|464094627|FG003|Overall Study|Lost to Follow-up|0|||
128947698|NCT04096326|464094628|FG004|Overall Study|Lost to Follow-up|0|||
128947699|NCT04096326|464094629|FG005|Overall Study|Lost to Follow-up|0|||
128947700|NCT04096326|464094630|FG006|Overall Study|Lost to Follow-up|0|||
128947701|NCT04096326|464094631|FG007|Overall Study|Lost to Follow-up|0|||
128947702|NCT04096326|464094632|FG008|Overall Study|Lost to Follow-up|0|||
128947703|NCT04096326|464094633|FG009|Overall Study|Lost to Follow-up|0|||
128947704|NCT04096326|464094624|FG000|Overall Study|COVID-19-related reasons|0|||
128947705|NCT04096326|464094625|FG001|Overall Study|COVID-19-related reasons|0|||
128947706|NCT04096326|464094626|FG002|Overall Study|COVID-19-related reasons|0|||
128947707|NCT04096326|464094627|FG003|Overall Study|COVID-19-related reasons|0|||
128947708|NCT04096326|464094628|FG004|Overall Study|COVID-19-related reasons|1|||
128947709|NCT04096326|464094629|FG005|Overall Study|COVID-19-related reasons|5|||
128947710|NCT04096326|464094630|FG006|Overall Study|COVID-19-related reasons|0|||
128947711|NCT04096326|464094631|FG007|Overall Study|COVID-19-related reasons|0|||
128947712|NCT04096326|464094632|FG008|Overall Study|COVID-19-related reasons|0|||
128947713|NCT04096326|464094633|FG009|Overall Study|COVID-19-related reasons|0|||
128947714|NCT00194025|464094634|FG000|Overall Study|Adverse Event|1|||
128947715|NCT00194025|464094634|FG000|Overall Study|non-adherence with study medication|4|||
128947716|NCT04804033|464094638|FG000|Period 1: DBT Phase|Adverse Event|1|||
128947717|NCT04804033|464094639|FG001|Period 1: DBT Phase|Adverse Event|5|||
128947718|NCT04804033|464094640|FG002|Period 1: DBT Phase|Adverse Event|3|||
128947719|NCT04804033|464094641|FG003|Period 1: DBT Phase|Adverse Event|4|||
128947720|NCT04804033|464094638|FG000|Period 1: DBT Phase|Death|1|||
128947721|NCT04804033|464094639|FG001|Period 1: DBT Phase|Death|0|||
128947722|NCT04804033|464094640|FG002|Period 1: DBT Phase|Death|0|||
128947723|NCT04804033|464094641|FG003|Period 1: DBT Phase|Death|0|||
128947724|NCT04804033|464094638|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
128947725|NCT04804033|464094639|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
128947726|NCT04804033|464094640|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
128947727|NCT04804033|464094641|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
128947728|NCT04804033|464094638|FG000|Period 1: DBT Phase|Non-compliance|1|||
128947729|NCT04804033|464094639|FG001|Period 1: DBT Phase|Non-compliance|0|||
128947730|NCT04804033|464094640|FG002|Period 1: DBT Phase|Non-compliance|1|||
128947731|NCT04804033|464094641|FG003|Period 1: DBT Phase|Non-compliance|2|||
129034098|NCT01688882|464414206|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129034099|NCT01688882|464414205|FG000|Overall Study|Administrative problems|1|||
129034100|NCT01688882|464414206|FG001|Overall Study|Administrative problems|0|||
129034101|NCT00889252|464414208|FG000|Overall Study|Adverse Event|2|||
129034102|NCT00889252|464414209|FG001|Overall Study|Adverse Event|4|||
129034103|NCT00889252|464414208|FG000|Overall Study|Withdrawal by Subject|3|||
129034104|NCT00889252|464414209|FG001|Overall Study|Withdrawal by Subject|0|||
129034105|NCT00889252|464414208|FG000|Overall Study|Protocol Violation|2|||
129034106|NCT00889252|464414209|FG001|Overall Study|Protocol Violation|0|||
129034107|NCT01160640|464414213|FG000|Overall Study|Physician Decision|3|||
129034108|NCT01160640|464414214|FG001|Overall Study|Physician Decision|3|||
129034109|NCT01160640|464414213|FG000|Overall Study|Incarceration|1|||
129034110|NCT01160640|464414214|FG001|Overall Study|Incarceration|0|||
129034111|NCT01160640|464414213|FG000|Overall Study|Withdrawal by Subject|0|||
129034112|NCT01160640|464414214|FG001|Overall Study|Withdrawal by Subject|3|||
129034113|NCT00642811|464414215|FG000|Overall Study|Adverse Event|2|||
129034114|NCT00642811|464414216|FG001|Overall Study|Adverse Event|3|||
129034115|NCT00642811|464414217|FG002|Overall Study|Adverse Event|0|||
129034116|NCT00642811|464414218|FG003|Overall Study|Adverse Event|0|||
129034117|NCT00642811|464414219|FG004|Overall Study|Adverse Event|0|||
129034118|NCT00642811|464414220|FG005|Overall Study|Adverse Event|1|||
129034119|NCT00642811|464414215|FG000|Overall Study|Developement of discontinuation criteria|0|||
129034120|NCT00642811|464414216|FG001|Overall Study|Developement of discontinuation criteria|0|||
129034121|NCT00642811|464414217|FG002|Overall Study|Developement of discontinuation criteria|0|||
129034122|NCT00642811|464414218|FG003|Overall Study|Developement of discontinuation criteria|0|||
128708739|NCT01365910|463228501|FG000|Overall Study|other complicating disease|1|||
128947732|NCT04804033|464094638|FG000|Period 1: DBT Phase|Other|0|||
128947733|NCT04804033|464094639|FG001|Period 1: DBT Phase|Other|1|||
128947734|NCT04804033|464094640|FG002|Period 1: DBT Phase|Other|0|||
128947735|NCT04804033|464094641|FG003|Period 1: DBT Phase|Other|0|||
128947736|NCT04804033|464094638|FG000|Period 1: DBT Phase|Pregnancy|2|||
128947737|NCT04804033|464094639|FG001|Period 1: DBT Phase|Pregnancy|0|||
128947738|NCT04804033|464094640|FG002|Period 1: DBT Phase|Pregnancy|0|||
128947739|NCT04804033|464094641|FG003|Period 1: DBT Phase|Pregnancy|0|||
129034123|NCT00642811|464414219|FG004|Overall Study|Developement of discontinuation criteria|1|||
129034124|NCT00642811|464414220|FG005|Overall Study|Developement of discontinuation criteria|0|||
129124282|NCT00296517|464749562|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
128708740|NCT01365910|463228501|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
128708741|NCT00371137|463228502|FG000|Overall Study|Adverse Event|20|||
128947740|NCT04804033|464094638|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
128947741|NCT04804033|464094639|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
128708742|NCT00371137|463228503|FG001|Overall Study|Adverse Event|35|||
128708743|NCT00371137|463228504|FG002|Overall Study|Adverse Event|42|||
128708744|NCT00371137|463228502|FG000|Overall Study|Withdrawal by Subject|11|||
128708745|NCT00371137|463228503|FG001|Overall Study|Withdrawal by Subject|10|||
128708746|NCT00371137|463228504|FG002|Overall Study|Withdrawal by Subject|15|||
128708747|NCT00371137|463228502|FG000|Overall Study|Lost to Follow-up|6|||
128947742|NCT04804033|464094640|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
128947743|NCT04804033|464094641|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
128947744|NCT04804033|464094638|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
128947745|NCT04804033|464094639|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
128947746|NCT04804033|464094640|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
128947747|NCT04804033|464094641|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
128947748|NCT04804033|464094638|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
128947749|NCT04804033|464094639|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
128947750|NCT04804033|464094640|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
128947751|NCT04804033|464094641|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
128947752|NCT04804033|464094638|FG000|Period 2: OLE Phase|Adverse Event|3|||
128947753|NCT04804033|464094639|FG001|Period 2: OLE Phase|Adverse Event|4|||
128947754|NCT04804033|464094640|FG002|Period 2: OLE Phase|Adverse Event|2|||
128947755|NCT04804033|464094641|FG003|Period 2: OLE Phase|Adverse Event|0|||
128947756|NCT04804033|464094638|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
128947757|NCT04804033|464094639|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
128947758|NCT04804033|464094640|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
128947759|NCT04804033|464094641|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
128947760|NCT04804033|464094638|FG000|Period 2: OLE Phase|Non-compliance|2|||
128947761|NCT04804033|464094639|FG001|Period 2: OLE Phase|Non-compliance|2|||
128947762|NCT04804033|464094640|FG002|Period 2: OLE Phase|Non-compliance|0|||
128947763|NCT04804033|464094641|FG003|Period 2: OLE Phase|Non-compliance|1|||
128947764|NCT04804033|464094638|FG000|Period 2: OLE Phase|Other|0|||
128947765|NCT04804033|464094639|FG001|Period 2: OLE Phase|Other|2|||
128947766|NCT04804033|464094640|FG002|Period 2: OLE Phase|Other|0|||
128947767|NCT04804033|464094641|FG003|Period 2: OLE Phase|Other|0|||
128947768|NCT04804033|464094638|FG000|Period 2: OLE Phase|Physician Decision|1|||
128947769|NCT04804033|464094639|FG001|Period 2: OLE Phase|Physician Decision|1|||
128947770|NCT04804033|464094640|FG002|Period 2: OLE Phase|Physician Decision|0|||
128947771|NCT04804033|464094641|FG003|Period 2: OLE Phase|Physician Decision|0|||
128947772|NCT04804033|464094638|FG000|Period 2: OLE Phase|Pregnancy|0|||
128947773|NCT04804033|464094639|FG001|Period 2: OLE Phase|Pregnancy|0|||
128947774|NCT04804033|464094640|FG002|Period 2: OLE Phase|Pregnancy|2|||
128947775|NCT04804033|464094641|FG003|Period 2: OLE Phase|Pregnancy|0|||
128947776|NCT04804033|464094638|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
128947777|NCT04804033|464094639|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
128947778|NCT04804033|464094640|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
128947779|NCT04804033|464094641|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
128947780|NCT04804033|464094638|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
128947781|NCT04804033|464094639|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
128947782|NCT04804033|464094640|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
128947783|NCT04804033|464094641|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
128947784|NCT04804033|464094638|FG000|Period 2: OLE Phase|Not reported|0|||
128947785|NCT04804033|464094639|FG001|Period 2: OLE Phase|Not reported|2|||
128947786|NCT04804033|464094640|FG002|Period 2: OLE Phase|Not reported|0|||
129124283|NCT01155570|464749563|FG000|Overall Study|Adverse Event|39|||
129124284|NCT01155570|464749563|FG000|Overall Study|Lack of Efficacy|46|||
129124285|NCT01155570|464749563|FG000|Overall Study|Participant's Economic Reasons|17|||
129124286|NCT01155570|464749563|FG000|Overall Study|No Hospital Visits|7|||
129124287|NCT01155570|464749563|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
129124288|NCT01155570|464749563|FG000|Overall Study|Adverse Event + Other Reasons|7|||
129124289|NCT01155570|464749563|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
129124290|NCT01155570|464749563|FG000|Overall Study|Other Reasons|23|||
129124291|NCT04584788|464749582|FG000|Overall Study|Physician Decision|8|||
129124292|NCT04584788|464749582|FG000|Overall Study|Withdrawal by Subject|1|||
128947787|NCT04804033|464094641|FG003|Period 2: OLE Phase|Not reported|0|||
128947788|NCT04804033|464094638|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
129124293|NCT04584788|464749582|FG000|Overall Study|Adverse Event|3|||
129124294|NCT03095287|464751302|FG000|Overall Study|Treatment Failure|1|||
129124295|NCT03095287|464751302|FG000|Overall Study|Adverse Event|1|||
128947789|NCT04804033|464094639|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
128947790|NCT04804033|464094640|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
129124296|NCT02394275|464751305|FG000|Overall Study|Adverse Event|22|||
128708748|NCT00371137|463228503|FG001|Overall Study|Lost to Follow-up|3|||
128947791|NCT04804033|464094641|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
128947792|NCT04804033|464094638|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
128947793|NCT04804033|464094639|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
128947794|NCT04804033|464094640|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
129124297|NCT02394275|464751305|FG000|Overall Study|Lost to Follow-up|7|||
129124298|NCT04757636|464751311|FG000|Overall Study|Adverse Event|25|||
128947795|NCT04804033|464094641|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
128947796|NCT04804033|464094638|FG000|Period 3: Follow-up Phase|Other|0|||
128947797|NCT04804033|464094639|FG001|Period 3: Follow-up Phase|Other|1|||
128947798|NCT04804033|464094640|FG002|Period 3: Follow-up Phase|Other|2|||
128947799|NCT04804033|464094641|FG003|Period 3: Follow-up Phase|Other|1|||
128947800|NCT04804033|464094638|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
128947801|NCT04804033|464094639|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
128947802|NCT04804033|464094640|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
128947803|NCT04804033|464094641|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
128947804|NCT04804033|464094638|FG000|Period 3: Follow-up Phase|Not reported|18|||
128947805|NCT04804033|464094639|FG001|Period 3: Follow-up Phase|Not reported|15|||
128947806|NCT04804033|464094640|FG002|Period 3: Follow-up Phase|Not reported|1|||
128947807|NCT04804033|464094641|FG003|Period 3: Follow-up Phase|Not reported|4|||
128947808|NCT00209170|464094642|FG000|Overall Study|Adverse Event|0|||
128947809|NCT00209170|464094643|FG001|Overall Study|Adverse Event|1|||
128947810|NCT00209170|464094642|FG000|Overall Study|Withdrawal by Subject|2|||
128947811|NCT00209170|464094643|FG001|Overall Study|Withdrawal by Subject|1|||
128947812|NCT00209170|464094642|FG000|Overall Study|Lack of Efficacy|0|||
128947813|NCT00209170|464094643|FG001|Overall Study|Lack of Efficacy|1|||
128947814|NCT00543569|464094644|FG000|Overall Study|Death|2|||
128947815|NCT00543569|464094645|FG001|Overall Study|Death|2|||
128947816|NCT00543569|464094646|FG002|Overall Study|Death|3|||
128947817|NCT00543569|464094647|FG003|Overall Study|Death|1|||
128947818|NCT00543569|464094644|FG000|Overall Study|Lost to Follow-up|0|||
128947819|NCT00543569|464094645|FG001|Overall Study|Lost to Follow-up|0|||
128947820|NCT00543569|464094646|FG002|Overall Study|Lost to Follow-up|1|||
128947821|NCT00543569|464094647|FG003|Overall Study|Lost to Follow-up|1|||
128947822|NCT00543569|464094644|FG000|Overall Study|Miscellaneous Reasons|7|||
128947823|NCT00543569|464094645|FG001|Overall Study|Miscellaneous Reasons|3|||
129034125|NCT00642811|464414215|FG000|Overall Study|Severe Non-compliance to protocol|1|||
129218140|NCT02754440|465098564|FG002|Overall Study|Subject issues not resulting in AE|0|||
129218141|NCT02754440|465098565|FG003|Overall Study|Subject issues not resulting in AE|12|||
129218142|NCT01189032|465098568|FG000|Overall Study|Adverse Event|1|||
129218143|NCT01189032|465098569|FG001|Overall Study|Adverse Event|3|||
129218144|NCT01189032|465098570|FG002|Overall Study|Adverse Event|4|||
129218145|NCT01189032|465098568|FG000|Overall Study|Lack of Efficacy|2|||
129218146|NCT01189032|465098569|FG001|Overall Study|Lack of Efficacy|3|||
129218147|NCT01189032|465098570|FG002|Overall Study|Lack of Efficacy|0|||
129218148|NCT01189032|465098568|FG000|Overall Study|Withdrawal by Subject|1|||
129218149|NCT01189032|465098569|FG001|Overall Study|Withdrawal by Subject|0|||
129218150|NCT01189032|465098570|FG002|Overall Study|Withdrawal by Subject|1|||
129218151|NCT01189032|465098568|FG000|Overall Study|Protocol Violation|1|||
129218152|NCT01189032|465098569|FG001|Overall Study|Protocol Violation|1|||
129218153|NCT01189032|465098570|FG002|Overall Study|Protocol Violation|1|||
129218154|NCT03388164|465098575|FG000|Overall Study|Withdrawal by Subject|3|||
129218155|NCT03388164|465098576|FG001|Overall Study|Withdrawal by Subject|1|||
129218156|NCT05375760|465098579|FG000|Overall Study|Adverse Event|1|||
129218157|NCT05375760|465098580|FG001|Overall Study|Adverse Event|0|||
129218158|NCT05375760|465098579|FG000|Overall Study|Death|0|||
129218159|NCT05375760|465098580|FG001|Overall Study|Death|1|||
129218160|NCT05375760|465098579|FG000|Overall Study|Lost to Follow-up|6|||
129218161|NCT05375760|465098580|FG001|Overall Study|Lost to Follow-up|6|||
129218162|NCT05375760|465098579|FG000|Overall Study|Withdrawal by Subject|17|||
129218163|NCT05375760|465098580|FG001|Overall Study|Withdrawal by Subject|19|||
129218164|NCT05375760|465098579|FG000|Overall Study|Dosing halted by FDA|96|||
129218165|NCT05375760|465098580|FG001|Overall Study|Dosing halted by FDA|100|||
129218166|NCT05375760|465098579|FG000|Overall Study|Not compliant with study visit|2|||
129218167|NCT05375760|465098580|FG001|Overall Study|Not compliant with study visit|0|||
129218168|NCT05375760|465098579|FG000|Overall Study|Physician Decision|1|||
128708749|NCT00371137|463228504|FG002|Overall Study|Lost to Follow-up|5|||
128708750|NCT00371137|463228502|FG000|Overall Study|Lack of Efficacy|30|||
128708751|NCT00371137|463228503|FG001|Overall Study|Lack of Efficacy|12|||
128947824|NCT00543569|464094646|FG002|Overall Study|Miscellaneous Reasons|11|||
128947825|NCT00543569|464094647|FG003|Overall Study|Miscellaneous Reasons|4|||
129218169|NCT05375760|465098580|FG001|Overall Study|Physician Decision|0|||
129218170|NCT05375760|465098579|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
129218171|NCT05375760|465098580|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
129218172|NCT05375760|465098579|FG000|Overall Study|Participant moved|1|||
129218173|NCT05375760|465098580|FG001|Overall Study|Participant moved|0|||
129218174|NCT00363480|465098581|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
128708752|NCT00371137|463228504|FG002|Overall Study|Lack of Efficacy|13|||
128947826|NCT00543569|464094644|FG000|Overall Study|Randomized but never received study drug|3|||
128947827|NCT00543569|464094645|FG001|Overall Study|Randomized but never received study drug|3|||
128947828|NCT00543569|464094646|FG002|Overall Study|Randomized but never received study drug|5|||
129218175|NCT00363480|465098581|FG000|Overall Study|Adverse Event|4|||
128947829|NCT00543569|464094647|FG003|Overall Study|Randomized but never received study drug|3|||
129218176|NCT00363480|465098581|FG000|Overall Study|Lost to Follow-up|5|||
128708753|NCT00371137|463228502|FG000|Overall Study|Sponsor Decision|2|||
128708754|NCT00371137|463228503|FG001|Overall Study|Sponsor Decision|1|||
128708755|NCT00371137|463228504|FG002|Overall Study|Sponsor Decision|2|||
128708756|NCT00371137|463228502|FG000|Overall Study|Physician Decision|1|||
128708757|NCT00371137|463228503|FG001|Overall Study|Physician Decision|1|||
128708758|NCT00371137|463228504|FG002|Overall Study|Physician Decision|1|||
128708759|NCT00371137|463228502|FG000|Overall Study|Protocol Violation|2|||
128708760|NCT00371137|463228503|FG001|Overall Study|Protocol Violation|1|||
128708761|NCT00371137|463228504|FG002|Overall Study|Protocol Violation|1|||
128708762|NCT00536198|463228505|FG000|Overall Study|Lost to Follow-up|15|||
128947830|NCT02124707|464094648|FG000|Overall Study|Adverse Event|5|||
128947831|NCT02124707|464094648|FG000|Overall Study|Physician Decision|1|||
128947832|NCT02124707|464094648|FG000|Overall Study|Death|1|||
128947833|NCT00089479|464094657|FG000|Overall Study|Death|108|||
128947834|NCT00089479|464094658|FG001|Overall Study|Death|75|||
128947835|NCT00089479|464094657|FG000|Overall Study|Withdrawal by Subject|86|||
128947836|NCT00089479|464094658|FG001|Overall Study|Withdrawal by Subject|107|||
128947837|NCT00089479|464094657|FG000|Overall Study|Lost to Follow-up|137|||
128947838|NCT00089479|464094658|FG001|Overall Study|Lost to Follow-up|107|||
128947839|NCT01124448|464094661|FG000|Overall Study|Lost to Follow-up|0|||
128947840|NCT01124448|464094662|FG001|Overall Study|Lost to Follow-up|3|||
128947841|NCT01124448|464094661|FG000|Overall Study|Protocol Violation|2|||
128947842|NCT01124448|464094662|FG001|Overall Study|Protocol Violation|0|||
128947843|NCT03198754|464094664|FG000|Overall Study|Withdrawal by Subject|5|||
128947844|NCT03198754|464094665|FG001|Overall Study|Withdrawal by Subject|4|||
128947845|NCT03198754|464094664|FG000|Overall Study|Lost to Follow-up|4|||
128947846|NCT03198754|464094665|FG001|Overall Study|Lost to Follow-up|3|||
128947847|NCT03198754|464094664|FG000|Overall Study|Ineligible|2|||
128947848|NCT03198754|464094665|FG001|Overall Study|Ineligible|1|||
128947849|NCT00305253|464094670|FG000|Overall Study|Withdrawal by Subject|0|||
128947850|NCT00305253|464094671|FG001|Overall Study|Withdrawal by Subject|1|||
128947851|NCT05373706|464094675|FG000|Overall Study|Lost to Follow-up|2|||
128947852|NCT05373706|464094676|FG001|Overall Study|Lost to Follow-up|2|||
128947853|NCT01479374|464094681|FG000|Overall Study|Adverse Event|2|||
128947854|NCT01479374|464094682|FG001|Overall Study|Adverse Event|1|||
128947855|NCT01479374|464094683|FG002|Overall Study|Adverse Event|0|||
128947856|NCT01479374|464094681|FG000|Overall Study|Lost to Follow-up|1|||
128947857|NCT01479374|464094682|FG001|Overall Study|Lost to Follow-up|2|||
128947858|NCT01479374|464094683|FG002|Overall Study|Lost to Follow-up|0|||
128947859|NCT01479374|464094681|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
128947860|NCT01479374|464094682|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
128947861|NCT01479374|464094683|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
128947862|NCT01479374|464094681|FG000|Overall Study|Other|0|||
128947863|NCT01479374|464094682|FG001|Overall Study|Other|4|||
128947864|NCT01479374|464094683|FG002|Overall Study|Other|5|||
128947865|NCT03599141|464094689|FG000|Overall Study|Lost to Follow-up|3|||
128947866|NCT03599141|464094690|FG001|Overall Study|Lost to Follow-up|1|||
128947867|NCT01081873|464094691|FG000|Overall Study|Death|86|||
128947868|NCT01081873|464094691|FG000|Overall Study|Withdrawal by Subject|10|||
128947869|NCT01081873|464094691|FG000|Overall Study|Lost to Follow-up|142|||
128947870|NCT01081873|464094691|FG000|Overall Study|Progression of prostate cancer|13|||
128947871|NCT01081873|464094691|FG000|Overall Study|Other|47|||
128947872|NCT03011840|464094692|FG000|Overall Study|Not received PIL in post PIL phase|0|||
128947873|NCT03011840|464094693|FG001|Overall Study|Not received PIL in post PIL phase|21|||
128947874|NCT01165021|464094694|FG000|Overall Study|Death|1|||
128947875|NCT02491073|464094695|FG000|Overall Study|screen failure|1|||
128947876|NCT02491073|464094696|FG001|Overall Study|screen failure|0|||
128947877|NCT03095521|464094697|FG000|Overall Study|Withdrawal by Subject|0|||
128947878|NCT03095521|464094698|FG001|Overall Study|Withdrawal by Subject|1|||
128947879|NCT03095521|464094697|FG000|Overall Study|Lost to Follow-up|0|||
128947880|NCT03095521|464094698|FG001|Overall Study|Lost to Follow-up|1|||
128947881|NCT01810042|464094699|FG000|Overall Study|Lost to Follow-up|10|||
128947882|NCT02773238|464094701|FG000|Overall Study|Lack of Efficacy|4|||
128947883|NCT01877382|464094707|FG000|Dose Escalation|Progressive disease|2|||
128947884|NCT01877382|464094708|FG001|Dose Escalation|Progressive disease|0|||
128947885|NCT01877382|464094709|FG002|Dose Escalation|Progressive disease|1|||
128947886|NCT01877382|464094710|FG003|Dose Escalation|Progressive disease|6|||
128947887|NCT01877382|464094711|FG004|Dose Escalation|Progressive disease|1|||
128947888|NCT01877382|464094712|FG005|Dose Escalation|Progressive disease|0|||
128947889|NCT01877382|464094713|FG006|Dose Escalation|Progressive disease|3|||
128947890|NCT01877382|464094714|FG007|Dose Escalation|Progressive disease|10|||
128708763|NCT00536198|463228506|FG001|Overall Study|Lost to Follow-up|14|||
128708764|NCT00536198|463228505|FG000|Overall Study|Withdrawal by Subject|16|||
128708765|NCT00536198|463228506|FG001|Overall Study|Withdrawal by Subject|12|||
128947891|NCT01877382|464094715|FG008|Dose Escalation|Progressive disease|4|||
128947892|NCT01877382|464094716|FG009|Dose Escalation|Progressive disease|2|||
128947893|NCT01877382|464094717|FG010|Dose Escalation|Progressive disease|3|||
128947894|NCT01877382|464094718|FG011|Dose Escalation|Progressive disease|3|||
128947895|NCT01877382|464094719|FG012|Dose Escalation|Progressive disease|13|||
128947896|NCT01877382|464094720|FG013|Dose Escalation|Progressive disease|1|||
128947897|NCT01877382|464094721|FG014|Dose Escalation|Progressive disease|0|||
128947898|NCT01877382|464094707|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
128947899|NCT01877382|464094708|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947900|NCT01877382|464094709|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947901|NCT01877382|464094710|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
128947902|NCT01877382|464094711|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947903|NCT01877382|464094712|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947904|NCT01877382|464094713|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
128947905|NCT01877382|464094714|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947906|NCT01877382|464094715|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947907|NCT01877382|464094716|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947908|NCT01877382|464094717|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947909|NCT01877382|464094718|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947910|NCT01877382|464094719|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947911|NCT01877382|464094720|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947912|NCT01877382|464094721|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128947913|NCT01877382|464094707|FG000|Dose Escalation|Clinical progression|0|||
128947914|NCT01877382|464094708|FG001|Dose Escalation|Clinical progression|1|||
128947915|NCT01877382|464094709|FG002|Dose Escalation|Clinical progression|0|||
128947916|NCT01877382|464094710|FG003|Dose Escalation|Clinical progression|2|||
128947917|NCT01877382|464094711|FG004|Dose Escalation|Clinical progression|0|||
128947918|NCT01877382|464094712|FG005|Dose Escalation|Clinical progression|0|||
128947919|NCT01877382|464094713|FG006|Dose Escalation|Clinical progression|1|||
128947920|NCT01877382|464094714|FG007|Dose Escalation|Clinical progression|0|||
128947921|NCT01877382|464094715|FG008|Dose Escalation|Clinical progression|0|||
128947922|NCT01877382|464094716|FG009|Dose Escalation|Clinical progression|1|||
128947923|NCT01877382|464094717|FG010|Dose Escalation|Clinical progression|0|||
128947924|NCT01877382|464094718|FG011|Dose Escalation|Clinical progression|0|||
128947925|NCT01877382|464094719|FG012|Dose Escalation|Clinical progression|2|||
128947926|NCT01877382|464094720|FG013|Dose Escalation|Clinical progression|1|||
128947927|NCT01877382|464094721|FG014|Dose Escalation|Clinical progression|0|||
128947928|NCT01877382|464094707|FG000|Dose Escalation|Adverse Event|0|||
128947929|NCT01877382|464094708|FG001|Dose Escalation|Adverse Event|0|||
128947930|NCT01877382|464094709|FG002|Dose Escalation|Adverse Event|0|||
128947931|NCT01877382|464094710|FG003|Dose Escalation|Adverse Event|4|||
128947932|NCT01877382|464094711|FG004|Dose Escalation|Adverse Event|1|||
128947933|NCT01877382|464094712|FG005|Dose Escalation|Adverse Event|2|||
128947934|NCT01877382|464094713|FG006|Dose Escalation|Adverse Event|1|||
128947935|NCT01877382|464094714|FG007|Dose Escalation|Adverse Event|2|||
128947936|NCT01877382|464094715|FG008|Dose Escalation|Adverse Event|0|||
128947937|NCT01877382|464094716|FG009|Dose Escalation|Adverse Event|0|||
128947938|NCT01877382|464094717|FG010|Dose Escalation|Adverse Event|0|||
128947939|NCT01877382|464094718|FG011|Dose Escalation|Adverse Event|0|||
129124299|NCT04757636|464751312|FG001|Overall Study|Adverse Event|8|||
129124300|NCT04757636|464751313|FG002|Overall Study|Adverse Event|11|||
129124301|NCT04757636|464751311|FG000|Overall Study|Death|9|||
129124302|NCT04757636|464751312|FG001|Overall Study|Death|12|||
129124303|NCT04757636|464751313|FG002|Overall Study|Death|6|||
129124304|NCT04757636|464751311|FG000|Overall Study|Lack of Efficacy|2|||
129124305|NCT04757636|464751312|FG001|Overall Study|Lack of Efficacy|0|||
129124306|NCT04757636|464751313|FG002|Overall Study|Lack of Efficacy|0|||
129124307|NCT04757636|464751311|FG000|Overall Study|Lost to Follow-up|1|||
129124308|NCT04757636|464751312|FG001|Overall Study|Lost to Follow-up|6|||
129124309|NCT04757636|464751313|FG002|Overall Study|Lost to Follow-up|7|||
129124310|NCT04757636|464751311|FG000|Overall Study|Physician Decision|1|||
129124311|NCT04757636|464751312|FG001|Overall Study|Physician Decision|3|||
129124312|NCT04757636|464751313|FG002|Overall Study|Physician Decision|4|||
129124313|NCT04757636|464751311|FG000|Overall Study|Withdrawal by Subject|20|||
129218177|NCT00363480|465098581|FG000|Overall Study|Withdrawal by Subject|5|||
129218178|NCT00363480|465098581|FG000|Overall Study|Non-compliance of subject|1|||
129218179|NCT00363480|465098581|FG000|Overall Study|Participant discontinued on its own|1|||
128770346|NCT02736968|463450225|FG003|Overall Study|COVID-19 Pandemic|0|||
128947940|NCT01877382|464094719|FG012|Dose Escalation|Adverse Event|1|||
128947941|NCT01877382|464094720|FG013|Dose Escalation|Adverse Event|0|||
128947942|NCT01877382|464094721|FG014|Dose Escalation|Adverse Event|0|||
128947943|NCT01877382|464094707|FG000|Dose Escalation|Withdrawal by Subject|0|||
128947944|NCT01877382|464094708|FG001|Dose Escalation|Withdrawal by Subject|0|||
128947945|NCT01877382|464094709|FG002|Dose Escalation|Withdrawal by Subject|0|||
129124314|NCT04757636|464751312|FG001|Overall Study|Withdrawal by Subject|23|||
129124315|NCT04757636|464751313|FG002|Overall Study|Withdrawal by Subject|18|||
129124316|NCT04757636|464751311|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
128708766|NCT00536198|463228505|FG000|Overall Study|Adverse Event|2|||
128947946|NCT01877382|464094710|FG003|Dose Escalation|Withdrawal by Subject|0|||
128947947|NCT01877382|464094711|FG004|Dose Escalation|Withdrawal by Subject|0|||
128947948|NCT01877382|464094712|FG005|Dose Escalation|Withdrawal by Subject|3|||
128947949|NCT01877382|464094713|FG006|Dose Escalation|Withdrawal by Subject|2|||
128947950|NCT01877382|464094714|FG007|Dose Escalation|Withdrawal by Subject|1|||
128947951|NCT01877382|464094715|FG008|Dose Escalation|Withdrawal by Subject|1|||
128947952|NCT01877382|464094716|FG009|Dose Escalation|Withdrawal by Subject|0|||
128947953|NCT01877382|464094717|FG010|Dose Escalation|Withdrawal by Subject|0|||
128947954|NCT01877382|464094718|FG011|Dose Escalation|Withdrawal by Subject|0|||
128947955|NCT01877382|464094719|FG012|Dose Escalation|Withdrawal by Subject|0|||
128947956|NCT01877382|464094720|FG013|Dose Escalation|Withdrawal by Subject|0|||
128947957|NCT01877382|464094721|FG014|Dose Escalation|Withdrawal by Subject|0|||
128947958|NCT01877382|464094707|FG000|Dose Escalation|Protocol Violation|0|||
128947959|NCT01877382|464094708|FG001|Dose Escalation|Protocol Violation|0|||
128947960|NCT01877382|464094709|FG002|Dose Escalation|Protocol Violation|0|||
128947961|NCT01877382|464094710|FG003|Dose Escalation|Protocol Violation|0|||
128947962|NCT01877382|464094711|FG004|Dose Escalation|Protocol Violation|0|||
128947963|NCT01877382|464094712|FG005|Dose Escalation|Protocol Violation|0|||
128947964|NCT01877382|464094713|FG006|Dose Escalation|Protocol Violation|1|||
128947965|NCT01877382|464094714|FG007|Dose Escalation|Protocol Violation|0|||
128947966|NCT01877382|464094715|FG008|Dose Escalation|Protocol Violation|0|||
128947967|NCT01877382|464094716|FG009|Dose Escalation|Protocol Violation|0|||
128947968|NCT01877382|464094717|FG010|Dose Escalation|Protocol Violation|0|||
128947969|NCT01877382|464094718|FG011|Dose Escalation|Protocol Violation|0|||
128947970|NCT01877382|464094719|FG012|Dose Escalation|Protocol Violation|0|||
128947971|NCT01877382|464094720|FG013|Dose Escalation|Protocol Violation|0|||
128947972|NCT01877382|464094721|FG014|Dose Escalation|Protocol Violation|0|||
128947973|NCT01877382|464094707|FG000|Dose Escalation|Study terminated by sponsor|0|||
128947974|NCT01877382|464094708|FG001|Dose Escalation|Study terminated by sponsor|0|||
128947975|NCT01877382|464094709|FG002|Dose Escalation|Study terminated by sponsor|0|||
128947976|NCT01877382|464094710|FG003|Dose Escalation|Study terminated by sponsor|0|||
128947977|NCT01877382|464094711|FG004|Dose Escalation|Study terminated by sponsor|0|||
128947978|NCT01877382|464094712|FG005|Dose Escalation|Study terminated by sponsor|0|||
128947979|NCT01877382|464094713|FG006|Dose Escalation|Study terminated by sponsor|0|||
128947980|NCT01877382|464094714|FG007|Dose Escalation|Study terminated by sponsor|1|||
128947981|NCT01877382|464094715|FG008|Dose Escalation|Study terminated by sponsor|1|||
128947982|NCT01877382|464094716|FG009|Dose Escalation|Study terminated by sponsor|0|||
128947983|NCT01877382|464094717|FG010|Dose Escalation|Study terminated by sponsor|0|||
128947984|NCT01877382|464094718|FG011|Dose Escalation|Study terminated by sponsor|0|||
128947985|NCT01877382|464094719|FG012|Dose Escalation|Study terminated by sponsor|3|||
128947986|NCT01877382|464094720|FG013|Dose Escalation|Study terminated by sponsor|0|||
128947987|NCT01877382|464094721|FG014|Dose Escalation|Study terminated by sponsor|0|||
128947988|NCT01877382|464094707|FG000|Dose Escalation|Death|0|||
128947989|NCT01877382|464094708|FG001|Dose Escalation|Death|0|||
128947990|NCT01877382|464094709|FG002|Dose Escalation|Death|0|||
128947991|NCT01877382|464094710|FG003|Dose Escalation|Death|0|||
128947992|NCT01877382|464094711|FG004|Dose Escalation|Death|0|||
128947993|NCT01877382|464094712|FG005|Dose Escalation|Death|0|||
128947994|NCT01877382|464094713|FG006|Dose Escalation|Death|0|||
128947995|NCT01877382|464094714|FG007|Dose Escalation|Death|1|||
129124317|NCT04757636|464751312|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
129124318|NCT04757636|464751313|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
129124319|NCT04757636|464751311|FG000|Overall Study|Study Terminated by Sponsor|103|||
129124320|NCT04757636|464751312|FG001|Overall Study|Study Terminated by Sponsor|104|||
129124321|NCT04757636|464751313|FG002|Overall Study|Study Terminated by Sponsor|114|||
129124322|NCT04757636|464751311|FG000|Overall Study|Sponsor Decision|0|||
128708767|NCT00536198|463228506|FG001|Overall Study|Adverse Event|2|||
128708768|NCT00536198|463228505|FG000|Overall Study|Rescue|3|||
128947996|NCT01877382|464094715|FG008|Dose Escalation|Death|0|||
128947997|NCT01877382|464094716|FG009|Dose Escalation|Death|0|||
128947998|NCT01877382|464094717|FG010|Dose Escalation|Death|0|||
129124323|NCT04757636|464751312|FG001|Overall Study|Sponsor Decision|0|||
128947999|NCT01877382|464094718|FG011|Dose Escalation|Death|0|||
128948000|NCT01877382|464094719|FG012|Dose Escalation|Death|1|||
129124324|NCT04757636|464751313|FG002|Overall Study|Sponsor Decision|1|||
129124325|NCT04757636|464751311|FG000|Overall Study|Randomized in Error|0|||
129124326|NCT04757636|464751312|FG001|Overall Study|Randomized in Error|0|||
128708769|NCT00536198|463228506|FG001|Overall Study|Rescue|9|||
128708770|NCT00536198|463228505|FG000|Overall Study|Pregnancy|1|||
128948001|NCT01877382|464094720|FG013|Dose Escalation|Death|1|||
129124327|NCT04757636|464751313|FG002|Overall Study|Randomized in Error|2|||
128948002|NCT01877382|464094721|FG014|Dose Escalation|Death|0|||
128948003|NCT01877382|464094707|FG000|Dose Expansion|Progressive disease|0|||
128948004|NCT01877382|464094708|FG001|Dose Expansion|Progressive disease|0|||
129124328|NCT00435942|464751319|FG000|Overall Study|Death|17|||
128948005|NCT01877382|464094709|FG002|Dose Expansion|Progressive disease|0|||
128708771|NCT00536198|463228506|FG001|Overall Study|Pregnancy|1|||
128708772|NCT00536198|463228505|FG000|Overall Study|Protocol Violation|0|||
128708773|NCT00536198|463228506|FG001|Overall Study|Protocol Violation|1|||
128708774|NCT02013791|463228507|FG000|Period 1|Lost to Follow-up|0|||
128708775|NCT02013791|463228508|FG001|Period 1|Lost to Follow-up|0|||
128708776|NCT02013791|463228509|FG002|Period 1|Lost to Follow-up|0|||
128708777|NCT02013791|463228510|FG003|Period 1|Lost to Follow-up|1|||
128708778|NCT02013791|463228511|FG004|Period 1|Lost to Follow-up|0|||
128948006|NCT01877382|464094710|FG003|Dose Expansion|Progressive disease|0|||
128948007|NCT01877382|464094711|FG004|Dose Expansion|Progressive disease|0|||
128948008|NCT01877382|464094712|FG005|Dose Expansion|Progressive disease|0|||
128948009|NCT01877382|464094713|FG006|Dose Expansion|Progressive disease|0|||
128948010|NCT01877382|464094714|FG007|Dose Expansion|Progressive disease|0|||
128948011|NCT01877382|464094715|FG008|Dose Expansion|Progressive disease|0|||
128948012|NCT01877382|464094716|FG009|Dose Expansion|Progressive disease|0|||
128948013|NCT01877382|464094717|FG010|Dose Expansion|Progressive disease|0|||
128948014|NCT01877382|464094718|FG011|Dose Expansion|Progressive disease|0|||
128948015|NCT01877382|464094719|FG012|Dose Expansion|Progressive disease|0|||
128948016|NCT01877382|464094720|FG013|Dose Expansion|Progressive disease|0|||
128948017|NCT01877382|464094721|FG014|Dose Expansion|Progressive disease|11|||
128948018|NCT01877382|464094707|FG000|Dose Expansion|Clinical progression|0|||
128948019|NCT01877382|464094708|FG001|Dose Expansion|Clinical progression|0|||
128948020|NCT01877382|464094709|FG002|Dose Expansion|Clinical progression|0|||
128948021|NCT01877382|464094710|FG003|Dose Expansion|Clinical progression|0|||
128948022|NCT01877382|464094711|FG004|Dose Expansion|Clinical progression|0|||
128948023|NCT01877382|464094712|FG005|Dose Expansion|Clinical progression|0|||
128948024|NCT01877382|464094713|FG006|Dose Expansion|Clinical progression|0|||
128948025|NCT01877382|464094714|FG007|Dose Expansion|Clinical progression|0|||
128948026|NCT01877382|464094715|FG008|Dose Expansion|Clinical progression|0|||
128948027|NCT01877382|464094716|FG009|Dose Expansion|Clinical progression|0|||
128948028|NCT01877382|464094717|FG010|Dose Expansion|Clinical progression|0|||
128948029|NCT01877382|464094718|FG011|Dose Expansion|Clinical progression|0|||
128948030|NCT01877382|464094719|FG012|Dose Expansion|Clinical progression|0|||
128948031|NCT01877382|464094720|FG013|Dose Expansion|Clinical progression|0|||
128948032|NCT01877382|464094721|FG014|Dose Expansion|Clinical progression|6|||
128948033|NCT01877382|464094707|FG000|Dose Expansion|Adverse Event|0|||
128948034|NCT01877382|464094708|FG001|Dose Expansion|Adverse Event|0|||
128948035|NCT01877382|464094709|FG002|Dose Expansion|Adverse Event|0|||
128948036|NCT01877382|464094710|FG003|Dose Expansion|Adverse Event|0|||
128948037|NCT01877382|464094711|FG004|Dose Expansion|Adverse Event|0|||
128948038|NCT01877382|464094712|FG005|Dose Expansion|Adverse Event|0|||
128948039|NCT01877382|464094713|FG006|Dose Expansion|Adverse Event|0|||
128948040|NCT01877382|464094714|FG007|Dose Expansion|Adverse Event|0|||
128948041|NCT01877382|464094715|FG008|Dose Expansion|Adverse Event|0|||
129124329|NCT00435942|464751320|FG001|Overall Study|Death|10|||
129124330|NCT00435942|464751319|FG000|Overall Study|Withdrawal by Subject|2|||
129124331|NCT00435942|464751320|FG001|Overall Study|Withdrawal by Subject|0|||
129124332|NCT00435942|464751319|FG000|Overall Study|Lost to Follow-up|0|||
129124333|NCT00435942|464751320|FG001|Overall Study|Lost to Follow-up|16|||
129124334|NCT00435942|464751319|FG000|Overall Study|Conversion to Open Repair|1|||
129124335|NCT00435942|464751320|FG001|Overall Study|Conversion to Open Repair|0|||
129124336|NCT00435942|464751319|FG000|Overall Study|Technical Failure|3|||
129124337|NCT00435942|464751320|FG001|Overall Study|Technical Failure|0|||
129124338|NCT00435942|464751319|FG000|Overall Study|Other|0|||
129124339|NCT00435942|464751320|FG001|Overall Study|Other|1|||
129124340|NCT04491994|464751321|FG000|Overall Study|Withdrawal by Subject|10|||
129124341|NCT04491994|464751322|FG001|Overall Study|Withdrawal by Subject|5|||
129124342|NCT04491994|464751321|FG000|Overall Study|developed fever > 3 days|4|||
129124343|NCT04491994|464751322|FG001|Overall Study|developed fever > 3 days|1|||
129124344|NCT04491994|464751321|FG000|Overall Study|Protocol Violation|11|||
129124345|NCT04491994|464751322|FG001|Overall Study|Protocol Violation|2|||
129124346|NCT04491994|464751321|FG000|Overall Study|Lost to Follow-up|4|||
129124347|NCT04491994|464751322|FG001|Overall Study|Lost to Follow-up|3|||
129124348|NCT04167462|464751330|FG000|Overall Study|Other reasons|3|||
129124349|NCT04167462|464751331|FG001|Overall Study|Other reasons|2|||
128708779|NCT02013791|463228512|FG005|Period 1|Lost to Follow-up|0|||
128708780|NCT02013791|463228513|FG006|Period 1|Lost to Follow-up|1|||
128948042|NCT01877382|464094716|FG009|Dose Expansion|Adverse Event|0|||
128948043|NCT01877382|464094717|FG010|Dose Expansion|Adverse Event|0|||
128708781|NCT02013791|463228514|FG007|Period 1|Lost to Follow-up|1|||
128948044|NCT01877382|464094718|FG011|Dose Expansion|Adverse Event|0|||
128948045|NCT01877382|464094719|FG012|Dose Expansion|Adverse Event|0|||
128948046|NCT01877382|464094720|FG013|Dose Expansion|Adverse Event|0|||
129124350|NCT04167462|464751330|FG000|Overall Study|Withdrawal by Subject|6|||
129124351|NCT04167462|464751331|FG001|Overall Study|Withdrawal by Subject|7|||
129124352|NCT04167462|464751330|FG000|Overall Study|Adverse Event|4|||
129124353|NCT04167462|464751331|FG001|Overall Study|Adverse Event|0|||
129124354|NCT04167462|464751330|FG000|Overall Study|Pregnancy|1|||
128948047|NCT01877382|464094721|FG014|Dose Expansion|Adverse Event|1|||
128708782|NCT02013791|463228515|FG008|Period 1|Lost to Follow-up|0|||
128708783|NCT02013791|463228507|FG000|Period 1|Other Miscellaneous Reasons|0|||
128708784|NCT02013791|463228508|FG001|Period 1|Other Miscellaneous Reasons|2|||
128708785|NCT02013791|463228509|FG002|Period 1|Other Miscellaneous Reasons|0|||
128708786|NCT02013791|463228510|FG003|Period 1|Other Miscellaneous Reasons|0|||
128708787|NCT02013791|463228511|FG004|Period 1|Other Miscellaneous Reasons|0|||
128708788|NCT02013791|463228512|FG005|Period 1|Other Miscellaneous Reasons|0|||
128708789|NCT02013791|463228513|FG006|Period 1|Other Miscellaneous Reasons|0|||
128708790|NCT02013791|463228514|FG007|Period 1|Other Miscellaneous Reasons|0|||
128708791|NCT02013791|463228515|FG008|Period 1|Other Miscellaneous Reasons|0|||
128708792|NCT03798483|463228516|FG000|Overall Study|Lost to Follow-up|2|||
128708793|NCT01666782|463228517|FG000|Overall Study|Received 2 doses of vaccine|0|||
128708794|NCT01666782|463228518|FG001|Overall Study|Received 2 doses of vaccine|1|||
128708795|NCT01666782|463228517|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
128708796|NCT01666782|463228518|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
128708797|NCT01858389|463228536|FG000|Overall Study|Death|1|||
128708798|NCT01858389|463228537|FG001|Overall Study|Death|3|||
128708799|NCT01858389|463228536|FG000|Overall Study|Study terminated by sponsor|0|||
128708800|NCT01858389|463228537|FG001|Overall Study|Study terminated by sponsor|2|||
128708801|NCT01858389|463228536|FG000|Overall Study|Withdrawal by Subject|0|||
128708802|NCT01858389|463228537|FG001|Overall Study|Withdrawal by Subject|1|||
128708803|NCT01858389|463228536|FG000|Overall Study|Progressive disease|10|||
128708804|NCT01858389|463228537|FG001|Overall Study|Progressive disease|11|||
128708805|NCT01858389|463228536|FG000|Overall Study|Other|2|||
128708806|NCT01858389|463228537|FG001|Overall Study|Other|4|||
128708807|NCT01858389|463228536|FG000|Overall Study|Adverse Event|3|||
128708808|NCT01858389|463228537|FG001|Overall Study|Adverse Event|1|||
128708809|NCT01858389|463228536|FG000|Overall Study|Did not receive treatment|0|||
128708810|NCT01858389|463228537|FG001|Overall Study|Did not receive treatment|3|||
128708811|NCT01691781|463228538|FG000|Overall Study|Withdrawal by Subject|4|||
128708812|NCT01691781|463228539|FG001|Overall Study|Withdrawal by Subject|3|||
128708813|NCT01691781|463228538|FG000|Overall Study|Physician Decision|1|||
128708814|NCT01691781|463228539|FG001|Overall Study|Physician Decision|1|||
128708815|NCT01691781|463228538|FG000|Overall Study|Protocol Violation|2|||
128708816|NCT01691781|463228539|FG001|Overall Study|Protocol Violation|2|||
128708817|NCT01691781|463228538|FG000|Overall Study|Adverse Event|0|||
128708818|NCT01691781|463228539|FG001|Overall Study|Adverse Event|1|||
128708819|NCT00687323|463228540|FG000|Overall Study|Death|25|||
128708820|NCT00687323|463228540|FG000|Overall Study|Withdrawal by Subject|1|||
128708821|NCT00687323|463228540|FG000|Overall Study|Excluded from efficacy evaluations|6|||
128708822|NCT00687323|463228540|FG000|Overall Study|Screen failure|148|||
128708823|NCT01927367|463228541|FG000|Overall Study|Withdrawal by Subject|7|||
128708824|NCT01927367|463228542|FG001|Overall Study|Withdrawal by Subject|4|||
128708825|NCT01927367|463228541|FG000|Overall Study|No baseline data|0|||
128708826|NCT01927367|463228542|FG001|Overall Study|No baseline data|1|||
128708827|NCT02760069|463228545|FG000|Overall Study|Withdrawal by Subject|0|||
128708828|NCT02760069|463228546|FG001|Overall Study|Withdrawal by Subject|1|||
128708829|NCT02760069|463228547|FG002|Overall Study|Withdrawal by Subject|1|||
128708830|NCT02547454|463228553|FG000|Overall Study|Due to hemodialysis|53|||
128948048|NCT01877382|464094707|FG000|Dose Expansion|Death|0|||
128948049|NCT01877382|464094708|FG001|Dose Expansion|Death|0|||
128948050|NCT01877382|464094709|FG002|Dose Expansion|Death|0|||
128948051|NCT01877382|464094710|FG003|Dose Expansion|Death|0|||
128948052|NCT01877382|464094711|FG004|Dose Expansion|Death|0|||
128948053|NCT01877382|464094712|FG005|Dose Expansion|Death|0|||
128948054|NCT01877382|464094713|FG006|Dose Expansion|Death|0|||
128948055|NCT01877382|464094714|FG007|Dose Expansion|Death|0|||
128948056|NCT01877382|464094715|FG008|Dose Expansion|Death|0|||
128948057|NCT01877382|464094716|FG009|Dose Expansion|Death|0|||
128948058|NCT01877382|464094717|FG010|Dose Expansion|Death|0|||
128948059|NCT01877382|464094718|FG011|Dose Expansion|Death|0|||
128708831|NCT02547454|463228553|FG000|Overall Study|Due to transplantation|1|||
128708832|NCT02547454|463228553|FG000|Overall Study|Due to no further need to treat|4|||
128708833|NCT02547454|463228553|FG000|Overall Study|Death|38|||
128948060|NCT01877382|464094719|FG012|Dose Expansion|Death|0|||
128708834|NCT02547454|463228553|FG000|Overall Study|Lost to Follow-up|26|||
128708835|NCT02547454|463228553|FG000|Overall Study|Other|39|||
128708836|NCT02547454|463228553|FG000|Overall Study|No data|11|||
128948061|NCT01877382|464094720|FG013|Dose Expansion|Death|0|||
128708837|NCT03694821|463228554|FG000|Overall Study|Study terminated|4|||
128708838|NCT03694821|463228555|FG001|Overall Study|Study terminated|8|||
128708839|NCT03694821|463228556|FG002|Overall Study|Study terminated|4|||
128708840|NCT00203996|463228557|FG000|Overall Study|Lost to Follow-up|0|||
128708841|NCT00203996|463228558|FG001|Overall Study|Lost to Follow-up|0|||
128948062|NCT01877382|464094721|FG014|Dose Expansion|Death|1|||
128708842|NCT00203996|463228559|FG002|Overall Study|Lost to Follow-up|0|||
128708843|NCT00203996|463228560|FG003|Overall Study|Lost to Follow-up|1|||
128708844|NCT00203996|463228561|FG004|Overall Study|Lost to Follow-up|0|||
128948063|NCT01877382|464094707|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129124355|NCT04167462|464751331|FG001|Overall Study|Pregnancy|0|||
128708845|NCT00203996|463228562|FG005|Overall Study|Lost to Follow-up|0|||
128708846|NCT00203996|463228563|FG006|Overall Study|Lost to Follow-up|0|||
128948064|NCT01877382|464094708|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128708847|NCT00203996|463228564|FG007|Overall Study|Lost to Follow-up|0|||
128708848|NCT00203996|463228565|FG008|Overall Study|Lost to Follow-up|0|||
128708849|NCT00203996|463228566|FG009|Overall Study|Lost to Follow-up|0|||
128708850|NCT00203996|463228557|FG000|Overall Study|Protocol Violation|0|||
128708851|NCT00203996|463228558|FG001|Overall Study|Protocol Violation|0|||
128708852|NCT00203996|463228559|FG002|Overall Study|Protocol Violation|0|||
128708853|NCT00203996|463228560|FG003|Overall Study|Protocol Violation|6|||
128708854|NCT00203996|463228561|FG004|Overall Study|Protocol Violation|1|||
128708855|NCT00203996|463228562|FG005|Overall Study|Protocol Violation|0|||
128708856|NCT00203996|463228563|FG006|Overall Study|Protocol Violation|0|||
128708857|NCT00203996|463228564|FG007|Overall Study|Protocol Violation|0|||
128708858|NCT00203996|463228565|FG008|Overall Study|Protocol Violation|0|||
128708859|NCT00203996|463228566|FG009|Overall Study|Protocol Violation|0|||
128708860|NCT00203996|463228557|FG000|Overall Study|Physician Decision|0|||
128708861|NCT00203996|463228558|FG001|Overall Study|Physician Decision|0|||
128708862|NCT00203996|463228559|FG002|Overall Study|Physician Decision|0|||
128708863|NCT00203996|463228560|FG003|Overall Study|Physician Decision|2|||
128708864|NCT00203996|463228561|FG004|Overall Study|Physician Decision|0|||
128708865|NCT00203996|463228562|FG005|Overall Study|Physician Decision|0|||
128708866|NCT00203996|463228563|FG006|Overall Study|Physician Decision|0|||
128708867|NCT00203996|463228564|FG007|Overall Study|Physician Decision|0|||
128708868|NCT00203996|463228565|FG008|Overall Study|Physician Decision|0|||
128948065|NCT01877382|464094709|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948066|NCT01877382|464094710|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948067|NCT01877382|464094711|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948068|NCT01877382|464094712|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948069|NCT01877382|464094713|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948070|NCT01877382|464094714|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948071|NCT01877382|464094715|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948072|NCT01877382|464094716|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948073|NCT01877382|464094717|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948074|NCT01877382|464094718|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948075|NCT01877382|464094719|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948076|NCT01877382|464094720|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
128948077|NCT01877382|464094721|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
128948078|NCT02115113|464096322|FG000|Participants in Run-in Period|Death|0|||
128948079|NCT02115113|464096323|FG001|Participants in Run-in Period|Death|0|||
128948080|NCT02115113|464096324|FG002|Participants in Run-in Period|Death|1|||
128948081|NCT02115113|464096322|FG000|Participants in Run-in Period|Administrative problems|0|||
128948082|NCT02115113|464096323|FG001|Participants in Run-in Period|Administrative problems|0|||
128948083|NCT02115113|464096324|FG002|Participants in Run-in Period|Administrative problems|1|||
128948084|NCT02115113|464096322|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
128948085|NCT02115113|464096323|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
128948086|NCT02115113|464096324|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
128948087|NCT02115113|464096322|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
128948088|NCT02115113|464096323|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
128948089|NCT02115113|464096324|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
128948090|NCT02115113|464096322|FG000|Participants Randomized|Lost to Follow-up|1|||
128948091|NCT02115113|464096323|FG001|Participants Randomized|Lost to Follow-up|0|||
128948092|NCT02115113|464096324|FG002|Participants Randomized|Lost to Follow-up|0|||
128948093|NCT02115113|464096322|FG000|Participants Randomized|Death|1|||
128948094|NCT02115113|464096323|FG001|Participants Randomized|Death|0|||
128948095|NCT02115113|464096324|FG002|Participants Randomized|Death|0|||
128948096|NCT02395653|464096325|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
128948097|NCT02395653|464096325|FG000|Overall Study|Consent Withdrawn at Screening|1|||
128948098|NCT02395653|464096325|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
128948099|NCT02395653|464096325|FG000|Overall Study|Investigator Decision at Screening|1|||
128948100|NCT02395653|464096325|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
129124356|NCT04167462|464751330|FG000|Overall Study|Lack of Efficacy|0|||
129124357|NCT04167462|464751331|FG001|Overall Study|Lack of Efficacy|1|||
128708869|NCT00203996|463228566|FG009|Overall Study|Physician Decision|1|||
128708870|NCT00203996|463228557|FG000|Overall Study|CPAP machine malfunction|0|||
128708871|NCT00203996|463228558|FG001|Overall Study|CPAP machine malfunction|0|||
128708872|NCT00203996|463228559|FG002|Overall Study|CPAP machine malfunction|0|||
129124358|NCT02606253|464751332|FG000|Overall Study|Adverse Event|2|||
129124359|NCT02606253|464751333|FG001|Overall Study|Adverse Event|0|||
128708873|NCT00203996|463228560|FG003|Overall Study|CPAP machine malfunction|1|||
128708874|NCT00203996|463228561|FG004|Overall Study|CPAP machine malfunction|0|||
128948101|NCT02395653|464096325|FG000|Overall Study|Withdrawal by Subject|1|||
128948102|NCT02395653|464096325|FG000|Overall Study|Lost to Follow-up|1|||
128948103|NCT00967226|464096329|FG000|Overall Study|Adverse Event|0|||
128948104|NCT00967226|464096330|FG001|Overall Study|Adverse Event|5|||
128948105|NCT00967226|464096329|FG000|Overall Study|Protocol Violation|2|||
128948106|NCT00967226|464096330|FG001|Overall Study|Protocol Violation|0|||
128948107|NCT00967226|464096329|FG000|Overall Study|Physician Decision|0|||
128948108|NCT00967226|464096330|FG001|Overall Study|Physician Decision|1|||
128948109|NCT00605722|464096331|FG000|Overall Study|Adverse Event|6|||
128948110|NCT00605722|464096331|FG000|Overall Study|Insufficient therapeutic response|44|||
128948111|NCT00605722|464096331|FG000|Overall Study|Failure to return|1|||
128948112|NCT00296725|464096332|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
128948113|NCT00296725|464096332|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
128948114|NCT00296725|464096332|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
128948115|NCT02622724|464096333|FG000|Overall Study|Death|51|||
128948116|NCT02622724|464096334|FG001|Overall Study|Death|53|||
128948117|NCT02622724|464096333|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
128948118|NCT02622724|464096334|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
128948119|NCT02622724|464096333|FG000|Overall Study|Early termination of study|38|||
128948120|NCT02622724|464096334|FG001|Overall Study|Early termination of study|43|||
128948121|NCT00487084|464096335|FG000|Overall Study|Did not receive intervention|4|||
128948122|NCT00487084|464096336|FG001|Overall Study|Did not receive intervention|3|||
128948123|NCT00487084|464096337|FG002|Overall Study|Did not receive intervention|5|||
128948124|NCT00356863|464096338|FG000|Overall Study|Death|16|||
128948125|NCT00356863|464096339|FG001|Overall Study|Death|32|||
128948126|NCT00356863|464096338|FG000|Overall Study|Lost to Follow-up|76|||
128948127|NCT00356863|464096339|FG001|Overall Study|Lost to Follow-up|43|||
128948128|NCT02690207|464096346|FG000|Overall Study|Lost to Follow-up|48|||
128948129|NCT02690207|464096346|FG000|Overall Study|Withdrawal by Subject|46|||
128948130|NCT02690207|464096346|FG000|Overall Study|Protocol Violation|2|||
128948131|NCT02690207|464096346|FG000|Overall Study|Serious adverse event|110|||
128948132|NCT02690207|464096346|FG000|Overall Study|Non-serious Adverse Event|18|||
128948133|NCT02690207|464096346|FG000|Overall Study|Migrated/moved from study area|5|||
128948134|NCT02690207|464096346|FG000|Overall Study|Suspected HZ Episode|1|||
128948135|NCT02690207|464096346|FG000|Overall Study|Other reasons for withdrawal|23|||
128948136|NCT03712345|464096349|FG000|Overall Study|Failure to meet randomization criteria|0|||
128948137|NCT03712345|464096350|FG001|Overall Study|Failure to meet randomization criteria|0|||
128948138|NCT03712345|464096351|FG002|Overall Study|Failure to meet randomization criteria|1|||
128948139|NCT02585999|464096352|FG000|Overall Study|Lost to Follow-up|1|||
128948140|NCT02585999|464096352|FG000|Overall Study|Protocol Violation|1|||
128948141|NCT00485589|464096353|FG000|Overall Study|Death|2|||
128948142|NCT00485589|464096354|FG001|Overall Study|Death|2|||
128948143|NCT00485589|464096355|FG002|Overall Study|Death|0|||
128948144|NCT00485589|464096353|FG000|Overall Study|Failure to return|6|||
128948145|NCT00485589|464096354|FG001|Overall Study|Failure to return|5|||
128948146|NCT00485589|464096355|FG002|Overall Study|Failure to return|1|||
128948147|NCT00485589|464096353|FG000|Overall Study|Protocol Violation|1|||
128948148|NCT00485589|464096354|FG001|Overall Study|Protocol Violation|0|||
128948149|NCT00485589|464096355|FG002|Overall Study|Protocol Violation|0|||
128948150|NCT00485589|464096353|FG000|Overall Study|Violation of selection criteria at entry|0|||
128948151|NCT00485589|464096354|FG001|Overall Study|Violation of selection criteria at entry|3|||
128948152|NCT00485589|464096355|FG002|Overall Study|Violation of selection criteria at entry|1|||
128948153|NCT00485589|464096353|FG000|Overall Study|Administrative/Other|1|||
128948154|NCT00485589|464096354|FG001|Overall Study|Administrative/Other|2|||
128948155|NCT00485589|464096355|FG002|Overall Study|Administrative/Other|1|||
128948156|NCT00485589|464096353|FG000|Overall Study|Insufficient therapeutic response|10|||
128948157|NCT00485589|464096354|FG001|Overall Study|Insufficient therapeutic response|3|||
128948158|NCT00485589|464096355|FG002|Overall Study|Insufficient therapeutic response|1|||
128948159|NCT00485589|464096353|FG000|Overall Study|Refused treatment/did not cooperate|1|||
128948160|NCT00485589|464096354|FG001|Overall Study|Refused treatment/did not cooperate|0|||
128948161|NCT00485589|464096355|FG002|Overall Study|Refused treatment/did not cooperate|2|||
128948162|NCT00485589|464096353|FG000|Overall Study|Withdrawal by Subject|3|||
128948163|NCT00485589|464096354|FG001|Overall Study|Withdrawal by Subject|2|||
128948164|NCT00485589|464096355|FG002|Overall Study|Withdrawal by Subject|2|||
128948165|NCT00485589|464096353|FG000|Overall Study|Adverse Event|3|||
128948166|NCT00485589|464096354|FG001|Overall Study|Adverse Event|3|||
128948167|NCT00485589|464096355|FG002|Overall Study|Adverse Event|10|||
128948168|NCT01369849|464096356|FG000|Overall Study|Ineligible prior to treatment|0|||
128948169|NCT01369849|464096357|FG001|Overall Study|Ineligible prior to treatment|0|||
129034126|NCT00642811|464414216|FG001|Overall Study|Severe Non-compliance to protocol|0|||
129034127|NCT00642811|464414217|FG002|Overall Study|Severe Non-compliance to protocol|0|||
128948170|NCT01369849|464096358|FG002|Overall Study|Ineligible prior to treatment|1|||
128948171|NCT01369849|464096356|FG000|Overall Study|Ineligible after receiving treatment|0|||
128948172|NCT01369849|464096357|FG001|Overall Study|Ineligible after receiving treatment|1|||
128948173|NCT01369849|464096358|FG002|Overall Study|Ineligible after receiving treatment|0|||
128948174|NCT00756886|464096359|FG000|Overall Study|Lost to Follow-up|1|||
128948175|NCT00756886|464096360|FG001|Overall Study|Lost to Follow-up|0|||
128948176|NCT00756886|464096359|FG000|Overall Study|Adverse Event|0|||
128948177|NCT00756886|464096360|FG001|Overall Study|Adverse Event|3|||
128948178|NCT00756886|464096359|FG000|Overall Study|Lack of Efficacy|1|||
128948179|NCT00756886|464096360|FG001|Overall Study|Lack of Efficacy|0|||
128948180|NCT00756886|464096359|FG000|Overall Study|Ineligible|9|||
128948181|NCT00756886|464096360|FG001|Overall Study|Ineligible|4|||
128948182|NCT00174785|464096364|FG000|Overall Study|Adverse Event|293|||
128948183|NCT00174785|464096365|FG001|Overall Study|Adverse Event|191|||
128948184|NCT00174785|464096364|FG000|Overall Study|Protocol Violation|14|||
128948185|NCT00174785|464096365|FG001|Overall Study|Protocol Violation|14|||
128948186|NCT00174785|464096364|FG000|Overall Study|Withdrawal by Subject|173|||
128948187|NCT00174785|464096365|FG001|Overall Study|Withdrawal by Subject|175|||
128948188|NCT00174785|464096364|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
128948189|NCT00174785|464096365|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
128948190|NCT00174785|464096364|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
128948191|NCT00174785|464096365|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
128948192|NCT00174785|464096364|FG000|Overall Study|Other prohibited medication|5|||
128948193|NCT00174785|464096365|FG001|Overall Study|Other prohibited medication|3|||
128948194|NCT00174785|464096364|FG000|Overall Study|Family request|6|||
128948195|NCT00174785|464096365|FG001|Overall Study|Family request|8|||
128948196|NCT00174785|464096364|FG000|Overall Study|Not pre-specified/Not coded|56|||
128948197|NCT00174785|464096365|FG001|Overall Study|Not pre-specified/Not coded|70|||
128948198|NCT00120289|464096367|FG000|Overall Study|Death|96|||
128948199|NCT00120289|464096368|FG001|Overall Study|Death|82|||
128948200|NCT00120289|464096367|FG000|Overall Study|Lost to Follow-up|11|||
128948201|NCT00120289|464096368|FG001|Overall Study|Lost to Follow-up|14|||
128948202|NCT00120289|464096367|FG000|Overall Study|Withdrawal by Subject|14|||
128948203|NCT00120289|464096368|FG001|Overall Study|Withdrawal by Subject|13|||
128948204|NCT01944969|464096369|FG000|Overall Study|Adverse Event|1|||
128948205|NCT01944969|464096369|FG000|Overall Study|Lack of Efficacy|1|||
128948206|NCT01944969|464096369|FG000|Overall Study|Non-compliance with IMP|1|||
128948207|NCT01944969|464096369|FG000|Overall Study|Administrative or other reasons|23|||
129124360|NCT02606253|464751334|FG002|Overall Study|Adverse Event|0|||
129124361|NCT02606253|464751332|FG000|Overall Study|Protocol Violation|2|||
129124362|NCT02606253|464751333|FG001|Overall Study|Protocol Violation|1|||
129124363|NCT02606253|464751334|FG002|Overall Study|Protocol Violation|0|||
129124364|NCT02606253|464751332|FG000|Overall Study|Physician Decision|1|||
129124365|NCT02606253|464751333|FG001|Overall Study|Physician Decision|1|||
129124366|NCT02606253|464751334|FG002|Overall Study|Physician Decision|0|||
129124367|NCT05383209|464751337|FG000|Overall Study|Adverse Event: Non-ocular|0|||
129124368|NCT05383209|464751338|FG001|Overall Study|Adverse Event: Non-ocular|1|||
129124369|NCT05383209|464751339|FG002|Overall Study|Adverse Event: Non-ocular|0|||
129124370|NCT05383209|464751337|FG000|Overall Study|Lost to Follow-up|2|||
129124371|NCT05383209|464751338|FG001|Overall Study|Lost to Follow-up|1|||
129124372|NCT05383209|464751339|FG002|Overall Study|Lost to Follow-up|4|||
129124373|NCT05383209|464751337|FG000|Overall Study|Withdrawal by Subject|2|||
129124374|NCT05383209|464751338|FG001|Overall Study|Withdrawal by Subject|0|||
129124375|NCT05383209|464751339|FG002|Overall Study|Withdrawal by Subject|1|||
129124376|NCT05383209|464751337|FG000|Overall Study|Death|1|||
129124377|NCT05383209|464751338|FG001|Overall Study|Death|0|||
129124378|NCT05383209|464751339|FG002|Overall Study|Death|0|||
128948208|NCT02938585|464096378|FG000|Overall Study|Withdrawal by parent or guardian|0|||
128948209|NCT02938585|464096379|FG001|Overall Study|Withdrawal by parent or guardian|1|||
128948210|NCT02938585|464096380|FG002|Overall Study|Withdrawal by parent or guardian|0|||
128948211|NCT02938585|464096381|FG003|Overall Study|Withdrawal by parent or guardian|0|||
128948212|NCT02938585|464096378|FG000|Overall Study|Withdrawal by Subject|0|||
128948213|NCT02938585|464096379|FG001|Overall Study|Withdrawal by Subject|0|||
128948214|NCT02938585|464096380|FG002|Overall Study|Withdrawal by Subject|0|||
128948215|NCT02938585|464096381|FG003|Overall Study|Withdrawal by Subject|5|||
129124379|NCT05383209|464751337|FG000|Overall Study|Other|0|||
128948216|NCT02411201|464096382|FG000|Overall Study|Adverse Event|2|||
128948217|NCT02411201|464096382|FG000|Overall Study|Withdrawal by Subject|2|||
129124380|NCT05383209|464751338|FG001|Overall Study|Other|1|||
129124381|NCT05383209|464751339|FG002|Overall Study|Other|0|||
129124382|NCT00717886|464751340|FG000|Overall Study|Withdrawal by Subject|3|||
129124383|NCT00717886|464751340|FG000|Overall Study|Treatment Failure|1|||
129124384|NCT00716417|464751341|FG000|Overall Study|Adverse Event|0|||
129124385|NCT00716417|464751342|FG001|Overall Study|Adverse Event|0|||
129124386|NCT00716417|464751343|FG002|Overall Study|Adverse Event|2|||
129124387|NCT00716417|464751344|FG003|Overall Study|Adverse Event|1|||
129124388|NCT00716417|464751345|FG004|Overall Study|Adverse Event|0|||
129124389|NCT00716417|464751346|FG005|Overall Study|Adverse Event|0|||
128948218|NCT02411201|464096382|FG000|Overall Study|Age group completed|2|||
128948219|NCT01260467|464096383|FG000|Overall Study|Withdrawal by Subject|2|||
129124390|NCT00716417|464751347|FG006|Overall Study|Adverse Event|3|||
129124391|NCT00716417|464751348|FG007|Overall Study|Adverse Event|1|||
128708875|NCT00203996|463228562|FG005|Overall Study|CPAP machine malfunction|0|||
128708876|NCT00203996|463228563|FG006|Overall Study|CPAP machine malfunction|0|||
128708877|NCT00203996|463228564|FG007|Overall Study|CPAP machine malfunction|0|||
128948220|NCT02504268|464096387|FG000|Overall Study|Adverse Event|18|||
128948221|NCT02504268|464096388|FG001|Overall Study|Adverse Event|8|||
128948222|NCT02504268|464096389|FG002|Overall Study|Adverse Event|14|||
129124392|NCT00716417|464751349|FG008|Overall Study|Adverse Event|0|||
129124393|NCT00716417|464751350|FG009|Overall Study|Adverse Event|3|||
129124394|NCT00716417|464751341|FG000|Overall Study|Withdrawal by Subject|0|||
129124395|NCT00716417|464751342|FG001|Overall Study|Withdrawal by Subject|1|||
129124396|NCT00716417|464751343|FG002|Overall Study|Withdrawal by Subject|0|||
129124397|NCT00716417|464751344|FG003|Overall Study|Withdrawal by Subject|2|||
129124398|NCT00716417|464751345|FG004|Overall Study|Withdrawal by Subject|0|||
129124399|NCT00716417|464751346|FG005|Overall Study|Withdrawal by Subject|0|||
129124400|NCT00716417|464751347|FG006|Overall Study|Withdrawal by Subject|1|||
128948223|NCT02504268|464096390|FG003|Overall Study|Adverse Event|0|||
128948224|NCT02504268|464096391|FG004|Overall Study|Adverse Event|0|||
128948225|NCT02504268|464096392|FG005|Overall Study|Adverse Event|0|||
128948226|NCT02504268|464096393|FG006|Overall Study|Adverse Event|0|||
128948227|NCT02504268|464096394|FG007|Overall Study|Adverse Event|0|||
128948228|NCT02504268|464096395|FG008|Overall Study|Adverse Event|0|||
128948229|NCT02504268|464096387|FG000|Overall Study|Withdrawal of Consent|11|||
128948230|NCT02504268|464096388|FG001|Overall Study|Withdrawal of Consent|10|||
128948231|NCT02504268|464096389|FG002|Overall Study|Withdrawal of Consent|3|||
128948232|NCT02504268|464096390|FG003|Overall Study|Withdrawal of Consent|0|||
128948233|NCT02504268|464096391|FG004|Overall Study|Withdrawal of Consent|0|||
128948234|NCT02504268|464096392|FG005|Overall Study|Withdrawal of Consent|0|||
128948235|NCT02504268|464096393|FG006|Overall Study|Withdrawal of Consent|0|||
128948236|NCT02504268|464096394|FG007|Overall Study|Withdrawal of Consent|0|||
128948237|NCT02504268|464096395|FG008|Overall Study|Withdrawal of Consent|0|||
128948238|NCT02504268|464096387|FG000|Overall Study|Pregnancy|2|||
128948239|NCT02504268|464096388|FG001|Overall Study|Pregnancy|0|||
128948240|NCT02504268|464096389|FG002|Overall Study|Pregnancy|0|||
128948241|NCT02504268|464096390|FG003|Overall Study|Pregnancy|0|||
128948242|NCT02504268|464096391|FG004|Overall Study|Pregnancy|0|||
128948243|NCT02504268|464096392|FG005|Overall Study|Pregnancy|0|||
128948244|NCT02504268|464096393|FG006|Overall Study|Pregnancy|0|||
128948245|NCT02504268|464096394|FG007|Overall Study|Pregnancy|0|||
128948246|NCT02504268|464096395|FG008|Overall Study|Pregnancy|0|||
128948247|NCT02504268|464096387|FG000|Overall Study|Lost to Follow-up|3|||
128948248|NCT02504268|464096388|FG001|Overall Study|Lost to Follow-up|6|||
128948249|NCT02504268|464096389|FG002|Overall Study|Lost to Follow-up|4|||
128948250|NCT02504268|464096390|FG003|Overall Study|Lost to Follow-up|0|||
128948251|NCT02504268|464096391|FG004|Overall Study|Lost to Follow-up|0|||
128948252|NCT02504268|464096392|FG005|Overall Study|Lost to Follow-up|0|||
128948253|NCT02504268|464096393|FG006|Overall Study|Lost to Follow-up|0|||
128948254|NCT02504268|464096394|FG007|Overall Study|Lost to Follow-up|0|||
129124401|NCT00716417|464751348|FG007|Overall Study|Withdrawal by Subject|0|||
129124402|NCT00716417|464751349|FG008|Overall Study|Withdrawal by Subject|0|||
129124403|NCT00716417|464751350|FG009|Overall Study|Withdrawal by Subject|0|||
128708878|NCT00203996|463228565|FG008|Overall Study|CPAP machine malfunction|0|||
128708879|NCT00203996|463228566|FG009|Overall Study|CPAP machine malfunction|0|||
128708880|NCT00203996|463228557|FG000|Overall Study|Scheduling issue|0|||
128948255|NCT02504268|464096395|FG008|Overall Study|Lost to Follow-up|0|||
128948256|NCT02504268|464096387|FG000|Overall Study|Death|1|||
129124404|NCT00716417|464751341|FG000|Overall Study|Progressive disease|3|||
129124405|NCT00716417|464751342|FG001|Overall Study|Progressive disease|5|||
129124406|NCT00716417|464751343|FG002|Overall Study|Progressive disease|3|||
128708881|NCT00203996|463228558|FG001|Overall Study|Scheduling issue|0|||
128948257|NCT02504268|464096388|FG001|Overall Study|Death|1|||
128948258|NCT02504268|464096389|FG002|Overall Study|Death|0|||
129124407|NCT00716417|464751344|FG003|Overall Study|Progressive disease|8|||
128948259|NCT02504268|464096390|FG003|Overall Study|Death|0|||
128948260|NCT02504268|464096391|FG004|Overall Study|Death|0|||
128948261|NCT02504268|464096392|FG005|Overall Study|Death|0|||
128948262|NCT02504268|464096393|FG006|Overall Study|Death|0|||
128948263|NCT02504268|464096394|FG007|Overall Study|Death|0|||
128948264|NCT02504268|464096395|FG008|Overall Study|Death|0|||
128948265|NCT02504268|464096387|FG000|Overall Study|Subject Request to Discontinue|11|||
128948266|NCT02504268|464096388|FG001|Overall Study|Subject Request to Discontinue|3|||
128948267|NCT02504268|464096389|FG002|Overall Study|Subject Request to Discontinue|6|||
128948268|NCT02504268|464096390|FG003|Overall Study|Subject Request to Discontinue|0|||
128948269|NCT02504268|464096391|FG004|Overall Study|Subject Request to Discontinue|0|||
128948270|NCT02504268|464096392|FG005|Overall Study|Subject Request to Discontinue|0|||
128948271|NCT02504268|464096393|FG006|Overall Study|Subject Request to Discontinue|0|||
129124408|NCT00716417|464751345|FG004|Overall Study|Progressive disease|0|||
128708882|NCT00203996|463228559|FG002|Overall Study|Scheduling issue|0|||
128708883|NCT00203996|463228560|FG003|Overall Study|Scheduling issue|0|||
128948272|NCT02504268|464096394|FG007|Overall Study|Subject Request to Discontinue|0|||
129124409|NCT00716417|464751346|FG005|Overall Study|Progressive disease|3|||
129124410|NCT00716417|464751347|FG006|Overall Study|Progressive disease|3|||
129124411|NCT00716417|464751348|FG007|Overall Study|Progressive disease|1|||
129124412|NCT00716417|464751349|FG008|Overall Study|Progressive disease|5|||
129124413|NCT00716417|464751350|FG009|Overall Study|Progressive disease|0|||
128948273|NCT02504268|464096395|FG008|Overall Study|Subject Request to Discontinue|0|||
128948274|NCT02504268|464096387|FG000|Overall Study|No Longer Meets Study Criteria|2|||
128948275|NCT02504268|464096388|FG001|Overall Study|No Longer Meets Study Criteria|3|||
128948276|NCT02504268|464096389|FG002|Overall Study|No Longer Meets Study Criteria|0|||
128948277|NCT02504268|464096390|FG003|Overall Study|No Longer Meets Study Criteria|0|||
128948278|NCT02504268|464096391|FG004|Overall Study|No Longer Meets Study Criteria|0|||
128948279|NCT02504268|464096392|FG005|Overall Study|No Longer Meets Study Criteria|0|||
128948280|NCT02504268|464096393|FG006|Overall Study|No Longer Meets Study Criteria|0|||
128948281|NCT02504268|464096394|FG007|Overall Study|No Longer Meets Study Criteria|0|||
128948282|NCT02504268|464096395|FG008|Overall Study|No Longer Meets Study Criteria|0|||
128948283|NCT02504268|464096387|FG000|Overall Study|Lack of Efficacy|11|||
128948284|NCT02504268|464096388|FG001|Overall Study|Lack of Efficacy|35|||
128948285|NCT02504268|464096389|FG002|Overall Study|Lack of Efficacy|9|||
128948286|NCT02504268|464096390|FG003|Overall Study|Lack of Efficacy|0|||
128948287|NCT02504268|464096391|FG004|Overall Study|Lack of Efficacy|0|||
128948288|NCT02504268|464096392|FG005|Overall Study|Lack of Efficacy|0|||
128948289|NCT02504268|464096393|FG006|Overall Study|Lack of Efficacy|0|||
128948290|NCT02504268|464096394|FG007|Overall Study|Lack of Efficacy|0|||
128948291|NCT02504268|464096395|FG008|Overall Study|Lack of Efficacy|0|||
128948292|NCT02504268|464096387|FG000|Overall Study|Poor/Non-Compliance|3|||
128948293|NCT02504268|464096388|FG001|Overall Study|Poor/Non-Compliance|2|||
128948294|NCT02504268|464096389|FG002|Overall Study|Poor/Non-Compliance|3|||
128948295|NCT02504268|464096390|FG003|Overall Study|Poor/Non-Compliance|0|||
128948296|NCT02504268|464096391|FG004|Overall Study|Poor/Non-Compliance|0|||
128948297|NCT02504268|464096392|FG005|Overall Study|Poor/Non-Compliance|0|||
128948298|NCT02504268|464096393|FG006|Overall Study|Poor/Non-Compliance|0|||
128948299|NCT02504268|464096394|FG007|Overall Study|Poor/Non-Compliance|0|||
128948300|NCT02504268|464096395|FG008|Overall Study|Poor/Non-Compliance|0|||
128948301|NCT02504268|464096387|FG000|Overall Study|Not Disclosed|1|||
128948302|NCT02504268|464096388|FG001|Overall Study|Not Disclosed|0|||
128948303|NCT02504268|464096389|FG002|Overall Study|Not Disclosed|2|||
128948304|NCT02504268|464096390|FG003|Overall Study|Not Disclosed|0|||
128948305|NCT02504268|464096391|FG004|Overall Study|Not Disclosed|0|||
128948306|NCT02504268|464096392|FG005|Overall Study|Not Disclosed|0|||
128948307|NCT02504268|464096393|FG006|Overall Study|Not Disclosed|0|||
128948308|NCT02504268|464096394|FG007|Overall Study|Not Disclosed|0|||
128948309|NCT02504268|464096395|FG008|Overall Study|Not Disclosed|0|||
128948310|NCT02130427|464096396|FG000|Overall Study|Imaging results not interpretable|30|||
128948311|NCT03150095|464096401|FG000|Overall Study|Death|0|||
128948312|NCT03150095|464096402|FG001|Overall Study|Death|1|||
128948313|NCT03150095|464096401|FG000|Overall Study|Lost to Follow-up|1|||
128948314|NCT03150095|464096402|FG001|Overall Study|Lost to Follow-up|1|||
128948315|NCT03150095|464096401|FG000|Overall Study|Withdrawal by Subject|4|||
128948316|NCT03150095|464096402|FG001|Overall Study|Withdrawal by Subject|0|||
128948317|NCT03150095|464096401|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
128948318|NCT03150095|464096402|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
128948319|NCT02108951|464096406|FG000|Overall Study|Lost to Follow-up|1|||
128948320|NCT02108951|464096406|FG000|Overall Study|Patient's/guardian's decision|1|||
128948321|NCT02108951|464096406|FG000|Overall Study|Study Terminated by Sponsor|14|||
128948322|NCT00718666|464096407|FG000|Booster Phase Year 5|No active participation request|0|||
128948323|NCT00718666|464096408|FG001|Booster Phase Year 5|No active participation request|0|||
128948324|NCT00718666|464096409|FG002|Booster Phase Year 5|No active participation request|1|||
128948325|NCT00718666|464096407|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
128948326|NCT00718666|464096408|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
128948327|NCT00718666|464096409|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
128948328|NCT00718666|464096407|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
128948329|NCT00718666|464096408|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
128948330|NCT00718666|464096409|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
129124414|NCT00716417|464751341|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
129124415|NCT00716417|464751342|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
129124416|NCT00716417|464751343|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
129124417|NCT00716417|464751344|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
129124418|NCT00716417|464751345|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
128948331|NCT00718666|464096407|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
129124419|NCT00716417|464751346|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
129218180|NCT01457703|465098582|FG000|Overall Study|Screen Failure|5|||
128948332|NCT00718666|464096408|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
128948333|NCT00718666|464096409|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
128948334|NCT00421343|464096412|FG000|Overall Study|Death|1|||
128948335|NCT00421343|464096412|FG000|Overall Study|Withdrawal by Subject|2|||
128948336|NCT00421343|464096412|FG000|Overall Study|Lost to Follow-up|3|||
128948337|NCT03471767|464096418|FG000|Overall Study|Withdrawal by Subject|3|||
128948338|NCT03471767|464096419|FG001|Overall Study|Withdrawal by Subject|1|||
128948339|NCT03471767|464096418|FG000|Overall Study|Adverse Event|1|||
128948340|NCT03471767|464096419|FG001|Overall Study|Adverse Event|0|||
128948341|NCT03471767|464096418|FG000|Overall Study|Lost to Follow-up|1|||
128948342|NCT03471767|464096419|FG001|Overall Study|Lost to Follow-up|0|||
128948343|NCT03471767|464096418|FG000|Overall Study|PI Withdrawal|1|||
128948344|NCT03471767|464096419|FG001|Overall Study|PI Withdrawal|3|||
128948345|NCT00678587|464096420|FG000|Overall Study|Adverse Event|3|||
128948346|NCT00678587|464096421|FG001|Overall Study|Adverse Event|3|||
128948347|NCT00678587|464096420|FG000|Overall Study|Lack of Efficacy|1|||
128948348|NCT00678587|464096421|FG001|Overall Study|Lack of Efficacy|0|||
128948349|NCT00678587|464096420|FG000|Overall Study|Protocol Violation|2|||
128948350|NCT00678587|464096421|FG001|Overall Study|Protocol Violation|1|||
128948351|NCT00678587|464096420|FG000|Overall Study|Study Closed/Terminated|1|||
128948352|NCT00678587|464096421|FG001|Overall Study|Study Closed/Terminated|0|||
128948353|NCT00678587|464096420|FG000|Overall Study|Lost to Follow-up|3|||
128948354|NCT00678587|464096421|FG001|Overall Study|Lost to Follow-up|5|||
128948355|NCT00678587|464096420|FG000|Overall Study|Investigator Discretion|2|||
128948356|NCT00678587|464096421|FG001|Overall Study|Investigator Discretion|6|||
128948357|NCT00678587|464096420|FG000|Overall Study|Withdrew Consent|8|||
128948358|NCT00678587|464096421|FG001|Overall Study|Withdrew Consent|3|||
128948359|NCT03806179|464096422|FG000|Overall Study|Progressive disease|0|||
128948360|NCT03806179|464096423|FG001|Overall Study|Progressive disease|2|||
128948361|NCT01952730|464096426|FG000|Overall Study|FDA shut down core lab used by study|1|||
128948362|NCT01606761|464096429|FG000|Prior to Week 24|Lost to Follow-up|0|||
128948363|NCT01606761|464096430|FG001|Prior to Week 24|Lost to Follow-up|3|||
128948364|NCT01606761|464096431|FG002|Prior to Week 24|Lost to Follow-up|2|||
128948365|NCT01606761|464096432|FG003|Prior to Week 24|Lost to Follow-up|0|||
128948366|NCT01606761|464096433|FG004|Prior to Week 24|Lost to Follow-up|0|||
128948367|NCT01606761|464096429|FG000|Prior to Week 24|Withdrawal by Subject|12|||
128948368|NCT01606761|464096430|FG001|Prior to Week 24|Withdrawal by Subject|10|||
128948369|NCT01606761|464096431|FG002|Prior to Week 24|Withdrawal by Subject|9|||
128948370|NCT01606761|464096432|FG003|Prior to Week 24|Withdrawal by Subject|0|||
128948371|NCT01606761|464096433|FG004|Prior to Week 24|Withdrawal by Subject|0|||
128948372|NCT01606761|464096429|FG000|Prior to Week 24|Adverse Event|11|||
128948373|NCT01606761|464096430|FG001|Prior to Week 24|Adverse Event|18|||
128948374|NCT01606761|464096431|FG002|Prior to Week 24|Adverse Event|22|||
128948375|NCT01606761|464096432|FG003|Prior to Week 24|Adverse Event|0|||
128948376|NCT01606761|464096433|FG004|Prior to Week 24|Adverse Event|0|||
128948377|NCT01606761|464096429|FG000|Prior to Week 24|Lack of Efficacy|15|||
128948378|NCT01606761|464096430|FG001|Prior to Week 24|Lack of Efficacy|14|||
128948379|NCT01606761|464096431|FG002|Prior to Week 24|Lack of Efficacy|8|||
128948380|NCT01606761|464096432|FG003|Prior to Week 24|Lack of Efficacy|0|||
128948381|NCT01606761|464096433|FG004|Prior to Week 24|Lack of Efficacy|0|||
128948382|NCT01606761|464096429|FG000|Prior to Week 24|Physician Decision|0|||
128948383|NCT01606761|464096430|FG001|Prior to Week 24|Physician Decision|3|||
128948384|NCT01606761|464096431|FG002|Prior to Week 24|Physician Decision|1|||
128948385|NCT01606761|464096432|FG003|Prior to Week 24|Physician Decision|0|||
128948386|NCT01606761|464096433|FG004|Prior to Week 24|Physician Decision|0|||
128948387|NCT01606761|464096429|FG000|Prior to Week 24|Other|4|||
128948388|NCT01606761|464096430|FG001|Prior to Week 24|Other|7|||
129124420|NCT00716417|464751347|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
129124421|NCT00716417|464751348|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
128948389|NCT01606761|464096431|FG002|Prior to Week 24|Other|5|||
128948390|NCT01606761|464096432|FG003|Prior to Week 24|Other|0|||
128948391|NCT01606761|464096433|FG004|Prior to Week 24|Other|0|||
128948392|NCT01606761|464096429|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
128948393|NCT01606761|464096430|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
128948394|NCT01606761|464096431|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
128948395|NCT01606761|464096432|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
128948396|NCT01606761|464096433|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
128948397|NCT01606761|464096429|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
128948398|NCT01606761|464096430|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
128948399|NCT01606761|464096431|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
128948400|NCT01606761|464096432|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
128948401|NCT01606761|464096433|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
128948402|NCT01606761|464096429|FG000|Week 24 to Week 52|Adverse Event|0|||
128948403|NCT01606761|464096430|FG001|Week 24 to Week 52|Adverse Event|11|||
128948404|NCT01606761|464096431|FG002|Week 24 to Week 52|Adverse Event|14|||
128948405|NCT01606761|464096432|FG003|Week 24 to Week 52|Adverse Event|3|||
128948406|NCT01606761|464096433|FG004|Week 24 to Week 52|Adverse Event|15|||
128948407|NCT01606761|464096429|FG000|Week 24 to Week 52|Death|0|||
128948408|NCT01606761|464096430|FG001|Week 24 to Week 52|Death|0|||
128948409|NCT01606761|464096431|FG002|Week 24 to Week 52|Death|2|||
128948410|NCT01606761|464096432|FG003|Week 24 to Week 52|Death|1|||
128948411|NCT01606761|464096433|FG004|Week 24 to Week 52|Death|0|||
128948412|NCT01606761|464096429|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
128948413|NCT01606761|464096430|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
129034128|NCT00642811|464414218|FG003|Overall Study|Severe Non-compliance to protocol|0|||
128770347|NCT02736968|463450226|FG004|Overall Study|COVID-19 Pandemic|0|||
128948414|NCT01606761|464096431|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
128948415|NCT01606761|464096432|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
128948416|NCT01606761|464096433|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
128948417|NCT01606761|464096429|FG000|Week 24 to Week 52|Physician Decision|0|||
128948418|NCT01606761|464096430|FG001|Week 24 to Week 52|Physician Decision|1|||
128948419|NCT01606761|464096431|FG002|Week 24 to Week 52|Physician Decision|1|||
128948420|NCT01606761|464096432|FG003|Week 24 to Week 52|Physician Decision|0|||
128948421|NCT01606761|464096433|FG004|Week 24 to Week 52|Physician Decision|0|||
128948422|NCT01606761|464096429|FG000|Week 24 to Week 52|Other|0|||
128948423|NCT01606761|464096430|FG001|Week 24 to Week 52|Other|1|||
128948424|NCT01606761|464096431|FG002|Week 24 to Week 52|Other|5|||
128948425|NCT01606761|464096432|FG003|Week 24 to Week 52|Other|2|||
128948426|NCT01606761|464096433|FG004|Week 24 to Week 52|Other|2|||
128948427|NCT01606761|464096429|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
128948428|NCT01606761|464096430|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
128948429|NCT01606761|464096431|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
128948430|NCT01606761|464096432|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
128948431|NCT01606761|464096433|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
128948432|NCT01606761|464096429|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
128948433|NCT01606761|464096430|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
128948434|NCT01606761|464096431|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
128948435|NCT01606761|464096432|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
128948436|NCT01606761|464096433|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
128948437|NCT01606761|464096429|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
128948438|NCT01606761|464096430|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
128948439|NCT01606761|464096431|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
128948440|NCT01606761|464096432|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
128948441|NCT01606761|464096433|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
128948442|NCT01606761|464096429|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
128948443|NCT01606761|464096430|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
128948444|NCT01606761|464096431|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
128948445|NCT01606761|464096432|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
128948446|NCT01606761|464096433|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
128948447|NCT05086289|464096434|FG000|Overall Study|Adverse Event|4|||
128948448|NCT05086289|464096435|FG001|Overall Study|Adverse Event|2|||
128948449|NCT05086289|464096434|FG000|Overall Study|Lost to Follow-up|2|||
128948450|NCT05086289|464096435|FG001|Overall Study|Lost to Follow-up|0|||
128948451|NCT05086289|464096434|FG000|Overall Study|Non-compliance with study drug|2|||
128948452|NCT05086289|464096435|FG001|Overall Study|Non-compliance with study drug|1|||
128948453|NCT05086289|464096434|FG000|Overall Study|Physician Decision|2|||
128948454|NCT05086289|464096435|FG001|Overall Study|Physician Decision|0|||
128948455|NCT05086289|464096434|FG000|Overall Study|Withdrawal by Subject|5|||
129034129|NCT00642811|464414219|FG004|Overall Study|Severe Non-compliance to protocol|0|||
129034130|NCT00642811|464414220|FG005|Overall Study|Severe Non-compliance to protocol|0|||
129034131|NCT00642811|464414215|FG000|Overall Study|Other|0|||
129034132|NCT00642811|464414216|FG001|Overall Study|Other|1|||
129034133|NCT00642811|464414217|FG002|Overall Study|Other|0|||
129034134|NCT00642811|464414218|FG003|Overall Study|Other|1|||
129034135|NCT00642811|464414219|FG004|Overall Study|Other|0|||
129034136|NCT00642811|464414220|FG005|Overall Study|Other|0|||
129034137|NCT03108820|464414224|FG000|Overall Study|Lost to Follow-up|30|||
129034138|NCT03108820|464414225|FG001|Overall Study|Lost to Follow-up|28|||
129034139|NCT03108820|464414224|FG000|Overall Study|Withdrawal by Subject|32|||
129034140|NCT03108820|464414225|FG001|Overall Study|Withdrawal by Subject|24|||
129124422|NCT00716417|464751349|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
129124423|NCT00716417|464751350|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
129124424|NCT00716417|464751341|FG000|Overall Study|On patient request due to toxicities|0|||
129124425|NCT00716417|464751342|FG001|Overall Study|On patient request due to toxicities|0|||
129124426|NCT00716417|464751343|FG002|Overall Study|On patient request due to toxicities|0|||
129124427|NCT00716417|464751344|FG003|Overall Study|On patient request due to toxicities|0|||
129124428|NCT00716417|464751345|FG004|Overall Study|On patient request due to toxicities|0|||
129124429|NCT00716417|464751346|FG005|Overall Study|On patient request due to toxicities|0|||
129124430|NCT00716417|464751347|FG006|Overall Study|On patient request due to toxicities|0|||
129124431|NCT00716417|464751348|FG007|Overall Study|On patient request due to toxicities|1|||
129124432|NCT00716417|464751349|FG008|Overall Study|On patient request due to toxicities|0|||
129124433|NCT00716417|464751350|FG009|Overall Study|On patient request due to toxicities|0|||
129124434|NCT01553851|464751351|FG000|Overall Study|Adverse Event|2|||
129124435|NCT01553851|464751351|FG000|Overall Study|constipation|1|||
129034141|NCT03108820|464414224|FG000|Overall Study|Death|6|||
129034142|NCT03108820|464414225|FG001|Overall Study|Death|11|||
129034143|NCT00089973|464414228|FG000|Overall Study|Adverse Event|3|||
128948456|NCT05086289|464096435|FG001|Overall Study|Withdrawal by Subject|2|||
128948457|NCT02237157|464096436|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
128948458|NCT02237157|464096437|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
128948459|NCT02237157|464096438|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
128948460|NCT02237157|464096439|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
128948461|NCT02237157|464096436|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
128948462|NCT02237157|464096437|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
128948463|NCT02237157|464096438|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
128948464|NCT02237157|464096439|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
128948465|NCT01996748|464096440|FG000|Overall Study|Personal reason|1|||
128948466|NCT01996748|464096441|FG001|Overall Study|Personal reason|0|||
128948467|NCT01996748|464096440|FG000|Overall Study|Physician Decision|2|||
128948468|NCT01996748|464096441|FG001|Overall Study|Physician Decision|0|||
128948469|NCT01996748|464096440|FG000|Overall Study|Adverse Event|1|||
128948470|NCT01996748|464096441|FG001|Overall Study|Adverse Event|4|||
128948471|NCT01996748|464096440|FG000|Overall Study|Withdrawal by Subject|0|||
128948472|NCT01996748|464096441|FG001|Overall Study|Withdrawal by Subject|1|||
128948473|NCT01996748|464096440|FG000|Overall Study|Lost to Follow-up|4|||
128948474|NCT01996748|464096441|FG001|Overall Study|Lost to Follow-up|1|||
128948475|NCT00807846|464096442|FG000|Overall Study|Adverse Event|5|||
128948476|NCT00807846|464096443|FG001|Overall Study|Adverse Event|0|||
128948477|NCT00807846|464096442|FG000|Overall Study|Lack of Efficacy|2|||
128948478|NCT00807846|464096443|FG001|Overall Study|Lack of Efficacy|0|||
128948479|NCT00807846|464096442|FG000|Overall Study|Protocol Violation|2|||
128948480|NCT00807846|464096443|FG001|Overall Study|Protocol Violation|1|||
128948481|NCT00807846|464096442|FG000|Overall Study|Withdrawal by Subject|2|||
128948482|NCT00807846|464096443|FG001|Overall Study|Withdrawal by Subject|1|||
128948483|NCT00807846|464096442|FG000|Overall Study|Other|1|||
128708884|NCT00203996|463228561|FG004|Overall Study|Scheduling issue|0|||
128948484|NCT00807846|464096443|FG001|Overall Study|Other|2|||
128948485|NCT01419665|464096445|FG000|Combination Treatment|Adverse Event|7|||
128948486|NCT01419665|464096446|FG001|Combination Treatment|Adverse Event|10|||
128948487|NCT01419665|464096445|FG000|Combination Treatment|Physician Decision|5|||
128948488|NCT01419665|464096446|FG001|Combination Treatment|Physician Decision|8|||
128948489|NCT01419665|464096445|FG000|Combination Treatment|Protocol Violation|6|||
128948490|NCT01419665|464096446|FG001|Combination Treatment|Protocol Violation|2|||
128948491|NCT01419665|464096445|FG000|Combination Treatment|disease progression|10|||
128948492|NCT01419665|464096446|FG001|Combination Treatment|disease progression|9|||
128948493|NCT01419665|464096445|FG000|Combination Treatment|Death|5|||
128948494|NCT01419665|464096446|FG001|Combination Treatment|Death|7|||
128948495|NCT01419665|464096445|FG000|Combination Treatment|administrative problems|0|||
128948496|NCT01419665|464096446|FG001|Combination Treatment|administrative problems|1|||
128948497|NCT01419665|464096445|FG000|Combination Treatment|Withdrawal by Subject|5|||
128948498|NCT01419665|464096446|FG001|Combination Treatment|Withdrawal by Subject|4|||
128948499|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
128948500|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
128948501|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
128948502|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
128948503|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
128948504|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
128948505|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
128948506|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
128708885|NCT00203996|463228562|FG005|Overall Study|Scheduling issue|0|||
128948507|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
128948508|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
128948509|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
128948510|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
128948511|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|Death|1|||
128948512|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|Death|2|||
128948513|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
128948514|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
128708886|NCT00203996|463228563|FG006|Overall Study|Scheduling issue|0|||
129034144|NCT00089973|464414228|FG000|Overall Study|Withdrawal by Subject|1|||
129034145|NCT00089973|464414228|FG000|Overall Study|Disease progression|45|||
129034146|NCT00089973|464414228|FG000|Overall Study|Death|1|||
129034147|NCT01992094|464414229|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
129034148|NCT01992094|464414230|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
129034149|NCT01992094|464414231|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
129034150|NCT01992094|464414229|FG000|Overall Study|Adverse Event|1|||
129034151|NCT01992094|464414230|FG001|Overall Study|Adverse Event|0|||
129034152|NCT01992094|464414231|FG002|Overall Study|Adverse Event|0|||
129034153|NCT01992094|464414229|FG000|Overall Study|Death|5|||
129034154|NCT01992094|464414230|FG001|Overall Study|Death|5|||
128948515|NCT01419665|464096445|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
128948516|NCT01419665|464096446|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
128948517|NCT01419665|464096445|FG000|Open Label Phase|Death|1|||
128948518|NCT01419665|464096446|FG001|Open Label Phase|Death|0|||
128948519|NCT01419665|464096445|FG000|Open Label Phase|disease progression|0|||
128948520|NCT01419665|464096446|FG001|Open Label Phase|disease progression|1|||
128948521|NCT03738566|464096447|FG000|Initial Study Phase|Withdrawal by Subject|1|||
128948522|NCT03738566|464096448|FG001|Initial Study Phase|Withdrawal by Subject|1|||
128948523|NCT03738566|464096449|FG002|Initial Study Phase|Withdrawal by Subject|2|||
128948524|NCT03738566|464096450|FG003|Initial Study Phase|Withdrawal by Subject|0|||
128948525|NCT03738566|464096447|FG000|Initial Study Phase|Death|0|||
128948526|NCT03738566|464096448|FG001|Initial Study Phase|Death|1|||
128948527|NCT03738566|464096449|FG002|Initial Study Phase|Death|0|||
128948528|NCT03738566|464096450|FG003|Initial Study Phase|Death|0|||
128948529|NCT03738566|464096447|FG000|Initial Study Phase|Treatment failure|5|||
128948530|NCT03738566|464096448|FG001|Initial Study Phase|Treatment failure|0|||
128948531|NCT03738566|464096449|FG002|Initial Study Phase|Treatment failure|0|||
128948532|NCT03738566|464096450|FG003|Initial Study Phase|Treatment failure|0|||
128948533|NCT03738566|464096447|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
128948534|NCT03738566|464096448|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
128948535|NCT03738566|464096449|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
128948536|NCT03738566|464096450|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
128948537|NCT01655823|464096451|FG000|Overall Study|Lost to Follow-up|0|||
128948538|NCT01655823|464096452|FG001|Overall Study|Lost to Follow-up|1|||
128948539|NCT01655823|464096453|FG002|Overall Study|Lost to Follow-up|0|||
128948540|NCT01655823|464096454|FG003|Overall Study|Lost to Follow-up|0|||
128948541|NCT01655823|464096455|FG004|Overall Study|Lost to Follow-up|1|||
128948542|NCT01655823|464096451|FG000|Overall Study|Withdrawal by Subject|0|||
128948543|NCT01655823|464096452|FG001|Overall Study|Withdrawal by Subject|1|||
128948544|NCT01655823|464096453|FG002|Overall Study|Withdrawal by Subject|0|||
128948545|NCT01655823|464096454|FG003|Overall Study|Withdrawal by Subject|1|||
128948546|NCT01655823|464096455|FG004|Overall Study|Withdrawal by Subject|0|||
128948547|NCT04799405|464096458|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
128948548|NCT02683525|464096459|FG000|Overall Study|Lost to Follow-up|1|||
128948549|NCT02683525|464096459|FG000|Overall Study|Physician Decision|1|||
128948550|NCT02683525|464096459|FG000|Overall Study|Disease Progression|6|||
128948551|NCT00926796|464096463|FG000|Overall Study|Did not receive randomized treatment|4|||
128948552|NCT00926796|464096464|FG001|Overall Study|Did not receive randomized treatment|7|||
128948553|NCT00926796|464096463|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
128948554|NCT00926796|464096464|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
128948555|NCT00926796|464096463|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
128708887|NCT00203996|463228564|FG007|Overall Study|Scheduling issue|2|||
128948556|NCT00926796|464096464|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
128948557|NCT00926796|464096463|FG000|Overall Study|Adverse Event|7|||
128948558|NCT00926796|464096464|FG001|Overall Study|Adverse Event|14|||
128948559|NCT00926796|464096463|FG000|Overall Study|Lost to Follow-up|22|||
128948560|NCT00926796|464096464|FG001|Overall Study|Lost to Follow-up|13|||
128948561|NCT00926796|464096463|FG000|Overall Study|Protocol Violation|15|||
129034155|NCT01992094|464414231|FG002|Overall Study|Death|2|||
129034156|NCT01992094|464414229|FG000|Overall Study|Lost to Follow-up|26|||
129034157|NCT01992094|464414230|FG001|Overall Study|Lost to Follow-up|9|||
129034158|NCT01992094|464414231|FG002|Overall Study|Lost to Follow-up|13|||
129034159|NCT01992094|464414229|FG000|Overall Study|OTHER|4|||
129034160|NCT01992094|464414230|FG001|Overall Study|OTHER|0|||
129034161|NCT01992094|464414231|FG002|Overall Study|OTHER|0|||
129034162|NCT01992094|464414229|FG000|Overall Study|Protocol Violation|1|||
129034163|NCT01992094|464414230|FG001|Overall Study|Protocol Violation|0|||
129034164|NCT01992094|464414231|FG002|Overall Study|Protocol Violation|1|||
129034165|NCT01992094|464414229|FG000|Overall Study|Withdrawal by Subject|7|||
129034166|NCT01992094|464414230|FG001|Overall Study|Withdrawal by Subject|3|||
129034167|NCT01992094|464414231|FG002|Overall Study|Withdrawal by Subject|4|||
129034168|NCT01214239|464414232|FG000|Overall Study|Adverse Event|3|||
129034169|NCT01214239|464414233|FG001|Overall Study|Adverse Event|4|||
129034170|NCT01214239|464414232|FG000|Overall Study|Protocol Violation|2|||
129034171|NCT01214239|464414233|FG001|Overall Study|Protocol Violation|1|||
129034172|NCT01214239|464414232|FG000|Overall Study|Lost to Follow-up|1|||
129034173|NCT01214239|464414233|FG001|Overall Study|Lost to Follow-up|1|||
129034174|NCT01214239|464414232|FG000|Overall Study|Withdrawal by Subject|4|||
129034175|NCT01214239|464414233|FG001|Overall Study|Withdrawal by Subject|9|||
129124436|NCT01369433|464751352|FG000|Overall Study|Adverse Event|31|||
128948562|NCT00926796|464096464|FG001|Overall Study|Protocol Violation|11|||
129034176|NCT01214239|464414232|FG000|Overall Study|Lack of Efficacy|1|||
129124437|NCT01369433|464751353|FG001|Overall Study|Adverse Event|1|||
129124438|NCT01369433|464751352|FG000|Overall Study|Required significant surgical procedure|1|||
129124439|NCT01369433|464751353|FG001|Overall Study|Required significant surgical procedure|0|||
128948563|NCT00926796|464096463|FG000|Overall Study|Withdrawal by Subject|1|||
129034177|NCT01214239|464414233|FG001|Overall Study|Lack of Efficacy|2|||
129034178|NCT01214239|464414232|FG000|Overall Study|patient's private reason|1|||
129034179|NCT01214239|464414233|FG001|Overall Study|patient's private reason|1|||
129034180|NCT01049581|464414234|FG000|Overall Study|Lost to Follow-up|2|||
129034181|NCT01049581|464414235|FG001|Overall Study|Lost to Follow-up|1|||
129034182|NCT03203642|464414236|FG000|Overall Study|Adverse Event|3|||
129034183|NCT03203642|464414237|FG001|Overall Study|Adverse Event|1|||
129034184|NCT03203642|464414236|FG000|Overall Study|Withdrawal by Subject|6|||
129034185|NCT03203642|464414237|FG001|Overall Study|Withdrawal by Subject|6|||
129034186|NCT03203642|464414236|FG000|Overall Study|Lost to Follow-up|2|||
129034187|NCT03203642|464414237|FG001|Overall Study|Lost to Follow-up|1|||
129034188|NCT03203642|464414236|FG000|Overall Study|Termination of the study by sponsor|1|||
129034189|NCT03203642|464414237|FG001|Overall Study|Termination of the study by sponsor|1|||
129034190|NCT03203642|464414236|FG000|Overall Study|Participant moved|0|||
129124440|NCT01369433|464751352|FG000|Overall Study|Non-compliance|1|||
129124441|NCT01369433|464751353|FG001|Overall Study|Non-compliance|0|||
129124442|NCT01369433|464751352|FG000|Overall Study|Withdrawal by Subject|5|||
129124443|NCT01369433|464751353|FG001|Overall Study|Withdrawal by Subject|2|||
129124444|NCT01369433|464751352|FG000|Overall Study|Study terminated by Sponsor|67|||
129124445|NCT01369433|464751353|FG001|Overall Study|Study terminated by Sponsor|0|||
129124446|NCT01369433|464751352|FG000|Overall Study|Lost to Follow-up|1|||
129124447|NCT01369433|464751353|FG001|Overall Study|Lost to Follow-up|0|||
129124448|NCT01369433|464751352|FG000|Overall Study|Death|5|||
129124449|NCT01369433|464751353|FG001|Overall Study|Death|0|||
129124450|NCT01369433|464751352|FG000|Overall Study|Investigator discretion|6|||
129124451|NCT01369433|464751353|FG001|Overall Study|Investigator discretion|1|||
129124452|NCT01369433|464751352|FG000|Overall Study|Progressive Disease|92|||
129124453|NCT01369433|464751353|FG001|Overall Study|Progressive Disease|12|||
129124454|NCT03881371|464751364|FG000|Overall Study|Adverse Event|8|||
129124455|NCT03881371|464751365|FG001|Overall Study|Adverse Event|9|||
129124456|NCT03881371|464751364|FG000|Overall Study|Death|1|||
129124457|NCT03881371|464751365|FG001|Overall Study|Death|0|||
129124458|NCT03881371|464751364|FG000|Overall Study|Lost to Follow-up|1|||
129124459|NCT03881371|464751365|FG001|Overall Study|Lost to Follow-up|0|||
129124460|NCT03881371|464751364|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129124461|NCT03881371|464751365|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129124462|NCT03881371|464751364|FG000|Overall Study|Physician Decision|3|||
129124463|NCT03881371|464751365|FG001|Overall Study|Physician Decision|3|||
129124464|NCT03881371|464751364|FG000|Overall Study|Withdrawal by Subject|2|||
129124465|NCT03881371|464751365|FG001|Overall Study|Withdrawal by Subject|10|||
129124466|NCT03881371|464751364|FG000|Overall Study|Discontinuation from Study|1|||
129124467|NCT03881371|464751365|FG001|Overall Study|Discontinuation from Study|0|||
129124468|NCT00933933|464751369|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
129124469|NCT00933933|464751370|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
129124470|NCT00933933|464751371|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
129124471|NCT00933933|464751369|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
129124472|NCT00933933|464751370|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
129124473|NCT00933933|464751371|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
129124474|NCT01138046|464751372|FG000|Overall Study|Withdrawal due to death|6|||
129124475|NCT02178956|464751373|FG000|Overall Study|Lost to Follow-up|4|||
129124476|NCT02178956|464751374|FG001|Overall Study|Lost to Follow-up|4|||
129124477|NCT02178956|464751373|FG000|Overall Study|Sponsor terminated study|49|||
129124478|NCT02178956|464751374|FG001|Overall Study|Sponsor terminated study|58|||
129124479|NCT02178956|464751373|FG000|Overall Study|Withdrawal by Subject|15|||
129124480|NCT02178956|464751374|FG001|Overall Study|Withdrawal by Subject|11|||
129124481|NCT02178956|464751373|FG000|Overall Study|Various Reasons|3|||
129124482|NCT02178956|464751374|FG001|Overall Study|Various Reasons|5|||
129124483|NCT01900314|464751375|FG000|Overall Study|Lost to Follow-up|1|||
129124484|NCT01900314|464751376|FG001|Overall Study|Lost to Follow-up|0|||
129124485|NCT01900314|464751375|FG000|Overall Study|Protocol Violation|0|||
129124486|NCT01900314|464751376|FG001|Overall Study|Protocol Violation|1|||
129034191|NCT03203642|464414237|FG001|Overall Study|Participant moved|1|||
129034192|NCT03203642|464414236|FG000|Overall Study|Investigator's decision|3|||
129034193|NCT03203642|464414237|FG001|Overall Study|Investigator's decision|0|||
129124487|NCT01900314|464751375|FG000|Overall Study|Withdrawal by Subject|3|||
129124488|NCT01900314|464751376|FG001|Overall Study|Withdrawal by Subject|3|||
129124489|NCT04225832|464751377|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
129124490|NCT04225832|464751378|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
129124491|NCT04225832|464751377|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
129124492|NCT04225832|464751378|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
129124493|NCT03282097|464751379|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
129124494|NCT03282097|464751380|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
129034194|NCT03203642|464414236|FG000|Overall Study|Other than above specified|0|||
129034195|NCT03203642|464414237|FG001|Overall Study|Other than above specified|1|||
129034196|NCT05068284|464414250|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
128948564|NCT00926796|464096464|FG001|Overall Study|Withdrawal by Subject|0|||
128948565|NCT01341652|464096465|FG000|Overall Study|Incorrect Random Assignment|0|||
128948566|NCT01341652|464096466|FG001|Overall Study|Incorrect Random Assignment|1|||
128948567|NCT01341652|464096465|FG000|Overall Study|ineligible; presence metastatic disease|0|||
128948568|NCT01341652|464096466|FG001|Overall Study|ineligible; presence metastatic disease|1|||
128948569|NCT03731364|464096474|FG000|Overall Study|Adverse Event|0|||
128948570|NCT03731364|464096475|FG001|Overall Study|Adverse Event|0|||
128948571|NCT03731364|464096476|FG002|Overall Study|Adverse Event|1|||
128948572|NCT03731364|464096477|FG003|Overall Study|Adverse Event|2|||
128948573|NCT03731364|464096478|FG004|Overall Study|Adverse Event|1|||
128948574|NCT01934192|464096479|FG000|Overall Study|Protocol Violation|0|||
128948575|NCT01934192|464096480|FG001|Overall Study|Protocol Violation|0|||
128948576|NCT01934192|464096481|FG002|Overall Study|Protocol Violation|0|||
128948577|NCT01934192|464096482|FG003|Overall Study|Protocol Violation|1|||
128948578|NCT01934192|464096479|FG000|Overall Study|Other: reached stopping criteria|6|||
128948579|NCT01934192|464096480|FG001|Overall Study|Other: reached stopping criteria|5|||
128948580|NCT01934192|464096481|FG002|Overall Study|Other: reached stopping criteria|1|||
128948581|NCT01934192|464096482|FG003|Overall Study|Other: reached stopping criteria|0|||
128948582|NCT01934192|464096479|FG000|Overall Study|Physician Decision|3|||
128948583|NCT01934192|464096480|FG001|Overall Study|Physician Decision|2|||
128948584|NCT01934192|464096481|FG002|Overall Study|Physician Decision|0|||
128948585|NCT01934192|464096482|FG003|Overall Study|Physician Decision|0|||
128948586|NCT02357849|464096483|FG000|Overall Study|Withdrawal by Subject|2|||
128948587|NCT02357849|464096484|FG001|Overall Study|Withdrawal by Subject|3|||
128948588|NCT01536119|464096485|FG000|Overall Study|Lost to Follow-up|17|||
128948589|NCT01536119|464096486|FG001|Overall Study|Lost to Follow-up|14|||
128948590|NCT00213980|464098982|FG000|Overall Study|Withdrawal by Subject|3|||
128948591|NCT00213980|464098983|FG001|Overall Study|Withdrawal by Subject|1|||
128948592|NCT00213980|464098982|FG000|Overall Study|Adverse Event|1|||
128948593|NCT00213980|464098983|FG001|Overall Study|Adverse Event|1|||
128948594|NCT00213980|464098982|FG000|Overall Study|Disease progression|0|||
128948595|NCT00213980|464098983|FG001|Overall Study|Disease progression|2|||
128948596|NCT00213980|464098982|FG000|Overall Study|Developed ovarian cancer|1|||
128948597|NCT00213980|464098983|FG001|Overall Study|Developed ovarian cancer|0|||
128948598|NCT00213980|464098982|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
128948599|NCT00213980|464098983|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
128948600|NCT00798694|464098984|FG000|Overall Study|Lost to Follow-up|1|||
128948601|NCT00798694|464098985|FG001|Overall Study|Lost to Follow-up|1|||
128948602|NCT00798694|464098984|FG000|Overall Study|Physician Decision|1|||
128948603|NCT00798694|464098985|FG001|Overall Study|Physician Decision|0|||
128948604|NCT01774344|464098987|FG000|Overall Study|Withdrawal by Subject|3|||
128948605|NCT01774344|464098988|FG001|Overall Study|Withdrawal by Subject|10|||
128948606|NCT01774344|464098987|FG000|Overall Study|Protocol Violation|0|||
128948607|NCT01774344|464098988|FG001|Overall Study|Protocol Violation|1|||
128948608|NCT01774344|464098987|FG000|Overall Study|Lost to Follow-up|4|||
128948609|NCT01774344|464098988|FG001|Overall Study|Lost to Follow-up|10|||
128948610|NCT01774344|464098987|FG000|Overall Study|End of survival follow-up not available|2|||
128948611|NCT01774344|464098988|FG001|Overall Study|End of survival follow-up not available|2|||
128948612|NCT01774344|464098987|FG000|Overall Study|Data collection finished|4|||
128948613|NCT01774344|464098988|FG001|Overall Study|Data collection finished|14|||
128948614|NCT01774344|464098987|FG000|Overall Study|Other|0|||
128948615|NCT01774344|464098988|FG001|Overall Study|Other|1|||
128948616|NCT01774344|464098987|FG000|Overall Study|Did not enter Survival Follow up|49|||
128948617|NCT01774344|464098988|FG001|Overall Study|Did not enter Survival Follow up|83|||
128948618|NCT01397552|464099001|FG000|Overall Study|Adverse Event|1|||
129124495|NCT03282097|464751379|FG000|Intervention Visit Complete|Patient Death|13|||
129124496|NCT03282097|464751380|FG001|Intervention Visit Complete|Patient Death|15|||
129124497|NCT03282097|464751379|FG000|Intervention Visit Complete|Caregiver Death|0|||
129124498|NCT03282097|464751380|FG001|Intervention Visit Complete|Caregiver Death|3|||
128948619|NCT01397552|464099002|FG001|Overall Study|Adverse Event|0|||
128948620|NCT01397552|464099001|FG000|Overall Study|Withdrawal by Subject|2|||
128948621|NCT01397552|464099002|FG001|Overall Study|Withdrawal by Subject|1|||
128948622|NCT01089582|464099003|FG000|Overall Study|Death|2|||
128948623|NCT01089582|464099003|FG000|Overall Study|Adverse Event|15|||
128948624|NCT01089582|464099003|FG000|Overall Study|Lost to Follow-up|8|||
128948625|NCT01089582|464099003|FG000|Overall Study|Other|4|||
128948626|NCT01089582|464099003|FG000|Overall Study|Withdrawal by Subject|1|||
128948627|NCT02108600|464099004|FG000|Overall Study|Withdrawal by Subject|2|||
128948628|NCT02108600|464099005|FG001|Overall Study|Withdrawal by Subject|0|||
129124499|NCT03282097|464751379|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
129218181|NCT01457703|465098583|FG001|Overall Study|Screen Failure|7|||
128948629|NCT02108600|464099004|FG000|Overall Study|Lost to Follow-up|1|||
128948630|NCT02108600|464099005|FG001|Overall Study|Lost to Follow-up|1|||
128948631|NCT00862849|464099006|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
128948632|NCT00862849|464099007|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
128948633|NCT00862849|464099008|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
128948634|NCT00862849|464099009|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129124500|NCT03282097|464751380|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
129124501|NCT03282097|464751379|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
129124502|NCT03282097|464751380|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
129124503|NCT03282097|464751379|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
129124504|NCT03282097|464751380|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
128708888|NCT00203996|463228565|FG008|Overall Study|Scheduling issue|0|||
128708889|NCT00203996|463228566|FG009|Overall Study|Scheduling issue|0|||
128708890|NCT03064451|463228567|FG000|Overall Study|Lost to Follow-up|1|||
128708891|NCT03064451|463228567|FG000|Overall Study|Mapping Failure|4|||
128708892|NCT03064451|463228567|FG000|Overall Study|Exited prior to procedure|8|||
128708893|NCT03064451|463228567|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
128708894|NCT03918447|463228570|FG000|Overall Study|Death|1|||
128708895|NCT03918447|463228571|FG001|Overall Study|Death|0|||
128708896|NCT03918447|463228570|FG000|Overall Study|Lost to Follow-up|13|||
128708897|NCT03918447|463228571|FG001|Overall Study|Lost to Follow-up|6|||
128708898|NCT03918447|463228570|FG000|Overall Study|Withdrawal by Subject|19|||
128708899|NCT03918447|463228571|FG001|Overall Study|Withdrawal by Subject|17|||
128708900|NCT03918447|463228570|FG000|Overall Study|Study Terminated by Sponsor|195|||
128708901|NCT03918447|463228571|FG001|Overall Study|Study Terminated by Sponsor|197|||
128708902|NCT03918447|463228570|FG000|Overall Study|Reason not Specified|0|||
128708903|NCT03918447|463228571|FG001|Overall Study|Reason not Specified|1|||
128708904|NCT03278613|463228572|FG000|Overall Study|Lost to Follow-up|3|||
128708905|NCT03278613|463228573|FG001|Overall Study|Lost to Follow-up|1|||
128708906|NCT01405456|463228574|FG000|Overall Study|Lost to Follow-up|2|||
128708907|NCT01405456|463228575|FG001|Overall Study|Lost to Follow-up|1|||
128708908|NCT01405456|463228574|FG000|Overall Study|Physician Decision|1|||
128708909|NCT01405456|463228575|FG001|Overall Study|Physician Decision|0|||
128708910|NCT00850564|463228576|FG000|Overall Study|Withdrawal by Subject|2|||
128708911|NCT05355805|463228577|FG000|Overall Study|Lost to Follow-up|6|||
128708912|NCT05355805|463228578|FG001|Overall Study|Lost to Follow-up|11|||
128708913|NCT05355805|463228579|FG002|Overall Study|Lost to Follow-up|10|||
128708914|NCT05355805|463228580|FG003|Overall Study|Lost to Follow-up|6|||
128708915|NCT05355805|463228577|FG000|Overall Study|Decision by Sponsor|0|||
128708916|NCT05355805|463228578|FG001|Overall Study|Decision by Sponsor|0|||
128708917|NCT05355805|463228579|FG002|Overall Study|Decision by Sponsor|1|||
128948635|NCT00862849|464099010|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
128948636|NCT00862849|464099011|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
128948637|NCT00862849|464099006|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
128948638|NCT00862849|464099007|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
128948639|NCT00862849|464099008|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
128948640|NCT00862849|464099009|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
128948641|NCT00862849|464099010|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
128948642|NCT00862849|464099011|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
128948643|NCT04032171|464099019|FG000|Overall Study|Study Termination|1|||
128948644|NCT04032171|464099020|FG001|Overall Study|Study Termination|0|||
128948645|NCT00992784|464099021|FG000|Overall Study|Adverse Event|2|||
128948646|NCT00992784|464099022|FG001|Overall Study|Adverse Event|1|||
128948647|NCT00992784|464099023|FG002|Overall Study|Adverse Event|0|||
128948648|NCT00992784|464099021|FG000|Overall Study|Withdrawal by Subject|1|||
128948649|NCT00992784|464099022|FG001|Overall Study|Withdrawal by Subject|1|||
128948650|NCT00992784|464099023|FG002|Overall Study|Withdrawal by Subject|1|||
128948651|NCT01363713|464099024|FG000|Overall Study|Adverse Event|1|||
128948652|NCT01363713|464099024|FG000|Overall Study|Protocol Violation|3|||
129124505|NCT03282097|464751379|FG000|Primary Outcome Data Collection Complete|Missing|2|||
129124506|NCT03282097|464751380|FG001|Primary Outcome Data Collection Complete|Missing|3|||
129124507|NCT03282097|464751379|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
129124508|NCT03282097|464751380|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
129124509|NCT03282097|464751379|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
128948653|NCT01363713|464099024|FG000|Overall Study|Withdrawal by Subject|2|||
129124510|NCT03282097|464751380|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
128708918|NCT05355805|463228580|FG003|Overall Study|Decision by Sponsor|0|||
128708919|NCT05355805|463228577|FG000|Overall Study|Withdrawal by Subject|7|||
128708920|NCT05355805|463228578|FG001|Overall Study|Withdrawal by Subject|14|||
128708921|NCT05355805|463228579|FG002|Overall Study|Withdrawal by Subject|15|||
128708922|NCT05355805|463228580|FG003|Overall Study|Withdrawal by Subject|13|||
128708923|NCT01937559|463228581|FG000|Overall Study|Physician Decision|3|||
128708924|NCT01937559|463228582|FG001|Overall Study|Physician Decision|3|||
128948654|NCT01658579|464099025|FG000|Treatment Period A|Other|0|||
128948655|NCT01658579|464099026|FG001|Treatment Period A|Other|0|||
128948656|NCT01658579|464099027|FG002|Treatment Period A|Other|1|||
128708925|NCT01937559|463228583|FG002|Overall Study|Physician Decision|0|||
128708926|NCT01937559|463228581|FG000|Overall Study|Withdrawal by Subject|6|||
128708927|NCT01937559|463228582|FG001|Overall Study|Withdrawal by Subject|4|||
128708928|NCT01937559|463228583|FG002|Overall Study|Withdrawal by Subject|0|||
128708929|NCT01937559|463228581|FG000|Overall Study|screen fail|2|||
128708930|NCT01937559|463228582|FG001|Overall Study|screen fail|4|||
128948657|NCT01658579|464099028|FG003|Treatment Period A|Other|1|||
128948658|NCT01658579|464099025|FG000|Treatment Period A|Adverse Event|1|||
128948659|NCT01658579|464099026|FG001|Treatment Period A|Adverse Event|0|||
128948660|NCT01658579|464099027|FG002|Treatment Period A|Adverse Event|0|||
128948661|NCT01658579|464099028|FG003|Treatment Period A|Adverse Event|0|||
128948662|NCT01658579|464099025|FG000|Treatment Period B|Other|0|||
128948663|NCT01658579|464099026|FG001|Treatment Period B|Other|0|||
128948664|NCT01658579|464099027|FG002|Treatment Period B|Other|0|||
128948665|NCT01658579|464099028|FG003|Treatment Period B|Other|1|||
128948666|NCT00608530|464099029|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
128948667|NCT00608530|464099030|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
128948668|NCT00608530|464099031|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
128948669|NCT00608530|464099032|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
128948670|NCT00608530|464099029|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
128948671|NCT00608530|464099030|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
128948672|NCT00608530|464099031|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
128948673|NCT00608530|464099032|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
128948674|NCT00608530|464099029|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
128948675|NCT00608530|464099030|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
128948676|NCT00608530|464099031|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
128948677|NCT00608530|464099032|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
128948678|NCT00608530|464099029|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
128948679|NCT00608530|464099030|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
128948680|NCT00608530|464099031|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
128948681|NCT00608530|464099032|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
128948682|NCT00608530|464099029|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
128948683|NCT00608530|464099030|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
128948684|NCT00608530|464099031|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
128948685|NCT00608530|464099032|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
128948686|NCT00608530|464099029|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
128948687|NCT00608530|464099030|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
128948688|NCT00608530|464099031|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
128948689|NCT00608530|464099032|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
128948690|NCT01357915|464099033|FG000|Overall Study|Lost to Follow-up|3|||
128948691|NCT01357915|464099034|FG001|Overall Study|Lost to Follow-up|0|||
128948692|NCT01514188|464099035|FG000|Overall Study|Adverse Event|3|||
128948693|NCT01514188|464099036|FG001|Overall Study|Adverse Event|5|||
128948694|NCT01514188|464099035|FG000|Overall Study|Withdrawal by Subject|2|||
128948695|NCT01514188|464099036|FG001|Overall Study|Withdrawal by Subject|4|||
128948696|NCT01514188|464099035|FG000|Overall Study|Protocol Violation|2|||
128948697|NCT01514188|464099036|FG001|Overall Study|Protocol Violation|4|||
128948698|NCT01514188|464099035|FG000|Overall Study|Physician Decision|0|||
128948699|NCT01514188|464099036|FG001|Overall Study|Physician Decision|2|||
128948700|NCT01514188|464099035|FG000|Overall Study|Disease Progression|13|||
128948701|NCT01514188|464099036|FG001|Overall Study|Disease Progression|14|||
128948702|NCT01514188|464099035|FG000|Overall Study|Death|1|||
128948703|NCT01514188|464099036|FG001|Overall Study|Death|3|||
128948704|NCT01514188|464099035|FG000|Overall Study|Other|2|||
128948705|NCT01514188|464099036|FG001|Overall Study|Other|1|||
128948706|NCT01019486|464099037|FG000|Overall Study|Withdrawal by Subject|1|||
128948707|NCT01019486|464099038|FG001|Overall Study|Withdrawal by Subject|1|||
128948708|NCT01019486|464099039|FG002|Overall Study|Withdrawal by Subject|1|||
128948709|NCT02932332|464099044|FG000|Overall Study|Withdrawal by Subject|1|||
128948710|NCT02932332|464099045|FG001|Overall Study|Withdrawal by Subject|1|||
128948711|NCT02932332|464099046|FG002|Overall Study|Withdrawal by Subject|0|||
128948712|NCT02932332|464099047|FG003|Overall Study|Withdrawal by Subject|1|||
128948713|NCT02932332|464099044|FG000|Overall Study|Chest pain|0|||
128948714|NCT02932332|464099045|FG001|Overall Study|Chest pain|0|||
128948715|NCT02932332|464099046|FG002|Overall Study|Chest pain|0|||
128948716|NCT02932332|464099047|FG003|Overall Study|Chest pain|1|||
128948717|NCT02932332|464099044|FG000|Overall Study|Not Dyspneic cough|1|||
128948718|NCT02932332|464099045|FG001|Overall Study|Not Dyspneic cough|2|||
128948719|NCT02932332|464099046|FG002|Overall Study|Not Dyspneic cough|1|||
128948720|NCT02932332|464099047|FG003|Overall Study|Not Dyspneic cough|0|||
128948721|NCT02841787|464099048|FG000|Overall Study|Lost to Follow-up|1|||
128948722|NCT02841787|464099049|FG001|Overall Study|Lost to Follow-up|0|||
128948723|NCT02841787|464099050|FG002|Overall Study|Lost to Follow-up|0|||
128948724|NCT02841787|464099048|FG000|Overall Study|Symptoms dropped below threshold|1|||
128948725|NCT02841787|464099049|FG001|Overall Study|Symptoms dropped below threshold|0|||
128948726|NCT02841787|464099050|FG002|Overall Study|Symptoms dropped below threshold|0|||
128948727|NCT02841787|464099048|FG000|Overall Study|Withdrawal by Subject|1|||
128948728|NCT02841787|464099049|FG001|Overall Study|Withdrawal by Subject|4|||
128948729|NCT02841787|464099050|FG002|Overall Study|Withdrawal by Subject|0|||
128948730|NCT03633227|464099051|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
128948731|NCT03633227|464099052|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
128948732|NCT03633227|464099051|FG000|Double Blind (DB), up to Week 48|Death|2|||
128948733|NCT03633227|464099052|FG001|Double Blind (DB), up to Week 48|Death|1|||
128948734|NCT03633227|464099051|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
128948735|NCT03633227|464099052|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
128948736|NCT03633227|464099051|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
128948737|NCT03633227|464099052|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
128948738|NCT03633227|464099051|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
128948739|NCT03633227|464099052|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
128948740|NCT03633227|464099051|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
128948741|NCT03633227|464099052|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
128948742|NCT03633227|464099051|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
128948743|NCT03633227|464099052|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
128948744|NCT03633227|464099051|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
128948745|NCT03633227|464099052|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
128948746|NCT03633227|464099051|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
128948747|NCT03633227|464099052|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
128948748|NCT03633227|464099051|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
128948749|NCT03633227|464099052|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
128948750|NCT03633227|464099051|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
128948751|NCT03633227|464099052|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
128948752|NCT03633227|464099051|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
128948753|NCT03633227|464099052|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
128948754|NCT03029650|464099057|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
128948755|NCT03029650|464099058|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
128948756|NCT03029650|464099057|FG000|Washout (1 Week)|Physician Decision|0|||
128948757|NCT03029650|464099058|FG001|Washout (1 Week)|Physician Decision|1|||
128948758|NCT01875367|464099059|FG000|Overall Study|Not complete at least 2 questionaries|4|||
128948759|NCT01875367|464099060|FG001|Overall Study|Not complete at least 2 questionaries|2|||
128948760|NCT01875367|464099059|FG000|Overall Study|Not receive study treatment|1|||
128948761|NCT01875367|464099060|FG001|Overall Study|Not receive study treatment|0|||
128948762|NCT04533815|464099061|FG000|Overall Study|Adverse Event|2|||
128948763|NCT04533815|464099061|FG000|Overall Study|Site withdrew|5|||
128948764|NCT02951988|464099064|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
128948765|NCT02951988|464099065|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
128948766|NCT02951988|464099066|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
128948767|NCT02951988|464099067|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
128948768|NCT02951988|464099064|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
128948769|NCT02951988|464099065|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
128948770|NCT02951988|464099066|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
128948771|NCT02951988|464099067|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
128948772|NCT02951988|464099064|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
128948773|NCT02951988|464099065|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
128948774|NCT02951988|464099066|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
128948775|NCT02951988|464099067|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
128948776|NCT02951988|464099064|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
129124511|NCT03282097|464751379|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
129124512|NCT03282097|464751380|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
129124513|NCT06001021|464751384|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
129124514|NCT06001021|464751385|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
129124515|NCT06001021|464751386|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
129124516|NCT06001021|464751387|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
129124517|NCT06001021|464751388|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
129124518|NCT06001021|464751389|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
129124519|NCT06001021|464751390|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
129124520|NCT06001021|464751384|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
129124521|NCT06001021|464751385|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129124522|NCT06001021|464751386|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129124523|NCT06001021|464751387|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
129218182|NCT01457703|465098582|FG000|Overall Study|Withdrawal by Subject|1|||
129218183|NCT01457703|465098583|FG001|Overall Study|Withdrawal by Subject|4|||
129218184|NCT00949702|465098584|FG000|Overall Study|Death|40|||
129218185|NCT00949702|465098584|FG000|Overall Study|Disease progression|7|||
128948777|NCT02951988|464099065|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
128948778|NCT02951988|464099066|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
129218186|NCT00949702|465098584|FG000|Overall Study|Withdrawal of consent|1|||
129218187|NCT06042855|465098587|FG000|Overall Study|No Receipt of Study Drug|48|||
128948779|NCT02951988|464099067|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
128948780|NCT02951988|464099064|FG000|Open-Label Treatment Period|Protocol Violation|22|||
128948781|NCT02951988|464099065|FG001|Open-Label Treatment Period|Protocol Violation|0|||
128948782|NCT02951988|464099066|FG002|Open-Label Treatment Period|Protocol Violation|0|||
128948783|NCT02951988|464099067|FG003|Open-Label Treatment Period|Protocol Violation|0|||
128948784|NCT02951988|464099064|FG000|Open-Label Treatment Period|Pregnancy|2|||
128948785|NCT02951988|464099065|FG001|Open-Label Treatment Period|Pregnancy|0|||
128948786|NCT02951988|464099066|FG002|Open-Label Treatment Period|Pregnancy|0|||
128948787|NCT02951988|464099067|FG003|Open-Label Treatment Period|Pregnancy|0|||
128948788|NCT02951988|464099064|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
128948789|NCT02951988|464099065|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
128948790|NCT02951988|464099066|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
128948791|NCT02951988|464099067|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
128948792|NCT02951988|464099064|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
128948793|NCT02951988|464099065|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
128948794|NCT02951988|464099066|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
128948795|NCT02951988|464099067|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
128948796|NCT02951988|464099064|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
128948797|NCT02951988|464099065|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
128948798|NCT02951988|464099066|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
128948799|NCT02951988|464099067|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
128948800|NCT02951988|464099064|FG000|Open-Label Treatment Period|Adverse Event|45|||
128948801|NCT02951988|464099065|FG001|Open-Label Treatment Period|Adverse Event|0|||
128948802|NCT02951988|464099066|FG002|Open-Label Treatment Period|Adverse Event|0|||
128948803|NCT02951988|464099067|FG003|Open-Label Treatment Period|Adverse Event|0|||
128948804|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
128948805|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
128948806|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
128948807|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
128948808|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
128948809|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
128948810|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
128948811|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
128948812|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
128948813|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
128948814|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
128948815|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
128948816|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
128948817|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
129034197|NCT05068284|464414251|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
129034198|NCT05068284|464414252|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129034199|NCT05068284|464414253|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129034200|NCT05068284|464414254|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129034201|NCT05068284|464414255|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129034202|NCT05068284|464414256|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129034203|NCT05068284|464414257|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129034204|NCT05068284|464414250|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129034205|NCT05068284|464414251|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129034206|NCT05068284|464414252|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
129034207|NCT05068284|464414253|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129034208|NCT05068284|464414254|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129034209|NCT05068284|464414255|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129034210|NCT05068284|464414256|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129034211|NCT05068284|464414257|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129034212|NCT05068284|464414250|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
129034213|NCT05068284|464414251|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
129034214|NCT05068284|464414252|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
129034215|NCT05068284|464414253|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
129034216|NCT05068284|464414254|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
129034217|NCT05068284|464414255|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
129034218|NCT05068284|464414256|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
129034219|NCT05068284|464414257|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
129034220|NCT05068284|464414250|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129124524|NCT06001021|464751388|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
129124525|NCT06001021|464751389|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129124526|NCT06001021|464751390|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129124527|NCT02755090|464751391|FG000|Overall Study|equipment malfunction|1|||
129124528|NCT02755090|464751392|FG001|Overall Study|equipment malfunction|0|||
128708931|NCT01937559|463228583|FG002|Overall Study|screen fail|0|||
128708932|NCT02167893|463228584|FG000|Overall Study|Investigator transferred|85|||
128708933|NCT02167893|463228584|FG000|Overall Study|Investigator health reasons|10|||
128708934|NCT02167893|463228584|FG000|Overall Study|Case report forms not collected|68|||
128708935|NCT04818840|463228585|FG000|Overall Study|Lost to Follow-up|0|||
128708936|NCT04818840|463228586|FG001|Overall Study|Lost to Follow-up|5|||
128708937|NCT04818840|463228585|FG000|Overall Study|Physician Decision|1|||
128708938|NCT04818840|463228586|FG001|Overall Study|Physician Decision|0|||
128708939|NCT04818840|463228585|FG000|Overall Study|Site Terminated by Sponsor|0|||
128708940|NCT04818840|463228586|FG001|Overall Study|Site Terminated by Sponsor|3|||
128708941|NCT04818840|463228585|FG000|Overall Study|Study Terminated by Sponsor|43|||
128708942|NCT04818840|463228586|FG001|Overall Study|Study Terminated by Sponsor|7|||
128708943|NCT04818840|463228585|FG000|Overall Study|Withdrawal by Subject|0|||
128708944|NCT04818840|463228586|FG001|Overall Study|Withdrawal by Subject|1|||
128708945|NCT00524368|463230016|FG000|Overall Study|Adverse Event|10|||
128708946|NCT00524368|463230017|FG001|Overall Study|Adverse Event|12|||
128708947|NCT00524368|463230016|FG000|Overall Study|Lost to Follow-up|9|||
128708948|NCT00524368|463230017|FG001|Overall Study|Lost to Follow-up|13|||
128708949|NCT00524368|463230016|FG000|Overall Study|Withdrawal by Subject|4|||
128708950|NCT00524368|463230017|FG001|Overall Study|Withdrawal by Subject|5|||
128708951|NCT00524368|463230016|FG000|Overall Study|Non-compliant|8|||
128708952|NCT00524368|463230017|FG001|Overall Study|Non-compliant|9|||
128708953|NCT00524368|463230016|FG000|Overall Study|Reached a Virologic Endpoint|3|||
128708954|NCT00524368|463230017|FG001|Overall Study|Reached a Virologic Endpoint|2|||
128708955|NCT00524368|463230016|FG000|Overall Study|Sponsor's Decision|2|||
128708956|NCT00524368|463230017|FG001|Overall Study|Sponsor's Decision|0|||
128708957|NCT00524368|463230016|FG000|Overall Study|Ineligible to Continue the study|2|||
128708958|NCT00524368|463230017|FG001|Overall Study|Ineligible to Continue the study|5|||
128708959|NCT00524368|463230016|FG000|Overall Study|Other|3|||
128708960|NCT00524368|463230017|FG001|Overall Study|Other|2|||
128708961|NCT00793598|463230018|FG000|Overall Study|Patient Request|0|||
128708962|NCT00793598|463230019|FG001|Overall Study|Patient Request|1|||
128708963|NCT00793598|463230020|FG002|Overall Study|Patient Request|0|||
128708964|NCT00793598|463230021|FG003|Overall Study|Patient Request|0|||
128708965|NCT00793598|463230022|FG004|Overall Study|Patient Request|0|||
128708966|NCT00793598|463230023|FG005|Overall Study|Patient Request|0|||
128708967|NCT00793598|463230024|FG006|Overall Study|Patient Request|0|||
128708968|NCT00793598|463230025|FG007|Overall Study|Patient Request|0|||
128708969|NCT00793598|463230018|FG000|Overall Study|Protocol Violation|0|||
128708970|NCT00793598|463230019|FG001|Overall Study|Protocol Violation|0|||
128708971|NCT00793598|463230020|FG002|Overall Study|Protocol Violation|0|||
128708972|NCT00793598|463230021|FG003|Overall Study|Protocol Violation|0|||
128708973|NCT00793598|463230022|FG004|Overall Study|Protocol Violation|0|||
128708974|NCT00793598|463230023|FG005|Overall Study|Protocol Violation|0|||
128708975|NCT00793598|463230024|FG006|Overall Study|Protocol Violation|0|||
128708976|NCT00793598|463230025|FG007|Overall Study|Protocol Violation|1|||
128708977|NCT00793598|463230018|FG000|Overall Study|Subject not dosed|0|||
128708978|NCT00793598|463230019|FG001|Overall Study|Subject not dosed|0|||
128708979|NCT00793598|463230020|FG002|Overall Study|Subject not dosed|0|||
128770348|NCT02736968|463450227|FG005|Overall Study|COVID-19 Pandemic|0|||
128948818|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
128948819|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
128948820|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Pregnancy|0|||
128948821|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Pregnancy|1|||
128948822|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Pregnancy|1|||
128948823|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Pregnancy|0|||
128948824|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128948825|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
128948826|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
128948827|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
128948828|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128770349|NCT02736968|463450228|FG006|Overall Study|COVID-19 Pandemic|2|||
128948829|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
128708980|NCT00793598|463230021|FG003|Overall Study|Subject not dosed|0|||
128708981|NCT00793598|463230022|FG004|Overall Study|Subject not dosed|0|||
128708982|NCT00793598|463230023|FG005|Overall Study|Subject not dosed|1|||
128770350|NCT02736968|463450229|FG007|Overall Study|COVID-19 Pandemic|0|||
128708983|NCT00793598|463230024|FG006|Overall Study|Subject not dosed|0|||
128708984|NCT00793598|463230025|FG007|Overall Study|Subject not dosed|0|||
128708985|NCT02154490|463230028|FG000|Overall Study|No tissue submitted|23|||
128708986|NCT02154490|463230028|FG000|Overall Study|No biomarker results|167|||
128708987|NCT02154490|463230028|FG000|Overall Study|Not assigned to a sub-study|270|||
128708988|NCT02154490|463230028|FG000|Overall Study|Did not register to a sub-study|749|||
128708989|NCT02961751|463230037|FG000|Overall Study|Lost to Follow-up|11|||
128708990|NCT02961751|463230037|FG000|Overall Study|Physician Decision|2|||
128708991|NCT02961751|463230037|FG000|Overall Study|Not Eligible at Enrollment|1|||
128708992|NCT02961751|463230037|FG000|Overall Study|Protocol Violation|1|||
129124529|NCT04797169|464751394|FG000|Overall Study|Lost to Follow-up|84|||
128708993|NCT02373202|463230038|FG000|Overall Study|Adverse Event|2|||
128708994|NCT02373202|463230039|FG001|Overall Study|Adverse Event|5|||
128708995|NCT02373202|463230040|FG002|Overall Study|Adverse Event|2|||
128708996|NCT02373202|463230041|FG003|Overall Study|Adverse Event|1|||
128708997|NCT02373202|463230038|FG000|Overall Study|Lack of Efficacy|0|||
128708998|NCT02373202|463230039|FG001|Overall Study|Lack of Efficacy|0|||
128708999|NCT02373202|463230040|FG002|Overall Study|Lack of Efficacy|1|||
128948830|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
128948831|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
128948832|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128948833|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Adverse Event|8|||
128948834|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Adverse Event|3|||
128948835|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Adverse Event|6|||
128948836|NCT02951988|464099064|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
128948837|NCT02951988|464099065|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
128948838|NCT02951988|464099066|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
128948839|NCT02951988|464099067|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
128948840|NCT00603980|464099069|FG000|Study Qualification|Protocol Violation|3|||
128948841|NCT00603980|464099069|FG000|Study Qualification|Inconsistent data reporting|13|||
128948842|NCT00603980|464099069|FG000|Main Study|14th subject completed trial|1|||
128948843|NCT01627067|464099070|FG000|Overall Study|Screen Failure|1|||
128948844|NCT00632463|464099071|FG000|Overall Study|Adverse Event|0|||
129034221|NCT05068284|464414251|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
128709000|NCT02373202|463230041|FG003|Overall Study|Lack of Efficacy|0|||
128709001|NCT02373202|463230038|FG000|Overall Study|Other|0|||
128709002|NCT02373202|463230039|FG001|Overall Study|Other|1|||
128948845|NCT00632463|464099072|FG001|Overall Study|Adverse Event|1|||
128948846|NCT00632463|464099073|FG002|Overall Study|Adverse Event|0|||
129034222|NCT05068284|464414252|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
129034223|NCT05068284|464414253|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129034224|NCT05068284|464414254|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
129034225|NCT05068284|464414255|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129034226|NCT05068284|464414256|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129034227|NCT05068284|464414257|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129034228|NCT05068284|464414250|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129034229|NCT05068284|464414251|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129034230|NCT05068284|464414252|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129034231|NCT05068284|464414253|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
129034232|NCT05068284|464414254|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129034233|NCT05068284|464414255|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129034234|NCT05068284|464414256|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129034235|NCT05068284|464414257|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129034236|NCT05068284|464414250|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129034237|NCT05068284|464414251|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129034238|NCT05068284|464414252|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
129034239|NCT05068284|464414253|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
129034240|NCT05068284|464414254|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129034241|NCT05068284|464414255|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129034242|NCT05068284|464414256|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129034243|NCT05068284|464414257|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129034244|NCT05068284|464414250|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129034245|NCT05068284|464414251|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129034246|NCT05068284|464414252|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
129034247|NCT05068284|464414253|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129034248|NCT05068284|464414254|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129034249|NCT05068284|464414255|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129034250|NCT05068284|464414256|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129034251|NCT05068284|464414257|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129034252|NCT05068284|464414250|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
129034253|NCT05068284|464414251|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129034254|NCT05068284|464414252|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129034255|NCT05068284|464414253|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129034256|NCT05068284|464414254|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129124530|NCT04797169|464751395|FG001|Overall Study|Lost to Follow-up|67|||
128709003|NCT02373202|463230040|FG002|Overall Study|Other|0|||
128948847|NCT00586924|464099074|FG000|Overall Study|Adverse event/serious adverse event|0|||
128709004|NCT02373202|463230041|FG003|Overall Study|Other|0|||
128948848|NCT00586924|464099075|FG001|Overall Study|Adverse event/serious adverse event|0|||
128948849|NCT00586924|464099076|FG002|Overall Study|Adverse event/serious adverse event|0|||
128948850|NCT00586924|464099077|FG003|Overall Study|Adverse event/serious adverse event|1|||
128948851|NCT00586924|464099078|FG004|Overall Study|Adverse event/serious adverse event|0|||
128948852|NCT00586924|464099079|FG005|Overall Study|Adverse event/serious adverse event|2|||
128948853|NCT00586924|464099074|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
128948854|NCT00586924|464099075|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
129124531|NCT04797169|464751394|FG000|Overall Study|Pregnancy|1|||
129124532|NCT04797169|464751395|FG001|Overall Study|Pregnancy|3|||
129124533|NCT04797169|464751394|FG000|Overall Study|Withdrawal by Subject|27|||
129124534|NCT04797169|464751395|FG001|Overall Study|Withdrawal by Subject|35|||
129124535|NCT03839641|464751404|FG000|Overall Study|Withdrawal by Subject|1|||
129124536|NCT03839641|464751405|FG001|Overall Study|Withdrawal by Subject|1|||
129124537|NCT02550795|464751412|FG000|Overall Study|Physician Decision|0|||
129124538|NCT02550795|464751413|FG001|Overall Study|Physician Decision|1|||
129124539|NCT02550795|464751414|FG002|Overall Study|Physician Decision|0|||
129124540|NCT00879658|464751415|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129124541|NCT00879658|464751416|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129124542|NCT00879658|464751417|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129124543|NCT00879658|464751418|FG003|Overall Study|Abnormal laboratory value(s)|1|||
129124544|NCT00879658|464751419|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129124545|NCT00879658|464751420|FG005|Overall Study|Abnormal laboratory value(s)|0|||
129124546|NCT00879658|464751421|FG006|Overall Study|Abnormal laboratory value(s)|0|||
129124547|NCT00879658|464751415|FG000|Overall Study|Administrative problems|2|||
129124548|NCT00879658|464751416|FG001|Overall Study|Administrative problems|1|||
129124549|NCT00879658|464751417|FG002|Overall Study|Administrative problems|0|||
129124550|NCT00879658|464751418|FG003|Overall Study|Administrative problems|1|||
129124551|NCT00879658|464751419|FG004|Overall Study|Administrative problems|0|||
129124552|NCT00879658|464751420|FG005|Overall Study|Administrative problems|0|||
129124553|NCT00879658|464751421|FG006|Overall Study|Administrative problems|0|||
129124554|NCT00879658|464751415|FG000|Overall Study|Adverse Event|6|||
129124555|NCT00879658|464751416|FG001|Overall Study|Adverse Event|4|||
129124556|NCT00879658|464751417|FG002|Overall Study|Adverse Event|3|||
129124557|NCT00879658|464751418|FG003|Overall Study|Adverse Event|1|||
129124558|NCT00879658|464751419|FG004|Overall Study|Adverse Event|2|||
129124559|NCT00879658|464751420|FG005|Overall Study|Adverse Event|0|||
129124560|NCT00879658|464751421|FG006|Overall Study|Adverse Event|0|||
129124561|NCT00879658|464751415|FG000|Overall Study|Protocol Violation|1|||
129124562|NCT00879658|464751416|FG001|Overall Study|Protocol Violation|0|||
129124563|NCT00879658|464751417|FG002|Overall Study|Protocol Violation|0|||
129124564|NCT00879658|464751418|FG003|Overall Study|Protocol Violation|0|||
129124565|NCT00879658|464751419|FG004|Overall Study|Protocol Violation|0|||
129124566|NCT00879658|464751420|FG005|Overall Study|Protocol Violation|0|||
129124567|NCT00879658|464751421|FG006|Overall Study|Protocol Violation|0|||
129124568|NCT00879658|464751415|FG000|Overall Study|Withdrawal by Subject|3|||
129124569|NCT00879658|464751416|FG001|Overall Study|Withdrawal by Subject|0|||
129124570|NCT00879658|464751417|FG002|Overall Study|Withdrawal by Subject|2|||
129124571|NCT00879658|464751418|FG003|Overall Study|Withdrawal by Subject|0|||
129124572|NCT00879658|464751419|FG004|Overall Study|Withdrawal by Subject|0|||
129124573|NCT00879658|464751420|FG005|Overall Study|Withdrawal by Subject|1|||
129124574|NCT00879658|464751421|FG006|Overall Study|Withdrawal by Subject|0|||
129124575|NCT00879658|464751415|FG000|Overall Study|Lack of Efficacy|0|||
129124576|NCT00879658|464751416|FG001|Overall Study|Lack of Efficacy|0|||
129124577|NCT00879658|464751417|FG002|Overall Study|Lack of Efficacy|2|||
129124578|NCT00879658|464751418|FG003|Overall Study|Lack of Efficacy|0|||
129124579|NCT00879658|464751419|FG004|Overall Study|Lack of Efficacy|0|||
129124580|NCT00879658|464751420|FG005|Overall Study|Lack of Efficacy|0|||
129124581|NCT00879658|464751421|FG006|Overall Study|Lack of Efficacy|0|||
129124582|NCT00879658|464751415|FG000|Overall Study|misrandomized (never received study med)|0|||
129124583|NCT00879658|464751416|FG001|Overall Study|misrandomized (never received study med)|0|||
129124584|NCT00879658|464751417|FG002|Overall Study|misrandomized (never received study med)|0|||
129124585|NCT00879658|464751418|FG003|Overall Study|misrandomized (never received study med)|1|||
129124586|NCT00879658|464751419|FG004|Overall Study|misrandomized (never received study med)|0|||
129124587|NCT00879658|464751420|FG005|Overall Study|misrandomized (never received study med)|0|||
129124588|NCT00879658|464751421|FG006|Overall Study|misrandomized (never received study med)|0|||
129124589|NCT00580840|464751422|FG000|Run-in|Adverse Event|17|||
129124590|NCT00580840|464751423|FG001|Run-in|Adverse Event|0|||
128948855|NCT00586924|464099076|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
128948856|NCT00586924|464099077|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
129124591|NCT00580840|464751424|FG002|Run-in|Adverse Event|0|||
129124592|NCT00580840|464751425|FG003|Run-in|Adverse Event|0|||
129124593|NCT00580840|464751422|FG000|Run-in|Lack of Efficacy|93|||
129124594|NCT00580840|464751423|FG001|Run-in|Lack of Efficacy|0|||
129124595|NCT00580840|464751424|FG002|Run-in|Lack of Efficacy|0|||
129124596|NCT00580840|464751425|FG003|Run-in|Lack of Efficacy|0|||
129124597|NCT00580840|464751422|FG000|Run-in|Loss of Efficacy|1|||
129124598|NCT00580840|464751423|FG001|Run-in|Loss of Efficacy|0|||
129218188|NCT06042855|465098588|FG001|Overall Study|No Receipt of Study Drug|57|||
129218189|NCT06042855|465098587|FG000|Overall Study|Administratively Withdrawn|59|||
129218190|NCT06042855|465098588|FG001|Overall Study|Administratively Withdrawn|59|||
129218191|NCT02129699|465098593|FG000|Overall Study|Did not start treatment|3|||
129218192|NCT02129699|465098594|FG001|Overall Study|Did not start treatment|2|||
129218193|NCT00525161|465098597|FG000|Overall Study|Adverse Event|1|||
129218194|NCT01076361|465098601|FG000|Overall Study|22 leads were excluded from analysis|21|||
129218195|NCT02447003|465098602|FG000|Overall Study|Other|0|||
129218196|NCT02447003|465098603|FG001|Overall Study|Other|4|||
129218197|NCT02447003|465098602|FG000|Overall Study|Site discontinued|0|||
129218198|NCT02447003|465098603|FG001|Overall Study|Site discontinued|2|||
129218199|NCT02447003|465098602|FG000|Overall Study|Physician Decision|0|||
129218200|NCT02447003|465098603|FG001|Overall Study|Physician Decision|1|||
129218201|NCT02447003|465098602|FG000|Overall Study|Withdrawal by Subject|4|||
129218202|NCT02447003|465098603|FG001|Overall Study|Withdrawal by Subject|3|||
129218203|NCT02447003|465098602|FG000|Overall Study|Sponsor Decision|6|||
129218204|NCT02447003|465098603|FG001|Overall Study|Sponsor Decision|11|||
129218205|NCT02447003|465098602|FG000|Overall Study|Progressive Disease|1|||
129218206|NCT02447003|465098603|FG001|Overall Study|Progressive Disease|0|||
129218207|NCT02447003|465098602|FG000|Overall Study|Lost to Follow-up|5|||
129218208|NCT02447003|465098603|FG001|Overall Study|Lost to Follow-up|0|||
129218209|NCT02447003|465098602|FG000|Overall Study|Death|154|||
129218210|NCT02447003|465098603|FG001|Overall Study|Death|63|||
129218211|NCT03848728|465098604|FG000|Overall Study|Death|16|||
129218212|NCT03848728|465098605|FG001|Overall Study|Death|13|||
129218213|NCT03848728|465098604|FG000|Overall Study|Outmigrated to non-study community|98|||
129218214|NCT03848728|465098605|FG001|Overall Study|Outmigrated to non-study community|106|||
129218215|NCT03848728|465098604|FG000|Overall Study|Transfered to non-study clinic|32|||
129218216|NCT03848728|465098605|FG001|Overall Study|Transfered to non-study clinic|48|||
129218217|NCT03848728|465098604|FG000|Overall Study|Withdrawal by Subject|1|||
129218218|NCT03848728|465098605|FG001|Overall Study|Withdrawal by Subject|0|||
129218219|NCT00630838|465098608|FG000|Overall Study|Death|0|||
129218220|NCT00630838|465098609|FG001|Overall Study|Death|1|||
129218221|NCT00630838|465098608|FG000|Overall Study|Lost to Follow-up|0|||
129218222|NCT00630838|465098609|FG001|Overall Study|Lost to Follow-up|1|||
129218223|NCT04161157|465098613|FG000|Overall Study|Lost to Follow-up|4|||
129218224|NCT04161157|465098613|FG000|Overall Study|Death|3|||
129218225|NCT04161157|465098613|FG000|Overall Study|Ineligible|2|||
129218226|NCT04161157|465098613|FG000|Overall Study|Withdrawal by Subject|4|||
129218227|NCT01108185|465098614|FG000|Overall Study|Non-compliance|15|||
129218228|NCT01108185|465098614|FG000|Overall Study|Lost to Follow-up|12|||
129218229|NCT02581410|465098615|FG000|Vaccination Phase|Adverse Event|2|||
129218230|NCT02581410|465098616|FG001|Vaccination Phase|Adverse Event|1|||
129218231|NCT02581410|465098615|FG000|Vaccination Phase|Withdrawal by Subject|0|||
129218232|NCT02581410|465098616|FG001|Vaccination Phase|Withdrawal by Subject|1|||
129218233|NCT02581410|465098615|FG000|Vaccination Phase|Migrated/moved from study area|0|||
129218234|NCT02581410|465098616|FG001|Vaccination Phase|Migrated/moved from study area|1|||
129218235|NCT02581410|465098615|FG000|End of Study Phase|Adverse Event|4|||
129218236|NCT02581410|465098616|FG001|End of Study Phase|Adverse Event|3|||
129218237|NCT02581410|465098615|FG000|End of Study Phase|Withdrawal by Subject|1|||
129218238|NCT02581410|465098616|FG001|End of Study Phase|Withdrawal by Subject|2|||
129218239|NCT02581410|465098615|FG000|End of Study Phase|Migrated/moved from study area|0|||
129218240|NCT02581410|465098616|FG001|End of Study Phase|Migrated/moved from study area|3|||
129218241|NCT02581410|465098615|FG000|End of Study Phase|Lost to Follow-up|0|||
129218242|NCT02581410|465098616|FG001|End of Study Phase|Lost to Follow-up|2|||
129218243|NCT02581410|465098615|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
129218244|NCT02581410|465098616|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
129218245|NCT00670748|465098621|FG000|Overall Study|Death during treatment|1|||
129218246|NCT00670748|465098622|FG001|Overall Study|Death during treatment|1|||
129218247|NCT00670748|465098623|FG002|Overall Study|Death during treatment|1|||
129218248|NCT00670748|465098624|FG003|Overall Study|Death during treatment|0|||
129218249|NCT00670748|465098621|FG000|Overall Study|Not off study|2|||
128948857|NCT00586924|464099078|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
128948858|NCT00586924|464099079|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
129218250|NCT00670748|465098622|FG001|Overall Study|Not off study|1|||
129218251|NCT00670748|465098623|FG002|Overall Study|Not off study|1|||
129218252|NCT00670748|465098624|FG003|Overall Study|Not off study|1|||
128948859|NCT00586924|464099074|FG000|Overall Study|Disease progression|0|||
129218253|NCT06083506|465098629|FG000|Overall Study|Physician Decision|2|||
129218254|NCT06083506|465098629|FG000|Overall Study|Lack of Efficacy|1|||
129218255|NCT03529422|465098630|FG000|Overall Study|Withdrawal by Subject|1|||
129218256|NCT03529422|465098630|FG000|Overall Study|Protocol Violation|1|||
128770351|NCT02736968|463450222|FG000|Overall Study|Withdrawal by Subject|0|||
128948860|NCT00586924|464099075|FG001|Overall Study|Disease progression|0|||
129218257|NCT03529422|465098630|FG000|Overall Study|Disease progression|2|||
129218258|NCT02000115|465098631|FG000|Overall Study|Death|56|||
129218259|NCT02000115|465098632|FG001|Overall Study|Death|45|||
129218260|NCT02000115|465098633|FG002|Overall Study|Death|0|||
128709005|NCT03909295|463230042|FG000|Overall Study|Adverse Event|2|||
129218261|NCT02000115|465098634|FG003|Overall Study|Death|0|||
129218262|NCT02000115|465098631|FG000|Overall Study|Missed Visit|6|||
129218263|NCT02000115|465098632|FG001|Overall Study|Missed Visit|8|||
129218264|NCT02000115|465098633|FG002|Overall Study|Missed Visit|1|||
129218265|NCT02000115|465098634|FG003|Overall Study|Missed Visit|0|||
129218266|NCT02000115|465098631|FG000|Overall Study|Protocol Violation|2|||
129218267|NCT02000115|465098632|FG001|Overall Study|Protocol Violation|1|||
129218268|NCT02000115|465098633|FG002|Overall Study|Protocol Violation|0|||
129218269|NCT02000115|465098634|FG003|Overall Study|Protocol Violation|0|||
128709006|NCT03909295|463230042|FG000|Overall Study|Study terminated by sponsor|50|||
128709007|NCT01411228|463230043|FG000|Overall Study|Lost to Follow-up|0|||
128709008|NCT01411228|463230044|FG001|Overall Study|Lost to Follow-up|0|||
128709009|NCT01411228|463230045|FG002|Overall Study|Lost to Follow-up|1|||
128709010|NCT01411228|463230043|FG000|Overall Study|Withdrawal by Subject|1|||
128709011|NCT01411228|463230044|FG001|Overall Study|Withdrawal by Subject|0|||
128709012|NCT01411228|463230045|FG002|Overall Study|Withdrawal by Subject|0|||
128709013|NCT00720434|463230052|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
128709014|NCT00720434|463230053|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
128709015|NCT00720434|463230054|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
128709016|NCT00720434|463230055|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
128709017|NCT00720434|463230052|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
128709018|NCT00720434|463230053|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
128709019|NCT00720434|463230054|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
128709020|NCT00720434|463230055|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
128709021|NCT00720434|463230052|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
128709022|NCT00720434|463230053|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
128709023|NCT00720434|463230054|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
128709024|NCT00720434|463230055|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
128709025|NCT00720434|463230052|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
128709026|NCT00720434|463230053|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
128709027|NCT00720434|463230054|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
128709028|NCT00720434|463230055|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
128709029|NCT00720434|463230052|FG000|Open-Label Period (Week 5-72)|Other|4|||
128709030|NCT00720434|463230053|FG001|Open-Label Period (Week 5-72)|Other|3|||
128709031|NCT00720434|463230054|FG002|Open-Label Period (Week 5-72)|Other|3|||
128709032|NCT00720434|463230055|FG003|Open-Label Period (Week 5-72)|Other|2|||
128709033|NCT03138889|463230062|FG000|Overall Study|Withdrawal by Subject|5|||
128709034|NCT03138889|463230063|FG001|Overall Study|Withdrawal by Subject|5|||
128709035|NCT03138889|463230064|FG002|Overall Study|Withdrawal by Subject|0|||
128709036|NCT03138889|463230065|FG003|Overall Study|Withdrawal by Subject|2|||
128709037|NCT03138889|463230066|FG004|Overall Study|Withdrawal by Subject|1|||
128709038|NCT03138889|463230067|FG005|Overall Study|Withdrawal by Subject|3|||
128709039|NCT03138889|463230068|FG006|Overall Study|Withdrawal by Subject|0|||
128709040|NCT03138889|463230069|FG007|Overall Study|Withdrawal by Subject|1|||
128709041|NCT02289690|463230072|FG000|Overall Study|Adverse Event Related to Progression|0|||
128709042|NCT02289690|463230073|FG001|Overall Study|Adverse Event Related to Progression|1|||
128709043|NCT02289690|463230074|FG002|Overall Study|Adverse Event Related to Progression|1|||
128709044|NCT02289690|463230075|FG003|Overall Study|Adverse Event Related to Progression|0|||
128709045|NCT02289690|463230076|FG004|Overall Study|Adverse Event Related to Progression|1|||
128709046|NCT02289690|463230077|FG005|Overall Study|Adverse Event Related to Progression|0|||
128709047|NCT02289690|463230078|FG006|Overall Study|Adverse Event Related to Progression|1|||
128709048|NCT02289690|463230079|FG007|Overall Study|Adverse Event Related to Progression|0|||
128709049|NCT02289690|463230080|FG008|Overall Study|Adverse Event Related to Progression|0|||
128709050|NCT02289690|463230081|FG009|Overall Study|Adverse Event Related to Progression|0|||
128709051|NCT02289690|463230072|FG000|Overall Study|Withdrawal by Subject|1|||
128709052|NCT02289690|463230073|FG001|Overall Study|Withdrawal by Subject|0|||
128709053|NCT02289690|463230074|FG002|Overall Study|Withdrawal by Subject|0|||
128948861|NCT00586924|464099076|FG002|Overall Study|Disease progression|0|||
128948862|NCT00586924|464099077|FG003|Overall Study|Disease progression|1|||
128948863|NCT00586924|464099078|FG004|Overall Study|Disease progression|1|||
128948864|NCT00586924|464099079|FG005|Overall Study|Disease progression|0|||
128948865|NCT00586924|464099074|FG000|Overall Study|Development of neutralizing antibodies|2|||
129218270|NCT02000115|465098631|FG000|Overall Study|Physician Decision|2|||
129218271|NCT02000115|465098632|FG001|Overall Study|Physician Decision|0|||
128709054|NCT02289690|463230075|FG003|Overall Study|Withdrawal by Subject|0|||
128709055|NCT02289690|463230076|FG004|Overall Study|Withdrawal by Subject|1|||
128770352|NCT02736968|463450223|FG001|Overall Study|Withdrawal by Subject|0|||
128709056|NCT02289690|463230077|FG005|Overall Study|Withdrawal by Subject|1|||
128709057|NCT02289690|463230078|FG006|Overall Study|Withdrawal by Subject|0|||
128709058|NCT02289690|463230079|FG007|Overall Study|Withdrawal by Subject|0|||
129218272|NCT02000115|465098633|FG002|Overall Study|Physician Decision|0|||
129218273|NCT02000115|465098634|FG003|Overall Study|Physician Decision|0|||
128948866|NCT00586924|464099075|FG001|Overall Study|Development of neutralizing antibodies|2|||
128948867|NCT00586924|464099076|FG002|Overall Study|Development of neutralizing antibodies|2|||
128948868|NCT00586924|464099077|FG003|Overall Study|Development of neutralizing antibodies|0|||
128948869|NCT00586924|464099078|FG004|Overall Study|Development of neutralizing antibodies|0|||
128948870|NCT00586924|464099079|FG005|Overall Study|Development of neutralizing antibodies|22|||
128948871|NCT00586924|464099074|FG000|Overall Study|Complete response|0|||
128948872|NCT00586924|464099075|FG001|Overall Study|Complete response|1|||
128948873|NCT00586924|464099076|FG002|Overall Study|Complete response|0|||
128948874|NCT00586924|464099077|FG003|Overall Study|Complete response|0|||
128948875|NCT00586924|464099078|FG004|Overall Study|Complete response|2|||
128948876|NCT00586924|464099079|FG005|Overall Study|Complete response|2|||
128948877|NCT00586924|464099074|FG000|Overall Study|Other|1|||
128948878|NCT00586924|464099075|FG001|Overall Study|Other|0|||
128948879|NCT00586924|464099076|FG002|Overall Study|Other|1|||
128948880|NCT00586924|464099077|FG003|Overall Study|Other|1|||
128948881|NCT00586924|464099078|FG004|Overall Study|Other|1|||
128948882|NCT00586924|464099079|FG005|Overall Study|Other|6|||
128948883|NCT02998554|464099082|FG000|Overall Study|Adverse Event|8|||
128948884|NCT02998554|464099083|FG001|Overall Study|Adverse Event|3|||
128948885|NCT02998554|464099082|FG000|Overall Study|Protocol deviation|1|||
129124599|NCT00580840|464751424|FG002|Run-in|Loss of Efficacy|0|||
129124600|NCT00580840|464751425|FG003|Run-in|Loss of Efficacy|0|||
129124601|NCT00580840|464751422|FG000|Run-in|Lost to Follow-up|4|||
129124602|NCT00580840|464751423|FG001|Run-in|Lost to Follow-up|0|||
129124603|NCT00580840|464751424|FG002|Run-in|Lost to Follow-up|0|||
129124604|NCT00580840|464751425|FG003|Run-in|Lost to Follow-up|0|||
129124605|NCT00580840|464751422|FG000|Run-in|Withdrawal by Subject|5|||
129124606|NCT00580840|464751423|FG001|Run-in|Withdrawal by Subject|0|||
129124607|NCT00580840|464751424|FG002|Run-in|Withdrawal by Subject|0|||
129124608|NCT00580840|464751425|FG003|Run-in|Withdrawal by Subject|0|||
129124609|NCT00580840|464751422|FG000|Run-in|Other: Per Sponsor Request|2|||
129124610|NCT00580840|464751423|FG001|Run-in|Other: Per Sponsor Request|0|||
129124611|NCT00580840|464751424|FG002|Run-in|Other: Per Sponsor Request|0|||
129124612|NCT00580840|464751425|FG003|Run-in|Other: Per Sponsor Request|0|||
129124613|NCT00580840|464751422|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
129124614|NCT00580840|464751423|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
129124615|NCT00580840|464751424|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
129124616|NCT00580840|464751425|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
129124617|NCT00580840|464751422|FG000|Run-in|Other: Exclusionary Lab Value|1|||
129124618|NCT00580840|464751423|FG001|Run-in|Other: Exclusionary Lab Value|0|||
129124619|NCT00580840|464751424|FG002|Run-in|Other: Exclusionary Lab Value|0|||
129124620|NCT00580840|464751425|FG003|Run-in|Other: Exclusionary Lab Value|0|||
129124621|NCT00580840|464751422|FG000|Double-Blind|Adverse Event|0|||
129124622|NCT00580840|464751423|FG001|Double-Blind|Adverse Event|3|||
129124623|NCT00580840|464751424|FG002|Double-Blind|Adverse Event|4|||
129124624|NCT00580840|464751425|FG003|Double-Blind|Adverse Event|1|||
129124625|NCT00580840|464751422|FG000|Double-Blind|Loss of Efficacy|0|||
129124626|NCT00580840|464751423|FG001|Double-Blind|Loss of Efficacy|1|||
129124627|NCT00580840|464751424|FG002|Double-Blind|Loss of Efficacy|2|||
129124628|NCT00580840|464751425|FG003|Double-Blind|Loss of Efficacy|10|||
129124629|NCT00580840|464751422|FG000|Double-Blind|Lost to Follow-up|0|||
129124630|NCT00580840|464751423|FG001|Double-Blind|Lost to Follow-up|1|||
129124631|NCT00580840|464751424|FG002|Double-Blind|Lost to Follow-up|0|||
129124632|NCT00580840|464751425|FG003|Double-Blind|Lost to Follow-up|2|||
129124633|NCT00580840|464751422|FG000|Double-Blind|Withdrawal by Subject|0|||
129124634|NCT00580840|464751423|FG001|Double-Blind|Withdrawal by Subject|1|||
129124635|NCT00580840|464751424|FG002|Double-Blind|Withdrawal by Subject|2|||
129124636|NCT00580840|464751425|FG003|Double-Blind|Withdrawal by Subject|2|||
129124637|NCT00580840|464751422|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
129124638|NCT00580840|464751423|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
129124639|NCT00580840|464751424|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
129124640|NCT00580840|464751425|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
129124641|NCT00580840|464751422|FG000|Double-Blind|Other: Forbidden Medication|0|||
128948886|NCT02998554|464099083|FG001|Overall Study|Protocol deviation|0|||
128948887|NCT02998554|464099082|FG000|Overall Study|Withdrawal by Subject|2|||
129124642|NCT00580840|464751423|FG001|Double-Blind|Other: Forbidden Medication|0|||
129124643|NCT00580840|464751424|FG002|Double-Blind|Other: Forbidden Medication|1|||
129124644|NCT00580840|464751425|FG003|Double-Blind|Other: Forbidden Medication|0|||
129124645|NCT01551173|464751426|FG000|Overall Study|Withdrawal by Subject|11|||
129124646|NCT01551173|464751427|FG001|Overall Study|Withdrawal by Subject|16|||
129124647|NCT01551173|464751426|FG000|Overall Study|Adverse Event|7|||
129124648|NCT01551173|464751427|FG001|Overall Study|Adverse Event|6|||
129124649|NCT01551173|464751426|FG000|Overall Study|Lost to Follow-up|5|||
128948888|NCT02998554|464099083|FG001|Overall Study|Withdrawal by Subject|6|||
128948889|NCT02998554|464099082|FG000|Overall Study|Lost to Follow-up|0|||
128948890|NCT02998554|464099083|FG001|Overall Study|Lost to Follow-up|1|||
129124650|NCT01551173|464751427|FG001|Overall Study|Lost to Follow-up|7|||
129124651|NCT01551173|464751426|FG000|Overall Study|Other|5|||
129124652|NCT01551173|464751427|FG001|Overall Study|Other|3|||
129034257|NCT05068284|464414255|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129034258|NCT05068284|464414256|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129034259|NCT05068284|464414257|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129034260|NCT05068284|464414250|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
129034261|NCT05068284|464414251|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129034262|NCT05068284|464414252|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129034263|NCT05068284|464414253|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129034264|NCT05068284|464414254|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129034265|NCT05068284|464414255|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
129034266|NCT05068284|464414256|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
129034267|NCT05068284|464414257|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129034268|NCT05068284|464414250|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
129034269|NCT05068284|464414251|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129034270|NCT05068284|464414252|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129034271|NCT05068284|464414253|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129034272|NCT05068284|464414254|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129034273|NCT05068284|464414255|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129034274|NCT05068284|464414256|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
129034275|NCT05068284|464414257|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129034276|NCT05068284|464414250|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
129034277|NCT05068284|464414251|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129034278|NCT05068284|464414252|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129034279|NCT05068284|464414253|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129034280|NCT05068284|464414254|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129034281|NCT05068284|464414255|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129034282|NCT05068284|464414256|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129034283|NCT05068284|464414257|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129034284|NCT05068284|464414250|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
129034285|NCT05068284|464414251|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129034286|NCT05068284|464414252|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129034287|NCT05068284|464414253|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129034288|NCT05068284|464414254|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129034289|NCT05068284|464414255|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129034290|NCT05068284|464414256|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129034291|NCT05068284|464414257|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129034292|NCT05068284|464414250|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
129034293|NCT05068284|464414251|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129034294|NCT05068284|464414252|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129034295|NCT05068284|464414253|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129034296|NCT05068284|464414254|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129034297|NCT05068284|464414255|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
129034298|NCT05068284|464414256|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
129034299|NCT05068284|464414257|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
129034300|NCT05068284|464414250|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
129034301|NCT05068284|464414251|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
129034302|NCT05068284|464414252|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
129034303|NCT05068284|464414253|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
129034304|NCT05068284|464414254|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
129034305|NCT05068284|464414255|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
129034306|NCT05068284|464414256|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
129034307|NCT05068284|464414257|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
129034308|NCT00965731|464414258|FG000|Overall Study|Death|0|||
129034309|NCT00965731|464414259|FG001|Overall Study|Death|4|||
129034310|NCT00965731|464414258|FG000|Overall Study|Withdrawal by Subject|0|||
129034311|NCT00965731|464414259|FG001|Overall Study|Withdrawal by Subject|1|||
129034312|NCT00965731|464414258|FG000|Overall Study|Other|7|||
129034313|NCT00965731|464414259|FG001|Overall Study|Other|15|||
129034314|NCT00559637|464416419|FG000|Overall Study|Adverse Event|22|||
129124653|NCT04530344|464751428|FG000|Overall Study|Lost to Follow-up|3|||
129034315|NCT00559637|464416419|FG000|Overall Study|Withdrawal by Subject|4|||
129218274|NCT02000115|465098631|FG000|Overall Study|Withdrawal by Subject|11|||
129218275|NCT02000115|465098632|FG001|Overall Study|Withdrawal by Subject|11|||
129218276|NCT02000115|465098633|FG002|Overall Study|Withdrawal by Subject|0|||
129218277|NCT02000115|465098634|FG003|Overall Study|Withdrawal by Subject|0|||
129218278|NCT02000115|465098631|FG000|Overall Study|Lost to Follow-up|0|||
129218279|NCT02000115|465098632|FG001|Overall Study|Lost to Follow-up|1|||
129218280|NCT02000115|465098633|FG002|Overall Study|Lost to Follow-up|0|||
129218281|NCT02000115|465098634|FG003|Overall Study|Lost to Follow-up|0|||
129218282|NCT02000115|465098631|FG000|Overall Study|Non-compliance|2|||
129218283|NCT02000115|465098632|FG001|Overall Study|Non-compliance|1|||
129218284|NCT02000115|465098633|FG002|Overall Study|Non-compliance|0|||
129218285|NCT02000115|465098634|FG003|Overall Study|Non-compliance|0|||
129218286|NCT02000115|465098631|FG000|Overall Study|Withdrawn on day of randomization|0|||
129218287|NCT02000115|465098632|FG001|Overall Study|Withdrawn on day of randomization|1|||
129218288|NCT02000115|465098633|FG002|Overall Study|Withdrawn on day of randomization|0|||
129218289|NCT02000115|465098634|FG003|Overall Study|Withdrawn on day of randomization|0|||
129218290|NCT02000115|465098631|FG000|Overall Study|Still on Study|0|||
129218291|NCT02000115|465098632|FG001|Overall Study|Still on Study|0|||
129218292|NCT02000115|465098633|FG002|Overall Study|Still on Study|0|||
129218293|NCT02000115|465098634|FG003|Overall Study|Still on Study|53|||
129218294|NCT05006573|465098637|FG000|Double-blind Treatment Period|Physician Decision|2|||
129218295|NCT05006573|465098638|FG001|Double-blind Treatment Period|Physician Decision|0|||
129218296|NCT05006573|465098637|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
129218297|NCT05006573|465098638|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
129218298|NCT05006573|465098637|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
129218299|NCT05006573|465098638|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129218300|NCT05006573|465098637|FG000|Double-blind Treatment Period|Protocol Violation|2|||
129218301|NCT05006573|465098638|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129218302|NCT05006573|465098637|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
129218303|NCT05006573|465098638|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
129218304|NCT05006573|465098637|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
129218305|NCT05006573|465098638|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
129218306|NCT03493464|465098643|FG000|Overall Study|Surgery not performed|1|||
129218307|NCT05462756|465099753|FG000|Treatment Period|Adverse Event|3|||
129218308|NCT05462756|465099754|FG001|Treatment Period|Adverse Event|0|||
129218309|NCT05462756|465099753|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
129218310|NCT05462756|465099754|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
129218311|NCT05462756|465099753|FG000|Treatment Period|Death|0|||
129218312|NCT05462756|465099754|FG001|Treatment Period|Death|1|||
129218313|NCT05462756|465099753|FG000|Treatment Period|Lost to Follow-up|2|||
129218314|NCT05462756|465099754|FG001|Treatment Period|Lost to Follow-up|1|||
129218315|NCT05462756|465099753|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
128709059|NCT02289690|463230080|FG008|Overall Study|Withdrawal by Subject|4|||
128709060|NCT02289690|463230081|FG009|Overall Study|Withdrawal by Subject|2|||
128709061|NCT02289690|463230072|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
128709062|NCT02289690|463230073|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
129218316|NCT05462756|465099754|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
128709063|NCT02289690|463230074|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
128709064|NCT02289690|463230075|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
129034316|NCT00559637|464416419|FG000|Overall Study|Protocol Violation|6|||
129034317|NCT00559637|464416419|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
129034318|NCT00559637|464416419|FG000|Overall Study|Failure to return|6|||
129034319|NCT00559637|464416419|FG000|Overall Study|Insufficient response|3|||
129034320|NCT00559637|464416419|FG000|Overall Study|Started requiring dialysis after month 7|2|||
129034321|NCT00559637|464416419|FG000|Overall Study|Suspected lung cancer|1|||
129034322|NCT00559637|464416419|FG000|Overall Study|Participation in another study|1|||
129034323|NCT00559637|464416419|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
129034324|NCT00559637|464416419|FG000|Overall Study|Change of center|1|||
129034325|NCT00559637|464416419|FG000|Overall Study|Change of home|1|||
129034326|NCT00559637|464416419|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
129034327|NCT02832167|464416420|FG000|Treatment Period 1|Disease progression|90|||
129034328|NCT02832167|464416420|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
129034329|NCT02832167|464416420|FG000|Treatment Period 1|Death|2|||
129034330|NCT02832167|464416420|FG000|Treatment Period 1|Study Drug Toxicity|6|||
129218317|NCT05462756|465099753|FG000|Treatment Period|Physician Decision|2|||
129218318|NCT05462756|465099754|FG001|Treatment Period|Physician Decision|0|||
129218319|NCT05462756|465099753|FG000|Treatment Period|Protocol Violation|0|||
129218320|NCT05462756|465099754|FG001|Treatment Period|Protocol Violation|1|||
129218321|NCT05462756|465099753|FG000|Treatment Period|Withdrawal by Subject|5|||
129218322|NCT05462756|465099754|FG001|Treatment Period|Withdrawal by Subject|12|||
129218323|NCT05462756|465099753|FG000|Follow-Up Period|Adverse Event|1|||
128709065|NCT02289690|463230076|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
128709066|NCT02289690|463230077|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
128709067|NCT02289690|463230078|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
128709068|NCT02289690|463230079|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
128709069|NCT02289690|463230080|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
128709070|NCT02289690|463230081|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
128709071|NCT02289690|463230072|FG000|Overall Study|Lost to Follow-up|0|||
128709072|NCT02289690|463230073|FG001|Overall Study|Lost to Follow-up|0|||
128709073|NCT02289690|463230074|FG002|Overall Study|Lost to Follow-up|0|||
128709074|NCT02289690|463230075|FG003|Overall Study|Lost to Follow-up|0|||
128709075|NCT02289690|463230076|FG004|Overall Study|Lost to Follow-up|0|||
128709076|NCT02289690|463230077|FG005|Overall Study|Lost to Follow-up|0|||
128709077|NCT02289690|463230078|FG006|Overall Study|Lost to Follow-up|0|||
128709078|NCT02289690|463230079|FG007|Overall Study|Lost to Follow-up|1|||
128709079|NCT02289690|463230080|FG008|Overall Study|Lost to Follow-up|0|||
128709080|NCT02289690|463230081|FG009|Overall Study|Lost to Follow-up|2|||
128709081|NCT02289690|463230072|FG000|Overall Study|Death|0|||
128709082|NCT02289690|463230073|FG001|Overall Study|Death|0|||
128709083|NCT02289690|463230074|FG002|Overall Study|Death|0|||
128709084|NCT02289690|463230075|FG003|Overall Study|Death|0|||
128709085|NCT02289690|463230076|FG004|Overall Study|Death|0|||
128709086|NCT02289690|463230077|FG005|Overall Study|Death|0|||
128709087|NCT02289690|463230078|FG006|Overall Study|Death|0|||
128709088|NCT02289690|463230079|FG007|Overall Study|Death|49|||
128709089|NCT02289690|463230080|FG008|Overall Study|Death|45|||
128709090|NCT02289690|463230081|FG009|Overall Study|Death|41|||
128709091|NCT02289690|463230072|FG000|Overall Study|Sponsor Discontinued Study|0|||
128709092|NCT02289690|463230073|FG001|Overall Study|Sponsor Discontinued Study|0|||
128709093|NCT02289690|463230074|FG002|Overall Study|Sponsor Discontinued Study|0|||
128709094|NCT02289690|463230075|FG003|Overall Study|Sponsor Discontinued Study|0|||
128709095|NCT02289690|463230076|FG004|Overall Study|Sponsor Discontinued Study|0|||
128709096|NCT02289690|463230077|FG005|Overall Study|Sponsor Discontinued Study|0|||
128709097|NCT02289690|463230078|FG006|Overall Study|Sponsor Discontinued Study|0|||
128709098|NCT02289690|463230079|FG007|Overall Study|Sponsor Discontinued Study|9|||
128709099|NCT02289690|463230080|FG008|Overall Study|Sponsor Discontinued Study|7|||
128709100|NCT02289690|463230081|FG009|Overall Study|Sponsor Discontinued Study|15|||
128709101|NCT02289690|463230072|FG000|Overall Study|Other|0|||
128709102|NCT02289690|463230073|FG001|Overall Study|Other|0|||
128709103|NCT02289690|463230074|FG002|Overall Study|Other|0|||
128709104|NCT02289690|463230075|FG003|Overall Study|Other|1|||
128709105|NCT02289690|463230076|FG004|Overall Study|Other|1|||
128709106|NCT02289690|463230077|FG005|Overall Study|Other|0|||
128709107|NCT02289690|463230078|FG006|Overall Study|Other|1|||
128709108|NCT02289690|463230079|FG007|Overall Study|Other|2|||
128709109|NCT02289690|463230080|FG008|Overall Study|Other|3|||
128709110|NCT02289690|463230081|FG009|Overall Study|Other|1|||
128709111|NCT04166435|463230088|FG000|Overall Study|2 patients ineligible for response|2|||
128709112|NCT00553514|463230102|FG000|Overall Study|Protocol deviation|0|||
128709113|NCT00553514|463230103|FG001|Overall Study|Protocol deviation|0|||
128709114|NCT00553514|463230104|FG002|Overall Study|Protocol deviation|0|||
128709115|NCT00553514|463230105|FG003|Overall Study|Protocol deviation|1|||
128709116|NCT00553514|463230106|FG004|Overall Study|Protocol deviation|0|||
128709117|NCT00553514|463230102|FG000|Overall Study|Lack of ovarian response|4|||
128709118|NCT00553514|463230103|FG001|Overall Study|Lack of ovarian response|5|||
128709119|NCT00553514|463230104|FG002|Overall Study|Lack of ovarian response|5|||
128709120|NCT00553514|463230105|FG003|Overall Study|Lack of ovarian response|5|||
128709121|NCT00553514|463230106|FG004|Overall Study|Lack of ovarian response|6|||
128948891|NCT02998554|464099082|FG000|Overall Study|Lack of Efficacy|0|||
128948892|NCT02998554|464099083|FG001|Overall Study|Lack of Efficacy|1|||
128948893|NCT04167306|464099085|FG000|Overall Study|Lost to Follow-up|2|||
128948894|NCT04167306|464099086|FG001|Overall Study|Lost to Follow-up|2|||
128948895|NCT04167306|464099087|FG002|Overall Study|Lost to Follow-up|5|||
128948896|NCT04167306|464099088|FG003|Overall Study|Lost to Follow-up|5|||
128948897|NCT04167306|464099085|FG000|Overall Study|Adverse Event|13|||
129218324|NCT05462756|465099754|FG001|Follow-Up Period|Adverse Event|0|||
128709122|NCT00553514|463230102|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
128709123|NCT00553514|463230103|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
128709124|NCT00553514|463230104|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
128709125|NCT00553514|463230105|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
128709126|NCT00553514|463230106|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
128709127|NCT00553514|463230102|FG000|Overall Study|Risk of multiple pregnancy|0|||
128709128|NCT00553514|463230103|FG001|Overall Study|Risk of multiple pregnancy|2|||
128709129|NCT00553514|463230104|FG002|Overall Study|Risk of multiple pregnancy|0|||
128709130|NCT00553514|463230105|FG003|Overall Study|Risk of multiple pregnancy|1|||
128709131|NCT00553514|463230106|FG004|Overall Study|Risk of multiple pregnancy|0|||
128709132|NCT00553514|463230102|FG000|Overall Study|Other|1|||
128709133|NCT00553514|463230103|FG001|Overall Study|Other|1|||
128709134|NCT00553514|463230104|FG002|Overall Study|Other|0|||
128948898|NCT04167306|464099086|FG001|Overall Study|Adverse Event|14|||
128948899|NCT04167306|464099087|FG002|Overall Study|Adverse Event|5|||
128948900|NCT04167306|464099088|FG003|Overall Study|Adverse Event|4|||
128948901|NCT04167306|464099085|FG000|Overall Study|Withdrawal by Subject|4|||
128948902|NCT04167306|464099086|FG001|Overall Study|Withdrawal by Subject|6|||
128948903|NCT04167306|464099087|FG002|Overall Study|Withdrawal by Subject|8|||
128948904|NCT04167306|464099088|FG003|Overall Study|Withdrawal by Subject|3|||
128948905|NCT04167306|464099085|FG000|Overall Study|covid|1|||
128948906|NCT04167306|464099086|FG001|Overall Study|covid|1|||
128948907|NCT04167306|464099087|FG002|Overall Study|covid|2|||
128948908|NCT04167306|464099088|FG003|Overall Study|covid|1|||
128948909|NCT04167306|464099085|FG000|Overall Study|concomitant medication|0|||
128948910|NCT04167306|464099086|FG001|Overall Study|concomitant medication|0|||
128948911|NCT04167306|464099087|FG002|Overall Study|concomitant medication|0|||
128948912|NCT04167306|464099088|FG003|Overall Study|concomitant medication|1|||
128948913|NCT04167306|464099085|FG000|Overall Study|Alcohol treatment|0|||
128948914|NCT04167306|464099086|FG001|Overall Study|Alcohol treatment|4|||
129034331|NCT02832167|464416420|FG000|Treatment Period 1|Participant request to discontinue|9|||
128948915|NCT04167306|464099087|FG002|Overall Study|Alcohol treatment|3|||
128948916|NCT04167306|464099088|FG003|Overall Study|Alcohol treatment|2|||
128948917|NCT04167306|464099085|FG000|Overall Study|non-compliance|0|||
129034332|NCT02832167|464416420|FG000|Treatment Period 1|No longer meet study criteria|1|||
129034333|NCT02832167|464416420|FG000|Treatment Period 1|Participant withdrew consent|3|||
129034334|NCT02832167|464416420|FG000|Treatment Period 1|Other reasons|6|||
129034335|NCT02832167|464416420|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
129034336|NCT02832167|464416420|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
129034337|NCT02832167|464416420|FG000|Transition From Period 1 to Period 2|Death|2|||
129034338|NCT02832167|464416420|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
129034339|NCT02832167|464416420|FG000|Treatment Period 2|Disease progression|69|||
129034340|NCT02832167|464416420|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
129034341|NCT02832167|464416420|FG000|Treatment Period 2|Maximum clinical benefit|1|||
129034342|NCT02832167|464416420|FG000|Treatment Period 2|Study Drug Toxicity|5|||
129034343|NCT02832167|464416420|FG000|Treatment Period 2|Participant request to discontinue|2|||
129034344|NCT02832167|464416420|FG000|Treatment Period 2|Participant withdrew consent|3|||
129034345|NCT02832167|464416420|FG000|Treatment Period 2|Other reasons|3|||
129034346|NCT01958060|464416423|FG000|Overall Study|Not treated|2|||
129034347|NCT01958060|464416424|FG001|Overall Study|Not treated|0|||
129034348|NCT01958060|464416425|FG002|Overall Study|Not treated|0|||
129034349|NCT01958060|464416426|FG003|Overall Study|Not treated|0|||
129034350|NCT01958060|464416427|FG004|Overall Study|Not treated|1|||
129034351|NCT01958060|464416428|FG005|Overall Study|Not treated|0|||
129034352|NCT00224484|464416432|FG000|Overall Study|Serious Adverse Event|1|||
129034353|NCT00224484|464416433|FG001|Overall Study|Serious Adverse Event|1|||
129034354|NCT00224484|464416434|FG002|Overall Study|Serious Adverse Event|0|||
129034355|NCT00224484|464416432|FG000|Overall Study|Non-Serious Adverse Event|5|||
129034356|NCT00224484|464416433|FG001|Overall Study|Non-Serious Adverse Event|7|||
129034357|NCT00224484|464416434|FG002|Overall Study|Non-Serious Adverse Event|3|||
129034358|NCT00224484|464416432|FG000|Overall Study|Protocol Violation|2|||
129034359|NCT00224484|464416433|FG001|Overall Study|Protocol Violation|2|||
129034360|NCT00224484|464416434|FG002|Overall Study|Protocol Violation|0|||
129034361|NCT00224484|464416432|FG000|Overall Study|Withdrawal by Subject|49|||
129034362|NCT00224484|464416433|FG001|Overall Study|Withdrawal by Subject|18|||
129034363|NCT00224484|464416434|FG002|Overall Study|Withdrawal by Subject|16|||
129034364|NCT00224484|464416432|FG000|Overall Study|Migrated/moved from study area|18|||
129034365|NCT00224484|464416433|FG001|Overall Study|Migrated/moved from study area|5|||
129034366|NCT00224484|464416434|FG002|Overall Study|Migrated/moved from study area|5|||
129034367|NCT00224484|464416432|FG000|Overall Study|Lost to Follow-up|66|||
129034368|NCT00224484|464416433|FG001|Overall Study|Lost to Follow-up|28|||
129034369|NCT00224484|464416434|FG002|Overall Study|Lost to Follow-up|36|||
129034370|NCT00224484|464416432|FG000|Overall Study|Reason not specified|5|||
129034371|NCT00224484|464416433|FG001|Overall Study|Reason not specified|4|||
129034372|NCT00224484|464416434|FG002|Overall Study|Reason not specified|2|||
129034373|NCT01074008|464416435|FG000|Overall Study|Adverse Event|0|||
129034374|NCT01074008|464416436|FG001|Overall Study|Adverse Event|1|||
129034375|NCT01074008|464416437|FG002|Overall Study|Adverse Event|0|||
129034376|NCT01074008|464416438|FG003|Overall Study|Adverse Event|0|||
129034377|NCT01074008|464416439|FG004|Overall Study|Adverse Event|0|||
129034378|NCT01074008|464416440|FG005|Overall Study|Adverse Event|0|||
129034379|NCT01074008|464416441|FG006|Overall Study|Adverse Event|0|||
129034380|NCT01074008|464416442|FG007|Overall Study|Adverse Event|0|||
129034381|NCT01074008|464416443|FG008|Overall Study|Adverse Event|0|||
129034382|NCT01074008|464416435|FG000|Overall Study|Withdrawal by Subject|1|||
129034383|NCT01074008|464416436|FG001|Overall Study|Withdrawal by Subject|1|||
129034384|NCT01074008|464416437|FG002|Overall Study|Withdrawal by Subject|1|||
129034385|NCT01074008|464416438|FG003|Overall Study|Withdrawal by Subject|0|||
129034386|NCT01074008|464416439|FG004|Overall Study|Withdrawal by Subject|1|||
128948918|NCT04167306|464099086|FG001|Overall Study|non-compliance|0|||
128948919|NCT04167306|464099087|FG002|Overall Study|non-compliance|1|||
128948920|NCT04167306|464099088|FG003|Overall Study|non-compliance|0|||
128948921|NCT04167306|464099085|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
128948922|NCT04167306|464099086|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
128948923|NCT04167306|464099087|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
128948924|NCT04167306|464099088|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
128948925|NCT04146467|464099092|FG000|Overall Study|Adverse Event|0|||
128948926|NCT04146467|464099093|FG001|Overall Study|Adverse Event|1|||
128948927|NCT04146467|464099092|FG000|Overall Study|Lost to Follow-up|0|||
128948928|NCT04146467|464099093|FG001|Overall Study|Lost to Follow-up|2|||
128948929|NCT01189435|464099096|FG000|Overall Study|Withdrawal by Subject|1|||
128948930|NCT01189435|464099096|FG000|Overall Study|Physician Decision|1|||
128948931|NCT01982773|464099105|FG000|Overall Study|Withdrawal by Subject|1|||
128948932|NCT01982773|464099106|FG001|Overall Study|Withdrawal by Subject|3|||
128948933|NCT01982773|464099105|FG000|Overall Study|Lost to Follow-up|7|||
128948934|NCT01982773|464099106|FG001|Overall Study|Lost to Follow-up|1|||
128948935|NCT01029886|464099107|FG000|Overall Study|Adverse Event|12|||
128948936|NCT01029886|464099108|FG001|Overall Study|Adverse Event|25|||
128948937|NCT01029886|464099107|FG000|Overall Study|Lost to Follow-up|1|||
128948938|NCT01029886|464099108|FG001|Overall Study|Lost to Follow-up|0|||
128948939|NCT01029886|464099107|FG000|Overall Study|Physician Decision|2|||
128948940|NCT01029886|464099108|FG001|Overall Study|Physician Decision|6|||
128948941|NCT01029886|464099107|FG000|Overall Study|Protocol Violation|17|||
128948942|NCT01029886|464099108|FG001|Overall Study|Protocol Violation|5|||
128948943|NCT01029886|464099107|FG000|Overall Study|Withdrawal by Subject|8|||
128948944|NCT01029886|464099108|FG001|Overall Study|Withdrawal by Subject|18|||
129124654|NCT04530344|464751429|FG001|Overall Study|Lost to Follow-up|3|||
129124655|NCT04530344|464751430|FG002|Overall Study|Lost to Follow-up|3|||
129124656|NCT04530344|464751431|FG003|Overall Study|Lost to Follow-up|10|||
129124657|NCT04530344|464751428|FG000|Overall Study|Withdrawal by Subject|14|||
129124658|NCT04530344|464751429|FG001|Overall Study|Withdrawal by Subject|5|||
129124659|NCT04530344|464751430|FG002|Overall Study|Withdrawal by Subject|18|||
129124660|NCT04530344|464751431|FG003|Overall Study|Withdrawal by Subject|33|||
129124661|NCT04530344|464751428|FG000|Overall Study|Adverse Event|0|||
129124662|NCT04530344|464751429|FG001|Overall Study|Adverse Event|0|||
129124663|NCT04530344|464751430|FG002|Overall Study|Adverse Event|0|||
129124664|NCT04530344|464751431|FG003|Overall Study|Adverse Event|1|||
129124665|NCT04530344|464751428|FG000|Overall Study|Lack of Efficacy|0|||
129124666|NCT04530344|464751429|FG001|Overall Study|Lack of Efficacy|0|||
129124667|NCT04530344|464751430|FG002|Overall Study|Lack of Efficacy|0|||
129124668|NCT04530344|464751431|FG003|Overall Study|Lack of Efficacy|1|||
129124669|NCT04530344|464751428|FG000|Overall Study|Physician Decision|0|||
129124670|NCT04530344|464751429|FG001|Overall Study|Physician Decision|0|||
129124671|NCT04530344|464751430|FG002|Overall Study|Physician Decision|1|||
129124672|NCT04530344|464751431|FG003|Overall Study|Physician Decision|1|||
129124673|NCT04530344|464751428|FG000|Overall Study|Pregnancy|0|||
129124674|NCT04530344|464751429|FG001|Overall Study|Pregnancy|0|||
129124675|NCT04530344|464751430|FG002|Overall Study|Pregnancy|2|||
129124676|NCT04530344|464751431|FG003|Overall Study|Pregnancy|1|||
129124677|NCT04530344|464751428|FG000|Overall Study|Protocol Violation|0|||
129124678|NCT04530344|464751429|FG001|Overall Study|Protocol Violation|0|||
129124679|NCT04530344|464751430|FG002|Overall Study|Protocol Violation|0|||
129124680|NCT04530344|464751431|FG003|Overall Study|Protocol Violation|1|||
129124681|NCT04530344|464751428|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
129124682|NCT04530344|464751429|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
129124683|NCT04530344|464751430|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
129124684|NCT04530344|464751431|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
129124685|NCT04530344|464751428|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
129124686|NCT04530344|464751429|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
129124687|NCT04530344|464751430|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
129124688|NCT04530344|464751431|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
129124689|NCT04530344|464751428|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
129124690|NCT04530344|464751429|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
129124691|NCT04530344|464751430|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
129124692|NCT04530344|464751431|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
129124693|NCT04530344|464751428|FG000|Overall Study|Personal Reasons|0|||
128948945|NCT01029886|464099107|FG000|Overall Study|Entry Criteria Not Met|13|||
128948946|NCT01029886|464099108|FG001|Overall Study|Entry Criteria Not Met|5|||
128948947|NCT01029886|464099107|FG000|Overall Study|Sponsor Decision|1|||
128948948|NCT01029886|464099108|FG001|Overall Study|Sponsor Decision|0|||
128948949|NCT01029886|464099107|FG000|Overall Study|Loss Glucose Control|7|||
128948950|NCT01029886|464099108|FG001|Overall Study|Loss Glucose Control|1|||
129124694|NCT04530344|464751429|FG001|Overall Study|Personal Reasons|0|||
129124695|NCT04530344|464751430|FG002|Overall Study|Personal Reasons|0|||
129124696|NCT04530344|464751431|FG003|Overall Study|Personal Reasons|1|||
129124697|NCT04530344|464751428|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
129124698|NCT04530344|464751429|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
129124699|NCT04530344|464751430|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
129218325|NCT05462756|465099753|FG000|Follow-Up Period|Death|1|||
128948951|NCT03294681|464099109|FG000|Overall Study|Withdrawal by Subject|1|||
128948952|NCT01778127|464099110|FG000|Overall Study|Lost to Follow-up|5|||
128948953|NCT01778127|464099111|FG001|Overall Study|Lost to Follow-up|1|||
128948954|NCT01778127|464099112|FG002|Overall Study|Lost to Follow-up|2|||
128948955|NCT01778127|464099110|FG000|Overall Study|Withdrawal by Subject|3|||
128948956|NCT01778127|464099111|FG001|Overall Study|Withdrawal by Subject|1|||
128948957|NCT01778127|464099112|FG002|Overall Study|Withdrawal by Subject|4|||
128948958|NCT01348425|464099113|FG000|Overall Study|Imaging was not taken.|1|||
128948959|NCT01348425|464099114|FG001|Overall Study|Imaging was not taken.|1|||
128948960|NCT03722784|464099115|FG000|Overall Study|Withdrawal by Subject|1|||
128948961|NCT03722784|464099116|FG001|Overall Study|Withdrawal by Subject|0|||
128948962|NCT03722784|464099115|FG000|Overall Study|Physician Decision|1|||
128948963|NCT03722784|464099116|FG001|Overall Study|Physician Decision|1|||
128948964|NCT03722784|464099115|FG000|Overall Study|Protocol Violation|0|||
128948965|NCT03722784|464099116|FG001|Overall Study|Protocol Violation|1|||
128948966|NCT00751114|464099118|FG000|Overall Study|Adverse Event|2|||
128948967|NCT00751114|464099119|FG001|Overall Study|Adverse Event|4|||
128948968|NCT00751114|464099118|FG000|Overall Study|Protocol Violation|8|||
128948969|NCT00751114|464099119|FG001|Overall Study|Protocol Violation|9|||
128948970|NCT00751114|464099118|FG000|Overall Study|Withdrawal by Subject|9|||
128948971|NCT00751114|464099119|FG001|Overall Study|Withdrawal by Subject|4|||
128948972|NCT00751114|464099118|FG000|Overall Study|Lost to Follow-up|4|||
128948973|NCT00751114|464099119|FG001|Overall Study|Lost to Follow-up|7|||
128948974|NCT00751114|464099118|FG000|Overall Study|Lack of Efficacy|0|||
128948975|NCT00751114|464099119|FG001|Overall Study|Lack of Efficacy|7|||
128948976|NCT00751114|464099118|FG000|Overall Study|Not Treated|13|||
128948977|NCT00751114|464099119|FG001|Overall Study|Not Treated|1|||
128948978|NCT00751114|464099118|FG000|Overall Study|Out of country for 2 months|1|||
128948979|NCT00751114|464099119|FG001|Overall Study|Out of country for 2 months|0|||
128948980|NCT00751114|464099118|FG000|Overall Study|Move to another city|1|||
128948981|NCT00751114|464099119|FG001|Overall Study|Move to another city|0|||
129218326|NCT05462756|465099754|FG001|Follow-Up Period|Death|0|||
129218327|NCT05462756|465099753|FG000|Follow-Up Period|Lost to Follow-up|3|||
129218328|NCT05462756|465099754|FG001|Follow-Up Period|Lost to Follow-up|1|||
129218329|NCT05462756|465099753|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129218330|NCT05462756|465099754|FG001|Follow-Up Period|Withdrawal by Subject|4|||
129218331|NCT00990704|465099755|FG000|Overall Study|Adverse Event|1|||
128948982|NCT03259490|464099120|FG000|Period 1|Withdrawal by Subject|0|||
128948983|NCT03259490|464099121|FG001|Period 1|Withdrawal by Subject|1|||
128948984|NCT03259490|464099120|FG000|Period 2|Protocol Violation|1|||
128948985|NCT03259490|464099121|FG001|Period 2|Protocol Violation|0|||
128948986|NCT01963208|464099122|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
129218332|NCT00990704|465099756|FG001|Overall Study|Adverse Event|1|||
129218333|NCT00990704|465099755|FG000|Overall Study|Physician Decision|0|||
129218334|NCT00990704|465099756|FG001|Overall Study|Physician Decision|1|||
129218335|NCT04040933|465099757|FG000|Overall Study|Protocol Violation|1|||
129218336|NCT04040933|465099757|FG000|Overall Study|Withdrawal by Subject|2|||
129218337|NCT01354899|465099761|FG000|Overall Study|discharge from the hospital|2|||
129218338|NCT01354899|465099761|FG000|Overall Study|Protocol Violation|1|||
129218339|NCT01071798|465099762|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
128948987|NCT01963208|464099123|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
128948988|NCT01963208|464099124|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
128948989|NCT01963208|464099125|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
128948990|NCT01963208|464099126|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
128948991|NCT01963208|464099127|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
128948992|NCT01963208|464099122|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
128948993|NCT01963208|464099123|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
128948994|NCT01963208|464099124|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
128948995|NCT01963208|464099125|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
128948996|NCT01963208|464099126|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
128770353|NCT02736968|463450224|FG002|Overall Study|Withdrawal by Subject|0|||
128948997|NCT01963208|464099127|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
128948998|NCT01963208|464099122|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
128948999|NCT01963208|464099123|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
128949000|NCT01963208|464099124|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
128949001|NCT01963208|464099125|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
128949002|NCT01963208|464099126|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
128949003|NCT01963208|464099127|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
128949004|NCT01963208|464099122|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
128949005|NCT01963208|464099123|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
129218340|NCT01071798|465099762|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
129218341|NCT01071798|465099762|FG000|Participants Who Received One Cycle|Patient requirement|20|||
129218342|NCT01071798|465099762|FG000|Participants Who Received One Cycle|Death|5|||
129218343|NCT01071798|465099762|FG000|Participants Who Received One Cycle|Change of therapy|6|||
129218344|NCT01071798|465099762|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
129218345|NCT01071798|465099762|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
129218346|NCT01071798|465099762|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
129218347|NCT01071798|465099762|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
129218348|NCT01071798|465099762|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
129218349|NCT00641667|465099763|FG000|Overall Study|Withdrawal by Subject|1|||
129218350|NCT00641667|465099763|FG000|Overall Study|Adverse Event|1|||
129218351|NCT00641667|465099763|FG000|Overall Study|Physician Decision|1|||
129218352|NCT00641667|465099763|FG000|Overall Study|Worsening of underlying disease|3|||
129218353|NCT01235741|465099764|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
129218354|NCT01235741|465099765|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
129218355|NCT01235741|465099766|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
129218356|NCT01235741|465099764|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
129218357|NCT01235741|465099765|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
129218358|NCT01235741|465099766|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
129218359|NCT01235741|465099764|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
129218360|NCT01235741|465099765|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
129218361|NCT01235741|465099766|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
129218362|NCT01235741|465099764|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
129218363|NCT01235741|465099765|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
129218364|NCT01235741|465099766|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
129218365|NCT01235741|465099764|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
129218366|NCT01235741|465099765|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
129218367|NCT01235741|465099766|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
129218368|NCT01235741|465099764|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
129218369|NCT01235741|465099765|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
129218370|NCT01235741|465099766|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
129218371|NCT01235741|465099764|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
129218372|NCT01235741|465099765|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
129218373|NCT01235741|465099766|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
129218374|NCT01235741|465099764|FG000|Randomized to Treatment|Adverse Event|0|||
129218375|NCT01235741|465099765|FG001|Randomized to Treatment|Adverse Event|1|||
129218376|NCT01235741|465099766|FG002|Randomized to Treatment|Adverse Event|1|||
129218377|NCT01235741|465099764|FG000|Randomized to Treatment|Sponsor terminated study|0|||
129218378|NCT01235741|465099765|FG001|Randomized to Treatment|Sponsor terminated study|35|||
129218379|NCT01235741|465099766|FG002|Randomized to Treatment|Sponsor terminated study|34|||
129218380|NCT01235741|465099764|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
129218381|NCT01235741|465099765|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
129218382|NCT01235741|465099766|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
129218383|NCT01235741|465099764|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
129218384|NCT01235741|465099765|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
129218385|NCT01235741|465099766|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
129218386|NCT01235741|465099764|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
129218387|NCT01235741|465099765|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
129218388|NCT01235741|465099766|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
129218389|NCT00904033|465099771|FG000|Overall Study|Withdrawal by Subject|1|||
129218390|NCT00904033|465099772|FG001|Overall Study|Withdrawal by Subject|1|||
129218391|NCT00904033|465099773|FG002|Overall Study|Withdrawal by Subject|0|||
129218392|NCT00904033|465099774|FG003|Overall Study|Withdrawal by Subject|0|||
129218393|NCT00904033|465099771|FG000|Overall Study|Physician Decision|0|||
129218394|NCT00904033|465099772|FG001|Overall Study|Physician Decision|0|||
129218395|NCT00904033|465099773|FG002|Overall Study|Physician Decision|1|||
129218396|NCT00904033|465099774|FG003|Overall Study|Physician Decision|0|||
129218397|NCT00904033|465099771|FG000|Overall Study|Unable to obtain final blood draw|0|||
129218398|NCT00904033|465099772|FG001|Overall Study|Unable to obtain final blood draw|0|||
129218399|NCT00904033|465099773|FG002|Overall Study|Unable to obtain final blood draw|0|||
129218400|NCT00904033|465099774|FG003|Overall Study|Unable to obtain final blood draw|2|||
129218401|NCT01177397|465099775|FG000|Overall Study|Protocol Violation|0|||
129218402|NCT01177397|465099776|FG001|Overall Study|Protocol Violation|0|||
129218403|NCT01177397|465099777|FG002|Overall Study|Protocol Violation|0|||
129218404|NCT01177397|465099778|FG003|Overall Study|Protocol Violation|0|||
129218405|NCT01177397|465099779|FG004|Overall Study|Protocol Violation|0|||
129218406|NCT01177397|465099780|FG005|Overall Study|Protocol Violation|1|||
129218407|NCT01177397|465099781|FG006|Overall Study|Protocol Violation|0|||
128709135|NCT00553514|463230105|FG003|Overall Study|Other|0|||
128709136|NCT00553514|463230106|FG004|Overall Study|Other|1|||
129218408|NCT01177397|465099782|FG007|Overall Study|Protocol Violation|0|||
129218409|NCT01177397|465099783|FG008|Overall Study|Protocol Violation|0|||
129218410|NCT01177397|465099784|FG009|Overall Study|Protocol Violation|0|||
129218411|NCT01177397|465099785|FG010|Overall Study|Protocol Violation|0|||
128949006|NCT01963208|464099124|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
128949007|NCT01963208|464099125|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
128949008|NCT01963208|464099126|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
128949009|NCT01963208|464099127|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
128949010|NCT01963208|464099122|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
128949011|NCT01963208|464099123|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
128949012|NCT01963208|464099124|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
128949013|NCT01963208|464099125|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
128949014|NCT01963208|464099126|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
128949015|NCT01963208|464099127|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
128949016|NCT01963208|464099122|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
129218412|NCT01177397|465099786|FG011|Overall Study|Protocol Violation|0|||
129218413|NCT01177397|465099775|FG000|Overall Study|Lost to Follow-up|0|||
129218414|NCT01177397|465099776|FG001|Overall Study|Lost to Follow-up|0|||
129218415|NCT01177397|465099777|FG002|Overall Study|Lost to Follow-up|0|||
129218416|NCT01177397|465099778|FG003|Overall Study|Lost to Follow-up|0|||
129218417|NCT01177397|465099779|FG004|Overall Study|Lost to Follow-up|1|||
129218418|NCT01177397|465099780|FG005|Overall Study|Lost to Follow-up|0|||
129218419|NCT01177397|465099781|FG006|Overall Study|Lost to Follow-up|0|||
129218420|NCT01177397|465099782|FG007|Overall Study|Lost to Follow-up|2|||
129218421|NCT01177397|465099783|FG008|Overall Study|Lost to Follow-up|0|||
129218422|NCT01177397|465099784|FG009|Overall Study|Lost to Follow-up|0|||
129218423|NCT01177397|465099785|FG010|Overall Study|Lost to Follow-up|0|||
129218424|NCT01177397|465099786|FG011|Overall Study|Lost to Follow-up|0|||
129218425|NCT01177397|465099775|FG000|Overall Study|Death|0|||
129218426|NCT01177397|465099776|FG001|Overall Study|Death|0|||
129218427|NCT01177397|465099777|FG002|Overall Study|Death|1|||
129218428|NCT01177397|465099778|FG003|Overall Study|Death|1|||
129218429|NCT01177397|465099779|FG004|Overall Study|Death|0|||
129218430|NCT01177397|465099780|FG005|Overall Study|Death|0|||
129218431|NCT01177397|465099781|FG006|Overall Study|Death|0|||
129218432|NCT01177397|465099782|FG007|Overall Study|Death|5|||
129218433|NCT01177397|465099783|FG008|Overall Study|Death|2|||
129218434|NCT01177397|465099784|FG009|Overall Study|Death|1|||
129218435|NCT01177397|465099785|FG010|Overall Study|Death|0|||
129218436|NCT01177397|465099786|FG011|Overall Study|Death|0|||
129218437|NCT01177397|465099775|FG000|Overall Study|Withdrawal by Subject|0|||
129218438|NCT01177397|465099776|FG001|Overall Study|Withdrawal by Subject|0|||
129218439|NCT01177397|465099777|FG002|Overall Study|Withdrawal by Subject|1|||
129218440|NCT01177397|465099778|FG003|Overall Study|Withdrawal by Subject|1|||
129218441|NCT01177397|465099779|FG004|Overall Study|Withdrawal by Subject|1|||
129218442|NCT01177397|465099780|FG005|Overall Study|Withdrawal by Subject|2|||
129218443|NCT01177397|465099781|FG006|Overall Study|Withdrawal by Subject|0|||
129218444|NCT01177397|465099782|FG007|Overall Study|Withdrawal by Subject|5|||
129218445|NCT01177397|465099783|FG008|Overall Study|Withdrawal by Subject|9|||
129218446|NCT01177397|465099784|FG009|Overall Study|Withdrawal by Subject|1|||
129218447|NCT01177397|465099785|FG010|Overall Study|Withdrawal by Subject|1|||
129218448|NCT01177397|465099786|FG011|Overall Study|Withdrawal by Subject|0|||
129218449|NCT01177397|465099775|FG000|Overall Study|Adverse Event|0|||
129218450|NCT01177397|465099776|FG001|Overall Study|Adverse Event|0|||
129218451|NCT01177397|465099777|FG002|Overall Study|Adverse Event|1|||
129218452|NCT01177397|465099778|FG003|Overall Study|Adverse Event|2|||
129218453|NCT01177397|465099779|FG004|Overall Study|Adverse Event|0|||
129218454|NCT01177397|465099780|FG005|Overall Study|Adverse Event|12|||
129218455|NCT01177397|465099781|FG006|Overall Study|Adverse Event|1|||
129218456|NCT01177397|465099782|FG007|Overall Study|Adverse Event|14|||
129218457|NCT01177397|465099783|FG008|Overall Study|Adverse Event|8|||
129218458|NCT01177397|465099784|FG009|Overall Study|Adverse Event|6|||
129218459|NCT01177397|465099785|FG010|Overall Study|Adverse Event|3|||
129218460|NCT01177397|465099786|FG011|Overall Study|Adverse Event|7|||
129218461|NCT01177397|465099775|FG000|Overall Study|Disease progression|1|||
129218462|NCT01177397|465099776|FG001|Overall Study|Disease progression|2|||
128770354|NCT02736968|463450225|FG003|Overall Study|Withdrawal by Subject|0|||
129034387|NCT01074008|464416440|FG005|Overall Study|Withdrawal by Subject|0|||
129034388|NCT01074008|464416441|FG006|Overall Study|Withdrawal by Subject|0|||
129218463|NCT01177397|465099777|FG002|Overall Study|Disease progression|5|||
129218464|NCT01177397|465099778|FG003|Overall Study|Disease progression|5|||
129218465|NCT01177397|465099779|FG004|Overall Study|Disease progression|4|||
129218466|NCT01177397|465099780|FG005|Overall Study|Disease progression|10|||
129218467|NCT01177397|465099781|FG006|Overall Study|Disease progression|10|||
129218468|NCT01177397|465099782|FG007|Overall Study|Disease progression|21|||
129218469|NCT01177397|465099783|FG008|Overall Study|Disease progression|18|||
129218470|NCT01177397|465099784|FG009|Overall Study|Disease progression|12|||
129218471|NCT01177397|465099785|FG010|Overall Study|Disease progression|10|||
129218472|NCT01177397|465099786|FG011|Overall Study|Disease progression|8|||
129218473|NCT01177397|465099775|FG000|Overall Study|Other reasons|0|||
129218474|NCT01177397|465099776|FG001|Overall Study|Other reasons|0|||
129218475|NCT01177397|465099777|FG002|Overall Study|Other reasons|1|||
129218476|NCT01177397|465099778|FG003|Overall Study|Other reasons|0|||
129034389|NCT01074008|464416442|FG007|Overall Study|Withdrawal by Subject|0|||
129034390|NCT01074008|464416443|FG008|Overall Study|Withdrawal by Subject|0|||
129034391|NCT01074008|464416435|FG000|Overall Study|Lost to Follow-up|0|||
129034392|NCT01074008|464416436|FG001|Overall Study|Lost to Follow-up|1|||
129034393|NCT01074008|464416437|FG002|Overall Study|Lost to Follow-up|1|||
129034394|NCT01074008|464416438|FG003|Overall Study|Lost to Follow-up|1|||
129124700|NCT04530344|464751431|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
129124701|NCT01402700|464751432|FG000|Overall Study|Death|3|||
129124702|NCT01402700|464751432|FG000|Overall Study|Withdrawal by Subject|3|||
129124703|NCT01402700|464751432|FG000|Overall Study|Missed Visit|1|||
129124704|NCT02401230|464751436|FG000|Overall Study|Adverse Event|3|||
129124705|NCT02401230|464751437|FG001|Overall Study|Adverse Event|2|||
129124706|NCT02401230|464751438|FG002|Overall Study|Adverse Event|0|||
129124707|NCT02401230|464751436|FG000|Overall Study|Withdrawal by Subject|2|||
129124708|NCT02401230|464751437|FG001|Overall Study|Withdrawal by Subject|1|||
129124709|NCT02401230|464751438|FG002|Overall Study|Withdrawal by Subject|1|||
129124710|NCT02401230|464751436|FG000|Overall Study|Lost to Follow-up|1|||
129124711|NCT02401230|464751437|FG001|Overall Study|Lost to Follow-up|3|||
129124712|NCT02401230|464751438|FG002|Overall Study|Lost to Follow-up|3|||
129124713|NCT00830765|464751439|FG000|Overall Study|Protocol Violation|3|||
129124714|NCT00830765|464751440|FG001|Overall Study|Protocol Violation|2|||
129124715|NCT01299909|464751441|FG000|Overall Study|Lost to Follow-up|22|||
129124716|NCT01299909|464751442|FG001|Overall Study|Lost to Follow-up|18|||
129124717|NCT01299909|464751443|FG002|Overall Study|Lost to Follow-up|17|||
129124718|NCT00964782|464751444|FG000|Overall Study|Lost to Follow-up|1|||
129124719|NCT00964782|464751445|FG001|Overall Study|Lost to Follow-up|0|||
129124720|NCT01143324|464751451|FG000|Overall Study|Lost to Follow-up|11|||
129124721|NCT01143324|464751451|FG000|Overall Study|Withdrawal by Subject|4|||
129124722|NCT01143324|464751451|FG000|Overall Study|Explant of the device|4|||
129124723|NCT02774889|464751461|FG000|Overall Study|Lost to Follow-up|2|||
129124724|NCT02774889|464751462|FG001|Overall Study|Lost to Follow-up|1|||
129124725|NCT00858988|464751463|FG000|Analysis|Lactulose unable to be detected in urine|2|||
129124726|NCT00858988|464751464|FG001|Analysis|Lactulose unable to be detected in urine|1|||
129124727|NCT01349595|464751465|FG000|Overall Study|Lack of funding|2|||
129124728|NCT01349595|464751466|FG001|Overall Study|Lack of funding|2|||
129124729|NCT00549055|464753507|FG000|Overall Study|Adverse Event|4|||
129124730|NCT00549055|464753507|FG000|Overall Study|Lack of Efficacy|18|||
129124731|NCT00549055|464753507|FG000|Overall Study|Stabilization|5|||
129124732|NCT00549055|464753507|FG000|Overall Study|Progression to fibrosis|2|||
129124733|NCT00549055|464753507|FG000|Overall Study|Decrease of size|1|||
129124734|NCT00549055|464753507|FG000|Overall Study|Active choroidal neovascula increased|1|||
129124735|NCT00549055|464753507|FG000|Overall Study|Vitreous hemorrhage|1|||
129124736|NCT00549055|464753507|FG000|Overall Study|Growth choroidal neovascularisation|1|||
129124737|NCT00549055|464753507|FG000|Overall Study|Choroidal neovascularization|1|||
129124738|NCT00549055|464753507|FG000|Overall Study|Very low visual acuity (VA)|1|||
129124739|NCT00770809|464753512|FG000|Overall Study|Adverse Event|9|||
128770355|NCT02736968|463450226|FG004|Overall Study|Withdrawal by Subject|0|||
128770356|NCT02736968|463450227|FG005|Overall Study|Withdrawal by Subject|0|||
128770357|NCT02736968|463450228|FG006|Overall Study|Withdrawal by Subject|1|||
128770358|NCT02736968|463450229|FG007|Overall Study|Withdrawal by Subject|0|||
128770359|NCT00147225|463450230|FG000|Overall Study|Withdrawal by Subject|1|||
128770360|NCT00147225|463450231|FG001|Overall Study|Withdrawal by Subject|0|||
129034395|NCT01074008|464416439|FG004|Overall Study|Lost to Follow-up|1|||
129034396|NCT01074008|464416440|FG005|Overall Study|Lost to Follow-up|0|||
129034397|NCT01074008|464416441|FG006|Overall Study|Lost to Follow-up|1|||
129034398|NCT01074008|464416442|FG007|Overall Study|Lost to Follow-up|0|||
129034399|NCT01074008|464416443|FG008|Overall Study|Lost to Follow-up|4|||
129034400|NCT02805309|464416444|FG000|Overall Study|Lost to Follow-up|2|||
129034401|NCT02805309|464416445|FG001|Overall Study|Lost to Follow-up|2|||
129034402|NCT02805309|464416446|FG002|Overall Study|Lost to Follow-up|2|||
129034403|NCT02805309|464416444|FG000|Overall Study|Post-Randomization Exclusion|0|||
129034404|NCT02805309|464416445|FG001|Overall Study|Post-Randomization Exclusion|2|||
129034405|NCT02805309|464416446|FG002|Overall Study|Post-Randomization Exclusion|1|||
129034406|NCT00108628|464416454|FG000|Overall Study|Withdrawal by Subject|17|||
129034407|NCT00108628|464416455|FG001|Overall Study|Withdrawal by Subject|9|||
129034408|NCT00108628|464416454|FG000|Overall Study|Lack of Efficacy|2|||
129124740|NCT00770809|464753513|FG001|Overall Study|Adverse Event|1|||
129124741|NCT00770809|464753514|FG002|Overall Study|Adverse Event|12|||
129034409|NCT00108628|464416455|FG001|Overall Study|Lack of Efficacy|1|||
129034410|NCT00108628|464416454|FG000|Overall Study|Death|1|||
129034411|NCT00108628|464416455|FG001|Overall Study|Death|0|||
129124742|NCT00770809|464753512|FG000|Overall Study|Death|1|||
129124743|NCT00770809|464753513|FG001|Overall Study|Death|0|||
129124744|NCT00770809|464753514|FG002|Overall Study|Death|0|||
129124745|NCT00770809|464753512|FG000|Overall Study|Withdrawal by Subject|3|||
129124746|NCT00770809|464753513|FG001|Overall Study|Withdrawal by Subject|3|||
129124747|NCT00770809|464753514|FG002|Overall Study|Withdrawal by Subject|7|||
129034412|NCT01350934|464416458|FG000|Base Study|Adverse Event|6|||
129034413|NCT01350934|464416459|FG001|Base Study|Adverse Event|0|||
129034414|NCT01350934|464416458|FG000|Base Study|Lost to Follow-up|1|||
129034415|NCT01350934|464416459|FG001|Base Study|Lost to Follow-up|0|||
129034416|NCT01350934|464416458|FG000|Base Study|Protocol Violation|1|||
129034417|NCT01350934|464416459|FG001|Base Study|Protocol Violation|1|||
129034418|NCT01350934|464416458|FG000|Base Study|Withdrawal by Subject|1|||
129034419|NCT01350934|464416459|FG001|Base Study|Withdrawal by Subject|2|||
129034420|NCT01350934|464416458|FG000|Base Study|Non-Compliance With Study Drug|2|||
129034421|NCT01350934|464416459|FG001|Base Study|Non-Compliance With Study Drug|0|||
129034422|NCT01350934|464416458|FG000|Extension Study|Adverse Event|2|||
129034423|NCT01350934|464416459|FG001|Extension Study|Adverse Event|1|||
129034424|NCT01350934|464416458|FG000|Extension Study|Lost to Follow-up|2|||
129034425|NCT01350934|464416459|FG001|Extension Study|Lost to Follow-up|0|||
129034426|NCT01350934|464416458|FG000|Extension Study|Protocol Violation|1|||
129034427|NCT01350934|464416459|FG001|Extension Study|Protocol Violation|1|||
129034428|NCT01350934|464416458|FG000|Extension Study|Lack of Efficacy|0|||
129034429|NCT01350934|464416459|FG001|Extension Study|Lack of Efficacy|1|||
129034430|NCT01350934|464416458|FG000|Extension Study|Withdrawal by Subject|0|||
129034431|NCT01350934|464416459|FG001|Extension Study|Withdrawal by Subject|1|||
129034432|NCT03547635|464416460|FG000|Overall Study|Adverse Event|5|||
129034433|NCT03547635|464416461|FG001|Overall Study|Adverse Event|2|||
129034434|NCT03547635|464416462|FG002|Overall Study|Adverse Event|3|||
129034435|NCT03547635|464416460|FG000|Overall Study|Lost to Follow-up|1|||
129034436|NCT03547635|464416461|FG001|Overall Study|Lost to Follow-up|3|||
129034437|NCT03547635|464416462|FG002|Overall Study|Lost to Follow-up|4|||
129034438|NCT03547635|464416460|FG000|Overall Study|Withdrawal by Subject|1|||
129034439|NCT03547635|464416461|FG001|Overall Study|Withdrawal by Subject|0|||
129034440|NCT03547635|464416462|FG002|Overall Study|Withdrawal by Subject|0|||
129034441|NCT03547635|464416460|FG000|Overall Study|Withdrawal By PI|0|||
129034442|NCT03547635|464416461|FG001|Overall Study|Withdrawal By PI|1|||
129034443|NCT03547635|464416462|FG002|Overall Study|Withdrawal By PI|0|||
129034444|NCT03547635|464416460|FG000|Overall Study|Withdrawal by Sponsor|0|||
129034445|NCT03547635|464416461|FG001|Overall Study|Withdrawal by Sponsor|0|||
129034446|NCT03547635|464416462|FG002|Overall Study|Withdrawal by Sponsor|1|||
129034447|NCT03547635|464416460|FG000|Overall Study|Errant Randomization before Treatment|0|||
129034448|NCT03547635|464416461|FG001|Overall Study|Errant Randomization before Treatment|1|||
129034449|NCT03547635|464416462|FG002|Overall Study|Errant Randomization before Treatment|0|||
129034450|NCT03547635|464416460|FG000|Overall Study|Withdrawal by Subject|1|||
129034451|NCT03547635|464416461|FG001|Overall Study|Withdrawal by Subject|0|||
129034452|NCT03547635|464416462|FG002|Overall Study|Withdrawal by Subject|0|||
129034453|NCT01765270|464416472|FG000|Overall Study|Physician Decision|1|||
129034454|NCT01765270|464416473|FG001|Overall Study|Physician Decision|0|||
129034455|NCT01765270|464416472|FG000|Overall Study|Withdrawal by Subject|0|||
129034456|NCT01765270|464416473|FG001|Overall Study|Withdrawal by Subject|1|||
129034457|NCT03431337|464416476|FG000|Overall Study|Lost to Follow-up|21|||
129034458|NCT03431337|464416477|FG001|Overall Study|Lost to Follow-up|19|||
129034459|NCT03431337|464416476|FG000|Overall Study|Withdrawal by Subject|8|||
129034460|NCT03431337|464416477|FG001|Overall Study|Withdrawal by Subject|3|||
129034461|NCT00329160|464416478|FG000|Overall Study|Adverse Event|27|||
129034462|NCT00329160|464416478|FG000|Overall Study|Withdrawal by Subject|13|||
129034463|NCT00329160|464416478|FG000|Overall Study|Protocol Violation|2|||
129034464|NCT00329160|464416478|FG000|Overall Study|Did not Receive Study Drug|1|||
129034465|NCT00329160|464416478|FG000|Overall Study|Incomplete IVUS|45|||
129034466|NCT04501094|464416479|FG000|Overall Study|Death (unrelated to research)|1|||
129034467|NCT04501094|464416480|FG001|Overall Study|Death (unrelated to research)|0|||
129034468|NCT00063258|464416484|FG000|Overall Study|Physician Decision|2|||
129034469|NCT00063258|464416485|FG001|Overall Study|Physician Decision|0|||
129034470|NCT00063258|464416484|FG000|Overall Study|Lack of Efficacy|2|||
129034471|NCT00063258|464416485|FG001|Overall Study|Lack of Efficacy|0|||
129034472|NCT00685035|464416486|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
129034473|NCT00685035|464416487|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
129034474|NCT04241133|464416490|FG000|Overall Study|COVID19 Precautions|14|||
129034475|NCT04241133|464416491|FG001|Overall Study|COVID19 Precautions|34|||
129034476|NCT04982445|464416492|FG000|Overall Study|Protocol Violation|1|||
129034477|NCT04982445|464416492|FG000|Overall Study|Withdrawal by Subject|4|||
129034478|NCT04982445|464416492|FG000|Overall Study|Lost to Follow-up|1|||
129034479|NCT03653026|464416493|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
129034480|NCT03653026|464416494|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
128709137|NCT04502589|463230109|FG000|Overall Study|Physician Decision|1|||
128709138|NCT04502589|463230110|FG001|Overall Study|Physician Decision|0|||
128709139|NCT00137046|463230118|FG000|Overall Study|Death|2|||
128709140|NCT00137046|463230119|FG001|Overall Study|Death|1|||
129034481|NCT03653026|464416495|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
129034482|NCT03653026|464416496|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
129034483|NCT03653026|464416493|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
129034484|NCT03653026|464416494|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
129124748|NCT00770809|464753512|FG000|Overall Study|Progression|2|||
128709141|NCT00137046|463230118|FG000|Overall Study|Adverse Event|16|||
128709142|NCT00137046|463230119|FG001|Overall Study|Adverse Event|5|||
128949017|NCT01963208|464099123|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
128949018|NCT01963208|464099124|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
128949019|NCT01963208|464099125|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
128949020|NCT01963208|464099126|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
128949021|NCT01963208|464099127|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
128949022|NCT01963208|464099122|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
128949023|NCT01963208|464099123|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
128949024|NCT01963208|464099124|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
128949025|NCT01963208|464099125|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
128949026|NCT01963208|464099126|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
128949027|NCT01963208|464099127|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
128709143|NCT00137046|463230118|FG000|Overall Study|Laboratory Abnormality|2|||
128709144|NCT00137046|463230119|FG001|Overall Study|Laboratory Abnormality|0|||
128949028|NCT01963208|464099122|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
128949029|NCT01963208|464099123|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
128949030|NCT01963208|464099124|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
128949031|NCT01963208|464099125|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
129124749|NCT00770809|464753513|FG001|Overall Study|Progression|2|||
128709145|NCT00137046|463230118|FG000|Overall Study|Lack of Efficacy|13|||
128709146|NCT00137046|463230119|FG001|Overall Study|Lack of Efficacy|1|||
128709147|NCT00137046|463230118|FG000|Overall Study|Lost to Follow-up|8|||
128709148|NCT00137046|463230119|FG001|Overall Study|Lost to Follow-up|24|||
128709149|NCT00137046|463230118|FG000|Overall Study|Other|23|||
128709150|NCT00137046|463230119|FG001|Overall Study|Other|19|||
128709151|NCT00137046|463230118|FG000|Overall Study|Withdrawal by Subject|33|||
128709152|NCT00137046|463230119|FG001|Overall Study|Withdrawal by Subject|42|||
128709153|NCT00137046|463230118|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
128709154|NCT00137046|463230119|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
128709155|NCT00137046|463230118|FG000|Overall Study|Withdrew prior to study treatment|1|||
128709156|NCT00137046|463230119|FG001|Overall Study|Withdrew prior to study treatment|1|||
128709157|NCT00160251|463230120|FG000|Prior to Amendment 2|Adverse Event|2|||
128709158|NCT00160251|463230121|FG001|Prior to Amendment 2|Adverse Event|1|||
128709159|NCT00160251|463230122|FG002|Prior to Amendment 2|Adverse Event|3|||
128709160|NCT00160251|463230123|FG003|Prior to Amendment 2|Adverse Event|1|||
128709161|NCT00160251|463230124|FG004|Prior to Amendment 2|Adverse Event|1|||
128709162|NCT00160251|463230125|FG005|Prior to Amendment 2|Adverse Event|1|||
128709163|NCT00160251|463230126|FG006|Prior to Amendment 2|Adverse Event|1|||
128709164|NCT00160251|463230127|FG007|Prior to Amendment 2|Adverse Event|0|||
128709165|NCT00160251|463230120|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
128709166|NCT00160251|463230121|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
128709167|NCT00160251|463230122|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
128949032|NCT01963208|464099126|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
128949033|NCT01963208|464099127|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
128949034|NCT01963208|464099122|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
128949035|NCT01963208|464099123|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
128949036|NCT01963208|464099124|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
128949037|NCT01963208|464099125|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
128949038|NCT01963208|464099126|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
128949039|NCT01963208|464099127|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
128949040|NCT01963208|464099122|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
128949041|NCT01963208|464099123|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
128949042|NCT01963208|464099124|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
128949043|NCT01963208|464099125|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
128949044|NCT01963208|464099126|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
128949045|NCT01963208|464099127|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
128949046|NCT01963208|464099122|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
128949047|NCT01963208|464099123|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
128949048|NCT01963208|464099124|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
128949049|NCT01963208|464099125|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
128949050|NCT01963208|464099126|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
128949051|NCT01963208|464099127|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
128949052|NCT01963208|464099122|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
128949053|NCT01963208|464099123|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
128709168|NCT00160251|463230123|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
128709169|NCT00160251|463230124|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
128949054|NCT01963208|464099124|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
128949055|NCT01963208|464099125|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
128949056|NCT01963208|464099126|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
128949057|NCT01963208|464099127|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
128709170|NCT00160251|463230125|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
128709171|NCT00160251|463230126|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
128709172|NCT00160251|463230127|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
128709173|NCT00160251|463230120|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
128709174|NCT00160251|463230121|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
128709175|NCT00160251|463230122|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
128709176|NCT00160251|463230123|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
129124750|NCT00770809|464753514|FG002|Overall Study|Progression|0|||
129124751|NCT00770809|464753512|FG000|Overall Study|Complicating illness|0|||
129124752|NCT00770809|464753513|FG001|Overall Study|Complicating illness|0|||
129124753|NCT00770809|464753514|FG002|Overall Study|Complicating illness|1|||
129124754|NCT00770809|464753512|FG000|Overall Study|Other Medical Reasons|2|||
129124755|NCT00770809|464753513|FG001|Overall Study|Other Medical Reasons|4|||
129124756|NCT00770809|464753514|FG002|Overall Study|Other Medical Reasons|3|||
129124757|NCT02469233|464753515|FG000|Overall Study|Death|1|||
129124758|NCT02469233|464753516|FG001|Overall Study|Death|1|||
129124759|NCT02469233|464753515|FG000|Overall Study|Lost to post or 6 month follow up|7|||
129124760|NCT02469233|464753516|FG001|Overall Study|Lost to post or 6 month follow up|2|||
129124761|NCT03474107|464753517|FG000|Overall Study|Adverse Event|42|||
129124762|NCT03474107|464753518|FG001|Overall Study|Adverse Event|46|||
129124763|NCT03474107|464753517|FG000|Overall Study|Death|2|||
129124764|NCT03474107|464753518|FG001|Overall Study|Death|2|||
129124765|NCT03474107|464753517|FG000|Overall Study|Lost to Follow-up|0|||
129124766|NCT03474107|464753518|FG001|Overall Study|Lost to Follow-up|1|||
129124767|NCT03474107|464753517|FG000|Overall Study|Progressive Disease|177|||
129124768|NCT03474107|464753518|FG001|Overall Study|Progressive Disease|180|||
129124769|NCT03474107|464753517|FG000|Overall Study|Protocol Violation|1|||
129124770|NCT03474107|464753518|FG001|Overall Study|Protocol Violation|1|||
129124771|NCT03474107|464753517|FG000|Overall Study|Withdrawal by Subject|15|||
129124772|NCT03474107|464753518|FG001|Overall Study|Withdrawal by Subject|27|||
129124773|NCT03474107|464753517|FG000|Overall Study|Physician Decision|7|||
129124774|NCT03474107|464753518|FG001|Overall Study|Physician Decision|22|||
129124775|NCT03474107|464753517|FG000|Overall Study|Miscellaneous|1|||
129124776|NCT03474107|464753518|FG001|Overall Study|Miscellaneous|6|||
129124777|NCT02127671|464753519|FG000|Overall Study|Death|2|||
129124778|NCT02127671|464753520|FG001|Overall Study|Death|2|||
129124779|NCT02127671|464753519|FG000|Overall Study|Lost to Follow-up|4|||
129124780|NCT02127671|464753520|FG001|Overall Study|Lost to Follow-up|2|||
129124781|NCT02127671|464753519|FG000|Overall Study|Physician Decision|1|||
129124782|NCT02127671|464753520|FG001|Overall Study|Physician Decision|0|||
129124783|NCT02127671|464753519|FG000|Overall Study|incarceration|0|||
129124784|NCT02127671|464753520|FG001|Overall Study|incarceration|1|||
129124785|NCT02127671|464753519|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
129124786|NCT02127671|464753520|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
129124787|NCT00764517|464753521|FG000|Overall Study|Adverse Event|9|||
129124788|NCT00764517|464753522|FG001|Overall Study|Adverse Event|3|||
128709177|NCT00160251|463230124|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
128709178|NCT00160251|463230125|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
129124789|NCT00764517|464753521|FG000|Overall Study|Death|3|||
129124790|NCT00764517|464753522|FG001|Overall Study|Death|11|||
129124791|NCT00764517|464753521|FG000|Overall Study|Physician Decision|3|||
129124792|NCT00764517|464753522|FG001|Overall Study|Physician Decision|0|||
129124793|NCT05350423|464753524|FG000|Overall Study|Lost to Follow-up|3|||
129124794|NCT05350423|464753525|FG001|Overall Study|Lost to Follow-up|3|||
129124795|NCT05350423|464753524|FG000|Overall Study|screen failure|5|||
129124796|NCT05350423|464753525|FG001|Overall Study|screen failure|6|||
129124797|NCT02097277|464753528|FG000|Overall Study|Subject no longer meets study criteria|0|||
129124798|NCT02097277|464753529|FG001|Overall Study|Subject no longer meets study criteria|1|||
129124799|NCT02097277|464753530|FG002|Overall Study|Subject no longer meets study criteria|0|||
129124800|NCT02097277|464753531|FG003|Overall Study|Subject no longer meets study criteria|1|||
129124801|NCT02097277|464753532|FG004|Overall Study|Subject no longer meets study criteria|0|||
129124802|NCT02097277|464753528|FG000|Overall Study|Subject request to discontinue treatment|0|||
129218477|NCT01177397|465099779|FG004|Overall Study|Other reasons|1|||
129218478|NCT01177397|465099780|FG005|Overall Study|Other reasons|1|||
129218479|NCT01177397|465099781|FG006|Overall Study|Other reasons|2|||
128709179|NCT00160251|463230126|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
128709180|NCT00160251|463230127|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
128709181|NCT00160251|463230120|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
128709182|NCT00160251|463230121|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
128709183|NCT00160251|463230122|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
129124803|NCT02097277|464753529|FG001|Overall Study|Subject request to discontinue treatment|0|||
129124804|NCT02097277|464753530|FG002|Overall Study|Subject request to discontinue treatment|0|||
129124805|NCT02097277|464753531|FG003|Overall Study|Subject request to discontinue treatment|0|||
129124806|NCT02097277|464753532|FG004|Overall Study|Subject request to discontinue treatment|1|||
129124807|NCT02097277|464753528|FG000|Overall Study|Lost to Follow-up|0|||
129218480|NCT01177397|465099782|FG007|Overall Study|Other reasons|6|||
129218481|NCT01177397|465099783|FG008|Overall Study|Other reasons|10|||
128709184|NCT00160251|463230123|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
128709185|NCT00160251|463230124|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
128709186|NCT00160251|463230125|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
128709187|NCT00160251|463230126|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
128709188|NCT00160251|463230127|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
128709189|NCT00160251|463230120|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
128709190|NCT00160251|463230121|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
128709191|NCT00160251|463230122|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
128709192|NCT00160251|463230123|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
128709193|NCT00160251|463230124|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
128709194|NCT00160251|463230125|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
128709195|NCT00160251|463230126|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
128709196|NCT00160251|463230127|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
128709197|NCT00160251|463230120|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
128709198|NCT00160251|463230121|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
128709199|NCT00160251|463230122|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
128709200|NCT00160251|463230123|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
128709201|NCT00160251|463230124|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
128709202|NCT00160251|463230125|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
128709203|NCT00160251|463230126|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
128709204|NCT00160251|463230127|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
128709205|NCT00160251|463230120|FG000|Post-amendment 2|Adverse Event|0|||
128709206|NCT00160251|463230121|FG001|Post-amendment 2|Adverse Event|0|||
128709207|NCT00160251|463230122|FG002|Post-amendment 2|Adverse Event|0|||
128709208|NCT00160251|463230123|FG003|Post-amendment 2|Adverse Event|0|||
128709209|NCT00160251|463230124|FG004|Post-amendment 2|Adverse Event|0|||
128709210|NCT00160251|463230125|FG005|Post-amendment 2|Adverse Event|0|||
128709211|NCT00160251|463230126|FG006|Post-amendment 2|Adverse Event|0|||
129218482|NCT01177397|465099784|FG009|Overall Study|Other reasons|8|||
129218483|NCT01177397|465099785|FG010|Overall Study|Other reasons|0|||
129218484|NCT01177397|465099786|FG011|Overall Study|Other reasons|2|||
128770361|NCT00147225|463450232|FG002|Overall Study|Withdrawal by Subject|1|||
128709212|NCT00160251|463230127|FG007|Post-amendment 2|Adverse Event|20|||
128709213|NCT00160251|463230120|FG000|Post-amendment 2|Lack of Efficacy|0|||
129218485|NCT00118417|465099787|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
129218486|NCT00118417|465099788|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
129218487|NCT00118417|465099787|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
129218488|NCT00118417|465099788|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
129218489|NCT00118417|465099787|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
129218490|NCT00118417|465099788|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
129218491|NCT00118417|465099787|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
129218492|NCT00118417|465099788|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
129218493|NCT00118417|465099787|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
129218494|NCT00118417|465099788|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
129218495|NCT01383356|465099791|FG000|Period 1|Adverse Event|5|||
129218496|NCT01383356|465099792|FG001|Period 1|Adverse Event|3|||
129218497|NCT01383356|465099791|FG000|Period 1|Non-compliance|3|||
129218498|NCT01383356|465099792|FG001|Period 1|Non-compliance|0|||
129218499|NCT01383356|465099791|FG000|Period 1|Out of Range Mid-study-Test|0|||
129218500|NCT01383356|465099792|FG001|Period 1|Out of Range Mid-study-Test|1|||
129218501|NCT01383356|465099791|FG000|Period 1|Personal|0|||
129218502|NCT01383356|465099792|FG001|Period 1|Personal|2|||
129218503|NCT00098813|465099793|FG000|Overall Study|Death|8|||
129218504|NCT00098813|465099793|FG000|Overall Study|Protocol Violation|1|||
129218505|NCT00098813|465099793|FG000|Overall Study|Withdrawal by Subject|7|||
129218506|NCT00098813|465099793|FG000|Overall Study|Progression of Disease|1|||
129218507|NCT00098813|465099793|FG000|Overall Study|Other complicating disease|1|||
129218508|NCT00098813|465099793|FG000|Overall Study|Reversal of RAI resistance|1|||
129218509|NCT00998296|465099794|FG000|Overall Study|Progressive disease|0|||
129218510|NCT00998296|465099795|FG001|Overall Study|Progressive disease|1|||
128770362|NCT00147225|463450233|FG003|Overall Study|Withdrawal by Subject|0|||
128709214|NCT00160251|463230121|FG001|Post-amendment 2|Lack of Efficacy|0|||
129218511|NCT00998296|465099796|FG002|Overall Study|Progressive disease|0|||
128709215|NCT00160251|463230122|FG002|Post-amendment 2|Lack of Efficacy|0|||
128709216|NCT00160251|463230123|FG003|Post-amendment 2|Lack of Efficacy|0|||
128770363|NCT00147225|463450234|FG004|Overall Study|Withdrawal by Subject|0|||
128709217|NCT00160251|463230124|FG004|Post-amendment 2|Lack of Efficacy|0|||
128709218|NCT00160251|463230125|FG005|Post-amendment 2|Lack of Efficacy|0|||
128709219|NCT00160251|463230126|FG006|Post-amendment 2|Lack of Efficacy|0|||
129218512|NCT00998296|465099797|FG003|Overall Study|Progressive disease|0|||
129218513|NCT00998296|465099798|FG004|Overall Study|Progressive disease|0|||
129218514|NCT00998296|465099799|FG005|Overall Study|Progressive disease|0|||
129218515|NCT00998296|465099800|FG006|Overall Study|Progressive disease|1|||
129218516|NCT00998296|465099801|FG007|Overall Study|Progressive disease|0|||
129218517|NCT00998296|465099802|FG008|Overall Study|Progressive disease|0|||
129218518|NCT00998296|465099803|FG009|Overall Study|Progressive disease|14|||
129218519|NCT00998296|465099804|FG010|Overall Study|Progressive disease|5|||
128709220|NCT00160251|463230127|FG007|Post-amendment 2|Lack of Efficacy|24|||
128709221|NCT00160251|463230120|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
128709222|NCT00160251|463230121|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
128709223|NCT00160251|463230122|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
128709224|NCT00160251|463230123|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
128709225|NCT00160251|463230124|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
128709226|NCT00160251|463230125|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
128709227|NCT00160251|463230126|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
128709228|NCT00160251|463230127|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
128709229|NCT03944954|463230129|FG000|Overall Study|Withdrawal by Subject|22|||
128709230|NCT03944954|463230130|FG001|Overall Study|Withdrawal by Subject|4|||
128709231|NCT03944954|463230129|FG000|Overall Study|Lost to Follow-up|18|||
128709232|NCT03944954|463230130|FG001|Overall Study|Lost to Follow-up|0|||
128709233|NCT03944954|463230129|FG000|Overall Study|Failed Medical Screening|7|||
128709234|NCT03944954|463230130|FG001|Overall Study|Failed Medical Screening|0|||
128709235|NCT02268084|463230136|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
128709236|NCT02268084|463230137|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
128709237|NCT02268084|463230136|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
128709238|NCT02268084|463230137|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
128709239|NCT05227027|463230138|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
128709240|NCT05227027|463230139|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
128709241|NCT02725710|463230141|FG000|Overall Study|Lost to Follow-up|1|||
128709242|NCT02725710|463230142|FG001|Overall Study|Lost to Follow-up|0|||
128709243|NCT00640601|463230147|FG000|Overall Study|Adverse Event|43|||
128709244|NCT00640601|463230147|FG000|Overall Study|Withdrawal by Subject|20|||
128709245|NCT00640601|463230147|FG000|Overall Study|Protocol Violation|6|||
128709246|NCT00640601|463230147|FG000|Overall Study|Lack of Efficacy|16|||
128709247|NCT00640601|463230147|FG000|Overall Study|Lost to Follow-up|9|||
128709248|NCT00640601|463230147|FG000|Overall Study|Physician Decision|8|||
128709249|NCT00640601|463230147|FG000|Overall Study|treatment naive, combination therapy|10|||
128709250|NCT03681405|463230150|FG000|Overall Study|Found to be ineligible after randomized|1|||
128709251|NCT03681405|463230151|FG001|Overall Study|Found to be ineligible after randomized|0|||
128770364|NCT00147225|463450235|FG005|Overall Study|Withdrawal by Subject|1|||
128770365|NCT00147225|463450230|FG000|Overall Study|Adverse Event|0|||
129124808|NCT02097277|464753529|FG001|Overall Study|Lost to Follow-up|1|||
129124809|NCT02097277|464753530|FG002|Overall Study|Lost to Follow-up|1|||
129124810|NCT02097277|464753531|FG003|Overall Study|Lost to Follow-up|0|||
129124811|NCT02097277|464753532|FG004|Overall Study|Lost to Follow-up|0|||
129124812|NCT02097277|464753528|FG000|Overall Study|Withdrawal by Subject|2|||
129124813|NCT02097277|464753529|FG001|Overall Study|Withdrawal by Subject|1|||
129124814|NCT02097277|464753530|FG002|Overall Study|Withdrawal by Subject|0|||
129124815|NCT02097277|464753531|FG003|Overall Study|Withdrawal by Subject|1|||
129124816|NCT02097277|464753532|FG004|Overall Study|Withdrawal by Subject|0|||
129124817|NCT02097277|464753528|FG000|Overall Study|Adverse Event|0|||
129124818|NCT02097277|464753529|FG001|Overall Study|Adverse Event|0|||
129124819|NCT02097277|464753530|FG002|Overall Study|Adverse Event|1|||
129124820|NCT02097277|464753531|FG003|Overall Study|Adverse Event|2|||
129124821|NCT02097277|464753532|FG004|Overall Study|Adverse Event|0|||
129124822|NCT01091259|464753536|FG000|Overall Study|Adverse Event|3|||
129124823|NCT01091259|464753536|FG000|Overall Study|Lack of Efficacy|2|||
129124824|NCT03813654|464753539|FG000|Overall Study|Protocol Violation|0|||
129124825|NCT03813654|464753540|FG001|Overall Study|Protocol Violation|1|||
129124826|NCT03813654|464753541|FG002|Overall Study|Protocol Violation|2|||
129124827|NCT03813654|464753539|FG000|Overall Study|Withdrawal by Subject|1|||
129124828|NCT03813654|464753540|FG001|Overall Study|Withdrawal by Subject|0|||
129124829|NCT03813654|464753541|FG002|Overall Study|Withdrawal by Subject|0|||
129124830|NCT01208051|464753542|FG000|Total Enrollment|Withdrawal by Subject|0|||
129124831|NCT01208051|464753543|FG001|Total Enrollment|Withdrawal by Subject|1|||
129124832|NCT01208051|464753544|FG002|Total Enrollment|Withdrawal by Subject|0|||
129124833|NCT01208051|464753545|FG003|Total Enrollment|Withdrawal by Subject|0|||
129124834|NCT01208051|464753546|FG004|Total Enrollment|Withdrawal by Subject|2|||
129124835|NCT01208051|464753542|FG000|Total Enrollment|Brain metastases|0|||
129124836|NCT01208051|464753543|FG001|Total Enrollment|Brain metastases|0|||
129124837|NCT01208051|464753544|FG002|Total Enrollment|Brain metastases|1|||
129124838|NCT01208051|464753545|FG003|Total Enrollment|Brain metastases|0|||
129124839|NCT01208051|464753546|FG004|Total Enrollment|Brain metastases|0|||
129124840|NCT00671060|464753547|FG000|Overall Study|Protocol Violation|1|||
129124841|NCT00671060|464753548|FG001|Overall Study|Protocol Violation|0|||
129124842|NCT00671060|464753547|FG000|Overall Study|Physician Decision|0|||
129124843|NCT00671060|464753548|FG001|Overall Study|Physician Decision|1|||
129124844|NCT06057064|464753549|FG000|Overall Study|Death|2|||
129124845|NCT06057064|464753550|FG001|Overall Study|Death|0|||
129124846|NCT06057064|464753549|FG000|Overall Study|Physician Decision|1|||
128709252|NCT03978520|463230152|FG000|Overall Study|Adverse Event|2|||
128709253|NCT03978520|463230153|FG001|Overall Study|Adverse Event|5|||
128949058|NCT01963208|464099122|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
128949059|NCT01963208|464099123|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
128949060|NCT01963208|464099124|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
128949061|NCT01963208|464099125|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
128949062|NCT01963208|464099126|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
128949063|NCT01963208|464099127|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
128949064|NCT01963208|464099122|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
128949065|NCT01963208|464099123|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
128949066|NCT01963208|464099124|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
128949067|NCT01963208|464099125|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
128949068|NCT01963208|464099126|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
128949069|NCT01963208|464099127|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
128949070|NCT00448916|464099128|FG000|Overall Study|Adverse Event|2|||
128949071|NCT00448916|464099129|FG001|Overall Study|Adverse Event|2|||
128949072|NCT00448916|464099130|FG002|Overall Study|Adverse Event|3|||
129124847|NCT06057064|464753550|FG001|Overall Study|Physician Decision|0|||
129124848|NCT06057064|464753549|FG000|Overall Study|Withdrawal by Subject|1|||
128709254|NCT03978520|463230154|FG002|Overall Study|Adverse Event|3|||
128709255|NCT03978520|463230155|FG003|Overall Study|Adverse Event|5|||
128709256|NCT03978520|463230156|FG004|Overall Study|Adverse Event|6|||
128709257|NCT03978520|463230152|FG000|Overall Study|Withdrawal by Subject|10|||
128709258|NCT03978520|463230153|FG001|Overall Study|Withdrawal by Subject|4|||
128709259|NCT03978520|463230154|FG002|Overall Study|Withdrawal by Subject|5|||
128709260|NCT03978520|463230155|FG003|Overall Study|Withdrawal by Subject|6|||
128709261|NCT03978520|463230156|FG004|Overall Study|Withdrawal by Subject|5|||
128709262|NCT03978520|463230152|FG000|Overall Study|Lost to Follow-up|2|||
128709263|NCT03978520|463230153|FG001|Overall Study|Lost to Follow-up|2|||
128709264|NCT03978520|463230154|FG002|Overall Study|Lost to Follow-up|2|||
128709265|NCT03978520|463230155|FG003|Overall Study|Lost to Follow-up|0|||
128709266|NCT03978520|463230156|FG004|Overall Study|Lost to Follow-up|1|||
128709267|NCT03978520|463230152|FG000|Overall Study|COVID-19 infection|0|||
128709268|NCT03978520|463230153|FG001|Overall Study|COVID-19 infection|1|||
128709269|NCT03978520|463230154|FG002|Overall Study|COVID-19 infection|0|||
128709270|NCT03978520|463230155|FG003|Overall Study|COVID-19 infection|0|||
128709271|NCT03978520|463230156|FG004|Overall Study|COVID-19 infection|0|||
128709272|NCT03978520|463230152|FG000|Overall Study|Other, not specified|9|||
128709273|NCT03978520|463230153|FG001|Overall Study|Other, not specified|4|||
128709274|NCT03978520|463230154|FG002|Overall Study|Other, not specified|1|||
129124849|NCT06057064|464753550|FG001|Overall Study|Withdrawal by Subject|1|||
129124850|NCT01541748|464753551|FG000|Overall Study|Lost to Follow-up|17|||
129124851|NCT01541748|464753551|FG000|Overall Study|Moved out of state|1|||
129124852|NCT01541748|464753551|FG000|Overall Study|Withdrawal by Subject|7|||
129124853|NCT01541748|464753551|FG000|Overall Study|Screen failure|5|||
129124854|NCT01541748|464753551|FG000|Overall Study|Did not receive study device|1|||
129124855|NCT02832037|464753552|FG000|Overall Study|Administrative reasons|0|||
129124856|NCT02832037|464753553|FG001|Overall Study|Administrative reasons|0|||
129124857|NCT02832037|464753554|FG002|Overall Study|Administrative reasons|1|||
129124858|NCT02832037|464753555|FG003|Overall Study|Administrative reasons|0|||
129124859|NCT02832037|464753556|FG004|Overall Study|Administrative reasons|0|||
129124860|NCT02832037|464753552|FG000|Overall Study|Protocol Violation|3|||
129124861|NCT02832037|464753553|FG001|Overall Study|Protocol Violation|0|||
129124862|NCT02832037|464753554|FG002|Overall Study|Protocol Violation|4|||
129124863|NCT02832037|464753555|FG003|Overall Study|Protocol Violation|1|||
129124864|NCT02832037|464753556|FG004|Overall Study|Protocol Violation|2|||
129124865|NCT02832037|464753552|FG000|Overall Study|Lost to Follow-up|2|||
129124866|NCT02832037|464753553|FG001|Overall Study|Lost to Follow-up|0|||
129124867|NCT02832037|464753554|FG002|Overall Study|Lost to Follow-up|3|||
129124868|NCT02832037|464753555|FG003|Overall Study|Lost to Follow-up|0|||
129124869|NCT02832037|464753556|FG004|Overall Study|Lost to Follow-up|5|||
129124870|NCT02832037|464753552|FG000|Overall Study|Withdrawal by Subject|9|||
129218520|NCT00998296|465099794|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
128709275|NCT03978520|463230155|FG003|Overall Study|Other, not specified|1|||
128709276|NCT03978520|463230156|FG004|Overall Study|Other, not specified|2|||
128709277|NCT03978520|463230152|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
128709278|NCT03978520|463230153|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
128709279|NCT03978520|463230154|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
128709280|NCT03978520|463230155|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
128949073|NCT00448916|464099131|FG003|Overall Study|Adverse Event|2|||
128949074|NCT00448916|464099128|FG000|Overall Study|Lack of Efficacy|1|||
128949075|NCT00448916|464099129|FG001|Overall Study|Lack of Efficacy|0|||
129124871|NCT02832037|464753553|FG001|Overall Study|Withdrawal by Subject|8|||
129124872|NCT02832037|464753554|FG002|Overall Study|Withdrawal by Subject|0|||
129124873|NCT02832037|464753555|FG003|Overall Study|Withdrawal by Subject|4|||
128709281|NCT03978520|463230156|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
128709282|NCT00598832|463230159|FG000|Overall Study|Lack of Efficacy|3|||
128709283|NCT00598832|463230160|FG001|Overall Study|Lack of Efficacy|7|||
128709284|NCT00598832|463230159|FG000|Overall Study|Adverse Event|6|||
128709285|NCT00598832|463230160|FG001|Overall Study|Adverse Event|2|||
128709286|NCT00598832|463230159|FG000|Overall Study|Withdrawal by Subject|25|||
128709287|NCT00598832|463230160|FG001|Overall Study|Withdrawal by Subject|36|||
128709288|NCT00598832|463230159|FG000|Overall Study|Protocol Violation|0|||
128709289|NCT00598832|463230160|FG001|Overall Study|Protocol Violation|2|||
128709290|NCT00598832|463230159|FG000|Overall Study|Lost to Follow-up|24|||
128709291|NCT00598832|463230160|FG001|Overall Study|Lost to Follow-up|29|||
128709292|NCT00598832|463230159|FG000|Overall Study|Pregnancy|2|||
128709293|NCT00598832|463230160|FG001|Overall Study|Pregnancy|2|||
128709294|NCT00598832|463230159|FG000|Overall Study|Physician Decision|1|||
128709295|NCT00598832|463230160|FG001|Overall Study|Physician Decision|4|||
128709296|NCT00598832|463230159|FG000|Overall Study|Non compliance|1|||
128709297|NCT00598832|463230160|FG001|Overall Study|Non compliance|0|||
128709298|NCT01648205|463230165|FG000|Placebo|Pregnancy|1|||
128709299|NCT01648205|463230165|FG000|Placebo|Withdrawal by Subject|1|||
128709300|NCT01648205|463230165|FG000|Placebo|Protocol Violation|2|||
128709301|NCT01648205|463230165|FG000|Ranolazine|Death|1|||
128709302|NCT01648205|463230165|FG000|Ranolazine|Withdrawal by Subject|1|||
128709303|NCT01648205|463230165|FG000|Ranolazine|Protocol Violation|3|||
128709304|NCT02142959|463230168|FG000|Overall Study|Adverse Event|1|||
128709305|NCT02142959|463230169|FG001|Overall Study|Adverse Event|0|||
128709306|NCT02142959|463230170|FG002|Overall Study|Adverse Event|0|||
128709307|NCT02142959|463230168|FG000|Overall Study|Death|0|||
128709308|NCT02142959|463230169|FG001|Overall Study|Death|1|||
128709309|NCT02142959|463230170|FG002|Overall Study|Death|0|||
128709310|NCT02142959|463230168|FG000|Overall Study|Withdrawal by Subject|3|||
128709311|NCT02142959|463230169|FG001|Overall Study|Withdrawal by Subject|1|||
128709312|NCT02142959|463230170|FG002|Overall Study|Withdrawal by Subject|3|||
128709313|NCT02142959|463230168|FG000|Overall Study|Administrative Reasons|1|||
128709314|NCT02142959|463230169|FG001|Overall Study|Administrative Reasons|0|||
128709315|NCT02142959|463230170|FG002|Overall Study|Administrative Reasons|1|||
128949076|NCT00448916|464099130|FG002|Overall Study|Lack of Efficacy|2|||
128949077|NCT00448916|464099131|FG003|Overall Study|Lack of Efficacy|1|||
128949078|NCT00448916|464099128|FG000|Overall Study|Withdrawal by Subject|3|||
128949079|NCT00448916|464099129|FG001|Overall Study|Withdrawal by Subject|3|||
128949080|NCT00448916|464099130|FG002|Overall Study|Withdrawal by Subject|1|||
128949081|NCT00448916|464099131|FG003|Overall Study|Withdrawal by Subject|1|||
128949082|NCT00448916|464099128|FG000|Overall Study|Other|1|||
128949083|NCT00448916|464099129|FG001|Overall Study|Other|0|||
128949084|NCT00448916|464099130|FG002|Overall Study|Other|0|||
128949085|NCT00448916|464099131|FG003|Overall Study|Other|0|||
128709316|NCT02142959|463230168|FG000|Overall Study|Missing|0|||
128709317|NCT02142959|463230169|FG001|Overall Study|Missing|1|||
128709318|NCT02142959|463230170|FG002|Overall Study|Missing|0|||
128709319|NCT02142959|463230168|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
128709320|NCT02142959|463230169|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
128709321|NCT02142959|463230170|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
128949086|NCT00448916|464099128|FG000|Overall Study|Lost to Follow-up|0|||
128949087|NCT00448916|464099129|FG001|Overall Study|Lost to Follow-up|1|||
128949088|NCT00448916|464099130|FG002|Overall Study|Lost to Follow-up|0|||
128949089|NCT00448916|464099131|FG003|Overall Study|Lost to Follow-up|1|||
128949090|NCT00448916|464099128|FG000|Overall Study|Protocol Violation|0|||
128949091|NCT00448916|464099129|FG001|Overall Study|Protocol Violation|0|||
128949092|NCT00448916|464099130|FG002|Overall Study|Protocol Violation|0|||
128949093|NCT00448916|464099131|FG003|Overall Study|Protocol Violation|1|||
128949094|NCT03521193|464099132|FG000|Overall Study|Withdrawal by Subject|8|||
128949095|NCT03521193|464099133|FG001|Overall Study|Withdrawal by Subject|0|||
128949096|NCT03521193|464099132|FG000|Overall Study|non compliant to ASA treatment|8|||
128949097|NCT03521193|464099133|FG001|Overall Study|non compliant to ASA treatment|0|||
128949098|NCT00012012|464099134|FG000|Overall Study|Protocol Violation|1|||
128949099|NCT00012012|464099135|FG001|Overall Study|Protocol Violation|1|||
128949100|NCT00012012|464099134|FG000|Overall Study|Withdrawal by Subject|0|||
128949101|NCT00012012|464099135|FG001|Overall Study|Withdrawal by Subject|2|||
128949102|NCT03707158|464099136|FG000|Midtreatment|Lost to Follow-up|16|||
128949103|NCT03707158|464099137|FG001|Midtreatment|Lost to Follow-up|7|||
128949104|NCT03707158|464099136|FG000|Midtreatment|Withdrawal by Subject|28|||
128949105|NCT03707158|464099137|FG001|Midtreatment|Withdrawal by Subject|19|||
128949106|NCT03707158|464099136|FG000|Posttreatment|Lost to Follow-up|0|||
128949107|NCT03707158|464099137|FG001|Posttreatment|Lost to Follow-up|5|||
128949108|NCT03707158|464099136|FG000|Follow-up|Lost to Follow-up|19|||
128949109|NCT03707158|464099137|FG001|Follow-up|Lost to Follow-up|18|||
128949110|NCT03707158|464099136|FG000|Follow-up|Withdrawal by Subject|13|||
128949111|NCT03707158|464099137|FG001|Follow-up|Withdrawal by Subject|6|||
128949112|NCT03260205|464099143|FG000|Overall Study|Adverse Event|2|||
128949113|NCT03260205|464099144|FG001|Overall Study|Adverse Event|0|||
129034485|NCT03653026|464416495|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129034486|NCT03653026|464416496|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129034487|NCT03653026|464416493|FG000|Part 1: Placebo-controlled Period|Other|0|||
129034488|NCT03653026|464416494|FG001|Part 1: Placebo-controlled Period|Other|3|||
129034489|NCT03653026|464416495|FG002|Part 1: Placebo-controlled Period|Other|0|||
129034490|NCT03653026|464416496|FG003|Part 1: Placebo-controlled Period|Other|0|||
129034491|NCT03653026|464416493|FG000|Part 2: Open-label Extension|Adverse Event|0|||
129034492|NCT03653026|464416494|FG001|Part 2: Open-label Extension|Adverse Event|0|||
129034493|NCT03653026|464416495|FG002|Part 2: Open-label Extension|Adverse Event|1|||
129034494|NCT03653026|464416496|FG003|Part 2: Open-label Extension|Adverse Event|1|||
129034495|NCT03653026|464416493|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129034496|NCT03653026|464416494|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129034497|NCT03653026|464416495|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
129034498|NCT03653026|464416496|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
129034499|NCT03653026|464416493|FG000|Part 2: Open-label Extension|Other|0|||
129034500|NCT03653026|464416494|FG001|Part 2: Open-label Extension|Other|0|||
129034501|NCT03653026|464416495|FG002|Part 2: Open-label Extension|Other|1|||
129034502|NCT03653026|464416496|FG003|Part 2: Open-label Extension|Other|2|||
129034503|NCT02457819|464416497|FG000|Overall Study|reason not given|8|||
129034504|NCT02457819|464416497|FG000|Overall Study|Withdrawal by Subject|24|||
129034505|NCT02457819|464416497|FG000|Overall Study|Protocol Violation|1|||
129034506|NCT02457819|464416497|FG000|Overall Study|non compliance with study drug|4|||
129034507|NCT02457819|464416497|FG000|Overall Study|Lost to Follow-up|10|||
129034508|NCT02457819|464416497|FG000|Overall Study|Lack of Efficacy|19|||
129034509|NCT02457819|464416497|FG000|Overall Study|Adverse Event|33|||
129034510|NCT02005276|464416500|FG000|Overall Study|No longer interested|5|||
129034511|NCT02005276|464416501|FG001|Overall Study|No longer interested|2|||
129034512|NCT02005276|464416502|FG002|Overall Study|No longer interested|3|||
129034513|NCT02005276|464416503|FG003|Overall Study|No longer interested|3|||
129034514|NCT04994431|464416504|FG000|Overall Study|Adverse Event|1|||
129034515|NCT04994431|464416505|FG001|Overall Study|Adverse Event|0|||
129034516|NCT02914457|464416508|FG000|Overall Study|Withdrawal by Subject|1|||
129034517|NCT02914457|464416508|FG000|Overall Study|Physician Decision|1|||
129034518|NCT02914457|464416508|FG000|Overall Study|No veins available for lead placement|1|||
129034519|NCT02914457|464416508|FG000|Overall Study|Electrical instability of patient|1|||
129034520|NCT02914457|464416508|FG000|Overall Study|ECG acquisition error due to sweating|1|||
129034521|NCT02914457|464416508|FG000|Overall Study|Protocol Violation|1|||
129034522|NCT01849458|464416511|FG000|Overall Study|Lost to Follow-up|4|||
129034523|NCT01863433|464416512|FG000|Overall Study|Protocol Violation|1|||
129034524|NCT03310619|464416515|FG000|Pre-Treatment Period|Death|1|||
129034525|NCT03310619|464416516|FG001|Pre-Treatment Period|Death|0|||
129034526|NCT03310619|464416517|FG002|Pre-Treatment Period|Death|0|||
129034527|NCT03310619|464416518|FG003|Pre-Treatment Period|Death|0|||
129034528|NCT03310619|464416519|FG004|Pre-Treatment Period|Death|1|||
129034529|NCT03310619|464416520|FG005|Pre-Treatment Period|Death|0|||
129034530|NCT03310619|464416521|FG006|Pre-Treatment Period|Death|0|||
129034531|NCT03310619|464416522|FG007|Pre-Treatment Period|Death|0|||
129034532|NCT03310619|464416515|FG000|Pre-Treatment Period|Other reasons|2|||
129034533|NCT03310619|464416516|FG001|Pre-Treatment Period|Other reasons|1|||
129034534|NCT03310619|464416517|FG002|Pre-Treatment Period|Other reasons|2|||
129034535|NCT03310619|464416518|FG003|Pre-Treatment Period|Other reasons|0|||
129034536|NCT03310619|464416519|FG004|Pre-Treatment Period|Other reasons|0|||
129034537|NCT03310619|464416520|FG005|Pre-Treatment Period|Other reasons|0|||
129034538|NCT03310619|464416521|FG006|Pre-Treatment Period|Other reasons|2|||
129034539|NCT03310619|464416522|FG007|Pre-Treatment Period|Other reasons|0|||
129034540|NCT03310619|464416515|FG000|Treatment Period|Death|1|||
129034541|NCT03310619|464416516|FG001|Treatment Period|Death|2|||
129034542|NCT03310619|464416517|FG002|Treatment Period|Death|0|||
129034543|NCT03310619|464416518|FG003|Treatment Period|Death|0|||
129034544|NCT03310619|464416519|FG004|Treatment Period|Death|1|||
129034545|NCT03310619|464416520|FG005|Treatment Period|Death|0|||
129034546|NCT03310619|464416521|FG006|Treatment Period|Death|2|||
129034547|NCT03310619|464416522|FG007|Treatment Period|Death|0|||
129034548|NCT03310619|464416515|FG000|Treatment Period|Adverse Event|0|||
129034549|NCT03310619|464416516|FG001|Treatment Period|Adverse Event|1|||
129034550|NCT03310619|464416517|FG002|Treatment Period|Adverse Event|4|||
129034551|NCT03310619|464416518|FG003|Treatment Period|Adverse Event|1|||
129034552|NCT03310619|464416519|FG004|Treatment Period|Adverse Event|0|||
129034553|NCT03310619|464416520|FG005|Treatment Period|Adverse Event|0|||
128770366|NCT00147225|463450231|FG001|Overall Study|Adverse Event|0|||
129034554|NCT03310619|464416521|FG006|Treatment Period|Adverse Event|0|||
129034555|NCT03310619|464416522|FG007|Treatment Period|Adverse Event|0|||
129034556|NCT03310619|464416515|FG000|Treatment Period|Withdrawal by participant|0|||
129034557|NCT03310619|464416516|FG001|Treatment Period|Withdrawal by participant|0|||
129034558|NCT03310619|464416517|FG002|Treatment Period|Withdrawal by participant|1|||
129034559|NCT03310619|464416518|FG003|Treatment Period|Withdrawal by participant|0|||
129124874|NCT02832037|464753556|FG004|Overall Study|Withdrawal by Subject|8|||
129124875|NCT02832037|464753552|FG000|Overall Study|Adverse Event|5|||
128709322|NCT02142959|463230168|FG000|Overall Study|Patient didn't complete end of study visit|0|||
128709323|NCT02142959|463230169|FG001|Overall Study|Patient didn't complete end of study visit|0|||
129124876|NCT02832037|464753553|FG001|Overall Study|Adverse Event|4|||
129124877|NCT02832037|464753554|FG002|Overall Study|Adverse Event|0|||
129124878|NCT02832037|464753555|FG003|Overall Study|Adverse Event|2|||
129124879|NCT02832037|464753556|FG004|Overall Study|Adverse Event|4|||
129124880|NCT02107898|464753559|FG000|Overall Study|Adverse Event|4|||
129124881|NCT02107898|464753560|FG001|Overall Study|Adverse Event|7|||
128709324|NCT02142959|463230170|FG002|Overall Study|Patient didn't complete end of study visit|1|||
128709325|NCT03547687|463230171|FG000|Overall Study|Withdrawal by Subject|1|||
128709326|NCT03547687|463230171|FG000|Overall Study|Death|1|||
128709327|NCT03667924|463230172|FG000|Baseline Completed|Lost to Follow-up|0|||
128709328|NCT03667924|463230173|FG001|Baseline Completed|Lost to Follow-up|2|||
128709329|NCT03667924|463230174|FG002|Baseline Completed|Lost to Follow-up|0|||
128709330|NCT03667924|463230172|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
128709331|NCT03667924|463230173|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
128709332|NCT03667924|463230174|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
128709333|NCT03667924|463230172|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
128709334|NCT03667924|463230173|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
128709335|NCT03667924|463230174|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
128709336|NCT03667924|463230172|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
128709337|NCT03667924|463230173|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
128709338|NCT03667924|463230174|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
128709339|NCT03667924|463230172|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
128709340|NCT03667924|463230173|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
128709341|NCT03667924|463230174|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
128709342|NCT03667924|463230172|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
128709343|NCT03667924|463230173|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
128709344|NCT03667924|463230174|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
128709345|NCT03667924|463230172|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
128709346|NCT03667924|463230173|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
128709347|NCT03667924|463230174|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
128709348|NCT04557371|463230184|FG000|Overall Study|Covid-19-related|0|||
128709349|NCT04557371|463230185|FG001|Overall Study|Covid-19-related|1|||
128709350|NCT04557371|463230186|FG002|Overall Study|Covid-19-related|0|||
128709351|NCT04557371|463230184|FG000|Overall Study|Withdrawal by Subject|0|||
128709352|NCT04557371|463230185|FG001|Overall Study|Withdrawal by Subject|1|||
128709353|NCT04557371|463230186|FG002|Overall Study|Withdrawal by Subject|0|||
128709354|NCT04557371|463230184|FG000|Overall Study|Adverse Event|1|||
128709355|NCT04557371|463230185|FG001|Overall Study|Adverse Event|0|||
128709356|NCT04557371|463230186|FG002|Overall Study|Adverse Event|0|||
128709357|NCT00750204|463230189|FG000|Overall Study|study halted prematurely|1|||
128709358|NCT00750204|463230190|FG001|Overall Study|study halted prematurely|1|||
128709359|NCT01774968|463230191|FG000|Overall Study|Adverse Event|4|||
128709360|NCT01774968|463230192|FG001|Overall Study|Adverse Event|4|||
128709361|NCT01774968|463230191|FG000|Overall Study|Death|0|||
128709362|NCT01774968|463230192|FG001|Overall Study|Death|1|||
128709363|NCT01774968|463230191|FG000|Overall Study|Lost to Follow-up|1|||
128949114|NCT03260205|464099145|FG002|Overall Study|Adverse Event|2|||
128949115|NCT03260205|464099146|FG003|Overall Study|Adverse Event|2|||
128949116|NCT03260205|464099147|FG004|Overall Study|Adverse Event|4|||
128949117|NCT03260205|464099143|FG000|Overall Study|Lost to Follow-up|2|||
128949118|NCT03260205|464099144|FG001|Overall Study|Lost to Follow-up|2|||
128949119|NCT03260205|464099145|FG002|Overall Study|Lost to Follow-up|1|||
128949120|NCT03260205|464099146|FG003|Overall Study|Lost to Follow-up|1|||
128949121|NCT03260205|464099147|FG004|Overall Study|Lost to Follow-up|5|||
129124882|NCT02107898|464753559|FG000|Overall Study|Poor compliance to protocol|0|||
128709364|NCT01774968|463230192|FG001|Overall Study|Lost to Follow-up|3|||
128709365|NCT01774968|463230191|FG000|Overall Study|Physician Decision|5|||
128709366|NCT01774968|463230192|FG001|Overall Study|Physician Decision|1|||
128709367|NCT01774968|463230191|FG000|Overall Study|Protocol Violation|14|||
128709368|NCT01774968|463230192|FG001|Overall Study|Protocol Violation|13|||
128770367|NCT00147225|463450232|FG002|Overall Study|Adverse Event|1|||
128770368|NCT00147225|463450233|FG003|Overall Study|Adverse Event|1|||
128949122|NCT03260205|464099143|FG000|Overall Study|Protocol Violation|0|||
128949123|NCT03260205|464099144|FG001|Overall Study|Protocol Violation|0|||
128949124|NCT03260205|464099145|FG002|Overall Study|Protocol Violation|2|||
129124883|NCT02107898|464753560|FG001|Overall Study|Poor compliance to protocol|1|||
129124884|NCT02107898|464753559|FG000|Overall Study|Participant moved|0|||
129124885|NCT02107898|464753560|FG001|Overall Study|Participant moved|2|||
129124886|NCT02107898|464753559|FG000|Overall Study|Consent withdrawn by participant|2|||
128709369|NCT01774968|463230191|FG000|Overall Study|Sponsor Decision|0|||
128709370|NCT01774968|463230192|FG001|Overall Study|Sponsor Decision|2|||
128709371|NCT01774968|463230191|FG000|Overall Study|Withdrawal by Subject|6|||
129124887|NCT02107898|464753560|FG001|Overall Study|Consent withdrawn by participant|1|||
129124888|NCT02107898|464753559|FG000|Overall Study|Randomized but not treated|0|||
129124889|NCT02107898|464753560|FG001|Overall Study|Randomized but not treated|1|||
129124890|NCT03329989|464753561|FG000|Overall Study|Withdrawal by Subject|9|||
128949125|NCT03260205|464099146|FG003|Overall Study|Protocol Violation|0|||
129124891|NCT03329989|464753561|FG000|Overall Study|Lost to Follow-up|8|||
129124892|NCT03329989|464753561|FG000|Overall Study|Adverse Event|5|||
128709372|NCT01774968|463230192|FG001|Overall Study|Withdrawal by Subject|11|||
128709373|NCT00531232|463231987|FG000|Overall Study|Investigator decision|0|||
128709374|NCT00531232|463231988|FG001|Overall Study|Investigator decision|0|||
128709375|NCT00531232|463231989|FG002|Overall Study|Investigator decision|4|||
128709376|NCT00531232|463231987|FG000|Overall Study|Participants refused further treatment|0|||
128709377|NCT00531232|463231988|FG001|Overall Study|Participants refused further treatment|1|||
128709378|NCT00531232|463231989|FG002|Overall Study|Participants refused further treatment|2|||
128709379|NCT00531232|463231987|FG000|Overall Study|Adverse events (AEs)|1|||
128709380|NCT00531232|463231988|FG001|Overall Study|Adverse events (AEs)|2|||
128709381|NCT00531232|463231989|FG002|Overall Study|Adverse events (AEs)|2|||
128709382|NCT00531232|463231987|FG000|Overall Study|Treatment failure|1|||
128709383|NCT00531232|463231988|FG001|Overall Study|Treatment failure|3|||
128709384|NCT00531232|463231989|FG002|Overall Study|Treatment failure|7|||
128709385|NCT00531232|463231987|FG000|Overall Study|Disease recurrence|0|||
128709386|NCT00531232|463231988|FG001|Overall Study|Disease recurrence|0|||
128709387|NCT00531232|463231989|FG002|Overall Study|Disease recurrence|1|||
128709388|NCT00531232|463231987|FG000|Overall Study|Deceased|2|||
128709389|NCT00531232|463231988|FG001|Overall Study|Deceased|2|||
128709390|NCT00531232|463231989|FG002|Overall Study|Deceased|2|||
128709391|NCT00531232|463231987|FG000|Overall Study|Withdrawal by Subject|0|||
128709392|NCT00531232|463231988|FG001|Overall Study|Withdrawal by Subject|1|||
128709393|NCT00531232|463231989|FG002|Overall Study|Withdrawal by Subject|2|||
128709394|NCT00531232|463231987|FG000|Overall Study|Other|0|||
128709395|NCT00531232|463231988|FG001|Overall Study|Other|0|||
128709396|NCT00531232|463231989|FG002|Overall Study|Other|5|||
128709397|NCT02345850|463231995|FG000|Overall Study|Not transplanted|10|||
128709398|NCT02345850|463231996|FG001|Overall Study|Not transplanted|5|||
128709399|NCT02345850|463231997|FG002|Overall Study|Not transplanted|4|||
128709400|NCT02345850|463231995|FG000|Overall Study|Lost to Follow-up|2|||
128709401|NCT02345850|463231996|FG001|Overall Study|Lost to Follow-up|3|||
128709402|NCT02345850|463231997|FG002|Overall Study|Lost to Follow-up|2|||
128709403|NCT02345850|463231995|FG000|Overall Study|Withdrawal by Subject|1|||
128709404|NCT02345850|463231996|FG001|Overall Study|Withdrawal by Subject|0|||
128709405|NCT02345850|463231997|FG002|Overall Study|Withdrawal by Subject|0|||
128709406|NCT01991067|463232005|FG000|Overall Study|Lost to Follow-up|6|||
128709407|NCT01991067|463232006|FG001|Overall Study|Lost to Follow-up|5|||
128709408|NCT02670083|463232011|FG000|Overall Study|Adverse Event|16|||
128709409|NCT02670083|463232012|FG001|Overall Study|Adverse Event|13|||
128709410|NCT02670083|463232011|FG000|Overall Study|Death|4|||
128709411|NCT02670083|463232012|FG001|Overall Study|Death|6|||
128709412|NCT02670083|463232011|FG000|Overall Study|Lost to Follow-up|2|||
128709413|NCT02670083|463232012|FG001|Overall Study|Lost to Follow-up|2|||
128709414|NCT02670083|463232011|FG000|Overall Study|Multiple Reasons|9|||
128709415|NCT02670083|463232012|FG001|Overall Study|Multiple Reasons|9|||
128709416|NCT02670083|463232011|FG000|Overall Study|Physician Decision|0|||
128709417|NCT02670083|463232012|FG001|Overall Study|Physician Decision|2|||
128709418|NCT02670083|463232011|FG000|Overall Study|Study Terminated By Sponsor|257|||
128709419|NCT02670083|463232012|FG001|Overall Study|Study Terminated By Sponsor|254|||
128709420|NCT02670083|463232011|FG000|Overall Study|Symptomatic Deterioration|0|||
128709421|NCT02670083|463232012|FG001|Overall Study|Symptomatic Deterioration|2|||
128709422|NCT02670083|463232011|FG000|Overall Study|Withdrawal by Subject|32|||
128709423|NCT02670083|463232012|FG001|Overall Study|Withdrawal by Subject|31|||
128709424|NCT02670083|463232011|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128709425|NCT02670083|463232012|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128709426|NCT00464087|463232014|FG000|Overall Study|No PCI per inclusion criteria|0|||
128709427|NCT00464087|463232015|FG001|Overall Study|No PCI per inclusion criteria|0|||
128709428|NCT00464087|463232016|FG002|Overall Study|No PCI per inclusion criteria|29|||
128709429|NCT00609492|463232017|FG000|Overall Study|Withdrawal by Subject|0|||
128709430|NCT00609492|463232018|FG001|Overall Study|Withdrawal by Subject|2|||
128709431|NCT00609492|463232019|FG002|Overall Study|Withdrawal by Subject|3|||
128709432|NCT00609492|463232017|FG000|Overall Study|Lost to Follow-up|1|||
128709433|NCT00609492|463232018|FG001|Overall Study|Lost to Follow-up|1|||
128709434|NCT00609492|463232019|FG002|Overall Study|Lost to Follow-up|4|||
128709435|NCT02057406|463232020|FG000|Overall Study|Physician Decision|0|||
128709436|NCT02057406|463232021|FG001|Overall Study|Physician Decision|0|||
128709437|NCT02057406|463232022|FG002|Overall Study|Physician Decision|2|||
128709438|NCT02057406|463232020|FG000|Overall Study|Withdrawal by Subject|0|||
128709439|NCT02057406|463232021|FG001|Overall Study|Withdrawal by Subject|2|||
128709440|NCT02057406|463232022|FG002|Overall Study|Withdrawal by Subject|0|||
128709441|NCT02057406|463232020|FG000|Overall Study|Lost to Follow-up|0|||
128709442|NCT02057406|463232021|FG001|Overall Study|Lost to Follow-up|0|||
128709443|NCT02057406|463232022|FG002|Overall Study|Lost to Follow-up|1|||
128709444|NCT02057406|463232020|FG000|Overall Study|Death|1|||
128709445|NCT02057406|463232021|FG001|Overall Study|Death|0|||
128709446|NCT02057406|463232022|FG002|Overall Study|Death|0|||
128709447|NCT02057406|463232020|FG000|Overall Study|Protocol Violation|0|||
128709448|NCT02057406|463232021|FG001|Overall Study|Protocol Violation|1|||
128709449|NCT02057406|463232022|FG002|Overall Study|Protocol Violation|0|||
128709450|NCT02057406|463232020|FG000|Overall Study|Patient transportation issues|0|||
128709451|NCT02057406|463232021|FG001|Overall Study|Patient transportation issues|0|||
128709452|NCT02057406|463232022|FG002|Overall Study|Patient transportation issues|1|||
128709453|NCT02425046|463232023|FG000|Overall Study|Lost to Follow-up|52|||
128709454|NCT02425046|463232024|FG001|Overall Study|Lost to Follow-up|50|||
128709455|NCT02425046|463232025|FG002|Overall Study|Lost to Follow-up|56|||
128709456|NCT02425046|463232023|FG000|Overall Study|Withdrawal by Subject|16|||
128709457|NCT02425046|463232024|FG001|Overall Study|Withdrawal by Subject|12|||
128709458|NCT02425046|463232025|FG002|Overall Study|Withdrawal by Subject|0|||
128709459|NCT03654651|463232026|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
128709460|NCT03654651|463232027|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
128709461|NCT00856284|463232034|FG000|Overall Study|Hyperglycemic rescue|231|||
128709462|NCT00856284|463232035|FG001|Overall Study|Hyperglycemic rescue|201|||
128709463|NCT00856284|463232036|FG002|Overall Study|Hyperglycemic rescue|235|||
128709464|NCT00856284|463232034|FG000|Overall Study|Adverse Event|60|||
128709465|NCT00856284|463232035|FG001|Overall Study|Adverse Event|74|||
128709466|NCT00856284|463232036|FG002|Overall Study|Adverse Event|82|||
128709467|NCT00856284|463232034|FG000|Overall Study|Major protocol deviation|24|||
128709468|NCT00856284|463232035|FG001|Overall Study|Major protocol deviation|16|||
128709469|NCT00856284|463232036|FG002|Overall Study|Major protocol deviation|15|||
128709470|NCT00856284|463232034|FG000|Overall Study|Lost to Follow-up|20|||
128709471|NCT00856284|463232035|FG001|Overall Study|Lost to Follow-up|22|||
128709472|NCT00856284|463232036|FG002|Overall Study|Lost to Follow-up|28|||
128709473|NCT00856284|463232034|FG000|Overall Study|Voluntary withdrawal|48|||
128709474|NCT00856284|463232035|FG001|Overall Study|Voluntary withdrawal|52|||
128709475|NCT00856284|463232036|FG002|Overall Study|Voluntary withdrawal|62|||
128709476|NCT00856284|463232034|FG000|Overall Study|Pregnancy|1|||
128709477|NCT00856284|463232035|FG001|Overall Study|Pregnancy|2|||
128709478|NCT00856284|463232036|FG002|Overall Study|Pregnancy|0|||
128709479|NCT00856284|463232034|FG000|Overall Study|Investigator discretion|9|||
128709480|NCT00856284|463232035|FG001|Overall Study|Investigator discretion|8|||
128709481|NCT00856284|463232036|FG002|Overall Study|Investigator discretion|10|||
128709482|NCT00856284|463232034|FG000|Overall Study|Other|15|||
128709483|NCT00856284|463232035|FG001|Overall Study|Other|17|||
128949126|NCT03260205|464099147|FG004|Overall Study|Protocol Violation|1|||
128949127|NCT03260205|464099143|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
128949128|NCT03260205|464099144|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
128949129|NCT03260205|464099145|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
128949130|NCT03260205|464099146|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
128709484|NCT00856284|463232036|FG002|Overall Study|Other|14|||
128709485|NCT00856284|463232034|FG000|Overall Study|Randomized in error|0|||
128709486|NCT00856284|463232035|FG001|Overall Study|Randomized in error|0|||
128709487|NCT00856284|463232036|FG002|Overall Study|Randomized in error|1|||
128709488|NCT02904512|463232038|FG000|Overall Study|Withdrawal by Subject|1|||
128709489|NCT02904512|463232039|FG001|Overall Study|Withdrawal by Subject|0|||
128709490|NCT02904512|463232038|FG000|Overall Study|Transferred to ICU|1|||
128709491|NCT02904512|463232039|FG001|Overall Study|Transferred to ICU|0|||
128709492|NCT02904512|463232038|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
128709493|NCT02904512|463232039|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
128709494|NCT00267046|463232044|FG000|Overall Study|Disease progression|4|||
128709495|NCT00267046|463232045|FG001|Overall Study|Disease progression|2|||
128709496|NCT00267046|463232044|FG000|Overall Study|Chemotoxicity|2|||
128709497|NCT00267046|463232045|FG001|Overall Study|Chemotoxicity|0|||
128709498|NCT00267046|463232044|FG000|Overall Study|Open-label palifermin|2|||
128709499|NCT00267046|463232045|FG001|Overall Study|Open-label palifermin|7|||
128709500|NCT00267046|463232044|FG000|Overall Study|Surgery|3|||
128709501|NCT00267046|463232045|FG001|Overall Study|Surgery|1|||
128709502|NCT00267046|463232044|FG000|Overall Study|Withdrawal by Subject|1|||
128709503|NCT00267046|463232045|FG001|Overall Study|Withdrawal by Subject|0|||
128709504|NCT00267046|463232044|FG000|Overall Study|Radiation|0|||
128709505|NCT00267046|463232045|FG001|Overall Study|Radiation|1|||
128709506|NCT00460408|463232046|FG000|Overall Study|Adverse Event|1|||
128709507|NCT00460408|463232047|FG001|Overall Study|Adverse Event|0|||
128709508|NCT00460408|463232048|FG002|Overall Study|Adverse Event|0|||
128949131|NCT03260205|464099147|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
128709509|NCT00460408|463232049|FG003|Overall Study|Adverse Event|0|||
128709510|NCT00460408|463232046|FG000|Overall Study|Death|7|||
128709511|NCT00460408|463232047|FG001|Overall Study|Death|0|||
128709512|NCT00460408|463232048|FG002|Overall Study|Death|0|||
128709513|NCT00460408|463232049|FG003|Overall Study|Death|0|||
128709514|NCT00460408|463232046|FG000|Overall Study|Lost to Follow-up|11|||
128709515|NCT00460408|463232047|FG001|Overall Study|Lost to Follow-up|0|||
128709516|NCT00460408|463232048|FG002|Overall Study|Lost to Follow-up|1|||
128709517|NCT00460408|463232049|FG003|Overall Study|Lost to Follow-up|0|||
128709518|NCT00460408|463232046|FG000|Overall Study|Withdrawal by Subject|31|||
128709519|NCT00460408|463232047|FG001|Overall Study|Withdrawal by Subject|0|||
128949132|NCT03260205|464099143|FG000|Overall Study|Other: Unspecified|0|||
128949133|NCT03260205|464099144|FG001|Overall Study|Other: Unspecified|0|||
128949134|NCT03260205|464099145|FG002|Overall Study|Other: Unspecified|3|||
128949135|NCT03260205|464099146|FG003|Overall Study|Other: Unspecified|1|||
128949136|NCT03260205|464099147|FG004|Overall Study|Other: Unspecified|1|||
128949137|NCT03260205|464099143|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
128949138|NCT03260205|464099144|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
128949139|NCT03260205|464099145|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
128949140|NCT03260205|464099146|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
128949141|NCT03260205|464099147|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
128949142|NCT05301322|464099148|FG000|Overall Study|Adverse Event|7|||
128949143|NCT05301322|464099149|FG001|Overall Study|Adverse Event|3|||
128949144|NCT05301322|464099148|FG000|Overall Study|Death|0|||
128949145|NCT05301322|464099149|FG001|Overall Study|Death|1|||
128949146|NCT05301322|464099148|FG000|Overall Study|Lost to Follow-up|2|||
128949147|NCT05301322|464099149|FG001|Overall Study|Lost to Follow-up|1|||
128949148|NCT05301322|464099148|FG000|Overall Study|Protocol Violation|3|||
128949149|NCT05301322|464099149|FG001|Overall Study|Protocol Violation|1|||
129034560|NCT03310619|464416519|FG004|Treatment Period|Withdrawal by participant|0|||
129034561|NCT03310619|464416520|FG005|Treatment Period|Withdrawal by participant|0|||
129034562|NCT03310619|464416521|FG006|Treatment Period|Withdrawal by participant|0|||
129034563|NCT03310619|464416522|FG007|Treatment Period|Withdrawal by participant|0|||
129034564|NCT03310619|464416515|FG000|Treatment Period|Lost to Follow-up|0|||
129034565|NCT03310619|464416516|FG001|Treatment Period|Lost to Follow-up|0|||
129034566|NCT03310619|464416517|FG002|Treatment Period|Lost to Follow-up|0|||
129034567|NCT03310619|464416518|FG003|Treatment Period|Lost to Follow-up|0|||
129034568|NCT03310619|464416519|FG004|Treatment Period|Lost to Follow-up|0|||
129034569|NCT03310619|464416520|FG005|Treatment Period|Lost to Follow-up|0|||
129034570|NCT03310619|464416521|FG006|Treatment Period|Lost to Follow-up|0|||
129034571|NCT03310619|464416522|FG007|Treatment Period|Lost to Follow-up|1|||
129034572|NCT03310619|464416515|FG000|Treatment Period|Study terminated by sponsor|0|||
129034573|NCT03310619|464416516|FG001|Treatment Period|Study terminated by sponsor|0|||
129034574|NCT03310619|464416517|FG002|Treatment Period|Study terminated by sponsor|0|||
129034575|NCT03310619|464416518|FG003|Treatment Period|Study terminated by sponsor|0|||
129034576|NCT03310619|464416519|FG004|Treatment Period|Study terminated by sponsor|0|||
129034577|NCT03310619|464416520|FG005|Treatment Period|Study terminated by sponsor|0|||
129034578|NCT03310619|464416521|FG006|Treatment Period|Study terminated by sponsor|0|||
129034579|NCT03310619|464416522|FG007|Treatment Period|Study terminated by sponsor|1|||
129034580|NCT03310619|464416515|FG000|Treatment Period|Physician Decision|0|||
129034581|NCT03310619|464416516|FG001|Treatment Period|Physician Decision|0|||
129034582|NCT03310619|464416517|FG002|Treatment Period|Physician Decision|0|||
129034583|NCT03310619|464416518|FG003|Treatment Period|Physician Decision|0|||
129034584|NCT03310619|464416519|FG004|Treatment Period|Physician Decision|3|||
129034585|NCT03310619|464416520|FG005|Treatment Period|Physician Decision|0|||
129034586|NCT03310619|464416521|FG006|Treatment Period|Physician Decision|0|||
129034587|NCT03310619|464416522|FG007|Treatment Period|Physician Decision|0|||
129034588|NCT03310619|464416515|FG000|Treatment Period|Other reasons|1|||
129034589|NCT03310619|464416516|FG001|Treatment Period|Other reasons|0|||
129034590|NCT03310619|464416517|FG002|Treatment Period|Other reasons|2|||
129034591|NCT03310619|464416518|FG003|Treatment Period|Other reasons|0|||
129034592|NCT03310619|464416519|FG004|Treatment Period|Other reasons|0|||
129034593|NCT03310619|464416520|FG005|Treatment Period|Other reasons|0|||
129034594|NCT03310619|464416521|FG006|Treatment Period|Other reasons|0|||
129034595|NCT03310619|464416522|FG007|Treatment Period|Other reasons|0|||
129034596|NCT02427399|464416523|FG000|Overall Study|Protocol Violation|14|||
129034597|NCT02427399|464416524|FG001|Overall Study|Protocol Violation|16|||
128949150|NCT05301322|464099148|FG000|Overall Study|Withdrawal by Subject|3|||
128949151|NCT05301322|464099149|FG001|Overall Study|Withdrawal by Subject|0|||
128949152|NCT05301322|464099148|FG000|Overall Study|Other|4|||
128709520|NCT00460408|463232048|FG002|Overall Study|Withdrawal by Subject|0|||
128949153|NCT05301322|464099149|FG001|Overall Study|Other|0|||
128949154|NCT00808249|464099152|FG000|Overall Study|Adverse Event|4|||
128949155|NCT00808249|464099153|FG001|Overall Study|Adverse Event|7|||
128949156|NCT00808249|464099154|FG002|Overall Study|Adverse Event|10|||
128709521|NCT00460408|463232049|FG003|Overall Study|Withdrawal by Subject|0|||
128770369|NCT00147225|463450234|FG004|Overall Study|Adverse Event|0|||
128709522|NCT00460408|463232046|FG000|Overall Study|Insufficient clinical response|5|||
128709523|NCT00460408|463232047|FG001|Overall Study|Insufficient clinical response|1|||
128709524|NCT00460408|463232048|FG002|Overall Study|Insufficient clinical response|5|||
128709525|NCT00460408|463232049|FG003|Overall Study|Insufficient clinical response|0|||
128709526|NCT00460408|463232046|FG000|Overall Study|Other|12|||
128709527|NCT00460408|463232047|FG001|Overall Study|Other|2|||
128709528|NCT00460408|463232048|FG002|Overall Study|Other|0|||
128709529|NCT00460408|463232049|FG003|Overall Study|Other|0|||
128949157|NCT00808249|464099155|FG003|Overall Study|Adverse Event|6|||
128949158|NCT00808249|464099152|FG000|Overall Study|Lost to Follow-up|2|||
128949159|NCT00808249|464099153|FG001|Overall Study|Lost to Follow-up|3|||
128949160|NCT00808249|464099154|FG002|Overall Study|Lost to Follow-up|3|||
128949161|NCT00808249|464099155|FG003|Overall Study|Lost to Follow-up|5|||
128949162|NCT00808249|464099152|FG000|Overall Study|Withdrawal by Subject|4|||
128949163|NCT00808249|464099153|FG001|Overall Study|Withdrawal by Subject|0|||
128949164|NCT00808249|464099154|FG002|Overall Study|Withdrawal by Subject|2|||
128949165|NCT00808249|464099155|FG003|Overall Study|Withdrawal by Subject|4|||
129218521|NCT00998296|465099795|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
129218522|NCT00998296|465099796|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
129218523|NCT00998296|465099797|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
129218524|NCT00998296|465099798|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
129218525|NCT00998296|465099799|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
129218526|NCT00998296|465099800|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
129218527|NCT00998296|465099801|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
129218528|NCT00998296|465099802|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
129218529|NCT00998296|465099803|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
129218530|NCT00998296|465099804|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
129218531|NCT00998296|465099794|FG000|Overall Study|Other adverse event|0|||
129218532|NCT00998296|465099795|FG001|Overall Study|Other adverse event|0|||
129218533|NCT00998296|465099796|FG002|Overall Study|Other adverse event|0|||
129218534|NCT00998296|465099797|FG003|Overall Study|Other adverse event|0|||
129218535|NCT00998296|465099798|FG004|Overall Study|Other adverse event|1|||
129218536|NCT00998296|465099799|FG005|Overall Study|Other adverse event|0|||
129218537|NCT00998296|465099800|FG006|Overall Study|Other adverse event|0|||
129218538|NCT00998296|465099801|FG007|Overall Study|Other adverse event|0|||
129218539|NCT00998296|465099802|FG008|Overall Study|Other adverse event|0|||
129218540|NCT00998296|465099803|FG009|Overall Study|Other adverse event|1|||
129218541|NCT00998296|465099804|FG010|Overall Study|Other adverse event|2|||
129218542|NCT00998296|465099794|FG000|Overall Study|Refused to continue taking trial med.|0|||
129218543|NCT00998296|465099795|FG001|Overall Study|Refused to continue taking trial med.|0|||
129218544|NCT00998296|465099796|FG002|Overall Study|Refused to continue taking trial med.|0|||
129218545|NCT00998296|465099797|FG003|Overall Study|Refused to continue taking trial med.|0|||
129218546|NCT00998296|465099798|FG004|Overall Study|Refused to continue taking trial med.|0|||
129218547|NCT00998296|465099799|FG005|Overall Study|Refused to continue taking trial med.|0|||
129218548|NCT00998296|465099800|FG006|Overall Study|Refused to continue taking trial med.|0|||
129218549|NCT00998296|465099801|FG007|Overall Study|Refused to continue taking trial med.|0|||
129218550|NCT00998296|465099802|FG008|Overall Study|Refused to continue taking trial med.|0|||
129218551|NCT00998296|465099803|FG009|Overall Study|Refused to continue taking trial med.|2|||
129218552|NCT00998296|465099804|FG010|Overall Study|Refused to continue taking trial med.|0|||
129218553|NCT00998296|465099794|FG000|Overall Study|Reason other than those specified above|0|||
129218554|NCT00998296|465099795|FG001|Overall Study|Reason other than those specified above|0|||
129218555|NCT00998296|465099796|FG002|Overall Study|Reason other than those specified above|0|||
129218556|NCT00998296|465099797|FG003|Overall Study|Reason other than those specified above|0|||
129218557|NCT00998296|465099798|FG004|Overall Study|Reason other than those specified above|0|||
128949166|NCT00808249|464099152|FG000|Overall Study|Protocol Violation|3|||
128949167|NCT00808249|464099153|FG001|Overall Study|Protocol Violation|3|||
128949168|NCT00808249|464099154|FG002|Overall Study|Protocol Violation|3|||
128949169|NCT00808249|464099155|FG003|Overall Study|Protocol Violation|0|||
128949170|NCT00808249|464099152|FG000|Overall Study|Lack of Efficacy|1|||
129034598|NCT02427399|464416525|FG002|Overall Study|Protocol Violation|12|||
128770370|NCT00147225|463450235|FG005|Overall Study|Adverse Event|0|||
128770371|NCT00147225|463450230|FG000|Overall Study|Screen Failure|0|||
128770372|NCT00147225|463450231|FG001|Overall Study|Screen Failure|0|||
128770373|NCT00147225|463450232|FG002|Overall Study|Screen Failure|0|||
128949171|NCT00808249|464099153|FG001|Overall Study|Lack of Efficacy|1|||
129034599|NCT02427399|464416526|FG003|Overall Study|Protocol Violation|18|||
129218558|NCT00998296|465099799|FG005|Overall Study|Reason other than those specified above|0|||
129218559|NCT00998296|465099800|FG006|Overall Study|Reason other than those specified above|0|||
128709530|NCT00865124|463232050|FG000|Overall Study|Physician Decision|2|||
128949172|NCT00808249|464099154|FG002|Overall Study|Lack of Efficacy|0|||
128949173|NCT00808249|464099155|FG003|Overall Study|Lack of Efficacy|0|||
128709531|NCT00865124|463232051|FG001|Overall Study|Physician Decision|1|||
128709532|NCT00865124|463232052|FG002|Overall Study|Physician Decision|0|||
128709533|NCT00865124|463232050|FG000|Overall Study|Withdrawn consent|2|||
129218560|NCT00998296|465099801|FG007|Overall Study|Reason other than those specified above|0|||
129218561|NCT00998296|465099802|FG008|Overall Study|Reason other than those specified above|0|||
128709534|NCT00865124|463232051|FG001|Overall Study|Withdrawn consent|0|||
128770374|NCT00147225|463450233|FG003|Overall Study|Screen Failure|0|||
128770375|NCT00147225|463450234|FG004|Overall Study|Screen Failure|1|||
128770376|NCT00147225|463450235|FG005|Overall Study|Screen Failure|0|||
128770377|NCT00147225|463450230|FG000|Overall Study|Chemotherapy Changed|0|||
128949174|NCT00808249|464099152|FG000|Overall Study|study specific discontinuation criteria|1|||
128949175|NCT00808249|464099153|FG001|Overall Study|study specific discontinuation criteria|0|||
128949176|NCT00808249|464099154|FG002|Overall Study|study specific discontinuation criteria|1|||
128949177|NCT00808249|464099155|FG003|Overall Study|study specific discontinuation criteria|0|||
128709535|NCT00865124|463232052|FG002|Overall Study|Withdrawn consent|0|||
128709536|NCT03247530|463232056|FG000|Overall Study|Withdrawal by caregiver|19|||
128709537|NCT03247530|463232057|FG001|Overall Study|Withdrawal by caregiver|8|||
128709538|NCT03247530|463232058|FG002|Overall Study|Withdrawal by caregiver|10|||
128709539|NCT03247530|463232056|FG000|Overall Study|Lost to Follow-up|3|||
128709540|NCT03247530|463232057|FG001|Overall Study|Lost to Follow-up|9|||
128709541|NCT03247530|463232058|FG002|Overall Study|Lost to Follow-up|6|||
128709542|NCT03247530|463232056|FG000|Overall Study|Adverse Event|2|||
128709543|NCT03247530|463232057|FG001|Overall Study|Adverse Event|5|||
128709544|NCT03247530|463232058|FG002|Overall Study|Adverse Event|2|||
128709545|NCT03247530|463232056|FG000|Overall Study|Failure to follow procedure|1|||
128709546|NCT03247530|463232057|FG001|Overall Study|Failure to follow procedure|1|||
128709547|NCT03247530|463232058|FG002|Overall Study|Failure to follow procedure|1|||
128949178|NCT00808249|464099152|FG000|Overall Study|All other reasons|2|||
128949179|NCT00808249|464099153|FG001|Overall Study|All other reasons|1|||
128949180|NCT00808249|464099154|FG002|Overall Study|All other reasons|3|||
128949181|NCT00808249|464099155|FG003|Overall Study|All other reasons|1|||
128949182|NCT03829332|464099156|FG000|Overall Study|Death|225|||
128949183|NCT03829332|464099157|FG001|Overall Study|Death|230|||
128949184|NCT03829332|464099156|FG000|Overall Study|Lost to Follow-up|1|||
128949185|NCT03829332|464099157|FG001|Overall Study|Lost to Follow-up|3|||
128949186|NCT03829332|464099156|FG000|Overall Study|Physician Decision|1|||
128949187|NCT03829332|464099157|FG001|Overall Study|Physician Decision|0|||
128949188|NCT03829332|464099156|FG000|Overall Study|Sponsor Decision|71|||
128949189|NCT03829332|464099157|FG001|Overall Study|Sponsor Decision|72|||
128949190|NCT03829332|464099156|FG000|Overall Study|Withdrawal by Subject|11|||
128949191|NCT03829332|464099157|FG001|Overall Study|Withdrawal by Subject|9|||
128949192|NCT00430521|464099158|FG000|Overall Study|Adverse Event|0|||
128949193|NCT00430521|464099159|FG001|Overall Study|Adverse Event|0|||
128949194|NCT00430521|464099160|FG002|Overall Study|Adverse Event|0|||
128949195|NCT00430521|464099161|FG003|Overall Study|Adverse Event|0|||
128949196|NCT00430521|464099162|FG004|Overall Study|Adverse Event|0|||
128949197|NCT00430521|464099163|FG005|Overall Study|Adverse Event|2|||
128949198|NCT00430521|464099164|FG006|Overall Study|Adverse Event|1|||
128949199|NCT00430521|464099165|FG007|Overall Study|Adverse Event|0|||
128949200|NCT00430521|464099158|FG000|Overall Study|Lost to Follow-up|7|||
128949201|NCT00430521|464099159|FG001|Overall Study|Lost to Follow-up|8|||
128949202|NCT00430521|464099160|FG002|Overall Study|Lost to Follow-up|3|||
128949203|NCT00430521|464099161|FG003|Overall Study|Lost to Follow-up|5|||
128949204|NCT00430521|464099162|FG004|Overall Study|Lost to Follow-up|5|||
128949205|NCT00430521|464099163|FG005|Overall Study|Lost to Follow-up|2|||
128949206|NCT00430521|464099164|FG006|Overall Study|Lost to Follow-up|8|||
128949207|NCT00430521|464099165|FG007|Overall Study|Lost to Follow-up|10|||
128949208|NCT00430521|464099158|FG000|Overall Study|Pregnancy|0|||
128949209|NCT00430521|464099159|FG001|Overall Study|Pregnancy|0|||
128949210|NCT00430521|464099160|FG002|Overall Study|Pregnancy|0|||
128949211|NCT00430521|464099161|FG003|Overall Study|Pregnancy|0|||
128949212|NCT00430521|464099162|FG004|Overall Study|Pregnancy|0|||
128949213|NCT00430521|464099163|FG005|Overall Study|Pregnancy|0|||
128949214|NCT00430521|464099164|FG006|Overall Study|Pregnancy|1|||
128949215|NCT00430521|464099165|FG007|Overall Study|Pregnancy|0|||
128949216|NCT00430521|464099158|FG000|Overall Study|Vaccine Expired|0|||
128949217|NCT00430521|464099159|FG001|Overall Study|Vaccine Expired|0|||
128949218|NCT00430521|464099160|FG002|Overall Study|Vaccine Expired|0|||
128949219|NCT00430521|464099161|FG003|Overall Study|Vaccine Expired|0|||
128949220|NCT00430521|464099162|FG004|Overall Study|Vaccine Expired|0|||
128949221|NCT00430521|464099163|FG005|Overall Study|Vaccine Expired|1|||
128949222|NCT00430521|464099164|FG006|Overall Study|Vaccine Expired|0|||
128949223|NCT00430521|464099165|FG007|Overall Study|Vaccine Expired|0|||
128949224|NCT00430521|464099158|FG000|Overall Study|Protocol Violation|1|||
128949225|NCT00430521|464099159|FG001|Overall Study|Protocol Violation|0|||
128949226|NCT00430521|464099160|FG002|Overall Study|Protocol Violation|0|||
128949227|NCT00430521|464099161|FG003|Overall Study|Protocol Violation|0|||
128709548|NCT03247530|463232056|FG000|Overall Study|Withdrawal by Subject|1|||
128709549|NCT03247530|463232057|FG001|Overall Study|Withdrawal by Subject|1|||
128949228|NCT00430521|464099162|FG004|Overall Study|Protocol Violation|0|||
128949229|NCT00430521|464099163|FG005|Overall Study|Protocol Violation|0|||
128949230|NCT00430521|464099164|FG006|Overall Study|Protocol Violation|0|||
128949231|NCT00430521|464099165|FG007|Overall Study|Protocol Violation|0|||
128709550|NCT03247530|463232058|FG002|Overall Study|Withdrawal by Subject|0|||
128709551|NCT03247530|463232056|FG000|Overall Study|Study medication misuse|0|||
128709552|NCT03247530|463232057|FG001|Overall Study|Study medication misuse|1|||
128709553|NCT03247530|463232058|FG002|Overall Study|Study medication misuse|0|||
128709554|NCT03247530|463232056|FG000|Overall Study|Other, multiple categories|1|||
128709555|NCT03247530|463232057|FG001|Overall Study|Other, multiple categories|3|||
128709556|NCT03247530|463232058|FG002|Overall Study|Other, multiple categories|1|||
128709557|NCT01442493|463232062|FG000|Overall Study|withdrawn from study|3|||
128709558|NCT01442493|463232063|FG001|Overall Study|withdrawn from study|2|||
128709559|NCT01986985|463232066|FG000|Overall Study|Withdrawal by Subject|4|||
128709560|NCT01986985|463232066|FG000|Overall Study|Scan not completed due to malfunction|3|||
128709561|NCT03042533|463232067|FG000|Overall Study|MD left program|1|||
128709562|NCT03042533|463232068|FG001|Overall Study|MD left program|4|||
128709563|NCT03042533|463232069|FG002|Overall Study|MD left program|1|||
128709564|NCT02288559|463232071|FG000|Overall Study|Adverse Event|1|||
128709565|NCT02288559|463232072|FG001|Overall Study|Adverse Event|1|||
128709566|NCT02288559|463232073|FG002|Overall Study|Adverse Event|5|||
128709567|NCT02288559|463232074|FG003|Overall Study|Adverse Event|0|||
128709568|NCT02288559|463232071|FG000|Overall Study|Death|0|||
128709569|NCT02288559|463232072|FG001|Overall Study|Death|0|||
128709570|NCT02288559|463232073|FG002|Overall Study|Death|1|||
128709571|NCT02288559|463232074|FG003|Overall Study|Death|0|||
128709572|NCT02288559|463232071|FG000|Overall Study|Lost to Follow-up|0|||
128709573|NCT02288559|463232072|FG001|Overall Study|Lost to Follow-up|0|||
128709574|NCT02288559|463232073|FG002|Overall Study|Lost to Follow-up|0|||
128709575|NCT02288559|463232074|FG003|Overall Study|Lost to Follow-up|1|||
128709576|NCT02288559|463232071|FG000|Overall Study|Withdrawal by Subject|0|||
128709577|NCT02288559|463232072|FG001|Overall Study|Withdrawal by Subject|0|||
128709578|NCT02288559|463232073|FG002|Overall Study|Withdrawal by Subject|2|||
128709579|NCT02288559|463232074|FG003|Overall Study|Withdrawal by Subject|1|||
128709580|NCT02288559|463232071|FG000|Overall Study|Reason Not Specified|0|||
128709581|NCT02288559|463232072|FG001|Overall Study|Reason Not Specified|0|||
128709582|NCT02288559|463232073|FG002|Overall Study|Reason Not Specified|3|||
128709583|NCT02288559|463232074|FG003|Overall Study|Reason Not Specified|0|||
128709584|NCT03303079|463232075|FG000|Overall Study|Adverse Event|0|||
128709585|NCT03303079|463232076|FG001|Overall Study|Adverse Event|1|||
129124893|NCT03329989|464753561|FG000|Overall Study|Protocol Violation|1|||
129124894|NCT01283386|464753562|FG000|Overall Study|Death|2|||
128709586|NCT03303079|463232077|FG002|Overall Study|Adverse Event|3|||
128709587|NCT03303079|463232075|FG000|Overall Study|Protocol Violation|5|||
128709588|NCT03303079|463232076|FG001|Overall Study|Protocol Violation|4|||
128709589|NCT03303079|463232077|FG002|Overall Study|Protocol Violation|7|||
128709590|NCT03303079|463232075|FG000|Overall Study|Withdrawal by Subject|2|||
128709591|NCT03303079|463232076|FG001|Overall Study|Withdrawal by Subject|4|||
128709592|NCT03303079|463232077|FG002|Overall Study|Withdrawal by Subject|2|||
128709593|NCT03303079|463232075|FG000|Overall Study|Other than specified|0|||
128709594|NCT03303079|463232076|FG001|Overall Study|Other than specified|2|||
128709595|NCT03303079|463232077|FG002|Overall Study|Other than specified|0|||
128709596|NCT02005445|463232078|FG000|Overall Study|Dual study enrollment|0|||
128709597|NCT02005445|463232079|FG001|Overall Study|Dual study enrollment|1|||
128709598|NCT01111149|463232080|FG000|Overall Study|Protocol Violation|1|||
128709599|NCT01111149|463232081|FG001|Overall Study|Protocol Violation|1|||
128709600|NCT01111149|463232082|FG002|Overall Study|Protocol Violation|2|||
128709601|NCT01111149|463232080|FG000|Overall Study|Withdrawal by Subject|1|||
128709602|NCT01111149|463232081|FG001|Overall Study|Withdrawal by Subject|0|||
128709603|NCT01111149|463232082|FG002|Overall Study|Withdrawal by Subject|2|||
129124895|NCT01283386|464753563|FG001|Overall Study|Death|0|||
129124896|NCT01283386|464753562|FG000|Overall Study|Withdrawal by Subject|2|||
129124897|NCT01283386|464753563|FG001|Overall Study|Withdrawal by Subject|1|||
129124898|NCT01283386|464753562|FG000|Overall Study|Relapse of underlying disease|1|||
129124899|NCT01283386|464753563|FG001|Overall Study|Relapse of underlying disease|3|||
129124900|NCT01283386|464753562|FG000|Overall Study|Progression of underlying disease|2|||
129124901|NCT01283386|464753563|FG001|Overall Study|Progression of underlying disease|7|||
129218562|NCT00998296|465099803|FG009|Overall Study|Reason other than those specified above|1|||
128709604|NCT00759954|463232083|FG000|Overall Study|Personal reason|1|||
128709605|NCT00759954|463232084|FG001|Overall Study|Personal reason|0|||
128709606|NCT00759954|463232083|FG000|Overall Study|Adverse Event|1|||
128709607|NCT00759954|463232084|FG001|Overall Study|Adverse Event|2|||
128709608|NCT02320149|463232086|FG000|Overall Study|Adverse Event|3|||
128709609|NCT02320149|463232087|FG001|Overall Study|Adverse Event|7|||
128709610|NCT02320149|463232086|FG000|Overall Study|Withdrawal of Consent|28|||
128709611|NCT02320149|463232087|FG001|Overall Study|Withdrawal of Consent|32|||
128709612|NCT02320149|463232086|FG000|Overall Study|Lost to Follow-up|21|||
128709613|NCT02320149|463232087|FG001|Overall Study|Lost to Follow-up|34|||
128709614|NCT02320149|463232086|FG000|Overall Study|Protocol Violation|2|||
128709615|NCT02320149|463232087|FG001|Overall Study|Protocol Violation|1|||
128709616|NCT02320149|463232086|FG000|Overall Study|Noncompliance with Study Treatment|7|||
129218563|NCT00998296|465099804|FG010|Overall Study|Reason other than those specified above|0|||
129218564|NCT04396639|465099807|FG000|Overall Study|Withdrawal by Subject|1|||
129218565|NCT04396639|465099807|FG000|Overall Study|Other|1|||
129218566|NCT01544335|465099808|FG000|Overall Study|Lost to Follow-up|27|||
129218567|NCT01544335|465099808|FG000|Overall Study|Death|4|||
129218568|NCT01544335|465099808|FG000|Overall Study|Disease progression|3|||
129218569|NCT01544335|465099808|FG000|Overall Study|Baseline Measurements not Available|19|||
129218570|NCT03219528|465099809|FG000|Overall Study|Lost to Follow-up|5|||
129218571|NCT03219528|465099810|FG001|Overall Study|Lost to Follow-up|4|||
129218572|NCT03219528|465099809|FG000|Overall Study|Withdrawal by Subject|4|||
129218573|NCT03219528|465099810|FG001|Overall Study|Withdrawal by Subject|4|||
129218574|NCT01532986|465099813|FG000|Overall Study|Death|9|||
129218575|NCT01532986|465099814|FG001|Overall Study|Death|9|||
129218576|NCT01532986|465099813|FG000|Overall Study|Withdrawal by Subject|7|||
129218577|NCT01532986|465099814|FG001|Overall Study|Withdrawal by Subject|10|||
129218578|NCT01532986|465099813|FG000|Overall Study|Physician Decision|7|||
129218579|NCT01532986|465099814|FG001|Overall Study|Physician Decision|5|||
129218580|NCT02120898|465099815|FG000|Overall Study|Withdrawal by Subject|4|||
129218581|NCT02120898|465099816|FG001|Overall Study|Withdrawal by Subject|2|||
129218582|NCT02120898|465099817|FG002|Overall Study|Withdrawal by Subject|2|||
129218583|NCT02120898|465099815|FG000|Overall Study|Non-compliance with study drug|3|||
129218584|NCT02120898|465099816|FG001|Overall Study|Non-compliance with study drug|0|||
129218585|NCT02120898|465099817|FG002|Overall Study|Non-compliance with study drug|0|||
129218586|NCT02120898|465099815|FG000|Overall Study|Adverse Event|1|||
129218587|NCT02120898|465099816|FG001|Overall Study|Adverse Event|2|||
129218588|NCT02120898|465099817|FG002|Overall Study|Adverse Event|1|||
129218589|NCT02120898|465099815|FG000|Overall Study|Protocol Violation|1|||
129218590|NCT02120898|465099816|FG001|Overall Study|Protocol Violation|2|||
129218591|NCT02120898|465099817|FG002|Overall Study|Protocol Violation|0|||
129218592|NCT02120898|465099815|FG000|Overall Study|Lost to Follow-up|0|||
129218593|NCT02120898|465099816|FG001|Overall Study|Lost to Follow-up|0|||
129218594|NCT02120898|465099817|FG002|Overall Study|Lost to Follow-up|1|||
129218595|NCT00043979|465099818|FG000|Period 1|recipient with progressive disease|7|||
129218596|NCT00043979|465099819|FG001|Period 1|recipient with progressive disease|4|||
129218597|NCT00043979|465099820|FG002|Period 1|recipient with progressive disease|3|||
129218598|NCT04085289|465099821|FG000|Overall Study|Withdrawal by Subject|0|||
129218599|NCT04085289|465099822|FG001|Overall Study|Withdrawal by Subject|0|||
129218600|NCT04085289|465099823|FG002|Overall Study|Withdrawal by Subject|1|||
129218601|NCT02919995|465099827|FG000|Overall Study|Adverse Event|0|||
129218602|NCT02919995|465099828|FG001|Overall Study|Adverse Event|0|||
129218603|NCT02919995|465099829|FG002|Overall Study|Adverse Event|0|||
129034600|NCT02427399|464416527|FG004|Overall Study|Protocol Violation|15|||
129218604|NCT02919995|465099830|FG003|Overall Study|Adverse Event|0|||
129218605|NCT02919995|465099831|FG004|Overall Study|Adverse Event|0|||
129218606|NCT02919995|465099832|FG005|Overall Study|Adverse Event|1|||
129218607|NCT02560558|465099833|FG000|Overall Study|Adverse Event|1|||
129218608|NCT02560558|465099834|FG001|Overall Study|Adverse Event|0|||
129218609|NCT02560558|465099833|FG000|Overall Study|Death|0|||
129218610|NCT02560558|465099834|FG001|Overall Study|Death|2|||
129218611|NCT02560558|465099833|FG000|Overall Study|Lost to Follow-up|0|||
129218612|NCT02560558|465099834|FG001|Overall Study|Lost to Follow-up|4|||
129218613|NCT02560558|465099833|FG000|Overall Study|Protocol Violation|3|||
129218614|NCT02560558|465099834|FG001|Overall Study|Protocol Violation|0|||
129218615|NCT02560558|465099833|FG000|Overall Study|Withdrawal by Subject|3|||
129034601|NCT01115933|464416528|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
129034602|NCT00756717|464416529|FG000|Overall Study|Withdrawal by Subject|2|||
129034603|NCT00603512|464416530|FG000|Overall Study|Adverse Event|0|||
129034604|NCT00603512|464416531|FG001|Overall Study|Adverse Event|2|||
129034605|NCT00603512|464416532|FG002|Overall Study|Adverse Event|4|||
129034606|NCT00603512|464416533|FG003|Overall Study|Adverse Event|4|||
129034607|NCT00603512|464416534|FG004|Overall Study|Adverse Event|2|||
129034608|NCT00603512|464416530|FG000|Overall Study|Lack of Efficacy|0|||
129034609|NCT00603512|464416531|FG001|Overall Study|Lack of Efficacy|1|||
129034610|NCT00603512|464416532|FG002|Overall Study|Lack of Efficacy|0|||
129034611|NCT00603512|464416533|FG003|Overall Study|Lack of Efficacy|0|||
129034612|NCT00603512|464416534|FG004|Overall Study|Lack of Efficacy|1|||
129034613|NCT00603512|464416530|FG000|Overall Study|Other|2|||
129218616|NCT02560558|465099834|FG001|Overall Study|Withdrawal by Subject|0|||
129218617|NCT02454517|465099841|FG000|Overall Study|Withdrawal by Subject|3|||
129218618|NCT02454517|465099842|FG001|Overall Study|Withdrawal by Subject|0|||
129218619|NCT02454517|465099841|FG000|Overall Study|Lost to Follow-up|4|||
129218620|NCT02454517|465099842|FG001|Overall Study|Lost to Follow-up|7|||
129218621|NCT02454517|465099841|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
129218622|NCT02454517|465099842|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
129218623|NCT00275509|465099843|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
129034614|NCT00603512|464416531|FG001|Overall Study|Other|1|||
129034615|NCT00603512|464416532|FG002|Overall Study|Other|0|||
129034616|NCT00603512|464416533|FG003|Overall Study|Other|1|||
128709617|NCT02320149|463232087|FG001|Overall Study|Noncompliance with Study Treatment|2|||
128709618|NCT02320149|463232086|FG000|Overall Study|Lack of Efficacy|0|||
128709619|NCT02320149|463232087|FG001|Overall Study|Lack of Efficacy|1|||
128709620|NCT02320149|463232086|FG000|Overall Study|Other Miscellaneous Reasons|2|||
128709621|NCT02320149|463232087|FG001|Overall Study|Other Miscellaneous Reasons|3|||
128709622|NCT01156311|463232091|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
128709623|NCT01156311|463232092|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
128709624|NCT01156311|463232093|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
128709625|NCT01156311|463232094|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
128709626|NCT01156311|463232091|FG000|2-Month Monotherapy Period|Physician Decision|0|||
128949232|NCT00430521|464099158|FG000|Overall Study|Withdrawal by Subject|3|||
128949233|NCT00430521|464099159|FG001|Overall Study|Withdrawal by Subject|1|||
128949234|NCT00430521|464099160|FG002|Overall Study|Withdrawal by Subject|0|||
128949235|NCT00430521|464099161|FG003|Overall Study|Withdrawal by Subject|3|||
128949236|NCT00430521|464099162|FG004|Overall Study|Withdrawal by Subject|0|||
128949237|NCT00430521|464099163|FG005|Overall Study|Withdrawal by Subject|0|||
128949238|NCT00430521|464099164|FG006|Overall Study|Withdrawal by Subject|0|||
128709627|NCT01156311|463232092|FG001|2-Month Monotherapy Period|Physician Decision|1|||
128709628|NCT01156311|463232093|FG002|2-Month Monotherapy Period|Physician Decision|0|||
128709629|NCT01156311|463232094|FG003|2-Month Monotherapy Period|Physician Decision|0|||
128709630|NCT01156311|463232091|FG000|2-Month Monotherapy Period|Other|1|||
128709631|NCT01156311|463232092|FG001|2-Month Monotherapy Period|Other|0|||
128709632|NCT01156311|463232093|FG002|2-Month Monotherapy Period|Other|0|||
128709633|NCT01156311|463232094|FG003|2-Month Monotherapy Period|Other|0|||
128709634|NCT01156311|463232091|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
128709635|NCT01156311|463232092|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
128709636|NCT01156311|463232093|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
128949239|NCT00430521|464099165|FG007|Overall Study|Withdrawal by Subject|2|||
128949240|NCT05108805|464099166|FG000|Overall Study|T-cell expansion was not successful.|5|||
129034617|NCT00603512|464416534|FG004|Overall Study|Other|1|||
128709637|NCT01156311|463232094|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
128709638|NCT01156311|463232091|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
128709639|NCT01156311|463232092|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
128709640|NCT01156311|463232093|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
128709641|NCT01156311|463232094|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
128709642|NCT01156311|463232091|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
128709643|NCT01156311|463232092|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
128709644|NCT01156311|463232093|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
128709645|NCT01156311|463232094|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
128709646|NCT01156311|463232091|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
128709647|NCT01156311|463232092|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
128709648|NCT01156311|463232093|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
128709649|NCT01156311|463232094|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
128709650|NCT01156311|463232091|FG000|6-month Add-on Therapy Period|Other|0|||
128709651|NCT01156311|463232092|FG001|6-month Add-on Therapy Period|Other|0|||
128709652|NCT01156311|463232093|FG002|6-month Add-on Therapy Period|Other|1|||
128709653|NCT01156311|463232094|FG003|6-month Add-on Therapy Period|Other|2|||
128709654|NCT01741701|463232095|FG000|Overall Study|Adverse Event|5|||
128709655|NCT01741701|463232096|FG001|Overall Study|Adverse Event|1|||
128709656|NCT01741701|463232095|FG000|Overall Study|Withdrawal by Subject|0|||
128709657|NCT01741701|463232096|FG001|Overall Study|Withdrawal by Subject|1|||
128709658|NCT03033394|463232111|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
128949241|NCT00280150|464100993|FG000|Overall Study|Adverse Event|0|||
128949242|NCT00280150|464100994|FG001|Overall Study|Adverse Event|1|||
128709659|NCT03033394|463232111|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
128709660|NCT03033394|463232111|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
128949243|NCT00280150|464100995|FG002|Overall Study|Adverse Event|2|||
128949244|NCT00280150|464100996|FG003|Overall Study|Adverse Event|3|||
128949245|NCT00280150|464100993|FG000|Overall Study|Lack of Efficacy|0|||
128949246|NCT00280150|464100994|FG001|Overall Study|Lack of Efficacy|0|||
128949247|NCT00280150|464100995|FG002|Overall Study|Lack of Efficacy|0|||
128949248|NCT00280150|464100996|FG003|Overall Study|Lack of Efficacy|3|||
128949249|NCT00280150|464100993|FG000|Overall Study|Physician Decision|0|||
128949250|NCT00280150|464100994|FG001|Overall Study|Physician Decision|0|||
128949251|NCT00280150|464100995|FG002|Overall Study|Physician Decision|0|||
128949252|NCT00280150|464100996|FG003|Overall Study|Physician Decision|1|||
128949253|NCT00280150|464100993|FG000|Overall Study|Protocol Violation|0|||
128949254|NCT00280150|464100994|FG001|Overall Study|Protocol Violation|0|||
128949255|NCT00280150|464100995|FG002|Overall Study|Protocol Violation|0|||
128949256|NCT00280150|464100996|FG003|Overall Study|Protocol Violation|1|||
128949257|NCT00280150|464100993|FG000|Overall Study|Withdrawal by Subject|0|||
128949258|NCT00280150|464100994|FG001|Overall Study|Withdrawal by Subject|0|||
128949259|NCT00280150|464100995|FG002|Overall Study|Withdrawal by Subject|0|||
128949260|NCT00280150|464100996|FG003|Overall Study|Withdrawal by Subject|1|||
129218624|NCT00275509|465099844|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
129218625|NCT00594815|465099845|FG000|Overall Study|Never Treated|3|||
129218626|NCT00594815|465099845|FG000|Overall Study|Withdrawal by Subject|2|||
129218627|NCT00594815|465099845|FG000|Overall Study|Toxicity|4|||
129218628|NCT00131248|465099846|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
129218629|NCT00131248|465099847|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
129218630|NCT03023397|465099848|FG000|Run-In|Failed screening allergen challenge|1|||
129218631|NCT03023397|465099849|FG001|Run-In|Failed screening allergen challenge|0|||
129218632|NCT03023397|465099850|FG002|Run-In|Failed screening allergen challenge|0|||
129218633|NCT03023397|465099848|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
129218634|NCT03023397|465099849|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
129218635|NCT03023397|465099850|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
129218636|NCT01146795|465099854|FG000|Overall Study|Withdrawal by Subject|4|||
129218637|NCT01146795|465099854|FG000|Overall Study|Adverse Event|6|||
129218638|NCT01146795|465099854|FG000|Overall Study|Still in treatment at study closure|10|||
129218639|NCT01106248|465099856|FG000|Overall Study|Adverse Event|1|||
129218640|NCT01106248|465099856|FG000|Overall Study|Administrative|2|||
129218641|NCT00357903|465099857|FG000|Overall Study|Adverse Event|87|||
129218642|NCT00357903|465099858|FG001|Overall Study|Adverse Event|4|||
128709661|NCT03033394|463232111|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
128709662|NCT03033394|463232111|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
128709663|NCT02036294|463232112|FG000|Overall Study|Death|7|||
128949261|NCT00280150|464100993|FG000|Overall Study|Did not get consolidation therapy|3|||
128949262|NCT00280150|464100994|FG001|Overall Study|Did not get consolidation therapy|0|||
128949263|NCT00280150|464100995|FG002|Overall Study|Did not get consolidation therapy|3|||
128949264|NCT00280150|464100996|FG003|Overall Study|Did not get consolidation therapy|0|||
128949265|NCT00280150|464100993|FG000|Overall Study|Declining Performance Status|0|||
128709664|NCT02036294|463232113|FG001|Overall Study|Death|8|||
128709665|NCT02036294|463232112|FG000|Overall Study|Withdrawal by Subject|2|||
128949266|NCT00280150|464100994|FG001|Overall Study|Declining Performance Status|0|||
128949267|NCT00280150|464100995|FG002|Overall Study|Declining Performance Status|0|||
128949268|NCT00280150|464100996|FG003|Overall Study|Declining Performance Status|1|||
128949269|NCT02871401|464101000|FG000|Overall Study|Adverse Event|1|||
128949270|NCT02871401|464101001|FG001|Overall Study|Adverse Event|0|||
128949271|NCT01120379|464101002|FG000|One Year Timepoint|Withdrawal by Subject|41|||
128949272|NCT01120379|464101002|FG000|One Year Timepoint|Lost to Follow-up|115|||
129034618|NCT00603512|464416530|FG000|Overall Study|Withdrawal by Subject|0|||
128709666|NCT02036294|463232113|FG001|Overall Study|Withdrawal by Subject|3|||
128709667|NCT01830972|463232114|FG000|Part II|Withdrawal by Subject|2|||
128709668|NCT01830972|463232115|FG001|Part II|Withdrawal by Subject|2|||
128709669|NCT01830972|463232114|FG000|Part III|Withdrawal by Subject|1|||
128709670|NCT01830972|463232115|FG001|Part III|Withdrawal by Subject|0|||
128709671|NCT01830972|463232114|FG000|Part III|Noncompliance|1|||
128709672|NCT01830972|463232115|FG001|Part III|Noncompliance|0|||
128709673|NCT01830972|463232114|FG000|Part IV|Withdrawal by Subject|2|||
128709674|NCT01830972|463232115|FG001|Part IV|Withdrawal by Subject|1|||
128709675|NCT01830972|463232114|FG000|Part IV|Non-Compliance|1|||
128709676|NCT01830972|463232115|FG001|Part IV|Non-Compliance|0|||
128709677|NCT01574326|463232118|FG000|Overall Study|Randomized but not treated|0|||
128709678|NCT01574326|463232119|FG001|Overall Study|Randomized but not treated|1|||
128709679|NCT01574326|463232118|FG000|Overall Study|Withdrawal by Participant|2|||
128709680|NCT01574326|463232119|FG001|Overall Study|Withdrawal by Participant|4|||
128709681|NCT01574326|463232118|FG000|Overall Study|Physician Decision|5|||
128709682|NCT01574326|463232119|FG001|Overall Study|Physician Decision|3|||
128709683|NCT01574326|463232118|FG000|Overall Study|Adverse Event|1|||
128709684|NCT01574326|463232119|FG001|Overall Study|Adverse Event|3|||
128709685|NCT01574326|463232118|FG000|Overall Study|Other: Mainly kidney transplant|8|||
128709686|NCT01574326|463232119|FG001|Overall Study|Other: Mainly kidney transplant|8|||
128709687|NCT04997161|463232120|FG000|Overall Study|Study terminated by sponsor|3|||
128709688|NCT02407704|463232123|FG000|Overall Study|Lost to Follow-up|0|||
128709689|NCT02407704|463232124|FG001|Overall Study|Lost to Follow-up|0|||
129034619|NCT00603512|464416531|FG001|Overall Study|Withdrawal by Subject|0|||
129218643|NCT00357903|465099857|FG000|Overall Study|Death|33|||
128709690|NCT02407704|463232125|FG002|Overall Study|Lost to Follow-up|0|||
128709691|NCT02407704|463232126|FG003|Overall Study|Lost to Follow-up|2|||
128709692|NCT02407704|463232123|FG000|Overall Study|Protocol Violation|0|||
128709693|NCT02407704|463232124|FG001|Overall Study|Protocol Violation|0|||
128949273|NCT01120379|464101002|FG000|One Year Timepoint|Death|108|||
129218644|NCT00357903|465099858|FG001|Overall Study|Death|0|||
129218645|NCT00357903|465099857|FG000|Overall Study|Lost to Follow-up|23|||
128709694|NCT02407704|463232125|FG002|Overall Study|Protocol Violation|0|||
128709695|NCT02407704|463232126|FG003|Overall Study|Protocol Violation|1|||
128709696|NCT02407704|463232123|FG000|Overall Study|Withdrawal by Subject|0|||
128949274|NCT01120379|464101002|FG000|One Year Timepoint|Physician Decision|9|||
128709697|NCT02407704|463232124|FG001|Overall Study|Withdrawal by Subject|0|||
128709698|NCT02407704|463232125|FG002|Overall Study|Withdrawal by Subject|1|||
128709699|NCT02407704|463232126|FG003|Overall Study|Withdrawal by Subject|0|||
128709700|NCT04044716|463232127|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
128709701|NCT04044716|463232128|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
128709702|NCT04044716|463232129|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
128709703|NCT04044716|463232127|FG000|Overall Study|Lost to Follow-up|2|||
128709704|NCT04044716|463232128|FG001|Overall Study|Lost to Follow-up|3|||
128709705|NCT04044716|463232129|FG002|Overall Study|Lost to Follow-up|0|||
128709706|NCT02730455|463232130|FG000|Overall Study|Death|5|||
128709707|NCT02730455|463232131|FG001|Overall Study|Death|6|||
128709708|NCT02730455|463232132|FG002|Overall Study|Death|4|||
128709709|NCT02730455|463232130|FG000|Overall Study|Consent withdrawn|2|||
128709710|NCT02730455|463232131|FG001|Overall Study|Consent withdrawn|4|||
128709711|NCT02730455|463232132|FG002|Overall Study|Consent withdrawn|1|||
128709712|NCT02730455|463232130|FG000|Overall Study|Lost to Follow-up|3|||
128709713|NCT02730455|463232131|FG001|Overall Study|Lost to Follow-up|1|||
128709714|NCT02730455|463232132|FG002|Overall Study|Lost to Follow-up|4|||
128709715|NCT02730455|463232130|FG000|Overall Study|Other|1|||
128709716|NCT02730455|463232131|FG001|Overall Study|Other|1|||
128709717|NCT02730455|463232132|FG002|Overall Study|Other|2|||
128709718|NCT02730455|463232130|FG000|Overall Study|Other|2|||
128709719|NCT02730455|463232131|FG001|Overall Study|Other|2|||
129034620|NCT00603512|464416532|FG002|Overall Study|Withdrawal by Subject|0|||
129034621|NCT00603512|464416533|FG003|Overall Study|Withdrawal by Subject|0|||
129034622|NCT00603512|464416534|FG004|Overall Study|Withdrawal by Subject|1|||
129034623|NCT00603512|464416530|FG000|Overall Study|Randomized but not treated|0|||
129034624|NCT00603512|464416531|FG001|Overall Study|Randomized but not treated|1|||
129034625|NCT00603512|464416532|FG002|Overall Study|Randomized but not treated|1|||
129034626|NCT00603512|464416533|FG003|Overall Study|Randomized but not treated|2|||
129034627|NCT00603512|464416534|FG004|Overall Study|Randomized but not treated|0|||
129034628|NCT04979858|464416535|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
129034629|NCT04979858|464416536|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
129034630|NCT02654015|464416537|FG000|Overall Study|Death|12|||
129034631|NCT02654015|464416537|FG000|Overall Study|Lost to Follow-up|3|||
129034632|NCT02418754|464416540|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129034633|NCT02418754|464416541|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
129034634|NCT02418754|464416542|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129034635|NCT02418754|464416543|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129034636|NCT02418754|464416544|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129034637|NCT02418754|464416540|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
129034638|NCT02418754|464416541|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
129034639|NCT02418754|464416542|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
129034640|NCT02418754|464416543|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
129034641|NCT02418754|464416544|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
129034642|NCT02418754|464416540|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
129034643|NCT02418754|464416541|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129034644|NCT02418754|464416542|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129034645|NCT02418754|464416543|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129034646|NCT02418754|464416544|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129034647|NCT02418754|464416540|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
129034648|NCT02418754|464416541|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
129034649|NCT02418754|464416542|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
129034650|NCT02418754|464416543|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
129034651|NCT02418754|464416544|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
129034652|NCT02418754|464416540|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129034653|NCT02418754|464416541|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129034654|NCT02418754|464416542|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
129034655|NCT02418754|464416543|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129034656|NCT02418754|464416544|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129034657|NCT02418754|464416540|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
129034658|NCT02418754|464416541|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
129034659|NCT02418754|464416542|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
129034660|NCT02418754|464416543|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
129034661|NCT02418754|464416544|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
129034662|NCT02418754|464416540|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
129034663|NCT02418754|464416541|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
129034664|NCT02418754|464416542|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
128709720|NCT02730455|463232132|FG002|Overall Study|Other|0|||
128709721|NCT01018186|463232136|FG000|2-week Run-in Period|Protocol Violation|1|||
128709722|NCT01018186|463232137|FG001|2-week Run-in Period|Protocol Violation|0|||
128709723|NCT01018186|463232138|FG002|2-week Run-in Period|Protocol Violation|0|||
128709724|NCT01018186|463232139|FG003|2-week Run-in Period|Protocol Violation|0|||
128709725|NCT01018186|463232136|FG000|2-week Run-in Period|Lost to Follow-up|2|||
128709726|NCT01018186|463232137|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129124902|NCT01283386|464753562|FG000|Overall Study|Reason not specified|1|||
129124903|NCT01283386|464753563|FG001|Overall Study|Reason not specified|0|||
129124904|NCT01283386|464753562|FG000|Overall Study|Protocol Violation|0|||
129124905|NCT01283386|464753563|FG001|Overall Study|Protocol Violation|1|||
129124906|NCT01531153|464753566|FG000|Overall Study|Withdrawal by Subject|10|||
129124907|NCT01531153|464753567|FG001|Overall Study|Withdrawal by Subject|9|||
129124908|NCT01531153|464753568|FG002|Overall Study|Withdrawal by Subject|15|||
129124909|NCT00770367|464753569|FG000|First Intervention|Withdrawal by Subject|0|||
129124910|NCT00770367|464753570|FG001|First Intervention|Withdrawal by Subject|2|||
129124911|NCT00770367|464753569|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
129124912|NCT00770367|464753570|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
129124913|NCT00770367|464753569|FG000|Second Intervention|Lost to Follow-up|2|||
129124914|NCT00770367|464753570|FG001|Second Intervention|Lost to Follow-up|0|||
128709727|NCT01018186|463232138|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129124915|NCT00920816|464753572|FG000|Overall Study|Death|116|||
129124916|NCT00920816|464753573|FG001|Overall Study|Death|63|||
129124917|NCT00920816|464753574|FG002|Overall Study|Death|8|||
129124918|NCT00920816|464753575|FG003|Overall Study|Death|3|||
129124919|NCT00920816|464753572|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
129124920|NCT00920816|464753573|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
129124921|NCT00920816|464753574|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
129124922|NCT00920816|464753575|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
129124923|NCT00920816|464753572|FG000|Overall Study|Global deterioration of health status|2|||
129124924|NCT00920816|464753573|FG001|Overall Study|Global deterioration of health status|0|||
129124925|NCT00920816|464753574|FG002|Overall Study|Global deterioration of health status|0|||
129124926|NCT00920816|464753575|FG003|Overall Study|Global deterioration of health status|0|||
129124927|NCT00920816|464753572|FG000|Overall Study|Objective progression or relapse|6|||
129124928|NCT00920816|464753573|FG001|Overall Study|Objective progression or relapse|2|||
129124929|NCT00920816|464753574|FG002|Overall Study|Objective progression or relapse|0|||
129124930|NCT00920816|464753575|FG003|Overall Study|Objective progression or relapse|0|||
129124931|NCT00920816|464753572|FG000|Overall Study|Other|26|||
129124932|NCT00920816|464753573|FG001|Overall Study|Other|15|||
129124933|NCT00920816|464753574|FG002|Overall Study|Other|1|||
129124934|NCT00920816|464753575|FG003|Overall Study|Other|2|||
129124935|NCT00920816|464753572|FG000|Overall Study|Lost to Follow-up|11|||
129124936|NCT00920816|464753573|FG001|Overall Study|Lost to Follow-up|2|||
129124937|NCT00920816|464753574|FG002|Overall Study|Lost to Follow-up|0|||
129124938|NCT00920816|464753575|FG003|Overall Study|Lost to Follow-up|0|||
129124939|NCT00920816|464753572|FG000|Overall Study|Adverse Event|1|||
129124940|NCT00920816|464753573|FG001|Overall Study|Adverse Event|1|||
129124941|NCT00920816|464753574|FG002|Overall Study|Adverse Event|1|||
129124942|NCT00920816|464753575|FG003|Overall Study|Adverse Event|0|||
129218646|NCT00357903|465099858|FG001|Overall Study|Lost to Follow-up|4|||
128709728|NCT01018186|463232139|FG003|2-week Run-in Period|Lost to Follow-up|0|||
128709729|NCT01018186|463232136|FG000|2-week Run-in Period|Physician Decision|3|||
128709730|NCT01018186|463232137|FG001|2-week Run-in Period|Physician Decision|0|||
128709731|NCT01018186|463232138|FG002|2-week Run-in Period|Physician Decision|0|||
128709732|NCT01018186|463232139|FG003|2-week Run-in Period|Physician Decision|0|||
128709733|NCT01018186|463232136|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
128709734|NCT01018186|463232137|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
128709735|NCT01018186|463232138|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
128709736|NCT01018186|463232139|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
128709737|NCT01018186|463232136|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
128709738|NCT01018186|463232137|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
128709739|NCT01018186|463232138|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
128709740|NCT01018186|463232139|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
128709741|NCT01018186|463232136|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
129124943|NCT00920816|464753572|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
129124944|NCT00920816|464753573|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
129124945|NCT00920816|464753574|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
129124946|NCT00920816|464753575|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
129124947|NCT00920816|464753572|FG000|Overall Study|Randomized but not treated|3|||
129124948|NCT00920816|464753573|FG001|Overall Study|Randomized but not treated|0|||
129124949|NCT00920816|464753574|FG002|Overall Study|Randomized but not treated|0|||
129124950|NCT00920816|464753575|FG003|Overall Study|Randomized but not treated|0|||
129124951|NCT01180777|464753576|FG000|Overall Study|Protocol Violation|6|||
128709742|NCT01018186|463232137|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
128709743|NCT01018186|463232138|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
128709744|NCT01018186|463232139|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
129124952|NCT01180777|464753576|FG000|Overall Study|Poor lens fit|4|||
129124953|NCT01180777|464753576|FG000|Overall Study|Lost to Follow-up|1|||
129124954|NCT01180777|464753576|FG000|Overall Study|Adverse Event|1|||
128709745|NCT01018186|463232136|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
128709746|NCT01018186|463232137|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
128709747|NCT01018186|463232138|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
128709748|NCT01018186|463232139|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
128709749|NCT01018186|463232136|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
128709750|NCT01018186|463232137|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
128709751|NCT01018186|463232138|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
128709752|NCT01018186|463232139|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
128709753|NCT01018186|463232136|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
128709754|NCT01018186|463232137|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
128709755|NCT01018186|463232138|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
128709756|NCT01018186|463232139|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
128709757|NCT01018186|463232136|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
128709758|NCT01018186|463232137|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
128709759|NCT01018186|463232138|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
128709760|NCT01018186|463232139|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
128709761|NCT01018186|463232136|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
128709762|NCT01018186|463232137|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
128709763|NCT01018186|463232138|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
128709764|NCT01018186|463232139|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
128709765|NCT01018186|463232136|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
128709766|NCT01018186|463232137|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
128709767|NCT01018186|463232138|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
128709768|NCT01018186|463232139|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
128709769|NCT03049280|463232140|FG000|Overall Study|Physician Decision|1|||
128709770|NCT03552198|463232141|FG000|Overall Study|Lost to Follow-up|42|||
128709771|NCT03552198|463232142|FG001|Overall Study|Lost to Follow-up|48|||
128709772|NCT03552198|463232143|FG002|Overall Study|Lost to Follow-up|15|||
128709773|NCT03552198|463232144|FG003|Overall Study|Lost to Follow-up|19|||
128709774|NCT03552198|463232141|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
128709775|NCT03552198|463232142|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
128709776|NCT03552198|463232143|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
128709777|NCT03552198|463232144|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
128709778|NCT03552198|463232141|FG000|Overall Study|Did not receive air alerts|1|||
128709779|NCT03552198|463232142|FG001|Overall Study|Did not receive air alerts|0|||
128709780|NCT03552198|463232143|FG002|Overall Study|Did not receive air alerts|0|||
128709781|NCT03552198|463232144|FG003|Overall Study|Did not receive air alerts|1|||
128709782|NCT03235154|463232145|FG000|Overall Study|Withdrawal by Subject|1|||
128709783|NCT03235154|463232145|FG000|Overall Study|Adverse Event|1|||
128709784|NCT03235154|463232145|FG000|Overall Study|Lost to Follow-up|2|||
128709785|NCT01324999|463232146|FG000|Overall Study|Adverse Event|3|||
128709786|NCT01324999|463232146|FG000|Overall Study|Withdrawal by Subject|2|||
128709787|NCT00276744|463232147|FG000|PART A|Reason unknown|98|||
128709788|NCT00230607|463232148|FG000|Overall Study|Other|3|||
128709789|NCT02860169|463232149|FG000|Part A|Withdrawal by Subject|1|||
128709790|NCT02860169|463232149|FG000|Part A|Other (Screening failure)|6|||
128709791|NCT02860169|463232149|FG000|Part A|Other (Survey not completed)|3|||
128709792|NCT02860169|463232149|FG000|Part A|Other (did not completed consent)|1|||
128709793|NCT02860169|463232149|FG000|Part B|Other (Screening failure)|10|||
128709794|NCT02860169|463232149|FG000|Part B|Withdrawal by Subject|1|||
128709795|NCT02860169|463232149|FG000|Part C|Other (Screening failure)|1|||
128709796|NCT00897104|463232151|FG000|Overall Study|Lost to Follow-up|12|||
128709797|NCT00897104|463232152|FG001|Overall Study|Lost to Follow-up|17|||
128709798|NCT00897104|463232153|FG002|Overall Study|Lost to Follow-up|2|||
128709799|NCT00897104|463232151|FG000|Overall Study|Pregnancy|0|||
128709800|NCT00897104|463232152|FG001|Overall Study|Pregnancy|1|||
128709801|NCT00897104|463232153|FG002|Overall Study|Pregnancy|0|||
128709802|NCT00897104|463232151|FG000|Overall Study|Protocol Violation|0|||
128709803|NCT00897104|463232152|FG001|Overall Study|Protocol Violation|1|||
128709804|NCT00897104|463232153|FG002|Overall Study|Protocol Violation|0|||
128949275|NCT01120379|464101002|FG000|One Year Timepoint|Any other reason for early termination|5|||
128949276|NCT01120379|464101002|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
128949277|NCT01120379|464101002|FG000|Two Year Timepoint|Lost to Follow-up|87|||
128949278|NCT01120379|464101002|FG000|Two Year Timepoint|Death|123|||
128949279|NCT01120379|464101002|FG000|Two Year Timepoint|Physician Decision|12|||
128949280|NCT01120379|464101002|FG000|Two Year Timepoint|Any other reason for early termination|4|||
128949281|NCT01120379|464101002|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
128949282|NCT01120379|464101002|FG000|Three Year Timepoint|Lost to Follow-up|43|||
128709805|NCT00897104|463232151|FG000|Overall Study|Withdrawal by Subject|23|||
128709806|NCT00897104|463232152|FG001|Overall Study|Withdrawal by Subject|27|||
128709807|NCT00897104|463232153|FG002|Overall Study|Withdrawal by Subject|3|||
128949283|NCT01120379|464101002|FG000|Three Year Timepoint|Death|120|||
129218647|NCT00357903|465099857|FG000|Overall Study|Physician Decision|39|||
129218648|NCT00357903|465099858|FG001|Overall Study|Physician Decision|5|||
129218649|NCT00357903|465099857|FG000|Overall Study|Withdrawal by Subject|57|||
129218650|NCT00357903|465099858|FG001|Overall Study|Withdrawal by Subject|7|||
129218651|NCT00357903|465099857|FG000|Overall Study|Completed month 12 only|0|||
129218652|NCT00357903|465099858|FG001|Overall Study|Completed month 12 only|1|||
129218653|NCT00357903|465099857|FG000|Overall Study|Protocol issues|14|||
129218654|NCT00357903|465099858|FG001|Overall Study|Protocol issues|3|||
129218655|NCT00357903|465099857|FG000|Overall Study|Response status|61|||
129218656|NCT00357903|465099858|FG001|Overall Study|Response status|9|||
129218657|NCT00357903|465099857|FG000|Overall Study|Other|49|||
129218658|NCT00357903|465099858|FG001|Overall Study|Other|10|||
129218659|NCT00606593|465099859|FG000|Overall Study|Adverse Event|0|||
129218660|NCT00606593|465099860|FG001|Overall Study|Adverse Event|0|||
129218661|NCT00606593|465099861|FG002|Overall Study|Adverse Event|0|||
129218662|NCT00606593|465099862|FG003|Overall Study|Adverse Event|1|||
129218663|NCT00606593|465099863|FG004|Overall Study|Adverse Event|1|||
129218664|NCT00606593|465099864|FG005|Overall Study|Adverse Event|0|||
129218665|NCT00606593|465099865|FG006|Overall Study|Adverse Event|1|||
129218666|NCT00606593|465099866|FG007|Overall Study|Adverse Event|2|||
129218667|NCT00606593|465099867|FG008|Overall Study|Adverse Event|1|||
129218668|NCT00606593|465099868|FG009|Overall Study|Adverse Event|0|||
129218669|NCT00606593|465099859|FG000|Overall Study|Withdrawal of consent|1|||
129218670|NCT00606593|465099860|FG001|Overall Study|Withdrawal of consent|0|||
129218671|NCT00606593|465099861|FG002|Overall Study|Withdrawal of consent|1|||
129218672|NCT00606593|465099862|FG003|Overall Study|Withdrawal of consent|0|||
129218673|NCT00606593|465099863|FG004|Overall Study|Withdrawal of consent|0|||
129218674|NCT00606593|465099864|FG005|Overall Study|Withdrawal of consent|0|||
129218675|NCT00606593|465099865|FG006|Overall Study|Withdrawal of consent|0|||
129218676|NCT00606593|465099866|FG007|Overall Study|Withdrawal of consent|0|||
129218677|NCT00606593|465099867|FG008|Overall Study|Withdrawal of consent|0|||
129218678|NCT00606593|465099868|FG009|Overall Study|Withdrawal of consent|0|||
129218679|NCT00606593|465099859|FG000|Overall Study|Administrative/Other|0|||
129218680|NCT00606593|465099860|FG001|Overall Study|Administrative/Other|0|||
129218681|NCT00606593|465099861|FG002|Overall Study|Administrative/Other|1|||
129218682|NCT00606593|465099862|FG003|Overall Study|Administrative/Other|0|||
129218683|NCT00606593|465099863|FG004|Overall Study|Administrative/Other|0|||
129218684|NCT00606593|465099864|FG005|Overall Study|Administrative/Other|0|||
129218685|NCT00606593|465099865|FG006|Overall Study|Administrative/Other|0|||
129218686|NCT00606593|465099866|FG007|Overall Study|Administrative/Other|0|||
129218687|NCT00606593|465099867|FG008|Overall Study|Administrative/Other|0|||
129218688|NCT00606593|465099868|FG009|Overall Study|Administrative/Other|0|||
129218689|NCT03181529|465099869|FG000|Overall Study|Withdrawal by Subject|1|||
129218690|NCT03181529|465099870|FG001|Overall Study|Withdrawal by Subject|1|||
129218691|NCT03181529|465099869|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
129218692|NCT03181529|465099870|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
129218693|NCT02374450|465099871|FG000|Overall Study|Protocol Violation|0|||
129218694|NCT02374450|465099872|FG001|Overall Study|Protocol Violation|1|||
129218695|NCT02374450|465099873|FG002|Overall Study|Protocol Violation|0|||
129218696|NCT02374450|465099871|FG000|Overall Study|Withdrawal by Subject|91|||
129218697|NCT02374450|465099872|FG001|Overall Study|Withdrawal by Subject|110|||
129218698|NCT02374450|465099873|FG002|Overall Study|Withdrawal by Subject|4|||
129218699|NCT02374450|465099871|FG000|Overall Study|Lost to Follow-up|168|||
129218700|NCT02374450|465099872|FG001|Overall Study|Lost to Follow-up|194|||
129218701|NCT02374450|465099873|FG002|Overall Study|Lost to Follow-up|138|||
129218702|NCT02374450|465099871|FG000|Overall Study|Death|173|||
129218703|NCT02374450|465099872|FG001|Overall Study|Death|185|||
129218704|NCT02374450|465099873|FG002|Overall Study|Death|81|||
129218705|NCT02374450|465099871|FG000|Overall Study|Migrated from the study area|538|||
129218706|NCT02374450|465099872|FG001|Overall Study|Migrated from the study area|648|||
128709808|NCT00897104|463232151|FG000|Overall Study|Abnormal Prestudy Labs|2|||
128709809|NCT00897104|463232152|FG001|Overall Study|Abnormal Prestudy Labs|0|||
128709810|NCT00897104|463232153|FG002|Overall Study|Abnormal Prestudy Labs|0|||
128709811|NCT00897104|463232151|FG000|Overall Study|Abnormal Baseline ECG|2|||
129218707|NCT02374450|465099873|FG002|Overall Study|Migrated from the study area|181|||
129218708|NCT02374450|465099871|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
129218709|NCT02374450|465099872|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
129218710|NCT02374450|465099873|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
129218711|NCT02374450|465099871|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
129218712|NCT02374450|465099872|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
129218713|NCT02374450|465099873|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
129218714|NCT02374450|465099871|FG000|Overall Study|Other|0|||
129218715|NCT02374450|465099872|FG001|Overall Study|Other|21|||
129218716|NCT02374450|465099873|FG002|Overall Study|Other|79|||
129218717|NCT01442103|465101575|FG000|Overall Study|Lost to Follow-up|2|||
129218718|NCT02202759|465101576|FG000|Overall Study|Study Terminated by Sponsor|3|||
129124955|NCT03517137|464753579|FG000|Overall Study|Lack of Efficacy|1|||
129124956|NCT03517137|464753579|FG000|Overall Study|Adverse Event|2|||
129124957|NCT03517137|464753579|FG000|Overall Study|Withdrawal by Subject|2|||
129124958|NCT03517137|464753579|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
129124959|NCT01582451|464753580|FG000|Overall Study|Adverse Event|1|||
129124960|NCT01582451|464753581|FG001|Overall Study|Adverse Event|3|||
129124961|NCT01582451|464753580|FG000|Overall Study|Death|3|||
129124962|NCT01582451|464753581|FG001|Overall Study|Death|3|||
129124963|NCT01582451|464753580|FG000|Overall Study|Lost to Follow-up|0|||
129124964|NCT01582451|464753581|FG001|Overall Study|Lost to Follow-up|2|||
129124965|NCT01582451|464753580|FG000|Overall Study|Protocol Violation|11|||
129124966|NCT01582451|464753581|FG001|Overall Study|Protocol Violation|3|||
129124967|NCT01582451|464753580|FG000|Overall Study|Withdrawal by Subject|13|||
129124968|NCT01582451|464753581|FG001|Overall Study|Withdrawal by Subject|9|||
129124969|NCT01582451|464753580|FG000|Overall Study|Physician Decision|3|||
129124970|NCT01582451|464753581|FG001|Overall Study|Physician Decision|0|||
129124971|NCT01582451|464753580|FG000|Overall Study|Sponsor Decision|1|||
129124972|NCT01582451|464753581|FG001|Overall Study|Sponsor Decision|0|||
129124973|NCT00487188|464753585|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
129124974|NCT00487188|464753586|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
129124975|NCT00487188|464753587|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
129124976|NCT00487188|464753585|FG000|Induction Phase|Adverse Event|5|||
129124977|NCT00487188|464753586|FG001|Induction Phase|Adverse Event|0|||
129124978|NCT00487188|464753587|FG002|Induction Phase|Adverse Event|0|||
129124979|NCT00487188|464753585|FG000|Induction Phase|Lack of Efficacy|0|||
129124980|NCT00487188|464753586|FG001|Induction Phase|Lack of Efficacy|1|||
129124981|NCT00487188|464753587|FG002|Induction Phase|Lack of Efficacy|0|||
129124982|NCT00487188|464753585|FG000|Induction Phase|Protocol Violation|1|||
129124983|NCT00487188|464753586|FG001|Induction Phase|Protocol Violation|0|||
129124984|NCT00487188|464753587|FG002|Induction Phase|Protocol Violation|0|||
129124985|NCT00487188|464753585|FG000|Induction Phase|Refused Treatment|1|||
129124986|NCT00487188|464753586|FG001|Induction Phase|Refused Treatment|2|||
129124987|NCT00487188|464753587|FG002|Induction Phase|Refused Treatment|0|||
129124988|NCT00487188|464753585|FG000|Induction Phase|Lost to Follow-up|2|||
129124989|NCT00487188|464753586|FG001|Induction Phase|Lost to Follow-up|2|||
129124990|NCT00487188|464753587|FG002|Induction Phase|Lost to Follow-up|0|||
129124991|NCT00487188|464753585|FG000|Induction Phase|Administrative|0|||
129124992|NCT00487188|464753586|FG001|Induction Phase|Administrative|1|||
129124993|NCT00487188|464753587|FG002|Induction Phase|Administrative|0|||
129124994|NCT00487188|464753585|FG000|Maintenance Phase|Adverse Event|1|||
129124995|NCT00487188|464753586|FG001|Maintenance Phase|Adverse Event|0|||
129124996|NCT00487188|464753587|FG002|Maintenance Phase|Adverse Event|0|||
129124997|NCT00487188|464753585|FG000|Maintenance Phase|Death|1|||
129124998|NCT00487188|464753586|FG001|Maintenance Phase|Death|0|||
129124999|NCT00487188|464753587|FG002|Maintenance Phase|Death|0|||
129125000|NCT00487188|464753585|FG000|Maintenance Phase|Lost to Follow-up|1|||
129125001|NCT00487188|464753586|FG001|Maintenance Phase|Lost to Follow-up|0|||
129125002|NCT00487188|464753587|FG002|Maintenance Phase|Lost to Follow-up|0|||
129125003|NCT00487188|464753585|FG000|Maintenance Phase|Administrative|0|||
129125004|NCT00487188|464753586|FG001|Maintenance Phase|Administrative|0|||
129125005|NCT00487188|464753587|FG002|Maintenance Phase|Administrative|1|||
129125006|NCT03822416|464753590|FG000|Overall Study|Lost to Follow-up|1|||
129125007|NCT03822416|464753591|FG001|Overall Study|Lost to Follow-up|0|||
129125008|NCT03822416|464753590|FG000|Overall Study|Withdrawal by Subject|0|||
129125009|NCT03822416|464753591|FG001|Overall Study|Withdrawal by Subject|1|||
129125010|NCT01995201|464753594|FG000|From Baseline Until Week 24|Adverse Event|4|||
129125011|NCT01995201|464753595|FG001|From Baseline Until Week 24|Adverse Event|15|||
129125012|NCT01995201|464753596|FG002|From Baseline Until Week 24|Adverse Event|0|||
129125013|NCT01995201|464753597|FG003|From Baseline Until Week 24|Adverse Event|0|||
129125014|NCT01995201|464753598|FG004|From Baseline Until Week 24|Adverse Event|0|||
129125015|NCT01995201|464753599|FG005|From Baseline Until Week 24|Adverse Event|0|||
129125016|NCT01995201|464753600|FG006|From Baseline Until Week 24|Adverse Event|0|||
129125017|NCT01995201|464753594|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129125018|NCT01995201|464753595|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
129125019|NCT01995201|464753596|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129125020|NCT01995201|464753597|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129125021|NCT01995201|464753598|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129125022|NCT01995201|464753599|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129125023|NCT01995201|464753600|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129125024|NCT01995201|464753594|FG000|From Baseline Until Week 24|Death|0|||
129125025|NCT01995201|464753595|FG001|From Baseline Until Week 24|Death|1|||
129125026|NCT01995201|464753596|FG002|From Baseline Until Week 24|Death|0|||
129125027|NCT01995201|464753597|FG003|From Baseline Until Week 24|Death|0|||
129125028|NCT01995201|464753598|FG004|From Baseline Until Week 24|Death|0|||
129125029|NCT01995201|464753599|FG005|From Baseline Until Week 24|Death|0|||
129125030|NCT01995201|464753600|FG006|From Baseline Until Week 24|Death|0|||
129034665|NCT02418754|464416543|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
129034666|NCT02418754|464416544|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
129034667|NCT02418754|464416540|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
129034668|NCT02418754|464416541|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
129034669|NCT02418754|464416542|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
129034670|NCT02418754|464416543|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
129034671|NCT02418754|464416544|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
129034672|NCT02418754|464416540|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
129034673|NCT02418754|464416541|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
129034674|NCT02418754|464416542|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
129034675|NCT02418754|464416543|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
129034676|NCT02418754|464416544|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
129034677|NCT02418754|464416540|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
129034678|NCT02418754|464416541|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
129034679|NCT02418754|464416542|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
129034680|NCT02418754|464416543|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
129034681|NCT02418754|464416544|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
129034682|NCT02418754|464416540|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
129034683|NCT02418754|464416541|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
129034684|NCT02418754|464416542|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
129034685|NCT02418754|464416543|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
129034686|NCT02418754|464416544|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
129034687|NCT01896505|464416545|FG000|Overall Study|Adverse Event|1|||
129034688|NCT01896505|464416546|FG001|Overall Study|Adverse Event|0|||
129034689|NCT01896505|464416547|FG002|Overall Study|Adverse Event|2|||
129034690|NCT01896505|464416548|FG003|Overall Study|Adverse Event|1|||
129034691|NCT01896505|464416549|FG004|Overall Study|Adverse Event|1|||
129034692|NCT01896505|464416550|FG005|Overall Study|Adverse Event|0|||
129034693|NCT01896505|464416545|FG000|Overall Study|Physician Decision|1|||
129125031|NCT01995201|464753594|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
129125032|NCT01995201|464753595|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
129125033|NCT01995201|464753596|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
129125034|NCT01995201|464753597|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
129125035|NCT01995201|464753598|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
129125036|NCT01995201|464753599|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
129125037|NCT01995201|464753600|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
129125038|NCT01995201|464753594|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
129125039|NCT01995201|464753595|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
129125040|NCT01995201|464753596|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
129125041|NCT01995201|464753597|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
129125042|NCT01995201|464753598|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
129125043|NCT01995201|464753599|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
129125044|NCT01995201|464753600|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
129125045|NCT01995201|464753594|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
129125046|NCT01995201|464753595|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
129125047|NCT01995201|464753596|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
129125048|NCT01995201|464753597|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
129125049|NCT01995201|464753598|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
129125050|NCT01995201|464753599|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
129125051|NCT01995201|464753600|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
129125052|NCT01995201|464753594|FG000|From Baseline Until Week 24|Physician Decision|0|||
129125053|NCT01995201|464753595|FG001|From Baseline Until Week 24|Physician Decision|2|||
129125054|NCT01995201|464753596|FG002|From Baseline Until Week 24|Physician Decision|0|||
129125055|NCT01995201|464753597|FG003|From Baseline Until Week 24|Physician Decision|0|||
129125056|NCT01995201|464753598|FG004|From Baseline Until Week 24|Physician Decision|0|||
129125057|NCT01995201|464753599|FG005|From Baseline Until Week 24|Physician Decision|0|||
129125058|NCT01995201|464753600|FG006|From Baseline Until Week 24|Physician Decision|0|||
129125059|NCT01995201|464753594|FG000|From Baseline Until Week 24|Protocol Violation|0|||
129125060|NCT01995201|464753595|FG001|From Baseline Until Week 24|Protocol Violation|9|||
129125061|NCT01995201|464753596|FG002|From Baseline Until Week 24|Protocol Violation|0|||
129125062|NCT01995201|464753597|FG003|From Baseline Until Week 24|Protocol Violation|0|||
129125063|NCT01995201|464753598|FG004|From Baseline Until Week 24|Protocol Violation|0|||
129125064|NCT01995201|464753599|FG005|From Baseline Until Week 24|Protocol Violation|0|||
129125065|NCT01995201|464753600|FG006|From Baseline Until Week 24|Protocol Violation|0|||
129125066|NCT01995201|464753594|FG000|From Week 24 Until Week 48|Adverse Event|0|||
129125067|NCT01995201|464753595|FG001|From Week 24 Until Week 48|Adverse Event|0|||
129125068|NCT01995201|464753596|FG002|From Week 24 Until Week 48|Adverse Event|2|||
129125069|NCT01995201|464753597|FG003|From Week 24 Until Week 48|Adverse Event|1|||
129034694|NCT01896505|464416546|FG001|Overall Study|Physician Decision|3|||
129034695|NCT01896505|464416547|FG002|Overall Study|Physician Decision|2|||
129034696|NCT01896505|464416548|FG003|Overall Study|Physician Decision|0|||
129034697|NCT01896505|464416549|FG004|Overall Study|Physician Decision|0|||
129034698|NCT01896505|464416550|FG005|Overall Study|Physician Decision|1|||
129034699|NCT01896505|464416545|FG000|Overall Study|Withdrawal by Subject|1|||
129034700|NCT01896505|464416546|FG001|Overall Study|Withdrawal by Subject|0|||
129034701|NCT01896505|464416547|FG002|Overall Study|Withdrawal by Subject|3|||
129034702|NCT01896505|464416548|FG003|Overall Study|Withdrawal by Subject|1|||
129034703|NCT01896505|464416549|FG004|Overall Study|Withdrawal by Subject|0|||
129034704|NCT01896505|464416550|FG005|Overall Study|Withdrawal by Subject|0|||
129034705|NCT01896505|464416545|FG000|Overall Study|Disease Progression|7|||
129034706|NCT01896505|464416546|FG001|Overall Study|Disease Progression|5|||
129034707|NCT01896505|464416547|FG002|Overall Study|Disease Progression|8|||
129034708|NCT01896505|464416548|FG003|Overall Study|Disease Progression|4|||
129034709|NCT01896505|464416549|FG004|Overall Study|Disease Progression|4|||
129034710|NCT01896505|464416550|FG005|Overall Study|Disease Progression|4|||
129034711|NCT01896505|464416545|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
129034712|NCT01896505|464416546|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
129034713|NCT01896505|464416547|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
129125070|NCT01995201|464753598|FG004|From Week 24 Until Week 48|Adverse Event|1|||
129125071|NCT01995201|464753599|FG005|From Week 24 Until Week 48|Adverse Event|3|||
129125072|NCT01995201|464753600|FG006|From Week 24 Until Week 48|Adverse Event|1|||
129125073|NCT01995201|464753594|FG000|From Week 24 Until Week 48|Death|0|||
129125074|NCT01995201|464753595|FG001|From Week 24 Until Week 48|Death|0|||
129125075|NCT01995201|464753596|FG002|From Week 24 Until Week 48|Death|0|||
129125076|NCT01995201|464753597|FG003|From Week 24 Until Week 48|Death|0|||
129125077|NCT01995201|464753598|FG004|From Week 24 Until Week 48|Death|0|||
129125078|NCT01995201|464753599|FG005|From Week 24 Until Week 48|Death|2|||
129125079|NCT01995201|464753600|FG006|From Week 24 Until Week 48|Death|0|||
129125080|NCT01995201|464753594|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
129125081|NCT01995201|464753595|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
129125082|NCT01995201|464753596|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
129125083|NCT01995201|464753597|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
129125084|NCT01995201|464753598|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
129125085|NCT01995201|464753599|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
129125086|NCT01995201|464753600|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
129125087|NCT01995201|464753594|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
129125088|NCT01995201|464753595|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
129125089|NCT01995201|464753596|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
129125090|NCT01995201|464753597|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
129125091|NCT01995201|464753598|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
129125092|NCT01995201|464753599|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
129125093|NCT01995201|464753600|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
129125094|NCT01995201|464753594|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129125095|NCT01995201|464753595|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129125096|NCT01995201|464753596|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
129125097|NCT01995201|464753597|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129125098|NCT01995201|464753598|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
129125099|NCT01995201|464753599|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129125100|NCT01995201|464753600|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129125101|NCT01995201|464753594|FG000|From Week 24 Until Week 48|Physician Decision|0|||
129125102|NCT01995201|464753595|FG001|From Week 24 Until Week 48|Physician Decision|0|||
129125103|NCT01995201|464753596|FG002|From Week 24 Until Week 48|Physician Decision|0|||
129125104|NCT01995201|464753597|FG003|From Week 24 Until Week 48|Physician Decision|0|||
129125105|NCT01995201|464753598|FG004|From Week 24 Until Week 48|Physician Decision|1|||
129125106|NCT01995201|464753599|FG005|From Week 24 Until Week 48|Physician Decision|0|||
129125107|NCT01995201|464753600|FG006|From Week 24 Until Week 48|Physician Decision|0|||
129125108|NCT01995201|464753594|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
129125109|NCT01995201|464753595|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
129125110|NCT01995201|464753596|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
129125111|NCT01995201|464753597|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
129125112|NCT01995201|464753598|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
129034714|NCT01896505|464416548|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
129034715|NCT01896505|464416549|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
129034716|NCT01896505|464416550|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
129034717|NCT01896505|464416545|FG000|Overall Study|Intercurrent illness|0|||
129034718|NCT01896505|464416546|FG001|Overall Study|Intercurrent illness|1|||
129034719|NCT01896505|464416547|FG002|Overall Study|Intercurrent illness|0|||
129034720|NCT01896505|464416548|FG003|Overall Study|Intercurrent illness|0|||
129125113|NCT01995201|464753599|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
129125114|NCT01995201|464753600|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
129125115|NCT03329001|464753601|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129218719|NCT02202759|465101577|FG001|Overall Study|Study Terminated by Sponsor|3|||
129218720|NCT02202759|465101578|FG002|Overall Study|Study Terminated by Sponsor|3|||
129218721|NCT02202759|465101576|FG000|Overall Study|Withdrawal by Subject|2|||
129218722|NCT02202759|465101577|FG001|Overall Study|Withdrawal by Subject|1|||
129218723|NCT02202759|465101578|FG002|Overall Study|Withdrawal by Subject|1|||
129218724|NCT02202759|465101576|FG000|Overall Study|Reason not Specified|4|||
129218725|NCT02202759|465101577|FG001|Overall Study|Reason not Specified|11|||
129218726|NCT02202759|465101578|FG002|Overall Study|Reason not Specified|10|||
129218727|NCT01987453|465101579|FG000|Overall Study|Death|0|||
129218728|NCT01987453|465101580|FG001|Overall Study|Death|0|||
129218729|NCT01987453|465101581|FG002|Overall Study|Death|1|||
129218730|NCT01987453|465101579|FG000|Overall Study|Lack of Efficacy|1|||
129218731|NCT01987453|465101580|FG001|Overall Study|Lack of Efficacy|12|||
129218732|NCT01987453|465101581|FG002|Overall Study|Lack of Efficacy|0|||
129218733|NCT04953728|465101583|FG000|Overall Study|Withdrawal by Subject|3|||
129218734|NCT04953728|465101583|FG000|Overall Study|Physician Decision|1|||
129218735|NCT02105662|465101584|FG000|Overall Study|Lost to Follow-up|5|||
129218736|NCT02105662|465101584|FG000|Overall Study|Withdrawal by Subject|1|||
129218737|NCT02331277|465101587|FG000|Overall Study|Withdrawal by Subject|1|||
129218738|NCT02331277|465101588|FG001|Overall Study|Withdrawal by Subject|0|||
129218739|NCT03978117|465101589|FG000|Overall Study|Non-Compliance|26|||
129218740|NCT03978117|465101590|FG001|Overall Study|Non-Compliance|26|||
129218741|NCT03978117|465101589|FG000|Overall Study|Lost to Follow-up|4|||
129218742|NCT03978117|465101590|FG001|Overall Study|Lost to Follow-up|4|||
129218743|NCT01528969|465101596|FG000|Overall Study|absent from the school at baseline|2|||
129218744|NCT01528969|465101597|FG001|Overall Study|absent from the school at baseline|0|||
129218745|NCT04614974|465101598|FG000|Overall Study|Lost to Follow-up|14|||
129218746|NCT04614974|465101599|FG001|Overall Study|Lost to Follow-up|11|||
129218747|NCT01635153|465101600|FG000|Overall Study|Lost to Follow-up|40|||
129218748|NCT01635153|465101601|FG001|Overall Study|Lost to Follow-up|43|||
129218749|NCT01263197|465101613|FG000|First Intervention (Period 1)|Adverse Event|0|||
129218750|NCT01263197|465101614|FG001|First Intervention (Period 1)|Adverse Event|0|||
129218751|NCT01263197|465101615|FG002|First Intervention (Period 1)|Adverse Event|0|||
129218752|NCT01263197|465101616|FG003|First Intervention (Period 1)|Adverse Event|0|||
129218753|NCT01263197|465101617|FG004|First Intervention (Period 1)|Adverse Event|0|||
129218754|NCT01263197|465101618|FG005|First Intervention (Period 1)|Adverse Event|1|||
129218755|NCT01263197|465101613|FG000|Washout Period 1|Protocol Violation|0|||
129218756|NCT01263197|465101614|FG001|Washout Period 1|Protocol Violation|0|||
129218757|NCT01263197|465101615|FG002|Washout Period 1|Protocol Violation|0|||
129218758|NCT01263197|465101616|FG003|Washout Period 1|Protocol Violation|0|||
129218759|NCT01263197|465101617|FG004|Washout Period 1|Protocol Violation|1|||
129218760|NCT01263197|465101618|FG005|Washout Period 1|Protocol Violation|0|||
129218761|NCT01263197|465101613|FG000|Washout Period 2|Physician Decision|0|||
129218762|NCT01263197|465101614|FG001|Washout Period 2|Physician Decision|0|||
129218763|NCT01263197|465101615|FG002|Washout Period 2|Physician Decision|0|||
129218764|NCT01263197|465101616|FG003|Washout Period 2|Physician Decision|0|||
129218765|NCT01263197|465101617|FG004|Washout Period 2|Physician Decision|0|||
129218766|NCT01263197|465101618|FG005|Washout Period 2|Physician Decision|1|||
129218767|NCT01263197|465101613|FG000|Washout Period 2|Protocol Violation|0|||
129218768|NCT01263197|465101614|FG001|Washout Period 2|Protocol Violation|0|||
129218769|NCT01263197|465101615|FG002|Washout Period 2|Protocol Violation|0|||
129218770|NCT01263197|465101616|FG003|Washout Period 2|Protocol Violation|1|||
129218771|NCT01263197|465101617|FG004|Washout Period 2|Protocol Violation|0|||
129218772|NCT01263197|465101618|FG005|Washout Period 2|Protocol Violation|0|||
129218773|NCT01263197|465101613|FG000|Third Intervention (Period 3)|Adverse Event|0|||
129218774|NCT01263197|465101614|FG001|Third Intervention (Period 3)|Adverse Event|1|||
129218775|NCT01263197|465101615|FG002|Third Intervention (Period 3)|Adverse Event|0|||
128709812|NCT00897104|463232152|FG001|Overall Study|Abnormal Baseline ECG|2|||
128709813|NCT00897104|463232153|FG002|Overall Study|Abnormal Baseline ECG|0|||
128709814|NCT00897104|463232151|FG000|Overall Study|Need for Concom. Med.|0|||
128709815|NCT00897104|463232152|FG001|Overall Study|Need for Concom. Med.|1|||
128949284|NCT01120379|464101002|FG000|Three Year Timepoint|Physician Decision|9|||
128949285|NCT01120379|464101002|FG000|Three Year Timepoint|Any other reason for early termination|17|||
128949286|NCT01120379|464101002|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
128949287|NCT01120379|464101002|FG000|Four Year Timepoint|Lost to Follow-up|10|||
128949288|NCT01120379|464101002|FG000|Four Year Timepoint|Death|131|||
128949289|NCT01120379|464101002|FG000|Four Year Timepoint|Physician Decision|5|||
128949290|NCT01120379|464101002|FG000|Four Year Timepoint|Any other reason for early termination|217|||
129218776|NCT01263197|465101616|FG003|Third Intervention (Period 3)|Adverse Event|0|||
129218777|NCT01263197|465101617|FG004|Third Intervention (Period 3)|Adverse Event|0|||
128709816|NCT00897104|463232153|FG002|Overall Study|Need for Concom. Med.|1|||
128949291|NCT03162055|464101003|FG000|Overall Study|Adverse Event|6|||
129218778|NCT01263197|465101618|FG005|Third Intervention (Period 3)|Adverse Event|0|||
129218779|NCT00473382|465101619|FG000|Core Study|Adverse Event|3|||
129218780|NCT00473382|465101620|FG001|Core Study|Adverse Event|1|||
129218781|NCT00473382|465101621|FG002|Core Study|Adverse Event|1|||
128709817|NCT00897104|463232151|FG000|Overall Study|Lack of Migraine Attack|20|||
128709818|NCT00897104|463232152|FG001|Overall Study|Lack of Migraine Attack|22|||
128709819|NCT00897104|463232153|FG002|Overall Study|Lack of Migraine Attack|1|||
128709820|NCT00897104|463232151|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
128709821|NCT00897104|463232152|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128709822|NCT00897104|463232153|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128709823|NCT00897104|463232151|FG000|Overall Study|Other|3|||
128709824|NCT00897104|463232152|FG001|Overall Study|Other|0|||
128709825|NCT00897104|463232153|FG002|Overall Study|Other|0|||
128709826|NCT00897104|463232151|FG000|Overall Study|Protocol Violation|1|||
128709827|NCT00897104|463232152|FG001|Overall Study|Protocol Violation|0|||
128709828|NCT00897104|463232153|FG002|Overall Study|Protocol Violation|0|||
128709829|NCT00897104|463232151|FG000|Overall Study|Withdrawal by Subject|0|||
128709830|NCT00897104|463232152|FG001|Overall Study|Withdrawal by Subject|0|||
128709831|NCT00897104|463232153|FG002|Overall Study|Withdrawal by Subject|1|||
128709832|NCT00477971|463232154|FG000|Overall Study|Disease progression|6|||
128709833|NCT00477971|463232155|FG001|Overall Study|Disease progression|0|||
128709834|NCT00477971|463232154|FG000|Overall Study|Withdrawal by Subject|3|||
128709835|NCT00477971|463232155|FG001|Overall Study|Withdrawal by Subject|1|||
128709836|NCT00477971|463232154|FG000|Overall Study|Adverse Event|3|||
128709837|NCT00477971|463232155|FG001|Overall Study|Adverse Event|0|||
128709838|NCT00477971|463232154|FG000|Overall Study|Death|2|||
128709839|NCT00477971|463232155|FG001|Overall Study|Death|4|||
128709840|NCT00477971|463232154|FG000|Overall Study|Alternative treatment|3|||
128709841|NCT00477971|463232155|FG001|Overall Study|Alternative treatment|1|||
128709842|NCT03700671|463232156|FG000|Overall Study|Lack of Efficacy|1|||
128709843|NCT03700671|463232157|FG001|Overall Study|Lack of Efficacy|2|||
128709844|NCT04203238|463234316|FG000|Overall Study|Withdrawal by Subject|1|||
128709845|NCT04203238|463234317|FG001|Overall Study|Withdrawal by Subject|1|||
128709846|NCT04203238|463234316|FG000|Overall Study|Covid-19|3|||
128709847|NCT04203238|463234317|FG001|Overall Study|Covid-19|0|||
128709848|NCT01955733|463234318|FG000|Period 1|Lost to Follow-up|1|||
128709849|NCT01955733|463234319|FG001|Period 1|Lost to Follow-up|0|||
128709850|NCT01955733|463234320|FG002|Period 1|Lost to Follow-up|0|||
128709851|NCT01955733|463234318|FG000|Period 2|Adverse Event|1|||
128709852|NCT01955733|463234319|FG001|Period 2|Adverse Event|0|||
128709853|NCT01955733|463234320|FG002|Period 2|Adverse Event|0|||
128709854|NCT01955733|463234318|FG000|Period 2|Physician Decision|0|||
128709855|NCT01955733|463234319|FG001|Period 2|Physician Decision|0|||
128709856|NCT01955733|463234320|FG002|Period 2|Physician Decision|1|||
128709857|NCT01955733|463234318|FG000|Period 2|Withdrawal by Subject|1|||
128709858|NCT01955733|463234319|FG001|Period 2|Withdrawal by Subject|3|||
128949292|NCT03162055|464101004|FG001|Overall Study|Adverse Event|5|||
128949293|NCT03162055|464101003|FG000|Overall Study|Death|3|||
128949294|NCT03162055|464101004|FG001|Overall Study|Death|3|||
128949295|NCT03162055|464101003|FG000|Overall Study|Lost to Follow-up|0|||
128949296|NCT03162055|464101004|FG001|Overall Study|Lost to Follow-up|1|||
128949297|NCT03162055|464101003|FG000|Overall Study|Study-specific withdrawal criteria|22|||
128949298|NCT03162055|464101004|FG001|Overall Study|Study-specific withdrawal criteria|14|||
129034721|NCT01896505|464416549|FG004|Overall Study|Intercurrent illness|0|||
129034722|NCT01896505|464416550|FG005|Overall Study|Intercurrent illness|0|||
129034723|NCT01896505|464416545|FG000|Overall Study|Death|0|||
129034724|NCT01896505|464416546|FG001|Overall Study|Death|0|||
129034725|NCT01896505|464416547|FG002|Overall Study|Death|1|||
129034726|NCT01896505|464416548|FG003|Overall Study|Death|1|||
129034727|NCT01896505|464416549|FG004|Overall Study|Death|0|||
129034728|NCT01896505|464416550|FG005|Overall Study|Death|1|||
129034729|NCT04974580|464416551|FG000|Overall Study|Lost to Follow-up|33|||
129034730|NCT04974580|464416552|FG001|Overall Study|Lost to Follow-up|39|||
129034731|NCT04974580|464416553|FG002|Overall Study|Lost to Follow-up|30|||
129034732|NCT04974580|464416554|FG003|Overall Study|Lost to Follow-up|29|||
129034733|NCT03919695|464416569|FG000|3-month Follow-up|Death|1|||
129034734|NCT03919695|464416570|FG001|3-month Follow-up|Death|1|||
128709859|NCT01955733|463234320|FG002|Period 2|Withdrawal by Subject|2|||
128949299|NCT03162055|464101003|FG000|Overall Study|Withdrawal by Subject|17|||
128709860|NCT01955733|463234318|FG000|Period 2|Study terminated by sponsor|8|||
128709861|NCT01955733|463234319|FG001|Period 2|Study terminated by sponsor|14|||
128709862|NCT01955733|463234320|FG002|Period 2|Study terminated by sponsor|16|||
128709863|NCT01955733|463234318|FG000|Period 2|Lost to Follow-up|2|||
128709864|NCT01955733|463234319|FG001|Period 2|Lost to Follow-up|0|||
128709865|NCT01955733|463234320|FG002|Period 2|Lost to Follow-up|0|||
128949300|NCT03162055|464101004|FG001|Overall Study|Withdrawal by Subject|2|||
128949301|NCT03162055|464101003|FG000|Overall Study|Did not receive treatment|2|||
129034735|NCT03919695|464416569|FG000|3-month Follow-up|unable to contact|0|||
129034736|NCT03919695|464416570|FG001|3-month Follow-up|unable to contact|3|||
128709866|NCT01955733|463234318|FG000|Period 2|Other not defined above|0|||
128709867|NCT01955733|463234319|FG001|Period 2|Other not defined above|2|||
128709868|NCT01955733|463234320|FG002|Period 2|Other not defined above|2|||
128709869|NCT00733408|463234321|FG000|Overall Study|Adverse Event|4|||
129034737|NCT03919695|464416569|FG000|3-month Follow-up|in prison|0|||
128709870|NCT02762266|463234322|FG000|Overall Study|Physician Decision|2|||
128709871|NCT02762266|463234323|FG001|Overall Study|Physician Decision|0|||
128709872|NCT01438424|463234324|FG000|Overall Study|Continuing treatment|29|||
128709873|NCT01438424|463234324|FG000|Overall Study|Minimal virologic response|95|||
128949302|NCT03162055|464101004|FG001|Overall Study|Did not receive treatment|0|||
128949303|NCT03162055|464101003|FG000|Overall Study|Incorrect randomization|4|||
128949304|NCT03162055|464101004|FG001|Overall Study|Incorrect randomization|3|||
128949305|NCT03162055|464101003|FG000|Overall Study|Other|8|||
128949306|NCT03162055|464101004|FG001|Overall Study|Other|15|||
128949307|NCT00289185|464101014|FG000|Overall Study|Withdrawal by Subject|4|||
128949308|NCT00289185|464101015|FG001|Overall Study|Withdrawal by Subject|8|||
128949309|NCT00289185|464101014|FG000|Overall Study|Lost to Follow-up|23|||
128949310|NCT00289185|464101015|FG001|Overall Study|Lost to Follow-up|17|||
128949311|NCT00289185|464101014|FG000|Overall Study|Death|1|||
128949312|NCT00289185|464101015|FG001|Overall Study|Death|1|||
128949313|NCT02432040|464101018|FG000|Overall Study|Lack of Efficacy|3|||
128949314|NCT02432040|464101019|FG001|Overall Study|Lack of Efficacy|0|||
128949315|NCT02432040|464101018|FG000|Overall Study|Lost to Follow-up|4|||
128949316|NCT02432040|464101019|FG001|Overall Study|Lost to Follow-up|5|||
128949317|NCT02432040|464101018|FG000|Overall Study|Physician Decision|1|||
128949318|NCT02432040|464101019|FG001|Overall Study|Physician Decision|1|||
128949319|NCT05836818|464101022|FG000|Overall Study|Physician Decision|1|||
128949320|NCT05836818|464101023|FG001|Overall Study|Physician Decision|1|||
128949321|NCT05836818|464101024|FG002|Overall Study|Physician Decision|0|||
128709874|NCT01438424|463234324|FG000|Overall Study|Not identified|55|||
128709875|NCT01438424|463234324|FG000|Overall Study|Withdrawal by Subject|104|||
128709876|NCT01438424|463234324|FG000|Overall Study|Progression of chronic hepatitis B|22|||
128709877|NCT01438424|463234324|FG000|Overall Study|Death|22|||
129125116|NCT03329001|464753602|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
128709878|NCT01438424|463234324|FG000|Overall Study|Adverse Event|17|||
129125117|NCT03329001|464753603|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
129125118|NCT03329001|464753604|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
129125119|NCT03329001|464753605|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129125120|NCT03329001|464753606|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129125121|NCT03329001|464753607|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129125122|NCT03329001|464753608|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129125123|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129125124|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129125125|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129125126|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
129125127|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129125128|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129125129|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129125130|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129125131|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129125132|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129125133|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129125134|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
129125135|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129125136|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129125137|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129125138|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129125139|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129125140|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129125141|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129125142|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
129125143|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129218782|NCT00473382|465101619|FG000|Core Study|Death|3|||
129218783|NCT00473382|465101620|FG001|Core Study|Death|5|||
128709879|NCT01438424|463234324|FG000|Overall Study|Lost to Follow-up|17|||
128709880|NCT01438424|463234324|FG000|Overall Study|Abnormal laboratory test result|14|||
128709881|NCT01438424|463234324|FG000|Overall Study|Need for drug prohibited by protocol|14|||
128949322|NCT05836818|464101022|FG000|Overall Study|Withdrawal by Subject|0|||
128709882|NCT01438424|463234324|FG000|Overall Study|Pregnancy|7|||
128709883|NCT01438424|463234324|FG000|Overall Study|No longer met inclusion criteria|1|||
128709884|NCT01438424|463234324|FG000|Overall Study|Participant noncompliance|20|||
128949323|NCT05836818|464101023|FG001|Overall Study|Withdrawal by Subject|0|||
128949324|NCT05836818|464101024|FG002|Overall Study|Withdrawal by Subject|1|||
128949325|NCT05836818|464101022|FG000|Overall Study|Later found to be previously vaccinated|0|||
128709885|NCT02141282|463234329|FG000|Overall Study|Adverse event, not related to progression|8|||
128709886|NCT02141282|463234330|FG001|Overall Study|Adverse event, not related to progression|1|||
128709887|NCT02141282|463234331|FG002|Overall Study|Adverse event, not related to progression|3|||
128709888|NCT02141282|463234332|FG003|Overall Study|Adverse event, not related to progression|1|||
128709889|NCT02141282|463234329|FG000|Overall Study|Adverse event, related to progression|1|||
128949326|NCT05836818|464101023|FG001|Overall Study|Later found to be previously vaccinated|1|||
128949327|NCT05836818|464101024|FG002|Overall Study|Later found to be previously vaccinated|3|||
128949328|NCT05836818|464101022|FG000|Overall Study|Pregnancy|0|||
128949329|NCT05836818|464101023|FG001|Overall Study|Pregnancy|1|||
128949330|NCT05836818|464101024|FG002|Overall Study|Pregnancy|0|||
128949331|NCT05836818|464101022|FG000|Overall Study|Allergic to vaccines|0|||
128949332|NCT05836818|464101023|FG001|Overall Study|Allergic to vaccines|1|||
128949333|NCT05836818|464101024|FG002|Overall Study|Allergic to vaccines|0|||
128949334|NCT03977727|464101025|FG000|Second Treatment|Lost to Follow-up|0|||
128949335|NCT03977727|464101026|FG001|Second Treatment|Lost to Follow-up|3|||
128949336|NCT00621855|464101039|FG000|Overall Study|Adverse Event|32|||
128949337|NCT00621855|464101040|FG001|Overall Study|Adverse Event|31|||
128949338|NCT00621855|464101041|FG002|Overall Study|Adverse Event|48|||
128949339|NCT00621855|464101042|FG003|Overall Study|Adverse Event|34|||
128949340|NCT00621855|464101043|FG004|Overall Study|Adverse Event|31|||
128949341|NCT00621855|464101039|FG000|Overall Study|Lost to Follow-up|0|||
128949342|NCT00621855|464101040|FG001|Overall Study|Lost to Follow-up|1|||
128949343|NCT00621855|464101041|FG002|Overall Study|Lost to Follow-up|3|||
128949344|NCT00621855|464101042|FG003|Overall Study|Lost to Follow-up|4|||
128949345|NCT00621855|464101043|FG004|Overall Study|Lost to Follow-up|1|||
128949346|NCT00621855|464101039|FG000|Overall Study|Protocol Violation|16|||
128949347|NCT00621855|464101040|FG001|Overall Study|Protocol Violation|8|||
128949348|NCT00621855|464101041|FG002|Overall Study|Protocol Violation|6|||
128949349|NCT00621855|464101042|FG003|Overall Study|Protocol Violation|7|||
128949350|NCT00621855|464101043|FG004|Overall Study|Protocol Violation|8|||
128949351|NCT00621855|464101039|FG000|Overall Study|Withdrawal by Subject|16|||
128949352|NCT00621855|464101040|FG001|Overall Study|Withdrawal by Subject|11|||
128949353|NCT00621855|464101041|FG002|Overall Study|Withdrawal by Subject|13|||
128949354|NCT00621855|464101042|FG003|Overall Study|Withdrawal by Subject|13|||
128949355|NCT00621855|464101043|FG004|Overall Study|Withdrawal by Subject|9|||
128949356|NCT00621855|464101039|FG000|Overall Study|Other|9|||
128949357|NCT00621855|464101040|FG001|Overall Study|Other|7|||
128949358|NCT00621855|464101041|FG002|Overall Study|Other|6|||
128949359|NCT00621855|464101042|FG003|Overall Study|Other|5|||
128949360|NCT00621855|464101043|FG004|Overall Study|Other|4|||
128949361|NCT00621855|464101039|FG000|Overall Study|Patients did not receive study drug|3|||
128949362|NCT00621855|464101040|FG001|Overall Study|Patients did not receive study drug|3|||
128949363|NCT00621855|464101041|FG002|Overall Study|Patients did not receive study drug|5|||
128949364|NCT00621855|464101042|FG003|Overall Study|Patients did not receive study drug|4|||
128949365|NCT00621855|464101043|FG004|Overall Study|Patients did not receive study drug|2|||
128949366|NCT02953782|464101044|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
128949367|NCT02953782|464101045|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
128949368|NCT02953782|464101046|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
128949369|NCT02953782|464101047|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
128949370|NCT02953782|464101048|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
128949371|NCT02953782|464101049|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
128949372|NCT02953782|464101050|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
128949373|NCT02953782|464101051|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
128949374|NCT02953782|464101044|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
128949375|NCT02953782|464101045|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
128949376|NCT02953782|464101046|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
128949377|NCT02953782|464101047|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
128949378|NCT02953782|464101048|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
128949379|NCT02953782|464101049|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
128949380|NCT02953782|464101050|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
128949381|NCT02953782|464101051|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
128949382|NCT02953782|464101044|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
128949383|NCT02953782|464101045|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
128949384|NCT02953782|464101046|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
128949385|NCT02953782|464101047|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
128949386|NCT02953782|464101048|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
128949387|NCT02953782|464101049|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
128949388|NCT02953782|464101050|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
128949389|NCT02953782|464101051|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
128949390|NCT02953782|464101044|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
129034738|NCT03919695|464416570|FG001|3-month Follow-up|in prison|1|||
129034739|NCT03919695|464416569|FG000|6-month Follow-up|Death|0|||
129034740|NCT03919695|464416570|FG001|6-month Follow-up|Death|1|||
129034741|NCT03919695|464416569|FG000|6-month Follow-up|Lost to Follow-up|1|||
129034742|NCT03919695|464416570|FG001|6-month Follow-up|Lost to Follow-up|2|||
129034743|NCT03919695|464416569|FG000|6-month Follow-up|in prison|0|||
129034744|NCT03919695|464416570|FG001|6-month Follow-up|in prison|2|||
129034745|NCT03919695|464416569|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
129034746|NCT03919695|464416570|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
129034747|NCT03919695|464416569|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
129034748|NCT03919695|464416570|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
129034749|NCT03259789|464416571|FG000|Overall Study|Adverse Event|3|||
129034750|NCT03259789|464416572|FG001|Overall Study|Adverse Event|2|||
129034751|NCT03259789|464416573|FG002|Overall Study|Adverse Event|1|||
129034752|NCT03259789|464416571|FG000|Overall Study|Withdrawal by Subject|9|||
129034753|NCT03259789|464416572|FG001|Overall Study|Withdrawal by Subject|5|||
129034754|NCT03259789|464416573|FG002|Overall Study|Withdrawal by Subject|1|||
129034755|NCT03259789|464416571|FG000|Overall Study|Lost to Follow-up|5|||
129034756|NCT03259789|464416572|FG001|Overall Study|Lost to Follow-up|9|||
129034757|NCT03259789|464416573|FG002|Overall Study|Lost to Follow-up|4|||
129034758|NCT03259789|464416571|FG000|Overall Study|Physician Decision|0|||
129034759|NCT03259789|464416572|FG001|Overall Study|Physician Decision|1|||
129034760|NCT03259789|464416573|FG002|Overall Study|Physician Decision|0|||
129034761|NCT02063217|464416574|FG000|Overall Study|Withdrawal by Subject|1|||
129034762|NCT02063217|464416575|FG001|Overall Study|Withdrawal by Subject|0|||
129034763|NCT02063217|464416576|FG002|Overall Study|Withdrawal by Subject|0|||
129034764|NCT02416934|464416577|FG000|Overall Study|given steroids|1|||
129034765|NCT02416934|464416578|FG001|Overall Study|given steroids|2|||
129034766|NCT02416934|464416577|FG000|Overall Study|Lost to Follow-up|0|||
129034767|NCT02416934|464416578|FG001|Overall Study|Lost to Follow-up|2|||
129034768|NCT02416934|464416577|FG000|Overall Study|Withdrawal by Subject|1|||
129034769|NCT02416934|464416578|FG001|Overall Study|Withdrawal by Subject|0|||
129034770|NCT02416934|464416577|FG000|Overall Study|recruited during continuing renewal proc|0|||
129034771|NCT02416934|464416578|FG001|Overall Study|recruited during continuing renewal proc|1|||
129034772|NCT02416934|464416577|FG000|Overall Study|Protocol Violation|0|||
129034773|NCT02416934|464416578|FG001|Overall Study|Protocol Violation|1|||
129034774|NCT02416934|464416577|FG000|Overall Study|surgery started late|0|||
129034775|NCT02416934|464416578|FG001|Overall Study|surgery started late|1|||
128949391|NCT02953782|464101045|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
128949392|NCT02953782|464101046|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
128949393|NCT02953782|464101047|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
128949394|NCT02953782|464101048|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
128949395|NCT02953782|464101049|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
128949396|NCT02953782|464101050|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
128709890|NCT02141282|463234330|FG001|Overall Study|Adverse event, related to progression|0|||
128709891|NCT02141282|463234331|FG002|Overall Study|Adverse event, related to progression|2|||
128709892|NCT02141282|463234332|FG003|Overall Study|Adverse event, related to progression|0|||
128709893|NCT02141282|463234329|FG000|Overall Study|COVID-19 infection|1|||
128709894|NCT02141282|463234330|FG001|Overall Study|COVID-19 infection|0|||
128709895|NCT02141282|463234331|FG002|Overall Study|COVID-19 infection|0|||
128709896|NCT02141282|463234332|FG003|Overall Study|COVID-19 infection|0|||
128709897|NCT02141282|463234329|FG000|Overall Study|Lost to Follow-up|0|||
128709898|NCT02141282|463234330|FG001|Overall Study|Lost to Follow-up|0|||
128709899|NCT02141282|463234331|FG002|Overall Study|Lost to Follow-up|4|||
128709900|NCT02141282|463234332|FG003|Overall Study|Lost to Follow-up|2|||
128949397|NCT02953782|464101051|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
128949398|NCT02953782|464101044|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
128949399|NCT02953782|464101045|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
128949400|NCT02953782|464101046|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
128949401|NCT02953782|464101047|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
128949402|NCT02953782|464101048|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
128949403|NCT02953782|464101049|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
128949404|NCT02953782|464101050|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
128949405|NCT02953782|464101051|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
128949406|NCT02953782|464101044|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
129034776|NCT02416934|464416577|FG000|Overall Study|re-operation|1|||
129034777|NCT02416934|464416578|FG001|Overall Study|re-operation|0|||
129034778|NCT01020526|464416579|FG000|Overall Study|Withdrawal by Subject|5|||
129034779|NCT01020526|464416579|FG000|Overall Study|Other reasons|3|||
129034780|NCT01020526|464416579|FG000|Overall Study|Insufficient clinical response|3|||
129125144|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129034781|NCT01020526|464416579|FG000|Overall Study|Lost to Follow-up|1|||
129034782|NCT01020526|464416579|FG000|Overall Study|Adverse Event|2|||
129034783|NCT02169336|464416584|FG000|Overall Study|Lack of Efficacy|1|||
129034784|NCT02169336|464416585|FG001|Overall Study|Lack of Efficacy|1|||
128949407|NCT02953782|464101045|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
128949408|NCT02953782|464101046|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
128949409|NCT02953782|464101047|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
128949410|NCT02953782|464101048|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
128949411|NCT02953782|464101049|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
128949412|NCT02953782|464101050|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
128949413|NCT02953782|464101051|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
128949414|NCT02953782|464101044|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
128949415|NCT02953782|464101045|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
128949416|NCT02953782|464101046|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
128949417|NCT02953782|464101047|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
128949418|NCT02953782|464101048|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
128949419|NCT02953782|464101049|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
128949420|NCT02953782|464101050|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
128949421|NCT02953782|464101051|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
128949422|NCT02953782|464101044|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
128949423|NCT02953782|464101045|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
128949424|NCT02953782|464101046|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
128949425|NCT02953782|464101047|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
128949426|NCT02953782|464101048|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
128949427|NCT02953782|464101049|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
128949428|NCT02953782|464101050|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
128949429|NCT02953782|464101051|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
128949430|NCT01737840|464101052|FG000|Overall Study|Diagnosed with an other pathology|2|||
128949431|NCT01737840|464101053|FG001|Overall Study|Diagnosed with an other pathology|2|||
128949432|NCT03105700|464101056|FG000|Overall Study|screen fail|3|||
128949433|NCT03105700|464101056|FG000|Overall Study|Lost to Follow-up|4|||
128949434|NCT00403559|464101057|FG000|Overall Study|Adverse Event|0|||
128949435|NCT00403559|464101058|FG001|Overall Study|Adverse Event|1|||
128949436|NCT00403559|464101057|FG000|Overall Study|Lost to Follow-up|3|||
128949437|NCT00403559|464101058|FG001|Overall Study|Lost to Follow-up|3|||
128949438|NCT00403559|464101057|FG000|Overall Study|Withdrawal by Subject|1|||
128949439|NCT00403559|464101058|FG001|Overall Study|Withdrawal by Subject|0|||
128949440|NCT01253421|464101059|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
128949441|NCT01253421|464101060|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
128949442|NCT01253421|464101061|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
128949443|NCT01253421|464101062|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
128949444|NCT01253421|464101063|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
128949445|NCT01253421|464101059|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
128949446|NCT01253421|464101060|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
128949447|NCT01253421|464101061|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
128949448|NCT01253421|464101062|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
128949449|NCT01253421|464101063|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
128709901|NCT02141282|463234329|FG000|Overall Study|Other, not specified|14|||
128709902|NCT02141282|463234330|FG001|Overall Study|Other, not specified|11|||
128709903|NCT02141282|463234331|FG002|Overall Study|Other, not specified|23|||
128709904|NCT02141282|463234332|FG003|Overall Study|Other, not specified|9|||
128709905|NCT02141282|463234329|FG000|Overall Study|Progressive disease, Richter's|4|||
128709906|NCT02141282|463234330|FG001|Overall Study|Progressive disease, Richter's|1|||
128709907|NCT02141282|463234331|FG002|Overall Study|Progressive disease, Richter's|1|||
128709908|NCT02141282|463234332|FG003|Overall Study|Progressive disease, Richter's|1|||
128709909|NCT02141282|463234329|FG000|Overall Study|Progressive disease per protocol|12|||
128709910|NCT02141282|463234330|FG001|Overall Study|Progressive disease per protocol|7|||
128709911|NCT02141282|463234331|FG002|Overall Study|Progressive disease per protocol|9|||
128709912|NCT02141282|463234332|FG003|Overall Study|Progressive disease per protocol|2|||
128709913|NCT02141282|463234329|FG000|Overall Study|Stem cell transplant|1|||
128709914|NCT02141282|463234330|FG001|Overall Study|Stem cell transplant|0|||
128709915|NCT02141282|463234331|FG002|Overall Study|Stem cell transplant|1|||
128709916|NCT02141282|463234332|FG003|Overall Study|Stem cell transplant|0|||
128709917|NCT02141282|463234329|FG000|Overall Study|Study terminated by Sponsor|0|||
128709918|NCT02141282|463234330|FG001|Overall Study|Study terminated by Sponsor|1|||
128709919|NCT02141282|463234331|FG002|Overall Study|Study terminated by Sponsor|0|||
128709920|NCT02141282|463234332|FG003|Overall Study|Study terminated by Sponsor|0|||
128709921|NCT02141282|463234329|FG000|Overall Study|Subject non-compliance|0|||
128709922|NCT02141282|463234330|FG001|Overall Study|Subject non-compliance|0|||
128709923|NCT02141282|463234331|FG002|Overall Study|Subject non-compliance|1|||
128709924|NCT02141282|463234332|FG003|Overall Study|Subject non-compliance|0|||
128709925|NCT02141282|463234329|FG000|Overall Study|Withdrew consent|2|||
128709926|NCT02141282|463234330|FG001|Overall Study|Withdrew consent|0|||
128709927|NCT02141282|463234331|FG002|Overall Study|Withdrew consent|4|||
128709928|NCT02141282|463234332|FG003|Overall Study|Withdrew consent|0|||
128709929|NCT01752907|463234333|FG000|Overall Study|Withdrawal by Subject|4|||
128709930|NCT01752907|463234334|FG001|Overall Study|Withdrawal by Subject|10|||
128709931|NCT01752907|463234333|FG000|Overall Study|Lost to Follow-up|2|||
128709932|NCT01752907|463234334|FG001|Overall Study|Lost to Follow-up|1|||
128709933|NCT01752907|463234333|FG000|Overall Study|Decision by Sponsor|6|||
128709934|NCT01752907|463234334|FG001|Overall Study|Decision by Sponsor|9|||
128949450|NCT01253421|464101059|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
128949451|NCT01253421|464101060|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
128949452|NCT01253421|464101061|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
128949453|NCT01253421|464101062|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
128949454|NCT01253421|464101063|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
128949455|NCT01253421|464101059|FG000|Assessment and Scheduling|Physician Decision|1|||
128949456|NCT01253421|464101060|FG001|Assessment and Scheduling|Physician Decision|0|||
128949457|NCT01253421|464101061|FG002|Assessment and Scheduling|Physician Decision|0|||
128949458|NCT01253421|464101062|FG003|Assessment and Scheduling|Physician Decision|0|||
128949459|NCT01253421|464101063|FG004|Assessment and Scheduling|Physician Decision|0|||
128949460|NCT01253421|464101059|FG000|Drug+Scanning Visit|Physician Decision|0|||
128709935|NCT02692716|463234336|FG000|Overall Study|Lost to Follow-up|2|||
128709936|NCT02692716|463234337|FG001|Overall Study|Lost to Follow-up|5|||
128709937|NCT02692716|463234336|FG000|Overall Study|Withdrawal by Subject|3|||
128709938|NCT02692716|463234337|FG001|Overall Study|Withdrawal by Subject|1|||
128709939|NCT02782780|463234338|FG000|Overall Study|dropped out after randomization.|7|||
128709940|NCT02782780|463234339|FG001|Overall Study|dropped out after randomization.|5|||
128709941|NCT02782780|463234338|FG000|Overall Study|Protocol Violation|0|||
128709942|NCT02782780|463234339|FG001|Overall Study|Protocol Violation|2|||
128949461|NCT01253421|464101060|FG001|Drug+Scanning Visit|Physician Decision|0|||
128949462|NCT01253421|464101061|FG002|Drug+Scanning Visit|Physician Decision|0|||
128949463|NCT01253421|464101062|FG003|Drug+Scanning Visit|Physician Decision|0|||
128949464|NCT01253421|464101063|FG004|Drug+Scanning Visit|Physician Decision|1|||
128949465|NCT00929734|464101064|FG000|Overall Study|Lost to Follow-up|2|||
128949466|NCT00929734|464101065|FG001|Overall Study|Lost to Follow-up|1|||
128949467|NCT00929734|464101064|FG000|Overall Study|Withdrawal by Subject|0|||
128709943|NCT03562481|463234340|FG000|First Intervention|Lost to Follow-up|1|||
128709944|NCT03562481|463234341|FG001|First Intervention|Lost to Follow-up|0|||
128709945|NCT01413191|463234342|FG000|Overall Study|Lost to Follow-up|5|||
128709946|NCT01413191|463234342|FG000|Overall Study|Disease Progression|5|||
128709947|NCT01413191|463234342|FG000|Overall Study|Death|1|||
128709948|NCT01702454|463234343|FG000|Overall Study|Consent withdrawal|0|||
128709949|NCT01702454|463234344|FG001|Overall Study|Consent withdrawal|1|||
128709950|NCT01702454|463234343|FG000|Overall Study|Migrated/moved from study area|0|||
128709951|NCT01702454|463234344|FG001|Overall Study|Migrated/moved from study area|1|||
128709952|NCT01702454|463234343|FG000|Overall Study|Lost to Follow-up|3|||
128709953|NCT01702454|463234344|FG001|Overall Study|Lost to Follow-up|6|||
128709954|NCT03510884|463234345|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
128709955|NCT03510884|463234346|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
128709956|NCT03510884|463234347|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
128709957|NCT03510884|463234348|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
128709958|NCT03510884|463234345|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
128709959|NCT03510884|463234346|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
128709960|NCT03510884|463234347|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
128709961|NCT03510884|463234348|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
128949468|NCT00929734|464101065|FG001|Overall Study|Withdrawal by Subject|2|||
128949469|NCT00980980|464101067|FG000|Overall Study|Withdrawal by Hospital|0|||
128949470|NCT00980980|464101068|FG001|Overall Study|Withdrawal by Hospital|1|||
129034785|NCT02169336|464416586|FG002|Overall Study|Lack of Efficacy|0|||
129034786|NCT02169336|464416584|FG000|Overall Study|Adverse Event|2|||
129034787|NCT02169336|464416585|FG001|Overall Study|Adverse Event|3|||
129034788|NCT02169336|464416586|FG002|Overall Study|Adverse Event|1|||
129034789|NCT02169336|464416584|FG000|Overall Study|Withdrawal by Subject|1|||
129034790|NCT02169336|464416585|FG001|Overall Study|Withdrawal by Subject|0|||
129034791|NCT02169336|464416586|FG002|Overall Study|Withdrawal by Subject|0|||
129034792|NCT02169336|464416584|FG000|Overall Study|Physician Decision|0|||
129034793|NCT02169336|464416585|FG001|Overall Study|Physician Decision|0|||
129034794|NCT02169336|464416586|FG002|Overall Study|Physician Decision|1|||
129034795|NCT02169336|464416584|FG000|Overall Study|Subject declined to continue dosing|0|||
129034796|NCT02169336|464416585|FG001|Overall Study|Subject declined to continue dosing|0|||
129034797|NCT02169336|464416586|FG002|Overall Study|Subject declined to continue dosing|1|||
129125145|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129125146|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129125147|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129125148|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129125149|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
128949471|NCT00980980|464101069|FG002|Overall Study|Withdrawal by Hospital|0|||
128949472|NCT00121992|464101070|FG000|Overall Study|Treatment not received|2|||
128949473|NCT00121992|464101071|FG001|Overall Study|Treatment not received|11|||
128949474|NCT01449682|464101072|FG000|Overall Study|Death|0|||
128949475|NCT01449682|464101073|FG001|Overall Study|Death|1|||
128949476|NCT01449682|464101072|FG000|Overall Study|Adverse Event|1|||
128949477|NCT01449682|464101073|FG001|Overall Study|Adverse Event|0|||
128949478|NCT04863014|464101074|FG000|Overall Study|Lost to Follow-up|3|||
128949479|NCT04863014|464101075|FG001|Overall Study|Lost to Follow-up|2|||
128949480|NCT04863014|464101074|FG000|Overall Study|Subject Decision|0|||
128949481|NCT04863014|464101075|FG001|Overall Study|Subject Decision|4|||
128949482|NCT04633473|464101076|FG000|Overall Study|Withdrawal by Subject|6|||
128949483|NCT01553916|464101077|FG000|Overall Study|Withdrawal by Subject|2|||
128949484|NCT01553916|464101077|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
128949485|NCT03089216|464101080|FG000|Overall Study|Adverse Event|0|||
128949486|NCT03089216|464101081|FG001|Overall Study|Adverse Event|0|||
128949487|NCT03089216|464101082|FG002|Overall Study|Adverse Event|0|||
128949488|NCT03089216|464101083|FG003|Overall Study|Adverse Event|1|||
128949489|NCT04348591|464101086|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
128949490|NCT04348591|464101087|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
128949491|NCT04348591|464101086|FG000|Imaging Session (120 Min)|Physician Decision|0|||
129125150|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129125151|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129125152|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129125153|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129125154|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129125155|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129125156|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129125157|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
129125158|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129125159|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128770378|NCT00147225|463450231|FG001|Overall Study|Chemotherapy Changed|0|||
128770379|NCT00147225|463450232|FG002|Overall Study|Chemotherapy Changed|0|||
128770380|NCT00147225|463450233|FG003|Overall Study|Chemotherapy Changed|0|||
128949492|NCT04348591|464101087|FG001|Imaging Session (120 Min)|Physician Decision|1|||
128949493|NCT04348591|464101086|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
128949494|NCT04348591|464101087|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
128949495|NCT00417976|464101088|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
128949496|NCT00417976|464101088|FG000|Overall Study|Treatment -related toxicity|2|||
128949497|NCT02104804|464101093|FG000|Overall Study|Did not take study medication|0|||
128949498|NCT02104804|464101094|FG001|Overall Study|Did not take study medication|1|||
128949499|NCT02104804|464101093|FG000|Overall Study|Study specific discontinuation criteria|6|||
128949500|NCT02104804|464101094|FG001|Overall Study|Study specific discontinuation criteria|1|||
128949501|NCT02104804|464101093|FG000|Overall Study|Other listed|2|||
128949502|NCT02104804|464101094|FG001|Overall Study|Other listed|1|||
128949503|NCT02104804|464101093|FG000|Overall Study|Protocol Violation|0|||
128949504|NCT02104804|464101094|FG001|Overall Study|Protocol Violation|1|||
128949505|NCT02104804|464101093|FG000|Overall Study|Adverse Event|4|||
128949506|NCT02104804|464101094|FG001|Overall Study|Adverse Event|3|||
128949507|NCT02104804|464101093|FG000|Overall Study|Withdrawal by Subject|4|||
128949508|NCT02104804|464101094|FG001|Overall Study|Withdrawal by Subject|12|||
128949509|NCT02720016|464101095|FG000|Overall Study|Separation of couple|6|||
128949510|NCT02720016|464101096|FG001|Overall Study|Separation of couple|8|||
128949511|NCT02720016|464101097|FG002|Overall Study|Separation of couple|2|||
128949512|NCT02720016|464101095|FG000|Overall Study|Withdrawal by Subject|6|||
128949513|NCT02720016|464101096|FG001|Overall Study|Withdrawal by Subject|6|||
128949514|NCT02720016|464101097|FG002|Overall Study|Withdrawal by Subject|4|||
128949515|NCT02720016|464101095|FG000|Overall Study|Scheduling issues|2|||
128949516|NCT02720016|464101096|FG001|Overall Study|Scheduling issues|4|||
128949517|NCT02720016|464101097|FG002|Overall Study|Scheduling issues|7|||
128949518|NCT02720016|464101095|FG000|Overall Study|Childcare|2|||
128949519|NCT02720016|464101096|FG001|Overall Study|Childcare|0|||
128949520|NCT02720016|464101097|FG002|Overall Study|Childcare|2|||
128949521|NCT02720016|464101095|FG000|Overall Study|Withdrawal by PI|2|||
128949522|NCT02720016|464101096|FG001|Overall Study|Withdrawal by PI|2|||
128949523|NCT02720016|464101097|FG002|Overall Study|Withdrawal by PI|0|||
128949524|NCT02720016|464101095|FG000|Overall Study|Moved away|2|||
128949525|NCT02720016|464101096|FG001|Overall Study|Moved away|0|||
128949526|NCT02720016|464101097|FG002|Overall Study|Moved away|0|||
128949527|NCT02720016|464101095|FG000|Overall Study|Not Primary Health Concern|0|||
128949528|NCT02720016|464101096|FG001|Overall Study|Not Primary Health Concern|0|||
128949529|NCT02720016|464101097|FG002|Overall Study|Not Primary Health Concern|2|||
128949530|NCT02720016|464101095|FG000|Overall Study|Transportation issues|0|||
128949531|NCT02720016|464101096|FG001|Overall Study|Transportation issues|0|||
128949532|NCT02720016|464101097|FG002|Overall Study|Transportation issues|1|||
128949533|NCT02720016|464101095|FG000|Overall Study|Other|0|||
128949534|NCT02720016|464101096|FG001|Overall Study|Other|0|||
128709962|NCT03510884|463234345|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
128709963|NCT03510884|463234346|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
128709964|NCT03510884|463234347|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
128709965|NCT03510884|463234348|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
128709966|NCT03510884|463234345|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
128709967|NCT03510884|463234346|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
128770381|NCT00147225|463450234|FG004|Overall Study|Chemotherapy Changed|0|||
128770382|NCT00147225|463450235|FG005|Overall Study|Chemotherapy Changed|1|||
128770383|NCT02049710|463450238|FG000|Overall Study|Lost to Follow-up|319|||
128770384|NCT02049710|463450239|FG001|Overall Study|Lost to Follow-up|324|||
128770385|NCT03713021|463450242|FG000|Overall Study|Did not have CT sim scan available|6|||
128770386|NCT03713021|463450242|FG000|Overall Study|Not eligible|4|||
128709968|NCT03510884|463234347|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
128709969|NCT03510884|463234348|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
128709970|NCT03510884|463234345|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
128709971|NCT03510884|463234346|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
128709972|NCT03510884|463234347|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
128709973|NCT03510884|463234348|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
128709974|NCT03510884|463234345|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
128770387|NCT03713021|463450242|FG000|Overall Study|Issues with TraceIT markers|5|||
128770388|NCT00386308|463451491|FG000|Overall Study|Adverse Event|3|||
128770389|NCT00386308|463451492|FG001|Overall Study|Adverse Event|3|||
128709975|NCT03510884|463234346|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
128709976|NCT03510884|463234347|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
128709977|NCT03510884|463234348|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
128709978|NCT03510884|463234345|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
128709979|NCT03510884|463234346|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
128709980|NCT03510884|463234347|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
128709981|NCT03510884|463234348|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
128709982|NCT03510884|463234345|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
128770390|NCT00386308|463451491|FG000|Overall Study|Protocol Violation|2|||
128770391|NCT00386308|463451492|FG001|Overall Study|Protocol Violation|5|||
128770392|NCT00386308|463451491|FG000|Overall Study|Lack of Efficacy|0|||
128770393|NCT00386308|463451492|FG001|Overall Study|Lack of Efficacy|2|||
128770394|NCT00386308|463451491|FG000|Overall Study|Lost to Follow-up|10|||
128770395|NCT00386308|463451492|FG001|Overall Study|Lost to Follow-up|6|||
128770396|NCT00386308|463451491|FG000|Overall Study|Withdrawal by Subject|6|||
128770397|NCT00386308|463451492|FG001|Overall Study|Withdrawal by Subject|2|||
128709983|NCT03510884|463234346|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
128709984|NCT03510884|463234347|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
128709985|NCT03510884|463234348|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
128709986|NCT03510884|463234345|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
128709987|NCT03510884|463234346|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
128709988|NCT03510884|463234347|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
128709989|NCT03510884|463234348|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
128709990|NCT03510884|463234345|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
128709991|NCT03510884|463234346|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
128709992|NCT03510884|463234347|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
128709993|NCT03510884|463234348|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
128709994|NCT01124422|463234353|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
128709995|NCT01124422|463234354|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
128709996|NCT01124422|463234355|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
128709997|NCT01124422|463234353|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
128709998|NCT01124422|463234354|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
128770398|NCT00386308|463451491|FG000|Overall Study|Other Event|8|||
128770399|NCT00386308|463451492|FG001|Overall Study|Other Event|1|||
128770400|NCT02906683|463451493|FG000|Overall Study|Adverse Event|0|||
128770401|NCT02906683|463451494|FG001|Overall Study|Adverse Event|1|||
128770402|NCT02906683|463451495|FG002|Overall Study|Adverse Event|0|||
128770403|NCT02906683|463451493|FG000|Overall Study|Physician Decision|0|||
128949535|NCT02720016|464101097|FG002|Overall Study|Other|2|||
128949536|NCT01968954|464101104|FG000|Overall Study|Adverse Event|6|||
128709999|NCT01124422|463234355|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
128710000|NCT01124422|463234353|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
128710001|NCT01124422|463234354|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
128710002|NCT01124422|463234355|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
128710003|NCT01124422|463234353|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
128710004|NCT01124422|463234354|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
128710005|NCT01124422|463234355|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
128710006|NCT01124422|463234353|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
128710007|NCT01124422|463234354|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
128710008|NCT01124422|463234355|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
128710009|NCT01124422|463234353|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
128710010|NCT01124422|463234354|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
128710011|NCT01124422|463234355|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
128710012|NCT01124422|463234353|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
128710013|NCT01124422|463234354|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
128710014|NCT01124422|463234355|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
128710015|NCT01124422|463234353|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
128710016|NCT01124422|463234354|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
128710017|NCT01124422|463234355|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
128710018|NCT01124422|463234353|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
128710019|NCT01124422|463234354|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
128710020|NCT01124422|463234355|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
128710021|NCT01124422|463234353|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
128710022|NCT01124422|463234354|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
128770404|NCT02906683|463451494|FG001|Overall Study|Physician Decision|1|||
128770405|NCT02906683|463451495|FG002|Overall Study|Physician Decision|1|||
128949537|NCT01968954|464101105|FG001|Overall Study|Adverse Event|3|||
128949538|NCT01968954|464101104|FG000|Overall Study|Death|1|||
129125160|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
128770406|NCT02906683|463451493|FG000|Overall Study|Withdrawal by Subject|0|||
128770407|NCT02906683|463451494|FG001|Overall Study|Withdrawal by Subject|2|||
128770408|NCT02906683|463451495|FG002|Overall Study|Withdrawal by Subject|1|||
128770409|NCT02906683|463451493|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
128770410|NCT02906683|463451494|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
128770411|NCT02906683|463451495|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
128770412|NCT02906683|463451493|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
128770413|NCT02906683|463451494|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
128770414|NCT02906683|463451495|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
128770415|NCT01340482|463451496|FG000|Overall Study|Adverse Event|2|||
128770416|NCT01340482|463451497|FG001|Overall Study|Adverse Event|0|||
128770417|NCT01340482|463451498|FG002|Overall Study|Adverse Event|0|||
128770418|NCT01282476|463451499|FG000|Overall Study|Death|11|||
128770419|NCT00437125|463451502|FG000|Overall Study|Adverse Event|12|||
128770420|NCT00437125|463451502|FG000|Overall Study|Death|1|||
128770421|NCT00437125|463451502|FG000|Overall Study|Clinical Relapse|1|||
128770422|NCT00437125|463451502|FG000|Overall Study|Lack of Efficacy|1|||
128770423|NCT00437125|463451502|FG000|Overall Study|Lost to Follow-up|1|||
128770424|NCT00437125|463451502|FG000|Overall Study|Withdrawal by Subject|13|||
128770425|NCT00437125|463451502|FG000|Overall Study|Withdrawal by Caregiver|2|||
128770426|NCT00437125|463451502|FG000|Overall Study|Physician Decision|1|||
128770427|NCT02248961|463451503|FG000|Overall Study|Adverse Event|1|||
128770428|NCT02248961|463451504|FG001|Overall Study|Adverse Event|0|||
128770429|NCT02248961|463451503|FG000|Overall Study|Withdrawal by Subject|1|||
128770430|NCT02248961|463451504|FG001|Overall Study|Withdrawal by Subject|2|||
128770431|NCT02248961|463451503|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
128770432|NCT02248961|463451504|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
128770433|NCT00453310|463451509|FG000|Overall Study|Progression of Disease|10|||
128770434|NCT01267825|463451510|FG000|Overall Study|study terminated. no data collected.|1|||
128770435|NCT01267825|463451511|FG001|Overall Study|study terminated. no data collected.|0|||
128770436|NCT00871351|463451514|FG000|Overall Study|Withdrawal by Subject|1|||
128770437|NCT00871351|463451515|FG001|Overall Study|Withdrawal by Subject|0|||
128770438|NCT00871351|463451516|FG002|Overall Study|Withdrawal by Subject|0|||
128770439|NCT00871351|463451514|FG000|Overall Study|Adverse Event|3|||
128949539|NCT01968954|464101105|FG001|Overall Study|Death|2|||
128949540|NCT01968954|464101104|FG000|Overall Study|Lost to Follow-up|6|||
128949541|NCT01968954|464101105|FG001|Overall Study|Lost to Follow-up|4|||
128949542|NCT01968954|464101104|FG000|Overall Study|Withdrawal by Subject|20|||
128949543|NCT01968954|464101105|FG001|Overall Study|Withdrawal by Subject|23|||
128949544|NCT01968954|464101104|FG000|Overall Study|Other|7|||
128949545|NCT01968954|464101105|FG001|Overall Study|Other|8|||
128949546|NCT01968954|464101104|FG000|Overall Study|Protocol Violation|0|||
128949547|NCT01968954|464101105|FG001|Overall Study|Protocol Violation|1|||
128949548|NCT01968954|464101104|FG000|Overall Study|Did not met inclusion criteria|0|||
128949549|NCT01968954|464101105|FG001|Overall Study|Did not met inclusion criteria|2|||
128949550|NCT05319080|464101106|FG000|Overall Study|Withdrawal by Subject|2|||
128949551|NCT05319080|464101106|FG000|Overall Study|Physician Decision|4|||
128949552|NCT04465396|464101109|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
128949553|NCT04465396|464101110|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
128949554|NCT04465396|464101111|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
128949555|NCT04465396|464101112|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
128949556|NCT02648724|464101115|FG000|Overall Study|Withdrawal by Subject|0|||
128949557|NCT02648724|464101116|FG001|Overall Study|Withdrawal by Subject|1|||
128949558|NCT02648724|464101117|FG002|Overall Study|Withdrawal by Subject|1|||
128949559|NCT02648724|464101118|FG003|Overall Study|Withdrawal by Subject|0|||
128949560|NCT02648724|464101119|FG004|Overall Study|Withdrawal by Subject|1|||
128949561|NCT02648724|464101120|FG005|Overall Study|Withdrawal by Subject|0|||
128949562|NCT02648724|464101121|FG006|Overall Study|Withdrawal by Subject|0|||
128949563|NCT02648724|464101115|FG000|Overall Study|Progressive disease|2|||
128949564|NCT02648724|464101116|FG001|Overall Study|Progressive disease|2|||
128949565|NCT02648724|464101117|FG002|Overall Study|Progressive disease|2|||
128949566|NCT02648724|464101118|FG003|Overall Study|Progressive disease|3|||
128949567|NCT02648724|464101119|FG004|Overall Study|Progressive disease|22|||
128949568|NCT02648724|464101120|FG005|Overall Study|Progressive disease|7|||
128949569|NCT02648724|464101121|FG006|Overall Study|Progressive disease|8|||
128949570|NCT02648724|464101115|FG000|Overall Study|Other reason (unknown)|1|||
128949571|NCT02648724|464101116|FG001|Overall Study|Other reason (unknown)|0|||
128949572|NCT02648724|464101117|FG002|Overall Study|Other reason (unknown)|0|||
128949573|NCT02648724|464101118|FG003|Overall Study|Other reason (unknown)|0|||
128949574|NCT02648724|464101119|FG004|Overall Study|Other reason (unknown)|0|||
128949575|NCT02648724|464101120|FG005|Overall Study|Other reason (unknown)|0|||
128949576|NCT02648724|464101121|FG006|Overall Study|Other reason (unknown)|0|||
128949577|NCT02648724|464101115|FG000|Overall Study|Protocol Violation|0|||
128949578|NCT02648724|464101116|FG001|Overall Study|Protocol Violation|0|||
128949579|NCT02648724|464101117|FG002|Overall Study|Protocol Violation|0|||
129125161|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129125162|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129125163|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129125164|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129125165|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
129125166|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129125167|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129125168|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129125169|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129125170|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129125171|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129125172|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129125173|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
129125174|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129125175|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129125176|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129125177|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129125178|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129125179|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129125180|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129125181|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
129125182|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
129125183|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129125184|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129125185|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129125186|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
128949580|NCT02648724|464101118|FG003|Overall Study|Protocol Violation|0|||
128949581|NCT02648724|464101119|FG004|Overall Study|Protocol Violation|1|||
128949582|NCT02648724|464101120|FG005|Overall Study|Protocol Violation|0|||
128949583|NCT02648724|464101121|FG006|Overall Study|Protocol Violation|0|||
128949584|NCT02648724|464101115|FG000|Overall Study|Death|0|||
128949585|NCT02648724|464101116|FG001|Overall Study|Death|0|||
128949586|NCT02648724|464101117|FG002|Overall Study|Death|0|||
128949587|NCT02648724|464101118|FG003|Overall Study|Death|0|||
128949588|NCT02648724|464101119|FG004|Overall Study|Death|0|||
128949589|NCT02648724|464101120|FG005|Overall Study|Death|0|||
128949590|NCT02648724|464101121|FG006|Overall Study|Death|3|||
128949591|NCT02648724|464101115|FG000|Overall Study|Physician Decision|0|||
128949592|NCT02648724|464101116|FG001|Overall Study|Physician Decision|0|||
128770440|NCT00871351|463451515|FG001|Overall Study|Adverse Event|1|||
128770441|NCT00871351|463451516|FG002|Overall Study|Adverse Event|0|||
128770442|NCT00744237|463451517|FG000|Overall Study|Lack of Efficacy|1|||
128770443|NCT00744237|463451518|FG001|Overall Study|Lack of Efficacy|1|||
128770444|NCT00744237|463451519|FG002|Overall Study|Lack of Efficacy|0|||
128770445|NCT00744237|463451517|FG000|Overall Study|Withdrawal by Subject|9|||
128770446|NCT00744237|463451518|FG001|Overall Study|Withdrawal by Subject|5|||
128770447|NCT00744237|463451519|FG002|Overall Study|Withdrawal by Subject|3|||
128770448|NCT00744237|463451517|FG000|Overall Study|Lost to Follow-up|1|||
128770449|NCT00744237|463451518|FG001|Overall Study|Lost to Follow-up|1|||
128770450|NCT00744237|463451519|FG002|Overall Study|Lost to Follow-up|1|||
128770451|NCT00744237|463451517|FG000|Overall Study|Protocol Violation|3|||
128770452|NCT00744237|463451518|FG001|Overall Study|Protocol Violation|4|||
128770453|NCT00744237|463451519|FG002|Overall Study|Protocol Violation|3|||
128770454|NCT00744237|463451517|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
128770455|NCT00744237|463451518|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
128770456|NCT00744237|463451519|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
128770457|NCT00744237|463451517|FG000|Overall Study|Dosing Error|1|||
128770458|NCT00744237|463451518|FG001|Overall Study|Dosing Error|0|||
128770459|NCT00744237|463451519|FG002|Overall Study|Dosing Error|1|||
128770460|NCT00744237|463451517|FG000|Overall Study|Study Drug Error|1|||
128770461|NCT00744237|463451518|FG001|Overall Study|Study Drug Error|0|||
128770462|NCT00744237|463451519|FG002|Overall Study|Study Drug Error|0|||
128949593|NCT02648724|464101117|FG002|Overall Study|Physician Decision|0|||
128949594|NCT02648724|464101118|FG003|Overall Study|Physician Decision|0|||
128949595|NCT02648724|464101119|FG004|Overall Study|Physician Decision|1|||
128949596|NCT02648724|464101120|FG005|Overall Study|Physician Decision|0|||
128949597|NCT02648724|464101121|FG006|Overall Study|Physician Decision|1|||
128949598|NCT02648724|464101115|FG000|Overall Study|Transferred to named patient program|0|||
128949599|NCT02648724|464101116|FG001|Overall Study|Transferred to named patient program|0|||
128949600|NCT02648724|464101117|FG002|Overall Study|Transferred to named patient program|0|||
128949601|NCT02648724|464101118|FG003|Overall Study|Transferred to named patient program|0|||
128949602|NCT02648724|464101119|FG004|Overall Study|Transferred to named patient program|0|||
128949603|NCT02648724|464101120|FG005|Overall Study|Transferred to named patient program|1|||
128949604|NCT02648724|464101121|FG006|Overall Study|Transferred to named patient program|0|||
128949605|NCT03076190|464101122|FG000|Overall Study|Lost to Follow-up|9|||
128949606|NCT03076190|464101123|FG001|Overall Study|Lost to Follow-up|34|||
128949607|NCT03076190|464101122|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
128949608|NCT03076190|464101123|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
128949609|NCT00434122|464101124|FG000|Overall Study|Non-compliance with protocol|0|||
128949610|NCT00434122|464101125|FG001|Overall Study|Non-compliance with protocol|1|||
128949611|NCT00434122|464101124|FG000|Overall Study|loss of subject contact|1|||
128949612|NCT00434122|464101125|FG001|Overall Study|loss of subject contact|1|||
128949613|NCT00434122|464101124|FG000|Overall Study|Personal reasons|1|||
128949614|NCT00434122|464101125|FG001|Overall Study|Personal reasons|1|||
128949615|NCT00434122|464101124|FG000|Overall Study|Large follicle size|2|||
128949616|NCT00434122|464101125|FG001|Overall Study|Large follicle size|2|||
128949617|NCT00434122|464101124|FG000|Overall Study|Low follicular response.|1|||
128949618|NCT00434122|464101125|FG001|Overall Study|Low follicular response.|2|||
128949619|NCT00434122|464101124|FG000|Overall Study|Travelling of subject.|1|||
128949620|NCT00434122|464101125|FG001|Overall Study|Travelling of subject.|0|||
128949621|NCT04191577|464101126|FG000|Overall Study|Withdrawal by Subject|2|||
128949622|NCT04191577|464101127|FG001|Overall Study|Withdrawal by Subject|2|||
128949623|NCT04191577|464101128|FG002|Overall Study|Withdrawal by Subject|1|||
128949624|NCT04191577|464101126|FG000|Overall Study|Physician Decision|1|||
128949625|NCT04191577|464101127|FG001|Overall Study|Physician Decision|1|||
128949626|NCT04191577|464101128|FG002|Overall Study|Physician Decision|0|||
128949627|NCT04191577|464101126|FG000|Overall Study|Adverse Event|0|||
128949628|NCT04191577|464101127|FG001|Overall Study|Adverse Event|0|||
128770463|NCT00744237|463451517|FG000|Overall Study|Prohibited Concomitant Medication|0|||
128770464|NCT00744237|463451518|FG001|Overall Study|Prohibited Concomitant Medication|0|||
128770465|NCT00744237|463451519|FG002|Overall Study|Prohibited Concomitant Medication|1|||
128949629|NCT04191577|464101128|FG002|Overall Study|Adverse Event|1|||
129125187|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
128770466|NCT00744237|463451517|FG000|Overall Study|Poor Compliance|0|||
128949630|NCT04191577|464101126|FG000|Overall Study|Death|0|||
128949631|NCT04191577|464101127|FG001|Overall Study|Death|0|||
128949632|NCT04191577|464101128|FG002|Overall Study|Death|1|||
129125188|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129034798|NCT01148225|464416587|FG000|Overall Study|Other|185|||
129034799|NCT02212457|464416588|FG000|Overall Study|Adverse Event|1|||
129034800|NCT02212457|464416589|FG001|Overall Study|Adverse Event|2|||
129034801|NCT02212457|464416590|FG002|Overall Study|Adverse Event|2|||
129034802|NCT02212457|464416591|FG003|Overall Study|Adverse Event|2|||
129218784|NCT00473382|465101621|FG002|Core Study|Death|10|||
129218785|NCT00473382|465101619|FG000|Core Study|Lost to Follow-up|3|||
129218786|NCT00473382|465101620|FG001|Core Study|Lost to Follow-up|3|||
129218787|NCT00473382|465101621|FG002|Core Study|Lost to Follow-up|3|||
129218788|NCT00473382|465101619|FG000|Core Study|Physician Decision|1|||
129218789|NCT00473382|465101620|FG001|Core Study|Physician Decision|2|||
129218790|NCT00473382|465101621|FG002|Core Study|Physician Decision|2|||
129218791|NCT00473382|465101619|FG000|Core Study|Subject non-compliance|5|||
129218792|NCT00473382|465101620|FG001|Core Study|Subject non-compliance|2|||
129218793|NCT00473382|465101621|FG002|Core Study|Subject non-compliance|1|||
129218794|NCT00473382|465101619|FG000|Core Study|Subject needed other treatment|1|||
129218795|NCT00473382|465101620|FG001|Core Study|Subject needed other treatment|3|||
129218796|NCT00473382|465101621|FG002|Core Study|Subject needed other treatment|2|||
129218797|NCT00473382|465101619|FG000|Core Study|Subject's decision|12|||
129218798|NCT00473382|465101620|FG001|Core Study|Subject's decision|11|||
129218799|NCT00473382|465101621|FG002|Core Study|Subject's decision|10|||
129218800|NCT00473382|465101619|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
129218801|NCT00473382|465101620|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
128949633|NCT01185249|464101129|FG000|Overall Study|Patients discharged or change in status|42|||
128949634|NCT00406783|464101132|FG000|Overall Study|Adverse Event|4|||
128949635|NCT00406783|464101133|FG001|Overall Study|Adverse Event|4|||
128949636|NCT00406783|464101132|FG000|Overall Study|Treatment Failure|2|||
128949637|NCT00406783|464101133|FG001|Overall Study|Treatment Failure|3|||
128949638|NCT00406783|464101132|FG000|Overall Study|Lost to Follow-up|3|||
128949639|NCT00406783|464101133|FG001|Overall Study|Lost to Follow-up|0|||
128949640|NCT00406783|464101132|FG000|Overall Study|Withdrawal by Subject|1|||
128949641|NCT00406783|464101133|FG001|Overall Study|Withdrawal by Subject|4|||
129034803|NCT02212457|464416592|FG004|Overall Study|Adverse Event|0|||
129034804|NCT02212457|464416593|FG005|Overall Study|Adverse Event|1|||
128949642|NCT00406783|464101132|FG000|Overall Study|Protocol Violation|4|||
128949643|NCT00406783|464101133|FG001|Overall Study|Protocol Violation|4|||
128949644|NCT01391819|464101134|FG000|Overall Study|Withdrawal by Subject|56|||
128949645|NCT01391819|464101134|FG000|Overall Study|Migrated/moved from study area|82|||
128949646|NCT01391819|464101134|FG000|Overall Study|Lost to Follow-up|252|||
128949647|NCT01391819|464101134|FG000|Overall Study|Death|3|||
128949648|NCT01391819|464101134|FG000|Overall Study|Other|9|||
128949649|NCT01208038|464101137|FG000|Overall Study|Withdrawal by Subject|1|||
128949650|NCT00479557|464101138|FG000|Overall Study|Death|0|||
128949651|NCT00479557|464101139|FG001|Overall Study|Death|0|||
128949652|NCT00479557|464101140|FG002|Overall Study|Death|0|||
128949653|NCT00479557|464101141|FG003|Overall Study|Death|0|||
128949654|NCT00479557|464101142|FG004|Overall Study|Death|0|||
128949655|NCT00479557|464101143|FG005|Overall Study|Death|1|||
128949656|NCT00479557|464101144|FG006|Overall Study|Death|0|||
128949657|NCT00479557|464101138|FG000|Overall Study|Lack of Efficacy|1|||
128949658|NCT00479557|464101139|FG001|Overall Study|Lack of Efficacy|0|||
128949659|NCT00479557|464101140|FG002|Overall Study|Lack of Efficacy|0|||
128949660|NCT00479557|464101141|FG003|Overall Study|Lack of Efficacy|0|||
128949661|NCT00479557|464101142|FG004|Overall Study|Lack of Efficacy|0|||
128949662|NCT00479557|464101143|FG005|Overall Study|Lack of Efficacy|0|||
128949663|NCT00479557|464101144|FG006|Overall Study|Lack of Efficacy|0|||
128949664|NCT00479557|464101138|FG000|Overall Study|Lost to Follow-up|0|||
128949665|NCT00479557|464101139|FG001|Overall Study|Lost to Follow-up|2|||
128949666|NCT00479557|464101140|FG002|Overall Study|Lost to Follow-up|0|||
128949667|NCT00479557|464101141|FG003|Overall Study|Lost to Follow-up|2|||
129034805|NCT02212457|464416588|FG000|Overall Study|Withdrawal by Subject|8|||
129125189|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
129125190|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129125191|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129125192|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129125193|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129125194|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129125195|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129125196|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129125197|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
129125198|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
129125199|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129125200|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129125201|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129125202|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
128710023|NCT01124422|463234355|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
128710024|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Death|3|||
128710025|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Death|3|||
128710026|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Death|0|||
128710027|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Death|0|||
128710028|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
128710029|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
128710030|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
128710031|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
128710032|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
128710033|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
128710034|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
128710035|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
128710036|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
128710037|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
128710038|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
128710039|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
128710040|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
128710041|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
128710042|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
128710043|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
128710044|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
128710045|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
128710046|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
128710047|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
128710048|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
128770467|NCT00744237|463451518|FG001|Overall Study|Poor Compliance|2|||
128949668|NCT00479557|464101142|FG004|Overall Study|Lost to Follow-up|0|||
128949669|NCT00479557|464101143|FG005|Overall Study|Lost to Follow-up|0|||
128949670|NCT00479557|464101144|FG006|Overall Study|Lost to Follow-up|0|||
128949671|NCT00479557|464101138|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
128949672|NCT00479557|464101139|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
128949673|NCT00479557|464101140|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
128949674|NCT00479557|464101141|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
128949675|NCT00479557|464101142|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
128949676|NCT00479557|464101143|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
128949677|NCT00479557|464101144|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
128949678|NCT00479557|464101138|FG000|Overall Study|AE not related to Study Drug|1|||
128949679|NCT00479557|464101139|FG001|Overall Study|AE not related to Study Drug|3|||
128949680|NCT00479557|464101140|FG002|Overall Study|AE not related to Study Drug|0|||
128949681|NCT00479557|464101141|FG003|Overall Study|AE not related to Study Drug|0|||
128949682|NCT00479557|464101142|FG004|Overall Study|AE not related to Study Drug|2|||
128949683|NCT00479557|464101143|FG005|Overall Study|AE not related to Study Drug|2|||
128949684|NCT00479557|464101144|FG006|Overall Study|AE not related to Study Drug|1|||
128949685|NCT00479557|464101138|FG000|Overall Study|Caregiver Request|2|||
128949686|NCT00479557|464101139|FG001|Overall Study|Caregiver Request|2|||
128949687|NCT00479557|464101140|FG002|Overall Study|Caregiver Request|2|||
128949688|NCT00479557|464101141|FG003|Overall Study|Caregiver Request|0|||
128949689|NCT00479557|464101142|FG004|Overall Study|Caregiver Request|1|||
128949690|NCT00479557|464101143|FG005|Overall Study|Caregiver Request|2|||
128949691|NCT00479557|464101144|FG006|Overall Study|Caregiver Request|0|||
128949692|NCT00479557|464101138|FG000|Overall Study|Investigator Request|0|||
129034806|NCT02212457|464416589|FG001|Overall Study|Withdrawal by Subject|10|||
128710049|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
128710050|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
128710051|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
128710052|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Other|6|||
128710053|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Other|3|||
128710054|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Other|0|||
128710055|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Other|0|||
128710056|NCT02051608|463234360|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
128710057|NCT02051608|463234361|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
128710058|NCT02051608|463234362|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
128949693|NCT00479557|464101139|FG001|Overall Study|Investigator Request|0|||
128949694|NCT00479557|464101140|FG002|Overall Study|Investigator Request|1|||
128949695|NCT00479557|464101141|FG003|Overall Study|Investigator Request|0|||
128949696|NCT00479557|464101142|FG004|Overall Study|Investigator Request|0|||
128949697|NCT00479557|464101143|FG005|Overall Study|Investigator Request|0|||
128710059|NCT02051608|463234363|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
128770468|NCT00744237|463451519|FG002|Overall Study|Poor Compliance|0|||
128770469|NCT00744237|463451517|FG000|Overall Study|Administrative. Site Closed|1|||
129218802|NCT00473382|465101621|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
129218803|NCT00473382|465101619|FG000|Open-label Extension Through Month 48|Death|1|||
129218804|NCT00473382|465101620|FG001|Open-label Extension Through Month 48|Death|3|||
129218805|NCT00473382|465101621|FG002|Open-label Extension Through Month 48|Death|3|||
129218806|NCT00473382|465101619|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
129218807|NCT00473382|465101620|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
129218808|NCT00473382|465101621|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
129218809|NCT00473382|465101619|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
129218810|NCT00473382|465101620|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
129218811|NCT00473382|465101621|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
129218812|NCT00473382|465101619|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
129218813|NCT00473382|465101620|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
129218814|NCT00473382|465101621|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
129218815|NCT00473382|465101619|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
129218816|NCT00473382|465101620|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
129218817|NCT00473382|465101621|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
129218818|NCT00473382|465101619|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
129218819|NCT00473382|465101620|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
129218820|NCT00473382|465101621|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
129218821|NCT00473382|465101619|FG000|Open-label Extension Through Month 60|Death|1|||
129218822|NCT00473382|465101620|FG001|Open-label Extension Through Month 60|Death|7|||
129218823|NCT00473382|465101621|FG002|Open-label Extension Through Month 60|Death|4|||
129218824|NCT00473382|465101619|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
129218825|NCT00473382|465101620|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
129218826|NCT00473382|465101621|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
129218827|NCT00473382|465101619|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
129218828|NCT00473382|465101620|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
129218829|NCT00473382|465101621|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
129218830|NCT00473382|465101619|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
129218831|NCT00473382|465101620|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
129218832|NCT00473382|465101621|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
129218833|NCT00473382|465101619|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
129218834|NCT00473382|465101620|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
129218835|NCT00473382|465101621|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
129218836|NCT01134055|465101622|FG000|Overall Study|Adverse Event|5|||
129218837|NCT01134055|465101623|FG001|Overall Study|Adverse Event|2|||
129218838|NCT01134055|465101624|FG002|Overall Study|Adverse Event|2|||
129218839|NCT01134055|465101625|FG003|Overall Study|Adverse Event|2|||
129218840|NCT01134055|465101626|FG004|Overall Study|Adverse Event|5|||
129218841|NCT01134055|465101627|FG005|Overall Study|Adverse Event|7|||
129218842|NCT01134055|465101628|FG006|Overall Study|Adverse Event|2|||
129218843|NCT01134055|465101622|FG000|Overall Study|Lost to Follow-up|0|||
129218844|NCT01134055|465101623|FG001|Overall Study|Lost to Follow-up|1|||
129218845|NCT01134055|465101624|FG002|Overall Study|Lost to Follow-up|0|||
129218846|NCT01134055|465101625|FG003|Overall Study|Lost to Follow-up|1|||
129218847|NCT01134055|465101626|FG004|Overall Study|Lost to Follow-up|0|||
129218848|NCT01134055|465101627|FG005|Overall Study|Lost to Follow-up|0|||
129218849|NCT01134055|465101628|FG006|Overall Study|Lost to Follow-up|0|||
129218850|NCT01134055|465101622|FG000|Overall Study|Withdrawal by Subject|3|||
129218851|NCT01134055|465101623|FG001|Overall Study|Withdrawal by Subject|3|||
129218852|NCT01134055|465101624|FG002|Overall Study|Withdrawal by Subject|1|||
129218853|NCT01134055|465101625|FG003|Overall Study|Withdrawal by Subject|2|||
129218854|NCT01134055|465101626|FG004|Overall Study|Withdrawal by Subject|0|||
129218855|NCT01134055|465101627|FG005|Overall Study|Withdrawal by Subject|0|||
129218856|NCT01134055|465101628|FG006|Overall Study|Withdrawal by Subject|8|||
129218857|NCT01134055|465101622|FG000|Overall Study|Protocol Violation|0|||
129218858|NCT01134055|465101623|FG001|Overall Study|Protocol Violation|0|||
129218859|NCT01134055|465101624|FG002|Overall Study|Protocol Violation|0|||
129218860|NCT01134055|465101625|FG003|Overall Study|Protocol Violation|1|||
129218861|NCT01134055|465101626|FG004|Overall Study|Protocol Violation|1|||
129218862|NCT01134055|465101627|FG005|Overall Study|Protocol Violation|0|||
129218863|NCT01134055|465101628|FG006|Overall Study|Protocol Violation|0|||
129218864|NCT01134055|465101622|FG000|Overall Study|Physician Decision|0|||
129218865|NCT01134055|465101623|FG001|Overall Study|Physician Decision|0|||
129218866|NCT01134055|465101624|FG002|Overall Study|Physician Decision|0|||
129218867|NCT01134055|465101625|FG003|Overall Study|Physician Decision|0|||
128949698|NCT00479557|464101144|FG006|Overall Study|Investigator Request|0|||
129218868|NCT01134055|465101626|FG004|Overall Study|Physician Decision|0|||
129218869|NCT01134055|465101627|FG005|Overall Study|Physician Decision|0|||
129218870|NCT01134055|465101628|FG006|Overall Study|Physician Decision|1|||
128949699|NCT00479557|464101138|FG000|Overall Study|Subject Request|3|||
128949700|NCT00479557|464101139|FG001|Overall Study|Subject Request|0|||
128949701|NCT00479557|464101140|FG002|Overall Study|Subject Request|1|||
128949702|NCT00479557|464101141|FG003|Overall Study|Subject Request|1|||
128949703|NCT00479557|464101142|FG004|Overall Study|Subject Request|1|||
128949704|NCT00479557|464101143|FG005|Overall Study|Subject Request|4|||
128949705|NCT00479557|464101144|FG006|Overall Study|Subject Request|1|||
128949706|NCT00479557|464101138|FG000|Overall Study|Other|2|||
128949707|NCT00479557|464101139|FG001|Overall Study|Other|3|||
128949708|NCT00479557|464101140|FG002|Overall Study|Other|1|||
128949709|NCT00479557|464101141|FG003|Overall Study|Other|0|||
128949710|NCT00479557|464101142|FG004|Overall Study|Other|0|||
128949711|NCT00479557|464101143|FG005|Overall Study|Other|3|||
128949712|NCT00479557|464101144|FG006|Overall Study|Other|0|||
128949713|NCT04752189|464101145|FG000|Overall Study|Withdrawal by Subject|0|||
128949714|NCT04752189|464101146|FG001|Overall Study|Withdrawal by Subject|150|||
128949715|NCT04752189|464101145|FG000|Overall Study|Lost to Follow-up|261|||
128949716|NCT04752189|464101146|FG001|Overall Study|Lost to Follow-up|126|||
128949717|NCT03422133|464101147|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
128949718|NCT03422133|464101148|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
128949719|NCT03003403|464101149|FG000|Overall Study|Ineligible|8|||
128949720|NCT03003403|464101150|FG001|Overall Study|Ineligible|7|||
128949721|NCT03003403|464101149|FG000|Overall Study|Withdrawal by Subject|3|||
128949722|NCT03003403|464101150|FG001|Overall Study|Withdrawal by Subject|1|||
129218871|NCT02892448|465101629|FG000|Overall Study|Screening failure|2|||
129218872|NCT02892448|465101630|FG001|Overall Study|Screening failure|2|||
129218873|NCT02892448|465101631|FG002|Overall Study|Screening failure|1|||
129218874|NCT00499083|465101632|FG000|Overall Study|Not evaluable|3|||
129218875|NCT00686686|465101633|FG000|Overall Study|Non-compliance|1|||
129218876|NCT00686686|465101633|FG000|Overall Study|Adverse Event|2|||
129218877|NCT00686686|465101633|FG000|Overall Study|Lost to Follow-up|3|||
129218878|NCT01012440|465101634|FG000|Overall Study|Withdrawal by Subject|2|||
129218879|NCT01254422|465101638|FG000|Overall Study|Protocol Violation|1|||
129218880|NCT01254422|465101639|FG001|Overall Study|Protocol Violation|0|||
129218881|NCT01254422|465101638|FG000|Overall Study|Adverse Event|1|||
129218882|NCT01254422|465101639|FG001|Overall Study|Adverse Event|0|||
129218883|NCT01254422|465101638|FG000|Overall Study|Serious adverse event|0|||
129218884|NCT01254422|465101639|FG001|Overall Study|Serious adverse event|1|||
129218885|NCT01254422|465101638|FG000|Overall Study|Lost to Follow-up|1|||
128949723|NCT02198651|464103036|FG000|Lead-in Period|Withdrew consent|13|||
129218886|NCT01254422|465101639|FG001|Overall Study|Lost to Follow-up|0|||
128949724|NCT02198651|464103037|FG001|Lead-in Period|Withdrew consent|0|||
128949725|NCT02198651|464103038|FG002|Lead-in Period|Withdrew consent|0|||
128949726|NCT02198651|464103039|FG003|Lead-in Period|Withdrew consent|0|||
128949727|NCT02198651|464103040|FG004|Lead-in Period|Withdrew consent|0|||
128949728|NCT02198651|464103036|FG000|Lead-in Period|Adverse Event|2|||
128949729|NCT02198651|464103037|FG001|Lead-in Period|Adverse Event|0|||
128949730|NCT02198651|464103038|FG002|Lead-in Period|Adverse Event|0|||
128949731|NCT02198651|464103039|FG003|Lead-in Period|Adverse Event|0|||
128949732|NCT02198651|464103040|FG004|Lead-in Period|Adverse Event|0|||
128949733|NCT02198651|464103036|FG000|Lead-in Period|Other, not specified|22|||
128949734|NCT02198651|464103037|FG001|Lead-in Period|Other, not specified|0|||
128949735|NCT02198651|464103038|FG002|Lead-in Period|Other, not specified|0|||
128949736|NCT02198651|464103039|FG003|Lead-in Period|Other, not specified|0|||
128949737|NCT02198651|464103040|FG004|Lead-in Period|Other, not specified|0|||
128949738|NCT02198651|464103036|FG000|Double-blind Period|Withdrew consent|0|||
128949739|NCT02198651|464103037|FG001|Double-blind Period|Withdrew consent|4|||
128949740|NCT02198651|464103038|FG002|Double-blind Period|Withdrew consent|0|||
128949741|NCT02198651|464103039|FG003|Double-blind Period|Withdrew consent|0|||
128949742|NCT02198651|464103040|FG004|Double-blind Period|Withdrew consent|0|||
129218887|NCT00643162|465101640|FG000|Overall Study|Withdrawal by Subject|1|||
129218888|NCT00643162|465101641|FG001|Overall Study|Withdrawal by Subject|1|||
129218889|NCT02691507|465101642|FG000|Overall Study|Missed Visit 3|0|||
129218890|NCT02691507|465101643|FG001|Overall Study|Missed Visit 3|1|||
129218891|NCT00541385|465101644|FG000|Overall Study|Adverse Event|6|||
128949743|NCT02198651|464103036|FG000|Double-blind Period|Adverse Event|0|||
128949744|NCT02198651|464103037|FG001|Double-blind Period|Adverse Event|1|||
128949745|NCT02198651|464103038|FG002|Double-blind Period|Adverse Event|0|||
128949746|NCT02198651|464103039|FG003|Double-blind Period|Adverse Event|0|||
128949747|NCT02198651|464103040|FG004|Double-blind Period|Adverse Event|0|||
128949748|NCT02198651|464103036|FG000|Double-blind Period|Other, not specified|0|||
128949749|NCT02198651|464103037|FG001|Double-blind Period|Other, not specified|4|||
128949750|NCT02198651|464103038|FG002|Double-blind Period|Other, not specified|1|||
128949751|NCT02198651|464103039|FG003|Double-blind Period|Other, not specified|0|||
128949752|NCT02198651|464103040|FG004|Double-blind Period|Other, not specified|0|||
128949753|NCT02198651|464103036|FG000|Open-label Rescue Period|Withdrew consent|0|||
128949754|NCT02198651|464103037|FG001|Open-label Rescue Period|Withdrew consent|0|||
128949755|NCT02198651|464103038|FG002|Open-label Rescue Period|Withdrew consent|0|||
128949756|NCT02198651|464103039|FG003|Open-label Rescue Period|Withdrew consent|2|||
128949757|NCT02198651|464103040|FG004|Open-label Rescue Period|Withdrew consent|0|||
128949758|NCT02198651|464103036|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
128949759|NCT02198651|464103037|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
128949760|NCT02198651|464103038|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
128949761|NCT02198651|464103039|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
128949762|NCT02198651|464103040|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
128949763|NCT03073213|464103041|FG000|Multiple Dose Period|Protocol Violation|0|||
128949764|NCT03073213|464103042|FG001|Multiple Dose Period|Protocol Violation|0|||
128949765|NCT03073213|464103043|FG002|Multiple Dose Period|Protocol Violation|1|||
128949766|NCT01993615|464103048|FG000|Overall Study|Death|1|||
128949767|NCT01993615|464103049|FG001|Overall Study|Death|0|||
128949768|NCT01617655|464103050|FG000|Overall Study|Adverse Event|2|||
128949769|NCT01617655|464103051|FG001|Overall Study|Adverse Event|3|||
128949770|NCT01617655|464103050|FG000|Overall Study|Poor compliance to protocol|1|||
128949771|NCT01617655|464103051|FG001|Overall Study|Poor compliance to protocol|4|||
128949772|NCT01617655|464103050|FG000|Overall Study|Participants moved|0|||
128949773|NCT01617655|464103051|FG001|Overall Study|Participants moved|4|||
128949774|NCT01617655|464103050|FG000|Overall Study|Consent withdrawn by participant|1|||
128949775|NCT01617655|464103051|FG001|Overall Study|Consent withdrawn by participant|1|||
128949776|NCT01617655|464103050|FG000|Overall Study|Last visit outside protocol visit window|1|||
128949777|NCT01617655|464103051|FG001|Overall Study|Last visit outside protocol visit window|10|||
128949778|NCT01617655|464103050|FG000|Overall Study|Site closure|3|||
128949779|NCT01617655|464103051|FG001|Overall Study|Site closure|5|||
128949780|NCT01617655|464103050|FG000|Overall Study|Other than specified above|1|||
128949781|NCT01617655|464103051|FG001|Overall Study|Other than specified above|2|||
128949782|NCT01175213|464103052|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
128949783|NCT01175213|464103053|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
128949784|NCT01175213|464103052|FG000|IGSC, 10%/rHuPH20|Death|1|||
128949785|NCT01175213|464103053|FG001|IGSC, 10%/rHuPH20|Death|0|||
128949786|NCT01175213|464103052|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
128949787|NCT01175213|464103053|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
128949788|NCT01175213|464103052|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
128949789|NCT01175213|464103053|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
128949790|NCT01175213|464103052|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
128949791|NCT01175213|464103053|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
128949792|NCT01175213|464103052|FG000|Safety Follow-up|Adverse Event|1|||
128949793|NCT01175213|464103053|FG001|Safety Follow-up|Adverse Event|0|||
128949794|NCT01245764|464103060|FG000|Study Phase A|Other|3|||
128949795|NCT01245764|464103061|FG001|Study Phase A|Other|2|||
128949796|NCT01245764|464103062|FG002|Study Phase A|Other|3|||
128949797|NCT01245764|464103063|FG003|Study Phase A|Other|1|||
128949798|NCT01245764|464103060|FG000|Study Phase A|Protocol Violation|6|||
128949799|NCT01245764|464103061|FG001|Study Phase A|Protocol Violation|3|||
128949800|NCT01245764|464103062|FG002|Study Phase A|Protocol Violation|2|||
128949801|NCT01245764|464103063|FG003|Study Phase A|Protocol Violation|2|||
128949802|NCT01245764|464103060|FG000|Study Phase A|Lost to Follow-up|0|||
128949803|NCT01245764|464103061|FG001|Study Phase A|Lost to Follow-up|0|||
128949804|NCT01245764|464103062|FG002|Study Phase A|Lost to Follow-up|5|||
128949805|NCT01245764|464103063|FG003|Study Phase A|Lost to Follow-up|0|||
128949806|NCT00003476|464103064|FG000|Overall Study|Not evaluable|1|||
128949807|NCT00781963|464103069|FG000|Overall Study|Death|3|||
128949808|NCT00781963|464103070|FG001|Overall Study|Death|0|||
128949809|NCT00781963|464103069|FG000|Overall Study|Lost to Follow-up|2|||
128949810|NCT00781963|464103070|FG001|Overall Study|Lost to Follow-up|1|||
128949811|NCT00781963|464103069|FG000|Overall Study|Withdrawal by Subject|3|||
128949812|NCT00781963|464103070|FG001|Overall Study|Withdrawal by Subject|1|||
128949813|NCT00781963|464103069|FG000|Overall Study|Refused follow-up|9|||
128949814|NCT00781963|464103070|FG001|Overall Study|Refused follow-up|0|||
128949815|NCT03057951|464103074|FG000|Overall Study|Adverse Event|553|||
128949816|NCT03057951|464103075|FG001|Overall Study|Adverse Event|575|||
128949817|NCT03057951|464103074|FG000|Overall Study|Protocol Violation|30|||
128949818|NCT03057951|464103075|FG001|Overall Study|Protocol Violation|24|||
128949819|NCT03057951|464103074|FG000|Overall Study|Lost to Follow-up|6|||
128949820|NCT03057951|464103075|FG001|Overall Study|Lost to Follow-up|16|||
128949821|NCT03057951|464103074|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
129034807|NCT02212457|464416590|FG002|Overall Study|Withdrawal by Subject|8|||
129034808|NCT02212457|464416591|FG003|Overall Study|Withdrawal by Subject|6|||
129034809|NCT02212457|464416592|FG004|Overall Study|Withdrawal by Subject|5|||
128949822|NCT03057951|464103075|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
128949823|NCT03057951|464103074|FG000|Overall Study|Study drug stopped, reason missing|6|||
128949824|NCT03057951|464103075|FG001|Overall Study|Study drug stopped, reason missing|1|||
128949825|NCT03057951|464103074|FG000|Overall Study|Medical advice|6|||
128949826|NCT03057951|464103075|FG001|Overall Study|Medical advice|2|||
128949827|NCT03057951|464103074|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
128949828|NCT03057951|464103075|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
129218892|NCT00541385|465101645|FG001|Overall Study|Adverse Event|3|||
128710060|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Adverse Event|0|||
128710061|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Adverse Event|0|||
128710062|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Adverse Event|6|||
128710063|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Adverse Event|8|||
128710064|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Death|0|||
128710065|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Death|0|||
128710066|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Death|7|||
128710067|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Death|4|||
128710068|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
128710069|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
128710070|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
128710071|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
128710072|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
128710073|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
128949829|NCT03057951|464103074|FG000|Overall Study|Investigator decision|2|||
128949830|NCT03057951|464103075|FG001|Overall Study|Investigator decision|0|||
128949831|NCT03057951|464103074|FG000|Overall Study|Patient decision|5|||
128949832|NCT03057951|464103075|FG001|Overall Study|Patient decision|2|||
128949833|NCT03057951|464103074|FG000|Overall Study|Not attending study visits|3|||
128949834|NCT03057951|464103075|FG001|Overall Study|Not attending study visits|0|||
128949835|NCT03057951|464103074|FG000|Overall Study|Patient moved away|3|||
128949836|NCT03057951|464103075|FG001|Overall Study|Patient moved away|4|||
128949837|NCT03057951|464103074|FG000|Overall Study|Other reason than stated above|23|||
128949838|NCT03057951|464103075|FG001|Overall Study|Other reason than stated above|29|||
128949839|NCT03057951|464103074|FG000|Overall Study|Not treated|2|||
128949840|NCT03057951|464103075|FG001|Overall Study|Not treated|1|||
128949841|NCT02064205|464103076|FG000|Overall Study|Withdrawal by Subject|1|||
128949842|NCT00696436|464103077|FG000|Overall Study|Adverse Event|7|||
128949843|NCT00696436|464103078|FG001|Overall Study|Adverse Event|9|||
128949844|NCT00696436|464103079|FG002|Overall Study|Adverse Event|8|||
128949845|NCT00696436|464103080|FG003|Overall Study|Adverse Event|6|||
128949846|NCT00696436|464103081|FG004|Overall Study|Adverse Event|4|||
128949847|NCT00696436|464103077|FG000|Overall Study|Protocol Violation|3|||
128949848|NCT00696436|464103078|FG001|Overall Study|Protocol Violation|2|||
128949849|NCT00696436|464103079|FG002|Overall Study|Protocol Violation|2|||
128949850|NCT00696436|464103080|FG003|Overall Study|Protocol Violation|0|||
128949851|NCT00696436|464103081|FG004|Overall Study|Protocol Violation|1|||
128949852|NCT00696436|464103077|FG000|Overall Study|Lost to Follow-up|1|||
128949853|NCT00696436|464103078|FG001|Overall Study|Lost to Follow-up|6|||
128949854|NCT00696436|464103079|FG002|Overall Study|Lost to Follow-up|2|||
128949855|NCT00696436|464103080|FG003|Overall Study|Lost to Follow-up|4|||
128949856|NCT00696436|464103081|FG004|Overall Study|Lost to Follow-up|3|||
128949857|NCT00696436|464103077|FG000|Overall Study|Withdrawal by Subject|4|||
128949858|NCT00696436|464103078|FG001|Overall Study|Withdrawal by Subject|11|||
128949859|NCT00696436|464103079|FG002|Overall Study|Withdrawal by Subject|5|||
128949860|NCT00696436|464103080|FG003|Overall Study|Withdrawal by Subject|7|||
128949861|NCT00696436|464103081|FG004|Overall Study|Withdrawal by Subject|1|||
128949862|NCT00696436|464103077|FG000|Overall Study|Lack of Efficacy|3|||
128949863|NCT00696436|464103078|FG001|Overall Study|Lack of Efficacy|1|||
128949864|NCT00696436|464103079|FG002|Overall Study|Lack of Efficacy|5|||
128949865|NCT00696436|464103080|FG003|Overall Study|Lack of Efficacy|2|||
128949866|NCT00696436|464103081|FG004|Overall Study|Lack of Efficacy|4|||
128949867|NCT00696436|464103077|FG000|Overall Study|Participant Unavailability|2|||
128949868|NCT00696436|464103078|FG001|Overall Study|Participant Unavailability|0|||
128949869|NCT00696436|464103079|FG002|Overall Study|Participant Unavailability|2|||
128949870|NCT00696436|464103080|FG003|Overall Study|Participant Unavailability|1|||
128710074|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
128710075|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
128710076|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
128949871|NCT00696436|464103081|FG004|Overall Study|Participant Unavailability|0|||
128949872|NCT00696436|464103077|FG000|Overall Study|Administrative Error|2|||
128949873|NCT00696436|464103078|FG001|Overall Study|Administrative Error|0|||
128949874|NCT00696436|464103079|FG002|Overall Study|Administrative Error|2|||
128949875|NCT00696436|464103080|FG003|Overall Study|Administrative Error|0|||
128949876|NCT00696436|464103081|FG004|Overall Study|Administrative Error|0|||
128949877|NCT00696436|464103077|FG000|Overall Study|Participant Non-compliance|0|||
128949878|NCT00696436|464103078|FG001|Overall Study|Participant Non-compliance|0|||
128949879|NCT00696436|464103079|FG002|Overall Study|Participant Non-compliance|1|||
129218893|NCT00541385|465101644|FG000|Overall Study|Withdrawal by Subject|2|||
128710077|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
128949880|NCT00696436|464103080|FG003|Overall Study|Participant Non-compliance|2|||
128949881|NCT00696436|464103081|FG004|Overall Study|Participant Non-compliance|0|||
128949882|NCT00696436|464103077|FG000|Overall Study|Administrative Decision|1|||
128949883|NCT00696436|464103078|FG001|Overall Study|Administrative Decision|0|||
128949884|NCT00696436|464103079|FG002|Overall Study|Administrative Decision|0|||
128949885|NCT00696436|464103080|FG003|Overall Study|Administrative Decision|0|||
128710078|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
128710079|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
128710080|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
128710081|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
128710082|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
128710083|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
128710084|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Physician Decision|0|||
128710085|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Physician Decision|0|||
128710086|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Physician Decision|8|||
128710087|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Physician Decision|5|||
128710088|NCT02051608|463234360|FG000|Part 2: Open-label Extension|Other|0|||
128710089|NCT02051608|463234361|FG001|Part 2: Open-label Extension|Other|0|||
128710090|NCT02051608|463234362|FG002|Part 2: Open-label Extension|Other|9|||
128710091|NCT02051608|463234363|FG003|Part 2: Open-label Extension|Other|9|||
128770470|NCT00744237|463451518|FG001|Overall Study|Administrative. Site Closed|1|||
128949886|NCT00696436|464103081|FG004|Overall Study|Administrative Decision|0|||
128949887|NCT00696436|464103077|FG000|Overall Study|Missing|0|||
128949888|NCT00696436|464103078|FG001|Overall Study|Missing|1|||
128949889|NCT00696436|464103079|FG002|Overall Study|Missing|1|||
128949890|NCT00696436|464103080|FG003|Overall Study|Missing|0|||
128949891|NCT00696436|464103081|FG004|Overall Study|Missing|0|||
128949892|NCT02282982|464103082|FG000|Overall Study|Lost to Follow-up|15|||
128949893|NCT02282982|464103082|FG000|Overall Study|Withdrew consent|2|||
128949894|NCT02282982|464103082|FG000|Overall Study|Death|4|||
128770471|NCT00744237|463451519|FG002|Overall Study|Administrative. Site Closed|1|||
128770472|NCT00744237|463451517|FG000|Overall Study|Adverse Event|9|||
128949895|NCT02282982|464103082|FG000|Overall Study|Lack of product|156|||
128949896|NCT02282982|464103082|FG000|Overall Study|Palivizumab is ended|11|||
128949897|NCT02282982|464103082|FG000|Overall Study|Other, not specified|18|||
128949898|NCT02062463|464103083|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
128949899|NCT02062463|464103084|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
128949900|NCT02062463|464103085|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
128770473|NCT00744237|463451518|FG001|Overall Study|Adverse Event|13|||
128770474|NCT00744237|463451519|FG002|Overall Study|Adverse Event|5|||
128770475|NCT02791490|463451521|FG000|Overall Study|Lost to Follow-up|1|||
128949901|NCT02062463|464103086|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
128949902|NCT02062463|464103083|FG000|Stage 2|Adverse Event|0|||
128949903|NCT02062463|464103084|FG001|Stage 2|Adverse Event|0|||
128949904|NCT02062463|464103085|FG002|Stage 2|Adverse Event|12|||
128949905|NCT02062463|464103086|FG003|Stage 2|Adverse Event|20|||
128770476|NCT02791490|463451522|FG001|Overall Study|Lost to Follow-up|2|||
128770477|NCT02791490|463451521|FG000|Overall Study|Withdrawal by Subject|2|||
128770478|NCT02791490|463451522|FG001|Overall Study|Withdrawal by Subject|6|||
128770479|NCT01984424|463451523|FG000|Overall Study|Withdrawal by Subject|3|||
128770480|NCT01984424|463451524|FG001|Overall Study|Withdrawal by Subject|5|||
128770481|NCT01984424|463451523|FG000|Overall Study|Sponsor Decision|0|||
128770482|NCT01984424|463451524|FG001|Overall Study|Sponsor Decision|1|||
128770483|NCT01984424|463451523|FG000|Overall Study|Lost to Follow-up|0|||
128770484|NCT01984424|463451524|FG001|Overall Study|Lost to Follow-up|1|||
128770485|NCT02802319|463451525|FG000|Overall Study|Physician Decision|2|||
128770486|NCT02802319|463451526|FG001|Overall Study|Physician Decision|1|||
128770487|NCT02802319|463451525|FG000|Overall Study|Lost to Follow-up|0|||
128770488|NCT02802319|463451526|FG001|Overall Study|Lost to Follow-up|4|||
128770489|NCT00077636|463451527|FG000|Overall Study|Refused Treatment|9|||
128770490|NCT00077636|463451528|FG001|Overall Study|Refused Treatment|31|||
128770491|NCT00077636|463451527|FG000|Overall Study|Admin|3|||
128949906|NCT02062463|464103083|FG000|Stage 2|Lack of Efficacy|0|||
129125203|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128710092|NCT04876274|463234364|FG000|Overall Study|Lost to Follow-up|9|||
128710093|NCT04876274|463234365|FG001|Overall Study|Lost to Follow-up|12|||
128770492|NCT00077636|463451528|FG001|Overall Study|Admin|3|||
128770493|NCT00077636|463451527|FG000|Overall Study|Withdrawal by Subject|2|||
128770494|NCT00077636|463451528|FG001|Overall Study|Withdrawal by Subject|2|||
129125204|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128770495|NCT00077636|463451527|FG000|Overall Study|Adverse Event|17|||
128770496|NCT00077636|463451528|FG001|Overall Study|Adverse Event|34|||
128770497|NCT00077636|463451527|FG000|Overall Study|Protocol Violation|0|||
128770498|NCT00077636|463451528|FG001|Overall Study|Protocol Violation|2|||
128770499|NCT00077636|463451527|FG000|Overall Study|Lost to Follow-up|10|||
128949907|NCT02062463|464103084|FG001|Stage 2|Lack of Efficacy|0|||
128949908|NCT02062463|464103085|FG002|Stage 2|Lack of Efficacy|3|||
128710094|NCT03454893|463234366|FG000|Overall Study|Study Terminated by the Sponsor|5|||
128710095|NCT03454893|463234366|FG000|Overall Study|Did not pass screening|4|||
128770500|NCT00077636|463451528|FG001|Overall Study|Lost to Follow-up|18|||
128949909|NCT02062463|464103086|FG003|Stage 2|Lack of Efficacy|4|||
128949910|NCT02062463|464103083|FG000|Stage 2|Lost to Follow-up|0|||
128949911|NCT02062463|464103084|FG001|Stage 2|Lost to Follow-up|0|||
128949912|NCT02062463|464103085|FG002|Stage 2|Lost to Follow-up|20|||
128949913|NCT02062463|464103086|FG003|Stage 2|Lost to Follow-up|20|||
128949914|NCT02062463|464103083|FG000|Stage 2|Non-Compliance|0|||
128949915|NCT02062463|464103084|FG001|Stage 2|Non-Compliance|0|||
128949916|NCT02062463|464103085|FG002|Stage 2|Non-Compliance|0|||
128949917|NCT02062463|464103086|FG003|Stage 2|Non-Compliance|1|||
128949918|NCT02062463|464103083|FG000|Stage 2|Other than specified|0|||
128949919|NCT02062463|464103084|FG001|Stage 2|Other than specified|0|||
128949920|NCT02062463|464103085|FG002|Stage 2|Other than specified|3|||
128949921|NCT02062463|464103086|FG003|Stage 2|Other than specified|1|||
128949922|NCT02062463|464103083|FG000|Stage 2|Withdrawal by Subject|0|||
128949923|NCT02062463|464103084|FG001|Stage 2|Withdrawal by Subject|0|||
128949924|NCT02062463|464103085|FG002|Stage 2|Withdrawal by Subject|15|||
128949925|NCT02062463|464103086|FG003|Stage 2|Withdrawal by Subject|10|||
128949926|NCT04124692|464103087|FG000|Overall Study|Medical reason|0|||
128949927|NCT04124692|464103088|FG001|Overall Study|Medical reason|1|||
128949928|NCT04124692|464103087|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
128949929|NCT04124692|464103088|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
128949930|NCT04124692|464103087|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
128949931|NCT04124692|464103088|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
128949932|NCT04124692|464103087|FG000|Overall Study|Lost to Follow-up|2|||
128949933|NCT04124692|464103088|FG001|Overall Study|Lost to Follow-up|4|||
128949934|NCT04124692|464103087|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
128949935|NCT04124692|464103088|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
128949936|NCT02924688|464103089|FG000|Overall Study|Adverse Event|9|||
128949937|NCT02924688|464103090|FG001|Overall Study|Adverse Event|3|||
128949938|NCT02924688|464103091|FG002|Overall Study|Adverse Event|2|||
128949939|NCT02924688|464103092|FG003|Overall Study|Adverse Event|2|||
128949940|NCT02924688|464103093|FG004|Overall Study|Adverse Event|3|||
128949941|NCT02924688|464103094|FG005|Overall Study|Adverse Event|2|||
128949942|NCT02924688|464103089|FG000|Overall Study|Lack of Efficacy|2|||
128949943|NCT02924688|464103090|FG001|Overall Study|Lack of Efficacy|3|||
128949944|NCT02924688|464103091|FG002|Overall Study|Lack of Efficacy|4|||
128949945|NCT02924688|464103092|FG003|Overall Study|Lack of Efficacy|2|||
128949946|NCT02924688|464103093|FG004|Overall Study|Lack of Efficacy|1|||
128949947|NCT02924688|464103094|FG005|Overall Study|Lack of Efficacy|1|||
128949948|NCT02924688|464103089|FG000|Overall Study|Protocol Violation|3|||
128949949|NCT02924688|464103090|FG001|Overall Study|Protocol Violation|7|||
128949950|NCT02924688|464103091|FG002|Overall Study|Protocol Violation|5|||
128949951|NCT02924688|464103092|FG003|Overall Study|Protocol Violation|6|||
128949952|NCT02924688|464103093|FG004|Overall Study|Protocol Violation|2|||
128949953|NCT02924688|464103094|FG005|Overall Study|Protocol Violation|2|||
128949954|NCT02924688|464103089|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
128949955|NCT02924688|464103090|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
128949956|NCT02924688|464103091|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
128949957|NCT02924688|464103092|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
128949958|NCT02924688|464103093|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
128949959|NCT02924688|464103094|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
128949960|NCT02924688|464103089|FG000|Overall Study|Lost to Follow-up|2|||
128949961|NCT02924688|464103090|FG001|Overall Study|Lost to Follow-up|4|||
128949962|NCT02924688|464103091|FG002|Overall Study|Lost to Follow-up|2|||
128949963|NCT02924688|464103092|FG003|Overall Study|Lost to Follow-up|4|||
128949964|NCT02924688|464103093|FG004|Overall Study|Lost to Follow-up|2|||
128949965|NCT02924688|464103094|FG005|Overall Study|Lost to Follow-up|4|||
128949966|NCT02924688|464103089|FG000|Overall Study|Physician Decision|2|||
128949967|NCT02924688|464103090|FG001|Overall Study|Physician Decision|1|||
128949968|NCT02924688|464103091|FG002|Overall Study|Physician Decision|0|||
128949969|NCT02924688|464103092|FG003|Overall Study|Physician Decision|1|||
129034810|NCT02212457|464416593|FG005|Overall Study|Withdrawal by Subject|4|||
129034811|NCT02212457|464416588|FG000|Overall Study|Lost to Follow-up|6|||
129034812|NCT02212457|464416589|FG001|Overall Study|Lost to Follow-up|7|||
128770501|NCT00077636|463451527|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
128949970|NCT02924688|464103093|FG004|Overall Study|Physician Decision|1|||
128949971|NCT02924688|464103094|FG005|Overall Study|Physician Decision|1|||
128949972|NCT02924688|464103089|FG000|Overall Study|Withdrawal by Subject|14|||
128949973|NCT02924688|464103090|FG001|Overall Study|Withdrawal by Subject|13|||
129034813|NCT02212457|464416590|FG002|Overall Study|Lost to Follow-up|4|||
128949974|NCT02924688|464103091|FG002|Overall Study|Withdrawal by Subject|9|||
128949975|NCT02924688|464103092|FG003|Overall Study|Withdrawal by Subject|12|||
128949976|NCT02924688|464103093|FG004|Overall Study|Withdrawal by Subject|13|||
129034814|NCT02212457|464416591|FG003|Overall Study|Lost to Follow-up|1|||
128949977|NCT02924688|464103094|FG005|Overall Study|Withdrawal by Subject|14|||
128949978|NCT01754922|464103095|FG000|Overall Study|Adverse Event|0|||
128949979|NCT01754922|464103096|FG001|Overall Study|Adverse Event|1|||
128949980|NCT00310388|464103098|FG000|Primary Reporting Phase|Adverse Event|101|||
129034815|NCT02212457|464416592|FG004|Overall Study|Lost to Follow-up|8|||
129034816|NCT02212457|464416593|FG005|Overall Study|Lost to Follow-up|4|||
128949981|NCT00310388|464103099|FG001|Primary Reporting Phase|Adverse Event|0|||
129218894|NCT00541385|465101645|FG001|Overall Study|Withdrawal by Subject|2|||
129218895|NCT00541385|465101644|FG000|Overall Study|Lost to Follow-up|6|||
129218896|NCT00541385|465101645|FG001|Overall Study|Lost to Follow-up|1|||
129218897|NCT00541385|465101644|FG000|Overall Study|Parasite reappearance/malaria|67|||
129218898|NCT00541385|465101645|FG001|Overall Study|Parasite reappearance/malaria|32|||
129218899|NCT04139798|465101647|FG000|Overall Study|Withdrawal by Subject|6|||
129218900|NCT04139798|465101648|FG001|Overall Study|Withdrawal by Subject|5|||
129218901|NCT04139798|465101647|FG000|Overall Study|Lost to Follow-up|2|||
129218902|NCT04139798|465101648|FG001|Overall Study|Lost to Follow-up|5|||
129218903|NCT04139798|465101647|FG000|Overall Study|Discontinued|4|||
129218904|NCT04139798|465101648|FG001|Overall Study|Discontinued|2|||
129218905|NCT04139798|465101647|FG000|Overall Study|Adverse Event|1|||
129218906|NCT04139798|465101648|FG001|Overall Study|Adverse Event|3|||
129218907|NCT04139798|465101647|FG000|Overall Study|Protocol Violation|1|||
129218908|NCT04139798|465101648|FG001|Overall Study|Protocol Violation|0|||
129218909|NCT03155841|465101649|FG000|Overall Study|Protocol Violation|3|||
128949982|NCT00310388|464103098|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
128949983|NCT00310388|464103099|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
128949984|NCT00310388|464103098|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
128949985|NCT00310388|464103099|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
128949986|NCT00310388|464103098|FG000|Primary Reporting Phase|Protocol Violation|10|||
128949987|NCT00310388|464103099|FG001|Primary Reporting Phase|Protocol Violation|0|||
128949988|NCT00310388|464103098|FG000|Primary Reporting Phase|Pregnancy|3|||
128949989|NCT00310388|464103099|FG001|Primary Reporting Phase|Pregnancy|0|||
128949990|NCT00310388|464103098|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
128949991|NCT00310388|464103099|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
128949992|NCT00310388|464103098|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
128949993|NCT00310388|464103099|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
128949994|NCT00310388|464103098|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
128710096|NCT01948050|463234369|FG000|Overall Study|Withdrawal by Subject|0|||
128710097|NCT01948050|463234370|FG001|Overall Study|Withdrawal by Subject|1|||
128710098|NCT01961323|463234371|FG000|Overall Study|Withdrawal by Subject|7|||
128710099|NCT01961323|463234371|FG000|Overall Study|Lost to Follow-up|8|||
128710100|NCT01961323|463234371|FG000|Overall Study|screen failure|34|||
128710101|NCT02875860|463234374|FG000|Overall Study|Withdrawal by Subject|0|||
128710102|NCT02875860|463234375|FG001|Overall Study|Withdrawal by Subject|1|||
128710103|NCT01426373|463234377|FG000|Overall Study|Adverse Event|6|||
128710104|NCT01426373|463234377|FG000|Overall Study|Lost to Follow-up|14|||
128710105|NCT01426373|463234377|FG000|Overall Study|Participant Convenience|10|||
128710106|NCT01426373|463234377|FG000|Overall Study|Miscellaneous Reasons|4|||
128710107|NCT04952402|463234378|FG000|Overall Study|Lost to Follow-up|1|||
128710108|NCT04952402|463234379|FG001|Overall Study|Lost to Follow-up|3|||
128710109|NCT04952402|463234378|FG000|Overall Study|Lack Of Venous Access|0|||
128710110|NCT04952402|463234379|FG001|Overall Study|Lack Of Venous Access|1|||
128710111|NCT00726661|463234380|FG000|Overall Study|Lost to Follow-up|36|||
128710112|NCT00726661|463234381|FG001|Overall Study|Lost to Follow-up|11|||
128710113|NCT00726661|463234380|FG000|Overall Study|Withdrawal by Subject|17|||
128710114|NCT00726661|463234381|FG001|Overall Study|Withdrawal by Subject|13|||
128710115|NCT00726661|463234380|FG000|Overall Study|Trial terminated by sponsor|214|||
128710116|NCT00726661|463234381|FG001|Overall Study|Trial terminated by sponsor|187|||
128710117|NCT00726661|463234380|FG000|Overall Study|Death|475|||
128710118|NCT00726661|463234381|FG001|Overall Study|Death|159|||
128710119|NCT00726661|463234380|FG000|Overall Study|Physician Decision|25|||
128710120|NCT00726661|463234381|FG001|Overall Study|Physician Decision|13|||
128710121|NCT00726661|463234380|FG000|Overall Study|Other|47|||
128710122|NCT00726661|463234381|FG001|Overall Study|Other|35|||
128710123|NCT01285310|463234382|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
128710124|NCT01285310|463234383|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
128710125|NCT01285310|463234384|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
128710126|NCT01285310|463234385|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
128710127|NCT01285310|463234386|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
128949995|NCT00310388|464103099|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
128949996|NCT00310388|464103098|FG000|Primary Reporting Phase|Physician Decision|2|||
128949997|NCT00310388|464103099|FG001|Primary Reporting Phase|Physician Decision|0|||
129218910|NCT03155841|465101650|FG001|Overall Study|Protocol Violation|4|||
129218911|NCT02699749|465101660|FG000|Overall Study|Other|0|||
129218912|NCT02699749|465101661|FG001|Overall Study|Other|0|||
128710128|NCT01285310|463234382|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
128949998|NCT00310388|464103098|FG000|Primary Reporting Phase|Request of the sponsor|19|||
128949999|NCT00310388|464103099|FG001|Primary Reporting Phase|Request of the sponsor|0|||
129218913|NCT02699749|465101662|FG002|Overall Study|Other|2|||
129218914|NCT02699749|465101663|FG003|Overall Study|Other|0|||
128710129|NCT01285310|463234383|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
128710130|NCT01285310|463234384|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
128710131|NCT01285310|463234385|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
128710132|NCT01285310|463234386|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
128710133|NCT01285310|463234382|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
128710134|NCT01285310|463234383|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
128710135|NCT01285310|463234384|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
128710136|NCT01285310|463234385|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
128710137|NCT01285310|463234386|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
128710138|NCT01285310|463234382|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
128710139|NCT01285310|463234383|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
128710140|NCT01285310|463234384|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
128710141|NCT01285310|463234385|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
128710142|NCT01285310|463234386|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
128710143|NCT01285310|463234382|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
128710144|NCT01285310|463234383|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
128710145|NCT01285310|463234384|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
128710146|NCT01285310|463234385|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
128710147|NCT01285310|463234386|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
128710148|NCT01285310|463234382|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
128710149|NCT01285310|463234383|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
128710150|NCT01285310|463234384|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
128710151|NCT01285310|463234385|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
128710152|NCT01285310|463234386|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
128710153|NCT01285310|463234382|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
128710154|NCT01285310|463234383|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
128710155|NCT01285310|463234384|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
128710156|NCT01285310|463234385|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
128710157|NCT01285310|463234386|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
128710158|NCT01285310|463234382|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
128710159|NCT01285310|463234383|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
128710160|NCT01285310|463234384|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
128710161|NCT01285310|463234385|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
128710162|NCT01285310|463234386|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
128710163|NCT01285310|463234382|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
128710164|NCT01285310|463234383|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
128710165|NCT01285310|463234384|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
128710166|NCT01285310|463234385|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
128710167|NCT01285310|463234386|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
128710168|NCT01285310|463234382|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
128710169|NCT01285310|463234383|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
128710170|NCT01285310|463234384|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
128710171|NCT01285310|463234385|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
128710172|NCT01285310|463234386|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
128710173|NCT01285310|463234382|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
128710174|NCT01285310|463234383|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
128710175|NCT01285310|463234384|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
129034817|NCT02212457|464416588|FG000|Overall Study|Protocol Violation|2|||
128710176|NCT01285310|463234385|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
128710177|NCT01285310|463234386|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
128710178|NCT01285310|463234382|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
128710179|NCT01285310|463234383|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
128710180|NCT01285310|463234384|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
128710181|NCT01285310|463234385|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
128710182|NCT01285310|463234386|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
128710183|NCT00005937|463234409|FG000|Overall Study|Lack of Efficacy|5|||
128710184|NCT01574612|463234410|FG000|Overall Study|Adverse Event|3|||
128710185|NCT01574612|463234410|FG000|Overall Study|non compliant with drug|2|||
128710186|NCT01574612|463234410|FG000|Overall Study|Withdrawal by Subject|1|||
128710187|NCT01574612|463234410|FG000|Overall Study|Lost to Follow-up|2|||
128710188|NCT01957644|463234413|FG000|Overall Study|Adverse Event|4|||
128710189|NCT01957644|463234414|FG001|Overall Study|Adverse Event|2|||
128710190|NCT01957644|463234415|FG002|Overall Study|Adverse Event|0|||
128710191|NCT01957644|463234416|FG003|Overall Study|Adverse Event|0|||
128710192|NCT01957644|463234417|FG004|Overall Study|Adverse Event|1|||
128710193|NCT01957644|463234413|FG000|Overall Study|Progressive disease / relapse|0|||
128710194|NCT01957644|463234414|FG001|Overall Study|Progressive disease / relapse|1|||
128710195|NCT01957644|463234415|FG002|Overall Study|Progressive disease / relapse|0|||
128710196|NCT01957644|463234416|FG003|Overall Study|Progressive disease / relapse|1|||
128770502|NCT00077636|463451528|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
129034818|NCT02212457|464416589|FG001|Overall Study|Protocol Violation|1|||
128950000|NCT00310388|464103098|FG000|Primary Reporting Phase|Failed to return|8|||
128950001|NCT00310388|464103099|FG001|Primary Reporting Phase|Failed to return|0|||
128950002|NCT00310388|464103098|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
128950003|NCT00310388|464103099|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
128950004|NCT00310388|464103098|FG000|Primary Reporting Phase|Participant request|2|||
128950005|NCT00310388|464103099|FG001|Primary Reporting Phase|Participant request|0|||
128950006|NCT00310388|464103098|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
128950007|NCT00310388|464103099|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
128950008|NCT00310388|464103098|FG000|Primary Reporting Phase|Discontinuation of study|1|||
128950009|NCT00310388|464103099|FG001|Primary Reporting Phase|Discontinuation of study|0|||
128950010|NCT00310388|464103098|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
128950011|NCT00310388|464103099|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
128950012|NCT00310388|464103098|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
128950013|NCT00310388|464103099|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
128950014|NCT00310388|464103098|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
128950015|NCT00310388|464103099|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
128950016|NCT00310388|464103098|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
128950017|NCT00310388|464103099|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
128950018|NCT00310388|464103098|FG000|Primary Reporting Phase|Participant passed away|1|||
128950019|NCT00310388|464103099|FG001|Primary Reporting Phase|Participant passed away|0|||
128950020|NCT00310388|464103098|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
128950021|NCT00310388|464103099|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
128950022|NCT00310388|464103098|FG000|Primary Reporting Phase|Missing|1|||
128950023|NCT00310388|464103099|FG001|Primary Reporting Phase|Missing|0|||
128950024|NCT00310388|464103098|FG000|Primary Reporting Phase|Other|1|||
128950025|NCT00310388|464103099|FG001|Primary Reporting Phase|Other|0|||
128950026|NCT00310388|464103098|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
128950027|NCT00310388|464103099|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
128950028|NCT00310388|464103098|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
128950029|NCT00310388|464103099|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
128950030|NCT00310388|464103098|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
128950031|NCT00310388|464103099|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
128950032|NCT00310388|464103098|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
128950033|NCT00310388|464103099|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
128950034|NCT02370498|464103101|FG000|Overall Study|Adverse Event|10|||
128950035|NCT02370498|464103102|FG001|Overall Study|Adverse Event|8|||
128950036|NCT02370498|464103101|FG000|Overall Study|Death|263|||
128950037|NCT02370498|464103102|FG001|Overall Study|Death|265|||
128950038|NCT02370498|464103101|FG000|Overall Study|Protocol Violation|1|||
128950039|NCT02370498|464103102|FG001|Overall Study|Protocol Violation|2|||
128950040|NCT02370498|464103101|FG000|Overall Study|Withdrawal by Subject|7|||
128950041|NCT02370498|464103102|FG001|Overall Study|Withdrawal by Subject|12|||
128950042|NCT02370498|464103101|FG000|Overall Study|Sponsor's decision|15|||
128950043|NCT02370498|464103102|FG001|Overall Study|Sponsor's decision|9|||
128950044|NCT00848250|464103103|FG000|Overall Study|surgery was completed without cardiopulm|0|||
128950045|NCT00848250|464103104|FG001|Overall Study|surgery was completed without cardiopulm|1|||
128950046|NCT03457103|464103115|FG000|Overall Study|illness/hospitalization|4|||
128950047|NCT03457103|464103116|FG001|Overall Study|illness/hospitalization|2|||
128950048|NCT03457103|464103115|FG000|Overall Study|Lost to Follow-up|2|||
128950049|NCT03457103|464103116|FG001|Overall Study|Lost to Follow-up|1|||
128950050|NCT03457103|464103115|FG000|Overall Study|Withdrawal by Subject|1|||
128950051|NCT03457103|464103116|FG001|Overall Study|Withdrawal by Subject|2|||
128950052|NCT03457103|464103115|FG000|Overall Study|financial/ insurance issues|1|||
128950053|NCT03457103|464103116|FG001|Overall Study|financial/ insurance issues|1|||
128950054|NCT00502320|464103117|FG000|Overall Study|Lost to Follow-up|1|||
128950055|NCT00502320|464103118|FG001|Overall Study|Lost to Follow-up|1|||
128950056|NCT00502320|464103117|FG000|Overall Study|Withdrew Consent|1|||
128950057|NCT00502320|464103118|FG001|Overall Study|Withdrew Consent|0|||
128950058|NCT00502320|464103117|FG000|Overall Study|No longer met criteria|1|||
128950059|NCT00502320|464103118|FG001|Overall Study|No longer met criteria|0|||
129218915|NCT02699749|465101664|FG004|Overall Study|Other|0|||
129218916|NCT02699749|465101665|FG005|Overall Study|Other|1|||
128950060|NCT00502320|464103117|FG000|Overall Study|Screen Failure|0|||
128950061|NCT00502320|464103118|FG001|Overall Study|Screen Failure|1|||
128950062|NCT00502320|464103117|FG000|Overall Study|Adverse Event|3|||
129034819|NCT02212457|464416590|FG002|Overall Study|Protocol Violation|0|||
129218917|NCT02699749|465101666|FG006|Overall Study|Other|1|||
129218918|NCT02699749|465101667|FG007|Overall Study|Other|0|||
128950063|NCT00502320|464103118|FG001|Overall Study|Adverse Event|5|||
128950064|NCT02394808|464103121|FG000|Period 1|Unsatisfactory lens fitting|0|||
129218919|NCT02699749|465101668|FG008|Overall Study|Other|0|||
129218920|NCT02699749|465101669|FG009|Overall Study|Other|0|||
129218921|NCT02699749|465101670|FG010|Overall Study|Other|1|||
128710197|NCT01957644|463234417|FG004|Overall Study|Progressive disease / relapse|0|||
128710198|NCT01957644|463234413|FG000|Overall Study|Other reason|1|||
128710199|NCT01957644|463234414|FG001|Overall Study|Other reason|2|||
128710200|NCT01957644|463234415|FG002|Overall Study|Other reason|1|||
128950065|NCT02394808|464103122|FG001|Period 1|Unsatisfactory lens fitting|1|||
128950066|NCT02394808|464103121|FG000|Period 2|Lost to Follow-up|1|||
128950067|NCT02394808|464103122|FG001|Period 2|Lost to Follow-up|0|||
128950068|NCT03943953|464103123|FG000|Trial of ITG 1|Lost to Follow-up|19|||
128950069|NCT03943953|464103124|FG001|Trial of ITG 1|Lost to Follow-up|1|||
128950070|NCT03943953|464103123|FG000|Trial of ITG 2|Lost to Follow-up|8|||
128950071|NCT03943953|464103124|FG001|Trial of ITG 2|Lost to Follow-up|0|||
128950072|NCT03943953|464103123|FG000|Trial of ITG 3|Lost to Follow-up|2|||
128950073|NCT03943953|464103124|FG001|Trial of ITG 3|Lost to Follow-up|0|||
128950074|NCT03943953|464103123|FG000|Trial of ITG 4|Lost to Follow-up|2|||
128950075|NCT03943953|464103124|FG001|Trial of ITG 4|Lost to Follow-up|0|||
128950076|NCT01199055|464103125|FG000|Overall Study|Death|0|||
128950077|NCT01199055|464103126|FG001|Overall Study|Death|1|||
128950078|NCT01199055|464103127|FG002|Overall Study|Death|0|||
128950079|NCT01199055|464103125|FG000|Overall Study|Physician Decision|0|||
128950080|NCT01199055|464103126|FG001|Overall Study|Physician Decision|1|||
128950081|NCT01199055|464103127|FG002|Overall Study|Physician Decision|1|||
128950082|NCT01199055|464103125|FG000|Overall Study|Progressive disease|2|||
128950083|NCT01199055|464103126|FG001|Overall Study|Progressive disease|1|||
128950084|NCT01199055|464103127|FG002|Overall Study|Progressive disease|2|||
128950085|NCT01199055|464103125|FG000|Overall Study|Withdrawal by Subject|0|||
128950086|NCT01199055|464103126|FG001|Overall Study|Withdrawal by Subject|0|||
128950087|NCT01199055|464103127|FG002|Overall Study|Withdrawal by Subject|1|||
128950088|NCT01069523|464103128|FG000|Overall Study|Withdrawal by Subject|4|||
128950089|NCT01069523|464103129|FG001|Overall Study|Withdrawal by Subject|7|||
128950090|NCT00488592|464103142|FG000|Overall Study|Withdrawal by Subject|1|||
128950091|NCT00488592|464103142|FG000|Overall Study|Disease progression|1|||
128950092|NCT00488592|464103142|FG000|Overall Study|Enrolled but not treated|1|||
128950093|NCT03670641|464103143|FG000|Overall Study|Lost to Follow-up|3|||
128950094|NCT00118482|464103144|FG000|Overall Study|Lost to Follow-up|7|||
128950095|NCT00118482|464103145|FG001|Overall Study|Lost to Follow-up|7|||
128950096|NCT00118482|464103144|FG000|Overall Study|Withdrawal by Subject|23|||
128950097|NCT00118482|464103145|FG001|Overall Study|Withdrawal by Subject|22|||
128950098|NCT03970395|464103146|FG000|Overall Study|Withdrawal by Subject|3|||
128950099|NCT03970395|464103147|FG001|Overall Study|Withdrawal by Subject|4|||
128950100|NCT03970395|464103146|FG000|Overall Study|Lost to Follow-up|4|||
128950101|NCT03970395|464103147|FG001|Overall Study|Lost to Follow-up|8|||
128950102|NCT00125190|464103149|FG000|Overall Study|Subject/Parent Decision|7|||
128950103|NCT00125190|464103149|FG000|Overall Study|Non-compliance|2|||
128950104|NCT00125190|464103149|FG000|Overall Study|Adverse Event|1|||
128950105|NCT00125190|464103149|FG000|Overall Study|Other|1|||
128950106|NCT00125190|464103149|FG000|Overall Study|Lost to Follow-up|4|||
128950107|NCT03666858|464103152|FG000|Cohort 1|Adverse Event|1|||
128950108|NCT03666858|464103153|FG001|Cohort 1|Adverse Event|0|||
128950109|NCT03666858|464103152|FG000|Cohort 2|Adverse Event|0|||
128950110|NCT03666858|464103153|FG001|Cohort 2|Adverse Event|1|||
128950111|NCT02921919|464103154|FG000|Overall Study|Other|5|||
128950112|NCT02921919|464103155|FG001|Overall Study|Other|6|||
128950113|NCT02921919|464103154|FG000|Overall Study|Lost to Follow-up|0|||
128950114|NCT02921919|464103155|FG001|Overall Study|Lost to Follow-up|1|||
128950115|NCT02921919|464103154|FG000|Overall Study|Withdrawal by Subject|5|||
128950116|NCT02921919|464103155|FG001|Overall Study|Withdrawal by Subject|1|||
128950117|NCT02921919|464103154|FG000|Overall Study|Disease Progression|47|||
128950118|NCT02921919|464103155|FG001|Overall Study|Disease Progression|38|||
128950119|NCT02921919|464103154|FG000|Overall Study|Physician Decision|3|||
128710201|NCT01957644|463234416|FG003|Overall Study|Other reason|1|||
128710202|NCT01957644|463234417|FG004|Overall Study|Other reason|0|||
128950120|NCT02921919|464103155|FG001|Overall Study|Physician Decision|2|||
128950121|NCT02921919|464103154|FG000|Overall Study|Adverse Event|6|||
128950122|NCT02921919|464103155|FG001|Overall Study|Adverse Event|4|||
128950123|NCT03282357|464103156|FG000|Overall Study|Lost to Follow-up|3|||
129034820|NCT02212457|464416591|FG003|Overall Study|Protocol Violation|1|||
128950124|NCT03282357|464103156|FG000|Overall Study|Withdrawal by Subject|4|||
128950125|NCT03282357|464103156|FG000|Overall Study|Adverse Event|1|||
128950126|NCT03282357|464103156|FG000|Overall Study|Other|9|||
128950127|NCT01586156|464103157|FG000|Overall Study|Pregnancy|0|||
128950128|NCT01586156|464103158|FG001|Overall Study|Pregnancy|1|||
128950129|NCT01586156|464103159|FG002|Overall Study|Pregnancy|0|||
128950130|NCT00547378|464103160|FG000|Randomized Cohort|Withdrawal by Subject|7|||
128950131|NCT00547378|464103161|FG001|Randomized Cohort|Withdrawal by Subject|5|||
128710203|NCT01957644|463234413|FG000|Overall Study|Withdrawal by Subject|1|||
128950132|NCT00547378|464103162|FG002|Randomized Cohort|Withdrawal by Subject|0|||
128950133|NCT00547378|464103160|FG000|Randomized Cohort|Death|0|||
128950134|NCT00547378|464103161|FG001|Randomized Cohort|Death|1|||
128950135|NCT00547378|464103162|FG002|Randomized Cohort|Death|0|||
128950136|NCT00547378|464103160|FG000|Randomized Cohort|Lost to Follow-up|1|||
129034821|NCT02212457|464416592|FG004|Overall Study|Protocol Violation|2|||
128950137|NCT00547378|464103161|FG001|Randomized Cohort|Lost to Follow-up|0|||
128950138|NCT00547378|464103162|FG002|Randomized Cohort|Lost to Follow-up|0|||
128950139|NCT00547378|464103160|FG000|Randomized Cohort|Adverse Event|1|||
128950140|NCT00547378|464103161|FG001|Randomized Cohort|Adverse Event|0|||
128950141|NCT00547378|464103162|FG002|Randomized Cohort|Adverse Event|0|||
128950142|NCT00547378|464103160|FG000|Randomized Cohort|Other reasons|2|||
128950143|NCT00547378|464103161|FG001|Randomized Cohort|Other reasons|0|||
128950144|NCT00547378|464103162|FG002|Randomized Cohort|Other reasons|0|||
128950145|NCT00547378|464103160|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
128950146|NCT00547378|464103161|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
128950147|NCT00547378|464103162|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
128950148|NCT00547378|464103160|FG000|All Implanted Cohort|Adverse Event|4|||
128950149|NCT00547378|464103161|FG001|All Implanted Cohort|Adverse Event|10|||
128950150|NCT00547378|464103162|FG002|All Implanted Cohort|Adverse Event|17|||
129218922|NCT02699749|465101671|FG011|Overall Study|Other|0|||
129218923|NCT02699749|465101672|FG012|Overall Study|Other|0|||
129218924|NCT02699749|465101673|FG013|Overall Study|Other|0|||
129218925|NCT02699749|465101660|FG000|Overall Study|Progressive Disease|3|||
129218926|NCT02699749|465101661|FG001|Overall Study|Progressive Disease|3|||
129218927|NCT02699749|465101662|FG002|Overall Study|Progressive Disease|14|||
129218928|NCT02699749|465101663|FG003|Overall Study|Progressive Disease|3|||
129218929|NCT02699749|465101664|FG004|Overall Study|Progressive Disease|3|||
129218930|NCT02699749|465101665|FG005|Overall Study|Progressive Disease|7|||
129218931|NCT02699749|465101666|FG006|Overall Study|Progressive Disease|5|||
129218932|NCT02699749|465101667|FG007|Overall Study|Progressive Disease|5|||
129218933|NCT02699749|465101668|FG008|Overall Study|Progressive Disease|6|||
129218934|NCT02699749|465101669|FG009|Overall Study|Progressive Disease|6|||
129218935|NCT02699749|465101670|FG010|Overall Study|Progressive Disease|5|||
129218936|NCT02699749|465101671|FG011|Overall Study|Progressive Disease|4|||
129218937|NCT02699749|465101672|FG012|Overall Study|Progressive Disease|3|||
129218938|NCT02699749|465101673|FG013|Overall Study|Progressive Disease|5|||
129218939|NCT02699749|465101660|FG000|Overall Study|Death|0|||
129218940|NCT02699749|465101661|FG001|Overall Study|Death|0|||
129218941|NCT02699749|465101662|FG002|Overall Study|Death|0|||
129218942|NCT02699749|465101663|FG003|Overall Study|Death|0|||
129218943|NCT02699749|465101664|FG004|Overall Study|Death|0|||
129218944|NCT02699749|465101665|FG005|Overall Study|Death|0|||
129218945|NCT02699749|465101666|FG006|Overall Study|Death|0|||
129218946|NCT02699749|465101667|FG007|Overall Study|Death|0|||
129218947|NCT02699749|465101668|FG008|Overall Study|Death|0|||
129218948|NCT02699749|465101669|FG009|Overall Study|Death|0|||
129218949|NCT02699749|465101670|FG010|Overall Study|Death|0|||
129218950|NCT02699749|465101671|FG011|Overall Study|Death|0|||
129218951|NCT02699749|465101672|FG012|Overall Study|Death|0|||
129218952|NCT02699749|465101673|FG013|Overall Study|Death|1|||
129218953|NCT02699749|465101660|FG000|Overall Study|Lost to Follow-up|0|||
129218954|NCT02699749|465101661|FG001|Overall Study|Lost to Follow-up|0|||
129218955|NCT02699749|465101662|FG002|Overall Study|Lost to Follow-up|0|||
129218956|NCT02699749|465101663|FG003|Overall Study|Lost to Follow-up|0|||
129218957|NCT02699749|465101664|FG004|Overall Study|Lost to Follow-up|0|||
129218958|NCT02699749|465101665|FG005|Overall Study|Lost to Follow-up|1|||
129218959|NCT02699749|465101666|FG006|Overall Study|Lost to Follow-up|0|||
129218960|NCT02699749|465101667|FG007|Overall Study|Lost to Follow-up|1|||
129218961|NCT02699749|465101668|FG008|Overall Study|Lost to Follow-up|0|||
129218962|NCT02699749|465101669|FG009|Overall Study|Lost to Follow-up|0|||
129218963|NCT02699749|465101670|FG010|Overall Study|Lost to Follow-up|0|||
129218964|NCT02699749|465101671|FG011|Overall Study|Lost to Follow-up|0|||
129218965|NCT02699749|465101672|FG012|Overall Study|Lost to Follow-up|0|||
129218966|NCT02699749|465101673|FG013|Overall Study|Lost to Follow-up|0|||
129218967|NCT01599637|465101674|FG000|Overall Study|administrative problems|0|||
129218968|NCT01599637|465101675|FG001|Overall Study|administrative problems|2|||
129218969|NCT01599637|465101676|FG002|Overall Study|administrative problems|0|||
129218970|NCT01599637|465101674|FG000|Overall Study|Adverse Event|1|||
129218971|NCT01599637|465101675|FG001|Overall Study|Adverse Event|0|||
128770503|NCT03545113|463451529|FG000|Overall Study|Surgery Cancelled|1|||
128950151|NCT00547378|464103160|FG000|All Implanted Cohort|Lost to Follow-up|0|||
128950152|NCT00547378|464103161|FG001|All Implanted Cohort|Lost to Follow-up|1|||
128950153|NCT00547378|464103162|FG002|All Implanted Cohort|Lost to Follow-up|14|||
128950154|NCT00547378|464103160|FG000|All Implanted Cohort|Death|3|||
128950155|NCT00547378|464103161|FG001|All Implanted Cohort|Death|1|||
128950156|NCT00547378|464103162|FG002|All Implanted Cohort|Death|4|||
129218972|NCT01599637|465101676|FG002|Overall Study|Adverse Event|0|||
129218973|NCT02721966|465101678|FG000|Overall Study|Protocol Violation|1|||
129218974|NCT02721966|465101679|FG001|Overall Study|Protocol Violation|0|||
129218975|NCT02721966|465101680|FG002|Overall Study|Protocol Violation|0|||
129218976|NCT02721966|465101681|FG003|Overall Study|Protocol Violation|0|||
129218977|NCT02721966|465101682|FG004|Overall Study|Protocol Violation|0|||
129218978|NCT02721966|465101678|FG000|Overall Study|Withdrawal by Subject|9|||
129218979|NCT02721966|465101679|FG001|Overall Study|Withdrawal by Subject|2|||
129218980|NCT02721966|465101680|FG002|Overall Study|Withdrawal by Subject|3|||
129218981|NCT02721966|465101681|FG003|Overall Study|Withdrawal by Subject|7|||
128710204|NCT01957644|463234414|FG001|Overall Study|Withdrawal by Subject|0|||
128710205|NCT01957644|463234415|FG002|Overall Study|Withdrawal by Subject|0|||
128950157|NCT00547378|464103160|FG000|All Implanted Cohort|Physician Decision|0|||
128950158|NCT00547378|464103161|FG001|All Implanted Cohort|Physician Decision|2|||
128950159|NCT00547378|464103162|FG002|All Implanted Cohort|Physician Decision|6|||
128950160|NCT00547378|464103160|FG000|All Implanted Cohort|Site closure|2|||
128950161|NCT00547378|464103161|FG001|All Implanted Cohort|Site closure|0|||
128950162|NCT00547378|464103162|FG002|All Implanted Cohort|Site closure|1|||
128950163|NCT00547378|464103160|FG000|All Implanted Cohort|Other reasons|1|||
128950164|NCT00547378|464103161|FG001|All Implanted Cohort|Other reasons|0|||
128950165|NCT00547378|464103162|FG002|All Implanted Cohort|Other reasons|1|||
128950166|NCT02112994|464103163|FG000|Overall Study|Progressive Disease|0|||
128950167|NCT02112994|464103164|FG001|Overall Study|Progressive Disease|0|||
128950168|NCT02112994|464103165|FG002|Overall Study|Progressive Disease|1|||
128950169|NCT02112994|464103163|FG000|Overall Study|Pregnancy|0|||
128950170|NCT02112994|464103164|FG001|Overall Study|Pregnancy|1|||
128950171|NCT02112994|464103165|FG002|Overall Study|Pregnancy|1|||
128950172|NCT02112994|464103163|FG000|Overall Study|Liver Transplant|0|||
128950173|NCT02112994|464103164|FG001|Overall Study|Liver Transplant|1|||
128950174|NCT02112994|464103165|FG002|Overall Study|Liver Transplant|0|||
128950175|NCT02112994|464103163|FG000|Overall Study|Withdrawal by Subject|0|||
128950176|NCT02112994|464103164|FG001|Overall Study|Withdrawal by Subject|0|||
128950177|NCT02112994|464103165|FG002|Overall Study|Withdrawal by Subject|1|||
128950178|NCT04105244|464103167|FG000|Overall Study|Withdrawal by Subject|10|||
128950179|NCT04105244|464103168|FG001|Overall Study|Withdrawal by Subject|12|||
128950180|NCT04105244|464103167|FG000|Overall Study|Lost to Follow-up|20|||
128950181|NCT04105244|464103168|FG001|Overall Study|Lost to Follow-up|15|||
128950182|NCT04105244|464103167|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
128950183|NCT04105244|464103168|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
128950184|NCT04105244|464103167|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
128950185|NCT04105244|464103168|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
128950186|NCT00414960|464103169|FG000|Overall Study|Adverse Event|4|||
128950187|NCT00414960|464103170|FG001|Overall Study|Adverse Event|0|||
128950188|NCT00414960|464103169|FG000|Overall Study|Withdrawal by Subject|3|||
128950189|NCT00414960|464103170|FG001|Overall Study|Withdrawal by Subject|0|||
128950190|NCT00414960|464103169|FG000|Overall Study|Physician Decision|0|||
128950191|NCT00414960|464103170|FG001|Overall Study|Physician Decision|1|||
128950192|NCT02768194|464103171|FG000|Period 1|Adverse Event|0|||
128950193|NCT02768194|464103172|FG001|Period 1|Adverse Event|0|||
128950194|NCT02768194|464103173|FG002|Period 1|Adverse Event|0|||
128950195|NCT02768194|464103174|FG003|Period 1|Adverse Event|1|||
128950196|NCT02768194|464103175|FG004|Period 1|Adverse Event|0|||
128950197|NCT02768194|464103176|FG005|Period 1|Adverse Event|0|||
128950198|NCT02768194|464103171|FG000|Period 2|Other (Reason not specified)|1|||
128950199|NCT02768194|464103172|FG001|Period 2|Other (Reason not specified)|0|||
128950200|NCT02768194|464103173|FG002|Period 2|Other (Reason not specified)|0|||
128950201|NCT02768194|464103174|FG003|Period 2|Other (Reason not specified)|0|||
128950202|NCT02768194|464103175|FG004|Period 2|Other (Reason not specified)|0|||
128950203|NCT02768194|464103176|FG005|Period 2|Other (Reason not specified)|0|||
128950204|NCT02768194|464103171|FG000|Period 3|Other (Reason not specified)|0|||
128710206|NCT01957644|463234416|FG003|Overall Study|Withdrawal by Subject|0|||
128710207|NCT01957644|463234417|FG004|Overall Study|Withdrawal by Subject|0|||
128710208|NCT01957644|463234413|FG000|Overall Study|Protocol Violation|0|||
128710209|NCT01957644|463234414|FG001|Overall Study|Protocol Violation|1|||
128710210|NCT01957644|463234415|FG002|Overall Study|Protocol Violation|0|||
128710211|NCT01957644|463234416|FG003|Overall Study|Protocol Violation|0|||
128710212|NCT01957644|463234417|FG004|Overall Study|Protocol Violation|0|||
128710213|NCT02326025|463234420|FG000|Overall Study|Adverse Event|3|||
128710214|NCT02326025|463234421|FG001|Overall Study|Adverse Event|0|||
128770504|NCT03545113|463451530|FG001|Overall Study|Surgery Cancelled|0|||
128770505|NCT03545113|463451529|FG000|Overall Study|Death|1|||
128950205|NCT02768194|464103172|FG001|Period 3|Other (Reason not specified)|1|||
128950206|NCT02768194|464103173|FG002|Period 3|Other (Reason not specified)|0|||
128950207|NCT02768194|464103174|FG003|Period 3|Other (Reason not specified)|0|||
129125205|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
128950208|NCT02768194|464103175|FG004|Period 3|Other (Reason not specified)|0|||
128950209|NCT02768194|464103176|FG005|Period 3|Other (Reason not specified)|0|||
128950210|NCT00975195|464103177|FG000|Overall Study|Adverse Event|108|||
129125206|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
129125207|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128710215|NCT02326025|463234420|FG000|Overall Study|Physician Decision|1|||
128710216|NCT02326025|463234421|FG001|Overall Study|Physician Decision|2|||
128770506|NCT03545113|463451530|FG001|Overall Study|Death|0|||
128770507|NCT03545113|463451529|FG000|Overall Study|Adverse Event|2|||
128950211|NCT00975195|464103178|FG001|Overall Study|Adverse Event|101|||
128950212|NCT00975195|464103177|FG000|Overall Study|Lack of Efficacy|6|||
128950213|NCT00975195|464103178|FG001|Overall Study|Lack of Efficacy|6|||
128950214|NCT00975195|464103177|FG000|Overall Study|Protocol Violation|27|||
128770508|NCT03545113|463451530|FG001|Overall Study|Adverse Event|0|||
128950215|NCT00975195|464103178|FG001|Overall Study|Protocol Violation|23|||
128950216|NCT00975195|464103177|FG000|Overall Study|Lost to Follow-up|9|||
128950217|NCT00975195|464103178|FG001|Overall Study|Lost to Follow-up|7|||
128950218|NCT00975195|464103177|FG000|Overall Study|Withdrawal by Subject|48|||
128950219|NCT00975195|464103178|FG001|Overall Study|Withdrawal by Subject|61|||
128950220|NCT00975195|464103177|FG000|Overall Study|Other reason not defined above|29|||
128950221|NCT00975195|464103178|FG001|Overall Study|Other reason not defined above|33|||
128950222|NCT00975195|464103177|FG000|Overall Study|Not treated|1|||
128950223|NCT00975195|464103178|FG001|Overall Study|Not treated|2|||
128950224|NCT01608724|464103179|FG000|Overall Study|Withdrawal by Subject|131|||
128950225|NCT01608724|464103179|FG000|Overall Study|Lost to Follow-up|41|||
128950226|NCT01608724|464103179|FG000|Overall Study|Study-specific discontinuation criteria|32|||
128950227|NCT01608724|464103179|FG000|Overall Study|Adverse Event|29|||
128950228|NCT01608724|464103179|FG000|Overall Study|Protocol Violation|6|||
128950229|NCT01608724|464103179|FG000|Overall Study|bood sugar too high, etc.|3|||
128950230|NCT01608724|464103179|FG000|Overall Study|Safety reasons|1|||
128950231|NCT00264849|464103184|FG000|Overall Study|Adverse Event|7|||
128950232|NCT00264849|464103185|FG001|Overall Study|Adverse Event|2|||
128950233|NCT00264849|464103184|FG000|Overall Study|Withdrawal by Subject|7|||
128950234|NCT00264849|464103185|FG001|Overall Study|Withdrawal by Subject|11|||
128950235|NCT00264849|464103184|FG000|Overall Study|Protocol Violation|5|||
128950236|NCT00264849|464103185|FG001|Overall Study|Protocol Violation|3|||
128950237|NCT00264849|464103184|FG000|Overall Study|Lack of Efficacy|1|||
128950238|NCT00264849|464103185|FG001|Overall Study|Lack of Efficacy|6|||
128950239|NCT00264849|464103184|FG000|Overall Study|Lost to Follow-up|0|||
128950240|NCT00264849|464103185|FG001|Overall Study|Lost to Follow-up|2|||
128950241|NCT00264849|464103184|FG000|Overall Study|Death|0|||
128950242|NCT00264849|464103185|FG001|Overall Study|Death|1|||
128950243|NCT00264849|464103184|FG000|Overall Study|Administrative Problems|2|||
128950244|NCT00264849|464103185|FG001|Overall Study|Administrative Problems|0|||
128950245|NCT00099359|464103188|FG000|Overall Study|Death|11|||
128950246|NCT00099359|464103189|FG001|Overall Study|Death|15|||
128950247|NCT00099359|464103190|FG002|Overall Study|Death|17|||
128950248|NCT00099359|464103188|FG000|Overall Study|Withdrawal by Subject|19|||
129034822|NCT02212457|464416593|FG005|Overall Study|Protocol Violation|3|||
129218982|NCT02721966|465101682|FG004|Overall Study|Withdrawal by Subject|0|||
129218983|NCT02721966|465101678|FG000|Overall Study|Adverse Event|4|||
128770509|NCT03545113|463451529|FG000|Overall Study|Received different surgery|1|||
128770510|NCT03545113|463451530|FG001|Overall Study|Received different surgery|0|||
128770511|NCT02032173|463451531|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
128770512|NCT03321513|463451534|FG000|Overall Study|Death|11|||
128770513|NCT03321513|463451535|FG001|Overall Study|Death|5|||
128950249|NCT00099359|464103189|FG001|Overall Study|Withdrawal by Subject|19|||
128950250|NCT00099359|464103190|FG002|Overall Study|Withdrawal by Subject|23|||
128950251|NCT00099359|464103188|FG000|Overall Study|Lost to Follow-up|15|||
128950252|NCT00099359|464103189|FG001|Overall Study|Lost to Follow-up|24|||
128950253|NCT00099359|464103190|FG002|Overall Study|Lost to Follow-up|24|||
128950254|NCT00099359|464103188|FG000|Overall Study|moved out of area|9|||
128950255|NCT00099359|464103189|FG001|Overall Study|moved out of area|7|||
128950256|NCT00099359|464103190|FG002|Overall Study|moved out of area|4|||
128950257|NCT01822691|464103191|FG000|Overall Study|Withdrawal by Subject|2|||
128950258|NCT02756650|464103192|FG000|Overall Study|Physician Decision|1|||
128950259|NCT02756650|464103192|FG000|Overall Study|Adverse Event|1|||
128950260|NCT04501679|464103197|FG000|Overall Study|Pregnancy|0|||
128950261|NCT04501679|464103198|FG001|Overall Study|Pregnancy|1|||
128950262|NCT04501679|464103197|FG000|Overall Study|Adverse Event|4|||
128950263|NCT04501679|464103198|FG001|Overall Study|Adverse Event|2|||
128950264|NCT04501679|464103197|FG000|Overall Study|Withdrawal by Subject|2|||
128950265|NCT04501679|464103198|FG001|Overall Study|Withdrawal by Subject|0|||
128950266|NCT04501679|464103197|FG000|Overall Study|Physician Decision|1|||
128950267|NCT04501679|464103198|FG001|Overall Study|Physician Decision|0|||
128950268|NCT04501679|464103197|FG000|Overall Study|Lost to Follow-up|2|||
128950269|NCT04501679|464103198|FG001|Overall Study|Lost to Follow-up|0|||
128950270|NCT02358369|464103204|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
129218984|NCT02721966|465101679|FG001|Overall Study|Adverse Event|4|||
129218985|NCT02721966|465101680|FG002|Overall Study|Adverse Event|3|||
129218986|NCT02721966|465101681|FG003|Overall Study|Adverse Event|0|||
128950271|NCT02358369|464103205|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
128950272|NCT02358369|464103206|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
128950273|NCT02358369|464103207|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
128950274|NCT02358369|464103208|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
128950275|NCT02358369|464103204|FG000|Treatment Period A/B|Adverse Event|0|||
128950276|NCT02358369|464103205|FG001|Treatment Period A/B|Adverse Event|0|||
128950277|NCT02358369|464103206|FG002|Treatment Period A/B|Adverse Event|1|||
128950278|NCT02358369|464103207|FG003|Treatment Period A/B|Adverse Event|2|||
128950279|NCT02358369|464103208|FG004|Treatment Period A/B|Adverse Event|0|||
128770514|NCT03321513|463451534|FG000|Overall Study|Withdrawal by Subject|5|||
129218987|NCT02721966|465101682|FG004|Overall Study|Adverse Event|0|||
129218988|NCT02721966|465101678|FG000|Overall Study|Death|1|||
129218989|NCT02721966|465101679|FG001|Overall Study|Death|0|||
129218990|NCT02721966|465101680|FG002|Overall Study|Death|0|||
129218991|NCT02721966|465101681|FG003|Overall Study|Death|0|||
129218992|NCT02721966|465101682|FG004|Overall Study|Death|0|||
129218993|NCT02721966|465101678|FG000|Overall Study|Lack of Efficacy|7|||
129218994|NCT02721966|465101679|FG001|Overall Study|Lack of Efficacy|4|||
129218995|NCT02721966|465101680|FG002|Overall Study|Lack of Efficacy|0|||
129218996|NCT02721966|465101681|FG003|Overall Study|Lack of Efficacy|0|||
129218997|NCT02721966|465101682|FG004|Overall Study|Lack of Efficacy|0|||
129218998|NCT02721966|465101678|FG000|Overall Study|Lost to Follow-up|0|||
129218999|NCT02721966|465101679|FG001|Overall Study|Lost to Follow-up|0|||
129219000|NCT02721966|465101680|FG002|Overall Study|Lost to Follow-up|3|||
129219001|NCT02721966|465101681|FG003|Overall Study|Lost to Follow-up|0|||
129219002|NCT02721966|465101682|FG004|Overall Study|Lost to Follow-up|0|||
129219003|NCT02721966|465101678|FG000|Overall Study|Physician Decision|1|||
128770515|NCT03321513|463451535|FG001|Overall Study|Withdrawal by Subject|10|||
128770516|NCT03321513|463451534|FG000|Overall Study|Lost to Follow-up|10|||
128950280|NCT02358369|464103204|FG000|Treatment Period A/B|Death|0|||
128950281|NCT02358369|464103205|FG001|Treatment Period A/B|Death|0|||
128950282|NCT02358369|464103206|FG002|Treatment Period A/B|Death|1|||
128950283|NCT02358369|464103207|FG003|Treatment Period A/B|Death|0|||
128950284|NCT02358369|464103208|FG004|Treatment Period A/B|Death|0|||
128950285|NCT02358369|464103204|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
128950286|NCT02358369|464103205|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
128950287|NCT02358369|464103206|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
128950288|NCT02358369|464103207|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
128950289|NCT02358369|464103208|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
128950290|NCT02358369|464103204|FG000|Treatment Period C|Adverse Event|0|||
128950291|NCT02358369|464103205|FG001|Treatment Period C|Adverse Event|0|||
128950292|NCT02358369|464103206|FG002|Treatment Period C|Adverse Event|0|||
128950293|NCT02358369|464103207|FG003|Treatment Period C|Adverse Event|0|||
128950294|NCT02358369|464103208|FG004|Treatment Period C|Adverse Event|7|||
128950295|NCT03655717|464103213|FG000|Overall Study|Withdrawal by Subject|4|||
128950296|NCT03655717|464103214|FG001|Overall Study|Withdrawal by Subject|8|||
128950297|NCT03655717|464103215|FG002|Overall Study|Withdrawal by Subject|1|||
128950298|NCT03655717|464103216|FG003|Overall Study|Withdrawal by Subject|0|||
128950299|NCT03655717|464103217|FG004|Overall Study|Withdrawal by Subject|0|||
128950300|NCT03655717|464103218|FG005|Overall Study|Withdrawal by Subject|1|||
128950301|NCT03655717|464103219|FG006|Overall Study|Withdrawal by Subject|3|||
128950302|NCT03655717|464103220|FG007|Overall Study|Withdrawal by Subject|1|||
128950303|NCT03655717|464103221|FG008|Overall Study|Withdrawal by Subject|2|||
128950304|NCT03655717|464103222|FG009|Overall Study|Withdrawal by Subject|0|||
128950305|NCT03655717|464103223|FG010|Overall Study|Withdrawal by Subject|0|||
128950306|NCT03655717|464103224|FG011|Overall Study|Withdrawal by Subject|1|||
128950307|NCT03655717|464103225|FG012|Overall Study|Withdrawal by Subject|0|||
128950308|NCT03655717|464103226|FG013|Overall Study|Withdrawal by Subject|3|||
128950309|NCT03655717|464103227|FG014|Overall Study|Withdrawal by Subject|0|||
128950310|NCT03655717|464103228|FG015|Overall Study|Withdrawal by Subject|1|||
128950311|NCT03655717|464103229|FG016|Overall Study|Withdrawal by Subject|0|||
128950312|NCT03655717|464103230|FG017|Overall Study|Withdrawal by Subject|0|||
129219004|NCT02721966|465101679|FG001|Overall Study|Physician Decision|1|||
128770517|NCT03321513|463451535|FG001|Overall Study|Lost to Follow-up|11|||
128770518|NCT01993017|463451536|FG000|Overall Study|Death|23|||
128770519|NCT01993017|463451537|FG001|Overall Study|Death|26|||
128770520|NCT01993017|463451538|FG002|Overall Study|Death|18|||
128950313|NCT03655717|464103231|FG018|Overall Study|Withdrawal by Subject|1|||
129219005|NCT02721966|465101680|FG002|Overall Study|Physician Decision|0|||
129219006|NCT02721966|465101681|FG003|Overall Study|Physician Decision|0|||
129219007|NCT02721966|465101682|FG004|Overall Study|Physician Decision|0|||
129219008|NCT02721966|465101678|FG000|Overall Study|Pregnancy|1|||
128770521|NCT01993017|463451536|FG000|Overall Study|Could not be contacted|43|||
128950314|NCT03655717|464103232|FG019|Overall Study|Withdrawal by Subject|0|||
128950315|NCT03655717|464103233|FG020|Overall Study|Withdrawal by Subject|0|||
128950316|NCT03655717|464103234|FG021|Overall Study|Withdrawal by Subject|1|||
128950317|NCT03655717|464103235|FG022|Overall Study|Withdrawal by Subject|2|||
128950318|NCT03655717|464103236|FG023|Overall Study|Withdrawal by Subject|1|||
128950319|NCT03655717|464103237|FG024|Overall Study|Withdrawal by Subject|1|||
128950320|NCT03655717|464103238|FG025|Overall Study|Withdrawal by Subject|0|||
128950321|NCT03655717|464103213|FG000|Overall Study|Physician Decision|3|||
128950322|NCT03655717|464103214|FG001|Overall Study|Physician Decision|3|||
129219009|NCT02721966|465101679|FG001|Overall Study|Pregnancy|0|||
129219010|NCT02721966|465101680|FG002|Overall Study|Pregnancy|0|||
129219011|NCT02721966|465101681|FG003|Overall Study|Pregnancy|0|||
128770522|NCT01993017|463451537|FG001|Overall Study|Could not be contacted|42|||
128770523|NCT01993017|463451538|FG002|Overall Study|Could not be contacted|38|||
129219012|NCT02721966|465101682|FG004|Overall Study|Pregnancy|0|||
129219013|NCT02721966|465101678|FG000|Overall Study|Did not continue to period 2|5|||
128710217|NCT02326025|463234420|FG000|Overall Study|Physician and Participant Decision|1|||
128710218|NCT02326025|463234421|FG001|Overall Study|Physician and Participant Decision|0|||
128710219|NCT02326025|463234420|FG000|Overall Study|Withdrawal by Subject|0|||
128710220|NCT02326025|463234421|FG001|Overall Study|Withdrawal by Subject|2|||
128710221|NCT02326025|463234420|FG000|Overall Study|Protocol Violation|0|||
128710222|NCT02326025|463234421|FG001|Overall Study|Protocol Violation|1|||
128710223|NCT01714635|463234427|FG000|Overall Study|Discontinued|1|||
128710224|NCT01714635|463234428|FG001|Overall Study|Discontinued|0|||
128710225|NCT01714635|463234429|FG002|Overall Study|Discontinued|2|||
128710226|NCT01714635|463234427|FG000|Overall Study|Missed 6-month exam|1|||
128710227|NCT01714635|463234428|FG001|Overall Study|Missed 6-month exam|0|||
128710228|NCT01714635|463234429|FG002|Overall Study|Missed 6-month exam|0|||
128710229|NCT02743871|463234430|FG000|Overall Study|Lost to Follow-up|0|||
128710230|NCT02743871|463234431|FG001|Overall Study|Lost to Follow-up|0|||
128710231|NCT02743871|463234432|FG002|Overall Study|Lost to Follow-up|0|||
128710232|NCT02743871|463234433|FG003|Overall Study|Lost to Follow-up|1|||
128710233|NCT02743871|463234434|FG004|Overall Study|Lost to Follow-up|0|||
128710234|NCT02743871|463234435|FG005|Overall Study|Lost to Follow-up|0|||
128710235|NCT02743871|463234436|FG006|Overall Study|Lost to Follow-up|1|||
128710236|NCT02743871|463234437|FG007|Overall Study|Lost to Follow-up|0|||
128710237|NCT02743871|463234438|FG008|Overall Study|Lost to Follow-up|0|||
128710238|NCT02743871|463234439|FG009|Overall Study|Lost to Follow-up|0|||
128710239|NCT02743871|463234440|FG010|Overall Study|Lost to Follow-up|0|||
128950323|NCT03655717|464103215|FG002|Overall Study|Physician Decision|0|||
128950324|NCT03655717|464103216|FG003|Overall Study|Physician Decision|0|||
128950325|NCT03655717|464103217|FG004|Overall Study|Physician Decision|0|||
128950326|NCT03655717|464103218|FG005|Overall Study|Physician Decision|0|||
128950327|NCT03655717|464103219|FG006|Overall Study|Physician Decision|0|||
128950328|NCT03655717|464103220|FG007|Overall Study|Physician Decision|0|||
128950329|NCT03655717|464103221|FG008|Overall Study|Physician Decision|0|||
128950330|NCT03655717|464103222|FG009|Overall Study|Physician Decision|1|||
128950331|NCT03655717|464103223|FG010|Overall Study|Physician Decision|0|||
128950332|NCT03655717|464103224|FG011|Overall Study|Physician Decision|0|||
128950333|NCT03655717|464103225|FG012|Overall Study|Physician Decision|0|||
128950334|NCT03655717|464103226|FG013|Overall Study|Physician Decision|0|||
128950335|NCT03655717|464103227|FG014|Overall Study|Physician Decision|0|||
128950336|NCT03655717|464103228|FG015|Overall Study|Physician Decision|0|||
128950337|NCT03655717|464103229|FG016|Overall Study|Physician Decision|0|||
128950338|NCT03655717|464103230|FG017|Overall Study|Physician Decision|0|||
128950339|NCT03655717|464103231|FG018|Overall Study|Physician Decision|0|||
128950340|NCT03655717|464103232|FG019|Overall Study|Physician Decision|1|||
128950341|NCT03655717|464103233|FG020|Overall Study|Physician Decision|0|||
128950342|NCT03655717|464103234|FG021|Overall Study|Physician Decision|0|||
128950343|NCT03655717|464103235|FG022|Overall Study|Physician Decision|0|||
128950344|NCT03655717|464103236|FG023|Overall Study|Physician Decision|1|||
128950345|NCT03655717|464103237|FG024|Overall Study|Physician Decision|0|||
128950346|NCT03655717|464103238|FG025|Overall Study|Physician Decision|0|||
128950347|NCT03655717|464103213|FG000|Overall Study|Lost to Follow-up|3|||
128950348|NCT03655717|464103214|FG001|Overall Study|Lost to Follow-up|1|||
128950349|NCT03655717|464103215|FG002|Overall Study|Lost to Follow-up|0|||
128950350|NCT03655717|464103216|FG003|Overall Study|Lost to Follow-up|1|||
128950351|NCT03655717|464103217|FG004|Overall Study|Lost to Follow-up|0|||
128950352|NCT03655717|464103218|FG005|Overall Study|Lost to Follow-up|1|||
128710240|NCT02743871|463234441|FG011|Overall Study|Lost to Follow-up|2|||
128710241|NCT02743871|463234442|FG012|Overall Study|Lost to Follow-up|0|||
128710242|NCT02743871|463234443|FG013|Overall Study|Lost to Follow-up|0|||
128950353|NCT03655717|464103219|FG006|Overall Study|Lost to Follow-up|0|||
128950354|NCT03655717|464103220|FG007|Overall Study|Lost to Follow-up|0|||
128710243|NCT02743871|463234430|FG000|Overall Study|Withdrawal by Subject|0|||
128710244|NCT02743871|463234431|FG001|Overall Study|Withdrawal by Subject|0|||
128770524|NCT01993017|463451536|FG000|Overall Study|Dropped out|19|||
128950355|NCT03655717|464103221|FG008|Overall Study|Lost to Follow-up|0|||
128950356|NCT03655717|464103222|FG009|Overall Study|Lost to Follow-up|0|||
128950357|NCT03655717|464103223|FG010|Overall Study|Lost to Follow-up|0|||
128950358|NCT03655717|464103224|FG011|Overall Study|Lost to Follow-up|1|||
128950359|NCT03655717|464103225|FG012|Overall Study|Lost to Follow-up|0|||
129125208|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128710245|NCT02743871|463234432|FG002|Overall Study|Withdrawal by Subject|0|||
128710246|NCT02743871|463234433|FG003|Overall Study|Withdrawal by Subject|0|||
128710247|NCT02743871|463234434|FG004|Overall Study|Withdrawal by Subject|0|||
128950360|NCT03655717|464103226|FG013|Overall Study|Lost to Follow-up|0|||
128950361|NCT03655717|464103227|FG014|Overall Study|Lost to Follow-up|0|||
128950362|NCT03655717|464103228|FG015|Overall Study|Lost to Follow-up|0|||
128950363|NCT03655717|464103229|FG016|Overall Study|Lost to Follow-up|0|||
128950364|NCT03655717|464103230|FG017|Overall Study|Lost to Follow-up|0|||
128950365|NCT03655717|464103231|FG018|Overall Study|Lost to Follow-up|0|||
128710248|NCT02743871|463234435|FG005|Overall Study|Withdrawal by Subject|0|||
128710249|NCT02743871|463234436|FG006|Overall Study|Withdrawal by Subject|0|||
128710250|NCT02743871|463234437|FG007|Overall Study|Withdrawal by Subject|0|||
128770525|NCT01993017|463451537|FG001|Overall Study|Dropped out|6|||
128950366|NCT03655717|464103232|FG019|Overall Study|Lost to Follow-up|0|||
128950367|NCT03655717|464103233|FG020|Overall Study|Lost to Follow-up|0|||
128950368|NCT03655717|464103234|FG021|Overall Study|Lost to Follow-up|0|||
128950369|NCT03655717|464103235|FG022|Overall Study|Lost to Follow-up|0|||
128950370|NCT03655717|464103236|FG023|Overall Study|Lost to Follow-up|0|||
128950371|NCT03655717|464103237|FG024|Overall Study|Lost to Follow-up|0|||
128950372|NCT03655717|464103238|FG025|Overall Study|Lost to Follow-up|0|||
128950373|NCT03225716|464104617|FG000|Overall Study|Withdrawal by Subject|2|||
128950374|NCT03225716|464104618|FG001|Overall Study|Withdrawal by Subject|2|||
128950375|NCT03225716|464104619|FG002|Overall Study|Withdrawal by Subject|0|||
128950376|NCT03225716|464104617|FG000|Overall Study|Lack of Efficacy|1|||
128950377|NCT03225716|464104618|FG001|Overall Study|Lack of Efficacy|0|||
128950378|NCT03225716|464104619|FG002|Overall Study|Lack of Efficacy|0|||
128950379|NCT03225716|464104617|FG000|Overall Study|Adverse Event|2|||
128950380|NCT03225716|464104618|FG001|Overall Study|Adverse Event|0|||
128950381|NCT03225716|464104619|FG002|Overall Study|Adverse Event|1|||
128950382|NCT03225716|464104617|FG000|Overall Study|Study early termination by Sponsor|0|||
129034823|NCT02212457|464416588|FG000|Overall Study|Other|2|||
129034824|NCT02212457|464416589|FG001|Overall Study|Other|1|||
129034825|NCT02212457|464416590|FG002|Overall Study|Other|2|||
129034826|NCT02212457|464416591|FG003|Overall Study|Other|1|||
128950383|NCT03225716|464104618|FG001|Overall Study|Study early termination by Sponsor|0|||
128950384|NCT03225716|464104619|FG002|Overall Study|Study early termination by Sponsor|2|||
128950385|NCT00190983|464104620|FG000|Overall Study|Inevaluable (never treated)|2|||
128710251|NCT02743871|463234438|FG008|Overall Study|Withdrawal by Subject|0|||
128710252|NCT02743871|463234439|FG009|Overall Study|Withdrawal by Subject|0|||
128710253|NCT02743871|463234440|FG010|Overall Study|Withdrawal by Subject|1|||
128710254|NCT02743871|463234441|FG011|Overall Study|Withdrawal by Subject|0|||
128710255|NCT02743871|463234442|FG012|Overall Study|Withdrawal by Subject|12|||
128710256|NCT02743871|463234443|FG013|Overall Study|Withdrawal by Subject|6|||
128710257|NCT02743871|463234430|FG000|Overall Study|Adverse Event|1|||
128710258|NCT02743871|463234431|FG001|Overall Study|Adverse Event|0|||
128710259|NCT02743871|463234432|FG002|Overall Study|Adverse Event|0|||
128710260|NCT02743871|463234433|FG003|Overall Study|Adverse Event|0|||
128710261|NCT02743871|463234434|FG004|Overall Study|Adverse Event|0|||
128710262|NCT02743871|463234435|FG005|Overall Study|Adverse Event|0|||
128710263|NCT02743871|463234436|FG006|Overall Study|Adverse Event|0|||
128710264|NCT02743871|463234437|FG007|Overall Study|Adverse Event|0|||
129034827|NCT02212457|464416592|FG004|Overall Study|Other|0|||
129034828|NCT02212457|464416593|FG005|Overall Study|Other|1|||
128710265|NCT02743871|463234438|FG008|Overall Study|Adverse Event|0|||
128710266|NCT02743871|463234439|FG009|Overall Study|Adverse Event|0|||
128710267|NCT02743871|463234440|FG010|Overall Study|Adverse Event|0|||
128710268|NCT02743871|463234441|FG011|Overall Study|Adverse Event|0|||
128710269|NCT02743871|463234442|FG012|Overall Study|Adverse Event|0|||
128710270|NCT02743871|463234443|FG013|Overall Study|Adverse Event|0|||
128710271|NCT02743871|463234430|FG000|Overall Study|Other|0|||
128710272|NCT02743871|463234431|FG001|Overall Study|Other|0|||
128710273|NCT02743871|463234432|FG002|Overall Study|Other|0|||
128710274|NCT02743871|463234433|FG003|Overall Study|Other|0|||
128770526|NCT01993017|463451538|FG002|Overall Study|Dropped out|11|||
128770527|NCT01993017|463451536|FG000|Overall Study|Other reasons|17|||
128950386|NCT01453998|464104621|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
129034829|NCT02490800|464416594|FG000|Overall Study|Adverse Event|0|||
129034830|NCT02490800|464416595|FG001|Overall Study|Adverse Event|0|||
129034831|NCT02490800|464416596|FG002|Overall Study|Adverse Event|0|||
129034832|NCT02490800|464416597|FG003|Overall Study|Adverse Event|2|||
129034833|NCT02490800|464416598|FG004|Overall Study|Adverse Event|3|||
129034834|NCT02490800|464416599|FG005|Overall Study|Adverse Event|2|||
129034835|NCT02490800|464416600|FG006|Overall Study|Adverse Event|0|||
129034836|NCT02490800|464416601|FG007|Overall Study|Adverse Event|0|||
129034837|NCT02490800|464416602|FG008|Overall Study|Adverse Event|0|||
129034838|NCT02490800|464416603|FG009|Overall Study|Adverse Event|0|||
129034839|NCT02490800|464416604|FG010|Overall Study|Adverse Event|0|||
129034840|NCT02490800|464416605|FG011|Overall Study|Adverse Event|2|||
129125209|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
128710275|NCT02743871|463234434|FG004|Overall Study|Other|0|||
128710276|NCT02743871|463234435|FG005|Overall Study|Other|0|||
128950387|NCT01453998|464104622|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
128710277|NCT02743871|463234436|FG006|Overall Study|Other|0|||
128710278|NCT02743871|463234437|FG007|Overall Study|Other|0|||
128710279|NCT02743871|463234438|FG008|Overall Study|Other|0|||
128710280|NCT02743871|463234439|FG009|Overall Study|Other|0|||
128710281|NCT02743871|463234440|FG010|Overall Study|Other|0|||
128710282|NCT02743871|463234441|FG011|Overall Study|Other|1|||
128950388|NCT01453998|464104623|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
129034841|NCT02490800|464416606|FG012|Overall Study|Adverse Event|2|||
129034842|NCT02490800|464416594|FG000|Overall Study|Withdrawal by Subject|0|||
129034843|NCT02490800|464416595|FG001|Overall Study|Withdrawal by Subject|0|||
129034844|NCT02490800|464416596|FG002|Overall Study|Withdrawal by Subject|0|||
128950389|NCT03654755|464104627|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
128950390|NCT03654755|464104628|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
128950391|NCT03654755|464104629|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
128710283|NCT02743871|463234442|FG012|Overall Study|Other|1|||
128710284|NCT02743871|463234443|FG013|Overall Study|Other|1|||
128710285|NCT02743871|463234430|FG000|Overall Study|Protocol Violation|0|||
128950392|NCT03654755|464104627|FG000|Overall Study|Withdrawal by Subject|2|||
128950393|NCT03654755|464104628|FG001|Overall Study|Withdrawal by Subject|4|||
128950394|NCT03654755|464104629|FG002|Overall Study|Withdrawal by Subject|8|||
128950395|NCT03654755|464104627|FG000|Overall Study|Lost to Follow-up|1|||
128950396|NCT03654755|464104628|FG001|Overall Study|Lost to Follow-up|3|||
128950397|NCT03654755|464104629|FG002|Overall Study|Lost to Follow-up|7|||
128950398|NCT03654755|464104627|FG000|Overall Study|Physician Decision|0|||
128950399|NCT03654755|464104628|FG001|Overall Study|Physician Decision|1|||
128950400|NCT03654755|464104629|FG002|Overall Study|Physician Decision|0|||
128950401|NCT03654755|464104627|FG000|Overall Study|Adverse Event|0|||
129125210|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
129125211|NCT03329001|464753601|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129125212|NCT03329001|464753602|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129125213|NCT03329001|464753603|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
129125214|NCT03329001|464753604|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
129125215|NCT03329001|464753605|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129125216|NCT03329001|464753606|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129125217|NCT03329001|464753607|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129125218|NCT03329001|464753608|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129125219|NCT03329001|464753601|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129125220|NCT03329001|464753602|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129125221|NCT03329001|464753603|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129125222|NCT03329001|464753604|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
129125223|NCT03329001|464753605|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129125224|NCT03329001|464753606|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129125225|NCT03329001|464753607|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129125226|NCT03329001|464753608|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129125227|NCT03329001|464753601|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129125228|NCT03329001|464753602|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129125229|NCT03329001|464753603|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129125230|NCT03329001|464753604|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
129125231|NCT03329001|464753605|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129125232|NCT03329001|464753606|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129125233|NCT03329001|464753607|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129125234|NCT03329001|464753608|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129125235|NCT03329001|464753601|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129125236|NCT03329001|464753602|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129125237|NCT03329001|464753603|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
129125238|NCT03329001|464753604|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129125239|NCT03329001|464753605|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129125240|NCT03329001|464753606|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129125241|NCT03329001|464753607|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129125242|NCT03329001|464753608|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129125243|NCT03329001|464753601|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129125244|NCT03329001|464753602|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129125245|NCT03329001|464753603|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
129125246|NCT03329001|464753604|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
129125247|NCT03329001|464753605|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129125248|NCT03329001|464753606|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129125249|NCT03329001|464753607|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129125250|NCT03329001|464753608|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129125251|NCT03329001|464753601|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129125252|NCT03329001|464753602|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129125253|NCT03329001|464753603|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
128710286|NCT02743871|463234431|FG001|Overall Study|Protocol Violation|0|||
128950402|NCT03654755|464104628|FG001|Overall Study|Adverse Event|0|||
128710287|NCT02743871|463234432|FG002|Overall Study|Protocol Violation|0|||
128710288|NCT02743871|463234433|FG003|Overall Study|Protocol Violation|0|||
128950403|NCT03654755|464104629|FG002|Overall Study|Adverse Event|4|||
128770528|NCT01993017|463451537|FG001|Overall Study|Other reasons|11|||
128770529|NCT01993017|463451538|FG002|Overall Study|Other reasons|7|||
128950404|NCT03654755|464104627|FG000|Overall Study|Lack of Efficacy|0|||
128950405|NCT03654755|464104628|FG001|Overall Study|Lack of Efficacy|0|||
128950406|NCT03654755|464104629|FG002|Overall Study|Lack of Efficacy|1|||
128950407|NCT04580394|464104632|FG000|First Intervention|Incorrectly Randomized|1|||
128950408|NCT04580394|464104632|FG000|First Intervention|Physician Decision|1|||
128950409|NCT04580394|464104632|FG000|First Intervention|Lost to Follow-up|1|||
128950410|NCT04580394|464104632|FG000|Washout (One Week)|Withdrawal by Subject|1|||
128950411|NCT04580394|464104632|FG000|Washout (One Week)|Adverse Event|1|||
128950412|NCT04580394|464104632|FG000|Washout (One Week)|Withdrawal by Subject|2|||
128950413|NCT04580394|464104632|FG000|Third Intervention|Adverse Event|1|||
128950414|NCT04580394|464104632|FG000|Third Intervention|Withdrawal by Subject|1|||
128950415|NCT04580394|464104632|FG000|Washout (One Week)|Withdrawal by Subject|2|||
128950416|NCT00642746|464104634|FG000|Overall Study|Patient unevaluable|1|||
128950417|NCT00642746|464104635|FG001|Overall Study|Patient unevaluable|0|||
128950418|NCT03337152|464104638|FG000|Overall Study|Physician Decision|1|||
128950419|NCT03337152|464104639|FG001|Overall Study|Physician Decision|0|||
128950420|NCT03337152|464104638|FG000|Overall Study|Lost to Follow-up|1|||
128950421|NCT03337152|464104639|FG001|Overall Study|Lost to Follow-up|3|||
128950422|NCT03337152|464104638|FG000|Overall Study|Adverse Event|3|||
128950423|NCT03337152|464104639|FG001|Overall Study|Adverse Event|1|||
128950424|NCT03337152|464104638|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
128950425|NCT03337152|464104639|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
128950426|NCT00077610|464104640|FG000|Overall Study|Adverse Event|9|||
128950427|NCT00077610|464104641|FG001|Overall Study|Adverse Event|7|||
128950428|NCT00077610|464104642|FG002|Overall Study|Adverse Event|1|||
128950429|NCT00077610|464104640|FG000|Overall Study|Lost to Follow-up|0|||
128950430|NCT00077610|464104641|FG001|Overall Study|Lost to Follow-up|1|||
128950431|NCT00077610|464104642|FG002|Overall Study|Lost to Follow-up|2|||
128950432|NCT00077610|464104640|FG000|Overall Study|Withdrawal by Subject|4|||
128950433|NCT00077610|464104641|FG001|Overall Study|Withdrawal by Subject|10|||
128950434|NCT00077610|464104642|FG002|Overall Study|Withdrawal by Subject|6|||
128950435|NCT00077610|464104640|FG000|Overall Study|Death|17|||
128950436|NCT00077610|464104641|FG001|Overall Study|Death|13|||
128950437|NCT00077610|464104642|FG002|Overall Study|Death|13|||
128950438|NCT00077610|464104640|FG000|Overall Study|Renal transplant|12|||
128950439|NCT00077610|464104641|FG001|Overall Study|Renal transplant|15|||
128950440|NCT00077610|464104642|FG002|Overall Study|Renal transplant|11|||
128950441|NCT00077610|464104640|FG000|Overall Study|Withdrew from dialysis care|5|||
128950442|NCT00077610|464104641|FG001|Overall Study|Withdrew from dialysis care|0|||
128950443|NCT00077610|464104642|FG002|Overall Study|Withdrew from dialysis care|3|||
128950444|NCT00077610|464104640|FG000|Overall Study|Insufficient Therapeutic Response|1|||
128950445|NCT00077610|464104641|FG001|Overall Study|Insufficient Therapeutic Response|0|||
128950446|NCT00077610|464104642|FG002|Overall Study|Insufficient Therapeutic Response|0|||
128950447|NCT00077610|464104640|FG000|Overall Study|Multiple blood transfusions|0|||
128950448|NCT00077610|464104641|FG001|Overall Study|Multiple blood transfusions|0|||
128950449|NCT00077610|464104642|FG002|Overall Study|Multiple blood transfusions|1|||
128950450|NCT00077610|464104640|FG000|Overall Study|Principal Investigator's decision|1|||
128950451|NCT00077610|464104641|FG001|Overall Study|Principal Investigator's decision|0|||
128950452|NCT00077610|464104642|FG002|Overall Study|Principal Investigator's decision|1|||
128950453|NCT00077610|464104640|FG000|Overall Study|Worsening of health condition|1|||
128950454|NCT00077610|464104641|FG001|Overall Study|Worsening of health condition|1|||
128950455|NCT00077610|464104642|FG002|Overall Study|Worsening of health condition|0|||
128950456|NCT00077610|464104640|FG000|Overall Study|Given Epogen in hospital|1|||
128950457|NCT00077610|464104641|FG001|Overall Study|Given Epogen in hospital|0|||
128950458|NCT00077610|464104642|FG002|Overall Study|Given Epogen in hospital|0|||
128950459|NCT00077610|464104640|FG000|Overall Study|Transferred to other unit|0|||
128950460|NCT00077610|464104641|FG001|Overall Study|Transferred to other unit|0|||
128950461|NCT00077610|464104642|FG002|Overall Study|Transferred to other unit|1|||
128950462|NCT00077610|464104640|FG000|Overall Study|Transferred to nursing home|0|||
128950463|NCT00077610|464104641|FG001|Overall Study|Transferred to nursing home|0|||
128950464|NCT00077610|464104642|FG002|Overall Study|Transferred to nursing home|1|||
128950465|NCT00077610|464104640|FG000|Overall Study|Transfer to satellite unit|1|||
128950466|NCT00077610|464104641|FG001|Overall Study|Transfer to satellite unit|0|||
128950467|NCT00077610|464104642|FG002|Overall Study|Transfer to satellite unit|0|||
128950468|NCT00077610|464104640|FG000|Overall Study|Transfer to other center for surgery|1|||
128950469|NCT00077610|464104641|FG001|Overall Study|Transfer to other center for surgery|0|||
128950470|NCT00077610|464104642|FG002|Overall Study|Transfer to other center for surgery|0|||
128950471|NCT00077610|464104640|FG000|Overall Study|Change in dialysis modality|1|||
128950472|NCT00077610|464104641|FG001|Overall Study|Change in dialysis modality|0|||
128950473|NCT00077610|464104642|FG002|Overall Study|Change in dialysis modality|0|||
128950474|NCT00077610|464104640|FG000|Overall Study|Relocation|0|||
128950475|NCT00077610|464104641|FG001|Overall Study|Relocation|8|||
128950476|NCT00077610|464104642|FG002|Overall Study|Relocation|5|||
128950477|NCT00077610|464104640|FG000|Overall Study|Financial issues|0|||
128710289|NCT02743871|463234434|FG004|Overall Study|Protocol Violation|0|||
128710290|NCT02743871|463234435|FG005|Overall Study|Protocol Violation|0|||
128710291|NCT02743871|463234436|FG006|Overall Study|Protocol Violation|0|||
128710292|NCT02743871|463234437|FG007|Overall Study|Protocol Violation|0|||
128710293|NCT02743871|463234438|FG008|Overall Study|Protocol Violation|0|||
128710294|NCT02743871|463234439|FG009|Overall Study|Protocol Violation|0|||
128710295|NCT02743871|463234440|FG010|Overall Study|Protocol Violation|0|||
128710296|NCT02743871|463234441|FG011|Overall Study|Protocol Violation|0|||
128710297|NCT02743871|463234442|FG012|Overall Study|Protocol Violation|2|||
128710298|NCT02743871|463234443|FG013|Overall Study|Protocol Violation|0|||
128710299|NCT02848651|463234448|FG000|Overall Study|Death|85|||
128710300|NCT02848651|463234448|FG000|Overall Study|Lost to Follow-up|1|||
128710301|NCT02848651|463234448|FG000|Overall Study|Non-Compliance|1|||
128710302|NCT02848651|463234448|FG000|Overall Study|Symptomatic Deterioration|1|||
128710303|NCT02848651|463234448|FG000|Overall Study|Physician Decision|4|||
128710304|NCT02848651|463234448|FG000|Overall Study|Withdrawal by Subject|14|||
128710305|NCT01059799|463234451|FG000|Overall Study|Adverse Event|2|||
128710306|NCT01059799|463234452|FG001|Overall Study|Adverse Event|3|||
128710307|NCT01059799|463234451|FG000|Overall Study|Lack of Efficacy|1|||
128710308|NCT01059799|463234452|FG001|Overall Study|Lack of Efficacy|0|||
128710309|NCT01059799|463234451|FG000|Overall Study|Protocol Violation|3|||
128710310|NCT01059799|463234452|FG001|Overall Study|Protocol Violation|2|||
128710311|NCT01059799|463234451|FG000|Overall Study|Withdrawal criteria|13|||
128710312|NCT01059799|463234452|FG001|Overall Study|Withdrawal criteria|2|||
128710313|NCT01059799|463234451|FG000|Overall Study|Other|12|||
128710314|NCT01059799|463234452|FG001|Overall Study|Other|3|||
128710315|NCT00662363|463234453|FG000|Overall Study|Withdrawal by Subject|6|||
128710316|NCT00662363|463234454|FG001|Overall Study|Withdrawal by Subject|5|||
128710317|NCT00662363|463234453|FG000|Overall Study|Adverse Event|0|||
128710318|NCT00662363|463234454|FG001|Overall Study|Adverse Event|3|||
128710319|NCT00662363|463234453|FG000|Overall Study|Discharged early from rehab|4|||
128710320|NCT00662363|463234454|FG001|Overall Study|Discharged early from rehab|1|||
128710321|NCT00662363|463234453|FG000|Overall Study|Protocol Violation|1|||
128710322|NCT00662363|463234454|FG001|Overall Study|Protocol Violation|1|||
128710323|NCT03789318|463234459|FG000|Overall Study|Adverse Event|0|||
128710324|NCT03789318|463234460|FG001|Overall Study|Adverse Event|0|||
128710325|NCT03789318|463234461|FG002|Overall Study|Adverse Event|1|||
128710326|NCT03789318|463234462|FG003|Overall Study|Adverse Event|1|||
128710327|NCT03789318|463234463|FG004|Overall Study|Adverse Event|0|||
128710328|NCT03789318|463234459|FG000|Overall Study|Lost to Follow-up|0|||
128710329|NCT03789318|463234460|FG001|Overall Study|Lost to Follow-up|0|||
128710330|NCT03789318|463234461|FG002|Overall Study|Lost to Follow-up|1|||
128710331|NCT03789318|463234462|FG003|Overall Study|Lost to Follow-up|0|||
128710332|NCT03789318|463234463|FG004|Overall Study|Lost to Follow-up|0|||
128710333|NCT03789318|463234459|FG000|Overall Study|Withdrawal by Subject|0|||
128710334|NCT03789318|463234460|FG001|Overall Study|Withdrawal by Subject|0|||
128710335|NCT03789318|463234461|FG002|Overall Study|Withdrawal by Subject|1|||
128710336|NCT03789318|463234462|FG003|Overall Study|Withdrawal by Subject|0|||
128710337|NCT03789318|463234463|FG004|Overall Study|Withdrawal by Subject|0|||
128710338|NCT01317160|463234464|FG000|Overall Study|Incorrect inclusion|1|||
128710339|NCT01317160|463234465|FG001|Overall Study|Incorrect inclusion|1|||
128710340|NCT01317160|463234464|FG000|Overall Study|Lost to Follow-up|3|||
128710341|NCT01317160|463234465|FG001|Overall Study|Lost to Follow-up|3|||
128710342|NCT01317160|463234464|FG000|Overall Study|Withdrawal by Subject|0|||
128710343|NCT01317160|463234465|FG001|Overall Study|Withdrawal by Subject|2|||
128710344|NCT04232124|463235985|FG000|Overall Study|Lost to Follow-up|3|||
128710345|NCT01404325|463235986|FG000|Overall Study|Lost to Follow-up|1|||
128710346|NCT01404325|463235987|FG001|Overall Study|Lost to Follow-up|0|||
128710347|NCT01404325|463235986|FG000|Overall Study|Death|2|||
128710348|NCT01404325|463235987|FG001|Overall Study|Death|0|||
128710349|NCT01404325|463235986|FG000|Overall Study|Graft loss/Retransplantation|1|||
128710350|NCT01404325|463235987|FG001|Overall Study|Graft loss/Retransplantation|0|||
128710351|NCT01404325|463235986|FG000|Overall Study|non-specified reason|0|||
128710352|NCT01404325|463235987|FG001|Overall Study|non-specified reason|2|||
128710353|NCT03312933|463235988|FG000|Overall Study|Protocol Violation|15|||
128710354|NCT03312933|463235988|FG000|Overall Study|Lost to Follow-up|36|||
128710355|NCT03312933|463235988|FG000|Overall Study|Withdrawal by Subject|3|||
128710356|NCT00224055|463235994|FG000|Overall Study|Adverse Event|9|||
128710357|NCT00224055|463235995|FG001|Overall Study|Adverse Event|3|||
128710358|NCT00224055|463235994|FG000|Overall Study|Lost to Follow-up|1|||
128710359|NCT00224055|463235995|FG001|Overall Study|Lost to Follow-up|2|||
128710360|NCT00224055|463235994|FG000|Overall Study|Protocol Violation|1|||
128710361|NCT00224055|463235995|FG001|Overall Study|Protocol Violation|1|||
128710362|NCT00224055|463235994|FG000|Overall Study|Inclusion Violation|3|||
128710363|NCT00224055|463235995|FG001|Overall Study|Inclusion Violation|6|||
128710364|NCT00224055|463235994|FG000|Overall Study|Withdrawal by Subject|0|||
128710365|NCT00224055|463235995|FG001|Overall Study|Withdrawal by Subject|2|||
128710366|NCT00224055|463235994|FG000|Overall Study|Other|1|||
128710367|NCT00224055|463235995|FG001|Overall Study|Other|0|||
128710368|NCT04317066|463235996|FG000|Overall Study|Sponsor decision|5|||
128950478|NCT00077610|464104641|FG001|Overall Study|Financial issues|1|||
128950479|NCT00077610|464104642|FG002|Overall Study|Financial issues|0|||
128950480|NCT00077610|464104640|FG000|Overall Study|Sponsors decision to withdraw|0|||
128950481|NCT00077610|464104641|FG001|Overall Study|Sponsors decision to withdraw|0|||
128950482|NCT00077610|464104642|FG002|Overall Study|Sponsors decision to withdraw|1|||
128950483|NCT00976950|464104643|FG000|Overall Study|Adverse Event|3|||
128950484|NCT00976950|464104643|FG000|Overall Study|Events with no relationship to Aptivus|3|||
128950485|NCT02662985|464104650|FG000|Treatment Period 1|Adverse Event|0|||
128950486|NCT02662985|464104651|FG001|Treatment Period 1|Adverse Event|2|||
128950487|NCT02662985|464104650|FG000|Treatment Period 1|Protocol Violation|0|||
128950488|NCT02662985|464104651|FG001|Treatment Period 1|Protocol Violation|1|||
128950489|NCT02662985|464104650|FG000|Treatment Period 1|Physician Decision|1|||
128950490|NCT02662985|464104651|FG001|Treatment Period 1|Physician Decision|0|||
128950491|NCT02662985|464104650|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128950492|NCT02662985|464104651|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128950493|NCT02662985|464104650|FG000|Treatment Period 2|Lack of Efficacy|0|||
128950494|NCT02662985|464104651|FG001|Treatment Period 2|Lack of Efficacy|1|||
128950495|NCT02662985|464104650|FG000|Treatment Period 2|Lost to Follow-up|1|||
128950496|NCT02662985|464104651|FG001|Treatment Period 2|Lost to Follow-up|0|||
128950497|NCT02662985|464104650|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
128950498|NCT02662985|464104651|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
128950499|NCT02662985|464104650|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
128950500|NCT02662985|464104651|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
128950501|NCT02662985|464104650|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
128950502|NCT02662985|464104651|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
128950503|NCT02662985|464104650|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
128950504|NCT02662985|464104651|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
128950505|NCT02662985|464104650|FG000|Treatment Period 3 (Extension Period)|Death|0|||
128950506|NCT02662985|464104651|FG001|Treatment Period 3 (Extension Period)|Death|1|||
128950507|NCT03442829|464104652|FG000|Overall Study|Scheduling clash|3|||
128950508|NCT03442829|464104653|FG001|Overall Study|Scheduling clash|1|||
128950509|NCT03442829|464104652|FG000|Overall Study|Illness unrelated to study|1|||
128950510|NCT03442829|464104653|FG001|Overall Study|Illness unrelated to study|1|||
128950511|NCT01486784|464104654|FG000|Overall Study|Withdrawal by Subject|0|||
128950512|NCT01486784|464104655|FG001|Overall Study|Withdrawal by Subject|0|||
128950513|NCT01486784|464104656|FG002|Overall Study|Withdrawal by Subject|1|||
128950514|NCT01486784|464104657|FG003|Overall Study|Withdrawal by Subject|0|||
129125254|NCT03329001|464753604|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129125255|NCT03329001|464753605|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129125256|NCT03329001|464753606|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129125257|NCT03329001|464753607|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129125258|NCT03329001|464753608|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129125259|NCT03329001|464753601|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129125260|NCT03329001|464753602|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129125261|NCT03329001|464753603|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
129125262|NCT03329001|464753604|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129125263|NCT03329001|464753605|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129125264|NCT03329001|464753606|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129125265|NCT03329001|464753607|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129125266|NCT03329001|464753608|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129125267|NCT03329001|464753601|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129125268|NCT03329001|464753602|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129125269|NCT03329001|464753603|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129125270|NCT03329001|464753604|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
129125271|NCT03329001|464753605|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129125272|NCT03329001|464753606|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129125273|NCT03329001|464753607|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129125274|NCT03329001|464753608|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129125275|NCT03329001|464753601|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129125276|NCT03329001|464753602|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129125277|NCT03329001|464753603|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129125278|NCT03329001|464753604|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129125279|NCT03329001|464753605|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129125280|NCT03329001|464753606|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
129125281|NCT03329001|464753607|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129125282|NCT03329001|464753608|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129125283|NCT03329001|464753601|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129125284|NCT03329001|464753602|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129125285|NCT03329001|464753603|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129125286|NCT03329001|464753604|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129125287|NCT03329001|464753605|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
128950515|NCT01486784|464104658|FG004|Overall Study|Withdrawal by Subject|1|||
128950516|NCT01486784|464104659|FG005|Overall Study|Withdrawal by Subject|2|||
128950517|NCT01486784|464104654|FG000|Overall Study|Subject did not meet entry criteria|0|||
128950518|NCT01486784|464104655|FG001|Overall Study|Subject did not meet entry criteria|0|||
128950519|NCT01486784|464104656|FG002|Overall Study|Subject did not meet entry criteria|0|||
128950520|NCT01486784|464104657|FG003|Overall Study|Subject did not meet entry criteria|0|||
128950521|NCT01486784|464104658|FG004|Overall Study|Subject did not meet entry criteria|1|||
128950522|NCT01486784|464104659|FG005|Overall Study|Subject did not meet entry criteria|0|||
128950523|NCT01486784|464104654|FG000|Overall Study|Death|0|||
128950524|NCT01486784|464104655|FG001|Overall Study|Death|0|||
128950525|NCT01486784|464104656|FG002|Overall Study|Death|0|||
128950526|NCT01486784|464104657|FG003|Overall Study|Death|0|||
128950527|NCT01486784|464104658|FG004|Overall Study|Death|0|||
128950528|NCT01486784|464104659|FG005|Overall Study|Death|1|||
128950529|NCT01021852|464104662|FG000|Treatment Period 1|Adverse Event|3|||
128950530|NCT01021852|464104663|FG001|Treatment Period 1|Adverse Event|1|||
128950531|NCT01021852|464104664|FG002|Treatment Period 1|Adverse Event|1|||
128950532|NCT01021852|464104665|FG003|Treatment Period 1|Adverse Event|0|||
128950533|NCT01021852|464104666|FG004|Treatment Period 1|Adverse Event|2|||
128950534|NCT01021852|464104667|FG005|Treatment Period 1|Adverse Event|2|||
128950535|NCT01021852|464104668|FG006|Treatment Period 1|Adverse Event|0|||
128950536|NCT01021852|464104669|FG007|Treatment Period 1|Adverse Event|0|||
128950537|NCT01021852|464104662|FG000|Treatment Period 1|Pregnancy|0|||
128950538|NCT01021852|464104663|FG001|Treatment Period 1|Pregnancy|0|||
128950539|NCT01021852|464104664|FG002|Treatment Period 1|Pregnancy|1|||
128950540|NCT01021852|464104665|FG003|Treatment Period 1|Pregnancy|0|||
128950541|NCT01021852|464104666|FG004|Treatment Period 1|Pregnancy|0|||
128950542|NCT01021852|464104667|FG005|Treatment Period 1|Pregnancy|0|||
128950543|NCT01021852|464104668|FG006|Treatment Period 1|Pregnancy|0|||
128950544|NCT01021852|464104669|FG007|Treatment Period 1|Pregnancy|0|||
128950545|NCT01021852|464104662|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128950546|NCT01021852|464104663|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128950547|NCT01021852|464104664|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128950548|NCT01021852|464104665|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128950549|NCT01021852|464104666|FG004|Treatment Period 1|Withdrawal by Subject|1|||
128950550|NCT01021852|464104667|FG005|Treatment Period 1|Withdrawal by Subject|0|||
128950551|NCT01021852|464104668|FG006|Treatment Period 1|Withdrawal by Subject|0|||
128950552|NCT01021852|464104669|FG007|Treatment Period 1|Withdrawal by Subject|1|||
128950553|NCT01021852|464104662|FG000|Treatment Period 1|Not Treated|0|||
128950554|NCT01021852|464104663|FG001|Treatment Period 1|Not Treated|0|||
128950555|NCT01021852|464104664|FG002|Treatment Period 1|Not Treated|0|||
128950556|NCT01021852|464104665|FG003|Treatment Period 1|Not Treated|2|||
128950557|NCT01021852|464104666|FG004|Treatment Period 1|Not Treated|0|||
128950558|NCT01021852|464104667|FG005|Treatment Period 1|Not Treated|0|||
128950559|NCT01021852|464104668|FG006|Treatment Period 1|Not Treated|0|||
128950560|NCT01021852|464104669|FG007|Treatment Period 1|Not Treated|0|||
128950561|NCT01021852|464104662|FG000|Washout Period-Placebo|Adverse Event|0|||
128950562|NCT01021852|464104663|FG001|Washout Period-Placebo|Adverse Event|0|||
128950563|NCT01021852|464104664|FG002|Washout Period-Placebo|Adverse Event|0|||
128950564|NCT01021852|464104665|FG003|Washout Period-Placebo|Adverse Event|1|||
128950565|NCT01021852|464104666|FG004|Washout Period-Placebo|Adverse Event|0|||
128950566|NCT01021852|464104667|FG005|Washout Period-Placebo|Adverse Event|1|||
128950567|NCT01021852|464104668|FG006|Washout Period-Placebo|Adverse Event|0|||
128950568|NCT01021852|464104669|FG007|Washout Period-Placebo|Adverse Event|0|||
128950569|NCT01021852|464104662|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
128950570|NCT01021852|464104663|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
128950571|NCT01021852|464104664|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
128950572|NCT01021852|464104665|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
128950573|NCT01021852|464104666|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
128950574|NCT01021852|464104667|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
128950575|NCT01021852|464104668|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
128950576|NCT01021852|464104669|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
128950577|NCT01021852|464104662|FG000|Washout Period-Placebo|Protocol Violation|0|||
128950578|NCT01021852|464104663|FG001|Washout Period-Placebo|Protocol Violation|0|||
128950579|NCT01021852|464104664|FG002|Washout Period-Placebo|Protocol Violation|0|||
128950580|NCT01021852|464104665|FG003|Washout Period-Placebo|Protocol Violation|0|||
128950581|NCT01021852|464104666|FG004|Washout Period-Placebo|Protocol Violation|0|||
128950582|NCT01021852|464104667|FG005|Washout Period-Placebo|Protocol Violation|0|||
128950583|NCT01021852|464104668|FG006|Washout Period-Placebo|Protocol Violation|1|||
128950584|NCT01021852|464104669|FG007|Washout Period-Placebo|Protocol Violation|0|||
128950585|NCT01021852|464104662|FG000|Washout Period-No Drug|Adverse Event|1|||
128950586|NCT01021852|464104663|FG001|Washout Period-No Drug|Adverse Event|0|||
128710369|NCT04317066|463235996|FG000|Overall Study|Death|2|||
128710370|NCT00848081|463235999|FG000|Overall Study|Adverse Event|6|||
128710371|NCT00848081|463236000|FG001|Overall Study|Adverse Event|7|||
128710372|NCT00848081|463235999|FG000|Overall Study|Protocol Violation|8|||
128710373|NCT00848081|463236000|FG001|Overall Study|Protocol Violation|5|||
128710374|NCT00848081|463235999|FG000|Overall Study|Lost to Follow-up|1|||
128710375|NCT00848081|463236000|FG001|Overall Study|Lost to Follow-up|0|||
128710376|NCT00848081|463235999|FG000|Overall Study|Physician Decision|0|||
128710377|NCT00848081|463236000|FG001|Overall Study|Physician Decision|3|||
128710378|NCT00848081|463235999|FG000|Overall Study|Withdrawal by Subject|5|||
128710379|NCT00848081|463236000|FG001|Overall Study|Withdrawal by Subject|3|||
128710380|NCT02064868|463236001|FG000|Overall Study|Lost to Follow-up|14|||
128710381|NCT02064868|463236002|FG001|Overall Study|Lost to Follow-up|8|||
128710382|NCT02064868|463236001|FG000|Overall Study|Physician Decision|1|||
128710383|NCT02064868|463236002|FG001|Overall Study|Physician Decision|0|||
128710384|NCT02064868|463236001|FG000|Overall Study|Withdrawal by Subject|14|||
128710385|NCT02064868|463236002|FG001|Overall Study|Withdrawal by Subject|3|||
128710386|NCT02064868|463236001|FG000|Overall Study|Technical Problems or Missing|5|||
128710387|NCT02064868|463236002|FG001|Overall Study|Technical Problems or Missing|2|||
128710388|NCT02014597|463236003|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
128710389|NCT02014597|463236004|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
128710390|NCT00754624|463236008|FG000|Overall Study|Adverse Event|16|||
128710391|NCT00754624|463236008|FG000|Overall Study|Death|1|||
128710392|NCT00754624|463236008|FG000|Overall Study|Physician Decision|8|||
128710393|NCT00754624|463236008|FG000|Overall Study|Protocol Violation|1|||
128710394|NCT00754624|463236008|FG000|Overall Study|Withdrawal by Subject|28|||
128710395|NCT00754624|463236008|FG000|Overall Study|Various|12|||
128710396|NCT00754624|463236008|FG000|Overall Study|Lost to Follow-up|3|||
128710397|NCT00418314|463236009|FG000|Overall Study|Withdrawal by Subject|1|||
128710398|NCT00418314|463236010|FG001|Overall Study|Withdrawal by Subject|2|||
128710399|NCT00931762|463236011|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
128710400|NCT00931762|463236011|FG000|Overall Study|Administrative Problems|5|||
128710401|NCT00931762|463236011|FG000|Overall Study|Death|1|||
128710402|NCT00931762|463236011|FG000|Overall Study|Disease Progression|3|||
128710403|NCT00931762|463236011|FG000|Overall Study|Adverse Event (s)|11|||
128710404|NCT00931762|463236011|FG000|Overall Study|Subject withdrew consent|13|||
128710405|NCT02664441|463236018|FG000|Randomization|Withdrawal by Subject|0|||
128950587|NCT01021852|464104664|FG002|Washout Period-No Drug|Adverse Event|0|||
128950588|NCT01021852|464104665|FG003|Washout Period-No Drug|Adverse Event|0|||
128950589|NCT01021852|464104666|FG004|Washout Period-No Drug|Adverse Event|0|||
128950590|NCT01021852|464104667|FG005|Washout Period-No Drug|Adverse Event|1|||
128950591|NCT01021852|464104668|FG006|Washout Period-No Drug|Adverse Event|0|||
128950592|NCT01021852|464104669|FG007|Washout Period-No Drug|Adverse Event|0|||
128950593|NCT01021852|464104662|FG000|Treatment Period 2|Adverse Event|0|||
128950594|NCT01021852|464104663|FG001|Treatment Period 2|Adverse Event|1|||
128950595|NCT01021852|464104664|FG002|Treatment Period 2|Adverse Event|0|||
128950596|NCT01021852|464104665|FG003|Treatment Period 2|Adverse Event|0|||
128950597|NCT01021852|464104666|FG004|Treatment Period 2|Adverse Event|1|||
128950598|NCT01021852|464104667|FG005|Treatment Period 2|Adverse Event|0|||
128950599|NCT01021852|464104668|FG006|Treatment Period 2|Adverse Event|1|||
128950600|NCT01021852|464104669|FG007|Treatment Period 2|Adverse Event|0|||
128950601|NCT01021852|464104662|FG000|Treatment Period 2|Lack of Efficacy|0|||
128950602|NCT01021852|464104663|FG001|Treatment Period 2|Lack of Efficacy|0|||
128950603|NCT01021852|464104664|FG002|Treatment Period 2|Lack of Efficacy|0|||
128950604|NCT01021852|464104665|FG003|Treatment Period 2|Lack of Efficacy|0|||
128950605|NCT01021852|464104666|FG004|Treatment Period 2|Lack of Efficacy|0|||
128950606|NCT01021852|464104667|FG005|Treatment Period 2|Lack of Efficacy|1|||
128710406|NCT02664441|463236019|FG001|Randomization|Withdrawal by Subject|1|||
128710407|NCT02664441|463236018|FG000|36-week Randomized Trial|Adverse Event|2|||
128950607|NCT01021852|464104668|FG006|Treatment Period 2|Lack of Efficacy|0|||
129034845|NCT02490800|464416597|FG003|Overall Study|Withdrawal by Subject|1|||
128710408|NCT02664441|463236019|FG001|36-week Randomized Trial|Adverse Event|0|||
128710409|NCT02664441|463236018|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
128710410|NCT02664441|463236019|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
128710411|NCT02664441|463236018|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
128710412|NCT02664441|463236019|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
128710413|NCT02664441|463236018|FG000|18-week Open Label Extension|Adverse Event|1|||
128710414|NCT02664441|463236019|FG001|18-week Open Label Extension|Adverse Event|0|||
128710415|NCT02664441|463236018|FG000|18-week Open Label Extension|Physician Decision|1|||
128710416|NCT02664441|463236019|FG001|18-week Open Label Extension|Physician Decision|0|||
128950608|NCT01021852|464104669|FG007|Treatment Period 2|Lack of Efficacy|0|||
128950609|NCT01021852|464104662|FG000|Treatment Period 2|Physician Decision|0|||
128950610|NCT01021852|464104663|FG001|Treatment Period 2|Physician Decision|0|||
128950611|NCT01021852|464104664|FG002|Treatment Period 2|Physician Decision|1|||
128710417|NCT02664441|463236018|FG000|18-week Open Label Extension|Death|1|||
128950612|NCT01021852|464104665|FG003|Treatment Period 2|Physician Decision|0|||
129034846|NCT02490800|464416598|FG004|Overall Study|Withdrawal by Subject|0|||
129125288|NCT03329001|464753606|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129125289|NCT03329001|464753607|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129125290|NCT03329001|464753608|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129125291|NCT03329001|464753601|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128770530|NCT01993017|463451536|FG000|Overall Study|Ineligible after randomization|4|||
129125292|NCT03329001|464753602|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
128950613|NCT01021852|464104666|FG004|Treatment Period 2|Physician Decision|0|||
128950614|NCT01021852|464104667|FG005|Treatment Period 2|Physician Decision|0|||
128950615|NCT01021852|464104668|FG006|Treatment Period 2|Physician Decision|0|||
128950616|NCT01021852|464104669|FG007|Treatment Period 2|Physician Decision|0|||
128950617|NCT01021852|464104662|FG000|Treatment Period 2|Protocol Violation|0|||
128950618|NCT01021852|464104663|FG001|Treatment Period 2|Protocol Violation|0|||
128950619|NCT01021852|464104664|FG002|Treatment Period 2|Protocol Violation|0|||
128950620|NCT01021852|464104665|FG003|Treatment Period 2|Protocol Violation|0|||
128950621|NCT01021852|464104666|FG004|Treatment Period 2|Protocol Violation|1|||
128950622|NCT01021852|464104667|FG005|Treatment Period 2|Protocol Violation|0|||
128950623|NCT01021852|464104668|FG006|Treatment Period 2|Protocol Violation|1|||
128950624|NCT01021852|464104669|FG007|Treatment Period 2|Protocol Violation|0|||
128950625|NCT01021852|464104662|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128950626|NCT01021852|464104663|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128950627|NCT01021852|464104664|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128950628|NCT01021852|464104665|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128950629|NCT01021852|464104666|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128950630|NCT01021852|464104667|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128950631|NCT01021852|464104668|FG006|Treatment Period 2|Withdrawal by Subject|1|||
128950632|NCT01021852|464104669|FG007|Treatment Period 2|Withdrawal by Subject|2|||
128950633|NCT02493426|464104670|FG000|Overall Study|Withdrawal by Subject|0|||
128950634|NCT02493426|464104671|FG001|Overall Study|Withdrawal by Subject|1|||
128950635|NCT03491553|464104672|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
128950636|NCT03491553|464104673|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
128950637|NCT03491553|464104674|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
128950638|NCT03491553|464104675|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
128950639|NCT03491553|464104676|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
128950640|NCT03491553|464104677|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
128950641|NCT03491553|464104672|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
128950642|NCT03491553|464104673|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
128950643|NCT03491553|464104674|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
128950644|NCT03491553|464104675|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
129125293|NCT03329001|464753603|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129125294|NCT03329001|464753604|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129125295|NCT03329001|464753605|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
129125296|NCT03329001|464753606|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
129125297|NCT03329001|464753607|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129125298|NCT03329001|464753608|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129125299|NCT03329001|464753601|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129125300|NCT03329001|464753602|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129125301|NCT03329001|464753603|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129125302|NCT03329001|464753604|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129125303|NCT03329001|464753605|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
129125304|NCT03329001|464753606|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129125305|NCT03329001|464753607|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129125306|NCT03329001|464753608|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129125307|NCT03329001|464753601|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129125308|NCT03329001|464753602|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129125309|NCT03329001|464753603|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129125310|NCT03329001|464753604|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129125311|NCT03329001|464753605|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
129125312|NCT03329001|464753606|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
129125313|NCT03329001|464753607|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129125314|NCT03329001|464753608|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
128950645|NCT03491553|464104676|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
128770531|NCT01993017|463451537|FG001|Overall Study|Ineligible after randomization|5|||
128950646|NCT03491553|464104677|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
128950647|NCT01025817|464104679|FG000|Completed Study Medication|Adverse Event|66|||
128950648|NCT01025817|464104680|FG001|Completed Study Medication|Adverse Event|39|||
128950649|NCT01025817|464104679|FG000|Completed Study Medication|Protocol Deviation|9|||
129034847|NCT02490800|464416599|FG005|Overall Study|Withdrawal by Subject|0|||
129034848|NCT02490800|464416600|FG006|Overall Study|Withdrawal by Subject|0|||
129034849|NCT02490800|464416601|FG007|Overall Study|Withdrawal by Subject|0|||
129034850|NCT02490800|464416602|FG008|Overall Study|Withdrawal by Subject|1|||
129034851|NCT02490800|464416603|FG009|Overall Study|Withdrawal by Subject|0|||
129034852|NCT02490800|464416604|FG010|Overall Study|Withdrawal by Subject|0|||
129034853|NCT02490800|464416605|FG011|Overall Study|Withdrawal by Subject|0|||
129034854|NCT02490800|464416606|FG012|Overall Study|Withdrawal by Subject|0|||
129034855|NCT02490800|464416594|FG000|Overall Study|Progressive disease|3|||
129034856|NCT02490800|464416595|FG001|Overall Study|Progressive disease|3|||
129034857|NCT02490800|464416596|FG002|Overall Study|Progressive disease|3|||
129034858|NCT02490800|464416597|FG003|Overall Study|Progressive disease|4|||
129034859|NCT02490800|464416598|FG004|Overall Study|Progressive disease|4|||
129034860|NCT02490800|464416599|FG005|Overall Study|Progressive disease|1|||
129034861|NCT02490800|464416600|FG006|Overall Study|Progressive disease|4|||
129034862|NCT02490800|464416601|FG007|Overall Study|Progressive disease|3|||
129034863|NCT02490800|464416602|FG008|Overall Study|Progressive disease|6|||
129034864|NCT02490800|464416603|FG009|Overall Study|Progressive disease|2|||
129034865|NCT02490800|464416604|FG010|Overall Study|Progressive disease|7|||
129034866|NCT02490800|464416605|FG011|Overall Study|Progressive disease|1|||
129034867|NCT02490800|464416606|FG012|Overall Study|Progressive disease|10|||
129034868|NCT02490800|464416594|FG000|Overall Study|Patient enrolled in post-trial access|0|||
129034869|NCT02490800|464416595|FG001|Overall Study|Patient enrolled in post-trial access|0|||
129034870|NCT02490800|464416596|FG002|Overall Study|Patient enrolled in post-trial access|0|||
129034871|NCT02490800|464416597|FG003|Overall Study|Patient enrolled in post-trial access|0|||
129034872|NCT02490800|464416598|FG004|Overall Study|Patient enrolled in post-trial access|0|||
129034873|NCT02490800|464416599|FG005|Overall Study|Patient enrolled in post-trial access|0|||
129034874|NCT02490800|464416600|FG006|Overall Study|Patient enrolled in post-trial access|0|||
129034875|NCT02490800|464416601|FG007|Overall Study|Patient enrolled in post-trial access|0|||
129034876|NCT02490800|464416602|FG008|Overall Study|Patient enrolled in post-trial access|0|||
128950650|NCT01025817|464104680|FG001|Completed Study Medication|Protocol Deviation|8|||
128950651|NCT01025817|464104679|FG000|Completed Study Medication|Withdrawal by Subject|8|||
128950652|NCT01025817|464104680|FG001|Completed Study Medication|Withdrawal by Subject|9|||
128950653|NCT01025817|464104679|FG000|Completed Study Medication|Administrative problems|7|||
128950654|NCT01025817|464104680|FG001|Completed Study Medication|Administrative problems|5|||
128950655|NCT01025817|464104679|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
128950656|NCT01025817|464104680|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
128950657|NCT01025817|464104679|FG000|Completed Study Medication|Abnormal test procedure|4|||
128950658|NCT01025817|464104680|FG001|Completed Study Medication|Abnormal test procedure|0|||
128950659|NCT01025817|464104679|FG000|Completed Study Medication|Graft loss|2|||
128950660|NCT01025817|464104680|FG001|Completed Study Medication|Graft loss|5|||
128950661|NCT01025817|464104679|FG000|Completed Study Medication|Death|2|||
128950662|NCT01025817|464104680|FG001|Completed Study Medication|Death|2|||
128950663|NCT01025817|464104679|FG000|Completed Study Medication|Abnormal lab values|0|||
128950664|NCT01025817|464104680|FG001|Completed Study Medication|Abnormal lab values|2|||
128950665|NCT01025817|464104679|FG000|Completed Study Medication|Subject no longer required study drug|0|||
128950666|NCT01025817|464104680|FG001|Completed Study Medication|Subject no longer required study drug|1|||
128950667|NCT01025817|464104679|FG000|Completed Study Medication|Lost to Follow-up|0|||
128950668|NCT01025817|464104680|FG001|Completed Study Medication|Lost to Follow-up|1|||
128950669|NCT01025817|464104679|FG000|Completed Study|Withdrawal by Subject|8|||
128950670|NCT01025817|464104680|FG001|Completed Study|Withdrawal by Subject|16|||
128950671|NCT01025817|464104679|FG000|Completed Study|Death|6|||
128950672|NCT01025817|464104680|FG001|Completed Study|Death|5|||
128950673|NCT01025817|464104679|FG000|Completed Study|Missing|2|||
128950674|NCT01025817|464104680|FG001|Completed Study|Missing|0|||
128950675|NCT01025817|464104679|FG000|Completed Study|Lost to Follow-up|0|||
128950676|NCT01025817|464104680|FG001|Completed Study|Lost to Follow-up|1|||
128950677|NCT01096849|464104681|FG000|Overall Study|Consent Withdrawn|1|||
128950678|NCT01096849|464104682|FG001|Overall Study|Consent Withdrawn|4|||
128950679|NCT01096849|464104683|FG002|Overall Study|Consent Withdrawn|2|||
128950680|NCT01096849|464104681|FG000|Overall Study|Lack of Efficacy|0|||
128950681|NCT01096849|464104682|FG001|Overall Study|Lack of Efficacy|2|||
128950682|NCT01096849|464104683|FG002|Overall Study|Lack of Efficacy|0|||
128950683|NCT01096849|464104681|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
128950684|NCT01096849|464104682|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
128950685|NCT01096849|464104683|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
128950686|NCT01096849|464104681|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
128950687|NCT01096849|464104682|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
129034877|NCT02490800|464416603|FG009|Overall Study|Patient enrolled in post-trial access|1|||
129034878|NCT02490800|464416604|FG010|Overall Study|Patient enrolled in post-trial access|1|||
129034879|NCT02490800|464416605|FG011|Overall Study|Patient enrolled in post-trial access|0|||
129034880|NCT02490800|464416606|FG012|Overall Study|Patient enrolled in post-trial access|6|||
129034881|NCT00654641|464416608|FG000|Overall Study|Lost to Follow-up|2|||
129034882|NCT00654641|464416609|FG001|Overall Study|Lost to Follow-up|3|||
129034883|NCT01337596|464416610|FG000|Overall Study|Withdrawal by Subject|0|||
129034884|NCT01337596|464416611|FG001|Overall Study|Withdrawal by Subject|0|||
129034885|NCT01337596|464416612|FG002|Overall Study|Withdrawal by Subject|0|||
129034886|NCT01337596|464416613|FG003|Overall Study|Withdrawal by Subject|0|||
129034887|NCT01337596|464416614|FG004|Overall Study|Withdrawal by Subject|2|||
129034888|NCT01337596|464416615|FG005|Overall Study|Withdrawal by Subject|0|||
129034889|NCT01337596|464416616|FG006|Overall Study|Withdrawal by Subject|0|||
129034890|NCT01337596|464416617|FG007|Overall Study|Withdrawal by Subject|0|||
129034891|NCT01337596|464416618|FG008|Overall Study|Withdrawal by Subject|0|||
129034892|NCT03693950|464416619|FG000|Overall Study|Withdrawal by Subject|1|||
129034893|NCT03693950|464416620|FG001|Overall Study|Withdrawal by Subject|0|||
129034894|NCT02415387|464418326|FG000|Overall Study|Withdrawal by Subject|6|||
129034895|NCT02415387|464418327|FG001|Overall Study|Withdrawal by Subject|1|||
129034896|NCT02415387|464418326|FG000|Overall Study|blood draw problem|0|||
129034897|NCT02415387|464418327|FG001|Overall Study|blood draw problem|1|||
129034898|NCT02415387|464418326|FG000|Overall Study|Protocol Violation|1|||
128710418|NCT02664441|463236019|FG001|18-week Open Label Extension|Death|0|||
128710419|NCT02664441|463236018|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
128710420|NCT02664441|463236019|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
128710421|NCT01529346|463236020|FG000|Overall Study|Lost to Follow-up|2|||
129034899|NCT02415387|464418327|FG001|Overall Study|Protocol Violation|0|||
129034900|NCT00676650|464418331|FG000|Overall Study|Death|45|||
129034901|NCT00676650|464418332|FG001|Overall Study|Death|14|||
128710422|NCT01529346|463236021|FG001|Overall Study|Lost to Follow-up|0|||
128950688|NCT01096849|464104683|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
128950689|NCT01096849|464104681|FG000|Overall Study|Administrative Reasons|0|||
128950690|NCT01096849|464104682|FG001|Overall Study|Administrative Reasons|1|||
128950691|NCT01096849|464104683|FG002|Overall Study|Administrative Reasons|2|||
128950692|NCT01096849|464104681|FG000|Overall Study|Lost to Follow-up|1|||
128950693|NCT01096849|464104682|FG001|Overall Study|Lost to Follow-up|3|||
128950694|NCT01096849|464104683|FG002|Overall Study|Lost to Follow-up|1|||
128950695|NCT00242580|464104685|FG000|Overall Study|Adverse Event|3|||
128950696|NCT00242580|464104686|FG001|Overall Study|Adverse Event|0|||
128950697|NCT00242580|464104687|FG002|Overall Study|Adverse Event|2|||
128950698|NCT00242580|464104685|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
128950699|NCT00242580|464104686|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
128950700|NCT00242580|464104687|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
128950701|NCT00242580|464104685|FG000|Overall Study|Protocol Violation|0|||
128950702|NCT00242580|464104686|FG001|Overall Study|Protocol Violation|0|||
129034902|NCT00676650|464418331|FG000|Overall Study|Adverse Event|159|||
129034903|NCT00676650|464418332|FG001|Overall Study|Adverse Event|21|||
129034904|NCT00676650|464418331|FG000|Overall Study|Global deterioration of health status|66|||
129034905|NCT00676650|464418332|FG001|Overall Study|Global deterioration of health status|31|||
128950703|NCT00242580|464104687|FG002|Overall Study|Protocol Violation|1|||
128950704|NCT00242580|464104685|FG000|Overall Study|Subject withdrew consent|2|||
129034906|NCT00676650|464418331|FG000|Overall Study|Lost to Follow-up|0|||
129034907|NCT00676650|464418332|FG001|Overall Study|Lost to Follow-up|1|||
129034908|NCT00676650|464418331|FG000|Overall Study|Objective progression or relapse|189|||
129034909|NCT00676650|464418332|FG001|Overall Study|Objective progression or relapse|140|||
129034910|NCT00676650|464418331|FG000|Overall Study|Other|14|||
129034911|NCT00676650|464418332|FG001|Overall Study|Other|10|||
129034912|NCT00676650|464418331|FG000|Overall Study|Protocol Violation|3|||
129034913|NCT00676650|464418332|FG001|Overall Study|Protocol Violation|1|||
129034914|NCT00676650|464418331|FG000|Overall Study|Study terminated by sponsor|57|||
129034915|NCT00676650|464418332|FG001|Overall Study|Study terminated by sponsor|43|||
129034916|NCT00676650|464418331|FG000|Overall Study|Withdrawal by Subject|48|||
129034917|NCT00676650|464418332|FG001|Overall Study|Withdrawal by Subject|24|||
129034918|NCT00676650|464418331|FG000|Overall Study|Randomized but not treated|3|||
129034919|NCT00676650|464418332|FG001|Overall Study|Randomized but not treated|4|||
129034920|NCT02297841|464418336|FG000|Overall Study|Withdrawal by Subject|1|||
129034921|NCT02297841|464418336|FG000|Overall Study|Protocol Violation|7|||
129034922|NCT00683592|464418337|FG000|Overall Study|Adverse Event|12|||
129034923|NCT00683592|464418338|FG001|Overall Study|Adverse Event|4|||
129034924|NCT00683592|464418337|FG000|Overall Study|Withdrawal by Subject|11|||
129034925|NCT00683592|464418338|FG001|Overall Study|Withdrawal by Subject|11|||
129034926|NCT00683592|464418337|FG000|Overall Study|Lost to Follow-up|17|||
129034927|NCT00683592|464418338|FG001|Overall Study|Lost to Follow-up|17|||
129034928|NCT00683592|464418337|FG000|Overall Study|Lack of Efficacy|3|||
129034929|NCT00683592|464418338|FG001|Overall Study|Lack of Efficacy|7|||
129034930|NCT00683592|464418337|FG000|Overall Study|Physician Decision|0|||
129034931|NCT00683592|464418338|FG001|Overall Study|Physician Decision|1|||
129034932|NCT00683592|464418337|FG000|Overall Study|Non-compliance|3|||
129034933|NCT00683592|464418338|FG001|Overall Study|Non-compliance|5|||
129034934|NCT00683592|464418337|FG000|Overall Study|Other|1|||
129034935|NCT00683592|464418338|FG001|Overall Study|Other|1|||
129034936|NCT01235715|464418339|FG000|Overall Study|Physician Decision|0|||
128710423|NCT01529346|463236022|FG002|Overall Study|Lost to Follow-up|1|||
128710424|NCT01529346|463236023|FG003|Overall Study|Lost to Follow-up|0|||
128710425|NCT01529346|463236024|FG004|Overall Study|Lost to Follow-up|0|||
128950705|NCT00242580|464104686|FG001|Overall Study|Subject withdrew consent|2|||
128950706|NCT00242580|464104687|FG002|Overall Study|Subject withdrew consent|5|||
128950707|NCT00242580|464104685|FG000|Overall Study|Lost to Follow-up|0|||
128950708|NCT00242580|464104686|FG001|Overall Study|Lost to Follow-up|3|||
128950709|NCT00242580|464104687|FG002|Overall Study|Lost to Follow-up|0|||
128950710|NCT00242580|464104685|FG000|Overall Study|Death|1|||
128710426|NCT01529346|463236020|FG000|Overall Study|Other|0|||
128710427|NCT01529346|463236021|FG001|Overall Study|Other|1|||
128710428|NCT01529346|463236022|FG002|Overall Study|Other|1|||
128710429|NCT01529346|463236023|FG003|Overall Study|Other|0|||
128710430|NCT01529346|463236024|FG004|Overall Study|Other|0|||
128710431|NCT00589914|463236028|FG000|Overall Study|Adverse Event|19|||
128710432|NCT00589914|463236029|FG001|Overall Study|Adverse Event|10|||
128710433|NCT00589914|463236028|FG000|Overall Study|Death|2|||
128710434|NCT00589914|463236029|FG001|Overall Study|Death|0|||
128710435|NCT00589914|463236028|FG000|Overall Study|Lack of Efficacy|40|||
128710436|NCT00589914|463236029|FG001|Overall Study|Lack of Efficacy|43|||
128710437|NCT00589914|463236028|FG000|Overall Study|Lost to Follow-up|11|||
128710438|NCT00589914|463236029|FG001|Overall Study|Lost to Follow-up|18|||
128710439|NCT00589914|463236028|FG000|Overall Study|Pregnancy|1|||
128710440|NCT00589914|463236029|FG001|Overall Study|Pregnancy|0|||
128710441|NCT00589914|463236028|FG000|Overall Study|Withdrawal by Subject|55|||
128710442|NCT00589914|463236029|FG001|Overall Study|Withdrawal by Subject|49|||
128710443|NCT00589914|463236028|FG000|Overall Study|Other|22|||
128710444|NCT00589914|463236029|FG001|Overall Study|Other|17|||
128710445|NCT01594125|463236035|FG000|Overall Study|Withdrawal by Subject|1|||
128710446|NCT01594125|463236036|FG001|Overall Study|Withdrawal by Subject|0|||
128710447|NCT01594125|463236037|FG002|Overall Study|Withdrawal by Subject|0|||
128710448|NCT01594125|463236038|FG003|Overall Study|Withdrawal by Subject|1|||
128710449|NCT01594125|463236039|FG004|Overall Study|Withdrawal by Subject|0|||
128710450|NCT01594125|463236035|FG000|Overall Study|Progressive Disease|3|||
128710451|NCT01594125|463236036|FG001|Overall Study|Progressive Disease|12|||
128710452|NCT01594125|463236037|FG002|Overall Study|Progressive Disease|3|||
128710453|NCT01594125|463236038|FG003|Overall Study|Progressive Disease|3|||
128710454|NCT01594125|463236039|FG004|Overall Study|Progressive Disease|7|||
128710455|NCT02618434|463236041|FG000|Overall Study|Withdrawal by Subject|0|||
128710456|NCT02618434|463236042|FG001|Overall Study|Withdrawal by Subject|2|||
128710457|NCT02618434|463236043|FG002|Overall Study|Withdrawal by Subject|3|||
128710458|NCT02618434|463236041|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
128710459|NCT02618434|463236042|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
128710460|NCT02618434|463236043|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
128710461|NCT02618434|463236041|FG000|Overall Study|Lost to Follow-up|3|||
128710462|NCT02618434|463236042|FG001|Overall Study|Lost to Follow-up|1|||
128710463|NCT02618434|463236043|FG002|Overall Study|Lost to Follow-up|3|||
128710464|NCT02618434|463236041|FG000|Overall Study|Adverse Event|1|||
128710465|NCT02618434|463236042|FG001|Overall Study|Adverse Event|0|||
128710466|NCT02618434|463236043|FG002|Overall Study|Adverse Event|12|||
128710467|NCT02618434|463236041|FG000|Overall Study|Physician Decision|0|||
128710468|NCT02618434|463236042|FG001|Overall Study|Physician Decision|1|||
128710469|NCT02618434|463236043|FG002|Overall Study|Physician Decision|0|||
128710470|NCT02618434|463236041|FG000|Overall Study|Protocol Violation|0|||
128710471|NCT02618434|463236042|FG001|Overall Study|Protocol Violation|0|||
128710472|NCT02618434|463236043|FG002|Overall Study|Protocol Violation|1|||
128710473|NCT02618434|463236041|FG000|Overall Study|Other, Multiple categories|1|||
128710474|NCT02618434|463236042|FG001|Overall Study|Other, Multiple categories|1|||
128710475|NCT02618434|463236043|FG002|Overall Study|Other, Multiple categories|1|||
128710476|NCT03590041|463236044|FG000|Overall Study|Protocol Violation|4|||
128950711|NCT00242580|464104686|FG001|Overall Study|Death|2|||
128950712|NCT00242580|464104687|FG002|Overall Study|Death|1|||
128950713|NCT01232894|464104688|FG000|Overall Study|Lost to Follow-up|0|||
128950714|NCT01232894|464104689|FG001|Overall Study|Lost to Follow-up|1|||
128710477|NCT03590041|463236045|FG001|Overall Study|Protocol Violation|3|||
128710478|NCT03590041|463236044|FG000|Overall Study|No session data recorded|14|||
128710479|NCT03590041|463236045|FG001|Overall Study|No session data recorded|2|||
128710480|NCT01402544|463236046|FG000|Overall Study|Withdrawal by Subject|6|||
128950715|NCT01232894|464104688|FG000|Overall Study|Death|1|||
128710481|NCT01314443|463236048|FG000|Overall Study|Withdrawal by Subject|2|||
128710482|NCT01314443|463236049|FG001|Overall Study|Withdrawal by Subject|1|||
128710483|NCT01314443|463236050|FG002|Overall Study|Withdrawal by Subject|1|||
128950716|NCT01232894|464104689|FG001|Overall Study|Death|0|||
128710484|NCT01314443|463236051|FG003|Overall Study|Withdrawal by Subject|1|||
128710485|NCT01314443|463236048|FG000|Overall Study|Protocol Violation|2|||
128710486|NCT01314443|463236049|FG001|Overall Study|Protocol Violation|2|||
128710487|NCT01314443|463236050|FG002|Overall Study|Protocol Violation|1|||
128710488|NCT01314443|463236051|FG003|Overall Study|Protocol Violation|1|||
128710489|NCT00449540|463236053|FG000|Pretreatment Phase|No migraine experienced|66|||
128950717|NCT01232894|464104688|FG000|Overall Study|Protocol Violation|1|||
128950718|NCT01232894|464104689|FG001|Overall Study|Protocol Violation|1|||
128950719|NCT01232894|464104688|FG000|Overall Study|Withdrawal by Subject|8|||
128950720|NCT01232894|464104689|FG001|Overall Study|Withdrawal by Subject|5|||
128950721|NCT01232894|464104688|FG000|Overall Study|Physician Decision|2|||
128710490|NCT00449540|463236054|FG001|Pretreatment Phase|No migraine experienced|0|||
128710491|NCT00449540|463236055|FG002|Pretreatment Phase|No migraine experienced|0|||
128710492|NCT00449540|463236053|FG000|Treatment Phase|did not experience or treat migraine|0|||
128710493|NCT00449540|463236054|FG001|Treatment Phase|did not experience or treat migraine|20|||
128710494|NCT00449540|463236055|FG002|Treatment Phase|did not experience or treat migraine|17|||
128710495|NCT02709785|463236056|FG000|Overall Study|Withdrawal by Subject|1|||
128710496|NCT02709785|463236057|FG001|Overall Study|Withdrawal by Subject|2|||
128710497|NCT02709785|463236058|FG002|Overall Study|Withdrawal by Subject|1|||
128710498|NCT00010374|463236061|FG000|Overall Study|False positive phrenic nerve test|1|||
128710499|NCT03315208|463236062|FG000|Overall Study|Lost to Follow-up|11|||
128710500|NCT03315208|463236063|FG001|Overall Study|Lost to Follow-up|6|||
128710501|NCT03315208|463236062|FG000|Overall Study|Withdrawal by Subject|2|||
128710502|NCT03315208|463236063|FG001|Overall Study|Withdrawal by Subject|0|||
128710503|NCT01881776|463236064|FG000|Overall Study|Lost to Follow-up|1|||
128710504|NCT01881776|463236065|FG001|Overall Study|Lost to Follow-up|2|||
128710505|NCT01881776|463236066|FG002|Overall Study|Lost to Follow-up|1|||
128710506|NCT01881776|463236064|FG000|Overall Study|Protocol Violation|0|||
128710507|NCT01881776|463236065|FG001|Overall Study|Protocol Violation|2|||
128710508|NCT01881776|463236066|FG002|Overall Study|Protocol Violation|1|||
128710509|NCT01359449|463236073|FG000|Overall Study|Lost to Follow-up|1|||
128710510|NCT01359449|463236074|FG001|Overall Study|Lost to Follow-up|0|||
128710511|NCT01359449|463236073|FG000|Overall Study|Protocol Violation|0|||
128710512|NCT01359449|463236074|FG001|Overall Study|Protocol Violation|2|||
128710513|NCT01359449|463236073|FG000|Overall Study|Withdrawal by Subject|3|||
128710514|NCT01359449|463236074|FG001|Overall Study|Withdrawal by Subject|2|||
128710515|NCT00372112|463236075|FG000|Overall Study|Adverse Event|0|||
128710516|NCT00372112|463236076|FG001|Overall Study|Adverse Event|1|||
128710517|NCT00372112|463236077|FG002|Overall Study|Adverse Event|1|||
128710518|NCT00372112|463236078|FG003|Overall Study|Adverse Event|1|||
128710519|NCT00372112|463236075|FG000|Overall Study|Withdrawal by Subject|0|||
128710520|NCT00372112|463236076|FG001|Overall Study|Withdrawal by Subject|0|||
128710521|NCT00372112|463236077|FG002|Overall Study|Withdrawal by Subject|2|||
128710522|NCT00372112|463236078|FG003|Overall Study|Withdrawal by Subject|1|||
128710523|NCT00372112|463236075|FG000|Overall Study|Exacerbation|0|||
128710524|NCT00372112|463236076|FG001|Overall Study|Exacerbation|0|||
128710525|NCT00372112|463236077|FG002|Overall Study|Exacerbation|0|||
128710526|NCT00372112|463236078|FG003|Overall Study|Exacerbation|1|||
128710527|NCT00372112|463236075|FG000|Overall Study|PR >240 at Visit 3|0|||
128710528|NCT00372112|463236076|FG001|Overall Study|PR >240 at Visit 3|0|||
128710529|NCT00372112|463236077|FG002|Overall Study|PR >240 at Visit 3|0|||
128710530|NCT00372112|463236078|FG003|Overall Study|PR >240 at Visit 3|1|||
128710531|NCT00372112|463236075|FG000|Overall Study|Hepatitis B|1|||
128710532|NCT00372112|463236076|FG001|Overall Study|Hepatitis B|0|||
128710533|NCT00372112|463236077|FG002|Overall Study|Hepatitis B|0|||
128710534|NCT00372112|463236078|FG003|Overall Study|Hepatitis B|0|||
128710535|NCT00372112|463236075|FG000|Overall Study|Other-protocol violation|0|||
128710536|NCT00372112|463236076|FG001|Overall Study|Other-protocol violation|0|||
128710537|NCT00372112|463236077|FG002|Overall Study|Other-protocol violation|1|||
128710538|NCT00372112|463236078|FG003|Overall Study|Other-protocol violation|0|||
128710539|NCT04649060|463236079|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
128710540|NCT04649060|463236080|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
128710541|NCT04649060|463236079|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
128710542|NCT04649060|463236080|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
128710543|NCT04649060|463236079|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
128710544|NCT04649060|463236080|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
128710545|NCT04649060|463236079|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
128710546|NCT04649060|463236080|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
128950722|NCT01232894|464104689|FG001|Overall Study|Physician Decision|1|||
128950723|NCT02128763|464104692|FG000|Overall Study|Death|1|||
128710547|NCT04649060|463236079|FG000|Arm A/Arm B Treatment|Patient Request|1|||
128710548|NCT04649060|463236080|FG001|Arm A/Arm B Treatment|Patient Request|0|||
128710549|NCT04649060|463236079|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
128710550|NCT04649060|463236080|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
128710551|NCT04649060|463236079|FG000|Arm A/Arm B Treatment|Other|1|||
128710552|NCT04649060|463236080|FG001|Arm A/Arm B Treatment|Other|0|||
128710553|NCT04649060|463236079|FG000|Crossover (Arm B)|Adverse Event|0|||
128710554|NCT04649060|463236080|FG001|Crossover (Arm B)|Adverse Event|1|||
128710555|NCT04649060|463236079|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
128710556|NCT04649060|463236080|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
128710557|NCT02205814|463236081|FG000|Overall Study|Lost to Follow-up|0|||
128710558|NCT02205814|463236082|FG001|Overall Study|Lost to Follow-up|0|||
128710559|NCT02205814|463236083|FG002|Overall Study|Lost to Follow-up|0|||
128710560|NCT02205814|463236084|FG003|Overall Study|Lost to Follow-up|1|||
128950724|NCT02128763|464104693|FG001|Overall Study|Death|0|||
128950725|NCT02128763|464104692|FG000|Overall Study|Lost to Follow-up|19|||
128950726|NCT02128763|464104693|FG001|Overall Study|Lost to Follow-up|16|||
128950727|NCT00363246|464104694|FG000|Overall Study|Death|40|||
128950728|NCT00363246|464104694|FG000|Overall Study|Withdrawal by Subject|19|||
128950729|NCT00363246|464104694|FG000|Overall Study|Lost to Follow-up|14|||
128950730|NCT00363246|464104694|FG000|Overall Study|Bad health|6|||
128950731|NCT00363246|464104694|FG000|Overall Study|Stopped using wheelchair|11|||
128950732|NCT00363246|464104694|FG000|Overall Study|Subject expressed security concerns|2|||
128950733|NCT00363246|464104694|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
128950734|NCT04387136|464104695|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
128950735|NCT04387136|464104696|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
128950736|NCT00910429|464104697|FG000|Overall Study|Death|18|||
128950737|NCT00910429|464104698|FG001|Overall Study|Death|12|||
128950738|NCT00910429|464104697|FG000|Overall Study|Withdrawal by Subject|3|||
128950739|NCT00910429|464104698|FG001|Overall Study|Withdrawal by Subject|2|||
128950740|NCT00910429|464104697|FG000|Overall Study|Protocol Violation|1|||
128950741|NCT00910429|464104698|FG001|Overall Study|Protocol Violation|0|||
128950742|NCT00910429|464104697|FG000|Overall Study|Lost to Follow-up|2|||
128950743|NCT00910429|464104698|FG001|Overall Study|Lost to Follow-up|1|||
128950744|NCT00910429|464104697|FG000|Overall Study|Adverse Event|10|||
128710561|NCT02205814|463236081|FG000|Overall Study|Lack of Efficacy|1|||
128710562|NCT02205814|463236082|FG001|Overall Study|Lack of Efficacy|0|||
128710563|NCT02205814|463236083|FG002|Overall Study|Lack of Efficacy|1|||
128710564|NCT02205814|463236084|FG003|Overall Study|Lack of Efficacy|1|||
128710565|NCT02205814|463236081|FG000|Overall Study|Physician Decision|0|||
128710566|NCT02205814|463236082|FG001|Overall Study|Physician Decision|0|||
128710567|NCT02205814|463236083|FG002|Overall Study|Physician Decision|1|||
128710568|NCT02205814|463236084|FG003|Overall Study|Physician Decision|0|||
128710569|NCT02205814|463236081|FG000|Overall Study|Protocol Violation|1|||
128710570|NCT02205814|463236082|FG001|Overall Study|Protocol Violation|0|||
128710571|NCT02205814|463236083|FG002|Overall Study|Protocol Violation|0|||
128710572|NCT02205814|463236084|FG003|Overall Study|Protocol Violation|1|||
128710573|NCT02205814|463236081|FG000|Overall Study|Withdrawal by Subject|0|||
128710574|NCT02205814|463236082|FG001|Overall Study|Withdrawal by Subject|1|||
128710575|NCT02205814|463236083|FG002|Overall Study|Withdrawal by Subject|2|||
128710576|NCT02205814|463236084|FG003|Overall Study|Withdrawal by Subject|1|||
128710577|NCT02205814|463236081|FG000|Overall Study|not compliant with study procedures|0|||
128710578|NCT02205814|463236082|FG001|Overall Study|not compliant with study procedures|0|||
128710579|NCT02205814|463236083|FG002|Overall Study|not compliant with study procedures|1|||
128710580|NCT02205814|463236084|FG003|Overall Study|not compliant with study procedures|0|||
128710581|NCT00110149|463236085|FG000|Overall Study|Physician Decision|3|||
128710582|NCT00563381|463236086|FG000|Overall Study|Adverse Event|264|||
128710583|NCT00563381|463236087|FG001|Overall Study|Adverse Event|292|||
128710584|NCT00563381|463236086|FG000|Overall Study|Protocol Violation|66|||
128710585|NCT00563381|463236087|FG001|Overall Study|Protocol Violation|74|||
128710586|NCT00563381|463236086|FG000|Overall Study|Lost to Follow-up|7|||
128710587|NCT00563381|463236087|FG001|Overall Study|Lost to Follow-up|15|||
128710588|NCT00563381|463236086|FG000|Overall Study|Withdrawal by Subject|192|||
128710589|NCT00563381|463236087|FG001|Overall Study|Withdrawal by Subject|209|||
128710590|NCT00563381|463236086|FG000|Overall Study|Lack of Efficacy|32|||
128710591|NCT00563381|463236087|FG001|Overall Study|Lack of Efficacy|24|||
128710592|NCT00563381|463236086|FG000|Overall Study|Individual different reasons|24|||
128710593|NCT00563381|463236087|FG001|Overall Study|Individual different reasons|34|||
128710594|NCT02452398|463236090|FG000|Overall Study|Adverse Event|1|||
128950745|NCT00910429|464104698|FG001|Overall Study|Adverse Event|5|||
128950746|NCT00910429|464104697|FG000|Overall Study|Drug non-compliance|1|||
128950747|NCT00910429|464104698|FG001|Overall Study|Drug non-compliance|0|||
128950748|NCT00910429|464104697|FG000|Overall Study|Lack of Efficacy|4|||
128950749|NCT00910429|464104698|FG001|Overall Study|Lack of Efficacy|1|||
128950750|NCT02121756|464104700|FG000|Overall Study|Adverse Event|3|||
128950751|NCT02121756|464104701|FG001|Overall Study|Adverse Event|0|||
128950752|NCT02121756|464104700|FG000|Overall Study|Protocol Violation|1|||
129125315|NCT03329001|464753601|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
128710595|NCT02452398|463236090|FG000|Overall Study|Lost to Follow-up|28|||
128710596|NCT02452398|463236090|FG000|Overall Study|Physician Decision|2|||
128710597|NCT02452398|463236090|FG000|Overall Study|Withdrawal by Subject|6|||
128950753|NCT02121756|464104701|FG001|Overall Study|Protocol Violation|1|||
128950754|NCT02121756|464104700|FG000|Overall Study|Physician Decision|2|||
128950755|NCT02121756|464104701|FG001|Overall Study|Physician Decision|1|||
128950756|NCT00255086|464104704|FG000|Overall Study|Adverse Event|1|||
128950757|NCT00255086|464104705|FG001|Overall Study|Adverse Event|1|||
128710598|NCT02452398|463236090|FG000|Overall Study|Moved away|4|||
128710599|NCT00001723|463236094|FG000|Overall Study|Lack of Efficacy|6|||
128710600|NCT00001723|463236095|FG001|Overall Study|Lack of Efficacy|7|||
128710601|NCT00001723|463236094|FG000|Overall Study|Lack of family interest|4|||
128950758|NCT00255086|464104704|FG000|Overall Study|Protocol Violation|1|||
128950759|NCT00255086|464104705|FG001|Overall Study|Protocol Violation|1|||
128950760|NCT02365584|464104707|FG000|Overall Study|Adverse Event|2|||
128950761|NCT02365584|464104708|FG001|Overall Study|Adverse Event|2|||
128950762|NCT02365584|464104707|FG000|Overall Study|Withdrawal by Subject|1|||
128950763|NCT02365584|464104708|FG001|Overall Study|Withdrawal by Subject|0|||
128950764|NCT02365584|464104707|FG000|Overall Study|Disease Progression|9|||
128710602|NCT00001723|463236095|FG001|Overall Study|Lack of family interest|5|||
128710603|NCT00001723|463236094|FG000|Overall Study|Lost to Follow-up|2|||
128710604|NCT00001723|463236095|FG001|Overall Study|Lost to Follow-up|2|||
128710605|NCT00001723|463236094|FG000|Overall Study|medication intolerance|1|||
128710606|NCT00001723|463236095|FG001|Overall Study|medication intolerance|2|||
128710607|NCT00927784|463236096|FG000|Overall Study|Death|1|||
128710608|NCT00927784|463236097|FG001|Overall Study|Death|0|||
128710609|NCT00927784|463236096|FG000|Overall Study|Withdrawal by Subject|1|||
128710610|NCT00927784|463236097|FG001|Overall Study|Withdrawal by Subject|0|||
128710611|NCT02170051|463236098|FG000|Overall Study|Withdrawal by Subject|10|||
128710612|NCT02170051|463236099|FG001|Overall Study|Withdrawal by Subject|10|||
128710613|NCT02170051|463236098|FG000|Overall Study|Lost to Follow-up|1|||
128710614|NCT02170051|463236099|FG001|Overall Study|Lost to Follow-up|3|||
128710615|NCT02643082|463236100|FG000|Period 1|Adverse Event|1|||
128710616|NCT02643082|463236101|FG001|Period 1|Adverse Event|0|||
128710617|NCT01867021|463236102|FG000|Overall Study|Adverse Event|0|||
128710618|NCT01867021|463236103|FG001|Overall Study|Adverse Event|1|||
128710619|NCT01867021|463236102|FG000|Overall Study|Not Eligible|0|||
128710620|NCT01867021|463236103|FG001|Overall Study|Not Eligible|1|||
128710621|NCT01867021|463236102|FG000|Overall Study|Death|1|||
128710622|NCT01867021|463236103|FG001|Overall Study|Death|0|||
128710623|NCT01867021|463236102|FG000|Overall Study|Lost to Follow-up|0|||
128710624|NCT01867021|463236103|FG001|Overall Study|Lost to Follow-up|2|||
128710625|NCT01867021|463236102|FG000|Overall Study|Withdrawal by Subject|1|||
128710626|NCT01867021|463236103|FG001|Overall Study|Withdrawal by Subject|6|||
128710627|NCT00881712|463236104|FG000|Overall Study|Death|1|||
128710628|NCT00881712|463236105|FG001|Overall Study|Death|0|||
128710629|NCT00881712|463236106|FG002|Overall Study|Death|0|||
128710630|NCT00881712|463236104|FG000|Overall Study|Withdrawal by Subject|1|||
128710631|NCT00881712|463236105|FG001|Overall Study|Withdrawal by Subject|0|||
128710632|NCT00881712|463236106|FG002|Overall Study|Withdrawal by Subject|0|||
128710633|NCT02505867|463236109|FG000|Overall Study|Lack of Efficacy|6|||
128710634|NCT02505867|463236110|FG001|Overall Study|Lack of Efficacy|6|||
128710635|NCT01862874|463236111|FG000|Overall Study|Randomized not treated|1|||
128710636|NCT01862874|463236112|FG001|Overall Study|Randomized not treated|0|||
128710637|NCT01862874|463236111|FG000|Overall Study|Adverse Event|0|||
128710638|NCT01862874|463236112|FG001|Overall Study|Adverse Event|3|||
128710639|NCT01862874|463236111|FG000|Overall Study|Lost to Follow-up|26|||
128710640|NCT01862874|463236112|FG001|Overall Study|Lost to Follow-up|29|||
128710641|NCT01862874|463236111|FG000|Overall Study|Physician Decision|5|||
128710642|NCT01862874|463236112|FG001|Overall Study|Physician Decision|3|||
128710643|NCT01862874|463236111|FG000|Overall Study|Withdrawn by parent/guardian|1|||
128710644|NCT01862874|463236112|FG001|Overall Study|Withdrawn by parent/guardian|1|||
128710645|NCT01862874|463236111|FG000|Overall Study|Withdrawal by Subject|46|||
128710646|NCT01862874|463236112|FG001|Overall Study|Withdrawal by Subject|40|||
128710647|NCT01862874|463236111|FG000|Overall Study|Death|0|||
128710648|NCT01862874|463236112|FG001|Overall Study|Death|1|||
128710649|NCT00071513|463236117|FG000|Intervention Component|Withdrawal by Subject|2|||
128710650|NCT00071513|463236118|FG001|Intervention Component|Withdrawal by Subject|3|||
128710651|NCT00071513|463236117|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
128710652|NCT00071513|463236118|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
128710653|NCT01244425|463236119|FG000|Overall Study|Withdrawal by Subject|2|||
128710654|NCT01244425|463236120|FG001|Overall Study|Withdrawal by Subject|2|||
128710655|NCT01244425|463236119|FG000|Overall Study|Adverse Event|1|||
128710656|NCT01244425|463236120|FG001|Overall Study|Adverse Event|1|||
128710657|NCT03241342|463236126|FG000|Overall Study|Adverse Event|5|||
128710658|NCT03241342|463236127|FG001|Overall Study|Adverse Event|8|||
128950765|NCT02365584|464104708|FG001|Overall Study|Disease Progression|12|||
128710659|NCT03241342|463236128|FG002|Overall Study|Adverse Event|4|||
128710660|NCT03241342|463236126|FG000|Overall Study|Lack of Efficacy|0|||
128710661|NCT03241342|463236127|FG001|Overall Study|Lack of Efficacy|0|||
128710662|NCT03241342|463236128|FG002|Overall Study|Lack of Efficacy|1|||
128710663|NCT03241342|463236126|FG000|Overall Study|noncompliance with study drug|2|||
128710664|NCT03241342|463236127|FG001|Overall Study|noncompliance with study drug|1|||
128710665|NCT03241342|463236128|FG002|Overall Study|noncompliance with study drug|1|||
128710666|NCT03241342|463236126|FG000|Overall Study|sponsor decision|0|||
128710667|NCT03241342|463236127|FG001|Overall Study|sponsor decision|1|||
128710668|NCT03241342|463236128|FG002|Overall Study|sponsor decision|2|||
128950766|NCT00349752|464104709|FG000|Overall Study|Adverse Event|8|||
128950767|NCT00349752|464104710|FG001|Overall Study|Adverse Event|12|||
128950768|NCT00349752|464104709|FG000|Overall Study|Lack of Efficacy|37|||
128710669|NCT03241342|463236126|FG000|Overall Study|not reported|15|||
128950769|NCT00349752|464104710|FG001|Overall Study|Lack of Efficacy|42|||
128710670|NCT03241342|463236127|FG001|Overall Study|not reported|21|||
128710671|NCT03241342|463236128|FG002|Overall Study|not reported|19|||
128710672|NCT01846611|463236130|FG000|Overall Study|Lost to Follow-up|4|||
128710673|NCT01846611|463236131|FG001|Overall Study|Lost to Follow-up|6|||
128710674|NCT01846611|463236130|FG000|Overall Study|Withdrawal by Subject|15|||
128710675|NCT01846611|463236131|FG001|Overall Study|Withdrawal by Subject|19|||
128710676|NCT01846611|463236130|FG000|Overall Study|Other|19|||
128710677|NCT01846611|463236131|FG001|Overall Study|Other|18|||
128710678|NCT02744391|463236132|FG000|Overall Study|Lost to Follow-up|9|||
128710679|NCT02744391|463236132|FG000|Overall Study|Physician Decision|2|||
128710680|NCT02744391|463236132|FG000|Overall Study|Withdrawal by Subject|3|||
128710681|NCT01428453|463236133|FG000|Overall Study|Adverse Event|2|||
128710682|NCT01428453|463236134|FG001|Overall Study|Adverse Event|7|||
128710683|NCT01428453|463236133|FG000|Overall Study|Protocol Violation|1|||
128710684|NCT01428453|463236134|FG001|Overall Study|Protocol Violation|0|||
128710685|NCT01428453|463236133|FG000|Overall Study|Lost to Follow-up|0|||
128710686|NCT01428453|463236134|FG001|Overall Study|Lost to Follow-up|1|||
128710687|NCT01428453|463236133|FG000|Overall Study|Withdrawal by Subject|3|||
128710688|NCT01428453|463236134|FG001|Overall Study|Withdrawal by Subject|1|||
128710689|NCT01996709|463236135|FG000|Overall Study|Withdrawal by Subject|1|||
128710690|NCT01996709|463236136|FG001|Overall Study|Withdrawal by Subject|0|||
128710691|NCT01996709|463236135|FG000|Overall Study|Lost to Follow-up|3|||
128710692|NCT01996709|463236136|FG001|Overall Study|Lost to Follow-up|0|||
128710693|NCT01996709|463236135|FG000|Overall Study|Subject Non-Compliant|1|||
128710694|NCT01996709|463236136|FG001|Overall Study|Subject Non-Compliant|0|||
128710695|NCT01996709|463236135|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
128710696|NCT01996709|463236136|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
128710697|NCT02480114|463236141|FG000|Overall Study|Not completing surveys|3|||
128710698|NCT02480114|463236142|FG001|Overall Study|Not completing surveys|2|||
128710699|NCT02480114|463236141|FG000|Overall Study|Withdrawal by Subject|2|||
128950770|NCT00349752|464104709|FG000|Overall Study|Lost to Follow-up|4|||
128950771|NCT00349752|464104710|FG001|Overall Study|Lost to Follow-up|2|||
128950772|NCT00349752|464104709|FG000|Overall Study|Personal reasons|6|||
128950773|NCT00349752|464104710|FG001|Overall Study|Personal reasons|5|||
128950774|NCT00349752|464104709|FG000|Overall Study|Other: Required exclusionary medication|0|||
128950775|NCT00349752|464104710|FG001|Overall Study|Other: Required exclusionary medication|1|||
128950776|NCT00349752|464104709|FG000|Overall Study|Other: Non compliance|0|||
128950777|NCT00349752|464104710|FG001|Overall Study|Other: Non compliance|1|||
128950778|NCT00349752|464104709|FG000|Overall Study|Other: Patient stopped steroids|0|||
128950779|NCT00349752|464104710|FG001|Overall Study|Other: Patient stopped steroids|1|||
128950780|NCT00349752|464104709|FG000|Overall Study|Other: Patient's steroid use|1|||
128950781|NCT00349752|464104710|FG001|Overall Study|Other: Patient's steroid use|0|||
128950782|NCT00349752|464104709|FG000|Overall Study|Other: Ineligible|1|||
128950783|NCT00349752|464104710|FG001|Overall Study|Other: Ineligible|0|||
128950784|NCT00349752|464104709|FG000|Overall Study|Other: Inadvertently unblinded|1|||
128950785|NCT00349752|464104710|FG001|Overall Study|Other: Inadvertently unblinded|0|||
128950786|NCT00349752|464104709|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
128950787|NCT00349752|464104710|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
128950788|NCT01973452|464104715|FG000|Overall Study|Lack of Efficacy|0|||
128950789|NCT01973452|464104716|FG001|Overall Study|Lack of Efficacy|1|||
128950790|NCT01973452|464104715|FG000|Overall Study|Lost to Follow-up|1|||
128950791|NCT01973452|464104716|FG001|Overall Study|Lost to Follow-up|0|||
128950792|NCT01973452|464104715|FG000|Overall Study|Withdrawal by Subject|10|||
128950793|NCT01973452|464104716|FG001|Overall Study|Withdrawal by Subject|9|||
128950794|NCT01973452|464104715|FG000|Overall Study|Ineligible|1|||
128950795|NCT01973452|464104716|FG001|Overall Study|Ineligible|1|||
128950796|NCT01973452|464104715|FG000|Overall Study|Surgery canceled by participant|5|||
128950797|NCT01973452|464104716|FG001|Overall Study|Surgery canceled by participant|3|||
128950798|NCT05294211|464104718|FG000|Overall Study|Withdrawal by Subject|3|||
128950799|NCT05294211|464104718|FG000|Overall Study|Physician Decision|2|||
128950800|NCT05294211|464104718|FG000|Overall Study|Progressed to active labor|1|||
128950801|NCT05294211|464104718|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
128950802|NCT05294211|464104718|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
128710700|NCT02480114|463236142|FG001|Overall Study|Withdrawal by Subject|4|||
128950803|NCT00064350|464104719|FG000|Induction Treatment|Disease Progression|5|||
128950804|NCT00064350|464104720|FG001|Induction Treatment|Disease Progression|1|||
128710701|NCT02480114|463236141|FG000|Overall Study|Disease progression|3|||
128950805|NCT00064350|464104721|FG002|Induction Treatment|Disease Progression|110|||
128950806|NCT00064350|464104719|FG000|Induction Treatment|Adverse Event|0|||
128950807|NCT00064350|464104720|FG001|Induction Treatment|Adverse Event|2|||
128950808|NCT00064350|464104721|FG002|Induction Treatment|Adverse Event|49|||
128950809|NCT00064350|464104719|FG000|Induction Treatment|Death|0|||
128950810|NCT00064350|464104720|FG001|Induction Treatment|Death|0|||
128950811|NCT00064350|464104721|FG002|Induction Treatment|Death|9|||
128950812|NCT00064350|464104719|FG000|Induction Treatment|Withdrawal by Subject|0|||
128950813|NCT00064350|464104720|FG001|Induction Treatment|Withdrawal by Subject|0|||
128710702|NCT02480114|463236142|FG001|Overall Study|Disease progression|0|||
128710703|NCT02480114|463236141|FG000|Overall Study|Improper completion of survey|1|||
128950814|NCT00064350|464104721|FG002|Induction Treatment|Withdrawal by Subject|21|||
128950815|NCT00064350|464104719|FG000|Induction Treatment|Ineligible or never started treatment|3|||
128950816|NCT00064350|464104720|FG001|Induction Treatment|Ineligible or never started treatment|6|||
128950817|NCT00064350|464104721|FG002|Induction Treatment|Ineligible or never started treatment|34|||
128950818|NCT00064350|464104719|FG000|Induction Treatment|Other|0|||
128950819|NCT00064350|464104720|FG001|Induction Treatment|Other|0|||
128950820|NCT00064350|464104721|FG002|Induction Treatment|Other|13|||
128950821|NCT00064350|464104719|FG000|Randomization|Adverse Event|8|||
128950822|NCT00064350|464104720|FG001|Randomization|Adverse Event|3|||
128950823|NCT00064350|464104721|FG002|Randomization|Adverse Event|0|||
128950824|NCT00064350|464104719|FG000|Randomization|Death|3|||
128950825|NCT00064350|464104720|FG001|Randomization|Death|0|||
128950826|NCT00064350|464104721|FG002|Randomization|Death|0|||
128950827|NCT00064350|464104719|FG000|Randomization|Withdrawal by Subject|1|||
128950828|NCT00064350|464104720|FG001|Randomization|Withdrawal by Subject|0|||
129125316|NCT03329001|464753602|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129125317|NCT03329001|464753603|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129125318|NCT03329001|464753604|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129125319|NCT03329001|464753605|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129125320|NCT03329001|464753606|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129125321|NCT03329001|464753607|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
129125322|NCT03329001|464753608|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
129125323|NCT03329001|464753601|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129125324|NCT03329001|464753602|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128950829|NCT00064350|464104721|FG002|Randomization|Withdrawal by Subject|0|||
128950830|NCT00064350|464104719|FG000|Randomization|Ineligible or never started treatment|9|||
128950831|NCT00064350|464104720|FG001|Randomization|Ineligible or never started treatment|15|||
128950832|NCT00064350|464104721|FG002|Randomization|Ineligible or never started treatment|0|||
128950833|NCT00064350|464104719|FG000|Randomization|Other|5|||
128950834|NCT00064350|464104720|FG001|Randomization|Other|0|||
128950835|NCT00064350|464104721|FG002|Randomization|Other|0|||
128950836|NCT00064350|464104719|FG000|Cross-Over|Adverse Event|0|||
128950837|NCT00064350|464104720|FG001|Cross-Over|Adverse Event|1|||
128950838|NCT00064350|464104721|FG002|Cross-Over|Adverse Event|0|||
128950839|NCT00064350|464104719|FG000|Cross-Over|Death|1|||
128950840|NCT00064350|464104720|FG001|Cross-Over|Death|3|||
128950841|NCT00064350|464104721|FG002|Cross-Over|Death|0|||
128950842|NCT00064350|464104719|FG000|Cross-Over|Withdrawal by Subject|2|||
128950843|NCT00064350|464104720|FG001|Cross-Over|Withdrawal by Subject|2|||
128950844|NCT00064350|464104721|FG002|Cross-Over|Withdrawal by Subject|0|||
128950845|NCT00064350|464104719|FG000|Cross-Over|Ineligible or never started treatment|3|||
128950846|NCT00064350|464104720|FG001|Cross-Over|Ineligible or never started treatment|6|||
128950847|NCT00064350|464104721|FG002|Cross-Over|Ineligible or never started treatment|0|||
128950848|NCT00064350|464104719|FG000|Cross-Over|Other|0|||
128950849|NCT00064350|464104720|FG001|Cross-Over|Other|2|||
128950850|NCT00064350|464104721|FG002|Cross-Over|Other|0|||
128950851|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
128950852|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
128950853|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
128950854|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
128950855|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
128950856|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
128950857|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
128950858|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
128950859|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
128950860|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
128950861|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
128950862|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
128950863|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
128950864|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
128950865|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
128950866|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
128950867|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Missing|3|||
128950868|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Missing|1|||
128950869|NCT00838916|464104722|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
128950870|NCT00838916|464104723|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
128950871|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
128950872|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
128950873|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
129125325|NCT03329001|464753603|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
128950874|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
128950875|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
128950876|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
128710704|NCT02480114|463236142|FG001|Overall Study|Improper completion of survey|1|||
128710705|NCT02480114|463236141|FG000|Overall Study|Not eligible|0|||
128950877|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
128950878|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
128950879|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
128950880|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
128950881|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
128950882|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
128950883|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
128950884|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
128950885|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
128950886|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
128950887|NCT00838916|464104722|FG000|Follow-up Period (8 Weeks)|Missing|3|||
128950888|NCT00838916|464104723|FG001|Follow-up Period (8 Weeks)|Missing|0|||
128950889|NCT02034474|464104724|FG000|Overall Study|Adverse Event|3|||
128950890|NCT02034474|464104725|FG001|Overall Study|Adverse Event|2|||
128950891|NCT02034474|464104724|FG000|Overall Study|Withdrawal by Subject|1|||
128950892|NCT02034474|464104725|FG001|Overall Study|Withdrawal by Subject|2|||
128950893|NCT03600714|464104726|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
128950894|NCT00675103|464104727|FG000|Overall Study|Lack of Efficacy|2|||
128950895|NCT00675103|464104727|FG000|Overall Study|Adverse Event|1|||
128950896|NCT02164513|464104728|FG000|Overall Study|Adverse Event|162|||
128950897|NCT02164513|464104729|FG001|Overall Study|Adverse Event|180|||
128950898|NCT02164513|464104730|FG002|Overall Study|Adverse Event|111|||
129125326|NCT03329001|464753604|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129125327|NCT03329001|464753605|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129125328|NCT03329001|464753606|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129125329|NCT03329001|464753607|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
129125330|NCT03329001|464753608|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129125331|NCT03329001|464753601|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129125332|NCT03329001|464753602|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129125333|NCT03329001|464753603|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129125334|NCT03329001|464753604|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129125335|NCT03329001|464753605|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129125336|NCT03329001|464753606|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129125337|NCT03329001|464753607|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
129125338|NCT03329001|464753608|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
129125339|NCT03329001|464753601|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129125340|NCT03329001|464753602|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129125341|NCT03329001|464753603|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129125342|NCT03329001|464753604|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129125343|NCT03329001|464753605|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129125344|NCT03329001|464753606|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129125345|NCT03329001|464753607|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
129125346|NCT03329001|464753608|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
128710706|NCT02480114|463236142|FG001|Overall Study|Not eligible|1|||
128950899|NCT02164513|464104728|FG000|Overall Study|Other: Study Closed or terminated|5|||
128950900|NCT02164513|464104729|FG001|Overall Study|Other: Study Closed or terminated|2|||
128950901|NCT02164513|464104730|FG002|Overall Study|Other: Study Closed or terminated|4|||
128950902|NCT02164513|464104728|FG000|Overall Study|Lost to Follow-up|30|||
128950903|NCT02164513|464104729|FG001|Overall Study|Lost to Follow-up|36|||
128950904|NCT02164513|464104730|FG002|Overall Study|Lost to Follow-up|22|||
128950905|NCT02164513|464104728|FG000|Overall Study|Physician Decision|47|||
128950906|NCT02164513|464104729|FG001|Overall Study|Physician Decision|57|||
128950907|NCT02164513|464104730|FG002|Overall Study|Physician Decision|28|||
128950908|NCT02164513|464104728|FG000|Overall Study|Withdrawal by Subject|192|||
128950909|NCT02164513|464104729|FG001|Overall Study|Withdrawal by Subject|261|||
128950910|NCT02164513|464104730|FG002|Overall Study|Withdrawal by Subject|130|||
128950911|NCT02164513|464104728|FG000|Overall Study|Other: Reason not provided by site|1|||
128950912|NCT02164513|464104729|FG001|Overall Study|Other: Reason not provided by site|0|||
128950913|NCT02164513|464104730|FG002|Overall Study|Other: Reason not provided by site|0|||
128950914|NCT02509494|464104737|FG000|Overall Study|Lost to Follow-up|8|||
128950915|NCT02509494|464104738|FG001|Overall Study|Lost to Follow-up|47|||
128950916|NCT02509494|464104739|FG002|Overall Study|Lost to Follow-up|19|||
128710707|NCT01535053|463236143|FG000|Overall Study|Ineligible|1|||
128950917|NCT02509494|464104740|FG003|Overall Study|Lost to Follow-up|6|||
128950918|NCT02509494|464104741|FG004|Overall Study|Lost to Follow-up|3|||
128950919|NCT02509494|464104742|FG005|Overall Study|Lost to Follow-up|3|||
128950920|NCT02509494|464104743|FG006|Overall Study|Lost to Follow-up|1|||
128950921|NCT02509494|464104744|FG007|Overall Study|Lost to Follow-up|3|||
128950922|NCT02509494|464104745|FG008|Overall Study|Lost to Follow-up|1|||
128710708|NCT01535053|463236144|FG001|Overall Study|Ineligible|2|||
129125347|NCT02709369|464753612|FG000|Overall Study|Lost to Follow-up|15|||
129125348|NCT02709369|464753612|FG000|Overall Study|Withdrawal by Subject|10|||
129125349|NCT02709369|464753612|FG000|Overall Study|Did not received intervention|2|||
129125350|NCT00963235|464753613|FG000|Overall Study|Withdrawal by Subject|22|||
129125351|NCT00963235|464753613|FG000|Overall Study|Lost to Follow-up|14|||
129125352|NCT00963235|464753613|FG000|Overall Study|Failed to return|9|||
129125353|NCT00963235|464753613|FG000|Overall Study|Protocol Violation|7|||
129125354|NCT00963235|464753613|FG000|Overall Study|Adverse Event|5|||
129125355|NCT00963235|464753613|FG000|Overall Study|Physician Decision|2|||
129125356|NCT00963235|464753613|FG000|Overall Study|Other|1|||
129125357|NCT01104766|464753615|FG000|Overall Study|Did not meet inc/exc criteria|1|||
129125358|NCT01104766|464753616|FG001|Overall Study|Did not meet inc/exc criteria|0|||
129125359|NCT01104766|464753617|FG002|Overall Study|Did not meet inc/exc criteria|0|||
129125360|NCT01104766|464753618|FG003|Overall Study|Did not meet inc/exc criteria|0|||
129125361|NCT01104766|464753615|FG000|Overall Study|Adverse Event|17|||
129125362|NCT01104766|464753616|FG001|Overall Study|Adverse Event|15|||
129125363|NCT01104766|464753617|FG002|Overall Study|Adverse Event|20|||
129125364|NCT01104766|464753618|FG003|Overall Study|Adverse Event|14|||
129125365|NCT01104766|464753615|FG000|Overall Study|Lack of Efficacy|20|||
129125366|NCT01104766|464753616|FG001|Overall Study|Lack of Efficacy|15|||
129125367|NCT01104766|464753617|FG002|Overall Study|Lack of Efficacy|14|||
129125368|NCT01104766|464753618|FG003|Overall Study|Lack of Efficacy|8|||
129125369|NCT01104766|464753615|FG000|Overall Study|Protocol Violation|2|||
129125370|NCT01104766|464753616|FG001|Overall Study|Protocol Violation|0|||
129125371|NCT01104766|464753617|FG002|Overall Study|Protocol Violation|0|||
129125372|NCT01104766|464753618|FG003|Overall Study|Protocol Violation|0|||
129125373|NCT01104766|464753615|FG000|Overall Study|Withdrawal by Subject|17|||
129125374|NCT01104766|464753616|FG001|Overall Study|Withdrawal by Subject|19|||
129125375|NCT01104766|464753617|FG002|Overall Study|Withdrawal by Subject|25|||
129125376|NCT01104766|464753618|FG003|Overall Study|Withdrawal by Subject|15|||
129125377|NCT01104766|464753615|FG000|Overall Study|Lost to Follow-up|1|||
129125378|NCT01104766|464753616|FG001|Overall Study|Lost to Follow-up|2|||
129125379|NCT01104766|464753617|FG002|Overall Study|Lost to Follow-up|1|||
129125380|NCT01104766|464753618|FG003|Overall Study|Lost to Follow-up|1|||
129125381|NCT01341470|464753619|FG000|Overall Study|Sponsor decision|0|||
129125382|NCT01341470|464753620|FG001|Overall Study|Sponsor decision|0|||
129125383|NCT01341470|464753621|FG002|Overall Study|Sponsor decision|1|||
129125384|NCT01341470|464753622|FG003|Overall Study|Sponsor decision|1|||
129125385|NCT01341470|464753623|FG004|Overall Study|Sponsor decision|0|||
129125386|NCT01341470|464753624|FG005|Overall Study|Sponsor decision|1|||
129125387|NCT01136915|464753626|FG000|Overall Study|Lost to Follow-up|2|||
129125388|NCT01136915|464753627|FG001|Overall Study|Lost to Follow-up|0|||
129125389|NCT01136915|464753626|FG000|Overall Study|Exclusion criterion met|0|||
129125390|NCT01136915|464753627|FG001|Overall Study|Exclusion criterion met|1|||
129125391|NCT01756235|464753628|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
129125392|NCT05376358|464753629|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
129125393|NCT05376358|464753630|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
129125394|NCT05376358|464753629|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
129125395|NCT05376358|464753630|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
129125396|NCT05376358|464753629|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
129125397|NCT05376358|464753630|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
129125398|NCT05376358|464753629|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
129125399|NCT05376358|464753630|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
129125400|NCT05376358|464753629|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
129125401|NCT05376358|464753630|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
129125402|NCT05376358|464753629|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
129125403|NCT05376358|464753630|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
129125404|NCT03965923|464753631|FG000|Overall Study|Withdrawal by Subject|1|||
129125405|NCT03965923|464753632|FG001|Overall Study|Withdrawal by Subject|2|||
129125406|NCT03965923|464753633|FG002|Overall Study|Withdrawal by Subject|3|||
129125407|NCT03965923|464753634|FG003|Overall Study|Withdrawal by Subject|1|||
129125408|NCT03965923|464753635|FG004|Overall Study|Withdrawal by Subject|2|||
129125409|NCT03965923|464753636|FG005|Overall Study|Withdrawal by Subject|0|||
129125410|NCT03965923|464753637|FG006|Overall Study|Withdrawal by Subject|4|||
129125411|NCT03965923|464753638|FG007|Overall Study|Withdrawal by Subject|3|||
128710709|NCT00512707|463236145|FG000|Overall Study|Lost to Follow-up|5|||
129125412|NCT03965923|464753639|FG008|Overall Study|Withdrawal by Subject|4|||
129125413|NCT03965923|464753640|FG009|Overall Study|Withdrawal by Subject|0|||
129125414|NCT03965923|464753641|FG010|Overall Study|Withdrawal by Subject|2|||
129125415|NCT03965923|464753642|FG011|Overall Study|Withdrawal by Subject|0|||
128950923|NCT02509494|464104737|FG000|Overall Study|Physician Decision|2|||
129219014|NCT02721966|465101679|FG001|Overall Study|Did not continue to period 2|12|||
129219015|NCT02721966|465101680|FG002|Overall Study|Did not continue to period 2|0|||
129219016|NCT02721966|465101681|FG003|Overall Study|Did not continue to period 2|0|||
129219017|NCT02721966|465101682|FG004|Overall Study|Did not continue to period 2|5|||
128950924|NCT02509494|464104738|FG001|Overall Study|Physician Decision|1|||
128950925|NCT02509494|464104739|FG002|Overall Study|Physician Decision|0|||
128950926|NCT02509494|464104740|FG003|Overall Study|Physician Decision|0|||
128950927|NCT02509494|464104741|FG004|Overall Study|Physician Decision|0|||
129219018|NCT03857867|465101683|FG000|Overall Study|Physician Decision|1|||
129219019|NCT02157883|465101684|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
129219020|NCT02157883|465101684|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
129219021|NCT02157883|465101684|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
129219022|NCT02157883|465101684|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
129219023|NCT02157883|465101684|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
129219024|NCT00888940|465101685|FG000|Overall Study|Adverse Event|12|||
129219025|NCT00888940|465101686|FG001|Overall Study|Adverse Event|3|||
129219026|NCT00888940|465101685|FG000|Overall Study|Lost to Follow-up|5|||
129219027|NCT00888940|465101686|FG001|Overall Study|Lost to Follow-up|5|||
129219028|NCT00888940|465101685|FG000|Overall Study|Randomized Not Treated|11|||
128710710|NCT00512707|463236146|FG001|Overall Study|Lost to Follow-up|11|||
128710711|NCT00512707|463236145|FG000|Overall Study|Developed skin irritation|2|||
128710712|NCT00512707|463236146|FG001|Overall Study|Developed skin irritation|1|||
128710713|NCT00512707|463236145|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
128710714|NCT00512707|463236146|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
128710715|NCT00512707|463236145|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
128710716|NCT00512707|463236146|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
128710717|NCT04405037|463236153|FG000|Overall Study|Withdrawal by Subject|1|||
128710718|NCT04405037|463236154|FG001|Overall Study|Withdrawal by Subject|0|||
128710719|NCT04405037|463236153|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
128710720|NCT04405037|463236154|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
128710721|NCT01134783|463237680|FG000|Overall Study|Pregnancy|16|||
128710722|NCT01134783|463237681|FG001|Overall Study|Pregnancy|8|||
128710723|NCT01134783|463237680|FG000|Overall Study|Withdrawal by Subject|15|||
128710724|NCT01134783|463237681|FG001|Overall Study|Withdrawal by Subject|9|||
128710725|NCT01134783|463237680|FG000|Overall Study|Lost to Follow-up|5|||
128710726|NCT01134783|463237681|FG001|Overall Study|Lost to Follow-up|20|||
128710727|NCT04221009|463237682|FG000|Overall Study|Withdrawal by Subject|4|||
128710728|NCT02329730|463237683|FG000|Overall Study|Protocol Violation|0|||
128710729|NCT02329730|463237684|FG001|Overall Study|Protocol Violation|0|||
128710730|NCT02329730|463237685|FG002|Overall Study|Protocol Violation|0|||
128710731|NCT02329730|463237686|FG003|Overall Study|Protocol Violation|0|||
128710732|NCT02329730|463237687|FG004|Overall Study|Protocol Violation|2|||
128710733|NCT02329730|463237688|FG005|Overall Study|Protocol Violation|2|||
128710734|NCT02329730|463237689|FG006|Overall Study|Protocol Violation|0|||
128710735|NCT02329730|463237690|FG007|Overall Study|Protocol Violation|0|||
128710736|NCT02329730|463237691|FG008|Overall Study|Protocol Violation|0|||
128710737|NCT02329730|463237692|FG009|Overall Study|Protocol Violation|0|||
128710738|NCT02329730|463237693|FG010|Overall Study|Protocol Violation|0|||
128710739|NCT02329730|463237694|FG011|Overall Study|Protocol Violation|0|||
128710740|NCT02329730|463237683|FG000|Overall Study|Withdrawal by Subject|0|||
128710741|NCT02329730|463237684|FG001|Overall Study|Withdrawal by Subject|0|||
128710742|NCT02329730|463237685|FG002|Overall Study|Withdrawal by Subject|0|||
128710743|NCT02329730|463237686|FG003|Overall Study|Withdrawal by Subject|0|||
128710744|NCT02329730|463237687|FG004|Overall Study|Withdrawal by Subject|1|||
128710745|NCT02329730|463237688|FG005|Overall Study|Withdrawal by Subject|0|||
128710746|NCT02329730|463237689|FG006|Overall Study|Withdrawal by Subject|1|||
128710747|NCT02329730|463237690|FG007|Overall Study|Withdrawal by Subject|1|||
128710748|NCT02329730|463237691|FG008|Overall Study|Withdrawal by Subject|1|||
128710749|NCT02329730|463237692|FG009|Overall Study|Withdrawal by Subject|1|||
128710750|NCT02329730|463237693|FG010|Overall Study|Withdrawal by Subject|0|||
128710751|NCT02329730|463237694|FG011|Overall Study|Withdrawal by Subject|0|||
128710752|NCT02392247|463237699|FG000|Overall Study|Withdrawal by Subject|1|||
128710753|NCT02392247|463237699|FG000|Overall Study|Surgery cancelled; no data|1|||
128710754|NCT03010254|463237700|FG000|Overall Study|Adverse Event|0|||
128710755|NCT03010254|463237701|FG001|Overall Study|Adverse Event|1|||
128710756|NCT03010254|463237700|FG000|Overall Study|Lost to Follow-up|4|||
128710757|NCT03010254|463237701|FG001|Overall Study|Lost to Follow-up|0|||
128710758|NCT03010254|463237700|FG000|Overall Study|Withdrawal by Subject|1|||
128950928|NCT02509494|464104742|FG005|Overall Study|Physician Decision|0|||
128710759|NCT03010254|463237701|FG001|Overall Study|Withdrawal by Subject|1|||
128710760|NCT03010254|463237700|FG000|Overall Study|Other|2|||
128710761|NCT03010254|463237701|FG001|Overall Study|Other|3|||
128710762|NCT02068443|463237707|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
128710763|NCT02068443|463237708|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
128950929|NCT02509494|464104743|FG006|Overall Study|Physician Decision|0|||
128710764|NCT02068443|463237709|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
128710765|NCT02068443|463237707|FG000|Overall Study|Voluntary Withdrawal|4|||
128710766|NCT02068443|463237708|FG001|Overall Study|Voluntary Withdrawal|0|||
128710767|NCT02068443|463237709|FG002|Overall Study|Voluntary Withdrawal|1|||
128710768|NCT02068443|463237707|FG000|Overall Study|Lack of Efficacy|2|||
128710769|NCT02068443|463237708|FG001|Overall Study|Lack of Efficacy|1|||
128710770|NCT02068443|463237709|FG002|Overall Study|Lack of Efficacy|0|||
128710771|NCT02068443|463237707|FG000|Overall Study|Other Reason Not Specified|1|||
128710772|NCT02068443|463237708|FG001|Overall Study|Other Reason Not Specified|0|||
128710773|NCT02068443|463237709|FG002|Overall Study|Other Reason Not Specified|0|||
128710774|NCT01986855|463237710|FG000|Overall Study|Adverse Event|1|||
128710775|NCT01986855|463237711|FG001|Overall Study|Adverse Event|0|||
128710776|NCT01986855|463237712|FG002|Overall Study|Adverse Event|0|||
128710777|NCT01986855|463237710|FG000|Overall Study|Death|3|||
128710778|NCT01986855|463237711|FG001|Overall Study|Death|4|||
128710779|NCT01986855|463237712|FG002|Overall Study|Death|4|||
128710780|NCT01986855|463237710|FG000|Overall Study|Lost to Follow-up|2|||
128710781|NCT01986855|463237711|FG001|Overall Study|Lost to Follow-up|1|||
128710782|NCT01986855|463237712|FG002|Overall Study|Lost to Follow-up|0|||
128710783|NCT01986855|463237710|FG000|Overall Study|Screen Failure|0|||
128710784|NCT01986855|463237711|FG001|Overall Study|Screen Failure|1|||
128710785|NCT01986855|463237712|FG002|Overall Study|Screen Failure|0|||
128710786|NCT01986855|463237710|FG000|Overall Study|Participant Moved|0|||
128710787|NCT01986855|463237711|FG001|Overall Study|Participant Moved|0|||
128710788|NCT01986855|463237712|FG002|Overall Study|Participant Moved|2|||
128710789|NCT01986855|463237710|FG000|Overall Study|Withdrawal by Subject|7|||
128710790|NCT01986855|463237711|FG001|Overall Study|Withdrawal by Subject|8|||
128710791|NCT01986855|463237712|FG002|Overall Study|Withdrawal by Subject|5|||
128710792|NCT00664742|463237713|FG000|Overall Study|Withdrawn due to adverse events|3|||
128710793|NCT00664742|463237713|FG000|Overall Study|Withdrawal by Subject|31|||
128710794|NCT00664742|463237713|FG000|Overall Study|Lost to Follow-up|92|||
128710795|NCT02825992|463237714|FG000|Overall Study|Withdrawal by Subject|4|||
128710796|NCT02825992|463237714|FG000|Overall Study|Lost to Follow-up|2|||
128710797|NCT02825992|463237714|FG000|Overall Study|Procedure terminated|2|||
128710798|NCT02279173|463237715|FG000|Overall Study|Protocol-specified Criteria|67|||
128710799|NCT02279173|463237715|FG000|Overall Study|Withdrawal by Subject|20|||
128710800|NCT02279173|463237715|FG000|Overall Study|Decision by Sponsor|4|||
128710801|NCT02279173|463237715|FG000|Overall Study|Lost to Follow-up|3|||
128710802|NCT00710710|463237716|FG000|Overall Study|Consent withdrawn|2|||
128710803|NCT00710710|463237717|FG001|Overall Study|Consent withdrawn|2|||
128710804|NCT00710710|463237716|FG000|Overall Study|Protocol Violation|0|||
128710805|NCT00710710|463237717|FG001|Overall Study|Protocol Violation|1|||
128710806|NCT00710710|463237716|FG000|Overall Study|Adverse Event|3|||
128710807|NCT00710710|463237717|FG001|Overall Study|Adverse Event|3|||
128710808|NCT00710710|463237716|FG000|Overall Study|Progressive disease|40|||
128710809|NCT00710710|463237717|FG001|Overall Study|Progressive disease|38|||
128710810|NCT00715078|463237718|FG000|Overall Study|Death|29|||
128710811|NCT00715078|463237719|FG001|Overall Study|Death|36|||
128710812|NCT00715078|463237720|FG002|Overall Study|Death|36|||
128950930|NCT02509494|464104744|FG007|Overall Study|Physician Decision|0|||
128950931|NCT02509494|464104745|FG008|Overall Study|Physician Decision|0|||
128950932|NCT02509494|464104737|FG000|Overall Study|Withdrawal by Subject|4|||
128950933|NCT02509494|464104738|FG001|Overall Study|Withdrawal by Subject|17|||
128950934|NCT02509494|464104739|FG002|Overall Study|Withdrawal by Subject|7|||
128950935|NCT02509494|464104740|FG003|Overall Study|Withdrawal by Subject|5|||
128950936|NCT02509494|464104741|FG004|Overall Study|Withdrawal by Subject|0|||
128710813|NCT00715078|463237718|FG000|Overall Study|Withdrawal by Subject|1|||
128710814|NCT00715078|463237719|FG001|Overall Study|Withdrawal by Subject|0|||
128710815|NCT00715078|463237720|FG002|Overall Study|Withdrawal by Subject|1|||
128950937|NCT02509494|464104742|FG005|Overall Study|Withdrawal by Subject|6|||
128950938|NCT02509494|464104743|FG006|Overall Study|Withdrawal by Subject|1|||
128950939|NCT02509494|464104744|FG007|Overall Study|Withdrawal by Subject|2|||
128950940|NCT02509494|464104745|FG008|Overall Study|Withdrawal by Subject|1|||
128950941|NCT02509494|464104737|FG000|Overall Study|Death|0|||
128950942|NCT02509494|464104738|FG001|Overall Study|Death|1|||
128950943|NCT02509494|464104739|FG002|Overall Study|Death|0|||
128950944|NCT02509494|464104740|FG003|Overall Study|Death|0|||
128950945|NCT02509494|464104741|FG004|Overall Study|Death|1|||
128710816|NCT00715078|463237718|FG000|Overall Study|Unable to start due to disease prog.|0|||
128710817|NCT00715078|463237719|FG001|Overall Study|Unable to start due to disease prog.|0|||
128710818|NCT00715078|463237720|FG002|Overall Study|Unable to start due to disease prog.|1|||
128710819|NCT00142584|463237721|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
128710820|NCT00142584|463237722|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
128710821|NCT00142584|463237721|FG000|Overall Study|Withdrawal by Subject|30|||
128710822|NCT00142584|463237722|FG001|Overall Study|Withdrawal by Subject|16|||
128710823|NCT00142584|463237721|FG000|Overall Study|Lost to Follow-up|22|||
128950946|NCT02509494|464104742|FG005|Overall Study|Death|0|||
128950947|NCT02509494|464104743|FG006|Overall Study|Death|0|||
128950948|NCT02509494|464104744|FG007|Overall Study|Death|1|||
128950949|NCT02509494|464104745|FG008|Overall Study|Death|0|||
128950950|NCT02509494|464104737|FG000|Overall Study|Other|0|||
128950951|NCT02509494|464104738|FG001|Overall Study|Other|4|||
128950952|NCT02509494|464104739|FG002|Overall Study|Other|5|||
128950953|NCT02509494|464104740|FG003|Overall Study|Other|0|||
128950954|NCT02509494|464104741|FG004|Overall Study|Other|0|||
128950955|NCT02509494|464104742|FG005|Overall Study|Other|0|||
128950956|NCT02509494|464104743|FG006|Overall Study|Other|0|||
128950957|NCT02509494|464104744|FG007|Overall Study|Other|0|||
128950958|NCT02509494|464104745|FG008|Overall Study|Other|0|||
128950959|NCT02509494|464104737|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128950960|NCT02509494|464104738|FG001|Overall Study|Non-Compliance With Study Drug|11|||
128950961|NCT02509494|464104739|FG002|Overall Study|Non-Compliance With Study Drug|7|||
128950962|NCT02509494|464104740|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128950963|NCT02509494|464104741|FG004|Overall Study|Non-Compliance With Study Drug|1|||
128950964|NCT02509494|464104742|FG005|Overall Study|Non-Compliance With Study Drug|2|||
128950965|NCT02509494|464104743|FG006|Overall Study|Non-Compliance With Study Drug|1|||
128950966|NCT02509494|464104744|FG007|Overall Study|Non-Compliance With Study Drug|1|||
128950967|NCT02509494|464104745|FG008|Overall Study|Non-Compliance With Study Drug|0|||
128950968|NCT01179347|464106143|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
128950969|NCT01179347|464106144|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
128950970|NCT01179347|464106143|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
128950971|NCT01179347|464106144|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
128950972|NCT01179347|464106143|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
128950973|NCT01179347|464106144|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
128950974|NCT01179347|464106143|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
128950975|NCT01179347|464106144|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
128950976|NCT01179347|464106143|FG000|Double-blind Period (12 Weeks)|Other|2|||
128950977|NCT01179347|464106144|FG001|Double-blind Period (12 Weeks)|Other|4|||
128950978|NCT01179347|464106143|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
128950979|NCT01179347|464106144|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
128950980|NCT01179347|464106143|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
128950981|NCT01179347|464106144|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
128950982|NCT01179347|464106143|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
128950983|NCT01179347|464106144|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
128950984|NCT01179347|464106143|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
128950985|NCT01179347|464106144|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
128950986|NCT01179347|464106143|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
128950987|NCT01179347|464106144|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
128950988|NCT01179347|464106143|FG000|Open-label Period (12 Weeks)|Other|7|||
128950989|NCT01179347|464106144|FG001|Open-label Period (12 Weeks)|Other|4|||
128950990|NCT00369967|464106145|FG000|Overall Study|Lost to Follow-up|23|||
128950991|NCT00369967|464106146|FG001|Overall Study|Lost to Follow-up|12|||
128950992|NCT02586077|464106147|FG000|Overall Study|Withdrawal by Subject|1|||
128950993|NCT02586077|464106147|FG000|Overall Study|Physician Decision|4|||
128950994|NCT02586077|464106147|FG000|Overall Study|Lost to Follow-up|3|||
128950995|NCT00205699|464106156|FG000|Overall Study|Lost to Follow-up|1|||
128950996|NCT00205699|464106157|FG001|Overall Study|Lost to Follow-up|3|||
128950997|NCT00205699|464106158|FG002|Overall Study|Lost to Follow-up|5|||
128950998|NCT00205699|464106156|FG000|Overall Study|Adverse Event|1|||
128950999|NCT00205699|464106157|FG001|Overall Study|Adverse Event|0|||
128951000|NCT00205699|464106158|FG002|Overall Study|Adverse Event|0|||
128951001|NCT00205699|464106156|FG000|Overall Study|Withdrawal by Subject|1|||
128951002|NCT00205699|464106157|FG001|Overall Study|Withdrawal by Subject|2|||
128951003|NCT00205699|464106158|FG002|Overall Study|Withdrawal by Subject|1|||
128951004|NCT00205699|464106156|FG000|Overall Study|Lack of Efficacy|0|||
128951005|NCT00205699|464106157|FG001|Overall Study|Lack of Efficacy|1|||
128951006|NCT00205699|464106158|FG002|Overall Study|Lack of Efficacy|0|||
128951007|NCT00571688|464106161|FG000|Overall Study|Lost to Follow-up|3|||
128951008|NCT00571688|464106162|FG001|Overall Study|Lost to Follow-up|6|||
128951009|NCT00571688|464106161|FG000|Overall Study|subject did not tolerate Consta|1|||
128951010|NCT00571688|464106162|FG001|Overall Study|subject did not tolerate Consta|0|||
128951011|NCT00571688|464106161|FG000|Overall Study|subject moved out of the area|1|||
128951012|NCT00571688|464106162|FG001|Overall Study|subject moved out of the area|0|||
128951013|NCT04321252|464106165|FG000|Overall Study|Withdrawal by Subject|0|||
128951014|NCT04321252|464106166|FG001|Overall Study|Withdrawal by Subject|0|||
128710824|NCT00142584|463237722|FG001|Overall Study|Lost to Follow-up|12|||
128710825|NCT00142584|463237721|FG000|Overall Study|Adverse Event|14|||
128951015|NCT04321252|464106167|FG002|Overall Study|Withdrawal by Subject|0|||
128951016|NCT04321252|464106168|FG003|Overall Study|Withdrawal by Subject|0|||
129219029|NCT00888940|465101686|FG001|Overall Study|Randomized Not Treated|13|||
128710826|NCT00142584|463237722|FG001|Overall Study|Adverse Event|5|||
128951017|NCT04321252|464106169|FG004|Overall Study|Withdrawal by Subject|0|||
128951018|NCT04321252|464106170|FG005|Overall Study|Withdrawal by Subject|1|||
128951019|NCT04321252|464106171|FG006|Overall Study|Withdrawal by Subject|0|||
128951020|NCT04321252|464106172|FG007|Overall Study|Withdrawal by Subject|0|||
128951021|NCT04321252|464106173|FG008|Overall Study|Withdrawal by Subject|0|||
128951022|NCT03004469|464106174|FG000|Overall Study|Adverse Event|6|||
128951023|NCT03004469|464106175|FG001|Overall Study|Adverse Event|4|||
128951024|NCT03004469|464106176|FG002|Overall Study|Adverse Event|6|||
128951025|NCT03004469|464106174|FG000|Overall Study|Lack of Efficacy|1|||
128951026|NCT03004469|464106175|FG001|Overall Study|Lack of Efficacy|0|||
128951027|NCT03004469|464106176|FG002|Overall Study|Lack of Efficacy|1|||
128951028|NCT03004469|464106174|FG000|Overall Study|Lost to Follow-up|23|||
128951029|NCT03004469|464106175|FG001|Overall Study|Lost to Follow-up|14|||
128951030|NCT03004469|464106176|FG002|Overall Study|Lost to Follow-up|6|||
128951031|NCT03004469|464106174|FG000|Overall Study|Non-Compliance with Study Drug|2|||
128951032|NCT03004469|464106175|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128951033|NCT03004469|464106176|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128951034|NCT03004469|464106174|FG000|Overall Study|Protocol Violation|0|||
128951035|NCT03004469|464106175|FG001|Overall Study|Protocol Violation|0|||
128951036|NCT03004469|464106176|FG002|Overall Study|Protocol Violation|1|||
128951037|NCT03004469|464106174|FG000|Overall Study|Withdrawal by Subject|29|||
128951038|NCT03004469|464106175|FG001|Overall Study|Withdrawal by Subject|27|||
128951039|NCT03004469|464106176|FG002|Overall Study|Withdrawal by Subject|10|||
128951040|NCT03004469|464106174|FG000|Overall Study|Other unspecified reason|0|||
128951041|NCT03004469|464106175|FG001|Overall Study|Other unspecified reason|4|||
128951042|NCT03004469|464106176|FG002|Overall Study|Other unspecified reason|1|||
128951043|NCT00259740|464106177|FG000|Overall Study|Physician Decision|1|||
128951044|NCT00259740|464106178|FG001|Overall Study|Physician Decision|1|||
128951045|NCT00259740|464106177|FG000|Overall Study|Adverse Event|0|||
128951046|NCT00259740|464106178|FG001|Overall Study|Adverse Event|2|||
128951047|NCT00259740|464106177|FG000|Overall Study|Withdrawal by Subject|2|||
128951048|NCT00259740|464106178|FG001|Overall Study|Withdrawal by Subject|6|||
128951049|NCT00259740|464106177|FG000|Overall Study|Death|1|||
128951050|NCT00259740|464106178|FG001|Overall Study|Death|1|||
128951051|NCT00259740|464106177|FG000|Overall Study|Disease progression|19|||
128951052|NCT00259740|464106178|FG001|Overall Study|Disease progression|36|||
128951053|NCT00259740|464106177|FG000|Overall Study|Ongoing|17|||
128951054|NCT00259740|464106178|FG001|Overall Study|Ongoing|3|||
128951055|NCT00259740|464106177|FG000|Overall Study|Other|3|||
128951056|NCT00259740|464106178|FG001|Overall Study|Other|0|||
128951057|NCT00259740|464106177|FG000|Overall Study|Requirement for alternative therapy|0|||
128951058|NCT00259740|464106178|FG001|Overall Study|Requirement for alternative therapy|4|||
128951059|NCT02287402|464106179|FG000|Treatment Period|Adverse Event|17|||
129125416|NCT03965923|464753631|FG000|Overall Study|Lost to Follow-up|2|||
129125417|NCT03965923|464753632|FG001|Overall Study|Lost to Follow-up|1|||
129125418|NCT03965923|464753633|FG002|Overall Study|Lost to Follow-up|1|||
129125419|NCT03965923|464753634|FG003|Overall Study|Lost to Follow-up|0|||
129125420|NCT03965923|464753635|FG004|Overall Study|Lost to Follow-up|2|||
129125421|NCT03965923|464753636|FG005|Overall Study|Lost to Follow-up|1|||
129125422|NCT03965923|464753637|FG006|Overall Study|Lost to Follow-up|2|||
128770532|NCT01993017|463451538|FG002|Overall Study|Ineligible after randomization|5|||
128770533|NCT01683994|463451539|FG000|Overall Study|Withdrawal by Subject|1|||
128770534|NCT01683994|463451540|FG001|Overall Study|Withdrawal by Subject|0|||
128770535|NCT01683994|463451541|FG002|Overall Study|Withdrawal by Subject|0|||
128770536|NCT01683994|463451542|FG003|Overall Study|Withdrawal by Subject|1|||
128770537|NCT01683994|463451543|FG004|Overall Study|Withdrawal by Subject|0|||
128770538|NCT01683994|463451539|FG000|Overall Study|Intercurrent illness|0|||
128770539|NCT01683994|463451540|FG001|Overall Study|Intercurrent illness|0|||
128770540|NCT01683994|463451541|FG002|Overall Study|Intercurrent illness|0|||
128951060|NCT02287402|464106179|FG000|Treatment Period|Voluntary Withdrawal|10|||
128951061|NCT02287402|464106179|FG000|Follow-up|Lost to Follow-up|1|||
128951062|NCT02287402|464106179|FG000|Follow-up|Voluntary Withdrawal|2|||
128770541|NCT01683994|463451542|FG003|Overall Study|Intercurrent illness|2|||
128951063|NCT01844830|464106180|FG000|Overall Study|Withdrawal by Subject|1|||
128951064|NCT01844830|464106181|FG001|Overall Study|Withdrawal by Subject|0|||
128951065|NCT04247815|464106182|FG000|Overall Study|Adverse Event|1|||
128951066|NCT04247815|464106183|FG001|Overall Study|Adverse Event|0|||
129125423|NCT03965923|464753638|FG007|Overall Study|Lost to Follow-up|1|||
129125424|NCT03965923|464753639|FG008|Overall Study|Lost to Follow-up|0|||
129125425|NCT03965923|464753640|FG009|Overall Study|Lost to Follow-up|2|||
129125426|NCT03965923|464753641|FG010|Overall Study|Lost to Follow-up|0|||
128770542|NCT01683994|463451543|FG004|Overall Study|Intercurrent illness|1|||
128951067|NCT04247815|464106182|FG000|Overall Study|Withdrawal by Subject|1|||
128951068|NCT04247815|464106183|FG001|Overall Study|Withdrawal by Subject|0|||
128951069|NCT04247815|464106182|FG000|Overall Study|Protocol Violation|0|||
128951070|NCT04247815|464106183|FG001|Overall Study|Protocol Violation|1|||
129125427|NCT03965923|464753642|FG011|Overall Study|Lost to Follow-up|0|||
129125428|NCT03965923|464753631|FG000|Overall Study|Death|0|||
128951071|NCT03495453|464106191|FG000|Overall Study|Withdrawal by Subject|0|||
129125429|NCT03965923|464753632|FG001|Overall Study|Death|0|||
128951072|NCT03495453|464106192|FG001|Overall Study|Withdrawal by Subject|1|||
129125430|NCT03965923|464753633|FG002|Overall Study|Death|0|||
128710827|NCT00142584|463237721|FG000|Overall Study|Protocol Violation|4|||
128710828|NCT00142584|463237722|FG001|Overall Study|Protocol Violation|7|||
128710829|NCT00142584|463237721|FG000|Overall Study|Treatment Failure|2|||
128710830|NCT00142584|463237722|FG001|Overall Study|Treatment Failure|0|||
128710831|NCT03070782|463237723|FG000|Overall Study|Adverse Event|3|||
128710832|NCT03070782|463237724|FG001|Overall Study|Adverse Event|0|||
128710833|NCT03070782|463237725|FG002|Overall Study|Adverse Event|3|||
128710834|NCT03070782|463237726|FG003|Overall Study|Adverse Event|1|||
128710835|NCT03070782|463237727|FG004|Overall Study|Adverse Event|6|||
128710836|NCT03070782|463237728|FG005|Overall Study|Adverse Event|2|||
128710837|NCT03070782|463237723|FG000|Overall Study|Withdrawal by Subject|2|||
128710838|NCT03070782|463237724|FG001|Overall Study|Withdrawal by Subject|1|||
128710839|NCT03070782|463237725|FG002|Overall Study|Withdrawal by Subject|1|||
128951073|NCT03341923|464106195|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
128951074|NCT03341923|464106196|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
128710840|NCT03070782|463237726|FG003|Overall Study|Withdrawal by Subject|0|||
128710841|NCT03070782|463237727|FG004|Overall Study|Withdrawal by Subject|4|||
128710842|NCT03070782|463237728|FG005|Overall Study|Withdrawal by Subject|3|||
128710843|NCT03070782|463237723|FG000|Overall Study|Reason Not Specified|2|||
128710844|NCT03070782|463237724|FG001|Overall Study|Reason Not Specified|0|||
128710845|NCT03070782|463237725|FG002|Overall Study|Reason Not Specified|0|||
128710846|NCT03070782|463237726|FG003|Overall Study|Reason Not Specified|1|||
128710847|NCT03070782|463237727|FG004|Overall Study|Reason Not Specified|2|||
128710848|NCT03070782|463237728|FG005|Overall Study|Reason Not Specified|1|||
128710849|NCT03070782|463237723|FG000|Overall Study|Ineligibility|0|||
128710850|NCT03070782|463237724|FG001|Overall Study|Ineligibility|0|||
128710851|NCT03070782|463237725|FG002|Overall Study|Ineligibility|0|||
128710852|NCT03070782|463237726|FG003|Overall Study|Ineligibility|1|||
128710853|NCT03070782|463237727|FG004|Overall Study|Ineligibility|0|||
128710854|NCT03070782|463237728|FG005|Overall Study|Ineligibility|1|||
128710855|NCT03070782|463237723|FG000|Overall Study|Pregnancy|0|||
128710856|NCT03070782|463237724|FG001|Overall Study|Pregnancy|0|||
128710857|NCT03070782|463237725|FG002|Overall Study|Pregnancy|0|||
128710858|NCT03070782|463237726|FG003|Overall Study|Pregnancy|1|||
128770543|NCT02960763|463451545|FG000|Step 1|Withdrawal by Subject|10|||
128951075|NCT00304915|464106198|FG000|Overall Study|Lost to Follow-up|11|||
128951076|NCT00304915|464106199|FG001|Overall Study|Lost to Follow-up|11|||
128951077|NCT00304915|464106198|FG000|Overall Study|Death|4|||
128951078|NCT00304915|464106199|FG001|Overall Study|Death|5|||
128951079|NCT00304915|464106198|FG000|Overall Study|Withdrawal by Subject|3|||
128951080|NCT00304915|464106199|FG001|Overall Study|Withdrawal by Subject|0|||
128951081|NCT00973921|464106203|FG000|Overall Study|IVUS results were not available|9|||
129125431|NCT03965923|464753634|FG003|Overall Study|Death|0|||
129125432|NCT03965923|464753635|FG004|Overall Study|Death|0|||
129125433|NCT03965923|464753636|FG005|Overall Study|Death|0|||
129125434|NCT03965923|464753637|FG006|Overall Study|Death|0|||
129125435|NCT03965923|464753638|FG007|Overall Study|Death|1|||
129125436|NCT03965923|464753639|FG008|Overall Study|Death|4|||
129125437|NCT03965923|464753640|FG009|Overall Study|Death|0|||
128951082|NCT04404010|464106207|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
128951083|NCT04404010|464106208|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
128951084|NCT02120157|464106209|FG000|Overall Study|Death|8|||
128951085|NCT00441103|464106214|FG000|Overall Study|Adverse Event|2|||
128951086|NCT00441103|464106215|FG001|Overall Study|Adverse Event|1|||
128951087|NCT00441103|464106214|FG000|Overall Study|Death|1|||
128951088|NCT00441103|464106215|FG001|Overall Study|Death|0|||
128951089|NCT00441103|464106214|FG000|Overall Study|Disease Progression|2|||
128951090|NCT00441103|464106215|FG001|Overall Study|Disease Progression|0|||
128951091|NCT00441103|464106214|FG000|Overall Study|Lost to Follow-up|1|||
128951092|NCT00441103|464106215|FG001|Overall Study|Lost to Follow-up|0|||
128951093|NCT00441103|464106214|FG000|Overall Study|Protocol Violation|1|||
128951094|NCT00441103|464106215|FG001|Overall Study|Protocol Violation|0|||
128951095|NCT00441103|464106214|FG000|Overall Study|Participant unable to use Rebiject II|1|||
128951096|NCT00441103|464106215|FG001|Overall Study|Participant unable to use Rebiject II|0|||
129125438|NCT03965923|464753641|FG010|Overall Study|Death|4|||
128951097|NCT00441103|464106214|FG000|Overall Study|Participant refused MRI|1|||
128951098|NCT00441103|464106215|FG001|Overall Study|Participant refused MRI|0|||
128951099|NCT00441103|464106214|FG000|Overall Study|Inclusion criteria absent|1|||
129125439|NCT03965923|464753642|FG011|Overall Study|Death|0|||
128710859|NCT03070782|463237727|FG004|Overall Study|Pregnancy|0|||
128710860|NCT03070782|463237728|FG005|Overall Study|Pregnancy|0|||
128710861|NCT03070782|463237723|FG000|Overall Study|Investigator Judgement|0|||
128710862|NCT03070782|463237724|FG001|Overall Study|Investigator Judgement|0|||
128710863|NCT03070782|463237725|FG002|Overall Study|Investigator Judgement|0|||
128710864|NCT03070782|463237726|FG003|Overall Study|Investigator Judgement|1|||
128710865|NCT03070782|463237727|FG004|Overall Study|Investigator Judgement|0|||
128710866|NCT03070782|463237728|FG005|Overall Study|Investigator Judgement|0|||
128710867|NCT01083576|463237729|FG000|Overall Study|Treatment Failure|6|||
128710868|NCT01083576|463237730|FG001|Overall Study|Treatment Failure|1|||
128951100|NCT00441103|464106215|FG001|Overall Study|Inclusion criteria absent|0|||
128951101|NCT00441103|464106214|FG000|Overall Study|Non-compliant|0|||
128951102|NCT00441103|464106215|FG001|Overall Study|Non-compliant|1|||
128951103|NCT00441103|464106214|FG000|Overall Study|Participant decided to withdraw|1|||
128951104|NCT00441103|464106215|FG001|Overall Study|Participant decided to withdraw|0|||
128951105|NCT00441103|464106214|FG000|Overall Study|Participant's reason|0|||
128951106|NCT00441103|464106215|FG001|Overall Study|Participant's reason|1|||
128951107|NCT00441103|464106214|FG000|Overall Study|Participant decided to stop|0|||
128951108|NCT00441103|464106215|FG001|Overall Study|Participant decided to stop|1|||
128951109|NCT02802878|464106218|FG000|Overall Study|Withdrawal by Subject|3|||
128951110|NCT02802878|464106219|FG001|Overall Study|Withdrawal by Subject|3|||
128951111|NCT02802878|464106218|FG000|Overall Study|Protocol Violation|1|||
128951112|NCT02802878|464106219|FG001|Overall Study|Protocol Violation|0|||
128951113|NCT01599754|464106220|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
128951114|NCT01599754|464106221|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
128951115|NCT01599754|464106220|FG000|Overall Study|Participant noncompliance|4|||
128951116|NCT01599754|464106221|FG001|Overall Study|Participant noncompliance|4|||
128951117|NCT01599754|464106220|FG000|Overall Study|Lost to Follow-up|13|||
128951118|NCT01599754|464106221|FG001|Overall Study|Lost to Follow-up|6|||
128951119|NCT01599754|464106220|FG000|Overall Study|Death|31|||
128951120|NCT01599754|464106221|FG001|Overall Study|Death|33|||
128951121|NCT01599754|464106220|FG000|Overall Study|Adverse Event|3|||
128951122|NCT01599754|464106221|FG001|Overall Study|Adverse Event|2|||
128951123|NCT01599754|464106220|FG000|Overall Study|Investigator decision|1|||
128951124|NCT01599754|464106221|FG001|Overall Study|Investigator decision|3|||
128951125|NCT01599754|464106220|FG000|Overall Study|Withdrawal by Subject|24|||
128951126|NCT01599754|464106221|FG001|Overall Study|Withdrawal by Subject|25|||
128951127|NCT01599754|464106220|FG000|Overall Study|Study terminated by sponsor|282|||
128951128|NCT01599754|464106221|FG001|Overall Study|Study terminated by sponsor|285|||
128951129|NCT01029002|464106222|FG000|Overall Study|Lost to Follow-up|2|||
128951130|NCT01029002|464106223|FG001|Overall Study|Lost to Follow-up|4|||
128951131|NCT00702052|464106224|FG000|Overall Study|Adverse Event|23|||
128951132|NCT00702052|464106224|FG000|Overall Study|Disease Progression|30|||
128951133|NCT00702052|464106224|FG000|Overall Study|Withdrawal by Subject|5|||
128951134|NCT01577160|464106225|FG000|Overall Study|Adverse Event|9|||
128951135|NCT01577160|464106225|FG000|Overall Study|Lack of Efficacy|15|||
128951136|NCT01577160|464106225|FG000|Overall Study|Lost to Follow-up|40|||
128951137|NCT01577160|464106225|FG000|Overall Study|Withdrawal by Subject|18|||
128951138|NCT01577160|464106225|FG000|Overall Study|Subject Uncooperative|7|||
128951139|NCT01577160|464106225|FG000|Overall Study|Other|9|||
128951140|NCT01551758|464106226|FG000|Overall Study|Adverse Event|29|||
128951141|NCT01551758|464106227|FG001|Overall Study|Adverse Event|43|||
128951142|NCT01551758|464106226|FG000|Overall Study|Lack of Efficacy|0|||
128951143|NCT01551758|464106227|FG001|Overall Study|Lack of Efficacy|1|||
128951144|NCT01551758|464106226|FG000|Overall Study|Protocol Violation|5|||
128951145|NCT01551758|464106227|FG001|Overall Study|Protocol Violation|6|||
128951146|NCT01551758|464106226|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
128951147|NCT01551758|464106227|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
128951148|NCT01551758|464106226|FG000|Overall Study|Lost to Follow-up|29|||
128951149|NCT01551758|464106227|FG001|Overall Study|Lost to Follow-up|25|||
128951150|NCT01551758|464106226|FG000|Overall Study|Physician Decision|9|||
128951151|NCT01551758|464106227|FG001|Overall Study|Physician Decision|3|||
128951152|NCT01551758|464106226|FG000|Overall Study|Withdrawal by Subject|14|||
129125440|NCT03965923|464753631|FG000|Overall Study|Other reason|0|||
129125441|NCT03965923|464753632|FG001|Overall Study|Other reason|0|||
129125442|NCT03965923|464753633|FG002|Overall Study|Other reason|0|||
129125443|NCT03965923|464753634|FG003|Overall Study|Other reason|1|||
129125444|NCT03965923|464753635|FG004|Overall Study|Other reason|0|||
129125445|NCT03965923|464753636|FG005|Overall Study|Other reason|0|||
129125446|NCT03965923|464753637|FG006|Overall Study|Other reason|0|||
128951153|NCT01551758|464106227|FG001|Overall Study|Withdrawal by Subject|17|||
128951154|NCT00101192|464106228|FG000|Overall Study|Ineligible|6|||
128951155|NCT00101192|464106228|FG000|Overall Study|Inevaluable|1|||
128951156|NCT02618928|464106231|FG000|Overall Study|Failure to Return|28|||
128951157|NCT02618928|464106231|FG000|Overall Study|Insufficient Virological Response|1|||
128951158|NCT02618928|464106231|FG000|Overall Study|Withdrawal by Subject|2|||
128951159|NCT02618928|464106231|FG000|Overall Study|Death|3|||
128951160|NCT02618928|464106231|FG000|Overall Study|Other|11|||
129125447|NCT03965923|464753638|FG007|Overall Study|Other reason|0|||
128951161|NCT02618928|464106231|FG000|Overall Study|Missing|6|||
128951162|NCT02618928|464106231|FG000|Overall Study|Treatment Never Started|7|||
128951163|NCT00916370|464106234|FG000|Overall Study|Death|3|||
128951164|NCT00916370|464106235|FG001|Overall Study|Death|1|||
128770544|NCT02960763|463451546|FG001|Step 1|Withdrawal by Subject|8|||
129125448|NCT03965923|464753639|FG008|Overall Study|Other reason|0|||
128951165|NCT00916370|464106234|FG000|Overall Study|Withdrawal by Subject|2|||
128951166|NCT00916370|464106235|FG001|Overall Study|Withdrawal by Subject|0|||
129125449|NCT03965923|464753640|FG009|Overall Study|Other reason|0|||
129125450|NCT03965923|464753641|FG010|Overall Study|Other reason|2|||
128951167|NCT00916370|464106234|FG000|Overall Study|Physician Decision|0|||
128951168|NCT00916370|464106235|FG001|Overall Study|Physician Decision|1|||
128951169|NCT00717366|464106236|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
128951170|NCT00717366|464106237|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
128951171|NCT00717366|464106236|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
128951172|NCT00717366|464106237|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
128951173|NCT00717366|464106236|FG000|Core Study Period (20 Weeks)|Death|0|||
128951174|NCT00717366|464106237|FG001|Core Study Period (20 Weeks)|Death|1|||
128951175|NCT00717366|464106236|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
128951176|NCT00717366|464106237|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
129125451|NCT03965923|464753642|FG011|Overall Study|Other reason|0|||
128951177|NCT00717366|464106236|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
128951178|NCT00717366|464106237|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
128951179|NCT00717366|464106236|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
128951180|NCT00717366|464106237|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
128951181|NCT00717366|464106236|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
128951182|NCT00717366|464106237|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
128951183|NCT01317615|464106240|FG000|Overall Study|Disease progression|25|||
128951184|NCT01317615|464106240|FG000|Overall Study|New cancer therapy|5|||
128951185|NCT01317615|464106240|FG000|Overall Study|Death|6|||
128951186|NCT01317615|464106240|FG000|Overall Study|Withdrawal by Subject|5|||
128951187|NCT01317615|464106240|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128951188|NCT01317615|464106240|FG000|Overall Study|Adverse Event|7|||
128951189|NCT00438399|464106243|FG000|Overall Study|Lost to Follow-up|2|||
128951190|NCT00438399|464106244|FG001|Overall Study|Lost to Follow-up|2|||
128951191|NCT00438399|464106245|FG002|Overall Study|Lost to Follow-up|1|||
128951192|NCT00438399|464106246|FG003|Overall Study|Lost to Follow-up|1|||
128951193|NCT00438399|464106247|FG004|Overall Study|Lost to Follow-up|1|||
128951194|NCT00438399|464106248|FG005|Overall Study|Lost to Follow-up|1|||
128951195|NCT00438399|464106243|FG000|Overall Study|Adverse Event|0|||
128951196|NCT00438399|464106244|FG001|Overall Study|Adverse Event|0|||
128951197|NCT00438399|464106245|FG002|Overall Study|Adverse Event|1|||
128951198|NCT00438399|464106246|FG003|Overall Study|Adverse Event|1|||
128951199|NCT00438399|464106247|FG004|Overall Study|Adverse Event|0|||
128951200|NCT00438399|464106248|FG005|Overall Study|Adverse Event|1|||
128951201|NCT00438399|464106243|FG000|Overall Study|Withdrawal by Subject|5|||
128951202|NCT00438399|464106244|FG001|Overall Study|Withdrawal by Subject|6|||
128951203|NCT00438399|464106245|FG002|Overall Study|Withdrawal by Subject|3|||
128951204|NCT00438399|464106246|FG003|Overall Study|Withdrawal by Subject|2|||
128951205|NCT00438399|464106247|FG004|Overall Study|Withdrawal by Subject|2|||
128951206|NCT00438399|464106248|FG005|Overall Study|Withdrawal by Subject|2|||
128951207|NCT00438399|464106243|FG000|Overall Study|Protocol Violation|0|||
128951208|NCT00438399|464106244|FG001|Overall Study|Protocol Violation|0|||
128951209|NCT00438399|464106245|FG002|Overall Study|Protocol Violation|1|||
128951210|NCT00438399|464106246|FG003|Overall Study|Protocol Violation|0|||
128951211|NCT00438399|464106247|FG004|Overall Study|Protocol Violation|0|||
128951212|NCT00438399|464106248|FG005|Overall Study|Protocol Violation|1|||
128951213|NCT00438399|464106243|FG000|Overall Study|Subje stopped study|0|||
128951214|NCT00438399|464106244|FG001|Overall Study|Subje stopped study|0|||
128951215|NCT00438399|464106245|FG002|Overall Study|Subje stopped study|1|||
128951216|NCT00438399|464106246|FG003|Overall Study|Subje stopped study|0|||
128951217|NCT00438399|464106247|FG004|Overall Study|Subje stopped study|0|||
128951218|NCT00438399|464106248|FG005|Overall Study|Subje stopped study|0|||
128951219|NCT00438399|464106243|FG000|Overall Study|Pregnancy|0|||
128951220|NCT00438399|464106244|FG001|Overall Study|Pregnancy|0|||
128951221|NCT00438399|464106245|FG002|Overall Study|Pregnancy|0|||
128951222|NCT00438399|464106246|FG003|Overall Study|Pregnancy|0|||
128951223|NCT00438399|464106247|FG004|Overall Study|Pregnancy|0|||
128951224|NCT00438399|464106248|FG005|Overall Study|Pregnancy|1|||
128951225|NCT00438399|464106243|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
128951226|NCT00438399|464106244|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
128951227|NCT00438399|464106245|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
128951228|NCT00438399|464106246|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
128951229|NCT00438399|464106247|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
129125452|NCT04221490|464753643|FG000|At 30 Days Follow-up|Death|7|||
129125453|NCT04221490|464753643|FG000|At 30 Days Follow-up|Missed Visit|4|||
129125454|NCT04221490|464753643|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
128951230|NCT00438399|464106248|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
128951231|NCT00632541|464106251|FG000|Overall Study|Adverse Event|7|||
128951232|NCT01842607|464106253|FG000|Overall Study|Adverse Event|11|||
128951233|NCT01842607|464106253|FG000|Overall Study|Lack of Efficacy|19|||
128951234|NCT01842607|464106253|FG000|Overall Study|Protocol Violation|8|||
128951235|NCT01842607|464106253|FG000|Overall Study|Protocol defined stopping criteria|2|||
128951236|NCT01842607|464106253|FG000|Overall Study|Lost to Follow-up|3|||
128951237|NCT01842607|464106253|FG000|Overall Study|Physician Decision|9|||
128951238|NCT01842607|464106253|FG000|Overall Study|Withdrawal by Subject|14|||
128951239|NCT00393913|464106254|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
128951240|NCT00393913|464106254|FG000|Initial Assessment|Withdrawal by Subject|16|||
128951241|NCT00393913|464106254|FG000|CPAP|Withdrawal by Subject|3|||
128951242|NCT00393913|464106254|FG000|CPAP|Physician Decision|1|||
128951243|NCT00393913|464106254|FG000|CPAP|TEchnical problem with CPAP|3|||
128951244|NCT01927419|464106255|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
128951245|NCT01927419|464106256|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
128951246|NCT01927419|464106255|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
128951247|NCT01927419|464106256|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
128951248|NCT01927419|464106255|FG000|Treatment Period|Disease progression|17|||
128951249|NCT01927419|464106256|FG001|Treatment Period|Disease progression|20|||
128951250|NCT01927419|464106255|FG000|Treatment Period|Study drug toxicity|48|||
128951251|NCT01927419|464106256|FG001|Treatment Period|Study drug toxicity|10|||
128951252|NCT01927419|464106255|FG000|Treatment Period|Death|0|||
128951253|NCT01927419|464106256|FG001|Treatment Period|Death|1|||
128951254|NCT01927419|464106255|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
128951255|NCT01927419|464106256|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
128951256|NCT01927419|464106255|FG000|Treatment Period|Participant request to discontinue|12|||
128951257|NCT01927419|464106256|FG001|Treatment Period|Participant request to discontinue|4|||
128951258|NCT01927419|464106255|FG000|Treatment Period|Withdrawal by Subject|1|||
128951259|NCT01927419|464106256|FG001|Treatment Period|Withdrawal by Subject|1|||
128951260|NCT01927419|464106255|FG000|Treatment Period|Maximum Clinical Benefit|6|||
128951261|NCT01927419|464106256|FG001|Treatment Period|Maximum Clinical Benefit|2|||
128951262|NCT01927419|464106255|FG000|Treatment Period|Other reasons|3|||
128951263|NCT01927419|464106256|FG001|Treatment Period|Other reasons|4|||
128951264|NCT01927419|464106255|FG000|Treatment Period|Not Reported|1|||
128951265|NCT01927419|464106256|FG001|Treatment Period|Not Reported|1|||
128951266|NCT03488251|464106257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
128951267|NCT03488251|464106258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
128951268|NCT03488251|464106259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
128951269|NCT03488251|464106260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
128951270|NCT03488251|464106257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
129219030|NCT01578486|465101687|FG000|Overall Study|Physician Decision|3|||
129219031|NCT01578486|465101687|FG000|Overall Study|Withdrawal by Subject|2|||
129219032|NCT02536963|465101688|FG000|Overall Study|Withdrawal by Subject|18|||
129219033|NCT02668393|465101690|FG000|Overall Study|Progressive disease|6|||
129219034|NCT02668393|465101691|FG001|Overall Study|Progressive disease|3|||
129219035|NCT02668393|465101690|FG000|Overall Study|Adverse Event|0|||
129219036|NCT02668393|465101691|FG001|Overall Study|Adverse Event|2|||
129219037|NCT02668393|465101690|FG000|Overall Study|Withdrawal from the trial|0|||
129219038|NCT02668393|465101691|FG001|Overall Study|Withdrawal from the trial|1|||
129219039|NCT02668393|465101690|FG000|Overall Study|Lack of benefit and side effects|1|||
129219040|NCT02668393|465101691|FG001|Overall Study|Lack of benefit and side effects|0|||
129219041|NCT02141204|465101692|FG000|Overall Study|Lost to Follow-up|2|||
129219042|NCT02141204|465101693|FG001|Overall Study|Lost to Follow-up|1|||
129219043|NCT02141204|465101692|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
129219044|NCT02141204|465101693|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
129219045|NCT02141204|465101692|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
129219046|NCT02141204|465101693|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
129219047|NCT02141204|465101692|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
129219048|NCT02141204|465101693|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
129219049|NCT00607373|465101694|FG000|Treatment Period|Adverse Event|0|||
129219050|NCT00607373|465101695|FG001|Treatment Period|Adverse Event|4|||
129219051|NCT00607373|465101694|FG000|Treatment Period|Physician Decision|0|||
129219052|NCT00607373|465101695|FG001|Treatment Period|Physician Decision|1|||
129219053|NCT00607373|465101694|FG000|Treatment Period|Withdrawal by Subject|0|||
129219054|NCT00607373|465101695|FG001|Treatment Period|Withdrawal by Subject|1|||
129219055|NCT00607373|465101694|FG000|Follow-up Period|Other|0|||
129219056|NCT00607373|465101695|FG001|Follow-up Period|Other|1|||
128710869|NCT03527966|463237731|FG000|Overall Study|Lost to Follow-up|3|||
128710870|NCT03527966|463237732|FG001|Overall Study|Lost to Follow-up|0|||
128951271|NCT03488251|464106258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
128951272|NCT03488251|464106259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
129219057|NCT00607373|465101694|FG000|Follow-up Period|Protocol Violation|0|||
129219058|NCT00607373|465101695|FG001|Follow-up Period|Protocol Violation|1|||
129219059|NCT00607373|465101694|FG000|Follow-up Period|Withdrawal by Subject|1|||
129219060|NCT00607373|465101695|FG001|Follow-up Period|Withdrawal by Subject|3|||
129219061|NCT02170077|465101696|FG000|Overall Study|Withdrawal by Subject|3|||
128951273|NCT03488251|464106260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
129219062|NCT02170077|465101697|FG001|Overall Study|Withdrawal by Subject|4|||
128710871|NCT00558025|463237733|FG000|Overall Study|Adverse Event|1|||
128710872|NCT00558025|463237734|FG001|Overall Study|Adverse Event|1|||
129034937|NCT01235715|464418340|FG001|Overall Study|Physician Decision|2|||
129219063|NCT02170077|465101698|FG002|Overall Study|Withdrawal by Subject|2|||
129219064|NCT02170077|465101696|FG000|Overall Study|Adverse Event|4|||
129219065|NCT02170077|465101697|FG001|Overall Study|Adverse Event|4|||
129219066|NCT02170077|465101698|FG002|Overall Study|Adverse Event|4|||
129219067|NCT02170077|465101696|FG000|Overall Study|Lost to Follow-up|0|||
129219068|NCT02170077|465101697|FG001|Overall Study|Lost to Follow-up|1|||
129219069|NCT02170077|465101698|FG002|Overall Study|Lost to Follow-up|0|||
129219070|NCT02170077|465101696|FG000|Overall Study|Exclusion criteria|2|||
129219071|NCT02170077|465101697|FG001|Overall Study|Exclusion criteria|2|||
129219072|NCT02170077|465101698|FG002|Overall Study|Exclusion criteria|5|||
129219073|NCT02170077|465101696|FG000|Overall Study|Exacerbation of seizures|0|||
129219074|NCT02170077|465101697|FG001|Overall Study|Exacerbation of seizures|2|||
129219075|NCT02170077|465101698|FG002|Overall Study|Exacerbation of seizures|1|||
129219076|NCT01780974|465101701|FG000|Overall Study|Death|1|||
129219077|NCT01780974|465101702|FG001|Overall Study|Death|0|||
129219078|NCT01780974|465101701|FG000|Overall Study|Adverse Event|1|||
129219079|NCT01780974|465101702|FG001|Overall Study|Adverse Event|3|||
129219080|NCT01724346|465101703|FG000|Overall Study|Death|42|||
129219081|NCT01724346|465101704|FG001|Overall Study|Death|42|||
129219082|NCT01724346|465101703|FG000|Overall Study|Lost to Follow-up|5|||
129219083|NCT01724346|465101704|FG001|Overall Study|Lost to Follow-up|1|||
129219084|NCT01724346|465101703|FG000|Overall Study|Withdrawal by Subject|27|||
129219085|NCT01724346|465101704|FG001|Overall Study|Withdrawal by Subject|19|||
129219086|NCT01724346|465101703|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
129219087|NCT01724346|465101704|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
129219088|NCT02876601|465101705|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
129219089|NCT02876601|465101706|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
129219090|NCT02876601|465101707|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
129219091|NCT02876601|465101708|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
129219092|NCT00256997|465101709|FG000|Overall Study|Protocol Violation|1|||
129219093|NCT00256997|465101710|FG001|Overall Study|Protocol Violation|4|||
129219094|NCT00256997|465101709|FG000|Overall Study|Lack of Efficacy|1|||
129219095|NCT00256997|465101710|FG001|Overall Study|Lack of Efficacy|4|||
129219096|NCT00256997|465101709|FG000|Overall Study|Death|2|||
129219097|NCT00256997|465101710|FG001|Overall Study|Death|0|||
128710873|NCT00558025|463237733|FG000|Overall Study|Withdrawal by Subject|2|||
128710874|NCT00558025|463237734|FG001|Overall Study|Withdrawal by Subject|2|||
129125455|NCT04221490|464753643|FG000|At 6 Months Follow-up|Death|9|||
129125456|NCT04221490|464753643|FG000|At 6 Months Follow-up|Physician Decision|1|||
129125457|NCT04221490|464753643|FG000|At 6 Months Follow-up|Missed Visit|8|||
129125458|NCT04221490|464753643|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
129125459|NCT03034967|464753644|FG000|Overall Study|Withdrawal by Subject|9|||
129125460|NCT03034967|464753645|FG001|Overall Study|Withdrawal by Subject|2|||
129125461|NCT03034967|464753646|FG002|Overall Study|Withdrawal by Subject|6|||
129125462|NCT03034967|464753647|FG003|Overall Study|Withdrawal by Subject|6|||
129125463|NCT03034967|464753648|FG004|Overall Study|Withdrawal by Subject|9|||
129125464|NCT03034967|464753649|FG005|Overall Study|Withdrawal by Subject|2|||
129125465|NCT03034967|464753644|FG000|Overall Study|Physician Decision|1|||
129125466|NCT03034967|464753645|FG001|Overall Study|Physician Decision|0|||
129125467|NCT03034967|464753646|FG002|Overall Study|Physician Decision|1|||
129125468|NCT03034967|464753647|FG003|Overall Study|Physician Decision|1|||
129125469|NCT03034967|464753648|FG004|Overall Study|Physician Decision|1|||
129125470|NCT03034967|464753649|FG005|Overall Study|Physician Decision|0|||
129125471|NCT03034967|464753644|FG000|Overall Study|Lost to Follow-up|0|||
129125472|NCT03034967|464753645|FG001|Overall Study|Lost to Follow-up|0|||
129125473|NCT03034967|464753646|FG002|Overall Study|Lost to Follow-up|0|||
129125474|NCT03034967|464753647|FG003|Overall Study|Lost to Follow-up|1|||
129125475|NCT03034967|464753648|FG004|Overall Study|Lost to Follow-up|0|||
129125476|NCT03034967|464753649|FG005|Overall Study|Lost to Follow-up|2|||
129125477|NCT03034967|464753644|FG000|Overall Study|Liver function test abnormality|0|||
129125478|NCT03034967|464753645|FG001|Overall Study|Liver function test abnormality|0|||
129125479|NCT03034967|464753646|FG002|Overall Study|Liver function test abnormality|1|||
129125480|NCT03034967|464753647|FG003|Overall Study|Liver function test abnormality|0|||
129125481|NCT03034967|464753648|FG004|Overall Study|Liver function test abnormality|0|||
129125482|NCT03034967|464753649|FG005|Overall Study|Liver function test abnormality|0|||
129125483|NCT03034967|464753644|FG000|Overall Study|Protocol Violation|1|||
129219098|NCT00256997|465101709|FG000|Overall Study|Adverse Event|4|||
129125484|NCT03034967|464753645|FG001|Overall Study|Protocol Violation|0|||
129125485|NCT03034967|464753646|FG002|Overall Study|Protocol Violation|0|||
129125486|NCT03034967|464753647|FG003|Overall Study|Protocol Violation|0|||
129219099|NCT00256997|465101710|FG001|Overall Study|Adverse Event|0|||
128710875|NCT00558025|463237733|FG000|Overall Study|Protocol Violation|1|||
129219100|NCT00256997|465101709|FG000|Overall Study|Lost to Follow-up|3|||
129219101|NCT00256997|465101710|FG001|Overall Study|Lost to Follow-up|5|||
129219102|NCT00256997|465101709|FG000|Overall Study|Withdrawal by Subject|13|||
129125487|NCT03034967|464753648|FG004|Overall Study|Protocol Violation|0|||
129125488|NCT03034967|464753649|FG005|Overall Study|Protocol Violation|2|||
128710876|NCT00558025|463237734|FG001|Overall Study|Protocol Violation|0|||
128951274|NCT03488251|464106257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
128951275|NCT03488251|464106258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
128951276|NCT03488251|464106259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
128951277|NCT03488251|464106260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
128951278|NCT03488251|464106257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
128951279|NCT03488251|464106258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
128951280|NCT03488251|464106259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
128951281|NCT03488251|464106260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
128951282|NCT03488251|464106257|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
128951283|NCT03488251|464106258|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
128951284|NCT03488251|464106259|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
128951285|NCT03488251|464106260|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
128951286|NCT00592553|464106266|FG000|Overall Study|Protocol Noncompliance|1|||
128951287|NCT00592553|464106267|FG001|Overall Study|Protocol Noncompliance|0|||
128951288|NCT00592553|464106268|FG002|Overall Study|Protocol Noncompliance|0|||
128951289|NCT02379390|464106271|FG000|Overall Study|Adverse Event|1|||
128951290|NCT02379390|464106272|FG001|Overall Study|Adverse Event|1|||
128951291|NCT02379390|464106271|FG000|Overall Study|Investigator's decision|1|||
128951292|NCT02379390|464106272|FG001|Overall Study|Investigator's decision|0|||
128951293|NCT02379390|464106271|FG000|Overall Study|Study Termination|0|||
128951294|NCT02379390|464106272|FG001|Overall Study|Study Termination|1|||
128951295|NCT01244191|464106273|FG000|Overall Study|Progressive disease|295|||
128951296|NCT01244191|464106274|FG001|Overall Study|Progressive disease|350|||
128951297|NCT01244191|464106273|FG000|Overall Study|Clinical disease progression|54|||
128951298|NCT01244191|464106274|FG001|Overall Study|Clinical disease progression|36|||
128951299|NCT01244191|464106273|FG000|Overall Study|Adverse Event|65|||
128951300|NCT01244191|464106274|FG001|Overall Study|Adverse Event|48|||
128951301|NCT01244191|464106273|FG000|Overall Study|Death|22|||
128951302|NCT01244191|464106274|FG001|Overall Study|Death|29|||
128951303|NCT01244191|464106273|FG000|Overall Study|Lost to Follow-up|0|||
128951304|NCT01244191|464106274|FG001|Overall Study|Lost to Follow-up|2|||
129125489|NCT03034967|464753644|FG000|Overall Study|Lack of Efficacy|0|||
129125490|NCT03034967|464753645|FG001|Overall Study|Lack of Efficacy|1|||
128951305|NCT01244191|464106273|FG000|Overall Study|Protocol Violation|1|||
128951306|NCT01244191|464106274|FG001|Overall Study|Protocol Violation|2|||
128951307|NCT01244191|464106273|FG000|Overall Study|Withdrawal by Subject|31|||
128951308|NCT01244191|464106274|FG001|Overall Study|Withdrawal by Subject|23|||
128951309|NCT01244191|464106273|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
128951310|NCT01244191|464106274|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
128951311|NCT01511107|464106276|FG000|Overall Study|Ineligible|3|||
128951312|NCT01511107|464106277|FG001|Overall Study|Ineligible|2|||
128951313|NCT01511107|464106276|FG000|Overall Study|Lost to Follow-up|10|||
128951314|NCT01511107|464106277|FG001|Overall Study|Lost to Follow-up|19|||
128951315|NCT01511107|464106276|FG000|Overall Study|Withdrawal by Subject|9|||
128951316|NCT01511107|464106277|FG001|Overall Study|Withdrawal by Subject|20|||
128951317|NCT01830816|464108682|FG000|Overall Study|Progressive Disease|12|||
128951318|NCT01830816|464108683|FG001|Overall Study|Progressive Disease|7|||
128951319|NCT01830816|464108684|FG002|Overall Study|Progressive Disease|7|||
128951320|NCT01830816|464108682|FG000|Overall Study|Adverse Event|3|||
128951321|NCT01830816|464108683|FG001|Overall Study|Adverse Event|4|||
128951322|NCT01830816|464108684|FG002|Overall Study|Adverse Event|0|||
128951323|NCT01830816|464108682|FG000|Overall Study|Study Terminated by Sponsor|1|||
128951324|NCT01830816|464108683|FG001|Overall Study|Study Terminated by Sponsor|1|||
128951325|NCT01830816|464108684|FG002|Overall Study|Study Terminated by Sponsor|0|||
128951326|NCT01830816|464108682|FG000|Overall Study|Withdrawal by Subject|1|||
128951327|NCT01830816|464108683|FG001|Overall Study|Withdrawal by Subject|1|||
128951328|NCT01830816|464108684|FG002|Overall Study|Withdrawal by Subject|0|||
128951329|NCT01830816|464108682|FG000|Overall Study|Lost to Follow-up|0|||
128951330|NCT01830816|464108683|FG001|Overall Study|Lost to Follow-up|1|||
128951331|NCT01830816|464108684|FG002|Overall Study|Lost to Follow-up|0|||
129125491|NCT03034967|464753646|FG002|Overall Study|Lack of Efficacy|2|||
129125492|NCT03034967|464753647|FG003|Overall Study|Lack of Efficacy|1|||
129125493|NCT03034967|464753648|FG004|Overall Study|Lack of Efficacy|1|||
128951332|NCT01830816|464108682|FG000|Overall Study|Symptomatic Deterioration|1|||
129125494|NCT03034967|464753649|FG005|Overall Study|Lack of Efficacy|0|||
129125495|NCT03034967|464753644|FG000|Overall Study|Adverse Event, non-fatal|3|||
129125496|NCT03034967|464753645|FG001|Overall Study|Adverse Event, non-fatal|1|||
128951333|NCT01830816|464108683|FG001|Overall Study|Symptomatic Deterioration|0|||
128951334|NCT01830816|464108684|FG002|Overall Study|Symptomatic Deterioration|0|||
128951335|NCT01830816|464108682|FG000|Overall Study|Reason not Specified|2|||
128951336|NCT01830816|464108683|FG001|Overall Study|Reason not Specified|0|||
128951337|NCT01830816|464108684|FG002|Overall Study|Reason not Specified|0|||
128951338|NCT00363051|464108685|FG000|Overall Study|Adminstrative problems|1|||
128951339|NCT00363051|464108686|FG001|Overall Study|Adminstrative problems|1|||
128710877|NCT02746874|463237736|FG000|Overall Study|Withdrawal by Subject|0|||
128710878|NCT02746874|463237737|FG001|Overall Study|Withdrawal by Subject|1|||
128710879|NCT02746874|463237736|FG000|Overall Study|Surgery Date Changed|0|||
128710880|NCT02746874|463237737|FG001|Overall Study|Surgery Date Changed|2|||
128710881|NCT00487747|463237742|FG000|Overall Study|Adverse Event|1|||
128710882|NCT00487747|463237742|FG000|Overall Study|Lost to Follow-up|9|||
128710883|NCT00487747|463237742|FG000|Overall Study|Lack of Efficacy|1|||
128710884|NCT00276159|463237743|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
128710885|NCT00333866|463237744|FG000|Overall Study|Adverse Event|23|||
128951340|NCT00363051|464108685|FG000|Overall Study|Adverse Event|21|||
128951341|NCT00363051|464108686|FG001|Overall Study|Adverse Event|12|||
128951342|NCT00363051|464108685|FG000|Overall Study|New Cancer Therapy|2|||
128951343|NCT00363051|464108686|FG001|Overall Study|New Cancer Therapy|1|||
128710886|NCT00333866|463237745|FG001|Overall Study|Adverse Event|37|||
128710887|NCT00333866|463237746|FG002|Overall Study|Adverse Event|38|||
128710888|NCT00333866|463237747|FG003|Overall Study|Adverse Event|47|||
128710889|NCT00333866|463237744|FG000|Overall Study|Other|3|||
128710890|NCT00333866|463237745|FG001|Overall Study|Other|2|||
128710891|NCT00333866|463237746|FG002|Overall Study|Other|2|||
128710892|NCT00333866|463237747|FG003|Overall Study|Other|2|||
128710893|NCT00333866|463237744|FG000|Overall Study|Lack of Efficacy|8|||
128710894|NCT00333866|463237745|FG001|Overall Study|Lack of Efficacy|6|||
128710895|NCT00333866|463237746|FG002|Overall Study|Lack of Efficacy|3|||
128710896|NCT00333866|463237747|FG003|Overall Study|Lack of Efficacy|5|||
128710897|NCT00333866|463237744|FG000|Overall Study|Lost to Follow-up|1|||
128710898|NCT00333866|463237745|FG001|Overall Study|Lost to Follow-up|2|||
128710899|NCT00333866|463237746|FG002|Overall Study|Lost to Follow-up|2|||
128710900|NCT00333866|463237747|FG003|Overall Study|Lost to Follow-up|2|||
128710901|NCT00333866|463237744|FG000|Overall Study|Withdrawal by Subject|8|||
128710902|NCT00333866|463237745|FG001|Overall Study|Withdrawal by Subject|14|||
128710903|NCT00333866|463237746|FG002|Overall Study|Withdrawal by Subject|4|||
128710904|NCT00333866|463237747|FG003|Overall Study|Withdrawal by Subject|9|||
128710905|NCT00333866|463237744|FG000|Overall Study|Randomized but not Treated|5|||
128710906|NCT00333866|463237745|FG001|Overall Study|Randomized but not Treated|3|||
128710907|NCT00333866|463237746|FG002|Overall Study|Randomized but not Treated|2|||
128710908|NCT00333866|463237747|FG003|Overall Study|Randomized but not Treated|1|||
128710909|NCT02393547|463237759|FG000|Overall Study|Adverse Event|2|||
128710910|NCT02393547|463237759|FG000|Overall Study|Withdrawal by Subject|3|||
128710911|NCT02393547|463237759|FG000|Overall Study|Lost to Follow-up|1|||
128710912|NCT02927431|463237760|FG000|Overall Study|Withdrawal by Subject|0|||
128710913|NCT02927431|463237761|FG001|Overall Study|Withdrawal by Subject|0|||
128951344|NCT00363051|464108685|FG000|Overall Study|Withdrawal by Subject|11|||
128951345|NCT00363051|464108686|FG001|Overall Study|Withdrawal by Subject|3|||
128951346|NCT00363051|464108685|FG000|Overall Study|Lost to Follow-up|0|||
128951347|NCT00363051|464108686|FG001|Overall Study|Lost to Follow-up|1|||
128951348|NCT00363051|464108685|FG000|Overall Study|Protocol Violation|0|||
128951349|NCT00363051|464108686|FG001|Overall Study|Protocol Violation|2|||
128951350|NCT00363051|464108685|FG000|Overall Study|Death|3|||
128951351|NCT00363051|464108686|FG001|Overall Study|Death|2|||
128951352|NCT00830115|464108689|FG000|Overall Study|Adverse Event|2|||
128951353|NCT00830115|464108689|FG000|Overall Study|Improvement/recovery|1|||
128951354|NCT01207388|464108697|FG000|Overall Study|Death|67|||
128951355|NCT01207388|464108697|FG000|Overall Study|Withdrawal by Subject|1|||
129125497|NCT03034967|464753646|FG002|Overall Study|Adverse Event, non-fatal|2|||
129125498|NCT03034967|464753647|FG003|Overall Study|Adverse Event, non-fatal|0|||
129125499|NCT03034967|464753648|FG004|Overall Study|Adverse Event, non-fatal|2|||
129125500|NCT03034967|464753649|FG005|Overall Study|Adverse Event, non-fatal|8|||
129125501|NCT03034967|464753644|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
129125502|NCT03034967|464753645|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
129125503|NCT03034967|464753646|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
129125504|NCT03034967|464753647|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
129125505|NCT03034967|464753648|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
129125506|NCT03034967|464753649|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
129125507|NCT04225039|464753656|FG000|Overall Study|Withdrawal by Subject|1|||
129125508|NCT04225039|464753657|FG001|Overall Study|Withdrawal by Subject|0|||
129125509|NCT04225039|464753658|FG002|Overall Study|Withdrawal by Subject|0|||
129125510|NCT04225039|464753659|FG003|Overall Study|Withdrawal by Subject|1|||
129125511|NCT04225039|464753656|FG000|Overall Study|Currently active on study treatment|0|||
129125512|NCT04225039|464753657|FG001|Overall Study|Currently active on study treatment|1|||
129125513|NCT04225039|464753658|FG002|Overall Study|Currently active on study treatment|0|||
129125514|NCT04225039|464753659|FG003|Overall Study|Currently active on study treatment|0|||
128710914|NCT02927431|463237762|FG002|Overall Study|Withdrawal by Subject|1|||
128770545|NCT02960763|463451547|FG002|Step 1|Withdrawal by Subject|13|||
128951356|NCT01885078|464108698|FG000|Treatment Period|Adverse Event|52|||
128951357|NCT01885078|464108699|FG001|Treatment Period|Adverse Event|136|||
128951358|NCT01885078|464108700|FG002|Treatment Period|Adverse Event|30|||
128951359|NCT01885078|464108701|FG003|Treatment Period|Adverse Event|73|||
128951360|NCT01885078|464108702|FG004|Treatment Period|Adverse Event|17|||
128951361|NCT01885078|464108703|FG005|Treatment Period|Adverse Event|72|||
128951362|NCT01885078|464108704|FG006|Treatment Period|Adverse Event|24|||
128951363|NCT01885078|464108705|FG007|Treatment Period|Adverse Event|5|||
128951364|NCT01885078|464108706|FG008|Treatment Period|Adverse Event|0|||
128951365|NCT01885078|464108707|FG009|Treatment Period|Adverse Event|0|||
128951366|NCT01885078|464108698|FG000|Treatment Period|Death|13|||
128951367|NCT01885078|464108699|FG001|Treatment Period|Death|33|||
128951368|NCT01885078|464108700|FG002|Treatment Period|Death|5|||
128951369|NCT01885078|464108701|FG003|Treatment Period|Death|9|||
128951370|NCT01885078|464108702|FG004|Treatment Period|Death|2|||
128951371|NCT01885078|464108703|FG005|Treatment Period|Death|10|||
128951372|NCT01885078|464108704|FG006|Treatment Period|Death|3|||
128951373|NCT01885078|464108705|FG007|Treatment Period|Death|2|||
128951374|NCT01885078|464108706|FG008|Treatment Period|Death|0|||
128951375|NCT01885078|464108707|FG009|Treatment Period|Death|0|||
128951376|NCT01885078|464108698|FG000|Treatment Period|Lack of Efficacy|12|||
128951377|NCT01885078|464108699|FG001|Treatment Period|Lack of Efficacy|33|||
128951378|NCT01885078|464108700|FG002|Treatment Period|Lack of Efficacy|10|||
129125515|NCT04225039|464753656|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
129125516|NCT04225039|464753657|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
129125517|NCT04225039|464753658|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
129125518|NCT04225039|464753659|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
129125519|NCT04225039|464753656|FG000|Overall Study|Ineligible for treatment|0|||
129125520|NCT04225039|464753657|FG001|Overall Study|Ineligible for treatment|0|||
129125521|NCT04225039|464753658|FG002|Overall Study|Ineligible for treatment|0|||
129125522|NCT04225039|464753659|FG003|Overall Study|Ineligible for treatment|4|||
129125523|NCT02879695|464753662|FG000|Overall Study|Did not start study treatment|2|||
129125524|NCT02879695|464753663|FG001|Overall Study|Did not start study treatment|0|||
129125525|NCT02879695|464753664|FG002|Overall Study|Did not start study treatment|3|||
129125526|NCT02879695|464753665|FG003|Overall Study|Did not start study treatment|0|||
129125527|NCT05523297|464753670|FG000|Overall Study|Death|7|||
129125528|NCT05523297|464753671|FG001|Overall Study|Death|8|||
129125529|NCT05523297|464753670|FG000|Overall Study|Lost to Follow-up|2|||
129125530|NCT05523297|464753671|FG001|Overall Study|Lost to Follow-up|1|||
129125531|NCT03462680|464753672|FG000|Overall Study|Withdrawal by Subject|3|||
129125532|NCT03462680|464753673|FG001|Overall Study|Withdrawal by Subject|5|||
129125533|NCT02246777|464753674|FG000|Overall Study|Adverse Event|2|||
129125534|NCT02246777|464753674|FG000|Overall Study|Change of residence|1|||
129125535|NCT04133909|464753675|FG000|Overall Study|Death|11|||
129125536|NCT04133909|464753676|FG001|Overall Study|Death|11|||
129125537|NCT04133909|464753675|FG000|Overall Study|Adverse Event|4|||
129125538|NCT04133909|464753676|FG001|Overall Study|Adverse Event|5|||
129125539|NCT04133909|464753675|FG000|Overall Study|Lost to Follow-up|3|||
129125540|NCT04133909|464753676|FG001|Overall Study|Lost to Follow-up|5|||
129125541|NCT04133909|464753675|FG000|Overall Study|Physician Decision|4|||
129125542|NCT04133909|464753676|FG001|Overall Study|Physician Decision|7|||
129125543|NCT04133909|464753675|FG000|Overall Study|Withdrawal by Subject|40|||
129125544|NCT04133909|464753676|FG001|Overall Study|Withdrawal by Subject|35|||
129125545|NCT04133909|464753675|FG000|Overall Study|Lack of Efficacy|2|||
129125546|NCT04133909|464753676|FG001|Overall Study|Lack of Efficacy|7|||
129125547|NCT04133909|464753675|FG000|Overall Study|Randomized in error|1|||
129125548|NCT04133909|464753676|FG001|Overall Study|Randomized in error|1|||
129125549|NCT04817410|464755478|FG000|Overall Study|Withdrawal by Subject|5|||
129125550|NCT04817410|464755478|FG000|Overall Study|Physician Decision|3|||
129125551|NCT03595748|464755479|FG000|Overall Study|Death|11|||
129125552|NCT03595748|464755480|FG001|Overall Study|Death|12|||
129125553|NCT03595748|464755479|FG000|Overall Study|Withdrawal by Subject|28|||
129125554|NCT03595748|464755480|FG001|Overall Study|Withdrawal by Subject|29|||
129125555|NCT03595748|464755479|FG000|Overall Study|Protocol Violation|0|||
129125556|NCT03595748|464755480|FG001|Overall Study|Protocol Violation|1|||
129125557|NCT04809974|464755482|FG000|Lead-in Phase|Withdrawal by Subject|3|||
129125558|NCT04809974|464755483|FG001|Lead-in Phase|Withdrawal by Subject|0|||
129125559|NCT04809974|464755484|FG002|Lead-in Phase|Withdrawal by Subject|0|||
129125560|NCT04809974|464755482|FG000|Lead-in Phase|No longer eligible|11|||
129125561|NCT04809974|464755483|FG001|Lead-in Phase|No longer eligible|0|||
129125562|NCT04809974|464755484|FG002|Lead-in Phase|No longer eligible|0|||
129125563|NCT04809974|464755482|FG000|Randomized Phase|Lost to Follow-up|0|||
128951379|NCT01885078|464108701|FG003|Treatment Period|Lack of Efficacy|23|||
128951380|NCT01885078|464108702|FG004|Treatment Period|Lack of Efficacy|24|||
128951381|NCT01885078|464108703|FG005|Treatment Period|Lack of Efficacy|58|||
128951382|NCT01885078|464108704|FG006|Treatment Period|Lack of Efficacy|9|||
128951383|NCT01885078|464108705|FG007|Treatment Period|Lack of Efficacy|5|||
128951384|NCT01885078|464108706|FG008|Treatment Period|Lack of Efficacy|0|||
128951385|NCT01885078|464108707|FG009|Treatment Period|Lack of Efficacy|0|||
129125564|NCT04809974|464755483|FG001|Randomized Phase|Lost to Follow-up|1|||
129125565|NCT04809974|464755484|FG002|Randomized Phase|Lost to Follow-up|5|||
129125566|NCT04809974|464755482|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
128710915|NCT00673465|463237765|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710916|NCT00673465|463237766|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710917|NCT00673465|463237767|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710918|NCT00673465|463237768|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710919|NCT00673465|463237769|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
128710920|NCT00673465|463237770|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
128710921|NCT00673465|463237771|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710922|NCT00673465|463237772|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710923|NCT00673465|463237773|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710924|NCT00673465|463237774|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710925|NCT00673465|463237775|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710926|NCT00673465|463237776|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
128710927|NCT00673465|463237765|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710928|NCT00673465|463237766|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710929|NCT00673465|463237767|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710930|NCT00673465|463237768|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710931|NCT00673465|463237769|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
128710932|NCT00673465|463237770|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710933|NCT00673465|463237771|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710934|NCT00673465|463237772|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710935|NCT00673465|463237773|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710936|NCT00673465|463237774|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710937|NCT00673465|463237775|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710938|NCT00673465|463237776|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
128710939|NCT00429104|463237777|FG000|Overall Study|Protocol Violation|1|||
128710940|NCT01829191|463237778|FG000|Overall Study|Relocation|0|||
128710941|NCT01829191|463237779|FG001|Overall Study|Relocation|1|||
128710942|NCT01829191|463237778|FG000|Overall Study|Lens discomfort|0|||
128710943|NCT01829191|463237779|FG001|Overall Study|Lens discomfort|3|||
128710944|NCT01829191|463237778|FG000|Overall Study|Lens handling difficulty|1|||
128710945|NCT01829191|463237779|FG001|Overall Study|Lens handling difficulty|4|||
128710946|NCT01829191|463237778|FG000|Overall Study|Protocol Violation|4|||
128710947|NCT01829191|463237779|FG001|Overall Study|Protocol Violation|1|||
128710948|NCT01829191|463237778|FG000|Overall Study|Withdrawal by Subject|2|||
128710949|NCT01829191|463237779|FG001|Overall Study|Withdrawal by Subject|3|||
128710950|NCT01829191|463237778|FG000|Overall Study|Lost to Follow-up|0|||
128710951|NCT01829191|463237779|FG001|Overall Study|Lost to Follow-up|1|||
128710952|NCT01829191|463237778|FG000|Overall Study|Subject was fit for ortho - k|0|||
128710953|NCT01829191|463237779|FG001|Overall Study|Subject was fit for ortho - k|1|||
128710954|NCT01907815|463237780|FG000|Overall Study|Withdrawal by Subject|1|||
128710955|NCT01907815|463237781|FG001|Overall Study|Withdrawal by Subject|0|||
128710956|NCT01276353|463237782|FG000|Double-blind|Adverse Event|2|||
128710957|NCT01276353|463237783|FG001|Double-blind|Adverse Event|0|||
128710958|NCT01276353|463237782|FG000|Double-blind|Withdrawal by Subject|1|||
128710959|NCT01276353|463237783|FG001|Double-blind|Withdrawal by Subject|0|||
128710960|NCT01276353|463237782|FG000|Extension|Adverse Event|2|||
128710961|NCT01276353|463237783|FG001|Extension|Adverse Event|5|||
128951386|NCT01885078|464108698|FG000|Treatment Period|Lost to Follow-up|16|||
128951387|NCT01885078|464108699|FG001|Treatment Period|Lost to Follow-up|19|||
128951388|NCT01885078|464108700|FG002|Treatment Period|Lost to Follow-up|7|||
128951389|NCT01885078|464108701|FG003|Treatment Period|Lost to Follow-up|9|||
128951390|NCT01885078|464108702|FG004|Treatment Period|Lost to Follow-up|2|||
128951391|NCT01885078|464108703|FG005|Treatment Period|Lost to Follow-up|8|||
128951392|NCT01885078|464108704|FG006|Treatment Period|Lost to Follow-up|2|||
128951393|NCT01885078|464108705|FG007|Treatment Period|Lost to Follow-up|0|||
128951394|NCT01885078|464108706|FG008|Treatment Period|Lost to Follow-up|0|||
128951395|NCT01885078|464108707|FG009|Treatment Period|Lost to Follow-up|0|||
128951396|NCT01885078|464108698|FG000|Treatment Period|Physician Decision|19|||
128951397|NCT01885078|464108699|FG001|Treatment Period|Physician Decision|21|||
128951398|NCT01885078|464108700|FG002|Treatment Period|Physician Decision|5|||
128951399|NCT01885078|464108701|FG003|Treatment Period|Physician Decision|12|||
129034938|NCT00396630|464418341|FG000|Overall Study|Lost to Follow-up|1|||
128710962|NCT01276353|463237782|FG000|Extension|Withdrawal by Subject|1|||
128710963|NCT01276353|463237783|FG001|Extension|Withdrawal by Subject|2|||
129034939|NCT00396630|464418342|FG001|Overall Study|Lost to Follow-up|1|||
128710964|NCT01276353|463237782|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
128710965|NCT01276353|463237783|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
128710966|NCT01276353|463237782|FG000|Extension|Physician Decision|1|||
128770546|NCT02960763|463451548|FG003|Step 1|Withdrawal by Subject|0|||
128951400|NCT01885078|464108702|FG004|Treatment Period|Physician Decision|9|||
128951401|NCT01885078|464108703|FG005|Treatment Period|Physician Decision|24|||
128951402|NCT01885078|464108704|FG006|Treatment Period|Physician Decision|4|||
129034940|NCT00396630|464418341|FG000|Overall Study|Withdrawal by Subject|1|||
129219103|NCT00256997|465101710|FG001|Overall Study|Withdrawal by Subject|3|||
129219104|NCT00256997|465101709|FG000|Overall Study|Started but not treated|2|||
129219105|NCT00256997|465101710|FG001|Overall Study|Started but not treated|0|||
129219106|NCT00256997|465101709|FG000|Overall Study|Other|5|||
129219107|NCT00256997|465101710|FG001|Overall Study|Other|8|||
129219108|NCT00256997|465101709|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
129219109|NCT00256997|465101710|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
129219110|NCT00256997|465101709|FG000|Overall Study|Participant Non-compliant|3|||
129219111|NCT00256997|465101710|FG001|Overall Study|Participant Non-compliant|6|||
129219112|NCT00256997|465101709|FG000|Overall Study|Investigator Withdrew Participant|2|||
129219113|NCT00256997|465101710|FG001|Overall Study|Investigator Withdrew Participant|1|||
129219114|NCT01967238|465101711|FG000|Overall Study|Adverse Event|1|||
129219115|NCT01967238|465101712|FG001|Overall Study|Adverse Event|1|||
129219116|NCT01967238|465101713|FG002|Overall Study|Adverse Event|0|||
129219117|NCT01967238|465101711|FG000|Overall Study|Lost to Follow-up|1|||
129219118|NCT01967238|465101712|FG001|Overall Study|Lost to Follow-up|0|||
129219119|NCT01967238|465101713|FG002|Overall Study|Lost to Follow-up|1|||
129219120|NCT01967238|465101711|FG000|Overall Study|Withdrawal by Subject|0|||
129219121|NCT01967238|465101712|FG001|Overall Study|Withdrawal by Subject|0|||
129219122|NCT01967238|465101713|FG002|Overall Study|Withdrawal by Subject|1|||
129219123|NCT05232682|465101714|FG000|Overall Study|Lost to Follow-up|2|||
129219124|NCT03387085|465101715|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
129219125|NCT01590888|465102960|FG000|Overall Study|Adverse Event|3|||
129219126|NCT01590888|465102961|FG001|Overall Study|Adverse Event|0|||
129219127|NCT01590888|465102962|FG002|Overall Study|Adverse Event|1|||
129219128|NCT01590888|465102960|FG000|Overall Study|Lost to Follow-up|1|||
129219129|NCT01590888|465102961|FG001|Overall Study|Lost to Follow-up|0|||
129219130|NCT01590888|465102962|FG002|Overall Study|Lost to Follow-up|0|||
129219131|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
129219132|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
129219133|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
129219134|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
129219135|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
129219136|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
129219137|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
129219138|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
129219139|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
129219140|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
129219141|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
129219142|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
128710967|NCT01276353|463237783|FG001|Extension|Physician Decision|0|||
128710968|NCT01276353|463237782|FG000|Extension|Prohibited concomitant medications|0|||
128710969|NCT01276353|463237783|FG001|Extension|Prohibited concomitant medications|1|||
128710970|NCT00143403|463237784|FG000|Overall Study|Adverse Event|3|||
128951403|NCT01885078|464108705|FG007|Treatment Period|Physician Decision|3|||
128951404|NCT01885078|464108706|FG008|Treatment Period|Physician Decision|0|||
128951405|NCT01885078|464108707|FG009|Treatment Period|Physician Decision|0|||
128951406|NCT01885078|464108698|FG000|Treatment Period|Protocol Violation|3|||
128951407|NCT01885078|464108699|FG001|Treatment Period|Protocol Violation|5|||
128951408|NCT01885078|464108700|FG002|Treatment Period|Protocol Violation|0|||
128951409|NCT01885078|464108701|FG003|Treatment Period|Protocol Violation|3|||
128951410|NCT01885078|464108702|FG004|Treatment Period|Protocol Violation|1|||
128951411|NCT01885078|464108703|FG005|Treatment Period|Protocol Violation|6|||
128951412|NCT01885078|464108704|FG006|Treatment Period|Protocol Violation|0|||
128951413|NCT01885078|464108705|FG007|Treatment Period|Protocol Violation|0|||
128951414|NCT01885078|464108706|FG008|Treatment Period|Protocol Violation|0|||
128951415|NCT01885078|464108707|FG009|Treatment Period|Protocol Violation|0|||
128951416|NCT01885078|464108698|FG000|Treatment Period|Sponsor Decision|245|||
128951417|NCT01885078|464108699|FG001|Treatment Period|Sponsor Decision|648|||
128951418|NCT01885078|464108700|FG002|Treatment Period|Sponsor Decision|49|||
128951419|NCT01885078|464108701|FG003|Treatment Period|Sponsor Decision|90|||
128951420|NCT01885078|464108702|FG004|Treatment Period|Sponsor Decision|20|||
128951421|NCT01885078|464108703|FG005|Treatment Period|Sponsor Decision|38|||
128951422|NCT01885078|464108704|FG006|Treatment Period|Sponsor Decision|162|||
128951423|NCT01885078|464108705|FG007|Treatment Period|Sponsor Decision|3|||
128951424|NCT01885078|464108706|FG008|Treatment Period|Sponsor Decision|0|||
128951425|NCT01885078|464108707|FG009|Treatment Period|Sponsor Decision|0|||
129219143|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
129219144|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
128951426|NCT01885078|464108698|FG000|Treatment Period|Withdrawal by Subject|72|||
129219145|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
128951427|NCT01885078|464108699|FG001|Treatment Period|Withdrawal by Subject|132|||
128951428|NCT01885078|464108700|FG002|Treatment Period|Withdrawal by Subject|25|||
128951429|NCT01885078|464108701|FG003|Treatment Period|Withdrawal by Subject|63|||
128951430|NCT01885078|464108702|FG004|Treatment Period|Withdrawal by Subject|15|||
128951431|NCT01885078|464108703|FG005|Treatment Period|Withdrawal by Subject|34|||
128951432|NCT01885078|464108704|FG006|Treatment Period|Withdrawal by Subject|17|||
128951433|NCT01885078|464108705|FG007|Treatment Period|Withdrawal by Subject|10|||
128951434|NCT01885078|464108706|FG008|Treatment Period|Withdrawal by Subject|0|||
128951435|NCT01885078|464108707|FG009|Treatment Period|Withdrawal by Subject|0|||
128951436|NCT01885078|464108698|FG000|Treatment Period|Other|0|||
128951437|NCT01885078|464108699|FG001|Treatment Period|Other|0|||
128951438|NCT01885078|464108700|FG002|Treatment Period|Other|0|||
128951439|NCT01885078|464108701|FG003|Treatment Period|Other|1|||
129034941|NCT00396630|464418342|FG001|Overall Study|Withdrawal by Subject|1|||
129034942|NCT00396630|464418341|FG000|Overall Study|Not vaccinated at Visit 3|3|||
129034943|NCT00396630|464418342|FG001|Overall Study|Not vaccinated at Visit 3|3|||
129034944|NCT02327325|464418343|FG000|Overall Study|Withdrawal by Subject|1|||
129034945|NCT02327325|464418344|FG001|Overall Study|Withdrawal by Subject|4|||
129034946|NCT02327325|464418345|FG002|Overall Study|Withdrawal by Subject|4|||
129034947|NCT02327325|464418343|FG000|Overall Study|Excluded by Study Team|0|||
129034948|NCT02327325|464418344|FG001|Overall Study|Excluded by Study Team|0|||
129034949|NCT02327325|464418345|FG002|Overall Study|Excluded by Study Team|1|||
129034950|NCT01755975|464418348|FG000|Overall Study|Adverse Event|0|||
129034951|NCT01755975|464418349|FG001|Overall Study|Adverse Event|0|||
129034952|NCT01755975|464418350|FG002|Overall Study|Adverse Event|1|||
129034953|NCT01755975|464418351|FG003|Overall Study|Adverse Event|0|||
129034954|NCT01755975|464418352|FG004|Overall Study|Adverse Event|2|||
129034955|NCT03330236|464418356|FG000|Overall Study|Death|2|||
129034956|NCT03330236|464418357|FG001|Overall Study|Death|1|||
129034957|NCT03330236|464418356|FG000|Overall Study|Withdrawal by Subject|2|||
129034958|NCT03330236|464418357|FG001|Overall Study|Withdrawal by Subject|4|||
129034959|NCT03330236|464418356|FG000|Overall Study|Lost to Follow-up|0|||
129034960|NCT03330236|464418357|FG001|Overall Study|Lost to Follow-up|2|||
129034961|NCT03330236|464418356|FG000|Overall Study|Physician Decision|2|||
129034962|NCT03330236|464418357|FG001|Overall Study|Physician Decision|0|||
129034963|NCT03330236|464418356|FG000|Overall Study|Protocol Violation|4|||
129034964|NCT03330236|464418357|FG001|Overall Study|Protocol Violation|3|||
129034965|NCT03330236|464418356|FG000|Overall Study|SedLine malfunction/blinding|19|||
129034966|NCT03330236|464418357|FG001|Overall Study|SedLine malfunction/blinding|14|||
129034967|NCT03330236|464418356|FG000|Overall Study|Volatile anesthetics used|11|||
129034968|NCT03330236|464418357|FG001|Overall Study|Volatile anesthetics used|8|||
129034969|NCT03330236|464418356|FG000|Overall Study|Surgery aborted/converted to open|60|||
129034970|NCT03330236|464418357|FG001|Overall Study|Surgery aborted/converted to open|52|||
129034971|NCT01901848|464418358|FG000|Randomized and Treated|Lost to Follow-up|3|||
129034972|NCT01901848|464418359|FG001|Randomized and Treated|Lost to Follow-up|6|||
129034973|NCT01901848|464418358|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
129034974|NCT01901848|464418359|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
129034975|NCT00763555|464418360|FG000|Overall Study|Adverse Event|2|||
129034976|NCT00763555|464418361|FG001|Overall Study|Adverse Event|1|||
129034977|NCT00763555|464418360|FG000|Overall Study|Withdrawal by Subject|2|||
129034978|NCT00763555|464418361|FG001|Overall Study|Withdrawal by Subject|6|||
129034979|NCT00763555|464418360|FG000|Overall Study|Lost to Follow-up|0|||
129034980|NCT00763555|464418361|FG001|Overall Study|Lost to Follow-up|3|||
129034981|NCT01729026|464418362|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
129034982|NCT01729026|464418363|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
129034983|NCT01729026|464418362|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
129034984|NCT01729026|464418363|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
129034985|NCT00852917|464418364|FG000|Overall Study|Adverse Event|13|||
129034986|NCT00852917|464418365|FG001|Overall Study|Adverse Event|20|||
129034987|NCT00852917|464418366|FG002|Overall Study|Adverse Event|35|||
129034988|NCT00852917|464418367|FG003|Overall Study|Adverse Event|17|||
129034989|NCT00852917|464418364|FG000|Overall Study|Lack of Efficacy|21|||
129034990|NCT00852917|464418365|FG001|Overall Study|Lack of Efficacy|11|||
129034991|NCT00852917|464418366|FG002|Overall Study|Lack of Efficacy|11|||
129034992|NCT00852917|464418367|FG003|Overall Study|Lack of Efficacy|47|||
129034993|NCT00852917|464418364|FG000|Overall Study|Withdrawal by Subject|4|||
129034994|NCT00852917|464418365|FG001|Overall Study|Withdrawal by Subject|8|||
129034995|NCT00852917|464418366|FG002|Overall Study|Withdrawal by Subject|10|||
129034996|NCT00852917|464418367|FG003|Overall Study|Withdrawal by Subject|9|||
129034997|NCT00852917|464418364|FG000|Overall Study|Physician Decision|6|||
128951440|NCT01885078|464108702|FG004|Treatment Period|Other|0|||
128951441|NCT01885078|464108703|FG005|Treatment Period|Other|0|||
128951442|NCT01885078|464108704|FG006|Treatment Period|Other|0|||
129034998|NCT00852917|464418365|FG001|Overall Study|Physician Decision|7|||
129034999|NCT00852917|464418366|FG002|Overall Study|Physician Decision|2|||
129035000|NCT00852917|464418367|FG003|Overall Study|Physician Decision|19|||
129035001|NCT00852917|464418364|FG000|Overall Study|Death|0|||
129035002|NCT00852917|464418365|FG001|Overall Study|Death|0|||
129035003|NCT00852917|464418366|FG002|Overall Study|Death|0|||
129035004|NCT00852917|464418367|FG003|Overall Study|Death|1|||
129040326|NCT00544817|464440116|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
128710971|NCT00143403|463237785|FG001|Overall Study|Adverse Event|8|||
128710972|NCT00143403|463237784|FG000|Overall Study|Death|1|||
128710973|NCT00143403|463237785|FG001|Overall Study|Death|0|||
128710974|NCT00143403|463237784|FG000|Overall Study|Withdrawal by Subject|3|||
128770547|NCT02960763|463451549|FG004|Step 1|Withdrawal by Subject|0|||
128770548|NCT02960763|463451545|FG000|Step 1|Lost to Follow-up|7|||
128770549|NCT02960763|463451546|FG001|Step 1|Lost to Follow-up|9|||
128770550|NCT02960763|463451547|FG002|Step 1|Lost to Follow-up|12|||
128710975|NCT00143403|463237785|FG001|Overall Study|Withdrawal by Subject|12|||
128710976|NCT00143403|463237784|FG000|Overall Study|Relapse|15|||
128710977|NCT00143403|463237785|FG001|Overall Study|Relapse|7|||
128710978|NCT00143403|463237784|FG000|Overall Study|Protocol Violation|2|||
128710979|NCT00143403|463237785|FG001|Overall Study|Protocol Violation|2|||
128710980|NCT00143403|463237784|FG000|Overall Study|specified by site|4|||
128710981|NCT00143403|463237785|FG001|Overall Study|specified by site|9|||
128710982|NCT00143403|463237784|FG000|Overall Study|Randomized Not Treated|7|||
128710983|NCT00143403|463237785|FG001|Overall Study|Randomized Not Treated|8|||
128710984|NCT00514540|463237786|FG000|First-Line Chemo|Withdrawal by Subject|1|||
128710985|NCT00514540|463237786|FG000|First-Line Chemo|Protocol Violation|7|||
128710986|NCT00514540|463237786|FG000|Second-Line|Physician/Patient Decision|31|||
128710987|NCT03402386|463237787|FG000|Overall Study|Adverse Event|3|||
128710988|NCT03402386|463237787|FG000|Overall Study|Physician Decision|1|||
128710989|NCT03402386|463237787|FG000|Overall Study|Difficult to control Hb|2|||
128710990|NCT00587639|463237788|FG000|Overall Study|Withdrawal by Subject|1|||
128710991|NCT01996982|463237793|FG000|Overall Study|PI/team left institution|7|||
128710992|NCT01195415|463237794|FG000|Overall Study|No repeat biopsy due to progression|2|||
128710993|NCT00533845|463237795|FG000|Overall Study|Physician Decision|1|||
128710994|NCT00533845|463237796|FG001|Overall Study|Physician Decision|0|||
128710995|NCT01288469|463237804|FG000|Overall Study|Adverse Event|4|||
128710996|NCT01288469|463237805|FG001|Overall Study|Adverse Event|1|||
128710997|NCT01288469|463237806|FG002|Overall Study|Adverse Event|1|||
128710998|NCT01288469|463237804|FG000|Overall Study|Poor compliance to protocol|0|||
128710999|NCT01288469|463237805|FG001|Overall Study|Poor compliance to protocol|1|||
128711000|NCT01288469|463237806|FG002|Overall Study|Poor compliance to protocol|0|||
128711001|NCT01288469|463237804|FG000|Overall Study|Participant Moved|1|||
128711002|NCT01288469|463237805|FG001|Overall Study|Participant Moved|0|||
128711003|NCT01288469|463237806|FG002|Overall Study|Participant Moved|0|||
128711004|NCT01288469|463237804|FG000|Overall Study|Consent withdrawn by subject|1|||
128711005|NCT01288469|463237805|FG001|Overall Study|Consent withdrawn by subject|1|||
128711006|NCT01288469|463237806|FG002|Overall Study|Consent withdrawn by subject|1|||
128711007|NCT01288469|463237804|FG000|Overall Study|Exclusion criteria finally met|1|||
128711008|NCT01288469|463237805|FG001|Overall Study|Exclusion criteria finally met|0|||
128711009|NCT01288469|463237806|FG002|Overall Study|Exclusion criteria finally met|0|||
128711010|NCT00255047|463237807|FG000|Overall Study|Serious Adverse Events|2|||
128711011|NCT00255047|463237808|FG001|Overall Study|Serious Adverse Events|1|||
128711012|NCT00255047|463237809|FG002|Overall Study|Serious Adverse Events|2|||
128711013|NCT00255047|463237810|FG003|Overall Study|Serious Adverse Events|1|||
128711014|NCT00255047|463237807|FG000|Overall Study|Adverse Event|0|||
128711015|NCT00255047|463237808|FG001|Overall Study|Adverse Event|3|||
128711016|NCT00255047|463237809|FG002|Overall Study|Adverse Event|2|||
128711017|NCT00255047|463237810|FG003|Overall Study|Adverse Event|1|||
128711018|NCT00255047|463237807|FG000|Overall Study|Protocol Violation|13|||
128711019|NCT00255047|463237808|FG001|Overall Study|Protocol Violation|13|||
128711020|NCT00255047|463237809|FG002|Overall Study|Protocol Violation|16|||
128711021|NCT00255047|463237810|FG003|Overall Study|Protocol Violation|20|||
128711022|NCT00255047|463237807|FG000|Overall Study|Lost to Follow-up|9|||
128711023|NCT00255047|463237808|FG001|Overall Study|Lost to Follow-up|8|||
128711024|NCT00255047|463237809|FG002|Overall Study|Lost to Follow-up|5|||
128770551|NCT02960763|463451548|FG003|Step 1|Lost to Follow-up|0|||
128770552|NCT02960763|463451549|FG004|Step 1|Lost to Follow-up|0|||
128770553|NCT02960763|463451545|FG000|Step 1|Death|1|||
128770554|NCT02960763|463451546|FG001|Step 1|Death|1|||
128770555|NCT02960763|463451547|FG002|Step 1|Death|1|||
128770556|NCT02960763|463451548|FG003|Step 1|Death|0|||
128951443|NCT01885078|464108705|FG007|Treatment Period|Other|0|||
128951444|NCT01885078|464108706|FG008|Treatment Period|Other|0|||
128951445|NCT01885078|464108707|FG009|Treatment Period|Other|0|||
128711025|NCT00255047|463237810|FG003|Overall Study|Lost to Follow-up|6|||
128711026|NCT00255047|463237807|FG000|Overall Study|Withdrawal by Subject|24|||
128711027|NCT00255047|463237808|FG001|Overall Study|Withdrawal by Subject|23|||
128711028|NCT00255047|463237809|FG002|Overall Study|Withdrawal by Subject|25|||
128770557|NCT02960763|463451549|FG004|Step 1|Death|0|||
128770558|NCT02960763|463451545|FG000|Step 1|Investigator discretion|1|||
128951446|NCT01885078|464108698|FG000|Step-down Period|Sponsor Decision|0|||
128770559|NCT02960763|463451546|FG001|Step 1|Investigator discretion|0|||
128711029|NCT00255047|463237810|FG003|Overall Study|Withdrawal by Subject|18|||
128711030|NCT01957553|463237812|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
128770560|NCT02960763|463451547|FG002|Step 1|Investigator discretion|1|||
128770561|NCT02960763|463451548|FG003|Step 1|Investigator discretion|0|||
128951447|NCT01885078|464108699|FG001|Step-down Period|Sponsor Decision|0|||
129035005|NCT03710590|464418368|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
129035006|NCT03710590|464418369|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
129035007|NCT02488824|464418370|FG000|Overall Study|Adverse Event|1|||
129035008|NCT02488824|464418371|FG001|Overall Study|Adverse Event|1|||
129035009|NCT01201759|464418373|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
129035010|NCT01201759|464418374|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
129035011|NCT01201759|464418373|FG000|Visit 3 - Washout|Adverse Event|0|||
129035012|NCT01201759|464418374|FG001|Visit 3 - Washout|Adverse Event|3|||
129035013|NCT01201759|464418373|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
129035014|NCT01201759|464418374|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
129035015|NCT01201759|464418373|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
129035016|NCT01201759|464418374|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
129035017|NCT01045707|464418375|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
129035018|NCT01045707|464418376|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
129035019|NCT01045707|464418375|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
129035020|NCT01045707|464418376|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
129035021|NCT01045707|464418375|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
129035022|NCT01045707|464418376|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
129035023|NCT01045707|464418375|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
129035024|NCT01045707|464418376|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
129035025|NCT01045707|464418375|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
129035026|NCT01045707|464418376|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
129035027|NCT01045707|464418375|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
129035028|NCT01045707|464418376|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
129035029|NCT01045707|464418375|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
128711031|NCT01957553|463237813|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
128711032|NCT01957553|463237812|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
128711033|NCT01957553|463237813|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
128711034|NCT01957553|463237812|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
129035030|NCT01045707|464418376|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
129035031|NCT01045707|464418375|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
128711035|NCT01957553|463237813|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
128711036|NCT01957553|463237812|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
128711037|NCT01957553|463237813|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
128711038|NCT01957553|463237812|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
129035032|NCT01045707|464418376|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
129035033|NCT01045707|464418375|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
129035034|NCT01045707|464418376|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
129035035|NCT00848042|464418377|FG000|Overall Study|Death|1|||
129035036|NCT00848042|464418378|FG001|Overall Study|Death|2|||
129035037|NCT00848042|464418379|FG002|Overall Study|Death|0|||
129035038|NCT00848042|464418377|FG000|Overall Study|Other Therapy|3|||
129035039|NCT00848042|464418378|FG001|Overall Study|Other Therapy|0|||
128711039|NCT01957553|463237813|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
128711040|NCT01957553|463237812|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
128711041|NCT01957553|463237813|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
128711042|NCT01957553|463237812|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
128711043|NCT01957553|463237813|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
128711044|NCT01957553|463237812|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
128711045|NCT01957553|463237813|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
128711046|NCT01957553|463237812|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
128711047|NCT01957553|463237813|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
128711048|NCT03060629|463237814|FG000|Overall Study|Death|4|||
128711049|NCT03060629|463237815|FG001|Overall Study|Death|5|||
128711050|NCT03060629|463237814|FG000|Overall Study|Withdrawal by Subject|50|||
128711051|NCT03060629|463237815|FG001|Overall Study|Withdrawal by Subject|35|||
129035040|NCT00848042|464418379|FG002|Overall Study|Other Therapy|0|||
129035041|NCT00979212|464418382|FG000|Overall Study|Protocol Violation|1|||
129035042|NCT00979212|464418383|FG001|Overall Study|Protocol Violation|8|||
129035043|NCT00979212|464418382|FG000|Overall Study|No protocol therapy received|1|||
129125567|NCT04809974|464755483|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
129125568|NCT04809974|464755484|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
129125569|NCT04809974|464755482|FG000|Randomized Phase|Adverse Event|0|||
129125570|NCT04809974|464755483|FG001|Randomized Phase|Adverse Event|1|||
129125571|NCT04809974|464755484|FG002|Randomized Phase|Adverse Event|4|||
129125572|NCT04809974|464755482|FG000|Randomized Phase|Withdrawal by Subject|0|||
129125573|NCT04809974|464755483|FG001|Randomized Phase|Withdrawal by Subject|0|||
129125574|NCT04809974|464755484|FG002|Randomized Phase|Withdrawal by Subject|5|||
129125575|NCT05493111|464755485|FG000|Overall Study|Adverse Event|3|||
129125576|NCT05493111|464755486|FG001|Overall Study|Adverse Event|4|||
129125577|NCT05493111|464755485|FG000|Overall Study|Withdrawal of Consent|19|||
128951448|NCT01885078|464108700|FG002|Step-down Period|Sponsor Decision|0|||
128951449|NCT01885078|464108701|FG003|Step-down Period|Sponsor Decision|0|||
128951450|NCT01885078|464108702|FG004|Step-down Period|Sponsor Decision|0|||
128951451|NCT01885078|464108703|FG005|Step-down Period|Sponsor Decision|0|||
128951452|NCT01885078|464108704|FG006|Step-down Period|Sponsor Decision|0|||
128951453|NCT01885078|464108705|FG007|Step-down Period|Sponsor Decision|0|||
128951454|NCT01885078|464108706|FG008|Step-down Period|Sponsor Decision|1|||
128951455|NCT01885078|464108707|FG009|Step-down Period|Sponsor Decision|1|||
128951456|NCT01885078|464108698|FG000|Step-down Period|Adverse Event|0|||
128951457|NCT01885078|464108699|FG001|Step-down Period|Adverse Event|0|||
128711052|NCT03060629|463237814|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
128711053|NCT03060629|463237815|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
128951458|NCT01885078|464108700|FG002|Step-down Period|Adverse Event|0|||
128951459|NCT01885078|464108701|FG003|Step-down Period|Adverse Event|0|||
128951460|NCT01885078|464108702|FG004|Step-down Period|Adverse Event|0|||
128951461|NCT01885078|464108703|FG005|Step-down Period|Adverse Event|0|||
128951462|NCT01885078|464108704|FG006|Step-down Period|Adverse Event|0|||
128951463|NCT01885078|464108705|FG007|Step-down Period|Adverse Event|0|||
128951464|NCT01885078|464108706|FG008|Step-down Period|Adverse Event|29|||
128951465|NCT01885078|464108707|FG009|Step-down Period|Adverse Event|38|||
128711054|NCT03060629|463237814|FG000|Overall Study|Participant Relocate|15|||
128951466|NCT01885078|464108698|FG000|Step-down Period|Withdrawal by Subject|0|||
128951467|NCT01885078|464108699|FG001|Step-down Period|Withdrawal by Subject|0|||
128951468|NCT01885078|464108700|FG002|Step-down Period|Withdrawal by Subject|0|||
128951469|NCT01885078|464108701|FG003|Step-down Period|Withdrawal by Subject|0|||
128951470|NCT01885078|464108702|FG004|Step-down Period|Withdrawal by Subject|0|||
128951471|NCT01885078|464108703|FG005|Step-down Period|Withdrawal by Subject|0|||
128951472|NCT01885078|464108704|FG006|Step-down Period|Withdrawal by Subject|0|||
128951473|NCT01885078|464108705|FG007|Step-down Period|Withdrawal by Subject|0|||
128951474|NCT01885078|464108706|FG008|Step-down Period|Withdrawal by Subject|25|||
128951475|NCT01885078|464108707|FG009|Step-down Period|Withdrawal by Subject|15|||
128951476|NCT01885078|464108698|FG000|Step-down Period|Physician Decision|0|||
128951477|NCT01885078|464108699|FG001|Step-down Period|Physician Decision|0|||
128951478|NCT01885078|464108700|FG002|Step-down Period|Physician Decision|0|||
128951479|NCT01885078|464108701|FG003|Step-down Period|Physician Decision|0|||
128951480|NCT01885078|464108702|FG004|Step-down Period|Physician Decision|0|||
128951481|NCT01885078|464108703|FG005|Step-down Period|Physician Decision|0|||
128951482|NCT01885078|464108704|FG006|Step-down Period|Physician Decision|0|||
128951483|NCT01885078|464108705|FG007|Step-down Period|Physician Decision|0|||
128951484|NCT01885078|464108706|FG008|Step-down Period|Physician Decision|7|||
128951485|NCT01885078|464108707|FG009|Step-down Period|Physician Decision|2|||
128951486|NCT01885078|464108698|FG000|Step-down Period|Death|0|||
128951487|NCT01885078|464108699|FG001|Step-down Period|Death|0|||
128951488|NCT01885078|464108700|FG002|Step-down Period|Death|0|||
128951489|NCT01885078|464108701|FG003|Step-down Period|Death|0|||
128951490|NCT01885078|464108702|FG004|Step-down Period|Death|0|||
128951491|NCT01885078|464108703|FG005|Step-down Period|Death|0|||
129035044|NCT00979212|464418383|FG001|Overall Study|No protocol therapy received|0|||
129035045|NCT04886063|464418388|FG000|Overall Study|Adverse Event|50|||
129035046|NCT04886063|464418388|FG000|Overall Study|Lack of Efficacy|31|||
129035047|NCT04886063|464418388|FG000|Overall Study|Withdrawal by Subject|45|||
129035048|NCT04886063|464418388|FG000|Overall Study|Physician Decision|3|||
129035049|NCT04886063|464418388|FG000|Overall Study|Protocol Violation|3|||
129035050|NCT04886063|464418388|FG000|Overall Study|Site closure|4|||
129035051|NCT04886063|464418388|FG000|Overall Study|Nursing home replacement|3|||
129035052|NCT04886063|464418388|FG000|Overall Study|Lost to Follow-up|5|||
129035053|NCT04886063|464418388|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
129035054|NCT04886063|464418388|FG000|Overall Study|>1 reason|20|||
129035055|NCT02448563|464418393|FG000|Overall Study|Lost to Follow-up|16|||
129035056|NCT02448563|464418394|FG001|Overall Study|Lost to Follow-up|10|||
129035057|NCT02448563|464418393|FG000|Overall Study|Withdrawal by Subject|0|||
129035058|NCT02448563|464418394|FG001|Overall Study|Withdrawal by Subject|1|||
129035059|NCT02340962|464418396|FG000|Overall Study|Lost to Follow-up|1|||
129035060|NCT02340962|464418397|FG001|Overall Study|Lost to Follow-up|0|||
129035061|NCT02174276|464418398|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
129035062|NCT02174276|464418399|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
129035063|NCT02174276|464418400|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
129035064|NCT02174276|464418401|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
129035065|NCT02174276|464418398|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
128951492|NCT01885078|464108704|FG006|Step-down Period|Death|0|||
128951493|NCT01885078|464108705|FG007|Step-down Period|Death|0|||
128951494|NCT01885078|464108706|FG008|Step-down Period|Death|4|||
128951495|NCT01885078|464108707|FG009|Step-down Period|Death|3|||
128951496|NCT01885078|464108698|FG000|Step-down Period|Lost to Follow-up|0|||
128951497|NCT01885078|464108699|FG001|Step-down Period|Lost to Follow-up|0|||
128951498|NCT01885078|464108700|FG002|Step-down Period|Lost to Follow-up|0|||
129035066|NCT02174276|464418399|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
129035067|NCT02174276|464418400|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
128951499|NCT01885078|464108701|FG003|Step-down Period|Lost to Follow-up|0|||
128951500|NCT01885078|464108702|FG004|Step-down Period|Lost to Follow-up|0|||
128951501|NCT01885078|464108703|FG005|Step-down Period|Lost to Follow-up|0|||
128951502|NCT01885078|464108704|FG006|Step-down Period|Lost to Follow-up|0|||
128951503|NCT01885078|464108705|FG007|Step-down Period|Lost to Follow-up|0|||
128951504|NCT01885078|464108706|FG008|Step-down Period|Lost to Follow-up|1|||
128951505|NCT01885078|464108707|FG009|Step-down Period|Lost to Follow-up|1|||
128951506|NCT01885078|464108698|FG000|Step-down Period|Lack of Efficacy|0|||
128951507|NCT01885078|464108699|FG001|Step-down Period|Lack of Efficacy|0|||
128951508|NCT01885078|464108700|FG002|Step-down Period|Lack of Efficacy|0|||
128951509|NCT01885078|464108701|FG003|Step-down Period|Lack of Efficacy|0|||
128951510|NCT01885078|464108702|FG004|Step-down Period|Lack of Efficacy|0|||
128951511|NCT01885078|464108703|FG005|Step-down Period|Lack of Efficacy|0|||
128951512|NCT01885078|464108704|FG006|Step-down Period|Lack of Efficacy|0|||
128951513|NCT01885078|464108705|FG007|Step-down Period|Lack of Efficacy|0|||
128951514|NCT01885078|464108706|FG008|Step-down Period|Lack of Efficacy|1|||
128951515|NCT01885078|464108707|FG009|Step-down Period|Lack of Efficacy|0|||
128951516|NCT01885078|464108698|FG000|Step-down Period|Protocol Violation|0|||
128951517|NCT01885078|464108699|FG001|Step-down Period|Protocol Violation|0|||
128951518|NCT01885078|464108700|FG002|Step-down Period|Protocol Violation|0|||
128951519|NCT01885078|464108701|FG003|Step-down Period|Protocol Violation|0|||
128951520|NCT01885078|464108702|FG004|Step-down Period|Protocol Violation|0|||
128951521|NCT01885078|464108703|FG005|Step-down Period|Protocol Violation|0|||
128951522|NCT01885078|464108704|FG006|Step-down Period|Protocol Violation|0|||
128951523|NCT01885078|464108705|FG007|Step-down Period|Protocol Violation|0|||
128951524|NCT01885078|464108706|FG008|Step-down Period|Protocol Violation|1|||
128951525|NCT01885078|464108707|FG009|Step-down Period|Protocol Violation|1|||
128951526|NCT03115112|464108708|FG000|Overall Study|Adverse Event|5|||
128951527|NCT03115112|464108709|FG001|Overall Study|Adverse Event|1|||
128711055|NCT03060629|463237815|FG001|Overall Study|Participant Relocate|15|||
128711056|NCT03060629|463237814|FG000|Overall Study|Unable to Contact Participant|34|||
128711057|NCT03060629|463237815|FG001|Overall Study|Unable to Contact Participant|23|||
128711058|NCT03060629|463237814|FG000|Overall Study|Investigator Decision|7|||
128711059|NCT03060629|463237815|FG001|Overall Study|Investigator Decision|7|||
128711060|NCT03060629|463237814|FG000|Overall Study|Study Terminated by Sponsor|1100|||
128711061|NCT03060629|463237815|FG001|Overall Study|Study Terminated by Sponsor|1123|||
128711062|NCT03060629|463237814|FG000|Overall Study|Other|4|||
128711063|NCT03060629|463237815|FG001|Overall Study|Other|4|||
128770562|NCT02960763|463451549|FG004|Step 1|Investigator discretion|0|||
128951528|NCT03115112|464108708|FG000|Overall Study|Withdrawal by Subject|4|||
128951529|NCT03115112|464108709|FG001|Overall Study|Withdrawal by Subject|2|||
128951530|NCT03115112|464108708|FG000|Overall Study|Lost to Follow-up|0|||
128951531|NCT03115112|464108709|FG001|Overall Study|Lost to Follow-up|1|||
128951532|NCT03115112|464108708|FG000|Overall Study|Death|1|||
128951533|NCT03115112|464108709|FG001|Overall Study|Death|0|||
128951534|NCT03115112|464108708|FG000|Overall Study|Pregnancy|1|||
128951535|NCT03115112|464108709|FG001|Overall Study|Pregnancy|0|||
128951536|NCT03115112|464108708|FG000|Overall Study|Site closure|1|||
128951537|NCT03115112|464108709|FG001|Overall Study|Site closure|1|||
128951538|NCT04019795|464108711|FG000|Overall Study|Withdrawal by Subject|1|||
128951539|NCT04019795|464108712|FG001|Overall Study|Withdrawal by Subject|2|||
128951540|NCT04019795|464108713|FG002|Overall Study|Withdrawal by Subject|2|||
128951541|NCT04019795|464108714|FG003|Overall Study|Withdrawal by Subject|1|||
128951542|NCT04019795|464108711|FG000|Overall Study|Lost to Follow-up|0|||
128951543|NCT04019795|464108712|FG001|Overall Study|Lost to Follow-up|1|||
128951544|NCT04019795|464108713|FG002|Overall Study|Lost to Follow-up|1|||
128951545|NCT04019795|464108714|FG003|Overall Study|Lost to Follow-up|2|||
128951546|NCT04019795|464108711|FG000|Overall Study|Treatment non-compliance|3|||
128951547|NCT04019795|464108712|FG001|Overall Study|Treatment non-compliance|1|||
128951548|NCT04019795|464108713|FG002|Overall Study|Treatment non-compliance|2|||
128951549|NCT04019795|464108714|FG003|Overall Study|Treatment non-compliance|0|||
128951550|NCT04019795|464108711|FG000|Overall Study|Physician Decision|0|||
128951551|NCT04019795|464108712|FG001|Overall Study|Physician Decision|0|||
128951552|NCT04019795|464108713|FG002|Overall Study|Physician Decision|1|||
128951553|NCT04019795|464108714|FG003|Overall Study|Physician Decision|0|||
128951554|NCT04019795|464108711|FG000|Overall Study|Adverse Event|1|||
128951555|NCT04019795|464108712|FG001|Overall Study|Adverse Event|0|||
128951556|NCT04019795|464108713|FG002|Overall Study|Adverse Event|0|||
129219146|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
128951557|NCT04019795|464108714|FG003|Overall Study|Adverse Event|0|||
128711064|NCT01405742|463237816|FG000|Overall Study|Lost to Follow-up|1|||
128711065|NCT01405742|463237817|FG001|Overall Study|Lost to Follow-up|0|||
128711066|NCT03672747|463237819|FG000|Overall Study|Lost to Follow-up|1|||
128951558|NCT01107405|464108715|FG000|Overall Study|Adverse Event|1|||
128951559|NCT01107405|464108716|FG001|Overall Study|Adverse Event|1|||
128951560|NCT01107405|464108717|FG002|Overall Study|Adverse Event|0|||
128951561|NCT01107405|464108718|FG003|Overall Study|Adverse Event|0|||
128951562|NCT01107405|464108719|FG004|Overall Study|Adverse Event|2|||
128951563|NCT01107405|464108715|FG000|Overall Study|Withdrawal by Subject|1|||
128951564|NCT01107405|464108716|FG001|Overall Study|Withdrawal by Subject|0|||
128951565|NCT01107405|464108717|FG002|Overall Study|Withdrawal by Subject|1|||
128951566|NCT01107405|464108718|FG003|Overall Study|Withdrawal by Subject|2|||
128951567|NCT01107405|464108719|FG004|Overall Study|Withdrawal by Subject|1|||
128951568|NCT01107405|464108715|FG000|Overall Study|Protocol Violation|0|||
128951569|NCT01107405|464108716|FG001|Overall Study|Protocol Violation|0|||
128951570|NCT01107405|464108717|FG002|Overall Study|Protocol Violation|1|||
128951571|NCT01107405|464108718|FG003|Overall Study|Protocol Violation|1|||
128951572|NCT01107405|464108719|FG004|Overall Study|Protocol Violation|0|||
128951573|NCT01895452|464108723|FG000|Overall Study|Adverse Event|1|||
128951574|NCT01895452|464108724|FG001|Overall Study|Adverse Event|4|||
128951575|NCT01895452|464108723|FG000|Overall Study|Lost to Follow-up|1|||
128951576|NCT01895452|464108724|FG001|Overall Study|Lost to Follow-up|5|||
128951577|NCT01895452|464108723|FG000|Overall Study|Pregnancy|0|||
128951578|NCT01895452|464108724|FG001|Overall Study|Pregnancy|1|||
128951579|NCT01895452|464108723|FG000|Overall Study|Withdrawal by Subject|2|||
128951580|NCT01895452|464108724|FG001|Overall Study|Withdrawal by Subject|14|||
128951581|NCT01895452|464108723|FG000|Overall Study|Underlying disease|0|||
128951582|NCT01895452|464108724|FG001|Overall Study|Underlying disease|3|||
128951583|NCT01895452|464108723|FG000|Overall Study|Noncompliance with study drug|0|||
128951584|NCT01895452|464108724|FG001|Overall Study|Noncompliance with study drug|1|||
128951585|NCT01653158|464108725|FG000|Overall Study|Death|0|||
128951586|NCT01653158|464108726|FG001|Overall Study|Death|0|||
128951587|NCT01653158|464108727|FG002|Overall Study|Death|0|||
128951588|NCT01653158|464108728|FG003|Overall Study|Death|1|||
128951589|NCT01653158|464108729|FG004|Overall Study|Death|0|||
128951590|NCT01653158|464108730|FG005|Overall Study|Death|0|||
128951591|NCT01653158|464108731|FG006|Overall Study|Death|0|||
128951592|NCT01653158|464108732|FG007|Overall Study|Death|2|||
128951593|NCT01653158|464108725|FG000|Overall Study|Adverse Event|0|||
128951594|NCT01653158|464108726|FG001|Overall Study|Adverse Event|0|||
128951595|NCT01653158|464108727|FG002|Overall Study|Adverse Event|0|||
128951596|NCT01653158|464108728|FG003|Overall Study|Adverse Event|1|||
128951597|NCT01653158|464108729|FG004|Overall Study|Adverse Event|0|||
128951598|NCT01653158|464108730|FG005|Overall Study|Adverse Event|0|||
128951599|NCT01653158|464108731|FG006|Overall Study|Adverse Event|0|||
128951600|NCT01653158|464108732|FG007|Overall Study|Adverse Event|3|||
128951601|NCT01653158|464108725|FG000|Overall Study|Other|0|||
128951602|NCT01653158|464108726|FG001|Overall Study|Other|0|||
128951603|NCT01653158|464108727|FG002|Overall Study|Other|0|||
128951604|NCT01653158|464108728|FG003|Overall Study|Other|0|||
128951605|NCT01653158|464108729|FG004|Overall Study|Other|0|||
128951606|NCT01653158|464108730|FG005|Overall Study|Other|0|||
128951607|NCT01653158|464108731|FG006|Overall Study|Other|0|||
128951608|NCT01653158|464108732|FG007|Overall Study|Other|1|||
128951609|NCT01653158|464108725|FG000|Overall Study|Progressive disease|0|||
128951610|NCT01653158|464108726|FG001|Overall Study|Progressive disease|0|||
128951611|NCT01653158|464108727|FG002|Overall Study|Progressive disease|0|||
128951612|NCT01653158|464108728|FG003|Overall Study|Progressive disease|0|||
128951613|NCT01653158|464108729|FG004|Overall Study|Progressive disease|1|||
128951614|NCT01653158|464108730|FG005|Overall Study|Progressive disease|1|||
128951615|NCT01653158|464108731|FG006|Overall Study|Progressive disease|2|||
128951616|NCT01653158|464108732|FG007|Overall Study|Progressive disease|9|||
128951617|NCT01653158|464108725|FG000|Overall Study|Withdrawal by Subject|1|||
128951618|NCT01653158|464108726|FG001|Overall Study|Withdrawal by Subject|0|||
128951619|NCT01653158|464108727|FG002|Overall Study|Withdrawal by Subject|0|||
128951620|NCT01653158|464108728|FG003|Overall Study|Withdrawal by Subject|0|||
128951621|NCT01653158|464108729|FG004|Overall Study|Withdrawal by Subject|0|||
128951622|NCT01653158|464108730|FG005|Overall Study|Withdrawal by Subject|0|||
128951623|NCT01653158|464108731|FG006|Overall Study|Withdrawal by Subject|0|||
129125578|NCT05493111|464755486|FG001|Overall Study|Withdrawal of Consent|10|||
129125579|NCT05493111|464755485|FG000|Overall Study|Non-compliance|1|||
129125580|NCT05493111|464755486|FG001|Overall Study|Non-compliance|1|||
129125581|NCT05493111|464755485|FG000|Overall Study|Lost to Follow-up|8|||
129125582|NCT05493111|464755486|FG001|Overall Study|Lost to Follow-up|1|||
129125583|NCT05493111|464755485|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
128770563|NCT02960763|463451545|FG000|Step 1|Other|0|||
129125584|NCT05493111|464755486|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
129125585|NCT05493111|464755485|FG000|Overall Study|Withdrawal by Subject|1|||
128951624|NCT01653158|464108732|FG007|Overall Study|Withdrawal by Subject|0|||
128951625|NCT00980343|464108735|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
128951626|NCT00980343|464108736|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
128951627|NCT01170702|464108739|FG000|Overall Study|Exclusion criteria met after consent|1|||
128951628|NCT01170702|464108740|FG001|Overall Study|Exclusion criteria met after consent|2|||
128951629|NCT01170702|464108741|FG002|Overall Study|Exclusion criteria met after consent|0|||
128951630|NCT01170702|464108742|FG003|Overall Study|Exclusion criteria met after consent|2|||
128951631|NCT01205451|464108743|FG000|Overall Study|Lost to Follow-up|1|||
128951632|NCT01205451|464108744|FG001|Overall Study|Lost to Follow-up|1|||
128951633|NCT01205451|464108743|FG000|Overall Study|Withdrawal by Subject|5|||
128951634|NCT01205451|464108744|FG001|Overall Study|Withdrawal by Subject|9|||
128951635|NCT01677507|464108745|FG000|Initial Assignment|Adverse Event|0|||
128951636|NCT01677507|464108746|FG001|Initial Assignment|Adverse Event|1|||
128951637|NCT01677507|464108745|FG000|Initial Assignment|Protocol Violation|0|||
128951638|NCT01677507|464108746|FG001|Initial Assignment|Protocol Violation|1|||
128951639|NCT01677507|464108745|FG000|Second Assigment|Withdrawal by Subject|2|||
129219147|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129219148|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129219149|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
129219150|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129219151|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129219152|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
128951640|NCT01677507|464108746|FG001|Second Assigment|Withdrawal by Subject|2|||
128951641|NCT01677507|464108745|FG000|Second Assigment|Adverse Event|1|||
128951642|NCT01677507|464108746|FG001|Second Assigment|Adverse Event|3|||
128951643|NCT01194869|464108747|FG000|Overall Study|Disease Progression|2|||
128951644|NCT01194869|464108747|FG000|Overall Study|Toxicity|2|||
129219153|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129219154|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129219155|NCT01106690|465102966|FG000|Core Period: Baseline to Week 26|Other|10|||
129219156|NCT01106690|465102967|FG001|Core Period: Baseline to Week 26|Other|2|||
128951645|NCT03084718|464108751|FG000|Overall Study|Withdrawal by Subject|4|||
128951646|NCT03084718|464108752|FG001|Overall Study|Withdrawal by Subject|3|||
128951647|NCT03084718|464108753|FG002|Overall Study|Withdrawal by Subject|4|||
128951648|NCT03084718|464108754|FG003|Overall Study|Withdrawal by Subject|0|||
129219157|NCT01106690|465102968|FG002|Core Period: Baseline to Week 26|Other|6|||
128951649|NCT03084718|464108755|FG004|Overall Study|Withdrawal by Subject|0|||
128951650|NCT03084718|464108751|FG000|Overall Study|Physician Decision|1|||
128951651|NCT03084718|464108752|FG001|Overall Study|Physician Decision|0|||
128951652|NCT03084718|464108753|FG002|Overall Study|Physician Decision|0|||
128951653|NCT03084718|464108754|FG003|Overall Study|Physician Decision|0|||
128951654|NCT03084718|464108755|FG004|Overall Study|Physician Decision|0|||
128951655|NCT03084718|464108751|FG000|Overall Study|Adverse Event|3|||
128951656|NCT03084718|464108752|FG001|Overall Study|Adverse Event|5|||
128951657|NCT03084718|464108753|FG002|Overall Study|Adverse Event|5|||
128951658|NCT03084718|464108754|FG003|Overall Study|Adverse Event|8|||
128951659|NCT03084718|464108755|FG004|Overall Study|Adverse Event|2|||
128951660|NCT03084718|464108751|FG000|Overall Study|Lack of Efficacy|2|||
128951661|NCT03084718|464108752|FG001|Overall Study|Lack of Efficacy|0|||
128951662|NCT03084718|464108753|FG002|Overall Study|Lack of Efficacy|1|||
128951663|NCT03084718|464108754|FG003|Overall Study|Lack of Efficacy|4|||
129035068|NCT02174276|464418401|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
129035069|NCT02174276|464418398|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
129035070|NCT02174276|464418399|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
129035071|NCT02174276|464418400|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
129035072|NCT02174276|464418401|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
129035073|NCT02174276|464418398|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
129035074|NCT02174276|464418399|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
129035075|NCT02174276|464418400|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
129035076|NCT02174276|464418401|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
129035077|NCT02174276|464418398|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
129035078|NCT02174276|464418399|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
129035079|NCT02174276|464418400|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
129035080|NCT02174276|464418401|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
129035081|NCT02174276|464418398|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
129035082|NCT02174276|464418399|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
129035083|NCT02174276|464418400|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
129035084|NCT02174276|464418401|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
129035085|NCT00434837|464418409|FG000|Overall Study|Lost to Follow-up|20|||
129035086|NCT00434837|464418410|FG001|Overall Study|Lost to Follow-up|23|||
129035087|NCT00434837|464418411|FG002|Overall Study|Lost to Follow-up|30|||
129035088|NCT00515216|464418412|FG000|Overall Study|Withdrawal by Subject|1|||
129035089|NCT02786927|464418414|FG000|Overall Study|Adverse Event|1|||
129035090|NCT02786927|464418414|FG000|Overall Study|Protocol Violation|4|||
129035091|NCT01801917|464418415|FG000|Period 1 - Randomized|Adverse Event|1|||
128951664|NCT03084718|464108755|FG004|Overall Study|Lack of Efficacy|0|||
128951665|NCT03084718|464108751|FG000|Overall Study|Lost to Follow-up|0|||
128951666|NCT03084718|464108752|FG001|Overall Study|Lost to Follow-up|1|||
128951667|NCT03084718|464108753|FG002|Overall Study|Lost to Follow-up|0|||
128951668|NCT03084718|464108754|FG003|Overall Study|Lost to Follow-up|0|||
128951669|NCT03084718|464108755|FG004|Overall Study|Lost to Follow-up|2|||
128951670|NCT03084718|464108751|FG000|Overall Study|Protocol Violation|0|||
129035092|NCT01801917|464418416|FG001|Period 1 - Randomized|Adverse Event|0|||
129035093|NCT01801917|464418417|FG002|Period 1 - Randomized|Adverse Event|1|||
128951671|NCT03084718|464108752|FG001|Overall Study|Protocol Violation|0|||
128951672|NCT03084718|464108753|FG002|Overall Study|Protocol Violation|1|||
128951673|NCT03084718|464108754|FG003|Overall Study|Protocol Violation|0|||
128951674|NCT03084718|464108755|FG004|Overall Study|Protocol Violation|0|||
128951675|NCT03084718|464108751|FG000|Overall Study|Death|0|||
128951676|NCT03084718|464108752|FG001|Overall Study|Death|1|||
128951677|NCT03084718|464108753|FG002|Overall Study|Death|0|||
128951678|NCT03084718|464108754|FG003|Overall Study|Death|0|||
128951679|NCT03084718|464108755|FG004|Overall Study|Death|0|||
128951680|NCT03084718|464108751|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
128951681|NCT03084718|464108752|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
128951682|NCT03084718|464108753|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
128951683|NCT03084718|464108754|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
128951684|NCT03084718|464108755|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
128951685|NCT03986190|464108756|FG000|Overall Study|Withdrawal by Subject|12|||
128951686|NCT03986190|464108757|FG001|Overall Study|Withdrawal by Subject|0|||
128951687|NCT04511819|464108758|FG000|Overall Study|Non-compliance with study drug|5|||
128951688|NCT04511819|464108759|FG001|Overall Study|Non-compliance with study drug|1|||
128951689|NCT04511819|464108758|FG000|Overall Study|Withdrawal by Subject|0|||
128951690|NCT04511819|464108759|FG001|Overall Study|Withdrawal by Subject|3|||
128951691|NCT04511819|464108758|FG000|Overall Study|Adverse Event|0|||
128951692|NCT04511819|464108759|FG001|Overall Study|Adverse Event|1|||
128951693|NCT04511819|464108758|FG000|Overall Study|Protocol deviation|1|||
128951694|NCT04511819|464108759|FG001|Overall Study|Protocol deviation|0|||
128951695|NCT04929613|464108760|FG000|Overall Study|Withdrawal by Subject|12|||
128951696|NCT01742078|464108761|FG000|Overall Study|Withdrawal by Subject|0|||
128951697|NCT01742078|464108762|FG001|Overall Study|Withdrawal by Subject|0|||
128951698|NCT01742078|464108763|FG002|Overall Study|Withdrawal by Subject|0|||
128951699|NCT01742078|464108764|FG003|Overall Study|Withdrawal by Subject|1|||
128951700|NCT01742078|464108765|FG004|Overall Study|Withdrawal by Subject|0|||
128951701|NCT01742078|464108766|FG005|Overall Study|Withdrawal by Subject|0|||
128951702|NCT01742078|464108767|FG006|Overall Study|Withdrawal by Subject|0|||
128951703|NCT01742078|464108768|FG007|Overall Study|Withdrawal by Subject|0|||
128951704|NCT01742078|464108769|FG008|Overall Study|Withdrawal by Subject|0|||
128951705|NCT00084929|464108771|FG000|Overall Study|ineligible - medical contraindication|1|||
128951706|NCT00084929|464108771|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
128951707|NCT00084929|464108771|FG000|Overall Study|Ineligible - Medical history|6|||
128951708|NCT00084929|464108771|FG000|Overall Study|Withdrawal by Subject|10|||
128951709|NCT00084929|464108771|FG000|Overall Study|Missing/incomplete CTC exam|9|||
128951710|NCT00084929|464108771|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
128951711|NCT03247413|464108773|FG000|Overall Study|Lost to Follow-up|28|||
128951712|NCT02767856|464108774|FG000|Overall Study|Lost to Follow-up|9|||
128951713|NCT02767856|464108775|FG001|Overall Study|Lost to Follow-up|1|||
128951714|NCT02767856|464108774|FG000|Overall Study|Withdrawal by Subject|2|||
128951715|NCT02767856|464108775|FG001|Overall Study|Withdrawal by Subject|1|||
128951716|NCT00424294|464108776|FG000|Overall Study|Adverse Event|4|||
128951717|NCT00424294|464108777|FG001|Overall Study|Adverse Event|10|||
128951718|NCT00424294|464108776|FG000|Overall Study|Lack of Efficacy|2|||
128951719|NCT00424294|464108777|FG001|Overall Study|Lack of Efficacy|1|||
128951720|NCT00424294|464108776|FG000|Overall Study|Withdrawal by Subject|1|||
128951721|NCT00424294|464108777|FG001|Overall Study|Withdrawal by Subject|2|||
128951722|NCT00424294|464108776|FG000|Overall Study|Other|0|||
128951723|NCT00424294|464108777|FG001|Overall Study|Other|2|||
128951724|NCT00424294|464108776|FG000|Overall Study|Randomized but not Treated|1|||
128951725|NCT00424294|464108777|FG001|Overall Study|Randomized but not Treated|0|||
128951726|NCT01464788|464108780|FG000|Overall Study|Lost to Follow-up|0|||
128951727|NCT01464788|464108781|FG001|Overall Study|Lost to Follow-up|1|||
128951728|NCT01464788|464108782|FG002|Overall Study|Lost to Follow-up|0|||
128951729|NCT01464788|464108780|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
128951730|NCT01464788|464108781|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
128951731|NCT01464788|464108782|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
128951732|NCT00091026|464108783|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
128951733|NCT00091026|464108784|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
128951734|NCT00091026|464108783|FG000|Overall Study|Patient withdrew and never received trea|0|||
128951735|NCT00091026|464108784|FG001|Overall Study|Patient withdrew and never received trea|2|||
128951736|NCT00091026|464108783|FG000|Overall Study|Unknown-never received treatment|0|||
128951737|NCT00091026|464108784|FG001|Overall Study|Unknown-never received treatment|1|||
128951738|NCT04397718|464108785|FG000|Overall Study|Death|7|||
128951739|NCT04397718|464108786|FG001|Overall Study|Death|11|||
128951740|NCT04397718|464108785|FG000|Overall Study|Lost to Follow-up|0|||
128951741|NCT04397718|464108786|FG001|Overall Study|Lost to Follow-up|4|||
128951742|NCT01797965|464108787|FG000|Overall Study|Adverse Event|104|||
128951743|NCT01797965|464108788|FG001|Overall Study|Adverse Event|129|||
128951744|NCT01797965|464108789|FG002|Overall Study|Adverse Event|4|||
128711067|NCT03672747|463237820|FG001|Overall Study|Lost to Follow-up|1|||
128711068|NCT03672747|463237821|FG002|Overall Study|Lost to Follow-up|2|||
128711069|NCT03672747|463237822|FG003|Overall Study|Lost to Follow-up|2|||
128711070|NCT03672747|463237823|FG004|Overall Study|Lost to Follow-up|2|||
128951745|NCT01797965|464108790|FG003|Overall Study|Adverse Event|21|||
128951746|NCT01797965|464108787|FG000|Overall Study|Lost to Follow-up|9|||
128951747|NCT01797965|464108788|FG001|Overall Study|Lost to Follow-up|8|||
128951748|NCT01797965|464108789|FG002|Overall Study|Lost to Follow-up|1|||
128951749|NCT01797965|464108790|FG003|Overall Study|Lost to Follow-up|2|||
128951750|NCT01797965|464108787|FG000|Overall Study|Consent withdrawn|130|||
128951751|NCT01797965|464108788|FG001|Overall Study|Consent withdrawn|117|||
128951752|NCT01797965|464108789|FG002|Overall Study|Consent withdrawn|3|||
128951753|NCT01797965|464108790|FG003|Overall Study|Consent withdrawn|35|||
128951754|NCT01797965|464108787|FG000|Overall Study|Investigator decision|21|||
128951755|NCT01797965|464108788|FG001|Overall Study|Investigator decision|15|||
128951756|NCT01797965|464108789|FG002|Overall Study|Investigator decision|0|||
128711071|NCT03672747|463237824|FG005|Overall Study|Lost to Follow-up|1|||
128711072|NCT01782495|463237828|FG000|Overall Study|Adverse Event|0|||
128711073|NCT01782495|463237829|FG001|Overall Study|Adverse Event|0|||
128711074|NCT01782495|463237830|FG002|Overall Study|Adverse Event|0|||
128711075|NCT01782495|463237831|FG003|Overall Study|Adverse Event|0|||
128711076|NCT01782495|463237832|FG004|Overall Study|Adverse Event|0|||
128711077|NCT01782495|463237833|FG005|Overall Study|Adverse Event|0|||
128711078|NCT01782495|463237834|FG006|Overall Study|Adverse Event|0|||
128711079|NCT01782495|463237835|FG007|Overall Study|Adverse Event|2|||
128711080|NCT01782495|463237836|FG008|Overall Study|Adverse Event|0|||
128711081|NCT01782495|463237837|FG009|Overall Study|Adverse Event|0|||
128711082|NCT01782495|463237838|FG010|Overall Study|Adverse Event|0|||
128711083|NCT01782495|463237828|FG000|Overall Study|Withdrew Consent|0|||
128711084|NCT01782495|463237829|FG001|Overall Study|Withdrew Consent|1|||
128711085|NCT01782495|463237830|FG002|Overall Study|Withdrew Consent|0|||
128711086|NCT01782495|463237831|FG003|Overall Study|Withdrew Consent|0|||
128711087|NCT01782495|463237832|FG004|Overall Study|Withdrew Consent|0|||
128711088|NCT01782495|463237833|FG005|Overall Study|Withdrew Consent|0|||
128711089|NCT01782495|463237834|FG006|Overall Study|Withdrew Consent|0|||
128711090|NCT01782495|463237835|FG007|Overall Study|Withdrew Consent|1|||
128711091|NCT01782495|463237836|FG008|Overall Study|Withdrew Consent|0|||
128711092|NCT01782495|463237837|FG009|Overall Study|Withdrew Consent|0|||
128711093|NCT01782495|463237838|FG010|Overall Study|Withdrew Consent|0|||
128711094|NCT03428360|463237839|FG000|Overall Study|Informed consent withdrawn|5|||
128711095|NCT03428360|463237839|FG000|Overall Study|Withdrawal by Subject|4|||
128711096|NCT03428360|463237839|FG000|Overall Study|Lost to Follow-up|5|||
128711097|NCT03428360|463237839|FG000|Overall Study|Physician Decision|2|||
128711098|NCT03428360|463237839|FG000|Overall Study|Informed consent withdrawn|5|||
128711099|NCT03428360|463237839|FG000|Overall Study|Study terminated by sponsor|10|||
128711100|NCT03428360|463237839|FG000|Overall Study|Non-compliant with study|1|||
128711101|NCT03428360|463237839|FG000|Overall Study|Non-compliant with study drug|3|||
128711102|NCT03428360|463237839|FG000|Overall Study|Death|3|||
128711103|NCT03428360|463237839|FG000|Overall Study|Adverse Event|1|||
128711104|NCT03428360|463237839|FG000|Overall Study|Not on antiepileptic drug|1|||
128711105|NCT02260921|463237840|FG000|Overall Study|Adverse Event|1|||
128711106|NCT02260921|463237841|FG001|Overall Study|Adverse Event|0|||
128711107|NCT02260921|463237840|FG000|Overall Study|Lost to Follow-up|4|||
128711108|NCT02260921|463237841|FG001|Overall Study|Lost to Follow-up|3|||
128951757|NCT01797965|464108790|FG003|Overall Study|Investigator decision|0|||
128711109|NCT02260921|463237840|FG000|Overall Study|Withdraw Consent|4|||
128711110|NCT02260921|463237841|FG001|Overall Study|Withdraw Consent|1|||
128711111|NCT02260921|463237840|FG000|Overall Study|Death|1|||
128711112|NCT02260921|463237841|FG001|Overall Study|Death|0|||
128711113|NCT02260921|463237840|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
128711114|NCT02260921|463237841|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
128711115|NCT02759471|463237842|FG000|Overall Study|discomfort|2|||
128711116|NCT02927080|463239810|FG000|Overall Study|Withdrawal by Subject|0|||
128711117|NCT02927080|463239811|FG001|Overall Study|Withdrawal by Subject|0|||
128711118|NCT02927080|463239812|FG002|Overall Study|Withdrawal by Subject|0|||
128711119|NCT02927080|463239813|FG003|Overall Study|Withdrawal by Subject|0|||
128711120|NCT02927080|463239814|FG004|Overall Study|Withdrawal by Subject|1|||
128711121|NCT02927080|463239815|FG005|Overall Study|Withdrawal by Subject|0|||
128711122|NCT02927080|463239816|FG006|Overall Study|Withdrawal by Subject|1|||
128711123|NCT02927080|463239817|FG007|Overall Study|Withdrawal by Subject|1|||
128711124|NCT02927080|463239818|FG008|Overall Study|Withdrawal by Subject|0|||
128711125|NCT02927080|463239819|FG009|Overall Study|Withdrawal by Subject|2|||
128711126|NCT02927080|463239810|FG000|Overall Study|Willingness to comply with protocol|0|||
128711127|NCT02927080|463239811|FG001|Overall Study|Willingness to comply with protocol|0|||
128711128|NCT02927080|463239812|FG002|Overall Study|Willingness to comply with protocol|0|||
128711129|NCT02927080|463239813|FG003|Overall Study|Willingness to comply with protocol|0|||
128711130|NCT02927080|463239814|FG004|Overall Study|Willingness to comply with protocol|0|||
128711131|NCT02927080|463239815|FG005|Overall Study|Willingness to comply with protocol|0|||
128711132|NCT02927080|463239816|FG006|Overall Study|Willingness to comply with protocol|0|||
128711133|NCT02927080|463239817|FG007|Overall Study|Willingness to comply with protocol|0|||
128711134|NCT02927080|463239818|FG008|Overall Study|Willingness to comply with protocol|0|||
128711135|NCT02927080|463239819|FG009|Overall Study|Willingness to comply with protocol|1|||
128951758|NCT01797965|464108787|FG000|Overall Study|Death|2|||
128951759|NCT01797965|464108788|FG001|Overall Study|Death|4|||
128951760|NCT01797965|464108789|FG002|Overall Study|Death|0|||
128951761|NCT01797965|464108790|FG003|Overall Study|Death|0|||
128951762|NCT01797965|464108787|FG000|Overall Study|Disease progression, defined by protocol|3|||
128951763|NCT01797965|464108788|FG001|Overall Study|Disease progression, defined by protocol|1|||
128951764|NCT01797965|464108789|FG002|Overall Study|Disease progression, defined by protocol|0|||
128951765|NCT01797965|464108790|FG003|Overall Study|Disease progression, defined by protocol|0|||
128951766|NCT01797965|464108787|FG000|Overall Study|Reason Not Specified|280|||
128951767|NCT01797965|464108788|FG001|Overall Study|Reason Not Specified|295|||
128951768|NCT01797965|464108789|FG002|Overall Study|Reason Not Specified|0|||
128951769|NCT01797965|464108790|FG003|Overall Study|Reason Not Specified|15|||
128951770|NCT00589979|464108791|FG000|Run-In Period|Adverse Event|5|||
128951771|NCT00589979|464108792|FG001|Run-In Period|Adverse Event|0|||
128951772|NCT00589979|464108793|FG002|Run-In Period|Adverse Event|0|||
128951773|NCT00589979|464108791|FG000|Run-In Period|Protocol Violation|3|||
128951774|NCT00589979|464108792|FG001|Run-In Period|Protocol Violation|0|||
128951775|NCT00589979|464108793|FG002|Run-In Period|Protocol Violation|0|||
128951776|NCT00589979|464108791|FG000|Run-In Period|Did not qualify for randomization|54|||
128951777|NCT00589979|464108792|FG001|Run-In Period|Did not qualify for randomization|0|||
128951778|NCT00589979|464108793|FG002|Run-In Period|Did not qualify for randomization|0|||
128951779|NCT00589979|464108791|FG000|Run-In Period|Withdrawal by Subject|10|||
128951780|NCT00589979|464108792|FG001|Run-In Period|Withdrawal by Subject|0|||
128951781|NCT00589979|464108793|FG002|Run-In Period|Withdrawal by Subject|0|||
128951782|NCT00589979|464108791|FG000|Run-In Period|Informed Consent Withdrawn|4|||
128951783|NCT00589979|464108792|FG001|Run-In Period|Informed Consent Withdrawn|0|||
128951784|NCT00589979|464108793|FG002|Run-In Period|Informed Consent Withdrawn|0|||
128951785|NCT00589979|464108791|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
128951786|NCT00589979|464108792|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
128951787|NCT00589979|464108793|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
128951788|NCT00589979|464108791|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
128951789|NCT00589979|464108792|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
128951790|NCT00589979|464108793|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
128951791|NCT00589979|464108791|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
128951792|NCT00589979|464108792|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
129035094|NCT01801917|464418418|FG003|Period 1 - Randomized|Adverse Event|0|||
129035095|NCT04307849|464418419|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
129035096|NCT04307849|464418420|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
129035097|NCT04307849|464418421|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
129035098|NCT04307849|464418422|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
129035099|NCT04307849|464418423|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
129035100|NCT04307849|464418424|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
129035101|NCT04307849|464418419|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129035102|NCT04307849|464418420|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129035103|NCT04307849|464418421|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
129035104|NCT04307849|464418422|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129035105|NCT04307849|464418423|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129035106|NCT04307849|464418424|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129035107|NCT04307849|464418419|FG000|Overall Study|Family member did not want them to continue|0|||
129035108|NCT04307849|464418420|FG001|Overall Study|Family member did not want them to continue|0|||
129035109|NCT04307849|464418421|FG002|Overall Study|Family member did not want them to continue|1|||
129035110|NCT04307849|464418422|FG003|Overall Study|Family member did not want them to continue|0|||
129035111|NCT04307849|464418423|FG004|Overall Study|Family member did not want them to continue|0|||
129035112|NCT04307849|464418424|FG005|Overall Study|Family member did not want them to continue|0|||
129035113|NCT04307849|464418419|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
129035114|NCT04307849|464418420|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
129035115|NCT04307849|464418421|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
129035116|NCT04307849|464418422|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
129035117|NCT04307849|464418423|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
129035118|NCT04307849|464418424|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
128711136|NCT02927080|463239810|FG000|Overall Study|Study terminated by Sponsor|0|||
128951793|NCT00589979|464108793|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
128951794|NCT00589979|464108791|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
128951795|NCT00589979|464108792|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
128711137|NCT02927080|463239811|FG001|Overall Study|Study terminated by Sponsor|0|||
128711138|NCT02927080|463239812|FG002|Overall Study|Study terminated by Sponsor|0|||
128711139|NCT02927080|463239813|FG003|Overall Study|Study terminated by Sponsor|0|||
128711140|NCT02927080|463239814|FG004|Overall Study|Study terminated by Sponsor|0|||
128711141|NCT02927080|463239815|FG005|Overall Study|Study terminated by Sponsor|0|||
128711142|NCT02927080|463239816|FG006|Overall Study|Study terminated by Sponsor|6|||
128711143|NCT02927080|463239817|FG007|Overall Study|Study terminated by Sponsor|7|||
128711144|NCT02927080|463239818|FG008|Overall Study|Study terminated by Sponsor|2|||
128711145|NCT02927080|463239819|FG009|Overall Study|Study terminated by Sponsor|3|||
128711146|NCT02927080|463239810|FG000|Overall Study|Adverse Event|0|||
128711147|NCT02927080|463239811|FG001|Overall Study|Adverse Event|1|||
128711148|NCT02927080|463239812|FG002|Overall Study|Adverse Event|0|||
128711149|NCT02927080|463239813|FG003|Overall Study|Adverse Event|0|||
128711150|NCT02927080|463239814|FG004|Overall Study|Adverse Event|0|||
128711151|NCT02927080|463239815|FG005|Overall Study|Adverse Event|0|||
128711152|NCT02927080|463239816|FG006|Overall Study|Adverse Event|0|||
128711153|NCT02927080|463239817|FG007|Overall Study|Adverse Event|1|||
128770564|NCT02960763|463451546|FG001|Step 1|Other|0|||
128770565|NCT02960763|463451547|FG002|Step 1|Other|1|||
128951796|NCT00589979|464108793|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
128951797|NCT00589979|464108791|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
128951798|NCT00589979|464108792|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
128951799|NCT00589979|464108793|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
128951800|NCT00589979|464108791|FG000|Double-Blind Treatment Period 2|Other|0|||
128951801|NCT00589979|464108792|FG001|Double-Blind Treatment Period 2|Other|0|||
128951802|NCT00589979|464108793|FG002|Double-Blind Treatment Period 2|Other|1|||
128951803|NCT00589979|464108791|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
128951804|NCT00589979|464108792|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
128951805|NCT00589979|464108793|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
128951806|NCT00589979|464108791|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
128951807|NCT00589979|464108792|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
128951808|NCT00589979|464108793|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
128951809|NCT00712322|464108794|FG000|Overall Study|Protocol deviation|0|||
128951810|NCT00712322|464108795|FG001|Overall Study|Protocol deviation|1|||
128951811|NCT00712322|464108796|FG002|Overall Study|Protocol deviation|0|||
128951812|NCT02670330|464108798|FG000|Overall Study|Protocol Deviation|1|||
128951813|NCT02670330|464108799|FG001|Overall Study|Protocol Deviation|0|||
128951814|NCT02670330|464108798|FG000|Overall Study|Study Terminated By Sponsor|36|||
128951815|NCT02670330|464108799|FG001|Overall Study|Study Terminated By Sponsor|43|||
128951816|NCT02670330|464108798|FG000|Overall Study|Adverse Event|1|||
128951817|NCT02670330|464108799|FG001|Overall Study|Adverse Event|3|||
128951818|NCT02670330|464108798|FG000|Overall Study|Withdrawal by Subject|34|||
128951819|NCT02670330|464108799|FG001|Overall Study|Withdrawal by Subject|29|||
128951820|NCT02670330|464108798|FG000|Overall Study|Lost to Follow-up|3|||
128951821|NCT02670330|464108799|FG001|Overall Study|Lost to Follow-up|2|||
128951822|NCT00239837|464108800|FG000|Overall Study|Lost to Follow-up|3|||
128951823|NCT00239837|464108801|FG001|Overall Study|Lost to Follow-up|7|||
128951824|NCT01153893|464108802|FG000|Overall Study|Adverse Event|1|||
128951825|NCT01153893|464108803|FG001|Overall Study|Adverse Event|0|||
128951826|NCT01838590|464108804|FG000|Overall Study|Lack of Efficacy|12|||
129035119|NCT01294449|464418427|FG000|Overall Study|Death|11|||
129035120|NCT01294449|464418428|FG001|Overall Study|Death|12|||
129035121|NCT01294449|464418427|FG000|Overall Study|Withdrawal by Subject|1|||
129035122|NCT01294449|464418428|FG001|Overall Study|Withdrawal by Subject|3|||
129035123|NCT05467982|464418429|FG000|Overall Study|Death|0|||
129035124|NCT05467982|464418430|FG001|Overall Study|Death|1|||
129035125|NCT05467982|464418429|FG000|Overall Study|Lost to Follow-up|3|||
129035126|NCT05467982|464418430|FG001|Overall Study|Lost to Follow-up|1|||
129035127|NCT00398073|464418446|FG000|Overall Study|Withdrawal by Subject|1|||
129035128|NCT00398073|464418447|FG001|Overall Study|Withdrawal by Subject|0|||
129035129|NCT01833169|464418452|FG000|Overall Study|Disease Progression|99|||
129035130|NCT01833169|464418452|FG000|Overall Study|Adverse Event|33|||
128711154|NCT02927080|463239818|FG008|Overall Study|Adverse Event|0|||
128951827|NCT01838590|464108805|FG001|Overall Study|Lack of Efficacy|4|||
128951828|NCT01838590|464108804|FG000|Overall Study|Lost to Follow-up|0|||
128951829|NCT01838590|464108805|FG001|Overall Study|Lost to Follow-up|1|||
128951830|NCT01354431|464108806|FG000|Pre-Treatment Period|Not reported|1|||
128951831|NCT01354431|464108807|FG001|Pre-Treatment Period|Not reported|0|||
128951832|NCT01354431|464108808|FG002|Pre-Treatment Period|Not reported|0|||
128951833|NCT01354431|464108806|FG000|Treatment Period|Disease Progression|50|||
128951834|NCT01354431|464108807|FG001|Treatment Period|Disease Progression|40|||
128951835|NCT01354431|464108808|FG002|Treatment Period|Disease Progression|44|||
129035131|NCT01833169|464418452|FG000|Overall Study|Withdrawal by Subject|9|||
128711155|NCT02927080|463239819|FG009|Overall Study|Adverse Event|1|||
128711156|NCT02927080|463239810|FG000|Overall Study|Other|0|||
128711157|NCT02927080|463239811|FG001|Overall Study|Other|0|||
128711158|NCT02927080|463239812|FG002|Overall Study|Other|0|||
128711159|NCT02927080|463239813|FG003|Overall Study|Other|0|||
128951836|NCT01354431|464108806|FG000|Treatment Period|Study Drug Toxicity|5|||
128951837|NCT01354431|464108807|FG001|Treatment Period|Study Drug Toxicity|8|||
128951838|NCT01354431|464108808|FG002|Treatment Period|Study Drug Toxicity|4|||
128951839|NCT01354431|464108806|FG000|Treatment Period|Death|0|||
128951840|NCT01354431|464108807|FG001|Treatment Period|Death|1|||
128951841|NCT01354431|464108808|FG002|Treatment Period|Death|0|||
128951842|NCT01354431|464108806|FG000|Treatment Period|AE unrelated to study drug|1|||
128951843|NCT01354431|464108807|FG001|Treatment Period|AE unrelated to study drug|2|||
128951844|NCT01354431|464108808|FG002|Treatment Period|AE unrelated to study drug|5|||
128951845|NCT01354431|464108806|FG000|Treatment Period|Participant request to discontinue|2|||
128951846|NCT01354431|464108807|FG001|Treatment Period|Participant request to discontinue|2|||
128951847|NCT01354431|464108808|FG002|Treatment Period|Participant request to discontinue|1|||
128951848|NCT01354431|464108806|FG000|Treatment Period|Participant withdrew consent|0|||
128951849|NCT01354431|464108807|FG001|Treatment Period|Participant withdrew consent|1|||
129219158|NCT01106690|465102966|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129219159|NCT01106690|465102967|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129219160|NCT01106690|465102968|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129219161|NCT01106690|465102966|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129219162|NCT01106690|465102967|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129219163|NCT01106690|465102968|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129219164|NCT01106690|465102966|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129219165|NCT01106690|465102967|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129219166|NCT01106690|465102968|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129219167|NCT01106690|465102966|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129219168|NCT01106690|465102967|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129219169|NCT01106690|465102968|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
128951850|NCT01354431|464108808|FG002|Treatment Period|Participant withdrew consent|0|||
128951851|NCT01354431|464108806|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
128951852|NCT01354431|464108807|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
128951853|NCT01354431|464108808|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
128951854|NCT00536978|464108809|FG000|Overall Study|Not eligible for Adback Infusion|22|||
128951855|NCT03550131|464108811|FG000|Overall Study|Lost to Follow-up|16|||
128951856|NCT03550131|464108812|FG001|Overall Study|Lost to Follow-up|24|||
128951857|NCT03550131|464108811|FG000|Overall Study|Withdrawal by Subject|36|||
128951858|NCT03550131|464108812|FG001|Overall Study|Withdrawal by Subject|28|||
128951859|NCT03550131|464108811|FG000|Overall Study|Illness of dyad member|10|||
128951860|NCT03550131|464108812|FG001|Overall Study|Illness of dyad member|2|||
128951861|NCT03550131|464108811|FG000|Overall Study|Death of person with dementia|4|||
128951862|NCT03550131|464108812|FG001|Overall Study|Death of person with dementia|8|||
128951863|NCT01318512|464108813|FG000|Maintenance Period (6 Months)|Death|2|||
128951864|NCT01318512|464108813|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
128951865|NCT01364233|464108815|FG000|Overall Study|Lost to Follow-up|1|||
128951866|NCT00878215|464108816|FG000|Overall Study|Determined to be ineligible|0|||
128951867|NCT00878215|464108817|FG001|Overall Study|Determined to be ineligible|10|||
128951868|NCT00878215|464108818|FG002|Overall Study|Determined to be ineligible|0|||
128951869|NCT00878215|464108819|FG003|Overall Study|Determined to be ineligible|0|||
128951870|NCT00819585|464108821|FG000|Core Study|Adverse Event|2|||
128951871|NCT00819585|464108822|FG001|Core Study|Adverse Event|1|||
128951872|NCT00819585|464108823|FG002|Core Study|Adverse Event|1|||
128951873|NCT00819585|464108824|FG003|Core Study|Adverse Event|4|||
128951874|NCT00819585|464108825|FG004|Core Study|Adverse Event|1|||
128951875|NCT00819585|464108826|FG005|Core Study|Adverse Event|0|||
128951876|NCT00819585|464108827|FG006|Core Study|Adverse Event|2|||
128951877|NCT00819585|464108828|FG007|Core Study|Adverse Event|0|||
128951878|NCT00819585|464108829|FG008|Core Study|Adverse Event|0|||
128951879|NCT00819585|464108830|FG009|Core Study|Adverse Event|0|||
128951880|NCT00819585|464108831|FG010|Core Study|Adverse Event|0|||
128951881|NCT00819585|464108821|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
128951882|NCT00819585|464108822|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
128951883|NCT00819585|464108823|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
128951884|NCT00819585|464108824|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
128951885|NCT00819585|464108825|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
128951886|NCT00819585|464108826|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
128951887|NCT00819585|464108827|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
128951888|NCT00819585|464108828|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
128951889|NCT00819585|464108829|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
128951890|NCT00819585|464108830|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
128951891|NCT00819585|464108831|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
128951892|NCT00819585|464108821|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951893|NCT00819585|464108822|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
128951894|NCT00819585|464108823|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951895|NCT00819585|464108824|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
129219170|NCT01106690|465102966|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129125586|NCT05493111|464755486|FG001|Overall Study|Withdrawal by Subject|1|||
129125587|NCT06125964|464755487|FG000|Overall Study|Lost to Follow-up|0|||
128951896|NCT00819585|464108825|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951897|NCT00819585|464108826|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951898|NCT00819585|464108827|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
128951899|NCT00819585|464108828|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951900|NCT00819585|464108829|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951901|NCT00819585|464108830|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951902|NCT00819585|464108831|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
128951903|NCT00819585|464108821|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
128951904|NCT00819585|464108822|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
128951905|NCT00819585|464108823|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
128951906|NCT00819585|464108824|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
128951907|NCT00819585|464108825|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
128951908|NCT00819585|464108826|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
128951909|NCT00819585|464108827|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
128951910|NCT00819585|464108828|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
128951911|NCT00819585|464108829|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
128951912|NCT00819585|464108830|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
128951913|NCT00819585|464108831|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
128951914|NCT00819585|464108821|FG000|Core Study|Subject Withdrew Consent|0|||
128951915|NCT00819585|464108822|FG001|Core Study|Subject Withdrew Consent|3|||
128951916|NCT00819585|464108823|FG002|Core Study|Subject Withdrew Consent|2|||
128951917|NCT00819585|464108824|FG003|Core Study|Subject Withdrew Consent|1|||
128951918|NCT00819585|464108825|FG004|Core Study|Subject Withdrew Consent|0|||
128951919|NCT00819585|464108826|FG005|Core Study|Subject Withdrew Consent|0|||
128951920|NCT00819585|464108827|FG006|Core Study|Subject Withdrew Consent|3|||
129125588|NCT06125964|464755488|FG001|Overall Study|Lost to Follow-up|1|||
129125589|NCT06125964|464755489|FG002|Overall Study|Lost to Follow-up|0|||
129125590|NCT06125964|464755490|FG003|Overall Study|Lost to Follow-up|0|||
129125591|NCT01787838|464755491|FG000|Overall Study|refused|1413|||
129125592|NCT01431976|464755492|FG000|Overall Study|Adverse Event|6|||
129125593|NCT01431976|464755492|FG000|Overall Study|Lack of Efficacy|2|||
129125594|NCT01431976|464755492|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
129125595|NCT01431976|464755492|FG000|Overall Study|Physician Decision|1|||
129125596|NCT01431976|464755492|FG000|Overall Study|Withdrawal by Subject|1|||
129125597|NCT01136954|464755494|FG000|Overall Study|Adverse Event|3|||
129125598|NCT01136954|464755495|FG001|Overall Study|Adverse Event|2|||
129125599|NCT01136954|464755494|FG000|Overall Study|Withdrawal by Subject|6|||
129125600|NCT01136954|464755495|FG001|Overall Study|Withdrawal by Subject|2|||
129125601|NCT01136954|464755494|FG000|Overall Study|Lack of Efficacy|14|||
129125602|NCT01136954|464755495|FG001|Overall Study|Lack of Efficacy|13|||
129125603|NCT01136954|464755494|FG000|Overall Study|Physician Decision|0|||
129125604|NCT01136954|464755495|FG001|Overall Study|Physician Decision|1|||
129125605|NCT01136954|464755494|FG000|Overall Study|Other|1|||
129125606|NCT01136954|464755495|FG001|Overall Study|Other|3|||
129125607|NCT00782067|464755496|FG000|Overall Study|Adverse Event|35|||
129125608|NCT00782067|464755496|FG000|Overall Study|Subject withdrew consent|11|||
129125609|NCT00782067|464755496|FG000|Overall Study|Lost to Follow-up|2|||
129125610|NCT00782067|464755496|FG000|Overall Study|Administrative problems|14|||
129125611|NCT00782067|464755496|FG000|Overall Study|Death|9|||
129125612|NCT00782067|464755496|FG000|Overall Study|Disease progression|43|||
129125613|NCT00782067|464755496|FG000|Overall Study|Protocol deviation|2|||
129125614|NCT00973973|464755502|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
129125615|NCT00973973|464755503|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
129125616|NCT00973973|464755502|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
129125617|NCT00973973|464755503|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
129125618|NCT00973973|464755502|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
129125619|NCT00973973|464755503|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
128711160|NCT02927080|463239814|FG004|Overall Study|Other|0|||
128711161|NCT02927080|463239815|FG005|Overall Study|Other|0|||
128711162|NCT02927080|463239816|FG006|Overall Study|Other|1|||
128951921|NCT00819585|464108828|FG007|Core Study|Subject Withdrew Consent|0|||
128951922|NCT00819585|464108829|FG008|Core Study|Subject Withdrew Consent|0|||
128951923|NCT00819585|464108830|FG009|Core Study|Subject Withdrew Consent|0|||
128951924|NCT00819585|464108831|FG010|Core Study|Subject Withdrew Consent|0|||
128951925|NCT00819585|464108821|FG000|Core Study|Lost to Follow-up|2|||
128951926|NCT00819585|464108822|FG001|Core Study|Lost to Follow-up|1|||
128951927|NCT00819585|464108823|FG002|Core Study|Lost to Follow-up|2|||
128951928|NCT00819585|464108824|FG003|Core Study|Lost to Follow-up|0|||
128951929|NCT00819585|464108825|FG004|Core Study|Lost to Follow-up|1|||
128951930|NCT00819585|464108826|FG005|Core Study|Lost to Follow-up|1|||
128951931|NCT00819585|464108827|FG006|Core Study|Lost to Follow-up|1|||
128951932|NCT00819585|464108828|FG007|Core Study|Lost to Follow-up|0|||
128951933|NCT00819585|464108829|FG008|Core Study|Lost to Follow-up|0|||
129035132|NCT01833169|464418452|FG000|Overall Study|Death|3|||
129035133|NCT01833169|464418452|FG000|Overall Study|Physician Decision|2|||
129035134|NCT00879684|464418456|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
129035135|NCT00879684|464418457|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
129035136|NCT00879684|464418458|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
129035137|NCT00879684|464418459|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
129035138|NCT00879684|464418460|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
129035139|NCT00879684|464418461|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
129035140|NCT00879684|464418462|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
129035141|NCT00879684|464418456|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
129035142|NCT00879684|464418457|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
129035143|NCT00879684|464418458|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
129035144|NCT00879684|464418459|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
129035145|NCT00879684|464418460|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
129035146|NCT00879684|464418461|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
129035147|NCT00879684|464418462|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
129035148|NCT00879684|464418456|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
129035149|NCT00879684|464418457|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
129035150|NCT00879684|464418458|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
129035151|NCT00879684|464418459|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
129035152|NCT00879684|464418460|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
129035153|NCT00879684|464418461|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
129035154|NCT00879684|464418462|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
129035155|NCT00879684|464418456|FG000|Stage 1: Dose Escalation|Death|0|||
129035156|NCT00879684|464418457|FG001|Stage 1: Dose Escalation|Death|0|||
129035157|NCT00879684|464418458|FG002|Stage 1: Dose Escalation|Death|1|||
129035158|NCT00879684|464418459|FG003|Stage 1: Dose Escalation|Death|0|||
129035159|NCT00879684|464418460|FG004|Stage 1: Dose Escalation|Death|0|||
129035160|NCT00879684|464418461|FG005|Stage 1: Dose Escalation|Death|0|||
129035161|NCT00879684|464418462|FG006|Stage 1: Dose Escalation|Death|0|||
129035162|NCT00879684|464418456|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129035163|NCT00879684|464418457|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
128711163|NCT02927080|463239817|FG007|Overall Study|Other|0|||
128711164|NCT02927080|463239818|FG008|Overall Study|Other|1|||
128711165|NCT02927080|463239819|FG009|Overall Study|Other|0|||
129035164|NCT00879684|464418458|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129035165|NCT00879684|464418459|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129035166|NCT00879684|464418460|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129035167|NCT00879684|464418461|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129035168|NCT00879684|464418462|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
129035169|NCT00879684|464418456|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
129035170|NCT00879684|464418457|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
129035171|NCT00879684|464418458|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
129035172|NCT00879684|464418459|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
129035173|NCT00879684|464418460|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
129035174|NCT00879684|464418461|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
129035175|NCT00879684|464418462|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
129035176|NCT00879684|464418456|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129035177|NCT00879684|464418457|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129035178|NCT00879684|464418458|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129035179|NCT00879684|464418459|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129035180|NCT00879684|464418460|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129035181|NCT00879684|464418461|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129035182|NCT00879684|464418462|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
129035183|NCT00105157|464418463|FG000|Double-Blind (DB)|Never Treated|1|||
129035184|NCT00105157|464418464|FG001|Double-Blind (DB)|Never Treated|0|||
129035185|NCT00105157|464418465|FG002|Double-Blind (DB)|Never Treated|0|||
129035186|NCT00105157|464418466|FG003|Double-Blind (DB)|Never Treated|0|||
128711166|NCT00157950|463239820|FG000|Overall Study|Death|1|||
129035187|NCT00105157|464418463|FG000|Double-Blind (DB)|Adverse Event|2|||
129035188|NCT00105157|464418464|FG001|Double-Blind (DB)|Adverse Event|0|||
129035189|NCT00105157|464418465|FG002|Double-Blind (DB)|Adverse Event|1|||
129035190|NCT00105157|464418466|FG003|Double-Blind (DB)|Adverse Event|1|||
129035191|NCT00105157|464418463|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
129035192|NCT00105157|464418464|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
129035193|NCT00105157|464418465|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
129035194|NCT00105157|464418466|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
129035195|NCT00105157|464418463|FG000|Open-Label Continuation of DB|Adverse Event|3|||
129035196|NCT00105157|464418464|FG001|Open-Label Continuation of DB|Adverse Event|1|||
129035197|NCT00105157|464418465|FG002|Open-Label Continuation of DB|Adverse Event|0|||
129035198|NCT00105157|464418466|FG003|Open-Label Continuation of DB|Adverse Event|0|||
129035199|NCT00105157|464418463|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
128951934|NCT00819585|464108830|FG009|Core Study|Lost to Follow-up|0|||
128951935|NCT00819585|464108831|FG010|Core Study|Lost to Follow-up|0|||
128951936|NCT00819585|464108821|FG000|Core Study|Administrative Problems|0|||
128951937|NCT00819585|464108822|FG001|Core Study|Administrative Problems|0|||
128951938|NCT00819585|464108823|FG002|Core Study|Administrative Problems|0|||
128951939|NCT00819585|464108824|FG003|Core Study|Administrative Problems|0|||
128951940|NCT00819585|464108825|FG004|Core Study|Administrative Problems|0|||
128951941|NCT00819585|464108826|FG005|Core Study|Administrative Problems|0|||
128951942|NCT00819585|464108827|FG006|Core Study|Administrative Problems|2|||
128951943|NCT00819585|464108828|FG007|Core Study|Administrative Problems|0|||
128951944|NCT00819585|464108829|FG008|Core Study|Administrative Problems|0|||
128951945|NCT00819585|464108830|FG009|Core Study|Administrative Problems|0|||
128951946|NCT00819585|464108831|FG010|Core Study|Administrative Problems|0|||
128951947|NCT00819585|464108821|FG000|Core Study|Death|0|||
128951948|NCT00819585|464108822|FG001|Core Study|Death|0|||
128951949|NCT00819585|464108823|FG002|Core Study|Death|0|||
128951950|NCT00819585|464108824|FG003|Core Study|Death|0|||
128951951|NCT00819585|464108825|FG004|Core Study|Death|0|||
128951952|NCT00819585|464108826|FG005|Core Study|Death|0|||
128951953|NCT00819585|464108827|FG006|Core Study|Death|1|||
128951954|NCT00819585|464108828|FG007|Core Study|Death|0|||
128951955|NCT00819585|464108829|FG008|Core Study|Death|0|||
128951956|NCT00819585|464108830|FG009|Core Study|Death|0|||
128951957|NCT00819585|464108831|FG010|Core Study|Death|0|||
128951958|NCT00819585|464108821|FG000|Core Study|Protocol Violation|0|||
128951959|NCT00819585|464108822|FG001|Core Study|Protocol Violation|0|||
128951960|NCT00819585|464108823|FG002|Core Study|Protocol Violation|1|||
128951961|NCT00819585|464108824|FG003|Core Study|Protocol Violation|0|||
128951962|NCT00819585|464108825|FG004|Core Study|Protocol Violation|0|||
128951963|NCT00819585|464108826|FG005|Core Study|Protocol Violation|1|||
128951964|NCT00819585|464108827|FG006|Core Study|Protocol Violation|3|||
128951965|NCT00819585|464108828|FG007|Core Study|Protocol Violation|0|||
128951966|NCT00819585|464108829|FG008|Core Study|Protocol Violation|0|||
128951967|NCT00819585|464108830|FG009|Core Study|Protocol Violation|0|||
128951968|NCT00819585|464108831|FG010|Core Study|Protocol Violation|0|||
128951969|NCT00819585|464108821|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
128951970|NCT00819585|464108822|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
128951971|NCT00819585|464108823|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
128951972|NCT00819585|464108824|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
128951973|NCT00819585|464108825|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
128951974|NCT00819585|464108826|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
128951975|NCT00819585|464108827|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
128951976|NCT00819585|464108828|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
128951977|NCT00819585|464108829|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
129125620|NCT00973973|464755502|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
129125621|NCT00973973|464755503|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
129125622|NCT00973973|464755502|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
129125623|NCT00973973|464755503|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
129125624|NCT00973973|464755502|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
129125625|NCT00973973|464755503|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
129125626|NCT00973973|464755502|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
129125627|NCT00973973|464755503|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
129125628|NCT00973973|464755502|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
129125629|NCT00973973|464755503|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
129125630|NCT00973973|464755502|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
129125631|NCT00973973|464755503|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
129125632|NCT00973973|464755502|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
129125633|NCT00973973|464755503|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
129125634|NCT00973973|464755502|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
129125635|NCT00973973|464755503|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
129125636|NCT00973973|464755502|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
129125637|NCT00973973|464755503|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
128951978|NCT00819585|464108830|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
128951979|NCT00819585|464108831|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
128951980|NCT00819585|464108821|FG000|Extension Study|Subject Withdrew Consent|0|||
128951981|NCT00819585|464108822|FG001|Extension Study|Subject Withdrew Consent|0|||
128951982|NCT00819585|464108823|FG002|Extension Study|Subject Withdrew Consent|0|||
128951983|NCT00819585|464108824|FG003|Extension Study|Subject Withdrew Consent|0|||
128951984|NCT00819585|464108825|FG004|Extension Study|Subject Withdrew Consent|0|||
128951985|NCT00819585|464108826|FG005|Extension Study|Subject Withdrew Consent|0|||
128951986|NCT00819585|464108827|FG006|Extension Study|Subject Withdrew Consent|0|||
128951987|NCT00819585|464108828|FG007|Extension Study|Subject Withdrew Consent|0|||
128951988|NCT00819585|464108829|FG008|Extension Study|Subject Withdrew Consent|3|||
128951989|NCT00819585|464108830|FG009|Extension Study|Subject Withdrew Consent|0|||
129035200|NCT00105157|464418464|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
129035201|NCT00105157|464418465|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
128951990|NCT00819585|464108831|FG010|Extension Study|Subject Withdrew Consent|1|||
128951991|NCT00819585|464108821|FG000|Extension Study|Lost to Follow-up|0|||
128951992|NCT00819585|464108822|FG001|Extension Study|Lost to Follow-up|0|||
128951993|NCT00819585|464108823|FG002|Extension Study|Lost to Follow-up|0|||
129035202|NCT00105157|464418466|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
129035203|NCT00105157|464418463|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
129035204|NCT00105157|464418464|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
129035205|NCT00105157|464418465|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
129035206|NCT00105157|464418466|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
129035207|NCT00105157|464418463|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
129035208|NCT00105157|464418464|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
129035209|NCT00105157|464418465|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
128951994|NCT00819585|464108824|FG003|Extension Study|Lost to Follow-up|0|||
128951995|NCT00819585|464108825|FG004|Extension Study|Lost to Follow-up|0|||
128951996|NCT00819585|464108826|FG005|Extension Study|Lost to Follow-up|0|||
128951997|NCT00819585|464108827|FG006|Extension Study|Lost to Follow-up|0|||
129035210|NCT00105157|464418466|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
129035211|NCT00105157|464418463|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
129035212|NCT00105157|464418464|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
129035213|NCT00105157|464418465|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
129035214|NCT00105157|464418466|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
129035215|NCT00105157|464418463|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
129035216|NCT00105157|464418464|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
129035217|NCT00105157|464418465|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
129035218|NCT00105157|464418466|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
129035219|NCT00105157|464418463|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
129035220|NCT00105157|464418464|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
129035221|NCT00105157|464418465|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
129035222|NCT00105157|464418466|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
129035223|NCT00105157|464418463|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
129035224|NCT00105157|464418464|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
129035225|NCT00105157|464418465|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
129035226|NCT00105157|464418466|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
129035227|NCT00105157|464418463|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
129035228|NCT00105157|464418464|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
129035229|NCT00105157|464418465|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
129035230|NCT00105157|464418466|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
129035231|NCT00105157|464418463|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
129035232|NCT00105157|464418464|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
129035233|NCT00105157|464418465|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
129035234|NCT00105157|464418466|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
129035235|NCT00105157|464418463|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
129035236|NCT00105157|464418464|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
129035237|NCT00105157|464418465|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
129035238|NCT00105157|464418466|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
129035239|NCT00420095|464418467|FG000|Overall Study|Adverse Event|1|||
129035240|NCT00420095|464418468|FG001|Overall Study|Adverse Event|0|||
129035241|NCT00420095|464418467|FG000|Overall Study|Protocol Violation|1|||
129035242|NCT00420095|464418468|FG001|Overall Study|Protocol Violation|1|||
129035243|NCT00420095|464418467|FG000|Overall Study|Lost to Follow-up|1|||
129035244|NCT00420095|464418468|FG001|Overall Study|Lost to Follow-up|0|||
128951998|NCT00819585|464108828|FG007|Extension Study|Lost to Follow-up|0|||
128951999|NCT00819585|464108829|FG008|Extension Study|Lost to Follow-up|2|||
128952000|NCT00819585|464108830|FG009|Extension Study|Lost to Follow-up|1|||
128952001|NCT00819585|464108831|FG010|Extension Study|Lost to Follow-up|1|||
128952002|NCT00819585|464108821|FG000|Extension Study|Death|0|||
128952003|NCT00819585|464108822|FG001|Extension Study|Death|0|||
128952004|NCT00819585|464108823|FG002|Extension Study|Death|0|||
128952005|NCT00819585|464108824|FG003|Extension Study|Death|0|||
128952006|NCT00819585|464108825|FG004|Extension Study|Death|0|||
129035245|NCT00393705|464418469|FG000|Overall Study|Adverse Event|0|||
129035246|NCT00393705|464418470|FG001|Overall Study|Adverse Event|2|||
129125638|NCT02020941|464755504|FG000|Overall Study|Adverse Event|1|||
129125639|NCT02020941|464755504|FG000|Overall Study|Physician Decision|2|||
129125640|NCT02020941|464755504|FG000|Overall Study|Withdrawal by Subject|1|||
129125641|NCT02020941|464755504|FG000|Overall Study|Disease Progression|4|||
129125642|NCT03483103|464755512|FG000|Pre-Treatment Phase|Other reasons|1|||
129125643|NCT03483103|464755512|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
128952007|NCT00819585|464108826|FG005|Extension Study|Death|0|||
128952008|NCT00819585|464108827|FG006|Extension Study|Death|0|||
128952009|NCT00819585|464108828|FG007|Extension Study|Death|0|||
128952010|NCT00819585|464108829|FG008|Extension Study|Death|2|||
128952011|NCT00819585|464108830|FG009|Extension Study|Death|0|||
128952012|NCT00819585|464108831|FG010|Extension Study|Death|0|||
128952013|NCT03334396|464108832|FG000|Overall Study|Adverse Event|1|||
128952014|NCT03334396|464108833|FG001|Overall Study|Adverse Event|0|||
128952015|NCT03334396|464108834|FG002|Overall Study|Adverse Event|1|||
128952016|NCT03334396|464108835|FG003|Overall Study|Adverse Event|0|||
128952017|NCT03334396|464108836|FG004|Overall Study|Adverse Event|0|||
128952018|NCT03334396|464108837|FG005|Overall Study|Adverse Event|0|||
128952019|NCT03334396|464108838|FG006|Overall Study|Adverse Event|0|||
128952020|NCT03334396|464108839|FG007|Overall Study|Adverse Event|0|||
128952021|NCT03334396|464108832|FG000|Overall Study|Lack of Efficacy|10|||
128952022|NCT03334396|464108833|FG001|Overall Study|Lack of Efficacy|4|||
128952023|NCT03334396|464108834|FG002|Overall Study|Lack of Efficacy|1|||
128952024|NCT03334396|464108835|FG003|Overall Study|Lack of Efficacy|3|||
128952025|NCT03334396|464108836|FG004|Overall Study|Lack of Efficacy|1|||
128952026|NCT03334396|464108837|FG005|Overall Study|Lack of Efficacy|0|||
128952027|NCT03334396|464108838|FG006|Overall Study|Lack of Efficacy|0|||
128952028|NCT03334396|464108839|FG007|Overall Study|Lack of Efficacy|1|||
128952029|NCT03334396|464108832|FG000|Overall Study|Lost to Follow-up|0|||
128952030|NCT03334396|464108833|FG001|Overall Study|Lost to Follow-up|0|||
128952031|NCT03334396|464108834|FG002|Overall Study|Lost to Follow-up|1|||
128952032|NCT03334396|464108835|FG003|Overall Study|Lost to Follow-up|0|||
128952033|NCT03334396|464108836|FG004|Overall Study|Lost to Follow-up|0|||
128952034|NCT03334396|464108837|FG005|Overall Study|Lost to Follow-up|0|||
128952035|NCT03334396|464108838|FG006|Overall Study|Lost to Follow-up|1|||
128952036|NCT03334396|464108839|FG007|Overall Study|Lost to Follow-up|0|||
128952037|NCT03334396|464108832|FG000|Overall Study|Physician Decision|1|||
128952038|NCT03334396|464108833|FG001|Overall Study|Physician Decision|0|||
128952039|NCT03334396|464108834|FG002|Overall Study|Physician Decision|0|||
128952040|NCT03334396|464108835|FG003|Overall Study|Physician Decision|0|||
128952041|NCT03334396|464108836|FG004|Overall Study|Physician Decision|0|||
128952042|NCT03334396|464108837|FG005|Overall Study|Physician Decision|0|||
128952043|NCT03334396|464108838|FG006|Overall Study|Physician Decision|0|||
128952044|NCT03334396|464108839|FG007|Overall Study|Physician Decision|0|||
128952045|NCT03334396|464108832|FG000|Overall Study|Withdrawal by Subject|10|||
128952046|NCT03334396|464108833|FG001|Overall Study|Withdrawal by Subject|5|||
128952047|NCT03334396|464108834|FG002|Overall Study|Withdrawal by Subject|7|||
128952048|NCT03334396|464108835|FG003|Overall Study|Withdrawal by Subject|2|||
128952049|NCT03334396|464108836|FG004|Overall Study|Withdrawal by Subject|2|||
128952050|NCT03334396|464108837|FG005|Overall Study|Withdrawal by Subject|1|||
128952051|NCT03334396|464108838|FG006|Overall Study|Withdrawal by Subject|2|||
128952052|NCT03334396|464108839|FG007|Overall Study|Withdrawal by Subject|0|||
128952053|NCT03334396|464108832|FG000|Overall Study|Pregnancy|0|||
128952054|NCT03334396|464108833|FG001|Overall Study|Pregnancy|1|||
128952055|NCT03334396|464108834|FG002|Overall Study|Pregnancy|0|||
128952056|NCT03334396|464108835|FG003|Overall Study|Pregnancy|0|||
128952057|NCT03334396|464108836|FG004|Overall Study|Pregnancy|0|||
128952058|NCT03334396|464108837|FG005|Overall Study|Pregnancy|0|||
128952059|NCT03334396|464108838|FG006|Overall Study|Pregnancy|0|||
128952060|NCT03334396|464108839|FG007|Overall Study|Pregnancy|0|||
128952061|NCT03334396|464108832|FG000|Overall Study|Ineligible|0|||
128952062|NCT03334396|464108833|FG001|Overall Study|Ineligible|1|||
128952063|NCT03334396|464108834|FG002|Overall Study|Ineligible|0|||
128952064|NCT03334396|464108835|FG003|Overall Study|Ineligible|0|||
128952065|NCT03334396|464108836|FG004|Overall Study|Ineligible|0|||
128952066|NCT03334396|464108837|FG005|Overall Study|Ineligible|0|||
128952067|NCT03334396|464108838|FG006|Overall Study|Ineligible|0|||
128952068|NCT03334396|464108839|FG007|Overall Study|Ineligible|0|||
128952069|NCT03334396|464108832|FG000|Overall Study|Started New Job|1|||
128952070|NCT03334396|464108833|FG001|Overall Study|Started New Job|0|||
128952071|NCT03334396|464108834|FG002|Overall Study|Started New Job|0|||
128952072|NCT03334396|464108835|FG003|Overall Study|Started New Job|0|||
128952073|NCT03334396|464108836|FG004|Overall Study|Started New Job|0|||
128952074|NCT03334396|464108837|FG005|Overall Study|Started New Job|0|||
128952075|NCT03334396|464108838|FG006|Overall Study|Started New Job|0|||
128952076|NCT03334396|464108839|FG007|Overall Study|Started New Job|0|||
128952077|NCT02927873|464108842|FG000|Overall Study|Lost to Follow-up|0|||
128952078|NCT02927873|464108843|FG001|Overall Study|Lost to Follow-up|1|||
128952079|NCT02927873|464108844|FG002|Overall Study|Lost to Follow-up|0|||
128952080|NCT02927873|464108845|FG003|Overall Study|Lost to Follow-up|0|||
128952081|NCT02927873|464108846|FG004|Overall Study|Lost to Follow-up|0|||
128952082|NCT02927873|464108847|FG005|Overall Study|Lost to Follow-up|0|||
128952083|NCT02927873|464108842|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
128952084|NCT02927873|464108843|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
128952085|NCT02927873|464108844|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
128952086|NCT02927873|464108845|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
128952087|NCT02927873|464108846|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
128711167|NCT00157950|463239821|FG001|Overall Study|Death|0|||
128711168|NCT02892760|463239822|FG000|Overall Study|Withdrawal by Subject|3|||
128711169|NCT00386776|463239827|FG000|Overall Study|Withdrawal by Subject|8|||
128711170|NCT01500629|463239828|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
128711171|NCT01500629|463239829|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
128952088|NCT02927873|464108847|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
128952089|NCT02927873|464108842|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128952090|NCT02927873|464108843|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128952091|NCT02927873|464108844|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128952092|NCT02927873|464108845|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128952093|NCT02927873|464108846|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128952094|NCT02927873|464108847|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128952095|NCT02927873|464108842|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
128952096|NCT02927873|464108843|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
128952097|NCT02927873|464108844|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
128952098|NCT02927873|464108845|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
128952099|NCT02927873|464108846|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
128952100|NCT02927873|464108847|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
128952101|NCT02927873|464108842|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
128952102|NCT02927873|464108843|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
128952103|NCT02927873|464108844|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
128952104|NCT02927873|464108845|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
128952105|NCT02927873|464108846|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
128952106|NCT02927873|464108847|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
128952107|NCT02927873|464108842|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
128952108|NCT02927873|464108843|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
128952109|NCT02927873|464108844|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
128952110|NCT02927873|464108845|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
128952111|NCT02927873|464108846|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
128952112|NCT02927873|464108847|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
128952113|NCT02159469|464108848|FG000|Overall Study|Missing Completion status|1|||
128952114|NCT02159469|464108848|FG000|Overall Study|Adverse Event|5|||
128952115|NCT02159469|464108848|FG000|Overall Study|Non-compliance|2|||
128952116|NCT02159469|464108848|FG000|Overall Study|Withdrawal by Subject|9|||
128952117|NCT02159469|464108848|FG000|Overall Study|Lost to Follow-up|1|||
128952118|NCT02159469|464108848|FG000|Overall Study|Sponsor's request|2|||
128952119|NCT02159469|464108848|FG000|Overall Study|Met Stopping Criteria|3|||
128952120|NCT02159469|464108848|FG000|Overall Study|Other|1|||
128952121|NCT02159469|464108848|FG000|Overall Study|Multiple|29|||
128952122|NCT03629041|464108854|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
128952123|NCT03629041|464108855|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
128952124|NCT03629041|464108856|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
128952125|NCT03629041|464108857|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
128952126|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
128952127|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
128952128|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
128952129|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
128952130|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
128952131|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
128952132|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
128952133|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
128952134|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
128952135|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
128952136|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
128952137|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
128952138|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
128952139|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
128952140|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
128952141|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
128952142|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
128952143|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
128952144|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
128952145|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
128952146|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
129035247|NCT00393705|464418469|FG000|Overall Study|Death|0|||
128711172|NCT00588848|463239830|FG000|Overall Study|Physician Decision|0|||
128952147|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
128952148|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
128952149|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
128952150|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
128952151|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
128952152|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
128952153|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
128952154|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
128952155|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
128952156|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
128952157|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
128952158|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
128952159|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
128952160|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
128952161|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
128952162|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
128952163|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
128952164|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
128952165|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
128952166|NCT00383721|464108859|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
128952167|NCT00383721|464108860|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
128952168|NCT00383721|464108861|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
128952169|NCT00383721|464108862|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
128952170|NCT00383721|464108863|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
128952171|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
128952172|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
128952173|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
128952174|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
128952175|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
128952176|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
128952177|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
128952178|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
128952179|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
128952180|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
128952181|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
128952182|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
128952183|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
128952184|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
128952185|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
128952186|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
128952187|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
128952188|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
128952189|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
128952190|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
128952191|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
128952192|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
128952193|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
128952194|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
128952195|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
128952196|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
128952197|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
128952198|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
128952199|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
128952200|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
128952201|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
128952202|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
128952203|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
128952204|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
128952205|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
128952206|NCT00383721|464108859|FG000|26-Week Treatment Safety Extension|Administrative|1|||
128952207|NCT00383721|464108860|FG001|26-Week Treatment Safety Extension|Administrative|2|||
128770566|NCT02960763|463451548|FG003|Step 1|Other|0|||
129035248|NCT00393705|464418470|FG001|Overall Study|Death|1|||
128952208|NCT00383721|464108861|FG002|26-Week Treatment Safety Extension|Administrative|3|||
128952209|NCT00383721|464108862|FG003|26-Week Treatment Safety Extension|Administrative|1|||
128952210|NCT00383721|464108863|FG004|26-Week Treatment Safety Extension|Administrative|0|||
128952211|NCT01146951|464110317|FG000|Overall Study|Adverse Event|4|||
128952212|NCT01146951|464110318|FG001|Overall Study|Adverse Event|1|||
128952213|NCT01747811|464110320|FG000|Overall Study|Lack of Efficacy|2|||
128952214|NCT01747811|464110321|FG001|Overall Study|Lack of Efficacy|4|||
128952215|NCT01337167|464110322|FG000|Infant Series|Adverse Event|1|||
128952216|NCT01337167|464110323|FG001|Infant Series|Adverse Event|1|||
128952217|NCT01337167|464110322|FG000|Infant Series|Death|1|||
128952218|NCT01337167|464110323|FG001|Infant Series|Death|1|||
128952219|NCT01337167|464110322|FG000|Infant Series|Lost to Follow-up|13|||
128952220|NCT01337167|464110323|FG001|Infant Series|Lost to Follow-up|7|||
128952221|NCT01337167|464110322|FG000|Infant Series|Non-compliance with study drug|2|||
128952222|NCT01337167|464110323|FG001|Infant Series|Non-compliance with study drug|1|||
128952223|NCT01337167|464110322|FG000|Infant Series|Physician Decision|3|||
128952224|NCT01337167|464110323|FG001|Infant Series|Physician Decision|1|||
128952225|NCT01337167|464110322|FG000|Infant Series|Protocol Violation|22|||
128952226|NCT01337167|464110323|FG001|Infant Series|Protocol Violation|9|||
128952227|NCT01337167|464110322|FG000|Infant Series|Withdrawal by Subject|15|||
128952228|NCT01337167|464110323|FG001|Infant Series|Withdrawal by Subject|4|||
128952229|NCT01337167|464110322|FG000|Infant Series|Randomized but not vaccinated|5|||
128952230|NCT01337167|464110323|FG001|Infant Series|Randomized but not vaccinated|3|||
128952231|NCT01337167|464110322|FG000|Interim Period|Lost to Follow-up|51|||
128952232|NCT01337167|464110323|FG001|Interim Period|Lost to Follow-up|23|||
128952233|NCT01337167|464110322|FG000|Interim Period|Non-compliance with study drug|1|||
128952234|NCT01337167|464110323|FG001|Interim Period|Non-compliance with study drug|0|||
128952235|NCT01337167|464110322|FG000|Interim Period|Physician Decision|6|||
128952236|NCT01337167|464110323|FG001|Interim Period|Physician Decision|3|||
128952237|NCT01337167|464110322|FG000|Interim Period|Protocol Violation|5|||
128952238|NCT01337167|464110323|FG001|Interim Period|Protocol Violation|3|||
128952239|NCT01337167|464110322|FG000|Interim Period|Withdrawal by Subject|18|||
128952240|NCT01337167|464110323|FG001|Interim Period|Withdrawal by Subject|10|||
128952241|NCT01337167|464110322|FG000|Interim Period|Other protocol criterion not met|0|||
128952242|NCT01337167|464110323|FG001|Interim Period|Other protocol criterion not met|1|||
128952243|NCT01337167|464110322|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
128952244|NCT01337167|464110323|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
128952245|NCT01337167|464110322|FG000|Toddler Vaccinations|Protocol Violation|0|||
128952246|NCT01337167|464110323|FG001|Toddler Vaccinations|Protocol Violation|1|||
128952247|NCT01337167|464110322|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
128952248|NCT01337167|464110323|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
128952249|NCT03833817|464110324|FG000|Overall Study|Withdrawal by Subject|3|||
128952250|NCT03833817|464110325|FG001|Overall Study|Withdrawal by Subject|3|||
128952251|NCT03833817|464110324|FG000|Overall Study|Lost to Follow-up|3|||
128952252|NCT03833817|464110325|FG001|Overall Study|Lost to Follow-up|3|||
129035249|NCT00393705|464418469|FG000|Overall Study|Lost to Follow-up|2|||
128952253|NCT03363919|464110330|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
128952254|NCT03363919|464110331|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
128952255|NCT03363919|464110330|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
128952256|NCT03363919|464110331|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
128952257|NCT01646398|464110332|FG000|Overall Study|Withdrawal by Subject|1|||
128952258|NCT01646398|464110333|FG001|Overall Study|Withdrawal by Subject|0|||
128952259|NCT00255034|464110334|FG000|Overall Study|Withdrawal by Subject|15|||
128952260|NCT00255034|464110335|FG001|Overall Study|Withdrawal by Subject|38|||
128952261|NCT00574119|464110336|FG000|Overall Study|Adverse Event|1|||
128952262|NCT00574119|464110336|FG000|Overall Study|Protocol Violation|1|||
128952263|NCT00574119|464110336|FG000|Overall Study|Withdrawal by Subject|1|||
128952264|NCT00574119|464110336|FG000|Overall Study|Physician Decision|1|||
128952265|NCT02667457|464110339|FG000|Overall Study|Withdrawal by Subject|1|||
128952266|NCT02667457|464110340|FG001|Overall Study|Withdrawal by Subject|0|||
128952267|NCT02667457|464110339|FG000|Overall Study|Other Reason|0|||
128952268|NCT02667457|464110340|FG001|Overall Study|Other Reason|2|||
128952269|NCT02475850|464110341|FG000|Overall Study|Death|155|||
128952270|NCT02475850|464110342|FG001|Overall Study|Death|141|||
128952271|NCT02475850|464110341|FG000|Overall Study|Lost to Follow-up|217|||
128952272|NCT02475850|464110342|FG001|Overall Study|Lost to Follow-up|188|||
128952273|NCT02475850|464110341|FG000|Overall Study|Withdrawal by Subject|221|||
128952274|NCT02475850|464110342|FG001|Overall Study|Withdrawal by Subject|155|||
128952275|NCT03297216|464110347|FG000|Overall Study|Death|0|||
128952276|NCT03297216|464110348|FG001|Overall Study|Death|1|||
128952277|NCT03297216|464110347|FG000|Overall Study|Miscarriage|0|||
128952278|NCT03297216|464110348|FG001|Overall Study|Miscarriage|2|||
128952279|NCT03297216|464110347|FG000|Overall Study|Lost to Follow-up|3|||
128952280|NCT03297216|464110348|FG001|Overall Study|Lost to Follow-up|2|||
128952281|NCT02700919|464110349|FG000|Overall Study|Physician Decision|1|||
128952282|NCT02700919|464110350|FG001|Overall Study|Physician Decision|0|||
129035250|NCT00393705|464418470|FG001|Overall Study|Lost to Follow-up|2|||
129035251|NCT00393705|464418469|FG000|Overall Study|Entry Criteria Not Met|10|||
129035252|NCT00393705|464418470|FG001|Overall Study|Entry Criteria Not Met|10|||
129035253|NCT00393705|464418469|FG000|Overall Study|Protocol Violation|4|||
129035254|NCT00393705|464418470|FG001|Overall Study|Protocol Violation|3|||
129035255|NCT00393705|464418469|FG000|Overall Study|Withdrawal by Subject|5|||
129035256|NCT00393705|464418470|FG001|Overall Study|Withdrawal by Subject|3|||
129035257|NCT00393705|464418469|FG000|Overall Study|Physician Decision|2|||
129035258|NCT00393705|464418470|FG001|Overall Study|Physician Decision|2|||
129219171|NCT01106690|465102967|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129219172|NCT01106690|465102968|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129219173|NCT01106690|465102966|FG000|Extension Period: Week 26 to Week 52|Other|8|||
129219174|NCT01106690|465102967|FG001|Extension Period: Week 26 to Week 52|Other|3|||
129219175|NCT01106690|465102968|FG002|Extension Period: Week 26 to Week 52|Other|4|||
129219176|NCT01106690|465102966|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
128711173|NCT00588848|463239831|FG001|Overall Study|Physician Decision|3|||
128711174|NCT01499667|463239832|FG000|Overall Study|administrative problems|4|||
128711175|NCT01499667|463239833|FG001|Overall Study|administrative problems|5|||
128711176|NCT01499667|463239834|FG002|Overall Study|administrative problems|5|||
128711177|NCT01499667|463239832|FG000|Overall Study|Protocol Violation|1|||
128711178|NCT01499667|463239833|FG001|Overall Study|Protocol Violation|3|||
128711179|NCT01499667|463239834|FG002|Overall Study|Protocol Violation|2|||
128711180|NCT01499667|463239832|FG000|Overall Study|Adverse Event|0|||
128711181|NCT01499667|463239833|FG001|Overall Study|Adverse Event|2|||
128711182|NCT01499667|463239834|FG002|Overall Study|Adverse Event|2|||
128711183|NCT01499667|463239832|FG000|Overall Study|Withdrawal by Subject|2|||
128711184|NCT01499667|463239833|FG001|Overall Study|Withdrawal by Subject|1|||
128711185|NCT01499667|463239834|FG002|Overall Study|Withdrawal by Subject|1|||
128711186|NCT01499667|463239832|FG000|Overall Study|Lack of Efficacy|2|||
128952283|NCT02700919|464110351|FG002|Overall Study|Physician Decision|0|||
128952284|NCT02700919|464110349|FG000|Overall Study|Protocol Violation|1|||
128952285|NCT02700919|464110350|FG001|Overall Study|Protocol Violation|0|||
128952286|NCT02700919|464110351|FG002|Overall Study|Protocol Violation|0|||
128952287|NCT02700919|464110349|FG000|Overall Study|Adverse Event|1|||
128952288|NCT02700919|464110350|FG001|Overall Study|Adverse Event|3|||
128952289|NCT02700919|464110351|FG002|Overall Study|Adverse Event|1|||
128952290|NCT02700919|464110349|FG000|Overall Study|Withdrawal by Subject|5|||
128952291|NCT02700919|464110350|FG001|Overall Study|Withdrawal by Subject|8|||
128952292|NCT02700919|464110351|FG002|Overall Study|Withdrawal by Subject|2|||
128952293|NCT02700919|464110349|FG000|Overall Study|Lost to Follow-up|2|||
128952294|NCT02700919|464110350|FG001|Overall Study|Lost to Follow-up|0|||
128952295|NCT02700919|464110351|FG002|Overall Study|Lost to Follow-up|0|||
128952296|NCT02700919|464110349|FG000|Overall Study|Other|2|||
128952297|NCT02700919|464110350|FG001|Overall Study|Other|1|||
128952298|NCT02700919|464110351|FG002|Overall Study|Other|1|||
128952299|NCT03434418|464110352|FG000|Overall Study|Disease Progression|11|||
128952300|NCT03434418|464110352|FG000|Overall Study|Adverse Event|2|||
128952301|NCT03434418|464110352|FG000|Overall Study|Physician Decision|1|||
128952302|NCT03434418|464110352|FG000|Overall Study|Decline in Performance Status (PS)|1|||
128952303|NCT01517412|464110355|FG000|Overall Study|Adverse Event|10|||
128952304|NCT01517412|464110356|FG001|Overall Study|Adverse Event|11|||
128952305|NCT01517412|464110355|FG000|Overall Study|Lack of Efficacy|10|||
128952306|NCT01517412|464110356|FG001|Overall Study|Lack of Efficacy|5|||
128952307|NCT01517412|464110355|FG000|Overall Study|Poor compliance to protocol|8|||
128952308|NCT01517412|464110356|FG001|Overall Study|Poor compliance to protocol|3|||
128952309|NCT01517412|464110355|FG000|Overall Study|Other than specified above|8|||
128952310|NCT01517412|464110356|FG001|Overall Study|Other than specified above|5|||
128952311|NCT01253187|464110357|FG000|Period 2|Withdrawal by Subject|0|||
128952312|NCT01253187|464110358|FG001|Period 2|Withdrawal by Subject|0|||
128952313|NCT01253187|464110359|FG002|Period 2|Withdrawal by Subject|0|||
128952314|NCT01253187|464110360|FG003|Period 2|Withdrawal by Subject|0|||
128952315|NCT01253187|464110361|FG004|Period 2|Withdrawal by Subject|1|||
128952316|NCT01253187|464110362|FG005|Period 2|Withdrawal by Subject|0|||
128952317|NCT01253187|464110357|FG000|Period 3|Pregnancy|1|||
128952318|NCT01253187|464110358|FG001|Period 3|Pregnancy|0|||
128952319|NCT01253187|464110359|FG002|Period 3|Pregnancy|0|||
129035259|NCT03185741|464418471|FG000|Baseline|Withdrawal by Subject|1|||
129035260|NCT03185741|464418472|FG001|Baseline|Withdrawal by Subject|3|||
129035261|NCT03185741|464418473|FG002|Baseline|Withdrawal by Subject|2|||
128711187|NCT01499667|463239833|FG001|Overall Study|Lack of Efficacy|0|||
128711188|NCT01499667|463239834|FG002|Overall Study|Lack of Efficacy|0|||
128711189|NCT02902965|463239835|FG000|Overall Study|Withdrawal by Subject|10|||
128711190|NCT02673489|463239836|FG000|Treatment Period|Lost to Follow-up|3|||
128952320|NCT01253187|464110360|FG003|Period 3|Pregnancy|0|||
128952321|NCT01253187|464110361|FG004|Period 3|Pregnancy|0|||
128952322|NCT01253187|464110362|FG005|Period 3|Pregnancy|0|||
128952323|NCT01253187|464110357|FG000|Period 3|difficulty with blood sampling|0|||
129035262|NCT03185741|464418471|FG000|Baseline|Lost to Follow-up|1|||
128952324|NCT01253187|464110358|FG001|Period 3|difficulty with blood sampling|1|||
128952325|NCT01253187|464110359|FG002|Period 3|difficulty with blood sampling|0|||
128952326|NCT01253187|464110360|FG003|Period 3|difficulty with blood sampling|0|||
128952327|NCT01253187|464110361|FG004|Period 3|difficulty with blood sampling|0|||
128952328|NCT01253187|464110362|FG005|Period 3|difficulty with blood sampling|0|||
128952329|NCT01253187|464110357|FG000|Period 3|non-compliance|0|||
128952330|NCT01253187|464110358|FG001|Period 3|non-compliance|0|||
128952331|NCT01253187|464110359|FG002|Period 3|non-compliance|0|||
129035263|NCT03185741|464418472|FG001|Baseline|Lost to Follow-up|2|||
129035264|NCT03185741|464418473|FG002|Baseline|Lost to Follow-up|3|||
129035265|NCT03185741|464418471|FG000|3Month|Death|1|||
129035266|NCT03185741|464418472|FG001|3Month|Death|1|||
129035267|NCT03185741|464418473|FG002|3Month|Death|2|||
129035268|NCT03185741|464418471|FG000|3Month|Withdrawal by Subject|1|||
128952332|NCT01253187|464110360|FG003|Period 3|non-compliance|0|||
128952333|NCT01253187|464110361|FG004|Period 3|non-compliance|1|||
128952334|NCT01253187|464110362|FG005|Period 3|non-compliance|0|||
128952335|NCT01956240|464110363|FG000|Overall Study|Lost to Follow-up|6|||
128952336|NCT01956240|464110364|FG001|Overall Study|Lost to Follow-up|20|||
128952337|NCT01956240|464110363|FG000|Overall Study|Adverse Event|17|||
128952338|NCT01956240|464110364|FG001|Overall Study|Adverse Event|4|||
128952339|NCT00600028|464110365|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
128952340|NCT00600028|464110366|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
129035269|NCT03185741|464418472|FG001|3Month|Withdrawal by Subject|5|||
129035270|NCT03185741|464418473|FG002|3Month|Withdrawal by Subject|1|||
129035271|NCT03185741|464418471|FG000|3Month|Lost to Follow-up|7|||
129035272|NCT03185741|464418472|FG001|3Month|Lost to Follow-up|9|||
129125644|NCT03483103|464755512|FG000|Pre-Treatment Phase|Disease-related complications|1|||
129125645|NCT03483103|464755512|FG000|Pre-Treatment Phase|Death|5|||
129125646|NCT03483103|464755512|FG000|Treatment Phase|Withdrawal by Subject|7|||
129125647|NCT03483103|464755512|FG000|Treatment Phase|Other reasons|1|||
129125648|NCT03483103|464755512|FG000|Treatment Phase|Death|23|||
129125649|NCT03483103|464755512|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
129125650|NCT03483103|464755512|FG000|Treatment Phase|Received nonconforming product|1|||
129125651|NCT02239328|464755513|FG000|Overall Study|Benign disease noted at time of surgery|6|||
129125652|NCT02239328|464755513|FG000|Overall Study|Equipment or website malfunction|2|||
129125653|NCT01481779|464755514|FG000|Overall Study|Adverse Event|23|||
129125654|NCT01481779|464755515|FG001|Overall Study|Adverse Event|5|||
129125655|NCT01481779|464755514|FG000|Overall Study|Lost to Follow-up|3|||
129125656|NCT01481779|464755515|FG001|Overall Study|Lost to Follow-up|2|||
129125657|NCT01481779|464755514|FG000|Overall Study|Protocol Violation|2|||
129125658|NCT01481779|464755515|FG001|Overall Study|Protocol Violation|3|||
129125659|NCT01481779|464755514|FG000|Overall Study|Withdrawal by Subject|26|||
129125660|NCT01481779|464755515|FG001|Overall Study|Withdrawal by Subject|13|||
129125661|NCT01481779|464755514|FG000|Overall Study|Physician Decision|13|||
129125662|NCT01481779|464755515|FG001|Overall Study|Physician Decision|4|||
129125663|NCT01481779|464755514|FG000|Overall Study|Sponsor Decision|3|||
129125664|NCT01481779|464755515|FG001|Overall Study|Sponsor Decision|1|||
129125665|NCT02378181|464755516|FG000|Overall Study|Lost to Follow-up|2|||
129125666|NCT02378181|464755517|FG001|Overall Study|Lost to Follow-up|5|||
129125667|NCT02378181|464755516|FG000|Overall Study|Withdrawal by Subject|1|||
129125668|NCT02378181|464755517|FG001|Overall Study|Withdrawal by Subject|1|||
129125669|NCT02378181|464755516|FG000|Overall Study|Incarcerated|0|||
129125670|NCT02378181|464755517|FG001|Overall Study|Incarcerated|1|||
129125671|NCT04115059|464755518|FG000|Overall Study|Withdrawal by Subject|1|||
129125672|NCT04115059|464755518|FG000|Overall Study|Lack of Efficacy|2|||
129125673|NCT06420232|464755527|FG000|Overall Study|Withdrawal by Subject|3|||
129125674|NCT00689936|464755528|FG000|Active Treatment Phase|Adverse Event|68|||
129125675|NCT00689936|464755529|FG001|Active Treatment Phase|Adverse Event|71|||
129125676|NCT00689936|464755530|FG002|Active Treatment Phase|Adverse Event|76|||
129125677|NCT00689936|464755528|FG000|Active Treatment Phase|Disease Progression|273|||
129125678|NCT00689936|464755529|FG001|Active Treatment Phase|Disease Progression|362|||
129125679|NCT00689936|464755530|FG002|Active Treatment Phase|Disease Progression|339|||
129125680|NCT00689936|464755528|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
129125681|NCT00689936|464755529|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
129125682|NCT00689936|464755530|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
129125683|NCT00689936|464755528|FG000|Active Treatment Phase|Death|60|||
129125684|NCT00689936|464755529|FG001|Active Treatment Phase|Death|28|||
129125685|NCT00689936|464755530|FG002|Active Treatment Phase|Death|37|||
129125686|NCT00689936|464755528|FG000|Active Treatment Phase|Lost to Follow-up|0|||
129125687|NCT00689936|464755529|FG001|Active Treatment Phase|Lost to Follow-up|2|||
129035273|NCT03185741|464418473|FG002|3Month|Lost to Follow-up|8|||
129125688|NCT00689936|464755530|FG002|Active Treatment Phase|Lost to Follow-up|2|||
128770567|NCT02960763|463451549|FG004|Step 1|Other|0|||
128952341|NCT00600028|464110365|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
128952342|NCT00600028|464110366|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
129035274|NCT03185741|464418471|FG000|3Month|Unavailable for 3Month|11|||
129125689|NCT00689936|464755528|FG000|Active Treatment Phase|Protocol Violation|2|||
128711191|NCT02673489|463239837|FG001|Treatment Period|Lost to Follow-up|0|||
128711192|NCT02673489|463239836|FG000|Treatment Period|Participant request to discontinue|1|||
128711193|NCT02673489|463239837|FG001|Treatment Period|Participant request to discontinue|1|||
128711194|NCT02673489|463239836|FG000|Treatment Period|Participant moved to another province|1|||
128711195|NCT02673489|463239837|FG001|Treatment Period|Participant moved to another province|0|||
128952343|NCT00600028|464110365|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
128952344|NCT00600028|464110366|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
128952345|NCT03172481|464110367|FG000|Double-blind|Withdrawal by Subject|1|||
128952346|NCT03172481|464110368|FG001|Double-blind|Withdrawal by Subject|0|||
128952347|NCT02168803|464110369|FG000|Overall Study|Lost to Follow-up|1|||
128952348|NCT02168803|464110370|FG001|Overall Study|Lost to Follow-up|0|||
128952349|NCT02168803|464110371|FG002|Overall Study|Lost to Follow-up|1|||
128952350|NCT02168803|464110369|FG000|Overall Study|Withdrawal by Subject|1|||
128952351|NCT02168803|464110370|FG001|Overall Study|Withdrawal by Subject|1|||
128952352|NCT02168803|464110371|FG002|Overall Study|Withdrawal by Subject|2|||
128952353|NCT02168803|464110369|FG000|Overall Study|Physician Decision|0|||
128952354|NCT02168803|464110370|FG001|Overall Study|Physician Decision|1|||
128952355|NCT02168803|464110371|FG002|Overall Study|Physician Decision|0|||
128952356|NCT02168803|464110369|FG000|Overall Study|Adverse Event|0|||
128952357|NCT02168803|464110370|FG001|Overall Study|Adverse Event|1|||
128952358|NCT02168803|464110371|FG002|Overall Study|Adverse Event|1|||
128952359|NCT02168803|464110369|FG000|Overall Study|Death|0|||
128952360|NCT02168803|464110370|FG001|Overall Study|Death|0|||
128952361|NCT02168803|464110371|FG002|Overall Study|Death|1|||
128952362|NCT02168803|464110369|FG000|Overall Study|Sponsor Decision|0|||
128952363|NCT02168803|464110370|FG001|Overall Study|Sponsor Decision|0|||
128952364|NCT02168803|464110371|FG002|Overall Study|Sponsor Decision|1|||
128952365|NCT01114373|464110376|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
128952366|NCT01114373|464110377|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
128952367|NCT01114373|464110376|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
128952368|NCT01114373|464110377|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
128952369|NCT01114373|464110376|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
128952370|NCT01114373|464110377|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
128952371|NCT01114373|464110376|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
128952372|NCT01114373|464110377|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
128952373|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
128952374|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
128952375|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
128952376|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
128952377|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
128952378|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
128952379|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
128952380|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
128952381|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
128952382|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
128952383|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
128952384|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
128952385|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
128952386|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
128952387|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
128952388|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
128952389|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
128952390|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
128952391|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
128952392|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
128952393|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
128952394|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
128952395|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
128952396|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
128952397|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
128952398|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
128952399|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
128952400|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
128952401|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
128952402|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
129219177|NCT01106690|465102967|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
128711196|NCT02673489|463239836|FG000|Treatment Period|Participant was incarcerated|0|||
128952403|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
128952404|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
129035275|NCT03185741|464418472|FG001|3Month|Unavailable for 3Month|10|||
129035276|NCT03185741|464418473|FG002|3Month|Unavailable for 3Month|11|||
129035277|NCT03185741|464418471|FG000|3Month|Protocol Violation|0|||
129035278|NCT03185741|464418472|FG001|3Month|Protocol Violation|0|||
128952405|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
128952406|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
128952407|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
128952408|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
128952409|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
128952410|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
128952411|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
128952412|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
128952413|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
128952414|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
128952415|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
129035279|NCT03185741|464418473|FG002|3Month|Protocol Violation|3|||
129035280|NCT03185741|464418471|FG000|6Month|Death|1|||
129219178|NCT01106690|465102968|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129219179|NCT00831181|465102975|FG000|Overall Study|Adverse Event|12|||
129035281|NCT03185741|464418472|FG001|6Month|Death|1|||
129035282|NCT03185741|464418473|FG002|6Month|Death|2|||
129035283|NCT03185741|464418471|FG000|6Month|Withdrawal by Subject|2|||
129035284|NCT03185741|464418472|FG001|6Month|Withdrawal by Subject|3|||
129035285|NCT03185741|464418473|FG002|6Month|Withdrawal by Subject|1|||
129035286|NCT03185741|464418471|FG000|6Month|Lost to Follow-up|16|||
129035287|NCT03185741|464418472|FG001|6Month|Lost to Follow-up|15|||
129035288|NCT03185741|464418473|FG002|6Month|Lost to Follow-up|16|||
129035289|NCT03365791|464418474|FG000|Overall Study|Adverse Event|5|||
129035290|NCT03365791|464418474|FG000|Overall Study|Death|1|||
129035291|NCT03365791|464418474|FG000|Overall Study|Lost to Follow-up|1|||
129035292|NCT03365791|464418474|FG000|Overall Study|Physician Decision|9|||
129035293|NCT03365791|464418474|FG000|Overall Study|Progressive disease|51|||
129035294|NCT03365791|464418474|FG000|Overall Study|Subject/guardian decision|5|||
129035295|NCT01636934|464419628|FG000|Overall Study|Withdrawal by Subject|3|||
129035296|NCT01636934|464419629|FG001|Overall Study|Withdrawal by Subject|2|||
129035297|NCT01636934|464419628|FG000|Overall Study|Chemo cancel|1|||
129035298|NCT01636934|464419629|FG001|Overall Study|Chemo cancel|0|||
129035299|NCT01636934|464419628|FG000|Overall Study|Too ill to continue|1|||
129035300|NCT01636934|464419629|FG001|Overall Study|Too ill to continue|0|||
129035301|NCT01636934|464419628|FG000|Overall Study|Never started study medication|1|||
129219180|NCT02863419|465102976|FG000|Overall Study|Lost to Follow-up|0|||
129219181|NCT02863419|465102977|FG001|Overall Study|Lost to Follow-up|1|||
128952416|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
129035302|NCT01636934|464419629|FG001|Overall Study|Never started study medication|1|||
128952417|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
128952418|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
128952419|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
128952420|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
128952421|NCT03444870|464110380|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
128952422|NCT03444870|464110381|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
128952423|NCT03444870|464110382|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
128952424|NCT03444870|464110383|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
128952425|NCT03444870|464110384|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
128952426|NCT03444870|464110385|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
128952427|NCT03444870|464110380|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128952428|NCT03444870|464110381|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128952429|NCT03444870|464110382|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128952430|NCT03444870|464110383|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128952431|NCT03444870|464110384|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
128952432|NCT03444870|464110385|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
128952433|NCT03444870|464110380|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
128952434|NCT03444870|464110381|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
128952435|NCT03444870|464110382|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
128770568|NCT02960763|463451545|FG000|Step 2|Withdrawal by Subject|0|||
128952436|NCT03444870|464110383|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
128952437|NCT03444870|464110384|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
129035303|NCT01011335|464419630|FG000|Overall Study|Lost to Follow-up|0|||
129035304|NCT01011335|464419631|FG001|Overall Study|Lost to Follow-up|0|||
128952438|NCT03444870|464110385|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
129035305|NCT01011335|464419632|FG002|Overall Study|Lost to Follow-up|1|||
129035306|NCT01011335|464419633|FG003|Overall Study|Lost to Follow-up|1|||
129035307|NCT01011335|464419634|FG004|Overall Study|Lost to Follow-up|1|||
129035308|NCT01011335|464419635|FG005|Overall Study|Lost to Follow-up|1|||
129035309|NCT01011335|464419636|FG006|Overall Study|Lost to Follow-up|2|||
129035310|NCT01011335|464419637|FG007|Overall Study|Lost to Follow-up|2|||
128952439|NCT03444870|464110380|FG000|Open-Label Extension (OLE) Period|Death|0|||
128711197|NCT02673489|463239837|FG001|Treatment Period|Participant was incarcerated|1|||
128711198|NCT02673489|463239836|FG000|Treatment Period|Adverse Event|0|||
128711199|NCT02673489|463239837|FG001|Treatment Period|Adverse Event|1|||
128711200|NCT02673489|463239836|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
128711201|NCT02673489|463239837|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
128711202|NCT02673489|463239836|FG000|Follow Up Period|Unable to return for follow-up|0|||
128711203|NCT02673489|463239837|FG001|Follow Up Period|Unable to return for follow-up|1|||
128711204|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
128711205|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
128711206|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
128711207|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
128711208|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
128711209|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
128711210|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
128711211|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
128711212|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
128711213|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
128711214|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
128711215|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
128711216|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
128711217|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
128711218|NCT00293254|463239838|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
128711219|NCT00293254|463239839|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
128711220|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
128711221|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
128711222|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Death|4|||
128711223|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Death|1|||
128711224|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
128711225|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
128711226|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
128711227|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
128711228|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
128952440|NCT03444870|464110381|FG001|Open-Label Extension (OLE) Period|Death|0|||
128952441|NCT03444870|464110382|FG002|Open-Label Extension (OLE) Period|Death|0|||
128952442|NCT03444870|464110383|FG003|Open-Label Extension (OLE) Period|Death|0|||
128952443|NCT03444870|464110384|FG004|Open-Label Extension (OLE) Period|Death|1|||
128952444|NCT03444870|464110385|FG005|Open-Label Extension (OLE) Period|Death|0|||
128952445|NCT02310906|464110388|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
128952446|NCT02310906|464110389|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
128952447|NCT02310906|464110390|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
128952448|NCT02310906|464110391|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
128952449|NCT02310906|464110388|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
128952450|NCT02310906|464110389|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
128952451|NCT02310906|464110390|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
128952452|NCT02310906|464110391|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
128952453|NCT02310906|464110388|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
128952454|NCT02310906|464110389|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
128952455|NCT02310906|464110390|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
128952456|NCT02310906|464110391|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
128952457|NCT02310906|464110388|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
128952458|NCT02310906|464110389|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
128952459|NCT02310906|464110390|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
128952460|NCT02310906|464110391|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
128952461|NCT01204697|464110392|FG000|Overall Study|Death|26|||
128952462|NCT01204697|464110393|FG001|Overall Study|Death|27|||
128952463|NCT01204697|464110392|FG000|Overall Study|Lost to Follow-up|3|||
128952464|NCT01204697|464110393|FG001|Overall Study|Lost to Follow-up|4|||
128711229|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
128952465|NCT01204697|464110392|FG000|Overall Study|Withdrawal by Subject|2|||
128952466|NCT01204697|464110393|FG001|Overall Study|Withdrawal by Subject|4|||
128952467|NCT01204697|464110392|FG000|Overall Study|Randomized, but not treated|0|||
128711230|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
128711231|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
128711232|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
128952468|NCT01204697|464110393|FG001|Overall Study|Randomized, but not treated|1|||
128952469|NCT00098020|464110399|FG000|Overall Study|Adverse Event|2|||
128952470|NCT00098020|464110399|FG000|Overall Study|Lost to Follow-up|1|||
128952471|NCT00098020|464110399|FG000|Overall Study|elevated liver enzymes|1|||
128952472|NCT00098020|464110399|FG000|Overall Study|Low urine PCR|1|||
128952473|NCT00098020|464110399|FG000|Overall Study|Low epidermal growth factor receptor|1|||
128952474|NCT01840228|464110403|FG000|Overall Study|Lost to Follow-up|1|||
128952475|NCT01840228|464110404|FG001|Overall Study|Lost to Follow-up|1|||
128952476|NCT00712933|464110407|FG000|Overall Study|Adverse Event|69|||
128952477|NCT00712933|464110407|FG000|Overall Study|Lack of Efficacy|6|||
128952478|NCT00712933|464110407|FG000|Overall Study|Lost to Follow-up|22|||
128952479|NCT00712933|464110407|FG000|Overall Study|Non-compliance with study drug|13|||
128952480|NCT00712933|464110407|FG000|Overall Study|Other Pregnancy|37|||
128952481|NCT00712933|464110407|FG000|Overall Study|Sponsor decision|14|||
128952482|NCT00712933|464110407|FG000|Overall Study|Withdrew consent|4|||
128952483|NCT00712933|464110407|FG000|Overall Study|Hip replacement surgery|1|||
128952484|NCT00712933|464110407|FG000|Overall Study|Involved in Clinical research|3|||
128952485|NCT00712933|464110407|FG000|Overall Study|Participant hospitalized|1|||
128952486|NCT00712933|464110407|FG000|Overall Study|Participant travelled overseas|2|||
128952487|NCT00712933|464110407|FG000|Overall Study|Death of patient|1|||
128952488|NCT00712933|464110407|FG000|Overall Study|Other Physician decision|1|||
128952489|NCT00712933|464110407|FG000|Overall Study|Not committed to contraception|1|||
128952490|NCT00712933|464110407|FG000|Overall Study|Participant received medication|1|||
128952491|NCT00712933|464110407|FG000|Overall Study|Physician Decision|36|||
128952492|NCT00712933|464110407|FG000|Overall Study|Protocol Violation|4|||
128952493|NCT00712933|464110407|FG000|Overall Study|Withdrawal by Subject|151|||
128952494|NCT01295580|464110410|FG000|Overall Study|Protocol Violation|4|||
128952495|NCT01295580|464110411|FG001|Overall Study|Protocol Violation|2|||
128952496|NCT01295580|464110410|FG000|Overall Study|Withdrawal by Subject|1|||
128952497|NCT01295580|464110411|FG001|Overall Study|Withdrawal by Subject|4|||
128952498|NCT01295580|464110410|FG000|Overall Study|Adverse Event|2|||
128952499|NCT01295580|464110411|FG001|Overall Study|Adverse Event|1|||
128952500|NCT01295580|464110410|FG000|Overall Study|Lost to Follow-up|1|||
128952501|NCT01295580|464110411|FG001|Overall Study|Lost to Follow-up|0|||
128952502|NCT01295580|464110410|FG000|Overall Study|Lack of Efficacy|1|||
128952503|NCT01295580|464110411|FG001|Overall Study|Lack of Efficacy|0|||
128952504|NCT01295580|464110410|FG000|Overall Study|Other: inconvenience|1|||
128952505|NCT01295580|464110411|FG001|Overall Study|Other: inconvenience|0|||
128952506|NCT01295580|464110410|FG000|Overall Study|Other: family objection|0|||
128952507|NCT01295580|464110411|FG001|Overall Study|Other: family objection|1|||
128952508|NCT02022033|464110417|FG000|Overall Study|Physician Decision|1|||
128952509|NCT01879319|464110420|FG000|Overall Study|Withdrawal by Subject|1|||
128952510|NCT01879319|464110421|FG001|Overall Study|Withdrawal by Subject|0|||
128952511|NCT01879319|464110420|FG000|Overall Study|Lost to Follow-up|1|||
128952512|NCT01879319|464110421|FG001|Overall Study|Lost to Follow-up|5|||
128952513|NCT01360762|464110422|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
128952514|NCT01360762|464110422|FG000|Main Study Period (12-month Treatment)|Death|5|||
128952515|NCT01360762|464110422|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
128952516|NCT01360762|464110422|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
128952517|NCT01360762|464110422|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
128952518|NCT01360762|464110422|FG000|Whole Study Period|Lost to Follow-up|10|||
128952519|NCT01360762|464110422|FG000|Whole Study Period|Death|7|||
128952520|NCT01360762|464110422|FG000|Whole Study Period|Patient relapsed|18|||
128952521|NCT01360762|464110422|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
128952522|NCT01103778|464110423|FG000|Overall Study|Lost to Follow-up|1|||
128952523|NCT01103778|464110423|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
128952524|NCT01103778|464110423|FG000|Overall Study|Screen failure|1|||
128952525|NCT04724733|464110424|FG000|Overall Study|Lost to Follow-up|1|||
128952526|NCT04724733|464110425|FG001|Overall Study|Lost to Follow-up|1|||
128952527|NCT04724733|464110426|FG002|Overall Study|Lost to Follow-up|1|||
128952528|NCT00844649|464110427|FG000|Overall Study|Progressive Disease|196|||
128952529|NCT00844649|464110428|FG001|Overall Study|Progressive Disease|245|||
128952530|NCT00844649|464110427|FG000|Overall Study|Adverse Event|128|||
128952531|NCT00844649|464110428|FG001|Overall Study|Adverse Event|73|||
128952532|NCT00844649|464110427|FG000|Overall Study|Physician Decision|25|||
128952533|NCT00844649|464110428|FG001|Overall Study|Physician Decision|18|||
128952534|NCT00844649|464110427|FG000|Overall Study|Protocol Violation|10|||
129125690|NCT00689936|464755529|FG001|Active Treatment Phase|Protocol Violation|2|||
128952535|NCT00844649|464110428|FG001|Overall Study|Protocol Violation|6|||
128952536|NCT00844649|464110427|FG000|Overall Study|Withdrawal by Subject|28|||
128952537|NCT00844649|464110428|FG001|Overall Study|Withdrawal by Subject|39|||
128952538|NCT00844649|464110427|FG000|Overall Study|Other|7|||
129125691|NCT00689936|464755530|FG002|Active Treatment Phase|Protocol Violation|4|||
128952539|NCT00844649|464110428|FG001|Overall Study|Other|10|||
128952540|NCT00844649|464110427|FG000|Overall Study|Withdrew prior to starting treatment|11|||
128952541|NCT00844649|464110428|FG001|Overall Study|Withdrew prior to starting treatment|27|||
128952542|NCT01397448|464110431|FG000|Overall Study|Adverse Event|4|||
129125692|NCT00689936|464755528|FG000|Active Treatment Phase|Study Close Out|64|||
128952543|NCT01397448|464110432|FG001|Overall Study|Adverse Event|4|||
128952544|NCT01397448|464110433|FG002|Overall Study|Adverse Event|6|||
128952545|NCT01397448|464110431|FG000|Overall Study|Withdrawal by Subject|4|||
128952546|NCT01397448|464110432|FG001|Overall Study|Withdrawal by Subject|4|||
128952547|NCT01397448|464110433|FG002|Overall Study|Withdrawal by Subject|3|||
128952548|NCT01397448|464110431|FG000|Overall Study|Lack of Efficacy|2|||
128952549|NCT01397448|464110432|FG001|Overall Study|Lack of Efficacy|0|||
128952550|NCT01397448|464110433|FG002|Overall Study|Lack of Efficacy|5|||
128952551|NCT01397448|464110431|FG000|Overall Study|Other|8|||
128952552|NCT01397448|464110432|FG001|Overall Study|Other|7|||
128952553|NCT01397448|464110433|FG002|Overall Study|Other|4|||
128952554|NCT02180217|464110436|FG000|Overall Study|Adverse Event|3|||
128952555|NCT02180217|464110437|FG001|Overall Study|Adverse Event|2|||
128952556|NCT02180217|464110438|FG002|Overall Study|Adverse Event|22|||
128952557|NCT02180217|464110436|FG000|Overall Study|Death|1|||
128952558|NCT02180217|464110437|FG001|Overall Study|Death|1|||
128952559|NCT02180217|464110438|FG002|Overall Study|Death|0|||
128952560|NCT02180217|464110436|FG000|Overall Study|Withdrawal by Subject|1|||
128952561|NCT02180217|464110437|FG001|Overall Study|Withdrawal by Subject|1|||
128952562|NCT02180217|464110438|FG002|Overall Study|Withdrawal by Subject|4|||
128952563|NCT02180217|464110436|FG000|Overall Study|Subject/Guardian decision|5|||
128952564|NCT02180217|464110437|FG001|Overall Study|Subject/Guardian decision|3|||
128952565|NCT02180217|464110438|FG002|Overall Study|Subject/Guardian decision|6|||
128952566|NCT02180217|464110436|FG000|Overall Study|Physician Decision|1|||
128952567|NCT02180217|464110437|FG001|Overall Study|Physician Decision|1|||
128952568|NCT02180217|464110438|FG002|Overall Study|Physician Decision|6|||
128952569|NCT02180217|464110436|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128952570|NCT02180217|464110437|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128952571|NCT02180217|464110438|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
128952572|NCT00302718|464110443|FG000|Overall Study|Participant left the hospital|1|||
128952573|NCT00302718|464110444|FG001|Overall Study|Participant left the hospital|0|||
128952574|NCT00302718|464110445|FG002|Overall Study|Participant left the hospital|0|||
128952575|NCT00302718|464110446|FG003|Overall Study|Participant left the hospital|1|||
128952576|NCT00302718|464110443|FG000|Overall Study|Withdrawal by Subject|0|||
128952577|NCT00302718|464110444|FG001|Overall Study|Withdrawal by Subject|1|||
128952578|NCT00302718|464110445|FG002|Overall Study|Withdrawal by Subject|0|||
128952579|NCT00302718|464110446|FG003|Overall Study|Withdrawal by Subject|0|||
128952580|NCT00302718|464110443|FG000|Overall Study|Participant left primary care setting|0|||
128952581|NCT00302718|464110444|FG001|Overall Study|Participant left primary care setting|0|||
128952582|NCT00302718|464110445|FG002|Overall Study|Participant left primary care setting|2|||
128952583|NCT00302718|464110446|FG003|Overall Study|Participant left primary care setting|1|||
128952584|NCT00738374|464110447|FG000|Induction Treatment Phase|Adverse Event|14|||
128952585|NCT00738374|464110448|FG001|Induction Treatment Phase|Adverse Event|0|||
128952586|NCT00738374|464110449|FG002|Induction Treatment Phase|Adverse Event|0|||
128952587|NCT00738374|464110450|FG003|Induction Treatment Phase|Adverse Event|0|||
128952588|NCT00738374|464110447|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
128952589|NCT00738374|464110448|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
128952590|NCT00738374|464110449|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
128952591|NCT00738374|464110450|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
128952592|NCT00738374|464110447|FG000|Induction Treatment Phase|Physician Decision|2|||
128952593|NCT00738374|464110448|FG001|Induction Treatment Phase|Physician Decision|0|||
128952594|NCT00738374|464110449|FG002|Induction Treatment Phase|Physician Decision|0|||
128952595|NCT00738374|464110450|FG003|Induction Treatment Phase|Physician Decision|0|||
128952596|NCT00738374|464110447|FG000|Induction Treatment Phase|Protocol Violation|2|||
128952597|NCT00738374|464110448|FG001|Induction Treatment Phase|Protocol Violation|0|||
128952598|NCT00738374|464110449|FG002|Induction Treatment Phase|Protocol Violation|0|||
129035311|NCT01011335|464419638|FG008|Overall Study|Lost to Follow-up|1|||
129035312|NCT01011335|464419639|FG009|Overall Study|Lost to Follow-up|0|||
129035313|NCT01011335|464419640|FG010|Overall Study|Lost to Follow-up|0|||
129035314|NCT01011335|464419641|FG011|Overall Study|Lost to Follow-up|1|||
129035315|NCT01011335|464419642|FG012|Overall Study|Lost to Follow-up|2|||
129035316|NCT01011335|464419630|FG000|Overall Study|Protocol Violation|0|||
129035317|NCT01011335|464419631|FG001|Overall Study|Protocol Violation|1|||
129035318|NCT01011335|464419632|FG002|Overall Study|Protocol Violation|0|||
129035319|NCT01011335|464419633|FG003|Overall Study|Protocol Violation|0|||
129035320|NCT01011335|464419634|FG004|Overall Study|Protocol Violation|0|||
128711233|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
129035321|NCT01011335|464419635|FG005|Overall Study|Protocol Violation|0|||
129035322|NCT01011335|464419636|FG006|Overall Study|Protocol Violation|0|||
128711234|NCT00293254|463239838|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
129035323|NCT01011335|464419637|FG007|Overall Study|Protocol Violation|0|||
128952599|NCT00738374|464110450|FG003|Induction Treatment Phase|Protocol Violation|0|||
128952600|NCT00738374|464110447|FG000|Induction Treatment Phase|Non-compliance|1|||
128952601|NCT00738374|464110448|FG001|Induction Treatment Phase|Non-compliance|0|||
129035324|NCT01011335|464419638|FG008|Overall Study|Protocol Violation|0|||
129035325|NCT01011335|464419639|FG009|Overall Study|Protocol Violation|0|||
129035326|NCT01011335|464419640|FG010|Overall Study|Protocol Violation|0|||
129035327|NCT01011335|464419641|FG011|Overall Study|Protocol Violation|0|||
129035328|NCT01011335|464419642|FG012|Overall Study|Protocol Violation|0|||
129035329|NCT01011335|464419630|FG000|Overall Study|Moved/deployed or no booster|1|||
129035330|NCT01011335|464419631|FG001|Overall Study|Moved/deployed or no booster|0|||
129035331|NCT01011335|464419632|FG002|Overall Study|Moved/deployed or no booster|0|||
129035332|NCT01011335|464419633|FG003|Overall Study|Moved/deployed or no booster|1|||
129035333|NCT01011335|464419634|FG004|Overall Study|Moved/deployed or no booster|0|||
129035334|NCT01011335|464419635|FG005|Overall Study|Moved/deployed or no booster|0|||
129035335|NCT01011335|464419636|FG006|Overall Study|Moved/deployed or no booster|1|||
129035336|NCT01011335|464419637|FG007|Overall Study|Moved/deployed or no booster|0|||
129035337|NCT01011335|464419638|FG008|Overall Study|Moved/deployed or no booster|1|||
129035338|NCT01011335|464419639|FG009|Overall Study|Moved/deployed or no booster|0|||
129035339|NCT01011335|464419640|FG010|Overall Study|Moved/deployed or no booster|2|||
129035340|NCT01011335|464419641|FG011|Overall Study|Moved/deployed or no booster|0|||
129035341|NCT01011335|464419642|FG012|Overall Study|Moved/deployed or no booster|0|||
129035342|NCT01011335|464419630|FG000|Overall Study|Adverse Event|0|||
129035343|NCT01011335|464419631|FG001|Overall Study|Adverse Event|0|||
129035344|NCT01011335|464419632|FG002|Overall Study|Adverse Event|0|||
129035345|NCT01011335|464419633|FG003|Overall Study|Adverse Event|0|||
129035346|NCT01011335|464419634|FG004|Overall Study|Adverse Event|0|||
129035347|NCT01011335|464419635|FG005|Overall Study|Adverse Event|0|||
129035348|NCT01011335|464419636|FG006|Overall Study|Adverse Event|0|||
129035349|NCT01011335|464419637|FG007|Overall Study|Adverse Event|0|||
129035350|NCT01011335|464419638|FG008|Overall Study|Adverse Event|0|||
128952602|NCT00738374|464110449|FG002|Induction Treatment Phase|Non-compliance|0|||
128952603|NCT00738374|464110450|FG003|Induction Treatment Phase|Non-compliance|0|||
128952604|NCT00738374|464110447|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
128952605|NCT00738374|464110448|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
128952606|NCT00738374|464110449|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
128952607|NCT00738374|464110450|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
128952608|NCT00738374|464110447|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
128952609|NCT00738374|464110448|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
128952610|NCT00738374|464110449|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
128952611|NCT00738374|464110450|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
128952612|NCT00738374|464110447|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
128952613|NCT00738374|464110448|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
128952614|NCT00738374|464110449|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
128952615|NCT00738374|464110450|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
128952616|NCT00738374|464110447|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
128952617|NCT00738374|464110448|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
128952618|NCT00738374|464110449|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
128952619|NCT00738374|464110450|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
128952620|NCT00738374|464110447|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
128952621|NCT00738374|464110448|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
128952622|NCT00738374|464110449|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
128952623|NCT00738374|464110450|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
128952624|NCT00738374|464110447|FG000|Maintenance Treatment/Observation Phase|Other|0|||
128952625|NCT00738374|464110448|FG001|Maintenance Treatment/Observation Phase|Other|1|||
129035351|NCT01011335|464419639|FG009|Overall Study|Adverse Event|0|||
129035352|NCT01011335|464419640|FG010|Overall Study|Adverse Event|4|||
129035353|NCT01011335|464419641|FG011|Overall Study|Adverse Event|0|||
128952626|NCT00738374|464110449|FG002|Maintenance Treatment/Observation Phase|Other|0|||
128952627|NCT00738374|464110450|FG003|Maintenance Treatment/Observation Phase|Other|0|||
128952628|NCT01969799|464110451|FG000|Overall Study|Adverse Event|0|||
128952629|NCT01969799|464110452|FG001|Overall Study|Adverse Event|1|||
128952630|NCT01969799|464110451|FG000|Overall Study|Death|16|||
128952631|NCT01969799|464110452|FG001|Overall Study|Death|11|||
129035354|NCT01011335|464419642|FG012|Overall Study|Adverse Event|1|||
129035355|NCT01765751|464419651|FG000|Overall Study|Lost to Follow-up|0|||
129035356|NCT01765751|464419652|FG001|Overall Study|Lost to Follow-up|2|||
129035357|NCT01765751|464419653|FG002|Overall Study|Lost to Follow-up|1|||
129035358|NCT03429049|464419654|FG000|Overall Study|Adverse Event|2|||
128952632|NCT01969799|464110451|FG000|Overall Study|Lost to Follow-up|0|||
129035359|NCT03429049|464419655|FG001|Overall Study|Adverse Event|3|||
129035360|NCT03429049|464419654|FG000|Overall Study|Death|0|||
129035361|NCT03429049|464419655|FG001|Overall Study|Death|1|||
129035362|NCT03429049|464419654|FG000|Overall Study|Lack of Efficacy|4|||
129035363|NCT03429049|464419655|FG001|Overall Study|Lack of Efficacy|2|||
129035364|NCT03429049|464419654|FG000|Overall Study|Lost to Follow-up|9|||
129035365|NCT03429049|464419655|FG001|Overall Study|Lost to Follow-up|8|||
129035366|NCT03429049|464419654|FG000|Overall Study|Physician Decision|1|||
128711235|NCT00293254|463239839|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
128952633|NCT01969799|464110452|FG001|Overall Study|Lost to Follow-up|2|||
128952634|NCT01969799|464110451|FG000|Overall Study|Physician Decision|1|||
128952635|NCT01969799|464110452|FG001|Overall Study|Physician Decision|0|||
128952636|NCT00995670|464110453|FG000|Overall Study|Failed arterial cannulation|1|||
128952637|NCT00995670|464110454|FG001|Overall Study|Failed arterial cannulation|0|||
128952638|NCT00995670|464110455|FG002|Overall Study|Failed arterial cannulation|3|||
128952639|NCT03519516|464110457|FG000|Overall Study|Adverse Event|0|||
128952640|NCT03519516|464110458|FG001|Overall Study|Adverse Event|1|||
128952641|NCT01935336|464110459|FG000|Overall Study|Adverse Event|1|||
128952642|NCT01935336|464110460|FG001|Overall Study|Adverse Event|0|||
128952643|NCT01935336|464110461|FG002|Overall Study|Adverse Event|0|||
128952644|NCT01935336|464110462|FG003|Overall Study|Adverse Event|0|||
128952645|NCT01935336|464110459|FG000|Overall Study|Progressive disease|5|||
128952646|NCT01935336|464110460|FG001|Overall Study|Progressive disease|3|||
128952647|NCT01935336|464110461|FG002|Overall Study|Progressive disease|47|||
128952648|NCT01935336|464110462|FG003|Overall Study|Progressive disease|66|||
128952649|NCT01255306|464112018|FG000|Overall Study|Physician Decision|1|||
128952650|NCT01255306|464112019|FG001|Overall Study|Physician Decision|1|||
128952651|NCT01283997|464112020|FG000|Overall Study|Physician Decision|8|||
128952652|NCT01283997|464112021|FG001|Overall Study|Physician Decision|10|||
128952653|NCT01283997|464112020|FG000|Overall Study|Withdrawal by Subject|3|||
128952654|NCT01283997|464112021|FG001|Overall Study|Withdrawal by Subject|2|||
128952655|NCT01283997|464112020|FG000|Overall Study|Physically unable to continue|0|||
128952656|NCT01283997|464112021|FG001|Overall Study|Physically unable to continue|1|||
128952657|NCT01283997|464112020|FG000|Overall Study|Progressive disease|1|||
128952658|NCT01283997|464112021|FG001|Overall Study|Progressive disease|0|||
128952659|NCT01283997|464112020|FG000|Overall Study|Other|4|||
128952660|NCT01283997|464112021|FG001|Overall Study|Other|4|||
128952661|NCT02017899|464112022|FG000|Overall Study|Withdrawal by Subject|0|||
128952662|NCT02017899|464112023|FG001|Overall Study|Withdrawal by Subject|0|||
128952663|NCT02017899|464112024|FG002|Overall Study|Withdrawal by Subject|0|||
128952664|NCT02017899|464112025|FG003|Overall Study|Withdrawal by Subject|1|||
128952665|NCT02017899|464112026|FG004|Overall Study|Withdrawal by Subject|1|||
128952666|NCT02017899|464112027|FG005|Overall Study|Withdrawal by Subject|0|||
128952667|NCT01677624|464112031|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
128952668|NCT00804843|464112035|FG000|Overall Study|Protocol Violation|1|||
128952669|NCT00804843|464112036|FG001|Overall Study|Protocol Violation|0|||
128952670|NCT00804843|464112035|FG000|Overall Study|Adverse Event|8|||
128952671|NCT00804843|464112036|FG001|Overall Study|Adverse Event|5|||
128952672|NCT00804843|464112035|FG000|Overall Study|Withdrawal by Subject|1|||
128952673|NCT00804843|464112036|FG001|Overall Study|Withdrawal by Subject|2|||
128952674|NCT00884221|464112041|FG000|Overall Study|Withdrawal by Subject|0|||
128952675|NCT00884221|464112042|FG001|Overall Study|Withdrawal by Subject|3|||
128952676|NCT00884221|464112041|FG000|Overall Study|Adverse Event|6|||
128952677|NCT00884221|464112042|FG001|Overall Study|Adverse Event|3|||
128952678|NCT00884221|464112041|FG000|Overall Study|Protocol Violation|16|||
128952679|NCT00884221|464112042|FG001|Overall Study|Protocol Violation|13|||
128952680|NCT00884221|464112041|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
128952681|NCT00884221|464112042|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
128952682|NCT02126670|464112045|FG000|Overall Study|Withdrawal by Subject|1|||
128952683|NCT02126670|464112046|FG001|Overall Study|Withdrawal by Subject|0|||
128952684|NCT02126670|464112047|FG002|Overall Study|Withdrawal by Subject|0|||
128952685|NCT02126670|464112048|FG003|Overall Study|Withdrawal by Subject|1|||
128952686|NCT01975246|464112051|FG000|Overall Study|Adverse Event|2|||
128952687|NCT01975246|464112052|FG001|Overall Study|Adverse Event|1|||
128952688|NCT01975246|464112051|FG000|Overall Study|Lack of Efficacy|1|||
128952689|NCT01975246|464112052|FG001|Overall Study|Lack of Efficacy|0|||
128952690|NCT01975246|464112051|FG000|Overall Study|Protocol Violation|1|||
128952691|NCT01975246|464112052|FG001|Overall Study|Protocol Violation|0|||
128952692|NCT01975246|464112051|FG000|Overall Study|Other than stated|0|||
128952693|NCT01975246|464112052|FG001|Overall Study|Other than stated|1|||
128952694|NCT01263093|464112053|FG000|Washout|Physician Decision|1|||
128952695|NCT01263093|464112054|FG001|Washout|Physician Decision|0|||
128952696|NCT01263093|464112053|FG000|Period 2|Adverse Event|1|||
128952697|NCT01263093|464112054|FG001|Period 2|Adverse Event|0|||
128952698|NCT00424346|464112055|FG000|Core Study|Adverse Event|5|||
128952699|NCT00424346|464112056|FG001|Core Study|Adverse Event|3|||
128952700|NCT00424346|464112057|FG002|Core Study|Adverse Event|1|||
128952701|NCT00424346|464112058|FG003|Core Study|Adverse Event|1|||
128952702|NCT00424346|464112055|FG000|Core Study|Abnormal Laboratory Values|0|||
128952703|NCT00424346|464112056|FG001|Core Study|Abnormal Laboratory Values|1|||
128952704|NCT00424346|464112057|FG002|Core Study|Abnormal Laboratory Values|0|||
128952705|NCT00424346|464112058|FG003|Core Study|Abnormal Laboratory Values|0|||
128952706|NCT00424346|464112055|FG000|Core Study|Lack of Efficacy|1|||
128952707|NCT00424346|464112056|FG001|Core Study|Lack of Efficacy|3|||
129035367|NCT03429049|464419655|FG001|Overall Study|Physician Decision|0|||
128952708|NCT00424346|464112057|FG002|Core Study|Lack of Efficacy|0|||
129035368|NCT03429049|464419654|FG000|Overall Study|Protocol Violation|3|||
128952709|NCT00424346|464112058|FG003|Core Study|Lack of Efficacy|4|||
128952710|NCT00424346|464112055|FG000|Core Study|Withdrawal by Subject|1|||
128952711|NCT00424346|464112056|FG001|Core Study|Withdrawal by Subject|0|||
128952712|NCT00424346|464112057|FG002|Core Study|Withdrawal by Subject|0|||
128952713|NCT00424346|464112058|FG003|Core Study|Withdrawal by Subject|2|||
128952714|NCT00424346|464112055|FG000|Core Study|Lost to Follow-up|1|||
128952715|NCT00424346|464112056|FG001|Core Study|Lost to Follow-up|1|||
128952716|NCT00424346|464112057|FG002|Core Study|Lost to Follow-up|0|||
128952717|NCT00424346|464112058|FG003|Core Study|Lost to Follow-up|0|||
128952718|NCT00424346|464112055|FG000|Core Study|Administrative Problems|1|||
128952719|NCT00424346|464112056|FG001|Core Study|Administrative Problems|0|||
128952720|NCT00424346|464112057|FG002|Core Study|Administrative Problems|1|||
128952721|NCT00424346|464112058|FG003|Core Study|Administrative Problems|0|||
128952722|NCT00424346|464112055|FG000|Core Study|Protocol Violation|0|||
128952723|NCT00424346|464112056|FG001|Core Study|Protocol Violation|0|||
128952724|NCT00424346|464112057|FG002|Core Study|Protocol Violation|2|||
128952725|NCT00424346|464112058|FG003|Core Study|Protocol Violation|0|||
128952726|NCT00424346|464112055|FG000|Extension Phase|Adverse Event|0|||
128952727|NCT00424346|464112056|FG001|Extension Phase|Adverse Event|9|||
128952728|NCT00424346|464112057|FG002|Extension Phase|Adverse Event|5|||
128952729|NCT00424346|464112058|FG003|Extension Phase|Adverse Event|4|||
128952730|NCT00424346|464112055|FG000|Extension Phase|Lack of Efficacy|0|||
128952731|NCT00424346|464112056|FG001|Extension Phase|Lack of Efficacy|16|||
128952732|NCT00424346|464112057|FG002|Extension Phase|Lack of Efficacy|14|||
128952733|NCT00424346|464112058|FG003|Extension Phase|Lack of Efficacy|11|||
128952734|NCT00424346|464112055|FG000|Extension Phase|Withdrawal by Subject|0|||
128952735|NCT00424346|464112056|FG001|Extension Phase|Withdrawal by Subject|5|||
128952736|NCT00424346|464112057|FG002|Extension Phase|Withdrawal by Subject|3|||
128952737|NCT00424346|464112058|FG003|Extension Phase|Withdrawal by Subject|4|||
128952738|NCT00424346|464112055|FG000|Extension Phase|Lost to Follow-up|0|||
128952739|NCT00424346|464112056|FG001|Extension Phase|Lost to Follow-up|2|||
128952740|NCT00424346|464112057|FG002|Extension Phase|Lost to Follow-up|0|||
128952741|NCT00424346|464112058|FG003|Extension Phase|Lost to Follow-up|0|||
128952742|NCT00424346|464112055|FG000|Extension Phase|Administrative Problems|0|||
128952743|NCT00424346|464112056|FG001|Extension Phase|Administrative Problems|69|||
128952744|NCT00424346|464112057|FG002|Extension Phase|Administrative Problems|32|||
128952745|NCT00424346|464112058|FG003|Extension Phase|Administrative Problems|35|||
128952746|NCT00424346|464112055|FG000|Extension Phase|Death|0|||
128952747|NCT00424346|464112056|FG001|Extension Phase|Death|0|||
128952748|NCT00424346|464112057|FG002|Extension Phase|Death|0|||
128952749|NCT00424346|464112058|FG003|Extension Phase|Death|1|||
128952750|NCT00424346|464112055|FG000|Extension Phase|Protocol Violation|0|||
128952751|NCT00424346|464112056|FG001|Extension Phase|Protocol Violation|1|||
128952752|NCT00424346|464112057|FG002|Extension Phase|Protocol Violation|1|||
128952753|NCT00424346|464112058|FG003|Extension Phase|Protocol Violation|0|||
128952754|NCT01827319|464112059|FG000|Overall Study|Lost to Follow-up|3|||
128952755|NCT00571519|464112060|FG000|Overall Study|Subject withdrew consent|0|||
128952756|NCT00571519|464112061|FG001|Overall Study|Subject withdrew consent|1|||
128952757|NCT00571519|464112062|FG002|Overall Study|Subject withdrew consent|0|||
128952758|NCT00571519|464112063|FG003|Overall Study|Subject withdrew consent|2|||
128952759|NCT00571519|464112064|FG004|Overall Study|Subject withdrew consent|1|||
128952760|NCT00571519|464112065|FG005|Overall Study|Subject withdrew consent|1|||
128952761|NCT00571519|464112066|FG006|Overall Study|Subject withdrew consent|2|||
128952762|NCT00571519|464112060|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
128952763|NCT00571519|464112061|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
128952764|NCT00571519|464112062|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
128952765|NCT00571519|464112063|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
128952766|NCT00571519|464112064|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
128952767|NCT00571519|464112065|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
128952768|NCT00571519|464112066|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
128952769|NCT00571519|464112060|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
128952770|NCT00571519|464112061|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
128952771|NCT00571519|464112062|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
128952772|NCT00571519|464112063|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
128952773|NCT00571519|464112064|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
128952774|NCT00571519|464112065|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
128952775|NCT00571519|464112066|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
128952776|NCT00571519|464112060|FG000|Overall Study|Termination of study by Sponsor|2|||
128952777|NCT00571519|464112061|FG001|Overall Study|Termination of study by Sponsor|7|||
128952778|NCT00571519|464112062|FG002|Overall Study|Termination of study by Sponsor|10|||
128711236|NCT00293254|463239838|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
128952779|NCT00571519|464112063|FG003|Overall Study|Termination of study by Sponsor|24|||
128952780|NCT00571519|464112064|FG004|Overall Study|Termination of study by Sponsor|8|||
128952781|NCT00571519|464112065|FG005|Overall Study|Termination of study by Sponsor|9|||
129035369|NCT03429049|464419655|FG001|Overall Study|Protocol Violation|0|||
128711237|NCT00293254|463239839|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
128711238|NCT00293254|463239838|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
128711239|NCT00293254|463239839|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
128711240|NCT00293254|463239838|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
128711241|NCT00293254|463239839|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
128711242|NCT00293254|463239838|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
128952782|NCT00571519|464112066|FG006|Overall Study|Termination of study by Sponsor|22|||
128952783|NCT00571519|464112060|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
128952784|NCT00571519|464112061|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
128952785|NCT00571519|464112062|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
128952786|NCT00571519|464112063|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
129125693|NCT00689936|464755529|FG001|Active Treatment Phase|Study Close Out|26|||
129125694|NCT00689936|464755530|FG002|Active Treatment Phase|Study Close Out|21|||
129125695|NCT00689936|464755528|FG000|Active Treatment Phase|Miscellaneous|52|||
129125696|NCT00689936|464755529|FG001|Active Treatment Phase|Miscellaneous|34|||
129125697|NCT00689936|464755530|FG002|Active Treatment Phase|Miscellaneous|47|||
129125698|NCT00689936|464755528|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
129125699|NCT00689936|464755529|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
129125700|NCT00689936|464755530|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
129125701|NCT01303419|464755531|FG000|Overall Study|Discontinuation of study|60|||
129125702|NCT01303419|464755531|FG000|Overall Study|Did not complete both imaging methods|5|||
129125703|NCT01303419|464755531|FG000|Overall Study|Did not meet all I/E after screening|31|||
129125704|NCT00311168|464755535|FG000|First Intervention|Withdrawal by Subject|2|||
129125705|NCT00311168|464755536|FG001|First Intervention|Withdrawal by Subject|2|||
129125706|NCT00311168|464755535|FG000|First Intervention|Lost to Follow-up|1|||
129125707|NCT00311168|464755536|FG001|First Intervention|Lost to Follow-up|1|||
129125708|NCT00311168|464755535|FG000|First Intervention|Protocol Violation|1|||
129125709|NCT00311168|464755536|FG001|First Intervention|Protocol Violation|1|||
129125710|NCT00311168|464755535|FG000|First Intervention|Adverse Event|1|||
129125711|NCT00311168|464755536|FG001|First Intervention|Adverse Event|0|||
129125712|NCT00311168|464755535|FG000|First Intervention|Other|2|||
129125713|NCT00311168|464755536|FG001|First Intervention|Other|2|||
129125714|NCT00311168|464755535|FG000|Second Intervention|Lost to Follow-up|9|||
129125715|NCT00311168|464755536|FG001|Second Intervention|Lost to Follow-up|2|||
129125716|NCT00311168|464755535|FG000|Second Intervention|Withdrawal by Subject|0|||
129125717|NCT00311168|464755536|FG001|Second Intervention|Withdrawal by Subject|1|||
129125718|NCT00311168|464755535|FG000|Second Intervention|Other|1|||
129125719|NCT00311168|464755536|FG001|Second Intervention|Other|1|||
129125720|NCT02337829|464755543|FG000|Overall Study|Death|0|||
129125721|NCT02337829|464755544|FG001|Overall Study|Death|1|||
129125722|NCT02337829|464755545|FG002|Overall Study|Death|0|||
129125723|NCT02337829|464755546|FG003|Overall Study|Death|0|||
129125724|NCT02337829|464755543|FG000|Overall Study|Study terminated by sponsor|12|||
129125725|NCT02337829|464755544|FG001|Overall Study|Study terminated by sponsor|10|||
129125726|NCT02337829|464755545|FG002|Overall Study|Study terminated by sponsor|5|||
129125727|NCT02337829|464755546|FG003|Overall Study|Study terminated by sponsor|6|||
129125728|NCT02337829|464755543|FG000|Overall Study|discontinued for other reasons|6|||
129125729|NCT02337829|464755544|FG001|Overall Study|discontinued for other reasons|3|||
129125730|NCT02337829|464755545|FG002|Overall Study|discontinued for other reasons|1|||
129125731|NCT02337829|464755546|FG003|Overall Study|discontinued for other reasons|4|||
129125732|NCT03330197|464755547|FG000|Overall Study|Adverse Event|0|||
129125733|NCT03330197|464755548|FG001|Overall Study|Adverse Event|1|||
129125734|NCT03330197|464755547|FG000|Overall Study|Withdrawal by Subject|0|||
129125735|NCT03330197|464755548|FG001|Overall Study|Withdrawal by Subject|1|||
129125736|NCT02802228|464755558|FG000|Overall Study|Withdrawal by Subject|2|||
129125737|NCT02802228|464755559|FG001|Overall Study|Withdrawal by Subject|0|||
129125738|NCT02802228|464755558|FG000|Overall Study|Lost to Follow-up|1|||
129125739|NCT02802228|464755559|FG001|Overall Study|Lost to Follow-up|0|||
129125740|NCT02802228|464755558|FG000|Overall Study|Adverse Event|1|||
129125741|NCT02802228|464755559|FG001|Overall Study|Adverse Event|0|||
129125742|NCT02802228|464755558|FG000|Overall Study|Physician Decision|1|||
129125743|NCT02802228|464755559|FG001|Overall Study|Physician Decision|0|||
129125744|NCT00695019|464755562|FG000|Overall Study|Withdrawal by Subject|8|||
129125745|NCT00695019|464755563|FG001|Overall Study|Withdrawal by Subject|6|||
129125746|NCT00695019|464755564|FG002|Overall Study|Withdrawal by Subject|4|||
129125747|NCT00695019|464755562|FG000|Overall Study|Protocol Violation|1|||
129125748|NCT00695019|464755563|FG001|Overall Study|Protocol Violation|3|||
129125749|NCT00695019|464755564|FG002|Overall Study|Protocol Violation|1|||
129125750|NCT00695019|464755562|FG000|Overall Study|Lack of Efficacy|0|||
129125751|NCT00695019|464755563|FG001|Overall Study|Lack of Efficacy|0|||
129125752|NCT00695019|464755564|FG002|Overall Study|Lack of Efficacy|1|||
128711243|NCT00293254|463239839|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
128770569|NCT02960763|463451546|FG001|Step 2|Withdrawal by Subject|0|||
129125753|NCT00695019|464755562|FG000|Overall Study|Various|4|||
128952787|NCT00571519|464112064|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
128952788|NCT00571519|464112065|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
128952789|NCT00571519|464112066|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
128952790|NCT02499575|464112068|FG000|Overall Study|Protocol Violation|0|||
128952791|NCT02499575|464112069|FG001|Overall Study|Protocol Violation|1|||
128952792|NCT02658968|464112070|FG000|Received Rituximab|Adverse Event|0|||
128952793|NCT02658968|464112071|FG001|Received Rituximab|Adverse Event|0|||
128952794|NCT02658968|464112072|FG002|Received Rituximab|Adverse Event|0|||
128952795|NCT02658968|464112073|FG003|Received Rituximab|Adverse Event|0|||
128952796|NCT02658968|464112074|FG004|Received Rituximab|Adverse Event|1|||
128952797|NCT02658968|464112070|FG000|Received Rituximab|Progressive disease|0|||
128952798|NCT02658968|464112071|FG001|Received Rituximab|Progressive disease|0|||
128952799|NCT02658968|464112072|FG002|Received Rituximab|Progressive disease|0|||
128952800|NCT02658968|464112073|FG003|Received Rituximab|Progressive disease|0|||
128952801|NCT02658968|464112074|FG004|Received Rituximab|Progressive disease|1|||
128952802|NCT02658968|464112070|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
128952803|NCT02658968|464112071|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
128952804|NCT02658968|464112072|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
128952805|NCT02658968|464112073|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
128952806|NCT02658968|464112074|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
128952807|NCT02658968|464112070|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
128952808|NCT02658968|464112071|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
129125754|NCT00695019|464755563|FG001|Overall Study|Various|5|||
129125755|NCT00695019|464755564|FG002|Overall Study|Various|4|||
129125756|NCT02225587|464755565|FG000|Overall Study|Adverse Event|5|||
129125757|NCT02225587|464755566|FG001|Overall Study|Adverse Event|5|||
129125758|NCT02225587|464755565|FG000|Overall Study|Lost to Follow-up|5|||
129125759|NCT02225587|464755566|FG001|Overall Study|Lost to Follow-up|5|||
129125760|NCT02225587|464755565|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129125761|NCT02225587|464755566|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129125762|NCT02225587|464755565|FG000|Overall Study|Physician Decision|2|||
129125763|NCT02225587|464755566|FG001|Overall Study|Physician Decision|0|||
129125764|NCT02225587|464755565|FG000|Overall Study|Protocol Violation|1|||
129125765|NCT02225587|464755566|FG001|Overall Study|Protocol Violation|0|||
129125766|NCT02225587|464755565|FG000|Overall Study|Participant Moved|1|||
129125767|NCT02225587|464755566|FG001|Overall Study|Participant Moved|0|||
129125768|NCT02225587|464755565|FG000|Overall Study|Withdrawal by Subject|13|||
129125769|NCT02225587|464755566|FG001|Overall Study|Withdrawal by Subject|28|||
128952809|NCT02658968|464112072|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
128952810|NCT02658968|464112073|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
128952811|NCT02658968|464112074|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
128952812|NCT02658968|464112070|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
128952813|NCT02658968|464112071|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
128952814|NCT02658968|464112072|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
128952815|NCT02658968|464112073|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
128952816|NCT02658968|464112074|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
128952817|NCT02658968|464112070|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
128952818|NCT02658968|464112071|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
128952819|NCT02658968|464112072|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
128952820|NCT02658968|464112073|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
128952821|NCT02658968|464112074|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
128952822|NCT02658968|464112070|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
128952823|NCT02658968|464112071|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
128952824|NCT02658968|464112072|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
128952825|NCT02658968|464112073|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
128952826|NCT02658968|464112074|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
128952827|NCT00912340|464112081|FG000|Overall Study|Adverse Event|2|||
128952828|NCT00912340|464112082|FG001|Overall Study|Adverse Event|4|||
128952829|NCT00912340|464112083|FG002|Overall Study|Adverse Event|0|||
128952830|NCT00912340|464112081|FG000|Overall Study|Protocol revised to remove arm|0|||
128952831|NCT00912340|464112082|FG001|Overall Study|Protocol revised to remove arm|0|||
128952832|NCT00912340|464112083|FG002|Overall Study|Protocol revised to remove arm|4|||
128952833|NCT01957709|464112091|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
128952834|NCT01061736|464112096|FG000|Overall Study|Dose regimen not selected|0|||
129125770|NCT03197129|464755569|FG000|Overall Study|did not answer the VPT: shyness|4|||
129125771|NCT03197129|464755570|FG001|Overall Study|did not answer the VPT: shyness|5|||
129125772|NCT01564407|464755571|FG000|Overall Study|Lost to Follow-up|0|||
129125773|NCT01564407|464755572|FG001|Overall Study|Lost to Follow-up|1|||
129125774|NCT01564407|464755573|FG002|Overall Study|Lost to Follow-up|0|||
129125775|NCT01564407|464755574|FG003|Overall Study|Lost to Follow-up|0|||
128711244|NCT00293254|463239838|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
128711245|NCT00293254|463239839|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
128711246|NCT00293254|463239838|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
128952835|NCT01061736|464112097|FG001|Overall Study|Dose regimen not selected|0|||
128711247|NCT00293254|463239839|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
128711248|NCT00293254|463239838|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
128711249|NCT00293254|463239839|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
128711250|NCT00293254|463239838|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
128711251|NCT00293254|463239839|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
128711252|NCT00293254|463239838|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
128952836|NCT01061736|464112098|FG002|Overall Study|Dose regimen not selected|0|||
128952837|NCT01061736|464112099|FG003|Overall Study|Dose regimen not selected|0|||
128952838|NCT01061736|464112100|FG004|Overall Study|Dose regimen not selected|0|||
128952839|NCT01061736|464112101|FG005|Overall Study|Dose regimen not selected|0|||
128952840|NCT01061736|464112102|FG006|Overall Study|Dose regimen not selected|79|||
128952841|NCT01061736|464112103|FG007|Overall Study|Dose regimen not selected|0|||
128952842|NCT01061736|464112104|FG008|Overall Study|Dose regimen not selected|0|||
128952843|NCT01061736|464112105|FG009|Overall Study|Dose regimen not selected|0|||
128952844|NCT01061736|464112096|FG000|Overall Study|Adverse Event|13|||
128952845|NCT01061736|464112097|FG001|Overall Study|Adverse Event|1|||
128952846|NCT01061736|464112098|FG002|Overall Study|Adverse Event|3|||
128952847|NCT01061736|464112099|FG003|Overall Study|Adverse Event|2|||
128952848|NCT01061736|464112100|FG004|Overall Study|Adverse Event|4|||
128952849|NCT01061736|464112101|FG005|Overall Study|Adverse Event|1|||
128952850|NCT01061736|464112102|FG006|Overall Study|Adverse Event|4|||
128952851|NCT01061736|464112103|FG007|Overall Study|Adverse Event|63|||
128952852|NCT01061736|464112104|FG008|Overall Study|Adverse Event|67|||
128711253|NCT00293254|463239839|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
128711254|NCT00293254|463239838|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
128952853|NCT01061736|464112105|FG009|Overall Study|Adverse Event|34|||
128952854|NCT01061736|464112096|FG000|Overall Study|Lack of Efficacy|0|||
128952855|NCT01061736|464112097|FG001|Overall Study|Lack of Efficacy|2|||
128952856|NCT01061736|464112098|FG002|Overall Study|Lack of Efficacy|1|||
128952857|NCT01061736|464112099|FG003|Overall Study|Lack of Efficacy|1|||
128952858|NCT01061736|464112100|FG004|Overall Study|Lack of Efficacy|1|||
128952859|NCT01061736|464112101|FG005|Overall Study|Lack of Efficacy|2|||
128952860|NCT01061736|464112102|FG006|Overall Study|Lack of Efficacy|1|||
129035370|NCT03429049|464419654|FG000|Overall Study|Sponsor Decision|2|||
129035371|NCT03429049|464419655|FG001|Overall Study|Sponsor Decision|0|||
129035372|NCT03429049|464419654|FG000|Overall Study|Withdrawal by Subject|4|||
129035373|NCT03429049|464419655|FG001|Overall Study|Withdrawal by Subject|20|||
128952861|NCT01061736|464112103|FG007|Overall Study|Lack of Efficacy|9|||
129125776|NCT01564407|464755575|FG004|Overall Study|Lost to Follow-up|0|||
129125777|NCT01564407|464755571|FG000|Overall Study|Withdrawal by Subject|0|||
129125778|NCT01564407|464755572|FG001|Overall Study|Withdrawal by Subject|1|||
129125779|NCT01564407|464755573|FG002|Overall Study|Withdrawal by Subject|0|||
129125780|NCT01564407|464755574|FG003|Overall Study|Withdrawal by Subject|0|||
129125781|NCT01564407|464755575|FG004|Overall Study|Withdrawal by Subject|0|||
129125782|NCT01564407|464755571|FG000|Overall Study|funding lost, study ended|0|||
129125783|NCT01564407|464755572|FG001|Overall Study|funding lost, study ended|0|||
129125784|NCT01564407|464755573|FG002|Overall Study|funding lost, study ended|0|||
129125785|NCT01564407|464755574|FG003|Overall Study|funding lost, study ended|1|||
129125786|NCT01564407|464755575|FG004|Overall Study|funding lost, study ended|0|||
129125787|NCT02442349|464755576|FG000|Overall Study|Death|95|||
129125788|NCT02442349|464755576|FG000|Overall Study|Withdrawal by Subject|27|||
129125789|NCT02442349|464755576|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
129125790|NCT02442349|464755576|FG000|Overall Study|Lost to Follow-up|1|||
129125791|NCT00314145|464755577|FG000|Overall Study|Withdrawal by Subject|8|||
129125792|NCT00314145|464755578|FG001|Overall Study|Withdrawal by Subject|10|||
129125793|NCT00314145|464755577|FG000|Overall Study|Lost to Follow-up|5|||
129125794|NCT00314145|464755578|FG001|Overall Study|Lost to Follow-up|12|||
129125795|NCT00314145|464755577|FG000|Overall Study|Physician Decision|3|||
129125796|NCT00314145|464755578|FG001|Overall Study|Physician Decision|4|||
129125797|NCT00314145|464755577|FG000|Overall Study|Adverse Event|0|||
129125798|NCT00314145|464755578|FG001|Overall Study|Adverse Event|3|||
129125799|NCT00314145|464755577|FG000|Overall Study|Protocol Violation|3|||
129125800|NCT00314145|464755578|FG001|Overall Study|Protocol Violation|0|||
129125801|NCT00314145|464755577|FG000|Overall Study|Sponsor Decision|2|||
129125802|NCT00314145|464755578|FG001|Overall Study|Sponsor Decision|0|||
129125803|NCT03507790|464755579|FG000|Overall Study|Adverse Event|0|||
129125804|NCT03507790|464755580|FG001|Overall Study|Adverse Event|11|||
129125805|NCT03507790|464755581|FG002|Overall Study|Adverse Event|3|||
129125806|NCT03507790|464755579|FG000|Overall Study|Withdrawal by Subject|2|||
129125807|NCT03507790|464755580|FG001|Overall Study|Withdrawal by Subject|0|||
129125808|NCT03507790|464755581|FG002|Overall Study|Withdrawal by Subject|0|||
128952862|NCT01061736|464112104|FG008|Overall Study|Lack of Efficacy|9|||
128952863|NCT01061736|464112105|FG009|Overall Study|Lack of Efficacy|10|||
128952864|NCT01061736|464112096|FG000|Overall Study|Poor compliance to protocol|0|||
128952865|NCT01061736|464112097|FG001|Overall Study|Poor compliance to protocol|0|||
128952866|NCT01061736|464112098|FG002|Overall Study|Poor compliance to protocol|0|||
128952867|NCT01061736|464112099|FG003|Overall Study|Poor compliance to protocol|0|||
128952868|NCT01061736|464112100|FG004|Overall Study|Poor compliance to protocol|0|||
128952869|NCT01061736|464112101|FG005|Overall Study|Poor compliance to protocol|0|||
128952870|NCT01061736|464112102|FG006|Overall Study|Poor compliance to protocol|0|||
129035374|NCT03429049|464419654|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
129219182|NCT02863419|465102978|FG002|Overall Study|Lost to Follow-up|4|||
129219183|NCT02863419|465102976|FG000|Overall Study|Withdrawal by Subject|5|||
129219184|NCT02863419|465102977|FG001|Overall Study|Withdrawal by Subject|5|||
129219185|NCT02863419|465102978|FG002|Overall Study|Withdrawal by Subject|3|||
129219186|NCT02863419|465102976|FG000|Overall Study|Died|3|||
129219187|NCT02863419|465102977|FG001|Overall Study|Died|4|||
129219188|NCT02863419|465102978|FG002|Overall Study|Died|1|||
129219189|NCT00196313|465102981|FG000|Overall Study|Protocol Violation|2|||
129219190|NCT00196313|465102982|FG001|Overall Study|Protocol Violation|3|||
129219191|NCT00196313|465102981|FG000|Overall Study|Withdrawal by Subject|3|||
129219192|NCT00196313|465102982|FG001|Overall Study|Withdrawal by Subject|1|||
129219193|NCT00196313|465102981|FG000|Overall Study|Adverse Event|3|||
129219194|NCT00196313|465102982|FG001|Overall Study|Adverse Event|1|||
129219195|NCT00196313|465102981|FG000|Overall Study|Subject Pregnant|1|||
129219196|NCT00196313|465102982|FG001|Overall Study|Subject Pregnant|1|||
129219197|NCT00196313|465102981|FG000|Overall Study|Lost to Follow-up|2|||
129219198|NCT00196313|465102982|FG001|Overall Study|Lost to Follow-up|2|||
129219199|NCT02577718|465102983|FG000|Overall Study|Death|6|||
129219200|NCT02577718|465102983|FG000|Overall Study|Withdrawal by Subject|2|||
129219201|NCT01967576|465102984|FG000|Overall Study|Withdrawal by Subject|3|||
129219202|NCT01967576|465102984|FG000|Overall Study|Progressed/Removed from treatment|1|||
129219203|NCT01967576|465102984|FG000|Overall Study|Study closing at site|1|||
129219204|NCT01967576|465102984|FG000|Overall Study|Adverse Event|1|||
129219205|NCT01967576|465102984|FG000|Overall Study|Refused further treatment|1|||
129219206|NCT03196349|465102985|FG000|Overall Study|Did not receive study drug|0|||
129219207|NCT03196349|465102986|FG001|Overall Study|Did not receive study drug|1|||
129219208|NCT03196349|465102987|FG002|Overall Study|Did not receive study drug|2|||
129219209|NCT03196349|465102985|FG000|Overall Study|No data entered|2|||
129219210|NCT03196349|465102986|FG001|Overall Study|No data entered|4|||
129219211|NCT03196349|465102987|FG002|Overall Study|No data entered|0|||
129035375|NCT03429049|464419655|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
129035376|NCT02459418|464419659|FG000|Overall Study|Exclusion Criteria|4|||
129035377|NCT02459418|464419660|FG001|Overall Study|Exclusion Criteria|0|||
129035378|NCT02459418|464419659|FG000|Overall Study|Protocol Violation|0|||
129035379|NCT02459418|464419660|FG001|Overall Study|Protocol Violation|2|||
129035380|NCT02459418|464419659|FG000|Overall Study|Physician Decision|0|||
129035381|NCT02459418|464419660|FG001|Overall Study|Physician Decision|2|||
129035382|NCT02459418|464419659|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
129035383|NCT02459418|464419660|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
129035384|NCT02459418|464419659|FG000|Overall Study|Adverse Event|0|||
129035385|NCT02459418|464419660|FG001|Overall Study|Adverse Event|1|||
129219212|NCT03196349|465102985|FG000|Overall Study|Study Terminated early|15|||
129219213|NCT03196349|465102986|FG001|Overall Study|Study Terminated early|9|||
128711255|NCT00293254|463239839|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
128711256|NCT00293254|463239838|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
128711257|NCT00293254|463239839|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
128711258|NCT02335489|463239840|FG000|Overall Study|Sponsor terminated study|4|||
128711259|NCT02335489|463239840|FG000|Overall Study|Lost to Follow-up|1|||
128711260|NCT02335489|463239840|FG000|Overall Study|Withdrawal by Subject|2|||
128711261|NCT02335489|463239840|FG000|Overall Study|Physician Decision|2|||
128711262|NCT02335489|463239840|FG000|Overall Study|Lack of Efficacy|1|||
128711263|NCT02259582|463239841|FG000|Overall Study|Physician Decision|0|||
128711264|NCT02259582|463239842|FG001|Overall Study|Physician Decision|1|||
128711265|NCT02259582|463239843|FG002|Overall Study|Physician Decision|0|||
129035386|NCT02459418|464419659|FG000|Overall Study|Withdrawal by Subject|1|||
129035387|NCT02459418|464419660|FG001|Overall Study|Withdrawal by Subject|1|||
129035388|NCT02459418|464419659|FG000|Overall Study|Elevated Creatine Kinase|1|||
129035389|NCT02459418|464419660|FG001|Overall Study|Elevated Creatine Kinase|0|||
129219214|NCT03196349|465102987|FG002|Overall Study|Study Terminated early|11|||
129219215|NCT03967444|465102988|FG000|Overall Study|Lost to Follow-up|1|||
129219216|NCT03967444|465102989|FG001|Overall Study|Lost to Follow-up|2|||
128711266|NCT02259582|463239841|FG000|Overall Study|Death|0|||
128711267|NCT02259582|463239842|FG001|Overall Study|Death|0|||
128770570|NCT02960763|463451547|FG002|Step 2|Withdrawal by Subject|0|||
129035390|NCT02459418|464419659|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
129219217|NCT01821118|465102996|FG000|Overall Study|Death|0|||
129219218|NCT01821118|465102997|FG001|Overall Study|Death|1|||
128952871|NCT01061736|464112103|FG007|Overall Study|Poor compliance to protocol|2|||
128952872|NCT01061736|464112104|FG008|Overall Study|Poor compliance to protocol|5|||
128952873|NCT01061736|464112105|FG009|Overall Study|Poor compliance to protocol|9|||
128952874|NCT01061736|464112096|FG000|Overall Study|Not treated|0|||
128952875|NCT01061736|464112097|FG001|Overall Study|Not treated|0|||
128952876|NCT01061736|464112098|FG002|Overall Study|Not treated|0|||
128952877|NCT01061736|464112099|FG003|Overall Study|Not treated|0|||
128952878|NCT01061736|464112100|FG004|Overall Study|Not treated|1|||
128952879|NCT01061736|464112101|FG005|Overall Study|Not treated|0|||
128952880|NCT01061736|464112102|FG006|Overall Study|Not treated|0|||
128952881|NCT01061736|464112103|FG007|Overall Study|Not treated|2|||
128952882|NCT01061736|464112104|FG008|Overall Study|Not treated|1|||
128952883|NCT01061736|464112105|FG009|Overall Study|Not treated|0|||
128952884|NCT01061736|464112096|FG000|Overall Study|Other than specified above|0|||
128952885|NCT01061736|464112097|FG001|Overall Study|Other than specified above|1|||
128952886|NCT01061736|464112098|FG002|Overall Study|Other than specified above|2|||
128952887|NCT01061736|464112099|FG003|Overall Study|Other than specified above|0|||
128952888|NCT01061736|464112100|FG004|Overall Study|Other than specified above|1|||
128952889|NCT01061736|464112101|FG005|Overall Study|Other than specified above|0|||
128952890|NCT01061736|464112102|FG006|Overall Study|Other than specified above|0|||
128952891|NCT01061736|464112103|FG007|Overall Study|Other than specified above|18|||
128952892|NCT01061736|464112104|FG008|Overall Study|Other than specified above|15|||
128952893|NCT01061736|464112105|FG009|Overall Study|Other than specified above|21|||
128952894|NCT01610076|464112106|FG000|Overall Study|Technical issue with video|0|||
128952895|NCT01610076|464112107|FG001|Overall Study|Technical issue with video|1|||
128952896|NCT01610076|464112106|FG000|Overall Study|Lost to Follow-up|3|||
128952897|NCT01610076|464112107|FG001|Overall Study|Lost to Follow-up|4|||
128952898|NCT02680587|464112110|FG000|Overall Study|Withdrawal by Subject|1|||
128952899|NCT02680587|464112111|FG001|Overall Study|Withdrawal by Subject|0|||
128952900|NCT02899377|464112112|FG000|Overall Study|Adverse Event|1|||
128952901|NCT02899377|464112113|FG001|Overall Study|Adverse Event|0|||
128952902|NCT00469209|464112115|FG000|Overall Study|Adverse Event|1|||
128952903|NCT00469209|464112116|FG001|Overall Study|Adverse Event|0|||
128952904|NCT00469209|464112117|FG002|Overall Study|Adverse Event|1|||
128952905|NCT00664209|464112124|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
128952906|NCT00664209|464112124|FG000|Study Treatment Period|Physician Decision|4|||
128952907|NCT00664209|464112124|FG000|Study Treatment Period|Withdrawal by Subject|2|||
128711268|NCT02259582|463239843|FG002|Overall Study|Death|1|||
128711269|NCT02259582|463239841|FG000|Overall Study|Adverse Event|1|||
128711270|NCT02259582|463239842|FG001|Overall Study|Adverse Event|0|||
128952908|NCT00418379|464112137|FG000|Year 1|Adverse Event|9|||
128952909|NCT00418379|464112138|FG001|Year 1|Adverse Event|15|||
128952910|NCT00418379|464112139|FG002|Year 1|Adverse Event|3|||
128952911|NCT00418379|464112137|FG000|Year 1|Withdrawal by Subject|7|||
128952912|NCT00418379|464112138|FG001|Year 1|Withdrawal by Subject|8|||
128952913|NCT00418379|464112139|FG002|Year 1|Withdrawal by Subject|5|||
129035391|NCT02459418|464419660|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
129035392|NCT01872715|464419661|FG000|Overall Study|Adverse Event|1|||
129035393|NCT01872715|464419661|FG000|Overall Study|Protocol Violation|1|||
129035394|NCT01872715|464419661|FG000|Overall Study|Withdrawal by Subject|2|||
129035395|NCT03303417|464419662|FG000|Overall Study|Withdrawal by Subject|1|||
129035396|NCT03303417|464419663|FG001|Overall Study|Withdrawal by Subject|1|||
129035397|NCT01848210|464419666|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
129035398|NCT01848210|464419667|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
129035399|NCT01848210|464419666|FG000|Overall Study|Lost to Follow-up|24|||
129035400|NCT01848210|464419667|FG001|Overall Study|Lost to Follow-up|12|||
129035401|NCT01848210|464419666|FG000|Overall Study|Protocol Violation|3|||
129035402|NCT01848210|464419667|FG001|Overall Study|Protocol Violation|5|||
129035403|NCT01848210|464419666|FG000|Overall Study|Use of Forbidden Drugs|9|||
129035404|NCT01848210|464419667|FG001|Overall Study|Use of Forbidden Drugs|10|||
129035405|NCT01848210|464419666|FG000|Overall Study|Impedition Condition|5|||
129035406|NCT01848210|464419667|FG001|Overall Study|Impedition Condition|9|||
129035407|NCT01848210|464419666|FG000|Overall Study|Adverse Event|7|||
129035408|NCT01848210|464419667|FG001|Overall Study|Adverse Event|9|||
129035409|NCT01848210|464419666|FG000|Overall Study|Discontinuation Criterion|5|||
129035410|NCT01848210|464419667|FG001|Overall Study|Discontinuation Criterion|7|||
129035411|NCT01848210|464419666|FG000|Overall Study|Hypesensitivity|1|||
129035412|NCT01848210|464419667|FG001|Overall Study|Hypesensitivity|0|||
129035413|NCT01848210|464419666|FG000|Overall Study|Hepatic Function Alteration|4|||
128711271|NCT02259582|463239843|FG002|Overall Study|Adverse Event|1|||
129035414|NCT01848210|464419667|FG001|Overall Study|Hepatic Function Alteration|0|||
129035415|NCT01848210|464419666|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
129035416|NCT01848210|464419667|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
129125809|NCT03507790|464755579|FG000|Overall Study|Subject moved to another location|1|||
129125810|NCT03507790|464755580|FG001|Overall Study|Subject moved to another location|2|||
128952914|NCT00418379|464112137|FG000|Year 1|Any other reason not above-mentioned|2|||
128952915|NCT00418379|464112138|FG001|Year 1|Any other reason not above-mentioned|5|||
128952916|NCT00418379|464112139|FG002|Year 1|Any other reason not above-mentioned|7|||
128952917|NCT00418379|464112137|FG000|Year 2|Adverse Event|5|||
128952918|NCT00418379|464112138|FG001|Year 2|Adverse Event|2|||
128952919|NCT00418379|464112139|FG002|Year 2|Adverse Event|1|||
128952920|NCT00418379|464112137|FG000|Year 2|Withdrawal by Subject|1|||
128952921|NCT00418379|464112138|FG001|Year 2|Withdrawal by Subject|1|||
128952922|NCT00418379|464112139|FG002|Year 2|Withdrawal by Subject|3|||
128952923|NCT00418379|464112137|FG000|Year 2|Any other reason not above-mentioned|2|||
128952924|NCT00418379|464112138|FG001|Year 2|Any other reason not above-mentioned|1|||
128952925|NCT00418379|464112139|FG002|Year 2|Any other reason not above-mentioned|6|||
128952926|NCT00418379|464112137|FG000|Year 3|Withdrawal by Subject|1|||
128952927|NCT00418379|464112138|FG001|Year 3|Withdrawal by Subject|1|||
128952928|NCT00418379|464112139|FG002|Year 3|Withdrawal by Subject|2|||
128952929|NCT00418379|464112137|FG000|Year 3|Any other reason not above-mentioned|2|||
128952930|NCT00418379|464112138|FG001|Year 3|Any other reason not above-mentioned|1|||
128952931|NCT00418379|464112139|FG002|Year 3|Any other reason not above-mentioned|1|||
128952932|NCT00418379|464112137|FG000|Year 4|Adverse Event|0|||
128952933|NCT00418379|464112138|FG001|Year 4|Adverse Event|1|||
128952934|NCT00418379|464112139|FG002|Year 4|Adverse Event|0|||
128952935|NCT00418379|464112137|FG000|Year 4|Withdrawal by Subject|2|||
128952936|NCT00418379|464112138|FG001|Year 4|Withdrawal by Subject|3|||
128952937|NCT00418379|464112139|FG002|Year 4|Withdrawal by Subject|2|||
128952938|NCT00418379|464112137|FG000|Year 4|Any other reason not above-mentioned|1|||
128952939|NCT00418379|464112138|FG001|Year 4|Any other reason not above-mentioned|1|||
128952940|NCT00418379|464112139|FG002|Year 4|Any other reason not above-mentioned|0|||
128952941|NCT00418379|464112137|FG000|Year 5|Adverse Event|0|||
128952942|NCT00418379|464112138|FG001|Year 5|Adverse Event|1|||
128952943|NCT00418379|464112139|FG002|Year 5|Adverse Event|0|||
128952944|NCT00418379|464112137|FG000|Year 5|Any other reason not above-mentioned|2|||
128952945|NCT00418379|464112138|FG001|Year 5|Any other reason not above-mentioned|4|||
128952946|NCT00418379|464112139|FG002|Year 5|Any other reason not above-mentioned|3|||
128952947|NCT00065442|464112140|FG000|Overall Study|Lost to Follow-up|1|||
128952948|NCT00065442|464112141|FG001|Overall Study|Lost to Follow-up|1|||
128952949|NCT00065442|464112140|FG000|Overall Study|Death|121|||
128952950|NCT00065442|464112141|FG001|Overall Study|Death|210|||
128952951|NCT00065442|464112140|FG000|Overall Study|Withdrawal by Subject|3|||
128952952|NCT00065442|464112141|FG001|Overall Study|Withdrawal by Subject|9|||
128952953|NCT01594333|464112142|FG000|Overall Study|Death|96|||
128952954|NCT01594333|464112143|FG001|Overall Study|Death|83|||
128952955|NCT01594333|464112142|FG000|Overall Study|Lost to Follow-up|5|||
128952956|NCT01594333|464112143|FG001|Overall Study|Lost to Follow-up|5|||
128952957|NCT01594333|464112142|FG000|Overall Study|Withdrawal by Subject|60|||
129035417|NCT01848210|464419666|FG000|Overall Study|Administrative|1|||
129035418|NCT01848210|464419667|FG001|Overall Study|Administrative|0|||
129035419|NCT00784979|464419668|FG000|Overall Study|incomplete data|6|||
129035420|NCT00894933|464419669|FG000|Overall Study|Lost to Follow-up|2|||
129035421|NCT00894933|464419669|FG000|Overall Study|Cancelled Procedure|1|||
129035422|NCT00894933|464419669|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
129035423|NCT03619876|464419674|FG000|Overall Study|Withdrawal by Subject|1|||
129035424|NCT03619876|464419675|FG001|Overall Study|Withdrawal by Subject|2|||
129035425|NCT03619876|464419674|FG000|Overall Study|Withdrawal due to incidental finding|0|||
129035426|NCT03619876|464419675|FG001|Overall Study|Withdrawal due to incidental finding|2|||
129035427|NCT02994394|464419676|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
129035428|NCT02994394|464419677|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
129035429|NCT02994394|464419678|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
129035430|NCT02994394|464419679|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
129035431|NCT02994394|464419680|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
129035432|NCT02994394|464419681|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
129035433|NCT02994394|464419676|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
129035434|NCT02994394|464419677|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
129035435|NCT02994394|464419678|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
129035436|NCT02994394|464419679|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
129035437|NCT02994394|464419680|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
129035438|NCT02994394|464419681|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
129035439|NCT00835796|464419685|FG000|First Intervention|Withdrawal by Subject|0|||
128711272|NCT02259582|463239841|FG000|Overall Study|Withdrawal by Subject|0|||
128711273|NCT02259582|463239842|FG001|Overall Study|Withdrawal by Subject|0|||
128952958|NCT01594333|464112143|FG001|Overall Study|Withdrawal by Subject|63|||
128952959|NCT00565058|464112144|FG000|Overall Study|Adverse Event|1|||
128952960|NCT00565058|464112145|FG001|Overall Study|Adverse Event|0|||
128952961|NCT00830804|464112148|FG000|Overall Study|Lost to Follow-up|4|||
128952962|NCT00830804|464112148|FG000|Overall Study|Death|1|||
128952963|NCT00830804|464112148|FG000|Overall Study|Unable to get to clinic|7|||
128952964|NCT00830804|464112148|FG000|Overall Study|Consent withdrawn|2|||
128952965|NCT00830804|464112148|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
129035440|NCT00835796|464419686|FG001|First Intervention|Withdrawal by Subject|1|||
129035441|NCT00651183|464419689|FG000|Overall Study|Lack of Efficacy|1|||
129035442|NCT00651183|464419690|FG001|Overall Study|Lack of Efficacy|0|||
128952966|NCT03691610|464112156|FG000|Overall Study|Adverse Event|0|||
128952967|NCT03691610|464112157|FG001|Overall Study|Adverse Event|1|||
128952968|NCT03691610|464112158|FG002|Overall Study|Adverse Event|0|||
128952969|NCT03691610|464112159|FG003|Overall Study|Adverse Event|0|||
128952970|NCT03691610|464112156|FG000|Overall Study|Protocol Deviation|15|||
128952971|NCT03691610|464112157|FG001|Overall Study|Protocol Deviation|8|||
128952972|NCT03691610|464112158|FG002|Overall Study|Protocol Deviation|1|||
128952973|NCT03691610|464112159|FG003|Overall Study|Protocol Deviation|2|||
128952974|NCT03691610|464112156|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
128952975|NCT03691610|464112157|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
128952976|NCT03691610|464112158|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
128952977|NCT03691610|464112159|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
128952978|NCT03691610|464112156|FG000|Overall Study|Lost to Follow-up|20|||
128952979|NCT03691610|464112157|FG001|Overall Study|Lost to Follow-up|11|||
128952980|NCT03691610|464112158|FG002|Overall Study|Lost to Follow-up|5|||
128952981|NCT03691610|464112159|FG003|Overall Study|Lost to Follow-up|2|||
128952982|NCT02475395|464112164|FG000|Overall Study|Protocol Violation|30|||
128952983|NCT02475395|464112165|FG001|Overall Study|Protocol Violation|3|||
128952984|NCT03730194|464112166|FG000|First Stage Treatment|Withdrawal by Subject|1|||
128952985|NCT03730194|464112167|FG001|First Stage Treatment|Withdrawal by Subject|1|||
128952986|NCT03730194|464112168|FG002|First Stage Treatment|Withdrawal by Subject|0|||
128952987|NCT03730194|464112169|FG003|First Stage Treatment|Withdrawal by Subject|0|||
128952988|NCT03730194|464112170|FG004|First Stage Treatment|Withdrawal by Subject|0|||
128952989|NCT03730194|464112171|FG005|First Stage Treatment|Withdrawal by Subject|0|||
128952990|NCT03730194|464112166|FG000|First Stage Treatment|Protocol Violation|3|||
128952991|NCT03730194|464112167|FG001|First Stage Treatment|Protocol Violation|3|||
129125811|NCT03507790|464755581|FG002|Overall Study|Subject moved to another location|0|||
129125812|NCT03507790|464755579|FG000|Overall Study|Non-compliance with study drug|0|||
129125813|NCT03507790|464755580|FG001|Overall Study|Non-compliance with study drug|0|||
129125814|NCT03507790|464755581|FG002|Overall Study|Non-compliance with study drug|1|||
129125815|NCT03507790|464755579|FG000|Overall Study|COVID 19 Pandemic|0|||
129125816|NCT03507790|464755580|FG001|Overall Study|COVID 19 Pandemic|1|||
129125817|NCT03507790|464755581|FG002|Overall Study|COVID 19 Pandemic|0|||
129125818|NCT03507790|464755579|FG000|Overall Study|Lost to Follow-up|0|||
129125819|NCT03507790|464755580|FG001|Overall Study|Lost to Follow-up|1|||
129125820|NCT03507790|464755581|FG002|Overall Study|Lost to Follow-up|0|||
129125821|NCT03507790|464755579|FG000|Overall Study|Discontinuation of the trial at the site|1|||
129125822|NCT03507790|464755580|FG001|Overall Study|Discontinuation of the trial at the site|1|||
129125823|NCT03507790|464755581|FG002|Overall Study|Discontinuation of the trial at the site|0|||
129125824|NCT03507790|464755579|FG000|Overall Study|Randomized in error|0|||
129125825|NCT03507790|464755580|FG001|Overall Study|Randomized in error|0|||
128952992|NCT03730194|464112168|FG002|First Stage Treatment|Protocol Violation|0|||
128952993|NCT03730194|464112169|FG003|First Stage Treatment|Protocol Violation|0|||
128952994|NCT03730194|464112170|FG004|First Stage Treatment|Protocol Violation|0|||
128952995|NCT03730194|464112171|FG005|First Stage Treatment|Protocol Violation|0|||
128952996|NCT00115765|464112172|FG000|Overall Study|Withdrawal by Subject|22|||
128952997|NCT00115765|464112173|FG001|Overall Study|Withdrawal by Subject|53|||
129125826|NCT03507790|464755581|FG002|Overall Study|Randomized in error|1|||
129125827|NCT02296125|464755584|FG000|Overall Study|Withdrawal by Subject|18|||
129125828|NCT02296125|464755585|FG001|Overall Study|Withdrawal by Subject|8|||
129125829|NCT02296125|464755586|FG002|Overall Study|Withdrawal by Subject|6|||
129125830|NCT02296125|464755587|FG003|Overall Study|Withdrawal by Subject|2|||
129125831|NCT02296125|464755584|FG000|Overall Study|Adverse Event|41|||
128952998|NCT00115765|464112174|FG002|Overall Study|Withdrawal by Subject|76|||
128952999|NCT00115765|464112175|FG003|Overall Study|Withdrawal by Subject|15|||
128953000|NCT00115765|464112172|FG000|Overall Study|Physician Decision|4|||
128953001|NCT00115765|464112173|FG001|Overall Study|Physician Decision|15|||
128953002|NCT00115765|464112174|FG002|Overall Study|Physician Decision|18|||
128953003|NCT00115765|464112175|FG003|Overall Study|Physician Decision|13|||
128953004|NCT00115765|464112172|FG000|Overall Study|Lost to Follow-up|3|||
128953005|NCT00115765|464112173|FG001|Overall Study|Lost to Follow-up|20|||
128953006|NCT00115765|464112174|FG002|Overall Study|Lost to Follow-up|18|||
128953007|NCT00115765|464112175|FG003|Overall Study|Lost to Follow-up|1|||
128953008|NCT00115765|464112172|FG000|Overall Study|Other|6|||
128953009|NCT00115765|464112173|FG001|Overall Study|Other|12|||
128953010|NCT00115765|464112174|FG002|Overall Study|Other|9|||
128953011|NCT00115765|464112175|FG003|Overall Study|Other|2|||
128953012|NCT00567541|464112176|FG000|Overall Study|Adverse Event|0|||
129125832|NCT02296125|464755585|FG001|Overall Study|Adverse Event|52|||
129125833|NCT02296125|464755586|FG002|Overall Study|Adverse Event|9|||
129125834|NCT02296125|464755587|FG003|Overall Study|Adverse Event|4|||
129125835|NCT02296125|464755584|FG000|Overall Study|Severe non-compliance to protocol|0|||
128953013|NCT00567541|464112177|FG001|Overall Study|Adverse Event|1|||
128953014|NCT01890512|464112178|FG000|Overall Study|Physician Decision|1|||
128953015|NCT01890512|464112178|FG000|Overall Study|Withdrawal by Subject|1|||
128953016|NCT01890512|464112178|FG000|Overall Study|Protocol Violation|1|||
128953017|NCT03337139|464112191|FG000|Phase I|Withdrawal by Subject|10|||
129035443|NCT00651183|464419689|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
129035444|NCT00651183|464419690|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
129035445|NCT00651183|464419689|FG000|Overall Study|Tolerability insufficient|5|||
129035446|NCT00651183|464419690|FG001|Overall Study|Tolerability insufficient|2|||
129035447|NCT00651183|464419689|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
129035448|NCT00651183|464419690|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
129035449|NCT00651183|464419689|FG000|Overall Study|Withdrawal by Subject|6|||
129035450|NCT00651183|464419690|FG001|Overall Study|Withdrawal by Subject|3|||
129035451|NCT00651183|464419689|FG000|Overall Study|Lost to Follow-up|3|||
129035452|NCT00651183|464419690|FG001|Overall Study|Lost to Follow-up|1|||
128953018|NCT03337139|464112192|FG001|Phase I|Withdrawal by Subject|0|||
129035453|NCT00651183|464419689|FG000|Overall Study|Other reasons|4|||
129035454|NCT00651183|464419690|FG001|Overall Study|Other reasons|2|||
129035455|NCT00651183|464419689|FG000|Overall Study|missing|1|||
129035456|NCT00651183|464419690|FG001|Overall Study|missing|0|||
129035457|NCT00996437|464419695|FG000|Overall Study|Death|1|||
129035458|NCT00996437|464419696|FG001|Overall Study|Death|0|||
129035459|NCT00996437|464419695|FG000|Overall Study|Dropped|2|||
129035460|NCT00996437|464419696|FG001|Overall Study|Dropped|2|||
129035461|NCT00996437|464419695|FG000|Overall Study|Missed|2|||
129035462|NCT00996437|464419696|FG001|Overall Study|Missed|5|||
129035463|NCT02576717|464419697|FG000|Overall Study|Other Reasons|16|||
129035464|NCT02576717|464419698|FG001|Overall Study|Other Reasons|18|||
129035465|NCT02576717|464419699|FG002|Overall Study|Other Reasons|15|||
129035466|NCT02576717|464419697|FG000|Overall Study|Covid-19 Pandemic|0|||
129035467|NCT02576717|464419698|FG001|Overall Study|Covid-19 Pandemic|1|||
128953019|NCT03288493|464112193|FG000|Overall Study|Withdrawal by Subject|4|||
128953020|NCT03288493|464112194|FG001|Overall Study|Withdrawal by Subject|0|||
128953021|NCT03288493|464112195|FG002|Overall Study|Withdrawal by Subject|0|||
128953022|NCT03288493|464112196|FG003|Overall Study|Withdrawal by Subject|0|||
128953023|NCT03288493|464112197|FG004|Overall Study|Withdrawal by Subject|0|||
128953024|NCT03288493|464112198|FG005|Overall Study|Withdrawal by Subject|2|||
128953025|NCT03288493|464112199|FG006|Overall Study|Withdrawal by Subject|0|||
128953026|NCT03288493|464112193|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
128953027|NCT03288493|464112194|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
128953028|NCT03288493|464112195|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
128953029|NCT03288493|464112196|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
129035468|NCT02576717|464419699|FG002|Overall Study|Covid-19 Pandemic|1|||
129035469|NCT02576717|464419697|FG000|Overall Study|Sponsor Decision|0|||
129035470|NCT02576717|464419698|FG001|Overall Study|Sponsor Decision|0|||
129035471|NCT02576717|464419699|FG002|Overall Study|Sponsor Decision|1|||
129035472|NCT02576717|464419697|FG000|Overall Study|Physician Decision|3|||
129035473|NCT02576717|464419698|FG001|Overall Study|Physician Decision|8|||
129035474|NCT02576717|464419699|FG002|Overall Study|Physician Decision|9|||
129035475|NCT02576717|464419697|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
129035476|NCT02576717|464419698|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
129035477|NCT02576717|464419699|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
129035478|NCT02576717|464419697|FG000|Overall Study|Death|3|||
129035479|NCT02576717|464419698|FG001|Overall Study|Death|5|||
129035480|NCT02576717|464419699|FG002|Overall Study|Death|3|||
129035481|NCT02576717|464419697|FG000|Overall Study|Lost to Follow-up|9|||
129035482|NCT02576717|464419698|FG001|Overall Study|Lost to Follow-up|10|||
129035483|NCT02576717|464419699|FG002|Overall Study|Lost to Follow-up|19|||
129035484|NCT02576717|464419697|FG000|Overall Study|Protocol Violation|4|||
129035485|NCT02576717|464419698|FG001|Overall Study|Protocol Violation|0|||
129035486|NCT02576717|464419699|FG002|Overall Study|Protocol Violation|5|||
129035487|NCT02576717|464419697|FG000|Overall Study|Lack of Efficacy|24|||
129035488|NCT02576717|464419698|FG001|Overall Study|Lack of Efficacy|28|||
129035489|NCT02576717|464419699|FG002|Overall Study|Lack of Efficacy|20|||
129035490|NCT02576717|464419697|FG000|Overall Study|Adverse Event|26|||
129035491|NCT02576717|464419698|FG001|Overall Study|Adverse Event|32|||
129035492|NCT02576717|464419699|FG002|Overall Study|Adverse Event|26|||
129035493|NCT00399893|464419700|FG000|Overall Study|Withdrawal by Subject|1|||
129035494|NCT00399893|464419701|FG001|Overall Study|Withdrawal by Subject|0|||
129035495|NCT01363011|464419702|FG000|Main Study|Adverse Event|2|||
129035496|NCT01363011|464419703|FG001|Main Study|Adverse Event|3|||
129035497|NCT01363011|464419702|FG000|Main Study|Investigator's Discretion|1|||
129035498|NCT01363011|464419703|FG001|Main Study|Investigator's Discretion|1|||
129035499|NCT01363011|464419702|FG000|Main Study|Withdrew Consent|1|||
129035500|NCT01363011|464419703|FG001|Main Study|Withdrew Consent|4|||
129035501|NCT01363011|464419702|FG000|Main Study|Protocol Violation|0|||
129035502|NCT01363011|464419703|FG001|Main Study|Protocol Violation|1|||
129035503|NCT01363011|464419702|FG000|Extension Phase|Adverse Event|1|||
129035504|NCT01363011|464419703|FG001|Extension Phase|Adverse Event|1|||
129035505|NCT01363011|464419702|FG000|Extension Phase|Lack of Efficacy|0|||
129035506|NCT01363011|464419703|FG001|Extension Phase|Lack of Efficacy|1|||
128953030|NCT03288493|464112197|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
128953031|NCT03288493|464112198|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
128953032|NCT03288493|464112199|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
128953033|NCT03288493|464112193|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
128953034|NCT03288493|464112194|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
128953035|NCT03288493|464112195|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
128953036|NCT03288493|464112196|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
128953037|NCT03288493|464112197|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
128953038|NCT03288493|464112198|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
128953039|NCT03288493|464112199|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
128953040|NCT03288493|464112193|FG000|Overall Study|Death|2|||
128953041|NCT03288493|464112194|FG001|Overall Study|Death|0|||
128953042|NCT03288493|464112195|FG002|Overall Study|Death|0|||
128953043|NCT03288493|464112196|FG003|Overall Study|Death|0|||
128953044|NCT03288493|464112197|FG004|Overall Study|Death|0|||
128953045|NCT03288493|464112198|FG005|Overall Study|Death|0|||
128953046|NCT03288493|464112199|FG006|Overall Study|Death|0|||
128953047|NCT03288493|464112193|FG000|Overall Study|other reason not listed above|2|||
128953048|NCT03288493|464112194|FG001|Overall Study|other reason not listed above|0|||
128953049|NCT03288493|464112195|FG002|Overall Study|other reason not listed above|0|||
128953050|NCT03288493|464112196|FG003|Overall Study|other reason not listed above|0|||
128953051|NCT03288493|464112197|FG004|Overall Study|other reason not listed above|0|||
128953052|NCT03288493|464112198|FG005|Overall Study|other reason not listed above|0|||
128953053|NCT03288493|464112199|FG006|Overall Study|other reason not listed above|0|||
128953054|NCT03784027|464112200|FG000|Period 1|Withdrawal by Subject|0|||
128953055|NCT03784027|464112201|FG001|Period 1|Withdrawal by Subject|1|||
128953056|NCT00646113|464114629|FG000|Overall Study|Lost to Follow-up|5|||
128953057|NCT00646113|464114629|FG000|Overall Study|Adverse Event|3|||
128953058|NCT04095442|464114630|FG000|Overall Study|Lost to Follow-up|0|||
128953059|NCT04095442|464114631|FG001|Overall Study|Lost to Follow-up|1|||
128953060|NCT04095442|464114630|FG000|Overall Study|Screen failure|1|||
128953061|NCT04095442|464114631|FG001|Overall Study|Screen failure|0|||
128953062|NCT03947255|464114634|FG000|Overall Study|Study Closure by Sponsor|2|||
128953063|NCT03947255|464114635|FG001|Overall Study|Study Closure by Sponsor|2|||
128953064|NCT03947255|464114634|FG000|Overall Study|Withdrawal by Subject|2|||
128953065|NCT03947255|464114635|FG001|Overall Study|Withdrawal by Subject|2|||
128953066|NCT03947255|464114634|FG000|Overall Study|Lost to Follow-up|2|||
128953067|NCT03947255|464114635|FG001|Overall Study|Lost to Follow-up|0|||
128953068|NCT03947255|464114634|FG000|Overall Study|Death|0|||
128953069|NCT03947255|464114635|FG001|Overall Study|Death|2|||
128953070|NCT00562640|464114636|FG000|Overall Study|Death|0|||
128953071|NCT00562640|464114637|FG001|Overall Study|Death|1|||
128953072|NCT00562640|464114638|FG002|Overall Study|Death|1|||
128953073|NCT00562640|464114639|FG003|Overall Study|Death|0|||
128953074|NCT05263921|464114640|FG000|Overall Study|Other: family emergency.|0|||
128953075|NCT05263921|464114641|FG001|Overall Study|Other: family emergency.|0|||
128953076|NCT05263921|464114642|FG002|Overall Study|Other: family emergency.|1|||
128953077|NCT05263921|464114643|FG003|Overall Study|Other: family emergency.|0|||
128953078|NCT04656418|464114647|FG000|Overall Study|Withdrawal by Subject|1|||
128953079|NCT04656418|464114648|FG001|Overall Study|Withdrawal by Subject|3|||
128953080|NCT00603733|464114652|FG000|Active Phase ITT|Adverse Event|8|||
128953081|NCT00603733|464114653|FG001|Active Phase ITT|Adverse Event|7|||
128953082|NCT00603733|464114652|FG000|Active Phase ITT|Withdrawal by Subject|0|||
128953083|NCT00603733|464114653|FG001|Active Phase ITT|Withdrawal by Subject|3|||
128953084|NCT00603733|464114652|FG000|Active Phase ITT|Lost to Follow-up|0|||
128953085|NCT00603733|464114653|FG001|Active Phase ITT|Lost to Follow-up|1|||
128953086|NCT00603733|464114652|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
128953087|NCT00603733|464114653|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
128953088|NCT00603733|464114652|FG000|Active Phase ITT|Lack of Efficacy|1|||
128953089|NCT00603733|464114653|FG001|Active Phase ITT|Lack of Efficacy|2|||
128953090|NCT00603733|464114652|FG000|Active Phase ITT|Subject moved, site closed|1|||
128953091|NCT00603733|464114653|FG001|Active Phase ITT|Subject moved, site closed|1|||
128953092|NCT00603733|464114652|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
128953093|NCT00603733|464114653|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
128953094|NCT00603733|464114652|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
128953095|NCT00603733|464114653|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
128953096|NCT00603733|464114652|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
128953097|NCT00603733|464114653|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
128953098|NCT00603733|464114652|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
129125836|NCT02296125|464755585|FG001|Overall Study|Severe non-compliance to protocol|1|||
128953099|NCT00603733|464114653|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
128953100|NCT00603733|464114652|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
128953101|NCT00603733|464114653|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
128953102|NCT00603733|464114652|FG000|Maintenance Phase ITT|Adverse Event|3|||
128953103|NCT00603733|464114653|FG001|Maintenance Phase ITT|Adverse Event|6|||
128953104|NCT00603733|464114652|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
128953105|NCT00603733|464114653|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
128953106|NCT00603733|464114652|FG000|Maintenance Phase ITT|Protocol Violation|1|||
128953107|NCT00603733|464114653|FG001|Maintenance Phase ITT|Protocol Violation|1|||
128953108|NCT00603733|464114652|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
128953109|NCT00603733|464114653|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
128953110|NCT00603733|464114652|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
128953111|NCT00603733|464114653|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
128953112|NCT00603733|464114652|FG000|Maintenance Phase ITT|Physician Decision|0|||
128953113|NCT00603733|464114653|FG001|Maintenance Phase ITT|Physician Decision|1|||
128953114|NCT00603733|464114652|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
128953115|NCT00603733|464114653|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
128953116|NCT01297309|464114660|FG000|Overall Study|Eligibility failure|2|||
128953117|NCT01297309|464114660|FG000|Overall Study|Screen failure|2|||
128953118|NCT01297309|464114660|FG000|Overall Study|Withdrawal by Subject|5|||
128953119|NCT01297309|464114660|FG000|Overall Study|Adverse Event|1|||
128953120|NCT01297309|464114660|FG000|Overall Study|Investigator Decision|2|||
128953121|NCT01297309|464114660|FG000|Overall Study|Death|1|||
128953122|NCT01297309|464114660|FG000|Overall Study|Participant not entering extensionperiod|1|||
128953123|NCT03039738|464114661|FG000|Overall Study|Incomplete data sets|54|||
128953124|NCT03039738|464114662|FG001|Overall Study|Incomplete data sets|0|||
128953125|NCT02716194|464114674|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
128953126|NCT02716194|464114675|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
128953127|NCT02716194|464114676|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
128953128|NCT01149343|464114682|FG000|Overall Study|Withdrawal by Subject|1|||
128953129|NCT01149343|464114683|FG001|Overall Study|Withdrawal by Subject|1|||
128953130|NCT01149343|464114684|FG002|Overall Study|Withdrawal by Subject|1|||
128953131|NCT01149343|464114685|FG003|Overall Study|Withdrawal by Subject|5|||
128953132|NCT01149343|464114682|FG000|Overall Study|Death|10|||
128953133|NCT01149343|464114683|FG001|Overall Study|Death|13|||
128953134|NCT01149343|464114684|FG002|Overall Study|Death|18|||
128953135|NCT01149343|464114685|FG003|Overall Study|Death|18|||
128953136|NCT01149343|464114682|FG000|Overall Study|Lost to Follow-up|1|||
128953137|NCT01149343|464114683|FG001|Overall Study|Lost to Follow-up|0|||
128953138|NCT01149343|464114684|FG002|Overall Study|Lost to Follow-up|0|||
128953139|NCT01149343|464114685|FG003|Overall Study|Lost to Follow-up|1|||
128953140|NCT01149343|464114682|FG000|Overall Study|Other|8|||
128953141|NCT01149343|464114683|FG001|Overall Study|Other|10|||
128953142|NCT01149343|464114684|FG002|Overall Study|Other|2|||
128953143|NCT01149343|464114685|FG003|Overall Study|Other|14|||
128953144|NCT01149343|464114682|FG000|Overall Study|Sponsor study termination|0|||
128953145|NCT01149343|464114683|FG001|Overall Study|Sponsor study termination|0|||
128953146|NCT01149343|464114684|FG002|Overall Study|Sponsor study termination|0|||
128953147|NCT01149343|464114685|FG003|Overall Study|Sponsor study termination|2|||
128953148|NCT01149343|464114682|FG000|Overall Study|Recurrence / Progressive disease|0|||
128953149|NCT01149343|464114683|FG001|Overall Study|Recurrence / Progressive disease|0|||
128953150|NCT01149343|464114684|FG002|Overall Study|Recurrence / Progressive disease|1|||
128953151|NCT01149343|464114685|FG003|Overall Study|Recurrence / Progressive disease|0|||
128953152|NCT01093755|464114686|FG000|Overall Study|Withdrawal by Subject|3|||
128953153|NCT01093755|464114687|FG001|Overall Study|Withdrawal by Subject|4|||
128953154|NCT00085917|464114691|FG000|Overall Study|Adverse Event|4|||
128953155|NCT00085917|464114692|FG001|Overall Study|Adverse Event|3|||
128953156|NCT01429077|464114693|FG000|Overall Study|Lost to Follow-up|0|||
128953157|NCT01429077|464114694|FG001|Overall Study|Lost to Follow-up|3|||
128953158|NCT03067129|464114696|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
128953159|NCT03067129|464114697|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
128953160|NCT03067129|464114698|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
128953161|NCT03067129|464114699|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
128953162|NCT03067129|464114696|FG000|Overall Study|Withdrawal by Subject|0|||
128953163|NCT03067129|464114697|FG001|Overall Study|Withdrawal by Subject|0|||
128953164|NCT03067129|464114698|FG002|Overall Study|Withdrawal by Subject|1|||
128953165|NCT03067129|464114699|FG003|Overall Study|Withdrawal by Subject|2|||
128953166|NCT03067129|464114696|FG000|Overall Study|Lost to Follow-up|5|||
129035507|NCT01363011|464419702|FG000|Extension Phase|Investigator's Discretion|2|||
129035508|NCT01363011|464419703|FG001|Extension Phase|Investigator's Discretion|2|||
128953167|NCT03067129|464114697|FG001|Overall Study|Lost to Follow-up|5|||
128953168|NCT03067129|464114698|FG002|Overall Study|Lost to Follow-up|4|||
128953169|NCT03067129|464114699|FG003|Overall Study|Lost to Follow-up|3|||
128953170|NCT03372603|464114700|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
128953171|NCT03372603|464114701|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
129035509|NCT01363011|464419702|FG000|Extension Phase|Withdrew Consent|0|||
129035510|NCT01363011|464419703|FG001|Extension Phase|Withdrew Consent|1|||
129035511|NCT01363011|464419702|FG000|Extension Phase|Lost to Follow-up|0|||
129035512|NCT01363011|464419703|FG001|Extension Phase|Lost to Follow-up|2|||
129035513|NCT01363011|464419702|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
129035514|NCT01363011|464419703|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
129035515|NCT01961882|464419708|FG000|Overall Study|Adverse Event|3|||
129035516|NCT01961882|464419709|FG001|Overall Study|Adverse Event|2|||
129035517|NCT01961882|464419708|FG000|Overall Study|Physician Decision|1|||
129035518|NCT01961882|464419709|FG001|Overall Study|Physician Decision|0|||
129035519|NCT01961882|464419708|FG000|Overall Study|Withdrawal by Subject|4|||
129035520|NCT01961882|464419709|FG001|Overall Study|Withdrawal by Subject|1|||
129035521|NCT01961882|464419708|FG000|Overall Study|Relapse of AML|39|||
129219219|NCT01605799|465102998|FG000|Overall Study|Withdrawal by Subject|2|||
129219220|NCT01605799|465102999|FG001|Overall Study|Withdrawal by Subject|1|||
129035522|NCT01961882|464419709|FG001|Overall Study|Relapse of AML|37|||
129035523|NCT01961882|464419708|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
129035524|NCT01961882|464419709|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
129035525|NCT01961882|464419708|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
129035526|NCT01961882|464419709|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
129035527|NCT00407745|464419710|FG000|Overall Study|Lack of Efficacy|1|||
129035528|NCT00407745|464419711|FG001|Overall Study|Lack of Efficacy|2|||
129035529|NCT00407745|464419710|FG000|Overall Study|Withdrawal by Subject|3|||
128953172|NCT03372603|464114700|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
128953173|NCT03372603|464114701|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
128953174|NCT02806947|464114702|FG000|Overall Study|Withdrawal by Subject|5|||
128953175|NCT02806947|464114703|FG001|Overall Study|Withdrawal by Subject|1|||
128953176|NCT00865189|464114704|FG000|Overall Study|Other|1|||
128953177|NCT00865189|464114705|FG001|Overall Study|Other|2|||
128953178|NCT00865189|464114704|FG000|Overall Study|Death|4|||
128953179|NCT00865189|464114705|FG001|Overall Study|Death|11|||
128953180|NCT00865189|464114704|FG000|Overall Study|Lost to Follow-up|6|||
128953181|NCT00865189|464114705|FG001|Overall Study|Lost to Follow-up|6|||
128953182|NCT00865189|464114704|FG000|Overall Study|Withdrawal by Subject|1|||
128953183|NCT00865189|464114705|FG001|Overall Study|Withdrawal by Subject|0|||
128953184|NCT00843843|464114706|FG000|Overall Study|Physician Decision|1|||
128953185|NCT00843843|464114707|FG001|Overall Study|Physician Decision|1|||
128953186|NCT00843843|464114706|FG000|Overall Study|Protocol Violation|1|||
128953187|NCT00843843|464114707|FG001|Overall Study|Protocol Violation|1|||
128953188|NCT02029638|464114709|FG000|Overall Study|Death|0|||
129035530|NCT00407745|464419711|FG001|Overall Study|Withdrawal by Subject|3|||
128953189|NCT02029638|464114710|FG001|Overall Study|Death|0|||
128953190|NCT02029638|464114711|FG002|Overall Study|Death|1|||
129035531|NCT00407745|464419710|FG000|Overall Study|Protocol Violation|5|||
129035532|NCT00407745|464419711|FG001|Overall Study|Protocol Violation|3|||
129035533|NCT00407745|464419710|FG000|Overall Study|Adverse Event|8|||
129035534|NCT00407745|464419711|FG001|Overall Study|Adverse Event|8|||
129035535|NCT00407745|464419710|FG000|Overall Study|Other|2|||
129035536|NCT00407745|464419711|FG001|Overall Study|Other|0|||
129035537|NCT00407745|464419710|FG000|Overall Study|Randomized, unknown if treated|0|||
129035538|NCT00407745|464419711|FG001|Overall Study|Randomized, unknown if treated|1|||
129035539|NCT00108082|464419712|FG000|Overall Study|Adverse Event|14|||
129035540|NCT00108082|464419713|FG001|Overall Study|Adverse Event|12|||
129035541|NCT00108082|464419714|FG002|Overall Study|Adverse Event|17|||
129035542|NCT00108082|464419712|FG000|Overall Study|Lost to Follow-up|6|||
129035543|NCT00108082|464419713|FG001|Overall Study|Lost to Follow-up|3|||
129035544|NCT00108082|464419714|FG002|Overall Study|Lost to Follow-up|7|||
129035545|NCT00108082|464419712|FG000|Overall Study|Consent Withdrawn|3|||
129035546|NCT00108082|464419713|FG001|Overall Study|Consent Withdrawn|3|||
129035547|NCT00108082|464419714|FG002|Overall Study|Consent Withdrawn|5|||
129035548|NCT00108082|464419712|FG000|Overall Study|Protocol Violation|1|||
129035549|NCT00108082|464419713|FG001|Overall Study|Protocol Violation|2|||
129035550|NCT00108082|464419714|FG002|Overall Study|Protocol Violation|0|||
129219221|NCT00345358|465103000|FG000|Primary Vaccination Phase|Other|0|||
129219222|NCT00345358|465103001|FG001|Primary Vaccination Phase|Other|1|||
129035551|NCT00108082|464419712|FG000|Overall Study|Lack of Efficacy|3|||
129035552|NCT00108082|464419713|FG001|Overall Study|Lack of Efficacy|1|||
129035553|NCT00108082|464419714|FG002|Overall Study|Lack of Efficacy|2|||
129035554|NCT00108082|464419712|FG000|Overall Study|Amendment 4: > Month 12|5|||
129035555|NCT00108082|464419713|FG001|Overall Study|Amendment 4: > Month 12|7|||
129035556|NCT00108082|464419714|FG002|Overall Study|Amendment 4: > Month 12|5|||
129035557|NCT00108082|464419712|FG000|Overall Study|Woman of Child-bearing Potential|2|||
129035558|NCT00108082|464419713|FG001|Overall Study|Woman of Child-bearing Potential|0|||
129219223|NCT00345358|465103002|FG002|Primary Vaccination Phase|Other|1|||
128953191|NCT02029638|464114709|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
128953192|NCT02029638|464114710|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
129035559|NCT00108082|464419714|FG002|Overall Study|Woman of Child-bearing Potential|2|||
129219224|NCT00345358|465103003|FG003|Primary Vaccination Phase|Other|0|||
128953193|NCT02029638|464114711|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
128953194|NCT01153841|464114712|FG000|Overall Study|Adverse Event|1|||
128953195|NCT01153841|464114713|FG001|Overall Study|Adverse Event|0|||
128953196|NCT01153841|464114712|FG000|Overall Study|Withdrawal by Subject|1|||
128953197|NCT01153841|464114713|FG001|Overall Study|Withdrawal by Subject|0|||
128953198|NCT01153841|464114712|FG000|Overall Study|Protocol Violation|2|||
128953199|NCT01153841|464114713|FG001|Overall Study|Protocol Violation|0|||
128953200|NCT01153841|464114712|FG000|Overall Study|Lost to Follow-up|2|||
128953201|NCT01153841|464114713|FG001|Overall Study|Lost to Follow-up|0|||
128953202|NCT03428997|464114714|FG000|Overall Study|Sponsor decision.|1|||
128953203|NCT03428997|464114714|FG000|Overall Study|Withdrawal by Subject|3|||
128953204|NCT03428997|464114714|FG000|Overall Study|Lost to Follow-up|4|||
128953205|NCT00510068|464114718|FG000|Double-blind Period|Disease progression|98|||
128953206|NCT00510068|464114719|FG001|Double-blind Period|Disease progression|169|||
128953207|NCT00510068|464114718|FG000|Double-blind Period|Final primary analysis|52|||
128953208|NCT00510068|464114719|FG001|Double-blind Period|Final primary analysis|18|||
128953209|NCT00510068|464114718|FG000|Double-blind Period|Adverse Event|37|||
128953210|NCT00510068|464114719|FG001|Double-blind Period|Adverse Event|7|||
128953211|NCT00510068|464114718|FG000|Double-blind Period|Withdrawal by Subject|8|||
128953212|NCT00510068|464114719|FG001|Double-blind Period|Withdrawal by Subject|6|||
128953213|NCT00510068|464114718|FG000|Double-blind Period|Death|4|||
128953214|NCT00510068|464114719|FG001|Double-blind Period|Death|3|||
128953215|NCT00510068|464114718|FG000|Double-blind Period|Abnormal test result (s)|1|||
128953216|NCT00510068|464114719|FG001|Double-blind Period|Abnormal test result (s)|0|||
128953217|NCT00510068|464114718|FG000|Double-blind Period|Lost to Follow-up|1|||
128953218|NCT00510068|464114719|FG001|Double-blind Period|Lost to Follow-up|0|||
128953219|NCT00510068|464114718|FG000|Double-blind Period|Protocol Violation|6|||
128953220|NCT00510068|464114719|FG001|Double-blind Period|Protocol Violation|0|||
128953221|NCT00510068|464114718|FG000|Open-label Period|Disease Progression|124|||
128953222|NCT00510068|464114719|FG001|Open-label Period|Disease Progression|0|||
128953223|NCT00510068|464114718|FG000|Open-label Period|Adverse Event|46|||
129219225|NCT00345358|465103000|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
129219226|NCT00345358|465103001|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
129219227|NCT00345358|465103002|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
129219228|NCT00345358|465103003|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
129219229|NCT00345358|465103000|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
129219230|NCT00345358|465103001|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
129219231|NCT00345358|465103002|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
129219232|NCT00345358|465103003|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
129219233|NCT00345358|465103000|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
129219234|NCT00345358|465103001|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
129219235|NCT00345358|465103002|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
129219236|NCT00345358|465103003|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
129219237|NCT00345358|465103000|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
129219238|NCT00345358|465103001|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129219239|NCT00345358|465103002|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
128953224|NCT00510068|464114719|FG001|Open-label Period|Adverse Event|0|||
128953225|NCT00510068|464114718|FG000|Open-label Period|Withdrawal by Subject|21|||
128953226|NCT00510068|464114719|FG001|Open-label Period|Withdrawal by Subject|0|||
128953227|NCT00510068|464114718|FG000|Open-label Period|Administrative problems|17|||
128953228|NCT00510068|464114719|FG001|Open-label Period|Administrative problems|0|||
128953229|NCT00510068|464114718|FG000|Open-label Period|Death|7|||
128953230|NCT00510068|464114719|FG001|Open-label Period|Death|0|||
128953231|NCT00510068|464114718|FG000|Open-label Period|New cancer therapy|7|||
128953232|NCT00510068|464114719|FG001|Open-label Period|New cancer therapy|0|||
128953233|NCT00510068|464114718|FG000|Open-label Period|Protocol Violation|2|||
128953234|NCT00510068|464114719|FG001|Open-label Period|Protocol Violation|0|||
128953235|NCT00510068|464114718|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
128953236|NCT00510068|464114719|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
128953237|NCT02563925|464114720|FG000|Overall Study|Withdrawal by Subject|2|||
128953238|NCT00400712|464114721|FG000|Overall Study|Death|1|||
128953239|NCT00400712|464114722|FG001|Overall Study|Death|0|||
128953240|NCT00400712|464114721|FG000|Overall Study|Withdrawal by Subject|11|||
128953241|NCT00400712|464114722|FG001|Overall Study|Withdrawal by Subject|12|||
128953242|NCT00400712|464114721|FG000|Overall Study|Physician Decision|5|||
128953243|NCT00400712|464114722|FG001|Overall Study|Physician Decision|4|||
128953244|NCT00622869|464114725|FG000|Overall Study|Subject Withdrew Consent|13|||
128953245|NCT00622869|464114726|FG001|Overall Study|Subject Withdrew Consent|17|||
128953246|NCT00622869|464114727|FG002|Overall Study|Subject Withdrew Consent|11|||
128953247|NCT00622869|464114725|FG000|Overall Study|Administrative Problems|11|||
128953248|NCT00622869|464114726|FG001|Overall Study|Administrative Problems|17|||
128953249|NCT00622869|464114727|FG002|Overall Study|Administrative Problems|13|||
128953250|NCT00622869|464114725|FG000|Overall Study|Death|12|||
128953251|NCT00622869|464114726|FG001|Overall Study|Death|15|||
128953252|NCT00622869|464114727|FG002|Overall Study|Death|10|||
128953253|NCT00622869|464114725|FG000|Overall Study|Lost to Follow-up|2|||
128953254|NCT00622869|464114726|FG001|Overall Study|Lost to Follow-up|4|||
128953255|NCT00622869|464114727|FG002|Overall Study|Lost to Follow-up|2|||
128953256|NCT00622869|464114725|FG000|Overall Study|Graft Loss|5|||
128953257|NCT00622869|464114726|FG001|Overall Study|Graft Loss|3|||
128953258|NCT00622869|464114727|FG002|Overall Study|Graft Loss|2|||
128953259|NCT00622869|464114725|FG000|Overall Study|Missing|0|||
128953260|NCT00622869|464114726|FG001|Overall Study|Missing|1|||
128953261|NCT00622869|464114727|FG002|Overall Study|Missing|1|||
128953262|NCT00645567|464114728|FG000|Overall Study|Adverse Event|1|||
128953263|NCT03814590|464114733|FG000|Overall Study|Adverse Event|0|||
128953264|NCT03814590|464114734|FG001|Overall Study|Adverse Event|0|||
128953265|NCT03814590|464114735|FG002|Overall Study|Adverse Event|0|||
128953266|NCT03814590|464114736|FG003|Overall Study|Adverse Event|0|||
128953267|NCT03814590|464114737|FG004|Overall Study|Adverse Event|0|||
128953268|NCT03814590|464114738|FG005|Overall Study|Adverse Event|1|||
128953269|NCT03814590|464114739|FG006|Overall Study|Adverse Event|1|||
128953270|NCT03814590|464114740|FG007|Overall Study|Adverse Event|1|||
128953271|NCT03814590|464114741|FG008|Overall Study|Adverse Event|0|||
128953272|NCT03814590|464114742|FG009|Overall Study|Adverse Event|0|||
128953273|NCT03814590|464114743|FG010|Overall Study|Adverse Event|1|||
128953274|NCT03814590|464114744|FG011|Overall Study|Adverse Event|0|||
128953275|NCT03814590|464114745|FG012|Overall Study|Adverse Event|3|||
128953276|NCT03814590|464114746|FG013|Overall Study|Adverse Event|0|||
128953277|NCT03814590|464114733|FG000|Overall Study|Lost to Follow-up|0|||
128953278|NCT03814590|464114734|FG001|Overall Study|Lost to Follow-up|2|||
128953279|NCT03814590|464114735|FG002|Overall Study|Lost to Follow-up|1|||
128953280|NCT03814590|464114736|FG003|Overall Study|Lost to Follow-up|0|||
128953281|NCT03814590|464114737|FG004|Overall Study|Lost to Follow-up|1|||
128953282|NCT03814590|464114738|FG005|Overall Study|Lost to Follow-up|1|||
128953283|NCT03814590|464114739|FG006|Overall Study|Lost to Follow-up|1|||
128953284|NCT03814590|464114740|FG007|Overall Study|Lost to Follow-up|1|||
128953285|NCT03814590|464114741|FG008|Overall Study|Lost to Follow-up|0|||
128953286|NCT03814590|464114742|FG009|Overall Study|Lost to Follow-up|0|||
128953287|NCT03814590|464114743|FG010|Overall Study|Lost to Follow-up|1|||
128953288|NCT03814590|464114744|FG011|Overall Study|Lost to Follow-up|0|||
128953289|NCT03814590|464114745|FG012|Overall Study|Lost to Follow-up|0|||
128953290|NCT03814590|464114746|FG013|Overall Study|Lost to Follow-up|1|||
128953291|NCT03814590|464114733|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953292|NCT03814590|464114734|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953293|NCT03814590|464114735|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953294|NCT03814590|464114736|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953295|NCT03814590|464114737|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953296|NCT03814590|464114738|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953297|NCT03814590|464114739|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953298|NCT03814590|464114740|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953299|NCT03814590|464114741|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953300|NCT03814590|464114742|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
128953301|NCT03814590|464114743|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953302|NCT03814590|464114744|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953303|NCT03814590|464114745|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953304|NCT03814590|464114746|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
128953305|NCT03814590|464114733|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
128953306|NCT03814590|464114734|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
128953307|NCT03814590|464114735|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
128953308|NCT03814590|464114736|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
128953309|NCT03814590|464114737|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
128953310|NCT03814590|464114738|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
128953311|NCT03814590|464114739|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
128953312|NCT03814590|464114740|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
128953313|NCT03814590|464114741|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
128953314|NCT03814590|464114742|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
128953315|NCT03814590|464114743|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
128953316|NCT03814590|464114744|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129125837|NCT02296125|464755586|FG002|Overall Study|Severe non-compliance to protocol|0|||
128953317|NCT03814590|464114745|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
128953318|NCT03814590|464114746|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
128953319|NCT03814590|464114733|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953320|NCT03814590|464114734|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953321|NCT03814590|464114735|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953322|NCT03814590|464114736|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953323|NCT03814590|464114737|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953324|NCT03814590|464114738|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953325|NCT03814590|464114739|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953326|NCT03814590|464114740|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128953327|NCT03814590|464114741|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953328|NCT03814590|464114742|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128953329|NCT03814590|464114743|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953330|NCT03814590|464114744|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953331|NCT03814590|464114745|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129125838|NCT02296125|464755587|FG003|Overall Study|Severe non-compliance to protocol|0|||
128953332|NCT03814590|464114746|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128953333|NCT03814590|464114733|FG000|Overall Study|UNKNOWN REASON|0|||
128953334|NCT03814590|464114734|FG001|Overall Study|UNKNOWN REASON|0|||
128953335|NCT03814590|464114735|FG002|Overall Study|UNKNOWN REASON|0|||
128953336|NCT03814590|464114736|FG003|Overall Study|UNKNOWN REASON|0|||
128953337|NCT03814590|464114737|FG004|Overall Study|UNKNOWN REASON|0|||
128953338|NCT03814590|464114738|FG005|Overall Study|UNKNOWN REASON|0|||
128953339|NCT03814590|464114739|FG006|Overall Study|UNKNOWN REASON|0|||
128953340|NCT03814590|464114740|FG007|Overall Study|UNKNOWN REASON|1|||
128953341|NCT03814590|464114741|FG008|Overall Study|UNKNOWN REASON|0|||
128953342|NCT03814590|464114742|FG009|Overall Study|UNKNOWN REASON|0|||
128953343|NCT03814590|464114743|FG010|Overall Study|UNKNOWN REASON|0|||
128953344|NCT03814590|464114744|FG011|Overall Study|UNKNOWN REASON|0|||
128953345|NCT03814590|464114745|FG012|Overall Study|UNKNOWN REASON|0|||
128953346|NCT03814590|464114746|FG013|Overall Study|UNKNOWN REASON|0|||
128953347|NCT00964158|464114751|FG000|Overall Study|Lost to Follow-up|0|||
128953348|NCT00964158|464114752|FG001|Overall Study|Lost to Follow-up|1|||
128953349|NCT00964158|464114753|FG002|Overall Study|Lost to Follow-up|2|||
128953350|NCT00964158|464114751|FG000|Overall Study|Withdrawal by Subject|0|||
128953351|NCT00964158|464114752|FG001|Overall Study|Withdrawal by Subject|0|||
128953352|NCT00964158|464114753|FG002|Overall Study|Withdrawal by Subject|6|||
128953353|NCT01054976|464114762|FG000|Overall Study|Adverse Event|16|||
128953354|NCT01054976|464114762|FG000|Overall Study|Uncooperative participations to study|7|||
128953355|NCT01054976|464114762|FG000|Overall Study|Withdrawal by Subject|4|||
128953356|NCT01054976|464114762|FG000|Overall Study|Other|8|||
128953357|NCT01763866|464114763|FG000|Overall Study|Withdrawal by Subject|2|||
128953358|NCT01763866|464114764|FG001|Overall Study|Withdrawal by Subject|1|||
129125839|NCT02296125|464755584|FG000|Overall Study|Condition under investigation worsened|153|||
129125840|NCT02296125|464755585|FG001|Overall Study|Condition under investigation worsened|199|||
129125841|NCT02296125|464755586|FG002|Overall Study|Condition under investigation worsened|39|||
129125842|NCT02296125|464755587|FG003|Overall Study|Condition under investigation worsened|56|||
129125843|NCT02296125|464755584|FG000|Overall Study|Any reason not specifically recorded|6|||
129125844|NCT02296125|464755585|FG001|Overall Study|Any reason not specifically recorded|4|||
129125845|NCT02296125|464755586|FG002|Overall Study|Any reason not specifically recorded|2|||
129125846|NCT02296125|464755587|FG003|Overall Study|Any reason not specifically recorded|0|||
129125847|NCT01160614|464755588|FG000|Overall Study|Withdrawal by Subject|0|||
129125848|NCT01160614|464755589|FG001|Overall Study|Withdrawal by Subject|2|||
129125849|NCT00157755|464755590|FG000|Overall Study|Death|2|||
129125850|NCT00157755|464755591|FG001|Overall Study|Death|3|||
129125851|NCT00157755|464755592|FG002|Overall Study|Death|3|||
129125852|NCT00157755|464755593|FG003|Overall Study|Death|2|||
129125853|NCT00157755|464755594|FG004|Overall Study|Death|0|||
129125854|NCT00157755|464755595|FG005|Overall Study|Death|0|||
128953359|NCT01763866|464114765|FG002|Overall Study|Withdrawal by Subject|4|||
128953360|NCT01763866|464114766|FG003|Overall Study|Withdrawal by Subject|0|||
128953361|NCT01763866|464114767|FG004|Overall Study|Withdrawal by Subject|0|||
128953362|NCT01763866|464114768|FG005|Overall Study|Withdrawal by Subject|3|||
128953363|NCT01763866|464114769|FG006|Overall Study|Withdrawal by Subject|4|||
128953364|NCT01763866|464114770|FG007|Overall Study|Withdrawal by Subject|0|||
128953365|NCT01763866|464114771|FG008|Overall Study|Withdrawal by Subject|1|||
128953366|NCT01763866|464114772|FG009|Overall Study|Withdrawal by Subject|1|||
128953367|NCT01763866|464114773|FG010|Overall Study|Withdrawal by Subject|2|||
128953368|NCT01763866|464114774|FG011|Overall Study|Withdrawal by Subject|2|||
128953369|NCT01763866|464114775|FG012|Overall Study|Withdrawal by Subject|2|||
129125855|NCT00157755|464755590|FG000|Overall Study|Lost to Follow-up|0|||
128953370|NCT01763866|464114776|FG013|Overall Study|Withdrawal by Subject|0|||
128953371|NCT01763866|464114777|FG014|Overall Study|Withdrawal by Subject|6|||
129125856|NCT00157755|464755591|FG001|Overall Study|Lost to Follow-up|0|||
129125857|NCT00157755|464755592|FG002|Overall Study|Lost to Follow-up|1|||
128711274|NCT02259582|463239843|FG002|Overall Study|Withdrawal by Subject|1|||
128711275|NCT02259582|463239841|FG000|Overall Study|Disease progression|14|||
128711276|NCT02259582|463239842|FG001|Overall Study|Disease progression|15|||
128711277|NCT02259582|463239843|FG002|Overall Study|Disease progression|17|||
128953372|NCT01763866|464114778|FG015|Overall Study|Withdrawal by Subject|3|||
128953373|NCT01763866|464114779|FG016|Overall Study|Withdrawal by Subject|0|||
128953374|NCT01763866|464114780|FG017|Overall Study|Withdrawal by Subject|1|||
128953375|NCT01763866|464114781|FG018|Overall Study|Withdrawal by Subject|1|||
128953376|NCT01763866|464114782|FG019|Overall Study|Withdrawal by Subject|1|||
128953377|NCT01763866|464114783|FG020|Overall Study|Withdrawal by Subject|2|||
128953378|NCT01763866|464114784|FG021|Overall Study|Withdrawal by Subject|1|||
128953379|NCT01763866|464114785|FG022|Overall Study|Withdrawal by Subject|2|||
128953380|NCT01763866|464114786|FG023|Overall Study|Withdrawal by Subject|1|||
128953381|NCT01763866|464114763|FG000|Overall Study|Decision by sponsor|0|||
128953382|NCT01763866|464114764|FG001|Overall Study|Decision by sponsor|0|||
128953383|NCT01763866|464114765|FG002|Overall Study|Decision by sponsor|1|||
128953384|NCT01763866|464114766|FG003|Overall Study|Decision by sponsor|0|||
128953385|NCT01763866|464114767|FG004|Overall Study|Decision by sponsor|2|||
128953386|NCT01763866|464114768|FG005|Overall Study|Decision by sponsor|0|||
128953387|NCT01763866|464114769|FG006|Overall Study|Decision by sponsor|2|||
128953388|NCT01763866|464114770|FG007|Overall Study|Decision by sponsor|0|||
128953389|NCT01763866|464114771|FG008|Overall Study|Decision by sponsor|2|||
128953390|NCT01763866|464114772|FG009|Overall Study|Decision by sponsor|0|||
128953391|NCT01763866|464114773|FG010|Overall Study|Decision by sponsor|6|||
128953392|NCT01763866|464114774|FG011|Overall Study|Decision by sponsor|0|||
128953393|NCT01763866|464114775|FG012|Overall Study|Decision by sponsor|1|||
128953394|NCT01763866|464114776|FG013|Overall Study|Decision by sponsor|0|||
128953395|NCT01763866|464114777|FG014|Overall Study|Decision by sponsor|5|||
128953396|NCT01763866|464114778|FG015|Overall Study|Decision by sponsor|0|||
128953397|NCT01763866|464114779|FG016|Overall Study|Decision by sponsor|0|||
128953398|NCT01763866|464114780|FG017|Overall Study|Decision by sponsor|0|||
128953399|NCT01763866|464114781|FG018|Overall Study|Decision by sponsor|4|||
128953400|NCT01763866|464114782|FG019|Overall Study|Decision by sponsor|0|||
128953401|NCT01763866|464114783|FG020|Overall Study|Decision by sponsor|2|||
129035560|NCT00108082|464419712|FG000|Overall Study|Incorrectly Randomized|0|||
128711278|NCT02259582|463239841|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
128953402|NCT01763866|464114784|FG021|Overall Study|Decision by sponsor|0|||
129035561|NCT00108082|464419713|FG001|Overall Study|Incorrectly Randomized|0|||
128953403|NCT01763866|464114785|FG022|Overall Study|Decision by sponsor|1|||
129035562|NCT00108082|464419714|FG002|Overall Study|Incorrectly Randomized|2|||
129035563|NCT00108082|464419712|FG000|Overall Study|Non-compliance|1|||
129035564|NCT00108082|464419713|FG001|Overall Study|Non-compliance|0|||
129035565|NCT00108082|464419714|FG002|Overall Study|Non-compliance|2|||
129035566|NCT00108082|464419712|FG000|Overall Study|Stopped Study Medication|0|||
129035567|NCT00108082|464419713|FG001|Overall Study|Stopped Study Medication|0|||
129035568|NCT00108082|464419714|FG002|Overall Study|Stopped Study Medication|1|||
129035569|NCT00108082|464419712|FG000|Overall Study|Site Closed Study|0|||
129035570|NCT00108082|464419713|FG001|Overall Study|Site Closed Study|2|||
129035571|NCT00108082|464419714|FG002|Overall Study|Site Closed Study|0|||
129035572|NCT00108082|464419712|FG000|Overall Study|Protocol Amendment|0|||
129035573|NCT00108082|464419713|FG001|Overall Study|Protocol Amendment|1|||
129035574|NCT00108082|464419714|FG002|Overall Study|Protocol Amendment|0|||
129035575|NCT00108082|464419712|FG000|Overall Study|Study Medication Not Tapered|0|||
129035576|NCT00108082|464419713|FG001|Overall Study|Study Medication Not Tapered|1|||
129035577|NCT00108082|464419714|FG002|Overall Study|Study Medication Not Tapered|0|||
129035578|NCT00108082|464419712|FG000|Overall Study|Subject Left Site Location|1|||
129035579|NCT00108082|464419713|FG001|Overall Study|Subject Left Site Location|0|||
129035580|NCT00108082|464419714|FG002|Overall Study|Subject Left Site Location|0|||
129035581|NCT00108082|464419712|FG000|Overall Study|Investigator Not at Site|1|||
129035582|NCT00108082|464419713|FG001|Overall Study|Investigator Not at Site|0|||
129035583|NCT00108082|464419714|FG002|Overall Study|Investigator Not at Site|0|||
129035584|NCT00108082|464419712|FG000|Overall Study|Blood Pressure Not Controlled|1|||
129035585|NCT00108082|464419713|FG001|Overall Study|Blood Pressure Not Controlled|0|||
129035586|NCT00108082|464419714|FG002|Overall Study|Blood Pressure Not Controlled|0|||
129035587|NCT00906373|464419715|FG000|Overall Study|Withdrawal by Subject|0|||
129035588|NCT00906373|464419716|FG001|Overall Study|Withdrawal by Subject|5|||
129035589|NCT00906373|464419715|FG000|Overall Study|Other|0|||
129035590|NCT00906373|464419716|FG001|Overall Study|Other|1|||
128953404|NCT01763866|464114786|FG023|Overall Study|Decision by sponsor|0|||
129035591|NCT00906373|464419715|FG000|Overall Study|Still on treatment at cutoff date|0|||
129035592|NCT00906373|464419716|FG001|Overall Study|Still on treatment at cutoff date|2|||
129035593|NCT01597479|464419717|FG000|Overall Study|Protocol Violation|1|||
128711279|NCT02259582|463239842|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
128953405|NCT01763866|464114763|FG000|Overall Study|Lost to Follow-up|0|||
128953406|NCT01763866|464114764|FG001|Overall Study|Lost to Follow-up|0|||
128953407|NCT01763866|464114765|FG002|Overall Study|Lost to Follow-up|0|||
128953408|NCT01763866|464114766|FG003|Overall Study|Lost to Follow-up|0|||
129035594|NCT01597479|464419718|FG001|Overall Study|Protocol Violation|0|||
128711280|NCT02259582|463239843|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
128711281|NCT00503308|463239844|FG000|Overall Study|Protocol Violation|2|||
128711282|NCT00503308|463239845|FG001|Overall Study|Protocol Violation|1|||
128711283|NCT00531050|463239846|FG000|Part 1: Period 1|Adverse Event|0|||
128711284|NCT00531050|463239847|FG001|Part 1: Period 1|Adverse Event|1|||
128711285|NCT00531050|463239848|FG002|Part 1: Period 1|Adverse Event|0|||
128711286|NCT00531050|463239849|FG003|Part 1: Period 1|Adverse Event|0|||
128711287|NCT00531050|463239850|FG004|Part 1: Period 1|Adverse Event|0|||
128711288|NCT00531050|463239851|FG005|Part 1: Period 1|Adverse Event|0|||
128711289|NCT00531050|463239846|FG000|Part 1: Period 1|Protocol Deviation|0|||
128711290|NCT00531050|463239847|FG001|Part 1: Period 1|Protocol Deviation|0|||
128711291|NCT00531050|463239848|FG002|Part 1: Period 1|Protocol Deviation|0|||
128711292|NCT00531050|463239849|FG003|Part 1: Period 1|Protocol Deviation|1|||
128711293|NCT00531050|463239850|FG004|Part 1: Period 1|Protocol Deviation|0|||
128711294|NCT00531050|463239851|FG005|Part 1: Period 1|Protocol Deviation|0|||
128711295|NCT00531050|463239846|FG000|Part 1: Period 3|Adverse Event|1|||
128711296|NCT00531050|463239847|FG001|Part 1: Period 3|Adverse Event|0|||
128711297|NCT00531050|463239848|FG002|Part 1: Period 3|Adverse Event|0|||
128711298|NCT00531050|463239849|FG003|Part 1: Period 3|Adverse Event|0|||
128711299|NCT00531050|463239850|FG004|Part 1: Period 3|Adverse Event|0|||
128711300|NCT00531050|463239851|FG005|Part 1: Period 3|Adverse Event|0|||
128711301|NCT00531050|463239846|FG000|Part 2: Period 1|Adverse Event|0|||
128711302|NCT00531050|463239847|FG001|Part 2: Period 1|Adverse Event|0|||
128711303|NCT00531050|463239848|FG002|Part 2: Period 1|Adverse Event|0|||
128711304|NCT00531050|463239849|FG003|Part 2: Period 1|Adverse Event|0|||
128711305|NCT00531050|463239850|FG004|Part 2: Period 1|Adverse Event|0|||
128711306|NCT00531050|463239851|FG005|Part 2: Period 1|Adverse Event|1|||
128711307|NCT00531050|463239846|FG000|Part 2: Period 3|Abnormal test procedure|1|||
128711308|NCT00531050|463239847|FG001|Part 2: Period 3|Abnormal test procedure|0|||
128711309|NCT00531050|463239848|FG002|Part 2: Period 3|Abnormal test procedure|0|||
128711310|NCT00531050|463239849|FG003|Part 2: Period 3|Abnormal test procedure|0|||
128711311|NCT00531050|463239850|FG004|Part 2: Period 3|Abnormal test procedure|0|||
128711312|NCT00531050|463239851|FG005|Part 2: Period 3|Abnormal test procedure|1|||
128711313|NCT02233309|463239855|FG000|Overall Study|Physician Decision|5|||
128711314|NCT00232817|463239856|FG000|Overall Study|Protocol Violation|2|||
128711315|NCT00232817|463239857|FG001|Overall Study|Protocol Violation|1|||
128711316|NCT00799487|463239858|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
128711317|NCT00799487|463239859|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
128711318|NCT00799487|463239860|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
128711319|NCT00799487|463239858|FG000|Dose Adjustment Period|Adverse Event|2|||
128711320|NCT00799487|463239859|FG001|Dose Adjustment Period|Adverse Event|0|||
128711321|NCT00799487|463239860|FG002|Dose Adjustment Period|Adverse Event|0|||
128711322|NCT00799487|463239858|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
128711323|NCT00799487|463239859|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
128711324|NCT00799487|463239860|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
128711325|NCT00799487|463239858|FG000|Dose Adjustment Period|Investigator Discretion|2|||
128711326|NCT00799487|463239859|FG001|Dose Adjustment Period|Investigator Discretion|0|||
128711327|NCT00799487|463239860|FG002|Dose Adjustment Period|Investigator Discretion|0|||
128711328|NCT00799487|463239858|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
128711329|NCT00799487|463239859|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
128711330|NCT00799487|463239860|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
128711331|NCT00799487|463239858|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
128711332|NCT00799487|463239859|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
128953409|NCT01763866|464114767|FG004|Overall Study|Lost to Follow-up|0|||
128953410|NCT01763866|464114768|FG005|Overall Study|Lost to Follow-up|0|||
128953411|NCT01763866|464114769|FG006|Overall Study|Lost to Follow-up|1|||
128953412|NCT01763866|464114770|FG007|Overall Study|Lost to Follow-up|0|||
128953413|NCT01763866|464114771|FG008|Overall Study|Lost to Follow-up|0|||
128953414|NCT01763866|464114772|FG009|Overall Study|Lost to Follow-up|0|||
128953415|NCT01763866|464114773|FG010|Overall Study|Lost to Follow-up|0|||
128711333|NCT00799487|463239860|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
128953416|NCT01763866|464114774|FG011|Overall Study|Lost to Follow-up|0|||
128711334|NCT00799487|463239858|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
128711335|NCT00799487|463239859|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
128711336|NCT00799487|463239860|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
128711337|NCT00799487|463239858|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
128711338|NCT00799487|463239859|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
128711339|NCT00799487|463239860|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
128711340|NCT00799487|463239858|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
128711341|NCT00799487|463239859|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
128711342|NCT00799487|463239860|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
128953417|NCT01763866|464114775|FG012|Overall Study|Lost to Follow-up|1|||
128711343|NCT00799487|463239858|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
128770571|NCT02960763|463451548|FG003|Step 2|Withdrawal by Subject|7|||
128953418|NCT01763866|464114776|FG013|Overall Study|Lost to Follow-up|0|||
128711344|NCT00799487|463239859|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
128711345|NCT00799487|463239860|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
128711346|NCT00799487|463239858|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
128711347|NCT00799487|463239859|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
128711348|NCT00799487|463239860|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
128711349|NCT00799487|463239858|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
128711350|NCT00799487|463239859|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
128711351|NCT00799487|463239860|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
128711352|NCT04481750|463239861|FG000|Period 1 (Fasted)|Adverse Event|0|||
128711353|NCT04481750|463239862|FG001|Period 1 (Fasted)|Adverse Event|0|||
128711354|NCT04481750|463239863|FG002|Period 1 (Fasted)|Adverse Event|1|||
128711355|NCT04481750|463239864|FG003|Period 1 (Fasted)|Adverse Event|0|||
128711356|NCT04481750|463239865|FG004|Period 1 (Fasted)|Adverse Event|0|||
128711357|NCT04481750|463239866|FG005|Period 1 (Fasted)|Adverse Event|0|||
128711358|NCT04481750|463239867|FG006|Period 1 (Fasted)|Adverse Event|0|||
128711359|NCT04481750|463239868|FG007|Period 1 (Fasted)|Adverse Event|0|||
128711360|NCT04481750|463239869|FG008|Period 1 (Fasted)|Adverse Event|0|||
128711361|NCT04481750|463239870|FG009|Period 1 (Fasted)|Adverse Event|0|||
128711362|NCT04481750|463239871|FG010|Period 1 (Fasted)|Adverse Event|0|||
128953419|NCT01763866|464114777|FG014|Overall Study|Lost to Follow-up|1|||
128953420|NCT01763866|464114778|FG015|Overall Study|Lost to Follow-up|0|||
128953421|NCT01763866|464114779|FG016|Overall Study|Lost to Follow-up|0|||
128953422|NCT01763866|464114780|FG017|Overall Study|Lost to Follow-up|0|||
128953423|NCT01763866|464114781|FG018|Overall Study|Lost to Follow-up|1|||
128953424|NCT01763866|464114782|FG019|Overall Study|Lost to Follow-up|1|||
128953425|NCT01763866|464114783|FG020|Overall Study|Lost to Follow-up|0|||
128953426|NCT01763866|464114784|FG021|Overall Study|Lost to Follow-up|0|||
128953427|NCT01763866|464114785|FG022|Overall Study|Lost to Follow-up|0|||
128953428|NCT01763866|464114786|FG023|Overall Study|Lost to Follow-up|1|||
128953429|NCT01763866|464114763|FG000|Overall Study|Death|0|||
128953430|NCT01763866|464114764|FG001|Overall Study|Death|0|||
128953431|NCT01763866|464114765|FG002|Overall Study|Death|0|||
128953432|NCT01763866|464114766|FG003|Overall Study|Death|0|||
128953433|NCT01763866|464114767|FG004|Overall Study|Death|0|||
128953434|NCT01763866|464114768|FG005|Overall Study|Death|0|||
128953435|NCT01763866|464114769|FG006|Overall Study|Death|0|||
128953436|NCT01763866|464114770|FG007|Overall Study|Death|0|||
128953437|NCT01763866|464114771|FG008|Overall Study|Death|0|||
128953438|NCT01763866|464114772|FG009|Overall Study|Death|0|||
128953439|NCT01763866|464114773|FG010|Overall Study|Death|0|||
128953440|NCT01763866|464114774|FG011|Overall Study|Death|0|||
128953441|NCT01763866|464114775|FG012|Overall Study|Death|0|||
128953442|NCT01763866|464114776|FG013|Overall Study|Death|0|||
128953443|NCT01763866|464114777|FG014|Overall Study|Death|0|||
128953444|NCT01763866|464114778|FG015|Overall Study|Death|0|||
128953445|NCT01763866|464114779|FG016|Overall Study|Death|1|||
128953446|NCT01763866|464114780|FG017|Overall Study|Death|0|||
128953447|NCT01763866|464114781|FG018|Overall Study|Death|0|||
128953448|NCT01763866|464114782|FG019|Overall Study|Death|0|||
128953449|NCT01763866|464114783|FG020|Overall Study|Death|0|||
128953450|NCT01763866|464114784|FG021|Overall Study|Death|0|||
128953451|NCT01763866|464114785|FG022|Overall Study|Death|0|||
128953452|NCT01763866|464114786|FG023|Overall Study|Death|0|||
128953453|NCT01669811|464114793|FG000|Overall Study|Investigator decision|0|||
128953454|NCT01669811|464114794|FG001|Overall Study|Investigator decision|1|||
128953455|NCT01669811|464114793|FG000|Overall Study|Withdrawal by Subject|1|||
128953456|NCT01669811|464114794|FG001|Overall Study|Withdrawal by Subject|2|||
128953457|NCT01669811|464114793|FG000|Overall Study|Adverse Event|2|||
128711363|NCT03263442|463239872|FG000|Inpatient Phase|Death|1|||
128711364|NCT03263442|463239873|FG001|Inpatient Phase|Death|0|||
128711365|NCT03263442|463239872|FG000|Inpatient Phase|Withdrawal by Subject|1|||
128953458|NCT01669811|464114794|FG001|Overall Study|Adverse Event|6|||
128953459|NCT01669811|464114793|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
128953460|NCT01669811|464114794|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
128953461|NCT03245723|464114795|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
128953462|NCT03245723|464114796|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
128953463|NCT03245723|464114795|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
128953464|NCT03245723|464114796|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
128953465|NCT03245723|464114795|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
129035595|NCT01597479|464419717|FG000|Overall Study|Lost to Follow-up|1|||
129035596|NCT01597479|464419718|FG001|Overall Study|Lost to Follow-up|0|||
128711366|NCT03263442|463239873|FG001|Inpatient Phase|Withdrawal by Subject|0|||
128711367|NCT03263442|463239872|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
128953466|NCT03245723|464114796|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
128953467|NCT03245723|464114795|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
128953468|NCT03245723|464114796|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
128953469|NCT00077376|464114797|FG000|Overall Study|Adverse Event|8|||
129035597|NCT04317599|464419723|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
128770572|NCT02960763|463451549|FG004|Step 2|Withdrawal by Subject|3|||
128953470|NCT00077376|464114797|FG000|Overall Study|Withdrawal by Subject|2|||
128953471|NCT00077376|464114797|FG000|Overall Study|Death|1|||
128953472|NCT00077376|464114797|FG000|Overall Study|Physician Decision|1|||
128953473|NCT00077376|464114797|FG000|Overall Study|Alternative therapy|5|||
128953474|NCT00077376|464114797|FG000|Overall Study|Complicating disease|1|||
128953475|NCT00077376|464114797|FG000|Overall Study|Still on treatment|1|||
128953476|NCT00077376|464114797|FG000|Overall Study|Symptomatic deterioration|1|||
128953477|NCT00077376|464114797|FG000|Overall Study|Surgery|1|||
128953478|NCT00077376|464114797|FG000|Overall Study|Insurance ran out|1|||
128953479|NCT02109744|464116546|FG000|Overall Study|Death|1|||
128953480|NCT02109744|464116547|FG001|Overall Study|Death|1|||
128953481|NCT02109744|464116546|FG000|Overall Study|no marrow exam|1|||
128953482|NCT02109744|464116547|FG001|Overall Study|no marrow exam|0|||
128953483|NCT03287245|464116548|FG000|Overall Study|Study terminated by sponsor|3|||
128953484|NCT03287245|464116549|FG001|Overall Study|Study terminated by sponsor|0|||
128953485|NCT03287245|464116550|FG002|Overall Study|Study terminated by sponsor|3|||
128953486|NCT03287245|464116551|FG003|Overall Study|Study terminated by sponsor|1|||
128953487|NCT03287245|464116548|FG000|Overall Study|Adverse Event|1|||
128953488|NCT03287245|464116549|FG001|Overall Study|Adverse Event|0|||
128953489|NCT03287245|464116550|FG002|Overall Study|Adverse Event|0|||
128953490|NCT03287245|464116551|FG003|Overall Study|Adverse Event|0|||
128953491|NCT03287245|464116548|FG000|Overall Study|Withdrawal by Subject|8|||
128953492|NCT03287245|464116549|FG001|Overall Study|Withdrawal by Subject|3|||
128953493|NCT03287245|464116550|FG002|Overall Study|Withdrawal by Subject|3|||
128953494|NCT03287245|464116551|FG003|Overall Study|Withdrawal by Subject|0|||
128953495|NCT03287245|464116548|FG000|Overall Study|Physician Decision|3|||
128953496|NCT03287245|464116549|FG001|Overall Study|Physician Decision|2|||
128953497|NCT03287245|464116550|FG002|Overall Study|Physician Decision|0|||
128953498|NCT03287245|464116551|FG003|Overall Study|Physician Decision|0|||
128953499|NCT03097614|464116552|FG000|Overall Study|Adverse Event|3|||
128953500|NCT02150213|464116553|FG000|Overall Study|Lost to Follow-up|1|||
128953501|NCT02150213|464116553|FG000|Overall Study|Withdrawal by Subject|1|||
128953502|NCT02678312|464116555|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
128953503|NCT02678312|464116556|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
128953504|NCT02678312|464116557|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
128953505|NCT02678312|464116558|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
128953506|NCT02678312|464116559|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
128953507|NCT02678312|464116555|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
128953508|NCT02678312|464116556|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
128953509|NCT02678312|464116557|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
128953510|NCT02678312|464116558|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
128953511|NCT02678312|464116559|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
128953512|NCT02678312|464116555|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
129219240|NCT00345358|465103003|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
128953513|NCT02678312|464116556|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
128953514|NCT02678312|464116557|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
128953515|NCT02678312|464116558|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
128953516|NCT02678312|464116559|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
128953517|NCT02678312|464116555|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
128953518|NCT02678312|464116556|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
128953519|NCT02678312|464116557|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
128953520|NCT02678312|464116558|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
128953521|NCT02678312|464116559|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
128953522|NCT02678312|464116555|FG000|Part 2 Double Blind Epoch|Death|0|||
128953523|NCT02678312|464116556|FG001|Part 2 Double Blind Epoch|Death|0|||
128953524|NCT02678312|464116557|FG002|Part 2 Double Blind Epoch|Death|0|||
128953525|NCT02678312|464116558|FG003|Part 2 Double Blind Epoch|Death|8|||
128953526|NCT02678312|464116559|FG004|Part 2 Double Blind Epoch|Death|12|||
128953527|NCT02678312|464116555|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
128953528|NCT02678312|464116556|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
128953529|NCT02678312|464116557|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
128953530|NCT02678312|464116558|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
128953531|NCT02678312|464116559|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
128953532|NCT02678312|464116555|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
128953533|NCT02678312|464116556|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
128953534|NCT02678312|464116557|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
128953535|NCT02678312|464116558|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
128953536|NCT02678312|464116559|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
128953537|NCT02678312|464116555|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
128953538|NCT02678312|464116556|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
128953539|NCT02678312|464116557|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
128953540|NCT02678312|464116558|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
129219241|NCT00345358|465103000|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
129035598|NCT04317599|464419723|FG000|Overall Study|treatment outside standard of care|4|||
129035599|NCT01186016|464419724|FG000|Overall Study|Withdrawal by Subject|46|||
129035600|NCT01186016|464419725|FG001|Overall Study|Withdrawal by Subject|29|||
129035601|NCT01098539|464419726|FG000|Overall Study|Adverse Event|26|||
129035602|NCT01098539|464419727|FG001|Overall Study|Adverse Event|26|||
129035603|NCT01098539|464419726|FG000|Overall Study|Protocol Violation|1|||
129035604|NCT01098539|464419727|FG001|Overall Study|Protocol Violation|4|||
129035605|NCT01098539|464419726|FG000|Overall Study|Noncompliance|3|||
129035606|NCT01098539|464419727|FG001|Overall Study|Noncompliance|5|||
129035607|NCT01098539|464419726|FG000|Overall Study|Lost to Follow-up|4|||
129035608|NCT01098539|464419727|FG001|Overall Study|Lost to Follow-up|4|||
129035609|NCT01098539|464419726|FG000|Overall Study|Withdrawal by Subject|12|||
129035610|NCT01098539|464419727|FG001|Overall Study|Withdrawal by Subject|26|||
129035611|NCT01098539|464419726|FG000|Overall Study|Physician Decision|5|||
129035612|NCT01098539|464419727|FG001|Overall Study|Physician Decision|3|||
129035613|NCT00721955|464419728|FG000|Overall Study|Adverse Event|0|||
129035614|NCT00721955|464419729|FG001|Overall Study|Adverse Event|0|||
129035615|NCT00721955|464419730|FG002|Overall Study|Adverse Event|2|||
129035616|NCT01055886|464419732|FG000|Overall Study|Withdrawal by Subject|4|||
129035617|NCT01055886|464419733|FG001|Overall Study|Withdrawal by Subject|9|||
129035618|NCT01055886|464419732|FG000|Overall Study|Lost to Follow-up|1|||
129035619|NCT01055886|464419733|FG001|Overall Study|Lost to Follow-up|1|||
129035620|NCT01055886|464419732|FG000|Overall Study|Withdrawal by PI|0|||
129035621|NCT01055886|464419733|FG001|Overall Study|Withdrawal by PI|1|||
129035622|NCT01077258|464419736|FG000|Overall Study|Lost to Follow-up|1390|||
129035623|NCT01077258|464419736|FG000|Overall Study|Adverse drug reaction|218|||
129035624|NCT01077258|464419736|FG000|Overall Study|Lack of Efficacy|663|||
129035625|NCT01077258|464419736|FG000|Overall Study|Clinical remission|37|||
129035626|NCT01077258|464419736|FG000|Overall Study|Other reasons|260|||
129035627|NCT00726895|464419737|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129035628|NCT00726895|464419738|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129035629|NCT00265785|464419739|FG000|Overall Study|Adverse Event|4|||
129035630|NCT00265785|464419739|FG000|Overall Study|Withdrawal by Subject|3|||
129035631|NCT00265785|464419739|FG000|Overall Study|Progression/Relapse|15|||
129035632|NCT00265785|464419739|FG000|Overall Study|Not protocol specified|2|||
129035633|NCT00265785|464419739|FG000|Overall Study|Ineligible|1|||
129035634|NCT00265785|464419739|FG000|Overall Study|Did not receive protocol treatment|2|||
129035635|NCT01475487|464419745|FG000|Overall Study|had to leave early for personal reasons|2|||
129035636|NCT01475487|464419746|FG001|Overall Study|had to leave early for personal reasons|1|||
129035637|NCT01977456|464419747|FG000|Overall Study|Death|5|||
129035638|NCT01142661|464419748|FG000|Overall Study|Adverse Event|2|||
129035639|NCT01142661|464419748|FG000|Overall Study|Withdrawal by Subject|1|||
129035640|NCT01142661|464419748|FG000|Overall Study|Physician Decision|1|||
129035641|NCT02129062|464421512|FG000|Overall Study|Death|1|||
129035642|NCT02129062|464421512|FG000|Overall Study|Disease Progression|2|||
129035643|NCT02722616|464421513|FG000|Overall Study|Sponsor closed study after one month|2|||
129035644|NCT02722616|464421514|FG001|Overall Study|Sponsor closed study after one month|0|||
129035645|NCT02722616|464421515|FG002|Overall Study|Sponsor closed study after one month|0|||
129035646|NCT01923311|464421516|FG000|Overall Study|Pregnancy|1|||
129035647|NCT01923311|464421517|FG001|Overall Study|Pregnancy|0|||
129035648|NCT01923311|464421516|FG000|Overall Study|Investigator's Discretion|1|||
129035649|NCT01923311|464421517|FG001|Overall Study|Investigator's Discretion|0|||
129035650|NCT01923311|464421516|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129035651|NCT01923311|464421517|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129035652|NCT01923311|464421516|FG000|Overall Study|Withdrew Consent|1|||
129035653|NCT01923311|464421517|FG001|Overall Study|Withdrew Consent|0|||
129035654|NCT01923311|464421516|FG000|Overall Study|Study Terminated by Sponsor|12|||
129035655|NCT01923311|464421517|FG001|Overall Study|Study Terminated by Sponsor|0|||
129035656|NCT02031237|464421518|FG000|Overall Study|Death|1|||
129035657|NCT02031237|464421519|FG001|Overall Study|Death|5|||
129035658|NCT02031237|464421520|FG002|Overall Study|Death|0|||
129035659|NCT02031237|464421518|FG000|Overall Study|Physician Decision|0|||
129035660|NCT02031237|464421519|FG001|Overall Study|Physician Decision|1|||
129035661|NCT02031237|464421520|FG002|Overall Study|Physician Decision|0|||
129035662|NCT02031237|464421518|FG000|Overall Study|Withdrawal by Subject|2|||
129035663|NCT02031237|464421519|FG001|Overall Study|Withdrawal by Subject|2|||
129035664|NCT02031237|464421520|FG002|Overall Study|Withdrawal by Subject|0|||
129035665|NCT02031237|464421518|FG000|Overall Study|Protocol Violation|2|||
129035666|NCT02031237|464421519|FG001|Overall Study|Protocol Violation|6|||
129035667|NCT02031237|464421520|FG002|Overall Study|Protocol Violation|0|||
129035668|NCT02031237|464421518|FG000|Overall Study|Alternate Treatment Given|0|||
129035669|NCT02031237|464421519|FG001|Overall Study|Alternate Treatment Given|0|||
129035670|NCT02031237|464421520|FG002|Overall Study|Alternate Treatment Given|3|||
129219242|NCT00345358|465103001|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
129035671|NCT01841060|464421524|FG000|Overall Study|Protocol Violation|10|||
129035672|NCT00653159|464421525|FG000|Overall Study|Adverse Event|4|||
129035673|NCT00653159|464421526|FG001|Overall Study|Adverse Event|1|||
129035674|NCT00653159|464421525|FG000|Overall Study|Lost to Follow-up|1|||
128953541|NCT02678312|464116559|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
128953542|NCT02254551|464116560|FG000|Dose Escalation|Physician Decision|1|||
128953543|NCT02254551|464116560|FG000|Dose Escalation|Dose-limiting toxicity|2|||
129125858|NCT00157755|464755593|FG003|Overall Study|Lost to Follow-up|0|||
129125859|NCT00157755|464755594|FG004|Overall Study|Lost to Follow-up|0|||
129125860|NCT00157755|464755595|FG005|Overall Study|Lost to Follow-up|0|||
128711368|NCT03263442|463239873|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
128711369|NCT03263442|463239872|FG000|1-month Follow-Up|Lost to Follow-up|1|||
128711370|NCT03263442|463239873|FG001|1-month Follow-Up|Lost to Follow-up|0|||
128711371|NCT03263442|463239872|FG000|3-month Follow-Up|Lost to Follow-up|1|||
128711372|NCT03263442|463239873|FG001|3-month Follow-Up|Lost to Follow-up|3|||
128711373|NCT03263442|463239872|FG000|6-month Follow-Up|Lost to Follow-up|2|||
128711374|NCT03263442|463239873|FG001|6-month Follow-Up|Lost to Follow-up|2|||
128711375|NCT00475176|463239874|FG000|Overall Study|Adverse Event|2|||
128953544|NCT00971425|464116561|FG000|Overall Study|Adverse Event|1|||
128953545|NCT00971425|464116562|FG001|Overall Study|Adverse Event|1|||
128953546|NCT00971425|464116561|FG000|Overall Study|Withdrawal by Subject|0|||
128953547|NCT00971425|464116562|FG001|Overall Study|Withdrawal by Subject|1|||
128953548|NCT03587584|464116566|FG000|Overall Study|SOC deviations|4|||
128953549|NCT03587584|464116567|FG001|Overall Study|SOC deviations|6|||
128953550|NCT03587584|464116566|FG000|Overall Study|Incomplete data|0|||
128953551|NCT03587584|464116567|FG001|Overall Study|Incomplete data|3|||
128953552|NCT00387348|464116568|FG000|Overall Study|Death|1|||
128953553|NCT00387348|464116569|FG001|Overall Study|Death|1|||
128953554|NCT00387348|464116570|FG002|Overall Study|Death|0|||
128953555|NCT00387348|464116568|FG000|Overall Study|Physician Decision|1|||
128953556|NCT00387348|464116569|FG001|Overall Study|Physician Decision|0|||
128953557|NCT00387348|464116570|FG002|Overall Study|Physician Decision|1|||
128953558|NCT00387348|464116568|FG000|Overall Study|Withdrawal by Subject|0|||
128953559|NCT00387348|464116569|FG001|Overall Study|Withdrawal by Subject|2|||
128953560|NCT00387348|464116570|FG002|Overall Study|Withdrawal by Subject|2|||
128953561|NCT00387348|464116568|FG000|Overall Study|Adverse Event|1|||
128953562|NCT00387348|464116569|FG001|Overall Study|Adverse Event|0|||
128953563|NCT00387348|464116570|FG002|Overall Study|Adverse Event|1|||
128953564|NCT00505752|464116571|FG000|Overall Study|Adverse Event|1|||
128953565|NCT00505752|464116572|FG001|Overall Study|Adverse Event|0|||
128953566|NCT00505752|464116573|FG002|Overall Study|Adverse Event|1|||
128953567|NCT00505752|464116574|FG003|Overall Study|Adverse Event|0|||
128953568|NCT00505752|464116571|FG000|Overall Study|Lost to Follow-up|1|||
128953569|NCT00505752|464116572|FG001|Overall Study|Lost to Follow-up|0|||
128953570|NCT00505752|464116573|FG002|Overall Study|Lost to Follow-up|0|||
128953571|NCT00505752|464116574|FG003|Overall Study|Lost to Follow-up|0|||
128953572|NCT00505752|464116571|FG000|Overall Study|Lack of ovarian response|1|||
128953573|NCT00505752|464116572|FG001|Overall Study|Lack of ovarian response|3|||
128953574|NCT00505752|464116573|FG002|Overall Study|Lack of ovarian response|0|||
128953575|NCT00505752|464116574|FG003|Overall Study|Lack of ovarian response|0|||
128953576|NCT00505752|464116571|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
128953577|NCT00505752|464116572|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
128953578|NCT00505752|464116573|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
128953579|NCT00505752|464116574|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
128953580|NCT00505752|464116571|FG000|Overall Study|No oocytes retrieved|0|||
128953581|NCT00505752|464116572|FG001|Overall Study|No oocytes retrieved|2|||
128953582|NCT00505752|464116573|FG002|Overall Study|No oocytes retrieved|0|||
128953583|NCT00505752|464116574|FG003|Overall Study|No oocytes retrieved|1|||
128953584|NCT00505752|464116571|FG000|Overall Study|No Fertilization|1|||
128953585|NCT00505752|464116572|FG001|Overall Study|No Fertilization|1|||
128953586|NCT00505752|464116573|FG002|Overall Study|No Fertilization|2|||
128953587|NCT00505752|464116574|FG003|Overall Study|No Fertilization|1|||
128953588|NCT00505752|464116571|FG000|Overall Study|All embryos/blastocysts discarded|0|||
128953589|NCT00505752|464116572|FG001|Overall Study|All embryos/blastocysts discarded|0|||
128953590|NCT00505752|464116573|FG002|Overall Study|All embryos/blastocysts discarded|1|||
128953591|NCT00505752|464116574|FG003|Overall Study|All embryos/blastocysts discarded|1|||
129125861|NCT00157755|464755590|FG000|Overall Study|Withdrawal by Subject|0|||
129125862|NCT00157755|464755591|FG001|Overall Study|Withdrawal by Subject|0|||
129125863|NCT00157755|464755592|FG002|Overall Study|Withdrawal by Subject|1|||
128953592|NCT00505752|464116571|FG000|Overall Study|Other|1|||
128953593|NCT00505752|464116572|FG001|Overall Study|Other|2|||
128953594|NCT00505752|464116573|FG002|Overall Study|Other|1|||
128953595|NCT00505752|464116574|FG003|Overall Study|Other|2|||
128953596|NCT01925612|464116575|FG000|Overall Study|Progressive Disease|1|||
128953597|NCT01925612|464116576|FG001|Overall Study|Progressive Disease|1|||
129125864|NCT00157755|464755593|FG003|Overall Study|Withdrawal by Subject|1|||
128953598|NCT01925612|464116577|FG002|Overall Study|Progressive Disease|1|||
128953599|NCT01925612|464116578|FG003|Overall Study|Progressive Disease|0|||
128953600|NCT01925612|464116579|FG004|Overall Study|Progressive Disease|0|||
128953601|NCT01925612|464116575|FG000|Overall Study|Adverse Event|3|||
129125865|NCT00157755|464755594|FG004|Overall Study|Withdrawal by Subject|1|||
129125866|NCT00157755|464755595|FG005|Overall Study|Withdrawal by Subject|2|||
128953602|NCT01925612|464116576|FG001|Overall Study|Adverse Event|3|||
128953603|NCT01925612|464116577|FG002|Overall Study|Adverse Event|0|||
128953604|NCT01925612|464116578|FG003|Overall Study|Adverse Event|1|||
128953605|NCT01925612|464116579|FG004|Overall Study|Adverse Event|2|||
128953606|NCT04624672|464116583|FG000|Overall Study|Early Study Closure|2|||
128953607|NCT04624672|464116584|FG001|Overall Study|Early Study Closure|1|||
128953608|NCT03472040|464116585|FG000|Overall Study|Physician Decision|0|||
128953609|NCT03472040|464116586|FG001|Overall Study|Physician Decision|3|||
128953610|NCT03472040|464116585|FG000|Overall Study|Withdrawal by Subject|10|||
128953611|NCT03472040|464116586|FG001|Overall Study|Withdrawal by Subject|23|||
128953612|NCT03472040|464116585|FG000|Overall Study|Perceived Lack of Efficacy|29|||
128953613|NCT03472040|464116586|FG001|Overall Study|Perceived Lack of Efficacy|30|||
128953614|NCT03472040|464116585|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
128953615|NCT03472040|464116586|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
128953616|NCT03472040|464116585|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
128953617|NCT03472040|464116586|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
128953618|NCT03472040|464116585|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
128953619|NCT03472040|464116586|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
128953620|NCT03472040|464116585|FG000|Overall Study|Subject Non-compliance|2|||
128953621|NCT03472040|464116586|FG001|Overall Study|Subject Non-compliance|5|||
128953622|NCT03472040|464116585|FG000|Overall Study|Discontinuation due to Rash|0|||
128953623|NCT03472040|464116586|FG001|Overall Study|Discontinuation due to Rash|1|||
128953624|NCT03472040|464116585|FG000|Overall Study|Subsequent Ineligibility|0|||
128953625|NCT03472040|464116586|FG001|Overall Study|Subsequent Ineligibility|2|||
128953626|NCT03472040|464116585|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
128953627|NCT03472040|464116586|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
128953628|NCT00225147|464116591|FG000|Open-label Phase|Lost to Follow-up|0|||
128953629|NCT00225147|464116592|FG001|Open-label Phase|Lost to Follow-up|0|||
128953630|NCT00225147|464116593|FG002|Open-label Phase|Lost to Follow-up|0|||
128953631|NCT00225147|464116594|FG003|Open-label Phase|Lost to Follow-up|4|||
128953632|NCT00225147|464116591|FG000|Open-label Phase|Withdrawal by Subject|0|||
128953633|NCT00225147|464116592|FG001|Open-label Phase|Withdrawal by Subject|0|||
128953634|NCT00225147|464116593|FG002|Open-label Phase|Withdrawal by Subject|0|||
128953635|NCT00225147|464116594|FG003|Open-label Phase|Withdrawal by Subject|6|||
128953636|NCT02685995|464116597|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
128953637|NCT02685995|464116598|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
128953638|NCT03625141|464116599|FG000|Overall Study|Adverse Event|0|||
128953639|NCT03625141|464116600|FG001|Overall Study|Adverse Event|2|||
128953640|NCT03625141|464116599|FG000|Overall Study|Study Terminated By Sponsor|1|||
128953641|NCT03625141|464116600|FG001|Overall Study|Study Terminated By Sponsor|13|||
128953642|NCT03625141|464116599|FG000|Overall Study|Withdrawal by Subject|3|||
128953643|NCT03625141|464116600|FG001|Overall Study|Withdrawal by Subject|0|||
128953644|NCT03625141|464116599|FG000|Overall Study|Withdrawal Of Consent|0|||
128953645|NCT03625141|464116600|FG001|Overall Study|Withdrawal Of Consent|1|||
128953646|NCT03625141|464116599|FG000|Overall Study|Death|11|||
128953647|NCT03625141|464116600|FG001|Overall Study|Death|47|||
128953648|NCT03625141|464116599|FG000|Overall Study|Progressive Disease|0|||
128953649|NCT03625141|464116600|FG001|Overall Study|Progressive Disease|2|||
128953650|NCT00868166|464116602|FG000|Overall Study|Death|58|||
128953651|NCT00868166|464116603|FG001|Overall Study|Death|65|||
128953652|NCT00868166|464116602|FG000|Overall Study|Withdrawal by Subject|33|||
128953653|NCT00868166|464116603|FG001|Overall Study|Withdrawal by Subject|25|||
128953654|NCT00868166|464116602|FG000|Overall Study|Protocol Violation|1|||
128953655|NCT00868166|464116603|FG001|Overall Study|Protocol Violation|0|||
128953656|NCT00868166|464116602|FG000|Overall Study|Lost to Follow-up|1|||
128953657|NCT00868166|464116603|FG001|Overall Study|Lost to Follow-up|3|||
128953658|NCT00868166|464116602|FG000|Overall Study|Adverse Event|9|||
128953659|NCT00868166|464116603|FG001|Overall Study|Adverse Event|10|||
129125867|NCT00157755|464755590|FG000|Overall Study|Explant due to infection|0|||
129125868|NCT00157755|464755591|FG001|Overall Study|Explant due to infection|0|||
129125869|NCT00157755|464755592|FG002|Overall Study|Explant due to infection|1|||
129125870|NCT00157755|464755593|FG003|Overall Study|Explant due to infection|0|||
129125871|NCT00157755|464755594|FG004|Overall Study|Explant due to infection|0|||
129125872|NCT00157755|464755595|FG005|Overall Study|Explant due to infection|0|||
129125873|NCT00157755|464755590|FG000|Overall Study|Medical reason|0|||
128953660|NCT00868166|464116602|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
128953661|NCT00868166|464116603|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
128953662|NCT00868166|464116602|FG000|Overall Study|Non-compliance with IMP|1|||
128953663|NCT00868166|464116603|FG001|Overall Study|Non-compliance with IMP|1|||
128953664|NCT00433446|464116610|FG000|Overall Study|Adverse Event|4|||
128953665|NCT00433446|464116610|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
128953666|NCT00433446|464116610|FG000|Overall Study|Progression|44|||
129125874|NCT00157755|464755591|FG001|Overall Study|Medical reason|0|||
129125875|NCT00157755|464755592|FG002|Overall Study|Medical reason|1|||
129125876|NCT00157755|464755593|FG003|Overall Study|Medical reason|1|||
128953667|NCT00433446|464116610|FG000|Overall Study|Other - Not Protocol specified|3|||
128953668|NCT00433446|464116610|FG000|Overall Study|Ineligible|9|||
128953669|NCT03819218|464116611|FG000|Overall Study|Protocol Violation|1|||
128953670|NCT02267278|464116612|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
128953671|NCT02267278|464116612|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
128953672|NCT02267278|464116612|FG000|Overall Study|Developed new cancer diagnoses|2|||
128953673|NCT02267278|464116612|FG000|Overall Study|prescribed prohibited medication|1|||
128953674|NCT00650091|464116613|FG000|Amended Study Design|Withdrawal by Subject|12|||
128953675|NCT00650091|464116614|FG001|Amended Study Design|Withdrawal by Subject|11|||
128953676|NCT00650091|464116615|FG002|Amended Study Design|Withdrawal by Subject|0|||
128953677|NCT00650091|464116613|FG000|Amended Study Design|Physician Decision|5|||
128953678|NCT00650091|464116614|FG001|Amended Study Design|Physician Decision|0|||
128953679|NCT00650091|464116615|FG002|Amended Study Design|Physician Decision|0|||
128953680|NCT00650091|464116613|FG000|Amended Study Design|Adverse Event|1|||
128953681|NCT00650091|464116614|FG001|Amended Study Design|Adverse Event|4|||
128953682|NCT00650091|464116615|FG002|Amended Study Design|Adverse Event|0|||
128953683|NCT00650091|464116613|FG000|Amended Study Design|Lung transplantation|4|||
128953684|NCT00650091|464116614|FG001|Amended Study Design|Lung transplantation|2|||
128953685|NCT00650091|464116615|FG002|Amended Study Design|Lung transplantation|0|||
128953686|NCT00650091|464116613|FG000|Amended Study Design|Other|1|||
128953687|NCT00650091|464116614|FG001|Amended Study Design|Other|3|||
128953688|NCT00650091|464116615|FG002|Amended Study Design|Other|0|||
128953689|NCT04116073|464116622|FG000|Overall Study|Withdrawal by Subject|2|||
128953690|NCT04116073|464116622|FG000|Overall Study|failed to maintained eligibility|1|||
128953691|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
128953692|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
128953693|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
128953694|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
128953695|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
128953696|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
128953697|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Death|1|||
128953698|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Death|3|||
128953699|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
128953700|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
128953701|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
128953702|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
128953703|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
128953704|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
128953705|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
128953706|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
128953707|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
128953708|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
128953709|NCT02553317|464116629|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
128953710|NCT02553317|464116630|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
128953711|NCT02940626|464116631|FG000|Overall Study|Death|40|||
128953712|NCT02940626|464116632|FG001|Overall Study|Death|32|||
128953713|NCT02940626|464116631|FG000|Overall Study|Lost to Follow-up|5|||
128953714|NCT02940626|464116632|FG001|Overall Study|Lost to Follow-up|2|||
128953715|NCT02940626|464116631|FG000|Overall Study|Withdrawal by Subject|1|||
128953716|NCT02940626|464116632|FG001|Overall Study|Withdrawal by Subject|0|||
128953717|NCT02940626|464116631|FG000|Overall Study|Transfer to Hospice Care|1|||
128953718|NCT02940626|464116632|FG001|Overall Study|Transfer to Hospice Care|0|||
128953719|NCT02940626|464116631|FG000|Overall Study|Prohibited Concomitant Medication|0|||
128953720|NCT02940626|464116632|FG001|Overall Study|Prohibited Concomitant Medication|1|||
128953721|NCT01996904|464116633|FG000|Overall Study|Lost to Follow-up|38|||
128953722|NCT01996904|464116634|FG001|Overall Study|Lost to Follow-up|27|||
128953723|NCT04664855|464116636|FG000|Overall Study|Withdrawal by Subject|0|||
128953724|NCT04664855|464116637|FG001|Overall Study|Withdrawal by Subject|2|||
128953725|NCT05127421|464116638|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
128953726|NCT05127421|464116639|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
128770573|NCT02960763|463451545|FG000|Step 2|Lost to Follow-up|0|||
128770574|NCT02960763|463451546|FG001|Step 2|Lost to Follow-up|0|||
128770575|NCT02960763|463451547|FG002|Step 2|Lost to Follow-up|0|||
128770576|NCT02960763|463451548|FG003|Step 2|Lost to Follow-up|4|||
128953727|NCT05127421|464116640|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
128953728|NCT05127421|464116641|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
128953729|NCT05127421|464116638|FG000|4-Week Double-Blind Period|Physician Decision|1|||
129035675|NCT00653159|464421526|FG001|Overall Study|Lost to Follow-up|2|||
128770577|NCT02960763|463451549|FG004|Step 2|Lost to Follow-up|1|||
128770578|NCT02960763|463451545|FG000|Step 2|Investigator discretion|0|||
128770579|NCT02960763|463451546|FG001|Step 2|Investigator discretion|0|||
128953730|NCT05127421|464116639|FG001|4-Week Double-Blind Period|Physician Decision|0|||
128953731|NCT05127421|464116640|FG002|4-Week Double-Blind Period|Physician Decision|0|||
128953732|NCT05127421|464116641|FG003|4-Week Double-Blind Period|Physician Decision|0|||
128953733|NCT05127421|464116638|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
128953734|NCT05127421|464116639|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
128953735|NCT05127421|464116640|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
128953736|NCT05127421|464116641|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
128953737|NCT05127421|464116638|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
128953738|NCT05127421|464116639|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
128953739|NCT05127421|464116640|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
128953740|NCT05127421|464116641|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
128953741|NCT05127421|464116638|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
128953742|NCT05127421|464116639|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
128953743|NCT05127421|464116640|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
128953744|NCT05127421|464116641|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
128953745|NCT05127421|464116638|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
128953746|NCT05127421|464116639|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
128953747|NCT05127421|464116640|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
128953748|NCT05127421|464116641|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
128953749|NCT05127421|464116638|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
128953750|NCT05127421|464116639|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
128953751|NCT05127421|464116640|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
128953752|NCT05127421|464116641|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
128953753|NCT05127421|464116638|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
128953754|NCT05127421|464116639|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
128953755|NCT05127421|464116640|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
128953756|NCT05127421|464116641|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
128953757|NCT02219087|464116642|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
128953758|NCT02219087|464116643|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
128953759|NCT00574496|464116646|FG000|Overall Study|Withdrawal by Subject|1|||
128953760|NCT03454412|464116647|FG000|Baseline Assesment|Physician Decision|12|||
128953761|NCT01518244|464116648|FG000|Overall Study|Adverse Event|3|||
128953762|NCT03543358|464116649|FG000|Overall Study|Death|1|||
128953763|NCT03543358|464116650|FG001|Overall Study|Death|0|||
128953764|NCT03543358|464116649|FG000|Overall Study|Disease Progression|1|||
128953765|NCT03543358|464116650|FG001|Overall Study|Disease Progression|0|||
128953766|NCT03543358|464116649|FG000|Overall Study|Parent Study Closure|1|||
128953767|NCT03543358|464116650|FG001|Overall Study|Parent Study Closure|0|||
128953768|NCT01766817|464116651|FG000|Overall Study|Drug-related adverse event|1|||
128953769|NCT01766817|464116652|FG001|Overall Study|Drug-related adverse event|2|||
128953770|NCT01766817|464116653|FG002|Overall Study|Drug-related adverse event|1|||
128953771|NCT01766817|464116651|FG000|Overall Study|Drug-unrelated adverse event|3|||
128953772|NCT01766817|464116652|FG001|Overall Study|Drug-unrelated adverse event|3|||
128953773|NCT01766817|464116653|FG002|Overall Study|Drug-unrelated adverse event|3|||
128953774|NCT01766817|464116651|FG000|Overall Study|Death|1|||
128953775|NCT01766817|464116652|FG001|Overall Study|Death|1|||
128953776|NCT01766817|464116653|FG002|Overall Study|Death|0|||
128953777|NCT01766817|464116651|FG000|Overall Study|Unable to take study drug|0|||
128953778|NCT01766817|464116652|FG001|Overall Study|Unable to take study drug|1|||
128953779|NCT01766817|464116653|FG002|Overall Study|Unable to take study drug|0|||
128953780|NCT01766817|464116651|FG000|Overall Study|Withdrawal by Subject|2|||
128953781|NCT01766817|464116652|FG001|Overall Study|Withdrawal by Subject|0|||
128953782|NCT01766817|464116653|FG002|Overall Study|Withdrawal by Subject|3|||
128953783|NCT01766817|464116651|FG000|Overall Study|Subject non-compliance|0|||
128953784|NCT01766817|464116652|FG001|Overall Study|Subject non-compliance|1|||
128953785|NCT01766817|464116653|FG002|Overall Study|Subject non-compliance|2|||
128953786|NCT01766817|464116651|FG000|Overall Study|Physician Decision|3|||
128953787|NCT01766817|464116652|FG001|Overall Study|Physician Decision|3|||
128953788|NCT01766817|464116653|FG002|Overall Study|Physician Decision|4|||
128953789|NCT01766817|464116651|FG000|Overall Study|Other|1|||
128953790|NCT01766817|464116652|FG001|Overall Study|Other|0|||
128953791|NCT01766817|464116653|FG002|Overall Study|Other|0|||
128953792|NCT00178464|464116654|FG000|Overall Study|Withdrawal by Subject|1|||
128953793|NCT00178464|464116654|FG000|Overall Study|Physician Decision|1|||
128953794|NCT00870818|464116655|FG000|Overall Study|Lost to Follow-up|3|||
128953795|NCT00870818|464116656|FG001|Overall Study|Lost to Follow-up|2|||
128953796|NCT00870818|464116657|FG002|Overall Study|Lost to Follow-up|1|||
128953797|NCT00870818|464116658|FG003|Overall Study|Lost to Follow-up|0|||
128953798|NCT00870818|464116659|FG004|Overall Study|Lost to Follow-up|0|||
128953799|NCT00870818|464116655|FG000|Overall Study|Withdrawal by Subject|0|||
128953800|NCT00870818|464116656|FG001|Overall Study|Withdrawal by Subject|0|||
128953801|NCT00870818|464116657|FG002|Overall Study|Withdrawal by Subject|1|||
128953802|NCT00870818|464116658|FG003|Overall Study|Withdrawal by Subject|2|||
129035676|NCT05258630|464421527|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
128953803|NCT00870818|464116659|FG004|Overall Study|Withdrawal by Subject|0|||
128953804|NCT00870818|464116655|FG000|Overall Study|Terminated by sponsor|29|||
128953805|NCT00870818|464116656|FG001|Overall Study|Terminated by sponsor|70|||
128953806|NCT00870818|464116657|FG002|Overall Study|Terminated by sponsor|36|||
128953807|NCT00870818|464116658|FG003|Overall Study|Terminated by sponsor|36|||
128953808|NCT00870818|464116659|FG004|Overall Study|Terminated by sponsor|38|||
128953809|NCT00870818|464116655|FG000|Overall Study|Other|0|||
128953810|NCT00870818|464116656|FG001|Overall Study|Other|1|||
128953811|NCT00870818|464116657|FG002|Overall Study|Other|0|||
128953812|NCT00870818|464116658|FG003|Overall Study|Other|0|||
128953813|NCT00870818|464116659|FG004|Overall Study|Other|0|||
128953814|NCT02227108|464116662|FG000|Overall Study|Did not receive treatment|2|||
128953815|NCT02227108|464116662|FG000|Overall Study|Other|3|||
128953816|NCT02227108|464116662|FG000|Overall Study|Progressive disease|17|||
128953817|NCT02227108|464116662|FG000|Overall Study|Initiation of alternative therapy|2|||
128953818|NCT02227108|464116662|FG000|Overall Study|Investigator discretion|1|||
128953819|NCT02227108|464116662|FG000|Overall Study|Adverse Event|6|||
128953820|NCT04900038|464116663|FG000|Overall Study|Adverse Event|1|||
128953821|NCT04900038|464116664|FG001|Overall Study|Adverse Event|0|||
128953822|NCT04900038|464116665|FG002|Overall Study|Adverse Event|1|||
128953823|NCT04900038|464116666|FG003|Overall Study|Adverse Event|1|||
128953824|NCT04900038|464116663|FG000|Overall Study|Withdrawal by Subject|0|||
128953825|NCT04900038|464116664|FG001|Overall Study|Withdrawal by Subject|1|||
128953826|NCT04900038|464116665|FG002|Overall Study|Withdrawal by Subject|0|||
128953827|NCT04900038|464116666|FG003|Overall Study|Withdrawal by Subject|0|||
128953828|NCT04900038|464116663|FG000|Overall Study|Study terminated by sponsor|18|||
128953829|NCT04900038|464116664|FG001|Overall Study|Study terminated by sponsor|15|||
128953830|NCT04900038|464116665|FG002|Overall Study|Study terminated by sponsor|17|||
128953831|NCT04900038|464116666|FG003|Overall Study|Study terminated by sponsor|14|||
128953832|NCT04900038|464116663|FG000|Overall Study|Protocol Deviation|1|||
128953833|NCT04900038|464116664|FG001|Overall Study|Protocol Deviation|1|||
128953834|NCT04900038|464116665|FG002|Overall Study|Protocol Deviation|0|||
128953835|NCT04900038|464116666|FG003|Overall Study|Protocol Deviation|0|||
128953836|NCT04900038|464116663|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
128953837|NCT04900038|464116664|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
128953838|NCT04900038|464116665|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
128953839|NCT04900038|464116666|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
128953840|NCT04900038|464116663|FG000|Overall Study|Lost to Follow-up|0|||
128953841|NCT04900038|464116664|FG001|Overall Study|Lost to Follow-up|0|||
128953842|NCT04900038|464116665|FG002|Overall Study|Lost to Follow-up|0|||
128953843|NCT04900038|464116666|FG003|Overall Study|Lost to Follow-up|1|||
128953844|NCT02486952|464116667|FG000|Overall Study|Not Started Induction Therapy|3|||
128953845|NCT02486952|464116667|FG000|Overall Study|Adverse Event|1|||
128953846|NCT02486952|464116667|FG000|Overall Study|Death|15|||
128953847|NCT02486952|464116667|FG000|Overall Study|Lack of Efficacy|3|||
128953848|NCT02486952|464116667|FG000|Overall Study|Lost to Follow-up|26|||
128953849|NCT02486952|464116667|FG000|Overall Study|Other|2|||
128953850|NCT01928485|464116668|FG000|Overall Study|Physician Decision|0|||
128953851|NCT01928485|464116669|FG001|Overall Study|Physician Decision|1|||
128953852|NCT03956225|464116670|FG000|Overall Study|Lack of Efficacy|1|||
128953853|NCT03956225|464116671|FG001|Overall Study|Lack of Efficacy|1|||
128953854|NCT03956225|464116670|FG000|Overall Study|Lost to Follow-up|0|||
128953855|NCT03956225|464116671|FG001|Overall Study|Lost to Follow-up|1|||
128953856|NCT03956225|464116670|FG000|Overall Study|Withdrawal by Subject|2|||
128953857|NCT03956225|464116671|FG001|Overall Study|Withdrawal by Subject|1|||
128953858|NCT03956225|464116670|FG000|Overall Study|Other Reasons|2|||
128953859|NCT03956225|464116671|FG001|Overall Study|Other Reasons|1|||
128953860|NCT04093258|464116672|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
128953861|NCT04093258|464116673|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
128953862|NCT00594204|464116674|FG000|Overall Study|Adverse Event|15|||
128953863|NCT00594204|464116675|FG001|Overall Study|Adverse Event|3|||
128953864|NCT00594204|464116674|FG000|Overall Study|Lost to Follow-up|9|||
129125877|NCT00157755|464755594|FG004|Overall Study|Medical reason|0|||
128953865|NCT00594204|464116675|FG001|Overall Study|Lost to Follow-up|5|||
128953866|NCT00594204|464116674|FG000|Overall Study|Withdrawal by Subject|23|||
128953867|NCT00594204|464116675|FG001|Overall Study|Withdrawal by Subject|29|||
128953868|NCT00594204|464116674|FG000|Overall Study|Other|4|||
128953869|NCT00594204|464116675|FG001|Overall Study|Other|3|||
128953870|NCT00594204|464116674|FG000|Overall Study|Lack of Efficacy|3|||
128953871|NCT00594204|464116675|FG001|Overall Study|Lack of Efficacy|4|||
128953872|NCT00594204|464116674|FG000|Overall Study|Randomized but not treated|4|||
128953873|NCT00594204|464116675|FG001|Overall Study|Randomized but not treated|1|||
128953874|NCT01529385|464116676|FG000|Overall Study|Lost to Follow-up|2|||
128953875|NCT01529385|464116677|FG001|Overall Study|Lost to Follow-up|1|||
128953876|NCT01401465|464116678|FG000|Treatment Period 1|Adverse Event|4|||
128953877|NCT01401465|464116679|FG001|Treatment Period 1|Adverse Event|1|||
128953878|NCT01401465|464116678|FG000|Treatment Period 1|Pregnancy|0|||
129125878|NCT00157755|464755595|FG005|Overall Study|Medical reason|0|||
128953879|NCT01401465|464116679|FG001|Treatment Period 1|Pregnancy|1|||
128953880|NCT01401465|464116678|FG000|Treatment Period 1|Protocol Violation|5|||
128953881|NCT01401465|464116679|FG001|Treatment Period 1|Protocol Violation|0|||
128953882|NCT01401465|464116678|FG000|Treatment Period 1|Withdrawal by Subject|1|||
128953883|NCT01401465|464116679|FG001|Treatment Period 1|Withdrawal by Subject|4|||
128953884|NCT01401465|464116678|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
128953885|NCT01401465|464116679|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
128953886|NCT01401465|464116678|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
128953887|NCT01401465|464116679|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
128953888|NCT01401465|464116678|FG000|Treatment Period 1|Scheduling Difficulties|1|||
128953889|NCT01401465|464116679|FG001|Treatment Period 1|Scheduling Difficulties|1|||
128953890|NCT01401465|464116678|FG000|Treatment Period 2|Lost to Follow-up|0|||
128953891|NCT01401465|464116679|FG001|Treatment Period 2|Lost to Follow-up|1|||
128953892|NCT01401465|464116678|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128953893|NCT01401465|464116679|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128953894|NCT01115738|464116680|FG000|Overall Study|Death|1|||
128953895|NCT01115738|464116681|FG001|Overall Study|Death|0|||
128953896|NCT01115738|464116682|FG002|Overall Study|Death|0|||
128953897|NCT01115738|464116680|FG000|Overall Study|Lost to Follow-up|0|||
128953898|NCT01115738|464116681|FG001|Overall Study|Lost to Follow-up|0|||
128953899|NCT01115738|464116682|FG002|Overall Study|Lost to Follow-up|1|||
128953900|NCT01115738|464116680|FG000|Overall Study|Physician Decision|18|||
128953901|NCT01115738|464116681|FG001|Overall Study|Physician Decision|15|||
128953902|NCT01115738|464116682|FG002|Overall Study|Physician Decision|17|||
128953903|NCT01115738|464116680|FG000|Overall Study|Withdrawal by Subject|6|||
128953904|NCT01115738|464116681|FG001|Overall Study|Withdrawal by Subject|6|||
128953905|NCT01115738|464116682|FG002|Overall Study|Withdrawal by Subject|9|||
128953906|NCT02721251|464116683|FG000|Overall Study|Withdrawal by Subject|8|||
128953907|NCT02721251|464116684|FG001|Overall Study|Withdrawal by Subject|7|||
128953908|NCT02721251|464116685|FG002|Overall Study|Withdrawal by Subject|9|||
128953909|NCT02721251|464116683|FG000|Overall Study|poor adherence|2|||
128953910|NCT02721251|464116684|FG001|Overall Study|poor adherence|2|||
128953911|NCT02721251|464116685|FG002|Overall Study|poor adherence|2|||
128953912|NCT01714817|464116686|FG000|Year 1 Period|Lack of Efficacy|11|||
128953913|NCT01714817|464116687|FG001|Year 1 Period|Lack of Efficacy|9|||
128953914|NCT01714817|464116686|FG000|Year 1 Period|Adverse Event|20|||
128953915|NCT01714817|464116687|FG001|Year 1 Period|Adverse Event|17|||
128953916|NCT01714817|464116686|FG000|Year 1 Period|Withdrawal by Subject|6|||
128953917|NCT01714817|464116687|FG001|Year 1 Period|Withdrawal by Subject|7|||
128953918|NCT01714817|464116686|FG000|Year 1 Period|Death|1|||
128953919|NCT01714817|464116687|FG001|Year 1 Period|Death|1|||
128953920|NCT01714817|464116686|FG000|Year 1 Period|Lost to Follow-up|0|||
128953921|NCT01714817|464116687|FG001|Year 1 Period|Lost to Follow-up|2|||
128953922|NCT01714817|464116686|FG000|Year 1 Period|Poor / non-compliance|0|||
128953923|NCT01714817|464116687|FG001|Year 1 Period|Poor / non-compliance|1|||
128953924|NCT01714817|464116686|FG000|Year 1 Period|Pregnancy|2|||
128953925|NCT01714817|464116687|FG001|Year 1 Period|Pregnancy|0|||
128953926|NCT01714817|464116686|FG000|Year 1 Period|Participant no longer meets criteria|6|||
128953927|NCT01714817|464116687|FG001|Year 1 Period|Participant no longer meets criteria|2|||
128953928|NCT01714817|464116686|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
128953929|NCT01714817|464116687|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
128953930|NCT01714817|464116686|FG000|Year 1 Period|Change in Concomitant Medication|0|||
128953931|NCT01714817|464116687|FG001|Year 1 Period|Change in Concomitant Medication|1|||
128953932|NCT01714817|464116686|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
128953933|NCT01714817|464116687|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
128953934|NCT01714817|464116686|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
128953935|NCT01714817|464116687|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
128953936|NCT01714817|464116686|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
128953937|NCT01714817|464116687|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
128953938|NCT01714817|464116686|FG000|Year 2 Period|Lack of Efficacy|4|||
128953939|NCT01714817|464116687|FG001|Year 2 Period|Lack of Efficacy|12|||
128953940|NCT01714817|464116686|FG000|Year 2 Period|Adverse Event|7|||
128953941|NCT01714817|464116687|FG001|Year 2 Period|Adverse Event|6|||
128953942|NCT01714817|464116686|FG000|Year 2 Period|Participant request to stop treatment|4|||
128953943|NCT01714817|464116687|FG001|Year 2 Period|Participant request to stop treatment|4|||
128953944|NCT01714817|464116686|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
128953945|NCT01714817|464116687|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
128953946|NCT01714817|464116686|FG000|Year 2 Period|Participant withdrew consent|1|||
128953947|NCT01714817|464116687|FG001|Year 2 Period|Participant withdrew consent|5|||
128953948|NCT01714817|464116686|FG000|Year 2 Period|Participant no longer meets criteria|1|||
129125879|NCT00157755|464755590|FG000|Overall Study|Study site closure|0|||
128953949|NCT01714817|464116687|FG001|Year 2 Period|Participant no longer meets criteria|4|||
128953950|NCT01714817|464116686|FG000|Year 2 Period|Lost to Follow-up|2|||
128953951|NCT01714817|464116687|FG001|Year 2 Period|Lost to Follow-up|0|||
129125880|NCT00157755|464755591|FG001|Overall Study|Study site closure|1|||
129035677|NCT05258630|464421528|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
129035678|NCT05258630|464421527|FG000|Overall Study|Lost to Follow-up|0|||
129035679|NCT05258630|464421528|FG001|Overall Study|Lost to Follow-up|2|||
129035680|NCT00109837|464421529|FG000|Overall Study|Adverse Event|2|||
129035681|NCT00109837|464421529|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
129035682|NCT00109837|464421529|FG000|Overall Study|Death|1|||
129035683|NCT00109837|464421529|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
129035684|NCT00109837|464421529|FG000|Overall Study|Not treated|1|||
129035685|NCT00109837|464421529|FG000|Overall Study|Ineligible|1|||
129035686|NCT00381849|464421530|FG000|Wash Out|Withdrawal by Subject|0|||
129035687|NCT00381849|464421531|FG001|Wash Out|Withdrawal by Subject|1|||
129035688|NCT00631007|464421537|FG000|Overall Study|Adverse Event|0|||
129035689|NCT00631007|464421538|FG001|Overall Study|Adverse Event|2|||
129035690|NCT00631007|464421539|FG002|Overall Study|Adverse Event|0|||
129035691|NCT00631007|464421540|FG003|Overall Study|Adverse Event|2|||
129035692|NCT00631007|464421541|FG004|Overall Study|Adverse Event|3|||
129035693|NCT00631007|464421542|FG005|Overall Study|Adverse Event|2|||
129035694|NCT00631007|464421537|FG000|Overall Study|Lost to Follow-up|2|||
129035695|NCT00631007|464421538|FG001|Overall Study|Lost to Follow-up|1|||
129035696|NCT00631007|464421539|FG002|Overall Study|Lost to Follow-up|2|||
129035697|NCT00631007|464421540|FG003|Overall Study|Lost to Follow-up|4|||
129035698|NCT00631007|464421541|FG004|Overall Study|Lost to Follow-up|5|||
129035699|NCT00631007|464421542|FG005|Overall Study|Lost to Follow-up|3|||
129035700|NCT00631007|464421537|FG000|Overall Study|Physician Decision|1|||
129035701|NCT00631007|464421538|FG001|Overall Study|Physician Decision|0|||
129035702|NCT00631007|464421539|FG002|Overall Study|Physician Decision|1|||
129035703|NCT00631007|464421540|FG003|Overall Study|Physician Decision|0|||
129035704|NCT00631007|464421541|FG004|Overall Study|Physician Decision|0|||
129035705|NCT00631007|464421542|FG005|Overall Study|Physician Decision|2|||
129035706|NCT00631007|464421537|FG000|Overall Study|Persistent Hyperglycemia|2|||
129035707|NCT00631007|464421538|FG001|Overall Study|Persistent Hyperglycemia|2|||
129035708|NCT00631007|464421539|FG002|Overall Study|Persistent Hyperglycemia|5|||
129035709|NCT00631007|464421540|FG003|Overall Study|Persistent Hyperglycemia|1|||
129035710|NCT00631007|464421541|FG004|Overall Study|Persistent Hyperglycemia|2|||
129035711|NCT00631007|464421542|FG005|Overall Study|Persistent Hyperglycemia|5|||
129035712|NCT00631007|464421537|FG000|Overall Study|Withdrawal by Subject|4|||
129035713|NCT00631007|464421538|FG001|Overall Study|Withdrawal by Subject|5|||
129035714|NCT00631007|464421539|FG002|Overall Study|Withdrawal by Subject|2|||
129035715|NCT00631007|464421540|FG003|Overall Study|Withdrawal by Subject|2|||
129035716|NCT00631007|464421541|FG004|Overall Study|Withdrawal by Subject|1|||
129035717|NCT00631007|464421542|FG005|Overall Study|Withdrawal by Subject|3|||
129035718|NCT00631007|464421537|FG000|Overall Study|Other|2|||
129035719|NCT00631007|464421538|FG001|Overall Study|Other|1|||
129035720|NCT00631007|464421539|FG002|Overall Study|Other|0|||
129035721|NCT00631007|464421540|FG003|Overall Study|Other|0|||
129035722|NCT00631007|464421541|FG004|Overall Study|Other|1|||
129035723|NCT00631007|464421542|FG005|Overall Study|Other|0|||
129035724|NCT00683787|464421543|FG000|Overall Study|Progression|3|||
129035725|NCT00683787|464421544|FG001|Overall Study|Progression|3|||
129035726|NCT00683787|464421545|FG002|Overall Study|Progression|0|||
129035727|NCT00683787|464421543|FG000|Overall Study|Adverse Event|0|||
129035728|NCT00683787|464421544|FG001|Overall Study|Adverse Event|0|||
129035729|NCT00683787|464421545|FG002|Overall Study|Adverse Event|2|||
129035730|NCT04167618|464421546|FG000|Overall Study|Trial terminated by sponsor|1|||
129035731|NCT04167618|464421547|FG001|Overall Study|Trial terminated by sponsor|1|||
129035732|NCT02940730|464421552|FG000|Intervention 2|Physician Decision|7|||
129035733|NCT02940730|464421553|FG001|Intervention 2|Physician Decision|0|||
129035734|NCT03036839|464421554|FG000|Overall Study|Adverse Event|0|||
129035735|NCT03036839|464421555|FG001|Overall Study|Adverse Event|0|||
129035736|NCT03036839|464421556|FG002|Overall Study|Adverse Event|1|||
129035737|NCT03036839|464421554|FG000|Overall Study|Death|3|||
129035738|NCT03036839|464421555|FG001|Overall Study|Death|0|||
129035739|NCT03036839|464421556|FG002|Overall Study|Death|3|||
129035740|NCT03036839|464421554|FG000|Overall Study|Withdrew Consent|0|||
129035741|NCT03036839|464421555|FG001|Overall Study|Withdrew Consent|0|||
129035742|NCT03036839|464421556|FG002|Overall Study|Withdrew Consent|1|||
129035743|NCT00412737|464421557|FG000|Overall Study|Death|1|||
129035744|NCT00412737|464421558|FG001|Overall Study|Death|0|||
129035745|NCT00412737|464421557|FG000|Overall Study|Adverse Event|3|||
129035746|NCT00412737|464421558|FG001|Overall Study|Adverse Event|2|||
129035747|NCT00412737|464421557|FG000|Overall Study|Refused Treatment|6|||
129035748|NCT00412737|464421558|FG001|Overall Study|Refused Treatment|2|||
129035749|NCT00412737|464421557|FG000|Overall Study|Failure to Return|6|||
129035750|NCT00412737|464421558|FG001|Overall Study|Failure to Return|2|||
129035751|NCT01064531|464421560|FG000|Overall Study|Lost to Follow-up|0|||
129035752|NCT01064531|464421561|FG001|Overall Study|Lost to Follow-up|2|||
129035753|NCT01064531|464421560|FG000|Overall Study|Physician Decision|0|||
129035754|NCT01064531|464421561|FG001|Overall Study|Physician Decision|1|||
129035755|NCT01064531|464421560|FG000|Overall Study|Withdrawal by Subject|2|||
129035756|NCT01064531|464421561|FG001|Overall Study|Withdrawal by Subject|2|||
129035757|NCT01064531|464421560|FG000|Overall Study|Revision due to femoral stem loosening|1|||
129219243|NCT00345358|465103002|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
129219244|NCT00345358|465103003|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
129219245|NCT00477386|465103004|FG000|Overall Study|Adverse Event|4|||
129219246|NCT00477386|465103005|FG001|Overall Study|Adverse Event|8|||
129219247|NCT00477386|465103004|FG000|Overall Study|Disease progression, relapse|3|||
129219248|NCT00477386|465103005|FG001|Overall Study|Disease progression, relapse|4|||
129219249|NCT00477386|465103004|FG000|Overall Study|Disease progression, refractory|1|||
129219250|NCT00477386|465103005|FG001|Overall Study|Disease progression, refractory|3|||
129219251|NCT00477386|465103004|FG000|Overall Study|Other|1|||
129219252|NCT00477386|465103005|FG001|Overall Study|Other|2|||
129219253|NCT00477386|465103004|FG000|Overall Study|Physician Decision|1|||
129219254|NCT00477386|465103005|FG001|Overall Study|Physician Decision|0|||
129219255|NCT00477386|465103004|FG000|Overall Study|Withdrawal by Subject|1|||
129219256|NCT00477386|465103005|FG001|Overall Study|Withdrawal by Subject|0|||
129219257|NCT02207088|465103006|FG000|Overall Study|Adverse Event|2|||
129219258|NCT01812252|465103007|FG000|Overall Study|Persistent Disease|1|||
129219259|NCT01812252|465103008|FG001|Overall Study|Persistent Disease|0|||
129219260|NCT01812252|465103007|FG000|Overall Study|Not transplanted|11|||
129219261|NCT01812252|465103008|FG001|Overall Study|Not transplanted|11|||
129219262|NCT01812252|465103007|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
129219263|NCT01812252|465103008|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
129219264|NCT01812252|465103007|FG000|Overall Study|Withdrawal by Subject|1|||
129219265|NCT01812252|465103008|FG001|Overall Study|Withdrawal by Subject|1|||
129219266|NCT01812252|465103007|FG000|Overall Study|Screen Failure|1|||
129219267|NCT01812252|465103008|FG001|Overall Study|Screen Failure|0|||
129219268|NCT02284243|465103009|FG000|Overall Study|Lack of Efficacy|3|||
128711376|NCT00475176|463239874|FG000|Overall Study|Withdrawal by Subject|1|||
128711377|NCT00475176|463239874|FG000|Overall Study|Protocol Violation|1|||
128711378|NCT01463878|463239875|FG000|Overall Study|no longer met criteria for tube feed|2|||
128711379|NCT01463878|463239876|FG001|Overall Study|no longer met criteria for tube feed|2|||
128953952|NCT01714817|464116686|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
128953953|NCT01714817|464116687|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
128953954|NCT01714817|464116686|FG000|Year 2 Period|Pregnancy|1|||
128953955|NCT01714817|464116687|FG001|Year 2 Period|Pregnancy|1|||
128953956|NCT01714817|464116686|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
128953957|NCT01714817|464116687|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
128953958|NCT01714817|464116686|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
128953959|NCT01714817|464116687|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
128953960|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
128953961|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
128953962|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
128953963|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
128953964|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
128953965|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
128953966|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
128953967|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
128953968|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
128953969|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
128953970|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
128953971|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
128953972|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
128953973|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
128953974|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
128953975|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
128953976|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
128953977|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
128953978|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
128953979|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
128953980|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
128953981|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
128953982|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
128953983|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
128953984|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
128953985|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
128953986|NCT01714817|464116686|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
128953987|NCT01714817|464116687|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
128953988|NCT02921763|464116688|FG000|Overall Study|Adverse Event|4|||
129219269|NCT02284243|465103010|FG001|Overall Study|Lack of Efficacy|3|||
129219270|NCT02284243|465103009|FG000|Overall Study|Adverse Event|1|||
128711380|NCT03804879|463239877|FG000|Overall Study|Adverse Event|3|||
128711381|NCT03804879|463239878|FG001|Overall Study|Adverse Event|0|||
128711382|NCT03804879|463239877|FG000|Overall Study|Study Terminated By Sponsor|10|||
128711383|NCT03804879|463239878|FG001|Overall Study|Study Terminated By Sponsor|12|||
128711384|NCT03804879|463239877|FG000|Overall Study|Withdrawal by Subject|3|||
128711385|NCT03804879|463239878|FG001|Overall Study|Withdrawal by Subject|1|||
128711386|NCT02436889|463239879|FG000|Overall Study|No improvement in symptoms|1|||
128711387|NCT02436889|463239880|FG001|Overall Study|No improvement in symptoms|0|||
128711388|NCT02436889|463239879|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
128711389|NCT02436889|463239880|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
128711390|NCT01585428|463239881|FG000|Overall Study|Death during treatment|1|||
128711391|NCT01585428|463239882|FG001|Overall Study|Death during treatment|0|||
128711392|NCT01084174|463239883|FG000|Overall Study|gastrointestinal symptoms|1|||
128711393|NCT01084174|463239884|FG001|Overall Study|gastrointestinal symptoms|1|||
128711394|NCT01084174|463239883|FG000|Overall Study|Eosinophilic esophagitis|0|||
128711395|NCT01084174|463239884|FG001|Overall Study|Eosinophilic esophagitis|1|||
128711396|NCT01084174|463239883|FG000|Overall Study|Anaphylaxis|0|||
128711397|NCT01084174|463239884|FG001|Overall Study|Anaphylaxis|1|||
128711398|NCT01084174|463239883|FG000|Overall Study|Participant noncompliance|0|||
128711399|NCT01084174|463239884|FG001|Overall Study|Participant noncompliance|1|||
128711400|NCT01034462|463239885|FG000|Overall Study|Adverse Event|7|||
128711401|NCT01034462|463239886|FG001|Overall Study|Adverse Event|17|||
128711402|NCT01034462|463239885|FG000|Overall Study|Lack of Efficacy|4|||
128711403|NCT01034462|463239886|FG001|Overall Study|Lack of Efficacy|4|||
128711404|NCT01034462|463239885|FG000|Overall Study|Protocol Violation|10|||
128711405|NCT01034462|463239886|FG001|Overall Study|Protocol Violation|7|||
128711406|NCT01034462|463239885|FG000|Overall Study|Withdrawal by Subject|9|||
128711407|NCT01034462|463239886|FG001|Overall Study|Withdrawal by Subject|8|||
128711408|NCT01034462|463239885|FG000|Overall Study|Lost to Follow-up|14|||
128711409|NCT01034462|463239886|FG001|Overall Study|Lost to Follow-up|16|||
128711410|NCT01034462|463239885|FG000|Overall Study|Other reasons|1|||
128711411|NCT01034462|463239886|FG001|Overall Study|Other reasons|2|||
128711412|NCT01484873|463239887|FG000|Overall Study|Withdrawal by Subject|2|||
128711413|NCT02564042|463239888|FG000|Overall Study|Adverse Event|4|||
128711414|NCT02564042|463239889|FG001|Overall Study|Adverse Event|4|||
128711415|NCT02564042|463239890|FG002|Overall Study|Adverse Event|3|||
128711416|NCT02564042|463239891|FG003|Overall Study|Adverse Event|0|||
128711417|NCT02564042|463239892|FG004|Overall Study|Adverse Event|0|||
128711418|NCT02564042|463239893|FG005|Overall Study|Adverse Event|1|||
128711419|NCT02564042|463239888|FG000|Overall Study|Lost to Follow-up|1|||
128711420|NCT02564042|463239889|FG001|Overall Study|Lost to Follow-up|1|||
128711421|NCT02564042|463239890|FG002|Overall Study|Lost to Follow-up|1|||
128711422|NCT02564042|463239891|FG003|Overall Study|Lost to Follow-up|0|||
128711423|NCT02564042|463239892|FG004|Overall Study|Lost to Follow-up|1|||
128711424|NCT02564042|463239893|FG005|Overall Study|Lost to Follow-up|1|||
128711425|NCT02564042|463239888|FG000|Overall Study|Physician Decision|1|||
128953989|NCT02921763|464116688|FG000|Overall Study|Lost to Follow-up|4|||
128953990|NCT02921763|464116688|FG000|Overall Study|Lack of Efficacy|3|||
128711426|NCT02564042|463239889|FG001|Overall Study|Physician Decision|0|||
128711427|NCT02564042|463239890|FG002|Overall Study|Physician Decision|0|||
128711428|NCT02564042|463239891|FG003|Overall Study|Physician Decision|1|||
128711429|NCT02564042|463239892|FG004|Overall Study|Physician Decision|0|||
128711430|NCT02564042|463239893|FG005|Overall Study|Physician Decision|0|||
128711431|NCT02564042|463239888|FG000|Overall Study|Withdrawal by Subject|5|||
128711432|NCT02564042|463239889|FG001|Overall Study|Withdrawal by Subject|3|||
128711433|NCT02564042|463239890|FG002|Overall Study|Withdrawal by Subject|2|||
128711434|NCT02564042|463239891|FG003|Overall Study|Withdrawal by Subject|2|||
128953991|NCT02921763|464116688|FG000|Overall Study|Protocol Violation|2|||
128953992|NCT02921763|464116688|FG000|Overall Study|Withdrawal by Subject|2|||
128953993|NCT02921763|464116688|FG000|Overall Study|Physician Decision|1|||
128953994|NCT02921763|464116688|FG000|Overall Study|No data obtained|2|||
128953995|NCT01582971|464116689|FG000|Overall Study|Death|2|||
128953996|NCT01582971|464116690|FG001|Overall Study|Death|1|||
128953997|NCT01582971|464116689|FG000|Overall Study|Lost to Follow-up|18|||
128953998|NCT01582971|464116690|FG001|Overall Study|Lost to Follow-up|21|||
128953999|NCT01582971|464116689|FG000|Overall Study|Withdrawal by Subject|4|||
128954000|NCT01582971|464116690|FG001|Overall Study|Withdrawal by Subject|2|||
128954001|NCT01582971|464116689|FG000|Overall Study|Other|15|||
128954002|NCT01582971|464116690|FG001|Overall Study|Other|13|||
128954003|NCT02554253|464116695|FG000|Overall Study|ineligible after enrollment|1|||
128954004|NCT02554253|464116696|FG001|Overall Study|ineligible after enrollment|0|||
129035758|NCT01064531|464421561|FG001|Overall Study|Revision due to femoral stem loosening|0|||
128954005|NCT02554253|464116695|FG000|Overall Study|converted to transcatheter procedure|0|||
128711435|NCT02564042|463239892|FG004|Overall Study|Withdrawal by Subject|10|||
128954006|NCT02554253|464116696|FG001|Overall Study|converted to transcatheter procedure|1|||
128954007|NCT02554253|464116695|FG000|Overall Study|received both drugs|0|||
129219271|NCT02284243|465103010|FG001|Overall Study|Adverse Event|0|||
128711436|NCT02564042|463239893|FG005|Overall Study|Withdrawal by Subject|12|||
128954008|NCT02554253|464116696|FG001|Overall Study|received both drugs|1|||
128954009|NCT01736254|464116699|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
128954010|NCT01736254|464116699|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
128954011|NCT02559206|464116700|FG000|Overall Study|Adverse Event|0|||
128954012|NCT02559206|464116701|FG001|Overall Study|Adverse Event|4|||
128954013|NCT02559206|464116702|FG002|Overall Study|Adverse Event|1|||
128954014|NCT02559206|464116703|FG003|Overall Study|Adverse Event|5|||
128954015|NCT02559206|464116704|FG004|Overall Study|Adverse Event|3|||
128954016|NCT02559206|464116705|FG005|Overall Study|Adverse Event|0|||
128954017|NCT02559206|464116706|FG006|Overall Study|Adverse Event|1|||
128954018|NCT02559206|464116707|FG007|Overall Study|Adverse Event|0|||
128954019|NCT02559206|464116700|FG000|Overall Study|Protocol Violation|1|||
128954020|NCT02559206|464116701|FG001|Overall Study|Protocol Violation|0|||
128954021|NCT02559206|464116702|FG002|Overall Study|Protocol Violation|1|||
129125881|NCT00157755|464755592|FG002|Overall Study|Study site closure|0|||
129125882|NCT00157755|464755593|FG003|Overall Study|Study site closure|0|||
129125883|NCT00157755|464755594|FG004|Overall Study|Study site closure|0|||
129125884|NCT00157755|464755595|FG005|Overall Study|Study site closure|0|||
129125885|NCT00157755|464755590|FG000|Overall Study|Subject non-compliance|0|||
129125886|NCT00157755|464755591|FG001|Overall Study|Subject non-compliance|0|||
129125887|NCT00157755|464755592|FG002|Overall Study|Subject non-compliance|0|||
129125888|NCT00157755|464755593|FG003|Overall Study|Subject non-compliance|0|||
129125889|NCT00157755|464755594|FG004|Overall Study|Subject non-compliance|0|||
129125890|NCT00157755|464755595|FG005|Overall Study|Subject non-compliance|1|||
129125891|NCT00157755|464755590|FG000|Overall Study|Study completion|0|||
129125892|NCT00157755|464755591|FG001|Overall Study|Study completion|0|||
129125893|NCT00157755|464755592|FG002|Overall Study|Study completion|0|||
129125894|NCT00157755|464755593|FG003|Overall Study|Study completion|0|||
129125895|NCT00157755|464755594|FG004|Overall Study|Study completion|1|||
128954022|NCT02559206|464116703|FG003|Overall Study|Protocol Violation|0|||
128954023|NCT02559206|464116704|FG004|Overall Study|Protocol Violation|0|||
128954024|NCT02559206|464116705|FG005|Overall Study|Protocol Violation|2|||
128954025|NCT02559206|464116706|FG006|Overall Study|Protocol Violation|0|||
128954026|NCT02559206|464116707|FG007|Overall Study|Protocol Violation|0|||
128954027|NCT02559206|464116700|FG000|Overall Study|Withdrawal by Subject|3|||
128954028|NCT02559206|464116701|FG001|Overall Study|Withdrawal by Subject|3|||
128954029|NCT02559206|464116702|FG002|Overall Study|Withdrawal by Subject|1|||
128954030|NCT02559206|464116703|FG003|Overall Study|Withdrawal by Subject|3|||
128954031|NCT02559206|464116704|FG004|Overall Study|Withdrawal by Subject|5|||
128954032|NCT02559206|464116705|FG005|Overall Study|Withdrawal by Subject|4|||
128954033|NCT02559206|464116706|FG006|Overall Study|Withdrawal by Subject|1|||
128954034|NCT02559206|464116707|FG007|Overall Study|Withdrawal by Subject|2|||
128954035|NCT02559206|464116700|FG000|Overall Study|Lost to Follow-up|3|||
128954036|NCT02559206|464116701|FG001|Overall Study|Lost to Follow-up|5|||
128954037|NCT02559206|464116702|FG002|Overall Study|Lost to Follow-up|3|||
128954038|NCT02559206|464116703|FG003|Overall Study|Lost to Follow-up|3|||
128954039|NCT02559206|464116704|FG004|Overall Study|Lost to Follow-up|2|||
128954040|NCT02559206|464116705|FG005|Overall Study|Lost to Follow-up|5|||
128954041|NCT02559206|464116706|FG006|Overall Study|Lost to Follow-up|1|||
128954042|NCT02559206|464116707|FG007|Overall Study|Lost to Follow-up|4|||
128954043|NCT02559206|464116700|FG000|Overall Study|Lack of Efficacy|1|||
128954044|NCT02559206|464116701|FG001|Overall Study|Lack of Efficacy|0|||
128954045|NCT02559206|464116702|FG002|Overall Study|Lack of Efficacy|3|||
128954046|NCT02559206|464116703|FG003|Overall Study|Lack of Efficacy|2|||
128954047|NCT02559206|464116704|FG004|Overall Study|Lack of Efficacy|2|||
128954048|NCT02559206|464116705|FG005|Overall Study|Lack of Efficacy|3|||
128954049|NCT02559206|464116706|FG006|Overall Study|Lack of Efficacy|3|||
128954050|NCT02559206|464116707|FG007|Overall Study|Lack of Efficacy|3|||
128954051|NCT02559206|464116700|FG000|Overall Study|Other Not Specified|0|||
128954052|NCT02559206|464116701|FG001|Overall Study|Other Not Specified|0|||
128954053|NCT02559206|464116702|FG002|Overall Study|Other Not Specified|0|||
128954054|NCT02559206|464116703|FG003|Overall Study|Other Not Specified|1|||
128954055|NCT02559206|464116704|FG004|Overall Study|Other Not Specified|0|||
128954056|NCT02559206|464116705|FG005|Overall Study|Other Not Specified|0|||
128954057|NCT02559206|464116706|FG006|Overall Study|Other Not Specified|0|||
128954058|NCT02559206|464116707|FG007|Overall Study|Other Not Specified|0|||
128954059|NCT01561560|464116708|FG000|First Two Weeks of Wear|Time/job conflict|0|||
128954060|NCT01561560|464116709|FG001|First Two Weeks of Wear|Time/job conflict|1|||
128954061|NCT01561560|464116708|FG000|First Two Weeks of Wear|Adverse Event|0|||
128954062|NCT01561560|464116709|FG001|First Two Weeks of Wear|Adverse Event|1|||
129125896|NCT00157755|464755595|FG005|Overall Study|Study completion|2|||
129125897|NCT03314935|464755598|FG000|Phase 1|Death|4|||
129125898|NCT03314935|464755599|FG001|Phase 1|Death|2|||
129125899|NCT03314935|464755600|FG002|Phase 1|Death|5|||
129125900|NCT03314935|464755601|FG003|Phase 1|Death|4|||
129125901|NCT03314935|464755602|FG004|Phase 1|Death|3|||
129125902|NCT03314935|464755603|FG005|Phase 1|Death|4|||
129125903|NCT03314935|464755604|FG006|Phase 1|Death|5|||
129125904|NCT03314935|464755605|FG007|Phase 1|Death|4|||
129125905|NCT03314935|464755606|FG008|Phase 1|Death|3|||
129125906|NCT03314935|464755607|FG009|Phase 1|Death|0|||
128954063|NCT01561560|464116708|FG000|Second Two Weeks of Wear|Adverse Event|0|||
128954064|NCT01561560|464116709|FG001|Second Two Weeks of Wear|Adverse Event|1|||
128954065|NCT06025396|464118362|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
128954066|NCT06025396|464118363|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
128954067|NCT06025396|464118364|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
128954068|NCT06025396|464118365|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
128954069|NCT06025396|464118366|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
128954070|NCT06025396|464118362|FG000|Overall Study|Withdrawal by Subject|0|||
128954071|NCT06025396|464118363|FG001|Overall Study|Withdrawal by Subject|1|||
128954072|NCT06025396|464118364|FG002|Overall Study|Withdrawal by Subject|1|||
128954073|NCT06025396|464118365|FG003|Overall Study|Withdrawal by Subject|0|||
128954074|NCT06025396|464118366|FG004|Overall Study|Withdrawal by Subject|0|||
128954075|NCT01512108|464118367|FG000|Overall Study|Adverse Event|9|||
128954076|NCT01512108|464118368|FG001|Overall Study|Adverse Event|4|||
128954077|NCT01512108|464118367|FG000|Overall Study|Protocol Violation|1|||
128954078|NCT01512108|464118368|FG001|Overall Study|Protocol Violation|2|||
128954079|NCT01512108|464118367|FG000|Overall Study|Withdrawal Criteria|1|||
128954080|NCT01512108|464118368|FG001|Overall Study|Withdrawal Criteria|0|||
128954081|NCT01512108|464118367|FG000|Overall Study|Unclassified|11|||
128954082|NCT01512108|464118368|FG001|Overall Study|Unclassified|3|||
128954083|NCT06422377|464118374|FG000|Overall Study|Study Terminated by Sponsor|1|||
128954084|NCT02843178|464118376|FG000|Overall Study|Lost to Follow-up|8|||
128954085|NCT02843178|464118377|FG001|Overall Study|Lost to Follow-up|8|||
128954086|NCT02843178|464118378|FG002|Overall Study|Lost to Follow-up|6|||
128954087|NCT02843178|464118379|FG003|Overall Study|Lost to Follow-up|3|||
128954088|NCT02843178|464118376|FG000|Overall Study|Withdrawal by Subject|0|||
129125907|NCT03314935|464755608|FG010|Phase 1|Death|0|||
129125908|NCT03314935|464755609|FG011|Phase 1|Death|0|||
129125909|NCT03314935|464755610|FG012|Phase 1|Death|0|||
129125910|NCT03314935|464755611|FG013|Phase 1|Death|0|||
129125911|NCT03314935|464755612|FG014|Phase 1|Death|0|||
129125912|NCT03314935|464755598|FG000|Phase 1|Withdrawal by Subject|2|||
129125913|NCT03314935|464755599|FG001|Phase 1|Withdrawal by Subject|1|||
129125914|NCT03314935|464755600|FG002|Phase 1|Withdrawal by Subject|1|||
129125915|NCT03314935|464755601|FG003|Phase 1|Withdrawal by Subject|2|||
129125916|NCT03314935|464755602|FG004|Phase 1|Withdrawal by Subject|1|||
129125917|NCT03314935|464755603|FG005|Phase 1|Withdrawal by Subject|0|||
129125918|NCT03314935|464755604|FG006|Phase 1|Withdrawal by Subject|1|||
129125919|NCT03314935|464755605|FG007|Phase 1|Withdrawal by Subject|0|||
129125920|NCT03314935|464755606|FG008|Phase 1|Withdrawal by Subject|1|||
129125921|NCT03314935|464755607|FG009|Phase 1|Withdrawal by Subject|0|||
129125922|NCT03314935|464755608|FG010|Phase 1|Withdrawal by Subject|0|||
129219272|NCT04269889|465103012|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
128954089|NCT02843178|464118377|FG001|Overall Study|Withdrawal by Subject|0|||
128954090|NCT02843178|464118378|FG002|Overall Study|Withdrawal by Subject|1|||
129035759|NCT01064531|464421560|FG000|Overall Study|Revision due to dislocation|0|||
129219273|NCT04634253|465103013|FG000|Overall Study|Adverse Event|1|||
128954091|NCT02843178|464118379|FG003|Overall Study|Withdrawal by Subject|1|||
128954092|NCT02701192|464118382|FG000|Overall Study|Protocol Violation|2|||
128954093|NCT02701192|464118382|FG000|Overall Study|Lost to Follow-up|4|||
128954094|NCT00949910|464118383|FG000|Overall Study|Progressive Disease|3750|||
128954095|NCT00949910|464118383|FG000|Overall Study|Symptomatic Deterioration|1088|||
129035760|NCT01064531|464421561|FG001|Overall Study|Revision due to dislocation|1|||
129035761|NCT01064531|464421560|FG000|Overall Study|Death|0|||
129035762|NCT01064531|464421561|FG001|Overall Study|Death|1|||
129035763|NCT00809965|464421566|FG000|Overall Study|Death|194|||
129035764|NCT00809965|464421567|FG001|Overall Study|Death|147|||
129035765|NCT00809965|464421568|FG002|Overall Study|Death|196|||
129035766|NCT00809965|464421566|FG000|Overall Study|Lost to Follow-up|17|||
129035767|NCT00809965|464421567|FG001|Overall Study|Lost to Follow-up|10|||
129035768|NCT00809965|464421568|FG002|Overall Study|Lost to Follow-up|18|||
129035769|NCT00809965|464421566|FG000|Overall Study|Withdrawal by Subject|405|||
129035770|NCT00809965|464421567|FG001|Overall Study|Withdrawal by Subject|448|||
129035771|NCT00809965|464421568|FG002|Overall Study|Withdrawal by Subject|441|||
128954096|NCT00949910|464118383|FG000|Overall Study|Lost to Follow-up|100|||
128954097|NCT00949910|464118383|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
128954098|NCT00949910|464118383|FG000|Overall Study|Participant Refusal|390|||
129035772|NCT00809965|464421566|FG000|Overall Study|Other Reason|167|||
129035773|NCT00809965|464421567|FG001|Overall Study|Other Reason|170|||
129125923|NCT03314935|464755609|FG011|Phase 1|Withdrawal by Subject|0|||
129125924|NCT03314935|464755610|FG012|Phase 1|Withdrawal by Subject|0|||
129125925|NCT03314935|464755611|FG013|Phase 1|Withdrawal by Subject|0|||
129125926|NCT03314935|464755612|FG014|Phase 1|Withdrawal by Subject|0|||
129125927|NCT03314935|464755598|FG000|Phase 1|Progressive Disease|2|||
129125928|NCT03314935|464755599|FG001|Phase 1|Progressive Disease|0|||
129125929|NCT03314935|464755600|FG002|Phase 1|Progressive Disease|0|||
129125930|NCT03314935|464755601|FG003|Phase 1|Progressive Disease|1|||
129125931|NCT03314935|464755602|FG004|Phase 1|Progressive Disease|0|||
129125932|NCT03314935|464755603|FG005|Phase 1|Progressive Disease|0|||
129125933|NCT03314935|464755604|FG006|Phase 1|Progressive Disease|0|||
129035774|NCT00809965|464421568|FG002|Overall Study|Other Reason|189|||
129035775|NCT02315066|464421569|FG000|Overall Study|Lost to Follow-up|0|||
129035776|NCT02315066|464421570|FG001|Overall Study|Lost to Follow-up|1|||
128954099|NCT00949910|464118383|FG000|Overall Study|Death Due to Malignant Disease|456|||
128954100|NCT00949910|464118383|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
128954101|NCT00949910|464118383|FG000|Overall Study|Death Due to Adverse Event|115|||
128954102|NCT00949910|464118383|FG000|Overall Study|Death Due to Toxicity|3|||
128954103|NCT00949910|464118383|FG000|Overall Study|Death from Unknown Cause|5|||
128954104|NCT00949910|464118383|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
129035777|NCT02315066|464421571|FG002|Overall Study|Lost to Follow-up|1|||
129035778|NCT02315066|464421572|FG003|Overall Study|Lost to Follow-up|0|||
129035779|NCT02315066|464421573|FG004|Overall Study|Lost to Follow-up|1|||
129035780|NCT02315066|464421574|FG005|Overall Study|Lost to Follow-up|0|||
129035781|NCT02315066|464421575|FG006|Overall Study|Lost to Follow-up|2|||
129035782|NCT02315066|464421576|FG007|Overall Study|Lost to Follow-up|1|||
129035783|NCT02315066|464421577|FG008|Overall Study|Lost to Follow-up|0|||
129035784|NCT02315066|464421578|FG009|Overall Study|Lost to Follow-up|0|||
129035785|NCT02315066|464421579|FG010|Overall Study|Lost to Follow-up|1|||
129035786|NCT02315066|464421580|FG011|Overall Study|Lost to Follow-up|2|||
129035787|NCT02315066|464421581|FG012|Overall Study|Lost to Follow-up|0|||
129035788|NCT02315066|464421582|FG013|Overall Study|Lost to Follow-up|4|||
129035789|NCT02315066|464421569|FG000|Overall Study|Death|2|||
129035790|NCT02315066|464421570|FG001|Overall Study|Death|7|||
129035791|NCT02315066|464421571|FG002|Overall Study|Death|6|||
129035792|NCT02315066|464421572|FG003|Overall Study|Death|11|||
129035793|NCT02315066|464421573|FG004|Overall Study|Death|10|||
129035794|NCT02315066|464421574|FG005|Overall Study|Death|3|||
129035795|NCT02315066|464421575|FG006|Overall Study|Death|9|||
129035796|NCT02315066|464421576|FG007|Overall Study|Death|9|||
129035797|NCT02315066|464421577|FG008|Overall Study|Death|10|||
129035798|NCT02315066|464421578|FG009|Overall Study|Death|8|||
129035799|NCT02315066|464421579|FG010|Overall Study|Death|10|||
129035800|NCT02315066|464421580|FG011|Overall Study|Death|7|||
129035801|NCT02315066|464421581|FG012|Overall Study|Death|8|||
129035802|NCT02315066|464421582|FG013|Overall Study|Death|21|||
128954105|NCT00949910|464118383|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
129125934|NCT03314935|464755605|FG007|Phase 1|Progressive Disease|0|||
129125935|NCT03314935|464755606|FG008|Phase 1|Progressive Disease|0|||
129125936|NCT03314935|464755607|FG009|Phase 1|Progressive Disease|0|||
129125937|NCT03314935|464755608|FG010|Phase 1|Progressive Disease|0|||
129125938|NCT03314935|464755609|FG011|Phase 1|Progressive Disease|0|||
129219274|NCT04634253|465103014|FG001|Overall Study|Adverse Event|1|||
128954106|NCT00949910|464118383|FG000|Overall Study|Switched to Commercial Treatment|4|||
128954107|NCT00949910|464118383|FG000|Overall Study|Violation of Eligibility|23|||
128954108|NCT00949910|464118383|FG000|Overall Study|Logistical Reasons|13|||
128954109|NCT00949910|464118383|FG000|Overall Study|Non-Compliance|10|||
128954110|NCT00949910|464118383|FG000|Overall Study|Prolonged Dosing Interruption|4|||
128954111|NCT00949910|464118383|FG000|Overall Study|Adverse Event|83|||
128954112|NCT00949910|464118383|FG000|Overall Study|Serious Adverse Event|6|||
128954113|NCT00949910|464118383|FG000|Overall Study|Physician/Participant Decision|7|||
128954114|NCT00949910|464118383|FG000|Overall Study|Other|4|||
128954115|NCT00949910|464118383|FG000|Overall Study|No Data|9|||
128954116|NCT02759562|464118386|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
128954117|NCT02759562|464118387|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
128954118|NCT02759562|464118386|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
128954119|NCT02759562|464118387|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
128954120|NCT02769832|464118392|FG000|Overall Study|Death|30|||
128954121|NCT01188538|464118400|FG000|Overall Study|Lost to Follow-up|0|||
128954122|NCT01188538|464118401|FG001|Overall Study|Lost to Follow-up|1|||
128954123|NCT01231607|464118405|FG000|Overall Study|Adverse Event|0|||
128954124|NCT01231607|464118406|FG001|Overall Study|Adverse Event|8|||
128954125|NCT01231607|464118407|FG002|Overall Study|Adverse Event|4|||
129035803|NCT02315066|464421569|FG000|Overall Study|Other|0|||
129035804|NCT02315066|464421570|FG001|Overall Study|Other|0|||
129035805|NCT02315066|464421571|FG002|Overall Study|Other|0|||
129035806|NCT02315066|464421572|FG003|Overall Study|Other|0|||
129035807|NCT02315066|464421573|FG004|Overall Study|Other|0|||
129035808|NCT02315066|464421574|FG005|Overall Study|Other|0|||
128954126|NCT01231607|464118408|FG003|Overall Study|Adverse Event|4|||
128954127|NCT01231607|464118409|FG004|Overall Study|Adverse Event|5|||
128954128|NCT01231607|464118405|FG000|Overall Study|Lost to Follow-up|13|||
129035809|NCT02315066|464421575|FG006|Overall Study|Other|0|||
128954129|NCT01231607|464118406|FG001|Overall Study|Lost to Follow-up|11|||
128954130|NCT01231607|464118407|FG002|Overall Study|Lost to Follow-up|10|||
129035810|NCT02315066|464421576|FG007|Overall Study|Other|1|||
129035811|NCT02315066|464421577|FG008|Overall Study|Other|1|||
129035812|NCT02315066|464421578|FG009|Overall Study|Other|2|||
129035813|NCT02315066|464421579|FG010|Overall Study|Other|0|||
129125939|NCT03314935|464755610|FG012|Phase 1|Progressive Disease|0|||
129125940|NCT03314935|464755611|FG013|Phase 1|Progressive Disease|0|||
129125941|NCT03314935|464755612|FG014|Phase 1|Progressive Disease|0|||
128954131|NCT01231607|464118408|FG003|Overall Study|Lost to Follow-up|10|||
128954132|NCT01231607|464118409|FG004|Overall Study|Lost to Follow-up|4|||
128954133|NCT01231607|464118405|FG000|Overall Study|Physician Decision|4|||
128954134|NCT01231607|464118406|FG001|Overall Study|Physician Decision|4|||
128954135|NCT01231607|464118407|FG002|Overall Study|Physician Decision|3|||
128954136|NCT01231607|464118408|FG003|Overall Study|Physician Decision|5|||
128954137|NCT01231607|464118409|FG004|Overall Study|Physician Decision|4|||
128954138|NCT01231607|464118405|FG000|Overall Study|Protocol Violation|3|||
128954139|NCT01231607|464118406|FG001|Overall Study|Protocol Violation|2|||
128954140|NCT01231607|464118407|FG002|Overall Study|Protocol Violation|0|||
128954141|NCT01231607|464118408|FG003|Overall Study|Protocol Violation|2|||
128954142|NCT01231607|464118409|FG004|Overall Study|Protocol Violation|2|||
129035814|NCT02315066|464421580|FG011|Overall Study|Other|0|||
129035815|NCT02315066|464421581|FG012|Overall Study|Other|0|||
129035816|NCT02315066|464421582|FG013|Overall Study|Other|0|||
129035817|NCT02315066|464421569|FG000|Overall Study|Subject refused further follow-up|0|||
129035818|NCT02315066|464421570|FG001|Overall Study|Subject refused further follow-up|2|||
129035819|NCT02315066|464421571|FG002|Overall Study|Subject refused further follow-up|2|||
129035820|NCT02315066|464421572|FG003|Overall Study|Subject refused further follow-up|0|||
129035821|NCT02315066|464421573|FG004|Overall Study|Subject refused further follow-up|0|||
129035822|NCT02315066|464421574|FG005|Overall Study|Subject refused further follow-up|0|||
129035823|NCT02315066|464421575|FG006|Overall Study|Subject refused further follow-up|2|||
129035824|NCT02315066|464421576|FG007|Overall Study|Subject refused further follow-up|3|||
129035825|NCT02315066|464421577|FG008|Overall Study|Subject refused further follow-up|0|||
129035826|NCT02315066|464421578|FG009|Overall Study|Subject refused further follow-up|1|||
129035827|NCT02315066|464421579|FG010|Overall Study|Subject refused further follow-up|1|||
129035828|NCT02315066|464421580|FG011|Overall Study|Subject refused further follow-up|2|||
129035829|NCT02315066|464421581|FG012|Overall Study|Subject refused further follow-up|2|||
129035830|NCT02315066|464421582|FG013|Overall Study|Subject refused further follow-up|4|||
129035831|NCT02315066|464421569|FG000|Overall Study|Study ongoing at date of cut-off|0|||
129035832|NCT02315066|464421570|FG001|Overall Study|Study ongoing at date of cut-off|0|||
129035833|NCT02315066|464421571|FG002|Overall Study|Study ongoing at date of cut-off|0|||
129035834|NCT02315066|464421572|FG003|Overall Study|Study ongoing at date of cut-off|0|||
129035835|NCT02315066|464421573|FG004|Overall Study|Study ongoing at date of cut-off|0|||
129035836|NCT02315066|464421574|FG005|Overall Study|Study ongoing at date of cut-off|0|||
129035837|NCT02315066|464421575|FG006|Overall Study|Study ongoing at date of cut-off|0|||
129035838|NCT02315066|464421576|FG007|Overall Study|Study ongoing at date of cut-off|0|||
129035839|NCT02315066|464421577|FG008|Overall Study|Study ongoing at date of cut-off|0|||
129035840|NCT02315066|464421578|FG009|Overall Study|Study ongoing at date of cut-off|0|||
129035841|NCT02315066|464421579|FG010|Overall Study|Study ongoing at date of cut-off|0|||
129035842|NCT02315066|464421580|FG011|Overall Study|Study ongoing at date of cut-off|0|||
129035843|NCT02315066|464421581|FG012|Overall Study|Study ongoing at date of cut-off|0|||
129035844|NCT02315066|464421582|FG013|Overall Study|Study ongoing at date of cut-off|1|||
129035845|NCT00112294|464421583|FG000|Overall Study|Still on study|5|||
129035846|NCT00112294|464421584|FG001|Overall Study|Still on study|0|||
129035847|NCT01142908|464421585|FG000|Overall Study|Lost to Follow-up|19|||
129035848|NCT01142908|464421586|FG001|Overall Study|Lost to Follow-up|13|||
129035849|NCT01142908|464421585|FG000|Overall Study|Death|1|||
129035850|NCT01142908|464421586|FG001|Overall Study|Death|4|||
129035851|NCT01142908|464421585|FG000|Overall Study|Excluded - did not meet criteria|9|||
129035852|NCT01142908|464421586|FG001|Overall Study|Excluded - did not meet criteria|5|||
129035853|NCT01142908|464421585|FG000|Overall Study|Withdrawal by Subject|3|||
129035854|NCT01142908|464421586|FG001|Overall Study|Withdrawal by Subject|0|||
129035855|NCT00035555|464421587|FG000|Overall Study|Adverse Event|5|||
129035856|NCT00035555|464421588|FG001|Overall Study|Adverse Event|8|||
129035857|NCT00035555|464421589|FG002|Overall Study|Adverse Event|9|||
129035858|NCT00035555|464421587|FG000|Overall Study|Allograft loss|1|||
129035859|NCT00035555|464421588|FG001|Overall Study|Allograft loss|1|||
129035860|NCT00035555|464421589|FG002|Overall Study|Allograft loss|2|||
129035861|NCT00035555|464421587|FG000|Overall Study|Death|0|||
129035862|NCT00035555|464421588|FG001|Overall Study|Death|0|||
129035863|NCT00035555|464421589|FG002|Overall Study|Death|2|||
129035864|NCT00035555|464421587|FG000|Overall Study|Lost to Follow-up|0|||
129035865|NCT00035555|464421588|FG001|Overall Study|Lost to Follow-up|0|||
129035866|NCT00035555|464421589|FG002|Overall Study|Lost to Follow-up|1|||
129035867|NCT00035555|464421587|FG000|Overall Study|Noncompliance|0|||
129035868|NCT00035555|464421588|FG001|Overall Study|Noncompliance|1|||
129035869|NCT00035555|464421589|FG002|Overall Study|Noncompliance|1|||
129035870|NCT00035555|464421587|FG000|Overall Study|Prohibited medication|1|||
129035871|NCT00035555|464421588|FG001|Overall Study|Prohibited medication|1|||
129035872|NCT00035555|464421589|FG002|Overall Study|Prohibited medication|0|||
129035873|NCT00035555|464421587|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
129035874|NCT00035555|464421588|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
129035875|NCT00035555|464421589|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
128954143|NCT01231607|464118405|FG000|Overall Study|Withdrawal by Subject|9|||
128954144|NCT01231607|464118406|FG001|Overall Study|Withdrawal by Subject|9|||
128954145|NCT01231607|464118407|FG002|Overall Study|Withdrawal by Subject|14|||
128954146|NCT01231607|464118408|FG003|Overall Study|Withdrawal by Subject|17|||
128954147|NCT01231607|464118409|FG004|Overall Study|Withdrawal by Subject|9|||
128954148|NCT02501902|464118410|FG000|Overall Study|Subject Refused Further Follow-up|0|||
128954149|NCT02501902|464118411|FG001|Overall Study|Subject Refused Further Follow-up|0|||
128954150|NCT02501902|464118412|FG002|Overall Study|Subject Refused Further Follow-up|0|||
128954151|NCT02501902|464118413|FG003|Overall Study|Subject Refused Further Follow-up|0|||
128954152|NCT02501902|464118414|FG004|Overall Study|Subject Refused Further Follow-up|0|||
128954153|NCT02501902|464118415|FG005|Overall Study|Subject Refused Further Follow-up|0|||
128954154|NCT02501902|464118416|FG006|Overall Study|Subject Refused Further Follow-up|0|||
128954155|NCT02501902|464118417|FG007|Overall Study|Subject Refused Further Follow-up|1|||
128954156|NCT02501902|464118410|FG000|Overall Study|Study Terminated by Sponsor|0|||
128954157|NCT02501902|464118411|FG001|Overall Study|Study Terminated by Sponsor|3|||
128954158|NCT02501902|464118412|FG002|Overall Study|Study Terminated by Sponsor|0|||
128954159|NCT02501902|464118413|FG003|Overall Study|Study Terminated by Sponsor|1|||
128954160|NCT02501902|464118414|FG004|Overall Study|Study Terminated by Sponsor|1|||
128954161|NCT02501902|464118415|FG005|Overall Study|Study Terminated by Sponsor|0|||
128954162|NCT02501902|464118416|FG006|Overall Study|Study Terminated by Sponsor|2|||
128954163|NCT02501902|464118417|FG007|Overall Study|Study Terminated by Sponsor|4|||
128954164|NCT02501902|464118410|FG000|Overall Study|Death|3|||
128954165|NCT02501902|464118411|FG001|Overall Study|Death|4|||
128954166|NCT02501902|464118412|FG002|Overall Study|Death|4|||
128954167|NCT02501902|464118413|FG003|Overall Study|Death|10|||
128954168|NCT02501902|464118414|FG004|Overall Study|Death|10|||
128954169|NCT02501902|464118415|FG005|Overall Study|Death|11|||
128954170|NCT02501902|464118416|FG006|Overall Study|Death|7|||
128954171|NCT02501902|464118417|FG007|Overall Study|Death|15|||
128954172|NCT02513771|464118418|FG000|Overall Study|Lost to Follow-up|1|||
128954173|NCT02513771|464118419|FG001|Overall Study|Lost to Follow-up|1|||
128954174|NCT02513771|464118418|FG000|Overall Study|Not being able to get to clinic|1|||
128954175|NCT02513771|464118419|FG001|Overall Study|Not being able to get to clinic|0|||
128954176|NCT01797445|464118422|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
128954177|NCT01797445|464118423|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
128954178|NCT01797445|464118422|FG000|Double-Blind Phase|Adverse Event|3|||
128954179|NCT01797445|464118423|FG001|Double-Blind Phase|Adverse Event|0|||
128954180|NCT01797445|464118422|FG000|Double-Blind Phase|Death|5|||
128954181|NCT01797445|464118423|FG001|Double-Blind Phase|Death|4|||
128954182|NCT01797445|464118422|FG000|Double-Blind Phase|Pregnancy|0|||
128954183|NCT01797445|464118423|FG001|Double-Blind Phase|Pregnancy|1|||
128954184|NCT01797445|464118422|FG000|Double-Blind Phase|Lack of Efficacy|1|||
128954185|NCT01797445|464118423|FG001|Double-Blind Phase|Lack of Efficacy|2|||
128954186|NCT01797445|464118422|FG000|Double-Blind Phase|Investigator's Discretion|15|||
128954187|NCT01797445|464118423|FG001|Double-Blind Phase|Investigator's Discretion|17|||
128954188|NCT01797445|464118422|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
128954189|NCT01797445|464118423|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
128954190|NCT01797445|464118422|FG000|Double-Blind Phase|Protocol Violation|0|||
128954191|NCT01797445|464118423|FG001|Double-Blind Phase|Protocol Violation|1|||
128954192|NCT01797445|464118422|FG000|Double-Blind Phase|Withdrew Consent|20|||
128954193|NCT01797445|464118423|FG001|Double-Blind Phase|Withdrew Consent|35|||
128954194|NCT01797445|464118422|FG000|Double-Blind Phase|Lost to Follow-up|34|||
128954195|NCT01797445|464118423|FG001|Double-Blind Phase|Lost to Follow-up|26|||
128954196|NCT01797445|464118422|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
128954197|NCT01797445|464118423|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
128954198|NCT01595438|464118426|FG000|Overall Study|Lost to Follow-up|20|||
128954199|NCT01595438|464118427|FG001|Overall Study|Lost to Follow-up|20|||
128954200|NCT01595438|464118426|FG000|Overall Study|Withdrawal by Subject|12|||
128954201|NCT01595438|464118427|FG001|Overall Study|Withdrawal by Subject|12|||
128954202|NCT01595438|464118426|FG000|Overall Study|Other Eligibility criteria|11|||
128954203|NCT01595438|464118427|FG001|Overall Study|Other Eligibility criteria|9|||
129035876|NCT00035555|464421587|FG000|Overall Study|Withdrawal by Subject|2|||
129035877|NCT00035555|464421588|FG001|Overall Study|Withdrawal by Subject|0|||
129035878|NCT00035555|464421589|FG002|Overall Study|Withdrawal by Subject|2|||
129035879|NCT00035555|464421587|FG000|Overall Study|Investigator deemed not a good candidate|0|||
129035880|NCT00035555|464421588|FG001|Overall Study|Investigator deemed not a good candidate|0|||
129035881|NCT00035555|464421589|FG002|Overall Study|Investigator deemed not a good candidate|1|||
129035882|NCT00035555|464421587|FG000|Overall Study|Received cyclosporin in error|0|||
129035883|NCT00035555|464421588|FG001|Overall Study|Received cyclosporin in error|0|||
129035884|NCT00035555|464421589|FG002|Overall Study|Received cyclosporin in error|1|||
129035885|NCT02972515|464421592|FG000|Overall Study|Lost to Follow-up|78|||
129035886|NCT01450800|464421593|FG000|Overall Study|Protocol Violation|1|||
129035887|NCT01450800|464421594|FG001|Overall Study|Protocol Violation|3|||
129035888|NCT01086969|464421602|FG000|Overall Study|Withdrawal by Subject|1|||
129035889|NCT01086969|464421603|FG001|Overall Study|Withdrawal by Subject|2|||
128954204|NCT01280266|464118434|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
128954205|NCT01280266|464118435|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
128711437|NCT01549392|463239894|FG000|Overall Study|Withdrawal by Subject|1|||
128711438|NCT01549392|463239895|FG001|Overall Study|Withdrawal by Subject|0|||
128711439|NCT01356966|463239896|FG000|Overall Study|Withdrawal by Subject|1|||
128711440|NCT01356966|463239897|FG001|Overall Study|Withdrawal by Subject|2|||
128711441|NCT01356966|463239896|FG000|Overall Study|Physician Decision|1|||
128711442|NCT01356966|463239897|FG001|Overall Study|Physician Decision|0|||
128711443|NCT02743806|463239898|FG000|Overall Study|Adverse Event|9|||
128711444|NCT02743806|463239898|FG000|Overall Study|Lost to Follow-up|8|||
128711445|NCT02743806|463239898|FG000|Overall Study|Voluntary Withdrawal|54|||
128711446|NCT02743806|463239898|FG000|Overall Study|Study Termination|65|||
128711447|NCT02743806|463239898|FG000|Overall Study|Pregnancy|6|||
128711448|NCT02743806|463239898|FG000|Overall Study|No Longer Clinically Benefiting|27|||
128711449|NCT02743806|463239898|FG000|Overall Study|Reason Not Specified|12|||
128711450|NCT04273217|463239900|FG000|Overall Study|Lost to Follow-up|0|||
128711451|NCT04273217|463239901|FG001|Overall Study|Lost to Follow-up|0|||
128711452|NCT04273217|463239902|FG002|Overall Study|Lost to Follow-up|0|||
128711453|NCT04273217|463239903|FG003|Overall Study|Lost to Follow-up|0|||
128711454|NCT04273217|463239904|FG004|Overall Study|Lost to Follow-up|0|||
128711455|NCT04273217|463239905|FG005|Overall Study|Lost to Follow-up|1|||
128711456|NCT04273217|463239900|FG000|Overall Study|Participant non-compliance|0|||
128711457|NCT04273217|463239901|FG001|Overall Study|Participant non-compliance|0|||
128711458|NCT04273217|463239902|FG002|Overall Study|Participant non-compliance|0|||
128711459|NCT04273217|463239903|FG003|Overall Study|Participant non-compliance|0|||
128711460|NCT04273217|463239904|FG004|Overall Study|Participant non-compliance|1|||
128711461|NCT04273217|463239905|FG005|Overall Study|Participant non-compliance|0|||
128711462|NCT04273217|463239900|FG000|Overall Study|Positive urine drug screen|1|||
128711463|NCT04273217|463239901|FG001|Overall Study|Positive urine drug screen|0|||
128711464|NCT04273217|463239902|FG002|Overall Study|Positive urine drug screen|1|||
128711465|NCT04273217|463239903|FG003|Overall Study|Positive urine drug screen|0|||
128711466|NCT04273217|463239904|FG004|Overall Study|Positive urine drug screen|0|||
128711467|NCT04273217|463239905|FG005|Overall Study|Positive urine drug screen|1|||
128711468|NCT00849381|463239906|FG000|Overall Study|Adverse Event|1|||
128711469|NCT00849381|463239906|FG000|Overall Study|Lost to Follow-up|129|||
128711470|NCT00849381|463239906|FG000|Overall Study|Protocol Violation|5|||
128711471|NCT00849381|463239906|FG000|Overall Study|Withdrawal by Subject|6|||
128711472|NCT00849381|463239906|FG000|Overall Study|Other|4|||
128711473|NCT01988103|463239911|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
128711474|NCT01988103|463239912|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
128711475|NCT01988103|463239913|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
128711476|NCT01988103|463239914|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
128711477|NCT01988103|463239915|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
128954206|NCT01280266|464118434|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
128954207|NCT01280266|464118435|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
128954208|NCT01413542|464118440|FG000|Overall Study|Physician Decision|1|||
128954209|NCT01413542|464118441|FG001|Overall Study|Physician Decision|0|||
128954210|NCT01413542|464118442|FG002|Overall Study|Physician Decision|3|||
128954211|NCT01413542|464118443|FG003|Overall Study|Physician Decision|0|||
128954212|NCT01413542|464118440|FG000|Overall Study|Adverse Event|0|||
128954213|NCT01413542|464118441|FG001|Overall Study|Adverse Event|0|||
128954214|NCT01413542|464118442|FG002|Overall Study|Adverse Event|0|||
128954215|NCT01413542|464118443|FG003|Overall Study|Adverse Event|1|||
128954216|NCT02505542|464118444|FG000|Part A: Open-Label Period|Adverse Event|31|||
128954217|NCT02505542|464118445|FG001|Part A: Open-Label Period|Adverse Event|0|||
128954218|NCT02505542|464118446|FG002|Part A: Open-Label Period|Adverse Event|0|||
129125942|NCT03314935|464755598|FG000|Phase 1|Study Terminated by Sponsor|0|||
129125943|NCT03314935|464755599|FG001|Phase 1|Study Terminated by Sponsor|1|||
129125944|NCT03314935|464755600|FG002|Phase 1|Study Terminated by Sponsor|0|||
129125945|NCT03314935|464755601|FG003|Phase 1|Study Terminated by Sponsor|0|||
129125946|NCT03314935|464755602|FG004|Phase 1|Study Terminated by Sponsor|0|||
129125947|NCT03314935|464755603|FG005|Phase 1|Study Terminated by Sponsor|0|||
128711478|NCT01988103|463239911|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
128954219|NCT02505542|464118447|FG003|Part A: Open-Label Period|Adverse Event|0|||
128954220|NCT02505542|464118444|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
128954221|NCT02505542|464118445|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
128954222|NCT02505542|464118446|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
128954223|NCT02505542|464118447|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
128711479|NCT01988103|463239912|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
128711480|NCT01988103|463239913|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
128711481|NCT01988103|463239914|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
128711482|NCT01988103|463239915|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
128711483|NCT01988103|463239911|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
128954224|NCT02505542|464118444|FG000|Part A: Open-Label Period|Protocol Violation|1|||
129125948|NCT03314935|464755604|FG006|Phase 1|Study Terminated by Sponsor|0|||
129125949|NCT03314935|464755605|FG007|Phase 1|Study Terminated by Sponsor|0|||
129125950|NCT03314935|464755606|FG008|Phase 1|Study Terminated by Sponsor|1|||
129035890|NCT01086969|464421604|FG002|Overall Study|Withdrawal by Subject|0|||
129035891|NCT04253236|464421607|FG000|Overall Study|Adverse Event|1|||
129035892|NCT04253236|464421608|FG001|Overall Study|Adverse Event|0|||
129035893|NCT04253236|464421607|FG000|Overall Study|Safety Concerns|1|||
129035894|NCT04253236|464421608|FG001|Overall Study|Safety Concerns|0|||
129035895|NCT04253236|464421607|FG000|Overall Study|Study Terminated by Sponsor|1|||
129035896|NCT04253236|464421608|FG001|Overall Study|Study Terminated by Sponsor|0|||
129035897|NCT00587431|464421609|FG000|Overall Study|Adverse Event|1|||
129035898|NCT00587431|464421610|FG001|Overall Study|Adverse Event|0|||
129035899|NCT00587431|464421609|FG000|Overall Study|Withdrawal by Subject|0|||
129035900|NCT00587431|464421610|FG001|Overall Study|Withdrawal by Subject|1|||
129035901|NCT00585312|464421621|FG000|Overall Study|Adverse Event|3|||
129035902|NCT00585312|464421622|FG001|Overall Study|Adverse Event|0|||
129035903|NCT00585312|464421621|FG000|Overall Study|Lack of Efficacy|6|||
129035904|NCT00585312|464421622|FG001|Overall Study|Lack of Efficacy|11|||
129035905|NCT00585312|464421621|FG000|Overall Study|Lost to Follow-up|1|||
129035906|NCT00585312|464421622|FG001|Overall Study|Lost to Follow-up|1|||
129035907|NCT00585312|464421621|FG000|Overall Study|Reason not specified|2|||
129035908|NCT00585312|464421622|FG001|Overall Study|Reason not specified|0|||
129035909|NCT00585312|464421621|FG000|Overall Study|Withdrawal by Subject|5|||
129035910|NCT00585312|464421622|FG001|Overall Study|Withdrawal by Subject|1|||
129035911|NCT00585312|464421621|FG000|Overall Study|Study terminated by the sponsor|34|||
129035912|NCT00585312|464421622|FG001|Overall Study|Study terminated by the sponsor|31|||
129035913|NCT04291508|464421626|FG000|Overall Study|Withdrawal by Subject|1|||
129035914|NCT04291508|464421627|FG001|Overall Study|Withdrawal by Subject|0|||
129035915|NCT04291508|464421628|FG002|Overall Study|Withdrawal by Subject|1|||
129035916|NCT04291508|464421629|FG003|Overall Study|Withdrawal by Subject|0|||
129035917|NCT04291508|464421626|FG000|Overall Study|lost to follow up|4|||
129035918|NCT04291508|464421627|FG001|Overall Study|lost to follow up|0|||
129035919|NCT04291508|464421628|FG002|Overall Study|lost to follow up|1|||
129035920|NCT04291508|464421629|FG003|Overall Study|lost to follow up|0|||
129035921|NCT03566238|464421630|FG000|Overall Study|Adverse Event|0|||
129035922|NCT03566238|464421631|FG001|Overall Study|Adverse Event|1|||
129035923|NCT03566238|464421632|FG002|Overall Study|Adverse Event|0|||
129035924|NCT03566238|464421630|FG000|Overall Study|Lack of Efficacy|4|||
129035925|NCT03566238|464421631|FG001|Overall Study|Lack of Efficacy|2|||
129035926|NCT03566238|464421632|FG002|Overall Study|Lack of Efficacy|5|||
129035927|NCT03566238|464421630|FG000|Overall Study|Other|1|||
129035928|NCT03566238|464421631|FG001|Overall Study|Other|0|||
129035929|NCT03566238|464421632|FG002|Overall Study|Other|0|||
129035930|NCT04203667|464421640|FG000|Overall Study|Withdrawal by Subject|1|||
129035931|NCT04203667|464421640|FG000|Overall Study|Lost to Follow-up|1|||
129125951|NCT03314935|464755607|FG009|Phase 1|Study Terminated by Sponsor|0|||
129125952|NCT03314935|464755608|FG010|Phase 1|Study Terminated by Sponsor|0|||
129125953|NCT03314935|464755609|FG011|Phase 1|Study Terminated by Sponsor|0|||
129125954|NCT03314935|464755610|FG012|Phase 1|Study Terminated by Sponsor|0|||
129125955|NCT03314935|464755611|FG013|Phase 1|Study Terminated by Sponsor|0|||
129125956|NCT03314935|464755612|FG014|Phase 1|Study Terminated by Sponsor|0|||
129125957|NCT03314935|464755598|FG000|Phase 1|"Captured as Other in Database"|0|||
129125958|NCT03314935|464755599|FG001|Phase 1|"Captured as Other in Database"|2|||
129125959|NCT03314935|464755600|FG002|Phase 1|"Captured as Other in Database"|0|||
129125960|NCT03314935|464755601|FG003|Phase 1|"Captured as Other in Database"|0|||
129125961|NCT03314935|464755602|FG004|Phase 1|"Captured as Other in Database"|0|||
129125962|NCT03314935|464755603|FG005|Phase 1|"Captured as Other in Database"|0|||
129125963|NCT03314935|464755604|FG006|Phase 1|"Captured as Other in Database"|1|||
129125964|NCT03314935|464755605|FG007|Phase 1|"Captured as Other in Database"|1|||
129125965|NCT03314935|464755606|FG008|Phase 1|"Captured as Other in Database"|1|||
129125966|NCT03314935|464755607|FG009|Phase 1|"Captured as Other in Database"|0|||
129125967|NCT03314935|464755608|FG010|Phase 1|"Captured as Other in Database"|0|||
129125968|NCT03314935|464755609|FG011|Phase 1|"Captured as Other in Database"|0|||
129125969|NCT03314935|464755610|FG012|Phase 1|"Captured as Other in Database"|0|||
129125970|NCT03314935|464755611|FG013|Phase 1|"Captured as Other in Database"|0|||
129035932|NCT04203667|464421640|FG000|Overall Study|Death|1|||
129035933|NCT04203667|464421640|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
129035934|NCT01183884|464421641|FG000|Overall Study|Progressive Disease|26|||
129035935|NCT01183884|464421641|FG000|Overall Study|Adverse Event|3|||
129035936|NCT01183884|464421641|FG000|Overall Study|Withdrawal by Subject|1|||
129035937|NCT01183884|464421641|FG000|Overall Study|Other Complicating Disease|3|||
129035938|NCT01183884|464421641|FG000|Overall Study|Not Treated|1|||
129035939|NCT01183884|464421641|FG000|Overall Study|Other|4|||
129035940|NCT00127166|464421642|FG000|Period I|Protocol Violation|0|||
129035941|NCT00127166|464421643|FG001|Period I|Protocol Violation|2|||
129035942|NCT00127166|464421642|FG000|Period I|Withdrawal by Subject|2|||
129035943|NCT00127166|464421643|FG001|Period I|Withdrawal by Subject|0|||
129125971|NCT03314935|464755612|FG014|Phase 1|"Captured as Other in Database"|0|||
129125972|NCT03314935|464755598|FG000|Phase 1|Lost to Follow-up|0|||
129125973|NCT03314935|464755599|FG001|Phase 1|Lost to Follow-up|0|||
129125974|NCT03314935|464755600|FG002|Phase 1|Lost to Follow-up|0|||
128954225|NCT02505542|464118445|FG001|Part A: Open-Label Period|Protocol Violation|0|||
128954226|NCT02505542|464118446|FG002|Part A: Open-Label Period|Protocol Violation|0|||
128954227|NCT02505542|464118447|FG003|Part A: Open-Label Period|Protocol Violation|0|||
128954228|NCT02505542|464118444|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
128711484|NCT01988103|463239912|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
128770580|NCT02960763|463451547|FG002|Step 2|Investigator discretion|0|||
128954229|NCT02505542|464118445|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
128954230|NCT02505542|464118446|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
128954231|NCT02505542|464118447|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
128954232|NCT02505542|464118444|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
129035944|NCT00127166|464421642|FG000|Period I|Patient did not meet inclusion criteria|1|||
129035945|NCT00127166|464421643|FG001|Period I|Patient did not meet inclusion criteria|0|||
129035946|NCT00127166|464421642|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
129035947|NCT00127166|464421643|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
129035948|NCT00127166|464421642|FG000|Period II|Withdrawal by Subject|2|||
129035949|NCT00127166|464421643|FG001|Period II|Withdrawal by Subject|0|||
129035950|NCT00127166|464421642|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
129035951|NCT00127166|464421643|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
129035952|NCT00708682|464421648|FG000|Infant Series|Adverse Event|1|||
129035953|NCT00708682|464421648|FG000|Infant Series|Lost to Follow-up|4|||
129035954|NCT00708682|464421648|FG000|Infant Series|Protocol Violation|1|||
129035955|NCT00708682|464421648|FG000|Infant Series|Parent/legal guardian request|6|||
129035956|NCT00708682|464421648|FG000|Infant Series|Failed to return|2|||
129035957|NCT00708682|464421648|FG000|Infant Series|Other|19|||
129035958|NCT00708682|464421648|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
129035959|NCT00708682|464421648|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
129035960|NCT00708682|464421648|FG000|Toddler Dose|Lost to Follow-up|3|||
129035961|NCT00708682|464421648|FG000|Toddler Dose|Failed to Return|4|||
129035962|NCT03689894|464421650|FG000|Overall Study|Adverse Event|1|||
129035963|NCT01169038|464421659|FG000|Overall Study|Death|1|||
129035964|NCT01169038|464421659|FG000|Overall Study|Adverse Event|5|||
129035965|NCT01169038|464421659|FG000|Overall Study|Required antibiotic administration|1|||
129035966|NCT01634854|464421660|FG000|Overall Study|Cesarean delivery|2|||
129035967|NCT01634854|464421661|FG001|Overall Study|Cesarean delivery|7|||
129035968|NCT01488448|464421662|FG000|Overall Study|Withdrawal by Subject|3|||
129035969|NCT01488448|464421663|FG001|Overall Study|Withdrawal by Subject|1|||
129035970|NCT01488448|464421662|FG000|Overall Study|Adverse Event|9|||
129035971|NCT01488448|464421663|FG001|Overall Study|Adverse Event|4|||
129035972|NCT01488448|464421662|FG000|Overall Study|Physician Decision|4|||
129035973|NCT01488448|464421663|FG001|Overall Study|Physician Decision|9|||
129035974|NCT01488448|464421662|FG000|Overall Study|Protocol Violation|4|||
129035975|NCT01488448|464421663|FG001|Overall Study|Protocol Violation|3|||
129035976|NCT02329431|464421664|FG000|Overall Study|Lost to Follow-up|20|||
129035977|NCT02329431|464421665|FG001|Overall Study|Lost to Follow-up|13|||
129035978|NCT01362296|464421666|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
129035979|NCT01362296|464421667|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
129035980|NCT01362296|464421668|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
129035981|NCT01362296|464421669|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
129035982|NCT01362296|464421666|FG000|Randomized Phase (RP)|Physician Decision|1|||
129035983|NCT01362296|464421667|FG001|Randomized Phase (RP)|Physician Decision|9|||
129035984|NCT01362296|464421668|FG002|Randomized Phase (RP)|Physician Decision|0|||
129035985|NCT01362296|464421669|FG003|Randomized Phase (RP)|Physician Decision|0|||
129035986|NCT01362296|464421666|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
129035987|NCT01362296|464421667|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
129035988|NCT01362296|464421668|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
129035989|NCT01362296|464421669|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
129035990|NCT01362296|464421666|FG000|Randomized Phase (RP)|Adverse Event|20|||
129035991|NCT01362296|464421667|FG001|Randomized Phase (RP)|Adverse Event|4|||
129035992|NCT01362296|464421668|FG002|Randomized Phase (RP)|Adverse Event|0|||
129035993|NCT01362296|464421669|FG003|Randomized Phase (RP)|Adverse Event|0|||
129035994|NCT01362296|464421666|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
129035995|NCT01362296|464421667|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
129035996|NCT01362296|464421668|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
129035997|NCT01362296|464421669|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
129219275|NCT04634253|465103015|FG002|Overall Study|Adverse Event|0|||
129035998|NCT01362296|464421666|FG000|Crossover Phase|PD including Death due to PD|0|||
129035999|NCT01362296|464421667|FG001|Crossover Phase|PD including Death due to PD|0|||
129036000|NCT01362296|464421668|FG002|Crossover Phase|PD including Death due to PD|16|||
129036001|NCT01362296|464421669|FG003|Crossover Phase|PD including Death due to PD|1|||
129036002|NCT01362296|464421666|FG000|Crossover Phase|Withdrawal by Subject|0|||
129036003|NCT01362296|464421667|FG001|Crossover Phase|Withdrawal by Subject|0|||
129036004|NCT01362296|464421668|FG002|Crossover Phase|Withdrawal by Subject|2|||
129036005|NCT01362296|464421669|FG003|Crossover Phase|Withdrawal by Subject|1|||
129036006|NCT01362296|464421666|FG000|Crossover Phase|Adverse Event|0|||
128954233|NCT02505542|464118445|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
128954234|NCT02505542|464118446|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
128954235|NCT02505542|464118447|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
128954236|NCT02505542|464118444|FG000|Part A: Open-Label Period|New medical history available|1|||
128954237|NCT02505542|464118445|FG001|Part A: Open-Label Period|New medical history available|0|||
128954238|NCT02505542|464118446|FG002|Part A: Open-Label Period|New medical history available|0|||
128954239|NCT02505542|464118447|FG003|Part A: Open-Label Period|New medical history available|0|||
128954240|NCT02505542|464118444|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
128954241|NCT02505542|464118445|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
128954242|NCT02505542|464118446|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
128954243|NCT02505542|464118447|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
128954244|NCT02505542|464118444|FG000|Part A: Open-Label Period|Pregnancy|2|||
128954245|NCT02505542|464118445|FG001|Part A: Open-Label Period|Pregnancy|0|||
128954246|NCT02505542|464118446|FG002|Part A: Open-Label Period|Pregnancy|0|||
128954247|NCT02505542|464118447|FG003|Part A: Open-Label Period|Pregnancy|0|||
128954248|NCT02505542|464118444|FG000|Part A: Open-Label Period|Sponsor directive|1|||
128954249|NCT02505542|464118445|FG001|Part A: Open-Label Period|Sponsor directive|0|||
128954250|NCT02505542|464118446|FG002|Part A: Open-Label Period|Sponsor directive|0|||
129125975|NCT03314935|464755601|FG003|Phase 1|Lost to Follow-up|0|||
128954251|NCT02505542|464118447|FG003|Part A: Open-Label Period|Sponsor directive|0|||
129125976|NCT03314935|464755602|FG004|Phase 1|Lost to Follow-up|0|||
129125977|NCT03314935|464755603|FG005|Phase 1|Lost to Follow-up|0|||
129125978|NCT03314935|464755604|FG006|Phase 1|Lost to Follow-up|0|||
129125979|NCT03314935|464755605|FG007|Phase 1|Lost to Follow-up|0|||
129125980|NCT03314935|464755606|FG008|Phase 1|Lost to Follow-up|1|||
129125981|NCT03314935|464755607|FG009|Phase 1|Lost to Follow-up|0|||
128954252|NCT02505542|464118444|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
128954253|NCT02505542|464118445|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
128954254|NCT02505542|464118446|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
128954255|NCT02505542|464118447|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
128954256|NCT02505542|464118444|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
128954257|NCT02505542|464118445|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
128954258|NCT02505542|464118446|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
128954259|NCT02505542|464118447|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
128954260|NCT02505542|464118444|FG000|Part A: Open-Label Period|Non-compliance|1|||
128954261|NCT02505542|464118445|FG001|Part A: Open-Label Period|Non-compliance|0|||
128954262|NCT02505542|464118446|FG002|Part A: Open-Label Period|Non-compliance|0|||
128954263|NCT02505542|464118447|FG003|Part A: Open-Label Period|Non-compliance|0|||
128954264|NCT02505542|464118444|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
128954265|NCT02505542|464118445|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
128954266|NCT02505542|464118446|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
128954267|NCT02505542|464118447|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
128954268|NCT02505542|464118444|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
128954269|NCT02505542|464118445|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
128954270|NCT02505542|464118446|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
128954271|NCT02505542|464118447|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
128954272|NCT02505542|464118444|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
128954273|NCT02505542|464118445|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
128954274|NCT02505542|464118446|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
128954275|NCT02505542|464118447|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
128954276|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Adverse Event|0|||
128954277|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Adverse Event|0|||
128954278|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Adverse Event|1|||
128954279|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Adverse Event|3|||
128954280|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
128954281|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
128954282|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
128954283|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
128954284|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
128954285|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
128954286|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
128954287|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
129125982|NCT03314935|464755608|FG010|Phase 1|Lost to Follow-up|0|||
128954288|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
128954289|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
129125983|NCT03314935|464755609|FG011|Phase 1|Lost to Follow-up|0|||
129125984|NCT03314935|464755610|FG012|Phase 1|Lost to Follow-up|0|||
129125985|NCT03314935|464755611|FG013|Phase 1|Lost to Follow-up|0|||
129125986|NCT03314935|464755612|FG014|Phase 1|Lost to Follow-up|0|||
129125987|NCT03314935|464755598|FG000|Phase 2|Death|0|||
128711485|NCT01988103|463239913|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
128711486|NCT01988103|463239914|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
128711487|NCT01988103|463239915|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
128711488|NCT01988103|463239911|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
128711489|NCT01988103|463239912|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
128711490|NCT01988103|463239913|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
128711491|NCT01988103|463239914|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
128711492|NCT01988103|463239915|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
128711493|NCT01988103|463239911|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
128711494|NCT01988103|463239912|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
128711495|NCT01988103|463239913|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
128711496|NCT01988103|463239914|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
128711497|NCT01988103|463239915|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
128711498|NCT01988103|463239911|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
128954290|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
128711499|NCT01988103|463239912|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
128711500|NCT01988103|463239913|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
128711501|NCT01988103|463239914|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
128711502|NCT01988103|463239915|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
128711503|NCT01988103|463239911|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
128711504|NCT01988103|463239912|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
128711505|NCT01988103|463239913|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
128711506|NCT01988103|463239914|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
128711507|NCT01988103|463239915|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
128711508|NCT02289898|463239916|FG000|Overall Study|Death|5|||
128711509|NCT02289898|463239917|FG001|Overall Study|Death|4|||
128711510|NCT02289898|463239918|FG002|Overall Study|Death|3|||
128711511|NCT02289898|463239916|FG000|Overall Study|Physician Decision|2|||
128711512|NCT02289898|463239917|FG001|Overall Study|Physician Decision|5|||
128711513|NCT02289898|463239918|FG002|Overall Study|Physician Decision|2|||
128954291|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
128954292|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
128954293|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
128954294|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
129219276|NCT04634253|465103013|FG000|Overall Study|Physician Decision|0|||
129219277|NCT04634253|465103014|FG001|Overall Study|Physician Decision|1|||
129219278|NCT04634253|465103015|FG002|Overall Study|Physician Decision|0|||
129219279|NCT04634253|465103013|FG000|Overall Study|Withdrawal by Subject|1|||
129219280|NCT04634253|465103014|FG001|Overall Study|Withdrawal by Subject|0|||
129219281|NCT04634253|465103015|FG002|Overall Study|Withdrawal by Subject|3|||
129219282|NCT01499355|465103016|FG000|Run-In Period|Study Termination|15|||
129219283|NCT01499355|465103017|FG001|Run-In Period|Study Termination|0|||
129219284|NCT01499355|465103018|FG002|Run-In Period|Study Termination|0|||
129219285|NCT01499355|465103019|FG003|Run-In Period|Study Termination|0|||
129219286|NCT01499355|465103016|FG000|Run-In Period|Other|3|||
129219287|NCT01499355|465103017|FG001|Run-In Period|Other|0|||
129219288|NCT01499355|465103018|FG002|Run-In Period|Other|0|||
129219289|NCT01499355|465103019|FG003|Run-In Period|Other|0|||
129219290|NCT01499355|465103016|FG000|Run-In Period|Death|2|||
129219291|NCT01499355|465103017|FG001|Run-In Period|Death|0|||
129219292|NCT01499355|465103018|FG002|Run-In Period|Death|0|||
128711514|NCT02289898|463239916|FG000|Overall Study|Withdrawal by Subject|0|||
128711515|NCT02289898|463239917|FG001|Overall Study|Withdrawal by Subject|4|||
128711516|NCT02289898|463239918|FG002|Overall Study|Withdrawal by Subject|1|||
128711517|NCT02289898|463239916|FG000|Overall Study|Adverse Event|3|||
128711518|NCT02289898|463239917|FG001|Overall Study|Adverse Event|5|||
128711519|NCT02289898|463239918|FG002|Overall Study|Adverse Event|5|||
128711520|NCT02289898|463239916|FG000|Overall Study|Disease progression|34|||
128711521|NCT02289898|463239917|FG001|Overall Study|Disease progression|28|||
128711522|NCT02289898|463239918|FG002|Overall Study|Disease progression|34|||
128711523|NCT02289898|463239916|FG000|Overall Study|Use of another anticancer therapy|0|||
128711524|NCT02289898|463239917|FG001|Overall Study|Use of another anticancer therapy|0|||
128711525|NCT02289898|463239918|FG002|Overall Study|Use of another anticancer therapy|1|||
128954295|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
129219293|NCT01499355|465103019|FG003|Run-In Period|Death|0|||
129219294|NCT01499355|465103016|FG000|Run-In Period|Investigator Decision|2|||
129219295|NCT01499355|465103017|FG001|Run-In Period|Investigator Decision|0|||
129219296|NCT01499355|465103018|FG002|Run-In Period|Investigator Decision|0|||
129219297|NCT01499355|465103019|FG003|Run-In Period|Investigator Decision|0|||
128954296|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
129036007|NCT01362296|464421667|FG001|Crossover Phase|Adverse Event|0|||
129219298|NCT01499355|465103016|FG000|Run-In Period|Consent Withdrawn|1|||
128954297|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
128954298|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
128954299|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
128954300|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
128954301|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
128954302|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
128954303|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
128954304|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Miscalculation|0|||
128954305|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Miscalculation|1|||
128954306|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Miscalculation|0|||
128954307|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Miscalculation|0|||
128954308|NCT02505542|464118444|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
128954309|NCT02505542|464118445|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
128954310|NCT02505542|464118446|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
128954311|NCT02505542|464118447|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
128954312|NCT01522443|464118450|FG000|Overall Study|No longer receiving clinical benefit|36|||
128954313|NCT01522443|464118451|FG001|Overall Study|No longer receiving clinical benefit|28|||
128954314|NCT01522443|464118450|FG000|Overall Study|Adverse Event|10|||
128954315|NCT01522443|464118451|FG001|Overall Study|Adverse Event|15|||
128954316|NCT01522443|464118450|FG000|Overall Study|Withdrawal by Subject|5|||
128954317|NCT01522443|464118451|FG001|Overall Study|Withdrawal by Subject|8|||
128954318|NCT01522443|464118450|FG000|Overall Study|No study treatment given|1|||
128954319|NCT01522443|464118451|FG001|Overall Study|No study treatment given|1|||
128954320|NCT01522443|464118450|FG000|Overall Study|Other|1|||
128954321|NCT01522443|464118451|FG001|Overall Study|Other|3|||
128954322|NCT05590767|464118454|FG000|Overall Study|Protocol Violation|1|||
128954323|NCT05590767|464118454|FG000|Overall Study|surgery canceled|1|||
128954324|NCT05590767|464118454|FG000|Overall Study|interscalene brachial block not performed|1|||
128954325|NCT01764256|464118455|FG000|Received All Vaccinations|Adverse Event|1|||
128954326|NCT01764256|464118456|FG001|Received All Vaccinations|Adverse Event|1|||
128954327|NCT01764256|464118457|FG002|Received All Vaccinations|Adverse Event|0|||
128954328|NCT01764256|464118458|FG003|Received All Vaccinations|Adverse Event|0|||
128954329|NCT01764256|464118455|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
128954330|NCT01764256|464118456|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
128954331|NCT01764256|464118457|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
128954332|NCT01764256|464118458|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
128954333|NCT01764256|464118455|FG000|Received All Vaccinations|Lost to Follow-up|1|||
128954334|NCT01764256|464118456|FG001|Received All Vaccinations|Lost to Follow-up|0|||
128954335|NCT01764256|464118457|FG002|Received All Vaccinations|Lost to Follow-up|0|||
128954336|NCT01764256|464118458|FG003|Received All Vaccinations|Lost to Follow-up|0|||
128954337|NCT01764256|464118455|FG000|Completed Study|Lost to Follow-up|0|||
128954338|NCT01764256|464118456|FG001|Completed Study|Lost to Follow-up|0|||
128954339|NCT01764256|464118457|FG002|Completed Study|Lost to Follow-up|0|||
128954340|NCT01764256|464118458|FG003|Completed Study|Lost to Follow-up|1|||
128954341|NCT00776555|464118468|FG000|Overall Study|Study terminated|3|||
128954342|NCT00776555|464118469|FG001|Overall Study|Study terminated|0|||
128954343|NCT03483116|464118472|FG000|Overall Study|Adverse Event|0|||
128954344|NCT03483116|464118473|FG001|Overall Study|Adverse Event|1|||
128954345|NCT03483116|464118474|FG002|Overall Study|Adverse Event|0|||
128954346|NCT03483116|464118475|FG003|Overall Study|Adverse Event|1|||
128954347|NCT03483116|464118472|FG000|Overall Study|Protocol Violation|1|||
128954348|NCT03483116|464118473|FG001|Overall Study|Protocol Violation|0|||
128954349|NCT03483116|464118474|FG002|Overall Study|Protocol Violation|0|||
128954350|NCT03483116|464118475|FG003|Overall Study|Protocol Violation|7|||
128954351|NCT03483116|464118472|FG000|Overall Study|Lost to Follow-up|9|||
128954352|NCT03483116|464118473|FG001|Overall Study|Lost to Follow-up|4|||
128954353|NCT03483116|464118474|FG002|Overall Study|Lost to Follow-up|9|||
128954354|NCT03483116|464118475|FG003|Overall Study|Lost to Follow-up|5|||
128954355|NCT03483116|464118472|FG000|Overall Study|Death|1|||
128954356|NCT03483116|464118473|FG001|Overall Study|Death|0|||
128954357|NCT03483116|464118474|FG002|Overall Study|Death|2|||
128954358|NCT03483116|464118475|FG003|Overall Study|Death|1|||
128954359|NCT03483116|464118472|FG000|Overall Study|Withdrawal by Subject|14|||
128954360|NCT03483116|464118473|FG001|Overall Study|Withdrawal by Subject|16|||
128954361|NCT03483116|464118474|FG002|Overall Study|Withdrawal by Subject|14|||
128954362|NCT03483116|464118475|FG003|Overall Study|Withdrawal by Subject|16|||
129036008|NCT01362296|464421668|FG002|Crossover Phase|Adverse Event|4|||
128954363|NCT03483116|464118472|FG000|Overall Study|Unknown other reason|3|||
128954364|NCT03483116|464118473|FG001|Overall Study|Unknown other reason|2|||
128954365|NCT03483116|464118474|FG002|Overall Study|Unknown other reason|1|||
128954366|NCT03483116|464118475|FG003|Overall Study|Unknown other reason|1|||
128954367|NCT01181102|464118476|FG000|Overall Study|Adverse Event|28|||
128954368|NCT01181102|464118477|FG001|Overall Study|Adverse Event|26|||
128954369|NCT01181102|464118476|FG000|Overall Study|Lack of Efficacy|3|||
129036009|NCT01362296|464421669|FG003|Crossover Phase|Adverse Event|0|||
128954370|NCT01181102|464118477|FG001|Overall Study|Lack of Efficacy|1|||
128954371|NCT01181102|464118476|FG000|Overall Study|Lost to Follow-up|2|||
128954372|NCT01181102|464118477|FG001|Overall Study|Lost to Follow-up|0|||
128954373|NCT01181102|464118476|FG000|Overall Study|Physician Decision|3|||
128954374|NCT01181102|464118477|FG001|Overall Study|Physician Decision|1|||
128954375|NCT01181102|464118476|FG000|Overall Study|Protocol Violation|5|||
128954376|NCT01181102|464118477|FG001|Overall Study|Protocol Violation|6|||
128954377|NCT01181102|464118476|FG000|Overall Study|Withdrawal by Subject|10|||
128954378|NCT01181102|464118477|FG001|Overall Study|Withdrawal by Subject|12|||
128954379|NCT04685499|464118480|FG000|Overall Study|Study Terminated Early|1|||
128954380|NCT03176277|464118481|FG000|Part A Dose Escalation Study|Adverse Event|1|||
128954381|NCT03176277|464118482|FG001|Part A Dose Escalation Study|Adverse Event|0|||
128954382|NCT03176277|464118483|FG002|Part A Dose Escalation Study|Adverse Event|1|||
128954383|NCT03176277|464118484|FG003|Part A Dose Escalation Study|Adverse Event|0|||
128954384|NCT03176277|464118481|FG000|Part A Dose Escalation Study|Physician Decision|1|||
128954385|NCT03176277|464118482|FG001|Part A Dose Escalation Study|Physician Decision|1|||
128954386|NCT03176277|464118483|FG002|Part A Dose Escalation Study|Physician Decision|2|||
128954387|NCT03176277|464118484|FG003|Part A Dose Escalation Study|Physician Decision|0|||
128954388|NCT03176277|464118481|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
128954389|NCT03176277|464118482|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
128954390|NCT03176277|464118483|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
128954391|NCT03176277|464118484|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
128954392|NCT03176277|464118481|FG000|Part A Dose Escalation Study|Progressive disease|3|||
128954393|NCT03176277|464118482|FG001|Part A Dose Escalation Study|Progressive disease|1|||
128954394|NCT03176277|464118483|FG002|Part A Dose Escalation Study|Progressive disease|3|||
128954395|NCT03176277|464118484|FG003|Part A Dose Escalation Study|Progressive disease|0|||
128954396|NCT00634114|464118485|FG000|Overall Study|Adverse Event|6|||
128954397|NCT00634114|464118486|FG001|Overall Study|Adverse Event|8|||
128954398|NCT00634114|464118487|FG002|Overall Study|Adverse Event|3|||
128954399|NCT00634114|464118485|FG000|Overall Study|Withdrawal by Subject|9|||
128954400|NCT00634114|464118486|FG001|Overall Study|Withdrawal by Subject|6|||
128954401|NCT00634114|464118487|FG002|Overall Study|Withdrawal by Subject|11|||
128954402|NCT00634114|464118485|FG000|Overall Study|Lost to Follow-up|0|||
128954403|NCT00634114|464118486|FG001|Overall Study|Lost to Follow-up|0|||
128954404|NCT00634114|464118487|FG002|Overall Study|Lost to Follow-up|1|||
128954405|NCT00634114|464118485|FG000|Overall Study|Protocol Violation|3|||
128954406|NCT00634114|464118486|FG001|Overall Study|Protocol Violation|3|||
128954407|NCT00634114|464118487|FG002|Overall Study|Protocol Violation|1|||
128954408|NCT00634114|464118485|FG000|Overall Study|Pregnancy|1|||
128954409|NCT00634114|464118486|FG001|Overall Study|Pregnancy|0|||
128954410|NCT00634114|464118487|FG002|Overall Study|Pregnancy|0|||
128954411|NCT00634114|464118485|FG000|Overall Study|Incorrect enrolment|0|||
128954412|NCT00634114|464118486|FG001|Overall Study|Incorrect enrolment|1|||
128954413|NCT00634114|464118487|FG002|Overall Study|Incorrect enrolment|0|||
128954414|NCT00634114|464118485|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
128954415|NCT00634114|464118486|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
128954416|NCT00634114|464118487|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
128954417|NCT00634114|464118485|FG000|Overall Study|Difficult to continue|3|||
128954418|NCT00634114|464118486|FG001|Overall Study|Difficult to continue|1|||
128954419|NCT00634114|464118487|FG002|Overall Study|Difficult to continue|1|||
128954420|NCT00634114|464118485|FG000|Overall Study|Other reason|1|||
128954421|NCT00634114|464118486|FG001|Overall Study|Other reason|1|||
128711526|NCT02289898|463239916|FG000|Overall Study|Other|8|||
128954422|NCT00634114|464118487|FG002|Overall Study|Other reason|1|||
128954423|NCT00585923|464118488|FG000|Overall Study|Physician decided not to continue|31|||
128954424|NCT00585923|464118489|FG001|Overall Study|Physician decided not to continue|33|||
128954425|NCT00618449|464118490|FG000|Overall Study|Lost to Follow-up|98|||
128954426|NCT00618449|464118491|FG001|Overall Study|Lost to Follow-up|110|||
128954427|NCT01441115|464118492|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
128954428|NCT01681576|464118497|FG000|Period 1|Adverse Event|1|||
128954429|NCT01681576|464118498|FG001|Period 1|Adverse Event|0|||
128954430|NCT01681576|464118497|FG000|Period 1|Protocol Deviation|1|||
128954431|NCT01681576|464118498|FG001|Period 1|Protocol Deviation|0|||
128711527|NCT02289898|463239917|FG001|Overall Study|Other|7|||
128954432|NCT01681576|464118497|FG000|Period 2|subject/guardian decision|3|||
128954433|NCT01681576|464118498|FG001|Period 2|subject/guardian decision|1|||
129125988|NCT03314935|464755599|FG001|Phase 2|Death|0|||
128711528|NCT02289898|463239918|FG002|Overall Study|Other|10|||
129125989|NCT03314935|464755600|FG002|Phase 2|Death|0|||
129125990|NCT03314935|464755601|FG003|Phase 2|Death|0|||
129125991|NCT03314935|464755602|FG004|Phase 2|Death|0|||
129125992|NCT03314935|464755603|FG005|Phase 2|Death|0|||
129125993|NCT03314935|464755604|FG006|Phase 2|Death|0|||
129125994|NCT03314935|464755605|FG007|Phase 2|Death|0|||
129125995|NCT03314935|464755606|FG008|Phase 2|Death|0|||
129125996|NCT03314935|464755607|FG009|Phase 2|Death|5|||
129125997|NCT03314935|464755608|FG010|Phase 2|Death|20|||
129125998|NCT03314935|464755609|FG011|Phase 2|Death|6|||
129125999|NCT03314935|464755610|FG012|Phase 2|Death|7|||
128954434|NCT01681576|464118497|FG000|Period 2|Non-compliance with study treatment|1|||
128954435|NCT01681576|464118498|FG001|Period 2|Non-compliance with study treatment|0|||
128954436|NCT04111107|464118503|FG000|Overall Study|Withdrawal by Subject|6|||
128954437|NCT04111107|464118503|FG000|Overall Study|Declining Health|5|||
128954438|NCT02260648|464118504|FG000|Overall Study|Adverse Event|3|||
128954439|NCT02260648|464118505|FG001|Overall Study|Adverse Event|0|||
128954440|NCT02260648|464118506|FG002|Overall Study|Adverse Event|1|||
128954441|NCT02260648|464118504|FG000|Overall Study|Withdrawal by Subject|1|||
128954442|NCT02260648|464118505|FG001|Overall Study|Withdrawal by Subject|1|||
128954443|NCT02260648|464118506|FG002|Overall Study|Withdrawal by Subject|0|||
128954444|NCT02260648|464118504|FG000|Overall Study|Protocol Violation|1|||
128954445|NCT02260648|464118505|FG001|Overall Study|Protocol Violation|0|||
128954446|NCT02260648|464118506|FG002|Overall Study|Protocol Violation|0|||
128954447|NCT02260648|464118504|FG000|Overall Study|Discontinue Due to Study Termination|13|||
128954448|NCT02260648|464118505|FG001|Overall Study|Discontinue Due to Study Termination|12|||
128954449|NCT02260648|464118506|FG002|Overall Study|Discontinue Due to Study Termination|7|||
128954450|NCT00986427|464118507|FG000|Overall Study|Lost to Follow-up|2|||
128954451|NCT00986427|464118508|FG001|Overall Study|Lost to Follow-up|0|||
128954452|NCT00986427|464118507|FG000|Overall Study|Lack of Efficacy|1|||
128954453|NCT00986427|464118508|FG001|Overall Study|Lack of Efficacy|0|||
128954454|NCT00986427|464118507|FG000|Overall Study|Withdrawal by Subject|1|||
128954455|NCT00986427|464118508|FG001|Overall Study|Withdrawal by Subject|0|||
128954456|NCT01871896|464118512|FG000|Overall Study|Lost to Follow-up|1|||
128954457|NCT05691829|464119962|FG000|Overall Study|Physician Decision|2|||
128954458|NCT05691829|464119962|FG000|Overall Study|Eligibility criteria not met|3|||
128954459|NCT00453180|464119967|FG000|Overall Study|Lost to Follow-up|2|||
128954460|NCT00453180|464119968|FG001|Overall Study|Lost to Follow-up|1|||
128954461|NCT00453180|464119967|FG000|Overall Study|Adverse Event|1|||
128954462|NCT00453180|464119968|FG001|Overall Study|Adverse Event|2|||
128954463|NCT02420795|464119975|FG000|Overall Study|Withdrawal by Subject|1|||
128954464|NCT02420795|464119976|FG001|Overall Study|Withdrawal by Subject|0|||
128954465|NCT02420795|464119977|FG002|Overall Study|Withdrawal by Subject|0|||
128954466|NCT02420795|464119975|FG000|Overall Study|Adverse Event|1|||
128954467|NCT02420795|464119976|FG001|Overall Study|Adverse Event|0|||
129219299|NCT01499355|465103017|FG001|Run-In Period|Consent Withdrawn|0|||
128954468|NCT02420795|464119977|FG002|Overall Study|Adverse Event|0|||
128954469|NCT02420795|464119975|FG000|Overall Study|Progressive disease|2|||
128954470|NCT02420795|464119976|FG001|Overall Study|Progressive disease|2|||
128954471|NCT02420795|464119977|FG002|Overall Study|Progressive disease|4|||
128954472|NCT02420795|464119975|FG000|Overall Study|Death|0|||
128954473|NCT02420795|464119976|FG001|Overall Study|Death|0|||
128954474|NCT02420795|464119977|FG002|Overall Study|Death|1|||
128954475|NCT01002742|464119980|FG000|Overall Study|Determined to be ineligible|0|||
128954476|NCT01002742|464119981|FG001|Overall Study|Determined to be ineligible|1|||
128954477|NCT02862548|464119993|FG000|Randomized Phase (Up to Week 48)|Death|0|||
128954478|NCT02862548|464119994|FG001|Randomized Phase (Up to Week 48)|Death|1|||
128954479|NCT02862548|464119993|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
128954480|NCT02862548|464119994|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
128954481|NCT02862548|464119993|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
128954482|NCT02862548|464119994|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
128954483|NCT02862548|464119993|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
128954484|NCT02862548|464119994|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
128954485|NCT00880763|464119995|FG000|Extension Period (Part 2)|Adverse Event|0|||
128954486|NCT00880763|464119996|FG001|Extension Period (Part 2)|Adverse Event|0|||
128954487|NCT00880763|464119997|FG002|Extension Period (Part 2)|Adverse Event|1|||
128954488|NCT00880763|464119998|FG003|Extension Period (Part 2)|Adverse Event|1|||
128954489|NCT00880763|464119995|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
128954490|NCT00880763|464119996|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
128954491|NCT00880763|464119997|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
128954492|NCT00880763|464119998|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
128954493|NCT00880763|464119995|FG000|Extension Period (Part 2)|Physician Decision|0|||
128954494|NCT00880763|464119996|FG001|Extension Period (Part 2)|Physician Decision|1|||
128954495|NCT00880763|464119997|FG002|Extension Period (Part 2)|Physician Decision|1|||
128954496|NCT00880763|464119998|FG003|Extension Period (Part 2)|Physician Decision|0|||
128954497|NCT00880763|464119995|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
128954498|NCT00880763|464119996|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
129036010|NCT01362296|464421666|FG000|Crossover Phase|Study Closed/Terminated|0|||
129036011|NCT01362296|464421667|FG001|Crossover Phase|Study Closed/Terminated|0|||
129036012|NCT01362296|464421668|FG002|Crossover Phase|Study Closed/Terminated|1|||
129036013|NCT01362296|464421669|FG003|Crossover Phase|Study Closed/Terminated|0|||
129036014|NCT02625974|464421671|FG000|Part 1|Lost to Follow-up|9|||
129036015|NCT02625974|464421672|FG001|Part 1|Lost to Follow-up|3|||
129036016|NCT02625974|464421671|FG000|Part 2|Lost to Follow-up|4|||
129036017|NCT02625974|464421672|FG001|Part 2|Lost to Follow-up|6|||
129036018|NCT02625974|464421671|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
129219300|NCT01499355|465103018|FG002|Run-In Period|Consent Withdrawn|0|||
129036019|NCT02625974|464421672|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
129036020|NCT00434590|464421673|FG000|Overall Study|Administrative problems|5|||
129036021|NCT00434590|464421674|FG001|Overall Study|Administrative problems|5|||
129036022|NCT04149535|464421676|FG000|Overall Study|Death|11|||
129036023|NCT04149535|464421677|FG001|Overall Study|Death|7|||
129036024|NCT04149535|464421676|FG000|Overall Study|Physician Decision|10|||
129036025|NCT04149535|464421677|FG001|Overall Study|Physician Decision|4|||
129036026|NCT04149535|464421676|FG000|Overall Study|Withdrawal by Subject|6|||
129036027|NCT04149535|464421677|FG001|Overall Study|Withdrawal by Subject|7|||
129036028|NCT04149535|464421676|FG000|Overall Study|Not described|2|||
129036029|NCT04149535|464421677|FG001|Overall Study|Not described|0|||
129036030|NCT02175368|464421678|FG000|Overall Study|Lost to Follow-up|1|||
129036031|NCT02875028|464421679|FG000|Washout Period|Withdrawal by Subject|0|||
129036032|NCT02875028|464421680|FG001|Washout Period|Withdrawal by Subject|1|||
129036033|NCT02426541|464423367|FG000|Overall Study|Protocol Violation|1|||
129036034|NCT02426541|464423368|FG001|Overall Study|Protocol Violation|0|||
129036035|NCT02674633|464423369|FG000|Overall Study|Lost to Follow-up|3|||
129036036|NCT02674633|464423370|FG001|Overall Study|Lost to Follow-up|2|||
129036037|NCT02674633|464423369|FG000|Overall Study|Physician Decision|1|||
129036038|NCT02674633|464423370|FG001|Overall Study|Physician Decision|0|||
129036039|NCT02674633|464423369|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129036040|NCT02674633|464423370|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129036041|NCT00460109|464423371|FG000|Overall Study|Death|1|||
129036042|NCT05996198|464423372|FG000|Overall Study|Withdrawal by Subject|1|||
129036043|NCT05996198|464423373|FG001|Overall Study|Withdrawal by Subject|0|||
129036044|NCT02014441|464423374|FG000|Overall Study|Withdrawal by Subject|12|||
129036045|NCT04412057|464423376|FG000|Overall Study|Death|3|||
129036046|NCT04412057|464423377|FG001|Overall Study|Death|7|||
129036047|NCT04412057|464423376|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
129036048|NCT04412057|464423377|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
129126000|NCT03314935|464755611|FG013|Phase 2|Death|6|||
129126001|NCT03314935|464755612|FG014|Phase 2|Death|17|||
129126002|NCT03314935|464755598|FG000|Phase 2|Withdrawal by Subject|0|||
129126003|NCT03314935|464755599|FG001|Phase 2|Withdrawal by Subject|0|||
129126004|NCT03314935|464755600|FG002|Phase 2|Withdrawal by Subject|0|||
129126005|NCT03314935|464755601|FG003|Phase 2|Withdrawal by Subject|0|||
129126006|NCT03314935|464755602|FG004|Phase 2|Withdrawal by Subject|0|||
128711529|NCT01828281|463239919|FG000|Overall Study|Withdrawal by Subject|1|||
128711530|NCT01828281|463239920|FG001|Overall Study|Withdrawal by Subject|0|||
128711531|NCT02611778|463239921|FG000|Overall Study|Withdrawal by Subject|2|||
128711532|NCT02611778|463239922|FG001|Overall Study|Withdrawal by Subject|8|||
128711533|NCT02611778|463239921|FG000|Overall Study|Adverse Event|1|||
128711534|NCT02611778|463239922|FG001|Overall Study|Adverse Event|2|||
129126007|NCT03314935|464755603|FG005|Phase 2|Withdrawal by Subject|0|||
129126008|NCT03314935|464755604|FG006|Phase 2|Withdrawal by Subject|0|||
129126009|NCT03314935|464755605|FG007|Phase 2|Withdrawal by Subject|0|||
129126010|NCT03314935|464755606|FG008|Phase 2|Withdrawal by Subject|0|||
129126011|NCT03314935|464755607|FG009|Phase 2|Withdrawal by Subject|1|||
129126012|NCT03314935|464755608|FG010|Phase 2|Withdrawal by Subject|4|||
129126013|NCT03314935|464755609|FG011|Phase 2|Withdrawal by Subject|0|||
129126014|NCT03314935|464755610|FG012|Phase 2|Withdrawal by Subject|1|||
129126015|NCT03314935|464755611|FG013|Phase 2|Withdrawal by Subject|0|||
129126016|NCT03314935|464755612|FG014|Phase 2|Withdrawal by Subject|1|||
129126017|NCT03314935|464755598|FG000|Phase 2|Progressive Disease|0|||
129126018|NCT03314935|464755599|FG001|Phase 2|Progressive Disease|0|||
129126019|NCT03314935|464755600|FG002|Phase 2|Progressive Disease|0|||
129126020|NCT03314935|464755601|FG003|Phase 2|Progressive Disease|0|||
129126021|NCT03314935|464755602|FG004|Phase 2|Progressive Disease|0|||
129126022|NCT03314935|464755603|FG005|Phase 2|Progressive Disease|0|||
129126023|NCT03314935|464755604|FG006|Phase 2|Progressive Disease|0|||
129126024|NCT03314935|464755605|FG007|Phase 2|Progressive Disease|0|||
129126025|NCT03314935|464755606|FG008|Phase 2|Progressive Disease|0|||
129126026|NCT03314935|464755607|FG009|Phase 2|Progressive Disease|1|||
129126027|NCT03314935|464755608|FG010|Phase 2|Progressive Disease|1|||
129126028|NCT03314935|464755609|FG011|Phase 2|Progressive Disease|1|||
129126029|NCT03314935|464755610|FG012|Phase 2|Progressive Disease|2|||
129036049|NCT01091103|464423387|FG000|Overall Study|Adverse Event|1|||
129036050|NCT01091103|464423387|FG000|Overall Study|Progressive Disease|3|||
129036051|NCT03449199|464423388|FG000|Overall Study|Lost to Follow-up|1|||
129036052|NCT03449199|464423389|FG001|Overall Study|Lost to Follow-up|1|||
129126030|NCT03314935|464755611|FG013|Phase 2|Progressive Disease|0|||
129126031|NCT03314935|464755612|FG014|Phase 2|Progressive Disease|1|||
129126032|NCT03314935|464755598|FG000|Phase 2|Study Terminated by Sponsor|0|||
129126033|NCT03314935|464755599|FG001|Phase 2|Study Terminated by Sponsor|0|||
129036053|NCT03449199|464423390|FG002|Overall Study|Lost to Follow-up|0|||
129036054|NCT03449199|464423388|FG000|Overall Study|Protocol Deviation|0|||
129126034|NCT03314935|464755600|FG002|Phase 2|Study Terminated by Sponsor|0|||
129126035|NCT03314935|464755601|FG003|Phase 2|Study Terminated by Sponsor|0|||
128711535|NCT02611778|463239921|FG000|Overall Study|Death|2|||
128954499|NCT00880763|464119997|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
128954500|NCT00880763|464119998|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
128954501|NCT00656084|464119999|FG000|Overall Study|Adverse Event|4|||
128954502|NCT00656084|464119999|FG000|Overall Study|Withdrawal by Subject|1|||
128954503|NCT00656084|464119999|FG000|Overall Study|Patient Request|1|||
128954504|NCT00656084|464119999|FG000|Overall Study|Investigator Request|1|||
128954505|NCT01293006|464120000|FG000|Period 2|Lost to Follow-up|1|||
128954506|NCT01293006|464120001|FG001|Period 2|Lost to Follow-up|0|||
128954507|NCT01293006|464120002|FG002|Period 2|Lost to Follow-up|0|||
128954508|NCT01293006|464120003|FG003|Period 2|Lost to Follow-up|0|||
128954509|NCT01494987|464120004|FG000|Overall Study|Adverse Event|6|||
128954510|NCT01494987|464120005|FG001|Overall Study|Adverse Event|5|||
128954511|NCT01494987|464120004|FG000|Overall Study|Hyperglycemia|6|||
128954512|NCT01494987|464120005|FG001|Overall Study|Hyperglycemia|4|||
128954513|NCT01494987|464120004|FG000|Overall Study|Investigator's Discretion|1|||
128954514|NCT01494987|464120005|FG001|Overall Study|Investigator's Discretion|2|||
128954515|NCT01494987|464120004|FG000|Overall Study|Lost to Follow-up|1|||
128954516|NCT01494987|464120005|FG001|Overall Study|Lost to Follow-up|1|||
128954517|NCT01494987|464120004|FG000|Overall Study|Protocol Violation|3|||
128954518|NCT01494987|464120005|FG001|Overall Study|Protocol Violation|3|||
128954519|NCT01494987|464120004|FG000|Overall Study|Subject Non-Compliance|9|||
128954520|NCT01494987|464120005|FG001|Overall Study|Subject Non-Compliance|10|||
128954521|NCT01494987|464120004|FG000|Overall Study|Subject Withdrew Consent|2|||
128954522|NCT01494987|464120005|FG001|Overall Study|Subject Withdrew Consent|3|||
128954523|NCT00436982|464120008|FG000|Overall Study|Withdrawal by Subject|3|||
128954524|NCT00436982|464120009|FG001|Overall Study|Withdrawal by Subject|1|||
128954525|NCT00436982|464120008|FG000|Overall Study|Did not receive allocated intervention|0|||
128954526|NCT00436982|464120009|FG001|Overall Study|Did not receive allocated intervention|1|||
128954527|NCT00436982|464120008|FG000|Overall Study|no RSA data|1|||
128954528|NCT00436982|464120009|FG001|Overall Study|no RSA data|2|||
128954529|NCT00953225|464120013|FG000|Overall Study|Withdrawal by Subject|2|||
128954530|NCT00953225|464120014|FG001|Overall Study|Withdrawal by Subject|0|||
128954531|NCT00640146|464120016|FG000|Overall Study|Adverse Event|2|||
128954532|NCT00640146|464120017|FG001|Overall Study|Adverse Event|0|||
128954533|NCT00640146|464120016|FG000|Overall Study|Lost to Follow-up|0|||
128954534|NCT00640146|464120017|FG001|Overall Study|Lost to Follow-up|1|||
128954535|NCT00640146|464120016|FG000|Overall Study|Lack of Efficacy|0|||
128954536|NCT00640146|464120017|FG001|Overall Study|Lack of Efficacy|1|||
128954537|NCT00640146|464120016|FG000|Overall Study|Withdrawal by Subject|1|||
128954538|NCT00640146|464120017|FG001|Overall Study|Withdrawal by Subject|1|||
128954539|NCT00640146|464120016|FG000|Overall Study|Randomized but not treated|1|||
128954540|NCT00640146|464120017|FG001|Overall Study|Randomized but not treated|3|||
128954541|NCT04058158|464120020|FG000|Period 1|Death|1|||
128954542|NCT04058158|464120021|FG001|Period 1|Death|0|||
129036055|NCT03449199|464423389|FG001|Overall Study|Protocol Deviation|0|||
128954543|NCT04058158|464120020|FG000|Period 1|Adverse Event|1|||
128954544|NCT04058158|464120021|FG001|Period 1|Adverse Event|1|||
128954545|NCT04058158|464120020|FG000|Period 1|Pregnancy|0|||
128954546|NCT04058158|464120021|FG001|Period 1|Pregnancy|1|||
128954547|NCT04847141|464120022|FG000|Overall Study|Adverse Event|1|||
128954548|NCT04847141|464120023|FG001|Overall Study|Adverse Event|0|||
128954549|NCT04847141|464120024|FG002|Overall Study|Adverse Event|1|||
128954550|NCT04847141|464120022|FG000|Overall Study|Withdrawal by Subject|2|||
128954551|NCT04847141|464120023|FG001|Overall Study|Withdrawal by Subject|4|||
128954552|NCT04847141|464120024|FG002|Overall Study|Withdrawal by Subject|3|||
128954553|NCT04847141|464120022|FG000|Overall Study|Lost to Follow-up|7|||
128954554|NCT04847141|464120023|FG001|Overall Study|Lost to Follow-up|5|||
128954555|NCT04847141|464120024|FG002|Overall Study|Lost to Follow-up|7|||
128954556|NCT04847141|464120022|FG000|Overall Study|Reason not Specified|0|||
128954557|NCT04847141|464120023|FG001|Overall Study|Reason not Specified|1|||
128954558|NCT04847141|464120024|FG002|Overall Study|Reason not Specified|0|||
128954559|NCT02215616|464120025|FG000|Overall Study|Sponsor requested to stop study drug|0|||
128954560|NCT02215616|464120026|FG001|Overall Study|Sponsor requested to stop study drug|0|||
128954561|NCT02215616|464120027|FG002|Overall Study|Sponsor requested to stop study drug|1|||
128954562|NCT02215616|464120028|FG003|Overall Study|Sponsor requested to stop study drug|4|||
128954563|NCT02215616|464120025|FG000|Overall Study|Death|1|||
128954564|NCT02215616|464120026|FG001|Overall Study|Death|0|||
128954565|NCT02215616|464120027|FG002|Overall Study|Death|0|||
128954566|NCT02215616|464120028|FG003|Overall Study|Death|0|||
128954567|NCT02215616|464120025|FG000|Overall Study|Adverse Event|7|||
128954568|NCT02215616|464120026|FG001|Overall Study|Adverse Event|4|||
128954569|NCT02215616|464120027|FG002|Overall Study|Adverse Event|9|||
128954570|NCT02215616|464120028|FG003|Overall Study|Adverse Event|2|||
128954571|NCT02215616|464120025|FG000|Overall Study|Withdrawal by Subject|1|||
128954572|NCT02215616|464120026|FG001|Overall Study|Withdrawal by Subject|8|||
128954573|NCT02215616|464120027|FG002|Overall Study|Withdrawal by Subject|2|||
128954574|NCT02215616|464120028|FG003|Overall Study|Withdrawal by Subject|5|||
128954575|NCT02215616|464120025|FG000|Overall Study|Non-compliance|0|||
128954576|NCT02215616|464120026|FG001|Overall Study|Non-compliance|2|||
128954577|NCT02215616|464120027|FG002|Overall Study|Non-compliance|1|||
128954578|NCT02215616|464120028|FG003|Overall Study|Non-compliance|0|||
128954579|NCT02215616|464120025|FG000|Overall Study|Protocol Violation|0|||
128954580|NCT02215616|464120026|FG001|Overall Study|Protocol Violation|2|||
128954581|NCT02215616|464120027|FG002|Overall Study|Protocol Violation|0|||
128954582|NCT02215616|464120028|FG003|Overall Study|Protocol Violation|0|||
128954583|NCT02215616|464120025|FG000|Overall Study|Lost to Follow-up|1|||
128954584|NCT02215616|464120026|FG001|Overall Study|Lost to Follow-up|1|||
128954585|NCT02215616|464120027|FG002|Overall Study|Lost to Follow-up|0|||
128954586|NCT02215616|464120028|FG003|Overall Study|Lost to Follow-up|1|||
128954587|NCT02215616|464120025|FG000|Overall Study|Other than specified|1|||
129219301|NCT01499355|465103019|FG003|Run-In Period|Consent Withdrawn|0|||
129219302|NCT01499355|465103016|FG000|Run-In Period|Adverse Event|8|||
129219303|NCT01499355|465103017|FG001|Run-In Period|Adverse Event|0|||
129219304|NCT01499355|465103018|FG002|Run-In Period|Adverse Event|0|||
129219305|NCT01499355|465103019|FG003|Run-In Period|Adverse Event|0|||
129219306|NCT01499355|465103016|FG000|Double-Blind Period|Adverse Event|0|||
129219307|NCT01499355|465103017|FG001|Double-Blind Period|Adverse Event|2|||
129219308|NCT01499355|465103018|FG002|Double-Blind Period|Adverse Event|3|||
129219309|NCT01499355|465103019|FG003|Double-Blind Period|Adverse Event|2|||
129219310|NCT01499355|465103016|FG000|Double-Blind Period|Study Termination|0|||
129219311|NCT01499355|465103017|FG001|Double-Blind Period|Study Termination|18|||
129219312|NCT01499355|465103018|FG002|Double-Blind Period|Study Termination|16|||
129219313|NCT01499355|465103019|FG003|Double-Blind Period|Study Termination|14|||
129219314|NCT01499355|465103016|FG000|Double-Blind Period|Other|0|||
129219315|NCT01499355|465103017|FG001|Double-Blind Period|Other|1|||
129219316|NCT01499355|465103018|FG002|Double-Blind Period|Other|2|||
129219317|NCT01499355|465103019|FG003|Double-Blind Period|Other|2|||
129219318|NCT01499355|465103016|FG000|Double-Blind Period|Death|0|||
129219319|NCT01499355|465103017|FG001|Double-Blind Period|Death|1|||
129219320|NCT01499355|465103018|FG002|Double-Blind Period|Death|0|||
129219321|NCT01499355|465103019|FG003|Double-Blind Period|Death|0|||
129219322|NCT01499355|465103016|FG000|Double-Blind Period|Investigator Decision|0|||
129219323|NCT01499355|465103017|FG001|Double-Blind Period|Investigator Decision|0|||
129219324|NCT01499355|465103018|FG002|Double-Blind Period|Investigator Decision|3|||
129219325|NCT01499355|465103019|FG003|Double-Blind Period|Investigator Decision|3|||
129219326|NCT01499355|465103016|FG000|Double-Blind Period|Consent Withdrawn|0|||
129219327|NCT01499355|465103017|FG001|Double-Blind Period|Consent Withdrawn|0|||
129219328|NCT01499355|465103018|FG002|Double-Blind Period|Consent Withdrawn|1|||
129219329|NCT01499355|465103019|FG003|Double-Blind Period|Consent Withdrawn|2|||
129219330|NCT01499355|465103016|FG000|Double-Blind Period|Lost to Follow-up|0|||
129219331|NCT01499355|465103017|FG001|Double-Blind Period|Lost to Follow-up|1|||
129219332|NCT01499355|465103018|FG002|Double-Blind Period|Lost to Follow-up|0|||
129219333|NCT01499355|465103019|FG003|Double-Blind Period|Lost to Follow-up|0|||
129219334|NCT01526733|465103020|FG000|Phase 1|Protocol Violation|1|||
129219335|NCT01526733|465103021|FG001|Phase 1|Protocol Violation|0|||
129219336|NCT01526733|465103020|FG000|Phase 1|Withdrawal by Subject|1|||
129219337|NCT01526733|465103021|FG001|Phase 1|Withdrawal by Subject|1|||
129219338|NCT01310075|465103022|FG000|Overall Study|Lost to Follow-up|1|||
129219339|NCT01310075|465103023|FG001|Overall Study|Lost to Follow-up|0|||
129219340|NCT01310075|465103022|FG000|Overall Study|Physician Decision|10|||
129219341|NCT01310075|465103023|FG001|Overall Study|Physician Decision|7|||
129219342|NCT01310075|465103022|FG000|Overall Study|Protocol Violation|2|||
129219343|NCT01310075|465103023|FG001|Overall Study|Protocol Violation|2|||
128711536|NCT02611778|463239922|FG001|Overall Study|Death|1|||
128954588|NCT02215616|464120026|FG001|Overall Study|Other than specified|0|||
128954589|NCT02215616|464120027|FG002|Overall Study|Other than specified|1|||
128954590|NCT02215616|464120028|FG003|Overall Study|Other than specified|1|||
128954591|NCT03728140|464120030|FG000|Overall Study|Abnormal embryo transfer operation|10|||
128954592|NCT03728140|464120031|FG001|Overall Study|Abnormal embryo transfer operation|7|||
128954593|NCT00881361|464120032|FG000|Overall Study|Terminated prior to surgery|27|||
128954594|NCT00881361|464120033|FG001|Overall Study|Terminated prior to surgery|7|||
128954595|NCT00881361|464120034|FG002|Overall Study|Terminated prior to surgery|0|||
128954596|NCT00881361|464120032|FG000|Overall Study|Ineligible|17|||
128954597|NCT00881361|464120033|FG001|Overall Study|Ineligible|2|||
128954598|NCT00881361|464120034|FG002|Overall Study|Ineligible|2|||
128954599|NCT01381718|464120035|FG000|Overall Study|Withdrawal by Subject|2|||
129219344|NCT01310075|465103022|FG000|Overall Study|Withdrawal by Subject|1|||
129219345|NCT01310075|465103023|FG001|Overall Study|Withdrawal by Subject|1|||
129219346|NCT02395081|465103024|FG000|Overall Study|Withdrawal by Subject|1|||
128954600|NCT01381718|464120036|FG001|Overall Study|Withdrawal by Subject|5|||
128954601|NCT01381718|464120035|FG000|Overall Study|Lost to Follow-up|3|||
129219347|NCT02395081|465103025|FG001|Overall Study|Withdrawal by Subject|1|||
129219348|NCT02395081|465103026|FG002|Overall Study|Withdrawal by Subject|0|||
128711537|NCT02611778|463239921|FG000|Overall Study|Protocol Violation|1|||
128954602|NCT01381718|464120036|FG001|Overall Study|Lost to Follow-up|5|||
128954603|NCT01381718|464120035|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
129219349|NCT02395081|465103024|FG000|Overall Study|Moved where blood couldn't be collected|4|||
128954604|NCT01381718|464120036|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
128954605|NCT02759861|464120039|FG000|Overall Study|Death|1|||
128954606|NCT00618995|464120040|FG000|Period 1|Adverse Event|0|||
128954607|NCT00618995|464120041|FG001|Period 1|Adverse Event|0|||
128954608|NCT00618995|464120042|FG002|Period 1|Adverse Event|1|||
128954609|NCT00618995|464120043|FG003|Period 1|Adverse Event|0|||
128954610|NCT00618995|464120040|FG000|Period 1|Protocol Violation|0|||
128954611|NCT00618995|464120041|FG001|Period 1|Protocol Violation|1|||
128954612|NCT00618995|464120042|FG002|Period 1|Protocol Violation|1|||
128954613|NCT00618995|464120043|FG003|Period 1|Protocol Violation|0|||
128954614|NCT00618995|464120040|FG000|Period 2|Protocol Violation|0|||
128954615|NCT00618995|464120041|FG001|Period 2|Protocol Violation|0|||
128954616|NCT00618995|464120042|FG002|Period 2|Protocol Violation|1|||
128954617|NCT00618995|464120043|FG003|Period 2|Protocol Violation|0|||
128954618|NCT00618995|464120040|FG000|Period 4|Adverse Event|1|||
128954619|NCT00618995|464120041|FG001|Period 4|Adverse Event|0|||
128954620|NCT00618995|464120042|FG002|Period 4|Adverse Event|0|||
128954621|NCT00618995|464120043|FG003|Period 4|Adverse Event|0|||
128954622|NCT02988219|464120044|FG000|Overall Study|Lack of Efficacy|1|||
128954623|NCT02988219|464120045|FG001|Overall Study|Lack of Efficacy|1|||
128954624|NCT02988219|464120044|FG000|Overall Study|Withdrawal by Subject|0|||
128954625|NCT02988219|464120045|FG001|Overall Study|Withdrawal by Subject|2|||
128954626|NCT01504971|464120046|FG000|Overall Study|Physician Decision|13|||
128954627|NCT00936117|464120047|FG000|Overall Study|Adverse Event|7|||
128954628|NCT00936117|464120047|FG000|Overall Study|Unable to continue oral medication|3|||
128954629|NCT00225212|464120057|FG000|Overall Study|Disease progression|2|||
128954630|NCT00225212|464120057|FG000|Overall Study|Death|1|||
128954631|NCT00225212|464120057|FG000|Overall Study|Adverse Event|2|||
128954632|NCT00225212|464120057|FG000|Overall Study|Intercurrent illness|1|||
128954633|NCT01309841|464120060|FG000|Overall Study|Other|0|||
128954634|NCT01309841|464120061|FG001|Overall Study|Other|1|||
128954635|NCT01309841|464120062|FG002|Overall Study|Other|1|||
128954636|NCT01309841|464120060|FG000|Overall Study|Lost to Follow-up|7|||
128954637|NCT01309841|464120061|FG001|Overall Study|Lost to Follow-up|6|||
128954638|NCT01309841|464120062|FG002|Overall Study|Lost to Follow-up|4|||
128954639|NCT01309841|464120060|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
128954640|NCT01309841|464120061|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
128954641|NCT01309841|464120062|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
128954642|NCT01309841|464120060|FG000|Overall Study|Lack of Efficacy|0|||
128954643|NCT01309841|464120061|FG001|Overall Study|Lack of Efficacy|0|||
128954644|NCT01309841|464120062|FG002|Overall Study|Lack of Efficacy|2|||
128954645|NCT01309841|464120060|FG000|Overall Study|Adverse Event|9|||
128954646|NCT01309841|464120061|FG001|Overall Study|Adverse Event|22|||
128954647|NCT01309841|464120062|FG002|Overall Study|Adverse Event|11|||
128954648|NCT01309841|464120060|FG000|Overall Study|Death|1|||
128954649|NCT01309841|464120061|FG001|Overall Study|Death|0|||
128954650|NCT01309841|464120062|FG002|Overall Study|Death|0|||
128711538|NCT02611778|463239922|FG001|Overall Study|Protocol Violation|0|||
128954651|NCT01309841|464120060|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
128954652|NCT01309841|464120061|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
128954653|NCT01309841|464120062|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
128954654|NCT01309841|464120060|FG000|Overall Study|Withdrawal by Subject|17|||
128954655|NCT01309841|464120061|FG001|Overall Study|Withdrawal by Subject|6|||
128954656|NCT01309841|464120062|FG002|Overall Study|Withdrawal by Subject|13|||
128954657|NCT01309841|464120060|FG000|Overall Study|Did Not Receive Treatment|2|||
128954658|NCT01309841|464120061|FG001|Overall Study|Did Not Receive Treatment|0|||
128954659|NCT01309841|464120062|FG002|Overall Study|Did Not Receive Treatment|1|||
128954660|NCT01309841|464120060|FG000|Overall Study|Severe non-compliance with protocol|0|||
128954661|NCT01309841|464120061|FG001|Overall Study|Severe non-compliance with protocol|5|||
128954662|NCT01309841|464120062|FG002|Overall Study|Severe non-compliance with protocol|2|||
128954663|NCT03699631|464120063|FG000|Overall Study|Adverse Event|3|||
128954664|NCT01324622|464120064|FG000|Overall Study|Lost to Follow-up|7|||
128954665|NCT01324622|464120065|FG001|Overall Study|Lost to Follow-up|7|||
128954666|NCT01324622|464120064|FG000|Overall Study|Death|1|||
128954667|NCT01324622|464120065|FG001|Overall Study|Death|0|||
128954668|NCT01324622|464120064|FG000|Overall Study|Lack of Efficacy|1|||
128954669|NCT01324622|464120065|FG001|Overall Study|Lack of Efficacy|0|||
128954670|NCT00138424|464120066|FG000|Overall Study|Physician Decision|0|||
128954671|NCT00138424|464120067|FG001|Overall Study|Physician Decision|1|||
128954672|NCT00138424|464120068|FG002|Overall Study|Physician Decision|0|||
128954673|NCT00138424|464120069|FG003|Overall Study|Physician Decision|0|||
128954674|NCT04311177|464120070|FG000|Overall Study|Adverse Event|3|||
128954675|NCT04311177|464120071|FG001|Overall Study|Adverse Event|1|||
128954676|NCT04311177|464120070|FG000|Overall Study|Physician Decision|4|||
128954677|NCT04311177|464120071|FG001|Overall Study|Physician Decision|3|||
128954678|NCT04311177|464120070|FG000|Overall Study|Withdrawal by Subject|1|||
128954679|NCT04311177|464120071|FG001|Overall Study|Withdrawal by Subject|0|||
128954680|NCT00413062|464120074|FG000|Overall Study|Adverse event/serious adverse event|289|||
129036056|NCT03449199|464423390|FG002|Overall Study|Protocol Deviation|1|||
128954681|NCT00413062|464120075|FG001|Overall Study|Adverse event/serious adverse event|56|||
128954682|NCT00413062|464120074|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
128954683|NCT00413062|464120075|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
128954684|NCT00413062|464120074|FG000|Overall Study|Withdrawal of informed consent|111|||
128954685|NCT00413062|464120075|FG001|Overall Study|Withdrawal of informed consent|36|||
128954686|NCT00413062|464120074|FG000|Overall Study|Pregnancy|15|||
128954687|NCT00413062|464120075|FG001|Overall Study|Pregnancy|5|||
128954688|NCT00413062|464120074|FG000|Overall Study|Pregnancy wish|17|||
128954689|NCT00413062|464120075|FG001|Overall Study|Pregnancy wish|6|||
129126036|NCT03314935|464755602|FG004|Phase 2|Study Terminated by Sponsor|0|||
129126037|NCT03314935|464755603|FG005|Phase 2|Study Terminated by Sponsor|0|||
129126038|NCT03314935|464755604|FG006|Phase 2|Study Terminated by Sponsor|0|||
129126039|NCT03314935|464755605|FG007|Phase 2|Study Terminated by Sponsor|0|||
129126040|NCT03314935|464755606|FG008|Phase 2|Study Terminated by Sponsor|0|||
129126041|NCT03314935|464755607|FG009|Phase 2|Study Terminated by Sponsor|0|||
129126042|NCT03314935|464755608|FG010|Phase 2|Study Terminated by Sponsor|7|||
129126043|NCT03314935|464755609|FG011|Phase 2|Study Terminated by Sponsor|2|||
129126044|NCT03314935|464755610|FG012|Phase 2|Study Terminated by Sponsor|1|||
129126045|NCT03314935|464755611|FG013|Phase 2|Study Terminated by Sponsor|4|||
129126046|NCT03314935|464755612|FG014|Phase 2|Study Terminated by Sponsor|4|||
129126047|NCT03314935|464755598|FG000|Phase 2|Lost to Follow-up|0|||
129126048|NCT03314935|464755599|FG001|Phase 2|Lost to Follow-up|0|||
129126049|NCT03314935|464755600|FG002|Phase 2|Lost to Follow-up|0|||
129126050|NCT03314935|464755601|FG003|Phase 2|Lost to Follow-up|0|||
129126051|NCT03314935|464755602|FG004|Phase 2|Lost to Follow-up|0|||
129126052|NCT03314935|464755603|FG005|Phase 2|Lost to Follow-up|0|||
129126053|NCT03314935|464755604|FG006|Phase 2|Lost to Follow-up|0|||
129126054|NCT03314935|464755605|FG007|Phase 2|Lost to Follow-up|0|||
129126055|NCT03314935|464755606|FG008|Phase 2|Lost to Follow-up|0|||
129126056|NCT03314935|464755607|FG009|Phase 2|Lost to Follow-up|1|||
129126057|NCT03314935|464755608|FG010|Phase 2|Lost to Follow-up|0|||
128954690|NCT00413062|464120074|FG000|Overall Study|Lost to Follow-up|175|||
128954691|NCT00413062|464120075|FG001|Overall Study|Lost to Follow-up|73|||
128954692|NCT00413062|464120074|FG000|Overall Study|Other reason|70|||
128954693|NCT00413062|464120075|FG001|Overall Study|Other reason|34|||
128954694|NCT02176291|464120076|FG000|Overall Study|Death|1|||
128954695|NCT02176291|464120077|FG001|Overall Study|Death|0|||
128954696|NCT02176291|464120076|FG000|Overall Study|non compliance with protocol|2|||
128954697|NCT02176291|464120077|FG001|Overall Study|non compliance with protocol|0|||
128954698|NCT02176291|464120076|FG000|Overall Study|Withdrawal by Subject|2|||
128954699|NCT02176291|464120077|FG001|Overall Study|Withdrawal by Subject|0|||
128954700|NCT02815293|464120080|FG000|Overall Study|Study termination by sponsor|10|||
128954701|NCT02815293|464120081|FG001|Overall Study|Study termination by sponsor|7|||
128954702|NCT02815293|464120082|FG002|Overall Study|Study termination by sponsor|0|||
128954703|NCT02815293|464120080|FG000|Overall Study|Participants not randomized|0|||
128954704|NCT02815293|464120081|FG001|Overall Study|Participants not randomized|0|||
128954705|NCT02815293|464120082|FG002|Overall Study|Participants not randomized|18|||
128954706|NCT02815293|464120080|FG000|Overall Study|Adverse Event|0|||
128954707|NCT02815293|464120081|FG001|Overall Study|Adverse Event|1|||
128954708|NCT02815293|464120082|FG002|Overall Study|Adverse Event|0|||
128954709|NCT00006604|464120083|FG000|Overall Study|Met study objective - no further FU|1|||
128954710|NCT00006604|464120084|FG001|Overall Study|Met study objective - no further FU|0|||
128954711|NCT00006604|464120085|FG002|Overall Study|Met study objective - no further FU|0|||
128954712|NCT00006604|464120086|FG003|Overall Study|Met study objective - no further FU|0|||
128954713|NCT00006604|464120087|FG004|Overall Study|Met study objective - no further FU|0|||
128954714|NCT00006604|464120088|FG005|Overall Study|Met study objective - no further FU|0|||
128954715|NCT00006604|464120089|FG006|Overall Study|Met study objective - no further FU|0|||
128954716|NCT00006604|464120090|FG007|Overall Study|Met study objective - no further FU|0|||
128954717|NCT00006604|464120091|FG008|Overall Study|Met study objective - no further FU|0|||
128954718|NCT00006604|464120092|FG009|Overall Study|Met study objective - no further FU|0|||
128954719|NCT00006604|464120093|FG010|Overall Study|Met study objective - no further FU|0|||
128954720|NCT00006604|464120094|FG011|Overall Study|Met study objective - no further FU|0|||
128954721|NCT00006604|464120095|FG012|Overall Study|Met study objective - no further FU|0|||
128954722|NCT00006604|464120096|FG013|Overall Study|Met study objective - no further FU|0|||
128954723|NCT00006604|464120097|FG014|Overall Study|Met study objective - no further FU|1|||
129126058|NCT03314935|464755609|FG011|Phase 2|Lost to Follow-up|0|||
129126059|NCT03314935|464755610|FG012|Phase 2|Lost to Follow-up|0|||
129126060|NCT03314935|464755611|FG013|Phase 2|Lost to Follow-up|0|||
128954724|NCT00006604|464120098|FG015|Overall Study|Met study objective - no further FU|1|||
128954725|NCT00006604|464120099|FG016|Overall Study|Met study objective - no further FU|0|||
129126061|NCT03314935|464755612|FG014|Phase 2|Lost to Follow-up|1|||
129126062|NCT03314935|464755598|FG000|Phase 2|Physician Decision|0|||
129126063|NCT03314935|464755599|FG001|Phase 2|Physician Decision|0|||
129126064|NCT03314935|464755600|FG002|Phase 2|Physician Decision|0|||
128954726|NCT00006604|464120083|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
129126065|NCT03314935|464755601|FG003|Phase 2|Physician Decision|0|||
129126066|NCT03314935|464755602|FG004|Phase 2|Physician Decision|0|||
128954727|NCT00006604|464120084|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
128954728|NCT00006604|464120085|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
128954729|NCT00006604|464120086|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
128954730|NCT00006604|464120087|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
128954731|NCT00006604|464120088|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
129219350|NCT02395081|465103025|FG001|Overall Study|Moved where blood couldn't be collected|1|||
129219351|NCT02395081|465103026|FG002|Overall Study|Moved where blood couldn't be collected|3|||
129219352|NCT02395081|465103024|FG000|Overall Study|Fetal Loss|2|||
129219353|NCT02395081|465103025|FG001|Overall Study|Fetal Loss|3|||
129219354|NCT02395081|465103026|FG002|Overall Study|Fetal Loss|1|||
129219355|NCT02991040|465103027|FG000|Overall Study|Withdrawal by Subject|2|||
129219356|NCT02991040|465103027|FG000|Overall Study|Lost to Follow-up|2|||
129219357|NCT01869764|465103028|FG000|Overall Study|Withdrawal by Subject|0|||
129219358|NCT01869764|465103029|FG001|Overall Study|Withdrawal by Subject|2|||
129219359|NCT01286480|465103030|FG000|Overall Study|Withdrawal by Subject|5|||
129219360|NCT01286480|465103031|FG001|Overall Study|Withdrawal by Subject|3|||
129219361|NCT01626872|465103032|FG000|Overall Study|Physician Decision|13|||
129219362|NCT01626872|465103033|FG001|Overall Study|Physician Decision|9|||
129219363|NCT01626872|465103034|FG002|Overall Study|Physician Decision|6|||
129219364|NCT01626872|465103032|FG000|Overall Study|Withdrawal by Subject|19|||
129219365|NCT01626872|465103033|FG001|Overall Study|Withdrawal by Subject|27|||
129219366|NCT01626872|465103034|FG002|Overall Study|Withdrawal by Subject|8|||
129219367|NCT01626872|465103032|FG000|Overall Study|Adverse Event (including Death)|20|||
129219368|NCT01626872|465103033|FG001|Overall Study|Adverse Event (including Death)|28|||
128954732|NCT00006604|464120089|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
128954733|NCT00006604|464120090|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
129219369|NCT01626872|465103034|FG002|Overall Study|Adverse Event (including Death)|8|||
129219370|NCT01626872|465103032|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
129219371|NCT01626872|465103033|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
129219372|NCT01626872|465103034|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
129219373|NCT01696188|465103035|FG000|Overall Study|Protocol Violation|1|||
129219374|NCT01696188|465103036|FG001|Overall Study|Protocol Violation|1|||
129219375|NCT00960999|465103037|FG000|Overall Study|Withdrawal by Subject|1|||
129219376|NCT00960999|465103038|FG001|Overall Study|Withdrawal by Subject|0|||
129219377|NCT00960999|465103037|FG000|Overall Study|Protocol Violation|5|||
129219378|NCT00960999|465103038|FG001|Overall Study|Protocol Violation|2|||
129219379|NCT00960999|465103037|FG000|Overall Study|RT dose constraints not met|2|||
129219380|NCT00960999|465103038|FG001|Overall Study|RT dose constraints not met|0|||
129219381|NCT01918306|465103039|FG000|Overall Study|progresive disease|4|||
129219382|NCT01918306|465103040|FG001|Overall Study|progresive disease|0|||
129219383|NCT01918306|465103041|FG002|Overall Study|progresive disease|1|||
129219384|NCT01918306|465103042|FG003|Overall Study|progresive disease|1|||
129219385|NCT01918306|465103039|FG000|Overall Study|Withdrawal by Subject|0|||
129219386|NCT01918306|465103040|FG001|Overall Study|Withdrawal by Subject|0|||
129219387|NCT01918306|465103041|FG002|Overall Study|Withdrawal by Subject|0|||
129219388|NCT01918306|465103042|FG003|Overall Study|Withdrawal by Subject|2|||
129219389|NCT01918306|465103039|FG000|Overall Study|neutropenia|1|||
129219390|NCT01918306|465103040|FG001|Overall Study|neutropenia|0|||
129219391|NCT01918306|465103041|FG002|Overall Study|neutropenia|0|||
129219392|NCT01918306|465103042|FG003|Overall Study|neutropenia|0|||
129219393|NCT01918306|465103039|FG000|Overall Study|Lack of Efficacy|1|||
129219394|NCT01918306|465103040|FG001|Overall Study|Lack of Efficacy|0|||
129219395|NCT01918306|465103041|FG002|Overall Study|Lack of Efficacy|0|||
129219396|NCT01918306|465103042|FG003|Overall Study|Lack of Efficacy|0|||
129219397|NCT01918306|465103039|FG000|Overall Study|progress disease, crossover|0|||
129219398|NCT01918306|465103040|FG001|Overall Study|progress disease, crossover|0|||
129219399|NCT01918306|465103041|FG002|Overall Study|progress disease, crossover|1|||
129219400|NCT01918306|465103042|FG003|Overall Study|progress disease, crossover|0|||
129219401|NCT01958164|465103044|FG000|Overall Study|Adverse Event|0|||
129219402|NCT01958164|465103045|FG001|Overall Study|Adverse Event|2|||
129219403|NCT01958164|465103044|FG000|Overall Study|Lost to Follow-up|2|||
128954734|NCT00006604|464120091|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
128954735|NCT00006604|464120092|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
128954736|NCT00006604|464120093|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
128954737|NCT00006604|464120094|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
129219404|NCT01958164|465103045|FG001|Overall Study|Lost to Follow-up|3|||
129219405|NCT02963506|465103046|FG000|Double-Blind Period|Adverse Event|0|||
129219406|NCT02963506|465103047|FG001|Double-Blind Period|Adverse Event|0|||
129219407|NCT02963506|465103048|FG002|Double-Blind Period|Adverse Event|1|||
129219408|NCT02963506|465103049|FG003|Double-Blind Period|Adverse Event|0|||
129219409|NCT02963506|465103050|FG004|Double-Blind Period|Adverse Event|0|||
129219410|NCT02963506|465103051|FG005|Double-Blind Period|Adverse Event|0|||
129219411|NCT02963506|465103052|FG006|Double-Blind Period|Adverse Event|0|||
129219412|NCT02963506|465103053|FG007|Double-Blind Period|Adverse Event|0|||
129219413|NCT02963506|465103054|FG008|Double-Blind Period|Adverse Event|0|||
129219414|NCT02963506|465103055|FG009|Double-Blind Period|Adverse Event|0|||
128954738|NCT00006604|464120095|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
128954739|NCT00006604|464120096|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
128954740|NCT00006604|464120097|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
128954741|NCT00006604|464120098|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
128954742|NCT00006604|464120099|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
128954743|NCT00006604|464120083|FG000|Overall Study|Death|0|||
128954744|NCT00006604|464120084|FG001|Overall Study|Death|0|||
128954745|NCT00006604|464120085|FG002|Overall Study|Death|0|||
128954746|NCT00006604|464120086|FG003|Overall Study|Death|0|||
128954747|NCT00006604|464120087|FG004|Overall Study|Death|0|||
128954748|NCT00006604|464120088|FG005|Overall Study|Death|0|||
128954749|NCT00006604|464120089|FG006|Overall Study|Death|0|||
128954750|NCT00006604|464120090|FG007|Overall Study|Death|0|||
128954751|NCT00006604|464120091|FG008|Overall Study|Death|0|||
128954752|NCT00006604|464120092|FG009|Overall Study|Death|1|||
128954753|NCT00006604|464120093|FG010|Overall Study|Death|1|||
128954754|NCT00006604|464120094|FG011|Overall Study|Death|1|||
128954755|NCT00006604|464120095|FG012|Overall Study|Death|0|||
128954756|NCT00006604|464120096|FG013|Overall Study|Death|0|||
128954757|NCT00006604|464120097|FG014|Overall Study|Death|0|||
128954758|NCT00006604|464120098|FG015|Overall Study|Death|0|||
128954759|NCT00006604|464120099|FG016|Overall Study|Death|0|||
128954760|NCT00006604|464120083|FG000|Overall Study|Severe debilitation, unable to continue|0|||
128954761|NCT00006604|464120084|FG001|Overall Study|Severe debilitation, unable to continue|0|||
128954762|NCT00006604|464120085|FG002|Overall Study|Severe debilitation, unable to continue|0|||
128954763|NCT00006604|464120086|FG003|Overall Study|Severe debilitation, unable to continue|0|||
128954764|NCT00006604|464120087|FG004|Overall Study|Severe debilitation, unable to continue|0|||
128954765|NCT00006604|464120088|FG005|Overall Study|Severe debilitation, unable to continue|0|||
128954766|NCT00006604|464120089|FG006|Overall Study|Severe debilitation, unable to continue|3|||
128954767|NCT00006604|464120090|FG007|Overall Study|Severe debilitation, unable to continue|0|||
128954768|NCT00006604|464120091|FG008|Overall Study|Severe debilitation, unable to continue|0|||
128954769|NCT00006604|464120092|FG009|Overall Study|Severe debilitation, unable to continue|5|||
128954770|NCT00006604|464120093|FG010|Overall Study|Severe debilitation, unable to continue|0|||
128954771|NCT00006604|464120094|FG011|Overall Study|Severe debilitation, unable to continue|2|||
128954772|NCT00006604|464120095|FG012|Overall Study|Severe debilitation, unable to continue|1|||
128954773|NCT00006604|464120096|FG013|Overall Study|Severe debilitation, unable to continue|0|||
128954774|NCT00006604|464120097|FG014|Overall Study|Severe debilitation, unable to continue|2|||
128954775|NCT00006604|464120098|FG015|Overall Study|Severe debilitation, unable to continue|0|||
128954776|NCT00006604|464120099|FG016|Overall Study|Severe debilitation, unable to continue|0|||
128954777|NCT00006604|464120083|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
128954778|NCT00006604|464120084|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
128954779|NCT00006604|464120085|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
129126067|NCT03314935|464755603|FG005|Phase 2|Physician Decision|0|||
129126068|NCT03314935|464755604|FG006|Phase 2|Physician Decision|0|||
129126069|NCT03314935|464755605|FG007|Phase 2|Physician Decision|0|||
129126070|NCT03314935|464755606|FG008|Phase 2|Physician Decision|0|||
129126071|NCT03314935|464755607|FG009|Phase 2|Physician Decision|0|||
129126072|NCT03314935|464755608|FG010|Phase 2|Physician Decision|1|||
129126073|NCT03314935|464755609|FG011|Phase 2|Physician Decision|0|||
129126074|NCT03314935|464755610|FG012|Phase 2|Physician Decision|0|||
129126075|NCT03314935|464755611|FG013|Phase 2|Physician Decision|0|||
129126076|NCT03314935|464755612|FG014|Phase 2|Physician Decision|0|||
129126077|NCT05845619|464755613|FG000|Overall Study|duplicate enrollment|2|||
129126078|NCT05845619|464755614|FG001|Overall Study|duplicate enrollment|2|||
129126079|NCT05845619|464755615|FG002|Overall Study|duplicate enrollment|1|||
129126080|NCT03636477|464755619|FG000|Overall Study|Adverse Event|0|||
129126081|NCT03636477|464755620|FG001|Overall Study|Adverse Event|0|||
129126082|NCT03636477|464755621|FG002|Overall Study|Adverse Event|1|||
129126083|NCT03621592|464755622|FG000|Overall Study|Lost to Follow-up|1|||
129126084|NCT03621592|464755623|FG001|Overall Study|Lost to Follow-up|0|||
128954780|NCT00006604|464120086|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
128954781|NCT00006604|464120087|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
128954782|NCT00006604|464120088|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
128954783|NCT00006604|464120089|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
128954784|NCT00006604|464120090|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
128954785|NCT00006604|464120091|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
128954786|NCT00006604|464120092|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
128954787|NCT00006604|464120093|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
129126085|NCT03621592|464755622|FG000|Overall Study|Lack of Improvement|1|||
129126086|NCT03621592|464755623|FG001|Overall Study|Lack of Improvement|0|||
129126087|NCT03621592|464755622|FG000|Overall Study|Preference to receive wound care closer to home|1|||
129126088|NCT03621592|464755623|FG001|Overall Study|Preference to receive wound care closer to home|0|||
129126089|NCT03621592|464755622|FG000|Overall Study|Lack of healing|0|||
129126090|NCT03621592|464755623|FG001|Overall Study|Lack of healing|2|||
128711539|NCT02611778|463239921|FG000|Overall Study|Lost to Follow-up|3|||
128711540|NCT02611778|463239922|FG001|Overall Study|Lost to Follow-up|1|||
128711541|NCT02611778|463239921|FG000|Overall Study|Need for alternative treatment|1|||
128711542|NCT02611778|463239922|FG001|Overall Study|Need for alternative treatment|0|||
128711543|NCT02611778|463239921|FG000|Overall Study|Other Reason|2|||
128711544|NCT02611778|463239922|FG001|Overall Study|Other Reason|1|||
128711545|NCT00022633|463239926|FG000|Overall Study|Adverse Event|11|||
128711546|NCT00022633|463239927|FG001|Overall Study|Adverse Event|1|||
128711547|NCT00022633|463239926|FG000|Overall Study|Refusal unrelated to adverse event|1|||
128711548|NCT00022633|463239927|FG001|Overall Study|Refusal unrelated to adverse event|0|||
128711549|NCT00022633|463239926|FG000|Overall Study|Progression/relapse|9|||
128711550|NCT00022633|463239927|FG001|Overall Study|Progression/relapse|2|||
128711551|NCT00022633|463239926|FG000|Overall Study|Death|4|||
128711552|NCT00022633|463239927|FG001|Overall Study|Death|0|||
128711553|NCT00022633|463239926|FG000|Overall Study|Other - not protocol specified|3|||
128711554|NCT00022633|463239927|FG001|Overall Study|Other - not protocol specified|2|||
128711555|NCT00022633|463239926|FG000|Overall Study|Ineligible|4|||
128711556|NCT00022633|463239927|FG001|Overall Study|Ineligible|0|||
129219415|NCT02963506|465103056|FG010|Double-Blind Period|Adverse Event|0|||
129219416|NCT02963506|465103057|FG011|Double-Blind Period|Adverse Event|0|||
129219417|NCT02963506|465103058|FG012|Double-Blind Period|Adverse Event|0|||
129219418|NCT02963506|465103046|FG000|Double-Blind Period|Death|0|||
129219419|NCT02963506|465103047|FG001|Double-Blind Period|Death|0|||
129219420|NCT02963506|465103048|FG002|Double-Blind Period|Death|0|||
129219421|NCT02963506|465103049|FG003|Double-Blind Period|Death|1|||
129219422|NCT02963506|465103050|FG004|Double-Blind Period|Death|0|||
129219423|NCT02963506|465103051|FG005|Double-Blind Period|Death|0|||
129219424|NCT02963506|465103052|FG006|Double-Blind Period|Death|0|||
129219425|NCT02963506|465103053|FG007|Double-Blind Period|Death|0|||
129219426|NCT02963506|465103054|FG008|Double-Blind Period|Death|0|||
129219427|NCT02963506|465103055|FG009|Double-Blind Period|Death|0|||
129219428|NCT02963506|465103056|FG010|Double-Blind Period|Death|0|||
129219429|NCT02963506|465103057|FG011|Double-Blind Period|Death|0|||
129219430|NCT02963506|465103058|FG012|Double-Blind Period|Death|0|||
129219431|NCT02963506|465103046|FG000|Double-Blind Period|Lost to Follow-up|0|||
129219432|NCT02963506|465103047|FG001|Double-Blind Period|Lost to Follow-up|1|||
129219433|NCT02963506|465103048|FG002|Double-Blind Period|Lost to Follow-up|0|||
128711557|NCT02485574|463239938|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
128711558|NCT01408914|463239940|FG000|Overall Study|Could not complete tx in protocol period|5|||
128711559|NCT01408914|463239941|FG001|Overall Study|Could not complete tx in protocol period|5|||
128711560|NCT01408914|463239942|FG002|Overall Study|Could not complete tx in protocol period|6|||
128711561|NCT01408914|463239940|FG000|Overall Study|Lost to Follow-up|4|||
128711562|NCT01408914|463239941|FG001|Overall Study|Lost to Follow-up|1|||
128954788|NCT00006604|464120094|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
129126091|NCT02382380|464755625|FG000|Overall Study|Withdrawal by Subject|2|||
129126092|NCT02382380|464755626|FG001|Overall Study|Withdrawal by Subject|2|||
129126093|NCT02382380|464755625|FG000|Overall Study|Lost to Follow-up|0|||
129126094|NCT02382380|464755626|FG001|Overall Study|Lost to Follow-up|1|||
129126095|NCT05168800|464755627|FG000|Time 1 Survey|Did not start T1 survey|182|||
129126096|NCT05168800|464755628|FG001|Time 1 Survey|Did not start T1 survey|150|||
129126097|NCT05168800|464755629|FG002|Time 1 Survey|Did not start T1 survey|140|||
129126098|NCT05168800|464755627|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
129126099|NCT05168800|464755628|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
129126100|NCT05168800|464755629|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
129126101|NCT05168800|464755627|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
129126102|NCT05168800|464755628|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
129126103|NCT05168800|464755629|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
129126104|NCT05168800|464755627|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
129126105|NCT05168800|464755628|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
129126106|NCT05168800|464755629|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
129126107|NCT05168800|464755627|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
129126108|NCT05168800|464755628|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
129126109|NCT05168800|464755629|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
129126110|NCT05168800|464755627|FG000|Time 1 Survey|Withdrawal by Subject|6|||
129126111|NCT05168800|464755628|FG001|Time 1 Survey|Withdrawal by Subject|3|||
129126112|NCT05168800|464755629|FG002|Time 1 Survey|Withdrawal by Subject|2|||
129126113|NCT05168800|464755627|FG000|Time 2 Survey|Already excluded at Time 1|228|||
129126114|NCT05168800|464755628|FG001|Time 2 Survey|Already excluded at Time 1|202|||
129126115|NCT05168800|464755629|FG002|Time 2 Survey|Already excluded at Time 1|173|||
129126116|NCT05168800|464755627|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
129126117|NCT05168800|464755628|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
129126118|NCT05168800|464755629|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
129219434|NCT02963506|465103049|FG003|Double-Blind Period|Lost to Follow-up|0|||
129219435|NCT02963506|465103050|FG004|Double-Blind Period|Lost to Follow-up|0|||
129219436|NCT02963506|465103051|FG005|Double-Blind Period|Lost to Follow-up|0|||
128954789|NCT00006604|464120095|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
128954790|NCT00006604|464120096|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
128954791|NCT00006604|464120097|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
128954792|NCT00006604|464120098|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
128954793|NCT00006604|464120099|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
128954794|NCT00006604|464120083|FG000|Overall Study|Site closing|0|||
128954795|NCT00006604|464120084|FG001|Overall Study|Site closing|0|||
128954796|NCT00006604|464120085|FG002|Overall Study|Site closing|1|||
128954797|NCT00006604|464120086|FG003|Overall Study|Site closing|1|||
129126119|NCT05168800|464755627|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
129126120|NCT05168800|464755628|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
129126121|NCT05168800|464755629|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
129126122|NCT05168800|464755627|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
129126123|NCT05168800|464755628|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
129126124|NCT05168800|464755629|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
129126125|NCT05168800|464755627|FG000|Time 2 Survey|Withdrawal by Subject|1|||
129126126|NCT05168800|464755628|FG001|Time 2 Survey|Withdrawal by Subject|0|||
129126127|NCT05168800|464755629|FG002|Time 2 Survey|Withdrawal by Subject|1|||
129126128|NCT05168800|464755627|FG000|Time 3 Survey|Already excluded at Time 1|228|||
129126129|NCT05168800|464755628|FG001|Time 3 Survey|Already excluded at Time 1|200|||
129126130|NCT05168800|464755629|FG002|Time 3 Survey|Already excluded at Time 1|173|||
129126131|NCT05168800|464755627|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
129126132|NCT05168800|464755628|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
129126133|NCT05168800|464755629|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
129126134|NCT05168800|464755627|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
128954798|NCT00006604|464120087|FG004|Overall Study|Site closing|0|||
128954799|NCT00006604|464120088|FG005|Overall Study|Site closing|0|||
128954800|NCT00006604|464120089|FG006|Overall Study|Site closing|0|||
128954801|NCT00006604|464120090|FG007|Overall Study|Site closing|1|||
128954802|NCT00006604|464120091|FG008|Overall Study|Site closing|0|||
128954803|NCT00006604|464120092|FG009|Overall Study|Site closing|0|||
128954804|NCT00006604|464120093|FG010|Overall Study|Site closing|0|||
128954805|NCT00006604|464120094|FG011|Overall Study|Site closing|1|||
128954806|NCT00006604|464120095|FG012|Overall Study|Site closing|1|||
128954807|NCT00006604|464120096|FG013|Overall Study|Site closing|1|||
128954808|NCT00006604|464120097|FG014|Overall Study|Site closing|0|||
128954809|NCT00006604|464120098|FG015|Overall Study|Site closing|0|||
128954810|NCT00006604|464120099|FG016|Overall Study|Site closing|1|||
128954811|NCT00006604|464120083|FG000|Overall Study|Withdrawal by Subject|1|||
128954812|NCT00006604|464120084|FG001|Overall Study|Withdrawal by Subject|0|||
129036057|NCT03449199|464423388|FG000|Overall Study|Withdrawal by Subject|0|||
129036058|NCT03449199|464423389|FG001|Overall Study|Withdrawal by Subject|0|||
129036059|NCT03449199|464423390|FG002|Overall Study|Withdrawal by Subject|1|||
129126135|NCT05168800|464755628|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
129126136|NCT05168800|464755629|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
129126137|NCT05168800|464755627|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
129126138|NCT05168800|464755628|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
129126139|NCT05168800|464755629|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
129126140|NCT04556097|464755630|FG000|Overall Study|Death|0|||
129126141|NCT04556097|464755631|FG001|Overall Study|Death|5|||
129126142|NCT04556097|464755632|FG002|Overall Study|Death|0|||
129126143|NCT04556097|464755633|FG003|Overall Study|Death|0|||
129219437|NCT02963506|465103052|FG006|Double-Blind Period|Lost to Follow-up|0|||
129219438|NCT02963506|465103053|FG007|Double-Blind Period|Lost to Follow-up|0|||
128770581|NCT02960763|463451548|FG003|Step 2|Investigator discretion|0|||
128770582|NCT02960763|463451549|FG004|Step 2|Investigator discretion|1|||
128770583|NCT03638635|463451553|FG000|Initial Hospitalization|Study terminated prematurely|0|||
128770584|NCT03638635|463451554|FG001|Initial Hospitalization|Study terminated prematurely|1|||
128954813|NCT00006604|464120085|FG002|Overall Study|Withdrawal by Subject|2|||
128954814|NCT00006604|464120086|FG003|Overall Study|Withdrawal by Subject|0|||
128954815|NCT00006604|464120087|FG004|Overall Study|Withdrawal by Subject|1|||
128954816|NCT00006604|464120088|FG005|Overall Study|Withdrawal by Subject|2|||
128954817|NCT00006604|464120089|FG006|Overall Study|Withdrawal by Subject|2|||
129036060|NCT01270620|464423391|FG000|Overall Study|Withdrawal by Subject|1|||
129036061|NCT01270620|464423392|FG001|Overall Study|Withdrawal by Subject|3|||
129036062|NCT02780167|464423393|FG000|Overall Study|Adverse Event|9|||
129036063|NCT02780167|464423394|FG001|Overall Study|Adverse Event|8|||
129036064|NCT02780167|464423395|FG002|Overall Study|Adverse Event|8|||
129036065|NCT02780167|464423396|FG003|Overall Study|Adverse Event|12|||
129126144|NCT04556097|464755630|FG000|Overall Study|No caregiver|43|||
129126145|NCT04556097|464755631|FG001|Overall Study|No caregiver|53|||
129126146|NCT04556097|464755632|FG002|Overall Study|No caregiver|0|||
129126147|NCT04556097|464755633|FG003|Overall Study|No caregiver|0|||
129126148|NCT04556097|464755630|FG000|Overall Study|Ineligible, SNF|2|||
128954818|NCT00006604|464120090|FG007|Overall Study|Withdrawal by Subject|0|||
128711563|NCT01408914|463239942|FG002|Overall Study|Lost to Follow-up|2|||
128711564|NCT01408914|463239940|FG000|Overall Study|Physician Decision|1|||
128711565|NCT01408914|463239941|FG001|Overall Study|Physician Decision|1|||
128711566|NCT01408914|463239942|FG002|Overall Study|Physician Decision|0|||
128711567|NCT01408914|463239940|FG000|Overall Study|Withdrawal by Subject|1|||
128711568|NCT01408914|463239941|FG001|Overall Study|Withdrawal by Subject|0|||
128711569|NCT01408914|463239942|FG002|Overall Study|Withdrawal by Subject|1|||
128954819|NCT00006604|464120091|FG008|Overall Study|Withdrawal by Subject|1|||
128954820|NCT00006604|464120092|FG009|Overall Study|Withdrawal by Subject|3|||
128954821|NCT00006604|464120093|FG010|Overall Study|Withdrawal by Subject|2|||
128954822|NCT00006604|464120094|FG011|Overall Study|Withdrawal by Subject|0|||
128954823|NCT00006604|464120095|FG012|Overall Study|Withdrawal by Subject|1|||
128954824|NCT00006604|464120096|FG013|Overall Study|Withdrawal by Subject|2|||
128711570|NCT01408914|463239940|FG000|Overall Study|Moved out of study jurisdiction|1|||
128711571|NCT01408914|463239941|FG001|Overall Study|Moved out of study jurisdiction|1|||
128711572|NCT01408914|463239942|FG002|Overall Study|Moved out of study jurisdiction|0|||
128711573|NCT01408914|463239940|FG000|Overall Study|Late exclusion|0|||
128711574|NCT01408914|463239941|FG001|Overall Study|Late exclusion|3|||
128711575|NCT01408914|463239942|FG002|Overall Study|Late exclusion|3|||
128711576|NCT01408914|463239940|FG000|Overall Study|Change in local TB/HIV norms|0|||
128711577|NCT01408914|463239941|FG001|Overall Study|Change in local TB/HIV norms|1|||
128711578|NCT01408914|463239942|FG002|Overall Study|Change in local TB/HIV norms|1|||
128711579|NCT00330616|463239945|FG000|Overall Study|Adverse Event|13|||
128711580|NCT00330616|463239945|FG000|Overall Study|Lack of Efficacy|1|||
128711581|NCT00330616|463239945|FG000|Overall Study|Lost to Follow-up|2|||
128954825|NCT00006604|464120097|FG014|Overall Study|Withdrawal by Subject|1|||
128954826|NCT00006604|464120098|FG015|Overall Study|Withdrawal by Subject|0|||
128954827|NCT00006604|464120099|FG016|Overall Study|Withdrawal by Subject|1|||
128954828|NCT00006604|464120083|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
128954829|NCT00006604|464120084|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
128954830|NCT00006604|464120085|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
128954831|NCT00006604|464120086|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
128954832|NCT00006604|464120087|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
128954833|NCT00006604|464120088|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
129126149|NCT04556097|464755631|FG001|Overall Study|Ineligible, SNF|2|||
129126150|NCT04556097|464755632|FG002|Overall Study|Ineligible, SNF|0|||
129126151|NCT04556097|464755633|FG003|Overall Study|Ineligible, SNF|0|||
129126152|NCT04556097|464755630|FG000|Overall Study|Ineligible, health|3|||
129126153|NCT04556097|464755631|FG001|Overall Study|Ineligible, health|4|||
129126154|NCT04556097|464755632|FG002|Overall Study|Ineligible, health|0|||
129126155|NCT04556097|464755633|FG003|Overall Study|Ineligible, health|0|||
129126156|NCT04556097|464755630|FG000|Overall Study|Ineligible, language|0|||
129126157|NCT04556097|464755631|FG001|Overall Study|Ineligible, language|1|||
129126158|NCT04556097|464755632|FG002|Overall Study|Ineligible, language|0|||
129126159|NCT04556097|464755633|FG003|Overall Study|Ineligible, language|0|||
129219439|NCT02963506|465103054|FG008|Double-Blind Period|Lost to Follow-up|0|||
128711582|NCT00330616|463239945|FG000|Overall Study|Withdrawal by Subject|4|||
128711583|NCT00330616|463239945|FG000|Overall Study|Other|1|||
128711584|NCT00811473|463239946|FG000|Overall Study|Adverse Event|3|||
128954834|NCT00006604|464120089|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
128954835|NCT00006604|464120090|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
128954836|NCT00006604|464120091|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
128954837|NCT00006604|464120092|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
128954838|NCT00006604|464120093|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
128954839|NCT00006604|464120094|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
128954840|NCT00006604|464120095|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
128954841|NCT00006604|464120096|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
128711585|NCT00811473|463239947|FG001|Overall Study|Adverse Event|12|||
128711586|NCT00811473|463239946|FG000|Overall Study|Lost to Follow-up|5|||
128711587|NCT00811473|463239947|FG001|Overall Study|Lost to Follow-up|1|||
128711588|NCT00811473|463239946|FG000|Overall Study|Withdrawal by Subject|2|||
128954842|NCT00006604|464120097|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
128954843|NCT00006604|464120098|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
128954844|NCT00006604|464120099|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
128954845|NCT00006604|464120083|FG000|Overall Study|Lost to Follow-up|0|||
128954846|NCT00006604|464120084|FG001|Overall Study|Lost to Follow-up|0|||
128954847|NCT00006604|464120085|FG002|Overall Study|Lost to Follow-up|0|||
128954848|NCT00006604|464120086|FG003|Overall Study|Lost to Follow-up|0|||
128711589|NCT00811473|463239947|FG001|Overall Study|Withdrawal by Subject|4|||
128954849|NCT00006604|464120087|FG004|Overall Study|Lost to Follow-up|0|||
129126160|NCT04556097|464755630|FG000|Overall Study|Ineligible, no longer in care management|0|||
129126161|NCT04556097|464755631|FG001|Overall Study|Ineligible, no longer in care management|2|||
129219440|NCT02963506|465103055|FG009|Double-Blind Period|Lost to Follow-up|0|||
128711590|NCT00811473|463239946|FG000|Overall Study|Severe non-compliance to protocol|2|||
128954850|NCT00006604|464120088|FG005|Overall Study|Lost to Follow-up|0|||
128954851|NCT00006604|464120089|FG006|Overall Study|Lost to Follow-up|0|||
128954852|NCT00006604|464120090|FG007|Overall Study|Lost to Follow-up|1|||
128954853|NCT00006604|464120091|FG008|Overall Study|Lost to Follow-up|0|||
128954854|NCT00006604|464120092|FG009|Overall Study|Lost to Follow-up|2|||
128954855|NCT00006604|464120093|FG010|Overall Study|Lost to Follow-up|0|||
128954856|NCT00006604|464120094|FG011|Overall Study|Lost to Follow-up|0|||
128954857|NCT00006604|464120095|FG012|Overall Study|Lost to Follow-up|0|||
128954858|NCT00006604|464120096|FG013|Overall Study|Lost to Follow-up|0|||
128954859|NCT00006604|464120097|FG014|Overall Study|Lost to Follow-up|0|||
128954860|NCT00006604|464120098|FG015|Overall Study|Lost to Follow-up|1|||
128954861|NCT00006604|464120099|FG016|Overall Study|Lost to Follow-up|3|||
128954862|NCT00006604|464120083|FG000|Overall Study|Other Reason|0|||
128954863|NCT00006604|464120084|FG001|Overall Study|Other Reason|0|||
128954864|NCT00006604|464120085|FG002|Overall Study|Other Reason|0|||
128954865|NCT00006604|464120086|FG003|Overall Study|Other Reason|0|||
128954866|NCT00006604|464120087|FG004|Overall Study|Other Reason|0|||
128954867|NCT00006604|464120088|FG005|Overall Study|Other Reason|1|||
128954868|NCT00006604|464120089|FG006|Overall Study|Other Reason|0|||
128954869|NCT00006604|464120090|FG007|Overall Study|Other Reason|0|||
128954870|NCT00006604|464120091|FG008|Overall Study|Other Reason|0|||
128954871|NCT00006604|464120092|FG009|Overall Study|Other Reason|1|||
128954872|NCT00006604|464120093|FG010|Overall Study|Other Reason|0|||
128954873|NCT00006604|464120094|FG011|Overall Study|Other Reason|0|||
128954874|NCT00006604|464120095|FG012|Overall Study|Other Reason|0|||
128954875|NCT00006604|464120096|FG013|Overall Study|Other Reason|0|||
128954876|NCT00006604|464120097|FG014|Overall Study|Other Reason|0|||
128954877|NCT00006604|464120098|FG015|Overall Study|Other Reason|0|||
128954878|NCT00006604|464120099|FG016|Overall Study|Other Reason|0|||
128954879|NCT01056341|464120102|FG000|Overall Study|Treatment Intolerance|0|||
128954880|NCT01056341|464120103|FG001|Overall Study|Treatment Intolerance|2|||
128954881|NCT01056341|464120104|FG002|Overall Study|Treatment Intolerance|0|||
128954882|NCT01056341|464120105|FG003|Overall Study|Treatment Intolerance|2|||
128954883|NCT01056341|464120106|FG004|Overall Study|Treatment Intolerance|0|||
128954884|NCT01056341|464120102|FG000|Overall Study|Lack of Efficacy|32|||
128954885|NCT01056341|464120103|FG001|Overall Study|Lack of Efficacy|30|||
128954886|NCT01056341|464120104|FG002|Overall Study|Lack of Efficacy|7|||
128954887|NCT01056341|464120105|FG003|Overall Study|Lack of Efficacy|25|||
128954888|NCT01056341|464120106|FG004|Overall Study|Lack of Efficacy|9|||
128954889|NCT01056341|464120102|FG000|Overall Study|Other reasons|4|||
128954890|NCT01056341|464120103|FG001|Overall Study|Other reasons|4|||
129036066|NCT02780167|464423397|FG004|Overall Study|Adverse Event|8|||
128770585|NCT03638635|463451553|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
129036067|NCT02780167|464423393|FG000|Overall Study|Lack of Efficacy|6|||
129036068|NCT02780167|464423394|FG001|Overall Study|Lack of Efficacy|5|||
129036069|NCT02780167|464423395|FG002|Overall Study|Lack of Efficacy|6|||
129036070|NCT02780167|464423396|FG003|Overall Study|Lack of Efficacy|1|||
129036071|NCT02780167|464423397|FG004|Overall Study|Lack of Efficacy|0|||
129036072|NCT02780167|464423393|FG000|Overall Study|Lost to Follow-up|2|||
129036073|NCT02780167|464423394|FG001|Overall Study|Lost to Follow-up|0|||
129036074|NCT02780167|464423395|FG002|Overall Study|Lost to Follow-up|1|||
129036075|NCT02780167|464423396|FG003|Overall Study|Lost to Follow-up|0|||
129036076|NCT02780167|464423397|FG004|Overall Study|Lost to Follow-up|0|||
129036077|NCT02780167|464423393|FG000|Overall Study|Does not meet entrance criteria|0|||
129036078|NCT02780167|464423394|FG001|Overall Study|Does not meet entrance criteria|0|||
129036079|NCT02780167|464423395|FG002|Overall Study|Does not meet entrance criteria|1|||
129036080|NCT02780167|464423396|FG003|Overall Study|Does not meet entrance criteria|0|||
129036081|NCT02780167|464423397|FG004|Overall Study|Does not meet entrance criteria|0|||
129036082|NCT02780167|464423393|FG000|Overall Study|No longer meets eligibility criteria|0|||
129036083|NCT02780167|464423394|FG001|Overall Study|No longer meets eligibility criteria|0|||
129036084|NCT02780167|464423395|FG002|Overall Study|No longer meets eligibility criteria|0|||
129036085|NCT02780167|464423396|FG003|Overall Study|No longer meets eligibility criteria|1|||
129036086|NCT02780167|464423397|FG004|Overall Study|No longer meets eligibility criteria|1|||
128954891|NCT01056341|464120104|FG002|Overall Study|Other reasons|8|||
128954892|NCT01056341|464120105|FG003|Overall Study|Other reasons|9|||
128954893|NCT01056341|464120106|FG004|Overall Study|Other reasons|5|||
128954894|NCT01167582|464120107|FG000|Overall Study|Lost to Follow-up|0|||
128954895|NCT01167582|464120108|FG001|Overall Study|Lost to Follow-up|1|||
128954896|NCT01182337|464120111|FG000|Overall Study|Withdrawal by Subject|3|||
128954897|NCT01182337|464120112|FG001|Overall Study|Withdrawal by Subject|1|||
128954898|NCT01182337|464120111|FG000|Overall Study|Lost to Follow-up|0|||
128954899|NCT01182337|464120112|FG001|Overall Study|Lost to Follow-up|1|||
129036087|NCT02780167|464423393|FG000|Overall Study|Protocol Violation|5|||
129036088|NCT02780167|464423394|FG001|Overall Study|Protocol Violation|5|||
129036089|NCT02780167|464423395|FG002|Overall Study|Protocol Violation|1|||
129036090|NCT02780167|464423396|FG003|Overall Study|Protocol Violation|1|||
128954900|NCT03103906|464120113|FG000|Overall Study|Adverse Event|2|||
128954901|NCT03103906|464120114|FG001|Overall Study|Adverse Event|3|||
128954902|NCT03103906|464120113|FG000|Overall Study|Other|2|||
128954903|NCT03103906|464120114|FG001|Overall Study|Other|0|||
128954904|NCT03571256|464120115|FG000|Overall Study|Adverse Event|3|||
128954905|NCT03571256|464120116|FG001|Overall Study|Adverse Event|0|||
128954906|NCT03571256|464120117|FG002|Overall Study|Adverse Event|1|||
128954907|NCT03571256|464120115|FG000|Overall Study|Withdrawal by Subject|3|||
128954908|NCT03571256|464120116|FG001|Overall Study|Withdrawal by Subject|1|||
128954909|NCT03571256|464120117|FG002|Overall Study|Withdrawal by Subject|1|||
128954910|NCT03571256|464120115|FG000|Overall Study|Other than specified|0|||
128954911|NCT03571256|464120116|FG001|Overall Study|Other than specified|1|||
128954912|NCT03571256|464120117|FG002|Overall Study|Other than specified|1|||
128954913|NCT03571256|464120115|FG000|Overall Study|Protocol Violation|0|||
128954914|NCT03571256|464120116|FG001|Overall Study|Protocol Violation|1|||
128954915|NCT03571256|464120117|FG002|Overall Study|Protocol Violation|1|||
128954916|NCT00575094|464120120|FG000|Overall Study|Adverse Event|2|||
128954917|NCT00575094|464120120|FG000|Overall Study|Withdrawal by Subject|1|||
128954918|NCT00772382|464120121|FG000|Overall Study|Adverse Event|19|||
128954919|NCT00772382|464120121|FG000|Overall Study|Death|6|||
128954920|NCT00772382|464120121|FG000|Overall Study|Lack of Efficacy|4|||
128954921|NCT00772382|464120121|FG000|Overall Study|Physician Decision|5|||
128954922|NCT00772382|464120121|FG000|Overall Study|Protocol Violation|1|||
128954923|NCT00772382|464120121|FG000|Overall Study|Withdrawal by Subject|10|||
128954924|NCT00772382|464120121|FG000|Overall Study|Other Reasons|10|||
128954925|NCT00643604|464120127|FG000|Overall Study|Death|1|||
128954926|NCT02702011|464120128|FG000|Overall Study|Withdrawal by Subject|0|||
128954927|NCT02702011|464120129|FG001|Overall Study|Withdrawal by Subject|1|||
128954928|NCT02702011|464120130|FG002|Overall Study|Withdrawal by Subject|0|||
128954929|NCT02702011|464120131|FG003|Overall Study|Withdrawal by Subject|0|||
128954930|NCT04142216|464120133|FG000|Overall Study|Hospitalization|0|||
128954931|NCT04142216|464120134|FG001|Overall Study|Hospitalization|2|||
129126162|NCT04556097|464755632|FG002|Overall Study|Ineligible, no longer in care management|1|||
129126163|NCT04556097|464755633|FG003|Overall Study|Ineligible, no longer in care management|0|||
129126164|NCT04556097|464755630|FG000|Overall Study|No dementia|13|||
129126165|NCT04556097|464755631|FG001|Overall Study|No dementia|3|||
129126166|NCT04556097|464755632|FG002|Overall Study|No dementia|0|||
129126167|NCT04556097|464755633|FG003|Overall Study|No dementia|0|||
129126168|NCT04556097|464755630|FG000|Overall Study|Missing identifier|2|||
129126169|NCT04556097|464755631|FG001|Overall Study|Missing identifier|4|||
129126170|NCT04556097|464755632|FG002|Overall Study|Missing identifier|0|||
129126171|NCT04556097|464755633|FG003|Overall Study|Missing identifier|0|||
129126172|NCT04556097|464755630|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
129126173|NCT04556097|464755631|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
129126174|NCT04556097|464755632|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
129126175|NCT04556097|464755633|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
129126176|NCT00620542|464757928|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
129126177|NCT00620542|464757929|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
129126178|NCT00620542|464757930|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
129126179|NCT00620542|464757931|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
128954932|NCT04142216|464120133|FG000|Overall Study|Death|3|||
128954933|NCT04142216|464120134|FG001|Overall Study|Death|1|||
128954934|NCT04142216|464120133|FG000|Overall Study|Referral to another hemodialysis unit|3|||
128954935|NCT04142216|464120134|FG001|Overall Study|Referral to another hemodialysis unit|2|||
128954936|NCT04142216|464120133|FG000|Overall Study|Use of clove|0|||
128954937|NCT04142216|464120134|FG001|Overall Study|Use of clove|1|||
128954938|NCT02007954|464120135|FG000|Overall Study|Received liver transplant|3|||
128954939|NCT02007954|464120135|FG000|Overall Study|Switch in treatment modality|2|||
128954940|NCT02007954|464120135|FG000|Overall Study|Disease progression and unrelated AE|1|||
128954941|NCT02007954|464120135|FG000|Overall Study|Death|1|||
128954942|NCT01195363|464120138|FG000|Overall Study|Lost to Follow-up|7|||
128954943|NCT01195363|464120139|FG001|Overall Study|Lost to Follow-up|4|||
128954944|NCT01195363|464120138|FG000|Overall Study|Adverse Event|3|||
128954945|NCT01195363|464120139|FG001|Overall Study|Adverse Event|1|||
129126180|NCT00620542|464757928|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
129126181|NCT00620542|464757929|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
128954946|NCT01195363|464120138|FG000|Overall Study|Lack of Efficacy|0|||
128954947|NCT01195363|464120139|FG001|Overall Study|Lack of Efficacy|4|||
128954948|NCT01195363|464120138|FG000|Overall Study|incarceration|1|||
128954949|NCT01195363|464120139|FG001|Overall Study|incarceration|0|||
128954950|NCT00475540|464120141|FG000|36 Months|Lost to Follow-up|4|||
128954951|NCT00475540|464120142|FG001|36 Months|Lost to Follow-up|4|||
128954952|NCT00475540|464120141|FG000|36 Months|Death|1|||
128954953|NCT00475540|464120142|FG001|36 Months|Death|2|||
128954954|NCT00475540|464120141|FG000|36 Months|Censored due to reoperation|3|||
128954955|NCT00475540|464120142|FG001|36 Months|Censored due to reoperation|0|||
128954956|NCT00377429|464120143|FG000|Overall Study|Withdrawal by Subject|5|||
128954957|NCT00377429|464120143|FG000|Overall Study|Adverse Event|8|||
129126182|NCT00620542|464757930|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
128711591|NCT00811473|463239947|FG001|Overall Study|Severe non-compliance to protocol|4|||
128954958|NCT00377429|464120143|FG000|Overall Study|Physician Decision|1|||
128954959|NCT00377429|464120143|FG000|Overall Study|Patient non-compliance|1|||
128954960|NCT03287869|464122124|FG000|Overall Study|Adverse Event|14|||
128954961|NCT03287869|464122125|FG001|Overall Study|Adverse Event|12|||
128954962|NCT03287869|464122124|FG000|Overall Study|Lack of Efficacy|1|||
128954963|NCT03287869|464122125|FG001|Overall Study|Lack of Efficacy|0|||
128954964|NCT03287869|464122124|FG000|Overall Study|Lost to Follow-up|13|||
128954965|NCT03287869|464122125|FG001|Overall Study|Lost to Follow-up|19|||
128954966|NCT03287869|464122124|FG000|Overall Study|Non-Compliance With Study Drug|5|||
128954967|NCT03287869|464122125|FG001|Overall Study|Non-Compliance With Study Drug|9|||
128954968|NCT03287869|464122124|FG000|Overall Study|Progressive Disease|1|||
128954969|NCT03287869|464122125|FG001|Overall Study|Progressive Disease|0|||
128954970|NCT03287869|464122124|FG000|Overall Study|Protocol Deviation|2|||
128954971|NCT03287869|464122125|FG001|Overall Study|Protocol Deviation|1|||
128954972|NCT03287869|464122124|FG000|Overall Study|Withdrawal by Subject|36|||
128954973|NCT03287869|464122125|FG001|Overall Study|Withdrawal by Subject|43|||
128954974|NCT03287869|464122124|FG000|Overall Study|Early Closure of the Site|0|||
128954975|NCT03287869|464122125|FG001|Overall Study|Early Closure of the Site|1|||
128954976|NCT03287869|464122124|FG000|Overall Study|Physician Decision|5|||
128954977|NCT03287869|464122125|FG001|Overall Study|Physician Decision|5|||
128954978|NCT03287869|464122124|FG000|Overall Study|Reason not Specified|6|||
128954979|NCT03287869|464122125|FG001|Overall Study|Reason not Specified|3|||
128954980|NCT03488238|464122126|FG000|Overall Study|Equipment malfunction|1|||
128954981|NCT03488238|464122126|FG000|Overall Study|Adverse Event|1|||
128954982|NCT02670928|464122127|FG000|Overall Study|Adverse Event|3|||
128954983|NCT02670928|464122128|FG001|Overall Study|Adverse Event|1|||
128954984|NCT02670928|464122127|FG000|Overall Study|Withdrawal by Subject|4|||
128954985|NCT02670928|464122128|FG001|Overall Study|Withdrawal by Subject|0|||
128954986|NCT02670928|464122127|FG000|Overall Study|Lost to Follow-up|1|||
128954987|NCT02670928|464122128|FG001|Overall Study|Lost to Follow-up|0|||
128954988|NCT02670928|464122127|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
128954989|NCT02670928|464122128|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
128954990|NCT02591238|464122129|FG000|Overall Study|Pregnancy|1|||
128954991|NCT02591238|464122130|FG001|Overall Study|Pregnancy|0|||
128954992|NCT02591238|464122131|FG002|Overall Study|Pregnancy|0|||
128954993|NCT02591238|464122132|FG003|Overall Study|Pregnancy|0|||
128954994|NCT02591238|464122129|FG000|Overall Study|Withdrawal by Subject|0|||
128954995|NCT02591238|464122130|FG001|Overall Study|Withdrawal by Subject|0|||
128954996|NCT02591238|464122131|FG002|Overall Study|Withdrawal by Subject|0|||
128954997|NCT02591238|464122132|FG003|Overall Study|Withdrawal by Subject|1|||
128954998|NCT02591238|464122129|FG000|Overall Study|influenza|0|||
128954999|NCT02591238|464122130|FG001|Overall Study|influenza|0|||
128955000|NCT02591238|464122131|FG002|Overall Study|influenza|0|||
128955001|NCT02591238|464122132|FG003|Overall Study|influenza|1|||
128955002|NCT02591238|464122129|FG000|Overall Study|personal circumstances|0|||
128955003|NCT02591238|464122130|FG001|Overall Study|personal circumstances|0|||
128955004|NCT02591238|464122131|FG002|Overall Study|personal circumstances|0|||
128955005|NCT02591238|464122132|FG003|Overall Study|personal circumstances|1|||
128955006|NCT02591238|464122129|FG000|Overall Study|personal circumstances|0|||
128955007|NCT02591238|464122130|FG001|Overall Study|personal circumstances|1|||
128955008|NCT02591238|464122131|FG002|Overall Study|personal circumstances|0|||
128955009|NCT02591238|464122132|FG003|Overall Study|personal circumstances|0|||
128955010|NCT01634113|464122133|FG000|Overall Study|Not treated|0|||
128955011|NCT01634113|464122134|FG001|Overall Study|Not treated|0|||
128955012|NCT01634113|464122135|FG002|Overall Study|Not treated|1|||
128955013|NCT00324740|464122136|FG000|Overall Study|Withdrawal by Subject|1|||
128955014|NCT00324740|464122137|FG001|Overall Study|Withdrawal by Subject|0|||
128955015|NCT00324740|464122138|FG002|Overall Study|Withdrawal by Subject|1|||
128955016|NCT00520299|464122141|FG000|Overall Study|Withdrawal by Subject|0|||
128955017|NCT00520299|464122142|FG001|Overall Study|Withdrawal by Subject|0|||
128711592|NCT00811473|463239946|FG000|Overall Study|Lack of therapeutic response|4|||
128955018|NCT00520299|464122143|FG002|Overall Study|Withdrawal by Subject|2|||
128955019|NCT00520299|464122141|FG000|Overall Study|Progressive disease|0|||
128955020|NCT00520299|464122142|FG001|Overall Study|Progressive disease|3|||
128955021|NCT00520299|464122143|FG002|Overall Study|Progressive disease|4|||
128711593|NCT00811473|463239947|FG001|Overall Study|Lack of therapeutic response|1|||
128955022|NCT01352845|464122145|FG000|Overall Study|Lost to Follow-up|313|||
128955023|NCT01352845|464122146|FG001|Overall Study|Lost to Follow-up|92|||
128955024|NCT01352845|464122145|FG000|Overall Study|No Longer Willing to Participate|205|||
128955025|NCT01352845|464122146|FG001|Overall Study|No Longer Willing to Participate|58|||
128955026|NCT01352845|464122145|FG000|Overall Study|Withdrawal by Subject|48|||
128955027|NCT01352845|464122146|FG001|Overall Study|Withdrawal by Subject|16|||
128955028|NCT01352845|464122145|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
128955029|NCT01352845|464122146|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
128955030|NCT01352845|464122145|FG000|Overall Study|Pregnancy|27|||
128955031|NCT01352845|464122146|FG001|Overall Study|Pregnancy|7|||
128955032|NCT01352845|464122145|FG000|Overall Study|Adverse Event|22|||
129219441|NCT02963506|465103056|FG010|Double-Blind Period|Lost to Follow-up|0|||
129219442|NCT02963506|465103057|FG011|Double-Blind Period|Lost to Follow-up|0|||
129219443|NCT02963506|465103058|FG012|Double-Blind Period|Lost to Follow-up|0|||
129219444|NCT02963506|465103046|FG000|Double-Blind Period|Withdrawal by Subject|0|||
129219445|NCT02963506|465103047|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129219446|NCT02963506|465103048|FG002|Double-Blind Period|Withdrawal by Subject|1|||
129219447|NCT02963506|465103049|FG003|Double-Blind Period|Withdrawal by Subject|1|||
129219448|NCT02963506|465103050|FG004|Double-Blind Period|Withdrawal by Subject|0|||
128711594|NCT00811473|463239946|FG000|Overall Study|Condition under investigation worsened|1|||
128711595|NCT00811473|463239947|FG001|Overall Study|Condition under investigation worsened|3|||
129219449|NCT02963506|465103051|FG005|Double-Blind Period|Withdrawal by Subject|0|||
129219450|NCT02963506|465103052|FG006|Double-Blind Period|Withdrawal by Subject|0|||
128711596|NCT00811473|463239946|FG000|Overall Study|Other 2|4|||
128711597|NCT00811473|463239947|FG001|Overall Study|Other 2|1|||
128711598|NCT00811473|463239946|FG000|Overall Study|Incorrect Enrollment|1|||
128711599|NCT00811473|463239947|FG001|Overall Study|Incorrect Enrollment|0|||
128711600|NCT00811473|463239946|FG000|Overall Study|Safety Reasons|1|||
128711601|NCT00811473|463239947|FG001|Overall Study|Safety Reasons|0|||
128711602|NCT00667368|463239955|FG000|Overall Study|Lost to Follow-up|176|||
128711603|NCT00667368|463239956|FG001|Overall Study|Lost to Follow-up|155|||
128711604|NCT00667368|463239955|FG000|Overall Study|Discontinued early|24|||
128711605|NCT00667368|463239956|FG001|Overall Study|Discontinued early|17|||
128711606|NCT01585194|463239959|FG000|Overall Study|Withdrawal by Subject|1|||
128711607|NCT01585194|463239959|FG000|Overall Study|Physician Decision|2|||
128711608|NCT01585194|463239959|FG000|Overall Study|Lack of insurance|1|||
128711609|NCT00732615|463239960|FG000|Overall Study|Withdrawal by Subject|3|||
128711610|NCT00732615|463239961|FG001|Overall Study|Withdrawal by Subject|1|||
128955033|NCT01352845|464122146|FG001|Overall Study|Adverse Event|6|||
128955034|NCT01352845|464122145|FG000|Overall Study|Other|17|||
128955035|NCT01352845|464122146|FG001|Overall Study|Other|7|||
128955036|NCT01352845|464122145|FG000|Overall Study|Protocol Violation|12|||
128955037|NCT01352845|464122146|FG001|Overall Study|Protocol Violation|6|||
128955038|NCT01352845|464122145|FG000|Overall Study|Death|3|||
128955039|NCT01352845|464122146|FG001|Overall Study|Death|0|||
128955040|NCT02528253|464122151|FG000|Overall Study|Adverse Event|3|||
128955041|NCT02528253|464122152|FG001|Overall Study|Adverse Event|4|||
128955042|NCT02528253|464122153|FG002|Overall Study|Adverse Event|4|||
128955043|NCT02528253|464122154|FG003|Overall Study|Adverse Event|8|||
128955044|NCT02528253|464122155|FG004|Overall Study|Adverse Event|18|||
128955045|NCT02528253|464122151|FG000|Overall Study|Death|2|||
128955046|NCT02528253|464122152|FG001|Overall Study|Death|2|||
128955047|NCT02528253|464122153|FG002|Overall Study|Death|1|||
128955048|NCT02528253|464122154|FG003|Overall Study|Death|0|||
128955049|NCT02528253|464122155|FG004|Overall Study|Death|1|||
128955050|NCT02528253|464122151|FG000|Overall Study|Insufficient clinical response|7|||
128955051|NCT02528253|464122152|FG001|Overall Study|Insufficient clinical response|10|||
128955052|NCT02528253|464122153|FG002|Overall Study|Insufficient clinical response|13|||
128955053|NCT02528253|464122154|FG003|Overall Study|Insufficient clinical response|12|||
128955054|NCT02528253|464122155|FG004|Overall Study|Insufficient clinical response|16|||
128955055|NCT02528253|464122151|FG000|Overall Study|Lost to Follow-up|16|||
128955056|NCT02528253|464122152|FG001|Overall Study|Lost to Follow-up|9|||
128955057|NCT02528253|464122153|FG002|Overall Study|Lost to Follow-up|31|||
128955058|NCT02528253|464122154|FG003|Overall Study|Lost to Follow-up|16|||
128955059|NCT02528253|464122155|FG004|Overall Study|Lost to Follow-up|34|||
128955060|NCT02528253|464122151|FG000|Overall Study|Other|21|||
128955061|NCT02528253|464122152|FG001|Overall Study|Other|22|||
128955062|NCT02528253|464122153|FG002|Overall Study|Other|58|||
128955063|NCT02528253|464122154|FG003|Overall Study|Other|52|||
128955064|NCT02528253|464122155|FG004|Overall Study|Other|76|||
128711611|NCT00732615|463239960|FG000|Overall Study|Lost to Follow-up|0|||
128711612|NCT00732615|463239961|FG001|Overall Study|Lost to Follow-up|1|||
128711613|NCT00732615|463239960|FG000|Overall Study|Adverse Event|0|||
128711614|NCT00732615|463239961|FG001|Overall Study|Adverse Event|2|||
128955065|NCT02528253|464122151|FG000|Overall Study|Withdrawal by Subject|25|||
128955066|NCT02528253|464122152|FG001|Overall Study|Withdrawal by Subject|20|||
128955067|NCT02528253|464122153|FG002|Overall Study|Withdrawal by Subject|29|||
129219451|NCT02963506|465103053|FG007|Double-Blind Period|Withdrawal by Subject|0|||
129219452|NCT02963506|465103054|FG008|Double-Blind Period|Withdrawal by Subject|0|||
128711615|NCT00732615|463239960|FG000|Overall Study|Physician Decision|3|||
128711616|NCT00732615|463239961|FG001|Overall Study|Physician Decision|0|||
128711617|NCT00732615|463239960|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
128711618|NCT00732615|463239961|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
128955068|NCT02528253|464122154|FG003|Overall Study|Withdrawal by Subject|48|||
128711619|NCT01333059|463239962|FG000|Overall Study|Physician Decision|3|||
128955069|NCT02528253|464122155|FG004|Overall Study|Withdrawal by Subject|73|||
128711620|NCT01333059|463239963|FG001|Overall Study|Physician Decision|3|||
128955070|NCT02528253|464122151|FG000|Overall Study|Protocol Violation|1|||
128955071|NCT02528253|464122152|FG001|Overall Study|Protocol Violation|2|||
129219453|NCT02963506|465103055|FG009|Double-Blind Period|Withdrawal by Subject|0|||
128711621|NCT01333059|463239962|FG000|Overall Study|Protocol Violation|3|||
128711622|NCT01333059|463239963|FG001|Overall Study|Protocol Violation|0|||
128711623|NCT03566823|463239964|FG000|Overall Study|Lack of Efficacy|0|||
128711624|NCT03566823|463239965|FG001|Overall Study|Lack of Efficacy|1|||
128711625|NCT03566823|463239966|FG002|Overall Study|Lack of Efficacy|0|||
128955072|NCT02528253|464122153|FG002|Overall Study|Protocol Violation|4|||
128955073|NCT02528253|464122154|FG003|Overall Study|Protocol Violation|0|||
128955074|NCT02528253|464122155|FG004|Overall Study|Protocol Violation|4|||
128955075|NCT02528253|464122151|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
128955076|NCT02528253|464122152|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
128955077|NCT02528253|464122153|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
128955078|NCT02528253|464122154|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
128955079|NCT02528253|464122155|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
128955080|NCT01357980|464122156|FG000|Overall Study|Lack of Efficacy|0|||
128955081|NCT01357980|464122157|FG001|Overall Study|Lack of Efficacy|1|||
128955082|NCT01357980|464122158|FG002|Overall Study|Lack of Efficacy|0|||
128955083|NCT01357980|464122159|FG003|Overall Study|Lack of Efficacy|0|||
128955084|NCT01357980|464122156|FG000|Overall Study|Consent withdrawn|0|||
128955085|NCT01357980|464122157|FG001|Overall Study|Consent withdrawn|0|||
128955086|NCT01357980|464122158|FG002|Overall Study|Consent withdrawn|1|||
128955087|NCT01357980|464122159|FG003|Overall Study|Consent withdrawn|0|||
128955088|NCT04507776|464122160|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
128955089|NCT02293993|464122161|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
128955090|NCT02293993|464122162|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
128955091|NCT02293993|464122163|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
128955092|NCT02293993|464122164|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
128955093|NCT02293993|464122161|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
128955094|NCT02293993|464122162|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
128955095|NCT02293993|464122163|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
128955096|NCT02293993|464122164|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
128955097|NCT02293993|464122161|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
128955098|NCT02293993|464122162|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
128955099|NCT02293993|464122163|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
128955100|NCT02293993|464122164|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
128955101|NCT02293993|464122161|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
128955102|NCT02293993|464122162|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
128955103|NCT02293993|464122163|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
128955104|NCT02293993|464122164|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
128955105|NCT02293993|464122161|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
128955106|NCT02293993|464122162|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
128955107|NCT02293993|464122163|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
128955108|NCT02293993|464122164|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
128955109|NCT00094835|464122165|FG000|Overall Study|Physician Decision|1|||
128955110|NCT00094835|464122166|FG001|Overall Study|Physician Decision|0|||
128955111|NCT00094835|464122167|FG002|Overall Study|Physician Decision|0|||
128955112|NCT00094835|464122168|FG003|Overall Study|Physician Decision|0|||
128955113|NCT00094835|464122169|FG004|Overall Study|Physician Decision|0|||
128955114|NCT00094835|464122170|FG005|Overall Study|Physician Decision|1|||
128955115|NCT00094835|464122171|FG006|Overall Study|Physician Decision|0|||
128955116|NCT00094835|464122165|FG000|Overall Study|Withdrawal by Subject|0|||
128955117|NCT00094835|464122166|FG001|Overall Study|Withdrawal by Subject|0|||
128955118|NCT00094835|464122167|FG002|Overall Study|Withdrawal by Subject|0|||
128955119|NCT00094835|464122168|FG003|Overall Study|Withdrawal by Subject|0|||
128955120|NCT00094835|464122169|FG004|Overall Study|Withdrawal by Subject|0|||
128955121|NCT00094835|464122170|FG005|Overall Study|Withdrawal by Subject|0|||
128955122|NCT00094835|464122171|FG006|Overall Study|Withdrawal by Subject|1|||
128955123|NCT00094835|464122165|FG000|Overall Study|Lost to Follow-up|0|||
128955124|NCT00094835|464122166|FG001|Overall Study|Lost to Follow-up|0|||
128955125|NCT00094835|464122167|FG002|Overall Study|Lost to Follow-up|0|||
128955126|NCT00094835|464122168|FG003|Overall Study|Lost to Follow-up|0|||
128955127|NCT00094835|464122169|FG004|Overall Study|Lost to Follow-up|1|||
128711626|NCT03566823|463239964|FG000|Overall Study|Withdrawal by Subject|1|||
128955128|NCT00094835|464122170|FG005|Overall Study|Lost to Follow-up|0|||
128955129|NCT00094835|464122171|FG006|Overall Study|Lost to Follow-up|0|||
128955130|NCT00094835|464122165|FG000|Overall Study|Death|1|||
128711627|NCT03566823|463239965|FG001|Overall Study|Withdrawal by Subject|2|||
128711628|NCT03566823|463239966|FG002|Overall Study|Withdrawal by Subject|0|||
128711629|NCT03566823|463239964|FG000|Overall Study|Adverse Event|1|||
128711630|NCT03566823|463239965|FG001|Overall Study|Adverse Event|0|||
128955131|NCT00094835|464122166|FG001|Overall Study|Death|0|||
128955132|NCT00094835|464122167|FG002|Overall Study|Death|0|||
128955133|NCT00094835|464122168|FG003|Overall Study|Death|0|||
128955134|NCT00094835|464122169|FG004|Overall Study|Death|1|||
128955135|NCT00094835|464122170|FG005|Overall Study|Death|0|||
129219454|NCT02963506|465103056|FG010|Double-Blind Period|Withdrawal by Subject|0|||
129219455|NCT02963506|465103057|FG011|Double-Blind Period|Withdrawal by Subject|0|||
129219456|NCT02963506|465103058|FG012|Double-Blind Period|Withdrawal by Subject|0|||
129219457|NCT02963506|465103046|FG000|Double-Blind Period|No compliance|0|||
129219458|NCT02963506|465103047|FG001|Double-Blind Period|No compliance|1|||
129219459|NCT02963506|465103048|FG002|Double-Blind Period|No compliance|0|||
129219460|NCT02963506|465103049|FG003|Double-Blind Period|No compliance|0|||
129219461|NCT02963506|465103050|FG004|Double-Blind Period|No compliance|0|||
129219462|NCT02963506|465103051|FG005|Double-Blind Period|No compliance|0|||
129219463|NCT02963506|465103052|FG006|Double-Blind Period|No compliance|0|||
128955136|NCT00094835|464122171|FG006|Overall Study|Death|0|||
128955137|NCT00094835|464122165|FG000|Overall Study|Non-compliance|1|||
129219464|NCT02963506|465103053|FG007|Double-Blind Period|No compliance|0|||
128955138|NCT00094835|464122166|FG001|Overall Study|Non-compliance|2|||
128955139|NCT00094835|464122167|FG002|Overall Study|Non-compliance|2|||
128955140|NCT00094835|464122168|FG003|Overall Study|Non-compliance|0|||
128955141|NCT00094835|464122169|FG004|Overall Study|Non-compliance|2|||
128955142|NCT00094835|464122170|FG005|Overall Study|Non-compliance|2|||
128955143|NCT00094835|464122171|FG006|Overall Study|Non-compliance|1|||
128955144|NCT00094835|464122165|FG000|Overall Study|Other|1|||
128955145|NCT00094835|464122166|FG001|Overall Study|Other|1|||
128955146|NCT00094835|464122167|FG002|Overall Study|Other|1|||
128955147|NCT00094835|464122168|FG003|Overall Study|Other|1|||
128955148|NCT00094835|464122169|FG004|Overall Study|Other|0|||
128955149|NCT00094835|464122170|FG005|Overall Study|Other|0|||
128955150|NCT00094835|464122171|FG006|Overall Study|Other|0|||
128955151|NCT03024255|464122174|FG000|Overall Study|Adverse Event|1|||
128955152|NCT03024255|464122175|FG001|Overall Study|Adverse Event|4|||
128955153|NCT03024255|464122176|FG002|Overall Study|Adverse Event|8|||
128955154|NCT03024255|464122177|FG003|Overall Study|Adverse Event|0|||
128955155|NCT03024255|464122174|FG000|Overall Study|Withdrawal by Subject|3|||
128955156|NCT03024255|464122175|FG001|Overall Study|Withdrawal by Subject|1|||
128955157|NCT03024255|464122176|FG002|Overall Study|Withdrawal by Subject|0|||
129219465|NCT02963506|465103054|FG008|Double-Blind Period|No compliance|0|||
129219466|NCT02963506|465103055|FG009|Double-Blind Period|No compliance|0|||
129219467|NCT02963506|465103056|FG010|Double-Blind Period|No compliance|0|||
129219468|NCT02963506|465103057|FG011|Double-Blind Period|No compliance|0|||
128711631|NCT03566823|463239966|FG002|Overall Study|Adverse Event|2|||
128711632|NCT02733367|463239967|FG000|Overall Study|Withdrawal by Subject|6|||
128711633|NCT01348347|463239968|FG000|Overall Study|Withdrawal by Subject|1|||
128955158|NCT03024255|464122177|FG003|Overall Study|Withdrawal by Subject|3|||
128955159|NCT03024255|464122174|FG000|Overall Study|Protocol Violation|0|||
128955160|NCT03024255|464122175|FG001|Overall Study|Protocol Violation|0|||
128955161|NCT03024255|464122176|FG002|Overall Study|Protocol Violation|2|||
128955162|NCT03024255|464122177|FG003|Overall Study|Protocol Violation|0|||
128955163|NCT03024255|464122174|FG000|Overall Study|Lost to Follow-up|1|||
128955164|NCT03024255|464122175|FG001|Overall Study|Lost to Follow-up|2|||
128955165|NCT03024255|464122176|FG002|Overall Study|Lost to Follow-up|1|||
128955166|NCT03024255|464122177|FG003|Overall Study|Lost to Follow-up|1|||
128955167|NCT03024255|464122174|FG000|Overall Study|Lack of Efficacy|1|||
128955168|NCT03024255|464122175|FG001|Overall Study|Lack of Efficacy|0|||
128955169|NCT03024255|464122176|FG002|Overall Study|Lack of Efficacy|0|||
128955170|NCT03024255|464122177|FG003|Overall Study|Lack of Efficacy|0|||
129219469|NCT02963506|465103058|FG012|Double-Blind Period|No compliance|0|||
129219470|NCT02963506|465103046|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
128955171|NCT03024255|464122174|FG000|Overall Study|Protocol Noncompliance|1|||
129219471|NCT02963506|465103047|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
129219472|NCT02963506|465103048|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129219473|NCT02963506|465103049|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
128955172|NCT03024255|464122175|FG001|Overall Study|Protocol Noncompliance|1|||
128955173|NCT03024255|464122176|FG002|Overall Study|Protocol Noncompliance|0|||
128955174|NCT03024255|464122177|FG003|Overall Study|Protocol Noncompliance|1|||
128955175|NCT03583606|464122178|FG000|Overall Study|Lost to Follow-up|0|||
128955176|NCT03583606|464122179|FG001|Overall Study|Lost to Follow-up|1|||
129219474|NCT02963506|465103050|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129219475|NCT02963506|465103051|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
128711634|NCT01348347|463239969|FG001|Overall Study|Withdrawal by Subject|1|||
128955177|NCT03583606|464122180|FG002|Overall Study|Lost to Follow-up|0|||
128955178|NCT03583606|464122178|FG000|Overall Study|Ineligible at baseline|1|||
128955179|NCT03583606|464122179|FG001|Overall Study|Ineligible at baseline|0|||
128955180|NCT03583606|464122180|FG002|Overall Study|Ineligible at baseline|0|||
128955181|NCT00126581|464122185|FG000|Overall Study|Adverse Event|3|||
128955182|NCT00126581|464122186|FG001|Overall Study|Adverse Event|7|||
128955183|NCT00126581|464122185|FG000|Overall Study|Death|3|||
128955184|NCT00126581|464122186|FG001|Overall Study|Death|2|||
128955185|NCT00126581|464122185|FG000|Overall Study|Withdrawal by Subject|1|||
128955186|NCT00126581|464122186|FG001|Overall Study|Withdrawal by Subject|4|||
128955187|NCT00126581|464122185|FG000|Overall Study|Alternative therapy|3|||
128955188|NCT00126581|464122186|FG001|Overall Study|Alternative therapy|3|||
128955189|NCT00126581|464122185|FG000|Overall Study|Other illness/MD discretion|3|||
128955190|NCT00126581|464122186|FG001|Overall Study|Other illness/MD discretion|4|||
128955191|NCT00793182|464122187|FG000|Overall Study|Adverse Event|0|||
128955192|NCT00793182|464122188|FG001|Overall Study|Adverse Event|1|||
128955193|NCT02197897|464122189|FG000|Overall Study|not eligible|1|||
128955194|NCT02384395|464122190|FG000|Overall Study|Physician Decision|4|||
128955195|NCT02384395|464122190|FG000|Overall Study|Withdrawal by Subject|3|||
128955196|NCT02384395|464122190|FG000|Overall Study|Lost to Follow-up|3|||
128955197|NCT04295356|464122192|FG000|Overall Study|Physician Decision|1|||
128955198|NCT04295356|464122193|FG001|Overall Study|Physician Decision|0|||
128955199|NCT04295356|464122192|FG000|Overall Study|Lost to Follow-up|0|||
128955200|NCT04295356|464122193|FG001|Overall Study|Lost to Follow-up|3|||
128955201|NCT04295356|464122192|FG000|Overall Study|Protocol Violation|0|||
128955202|NCT04295356|464122193|FG001|Overall Study|Protocol Violation|1|||
128955203|NCT01106391|464122194|FG000|Overall Study|Death|12|||
128955204|NCT01106391|464122194|FG000|Overall Study|Withdrawal by Subject|7|||
128955205|NCT03939637|464122204|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
128955206|NCT03939637|464122205|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
128955207|NCT03939637|464122204|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
128955208|NCT03939637|464122205|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
128955209|NCT05224076|464122206|FG000|Overall Study|Lost to Follow-up|24|||
128955210|NCT04268004|464122207|FG000|Overall Study|Excluded from analyses|0|||
128955211|NCT04268004|464122208|FG001|Overall Study|Excluded from analyses|1|||
128955212|NCT03783442|464122209|FG000|Overall Study|Death|252|||
128955213|NCT03783442|464122210|FG001|Overall Study|Death|268|||
128955214|NCT03783442|464122209|FG000|Overall Study|Withdrawal by Subject|19|||
128955215|NCT03783442|464122210|FG001|Overall Study|Withdrawal by Subject|21|||
128955216|NCT03783442|464122209|FG000|Overall Study|Lost to Follow-up|7|||
128955217|NCT03783442|464122210|FG001|Overall Study|Lost to Follow-up|6|||
128955218|NCT03783442|464122209|FG000|Overall Study|Sponsor Ended Study|48|||
128955219|NCT03783442|464122210|FG001|Overall Study|Sponsor Ended Study|28|||
128955220|NCT04190186|464122211|FG000|Overall Study|ILR is no longer functioning|0|||
128955221|NCT04190186|464122212|FG001|Overall Study|ILR is no longer functioning|1|||
128955222|NCT04190186|464122211|FG000|Overall Study|Lost to Follow-up|0|||
128955223|NCT04190186|464122212|FG001|Overall Study|Lost to Follow-up|1|||
128955224|NCT04190186|464122211|FG000|Overall Study|Withdrawal by Subject|2|||
128955225|NCT04190186|464122212|FG001|Overall Study|Withdrawal by Subject|0|||
128955226|NCT04190186|464122211|FG000|Overall Study|Subject choice to explant|1|||
128955227|NCT04190186|464122212|FG001|Overall Study|Subject choice to explant|0|||
128955228|NCT04190186|464122211|FG000|Overall Study|Physician Decision|0|||
128955229|NCT04190186|464122212|FG001|Overall Study|Physician Decision|1|||
128955230|NCT04190186|464122211|FG000|Overall Study|Study was stopped|4|||
128955231|NCT04190186|464122212|FG001|Overall Study|Study was stopped|5|||
128955232|NCT03017846|464122213|FG000|Overall Study|Lost to Follow-up|3|||
128955233|NCT03017846|464122213|FG000|Overall Study|Adverse Event|2|||
128955234|NCT02677220|464122216|FG000|Overall Study|Adverse Event|1|||
128955235|NCT00965146|464122217|FG000|Overall Study|Death|7|||
128955236|NCT00965146|464122217|FG000|Overall Study|Lost to Follow-up|22|||
128955237|NCT00965146|464122217|FG000|Overall Study|Withdrawal by Subject|17|||
128955238|NCT00965146|464122217|FG000|Overall Study|Unable to return|1|||
128955239|NCT00965146|464122217|FG000|Overall Study|Unwilling to return|11|||
128955240|NCT00965146|464122217|FG000|Overall Study|Intercurrent illness|1|||
128955241|NCT00965146|464122217|FG000|Overall Study|Revision / Removal of Study Implant|6|||
128955242|NCT00965146|464122217|FG000|Overall Study|Overall Study Termination|145|||
128955243|NCT00830960|464122218|FG000|Overall Study|Death|5|||
128955244|NCT00830960|464122219|FG001|Overall Study|Death|4|||
128955245|NCT00830960|464122220|FG002|Overall Study|Death|3|||
129036091|NCT02780167|464423397|FG004|Overall Study|Protocol Violation|2|||
128955246|NCT00830960|464122221|FG003|Overall Study|Death|2|||
128955247|NCT00830960|464122222|FG004|Overall Study|Death|6|||
128955248|NCT00830960|464122223|FG005|Overall Study|Death|1|||
128955249|NCT00830960|464122218|FG000|Overall Study|Lost to Follow-up|1|||
128955250|NCT00830960|464122219|FG001|Overall Study|Lost to Follow-up|1|||
128955251|NCT00830960|464122220|FG002|Overall Study|Lost to Follow-up|1|||
128955252|NCT00830960|464122221|FG003|Overall Study|Lost to Follow-up|0|||
128955253|NCT00830960|464122222|FG004|Overall Study|Lost to Follow-up|0|||
128955254|NCT00830960|464122223|FG005|Overall Study|Lost to Follow-up|1|||
128955255|NCT00830960|464122218|FG000|Overall Study|Withdrawal by Subject|19|||
128955256|NCT00830960|464122219|FG001|Overall Study|Withdrawal by Subject|19|||
128955257|NCT00830960|464122220|FG002|Overall Study|Withdrawal by Subject|18|||
128955258|NCT00830960|464122221|FG003|Overall Study|Withdrawal by Subject|23|||
129036092|NCT02780167|464423393|FG000|Overall Study|Withdrawal by Subject|6|||
129036093|NCT02780167|464423394|FG001|Overall Study|Withdrawal by Subject|4|||
128955259|NCT00830960|464122222|FG004|Overall Study|Withdrawal by Subject|16|||
128955260|NCT00830960|464122223|FG005|Overall Study|Withdrawal by Subject|21|||
128955261|NCT00830960|464122218|FG000|Overall Study|Sponsor Decision|1|||
128955262|NCT00830960|464122219|FG001|Overall Study|Sponsor Decision|2|||
128955263|NCT00830960|464122220|FG002|Overall Study|Sponsor Decision|3|||
128955264|NCT00830960|464122221|FG003|Overall Study|Sponsor Decision|4|||
128955265|NCT00830960|464122222|FG004|Overall Study|Sponsor Decision|5|||
128955266|NCT00830960|464122223|FG005|Overall Study|Sponsor Decision|7|||
128955267|NCT00830960|464122218|FG000|Overall Study|No study drug received|7|||
128955268|NCT00830960|464122219|FG001|Overall Study|No study drug received|2|||
128955269|NCT00830960|464122220|FG002|Overall Study|No study drug received|4|||
128955270|NCT00830960|464122221|FG003|Overall Study|No study drug received|3|||
128955271|NCT00830960|464122222|FG004|Overall Study|No study drug received|5|||
128955272|NCT00830960|464122223|FG005|Overall Study|No study drug received|7|||
128955273|NCT01086150|464122224|FG000|Overall Study|Withdrawal by Subject|0|||
128955274|NCT01086150|464122225|FG001|Overall Study|Withdrawal by Subject|4|||
128955275|NCT01086150|464122226|FG002|Overall Study|Withdrawal by Subject|1|||
128955276|NCT01086150|464122224|FG000|Overall Study|Lost to Follow-up|0|||
128955277|NCT01086150|464122225|FG001|Overall Study|Lost to Follow-up|1|||
128955278|NCT01086150|464122226|FG002|Overall Study|Lost to Follow-up|0|||
128955279|NCT01086150|464122224|FG000|Overall Study|Screen Failure|0|||
128955280|NCT01086150|464122225|FG001|Overall Study|Screen Failure|1|||
128955281|NCT01086150|464122226|FG002|Overall Study|Screen Failure|0|||
128955282|NCT00805545|464122227|FG000|Overall Study|Protocol Violation|3|||
128955283|NCT00805545|464122228|FG001|Overall Study|Protocol Violation|2|||
128955284|NCT00805545|464122227|FG000|Overall Study|Protocol Violation|3|||
128955285|NCT00805545|464122228|FG001|Overall Study|Protocol Violation|1|||
128955286|NCT03448224|464122229|FG000|Overall Study|Provided same answer to every question|1|||
128955287|NCT03448224|464122230|FG001|Overall Study|Provided same answer to every question|0|||
128955288|NCT01021813|464122231|FG000|DB Treatment Phase|Adverse Event|60|||
128955289|NCT01021813|464122232|FG001|DB Treatment Phase|Adverse Event|22|||
128955290|NCT01021813|464122233|FG002|DB Treatment Phase|Adverse Event|0|||
128955291|NCT01021813|464122234|FG003|DB Treatment Phase|Adverse Event|0|||
128955292|NCT01021813|464122235|FG004|DB Treatment Phase|Adverse Event|0|||
128955293|NCT01021813|464122231|FG000|DB Treatment Phase|Lack of Efficacy|44|||
128955294|NCT01021813|464122232|FG001|DB Treatment Phase|Lack of Efficacy|28|||
128955295|NCT01021813|464122233|FG002|DB Treatment Phase|Lack of Efficacy|0|||
128955296|NCT01021813|464122234|FG003|DB Treatment Phase|Lack of Efficacy|0|||
128955297|NCT01021813|464122235|FG004|DB Treatment Phase|Lack of Efficacy|0|||
128955298|NCT01021813|464122231|FG000|DB Treatment Phase|Lost to Follow-up|14|||
128955299|NCT01021813|464122232|FG001|DB Treatment Phase|Lost to Follow-up|12|||
128955300|NCT01021813|464122233|FG002|DB Treatment Phase|Lost to Follow-up|0|||
128955301|NCT01021813|464122234|FG003|DB Treatment Phase|Lost to Follow-up|0|||
128955302|NCT01021813|464122235|FG004|DB Treatment Phase|Lost to Follow-up|0|||
128955303|NCT01021813|464122231|FG000|DB Treatment Phase|Physician Decision|17|||
128955304|NCT01021813|464122232|FG001|DB Treatment Phase|Physician Decision|8|||
128955305|NCT01021813|464122233|FG002|DB Treatment Phase|Physician Decision|0|||
128955306|NCT01021813|464122234|FG003|DB Treatment Phase|Physician Decision|0|||
128955307|NCT01021813|464122235|FG004|DB Treatment Phase|Physician Decision|0|||
128955308|NCT01021813|464122231|FG000|DB Treatment Phase|Pregnancy|1|||
128955309|NCT01021813|464122232|FG001|DB Treatment Phase|Pregnancy|0|||
128955310|NCT01021813|464122233|FG002|DB Treatment Phase|Pregnancy|0|||
128955311|NCT01021813|464122234|FG003|DB Treatment Phase|Pregnancy|0|||
128955312|NCT01021813|464122235|FG004|DB Treatment Phase|Pregnancy|0|||
128955313|NCT01021813|464122231|FG000|DB Treatment Phase|Protocol Violation|4|||
128955314|NCT01021813|464122232|FG001|DB Treatment Phase|Protocol Violation|3|||
128955315|NCT01021813|464122233|FG002|DB Treatment Phase|Protocol Violation|0|||
128955316|NCT01021813|464122234|FG003|DB Treatment Phase|Protocol Violation|0|||
128955317|NCT01021813|464122235|FG004|DB Treatment Phase|Protocol Violation|0|||
128955318|NCT01021813|464122231|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
128955319|NCT01021813|464122232|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
128955320|NCT01021813|464122233|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
128955321|NCT01021813|464122234|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
128955322|NCT01021813|464122235|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
128955323|NCT01021813|464122231|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
128955324|NCT01021813|464122232|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
128955325|NCT01021813|464122233|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
128955326|NCT01021813|464122234|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
128955327|NCT01021813|464122235|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
128955328|NCT01021813|464122231|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
128955329|NCT01021813|464122232|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
128955330|NCT01021813|464122233|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
128955331|NCT01021813|464122234|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
128955332|NCT01021813|464122235|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
128955333|NCT01021813|464122231|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
128711635|NCT01348347|463239970|FG002|Overall Study|Withdrawal by Subject|1|||
128955334|NCT01021813|464122232|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
128955335|NCT01021813|464122233|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
128955336|NCT01021813|464122234|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
128955337|NCT01021813|464122235|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
128955338|NCT01021813|464122231|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
128955339|NCT01021813|464122232|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
128955340|NCT01021813|464122233|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
128955341|NCT01021813|464122234|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
128955342|NCT01021813|464122235|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
128955343|NCT01021813|464122231|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
128955344|NCT01021813|464122232|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
128955345|NCT01021813|464122233|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
128955346|NCT01021813|464122234|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
128955347|NCT01021813|464122235|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
128955348|NCT00862121|464122238|FG000|Overall Study|Adverse Event|1|||
128955349|NCT00862121|464122239|FG001|Overall Study|Adverse Event|2|||
128955350|NCT00862121|464122238|FG000|Overall Study|Lack of Efficacy|0|||
128955351|NCT00862121|464122239|FG001|Overall Study|Lack of Efficacy|3|||
128955352|NCT00862121|464122238|FG000|Overall Study|Protocol Violation|0|||
128955353|NCT00862121|464122239|FG001|Overall Study|Protocol Violation|1|||
128955354|NCT00862121|464122238|FG000|Overall Study|Exclusion criterion violation|0|||
128955355|NCT00862121|464122239|FG001|Overall Study|Exclusion criterion violation|1|||
128955356|NCT00862121|464122238|FG000|Overall Study|Incorrect randomisation|0|||
128955357|NCT00862121|464122239|FG001|Overall Study|Incorrect randomisation|1|||
128955358|NCT00171314|464122244|FG000|Overall Study|Adverse Event|44|||
128955359|NCT00171314|464122245|FG001|Overall Study|Adverse Event|41|||
128955360|NCT00171314|464122244|FG000|Overall Study|Lack of Efficacy|19|||
128955361|NCT00171314|464122245|FG001|Overall Study|Lack of Efficacy|14|||
128955362|NCT00171314|464122244|FG000|Overall Study|Withdrawal by Subject|9|||
128955363|NCT00171314|464122245|FG001|Overall Study|Withdrawal by Subject|6|||
128955364|NCT00171314|464122244|FG000|Overall Study|Abnormal Test Procedure Results|9|||
128955365|NCT00171314|464122245|FG001|Overall Study|Abnormal Test Procedure Results|3|||
128955366|NCT00171314|464122244|FG000|Overall Study|Protocol Violation|3|||
128955367|NCT00171314|464122245|FG001|Overall Study|Protocol Violation|7|||
128955368|NCT00171314|464122244|FG000|Overall Study|Administrative Problems|4|||
128955369|NCT00171314|464122245|FG001|Overall Study|Administrative Problems|3|||
128955370|NCT00171314|464122244|FG000|Overall Study|Lost to Follow-up|1|||
128955371|NCT00171314|464122245|FG001|Overall Study|Lost to Follow-up|3|||
128955372|NCT00171314|464122244|FG000|Overall Study|Death|2|||
128955373|NCT00171314|464122245|FG001|Overall Study|Death|1|||
128955374|NCT01033487|464122249|FG000|Fourth Intervention Period|Adverse Event|0|||
128955375|NCT01033487|464122250|FG001|Fourth Intervention Period|Adverse Event|0|||
128955376|NCT01033487|464122251|FG002|Fourth Intervention Period|Adverse Event|0|||
128955377|NCT01033487|464122252|FG003|Fourth Intervention Period|Adverse Event|0|||
128955378|NCT01033487|464122253|FG004|Fourth Intervention Period|Adverse Event|0|||
128955379|NCT01033487|464122254|FG005|Fourth Intervention Period|Adverse Event|0|||
128955380|NCT01033487|464122255|FG006|Fourth Intervention Period|Adverse Event|0|||
129126183|NCT00620542|464757931|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129126184|NCT00620542|464757928|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
129126185|NCT00620542|464757929|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
129126186|NCT00620542|464757930|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
129126187|NCT00620542|464757931|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
129126188|NCT00620542|464757928|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
129126189|NCT00620542|464757929|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
129126190|NCT00620542|464757930|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
129126191|NCT00620542|464757931|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
129126192|NCT00620542|464757928|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129126193|NCT00620542|464757929|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
129126194|NCT00620542|464757930|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129126195|NCT00620542|464757931|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129126196|NCT00620542|464757928|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
129126197|NCT00620542|464757929|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
129126198|NCT00620542|464757930|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
128955381|NCT01033487|464122256|FG007|Fourth Intervention Period|Adverse Event|0|||
128955382|NCT01033487|464122257|FG008|Fourth Intervention Period|Adverse Event|1|||
128955383|NCT01033487|464122258|FG009|Fourth Intervention Period|Adverse Event|0|||
129126199|NCT00620542|464757931|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
128955384|NCT02939599|464122259|FG000|Overall Study|Adverse Event|1|||
128955385|NCT02939599|464122260|FG001|Overall Study|Adverse Event|0|||
128955386|NCT02939599|464122259|FG000|Overall Study|Study Terminated By Sponsor|2|||
128955387|NCT02939599|464122260|FG001|Overall Study|Study Terminated By Sponsor|2|||
129126200|NCT00620542|464757928|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
128955388|NCT02148211|464122261|FG000|Overall Study|Lost to Follow-up|352|||
128955389|NCT02726113|464122262|FG000|Total Enrollment|Physician Decision|0|||
128955390|NCT02726113|464122263|FG001|Total Enrollment|Physician Decision|1|||
128955391|NCT02726113|464122262|FG000|Total Enrollment|Protocol Violation|1|||
128955392|NCT02726113|464122263|FG001|Total Enrollment|Protocol Violation|0|||
128955393|NCT02726113|464122262|FG000|Total Enrollment|Withdrawal by Subject|2|||
128955394|NCT02726113|464122263|FG001|Total Enrollment|Withdrawal by Subject|1|||
128955395|NCT02726113|464122262|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
128955396|NCT02726113|464122263|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
128955397|NCT02726113|464122262|FG000|Genomic Analysis|Protocol Violation|1|||
128955398|NCT02726113|464122263|FG001|Genomic Analysis|Protocol Violation|0|||
128955399|NCT02726113|464122262|FG000|Genomic Analysis|Withdrawal by Subject|2|||
128955400|NCT02726113|464122263|FG001|Genomic Analysis|Withdrawal by Subject|1|||
128955401|NCT02726113|464122262|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
128955402|NCT02726113|464122263|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
128955403|NCT03326869|464123701|FG000|Overall Study|Study data has been lost to natural disa|1|||
128955404|NCT03326869|464123702|FG001|Overall Study|Study data has been lost to natural disa|1|||
128955405|NCT03628599|464123704|FG000|Overall Study|Adverse Event|0|||
128955406|NCT03628599|464123705|FG001|Overall Study|Adverse Event|1|||
128955407|NCT01624506|464123706|FG000|Overall Study|Lost to Follow-up|29|||
128955408|NCT01624506|464123707|FG001|Overall Study|Lost to Follow-up|15|||
128955409|NCT01624506|464123706|FG000|Overall Study|Withdrawal by Subject|9|||
128955410|NCT01624506|464123707|FG001|Overall Study|Withdrawal by Subject|2|||
128955411|NCT01624506|464123706|FG000|Overall Study|Death|1|||
128955412|NCT01624506|464123707|FG001|Overall Study|Death|0|||
128955413|NCT01624506|464123706|FG000|Overall Study|LINX explants|23|||
128955414|NCT01624506|464123707|FG001|Overall Study|LINX explants|0|||
128955415|NCT01624506|464123706|FG000|Overall Study|Adverse Event|3|||
128955416|NCT01624506|464123707|FG001|Overall Study|Adverse Event|0|||
128955417|NCT00132314|464123710|FG000|Overall Study|Lost to Follow-up|70|||
128955418|NCT00132314|464123711|FG001|Overall Study|Lost to Follow-up|62|||
128955419|NCT00132314|464123710|FG000|Overall Study|Lacked SSN|1|||
128955420|NCT00132314|464123711|FG001|Overall Study|Lacked SSN|3|||
128955421|NCT00132314|464123710|FG000|Overall Study|Refused intervention at baseline|2|||
128955422|NCT00132314|464123711|FG001|Overall Study|Refused intervention at baseline|7|||
128955423|NCT02966353|464123714|FG000|Overall Study|Withdrawal by Subject|7|||
128955424|NCT02966353|464123714|FG000|Overall Study|Adverse Event|4|||
128955425|NCT02966353|464123714|FG000|Overall Study|Death|4|||
128955426|NCT02966353|464123714|FG000|Overall Study|Physician Decision|3|||
128955427|NCT02966353|464123714|FG000|Overall Study|Progressive disease|2|||
128955428|NCT02966353|464123714|FG000|Overall Study|Protocol deviation|2|||
128955429|NCT00093470|464123715|FG000|Overall Study|Disease progression|39|||
128955430|NCT00093470|464123716|FG001|Overall Study|Disease progression|0|||
128955431|NCT00093470|464123715|FG000|Overall Study|Adverse Event|15|||
128955432|NCT00093470|464123716|FG001|Overall Study|Adverse Event|0|||
128955433|NCT00093470|464123715|FG000|Overall Study|Death|2|||
128955434|NCT00093470|464123716|FG001|Overall Study|Death|0|||
128955435|NCT00093470|464123715|FG000|Overall Study|Withdrawal by Subject|8|||
128955436|NCT00093470|464123716|FG001|Overall Study|Withdrawal by Subject|0|||
128955437|NCT00093470|464123715|FG000|Overall Study|Alternative therapy|2|||
128955438|NCT00093470|464123716|FG001|Overall Study|Alternative therapy|0|||
128955439|NCT00093470|464123715|FG000|Overall Study|Other complicating disease|3|||
128955440|NCT00093470|464123716|FG001|Overall Study|Other complicating disease|0|||
128955441|NCT00093470|464123715|FG000|Overall Study|Physician Decision|2|||
128955442|NCT00093470|464123716|FG001|Overall Study|Physician Decision|0|||
128955443|NCT00093470|464123715|FG000|Overall Study|Never started treatment|1|||
128955444|NCT00093470|464123716|FG001|Overall Study|Never started treatment|0|||
128955445|NCT00093470|464123715|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
128955446|NCT00093470|464123716|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
128955447|NCT05905601|464123717|FG000|Overall Study|Lost to Follow-up|1|||
128955448|NCT05905601|464123718|FG001|Overall Study|Lost to Follow-up|3|||
128955449|NCT02514772|464123719|FG000|Overall Study|Adverse Event|1|||
128955450|NCT02514772|464123720|FG001|Overall Study|Adverse Event|0|||
128955451|NCT02514772|464123719|FG000|Overall Study|Death|0|||
128955452|NCT02514772|464123720|FG001|Overall Study|Death|1|||
129219476|NCT02963506|465103052|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
128955453|NCT02514772|464123719|FG000|Overall Study|Withdrawal by Subject|2|||
128955454|NCT02514772|464123720|FG001|Overall Study|Withdrawal by Subject|1|||
128955455|NCT01415908|464123721|FG000|Overall Study|Withdrawal by Subject|1|||
128955456|NCT01415908|464123722|FG001|Overall Study|Withdrawal by Subject|0|||
128955457|NCT03250377|464123723|FG000|Overall Study|Adverse Event|2|||
128955458|NCT03250377|464123724|FG001|Overall Study|Adverse Event|4|||
128955459|NCT03250377|464123725|FG002|Overall Study|Adverse Event|0|||
128955460|NCT03250377|464123726|FG003|Overall Study|Adverse Event|4|||
128955461|NCT03250377|464123723|FG000|Overall Study|Lack of Efficacy|5|||
128955462|NCT03250377|464123724|FG001|Overall Study|Lack of Efficacy|14|||
128955463|NCT03250377|464123725|FG002|Overall Study|Lack of Efficacy|1|||
128955464|NCT03250377|464123726|FG003|Overall Study|Lack of Efficacy|3|||
128955465|NCT03250377|464123723|FG000|Overall Study|Protocol Violation|0|||
128955466|NCT03250377|464123724|FG001|Overall Study|Protocol Violation|2|||
128955467|NCT03250377|464123725|FG002|Overall Study|Protocol Violation|0|||
128955468|NCT03250377|464123726|FG003|Overall Study|Protocol Violation|1|||
128955469|NCT03250377|464123723|FG000|Overall Study|Lost to Follow-up|0|||
128955470|NCT03250377|464123724|FG001|Overall Study|Lost to Follow-up|1|||
128955471|NCT03250377|464123725|FG002|Overall Study|Lost to Follow-up|0|||
128955472|NCT03250377|464123726|FG003|Overall Study|Lost to Follow-up|0|||
128955473|NCT03250377|464123723|FG000|Overall Study|Withdrawal by Subject|7|||
128955474|NCT03250377|464123724|FG001|Overall Study|Withdrawal by Subject|7|||
128955475|NCT03250377|464123725|FG002|Overall Study|Withdrawal by Subject|0|||
128955476|NCT03250377|464123726|FG003|Overall Study|Withdrawal by Subject|4|||
128955477|NCT03250377|464123723|FG000|Overall Study|Investigator's Judgment|1|||
128955478|NCT03250377|464123724|FG001|Overall Study|Investigator's Judgment|0|||
128955479|NCT03250377|464123725|FG002|Overall Study|Investigator's Judgment|0|||
128955480|NCT03250377|464123726|FG003|Overall Study|Investigator's Judgment|0|||
128955481|NCT03250377|464123723|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
128955482|NCT03250377|464123724|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
128955483|NCT03250377|464123725|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
128955484|NCT03250377|464123726|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
128955485|NCT03250377|464123723|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
128955486|NCT03250377|464123724|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
128955487|NCT03250377|464123725|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
128955488|NCT03250377|464123726|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
128955489|NCT03250377|464123723|FG000|Overall Study|Epilepsy Surgery|0|||
128955490|NCT03250377|464123724|FG001|Overall Study|Epilepsy Surgery|1|||
128955491|NCT03250377|464123725|FG002|Overall Study|Epilepsy Surgery|2|||
128955492|NCT03250377|464123726|FG003|Overall Study|Epilepsy Surgery|0|||
128955493|NCT03250377|464123723|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
128955494|NCT03250377|464123724|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
128955495|NCT03250377|464123725|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
128955496|NCT03250377|464123726|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
128955497|NCT03250377|464123723|FG000|Overall Study|Request From The Sponsor|0|||
128955498|NCT03250377|464123724|FG001|Overall Study|Request From The Sponsor|1|||
128955499|NCT03250377|464123725|FG002|Overall Study|Request From The Sponsor|0|||
128955500|NCT03250377|464123726|FG003|Overall Study|Request From The Sponsor|0|||
128955501|NCT03250377|464123723|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
128955502|NCT03250377|464123724|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
128955503|NCT03250377|464123725|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
128955504|NCT03250377|464123726|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
128955505|NCT03250377|464123723|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
128955506|NCT03250377|464123724|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
128955507|NCT03250377|464123725|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
128955508|NCT03250377|464123726|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
128955509|NCT03250377|464123723|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
128955510|NCT03250377|464123724|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
128955511|NCT03250377|464123725|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
128955512|NCT03250377|464123726|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
128955513|NCT03250377|464123723|FG000|Overall Study|Pregnancy Event|0|||
128955514|NCT03250377|464123724|FG001|Overall Study|Pregnancy Event|1|||
128955515|NCT03250377|464123725|FG002|Overall Study|Pregnancy Event|0|||
128955516|NCT03250377|464123726|FG003|Overall Study|Pregnancy Event|0|||
128955517|NCT03250377|464123723|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
128955518|NCT03250377|464123724|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
128955519|NCT03250377|464123725|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
128955520|NCT03250377|464123726|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
128955521|NCT03250377|464123723|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
129036094|NCT02780167|464423395|FG002|Overall Study|Withdrawal by Subject|4|||
129036095|NCT02780167|464423396|FG003|Overall Study|Withdrawal by Subject|3|||
129036096|NCT02780167|464423397|FG004|Overall Study|Withdrawal by Subject|4|||
129036097|NCT02780167|464423393|FG000|Overall Study|Other|0|||
129036098|NCT02780167|464423394|FG001|Overall Study|Other|0|||
129036099|NCT02780167|464423395|FG002|Overall Study|Other|3|||
129036100|NCT02780167|464423396|FG003|Overall Study|Other|1|||
129219477|NCT02963506|465103053|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129219478|NCT02963506|465103054|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
128955522|NCT03250377|464123724|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
128955523|NCT03250377|464123725|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
129036101|NCT02780167|464423397|FG004|Overall Study|Other|2|||
129036102|NCT03180801|464423398|FG000|Overall Study|Physician Decision|3|||
128955524|NCT03250377|464123726|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
128955525|NCT03250377|464123723|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
128955526|NCT03250377|464123724|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
128955527|NCT03250377|464123725|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
128955528|NCT03250377|464123726|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
128955529|NCT03250377|464123723|FG000|Overall Study|Patient requested to change hospital|0|||
128955530|NCT03250377|464123724|FG001|Overall Study|Patient requested to change hospital|0|||
128955531|NCT03250377|464123725|FG002|Overall Study|Patient requested to change hospital|0|||
128955532|NCT03250377|464123726|FG003|Overall Study|Patient requested to change hospital|1|||
128955533|NCT03250377|464123723|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
128955534|NCT03250377|464123724|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
128955535|NCT03250377|464123725|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
128955536|NCT03250377|464123726|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
128955537|NCT00817206|464123727|FG000|Overall Study|Adverse Event|10|||
128955538|NCT00817206|464123728|FG001|Overall Study|Adverse Event|3|||
128955539|NCT00817206|464123727|FG000|Overall Study|Protocol Violation|0|||
128955540|NCT00817206|464123728|FG001|Overall Study|Protocol Violation|2|||
128955541|NCT00817206|464123727|FG000|Overall Study|Lost to Follow-up|0|||
128955542|NCT00817206|464123728|FG001|Overall Study|Lost to Follow-up|1|||
128955543|NCT00817206|464123727|FG000|Overall Study|Death|2|||
128955544|NCT00817206|464123728|FG001|Overall Study|Death|0|||
128955545|NCT00817206|464123727|FG000|Overall Study|Withdrawal by Subject|7|||
128955546|NCT00817206|464123728|FG001|Overall Study|Withdrawal by Subject|3|||
128955547|NCT00817206|464123727|FG000|Overall Study|Physician Decision|2|||
128955548|NCT00817206|464123728|FG001|Overall Study|Physician Decision|0|||
128955549|NCT02034552|464123729|FG000|Overall Study|Never treated|3|||
128955550|NCT02034552|464123730|FG001|Overall Study|Never treated|2|||
128955551|NCT02034552|464123731|FG002|Overall Study|Never treated|0|||
128955552|NCT02034552|464123729|FG000|Overall Study|Radiological progression|3|||
128955553|NCT02034552|464123730|FG001|Overall Study|Radiological progression|5|||
128955554|NCT02034552|464123731|FG002|Overall Study|Radiological progression|4|||
128955555|NCT02034552|464123729|FG000|Overall Study|AE not assoc. with disease progression|1|||
128955556|NCT02034552|464123730|FG001|Overall Study|AE not assoc. with disease progression|4|||
128955557|NCT02034552|464123731|FG002|Overall Study|AE not assoc. with disease progression|2|||
128955558|NCT02034552|464123729|FG000|Overall Study|AE associated with disease progression|0|||
128955559|NCT02034552|464123730|FG001|Overall Study|AE associated with disease progression|1|||
128955560|NCT02034552|464123731|FG002|Overall Study|AE associated with disease progression|0|||
128955561|NCT02034552|464123729|FG000|Overall Study|Withdrawal by Subject|2|||
128955562|NCT02034552|464123730|FG001|Overall Study|Withdrawal by Subject|1|||
128955563|NCT02034552|464123731|FG002|Overall Study|Withdrawal by Subject|1|||
128955564|NCT02034552|464123729|FG000|Overall Study|Non-compliance with study drug|0|||
128955565|NCT02034552|464123730|FG001|Overall Study|Non-compliance with study drug|0|||
128955566|NCT02034552|464123731|FG002|Overall Study|Non-compliance with study drug|1|||
128955567|NCT02034552|464123729|FG000|Overall Study|Clinical progression|5|||
128955568|NCT02034552|464123730|FG001|Overall Study|Clinical progression|7|||
128955569|NCT02034552|464123731|FG002|Overall Study|Clinical progression|9|||
128955570|NCT00291499|464123737|FG000|Overall Study|Adverse Event|3|||
128955571|NCT00291499|464123738|FG001|Overall Study|Adverse Event|8|||
128955572|NCT00291499|464123737|FG000|Overall Study|Change to other therapy|2|||
128955573|NCT00291499|464123738|FG001|Overall Study|Change to other therapy|1|||
129126201|NCT00620542|464757929|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
128955574|NCT00291499|464123737|FG000|Overall Study|Intercurrent illness|1|||
128955575|NCT00291499|464123738|FG001|Overall Study|Intercurrent illness|0|||
128955576|NCT00291499|464123737|FG000|Overall Study|Protocol Violation|2|||
128955577|NCT00291499|464123738|FG001|Overall Study|Protocol Violation|2|||
128955578|NCT00291499|464123737|FG000|Overall Study|Other reasons|1|||
128955579|NCT00291499|464123738|FG001|Overall Study|Other reasons|4|||
128955580|NCT01532570|464123739|FG000|Overall Study|Lack of Efficacy|1|||
128955581|NCT01532570|464123740|FG001|Overall Study|Lack of Efficacy|0|||
129126202|NCT00620542|464757930|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
128955582|NCT01532570|464123741|FG002|Overall Study|Lack of Efficacy|0|||
128955583|NCT01532570|464123742|FG003|Overall Study|Lack of Efficacy|0|||
128955584|NCT01532570|464123739|FG000|Overall Study|Withdrawal by Subject|0|||
128955585|NCT01532570|464123740|FG001|Overall Study|Withdrawal by Subject|1|||
128955586|NCT01532570|464123741|FG002|Overall Study|Withdrawal by Subject|0|||
128955587|NCT01532570|464123742|FG003|Overall Study|Withdrawal by Subject|0|||
128955588|NCT04325906|464123743|FG000|Overall Study|Withdrawal by Subject|2|||
128955589|NCT04325906|464123744|FG001|Overall Study|Withdrawal by Subject|0|||
128955590|NCT01082367|464123745|FG000|Double-blind Period|Administrative problems|0|||
128955591|NCT01082367|464123746|FG001|Double-blind Period|Administrative problems|1|||
128955592|NCT01082367|464123745|FG000|Double-blind Period|Lack of Efficacy|5|||
128955593|NCT01082367|464123746|FG001|Double-blind Period|Lack of Efficacy|11|||
129126203|NCT00620542|464757931|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
128711636|NCT01348347|463239968|FG000|Overall Study|Progressive disease|2|||
128711637|NCT01348347|463239969|FG001|Overall Study|Progressive disease|5|||
128955594|NCT01082367|464123745|FG000|Double-blind Period|Adverse Event|0|||
128955595|NCT01082367|464123746|FG001|Double-blind Period|Adverse Event|1|||
128955596|NCT01082367|464123745|FG000|Follow-up (F-U) Period|Administrative problems|1|||
128955597|NCT01082367|464123746|FG001|Follow-up (F-U) Period|Administrative problems|0|||
128955598|NCT01082367|464123745|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
128955599|NCT01082367|464123746|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
128955600|NCT01082367|464123745|FG000|Follow-up (F-U) Period|Adverse Event|0|||
128955601|NCT01082367|464123746|FG001|Follow-up (F-U) Period|Adverse Event|1|||
128955602|NCT02016898|464123747|FG000|Overall Study|Death|1|||
128955603|NCT02016898|464123748|FG001|Overall Study|Death|1|||
128955604|NCT02016898|464123747|FG000|Overall Study|Lost to Follow-up|4|||
128955605|NCT02016898|464123748|FG001|Overall Study|Lost to Follow-up|4|||
128955606|NCT01665768|464123749|FG000|Overall Study|Adverse Event|3|||
128955607|NCT01665768|464123749|FG000|Overall Study|Lack of Efficacy|19|||
128955608|NCT01665768|464123749|FG000|Overall Study|Withdrawal by Subject|1|||
128955609|NCT01329341|464123750|FG000|Overall Study|Withdrawal by Subject|44|||
128955610|NCT04603391|464123751|FG000|First Intervention (4 Days)|Adverse Event|1|||
128955611|NCT04603391|464123752|FG001|First Intervention (4 Days)|Adverse Event|0|||
128955612|NCT04603391|464123751|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
128955613|NCT04603391|464123752|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
128955614|NCT02151682|464123753|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
128955615|NCT02151682|464123754|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
128955616|NCT02151682|464123755|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
128955617|NCT02151682|464123756|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
128955618|NCT02151682|464123757|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
128955619|NCT02151682|464123758|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
128955620|NCT02151682|464123753|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
128955621|NCT02151682|464123754|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
128955622|NCT02151682|464123755|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
128955623|NCT02151682|464123756|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
128955624|NCT02151682|464123757|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
128955625|NCT02151682|464123758|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
128955626|NCT02151682|464123753|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
128955627|NCT02151682|464123754|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
128955628|NCT02151682|464123755|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
128955629|NCT02151682|464123756|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
128955630|NCT02151682|464123757|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
128955631|NCT02151682|464123758|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
128955632|NCT02151682|464123753|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
128955633|NCT02151682|464123754|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
128955634|NCT02151682|464123755|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
128955635|NCT02151682|464123756|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
128955636|NCT02151682|464123757|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
128955637|NCT02151682|464123758|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
128955638|NCT02151682|464123753|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
128955639|NCT02151682|464123754|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
128955640|NCT02151682|464123755|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
128955641|NCT02151682|464123756|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
128955642|NCT02151682|464123757|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
128955643|NCT02151682|464123758|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
128955644|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
128955645|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
128955646|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
128955647|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
128955648|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
128955649|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
128955650|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
128955651|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
128955652|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
128955653|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
129219479|NCT02963506|465103055|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
128711638|NCT01348347|463239970|FG002|Overall Study|Progressive disease|5|||
128955654|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
128955655|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
128955656|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
128955657|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
128711639|NCT00748033|463239971|FG000|Overall Study|Adverse Event|0|||
128955658|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
128955659|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
128955660|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
128955661|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
128955662|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
128955663|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
128955664|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
128955665|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
128955666|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
128955667|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
128955668|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
128955669|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
128955670|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
128955671|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
128955672|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
128955673|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
128955674|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
128955675|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
128955676|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
128955677|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
128955678|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
128955679|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
128955680|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
128955681|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
128955682|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
128955683|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
128955684|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
128955685|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
128955686|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
128955687|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
128955688|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
128955689|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
128955690|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
128955691|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
128955692|NCT02151682|464123753|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
128955693|NCT02151682|464123754|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
128955694|NCT02151682|464123755|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
128955695|NCT02151682|464123756|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
128955696|NCT02151682|464123757|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
128955697|NCT02151682|464123758|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
128955698|NCT02151682|464123753|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
128955699|NCT02151682|464123754|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
128955700|NCT02151682|464123755|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
128955701|NCT02151682|464123756|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
128955702|NCT02151682|464123757|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
128955703|NCT02151682|464123758|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
128955704|NCT02151682|464123753|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
128955705|NCT02151682|464123754|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
128955706|NCT02151682|464123755|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
128955707|NCT02151682|464123756|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
128955708|NCT02151682|464123757|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
128955709|NCT02151682|464123758|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
128955710|NCT02151682|464123753|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
128955711|NCT02151682|464123754|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
128955712|NCT02151682|464123755|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
128955713|NCT02151682|464123756|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
128955714|NCT02151682|464123757|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
128955715|NCT02151682|464123758|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
129126204|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
129126205|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
129126206|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
129126207|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
129126208|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
129126209|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
129126210|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
128955716|NCT02151682|464123753|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
128955717|NCT02151682|464123754|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
128955718|NCT02151682|464123755|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
128955719|NCT02151682|464123756|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
128955720|NCT02151682|464123757|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
128955721|NCT02151682|464123758|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
128955722|NCT03260894|464123760|FG000|Overall Study|Death|6|||
128955723|NCT03260894|464123761|FG001|Overall Study|Death|8|||
128955724|NCT03260894|464123760|FG000|Overall Study|Withdrawal by Subject|4|||
128955725|NCT03260894|464123761|FG001|Overall Study|Withdrawal by Subject|11|||
128955726|NCT03260894|464123760|FG000|Overall Study|On-going at clinical cut off date|36|||
128955727|NCT03260894|464123761|FG001|Overall Study|On-going at clinical cut off date|31|||
128955728|NCT00992186|464123762|FG000|Overall Study|Withdrawal by Subject|2|||
128955729|NCT00992186|464123762|FG000|Overall Study|Protocol Violation|1|||
128955730|NCT00992186|464123762|FG000|Overall Study|Physician Decision|1|||
128955731|NCT00992186|464123762|FG000|Overall Study|Adverse Event|9|||
128955732|NCT00992186|464123762|FG000|Overall Study|Progressive Disease|30|||
128955733|NCT00992186|464123762|FG000|Overall Study|Refusal To Receive Study Agent|3|||
128955734|NCT00168064|464123763|FG000|Overall Study|Adverse Event|26|||
128955735|NCT00168064|464123764|FG001|Overall Study|Adverse Event|22|||
128955736|NCT00168064|464123763|FG000|Overall Study|Withdrawal by Subject|3|||
128955737|NCT00168064|464123764|FG001|Overall Study|Withdrawal by Subject|4|||
128955738|NCT00168064|464123763|FG000|Overall Study|Lack of Efficacy|4|||
128955739|NCT00168064|464123764|FG001|Overall Study|Lack of Efficacy|4|||
128955740|NCT00168064|464123763|FG000|Overall Study|Lost to Follow-up|4|||
128955741|NCT00168064|464123764|FG001|Overall Study|Lost to Follow-up|3|||
128955742|NCT00168064|464123763|FG000|Overall Study|Non-compliance|2|||
128955743|NCT00168064|464123764|FG001|Overall Study|Non-compliance|3|||
128955744|NCT00168064|464123763|FG000|Overall Study|Concurrent Illness|4|||
128955745|NCT00168064|464123764|FG001|Overall Study|Concurrent Illness|3|||
128955746|NCT00168064|464123763|FG000|Overall Study|Subject's Best interest|2|||
128955747|NCT00168064|464123764|FG001|Overall Study|Subject's Best interest|2|||
128955748|NCT00168064|464123763|FG000|Overall Study|Various|4|||
128955749|NCT00168064|464123764|FG001|Overall Study|Various|3|||
128955750|NCT00318565|464123765|FG000|Overall Study|Excluded per protocol|24|||
128955751|NCT01896856|464123766|FG000|Overall Study|Transportation issues / Non-compliance|0|||
128955752|NCT01896856|464123767|FG001|Overall Study|Transportation issues / Non-compliance|0|||
128955753|NCT01896856|464123768|FG002|Overall Study|Transportation issues / Non-compliance|1|||
128955754|NCT01896856|464123769|FG003|Overall Study|Transportation issues / Non-compliance|0|||
128955755|NCT01896856|464123770|FG004|Overall Study|Transportation issues / Non-compliance|0|||
128955756|NCT01896856|464123771|FG005|Overall Study|Transportation issues / Non-compliance|0|||
128955757|NCT00282867|464123772|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
128955758|NCT00282867|464123773|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
128955759|NCT00282867|464123774|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
128955760|NCT02855450|464123775|FG000|Overall Study|Adverse Event|1|||
128955761|NCT02855450|464123776|FG001|Overall Study|Adverse Event|0|||
128955762|NCT02855450|464123775|FG000|Overall Study|Lost to Follow-up|4|||
128955763|NCT02855450|464123776|FG001|Overall Study|Lost to Follow-up|0|||
128955764|NCT00426556|464123777|FG000|Phase I - Core Phase|Disease Progression|0|||
128955765|NCT00426556|464123778|FG001|Phase I - Core Phase|Disease Progression|6|||
128955766|NCT00426556|464123779|FG002|Phase I - Core Phase|Disease Progression|2|||
128955767|NCT00426556|464123780|FG003|Phase I - Core Phase|Disease Progression|0|||
128955768|NCT00426556|464123777|FG000|Phase I - Core Phase|Adverse Event|1|||
128955769|NCT00426556|464123778|FG001|Phase I - Core Phase|Adverse Event|3|||
128955770|NCT00426556|464123779|FG002|Phase I - Core Phase|Adverse Event|1|||
128955771|NCT00426556|464123780|FG003|Phase I - Core Phase|Adverse Event|0|||
128955772|NCT00426556|464123777|FG000|Phase I - Core Phase|Death|0|||
128955773|NCT00426556|464123778|FG001|Phase I - Core Phase|Death|1|||
128955774|NCT00426556|464123779|FG002|Phase I - Core Phase|Death|0|||
128955775|NCT00426556|464123780|FG003|Phase I - Core Phase|Death|0|||
128955776|NCT00426556|464123777|FG000|Phase I - Extension Phase|Adverse Event|0|||
128955777|NCT00426556|464123778|FG001|Phase I - Extension Phase|Adverse Event|1|||
128955778|NCT00426556|464123779|FG002|Phase I - Extension Phase|Adverse Event|1|||
128955779|NCT00426556|464123780|FG003|Phase I - Extension Phase|Adverse Event|0|||
128955780|NCT00426556|464123777|FG000|Phase I - Extension Phase|Disease Progression|5|||
128955781|NCT00426556|464123778|FG001|Phase I - Extension Phase|Disease Progression|5|||
128955782|NCT00426556|464123779|FG002|Phase I - Extension Phase|Disease Progression|6|||
128955783|NCT00426556|464123780|FG003|Phase I - Extension Phase|Disease Progression|0|||
128955784|NCT00426556|464123777|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
128955785|NCT00426556|464123778|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
128955786|NCT00426556|464123779|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
128955787|NCT00426556|464123780|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
128955788|NCT00426556|464123777|FG000|Phase II - Core Phase|Disease Progression|0|||
128955789|NCT00426556|464123778|FG001|Phase II - Core Phase|Disease Progression|0|||
128955790|NCT00426556|464123779|FG002|Phase II - Core Phase|Disease Progression|0|||
128955791|NCT00426556|464123780|FG003|Phase II - Core Phase|Disease Progression|16|||
128955792|NCT00426556|464123777|FG000|Phase II - Core Phase|Adverse Event|0|||
128955793|NCT00426556|464123778|FG001|Phase II - Core Phase|Adverse Event|0|||
128955794|NCT00426556|464123779|FG002|Phase II - Core Phase|Adverse Event|0|||
128955795|NCT00426556|464123780|FG003|Phase II - Core Phase|Adverse Event|8|||
128955796|NCT00426556|464123777|FG000|Phase II - Extension Phase|Disease Progression|0|||
128955797|NCT00426556|464123778|FG001|Phase II - Extension Phase|Disease Progression|0|||
128955798|NCT00426556|464123779|FG002|Phase II - Extension Phase|Disease Progression|0|||
128955799|NCT00426556|464123780|FG003|Phase II - Extension Phase|Disease Progression|21|||
128955800|NCT00426556|464123777|FG000|Phase II - Extension Phase|Adverse Event|0|||
128955801|NCT00426556|464123778|FG001|Phase II - Extension Phase|Adverse Event|0|||
128955802|NCT00426556|464123779|FG002|Phase II - Extension Phase|Adverse Event|0|||
128955803|NCT00426556|464123780|FG003|Phase II - Extension Phase|Adverse Event|2|||
128955804|NCT01376245|464123781|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
128955805|NCT01376245|464123782|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
128955806|NCT01376245|464123783|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
128955807|NCT01376245|464123784|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
128955808|NCT01376245|464123785|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
128955809|NCT01376245|464123781|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
128955810|NCT01376245|464123782|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
128955811|NCT01376245|464123783|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
128955812|NCT01376245|464123784|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
128955813|NCT01376245|464123785|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
128955814|NCT01376245|464123781|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
128955815|NCT01376245|464123782|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
128955816|NCT01376245|464123783|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
128955817|NCT01376245|464123784|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
128955818|NCT01376245|464123785|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
128955819|NCT01376245|464123781|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
128955820|NCT01376245|464123782|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
128955821|NCT01376245|464123783|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
128955822|NCT01376245|464123784|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
128955823|NCT01376245|464123785|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
128955824|NCT01376245|464123781|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
128955825|NCT01376245|464123782|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
128955826|NCT01376245|464123783|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
128955827|NCT01376245|464123784|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
128955828|NCT01376245|464123785|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
128955829|NCT01376245|464123781|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
128955830|NCT01376245|464123782|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
128955831|NCT01376245|464123783|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
128955832|NCT01376245|464123784|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
128955833|NCT01376245|464123785|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
128955834|NCT01376245|464123781|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
128955835|NCT01376245|464123782|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
128955836|NCT01376245|464123783|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
128955837|NCT01376245|464123784|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
128955838|NCT01376245|464123785|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
128955839|NCT01376245|464123781|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
128955840|NCT01376245|464123782|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
128955841|NCT01376245|464123783|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
128955842|NCT01376245|464123784|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
128955843|NCT01376245|464123785|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
128955844|NCT01376245|464123781|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
129219480|NCT02963506|465103056|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129219481|NCT02963506|465103057|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129036103|NCT03180801|464423399|FG001|Overall Study|Physician Decision|3|||
129036104|NCT03180801|464423400|FG002|Overall Study|Physician Decision|1|||
129036105|NCT03180801|464423398|FG000|Overall Study|Non-compliance|1|||
129036106|NCT03180801|464423399|FG001|Overall Study|Non-compliance|4|||
129036107|NCT03180801|464423400|FG002|Overall Study|Non-compliance|0|||
129036108|NCT03180801|464423398|FG000|Overall Study|Inoculation Target Reached|1|||
129036109|NCT03180801|464423399|FG001|Overall Study|Inoculation Target Reached|1|||
129036110|NCT03180801|464423400|FG002|Overall Study|Inoculation Target Reached|3|||
129036111|NCT03180801|464423398|FG000|Overall Study|Adverse Event|1|||
129036112|NCT03180801|464423399|FG001|Overall Study|Adverse Event|0|||
129126211|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
129126212|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
129126213|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
129126214|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
129126215|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
129126216|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
129126217|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
129126218|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
129126219|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
129126220|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
129126221|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
129126222|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
129126223|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
129126224|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
129126225|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
129126226|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
129126227|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
129126228|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
129126229|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
129126230|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
129126231|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
129219482|NCT02963506|465103058|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129219483|NCT02963506|465103046|FG000|Dose-Blind Period|Adverse Event|0|||
129219484|NCT02963506|465103047|FG001|Dose-Blind Period|Adverse Event|0|||
128955845|NCT01376245|464123782|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
128955846|NCT01376245|464123783|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
128955847|NCT01376245|464123784|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
128955848|NCT01376245|464123785|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
128955849|NCT01376245|464123781|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128955850|NCT01376245|464123782|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
128955851|NCT01376245|464123783|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
128955852|NCT01376245|464123784|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
128955853|NCT01376245|464123785|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
128955854|NCT01376245|464123781|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
128955855|NCT01376245|464123782|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
128955856|NCT01376245|464123783|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
128955857|NCT01376245|464123784|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
128955858|NCT01376245|464123785|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
128955859|NCT01376245|464123781|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
128955860|NCT01376245|464123782|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
128955861|NCT01376245|464123783|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
128955862|NCT01376245|464123784|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
129036113|NCT03180801|464423400|FG002|Overall Study|Adverse Event|2|||
129036114|NCT03180801|464423398|FG000|Overall Study|Withdrawal by Subject|2|||
129036115|NCT03180801|464423399|FG001|Overall Study|Withdrawal by Subject|2|||
129036116|NCT03180801|464423400|FG002|Overall Study|Withdrawal by Subject|1|||
129036117|NCT03180801|464423398|FG000|Overall Study|Lost to Follow-up|0|||
129036118|NCT03180801|464423399|FG001|Overall Study|Lost to Follow-up|2|||
129036119|NCT03180801|464423400|FG002|Overall Study|Lost to Follow-up|3|||
129036120|NCT02618382|464423403|FG000|Overall Study|Physician Decision|1|||
129036121|NCT02618382|464423403|FG000|Overall Study|Withdrawal by Subject|1|||
129036122|NCT02618382|464423403|FG000|Overall Study|Protocol Violation|1|||
129036123|NCT00309985|464423404|FG000|Overall Study|Disease progression|12|||
129036124|NCT00309985|464423405|FG001|Overall Study|Disease progression|0|||
129036125|NCT00309985|464423404|FG000|Overall Study|Adverse Event|30|||
129036126|NCT00309985|464423405|FG001|Overall Study|Adverse Event|0|||
129126232|NCT00620542|464757928|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
129219485|NCT02963506|465103048|FG002|Dose-Blind Period|Adverse Event|0|||
129219486|NCT02963506|465103049|FG003|Dose-Blind Period|Adverse Event|0|||
128955863|NCT01376245|464123785|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
128955864|NCT05159362|464123786|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
129036127|NCT00309985|464423404|FG000|Overall Study|Death|2|||
129036128|NCT00309985|464423405|FG001|Overall Study|Death|0|||
128770586|NCT03638635|463451554|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
129036129|NCT00309985|464423404|FG000|Overall Study|Withdrawal by Subject|5|||
129036130|NCT00309985|464423405|FG001|Overall Study|Withdrawal by Subject|1|||
129036131|NCT00309985|464423404|FG000|Overall Study|Physician Decision|3|||
129036132|NCT00309985|464423405|FG001|Overall Study|Physician Decision|0|||
129036133|NCT00309985|464423404|FG000|Overall Study|Never started treatment|7|||
129036134|NCT00309985|464423405|FG001|Overall Study|Never started treatment|0|||
128711640|NCT00748033|463239972|FG001|Overall Study|Adverse Event|1|||
128711641|NCT00191789|463239975|FG000|Overall Study|Adverse Event|5|||
128711642|NCT00191789|463239975|FG000|Overall Study|Patient: Satisfactory Response|5|||
128711643|NCT00191789|463239975|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
128711644|NCT00191789|463239975|FG000|Overall Study|Withdrawal by Subject|4|||
128711645|NCT00191789|463239975|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
128711646|NCT00191789|463239975|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
128711647|NCT00191789|463239975|FG000|Overall Study|Death - Not Study-Drug Related|1|||
128711648|NCT04772755|463239978|FG000|Overall Study|Withdrawal by Subject|1|||
128711649|NCT04772755|463239979|FG001|Overall Study|Withdrawal by Subject|0|||
128711650|NCT04772755|463239978|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
128711651|NCT04772755|463239979|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
128711652|NCT01905657|463239980|FG000|Overall Study|Adverse Event|23|||
128711653|NCT01905657|463239981|FG001|Overall Study|Adverse Event|17|||
128711654|NCT01905657|463239982|FG002|Overall Study|Adverse Event|18|||
128711655|NCT01905657|463239980|FG000|Overall Study|Clinical Progression|103|||
128711656|NCT01905657|463239981|FG001|Overall Study|Clinical Progression|78|||
128711657|NCT01905657|463239982|FG002|Overall Study|Clinical Progression|59|||
128711658|NCT01905657|463239980|FG000|Overall Study|Death|40|||
128711659|NCT01905657|463239981|FG001|Overall Study|Death|43|||
128955865|NCT05159362|464123787|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
128955866|NCT05159362|464123788|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
128711660|NCT01905657|463239982|FG002|Overall Study|Death|47|||
128955867|NCT01335698|464123789|FG000|Treatment Stage 1|Lack of Efficacy|3|||
128955868|NCT01335698|464123790|FG001|Treatment Stage 1|Lack of Efficacy|1|||
128955869|NCT01335698|464123791|FG002|Treatment Stage 1|Lack of Efficacy|3|||
128955870|NCT01335698|464123792|FG003|Treatment Stage 1|Lack of Efficacy|3|||
128955871|NCT01335698|464123793|FG004|Treatment Stage 1|Lack of Efficacy|1|||
128955872|NCT01335698|464123789|FG000|Treatment Stage 1|Adverse Event|1|||
128955873|NCT01335698|464123790|FG001|Treatment Stage 1|Adverse Event|2|||
128955874|NCT01335698|464123791|FG002|Treatment Stage 1|Adverse Event|2|||
128955875|NCT01335698|464123792|FG003|Treatment Stage 1|Adverse Event|1|||
128955876|NCT01335698|464123793|FG004|Treatment Stage 1|Adverse Event|1|||
128955877|NCT01335698|464123789|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
128955878|NCT01335698|464123790|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
128711661|NCT01905657|463239980|FG000|Overall Study|Excluded Medication|13|||
128955879|NCT01335698|464123791|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
128955880|NCT01335698|464123792|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
128955881|NCT01335698|464123793|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
128955882|NCT01335698|464123789|FG000|Treatment Stage 1|Lost to Follow-up|1|||
128955883|NCT01335698|464123790|FG001|Treatment Stage 1|Lost to Follow-up|1|||
128955884|NCT01335698|464123791|FG002|Treatment Stage 1|Lost to Follow-up|0|||
128955885|NCT01335698|464123792|FG003|Treatment Stage 1|Lost to Follow-up|0|||
128955886|NCT01335698|464123793|FG004|Treatment Stage 1|Lost to Follow-up|0|||
128955887|NCT01335698|464123789|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
128711662|NCT01905657|463239981|FG001|Overall Study|Excluded Medication|16|||
128711663|NCT01905657|463239982|FG002|Overall Study|Excluded Medication|9|||
128711664|NCT01905657|463239980|FG000|Overall Study|Lost to Follow-up|1|||
128711665|NCT01905657|463239981|FG001|Overall Study|Lost to Follow-up|2|||
128711666|NCT01905657|463239982|FG002|Overall Study|Lost to Follow-up|1|||
128711667|NCT01905657|463239980|FG000|Overall Study|Physician Decision|5|||
128711668|NCT01905657|463239981|FG001|Overall Study|Physician Decision|8|||
128711669|NCT01905657|463239982|FG002|Overall Study|Physician Decision|12|||
128711670|NCT01905657|463239980|FG000|Overall Study|Protocol Violation|2|||
128711671|NCT01905657|463239981|FG001|Overall Study|Protocol Violation|1|||
128711672|NCT01905657|463239982|FG002|Overall Study|Protocol Violation|1|||
128711673|NCT01905657|463239980|FG000|Overall Study|Screen Failure|0|||
128711674|NCT01905657|463239981|FG001|Overall Study|Screen Failure|1|||
128711675|NCT01905657|463239982|FG002|Overall Study|Screen Failure|0|||
128711676|NCT01905657|463239980|FG000|Overall Study|Withdrawal by Subject|15|||
128711677|NCT01905657|463239981|FG001|Overall Study|Withdrawal by Subject|21|||
128711678|NCT01905657|463239982|FG002|Overall Study|Withdrawal by Subject|53|||
128711679|NCT01905657|463239980|FG000|Overall Study|Sponsor Decision|1|||
128711680|NCT01905657|463239981|FG001|Overall Study|Sponsor Decision|0|||
128711681|NCT01905657|463239982|FG002|Overall Study|Sponsor Decision|0|||
128711682|NCT01386554|463239985|FG000|Overall Study|Lost to Follow-up|0|||
128711683|NCT01386554|463239986|FG001|Overall Study|Lost to Follow-up|0|||
128711684|NCT01386554|463239987|FG002|Overall Study|Lost to Follow-up|1|||
128711685|NCT01386554|463239985|FG000|Overall Study|Adverse Event|2|||
128711686|NCT01386554|463239986|FG001|Overall Study|Adverse Event|5|||
128711687|NCT01386554|463239987|FG002|Overall Study|Adverse Event|2|||
128711688|NCT01386554|463239985|FG000|Overall Study|Progressive disease|1|||
128711689|NCT01386554|463239986|FG001|Overall Study|Progressive disease|2|||
128955888|NCT01335698|464123790|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
128955889|NCT01335698|464123791|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
128955890|NCT01335698|464123792|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
128955891|NCT01335698|464123793|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
129219487|NCT02963506|465103050|FG004|Dose-Blind Period|Adverse Event|0|||
129219488|NCT02963506|465103051|FG005|Dose-Blind Period|Adverse Event|1|||
128955892|NCT01335698|464123789|FG000|Treatment Stage 1|No longer meets study criteria|1|||
128955893|NCT01335698|464123790|FG001|Treatment Stage 1|No longer meets study criteria|1|||
128955894|NCT01335698|464123791|FG002|Treatment Stage 1|No longer meets study criteria|0|||
128955895|NCT01335698|464123792|FG003|Treatment Stage 1|No longer meets study criteria|1|||
128955896|NCT01335698|464123793|FG004|Treatment Stage 1|No longer meets study criteria|0|||
128955897|NCT01335698|464123789|FG000|Treatment Stage 1|Other|1|||
128955898|NCT01335698|464123790|FG001|Treatment Stage 1|Other|0|||
128955899|NCT01335698|464123791|FG002|Treatment Stage 1|Other|0|||
128955900|NCT01335698|464123792|FG003|Treatment Stage 1|Other|1|||
128955901|NCT01335698|464123793|FG004|Treatment Stage 1|Other|0|||
128955902|NCT01335698|464123789|FG000|Treatment Stage 2|Lack of Efficacy|2|||
128955903|NCT01335698|464123790|FG001|Treatment Stage 2|Lack of Efficacy|1|||
128955904|NCT01335698|464123791|FG002|Treatment Stage 2|Lack of Efficacy|3|||
128955905|NCT01335698|464123792|FG003|Treatment Stage 2|Lack of Efficacy|1|||
128955906|NCT01335698|464123793|FG004|Treatment Stage 2|Lack of Efficacy|0|||
128955907|NCT01335698|464123789|FG000|Treatment Stage 2|Adverse Event|2|||
128955908|NCT01335698|464123790|FG001|Treatment Stage 2|Adverse Event|0|||
128955909|NCT01335698|464123791|FG002|Treatment Stage 2|Adverse Event|0|||
128955910|NCT01335698|464123792|FG003|Treatment Stage 2|Adverse Event|3|||
128955911|NCT01335698|464123793|FG004|Treatment Stage 2|Adverse Event|0|||
128955912|NCT01335698|464123789|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
128955913|NCT01335698|464123790|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
128955914|NCT01335698|464123791|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
128955915|NCT01335698|464123792|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
128955916|NCT01335698|464123793|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
128955917|NCT01335698|464123789|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
128955918|NCT01335698|464123790|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
128955919|NCT01335698|464123791|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
128955920|NCT01335698|464123792|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
128955921|NCT01335698|464123793|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
128955922|NCT01335698|464123789|FG000|Treatment Stage 2|Lost to Follow-up|1|||
128955923|NCT01335698|464123790|FG001|Treatment Stage 2|Lost to Follow-up|0|||
128955924|NCT01335698|464123791|FG002|Treatment Stage 2|Lost to Follow-up|0|||
128955925|NCT01335698|464123792|FG003|Treatment Stage 2|Lost to Follow-up|0|||
128955926|NCT01335698|464123793|FG004|Treatment Stage 2|Lost to Follow-up|0|||
128955927|NCT01335698|464123789|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
128955928|NCT01335698|464123790|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
128955929|NCT01335698|464123791|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
128955930|NCT01335698|464123792|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
128955931|NCT01335698|464123793|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
128955932|NCT01335698|464123789|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
128955933|NCT01335698|464123790|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
129219489|NCT02963506|465103052|FG006|Dose-Blind Period|Adverse Event|3|||
129219490|NCT02963506|465103053|FG007|Dose-Blind Period|Adverse Event|2|||
129219491|NCT02963506|465103054|FG008|Dose-Blind Period|Adverse Event|2|||
128955934|NCT01335698|464123791|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
128955935|NCT01335698|464123792|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
128955936|NCT01335698|464123793|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
128955937|NCT01335698|464123789|FG000|Treatment Stage 2|Switched to another formulation|1|||
128955938|NCT01335698|464123790|FG001|Treatment Stage 2|Switched to another formulation|1|||
128955939|NCT01335698|464123791|FG002|Treatment Stage 2|Switched to another formulation|0|||
128955940|NCT01335698|464123792|FG003|Treatment Stage 2|Switched to another formulation|0|||
128955941|NCT01335698|464123793|FG004|Treatment Stage 2|Switched to another formulation|0|||
128955942|NCT01357889|464123794|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
128955943|NCT01357889|464123795|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
128955944|NCT01357889|464123794|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
128955945|NCT01357889|464123795|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
129036135|NCT00309985|464423404|FG000|Overall Study|Complicating disease|1|||
129036136|NCT00309985|464423405|FG001|Overall Study|Complicating disease|0|||
129036137|NCT00309985|464423404|FG000|Overall Study|Non-compliance|1|||
129036138|NCT00309985|464423405|FG001|Overall Study|Non-compliance|0|||
129036139|NCT00309985|464423404|FG000|Overall Study|Chemotherapy discontinued only|1|||
129036140|NCT00309985|464423405|FG001|Overall Study|Chemotherapy discontinued only|0|||
129219492|NCT02963506|465103055|FG009|Dose-Blind Period|Adverse Event|2|||
128955946|NCT01357889|464123794|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
128955947|NCT01357889|464123795|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
128955948|NCT01357889|464123794|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
128955949|NCT01357889|464123795|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
129036141|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
129036142|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
129219493|NCT02963506|465103056|FG010|Dose-Blind Period|Adverse Event|1|||
129219494|NCT02963506|465103057|FG011|Dose-Blind Period|Adverse Event|1|||
129219495|NCT02963506|465103058|FG012|Dose-Blind Period|Adverse Event|6|||
129219496|NCT02963506|465103046|FG000|Dose-Blind Period|Lack of Efficacy|0|||
129219497|NCT02963506|465103047|FG001|Dose-Blind Period|Lack of Efficacy|0|||
129219498|NCT02963506|465103048|FG002|Dose-Blind Period|Lack of Efficacy|0|||
129219499|NCT02963506|465103049|FG003|Dose-Blind Period|Lack of Efficacy|0|||
129219500|NCT02963506|465103050|FG004|Dose-Blind Period|Lack of Efficacy|0|||
129219501|NCT02963506|465103051|FG005|Dose-Blind Period|Lack of Efficacy|0|||
129219502|NCT02963506|465103052|FG006|Dose-Blind Period|Lack of Efficacy|0|||
129219503|NCT02963506|465103053|FG007|Dose-Blind Period|Lack of Efficacy|1|||
129219504|NCT02963506|465103054|FG008|Dose-Blind Period|Lack of Efficacy|0|||
129219505|NCT02963506|465103055|FG009|Dose-Blind Period|Lack of Efficacy|1|||
129219506|NCT02963506|465103056|FG010|Dose-Blind Period|Lack of Efficacy|0|||
129219507|NCT02963506|465103057|FG011|Dose-Blind Period|Lack of Efficacy|0|||
129219508|NCT02963506|465103058|FG012|Dose-Blind Period|Lack of Efficacy|0|||
129219509|NCT02963506|465103046|FG000|Dose-Blind Period|Lost to Follow-up|0|||
129219510|NCT02963506|465103047|FG001|Dose-Blind Period|Lost to Follow-up|0|||
129219511|NCT02963506|465103048|FG002|Dose-Blind Period|Lost to Follow-up|0|||
129219512|NCT02963506|465103049|FG003|Dose-Blind Period|Lost to Follow-up|0|||
129219513|NCT02963506|465103050|FG004|Dose-Blind Period|Lost to Follow-up|0|||
129219514|NCT02963506|465103051|FG005|Dose-Blind Period|Lost to Follow-up|1|||
129219515|NCT02963506|465103052|FG006|Dose-Blind Period|Lost to Follow-up|0|||
129219516|NCT02963506|465103053|FG007|Dose-Blind Period|Lost to Follow-up|0|||
129219517|NCT02963506|465103054|FG008|Dose-Blind Period|Lost to Follow-up|1|||
128955950|NCT01357889|464123794|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
128955951|NCT01357889|464123795|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
128955952|NCT01357889|464123794|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
129219518|NCT02963506|465103055|FG009|Dose-Blind Period|Lost to Follow-up|0|||
129219519|NCT02963506|465103056|FG010|Dose-Blind Period|Lost to Follow-up|0|||
129219520|NCT02963506|465103057|FG011|Dose-Blind Period|Lost to Follow-up|1|||
129219521|NCT02963506|465103058|FG012|Dose-Blind Period|Lost to Follow-up|0|||
128955953|NCT01357889|464123795|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
128955954|NCT01357889|464123794|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
128955955|NCT01357889|464123795|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
128955956|NCT01357889|464123794|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
128955957|NCT01357889|464123795|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
128955958|NCT01357889|464123794|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
128955959|NCT01357889|464123795|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
128955960|NCT01357889|464123794|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
128955961|NCT01357889|464123795|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
128955962|NCT01357889|464123794|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
128955963|NCT01357889|464123795|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
128955964|NCT01357889|464123794|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
128955965|NCT01357889|464123795|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
128955966|NCT01357889|464123794|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
128955967|NCT01357889|464123795|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
128955968|NCT03970824|464123796|FG000|Overall Study|Withdrawal by Subject|1|||
128955969|NCT03970824|464123797|FG001|Overall Study|Withdrawal by Subject|1|||
128955970|NCT03970824|464123798|FG002|Overall Study|Withdrawal by Subject|3|||
128955971|NCT03970824|464123796|FG000|Overall Study|Lost to Follow-up|0|||
128955972|NCT03970824|464123797|FG001|Overall Study|Lost to Follow-up|2|||
128955973|NCT03970824|464123798|FG002|Overall Study|Lost to Follow-up|1|||
128955974|NCT03970824|464123796|FG000|Overall Study|Adverse Event|1|||
128955975|NCT03970824|464123797|FG001|Overall Study|Adverse Event|0|||
128955976|NCT03970824|464123798|FG002|Overall Study|Adverse Event|0|||
128955977|NCT00105560|464123799|FG000|Overall Study|Lost to Follow-up|1|||
128955978|NCT01361919|464123808|FG000|Overall Study|technical issues|10|||
128955979|NCT01361919|464123809|FG001|Overall Study|technical issues|12|||
128955980|NCT01361919|464123810|FG002|Overall Study|technical issues|10|||
128955981|NCT01767519|464123814|FG000|Overall Study|Other Reasons|4|||
129219522|NCT02963506|465103046|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
129219523|NCT02963506|465103047|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
129219524|NCT02963506|465103048|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
129219525|NCT02963506|465103049|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
129219526|NCT02963506|465103050|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
128955982|NCT01767519|464123815|FG001|Overall Study|Other Reasons|4|||
128955983|NCT01767519|464123816|FG002|Overall Study|Other Reasons|2|||
129219527|NCT02963506|465103051|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
128955984|NCT01767519|464123814|FG000|Overall Study|Protocol Violation|0|||
128955985|NCT01767519|464123815|FG001|Overall Study|Protocol Violation|3|||
129219528|NCT02963506|465103052|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
129219529|NCT02963506|465103053|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
129219530|NCT02963506|465103054|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
129219531|NCT02963506|465103055|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
129219532|NCT02963506|465103056|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
129219533|NCT02963506|465103057|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
129219534|NCT02963506|465103058|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
129219535|NCT02963506|465103046|FG000|Dose-Blind Period|Sponsor decision|0|||
129219536|NCT02963506|465103047|FG001|Dose-Blind Period|Sponsor decision|0|||
129219537|NCT02963506|465103048|FG002|Dose-Blind Period|Sponsor decision|0|||
129219538|NCT02963506|465103049|FG003|Dose-Blind Period|Sponsor decision|0|||
129219539|NCT02963506|465103050|FG004|Dose-Blind Period|Sponsor decision|0|||
128711690|NCT01386554|463239987|FG002|Overall Study|Progressive disease|2|||
128711691|NCT01386554|463239985|FG000|Overall Study|Administration of live vaccines|0|||
128711692|NCT01386554|463239986|FG001|Overall Study|Administration of live vaccines|1|||
128711693|NCT01386554|463239987|FG002|Overall Study|Administration of live vaccines|0|||
128711694|NCT01386554|463239985|FG000|Overall Study|Investigator discretion|0|||
128711695|NCT01386554|463239986|FG001|Overall Study|Investigator discretion|0|||
128711696|NCT01386554|463239987|FG002|Overall Study|Investigator discretion|1|||
128955986|NCT01767519|464123816|FG002|Overall Study|Protocol Violation|0|||
128955987|NCT01767519|464123814|FG000|Overall Study|Personal Reasons|1|||
128955988|NCT01767519|464123815|FG001|Overall Study|Personal Reasons|0|||
128955989|NCT01767519|464123816|FG002|Overall Study|Personal Reasons|0|||
128955990|NCT01767519|464123814|FG000|Overall Study|Lost to Follow-up|3|||
128955991|NCT01767519|464123815|FG001|Overall Study|Lost to Follow-up|1|||
128955992|NCT01767519|464123816|FG002|Overall Study|Lost to Follow-up|2|||
128955993|NCT01767519|464123814|FG000|Overall Study|Lack of Efficacy|1|||
128955994|NCT01767519|464123815|FG001|Overall Study|Lack of Efficacy|0|||
128955995|NCT01767519|464123816|FG002|Overall Study|Lack of Efficacy|0|||
128955996|NCT01767519|464123814|FG000|Overall Study|Adverse Event|5|||
128955997|NCT01767519|464123815|FG001|Overall Study|Adverse Event|5|||
128955998|NCT01767519|464123816|FG002|Overall Study|Adverse Event|1|||
128955999|NCT00039741|464123817|FG000|Overall Study|Death|0|||
128956000|NCT00039741|464123818|FG001|Overall Study|Death|1|||
128956001|NCT00039741|464123819|FG002|Overall Study|Death|0|||
128956002|NCT00039741|464123820|FG003|Overall Study|Death|0|||
128956003|NCT00039741|464123817|FG000|Overall Study|Lost to Follow-up|3|||
128956004|NCT00039741|464123818|FG001|Overall Study|Lost to Follow-up|1|||
128956005|NCT00039741|464123819|FG002|Overall Study|Lost to Follow-up|5|||
128956006|NCT00039741|464123820|FG003|Overall Study|Lost to Follow-up|2|||
128956007|NCT00039741|464123817|FG000|Overall Study|Confounding medical condition|1|||
128956008|NCT00039741|464123818|FG001|Overall Study|Confounding medical condition|0|||
128956009|NCT00039741|464123819|FG002|Overall Study|Confounding medical condition|0|||
128956010|NCT00039741|464123820|FG003|Overall Study|Confounding medical condition|0|||
128956011|NCT00039741|464123817|FG000|Overall Study|Not able to get to clinic|5|||
128956012|NCT00039741|464123818|FG001|Overall Study|Not able to get to clinic|2|||
128956013|NCT00039741|464123819|FG002|Overall Study|Not able to get to clinic|0|||
128956014|NCT00039741|464123820|FG003|Overall Study|Not able to get to clinic|3|||
128956015|NCT00039741|464123817|FG000|Overall Study|Moved|3|||
128956016|NCT00039741|464123818|FG001|Overall Study|Moved|2|||
128956017|NCT00039741|464123819|FG002|Overall Study|Moved|3|||
128956018|NCT00039741|464123820|FG003|Overall Study|Moved|6|||
128956019|NCT00039741|464123817|FG000|Overall Study|Non-compliance with protocol|1|||
128956020|NCT00039741|464123818|FG001|Overall Study|Non-compliance with protocol|0|||
128956021|NCT00039741|464123819|FG002|Overall Study|Non-compliance with protocol|1|||
128956022|NCT00039741|464123820|FG003|Overall Study|Non-compliance with protocol|0|||
128956023|NCT00039741|464123817|FG000|Overall Study|Withdrew consent|0|||
128956024|NCT00039741|464123818|FG001|Overall Study|Withdrew consent|5|||
128956025|NCT00039741|464123819|FG002|Overall Study|Withdrew consent|0|||
128956026|NCT00039741|464123820|FG003|Overall Study|Withdrew consent|1|||
128956027|NCT00039741|464123817|FG000|Overall Study|Missed final visit|2|||
128956028|NCT00039741|464123818|FG001|Overall Study|Missed final visit|1|||
128956029|NCT00039741|464123819|FG002|Overall Study|Missed final visit|2|||
128956030|NCT00039741|464123820|FG003|Overall Study|Missed final visit|2|||
128956031|NCT00946881|464123821|FG000|First Treatment|Withdrawal by Subject|1|||
128956032|NCT00946881|464123821|FG000|First Treatment|Patient relocated to another state|1|||
128956033|NCT00946881|464123821|FG000|Retreatment|Withdrawal by Subject|1|||
128956034|NCT00293423|464123822|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
128956035|NCT00293423|464123823|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
128956036|NCT00293423|464123822|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
128956037|NCT00293423|464123823|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
128956038|NCT00293423|464123822|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
128956039|NCT00293423|464123823|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
128956040|NCT00293423|464123822|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
128956041|NCT00293423|464123823|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
128956042|NCT00293423|464123822|FG000|Surgical Resection|processing error during surgical resection|1|||
128956043|NCT00293423|464123823|FG001|Surgical Resection|processing error during surgical resection|0|||
128956044|NCT00293423|464123822|FG000|Surgical Resection|Withdrawal by Subject|4|||
128956045|NCT00293423|464123823|FG001|Surgical Resection|Withdrawal by Subject|0|||
128956046|NCT00293423|464123822|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
128956047|NCT00293423|464123823|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
128956048|NCT00507416|464123824|FG000|Overall Study|Adverse Event|58|||
128956049|NCT00507416|464123825|FG001|Overall Study|Adverse Event|67|||
128956050|NCT00507416|464123826|FG002|Overall Study|Adverse Event|65|||
128956051|NCT00507416|464123824|FG000|Overall Study|Protocol Violation|1|||
128956052|NCT00507416|464123825|FG001|Overall Study|Protocol Violation|2|||
128956053|NCT00507416|464123826|FG002|Overall Study|Protocol Violation|0|||
128956054|NCT00507416|464123824|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
128956055|NCT00507416|464123825|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
128956056|NCT00507416|464123826|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
128956057|NCT00507416|464123824|FG000|Overall Study|Progressive Disease|20|||
128956058|NCT00507416|464123825|FG001|Overall Study|Progressive Disease|10|||
128956059|NCT00507416|464123826|FG002|Overall Study|Progressive Disease|13|||
128956060|NCT00507416|464123824|FG000|Overall Study|Patient declined further treatment|18|||
128956061|NCT00507416|464123825|FG001|Overall Study|Patient declined further treatment|14|||
128956062|NCT00507416|464123826|FG002|Overall Study|Patient declined further treatment|11|||
128956063|NCT00507416|464123824|FG000|Overall Study|Other|11|||
128956064|NCT00507416|464123825|FG001|Overall Study|Other|16|||
128956065|NCT00507416|464123826|FG002|Overall Study|Other|13|||
128956066|NCT00507416|464123824|FG000|Overall Study|Did not Receive Study Treatment|3|||
128956067|NCT00507416|464123825|FG001|Overall Study|Did not Receive Study Treatment|9|||
128956068|NCT00507416|464123826|FG002|Overall Study|Did not Receive Study Treatment|4|||
128956069|NCT02157506|464123829|FG000|Overall Study|Adverse Event|0|||
128956070|NCT02157506|464123830|FG001|Overall Study|Adverse Event|1|||
128956071|NCT02157506|464123831|FG002|Overall Study|Adverse Event|0|||
128956072|NCT02157506|464123832|FG003|Overall Study|Adverse Event|0|||
128956073|NCT02157506|464123833|FG004|Overall Study|Adverse Event|0|||
128956074|NCT02157506|464123829|FG000|Overall Study|Lost to Follow-up|0|||
128956075|NCT02157506|464123830|FG001|Overall Study|Lost to Follow-up|0|||
128956076|NCT02157506|464123831|FG002|Overall Study|Lost to Follow-up|1|||
128956077|NCT02157506|464123832|FG003|Overall Study|Lost to Follow-up|0|||
128956078|NCT02157506|464123833|FG004|Overall Study|Lost to Follow-up|0|||
128956079|NCT03101514|464123834|FG000|Overall Study|Withdrawal by Subject|4|||
128956080|NCT03101514|464123834|FG000|Overall Study|Protocol Violation|2|||
128956081|NCT03101514|464123834|FG000|Overall Study|patient's information was incomplete|1|||
128956082|NCT00764478|464123835|FG000|Overall Study|Adverse Event|1|||
128956083|NCT00764478|464123836|FG001|Overall Study|Adverse Event|1|||
128956084|NCT00764478|464123837|FG002|Overall Study|Adverse Event|1|||
128956085|NCT00764478|464123835|FG000|Overall Study|Withdrawal by Subject|7|||
128956086|NCT00764478|464123836|FG001|Overall Study|Withdrawal by Subject|12|||
128956087|NCT00764478|464123837|FG002|Overall Study|Withdrawal by Subject|1|||
128956088|NCT00764478|464123835|FG000|Overall Study|Lost to Follow-up|7|||
128956089|NCT00764478|464123836|FG001|Overall Study|Lost to Follow-up|8|||
128956090|NCT00764478|464123837|FG002|Overall Study|Lost to Follow-up|5|||
128956091|NCT00764478|464123835|FG000|Overall Study|Protocol Violation|0|||
128956092|NCT00764478|464123836|FG001|Overall Study|Protocol Violation|1|||
128956093|NCT00764478|464123837|FG002|Overall Study|Protocol Violation|1|||
128956094|NCT02270684|464123838|FG000|Overall Study|Lost to Follow-up|0|||
128956095|NCT02270684|464123839|FG001|Overall Study|Lost to Follow-up|3|||
128956096|NCT02270684|464123838|FG000|Overall Study|Study terminated|1|||
128956097|NCT02270684|464123839|FG001|Overall Study|Study terminated|0|||
128956098|NCT03498287|464123849|FG000|Overall Study|Withdrawal by Subject|3|||
128956099|NCT03498287|464123850|FG001|Overall Study|Withdrawal by Subject|0|||
128956100|NCT03498287|464123849|FG000|Overall Study|Protocol Violation|0|||
128956101|NCT03498287|464123850|FG001|Overall Study|Protocol Violation|4|||
128956102|NCT03498287|464123849|FG000|Overall Study|Adverse Event|0|||
128956103|NCT03498287|464123850|FG001|Overall Study|Adverse Event|1|||
128956104|NCT01374217|464123851|FG000|Overall Study|Lack of Efficacy|13|||
128956105|NCT01740388|464123852|FG000|Overall Study|Withdrawal by Subject|1|||
128956106|NCT01740388|464123853|FG001|Overall Study|Withdrawal by Subject|2|||
128956107|NCT01740388|464123852|FG000|Overall Study|Lost to Follow-up|2|||
128956108|NCT01740388|464123853|FG001|Overall Study|Lost to Follow-up|0|||
128956109|NCT01740388|464123852|FG000|Overall Study|Physician Decision|2|||
128956110|NCT01740388|464123853|FG001|Overall Study|Physician Decision|6|||
128956111|NCT01740388|464123852|FG000|Overall Study|Subjects missing data, completed|41|||
128956112|NCT01740388|464123853|FG001|Overall Study|Subjects missing data, completed|36|||
128956113|NCT01641991|464123854|FG000|Overall Study|Physician Decision|0|||
128956114|NCT01641991|464123855|FG001|Overall Study|Physician Decision|1|||
128956115|NCT01641991|464123856|FG002|Overall Study|Physician Decision|7|||
128956116|NCT01641991|464123857|FG003|Overall Study|Physician Decision|5|||
128956117|NCT01641991|464123854|FG000|Overall Study|Withdrawal by Subject|4|||
128956118|NCT01641991|464123855|FG001|Overall Study|Withdrawal by Subject|2|||
128956119|NCT01641991|464123856|FG002|Overall Study|Withdrawal by Subject|1|||
128956120|NCT01641991|464123857|FG003|Overall Study|Withdrawal by Subject|5|||
128956121|NCT01641991|464123854|FG000|Overall Study|Adverse Event|2|||
128956122|NCT01641991|464123855|FG001|Overall Study|Adverse Event|1|||
128956123|NCT01641991|464123856|FG002|Overall Study|Adverse Event|2|||
128956124|NCT01641991|464123857|FG003|Overall Study|Adverse Event|1|||
128956125|NCT01641991|464123854|FG000|Overall Study|Lost to Follow-up|0|||
128956126|NCT01641991|464123855|FG001|Overall Study|Lost to Follow-up|2|||
128956127|NCT01641991|464123856|FG002|Overall Study|Lost to Follow-up|3|||
128956128|NCT01641991|464123857|FG003|Overall Study|Lost to Follow-up|1|||
128956129|NCT01641991|464123854|FG000|Overall Study|Protocol Violation|1|||
128956130|NCT01641991|464123855|FG001|Overall Study|Protocol Violation|1|||
128956131|NCT01641991|464123856|FG002|Overall Study|Protocol Violation|3|||
128956132|NCT01641991|464123857|FG003|Overall Study|Protocol Violation|0|||
128956133|NCT01641991|464123854|FG000|Overall Study|Pregnancy|0|||
128956134|NCT01641991|464123855|FG001|Overall Study|Pregnancy|0|||
128956135|NCT01641991|464123856|FG002|Overall Study|Pregnancy|1|||
128956136|NCT01641991|464123857|FG003|Overall Study|Pregnancy|0|||
128956137|NCT01641991|464123854|FG000|Overall Study|no longer eligible|2|||
128956138|NCT01641991|464123855|FG001|Overall Study|no longer eligible|1|||
128956139|NCT01641991|464123856|FG002|Overall Study|no longer eligible|0|||
128956140|NCT01641991|464123857|FG003|Overall Study|no longer eligible|4|||
128956141|NCT01578785|464123858|FG000|Overall Study|Withdrawal by Subject|0|||
128956142|NCT01578785|464123859|FG001|Overall Study|Withdrawal by Subject|1|||
128956143|NCT01578785|464123858|FG000|Overall Study|Study terminated by sponsor|59|||
128956144|NCT01578785|464123859|FG001|Overall Study|Study terminated by sponsor|118|||
128956145|NCT03371732|464123860|FG000|Overall Study|Withdrawal by Subject|9|||
128956146|NCT03371732|464123861|FG001|Overall Study|Withdrawal by Subject|3|||
128956147|NCT03371732|464123860|FG000|Overall Study|Refusal to continue|3|||
128956148|NCT03371732|464123861|FG001|Overall Study|Refusal to continue|4|||
128956149|NCT02581982|464123862|FG000|Overall Study|Lack of Efficacy|12|||
128956150|NCT02581982|464123862|FG000|Overall Study|Adverse Event|3|||
128956151|NCT02581982|464123862|FG000|Overall Study|Physician Decision|1|||
128956152|NCT00599027|464123863|FG000|Overall Study|Withdrawal by Subject|1|||
128956153|NCT00599027|464123864|FG001|Overall Study|Withdrawal by Subject|1|||
128956154|NCT00599027|464123863|FG000|Overall Study|Adverse Event|0|||
128956155|NCT00599027|464123864|FG001|Overall Study|Adverse Event|1|||
128956156|NCT00599027|464123863|FG000|Overall Study|Treatment Failure|0|||
128956157|NCT00599027|464123864|FG001|Overall Study|Treatment Failure|1|||
128956158|NCT03479216|464123866|FG000|Overall Study|Withdrawal by Subject|3|||
128956159|NCT03479216|464123867|FG001|Overall Study|Withdrawal by Subject|2|||
128956160|NCT03479216|464123866|FG000|Overall Study|Physician Decision|2|||
128956161|NCT03479216|464123867|FG001|Overall Study|Physician Decision|3|||
128956162|NCT01181778|464123870|FG000|Overall Study|Physician Decision|48|||
128956163|NCT02332798|464125432|FG000|Overall Study|Unwilling to Participate in Study|0|||
128956164|NCT02332798|464125433|FG001|Overall Study|Unwilling to Participate in Study|1|||
128956165|NCT02332798|464125434|FG002|Overall Study|Unwilling to Participate in Study|1|||
128956166|NCT02332798|464125432|FG000|Overall Study|Positive Urine Drug Test|0|||
128956167|NCT02332798|464125433|FG001|Overall Study|Positive Urine Drug Test|1|||
128956168|NCT02332798|464125434|FG002|Overall Study|Positive Urine Drug Test|0|||
128956169|NCT02332798|464125432|FG000|Overall Study|Abnormal Laboratory Findings|1|||
128956170|NCT02332798|464125433|FG001|Overall Study|Abnormal Laboratory Findings|0|||
128956171|NCT02332798|464125434|FG002|Overall Study|Abnormal Laboratory Findings|0|||
128956172|NCT03788967|464125435|FG000|Overall Study|Lost to Follow-up|14|||
128956173|NCT03788967|464125436|FG001|Overall Study|Lost to Follow-up|10|||
128956174|NCT03788967|464125435|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
128956175|NCT03788967|464125436|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
128956176|NCT03788967|464125435|FG000|Overall Study|Participant Withdrawal of Consent|13|||
128956177|NCT03788967|464125436|FG001|Overall Study|Participant Withdrawal of Consent|5|||
128956178|NCT03788967|464125435|FG000|Overall Study|Adverse Event|1|||
128956179|NCT03788967|464125436|FG001|Overall Study|Adverse Event|1|||
128956180|NCT03788967|464125435|FG000|Overall Study|COVID-19|1|||
128956181|NCT03788967|464125436|FG001|Overall Study|COVID-19|2|||
128956182|NCT03927911|464125437|FG000|Overall Study|problems with eDiary|0|||
128956183|NCT03927911|464125438|FG001|Overall Study|problems with eDiary|1|||
128956184|NCT03927911|464125439|FG002|Overall Study|problems with eDiary|0|||
128956185|NCT03927911|464125440|FG003|Overall Study|problems with eDiary|1|||
128956186|NCT03927911|464125441|FG004|Overall Study|problems with eDiary|0|||
128956187|NCT03927911|464125442|FG005|Overall Study|problems with eDiary|4|||
128956188|NCT03927911|464125437|FG000|Overall Study|Adverse Event|0|||
128956189|NCT03927911|464125438|FG001|Overall Study|Adverse Event|0|||
128956190|NCT03927911|464125439|FG002|Overall Study|Adverse Event|0|||
128956191|NCT03927911|464125440|FG003|Overall Study|Adverse Event|0|||
128956192|NCT03927911|464125441|FG004|Overall Study|Adverse Event|0|||
128956193|NCT03927911|464125442|FG005|Overall Study|Adverse Event|1|||
128956194|NCT03927911|464125437|FG000|Overall Study|not treated -study terminated by sponsor|0|||
128956195|NCT03927911|464125438|FG001|Overall Study|not treated -study terminated by sponsor|1|||
128956196|NCT03927911|464125439|FG002|Overall Study|not treated -study terminated by sponsor|0|||
129219540|NCT02963506|465103051|FG005|Dose-Blind Period|Sponsor decision|1|||
129219541|NCT02963506|465103052|FG006|Dose-Blind Period|Sponsor decision|0|||
129219542|NCT02963506|465103053|FG007|Dose-Blind Period|Sponsor decision|0|||
129219543|NCT02963506|465103054|FG008|Dose-Blind Period|Sponsor decision|0|||
129219544|NCT02963506|465103055|FG009|Dose-Blind Period|Sponsor decision|0|||
129219545|NCT02963506|465103056|FG010|Dose-Blind Period|Sponsor decision|0|||
129219546|NCT02963506|465103057|FG011|Dose-Blind Period|Sponsor decision|0|||
129219547|NCT02963506|465103058|FG012|Dose-Blind Period|Sponsor decision|0|||
129219548|NCT02963506|465103046|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219549|NCT02963506|465103047|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219550|NCT02963506|465103048|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219551|NCT02963506|465103049|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219552|NCT02963506|465103050|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219553|NCT02963506|465103051|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219554|NCT02963506|465103052|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219555|NCT02963506|465103053|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
128956197|NCT03927911|464125440|FG003|Overall Study|not treated -study terminated by sponsor|0|||
128956198|NCT03927911|464125441|FG004|Overall Study|not treated -study terminated by sponsor|0|||
128956199|NCT03927911|464125442|FG005|Overall Study|not treated -study terminated by sponsor|0|||
128956200|NCT03927911|464125437|FG000|Overall Study|Surgery cancelled|0|||
128956201|NCT03927911|464125438|FG001|Overall Study|Surgery cancelled|0|||
128956202|NCT03927911|464125439|FG002|Overall Study|Surgery cancelled|0|||
128956203|NCT03927911|464125440|FG003|Overall Study|Surgery cancelled|1|||
128956204|NCT03927911|464125441|FG004|Overall Study|Surgery cancelled|0|||
128956205|NCT03927911|464125442|FG005|Overall Study|Surgery cancelled|1|||
128956206|NCT03927911|464125437|FG000|Overall Study|Protocol Violation|0|||
128956207|NCT03927911|464125438|FG001|Overall Study|Protocol Violation|0|||
128956208|NCT03927911|464125439|FG002|Overall Study|Protocol Violation|0|||
128956209|NCT03927911|464125440|FG003|Overall Study|Protocol Violation|0|||
128956210|NCT03927911|464125441|FG004|Overall Study|Protocol Violation|0|||
128956211|NCT03927911|464125442|FG005|Overall Study|Protocol Violation|1|||
128956212|NCT04432376|464125443|FG000|Double-blind Treatment Period|Adverse Event|2|||
128956213|NCT04432376|464125444|FG001|Double-blind Treatment Period|Adverse Event|6|||
128956214|NCT04432376|464125445|FG002|Double-blind Treatment Period|Adverse Event|0|||
128956215|NCT04432376|464125443|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
128956216|NCT04432376|464125444|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
128956217|NCT04432376|464125445|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
128956218|NCT04432376|464125443|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
128956219|NCT04432376|464125444|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
128956220|NCT04432376|464125445|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
128956221|NCT04432376|464125443|FG000|Double-blind Treatment Period|Protocol Violation|0|||
128956222|NCT04432376|464125444|FG001|Double-blind Treatment Period|Protocol Violation|1|||
128956223|NCT04432376|464125445|FG002|Double-blind Treatment Period|Protocol Violation|0|||
128956224|NCT04432376|464125443|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
128956225|NCT04432376|464125444|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
128956226|NCT04432376|464125445|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
128956227|NCT01824693|464125446|FG000|Overall Study|Death|0|||
128956228|NCT01824693|464125447|FG001|Overall Study|Death|1|||
128956229|NCT01824693|464125448|FG002|Overall Study|Death|0|||
128956230|NCT01824693|464125446|FG000|Overall Study|Physician Decision|1|||
128956231|NCT01824693|464125447|FG001|Overall Study|Physician Decision|1|||
128956232|NCT01824693|464125448|FG002|Overall Study|Physician Decision|1|||
128956233|NCT01824693|464125446|FG000|Overall Study|Withdrawal by Subject|0|||
128956234|NCT01824693|464125447|FG001|Overall Study|Withdrawal by Subject|0|||
128956235|NCT01824693|464125448|FG002|Overall Study|Withdrawal by Subject|1|||
128956236|NCT01824693|464125446|FG000|Overall Study|Progressive Disease|0|||
128956237|NCT01824693|464125447|FG001|Overall Study|Progressive Disease|5|||
128956238|NCT01824693|464125448|FG002|Overall Study|Progressive Disease|0|||
128956239|NCT01824693|464125446|FG000|Overall Study|Ineligible|0|||
128956240|NCT01824693|464125447|FG001|Overall Study|Ineligible|0|||
128956241|NCT01824693|464125448|FG002|Overall Study|Ineligible|3|||
128956242|NCT01824693|464125446|FG000|Overall Study|No Transplant Planned|0|||
128956243|NCT01824693|464125447|FG001|Overall Study|No Transplant Planned|0|||
128956244|NCT01824693|464125448|FG002|Overall Study|No Transplant Planned|10|||
128956245|NCT00525785|464125450|FG000|Overall Study|Withdrawal by Subject|1|||
128711697|NCT01386554|463239985|FG000|Overall Study|Reason not collected|0|||
128956246|NCT00525785|464125450|FG000|Overall Study|Lack of Efficacy|1|||
128956247|NCT00525785|464125450|FG000|Overall Study|Physician Decision|1|||
128711698|NCT01386554|463239986|FG001|Overall Study|Reason not collected|1|||
129219556|NCT02963506|465103054|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219557|NCT02963506|465103055|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129219558|NCT02963506|465103056|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
128711699|NCT01386554|463239987|FG002|Overall Study|Reason not collected|0|||
128956248|NCT02455388|464125451|FG000|Overall Study|Protocol Violation|1|||
128956249|NCT02455388|464125452|FG001|Overall Study|Protocol Violation|0|||
128956250|NCT02455388|464125453|FG002|Overall Study|Protocol Violation|4|||
128956251|NCT02455388|464125451|FG000|Overall Study|Withdrawal by Subject|0|||
128956252|NCT02455388|464125452|FG001|Overall Study|Withdrawal by Subject|0|||
128956253|NCT02455388|464125453|FG002|Overall Study|Withdrawal by Subject|7|||
128956254|NCT01316939|464125454|FG000|Overall Study|Study closed/terminated|26|||
128956255|NCT01316939|464125455|FG001|Overall Study|Study closed/terminated|25|||
128956256|NCT01316939|464125456|FG002|Overall Study|Study closed/terminated|23|||
128956257|NCT01316939|464125454|FG000|Overall Study|Lack of Efficacy|24|||
128956258|NCT01316939|464125455|FG001|Overall Study|Lack of Efficacy|25|||
128956259|NCT01316939|464125456|FG002|Overall Study|Lack of Efficacy|25|||
128956260|NCT01316939|464125454|FG000|Overall Study|Adverse Event|9|||
128956261|NCT01316939|464125455|FG001|Overall Study|Adverse Event|12|||
128956262|NCT01316939|464125456|FG002|Overall Study|Adverse Event|11|||
128956263|NCT01316939|464125454|FG000|Overall Study|Withdrawal by Subject|1|||
128956264|NCT01316939|464125455|FG001|Overall Study|Withdrawal by Subject|3|||
128956265|NCT01316939|464125456|FG002|Overall Study|Withdrawal by Subject|6|||
128956266|NCT01316939|464125454|FG000|Overall Study|Physician Decision|2|||
128956267|NCT01316939|464125455|FG001|Overall Study|Physician Decision|2|||
128956268|NCT01316939|464125456|FG002|Overall Study|Physician Decision|1|||
128956269|NCT01316939|464125454|FG000|Overall Study|Lost to Follow-up|0|||
128956270|NCT01316939|464125455|FG001|Overall Study|Lost to Follow-up|0|||
128956271|NCT01316939|464125456|FG002|Overall Study|Lost to Follow-up|2|||
128956272|NCT01316939|464125454|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
128956273|NCT01316939|464125455|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
128956274|NCT01316939|464125456|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
128956275|NCT01316939|464125454|FG000|Overall Study|Protocol Violation|0|||
128956276|NCT01316939|464125455|FG001|Overall Study|Protocol Violation|1|||
128956277|NCT01316939|464125456|FG002|Overall Study|Protocol Violation|0|||
128956278|NCT00801892|464125457|FG000|Main Study Period|Withdrawal by Subject|0|||
128956279|NCT00801892|464125458|FG001|Main Study Period|Withdrawal by Subject|1|||
128956280|NCT00801892|464125457|FG000|Sham Crossover Period|Lost to Follow-up|0|||
128956281|NCT00801892|464125458|FG001|Sham Crossover Period|Lost to Follow-up|2|||
128956282|NCT01188096|464125476|FG000|Overall Study|progression of disease|4|||
128956283|NCT01188096|464125476|FG000|Overall Study|Withdrawal by Subject|2|||
128956284|NCT00851253|464125480|FG000|Overall Study|Disease Progression|1|||
128956285|NCT00851253|464125481|FG001|Overall Study|Disease Progression|0|||
128956286|NCT02062398|464125482|FG000|Overall Study|Implant removal|1|||
128956287|NCT01779648|464125483|FG000|Overall Study|Protocol Violation|1|||
128956288|NCT01779648|464125484|FG001|Overall Study|Protocol Violation|0|||
128956289|NCT00415519|464125485|FG000|Overall Study|Adverse Event|1|||
128956290|NCT00415519|464125486|FG001|Overall Study|Adverse Event|0|||
128956291|NCT00415519|464125485|FG000|Overall Study|Withdrawal by Subject|2|||
128956292|NCT00415519|464125486|FG001|Overall Study|Withdrawal by Subject|0|||
128956293|NCT00415519|464125485|FG000|Overall Study|Patient's convenience|1|||
129126233|NCT00620542|464757929|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
129126234|NCT00620542|464757930|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
129126235|NCT00620542|464757931|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
129126236|NCT01970371|464757932|FG000|Overall Study|Death|8|||
129126237|NCT01970371|464757933|FG001|Overall Study|Death|13|||
129126238|NCT01970371|464757934|FG002|Overall Study|Death|12|||
129126239|NCT01970371|464757932|FG000|Overall Study|Lost to Follow-up|0|||
129126240|NCT01970371|464757933|FG001|Overall Study|Lost to Follow-up|0|||
129126241|NCT01970371|464757934|FG002|Overall Study|Lost to Follow-up|1|||
129126242|NCT01348269|464757935|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
129126243|NCT01348269|464757936|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
129126244|NCT01348269|464757935|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
129126245|NCT01348269|464757936|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
129126246|NCT01348269|464757935|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
129126247|NCT01348269|464757936|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
129126248|NCT04727749|464757937|FG000|Overall Study|Lost to Follow-up|10|||
129126249|NCT04727749|464757938|FG001|Overall Study|Lost to Follow-up|3|||
129126250|NCT03575364|464757942|FG000|Overall Study|Death|45|||
129126251|NCT03575364|464757942|FG000|Overall Study|Lost to Follow-up|114|||
129126252|NCT03575364|464757942|FG000|Overall Study|Withdrawal by Subject|21|||
129126253|NCT03575364|464757942|FG000|Overall Study|Physician Decision|11|||
129126254|NCT03575364|464757942|FG000|Overall Study|Subject Refused Follow-up|13|||
129126255|NCT03575364|464757942|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
128956294|NCT00415519|464125486|FG001|Overall Study|Patient's convenience|0|||
128956295|NCT03485222|464125493|FG000|Overall Study|Death|0|||
128956296|NCT03485222|464125494|FG001|Overall Study|Death|1|||
128956297|NCT03485222|464125493|FG000|Overall Study|Lost to Follow-up|2|||
128956298|NCT03485222|464125494|FG001|Overall Study|Lost to Follow-up|1|||
128956299|NCT03657810|464125495|FG000|Overall Study|Adverse Event|0|||
128956300|NCT03657810|464125496|FG001|Overall Study|Adverse Event|1|||
128956301|NCT03657810|464125497|FG002|Overall Study|Adverse Event|0|||
128956302|NCT03657810|464125495|FG000|Overall Study|Lack of Efficacy|4|||
128711700|NCT03334903|463239989|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
128711701|NCT03334903|463239990|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
128711702|NCT03334903|463239989|FG000|Overall Study|Protocol Violation|1|||
128711703|NCT03334903|463239990|FG001|Overall Study|Protocol Violation|3|||
128711704|NCT03334903|463239989|FG000|Overall Study|Surgery postponed|1|||
128711705|NCT03334903|463239990|FG001|Overall Study|Surgery postponed|0|||
128711706|NCT03334903|463239989|FG000|Overall Study|Adverse Event|1|||
128711707|NCT03334903|463239990|FG001|Overall Study|Adverse Event|1|||
128711708|NCT03334903|463239989|FG000|Overall Study|Withdrawal by Subject|0|||
128711709|NCT03334903|463239990|FG001|Overall Study|Withdrawal by Subject|1|||
128711710|NCT03032705|463239991|FG000|Overall Study|Lost to Follow-up|16|||
128711711|NCT03032705|463239992|FG001|Overall Study|Lost to Follow-up|17|||
128711712|NCT03032705|463239991|FG000|Overall Study|did not quality|6|||
128711713|NCT03032705|463239992|FG001|Overall Study|did not quality|6|||
128711714|NCT02879305|463239993|FG000|Overall Study|Investigator Site Closed|55|||
128711715|NCT02879305|463239994|FG001|Overall Study|Investigator Site Closed|57|||
128711716|NCT02879305|463239993|FG000|Overall Study|Withdrawal by Subject|44|||
128711717|NCT02879305|463239994|FG001|Overall Study|Withdrawal by Subject|42|||
128711718|NCT02879305|463239993|FG000|Overall Study|Lost to Follow-up|17|||
128711719|NCT02879305|463239994|FG001|Overall Study|Lost to Follow-up|12|||
128711720|NCT02879305|463239993|FG000|Overall Study|Other|1|||
128711721|NCT02879305|463239994|FG001|Overall Study|Other|0|||
128711722|NCT00001596|463241559|FG000|Overall Study|Death|1|||
128711723|NCT00001596|463241560|FG001|Overall Study|Death|0|||
128711724|NCT00001596|463241559|FG000|Overall Study|Withdrawal by Subject|3|||
128711725|NCT00001596|463241560|FG001|Overall Study|Withdrawal by Subject|1|||
128711726|NCT00001596|463241559|FG000|Overall Study|Study Termination|12|||
128711727|NCT00001596|463241560|FG001|Overall Study|Study Termination|9|||
128711728|NCT00001596|463241559|FG000|Overall Study|Adverse Event|1|||
128711729|NCT00001596|463241560|FG001|Overall Study|Adverse Event|0|||
128711730|NCT04067544|463241562|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
128711731|NCT02282020|463241565|FG000|Overall Study|Objective Disease Progression|128|||
128711732|NCT02282020|463241566|FG001|Overall Study|Objective Disease Progression|30|||
128711733|NCT02282020|463241565|FG000|Overall Study|Adverse Event|18|||
128711734|NCT02282020|463241566|FG001|Overall Study|Adverse Event|15|||
128711735|NCT02282020|463241565|FG000|Overall Study|Withdrawal by Subject|7|||
128711736|NCT02282020|463241566|FG001|Overall Study|Withdrawal by Subject|10|||
128711737|NCT02282020|463241565|FG000|Overall Study|Miscellaneous|5|||
128711738|NCT02282020|463241566|FG001|Overall Study|Miscellaneous|19|||
128956303|NCT03657810|464125496|FG001|Overall Study|Lack of Efficacy|1|||
128956304|NCT03657810|464125497|FG002|Overall Study|Lack of Efficacy|3|||
128956305|NCT03657810|464125495|FG000|Overall Study|Protocol Violation|1|||
128956306|NCT03657810|464125496|FG001|Overall Study|Protocol Violation|0|||
128956307|NCT03657810|464125497|FG002|Overall Study|Protocol Violation|0|||
128956308|NCT03657810|464125495|FG000|Overall Study|Lost to Follow-up|0|||
128956309|NCT03657810|464125496|FG001|Overall Study|Lost to Follow-up|1|||
128956310|NCT03657810|464125497|FG002|Overall Study|Lost to Follow-up|0|||
128956311|NCT03657810|464125495|FG000|Overall Study|Not provided|0|||
128956312|NCT03657810|464125496|FG001|Overall Study|Not provided|1|||
128956313|NCT03657810|464125497|FG002|Overall Study|Not provided|0|||
128956314|NCT00688545|464125498|FG000|Overall Study|Lost to Follow-up|1|||
128956315|NCT00688545|464125499|FG001|Overall Study|Lost to Follow-up|4|||
128956316|NCT00688545|464125498|FG000|Overall Study|Insurance/cost of drug|0|||
128956317|NCT00688545|464125499|FG001|Overall Study|Insurance/cost of drug|1|||
128956318|NCT00688545|464125498|FG000|Overall Study|Withdrawal by Subject|2|||
128956319|NCT00688545|464125499|FG001|Overall Study|Withdrawal by Subject|3|||
128956320|NCT00688545|464125498|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
128956321|NCT00688545|464125499|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
128956322|NCT01705587|464125503|FG000|Overall Study|Withdrawal by Subject|0|||
128956323|NCT01705587|464125504|FG001|Overall Study|Withdrawal by Subject|1|||
128956324|NCT01373918|464125505|FG000|Overall Study|Physician Decision|0|||
128956325|NCT01373918|464125506|FG001|Overall Study|Physician Decision|1|||
128956326|NCT03004976|464125508|FG000|Overall Study|Lost to Follow-up|7|||
128956327|NCT03004976|464125509|FG001|Overall Study|Lost to Follow-up|5|||
128711739|NCT02282020|463241565|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
128711740|NCT02282020|463241566|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
128711741|NCT02282020|463241565|FG000|Overall Study|Developed Discontinuation Criteria|0|||
128711742|NCT02282020|463241566|FG001|Overall Study|Developed Discontinuation Criteria|2|||
128711743|NCT02282020|463241565|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
128711744|NCT02282020|463241566|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
128956328|NCT03004976|464125508|FG000|Overall Study|Physician Decision|1|||
128956329|NCT03004976|464125509|FG001|Overall Study|Physician Decision|0|||
128956330|NCT03004976|464125508|FG000|Overall Study|Withdrawal by Subject|1|||
128956331|NCT03004976|464125509|FG001|Overall Study|Withdrawal by Subject|0|||
128956332|NCT03004976|464125508|FG000|Overall Study|Death|4|||
128711745|NCT00082355|463241567|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
128956333|NCT03004976|464125509|FG001|Overall Study|Death|1|||
128956334|NCT02137837|464125511|FG000|Overall Study|Adverse Event|0|||
128956335|NCT02137837|464125512|FG001|Overall Study|Adverse Event|2|||
128956336|NCT02137837|464125513|FG002|Overall Study|Adverse Event|1|||
128956337|NCT02137837|464125511|FG000|Overall Study|Refusal unrelated to adverse event|2|||
128956338|NCT02137837|464125512|FG001|Overall Study|Refusal unrelated to adverse event|2|||
128956339|NCT02137837|464125513|FG002|Overall Study|Refusal unrelated to adverse event|1|||
128956340|NCT02137837|464125511|FG000|Overall Study|Progression/relapse|9|||
128956341|NCT02137837|464125512|FG001|Overall Study|Progression/relapse|7|||
128956342|NCT02137837|464125513|FG002|Overall Study|Progression/relapse|7|||
128956343|NCT02137837|464125511|FG000|Overall Study|Not protocol specified|2|||
128956344|NCT02137837|464125512|FG001|Overall Study|Not protocol specified|1|||
128956345|NCT02137837|464125513|FG002|Overall Study|Not protocol specified|3|||
128956346|NCT02141217|464125514|FG000|Overall Study|Adverse Event|1|||
128956347|NCT02141217|464125515|FG001|Overall Study|Adverse Event|2|||
128956348|NCT02141217|464125514|FG000|Overall Study|Protocol Violation|1|||
128956349|NCT02141217|464125515|FG001|Overall Study|Protocol Violation|4|||
128956350|NCT02141217|464125514|FG000|Overall Study|Withdrawal by Subject|6|||
128956351|NCT02141217|464125515|FG001|Overall Study|Withdrawal by Subject|0|||
128956352|NCT02141217|464125514|FG000|Overall Study|Lost to Follow-up|1|||
128956353|NCT02141217|464125515|FG001|Overall Study|Lost to Follow-up|1|||
128956354|NCT02141217|464125514|FG000|Overall Study|Physician Decision|1|||
128956355|NCT02141217|464125515|FG001|Overall Study|Physician Decision|0|||
128956356|NCT02141217|464125514|FG000|Overall Study|Surgical Intervention|1|||
128956357|NCT02141217|464125515|FG001|Overall Study|Surgical Intervention|1|||
128956358|NCT01306032|464125516|FG000|First Intervention|Adverse Event|1|||
128956359|NCT01306032|464125517|FG001|First Intervention|Adverse Event|0|||
128956360|NCT01306032|464125518|FG002|First Intervention|Adverse Event|1|||
128956361|NCT01306032|464125519|FG003|First Intervention|Adverse Event|0|||
128956362|NCT01306032|464125520|FG004|First Intervention|Adverse Event|0|||
128956363|NCT01306032|464125521|FG005|First Intervention|Adverse Event|1|||
128956364|NCT01306032|464125516|FG000|First Intervention|Withdrawal by Subject|0|||
128956365|NCT01306032|464125517|FG001|First Intervention|Withdrawal by Subject|2|||
128956366|NCT01306032|464125518|FG002|First Intervention|Withdrawal by Subject|0|||
128956367|NCT01306032|464125519|FG003|First Intervention|Withdrawal by Subject|1|||
128956368|NCT01306032|464125520|FG004|First Intervention|Withdrawal by Subject|0|||
128956369|NCT01306032|464125521|FG005|First Intervention|Withdrawal by Subject|0|||
128956370|NCT01306032|464125516|FG000|First Intervention|Death|0|||
128956371|NCT01306032|464125517|FG001|First Intervention|Death|0|||
128956372|NCT01306032|464125518|FG002|First Intervention|Death|1|||
128956373|NCT01306032|464125519|FG003|First Intervention|Death|0|||
128956374|NCT01306032|464125520|FG004|First Intervention|Death|0|||
128956375|NCT01306032|464125521|FG005|First Intervention|Death|0|||
128956376|NCT01306032|464125516|FG000|First Intervention|Ineligible|0|||
128956377|NCT01306032|464125517|FG001|First Intervention|Ineligible|0|||
128956378|NCT01306032|464125518|FG002|First Intervention|Ineligible|0|||
128956379|NCT01306032|464125519|FG003|First Intervention|Ineligible|0|||
128956380|NCT01306032|464125520|FG004|First Intervention|Ineligible|0|||
128956381|NCT01306032|464125521|FG005|First Intervention|Ineligible|1|||
128956382|NCT01306032|464125516|FG000|First Intervention|Progressive disease|0|||
128956383|NCT01306032|464125517|FG001|First Intervention|Progressive disease|0|||
128956384|NCT01306032|464125518|FG002|First Intervention|Progressive disease|0|||
128956385|NCT01306032|464125519|FG003|First Intervention|Progressive disease|0|||
128956386|NCT01306032|464125520|FG004|First Intervention|Progressive disease|2|||
128956387|NCT01306032|464125521|FG005|First Intervention|Progressive disease|0|||
128956388|NCT01306032|464125516|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
128956389|NCT01306032|464125517|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
128711746|NCT00082355|463241567|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
128956390|NCT01306032|464125518|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
128956391|NCT01306032|464125519|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
128956392|NCT01306032|464125520|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
128956393|NCT01306032|464125521|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
128956394|NCT01306032|464125516|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
129219559|NCT02963506|465103057|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
128956395|NCT01306032|464125517|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
128956396|NCT01306032|464125518|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
128956397|NCT01306032|464125519|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
128956398|NCT01306032|464125520|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
128956399|NCT01306032|464125521|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
128956400|NCT00416312|464125527|FG000|Overall Study|tumors not visible on imaging|2|||
128956401|NCT02727660|464125530|FG000|Overall Study|Lack of Efficacy|40|||
128956402|NCT02727660|464125531|FG001|Overall Study|Lack of Efficacy|40|||
128956403|NCT02727660|464125532|FG002|Overall Study|Lack of Efficacy|70|||
128956404|NCT02727660|464125530|FG000|Overall Study|Adverse Event|28|||
128956405|NCT02727660|464125531|FG001|Overall Study|Adverse Event|21|||
128956406|NCT02727660|464125532|FG002|Overall Study|Adverse Event|32|||
128956407|NCT02727660|464125530|FG000|Overall Study|Withdrawal by Subject|26|||
128956408|NCT02727660|464125531|FG001|Overall Study|Withdrawal by Subject|25|||
128956409|NCT02727660|464125532|FG002|Overall Study|Withdrawal by Subject|30|||
128956410|NCT02727660|464125530|FG000|Overall Study|Physician Decision|3|||
128956411|NCT02727660|464125531|FG001|Overall Study|Physician Decision|8|||
128956412|NCT02727660|464125532|FG002|Overall Study|Physician Decision|14|||
128956413|NCT02727660|464125530|FG000|Overall Study|Lost to Follow-up|5|||
128956414|NCT02727660|464125531|FG001|Overall Study|Lost to Follow-up|9|||
128956415|NCT02727660|464125532|FG002|Overall Study|Lost to Follow-up|8|||
128956416|NCT02727660|464125530|FG000|Overall Study|Protocol Violation|7|||
128956417|NCT02727660|464125531|FG001|Overall Study|Protocol Violation|5|||
128956418|NCT02727660|464125532|FG002|Overall Study|Protocol Violation|5|||
128956419|NCT02727660|464125530|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
128956420|NCT02727660|464125531|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
128956421|NCT02727660|464125532|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
128956422|NCT02727660|464125530|FG000|Overall Study|Administrative Reasons|2|||
128956423|NCT02727660|464125531|FG001|Overall Study|Administrative Reasons|3|||
128956424|NCT02727660|464125532|FG002|Overall Study|Administrative Reasons|4|||
128956425|NCT00050960|464125533|FG000|Overall Study|Progressive Disease|137|||
128956426|NCT00050960|464125534|FG001|Overall Study|Progressive Disease|93|||
128956427|NCT00050960|464125533|FG000|Overall Study|Stable Disease|19|||
128956428|NCT00050960|464125534|FG001|Overall Study|Stable Disease|48|||
128956429|NCT00050960|464125533|FG000|Overall Study|Partial Response|14|||
128956430|NCT00050960|464125534|FG001|Overall Study|Partial Response|19|||
128956431|NCT00050960|464125533|FG000|Overall Study|Complete Response|0|||
128956432|NCT00050960|464125534|FG001|Overall Study|Complete Response|2|||
128956433|NCT00050960|464125533|FG000|Overall Study|Adverse Event|62|||
128956434|NCT00050960|464125534|FG001|Overall Study|Adverse Event|61|||
128956435|NCT00050960|464125533|FG000|Overall Study|Lost to Follow-up|0|||
128956436|NCT00050960|464125534|FG001|Overall Study|Lost to Follow-up|1|||
128956437|NCT00050960|464125533|FG000|Overall Study|Withdrawal by Subject|23|||
128956438|NCT00050960|464125534|FG001|Overall Study|Withdrawal by Subject|18|||
128956439|NCT00050960|464125533|FG000|Overall Study|Administrative|31|||
128956440|NCT00050960|464125534|FG001|Overall Study|Administrative|46|||
128956441|NCT00050960|464125533|FG000|Overall Study|Non-compliance|3|||
128956442|NCT00050960|464125534|FG001|Overall Study|Non-compliance|1|||
128956443|NCT00050960|464125533|FG000|Overall Study|Death|13|||
128956444|NCT00050960|464125534|FG001|Overall Study|Death|15|||
128956445|NCT00305604|464125535|FG000|Overall Study|Adverse Event|6|||
128956446|NCT00305604|464125536|FG001|Overall Study|Adverse Event|3|||
128956447|NCT00305604|464125535|FG000|Overall Study|Lack of Efficacy|11|||
128956448|NCT00305604|464125536|FG001|Overall Study|Lack of Efficacy|18|||
128956449|NCT00305604|464125535|FG000|Overall Study|Lost to Follow-up|0|||
128956450|NCT00305604|464125536|FG001|Overall Study|Lost to Follow-up|4|||
128956451|NCT00305604|464125535|FG000|Overall Study|Protocol Violation|2|||
128956452|NCT00305604|464125536|FG001|Overall Study|Protocol Violation|1|||
128956453|NCT00305604|464125535|FG000|Overall Study|Withdrawal by Subject|12|||
128956454|NCT00305604|464125536|FG001|Overall Study|Withdrawal by Subject|21|||
128956455|NCT00305604|464125535|FG000|Overall Study|Patient moved|1|||
128956456|NCT00305604|464125536|FG001|Overall Study|Patient moved|0|||
128956457|NCT01248364|464125537|FG000|Overall Study|Adverse Event|0|||
128956458|NCT01248364|464125538|FG001|Overall Study|Adverse Event|1|||
128956459|NCT01248364|464125539|FG002|Overall Study|Adverse Event|0|||
128956460|NCT01248364|464125540|FG003|Overall Study|Adverse Event|0|||
128956461|NCT00764946|464125541|FG000|Overall Study|Lack of Efficacy|1|||
128956462|NCT00764946|464125542|FG001|Overall Study|Lack of Efficacy|0|||
128956463|NCT00764946|464125543|FG002|Overall Study|Lack of Efficacy|0|||
128956464|NCT00764946|464125541|FG000|Overall Study|Lost to Follow-up|3|||
128956465|NCT00764946|464125542|FG001|Overall Study|Lost to Follow-up|4|||
128956466|NCT00764946|464125543|FG002|Overall Study|Lost to Follow-up|0|||
128956467|NCT00764946|464125541|FG000|Overall Study|Physician Decision|2|||
128956468|NCT00764946|464125542|FG001|Overall Study|Physician Decision|4|||
128956469|NCT00764946|464125543|FG002|Overall Study|Physician Decision|0|||
128956470|NCT00764946|464125541|FG000|Overall Study|Adverse Event|3|||
128956471|NCT00764946|464125542|FG001|Overall Study|Adverse Event|2|||
128956472|NCT00764946|464125543|FG002|Overall Study|Adverse Event|1|||
128956473|NCT00764946|464125541|FG000|Overall Study|Withdrawal by Subject|3|||
128956474|NCT00764946|464125542|FG001|Overall Study|Withdrawal by Subject|6|||
128956475|NCT00764946|464125543|FG002|Overall Study|Withdrawal by Subject|2|||
128956476|NCT00764946|464125541|FG000|Overall Study|Never Treated|1|||
128956477|NCT00764946|464125542|FG001|Overall Study|Never Treated|1|||
128956478|NCT00764946|464125543|FG002|Overall Study|Never Treated|1|||
128956479|NCT02146248|464125544|FG000|Overall Study|Withdrawal by Subject|2|||
128956480|NCT02431468|464125546|FG000|Overall Study|Adverse Event|2|||
128956481|NCT02431468|464125547|FG001|Overall Study|Adverse Event|4|||
128956482|NCT02431468|464125548|FG002|Overall Study|Adverse Event|5|||
128956483|NCT02431468|464125546|FG000|Overall Study|Withdrawal by Subject|4|||
128956484|NCT02431468|464125547|FG001|Overall Study|Withdrawal by Subject|12|||
128956485|NCT02431468|464125548|FG002|Overall Study|Withdrawal by Subject|2|||
128956486|NCT02431468|464125546|FG000|Overall Study|noncompliance, investigator termination,|2|||
128956487|NCT02431468|464125547|FG001|Overall Study|noncompliance, investigator termination,|2|||
128956488|NCT02431468|464125548|FG002|Overall Study|noncompliance, investigator termination,|2|||
128956489|NCT03589885|464125549|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
128956490|NCT03589885|464125550|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
128956491|NCT03589885|464125551|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
128956492|NCT03589885|464125552|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
128956493|NCT03589885|464125553|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
128956494|NCT03589885|464125549|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
128956495|NCT03589885|464125550|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
128956496|NCT03589885|464125551|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
128956497|NCT03589885|464125552|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
128956498|NCT03589885|464125553|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
128956499|NCT03589885|464125549|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
128956500|NCT03589885|464125550|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
128956501|NCT03589885|464125551|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
128956502|NCT03589885|464125552|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
128956503|NCT03589885|464125553|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
128956504|NCT03589885|464125549|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
128956505|NCT03589885|464125550|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
128956506|NCT03589885|464125551|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
128956507|NCT03589885|464125552|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
128956508|NCT03589885|464125553|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
128956509|NCT03589885|464125549|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
128956510|NCT03589885|464125550|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
128956511|NCT03589885|464125551|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
128956512|NCT03589885|464125552|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
128956513|NCT03589885|464125553|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
128956514|NCT03589885|464125549|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
128956515|NCT03589885|464125550|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
128956516|NCT03589885|464125551|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
128956517|NCT03589885|464125552|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
128956518|NCT03589885|464125553|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
128956519|NCT03589885|464125549|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
128956520|NCT03589885|464125550|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
128956521|NCT03589885|464125551|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
128956522|NCT03589885|464125552|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
128956523|NCT03589885|464125553|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
128956524|NCT03589885|464125549|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
128956525|NCT03589885|464125550|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
128956526|NCT03589885|464125551|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
128956527|NCT03589885|464125552|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
128956528|NCT03589885|464125553|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
128956529|NCT01117012|464125557|FG000|Overall Study|Adverse Event|0|||
128956530|NCT01117012|464125558|FG001|Overall Study|Adverse Event|1|||
128956531|NCT01117012|464125557|FG000|Overall Study|Death|1|||
128956532|NCT01117012|464125558|FG001|Overall Study|Death|1|||
128956533|NCT01117012|464125557|FG000|Overall Study|Withdrawal by Subject|3|||
128956534|NCT01117012|464125558|FG001|Overall Study|Withdrawal by Subject|0|||
128956535|NCT01117012|464125557|FG000|Overall Study|Undefined|4|||
128956536|NCT01117012|464125558|FG001|Overall Study|Undefined|3|||
128956537|NCT03695393|464125561|FG000|Overall Study|Death|3|||
128956538|NCT03695393|464125562|FG001|Overall Study|Death|1|||
129036143|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
129036144|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
129036145|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
129036146|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
129036147|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129036148|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129036149|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
129036150|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
129036151|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129036152|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129036153|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
128956539|NCT03695393|464125561|FG000|Overall Study|Lost to Follow-up|0|||
128956540|NCT03695393|464125562|FG001|Overall Study|Lost to Follow-up|1|||
128956541|NCT00673894|464125563|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
128956542|NCT00673894|464125564|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
128956543|NCT00673894|464125563|FG000|First Intervention 4 Weeks|Adverse Event|1|||
129036154|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
128956544|NCT00673894|464125564|FG001|First Intervention 4 Weeks|Adverse Event|0|||
128956545|NCT00493974|464125565|FG000|Overall Study|Death|1|||
128956546|NCT00493974|464125566|FG001|Overall Study|Death|2|||
128956547|NCT00493974|464125565|FG000|Overall Study|Withdrawal by Subject|8|||
128956548|NCT00493974|464125566|FG001|Overall Study|Withdrawal by Subject|6|||
128956549|NCT00493974|464125565|FG000|Overall Study|Lost to Follow-up|4|||
128956550|NCT00493974|464125566|FG001|Overall Study|Lost to Follow-up|6|||
128956551|NCT02555657|464125567|FG000|Overall Study|Death|274|||
128956552|NCT02555657|464125568|FG001|Overall Study|Death|262|||
128956553|NCT02555657|464125567|FG000|Overall Study|Physician Decision|0|||
128956554|NCT02555657|464125568|FG001|Overall Study|Physician Decision|1|||
128956555|NCT02555657|464125567|FG000|Overall Study|Sponsor Decision|27|||
128956556|NCT02555657|464125568|FG001|Overall Study|Sponsor Decision|15|||
128956557|NCT02555657|464125567|FG000|Overall Study|Withdrawal by Subject|11|||
128956558|NCT02555657|464125568|FG001|Overall Study|Withdrawal by Subject|32|||
128956559|NCT02807363|464125569|FG000|Dosing Period|Adverse Event|0|||
128956560|NCT02807363|464125570|FG001|Dosing Period|Adverse Event|1|||
128956561|NCT02807363|464125571|FG002|Dosing Period|Adverse Event|0|||
128956562|NCT02807363|464125572|FG003|Dosing Period|Adverse Event|0|||
128956563|NCT02188719|464125573|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
128956564|NCT02188719|464125574|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
128956565|NCT02188719|464125575|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
128956566|NCT02188719|464125576|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
128956567|NCT00966693|464125577|FG000|Overall Study|Adverse Event|0|||
128956568|NCT00966693|464125578|FG001|Overall Study|Adverse Event|0|||
128956569|NCT00966693|464125579|FG002|Overall Study|Adverse Event|1|||
128956570|NCT00966693|464125580|FG003|Overall Study|Adverse Event|2|||
128956571|NCT00966693|464125577|FG000|Overall Study|Death|0|||
128956572|NCT00966693|464125578|FG001|Overall Study|Death|0|||
128956573|NCT00966693|464125579|FG002|Overall Study|Death|1|||
128956574|NCT00966693|464125580|FG003|Overall Study|Death|0|||
128956575|NCT00966693|464125577|FG000|Overall Study|Withdrawal by Subject|1|||
128956576|NCT00966693|464125578|FG001|Overall Study|Withdrawal by Subject|0|||
128956577|NCT00966693|464125579|FG002|Overall Study|Withdrawal by Subject|0|||
128956578|NCT00966693|464125580|FG003|Overall Study|Withdrawal by Subject|5|||
128956579|NCT00966693|464125577|FG000|Overall Study|Disease Progression|0|||
128956580|NCT00966693|464125578|FG001|Overall Study|Disease Progression|0|||
128956581|NCT00966693|464125579|FG002|Overall Study|Disease Progression|1|||
128956582|NCT00966693|464125580|FG003|Overall Study|Disease Progression|16|||
128956583|NCT01164865|464125581|FG000|Overall Study|Lost to Follow-up|2|||
128956584|NCT01164865|464125582|FG001|Overall Study|Lost to Follow-up|1|||
128956585|NCT00405821|464125585|FG000|Overall Study|Death|5|||
128956586|NCT00405821|464125586|FG001|Overall Study|Death|7|||
128956587|NCT00405821|464125585|FG000|Overall Study|Lost to Follow-up|7|||
128956588|NCT00405821|464125586|FG001|Overall Study|Lost to Follow-up|7|||
128956589|NCT00405821|464125585|FG000|Overall Study|Protocol Violation|1|||
128956590|NCT00405821|464125586|FG001|Overall Study|Protocol Violation|0|||
128956591|NCT00405821|464125585|FG000|Overall Study|initiated ART|9|||
128956592|NCT00405821|464125586|FG001|Overall Study|initiated ART|8|||
129126256|NCT03575364|464757942|FG000|Overall Study|Patient moved out of the state|1|||
129126257|NCT03575364|464757942|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
129126258|NCT03575364|464757942|FG000|Overall Study|Patient is lost to follow up|1|||
129126259|NCT03575364|464757942|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
129126260|NCT02313155|464757943|FG000|Overall Study|Lost to Follow-up|0|||
129126261|NCT02313155|464757944|FG001|Overall Study|Lost to Follow-up|1|||
129126262|NCT02213926|464757945|FG000|Overall Study|Death|59|||
129126263|NCT02213926|464757945|FG000|Overall Study|Withdrawal by Subject|10|||
129126264|NCT02213926|464757945|FG000|Overall Study|study terminated by sponsor|51|||
129126265|NCT02213926|464757945|FG000|Overall Study|Lost to Follow-up|3|||
129126266|NCT02213926|464757945|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
129126267|NCT01697579|464757946|FG000|Base Study-Cycle 1|Adverse Event|1|||
129126268|NCT01697579|464757947|FG001|Base Study-Cycle 1|Adverse Event|0|||
129126269|NCT01697579|464757948|FG002|Base Study-Cycle 1|Adverse Event|0|||
129219560|NCT02963506|465103058|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
128956593|NCT01617187|464125601|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
128956594|NCT01617187|464125602|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
128956595|NCT01617187|464125603|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
128956596|NCT01617187|464125604|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
128956597|NCT01617187|464125601|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
128956598|NCT01617187|464125602|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
128956599|NCT01617187|464125603|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
128956600|NCT01617187|464125604|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
128956601|NCT01617187|464125601|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
128956602|NCT01617187|464125602|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
129219561|NCT00828204|465103061|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
129219562|NCT00828204|465103062|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
129219563|NCT00828204|465103061|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
129219564|NCT00828204|465103062|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
129219565|NCT00828204|465103061|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
129219566|NCT00828204|465103062|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
129219567|NCT00828204|465103061|FG000|Main Study: After Study Restart|Adverse Event|0|||
129219568|NCT00828204|465103062|FG001|Main Study: After Study Restart|Adverse Event|2|||
129219569|NCT00828204|465103061|FG000|Main Study: After Study Restart|Noncompliance|0|||
129219570|NCT00828204|465103062|FG001|Main Study: After Study Restart|Noncompliance|1|||
129219571|NCT00828204|465103061|FG000|Extension Study|Lost to Follow-up|0|||
129219572|NCT00828204|465103062|FG001|Extension Study|Lost to Follow-up|1|||
129219573|NCT00828204|465103061|FG000|Extension Study|Physician Decision|0|||
129219574|NCT00828204|465103062|FG001|Extension Study|Physician Decision|2|||
129219575|NCT00750438|465103065|FG000|Overall Study|Protocol Violation|4|||
129219576|NCT00750438|465103066|FG001|Overall Study|Protocol Violation|1|||
129219577|NCT00750438|465103065|FG000|Overall Study|Physician Decision|2|||
129219578|NCT00750438|465103066|FG001|Overall Study|Physician Decision|2|||
129219579|NCT00750438|465103065|FG000|Overall Study|Withdrawal by Subject|1|||
129219580|NCT00750438|465103066|FG001|Overall Study|Withdrawal by Subject|1|||
129219581|NCT00928408|465103071|FG000|Overall Study|Other|2|||
129219582|NCT00928408|465103071|FG000|Overall Study|Withdrawal by Subject|4|||
129219583|NCT00928408|465103071|FG000|Overall Study|Death|5|||
129219584|NCT00928408|465103071|FG000|Overall Study|Lost to Follow-up|12|||
129219585|NCT00536744|465103072|FG000|Overall Study|Adverse Event|13|||
129219586|NCT00536744|465103073|FG001|Overall Study|Adverse Event|10|||
129219587|NCT00536744|465103072|FG000|Overall Study|Death|2|||
129219588|NCT00536744|465103073|FG001|Overall Study|Death|1|||
129219589|NCT00536744|465103072|FG000|Overall Study|Physician Decision|3|||
129219590|NCT00536744|465103073|FG001|Overall Study|Physician Decision|1|||
129219591|NCT00536744|465103072|FG000|Overall Study|Lost to Follow-up|3|||
129219592|NCT00536744|465103073|FG001|Overall Study|Lost to Follow-up|5|||
129219593|NCT00536744|465103072|FG000|Overall Study|Withdrawal by Subject|7|||
129219594|NCT00536744|465103073|FG001|Overall Study|Withdrawal by Subject|8|||
129219595|NCT00536744|465103072|FG000|Overall Study|PI tried alternative treatment|1|||
129219596|NCT00536744|465103073|FG001|Overall Study|PI tried alternative treatment|3|||
129219597|NCT00787644|465103074|FG000|Overall Study|Lost to Follow-up|1|||
129219598|NCT00787644|465103075|FG001|Overall Study|Lost to Follow-up|1|||
129219599|NCT00787644|465103074|FG000|Overall Study|Withdrawal by Subject|1|||
129219600|NCT00787644|465103075|FG001|Overall Study|Withdrawal by Subject|1|||
129219601|NCT01642589|465103079|FG000|Overall Study|Withdrawal by Subject|1|||
129219602|NCT01642589|465103080|FG001|Overall Study|Withdrawal by Subject|1|||
129219603|NCT02736578|465103087|FG000|Overall Study|Adverse Event|1|||
128956603|NCT01617187|464125603|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
128956604|NCT01617187|464125604|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
128956605|NCT01617187|464125601|FG000|Treatment Through Study Completion|Adverse Event|1|||
128956606|NCT01617187|464125602|FG001|Treatment Through Study Completion|Adverse Event|1|||
128956607|NCT01617187|464125603|FG002|Treatment Through Study Completion|Adverse Event|0|||
128956608|NCT01617187|464125604|FG003|Treatment Through Study Completion|Adverse Event|1|||
128956609|NCT01617187|464125601|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
128956610|NCT01617187|464125602|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
128956611|NCT01617187|464125603|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
128956612|NCT01617187|464125604|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
128956613|NCT01617187|464125601|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
128956614|NCT01617187|464125602|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
128956615|NCT01617187|464125603|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
128956616|NCT01617187|464125604|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
128956617|NCT01617187|464125601|FG000|Treatment Through Study Completion|Protocol Violation|1|||
128956618|NCT01617187|464125602|FG001|Treatment Through Study Completion|Protocol Violation|0|||
128956619|NCT01617187|464125603|FG002|Treatment Through Study Completion|Protocol Violation|0|||
128956620|NCT01617187|464125604|FG003|Treatment Through Study Completion|Protocol Violation|1|||
128956621|NCT01265420|464125605|FG000|Overall Study|Lost to Follow-up|1|||
129219604|NCT02736578|465103088|FG001|Overall Study|Adverse Event|0|||
129219605|NCT00354432|465103089|FG000|Overall Study|Adverse Event|3|||
129219606|NCT00354432|465103090|FG001|Overall Study|Adverse Event|1|||
129219607|NCT00354432|465103091|FG002|Overall Study|Adverse Event|5|||
129219608|NCT00354432|465103092|FG003|Overall Study|Adverse Event|5|||
129219609|NCT00354432|465103089|FG000|Overall Study|Off/Toxicity|3|||
129219610|NCT00354432|465103090|FG001|Overall Study|Off/Toxicity|7|||
128770587|NCT03638635|463451553|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
128956622|NCT03862131|464125609|FG000|Overall Study|Lost to Follow-up|1|||
128956623|NCT03862131|464125610|FG001|Overall Study|Lost to Follow-up|0|||
129219611|NCT00354432|465103091|FG002|Overall Study|Off/Toxicity|5|||
128711747|NCT00082355|463241567|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
128956624|NCT03862131|464125611|FG002|Overall Study|Lost to Follow-up|1|||
128956625|NCT03862131|464125609|FG000|Overall Study|Determined to be ineligible|0|||
128956626|NCT03862131|464125610|FG001|Overall Study|Determined to be ineligible|0|||
128956627|NCT03862131|464125611|FG002|Overall Study|Determined to be ineligible|5|||
128956628|NCT03862131|464125609|FG000|Overall Study|Death|4|||
128956629|NCT03862131|464125610|FG001|Overall Study|Death|4|||
128956630|NCT03862131|464125611|FG002|Overall Study|Death|0|||
128956631|NCT03862131|464125609|FG000|Overall Study|Withdrawal by Subject|5|||
128956632|NCT03862131|464125610|FG001|Overall Study|Withdrawal by Subject|3|||
128956633|NCT03862131|464125611|FG002|Overall Study|Withdrawal by Subject|0|||
128956634|NCT03862131|464125609|FG000|Overall Study|Physician Decision|0|||
128956635|NCT03862131|464125610|FG001|Overall Study|Physician Decision|1|||
128956636|NCT03862131|464125611|FG002|Overall Study|Physician Decision|0|||
128956637|NCT01770145|464127408|FG000|Baseline|Adverse Event|20|||
128956638|NCT01770145|464127408|FG000|Baseline|Withdrawal by Subject|1|||
128956639|NCT01770145|464127408|FG000|Baseline|Lost to Follow-up|1|||
128956640|NCT01770145|464127408|FG000|Baseline|Unable to define optimal dose|4|||
128956641|NCT01770145|464127408|FG000|Treatment|Adverse Event|3|||
128956642|NCT01770145|464127408|FG000|Treatment|Withdrawal by Subject|1|||
128956643|NCT00595868|464127409|FG000|Overall Study|Lost to Follow-up|45|||
128956644|NCT00595868|464127410|FG001|Overall Study|Lost to Follow-up|50|||
128956645|NCT05406440|464127411|FG000|Overall Study|Lost to Follow-up|0|||
128956646|NCT05406440|464127412|FG001|Overall Study|Lost to Follow-up|0|||
128956647|NCT05406440|464127413|FG002|Overall Study|Lost to Follow-up|0|||
128956648|NCT05406440|464127414|FG003|Overall Study|Lost to Follow-up|0|||
128956649|NCT05406440|464127415|FG004|Overall Study|Lost to Follow-up|2|||
128956650|NCT05406440|464127416|FG005|Overall Study|Lost to Follow-up|0|||
128956651|NCT05406440|464127417|FG006|Overall Study|Lost to Follow-up|0|||
128956652|NCT05406440|464127411|FG000|Overall Study|Physician Decision|0|||
128956653|NCT05406440|464127412|FG001|Overall Study|Physician Decision|0|||
128956654|NCT05406440|464127413|FG002|Overall Study|Physician Decision|0|||
128956655|NCT05406440|464127414|FG003|Overall Study|Physician Decision|0|||
128956656|NCT05406440|464127415|FG004|Overall Study|Physician Decision|1|||
128956657|NCT05406440|464127416|FG005|Overall Study|Physician Decision|0|||
128956658|NCT05406440|464127417|FG006|Overall Study|Physician Decision|0|||
128956659|NCT05406440|464127411|FG000|Overall Study|Withdrawal by Subject|0|||
128956660|NCT05406440|464127412|FG001|Overall Study|Withdrawal by Subject|0|||
128956661|NCT05406440|464127413|FG002|Overall Study|Withdrawal by Subject|0|||
128956662|NCT05406440|464127414|FG003|Overall Study|Withdrawal by Subject|0|||
128956663|NCT05406440|464127415|FG004|Overall Study|Withdrawal by Subject|0|||
128956664|NCT05406440|464127416|FG005|Overall Study|Withdrawal by Subject|2|||
128956665|NCT05406440|464127417|FG006|Overall Study|Withdrawal by Subject|0|||
128956666|NCT04268303|464127419|FG000|Overall Study|Lost to Follow-up|1|||
128956667|NCT04268303|464127420|FG001|Overall Study|Lost to Follow-up|1|||
128956668|NCT04268303|464127421|FG002|Overall Study|Lost to Follow-up|2|||
128956669|NCT04268303|464127419|FG000|Overall Study|Withdrawal by Subject|0|||
128956670|NCT04268303|464127420|FG001|Overall Study|Withdrawal by Subject|1|||
128956671|NCT04268303|464127421|FG002|Overall Study|Withdrawal by Subject|1|||
128956672|NCT04268303|464127419|FG000|Overall Study|Adverse Event|2|||
128956673|NCT04268303|464127420|FG001|Overall Study|Adverse Event|0|||
128956674|NCT04268303|464127421|FG002|Overall Study|Adverse Event|0|||
128956675|NCT05742841|464127425|FG000|Overall Study|Withdrawal by Subject|1|||
128956676|NCT05742841|464127425|FG000|Overall Study|Lost to Follow-up|1|||
128956677|NCT01711541|464127426|FG000|Overall Study|Cancel prior to treatment|0|||
128956678|NCT01711541|464127427|FG001|Overall Study|Cancel prior to treatment|0|||
128956679|NCT01711541|464127428|FG002|Overall Study|Cancel prior to treatment|0|||
128956680|NCT01711541|464127429|FG003|Overall Study|Cancel prior to treatment|1|||
128956681|NCT01711541|464127430|FG004|Overall Study|Cancel prior to treatment|0|||
128956682|NCT01711541|464127426|FG000|Overall Study|Ineligible|0|||
128956683|NCT01711541|464127427|FG001|Overall Study|Ineligible|1|||
128956684|NCT01711541|464127428|FG002|Overall Study|Ineligible|0|||
128956685|NCT01711541|464127429|FG003|Overall Study|Ineligible|0|||
128956686|NCT01711541|464127430|FG004|Overall Study|Ineligible|0|||
128956687|NCT00728936|464127431|FG000|Overall Study|Withdrawal by Subject|0|||
128956688|NCT00728936|464127432|FG001|Overall Study|Withdrawal by Subject|0|||
128956689|NCT00728936|464127433|FG002|Overall Study|Withdrawal by Subject|0|||
128956690|NCT00728936|464127434|FG003|Overall Study|Withdrawal by Subject|0|||
128956691|NCT00728936|464127435|FG004|Overall Study|Withdrawal by Subject|0|||
128956692|NCT00728936|464127436|FG005|Overall Study|Withdrawal by Subject|1|||
128956693|NCT00728936|464127437|FG006|Overall Study|Withdrawal by Subject|0|||
128956694|NCT01175590|464127445|FG000|Overall Study|Lost to Follow-up|1|||
128956695|NCT01175590|464127446|FG001|Overall Study|Lost to Follow-up|0|||
128956696|NCT01175590|464127445|FG000|Overall Study|Withdrawal by Subject|0|||
128956697|NCT01175590|464127446|FG001|Overall Study|Withdrawal by Subject|2|||
128956698|NCT01175590|464127445|FG000|Overall Study|Adverse Event|4|||
128956699|NCT01175590|464127446|FG001|Overall Study|Adverse Event|0|||
128956700|NCT01175590|464127445|FG000|Overall Study|Physician Decision|1|||
128956701|NCT01175590|464127446|FG001|Overall Study|Physician Decision|4|||
128956702|NCT01175590|464127445|FG000|Overall Study|Lack of Efficacy|1|||
129219612|NCT00354432|465103092|FG003|Overall Study|Off/Toxicity|5|||
129219613|NCT02827877|465103095|FG000|Overall Study|Withdrawal by Subject|1|||
129219614|NCT04163016|465103096|FG000|Enrollment|Adverse Event|1|||
129219615|NCT04163016|465103097|FG001|Enrollment|Adverse Event|0|||
129219616|NCT04163016|465103098|FG002|Enrollment|Adverse Event|0|||
129219617|NCT04163016|465103099|FG003|Enrollment|Adverse Event|0|||
129219618|NCT04163016|465103096|FG000|Treatment|Adverse Event|0|||
129219619|NCT04163016|465103097|FG001|Treatment|Adverse Event|1|||
129219620|NCT04163016|465103098|FG002|Treatment|Adverse Event|0|||
129219621|NCT04163016|465103099|FG003|Treatment|Adverse Event|0|||
129219622|NCT04163016|465103096|FG000|Treatment|Withdrawal by Subject|0|||
129219623|NCT04163016|465103097|FG001|Treatment|Withdrawal by Subject|2|||
129219624|NCT04163016|465103098|FG002|Treatment|Withdrawal by Subject|0|||
129219625|NCT04163016|465103099|FG003|Treatment|Withdrawal by Subject|0|||
128956703|NCT01175590|464127446|FG001|Overall Study|Lack of Efficacy|1|||
128956704|NCT01175590|464127445|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
128956705|NCT01175590|464127446|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
128956706|NCT01175590|464127445|FG000|Overall Study|Treated not as randomized|3|||
128956707|NCT01175590|464127446|FG001|Overall Study|Treated not as randomized|2|||
128956708|NCT01175590|464127445|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
128956709|NCT01175590|464127446|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
128956710|NCT01175590|464127445|FG000|Overall Study|Protocol Violation|0|||
128956711|NCT01175590|464127446|FG001|Overall Study|Protocol Violation|1|||
128956712|NCT00877006|464127454|FG000|Treatment Period|Death|2|||
128956713|NCT00877006|464127455|FG001|Treatment Period|Death|1|||
128956714|NCT00877006|464127454|FG000|Treatment Period|Adverse Event|10|||
128956715|NCT00877006|464127455|FG001|Treatment Period|Adverse Event|3|||
128956716|NCT00877006|464127454|FG000|Treatment Period|Withdrawal by Subject|2|||
129219626|NCT04163016|465103096|FG000|Treatment|Indeterminate TB-test|0|||
129219627|NCT04163016|465103097|FG001|Treatment|Indeterminate TB-test|0|||
129219628|NCT04163016|465103098|FG002|Treatment|Indeterminate TB-test|0|||
129219629|NCT04163016|465103099|FG003|Treatment|Indeterminate TB-test|1|||
129219630|NCT04163016|465103096|FG000|Treatment|Participant did not want to continue in study|0|||
128711748|NCT00759863|463241569|FG000|Overall Study|Death, moved, or lost contact|20|||
128711749|NCT00759863|463241570|FG001|Overall Study|Death, moved, or lost contact|18|||
128711750|NCT00303498|463241574|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
128711751|NCT00303498|463241575|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
128711752|NCT00303498|463241574|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
128711753|NCT00303498|463241575|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
128711754|NCT00303498|463241574|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
128711755|NCT00303498|463241575|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
128711756|NCT00303498|463241574|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
128711757|NCT00303498|463241575|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
128711758|NCT00303498|463241574|FG000|Run-In-Phase (10 Weeks)|Other|4|||
128711759|NCT00303498|463241575|FG001|Run-In-Phase (10 Weeks)|Other|1|||
128711760|NCT00303498|463241574|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
128711761|NCT00303498|463241575|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
128711762|NCT00303498|463241574|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
128711763|NCT00303498|463241575|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
128711764|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
128711765|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
128711766|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Death|1|||
128711767|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Death|0|||
128711768|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
128711769|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
128711770|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
128711771|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
128711772|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
128711773|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
128711774|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
128711775|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
128711776|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Other|1|||
128711777|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Other|0|||
129219631|NCT04163016|465103097|FG001|Treatment|Participant did not want to continue in study|0|||
129219632|NCT04163016|465103098|FG002|Treatment|Participant did not want to continue in study|0|||
128711778|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
128711779|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
128717849|NCT05104567|463264066|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
128956717|NCT00877006|464127455|FG001|Treatment Period|Withdrawal by Subject|3|||
128956718|NCT00877006|464127454|FG000|Treatment Period|Protocol Violation|1|||
128956719|NCT00877006|464127455|FG001|Treatment Period|Protocol Violation|0|||
128956720|NCT00877006|464127454|FG000|Treatment Period|Lost to Follow-up|0|||
129219633|NCT04163016|465103099|FG003|Treatment|Participant did not want to continue in study|1|||
129219634|NCT00145158|465104542|FG000|Overall Study|premature withdrawal|2|||
129219635|NCT00145158|465104543|FG001|Overall Study|premature withdrawal|3|||
129219636|NCT00499616|465104544|FG000|Overall Study|Death|1|||
129219637|NCT00499616|465104545|FG001|Overall Study|Death|5|||
129219638|NCT00499616|465104546|FG002|Overall Study|Death|3|||
129219639|NCT00499616|465104547|FG003|Overall Study|Death|1|||
128711780|NCT00303498|463241574|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
128711781|NCT00303498|463241575|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
128956721|NCT00877006|464127455|FG001|Treatment Period|Lost to Follow-up|1|||
128956722|NCT00877006|464127454|FG000|Treatment Period|Disease Progression|1|||
128956723|NCT00877006|464127455|FG001|Treatment Period|Disease Progression|2|||
128956724|NCT00877006|464127454|FG000|Treatment Period|Started New Treatment Regimen|2|||
128956725|NCT00877006|464127455|FG001|Treatment Period|Started New Treatment Regimen|5|||
128956726|NCT00877006|464127454|FG000|Treatment Period|Other|4|||
128956727|NCT00877006|464127455|FG001|Treatment Period|Other|4|||
128956728|NCT00877006|464127454|FG000|Treatment Period|Randomized but Not Treated|3|||
128956729|NCT00877006|464127455|FG001|Treatment Period|Randomized but Not Treated|8|||
128956730|NCT00877006|464127454|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
128956731|NCT00877006|464127455|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
128956732|NCT00877006|464127454|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
128956733|NCT00877006|464127455|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
128956734|NCT00877006|464127454|FG000|Long-Term Follow-up Period|Death|26|||
128956735|NCT00877006|464127455|FG001|Long-Term Follow-up Period|Death|18|||
128956736|NCT00877006|464127454|FG000|Long-Term Follow-up Period|Other|7|||
128956737|NCT00877006|464127455|FG001|Long-Term Follow-up Period|Other|9|||
128956738|NCT04671342|464127456|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
128956739|NCT04671342|464127456|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
128956740|NCT04671342|464127456|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
128956741|NCT04671342|464127456|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
128956742|NCT04671342|464127456|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
128956743|NCT04671342|464127456|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
128956744|NCT03911869|464127457|FG000|Safety Lead-in Phase|Death|7|||
128956745|NCT03911869|464127458|FG001|Safety Lead-in Phase|Death|0|||
128956746|NCT03911869|464127459|FG002|Safety Lead-in Phase|Death|0|||
128956747|NCT03911869|464127457|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
128956748|NCT03911869|464127458|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
128956749|NCT03911869|464127459|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
128956750|NCT03911869|464127457|FG000|Safety Lead-in Phase|Other|1|||
128956751|NCT03911869|464127458|FG001|Safety Lead-in Phase|Other|0|||
129126270|NCT01697579|464757949|FG003|Base Study-Cycle 1|Adverse Event|0|||
129126271|NCT01697579|464757950|FG004|Base Study-Cycle 1|Adverse Event|0|||
129126272|NCT01697579|464757951|FG005|Base Study-Cycle 1|Adverse Event|0|||
129126273|NCT01697579|464757952|FG006|Base Study-Cycle 1|Adverse Event|0|||
129126274|NCT01697579|464757946|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
129126275|NCT01697579|464757947|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129126276|NCT01697579|464757948|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129126277|NCT01697579|464757949|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129126278|NCT01697579|464757950|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129126279|NCT01697579|464757951|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129219640|NCT00499616|465104544|FG000|Overall Study|Lack of Efficacy|5|||
129219641|NCT00499616|465104545|FG001|Overall Study|Lack of Efficacy|0|||
129219642|NCT00499616|465104546|FG002|Overall Study|Lack of Efficacy|19|||
128711782|NCT00103142|463241579|FG000|Overall Study|Adverse Event|1|||
128711783|NCT00103142|463241580|FG001|Overall Study|Adverse Event|0|||
128711784|NCT00103142|463241579|FG000|Overall Study|Progression of disease|2|||
128711785|NCT00103142|463241580|FG001|Overall Study|Progression of disease|1|||
128711786|NCT02598076|463241582|FG000|Overall Study|Lost to Follow-up|2|||
128711787|NCT02598076|463241583|FG001|Overall Study|Lost to Follow-up|3|||
128711788|NCT01946425|463241584|FG000|Overall Study|Protocol Violation|1|||
128711789|NCT01946425|463241585|FG001|Overall Study|Protocol Violation|0|||
128711790|NCT01946425|463241584|FG000|Overall Study|Withdrawal by Subject|1|||
128711791|NCT01946425|463241585|FG001|Overall Study|Withdrawal by Subject|0|||
128711792|NCT01896531|463241596|FG000|Overall Study|Death|57|||
128956752|NCT03911869|464127459|FG002|Safety Lead-in Phase|Other|0|||
128956753|NCT03911869|464127457|FG000|Phase 2|Death|0|||
128956754|NCT03911869|464127458|FG001|Phase 2|Death|3|||
128956755|NCT03911869|464127459|FG002|Phase 2|Death|0|||
128956756|NCT01878097|464127460|FG000|Baseline|Surveys not fully completed|2497|||
128956757|NCT01878097|464127461|FG001|Baseline|Surveys not fully completed|1800|||
128956758|NCT01878097|464127460|FG000|Implementation Year 1|Surveys not fully completed|3202|||
128956759|NCT01878097|464127461|FG001|Implementation Year 1|Surveys not fully completed|2549|||
128956760|NCT01878097|464127460|FG000|Implementation Year 2|Surveys not fully completed|3281|||
128711793|NCT01896531|463241597|FG001|Overall Study|Death|59|||
128711794|NCT01896531|463241596|FG000|Overall Study|Lost to Follow-up|3|||
128711795|NCT01896531|463241597|FG001|Overall Study|Lost to Follow-up|0|||
128711796|NCT01896531|463241596|FG000|Overall Study|Non-compliance|0|||
128956761|NCT01878097|464127461|FG001|Implementation Year 2|Surveys not fully completed|2841|||
128956762|NCT01878097|464127460|FG000|Implementation Year 3|Surveys not fully completed|3494|||
128956763|NCT01878097|464127461|FG001|Implementation Year 3|Surveys not fully completed|2980|||
128956764|NCT01878097|464127460|FG000|Implementation Year 4|Surveys not fully completed|3604|||
128956765|NCT01878097|464127461|FG001|Implementation Year 4|Surveys not fully completed|3007|||
128956766|NCT00367341|464127462|FG000|Overall Study|Physician Decision|1|||
128956767|NCT00367341|464127463|FG001|Overall Study|Physician Decision|0|||
128770588|NCT03638635|463451554|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
128770589|NCT00313911|463451561|FG000|Overall Study|Serious adverse event|6|||
128770590|NCT00313911|463451562|FG001|Overall Study|Serious adverse event|1|||
128770591|NCT00313911|463451561|FG000|Overall Study|Adverse Event|2|||
128770592|NCT00313911|463451562|FG001|Overall Study|Adverse Event|3|||
128770593|NCT00313911|463451561|FG000|Overall Study|Protocol Violation|19|||
128770594|NCT00313911|463451562|FG001|Overall Study|Protocol Violation|10|||
128770595|NCT00313911|463451561|FG000|Overall Study|Lost to Follow-up|27|||
128770596|NCT00313911|463451562|FG001|Overall Study|Lost to Follow-up|14|||
128770597|NCT00313911|463451561|FG000|Overall Study|Withdrawal by Subject|39|||
128770598|NCT00313911|463451562|FG001|Overall Study|Withdrawal by Subject|12|||
128770599|NCT00313911|463451561|FG000|Overall Study|Did not meet age criteria|1|||
128770600|NCT00313911|463451562|FG001|Overall Study|Did not meet age criteria|1|||
128770601|NCT01533714|463451563|FG000|Overall Study|Adverse Event|0|||
128770602|NCT01533714|463451564|FG001|Overall Study|Adverse Event|1|||
128770603|NCT01533714|463451565|FG002|Overall Study|Adverse Event|2|||
128770604|NCT01533714|463451566|FG003|Overall Study|Adverse Event|2|||
128770605|NCT01533714|463451567|FG004|Overall Study|Adverse Event|2|||
128770606|NCT01533714|463451568|FG005|Overall Study|Adverse Event|1|||
128770607|NCT01533714|463451563|FG000|Overall Study|Lack of Efficacy|0|||
128770608|NCT01533714|463451564|FG001|Overall Study|Lack of Efficacy|0|||
128770609|NCT01533714|463451565|FG002|Overall Study|Lack of Efficacy|0|||
128770610|NCT01533714|463451566|FG003|Overall Study|Lack of Efficacy|0|||
128770611|NCT01533714|463451567|FG004|Overall Study|Lack of Efficacy|0|||
128770612|NCT01533714|463451568|FG005|Overall Study|Lack of Efficacy|1|||
128770613|NCT01533714|463451563|FG000|Overall Study|Withdrawal by Subject|0|||
128770614|NCT01533714|463451564|FG001|Overall Study|Withdrawal by Subject|1|||
128770615|NCT01533714|463451565|FG002|Overall Study|Withdrawal by Subject|0|||
128770616|NCT01533714|463451566|FG003|Overall Study|Withdrawal by Subject|1|||
128770617|NCT01533714|463451567|FG004|Overall Study|Withdrawal by Subject|1|||
128770618|NCT01533714|463451568|FG005|Overall Study|Withdrawal by Subject|0|||
128770619|NCT01533714|463451563|FG000|Overall Study|Exclusion criteria|0|||
128770620|NCT01533714|463451564|FG001|Overall Study|Exclusion criteria|1|||
128770621|NCT01533714|463451565|FG002|Overall Study|Exclusion criteria|0|||
128770622|NCT01533714|463451566|FG003|Overall Study|Exclusion criteria|0|||
128770623|NCT01533714|463451567|FG004|Overall Study|Exclusion criteria|0|||
128770624|NCT01533714|463451568|FG005|Overall Study|Exclusion criteria|0|||
128770625|NCT01533714|463451563|FG000|Overall Study|Positive for purified protein derivative|0|||
128770626|NCT01533714|463451564|FG001|Overall Study|Positive for purified protein derivative|0|||
128770627|NCT01533714|463451565|FG002|Overall Study|Positive for purified protein derivative|1|||
128770628|NCT01533714|463451566|FG003|Overall Study|Positive for purified protein derivative|0|||
128770629|NCT01533714|463451567|FG004|Overall Study|Positive for purified protein derivative|1|||
128770630|NCT01533714|463451568|FG005|Overall Study|Positive for purified protein derivative|0|||
128770631|NCT01533714|463451563|FG000|Overall Study|Withdrawal criteria|0|||
128770632|NCT01533714|463451564|FG001|Overall Study|Withdrawal criteria|0|||
128770633|NCT01533714|463451565|FG002|Overall Study|Withdrawal criteria|1|||
128770634|NCT01533714|463451566|FG003|Overall Study|Withdrawal criteria|0|||
128711797|NCT01896531|463241597|FG001|Overall Study|Non-compliance|1|||
128711798|NCT01896531|463241596|FG000|Overall Study|Study Ended by Sponsor|7|||
128711799|NCT01896531|463241597|FG001|Overall Study|Study Ended by Sponsor|20|||
128711800|NCT01896531|463241596|FG000|Overall Study|Withdrawal by Subject|3|||
128711801|NCT01896531|463241597|FG001|Overall Study|Withdrawal by Subject|2|||
128711802|NCT01896531|463241596|FG000|Overall Study|Death Prior to Treatment|1|||
128770635|NCT01533714|463451567|FG004|Overall Study|Withdrawal criteria|3|||
129126280|NCT01697579|464757952|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129126281|NCT01697579|464757946|FG000|Base Study-Cycle 1|Protocol Violation|0|||
129126282|NCT01697579|464757947|FG001|Base Study-Cycle 1|Protocol Violation|0|||
128770636|NCT01533714|463451568|FG005|Overall Study|Withdrawal criteria|1|||
128770637|NCT01533714|463451563|FG000|Overall Study|Ineligibility reason|0|||
128770638|NCT01533714|463451564|FG001|Overall Study|Ineligibility reason|0|||
129126283|NCT01697579|464757948|FG002|Base Study-Cycle 1|Protocol Violation|0|||
129126284|NCT01697579|464757949|FG003|Base Study-Cycle 1|Protocol Violation|0|||
128711803|NCT01896531|463241597|FG001|Overall Study|Death Prior to Treatment|0|||
128770639|NCT01533714|463451565|FG002|Overall Study|Ineligibility reason|0|||
128770640|NCT01533714|463451566|FG003|Overall Study|Ineligibility reason|1|||
128770641|NCT01533714|463451567|FG004|Overall Study|Ineligibility reason|0|||
128956768|NCT00367341|464127462|FG000|Overall Study|Protocol Violation|1|||
128711804|NCT00770289|463241600|FG000|Overall Study|Other|6|||
128956769|NCT00367341|464127463|FG001|Overall Study|Protocol Violation|0|||
128956770|NCT03325556|464127464|FG000|Open-label Period|Lack of Response in OL period|70|||
128956771|NCT03325556|464127465|FG001|Open-label Period|Lack of Response in OL period|0|||
128956772|NCT03325556|464127466|FG002|Open-label Period|Lack of Response in OL period|0|||
128956773|NCT03325556|464127464|FG000|Open-label Period|Adverse Event|27|||
128956774|NCT03325556|464127465|FG001|Open-label Period|Adverse Event|0|||
128956775|NCT03325556|464127466|FG002|Open-label Period|Adverse Event|0|||
128956776|NCT03325556|464127464|FG000|Open-label Period|Death|1|||
128956777|NCT03325556|464127465|FG001|Open-label Period|Death|0|||
129219643|NCT00499616|465104547|FG003|Overall Study|Lack of Efficacy|0|||
129219644|NCT00499616|465104544|FG000|Overall Study|Lost to Follow-up|0|||
129219645|NCT00499616|465104545|FG001|Overall Study|Lost to Follow-up|0|||
129219646|NCT00499616|465104546|FG002|Overall Study|Lost to Follow-up|1|||
129219647|NCT00499616|465104547|FG003|Overall Study|Lost to Follow-up|0|||
129219648|NCT00499616|465104544|FG000|Overall Study|Physician Decision|6|||
129219649|NCT00499616|465104545|FG001|Overall Study|Physician Decision|16|||
129219650|NCT00499616|465104546|FG002|Overall Study|Physician Decision|9|||
129219651|NCT00499616|465104547|FG003|Overall Study|Physician Decision|0|||
129219652|NCT00499616|465104544|FG000|Overall Study|Withdrawal by Subject|1|||
129219653|NCT00499616|465104545|FG001|Overall Study|Withdrawal by Subject|0|||
129219654|NCT00499616|465104546|FG002|Overall Study|Withdrawal by Subject|1|||
129219655|NCT00499616|465104547|FG003|Overall Study|Withdrawal by Subject|0|||
129219656|NCT00499616|465104544|FG000|Overall Study|Ineligible|1|||
129219657|NCT00499616|465104545|FG001|Overall Study|Ineligible|2|||
129219658|NCT00499616|465104546|FG002|Overall Study|Ineligible|0|||
129219659|NCT00499616|465104547|FG003|Overall Study|Ineligible|15|||
129219660|NCT00499616|465104544|FG000|Overall Study|Not evaluable|0|||
129219661|NCT00499616|465104545|FG001|Overall Study|Not evaluable|0|||
129219662|NCT00499616|465104546|FG002|Overall Study|Not evaluable|0|||
129219663|NCT00499616|465104547|FG003|Overall Study|Not evaluable|41|||
129219664|NCT00499616|465104544|FG000|Overall Study|Patient/Parent Refusal|1|||
129219665|NCT00499616|465104545|FG001|Overall Study|Patient/Parent Refusal|5|||
129219666|NCT00499616|465104546|FG002|Overall Study|Patient/Parent Refusal|3|||
129219667|NCT00499616|465104547|FG003|Overall Study|Patient/Parent Refusal|0|||
129219668|NCT01938716|465104548|FG000|Overall Study|Physician Decision|2|||
129219669|NCT01938716|465104548|FG000|Overall Study|Withdrawal by Subject|2|||
129219670|NCT01358721|465104549|FG000|Overall Study|Withdrawal by Subject|0|||
129219671|NCT01358721|465104550|FG001|Overall Study|Withdrawal by Subject|0|||
129219672|NCT01358721|465104551|FG002|Overall Study|Withdrawal by Subject|0|||
129219673|NCT01358721|465104552|FG003|Overall Study|Withdrawal by Subject|1|||
129219674|NCT01358721|465104549|FG000|Overall Study|Death|0|||
129219675|NCT01358721|465104550|FG001|Overall Study|Death|2|||
129219676|NCT01358721|465104551|FG002|Overall Study|Death|0|||
129219677|NCT01358721|465104552|FG003|Overall Study|Death|0|||
129219678|NCT01358721|465104549|FG000|Overall Study|Study Drug Toxicity|1|||
129219679|NCT01358721|465104550|FG001|Overall Study|Study Drug Toxicity|3|||
129219680|NCT01358721|465104551|FG002|Overall Study|Study Drug Toxicity|4|||
128711805|NCT02956486|463241601|FG000|Core Phase|Adverse Event|51|||
128711806|NCT02956486|463241602|FG001|Core Phase|Adverse Event|88|||
128711807|NCT02956486|463241603|FG002|Core Phase|Adverse Event|0|||
128711808|NCT02956486|463241601|FG000|Core Phase|Lost to Follow-up|8|||
128711809|NCT02956486|463241602|FG001|Core Phase|Lost to Follow-up|6|||
128711810|NCT02956486|463241603|FG002|Core Phase|Lost to Follow-up|0|||
128711811|NCT02956486|463241601|FG000|Core Phase|Inadequate therapeutic effect|4|||
128711812|NCT02956486|463241602|FG001|Core Phase|Inadequate therapeutic effect|5|||
128711813|NCT02956486|463241603|FG002|Core Phase|Inadequate therapeutic effect|0|||
128711814|NCT02956486|463241601|FG000|Core Phase|Withdrawal by Subject|101|||
128711815|NCT02956486|463241602|FG001|Core Phase|Withdrawal by Subject|104|||
128711816|NCT02956486|463241603|FG002|Core Phase|Withdrawal by Subject|0|||
128711817|NCT02956486|463241601|FG000|Core Phase|Study terminated by sponsor|888|||
128711818|NCT02956486|463241602|FG001|Core Phase|Study terminated by sponsor|848|||
128711819|NCT02956486|463241603|FG002|Core Phase|Study terminated by sponsor|0|||
128711820|NCT02956486|463241601|FG000|Core Phase|Other|27|||
128711821|NCT02956486|463241602|FG001|Core Phase|Other|18|||
128711822|NCT02956486|463241603|FG002|Core Phase|Other|0|||
128711823|NCT02956486|463241601|FG000|Core Phase|Not treated|0|||
128711824|NCT02956486|463241602|FG001|Core Phase|Not treated|3|||
128711825|NCT02956486|463241603|FG002|Core Phase|Not treated|0|||
128711826|NCT02956486|463241601|FG000|Extension Phase|Adverse Event|0|||
128770642|NCT01533714|463451568|FG005|Overall Study|Ineligibility reason|0|||
128770643|NCT00258440|463451581|FG000|Overall Study|Withdrawal by Subject|0|||
128956778|NCT03325556|464127466|FG002|Open-label Period|Death|0|||
128956779|NCT03325556|464127464|FG000|Open-label Period|Lost to Follow-up|1|||
128711827|NCT02956486|463241602|FG001|Extension Phase|Adverse Event|0|||
128711828|NCT02956486|463241603|FG002|Extension Phase|Adverse Event|2|||
128711829|NCT02956486|463241601|FG000|Extension Phase|Study terminated by sponsor|0|||
128711830|NCT02956486|463241602|FG001|Extension Phase|Study terminated by sponsor|0|||
128711831|NCT02956486|463241603|FG002|Extension Phase|Study terminated by sponsor|16|||
128956780|NCT03325556|464127465|FG001|Open-label Period|Lost to Follow-up|0|||
129219681|NCT01358721|465104552|FG003|Overall Study|Study Drug Toxicity|5|||
128956781|NCT03325556|464127466|FG002|Open-label Period|Lost to Follow-up|0|||
128956782|NCT03325556|464127464|FG000|Open-label Period|Non-compliance with study drug|5|||
128956783|NCT03325556|464127465|FG001|Open-label Period|Non-compliance with study drug|0|||
128956784|NCT03325556|464127466|FG002|Open-label Period|Non-compliance with study drug|0|||
128956785|NCT03325556|464127464|FG000|Open-label Period|Use of prohibited medication|1|||
128956786|NCT03325556|464127465|FG001|Open-label Period|Use of prohibited medication|0|||
128956787|NCT03325556|464127466|FG002|Open-label Period|Use of prohibited medication|0|||
128956788|NCT03325556|464127464|FG000|Open-label Period|Protocol Violation|4|||
128956789|NCT03325556|464127465|FG001|Open-label Period|Protocol Violation|0|||
128956790|NCT03325556|464127466|FG002|Open-label Period|Protocol Violation|0|||
128956791|NCT03325556|464127464|FG000|Open-label Period|Withdrawal by Subject|17|||
128956792|NCT03325556|464127465|FG001|Open-label Period|Withdrawal by Subject|0|||
128956793|NCT03325556|464127466|FG002|Open-label Period|Withdrawal by Subject|0|||
128956794|NCT03325556|464127464|FG000|Open-label Period|Not otherwise specified|8|||
128956795|NCT03325556|464127465|FG001|Open-label Period|Not otherwise specified|0|||
128956796|NCT03325556|464127466|FG002|Open-label Period|Not otherwise specified|0|||
128956797|NCT03325556|464127464|FG000|Open-label Period|Administrative discont. at study termination|41|||
128956798|NCT03325556|464127465|FG001|Open-label Period|Administrative discont. at study termination|0|||
128956799|NCT03325556|464127466|FG002|Open-label Period|Administrative discont. at study termination|0|||
128956800|NCT03325556|464127464|FG000|Double-blind Period|Relapse|0|||
128956801|NCT03325556|464127465|FG001|Double-blind Period|Relapse|15|||
128956802|NCT03325556|464127466|FG002|Double-blind Period|Relapse|34|||
128956803|NCT03325556|464127464|FG000|Double-blind Period|Adverse Event|0|||
128956804|NCT03325556|464127465|FG001|Double-blind Period|Adverse Event|3|||
128956805|NCT03325556|464127466|FG002|Double-blind Period|Adverse Event|1|||
128956806|NCT03325556|464127464|FG000|Double-blind Period|Noncompliance with study drug|0|||
128956807|NCT03325556|464127465|FG001|Double-blind Period|Noncompliance with study drug|0|||
128956808|NCT03325556|464127466|FG002|Double-blind Period|Noncompliance with study drug|1|||
128956809|NCT03325556|464127464|FG000|Double-blind Period|Use of prohibited medication|0|||
128956810|NCT03325556|464127465|FG001|Double-blind Period|Use of prohibited medication|1|||
128956811|NCT03325556|464127466|FG002|Double-blind Period|Use of prohibited medication|0|||
128956812|NCT03325556|464127464|FG000|Double-blind Period|Physician Decision|0|||
128956813|NCT03325556|464127465|FG001|Double-blind Period|Physician Decision|0|||
128956814|NCT03325556|464127466|FG002|Double-blind Period|Physician Decision|1|||
128956815|NCT03325556|464127464|FG000|Double-blind Period|Withdrawal by Subject|0|||
128956816|NCT03325556|464127465|FG001|Double-blind Period|Withdrawal by Subject|6|||
128956817|NCT03325556|464127466|FG002|Double-blind Period|Withdrawal by Subject|4|||
128956818|NCT03325556|464127464|FG000|Double-blind Period|Not otherwise specified|0|||
128956819|NCT03325556|464127465|FG001|Double-blind Period|Not otherwise specified|1|||
128956820|NCT03325556|464127466|FG002|Double-blind Period|Not otherwise specified|5|||
128956821|NCT03325556|464127464|FG000|Double-blind Period|Administrative discont. at study termination|0|||
128956822|NCT03325556|464127465|FG001|Double-blind Period|Administrative discont. at study termination|35|||
128956823|NCT03325556|464127466|FG002|Double-blind Period|Administrative discont. at study termination|31|||
128956824|NCT02119026|464127467|FG000|1st-line Treatment|Adverse Event|9|||
128956825|NCT02119026|464127468|FG001|1st-line Treatment|Adverse Event|14|||
128956826|NCT02119026|464127467|FG000|1st-line Treatment|Physician Decision|3|||
128956827|NCT02119026|464127468|FG001|1st-line Treatment|Physician Decision|8|||
128956828|NCT02119026|464127467|FG000|1st-line Treatment|Withdrawal by Subject|4|||
128956829|NCT02119026|464127468|FG001|1st-line Treatment|Withdrawal by Subject|10|||
128956830|NCT02119026|464127467|FG000|1st-line Treatment|Patient condition or compliance|6|||
128956831|NCT02119026|464127468|FG001|1st-line Treatment|Patient condition or compliance|4|||
128956832|NCT02119026|464127467|FG000|1st-line Treatment|Surgery of metastases|2|||
129126285|NCT01697579|464757950|FG004|Base Study-Cycle 1|Protocol Violation|3|||
129126286|NCT01697579|464757951|FG005|Base Study-Cycle 1|Protocol Violation|0|||
129126287|NCT01697579|464757952|FG006|Base Study-Cycle 1|Protocol Violation|0|||
129126288|NCT01697579|464757946|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129126289|NCT01697579|464757947|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
129126290|NCT01697579|464757948|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129126291|NCT01697579|464757949|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129126292|NCT01697579|464757950|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129126293|NCT01697579|464757951|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129126294|NCT01697579|464757952|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
128956833|NCT02119026|464127468|FG001|1st-line Treatment|Surgery of metastases|1|||
128956834|NCT02119026|464127467|FG000|1st-line Treatment|Death|2|||
128956835|NCT02119026|464127468|FG001|1st-line Treatment|Death|1|||
128956836|NCT02119026|464127467|FG000|2nd-line Treatment|Lost to Follow-up|2|||
128956837|NCT02119026|464127468|FG001|2nd-line Treatment|Lost to Follow-up|0|||
128956838|NCT02119026|464127467|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
128956839|NCT02119026|464127468|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
128956840|NCT02119026|464127467|FG000|2nd-line Treatment|Adverse Event|4|||
128956841|NCT02119026|464127468|FG001|2nd-line Treatment|Adverse Event|1|||
128956842|NCT00340834|464127469|FG000|Core Phase of Study|Adverse Event|26|||
128956843|NCT00340834|464127470|FG001|Core Phase of Study|Adverse Event|9|||
128956844|NCT00340834|464127471|FG002|Core Phase of Study|Adverse Event|9|||
128956845|NCT00340834|464127472|FG003|Core Phase of Study|Adverse Event|0|||
128956846|NCT00340834|464127473|FG004|Core Phase of Study|Adverse Event|0|||
128956847|NCT00340834|464127469|FG000|Core Phase of Study|Withdrawal by Subject|11|||
128956848|NCT00340834|464127470|FG001|Core Phase of Study|Withdrawal by Subject|9|||
128956849|NCT00340834|464127471|FG002|Core Phase of Study|Withdrawal by Subject|16|||
128956850|NCT00340834|464127472|FG003|Core Phase of Study|Withdrawal by Subject|0|||
128956851|NCT00340834|464127473|FG004|Core Phase of Study|Withdrawal by Subject|0|||
128956852|NCT00340834|464127469|FG000|Core Phase of Study|Administrative Problems|6|||
128956853|NCT00340834|464127470|FG001|Core Phase of Study|Administrative Problems|2|||
128956854|NCT00340834|464127471|FG002|Core Phase of Study|Administrative Problems|7|||
128956855|NCT00340834|464127472|FG003|Core Phase of Study|Administrative Problems|0|||
128956856|NCT00340834|464127473|FG004|Core Phase of Study|Administrative Problems|0|||
128956857|NCT00340834|464127469|FG000|Core Phase of Study|Lack of Efficacy|3|||
128956858|NCT00340834|464127470|FG001|Core Phase of Study|Lack of Efficacy|3|||
128956859|NCT00340834|464127471|FG002|Core Phase of Study|Lack of Efficacy|7|||
128956860|NCT00340834|464127472|FG003|Core Phase of Study|Lack of Efficacy|0|||
128956861|NCT00340834|464127473|FG004|Core Phase of Study|Lack of Efficacy|0|||
128956862|NCT00340834|464127469|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
128956863|NCT00340834|464127470|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
128956864|NCT00340834|464127471|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
128956865|NCT00340834|464127472|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
128956866|NCT00340834|464127473|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
128956867|NCT00340834|464127469|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
128956868|NCT00340834|464127470|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
128956869|NCT00340834|464127471|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
129126295|NCT01697579|464757946|FG000|Base Study-Cycle 1|Technical Problems|0|||
129126296|NCT01697579|464757947|FG001|Base Study-Cycle 1|Technical Problems|0|||
129126297|NCT01697579|464757948|FG002|Base Study-Cycle 1|Technical Problems|1|||
128711832|NCT02956486|463241601|FG000|Extension Phase|Not Treated|0|||
128956870|NCT00340834|464127472|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
128956871|NCT00340834|464127473|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
128956872|NCT00340834|464127469|FG000|Core Phase of Study|Lost to Follow-up|1|||
128956873|NCT00340834|464127470|FG001|Core Phase of Study|Lost to Follow-up|1|||
128956874|NCT00340834|464127471|FG002|Core Phase of Study|Lost to Follow-up|4|||
128956875|NCT00340834|464127472|FG003|Core Phase of Study|Lost to Follow-up|0|||
128956876|NCT00340834|464127473|FG004|Core Phase of Study|Lost to Follow-up|0|||
128956877|NCT00340834|464127469|FG000|Core Phase of Study|Death|2|||
128956878|NCT00340834|464127470|FG001|Core Phase of Study|Death|0|||
128956879|NCT00340834|464127471|FG002|Core Phase of Study|Death|0|||
128956880|NCT00340834|464127472|FG003|Core Phase of Study|Death|0|||
128956881|NCT00340834|464127473|FG004|Core Phase of Study|Death|0|||
128956882|NCT00340834|464127469|FG000|Core Phase of Study|Protocol Violation|0|||
128956883|NCT00340834|464127470|FG001|Core Phase of Study|Protocol Violation|0|||
128956884|NCT00340834|464127471|FG002|Core Phase of Study|Protocol Violation|2|||
128956885|NCT00340834|464127472|FG003|Core Phase of Study|Protocol Violation|0|||
128956886|NCT00340834|464127473|FG004|Core Phase of Study|Protocol Violation|0|||
128956887|NCT00340834|464127469|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
128956888|NCT00340834|464127470|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
128956889|NCT00340834|464127471|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
128956890|NCT00340834|464127472|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
128956891|NCT00340834|464127473|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
128956892|NCT00340834|464127469|FG000|Extension Phase of Study|Subject withdrew consent|26|||
128956893|NCT00340834|464127470|FG001|Extension Phase of Study|Subject withdrew consent|31|||
128956894|NCT00340834|464127471|FG002|Extension Phase of Study|Subject withdrew consent|0|||
128956895|NCT00340834|464127472|FG003|Extension Phase of Study|Subject withdrew consent|12|||
128956896|NCT00340834|464127473|FG004|Extension Phase of Study|Subject withdrew consent|15|||
128956897|NCT00340834|464127469|FG000|Extension Phase of Study|Adverse Event|21|||
128956898|NCT00340834|464127470|FG001|Extension Phase of Study|Adverse Event|22|||
128956899|NCT00340834|464127471|FG002|Extension Phase of Study|Adverse Event|0|||
128956900|NCT00340834|464127472|FG003|Extension Phase of Study|Adverse Event|19|||
129126298|NCT01697579|464757949|FG003|Base Study-Cycle 1|Technical Problems|1|||
128956901|NCT00340834|464127473|FG004|Extension Phase of Study|Adverse Event|7|||
128956902|NCT00340834|464127469|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
129126299|NCT01697579|464757950|FG004|Base Study-Cycle 1|Technical Problems|0|||
128956903|NCT00340834|464127470|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
128956904|NCT00340834|464127471|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
128956905|NCT00340834|464127472|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
128956906|NCT00340834|464127473|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
128956907|NCT00340834|464127469|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
129126300|NCT01697579|464757951|FG005|Base Study-Cycle 1|Technical Problems|0|||
128956908|NCT00340834|464127470|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
128956909|NCT00340834|464127471|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
128956910|NCT00340834|464127472|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
128956911|NCT00340834|464127473|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
128956912|NCT00340834|464127469|FG000|Extension Phase of Study|Lost to Follow-up|1|||
128956913|NCT00340834|464127470|FG001|Extension Phase of Study|Lost to Follow-up|1|||
128711833|NCT02956486|463241602|FG001|Extension Phase|Not Treated|0|||
128711834|NCT02956486|463241603|FG002|Extension Phase|Not Treated|1|||
128711835|NCT03325075|463241606|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
128711836|NCT03325075|463241607|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
128711837|NCT03325075|463241608|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
128956914|NCT00340834|464127471|FG002|Extension Phase of Study|Lost to Follow-up|0|||
128956915|NCT00340834|464127472|FG003|Extension Phase of Study|Lost to Follow-up|2|||
128956916|NCT00340834|464127473|FG004|Extension Phase of Study|Lost to Follow-up|3|||
128956917|NCT00340834|464127469|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
128956918|NCT00340834|464127470|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
128956919|NCT00340834|464127471|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
128956920|NCT00340834|464127472|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
128956921|NCT00340834|464127473|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
128956922|NCT00340834|464127469|FG000|Extension Phase of Study|Administrative problems|3|||
128956923|NCT00340834|464127470|FG001|Extension Phase of Study|Administrative problems|0|||
128956924|NCT00340834|464127471|FG002|Extension Phase of Study|Administrative problems|0|||
128956925|NCT00340834|464127472|FG003|Extension Phase of Study|Administrative problems|1|||
128956926|NCT00340834|464127473|FG004|Extension Phase of Study|Administrative problems|1|||
128956927|NCT00340834|464127469|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
128956928|NCT00340834|464127470|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
128956929|NCT00340834|464127471|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
128956930|NCT00340834|464127472|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
128956931|NCT00340834|464127473|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
128956932|NCT00340834|464127469|FG000|Extension Phase of Study|Protocol Violation|3|||
128956933|NCT00340834|464127470|FG001|Extension Phase of Study|Protocol Violation|0|||
128956934|NCT00340834|464127471|FG002|Extension Phase of Study|Protocol Violation|0|||
128956935|NCT00340834|464127472|FG003|Extension Phase of Study|Protocol Violation|0|||
128956936|NCT00340834|464127473|FG004|Extension Phase of Study|Protocol Violation|0|||
128956937|NCT00340834|464127469|FG000|Extension Phase of Study|Death|0|||
128956938|NCT00340834|464127470|FG001|Extension Phase of Study|Death|0|||
128956939|NCT00340834|464127471|FG002|Extension Phase of Study|Death|0|||
128956940|NCT00340834|464127472|FG003|Extension Phase of Study|Death|0|||
128956941|NCT00340834|464127473|FG004|Extension Phase of Study|Death|1|||
128956942|NCT02786836|464127476|FG000|Overall Study|Death|1|||
128956943|NCT02786836|464127476|FG000|Overall Study|Lack of Efficacy|2|||
128956944|NCT02786836|464127476|FG000|Overall Study|Protocol Violation|3|||
128956945|NCT02786836|464127476|FG000|Overall Study|Withdrawal by Subject|3|||
128956946|NCT02786836|464127476|FG000|Overall Study|Liver Transplantation|2|||
128956947|NCT02786836|464127476|FG000|Overall Study|Device or Pharmacy Issues|3|||
128956948|NCT01143714|464127478|FG000|Overall Study|Adverse Event|4|||
128956949|NCT01143714|464127479|FG001|Overall Study|Adverse Event|2|||
128956950|NCT01143714|464127478|FG000|Overall Study|Withdrawal by Subject|1|||
128956951|NCT01143714|464127479|FG001|Overall Study|Withdrawal by Subject|0|||
128956952|NCT01143714|464127478|FG000|Overall Study|Subject non-compliance|0|||
128956953|NCT01143714|464127479|FG001|Overall Study|Subject non-compliance|1|||
128956954|NCT01143714|464127478|FG000|Overall Study|wound closed = deemed healed|1|||
128956955|NCT01143714|464127479|FG001|Overall Study|wound closed = deemed healed|0|||
128956956|NCT01143714|464127478|FG000|Overall Study|wound size increased|1|||
128956957|NCT01143714|464127479|FG001|Overall Study|wound size increased|0|||
128956958|NCT01387074|464127480|FG000|Overall Study|Lost to Follow-up|7|||
128956959|NCT01387074|464127480|FG000|Overall Study|Lack of Efficacy|1|||
128956960|NCT03892707|464127487|FG000|Overall Study|Screen failure|6|||
128956961|NCT03892707|464127488|FG001|Overall Study|Screen failure|0|||
128956962|NCT03892707|464127487|FG000|Overall Study|Pain resolution|0|||
128956963|NCT03892707|464127488|FG001|Overall Study|Pain resolution|4|||
128956964|NCT03892707|464127487|FG000|Overall Study|Withdrawal by Subject|0|||
128956965|NCT03892707|464127488|FG001|Overall Study|Withdrawal by Subject|1|||
128956966|NCT03892707|464127487|FG000|Overall Study|Other (long business trip)|0|||
128956967|NCT03892707|464127488|FG001|Overall Study|Other (long business trip)|1|||
128956968|NCT01807949|464127489|FG000|Overall Study|Adverse Event|1|||
128956969|NCT01807949|464127490|FG001|Overall Study|Adverse Event|2|||
128956970|NCT01807949|464127491|FG002|Overall Study|Adverse Event|2|||
128956971|NCT01807949|464127489|FG000|Overall Study|Withdrawal by Subject|1|||
128711838|NCT03325075|463241609|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
128711839|NCT03325075|463241606|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
129036155|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129036156|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129036157|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Death|2|||
129036158|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Death|1|||
129036159|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Death|0|||
129036160|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Death|0|||
129036161|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
129036162|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
129036163|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
129036164|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
129036165|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
129036166|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
129036167|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
129126301|NCT01697579|464757952|FG006|Base Study-Cycle 1|Technical Problems|0|||
129126302|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Death|0|||
129126303|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Death|0|||
129126304|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Death|0|||
129126305|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Death|0|||
129126306|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Death|0|||
129126307|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Death|0|||
129126308|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Death|2|||
129126309|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129126310|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129126311|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129126312|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129126313|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129126314|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
129126315|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
129126316|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
129126317|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
129126318|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
129126319|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
129126320|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
129126321|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
129126322|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
129126323|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129126324|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129126325|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129126326|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129126327|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129126328|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129126329|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
129126330|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129126331|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129126332|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129126333|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129126334|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129126335|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
129126336|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
129126337|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129126338|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129126339|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129126340|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129126341|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129126342|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
129126343|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129126344|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129126345|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129126346|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129126347|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129126348|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129126349|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
129126350|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
129126351|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129126352|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129036168|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
128711840|NCT03325075|463241607|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
128711841|NCT03325075|463241608|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
128711842|NCT03325075|463241609|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
128711843|NCT03325075|463241606|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
128711844|NCT03325075|463241607|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
128711845|NCT03325075|463241608|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
128711846|NCT03325075|463241609|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
128956972|NCT01807949|464127490|FG001|Overall Study|Withdrawal by Subject|2|||
128956973|NCT01807949|464127491|FG002|Overall Study|Withdrawal by Subject|2|||
128956974|NCT01807949|464127489|FG000|Overall Study|Non-Compliance|0|||
128956975|NCT01807949|464127490|FG001|Overall Study|Non-Compliance|0|||
128956976|NCT01807949|464127491|FG002|Overall Study|Non-Compliance|1|||
128956977|NCT01807949|464127489|FG000|Overall Study|Undefined|0|||
128956978|NCT01807949|464127490|FG001|Overall Study|Undefined|1|||
128956979|NCT01807949|464127491|FG002|Overall Study|Undefined|2|||
128956980|NCT01807949|464127489|FG000|Overall Study|Randomized But Not Treated|0|||
128956981|NCT01807949|464127490|FG001|Overall Study|Randomized But Not Treated|2|||
128956982|NCT01807949|464127491|FG002|Overall Study|Randomized But Not Treated|2|||
128956983|NCT01181141|464127498|FG000|Overall Study|Adverse Event|2|||
128956984|NCT01181141|464127499|FG001|Overall Study|Adverse Event|1|||
128956985|NCT01181141|464127498|FG000|Overall Study|Lack of Efficacy|1|||
128956986|NCT01181141|464127499|FG001|Overall Study|Lack of Efficacy|0|||
128956987|NCT01181141|464127498|FG000|Overall Study|Lost to Follow-up|1|||
128956988|NCT01181141|464127499|FG001|Overall Study|Lost to Follow-up|1|||
128956989|NCT01181141|464127498|FG000|Overall Study|Physician Decision|2|||
128956990|NCT01181141|464127499|FG001|Overall Study|Physician Decision|0|||
128956991|NCT01181141|464127498|FG000|Overall Study|Protocol Violation|3|||
128956992|NCT01181141|464127499|FG001|Overall Study|Protocol Violation|1|||
128956993|NCT01181141|464127498|FG000|Overall Study|Withdrawal by Subject|3|||
128956994|NCT01181141|464127499|FG001|Overall Study|Withdrawal by Subject|1|||
128711847|NCT00422591|463241610|FG000|Overall Study|Physician Decision|4|||
128711848|NCT00422591|463241610|FG000|Overall Study|Withdrawal by Subject|2|||
128711849|NCT01922089|463241613|FG000|Overall Study|Adverse Event|18|||
128711850|NCT01922089|463241614|FG001|Overall Study|Adverse Event|13|||
128711851|NCT01922089|463241613|FG000|Overall Study|Protocol Deviation|10|||
128711852|NCT01922089|463241614|FG001|Overall Study|Protocol Deviation|7|||
128711853|NCT01922089|463241613|FG000|Overall Study|Withdrawal by Subject|3|||
128711854|NCT01922089|463241614|FG001|Overall Study|Withdrawal by Subject|4|||
128711855|NCT01922089|463241613|FG000|Overall Study|administrative problems|4|||
128711856|NCT01922089|463241614|FG001|Overall Study|administrative problems|1|||
128711857|NCT01922089|463241613|FG000|Overall Study|Physician Decision|2|||
128711858|NCT01922089|463241614|FG001|Overall Study|Physician Decision|3|||
128711859|NCT01922089|463241613|FG000|Overall Study|Death|2|||
128711860|NCT01922089|463241614|FG001|Overall Study|Death|1|||
128711861|NCT01922089|463241613|FG000|Overall Study|Lost to Follow-up|0|||
128711862|NCT01922089|463241614|FG001|Overall Study|Lost to Follow-up|1|||
128711863|NCT04903626|463241618|FG000|Overall Study|Lost to Follow-up|6|||
128711864|NCT04903626|463241618|FG000|Overall Study|Withdrawal by Subject|1|||
128711865|NCT04903626|463241618|FG000|Overall Study|Other, Not Specified|1|||
128711866|NCT00165776|463241622|FG000|Overall Study|Lack of Efficacy|0|||
128711867|NCT00165776|463241623|FG001|Overall Study|Lack of Efficacy|0|||
128711868|NCT00165776|463241624|FG002|Overall Study|Lack of Efficacy|0|||
128711869|NCT00165776|463241625|FG003|Overall Study|Lack of Efficacy|1|||
128711870|NCT00165776|463241622|FG000|Overall Study|Withdrawal by Subject|4|||
128711871|NCT00165776|463241623|FG001|Overall Study|Withdrawal by Subject|1|||
128711872|NCT00165776|463241624|FG002|Overall Study|Withdrawal by Subject|2|||
128711873|NCT00165776|463241625|FG003|Overall Study|Withdrawal by Subject|0|||
128711874|NCT00165776|463241622|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
128711875|NCT00165776|463241623|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
128956995|NCT00448760|464127500|FG000|Overall Study|Death|3|||
128956996|NCT01213264|464127506|FG000|Overall Study|Adverse Event|1|||
128956997|NCT01213264|464127507|FG001|Overall Study|Adverse Event|0|||
128956998|NCT01213264|464127508|FG002|Overall Study|Adverse Event|0|||
128956999|NCT01213264|464127506|FG000|Overall Study|Lost to Follow-up|1|||
128957000|NCT01213264|464127507|FG001|Overall Study|Lost to Follow-up|2|||
128957001|NCT01213264|464127508|FG002|Overall Study|Lost to Follow-up|6|||
128957002|NCT00290589|464127509|FG000|Overall Study|Lost to Follow-up|2|||
128957003|NCT00290589|464127510|FG001|Overall Study|Lost to Follow-up|2|||
128957004|NCT00118911|464127511|FG000|Overall Study|Withdrawal by Subject|2|||
128957005|NCT00118911|464127512|FG001|Overall Study|Withdrawal by Subject|5|||
128957006|NCT05014542|464127513|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
128957007|NCT05014542|464127514|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
128957008|NCT05014542|464127513|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
128957009|NCT05014542|464127514|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
128711876|NCT00165776|463241624|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
128711877|NCT00165776|463241625|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
128711878|NCT02622321|463241628|FG000|Overall Study|Withdrawal by Subject|2|||
128770644|NCT00258440|463451582|FG001|Overall Study|Withdrawal by Subject|0|||
128770645|NCT00258440|463451583|FG002|Overall Study|Withdrawal by Subject|1|||
128770646|NCT00737061|463451584|FG000|Waiting Period|Lost to Follow-up|6|||
128770647|NCT00737061|463451584|FG000|Waiting Period|Withdrawal by Subject|1|||
128770648|NCT00737061|463451584|FG000|Waiting Period|Bilateral placement failure|34|||
128770649|NCT00737061|463451584|FG000|Waiting Period|Deemed patent following HSG|26|||
128770650|NCT00737061|463451584|FG000|Waiting Period|Alternative contraception failure|3|||
128770651|NCT00737061|463451584|FG000|Waiting Period|Elected surgical tubal ligation|5|||
128770652|NCT00737061|463451584|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
128770653|NCT00737061|463451584|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
128770654|NCT00737061|463451584|FG000|1 Year Wearing Period|Discontinued reilance|3|||
128770655|NCT00737061|463451584|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
128770656|NCT02153359|463451586|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
128770657|NCT02153359|463451587|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
128770658|NCT01964521|463451588|FG000|Overall Study|Lost to Follow-up|4|||
128770659|NCT01108510|463451589|FG000|Overall Study|Randomized but Not Treated|5|||
128770660|NCT01108510|463451590|FG001|Overall Study|Randomized but Not Treated|1|||
128770661|NCT01108510|463451589|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
128770662|NCT01108510|463451590|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
128770663|NCT01108510|463451589|FG000|Overall Study|Adverse Event|26|||
128770664|NCT01108510|463451590|FG001|Overall Study|Adverse Event|19|||
128770665|NCT01108510|463451589|FG000|Overall Study|Lost to Follow-up|20|||
128770666|NCT01108510|463451590|FG001|Overall Study|Lost to Follow-up|17|||
128770667|NCT01108510|463451589|FG000|Overall Study|Withdrew Consent|21|||
128770668|NCT01108510|463451590|FG001|Overall Study|Withdrew Consent|15|||
128770669|NCT01108510|463451589|FG000|Overall Study|Investigator's Discretion|12|||
128770670|NCT01108510|463451590|FG001|Overall Study|Investigator's Discretion|10|||
128770671|NCT01108510|463451589|FG000|Overall Study|Participant Noncompliance|5|||
128770672|NCT01108510|463451590|FG001|Overall Study|Participant Noncompliance|7|||
128770673|NCT01108510|463451589|FG000|Overall Study|Lack of Efficacy|3|||
128770674|NCT01108510|463451590|FG001|Overall Study|Lack of Efficacy|0|||
128770675|NCT01108510|463451589|FG000|Overall Study|Pregnancy|0|||
128770676|NCT01108510|463451590|FG001|Overall Study|Pregnancy|3|||
128770677|NCT01108510|463451589|FG000|Overall Study|Death|1|||
128770678|NCT01108510|463451590|FG001|Overall Study|Death|1|||
128770679|NCT02796963|463451591|FG000|Overall Study|Lost to Follow-up|89|||
128770680|NCT02796963|463451592|FG001|Overall Study|Lost to Follow-up|76|||
128770681|NCT02796963|463451593|FG002|Overall Study|Lost to Follow-up|69|||
128770682|NCT02796963|463451594|FG003|Overall Study|Lost to Follow-up|72|||
128770683|NCT00582491|463451595|FG000|Overall Study|Withdrawal by Subject|1|||
128770684|NCT00582491|463451596|FG001|Overall Study|Withdrawal by Subject|0|||
128770685|NCT04192630|463451597|FG000|Overall Study|Discontinued before surgery|2|||
128770686|NCT04192630|463451598|FG001|Overall Study|Discontinued before surgery|0|||
128770687|NCT04192630|463451597|FG000|Overall Study|Discontinued after surgery|5|||
128770688|NCT04192630|463451598|FG001|Overall Study|Discontinued after surgery|3|||
128770689|NCT01425632|463451599|FG000|Overall Study|Adverse Event|0|||
128770690|NCT01425632|463451600|FG001|Overall Study|Adverse Event|1|||
128770691|NCT01425632|463451601|FG002|Overall Study|Adverse Event|1|||
128770692|NCT01425632|463451599|FG000|Overall Study|Physician Decision|1|||
128770693|NCT01425632|463451600|FG001|Overall Study|Physician Decision|0|||
128770694|NCT01425632|463451601|FG002|Overall Study|Physician Decision|0|||
128770695|NCT01425632|463451599|FG000|Overall Study|Protocol Violation|0|||
128770696|NCT01425632|463451600|FG001|Overall Study|Protocol Violation|0|||
128770697|NCT01425632|463451601|FG002|Overall Study|Protocol Violation|2|||
128770698|NCT01425632|463451599|FG000|Overall Study|Withdrawal by Subject|0|||
128770699|NCT01425632|463451600|FG001|Overall Study|Withdrawal by Subject|0|||
129126353|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129126354|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129126355|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129126356|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
128770700|NCT01425632|463451601|FG002|Overall Study|Withdrawal by Subject|1|||
129126357|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
128770701|NCT01208415|463451604|FG000|Overall Study|Death|1|||
128770702|NCT01208415|463451604|FG000|Overall Study|Lost to Follow-up|2|||
128957010|NCT05014542|464127513|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
128957011|NCT05014542|464127514|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
128770703|NCT01208415|463451604|FG000|Overall Study|Withdrawal by Subject|3|||
128770704|NCT01208415|463451604|FG000|Overall Study|Device not placed|1|||
128770705|NCT01208415|463451604|FG000|Overall Study|Still be eligible for follow-up|33|||
128770706|NCT01115491|463451605|FG000|Overall Study|Death|22|||
128770707|NCT01115491|463451605|FG000|Overall Study|Adverse Event|3|||
128770708|NCT01115491|463451605|FG000|Overall Study|Lost to Follow-up|3|||
128957012|NCT05014542|464127513|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
128770709|NCT01115491|463451605|FG000|Overall Study|Withdrawal by Subject|1|||
128770710|NCT01115491|463451605|FG000|Overall Study|Physician Decision|1|||
128711879|NCT02622321|463241629|FG001|Overall Study|Withdrawal by Subject|0|||
128957013|NCT05014542|464127514|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
128957014|NCT05507580|464127515|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128957015|NCT05507580|464127516|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
128957016|NCT05507580|464127517|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
128957017|NCT05507580|464127518|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
128957018|NCT05507580|464127519|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
128957019|NCT05507580|464127520|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
129036169|NCT03110380|464423417|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
129036170|NCT03110380|464423418|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
129036171|NCT03110380|464423419|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
129036172|NCT03110380|464423420|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
129036173|NCT03110380|464423417|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129036174|NCT03110380|464423418|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129036175|NCT03110380|464423419|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
129036176|NCT03110380|464423420|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
129036177|NCT03110380|464423417|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
129036178|NCT03110380|464423418|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
128711880|NCT02622321|463241630|FG002|Overall Study|Withdrawal by Subject|0|||
128711881|NCT02622321|463241631|FG003|Overall Study|Withdrawal by Subject|0|||
128711882|NCT02622321|463241628|FG000|Overall Study|Death|0|||
128711883|NCT02622321|463241629|FG001|Overall Study|Death|0|||
128711884|NCT02622321|463241630|FG002|Overall Study|Death|1|||
128711885|NCT02622321|463241631|FG003|Overall Study|Death|0|||
128711886|NCT02622321|463241628|FG000|Overall Study|Physician Decision|1|||
128711887|NCT02622321|463241629|FG001|Overall Study|Physician Decision|0|||
128711888|NCT02622321|463241630|FG002|Overall Study|Physician Decision|0|||
128711889|NCT02622321|463241631|FG003|Overall Study|Physician Decision|0|||
128711890|NCT00241280|463241633|FG000|Overall Study|Adverse Event|2|||
128711891|NCT00241280|463241634|FG001|Overall Study|Adverse Event|6|||
128711892|NCT00241280|463241633|FG000|Overall Study|Discomfort|11|||
128711893|NCT00241280|463241634|FG001|Overall Study|Discomfort|16|||
128711894|NCT00241280|463241633|FG000|Overall Study|Pregnancy|1|||
128711895|NCT00241280|463241634|FG001|Overall Study|Pregnancy|5|||
128711896|NCT00241280|463241633|FG000|Overall Study|Lost to Follow-up|5|||
128711897|NCT00241280|463241634|FG001|Overall Study|Lost to Follow-up|8|||
128711898|NCT00241280|463241633|FG000|Overall Study|Withdrawal by Subject|7|||
128711899|NCT00241280|463241634|FG001|Overall Study|Withdrawal by Subject|4|||
128711900|NCT00241280|463241633|FG000|Overall Study|Protocol Violation|4|||
128711901|NCT00241280|463241634|FG001|Overall Study|Protocol Violation|10|||
128711902|NCT00241280|463241633|FG000|Overall Study|Relocation|4|||
128711903|NCT00241280|463241634|FG001|Overall Study|Relocation|4|||
128711904|NCT00241280|463241633|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
128711905|NCT00241280|463241634|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
128711906|NCT00241280|463241633|FG000|Overall Study|Unsatisfactory Visual Response|1|||
128711907|NCT00241280|463241634|FG001|Overall Study|Unsatisfactory Visual Response|1|||
128711908|NCT00241280|463241633|FG000|Overall Study|Diabetic|1|||
128711909|NCT00241280|463241634|FG001|Overall Study|Diabetic|0|||
128711910|NCT00241280|463241633|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
128711911|NCT00241280|463241634|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
128711912|NCT00241280|463241633|FG000|Overall Study|Dispensed incorrect test article|1|||
128711913|NCT00241280|463241634|FG001|Overall Study|Dispensed incorrect test article|2|||
128711914|NCT00241280|463241633|FG000|Overall Study|Unacceptable Fit|0|||
128711915|NCT00241280|463241634|FG001|Overall Study|Unacceptable Fit|1|||
128711916|NCT00241280|463241633|FG000|Overall Study|Scheduling Conflict|0|||
128711917|NCT00241280|463241634|FG001|Overall Study|Scheduling Conflict|2|||
128711918|NCT00241280|463241633|FG000|Overall Study|History of Ocular Surgery|0|||
128711919|NCT00241280|463241634|FG001|Overall Study|History of Ocular Surgery|1|||
128711920|NCT00241280|463241633|FG000|Overall Study|Coating on Lens|1|||
128711921|NCT00241280|463241634|FG001|Overall Study|Coating on Lens|0|||
128711922|NCT00241280|463241633|FG000|Overall Study|Excessive Dryness|0|||
128711923|NCT00241280|463241634|FG001|Overall Study|Excessive Dryness|1|||
128711924|NCT00965718|463241635|FG000|Overall Study|Withdrawal by Subject|4|||
128711925|NCT01958008|463241636|FG000|Overall Study|Worsening of disease under study|0|||
128711926|NCT01958008|463241637|FG001|Overall Study|Worsening of disease under study|0|||
128711927|NCT01958008|463241638|FG002|Overall Study|Worsening of disease under study|1|||
128711928|NCT01958008|463241639|FG003|Overall Study|Worsening of disease under study|0|||
128711929|NCT01958008|463241636|FG000|Overall Study|Other adverse event|1|||
128711930|NCT01958008|463241637|FG001|Overall Study|Other adverse event|0|||
128711931|NCT01958008|463241638|FG002|Overall Study|Other adverse event|0|||
128711932|NCT01958008|463241639|FG003|Overall Study|Other adverse event|0|||
128711933|NCT01634360|463241641|FG000|Overall Study|Adverse Event|10|||
128711934|NCT01634360|463241642|FG001|Overall Study|Adverse Event|34|||
128957020|NCT05507580|464127515|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
129036179|NCT03110380|464423419|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
128770711|NCT04297241|463451606|FG000|Overall Study|Withdrawal by Subject|1|||
128770712|NCT04297241|463451606|FG000|Overall Study|Adverse Event|1|||
128770713|NCT04297241|463451606|FG000|Overall Study|Physician Decision|3|||
128770714|NCT01003639|463451609|FG000|Overall Study|Lost to Follow-up|6|||
128770715|NCT01003639|463451610|FG001|Overall Study|Lost to Follow-up|9|||
128770716|NCT01003639|463451609|FG000|Overall Study|Withdrawal by Subject|9|||
128770717|NCT01003639|463451610|FG001|Overall Study|Withdrawal by Subject|5|||
128770718|NCT01003639|463451609|FG000|Overall Study|Lack of Efficacy|1|||
128770719|NCT01003639|463451610|FG001|Overall Study|Lack of Efficacy|6|||
128770720|NCT01003639|463451609|FG000|Overall Study|Adverse Event|0|||
128770721|NCT01003639|463451610|FG001|Overall Study|Adverse Event|1|||
128770722|NCT01003639|463451609|FG000|Overall Study|Protocol Violation|0|||
128770723|NCT01003639|463451610|FG001|Overall Study|Protocol Violation|1|||
128770724|NCT01003639|463451609|FG000|Overall Study|Physician Decision|1|||
128770725|NCT01003639|463451610|FG001|Overall Study|Physician Decision|0|||
128770726|NCT02401308|463451612|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
128770727|NCT02401308|463451613|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
128770728|NCT01734434|463451614|FG000|Overall Study|Death Infant|3|||
128770729|NCT01734434|463451615|FG001|Overall Study|Death Infant|1|||
128770730|NCT01734434|463451616|FG002|Overall Study|Death Infant|17|||
128770731|NCT01734434|463451617|FG003|Overall Study|Death Infant|5|||
128770732|NCT01734434|463451614|FG000|Overall Study|Lost to Follow-up|2|||
128770733|NCT01734434|463451615|FG001|Overall Study|Lost to Follow-up|9|||
128770734|NCT01734434|463451616|FG002|Overall Study|Lost to Follow-up|67|||
128770735|NCT01734434|463451617|FG003|Overall Study|Lost to Follow-up|11|||
128770736|NCT01734434|463451614|FG000|Overall Study|No Live Birth|1|||
128770737|NCT01734434|463451615|FG001|Overall Study|No Live Birth|2|||
128770738|NCT01734434|463451616|FG002|Overall Study|No Live Birth|32|||
128770739|NCT01734434|463451617|FG003|Overall Study|No Live Birth|6|||
128770740|NCT01734434|463451614|FG000|Overall Study|Withdrawal by Subject|4|||
128770741|NCT01734434|463451615|FG001|Overall Study|Withdrawal by Subject|0|||
128770742|NCT01734434|463451616|FG002|Overall Study|Withdrawal by Subject|8|||
128770743|NCT01734434|463451617|FG003|Overall Study|Withdrawal by Subject|1|||
128770744|NCT01734434|463451614|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
128770745|NCT01734434|463451615|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
128770746|NCT01734434|463451616|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
128770747|NCT01734434|463451617|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
128770748|NCT01734434|463451614|FG000|Overall Study|Subject Not Reachable|0|||
128770749|NCT01734434|463451615|FG001|Overall Study|Subject Not Reachable|0|||
128770750|NCT01734434|463451616|FG002|Overall Study|Subject Not Reachable|1|||
128770751|NCT01734434|463451617|FG003|Overall Study|Subject Not Reachable|0|||
128770752|NCT01734434|463451614|FG000|Overall Study|Treatment Defaulter|0|||
128770753|NCT01734434|463451615|FG001|Overall Study|Treatment Defaulter|0|||
128770754|NCT01734434|463451616|FG002|Overall Study|Treatment Defaulter|1|||
128770755|NCT01734434|463451617|FG003|Overall Study|Treatment Defaulter|0|||
128770756|NCT01734434|463451614|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
128770757|NCT01734434|463451615|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
129219682|NCT01358721|465104549|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
129219683|NCT01358721|465104550|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
128770758|NCT01734434|463451616|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
129036180|NCT03110380|464423420|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
129036181|NCT03110380|464423417|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
129036182|NCT03110380|464423418|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
129036183|NCT03110380|464423419|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
129036184|NCT03110380|464423420|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
129036185|NCT01355302|464423421|FG000|Phase 1b|Death|4|||
129036186|NCT01355302|464423422|FG001|Phase 1b|Death|0|||
129036187|NCT01355302|464423423|FG002|Phase 1b|Death|0|||
129036188|NCT01355302|464423421|FG000|Phase 1b|Study terminated by sponsor|2|||
129036189|NCT01355302|464423422|FG001|Phase 1b|Study terminated by sponsor|0|||
129036190|NCT01355302|464423423|FG002|Phase 1b|Study terminated by sponsor|0|||
129036191|NCT00693225|464423424|FG000|Overall Study|Lost to Follow-up|1|||
129036192|NCT00693225|464423425|FG001|Overall Study|Lost to Follow-up|2|||
129036193|NCT00693225|464423424|FG000|Overall Study|Adverse Event|1|||
129036194|NCT00693225|464423425|FG001|Overall Study|Adverse Event|3|||
129036195|NCT03750695|464423428|FG000|Overall Study|Lost to Follow-up|0|||
129036196|NCT03750695|464423429|FG001|Overall Study|Lost to Follow-up|1|||
129036197|NCT03843125|464423430|FG000|Overall Study|Adverse Event|17|||
129036198|NCT03843125|464423431|FG001|Overall Study|Adverse Event|13|||
128770759|NCT01734434|463451617|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
128770760|NCT01734434|463451614|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
128770761|NCT01734434|463451615|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
128770762|NCT01734434|463451616|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
128770763|NCT01734434|463451617|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
128770764|NCT00309608|463451618|FG000|Overall Study|Adverse Event|1|||
129036199|NCT03843125|464423432|FG002|Overall Study|Adverse Event|5|||
129036200|NCT03843125|464423433|FG003|Overall Study|Adverse Event|9|||
129036201|NCT03843125|464423430|FG000|Overall Study|Death|0|||
129036202|NCT03843125|464423431|FG001|Overall Study|Death|6|||
129036203|NCT03843125|464423432|FG002|Overall Study|Death|2|||
129036204|NCT03843125|464423433|FG003|Overall Study|Death|0|||
129036205|NCT03843125|464423430|FG000|Overall Study|Lack of Efficacy|14|||
129036206|NCT03843125|464423431|FG001|Overall Study|Lack of Efficacy|11|||
129036207|NCT03843125|464423432|FG002|Overall Study|Lack of Efficacy|9|||
129036208|NCT03843125|464423433|FG003|Overall Study|Lack of Efficacy|4|||
129036209|NCT03843125|464423430|FG000|Overall Study|Lost to Follow-up|3|||
129036210|NCT03843125|464423431|FG001|Overall Study|Lost to Follow-up|4|||
129036211|NCT03843125|464423432|FG002|Overall Study|Lost to Follow-up|0|||
129036212|NCT03843125|464423433|FG003|Overall Study|Lost to Follow-up|2|||
129036213|NCT03843125|464423430|FG000|Overall Study|Other|12|||
129036214|NCT03843125|464423431|FG001|Overall Study|Other|14|||
129036215|NCT03843125|464423432|FG002|Overall Study|Other|3|||
128711935|NCT01634360|463241641|FG000|Overall Study|subject withdrew consent|13|||
128711936|NCT01634360|463241642|FG001|Overall Study|subject withdrew consent|23|||
128711937|NCT01634360|463241641|FG000|Overall Study|Protocol Violation|1|||
128711938|NCT01634360|463241642|FG001|Overall Study|Protocol Violation|1|||
128711939|NCT01634360|463241641|FG000|Overall Study|Lack of Efficacy|4|||
128711940|NCT01634360|463241642|FG001|Overall Study|Lack of Efficacy|14|||
128711941|NCT01634360|463241641|FG000|Overall Study|Other|3|||
128711942|NCT01634360|463241642|FG001|Overall Study|Other|20|||
128711943|NCT01634360|463241641|FG000|Overall Study|Study termination by sponsor|18|||
128711944|NCT01634360|463241642|FG001|Overall Study|Study termination by sponsor|44|||
128711945|NCT02028065|463241645|FG000|Randomization Through Start Treatment|Not treated|1|||
128711946|NCT02028065|463241646|FG001|Randomization Through Start Treatment|Not treated|3|||
128770765|NCT00309608|463451619|FG001|Overall Study|Adverse Event|5|||
128770766|NCT00309608|463451620|FG002|Overall Study|Adverse Event|3|||
128770767|NCT00309608|463451621|FG003|Overall Study|Adverse Event|2|||
128770768|NCT00309608|463451622|FG004|Overall Study|Adverse Event|3|||
128770769|NCT00309608|463451618|FG000|Overall Study|Protocol Violation|2|||
128770770|NCT00309608|463451619|FG001|Overall Study|Protocol Violation|0|||
128770771|NCT00309608|463451620|FG002|Overall Study|Protocol Violation|0|||
128770772|NCT00309608|463451621|FG003|Overall Study|Protocol Violation|0|||
128770773|NCT00309608|463451622|FG004|Overall Study|Protocol Violation|0|||
128770774|NCT00309608|463451618|FG000|Overall Study|Lost to Follow-up|0|||
128770775|NCT00309608|463451619|FG001|Overall Study|Lost to Follow-up|0|||
128770776|NCT00309608|463451620|FG002|Overall Study|Lost to Follow-up|2|||
128770777|NCT00309608|463451621|FG003|Overall Study|Lost to Follow-up|0|||
128770778|NCT00309608|463451622|FG004|Overall Study|Lost to Follow-up|1|||
128770779|NCT00309608|463451618|FG000|Overall Study|Withdrawal by Subject|1|||
128770780|NCT00309608|463451619|FG001|Overall Study|Withdrawal by Subject|4|||
128770781|NCT00309608|463451620|FG002|Overall Study|Withdrawal by Subject|2|||
128770782|NCT00309608|463451621|FG003|Overall Study|Withdrawal by Subject|0|||
128770783|NCT00309608|463451622|FG004|Overall Study|Withdrawal by Subject|0|||
128770784|NCT00309608|463451618|FG000|Overall Study|Other incl. Lack of efficacy|10|||
128770785|NCT00309608|463451619|FG001|Overall Study|Other incl. Lack of efficacy|4|||
128770786|NCT00309608|463451620|FG002|Overall Study|Other incl. Lack of efficacy|3|||
128770787|NCT00309608|463451621|FG003|Overall Study|Other incl. Lack of efficacy|4|||
128770788|NCT00309608|463451622|FG004|Overall Study|Other incl. Lack of efficacy|0|||
128770789|NCT00621296|463451629|FG000|Overall Study|Adverse Event|2|||
128770790|NCT00621296|463451629|FG000|Overall Study|Lack of Efficacy|1|||
128770791|NCT00621296|463451629|FG000|Overall Study|Physician Decision|7|||
128770792|NCT00621296|463451629|FG000|Overall Study|Unmatch Criteria|1|||
128770793|NCT00621296|463451629|FG000|Overall Study|Stopping Criteria|3|||
128770794|NCT03391960|463451630|FG000|Overall Study|Protocol Violation|0|||
128770795|NCT03391960|463451631|FG001|Overall Study|Protocol Violation|0|||
128770796|NCT00999661|463453519|FG000|Overall Study|Lost to Follow-up|59|||
128770797|NCT00999661|463453519|FG000|Overall Study|Adverse Event|1|||
128770798|NCT00999661|463453519|FG000|Overall Study|Withdrawal by Subject|1|||
128770799|NCT00999661|463453519|FG000|Overall Study|Not meeting eligibility criteria|9|||
128770800|NCT00917267|463453520|FG000|Overall Study|Adverse Event|15|||
128770801|NCT00917267|463453521|FG001|Overall Study|Adverse Event|36|||
128770802|NCT00917267|463453520|FG000|Overall Study|Physician Decision|2|||
128770803|NCT00917267|463453521|FG001|Overall Study|Physician Decision|4|||
128711947|NCT02028065|463241647|FG002|Randomization Through Start Treatment|Not treated|3|||
128711948|NCT02028065|463241645|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
128770804|NCT00917267|463453520|FG000|Overall Study|Protocol Violation|9|||
128770805|NCT00917267|463453521|FG001|Overall Study|Protocol Violation|18|||
128770806|NCT00917267|463453520|FG000|Overall Study|Withdrawal by Subject|5|||
128770807|NCT00917267|463453521|FG001|Overall Study|Withdrawal by Subject|12|||
128770808|NCT00917267|463453520|FG000|Overall Study|Lost to follow up|0|||
128770809|NCT00917267|463453521|FG001|Overall Study|Lost to follow up|2|||
129036216|NCT03843125|464423433|FG003|Overall Study|Other|4|||
129036217|NCT03843125|464423430|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
129036218|NCT03843125|464423431|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
128770810|NCT00917267|463453520|FG000|Overall Study|Entry Criteria Not Met|1|||
128770811|NCT00917267|463453521|FG001|Overall Study|Entry Criteria Not Met|0|||
128770812|NCT00917267|463453520|FG000|Overall Study|Sponsor Decision|5|||
128770813|NCT00917267|463453521|FG001|Overall Study|Sponsor Decision|5|||
128770814|NCT00917267|463453520|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
128770815|NCT00917267|463453521|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
128770816|NCT00289770|463453526|FG000|Year 15|Withdrawal by Subject|1|||
128770817|NCT00251927|463453533|FG000|Overall Study|Adverse Event|3|||
128770818|NCT00251927|463453534|FG001|Overall Study|Adverse Event|15|||
128770819|NCT00251927|463453533|FG000|Overall Study|Lack of Efficacy|22|||
128770820|NCT00251927|463453534|FG001|Overall Study|Lack of Efficacy|16|||
128770821|NCT00251927|463453533|FG000|Overall Study|Lost to Follow-up|22|||
128770822|NCT00251927|463453534|FG001|Overall Study|Lost to Follow-up|8|||
128770823|NCT00251927|463453533|FG000|Overall Study|Protocol Violation|1|||
128770824|NCT00251927|463453534|FG001|Overall Study|Protocol Violation|2|||
128770825|NCT00251927|463453533|FG000|Overall Study|Pregnancy|2|||
128770826|NCT00251927|463453534|FG001|Overall Study|Pregnancy|0|||
128770827|NCT00251927|463453533|FG000|Overall Study|Withdrawal by Subject|40|||
128770828|NCT00251927|463453534|FG001|Overall Study|Withdrawal by Subject|25|||
128770829|NCT00251927|463453533|FG000|Overall Study|Study-specific discont. achieved|13|||
128770830|NCT00251927|463453534|FG001|Overall Study|Study-specific discont. achieved|2|||
128770831|NCT00251927|463453533|FG000|Overall Study|Study procedure non-compliance|5|||
128770832|NCT00251927|463453534|FG001|Overall Study|Study procedure non-compliance|6|||
128770833|NCT02222896|463453542|FG000|Abdomen|Did not qualify|34|||
128770834|NCT02222896|463453543|FG001|Abdomen|Did not qualify|10|||
128770835|NCT02222896|463453544|FG002|Abdomen|Did not qualify|32|||
128770836|NCT02222896|463453542|FG000|Groin|Did not qualify|43|||
128770837|NCT02222896|463453543|FG001|Groin|Did not qualify|9|||
128770838|NCT02222896|463453544|FG002|Groin|Did not qualify|40|||
128770839|NCT02226172|463453545|FG000|Overall Study|Participant refused further follow-up|4|||
128770840|NCT02226172|463453545|FG000|Overall Study|Other|5|||
128770841|NCT02226172|463453545|FG000|Overall Study|Death|1|||
128770842|NCT02226172|463453545|FG000|Overall Study|Study terminated by sponsor|1|||
128957021|NCT05507580|464127516|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
128770843|NCT02226172|463453545|FG000|Overall Study|Adverse Event|6|||
128770844|NCT01865617|463453546|FG000|Overall Study|Death|27|||
128770845|NCT01865617|463453547|FG001|Overall Study|Death|3|||
128770846|NCT01865617|463453548|FG002|Overall Study|Death|1|||
128770847|NCT01865617|463453549|FG003|Overall Study|Death|1|||
128770848|NCT01865617|463453550|FG004|Overall Study|Death|5|||
128770849|NCT01865617|463453551|FG005|Overall Study|Death|1|||
128770850|NCT01865617|463453552|FG006|Overall Study|Death|11|||
128770851|NCT01865617|463453553|FG007|Overall Study|Death|1|||
128770852|NCT01865617|463453554|FG008|Overall Study|Death|11|||
128770853|NCT01865617|463453555|FG009|Overall Study|Death|3|||
128770854|NCT01865617|463453556|FG010|Overall Study|Death|32|||
128770855|NCT01865617|463453557|FG011|Overall Study|Death|6|||
128770856|NCT01865617|463453558|FG012|Overall Study|Death|13|||
128770857|NCT01865617|463453546|FG000|Overall Study|Lost to Follow-up|2|||
128957022|NCT05507580|464127517|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128957023|NCT05507580|464127518|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128957024|NCT05507580|464127519|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128957025|NCT05507580|464127520|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128957026|NCT05507580|464127515|FG000|Double-Blind Treatment Period|Other, not specified|5|||
128957027|NCT05507580|464127516|FG001|Double-Blind Treatment Period|Other, not specified|4|||
128957028|NCT05507580|464127517|FG002|Double-Blind Treatment Period|Other, not specified|0|||
128957029|NCT05507580|464127518|FG003|Double-Blind Treatment Period|Other, not specified|0|||
128957030|NCT05507580|464127519|FG004|Double-Blind Treatment Period|Other, not specified|0|||
128957031|NCT05507580|464127520|FG005|Double-Blind Treatment Period|Other, not specified|0|||
128957032|NCT05507580|464127515|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
128957033|NCT05507580|464127516|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
128770858|NCT01865617|463453547|FG001|Overall Study|Lost to Follow-up|0|||
128770859|NCT01865617|463453548|FG002|Overall Study|Lost to Follow-up|0|||
128770860|NCT01865617|463453549|FG003|Overall Study|Lost to Follow-up|0|||
128770861|NCT01865617|463453550|FG004|Overall Study|Lost to Follow-up|0|||
128770862|NCT01865617|463453551|FG005|Overall Study|Lost to Follow-up|0|||
128770863|NCT01865617|463453552|FG006|Overall Study|Lost to Follow-up|0|||
128770864|NCT01865617|463453553|FG007|Overall Study|Lost to Follow-up|0|||
128770865|NCT01865617|463453554|FG008|Overall Study|Lost to Follow-up|0|||
128770866|NCT01865617|463453555|FG009|Overall Study|Lost to Follow-up|0|||
128770867|NCT01865617|463453556|FG010|Overall Study|Lost to Follow-up|0|||
128770868|NCT01865617|463453557|FG011|Overall Study|Lost to Follow-up|0|||
128770869|NCT01865617|463453558|FG012|Overall Study|Lost to Follow-up|0|||
128957034|NCT05507580|464127517|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
128770870|NCT01865617|463453546|FG000|Overall Study|Withdrawal by Subject|1|||
128770871|NCT01865617|463453547|FG001|Overall Study|Withdrawal by Subject|0|||
128770872|NCT01865617|463453548|FG002|Overall Study|Withdrawal by Subject|0|||
128770873|NCT01865617|463453549|FG003|Overall Study|Withdrawal by Subject|0|||
128770874|NCT01865617|463453550|FG004|Overall Study|Withdrawal by Subject|0|||
128770875|NCT01865617|463453551|FG005|Overall Study|Withdrawal by Subject|0|||
128770876|NCT01865617|463453552|FG006|Overall Study|Withdrawal by Subject|0|||
128770877|NCT01865617|463453553|FG007|Overall Study|Withdrawal by Subject|0|||
128770878|NCT01865617|463453554|FG008|Overall Study|Withdrawal by Subject|0|||
128770879|NCT01865617|463453555|FG009|Overall Study|Withdrawal by Subject|0|||
128770880|NCT01865617|463453556|FG010|Overall Study|Withdrawal by Subject|0|||
128770881|NCT01865617|463453557|FG011|Overall Study|Withdrawal by Subject|0|||
128770882|NCT01865617|463453558|FG012|Overall Study|Withdrawal by Subject|0|||
129126358|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129126359|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129126360|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129126361|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129126362|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129126363|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129126364|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
129126365|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
129126366|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
129126367|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
129126368|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
129126369|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
129126370|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
129126371|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
129126372|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
129126373|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
129126374|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
129126375|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
129126376|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
129126377|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
129126378|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
129126379|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129126380|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129126381|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129126382|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129126383|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129126384|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
129126385|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
129126386|NCT01697579|464757946|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129126387|NCT01697579|464757947|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129126388|NCT01697579|464757948|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129126389|NCT01697579|464757949|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129126390|NCT01697579|464757950|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129126391|NCT01697579|464757951|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129126392|NCT01697579|464757952|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
129126393|NCT02452190|464757953|FG000|Overall Study|Withdrawal by Sponsor|1|||
129126394|NCT02452190|464757954|FG001|Overall Study|Withdrawal by Sponsor|3|||
129126395|NCT02452190|464757953|FG000|Overall Study|Pregnancy|1|||
129126396|NCT02452190|464757954|FG001|Overall Study|Pregnancy|0|||
129126397|NCT02452190|464757953|FG000|Overall Study|Investigator's Decision|2|||
129126398|NCT02452190|464757954|FG001|Overall Study|Investigator's Decision|0|||
129126399|NCT02452190|464757953|FG000|Overall Study|Lack of Efficacy|3|||
129126400|NCT02452190|464757954|FG001|Overall Study|Lack of Efficacy|1|||
129126401|NCT02452190|464757953|FG000|Overall Study|Lost to Follow-up|4|||
129126402|NCT02452190|464757954|FG001|Overall Study|Lost to Follow-up|3|||
129126403|NCT02452190|464757953|FG000|Overall Study|Adverse Event|2|||
128770883|NCT01865617|463453546|FG000|Overall Study|Patient proceeded to new therapy|0|||
128770884|NCT01865617|463453547|FG001|Overall Study|Patient proceeded to new therapy|0|||
129126404|NCT02452190|464757954|FG001|Overall Study|Adverse Event|5|||
129126405|NCT02452190|464757953|FG000|Overall Study|Withdrawal by Subject|20|||
129126406|NCT02452190|464757954|FG001|Overall Study|Withdrawal by Subject|11|||
129126407|NCT02452190|464757953|FG000|Overall Study|Noncompliance with study drug|1|||
129126408|NCT02452190|464757954|FG001|Overall Study|Noncompliance with study drug|0|||
129126409|NCT02452190|464757953|FG000|Overall Study|Participant traveled abroad|1|||
129126410|NCT02452190|464757954|FG001|Overall Study|Participant traveled abroad|0|||
129126411|NCT02452190|464757953|FG000|Overall Study|Death|0|||
129126412|NCT02452190|464757954|FG001|Overall Study|Death|1|||
129126413|NCT01044498|464757955|FG000|Overall Study|Withdrew consent|1|||
128770885|NCT01865617|463453548|FG002|Overall Study|Patient proceeded to new therapy|0|||
128770886|NCT01865617|463453549|FG003|Overall Study|Patient proceeded to new therapy|0|||
128770887|NCT01865617|463453550|FG004|Overall Study|Patient proceeded to new therapy|2|||
129126414|NCT01044498|464757956|FG001|Overall Study|Withdrew consent|1|||
129126415|NCT01044498|464757955|FG000|Overall Study|Adverse Event|1|||
129126416|NCT01044498|464757956|FG001|Overall Study|Adverse Event|1|||
129126417|NCT01044498|464757955|FG000|Overall Study|Other|1|||
129126418|NCT01044498|464757956|FG001|Overall Study|Other|0|||
129126419|NCT02327078|464757961|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
129126420|NCT02327078|464757962|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
129126421|NCT02327078|464757963|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
129126422|NCT02327078|464757964|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
129126423|NCT02327078|464757965|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
129126424|NCT02327078|464757966|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
129126425|NCT02327078|464757967|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
129126426|NCT02327078|464757968|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
129126427|NCT02327078|464757969|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
129126428|NCT02327078|464757961|FG000|Overall Study|Death|2|||
129126429|NCT02327078|464757962|FG001|Overall Study|Death|4|||
129126430|NCT02327078|464757963|FG002|Overall Study|Death|10|||
129126431|NCT02327078|464757964|FG003|Overall Study|Death|6|||
129126432|NCT02327078|464757965|FG004|Overall Study|Death|4|||
129126433|NCT02327078|464757966|FG005|Overall Study|Death|3|||
129126434|NCT02327078|464757967|FG006|Overall Study|Death|2|||
129126435|NCT02327078|464757968|FG007|Overall Study|Death|51|||
129126436|NCT02327078|464757969|FG008|Overall Study|Death|97|||
128711949|NCT02028065|463241646|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
128711950|NCT02028065|463241647|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
128711951|NCT02028065|463241645|FG000|Treatment Through Study Completion|Physician Decision|1|||
128711952|NCT02028065|463241646|FG001|Treatment Through Study Completion|Physician Decision|0|||
128711953|NCT02028065|463241647|FG002|Treatment Through Study Completion|Physician Decision|0|||
128711954|NCT02028065|463241645|FG000|Treatment Through Study Completion|Protocol Violation|1|||
128711955|NCT02028065|463241646|FG001|Treatment Through Study Completion|Protocol Violation|4|||
128711956|NCT02028065|463241647|FG002|Treatment Through Study Completion|Protocol Violation|0|||
128711957|NCT02028065|463241645|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
128711958|NCT02028065|463241646|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
128711959|NCT02028065|463241647|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
128711960|NCT02028065|463241645|FG000|Treatment Through Study Completion|Adverse Event|3|||
128711961|NCT02028065|463241646|FG001|Treatment Through Study Completion|Adverse Event|3|||
128711962|NCT02028065|463241647|FG002|Treatment Through Study Completion|Adverse Event|5|||
128711963|NCT01414855|463241648|FG000|Overall Study|Death|17|||
128711964|NCT01414855|463241648|FG000|Overall Study|Lost to Follow-up|5|||
128711965|NCT01414855|463241648|FG000|Overall Study|Withdrawal by Subject|7|||
128711966|NCT00877383|463241652|FG000|Overall Study|Adverse Event|13|||
128711967|NCT00877383|463241653|FG001|Overall Study|Adverse Event|14|||
128711968|NCT00877383|463241652|FG000|Overall Study|Lost to Follow-up|5|||
128711969|NCT00877383|463241653|FG001|Overall Study|Lost to Follow-up|3|||
128711970|NCT00877383|463241652|FG000|Overall Study|Subject withdrew consent|3|||
128711971|NCT00877383|463241653|FG001|Overall Study|Subject withdrew consent|12|||
128711972|NCT00877383|463241652|FG000|Overall Study|Subject no longer requires study drug|2|||
128711973|NCT00877383|463241653|FG001|Overall Study|Subject no longer requires study drug|0|||
128711974|NCT00877383|463241652|FG000|Overall Study|Administrative problems|2|||
128711975|NCT00877383|463241653|FG001|Overall Study|Administrative problems|0|||
128711976|NCT00877383|463241652|FG000|Overall Study|Protocol deviation|2|||
128711977|NCT00877383|463241653|FG001|Overall Study|Protocol deviation|6|||
128711978|NCT00877383|463241652|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128711979|NCT00877383|463241653|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128711980|NCT00877383|463241652|FG000|Overall Study|Death|1|||
128711981|NCT00877383|463241653|FG001|Overall Study|Death|2|||
128711982|NCT04851314|463241654|FG000|Overall Study|Unable to complete research set-up procedures|0|||
128711983|NCT04851314|463241655|FG001|Overall Study|Unable to complete research set-up procedures|2|||
128711984|NCT04851314|463241654|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
128711985|NCT04851314|463241655|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
128711986|NCT02107482|463241662|FG000|Overall Study|inconveinence|2|||
128711987|NCT02107482|463241662|FG000|Overall Study|Lost to Follow-up|1|||
128770888|NCT01865617|463453551|FG005|Overall Study|Patient proceeded to new therapy|0|||
129126437|NCT02327078|464757961|FG000|Overall Study|Lost to Follow-up|0|||
129126438|NCT02327078|464757962|FG001|Overall Study|Lost to Follow-up|1|||
129126439|NCT02327078|464757963|FG002|Overall Study|Lost to Follow-up|1|||
129126440|NCT02327078|464757964|FG003|Overall Study|Lost to Follow-up|0|||
128711988|NCT02107482|463241662|FG000|Overall Study|Lack of Efficacy|1|||
128711989|NCT04868890|463241663|FG000|Overall Study|Death|2|||
128711990|NCT04868890|463241664|FG001|Overall Study|Death|1|||
128770889|NCT01865617|463453552|FG006|Overall Study|Patient proceeded to new therapy|0|||
129126441|NCT02327078|464757965|FG004|Overall Study|Lost to Follow-up|0|||
129126442|NCT02327078|464757966|FG005|Overall Study|Lost to Follow-up|0|||
129126443|NCT02327078|464757967|FG006|Overall Study|Lost to Follow-up|0|||
129126444|NCT02327078|464757968|FG007|Overall Study|Lost to Follow-up|2|||
129126445|NCT02327078|464757969|FG008|Overall Study|Lost to Follow-up|5|||
129126446|NCT02327078|464757961|FG000|Overall Study|Site Terminated by Sponsor|1|||
129126447|NCT02327078|464757962|FG001|Overall Study|Site Terminated by Sponsor|0|||
129126448|NCT02327078|464757963|FG002|Overall Study|Site Terminated by Sponsor|1|||
129126449|NCT02327078|464757964|FG003|Overall Study|Site Terminated by Sponsor|4|||
129126450|NCT02327078|464757965|FG004|Overall Study|Site Terminated by Sponsor|0|||
129126451|NCT02327078|464757966|FG005|Overall Study|Site Terminated by Sponsor|0|||
129126452|NCT02327078|464757967|FG006|Overall Study|Site Terminated by Sponsor|0|||
129126453|NCT02327078|464757968|FG007|Overall Study|Site Terminated by Sponsor|11|||
129126454|NCT02327078|464757969|FG008|Overall Study|Site Terminated by Sponsor|25|||
129126455|NCT02327078|464757961|FG000|Overall Study|Physician Decision|0|||
129126456|NCT02327078|464757962|FG001|Overall Study|Physician Decision|0|||
129126457|NCT02327078|464757963|FG002|Overall Study|Physician Decision|0|||
129126458|NCT02327078|464757964|FG003|Overall Study|Physician Decision|1|||
129126459|NCT02327078|464757965|FG004|Overall Study|Physician Decision|0|||
129126460|NCT02327078|464757966|FG005|Overall Study|Physician Decision|0|||
129126461|NCT02327078|464757967|FG006|Overall Study|Physician Decision|0|||
129126462|NCT02327078|464757968|FG007|Overall Study|Physician Decision|0|||
129126463|NCT02327078|464757969|FG008|Overall Study|Physician Decision|1|||
129126464|NCT02327078|464757961|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
128711991|NCT04868890|463241663|FG000|Overall Study|Withdrawal by Subject|1|||
128711992|NCT04868890|463241664|FG001|Overall Study|Withdrawal by Subject|5|||
128711993|NCT00867009|463241665|FG000|Induction Period|Nonserious Adverse Event|5|||
128711994|NCT00867009|463241665|FG000|Induction Period|Serious Adverse Event|10|||
128711995|NCT00867009|463241665|FG000|Induction Period|Death due to serious adverse event|6|||
128711996|NCT00867009|463241665|FG000|Induction Period|Death due to Study Disease|4|||
128711997|NCT00867009|463241665|FG000|Induction Period|Protocol Violation|1|||
128711998|NCT00867009|463241665|FG000|Induction Period|Withdrawal by Subject|8|||
128711999|NCT00867009|463241665|FG000|Induction Period|Physician Decision|3|||
128712000|NCT00867009|463241665|FG000|Induction Period|Progressive Disease (PD)|25|||
128712001|NCT00867009|463241665|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
128712002|NCT01850524|463241672|FG000|Overall Study|Lost to Follow-up|5|||
128712003|NCT01850524|463241673|FG001|Overall Study|Lost to Follow-up|10|||
128712004|NCT01850524|463241672|FG000|Overall Study|Withdrawal by Subject|24|||
128712005|NCT01850524|463241673|FG001|Overall Study|Withdrawal by Subject|22|||
128712006|NCT01850524|463241672|FG000|Overall Study|Reason not Specified|142|||
128712007|NCT01850524|463241673|FG001|Overall Study|Reason not Specified|141|||
128712008|NCT00368355|463241674|FG000|Overall Study|Adverse Event|1|||
128712009|NCT00368355|463241675|FG001|Overall Study|Adverse Event|0|||
128712010|NCT00368355|463241674|FG000|Overall Study|Death|2|||
128712011|NCT00368355|463241675|FG001|Overall Study|Death|4|||
128712012|NCT00368355|463241674|FG000|Overall Study|Relapse|6|||
128712013|NCT00368355|463241675|FG001|Overall Study|Relapse|10|||
128712014|NCT00368355|463241674|FG000|Overall Study|Subsequent transplant|0|||
128712015|NCT00368355|463241675|FG001|Overall Study|Subsequent transplant|3|||
128712016|NCT00368355|463241674|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
128712017|NCT00368355|463241675|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
128712018|NCT01339429|463241680|FG000|Overall Study|Withdrawal by Subject|1|||
128712019|NCT01339429|463241680|FG000|Overall Study|Physician Decision|3|||
128712020|NCT00459667|463241681|FG000|Overall Study|Adverse Event|9|||
128712021|NCT00459667|463241682|FG001|Overall Study|Adverse Event|12|||
128712022|NCT00459667|463241683|FG002|Overall Study|Adverse Event|8|||
128712023|NCT00459667|463241681|FG000|Overall Study|Lost to Follow-up|5|||
128712024|NCT00459667|463241682|FG001|Overall Study|Lost to Follow-up|9|||
128712025|NCT00459667|463241683|FG002|Overall Study|Lost to Follow-up|3|||
128712026|NCT00459667|463241681|FG000|Overall Study|Pregnancy|1|||
128712027|NCT00459667|463241682|FG001|Overall Study|Pregnancy|1|||
128712028|NCT00459667|463241683|FG002|Overall Study|Pregnancy|1|||
128712029|NCT00459667|463241681|FG000|Overall Study|Protocol Violation|1|||
128712030|NCT00459667|463241682|FG001|Overall Study|Protocol Violation|0|||
129126465|NCT02327078|464757962|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
129126466|NCT02327078|464757963|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
129126467|NCT02327078|464757964|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
129126468|NCT02327078|464757965|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
129126469|NCT02327078|464757966|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
128712031|NCT00459667|463241683|FG002|Overall Study|Protocol Violation|0|||
128957035|NCT05507580|464127518|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
128957036|NCT05507580|464127519|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
128712032|NCT00459667|463241681|FG000|Overall Study|Withdrawal by Subject|3|||
128712033|NCT00459667|463241682|FG001|Overall Study|Withdrawal by Subject|5|||
128712034|NCT00459667|463241683|FG002|Overall Study|Withdrawal by Subject|5|||
128712035|NCT00459667|463241681|FG000|Overall Study|Other disease modifying treatment|1|||
128770890|NCT01865617|463453553|FG007|Overall Study|Patient proceeded to new therapy|0|||
128770891|NCT01865617|463453554|FG008|Overall Study|Patient proceeded to new therapy|0|||
128770892|NCT01865617|463453555|FG009|Overall Study|Patient proceeded to new therapy|0|||
128770893|NCT01865617|463453556|FG010|Overall Study|Patient proceeded to new therapy|0|||
128770894|NCT01865617|463453557|FG011|Overall Study|Patient proceeded to new therapy|0|||
128770895|NCT01865617|463453558|FG012|Overall Study|Patient proceeded to new therapy|0|||
128770896|NCT01865617|463453546|FG000|Overall Study|Other|0|||
128770897|NCT01865617|463453547|FG001|Overall Study|Other|0|||
128770898|NCT01865617|463453548|FG002|Overall Study|Other|0|||
128770899|NCT01865617|463453549|FG003|Overall Study|Other|0|||
128770900|NCT01865617|463453550|FG004|Overall Study|Other|0|||
128770901|NCT01865617|463453551|FG005|Overall Study|Other|0|||
128957037|NCT05507580|464127520|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
128957038|NCT05507580|464127515|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
128957039|NCT05507580|464127516|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
128957040|NCT05507580|464127517|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
128957041|NCT05507580|464127518|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
128957042|NCT05507580|464127519|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
128957043|NCT05507580|464127520|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
128957044|NCT05507580|464127515|FG000|Single-Blind Treatment Period|Other, not specified|0|||
128957045|NCT05507580|464127516|FG001|Single-Blind Treatment Period|Other, not specified|0|||
128957046|NCT05507580|464127517|FG002|Single-Blind Treatment Period|Other, not specified|2|||
128957047|NCT05507580|464127518|FG003|Single-Blind Treatment Period|Other, not specified|7|||
128957048|NCT05507580|464127519|FG004|Single-Blind Treatment Period|Other, not specified|3|||
128957049|NCT05507580|464127520|FG005|Single-Blind Treatment Period|Other, not specified|5|||
128957050|NCT00555568|464127521|FG000|Overall Study|Lost to Follow-up|26|||
128957051|NCT00555568|464127522|FG001|Overall Study|Lost to Follow-up|16|||
128957052|NCT00555568|464127523|FG002|Overall Study|Lost to Follow-up|16|||
128957053|NCT04702984|464127524|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
128957054|NCT06000501|464127527|FG000|Overall Study|Screen failure|3|||
128957055|NCT06000501|464127527|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
128957056|NCT06000501|464127527|FG000|Overall Study|Physician Decision|4|||
128957057|NCT06000501|464127527|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
128957058|NCT06000501|464127527|FG000|Overall Study|Scheduling issues|2|||
128957059|NCT03496662|464127528|FG000|Overall Study|Adverse Event|0|||
128957060|NCT03496662|464127529|FG001|Overall Study|Adverse Event|0|||
128957061|NCT03496662|464127530|FG002|Overall Study|Adverse Event|4|||
128957062|NCT03496662|464127528|FG000|Overall Study|Withdrawal by Subject|1|||
128957063|NCT03496662|464127529|FG001|Overall Study|Withdrawal by Subject|0|||
128957064|NCT03496662|464127530|FG002|Overall Study|Withdrawal by Subject|2|||
128957065|NCT03496662|464127528|FG000|Overall Study|Death|0|||
128957066|NCT03496662|464127529|FG001|Overall Study|Death|0|||
128957067|NCT03496662|464127530|FG002|Overall Study|Death|2|||
128957068|NCT03496662|464127528|FG000|Overall Study|Noncompliance|0|||
128957069|NCT03496662|464127529|FG001|Overall Study|Noncompliance|0|||
128957070|NCT03496662|464127530|FG002|Overall Study|Noncompliance|1|||
128957071|NCT02378883|464127531|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
128957072|NCT02378883|464127531|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
128957073|NCT02378883|464127531|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
128957074|NCT02378883|464127531|FG000|30 Day Follow-Up|Physician Decision|2|||
128957075|NCT02378883|464127531|FG000|30 Day Follow-Up|Missed Visit|2|||
128957076|NCT02378883|464127531|FG000|30 Day Follow-Up|Death|1|||
128957077|NCT02378883|464127531|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
128957078|NCT02378883|464127531|FG000|12 Months Follow-Up|Death|2|||
128957079|NCT03037307|464127532|FG000|Period 1|Did Not Meet Study Criteria|0|||
128957080|NCT03037307|464127533|FG001|Period 1|Did Not Meet Study Criteria|0|||
128957081|NCT03037307|464127534|FG002|Period 1|Did Not Meet Study Criteria|0|||
128957082|NCT03037307|464127535|FG003|Period 1|Did Not Meet Study Criteria|1|||
128957083|NCT03037307|464127536|FG004|Period 1|Did Not Meet Study Criteria|0|||
129036219|NCT03843125|464423432|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
128957084|NCT03037307|464127537|FG005|Period 1|Did Not Meet Study Criteria|0|||
128957085|NCT00691093|464127538|FG000|Overall Study|Adverse Event|1|||
129036220|NCT03843125|464423433|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
128770902|NCT01865617|463453552|FG006|Overall Study|Other|1|||
128770903|NCT01865617|463453553|FG007|Overall Study|Other|0|||
128770904|NCT01865617|463453554|FG008|Overall Study|Other|0|||
128957086|NCT00691093|464127538|FG000|Overall Study|Lost to Follow-up|1|||
128957087|NCT00691093|464127538|FG000|Overall Study|Lack of Efficacy|1|||
128957088|NCT00691093|464127538|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
128957089|NCT01588353|464127539|FG000|Step2|Withdrawal by Subject|0|||
128957090|NCT01588353|464127540|FG001|Step2|Withdrawal by Subject|1|||
128957091|NCT01588353|464127541|FG002|Step2|Withdrawal by Subject|0|||
128957092|NCT01588353|464127539|FG000|Step3|Adverse Event|0|||
128957093|NCT01588353|464127540|FG001|Step3|Adverse Event|0|||
128957094|NCT01588353|464127541|FG002|Step3|Adverse Event|2|||
129036221|NCT03843125|464423430|FG000|Overall Study|Study Terminated by Sponsor|318|||
128712036|NCT00459667|463241682|FG001|Overall Study|Other disease modifying treatment|2|||
128712037|NCT00459667|463241683|FG002|Overall Study|Other disease modifying treatment|1|||
128712038|NCT00459667|463241681|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
128712039|NCT00459667|463241682|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
128712040|NCT00459667|463241683|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
128712041|NCT00459667|463241681|FG000|Overall Study|No treatment administered|6|||
128712042|NCT00459667|463241682|FG001|Overall Study|No treatment administered|3|||
128712043|NCT00459667|463241683|FG002|Overall Study|No treatment administered|1|||
128712044|NCT04140292|463241684|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
128712045|NCT04140292|463241685|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
128712046|NCT00396591|463241686|FG000|Overall Study|Disease Progression|13|||
128712047|NCT00396591|463241686|FG000|Overall Study|Adverse Event|2|||
128712048|NCT00396591|463241686|FG000|Overall Study|Participant request|1|||
128712049|NCT01013701|463241687|FG000|Overall Study|study prematurely terminated|7|||
128712050|NCT00556712|463241688|FG000|Overall Study|Adverse Event|7|||
128712051|NCT00556712|463241689|FG001|Overall Study|Adverse Event|19|||
128712052|NCT00556712|463241688|FG000|Overall Study|Death|5|||
128712053|NCT00556712|463241689|FG001|Overall Study|Death|10|||
128712054|NCT00556712|463241688|FG000|Overall Study|Progressive Disease|383|||
128712055|NCT00556712|463241689|FG001|Overall Study|Progressive Disease|320|||
128712056|NCT00556712|463241688|FG000|Overall Study|Protocol Violation|3|||
128712057|NCT00556712|463241689|FG001|Overall Study|Protocol Violation|2|||
128712058|NCT00556712|463241688|FG000|Overall Study|Refused Treatment|17|||
128712059|NCT00556712|463241689|FG001|Overall Study|Refused Treatment|16|||
128712060|NCT00556712|463241688|FG000|Overall Study|Failure to Return|2|||
128712061|NCT00556712|463241689|FG001|Overall Study|Failure to Return|3|||
128712062|NCT00556712|463241688|FG000|Overall Study|Other|2|||
128712063|NCT00556712|463241689|FG001|Overall Study|Other|2|||
128712064|NCT00556712|463241688|FG000|Overall Study|Ongoing at Data Cutoff|32|||
128712065|NCT00556712|463241689|FG001|Overall Study|Ongoing at Data Cutoff|66|||
128712066|NCT02671422|463241695|FG000|Overall Study|Lost to Follow-up|1|||
128712067|NCT02671422|463241695|FG000|Overall Study|Adverse Event|68|||
128712068|NCT02671422|463241695|FG000|Overall Study|Lack of Efficacy|1|||
128712069|NCT02671422|463241695|FG000|Overall Study|Lost to Follow-up|4|||
128712070|NCT02671422|463241695|FG000|Overall Study|Withdrawal by Subject|7|||
128712071|NCT02671422|463241695|FG000|Overall Study|Progressive Disease|156|||
128712072|NCT02671422|463241695|FG000|Overall Study|Worsening of Disease|4|||
128712073|NCT02671422|463241695|FG000|Overall Study|Sponsor decision|5|||
128712074|NCT02671422|463241695|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
128712075|NCT02671422|463241695|FG000|Overall Study|Not treated with Vargatef®|3|||
128712076|NCT02671422|463241695|FG000|Overall Study|Other not defined above|3|||
128770905|NCT01865617|463453555|FG009|Overall Study|Other|0|||
128770906|NCT01865617|463453556|FG010|Overall Study|Other|0|||
128770907|NCT01865617|463453557|FG011|Overall Study|Other|0|||
128770908|NCT01865617|463453558|FG012|Overall Study|Other|0|||
128770909|NCT00439179|463453561|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
128770910|NCT00439179|463453562|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
128770911|NCT00439179|463453563|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
128770912|NCT00439179|463453564|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
128770913|NCT01844115|463453567|FG000|Overall Study|Adverse Event|4|||
128770914|NCT01844115|463453568|FG001|Overall Study|Adverse Event|22|||
128770915|NCT01844115|463453567|FG000|Overall Study|Lack of Efficacy|1|||
128770916|NCT01844115|463453568|FG001|Overall Study|Lack of Efficacy|4|||
128770917|NCT01844115|463453567|FG000|Overall Study|Protocol Violation|12|||
128770918|NCT01844115|463453568|FG001|Overall Study|Protocol Violation|10|||
128770919|NCT01844115|463453567|FG000|Overall Study|Withdrawal by Subject|11|||
128770920|NCT01844115|463453568|FG001|Overall Study|Withdrawal by Subject|11|||
128770921|NCT01844115|463453567|FG000|Overall Study|Lost to Follow-up|11|||
128770922|NCT01844115|463453568|FG001|Overall Study|Lost to Follow-up|10|||
128770923|NCT01844115|463453567|FG000|Overall Study|Pregnancy|0|||
128770924|NCT01844115|463453568|FG001|Overall Study|Pregnancy|1|||
128712077|NCT04080297|463241697|FG000|Overall Study|Adverse Event|1|||
128712078|NCT04080297|463241698|FG001|Overall Study|Adverse Event|3|||
128712079|NCT04080297|463241697|FG000|Overall Study|concurrent illness|1|||
128712080|NCT04080297|463241698|FG001|Overall Study|concurrent illness|0|||
128712081|NCT04702997|463241699|FG000|Overall Study|Withdrawal by Subject|1|||
128712082|NCT04702997|463241700|FG001|Overall Study|Withdrawal by Subject|1|||
128712083|NCT02200445|463241703|FG000|Overall Study|Lack of Efficacy|1|||
128712084|NCT02200445|463241704|FG001|Overall Study|Lack of Efficacy|2|||
128712085|NCT02200445|463241705|FG002|Overall Study|Lack of Efficacy|2|||
128712086|NCT02200445|463241703|FG000|Overall Study|Adverse Event|0|||
128712087|NCT02200445|463241704|FG001|Overall Study|Adverse Event|2|||
128770925|NCT00758160|463453569|FG000|Overall Study|No Longer Requires Study Medication|4|||
128770926|NCT00758160|463453569|FG000|Overall Study|Administration Problems|3|||
128770927|NCT00758160|463453569|FG000|Overall Study|Adverse Event|15|||
128770928|NCT00758160|463453569|FG000|Overall Study|Lack of Efficacy|10|||
128770929|NCT00758160|463453569|FG000|Overall Study|Lost to Follow-up|14|||
128770930|NCT00758160|463453569|FG000|Overall Study|Protocol Violation|12|||
129036222|NCT03843125|464423431|FG001|Overall Study|Study Terminated by Sponsor|318|||
129036223|NCT03843125|464423432|FG002|Overall Study|Study Terminated by Sponsor|163|||
129036224|NCT03843125|464423433|FG003|Overall Study|Study Terminated by Sponsor|163|||
129036225|NCT03843125|464423430|FG000|Overall Study|Withdrawal by Subject|23|||
129036226|NCT03843125|464423431|FG001|Overall Study|Withdrawal by Subject|12|||
129036227|NCT03843125|464423432|FG002|Overall Study|Withdrawal by Subject|6|||
129036228|NCT03843125|464423433|FG003|Overall Study|Withdrawal by Subject|9|||
129036229|NCT03843125|464423430|FG000|Overall Study|Missing data|0|||
129036230|NCT03843125|464423431|FG001|Overall Study|Missing data|1|||
129036231|NCT03843125|464423432|FG002|Overall Study|Missing data|1|||
129036232|NCT03843125|464423433|FG003|Overall Study|Missing data|0|||
129036233|NCT03173560|464423434|FG000|Overall Study|Death|70|||
129036234|NCT03173560|464423435|FG001|Overall Study|Death|60|||
129036235|NCT03173560|464423434|FG000|Overall Study|Lost to Follow-up|1|||
129036236|NCT03173560|464423435|FG001|Overall Study|Lost to Follow-up|4|||
129036237|NCT03173560|464423434|FG000|Overall Study|Withdrawal by Subject|10|||
129036238|NCT03173560|464423435|FG001|Overall Study|Withdrawal by Subject|5|||
129036239|NCT03173560|464423434|FG000|Overall Study|Other|0|||
129036240|NCT03173560|464423435|FG001|Overall Study|Other|1|||
129036241|NCT04480307|464423436|FG000|Overall Study|Withdrawal by Subject|0|||
129036242|NCT04480307|464423437|FG001|Overall Study|Withdrawal by Subject|1|||
129036243|NCT04480307|464423438|FG002|Overall Study|Withdrawal by Subject|0|||
129036244|NCT04480307|464423439|FG003|Overall Study|Withdrawal by Subject|0|||
129036245|NCT04480307|464423436|FG000|Overall Study|Adverse Event|0|||
129036246|NCT04480307|464423437|FG001|Overall Study|Adverse Event|0|||
129036247|NCT04480307|464423438|FG002|Overall Study|Adverse Event|0|||
128712088|NCT02200445|463241705|FG002|Overall Study|Adverse Event|0|||
128712089|NCT00353262|463241709|FG000|Overall Study|Adverse Event|8|||
128712090|NCT00353262|463241709|FG000|Overall Study|Withdrawal by Subject|2|||
128712091|NCT00353262|463241709|FG000|Overall Study|Insufficient Therapeutic Response|13|||
128712092|NCT00353262|463241709|FG000|Overall Study|Progression|1|||
128712093|NCT00353262|463241709|FG000|Overall Study|Surgery|4|||
128712094|NCT00353262|463241709|FG000|Overall Study|Break from Chemotherapy|1|||
128712095|NCT00463346|463243749|FG000|Overall Study|Withdrawal by Subject|3|||
128712096|NCT00463346|463243750|FG001|Overall Study|Withdrawal by Subject|3|||
128712097|NCT00708162|463243759|FG000|Randomized Phase|Randomized but Not Treated|7|||
128712098|NCT00708162|463243760|FG001|Randomized Phase|Randomized but Not Treated|5|||
128712099|NCT00708162|463243759|FG000|Randomized Phase|Participant Noncompliance|40|||
128712100|NCT00708162|463243760|FG001|Randomized Phase|Participant Noncompliance|32|||
128712101|NCT00708162|463243759|FG000|Randomized Phase|Lost to Follow-up|34|||
128712102|NCT00708162|463243760|FG001|Randomized Phase|Lost to Follow-up|34|||
128712103|NCT00708162|463243759|FG000|Randomized Phase|Withdrew Consent|31|||
128712104|NCT00708162|463243760|FG001|Randomized Phase|Withdrew Consent|22|||
128712105|NCT00708162|463243759|FG000|Randomized Phase|Lack of Efficacy|14|||
128712106|NCT00708162|463243760|FG001|Randomized Phase|Lack of Efficacy|19|||
128712107|NCT00708162|463243759|FG000|Randomized Phase|Protocol Violation|10|||
128712108|NCT00708162|463243760|FG001|Randomized Phase|Protocol Violation|11|||
128712109|NCT00708162|463243759|FG000|Randomized Phase|Adverse Event|8|||
128712110|NCT00708162|463243760|FG001|Randomized Phase|Adverse Event|12|||
128712111|NCT00708162|463243759|FG000|Randomized Phase|Investigator's Discretion|7|||
128712112|NCT00708162|463243760|FG001|Randomized Phase|Investigator's Discretion|10|||
128712113|NCT00708162|463243759|FG000|Randomized Phase|Death|2|||
128712114|NCT00708162|463243760|FG001|Randomized Phase|Death|9|||
128712115|NCT00708162|463243759|FG000|Randomized Phase|Pregnancy|3|||
128712116|NCT00708162|463243760|FG001|Randomized Phase|Pregnancy|0|||
128712117|NCT00708162|463243759|FG000|Open-Label Phase|Lost to Follow-up|10|||
128712118|NCT00708162|463243760|FG001|Open-Label Phase|Lost to Follow-up|8|||
128712119|NCT00708162|463243759|FG000|Open-Label Phase|Withdrew Consent|12|||
128712120|NCT00708162|463243760|FG001|Open-Label Phase|Withdrew Consent|6|||
128712121|NCT00708162|463243759|FG000|Open-Label Phase|Participant Noncompliance|7|||
128712122|NCT00708162|463243760|FG001|Open-Label Phase|Participant Noncompliance|7|||
128712123|NCT00708162|463243759|FG000|Open-Label Phase|Lack of Efficacy|7|||
128712124|NCT00708162|463243760|FG001|Open-Label Phase|Lack of Efficacy|4|||
128712125|NCT00708162|463243759|FG000|Open-Label Phase|Investigator's Discretion|3|||
128712126|NCT00708162|463243760|FG001|Open-Label Phase|Investigator's Discretion|2|||
128712127|NCT00708162|463243759|FG000|Open-Label Phase|Death|3|||
128712128|NCT00708162|463243760|FG001|Open-Label Phase|Death|1|||
128712129|NCT00708162|463243759|FG000|Open-Label Phase|Adverse Event|1|||
128712130|NCT00708162|463243760|FG001|Open-Label Phase|Adverse Event|2|||
128712131|NCT00708162|463243759|FG000|Open-Label Phase|Other|1|||
128712132|NCT00708162|463243760|FG001|Open-Label Phase|Other|0|||
128712133|NCT00708643|463243761|FG000|Overall Study|Adverse Event|0|||
128712134|NCT00708643|463243762|FG001|Overall Study|Adverse Event|1|||
128712135|NCT01349803|463243763|FG000|Overall Study|Adverse Event|0|||
128712136|NCT01349803|463243764|FG001|Overall Study|Adverse Event|0|||
128712137|NCT01349803|463243765|FG002|Overall Study|Adverse Event|0|||
128712138|NCT01349803|463243766|FG003|Overall Study|Adverse Event|2|||
129036248|NCT04480307|464423439|FG003|Overall Study|Adverse Event|1|||
128712139|NCT01349803|463243763|FG000|Overall Study|Withdrawal by Subject|1|||
128712140|NCT01349803|463243764|FG001|Overall Study|Withdrawal by Subject|0|||
128712141|NCT01349803|463243765|FG002|Overall Study|Withdrawal by Subject|0|||
128712142|NCT01349803|463243766|FG003|Overall Study|Withdrawal by Subject|0|||
128712143|NCT01349803|463243763|FG000|Overall Study|Protocol-specified criteria|0|||
128712144|NCT01349803|463243764|FG001|Overall Study|Protocol-specified criteria|1|||
128712145|NCT01349803|463243765|FG002|Overall Study|Protocol-specified criteria|3|||
128712146|NCT01349803|463243766|FG003|Overall Study|Protocol-specified criteria|0|||
128712147|NCT01710033|463243767|FG000|Stage 2|Adverse Event|0|||
128712148|NCT01710033|463243768|FG001|Stage 2|Adverse Event|0|||
128712149|NCT01710033|463243769|FG002|Stage 2|Adverse Event|0|||
128712150|NCT01710033|463243770|FG003|Stage 2|Adverse Event|0|||
128712151|NCT01710033|463243771|FG004|Stage 2|Adverse Event|1|||
128712152|NCT00100815|463243772|FG000|Overall Study|Progression|24|||
128712153|NCT00100815|463243772|FG000|Overall Study|Adverse Event|18|||
128712154|NCT00100815|463243772|FG000|Overall Study|Death|4|||
128712155|NCT00100815|463243772|FG000|Overall Study|Other|3|||
128712156|NCT01647282|463243774|FG000|Overall Study|Physician Decision|7|||
128712157|NCT01647282|463243775|FG001|Overall Study|Physician Decision|5|||
128712158|NCT01244906|463243777|FG000|Overall Study|Death|2|||
128712159|NCT01244906|463243777|FG000|Overall Study|Progression of disease post treatment|6|||
128712160|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
128712161|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
128712162|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
128712163|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
128712164|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
128712165|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
128712166|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
128712167|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
128712168|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
128712169|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
128712170|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
128712171|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
128712172|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
128712173|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
128712174|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
128712175|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
128712176|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
128712177|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
128712178|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
128712179|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
128712180|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
128712181|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
128712182|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
128712183|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
128712184|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
128712185|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
128712186|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
128712187|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
128712188|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
128712189|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
128712190|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
129036249|NCT04254809|464423440|FG000|Overall Study|Lost to Follow-up|5|||
129036250|NCT04254809|464423441|FG001|Overall Study|Lost to Follow-up|10|||
129036251|NCT03023137|464423442|FG000|Overall Study|Multiple pregnancy|2|||
129036252|NCT03023137|464423443|FG001|Overall Study|Multiple pregnancy|4|||
129036253|NCT03023137|464423442|FG000|Overall Study|Lost to Follow-up|1|||
129036254|NCT03023137|464423443|FG001|Overall Study|Lost to Follow-up|1|||
129036255|NCT03023137|464423442|FG000|Overall Study|Protocol Violation|0|||
129036256|NCT03023137|464423443|FG001|Overall Study|Protocol Violation|4|||
129036257|NCT03023137|464423442|FG000|Overall Study|Lost the baby in a car accident|1|||
129036258|NCT03023137|464423443|FG001|Overall Study|Lost the baby in a car accident|0|||
129036259|NCT02608476|464423444|FG000|Overall Study|Withdrawal by Subject|30|||
129036260|NCT02608476|464423445|FG001|Overall Study|Withdrawal by Subject|37|||
129036261|NCT02608476|464423444|FG000|Overall Study|Lost to Follow-up|24|||
129036262|NCT02608476|464423445|FG001|Overall Study|Lost to Follow-up|24|||
128712191|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
129036263|NCT02608476|464423444|FG000|Overall Study|Adverse Event|2|||
129036264|NCT02608476|464423445|FG001|Overall Study|Adverse Event|8|||
129036265|NCT02608476|464423444|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
129036266|NCT02608476|464423445|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
129036267|NCT02608476|464423444|FG000|Overall Study|Noncompliance with treatment|1|||
128712192|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
128712193|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
128712194|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
128712195|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
128712196|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
128712197|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
128712198|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
128712199|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
128712200|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
128712201|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
128712202|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
128712203|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
128712204|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
128712205|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
128712206|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
128712207|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
128712208|NCT03720470|463243778|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
128712209|NCT03720470|463243779|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
128712210|NCT03720470|463243780|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
128712211|NCT03720470|463243781|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
128712212|NCT03720470|463243782|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
128712213|NCT03720470|463243783|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
128712214|NCT03720470|463243778|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
128712215|NCT03720470|463243779|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
128712216|NCT03720470|463243780|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
128712217|NCT03720470|463243781|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
128712218|NCT03720470|463243782|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
128712219|NCT03720470|463243783|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
128712220|NCT03720470|463243778|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
128712221|NCT03720470|463243779|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
128712222|NCT03720470|463243780|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
128712223|NCT03720470|463243781|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
128712224|NCT03720470|463243782|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
128712225|NCT03720470|463243783|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
128712226|NCT03720470|463243778|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
128712227|NCT03720470|463243779|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
128712228|NCT03720470|463243780|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
128712229|NCT03720470|463243781|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
128712230|NCT03720470|463243782|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
128712231|NCT03720470|463243783|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
128712232|NCT03720470|463243778|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
128712233|NCT03720470|463243779|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
128712234|NCT03720470|463243780|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
128712235|NCT03720470|463243781|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
128712236|NCT03720470|463243782|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
128712237|NCT03720470|463243783|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
128712238|NCT03720470|463243778|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
128712239|NCT03720470|463243779|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
128712240|NCT03720470|463243780|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
128712241|NCT03720470|463243781|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
128712242|NCT03720470|463243782|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
128712243|NCT03720470|463243783|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
128712244|NCT03720470|463243778|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
128712245|NCT03720470|463243779|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
128712246|NCT03720470|463243780|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
128712247|NCT03720470|463243781|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
128712248|NCT03720470|463243782|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
128712249|NCT03720470|463243783|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
128712250|NCT03720470|463243778|FG000|Treatment Period: Final 4 Weeks|Other|0|||
128712251|NCT03720470|463243779|FG001|Treatment Period: Final 4 Weeks|Other|1|||
128712252|NCT03720470|463243780|FG002|Treatment Period: Final 4 Weeks|Other|0|||
128712253|NCT03720470|463243781|FG003|Treatment Period: Final 4 Weeks|Other|2|||
128712254|NCT03720470|463243782|FG004|Treatment Period: Final 4 Weeks|Other|1|||
128957095|NCT00493467|464127542|FG000|Overall Study|Death|1|||
128712255|NCT03720470|463243783|FG005|Treatment Period: Final 4 Weeks|Other|0|||
128712256|NCT00460031|463243784|FG000|Overall Study|Adverse Event|5|||
128712257|NCT00460031|463243784|FG000|Overall Study|Withdrawal by Subject|5|||
128712258|NCT00460031|463243784|FG000|Overall Study|Death|1|||
128712259|NCT04532099|463243785|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
128712260|NCT04532099|463243786|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
128712261|NCT04532099|463243787|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
129126470|NCT02327078|464757967|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
129126471|NCT02327078|464757968|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
129126472|NCT02327078|464757969|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
129126473|NCT02327078|464757961|FG000|Overall Study|Reason not Specified|0|||
129126474|NCT02327078|464757962|FG001|Overall Study|Reason not Specified|0|||
129126475|NCT02327078|464757963|FG002|Overall Study|Reason not Specified|0|||
129126476|NCT02327078|464757964|FG003|Overall Study|Reason not Specified|0|||
129126477|NCT02327078|464757965|FG004|Overall Study|Reason not Specified|0|||
129126478|NCT02327078|464757966|FG005|Overall Study|Reason not Specified|0|||
129126479|NCT02327078|464757967|FG006|Overall Study|Reason not Specified|0|||
129126480|NCT02327078|464757968|FG007|Overall Study|Reason not Specified|5|||
129126481|NCT02327078|464757969|FG008|Overall Study|Reason not Specified|12|||
129126482|NCT05513950|464757970|FG000|Overall Study|Not treated due to technical reasons|0|||
129126483|NCT05513950|464757971|FG001|Overall Study|Not treated due to technical reasons|0|||
129126484|NCT05513950|464757972|FG002|Overall Study|Not treated due to technical reasons|1|||
129126485|NCT05513950|464757973|FG003|Overall Study|Not treated due to technical reasons|0|||
129126486|NCT06001866|464757974|FG000|Overall Study|Withdrawal by Subject|0|||
129126487|NCT06001866|464757975|FG001|Overall Study|Withdrawal by Subject|2|||
129126488|NCT06001866|464757974|FG000|Overall Study|Protocol Violation|0|||
129126489|NCT06001866|464757975|FG001|Overall Study|Protocol Violation|2|||
129126490|NCT02903914|464757976|FG000|Overall Study|Adverse Event|0|||
129126491|NCT02903914|464757977|FG001|Overall Study|Adverse Event|0|||
129126492|NCT02903914|464757978|FG002|Overall Study|Adverse Event|1|||
129126493|NCT02903914|464757979|FG003|Overall Study|Adverse Event|0|||
129126494|NCT02903914|464757980|FG004|Overall Study|Adverse Event|0|||
129126495|NCT02903914|464757981|FG005|Overall Study|Adverse Event|0|||
129126496|NCT02903914|464757982|FG006|Overall Study|Adverse Event|2|||
129126497|NCT02903914|464757983|FG007|Overall Study|Adverse Event|0|||
129126498|NCT02903914|464757976|FG000|Overall Study|Withdrawal by Subject|3|||
129126499|NCT02903914|464757977|FG001|Overall Study|Withdrawal by Subject|1|||
129126500|NCT02903914|464757978|FG002|Overall Study|Withdrawal by Subject|28|||
129126501|NCT02903914|464757979|FG003|Overall Study|Withdrawal by Subject|0|||
129126502|NCT02903914|464757980|FG004|Overall Study|Withdrawal by Subject|1|||
129126503|NCT02903914|464757981|FG005|Overall Study|Withdrawal by Subject|2|||
129126504|NCT02903914|464757982|FG006|Overall Study|Withdrawal by Subject|12|||
129126505|NCT02903914|464757983|FG007|Overall Study|Withdrawal by Subject|0|||
129126506|NCT02903914|464757976|FG000|Overall Study|Progressive Disease|1|||
129126507|NCT02903914|464757977|FG001|Overall Study|Progressive Disease|0|||
129126508|NCT02903914|464757978|FG002|Overall Study|Progressive Disease|4|||
129126509|NCT02903914|464757979|FG003|Overall Study|Progressive Disease|0|||
129126510|NCT02903914|464757980|FG004|Overall Study|Progressive Disease|0|||
129126511|NCT02903914|464757981|FG005|Overall Study|Progressive Disease|0|||
129126512|NCT02903914|464757982|FG006|Overall Study|Progressive Disease|2|||
129126513|NCT02903914|464757983|FG007|Overall Study|Progressive Disease|0|||
129126514|NCT02903914|464757976|FG000|Overall Study|Death|0|||
128712262|NCT00644995|463243794|FG000|Overall Study|Lost to Follow-up|1|||
128712263|NCT00644995|463243795|FG001|Overall Study|Lost to Follow-up|4|||
128712264|NCT00644995|463243794|FG000|Overall Study|Refused|1|||
128712265|NCT00644995|463243795|FG001|Overall Study|Refused|0|||
128712266|NCT02066233|463243801|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
128712267|NCT02066233|463243802|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
128712268|NCT02772081|463243803|FG000|Overall Study|Physician Decision|1|||
128712269|NCT02772081|463243804|FG001|Overall Study|Physician Decision|1|||
128712270|NCT02772081|463243803|FG000|Overall Study|Death|1|||
128712271|NCT02772081|463243804|FG001|Overall Study|Death|1|||
128712272|NCT00311623|463243810|FG000|Overall Study|Physician Decision|0|||
128712273|NCT00311623|463243811|FG001|Overall Study|Physician Decision|0|||
128712274|NCT00311623|463243812|FG002|Overall Study|Physician Decision|2|||
128712275|NCT03998189|463243813|FG000|Overall Study|Lack of Efficacy|0|||
128712276|NCT03998189|463243814|FG001|Overall Study|Lack of Efficacy|1|||
128712277|NCT03227029|463243815|FG000|Overall Study|Child Wheezed (no treatment)|0|||
129126515|NCT02903914|464757977|FG001|Overall Study|Death|0|||
129126516|NCT02903914|464757978|FG002|Overall Study|Death|9|||
129126517|NCT02903914|464757979|FG003|Overall Study|Death|0|||
129126518|NCT02903914|464757980|FG004|Overall Study|Death|1|||
129126519|NCT02903914|464757981|FG005|Overall Study|Death|3|||
129126520|NCT02903914|464757982|FG006|Overall Study|Death|24|||
128712278|NCT03227029|463243816|FG001|Overall Study|Child Wheezed (no treatment)|1|||
128712279|NCT03227029|463243817|FG002|Overall Study|Child Wheezed (no treatment)|0|||
128712280|NCT03227029|463243815|FG000|Overall Study|No post RSV season visit due to COVID|3|||
128712281|NCT03227029|463243816|FG001|Overall Study|No post RSV season visit due to COVID|3|||
128712282|NCT03227029|463243817|FG002|Overall Study|No post RSV season visit due to COVID|2|||
128712283|NCT03227029|463243815|FG000|Overall Study|Not able to get to clinic|0|||
128770931|NCT00758160|463453569|FG000|Overall Study|Withdrawal by Subject|8|||
128770932|NCT01613027|463453570|FG000|Overall Study|Lost to Follow-up|5|||
128770933|NCT01613027|463453570|FG000|Overall Study|Switched Physician|1|||
128770934|NCT01613027|463453570|FG000|Overall Study|Lack of Efficacy|1|||
128770935|NCT01613027|463453570|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
128770936|NCT00993317|463453571|FG000|Overall Study|Adverse Event|2|||
128770937|NCT00993317|463453572|FG001|Overall Study|Adverse Event|4|||
128770938|NCT00993317|463453571|FG000|Overall Study|Lack of Efficacy|18|||
128770939|NCT00993317|463453572|FG001|Overall Study|Lack of Efficacy|18|||
128770940|NCT00993317|463453571|FG000|Overall Study|Withdrawal by Subject|0|||
128770941|NCT00993317|463453572|FG001|Overall Study|Withdrawal by Subject|2|||
128770942|NCT00993317|463453571|FG000|Overall Study|Investigator's opinion|0|||
128770943|NCT00993317|463453572|FG001|Overall Study|Investigator's opinion|1|||
128770944|NCT00993317|463453571|FG000|Overall Study|Early study termination at the site|1|||
128770945|NCT00993317|463453572|FG001|Overall Study|Early study termination at the site|0|||
128770946|NCT04422639|463453573|FG000|Overall Study|Death|1|||
128770947|NCT04422639|463453574|FG001|Overall Study|Death|0|||
128770948|NCT04422639|463453573|FG000|Overall Study|study closed prior to completion of FU visits|0|||
128770949|NCT04422639|463453574|FG001|Overall Study|study closed prior to completion of FU visits|2|||
128770950|NCT01258660|463453576|FG000|Overall Study|Adverse Event|2|||
128770951|NCT01258660|463453577|FG001|Overall Study|Adverse Event|4|||
128770952|NCT01258660|463453576|FG000|Overall Study|Withdrawal by Subject|3|||
128770953|NCT01258660|463453577|FG001|Overall Study|Withdrawal by Subject|0|||
128770954|NCT01258660|463453576|FG000|Overall Study|due to relocation|2|||
128770955|NCT01258660|463453577|FG001|Overall Study|due to relocation|0|||
128770956|NCT01258660|463453576|FG000|Overall Study|Protocol Violation|0|||
128770957|NCT01258660|463453577|FG001|Overall Study|Protocol Violation|1|||
128770958|NCT01258660|463453576|FG000|Overall Study|Invalid for primary analysis data set|4|||
128770959|NCT01258660|463453577|FG001|Overall Study|Invalid for primary analysis data set|6|||
128770960|NCT01193582|463453578|FG000|Vaccination Series|Withdrawal by Subject|11|||
128770961|NCT01193582|463453579|FG001|Vaccination Series|Withdrawal by Subject|13|||
128770962|NCT01193582|463453580|FG002|Vaccination Series|Withdrawal by Subject|8|||
128770963|NCT01193582|463453581|FG003|Vaccination Series|Withdrawal by Subject|3|||
128770964|NCT01193582|463453578|FG000|12 Month Follow-up|Death|0|||
128770965|NCT01193582|463453579|FG001|12 Month Follow-up|Death|0|||
128770966|NCT01193582|463453580|FG002|12 Month Follow-up|Death|1|||
128770967|NCT01193582|463453581|FG003|12 Month Follow-up|Death|0|||
128770968|NCT01193582|463453578|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
128770969|NCT01193582|463453579|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
129126521|NCT02903914|464757983|FG007|Overall Study|Death|2|||
129126522|NCT02903914|464757976|FG000|Overall Study|Lost to Follow-up|0|||
128770970|NCT01193582|463453580|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
128770971|NCT01193582|463453581|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
128770972|NCT03856996|463453591|FG000|Overall Study|Withdrawal by Subject|1|||
128957096|NCT05489081|464127544|FG000|Overall Study|student left classroom|0|||
128957097|NCT05489081|464127545|FG001|Overall Study|student left classroom|1|||
128957098|NCT05489081|464127544|FG000|Overall Study|teacher left school|0|||
128957099|NCT05489081|464127545|FG001|Overall Study|teacher left school|2|||
128957100|NCT00810810|464127546|FG000|Overall Study|Withdrawal by Subject|0|||
128957101|NCT00810810|464127547|FG001|Overall Study|Withdrawal by Subject|8|||
128957102|NCT00810810|464127548|FG002|Overall Study|Withdrawal by Subject|10|||
128957103|NCT00810810|464127549|FG003|Overall Study|Withdrawal by Subject|8|||
128957104|NCT00810810|464127546|FG000|Overall Study|Physician Decision|0|||
128957105|NCT00810810|464127547|FG001|Overall Study|Physician Decision|3|||
128957106|NCT00810810|464127548|FG002|Overall Study|Physician Decision|1|||
128957107|NCT00810810|464127549|FG003|Overall Study|Physician Decision|5|||
128957108|NCT01409993|464127550|FG000|Overall Study|Adverse Event|4|||
128957109|NCT01409993|464127551|FG001|Overall Study|Adverse Event|4|||
128957110|NCT01409993|464127552|FG002|Overall Study|Adverse Event|3|||
128957111|NCT01409993|464127553|FG003|Overall Study|Adverse Event|1|||
128957112|NCT01409993|464127550|FG000|Overall Study|Withdrawal by Subject|0|||
128957113|NCT01409993|464127551|FG001|Overall Study|Withdrawal by Subject|0|||
128957114|NCT01409993|464127552|FG002|Overall Study|Withdrawal by Subject|0|||
128957115|NCT01409993|464127553|FG003|Overall Study|Withdrawal by Subject|4|||
128957116|NCT01409993|464127550|FG000|Overall Study|Lost to Follow-up|0|||
129126523|NCT02903914|464757977|FG001|Overall Study|Lost to Follow-up|1|||
128770973|NCT03856996|463453592|FG001|Overall Study|Withdrawal by Subject|0|||
128770974|NCT03856996|463453591|FG000|Overall Study|Lost to Follow-up|0|||
128957117|NCT01409993|464127551|FG001|Overall Study|Lost to Follow-up|1|||
128957118|NCT01409993|464127552|FG002|Overall Study|Lost to Follow-up|0|||
128957119|NCT01409993|464127553|FG003|Overall Study|Lost to Follow-up|0|||
128957120|NCT01700985|464127554|FG000|Overall Study|Incarcerated|0|||
128957121|NCT01700985|464127555|FG001|Overall Study|Incarcerated|1|||
128770975|NCT03856996|463453592|FG001|Overall Study|Lost to Follow-up|1|||
128770976|NCT03856996|463453591|FG000|Overall Study|Adverse Event|1|||
128770977|NCT03856996|463453592|FG001|Overall Study|Adverse Event|1|||
128957122|NCT05067452|464127556|FG000|Overall Study|Lost to Follow-up|0|||
128957123|NCT05067452|464127557|FG001|Overall Study|Lost to Follow-up|4|||
128770978|NCT03856996|463453591|FG000|Overall Study|Other|1|||
128770979|NCT03856996|463453592|FG001|Overall Study|Other|0|||
128770980|NCT02340520|463453593|FG000|Overall Study|Lost to Follow-up|1|||
128770981|NCT02340520|463453593|FG000|Overall Study|Patient did not take drug as specified|1|||
128770982|NCT02340520|463453593|FG000|Overall Study|Withdrawal by Subject|1|||
128770983|NCT01464255|463453594|FG000|Overall Study|unresolve corneal staining|0|||
128770984|NCT01464255|463453595|FG001|Overall Study|unresolve corneal staining|1|||
128770985|NCT01231503|463453596|FG000|Overall Study|Adverse Event|0|||
128770986|NCT01231503|463453597|FG001|Overall Study|Adverse Event|0|||
128770987|NCT01231503|463453598|FG002|Overall Study|Adverse Event|0|||
128770988|NCT01231503|463453599|FG003|Overall Study|Adverse Event|0|||
128957124|NCT03074149|464127558|FG000|Overall Study|Reason unknown|22|||
128957125|NCT03074149|464127559|FG001|Overall Study|Reason unknown|35|||
128957126|NCT03074149|464127558|FG000|Overall Study|Death|10|||
128957127|NCT03074149|464127559|FG001|Overall Study|Death|45|||
128957128|NCT00067470|464127562|FG000|Overall Study|Withdrawal by Subject|0|||
128957129|NCT00067470|464127563|FG001|Overall Study|Withdrawal by Subject|1|||
128957130|NCT00050622|464127564|FG000|Overall Study|Adverse Event|1|||
128957131|NCT01192204|464127565|FG000|Overall Study|could not keep recall appointments|1|||
128957132|NCT01192204|464127566|FG001|Overall Study|could not keep recall appointments|0|||
128957133|NCT01315847|464127567|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
128957134|NCT01315847|464127568|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
128957135|NCT01315847|464127567|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
128957136|NCT01315847|464127568|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
128957137|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
128957138|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
128957139|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
128957140|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
128957141|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
128957142|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
128957143|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
128957144|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
128957145|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
128957146|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
128957147|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
128957148|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
128957149|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
128957150|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
128957151|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
128957152|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
128957153|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
128957154|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
128957155|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
128957156|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
128770989|NCT01231503|463453600|FG004|Overall Study|Adverse Event|0|||
128770990|NCT01231503|463453601|FG005|Overall Study|Adverse Event|1|||
128770991|NCT01231503|463453602|FG006|Overall Study|Adverse Event|0|||
128770992|NCT01231503|463453603|FG007|Overall Study|Adverse Event|0|||
128770993|NCT01231503|463453596|FG000|Overall Study|Adverse event, serious fatal|0|||
128770994|NCT01231503|463453597|FG001|Overall Study|Adverse event, serious fatal|0|||
128770995|NCT01231503|463453598|FG002|Overall Study|Adverse event, serious fatal|1|||
128770996|NCT01231503|463453599|FG003|Overall Study|Adverse event, serious fatal|1|||
128770997|NCT01231503|463453600|FG004|Overall Study|Adverse event, serious fatal|0|||
128770998|NCT01231503|463453601|FG005|Overall Study|Adverse event, serious fatal|1|||
128770999|NCT01231503|463453602|FG006|Overall Study|Adverse event, serious fatal|0|||
128771000|NCT01231503|463453603|FG007|Overall Study|Adverse event, serious fatal|0|||
128771001|NCT01231503|463453596|FG000|Overall Study|Withdrawal by Subject|6|||
128771002|NCT01231503|463453597|FG001|Overall Study|Withdrawal by Subject|3|||
128771003|NCT01231503|463453598|FG002|Overall Study|Withdrawal by Subject|3|||
128771004|NCT01231503|463453599|FG003|Overall Study|Withdrawal by Subject|1|||
128957157|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
128957158|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
128957159|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
128957160|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
128957161|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
128957162|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
128957163|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
128771005|NCT01231503|463453600|FG004|Overall Study|Withdrawal by Subject|3|||
128771006|NCT01231503|463453601|FG005|Overall Study|Withdrawal by Subject|5|||
128957164|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
128957165|NCT00476996|464127569|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
128957166|NCT00476996|464127570|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
128957167|NCT00476996|464127571|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
128957168|NCT00476996|464127572|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
128957169|NCT00476996|464127569|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
129126524|NCT02903914|464757978|FG002|Overall Study|Lost to Follow-up|0|||
129126525|NCT02903914|464757979|FG003|Overall Study|Lost to Follow-up|0|||
129126526|NCT02903914|464757980|FG004|Overall Study|Lost to Follow-up|2|||
129126527|NCT02903914|464757981|FG005|Overall Study|Lost to Follow-up|0|||
129126528|NCT02903914|464757982|FG006|Overall Study|Lost to Follow-up|1|||
129126529|NCT02903914|464757983|FG007|Overall Study|Lost to Follow-up|0|||
129126530|NCT02903914|464757976|FG000|Overall Study|Physician Decision|0|||
129126531|NCT02903914|464757977|FG001|Overall Study|Physician Decision|0|||
129126532|NCT02903914|464757978|FG002|Overall Study|Physician Decision|1|||
129126533|NCT02903914|464757979|FG003|Overall Study|Physician Decision|0|||
129126534|NCT02903914|464757980|FG004|Overall Study|Physician Decision|0|||
129126535|NCT02903914|464757981|FG005|Overall Study|Physician Decision|0|||
129126536|NCT02903914|464757982|FG006|Overall Study|Physician Decision|1|||
129126537|NCT02903914|464757983|FG007|Overall Study|Physician Decision|0|||
128712284|NCT03227029|463243816|FG001|Overall Study|Not able to get to clinic|0|||
128712285|NCT03227029|463243817|FG002|Overall Study|Not able to get to clinic|1|||
128712286|NCT03227029|463243815|FG000|Overall Study|Withdrawal by Subject|1|||
128712287|NCT03227029|463243816|FG001|Overall Study|Withdrawal by Subject|0|||
128712288|NCT03227029|463243817|FG002|Overall Study|Withdrawal by Subject|0|||
128712289|NCT03227029|463243815|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
128712290|NCT03227029|463243816|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
128712291|NCT03227029|463243817|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
128712292|NCT00390858|463243818|FG000|Overall Study|Adverse Event|6|||
128712293|NCT00390858|463243819|FG001|Overall Study|Adverse Event|2|||
128712294|NCT00390858|463243818|FG000|Overall Study|Lack of Efficacy|0|||
128712295|NCT00390858|463243819|FG001|Overall Study|Lack of Efficacy|1|||
128712296|NCT00390858|463243818|FG000|Overall Study|Withdrawal by Subject|3|||
128712297|NCT00390858|463243819|FG001|Overall Study|Withdrawal by Subject|4|||
128712298|NCT03414424|463243820|FG000|Overall Study|Screened out after consent|0|||
128712299|NCT03414424|463243821|FG001|Overall Study|Screened out after consent|2|||
128712300|NCT03414424|463243820|FG000|Overall Study|Lost to Follow-up|0|||
128712301|NCT03414424|463243821|FG001|Overall Study|Lost to Follow-up|1|||
128712302|NCT01949051|463243823|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
128712303|NCT01949051|463243824|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
128712304|NCT01949051|463243825|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
128712305|NCT01949051|463243826|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
128712306|NCT01949051|463243827|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
128712307|NCT01949051|463243828|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
128712308|NCT01949051|463243823|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
128712309|NCT01949051|463243824|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128712310|NCT01949051|463243825|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128712311|NCT01949051|463243826|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128712312|NCT01949051|463243827|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128712313|NCT01949051|463243828|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
128712314|NCT01949051|463243823|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
128712315|NCT01949051|463243824|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
128712316|NCT01949051|463243825|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
128712317|NCT01949051|463243826|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
128712318|NCT01949051|463243827|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
128712319|NCT01949051|463243828|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
128712320|NCT01949051|463243823|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
128712321|NCT01949051|463243824|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
128712322|NCT01949051|463243825|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
128712323|NCT01949051|463243826|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
128712324|NCT01949051|463243827|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
128957170|NCT00476996|464127570|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
128957171|NCT00476996|464127571|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
129126538|NCT02903914|464757976|FG000|Overall Study|Symptomatic Deterioration|0|||
129126539|NCT02903914|464757977|FG001|Overall Study|Symptomatic Deterioration|0|||
128712325|NCT01949051|463243828|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
128712326|NCT01949051|463243823|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
128712327|NCT01949051|463243824|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
128712328|NCT01949051|463243825|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
128712329|NCT01949051|463243826|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
128712330|NCT01949051|463243827|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
128712331|NCT01949051|463243828|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129126540|NCT02903914|464757978|FG002|Overall Study|Symptomatic Deterioration|1|||
128712332|NCT01782859|463243829|FG000|Overall Study|Protocol Violation|6|||
128712333|NCT01782859|463243830|FG001|Overall Study|Protocol Violation|6|||
128957172|NCT00476996|464127572|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
128957173|NCT00476996|464127569|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
128957174|NCT00476996|464127570|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
128957175|NCT00476996|464127571|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
128957176|NCT00476996|464127572|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
128957177|NCT00476996|464127569|FG000|OLE Phase (From Week 48)|Death|0|||
128957178|NCT00476996|464127570|FG001|OLE Phase (From Week 48)|Death|0|||
128957179|NCT00476996|464127571|FG002|OLE Phase (From Week 48)|Death|0|||
128957180|NCT00476996|464127572|FG003|OLE Phase (From Week 48)|Death|7|||
128957181|NCT00476996|464127569|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
128957182|NCT00476996|464127570|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
129036268|NCT02608476|464423445|FG001|Overall Study|Noncompliance with treatment|5|||
129036269|NCT02608476|464423444|FG000|Overall Study|Lack of Efficacy|3|||
128957183|NCT00476996|464127571|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
129036270|NCT02608476|464423445|FG001|Overall Study|Lack of Efficacy|1|||
129036271|NCT02608476|464423444|FG000|Overall Study|Other|0|||
129036272|NCT02608476|464423445|FG001|Overall Study|Other|1|||
129036273|NCT02608476|464423444|FG000|Overall Study|Physician Decision|1|||
129036274|NCT02608476|464423445|FG001|Overall Study|Physician Decision|0|||
129036275|NCT02608476|464423444|FG000|Overall Study|Pregnancy|0|||
129036276|NCT02608476|464423445|FG001|Overall Study|Pregnancy|1|||
129036277|NCT02608476|464423444|FG000|Overall Study|Progressive disease|1|||
129036278|NCT02608476|464423445|FG001|Overall Study|Progressive disease|0|||
129036279|NCT02795676|464423446|FG000|Overall Study|Adverse Event|2|||
129036280|NCT02795676|464423447|FG001|Overall Study|Adverse Event|0|||
129036281|NCT02795676|464423446|FG000|Overall Study|Withdrawal by Subject|3|||
129036282|NCT02795676|464423447|FG001|Overall Study|Withdrawal by Subject|1|||
129036283|NCT01609582|464423448|FG000|Overall Study|Adverse Event|20|||
129036284|NCT01609582|464423449|FG001|Overall Study|Adverse Event|18|||
129036285|NCT01609582|464423448|FG000|Overall Study|Lost to Follow-up|10|||
128712334|NCT01782859|463243829|FG000|Overall Study|Withdrawal by Subject|0|||
128712335|NCT01782859|463243830|FG001|Overall Study|Withdrawal by Subject|1|||
128712336|NCT02659631|463243833|FG000|Overall Study|Lost to Follow-up|0|||
128712337|NCT02659631|463243834|FG001|Overall Study|Lost to Follow-up|0|||
128712338|NCT02659631|463243835|FG002|Overall Study|Lost to Follow-up|2|||
128712339|NCT02659631|463243836|FG003|Overall Study|Lost to Follow-up|0|||
129036286|NCT01609582|464423449|FG001|Overall Study|Lost to Follow-up|10|||
129036287|NCT01609582|464423448|FG000|Overall Study|Withdrawal by Subject|21|||
129036288|NCT01609582|464423449|FG001|Overall Study|Withdrawal by Subject|15|||
129036289|NCT01609582|464423448|FG000|Overall Study|Study Terminated by Sponsor|1543|||
129036290|NCT01609582|464423449|FG001|Overall Study|Study Terminated by Sponsor|1548|||
129036291|NCT01609582|464423448|FG000|Overall Study|Other|9|||
129036292|NCT01609582|464423449|FG001|Overall Study|Other|10|||
129036293|NCT01609582|464423448|FG000|Overall Study|Randomized, but not treated|0|||
129036294|NCT01609582|464423449|FG001|Overall Study|Randomized, but not treated|3|||
129036295|NCT00819767|464423450|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128712340|NCT02659631|463243837|FG004|Overall Study|Lost to Follow-up|0|||
128712341|NCT02659631|463243838|FG005|Overall Study|Lost to Follow-up|1|||
128712342|NCT02659631|463243839|FG006|Overall Study|Lost to Follow-up|0|||
128712343|NCT02659631|463243840|FG007|Overall Study|Lost to Follow-up|0|||
128712344|NCT02659631|463243841|FG008|Overall Study|Lost to Follow-up|0|||
128712345|NCT02659631|463243842|FG009|Overall Study|Lost to Follow-up|0|||
128712346|NCT02659631|463243833|FG000|Overall Study|Withdrawal prior to treatment|0|||
128712347|NCT02659631|463243834|FG001|Overall Study|Withdrawal prior to treatment|0|||
128712348|NCT02659631|463243835|FG002|Overall Study|Withdrawal prior to treatment|0|||
128712349|NCT02659631|463243836|FG003|Overall Study|Withdrawal prior to treatment|0|||
128712350|NCT02659631|463243837|FG004|Overall Study|Withdrawal prior to treatment|1|||
128712351|NCT02659631|463243838|FG005|Overall Study|Withdrawal prior to treatment|0|||
128712352|NCT02659631|463243839|FG006|Overall Study|Withdrawal prior to treatment|0|||
128712353|NCT02659631|463243840|FG007|Overall Study|Withdrawal prior to treatment|0|||
128712354|NCT02659631|463243841|FG008|Overall Study|Withdrawal prior to treatment|0|||
128712355|NCT02659631|463243842|FG009|Overall Study|Withdrawal prior to treatment|0|||
128712356|NCT02659631|463243833|FG000|Overall Study|Participant refused further follow-up|0|||
128712357|NCT02659631|463243834|FG001|Overall Study|Participant refused further follow-up|0|||
128712358|NCT02659631|463243835|FG002|Overall Study|Participant refused further follow-up|0|||
129036296|NCT00819767|464423451|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128712359|NCT02659631|463243836|FG003|Overall Study|Participant refused further follow-up|1|||
128957184|NCT00476996|464127572|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
128957185|NCT00476996|464127569|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
129036297|NCT00808509|464423461|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
128712360|NCT02659631|463243837|FG004|Overall Study|Participant refused further follow-up|0|||
128712361|NCT02659631|463243838|FG005|Overall Study|Participant refused further follow-up|0|||
128712362|NCT02659631|463243839|FG006|Overall Study|Participant refused further follow-up|0|||
129036298|NCT00808509|464423462|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
128771007|NCT01231503|463453602|FG006|Overall Study|Withdrawal by Subject|1|||
128771008|NCT01231503|463453603|FG007|Overall Study|Withdrawal by Subject|2|||
128771009|NCT01231503|463453596|FG000|Overall Study|Lost to Follow-up|8|||
128771010|NCT01231503|463453597|FG001|Overall Study|Lost to Follow-up|10|||
128771011|NCT01231503|463453598|FG002|Overall Study|Lost to Follow-up|8|||
128771012|NCT01231503|463453599|FG003|Overall Study|Lost to Follow-up|5|||
128771013|NCT01231503|463453600|FG004|Overall Study|Lost to Follow-up|7|||
128957186|NCT00476996|464127570|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
128957187|NCT00476996|464127571|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
128957188|NCT00476996|464127572|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
128957189|NCT00476996|464127569|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
128957190|NCT00476996|464127570|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
128957191|NCT00476996|464127571|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
128957192|NCT00476996|464127572|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
128957193|NCT00476996|464127569|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
128957194|NCT00476996|464127570|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
128957195|NCT00476996|464127571|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
128957196|NCT00476996|464127572|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
128957197|NCT02394795|464127573|FG000|Overall Study|Adverse Event|92|||
128957198|NCT02394795|464127574|FG001|Overall Study|Adverse Event|70|||
128712363|NCT02659631|463243840|FG007|Overall Study|Participant refused further follow-up|0|||
128712364|NCT02659631|463243841|FG008|Overall Study|Participant refused further follow-up|1|||
128712365|NCT02659631|463243842|FG009|Overall Study|Participant refused further follow-up|0|||
128712366|NCT02659631|463243833|FG000|Overall Study|Death (follow-up phase)|1|||
128712367|NCT02659631|463243834|FG001|Overall Study|Death (follow-up phase)|2|||
128712368|NCT02659631|463243835|FG002|Overall Study|Death (follow-up phase)|1|||
128712369|NCT02659631|463243836|FG003|Overall Study|Death (follow-up phase)|1|||
128712370|NCT02659631|463243837|FG004|Overall Study|Death (follow-up phase)|3|||
128957199|NCT02394795|464127573|FG000|Overall Study|Lost to Follow-up|0|||
128957200|NCT02394795|464127574|FG001|Overall Study|Lost to Follow-up|1|||
128957201|NCT02394795|464127573|FG000|Overall Study|Withdrawal by Subject|17|||
128957202|NCT02394795|464127574|FG001|Overall Study|Withdrawal by Subject|26|||
128957203|NCT02394795|464127573|FG000|Overall Study|Lack of Efficacy|181|||
128957204|NCT02394795|464127574|FG001|Overall Study|Lack of Efficacy|211|||
128712371|NCT02659631|463243838|FG005|Overall Study|Death (follow-up phase)|2|||
128771014|NCT01231503|463453601|FG005|Overall Study|Lost to Follow-up|9|||
128957205|NCT02394795|464127573|FG000|Overall Study|Death|4|||
128957206|NCT02394795|464127574|FG001|Overall Study|Death|5|||
128957207|NCT02394795|464127573|FG000|Overall Study|Physician Decision|109|||
128957208|NCT02394795|464127574|FG001|Overall Study|Physician Decision|93|||
128957209|NCT02031432|464127578|FG000|Overall Study|Protocol Violation|1|||
128957210|NCT02031432|464127578|FG000|Overall Study|Lack of Efficacy|5|||
128957211|NCT02031432|464127578|FG000|Overall Study|Cancer Progression|2|||
128957212|NCT02031432|464127578|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
128957213|NCT02031432|464127578|FG000|Overall Study|Adverse Event|8|||
128957214|NCT02031432|464127578|FG000|Overall Study|Withdrawal by Subject|5|||
128957215|NCT02031432|464127578|FG000|Overall Study|Lost to Follow-up|1|||
128957216|NCT02031432|464127578|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
128957217|NCT02031432|464127578|FG000|Overall Study|Death|10|||
128957218|NCT02293902|464127579|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
128957219|NCT02293902|464127580|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
128957220|NCT02293902|464127581|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
128957221|NCT02293902|464127582|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
128957222|NCT02293902|464127583|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
128957223|NCT02293902|464127579|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
128957224|NCT02293902|464127580|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
128957225|NCT02293902|464127581|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
128957226|NCT02293902|464127582|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
128957227|NCT02293902|464127583|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
128957228|NCT02293902|464127579|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
128957229|NCT02293902|464127580|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
128957230|NCT02293902|464127581|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
128957231|NCT02293902|464127582|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
128957232|NCT02293902|464127583|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
128957233|NCT02293902|464127579|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
128957234|NCT02293902|464127580|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
128957235|NCT02293902|464127581|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
128957236|NCT02293902|464127582|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
128957237|NCT02293902|464127583|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
128957238|NCT02293902|464127579|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
128957239|NCT02293902|464127580|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
128771015|NCT01231503|463453602|FG006|Overall Study|Lost to Follow-up|6|||
128771016|NCT01231503|463453603|FG007|Overall Study|Lost to Follow-up|6|||
128771017|NCT01231503|463453596|FG000|Overall Study|Protocol Violation|0|||
128771018|NCT01231503|463453597|FG001|Overall Study|Protocol Violation|0|||
128771019|NCT01231503|463453598|FG002|Overall Study|Protocol Violation|0|||
128771020|NCT01231503|463453599|FG003|Overall Study|Protocol Violation|1|||
128771021|NCT01231503|463453600|FG004|Overall Study|Protocol Violation|0|||
128771022|NCT01231503|463453601|FG005|Overall Study|Protocol Violation|0|||
128771023|NCT01231503|463453602|FG006|Overall Study|Protocol Violation|0|||
128771024|NCT01231503|463453603|FG007|Overall Study|Protocol Violation|0|||
128771025|NCT01586338|463453604|FG000|Overall Study|Adverse Event|3|||
128771026|NCT01586338|463453604|FG000|Overall Study|Lost to Follow-up|1|||
128771027|NCT01586338|463453604|FG000|Overall Study|Withdrawal by participant|3|||
128771028|NCT01586338|463453604|FG000|Overall Study|Other|1|||
128771029|NCT00284089|463453605|FG000|Multiple Dose Phase|Adverse Event|1|||
128771030|NCT00284089|463453606|FG001|Multiple Dose Phase|Adverse Event|0|||
128771031|NCT00284089|463453607|FG002|Multiple Dose Phase|Adverse Event|1|||
128771032|NCT00284089|463453608|FG003|Multiple Dose Phase|Adverse Event|1|||
128771033|NCT00284089|463453605|FG000|Multiple Dose Phase|Protocol Violation|0|||
128771034|NCT00284089|463453606|FG001|Multiple Dose Phase|Protocol Violation|0|||
128771035|NCT00284089|463453607|FG002|Multiple Dose Phase|Protocol Violation|1|||
128771036|NCT00284089|463453608|FG003|Multiple Dose Phase|Protocol Violation|0|||
128771037|NCT00284089|463453605|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
128771038|NCT00284089|463453606|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
128771039|NCT00284089|463453607|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
128771040|NCT00284089|463453608|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
128771041|NCT00284089|463453605|FG000|Multiple Dose Phase|Death|0|||
128957240|NCT02293902|464127581|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
128957241|NCT02293902|464127582|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
128957242|NCT02293902|464127583|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
128978109|NCT01854918|464205318|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
128771042|NCT00284089|463453606|FG001|Multiple Dose Phase|Death|0|||
128771043|NCT00284089|463453607|FG002|Multiple Dose Phase|Death|1|||
128771044|NCT00284089|463453608|FG003|Multiple Dose Phase|Death|1|||
128771045|NCT00284089|463453605|FG000|Extension Phase|Adverse Event|0|||
128771046|NCT00284089|463453606|FG001|Extension Phase|Adverse Event|0|||
128771047|NCT00284089|463453607|FG002|Extension Phase|Adverse Event|2|||
128978110|NCT01854918|464205317|FG000|SOC-controlled Period (Year 1)|Death|5|||
128978111|NCT01854918|464205318|FG001|SOC-controlled Period (Year 1)|Death|5|||
128978112|NCT01854918|464205317|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
128978113|NCT01854918|464205318|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
128978114|NCT01854918|464205317|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
128978115|NCT01854918|464205318|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
128978116|NCT01854918|464205317|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
128978117|NCT01854918|464205318|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
128978118|NCT01854918|464205317|FG000|All-IP Period (Years 2 and 3)|Death|5|||
128978119|NCT01854918|464205318|FG001|All-IP Period (Years 2 and 3)|Death|16|||
128978120|NCT02146352|464205319|FG000|Overall Study|Death|1|||
128978121|NCT02146352|464205319|FG000|Overall Study|Patient entered hospice care|1|||
128978122|NCT00939094|464205320|FG000|Overall Study|Adverse Event|9|||
128978123|NCT00939094|464205321|FG001|Overall Study|Adverse Event|0|||
128978124|NCT00939094|464205320|FG000|Overall Study|Withdrawal by Subject|1|||
128978125|NCT00939094|464205321|FG001|Overall Study|Withdrawal by Subject|6|||
128978126|NCT00939094|464205320|FG000|Overall Study|Lost to Follow-up|1|||
129036299|NCT00808509|464423461|FG000|Randomized Phase|Reduced methotrexate dose|1|||
129219684|NCT01358721|465104551|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
129219685|NCT01358721|465104552|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
129219686|NCT01358721|465104549|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
128771048|NCT00284089|463453608|FG003|Extension Phase|Adverse Event|2|||
128771049|NCT00284089|463453605|FG000|Extension Phase|condition no longer requires study drug|2|||
128771050|NCT00284089|463453606|FG001|Extension Phase|condition no longer requires study drug|0|||
128771051|NCT00284089|463453607|FG002|Extension Phase|condition no longer requires study drug|2|||
128771052|NCT00284089|463453608|FG003|Extension Phase|condition no longer requires study drug|7|||
128771053|NCT00284089|463453605|FG000|Extension Phase|Protocol Violation|0|||
128771054|NCT00284089|463453606|FG001|Extension Phase|Protocol Violation|0|||
128771055|NCT00284089|463453607|FG002|Extension Phase|Protocol Violation|1|||
129036300|NCT00808509|464423462|FG001|Randomized Phase|Reduced methotrexate dose|2|||
128978127|NCT00939094|464205321|FG001|Overall Study|Lost to Follow-up|1|||
128978128|NCT00939094|464205320|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
128978129|NCT00939094|464205321|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128978130|NCT00939094|464205320|FG000|Overall Study|Severe non-compliance to protocol|0|||
129219687|NCT01358721|465104550|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
128771056|NCT00284089|463453608|FG003|Extension Phase|Protocol Violation|0|||
128771057|NCT00284089|463453605|FG000|Extension Phase|Withdrawal by Subject|0|||
128771058|NCT00284089|463453606|FG001|Extension Phase|Withdrawal by Subject|0|||
129219688|NCT01358721|465104551|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
129219689|NCT01358721|465104552|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
129219690|NCT01358721|465104549|FG000|Overall Study|Adverse Event related to study drug|1|||
129219691|NCT01358721|465104550|FG001|Overall Study|Adverse Event related to study drug|0|||
129219692|NCT01358721|465104551|FG002|Overall Study|Adverse Event related to study drug|0|||
129219693|NCT01358721|465104552|FG003|Overall Study|Adverse Event related to study drug|1|||
129219694|NCT01358721|465104549|FG000|Overall Study|Disease Progression|19|||
129219695|NCT01358721|465104550|FG001|Overall Study|Disease Progression|15|||
129219696|NCT01358721|465104551|FG002|Overall Study|Disease Progression|17|||
129219697|NCT01358721|465104552|FG003|Overall Study|Disease Progression|15|||
129219698|NCT01358721|465104549|FG000|Overall Study|Out of State/Unmet Criteria|0|||
129219699|NCT01358721|465104550|FG001|Overall Study|Out of State/Unmet Criteria|0|||
129219700|NCT01358721|465104551|FG002|Overall Study|Out of State/Unmet Criteria|1|||
129219701|NCT01358721|465104552|FG003|Overall Study|Out of State/Unmet Criteria|0|||
129219702|NCT01908803|465104553|FG000|Overall Study|Adverse Event|1|||
129219703|NCT01908803|465104554|FG001|Overall Study|Adverse Event|0|||
129219704|NCT01908803|465104553|FG000|Overall Study|Physician Decision|0|||
129219705|NCT01908803|465104554|FG001|Overall Study|Physician Decision|1|||
129219706|NCT01908803|465104553|FG000|Overall Study|Withdrawal by Subject|1|||
129219707|NCT01908803|465104554|FG001|Overall Study|Withdrawal by Subject|0|||
129219708|NCT01908803|465104553|FG000|Overall Study|Randomization Error|1|||
129219709|NCT01908803|465104554|FG001|Overall Study|Randomization Error|0|||
129219710|NCT01908803|465104553|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
129219711|NCT01908803|465104554|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
129219712|NCT00867815|465104555|FG000|Overall Study|Lost to Follow-up|1|||
129219713|NCT00001213|465104556|FG000|Overall Study|Death|18|||
129219714|NCT01554241|465104557|FG000|Overall Study|Death|3|||
129219715|NCT01554241|465104558|FG001|Overall Study|Death|1|||
129219716|NCT01554241|465104559|FG002|Overall Study|Death|1|||
129219717|NCT01554241|465104560|FG003|Overall Study|Death|0|||
129219718|NCT01554241|465104557|FG000|Overall Study|protocol specified renal stone|0|||
129219719|NCT01554241|465104558|FG001|Overall Study|protocol specified renal stone|0|||
129219720|NCT01554241|465104559|FG002|Overall Study|protocol specified renal stone|0|||
129219721|NCT01554241|465104560|FG003|Overall Study|protocol specified renal stone|1|||
129219722|NCT01554241|465104557|FG000|Overall Study|protocol specified change in eGFR|0|||
129219723|NCT01554241|465104558|FG001|Overall Study|protocol specified change in eGFR|0|||
129219724|NCT01554241|465104559|FG002|Overall Study|protocol specified change in eGFR|1|||
129219725|NCT01554241|465104560|FG003|Overall Study|protocol specified change in eGFR|0|||
129219726|NCT01554241|465104557|FG000|Overall Study|Withdrawal by Subject|0|||
129219727|NCT01554241|465104558|FG001|Overall Study|Withdrawal by Subject|0|||
128712372|NCT02659631|463243839|FG006|Overall Study|Death (follow-up phase)|0|||
128712373|NCT02659631|463243840|FG007|Overall Study|Death (follow-up phase)|3|||
128712374|NCT02659631|463243841|FG008|Overall Study|Death (follow-up phase)|1|||
128712375|NCT02659631|463243842|FG009|Overall Study|Death (follow-up phase)|0|||
128712376|NCT02659631|463243833|FG000|Overall Study|Death (treatment phase)|0|||
128712377|NCT02659631|463243834|FG001|Overall Study|Death (treatment phase)|0|||
128712378|NCT02659631|463243835|FG002|Overall Study|Death (treatment phase)|0|||
128712379|NCT02659631|463243836|FG003|Overall Study|Death (treatment phase)|0|||
128712380|NCT02659631|463243837|FG004|Overall Study|Death (treatment phase)|1|||
128712381|NCT02659631|463243838|FG005|Overall Study|Death (treatment phase)|0|||
128712382|NCT02659631|463243839|FG006|Overall Study|Death (treatment phase)|1|||
128712383|NCT02659631|463243840|FG007|Overall Study|Death (treatment phase)|0|||
128712384|NCT02659631|463243841|FG008|Overall Study|Death (treatment phase)|0|||
128712385|NCT02659631|463243842|FG009|Overall Study|Death (treatment phase)|0|||
128712386|NCT02377466|463243843|FG000|Overall Study|Other: Randomized and not treated|0|||
128712387|NCT02377466|463243844|FG001|Overall Study|Other: Randomized and not treated|2|||
128712388|NCT00495170|463243845|FG000|Overall Study|Lost to Follow-up|9|||
128712389|NCT00495170|463243845|FG000|Overall Study|Withdrawal by Subject|3|||
128712390|NCT00495170|463243845|FG000|Overall Study|Inappropriate staging|8|||
128712391|NCT04210310|463243846|FG000|Overall Study|Lost to Follow-up|32|||
128712392|NCT04210310|463243847|FG001|Overall Study|Lost to Follow-up|1|||
128712393|NCT00993291|463243853|FG000|Overall Study|Withdrawal by Subject|1|||
128712394|NCT02763189|463243858|FG000|Overall Study|Device failure|0|||
128712395|NCT02763189|463243859|FG001|Overall Study|Device failure|2|||
128712396|NCT02049957|463243864|FG000|Overall Study|Progressive Disease|5|||
128712397|NCT02049957|463243865|FG001|Overall Study|Progressive Disease|4|||
128712398|NCT02049957|463243866|FG002|Overall Study|Progressive Disease|2|||
128712399|NCT02049957|463243867|FG003|Overall Study|Progressive Disease|2|||
128712400|NCT02049957|463243868|FG004|Overall Study|Progressive Disease|6|||
129219728|NCT01554241|465104559|FG002|Overall Study|Withdrawal by Subject|2|||
129219729|NCT01554241|465104560|FG003|Overall Study|Withdrawal by Subject|0|||
129219730|NCT00372593|465104567|FG000|Overall Study|Adverse Event|43|||
129219731|NCT00372593|465104568|FG001|Overall Study|Adverse Event|45|||
129219732|NCT00372593|465104569|FG002|Overall Study|Adverse Event|0|||
129219733|NCT00372593|465104567|FG000|Overall Study|Death|16|||
129219734|NCT00372593|465104568|FG001|Overall Study|Death|20|||
129219735|NCT00372593|465104569|FG002|Overall Study|Death|1|||
128712401|NCT02049957|463243869|FG005|Overall Study|Progressive Disease|35|||
128771059|NCT00284089|463453607|FG002|Extension Phase|Withdrawal by Subject|1|||
128771060|NCT00284089|463453608|FG003|Extension Phase|Withdrawal by Subject|3|||
128771061|NCT01146574|463453611|FG000|Overall Study|Death|0|||
128771062|NCT01146574|463453612|FG001|Overall Study|Death|1|||
128771063|NCT01146574|463453613|FG002|Overall Study|Death|1|||
128771064|NCT01146574|463453614|FG003|Overall Study|Death|0|||
128771065|NCT01146574|463453615|FG004|Overall Study|Death|0|||
128771066|NCT01146574|463453616|FG005|Overall Study|Death|0|||
128771067|NCT01146574|463453617|FG006|Overall Study|Death|0|||
128771068|NCT01146574|463453611|FG000|Overall Study|Other reasons|0|||
128771069|NCT01146574|463453612|FG001|Overall Study|Other reasons|0|||
128771070|NCT01146574|463453613|FG002|Overall Study|Other reasons|3|||
128771071|NCT01146574|463453614|FG003|Overall Study|Other reasons|0|||
128957243|NCT03351478|464129671|FG000|Overall Study|At the subject's own request|11|||
128957244|NCT03351478|464129672|FG001|Overall Study|At the subject's own request|12|||
128957245|NCT03351478|464129673|FG002|Overall Study|At the subject's own request|5|||
128957246|NCT03351478|464129671|FG000|Overall Study|Adverse Event|1|||
128957247|NCT03351478|464129672|FG001|Overall Study|Adverse Event|2|||
128957248|NCT03351478|464129673|FG002|Overall Study|Adverse Event|1|||
129219736|NCT00372593|465104567|FG000|Overall Study|Lack of Efficacy|82|||
128712402|NCT02049957|463243870|FG006|Overall Study|Progressive Disease|7|||
128712403|NCT02049957|463243871|FG007|Overall Study|Progressive Disease|26|||
128712404|NCT02049957|463243872|FG008|Overall Study|Progressive Disease|6|||
128712405|NCT02049957|463243864|FG000|Overall Study|Adverse Event|1|||
128712406|NCT02049957|463243865|FG001|Overall Study|Adverse Event|1|||
128712407|NCT02049957|463243866|FG002|Overall Study|Adverse Event|1|||
128712408|NCT02049957|463243867|FG003|Overall Study|Adverse Event|0|||
128712409|NCT02049957|463243868|FG004|Overall Study|Adverse Event|0|||
128712410|NCT02049957|463243869|FG005|Overall Study|Adverse Event|5|||
128712411|NCT02049957|463243870|FG006|Overall Study|Adverse Event|0|||
128712412|NCT02049957|463243871|FG007|Overall Study|Adverse Event|6|||
128712413|NCT02049957|463243872|FG008|Overall Study|Adverse Event|1|||
128712414|NCT02049957|463243864|FG000|Overall Study|Study Terminated by Sponsor|0|||
128712415|NCT02049957|463243865|FG001|Overall Study|Study Terminated by Sponsor|1|||
128712416|NCT02049957|463243866|FG002|Overall Study|Study Terminated by Sponsor|0|||
128712417|NCT02049957|463243867|FG003|Overall Study|Study Terminated by Sponsor|0|||
128712418|NCT02049957|463243868|FG004|Overall Study|Study Terminated by Sponsor|0|||
128712419|NCT02049957|463243869|FG005|Overall Study|Study Terminated by Sponsor|0|||
128712420|NCT02049957|463243870|FG006|Overall Study|Study Terminated by Sponsor|1|||
128712421|NCT02049957|463243871|FG007|Overall Study|Study Terminated by Sponsor|0|||
128712422|NCT02049957|463243872|FG008|Overall Study|Study Terminated by Sponsor|0|||
128712423|NCT02049957|463243864|FG000|Overall Study|Withdrawal by Subject|0|||
128712424|NCT02049957|463243865|FG001|Overall Study|Withdrawal by Subject|0|||
128712425|NCT02049957|463243866|FG002|Overall Study|Withdrawal by Subject|0|||
128712426|NCT02049957|463243867|FG003|Overall Study|Withdrawal by Subject|1|||
128712427|NCT02049957|463243868|FG004|Overall Study|Withdrawal by Subject|0|||
128712428|NCT02049957|463243869|FG005|Overall Study|Withdrawal by Subject|2|||
128712429|NCT02049957|463243870|FG006|Overall Study|Withdrawal by Subject|0|||
128712430|NCT02049957|463243871|FG007|Overall Study|Withdrawal by Subject|3|||
128712431|NCT02049957|463243872|FG008|Overall Study|Withdrawal by Subject|1|||
128712432|NCT02049957|463243864|FG000|Overall Study|Physician Decision|0|||
128712433|NCT02049957|463243865|FG001|Overall Study|Physician Decision|0|||
128712434|NCT02049957|463243866|FG002|Overall Study|Physician Decision|0|||
128712435|NCT02049957|463243867|FG003|Overall Study|Physician Decision|0|||
128712436|NCT02049957|463243868|FG004|Overall Study|Physician Decision|0|||
128712437|NCT02049957|463243869|FG005|Overall Study|Physician Decision|1|||
128712438|NCT02049957|463243870|FG006|Overall Study|Physician Decision|0|||
128712439|NCT02049957|463243871|FG007|Overall Study|Physician Decision|0|||
128712440|NCT02049957|463243872|FG008|Overall Study|Physician Decision|0|||
128712441|NCT00467259|463243877|FG000|Overall Study|Adverse Event|24|||
128712442|NCT00467259|463243878|FG001|Overall Study|Adverse Event|90|||
128712443|NCT00467259|463243877|FG000|Overall Study|Protocol Violation|1|||
128712444|NCT00467259|463243878|FG001|Overall Study|Protocol Violation|7|||
128712445|NCT00467259|463243877|FG000|Overall Study|Withdrawal by Subject|34|||
128771072|NCT01146574|463453615|FG004|Overall Study|Other reasons|0|||
129219737|NCT00372593|465104568|FG001|Overall Study|Lack of Efficacy|71|||
128712446|NCT00467259|463243878|FG001|Overall Study|Withdrawal by Subject|108|||
128712447|NCT00467259|463243877|FG000|Overall Study|Physician Decision|0|||
128712448|NCT00467259|463243878|FG001|Overall Study|Physician Decision|2|||
128712449|NCT00467259|463243877|FG000|Overall Study|Lost to Follow-up|14|||
128712450|NCT00467259|463243878|FG001|Overall Study|Lost to Follow-up|34|||
128712451|NCT00467259|463243877|FG000|Overall Study|Site Closed|2|||
128712452|NCT00467259|463243878|FG001|Overall Study|Site Closed|1|||
128957249|NCT03351478|464129671|FG000|Overall Study|Poor compliance to protocol|1|||
128712453|NCT01129960|463243886|FG000|Overall Study|Withdrawal by Subject|3|||
128771073|NCT01146574|463453616|FG005|Overall Study|Other reasons|0|||
128771074|NCT01146574|463453617|FG006|Overall Study|Other reasons|0|||
128957250|NCT03351478|464129672|FG001|Overall Study|Poor compliance to protocol|0|||
128771075|NCT01146574|463453611|FG000|Overall Study|Kidney transplant|0|||
128771076|NCT01146574|463453612|FG001|Overall Study|Kidney transplant|0|||
128771077|NCT01146574|463453613|FG002|Overall Study|Kidney transplant|1|||
128957251|NCT03351478|464129673|FG002|Overall Study|Poor compliance to protocol|0|||
128957252|NCT03351478|464129671|FG000|Overall Study|Reason not Specified|1|||
128771078|NCT01146574|463453614|FG003|Overall Study|Kidney transplant|1|||
128771079|NCT01146574|463453615|FG004|Overall Study|Kidney transplant|0|||
128957253|NCT03351478|464129672|FG001|Overall Study|Reason not Specified|3|||
128957254|NCT03351478|464129673|FG002|Overall Study|Reason not Specified|0|||
128957255|NCT03351478|464129671|FG000|Overall Study|Lost to Follow-up|0|||
128957256|NCT03351478|464129672|FG001|Overall Study|Lost to Follow-up|0|||
128957257|NCT03351478|464129673|FG002|Overall Study|Lost to Follow-up|1|||
128957258|NCT00510484|464129675|FG000|Wash-out Period|Adverse Event|0|||
128771080|NCT01146574|463453616|FG005|Overall Study|Kidney transplant|0|||
128771081|NCT01146574|463453617|FG006|Overall Study|Kidney transplant|0|||
128771082|NCT01146574|463453611|FG000|Overall Study|Withdrew consent|0|||
128771083|NCT01146574|463453612|FG001|Overall Study|Withdrew consent|0|||
128771084|NCT01146574|463453613|FG002|Overall Study|Withdrew consent|1|||
128771085|NCT01146574|463453614|FG003|Overall Study|Withdrew consent|1|||
128771086|NCT01146574|463453615|FG004|Overall Study|Withdrew consent|2|||
128771087|NCT01146574|463453616|FG005|Overall Study|Withdrew consent|1|||
128771088|NCT01146574|463453617|FG006|Overall Study|Withdrew consent|1|||
128771089|NCT03051659|463453618|FG000|Treatment Period|Withdrawal by Subject|0|||
128771090|NCT03051659|463453619|FG001|Treatment Period|Withdrawal by Subject|2|||
128957259|NCT00510484|464129676|FG001|Wash-out Period|Adverse Event|1|||
128957260|NCT00762268|464129679|FG000|Overall Study|Withdrawal by Subject|3|||
128771091|NCT03051659|463453618|FG000|Survival Follow-up|Lost to Follow-up|23|||
128771092|NCT03051659|463453619|FG001|Survival Follow-up|Lost to Follow-up|22|||
128771093|NCT01076088|463453620|FG000|Overall Study|Adverse Event|1|||
128771094|NCT01076088|463453621|FG001|Overall Study|Adverse Event|6|||
128771095|NCT01076088|463453622|FG002|Overall Study|Adverse Event|3|||
128771096|NCT01076088|463453623|FG003|Overall Study|Adverse Event|2|||
128771097|NCT01076088|463453624|FG004|Overall Study|Adverse Event|3|||
128771098|NCT01076088|463453625|FG005|Overall Study|Adverse Event|3|||
128771099|NCT01076088|463453620|FG000|Overall Study|Lost to Follow-up|1|||
128771100|NCT01076088|463453621|FG001|Overall Study|Lost to Follow-up|1|||
128771101|NCT01076088|463453622|FG002|Overall Study|Lost to Follow-up|0|||
128771102|NCT01076088|463453623|FG003|Overall Study|Lost to Follow-up|1|||
128771103|NCT01076088|463453624|FG004|Overall Study|Lost to Follow-up|1|||
128771104|NCT01076088|463453625|FG005|Overall Study|Lost to Follow-up|2|||
128957261|NCT00762268|464129680|FG001|Overall Study|Withdrawal by Subject|3|||
128957262|NCT02533401|464129681|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
128957263|NCT02533401|464129681|FG000|Overall Study|Death|5|||
128957264|NCT02533401|464129681|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
128957265|NCT02533401|464129681|FG000|Overall Study|Lost to Follow-up|1|||
128957266|NCT02533401|464129681|FG000|Overall Study|Violation of Selection Criteria|1|||
128957267|NCT01438307|464129687|FG000|Overall Study|Death|1|||
128957268|NCT01438307|464129688|FG001|Overall Study|Death|1|||
128957269|NCT00973622|464129690|FG000|Overall Study|did not attend MRI|14|||
128957270|NCT00973622|464129691|FG001|Overall Study|did not attend MRI|3|||
128957271|NCT00973622|464129690|FG000|Overall Study|did not pass MRI screen|6|||
128957272|NCT00973622|464129691|FG001|Overall Study|did not pass MRI screen|0|||
128957273|NCT00973622|464129690|FG000|Overall Study|did not complete rTMS sessions|11|||
128957274|NCT00973622|464129691|FG001|Overall Study|did not complete rTMS sessions|2|||
128957275|NCT03814005|464129695|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
128957276|NCT03814005|464129696|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
128957277|NCT03814005|464129697|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
128957278|NCT03814005|464129695|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
128957279|NCT03814005|464129696|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
129219738|NCT00372593|465104569|FG002|Overall Study|Lack of Efficacy|2|||
128771105|NCT01076088|463453620|FG000|Overall Study|Non-compliance with study drug|0|||
128771106|NCT01076088|463453621|FG001|Overall Study|Non-compliance with study drug|0|||
128957280|NCT03814005|464129697|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
128957281|NCT03814005|464129695|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
128957282|NCT03814005|464129696|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
128957283|NCT03814005|464129697|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
128957284|NCT03814005|464129695|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
128957285|NCT03814005|464129696|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
128957286|NCT03814005|464129697|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
128957287|NCT03814005|464129695|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
128957288|NCT03814005|464129696|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
128771107|NCT01076088|463453622|FG002|Overall Study|Non-compliance with study drug|0|||
128771108|NCT01076088|463453623|FG003|Overall Study|Non-compliance with study drug|1|||
128957289|NCT03814005|464129697|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
128957290|NCT03814005|464129695|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
128957291|NCT03814005|464129696|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
128712454|NCT01129960|463243887|FG001|Overall Study|Withdrawal by Subject|0|||
128712455|NCT01129960|463243888|FG002|Overall Study|Withdrawal by Subject|3|||
128712456|NCT01129960|463243889|FG003|Overall Study|Withdrawal by Subject|2|||
128957292|NCT03814005|464129697|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
128957293|NCT03395223|464129698|FG000|Overall Study|Lost to Follow-up|3|||
128957294|NCT03395223|464129698|FG000|Overall Study|Other|1|||
128957295|NCT01855945|464129704|FG000|Overall Study|Adverse Event|0|||
128957296|NCT01855945|464129705|FG001|Overall Study|Adverse Event|0|||
128957297|NCT01855945|464129706|FG002|Overall Study|Adverse Event|0|||
128957298|NCT01855945|464129707|FG003|Overall Study|Adverse Event|0|||
128957299|NCT01855945|464129708|FG004|Overall Study|Adverse Event|0|||
128957300|NCT01855945|464129709|FG005|Overall Study|Adverse Event|0|||
128957301|NCT01855945|464129710|FG006|Overall Study|Adverse Event|1|||
128957302|NCT01855945|464129711|FG007|Overall Study|Adverse Event|0|||
128957303|NCT01855945|464129712|FG008|Overall Study|Adverse Event|0|||
128957304|NCT01855945|464129713|FG009|Overall Study|Adverse Event|0|||
128957305|NCT01855945|464129714|FG010|Overall Study|Adverse Event|0|||
128957306|NCT01855945|464129715|FG011|Overall Study|Adverse Event|0|||
128957307|NCT01855945|464129704|FG000|Overall Study|Death|0|||
128957308|NCT01855945|464129705|FG001|Overall Study|Death|0|||
128957309|NCT01855945|464129706|FG002|Overall Study|Death|0|||
128957310|NCT01855945|464129707|FG003|Overall Study|Death|0|||
128957311|NCT01855945|464129708|FG004|Overall Study|Death|0|||
128957312|NCT01855945|464129709|FG005|Overall Study|Death|0|||
128957313|NCT01855945|464129710|FG006|Overall Study|Death|2|||
128957314|NCT01855945|464129711|FG007|Overall Study|Death|0|||
128957315|NCT01855945|464129712|FG008|Overall Study|Death|0|||
128957316|NCT01855945|464129713|FG009|Overall Study|Death|0|||
128957317|NCT01855945|464129714|FG010|Overall Study|Death|0|||
128957318|NCT01855945|464129715|FG011|Overall Study|Death|0|||
128957319|NCT01855945|464129704|FG000|Overall Study|Lost to Follow-up|11|||
128957320|NCT01855945|464129705|FG001|Overall Study|Lost to Follow-up|10|||
128957321|NCT01855945|464129706|FG002|Overall Study|Lost to Follow-up|7|||
128957322|NCT01855945|464129707|FG003|Overall Study|Lost to Follow-up|3|||
128957323|NCT01855945|464129708|FG004|Overall Study|Lost to Follow-up|0|||
128957324|NCT01855945|464129709|FG005|Overall Study|Lost to Follow-up|3|||
128957325|NCT01855945|464129710|FG006|Overall Study|Lost to Follow-up|4|||
129126541|NCT02903914|464757979|FG003|Overall Study|Symptomatic Deterioration|0|||
129126542|NCT02903914|464757980|FG004|Overall Study|Symptomatic Deterioration|0|||
129126543|NCT02903914|464757981|FG005|Overall Study|Symptomatic Deterioration|0|||
129126544|NCT02903914|464757982|FG006|Overall Study|Symptomatic Deterioration|0|||
129126545|NCT02903914|464757983|FG007|Overall Study|Symptomatic Deterioration|0|||
129126546|NCT02903914|464757976|FG000|Overall Study|New Cancer Therapy|2|||
129126547|NCT02903914|464757977|FG001|Overall Study|New Cancer Therapy|2|||
129126548|NCT02903914|464757978|FG002|Overall Study|New Cancer Therapy|21|||
129126549|NCT02903914|464757979|FG003|Overall Study|New Cancer Therapy|4|||
129126550|NCT02903914|464757980|FG004|Overall Study|New Cancer Therapy|3|||
129126551|NCT02903914|464757981|FG005|Overall Study|New Cancer Therapy|6|||
129126552|NCT02903914|464757982|FG006|Overall Study|New Cancer Therapy|56|||
129126553|NCT02903914|464757983|FG007|Overall Study|New Cancer Therapy|3|||
129126554|NCT02903914|464757976|FG000|Overall Study|Didn't Return to Site|1|||
129126555|NCT02903914|464757977|FG001|Overall Study|Didn't Return to Site|0|||
129126556|NCT02903914|464757978|FG002|Overall Study|Didn't Return to Site|1|||
129126557|NCT02903914|464757979|FG003|Overall Study|Didn't Return to Site|1|||
129126558|NCT02903914|464757980|FG004|Overall Study|Didn't Return to Site|0|||
129126559|NCT02903914|464757981|FG005|Overall Study|Didn't Return to Site|0|||
129126560|NCT02903914|464757982|FG006|Overall Study|Didn't Return to Site|2|||
129126561|NCT02903914|464757983|FG007|Overall Study|Didn't Return to Site|0|||
129126562|NCT02903914|464757976|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
129126563|NCT02903914|464757977|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
128712457|NCT01129960|463243886|FG000|Overall Study|Lack of Efficacy|1|||
129219739|NCT00372593|465104567|FG000|Overall Study|Lost to Follow-up|1|||
128712458|NCT01129960|463243887|FG001|Overall Study|Lack of Efficacy|1|||
128957326|NCT01855945|464129711|FG007|Overall Study|Lost to Follow-up|7|||
128957327|NCT01855945|464129712|FG008|Overall Study|Lost to Follow-up|2|||
128957328|NCT01855945|464129713|FG009|Overall Study|Lost to Follow-up|0|||
128957329|NCT01855945|464129714|FG010|Overall Study|Lost to Follow-up|0|||
128957330|NCT01855945|464129715|FG011|Overall Study|Lost to Follow-up|2|||
128957331|NCT01855945|464129704|FG000|Overall Study|Other - Unclassified|1|||
128957332|NCT01855945|464129705|FG001|Overall Study|Other - Unclassified|1|||
128957333|NCT01855945|464129706|FG002|Overall Study|Other - Unclassified|1|||
128957334|NCT01855945|464129707|FG003|Overall Study|Other - Unclassified|0|||
128957335|NCT01855945|464129708|FG004|Overall Study|Other - Unclassified|0|||
128957336|NCT01855945|464129709|FG005|Overall Study|Other - Unclassified|0|||
128957337|NCT01855945|464129710|FG006|Overall Study|Other - Unclassified|2|||
128957338|NCT01855945|464129711|FG007|Overall Study|Other - Unclassified|1|||
128957339|NCT01855945|464129712|FG008|Overall Study|Other - Unclassified|0|||
128712459|NCT01129960|463243888|FG002|Overall Study|Lack of Efficacy|1|||
128957340|NCT01855945|464129713|FG009|Overall Study|Other - Unclassified|0|||
128957341|NCT01855945|464129714|FG010|Overall Study|Other - Unclassified|1|||
128957342|NCT01855945|464129715|FG011|Overall Study|Other - Unclassified|0|||
128957343|NCT01855945|464129704|FG000|Overall Study|Withdrawal by Subject|4|||
128957344|NCT01855945|464129705|FG001|Overall Study|Withdrawal by Subject|0|||
128957345|NCT01855945|464129706|FG002|Overall Study|Withdrawal by Subject|4|||
128957346|NCT01855945|464129707|FG003|Overall Study|Withdrawal by Subject|1|||
128957347|NCT01855945|464129708|FG004|Overall Study|Withdrawal by Subject|1|||
128957348|NCT01855945|464129709|FG005|Overall Study|Withdrawal by Subject|0|||
128957349|NCT01855945|464129710|FG006|Overall Study|Withdrawal by Subject|1|||
128957350|NCT01855945|464129711|FG007|Overall Study|Withdrawal by Subject|0|||
128957351|NCT01855945|464129712|FG008|Overall Study|Withdrawal by Subject|0|||
128957352|NCT01855945|464129713|FG009|Overall Study|Withdrawal by Subject|2|||
128957353|NCT01855945|464129714|FG010|Overall Study|Withdrawal by Subject|4|||
128957354|NCT01855945|464129715|FG011|Overall Study|Withdrawal by Subject|1|||
128957355|NCT01148693|464129716|FG000|Overall Study|Attempts for cannulation were failed|13|||
128957356|NCT01148693|464129717|FG001|Overall Study|Attempts for cannulation were failed|10|||
128957357|NCT01135017|464129718|FG000|Overall Study|Adverse Event|3|||
128957358|NCT01135017|464129719|FG001|Overall Study|Adverse Event|8|||
128957359|NCT01135017|464129718|FG000|Overall Study|Other than above|3|||
128957360|NCT01135017|464129719|FG001|Overall Study|Other than above|4|||
128957361|NCT01074658|464129721|FG000|Overall Study|No implant attempted|19|||
128957362|NCT01342952|464129722|FG000|Overall Study|Adverse Event|0|||
128957363|NCT01342952|464129723|FG001|Overall Study|Adverse Event|5|||
128957364|NCT01342952|464129724|FG002|Overall Study|Adverse Event|1|||
128957365|NCT01342952|464129725|FG003|Overall Study|Adverse Event|0|||
128957366|NCT01342952|464129722|FG000|Overall Study|Lost to Follow-up|0|||
128957367|NCT01342952|464129723|FG001|Overall Study|Lost to Follow-up|2|||
128957368|NCT01342952|464129724|FG002|Overall Study|Lost to Follow-up|0|||
128957369|NCT01342952|464129725|FG003|Overall Study|Lost to Follow-up|0|||
128957370|NCT01342952|464129722|FG000|Overall Study|Withdrawal by Subject|1|||
128957371|NCT01342952|464129723|FG001|Overall Study|Withdrawal by Subject|1|||
128957372|NCT01342952|464129724|FG002|Overall Study|Withdrawal by Subject|0|||
128957373|NCT01342952|464129725|FG003|Overall Study|Withdrawal by Subject|0|||
128957374|NCT01342952|464129722|FG000|Overall Study|Physician Decision|3|||
128957375|NCT01342952|464129723|FG001|Overall Study|Physician Decision|3|||
128957376|NCT01342952|464129724|FG002|Overall Study|Physician Decision|1|||
128957377|NCT01342952|464129725|FG003|Overall Study|Physician Decision|0|||
128957378|NCT02156804|464129726|FG000|Overall Study|Withdrawal by Subject|1|||
128957379|NCT03228394|464129727|FG000|Overall Study|Lost to Follow-up|0|||
128957380|NCT03228394|464129728|FG001|Overall Study|Lost to Follow-up|0|||
128957381|NCT03228394|464129729|FG002|Overall Study|Lost to Follow-up|1|||
128957382|NCT03228394|464129730|FG003|Overall Study|Lost to Follow-up|1|||
128957383|NCT03228394|464129731|FG004|Overall Study|Lost to Follow-up|0|||
128957384|NCT03228394|464129732|FG005|Overall Study|Lost to Follow-up|0|||
128957385|NCT03228394|464129733|FG006|Overall Study|Lost to Follow-up|2|||
128957386|NCT03228394|464129734|FG007|Overall Study|Lost to Follow-up|0|||
128957387|NCT03228394|464129727|FG000|Overall Study|Withdrawal by Subject|0|||
128957388|NCT03228394|464129728|FG001|Overall Study|Withdrawal by Subject|0|||
128957389|NCT03228394|464129729|FG002|Overall Study|Withdrawal by Subject|1|||
128957390|NCT03228394|464129730|FG003|Overall Study|Withdrawal by Subject|0|||
128957391|NCT03228394|464129731|FG004|Overall Study|Withdrawal by Subject|0|||
128957392|NCT03228394|464129732|FG005|Overall Study|Withdrawal by Subject|0|||
128957393|NCT03228394|464129733|FG006|Overall Study|Withdrawal by Subject|1|||
128957394|NCT03228394|464129734|FG007|Overall Study|Withdrawal by Subject|3|||
128957395|NCT03228394|464129727|FG000|Overall Study|Protocol Violation|0|||
128957396|NCT03228394|464129728|FG001|Overall Study|Protocol Violation|0|||
128957397|NCT03228394|464129729|FG002|Overall Study|Protocol Violation|0|||
128957398|NCT03228394|464129730|FG003|Overall Study|Protocol Violation|1|||
128957399|NCT03228394|464129731|FG004|Overall Study|Protocol Violation|0|||
128957400|NCT03228394|464129732|FG005|Overall Study|Protocol Violation|0|||
128957401|NCT03228394|464129733|FG006|Overall Study|Protocol Violation|0|||
128957402|NCT03228394|464129734|FG007|Overall Study|Protocol Violation|0|||
128957403|NCT03228394|464129727|FG000|Overall Study|Physician Decision|0|||
128957404|NCT03228394|464129728|FG001|Overall Study|Physician Decision|0|||
128957405|NCT03228394|464129729|FG002|Overall Study|Physician Decision|0|||
128957406|NCT03228394|464129730|FG003|Overall Study|Physician Decision|0|||
128957407|NCT03228394|464129731|FG004|Overall Study|Physician Decision|0|||
129036301|NCT00808509|464423461|FG000|Randomized Phase|Patient refused rescue therapy|0|||
129036302|NCT00808509|464423462|FG001|Randomized Phase|Patient refused rescue therapy|3|||
129036303|NCT02169791|464423463|FG000|Overall Study|Death|6|||
129036304|NCT02169791|464423463|FG000|Overall Study|patient withdrew consent|1|||
129036305|NCT02762994|464423466|FG000|Overall Study|Withdrawal by Subject|0|||
129036306|NCT02762994|464423467|FG001|Overall Study|Withdrawal by Subject|1|||
129036307|NCT02762994|464423468|FG002|Overall Study|Withdrawal by Subject|2|||
129036308|NCT02762994|464423469|FG003|Overall Study|Withdrawal by Subject|0|||
129036309|NCT02762994|464423466|FG000|Overall Study|Protocol Violation|1|||
129036310|NCT02762994|464423467|FG001|Overall Study|Protocol Violation|0|||
129036311|NCT02762994|464423468|FG002|Overall Study|Protocol Violation|0|||
129036312|NCT02762994|464423469|FG003|Overall Study|Protocol Violation|2|||
128957408|NCT03228394|464129732|FG005|Overall Study|Physician Decision|0|||
128957409|NCT03228394|464129733|FG006|Overall Study|Physician Decision|1|||
128957410|NCT03228394|464129734|FG007|Overall Study|Physician Decision|0|||
128957411|NCT03228394|464129727|FG000|Overall Study|Noncompliance|0|||
128771109|NCT01076088|463453624|FG004|Overall Study|Non-compliance with study drug|0|||
128771110|NCT01076088|463453625|FG005|Overall Study|Non-compliance with study drug|0|||
128771111|NCT01076088|463453620|FG000|Overall Study|Physician Decision|1|||
128771112|NCT01076088|463453621|FG001|Overall Study|Physician Decision|3|||
128771113|NCT01076088|463453622|FG002|Overall Study|Physician Decision|0|||
128771114|NCT01076088|463453623|FG003|Overall Study|Physician Decision|1|||
128771115|NCT01076088|463453624|FG004|Overall Study|Physician Decision|1|||
128771116|NCT01076088|463453625|FG005|Overall Study|Physician Decision|0|||
128771117|NCT01076088|463453620|FG000|Overall Study|Withdrawal by Subject|8|||
128771118|NCT01076088|463453621|FG001|Overall Study|Withdrawal by Subject|8|||
128771119|NCT01076088|463453622|FG002|Overall Study|Withdrawal by Subject|14|||
128771120|NCT01076088|463453623|FG003|Overall Study|Withdrawal by Subject|10|||
128771121|NCT01076088|463453624|FG004|Overall Study|Withdrawal by Subject|11|||
128771122|NCT01076088|463453625|FG005|Overall Study|Withdrawal by Subject|17|||
128771123|NCT01076088|463453620|FG000|Overall Study|Other protocol specified criteria|0|||
128771124|NCT01076088|463453621|FG001|Overall Study|Other protocol specified criteria|0|||
128771125|NCT01076088|463453622|FG002|Overall Study|Other protocol specified criteria|0|||
128771126|NCT01076088|463453623|FG003|Overall Study|Other protocol specified criteria|0|||
128771127|NCT01076088|463453624|FG004|Overall Study|Other protocol specified criteria|0|||
128771128|NCT01076088|463453625|FG005|Overall Study|Other protocol specified criteria|1|||
128771129|NCT00786474|463453626|FG000|Overall Study|Death|5|||
128771130|NCT00786474|463453627|FG001|Overall Study|Death|4|||
128771131|NCT00786474|463453626|FG000|Overall Study|Withdrawal by Subject|23|||
128771132|NCT00786474|463453627|FG001|Overall Study|Withdrawal by Subject|31|||
128771133|NCT00786474|463453626|FG000|Overall Study|Lost to Follow-up|3|||
128771134|NCT00786474|463453627|FG001|Overall Study|Lost to Follow-up|3|||
128771135|NCT00786474|463453626|FG000|Overall Study|Physician Decision|2|||
128771136|NCT00786474|463453627|FG001|Overall Study|Physician Decision|1|||
128771137|NCT00786474|463453626|FG000|Overall Study|Other|4|||
128771138|NCT00786474|463453627|FG001|Overall Study|Other|4|||
128771139|NCT03053492|463453628|FG000|Overall Study|Adverse Event|1|||
128771140|NCT03053492|463453629|FG001|Overall Study|Adverse Event|1|||
128771141|NCT03053492|463453628|FG000|Overall Study|Withdrawal by Subject|7|||
128771142|NCT03053492|463453629|FG001|Overall Study|Withdrawal by Subject|5|||
128771143|NCT01868074|463453630|FG000|Overall Study|Lost to Follow-up|3|||
128771144|NCT01868074|463453631|FG001|Overall Study|Lost to Follow-up|2|||
128771145|NCT01868074|463453630|FG000|Overall Study|Withdrawal by Subject|4|||
128771146|NCT01868074|463453631|FG001|Overall Study|Withdrawal by Subject|2|||
128771147|NCT01544491|463453632|FG000|Overall Study|Withdrawal by Subject|3|||
128771148|NCT01544491|463453633|FG001|Overall Study|Withdrawal by Subject|2|||
128771149|NCT01544491|463453632|FG000|Overall Study|Lost to Follow-up|0|||
128771150|NCT01544491|463453633|FG001|Overall Study|Lost to Follow-up|1|||
128771151|NCT01544491|463453632|FG000|Overall Study|administrative problems|2|||
128771152|NCT01544491|463453633|FG001|Overall Study|administrative problems|0|||
128771153|NCT00967018|463453634|FG000|Overall Study|Adverse Event|2|||
128771154|NCT00967018|463453634|FG000|Overall Study|Physician Decision|7|||
129219740|NCT00372593|465104568|FG001|Overall Study|Lost to Follow-up|0|||
128771155|NCT00967018|463453634|FG000|Overall Study|Lost to Follow-up|2|||
128771156|NCT00967018|463453634|FG000|Overall Study|Withdrawal by Subject|1|||
128771157|NCT00967018|463453634|FG000|Overall Study|Miscellaneous Reasons|9|||
128771158|NCT04642469|463453640|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
128957412|NCT03228394|464129728|FG001|Overall Study|Noncompliance|0|||
128957413|NCT03228394|464129729|FG002|Overall Study|Noncompliance|0|||
128957414|NCT03228394|464129730|FG003|Overall Study|Noncompliance|0|||
128957415|NCT03228394|464129731|FG004|Overall Study|Noncompliance|0|||
128957416|NCT03228394|464129732|FG005|Overall Study|Noncompliance|0|||
128957417|NCT03228394|464129733|FG006|Overall Study|Noncompliance|1|||
128957418|NCT03228394|464129734|FG007|Overall Study|Noncompliance|0|||
128957419|NCT04581863|464129735|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
128957420|NCT04581863|464129736|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
128957421|NCT01803711|464129741|FG000|Overall Study|Adverse Event|1|||
128957422|NCT01803711|464129742|FG001|Overall Study|Adverse Event|1|||
128957423|NCT01170221|464129746|FG000|Overall Study|Lost to Follow-up|22|||
128957424|NCT01170221|464129747|FG001|Overall Study|Lost to Follow-up|21|||
128957425|NCT01170221|464129746|FG000|Overall Study|Withdrawal by Subject|9|||
128957426|NCT01170221|464129747|FG001|Overall Study|Withdrawal by Subject|7|||
128957427|NCT01170221|464129746|FG000|Overall Study|Subject completed only screening and LFU|1|||
128957428|NCT01170221|464129747|FG001|Overall Study|Subject completed only screening and LFU|0|||
128771159|NCT04642469|463453641|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
128771160|NCT04642469|463453640|FG000|Overall Study|Death|1|||
128771161|NCT04642469|463453641|FG001|Overall Study|Death|2|||
128771162|NCT04642469|463453640|FG000|Overall Study|Study/site closed following amendment 1|11|||
128771163|NCT04642469|463453641|FG001|Overall Study|Study/site closed following amendment 1|11|||
128771164|NCT04642469|463453640|FG000|Overall Study|Other|1|||
128771165|NCT04642469|463453641|FG001|Overall Study|Other|1|||
128771166|NCT04642469|463453640|FG000|Overall Study|Withdrawal by Subject|1|||
128771167|NCT04642469|463453641|FG001|Overall Study|Withdrawal by Subject|0|||
128771168|NCT00680056|463453643|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
128771169|NCT00680056|463453644|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
128771170|NCT00680056|463453643|FG000|Second Intervention|Protocol Violation|3|||
128771171|NCT00680056|463453644|FG001|Second Intervention|Protocol Violation|1|||
128771172|NCT02733042|463453645|FG000|Overall Study|Adverse Event|1|||
128771173|NCT02733042|463453646|FG001|Overall Study|Adverse Event|0|||
128771174|NCT02733042|463453647|FG002|Overall Study|Adverse Event|1|||
128771175|NCT02733042|463453648|FG003|Overall Study|Adverse Event|1|||
128771176|NCT02733042|463453649|FG004|Overall Study|Adverse Event|0|||
128771177|NCT02733042|463453650|FG005|Overall Study|Adverse Event|0|||
128771178|NCT02733042|463453651|FG006|Overall Study|Adverse Event|0|||
128771179|NCT02733042|463453652|FG007|Overall Study|Adverse Event|0|||
128771180|NCT02733042|463453653|FG008|Overall Study|Adverse Event|0|||
128771181|NCT02733042|463453654|FG009|Overall Study|Adverse Event|0|||
128771182|NCT02733042|463453655|FG010|Overall Study|Adverse Event|2|||
128771183|NCT02733042|463453656|FG011|Overall Study|Adverse Event|2|||
128771184|NCT02733042|463453657|FG012|Overall Study|Adverse Event|0|||
128771185|NCT02733042|463453658|FG013|Overall Study|Adverse Event|2|||
128771186|NCT02733042|463453659|FG014|Overall Study|Adverse Event|0|||
128771187|NCT02733042|463453660|FG015|Overall Study|Adverse Event|0|||
128771188|NCT02733042|463453661|FG016|Overall Study|Adverse Event|0|||
128771189|NCT02733042|463453662|FG017|Overall Study|Adverse Event|1|||
128771190|NCT02733042|463453663|FG018|Overall Study|Adverse Event|0|||
128771191|NCT02733042|463453645|FG000|Overall Study|Progressive Disease|2|||
128771192|NCT02733042|463453646|FG001|Overall Study|Progressive Disease|1|||
128771193|NCT02733042|463453647|FG002|Overall Study|Progressive Disease|3|||
128771194|NCT02733042|463453648|FG003|Overall Study|Progressive Disease|1|||
128771195|NCT02733042|463453649|FG004|Overall Study|Progressive Disease|2|||
128771196|NCT02733042|463453650|FG005|Overall Study|Progressive Disease|3|||
128771197|NCT02733042|463453651|FG006|Overall Study|Progressive Disease|0|||
128771198|NCT02733042|463453652|FG007|Overall Study|Progressive Disease|3|||
128771199|NCT02733042|463453653|FG008|Overall Study|Progressive Disease|3|||
128771200|NCT02733042|463453654|FG009|Overall Study|Progressive Disease|2|||
129126564|NCT02903914|464757978|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
129126565|NCT02903914|464757979|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
129126566|NCT02903914|464757980|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
129126567|NCT02903914|464757981|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
129126568|NCT02903914|464757982|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
129126569|NCT02903914|464757983|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
129126570|NCT02903914|464757976|FG000|Overall Study|Follow-up Did Not Occur|0|||
129126571|NCT02903914|464757977|FG001|Overall Study|Follow-up Did Not Occur|1|||
129126572|NCT02903914|464757978|FG002|Overall Study|Follow-up Did Not Occur|1|||
129126573|NCT02903914|464757979|FG003|Overall Study|Follow-up Did Not Occur|0|||
129126574|NCT02903914|464757980|FG004|Overall Study|Follow-up Did Not Occur|2|||
129126575|NCT02903914|464757981|FG005|Overall Study|Follow-up Did Not Occur|0|||
129126576|NCT02903914|464757982|FG006|Overall Study|Follow-up Did Not Occur|8|||
129126577|NCT02903914|464757983|FG007|Overall Study|Follow-up Did Not Occur|0|||
129126578|NCT02903914|464757976|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
129126579|NCT02903914|464757977|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
129126580|NCT02903914|464757978|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
129126581|NCT02903914|464757979|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
129126582|NCT02903914|464757980|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
129126583|NCT02903914|464757981|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
129126584|NCT02903914|464757982|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
129126585|NCT02903914|464757983|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
129126586|NCT02903914|464757976|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
129126587|NCT02903914|464757977|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
129126588|NCT02903914|464757978|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
129126589|NCT02903914|464757979|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
129126590|NCT02903914|464757980|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
128771201|NCT02733042|463453655|FG010|Overall Study|Progressive Disease|2|||
128771202|NCT02733042|463453656|FG011|Overall Study|Progressive Disease|2|||
128771203|NCT02733042|463453657|FG012|Overall Study|Progressive Disease|8|||
128771204|NCT02733042|463453658|FG013|Overall Study|Progressive Disease|1|||
128771205|NCT02733042|463453659|FG014|Overall Study|Progressive Disease|4|||
128771206|NCT02733042|463453660|FG015|Overall Study|Progressive Disease|7|||
128771207|NCT02733042|463453661|FG016|Overall Study|Progressive Disease|2|||
128771208|NCT02733042|463453662|FG017|Overall Study|Progressive Disease|3|||
128771209|NCT02733042|463453663|FG018|Overall Study|Progressive Disease|4|||
128771210|NCT02733042|463453645|FG000|Overall Study|Withdrawal by Subject|0|||
128712460|NCT01129960|463243889|FG003|Overall Study|Lack of Efficacy|1|||
128712461|NCT01129960|463243886|FG000|Overall Study|Adverse Event|23|||
128712462|NCT01129960|463243887|FG001|Overall Study|Adverse Event|16|||
128712463|NCT01129960|463243888|FG002|Overall Study|Adverse Event|16|||
128712464|NCT01129960|463243889|FG003|Overall Study|Adverse Event|7|||
128712465|NCT01129960|463243886|FG000|Overall Study|Protocol Violation|1|||
128712466|NCT01129960|463243887|FG001|Overall Study|Protocol Violation|2|||
128712467|NCT01129960|463243888|FG002|Overall Study|Protocol Violation|3|||
128771211|NCT02733042|463453646|FG001|Overall Study|Withdrawal by Subject|1|||
128771212|NCT02733042|463453647|FG002|Overall Study|Withdrawal by Subject|2|||
128771213|NCT02733042|463453648|FG003|Overall Study|Withdrawal by Subject|1|||
128771214|NCT02733042|463453649|FG004|Overall Study|Withdrawal by Subject|1|||
128771215|NCT02733042|463453650|FG005|Overall Study|Withdrawal by Subject|0|||
128771216|NCT02733042|463453651|FG006|Overall Study|Withdrawal by Subject|0|||
128771217|NCT02733042|463453652|FG007|Overall Study|Withdrawal by Subject|0|||
128771218|NCT02733042|463453653|FG008|Overall Study|Withdrawal by Subject|1|||
128771219|NCT02733042|463453654|FG009|Overall Study|Withdrawal by Subject|1|||
128771220|NCT02733042|463453655|FG010|Overall Study|Withdrawal by Subject|0|||
128771221|NCT02733042|463453656|FG011|Overall Study|Withdrawal by Subject|2|||
128771222|NCT02733042|463453657|FG012|Overall Study|Withdrawal by Subject|1|||
128771223|NCT02733042|463453658|FG013|Overall Study|Withdrawal by Subject|1|||
128771224|NCT02733042|463453659|FG014|Overall Study|Withdrawal by Subject|0|||
128771225|NCT02733042|463453660|FG015|Overall Study|Withdrawal by Subject|0|||
128771226|NCT02733042|463453661|FG016|Overall Study|Withdrawal by Subject|0|||
128771227|NCT02733042|463453662|FG017|Overall Study|Withdrawal by Subject|0|||
128771228|NCT02733042|463453663|FG018|Overall Study|Withdrawal by Subject|0|||
128771229|NCT02733042|463453645|FG000|Overall Study|Other Reasons|0|||
128771230|NCT02733042|463453646|FG001|Overall Study|Other Reasons|0|||
128771231|NCT02733042|463453647|FG002|Overall Study|Other Reasons|1|||
128771232|NCT02733042|463453648|FG003|Overall Study|Other Reasons|0|||
128771233|NCT02733042|463453649|FG004|Overall Study|Other Reasons|0|||
128771234|NCT02733042|463453650|FG005|Overall Study|Other Reasons|0|||
128771235|NCT02733042|463453651|FG006|Overall Study|Other Reasons|0|||
128771236|NCT02733042|463453652|FG007|Overall Study|Other Reasons|0|||
128771237|NCT02733042|463453653|FG008|Overall Study|Other Reasons|0|||
128771238|NCT02733042|463453654|FG009|Overall Study|Other Reasons|1|||
128771239|NCT02733042|463453655|FG010|Overall Study|Other Reasons|1|||
128771240|NCT02733042|463453656|FG011|Overall Study|Other Reasons|0|||
128771241|NCT02733042|463453657|FG012|Overall Study|Other Reasons|0|||
128771242|NCT02733042|463453658|FG013|Overall Study|Other Reasons|0|||
128771243|NCT02733042|463453659|FG014|Overall Study|Other Reasons|0|||
128771244|NCT02733042|463453660|FG015|Overall Study|Other Reasons|1|||
128771245|NCT02733042|463453661|FG016|Overall Study|Other Reasons|0|||
128771246|NCT02733042|463453662|FG017|Overall Study|Other Reasons|1|||
128771247|NCT02733042|463453663|FG018|Overall Study|Other Reasons|0|||
128771248|NCT02733042|463453645|FG000|Overall Study|Death|0|||
128771249|NCT02733042|463453646|FG001|Overall Study|Death|0|||
128771250|NCT02733042|463453647|FG002|Overall Study|Death|0|||
128771251|NCT02733042|463453648|FG003|Overall Study|Death|0|||
128771252|NCT02733042|463453649|FG004|Overall Study|Death|0|||
128771253|NCT02733042|463453650|FG005|Overall Study|Death|0|||
128771254|NCT02733042|463453651|FG006|Overall Study|Death|1|||
128771255|NCT02733042|463453652|FG007|Overall Study|Death|0|||
128957429|NCT01170221|464129746|FG000|Overall Study|Randomized but not treated|1|||
128957430|NCT01170221|464129747|FG001|Overall Study|Randomized but not treated|0|||
128957431|NCT00432562|464129748|FG000|Overall Study|Death|3|||
128957432|NCT00432562|464129749|FG001|Overall Study|Death|0|||
128957433|NCT02693691|464129750|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
128957434|NCT02693691|464129750|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
128957435|NCT02693691|464129750|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
128957436|NCT02693691|464129750|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
128771256|NCT02733042|463453653|FG008|Overall Study|Death|1|||
128771257|NCT02733042|463453654|FG009|Overall Study|Death|0|||
128771258|NCT02733042|463453655|FG010|Overall Study|Death|1|||
128771259|NCT02733042|463453656|FG011|Overall Study|Death|0|||
128957437|NCT02693691|464129750|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
128957438|NCT02693691|464129750|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
128712468|NCT01129960|463243889|FG003|Overall Study|Protocol Violation|0|||
128771260|NCT02733042|463453657|FG012|Overall Study|Death|0|||
128771261|NCT02733042|463453658|FG013|Overall Study|Death|0|||
128771262|NCT02733042|463453659|FG014|Overall Study|Death|1|||
128712469|NCT01129960|463243886|FG000|Overall Study|Lost to Follow-up|0|||
128771263|NCT02733042|463453660|FG015|Overall Study|Death|2|||
128771264|NCT02733042|463453661|FG016|Overall Study|Death|0|||
128771265|NCT02733042|463453662|FG017|Overall Study|Death|0|||
128771266|NCT02733042|463453663|FG018|Overall Study|Death|0|||
128771267|NCT01821898|463453664|FG000|Overall Study|Withdrawal by Subject|2|||
128771268|NCT01821898|463453665|FG001|Overall Study|Withdrawal by Subject|1|||
128771269|NCT00337662|463453668|FG000|Study Period II|Lost to Follow-up|0|||
128771270|NCT00337662|463453669|FG001|Study Period II|Lost to Follow-up|0|||
128712470|NCT01129960|463243887|FG001|Overall Study|Lost to Follow-up|2|||
128957439|NCT02693691|464129750|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
128957440|NCT01162304|464129753|FG000|Overall Study|Beck scale to high|11|||
128957441|NCT02247401|464129754|FG000|Overall Study|Adverse Event|1|||
128957442|NCT02247401|464129755|FG001|Overall Study|Adverse Event|0|||
128957443|NCT02247401|464129756|FG002|Overall Study|Adverse Event|0|||
128957444|NCT02247401|464129754|FG000|Overall Study|Withdrawal by Subject|4|||
128957445|NCT02247401|464129755|FG001|Overall Study|Withdrawal by Subject|1|||
128957446|NCT02247401|464129756|FG002|Overall Study|Withdrawal by Subject|1|||
128957447|NCT02247401|464129754|FG000|Overall Study|Lost to Follow-up|1|||
128957448|NCT02247401|464129755|FG001|Overall Study|Lost to Follow-up|1|||
128957449|NCT02247401|464129756|FG002|Overall Study|Lost to Follow-up|1|||
128957450|NCT00192036|464129760|FG000|Overall Study|Protocol Violation|3|||
128957451|NCT00192036|464129760|FG000|Overall Study|Adverse Event|6|||
128957452|NCT00192036|464129760|FG000|Overall Study|Patient/Physician Perception|1|||
128957453|NCT00192036|464129760|FG000|Overall Study|Objective Tumor Progression|4|||
128957454|NCT00192036|464129760|FG000|Overall Study|Clinical Disease Progression|1|||
128957455|NCT00192036|464129760|FG000|Overall Study|Death|1|||
128957456|NCT00192036|464129760|FG000|Overall Study|Unknown or Not Specified|5|||
128957457|NCT05425719|464129763|FG000|Overall Study|Lost to Follow-up|4|||
128957458|NCT05425719|464129764|FG001|Overall Study|Lost to Follow-up|0|||
128957459|NCT05425719|464129763|FG000|Overall Study|Withdrew consent|1|||
128957460|NCT05425719|464129764|FG001|Overall Study|Withdrew consent|1|||
128957461|NCT04682353|464129765|FG000|Overall Study|Lost to Follow-up|0|||
128771271|NCT00337662|463453670|FG002|Study Period II|Lost to Follow-up|0|||
128957462|NCT04682353|464129766|FG001|Overall Study|Lost to Follow-up|1|||
128957463|NCT04682353|464129767|FG002|Overall Study|Lost to Follow-up|0|||
128957464|NCT04682353|464129768|FG003|Overall Study|Lost to Follow-up|1|||
128957465|NCT04682353|464129765|FG000|Overall Study|Personal reasons|0|||
128957466|NCT04682353|464129766|FG001|Overall Study|Personal reasons|1|||
128957467|NCT04682353|464129767|FG002|Overall Study|Personal reasons|0|||
128957468|NCT04682353|464129768|FG003|Overall Study|Personal reasons|0|||
128957469|NCT01586806|464129774|FG000|Overall Study|Protocol Violation|0|||
128957470|NCT01586806|464129775|FG001|Overall Study|Protocol Violation|1|||
128712471|NCT01129960|463243888|FG002|Overall Study|Lost to Follow-up|3|||
128712472|NCT01129960|463243889|FG003|Overall Study|Lost to Follow-up|3|||
128712473|NCT01129960|463243886|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
128712474|NCT01129960|463243887|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
128712475|NCT01129960|463243888|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
128712476|NCT01129960|463243889|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
128712477|NCT01129960|463243886|FG000|Overall Study|Physician Decision|1|||
128712478|NCT01129960|463243887|FG001|Overall Study|Physician Decision|0|||
128712479|NCT01129960|463243888|FG002|Overall Study|Physician Decision|0|||
128712480|NCT01129960|463243889|FG003|Overall Study|Physician Decision|0|||
128712481|NCT01129960|463243886|FG000|Overall Study|Pregnancy|1|||
128712482|NCT01129960|463243887|FG001|Overall Study|Pregnancy|0|||
128712483|NCT01129960|463243888|FG002|Overall Study|Pregnancy|0|||
128712484|NCT01129960|463243889|FG003|Overall Study|Pregnancy|0|||
128712485|NCT04285879|463243890|FG000|Overall Study|Lost to Follow-up|1|||
128712486|NCT04285879|463243891|FG001|Overall Study|Lost to Follow-up|8|||
128712487|NCT04285879|463243890|FG000|Overall Study|medical/surgical exclusion|16|||
128712488|NCT04285879|463243891|FG001|Overall Study|medical/surgical exclusion|0|||
128712489|NCT02056340|463243893|FG000|Overall Study|Lost to Follow-up|5|||
128712490|NCT02056340|463243894|FG001|Overall Study|Lost to Follow-up|5|||
128712491|NCT02056340|463243893|FG000|Overall Study|Withdrawal by Subject|2|||
128712492|NCT02056340|463243894|FG001|Overall Study|Withdrawal by Subject|6|||
128712493|NCT03358290|463243896|FG000|Overall Study|Study discontinued by Sponsor|0|||
128712494|NCT03358290|463243897|FG001|Overall Study|Study discontinued by Sponsor|1|||
128712495|NCT03358290|463243898|FG002|Overall Study|Study discontinued by Sponsor|1|||
128712496|NCT03358290|463243899|FG003|Overall Study|Study discontinued by Sponsor|0|||
128712497|NCT03358290|463243900|FG004|Overall Study|Study discontinued by Sponsor|0|||
128712498|NCT03358290|463243896|FG000|Overall Study|Adverse Event|0|||
128771272|NCT00337662|463453671|FG003|Study Period II|Lost to Follow-up|35|||
128957471|NCT01586806|464129776|FG002|Overall Study|Protocol Violation|0|||
128957472|NCT01586806|464129774|FG000|Overall Study|Withdrawal by Subject|1|||
128957473|NCT01586806|464129775|FG001|Overall Study|Withdrawal by Subject|0|||
128957474|NCT01586806|464129776|FG002|Overall Study|Withdrawal by Subject|0|||
128957475|NCT01586806|464129774|FG000|Overall Study|Lost to Follow-up|2|||
128957476|NCT01586806|464129775|FG001|Overall Study|Lost to Follow-up|3|||
128957477|NCT01586806|464129776|FG002|Overall Study|Lost to Follow-up|2|||
128957478|NCT00862654|464129777|FG000|Overall Study|Lack of Efficacy|1|||
128957479|NCT00862654|464129778|FG001|Overall Study|Lack of Efficacy|0|||
128957480|NCT00862654|464129779|FG002|Overall Study|Lack of Efficacy|1|||
128957481|NCT00862654|464129780|FG003|Overall Study|Lack of Efficacy|0|||
128957482|NCT00862654|464129777|FG000|Overall Study|Lost to Follow-up|1|||
128957483|NCT00862654|464129778|FG001|Overall Study|Lost to Follow-up|2|||
128957484|NCT00862654|464129779|FG002|Overall Study|Lost to Follow-up|1|||
128712499|NCT03358290|463243897|FG001|Overall Study|Adverse Event|0|||
128771273|NCT00337662|463453668|FG000|Study Period II|Withdrawal by Subject|0|||
128771274|NCT00337662|463453669|FG001|Study Period II|Withdrawal by Subject|0|||
128771275|NCT00337662|463453670|FG002|Study Period II|Withdrawal by Subject|0|||
128771276|NCT00337662|463453671|FG003|Study Period II|Withdrawal by Subject|20|||
128771277|NCT00337662|463453668|FG000|Study Period II|Adverse Event|0|||
128771278|NCT00337662|463453669|FG001|Study Period II|Adverse Event|0|||
128771279|NCT00337662|463453670|FG002|Study Period II|Adverse Event|0|||
128771280|NCT00337662|463453671|FG003|Study Period II|Adverse Event|16|||
128771281|NCT00337662|463453668|FG000|Study Period II|Physician Decision|0|||
128771282|NCT00337662|463453669|FG001|Study Period II|Physician Decision|0|||
128771283|NCT00337662|463453670|FG002|Study Period II|Physician Decision|0|||
128771284|NCT00337662|463453671|FG003|Study Period II|Physician Decision|13|||
128771285|NCT00337662|463453668|FG000|Study Period II|Entry Criteria Not Met|0|||
128771286|NCT00337662|463453669|FG001|Study Period II|Entry Criteria Not Met|0|||
128771287|NCT00337662|463453670|FG002|Study Period II|Entry Criteria Not Met|0|||
128771288|NCT00337662|463453671|FG003|Study Period II|Entry Criteria Not Met|6|||
128771289|NCT00337662|463453668|FG000|Study Period II|Protocol Violation|0|||
128771290|NCT00337662|463453669|FG001|Study Period II|Protocol Violation|0|||
128771291|NCT00337662|463453670|FG002|Study Period II|Protocol Violation|0|||
128771292|NCT00337662|463453671|FG003|Study Period II|Protocol Violation|6|||
128771293|NCT00337662|463453668|FG000|Study Period II|Lack of Efficacy|0|||
128771294|NCT00337662|463453669|FG001|Study Period II|Lack of Efficacy|0|||
128771295|NCT00337662|463453670|FG002|Study Period II|Lack of Efficacy|0|||
128771296|NCT00337662|463453671|FG003|Study Period II|Lack of Efficacy|7|||
128957485|NCT00862654|464129780|FG003|Overall Study|Lost to Follow-up|3|||
128957486|NCT00862654|464129777|FG000|Overall Study|Adverse Event|0|||
128957487|NCT00862654|464129778|FG001|Overall Study|Adverse Event|1|||
128957488|NCT00862654|464129779|FG002|Overall Study|Adverse Event|1|||
128957489|NCT00862654|464129780|FG003|Overall Study|Adverse Event|0|||
128957490|NCT00862654|464129777|FG000|Overall Study|Pregnancy|1|||
128957491|NCT00862654|464129778|FG001|Overall Study|Pregnancy|1|||
128957492|NCT00862654|464129779|FG002|Overall Study|Pregnancy|0|||
128957493|NCT00862654|464129780|FG003|Overall Study|Pregnancy|0|||
128957494|NCT00862654|464129777|FG000|Overall Study|Withdrawal by Subject|2|||
128957495|NCT00862654|464129778|FG001|Overall Study|Withdrawal by Subject|2|||
128957496|NCT00862654|464129779|FG002|Overall Study|Withdrawal by Subject|2|||
128957497|NCT00862654|464129780|FG003|Overall Study|Withdrawal by Subject|3|||
128957498|NCT00862654|464129777|FG000|Overall Study|Subject mistake|0|||
128771297|NCT00337662|463453668|FG000|Study Period II|Sponsor Decision|0|||
128771298|NCT00337662|463453669|FG001|Study Period II|Sponsor Decision|0|||
128771299|NCT00337662|463453670|FG002|Study Period II|Sponsor Decision|0|||
128771300|NCT00337662|463453671|FG003|Study Period II|Sponsor Decision|2|||
128771301|NCT00337662|463453668|FG000|Study Period II|Parent/Caregiver Decision|0|||
128771302|NCT00337662|463453669|FG001|Study Period II|Parent/Caregiver Decision|0|||
128771303|NCT00337662|463453670|FG002|Study Period II|Parent/Caregiver Decision|0|||
128771304|NCT00337662|463453671|FG003|Study Period II|Parent/Caregiver Decision|1|||
128771305|NCT00337662|463453668|FG000|Study Period III|Lost to Follow-up|14|||
128771306|NCT00337662|463453669|FG001|Study Period III|Lost to Follow-up|16|||
128771307|NCT00337662|463453670|FG002|Study Period III|Lost to Follow-up|14|||
128771308|NCT00337662|463453671|FG003|Study Period III|Lost to Follow-up|0|||
128771309|NCT00337662|463453668|FG000|Study Period III|Withdrawal by Subject|18|||
128771310|NCT00337662|463453669|FG001|Study Period III|Withdrawal by Subject|14|||
128771311|NCT00337662|463453670|FG002|Study Period III|Withdrawal by Subject|12|||
128771312|NCT00337662|463453671|FG003|Study Period III|Withdrawal by Subject|0|||
128771313|NCT00337662|463453668|FG000|Study Period III|Adverse Event|9|||
128771314|NCT00337662|463453669|FG001|Study Period III|Adverse Event|10|||
128771315|NCT00337662|463453670|FG002|Study Period III|Adverse Event|8|||
128957499|NCT00862654|464129778|FG001|Overall Study|Subject mistake|1|||
128957500|NCT00862654|464129779|FG002|Overall Study|Subject mistake|0|||
128957501|NCT00862654|464129780|FG003|Overall Study|Subject mistake|0|||
128957502|NCT00862654|464129777|FG000|Overall Study|Familly constraint|0|||
128957503|NCT00862654|464129778|FG001|Overall Study|Familly constraint|1|||
129126591|NCT02903914|464757981|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
129126592|NCT02903914|464757982|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
129126593|NCT02903914|464757983|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
129126594|NCT02903914|464757976|FG000|Overall Study|Clinical Disease Progression|0|||
128771316|NCT00337662|463453671|FG003|Study Period III|Adverse Event|0|||
128771317|NCT00337662|463453668|FG000|Study Period III|Protocol Violation|3|||
128771318|NCT00337662|463453669|FG001|Study Period III|Protocol Violation|8|||
128957504|NCT00862654|464129779|FG002|Overall Study|Familly constraint|0|||
128957505|NCT00862654|464129780|FG003|Overall Study|Familly constraint|0|||
128957506|NCT00862654|464129777|FG000|Overall Study|Never used study drugs|1|||
128771319|NCT00337662|463453670|FG002|Study Period III|Protocol Violation|2|||
128771320|NCT00337662|463453671|FG003|Study Period III|Protocol Violation|0|||
128957507|NCT00862654|464129778|FG001|Overall Study|Never used study drugs|0|||
128771321|NCT00337662|463453668|FG000|Study Period III|Physician Decision|6|||
128957508|NCT00862654|464129779|FG002|Overall Study|Never used study drugs|0|||
128771322|NCT00337662|463453669|FG001|Study Period III|Physician Decision|5|||
128771323|NCT00337662|463453670|FG002|Study Period III|Physician Decision|0|||
128771324|NCT00337662|463453671|FG003|Study Period III|Physician Decision|0|||
128771325|NCT00337662|463453668|FG000|Study Period III|Entry Criteria Not Met|4|||
128771326|NCT00337662|463453669|FG001|Study Period III|Entry Criteria Not Met|1|||
129126595|NCT02903914|464757977|FG001|Overall Study|Clinical Disease Progression|0|||
129126596|NCT02903914|464757978|FG002|Overall Study|Clinical Disease Progression|2|||
129126597|NCT02903914|464757979|FG003|Overall Study|Clinical Disease Progression|0|||
129126598|NCT02903914|464757980|FG004|Overall Study|Clinical Disease Progression|0|||
129126599|NCT02903914|464757981|FG005|Overall Study|Clinical Disease Progression|0|||
129126600|NCT02903914|464757982|FG006|Overall Study|Clinical Disease Progression|0|||
129126601|NCT02903914|464757983|FG007|Overall Study|Clinical Disease Progression|0|||
129126602|NCT02903914|464757976|FG000|Overall Study|Completed Follow-up Period|0|||
128771327|NCT00337662|463453670|FG002|Study Period III|Entry Criteria Not Met|3|||
128771328|NCT00337662|463453671|FG003|Study Period III|Entry Criteria Not Met|0|||
128771329|NCT00337662|463453668|FG000|Study Period III|Lack of Efficacy|4|||
128771330|NCT00337662|463453669|FG001|Study Period III|Lack of Efficacy|4|||
128771331|NCT00337662|463453670|FG002|Study Period III|Lack of Efficacy|2|||
128771332|NCT00337662|463453671|FG003|Study Period III|Lack of Efficacy|0|||
128771333|NCT00337662|463453668|FG000|Study Period III|Parent/Caregiver Decision|0|||
128771334|NCT00337662|463453669|FG001|Study Period III|Parent/Caregiver Decision|0|||
128771335|NCT00337662|463453670|FG002|Study Period III|Parent/Caregiver Decision|2|||
128771336|NCT00337662|463453671|FG003|Study Period III|Parent/Caregiver Decision|0|||
128771337|NCT00337662|463453668|FG000|Study Period III|Sponsor Decision|1|||
128771338|NCT00337662|463453669|FG001|Study Period III|Sponsor Decision|0|||
128771339|NCT00337662|463453670|FG002|Study Period III|Sponsor Decision|1|||
128712500|NCT03358290|463243898|FG002|Overall Study|Adverse Event|1|||
128712501|NCT03358290|463243899|FG003|Overall Study|Adverse Event|2|||
128712502|NCT03358290|463243900|FG004|Overall Study|Adverse Event|0|||
128712503|NCT03358290|463243896|FG000|Overall Study|Withdrawal by Subject|0|||
128712504|NCT03358290|463243897|FG001|Overall Study|Withdrawal by Subject|0|||
128712505|NCT03358290|463243898|FG002|Overall Study|Withdrawal by Subject|0|||
128712506|NCT03358290|463243899|FG003|Overall Study|Withdrawal by Subject|0|||
128712507|NCT03358290|463243900|FG004|Overall Study|Withdrawal by Subject|1|||
128712508|NCT02999854|463243906|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
128712509|NCT02999854|463243907|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
128771340|NCT00337662|463453671|FG003|Study Period III|Sponsor Decision|0|||
128771341|NCT00337662|463453668|FG000|Study Period III|Clinical Relapse|1|||
128771342|NCT00337662|463453669|FG001|Study Period III|Clinical Relapse|0|||
128771343|NCT00337662|463453670|FG002|Study Period III|Clinical Relapse|0|||
128771344|NCT00337662|463453671|FG003|Study Period III|Clinical Relapse|0|||
128771345|NCT03691948|463453673|FG000|Overall Study|Lost to Follow-up|1|||
128771346|NCT03691948|463453674|FG001|Overall Study|Lost to Follow-up|3|||
128771347|NCT02344537|463453675|FG000|Overall Study|Protocol Violation|1|||
128771348|NCT02344537|463453676|FG001|Overall Study|Protocol Violation|1|||
128771349|NCT02344537|463453675|FG000|Overall Study|Subject started another treatment after wk 6|1|||
128957509|NCT00862654|464129780|FG003|Overall Study|Never used study drugs|0|||
128957510|NCT00862654|464129777|FG000|Overall Study|Included after end of inclusions|0|||
128957511|NCT00862654|464129778|FG001|Overall Study|Included after end of inclusions|0|||
128957512|NCT00862654|464129779|FG002|Overall Study|Included after end of inclusions|1|||
128957513|NCT00862654|464129780|FG003|Overall Study|Included after end of inclusions|0|||
128957514|NCT01769469|464129781|FG000|Overall Study|Consent Withdrawn|5|||
128957515|NCT01769469|464129781|FG000|Overall Study|Moved Out Of Area|3|||
128957516|NCT01769469|464129781|FG000|Overall Study|Lost to Follow-up|17|||
128957517|NCT01769469|464129781|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
128957518|NCT01769469|464129781|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
128957519|NCT04377672|464129789|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
128957520|NCT03954444|464129790|FG000|Overall Study|Withdrawal by Subject|5|||
128957521|NCT03954444|464129791|FG001|Overall Study|Withdrawal by Subject|5|||
128957522|NCT03954444|464129792|FG002|Overall Study|Withdrawal by Subject|5|||
128957523|NCT03954444|464129790|FG000|Overall Study|Adverse Event|1|||
129036313|NCT04234464|464423470|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
129036314|NCT04234464|464423471|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
129036315|NCT01701973|464423472|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129036316|NCT01701973|464423473|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
129036317|NCT01701973|464423474|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129036318|NCT01701973|464423475|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129036319|NCT01701973|464423476|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129126603|NCT02903914|464757977|FG001|Overall Study|Completed Follow-up Period|0|||
129126604|NCT02903914|464757978|FG002|Overall Study|Completed Follow-up Period|6|||
128712510|NCT02999854|463243906|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
128771350|NCT02344537|463453676|FG001|Overall Study|Subject started another treatment after wk 6|0|||
129126605|NCT02903914|464757979|FG003|Overall Study|Completed Follow-up Period|2|||
129126606|NCT02903914|464757980|FG004|Overall Study|Completed Follow-up Period|1|||
129126607|NCT02903914|464757981|FG005|Overall Study|Completed Follow-up Period|0|||
129126608|NCT02903914|464757982|FG006|Overall Study|Completed Follow-up Period|9|||
129126609|NCT02903914|464757983|FG007|Overall Study|Completed Follow-up Period|1|||
129126610|NCT02903914|464757976|FG000|Overall Study|Taken off Treatment per Protocol|0|||
128771351|NCT02344537|463453675|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
128771352|NCT02344537|463453676|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
129126611|NCT02903914|464757977|FG001|Overall Study|Taken off Treatment per Protocol|0|||
129126612|NCT02903914|464757978|FG002|Overall Study|Taken off Treatment per Protocol|0|||
129126613|NCT02903914|464757979|FG003|Overall Study|Taken off Treatment per Protocol|0|||
129126614|NCT02903914|464757980|FG004|Overall Study|Taken off Treatment per Protocol|0|||
129126615|NCT02903914|464757981|FG005|Overall Study|Taken off Treatment per Protocol|1|||
129126616|NCT02903914|464757982|FG006|Overall Study|Taken off Treatment per Protocol|0|||
128771353|NCT00960752|463453678|FG000|Overall Study|Adverse Event|0|||
128771354|NCT00960752|463453679|FG001|Overall Study|Adverse Event|0|||
128771355|NCT00960752|463453680|FG002|Overall Study|Adverse Event|1|||
128771356|NCT00960752|463453678|FG000|Overall Study|Progression|0|||
128957524|NCT03954444|464129791|FG001|Overall Study|Adverse Event|3|||
128957525|NCT03954444|464129792|FG002|Overall Study|Adverse Event|2|||
128957526|NCT03954444|464129790|FG000|Overall Study|Protocol Violation|0|||
128957527|NCT03954444|464129791|FG001|Overall Study|Protocol Violation|3|||
128957528|NCT03954444|464129792|FG002|Overall Study|Protocol Violation|5|||
128957529|NCT03954444|464129790|FG000|Overall Study|Use of prohibited therapy|1|||
129126617|NCT02903914|464757983|FG007|Overall Study|Taken off Treatment per Protocol|0|||
129126618|NCT02903914|464757976|FG000|Overall Study|Refused Further Treatment/Contact|0|||
129126619|NCT02903914|464757977|FG001|Overall Study|Refused Further Treatment/Contact|0|||
129126620|NCT02903914|464757978|FG002|Overall Study|Refused Further Treatment/Contact|0|||
129126621|NCT02903914|464757979|FG003|Overall Study|Refused Further Treatment/Contact|0|||
129126622|NCT02903914|464757980|FG004|Overall Study|Refused Further Treatment/Contact|0|||
128957530|NCT03954444|464129791|FG001|Overall Study|Use of prohibited therapy|1|||
128957531|NCT03954444|464129792|FG002|Overall Study|Use of prohibited therapy|2|||
128957532|NCT03954444|464129790|FG000|Overall Study|Lost to Follow-up|1|||
128957533|NCT03954444|464129791|FG001|Overall Study|Lost to Follow-up|0|||
128957534|NCT03954444|464129792|FG002|Overall Study|Lost to Follow-up|1|||
129126623|NCT02903914|464757981|FG005|Overall Study|Refused Further Treatment/Contact|0|||
129126624|NCT02903914|464757982|FG006|Overall Study|Refused Further Treatment/Contact|1|||
129126625|NCT02903914|464757983|FG007|Overall Study|Refused Further Treatment/Contact|0|||
129219741|NCT00372593|465104569|FG002|Overall Study|Lost to Follow-up|0|||
129219742|NCT00372593|465104567|FG000|Overall Study|Physician Decision|42|||
128957535|NCT03954444|464129790|FG000|Overall Study|Non-compliant with study drug application|2|||
128957536|NCT03954444|464129791|FG001|Overall Study|Non-compliant with study drug application|2|||
128957537|NCT03954444|464129792|FG002|Overall Study|Non-compliant with study drug application|0|||
128957538|NCT03954444|464129790|FG000|Overall Study|Administrative reasons|0|||
128957539|NCT03954444|464129791|FG001|Overall Study|Administrative reasons|0|||
128957540|NCT03954444|464129792|FG002|Overall Study|Administrative reasons|1|||
128957541|NCT03954444|464129790|FG000|Overall Study|Miscellaneous|3|||
128957542|NCT03954444|464129791|FG001|Overall Study|Miscellaneous|2|||
128957543|NCT03954444|464129792|FG002|Overall Study|Miscellaneous|1|||
128957544|NCT02447458|464129793|FG000|Overall Study|Other|0|||
128957545|NCT02447458|464129794|FG001|Overall Study|Other|0|||
128957546|NCT02447458|464129795|FG002|Overall Study|Other|1|||
128957547|NCT02447458|464129796|FG003|Overall Study|Other|0|||
128957548|NCT02447458|464129797|FG004|Overall Study|Other|0|||
128957549|NCT02447458|464129798|FG005|Overall Study|Other|0|||
128957550|NCT02133742|464129799|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
128957551|NCT02133742|464129799|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
128957552|NCT02133742|464129799|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
128957553|NCT02133742|464129799|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
128957554|NCT02133742|464129799|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
129126626|NCT02903914|464757976|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129219743|NCT00372593|465104568|FG001|Overall Study|Physician Decision|41|||
129219744|NCT00372593|465104569|FG002|Overall Study|Physician Decision|0|||
129219745|NCT00372593|465104567|FG000|Overall Study|Ineligible|20|||
128712511|NCT02999854|463243907|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
128712512|NCT02999854|463243906|FG000|Active Study Phase (up to 18 Months)|Death|7|||
128712513|NCT02999854|463243907|FG001|Active Study Phase (up to 18 Months)|Death|5|||
128712514|NCT02999854|463243906|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
128712515|NCT02999854|463243907|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
128712516|NCT02999854|463243906|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
128712517|NCT02999854|463243907|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
128712518|NCT02999854|463243906|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
128712519|NCT02999854|463243907|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
128712520|NCT02999854|463243906|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
128712521|NCT02999854|463243907|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
128712522|NCT02999854|463243906|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
128712523|NCT02999854|463243907|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
128712524|NCT01085591|463243908|FG000|Overall Study|Adverse Event|0|||
128712525|NCT01085591|463243909|FG001|Overall Study|Adverse Event|1|||
128712526|NCT01085591|463243910|FG002|Overall Study|Adverse Event|3|||
128712527|NCT01085591|463243908|FG000|Overall Study|Physician Decision|1|||
128771357|NCT00960752|463453679|FG001|Overall Study|Progression|0|||
128771358|NCT00960752|463453680|FG002|Overall Study|Progression|1|||
128771359|NCT02180438|463453686|FG000|Overall Study|Lost to Follow-up|1|||
128771360|NCT00180713|463453690|FG000|Overall Study|Withdrawal by Subject|2|||
128771361|NCT00180713|463453691|FG001|Overall Study|Withdrawal by Subject|0|||
128771362|NCT00180713|463453690|FG000|Overall Study|Adverse Event|3|||
128771363|NCT00180713|463453691|FG001|Overall Study|Adverse Event|3|||
128771364|NCT02998021|463453696|FG000|Overall Study|Withdrawal by Subject|3|||
128771365|NCT02998021|463453697|FG001|Overall Study|Withdrawal by Subject|1|||
128771366|NCT02998021|463453696|FG000|Overall Study|unsafe home|0|||
128771367|NCT02998021|463453697|FG001|Overall Study|unsafe home|1|||
128771368|NCT00655551|463453698|FG000|All Periods Combined|Adverse Event|0|||
128771369|NCT00655551|463453699|FG001|All Periods Combined|Adverse Event|3|||
128771370|NCT00655551|463453700|FG002|All Periods Combined|Adverse Event|4|||
128957555|NCT03505749|464129801|FG000|Overall Study|Lost to Follow-up|7|||
128957556|NCT03505749|464129802|FG001|Overall Study|Lost to Follow-up|11|||
128957557|NCT03505749|464129801|FG000|Overall Study|Withdrawal by Subject|6|||
128957558|NCT03505749|464129802|FG001|Overall Study|Withdrawal by Subject|0|||
128957559|NCT03505749|464129801|FG000|Overall Study|Discharged from treatment|3|||
129126627|NCT02903914|464757977|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129126628|NCT02903914|464757978|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129126629|NCT02903914|464757979|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129126630|NCT02903914|464757980|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129126631|NCT02903914|464757981|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129126632|NCT02903914|464757982|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
129126633|NCT02903914|464757983|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129126634|NCT03112603|464757987|FG000|End of Randomization Period|Lost to Follow-up|3|||
129126635|NCT03112603|464757988|FG001|End of Randomization Period|Lost to Follow-up|0|||
129126636|NCT03112603|464757989|FG002|End of Randomization Period|Lost to Follow-up|0|||
129126637|NCT03112603|464757987|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
129126638|NCT03112603|464757988|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
129126639|NCT03112603|464757989|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
129126640|NCT03112603|464757987|FG000|End of Randomization Period|Physician Decision|43|||
129126641|NCT03112603|464757988|FG001|End of Randomization Period|Physician Decision|18|||
129126642|NCT03112603|464757989|FG002|End of Randomization Period|Physician Decision|0|||
129126643|NCT03112603|464757987|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
129126644|NCT03112603|464757988|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
129126645|NCT03112603|464757989|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
129126646|NCT03112603|464757987|FG000|End of Randomization Period|Death|10|||
129126647|NCT03112603|464757988|FG001|End of Randomization Period|Death|7|||
129126648|NCT03112603|464757989|FG002|End of Randomization Period|Death|0|||
129126649|NCT03112603|464757987|FG000|End of Randomization Period|Disease Relapse|12|||
129126650|NCT03112603|464757988|FG001|End of Randomization Period|Disease Relapse|7|||
129126651|NCT03112603|464757989|FG002|End of Randomization Period|Disease Relapse|0|||
129126652|NCT03112603|464757987|FG000|End of Randomization Period|Lack of Efficacy|25|||
128957560|NCT03505749|464129802|FG001|Overall Study|Discharged from treatment|6|||
128957561|NCT01688635|464129803|FG000|Washout 1|Withdrawal by Subject|1|||
128957562|NCT01688635|464129804|FG001|Washout 1|Withdrawal by Subject|0|||
128957563|NCT01688635|464129803|FG000|Washout 1|Adverse Event|0|||
128957564|NCT01688635|464129804|FG001|Washout 1|Adverse Event|1|||
128957565|NCT01688635|464129803|FG000|Washout 1|Physician Decision|0|||
128957566|NCT01688635|464129804|FG001|Washout 1|Physician Decision|1|||
128957567|NCT01688635|464129803|FG000|Washout 2|Physician Decision|1|||
128957568|NCT01688635|464129804|FG001|Washout 2|Physician Decision|0|||
128957569|NCT01688635|464129803|FG000|Washout 2|Withdrawal by Subject|1|||
128957570|NCT01688635|464129804|FG001|Washout 2|Withdrawal by Subject|0|||
128957571|NCT01688635|464129803|FG000|Washout 2|Sponsor Decision|1|||
128712528|NCT01085591|463243909|FG001|Overall Study|Physician Decision|0|||
128712529|NCT01085591|463243910|FG002|Overall Study|Physician Decision|1|||
128771371|NCT00655551|463453698|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
128771372|NCT00655551|463453699|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
128957572|NCT01688635|464129804|FG001|Washout 2|Sponsor Decision|2|||
128957573|NCT01688635|464129803|FG000|Washout 3|Withdrawal by Subject|1|||
128771373|NCT00655551|463453700|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
129036320|NCT01701973|464423477|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129036321|NCT01701973|464423478|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129036322|NCT01701973|464423479|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129036323|NCT01899326|464423482|FG000|Overall Study|Withdrawal by Subject|1|||
129036324|NCT01899326|464423482|FG000|Overall Study|Adverse Event|2|||
129036325|NCT01899326|464423482|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
129036326|NCT00373425|464423483|FG000|Overall Study|Relapse of NSCLC|116|||
129036327|NCT00373425|464423484|FG001|Overall Study|Relapse of NSCLC|104|||
129036328|NCT00373425|464423485|FG002|Overall Study|Relapse of NSCLC|19|||
129036329|NCT00373425|464423486|FG003|Overall Study|Relapse of NSCLC|2|||
129036330|NCT00373425|464423487|FG004|Overall Study|Relapse of NSCLC|26|||
129036331|NCT00373425|464423483|FG000|Overall Study|Adverse Event|191|||
129036332|NCT00373425|464423484|FG001|Overall Study|Adverse Event|22|||
129036333|NCT00373425|464423485|FG002|Overall Study|Adverse Event|59|||
129036334|NCT00373425|464423486|FG003|Overall Study|Adverse Event|0|||
129036335|NCT00373425|464423487|FG004|Overall Study|Adverse Event|34|||
129036336|NCT00373425|464423483|FG000|Overall Study|Patient request|35|||
129036337|NCT00373425|464423484|FG001|Overall Study|Patient request|18|||
129036338|NCT00373425|464423485|FG002|Overall Study|Patient request|43|||
129036339|NCT00373425|464423486|FG003|Overall Study|Patient request|6|||
129036340|NCT00373425|464423487|FG004|Overall Study|Patient request|7|||
129036341|NCT00373425|464423483|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
129036342|NCT00373425|464423484|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
129036343|NCT00373425|464423485|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
129036344|NCT00373425|464423486|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
129036345|NCT00373425|464423487|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
129036346|NCT00373425|464423483|FG000|Overall Study|Death|7|||
129036347|NCT00373425|464423484|FG001|Overall Study|Death|0|||
129036348|NCT00373425|464423485|FG002|Overall Study|Death|3|||
129036349|NCT00373425|464423486|FG003|Overall Study|Death|1|||
129036350|NCT00373425|464423487|FG004|Overall Study|Death|0|||
129036351|NCT00551616|464423490|FG000|Overall Study|Lost to Follow-up|48|||
129036352|NCT00551616|464423491|FG001|Overall Study|Lost to Follow-up|40|||
129036353|NCT01263561|464423492|FG000|Overall Study|Death|1|||
129036354|NCT01263561|464423493|FG001|Overall Study|Death|2|||
129036355|NCT03942211|464423494|FG000|Overall Study|Death|1|||
129036356|NCT03942211|464423495|FG001|Overall Study|Death|0|||
129036357|NCT03942211|464423494|FG000|Overall Study|Study terminated by sponsor|5|||
129036358|NCT03942211|464423495|FG001|Overall Study|Study terminated by sponsor|3|||
129036359|NCT03942211|464423494|FG000|Overall Study|Adverse Event|0|||
129036360|NCT03942211|464423495|FG001|Overall Study|Adverse Event|1|||
129036361|NCT01396421|464423496|FG000|Overall Study|Lost to Follow-up|0|||
129036362|NCT01396421|464423497|FG001|Overall Study|Lost to Follow-up|0|||
129036363|NCT01396421|464423498|FG002|Overall Study|Lost to Follow-up|0|||
129036364|NCT01396421|464423499|FG003|Overall Study|Lost to Follow-up|1|||
129036365|NCT01396421|464423496|FG000|Overall Study|Adverse Event|17|||
129036366|NCT01396421|464423497|FG001|Overall Study|Adverse Event|15|||
129036367|NCT01396421|464423498|FG002|Overall Study|Adverse Event|12|||
129126653|NCT03112603|464757988|FG001|End of Randomization Period|Lack of Efficacy|77|||
129126654|NCT03112603|464757989|FG002|End of Randomization Period|Lack of Efficacy|0|||
129126655|NCT03112603|464757987|FG000|End of Randomization Period|Adverse Event|32|||
129126656|NCT03112603|464757988|FG001|End of Randomization Period|Adverse Event|12|||
129126657|NCT03112603|464757989|FG002|End of Randomization Period|Adverse Event|0|||
129126658|NCT03112603|464757987|FG000|End of Cross Over Period|Death|0|||
129126659|NCT03112603|464757988|FG001|End of Cross Over Period|Death|0|||
129126660|NCT03112603|464757989|FG002|End of Cross Over Period|Death|2|||
129126661|NCT03112603|464757987|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
129126662|NCT03112603|464757988|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
129126663|NCT03112603|464757989|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
129126664|NCT03112603|464757987|FG000|End of Cross Over Period|Physician Decision|0|||
129126665|NCT03112603|464757988|FG001|End of Cross Over Period|Physician Decision|0|||
128712530|NCT01085591|463243908|FG000|Overall Study|Withdrawal by Subject|0|||
128712531|NCT01085591|463243909|FG001|Overall Study|Withdrawal by Subject|2|||
128712532|NCT01085591|463243910|FG002|Overall Study|Withdrawal by Subject|1|||
129036368|NCT01396421|464423499|FG003|Overall Study|Adverse Event|32|||
129036369|NCT01396421|464423496|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
129036370|NCT01396421|464423497|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
129036371|NCT01396421|464423498|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
129036372|NCT01396421|464423499|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
129036373|NCT01396421|464423496|FG000|Overall Study|Physician Decision|1|||
129036374|NCT01396421|464423497|FG001|Overall Study|Physician Decision|1|||
129036375|NCT01396421|464423498|FG002|Overall Study|Physician Decision|0|||
129036376|NCT01396421|464423499|FG003|Overall Study|Physician Decision|3|||
129036377|NCT01396421|464423496|FG000|Overall Study|Withdrawal by Subject|31|||
129126666|NCT03112603|464757989|FG002|End of Cross Over Period|Physician Decision|29|||
129126667|NCT03112603|464757987|FG000|End of Cross Over Period|Lack of Efficacy|0|||
129036378|NCT01396421|464423497|FG001|Overall Study|Withdrawal by Subject|24|||
128712533|NCT01085591|463243908|FG000|Overall Study|Lost to Follow-up|0|||
128712534|NCT01085591|463243909|FG001|Overall Study|Lost to Follow-up|1|||
128712535|NCT01085591|463243910|FG002|Overall Study|Lost to Follow-up|1|||
128712536|NCT01085591|463243908|FG000|Overall Study|Protocol Violation|1|||
128712537|NCT01085591|463243909|FG001|Overall Study|Protocol Violation|1|||
128712538|NCT01085591|463243910|FG002|Overall Study|Protocol Violation|1|||
128712539|NCT01085591|463243908|FG000|Overall Study|Other|0|||
128712540|NCT01085591|463243909|FG001|Overall Study|Other|1|||
128712541|NCT01085591|463243910|FG002|Overall Study|Other|0|||
128712542|NCT01085591|463243908|FG000|Overall Study|Not Properly Consented|1|||
128712543|NCT01085591|463243909|FG001|Overall Study|Not Properly Consented|0|||
128712544|NCT01085591|463243910|FG002|Overall Study|Not Properly Consented|0|||
128712545|NCT03605303|463243911|FG000|Period 1|Study Terminated|2|||
128712546|NCT03605303|463243912|FG001|Period 1|Study Terminated|1|||
128712547|NCT02626520|463243913|FG000|Overall Study|Physician Decision|1|||
129126668|NCT03112603|464757988|FG001|End of Cross Over Period|Lack of Efficacy|0|||
129126669|NCT03112603|464757989|FG002|End of Cross Over Period|Lack of Efficacy|8|||
129126670|NCT03112603|464757987|FG000|End of Cross Over Period|Adverse Event|0|||
129126671|NCT03112603|464757988|FG001|End of Cross Over Period|Adverse Event|0|||
129126672|NCT03112603|464757989|FG002|End of Cross Over Period|Adverse Event|6|||
129126673|NCT03112603|464757987|FG000|End of Cross Over Period|Disease Relapse|0|||
129126674|NCT03112603|464757988|FG001|End of Cross Over Period|Disease Relapse|0|||
129126675|NCT03112603|464757989|FG002|End of Cross Over Period|Disease Relapse|2|||
129126676|NCT03916926|464757993|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
129126677|NCT03916926|464757994|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
129126678|NCT03916926|464757993|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
129126679|NCT03916926|464757994|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
129126680|NCT03916926|464757993|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
129126681|NCT03916926|464757994|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
129126682|NCT03916926|464757993|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
129126683|NCT03916926|464757994|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
129126684|NCT04725188|464757995|FG000|Overall Study|Death|72|||
129126685|NCT04725188|464757996|FG001|Overall Study|Death|69|||
129126686|NCT04725188|464757997|FG002|Overall Study|Death|76|||
129126687|NCT04725188|464757995|FG000|Overall Study|Lost to Follow-up|1|||
129126688|NCT04725188|464757996|FG001|Overall Study|Lost to Follow-up|0|||
128712548|NCT02626520|463243914|FG001|Overall Study|Physician Decision|1|||
128712549|NCT02626520|463243913|FG000|Overall Study|Adverse Event|0|||
128712550|NCT02626520|463243914|FG001|Overall Study|Adverse Event|4|||
129126689|NCT04725188|464757997|FG002|Overall Study|Lost to Follow-up|1|||
129126690|NCT04725188|464757995|FG000|Overall Study|Withdrawal by Subject|2|||
129126691|NCT04725188|464757996|FG001|Overall Study|Withdrawal by Subject|2|||
129126692|NCT04725188|464757997|FG002|Overall Study|Withdrawal by Subject|1|||
128712551|NCT02626520|463243913|FG000|Overall Study|Lack of Efficacy|0|||
128712552|NCT02626520|463243914|FG001|Overall Study|Lack of Efficacy|2|||
128712553|NCT02626520|463243913|FG000|Overall Study|Did not start protocol therapy|0|||
128712554|NCT02626520|463243914|FG001|Overall Study|Did not start protocol therapy|2|||
128712555|NCT02626520|463243913|FG000|Overall Study|Study terminated|0|||
128712556|NCT02626520|463243914|FG001|Overall Study|Study terminated|1|||
128712557|NCT03915496|463243915|FG000|Overall Study|Adverse Event|2|||
128712558|NCT03915496|463243916|FG001|Overall Study|Adverse Event|1|||
128712559|NCT03915496|463243917|FG002|Overall Study|Adverse Event|2|||
128712560|NCT01031069|463243918|FG000|Overall Study|Serious Adverse Event|0|||
128712561|NCT01031069|463243919|FG001|Overall Study|Serious Adverse Event|1|||
128712562|NCT01031069|463243920|FG002|Overall Study|Serious Adverse Event|0|||
128712563|NCT01031069|463243921|FG003|Overall Study|Serious Adverse Event|0|||
128712564|NCT01031069|463243918|FG000|Overall Study|Withdrawal by Subject|2|||
128712565|NCT01031069|463243919|FG001|Overall Study|Withdrawal by Subject|3|||
128712566|NCT01031069|463243920|FG002|Overall Study|Withdrawal by Subject|18|||
128712567|NCT01031069|463243921|FG003|Overall Study|Withdrawal by Subject|18|||
128712568|NCT01031069|463243918|FG000|Overall Study|Migrated/moved from study area|1|||
128712569|NCT01031069|463243919|FG001|Overall Study|Migrated/moved from study area|2|||
128712570|NCT01031069|463243920|FG002|Overall Study|Migrated/moved from study area|1|||
128712571|NCT01031069|463243921|FG003|Overall Study|Migrated/moved from study area|1|||
128712572|NCT01031069|463243918|FG000|Overall Study|Lost to Follow-up|9|||
128712573|NCT01031069|463243919|FG001|Overall Study|Lost to Follow-up|5|||
128712574|NCT01031069|463243920|FG002|Overall Study|Lost to Follow-up|21|||
129126693|NCT04725188|464757995|FG000|Overall Study|Sponsor Decision|12|||
129219746|NCT00372593|465104568|FG001|Overall Study|Ineligible|21|||
128712575|NCT01031069|463243921|FG003|Overall Study|Lost to Follow-up|15|||
128712576|NCT01031069|463243918|FG000|Overall Study|Other|0|||
128712577|NCT01031069|463243919|FG001|Overall Study|Other|0|||
128712578|NCT01031069|463243920|FG002|Overall Study|Other|1|||
128712579|NCT01031069|463243921|FG003|Overall Study|Other|0|||
128712580|NCT05286307|463243922|FG000|Overall Study|Incomplete outcome assessments|2|||
128712581|NCT05286307|463243923|FG001|Overall Study|Incomplete outcome assessments|1|||
128957574|NCT01688635|464129804|FG001|Washout 3|Withdrawal by Subject|0|||
128712582|NCT05286307|463243922|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
128712583|NCT05286307|463243923|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
128712584|NCT05286307|463243922|FG000|Overall Study|Lost to follow up at 6 months|25|||
128712585|NCT05286307|463243923|FG001|Overall Study|Lost to follow up at 6 months|35|||
128712586|NCT05286307|463243922|FG000|Overall Study|Study medication not available|1|||
128712587|NCT05286307|463243923|FG001|Overall Study|Study medication not available|1|||
128712588|NCT01103284|463243924|FG000|Overall Study|Death|2|||
128712589|NCT01103284|463243925|FG001|Overall Study|Death|0|||
128712590|NCT01103284|463243924|FG000|Overall Study|Lost to Follow-up|9|||
128712591|NCT01103284|463243925|FG001|Overall Study|Lost to Follow-up|10|||
128712592|NCT01103284|463243924|FG000|Overall Study|Pregnancy|3|||
128712593|NCT01103284|463243925|FG001|Overall Study|Pregnancy|1|||
128712594|NCT01103284|463243924|FG000|Overall Study|Protocol Violation|12|||
128712595|NCT01103284|463243925|FG001|Overall Study|Protocol Violation|5|||
128771374|NCT00655551|463453698|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
128771375|NCT00655551|463453699|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
128771376|NCT00655551|463453700|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
128771377|NCT00655551|463453698|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
128771378|NCT00655551|463453699|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
128771379|NCT00655551|463453700|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
128771380|NCT01567865|463453705|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
128771381|NCT01567865|463453706|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
128771382|NCT01567865|463453707|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
128771383|NCT01567865|463453708|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
128771384|NCT01567865|463453705|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
128771385|NCT01567865|463453706|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
128771386|NCT01567865|463453707|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
128771387|NCT01567865|463453708|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
128771388|NCT01051063|463453711|FG000|Overall Study|Death|2|||
128771389|NCT01051063|463453712|FG001|Overall Study|Death|2|||
128771390|NCT01051063|463453711|FG000|Overall Study|Withdrawal by Subject|1|||
128771391|NCT01051063|463453712|FG001|Overall Study|Withdrawal by Subject|1|||
128771392|NCT01051063|463453711|FG000|Overall Study|Termination of the study|5|||
128957575|NCT03549117|464129808|FG000|Overall Study|Withdrawal by Subject|1|||
128957576|NCT03549117|464129809|FG001|Overall Study|Withdrawal by Subject|0|||
128957577|NCT00888615|464129811|FG000|Overall Study|No treatment|2|||
128957578|NCT02091921|464129814|FG000|Overall Study|Adverse Event|3|||
128957579|NCT03307629|464129815|FG000|Overall Study|Withdrawal by Subject|0|||
128957580|NCT03307629|464129816|FG001|Overall Study|Withdrawal by Subject|0|||
128957581|NCT03307629|464129817|FG002|Overall Study|Withdrawal by Subject|0|||
128957582|NCT03307629|464129818|FG003|Overall Study|Withdrawal by Subject|2|||
128957583|NCT03307629|464129815|FG000|Overall Study|Disease Progression|0|||
128957584|NCT03307629|464129816|FG001|Overall Study|Disease Progression|0|||
128957585|NCT03307629|464129817|FG002|Overall Study|Disease Progression|0|||
128957586|NCT03307629|464129818|FG003|Overall Study|Disease Progression|3|||
128957587|NCT03307629|464129815|FG000|Overall Study|Death|0|||
128957588|NCT03307629|464129816|FG001|Overall Study|Death|3|||
128957589|NCT03307629|464129817|FG002|Overall Study|Death|0|||
128957590|NCT03307629|464129818|FG003|Overall Study|Death|1|||
128712596|NCT01103284|463243924|FG000|Overall Study|Adverse Event|0|||
128771393|NCT01051063|463453712|FG001|Overall Study|Termination of the study|0|||
128771394|NCT01051063|463453711|FG000|Overall Study|Moved from the study site area|1|||
128771395|NCT01051063|463453712|FG001|Overall Study|Moved from the study site area|0|||
128771396|NCT01051063|463453711|FG000|Overall Study|Other|1|||
128771397|NCT01051063|463453712|FG001|Overall Study|Other|0|||
128771398|NCT01051063|463453711|FG000|Overall Study|Lost to Follow-up|0|||
128771399|NCT01051063|463453712|FG001|Overall Study|Lost to Follow-up|1|||
128712597|NCT01103284|463243925|FG001|Overall Study|Adverse Event|5|||
128712598|NCT01103284|463243924|FG000|Overall Study|Withdrawal by Subject|14|||
128712599|NCT01103284|463243925|FG001|Overall Study|Withdrawal by Subject|18|||
128771400|NCT03857841|463453714|FG000|Overall Study|Death|1|||
128771401|NCT03857841|463453715|FG001|Overall Study|Death|0|||
128771402|NCT03857841|463453716|FG002|Overall Study|Death|0|||
128771403|NCT03857841|463453717|FG003|Overall Study|Death|0|||
128771404|NCT03857841|463453714|FG000|Overall Study|Study Terminated by Sponsor|1|||
128771405|NCT03857841|463453715|FG001|Overall Study|Study Terminated by Sponsor|0|||
128957591|NCT00719953|464129823|FG000|Overall Study|Adverse Event|4|||
128957592|NCT01626989|464129824|FG000|Screening Period|Screen Failure|15|||
128957593|NCT01626989|464129825|FG001|Screening Period|Screen Failure|0|||
128957594|NCT01626989|464129826|FG002|Screening Period|Screen Failure|0|||
128712600|NCT01103284|463243924|FG000|Overall Study|Dermal Hypersensitivity|0|||
128712601|NCT01103284|463243925|FG001|Overall Study|Dermal Hypersensitivity|1|||
128771406|NCT03857841|463453716|FG002|Overall Study|Study Terminated by Sponsor|0|||
128771407|NCT03857841|463453717|FG003|Overall Study|Study Terminated by Sponsor|0|||
128771408|NCT04921969|463453718|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
128771409|NCT04921969|463453719|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
128771410|NCT04921969|463453720|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
129126694|NCT04725188|464757996|FG001|Overall Study|Sponsor Decision|12|||
129126695|NCT04725188|464757997|FG002|Overall Study|Sponsor Decision|7|||
129126696|NCT03765073|464757998|FG000|Stage 1|Lost to Follow-up|1|||
129126697|NCT03765073|464757999|FG001|Stage 1|Lost to Follow-up|0|||
129126698|NCT03765073|464758000|FG002|Stage 1|Lost to Follow-up|0|||
129126699|NCT03765073|464758001|FG003|Stage 1|Lost to Follow-up|0|||
129126700|NCT03765073|464758002|FG004|Stage 1|Lost to Follow-up|0|||
129126701|NCT03765073|464758003|FG005|Stage 1|Lost to Follow-up|0|||
129126702|NCT03765073|464758004|FG006|Stage 1|Lost to Follow-up|0|||
129126703|NCT03765073|464758005|FG007|Stage 1|Lost to Follow-up|0|||
129126704|NCT03765073|464758006|FG008|Stage 1|Lost to Follow-up|0|||
129126705|NCT03765073|464758007|FG009|Stage 1|Lost to Follow-up|0|||
128771411|NCT04921969|463453721|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
128771412|NCT04921969|463453722|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
128771413|NCT04921969|463453723|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
128771414|NCT04921969|463453724|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
128771415|NCT04921969|463453718|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
128771416|NCT04921969|463453719|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128771417|NCT04921969|463453720|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128771418|NCT04921969|463453721|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128771419|NCT04921969|463453722|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128771420|NCT04921969|463453723|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128771421|NCT04921969|463453724|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128771422|NCT04921969|463453718|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
128771423|NCT04921969|463453719|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
128771424|NCT04921969|463453720|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
128771425|NCT04921969|463453721|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128771426|NCT04921969|463453722|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128771427|NCT04921969|463453723|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128771428|NCT04921969|463453724|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128957595|NCT01626989|464129824|FG000|Screening Period|Withdrawal by Subject|2|||
129126706|NCT03765073|464758008|FG010|Stage 1|Lost to Follow-up|0|||
128771429|NCT04921969|463453718|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
128771430|NCT04921969|463453719|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
128771431|NCT04921969|463453720|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
129126707|NCT03765073|464758009|FG011|Stage 1|Lost to Follow-up|0|||
129126708|NCT03765073|464758010|FG012|Stage 1|Lost to Follow-up|0|||
129126709|NCT03765073|464758011|FG013|Stage 1|Lost to Follow-up|0|||
129126710|NCT03765073|464758012|FG014|Stage 1|Lost to Follow-up|0|||
129126711|NCT03765073|464758013|FG015|Stage 1|Lost to Follow-up|0|||
129126712|NCT03765073|464758014|FG016|Stage 1|Lost to Follow-up|0|||
129126713|NCT03765073|464758015|FG017|Stage 1|Lost to Follow-up|0|||
129126714|NCT03765073|464758016|FG018|Stage 1|Lost to Follow-up|0|||
129126715|NCT03765073|464758017|FG019|Stage 1|Lost to Follow-up|0|||
129126716|NCT03765073|464758018|FG020|Stage 1|Lost to Follow-up|0|||
129126717|NCT03765073|464757998|FG000|Stage 1|Withdrawal by participant|0|||
129126718|NCT03765073|464757999|FG001|Stage 1|Withdrawal by participant|1|||
129126719|NCT03765073|464758000|FG002|Stage 1|Withdrawal by participant|0|||
129126720|NCT03765073|464758001|FG003|Stage 1|Withdrawal by participant|0|||
129219747|NCT00372593|465104569|FG002|Overall Study|Ineligible|1|||
128771432|NCT04921969|463453721|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
128771433|NCT04921969|463453722|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
128771434|NCT04921969|463453723|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
128771435|NCT04921969|463453724|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
128771436|NCT04921969|463453718|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
128771437|NCT04921969|463453719|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
128771438|NCT04921969|463453720|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
128771439|NCT04921969|463453721|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
128771440|NCT04921969|463453722|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
128771441|NCT04921969|463453723|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
128771442|NCT04921969|463453724|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
128771443|NCT04921969|463453718|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
128957596|NCT01626989|464129825|FG001|Screening Period|Withdrawal by Subject|0|||
128957597|NCT01626989|464129826|FG002|Screening Period|Withdrawal by Subject|0|||
128957598|NCT02947022|464129830|FG000|Overall Study|Study Stopped|1|||
129126721|NCT03765073|464758002|FG004|Stage 1|Withdrawal by participant|0|||
129126722|NCT03765073|464758003|FG005|Stage 1|Withdrawal by participant|0|||
129126723|NCT03765073|464758004|FG006|Stage 1|Withdrawal by participant|0|||
129126724|NCT03765073|464758005|FG007|Stage 1|Withdrawal by participant|0|||
129126725|NCT03765073|464758006|FG008|Stage 1|Withdrawal by participant|0|||
129126726|NCT03765073|464758007|FG009|Stage 1|Withdrawal by participant|0|||
128771444|NCT04921969|463453719|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
128771445|NCT04921969|463453720|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
128771446|NCT04921969|463453721|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129126727|NCT03765073|464758008|FG010|Stage 1|Withdrawal by participant|0|||
129126728|NCT03765073|464758009|FG011|Stage 1|Withdrawal by participant|0|||
129126729|NCT03765073|464758010|FG012|Stage 1|Withdrawal by participant|0|||
129036379|NCT01396421|464423498|FG002|Overall Study|Withdrawal by Subject|13|||
128712602|NCT01103284|463243924|FG000|Overall Study|Termination by the Sponsor|0|||
128712603|NCT01103284|463243925|FG001|Overall Study|Termination by the Sponsor|1|||
128712604|NCT01103284|463243924|FG000|Overall Study|Not described|2|||
128712605|NCT01103284|463243925|FG001|Overall Study|Not described|1|||
128712606|NCT01103284|463243924|FG000|Overall Study|Missing CRF entries for study completion|0|||
128712607|NCT01103284|463243925|FG001|Overall Study|Missing CRF entries for study completion|2|||
128712608|NCT00180414|463245886|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
128712609|NCT00180414|463245887|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
128712610|NCT01572909|463245888|FG000|Overall Study|Adverse Event|7|||
128712611|NCT01572909|463245889|FG001|Overall Study|Adverse Event|2|||
128712612|NCT01572909|463245888|FG000|Overall Study|Death|3|||
128712613|NCT01572909|463245889|FG001|Overall Study|Death|1|||
128712614|NCT01572909|463245888|FG000|Overall Study|Lost to Follow-up|8|||
128712615|NCT01572909|463245889|FG001|Overall Study|Lost to Follow-up|7|||
128712616|NCT01572909|463245888|FG000|Overall Study|Physician Decision|1|||
128712617|NCT01572909|463245889|FG001|Overall Study|Physician Decision|1|||
128712618|NCT01572909|463245888|FG000|Overall Study|Technical Issues|1|||
128712619|NCT01572909|463245889|FG001|Overall Study|Technical Issues|0|||
128712620|NCT01572909|463245888|FG000|Overall Study|Withdrawal by Subject|12|||
128712621|NCT01572909|463245889|FG001|Overall Study|Withdrawal by Subject|11|||
128712622|NCT01572909|463245888|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
128712623|NCT01572909|463245889|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
128712624|NCT03641651|463245890|FG000|Overall Study|organizational issues at one study site|1|||
128712625|NCT04779489|463245891|FG000|Overall Study|Physician Decision|1|||
128712626|NCT00623727|463245892|FG000|Double Blind (DB)|Adverse Event|1|||
128712627|NCT00623727|463245893|FG001|Double Blind (DB)|Adverse Event|3|||
128712628|NCT00623727|463245892|FG000|Double Blind (DB)|Physician Decision|0|||
128712629|NCT00623727|463245893|FG001|Double Blind (DB)|Physician Decision|1|||
128712630|NCT00623727|463245892|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
128712631|NCT00623727|463245893|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
128712632|NCT00623727|463245892|FG000|Double Blind (DB)|Lack of Efficacy|2|||
128712633|NCT00623727|463245893|FG001|Double Blind (DB)|Lack of Efficacy|2|||
128712634|NCT00623727|463245892|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
128712635|NCT00623727|463245893|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
128712636|NCT00623727|463245892|FG000|Double Blind (DB)|Lost to Follow-up|1|||
128712637|NCT00623727|463245893|FG001|Double Blind (DB)|Lost to Follow-up|1|||
128712638|NCT00623727|463245892|FG000|Double Blind (DB)|Protocol Violation|2|||
128712639|NCT00623727|463245893|FG001|Double Blind (DB)|Protocol Violation|2|||
128712640|NCT00623727|463245892|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
128712641|NCT00623727|463245893|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
128712642|NCT00623727|463245892|FG000|Open Label Follow-up|Study termination|0|||
128712643|NCT00623727|463245893|FG001|Open Label Follow-up|Study termination|6|||
128712644|NCT00623727|463245892|FG000|Open Label Follow-up|Participant convenience|0|||
128712645|NCT00623727|463245893|FG001|Open Label Follow-up|Participant convenience|1|||
128712646|NCT00951665|463245894|FG000|Phase 1b|Adverse Event|2|||
128712647|NCT00951665|463245895|FG001|Phase 1b|Adverse Event|1|||
128712648|NCT00951665|463245896|FG002|Phase 1b|Adverse Event|0|||
128712649|NCT00951665|463245897|FG003|Phase 1b|Adverse Event|1|||
128712650|NCT00951665|463245898|FG004|Phase 1b|Adverse Event|0|||
128712651|NCT00951665|463245899|FG005|Phase 1b|Adverse Event|0|||
128712652|NCT00951665|463245894|FG000|Phase 1b|Death|1|||
128712653|NCT00951665|463245895|FG001|Phase 1b|Death|0|||
128712654|NCT00951665|463245896|FG002|Phase 1b|Death|2|||
128712655|NCT00951665|463245897|FG003|Phase 1b|Death|0|||
128712656|NCT00951665|463245898|FG004|Phase 1b|Death|0|||
128712657|NCT00951665|463245899|FG005|Phase 1b|Death|0|||
128712658|NCT00951665|463245894|FG000|Phase 1b|Physician Decision|4|||
128712659|NCT00951665|463245895|FG001|Phase 1b|Physician Decision|0|||
129036380|NCT01396421|464423499|FG003|Overall Study|Withdrawal by Subject|21|||
129036381|NCT01396421|464423496|FG000|Overall Study|Protocol Deviation|2|||
129036382|NCT01396421|464423497|FG001|Overall Study|Protocol Deviation|1|||
128712660|NCT00951665|463245896|FG002|Phase 1b|Physician Decision|1|||
128712661|NCT00951665|463245897|FG003|Phase 1b|Physician Decision|0|||
128712662|NCT00951665|463245898|FG004|Phase 1b|Physician Decision|0|||
128712663|NCT00951665|463245899|FG005|Phase 1b|Physician Decision|0|||
128712664|NCT00951665|463245894|FG000|Phase 1b|Withdrawal by Subject|0|||
128712665|NCT00951665|463245895|FG001|Phase 1b|Withdrawal by Subject|1|||
128712666|NCT00951665|463245896|FG002|Phase 1b|Withdrawal by Subject|0|||
128712667|NCT00951665|463245897|FG003|Phase 1b|Withdrawal by Subject|0|||
128712668|NCT00951665|463245898|FG004|Phase 1b|Withdrawal by Subject|0|||
128712669|NCT00951665|463245899|FG005|Phase 1b|Withdrawal by Subject|0|||
128712670|NCT00951665|463245894|FG000|Phase 1b|Disease Progression|13|||
128712671|NCT00951665|463245895|FG001|Phase 1b|Disease Progression|2|||
128712672|NCT00951665|463245896|FG002|Phase 1b|Disease Progression|14|||
128712673|NCT00951665|463245897|FG003|Phase 1b|Disease Progression|0|||
128712674|NCT00951665|463245898|FG004|Phase 1b|Disease Progression|0|||
128712675|NCT00951665|463245899|FG005|Phase 1b|Disease Progression|0|||
128771447|NCT04921969|463453722|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128771448|NCT04921969|463453723|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128771449|NCT04921969|463453724|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128771450|NCT04921969|463453718|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
128771451|NCT04921969|463453719|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
128771452|NCT04921969|463453720|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
128771453|NCT04921969|463453721|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
128771454|NCT04921969|463453722|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
128771455|NCT04921969|463453723|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
128771456|NCT04921969|463453724|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
128771457|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
128771458|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
128771459|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
128957599|NCT01230749|464129831|FG000|Overall Study|Adverse Event|0|||
128957600|NCT01230749|464129832|FG001|Overall Study|Adverse Event|0|||
128957601|NCT01230749|464129833|FG002|Overall Study|Adverse Event|0|||
128957602|NCT01230749|464129834|FG003|Overall Study|Adverse Event|1|||
128957603|NCT01230749|464129831|FG000|Overall Study|Physician Decision|0|||
128957604|NCT01230749|464129832|FG001|Overall Study|Physician Decision|0|||
128957605|NCT01230749|464129833|FG002|Overall Study|Physician Decision|1|||
128957606|NCT01230749|464129834|FG003|Overall Study|Physician Decision|0|||
128957607|NCT01230749|464129831|FG000|Overall Study|Withdrawal by Subject|0|||
128957608|NCT01230749|464129832|FG001|Overall Study|Withdrawal by Subject|1|||
128957609|NCT01230749|464129833|FG002|Overall Study|Withdrawal by Subject|0|||
128957610|NCT01230749|464129834|FG003|Overall Study|Withdrawal by Subject|0|||
128957611|NCT01230749|464129831|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
128957612|NCT01230749|464129832|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
128957613|NCT01230749|464129833|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
128957614|NCT01230749|464129834|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
128957615|NCT04021706|464132043|FG000|Overall Study|Adverse Event|2|||
128957616|NCT04021706|464132044|FG001|Overall Study|Adverse Event|0|||
128957617|NCT04021706|464132043|FG000|Overall Study|Withdrawal by Subject|1|||
128957618|NCT04021706|464132044|FG001|Overall Study|Withdrawal by Subject|2|||
128957619|NCT04021706|464132043|FG000|Overall Study|Physician Decision|1|||
128957620|NCT04021706|464132044|FG001|Overall Study|Physician Decision|0|||
128957621|NCT01412151|464132045|FG000|Week 0 - 306 - Treatment Period|Death|1|||
128957622|NCT01412151|464132045|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
128771460|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
128771461|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
128771462|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
128771463|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
128771464|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128771465|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128771466|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128771467|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
128957623|NCT01412151|464132045|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
128957624|NCT01412151|464132045|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
128957625|NCT03127852|464132047|FG000|Overall Study|Withdrawal by Subject|4|||
128957626|NCT03127852|464132048|FG001|Overall Study|Withdrawal by Subject|1|||
128957627|NCT03127852|464132047|FG000|Overall Study|Death|1|||
129036383|NCT01396421|464423498|FG002|Overall Study|Protocol Deviation|1|||
129036384|NCT01396421|464423499|FG003|Overall Study|Protocol Deviation|0|||
129036385|NCT01396421|464423496|FG000|Overall Study|Lack of Efficacy|7|||
129036386|NCT01396421|464423497|FG001|Overall Study|Lack of Efficacy|17|||
129036387|NCT01396421|464423498|FG002|Overall Study|Lack of Efficacy|7|||
129036388|NCT01396421|464423499|FG003|Overall Study|Lack of Efficacy|18|||
129036389|NCT00569777|464423503|FG000|Overall Study|Withdrawal by Subject|4|||
129036390|NCT00569777|464423504|FG001|Overall Study|Withdrawal by Subject|0|||
129036391|NCT00569777|464423503|FG000|Overall Study|Adverse Event|3|||
129036392|NCT00569777|464423504|FG001|Overall Study|Adverse Event|0|||
129036393|NCT00569777|464423503|FG000|Overall Study|Lost to Follow-up|1|||
129036394|NCT00569777|464423504|FG001|Overall Study|Lost to Follow-up|0|||
128957628|NCT03127852|464132048|FG001|Overall Study|Death|1|||
129036395|NCT00569777|464423503|FG000|Overall Study|scheduled eye surgery|0|||
129036396|NCT00569777|464423504|FG001|Overall Study|scheduled eye surgery|1|||
129036397|NCT00569777|464423503|FG000|Overall Study|did not meet exclusion criteria|1|||
129036398|NCT00569777|464423504|FG001|Overall Study|did not meet exclusion criteria|2|||
129036399|NCT00569777|464423503|FG000|Overall Study|pregnant|1|||
129036400|NCT00569777|464423504|FG001|Overall Study|pregnant|0|||
129126730|NCT03765073|464758011|FG013|Stage 1|Withdrawal by participant|0|||
128957629|NCT00859573|464132050|FG000|Overall Study|Withdrawal by Subject|4|||
129036401|NCT04718129|464423509|FG000|Overall Study|Lost to Follow-up|6|||
129036402|NCT04718129|464423510|FG001|Overall Study|Lost to Follow-up|7|||
129036403|NCT02030535|464423511|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
128957630|NCT00859573|464132051|FG001|Overall Study|Withdrawal by Subject|1|||
128957631|NCT00859573|464132050|FG000|Overall Study|Physician Decision|1|||
128957632|NCT00859573|464132051|FG001|Overall Study|Physician Decision|1|||
128957633|NCT01432457|464132052|FG000|Overall Study|Adverse Event|7|||
128957634|NCT01432457|464132053|FG001|Overall Study|Adverse Event|10|||
128957635|NCT01432457|464132054|FG002|Overall Study|Adverse Event|16|||
128957636|NCT01432457|464132052|FG000|Overall Study|Lack of Efficacy|2|||
128957637|NCT01432457|464132053|FG001|Overall Study|Lack of Efficacy|1|||
128957638|NCT01432457|464132054|FG002|Overall Study|Lack of Efficacy|1|||
128957639|NCT01432457|464132052|FG000|Overall Study|Lost to Follow-up|11|||
128957640|NCT01432457|464132053|FG001|Overall Study|Lost to Follow-up|15|||
128957641|NCT01432457|464132054|FG002|Overall Study|Lost to Follow-up|20|||
128957642|NCT01432457|464132052|FG000|Overall Study|Protocol Violation|3|||
128957643|NCT01432457|464132053|FG001|Overall Study|Protocol Violation|2|||
128957644|NCT01432457|464132054|FG002|Overall Study|Protocol Violation|6|||
128957645|NCT01432457|464132052|FG000|Overall Study|Withdrawal by Subject|6|||
128957646|NCT01432457|464132053|FG001|Overall Study|Withdrawal by Subject|11|||
128957647|NCT01432457|464132054|FG002|Overall Study|Withdrawal by Subject|9|||
128957648|NCT01432457|464132052|FG000|Overall Study|Reasons not defined|2|||
128957649|NCT01432457|464132053|FG001|Overall Study|Reasons not defined|3|||
128957650|NCT01432457|464132054|FG002|Overall Study|Reasons not defined|4|||
128957651|NCT01432457|464132052|FG000|Overall Study|Did not take study drug|6|||
128957652|NCT01432457|464132053|FG001|Overall Study|Did not take study drug|6|||
128957653|NCT01432457|464132054|FG002|Overall Study|Did not take study drug|3|||
128957654|NCT02574481|464132055|FG000|Overall Study|Withdrawal by Subject|29|||
128957655|NCT02574481|464132056|FG001|Overall Study|Withdrawal by Subject|15|||
128957656|NCT02574481|464132057|FG002|Overall Study|Withdrawal by Subject|4|||
128957657|NCT02574481|464132058|FG003|Overall Study|Withdrawal by Subject|1|||
128957658|NCT02574481|464132055|FG000|Overall Study|Adverse Event|5|||
128957659|NCT02574481|464132056|FG001|Overall Study|Adverse Event|1|||
128957660|NCT02574481|464132057|FG002|Overall Study|Adverse Event|1|||
128957661|NCT02574481|464132058|FG003|Overall Study|Adverse Event|0|||
128957662|NCT02574481|464132055|FG000|Overall Study|Visit Missed|15|||
128957663|NCT02574481|464132056|FG001|Overall Study|Visit Missed|7|||
128957664|NCT02574481|464132057|FG002|Overall Study|Visit Missed|5|||
128957665|NCT02574481|464132058|FG003|Overall Study|Visit Missed|0|||
128957666|NCT02574481|464132055|FG000|Overall Study|Other|7|||
128957667|NCT02574481|464132056|FG001|Overall Study|Other|2|||
128957668|NCT02574481|464132057|FG002|Overall Study|Other|0|||
128957669|NCT02574481|464132058|FG003|Overall Study|Other|0|||
128957670|NCT02574481|464132055|FG000|Overall Study|Death|48|||
128957671|NCT02574481|464132056|FG001|Overall Study|Death|26|||
128957672|NCT02574481|464132057|FG002|Overall Study|Death|12|||
128957673|NCT02574481|464132058|FG003|Overall Study|Death|4|||
129126731|NCT03765073|464758012|FG014|Stage 1|Withdrawal by participant|0|||
129126732|NCT03765073|464758013|FG015|Stage 1|Withdrawal by participant|0|||
129126733|NCT03765073|464758014|FG016|Stage 1|Withdrawal by participant|0|||
128712676|NCT00951665|463245894|FG000|Phase 1b|Protocol Violation|2|||
128712677|NCT00951665|463245895|FG001|Phase 1b|Protocol Violation|0|||
128712678|NCT00951665|463245896|FG002|Phase 1b|Protocol Violation|0|||
128712679|NCT00951665|463245897|FG003|Phase 1b|Protocol Violation|0|||
128712680|NCT00951665|463245898|FG004|Phase 1b|Protocol Violation|0|||
128712681|NCT00951665|463245899|FG005|Phase 1b|Protocol Violation|0|||
128712682|NCT00951665|463245894|FG000|Phase 2a|Adverse Event|0|||
128712683|NCT00951665|463245895|FG001|Phase 2a|Adverse Event|0|||
128712684|NCT00951665|463245896|FG002|Phase 2a|Adverse Event|0|||
128712685|NCT00951665|463245897|FG003|Phase 2a|Adverse Event|0|||
128712686|NCT00951665|463245898|FG004|Phase 2a|Adverse Event|2|||
128712687|NCT00951665|463245899|FG005|Phase 2a|Adverse Event|0|||
128712688|NCT00951665|463245894|FG000|Phase 2a|Death|0|||
128712689|NCT00951665|463245895|FG001|Phase 2a|Death|0|||
128712690|NCT00951665|463245896|FG002|Phase 2a|Death|0|||
128712691|NCT00951665|463245897|FG003|Phase 2a|Death|0|||
128712692|NCT00951665|463245898|FG004|Phase 2a|Death|1|||
128712693|NCT00951665|463245899|FG005|Phase 2a|Death|1|||
128712694|NCT00951665|463245894|FG000|Phase 2a|Lost to Follow-up|0|||
128712695|NCT00951665|463245895|FG001|Phase 2a|Lost to Follow-up|0|||
128712696|NCT00951665|463245896|FG002|Phase 2a|Lost to Follow-up|0|||
128712697|NCT00951665|463245897|FG003|Phase 2a|Lost to Follow-up|0|||
128712698|NCT00951665|463245898|FG004|Phase 2a|Lost to Follow-up|1|||
128712699|NCT00951665|463245899|FG005|Phase 2a|Lost to Follow-up|0|||
128712700|NCT00951665|463245894|FG000|Phase 2a|Physician Decision|0|||
128712701|NCT00951665|463245895|FG001|Phase 2a|Physician Decision|0|||
128712702|NCT00951665|463245896|FG002|Phase 2a|Physician Decision|0|||
128712703|NCT00951665|463245897|FG003|Phase 2a|Physician Decision|0|||
128712704|NCT00951665|463245898|FG004|Phase 2a|Physician Decision|0|||
128712705|NCT00951665|463245899|FG005|Phase 2a|Physician Decision|1|||
128712706|NCT00951665|463245894|FG000|Phase 2a|Withdrawal by Subject|0|||
128712707|NCT00951665|463245895|FG001|Phase 2a|Withdrawal by Subject|0|||
128712708|NCT00951665|463245896|FG002|Phase 2a|Withdrawal by Subject|0|||
128712709|NCT00951665|463245897|FG003|Phase 2a|Withdrawal by Subject|0|||
128957674|NCT02574481|464132055|FG000|Overall Study|Physician Decision|5|||
128957675|NCT02574481|464132056|FG001|Overall Study|Physician Decision|2|||
128957676|NCT02574481|464132057|FG002|Overall Study|Physician Decision|0|||
128957677|NCT02574481|464132058|FG003|Overall Study|Physician Decision|0|||
128957678|NCT02574481|464132055|FG000|Overall Study|Lost to Follow-up|5|||
128957679|NCT02574481|464132056|FG001|Overall Study|Lost to Follow-up|1|||
128957680|NCT02574481|464132057|FG002|Overall Study|Lost to Follow-up|3|||
128957681|NCT02574481|464132058|FG003|Overall Study|Lost to Follow-up|0|||
128957682|NCT04134728|464132059|FG000|Overall Study|Adverse Event|3|||
128957683|NCT04134728|464132060|FG001|Overall Study|Adverse Event|2|||
128957684|NCT04134728|464132061|FG002|Overall Study|Adverse Event|9|||
128957685|NCT04134728|464132062|FG003|Overall Study|Adverse Event|0|||
128957686|NCT04134728|464132063|FG004|Overall Study|Adverse Event|0|||
128957687|NCT04134728|464132064|FG005|Overall Study|Adverse Event|0|||
128957688|NCT04134728|464132059|FG000|Overall Study|Lack of Efficacy|3|||
128957689|NCT04134728|464132060|FG001|Overall Study|Lack of Efficacy|3|||
128957690|NCT04134728|464132061|FG002|Overall Study|Lack of Efficacy|1|||
128957691|NCT04134728|464132062|FG003|Overall Study|Lack of Efficacy|2|||
128957692|NCT04134728|464132063|FG004|Overall Study|Lack of Efficacy|0|||
128957693|NCT04134728|464132064|FG005|Overall Study|Lack of Efficacy|0|||
129219748|NCT00433004|465104570|FG000|Overall Study|Lost to Follow-up|5|||
129219749|NCT00433004|465104571|FG001|Overall Study|Lost to Follow-up|7|||
129219750|NCT03534180|465104572|FG000|Overall Study|Withdrawal by Subject|1|||
129219751|NCT00220636|465104573|FG000|Overall Study|Withdrawal by Subject|4|||
129219752|NCT00330967|465104574|FG000|Overall Study|Withdrawal by Subject|0|||
129219753|NCT00330967|465104575|FG001|Overall Study|Withdrawal by Subject|5|||
129219754|NCT00330967|465104574|FG000|Overall Study|Physician Decision|0|||
129219755|NCT00330967|465104575|FG001|Overall Study|Physician Decision|9|||
129219756|NCT00790088|465104578|FG000|Overall Study|Protocol Violation|11|||
128957694|NCT04134728|464132059|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
128957695|NCT04134728|464132060|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129219757|NCT00790088|465104578|FG000|Overall Study|Withdrawal by Subject|17|||
128712710|NCT00951665|463245898|FG004|Phase 2a|Withdrawal by Subject|2|||
128712711|NCT00951665|463245899|FG005|Phase 2a|Withdrawal by Subject|0|||
128712712|NCT00951665|463245894|FG000|Phase 2a|Disease Progression|0|||
128712713|NCT00951665|463245895|FG001|Phase 2a|Disease Progression|0|||
128712714|NCT00951665|463245896|FG002|Phase 2a|Disease Progression|0|||
128712715|NCT00951665|463245897|FG003|Phase 2a|Disease Progression|0|||
128712716|NCT00951665|463245898|FG004|Phase 2a|Disease Progression|6|||
128712717|NCT00951665|463245899|FG005|Phase 2a|Disease Progression|5|||
128712718|NCT01199289|463245900|FG000|Overall Study|Ineligibility determined|2|||
128712719|NCT01199289|463245901|FG001|Overall Study|Ineligibility determined|1|||
128712720|NCT01199289|463245902|FG002|Overall Study|Ineligibility determined|0|||
128712721|NCT01199289|463245903|FG003|Overall Study|Ineligibility determined|0|||
128712722|NCT01199289|463245900|FG000|Overall Study|Protocol Violation|1|||
128712723|NCT01199289|463245901|FG001|Overall Study|Protocol Violation|0|||
128712724|NCT01199289|463245902|FG002|Overall Study|Protocol Violation|0|||
128712725|NCT01199289|463245903|FG003|Overall Study|Protocol Violation|1|||
128712726|NCT01199289|463245900|FG000|Overall Study|Noncompliance|1|||
128712727|NCT01199289|463245901|FG001|Overall Study|Noncompliance|0|||
128712728|NCT01199289|463245902|FG002|Overall Study|Noncompliance|2|||
128712729|NCT01199289|463245903|FG003|Overall Study|Noncompliance|0|||
128712730|NCT01199289|463245900|FG000|Overall Study|Adverse Event|0|||
128712731|NCT01199289|463245901|FG001|Overall Study|Adverse Event|3|||
128712732|NCT01199289|463245902|FG002|Overall Study|Adverse Event|1|||
128712733|NCT01199289|463245903|FG003|Overall Study|Adverse Event|4|||
128712734|NCT01199289|463245900|FG000|Overall Study|Full consent withdrawn|2|||
128712735|NCT01199289|463245901|FG001|Overall Study|Full consent withdrawn|2|||
128712736|NCT01199289|463245902|FG002|Overall Study|Full consent withdrawn|2|||
128712737|NCT01199289|463245903|FG003|Overall Study|Full consent withdrawn|3|||
128712738|NCT01199289|463245900|FG000|Overall Study|Administrative decision|0|||
128712739|NCT01199289|463245901|FG001|Overall Study|Administrative decision|0|||
128712740|NCT01199289|463245902|FG002|Overall Study|Administrative decision|0|||
128712741|NCT01199289|463245903|FG003|Overall Study|Administrative decision|1|||
128712742|NCT01199289|463245900|FG000|Overall Study|Lost to Follow-up|0|||
128957696|NCT04134728|464132061|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
128712743|NCT01199289|463245901|FG001|Overall Study|Lost to Follow-up|0|||
128712744|NCT01199289|463245902|FG002|Overall Study|Lost to Follow-up|0|||
128712745|NCT01199289|463245903|FG003|Overall Study|Lost to Follow-up|1|||
128712746|NCT01199289|463245900|FG000|Overall Study|Protocol-specified criteria|3|||
128957697|NCT04134728|464132062|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128957698|NCT04134728|464132063|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128957699|NCT04134728|464132064|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128957700|NCT04134728|464132059|FG000|Overall Study|Protocol Deviation|0|||
129219758|NCT00790088|465104578|FG000|Overall Study|Lost to Follow-up|7|||
129219759|NCT00790088|465104578|FG000|Overall Study|Physician Decision|4|||
128712747|NCT01199289|463245901|FG001|Overall Study|Protocol-specified criteria|0|||
128712748|NCT01199289|463245902|FG002|Overall Study|Protocol-specified criteria|0|||
128712749|NCT01199289|463245903|FG003|Overall Study|Protocol-specified criteria|1|||
128712750|NCT01199289|463245900|FG000|Overall Study|Pregnancy|0|||
128957701|NCT04134728|464132060|FG001|Overall Study|Protocol Deviation|0|||
128957702|NCT04134728|464132061|FG002|Overall Study|Protocol Deviation|1|||
128957703|NCT04134728|464132062|FG003|Overall Study|Protocol Deviation|0|||
128957704|NCT04134728|464132063|FG004|Overall Study|Protocol Deviation|0|||
128957705|NCT04134728|464132064|FG005|Overall Study|Protocol Deviation|0|||
128957706|NCT04134728|464132059|FG000|Overall Study|Informed Consent Withdrawn|3|||
128957707|NCT04134728|464132060|FG001|Overall Study|Informed Consent Withdrawn|6|||
128957708|NCT04134728|464132061|FG002|Overall Study|Informed Consent Withdrawn|8|||
129126734|NCT03765073|464758015|FG017|Stage 1|Withdrawal by participant|0|||
129126735|NCT03765073|464758016|FG018|Stage 1|Withdrawal by participant|0|||
129126736|NCT03765073|464758017|FG019|Stage 1|Withdrawal by participant|0|||
129126737|NCT03765073|464758018|FG020|Stage 1|Withdrawal by participant|0|||
129126738|NCT03765073|464757998|FG000|Stage 2|Death|0|||
129126739|NCT03765073|464757999|FG001|Stage 2|Death|0|||
129126740|NCT03765073|464758000|FG002|Stage 2|Death|0|||
129126741|NCT03765073|464758001|FG003|Stage 2|Death|0|||
129126742|NCT03765073|464758002|FG004|Stage 2|Death|0|||
129126743|NCT03765073|464758003|FG005|Stage 2|Death|0|||
129126744|NCT03765073|464758004|FG006|Stage 2|Death|0|||
129126745|NCT03765073|464758005|FG007|Stage 2|Death|0|||
129126746|NCT03765073|464758006|FG008|Stage 2|Death|0|||
129126747|NCT03765073|464758007|FG009|Stage 2|Death|1|||
129126748|NCT03765073|464758008|FG010|Stage 2|Death|0|||
129126749|NCT03765073|464758009|FG011|Stage 2|Death|1|||
128712751|NCT01199289|463245901|FG001|Overall Study|Pregnancy|1|||
128712752|NCT01199289|463245902|FG002|Overall Study|Pregnancy|0|||
128712753|NCT01199289|463245903|FG003|Overall Study|Pregnancy|1|||
128712754|NCT02723084|463245904|FG000|Overall Study|Withdrawal by Subject|1|||
128712755|NCT02723084|463245905|FG001|Overall Study|Withdrawal by Subject|1|||
128712756|NCT02723084|463245904|FG000|Overall Study|Lost to Follow-up|3|||
128712757|NCT02723084|463245905|FG001|Overall Study|Lost to Follow-up|0|||
128712758|NCT05024058|463245908|FG000|Treatment|Study terminated by sponsor|5|||
128712759|NCT05024058|463245909|FG001|Treatment|Study terminated by sponsor|6|||
128712760|NCT05024058|463245910|FG002|Treatment|Study terminated by sponsor|4|||
128712761|NCT05024058|463245911|FG003|Treatment|Study terminated by sponsor|2|||
128712762|NCT05024058|463245912|FG004|Treatment|Study terminated by sponsor|3|||
128712763|NCT05024058|463245913|FG005|Treatment|Study terminated by sponsor|3|||
128712764|NCT05024058|463245914|FG006|Treatment|Study terminated by sponsor|1|||
128712765|NCT05024058|463245915|FG007|Treatment|Study terminated by sponsor|3|||
128712766|NCT05024058|463245916|FG008|Treatment|Study terminated by sponsor|6|||
128712767|NCT05024058|463245917|FG009|Treatment|Study terminated by sponsor|6|||
128712768|NCT05024058|463245908|FG000|Follow-up|Withdrawal by Subject|1|||
128712769|NCT05024058|463245909|FG001|Follow-up|Withdrawal by Subject|0|||
128712770|NCT05024058|463245910|FG002|Follow-up|Withdrawal by Subject|1|||
128712771|NCT05024058|463245911|FG003|Follow-up|Withdrawal by Subject|0|||
128712772|NCT05024058|463245912|FG004|Follow-up|Withdrawal by Subject|0|||
128712773|NCT05024058|463245913|FG005|Follow-up|Withdrawal by Subject|0|||
128712774|NCT05024058|463245914|FG006|Follow-up|Withdrawal by Subject|0|||
128712775|NCT05024058|463245915|FG007|Follow-up|Withdrawal by Subject|1|||
128712776|NCT05024058|463245916|FG008|Follow-up|Withdrawal by Subject|0|||
128712777|NCT05024058|463245917|FG009|Follow-up|Withdrawal by Subject|1|||
128712778|NCT00501293|463245918|FG000|Optimization Period|Enrolled in error|1|||
128712779|NCT00501293|463245919|FG001|Optimization Period|Enrolled in error|0|||
128712780|NCT00501293|463245918|FG000|Maintenance Period|Withdrawal by Subject|14|||
128712781|NCT00501293|463245919|FG001|Maintenance Period|Withdrawal by Subject|13|||
128712782|NCT00501293|463245918|FG000|Maintenance Period|Lost to Follow-up|12|||
128712783|NCT00501293|463245919|FG001|Maintenance Period|Lost to Follow-up|7|||
128712784|NCT00501293|463245918|FG000|Maintenance Period|Adverse Event|6|||
128712785|NCT00501293|463245919|FG001|Maintenance Period|Adverse Event|6|||
128712786|NCT00501293|463245918|FG000|Maintenance Period|Protocol Violation|2|||
128712787|NCT00501293|463245919|FG001|Maintenance Period|Protocol Violation|1|||
128712788|NCT00501293|463245918|FG000|Maintenance Period|Lack of Efficacy|4|||
128712789|NCT00501293|463245919|FG001|Maintenance Period|Lack of Efficacy|1|||
128712790|NCT00501293|463245918|FG000|Maintenance Period|Noncompliant with study medication|5|||
128712791|NCT00501293|463245919|FG001|Maintenance Period|Noncompliant with study medication|0|||
128712792|NCT00501293|463245918|FG000|Maintenance Period|Went into rehabilitation|1|||
128957709|NCT04134728|464132062|FG003|Overall Study|Informed Consent Withdrawn|1|||
129126750|NCT03765073|464758010|FG012|Stage 2|Death|0|||
129126751|NCT03765073|464758011|FG013|Stage 2|Death|0|||
129126752|NCT03765073|464758012|FG014|Stage 2|Death|0|||
128712793|NCT00501293|463245919|FG001|Maintenance Period|Went into rehabilitation|0|||
128712794|NCT00501293|463245918|FG000|Maintenance Period|Would not wear patch|1|||
128712795|NCT00501293|463245919|FG001|Maintenance Period|Would not wear patch|0|||
128957710|NCT04134728|464132063|FG004|Overall Study|Informed Consent Withdrawn|1|||
128957711|NCT04134728|464132064|FG005|Overall Study|Informed Consent Withdrawn|0|||
129126753|NCT03765073|464758013|FG015|Stage 2|Death|0|||
129126754|NCT03765073|464758014|FG016|Stage 2|Death|2|||
129126755|NCT03765073|464758015|FG017|Stage 2|Death|0|||
129126756|NCT03765073|464758016|FG018|Stage 2|Death|0|||
128957712|NCT04134728|464132059|FG000|Overall Study|Physician Decision|2|||
128957713|NCT04134728|464132060|FG001|Overall Study|Physician Decision|0|||
128957714|NCT04134728|464132061|FG002|Overall Study|Physician Decision|0|||
128957715|NCT04134728|464132062|FG003|Overall Study|Physician Decision|0|||
128957716|NCT04134728|464132063|FG004|Overall Study|Physician Decision|0|||
128957717|NCT04134728|464132064|FG005|Overall Study|Physician Decision|0|||
128957718|NCT04134728|464132059|FG000|Overall Study|Lost to Follow-up|1|||
128957719|NCT04134728|464132060|FG001|Overall Study|Lost to Follow-up|2|||
129126757|NCT03765073|464758017|FG019|Stage 2|Death|0|||
129126758|NCT03765073|464758018|FG020|Stage 2|Death|0|||
129126759|NCT03765073|464757998|FG000|Stage 2|Lost to Follow-up|0|||
129126760|NCT03765073|464757999|FG001|Stage 2|Lost to Follow-up|0|||
129126761|NCT03765073|464758000|FG002|Stage 2|Lost to Follow-up|0|||
129126762|NCT03765073|464758001|FG003|Stage 2|Lost to Follow-up|5|||
129126763|NCT03765073|464758002|FG004|Stage 2|Lost to Follow-up|1|||
129126764|NCT03765073|464758003|FG005|Stage 2|Lost to Follow-up|0|||
129126765|NCT03765073|464758004|FG006|Stage 2|Lost to Follow-up|3|||
129126766|NCT03765073|464758005|FG007|Stage 2|Lost to Follow-up|3|||
129126767|NCT03765073|464758006|FG008|Stage 2|Lost to Follow-up|1|||
129126768|NCT03765073|464758007|FG009|Stage 2|Lost to Follow-up|6|||
129126769|NCT03765073|464758008|FG010|Stage 2|Lost to Follow-up|5|||
129126770|NCT03765073|464758009|FG011|Stage 2|Lost to Follow-up|1|||
129126771|NCT03765073|464758010|FG012|Stage 2|Lost to Follow-up|1|||
129126772|NCT03765073|464758011|FG013|Stage 2|Lost to Follow-up|3|||
128712796|NCT00501293|463245918|FG000|Maintenance Period|Application site reaction|1|||
128712797|NCT00501293|463245919|FG001|Maintenance Period|Application site reaction|0|||
128712798|NCT00127712|463245922|FG000|Overall Study|Adverse Event|3|||
128712799|NCT00127712|463245923|FG001|Overall Study|Adverse Event|0|||
128712800|NCT00127712|463245922|FG000|Overall Study|Lack of GI access to continue|2|||
128712801|NCT00127712|463245923|FG001|Overall Study|Lack of GI access to continue|0|||
128712802|NCT02642614|463245924|FG000|Overall Study|Adverse Event|1|||
128712803|NCT02642614|463245925|FG001|Overall Study|Adverse Event|1|||
128712804|NCT02642614|463245926|FG002|Overall Study|Adverse Event|2|||
128712805|NCT02642614|463245927|FG003|Overall Study|Adverse Event|2|||
128712806|NCT02642614|463245924|FG000|Overall Study|Lost to Follow-up|1|||
128712807|NCT02642614|463245925|FG001|Overall Study|Lost to Follow-up|0|||
128712808|NCT02642614|463245926|FG002|Overall Study|Lost to Follow-up|0|||
128712809|NCT02642614|463245927|FG003|Overall Study|Lost to Follow-up|0|||
128712810|NCT02642614|463245924|FG000|Overall Study|Withdrawal by Subject|1|||
128712811|NCT02642614|463245925|FG001|Overall Study|Withdrawal by Subject|1|||
128712812|NCT02642614|463245926|FG002|Overall Study|Withdrawal by Subject|0|||
128712813|NCT02642614|463245927|FG003|Overall Study|Withdrawal by Subject|0|||
128712814|NCT02450903|463245928|FG000|Overall Study|Adverse Event|3|||
128712815|NCT02450903|463245928|FG000|Overall Study|Progressive disease|15|||
128712816|NCT02450903|463245928|FG000|Overall Study|Switched to commercial drug|1|||
128712817|NCT02450903|463245928|FG000|Overall Study|Subject/guardian decision|1|||
128712818|NCT01164956|463245929|FG000|Overall Study|Side Effects|1|||
128712819|NCT01164956|463245930|FG001|Overall Study|Side Effects|0|||
128712820|NCT01164956|463245931|FG002|Overall Study|Side Effects|1|||
128712821|NCT00967798|463245932|FG000|Overall Study|Withdrawal by Subject|5|||
128712822|NCT00967798|463245933|FG001|Overall Study|Withdrawal by Subject|2|||
128712823|NCT00967798|463245932|FG000|Overall Study|Lost to Follow-up|4|||
128712824|NCT00967798|463245933|FG001|Overall Study|Lost to Follow-up|1|||
128712825|NCT01320085|463245934|FG000|Overall Study|Disease Progression|26|||
128712826|NCT01320085|463245935|FG001|Overall Study|Disease Progression|93|||
128712827|NCT01320085|463245936|FG002|Overall Study|Disease Progression|17|||
128712828|NCT01320085|463245934|FG000|Overall Study|Adverse Event|12|||
128712829|NCT01320085|463245935|FG001|Overall Study|Adverse Event|20|||
128712830|NCT01320085|463245936|FG002|Overall Study|Adverse Event|5|||
128712831|NCT01320085|463245934|FG000|Overall Study|Withdrawal by Subject|2|||
128712832|NCT01320085|463245935|FG001|Overall Study|Withdrawal by Subject|4|||
128712833|NCT01320085|463245936|FG002|Overall Study|Withdrawal by Subject|1|||
128712834|NCT01320085|463245934|FG000|Overall Study|Protocol Deviation|1|||
128712835|NCT01320085|463245935|FG001|Overall Study|Protocol Deviation|0|||
129126773|NCT03765073|464758012|FG014|Stage 2|Lost to Follow-up|3|||
129126774|NCT03765073|464758013|FG015|Stage 2|Lost to Follow-up|1|||
129126775|NCT03765073|464758014|FG016|Stage 2|Lost to Follow-up|6|||
129126776|NCT03765073|464758015|FG017|Stage 2|Lost to Follow-up|0|||
129126777|NCT03765073|464758016|FG018|Stage 2|Lost to Follow-up|0|||
128712836|NCT01320085|463245936|FG002|Overall Study|Protocol Deviation|1|||
128712837|NCT01320085|463245934|FG000|Overall Study|Administrative problems|0|||
128712838|NCT01320085|463245935|FG001|Overall Study|Administrative problems|0|||
128712839|NCT01320085|463245936|FG002|Overall Study|Administrative problems|1|||
128712840|NCT03316131|463245937|FG000|Treatment Period 2|Protocol deviation|1|||
128712841|NCT03316131|463245938|FG001|Treatment Period 2|Protocol deviation|0|||
128712842|NCT01409564|463245939|FG000|Overall Study|low medication compliance|4|||
128712843|NCT01409564|463245940|FG001|Overall Study|low medication compliance|3|||
128957720|NCT04134728|464132061|FG002|Overall Study|Lost to Follow-up|1|||
129126778|NCT03765073|464758017|FG019|Stage 2|Lost to Follow-up|0|||
129126779|NCT03765073|464758018|FG020|Stage 2|Lost to Follow-up|0|||
129126780|NCT03765073|464757998|FG000|Stage 2|Other|0|||
128957721|NCT04134728|464132062|FG003|Overall Study|Lost to Follow-up|0|||
128957722|NCT04134728|464132063|FG004|Overall Study|Lost to Follow-up|0|||
128957723|NCT04134728|464132064|FG005|Overall Study|Lost to Follow-up|1|||
128957724|NCT04134728|464132059|FG000|Overall Study|Investigator Site Closed|0|||
128957725|NCT04134728|464132060|FG001|Overall Study|Investigator Site Closed|1|||
128957726|NCT04134728|464132061|FG002|Overall Study|Investigator Site Closed|1|||
128957727|NCT04134728|464132062|FG003|Overall Study|Investigator Site Closed|0|||
128957728|NCT04134728|464132063|FG004|Overall Study|Investigator Site Closed|0|||
128957729|NCT04134728|464132064|FG005|Overall Study|Investigator Site Closed|0|||
128957730|NCT02905825|464132073|FG000|Overall Study|Protocol Violation|11|||
128957731|NCT02905825|464132073|FG000|Overall Study|Device Malfunction|1|||
128957732|NCT01281189|464132074|FG000|Overall Study|Adverse Event|7|||
128957733|NCT01281189|464132075|FG001|Overall Study|Adverse Event|9|||
128957734|NCT01281189|464132074|FG000|Overall Study|Lost to Follow-up|6|||
128957735|NCT01281189|464132075|FG001|Overall Study|Lost to Follow-up|4|||
128957736|NCT01281189|464132074|FG000|Overall Study|Withdrawal by Subject|21|||
128957737|NCT01281189|464132075|FG001|Overall Study|Withdrawal by Subject|24|||
128957738|NCT01281189|464132074|FG000|Overall Study|Physician Decision|2|||
128957739|NCT01281189|464132075|FG001|Overall Study|Physician Decision|3|||
128957740|NCT01281189|464132074|FG000|Overall Study|Death|103|||
128957741|NCT01281189|464132075|FG001|Overall Study|Death|91|||
128957742|NCT01281189|464132074|FG000|Overall Study|Other|8|||
128957743|NCT01281189|464132075|FG001|Overall Study|Other|12|||
128957744|NCT05355818|464132076|FG000|Overall Study|Adverse Event|1|||
128957745|NCT05355818|464132077|FG001|Overall Study|Adverse Event|1|||
128957746|NCT05355818|464132076|FG000|Overall Study|Lack of Efficacy|2|||
128957747|NCT05355818|464132077|FG001|Overall Study|Lack of Efficacy|1|||
128957748|NCT05355818|464132076|FG000|Overall Study|Lost to Follow-up|0|||
128957749|NCT05355818|464132077|FG001|Overall Study|Lost to Follow-up|1|||
128957750|NCT01136746|464132080|FG000|Overall Study|Lost to Follow-up|0|||
128957751|NCT01136746|464132081|FG001|Overall Study|Lost to Follow-up|2|||
128957752|NCT01136746|464132080|FG000|Overall Study|Protocol Violation|2|||
128957753|NCT01136746|464132081|FG001|Overall Study|Protocol Violation|1|||
128957754|NCT01136746|464132080|FG000|Overall Study|Death|1|||
128957755|NCT01136746|464132081|FG001|Overall Study|Death|0|||
128957756|NCT00092677|464132091|FG000|Overall Study|Lost to Follow-up|0|||
128957757|NCT00092677|464132092|FG001|Overall Study|Lost to Follow-up|2|||
128957758|NCT00092677|464132091|FG000|Overall Study|Adminstrative|5|||
128957759|NCT00092677|464132092|FG001|Overall Study|Adminstrative|9|||
128957760|NCT01090102|464132093|FG000|First 12 Weeks|Withdrawal by Subject|1|||
128957761|NCT01090102|464132094|FG001|First 12 Weeks|Withdrawal by Subject|1|||
128957762|NCT01090102|464132093|FG000|First 12 Weeks|Adverse Event|2|||
128957763|NCT01090102|464132094|FG001|First 12 Weeks|Adverse Event|0|||
128957764|NCT01090102|464132093|FG000|First 12 Weeks|Death|1|||
128957765|NCT01090102|464132094|FG001|First 12 Weeks|Death|1|||
128957766|NCT01090102|464132093|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
128957767|NCT01090102|464132094|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
128957768|NCT01601704|464132095|FG000|Overall Study|Randomized but not dispensed study med|1|||
128957769|NCT01601704|464132096|FG001|Overall Study|Randomized but not dispensed study med|4|||
128957770|NCT03518034|464132097|FG000|Overall Study|Not Treated|5|||
129036404|NCT01588548|464423512|FG000|Overall Study|Withdrawal by Subject|0|||
129036405|NCT01588548|464423513|FG001|Overall Study|Withdrawal by Subject|1|||
129036406|NCT01588548|464423514|FG002|Overall Study|Withdrawal by Subject|1|||
129036407|NCT01588548|464423515|FG003|Overall Study|Withdrawal by Subject|1|||
129036408|NCT01588548|464423516|FG004|Overall Study|Withdrawal by Subject|2|||
129036409|NCT01588548|464423517|FG005|Overall Study|Withdrawal by Subject|3|||
129126781|NCT03765073|464757999|FG001|Stage 2|Other|0|||
129126782|NCT03765073|464758000|FG002|Stage 2|Other|0|||
129126783|NCT03765073|464758001|FG003|Stage 2|Other|0|||
128957771|NCT03518034|464132098|FG001|Overall Study|Not Treated|1|||
129036410|NCT01588548|464423512|FG000|Overall Study|Adverse Event|0|||
129036411|NCT01588548|464423513|FG001|Overall Study|Adverse Event|0|||
129036412|NCT01588548|464423514|FG002|Overall Study|Adverse Event|1|||
129036413|NCT01588548|464423515|FG003|Overall Study|Adverse Event|2|||
129036414|NCT01588548|464423516|FG004|Overall Study|Adverse Event|1|||
129036415|NCT01588548|464423517|FG005|Overall Study|Adverse Event|0|||
128957772|NCT03518034|464132097|FG000|Overall Study|Withdrawal by Subject|309|||
128957773|NCT03518034|464132098|FG001|Overall Study|Withdrawal by Subject|351|||
128957774|NCT03518034|464132097|FG000|Overall Study|Lost to Follow-up|446|||
128957775|NCT03518034|464132098|FG001|Overall Study|Lost to Follow-up|458|||
128957776|NCT03518034|464132097|FG000|Overall Study|Adverse Event|138|||
128957777|NCT03518034|464132098|FG001|Overall Study|Adverse Event|130|||
128957778|NCT03518034|464132097|FG000|Overall Study|Lack of Efficacy|11|||
128957779|NCT03518034|464132098|FG001|Overall Study|Lack of Efficacy|23|||
128957780|NCT03518034|464132097|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
128957781|NCT03518034|464132098|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
129036416|NCT01588548|464423512|FG000|Overall Study|Condition Under Investigation Worsened|3|||
129036417|NCT01588548|464423513|FG001|Overall Study|Condition Under Investigation Worsened|6|||
129036418|NCT01588548|464423514|FG002|Overall Study|Condition Under Investigation Worsened|4|||
129126784|NCT03765073|464758002|FG004|Stage 2|Other|0|||
128957782|NCT03518034|464132097|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
128957783|NCT03518034|464132098|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
128957784|NCT03518034|464132097|FG000|Overall Study|Other, Not Specified|84|||
128957785|NCT03518034|464132098|FG001|Overall Study|Other, Not Specified|53|||
128957786|NCT03518034|464132097|FG000|Overall Study|Reason Missing|2|||
128957787|NCT03518034|464132098|FG001|Overall Study|Reason Missing|3|||
128957788|NCT00010803|464132104|FG000|Overall Study|Withdrawal by Subject|97|||
128957789|NCT00010803|464132105|FG001|Overall Study|Withdrawal by Subject|98|||
128957790|NCT01019252|464132106|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
128957791|NCT01019252|464132107|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
128957792|NCT01019252|464132106|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
128957793|NCT01019252|464132107|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
128957794|NCT01019252|464132106|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
128957795|NCT01019252|464132107|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
128957796|NCT01019252|464132106|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
128957797|NCT01019252|464132107|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
128957798|NCT02273037|464132108|FG000|Overall Study|Lost to Follow-up|1|||
128957799|NCT02273037|464132109|FG001|Overall Study|Lost to Follow-up|0|||
128957800|NCT02273037|464132108|FG000|Overall Study|Delivered before monitoring initiated|1|||
128957801|NCT02273037|464132109|FG001|Overall Study|Delivered before monitoring initiated|3|||
128957802|NCT02273037|464132108|FG000|Overall Study|Breech delivery|2|||
128957803|NCT02273037|464132109|FG001|Overall Study|Breech delivery|3|||
128957804|NCT02273037|464132108|FG000|Overall Study|Multiple delivery|2|||
128957805|NCT02273037|464132109|FG001|Overall Study|Multiple delivery|2|||
128957806|NCT02273037|464132108|FG000|Overall Study|Other complication|2|||
128957807|NCT02273037|464132109|FG001|Overall Study|Other complication|0|||
128957808|NCT00985738|464132114|FG000|Overall Study|Study closed prematurely|8|||
128957809|NCT00985738|464132115|FG001|Overall Study|Study closed prematurely|8|||
128957810|NCT02227849|464132117|FG000|Overall Study|Adverse Event|4|||
128957811|NCT02227849|464132117|FG000|Overall Study|Physician Decision|1|||
128957812|NCT02227849|464132117|FG000|Overall Study|Withdrawal by Subject|3|||
128957813|NCT01590212|464132120|FG000|Overall Study|Withdrawal by Subject|2|||
128957814|NCT01590212|464132121|FG001|Overall Study|Withdrawal by Subject|2|||
128957815|NCT01590212|464132122|FG002|Overall Study|Withdrawal by Subject|2|||
128957816|NCT01590212|464132120|FG000|Overall Study|Lost to Follow-up|1|||
128957817|NCT01590212|464132121|FG001|Overall Study|Lost to Follow-up|2|||
128957818|NCT01590212|464132122|FG002|Overall Study|Lost to Follow-up|3|||
128957819|NCT04897594|464132126|FG000|Overall Study|Lost to Follow-up|0|||
128957820|NCT04897594|464132127|FG001|Overall Study|Lost to Follow-up|1|||
128957821|NCT04897594|464132128|FG002|Overall Study|Lost to Follow-up|1|||
128957822|NCT04897594|464132126|FG000|Overall Study|Sponsor Decision|0|||
128957823|NCT04897594|464132127|FG001|Overall Study|Sponsor Decision|0|||
128957824|NCT04897594|464132128|FG002|Overall Study|Sponsor Decision|1|||
128957825|NCT04897594|464132126|FG000|Overall Study|Withdrawal by Subject|1|||
128957826|NCT04897594|464132127|FG001|Overall Study|Withdrawal by Subject|0|||
128957827|NCT04897594|464132128|FG002|Overall Study|Withdrawal by Subject|1|||
128957828|NCT00150345|464132131|FG000|Overall Study|Death|5|||
128957829|NCT00150345|464132132|FG001|Overall Study|Death|2|||
128957830|NCT00150345|464132131|FG000|Overall Study|Adverse Event|8|||
128957831|NCT00150345|464132132|FG001|Overall Study|Adverse Event|6|||
128957832|NCT00150345|464132131|FG000|Overall Study|Lack of Efficacy|5|||
128957833|NCT00150345|464132132|FG001|Overall Study|Lack of Efficacy|4|||
128957834|NCT00150345|464132131|FG000|Overall Study|Withdrawal by Subject|3|||
128957835|NCT00150345|464132132|FG001|Overall Study|Withdrawal by Subject|4|||
128957836|NCT00150345|464132131|FG000|Overall Study|Laboratory abnormality|1|||
128957837|NCT00150345|464132132|FG001|Overall Study|Laboratory abnormality|2|||
128957838|NCT00150345|464132131|FG000|Overall Study|Other|12|||
129126785|NCT03765073|464758003|FG005|Stage 2|Other|0|||
129126786|NCT03765073|464758004|FG006|Stage 2|Other|0|||
129126787|NCT03765073|464758005|FG007|Stage 2|Other|1|||
129126788|NCT03765073|464758006|FG008|Stage 2|Other|1|||
129126789|NCT03765073|464758007|FG009|Stage 2|Other|3|||
128957839|NCT00150345|464132132|FG001|Overall Study|Other|14|||
128957840|NCT01457924|464132135|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
128957841|NCT01457924|464132136|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
128957842|NCT01457924|464132137|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
128957843|NCT01457924|464132138|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
128957844|NCT01457924|464132139|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
128957845|NCT01457924|464132135|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
128957846|NCT01457924|464132136|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
129126790|NCT03765073|464758008|FG010|Stage 2|Other|0|||
129126791|NCT03765073|464758009|FG011|Stage 2|Other|0|||
128957847|NCT01457924|464132137|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
128957848|NCT01457924|464132138|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
128957849|NCT01457924|464132139|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
129126792|NCT03765073|464758010|FG012|Stage 2|Other|0|||
129126793|NCT03765073|464758011|FG013|Stage 2|Other|0|||
128957850|NCT01457924|464132135|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
128957851|NCT01457924|464132136|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
128957852|NCT01457924|464132137|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
128957853|NCT01457924|464132138|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
128957854|NCT01457924|464132139|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
128957855|NCT01457924|464132135|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
128957856|NCT01457924|464132136|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
128957857|NCT01457924|464132137|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
128957858|NCT01457924|464132138|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
128957859|NCT01457924|464132139|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
128957860|NCT01457924|464132135|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
128957861|NCT01457924|464132136|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
128957862|NCT01457924|464132137|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
128957863|NCT01457924|464132138|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
128957864|NCT01457924|464132139|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
128957865|NCT01457924|464132135|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
128957866|NCT01457924|464132136|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
128957867|NCT01457924|464132137|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
128957868|NCT01457924|464132138|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
128957869|NCT01457924|464132139|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
128957870|NCT01457924|464132135|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
128957871|NCT01457924|464132136|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
128957872|NCT01457924|464132137|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
128957873|NCT01457924|464132138|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
128957874|NCT01457924|464132139|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
128957875|NCT01457924|464132135|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
128957876|NCT01457924|464132136|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
128957877|NCT01457924|464132137|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
128957878|NCT01457924|464132138|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
128957879|NCT01457924|464132139|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
128957880|NCT01457924|464132135|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
128957881|NCT01457924|464132136|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
128957882|NCT01457924|464132137|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
128957883|NCT01457924|464132138|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
128957884|NCT01457924|464132139|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
128957885|NCT01457924|464132135|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
128957886|NCT01457924|464132136|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
128957887|NCT01457924|464132137|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
128957888|NCT01457924|464132138|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
128957889|NCT01457924|464132139|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
128957890|NCT01457924|464132135|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
128957891|NCT01457924|464132136|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
128957892|NCT01457924|464132137|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
128957893|NCT01457924|464132138|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
128957894|NCT01457924|464132139|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
128957895|NCT01457924|464132135|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
128957896|NCT01457924|464132136|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
128957897|NCT01457924|464132137|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
128957898|NCT01457924|464132138|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
128957899|NCT01457924|464132139|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
128957900|NCT01457924|464132135|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
128957901|NCT01457924|464132136|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
128957902|NCT01457924|464132137|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
128957903|NCT01457924|464132138|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
128957904|NCT01457924|464132139|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
128957905|NCT00636441|464132145|FG000|Overall Study|Adverse Event|0|||
128957906|NCT00636441|464132146|FG001|Overall Study|Adverse Event|1|||
129036419|NCT01588548|464423515|FG003|Overall Study|Condition Under Investigation Worsened|4|||
129036420|NCT01588548|464423516|FG004|Overall Study|Condition Under Investigation Worsened|3|||
129036421|NCT01588548|464423517|FG005|Overall Study|Condition Under Investigation Worsened|3|||
129036422|NCT01835548|464423518|FG000|Dose Optimization Period|Adverse Event|0|||
129036423|NCT01835548|464423519|FG001|Dose Optimization Period|Adverse Event|0|||
129036424|NCT01835548|464423520|FG002|Dose Optimization Period|Adverse Event|1|||
129036425|NCT01835548|464423518|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
129036426|NCT01835548|464423519|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
129036427|NCT01835548|464423520|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
129036428|NCT01835548|464423518|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128957907|NCT00636441|464132147|FG002|Overall Study|Adverse Event|1|||
128957908|NCT00636441|464132148|FG003|Overall Study|Adverse Event|0|||
128957909|NCT00636441|464132149|FG004|Overall Study|Adverse Event|0|||
128957910|NCT00636441|464132150|FG005|Overall Study|Adverse Event|1|||
128957911|NCT00636441|464132151|FG006|Overall Study|Adverse Event|0|||
128957912|NCT00636441|464132145|FG000|Overall Study|Late, ineligible|0|||
128957913|NCT00636441|464132146|FG001|Overall Study|Late, ineligible|0|||
129219760|NCT05661409|465104579|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
129219761|NCT05661409|465104580|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
129219762|NCT05661409|465104581|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
128957914|NCT00636441|464132147|FG002|Overall Study|Late, ineligible|0|||
128957915|NCT00636441|464132148|FG003|Overall Study|Late, ineligible|0|||
128957916|NCT00636441|464132149|FG004|Overall Study|Late, ineligible|0|||
128957917|NCT00636441|464132150|FG005|Overall Study|Late, ineligible|0|||
128957918|NCT00636441|464132151|FG006|Overall Study|Late, ineligible|1|||
128957919|NCT00636441|464132145|FG000|Overall Study|Screen Failure|0|||
128957920|NCT00636441|464132146|FG001|Overall Study|Screen Failure|0|||
128957921|NCT00636441|464132147|FG002|Overall Study|Screen Failure|0|||
128957922|NCT00636441|464132148|FG003|Overall Study|Screen Failure|0|||
128957923|NCT00636441|464132149|FG004|Overall Study|Screen Failure|0|||
128957924|NCT00636441|464132150|FG005|Overall Study|Screen Failure|0|||
128957925|NCT00636441|464132151|FG006|Overall Study|Screen Failure|17|||
128957926|NCT03495817|464132152|FG000|26 Week Open Label|Adverse Event|3|||
128957927|NCT03495817|464132152|FG000|26 Week Open Label|Withdrawal by Subject|4|||
128957928|NCT03495817|464132152|FG000|26 Week Open Label|Lost to Follow-up|1|||
128957929|NCT03495817|464132152|FG000|26 Week Extension|Lost to Follow-up|2|||
128957930|NCT04585451|464132157|FG000|Overall Study|Withdrawal by Subject|26|||
128957931|NCT04585451|464132158|FG001|Overall Study|Withdrawal by Subject|0|||
128957932|NCT00326417|464132159|FG000|Overall Study|Withdrawal by Subject|0|||
128957933|NCT00326417|464132160|FG001|Overall Study|Withdrawal by Subject|0|||
128957934|NCT00326417|464132161|FG002|Overall Study|Withdrawal by Subject|1|||
128957935|NCT00326417|464132162|FG003|Overall Study|Withdrawal by Subject|0|||
128957936|NCT00326417|464132159|FG000|Overall Study|Arm Closed|7|||
128957937|NCT00326417|464132160|FG001|Overall Study|Arm Closed|0|||
128957938|NCT00326417|464132161|FG002|Overall Study|Arm Closed|0|||
128957939|NCT00326417|464132162|FG003|Overall Study|Arm Closed|3|||
128957940|NCT00326417|464132159|FG000|Overall Study|Death|7|||
128957941|NCT00326417|464132160|FG001|Overall Study|Death|0|||
128957942|NCT00326417|464132161|FG002|Overall Study|Death|0|||
128957943|NCT00326417|464132162|FG003|Overall Study|Death|0|||
128957944|NCT00844285|464132163|FG000|Overall Study|Other|0|||
128957945|NCT00844285|464132164|FG001|Overall Study|Other|1|||
128957946|NCT00844285|464132165|FG002|Overall Study|Other|0|||
128957947|NCT00844285|464132163|FG000|Overall Study|Other than specified|95|||
128957948|NCT00844285|464132164|FG001|Overall Study|Other than specified|129|||
128957949|NCT00844285|464132165|FG002|Overall Study|Other than specified|12|||
128957950|NCT00844285|464132163|FG000|Overall Study|Site closure|256|||
128957951|NCT00844285|464132164|FG001|Overall Study|Site closure|450|||
128957952|NCT00844285|464132165|FG002|Overall Study|Site closure|50|||
128957953|NCT00844285|464132163|FG000|Overall Study|Follow-up < 8 years|16|||
128957954|NCT00844285|464132164|FG001|Overall Study|Follow-up < 8 years|23|||
128957955|NCT00844285|464132165|FG002|Overall Study|Follow-up < 8 years|4|||
129219763|NCT05661409|465104582|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
129219764|NCT05661409|465104583|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
129219765|NCT05661409|465104584|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
129219766|NCT05661409|465104579|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
129219767|NCT05661409|465104580|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
129219768|NCT05661409|465104581|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
129219769|NCT05661409|465104582|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
129219770|NCT05661409|465104583|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
129219771|NCT05661409|465104584|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
129219772|NCT05661409|465104579|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
128957956|NCT00844285|464132163|FG000|Overall Study|Protocol Violation|26|||
128957957|NCT00844285|464132164|FG001|Overall Study|Protocol Violation|28|||
129036429|NCT01835548|464423519|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129036430|NCT01835548|464423520|FG002|Double-Blind Treatment Period|Adverse Event|0|||
128957958|NCT00844285|464132165|FG002|Overall Study|Protocol Violation|54|||
128957959|NCT00844285|464132163|FG000|Overall Study|Death|22|||
128957960|NCT00844285|464132164|FG001|Overall Study|Death|21|||
128957961|NCT00844285|464132165|FG002|Overall Study|Death|8|||
129219773|NCT05661409|465104580|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
128957962|NCT00844285|464132163|FG000|Overall Study|Withdrew Consent|344|||
128957963|NCT00844285|464132164|FG001|Overall Study|Withdrew Consent|466|||
128957964|NCT00844285|464132165|FG002|Overall Study|Withdrew Consent|70|||
128957965|NCT00844285|464132163|FG000|Overall Study|Lost to Follow-up|330|||
128957966|NCT00844285|464132164|FG001|Overall Study|Lost to Follow-up|486|||
128957967|NCT00844285|464132165|FG002|Overall Study|Lost to Follow-up|74|||
128957968|NCT03219567|464132168|FG000|Overall Study|Withdrawal by Subject|0|||
128957969|NCT03219567|464132169|FG001|Overall Study|Withdrawal by Subject|1|||
128957970|NCT02849626|464132170|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
129036431|NCT01835548|464423518|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129036432|NCT01835548|464423519|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129036433|NCT01835548|464423520|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129036434|NCT03257254|464423521|FG000|Overall Study|Withdrawal by Subject|7|||
129036435|NCT03257254|464423521|FG000|Overall Study|Lost to Follow-up|9|||
129036436|NCT03257254|464423521|FG000|Overall Study|Study discontinued by sponsor|5|||
129036437|NCT00537017|464423522|FG000|Treatment Phase|Adverse Event|19|||
129036438|NCT00537017|464423522|FG000|Treatment Phase|Withdrawal by Subject|13|||
129036439|NCT00537017|464423522|FG000|Treatment Phase|Protocol Violation|2|||
129036440|NCT00537017|464423522|FG000|Follow-up Phase|Withdrawal by Subject|9|||
129036441|NCT03168906|464423527|FG000|Overall Study|Lack of Efficacy|6|||
129036442|NCT03168906|464423528|FG001|Overall Study|Lack of Efficacy|6|||
129036443|NCT01321697|464423529|FG000|Overall Study|Study Terminated|7|||
129036444|NCT00857818|464423532|FG000|Overall Study|Lack of Efficacy|1|||
129036445|NCT00857818|464423533|FG001|Overall Study|Lack of Efficacy|0|||
129036446|NCT00857818|464423532|FG000|Overall Study|Adverse Event|3|||
129036447|NCT00857818|464423533|FG001|Overall Study|Adverse Event|0|||
129036448|NCT00857818|464423532|FG000|Overall Study|Withdrawal by Subject|0|||
129036449|NCT00857818|464423533|FG001|Overall Study|Withdrawal by Subject|4|||
129036450|NCT00857818|464423532|FG000|Overall Study|Sponsor terminated study|6|||
129036451|NCT00857818|464423533|FG001|Overall Study|Sponsor terminated study|4|||
129036452|NCT00857818|464423532|FG000|Overall Study|Investigator decision|1|||
129036453|NCT00857818|464423533|FG001|Overall Study|Investigator decision|0|||
129036454|NCT02839798|464425025|FG000|Overall Study|Withdrawal by Subject|2|||
129036455|NCT02447887|464425026|FG000|Overall Study|Study was terminated|3|||
129036456|NCT00401245|464425029|FG000|Double Blind Titration Phase|Adverse Event|3|||
129036457|NCT00401245|464425030|FG001|Double Blind Titration Phase|Adverse Event|2|||
129036458|NCT00401245|464425031|FG002|Double Blind Titration Phase|Adverse Event|5|||
129036459|NCT00401245|464425032|FG003|Double Blind Titration Phase|Adverse Event|12|||
129036460|NCT00401245|464425033|FG004|Double Blind Titration Phase|Adverse Event|0|||
129036461|NCT00401245|464425034|FG005|Double Blind Titration Phase|Adverse Event|0|||
128712844|NCT01409564|463245939|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
129036462|NCT00401245|464425035|FG006|Double Blind Titration Phase|Adverse Event|0|||
129036463|NCT00401245|464425036|FG007|Double Blind Titration Phase|Adverse Event|0|||
129036464|NCT00401245|464425029|FG000|Double Blind Titration Phase|Other|0|||
129036465|NCT00401245|464425030|FG001|Double Blind Titration Phase|Other|0|||
128712845|NCT01409564|463245940|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
129036466|NCT00401245|464425031|FG002|Double Blind Titration Phase|Other|1|||
129036467|NCT00401245|464425032|FG003|Double Blind Titration Phase|Other|0|||
129036468|NCT00401245|464425033|FG004|Double Blind Titration Phase|Other|0|||
129036469|NCT00401245|464425034|FG005|Double Blind Titration Phase|Other|0|||
129036470|NCT00401245|464425035|FG006|Double Blind Titration Phase|Other|0|||
129036471|NCT00401245|464425036|FG007|Double Blind Titration Phase|Other|0|||
129036472|NCT00401245|464425029|FG000|Double Blind Titration Phase|Protocol Violation|0|||
129036473|NCT00401245|464425030|FG001|Double Blind Titration Phase|Protocol Violation|0|||
129036474|NCT00401245|464425031|FG002|Double Blind Titration Phase|Protocol Violation|0|||
129036475|NCT00401245|464425032|FG003|Double Blind Titration Phase|Protocol Violation|1|||
129036476|NCT00401245|464425033|FG004|Double Blind Titration Phase|Protocol Violation|0|||
129036477|NCT00401245|464425034|FG005|Double Blind Titration Phase|Protocol Violation|0|||
129036478|NCT00401245|464425035|FG006|Double Blind Titration Phase|Protocol Violation|0|||
129036479|NCT00401245|464425036|FG007|Double Blind Titration Phase|Protocol Violation|0|||
129036480|NCT00401245|464425029|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
129036481|NCT00401245|464425030|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
129036482|NCT00401245|464425031|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
129036483|NCT00401245|464425032|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
129036484|NCT00401245|464425033|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
129036485|NCT00401245|464425034|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
129036486|NCT00401245|464425035|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
129036487|NCT00401245|464425036|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
129036488|NCT00401245|464425029|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129036489|NCT00401245|464425030|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
129036490|NCT00401245|464425031|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129036491|NCT00401245|464425032|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
129036492|NCT00401245|464425033|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129036493|NCT00401245|464425034|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129036494|NCT00401245|464425035|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129036495|NCT00401245|464425036|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129036496|NCT00401245|464425029|FG000|Open Label Phase|Adverse Event|5|||
129036497|NCT00401245|464425030|FG001|Open Label Phase|Adverse Event|14|||
129036498|NCT00401245|464425031|FG002|Open Label Phase|Adverse Event|6|||
129036499|NCT00401245|464425032|FG003|Open Label Phase|Adverse Event|7|||
128957971|NCT02849626|464132171|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
128957972|NCT02849626|464132172|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
128957973|NCT02849626|464132173|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
128957974|NCT02849626|464132170|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
128957975|NCT02849626|464132171|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
128957976|NCT02849626|464132172|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
128957977|NCT02849626|464132173|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
128957978|NCT02849626|464132170|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
128957979|NCT02849626|464132171|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
128957980|NCT02849626|464132172|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
128957981|NCT02849626|464132173|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
128957982|NCT02849626|464132170|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
128957983|NCT02849626|464132171|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
128957984|NCT02849626|464132172|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
128957985|NCT02849626|464132173|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
128957986|NCT02849626|464132170|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
128957987|NCT02849626|464132171|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
128957988|NCT02849626|464132172|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
128957989|NCT02849626|464132173|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
128957990|NCT02849626|464132170|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
128957991|NCT02849626|464132171|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
128957992|NCT02849626|464132172|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
128957993|NCT02849626|464132173|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
128957994|NCT02849626|464132170|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
128957995|NCT02849626|464132171|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
128957996|NCT02849626|464132172|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
128957997|NCT02849626|464132173|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
128957998|NCT02849626|464132170|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
128957999|NCT02849626|464132171|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
128958000|NCT02849626|464132172|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
128958001|NCT02849626|464132173|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
128958002|NCT02849626|464132170|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
128958003|NCT02849626|464132171|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
128958004|NCT02849626|464132172|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
128958005|NCT02849626|464132173|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
128958006|NCT02849626|464132170|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
128958007|NCT02849626|464132171|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
128958008|NCT02849626|464132172|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
128958009|NCT02849626|464132173|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
128958010|NCT02849626|464132170|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
128958011|NCT02849626|464132171|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
128958012|NCT02849626|464132172|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
128958013|NCT02849626|464132173|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
128958014|NCT01313208|464132174|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
128958015|NCT01313208|464132175|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
128958016|NCT01313208|464132174|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
128958017|NCT01313208|464132175|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
128958018|NCT01313208|464132174|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
128958019|NCT01313208|464132175|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
128958020|NCT01313208|464132174|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
128958021|NCT01313208|464132175|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
128958022|NCT01313208|464132174|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
128958023|NCT01313208|464132175|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
128958024|NCT01313208|464132174|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
128958025|NCT01313208|464132175|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
128958026|NCT01313208|464132174|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
128958027|NCT01313208|464132175|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
128958028|NCT01313208|464132174|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
128958029|NCT01313208|464132175|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
128958030|NCT01313208|464132174|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
128958031|NCT01313208|464132175|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
128958032|NCT01654523|464132176|FG000|Overall Study|Withdrawal by Subject|1|||
128958033|NCT01957787|464132177|FG000|Overall Study|Death|18|||
128958034|NCT01957787|464132177|FG000|Overall Study|Lost to Follow-up|3|||
129219774|NCT05661409|465104581|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
128958035|NCT01957787|464132177|FG000|Overall Study|Withdrawal by Subject|3|||
128958036|NCT01957787|464132177|FG000|Overall Study|Entered Hospice or Similar Program|2|||
128958037|NCT01957787|464132177|FG000|Overall Study|Index Tumor(s) Resected|2|||
128958038|NCT01957787|464132177|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
128958039|NCT01957787|464132177|FG000|Overall Study|Local therapy, not cryoablation|6|||
128958040|NCT04176445|464132178|FG000|Overall Study|Adverse Event|0|||
128958041|NCT04176445|464132179|FG001|Overall Study|Adverse Event|1|||
128958042|NCT04176445|464132178|FG000|Overall Study|change plans weaning after first intervention|0|||
128958043|NCT04176445|464132179|FG001|Overall Study|change plans weaning after first intervention|1|||
128958044|NCT00405652|464132180|FG000|Overall Study|Adverse Event|4|||
128958045|NCT00435994|464132182|FG000|Overall Study|Lost to Follow-up|7|||
128958046|NCT00435994|464132183|FG001|Overall Study|Lost to Follow-up|0|||
128958047|NCT00435994|464132184|FG002|Overall Study|Lost to Follow-up|0|||
128958048|NCT03846219|464132188|FG000|Overall Study|Withdrawal by Subject|3|||
128958049|NCT03846219|464132189|FG001|Overall Study|Withdrawal by Subject|2|||
128958050|NCT03846219|464132190|FG002|Overall Study|Withdrawal by Subject|2|||
128958051|NCT03846219|464132188|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
128958052|NCT03846219|464132189|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
128958053|NCT03846219|464132190|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
128958054|NCT03846219|464132188|FG000|Overall Study|Physician Decision|0|||
128958055|NCT03846219|464132189|FG001|Overall Study|Physician Decision|0|||
128958056|NCT03846219|464132190|FG002|Overall Study|Physician Decision|2|||
128958057|NCT05109702|464132191|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
128958058|NCT05109702|464132192|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
128958059|NCT05109702|464132193|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
128958060|NCT05109702|464132191|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
128958061|NCT05109702|464132192|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
128958062|NCT05109702|464132193|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
128958063|NCT05109702|464132191|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
128958064|NCT05109702|464132192|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
128958065|NCT05109702|464132193|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
128958066|NCT05109702|464132191|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
128958067|NCT05109702|464132192|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
128958068|NCT05109702|464132193|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
128958069|NCT05109702|464132191|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
128958070|NCT05109702|464132192|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
128958071|NCT05109702|464132193|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
128958072|NCT01392378|464132198|FG000|Infant Series|Adverse Event|0|||
128958073|NCT01392378|464132199|FG001|Infant Series|Adverse Event|0|||
128958074|NCT01392378|464132200|FG002|Infant Series|Adverse Event|0|||
128958075|NCT01392378|464132201|FG003|Infant Series|Adverse Event|1|||
128958076|NCT01392378|464132202|FG004|Infant Series|Adverse Event|0|||
128958077|NCT01392378|464132198|FG000|Infant Series|Lost to Follow-up|0|||
128958078|NCT01392378|464132199|FG001|Infant Series|Lost to Follow-up|0|||
128958079|NCT01392378|464132200|FG002|Infant Series|Lost to Follow-up|0|||
128958080|NCT01392378|464132201|FG003|Infant Series|Lost to Follow-up|1|||
128958081|NCT01392378|464132202|FG004|Infant Series|Lost to Follow-up|0|||
128958082|NCT01392378|464132198|FG000|Infant Series|Protocol Violation|0|||
128958083|NCT01392378|464132199|FG001|Infant Series|Protocol Violation|1|||
128958084|NCT01392378|464132200|FG002|Infant Series|Protocol Violation|0|||
128958085|NCT01392378|464132201|FG003|Infant Series|Protocol Violation|0|||
128958086|NCT01392378|464132202|FG004|Infant Series|Protocol Violation|0|||
128958087|NCT01392378|464132198|FG000|Infant Series|Withdrawal by Parent|4|||
128958088|NCT01392378|464132199|FG001|Infant Series|Withdrawal by Parent|1|||
128958089|NCT01392378|464132200|FG002|Infant Series|Withdrawal by Parent|0|||
128958090|NCT01392378|464132201|FG003|Infant Series|Withdrawal by Parent|0|||
128958091|NCT01392378|464132202|FG004|Infant Series|Withdrawal by Parent|0|||
128958092|NCT01392378|464132198|FG000|After Infant Series|Lost to Follow-up|0|||
128958093|NCT01392378|464132199|FG001|After Infant Series|Lost to Follow-up|0|||
128958094|NCT01392378|464132200|FG002|After Infant Series|Lost to Follow-up|1|||
128958095|NCT01392378|464132201|FG003|After Infant Series|Lost to Follow-up|0|||
128958096|NCT01392378|464132202|FG004|After Infant Series|Lost to Follow-up|0|||
128958097|NCT01392378|464132198|FG000|After Infant Series|Withdrawal by Parent|0|||
128958098|NCT01392378|464132199|FG001|After Infant Series|Withdrawal by Parent|1|||
128958099|NCT01392378|464132200|FG002|After Infant Series|Withdrawal by Parent|1|||
128958100|NCT01392378|464132201|FG003|After Infant Series|Withdrawal by Parent|0|||
128958101|NCT01392378|464132202|FG004|After Infant Series|Withdrawal by Parent|1|||
128958102|NCT01392378|464132198|FG000|Toddler Dose|Lost to Follow-up|0|||
128958103|NCT01392378|464132199|FG001|Toddler Dose|Lost to Follow-up|0|||
128958104|NCT01392378|464132200|FG002|Toddler Dose|Lost to Follow-up|0|||
128958105|NCT01392378|464132201|FG003|Toddler Dose|Lost to Follow-up|1|||
128958106|NCT01392378|464132202|FG004|Toddler Dose|Lost to Follow-up|0|||
128958107|NCT01392378|464132198|FG000|Toddler Dose|Withdrawal by Parent|0|||
128958108|NCT01392378|464132199|FG001|Toddler Dose|Withdrawal by Parent|1|||
128958109|NCT01392378|464132200|FG002|Toddler Dose|Withdrawal by Parent|0|||
128958110|NCT01392378|464132201|FG003|Toddler Dose|Withdrawal by Parent|1|||
128958111|NCT01392378|464132202|FG004|Toddler Dose|Withdrawal by Parent|1|||
128958112|NCT02322411|464132207|FG000|Overall Study|Lost to Follow-up|4|||
128958113|NCT02322411|464132208|FG001|Overall Study|Lost to Follow-up|7|||
128958114|NCT02322411|464132207|FG000|Overall Study|Withdrawal by Subject|1|||
128958115|NCT02322411|464132208|FG001|Overall Study|Withdrawal by Subject|0|||
128958116|NCT02713789|464132210|FG000|Overall Study|Lost to Follow-up|0|||
128958117|NCT02713789|464132211|FG001|Overall Study|Lost to Follow-up|1|||
128958118|NCT02713789|464132212|FG002|Overall Study|Lost to Follow-up|1|||
128958119|NCT00903370|464132213|FG000|Overall Study|Death|13|||
128958120|NCT00903370|464132214|FG001|Overall Study|Death|10|||
128958121|NCT00903370|464132213|FG000|Overall Study|Withdrawal by Subject|9|||
128958122|NCT00903370|464132214|FG001|Overall Study|Withdrawal by Subject|6|||
128958123|NCT00903370|464132213|FG000|Overall Study|Lost to Follow-up|6|||
128958124|NCT00903370|464132214|FG001|Overall Study|Lost to Follow-up|8|||
128958125|NCT00367432|464132215|FG000|First Period (16 Weeks)|Adverse Event|6|||
128958126|NCT00367432|464132216|FG001|First Period (16 Weeks)|Adverse Event|0|||
128958127|NCT00367432|464132215|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
128958128|NCT00367432|464132216|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
128958129|NCT00367432|464132215|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
128958130|NCT00367432|464132216|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
128958131|NCT00367432|464132215|FG000|First Period (16 Weeks)|Other Reason|2|||
128958132|NCT00367432|464132216|FG001|First Period (16 Weeks)|Other Reason|0|||
128958133|NCT00367432|464132215|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
128958134|NCT00367432|464132216|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
128958135|NCT00367432|464132215|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
128958136|NCT00367432|464132216|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
128958137|NCT00367432|464132215|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
128958138|NCT00367432|464132216|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
128958139|NCT00367432|464132215|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
128958140|NCT00367432|464132216|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
128958141|NCT00367432|464132215|FG000|Second Period (up to 54 Months)|Other Reason|6|||
128958142|NCT00367432|464132216|FG001|Second Period (up to 54 Months)|Other Reason|2|||
128958143|NCT00014911|464132217|FG000|Overall Study|Adverse Event|1|||
128958144|NCT00014911|464132217|FG000|Overall Study|Lost to Follow-up|1|||
128958145|NCT00014911|464132217|FG000|Overall Study|Withdrawal by Subject|6|||
128958146|NCT00014911|464132217|FG000|Overall Study|Unknown Reasons|2|||
128958147|NCT00014911|464132217|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
128958148|NCT01924299|464132218|FG000|Period 2|Withdrawal by Subject|1|||
128958149|NCT01924299|464132219|FG001|Period 2|Withdrawal by Subject|0|||
128958150|NCT01924299|464132218|FG000|Period 2|Adverse Event|0|||
128958151|NCT01924299|464132219|FG001|Period 2|Adverse Event|1|||
128958152|NCT01999946|464132223|FG000|Overall Study|Participant not released from jail|2|||
128958153|NCT01999946|464132224|FG001|Overall Study|Participant not released from jail|2|||
128958154|NCT01999946|464132225|FG002|Overall Study|Participant not released from jail|0|||
128958155|NCT01999946|464132223|FG000|Overall Study|Not included in primary outcome analysis|0|||
128958156|NCT01999946|464132224|FG001|Overall Study|Not included in primary outcome analysis|0|||
128958157|NCT01999946|464132225|FG002|Overall Study|Not included in primary outcome analysis|79|||
128958158|NCT00355134|464133415|FG000|Core Phase|Withdrawal by Subject|35|||
128958159|NCT00355134|464133416|FG001|Core Phase|Withdrawal by Subject|24|||
128958160|NCT00355134|464133417|FG002|Core Phase|Withdrawal by Subject|35|||
128958161|NCT00355134|464133418|FG003|Core Phase|Withdrawal by Subject|0|||
128958162|NCT00355134|464133419|FG004|Core Phase|Withdrawal by Subject|0|||
128958163|NCT00355134|464133415|FG000|Core Phase|Adverse Event|28|||
128958164|NCT00355134|464133416|FG001|Core Phase|Adverse Event|22|||
128958165|NCT00355134|464133417|FG002|Core Phase|Adverse Event|16|||
128958166|NCT00355134|464133418|FG003|Core Phase|Adverse Event|0|||
129219775|NCT05661409|465104582|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
128958167|NCT00355134|464133419|FG004|Core Phase|Adverse Event|0|||
128958168|NCT00355134|464133415|FG000|Core Phase|Lost to Follow-up|17|||
128958169|NCT00355134|464133416|FG001|Core Phase|Lost to Follow-up|13|||
128958170|NCT00355134|464133417|FG002|Core Phase|Lost to Follow-up|21|||
128958171|NCT00355134|464133418|FG003|Core Phase|Lost to Follow-up|0|||
128958172|NCT00355134|464133419|FG004|Core Phase|Lost to Follow-up|0|||
128958173|NCT00355134|464133415|FG000|Core Phase|Abnormal laboratory value(s)|19|||
129036500|NCT00401245|464425033|FG004|Open Label Phase|Adverse Event|0|||
129036501|NCT00401245|464425034|FG005|Open Label Phase|Adverse Event|0|||
129036502|NCT00401245|464425035|FG006|Open Label Phase|Adverse Event|0|||
129036503|NCT00401245|464425036|FG007|Open Label Phase|Adverse Event|0|||
129036504|NCT00401245|464425029|FG000|Open Label Phase|Lost to Follow-up|5|||
129036505|NCT00401245|464425030|FG001|Open Label Phase|Lost to Follow-up|7|||
129036506|NCT00401245|464425031|FG002|Open Label Phase|Lost to Follow-up|5|||
129036507|NCT00401245|464425032|FG003|Open Label Phase|Lost to Follow-up|4|||
129036508|NCT00401245|464425033|FG004|Open Label Phase|Lost to Follow-up|0|||
129036509|NCT00401245|464425034|FG005|Open Label Phase|Lost to Follow-up|0|||
129036510|NCT00401245|464425035|FG006|Open Label Phase|Lost to Follow-up|0|||
129036511|NCT00401245|464425036|FG007|Open Label Phase|Lost to Follow-up|0|||
129036512|NCT00401245|464425029|FG000|Open Label Phase|Other|4|||
129036513|NCT00401245|464425030|FG001|Open Label Phase|Other|8|||
129036514|NCT00401245|464425031|FG002|Open Label Phase|Other|7|||
129036515|NCT00401245|464425032|FG003|Open Label Phase|Other|8|||
128958174|NCT00355134|464133416|FG001|Core Phase|Abnormal laboratory value(s)|14|||
128958175|NCT00355134|464133417|FG002|Core Phase|Abnormal laboratory value(s)|2|||
128958176|NCT00355134|464133418|FG003|Core Phase|Abnormal laboratory value(s)|0|||
128958177|NCT00355134|464133419|FG004|Core Phase|Abnormal laboratory value(s)|0|||
128958178|NCT00355134|464133415|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
128958179|NCT00355134|464133416|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
128958180|NCT00355134|464133417|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
128958181|NCT00355134|464133418|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
128958182|NCT00355134|464133419|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
128958183|NCT00355134|464133415|FG000|Core Phase|Administrative problems|5|||
128958184|NCT00355134|464133416|FG001|Core Phase|Administrative problems|3|||
128958185|NCT00355134|464133417|FG002|Core Phase|Administrative problems|5|||
128958186|NCT00355134|464133418|FG003|Core Phase|Administrative problems|0|||
128958187|NCT00355134|464133419|FG004|Core Phase|Administrative problems|0|||
128958188|NCT00355134|464133415|FG000|Core Phase|Protocol Violation|3|||
128958189|NCT00355134|464133416|FG001|Core Phase|Protocol Violation|2|||
128958190|NCT00355134|464133417|FG002|Core Phase|Protocol Violation|2|||
128958191|NCT00355134|464133418|FG003|Core Phase|Protocol Violation|0|||
128958192|NCT00355134|464133419|FG004|Core Phase|Protocol Violation|0|||
128958193|NCT00355134|464133415|FG000|Core Phase|Abnormal test procedure result(s)|1|||
128958194|NCT00355134|464133416|FG001|Core Phase|Abnormal test procedure result(s)|2|||
128958195|NCT00355134|464133417|FG002|Core Phase|Abnormal test procedure result(s)|1|||
128958196|NCT00355134|464133418|FG003|Core Phase|Abnormal test procedure result(s)|0|||
128958197|NCT00355134|464133419|FG004|Core Phase|Abnormal test procedure result(s)|0|||
128958198|NCT00355134|464133415|FG000|Core Phase|Condition no longer requires study drug|1|||
128958199|NCT00355134|464133416|FG001|Core Phase|Condition no longer requires study drug|0|||
128958200|NCT00355134|464133417|FG002|Core Phase|Condition no longer requires study drug|1|||
128958201|NCT00355134|464133418|FG003|Core Phase|Condition no longer requires study drug|0|||
128958202|NCT00355134|464133419|FG004|Core Phase|Condition no longer requires study drug|0|||
128958203|NCT00355134|464133415|FG000|Extension Phase|Withdrawal by Subject|7|||
128958204|NCT00355134|464133416|FG001|Extension Phase|Withdrawal by Subject|11|||
128958205|NCT00355134|464133417|FG002|Extension Phase|Withdrawal by Subject|0|||
128958206|NCT00355134|464133418|FG003|Extension Phase|Withdrawal by Subject|7|||
128958207|NCT00355134|464133419|FG004|Extension Phase|Withdrawal by Subject|5|||
128958208|NCT00355134|464133415|FG000|Extension Phase|Adverse Event|13|||
128958209|NCT00355134|464133416|FG001|Extension Phase|Adverse Event|9|||
128958210|NCT00355134|464133417|FG002|Extension Phase|Adverse Event|0|||
128958211|NCT00355134|464133418|FG003|Extension Phase|Adverse Event|3|||
128958212|NCT00355134|464133419|FG004|Extension Phase|Adverse Event|5|||
128958213|NCT00355134|464133415|FG000|Extension Phase|Lost to Follow-up|2|||
128958214|NCT00355134|464133416|FG001|Extension Phase|Lost to Follow-up|6|||
128958215|NCT00355134|464133417|FG002|Extension Phase|Lost to Follow-up|0|||
129126794|NCT03765073|464758012|FG014|Stage 2|Other|0|||
129126795|NCT03765073|464758013|FG015|Stage 2|Other|1|||
129126796|NCT03765073|464758014|FG016|Stage 2|Other|2|||
129126797|NCT03765073|464758015|FG017|Stage 2|Other|0|||
129126798|NCT03765073|464758016|FG018|Stage 2|Other|0|||
129126799|NCT03765073|464758017|FG019|Stage 2|Other|0|||
129126800|NCT03765073|464758018|FG020|Stage 2|Other|0|||
129126801|NCT03765073|464757998|FG000|Stage 2|Withdrawal by parent/guardian|0|||
129126802|NCT03765073|464757999|FG001|Stage 2|Withdrawal by parent/guardian|0|||
129126803|NCT03765073|464758000|FG002|Stage 2|Withdrawal by parent/guardian|0|||
129126804|NCT03765073|464758001|FG003|Stage 2|Withdrawal by parent/guardian|0|||
129126805|NCT03765073|464758002|FG004|Stage 2|Withdrawal by parent/guardian|0|||
129126806|NCT03765073|464758003|FG005|Stage 2|Withdrawal by parent/guardian|0|||
129126807|NCT03765073|464758004|FG006|Stage 2|Withdrawal by parent/guardian|0|||
129126808|NCT03765073|464758005|FG007|Stage 2|Withdrawal by parent/guardian|0|||
129126809|NCT03765073|464758006|FG008|Stage 2|Withdrawal by parent/guardian|0|||
129126810|NCT03765073|464758007|FG009|Stage 2|Withdrawal by parent/guardian|0|||
129126811|NCT03765073|464758008|FG010|Stage 2|Withdrawal by parent/guardian|3|||
129126812|NCT03765073|464758009|FG011|Stage 2|Withdrawal by parent/guardian|3|||
129126813|NCT03765073|464758010|FG012|Stage 2|Withdrawal by parent/guardian|3|||
128958216|NCT00355134|464133418|FG003|Extension Phase|Lost to Follow-up|2|||
129126814|NCT03765073|464758011|FG013|Stage 2|Withdrawal by parent/guardian|1|||
128958217|NCT00355134|464133419|FG004|Extension Phase|Lost to Follow-up|4|||
128958218|NCT00355134|464133415|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
128958219|NCT00355134|464133416|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
128958220|NCT00355134|464133417|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
128958221|NCT00355134|464133418|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
129126815|NCT03765073|464758012|FG014|Stage 2|Withdrawal by parent/guardian|1|||
129126816|NCT03765073|464758013|FG015|Stage 2|Withdrawal by parent/guardian|0|||
129126817|NCT03765073|464758014|FG016|Stage 2|Withdrawal by parent/guardian|3|||
129126818|NCT03765073|464758015|FG017|Stage 2|Withdrawal by parent/guardian|0|||
128958222|NCT00355134|464133419|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
129126819|NCT03765073|464758016|FG018|Stage 2|Withdrawal by parent/guardian|0|||
129126820|NCT03765073|464758017|FG019|Stage 2|Withdrawal by parent/guardian|0|||
128958223|NCT00355134|464133415|FG000|Extension Phase|Administrative problems|2|||
128958224|NCT00355134|464133416|FG001|Extension Phase|Administrative problems|4|||
128958225|NCT00355134|464133417|FG002|Extension Phase|Administrative problems|0|||
128958226|NCT00355134|464133418|FG003|Extension Phase|Administrative problems|1|||
128958227|NCT00355134|464133419|FG004|Extension Phase|Administrative problems|1|||
128958228|NCT00355134|464133415|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
128958229|NCT00355134|464133416|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
128958230|NCT00355134|464133417|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
128958231|NCT00355134|464133418|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
128958232|NCT00355134|464133419|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
128958233|NCT00355134|464133415|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
128958234|NCT00355134|464133416|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
128958235|NCT00355134|464133417|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
128958236|NCT00355134|464133418|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
128958237|NCT00355134|464133419|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
128958238|NCT00355134|464133415|FG000|Extension Phase|Protocol Violation|0|||
128958239|NCT00355134|464133416|FG001|Extension Phase|Protocol Violation|0|||
128958240|NCT00355134|464133417|FG002|Extension Phase|Protocol Violation|0|||
128958241|NCT00355134|464133418|FG003|Extension Phase|Protocol Violation|1|||
128958242|NCT00355134|464133419|FG004|Extension Phase|Protocol Violation|0|||
128958243|NCT02848313|464133420|FG000|Overall Study|Adverse Event|1|||
128958244|NCT02848313|464133421|FG001|Overall Study|Adverse Event|2|||
128958245|NCT02848313|464133420|FG000|Overall Study|Lack of Efficacy|0|||
128958246|NCT02848313|464133421|FG001|Overall Study|Lack of Efficacy|1|||
128958247|NCT02848313|464133420|FG000|Overall Study|Withdrawal by Subject|1|||
128958248|NCT02848313|464133421|FG001|Overall Study|Withdrawal by Subject|1|||
128958249|NCT02848313|464133420|FG000|Overall Study|Lost to follow up|1|||
128958250|NCT02848313|464133421|FG001|Overall Study|Lost to follow up|0|||
128958251|NCT01544478|464133422|FG000|Overall Study|Adverse Event|1|||
128958252|NCT01544478|464133422|FG000|Overall Study|Death|1|||
128958253|NCT01544478|464133422|FG000|Overall Study|Lost to Follow-up|48|||
128958254|NCT01544478|464133422|FG000|Overall Study|Physician Decision|15|||
128958255|NCT01544478|464133422|FG000|Overall Study|Pregnancy|1|||
128958256|NCT01544478|464133422|FG000|Overall Study|Withdrawal by Subject|52|||
128958257|NCT03382262|464133426|FG000|Overall Study|Physician Decision|0|||
128958258|NCT03382262|464133427|FG001|Overall Study|Physician Decision|0|||
128958259|NCT03382262|464133428|FG002|Overall Study|Physician Decision|1|||
128958260|NCT03382262|464133429|FG003|Overall Study|Physician Decision|0|||
128958261|NCT03382262|464133426|FG000|Overall Study|Withdrawal by Subject|0|||
128958262|NCT03382262|464133427|FG001|Overall Study|Withdrawal by Subject|0|||
128958263|NCT03382262|464133428|FG002|Overall Study|Withdrawal by Subject|0|||
128958264|NCT03382262|464133429|FG003|Overall Study|Withdrawal by Subject|1|||
128958265|NCT02038790|464133431|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
128958266|NCT02038790|464133432|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
128958267|NCT00438464|464133436|FG000|Overall Study|Terminated Early|14|||
128958268|NCT00438464|464133437|FG001|Overall Study|Terminated Early|5|||
128958269|NCT00438464|464133436|FG000|Overall Study|Incomplete data submission|0|||
128958270|NCT00438464|464133437|FG001|Overall Study|Incomplete data submission|2|||
128958271|NCT03943446|464133439|FG000|Overall Study|Lost to Follow-up|0|||
128958272|NCT03943446|464133440|FG001|Overall Study|Lost to Follow-up|0|||
128958273|NCT03943446|464133441|FG002|Overall Study|Lost to Follow-up|1|||
128958274|NCT03943446|464133439|FG000|Overall Study|Withdrawal by Subject|1|||
128958275|NCT03943446|464133440|FG001|Overall Study|Withdrawal by Subject|1|||
128958276|NCT03943446|464133441|FG002|Overall Study|Withdrawal by Subject|2|||
128958277|NCT03943446|464133439|FG000|Overall Study|Study Terminated by Sponsor|1|||
128958278|NCT03943446|464133440|FG001|Overall Study|Study Terminated by Sponsor|2|||
128958279|NCT03943446|464133441|FG002|Overall Study|Study Terminated by Sponsor|1|||
128958280|NCT03943446|464133439|FG000|Overall Study|Reason not Specified|5|||
128958281|NCT03943446|464133440|FG001|Overall Study|Reason not Specified|1|||
128958282|NCT03943446|464133441|FG002|Overall Study|Reason not Specified|3|||
128958283|NCT04209530|464133444|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
128958284|NCT04209530|464133445|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
128958285|NCT04209530|464133444|FG000|Overall Study|Withdrawal by Subject|0|||
128958286|NCT04209530|464133445|FG001|Overall Study|Withdrawal by Subject|1|||
128958287|NCT03862495|464133447|FG000|Overall Study|Lost to Follow-up|37|||
129036516|NCT00401245|464425033|FG004|Open Label Phase|Other|0|||
129036517|NCT00401245|464425034|FG005|Open Label Phase|Other|0|||
129036518|NCT00401245|464425035|FG006|Open Label Phase|Other|0|||
129036519|NCT00401245|464425036|FG007|Open Label Phase|Other|0|||
129036520|NCT00401245|464425029|FG000|Open Label Phase|Protocol Violation|0|||
128958288|NCT03862495|464133448|FG001|Overall Study|Lost to Follow-up|35|||
128958289|NCT00615914|464133449|FG000|Overall Study|Adverse Event|274|||
128958290|NCT00615914|464133449|FG000|Overall Study|Death|20|||
128958291|NCT00615914|464133449|FG000|Overall Study|Lack of Efficacy|59|||
129036521|NCT00401245|464425030|FG001|Open Label Phase|Protocol Violation|1|||
129036522|NCT00401245|464425031|FG002|Open Label Phase|Protocol Violation|0|||
129219776|NCT05661409|465104583|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
128712846|NCT03020407|463245946|FG000|Overall Study|Withdrawal by Subject|2|||
128712847|NCT03020407|463245947|FG001|Overall Study|Withdrawal by Subject|1|||
128712848|NCT03020407|463245946|FG000|Overall Study|Lost to Follow-up|2|||
128712849|NCT03020407|463245947|FG001|Overall Study|Lost to Follow-up|3|||
128958292|NCT00615914|464133449|FG000|Overall Study|Lost to Follow-up|187|||
128958293|NCT00615914|464133449|FG000|Overall Study|Withdrawal by Subject|16|||
128958294|NCT00615914|464133449|FG000|Overall Study|Physician Decision|4|||
128958295|NCT00615914|464133449|FG000|Overall Study|No data was collected.|65|||
128958296|NCT00615914|464133449|FG000|Overall Study|No treatment|2|||
128958297|NCT00615914|464133449|FG000|Overall Study|Irregularly enrolled patients|10|||
128958298|NCT03673956|464133450|FG000|Overall Study|Lost to Follow-up|1|||
128958299|NCT03673956|464133451|FG001|Overall Study|Lost to Follow-up|0|||
128958300|NCT03673956|464133452|FG002|Overall Study|Lost to Follow-up|0|||
128958301|NCT03673956|464133453|FG003|Overall Study|Lost to Follow-up|0|||
128958302|NCT03673956|464133450|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
128958303|NCT03673956|464133451|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
128958304|NCT03673956|464133452|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
128958305|NCT03673956|464133453|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
128958306|NCT00270998|464133454|FG000|3 Month Follow-up|Adverse Event|1|||
128958307|NCT00270998|464133455|FG001|3 Month Follow-up|Adverse Event|0|||
128958308|NCT00270998|464133456|FG002|3 Month Follow-up|Adverse Event|0|||
128958309|NCT00270998|464133454|FG000|3 Month Follow-up|Lack of Efficacy|1|||
128958310|NCT00270998|464133455|FG001|3 Month Follow-up|Lack of Efficacy|2|||
128958311|NCT00270998|464133456|FG002|3 Month Follow-up|Lack of Efficacy|1|||
128958312|NCT00270998|464133454|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
128958313|NCT00270998|464133455|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
128958314|NCT00270998|464133456|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
128958315|NCT00270998|464133454|FG000|3 Month Follow-up|Pessary did not fit|12|||
129126821|NCT03765073|464758018|FG020|Stage 2|Withdrawal by parent/guardian|0|||
129126822|NCT03765073|464757998|FG000|Stage 2|Withdrawal by Subject|0|||
129126823|NCT03765073|464757999|FG001|Stage 2|Withdrawal by Subject|0|||
129126824|NCT03765073|464758000|FG002|Stage 2|Withdrawal by Subject|0|||
129126825|NCT03765073|464758001|FG003|Stage 2|Withdrawal by Subject|3|||
129126826|NCT03765073|464758002|FG004|Stage 2|Withdrawal by Subject|3|||
129126827|NCT03765073|464758003|FG005|Stage 2|Withdrawal by Subject|3|||
129126828|NCT03765073|464758004|FG006|Stage 2|Withdrawal by Subject|0|||
129126829|NCT03765073|464758005|FG007|Stage 2|Withdrawal by Subject|1|||
129126830|NCT03765073|464758006|FG008|Stage 2|Withdrawal by Subject|0|||
129126831|NCT03765073|464758007|FG009|Stage 2|Withdrawal by Subject|5|||
129126832|NCT03765073|464758008|FG010|Stage 2|Withdrawal by Subject|0|||
129126833|NCT03765073|464758009|FG011|Stage 2|Withdrawal by Subject|0|||
129126834|NCT03765073|464758010|FG012|Stage 2|Withdrawal by Subject|0|||
129126835|NCT03765073|464758011|FG013|Stage 2|Withdrawal by Subject|0|||
129126836|NCT03765073|464758012|FG014|Stage 2|Withdrawal by Subject|0|||
129126837|NCT03765073|464758013|FG015|Stage 2|Withdrawal by Subject|0|||
129126838|NCT03765073|464758014|FG016|Stage 2|Withdrawal by Subject|0|||
129126839|NCT03765073|464758015|FG017|Stage 2|Withdrawal by Subject|0|||
129126840|NCT03765073|464758016|FG018|Stage 2|Withdrawal by Subject|0|||
129126841|NCT03765073|464758017|FG019|Stage 2|Withdrawal by Subject|0|||
129126842|NCT03765073|464758018|FG020|Stage 2|Withdrawal by Subject|0|||
129126843|NCT03765073|464757998|FG000|Stage 3|Adverse Event|0|||
129126844|NCT03765073|464757999|FG001|Stage 3|Adverse Event|0|||
129126845|NCT03765073|464758000|FG002|Stage 3|Adverse Event|0|||
129126846|NCT03765073|464758001|FG003|Stage 3|Adverse Event|0|||
129126847|NCT03765073|464758002|FG004|Stage 3|Adverse Event|0|||
129126848|NCT03765073|464758003|FG005|Stage 3|Adverse Event|0|||
129126849|NCT03765073|464758004|FG006|Stage 3|Adverse Event|0|||
129126850|NCT03765073|464758005|FG007|Stage 3|Adverse Event|0|||
129126851|NCT03765073|464758006|FG008|Stage 3|Adverse Event|0|||
129126852|NCT03765073|464758007|FG009|Stage 3|Adverse Event|0|||
129126853|NCT03765073|464758008|FG010|Stage 3|Adverse Event|0|||
129126854|NCT03765073|464758009|FG011|Stage 3|Adverse Event|0|||
129126855|NCT03765073|464758010|FG012|Stage 3|Adverse Event|0|||
129126856|NCT03765073|464758011|FG013|Stage 3|Adverse Event|0|||
129126857|NCT03765073|464758012|FG014|Stage 3|Adverse Event|0|||
129219777|NCT05661409|465104584|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
128712850|NCT03020407|463245946|FG000|Overall Study|Protocol Violation|0|||
128958316|NCT00270998|464133455|FG001|3 Month Follow-up|Pessary did not fit|0|||
128958317|NCT00270998|464133456|FG002|3 Month Follow-up|Pessary did not fit|0|||
128958318|NCT00270998|464133454|FG000|3 Month Follow-up|Personal/family health|1|||
129126858|NCT03765073|464758013|FG015|Stage 3|Adverse Event|0|||
129126859|NCT03765073|464758014|FG016|Stage 3|Adverse Event|0|||
129126860|NCT03765073|464758015|FG017|Stage 3|Adverse Event|0|||
129126861|NCT03765073|464758016|FG018|Stage 3|Adverse Event|1|||
129126862|NCT03765073|464758017|FG019|Stage 3|Adverse Event|0|||
129126863|NCT03765073|464758018|FG020|Stage 3|Adverse Event|0|||
129126864|NCT03765073|464757998|FG000|Stage 3|Death|0|||
129126865|NCT03765073|464757999|FG001|Stage 3|Death|0|||
129126866|NCT03765073|464758000|FG002|Stage 3|Death|0|||
128958319|NCT00270998|464133455|FG001|3 Month Follow-up|Personal/family health|1|||
128958320|NCT00270998|464133456|FG002|3 Month Follow-up|Personal/family health|0|||
128958321|NCT00270998|464133454|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
128958322|NCT00270998|464133455|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
128958323|NCT00270998|464133456|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
128958324|NCT00270998|464133454|FG000|12 Month Follow-up|Lack of Efficacy|5|||
128958325|NCT00270998|464133455|FG001|12 Month Follow-up|Lack of Efficacy|4|||
128958326|NCT00270998|464133456|FG002|12 Month Follow-up|Lack of Efficacy|3|||
128958327|NCT00270998|464133454|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
128958328|NCT00270998|464133455|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
128958329|NCT00270998|464133456|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
128958330|NCT00270998|464133454|FG000|12 Month Follow-up|Pessary did not fit|1|||
128958331|NCT00270998|464133455|FG001|12 Month Follow-up|Pessary did not fit|0|||
128958332|NCT00270998|464133456|FG002|12 Month Follow-up|Pessary did not fit|0|||
128958333|NCT00270998|464133454|FG000|12 Month Follow-up|Personal/family health|0|||
128958334|NCT00270998|464133455|FG001|12 Month Follow-up|Personal/family health|5|||
128958335|NCT00270998|464133456|FG002|12 Month Follow-up|Personal/family health|1|||
128958336|NCT00270998|464133454|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
128958337|NCT00270998|464133455|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
128958338|NCT00270998|464133456|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
128958339|NCT00425113|464133457|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
128958340|NCT00425113|464133458|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
128958341|NCT00425113|464133457|FG000|Overall Study|diagnosis of abdominal TB|0|||
128958342|NCT00425113|464133458|FG001|Overall Study|diagnosis of abdominal TB|1|||
128958343|NCT00425113|464133457|FG000|Overall Study|missing study drug more than 14 days|0|||
128958344|NCT00425113|464133458|FG001|Overall Study|missing study drug more than 14 days|1|||
128958345|NCT00425113|464133457|FG000|Overall Study|Withdrawal by Subject|1|||
128958346|NCT00425113|464133458|FG001|Overall Study|Withdrawal by Subject|0|||
128958347|NCT00425100|464133463|FG000|Overall Study|Adverse Event|36|||
128958348|NCT00425100|464133463|FG000|Overall Study|Lack of Efficacy|4|||
128958349|NCT00425100|464133463|FG000|Overall Study|Lost to Follow-up|2|||
128958350|NCT00425100|464133463|FG000|Overall Study|Protocol Violation|4|||
128958351|NCT00425100|464133463|FG000|Overall Study|Withdrawal by Subject|7|||
128958352|NCT04169061|464133464|FG000|Overall Study|Adverse Event|2|||
128958353|NCT04169061|464133464|FG000|Overall Study|Death|1|||
128958354|NCT04169061|464133464|FG000|Overall Study|Withdrawal by Subject|1|||
128958355|NCT04169061|464133464|FG000|Overall Study|Protocol Violation|1|||
128958356|NCT00555906|464133465|FG000|Phase 1|Objective Progression or Relapse|3|||
128958357|NCT00555906|464133466|FG001|Phase 1|Objective Progression or Relapse|5|||
128958358|NCT00555906|464133467|FG002|Phase 1|Objective Progression or Relapse|3|||
128958359|NCT00555906|464133468|FG003|Phase 1|Objective Progression or Relapse|1|||
128958360|NCT00555906|464133469|FG004|Phase 1|Objective Progression or Relapse|0|||
128958361|NCT00555906|464133465|FG000|Phase 1|Global Deterioration of Health Status|0|||
128958362|NCT00555906|464133466|FG001|Phase 1|Global Deterioration of Health Status|1|||
128958363|NCT00555906|464133467|FG002|Phase 1|Global Deterioration of Health Status|1|||
128958364|NCT00555906|464133468|FG003|Phase 1|Global Deterioration of Health Status|1|||
128958365|NCT00555906|464133469|FG004|Phase 1|Global Deterioration of Health Status|0|||
128958366|NCT00555906|464133465|FG000|Phase 1|Adverse Event|0|||
128958367|NCT00555906|464133466|FG001|Phase 1|Adverse Event|0|||
128958368|NCT00555906|464133467|FG002|Phase 1|Adverse Event|3|||
128958369|NCT00555906|464133468|FG003|Phase 1|Adverse Event|2|||
128958370|NCT00555906|464133469|FG004|Phase 1|Adverse Event|0|||
128958371|NCT00555906|464133465|FG000|Phase 1|Withdrawal by Subject|0|||
128958372|NCT00555906|464133466|FG001|Phase 1|Withdrawal by Subject|0|||
128958373|NCT00555906|464133467|FG002|Phase 1|Withdrawal by Subject|0|||
128958374|NCT00555906|464133468|FG003|Phase 1|Withdrawal by Subject|1|||
128958375|NCT00555906|464133469|FG004|Phase 1|Withdrawal by Subject|0|||
128958376|NCT00555906|464133465|FG000|Phase 2|Adverse Event|0|||
128958377|NCT00555906|464133466|FG001|Phase 2|Adverse Event|0|||
128958378|NCT00555906|464133467|FG002|Phase 2|Adverse Event|0|||
128958379|NCT00555906|464133468|FG003|Phase 2|Adverse Event|0|||
128958380|NCT00555906|464133469|FG004|Phase 2|Adverse Event|4|||
128958381|NCT00555906|464133465|FG000|Phase 2|Global Deterioration of Health Status|0|||
128958382|NCT00555906|464133466|FG001|Phase 2|Global Deterioration of Health Status|0|||
128958383|NCT00555906|464133467|FG002|Phase 2|Global Deterioration of Health Status|0|||
128958384|NCT00555906|464133468|FG003|Phase 2|Global Deterioration of Health Status|0|||
128958385|NCT00555906|464133469|FG004|Phase 2|Global Deterioration of Health Status|2|||
128958386|NCT00555906|464133465|FG000|Phase 2|Objective Progression or Relapse|0|||
128958387|NCT00555906|464133466|FG001|Phase 2|Objective Progression or Relapse|0|||
128958388|NCT00555906|464133467|FG002|Phase 2|Objective Progression or Relapse|0|||
128958389|NCT00555906|464133468|FG003|Phase 2|Objective Progression or Relapse|0|||
128958390|NCT00555906|464133469|FG004|Phase 2|Objective Progression or Relapse|16|||
128958391|NCT00555906|464133465|FG000|Phase 2|Withdrawal by Subject|0|||
128958392|NCT00555906|464133466|FG001|Phase 2|Withdrawal by Subject|0|||
128958393|NCT00555906|464133467|FG002|Phase 2|Withdrawal by Subject|0|||
128958394|NCT00555906|464133468|FG003|Phase 2|Withdrawal by Subject|0|||
129036523|NCT00401245|464425032|FG003|Open Label Phase|Protocol Violation|1|||
129036524|NCT00401245|464425033|FG004|Open Label Phase|Protocol Violation|0|||
129036525|NCT00401245|464425034|FG005|Open Label Phase|Protocol Violation|0|||
129036526|NCT00401245|464425035|FG006|Open Label Phase|Protocol Violation|0|||
129036527|NCT00401245|464425036|FG007|Open Label Phase|Protocol Violation|0|||
128958395|NCT00555906|464133469|FG004|Phase 2|Withdrawal by Subject|2|||
129036528|NCT00401245|464425029|FG000|Open Label Phase|Withdrawal by Subject|3|||
129036529|NCT00401245|464425030|FG001|Open Label Phase|Withdrawal by Subject|3|||
129036530|NCT00401245|464425031|FG002|Open Label Phase|Withdrawal by Subject|2|||
129036531|NCT00401245|464425032|FG003|Open Label Phase|Withdrawal by Subject|1|||
129036532|NCT00401245|464425033|FG004|Open Label Phase|Withdrawal by Subject|0|||
129036533|NCT00401245|464425034|FG005|Open Label Phase|Withdrawal by Subject|0|||
129036534|NCT00401245|464425035|FG006|Open Label Phase|Withdrawal by Subject|0|||
129036535|NCT00401245|464425036|FG007|Open Label Phase|Withdrawal by Subject|0|||
129036536|NCT00401245|464425029|FG000|Open Label Phase|Lack of Efficacy|4|||
129036537|NCT00401245|464425030|FG001|Open Label Phase|Lack of Efficacy|2|||
129036538|NCT00401245|464425031|FG002|Open Label Phase|Lack of Efficacy|3|||
129036539|NCT00401245|464425032|FG003|Open Label Phase|Lack of Efficacy|0|||
129036540|NCT00401245|464425033|FG004|Open Label Phase|Lack of Efficacy|0|||
129036541|NCT00401245|464425034|FG005|Open Label Phase|Lack of Efficacy|0|||
129036542|NCT00401245|464425035|FG006|Open Label Phase|Lack of Efficacy|0|||
129036543|NCT00401245|464425036|FG007|Open Label Phase|Lack of Efficacy|0|||
129036544|NCT00401245|464425029|FG000|Double Blind Tapering Phase|Adverse Event|0|||
129036545|NCT00401245|464425030|FG001|Double Blind Tapering Phase|Adverse Event|0|||
129036546|NCT00401245|464425031|FG002|Double Blind Tapering Phase|Adverse Event|0|||
129036547|NCT00401245|464425032|FG003|Double Blind Tapering Phase|Adverse Event|0|||
129036548|NCT00401245|464425033|FG004|Double Blind Tapering Phase|Adverse Event|1|||
129036549|NCT00401245|464425034|FG005|Double Blind Tapering Phase|Adverse Event|1|||
129036550|NCT00401245|464425035|FG006|Double Blind Tapering Phase|Adverse Event|2|||
129036551|NCT00401245|464425036|FG007|Double Blind Tapering Phase|Adverse Event|4|||
129036552|NCT00401245|464425029|FG000|Double Blind Tapering Phase|Investigator request|0|||
129036553|NCT00401245|464425030|FG001|Double Blind Tapering Phase|Investigator request|0|||
129036554|NCT00401245|464425031|FG002|Double Blind Tapering Phase|Investigator request|0|||
129036555|NCT00401245|464425032|FG003|Double Blind Tapering Phase|Investigator request|0|||
129036556|NCT00401245|464425033|FG004|Double Blind Tapering Phase|Investigator request|0|||
129036557|NCT00401245|464425034|FG005|Double Blind Tapering Phase|Investigator request|0|||
129036558|NCT00401245|464425035|FG006|Double Blind Tapering Phase|Investigator request|0|||
129036559|NCT00401245|464425036|FG007|Double Blind Tapering Phase|Investigator request|1|||
129036560|NCT00401245|464425029|FG000|Double Blind Tapering Phase|Other|0|||
129036561|NCT00401245|464425030|FG001|Double Blind Tapering Phase|Other|0|||
129036562|NCT00401245|464425031|FG002|Double Blind Tapering Phase|Other|0|||
129036563|NCT00401245|464425032|FG003|Double Blind Tapering Phase|Other|0|||
129036564|NCT00401245|464425033|FG004|Double Blind Tapering Phase|Other|1|||
129036565|NCT00401245|464425034|FG005|Double Blind Tapering Phase|Other|0|||
129036566|NCT00401245|464425035|FG006|Double Blind Tapering Phase|Other|2|||
128958396|NCT00555906|464133465|FG000|Phase 2|Other|0|||
128958397|NCT00555906|464133466|FG001|Phase 2|Other|0|||
129036567|NCT00401245|464425036|FG007|Double Blind Tapering Phase|Other|2|||
129036568|NCT00401245|464425029|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129036569|NCT00401245|464425030|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129036570|NCT00401245|464425031|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
128958398|NCT00555906|464133467|FG002|Phase 2|Other|0|||
128958399|NCT00555906|464133468|FG003|Phase 2|Other|0|||
128958400|NCT00555906|464133469|FG004|Phase 2|Other|6|||
128958401|NCT00555906|464133465|FG000|Phase 2|Randomized but not Treated|0|||
128958402|NCT00555906|464133466|FG001|Phase 2|Randomized but not Treated|0|||
128958403|NCT00555906|464133467|FG002|Phase 2|Randomized but not Treated|0|||
128958404|NCT00555906|464133468|FG003|Phase 2|Randomized but not Treated|0|||
128958405|NCT00555906|464133469|FG004|Phase 2|Randomized but not Treated|2|||
128958406|NCT04046341|464133473|FG000|Overall Study|Lost to Follow-up|2|||
128958407|NCT04046341|464133473|FG000|Overall Study|Withdrawal by Subject|1|||
128958408|NCT00788697|464133481|FG000|Overall Study|No study drug administered|12|||
128958409|NCT00788697|464133481|FG000|Overall Study|Training Patients|74|||
129036571|NCT00401245|464425032|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129036572|NCT00401245|464425033|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
129036573|NCT00401245|464425034|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
129036574|NCT00401245|464425035|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
129036575|NCT00401245|464425036|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129036576|NCT00401245|464425029|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
129036577|NCT00401245|464425030|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
129126867|NCT03765073|464758001|FG003|Stage 3|Death|0|||
129126868|NCT03765073|464758002|FG004|Stage 3|Death|0|||
128958410|NCT00788697|464133481|FG000|Overall Study|no truth standard procedure available|5|||
129126869|NCT03765073|464758003|FG005|Stage 3|Death|0|||
128958411|NCT00788697|464133481|FG000|Overall Study|Technically inadequate truth standard|1|||
128958412|NCT00788697|464133481|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
129126870|NCT03765073|464758004|FG006|Stage 3|Death|0|||
129219778|NCT05661409|465104579|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
129219779|NCT05661409|465104580|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
129219780|NCT05661409|465104581|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
129219781|NCT05661409|465104582|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
129219782|NCT05661409|465104583|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
129219783|NCT05661409|465104584|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
129219784|NCT05661409|465104579|FG000|Overall Study|Miscommu-nication about administration|0|||
129219785|NCT05661409|465104580|FG001|Overall Study|Miscommu-nication about administration|0|||
129219786|NCT05661409|465104581|FG002|Overall Study|Miscommu-nication about administration|0|||
129219787|NCT05661409|465104582|FG003|Overall Study|Miscommu-nication about administration|0|||
129219788|NCT05661409|465104583|FG004|Overall Study|Miscommu-nication about administration|0|||
129219789|NCT05661409|465104584|FG005|Overall Study|Miscommu-nication about administration|1|||
129219790|NCT04439136|465104585|FG000|Overall Study|Ineligible|1|||
129219791|NCT04439136|465104585|FG000|Overall Study|Never Started Treatment|2|||
129219792|NCT04439136|465104585|FG000|Overall Study|Adverse Event|4|||
129219793|NCT04439136|465104585|FG000|Overall Study|Death|3|||
129219794|NCT04439136|465104585|FG000|Overall Study|Disease Progression|27|||
129219795|NCT04439136|465104585|FG000|Overall Study|Alternative Therapy|1|||
129219796|NCT04439136|465104585|FG000|Overall Study|Increased Tumor Burden|1|||
129219797|NCT04439136|465104585|FG000|Overall Study|Symptomatic Detrioration|1|||
129219798|NCT02578706|465104589|FG000|Overall Study|Withdrawal by Subject|1|||
129219799|NCT02578706|465104590|FG001|Overall Study|Withdrawal by Subject|0|||
129219800|NCT02578706|465104591|FG002|Overall Study|Withdrawal by Subject|0|||
129219801|NCT02578706|465104589|FG000|Overall Study|Lost to Follow-up|0|||
129219802|NCT02578706|465104590|FG001|Overall Study|Lost to Follow-up|4|||
129219803|NCT02578706|465104591|FG002|Overall Study|Lost to Follow-up|0|||
129219804|NCT02578706|465104589|FG000|Overall Study|Physician Decision|0|||
129219805|NCT02578706|465104590|FG001|Overall Study|Physician Decision|1|||
129219806|NCT02578706|465104591|FG002|Overall Study|Physician Decision|0|||
128958413|NCT02248857|464133482|FG000|3 Month|Withdrawal by Subject|9|||
128958414|NCT02248857|464133483|FG001|3 Month|Withdrawal by Subject|3|||
128958415|NCT02248857|464133484|FG002|3 Month|Withdrawal by Subject|4|||
128958416|NCT02248857|464133482|FG000|3 Month|Unable to reach for 3 month|35|||
128958417|NCT02248857|464133483|FG001|3 Month|Unable to reach for 3 month|29|||
128958418|NCT02248857|464133484|FG002|3 Month|Unable to reach for 3 month|26|||
128958419|NCT02248857|464133482|FG000|3 Month|Partially completed, unable to finish|2|||
128958420|NCT02248857|464133483|FG001|3 Month|Partially completed, unable to finish|2|||
128958421|NCT02248857|464133484|FG002|3 Month|Partially completed, unable to finish|1|||
128958422|NCT02248857|464133482|FG000|6 Month|Lost to Follow-up|27|||
128958423|NCT02248857|464133483|FG001|6 Month|Lost to Follow-up|26|||
128958424|NCT02248857|464133484|FG002|6 Month|Lost to Follow-up|15|||
128958425|NCT02248857|464133482|FG000|6 Month|Partially completed, unable to finish|0|||
128958426|NCT02248857|464133483|FG001|6 Month|Partially completed, unable to finish|1|||
128958427|NCT02248857|464133484|FG002|6 Month|Partially completed, unable to finish|0|||
128958428|NCT02248857|464133482|FG000|6 Month|Withdrawal by Subject|0|||
128958429|NCT02248857|464133483|FG001|6 Month|Withdrawal by Subject|2|||
128958430|NCT02248857|464133484|FG002|6 Month|Withdrawal by Subject|2|||
128958431|NCT02248857|464133482|FG000|6 Month|Death|1|||
128958432|NCT02248857|464133483|FG001|6 Month|Death|0|||
128958433|NCT02248857|464133484|FG002|6 Month|Death|0|||
128958434|NCT02671461|464133485|FG000|Treatment|Adverse Event|0|||
128958435|NCT02671461|464133486|FG001|Treatment|Adverse Event|0|||
128958436|NCT02671461|464133487|FG002|Treatment|Adverse Event|1|||
128958437|NCT02671461|464133485|FG000|Treatment|Administrative Reason by Sponsor|1|||
128958438|NCT02671461|464133486|FG001|Treatment|Administrative Reason by Sponsor|3|||
128958439|NCT02671461|464133487|FG002|Treatment|Administrative Reason by Sponsor|4|||
128958440|NCT02671461|464133485|FG000|Treatment|Randomized, not treated|1|||
128958441|NCT02671461|464133486|FG001|Treatment|Randomized, not treated|0|||
128958442|NCT02671461|464133487|FG002|Treatment|Randomized, not treated|0|||
128958443|NCT02671461|464133485|FG000|Follow-up|Withdrawal by Subject|1|||
128958444|NCT02671461|464133486|FG001|Follow-up|Withdrawal by Subject|0|||
129219807|NCT02015637|465104595|FG000|Overall Study|Lost to Follow-up|3|||
128712851|NCT03020407|463245947|FG001|Overall Study|Protocol Violation|1|||
128712852|NCT02699554|463245948|FG000|Overall Study|Lost to Follow-up|9|||
129219808|NCT02015637|465104596|FG001|Overall Study|Lost to Follow-up|5|||
129219809|NCT02015637|465104595|FG000|Overall Study|Adverse Event|3|||
128712853|NCT00788151|463245949|FG000|Overall Study|Other adverse event|0|||
128958445|NCT02671461|464133487|FG002|Follow-up|Withdrawal by Subject|0|||
128958446|NCT02671461|464133485|FG000|Follow-up|Lost to Follow-up|0|||
128958447|NCT02671461|464133486|FG001|Follow-up|Lost to Follow-up|0|||
128958448|NCT02671461|464133487|FG002|Follow-up|Lost to Follow-up|1|||
128958449|NCT02671461|464133485|FG000|Follow-up|Administrative Reason by Sponsor|0|||
128958450|NCT02671461|464133486|FG001|Follow-up|Administrative Reason by Sponsor|1|||
128958451|NCT02671461|464133487|FG002|Follow-up|Administrative Reason by Sponsor|0|||
129219810|NCT02015637|465104596|FG001|Overall Study|Adverse Event|0|||
129219811|NCT02015637|465104595|FG000|Overall Study|Did not take study drug|2|||
128958452|NCT02261883|464133488|FG000|Overall Study|Death|3|||
128958453|NCT02261883|464133489|FG001|Overall Study|Death|2|||
128958454|NCT02261883|464133488|FG000|Overall Study|Physician Decision|1|||
128958455|NCT02261883|464133489|FG001|Overall Study|Physician Decision|0|||
128958456|NCT02261883|464133488|FG000|Overall Study|Protocol Violation|1|||
128958457|NCT02261883|464133489|FG001|Overall Study|Protocol Violation|0|||
128958458|NCT02261883|464133488|FG000|Overall Study|Withdrawal by Subject|0|||
128958459|NCT02261883|464133489|FG001|Overall Study|Withdrawal by Subject|1|||
128958460|NCT02261883|464133488|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
128958461|NCT02261883|464133489|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
128958462|NCT01412060|464133490|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
128958463|NCT01412060|464133491|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
128958464|NCT01412060|464133492|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
128958465|NCT01412060|464133490|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
128958466|NCT01412060|464133491|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
128958467|NCT01412060|464133492|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
128958468|NCT01412060|464133490|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
128958469|NCT01412060|464133491|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
128958470|NCT01412060|464133492|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
128958471|NCT01412060|464133490|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
128958472|NCT01412060|464133491|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
128958473|NCT01412060|464133492|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
128958474|NCT01412060|464133490|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
128958475|NCT01412060|464133491|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
128958476|NCT01412060|464133492|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
128958477|NCT01412060|464133490|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
128958478|NCT01412060|464133491|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
128958479|NCT01412060|464133492|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
128958480|NCT01412060|464133490|FG000|Period Between RIP and SP|Adverse Event|4|||
128958481|NCT01412060|464133491|FG001|Period Between RIP and SP|Adverse Event|0|||
128958482|NCT01412060|464133492|FG002|Period Between RIP and SP|Adverse Event|0|||
128712854|NCT00788151|463245950|FG001|Overall Study|Other adverse event|2|||
128712855|NCT00788151|463245949|FG000|Overall Study|Protocol Violation|0|||
128712856|NCT00788151|463245950|FG001|Overall Study|Protocol Violation|1|||
128712857|NCT00788151|463245949|FG000|Overall Study|Withdrawal by Subject|13|||
128712858|NCT00788151|463245950|FG001|Overall Study|Withdrawal by Subject|6|||
128712859|NCT00788151|463245949|FG000|Overall Study|Enrolled but not treated|1|||
128712860|NCT00788151|463245950|FG001|Overall Study|Enrolled but not treated|1|||
128712861|NCT00503009|463245951|FG000|Overall Study|Protocol Violation|1|||
128712862|NCT00503009|463245952|FG001|Overall Study|Protocol Violation|0|||
128712863|NCT00503009|463245953|FG002|Overall Study|Protocol Violation|1|||
128712864|NCT00503009|463245951|FG000|Overall Study|Withdrawal by Subject|0|||
128712865|NCT00503009|463245952|FG001|Overall Study|Withdrawal by Subject|1|||
128712866|NCT00503009|463245953|FG002|Overall Study|Withdrawal by Subject|1|||
128712867|NCT00503009|463245951|FG000|Overall Study|Physician Decision|0|||
128712868|NCT00503009|463245952|FG001|Overall Study|Physician Decision|1|||
128712869|NCT00503009|463245953|FG002|Overall Study|Physician Decision|1|||
128958483|NCT01412060|464133490|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
128958484|NCT01412060|464133491|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
128958485|NCT01412060|464133492|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
128958486|NCT01412060|464133490|FG000|Period Between RIP and SP|Protocol Violation|2|||
128958487|NCT01412060|464133491|FG001|Period Between RIP and SP|Protocol Violation|0|||
128958488|NCT01412060|464133492|FG002|Period Between RIP and SP|Protocol Violation|0|||
128958489|NCT01412060|464133490|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
128712870|NCT01525550|463245954|FG000|Overall Study|Lost to Follow-up|8|||
128712871|NCT01525550|463245955|FG001|Overall Study|Lost to Follow-up|2|||
128958490|NCT01412060|464133491|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
128958491|NCT01412060|464133492|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
128958492|NCT01412060|464133490|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
128958493|NCT01412060|464133491|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
129126871|NCT03765073|464758005|FG007|Stage 3|Death|0|||
129126872|NCT03765073|464758006|FG008|Stage 3|Death|0|||
129126873|NCT03765073|464758007|FG009|Stage 3|Death|0|||
129126874|NCT03765073|464758008|FG010|Stage 3|Death|0|||
129126875|NCT03765073|464758009|FG011|Stage 3|Death|0|||
129126876|NCT03765073|464758010|FG012|Stage 3|Death|0|||
129126877|NCT03765073|464758011|FG013|Stage 3|Death|0|||
129126878|NCT03765073|464758012|FG014|Stage 3|Death|0|||
129126879|NCT03765073|464758013|FG015|Stage 3|Death|0|||
129126880|NCT03765073|464758014|FG016|Stage 3|Death|0|||
129126881|NCT03765073|464758015|FG017|Stage 3|Death|0|||
129126882|NCT03765073|464758016|FG018|Stage 3|Death|0|||
129126883|NCT03765073|464758017|FG019|Stage 3|Death|3|||
129126884|NCT03765073|464758018|FG020|Stage 3|Death|2|||
129126885|NCT03765073|464757998|FG000|Stage 3|Lost to Follow-up|0|||
128958494|NCT01412060|464133492|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
128958495|NCT01412060|464133490|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
128958496|NCT01412060|464133491|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
128958497|NCT01412060|464133492|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
128958498|NCT01412060|464133490|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
128958499|NCT01412060|464133491|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
128958500|NCT01412060|464133492|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
128958501|NCT01412060|464133490|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
128958502|NCT01412060|464133491|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
128958503|NCT01412060|464133492|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
128958504|NCT01412060|464133490|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
128958505|NCT01412060|464133491|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
128958506|NCT01412060|464133492|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
128958507|NCT01412060|464133490|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
128958508|NCT01412060|464133491|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
128958509|NCT01412060|464133492|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
128958510|NCT01412060|464133490|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
128958511|NCT01412060|464133491|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
128958512|NCT01412060|464133492|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
128958513|NCT01412060|464133490|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
128958514|NCT01412060|464133491|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
128958515|NCT01412060|464133492|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
128958516|NCT01412060|464133490|FG000|Period Between SP and DBP|Protocol Violation|2|||
128958517|NCT01412060|464133491|FG001|Period Between SP and DBP|Protocol Violation|0|||
128958518|NCT01412060|464133492|FG002|Period Between SP and DBP|Protocol Violation|0|||
128958519|NCT01412060|464133490|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
128958520|NCT01412060|464133491|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
128958521|NCT01412060|464133492|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
128958522|NCT01412060|464133490|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
128958523|NCT01412060|464133491|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
128958524|NCT01412060|464133492|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
128958525|NCT01412060|464133490|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
129036578|NCT00401245|464425031|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
129036579|NCT00401245|464425032|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
129036580|NCT00401245|464425033|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
129036581|NCT00401245|464425034|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
129036582|NCT00401245|464425035|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
129036583|NCT00401245|464425036|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
129036584|NCT01989676|464425037|FG000|Overall Study|Death|52|||
129036585|NCT01989676|464425038|FG001|Overall Study|Death|60|||
129036586|NCT01989676|464425037|FG000|Overall Study|Protocol Violation|2|||
129036587|NCT01989676|464425038|FG001|Overall Study|Protocol Violation|1|||
129036588|NCT01989676|464425037|FG000|Overall Study|Lost to Follow-up|8|||
129036589|NCT01989676|464425038|FG001|Overall Study|Lost to Follow-up|18|||
129036590|NCT01989676|464425037|FG000|Overall Study|No longer willing to participate in study|26|||
129036591|NCT01989676|464425038|FG001|Overall Study|No longer willing to participate in study|26|||
129036592|NCT01989676|464425037|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
129036593|NCT01989676|464425038|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
129036594|NCT01989676|464425037|FG000|Overall Study|Other|4|||
129036595|NCT01989676|464425038|FG001|Overall Study|Other|3|||
129036596|NCT03941834|464425039|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
129036597|NCT03941834|464425040|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
129036598|NCT03941834|464425041|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
129036599|NCT03941834|464425039|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
129036600|NCT03941834|464425040|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
129036601|NCT03941834|464425041|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
129036602|NCT03941834|464425039|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
129036603|NCT03941834|464425040|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
129036604|NCT03941834|464425041|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
129036605|NCT03941834|464425039|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
129036606|NCT03941834|464425040|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
129036607|NCT03941834|464425041|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
129036608|NCT03941834|464425039|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
129036609|NCT03941834|464425040|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
128958526|NCT01412060|464133491|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
129036610|NCT03941834|464425041|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
128958527|NCT01412060|464133492|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
129036611|NCT03941834|464425039|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
128958528|NCT01412060|464133490|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
128958529|NCT01412060|464133491|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
128958530|NCT01412060|464133492|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
128958531|NCT01412060|464133490|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
128958532|NCT01412060|464133491|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
128958533|NCT01412060|464133492|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
128958534|NCT01412060|464133490|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
128958535|NCT01412060|464133491|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
128958536|NCT01412060|464133492|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
128958537|NCT01412060|464133490|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
128958538|NCT01412060|464133491|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
128958539|NCT01412060|464133492|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
128958540|NCT01412060|464133490|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
128958541|NCT01412060|464133491|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
128958542|NCT01412060|464133492|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
128958543|NCT01412060|464133490|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
128958544|NCT01412060|464133491|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
128958545|NCT01412060|464133492|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
128958546|NCT01412060|464133490|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
128958547|NCT01412060|464133491|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
128958548|NCT01412060|464133492|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
128958549|NCT02674685|464133497|FG000|Overall Study|Withdrawal by Subject|4|||
128958550|NCT05567393|464133501|FG000|Overall Study|Voluntary Withdrawal|0|||
128958551|NCT05567393|464133502|FG001|Overall Study|Voluntary Withdrawal|0|||
128958552|NCT05567393|464133503|FG002|Overall Study|Voluntary Withdrawal|0|||
128958553|NCT05567393|464133504|FG003|Overall Study|Voluntary Withdrawal|0|||
128958554|NCT05567393|464133505|FG004|Overall Study|Voluntary Withdrawal|0|||
128958555|NCT05567393|464133506|FG005|Overall Study|Voluntary Withdrawal|0|||
128958556|NCT05567393|464133507|FG006|Overall Study|Voluntary Withdrawal|0|||
128958557|NCT05567393|464133508|FG007|Overall Study|Voluntary Withdrawal|0|||
128958558|NCT05567393|464133509|FG008|Overall Study|Voluntary Withdrawal|0|||
128958559|NCT05567393|464133510|FG009|Overall Study|Voluntary Withdrawal|0|||
128958560|NCT05567393|464133511|FG010|Overall Study|Voluntary Withdrawal|0|||
128958561|NCT05567393|464133512|FG011|Overall Study|Voluntary Withdrawal|0|||
128958562|NCT05567393|464133513|FG012|Overall Study|Voluntary Withdrawal|0|||
128958563|NCT05567393|464133514|FG013|Overall Study|Voluntary Withdrawal|1|||
128958564|NCT05567393|464133515|FG014|Overall Study|Voluntary Withdrawal|0|||
128958565|NCT05567393|464133516|FG015|Overall Study|Voluntary Withdrawal|0|||
128958566|NCT05567393|464133517|FG016|Overall Study|Voluntary Withdrawal|0|||
128958567|NCT05567393|464133518|FG017|Overall Study|Voluntary Withdrawal|0|||
128958568|NCT04199793|464133519|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
128958569|NCT04199793|464133520|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
128958570|NCT04199793|464133519|FG000|Overall Study|Withdrawal by Subject|1|||
128958571|NCT04199793|464133520|FG001|Overall Study|Withdrawal by Subject|1|||
128958572|NCT04179786|464133521|FG000|Overall Study|Withdrawal by Subject|8|||
128958573|NCT03310580|464133522|FG000|Overall Study|Adverse Event|0|||
128958574|NCT03310580|464133523|FG001|Overall Study|Adverse Event|1|||
128958575|NCT03310580|464133524|FG002|Overall Study|Adverse Event|0|||
128958576|NCT04186663|464133531|FG000|Overall Study|Lost to Follow-up|1|||
128958577|NCT04186663|464133531|FG000|Overall Study|Unable to complete blood draw|3|||
129126886|NCT03765073|464757999|FG001|Stage 3|Lost to Follow-up|0|||
129126887|NCT03765073|464758000|FG002|Stage 3|Lost to Follow-up|0|||
129126888|NCT03765073|464758001|FG003|Stage 3|Lost to Follow-up|0|||
129126889|NCT03765073|464758002|FG004|Stage 3|Lost to Follow-up|0|||
129126890|NCT03765073|464758003|FG005|Stage 3|Lost to Follow-up|0|||
129126891|NCT03765073|464758004|FG006|Stage 3|Lost to Follow-up|0|||
128771468|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128771469|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
128771470|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
128958578|NCT00642018|464133539|FG000|Overall Study|Adverse Event|11|||
128958579|NCT00642018|464133540|FG001|Overall Study|Adverse Event|36|||
128958580|NCT00642018|464133539|FG000|Overall Study|Withdrawal by Subject|4|||
128958581|NCT00642018|464133540|FG001|Overall Study|Withdrawal by Subject|10|||
128958582|NCT00642018|464133539|FG000|Overall Study|Progressive Disease|13|||
128958583|NCT00642018|464133540|FG001|Overall Study|Progressive Disease|18|||
128958584|NCT00642018|464133539|FG000|Overall Study|Physician Decision|0|||
128958585|NCT00642018|464133540|FG001|Overall Study|Physician Decision|10|||
128958586|NCT00642018|464133539|FG000|Overall Study|Protocol Violation|0|||
128958587|NCT00642018|464133540|FG001|Overall Study|Protocol Violation|1|||
128958588|NCT00642018|464133539|FG000|Overall Study|Death|0|||
129126892|NCT03765073|464758005|FG007|Stage 3|Lost to Follow-up|0|||
129126893|NCT03765073|464758006|FG008|Stage 3|Lost to Follow-up|0|||
129126894|NCT03765073|464758007|FG009|Stage 3|Lost to Follow-up|0|||
129126895|NCT03765073|464758008|FG010|Stage 3|Lost to Follow-up|0|||
128958589|NCT00642018|464133540|FG001|Overall Study|Death|3|||
128958590|NCT00642018|464133539|FG000|Overall Study|Entry Criteria Not Met|0|||
128958591|NCT00642018|464133540|FG001|Overall Study|Entry Criteria Not Met|1|||
128958592|NCT00107172|464135499|FG000|Overall Study|Withdrawal by Subject|1|||
128958593|NCT00107172|464135500|FG001|Overall Study|Withdrawal by Subject|0|||
128958594|NCT00107172|464135499|FG000|Overall Study|Death|0|||
128958595|NCT00107172|464135500|FG001|Overall Study|Death|2|||
128958596|NCT00107172|464135499|FG000|Overall Study|Other Reason|4|||
128958597|NCT00107172|464135500|FG001|Overall Study|Other Reason|3|||
128958598|NCT02687711|464135501|FG000|Overall Study|Adverse Event|89|||
128958599|NCT02687711|464135501|FG000|Overall Study|Lack of Efficacy|70|||
128712872|NCT01525550|463245954|FG000|Overall Study|Death|19|||
128712873|NCT01525550|463245955|FG001|Overall Study|Death|28|||
128958600|NCT02687711|464135501|FG000|Overall Study|Lost to Follow-up|20|||
128958601|NCT02687711|464135501|FG000|Overall Study|Consent withdrawn|15|||
128958602|NCT02687711|464135501|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
128958603|NCT02687711|464135501|FG000|Overall Study|Too expensive|4|||
128958604|NCT02687711|464135501|FG000|Overall Study|Participant moved abroad|1|||
128958605|NCT02687711|464135501|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
128958606|NCT02687711|464135501|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
128958607|NCT02687711|464135501|FG000|Overall Study|Disliked taste|1|||
128958608|NCT02687711|464135501|FG000|Overall Study|Low mood|1|||
128958609|NCT02687711|464135501|FG000|Overall Study|Side effects|1|||
128958610|NCT02687711|464135501|FG000|Overall Study|Change of Hospital|1|||
128958611|NCT02687711|464135501|FG000|Overall Study|Liver Encephalopathy|1|||
128958612|NCT02687711|464135501|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
128958613|NCT02687711|464135501|FG000|Overall Study|Withdrawn due to intake interruption|1|||
128958614|NCT02687711|464135501|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
128958615|NCT02687711|464135501|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
128958616|NCT02687711|464135501|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
128958617|NCT03621189|464135502|FG000|Overall Study|Withdrawal by Subject|0|||
128958618|NCT03621189|464135503|FG001|Overall Study|Withdrawal by Subject|3|||
128958619|NCT03621189|464135502|FG000|Overall Study|Physician Decision|0|||
128958620|NCT03621189|464135503|FG001|Overall Study|Physician Decision|2|||
128958621|NCT03706040|464135506|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
128958622|NCT03706040|464135507|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
128958623|NCT03706040|464135508|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
128958624|NCT03706040|464135509|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
128958625|NCT03706040|464135510|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
128958626|NCT03706040|464135511|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
128958627|NCT03706040|464135512|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
128958628|NCT03706040|464135506|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
128958629|NCT03706040|464135507|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
128958630|NCT03706040|464135508|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
128958631|NCT03706040|464135509|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
128958632|NCT03706040|464135510|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
128958633|NCT03706040|464135511|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
128958634|NCT03706040|464135512|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
128958635|NCT03706040|464135506|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
129126896|NCT03765073|464758009|FG011|Stage 3|Lost to Follow-up|0|||
129126897|NCT03765073|464758010|FG012|Stage 3|Lost to Follow-up|0|||
129126898|NCT03765073|464758011|FG013|Stage 3|Lost to Follow-up|0|||
129126899|NCT03765073|464758012|FG014|Stage 3|Lost to Follow-up|0|||
129126900|NCT03765073|464758013|FG015|Stage 3|Lost to Follow-up|0|||
129126901|NCT03765073|464758014|FG016|Stage 3|Lost to Follow-up|0|||
129126902|NCT03765073|464758015|FG017|Stage 3|Lost to Follow-up|8|||
129126903|NCT03765073|464758016|FG018|Stage 3|Lost to Follow-up|5|||
129126904|NCT03765073|464758017|FG019|Stage 3|Lost to Follow-up|7|||
129126905|NCT03765073|464758018|FG020|Stage 3|Lost to Follow-up|4|||
129126906|NCT03765073|464757998|FG000|Stage 3|No longer meets eligibility criteria|0|||
129126907|NCT03765073|464757999|FG001|Stage 3|No longer meets eligibility criteria|0|||
129219812|NCT02015637|465104596|FG001|Overall Study|Did not take study drug|0|||
129219813|NCT02223858|465104599|FG000|Overall Study|Death|1|||
128712874|NCT01525550|463245954|FG000|Overall Study|Other|0|||
128712875|NCT01525550|463245955|FG001|Overall Study|Other|4|||
128958636|NCT03706040|464135507|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
128958637|NCT03706040|464135508|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
128958638|NCT03706040|464135509|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
128958639|NCT03706040|464135510|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
128958640|NCT03706040|464135511|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
129219814|NCT02223858|465104600|FG001|Overall Study|Death|1|||
129126908|NCT03765073|464758000|FG002|Stage 3|No longer meets eligibility criteria|0|||
129126909|NCT03765073|464758001|FG003|Stage 3|No longer meets eligibility criteria|0|||
129219815|NCT02223858|465104599|FG000|Overall Study|Lost to Follow-up|6|||
129219816|NCT02223858|465104600|FG001|Overall Study|Lost to Follow-up|11|||
129219817|NCT02223858|465104599|FG000|Overall Study|Withdrawal by Subject|8|||
129219818|NCT02223858|465104600|FG001|Overall Study|Withdrawal by Subject|5|||
129219819|NCT02223858|465104599|FG000|Overall Study|Refused|9|||
129219820|NCT02223858|465104600|FG001|Overall Study|Refused|9|||
129219821|NCT04455815|465104603|FG000|Randomisation Phase|Adverse Event|1|||
129219822|NCT04455815|465104604|FG001|Randomisation Phase|Adverse Event|0|||
129219823|NCT04455815|465104603|FG000|Treatment Phase|Adverse Event|0|||
129219824|NCT04455815|465104604|FG001|Treatment Phase|Adverse Event|1|||
128958641|NCT03706040|464135512|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
128958642|NCT03706040|464135506|FG000|Period A (Week 0 to Week 16)|Other|2|||
128958643|NCT03706040|464135507|FG001|Period A (Week 0 to Week 16)|Other|0|||
128958644|NCT03706040|464135508|FG002|Period A (Week 0 to Week 16)|Other|2|||
128958645|NCT03706040|464135509|FG003|Period A (Week 0 to Week 16)|Other|0|||
128958646|NCT03706040|464135510|FG004|Period A (Week 0 to Week 16)|Other|0|||
128958647|NCT03706040|464135511|FG005|Period A (Week 0 to Week 16)|Other|0|||
128958648|NCT03706040|464135512|FG006|Period A (Week 0 to Week 16)|Other|0|||
128958649|NCT03706040|464135506|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
128958650|NCT03706040|464135507|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
128958651|NCT03706040|464135508|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
128958652|NCT03706040|464135509|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
128958653|NCT03706040|464135510|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
128958654|NCT03706040|464135511|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
128958655|NCT03706040|464135512|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
128958656|NCT03706040|464135506|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
128958657|NCT03706040|464135507|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
128958658|NCT03706040|464135508|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
128958659|NCT03706040|464135509|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
128958660|NCT03706040|464135510|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
128958661|NCT03706040|464135511|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
128958662|NCT03706040|464135512|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
128958663|NCT03706040|464135506|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
128958664|NCT03706040|464135507|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
128958665|NCT03706040|464135508|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
128958666|NCT03706040|464135509|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
128958667|NCT03706040|464135510|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
128958668|NCT03706040|464135511|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
128958669|NCT03706040|464135512|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
128958670|NCT03706040|464135506|FG000|Period B (Week 16 to Week 52)|Other|0|||
128958671|NCT03706040|464135507|FG001|Period B (Week 16 to Week 52)|Other|0|||
128958672|NCT03706040|464135508|FG002|Period B (Week 16 to Week 52)|Other|0|||
128958673|NCT03706040|464135509|FG003|Period B (Week 16 to Week 52)|Other|4|||
128958674|NCT03706040|464135510|FG004|Period B (Week 16 to Week 52)|Other|5|||
128958675|NCT03706040|464135511|FG005|Period B (Week 16 to Week 52)|Other|23|||
128958676|NCT03706040|464135512|FG006|Period B (Week 16 to Week 52)|Other|17|||
128958677|NCT03077243|464135513|FG000|Overall Study|Death|1|||
128958678|NCT03077243|464135514|FG001|Overall Study|Death|2|||
128958679|NCT03077243|464135515|FG002|Overall Study|Death|0|||
128958680|NCT03077243|464135516|FG003|Overall Study|Death|0|||
128958681|NCT03077243|464135513|FG000|Overall Study|Withdrawal by Subject|1|||
128958682|NCT03077243|464135514|FG001|Overall Study|Withdrawal by Subject|3|||
128958683|NCT03077243|464135515|FG002|Overall Study|Withdrawal by Subject|0|||
129219825|NCT04455815|465104603|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
128712876|NCT01525550|463245954|FG000|Overall Study|Sponsor's Decision|30|||
128958684|NCT03077243|464135516|FG003|Overall Study|Withdrawal by Subject|0|||
128958685|NCT03077243|464135513|FG000|Overall Study|Physician Decision|1|||
128958686|NCT03077243|464135514|FG001|Overall Study|Physician Decision|0|||
128958687|NCT03077243|464135515|FG002|Overall Study|Physician Decision|0|||
128958688|NCT03077243|464135516|FG003|Overall Study|Physician Decision|0|||
128958689|NCT03077243|464135513|FG000|Overall Study|Research at two study sites terminated early|0|||
128958690|NCT03077243|464135514|FG001|Overall Study|Research at two study sites terminated early|0|||
128958691|NCT03077243|464135515|FG002|Overall Study|Research at two study sites terminated early|0|||
128958692|NCT03077243|464135516|FG003|Overall Study|Research at two study sites terminated early|69|||
128958693|NCT00607919|464135517|FG000|Acute Phase|Adverse Event|9|||
128958694|NCT00607919|464135518|FG001|Acute Phase|Adverse Event|2|||
128958695|NCT00607919|464135517|FG000|Acute Phase|Entry Criteria Not Met|1|||
128958696|NCT00607919|464135518|FG001|Acute Phase|Entry Criteria Not Met|1|||
128958697|NCT00607919|464135517|FG000|Acute Phase|Lack of Efficacy|1|||
128958698|NCT00607919|464135518|FG001|Acute Phase|Lack of Efficacy|2|||
128958699|NCT00607919|464135517|FG000|Acute Phase|Lost to Follow-up|9|||
129036612|NCT03941834|464425040|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
128712877|NCT01525550|463245955|FG001|Overall Study|Sponsor's Decision|11|||
129219826|NCT04455815|465104604|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
129219827|NCT04455815|465104603|FG000|Treatment Phase|Withdrawal by Subject|1|||
128712878|NCT01525550|463245954|FG000|Overall Study|Withdrawal by Subject|4|||
128712879|NCT01525550|463245955|FG001|Overall Study|Withdrawal by Subject|0|||
128712880|NCT00453921|463245964|FG000|Overall Study|Withdrawal by Subject|1|||
128712881|NCT00453921|463245965|FG001|Overall Study|Withdrawal by Subject|1|||
128958700|NCT00607919|464135518|FG001|Acute Phase|Lost to Follow-up|3|||
128958701|NCT00607919|464135517|FG000|Acute Phase|Parent/Caregiver Decision|6|||
128958702|NCT00607919|464135518|FG001|Acute Phase|Parent/Caregiver Decision|4|||
128958703|NCT00607919|464135517|FG000|Acute Phase|Protocol Violation|5|||
128958704|NCT00607919|464135518|FG001|Acute Phase|Protocol Violation|1|||
128958705|NCT00607919|464135517|FG000|Acute Phase|Withdrawal by Subject|3|||
128958706|NCT00607919|464135518|FG001|Acute Phase|Withdrawal by Subject|3|||
128958707|NCT00607919|464135517|FG000|Open-Label Phase|Adverse Event|1|||
128958708|NCT00607919|464135518|FG001|Open-Label Phase|Adverse Event|5|||
128958709|NCT00607919|464135517|FG000|Open-Label Phase|Lost to Follow-up|4|||
128958710|NCT00607919|464135518|FG001|Open-Label Phase|Lost to Follow-up|1|||
128958711|NCT00607919|464135517|FG000|Open-Label Phase|Protocol Violation|2|||
129126910|NCT03765073|464758002|FG004|Stage 3|No longer meets eligibility criteria|0|||
129126911|NCT03765073|464758003|FG005|Stage 3|No longer meets eligibility criteria|0|||
129126912|NCT03765073|464758004|FG006|Stage 3|No longer meets eligibility criteria|0|||
129126913|NCT03765073|464758005|FG007|Stage 3|No longer meets eligibility criteria|0|||
129126914|NCT03765073|464758006|FG008|Stage 3|No longer meets eligibility criteria|0|||
129126915|NCT03765073|464758007|FG009|Stage 3|No longer meets eligibility criteria|0|||
129126916|NCT03765073|464758008|FG010|Stage 3|No longer meets eligibility criteria|0|||
129126917|NCT03765073|464758009|FG011|Stage 3|No longer meets eligibility criteria|0|||
129126918|NCT03765073|464758010|FG012|Stage 3|No longer meets eligibility criteria|0|||
129126919|NCT03765073|464758011|FG013|Stage 3|No longer meets eligibility criteria|0|||
129126920|NCT03765073|464758012|FG014|Stage 3|No longer meets eligibility criteria|0|||
129126921|NCT03765073|464758013|FG015|Stage 3|No longer meets eligibility criteria|0|||
129126922|NCT03765073|464758014|FG016|Stage 3|No longer meets eligibility criteria|0|||
129126923|NCT03765073|464758015|FG017|Stage 3|No longer meets eligibility criteria|0|||
129126924|NCT03765073|464758016|FG018|Stage 3|No longer meets eligibility criteria|1|||
129126925|NCT03765073|464758017|FG019|Stage 3|No longer meets eligibility criteria|0|||
129126926|NCT03765073|464758018|FG020|Stage 3|No longer meets eligibility criteria|1|||
129126927|NCT03765073|464757998|FG000|Stage 3|Other|0|||
129126928|NCT03765073|464757999|FG001|Stage 3|Other|0|||
129126929|NCT03765073|464758000|FG002|Stage 3|Other|0|||
129126930|NCT03765073|464758001|FG003|Stage 3|Other|0|||
129126931|NCT03765073|464758002|FG004|Stage 3|Other|0|||
129126932|NCT03765073|464758003|FG005|Stage 3|Other|0|||
129126933|NCT03765073|464758004|FG006|Stage 3|Other|0|||
129126934|NCT03765073|464758005|FG007|Stage 3|Other|0|||
129126935|NCT03765073|464758006|FG008|Stage 3|Other|0|||
129126936|NCT03765073|464758007|FG009|Stage 3|Other|0|||
129126937|NCT03765073|464758008|FG010|Stage 3|Other|0|||
129126938|NCT03765073|464758009|FG011|Stage 3|Other|0|||
129126939|NCT03765073|464758010|FG012|Stage 3|Other|0|||
129126940|NCT03765073|464758011|FG013|Stage 3|Other|0|||
129126941|NCT03765073|464758012|FG014|Stage 3|Other|0|||
129126942|NCT03765073|464758013|FG015|Stage 3|Other|0|||
129126943|NCT03765073|464758014|FG016|Stage 3|Other|0|||
129126944|NCT03765073|464758015|FG017|Stage 3|Other|1|||
129126945|NCT03765073|464758016|FG018|Stage 3|Other|2|||
129126946|NCT03765073|464758017|FG019|Stage 3|Other|2|||
129126947|NCT03765073|464758018|FG020|Stage 3|Other|2|||
129126948|NCT03765073|464757998|FG000|Stage 3|Withdrawal by parent/guardian|0|||
129126949|NCT03765073|464757999|FG001|Stage 3|Withdrawal by parent/guardian|0|||
129126950|NCT03765073|464758000|FG002|Stage 3|Withdrawal by parent/guardian|0|||
129126951|NCT03765073|464758001|FG003|Stage 3|Withdrawal by parent/guardian|0|||
129126952|NCT03765073|464758002|FG004|Stage 3|Withdrawal by parent/guardian|0|||
129126953|NCT03765073|464758003|FG005|Stage 3|Withdrawal by parent/guardian|0|||
128712882|NCT00453921|463245966|FG002|Overall Study|Withdrawal by Subject|1|||
128712883|NCT00453921|463245967|FG003|Overall Study|Withdrawal by Subject|1|||
128712884|NCT00453921|463245964|FG000|Overall Study|Lost to Follow-up|0|||
128712885|NCT00453921|463245965|FG001|Overall Study|Lost to Follow-up|0|||
128712886|NCT00453921|463245966|FG002|Overall Study|Lost to Follow-up|1|||
128712887|NCT00453921|463245967|FG003|Overall Study|Lost to Follow-up|0|||
128958712|NCT00607919|464135518|FG001|Open-Label Phase|Protocol Violation|2|||
129126954|NCT03765073|464758004|FG006|Stage 3|Withdrawal by parent/guardian|0|||
129126955|NCT03765073|464758005|FG007|Stage 3|Withdrawal by parent/guardian|0|||
129126956|NCT03765073|464758006|FG008|Stage 3|Withdrawal by parent/guardian|0|||
129126957|NCT03765073|464758007|FG009|Stage 3|Withdrawal by parent/guardian|0|||
129126958|NCT03765073|464758008|FG010|Stage 3|Withdrawal by parent/guardian|0|||
129126959|NCT03765073|464758009|FG011|Stage 3|Withdrawal by parent/guardian|0|||
129126960|NCT03765073|464758010|FG012|Stage 3|Withdrawal by parent/guardian|0|||
128958713|NCT00607919|464135517|FG000|Open-Label Phase|Withdrawal by Subject|2|||
129126961|NCT03765073|464758011|FG013|Stage 3|Withdrawal by parent/guardian|0|||
129126962|NCT03765073|464758012|FG014|Stage 3|Withdrawal by parent/guardian|0|||
129126963|NCT03765073|464758013|FG015|Stage 3|Withdrawal by parent/guardian|0|||
129126964|NCT03765073|464758014|FG016|Stage 3|Withdrawal by parent/guardian|0|||
128958714|NCT00607919|464135518|FG001|Open-Label Phase|Withdrawal by Subject|2|||
128958715|NCT00607919|464135517|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
128958716|NCT00607919|464135518|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
128958717|NCT02580240|464135531|FG000|Overall Study|Physician Decision|2|||
128958718|NCT02580240|464135532|FG001|Overall Study|Physician Decision|0|||
128958719|NCT02007252|464135535|FG000|Overall Study|Administrative problems|3|||
128958720|NCT02007252|464135536|FG001|Overall Study|Administrative problems|7|||
128958721|NCT02007252|464135535|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128958722|NCT02007252|464135536|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128958723|NCT02007252|464135535|FG000|Overall Study|Adverse Event|7|||
128958724|NCT02007252|464135536|FG001|Overall Study|Adverse Event|4|||
128958725|NCT02001688|464135537|FG000|Overall Study|Withdrawal by Subject|0|||
128958726|NCT02001688|464135538|FG001|Overall Study|Withdrawal by Subject|0|||
128958727|NCT02001688|464135539|FG002|Overall Study|Withdrawal by Subject|1|||
128958728|NCT02001688|464135537|FG000|Overall Study|Adverse Event|0|||
128958729|NCT02001688|464135538|FG001|Overall Study|Adverse Event|1|||
128958730|NCT02001688|464135539|FG002|Overall Study|Adverse Event|0|||
128958731|NCT01989754|464135540|FG000|Overall Study|Withdrawal by Subject|10|||
128958732|NCT01989754|464135541|FG001|Overall Study|Withdrawal by Subject|14|||
128958733|NCT01989754|464135540|FG000|Overall Study|Lost to Follow-up|28|||
128958734|NCT01989754|464135541|FG001|Overall Study|Lost to Follow-up|20|||
128958735|NCT01989754|464135540|FG000|Overall Study|Closed Site|1|||
128958736|NCT01989754|464135541|FG001|Overall Study|Closed Site|1|||
128958737|NCT05441540|464135542|FG000|Overall Study|Withdrawal by Subject|2|||
128958738|NCT00813917|464135543|FG000|Overall Study|Adverse Event|0|||
128958739|NCT00813917|464135544|FG001|Overall Study|Adverse Event|1|||
129126965|NCT03765073|464758015|FG017|Stage 3|Withdrawal by parent/guardian|0|||
129126966|NCT03765073|464758016|FG018|Stage 3|Withdrawal by parent/guardian|0|||
129126967|NCT03765073|464758017|FG019|Stage 3|Withdrawal by parent/guardian|6|||
129126968|NCT03765073|464758018|FG020|Stage 3|Withdrawal by parent/guardian|9|||
129126969|NCT03765073|464757998|FG000|Stage 3|Withdrawal by Subject|0|||
129126970|NCT03765073|464757999|FG001|Stage 3|Withdrawal by Subject|0|||
129126971|NCT03765073|464758000|FG002|Stage 3|Withdrawal by Subject|0|||
129126972|NCT03765073|464758001|FG003|Stage 3|Withdrawal by Subject|0|||
129126973|NCT03765073|464758002|FG004|Stage 3|Withdrawal by Subject|0|||
129126974|NCT03765073|464758003|FG005|Stage 3|Withdrawal by Subject|0|||
129126975|NCT03765073|464758004|FG006|Stage 3|Withdrawal by Subject|0|||
129126976|NCT03765073|464758005|FG007|Stage 3|Withdrawal by Subject|0|||
129126977|NCT03765073|464758006|FG008|Stage 3|Withdrawal by Subject|0|||
129126978|NCT03765073|464758007|FG009|Stage 3|Withdrawal by Subject|0|||
129126979|NCT03765073|464758008|FG010|Stage 3|Withdrawal by Subject|0|||
129126980|NCT03765073|464758009|FG011|Stage 3|Withdrawal by Subject|0|||
129126981|NCT03765073|464758010|FG012|Stage 3|Withdrawal by Subject|0|||
129126982|NCT03765073|464758011|FG013|Stage 3|Withdrawal by Subject|0|||
129219828|NCT04455815|465104604|FG001|Treatment Phase|Withdrawal by Subject|1|||
129219829|NCT02106390|465104605|FG000|Overall Study|Withdrawal by Subject|15|||
129219830|NCT02106390|465104606|FG001|Overall Study|Withdrawal by Subject|16|||
128958740|NCT00813917|464135543|FG000|Overall Study|Withdrawal by Subject|3|||
128958741|NCT00813917|464135544|FG001|Overall Study|Withdrawal by Subject|4|||
128958742|NCT00813917|464135543|FG000|Overall Study|Lost to Follow-up|3|||
128958743|NCT00813917|464135544|FG001|Overall Study|Lost to Follow-up|1|||
128958744|NCT00792701|464135548|FG000|Overall Study|Adverse Event|0|||
128958745|NCT00792701|464135549|FG001|Overall Study|Adverse Event|22|||
128958746|NCT00792701|464135548|FG000|Overall Study|Ineligible|1|||
129036613|NCT03941834|464425041|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
129036614|NCT01560819|464425045|FG000|Overall Study|Physician Decision|1|||
129036615|NCT01560819|464425046|FG001|Overall Study|Physician Decision|0|||
129036616|NCT02344745|464425047|FG000|Overall Study|Data collection sheets were lost|2|||
129036617|NCT02344745|464425048|FG001|Overall Study|Data collection sheets were lost|0|||
129036618|NCT02788513|464425049|FG000|Overall Study|Withdrawal by Subject|3|||
129036619|NCT02788513|464425050|FG001|Overall Study|Withdrawal by Subject|0|||
129036620|NCT02788513|464425051|FG002|Overall Study|Withdrawal by Subject|2|||
129036621|NCT02788513|464425052|FG003|Overall Study|Withdrawal by Subject|3|||
129036622|NCT02788513|464425053|FG004|Overall Study|Withdrawal by Subject|1|||
129036623|NCT02788513|464425049|FG000|Overall Study|Lost to Follow-up|1|||
129036624|NCT02788513|464425050|FG001|Overall Study|Lost to Follow-up|0|||
129036625|NCT02788513|464425051|FG002|Overall Study|Lost to Follow-up|0|||
129036626|NCT02788513|464425052|FG003|Overall Study|Lost to Follow-up|0|||
129036627|NCT02788513|464425053|FG004|Overall Study|Lost to Follow-up|1|||
129036628|NCT02788513|464425049|FG000|Overall Study|Adverse Event|5|||
129036629|NCT02788513|464425050|FG001|Overall Study|Adverse Event|8|||
129126983|NCT03765073|464758012|FG014|Stage 3|Withdrawal by Subject|0|||
129126984|NCT03765073|464758013|FG015|Stage 3|Withdrawal by Subject|0|||
129126985|NCT03765073|464758014|FG016|Stage 3|Withdrawal by Subject|0|||
129126986|NCT03765073|464758015|FG017|Stage 3|Withdrawal by Subject|8|||
129126987|NCT03765073|464758016|FG018|Stage 3|Withdrawal by Subject|11|||
128958747|NCT00792701|464135549|FG001|Overall Study|Ineligible|3|||
128958748|NCT00792701|464135548|FG000|Overall Study|Withdrawal by Subject|1|||
128958749|NCT00792701|464135549|FG001|Overall Study|Withdrawal by Subject|19|||
128958750|NCT00792701|464135548|FG000|Overall Study|Not protocol specified|17|||
128958751|NCT00792701|464135549|FG001|Overall Study|Not protocol specified|0|||
128958752|NCT02143141|464135557|FG000|Overall Study|pain scores at 24 hours not collected|1|||
128958753|NCT02143141|464135558|FG001|Overall Study|pain scores at 24 hours not collected|0|||
128958754|NCT00064077|464135559|FG000|Overall Study|Improper prior treatment|1|||
128958755|NCT00064077|464135560|FG001|Overall Study|Improper prior treatment|0|||
128958756|NCT00064077|464135561|FG002|Overall Study|Improper prior treatment|0|||
128958757|NCT00064077|464135562|FG003|Overall Study|Improper prior treatment|0|||
128958758|NCT00064077|464135559|FG000|Overall Study|Poor risk|2|||
128958759|NCT00064077|464135560|FG001|Overall Study|Poor risk|0|||
128958760|NCT00064077|464135561|FG002|Overall Study|Poor risk|1|||
128958761|NCT00064077|464135562|FG003|Overall Study|Poor risk|1|||
128958762|NCT00064077|464135559|FG000|Overall Study|Pathology|10|||
128958763|NCT00064077|464135560|FG001|Overall Study|Pathology|7|||
128958764|NCT00064077|464135561|FG002|Overall Study|Pathology|3|||
128958765|NCT00064077|464135562|FG003|Overall Study|Pathology|4|||
128958766|NCT00064077|464135559|FG000|Overall Study|No surgery|0|||
128958767|NCT00064077|464135560|FG001|Overall Study|No surgery|0|||
128958768|NCT00064077|464135561|FG002|Overall Study|No surgery|1|||
128958769|NCT00064077|464135562|FG003|Overall Study|No surgery|0|||
128958770|NCT00064077|464135559|FG000|Overall Study|No tumor|0|||
128958771|NCT00064077|464135560|FG001|Overall Study|No tumor|0|||
128958772|NCT00064077|464135561|FG002|Overall Study|No tumor|1|||
128958773|NCT00064077|464135562|FG003|Overall Study|No tumor|0|||
128958774|NCT00064077|464135559|FG000|Overall Study|Other reasons|2|||
128958775|NCT00064077|464135560|FG001|Overall Study|Other reasons|2|||
128958776|NCT00064077|464135561|FG002|Overall Study|Other reasons|1|||
128958777|NCT00064077|464135562|FG003|Overall Study|Other reasons|2|||
128958778|NCT01467661|464135563|FG000|Overall Study|Adverse Event|16|||
128958779|NCT01467661|464135563|FG000|Overall Study|Withdrawal by Subject|1|||
128958780|NCT01467661|464135563|FG000|Overall Study|Lack of Efficacy|3|||
128958781|NCT01467661|464135563|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
128958782|NCT00879437|464135564|FG000|Overall Study|Protocol Violation|0|||
128958783|NCT00879437|464135565|FG001|Overall Study|Protocol Violation|1|||
128958784|NCT00879437|464135564|FG000|Overall Study|Death|1|||
128958785|NCT00879437|464135565|FG001|Overall Study|Death|0|||
128958786|NCT03000686|464135566|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
128958787|NCT03000686|464135567|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
128958788|NCT03000686|464135568|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
128958789|NCT03000686|464135569|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
128958790|NCT01112982|464135572|FG000|Overall Study|Withdrawal by Subject|1|||
128958791|NCT01112982|464135572|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
128958792|NCT01001234|464135579|FG000|Overall Study|Withdrawal by Subject|2|||
128958793|NCT01001234|464135580|FG001|Overall Study|Withdrawal by Subject|0|||
128958794|NCT01001234|464135581|FG002|Overall Study|Withdrawal by Subject|3|||
128958795|NCT01001234|464135582|FG003|Overall Study|Withdrawal by Subject|0|||
128958796|NCT01001234|464135583|FG004|Overall Study|Withdrawal by Subject|0|||
128958797|NCT01001234|464135579|FG000|Overall Study|Protocol Violation|34|||
128958798|NCT01001234|464135580|FG001|Overall Study|Protocol Violation|3|||
128958799|NCT01001234|464135581|FG002|Overall Study|Protocol Violation|19|||
128958800|NCT01001234|464135582|FG003|Overall Study|Protocol Violation|18|||
128958801|NCT01001234|464135583|FG004|Overall Study|Protocol Violation|0|||
128958802|NCT01001234|464135579|FG000|Overall Study|Lost to Follow-up|0|||
128958803|NCT01001234|464135580|FG001|Overall Study|Lost to Follow-up|0|||
128958804|NCT01001234|464135581|FG002|Overall Study|Lost to Follow-up|1|||
128958805|NCT01001234|464135582|FG003|Overall Study|Lost to Follow-up|2|||
128958806|NCT01001234|464135583|FG004|Overall Study|Lost to Follow-up|0|||
128958807|NCT01001234|464135579|FG000|Overall Study|Physician Decision|1|||
128958808|NCT01001234|464135580|FG001|Overall Study|Physician Decision|0|||
128958809|NCT01001234|464135581|FG002|Overall Study|Physician Decision|0|||
128771471|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
128958810|NCT01001234|464135582|FG003|Overall Study|Physician Decision|0|||
128958811|NCT01001234|464135583|FG004|Overall Study|Physician Decision|0|||
128958812|NCT01001234|464135579|FG000|Overall Study|Not Treated: Adverse Event|1|||
128958813|NCT01001234|464135580|FG001|Overall Study|Not Treated: Adverse Event|0|||
128958814|NCT01001234|464135581|FG002|Overall Study|Not Treated: Adverse Event|0|||
128958815|NCT01001234|464135582|FG003|Overall Study|Not Treated: Adverse Event|0|||
128958816|NCT01001234|464135583|FG004|Overall Study|Not Treated: Adverse Event|0|||
128958817|NCT01001234|464135579|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
128958818|NCT01001234|464135580|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
128958819|NCT01001234|464135581|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
128958820|NCT01001234|464135582|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
128958821|NCT01001234|464135583|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
128958822|NCT01001234|464135579|FG000|Overall Study|Not Treated: Protocol Violation|3|||
128958823|NCT01001234|464135580|FG001|Overall Study|Not Treated: Protocol Violation|0|||
128958824|NCT01001234|464135581|FG002|Overall Study|Not Treated: Protocol Violation|0|||
128958825|NCT01001234|464135582|FG003|Overall Study|Not Treated: Protocol Violation|0|||
128958826|NCT01001234|464135583|FG004|Overall Study|Not Treated: Protocol Violation|0|||
128958827|NCT01001234|464135579|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
128958828|NCT01001234|464135580|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
128958829|NCT01001234|464135581|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
128958830|NCT01001234|464135582|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
128958831|NCT01001234|464135583|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
128958832|NCT01001234|464135579|FG000|Overall Study|Not Treated: Pregnancy|3|||
128958833|NCT01001234|464135580|FG001|Overall Study|Not Treated: Pregnancy|0|||
128958834|NCT01001234|464135581|FG002|Overall Study|Not Treated: Pregnancy|0|||
128958835|NCT01001234|464135582|FG003|Overall Study|Not Treated: Pregnancy|0|||
128958836|NCT01001234|464135583|FG004|Overall Study|Not Treated: Pregnancy|0|||
128958837|NCT01001234|464135579|FG000|Overall Study|Not Treated: Physician Decision|37|||
128958838|NCT01001234|464135580|FG001|Overall Study|Not Treated: Physician Decision|4|||
128958839|NCT01001234|464135581|FG002|Overall Study|Not Treated: Physician Decision|0|||
128958840|NCT01001234|464135582|FG003|Overall Study|Not Treated: Physician Decision|0|||
128958841|NCT01001234|464135583|FG004|Overall Study|Not Treated: Physician Decision|0|||
128958842|NCT01001234|464135579|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
128958843|NCT01001234|464135580|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
128958844|NCT01001234|464135581|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
128958845|NCT01001234|464135582|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
128958846|NCT01001234|464135583|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
128958847|NCT03379376|464135585|FG000|Overall Study|Lost to Follow-up|2|||
128958848|NCT03379376|464135585|FG000|Overall Study|Did not wish to complete follow up|1|||
128958849|NCT03379376|464135585|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
128958850|NCT03379376|464135585|FG000|Overall Study|Death|1|||
128958851|NCT01611298|464135586|FG000|Overall Study|Relapsed|2|||
128958852|NCT00753623|464135587|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
128958853|NCT00753623|464135588|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
128958854|NCT00753623|464135587|FG000|Phase I (14 Days)|Physician Decision|1|||
128958855|NCT00753623|464135588|FG001|Phase I (14 Days)|Physician Decision|2|||
128958856|NCT00753623|464135587|FG000|Phase I (14 Days)|Adverse Event|0|||
128958857|NCT00753623|464135588|FG001|Phase I (14 Days)|Adverse Event|1|||
128958858|NCT00753623|464135587|FG000|Washout (7 Days)|Physician Decision|1|||
128712888|NCT01291173|463245971|FG000|Overall Study|Adverse Event|0|||
128712889|NCT01291173|463245972|FG001|Overall Study|Adverse Event|3|||
128712890|NCT01291173|463245973|FG002|Overall Study|Adverse Event|1|||
128712891|NCT01291173|463245974|FG003|Overall Study|Adverse Event|3|||
128712892|NCT01291173|463245971|FG000|Overall Study|Protocol Violation|7|||
128712893|NCT01291173|463245972|FG001|Overall Study|Protocol Violation|2|||
128712894|NCT01291173|463245973|FG002|Overall Study|Protocol Violation|2|||
128712895|NCT01291173|463245974|FG003|Overall Study|Protocol Violation|5|||
128712896|NCT01291173|463245971|FG000|Overall Study|Withdrawal by Subject|6|||
128712897|NCT01291173|463245972|FG001|Overall Study|Withdrawal by Subject|4|||
128712898|NCT01291173|463245973|FG002|Overall Study|Withdrawal by Subject|4|||
128712899|NCT01291173|463245974|FG003|Overall Study|Withdrawal by Subject|2|||
128712900|NCT01291173|463245971|FG000|Overall Study|Lost to Follow-up|4|||
128712901|NCT01291173|463245972|FG001|Overall Study|Lost to Follow-up|6|||
128712902|NCT01291173|463245973|FG002|Overall Study|Lost to Follow-up|3|||
128712903|NCT01291173|463245974|FG003|Overall Study|Lost to Follow-up|2|||
128712904|NCT01291173|463245971|FG000|Overall Study|Unable to meet visit schedule|0|||
128712905|NCT01291173|463245972|FG001|Overall Study|Unable to meet visit schedule|0|||
128712906|NCT01291173|463245973|FG002|Overall Study|Unable to meet visit schedule|1|||
128712907|NCT01291173|463245974|FG003|Overall Study|Unable to meet visit schedule|0|||
128712908|NCT01291173|463245971|FG000|Overall Study|Lack of compliance|0|||
128712909|NCT01291173|463245972|FG001|Overall Study|Lack of compliance|0|||
128712910|NCT01291173|463245973|FG002|Overall Study|Lack of compliance|0|||
128958859|NCT00753623|464135588|FG001|Washout (7 Days)|Physician Decision|0|||
128958860|NCT00753623|464135587|FG000|Phase II (14 Days)|Physician Decision|0|||
129126988|NCT03765073|464758017|FG019|Stage 3|Withdrawal by Subject|0|||
129126989|NCT03765073|464758018|FG020|Stage 3|Withdrawal by Subject|0|||
129126990|NCT04537299|464758019|FG000|Overall Study|Withdrawal by Subject|2|||
129126991|NCT04537299|464758020|FG001|Overall Study|Withdrawal by Subject|0|||
129126992|NCT04537299|464758019|FG000|Overall Study|Protocol Violation|1|||
129126993|NCT04537299|464758020|FG001|Overall Study|Protocol Violation|1|||
129126994|NCT00876343|464758029|FG000|Overall Study|Adverse Event|7|||
128712911|NCT01291173|463245974|FG003|Overall Study|Lack of compliance|1|||
128958861|NCT00753623|464135588|FG001|Phase II (14 Days)|Physician Decision|1|||
128958862|NCT03332303|464135589|FG000|Overall Study|Participant did not dose|1|||
129126995|NCT00876343|464758030|FG001|Overall Study|Adverse Event|8|||
129126996|NCT00876343|464758031|FG002|Overall Study|Adverse Event|2|||
129126997|NCT00876343|464758029|FG000|Overall Study|Withdrawal by Subject|4|||
128712912|NCT01291173|463245971|FG000|Overall Study|Subject was unblinded|0|||
128712913|NCT01291173|463245972|FG001|Overall Study|Subject was unblinded|0|||
128712914|NCT01291173|463245973|FG002|Overall Study|Subject was unblinded|1|||
128712915|NCT01291173|463245974|FG003|Overall Study|Subject was unblinded|0|||
128958863|NCT03332303|464135590|FG001|Overall Study|Participant did not dose|2|||
128958864|NCT03332303|464135591|FG002|Overall Study|Participant did not dose|0|||
128958865|NCT03332303|464135589|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
128958866|NCT03332303|464135590|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
128958867|NCT03332303|464135591|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
128958868|NCT03332303|464135589|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
128958869|NCT03332303|464135590|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
128958870|NCT03332303|464135591|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
128958871|NCT03332303|464135589|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
128958872|NCT03332303|464135590|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
128958873|NCT03332303|464135591|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
128958874|NCT03332303|464135589|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
128958875|NCT03332303|464135590|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
128958876|NCT03332303|464135591|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
128958877|NCT03332303|464135589|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
128958878|NCT03332303|464135590|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
128958879|NCT03332303|464135591|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
128958880|NCT03332303|464135589|FG000|Overall Study|Participant had a significant protocol deviation|0|||
128958881|NCT03332303|464135590|FG001|Overall Study|Participant had a significant protocol deviation|1|||
128958882|NCT03332303|464135591|FG002|Overall Study|Participant had a significant protocol deviation|0|||
128958883|NCT03639987|464135592|FG000|Overall Study|Study terminated by sponsor|26|||
128958884|NCT03639987|464135593|FG001|Overall Study|Study terminated by sponsor|25|||
128958885|NCT03639987|464135592|FG000|Overall Study|Lost to Follow-up|0|||
128958886|NCT03639987|464135593|FG001|Overall Study|Lost to Follow-up|1|||
128958887|NCT00889681|464135598|FG000|Overall Study|Not meeting qualification Criteria|2|||
128958888|NCT00889681|464135598|FG000|Overall Study|Insurance disapproval|1|||
128958889|NCT01185704|464135599|FG000|Overall Study|Randomized but not treated|3|||
128958890|NCT01185704|464135600|FG001|Overall Study|Randomized but not treated|3|||
128958891|NCT01185704|464135599|FG000|Overall Study|Lack of ovarian response|5|||
128958892|NCT01185704|464135600|FG001|Overall Study|Lack of ovarian response|1|||
128958893|NCT01185704|464135599|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
128958894|NCT01185704|464135600|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
128958895|NCT01185704|464135599|FG000|Overall Study|Ectopic pregnancy|0|||
128958896|NCT01185704|464135600|FG001|Overall Study|Ectopic pregnancy|1|||
128958897|NCT01686958|464135601|FG000|Overall Study|Withdrawal by Subject|1|||
128958898|NCT01151540|464135602|FG000|Overall Study|Other|2|||
128958899|NCT01151540|464135602|FG000|Overall Study|Adverse event, non-fatal|4|||
128958900|NCT01151540|464135602|FG000|Overall Study|Withdrawal by Subject|7|||
128958901|NCT03094832|464135603|FG000|Overall Study|Lost to Follow-up|0|||
128958902|NCT03094832|464135604|FG001|Overall Study|Lost to Follow-up|0|||
128958903|NCT03094832|464135605|FG002|Overall Study|Lost to Follow-up|0|||
128958904|NCT03094832|464135606|FG003|Overall Study|Lost to Follow-up|1|||
128958905|NCT03094832|464135607|FG004|Overall Study|Lost to Follow-up|1|||
128958906|NCT03094832|464135603|FG000|Overall Study|Death|1|||
128958907|NCT03094832|464135604|FG001|Overall Study|Death|0|||
128958908|NCT03094832|464135605|FG002|Overall Study|Death|0|||
128958909|NCT03094832|464135606|FG003|Overall Study|Death|0|||
128958910|NCT03094832|464135607|FG004|Overall Study|Death|0|||
128958911|NCT03094832|464135603|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
128958912|NCT03094832|464135604|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128958913|NCT03094832|464135605|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128958914|NCT03094832|464135606|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128958915|NCT03094832|464135607|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
128958916|NCT03094832|464135603|FG000|Overall Study|Other|13|||
128958917|NCT03094832|464135604|FG001|Overall Study|Other|20|||
128958918|NCT03094832|464135605|FG002|Overall Study|Other|1|||
128958919|NCT03094832|464135606|FG003|Overall Study|Other|7|||
128958920|NCT03094832|464135607|FG004|Overall Study|Other|1|||
128958921|NCT01998880|464135608|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
128958922|NCT01998880|464135609|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
128958923|NCT01998880|464135608|FG000|Overall Study|Disease Progression|1|||
128958924|NCT01998880|464135609|FG001|Overall Study|Disease Progression|8|||
128958925|NCT01998880|464135608|FG000|Overall Study|Withdrew Consent|2|||
128958926|NCT01998880|464135609|FG001|Overall Study|Withdrew Consent|1|||
128958927|NCT01998880|464135608|FG000|Overall Study|Death|3|||
128771472|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
128771473|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
128771474|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
128958928|NCT01998880|464135609|FG001|Overall Study|Death|6|||
128958929|NCT01998880|464135608|FG000|Overall Study|Insufficient Therapeutic Response|1|||
128958930|NCT01998880|464135609|FG001|Overall Study|Insufficient Therapeutic Response|5|||
128958931|NCT01998880|464135608|FG000|Overall Study|Administrative/Other|1|||
128958932|NCT01998880|464135609|FG001|Overall Study|Administrative/Other|1|||
128958933|NCT01998880|464135608|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
128958934|NCT01998880|464135609|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
128958935|NCT01998880|464135608|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
128958936|NCT01998880|464135609|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
128958937|NCT01998880|464135608|FG000|Overall Study|Did Not Receive Treatment|3|||
128958938|NCT01998880|464135609|FG001|Overall Study|Did Not Receive Treatment|2|||
128958939|NCT00004732|464135610|FG000|Overall Study|Withdrawal by Subject|36|||
128958940|NCT00004732|464135611|FG001|Overall Study|Withdrawal by Subject|64|||
128958941|NCT00004732|464135610|FG000|Overall Study|Lost to Follow-up|33|||
128958942|NCT00004732|464135611|FG001|Overall Study|Lost to Follow-up|47|||
128958943|NCT03820726|464135613|FG000|Overall Study|Other than listed|23|||
128958944|NCT03820726|464135613|FG000|Overall Study|Withdrawal by Subject|37|||
128958945|NCT03820726|464135613|FG000|Overall Study|Lost to Follow-up|3|||
128958946|NCT03820726|464135613|FG000|Overall Study|Protocol deviation|1|||
128958947|NCT03820726|464135613|FG000|Overall Study|Adverse Event|146|||
128958948|NCT03820726|464135613|FG000|Overall Study|Not treated|1|||
128958949|NCT00345540|464135618|FG000|Overall Study|Withdrawal by Subject|1|||
128958950|NCT01406652|464135619|FG000|Overall Study|Lost-to-follow-up|3|||
128958951|NCT01406652|464135620|FG001|Overall Study|Lost-to-follow-up|4|||
128958952|NCT01406652|464135619|FG000|Overall Study|Withdrawal by Subject|2|||
128958953|NCT01406652|464135620|FG001|Overall Study|Withdrawal by Subject|2|||
128958954|NCT01406652|464135619|FG000|Overall Study|Insufficient follow-up|5|||
128958955|NCT01406652|464135620|FG001|Overall Study|Insufficient follow-up|4|||
128958956|NCT01406652|464135619|FG000|Overall Study|Infection not sure|10|||
128958957|NCT01406652|464135620|FG001|Overall Study|Infection not sure|10|||
128958958|NCT00141037|464135621|FG000|Overall Study|Physician Decision|1|||
128958959|NCT00141037|464135622|FG001|Overall Study|Physician Decision|2|||
128958960|NCT00141037|464135621|FG000|Overall Study|Lost to Follow-up|3|||
128958961|NCT00141037|464135622|FG001|Overall Study|Lost to Follow-up|1|||
128958962|NCT00141037|464135621|FG000|Overall Study|Protocol Violation|0|||
128958963|NCT00141037|464135622|FG001|Overall Study|Protocol Violation|2|||
128958964|NCT00141037|464135621|FG000|Overall Study|Withdrawal by Subject|2|||
128958965|NCT00141037|464135622|FG001|Overall Study|Withdrawal by Subject|1|||
128958966|NCT00141037|464135621|FG000|Overall Study|Other|0|||
128958967|NCT00141037|464135622|FG001|Overall Study|Other|1|||
128958968|NCT00141037|464135621|FG000|Overall Study|Moved from area|1|||
128958969|NCT00141037|464135622|FG001|Overall Study|Moved from area|7|||
128958970|NCT00141037|464135621|FG000|Overall Study|Graft Failure|3|||
128958971|NCT00141037|464135622|FG001|Overall Study|Graft Failure|4|||
128958972|NCT00861380|464135623|FG000|Overall Study|Withdrawal Information not recorded|8427|||
128958973|NCT00861380|464135624|FG001|Overall Study|Withdrawal Information not recorded|9112|||
128958974|NCT00861380|464135625|FG002|Overall Study|Withdrawal Information not recorded|8872|||
128958975|NCT00861380|464135626|FG003|Overall Study|Withdrawal Information not recorded|3689|||
128958976|NCT00861380|464135627|FG004|Overall Study|Withdrawal Information not recorded|1812|||
128958977|NCT00861380|464135628|FG005|Overall Study|Withdrawal Information not recorded|6249|||
128958978|NCT00861380|464135629|FG006|Overall Study|Withdrawal Information not recorded|3020|||
128958979|NCT00260429|464135630|FG000|Overall Study|failure to follow appointments|1|||
128958980|NCT00260429|464135631|FG001|Overall Study|failure to follow appointments|0|||
128958981|NCT00260429|464135630|FG000|Overall Study|scheduled hand surgery|1|||
128958982|NCT00260429|464135631|FG001|Overall Study|scheduled hand surgery|0|||
128958983|NCT00628758|464135632|FG000|Overall Study|Adverse Event|2|||
128958984|NCT00628758|464135633|FG001|Overall Study|Adverse Event|3|||
128958985|NCT00628758|464135632|FG000|Overall Study|Withdrawal by Subject|6|||
128958986|NCT00628758|464135633|FG001|Overall Study|Withdrawal by Subject|3|||
129219831|NCT02106390|465104607|FG002|Overall Study|Withdrawal by Subject|15|||
129219832|NCT02106390|465104605|FG000|Overall Study|Lost to Follow-up|25|||
129219833|NCT02106390|465104606|FG001|Overall Study|Lost to Follow-up|20|||
129219834|NCT02106390|465104607|FG002|Overall Study|Lost to Follow-up|13|||
129219835|NCT02106390|465104605|FG000|Overall Study|Other: Administrative Reason|8|||
128712916|NCT01291173|463245971|FG000|Overall Study|Excluded therapy|0|||
128958987|NCT00628758|464135632|FG000|Overall Study|Death|1|||
128712917|NCT01291173|463245972|FG001|Overall Study|Excluded therapy|0|||
129036630|NCT02788513|464425051|FG002|Overall Study|Adverse Event|4|||
129036631|NCT02788513|464425052|FG003|Overall Study|Adverse Event|2|||
129036632|NCT02788513|464425053|FG004|Overall Study|Adverse Event|2|||
128958988|NCT00628758|464135633|FG001|Overall Study|Death|0|||
128958989|NCT00628758|464135632|FG000|Overall Study|Protocol Violation|5|||
128958990|NCT00628758|464135633|FG001|Overall Study|Protocol Violation|1|||
128958991|NCT00628758|464135632|FG000|Overall Study|Lost to Follow-up|25|||
128958992|NCT00628758|464135633|FG001|Overall Study|Lost to Follow-up|31|||
128958993|NCT00628758|464135632|FG000|Overall Study|Pregnancy|2|||
128958994|NCT00628758|464135633|FG001|Overall Study|Pregnancy|2|||
128958995|NCT00628758|464135632|FG000|Overall Study|Investigator Moved|3|||
129036633|NCT02788513|464425049|FG000|Overall Study|Protocol Violation|0|||
129219836|NCT02106390|465104606|FG001|Overall Study|Other: Administrative Reason|5|||
129219837|NCT02106390|465104607|FG002|Overall Study|Other: Administrative Reason|12|||
128958996|NCT00628758|464135633|FG001|Overall Study|Investigator Moved|0|||
128958997|NCT00628758|464135632|FG000|Overall Study|Treatment Failure|0|||
128958998|NCT00628758|464135633|FG001|Overall Study|Treatment Failure|2|||
128958999|NCT00637377|464135634|FG000|Overall Study|Adverse Event|2|||
128959000|NCT00637377|464135635|FG001|Overall Study|Adverse Event|6|||
128959001|NCT00637377|464135636|FG002|Overall Study|Adverse Event|8|||
128959002|NCT00637377|464135637|FG003|Overall Study|Adverse Event|9|||
128959003|NCT00637377|464135634|FG000|Overall Study|Death|1|||
128712918|NCT01291173|463245973|FG002|Overall Study|Excluded therapy|1|||
128712919|NCT01291173|463245974|FG003|Overall Study|Excluded therapy|0|||
128712920|NCT01113801|463245975|FG000|Overall Study|Adverse Event|4|||
128712921|NCT01113801|463245976|FG001|Overall Study|Adverse Event|0|||
128712922|NCT01113801|463245977|FG002|Overall Study|Adverse Event|2|||
128712923|NCT01113801|463245978|FG003|Overall Study|Adverse Event|6|||
128712924|NCT01113801|463245975|FG000|Overall Study|Death|4|||
128712925|NCT01113801|463245976|FG001|Overall Study|Death|5|||
128712926|NCT01113801|463245977|FG002|Overall Study|Death|3|||
128712927|NCT01113801|463245978|FG003|Overall Study|Death|4|||
128712928|NCT01113801|463245975|FG000|Overall Study|Protocol Violation|0|||
128712929|NCT01113801|463245976|FG001|Overall Study|Protocol Violation|1|||
128712930|NCT01113801|463245977|FG002|Overall Study|Protocol Violation|0|||
128712931|NCT01113801|463245978|FG003|Overall Study|Protocol Violation|0|||
128712932|NCT01113801|463245975|FG000|Overall Study|Withdrawal by Subject|9|||
128712933|NCT01113801|463245976|FG001|Overall Study|Withdrawal by Subject|7|||
128712934|NCT01113801|463245977|FG002|Overall Study|Withdrawal by Subject|7|||
128712935|NCT01113801|463245978|FG003|Overall Study|Withdrawal by Subject|8|||
128712936|NCT01113801|463245975|FG000|Overall Study|Physician Decision|2|||
128712937|NCT01113801|463245976|FG001|Overall Study|Physician Decision|2|||
129126998|NCT00876343|464758030|FG001|Overall Study|Withdrawal by Subject|4|||
129126999|NCT00876343|464758031|FG002|Overall Study|Withdrawal by Subject|3|||
129127000|NCT00876343|464758029|FG000|Overall Study|Lack of Efficacy|0|||
129127001|NCT00876343|464758030|FG001|Overall Study|Lack of Efficacy|0|||
129127002|NCT00876343|464758031|FG002|Overall Study|Lack of Efficacy|1|||
129127003|NCT00876343|464758029|FG000|Overall Study|Protocol Violation|4|||
129127004|NCT00876343|464758030|FG001|Overall Study|Protocol Violation|1|||
129127005|NCT00876343|464758031|FG002|Overall Study|Protocol Violation|1|||
129127006|NCT00876343|464758029|FG000|Overall Study|Physician Decision|0|||
129127007|NCT00876343|464758030|FG001|Overall Study|Physician Decision|1|||
129127008|NCT00876343|464758031|FG002|Overall Study|Physician Decision|1|||
129127009|NCT00876343|464758029|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
129127010|NCT00876343|464758030|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
129127011|NCT00876343|464758031|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
129127012|NCT00876343|464758029|FG000|Overall Study|Change of residence or other commitments|2|||
128712938|NCT01113801|463245977|FG002|Overall Study|Physician Decision|3|||
128712939|NCT01113801|463245978|FG003|Overall Study|Physician Decision|3|||
128712940|NCT01113801|463245975|FG000|Overall Study|Sponsor Decision|15|||
128712941|NCT01113801|463245976|FG001|Overall Study|Sponsor Decision|21|||
128959004|NCT00637377|464135635|FG001|Overall Study|Death|3|||
128959005|NCT00637377|464135636|FG002|Overall Study|Death|2|||
128959006|NCT00637377|464135637|FG003|Overall Study|Death|1|||
128959007|NCT00637377|464135634|FG000|Overall Study|Lack of Efficacy|0|||
128959008|NCT00637377|464135635|FG001|Overall Study|Lack of Efficacy|0|||
129127013|NCT00876343|464758030|FG001|Overall Study|Change of residence or other commitments|2|||
129127014|NCT00876343|464758031|FG002|Overall Study|Change of residence or other commitments|3|||
129127015|NCT01933932|464758032|FG000|Overall Study|Death|173|||
129127016|NCT01933932|464758033|FG001|Overall Study|Death|163|||
129127017|NCT01933932|464758032|FG000|Overall Study|Withdrawal by Subject|11|||
129127018|NCT01933932|464758033|FG001|Overall Study|Withdrawal by Subject|14|||
129127019|NCT01933932|464758032|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129127020|NCT01933932|464758033|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129127021|NCT01925794|464758041|FG000|180 Days|Death|2|||
129127022|NCT01925794|464758041|FG000|180 Days|Withdrawal by Subject|2|||
129127023|NCT01925794|464758041|FG000|270 Days|Death|2|||
128712942|NCT01113801|463245977|FG002|Overall Study|Sponsor Decision|20|||
128712943|NCT01113801|463245978|FG003|Overall Study|Sponsor Decision|15|||
128712944|NCT01113801|463245975|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
128959009|NCT00637377|464135636|FG002|Overall Study|Lack of Efficacy|1|||
128959010|NCT00637377|464135637|FG003|Overall Study|Lack of Efficacy|1|||
128712945|NCT01113801|463245976|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
128712946|NCT01113801|463245977|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
128712947|NCT01113801|463245978|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
128712948|NCT01506479|463245979|FG000|Overall Study|Lost to Follow-up|1|||
128959011|NCT00637377|464135634|FG000|Overall Study|Lost to Follow-up|4|||
129127024|NCT01925794|464758041|FG000|270 Days|Protocol Violation|3|||
129127025|NCT00790036|464758042|FG000|Overall Study|Abnormal lab values|3|||
128712949|NCT01506479|463245980|FG001|Overall Study|Lost to Follow-up|2|||
128712950|NCT01506479|463245981|FG002|Overall Study|Lost to Follow-up|2|||
128959012|NCT00637377|464135635|FG001|Overall Study|Lost to Follow-up|1|||
128712951|NCT01506479|463245979|FG000|Overall Study|Withdrawal by Subject|1|||
128959013|NCT00637377|464135636|FG002|Overall Study|Lost to Follow-up|2|||
128959014|NCT00637377|464135637|FG003|Overall Study|Lost to Follow-up|2|||
128959015|NCT00637377|464135634|FG000|Overall Study|Protocol Violation|2|||
128959016|NCT00637377|464135635|FG001|Overall Study|Protocol Violation|1|||
128959017|NCT00637377|464135636|FG002|Overall Study|Protocol Violation|1|||
128959018|NCT00637377|464135637|FG003|Overall Study|Protocol Violation|0|||
128959019|NCT00637377|464135634|FG000|Overall Study|Withdrawal by Subject|11|||
128959020|NCT00637377|464135635|FG001|Overall Study|Withdrawal by Subject|15|||
128959021|NCT00637377|464135636|FG002|Overall Study|Withdrawal by Subject|13|||
128959022|NCT00637377|464135637|FG003|Overall Study|Withdrawal by Subject|11|||
128959023|NCT00637377|464135634|FG000|Overall Study|Other (no further information available)|7|||
128959024|NCT00637377|464135635|FG001|Overall Study|Other (no further information available)|6|||
128959025|NCT00637377|464135636|FG002|Overall Study|Other (no further information available)|10|||
128959026|NCT00637377|464135637|FG003|Overall Study|Other (no further information available)|5|||
128959027|NCT01938001|464135638|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
128959028|NCT01938001|464135639|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
128959029|NCT01938001|464135638|FG000|Pre-Treatment|Death|1|||
128959030|NCT01938001|464135639|FG001|Pre-Treatment|Death|0|||
128959031|NCT01938001|464135638|FG000|Treatment|Death|2|||
128959032|NCT01938001|464135639|FG001|Treatment|Death|0|||
128959033|NCT01938001|464135638|FG000|Treatment|Adverse Event|14|||
128959034|NCT01938001|464135639|FG001|Treatment|Adverse Event|8|||
128959035|NCT01938001|464135638|FG000|Treatment|Progressive Disease|21|||
128959036|NCT01938001|464135639|FG001|Treatment|Progressive Disease|54|||
128959037|NCT01938001|464135638|FG000|Treatment|Withdrawal by Subject|13|||
128959038|NCT01938001|464135639|FG001|Treatment|Withdrawal by Subject|7|||
128959039|NCT01938001|464135638|FG000|Treatment|Other reasons|2|||
128959040|NCT01938001|464135639|FG001|Treatment|Other reasons|1|||
128959041|NCT02762708|464135640|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
128959042|NCT02762708|464135641|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
128959043|NCT02762708|464135642|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
128959044|NCT02762708|464135643|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
128959045|NCT01468701|464135650|FG000|Overall Study|Not eligible|91|||
128959046|NCT01468701|464135651|FG001|Overall Study|Not eligible|140|||
128959047|NCT01468701|464135652|FG002|Overall Study|Not eligible|29|||
128959048|NCT01468701|464135653|FG003|Overall Study|Not eligible|12|||
128959049|NCT01468701|464135654|FG004|Overall Study|Not eligible|22|||
128959050|NCT01468701|464135655|FG005|Overall Study|Not eligible|2|||
128959051|NCT01468701|464135656|FG006|Overall Study|Not eligible|39|||
128959052|NCT01468701|464135657|FG007|Overall Study|Not eligible|1|||
128959053|NCT01468701|464135658|FG008|Overall Study|Not eligible|40|||
128959054|NCT01468701|464135659|FG009|Overall Study|Not eligible|126|||
128959055|NCT01468701|464135660|FG010|Overall Study|Not eligible|39|||
128959056|NCT01468701|464135661|FG011|Overall Study|Not eligible|33|||
128959057|NCT01468701|464135662|FG012|Overall Study|Not eligible|1|||
128959058|NCT01468701|464135663|FG013|Overall Study|Not eligible|19|||
128959059|NCT01468701|464135664|FG014|Overall Study|Not eligible|1|||
128959060|NCT01468701|464135665|FG015|Overall Study|Not eligible|32|||
128959061|NCT01468701|464135666|FG016|Overall Study|Not eligible|0|||
128959062|NCT01468701|464135650|FG000|Overall Study|Lost to Follow-up|306|||
128959063|NCT01468701|464135651|FG001|Overall Study|Lost to Follow-up|0|||
128959064|NCT01468701|464135652|FG002|Overall Study|Lost to Follow-up|0|||
128959065|NCT01468701|464135653|FG003|Overall Study|Lost to Follow-up|0|||
128959066|NCT01468701|464135654|FG004|Overall Study|Lost to Follow-up|0|||
128959067|NCT01468701|464135655|FG005|Overall Study|Lost to Follow-up|0|||
128959068|NCT01468701|464135656|FG006|Overall Study|Lost to Follow-up|0|||
128959069|NCT01468701|464135657|FG007|Overall Study|Lost to Follow-up|0|||
128959070|NCT01468701|464135658|FG008|Overall Study|Lost to Follow-up|215|||
128959071|NCT01468701|464135659|FG009|Overall Study|Lost to Follow-up|309|||
128959072|NCT01468701|464135660|FG010|Overall Study|Lost to Follow-up|224|||
128712952|NCT01506479|463245980|FG001|Overall Study|Withdrawal by Subject|2|||
129036634|NCT02788513|464425050|FG001|Overall Study|Protocol Violation|0|||
129036635|NCT02788513|464425051|FG002|Overall Study|Protocol Violation|1|||
129036636|NCT02788513|464425052|FG003|Overall Study|Protocol Violation|1|||
129036637|NCT02788513|464425053|FG004|Overall Study|Protocol Violation|0|||
128959073|NCT01468701|464135661|FG011|Overall Study|Lost to Follow-up|212|||
128959074|NCT01468701|464135662|FG012|Overall Study|Lost to Follow-up|11|||
128959075|NCT01468701|464135663|FG013|Overall Study|Lost to Follow-up|164|||
128959076|NCT01468701|464135664|FG014|Overall Study|Lost to Follow-up|17|||
128959077|NCT01468701|464135665|FG015|Overall Study|Lost to Follow-up|127|||
128959078|NCT01468701|464135666|FG016|Overall Study|Lost to Follow-up|1|||
128959079|NCT01468701|464135650|FG000|Overall Study|Withdrawal by Subject|165|||
128959080|NCT01468701|464135651|FG001|Overall Study|Withdrawal by Subject|0|||
128959081|NCT01468701|464135652|FG002|Overall Study|Withdrawal by Subject|0|||
128959082|NCT01468701|464135653|FG003|Overall Study|Withdrawal by Subject|0|||
128959083|NCT01468701|464135654|FG004|Overall Study|Withdrawal by Subject|0|||
128712953|NCT01506479|463245981|FG002|Overall Study|Withdrawal by Subject|1|||
129036638|NCT02788513|464425049|FG000|Overall Study|Subject decided to stop taking treatment|0|||
128959084|NCT01468701|464135655|FG005|Overall Study|Withdrawal by Subject|0|||
128959085|NCT01468701|464135656|FG006|Overall Study|Withdrawal by Subject|0|||
128959086|NCT01468701|464135657|FG007|Overall Study|Withdrawal by Subject|0|||
128959087|NCT01468701|464135658|FG008|Overall Study|Withdrawal by Subject|83|||
128959088|NCT01468701|464135659|FG009|Overall Study|Withdrawal by Subject|88|||
128959089|NCT01468701|464135660|FG010|Overall Study|Withdrawal by Subject|100|||
128959090|NCT01468701|464135661|FG011|Overall Study|Withdrawal by Subject|114|||
128959091|NCT01468701|464135662|FG012|Overall Study|Withdrawal by Subject|9|||
128959092|NCT01468701|464135663|FG013|Overall Study|Withdrawal by Subject|47|||
128959093|NCT01468701|464135664|FG014|Overall Study|Withdrawal by Subject|6|||
128959094|NCT01468701|464135665|FG015|Overall Study|Withdrawal by Subject|31|||
128959095|NCT01468701|464135666|FG016|Overall Study|Withdrawal by Subject|0|||
128959096|NCT01468701|464135650|FG000|Overall Study|Other reasons than listed|437|||
128959097|NCT01468701|464135651|FG001|Overall Study|Other reasons than listed|0|||
128959098|NCT01468701|464135652|FG002|Overall Study|Other reasons than listed|0|||
128959099|NCT01468701|464135653|FG003|Overall Study|Other reasons than listed|0|||
128959100|NCT01468701|464135654|FG004|Overall Study|Other reasons than listed|0|||
128959101|NCT01468701|464135655|FG005|Overall Study|Other reasons than listed|0|||
128959102|NCT01468701|464135656|FG006|Overall Study|Other reasons than listed|0|||
128959103|NCT01468701|464135657|FG007|Overall Study|Other reasons than listed|0|||
128959104|NCT01468701|464135658|FG008|Overall Study|Other reasons than listed|318|||
128959105|NCT01468701|464135659|FG009|Overall Study|Other reasons than listed|658|||
128959106|NCT01468701|464135660|FG010|Overall Study|Other reasons than listed|433|||
128959107|NCT01468701|464135661|FG011|Overall Study|Other reasons than listed|504|||
128959108|NCT01468701|464135662|FG012|Overall Study|Other reasons than listed|28|||
128959109|NCT01468701|464135663|FG013|Overall Study|Other reasons than listed|239|||
128959110|NCT01468701|464135664|FG014|Overall Study|Other reasons than listed|39|||
128959111|NCT01468701|464135665|FG015|Overall Study|Other reasons than listed|172|||
128959112|NCT01468701|464135666|FG016|Overall Study|Other reasons than listed|0|||
128959113|NCT01468701|464135650|FG000|Overall Study|No end of study case report form|0|||
128959114|NCT01468701|464135651|FG001|Overall Study|No end of study case report form|0|||
128959115|NCT01468701|464135652|FG002|Overall Study|No end of study case report form|0|||
128959116|NCT01468701|464135653|FG003|Overall Study|No end of study case report form|0|||
128959117|NCT01468701|464135654|FG004|Overall Study|No end of study case report form|0|||
128959118|NCT01468701|464135655|FG005|Overall Study|No end of study case report form|0|||
128959119|NCT01468701|464135656|FG006|Overall Study|No end of study case report form|0|||
128959120|NCT01468701|464135657|FG007|Overall Study|No end of study case report form|0|||
128959121|NCT01468701|464135658|FG008|Overall Study|No end of study case report form|4|||
128959122|NCT01468701|464135659|FG009|Overall Study|No end of study case report form|1|||
128959123|NCT01468701|464135660|FG010|Overall Study|No end of study case report form|2|||
128959124|NCT01468701|464135661|FG011|Overall Study|No end of study case report form|3|||
128959125|NCT01468701|464135662|FG012|Overall Study|No end of study case report form|0|||
128959126|NCT01468701|464135663|FG013|Overall Study|No end of study case report form|1|||
128959127|NCT01468701|464135664|FG014|Overall Study|No end of study case report form|0|||
128959128|NCT01468701|464135665|FG015|Overall Study|No end of study case report form|0|||
128959129|NCT01468701|464135666|FG016|Overall Study|No end of study case report form|0|||
128959130|NCT01468701|464135650|FG000|Overall Study|Not being followed up|0|||
128959131|NCT01468701|464135651|FG001|Overall Study|Not being followed up|4963|||
128959132|NCT01468701|464135652|FG002|Overall Study|Not being followed up|1755|||
128959133|NCT01468701|464135653|FG003|Overall Study|Not being followed up|703|||
128959134|NCT01468701|464135654|FG004|Overall Study|Not being followed up|1714|||
128959135|NCT01468701|464135655|FG005|Overall Study|Not being followed up|126|||
128959136|NCT01468701|464135656|FG006|Overall Study|Not being followed up|1170|||
128959137|NCT01468701|464135657|FG007|Overall Study|Not being followed up|4|||
128959138|NCT01468701|464135658|FG008|Overall Study|Not being followed up|0|||
128959139|NCT01468701|464135659|FG009|Overall Study|Not being followed up|0|||
128959140|NCT01468701|464135660|FG010|Overall Study|Not being followed up|0|||
128959141|NCT01468701|464135661|FG011|Overall Study|Not being followed up|0|||
128959142|NCT01468701|464135662|FG012|Overall Study|Not being followed up|0|||
128959143|NCT01468701|464135663|FG013|Overall Study|Not being followed up|0|||
128959144|NCT01468701|464135664|FG014|Overall Study|Not being followed up|0|||
128959145|NCT01468701|464135665|FG015|Overall Study|Not being followed up|0|||
128959146|NCT01468701|464135666|FG016|Overall Study|Not being followed up|0|||
128959147|NCT01068717|464135667|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
128959148|NCT01068717|464135668|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
128959149|NCT01068717|464135669|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
128959150|NCT01068717|464135670|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
128959151|NCT01822223|464135671|FG000|Overall Study|Death|0|||
128959152|NCT01822223|464135672|FG001|Overall Study|Death|1|||
128959153|NCT00719862|464135676|FG000|Overall Study|Adverse Event|1|||
128959154|NCT00719862|464135677|FG001|Overall Study|Adverse Event|2|||
128959155|NCT00719862|464135676|FG000|Overall Study|Lack of Efficacy|3|||
128959156|NCT00719862|464135677|FG001|Overall Study|Lack of Efficacy|0|||
128959157|NCT00719862|464135676|FG000|Overall Study|Non-Compliance|1|||
128959158|NCT00719862|464135677|FG001|Overall Study|Non-Compliance|0|||
128959159|NCT00719862|464135676|FG000|Overall Study|Withdrawal by Subject|1|||
128959160|NCT00719862|464135677|FG001|Overall Study|Withdrawal by Subject|0|||
128959161|NCT00719862|464135676|FG000|Overall Study|Lost to Follow-up|0|||
128959162|NCT00719862|464135677|FG001|Overall Study|Lost to Follow-up|1|||
128959163|NCT00719862|464135676|FG000|Overall Study|Other|2|||
128959164|NCT00719862|464135677|FG001|Overall Study|Other|3|||
128959165|NCT00892957|464135679|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
128959166|NCT00892957|464135680|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
128959167|NCT00892957|464135679|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
128959168|NCT00892957|464135680|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
128959169|NCT01184846|464135681|FG000|Overall Study|Adverse Event|2|||
128959170|NCT01184846|464135681|FG000|Overall Study|Insufficient response|1|||
128959171|NCT04876599|464135682|FG000|Overall Study|Missed|2|||
128959172|NCT04876599|464135683|FG001|Overall Study|Missed|0|||
128959173|NCT04876599|464135682|FG000|Overall Study|Declined|2|||
128959174|NCT04876599|464135683|FG001|Overall Study|Declined|3|||
128959175|NCT03175562|464135684|FG000|Overall Study|Adverse Event|1|||
128959176|NCT03175562|464135684|FG000|Overall Study|Lost to Follow-up|3|||
128959177|NCT03175562|464135684|FG000|Overall Study|Withdrawal by Subject|7|||
128959178|NCT03175562|464135684|FG000|Overall Study|Other (Not Specified)|5|||
128959179|NCT02146833|464135685|FG000|Overall Study|Death|10|||
128959180|NCT02146833|464135685|FG000|Overall Study|No longer consented to study treatment|1|||
128959181|NCT03700736|464135686|FG000|Overall Study|Pregnancy|1|||
128959182|NCT03700736|464135687|FG001|Overall Study|Pregnancy|1|||
128959183|NCT03700736|464135686|FG000|Overall Study|Withdrawal by Subject|2|||
128959184|NCT03700736|464135687|FG001|Overall Study|Withdrawal by Subject|6|||
128959185|NCT04126031|464135690|FG000|Part A|Withdrawal by Subject|0|||
128959186|NCT04126031|464135691|FG001|Part A|Withdrawal by Subject|0|||
128959187|NCT04126031|464135692|FG002|Part A|Withdrawal by Subject|1|||
128959188|NCT04126031|464135693|FG003|Part A|Withdrawal by Subject|0|||
128959189|NCT04126031|464135694|FG004|Part A|Withdrawal by Subject|0|||
128959190|NCT04126031|464135695|FG005|Part A|Withdrawal by Subject|0|||
128959191|NCT04126031|464135690|FG000|Part A|Other|1|||
128959192|NCT04126031|464135691|FG001|Part A|Other|0|||
128959193|NCT04126031|464135692|FG002|Part A|Other|0|||
128959194|NCT04126031|464135693|FG003|Part A|Other|0|||
128959195|NCT04126031|464135694|FG004|Part A|Other|0|||
128959196|NCT04126031|464135695|FG005|Part A|Other|0|||
128959197|NCT04126031|464135690|FG000|Part B|Adverse Event|0|||
128959198|NCT04126031|464135691|FG001|Part B|Adverse Event|0|||
128959199|NCT04126031|464135692|FG002|Part B|Adverse Event|0|||
128959200|NCT04126031|464135693|FG003|Part B|Adverse Event|0|||
128959201|NCT04126031|464135694|FG004|Part B|Adverse Event|0|||
128959202|NCT04126031|464135695|FG005|Part B|Adverse Event|2|||
128959203|NCT04126031|464135690|FG000|Part B|Pre-existing hypertransaminasemia|0|||
128959204|NCT04126031|464135691|FG001|Part B|Pre-existing hypertransaminasemia|0|||
128959205|NCT04126031|464135692|FG002|Part B|Pre-existing hypertransaminasemia|0|||
128959206|NCT04126031|464135693|FG003|Part B|Pre-existing hypertransaminasemia|0|||
128959207|NCT04126031|464135694|FG004|Part B|Pre-existing hypertransaminasemia|1|||
128959208|NCT04126031|464135695|FG005|Part B|Pre-existing hypertransaminasemia|0|||
128959209|NCT00131664|464135696|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
128959210|NCT00131664|464135697|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
128959211|NCT00131664|464135698|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
128959212|NCT00131664|464135699|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
128959213|NCT00131664|464135700|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
128959214|NCT00131664|464135701|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
128959215|NCT00131664|464135696|FG000|First Period (First 6 Months)|Death|0|||
128771475|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
128771476|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
128771477|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
128771478|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
128959216|NCT00131664|464135697|FG001|First Period (First 6 Months)|Death|1|||
128959217|NCT00131664|464135698|FG002|First Period (First 6 Months)|Death|0|||
128959218|NCT00131664|464135699|FG003|First Period (First 6 Months)|Death|0|||
128771479|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
128959219|NCT00131664|464135700|FG004|First Period (First 6 Months)|Death|0|||
128959220|NCT00131664|464135701|FG005|First Period (First 6 Months)|Death|0|||
128959221|NCT00131664|464135696|FG000|First Period (First 6 Months)|Protocol Violation|2|||
128959222|NCT00131664|464135697|FG001|First Period (First 6 Months)|Protocol Violation|2|||
128959223|NCT00131664|464135698|FG002|First Period (First 6 Months)|Protocol Violation|1|||
128959224|NCT00131664|464135699|FG003|First Period (First 6 Months)|Protocol Violation|0|||
128959225|NCT00131664|464135700|FG004|First Period (First 6 Months)|Protocol Violation|0|||
128959226|NCT00131664|464135701|FG005|First Period (First 6 Months)|Protocol Violation|0|||
128959227|NCT00131664|464135696|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
128959228|NCT00131664|464135697|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
129127026|NCT00790036|464758043|FG001|Overall Study|Abnormal lab values|2|||
128771480|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
128771481|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
128771482|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
128771483|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
128771484|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
128771485|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
128771486|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
128771487|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
128771488|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
128771489|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
128771490|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
128771491|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
128771492|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
128771493|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
128771494|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
128771495|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
128771496|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
128771497|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
128771498|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
128771499|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
128959229|NCT00131664|464135698|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
128959230|NCT00131664|464135699|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
128959231|NCT00131664|464135700|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
128959232|NCT00131664|464135701|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
128959233|NCT00131664|464135696|FG000|First Period (First 6 Months)|Adverse Event|9|||
128959234|NCT00131664|464135697|FG001|First Period (First 6 Months)|Adverse Event|4|||
128959235|NCT00131664|464135698|FG002|First Period (First 6 Months)|Adverse Event|5|||
128959236|NCT00131664|464135699|FG003|First Period (First 6 Months)|Adverse Event|0|||
128959237|NCT00131664|464135700|FG004|First Period (First 6 Months)|Adverse Event|0|||
128959238|NCT00131664|464135701|FG005|First Period (First 6 Months)|Adverse Event|0|||
128959239|NCT00131664|464135696|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
128959240|NCT00131664|464135697|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
128959241|NCT00131664|464135698|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
128959242|NCT00131664|464135699|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
128959243|NCT00131664|464135700|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
128959244|NCT00131664|464135701|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
128959245|NCT00131664|464135696|FG000|First Period (First 6 Months)|Administrative reasons|2|||
128959246|NCT00131664|464135697|FG001|First Period (First 6 Months)|Administrative reasons|0|||
128959247|NCT00131664|464135698|FG002|First Period (First 6 Months)|Administrative reasons|5|||
128959248|NCT00131664|464135699|FG003|First Period (First 6 Months)|Administrative reasons|0|||
128959249|NCT00131664|464135700|FG004|First Period (First 6 Months)|Administrative reasons|0|||
128959250|NCT00131664|464135701|FG005|First Period (First 6 Months)|Administrative reasons|0|||
128959251|NCT00131664|464135696|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
128959252|NCT00131664|464135697|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
128959253|NCT00131664|464135698|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
128959254|NCT00131664|464135699|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
128959255|NCT00131664|464135700|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
128959256|NCT00131664|464135701|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
128959257|NCT00131664|464135696|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
128959258|NCT00131664|464135697|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
128959259|NCT00131664|464135698|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
128959260|NCT00131664|464135699|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
128959261|NCT00131664|464135700|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
128959262|NCT00131664|464135701|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
128959263|NCT00131664|464135696|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
128959264|NCT00131664|464135697|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
128959265|NCT00131664|464135698|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
128959266|NCT00131664|464135699|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
128959267|NCT00131664|464135700|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
128959268|NCT00131664|464135701|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
128959269|NCT00131664|464135696|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
129127027|NCT00790036|464758042|FG000|Overall Study|Administrative problems|5|||
129127028|NCT00790036|464758043|FG001|Overall Study|Administrative problems|9|||
129127029|NCT00790036|464758042|FG000|Overall Study|Adverse Event|113|||
129127030|NCT00790036|464758043|FG001|Overall Study|Adverse Event|44|||
128959270|NCT00131664|464135697|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
128959271|NCT00131664|464135698|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
128959272|NCT00131664|464135699|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
128959273|NCT00131664|464135700|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
128959274|NCT00131664|464135701|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
128959275|NCT00131664|464135696|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
128959276|NCT00131664|464135697|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
128959277|NCT00131664|464135698|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
128959278|NCT00131664|464135699|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
128959279|NCT00131664|464135700|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
128959280|NCT00131664|464135701|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
128959281|NCT00131664|464135696|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
128959282|NCT00131664|464135697|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
128959283|NCT00131664|464135698|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
128959284|NCT00131664|464135699|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
128959285|NCT00131664|464135700|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
128959286|NCT00131664|464135701|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
128959287|NCT00617656|464135702|FG000|Overall Study|Inclusion error|4|||
128959288|NCT00617656|464135703|FG001|Overall Study|Inclusion error|4|||
128959289|NCT00617656|464135704|FG002|Overall Study|Inclusion error|0|||
128959290|NCT00617656|464135705|FG003|Overall Study|Inclusion error|0|||
128959291|NCT00617656|464135702|FG000|Overall Study|Missing data|44|||
128959292|NCT00617656|464135703|FG001|Overall Study|Missing data|30|||
128959293|NCT00617656|464135704|FG002|Overall Study|Missing data|13|||
128959294|NCT00617656|464135705|FG003|Overall Study|Missing data|6|||
128959295|NCT00617656|464135702|FG000|Overall Study|Withdrawal by Subject|0|||
128959296|NCT00617656|464135703|FG001|Overall Study|Withdrawal by Subject|2|||
128959297|NCT00617656|464135704|FG002|Overall Study|Withdrawal by Subject|0|||
128959298|NCT00617656|464135705|FG003|Overall Study|Withdrawal by Subject|0|||
128959299|NCT02688153|464138316|FG000|Overall Study|Death|7|||
128959300|NCT02688153|464138317|FG001|Overall Study|Death|5|||
128959301|NCT02688153|464138316|FG000|Overall Study|Withdrawal by Subject|4|||
128959302|NCT02688153|464138317|FG001|Overall Study|Withdrawal by Subject|2|||
128959303|NCT02688153|464138316|FG000|Overall Study|Valve Explant|1|||
128959304|NCT02688153|464138317|FG001|Overall Study|Valve Explant|0|||
128959305|NCT02688153|464138316|FG000|Overall Study|Conversion to Commercial Valve|3|||
128959306|NCT02688153|464138317|FG001|Overall Study|Conversion to Commercial Valve|0|||
128959307|NCT01102140|464138318|FG000|Overall Study|Lost to Follow-up|1|||
128959308|NCT01102140|464138319|FG001|Overall Study|Lost to Follow-up|0|||
128959309|NCT01102140|464138318|FG000|Overall Study|Investigator terminated study|2|||
128959310|NCT01102140|464138319|FG001|Overall Study|Investigator terminated study|2|||
128959311|NCT01742091|464138322|FG000|Overall Study|Adverse Event|0|||
128959312|NCT01742091|464138323|FG001|Overall Study|Adverse Event|0|||
128959313|NCT01742091|464138324|FG002|Overall Study|Adverse Event|0|||
128959314|NCT01742091|464138325|FG003|Overall Study|Adverse Event|0|||
128959315|NCT01742091|464138326|FG004|Overall Study|Adverse Event|1|||
128959316|NCT01742091|464138327|FG005|Overall Study|Adverse Event|0|||
128959317|NCT01742091|464138322|FG000|Overall Study|Physician Decision|0|||
128959318|NCT01742091|464138323|FG001|Overall Study|Physician Decision|0|||
128959319|NCT01742091|464138324|FG002|Overall Study|Physician Decision|0|||
128959320|NCT01742091|464138325|FG003|Overall Study|Physician Decision|0|||
128959321|NCT01742091|464138326|FG004|Overall Study|Physician Decision|0|||
128959322|NCT01742091|464138327|FG005|Overall Study|Physician Decision|1|||
128959323|NCT01742091|464138322|FG000|Overall Study|Withdrawal by Subject|0|||
129036639|NCT02788513|464425050|FG001|Overall Study|Subject decided to stop taking treatment|0|||
129036640|NCT02788513|464425051|FG002|Overall Study|Subject decided to stop taking treatment|1|||
129036641|NCT02788513|464425052|FG003|Overall Study|Subject decided to stop taking treatment|0|||
129036642|NCT02788513|464425053|FG004|Overall Study|Subject decided to stop taking treatment|0|||
129036643|NCT02788513|464425049|FG000|Overall Study|Decision by the study team|0|||
129036644|NCT02788513|464425050|FG001|Overall Study|Decision by the study team|0|||
129036645|NCT02788513|464425051|FG002|Overall Study|Decision by the study team|0|||
129036646|NCT02788513|464425052|FG003|Overall Study|Decision by the study team|0|||
129036647|NCT02788513|464425053|FG004|Overall Study|Decision by the study team|1|||
129036648|NCT00114231|464425055|FG000|Overall Study|No consent|2|||
129036649|NCT00114231|464425056|FG001|Overall Study|No consent|0|||
129036650|NCT00114231|464425055|FG000|Overall Study|QARC requirement not met|1|||
129036651|NCT00114231|464425056|FG001|Overall Study|QARC requirement not met|0|||
129036652|NCT00114231|464425055|FG000|Overall Study|Suspected metastatic disease|1|||
128959324|NCT01742091|464138323|FG001|Overall Study|Withdrawal by Subject|0|||
128959325|NCT01742091|464138324|FG002|Overall Study|Withdrawal by Subject|0|||
129036653|NCT00114231|464425056|FG001|Overall Study|Suspected metastatic disease|0|||
129036654|NCT00114231|464425055|FG000|Overall Study|No adenocarcinoma|1|||
128959326|NCT01742091|464138325|FG003|Overall Study|Withdrawal by Subject|1|||
128959327|NCT01742091|464138326|FG004|Overall Study|Withdrawal by Subject|0|||
128959328|NCT01742091|464138327|FG005|Overall Study|Withdrawal by Subject|0|||
128959329|NCT01742091|464138322|FG000|Overall Study|Lost to Follow-up|0|||
128959330|NCT01742091|464138323|FG001|Overall Study|Lost to Follow-up|0|||
129219838|NCT02106390|465104605|FG000|Overall Study|Other: Unspecified|1|||
129219839|NCT02106390|465104606|FG001|Overall Study|Other: Unspecified|4|||
129219840|NCT02106390|465104607|FG002|Overall Study|Other: Unspecified|2|||
129219841|NCT02106390|465104605|FG000|Overall Study|Adverse Event|0|||
129219842|NCT02106390|465104606|FG001|Overall Study|Adverse Event|2|||
129219843|NCT02106390|465104607|FG002|Overall Study|Adverse Event|1|||
129219844|NCT02106390|465104605|FG000|Overall Study|Protocol Violation|0|||
128712954|NCT01506479|463245979|FG000|Overall Study|Missing assessment|1|||
128712955|NCT01506479|463245980|FG001|Overall Study|Missing assessment|0|||
128712956|NCT01506479|463245981|FG002|Overall Study|Missing assessment|0|||
128712957|NCT01506479|463245979|FG000|Overall Study|Adverse Event|0|||
128959331|NCT01742091|464138324|FG002|Overall Study|Lost to Follow-up|0|||
128959332|NCT01742091|464138325|FG003|Overall Study|Lost to Follow-up|0|||
128959333|NCT01742091|464138326|FG004|Overall Study|Lost to Follow-up|0|||
128959334|NCT01742091|464138327|FG005|Overall Study|Lost to Follow-up|1|||
128959335|NCT00212758|464138331|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
128959336|NCT00212758|464138332|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
128959337|NCT00212758|464138331|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
128959338|NCT00212758|464138332|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
128959339|NCT00948194|464138333|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
128959340|NCT00948194|464138334|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
128959341|NCT02431793|464138335|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
128959342|NCT02431793|464138336|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
128959343|NCT02431793|464138337|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
128959344|NCT02431793|464138335|FG000|Overall Study|Withdrawal by Subject|7|||
128959345|NCT02431793|464138336|FG001|Overall Study|Withdrawal by Subject|5|||
128959346|NCT02431793|464138337|FG002|Overall Study|Withdrawal by Subject|5|||
128959347|NCT02431793|464138335|FG000|Overall Study|Lost to Follow-up|101|||
128959348|NCT02431793|464138336|FG001|Overall Study|Lost to Follow-up|122|||
128959349|NCT02431793|464138337|FG002|Overall Study|Lost to Follow-up|104|||
128959350|NCT00233324|464138338|FG000|Main Study|Death|68|||
128959351|NCT00233324|464138339|FG001|Main Study|Death|60|||
128959352|NCT00233324|464138340|FG002|Main Study|Death|62|||
128959353|NCT00233324|464138341|FG003|Main Study|Death|47|||
128959354|NCT00233324|464138338|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
128959355|NCT00233324|464138339|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
128959356|NCT00233324|464138340|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
129127031|NCT00790036|464758042|FG000|Overall Study|Death|1|||
128712958|NCT01506479|463245980|FG001|Overall Study|Adverse Event|1|||
128712959|NCT01506479|463245981|FG002|Overall Study|Adverse Event|0|||
128712960|NCT03318315|463245982|FG000|Overall Study|Lost to Follow-up|3|||
128712961|NCT03318315|463245983|FG001|Overall Study|Lost to Follow-up|2|||
128712962|NCT03318315|463245984|FG002|Overall Study|Lost to Follow-up|1|||
128771500|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
128771501|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
128959357|NCT00233324|464138341|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
128959358|NCT00233324|464138338|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
129127032|NCT00790036|464758043|FG001|Overall Study|Death|0|||
129127033|NCT00790036|464758042|FG000|Overall Study|Disease progression|24|||
129127034|NCT00790036|464758043|FG001|Overall Study|Disease progression|48|||
129127035|NCT00790036|464758042|FG000|Overall Study|Lost to Follow-up|1|||
128771502|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
129127036|NCT00790036|464758043|FG001|Overall Study|Lost to Follow-up|2|||
129127037|NCT00790036|464758042|FG000|Overall Study|Protocol Violation|10|||
129127038|NCT00790036|464758043|FG001|Overall Study|Protocol Violation|2|||
129127039|NCT00790036|464758042|FG000|Overall Study|Withdrawal by Subject|18|||
129127040|NCT00790036|464758043|FG001|Overall Study|Withdrawal by Subject|7|||
129127041|NCT00790036|464758042|FG000|Overall Study|Subject/guardian decision|20|||
129127042|NCT00790036|464758043|FG001|Overall Study|Subject/guardian decision|7|||
129127043|NCT03126110|464758052|FG000|Phase 1|Death|2|||
128712963|NCT03318315|463245982|FG000|Overall Study|Protocol Violation|1|||
128959359|NCT00233324|464138339|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
128959360|NCT00233324|464138340|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
128959361|NCT00233324|464138341|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
128959362|NCT03170258|464138347|FG000|Overall Study|Physician Decision|4|||
128959363|NCT03170258|464138348|FG001|Overall Study|Physician Decision|0|||
129127044|NCT03126110|464758053|FG001|Phase 1|Death|2|||
129127045|NCT03126110|464758054|FG002|Phase 1|Death|4|||
129219845|NCT02106390|465104606|FG001|Overall Study|Protocol Violation|1|||
129219846|NCT02106390|465104607|FG002|Overall Study|Protocol Violation|0|||
129219847|NCT03198507|465104608|FG000|Overall Study|Withdrawal by Subject|1|||
128959364|NCT03170258|464138347|FG000|Overall Study|Equipment issues|1|||
128959365|NCT03170258|464138348|FG001|Overall Study|Equipment issues|0|||
128959366|NCT03170258|464138347|FG000|Overall Study|Medication|1|||
128959367|NCT03170258|464138348|FG001|Overall Study|Medication|0|||
128959368|NCT03170258|464138347|FG000|Overall Study|Sleep issues|1|||
128959369|NCT03170258|464138348|FG001|Overall Study|Sleep issues|0|||
128959370|NCT01563107|464138349|FG000|Overall Study|Physician Decision|0|||
128959371|NCT01563107|464138350|FG001|Overall Study|Physician Decision|1|||
128959372|NCT01563107|464138351|FG002|Overall Study|Physician Decision|1|||
128959373|NCT01563107|464138352|FG003|Overall Study|Physician Decision|3|||
128959374|NCT01563107|464138349|FG000|Overall Study|Withdrawal by Subject|1|||
128959375|NCT01563107|464138350|FG001|Overall Study|Withdrawal by Subject|2|||
128959376|NCT01563107|464138351|FG002|Overall Study|Withdrawal by Subject|1|||
128959377|NCT01563107|464138352|FG003|Overall Study|Withdrawal by Subject|2|||
128959378|NCT00247273|464138356|FG000|Overall Study|Adverse Event|85|||
128959379|NCT00247273|464138357|FG001|Overall Study|Adverse Event|80|||
128959380|NCT00247273|464138356|FG000|Overall Study|Physician Decision|6|||
128959381|NCT00247273|464138357|FG001|Overall Study|Physician Decision|3|||
128959382|NCT00247273|464138356|FG000|Overall Study|Lost to Follow-up|7|||
128959383|NCT00247273|464138357|FG001|Overall Study|Lost to Follow-up|7|||
129127046|NCT03126110|464758055|FG003|Phase 1|Death|3|||
128959384|NCT00247273|464138356|FG000|Overall Study|Withdrawal by Subject|46|||
128959385|NCT00247273|464138357|FG001|Overall Study|Withdrawal by Subject|47|||
129127047|NCT03126110|464758056|FG004|Phase 1|Death|4|||
129127048|NCT03126110|464758057|FG005|Phase 1|Death|4|||
129127049|NCT03126110|464758058|FG006|Phase 1|Death|3|||
129127050|NCT03126110|464758059|FG007|Phase 1|Death|4|||
129127051|NCT03126110|464758060|FG008|Phase 1|Death|5|||
129127052|NCT03126110|464758061|FG009|Phase 1|Death|2|||
129127053|NCT03126110|464758062|FG010|Phase 1|Death|6|||
129127054|NCT03126110|464758063|FG011|Phase 1|Death|0|||
129127055|NCT03126110|464758064|FG012|Phase 1|Death|0|||
129127056|NCT03126110|464758065|FG013|Phase 1|Death|0|||
129127057|NCT03126110|464758066|FG014|Phase 1|Death|0|||
129127058|NCT03126110|464758067|FG015|Phase 1|Death|0|||
129127059|NCT03126110|464758068|FG016|Phase 1|Death|0|||
129127060|NCT03126110|464758052|FG000|Phase 1|Lost to Follow-up|0|||
129127061|NCT03126110|464758053|FG001|Phase 1|Lost to Follow-up|1|||
129127062|NCT03126110|464758054|FG002|Phase 1|Lost to Follow-up|0|||
129127063|NCT03126110|464758055|FG003|Phase 1|Lost to Follow-up|0|||
129127064|NCT03126110|464758056|FG004|Phase 1|Lost to Follow-up|0|||
129127065|NCT03126110|464758057|FG005|Phase 1|Lost to Follow-up|0|||
129127066|NCT03126110|464758058|FG006|Phase 1|Lost to Follow-up|0|||
129127067|NCT03126110|464758059|FG007|Phase 1|Lost to Follow-up|0|||
129127068|NCT03126110|464758060|FG008|Phase 1|Lost to Follow-up|1|||
129127069|NCT03126110|464758061|FG009|Phase 1|Lost to Follow-up|0|||
129127070|NCT03126110|464758062|FG010|Phase 1|Lost to Follow-up|0|||
129127071|NCT03126110|464758063|FG011|Phase 1|Lost to Follow-up|0|||
129127072|NCT03126110|464758064|FG012|Phase 1|Lost to Follow-up|0|||
129127073|NCT03126110|464758065|FG013|Phase 1|Lost to Follow-up|0|||
129127074|NCT03126110|464758066|FG014|Phase 1|Lost to Follow-up|0|||
129127075|NCT03126110|464758067|FG015|Phase 1|Lost to Follow-up|0|||
129127076|NCT03126110|464758068|FG016|Phase 1|Lost to Follow-up|0|||
129127077|NCT03126110|464758052|FG000|Phase 1|Withdrawal by Subject|1|||
129127078|NCT03126110|464758053|FG001|Phase 1|Withdrawal by Subject|0|||
129127079|NCT03126110|464758054|FG002|Phase 1|Withdrawal by Subject|0|||
128771503|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
128959386|NCT00247273|464138356|FG000|Overall Study|Did not take any study drug|2|||
128959387|NCT00247273|464138357|FG001|Overall Study|Did not take any study drug|0|||
128959388|NCT01419015|464138359|FG000|Overall Study|Death|2|||
128959389|NCT03276572|464138361|FG000|Overall Study|In follow-up|0|||
128959390|NCT03276572|464138362|FG001|Overall Study|In follow-up|0|||
128959391|NCT03276572|464138363|FG002|Overall Study|In follow-up|0|||
129127080|NCT03126110|464758055|FG003|Phase 1|Withdrawal by Subject|1|||
129127081|NCT03126110|464758056|FG004|Phase 1|Withdrawal by Subject|1|||
129127082|NCT03126110|464758057|FG005|Phase 1|Withdrawal by Subject|0|||
129127083|NCT03126110|464758058|FG006|Phase 1|Withdrawal by Subject|0|||
129127084|NCT03126110|464758059|FG007|Phase 1|Withdrawal by Subject|0|||
129127085|NCT03126110|464758060|FG008|Phase 1|Withdrawal by Subject|2|||
128959392|NCT03276572|464138364|FG003|Overall Study|In follow-up|0|||
128959393|NCT03276572|464138365|FG004|Overall Study|In follow-up|0|||
128959394|NCT03276572|464138366|FG005|Overall Study|In follow-up|1|||
128959395|NCT03276572|464138367|FG006|Overall Study|In follow-up|1|||
129127086|NCT03126110|464758061|FG009|Phase 1|Withdrawal by Subject|1|||
129127087|NCT03126110|464758062|FG010|Phase 1|Withdrawal by Subject|0|||
128959396|NCT03276572|464138361|FG000|Overall Study|Lost to Follow-up|0|||
129127088|NCT03126110|464758063|FG011|Phase 1|Withdrawal by Subject|0|||
129127089|NCT03126110|464758064|FG012|Phase 1|Withdrawal by Subject|0|||
129127090|NCT03126110|464758065|FG013|Phase 1|Withdrawal by Subject|0|||
129127091|NCT03126110|464758066|FG014|Phase 1|Withdrawal by Subject|0|||
129127092|NCT03126110|464758067|FG015|Phase 1|Withdrawal by Subject|0|||
129127093|NCT03126110|464758068|FG016|Phase 1|Withdrawal by Subject|0|||
129127094|NCT03126110|464758052|FG000|Phase 1|Safety follow-up no longer necessary|1|||
129127095|NCT03126110|464758053|FG001|Phase 1|Safety follow-up no longer necessary|0|||
129219848|NCT03198507|465104609|FG001|Overall Study|Withdrawal by Subject|0|||
129219849|NCT00241839|465104611|FG000|Overall Study|Withdrawal by Subject|18|||
129219850|NCT00241839|465104612|FG001|Overall Study|Withdrawal by Subject|17|||
129219851|NCT00241839|465104611|FG000|Overall Study|Adverse Event|1|||
129219852|NCT00241839|465104612|FG001|Overall Study|Adverse Event|1|||
129219853|NCT01662102|465104615|FG000|Overall Study|Sponsor's decision|1|||
129219854|NCT01662102|465104616|FG001|Overall Study|Sponsor's decision|0|||
129219855|NCT01995838|465104619|FG000|Overall Study|Lost to Follow-up|0|||
129219856|NCT01995838|465104620|FG001|Overall Study|Lost to Follow-up|1|||
129219857|NCT01995838|465104621|FG002|Overall Study|Lost to Follow-up|0|||
129219858|NCT01995838|465104622|FG003|Overall Study|Lost to Follow-up|0|||
129219859|NCT01995838|465104623|FG004|Overall Study|Lost to Follow-up|0|||
129127096|NCT03126110|464758054|FG002|Phase 1|Safety follow-up no longer necessary|0|||
129127097|NCT03126110|464758055|FG003|Phase 1|Safety follow-up no longer necessary|0|||
129127098|NCT03126110|464758056|FG004|Phase 1|Safety follow-up no longer necessary|0|||
129127099|NCT03126110|464758057|FG005|Phase 1|Safety follow-up no longer necessary|0|||
129127100|NCT03126110|464758058|FG006|Phase 1|Safety follow-up no longer necessary|0|||
129127101|NCT03126110|464758059|FG007|Phase 1|Safety follow-up no longer necessary|0|||
129127102|NCT03126110|464758060|FG008|Phase 1|Safety follow-up no longer necessary|0|||
129127103|NCT03126110|464758061|FG009|Phase 1|Safety follow-up no longer necessary|0|||
129127104|NCT03126110|464758062|FG010|Phase 1|Safety follow-up no longer necessary|0|||
129219860|NCT01995838|465104624|FG005|Overall Study|Lost to Follow-up|0|||
128712964|NCT03318315|463245983|FG001|Overall Study|Protocol Violation|1|||
128712965|NCT03318315|463245984|FG002|Overall Study|Protocol Violation|1|||
128959397|NCT03276572|464138362|FG001|Overall Study|Lost to Follow-up|0|||
128959398|NCT03276572|464138363|FG002|Overall Study|Lost to Follow-up|0|||
128959399|NCT03276572|464138364|FG003|Overall Study|Lost to Follow-up|0|||
128959400|NCT03276572|464138365|FG004|Overall Study|Lost to Follow-up|0|||
128959401|NCT03276572|464138366|FG005|Overall Study|Lost to Follow-up|0|||
128959402|NCT03276572|464138367|FG006|Overall Study|Lost to Follow-up|1|||
128959403|NCT01709708|464138368|FG000|Overall Study|Protocol Violation|1|||
128959404|NCT01709708|464138369|FG001|Overall Study|Protocol Violation|2|||
128959405|NCT01527110|464138370|FG000|Overall Study|Adverse Event|1|||
128959406|NCT00527072|464138371|FG000|Overall Study|Adverse Event|13|||
128959407|NCT00527072|464138371|FG000|Overall Study|Lack of Efficacy|11|||
128959408|NCT00527072|464138371|FG000|Overall Study|Lost to Follow-up|3|||
128959409|NCT00527072|464138371|FG000|Overall Study|Protocol Violation|2|||
128959410|NCT00527072|464138371|FG000|Overall Study|Withdrawal by Subject|7|||
128959411|NCT02657434|464138372|FG000|Overall Study|Study Terminated By Sponsor|64|||
128959412|NCT02657434|464138373|FG001|Overall Study|Study Terminated By Sponsor|82|||
128959413|NCT02657434|464138372|FG000|Overall Study|Death|189|||
128959414|NCT02657434|464138373|FG001|Overall Study|Death|190|||
128959415|NCT02657434|464138372|FG000|Overall Study|Lost to Follow-up|2|||
128959416|NCT02657434|464138373|FG001|Overall Study|Lost to Follow-up|2|||
128959417|NCT02657434|464138372|FG000|Overall Study|Randomization by Error|2|||
128959418|NCT02657434|464138373|FG001|Overall Study|Randomization by Error|0|||
128959419|NCT02657434|464138372|FG000|Overall Study|Withdrawal by Subject|28|||
128959420|NCT02657434|464138373|FG001|Overall Study|Withdrawal by Subject|17|||
128959421|NCT02657434|464138372|FG000|Overall Study|Protocol Violation|1|||
128959422|NCT02657434|464138373|FG001|Overall Study|Protocol Violation|0|||
128959423|NCT02657434|464138372|FG000|Overall Study|Physician Decision|0|||
128959424|NCT02657434|464138373|FG001|Overall Study|Physician Decision|1|||
128959425|NCT01628393|464138374|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
128959426|NCT01628393|464138375|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
128959427|NCT01628393|464138376|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
128959428|NCT01628393|464138377|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
128959429|NCT01628393|464138378|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
128959430|NCT01628393|464138374|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
128959431|NCT01628393|464138375|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
128959432|NCT01628393|464138376|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
128959433|NCT01628393|464138377|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
128959434|NCT01628393|464138378|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
128959435|NCT01628393|464138374|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
128959436|NCT01628393|464138375|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
128959437|NCT01628393|464138376|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
128959438|NCT01628393|464138377|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
128959439|NCT01628393|464138378|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
128959440|NCT01628393|464138374|FG000|Blinded Active Extension Period|Adverse Event|0|||
128959441|NCT01628393|464138375|FG001|Blinded Active Extension Period|Adverse Event|1|||
128959442|NCT01628393|464138376|FG002|Blinded Active Extension Period|Adverse Event|0|||
129127105|NCT03126110|464758063|FG011|Phase 1|Safety follow-up no longer necessary|0|||
129127106|NCT03126110|464758064|FG012|Phase 1|Safety follow-up no longer necessary|0|||
129219861|NCT01995838|465104625|FG006|Overall Study|Lost to Follow-up|1|||
129219862|NCT01995838|465104619|FG000|Overall Study|Participant choice|2|||
129219863|NCT01995838|465104620|FG001|Overall Study|Participant choice|0|||
129219864|NCT01995838|465104621|FG002|Overall Study|Participant choice|0|||
129219865|NCT01995838|465104622|FG003|Overall Study|Participant choice|0|||
129219866|NCT01995838|465104623|FG004|Overall Study|Participant choice|0|||
129219867|NCT01995838|465104624|FG005|Overall Study|Participant choice|1|||
129219868|NCT01995838|465104625|FG006|Overall Study|Participant choice|1|||
129219869|NCT01995838|465104619|FG000|Overall Study|Adverse Event|0|||
129219870|NCT01995838|465104620|FG001|Overall Study|Adverse Event|0|||
129219871|NCT01995838|465104621|FG002|Overall Study|Adverse Event|0|||
129219872|NCT01995838|465104622|FG003|Overall Study|Adverse Event|0|||
129219873|NCT01995838|465104623|FG004|Overall Study|Adverse Event|0|||
129219874|NCT01995838|465104624|FG005|Overall Study|Adverse Event|0|||
129219875|NCT01995838|465104625|FG006|Overall Study|Adverse Event|1|||
129219876|NCT01995838|465104619|FG000|Overall Study|Withdrawal by Subject|0|||
129219877|NCT01995838|465104620|FG001|Overall Study|Withdrawal by Subject|0|||
129219878|NCT01995838|465104621|FG002|Overall Study|Withdrawal by Subject|0|||
129219879|NCT01995838|465104622|FG003|Overall Study|Withdrawal by Subject|0|||
129219880|NCT01995838|465104623|FG004|Overall Study|Withdrawal by Subject|1|||
129219881|NCT01995838|465104624|FG005|Overall Study|Withdrawal by Subject|0|||
129219882|NCT01995838|465104625|FG006|Overall Study|Withdrawal by Subject|0|||
129219883|NCT01995838|465104619|FG000|Overall Study|Other|3|||
129219884|NCT01995838|465104620|FG001|Overall Study|Other|1|||
129219885|NCT01995838|465104621|FG002|Overall Study|Other|0|||
129219886|NCT01995838|465104622|FG003|Overall Study|Other|2|||
129219887|NCT01995838|465104623|FG004|Overall Study|Other|1|||
129219888|NCT01995838|465104624|FG005|Overall Study|Other|1|||
129219889|NCT01995838|465104625|FG006|Overall Study|Other|2|||
129219890|NCT00439517|465104629|FG000|Overall Study|Subject on treatment|1|||
129219891|NCT00439517|465104630|FG001|Overall Study|Subject on treatment|0|||
129219892|NCT00439517|465104629|FG000|Overall Study|Subject in survival follow-up|1|||
128959443|NCT01628393|464138377|FG003|Blinded Active Extension Period|Adverse Event|2|||
128959444|NCT01628393|464138378|FG004|Blinded Active Extension Period|Adverse Event|2|||
128959445|NCT01628393|464138374|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
128959446|NCT01628393|464138375|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
128959447|NCT01628393|464138376|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
128959448|NCT01628393|464138377|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
128959449|NCT01628393|464138378|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
128959450|NCT01628393|464138374|FG000|Blinded Active Extension Period|Physician Decision|0|||
128959451|NCT01628393|464138375|FG001|Blinded Active Extension Period|Physician Decision|3|||
128959452|NCT01628393|464138376|FG002|Blinded Active Extension Period|Physician Decision|0|||
128959453|NCT01628393|464138377|FG003|Blinded Active Extension Period|Physician Decision|1|||
128959454|NCT01628393|464138378|FG004|Blinded Active Extension Period|Physician Decision|0|||
128959455|NCT01628393|464138374|FG000|Blinded Active Extension Period|Protocol Violation|0|||
128959456|NCT01628393|464138375|FG001|Blinded Active Extension Period|Protocol Violation|0|||
128959457|NCT01628393|464138376|FG002|Blinded Active Extension Period|Protocol Violation|2|||
128959458|NCT01628393|464138377|FG003|Blinded Active Extension Period|Protocol Violation|1|||
128959459|NCT01628393|464138378|FG004|Blinded Active Extension Period|Protocol Violation|0|||
128959460|NCT01628393|464138374|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
128959461|NCT01628393|464138375|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
128959462|NCT01628393|464138376|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
128959463|NCT01628393|464138377|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
128959464|NCT01628393|464138378|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
128959465|NCT01369225|464138385|FG000|Overall Study|Withdrawal by Subject|1|||
128959466|NCT01369225|464138386|FG001|Overall Study|Withdrawal by Subject|0|||
128959467|NCT01369225|464138387|FG002|Overall Study|Withdrawal by Subject|2|||
128959468|NCT01369225|464138388|FG003|Overall Study|Withdrawal by Subject|1|||
128959469|NCT01369225|464138389|FG004|Overall Study|Withdrawal by Subject|0|||
128959470|NCT01369225|464138390|FG005|Overall Study|Withdrawal by Subject|0|||
128959471|NCT01369225|464138385|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
128959472|NCT01369225|464138386|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
128959473|NCT01369225|464138387|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
128959474|NCT01369225|464138388|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
128959475|NCT01369225|464138389|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
128959476|NCT01369225|464138390|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
128959477|NCT01369225|464138385|FG000|Overall Study|Other|1|||
129219893|NCT00439517|465104630|FG001|Overall Study|Subject in survival follow-up|0|||
128959478|NCT01369225|464138386|FG001|Overall Study|Other|0|||
129219894|NCT00060840|465104640|FG000|Overall Study|Change in surgical plan|2|||
129219895|NCT00060840|465104641|FG001|Overall Study|Change in surgical plan|6|||
129219896|NCT00060840|465104640|FG000|Overall Study|Death|0|||
129219897|NCT00060840|465104641|FG001|Overall Study|Death|1|||
129219898|NCT00060840|465104640|FG000|Overall Study|Withdrawal by Subject|0|||
129219899|NCT00060840|465104641|FG001|Overall Study|Withdrawal by Subject|1|||
129219900|NCT00060840|465104640|FG000|Overall Study|Subinvestigator unavailable|0|||
129219901|NCT00060840|465104641|FG001|Overall Study|Subinvestigator unavailable|1|||
128959479|NCT01369225|464138387|FG002|Overall Study|Other|0|||
128959480|NCT01369225|464138388|FG003|Overall Study|Other|0|||
128959481|NCT01369225|464138389|FG004|Overall Study|Other|1|||
128959482|NCT01369225|464138390|FG005|Overall Study|Other|0|||
128959483|NCT01369225|464138385|FG000|Overall Study|Adverse Event|0|||
128959484|NCT01369225|464138386|FG001|Overall Study|Adverse Event|0|||
128959485|NCT01369225|464138387|FG002|Overall Study|Adverse Event|0|||
128959486|NCT01369225|464138388|FG003|Overall Study|Adverse Event|1|||
128959487|NCT01369225|464138389|FG004|Overall Study|Adverse Event|1|||
128959488|NCT01369225|464138390|FG005|Overall Study|Adverse Event|0|||
128959489|NCT00105183|464138391|FG000|Overall Study|Death|19|||
128959490|NCT00105183|464138392|FG001|Overall Study|Death|13|||
128959491|NCT00105183|464138393|FG002|Overall Study|Death|15|||
128959492|NCT00105183|464138391|FG000|Overall Study|Withdrawal by Subject|1|||
128959493|NCT00105183|464138392|FG001|Overall Study|Withdrawal by Subject|1|||
128959494|NCT00105183|464138393|FG002|Overall Study|Withdrawal by Subject|4|||
128959495|NCT00105183|464138391|FG000|Overall Study|Physician Decision|1|||
128959496|NCT00105183|464138392|FG001|Overall Study|Physician Decision|2|||
128959497|NCT00105183|464138393|FG002|Overall Study|Physician Decision|3|||
128959498|NCT00105183|464138391|FG000|Overall Study|Lost to Follow-up|0|||
128959499|NCT00105183|464138392|FG001|Overall Study|Lost to Follow-up|1|||
128959500|NCT00105183|464138393|FG002|Overall Study|Lost to Follow-up|1|||
128959501|NCT00105183|464138391|FG000|Overall Study|Other reason|1|||
128959502|NCT00105183|464138392|FG001|Overall Study|Other reason|2|||
128959503|NCT00105183|464138393|FG002|Overall Study|Other reason|0|||
128959504|NCT02980692|464138394|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
128959505|NCT02980692|464138395|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
128959506|NCT02980692|464138396|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
128959507|NCT02980692|464138397|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
128959508|NCT02980692|464138398|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
128959509|NCT02980692|464138394|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
128959510|NCT02980692|464138395|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
128959511|NCT02980692|464138396|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
128959512|NCT02980692|464138397|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
129036655|NCT00114231|464425056|FG001|Overall Study|No adenocarcinoma|0|||
129036656|NCT00114231|464425055|FG000|Overall Study|Low creatinine clearance|0|||
128771504|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
128771505|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
128959513|NCT02980692|464138398|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
128959514|NCT02980692|464138394|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
128959515|NCT02980692|464138395|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
128959516|NCT02980692|464138396|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
128959517|NCT02980692|464138397|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
128959518|NCT02980692|464138398|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
128959519|NCT02980692|464138394|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
128959520|NCT02980692|464138395|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
128959521|NCT02980692|464138396|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
128959522|NCT02980692|464138397|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
128959523|NCT02980692|464138398|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
128959524|NCT02980692|464138394|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
128959525|NCT02980692|464138395|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
128959526|NCT02980692|464138396|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
128959527|NCT02980692|464138397|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
128959528|NCT02980692|464138398|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
128959529|NCT02980692|464138394|FG000|Double Blind Placebo Controlled Period|Other|1|||
128959530|NCT02980692|464138395|FG001|Double Blind Placebo Controlled Period|Other|0|||
128959531|NCT02980692|464138396|FG002|Double Blind Placebo Controlled Period|Other|0|||
128959532|NCT02980692|464138397|FG003|Double Blind Placebo Controlled Period|Other|0|||
128959533|NCT02980692|464138398|FG004|Double Blind Placebo Controlled Period|Other|1|||
128959534|NCT02980692|464138394|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
128959535|NCT02980692|464138395|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
128959536|NCT02980692|464138396|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
128959537|NCT02980692|464138397|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
128959538|NCT02980692|464138398|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
128959539|NCT02980692|464138394|FG000|Double-blind Follow-up Period|Adverse Event|0|||
128959540|NCT02980692|464138395|FG001|Double-blind Follow-up Period|Adverse Event|0|||
128959541|NCT02980692|464138396|FG002|Double-blind Follow-up Period|Adverse Event|0|||
129036657|NCT00114231|464425056|FG001|Overall Study|Low creatinine clearance|1|||
128771506|NCT04921969|463453718|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
128959542|NCT02980692|464138397|FG003|Double-blind Follow-up Period|Adverse Event|1|||
128959543|NCT02980692|464138398|FG004|Double-blind Follow-up Period|Adverse Event|1|||
128959544|NCT02980692|464138394|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
128959545|NCT02980692|464138395|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
128959546|NCT02980692|464138396|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
128959547|NCT02980692|464138397|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
128959548|NCT02980692|464138398|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
128959549|NCT02980692|464138394|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
128959550|NCT02980692|464138395|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
128959551|NCT02980692|464138396|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
128959552|NCT02980692|464138397|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
128959553|NCT02980692|464138398|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
128959554|NCT02980692|464138394|FG000|Double-blind Follow-up Period|Pregnancy|0|||
128959555|NCT02980692|464138395|FG001|Double-blind Follow-up Period|Pregnancy|0|||
128959556|NCT02980692|464138396|FG002|Double-blind Follow-up Period|Pregnancy|1|||
128959557|NCT02980692|464138397|FG003|Double-blind Follow-up Period|Pregnancy|1|||
128959558|NCT02980692|464138398|FG004|Double-blind Follow-up Period|Pregnancy|0|||
128959559|NCT02980692|464138394|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
128959560|NCT02980692|464138395|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
128959561|NCT02980692|464138396|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
128959562|NCT02980692|464138397|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
128959563|NCT02980692|464138398|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
128959564|NCT02980692|464138394|FG000|Double-blind Follow-up Period|Other|0|||
128959565|NCT02980692|464138395|FG001|Double-blind Follow-up Period|Other|0|||
128959566|NCT02980692|464138396|FG002|Double-blind Follow-up Period|Other|1|||
128959567|NCT02980692|464138397|FG003|Double-blind Follow-up Period|Other|1|||
128959568|NCT02980692|464138398|FG004|Double-blind Follow-up Period|Other|3|||
128959569|NCT00563368|464138402|FG000|Overall Study|Lost to Follow-up|14|||
128959570|NCT00563368|464138403|FG001|Overall Study|Lost to Follow-up|14|||
128959571|NCT00563368|464138404|FG002|Overall Study|Lost to Follow-up|12|||
128959572|NCT00563368|464138405|FG003|Overall Study|Lost to Follow-up|6|||
128959573|NCT00563368|464138406|FG004|Overall Study|Lost to Follow-up|9|||
128959574|NCT00563368|464138407|FG005|Overall Study|Lost to Follow-up|8|||
128959575|NCT00563368|464138408|FG006|Overall Study|Lost to Follow-up|9|||
128959576|NCT00563368|464138402|FG000|Overall Study|Adverse Event|3|||
128959577|NCT00563368|464138403|FG001|Overall Study|Adverse Event|4|||
129127107|NCT03126110|464758065|FG013|Phase 1|Safety follow-up no longer necessary|0|||
129127108|NCT03126110|464758066|FG014|Phase 1|Safety follow-up no longer necessary|0|||
129127109|NCT03126110|464758067|FG015|Phase 1|Safety follow-up no longer necessary|0|||
129127110|NCT03126110|464758068|FG016|Phase 1|Safety follow-up no longer necessary|0|||
129127111|NCT03126110|464758052|FG000|Phase 1|Survival follow-up no longer necessary|0|||
129127112|NCT03126110|464758053|FG001|Phase 1|Survival follow-up no longer necessary|0|||
129127113|NCT03126110|464758054|FG002|Phase 1|Survival follow-up no longer necessary|1|||
129127114|NCT03126110|464758055|FG003|Phase 1|Survival follow-up no longer necessary|0|||
129127115|NCT03126110|464758056|FG004|Phase 1|Survival follow-up no longer necessary|0|||
129127116|NCT03126110|464758057|FG005|Phase 1|Survival follow-up no longer necessary|0|||
129127117|NCT03126110|464758058|FG006|Phase 1|Survival follow-up no longer necessary|0|||
129127118|NCT03126110|464758059|FG007|Phase 1|Survival follow-up no longer necessary|0|||
129127119|NCT03126110|464758060|FG008|Phase 1|Survival follow-up no longer necessary|0|||
129127120|NCT03126110|464758061|FG009|Phase 1|Survival follow-up no longer necessary|0|||
129127121|NCT03126110|464758062|FG010|Phase 1|Survival follow-up no longer necessary|0|||
129127122|NCT03126110|464758063|FG011|Phase 1|Survival follow-up no longer necessary|0|||
129127123|NCT03126110|464758064|FG012|Phase 1|Survival follow-up no longer necessary|0|||
129127124|NCT03126110|464758065|FG013|Phase 1|Survival follow-up no longer necessary|0|||
129127125|NCT03126110|464758066|FG014|Phase 1|Survival follow-up no longer necessary|0|||
129127126|NCT03126110|464758067|FG015|Phase 1|Survival follow-up no longer necessary|0|||
129127127|NCT03126110|464758068|FG016|Phase 1|Survival follow-up no longer necessary|0|||
129127128|NCT03126110|464758052|FG000|Phase 2|Study terminated by the sponsor|0|||
129127129|NCT03126110|464758053|FG001|Phase 2|Study terminated by the sponsor|0|||
129127130|NCT03126110|464758054|FG002|Phase 2|Study terminated by the sponsor|0|||
129127131|NCT03126110|464758055|FG003|Phase 2|Study terminated by the sponsor|0|||
129127132|NCT03126110|464758056|FG004|Phase 2|Study terminated by the sponsor|0|||
128959578|NCT00563368|464138404|FG002|Overall Study|Adverse Event|5|||
129127133|NCT03126110|464758057|FG005|Phase 2|Study terminated by the sponsor|0|||
129127134|NCT03126110|464758058|FG006|Phase 2|Study terminated by the sponsor|0|||
129127135|NCT03126110|464758059|FG007|Phase 2|Study terminated by the sponsor|0|||
129127136|NCT03126110|464758060|FG008|Phase 2|Study terminated by the sponsor|0|||
129127137|NCT03126110|464758061|FG009|Phase 2|Study terminated by the sponsor|0|||
128959579|NCT00563368|464138405|FG003|Overall Study|Adverse Event|9|||
128959580|NCT00563368|464138406|FG004|Overall Study|Adverse Event|6|||
128959581|NCT00563368|464138407|FG005|Overall Study|Adverse Event|10|||
128712966|NCT03318315|463245982|FG000|Overall Study|Withdrawal by Subject|0|||
128712967|NCT03318315|463245983|FG001|Overall Study|Withdrawal by Subject|0|||
128712968|NCT03318315|463245984|FG002|Overall Study|Withdrawal by Subject|2|||
128712969|NCT00674661|463245985|FG000|Overall Study|Other|5|||
128959582|NCT00563368|464138408|FG006|Overall Study|Adverse Event|17|||
128959583|NCT00563368|464138402|FG000|Overall Study|Withdrawal by Subject|11|||
128959584|NCT00563368|464138403|FG001|Overall Study|Withdrawal by Subject|6|||
128959585|NCT00563368|464138404|FG002|Overall Study|Withdrawal by Subject|5|||
128959586|NCT00563368|464138405|FG003|Overall Study|Withdrawal by Subject|7|||
128959587|NCT00563368|464138406|FG004|Overall Study|Withdrawal by Subject|8|||
128959588|NCT00563368|464138407|FG005|Overall Study|Withdrawal by Subject|5|||
128959589|NCT00563368|464138408|FG006|Overall Study|Withdrawal by Subject|4|||
128959590|NCT00563368|464138402|FG000|Overall Study|protocol non-compliance|1|||
128959591|NCT00563368|464138403|FG001|Overall Study|protocol non-compliance|1|||
128959592|NCT00563368|464138404|FG002|Overall Study|protocol non-compliance|2|||
128959593|NCT00563368|464138405|FG003|Overall Study|protocol non-compliance|1|||
128959594|NCT00563368|464138406|FG004|Overall Study|protocol non-compliance|0|||
128959595|NCT00563368|464138407|FG005|Overall Study|protocol non-compliance|1|||
128959596|NCT00563368|464138408|FG006|Overall Study|protocol non-compliance|3|||
128959597|NCT00563368|464138402|FG000|Overall Study|Pregnancy|1|||
128959598|NCT00563368|464138403|FG001|Overall Study|Pregnancy|0|||
128959599|NCT00563368|464138404|FG002|Overall Study|Pregnancy|1|||
128959600|NCT00563368|464138405|FG003|Overall Study|Pregnancy|2|||
128959601|NCT00563368|464138406|FG004|Overall Study|Pregnancy|1|||
128959602|NCT00563368|464138407|FG005|Overall Study|Pregnancy|2|||
128959603|NCT00563368|464138408|FG006|Overall Study|Pregnancy|0|||
128959604|NCT00563368|464138402|FG000|Overall Study|requirement for restricted medication|0|||
128959605|NCT00563368|464138403|FG001|Overall Study|requirement for restricted medication|0|||
128959606|NCT00563368|464138404|FG002|Overall Study|requirement for restricted medication|2|||
128959607|NCT00563368|464138405|FG003|Overall Study|requirement for restricted medication|0|||
128959608|NCT00563368|464138406|FG004|Overall Study|requirement for restricted medication|0|||
128959609|NCT00563368|464138407|FG005|Overall Study|requirement for restricted medication|0|||
129036658|NCT00114231|464425055|FG000|Overall Study|Tumor size > 4cm|1|||
129036659|NCT00114231|464425056|FG001|Overall Study|Tumor size > 4cm|0|||
128712970|NCT00674661|463245986|FG001|Overall Study|Other|7|||
128712971|NCT00674661|463245985|FG000|Overall Study|Lost to Follow-up|6|||
128959610|NCT00563368|464138408|FG006|Overall Study|requirement for restricted medication|0|||
129036660|NCT00114231|464425055|FG000|Overall Study|Tumor fixed on digital exam|0|||
129036661|NCT00114231|464425056|FG001|Overall Study|Tumor fixed on digital exam|1|||
129036662|NCT00114231|464425055|FG000|Overall Study|No Absolute Neutrophil Count|2|||
129036663|NCT00114231|464425056|FG001|Overall Study|No Absolute Neutrophil Count|0|||
129036664|NCT00114231|464425055|FG000|Overall Study|Biopsy done after registration|1|||
129036665|NCT00114231|464425056|FG001|Overall Study|Biopsy done after registration|0|||
129036666|NCT01933919|464425057|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
129036667|NCT01933919|464425058|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
129036668|NCT01933919|464425057|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
129036669|NCT01933919|464425058|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
129036670|NCT01933919|464425057|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
129036671|NCT01933919|464425058|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
129036672|NCT01933919|464425057|FG000|Open-label Long-term Phase|Adverse Event|2|||
129036673|NCT01933919|464425058|FG001|Open-label Long-term Phase|Adverse Event|0|||
129036674|NCT01933919|464425057|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
129036675|NCT01933919|464425058|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
129036676|NCT01933919|464425057|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
129036677|NCT01933919|464425058|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
129036678|NCT01933919|464425057|FG000|Open-label Long-term Phase|Other|1|||
129036679|NCT01933919|464425058|FG001|Open-label Long-term Phase|Other|2|||
129036680|NCT02510261|464425065|FG000|Overall Study|Adverse Event|5|||
129036681|NCT02510261|464425066|FG001|Overall Study|Adverse Event|8|||
129036682|NCT02510261|464425067|FG002|Overall Study|Adverse Event|0|||
128712972|NCT00674661|463245986|FG001|Overall Study|Lost to Follow-up|3|||
128712973|NCT00674661|463245985|FG000|Overall Study|Withdrawal by Subject|0|||
129036683|NCT02510261|464425065|FG000|Overall Study|Physician Decision|1|||
129036684|NCT02510261|464425066|FG001|Overall Study|Physician Decision|5|||
129036685|NCT02510261|464425067|FG002|Overall Study|Physician Decision|0|||
129036686|NCT02510261|464425065|FG000|Overall Study|Death|19|||
128959611|NCT00563368|464138402|FG000|Overall Study|Other|5|||
128959612|NCT00563368|464138403|FG001|Overall Study|Other|5|||
128959613|NCT00563368|464138404|FG002|Overall Study|Other|3|||
128959614|NCT00563368|464138405|FG003|Overall Study|Other|4|||
129036687|NCT02510261|464425066|FG001|Overall Study|Death|19|||
129036688|NCT02510261|464425067|FG002|Overall Study|Death|0|||
129036689|NCT02510261|464425065|FG000|Overall Study|Withdrawal by Subject|3|||
129036690|NCT02510261|464425066|FG001|Overall Study|Withdrawal by Subject|10|||
128712974|NCT00674661|463245986|FG001|Overall Study|Withdrawal by Subject|5|||
128959615|NCT00563368|464138406|FG004|Overall Study|Other|4|||
129127138|NCT03126110|464758062|FG010|Phase 2|Study terminated by the sponsor|0|||
129127139|NCT03126110|464758063|FG011|Phase 2|Study terminated by the sponsor|0|||
129127140|NCT03126110|464758064|FG012|Phase 2|Study terminated by the sponsor|0|||
129127141|NCT03126110|464758065|FG013|Phase 2|Study terminated by the sponsor|4|||
129127142|NCT03126110|464758066|FG014|Phase 2|Study terminated by the sponsor|0|||
129127143|NCT03126110|464758067|FG015|Phase 2|Study terminated by the sponsor|0|||
129127144|NCT03126110|464758068|FG016|Phase 2|Study terminated by the sponsor|0|||
129127145|NCT03126110|464758052|FG000|Phase 2|Withdrawal by Subject|0|||
129127146|NCT03126110|464758053|FG001|Phase 2|Withdrawal by Subject|0|||
128712975|NCT00573534|463245987|FG000|Overall Study|oppositional behavior|3|||
128712976|NCT04900220|463245993|FG000|Overall Study|Lost to Follow-up|1|||
128959616|NCT00563368|464138407|FG005|Overall Study|Other|4|||
128959617|NCT00563368|464138408|FG006|Overall Study|Other|0|||
128959618|NCT01819506|464138409|FG000|Overall Study|Physician Decision|5|||
128959619|NCT01819506|464138410|FG001|Overall Study|Physician Decision|2|||
128959620|NCT01819506|464138409|FG000|Overall Study|Withdrawal by Subject|3|||
128959621|NCT01819506|464138410|FG001|Overall Study|Withdrawal by Subject|3|||
128959622|NCT00294684|464138412|FG000|Overall Study|Lost to Follow-up|5|||
128959623|NCT00294684|464138413|FG001|Overall Study|Lost to Follow-up|8|||
128959624|NCT00389441|464138414|FG000|Overall Study|Adverse Event|7|||
128959625|NCT00389441|464138414|FG000|Overall Study|Death|4|||
128959626|NCT00389441|464138414|FG000|Overall Study|Lost to Follow-up|2|||
128959627|NCT00389441|464138414|FG000|Overall Study|Withdrawal by Subject|4|||
128959628|NCT00389441|464138414|FG000|Overall Study|Physician Decision|1|||
128959629|NCT00389441|464138414|FG000|Overall Study|Protocol Violation|1|||
128959630|NCT00389441|464138414|FG000|Overall Study|Global deterioration of health status|4|||
128959631|NCT00389441|464138414|FG000|Overall Study|Objective progression or relapse|26|||
128959632|NCT00389441|464138414|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
128959633|NCT00389441|464138414|FG000|Overall Study|Clinical progression|1|||
128959634|NCT01981109|464138415|FG000|Overall Study|Death|36|||
128959635|NCT01981109|464138415|FG000|Overall Study|Withdrawal by Subject|40|||
128959636|NCT01981109|464138415|FG000|Overall Study|Lost to Follow-up|9|||
128959637|NCT01981109|464138415|FG000|Overall Study|No Discontinuation Documentation|37|||
128959638|NCT01981109|464138415|FG000|Overall Study|Study Termination|100|||
128959639|NCT01981109|464138415|FG000|Overall Study|No data available|2|||
128959640|NCT00126672|464138416|FG000|Overall Study|Adverse Event|4|||
128959641|NCT00126672|464138416|FG000|Overall Study|Lost to Follow-up|4|||
128959642|NCT02076334|464138417|FG000|Overall Study|Protocol Violation|1|||
128959643|NCT02076334|464138418|FG001|Overall Study|Protocol Violation|0|||
128959644|NCT02076334|464138419|FG002|Overall Study|Protocol Violation|0|||
128959645|NCT02076334|464138420|FG003|Overall Study|Protocol Violation|0|||
128959646|NCT02076334|464138417|FG000|Overall Study|Lost to Follow-up|0|||
128959647|NCT02076334|464138418|FG001|Overall Study|Lost to Follow-up|1|||
128959648|NCT02076334|464138419|FG002|Overall Study|Lost to Follow-up|1|||
128959649|NCT02076334|464138420|FG003|Overall Study|Lost to Follow-up|0|||
128959650|NCT02076334|464138417|FG000|Overall Study|muscle soreness|0|||
128959651|NCT02076334|464138418|FG001|Overall Study|muscle soreness|0|||
128959652|NCT02076334|464138419|FG002|Overall Study|muscle soreness|0|||
128959653|NCT02076334|464138420|FG003|Overall Study|muscle soreness|1|||
128959654|NCT01296698|464138423|FG000|Overall Study|Adverse Event|1|||
128959655|NCT01296698|464138424|FG001|Overall Study|Adverse Event|0|||
128959656|NCT01296698|464138423|FG000|Overall Study|Death|1|||
128959657|NCT01296698|464138424|FG001|Overall Study|Death|0|||
128959658|NCT01296698|464138423|FG000|Overall Study|Lost to Follow-up|19|||
128959659|NCT01296698|464138424|FG001|Overall Study|Lost to Follow-up|1|||
128959660|NCT01296698|464138423|FG000|Overall Study|Withdrawal by Subject|12|||
128959661|NCT01296698|464138424|FG001|Overall Study|Withdrawal by Subject|0|||
128959662|NCT01296698|464138423|FG000|Overall Study|Difficulty Contacting Subject|2|||
128959663|NCT01296698|464138424|FG001|Overall Study|Difficulty Contacting Subject|0|||
128959664|NCT01296698|464138423|FG000|Overall Study|Study Terminated by Sponsor|209|||
128959665|NCT01296698|464138424|FG001|Overall Study|Study Terminated by Sponsor|12|||
128959666|NCT00729326|464138429|FG000|Overall Study|Lost to Follow-up|2|||
128959667|NCT00729326|464138430|FG001|Overall Study|Lost to Follow-up|0|||
128959668|NCT00729326|464138429|FG000|Overall Study|Physician Decision|0|||
129219902|NCT00060840|465104640|FG000|Overall Study|Physician Decision|1|||
128959669|NCT00729326|464138430|FG001|Overall Study|Physician Decision|1|||
128959670|NCT00729326|464138429|FG000|Overall Study|Protocol Violation|3|||
128959671|NCT00729326|464138430|FG001|Overall Study|Protocol Violation|2|||
128959672|NCT00729326|464138429|FG000|Overall Study|Subject Decision|4|||
129127147|NCT03126110|464758054|FG002|Phase 2|Withdrawal by Subject|0|||
129219903|NCT00060840|465104641|FG001|Overall Study|Physician Decision|0|||
128959673|NCT00729326|464138430|FG001|Overall Study|Subject Decision|4|||
128959674|NCT00729326|464138429|FG000|Overall Study|Sponsor Decision|1|||
128959675|NCT00729326|464138430|FG001|Overall Study|Sponsor Decision|2|||
128959676|NCT01235728|464138431|FG000|Overall Study|Protocol Violation|0|||
128959677|NCT01235728|464138432|FG001|Overall Study|Protocol Violation|0|||
128959678|NCT01235728|464138433|FG002|Overall Study|Protocol Violation|0|||
128959679|NCT01235728|464138434|FG003|Overall Study|Protocol Violation|1|||
129127148|NCT03126110|464758055|FG003|Phase 2|Withdrawal by Subject|0|||
129127149|NCT03126110|464758056|FG004|Phase 2|Withdrawal by Subject|0|||
129127150|NCT03126110|464758057|FG005|Phase 2|Withdrawal by Subject|0|||
129127151|NCT03126110|464758058|FG006|Phase 2|Withdrawal by Subject|0|||
128959680|NCT01235728|464138435|FG004|Overall Study|Protocol Violation|0|||
128959681|NCT01235728|464138436|FG005|Overall Study|Protocol Violation|0|||
128959682|NCT01235728|464138437|FG006|Overall Study|Protocol Violation|0|||
128959683|NCT01235728|464138438|FG007|Overall Study|Protocol Violation|0|||
128959684|NCT02559713|464138439|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
128959685|NCT02193828|464138443|FG000|Overall Study|Withdrawal by Subject|0|||
128959686|NCT02193828|464138444|FG001|Overall Study|Withdrawal by Subject|0|||
128959687|NCT02193828|464138445|FG002|Overall Study|Withdrawal by Subject|1|||
128959688|NCT02193828|464138446|FG003|Overall Study|Withdrawal by Subject|1|||
128959689|NCT01419080|464138449|FG000|Overall Study|Withdrawal by Subject|75|||
128959690|NCT01419080|464138449|FG000|Overall Study|Death|30|||
128959691|NCT01419080|464138449|FG000|Overall Study|Lost to Follow-up|23|||
128959692|NCT01419080|464138449|FG000|Overall Study|Too Ill|3|||
128959693|NCT03199638|464138453|FG000|Overall Study|inability to drink glutamine during regularly|0|||
128959694|NCT03199638|464138454|FG001|Overall Study|inability to drink glutamine during regularly|2|||
128959695|NCT01575899|464138455|FG000|Overall Study|Lost to Follow-up|3|||
128959696|NCT01575899|464138456|FG001|Overall Study|Lost to Follow-up|4|||
128959697|NCT01575899|464138457|FG002|Overall Study|Lost to Follow-up|2|||
128959698|NCT01575899|464138455|FG000|Overall Study|Protocol Violation|2|||
128959699|NCT01575899|464138456|FG001|Overall Study|Protocol Violation|1|||
128959700|NCT01575899|464138457|FG002|Overall Study|Protocol Violation|0|||
128959701|NCT02807844|464138458|FG000|Overall Study|Physician Decision|0|||
128959702|NCT02807844|464138459|FG001|Overall Study|Physician Decision|0|||
128959703|NCT02807844|464138460|FG002|Overall Study|Physician Decision|0|||
128959704|NCT02807844|464138461|FG003|Overall Study|Physician Decision|0|||
128959705|NCT02807844|464138462|FG004|Overall Study|Physician Decision|0|||
128959706|NCT02807844|464138463|FG005|Overall Study|Physician Decision|0|||
128959707|NCT02807844|464138464|FG006|Overall Study|Physician Decision|3|||
128959708|NCT02807844|464138465|FG007|Overall Study|Physician Decision|0|||
128959709|NCT02807844|464138466|FG008|Overall Study|Physician Decision|1|||
128959710|NCT02807844|464138467|FG009|Overall Study|Physician Decision|2|||
128959711|NCT02807844|464138458|FG000|Overall Study|Death|0|||
128959712|NCT02807844|464138459|FG001|Overall Study|Death|0|||
128959713|NCT02807844|464138460|FG002|Overall Study|Death|2|||
128959714|NCT02807844|464138461|FG003|Overall Study|Death|4|||
128959715|NCT02807844|464138462|FG004|Overall Study|Death|1|||
128959716|NCT02807844|464138463|FG005|Overall Study|Death|2|||
128959717|NCT02807844|464138464|FG006|Overall Study|Death|1|||
128959718|NCT02807844|464138465|FG007|Overall Study|Death|2|||
128959719|NCT02807844|464138466|FG008|Overall Study|Death|0|||
129127152|NCT03126110|464758059|FG007|Phase 2|Withdrawal by Subject|0|||
129127153|NCT03126110|464758060|FG008|Phase 2|Withdrawal by Subject|0|||
129127154|NCT03126110|464758061|FG009|Phase 2|Withdrawal by Subject|0|||
129127155|NCT03126110|464758062|FG010|Phase 2|Withdrawal by Subject|0|||
129127156|NCT03126110|464758063|FG011|Phase 2|Withdrawal by Subject|1|||
129127157|NCT03126110|464758064|FG012|Phase 2|Withdrawal by Subject|3|||
129127158|NCT03126110|464758065|FG013|Phase 2|Withdrawal by Subject|3|||
129127159|NCT03126110|464758066|FG014|Phase 2|Withdrawal by Subject|2|||
129127160|NCT03126110|464758067|FG015|Phase 2|Withdrawal by Subject|1|||
129127161|NCT03126110|464758068|FG016|Phase 2|Withdrawal by Subject|0|||
129127162|NCT03126110|464758052|FG000|Phase 2|Lost to Follow-up|0|||
129127163|NCT03126110|464758053|FG001|Phase 2|Lost to Follow-up|0|||
129127164|NCT03126110|464758054|FG002|Phase 2|Lost to Follow-up|0|||
129127165|NCT03126110|464758055|FG003|Phase 2|Lost to Follow-up|0|||
129127166|NCT03126110|464758056|FG004|Phase 2|Lost to Follow-up|0|||
128959720|NCT02807844|464138467|FG009|Overall Study|Death|1|||
128959721|NCT02807844|464138458|FG000|Overall Study|Withdrawal by Subject|0|||
129127167|NCT03126110|464758057|FG005|Phase 2|Lost to Follow-up|0|||
129127168|NCT03126110|464758058|FG006|Phase 2|Lost to Follow-up|0|||
129127169|NCT03126110|464758059|FG007|Phase 2|Lost to Follow-up|0|||
128959722|NCT02807844|464138459|FG001|Overall Study|Withdrawal by Subject|0|||
128959723|NCT02807844|464138460|FG002|Overall Study|Withdrawal by Subject|2|||
128959724|NCT02807844|464138461|FG003|Overall Study|Withdrawal by Subject|1|||
128959725|NCT02807844|464138462|FG004|Overall Study|Withdrawal by Subject|1|||
128959726|NCT02807844|464138463|FG005|Overall Study|Withdrawal by Subject|0|||
128959727|NCT02807844|464138464|FG006|Overall Study|Withdrawal by Subject|1|||
129127170|NCT03126110|464758060|FG008|Phase 2|Lost to Follow-up|0|||
128959728|NCT02807844|464138465|FG007|Overall Study|Withdrawal by Subject|0|||
128959729|NCT02807844|464138466|FG008|Overall Study|Withdrawal by Subject|0|||
128959730|NCT02807844|464138467|FG009|Overall Study|Withdrawal by Subject|0|||
128959731|NCT02807844|464138458|FG000|Overall Study|Progressive disease|5|||
128959732|NCT02807844|464138459|FG001|Overall Study|Progressive disease|12|||
129127171|NCT03126110|464758061|FG009|Phase 2|Lost to Follow-up|0|||
129127172|NCT03126110|464758062|FG010|Phase 2|Lost to Follow-up|0|||
129127173|NCT03126110|464758063|FG011|Phase 2|Lost to Follow-up|1|||
129127174|NCT03126110|464758064|FG012|Phase 2|Lost to Follow-up|1|||
129127175|NCT03126110|464758065|FG013|Phase 2|Lost to Follow-up|1|||
129127176|NCT03126110|464758066|FG014|Phase 2|Lost to Follow-up|2|||
128959733|NCT02807844|464138460|FG002|Overall Study|Progressive disease|8|||
128959734|NCT02807844|464138461|FG003|Overall Study|Progressive disease|8|||
128959735|NCT02807844|464138462|FG004|Overall Study|Progressive disease|3|||
128959736|NCT02807844|464138463|FG005|Overall Study|Progressive disease|8|||
128959737|NCT02807844|464138464|FG006|Overall Study|Progressive disease|14|||
128959738|NCT02807844|464138465|FG007|Overall Study|Progressive disease|17|||
128959739|NCT02807844|464138466|FG008|Overall Study|Progressive disease|19|||
128959740|NCT02807844|464138467|FG009|Overall Study|Progressive disease|15|||
128959741|NCT02807844|464138458|FG000|Overall Study|Adverse Event|1|||
128959742|NCT02807844|464138459|FG001|Overall Study|Adverse Event|0|||
128959743|NCT02807844|464138460|FG002|Overall Study|Adverse Event|0|||
128959744|NCT02807844|464138461|FG003|Overall Study|Adverse Event|0|||
129219904|NCT00060840|465104640|FG000|Overall Study|Other|1|||
129219905|NCT00060840|465104641|FG001|Overall Study|Other|0|||
129219906|NCT01216189|465104646|FG000|Overall Study|Lost to Follow-up|21|||
129219907|NCT01216189|465104647|FG001|Overall Study|Lost to Follow-up|3|||
129219908|NCT01216189|465104646|FG000|Overall Study|Death|4|||
129219909|NCT01216189|465104647|FG001|Overall Study|Death|2|||
129219910|NCT00125164|465104648|FG000|Overall Study|Adverse Event|0|||
129219911|NCT00125164|465104649|FG001|Overall Study|Adverse Event|0|||
129219912|NCT00125164|465104650|FG002|Overall Study|Adverse Event|2|||
129219913|NCT00125164|465104651|FG003|Overall Study|Adverse Event|4|||
129219914|NCT00125164|465104648|FG000|Overall Study|Lost to Follow-up|0|||
128959745|NCT02807844|464138462|FG004|Overall Study|Adverse Event|1|||
128959746|NCT02807844|464138463|FG005|Overall Study|Adverse Event|1|||
128959747|NCT02807844|464138464|FG006|Overall Study|Adverse Event|1|||
128959748|NCT02807844|464138465|FG007|Overall Study|Adverse Event|1|||
128959749|NCT02807844|464138466|FG008|Overall Study|Adverse Event|1|||
128959750|NCT02807844|464138467|FG009|Overall Study|Adverse Event|2|||
128959751|NCT04294095|464138468|FG000|Overall Study|Adverse Event|1|||
128959752|NCT04294095|464138469|FG001|Overall Study|Adverse Event|0|||
128959753|NCT02661464|464138470|FG000|Overall Study|Lost to Follow-up|28|||
128959754|NCT02661464|464138471|FG001|Overall Study|Lost to Follow-up|0|||
128959755|NCT02661464|464138472|FG002|Overall Study|Lost to Follow-up|0|||
128959756|NCT02661464|464138473|FG003|Overall Study|Lost to Follow-up|0|||
128959757|NCT02661464|464138470|FG000|Overall Study|Withdrawal by Subject|3|||
128959758|NCT02661464|464138471|FG001|Overall Study|Withdrawal by Subject|1|||
128959759|NCT02661464|464138472|FG002|Overall Study|Withdrawal by Subject|0|||
128959760|NCT02661464|464138473|FG003|Overall Study|Withdrawal by Subject|0|||
129219915|NCT00125164|465104649|FG001|Overall Study|Lost to Follow-up|0|||
129219916|NCT00125164|465104650|FG002|Overall Study|Lost to Follow-up|1|||
129219917|NCT00125164|465104651|FG003|Overall Study|Lost to Follow-up|1|||
129219918|NCT00125164|465104648|FG000|Overall Study|Withdrawal by Subject|2|||
129219919|NCT00125164|465104649|FG001|Overall Study|Withdrawal by Subject|0|||
129219920|NCT00125164|465104650|FG002|Overall Study|Withdrawal by Subject|1|||
129219921|NCT00125164|465104651|FG003|Overall Study|Withdrawal by Subject|1|||
129219922|NCT01339052|465104652|FG000|Overall Study|Disease progression|13|||
129219923|NCT01339052|465104653|FG001|Overall Study|Disease progression|46|||
129219924|NCT01339052|465104652|FG000|Overall Study|Adverse Event|1|||
129219925|NCT01339052|465104653|FG001|Overall Study|Adverse Event|1|||
129219926|NCT01339052|465104652|FG000|Overall Study|Withdrawal by Subject|0|||
128712977|NCT04900220|463245994|FG001|Overall Study|Lost to Follow-up|1|||
128712978|NCT02196558|463245995|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
128712979|NCT02196558|463245996|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
128712980|NCT02196558|463245997|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
128712981|NCT02196558|463245995|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
128712982|NCT02196558|463245996|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
128712983|NCT02196558|463245997|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
128712984|NCT02196558|463245995|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
128712985|NCT02196558|463245996|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
128712986|NCT02196558|463245997|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
128712987|NCT02196558|463245995|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
128712988|NCT02196558|463245996|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
128959761|NCT02661464|464138470|FG000|Overall Study|Participants terminated prematurely|288|||
128959762|NCT02661464|464138471|FG001|Overall Study|Participants terminated prematurely|52|||
128959763|NCT02661464|464138472|FG002|Overall Study|Participants terminated prematurely|1|||
128959764|NCT02661464|464138473|FG003|Overall Study|Participants terminated prematurely|1|||
128959765|NCT02661464|464138470|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
128959766|NCT02661464|464138471|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
128959767|NCT02661464|464138472|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
129219927|NCT01339052|465104653|FG001|Overall Study|Withdrawal by Subject|3|||
129219928|NCT01339052|465104652|FG000|Overall Study|Physician Decision|1|||
129219929|NCT01339052|465104653|FG001|Overall Study|Physician Decision|0|||
129219930|NCT02637037|465104654|FG000|Overall Study|Positive drug screen at admission|1|||
129219931|NCT02637037|465104655|FG001|Overall Study|Positive drug screen at admission|0|||
129219932|NCT02637037|465104654|FG000|Overall Study|Withdrawal by Subject|2|||
129219933|NCT02637037|465104655|FG001|Overall Study|Withdrawal by Subject|1|||
128712989|NCT02196558|463245997|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
128712990|NCT02196558|463245995|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
128712991|NCT02196558|463245996|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
128959768|NCT02661464|464138473|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
128959769|NCT03148756|464138474|FG000|Overall Study|Study Terminated|0|||
128959770|NCT03148756|464138475|FG001|Overall Study|Study Terminated|1|||
128959771|NCT02177175|464138478|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
128959772|NCT02177175|464138479|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
128959773|NCT03205982|464138485|FG000|Overall Study|Lost to Follow-up|20|||
128959774|NCT03205982|464138486|FG001|Overall Study|Lost to Follow-up|19|||
128959775|NCT03205982|464138485|FG000|Overall Study|Withdrawal by Subject|4|||
128959776|NCT03205982|464138486|FG001|Overall Study|Withdrawal by Subject|3|||
128959777|NCT03205982|464138485|FG000|Overall Study|Withdrawal by PI|0|||
128959778|NCT03205982|464138486|FG001|Overall Study|Withdrawal by PI|1|||
128959779|NCT00994162|464138487|FG000|Overall Study|Withdrawal by Subject|1|||
128959780|NCT00994162|464138487|FG000|Overall Study|Lost to Follow-up|2|||
128959781|NCT00994162|464138487|FG000|Overall Study|Product Complaint|1|||
128959782|NCT00994162|464138487|FG000|Overall Study|Poor Compliance|5|||
128959783|NCT00994162|464138487|FG000|Overall Study|Lack of Response|3|||
128959784|NCT00994162|464138487|FG000|Overall Study|Discharged from Hospital|4|||
128959785|NCT00994162|464138487|FG000|Overall Study|Death|2|||
128959786|NCT00994162|464138487|FG000|Overall Study|Care Transferred to Another Physician|2|||
128959787|NCT00994162|464138487|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
128959788|NCT00994162|464138487|FG000|Overall Study|Physician Decision|2|||
128959789|NCT00994162|464138487|FG000|Overall Study|Surrounding Wound Erythematous|1|||
128959790|NCT00994162|464138487|FG000|Overall Study|Machine Losing Vaccum|1|||
128959791|NCT00994162|464138487|FG000|Overall Study|Patient Lived Too Far Away|1|||
128959792|NCT00994162|464138487|FG000|Overall Study|Above Knee Amputation|1|||
128959793|NCT00994162|464138487|FG000|Overall Study|Reason Not Reported By Site|1|||
128959794|NCT00631540|464138492|FG000|Overall Study|Withdrawal by Subject|5|||
128959795|NCT00631540|464138492|FG000|Overall Study|Death|4|||
128959796|NCT00631540|464138492|FG000|Overall Study|Lost to Follow-up|2|||
128959797|NCT00631540|464138492|FG000|Overall Study|Core Lab Data Unavailable|3|||
128959798|NCT05200455|464138493|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
128959799|NCT01602549|464138494|FG000|Overall Study|Protocol Violation|0|||
128959800|NCT01602549|464138495|FG001|Overall Study|Protocol Violation|1|||
128959801|NCT01602549|464138494|FG000|Overall Study|Withdrawal by Subject|1|||
128959802|NCT01602549|464138495|FG001|Overall Study|Withdrawal by Subject|0|||
128959803|NCT02483078|464138504|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
128959804|NCT02483078|464138505|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
128959805|NCT02483078|464138504|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
128959806|NCT02483078|464138505|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
128959807|NCT02483078|464138504|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
128959808|NCT02483078|464138505|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
128959809|NCT02483078|464138504|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
128959810|NCT02483078|464138505|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
129127177|NCT03126110|464758067|FG015|Phase 2|Lost to Follow-up|0|||
129127178|NCT03126110|464758068|FG016|Phase 2|Lost to Follow-up|0|||
129127179|NCT03126110|464758052|FG000|Phase 2|Death|0|||
129127180|NCT03126110|464758053|FG001|Phase 2|Death|0|||
129127181|NCT03126110|464758054|FG002|Phase 2|Death|0|||
129127182|NCT03126110|464758055|FG003|Phase 2|Death|0|||
129127183|NCT03126110|464758056|FG004|Phase 2|Death|0|||
129127184|NCT03126110|464758057|FG005|Phase 2|Death|0|||
129127185|NCT03126110|464758058|FG006|Phase 2|Death|0|||
129127186|NCT03126110|464758059|FG007|Phase 2|Death|0|||
129127187|NCT03126110|464758060|FG008|Phase 2|Death|0|||
129127188|NCT03126110|464758061|FG009|Phase 2|Death|0|||
129127189|NCT03126110|464758062|FG010|Phase 2|Death|0|||
129127190|NCT03126110|464758063|FG011|Phase 2|Death|6|||
129127191|NCT03126110|464758064|FG012|Phase 2|Death|12|||
128959811|NCT02483078|464138504|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
128959812|NCT02483078|464138505|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
128959813|NCT02483078|464138504|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
128959814|NCT02483078|464138505|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
129127192|NCT03126110|464758065|FG013|Phase 2|Death|25|||
128959815|NCT02853032|464138506|FG000|Overall Study|Adverse Event|4|||
128959816|NCT02853032|464138507|FG001|Overall Study|Adverse Event|0|||
129127193|NCT03126110|464758066|FG014|Phase 2|Death|11|||
129219934|NCT02637037|465104654|FG000|Overall Study|Adverse Event|1|||
128959817|NCT02853032|464138506|FG000|Overall Study|Withdrawal by Subject|3|||
128959818|NCT02853032|464138507|FG001|Overall Study|Withdrawal by Subject|1|||
129127194|NCT03126110|464758067|FG015|Phase 2|Death|3|||
129127195|NCT03126110|464758068|FG016|Phase 2|Death|2|||
129127196|NCT03126110|464758052|FG000|Phase 2|Progressive Disease|0|||
129127197|NCT03126110|464758053|FG001|Phase 2|Progressive Disease|0|||
129127198|NCT03126110|464758054|FG002|Phase 2|Progressive Disease|0|||
129127199|NCT03126110|464758055|FG003|Phase 2|Progressive Disease|0|||
129036691|NCT02510261|464425067|FG002|Overall Study|Withdrawal by Subject|3|||
129036692|NCT01563237|464425068|FG000|Overall Study|Lost to Follow-up|6|||
129036693|NCT01563237|464425069|FG001|Overall Study|Lost to Follow-up|0|||
129036694|NCT01563237|464425068|FG000|Overall Study|Withdrawal by Subject|1|||
129036695|NCT01563237|464425069|FG001|Overall Study|Withdrawal by Subject|0|||
129036696|NCT01563237|464425068|FG000|Overall Study|Adverse Event|1|||
129036697|NCT01563237|464425069|FG001|Overall Study|Adverse Event|0|||
129036698|NCT01563237|464425068|FG000|Overall Study|Medical Reasons|1|||
129036699|NCT01563237|464425069|FG001|Overall Study|Medical Reasons|0|||
129036700|NCT01563237|464425068|FG000|Overall Study|Death|1|||
129036701|NCT01563237|464425069|FG001|Overall Study|Death|0|||
129036702|NCT01124695|464425070|FG000|Overall Study|Disease progression|77|||
129036703|NCT01124695|464425070|FG000|Overall Study|Adverse Event|11|||
129036704|NCT01124695|464425070|FG000|Overall Study|Death|1|||
129036705|NCT01124695|464425070|FG000|Overall Study|Withdrawal by Subject|7|||
129036706|NCT01124695|464425070|FG000|Overall Study|Physician Decision|3|||
129036707|NCT01124695|464425070|FG000|Overall Study|Alternative therapy|9|||
129036708|NCT01124695|464425070|FG000|Overall Study|No documentation that patient went off treatment|4|||
129036709|NCT01124695|464425070|FG000|Overall Study|Ineligible|9|||
129036710|NCT01124695|464425070|FG000|Overall Study|Ineligible and never start treatment|2|||
129036711|NCT02443324|464425074|FG000|Overall Study|Death|4|||
129036712|NCT02443324|464425075|FG001|Overall Study|Death|1|||
129036713|NCT02443324|464425076|FG002|Overall Study|Death|0|||
129036714|NCT02443324|464425077|FG003|Overall Study|Death|3|||
129036715|NCT02443324|464425078|FG004|Overall Study|Death|1|||
129036716|NCT02443324|464425079|FG005|Overall Study|Death|3|||
129036717|NCT02443324|464425080|FG006|Overall Study|Death|2|||
129036718|NCT02443324|464425074|FG000|Overall Study|Lost to Follow-up|0|||
129036719|NCT02443324|464425075|FG001|Overall Study|Lost to Follow-up|0|||
129036720|NCT02443324|464425076|FG002|Overall Study|Lost to Follow-up|0|||
129036721|NCT02443324|464425077|FG003|Overall Study|Lost to Follow-up|1|||
129036722|NCT02443324|464425078|FG004|Overall Study|Lost to Follow-up|0|||
129036723|NCT02443324|464425079|FG005|Overall Study|Lost to Follow-up|1|||
129036724|NCT02443324|464425080|FG006|Overall Study|Lost to Follow-up|0|||
129036725|NCT02443324|464425074|FG000|Overall Study|Physician Decision|0|||
129036726|NCT02443324|464425075|FG001|Overall Study|Physician Decision|3|||
129036727|NCT02443324|464425076|FG002|Overall Study|Physician Decision|5|||
129036728|NCT02443324|464425077|FG003|Overall Study|Physician Decision|1|||
129036729|NCT02443324|464425078|FG004|Overall Study|Physician Decision|1|||
129036730|NCT02443324|464425079|FG005|Overall Study|Physician Decision|0|||
129036731|NCT02443324|464425080|FG006|Overall Study|Physician Decision|2|||
129036732|NCT02443324|464425074|FG000|Overall Study|Progressive Disease|20|||
129036733|NCT02443324|464425075|FG001|Overall Study|Progressive Disease|20|||
129036734|NCT02443324|464425076|FG002|Overall Study|Progressive Disease|13|||
129036735|NCT02443324|464425077|FG003|Overall Study|Progressive Disease|10|||
129036736|NCT02443324|464425078|FG004|Overall Study|Progressive Disease|13|||
129036737|NCT02443324|464425079|FG005|Overall Study|Progressive Disease|17|||
129036738|NCT02443324|464425080|FG006|Overall Study|Progressive Disease|10|||
129036739|NCT02443324|464425074|FG000|Overall Study|Withdrawal by Subject|0|||
129036740|NCT02443324|464425075|FG001|Overall Study|Withdrawal by Subject|0|||
129036741|NCT02443324|464425076|FG002|Overall Study|Withdrawal by Subject|3|||
129036742|NCT02443324|464425077|FG003|Overall Study|Withdrawal by Subject|1|||
129036743|NCT02443324|464425078|FG004|Overall Study|Withdrawal by Subject|1|||
129036744|NCT02443324|464425079|FG005|Overall Study|Withdrawal by Subject|0|||
129036745|NCT02443324|464425080|FG006|Overall Study|Withdrawal by Subject|1|||
129219935|NCT02637037|465104655|FG001|Overall Study|Adverse Event|0|||
129219936|NCT01469377|465104658|FG000|Overall Study|Protocol Deviation|7|||
129219937|NCT01469377|465104659|FG001|Overall Study|Protocol Deviation|10|||
129219938|NCT01469377|465104660|FG002|Overall Study|Protocol Deviation|10|||
129219939|NCT01469377|465104658|FG000|Overall Study|Lost to Follow-up|3|||
128712992|NCT02196558|463245997|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
128712993|NCT02669433|463246001|FG000|Overall Study|Protocol Violation|0|||
129036746|NCT02443324|464425074|FG000|Overall Study|Adverse Event|0|||
128712994|NCT02669433|463246002|FG001|Overall Study|Protocol Violation|4|||
129036747|NCT02443324|464425075|FG001|Overall Study|Adverse Event|1|||
129036748|NCT02443324|464425076|FG002|Overall Study|Adverse Event|3|||
129036749|NCT02443324|464425077|FG003|Overall Study|Adverse Event|0|||
129036750|NCT02443324|464425078|FG004|Overall Study|Adverse Event|4|||
129036751|NCT02443324|464425079|FG005|Overall Study|Adverse Event|3|||
129036752|NCT02443324|464425080|FG006|Overall Study|Adverse Event|3|||
129036753|NCT02443324|464425074|FG000|Overall Study|Enrolled but Never Treated|0|||
129036754|NCT02443324|464425075|FG001|Overall Study|Enrolled but Never Treated|0|||
129036755|NCT02443324|464425076|FG002|Overall Study|Enrolled but Never Treated|1|||
129036756|NCT02443324|464425077|FG003|Overall Study|Enrolled but Never Treated|0|||
129036757|NCT02443324|464425078|FG004|Overall Study|Enrolled but Never Treated|1|||
129036758|NCT02443324|464425079|FG005|Overall Study|Enrolled but Never Treated|0|||
129036759|NCT02443324|464425080|FG006|Overall Study|Enrolled but Never Treated|1|||
129219940|NCT01469377|465104659|FG001|Overall Study|Lost to Follow-up|2|||
129219941|NCT01469377|465104660|FG002|Overall Study|Lost to Follow-up|5|||
129219942|NCT01469377|465104658|FG000|Overall Study|Withdrawal of Consent|12|||
129127200|NCT03126110|464758056|FG004|Phase 2|Progressive Disease|0|||
129127201|NCT03126110|464758057|FG005|Phase 2|Progressive Disease|0|||
129127202|NCT03126110|464758058|FG006|Phase 2|Progressive Disease|0|||
129127203|NCT03126110|464758059|FG007|Phase 2|Progressive Disease|0|||
129127204|NCT03126110|464758060|FG008|Phase 2|Progressive Disease|0|||
129127205|NCT03126110|464758061|FG009|Phase 2|Progressive Disease|0|||
129127206|NCT03126110|464758062|FG010|Phase 2|Progressive Disease|0|||
129127207|NCT03126110|464758063|FG011|Phase 2|Progressive Disease|0|||
128959819|NCT02853032|464138506|FG000|Overall Study|Requested to withdraw from all treatment|2|||
128959820|NCT02853032|464138507|FG001|Overall Study|Requested to withdraw from all treatment|2|||
128959821|NCT01410799|464138508|FG000|Overall Study|PI decision|13|||
128959822|NCT01946412|464138509|FG000|Overall Study|Adverse Event|1|||
128959823|NCT01946412|464138509|FG000|Overall Study|Non-Compliance|1|||
128959824|NCT01946412|464138509|FG000|Overall Study|Continued with commercial Kalydeco|2|||
128959825|NCT01946412|464138509|FG000|Overall Study|Difficulty in swallowing|1|||
128959826|NCT03682055|464140679|FG000|Overall Study|Lack of Efficacy|1|||
128959827|NCT03682055|464140680|FG001|Overall Study|Lack of Efficacy|2|||
128959828|NCT03682055|464140681|FG002|Overall Study|Lack of Efficacy|1|||
128959829|NCT03682055|464140682|FG003|Overall Study|Lack of Efficacy|2|||
128959830|NCT03682055|464140683|FG004|Overall Study|Lack of Efficacy|1|||
128959831|NCT03682055|464140684|FG005|Overall Study|Lack of Efficacy|3|||
128959832|NCT03682055|464140679|FG000|Overall Study|Withdrawal by Subject|0|||
128959833|NCT03682055|464140680|FG001|Overall Study|Withdrawal by Subject|0|||
128959834|NCT03682055|464140681|FG002|Overall Study|Withdrawal by Subject|0|||
128959835|NCT03682055|464140682|FG003|Overall Study|Withdrawal by Subject|0|||
128959836|NCT03682055|464140683|FG004|Overall Study|Withdrawal by Subject|0|||
128959837|NCT03682055|464140684|FG005|Overall Study|Withdrawal by Subject|1|||
128959838|NCT03682055|464140679|FG000|Overall Study|Termination of Study by Sponsor|0|||
128959839|NCT03682055|464140680|FG001|Overall Study|Termination of Study by Sponsor|0|||
128959840|NCT03682055|464140681|FG002|Overall Study|Termination of Study by Sponsor|0|||
128959841|NCT03682055|464140682|FG003|Overall Study|Termination of Study by Sponsor|0|||
128959842|NCT03682055|464140683|FG004|Overall Study|Termination of Study by Sponsor|0|||
129127208|NCT03126110|464758064|FG012|Phase 2|Progressive Disease|0|||
129127209|NCT03126110|464758065|FG013|Phase 2|Progressive Disease|1|||
129127210|NCT03126110|464758066|FG014|Phase 2|Progressive Disease|0|||
129127211|NCT03126110|464758067|FG015|Phase 2|Progressive Disease|0|||
129127212|NCT03126110|464758068|FG016|Phase 2|Progressive Disease|0|||
129127213|NCT03126110|464758052|FG000|Phase 2|Started new treatment|0|||
129127214|NCT03126110|464758053|FG001|Phase 2|Started new treatment|0|||
129127215|NCT03126110|464758054|FG002|Phase 2|Started new treatment|0|||
129127216|NCT03126110|464758055|FG003|Phase 2|Started new treatment|0|||
129127217|NCT03126110|464758056|FG004|Phase 2|Started new treatment|0|||
129127218|NCT03126110|464758057|FG005|Phase 2|Started new treatment|0|||
129127219|NCT03126110|464758058|FG006|Phase 2|Started new treatment|0|||
129127220|NCT03126110|464758059|FG007|Phase 2|Started new treatment|0|||
129127221|NCT03126110|464758060|FG008|Phase 2|Started new treatment|0|||
129127222|NCT03126110|464758061|FG009|Phase 2|Started new treatment|0|||
129127223|NCT03126110|464758062|FG010|Phase 2|Started new treatment|0|||
129127224|NCT03126110|464758063|FG011|Phase 2|Started new treatment|0|||
129127225|NCT03126110|464758064|FG012|Phase 2|Started new treatment|0|||
129127226|NCT03126110|464758065|FG013|Phase 2|Started new treatment|0|||
129127227|NCT03126110|464758066|FG014|Phase 2|Started new treatment|1|||
129127228|NCT03126110|464758067|FG015|Phase 2|Started new treatment|0|||
129127229|NCT03126110|464758068|FG016|Phase 2|Started new treatment|0|||
128712995|NCT02669433|463246003|FG002|Overall Study|Protocol Violation|1|||
128959843|NCT03682055|464140684|FG005|Overall Study|Termination of Study by Sponsor|3|||
128959844|NCT01135394|464140685|FG000|Screening|Lost to Follow-up|2|||
128959845|NCT01135394|464140685|FG000|Screening|Withdrawal by Subject|10|||
128959846|NCT01135394|464140685|FG000|Screening|Screening failure|16|||
128959847|NCT01135394|464140685|FG000|Screening|Physician Decision|5|||
128959848|NCT01135394|464140685|FG000|Baseline Assessment|Withdrawal by Subject|9|||
128959849|NCT01135394|464140685|FG000|Baseline Assessment|Physician Decision|3|||
128959850|NCT01135394|464140685|FG000|Baseline Assessment|Lost to Follow-up|2|||
128959851|NCT01135394|464140685|FG000|Baseline Assessment|Adverse Event|1|||
128959852|NCT01135394|464140685|FG000|Study Treatment|Withdrawal by Subject|1|||
128959853|NCT01135394|464140685|FG000|Study Treatment|Physician Decision|1|||
128959854|NCT01135394|464140685|FG000|Study Treatment|Adverse Event|2|||
128959855|NCT00191386|464140686|FG000|Overall Study|Adverse Event|16|||
129127230|NCT04967222|464758078|FG000|Randomized|Lost to Follow-up|0|||
129127231|NCT04967222|464758079|FG001|Randomized|Lost to Follow-up|1|||
129127232|NCT04967222|464758080|FG002|Randomized|Lost to Follow-up|1|||
128959856|NCT00191386|464140686|FG000|Overall Study|Lost to Follow-up|1|||
128959857|NCT00191386|464140686|FG000|Overall Study|Entry Criteria Exclusion|3|||
128959858|NCT00191386|464140686|FG000|Overall Study|Protocol Violation|18|||
129127233|NCT04967222|464758078|FG000|Randomized|Physician Decision|0|||
129127234|NCT04967222|464758079|FG001|Randomized|Physician Decision|0|||
129127235|NCT04967222|464758080|FG002|Randomized|Physician Decision|1|||
129127236|NCT04967222|464758078|FG000|Randomized|Withdrawal by Subject|0|||
129127237|NCT04967222|464758079|FG001|Randomized|Withdrawal by Subject|0|||
129127238|NCT04967222|464758080|FG002|Randomized|Withdrawal by Subject|2|||
129127239|NCT04967222|464758078|FG000|Randomized|abnormal finding in MRI|0|||
129127240|NCT04967222|464758079|FG001|Randomized|abnormal finding in MRI|2|||
129127241|NCT04967222|464758080|FG002|Randomized|abnormal finding in MRI|0|||
129127242|NCT01295944|464758081|FG000|Overall Study|Switched to alternative treatment|1|||
128712996|NCT02669433|463246001|FG000|Overall Study|Disease Progression|1|||
128959859|NCT00191386|464140686|FG000|Overall Study|Withdrawal by Subject|96|||
128959860|NCT00191386|464140686|FG000|Overall Study|Physician Decision|11|||
128959861|NCT00191386|464140686|FG000|Overall Study|Lack of Efficacy|15|||
128959862|NCT00462488|464140687|FG000|Overall Study|Protocol Violation|1|||
128959863|NCT00462488|464140688|FG001|Overall Study|Protocol Violation|0|||
128959864|NCT00462488|464140687|FG000|Overall Study|Lack of Efficacy|19|||
128959865|NCT00462488|464140688|FG001|Overall Study|Lack of Efficacy|17|||
128959866|NCT03750240|464140689|FG000|Overall Study|Technical Difficulties|2|||
128959867|NCT00927758|464140690|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
128959868|NCT00927758|464140691|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
128959869|NCT00927758|464140692|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
128959870|NCT00927758|464140693|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
128959871|NCT00927758|464140694|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
128959872|NCT00927758|464140695|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
128959873|NCT00927758|464140690|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
128959874|NCT00927758|464140691|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
128959875|NCT00927758|464140692|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
128959876|NCT00927758|464140693|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
128959877|NCT00927758|464140694|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
128959878|NCT00927758|464140695|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
128959879|NCT00439725|464140697|FG000|Treatment Period|Withdrawal by Subject|22|||
128959880|NCT00439725|464140698|FG001|Treatment Period|Withdrawal by Subject|19|||
128959881|NCT00439725|464140697|FG000|Treatment Period|Study terminated by sponsor|156|||
128959882|NCT00439725|464140698|FG001|Treatment Period|Study terminated by sponsor|148|||
128959883|NCT00439725|464140697|FG000|Treatment Period|Site closed by investigator|1|||
128959884|NCT00439725|464140698|FG001|Treatment Period|Site closed by investigator|2|||
128959885|NCT00439725|464140697|FG000|Treatment Period|Adverse Event|39|||
128959886|NCT00439725|464140698|FG001|Treatment Period|Adverse Event|18|||
128959887|NCT00439725|464140697|FG000|Treatment Period|Physician Decision|1|||
128959888|NCT00439725|464140698|FG001|Treatment Period|Physician Decision|1|||
128959889|NCT00439725|464140697|FG000|Treatment Period|Protocol Violation|2|||
128959890|NCT00439725|464140698|FG001|Treatment Period|Protocol Violation|1|||
128959891|NCT00439725|464140697|FG000|Treatment Period|Clinical endpoint reached|6|||
128959892|NCT00439725|464140698|FG001|Treatment Period|Clinical endpoint reached|50|||
128959893|NCT00439725|464140697|FG000|Treatment Period|Technical problems|1|||
128959894|NCT00439725|464140698|FG001|Treatment Period|Technical problems|0|||
128959895|NCT00439725|464140697|FG000|Treatment Period|Lost to Follow-up|1|||
128959896|NCT00439725|464140698|FG001|Treatment Period|Lost to Follow-up|1|||
128959897|NCT00439725|464140697|FG000|Treatment Period|Participant convenience|1|||
128959898|NCT00439725|464140698|FG001|Treatment Period|Participant convenience|0|||
128959899|NCT00439725|464140697|FG000|Treatment Period|Protocol driven decision point|1|||
128959900|NCT00439725|464140698|FG001|Treatment Period|Protocol driven decision point|1|||
128959901|NCT00439725|464140697|FG000|Treatment Period|Death|1|||
128959902|NCT00439725|464140698|FG001|Treatment Period|Death|1|||
128959903|NCT00439725|464140697|FG000|Treatment Period|Participant did not receive treatment|4|||
128959904|NCT00439725|464140698|FG001|Treatment Period|Participant did not receive treatment|4|||
128959905|NCT00439725|464140697|FG000|Observational Period|Withdrawal by Subject|2|||
128959906|NCT00439725|464140698|FG001|Observational Period|Withdrawal by Subject|2|||
128959907|NCT00439725|464140697|FG000|Observational Period|Lost to Follow-up|0|||
128959908|NCT00439725|464140698|FG001|Observational Period|Lost to Follow-up|1|||
128959909|NCT00439725|464140697|FG000|Observational Period|Death|0|||
128959910|NCT00439725|464140698|FG001|Observational Period|Death|2|||
128959911|NCT00439725|464140697|FG000|Observational Period|Study termination by sponsor|1|||
128959912|NCT00439725|464140698|FG001|Observational Period|Study termination by sponsor|1|||
128959913|NCT00439725|464140697|FG000|Observational Period|Clinical endpoint reached|3|||
128959914|NCT00439725|464140698|FG001|Observational Period|Clinical endpoint reached|1|||
128959915|NCT00439725|464140697|FG000|Observational Period|Technical problems|1|||
128959916|NCT00439725|464140698|FG001|Observational Period|Technical problems|0|||
128959917|NCT00439725|464140697|FG000|Observational Period|Participant convenience|1|||
128959918|NCT00439725|464140698|FG001|Observational Period|Participant convenience|0|||
128959919|NCT03510910|464140699|FG000|Overall Study|Incomplete Survey|2|||
129127243|NCT01295944|464758081|FG000|Overall Study|Ineligible|9|||
128959920|NCT03510910|464140700|FG001|Overall Study|Incomplete Survey|3|||
128959921|NCT01105936|464140701|FG000|Period 1|Adverse Event|0|||
128959922|NCT01105936|464140702|FG001|Period 1|Adverse Event|0|||
128959923|NCT01105936|464140703|FG002|Period 1|Adverse Event|0|||
128959924|NCT01105936|464140704|FG003|Period 1|Adverse Event|1|||
128959925|NCT01105936|464140701|FG000|Period 2|Adverse Event|1|||
128959926|NCT01105936|464140702|FG001|Period 2|Adverse Event|0|||
128959927|NCT01105936|464140703|FG002|Period 2|Adverse Event|0|||
128959928|NCT01105936|464140704|FG003|Period 2|Adverse Event|0|||
128959929|NCT01105936|464140701|FG000|Period 3|Protocol Violation|0|||
128959930|NCT01105936|464140702|FG001|Period 3|Protocol Violation|2|||
128959931|NCT01105936|464140703|FG002|Period 3|Protocol Violation|0|||
128959932|NCT01105936|464140704|FG003|Period 3|Protocol Violation|0|||
128959933|NCT01673490|464140705|FG000|Overall Study|Lost to Follow-up|1|||
128959934|NCT01673490|464140705|FG000|Overall Study|Adverse Event|3|||
128959935|NCT01673490|464140705|FG000|Overall Study|Withdrawal by Subject|3|||
128959936|NCT00379236|464140706|FG000|Double-blind|Adverse Event|11|||
128959937|NCT00379236|464140707|FG001|Double-blind|Adverse Event|6|||
128959938|NCT00379236|464140708|FG002|Double-blind|Adverse Event|0|||
128959939|NCT00379236|464140706|FG000|Double-blind|Protocol Violation|3|||
128959940|NCT00379236|464140707|FG001|Double-blind|Protocol Violation|3|||
128959941|NCT00379236|464140708|FG002|Double-blind|Protocol Violation|0|||
128959942|NCT00379236|464140706|FG000|Double-blind|Withdrawal by Subject|12|||
128959943|NCT00379236|464140707|FG001|Double-blind|Withdrawal by Subject|13|||
128959944|NCT00379236|464140708|FG002|Double-blind|Withdrawal by Subject|0|||
128959945|NCT00379236|464140706|FG000|Double-blind|Lost to Follow-up|4|||
128959946|NCT00379236|464140707|FG001|Double-blind|Lost to Follow-up|3|||
128959947|NCT00379236|464140708|FG002|Double-blind|Lost to Follow-up|0|||
128959948|NCT00379236|464140706|FG000|Double-blind|Use of exclusionary medication|1|||
128959949|NCT00379236|464140707|FG001|Double-blind|Use of exclusionary medication|2|||
128959950|NCT00379236|464140708|FG002|Double-blind|Use of exclusionary medication|0|||
128959951|NCT00379236|464140706|FG000|Double-blind|Other|3|||
128959952|NCT00379236|464140707|FG001|Double-blind|Other|7|||
128959953|NCT00379236|464140708|FG002|Double-blind|Other|0|||
128959954|NCT00379236|464140706|FG000|Double-blind|Data could not be retrieved|2|||
128959955|NCT00379236|464140707|FG001|Double-blind|Data could not be retrieved|2|||
128959956|NCT00379236|464140708|FG002|Double-blind|Data could not be retrieved|0|||
128959957|NCT00379236|464140706|FG000|Open-label Extension|Adverse Event|0|||
128959958|NCT00379236|464140707|FG001|Open-label Extension|Adverse Event|0|||
128959959|NCT00379236|464140708|FG002|Open-label Extension|Adverse Event|13|||
128959960|NCT00379236|464140706|FG000|Open-label Extension|Protocol Violation|0|||
128959961|NCT00379236|464140707|FG001|Open-label Extension|Protocol Violation|0|||
128959962|NCT00379236|464140708|FG002|Open-label Extension|Protocol Violation|7|||
128959963|NCT00379236|464140706|FG000|Open-label Extension|Withdrawal by Subject|0|||
128959964|NCT00379236|464140707|FG001|Open-label Extension|Withdrawal by Subject|0|||
128959965|NCT00379236|464140708|FG002|Open-label Extension|Withdrawal by Subject|13|||
128959966|NCT00379236|464140706|FG000|Open-label Extension|Lost to Follow-up|0|||
129127244|NCT01295944|464758081|FG000|Overall Study|Withdrawal by Subject|1|||
129127245|NCT01295944|464758081|FG000|Overall Study|Participant chose to be treated in Peru|1|||
129127246|NCT01295944|464758081|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
129127247|NCT01295944|464758081|FG000|Overall Study|Physician Decision|1|||
129127248|NCT01295944|464758081|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
129127249|NCT01295944|464758081|FG000|Overall Study|Disease progression|4|||
129127250|NCT01295944|464758081|FG000|Overall Study|Transferred care before starting new treatment|1|||
129127251|NCT02783274|464758089|FG000|Overall Study|Withdrawal by Subject|16|||
129127252|NCT02783274|464758089|FG000|Overall Study|Physician Decision|6|||
129127253|NCT02783274|464758089|FG000|Overall Study|Death|9|||
129127254|NCT02783274|464758089|FG000|Overall Study|Lost to Follow-up|22|||
129127255|NCT02783274|464758089|FG000|Overall Study|Other|22|||
129127256|NCT04717557|464758090|FG000|Overall Study|Withdrawal by Subject|2|||
129127257|NCT04717557|464758091|FG001|Overall Study|Withdrawal by Subject|0|||
129127258|NCT04717557|464758090|FG000|Overall Study|Death|1|||
129127259|NCT04717557|464758091|FG001|Overall Study|Death|0|||
129127260|NCT02516241|464758095|FG000|Overall Study|Death|255|||
129127261|NCT02516241|464758096|FG001|Overall Study|Death|262|||
129127262|NCT02516241|464758097|FG002|Overall Study|Death|270|||
129127263|NCT02516241|464758095|FG000|Overall Study|Lost to Follow-up|1|||
129127264|NCT02516241|464758096|FG001|Overall Study|Lost to Follow-up|1|||
128959967|NCT00379236|464140707|FG001|Open-label Extension|Lost to Follow-up|0|||
128959968|NCT00379236|464140708|FG002|Open-label Extension|Lost to Follow-up|12|||
128959969|NCT00379236|464140706|FG000|Open-label Extension|Use of exclusionary medication|0|||
129127265|NCT02516241|464758097|FG002|Overall Study|Lost to Follow-up|3|||
129127266|NCT02516241|464758095|FG000|Overall Study|Withdrawal by Subject|2|||
129127267|NCT02516241|464758096|FG001|Overall Study|Withdrawal by Subject|7|||
129127268|NCT02516241|464758097|FG002|Overall Study|Withdrawal by Subject|12|||
129127269|NCT02516241|464758095|FG000|Overall Study|participants ongoing at data cut-off|84|||
129127270|NCT02516241|464758096|FG001|Overall Study|participants ongoing at data cut-off|76|||
129127271|NCT02516241|464758097|FG002|Overall Study|participants ongoing at data cut-off|59|||
129127272|NCT00724945|464758098|FG000|Period 1|non-compliance|1|||
129127273|NCT00724945|464758099|FG001|Period 1|non-compliance|0|||
129127274|NCT00724945|464758098|FG000|Period 1|Adverse Event|1|||
129127275|NCT00724945|464758099|FG001|Period 1|Adverse Event|1|||
128712997|NCT02669433|463246002|FG001|Overall Study|Disease Progression|0|||
128959970|NCT00379236|464140707|FG001|Open-label Extension|Use of exclusionary medication|0|||
128959971|NCT00379236|464140708|FG002|Open-label Extension|Use of exclusionary medication|3|||
128959972|NCT00379236|464140706|FG000|Open-label Extension|Other|0|||
128959973|NCT00379236|464140707|FG001|Open-label Extension|Other|0|||
128959974|NCT00379236|464140708|FG002|Open-label Extension|Other|7|||
128959975|NCT02940860|464140716|FG000|Overall Study|Non-serious AE|1|||
128959976|NCT02940860|464140717|FG001|Overall Study|Non-serious AE|2|||
128959977|NCT02940860|464140716|FG000|Overall Study|Serious AE|7|||
128959978|NCT02940860|464140717|FG001|Overall Study|Serious AE|3|||
128959979|NCT02940860|464140716|FG000|Overall Study|Withdrawal by Subject|19|||
128959980|NCT02940860|464140717|FG001|Overall Study|Withdrawal by Subject|9|||
128959981|NCT02940860|464140716|FG000|Overall Study|Lost to Follow-up|13|||
128959982|NCT02940860|464140717|FG001|Overall Study|Lost to Follow-up|7|||
128959983|NCT02940860|464140716|FG000|Overall Study|Physician Decision|5|||
128959984|NCT02940860|464140717|FG001|Overall Study|Physician Decision|3|||
128959985|NCT02940860|464140716|FG000|Overall Study|Sponsor Decision|0|||
128959986|NCT02940860|464140717|FG001|Overall Study|Sponsor Decision|1|||
128959987|NCT02940860|464140716|FG000|Overall Study|Protocol Violation|0|||
128959988|NCT02940860|464140717|FG001|Overall Study|Protocol Violation|2|||
128959989|NCT02940860|464140716|FG000|Overall Study|Death|3|||
128959990|NCT02940860|464140717|FG001|Overall Study|Death|2|||
128959991|NCT02940860|464140716|FG000|Overall Study|Moved, poor venous access, transport|6|||
128959992|NCT02940860|464140717|FG001|Overall Study|Moved, poor venous access, transport|4|||
128959993|NCT02940860|464140716|FG000|Overall Study|Not treated|2|||
128959994|NCT02940860|464140717|FG001|Overall Study|Not treated|2|||
128959995|NCT04914819|464140718|FG000|Overall Study|Pregnancy|3|||
128959996|NCT04914819|464140719|FG001|Overall Study|Pregnancy|1|||
128959997|NCT04914819|464140718|FG000|Overall Study|Discontinued study|4|||
128959998|NCT04914819|464140719|FG001|Overall Study|Discontinued study|1|||
128959999|NCT04914819|464140718|FG000|Overall Study|Lost to Follow-up|7|||
128960000|NCT04914819|464140719|FG001|Overall Study|Lost to Follow-up|0|||
128960001|NCT02715804|464140720|FG000|Overall Study|Death|222|||
128960002|NCT02715804|464140721|FG001|Overall Study|Death|106|||
128960003|NCT02715804|464140720|FG000|Overall Study|Withdrawal by Subject|5|||
128960004|NCT02715804|464140721|FG001|Overall Study|Withdrawal by Subject|4|||
128960005|NCT02715804|464140720|FG000|Overall Study|Other than specified|2|||
128960006|NCT02715804|464140721|FG001|Overall Study|Other than specified|3|||
128960007|NCT04038385|464140722|FG000|Overall Study|Completed baseline assessment only|7|||
128960008|NCT04038385|464140723|FG001|Overall Study|Completed baseline assessment only|4|||
128960009|NCT04038385|464140722|FG000|Overall Study|Moved out of area|4|||
128960010|NCT04038385|464140723|FG001|Overall Study|Moved out of area|2|||
128960011|NCT04038385|464140722|FG000|Overall Study|Discontinued study involvement|6|||
128960012|NCT04038385|464140723|FG001|Overall Study|Discontinued study involvement|1|||
128960013|NCT01625611|464140724|FG000|Overall Study|No adlib drinks Lab 1|3|||
128960014|NCT01625611|464140725|FG001|Overall Study|No adlib drinks Lab 1|0|||
128960015|NCT01625611|464140724|FG000|Overall Study|Technical issues with PET|1|||
128960016|NCT01625611|464140725|FG001|Overall Study|Technical issues with PET|0|||
128960017|NCT01625611|464140724|FG000|Overall Study|Unable to complete study procedures|1|||
128960018|NCT01625611|464140725|FG001|Overall Study|Unable to complete study procedures|0|||
128960019|NCT01625611|464140724|FG000|Overall Study|Withdrawal by Subject|3|||
128960020|NCT01625611|464140725|FG001|Overall Study|Withdrawal by Subject|0|||
128960021|NCT01998958|464140728|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960022|NCT01998958|464140729|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
128960023|NCT01998958|464140730|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960024|NCT01998958|464140731|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960025|NCT01998958|464140732|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960026|NCT01998958|464140733|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960027|NCT01998958|464140734|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960028|NCT01998958|464140735|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960029|NCT01998958|464140736|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960030|NCT01998958|464140737|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960031|NCT01998958|464140738|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960032|NCT01998958|464140739|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960033|NCT01998958|464140740|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960034|NCT01998958|464140741|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960035|NCT01998958|464140742|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960036|NCT01998958|464140743|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960037|NCT01998958|464140744|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960038|NCT01998958|464140745|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960039|NCT01998958|464140746|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960040|NCT01998958|464140747|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960041|NCT01998958|464140748|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960042|NCT01998958|464140749|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960043|NCT01998958|464140750|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128712998|NCT02669433|463246003|FG002|Overall Study|Disease Progression|0|||
128712999|NCT02669433|463246001|FG000|Overall Study|Physician Decision|1|||
128713000|NCT02669433|463246002|FG001|Overall Study|Physician Decision|1|||
128960044|NCT01998958|464140751|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960045|NCT01998958|464140752|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960046|NCT01998958|464140753|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960047|NCT01998958|464140754|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960048|NCT01998958|464140755|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960049|NCT01998958|464140756|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960050|NCT01998958|464140757|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960051|NCT01998958|464140758|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960052|NCT01998958|464140759|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
128960053|NCT01998958|464140728|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960054|NCT01998958|464140729|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
128960055|NCT01998958|464140730|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960056|NCT01998958|464140731|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960057|NCT01998958|464140732|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960058|NCT01998958|464140733|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960059|NCT01998958|464140734|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960060|NCT01998958|464140735|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960061|NCT01998958|464140736|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960062|NCT01998958|464140737|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960063|NCT01998958|464140738|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960064|NCT01998958|464140739|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129127276|NCT00724945|464758098|FG000|Period 1|Lost to Follow-up|1|||
128960065|NCT01998958|464140740|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960066|NCT01998958|464140741|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960067|NCT01998958|464140742|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960068|NCT01998958|464140743|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129127277|NCT00724945|464758099|FG001|Period 1|Lost to Follow-up|0|||
128960069|NCT01998958|464140744|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960070|NCT01998958|464140745|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960071|NCT01998958|464140746|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960072|NCT01998958|464140747|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960073|NCT01998958|464140748|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960074|NCT01998958|464140749|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960075|NCT01998958|464140750|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960076|NCT01998958|464140751|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960077|NCT01998958|464140752|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960078|NCT01998958|464140753|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960079|NCT01998958|464140754|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129127278|NCT00724945|464758098|FG000|Period 2|lens comfort issue|3|||
129127279|NCT00724945|464758099|FG001|Period 2|lens comfort issue|0|||
129127280|NCT00724945|464758098|FG000|Period 2|lens physiology issue|1|||
129127281|NCT00724945|464758099|FG001|Period 2|lens physiology issue|0|||
129127282|NCT04835441|464758100|FG000|Overall Study|Physician Decision|4|||
129127283|NCT04835441|464758101|FG001|Overall Study|Physician Decision|4|||
129127284|NCT04835441|464758100|FG000|Overall Study|Other|1|||
129127285|NCT04835441|464758101|FG001|Overall Study|Other|1|||
129127286|NCT04835441|464758100|FG000|Overall Study|Lost to Follow-up|0|||
129127287|NCT04835441|464758101|FG001|Overall Study|Lost to Follow-up|1|||
129127288|NCT03069989|464758105|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
129127289|NCT03069989|464758106|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
129127290|NCT03806296|464759252|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
129127291|NCT03806296|464759253|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
129127292|NCT03806296|464759254|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
129127293|NCT03806296|464759252|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
128960080|NCT01998958|464140755|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960081|NCT01998958|464140756|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129127294|NCT03806296|464759253|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
129127295|NCT03806296|464759254|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
129127296|NCT03806296|464759252|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
128713001|NCT02669433|463246003|FG002|Overall Study|Physician Decision|0|||
129127297|NCT03806296|464759253|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
129127298|NCT03806296|464759254|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
128960082|NCT01998958|464140757|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960083|NCT01998958|464140758|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960084|NCT01998958|464140759|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
128960085|NCT01998958|464140728|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
128960086|NCT01998958|464140729|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
128960087|NCT01998958|464140730|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
129127299|NCT04235374|464759257|FG000|Overall Study|Death|91|||
128713002|NCT02669433|463246001|FG000|Overall Study|Adverse Event|6|||
128960088|NCT01998958|464140731|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
128960089|NCT01998958|464140732|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
128960090|NCT01998958|464140733|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
128960091|NCT01998958|464140734|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
128960092|NCT01998958|464140735|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
128960093|NCT01998958|464140736|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
128960094|NCT01998958|464140737|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
128960095|NCT01998958|464140738|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
128960096|NCT01998958|464140739|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
128960097|NCT01998958|464140740|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
128960098|NCT01998958|464140741|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
128960099|NCT01998958|464140742|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
128960100|NCT01998958|464140743|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
128960101|NCT01998958|464140744|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
128960102|NCT01998958|464140745|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
128960103|NCT01998958|464140746|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
128960104|NCT01998958|464140747|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
128960105|NCT01998958|464140748|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
128960106|NCT01998958|464140749|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
128960107|NCT01998958|464140750|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
128960108|NCT01998958|464140751|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
128960109|NCT01998958|464140752|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
128960110|NCT01998958|464140753|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
128960111|NCT01998958|464140754|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
128960112|NCT01998958|464140755|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
128960113|NCT01998958|464140756|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
128960114|NCT01998958|464140757|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
128960115|NCT01998958|464140758|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
128960116|NCT01998958|464140759|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
128960117|NCT01998958|464140728|FG000|Period 1 (Panel A and B)|Other|1|||
128960118|NCT01998958|464140729|FG001|Period 1 (Panel A and B)|Other|0|||
128960119|NCT01998958|464140730|FG002|Period 1 (Panel A and B)|Other|0|||
128960120|NCT01998958|464140731|FG003|Period 1 (Panel A and B)|Other|0|||
128960121|NCT01998958|464140732|FG004|Period 1 (Panel A and B)|Other|0|||
128960122|NCT01998958|464140733|FG005|Period 1 (Panel A and B)|Other|0|||
128960123|NCT01998958|464140734|FG006|Period 1 (Panel A and B)|Other|0|||
128960124|NCT01998958|464140735|FG007|Period 1 (Panel A and B)|Other|0|||
128960125|NCT01998958|464140736|FG008|Period 1 (Panel A and B)|Other|0|||
128960126|NCT01998958|464140737|FG009|Period 1 (Panel A and B)|Other|0|||
128960127|NCT01998958|464140738|FG010|Period 1 (Panel A and B)|Other|0|||
128960128|NCT01998958|464140739|FG011|Period 1 (Panel A and B)|Other|0|||
128960129|NCT01998958|464140740|FG012|Period 1 (Panel A and B)|Other|0|||
128960130|NCT01998958|464140741|FG013|Period 1 (Panel A and B)|Other|0|||
128960131|NCT01998958|464140742|FG014|Period 1 (Panel A and B)|Other|0|||
128960132|NCT01998958|464140743|FG015|Period 1 (Panel A and B)|Other|0|||
128960133|NCT01998958|464140744|FG016|Period 1 (Panel A and B)|Other|0|||
128960134|NCT01998958|464140745|FG017|Period 1 (Panel A and B)|Other|0|||
128960135|NCT01998958|464140746|FG018|Period 1 (Panel A and B)|Other|0|||
128960136|NCT01998958|464140747|FG019|Period 1 (Panel A and B)|Other|0|||
128960137|NCT01998958|464140748|FG020|Period 1 (Panel A and B)|Other|0|||
128960138|NCT01998958|464140749|FG021|Period 1 (Panel A and B)|Other|0|||
128960139|NCT01998958|464140750|FG022|Period 1 (Panel A and B)|Other|0|||
128960140|NCT01998958|464140751|FG023|Period 1 (Panel A and B)|Other|0|||
129036760|NCT00684567|464425081|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
128960141|NCT01998958|464140752|FG024|Period 1 (Panel A and B)|Other|0|||
128960142|NCT01998958|464140753|FG025|Period 1 (Panel A and B)|Other|0|||
128960143|NCT01998958|464140754|FG026|Period 1 (Panel A and B)|Other|0|||
128960144|NCT01998958|464140755|FG027|Period 1 (Panel A and B)|Other|0|||
129036761|NCT00684567|464425081|FG000|Monotherapy Period|Adverse Event|2|||
129036762|NCT00684567|464425081|FG000|Monotherapy Period|Death|1|||
129036763|NCT00684567|464425081|FG000|Monotherapy Period|Progression of primary disease|11|||
129036764|NCT00988208|464425086|FG000|Overall Study|Adverse Event|71|||
129036765|NCT00988208|464425087|FG001|Overall Study|Adverse Event|122|||
129036766|NCT00988208|464425086|FG000|Overall Study|Disease Progression|103|||
129036767|NCT00988208|464425087|FG001|Overall Study|Disease Progression|89|||
128960145|NCT01998958|464140756|FG028|Period 1 (Panel A and B)|Other|0|||
128960146|NCT01998958|464140757|FG029|Period 1 (Panel A and B)|Other|0|||
128960147|NCT01998958|464140758|FG030|Period 1 (Panel A and B)|Other|0|||
128960148|NCT01998958|464140759|FG031|Period 1 (Panel A and B)|Other|0|||
128960149|NCT01998958|464140728|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
128960150|NCT01998958|464140729|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
128960151|NCT01998958|464140730|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
128960152|NCT01998958|464140731|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
129036768|NCT00988208|464425086|FG000|Overall Study|Withdrawal by Subject|50|||
128960153|NCT01998958|464140732|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
128960154|NCT01998958|464140733|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
128960155|NCT01998958|464140734|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
128960156|NCT01998958|464140735|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
128960157|NCT01998958|464140736|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
128960158|NCT01998958|464140737|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
128960159|NCT01998958|464140738|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
128960160|NCT01998958|464140739|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
128960161|NCT01998958|464140740|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
128960162|NCT01998958|464140741|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
128960163|NCT01998958|464140742|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
128960164|NCT01998958|464140743|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
128960165|NCT01998958|464140744|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
128960166|NCT01998958|464140745|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
128960167|NCT01998958|464140746|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
128960168|NCT01998958|464140747|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
128960169|NCT01998958|464140748|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
128960170|NCT01998958|464140749|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
128960171|NCT01998958|464140750|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
128960172|NCT01998958|464140751|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
128960173|NCT01998958|464140752|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
128960174|NCT01998958|464140753|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
128960175|NCT01998958|464140754|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
128960176|NCT01998958|464140755|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
128960177|NCT01998958|464140756|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
128960178|NCT01998958|464140757|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
128960179|NCT01998958|464140758|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
128960180|NCT01998958|464140759|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
128960181|NCT01998958|464140728|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960182|NCT01998958|464140729|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960183|NCT01998958|464140730|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960184|NCT01998958|464140731|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960185|NCT01998958|464140732|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960186|NCT01998958|464140733|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960187|NCT01998958|464140734|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960188|NCT01998958|464140735|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960189|NCT01998958|464140736|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960190|NCT01998958|464140737|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960191|NCT01998958|464140738|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960192|NCT01998958|464140739|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960193|NCT01998958|464140740|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960194|NCT01998958|464140741|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960195|NCT01998958|464140742|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
128960196|NCT01998958|464140743|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960197|NCT01998958|464140744|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960198|NCT01998958|464140745|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960199|NCT01998958|464140746|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
128960200|NCT01998958|464140747|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960201|NCT01998958|464140748|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960202|NCT01998958|464140749|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960203|NCT01998958|464140750|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960204|NCT01998958|464140751|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960205|NCT01998958|464140752|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960206|NCT01998958|464140753|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128713003|NCT02669433|463246002|FG001|Overall Study|Adverse Event|7|||
128713004|NCT02669433|463246003|FG002|Overall Study|Adverse Event|10|||
128713005|NCT02669433|463246001|FG000|Overall Study|Sponsor Termination|1|||
128713006|NCT02669433|463246002|FG001|Overall Study|Sponsor Termination|0|||
128960207|NCT01998958|464140754|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960208|NCT01998958|464140755|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960209|NCT01998958|464140756|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960210|NCT01998958|464140757|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960211|NCT01998958|464140758|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960212|NCT01998958|464140759|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
128960213|NCT01998958|464140728|FG000|Open Label Phase (Optional)|Adverse Event|0|||
128960214|NCT01998958|464140729|FG001|Open Label Phase (Optional)|Adverse Event|0|||
128960215|NCT01998958|464140730|FG002|Open Label Phase (Optional)|Adverse Event|0|||
128960216|NCT01998958|464140731|FG003|Open Label Phase (Optional)|Adverse Event|0|||
128960217|NCT01998958|464140732|FG004|Open Label Phase (Optional)|Adverse Event|0|||
128960218|NCT01998958|464140733|FG005|Open Label Phase (Optional)|Adverse Event|0|||
128960219|NCT01998958|464140734|FG006|Open Label Phase (Optional)|Adverse Event|0|||
128960220|NCT01998958|464140735|FG007|Open Label Phase (Optional)|Adverse Event|0|||
128960221|NCT01998958|464140736|FG008|Open Label Phase (Optional)|Adverse Event|0|||
128960222|NCT01998958|464140737|FG009|Open Label Phase (Optional)|Adverse Event|0|||
128960223|NCT01998958|464140738|FG010|Open Label Phase (Optional)|Adverse Event|0|||
128960224|NCT01998958|464140739|FG011|Open Label Phase (Optional)|Adverse Event|0|||
128960225|NCT01998958|464140740|FG012|Open Label Phase (Optional)|Adverse Event|0|||
128960226|NCT01998958|464140741|FG013|Open Label Phase (Optional)|Adverse Event|0|||
128960227|NCT01998958|464140742|FG014|Open Label Phase (Optional)|Adverse Event|0|||
128960228|NCT01998958|464140743|FG015|Open Label Phase (Optional)|Adverse Event|0|||
128960229|NCT01998958|464140744|FG016|Open Label Phase (Optional)|Adverse Event|0|||
128960230|NCT01998958|464140745|FG017|Open Label Phase (Optional)|Adverse Event|0|||
128960231|NCT01998958|464140746|FG018|Open Label Phase (Optional)|Adverse Event|0|||
128960232|NCT01998958|464140747|FG019|Open Label Phase (Optional)|Adverse Event|0|||
128960233|NCT01998958|464140748|FG020|Open Label Phase (Optional)|Adverse Event|0|||
128960234|NCT01998958|464140749|FG021|Open Label Phase (Optional)|Adverse Event|0|||
128960235|NCT01998958|464140750|FG022|Open Label Phase (Optional)|Adverse Event|0|||
128960236|NCT01998958|464140751|FG023|Open Label Phase (Optional)|Adverse Event|1|||
128960237|NCT01998958|464140752|FG024|Open Label Phase (Optional)|Adverse Event|0|||
128960238|NCT01998958|464140753|FG025|Open Label Phase (Optional)|Adverse Event|0|||
128960239|NCT01998958|464140754|FG026|Open Label Phase (Optional)|Adverse Event|0|||
128960240|NCT01998958|464140755|FG027|Open Label Phase (Optional)|Adverse Event|0|||
128960241|NCT01998958|464140756|FG028|Open Label Phase (Optional)|Adverse Event|0|||
128960242|NCT01998958|464140757|FG029|Open Label Phase (Optional)|Adverse Event|0|||
128960243|NCT01998958|464140758|FG030|Open Label Phase (Optional)|Adverse Event|0|||
128960244|NCT01998958|464140759|FG031|Open Label Phase (Optional)|Adverse Event|0|||
128960245|NCT01998958|464140728|FG000|Open Label Phase (Optional)|Other|0|||
128960246|NCT01998958|464140729|FG001|Open Label Phase (Optional)|Other|0|||
128960247|NCT01998958|464140730|FG002|Open Label Phase (Optional)|Other|0|||
128960248|NCT01998958|464140731|FG003|Open Label Phase (Optional)|Other|0|||
128960249|NCT01998958|464140732|FG004|Open Label Phase (Optional)|Other|0|||
128960250|NCT01998958|464140733|FG005|Open Label Phase (Optional)|Other|0|||
128960251|NCT01998958|464140734|FG006|Open Label Phase (Optional)|Other|0|||
128960252|NCT01998958|464140735|FG007|Open Label Phase (Optional)|Other|0|||
128960253|NCT01998958|464140736|FG008|Open Label Phase (Optional)|Other|0|||
128960254|NCT01998958|464140737|FG009|Open Label Phase (Optional)|Other|0|||
128960255|NCT01998958|464140738|FG010|Open Label Phase (Optional)|Other|0|||
128960256|NCT01998958|464140739|FG011|Open Label Phase (Optional)|Other|0|||
128960257|NCT01998958|464140740|FG012|Open Label Phase (Optional)|Other|0|||
128960258|NCT01998958|464140741|FG013|Open Label Phase (Optional)|Other|0|||
128960259|NCT01998958|464140742|FG014|Open Label Phase (Optional)|Other|0|||
128960260|NCT01998958|464140743|FG015|Open Label Phase (Optional)|Other|0|||
128960261|NCT01998958|464140744|FG016|Open Label Phase (Optional)|Other|0|||
128960262|NCT01998958|464140745|FG017|Open Label Phase (Optional)|Other|0|||
128960263|NCT01998958|464140746|FG018|Open Label Phase (Optional)|Other|0|||
128960264|NCT01998958|464140747|FG019|Open Label Phase (Optional)|Other|0|||
128960265|NCT01998958|464140748|FG020|Open Label Phase (Optional)|Other|0|||
128960266|NCT01998958|464140749|FG021|Open Label Phase (Optional)|Other|0|||
128960267|NCT01998958|464140750|FG022|Open Label Phase (Optional)|Other|5|||
128960268|NCT01998958|464140751|FG023|Open Label Phase (Optional)|Other|1|||
128960269|NCT01998958|464140752|FG024|Open Label Phase (Optional)|Other|0|||
128960270|NCT01998958|464140753|FG025|Open Label Phase (Optional)|Other|0|||
128960271|NCT01998958|464140754|FG026|Open Label Phase (Optional)|Other|0|||
128960272|NCT01998958|464140755|FG027|Open Label Phase (Optional)|Other|0|||
128960273|NCT01998958|464140756|FG028|Open Label Phase (Optional)|Other|0|||
128960274|NCT01998958|464140757|FG029|Open Label Phase (Optional)|Other|0|||
128960275|NCT01998958|464140758|FG030|Open Label Phase (Optional)|Other|0|||
128960276|NCT01998958|464140759|FG031|Open Label Phase (Optional)|Other|0|||
128960277|NCT01998958|464140728|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960278|NCT01998958|464140729|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960279|NCT01998958|464140730|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960280|NCT01998958|464140731|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960281|NCT01998958|464140732|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960282|NCT01998958|464140733|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960283|NCT01998958|464140734|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960284|NCT01998958|464140735|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960285|NCT01998958|464140736|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960286|NCT01998958|464140737|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960287|NCT01998958|464140738|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960288|NCT01998958|464140739|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960289|NCT01998958|464140740|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960290|NCT01998958|464140741|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960291|NCT01998958|464140742|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960292|NCT01998958|464140743|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960293|NCT01998958|464140744|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960294|NCT01998958|464140745|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960295|NCT01998958|464140746|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960296|NCT01998958|464140747|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960297|NCT01998958|464140748|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960298|NCT01998958|464140749|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960299|NCT01998958|464140750|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
128960300|NCT01998958|464140751|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960301|NCT01998958|464140752|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
129219943|NCT01469377|465104659|FG001|Overall Study|Withdrawal of Consent|14|||
129219944|NCT01469377|465104660|FG002|Overall Study|Withdrawal of Consent|15|||
129219945|NCT01469377|465104658|FG000|Overall Study|Adverse Event|8|||
129219946|NCT01469377|465104659|FG001|Overall Study|Adverse Event|18|||
129219947|NCT01469377|465104660|FG002|Overall Study|Adverse Event|36|||
129219948|NCT01469377|465104658|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129219949|NCT01469377|465104659|FG001|Overall Study|Insufficient Therapeutic Response|4|||
129219950|NCT01469377|465104660|FG002|Overall Study|Insufficient Therapeutic Response|0|||
129219951|NCT01469377|465104658|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129219952|NCT01469377|465104659|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129219953|NCT01469377|465104660|FG002|Overall Study|Other Miscellaneous Reasons|0|||
128713007|NCT02669433|463246003|FG002|Overall Study|Sponsor Termination|1|||
128713008|NCT02669433|463246001|FG000|Overall Study|Withdrawal by Subject|5|||
128713009|NCT02669433|463246002|FG001|Overall Study|Withdrawal by Subject|1|||
128713010|NCT02669433|463246003|FG002|Overall Study|Withdrawal by Subject|0|||
128713011|NCT02669433|463246001|FG000|Overall Study|Withdrawal by Caregiver|1|||
128713012|NCT02669433|463246002|FG001|Overall Study|Withdrawal by Caregiver|0|||
128713013|NCT02669433|463246003|FG002|Overall Study|Withdrawal by Caregiver|2|||
128713014|NCT02669433|463246001|FG000|Overall Study|Death|0|||
128713015|NCT02669433|463246002|FG001|Overall Study|Death|1|||
128713016|NCT02669433|463246003|FG002|Overall Study|Death|1|||
128713017|NCT00576927|463246004|FG000|Clinical Assessment|Lack of Efficacy|24|||
128713018|NCT00576927|463246004|FG000|Clinical Assessment|Death|1|||
128713019|NCT00576927|463246004|FG000|Clinical Assessment|Withdrawal by Subject|10|||
128713020|NCT00576927|463246004|FG000|Clinical Assessment|Physician Decision|1|||
128713021|NCT00576927|463246004|FG000|Baseline|Physician Decision|9|||
128713022|NCT00576927|463246004|FG000|Baseline|Medication Change by PCP of subject|1|||
128713023|NCT00576927|463246004|FG000|Baseline|Withdrawal by Subject|3|||
128713024|NCT00576927|463246004|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
128713025|NCT00576927|463246004|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
128713026|NCT00576927|463246004|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
128713027|NCT00576927|463246004|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
128713028|NCT00576927|463246004|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
128713029|NCT03128892|463246005|FG000|Overall Study|Withdrawal by Subject|2|||
128713030|NCT03128892|463246005|FG000|Overall Study|Physician Decision|1|||
128713031|NCT00459108|463246007|FG000|Overall Study|Withdrawal by Subject|5|||
128713032|NCT00459108|463246007|FG000|Overall Study|Adverse Event|3|||
128960302|NCT01998958|464140753|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960303|NCT01998958|464140754|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960304|NCT01998958|464140755|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960305|NCT01998958|464140756|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960306|NCT01998958|464140757|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960307|NCT01998958|464140758|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960308|NCT01998958|464140759|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
128960309|NCT01998958|464140728|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960310|NCT01998958|464140729|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960311|NCT01998958|464140730|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960312|NCT01998958|464140731|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960313|NCT01998958|464140732|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960314|NCT01998958|464140733|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960315|NCT01998958|464140734|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960316|NCT01998958|464140735|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960317|NCT01998958|464140736|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960318|NCT01998958|464140737|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960319|NCT01998958|464140738|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960320|NCT01998958|464140739|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
128713033|NCT00459108|463246007|FG000|Overall Study|Death|2|||
128713034|NCT00459108|463246007|FG000|Overall Study|Progression|1|||
128960321|NCT01998958|464140740|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960322|NCT01998958|464140741|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960323|NCT01998958|464140742|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960324|NCT01998958|464140743|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
129219954|NCT01733680|465104661|FG000|Overall Study|Withdrawal by Subject|0|||
129219955|NCT01733680|465104662|FG001|Overall Study|Withdrawal by Subject|1|||
129219956|NCT04308291|465104669|FG000|Run-In Phase|Withdrawal by Subject|4|||
129219957|NCT04308291|465104669|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
129219958|NCT04308291|465104669|FG000|Study Phase 6-M|Physician Decision|2|||
129219959|NCT04308291|465104669|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
128713035|NCT03473808|463246010|FG000|Overall Study|Withdrawal by Subject|1|||
128713036|NCT03715764|463246011|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
128713037|NCT03715764|463246012|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
128960325|NCT01998958|464140744|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960326|NCT01998958|464140745|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
128713038|NCT03715764|463246011|FG000|3 Month Follow-up|Lost to Follow-up|2|||
128960327|NCT01998958|464140746|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960328|NCT01998958|464140747|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960329|NCT01998958|464140748|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960330|NCT01998958|464140749|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
128960331|NCT01998958|464140750|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
128960332|NCT01998958|464140751|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960333|NCT01998958|464140752|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960334|NCT01998958|464140753|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960335|NCT01998958|464140754|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960336|NCT01998958|464140755|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960337|NCT01998958|464140756|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960338|NCT01998958|464140757|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960339|NCT01998958|464140758|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960340|NCT01998958|464140759|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
128960341|NCT01998958|464140728|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960342|NCT01998958|464140729|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960343|NCT01998958|464140730|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960344|NCT01998958|464140731|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960345|NCT01998958|464140732|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960346|NCT01998958|464140733|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960347|NCT01998958|464140734|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960348|NCT01998958|464140735|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960349|NCT01998958|464140736|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960350|NCT01998958|464140737|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960351|NCT01998958|464140738|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960352|NCT01998958|464140739|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960353|NCT01998958|464140740|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960354|NCT01998958|464140741|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960355|NCT01998958|464140742|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960356|NCT01998958|464140743|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960357|NCT01998958|464140744|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960358|NCT01998958|464140745|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960359|NCT01998958|464140746|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960360|NCT01998958|464140747|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960361|NCT01998958|464140748|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960362|NCT01998958|464140749|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
128960363|NCT01998958|464140750|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
128960364|NCT01998958|464140751|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
128960365|NCT01998958|464140752|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960366|NCT01998958|464140753|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960367|NCT01998958|464140754|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960368|NCT01998958|464140755|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960369|NCT01998958|464140756|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960370|NCT01998958|464140757|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960371|NCT01998958|464140758|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960372|NCT01998958|464140759|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
128960373|NCT00968708|464140767|FG000|Overall Study|Adverse Event|169|||
128960374|NCT00968708|464140768|FG001|Overall Study|Adverse Event|150|||
128960375|NCT00968708|464140767|FG000|Overall Study|Major Protocol Deviation|0|||
128960376|NCT00968708|464140768|FG001|Overall Study|Major Protocol Deviation|1|||
128960377|NCT00968708|464140767|FG000|Overall Study|Lost to Follow-up|19|||
128960378|NCT00968708|464140768|FG001|Overall Study|Lost to Follow-up|11|||
128960379|NCT00968708|464140767|FG000|Overall Study|Voluntary Withdrawal|104|||
128960380|NCT00968708|464140768|FG001|Overall Study|Voluntary Withdrawal|101|||
128960381|NCT00968708|464140767|FG000|Overall Study|Investigator Discretion|0|||
128960382|NCT00968708|464140768|FG001|Overall Study|Investigator Discretion|1|||
128960383|NCT00968708|464140767|FG000|Overall Study|Other|26|||
128960384|NCT00968708|464140768|FG001|Overall Study|Other|34|||
128960385|NCT03407170|464140769|FG000|Overall Study|Adverse Event|1|||
128960386|NCT01851863|464140774|FG000|Overall Study|Did not receive study medication|2|||
128713039|NCT03715764|463246012|FG001|3 Month Follow-up|Lost to Follow-up|2|||
128713040|NCT03715764|463246011|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
128713041|NCT03715764|463246012|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
128713042|NCT03715764|463246011|FG000|6 Month Follow-up|Lost to Follow-up|3|||
128960387|NCT01851863|464140775|FG001|Overall Study|Did not receive study medication|5|||
128713043|NCT03715764|463246012|FG001|6 Month Follow-up|Lost to Follow-up|0|||
128713044|NCT03715764|463246011|FG000|12 Month Follow-up|Lost to Follow-up|2|||
128960388|NCT01851863|464140776|FG002|Overall Study|Did not receive study medication|3|||
128960389|NCT01851863|464140777|FG003|Overall Study|Did not receive study medication|0|||
128713045|NCT03715764|463246012|FG001|12 Month Follow-up|Lost to Follow-up|3|||
128713046|NCT03715764|463246011|FG000|12 Month Follow-up|Pregnancy|0|||
128960390|NCT01851863|464140774|FG000|Overall Study|Lost to Follow-up|3|||
128960391|NCT01851863|464140775|FG001|Overall Study|Lost to Follow-up|4|||
128960392|NCT01851863|464140776|FG002|Overall Study|Lost to Follow-up|2|||
128960393|NCT01851863|464140777|FG003|Overall Study|Lost to Follow-up|3|||
128960394|NCT03238352|464140778|FG000|Overall Study|Lost to Follow-up|0|||
128960395|NCT03238352|464140779|FG001|Overall Study|Lost to Follow-up|2|||
128960396|NCT03238352|464140780|FG002|Overall Study|Lost to Follow-up|1|||
128960397|NCT03238352|464140778|FG000|Overall Study|Withdrawal by Subject|0|||
128960398|NCT03238352|464140779|FG001|Overall Study|Withdrawal by Subject|1|||
128960399|NCT03238352|464140780|FG002|Overall Study|Withdrawal by Subject|0|||
128960400|NCT00928512|464140781|FG000|Overall Study|Adverse Event|4|||
128960401|NCT00928512|464140782|FG001|Overall Study|Adverse Event|3|||
128960402|NCT00928512|464140783|FG002|Overall Study|Adverse Event|2|||
128960403|NCT00928512|464140784|FG003|Overall Study|Adverse Event|8|||
128960404|NCT00928512|464140785|FG004|Overall Study|Adverse Event|6|||
128960405|NCT00928512|464140781|FG000|Overall Study|Lack of Efficacy|2|||
128960406|NCT00928512|464140782|FG001|Overall Study|Lack of Efficacy|0|||
128960407|NCT00928512|464140783|FG002|Overall Study|Lack of Efficacy|4|||
128960408|NCT00928512|464140784|FG003|Overall Study|Lack of Efficacy|7|||
128960409|NCT00928512|464140785|FG004|Overall Study|Lack of Efficacy|3|||
128960410|NCT00928512|464140781|FG000|Overall Study|Protocol Violation|0|||
128960411|NCT00928512|464140782|FG001|Overall Study|Protocol Violation|1|||
128960412|NCT00928512|464140783|FG002|Overall Study|Protocol Violation|0|||
128960413|NCT00928512|464140784|FG003|Overall Study|Protocol Violation|1|||
128960414|NCT00928512|464140785|FG004|Overall Study|Protocol Violation|3|||
128960415|NCT00928512|464140781|FG000|Overall Study|Withdrawal by Subject|3|||
128960416|NCT00928512|464140782|FG001|Overall Study|Withdrawal by Subject|0|||
128960417|NCT00928512|464140783|FG002|Overall Study|Withdrawal by Subject|3|||
128960418|NCT00928512|464140784|FG003|Overall Study|Withdrawal by Subject|4|||
128960419|NCT00928512|464140785|FG004|Overall Study|Withdrawal by Subject|0|||
128960420|NCT00928512|464140781|FG000|Overall Study|Lost to Follow-up|1|||
128960421|NCT00928512|464140782|FG001|Overall Study|Lost to Follow-up|1|||
128960422|NCT00928512|464140783|FG002|Overall Study|Lost to Follow-up|2|||
128960423|NCT00928512|464140784|FG003|Overall Study|Lost to Follow-up|1|||
128960424|NCT00928512|464140785|FG004|Overall Study|Lost to Follow-up|3|||
128960425|NCT00928512|464140781|FG000|Overall Study|Administrative Problems|0|||
128960426|NCT00928512|464140782|FG001|Overall Study|Administrative Problems|1|||
128960427|NCT00928512|464140783|FG002|Overall Study|Administrative Problems|0|||
128960428|NCT00928512|464140784|FG003|Overall Study|Administrative Problems|0|||
128960429|NCT00928512|464140785|FG004|Overall Study|Administrative Problems|0|||
128960430|NCT01963780|464140786|FG000|Overall Study|Death|7|||
128960431|NCT04153929|464140787|FG000|Overall Study|Other than listed|2|||
128960432|NCT04153929|464140788|FG001|Overall Study|Other than listed|2|||
128960433|NCT04153929|464140789|FG002|Overall Study|Other than listed|0|||
128960434|NCT04153929|464140790|FG003|Overall Study|Other than listed|1|||
128960435|NCT04153929|464140791|FG004|Overall Study|Other than listed|0|||
128960436|NCT04153929|464140792|FG005|Overall Study|Other than listed|2|||
128960437|NCT04153929|464140793|FG006|Overall Study|Other than listed|2|||
129127300|NCT04235374|464759258|FG001|Overall Study|Death|91|||
129127301|NCT04235374|464759257|FG000|Overall Study|Refused|2|||
129127302|NCT04235374|464759258|FG001|Overall Study|Refused|2|||
129127303|NCT04235374|464759257|FG000|Overall Study|Unavailable|12|||
129127304|NCT04235374|464759258|FG001|Overall Study|Unavailable|3|||
129127305|NCT04235374|464759257|FG000|Overall Study|Withdrawal by Subject|0|||
129127306|NCT04235374|464759258|FG001|Overall Study|Withdrawal by Subject|1|||
129127307|NCT04235374|464759257|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
129127308|NCT04235374|464759258|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
129127309|NCT00088153|464759259|FG000|Overall Study|Physician Decision|3|||
129127310|NCT00088153|464759260|FG001|Overall Study|Physician Decision|3|||
129127311|NCT00088153|464759259|FG000|Overall Study|Withdrawal by Subject|10|||
129127312|NCT00088153|464759260|FG001|Overall Study|Withdrawal by Subject|10|||
129127313|NCT00088153|464759259|FG000|Overall Study|Lost to Follow-up|11|||
129127314|NCT00088153|464759260|FG001|Overall Study|Lost to Follow-up|12|||
129127315|NCT00976027|464759262|FG000|Overall Study|Serious Adverse Event|36|||
129127316|NCT00976027|464759263|FG001|Overall Study|Serious Adverse Event|17|||
129127317|NCT00976027|464759262|FG000|Overall Study|Adverse Event|0|||
129127318|NCT00976027|464759263|FG001|Overall Study|Adverse Event|2|||
129127319|NCT00976027|464759262|FG000|Overall Study|Protocol Violation|60|||
129127320|NCT00976027|464759263|FG001|Overall Study|Protocol Violation|27|||
129127321|NCT00976027|464759262|FG000|Overall Study|Lost to Follow-up|208|||
129127322|NCT00976027|464759263|FG001|Overall Study|Lost to Follow-up|103|||
129127323|NCT00976027|464759262|FG000|Overall Study|Withdrawal by Subject|107|||
129127324|NCT00976027|464759263|FG001|Overall Study|Withdrawal by Subject|66|||
129127325|NCT04435626|464759268|FG000|Overall Study|Lost to Follow-up|1|||
128960438|NCT04153929|464140794|FG007|Overall Study|Other than listed|1|||
128960439|NCT04153929|464140787|FG000|Overall Study|Lost to Follow-up|2|||
128960440|NCT04153929|464140788|FG001|Overall Study|Lost to Follow-up|1|||
129127326|NCT04435626|464759269|FG001|Overall Study|Lost to Follow-up|5|||
129127327|NCT04435626|464759268|FG000|Overall Study|Withdrawal by Subject|6|||
129127328|NCT04435626|464759269|FG001|Overall Study|Withdrawal by Subject|7|||
129127329|NCT04435626|464759268|FG000|Overall Study|major GCP violations|8|||
129127330|NCT04435626|464759269|FG001|Overall Study|major GCP violations|7|||
129127331|NCT01771107|464759275|FG000|Overall Study|Adverse Event|1|||
129127332|NCT01771107|464759276|FG001|Overall Study|Adverse Event|3|||
129127333|NCT01771107|464759275|FG000|Overall Study|Withdrawal by Subject|0|||
129127334|NCT01771107|464759276|FG001|Overall Study|Withdrawal by Subject|2|||
129127335|NCT01771107|464759275|FG000|Overall Study|Lost to Follow-up|0|||
129127336|NCT01771107|464759276|FG001|Overall Study|Lost to Follow-up|1|||
129127337|NCT01771107|464759275|FG000|Overall Study|participant moved|0|||
129127338|NCT01771107|464759276|FG001|Overall Study|participant moved|1|||
129127339|NCT01771107|464759275|FG000|Overall Study|Other|0|||
129127340|NCT01771107|464759276|FG001|Overall Study|Other|1|||
129127341|NCT05248386|464759278|FG000|Overall Study|Technical problems|0|||
129127342|NCT05248386|464759279|FG001|Overall Study|Technical problems|1|||
129127343|NCT05248386|464759278|FG000|Overall Study|Withdrawal by Subject|15|||
129127344|NCT05248386|464759279|FG001|Overall Study|Withdrawal by Subject|10|||
129127345|NCT05248386|464759278|FG000|Overall Study|Physician Decision|0|||
129127346|NCT05248386|464759279|FG001|Overall Study|Physician Decision|1|||
129127347|NCT05248386|464759278|FG000|Overall Study|Adverse Event|2|||
129127348|NCT05248386|464759279|FG001|Overall Study|Adverse Event|4|||
129127349|NCT05248386|464759278|FG000|Overall Study|Other|1|||
129127350|NCT05248386|464759279|FG001|Overall Study|Other|0|||
129127351|NCT05248386|464759278|FG000|Overall Study|Lack of Efficacy|14|||
129127352|NCT05248386|464759279|FG001|Overall Study|Lack of Efficacy|12|||
129127353|NCT02864992|464759280|FG000|Overall Study|still on treatment|15|||
129127354|NCT02864992|464759281|FG001|Overall Study|still on treatment|1|||
129127355|NCT02864992|464759282|FG002|Overall Study|still on treatment|33|||
129127356|NCT03785366|464759283|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
129127357|NCT03785366|464759284|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
129127358|NCT03785366|464759283|FG000|Overall Study|Lost to Follow-up|1|||
129127359|NCT03785366|464759284|FG001|Overall Study|Lost to Follow-up|0|||
129127360|NCT03785366|464759283|FG000|Overall Study|Partial IUD Expulsion|0|||
129127361|NCT03785366|464759284|FG001|Overall Study|Partial IUD Expulsion|2|||
129127362|NCT03785366|464759283|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
128960441|NCT04153929|464140789|FG002|Overall Study|Lost to Follow-up|0|||
128960442|NCT04153929|464140790|FG003|Overall Study|Lost to Follow-up|1|||
128960443|NCT04153929|464140791|FG004|Overall Study|Lost to Follow-up|1|||
128960444|NCT04153929|464140792|FG005|Overall Study|Lost to Follow-up|0|||
128960445|NCT04153929|464140793|FG006|Overall Study|Lost to Follow-up|0|||
128960446|NCT04153929|464140794|FG007|Overall Study|Lost to Follow-up|0|||
128960447|NCT04153929|464140787|FG000|Overall Study|Withdrawal by Subject|3|||
128960448|NCT04153929|464140788|FG001|Overall Study|Withdrawal by Subject|1|||
128960449|NCT04153929|464140789|FG002|Overall Study|Withdrawal by Subject|0|||
128960450|NCT04153929|464140790|FG003|Overall Study|Withdrawal by Subject|3|||
128960451|NCT04153929|464140791|FG004|Overall Study|Withdrawal by Subject|1|||
128960452|NCT04153929|464140792|FG005|Overall Study|Withdrawal by Subject|0|||
128960453|NCT04153929|464140793|FG006|Overall Study|Withdrawal by Subject|1|||
128960454|NCT04153929|464140794|FG007|Overall Study|Withdrawal by Subject|0|||
128960455|NCT04153929|464140787|FG000|Overall Study|Protocol Violation|0|||
128960456|NCT04153929|464140788|FG001|Overall Study|Protocol Violation|0|||
128960457|NCT04153929|464140789|FG002|Overall Study|Protocol Violation|0|||
128960458|NCT04153929|464140790|FG003|Overall Study|Protocol Violation|0|||
128960459|NCT04153929|464140791|FG004|Overall Study|Protocol Violation|0|||
128960460|NCT04153929|464140792|FG005|Overall Study|Protocol Violation|0|||
128960461|NCT04153929|464140793|FG006|Overall Study|Protocol Violation|1|||
128960462|NCT04153929|464140794|FG007|Overall Study|Protocol Violation|2|||
128960463|NCT04153929|464140787|FG000|Overall Study|Adverse Event|3|||
128960464|NCT04153929|464140788|FG001|Overall Study|Adverse Event|5|||
128960465|NCT04153929|464140789|FG002|Overall Study|Adverse Event|5|||
128960466|NCT04153929|464140790|FG003|Overall Study|Adverse Event|11|||
128960467|NCT04153929|464140791|FG004|Overall Study|Adverse Event|15|||
129127363|NCT03785366|464759284|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
129127364|NCT03240874|464759285|FG000|Overall Study|Lost to Follow-up|0|||
128960468|NCT04153929|464140792|FG005|Overall Study|Adverse Event|4|||
128960469|NCT04153929|464140793|FG006|Overall Study|Adverse Event|8|||
128960470|NCT04153929|464140794|FG007|Overall Study|Adverse Event|2|||
129127365|NCT03240874|464759286|FG001|Overall Study|Lost to Follow-up|2|||
129127366|NCT03240874|464759287|FG002|Overall Study|Lost to Follow-up|4|||
129127367|NCT03240874|464759288|FG003|Overall Study|Lost to Follow-up|1|||
129127368|NCT05252702|464759289|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
129127369|NCT05252702|464759289|FG000|Overall Study|Death|16|||
128960471|NCT04153929|464140787|FG000|Overall Study|Not treated|1|||
128960472|NCT04153929|464140788|FG001|Overall Study|Not treated|0|||
128960473|NCT04153929|464140789|FG002|Overall Study|Not treated|0|||
129127370|NCT05252702|464759289|FG000|Overall Study|System explant|5|||
129127371|NCT05252702|464759289|FG000|Overall Study|Lost to Follow-up|1|||
129127372|NCT05252702|464759289|FG000|Overall Study|Withdrawn by investigator|1|||
129127373|NCT05252702|464759289|FG000|Overall Study|Visit not due|306|||
129127374|NCT05252702|464759289|FG000|Overall Study|Visit within window but not completed|92|||
128960474|NCT04153929|464140790|FG003|Overall Study|Not treated|0|||
128960475|NCT04153929|464140791|FG004|Overall Study|Not treated|0|||
128960476|NCT04153929|464140792|FG005|Overall Study|Not treated|0|||
128960477|NCT04153929|464140793|FG006|Overall Study|Not treated|1|||
128960478|NCT04153929|464140794|FG007|Overall Study|Not treated|0|||
128960479|NCT04083794|464140795|FG000|Overall Study|Lost to Follow-up|9|||
128960480|NCT03383614|464140796|FG000|Overall Study|Withdrawal by Subject|0|||
128960481|NCT03383614|464140797|FG001|Overall Study|Withdrawal by Subject|1|||
128960482|NCT03383614|464140798|FG002|Overall Study|Withdrawal by Subject|0|||
128960483|NCT03383614|464140799|FG003|Overall Study|Withdrawal by Subject|0|||
128960484|NCT01202760|464140804|FG000|Overall Study|Entry Criteria Not Met|0|||
128960485|NCT01202760|464140805|FG001|Overall Study|Entry Criteria Not Met|3|||
128960486|NCT01202760|464140806|FG002|Overall Study|Entry Criteria Not Met|1|||
128960487|NCT01202760|464140804|FG000|Overall Study|Adverse Event|11|||
128960488|NCT01202760|464140805|FG001|Overall Study|Adverse Event|9|||
128960489|NCT01202760|464140806|FG002|Overall Study|Adverse Event|10|||
128960490|NCT01202760|464140804|FG000|Overall Study|Death|2|||
128960491|NCT01202760|464140805|FG001|Overall Study|Death|1|||
128960492|NCT01202760|464140806|FG002|Overall Study|Death|0|||
128960493|NCT01202760|464140804|FG000|Overall Study|Lack of Efficacy|6|||
128960494|NCT01202760|464140805|FG001|Overall Study|Lack of Efficacy|8|||
128960495|NCT01202760|464140806|FG002|Overall Study|Lack of Efficacy|7|||
128960496|NCT01202760|464140804|FG000|Overall Study|Lost to Follow-up|0|||
128960497|NCT01202760|464140805|FG001|Overall Study|Lost to Follow-up|2|||
128960498|NCT01202760|464140806|FG002|Overall Study|Lost to Follow-up|1|||
128960499|NCT01202760|464140804|FG000|Overall Study|Parent / Caregiver Decision|0|||
128960500|NCT01202760|464140805|FG001|Overall Study|Parent / Caregiver Decision|1|||
128960501|NCT01202760|464140806|FG002|Overall Study|Parent / Caregiver Decision|0|||
128960502|NCT01202760|464140804|FG000|Overall Study|Withdrawal by Subject|17|||
128960503|NCT01202760|464140805|FG001|Overall Study|Withdrawal by Subject|18|||
128960504|NCT01202760|464140806|FG002|Overall Study|Withdrawal by Subject|14|||
128960505|NCT01202760|464140804|FG000|Overall Study|Physician Decision|0|||
128960506|NCT01202760|464140805|FG001|Overall Study|Physician Decision|1|||
128960507|NCT01202760|464140806|FG002|Overall Study|Physician Decision|0|||
128960508|NCT01202760|464140804|FG000|Overall Study|Protocol Violation|7|||
128960509|NCT01202760|464140805|FG001|Overall Study|Protocol Violation|5|||
128960510|NCT01202760|464140806|FG002|Overall Study|Protocol Violation|2|||
128960511|NCT01202760|464140804|FG000|Overall Study|Sponsor Decision|4|||
128960512|NCT01202760|464140805|FG001|Overall Study|Sponsor Decision|4|||
128960513|NCT01202760|464140806|FG002|Overall Study|Sponsor Decision|0|||
128960514|NCT00871572|464140807|FG000|Overall Study|Adverse Event|0|||
128960515|NCT00871572|464140808|FG001|Overall Study|Adverse Event|2|||
129127375|NCT05252702|464759289|FG000|Overall Study|Unsuccessful implant|1|||
129127376|NCT04153864|464759290|FG000|Overall Study|Withdrawal by Subject|21|||
129127377|NCT04153864|464759291|FG001|Overall Study|Withdrawal by Subject|7|||
129127378|NCT04153864|464759292|FG002|Overall Study|Withdrawal by Subject|23|||
129127379|NCT04153864|464759293|FG003|Overall Study|Withdrawal by Subject|2|||
129127380|NCT04153864|464759290|FG000|Overall Study|Lost to Follow-up|4|||
129127381|NCT04153864|464759291|FG001|Overall Study|Lost to Follow-up|0|||
129127382|NCT04153864|464759292|FG002|Overall Study|Lost to Follow-up|3|||
129127383|NCT04153864|464759293|FG003|Overall Study|Lost to Follow-up|0|||
129127384|NCT04153864|464759290|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
129127385|NCT04153864|464759291|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
129127386|NCT04153864|464759292|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
129127387|NCT04153864|464759293|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
129127388|NCT04958707|464759294|FG000|Post Intervention|Withdrawal by Subject|1|||
129127389|NCT04958707|464759295|FG001|Post Intervention|Withdrawal by Subject|0|||
129127390|NCT04958707|464759296|FG002|Post Intervention|Withdrawal by Subject|0|||
128713047|NCT03715764|463246012|FG001|12 Month Follow-up|Pregnancy|1|||
128713048|NCT03715764|463246011|FG000|12 Month Follow-up|Surgery|2|||
128960516|NCT00871572|464140809|FG002|Overall Study|Adverse Event|0|||
128713049|NCT03715764|463246012|FG001|12 Month Follow-up|Surgery|0|||
128960517|NCT00871572|464140810|FG003|Overall Study|Adverse Event|3|||
128960518|NCT00871572|464140807|FG000|Overall Study|Investigator Decision|0|||
128713050|NCT03715764|463246011|FG000|12 Month Follow-up|Wrong address|1|||
128960519|NCT00871572|464140808|FG001|Overall Study|Investigator Decision|1|||
128960520|NCT00871572|464140809|FG002|Overall Study|Investigator Decision|0|||
128960521|NCT00871572|464140810|FG003|Overall Study|Investigator Decision|1|||
128960522|NCT00871572|464140807|FG000|Overall Study|Lost to Follow-up|0|||
128960523|NCT00871572|464140808|FG001|Overall Study|Lost to Follow-up|1|||
128960524|NCT00871572|464140809|FG002|Overall Study|Lost to Follow-up|0|||
128960525|NCT00871572|464140810|FG003|Overall Study|Lost to Follow-up|1|||
128960526|NCT00871572|464140807|FG000|Overall Study|Protocol Violation|0|||
128960527|NCT00871572|464140808|FG001|Overall Study|Protocol Violation|0|||
128960528|NCT00871572|464140809|FG002|Overall Study|Protocol Violation|1|||
128960529|NCT00871572|464140810|FG003|Overall Study|Protocol Violation|1|||
128960530|NCT00871572|464140807|FG000|Overall Study|Sponsor Decision|1|||
128960531|NCT00871572|464140808|FG001|Overall Study|Sponsor Decision|0|||
128960532|NCT00871572|464140809|FG002|Overall Study|Sponsor Decision|0|||
128960533|NCT00871572|464140810|FG003|Overall Study|Sponsor Decision|0|||
128960534|NCT00871572|464140807|FG000|Overall Study|Withdrawal by Subject|1|||
128960535|NCT00871572|464140808|FG001|Overall Study|Withdrawal by Subject|2|||
128960536|NCT00871572|464140809|FG002|Overall Study|Withdrawal by Subject|3|||
128960537|NCT00871572|464140810|FG003|Overall Study|Withdrawal by Subject|1|||
128960538|NCT04354155|464140813|FG000|Overall Study|Withdrawal by Subject|1|||
128960539|NCT04354155|464140813|FG000|Overall Study|Did not meet criteria for study intervention|1|||
128960540|NCT00187889|464140814|FG000|Overall Study|Withdrawal by Subject|6|||
128960541|NCT00187889|464140815|FG001|Overall Study|Withdrawal by Subject|4|||
128960542|NCT03097029|464140820|FG000|Overall Study|Withdrawal by Subject|1|||
128960543|NCT00709124|464140822|FG000|Overall Study|Death|3|||
128960544|NCT00709124|464140823|FG001|Overall Study|Death|1|||
128960545|NCT00709124|464140822|FG000|Overall Study|encephalopathy; can't do assessment|1|||
128960546|NCT00709124|464140823|FG001|Overall Study|encephalopathy; can't do assessment|0|||
128960547|NCT00373490|464140824|FG000|Overall Study|Adverse Event|0|||
128960548|NCT00373490|464140825|FG001|Overall Study|Adverse Event|1|||
128960549|NCT00373490|464140824|FG000|Overall Study|Lack of Efficacy|9|||
128960550|NCT00373490|464140825|FG001|Overall Study|Lack of Efficacy|4|||
128960551|NCT00373490|464140824|FG000|Overall Study|Withdrawal by Subject|0|||
128960552|NCT00373490|464140825|FG001|Overall Study|Withdrawal by Subject|1|||
128960553|NCT00108953|464140832|FG000|Follow-up|Death|18|||
128960554|NCT00108953|464140833|FG001|Follow-up|Death|26|||
128960555|NCT00108953|464140832|FG000|Follow-up|Lost to Follow-up|1|||
128960556|NCT00108953|464140833|FG001|Follow-up|Lost to Follow-up|1|||
128960557|NCT00108953|464140832|FG000|Follow-up|Study terminated by sponsor|10|||
128960558|NCT00108953|464140833|FG001|Follow-up|Study terminated by sponsor|6|||
128960559|NCT02999100|464140839|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
128960560|NCT02999100|464140840|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
128960561|NCT02999100|464140841|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
128960562|NCT02999100|464140842|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
128960563|NCT02999100|464140843|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
128960564|NCT02999100|464140844|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
128960565|NCT02999100|464140839|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
128960566|NCT02999100|464140840|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
128960567|NCT02999100|464140841|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129127391|NCT04958707|464759294|FG000|3 Months Follow- up|Lost to Follow-up|0|||
129127392|NCT04958707|464759295|FG001|3 Months Follow- up|Lost to Follow-up|3|||
129127393|NCT04958707|464759296|FG002|3 Months Follow- up|Lost to Follow-up|0|||
129127394|NCT04958707|464759294|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
129127395|NCT04958707|464759295|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
129127396|NCT04958707|464759296|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
129127397|NCT04279522|464759297|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
129127398|NCT04279522|464759298|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
129127399|NCT04279522|464759297|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
129127400|NCT04279522|464759298|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
129127401|NCT04279522|464759297|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
129127402|NCT04279522|464759298|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
129127403|NCT04279522|464759297|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
129127404|NCT04279522|464759298|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
129127405|NCT04279522|464759297|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
129127406|NCT04279522|464759298|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
129127407|NCT04279522|464759297|FG000|Period 2: Open Label Phase|Physician Decision|0|||
129127408|NCT04279522|464759298|FG001|Period 2: Open Label Phase|Physician Decision|3|||
129127409|NCT04279522|464759297|FG000|Period 2: Open Label Phase|Adverse Event|0|||
129127410|NCT04279522|464759298|FG001|Period 2: Open Label Phase|Adverse Event|1|||
129127411|NCT04279522|464759297|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
129127412|NCT04279522|464759298|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
129127413|NCT02629159|464759301|FG000|Overall Study|Adverse Event|17|||
129127414|NCT02629159|464759302|FG001|Overall Study|Adverse Event|20|||
129127415|NCT02629159|464759303|FG002|Overall Study|Adverse Event|22|||
129127416|NCT02629159|464759301|FG000|Overall Study|Withdrawal by Subject|22|||
129127417|NCT02629159|464759302|FG001|Overall Study|Withdrawal by Subject|11|||
129127418|NCT02629159|464759303|FG002|Overall Study|Withdrawal by Subject|15|||
128960568|NCT02999100|464140842|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
128960569|NCT02999100|464140843|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129127419|NCT02629159|464759301|FG000|Overall Study|Lost to Follow-up|7|||
128960570|NCT02999100|464140844|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
128960571|NCT02999100|464140839|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
128960572|NCT02999100|464140840|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129127420|NCT02629159|464759302|FG001|Overall Study|Lost to Follow-up|4|||
128960573|NCT02999100|464140841|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
129127421|NCT02629159|464759303|FG002|Overall Study|Lost to Follow-up|5|||
129219960|NCT04308291|465104669|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
129219961|NCT04308291|465104669|FG000|Study Phase 12-M|Physician Decision|2|||
129219962|NCT04308291|465104669|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
129219963|NCT02565108|465104670|FG000|Overall Study|Adverse Event|1|||
129219964|NCT02565108|465104671|FG001|Overall Study|Adverse Event|0|||
129219965|NCT02565108|465104670|FG000|Overall Study|Withdrew Consent|1|||
129219966|NCT02565108|465104671|FG001|Overall Study|Withdrew Consent|0|||
129219967|NCT02908672|465104672|FG000|Run-in Period|Death|12|||
129219968|NCT02908672|465104673|FG001|Run-in Period|Death|10|||
129219969|NCT02908672|465104674|FG002|Run-in Period|Death|0|||
129219970|NCT02908672|465104675|FG003|Run-in Period|Death|0|||
129219971|NCT02908672|465104672|FG000|Run-in Period|Lost to Follow-up|1|||
129219972|NCT02908672|465104673|FG001|Run-in Period|Lost to Follow-up|1|||
128713051|NCT03715764|463246012|FG001|12 Month Follow-up|Wrong address|0|||
128713052|NCT03715764|463246011|FG000|12 Month Follow-up|No symptoms|1|||
128713053|NCT03715764|463246012|FG001|12 Month Follow-up|No symptoms|0|||
128713054|NCT03715764|463246011|FG000|12 Month Follow-up|Changed primary care centre|0|||
128713055|NCT03715764|463246012|FG001|12 Month Follow-up|Changed primary care centre|1|||
128713056|NCT00818662|463246018|FG000|Overall Study|Adverse Event|5|||
128713057|NCT00818662|463246019|FG001|Overall Study|Adverse Event|14|||
128713058|NCT00818662|463246020|FG002|Overall Study|Adverse Event|4|||
128713059|NCT00818662|463246021|FG003|Overall Study|Adverse Event|3|||
128713060|NCT00818662|463246018|FG000|Overall Study|Withdrawal by Subject|5|||
128713061|NCT00818662|463246019|FG001|Overall Study|Withdrawal by Subject|4|||
128713062|NCT00818662|463246020|FG002|Overall Study|Withdrawal by Subject|2|||
128713063|NCT00818662|463246021|FG003|Overall Study|Withdrawal by Subject|2|||
128713064|NCT00818662|463246018|FG000|Overall Study|Death|1|||
128713065|NCT00818662|463246019|FG001|Overall Study|Death|3|||
128713066|NCT00818662|463246020|FG002|Overall Study|Death|0|||
128713067|NCT00818662|463246021|FG003|Overall Study|Death|0|||
128713068|NCT00818662|463246018|FG000|Overall Study|Physician Decision|1|||
128713069|NCT00818662|463246019|FG001|Overall Study|Physician Decision|0|||
128713070|NCT00818662|463246020|FG002|Overall Study|Physician Decision|0|||
128713071|NCT00818662|463246021|FG003|Overall Study|Physician Decision|0|||
128713072|NCT00818662|463246018|FG000|Overall Study|Lost to Follow-up|0|||
128713073|NCT00818662|463246019|FG001|Overall Study|Lost to Follow-up|0|||
128713074|NCT00818662|463246020|FG002|Overall Study|Lost to Follow-up|0|||
128713075|NCT00818662|463246021|FG003|Overall Study|Lost to Follow-up|1|||
128713076|NCT00818662|463246018|FG000|Overall Study|Unwilling or Unable to Participate|4|||
128960574|NCT02999100|464140842|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
128960575|NCT02999100|464140843|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
128960576|NCT02999100|464140844|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
128960577|NCT01125293|464140848|FG000|Overall Study|Disease Progression|1|||
128960578|NCT01125293|464140849|FG001|Overall Study|Disease Progression|3|||
128960579|NCT01125293|464140850|FG002|Overall Study|Disease Progression|4|||
128960580|NCT01125293|464140851|FG003|Overall Study|Disease Progression|3|||
128960581|NCT01125293|464140852|FG004|Overall Study|Disease Progression|5|||
128960582|NCT01125293|464140853|FG005|Overall Study|Disease Progression|12|||
128960583|NCT01125293|464140848|FG000|Overall Study|Adverse Event|1|||
128960584|NCT01125293|464140849|FG001|Overall Study|Adverse Event|0|||
128960585|NCT01125293|464140850|FG002|Overall Study|Adverse Event|0|||
128960586|NCT01125293|464140851|FG003|Overall Study|Adverse Event|0|||
128960587|NCT01125293|464140852|FG004|Overall Study|Adverse Event|2|||
128960588|NCT01125293|464140853|FG005|Overall Study|Adverse Event|8|||
128960589|NCT01125293|464140848|FG000|Overall Study|Symptomatic Deterioration|1|||
128960590|NCT01125293|464140849|FG001|Overall Study|Symptomatic Deterioration|0|||
128960591|NCT01125293|464140850|FG002|Overall Study|Symptomatic Deterioration|0|||
128960592|NCT01125293|464140851|FG003|Overall Study|Symptomatic Deterioration|0|||
128960593|NCT01125293|464140852|FG004|Overall Study|Symptomatic Deterioration|0|||
128960594|NCT01125293|464140853|FG005|Overall Study|Symptomatic Deterioration|0|||
128960595|NCT01125293|464140848|FG000|Overall Study|Death|0|||
128960596|NCT01125293|464140849|FG001|Overall Study|Death|0|||
128960597|NCT01125293|464140850|FG002|Overall Study|Death|0|||
128960598|NCT01125293|464140851|FG003|Overall Study|Death|0|||
128960599|NCT01125293|464140852|FG004|Overall Study|Death|1|||
128960600|NCT01125293|464140853|FG005|Overall Study|Death|0|||
128960601|NCT01125293|464140848|FG000|Overall Study|Withdrawal by Subject|0|||
128960602|NCT01125293|464140849|FG001|Overall Study|Withdrawal by Subject|0|||
128713077|NCT00818662|463246019|FG001|Overall Study|Unwilling or Unable to Participate|6|||
128960603|NCT01125293|464140850|FG002|Overall Study|Withdrawal by Subject|0|||
128960604|NCT01125293|464140851|FG003|Overall Study|Withdrawal by Subject|0|||
128960605|NCT01125293|464140852|FG004|Overall Study|Withdrawal by Subject|2|||
128960606|NCT01125293|464140853|FG005|Overall Study|Withdrawal by Subject|1|||
128960607|NCT01125293|464140848|FG000|Overall Study|Physician Decision|0|||
128960608|NCT01125293|464140849|FG001|Overall Study|Physician Decision|0|||
129219973|NCT02908672|465104674|FG002|Run-in Period|Lost to Follow-up|0|||
129219974|NCT02908672|465104675|FG003|Run-in Period|Lost to Follow-up|0|||
129219975|NCT02908672|465104672|FG000|Run-in Period|Reason Not Specified|2|||
129219976|NCT02908672|465104673|FG001|Run-in Period|Reason Not Specified|0|||
128960609|NCT01125293|464140850|FG002|Overall Study|Physician Decision|0|||
128960610|NCT01125293|464140851|FG003|Overall Study|Physician Decision|0|||
128960611|NCT01125293|464140852|FG004|Overall Study|Physician Decision|0|||
128960612|NCT01125293|464140853|FG005|Overall Study|Physician Decision|2|||
128960613|NCT02224638|464140854|FG000|Overall Study|Adverse Event|1|||
128960614|NCT02224638|464140855|FG001|Overall Study|Adverse Event|1|||
128960615|NCT01270958|464140860|FG000|Overall Study|Lost to Follow-up|2|||
128960616|NCT01270958|464140860|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
128960617|NCT01455415|464140866|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
128960618|NCT01455415|464140867|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
128960619|NCT01455415|464140866|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
128960620|NCT01455415|464140867|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
128960621|NCT01455415|464140866|FG000|Period 1|Drug Error not Associated to AE|0|||
128960622|NCT01455415|464140867|FG001|Period 1|Drug Error not Associated to AE|1|||
128960623|NCT01455415|464140866|FG000|Period 1|AE Not Related to Study Drug|2|||
128960624|NCT01455415|464140867|FG001|Period 1|AE Not Related to Study Drug|6|||
128960625|NCT01455415|464140866|FG000|Period 1|Withdrawal by Subject|4|||
128960626|NCT01455415|464140867|FG001|Period 1|Withdrawal by Subject|5|||
128960627|NCT01455415|464140866|FG000|Period 1|Unspecified Reason|1|||
128960628|NCT01455415|464140867|FG001|Period 1|Unspecified Reason|1|||
128960629|NCT01455415|464140866|FG000|Period 1|Protocol Violation|0|||
128960630|NCT01455415|464140867|FG001|Period 1|Protocol Violation|2|||
128960631|NCT01455415|464140866|FG000|Washout|AE Related to Study Drug|2|||
128960632|NCT01455415|464140867|FG001|Washout|AE Related to Study Drug|0|||
128960633|NCT01455415|464140866|FG000|Washout|Lost to Follow-up|1|||
128960634|NCT01455415|464140867|FG001|Washout|Lost to Follow-up|0|||
128960635|NCT01455415|464140866|FG000|Washout|Drug Error not Associated to AE|2|||
128960636|NCT01455415|464140867|FG001|Washout|Drug Error not Associated to AE|1|||
128960637|NCT01455415|464140866|FG000|Washout|AE Not Related to Study Drug|2|||
128960638|NCT01455415|464140867|FG001|Washout|AE Not Related to Study Drug|3|||
128960639|NCT01455415|464140866|FG000|Washout|Unspecified Reason|1|||
128960640|NCT01455415|464140867|FG001|Washout|Unspecified Reason|2|||
128960641|NCT01455415|464140866|FG000|Washout|Protocol Violation|0|||
128960642|NCT01455415|464140867|FG001|Washout|Protocol Violation|1|||
128960643|NCT01455415|464140866|FG000|Period 2|AE Related to Study Drug|1|||
128960644|NCT01455415|464140867|FG001|Period 2|AE Related to Study Drug|2|||
128960645|NCT01455415|464140866|FG000|Period 2|Lost to Follow-up|2|||
128960646|NCT01455415|464140867|FG001|Period 2|Lost to Follow-up|1|||
128960647|NCT01455415|464140866|FG000|Period 2|AE Not Related to Study Drug|2|||
128960648|NCT01455415|464140867|FG001|Period 2|AE Not Related to Study Drug|1|||
128960649|NCT01455415|464140866|FG000|Period 2|Lack of Efficacy|2|||
128960650|NCT01455415|464140867|FG001|Period 2|Lack of Efficacy|0|||
128960651|NCT01455415|464140866|FG000|Period 2|Withdrawal by Subject|2|||
128960652|NCT01455415|464140867|FG001|Period 2|Withdrawal by Subject|3|||
128960653|NCT01455415|464140866|FG000|Period 2|Unspecified Reason|2|||
128960654|NCT01455415|464140867|FG001|Period 2|Unspecified Reason|3|||
128960655|NCT01455415|464140866|FG000|Period 2|Protocol Violation|2|||
128960656|NCT01455415|464140867|FG001|Period 2|Protocol Violation|0|||
128960657|NCT01455415|464140866|FG000|Follow-up|AE Related to Study Drug|0|||
128960658|NCT01455415|464140867|FG001|Follow-up|AE Related to Study Drug|1|||
128960659|NCT01455415|464140866|FG000|Follow-up|Lack of Efficacy|0|||
129127422|NCT02629159|464759301|FG000|Overall Study|Lack of Efficacy|4|||
129127423|NCT02629159|464759302|FG001|Overall Study|Lack of Efficacy|0|||
129127424|NCT02629159|464759303|FG002|Overall Study|Lack of Efficacy|1|||
129127425|NCT02629159|464759301|FG000|Overall Study|Other|6|||
129127426|NCT02629159|464759302|FG001|Overall Study|Other|4|||
129127427|NCT02629159|464759303|FG002|Overall Study|Other|8|||
129127428|NCT05352399|464759316|FG000|Overall Study|Discontinued intervention|6|||
129127429|NCT01802281|464759317|FG000|Overall Study|Death|1|||
129127430|NCT01802281|464759318|FG001|Overall Study|Death|2|||
129127431|NCT01802281|464759317|FG000|Overall Study|Withdrawal by Subject|2|||
129127432|NCT01802281|464759318|FG001|Overall Study|Withdrawal by Subject|1|||
128960660|NCT01455415|464140867|FG001|Follow-up|Lack of Efficacy|1|||
128960661|NCT01455415|464140866|FG000|Follow-up|Withdrawal by Subject|2|||
128960662|NCT01455415|464140867|FG001|Follow-up|Withdrawal by Subject|0|||
128960663|NCT01455415|464140866|FG000|Follow-up|Unspecified Reason|1|||
128960664|NCT01455415|464140867|FG001|Follow-up|Unspecified Reason|0|||
128960665|NCT00587301|464140868|FG000|Overall Study|Screen Failure|9|||
128960666|NCT00587301|464140868|FG000|Overall Study|Lost to Follow-up|22|||
129127433|NCT01802281|464759317|FG000|Overall Study|Ineligible|5|||
129219977|NCT02908672|465104674|FG002|Run-in Period|Reason Not Specified|0|||
129127434|NCT01802281|464759318|FG001|Overall Study|Ineligible|3|||
128960667|NCT00587301|464140868|FG000|Overall Study|Withdrawal by Subject|7|||
128960668|NCT00587301|464140868|FG000|Overall Study|Protocol Violation|7|||
128960669|NCT02758613|464140870|FG000|Treatment|Physician and Sponsor Decision|1|||
128960670|NCT02758613|464140871|FG001|Treatment|Physician and Sponsor Decision|0|||
128960671|NCT02758613|464140872|FG002|Treatment|Physician and Sponsor Decision|0|||
128960672|NCT02758613|464140873|FG003|Treatment|Physician and Sponsor Decision|0|||
129127435|NCT02685735|464759319|FG000|Overall Study|Surgery Cancelled|4|||
128960673|NCT02758613|464140870|FG000|Treatment|Withdrawal by Subject|1|||
128960674|NCT02758613|464140871|FG001|Treatment|Withdrawal by Subject|0|||
128960675|NCT02758613|464140872|FG002|Treatment|Withdrawal by Subject|1|||
128960676|NCT02758613|464140873|FG003|Treatment|Withdrawal by Subject|0|||
128960677|NCT01496274|464140874|FG000|Overall Study|Protocol Violation|0|||
128960678|NCT01496274|464140875|FG001|Overall Study|Protocol Violation|1|||
128960679|NCT01496274|464140874|FG000|Overall Study|Adverse Event|1|||
128960680|NCT01496274|464140875|FG001|Overall Study|Adverse Event|1|||
128960681|NCT01496274|464140874|FG000|Overall Study|Withdrawal by Subject|2|||
128960682|NCT01496274|464140875|FG001|Overall Study|Withdrawal by Subject|0|||
128960683|NCT01496274|464140874|FG000|Overall Study|Lost to Follow-up|0|||
128960684|NCT01496274|464140875|FG001|Overall Study|Lost to Follow-up|3|||
128960685|NCT00351819|464140876|FG000|Overall Study|Lost to Follow-up|4|||
128960686|NCT00351819|464140877|FG001|Overall Study|Lost to Follow-up|4|||
128960687|NCT00351819|464140876|FG000|Overall Study|Withdrawal by Subject|0|||
128960688|NCT00351819|464140877|FG001|Overall Study|Withdrawal by Subject|4|||
128960689|NCT00351819|464140876|FG000|Overall Study|Elevated PSA|1|||
128960690|NCT00351819|464140877|FG001|Overall Study|Elevated PSA|1|||
128960691|NCT00351819|464140876|FG000|Overall Study|Traumatic ankle fracture|1|||
128960692|NCT00351819|464140877|FG001|Overall Study|Traumatic ankle fracture|0|||
128960693|NCT00351819|464140876|FG000|Overall Study|Unprofessional behavior|1|||
128960694|NCT00351819|464140877|FG001|Overall Study|Unprofessional behavior|0|||
128960695|NCT00351819|464140876|FG000|Overall Study|Non-compliance|0|||
128960696|NCT00351819|464140877|FG001|Overall Study|Non-compliance|1|||
128960697|NCT00351819|464140876|FG000|Overall Study|Incarcerated|0|||
128960698|NCT00351819|464140877|FG001|Overall Study|Incarcerated|1|||
128960699|NCT00351819|464140876|FG000|Overall Study|Enrolled in another trial|0|||
128960700|NCT00351819|464140877|FG001|Overall Study|Enrolled in another trial|1|||
128960701|NCT01425749|464140878|FG000|Overall Study|progression of melanoma|0|||
128960702|NCT01425749|464140879|FG001|Overall Study|progression of melanoma|1|||
128960703|NCT01293084|464140880|FG000|Overall Study|Physician Decision|3|||
128960704|NCT01293084|464140880|FG000|Overall Study|Withdrawal by Subject|2|||
128960705|NCT02096042|464140881|FG000|Overall Study|Disease Progression|1|||
128960706|NCT02096042|464140882|FG001|Overall Study|Disease Progression|0|||
128960707|NCT02096042|464140883|FG002|Overall Study|Disease Progression|0|||
128960708|NCT02983799|464140884|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
128960709|NCT02983799|464140885|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
128960710|NCT02983799|464140886|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
128960711|NCT02983799|464140887|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
128960712|NCT02983799|464140888|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
128960713|NCT02983799|464140884|FG000|Overall Study|Death|20|||
128960714|NCT02983799|464140885|FG001|Overall Study|Death|5|||
128960715|NCT02983799|464140886|FG002|Overall Study|Death|23|||
128960716|NCT02983799|464140887|FG003|Overall Study|Death|47|||
128960717|NCT02983799|464140888|FG004|Overall Study|Death|7|||
128960718|NCT02983799|464140884|FG000|Overall Study|Withdrawal by Subject|1|||
128960719|NCT02983799|464140885|FG001|Overall Study|Withdrawal by Subject|0|||
128960720|NCT02983799|464140886|FG002|Overall Study|Withdrawal by Subject|3|||
128960721|NCT02983799|464140887|FG003|Overall Study|Withdrawal by Subject|4|||
128960722|NCT02983799|464140888|FG004|Overall Study|Withdrawal by Subject|1|||
128960723|NCT02983799|464140884|FG000|Overall Study|Protocol Violation|0|||
129036769|NCT00988208|464425087|FG001|Overall Study|Withdrawal by Subject|57|||
128960724|NCT02983799|464140885|FG001|Overall Study|Protocol Violation|1|||
128960725|NCT02983799|464140886|FG002|Overall Study|Protocol Violation|0|||
128960726|NCT02983799|464140887|FG003|Overall Study|Protocol Violation|0|||
128960727|NCT02983799|464140888|FG004|Overall Study|Protocol Violation|1|||
128960728|NCT02983799|464140884|FG000|Overall Study|Lost to Follow-up|1|||
128960729|NCT02983799|464140885|FG001|Overall Study|Lost to Follow-up|0|||
128960730|NCT02983799|464140886|FG002|Overall Study|Lost to Follow-up|1|||
128960731|NCT02983799|464140887|FG003|Overall Study|Lost to Follow-up|0|||
128960732|NCT02983799|464140888|FG004|Overall Study|Lost to Follow-up|0|||
128960733|NCT03136367|464140894|FG000|T1 Consultation|discontinued mistakenly included|2|||
128960734|NCT03136367|464140895|FG001|T1 Consultation|discontinued mistakenly included|6|||
128960735|NCT03136367|464140896|FG002|T1 Consultation|discontinued mistakenly included|1|||
128960736|NCT03136367|464140894|FG000|T1 Consultation|Discontinued other|0|||
128960737|NCT03136367|464140895|FG001|T1 Consultation|Discontinued other|1|||
128960738|NCT03136367|464140896|FG002|T1 Consultation|Discontinued other|0|||
128960739|NCT03136367|464140894|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
128960740|NCT03136367|464140895|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
129036770|NCT00988208|464425086|FG000|Overall Study|Death|9|||
128960741|NCT03136367|464140896|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
128960742|NCT03136367|464140894|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
128960743|NCT03136367|464140895|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
128960744|NCT03136367|464140896|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
128960745|NCT03136367|464140894|FG000|T2 Post-consultation|Discontinued other|0|||
128960746|NCT03136367|464140895|FG001|T2 Post-consultation|Discontinued other|2|||
128960747|NCT03136367|464140896|FG002|T2 Post-consultation|Discontinued other|6|||
128960748|NCT03136367|464140894|FG000|T2 Post-consultation|Discontinued transferred care|0|||
128960749|NCT03136367|464140895|FG001|T2 Post-consultation|Discontinued transferred care|0|||
128960750|NCT03136367|464140896|FG002|T2 Post-consultation|Discontinued transferred care|3|||
128960751|NCT03136367|464140894|FG000|T2 Post-consultation|Discontinued lost contact|0|||
128960752|NCT03136367|464140895|FG001|T2 Post-consultation|Discontinued lost contact|1|||
128960753|NCT03136367|464140896|FG002|T2 Post-consultation|Discontinued lost contact|0|||
128960754|NCT03136367|464140894|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
128960755|NCT03136367|464140895|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
128960756|NCT03136367|464140896|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
128960757|NCT03136367|464140894|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
128960758|NCT03136367|464140895|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
128960759|NCT03136367|464140896|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
128960760|NCT03136367|464140894|FG000|T3 1 Week After Surgery|other discontinued|2|||
128960761|NCT03136367|464140895|FG001|T3 1 Week After Surgery|other discontinued|4|||
128960762|NCT03136367|464140896|FG002|T3 1 Week After Surgery|other discontinued|3|||
128960763|NCT03136367|464140894|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
128960764|NCT03136367|464140895|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
128960765|NCT03136367|464140896|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
128960766|NCT03136367|464140894|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
128960767|NCT03136367|464140895|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
128960768|NCT03136367|464140896|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
128960769|NCT03136367|464140894|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
128960770|NCT03136367|464140895|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
128960771|NCT03136367|464140896|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
128960772|NCT03136367|464140894|FG000|T4 12 Weeks After Surgery|Death|0|||
128960773|NCT03136367|464140895|FG001|T4 12 Weeks After Surgery|Death|1|||
128960774|NCT03136367|464140896|FG002|T4 12 Weeks After Surgery|Death|3|||
128960775|NCT03136367|464140894|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
128960776|NCT03136367|464140895|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
128960777|NCT03136367|464140896|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
128960778|NCT03136367|464140894|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
128960779|NCT03136367|464140895|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
128960780|NCT03136367|464140896|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
128960781|NCT03136367|464140894|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
128960782|NCT03136367|464140895|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
128960783|NCT03136367|464140896|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
128960784|NCT03136367|464140894|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
128960785|NCT03136367|464140895|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
128960786|NCT03136367|464140896|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
128960787|NCT03136367|464140894|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
128960788|NCT03136367|464140895|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
128960789|NCT03136367|464140896|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
128960790|NCT03136367|464140894|FG000|T5 1 Year After Surgery|Death|0|||
128960791|NCT03136367|464140895|FG001|T5 1 Year After Surgery|Death|0|||
128960792|NCT03136367|464140896|FG002|T5 1 Year After Surgery|Death|1|||
128960793|NCT03136367|464140894|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
128960794|NCT03136367|464140895|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
128960795|NCT03136367|464140896|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
128960796|NCT03136367|464140894|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
128960797|NCT03136367|464140895|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
128960798|NCT03136367|464140896|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
128960799|NCT03136367|464140894|FG000|T5 1 Year After Surgery|study ended before due|31|||
128960800|NCT03136367|464140895|FG001|T5 1 Year After Surgery|study ended before due|103|||
128960801|NCT03136367|464140896|FG002|T5 1 Year After Surgery|study ended before due|110|||
128960802|NCT03136367|464140894|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
129036771|NCT00988208|464425087|FG001|Overall Study|Death|15|||
129036772|NCT00988208|464425086|FG000|Overall Study|Lost to Follow-up|2|||
129036773|NCT00988208|464425087|FG001|Overall Study|Lost to Follow-up|3|||
129036774|NCT00988208|464425086|FG000|Overall Study|Protocol Violation|9|||
129036775|NCT00988208|464425087|FG001|Overall Study|Protocol Violation|2|||
129036776|NCT00988208|464425086|FG000|Overall Study|Sponsor Decision|102|||
129036777|NCT00988208|464425087|FG001|Overall Study|Sponsor Decision|78|||
129036778|NCT00988208|464425086|FG000|Overall Study|Clinical Progression|17|||
129036779|NCT00988208|464425087|FG001|Overall Study|Clinical Progression|16|||
129036780|NCT00988208|464425086|FG000|Overall Study|Biochemical Progression|21|||
129036781|NCT00988208|464425087|FG001|Overall Study|Biochemical Progression|7|||
129036782|NCT00988208|464425086|FG000|Overall Study|Clinical Deterioration|7|||
129036783|NCT00988208|464425087|FG001|Overall Study|Clinical Deterioration|14|||
129036784|NCT00988208|464425086|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
129036785|NCT00988208|464425087|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
129036786|NCT00988208|464425086|FG000|Overall Study|Other|8|||
129127436|NCT02685735|464759320|FG001|Overall Study|Surgery Cancelled|9|||
129127437|NCT02685735|464759319|FG000|Overall Study|Adverse Event|10|||
128960803|NCT03136367|464140895|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
128960804|NCT03136367|464140896|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
128960805|NCT00676208|464140897|FG000|Overall Study|Lost to Follow-up|0|||
128960806|NCT00676208|464140898|FG001|Overall Study|Lost to Follow-up|2|||
128960807|NCT00676208|464140897|FG000|Overall Study|Incomplete data|2|||
128960808|NCT00676208|464140898|FG001|Overall Study|Incomplete data|4|||
128960809|NCT03726333|464140899|FG000|Overall Study|Progressive Disease|0|||
128960810|NCT03726333|464140900|FG001|Overall Study|Progressive Disease|0|||
128960811|NCT03726333|464140901|FG002|Overall Study|Progressive Disease|1|||
128960812|NCT03726333|464140902|FG003|Overall Study|Progressive Disease|0|||
128960813|NCT03726333|464140903|FG004|Overall Study|Progressive Disease|0|||
128960814|NCT03907969|464142536|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
128960815|NCT03907969|464142537|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
128960816|NCT03907969|464142538|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
128960817|NCT03907969|464142539|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
128960818|NCT03907969|464142540|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
128960819|NCT03907969|464142541|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
128960820|NCT03907969|464142542|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
128960821|NCT03907969|464142543|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
128960822|NCT03907969|464142544|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
128960823|NCT03907969|464142545|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
128960824|NCT03907969|464142546|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
128960825|NCT03907969|464142536|FG000|Monotherapy Part A|Progressive Disease|0|||
128960826|NCT03907969|464142537|FG001|Monotherapy Part A|Progressive Disease|1|||
128960827|NCT03907969|464142538|FG002|Monotherapy Part A|Progressive Disease|0|||
128960828|NCT03907969|464142539|FG003|Monotherapy Part A|Progressive Disease|0|||
128960829|NCT03907969|464142540|FG004|Monotherapy Part A|Progressive Disease|0|||
128960830|NCT03907969|464142541|FG005|Monotherapy Part A|Progressive Disease|1|||
128960831|NCT03907969|464142542|FG006|Monotherapy Part A|Progressive Disease|2|||
128960832|NCT03907969|464142543|FG007|Monotherapy Part A|Progressive Disease|0|||
128960833|NCT03907969|464142544|FG008|Monotherapy Part A|Progressive Disease|0|||
128960834|NCT03907969|464142545|FG009|Monotherapy Part A|Progressive Disease|0|||
128960835|NCT03907969|464142546|FG010|Monotherapy Part A|Progressive Disease|0|||
128960836|NCT03907969|464142536|FG000|Monotherapy Part A|Death|0|||
128960837|NCT03907969|464142537|FG001|Monotherapy Part A|Death|0|||
128960838|NCT03907969|464142538|FG002|Monotherapy Part A|Death|1|||
128960839|NCT03907969|464142539|FG003|Monotherapy Part A|Death|1|||
128960840|NCT03907969|464142540|FG004|Monotherapy Part A|Death|0|||
128960841|NCT03907969|464142541|FG005|Monotherapy Part A|Death|1|||
128960842|NCT03907969|464142542|FG006|Monotherapy Part A|Death|0|||
128960843|NCT03907969|464142543|FG007|Monotherapy Part A|Death|0|||
128960844|NCT03907969|464142544|FG008|Monotherapy Part A|Death|0|||
128960845|NCT03907969|464142545|FG009|Monotherapy Part A|Death|0|||
128960846|NCT03907969|464142546|FG010|Monotherapy Part A|Death|0|||
128960847|NCT03907969|464142536|FG000|Combination Therapy Part A|Adverse Event|0|||
128960848|NCT03907969|464142537|FG001|Combination Therapy Part A|Adverse Event|0|||
128960849|NCT03907969|464142538|FG002|Combination Therapy Part A|Adverse Event|0|||
129036787|NCT00988208|464425087|FG001|Overall Study|Other|3|||
129036788|NCT03235479|464425094|FG000|Overall Study|Lost to Follow-up|8|||
129036789|NCT03235479|464425095|FG001|Overall Study|Lost to Follow-up|11|||
129036790|NCT03235479|464425094|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
129036791|NCT03235479|464425095|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
129036792|NCT03235479|464425094|FG000|Overall Study|Pregnancy|1|||
129036793|NCT03235479|464425095|FG001|Overall Study|Pregnancy|0|||
129036794|NCT03235479|464425094|FG000|Overall Study|Protocol Deviation|1|||
129036795|NCT03235479|464425095|FG001|Overall Study|Protocol Deviation|3|||
129127438|NCT02685735|464759320|FG001|Overall Study|Adverse Event|3|||
129127439|NCT02685735|464759319|FG000|Overall Study|Preop testing found to be incomplete|2|||
129127440|NCT02685735|464759320|FG001|Overall Study|Preop testing found to be incomplete|2|||
129127441|NCT02685735|464759319|FG000|Overall Study|Withdrawal by Subject|1|||
129127442|NCT02685735|464759320|FG001|Overall Study|Withdrawal by Subject|2|||
129127443|NCT02685735|464759319|FG000|Overall Study|Death|1|||
129127444|NCT02685735|464759320|FG001|Overall Study|Death|0|||
129127445|NCT00927472|464759330|FG000|Overall Study|Withdrawal by Subject|10|||
129127446|NCT00927472|464759331|FG001|Overall Study|Withdrawal by Subject|11|||
129127447|NCT00927472|464759330|FG000|Overall Study|Lost to Follow-up|1|||
129127448|NCT00927472|464759331|FG001|Overall Study|Lost to Follow-up|6|||
129127449|NCT00927472|464759330|FG000|Overall Study|Protocol Violation|0|||
129127450|NCT00927472|464759331|FG001|Overall Study|Protocol Violation|1|||
129127451|NCT00927472|464759330|FG000|Overall Study|Post treatment Assessment out of window|0|||
129127452|NCT00927472|464759331|FG001|Overall Study|Post treatment Assessment out of window|4|||
129127453|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
128960850|NCT03907969|464142539|FG003|Combination Therapy Part A|Adverse Event|0|||
129036796|NCT03235479|464425094|FG000|Overall Study|Technical Problems|3|||
129036797|NCT03235479|464425095|FG001|Overall Study|Technical Problems|2|||
129127454|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
129127455|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
129127456|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
128713078|NCT00818662|463246020|FG002|Overall Study|Unwilling or Unable to Participate|2|||
128960851|NCT03907969|464142540|FG004|Combination Therapy Part A|Adverse Event|0|||
128960852|NCT03907969|464142541|FG005|Combination Therapy Part A|Adverse Event|0|||
128960853|NCT03907969|464142542|FG006|Combination Therapy Part A|Adverse Event|0|||
128960854|NCT03907969|464142543|FG007|Combination Therapy Part A|Adverse Event|0|||
128960855|NCT03907969|464142544|FG008|Combination Therapy Part A|Adverse Event|0|||
128960856|NCT03907969|464142545|FG009|Combination Therapy Part A|Adverse Event|1|||
128960857|NCT03907969|464142546|FG010|Combination Therapy Part A|Adverse Event|1|||
128960858|NCT03907969|464142536|FG000|Combination Therapy Part A|Progressive disease|0|||
128960859|NCT03907969|464142537|FG001|Combination Therapy Part A|Progressive disease|0|||
128960860|NCT03907969|464142538|FG002|Combination Therapy Part A|Progressive disease|0|||
128960861|NCT03907969|464142539|FG003|Combination Therapy Part A|Progressive disease|0|||
128960862|NCT03907969|464142540|FG004|Combination Therapy Part A|Progressive disease|0|||
128960863|NCT03907969|464142541|FG005|Combination Therapy Part A|Progressive disease|0|||
128960864|NCT03907969|464142542|FG006|Combination Therapy Part A|Progressive disease|0|||
128960865|NCT03907969|464142543|FG007|Combination Therapy Part A|Progressive disease|1|||
128960866|NCT03907969|464142544|FG008|Combination Therapy Part A|Progressive disease|0|||
128960867|NCT03907969|464142545|FG009|Combination Therapy Part A|Progressive disease|2|||
128960868|NCT03907969|464142546|FG010|Combination Therapy Part A|Progressive disease|3|||
128960869|NCT03907969|464142536|FG000|Combination Therapy Part A|Death|0|||
128960870|NCT03907969|464142537|FG001|Combination Therapy Part A|Death|0|||
128960871|NCT03907969|464142538|FG002|Combination Therapy Part A|Death|0|||
128960872|NCT03907969|464142539|FG003|Combination Therapy Part A|Death|0|||
128960873|NCT03907969|464142540|FG004|Combination Therapy Part A|Death|0|||
128960874|NCT03907969|464142541|FG005|Combination Therapy Part A|Death|0|||
128960875|NCT03907969|464142542|FG006|Combination Therapy Part A|Death|0|||
128960876|NCT03907969|464142543|FG007|Combination Therapy Part A|Death|0|||
128960877|NCT03907969|464142544|FG008|Combination Therapy Part A|Death|1|||
128960878|NCT03907969|464142545|FG009|Combination Therapy Part A|Death|0|||
128960879|NCT03907969|464142546|FG010|Combination Therapy Part A|Death|1|||
128960880|NCT03907969|464142536|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
128960881|NCT03907969|464142537|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
128960882|NCT03907969|464142538|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
128960883|NCT03907969|464142539|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
128960884|NCT03907969|464142540|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
128960885|NCT03907969|464142541|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
128960886|NCT03907969|464142542|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
128960887|NCT03907969|464142543|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
128960888|NCT03907969|464142544|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
128960889|NCT03907969|464142545|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
128960890|NCT03907969|464142546|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
128960891|NCT03907969|464142536|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
128960892|NCT03907969|464142537|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
128960893|NCT03907969|464142538|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
128960894|NCT03907969|464142539|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
128960895|NCT03907969|464142540|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
128960896|NCT03907969|464142541|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
128960897|NCT03907969|464142542|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
128960898|NCT03907969|464142543|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
128960899|NCT03907969|464142544|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
128960900|NCT03907969|464142545|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
128960901|NCT03907969|464142546|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
128960902|NCT03907969|464142536|FG000|Combination Therapy Part A|Physician Decision|0|||
128960903|NCT03907969|464142537|FG001|Combination Therapy Part A|Physician Decision|0|||
128960904|NCT03907969|464142538|FG002|Combination Therapy Part A|Physician Decision|0|||
128960905|NCT03907969|464142539|FG003|Combination Therapy Part A|Physician Decision|0|||
128960906|NCT03907969|464142540|FG004|Combination Therapy Part A|Physician Decision|0|||
128960907|NCT03907969|464142541|FG005|Combination Therapy Part A|Physician Decision|0|||
128960908|NCT03907969|464142542|FG006|Combination Therapy Part A|Physician Decision|0|||
128713079|NCT00818662|463246021|FG003|Overall Study|Unwilling or Unable to Participate|4|||
128960909|NCT03907969|464142543|FG007|Combination Therapy Part A|Physician Decision|1|||
128960910|NCT03907969|464142544|FG008|Combination Therapy Part A|Physician Decision|0|||
128960911|NCT03907969|464142545|FG009|Combination Therapy Part A|Physician Decision|0|||
128960912|NCT03907969|464142546|FG010|Combination Therapy Part A|Physician Decision|1|||
129127457|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
128960913|NCT00608881|464142548|FG000|Overall Study|Death|22|||
129127458|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
128713080|NCT00818662|463246018|FG000|Overall Study|Protocol Violation|1|||
128713081|NCT00818662|463246019|FG001|Overall Study|Protocol Violation|1|||
129036798|NCT03235479|464425094|FG000|Overall Study|Withdrawal by Subject|2|||
129036799|NCT03235479|464425095|FG001|Overall Study|Withdrawal by Subject|2|||
129036800|NCT03235479|464425094|FG000|Overall Study|Other Reasons|3|||
129036801|NCT03235479|464425095|FG001|Overall Study|Other Reasons|5|||
129036802|NCT01546519|464425099|FG000|Overall Study|Adverse Event|0|||
129036803|NCT01546519|464425100|FG001|Overall Study|Adverse Event|0|||
129036804|NCT01546519|464425101|FG002|Overall Study|Adverse Event|1|||
129036805|NCT01546519|464425102|FG003|Overall Study|Adverse Event|1|||
129036806|NCT01546519|464425099|FG000|Overall Study|Death|0|||
129036807|NCT01546519|464425100|FG001|Overall Study|Death|1|||
129036808|NCT01546519|464425101|FG002|Overall Study|Death|3|||
129036809|NCT01546519|464425102|FG003|Overall Study|Death|1|||
129036810|NCT01546519|464425099|FG000|Overall Study|related to disease progression|2|||
129036811|NCT01546519|464425100|FG001|Overall Study|related to disease progression|2|||
129036812|NCT01546519|464425101|FG002|Overall Study|related to disease progression|2|||
129036813|NCT01546519|464425102|FG003|Overall Study|related to disease progression|1|||
129036814|NCT01546519|464425099|FG000|Overall Study|Physician Decision|6|||
129036815|NCT01546519|464425100|FG001|Overall Study|Physician Decision|5|||
129036816|NCT01546519|464425101|FG002|Overall Study|Physician Decision|2|||
129036817|NCT01546519|464425102|FG003|Overall Study|Physician Decision|3|||
129036818|NCT01546519|464425099|FG000|Overall Study|Withdrawal by Subject|1|||
129036819|NCT01546519|464425100|FG001|Overall Study|Withdrawal by Subject|0|||
129036820|NCT01546519|464425101|FG002|Overall Study|Withdrawal by Subject|0|||
129036821|NCT01546519|464425102|FG003|Overall Study|Withdrawal by Subject|0|||
129036822|NCT01315028|464425103|FG000|Overall Study|Lost to Follow-up|1|||
128713082|NCT00818662|463246020|FG002|Overall Study|Protocol Violation|0|||
128713083|NCT00818662|463246021|FG003|Overall Study|Protocol Violation|0|||
129036823|NCT01315028|464425104|FG001|Overall Study|Lost to Follow-up|0|||
129036824|NCT01315028|464425103|FG000|Overall Study|Death|0|||
129036825|NCT01315028|464425104|FG001|Overall Study|Death|1|||
129036826|NCT02531594|464425105|FG000|Overall Study|Withdrawal by Subject|7|||
129036827|NCT02531594|464425106|FG001|Overall Study|Withdrawal by Subject|8|||
129036828|NCT00725764|464425109|FG000|Overall Study|Withdrawal by Subject|2|||
129036829|NCT00725764|464425109|FG000|Overall Study|Physician Decision|1|||
129036830|NCT00725764|464425109|FG000|Overall Study|Progressive Disease|7|||
129036831|NCT00725764|464425109|FG000|Overall Study|Lost to Follow-up|1|||
129036832|NCT00725764|464425109|FG000|Overall Study|Death|1|||
129036833|NCT00725764|464425109|FG000|Overall Study|Participant non compliant with protocol|1|||
129036834|NCT00725764|464425109|FG000|Overall Study|Decline in performance status|1|||
129036835|NCT01203917|464425112|FG000|Overall Study|Death|29|||
129036836|NCT01203917|464425112|FG000|Overall Study|Lost to Follow-up|2|||
129036837|NCT01203917|464425112|FG000|Overall Study|Withdrawal by Subject|3|||
129036838|NCT01203917|464425112|FG000|Overall Study|Due to objective disease progression|1|||
129036839|NCT01203917|464425112|FG000|Overall Study|Due to EGFR M+I patient|1|||
129036840|NCT01264835|464425113|FG000|Overall Study|Lost to Follow-up|1|||
129036841|NCT04660032|464425121|FG000|Overall Study|Protocol Violation|1|||
129036842|NCT04660032|464425122|FG001|Overall Study|Protocol Violation|1|||
129036843|NCT00090753|464425123|FG000|First Treatment Period|Adverse Event|20|||
129036844|NCT00090753|464425124|FG001|First Treatment Period|Adverse Event|8|||
129036845|NCT00090753|464425123|FG000|First Treatment Period|Death|88|||
129036846|NCT00090753|464425124|FG001|First Treatment Period|Death|62|||
129036847|NCT00090753|464425123|FG000|First Treatment Period|Lack of Efficacy|2|||
129036848|NCT00090753|464425124|FG001|First Treatment Period|Lack of Efficacy|1|||
129036849|NCT00090753|464425123|FG000|First Treatment Period|Refused Treatment|32|||
129036850|NCT00090753|464425124|FG001|First Treatment Period|Refused Treatment|25|||
129036851|NCT00090753|464425123|FG000|First Treatment Period|Lost to Follow-up|4|||
129036852|NCT00090753|464425124|FG001|First Treatment Period|Lost to Follow-up|4|||
129036853|NCT00090753|464425123|FG000|First Treatment Period|Renal Transplant|70|||
129036854|NCT00090753|464425124|FG001|First Treatment Period|Renal Transplant|50|||
129036855|NCT00090753|464425123|FG000|First Treatment Period|Mircera Commercialization|1|||
129036856|NCT00090753|464425124|FG001|First Treatment Period|Mircera Commercialization|0|||
129036857|NCT00090753|464425123|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
129036858|NCT00090753|464425124|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
129036859|NCT00090753|464425123|FG000|Extended Treatment Period|Adverse Event|11|||
129036860|NCT00090753|464425124|FG001|Extended Treatment Period|Adverse Event|0|||
129036861|NCT00090753|464425123|FG000|Extended Treatment Period|Death|58|||
129036862|NCT00090753|464425124|FG001|Extended Treatment Period|Death|30|||
129036863|NCT00090753|464425123|FG000|Extended Treatment Period|Lack of Efficacy|1|||
129036864|NCT00090753|464425124|FG001|Extended Treatment Period|Lack of Efficacy|0|||
129036865|NCT00090753|464425123|FG000|Extended Treatment Period|Refused Treatment|18|||
129036866|NCT00090753|464425124|FG001|Extended Treatment Period|Refused Treatment|12|||
129036867|NCT00090753|464425123|FG000|Extended Treatment Period|Lost to Follow-up|3|||
129036868|NCT00090753|464425124|FG001|Extended Treatment Period|Lost to Follow-up|1|||
129036869|NCT00090753|464425123|FG000|Extended Treatment Period|Renal Transplant|15|||
128960914|NCT00608881|464142549|FG001|Overall Study|Death|13|||
128960915|NCT00608881|464142548|FG000|Overall Study|Adverse Event|5|||
128960916|NCT00608881|464142549|FG001|Overall Study|Adverse Event|3|||
128960917|NCT00608881|464142548|FG000|Overall Study|Lost to Follow-up|28|||
128960918|NCT00608881|464142549|FG001|Overall Study|Lost to Follow-up|14|||
128960919|NCT00608881|464142548|FG000|Overall Study|Withdrawal by Subject|18|||
128960920|NCT00608881|464142549|FG001|Overall Study|Withdrawal by Subject|29|||
128960921|NCT00608881|464142548|FG000|Overall Study|Physician Decision|5|||
128713084|NCT00818662|463246018|FG000|Overall Study|Requires a Prohibited Medication|1|||
128713085|NCT00818662|463246019|FG001|Overall Study|Requires a Prohibited Medication|0|||
128713086|NCT00818662|463246020|FG002|Overall Study|Requires a Prohibited Medication|0|||
128713087|NCT00818662|463246021|FG003|Overall Study|Requires a Prohibited Medication|0|||
128960922|NCT00608881|464142549|FG001|Overall Study|Physician Decision|5|||
128960923|NCT00608881|464142548|FG000|Overall Study|Institutionalized|1|||
128960924|NCT00608881|464142549|FG001|Overall Study|Institutionalized|2|||
128960925|NCT00511108|464142551|FG000|Overall Study|Adverse Event|2|||
128960926|NCT00511108|464142552|FG001|Overall Study|Adverse Event|0|||
128960927|NCT00511108|464142553|FG002|Overall Study|Adverse Event|1|||
128960928|NCT00511108|464142554|FG003|Overall Study|Adverse Event|2|||
128960929|NCT00511108|464142551|FG000|Overall Study|Lost to Follow-up|0|||
128960930|NCT00511108|464142552|FG001|Overall Study|Lost to Follow-up|2|||
128713088|NCT00818662|463246018|FG000|Overall Study|Safety Risk|1|||
128713089|NCT00818662|463246019|FG001|Overall Study|Safety Risk|1|||
128713090|NCT00818662|463246020|FG002|Overall Study|Safety Risk|0|||
128713091|NCT00818662|463246021|FG003|Overall Study|Safety Risk|1|||
128960931|NCT00511108|464142553|FG002|Overall Study|Lost to Follow-up|1|||
128960932|NCT00511108|464142554|FG003|Overall Study|Lost to Follow-up|0|||
128960933|NCT00511108|464142551|FG000|Overall Study|Physician Decision|0|||
128960934|NCT00511108|464142552|FG001|Overall Study|Physician Decision|0|||
128960935|NCT00511108|464142553|FG002|Overall Study|Physician Decision|0|||
128960936|NCT00511108|464142554|FG003|Overall Study|Physician Decision|1|||
128960937|NCT00511108|464142551|FG000|Overall Study|Withdrawal by Subject|4|||
128960938|NCT00511108|464142552|FG001|Overall Study|Withdrawal by Subject|0|||
128960939|NCT00511108|464142553|FG002|Overall Study|Withdrawal by Subject|3|||
128960940|NCT00511108|464142554|FG003|Overall Study|Withdrawal by Subject|2|||
128960941|NCT02954952|464142557|FG000|Overall Study|Withdrawal by Subject|1|||
128960942|NCT02954952|464142558|FG001|Overall Study|Withdrawal by Subject|0|||
128960943|NCT02954952|464142559|FG002|Overall Study|Withdrawal by Subject|0|||
128960944|NCT02954952|464142557|FG000|Overall Study|No data collected|0|||
128960945|NCT02954952|464142558|FG001|Overall Study|No data collected|1|||
128960946|NCT02954952|464142559|FG002|Overall Study|No data collected|0|||
128960947|NCT04179032|464142562|FG000|Part B (Up to Week 52)|Adverse Event|1|||
128960948|NCT04179032|464142562|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
128960949|NCT04179032|464142562|FG000|Access Extension Phase|Ongoing|11|||
128960950|NCT00724815|464142563|FG000|Overall Study|Randomized, not treated|31|||
128960951|NCT00724815|464142564|FG001|Overall Study|Randomized, not treated|30|||
128960952|NCT00724815|464142563|FG000|Overall Study|Adverse Event|5|||
128960953|NCT00724815|464142564|FG001|Overall Study|Adverse Event|3|||
128960954|NCT00724815|464142563|FG000|Overall Study|Lost to Follow-up|4|||
128960955|NCT00724815|464142564|FG001|Overall Study|Lost to Follow-up|1|||
128960956|NCT00724815|464142563|FG000|Overall Study|Other Various|3|||
128960957|NCT00724815|464142564|FG001|Overall Study|Other Various|5|||
128960958|NCT00810043|464142565|FG000|Overall Study|Withdrawal by Subject|1|||
128960959|NCT00810043|464142566|FG001|Overall Study|Withdrawal by Subject|0|||
128960960|NCT00810043|464142567|FG002|Overall Study|Withdrawal by Subject|2|||
128960961|NCT00810043|464142565|FG000|Overall Study|Lost to Follow-up|1|||
128960962|NCT00810043|464142566|FG001|Overall Study|Lost to Follow-up|0|||
128960963|NCT00810043|464142567|FG002|Overall Study|Lost to Follow-up|0|||
128960964|NCT00810043|464142565|FG000|Overall Study|Physician Decision|0|||
128960965|NCT00810043|464142566|FG001|Overall Study|Physician Decision|0|||
128960966|NCT00810043|464142567|FG002|Overall Study|Physician Decision|2|||
128960967|NCT00810043|464142565|FG000|Overall Study|Death|2|||
128960968|NCT00810043|464142566|FG001|Overall Study|Death|0|||
128960969|NCT00810043|464142567|FG002|Overall Study|Death|0|||
128713092|NCT00818662|463246018|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
128960970|NCT00810043|464142565|FG000|Overall Study|Unrelated medical problem|0|||
128960971|NCT00810043|464142566|FG001|Overall Study|Unrelated medical problem|1|||
128960972|NCT00810043|464142567|FG002|Overall Study|Unrelated medical problem|0|||
128960973|NCT00810043|464142565|FG000|Overall Study|Non-medical problem|0|||
128960974|NCT00810043|464142566|FG001|Overall Study|Non-medical problem|0|||
128960975|NCT00810043|464142567|FG002|Overall Study|Non-medical problem|1|||
128960976|NCT00810043|464142565|FG000|Overall Study|No longer met enrollment criteria|0|||
128960977|NCT00810043|464142566|FG001|Overall Study|No longer met enrollment criteria|0|||
128960978|NCT00810043|464142567|FG002|Overall Study|No longer met enrollment criteria|3|||
128960979|NCT00445341|464142568|FG000|Overall Study|refused further treatment|1|||
128960980|NCT00445341|464142568|FG000|Overall Study|taken off treatment too early|1|||
128960981|NCT01359046|464142569|FG000|Overall Study|Did not receive allocated intervention|6|||
128960982|NCT01359046|464142570|FG001|Overall Study|Did not receive allocated intervention|6|||
128713093|NCT00818662|463246019|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
128713094|NCT00818662|463246020|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
128713095|NCT00818662|463246021|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
128713096|NCT00818662|463246018|FG000|Overall Study|Participant's health declined|0|||
128713097|NCT00818662|463246019|FG001|Overall Study|Participant's health declined|0|||
128713098|NCT00818662|463246020|FG002|Overall Study|Participant's health declined|0|||
128713099|NCT00818662|463246021|FG003|Overall Study|Participant's health declined|1|||
128713100|NCT00818662|463246018|FG000|Overall Study|Caregiver to pursue other treatment|0|||
128713101|NCT00818662|463246019|FG001|Overall Study|Caregiver to pursue other treatment|1|||
128713102|NCT00818662|463246020|FG002|Overall Study|Caregiver to pursue other treatment|0|||
128713103|NCT00818662|463246021|FG003|Overall Study|Caregiver to pursue other treatment|0|||
128713104|NCT00818662|463246018|FG000|Overall Study|Moving out of state|0|||
128713105|NCT00818662|463246019|FG001|Overall Study|Moving out of state|0|||
128713106|NCT00818662|463246020|FG002|Overall Study|Moving out of state|0|||
128713107|NCT00818662|463246021|FG003|Overall Study|Moving out of state|1|||
128713108|NCT00818662|463246018|FG000|Overall Study|Declined move to another study site|1|||
128713109|NCT00818662|463246019|FG001|Overall Study|Declined move to another study site|0|||
128960983|NCT01359046|464142569|FG000|Overall Study|Physician Decision|1|||
128960984|NCT01359046|464142570|FG001|Overall Study|Physician Decision|11|||
128960985|NCT04539262|464142574|FG000|Overall Study|Adverse Event|0|||
128960986|NCT04539262|464142575|FG001|Overall Study|Adverse Event|0|||
128960987|NCT04539262|464142576|FG002|Overall Study|Adverse Event|1|||
128960988|NCT04539262|464142577|FG003|Overall Study|Adverse Event|0|||
128960989|NCT04539262|464142578|FG004|Overall Study|Adverse Event|0|||
128960990|NCT04539262|464142579|FG005|Overall Study|Adverse Event|0|||
128960991|NCT04539262|464142580|FG006|Overall Study|Adverse Event|0|||
128960992|NCT04539262|464142581|FG007|Overall Study|Adverse Event|0|||
128960993|NCT04539262|464142574|FG000|Overall Study|Withdrew Consent|0|||
128960994|NCT04539262|464142575|FG001|Overall Study|Withdrew Consent|0|||
128960995|NCT04539262|464142576|FG002|Overall Study|Withdrew Consent|0|||
128960996|NCT04539262|464142577|FG003|Overall Study|Withdrew Consent|1|||
128960997|NCT04539262|464142578|FG004|Overall Study|Withdrew Consent|0|||
128960998|NCT04539262|464142579|FG005|Overall Study|Withdrew Consent|0|||
128960999|NCT04539262|464142580|FG006|Overall Study|Withdrew Consent|0|||
128961000|NCT04539262|464142581|FG007|Overall Study|Withdrew Consent|0|||
128961001|NCT04539262|464142574|FG000|Overall Study|Randomized, Not treated|0|||
128961002|NCT04539262|464142575|FG001|Overall Study|Randomized, Not treated|1|||
128961003|NCT04539262|464142576|FG002|Overall Study|Randomized, Not treated|0|||
128961004|NCT04539262|464142577|FG003|Overall Study|Randomized, Not treated|0|||
128961005|NCT04539262|464142578|FG004|Overall Study|Randomized, Not treated|0|||
128961006|NCT04539262|464142579|FG005|Overall Study|Randomized, Not treated|0|||
128961007|NCT04539262|464142580|FG006|Overall Study|Randomized, Not treated|1|||
128961008|NCT04539262|464142581|FG007|Overall Study|Randomized, Not treated|0|||
128961009|NCT01061567|464142588|FG000|Overall Study|Adverse Event|32|||
128961010|NCT01061567|464142588|FG000|Overall Study|Death|2|||
128961011|NCT01061567|464142588|FG000|Overall Study|Lack of Efficacy|3|||
128961012|NCT01061567|464142588|FG000|Overall Study|Lost to Follow-up|24|||
128961013|NCT01061567|464142588|FG000|Overall Study|Protocol Violation|1|||
128961014|NCT01061567|464142588|FG000|Overall Study|Withdrawal by Subject|11|||
128961015|NCT01061567|464142588|FG000|Overall Study|Other reason than stated above|3|||
128961016|NCT01831804|464142589|FG000|Overall Study|Adverse Event|0|||
128961017|NCT01831804|464142590|FG001|Overall Study|Adverse Event|0|||
128961018|NCT01831804|464142591|FG002|Overall Study|Adverse Event|0|||
128961019|NCT01831804|464142592|FG003|Overall Study|Adverse Event|0|||
128961020|NCT01831804|464142593|FG004|Overall Study|Adverse Event|0|||
128961021|NCT01831804|464142594|FG005|Overall Study|Adverse Event|0|||
128961022|NCT01831804|464142595|FG006|Overall Study|Adverse Event|1|||
128961023|NCT01831804|464142596|FG007|Overall Study|Adverse Event|0|||
128961024|NCT01831804|464142597|FG008|Overall Study|Adverse Event|1|||
128961025|NCT01831804|464142589|FG000|Overall Study|Protocol Violation|0|||
128961026|NCT01831804|464142590|FG001|Overall Study|Protocol Violation|0|||
128961027|NCT01831804|464142591|FG002|Overall Study|Protocol Violation|2|||
128713110|NCT00818662|463246020|FG002|Overall Study|Declined move to another study site|0|||
128961028|NCT01831804|464142592|FG003|Overall Study|Protocol Violation|0|||
128961029|NCT01831804|464142593|FG004|Overall Study|Protocol Violation|0|||
128961030|NCT01831804|464142594|FG005|Overall Study|Protocol Violation|0|||
128961031|NCT01831804|464142595|FG006|Overall Study|Protocol Violation|0|||
128961032|NCT01831804|464142596|FG007|Overall Study|Protocol Violation|0|||
128713111|NCT00818662|463246021|FG003|Overall Study|Declined move to another study site|0|||
128961033|NCT01831804|464142597|FG008|Overall Study|Protocol Violation|0|||
128961034|NCT01831804|464142589|FG000|Overall Study|Protocol defined stopping criteria|1|||
128961035|NCT01831804|464142590|FG001|Overall Study|Protocol defined stopping criteria|1|||
128961036|NCT01831804|464142591|FG002|Overall Study|Protocol defined stopping criteria|3|||
128961037|NCT01831804|464142592|FG003|Overall Study|Protocol defined stopping criteria|0|||
129036870|NCT00090753|464425124|FG001|Extended Treatment Period|Renal Transplant|12|||
128961038|NCT01831804|464142593|FG004|Overall Study|Protocol defined stopping criteria|1|||
128961039|NCT01831804|464142594|FG005|Overall Study|Protocol defined stopping criteria|0|||
128961040|NCT01831804|464142595|FG006|Overall Study|Protocol defined stopping criteria|0|||
128961041|NCT01831804|464142596|FG007|Overall Study|Protocol defined stopping criteria|0|||
128961042|NCT01831804|464142597|FG008|Overall Study|Protocol defined stopping criteria|0|||
128961043|NCT01831804|464142589|FG000|Overall Study|Lost to Follow-up|0|||
128961044|NCT01831804|464142590|FG001|Overall Study|Lost to Follow-up|0|||
128961045|NCT01831804|464142591|FG002|Overall Study|Lost to Follow-up|1|||
128961046|NCT01831804|464142592|FG003|Overall Study|Lost to Follow-up|0|||
128961047|NCT01831804|464142593|FG004|Overall Study|Lost to Follow-up|0|||
128961048|NCT01831804|464142594|FG005|Overall Study|Lost to Follow-up|0|||
128961049|NCT01831804|464142595|FG006|Overall Study|Lost to Follow-up|0|||
128961050|NCT01831804|464142596|FG007|Overall Study|Lost to Follow-up|0|||
128961051|NCT01831804|464142597|FG008|Overall Study|Lost to Follow-up|1|||
128961052|NCT01831804|464142589|FG000|Overall Study|Investigator discretion|0|||
128961053|NCT01831804|464142590|FG001|Overall Study|Investigator discretion|0|||
128713112|NCT00818662|463246018|FG000|Overall Study|Change in living situation|0|||
128713113|NCT00818662|463246019|FG001|Overall Study|Change in living situation|0|||
128961054|NCT01831804|464142591|FG002|Overall Study|Investigator discretion|0|||
128961055|NCT01831804|464142592|FG003|Overall Study|Investigator discretion|0|||
128961056|NCT01831804|464142593|FG004|Overall Study|Investigator discretion|1|||
128961057|NCT01831804|464142594|FG005|Overall Study|Investigator discretion|0|||
128961058|NCT01831804|464142595|FG006|Overall Study|Investigator discretion|0|||
128961059|NCT01831804|464142596|FG007|Overall Study|Investigator discretion|1|||
128961060|NCT01831804|464142597|FG008|Overall Study|Investigator discretion|0|||
128961061|NCT01831804|464142589|FG000|Overall Study|Withdrew Consent|0|||
128961062|NCT01831804|464142590|FG001|Overall Study|Withdrew Consent|1|||
128961063|NCT01831804|464142591|FG002|Overall Study|Withdrew Consent|0|||
128961064|NCT01831804|464142592|FG003|Overall Study|Withdrew Consent|0|||
128961065|NCT01831804|464142593|FG004|Overall Study|Withdrew Consent|0|||
128961066|NCT01831804|464142594|FG005|Overall Study|Withdrew Consent|0|||
128961067|NCT01831804|464142595|FG006|Overall Study|Withdrew Consent|0|||
128961068|NCT01831804|464142596|FG007|Overall Study|Withdrew Consent|2|||
128961069|NCT01831804|464142597|FG008|Overall Study|Withdrew Consent|0|||
128961070|NCT01156532|464142598|FG000|Overall Study|Family Reasons|1|||
128961071|NCT01156532|464142598|FG000|Overall Study|Lost to Follow-up|1|||
128961072|NCT00268463|464142599|FG000|Overall Study|study terminated due to low accrual|10|||
128961073|NCT00268463|464142600|FG001|Overall Study|study terminated due to low accrual|12|||
128961074|NCT02920450|464142601|FG000|Overall Study|Death|1|||
128961075|NCT02920450|464142602|FG001|Overall Study|Death|0|||
128961076|NCT02920450|464142603|FG002|Overall Study|Death|0|||
128961077|NCT02920450|464142604|FG003|Overall Study|Death|0|||
128961078|NCT02920450|464142601|FG000|Overall Study|Withdrawal by Subject|1|||
128961079|NCT02920450|464142602|FG001|Overall Study|Withdrawal by Subject|0|||
128713114|NCT00818662|463246020|FG002|Overall Study|Change in living situation|0|||
128713115|NCT00818662|463246021|FG003|Overall Study|Change in living situation|1|||
128713116|NCT00818662|463246018|FG000|Overall Study|Study partner decision|0|||
128713117|NCT00818662|463246019|FG001|Overall Study|Study partner decision|0|||
128713118|NCT00818662|463246020|FG002|Overall Study|Study partner decision|0|||
128713119|NCT00818662|463246021|FG003|Overall Study|Study partner decision|1|||
128713120|NCT00818662|463246018|FG000|Overall Study|Admitted to long term nursing care|0|||
128713121|NCT00818662|463246019|FG001|Overall Study|Admitted to long term nursing care|1|||
128713122|NCT00818662|463246020|FG002|Overall Study|Admitted to long term nursing care|0|||
128713123|NCT00818662|463246021|FG003|Overall Study|Admitted to long term nursing care|0|||
128713124|NCT01472081|463246022|FG000|Overall Study|Continuing treatment at time of analysis|1|||
128713125|NCT01472081|463246023|FG001|Overall Study|Continuing treatment at time of analysis|4|||
128713126|NCT01472081|463246024|FG002|Overall Study|Continuing treatment at time of analysis|1|||
128713127|NCT01472081|463246025|FG003|Overall Study|Continuing treatment at time of analysis|8|||
128961080|NCT02920450|464142603|FG002|Overall Study|Withdrawal by Subject|0|||
128961081|NCT02920450|464142604|FG003|Overall Study|Withdrawal by Subject|0|||
128961082|NCT02443805|464142609|FG000|Overall Study|Adverse Event|100|||
128961083|NCT02443805|464142610|FG001|Overall Study|Adverse Event|18|||
128961084|NCT02443805|464142609|FG000|Overall Study|Withdrawal by Subject|73|||
128961085|NCT02443805|464142610|FG001|Overall Study|Withdrawal by Subject|74|||
129036871|NCT00090753|464425123|FG000|Extended Treatment Period|Mircera Commercialization|188|||
128713128|NCT01472081|463246026|FG004|Overall Study|Continuing treatment at time of analysis|9|||
128771507|NCT04921969|463453719|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
128771508|NCT04921969|463453720|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
128961086|NCT02443805|464142609|FG000|Overall Study|Lost to Follow-up|19|||
128961087|NCT02443805|464142610|FG001|Overall Study|Lost to Follow-up|14|||
128961088|NCT02443805|464142609|FG000|Overall Study|Pregnancy|6|||
128961089|NCT02443805|464142610|FG001|Overall Study|Pregnancy|5|||
128961090|NCT02443805|464142609|FG000|Overall Study|Protocol Violation|2|||
128961091|NCT02443805|464142610|FG001|Overall Study|Protocol Violation|4|||
128961092|NCT02443805|464142609|FG000|Overall Study|Lack of Efficacy|1|||
128961093|NCT02443805|464142610|FG001|Overall Study|Lack of Efficacy|1|||
128961094|NCT02443805|464142609|FG000|Overall Study|Non-compliance with study drug|6|||
128961095|NCT02443805|464142610|FG001|Overall Study|Non-compliance with study drug|4|||
128961096|NCT02443805|464142609|FG000|Overall Study|Withdrawal by parent/guardian|3|||
128961097|NCT02443805|464142610|FG001|Overall Study|Withdrawal by parent/guardian|5|||
128961098|NCT02443805|464142609|FG000|Overall Study|Any other reason not above-mentioned|3|||
128961099|NCT02443805|464142610|FG001|Overall Study|Any other reason not above-mentioned|2|||
128961100|NCT04362813|464142611|FG000|Overall Study|Death|12|||
128961101|NCT04362813|464142612|FG001|Overall Study|Death|16|||
128961102|NCT04362813|464142611|FG000|Overall Study|Withdrawal by Subject|3|||
128961103|NCT04362813|464142612|FG001|Overall Study|Withdrawal by Subject|1|||
128961104|NCT04362813|464142611|FG000|Overall Study|Protocol Violation|0|||
128961105|NCT04362813|464142612|FG001|Overall Study|Protocol Violation|3|||
128961106|NCT04362813|464142611|FG000|Overall Study|Lost to Follow-up|1|||
128961107|NCT04362813|464142612|FG001|Overall Study|Lost to Follow-up|1|||
128961108|NCT04362813|464142611|FG000|Overall Study|Enrolled but did not receive treatment|2|||
128961109|NCT04362813|464142612|FG001|Overall Study|Enrolled but did not receive treatment|4|||
128961110|NCT00961116|464142613|FG000|Washout Period of 7 Days|Adverse Event|1|||
128961111|NCT00961116|464142614|FG001|Washout Period of 7 Days|Adverse Event|1|||
128961112|NCT00961116|464142613|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
128961113|NCT00961116|464142614|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
128961114|NCT00961116|464142613|FG000|Washout Period of 7 Days|Protocol Violation|0|||
128961115|NCT00961116|464142614|FG001|Washout Period of 7 Days|Protocol Violation|1|||
128961116|NCT01732107|464142615|FG000|Overall Study|Adverse Event|2|||
128961117|NCT01732107|464142615|FG000|Overall Study|Disease Progression|8|||
128961118|NCT01732107|464142615|FG000|Overall Study|Physician Decision|1|||
128961119|NCT01732107|464142615|FG000|Overall Study|Withdrawal by Subject|2|||
128961120|NCT00615459|464142616|FG000|Period I|Adverse Event|2|||
128961121|NCT00615459|464142617|FG001|Period I|Adverse Event|0|||
128961122|NCT00615459|464142618|FG002|Period I|Adverse Event|1|||
128961123|NCT00615459|464142619|FG003|Period I|Adverse Event|0|||
128961124|NCT00615459|464142616|FG000|Period I|Subject withdrew consent|1|||
128961125|NCT00615459|464142617|FG001|Period I|Subject withdrew consent|0|||
128961126|NCT00615459|464142618|FG002|Period I|Subject withdrew consent|0|||
128961127|NCT00615459|464142619|FG003|Period I|Subject withdrew consent|1|||
129036872|NCT00090753|464425124|FG001|Extended Treatment Period|Mircera Commercialization|93|||
129036873|NCT00090753|464425123|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
129036874|NCT00090753|464425124|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
129036875|NCT00605176|464425129|FG000|Overall Study|Adverse Event|2|||
129036876|NCT00605176|464425130|FG001|Overall Study|Adverse Event|1|||
129036877|NCT00605176|464425131|FG002|Overall Study|Adverse Event|3|||
129036878|NCT00605176|464425129|FG000|Overall Study|Withdrawal by Subject|4|||
129036879|NCT00605176|464425130|FG001|Overall Study|Withdrawal by Subject|2|||
129036880|NCT00605176|464425131|FG002|Overall Study|Withdrawal by Subject|4|||
129036881|NCT00605176|464425129|FG000|Overall Study|Lost to Follow-up|2|||
129036882|NCT00605176|464425130|FG001|Overall Study|Lost to Follow-up|2|||
129036883|NCT00605176|464425131|FG002|Overall Study|Lost to Follow-up|1|||
129036884|NCT00605176|464425129|FG000|Overall Study|Non-complicance with study procedures|1|||
129036885|NCT00605176|464425130|FG001|Overall Study|Non-complicance with study procedures|0|||
129036886|NCT00605176|464425131|FG002|Overall Study|Non-complicance with study procedures|0|||
129036887|NCT00605176|464425129|FG000|Overall Study|Use of concomitant therapy|1|||
129036888|NCT00605176|464425130|FG001|Overall Study|Use of concomitant therapy|0|||
129036889|NCT00605176|464425131|FG002|Overall Study|Use of concomitant therapy|1|||
129036890|NCT00605176|464425129|FG000|Overall Study|Other (not due to AE)|1|||
129036891|NCT00605176|464425130|FG001|Overall Study|Other (not due to AE)|1|||
129036892|NCT00605176|464425131|FG002|Overall Study|Other (not due to AE)|0|||
129036893|NCT01466036|464425144|FG000|Overall Study|Death|1|||
129036894|NCT01466036|464425145|FG001|Overall Study|Death|1|||
129036895|NCT01466036|464425144|FG000|Overall Study|Physician Decision|0|||
129036896|NCT01466036|464425145|FG001|Overall Study|Physician Decision|4|||
129036897|NCT01466036|464425144|FG000|Overall Study|Adverse Event|2|||
129036898|NCT01466036|464425145|FG001|Overall Study|Adverse Event|6|||
129036899|NCT01466036|464425144|FG000|Overall Study|Withdrawal by Subject|2|||
129036900|NCT01466036|464425145|FG001|Overall Study|Withdrawal by Subject|8|||
129036901|NCT01466036|464425144|FG000|Overall Study|progression/relapse|14|||
129036902|NCT01466036|464425145|FG001|Overall Study|progression/relapse|21|||
129036903|NCT01466036|464425144|FG000|Overall Study|prolonged treatment delay|1|||
129036904|NCT01466036|464425145|FG001|Overall Study|prolonged treatment delay|1|||
129036905|NCT00436917|464425152|FG000|Overall Study|Withdrawal by Subject|13|||
129127459|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
129127460|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
129127461|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
129127462|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
129127463|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
129127464|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
129127465|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
129127466|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
129127467|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
129127468|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
129127469|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
129127470|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
128713129|NCT01472081|463246027|FG005|Overall Study|Continuing treatment at time of analysis|0|||
128713130|NCT01472081|463246022|FG000|Overall Study|Disease Progression|4|||
128713131|NCT01472081|463246023|FG001|Overall Study|Disease Progression|10|||
128961128|NCT00615459|464142616|FG000|Period I|Abnormal test procedure results|1|||
128961129|NCT00615459|464142617|FG001|Period I|Abnormal test procedure results|1|||
128961130|NCT00615459|464142618|FG002|Period I|Abnormal test procedure results|1|||
128961131|NCT00615459|464142619|FG003|Period I|Abnormal test procedure results|0|||
128961132|NCT00615459|464142616|FG000|Period II|Adverse Event|1|||
128961133|NCT00615459|464142617|FG001|Period II|Adverse Event|0|||
128961134|NCT00615459|464142618|FG002|Period II|Adverse Event|0|||
128961135|NCT00615459|464142619|FG003|Period II|Adverse Event|0|||
128961136|NCT00615459|464142616|FG000|Period II|Lost to Follow-up|0|||
128961137|NCT00615459|464142617|FG001|Period II|Lost to Follow-up|0|||
128961138|NCT00615459|464142618|FG002|Period II|Lost to Follow-up|0|||
128961139|NCT00615459|464142619|FG003|Period II|Lost to Follow-up|1|||
128961140|NCT00615459|464142616|FG000|Period III|Adverse Event|0|||
128961141|NCT00615459|464142617|FG001|Period III|Adverse Event|1|||
128961142|NCT00615459|464142618|FG002|Period III|Adverse Event|0|||
128961143|NCT00615459|464142619|FG003|Period III|Adverse Event|0|||
128961144|NCT00615459|464142616|FG000|Period III|Administrative problems|0|||
128961145|NCT00615459|464142617|FG001|Period III|Administrative problems|1|||
128961146|NCT00615459|464142618|FG002|Period III|Administrative problems|1|||
128961147|NCT00615459|464142619|FG003|Period III|Administrative problems|0|||
128961148|NCT00615459|464142616|FG000|Period III|Unsatisfactory therapeutic effect|0|||
128961149|NCT00615459|464142617|FG001|Period III|Unsatisfactory therapeutic effect|1|||
128961150|NCT00615459|464142618|FG002|Period III|Unsatisfactory therapeutic effect|0|||
128961151|NCT00615459|464142619|FG003|Period III|Unsatisfactory therapeutic effect|0|||
128961152|NCT01975675|464142620|FG000|Overall Study|Death|0|||
128961153|NCT01975675|464142621|FG001|Overall Study|Death|1|||
128961154|NCT01975675|464142622|FG002|Overall Study|Death|0|||
128961155|NCT01975675|464142623|FG003|Overall Study|Death|0|||
128961156|NCT00224003|464142624|FG000|Overall Study|Adverse Event|1|||
128961157|NCT00224003|464142624|FG000|Overall Study|Protocol Violation|2|||
128961158|NCT00224003|464142624|FG000|Overall Study|Withdrawal by Subject|1|||
128961159|NCT00224003|464142624|FG000|Overall Study|unk|3|||
128961160|NCT00753688|464142625|FG000|Overall Study|Death|102|||
128961161|NCT00753688|464142626|FG001|Overall Study|Death|203|||
128961162|NCT00753688|464142625|FG000|Overall Study|Missing|4|||
128961163|NCT00753688|464142626|FG001|Overall Study|Missing|9|||
128961164|NCT00753688|464142625|FG000|Overall Study|Participant Withdrew Consent|2|||
128961165|NCT00753688|464142626|FG001|Overall Study|Participant Withdrew Consent|2|||
128961166|NCT00753688|464142625|FG000|Overall Study|Ongoing - in Follow-up|15|||
128961167|NCT00753688|464142626|FG001|Overall Study|Ongoing - in Follow-up|31|||
128961168|NCT00753688|464142625|FG000|Overall Study|Adverse Event|0|||
128961169|NCT00753688|464142626|FG001|Overall Study|Adverse Event|1|||
128961170|NCT03595384|464142627|FG000|Overall Study|Other time commitments|8|||
128961171|NCT03595384|464142627|FG000|Overall Study|Changes to session time|7|||
128961172|NCT03595384|464142627|FG000|Overall Study|Relocation out of country|1|||
128961173|NCT00293241|464142628|FG000|Overall Study|Lost to Follow-up|9|||
129036906|NCT00436917|464425152|FG000|Overall Study|Adverse Event|2|||
129036907|NCT00436917|464425152|FG000|Overall Study|Physician Decision|1|||
129036908|NCT00436917|464425152|FG000|Overall Study|Death|1|||
129036909|NCT00436917|464425152|FG000|Overall Study|Lost to Follow-up|1|||
129036910|NCT00436917|464425152|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
129036911|NCT00436917|464425152|FG000|Overall Study|Increased creatinine|1|||
129036912|NCT00436917|464425152|FG000|Overall Study|Personal conflicts of patient|1|||
129036913|NCT05103657|464425159|FG000|Overall Study|Other reasons than listed|9|||
129036914|NCT05103657|464425160|FG001|Overall Study|Other reasons than listed|8|||
129036915|NCT05103657|464425159|FG000|Overall Study|Protocol deviation|2|||
129036916|NCT05103657|464425160|FG001|Overall Study|Protocol deviation|2|||
129036917|NCT05103657|464425159|FG000|Overall Study|No reason available|5|||
129036918|NCT05103657|464425160|FG001|Overall Study|No reason available|4|||
129036919|NCT05103657|464425159|FG000|Overall Study|Burden of study procedures|3|||
129036920|NCT05103657|464425160|FG001|Overall Study|Burden of study procedures|1|||
129036921|NCT05103657|464425159|FG000|Overall Study|Perceived lack of efficacy|1|||
129036922|NCT05103657|464425160|FG001|Overall Study|Perceived lack of efficacy|1|||
129036923|NCT05103657|464425159|FG000|Overall Study|Adverse Event|6|||
129036924|NCT05103657|464425160|FG001|Overall Study|Adverse Event|14|||
128961174|NCT00293241|464142629|FG001|Overall Study|Lost to Follow-up|16|||
128961175|NCT00293241|464142628|FG000|Overall Study|Physician Decision|23|||
128961176|NCT00293241|464142629|FG001|Overall Study|Physician Decision|17|||
128961177|NCT00293241|464142628|FG000|Overall Study|Withdrawal by Subject|4|||
129036925|NCT05103657|464425159|FG000|Overall Study|Not Treated|1|||
129036926|NCT05103657|464425160|FG001|Overall Study|Not Treated|1|||
129036927|NCT03635983|464425164|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
129036928|NCT03635983|464425165|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
129036929|NCT03635983|464425164|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129036930|NCT03635983|464425165|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129036931|NCT03635983|464425164|FG000|Pre-Treatment Period|Other reasons|0|||
129036932|NCT03635983|464425165|FG001|Pre-Treatment Period|Other reasons|1|||
129036933|NCT03635983|464425164|FG000|Pre-Treatment Period|Disease Progression|0|||
129036934|NCT03635983|464425165|FG001|Pre-Treatment Period|Disease Progression|1|||
129036935|NCT03635983|464425164|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
129036936|NCT03635983|464425165|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
129036937|NCT03635983|464425164|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
129036938|NCT03635983|464425165|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
129036939|NCT03635983|464425164|FG000|Treatment Period|Withdrawal by Subject|3|||
129036940|NCT03635983|464425165|FG001|Treatment Period|Withdrawal by Subject|5|||
129036941|NCT03635983|464425164|FG000|Treatment Period|Death|3|||
129036942|NCT03635983|464425165|FG001|Treatment Period|Death|5|||
129036943|NCT03635983|464425164|FG000|Treatment Period|Poor/Non-compliance|2|||
129036944|NCT03635983|464425165|FG001|Treatment Period|Poor/Non-compliance|1|||
129036945|NCT03635983|464425164|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
129036946|NCT03635983|464425165|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
129036947|NCT03635983|464425164|FG000|Treatment Period|Other reasons|7|||
129036948|NCT03635983|464425165|FG001|Treatment Period|Other reasons|4|||
129036949|NCT03635983|464425164|FG000|Treatment Period|Disease progression|230|||
129036950|NCT03635983|464425165|FG001|Treatment Period|Disease progression|201|||
129036951|NCT03635983|464425164|FG000|Treatment Period|Study drug toxicity|35|||
129036952|NCT03635983|464425165|FG001|Treatment Period|Study drug toxicity|36|||
129036953|NCT03635983|464425164|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
129036954|NCT03635983|464425165|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
129036955|NCT03635983|464425164|FG000|Treatment Period|Maximum clinical benefit|3|||
129036956|NCT03635983|464425165|FG001|Treatment Period|Maximum clinical benefit|5|||
129036957|NCT03635983|464425164|FG000|Treatment Period|Administrative reason by the sponsor|1|||
129036958|NCT03635983|464425165|FG001|Treatment Period|Administrative reason by the sponsor|2|||
129036959|NCT03635983|464425164|FG000|Treatment Period|Lost to Follow-up|0|||
129036960|NCT03635983|464425165|FG001|Treatment Period|Lost to Follow-up|1|||
129036961|NCT04126343|464425167|FG000|Overall Study|Adverse Event|0|||
129036962|NCT04126343|464425168|FG001|Overall Study|Adverse Event|0|||
129036963|NCT04126343|464425169|FG002|Overall Study|Adverse Event|0|||
129036964|NCT04126343|464425170|FG003|Overall Study|Adverse Event|0|||
129036965|NCT04126343|464425171|FG004|Overall Study|Adverse Event|0|||
129036966|NCT04126343|464425172|FG005|Overall Study|Adverse Event|1|||
129036967|NCT04126343|464425167|FG000|Overall Study|Withdrawal by Subject|0|||
129036968|NCT04126343|464425168|FG001|Overall Study|Withdrawal by Subject|0|||
129036969|NCT04126343|464425169|FG002|Overall Study|Withdrawal by Subject|0|||
129036970|NCT04126343|464425170|FG003|Overall Study|Withdrawal by Subject|1|||
129036971|NCT04126343|464425171|FG004|Overall Study|Withdrawal by Subject|0|||
129036972|NCT04126343|464425172|FG005|Overall Study|Withdrawal by Subject|0|||
129036973|NCT04126343|464425167|FG000|Overall Study|Related to COVID-19 pandemic|3|||
129036974|NCT04126343|464425168|FG001|Overall Study|Related to COVID-19 pandemic|4|||
128961178|NCT00293241|464142629|FG001|Overall Study|Withdrawal by Subject|8|||
128961179|NCT03803202|464142630|FG000|Overall Study|Other|0|||
128961180|NCT03803202|464142631|FG001|Overall Study|Other|1|||
128961181|NCT03803202|464142632|FG002|Overall Study|Other|0|||
128961182|NCT03803202|464142633|FG003|Overall Study|Other|0|||
128961183|NCT03803202|464142634|FG004|Overall Study|Other|0|||
128961184|NCT03803202|464142635|FG005|Overall Study|Other|0|||
128961185|NCT03803202|464142636|FG006|Overall Study|Other|0|||
129036975|NCT04126343|464425169|FG002|Overall Study|Related to COVID-19 pandemic|3|||
129036976|NCT04126343|464425170|FG003|Overall Study|Related to COVID-19 pandemic|3|||
129036977|NCT04126343|464425171|FG004|Overall Study|Related to COVID-19 pandemic|3|||
129036978|NCT04126343|464425172|FG005|Overall Study|Related to COVID-19 pandemic|3|||
129036979|NCT03712124|464425173|FG000|Overall Study|Protocol Violation|1|||
129036980|NCT03712124|464425174|FG001|Overall Study|Protocol Violation|0|||
128961186|NCT03803202|464142637|FG007|Overall Study|Other|0|||
128961187|NCT03803202|464142638|FG008|Overall Study|Other|0|||
128961188|NCT03803202|464142630|FG000|Overall Study|Death|0|||
129036981|NCT02412722|464425176|FG000|Overall Study|Adverse Event|0|||
129036982|NCT02412722|464425177|FG001|Overall Study|Adverse Event|2|||
129036983|NCT02412722|464425178|FG002|Overall Study|Adverse Event|0|||
128961189|NCT03803202|464142631|FG001|Overall Study|Death|0|||
128961190|NCT03803202|464142632|FG002|Overall Study|Death|0|||
129036984|NCT02412722|464425179|FG003|Overall Study|Adverse Event|3|||
129036985|NCT02412722|464425180|FG004|Overall Study|Adverse Event|0|||
129036986|NCT02412722|464425181|FG005|Overall Study|Adverse Event|3|||
129036987|NCT02412722|464425176|FG000|Overall Study|Progressive Disease|6|||
129036988|NCT02412722|464425177|FG001|Overall Study|Progressive Disease|4|||
129036989|NCT02412722|464425178|FG002|Overall Study|Progressive Disease|4|||
128961191|NCT03803202|464142633|FG003|Overall Study|Death|0|||
128961192|NCT03803202|464142634|FG004|Overall Study|Death|0|||
128961193|NCT03803202|464142635|FG005|Overall Study|Death|1|||
128961194|NCT03803202|464142636|FG006|Overall Study|Death|0|||
128961195|NCT03803202|464142637|FG007|Overall Study|Death|0|||
128961196|NCT03803202|464142638|FG008|Overall Study|Death|0|||
128961197|NCT03803202|464142630|FG000|Overall Study|Withdrawal by Subject|0|||
128961198|NCT03803202|464142631|FG001|Overall Study|Withdrawal by Subject|0|||
128961199|NCT03803202|464142632|FG002|Overall Study|Withdrawal by Subject|1|||
128961200|NCT03803202|464142633|FG003|Overall Study|Withdrawal by Subject|0|||
128961201|NCT03803202|464142634|FG004|Overall Study|Withdrawal by Subject|0|||
128961202|NCT03803202|464142635|FG005|Overall Study|Withdrawal by Subject|0|||
128961203|NCT03803202|464142636|FG006|Overall Study|Withdrawal by Subject|0|||
128961204|NCT03803202|464142637|FG007|Overall Study|Withdrawal by Subject|1|||
128961205|NCT03803202|464142638|FG008|Overall Study|Withdrawal by Subject|0|||
128961206|NCT03803202|464142630|FG000|Overall Study|Lost to Follow-up|0|||
128961207|NCT03803202|464142631|FG001|Overall Study|Lost to Follow-up|0|||
128961208|NCT03803202|464142632|FG002|Overall Study|Lost to Follow-up|0|||
128961209|NCT03803202|464142633|FG003|Overall Study|Lost to Follow-up|1|||
128961210|NCT03803202|464142634|FG004|Overall Study|Lost to Follow-up|1|||
128961211|NCT03803202|464142635|FG005|Overall Study|Lost to Follow-up|0|||
128961212|NCT03803202|464142636|FG006|Overall Study|Lost to Follow-up|1|||
128961213|NCT03803202|464142637|FG007|Overall Study|Lost to Follow-up|0|||
128961214|NCT03803202|464142638|FG008|Overall Study|Lost to Follow-up|0|||
128961215|NCT00659126|464142643|FG000|Overall Study|Adverse Event|2|||
128961216|NCT00659126|464142644|FG001|Overall Study|Adverse Event|2|||
128961217|NCT00659126|464142643|FG000|Overall Study|Screen failure|1|||
128961218|NCT00659126|464142644|FG001|Overall Study|Screen failure|1|||
128961219|NCT00659126|464142643|FG000|Overall Study|Technical problems with MRI|0|||
128961220|NCT00659126|464142644|FG001|Overall Study|Technical problems with MRI|1|||
128961221|NCT02633046|464142647|FG000|Overall Study|Adverse Event|8|||
128961222|NCT02633046|464142647|FG000|Overall Study|Physician Decision|7|||
128961223|NCT02633046|464142647|FG000|Overall Study|Withdrawal by Subject|8|||
128961224|NCT02633046|464142647|FG000|Overall Study|Increased proteinuria|2|||
128961225|NCT02633046|464142647|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
128961226|NCT02633046|464142647|FG000|Overall Study|Mutual decision patient and physician|1|||
128961227|NCT02910219|464142657|FG000|Overall Study|Withdrawal by Subject|1|||
128961228|NCT02910219|464142658|FG001|Overall Study|Withdrawal by Subject|1|||
128961229|NCT00701441|464142660|FG000|Overall Study|failure in cpap compliance|0|||
128961230|NCT00701441|464142661|FG001|Overall Study|failure in cpap compliance|4|||
128961231|NCT01313078|464142665|FG000|Overall Study|Death|1|||
128961232|NCT01313078|464142665|FG000|Overall Study|Discontinued study drug|1|||
128961233|NCT01313078|464142665|FG000|Overall Study|Withdrawal by Subject|1|||
128961234|NCT01225172|464142670|FG000|Overall Study|Subject decision to stop|1|||
128961235|NCT01225172|464142671|FG001|Overall Study|Subject decision to stop|0|||
128961236|NCT01225172|464142670|FG000|Overall Study|Subject request to discontinue treatment|3|||
128961237|NCT01225172|464142671|FG001|Overall Study|Subject request to discontinue treatment|1|||
128961238|NCT01225172|464142670|FG000|Overall Study|Subject no longer meets study criteria|1|||
128961239|NCT01225172|464142671|FG001|Overall Study|Subject no longer meets study criteria|0|||
128961240|NCT01225172|464142670|FG000|Overall Study|Withdrawal by Subject|1|||
128961241|NCT01225172|464142671|FG001|Overall Study|Withdrawal by Subject|0|||
128961242|NCT02679781|464142672|FG000|Overall Study|Lost to Follow-up|1|||
128961243|NCT02679781|464142673|FG001|Overall Study|Lost to Follow-up|2|||
128961244|NCT02679781|464142672|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
128961245|NCT02679781|464142673|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
128961246|NCT04209400|464142674|FG000|Overall Study|Withdrawal by Subject|0|||
128961247|NCT04209400|464142675|FG001|Overall Study|Withdrawal by Subject|1|||
128961248|NCT00970268|464142684|FG000|Overall Study|Withdrawal by Subject|12|||
128961249|NCT00970268|464142685|FG001|Overall Study|Withdrawal by Subject|19|||
128961250|NCT00970268|464142684|FG000|Overall Study|Adverse Event|15|||
128961251|NCT00970268|464142685|FG001|Overall Study|Adverse Event|12|||
128961252|NCT00970268|464142684|FG000|Overall Study|Lack of Efficacy|3|||
128961253|NCT00970268|464142685|FG001|Overall Study|Lack of Efficacy|6|||
128961254|NCT00970268|464142684|FG000|Overall Study|Protocol Violation|4|||
128961255|NCT00970268|464142685|FG001|Overall Study|Protocol Violation|7|||
128961256|NCT00970268|464142684|FG000|Overall Study|Other Reason|3|||
128961257|NCT00970268|464142685|FG001|Overall Study|Other Reason|1|||
128961258|NCT00970268|464142684|FG000|Overall Study|COPD Exacerbation|4|||
128961259|NCT00970268|464142685|FG001|Overall Study|COPD Exacerbation|2|||
128961260|NCT00970268|464142684|FG000|Overall Study|Lost to Follow-up|1|||
128961261|NCT00970268|464142685|FG001|Overall Study|Lost to Follow-up|2|||
128961262|NCT00970268|464142684|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
128961263|NCT00970268|464142685|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
128961264|NCT01375647|464144854|FG000|Overall Study|Lost to Follow-up|3|||
128961265|NCT01375647|464144855|FG001|Overall Study|Lost to Follow-up|3|||
128961266|NCT01375647|464144856|FG002|Overall Study|Lost to Follow-up|7|||
128961267|NCT01375647|464144857|FG003|Overall Study|Lost to Follow-up|10|||
128961268|NCT01375647|464144854|FG000|Overall Study|Death|1|||
128961269|NCT01375647|464144855|FG001|Overall Study|Death|2|||
128961270|NCT01375647|464144856|FG002|Overall Study|Death|1|||
128961271|NCT01375647|464144857|FG003|Overall Study|Death|0|||
128961272|NCT01375647|464144854|FG000|Overall Study|Withdrawal by Subject|17|||
128961273|NCT01375647|464144855|FG001|Overall Study|Withdrawal by Subject|20|||
128961274|NCT01375647|464144856|FG002|Overall Study|Withdrawal by Subject|26|||
128961275|NCT01375647|464144857|FG003|Overall Study|Withdrawal by Subject|14|||
128961276|NCT01375647|464144854|FG000|Overall Study|Physician Decision|1|||
128961277|NCT01375647|464144855|FG001|Overall Study|Physician Decision|0|||
128961278|NCT01375647|464144856|FG002|Overall Study|Physician Decision|0|||
128961279|NCT01375647|464144857|FG003|Overall Study|Physician Decision|0|||
128961280|NCT03366844|464144858|FG000|Overall Study|Physician Decision|1|||
128961281|NCT03366844|464144858|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
128961282|NCT02088541|464144863|FG000|Overall Study|Adverse Event|3|||
128961283|NCT02088541|464144864|FG001|Overall Study|Adverse Event|0|||
128961284|NCT02088541|464144865|FG002|Overall Study|Adverse Event|3|||
128961285|NCT02088541|464144866|FG003|Overall Study|Adverse Event|3|||
128961286|NCT02088541|464144867|FG004|Overall Study|Adverse Event|0|||
128961287|NCT02088541|464144863|FG000|Overall Study|Death|51|||
128961288|NCT02088541|464144864|FG001|Overall Study|Death|21|||
128961289|NCT02088541|464144865|FG002|Overall Study|Death|85|||
128961290|NCT02088541|464144866|FG003|Overall Study|Death|28|||
128961291|NCT02088541|464144867|FG004|Overall Study|Death|38|||
128961292|NCT02088541|464144863|FG000|Overall Study|Lost to Follow-up|2|||
128961293|NCT02088541|464144864|FG001|Overall Study|Lost to Follow-up|0|||
128961294|NCT02088541|464144865|FG002|Overall Study|Lost to Follow-up|1|||
128961295|NCT02088541|464144866|FG003|Overall Study|Lost to Follow-up|0|||
128961296|NCT02088541|464144867|FG004|Overall Study|Lost to Follow-up|0|||
128961297|NCT02088541|464144863|FG000|Overall Study|Physician Decision|2|||
128961298|NCT02088541|464144864|FG001|Overall Study|Physician Decision|1|||
128961299|NCT02088541|464144865|FG002|Overall Study|Physician Decision|2|||
128961300|NCT02088541|464144866|FG003|Overall Study|Physician Decision|0|||
128961301|NCT02088541|464144867|FG004|Overall Study|Physician Decision|2|||
128961302|NCT02088541|464144863|FG000|Overall Study|Disease progression|7|||
128961303|NCT02088541|464144864|FG001|Overall Study|Disease progression|1|||
128961304|NCT02088541|464144865|FG002|Overall Study|Disease progression|2|||
128961305|NCT02088541|464144866|FG003|Overall Study|Disease progression|3|||
128961306|NCT02088541|464144867|FG004|Overall Study|Disease progression|1|||
128961307|NCT02088541|464144863|FG000|Overall Study|Study terminated by sponsor|1|||
128961308|NCT02088541|464144864|FG001|Overall Study|Study terminated by sponsor|1|||
128961309|NCT02088541|464144865|FG002|Overall Study|Study terminated by sponsor|12|||
128961310|NCT02088541|464144866|FG003|Overall Study|Study terminated by sponsor|2|||
128961311|NCT02088541|464144867|FG004|Overall Study|Study terminated by sponsor|6|||
128961312|NCT02088541|464144863|FG000|Overall Study|Withdrawal by Subject|3|||
128961313|NCT02088541|464144864|FG001|Overall Study|Withdrawal by Subject|2|||
128961314|NCT02088541|464144865|FG002|Overall Study|Withdrawal by Subject|9|||
128961315|NCT02088541|464144866|FG003|Overall Study|Withdrawal by Subject|7|||
128961316|NCT02088541|464144867|FG004|Overall Study|Withdrawal by Subject|10|||
128961317|NCT02088541|464144863|FG000|Overall Study|Other|2|||
128961318|NCT02088541|464144864|FG001|Overall Study|Other|1|||
128961319|NCT02088541|464144865|FG002|Overall Study|Other|3|||
128961320|NCT02088541|464144866|FG003|Overall Study|Other|1|||
128961321|NCT02088541|464144867|FG004|Overall Study|Other|1|||
128961322|NCT00323310|464144868|FG000|Overall Study|Withdrawal by Subject|1|||
128961323|NCT00323310|464144868|FG000|Overall Study|a parent refused blood draw|1|||
128961324|NCT00323310|464144868|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
128961325|NCT03984812|464144869|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961326|NCT03984812|464144870|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961327|NCT03984812|464144871|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
128961328|NCT03984812|464144872|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961329|NCT03984812|464144873|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961330|NCT03984812|464144874|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961331|NCT03984812|464144875|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961332|NCT03984812|464144876|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961333|NCT03984812|464144877|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961334|NCT03984812|464144878|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961335|NCT03984812|464144879|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
128961336|NCT02707601|464144880|FG000|Overall Study|Death|0|||
129219978|NCT02908672|465104675|FG003|Run-in Period|Reason Not Specified|0|||
128961337|NCT02707601|464144881|FG001|Overall Study|Death|1|||
128961338|NCT02707601|464144880|FG000|Overall Study|Lack of Efficacy|0|||
128961339|NCT02707601|464144881|FG001|Overall Study|Lack of Efficacy|1|||
128961340|NCT02707601|464144880|FG000|Overall Study|Investigator's Discretion|1|||
128961341|NCT02707601|464144881|FG001|Overall Study|Investigator's Discretion|0|||
128961342|NCT02707601|464144880|FG000|Overall Study|Withdrew Consent|0|||
128961343|NCT02707601|464144881|FG001|Overall Study|Withdrew Consent|1|||
128961344|NCT02707601|464144880|FG000|Overall Study|Lost to Follow-up|1|||
129127471|NCT01069939|464759341|FG000|Randomised and Included in the Analyses|Removal|1|||
129127472|NCT01069939|464759342|FG001|Randomised and Included in the Analyses|Removal|0|||
129127473|NCT00191100|464759349|FG000|Overall Study|Adverse Event|18|||
129127474|NCT00191100|464759350|FG001|Overall Study|Adverse Event|1|||
129127475|NCT00191100|464759349|FG000|Overall Study|Lost to Follow-up|2|||
129127476|NCT00191100|464759350|FG001|Overall Study|Lost to Follow-up|0|||
129127477|NCT00191100|464759349|FG000|Overall Study|Patient Moved|0|||
129127478|NCT00191100|464759350|FG001|Overall Study|Patient Moved|1|||
129127479|NCT00191100|464759349|FG000|Overall Study|Withdrawal by Subject|9|||
129127480|NCT00191100|464759350|FG001|Overall Study|Withdrawal by Subject|3|||
129127481|NCT00191100|464759349|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
129127482|NCT00191100|464759350|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
129127483|NCT00191100|464759349|FG000|Overall Study|Clinical Relapse|2|||
129127484|NCT00191100|464759350|FG001|Overall Study|Clinical Relapse|1|||
129127485|NCT00191100|464759349|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
129127486|NCT00191100|464759350|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
128713132|NCT01472081|463246024|FG002|Overall Study|Disease Progression|12|||
128713133|NCT01472081|463246025|FG003|Overall Study|Disease Progression|31|||
128961345|NCT02707601|464144881|FG001|Overall Study|Lost to Follow-up|1|||
128961346|NCT02707601|464144880|FG000|Overall Study|Participants Randomized but Not Treated|2|||
128961347|NCT02707601|464144881|FG001|Overall Study|Participants Randomized but Not Treated|0|||
128961348|NCT00666536|464144883|FG000|Overall Study|Adverse Event|9|||
128961349|NCT00666536|464144884|FG001|Overall Study|Adverse Event|19|||
128961350|NCT00666536|464144883|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128961351|NCT00666536|464144884|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128961352|NCT00666536|464144883|FG000|Overall Study|Protocol deviation(s)|8|||
128961353|NCT00666536|464144884|FG001|Overall Study|Protocol deviation(s)|6|||
128961354|NCT00666536|464144883|FG000|Overall Study|Withdrawal by Subject|10|||
128961355|NCT00666536|464144884|FG001|Overall Study|Withdrawal by Subject|9|||
128961356|NCT00666536|464144883|FG000|Overall Study|Lost to Follow-up|4|||
128961357|NCT00666536|464144884|FG001|Overall Study|Lost to Follow-up|3|||
128961358|NCT02147691|464144891|FG000|Overall Study|Withdrawal by Subject|2|||
128961359|NCT02147691|464144892|FG001|Overall Study|Withdrawal by Subject|0|||
128961360|NCT02147691|464144891|FG000|Overall Study|Adverse Event|2|||
128961361|NCT02147691|464144892|FG001|Overall Study|Adverse Event|0|||
128961362|NCT02147691|464144891|FG000|Overall Study|Lost to Follow-up|0|||
128961363|NCT02147691|464144892|FG001|Overall Study|Lost to Follow-up|1|||
128961364|NCT01392742|464144893|FG000|Overall Study|Premature study termination|42|||
128961365|NCT01392742|464144893|FG000|Overall Study|Failure to return|35|||
128961366|NCT01392742|464144893|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
128961367|NCT01392742|464144893|FG000|Overall Study|Lost to Follow-up|34|||
128961368|NCT01392742|464144893|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
128961369|NCT01392742|464144893|FG000|Overall Study|ITR and Protocol deviation|1|||
128961370|NCT01392742|464144893|FG000|Overall Study|Adverse event/intercurrent illness|17|||
128961371|NCT01392742|464144893|FG000|Overall Study|Protocol Violation|14|||
128961372|NCT01392742|464144893|FG000|Overall Study|Other|3|||
128961373|NCT01392742|464144893|FG000|Overall Study|Missing information|13|||
128961374|NCT02432703|464144894|FG000|Overall Study|Adverse Event|1|||
128961375|NCT02432703|464144895|FG001|Overall Study|Adverse Event|4|||
128961376|NCT02432703|464144894|FG000|Overall Study|Lack of Efficacy|1|||
128961377|NCT02432703|464144895|FG001|Overall Study|Lack of Efficacy|0|||
128961378|NCT02432703|464144894|FG000|Overall Study|Lost to Follow-up|5|||
128961379|NCT02432703|464144895|FG001|Overall Study|Lost to Follow-up|3|||
128961380|NCT02432703|464144894|FG000|Overall Study|Withdrawal by Subject|9|||
128961381|NCT02432703|464144895|FG001|Overall Study|Withdrawal by Subject|6|||
128961382|NCT02432703|464144894|FG000|Overall Study|Other|6|||
128961383|NCT02432703|464144895|FG001|Overall Study|Other|5|||
128961384|NCT03210220|464144896|FG000|Overall Study|Physician Decision|1|||
128961385|NCT03210220|464144897|FG001|Overall Study|Physician Decision|0|||
128961386|NCT02911519|464144898|FG000|Overall Study|Lost to Follow-up|2|||
128961387|NCT02911519|464144899|FG001|Overall Study|Lost to Follow-up|2|||
128961388|NCT02911519|464144898|FG000|Overall Study|Death|0|||
128961389|NCT02911519|464144899|FG001|Overall Study|Death|2|||
128961390|NCT00653328|464144900|FG000|Overall Study|Withdrawal by Subject|1|||
128961391|NCT00653328|464144900|FG000|Overall Study|Adverse Event|2|||
128961392|NCT00653328|464144900|FG000|Overall Study|Disease progression|10|||
128961393|NCT00653328|464144900|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
128961394|NCT00839436|464144903|FG000|Overall Study|Developed exclusionary condition|1|||
128961395|NCT00839436|464144904|FG001|Overall Study|Developed exclusionary condition|0|||
128961396|NCT00839436|464144905|FG002|Overall Study|Developed exclusionary condition|0|||
128961397|NCT00839436|464144903|FG000|Overall Study|Withdrawal by Subject|0|||
128961398|NCT00839436|464144904|FG001|Overall Study|Withdrawal by Subject|1|||
129219979|NCT02908672|465104672|FG000|Run-in Period|Protocol Violation|1|||
128961399|NCT00839436|464144905|FG002|Overall Study|Withdrawal by Subject|0|||
128961400|NCT00839436|464144903|FG000|Overall Study|Study drug no longer available|0|||
128961401|NCT00839436|464144904|FG001|Overall Study|Study drug no longer available|0|||
129219980|NCT02908672|465104673|FG001|Run-in Period|Protocol Violation|1|||
128961402|NCT00839436|464144905|FG002|Overall Study|Study drug no longer available|1|||
128961403|NCT01444898|464144907|FG000|Overall Study|Withdrawal by Subject|1|||
128961404|NCT02580591|464144909|FG000|Overall Study|Adverse Event|0|||
128961405|NCT02580591|464144910|FG001|Overall Study|Adverse Event|1|||
128961406|NCT02580591|464144911|FG002|Overall Study|Adverse Event|2|||
128961407|NCT02580591|464144912|FG003|Overall Study|Adverse Event|5|||
128961408|NCT02580591|464144909|FG000|Overall Study|Protocol Violation|3|||
128961409|NCT02580591|464144910|FG001|Overall Study|Protocol Violation|2|||
128961410|NCT02580591|464144911|FG002|Overall Study|Protocol Violation|1|||
128961411|NCT02580591|464144912|FG003|Overall Study|Protocol Violation|1|||
128961412|NCT02580591|464144909|FG000|Overall Study|Lost to Follow-up|5|||
128961413|NCT02580591|464144910|FG001|Overall Study|Lost to Follow-up|3|||
128961414|NCT02580591|464144911|FG002|Overall Study|Lost to Follow-up|3|||
128961415|NCT02580591|464144912|FG003|Overall Study|Lost to Follow-up|1|||
128961416|NCT02580591|464144909|FG000|Overall Study|Withdrawal by Subject|6|||
128961417|NCT02580591|464144910|FG001|Overall Study|Withdrawal by Subject|1|||
128961418|NCT02580591|464144911|FG002|Overall Study|Withdrawal by Subject|2|||
128961419|NCT02580591|464144912|FG003|Overall Study|Withdrawal by Subject|3|||
128961420|NCT02580591|464144909|FG000|Overall Study|Not treated|1|||
128961421|NCT02580591|464144910|FG001|Overall Study|Not treated|1|||
128961422|NCT02580591|464144911|FG002|Overall Study|Not treated|0|||
128961423|NCT02580591|464144912|FG003|Overall Study|Not treated|0|||
128961424|NCT02580591|464144909|FG000|Overall Study|Other than specified|3|||
128961425|NCT02580591|464144910|FG001|Overall Study|Other than specified|2|||
128961426|NCT02580591|464144911|FG002|Overall Study|Other than specified|5|||
128961427|NCT02580591|464144912|FG003|Overall Study|Other than specified|2|||
128961428|NCT00561340|464144916|FG000|Overall Study|refused to drink pediasure|6|||
128961429|NCT00561340|464144917|FG001|Overall Study|refused to drink pediasure|0|||
128961430|NCT03051217|464144918|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
128961431|NCT03051217|464144919|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
128961432|NCT03051217|464144920|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
128961433|NCT03051217|464144921|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
128961434|NCT03051217|464144922|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
128961435|NCT03051217|464144923|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
128961436|NCT03051217|464144924|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
128961437|NCT03051217|464144918|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
128961438|NCT03051217|464144919|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
128961439|NCT03051217|464144920|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
128961440|NCT03051217|464144921|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
128961441|NCT03051217|464144922|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
128961442|NCT03051217|464144923|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
128961443|NCT03051217|464144924|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
128961444|NCT03051217|464144918|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
128961445|NCT03051217|464144919|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
128961446|NCT03051217|464144920|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
128961447|NCT03051217|464144921|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128961448|NCT03051217|464144922|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128961449|NCT03051217|464144923|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128961450|NCT03051217|464144924|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
128961451|NCT03051217|464144918|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
128961452|NCT03051217|464144919|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
128961453|NCT03051217|464144920|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
128961454|NCT03051217|464144921|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
128961455|NCT03051217|464144922|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
128961456|NCT03051217|464144923|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
128961457|NCT03051217|464144924|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
128961458|NCT03051217|464144918|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
128961459|NCT03051217|464144919|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
128961460|NCT03051217|464144920|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
128961461|NCT03051217|464144921|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
128961462|NCT03051217|464144922|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
128961463|NCT03051217|464144923|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
128961464|NCT03051217|464144924|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
128961465|NCT03051217|464144918|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
128961466|NCT03051217|464144919|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
128961467|NCT03051217|464144920|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
128961468|NCT03051217|464144921|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
128961469|NCT03051217|464144922|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
128961470|NCT03051217|464144923|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
128961471|NCT03051217|464144924|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
128961472|NCT03051217|464144918|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
128961473|NCT03051217|464144919|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
128961474|NCT03051217|464144920|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
128961475|NCT03051217|464144921|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
128961476|NCT03051217|464144922|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
128961477|NCT03051217|464144923|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
128961478|NCT03051217|464144924|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
128961479|NCT03051217|464144918|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
128961480|NCT03051217|464144919|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
128961481|NCT03051217|464144920|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
128961482|NCT03051217|464144921|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
128961483|NCT03051217|464144922|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
128961484|NCT03051217|464144923|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
128961485|NCT03051217|464144924|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
128961486|NCT00109772|464144925|FG000|Double-blind Treatment|Adverse Event|14|||
128961487|NCT00109772|464144926|FG001|Double-blind Treatment|Adverse Event|5|||
128961488|NCT00109772|464144925|FG000|Double-blind Treatment|Lack of Efficacy|1|||
128961489|NCT00109772|464144926|FG001|Double-blind Treatment|Lack of Efficacy|0|||
128961490|NCT00109772|464144925|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
128961491|NCT00109772|464144926|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
128961492|NCT00109772|464144925|FG000|Double-blind Treatment|Lost to Follow-up|2|||
128961493|NCT00109772|464144926|FG001|Double-blind Treatment|Lost to Follow-up|3|||
128961494|NCT00109772|464144925|FG000|Double-blind Treatment|Protocol Violation|0|||
128961495|NCT00109772|464144926|FG001|Double-blind Treatment|Protocol Violation|1|||
128961496|NCT00109772|464144925|FG000|Double-blind Treatment|Other|0|||
129036990|NCT02412722|464425179|FG003|Overall Study|Progressive Disease|9|||
129036991|NCT02412722|464425180|FG004|Overall Study|Progressive Disease|3|||
129036992|NCT02412722|464425181|FG005|Overall Study|Progressive Disease|3|||
129036993|NCT02412722|464425176|FG000|Overall Study|Withdrawal by Subject|2|||
129036994|NCT02412722|464425177|FG001|Overall Study|Withdrawal by Subject|0|||
129036995|NCT02412722|464425178|FG002|Overall Study|Withdrawal by Subject|1|||
129036996|NCT02412722|464425179|FG003|Overall Study|Withdrawal by Subject|2|||
129036997|NCT02412722|464425180|FG004|Overall Study|Withdrawal by Subject|1|||
129036998|NCT02412722|464425181|FG005|Overall Study|Withdrawal by Subject|1|||
129036999|NCT02412722|464425176|FG000|Overall Study|Lost to Follow-up|0|||
129037000|NCT02412722|464425177|FG001|Overall Study|Lost to Follow-up|0|||
129037001|NCT02412722|464425178|FG002|Overall Study|Lost to Follow-up|0|||
129037002|NCT02412722|464425179|FG003|Overall Study|Lost to Follow-up|0|||
129037003|NCT02412722|464425180|FG004|Overall Study|Lost to Follow-up|1|||
129037004|NCT02412722|464425181|FG005|Overall Study|Lost to Follow-up|0|||
129037005|NCT02412722|464425176|FG000|Overall Study|Received drug in run-in and discontinued|0|||
129037006|NCT02412722|464425177|FG001|Overall Study|Received drug in run-in and discontinued|2|||
129037007|NCT02412722|464425178|FG002|Overall Study|Received drug in run-in and discontinued|0|||
129037008|NCT02412722|464425179|FG003|Overall Study|Received drug in run-in and discontinued|0|||
129037009|NCT02412722|464425180|FG004|Overall Study|Received drug in run-in and discontinued|0|||
129037010|NCT02412722|464425181|FG005|Overall Study|Received drug in run-in and discontinued|0|||
129037011|NCT02412722|464425176|FG000|Overall Study|Reason not Specified|3|||
129037012|NCT02412722|464425177|FG001|Overall Study|Reason not Specified|0|||
129037013|NCT02412722|464425178|FG002|Overall Study|Reason not Specified|2|||
129037014|NCT02412722|464425179|FG003|Overall Study|Reason not Specified|1|||
129037015|NCT02412722|464425180|FG004|Overall Study|Reason not Specified|2|||
129037016|NCT02412722|464425181|FG005|Overall Study|Reason not Specified|6|||
129037017|NCT02941523|464425182|FG000|Monotherapy|Withdrawal by Subject|0|||
129037018|NCT02941523|464425183|FG001|Monotherapy|Withdrawal by Subject|1|||
129037019|NCT02941523|464425182|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
129037020|NCT02941523|464425183|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
129037021|NCT02941523|464425182|FG000|Carboplatin Combination Therapy|Death|1|||
129037022|NCT02941523|464425183|FG001|Carboplatin Combination Therapy|Death|2|||
129037023|NCT02941523|464425182|FG000|Carboplatin Combination Therapy|Disease progression|2|||
129037024|NCT02941523|464425183|FG001|Carboplatin Combination Therapy|Disease progression|0|||
129037025|NCT02941523|464425182|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
129037026|NCT02941523|464425183|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
129037027|NCT04449341|464425184|FG000|Overall Study|Protocol Violation|1|||
129037028|NCT04449341|464425185|FG001|Overall Study|Protocol Violation|0|||
129037029|NCT04499482|464425186|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
129127487|NCT00191100|464759349|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
129127488|NCT00191100|464759350|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
129037030|NCT04330157|464425187|FG000|Overall Study|Protocol Violation|4|||
129127489|NCT00191100|464759349|FG000|Overall Study|Physician Decision|3|||
129037031|NCT04330157|464425187|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
128961497|NCT00109772|464144926|FG001|Double-blind Treatment|Other|4|||
128961498|NCT00109772|464144925|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
128961499|NCT00109772|464144926|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
128961500|NCT00109772|464144925|FG000|Open-label Extension|Adverse Event|10|||
128961501|NCT00109772|464144926|FG001|Open-label Extension|Adverse Event|19|||
128961502|NCT00109772|464144925|FG000|Open-label Extension|Lack of Efficacy|19|||
128961503|NCT00109772|464144926|FG001|Open-label Extension|Lack of Efficacy|11|||
128961504|NCT00109772|464144925|FG000|Open-label Extension|Withdrawal by Subject|9|||
128961505|NCT00109772|464144926|FG001|Open-label Extension|Withdrawal by Subject|6|||
128961506|NCT00109772|464144925|FG000|Open-label Extension|Lost to Follow-up|1|||
128961507|NCT00109772|464144926|FG001|Open-label Extension|Lost to Follow-up|0|||
128961508|NCT00109772|464144925|FG000|Open-label Extension|Death|0|||
128961509|NCT00109772|464144926|FG001|Open-label Extension|Death|1|||
128961510|NCT00109772|464144925|FG000|Open-label Extension|Protocol Violation|2|||
128961511|NCT00109772|464144926|FG001|Open-label Extension|Protocol Violation|2|||
128961512|NCT00109772|464144925|FG000|Open-label Extension|Other|4|||
128961513|NCT00109772|464144926|FG001|Open-label Extension|Other|10|||
128961514|NCT01057862|464144929|FG000|Overall Study|Withdrawal by Subject|1|||
128961515|NCT01057862|464144930|FG001|Overall Study|Withdrawal by Subject|2|||
128961516|NCT00415584|464144931|FG000|Overall Study|Withdrawal by Subject|1|||
128961517|NCT00802867|464144932|FG000|Overall Study|Lost to Follow-up|6|||
128961518|NCT00802867|464144932|FG000|Overall Study|Protocol Violation|6|||
128961519|NCT00802867|464144932|FG000|Overall Study|Withdrawal by Subject|1|||
128961520|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
128961521|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
128961522|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
128961523|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
128961524|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
128961525|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
128961526|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
128961527|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
128961528|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
128961529|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
128961530|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
128961531|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
128961532|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
128961533|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
128961534|NCT03434041|464144933|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
129037032|NCT02219308|464425188|FG000|Overall Study|Withdrawal by Subject|1|||
129037033|NCT02219308|464425189|FG001|Overall Study|Withdrawal by Subject|2|||
129037034|NCT03180528|464426313|FG000|Overall Study|Adverse Event|1|||
129037035|NCT03180528|464426313|FG000|Overall Study|Withdrawal by Subject|1|||
129037036|NCT03180528|464426313|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
129037037|NCT04703855|464426314|FG000|Overall Study|Heart Transplant|1|||
129037038|NCT00991510|464426317|FG000|Period I (Days 1-14)|Adverse Event|1|||
129037039|NCT00991510|464426318|FG001|Period I (Days 1-14)|Adverse Event|0|||
129037040|NCT00991510|464426317|FG000|Period III (Days 29-112)|Adverse Event|1|||
129037041|NCT00991510|464426318|FG001|Period III (Days 29-112)|Adverse Event|1|||
129037042|NCT01976728|464426319|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
129037043|NCT01976728|464426320|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
129037044|NCT01976728|464426321|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
129037045|NCT01976728|464426322|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
129037046|NCT02356211|464426323|FG000|Overall Study|Withdrawal by Subject|2|||
129037047|NCT02356211|464426324|FG001|Overall Study|Withdrawal by Subject|2|||
129037048|NCT02356211|464426323|FG000|Overall Study|ineligible|1|||
129037049|NCT02356211|464426324|FG001|Overall Study|ineligible|8|||
129037050|NCT00966381|464426328|FG000|Overall Study|Withdrawal by Subject|2|||
129037051|NCT00966381|464426329|FG001|Overall Study|Withdrawal by Subject|2|||
129037052|NCT00097786|464426333|FG000|Overall Study|lost to follow-up for all-cause death|296|||
129037053|NCT00097786|464426334|FG001|Overall Study|lost to follow-up for all-cause death|292|||
129037054|NCT00097786|464426335|FG002|Overall Study|lost to follow-up for all-cause death|313|||
129037055|NCT00097786|464426336|FG003|Overall Study|lost to follow-up for all-cause death|310|||
129037056|NCT02668822|464426337|FG000|Overall Study|Protocol Violation|2|||
129037057|NCT02668822|464426338|FG001|Overall Study|Protocol Violation|0|||
129037058|NCT02668822|464426337|FG000|Overall Study|Study Terminated by Sponsor|7|||
129037059|NCT02668822|464426338|FG001|Overall Study|Study Terminated by Sponsor|9|||
129037060|NCT01522950|464426339|FG000|Overall Study|Withdrawal by Subject|3|||
128961535|NCT03434041|464144934|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
129037061|NCT01522950|464426340|FG001|Overall Study|Withdrawal by Subject|2|||
129037062|NCT01522950|464426341|FG002|Overall Study|Withdrawal by Subject|1|||
128961536|NCT03434041|464144933|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
129037063|NCT01522950|464426339|FG000|Overall Study|Adverse Event|3|||
129127490|NCT00191100|464759350|FG001|Overall Study|Physician Decision|1|||
129127491|NCT00191100|464759349|FG000|Overall Study|Death from Study Drug Toxicity|2|||
129127492|NCT00191100|464759350|FG001|Overall Study|Death from Study Drug Toxicity|0|||
129127493|NCT00191100|464759349|FG000|Overall Study|Protocol Violation|1|||
129127494|NCT00191100|464759350|FG001|Overall Study|Protocol Violation|1|||
129127495|NCT00191100|464759349|FG000|Overall Study|Death from Other Cause|1|||
129127496|NCT00191100|464759350|FG001|Overall Study|Death from Other Cause|0|||
129127497|NCT00191100|464759349|FG000|Overall Study|Reason Not Specified|0|||
129127498|NCT00191100|464759350|FG001|Overall Study|Reason Not Specified|1|||
129127499|NCT01525589|464759354|FG000|Overall Study|Non-treatment-related AE|1|||
129127500|NCT01525589|464759355|FG001|Overall Study|Non-treatment-related AE|0|||
129127501|NCT01525589|464759356|FG002|Overall Study|Non-treatment-related AE|0|||
129127502|NCT01525589|464759354|FG000|Overall Study|Progressive disease|48|||
129127503|NCT01525589|464759355|FG001|Overall Study|Progressive disease|15|||
129127504|NCT01525589|464759356|FG002|Overall Study|Progressive disease|29|||
129127505|NCT01525589|464759354|FG000|Overall Study|Never treated|2|||
129127506|NCT01525589|464759355|FG001|Overall Study|Never treated|0|||
129127507|NCT01525589|464759356|FG002|Overall Study|Never treated|0|||
129127508|NCT01525589|464759354|FG000|Overall Study|Physician Decision|4|||
129127509|NCT01525589|464759355|FG001|Overall Study|Physician Decision|2|||
129127510|NCT01525589|464759356|FG002|Overall Study|Physician Decision|2|||
129127511|NCT01525589|464759354|FG000|Overall Study|Death|0|||
129127512|NCT01525589|464759355|FG001|Overall Study|Death|0|||
129127513|NCT01525589|464759356|FG002|Overall Study|Death|2|||
129127514|NCT01525589|464759354|FG000|Overall Study|Treatment-related AE|1|||
129127515|NCT01525589|464759355|FG001|Overall Study|Treatment-related AE|1|||
129127516|NCT01525589|464759356|FG002|Overall Study|Treatment-related AE|2|||
129127517|NCT01525589|464759354|FG000|Overall Study|Other reasons|0|||
129127518|NCT01525589|464759355|FG001|Overall Study|Other reasons|1|||
129127519|NCT01525589|464759356|FG002|Overall Study|Other reasons|0|||
129127520|NCT01525589|464759354|FG000|Overall Study|Withdrawal by Subject|0|||
129127521|NCT01525589|464759355|FG001|Overall Study|Withdrawal by Subject|1|||
129127522|NCT01525589|464759356|FG002|Overall Study|Withdrawal by Subject|0|||
129127523|NCT02101853|464759357|FG000|Block 1 Induction|Adverse Event|11|||
129127524|NCT02101853|464759358|FG001|Block 1 Induction|Adverse Event|0|||
129127525|NCT02101853|464759359|FG002|Block 1 Induction|Adverse Event|0|||
129127526|NCT02101853|464759360|FG003|Block 1 Induction|Adverse Event|0|||
129127527|NCT02101853|464759361|FG004|Block 1 Induction|Adverse Event|0|||
129127528|NCT02101853|464759362|FG005|Block 1 Induction|Adverse Event|0|||
129127529|NCT02101853|464759357|FG000|Block 1 Induction|Death|20|||
129127530|NCT02101853|464759358|FG001|Block 1 Induction|Death|0|||
129127531|NCT02101853|464759359|FG002|Block 1 Induction|Death|0|||
129127532|NCT02101853|464759360|FG003|Block 1 Induction|Death|0|||
129127533|NCT02101853|464759361|FG004|Block 1 Induction|Death|0|||
129127534|NCT02101853|464759362|FG005|Block 1 Induction|Death|0|||
129127535|NCT02101853|464759357|FG000|Block 1 Induction|Lack of Efficacy|6|||
129127536|NCT02101853|464759358|FG001|Block 1 Induction|Lack of Efficacy|0|||
129127537|NCT02101853|464759359|FG002|Block 1 Induction|Lack of Efficacy|0|||
129127538|NCT02101853|464759360|FG003|Block 1 Induction|Lack of Efficacy|0|||
129127539|NCT02101853|464759361|FG004|Block 1 Induction|Lack of Efficacy|0|||
129127540|NCT02101853|464759362|FG005|Block 1 Induction|Lack of Efficacy|0|||
129127541|NCT02101853|464759357|FG000|Block 1 Induction|Physician Decision|61|||
129127542|NCT02101853|464759358|FG001|Block 1 Induction|Physician Decision|0|||
129127543|NCT02101853|464759359|FG002|Block 1 Induction|Physician Decision|0|||
129127544|NCT02101853|464759360|FG003|Block 1 Induction|Physician Decision|0|||
129127545|NCT02101853|464759361|FG004|Block 1 Induction|Physician Decision|0|||
129127546|NCT02101853|464759362|FG005|Block 1 Induction|Physician Decision|0|||
129127547|NCT02101853|464759357|FG000|Block 1 Induction|Protocol Violation|2|||
129127548|NCT02101853|464759358|FG001|Block 1 Induction|Protocol Violation|0|||
129127549|NCT02101853|464759359|FG002|Block 1 Induction|Protocol Violation|0|||
128961537|NCT03434041|464144934|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
128961538|NCT03434041|464144933|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
129127550|NCT02101853|464759360|FG003|Block 1 Induction|Protocol Violation|0|||
129127551|NCT02101853|464759361|FG004|Block 1 Induction|Protocol Violation|0|||
129127552|NCT02101853|464759362|FG005|Block 1 Induction|Protocol Violation|0|||
129127553|NCT02101853|464759357|FG000|Block 1 Induction|Withdrawal by Subject|65|||
129127554|NCT02101853|464759358|FG001|Block 1 Induction|Withdrawal by Subject|0|||
129127555|NCT02101853|464759359|FG002|Block 1 Induction|Withdrawal by Subject|0|||
129127556|NCT02101853|464759360|FG003|Block 1 Induction|Withdrawal by Subject|0|||
129127557|NCT02101853|464759361|FG004|Block 1 Induction|Withdrawal by Subject|0|||
129219981|NCT02908672|465104674|FG002|Run-in Period|Protocol Violation|0|||
129127558|NCT02101853|464759362|FG005|Block 1 Induction|Withdrawal by Subject|0|||
129127559|NCT02101853|464759357|FG000|Block 1 Induction|Ineligible|8|||
129127560|NCT02101853|464759358|FG001|Block 1 Induction|Ineligible|0|||
129127561|NCT02101853|464759359|FG002|Block 1 Induction|Ineligible|0|||
129127562|NCT02101853|464759360|FG003|Block 1 Induction|Ineligible|0|||
129127563|NCT02101853|464759361|FG004|Block 1 Induction|Ineligible|0|||
128713134|NCT01472081|463246026|FG004|Overall Study|Disease Progression|22|||
129127564|NCT02101853|464759362|FG005|Block 1 Induction|Ineligible|0|||
129127565|NCT02101853|464759357|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
129127566|NCT02101853|464759358|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129127567|NCT02101853|464759359|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129127568|NCT02101853|464759360|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129127569|NCT02101853|464759361|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129127570|NCT02101853|464759362|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129127571|NCT02101853|464759357|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
129127572|NCT02101853|464759358|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127573|NCT02101853|464759359|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127574|NCT02101853|464759360|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127575|NCT02101853|464759361|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127576|NCT02101853|464759362|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127577|NCT02101853|464759357|FG000|Post Induction Randomization|Adverse Event|0|||
129127578|NCT02101853|464759358|FG001|Post Induction Randomization|Adverse Event|3|||
129127579|NCT02101853|464759359|FG002|Post Induction Randomization|Adverse Event|8|||
129127580|NCT02101853|464759360|FG003|Post Induction Randomization|Adverse Event|4|||
129127581|NCT02101853|464759361|FG004|Post Induction Randomization|Adverse Event|4|||
129127582|NCT02101853|464759362|FG005|Post Induction Randomization|Adverse Event|0|||
129127583|NCT02101853|464759357|FG000|Post Induction Randomization|Death|0|||
129127584|NCT02101853|464759358|FG001|Post Induction Randomization|Death|9|||
129127585|NCT02101853|464759359|FG002|Post Induction Randomization|Death|2|||
129127586|NCT02101853|464759360|FG003|Post Induction Randomization|Death|2|||
129127587|NCT02101853|464759361|FG004|Post Induction Randomization|Death|0|||
129127588|NCT02101853|464759362|FG005|Post Induction Randomization|Death|0|||
129127589|NCT02101853|464759357|FG000|Post Induction Randomization|Lack of Efficacy|0|||
129127590|NCT02101853|464759358|FG001|Post Induction Randomization|Lack of Efficacy|14|||
129127591|NCT02101853|464759359|FG002|Post Induction Randomization|Lack of Efficacy|23|||
129127592|NCT02101853|464759360|FG003|Post Induction Randomization|Lack of Efficacy|18|||
129127593|NCT02101853|464759361|FG004|Post Induction Randomization|Lack of Efficacy|21|||
129127594|NCT02101853|464759362|FG005|Post Induction Randomization|Lack of Efficacy|0|||
129127595|NCT02101853|464759357|FG000|Post Induction Randomization|Physician Decision|0|||
129127596|NCT02101853|464759358|FG001|Post Induction Randomization|Physician Decision|43|||
129127597|NCT02101853|464759359|FG002|Post Induction Randomization|Physician Decision|23|||
129127598|NCT02101853|464759360|FG003|Post Induction Randomization|Physician Decision|14|||
129127599|NCT02101853|464759361|FG004|Post Induction Randomization|Physician Decision|14|||
129127600|NCT02101853|464759362|FG005|Post Induction Randomization|Physician Decision|0|||
129127601|NCT02101853|464759357|FG000|Post Induction Randomization|Protocol Violation|0|||
129127602|NCT02101853|464759358|FG001|Post Induction Randomization|Protocol Violation|3|||
129127603|NCT02101853|464759359|FG002|Post Induction Randomization|Protocol Violation|0|||
129127604|NCT02101853|464759360|FG003|Post Induction Randomization|Protocol Violation|0|||
129127605|NCT02101853|464759361|FG004|Post Induction Randomization|Protocol Violation|0|||
129127606|NCT02101853|464759362|FG005|Post Induction Randomization|Protocol Violation|0|||
129127607|NCT02101853|464759357|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
129127608|NCT02101853|464759358|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
129127609|NCT02101853|464759359|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
129127610|NCT02101853|464759360|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
129127611|NCT02101853|464759361|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
129127612|NCT02101853|464759362|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
129127613|NCT02101853|464759357|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127614|NCT02101853|464759358|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127615|NCT02101853|464759359|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127616|NCT02101853|464759360|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
129127617|NCT02101853|464759361|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127618|NCT02101853|464759362|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129127619|NCT02101853|464759357|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
129127620|NCT02101853|464759358|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
128713135|NCT01472081|463246027|FG005|Overall Study|Disease Progression|3|||
128713136|NCT01472081|463246022|FG000|Overall Study|Study drug toxicity|2|||
128713137|NCT01472081|463246023|FG001|Overall Study|Study drug toxicity|9|||
128713138|NCT01472081|463246024|FG002|Overall Study|Study drug toxicity|4|||
128713139|NCT01472081|463246025|FG003|Overall Study|Study drug toxicity|6|||
128713140|NCT01472081|463246026|FG004|Overall Study|Study drug toxicity|13|||
128713141|NCT01472081|463246027|FG005|Overall Study|Study drug toxicity|2|||
128713142|NCT01472081|463246022|FG000|Overall Study|Death|0|||
128713143|NCT01472081|463246023|FG001|Overall Study|Death|0|||
128713144|NCT01472081|463246024|FG002|Overall Study|Death|0|||
128713145|NCT01472081|463246025|FG003|Overall Study|Death|0|||
128713146|NCT01472081|463246026|FG004|Overall Study|Death|1|||
128713147|NCT01472081|463246027|FG005|Overall Study|Death|0|||
128713148|NCT01472081|463246022|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
128713149|NCT01472081|463246023|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
128961539|NCT03434041|464144934|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
128961540|NCT03434041|464144933|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
128961541|NCT03434041|464144934|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
128961542|NCT04075396|464144935|FG000|Overall Study|Death|11|||
128961543|NCT04075396|464144936|FG001|Overall Study|Death|9|||
128961544|NCT04075396|464144935|FG000|Overall Study|Withdrawal by Subject|1|||
128961545|NCT04075396|464144936|FG001|Overall Study|Withdrawal by Subject|2|||
128961546|NCT04075396|464144935|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
128961547|NCT04075396|464144936|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
128961548|NCT04075396|464144935|FG000|Overall Study|Enrolled but not-treated|0|||
128961549|NCT04075396|464144936|FG001|Overall Study|Enrolled but not-treated|1|||
128961550|NCT03363165|464144943|FG000|3-month Follow-up|Death|0|||
128961551|NCT03363165|464144944|FG001|3-month Follow-up|Death|1|||
128961552|NCT03363165|464144943|FG000|6-month Follow-up|Death|0|||
128961553|NCT03363165|464144944|FG001|6-month Follow-up|Death|1|||
128961554|NCT03363165|464144943|FG000|6-month Follow-up|Withdrawal by Subject|1|||
128961555|NCT03363165|464144944|FG001|6-month Follow-up|Withdrawal by Subject|1|||
128961556|NCT03363165|464144943|FG000|12-month Follow-up|Death|1|||
128961557|NCT03363165|464144944|FG001|12-month Follow-up|Death|1|||
128961558|NCT03363165|464144943|FG000|12-month Follow-up|Withdrawal by Subject|1|||
128961559|NCT03363165|464144944|FG001|12-month Follow-up|Withdrawal by Subject|1|||
128961560|NCT02255760|464144945|FG000|Overall Study|Lost to Follow-up|0|||
128961561|NCT02255760|464144946|FG001|Overall Study|Lost to Follow-up|1|||
128961562|NCT02255760|464144947|FG002|Overall Study|Lost to Follow-up|0|||
128961563|NCT02255760|464144948|FG003|Overall Study|Lost to Follow-up|0|||
128961564|NCT02255760|464144949|FG004|Overall Study|Lost to Follow-up|0|||
128961565|NCT00618813|464144950|FG000|Overall Study|Lack of Efficacy|1|||
128961566|NCT00618813|464144950|FG000|Overall Study|Physician Decision|2|||
128961567|NCT00618813|464144950|FG000|Overall Study|Withdrawal by Subject|1|||
128961568|NCT00003838|464144951|FG000|Overall Study|Death|0|||
128961569|NCT00003838|464144952|FG001|Overall Study|Death|12|||
128961570|NCT00003838|464144953|FG002|Overall Study|Death|7|||
128961571|NCT00003838|464144951|FG000|Overall Study|Lost to Follow-up|0|||
128961572|NCT00003838|464144952|FG001|Overall Study|Lost to Follow-up|1|||
128961573|NCT00003838|464144953|FG002|Overall Study|Lost to Follow-up|1|||
128961574|NCT00003838|464144951|FG000|Overall Study|Disease Progression|0|||
128961575|NCT00003838|464144952|FG001|Overall Study|Disease Progression|12|||
128961576|NCT00003838|464144953|FG002|Overall Study|Disease Progression|0|||
128961577|NCT01809197|464144954|FG000|Overall Study|Lost to Follow-up|4|||
128961578|NCT01809197|464144955|FG001|Overall Study|Lost to Follow-up|2|||
128961579|NCT01809197|464144954|FG000|Overall Study|Adverse Event|2|||
128961580|NCT01809197|464144955|FG001|Overall Study|Adverse Event|3|||
128961581|NCT01809197|464144954|FG000|Overall Study|Failed slit lamp exam|1|||
128961582|NCT01809197|464144955|FG001|Overall Study|Failed slit lamp exam|0|||
128961583|NCT01809197|464144954|FG000|Overall Study|Non-Compliance|1|||
128961584|NCT01809197|464144955|FG001|Overall Study|Non-Compliance|1|||
128961585|NCT01809197|464144954|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
128961586|NCT01809197|464144955|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
128961587|NCT01809197|464144954|FG000|Overall Study|Withdrawal by Subject|1|||
128961588|NCT01809197|464144955|FG001|Overall Study|Withdrawal by Subject|1|||
128961589|NCT01809197|464144954|FG000|Overall Study|Product not available|0|||
128961590|NCT01809197|464144955|FG001|Overall Study|Product not available|1|||
129127621|NCT02101853|464759359|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
128713150|NCT01472081|463246024|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
128713151|NCT01472081|463246025|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
128713152|NCT01472081|463246026|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
129127622|NCT02101853|464759360|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
129127623|NCT02101853|464759361|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
128713153|NCT01472081|463246027|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
128713154|NCT01472081|463246022|FG000|Overall Study|Withdrawal by Subject|0|||
128713155|NCT01472081|463246023|FG001|Overall Study|Withdrawal by Subject|0|||
128713156|NCT01472081|463246024|FG002|Overall Study|Withdrawal by Subject|0|||
128961591|NCT00291187|464144958|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
128961592|NCT00291187|464144959|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
128961593|NCT00291187|464144960|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
128961594|NCT00291187|464144961|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
128961595|NCT02708966|464144963|FG000|Overall Study|Lost to Follow-up|2|||
128961596|NCT02708966|464144964|FG001|Overall Study|Lost to Follow-up|2|||
128961597|NCT02959190|464144967|FG000|Open Label|Adverse Event|5|||
128961598|NCT02959190|464144968|FG001|Open Label|Adverse Event|7|||
128961599|NCT02959190|464144969|FG002|Open Label|Adverse Event|3|||
128961600|NCT02959190|464144970|FG003|Open Label|Adverse Event|4|||
128961601|NCT02959190|464144967|FG000|Open Label|Pregnancy|0|||
128961602|NCT02959190|464144968|FG001|Open Label|Pregnancy|1|||
128961603|NCT02959190|464144969|FG002|Open Label|Pregnancy|0|||
128961604|NCT02959190|464144970|FG003|Open Label|Pregnancy|0|||
128961605|NCT02959190|464144967|FG000|Open Label|Withdrawal by Subject|2|||
128961606|NCT02959190|464144968|FG001|Open Label|Withdrawal by Subject|8|||
128961607|NCT02959190|464144969|FG002|Open Label|Withdrawal by Subject|0|||
128961608|NCT02959190|464144970|FG003|Open Label|Withdrawal by Subject|0|||
128961609|NCT02959190|464144967|FG000|Open Label|Physician Decision|0|||
128961610|NCT02959190|464144968|FG001|Open Label|Physician Decision|0|||
128961611|NCT02959190|464144969|FG002|Open Label|Physician Decision|1|||
128961612|NCT02959190|464144970|FG003|Open Label|Physician Decision|0|||
128961613|NCT02959190|464144967|FG000|Open Label|Protocol Violation|0|||
128961614|NCT02959190|464144968|FG001|Open Label|Protocol Violation|0|||
128961615|NCT02959190|464144969|FG002|Open Label|Protocol Violation|0|||
128961616|NCT02959190|464144970|FG003|Open Label|Protocol Violation|2|||
128961617|NCT02959190|464144967|FG000|Post Treatment Follow Up|Adverse Event|1|||
128961618|NCT02959190|464144968|FG001|Post Treatment Follow Up|Adverse Event|1|||
128961619|NCT02959190|464144969|FG002|Post Treatment Follow Up|Adverse Event|0|||
128961620|NCT02959190|464144970|FG003|Post Treatment Follow Up|Adverse Event|0|||
128961621|NCT02959190|464144967|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
128961622|NCT02959190|464144968|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
129127624|NCT02101853|464759362|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
129127625|NCT02101853|464759357|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
128961623|NCT02959190|464144969|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
128961624|NCT02959190|464144970|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
128961625|NCT02023268|464144971|FG000|Overall Study|Lack of Efficacy|0|||
128961626|NCT02023268|464144972|FG001|Overall Study|Lack of Efficacy|1|||
128961627|NCT02023268|464144971|FG000|Overall Study|Adverse Event|0|||
128961628|NCT02023268|464144972|FG001|Overall Study|Adverse Event|2|||
128961629|NCT02023268|464144971|FG000|Overall Study|Withdrawal by Subject|0|||
128961630|NCT02023268|464144972|FG001|Overall Study|Withdrawal by Subject|1|||
128961631|NCT02925312|464144975|FG000|Overall Study|Lost to Follow-up|25|||
128961632|NCT02925312|464144976|FG001|Overall Study|Lost to Follow-up|0|||
128961633|NCT02925312|464144975|FG000|Overall Study|Adverse Event|2|||
128961634|NCT02925312|464144976|FG001|Overall Study|Adverse Event|0|||
128961635|NCT00418717|464144980|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
128961636|NCT00418717|464144980|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
128961637|NCT00719537|464144984|FG000|Overall Study|Withdrawal by Subject|1|||
129127626|NCT02101853|464759358|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
129127627|NCT02101853|464759359|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129127628|NCT02101853|464759360|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129127629|NCT02101853|464759361|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129127630|NCT02101853|464759362|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129127631|NCT02101853|464759357|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129127632|NCT02101853|464759358|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129127633|NCT02101853|464759359|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129127634|NCT02101853|464759360|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
129127635|NCT02101853|464759361|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
129127636|NCT02101853|464759362|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129127637|NCT02101853|464759357|FG000|Blinatumomab Salvage Therapy|Death|0|||
129219982|NCT02908672|465104675|FG003|Run-in Period|Protocol Violation|0|||
129219983|NCT02908672|465104672|FG000|Run-in Period|Study Ended by Sponsor|5|||
128961638|NCT00719537|464144985|FG001|Overall Study|Withdrawal by Subject|0|||
128961639|NCT00719537|464144984|FG000|Overall Study|Lost to Follow-up|0|||
128961640|NCT00719537|464144985|FG001|Overall Study|Lost to Follow-up|1|||
128961641|NCT01142193|464144986|FG000|Overall Study|Adverse Event|12|||
128961642|NCT01142193|464144987|FG001|Overall Study|Adverse Event|4|||
128961643|NCT01142193|464144986|FG000|Overall Study|Lack of Efficacy|2|||
128961644|NCT01142193|464144987|FG001|Overall Study|Lack of Efficacy|1|||
128961645|NCT01142193|464144986|FG000|Overall Study|Physician Decision|1|||
128961646|NCT01142193|464144987|FG001|Overall Study|Physician Decision|1|||
128961647|NCT01142193|464144986|FG000|Overall Study|Withdrawal by Subject|4|||
128961648|NCT01142193|464144987|FG001|Overall Study|Withdrawal by Subject|3|||
128961649|NCT01142193|464144986|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
128961650|NCT01142193|464144987|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
128961651|NCT01142193|464144986|FG000|Overall Study|Other|1|||
128961652|NCT01142193|464144987|FG001|Overall Study|Other|2|||
128961653|NCT01459068|464144988|FG000|Overall Study|Withdrawal by Subject|8|||
128961654|NCT01459068|464144989|FG001|Overall Study|Withdrawal by Subject|18|||
128961655|NCT01459068|464144988|FG000|Overall Study|Lost to Follow-up|31|||
128961656|NCT01459068|464144989|FG001|Overall Study|Lost to Follow-up|15|||
128961657|NCT01459068|464144988|FG000|Overall Study|Death|0|||
128961658|NCT01459068|464144989|FG001|Overall Study|Death|1|||
128961659|NCT00196196|464144992|FG000|Overall Study|Withdrawal by Subject|2|||
128961660|NCT00196196|464144992|FG000|Overall Study|Did not have required condition (hydroce|5|||
128961661|NCT01015820|464144993|FG000|Overall Study|Suboptimal measurements|1|||
128961662|NCT01015820|464144994|FG001|Overall Study|Suboptimal measurements|0|||
128961663|NCT00795509|464144995|FG000|Overall Study|Protocol Violation|31|||
128961664|NCT01601470|464144996|FG000|Period 2 - LCZ696|Physician Decision|1|||
128961665|NCT01203787|464144997|FG000|Overall Study|Death|12|||
128961666|NCT01203787|464144998|FG001|Overall Study|Death|10|||
128961667|NCT01203787|464144997|FG000|Overall Study|Withdrawal by Subject|6|||
128961668|NCT01203787|464144998|FG001|Overall Study|Withdrawal by Subject|2|||
128961669|NCT01203787|464144997|FG000|Overall Study|Lost to Follow-up|2|||
128961670|NCT01203787|464144998|FG001|Overall Study|Lost to Follow-up|0|||
128961671|NCT01203787|464144997|FG000|Overall Study|Adverse Event|11|||
128961672|NCT01203787|464144998|FG001|Overall Study|Adverse Event|15|||
128961673|NCT03404518|464144999|FG000|Overall Study|Lost to Follow-up|28|||
128961674|NCT03404518|464145000|FG001|Overall Study|Lost to Follow-up|30|||
128961675|NCT03404518|464144999|FG000|Overall Study|Protocol Violation|13|||
128961676|NCT03404518|464145000|FG001|Overall Study|Protocol Violation|6|||
128961677|NCT01079195|464145001|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
128961678|NCT01079195|464145001|FG000|Overall Study|No Documentation Available|437|||
128961679|NCT01079195|464145001|FG000|Overall Study|Adverse Event|157|||
128961680|NCT01079195|464145001|FG000|Overall Study|Reason Unknown|39|||
128961681|NCT01079195|464145001|FG000|Overall Study|Withdrawal by Subject|18|||
128961682|NCT01079195|464145001|FG000|Overall Study|Financial Reasons|15|||
128961683|NCT01079195|464145001|FG000|Overall Study|Lack of Effectiveness|12|||
128961684|NCT01079195|464145001|FG000|Overall Study|Physician Decision|4|||
128961685|NCT01079195|464145001|FG000|Overall Study|Improved Status of Participant|4|||
128961686|NCT01079195|464145001|FG000|Overall Study|No Follow-up Documentation Available|4|||
128961687|NCT01079195|464145001|FG000|Overall Study|Non-compliance|2|||
128961688|NCT03693404|464145006|FG000|Overall Study|Withdrawal by Subject|1|||
128961689|NCT03693404|464145007|FG001|Overall Study|Withdrawal by Subject|0|||
128961690|NCT03693404|464145006|FG000|Overall Study|Lost to Follow-up|0|||
128961691|NCT03693404|464145007|FG001|Overall Study|Lost to Follow-up|5|||
128961692|NCT03693404|464145006|FG000|Overall Study|Excluded from Analysis|0|||
128961693|NCT03693404|464145007|FG001|Overall Study|Excluded from Analysis|1|||
128961694|NCT02079519|464145008|FG000|Overall Study|Disease Progression|9|||
128961695|NCT02079519|464145008|FG000|Overall Study|Adverse Event|1|||
128961696|NCT01041404|464145014|FG000|Overall Study|Adverse Event|45|||
128961697|NCT01041404|464145015|FG001|Overall Study|Adverse Event|35|||
128961698|NCT01041404|464145014|FG000|Overall Study|Lack of Efficacy|200|||
128961699|NCT01041404|464145015|FG001|Overall Study|Lack of Efficacy|210|||
128961700|NCT01041404|464145014|FG000|Overall Study|Violation of Selection Criteria|0|||
128961701|NCT01041404|464145015|FG001|Overall Study|Violation of Selection Criteria|1|||
128961702|NCT01041404|464145014|FG000|Overall Study|Protocol Violation|4|||
128961703|NCT01041404|464145015|FG001|Overall Study|Protocol Violation|0|||
128961704|NCT01041404|464145014|FG000|Overall Study|Withdrawal by Subject|29|||
128961705|NCT01041404|464145015|FG001|Overall Study|Withdrawal by Subject|23|||
128961706|NCT01041404|464145014|FG000|Overall Study|Failure to Return|1|||
128961707|NCT01041404|464145015|FG001|Overall Study|Failure to Return|2|||
128961708|NCT01041404|464145014|FG000|Overall Study|Other|11|||
128961709|NCT01041404|464145015|FG001|Overall Study|Other|23|||
128961710|NCT01685203|464145017|FG000|Overall Study|Lost to Follow-up|3|||
128961711|NCT01685203|464145018|FG001|Overall Study|Lost to Follow-up|3|||
128961712|NCT01685203|464145019|FG002|Overall Study|Lost to Follow-up|0|||
128961713|NCT01685203|464145020|FG003|Overall Study|Lost to Follow-up|1|||
128961714|NCT01685203|464145021|FG004|Overall Study|Lost to Follow-up|0|||
128961715|NCT01685203|464145022|FG005|Overall Study|Lost to Follow-up|0|||
128961716|NCT01685203|464145023|FG006|Overall Study|Lost to Follow-up|0|||
128961717|NCT01685203|464145017|FG000|Overall Study|Adverse Event|0|||
128961718|NCT01685203|464145018|FG001|Overall Study|Adverse Event|0|||
128961719|NCT01685203|464145019|FG002|Overall Study|Adverse Event|0|||
128961720|NCT01685203|464145020|FG003|Overall Study|Adverse Event|0|||
128961721|NCT01685203|464145021|FG004|Overall Study|Adverse Event|0|||
128961722|NCT01685203|464145022|FG005|Overall Study|Adverse Event|2|||
129037064|NCT01522950|464426340|FG001|Overall Study|Adverse Event|1|||
129037065|NCT01522950|464426341|FG002|Overall Study|Adverse Event|1|||
128961723|NCT01685203|464145023|FG006|Overall Study|Adverse Event|0|||
128961724|NCT01685203|464145017|FG000|Overall Study|Adverse event and withdrew consent|1|||
128961725|NCT01685203|464145018|FG001|Overall Study|Adverse event and withdrew consent|0|||
128961726|NCT01685203|464145019|FG002|Overall Study|Adverse event and withdrew consent|0|||
128961727|NCT01685203|464145020|FG003|Overall Study|Adverse event and withdrew consent|0|||
128713157|NCT01472081|463246025|FG003|Overall Study|Withdrawal by Subject|0|||
128713158|NCT01472081|463246026|FG004|Overall Study|Withdrawal by Subject|0|||
128713159|NCT01472081|463246027|FG005|Overall Study|Withdrawal by Subject|1|||
128713160|NCT01472081|463246022|FG000|Overall Study|Poor/non-compliance|0|||
128713161|NCT01472081|463246023|FG001|Overall Study|Poor/non-compliance|0|||
128713162|NCT01472081|463246024|FG002|Overall Study|Poor/non-compliance|1|||
128713163|NCT01472081|463246025|FG003|Overall Study|Poor/non-compliance|0|||
128713164|NCT01472081|463246026|FG004|Overall Study|Poor/non-compliance|1|||
128713165|NCT01472081|463246027|FG005|Overall Study|Poor/non-compliance|0|||
128713166|NCT01472081|463246022|FG000|Overall Study|No longer meets study criteria|0|||
128713167|NCT01472081|463246023|FG001|Overall Study|No longer meets study criteria|0|||
128713168|NCT01472081|463246024|FG002|Overall Study|No longer meets study criteria|1|||
128713169|NCT01472081|463246025|FG003|Overall Study|No longer meets study criteria|0|||
128713170|NCT01472081|463246026|FG004|Overall Study|No longer meets study criteria|0|||
128713171|NCT01472081|463246027|FG005|Overall Study|No longer meets study criteria|0|||
128961728|NCT01685203|464145021|FG004|Overall Study|Adverse event and withdrew consent|0|||
128961729|NCT01685203|464145022|FG005|Overall Study|Adverse event and withdrew consent|0|||
128961730|NCT01685203|464145023|FG006|Overall Study|Adverse event and withdrew consent|0|||
128961731|NCT01685203|464145017|FG000|Overall Study|Patient's decision|0|||
128961732|NCT01685203|464145018|FG001|Overall Study|Patient's decision|0|||
128961733|NCT01685203|464145019|FG002|Overall Study|Patient's decision|0|||
128961734|NCT01685203|464145020|FG003|Overall Study|Patient's decision|0|||
128961735|NCT01685203|464145021|FG004|Overall Study|Patient's decision|0|||
128961736|NCT01685203|464145022|FG005|Overall Study|Patient's decision|1|||
128961737|NCT01685203|464145023|FG006|Overall Study|Patient's decision|0|||
128961738|NCT00383708|464145024|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
128961739|NCT00383708|464145024|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
128961740|NCT00383708|464145024|FG000|Run-in Period|Protocol Violation|4|||
128961741|NCT00383708|464145024|FG000|Run-in Period|Adverse Event|2|||
128961742|NCT00383708|464145024|FG000|Run-in Period|Claustrophobia|1|||
128961743|NCT00383708|464145024|FG000|Co-administration Period|Adverse Event|5|||
128961744|NCT00318370|464145025|FG000|Period 1|Lack of Efficacy|5|||
128961745|NCT00318370|464145026|FG001|Period 1|Lack of Efficacy|0|||
128961746|NCT00318370|464145027|FG002|Period 1|Lack of Efficacy|0|||
128961747|NCT00318370|464145025|FG000|Period 1|Physician Decision|1|||
128961748|NCT00318370|464145026|FG001|Period 1|Physician Decision|0|||
128961749|NCT00318370|464145027|FG002|Period 1|Physician Decision|0|||
128961750|NCT00318370|464145025|FG000|Period 1|Withdrawal by Subject|1|||
128961751|NCT00318370|464145026|FG001|Period 1|Withdrawal by Subject|0|||
128961752|NCT00318370|464145027|FG002|Period 1|Withdrawal by Subject|0|||
128961753|NCT00318370|464145025|FG000|Period 2|Adverse Event|0|||
128961754|NCT00318370|464145026|FG001|Period 2|Adverse Event|3|||
128961755|NCT00318370|464145027|FG002|Period 2|Adverse Event|0|||
128961756|NCT00318370|464145025|FG000|Period 2|Lack of Efficacy|0|||
128961757|NCT00318370|464145026|FG001|Period 2|Lack of Efficacy|5|||
128961758|NCT00318370|464145027|FG002|Period 2|Lack of Efficacy|0|||
128961759|NCT00318370|464145025|FG000|Period 2|Physician Decision|0|||
128961760|NCT00318370|464145026|FG001|Period 2|Physician Decision|1|||
128961761|NCT00318370|464145027|FG002|Period 2|Physician Decision|0|||
128961762|NCT00318370|464145025|FG000|Period 2|Withdrawal by Subject|0|||
128961763|NCT00318370|464145026|FG001|Period 2|Withdrawal by Subject|1|||
128961764|NCT00318370|464145027|FG002|Period 2|Withdrawal by Subject|0|||
128961765|NCT00318370|464145025|FG000|Period 2|Other|0|||
128961766|NCT00318370|464145026|FG001|Period 2|Other|1|||
128961767|NCT00318370|464145027|FG002|Period 2|Other|0|||
128961768|NCT00318370|464145025|FG000|Period 3|Adverse Event|0|||
128961769|NCT00318370|464145026|FG001|Period 3|Adverse Event|0|||
128961770|NCT00318370|464145027|FG002|Period 3|Adverse Event|1|||
128713172|NCT01472081|463246022|FG000|Overall Study|Subject request to discontinue treatment|0|||
128713173|NCT01472081|463246023|FG001|Overall Study|Subject request to discontinue treatment|3|||
128713174|NCT01472081|463246024|FG002|Overall Study|Subject request to discontinue treatment|1|||
128713175|NCT01472081|463246025|FG003|Overall Study|Subject request to discontinue treatment|1|||
128713176|NCT01472081|463246026|FG004|Overall Study|Subject request to discontinue treatment|0|||
128961771|NCT00318370|464145025|FG000|Period 3|Lack of Efficacy|0|||
129219984|NCT02908672|465104673|FG001|Run-in Period|Study Ended by Sponsor|1|||
129219985|NCT02908672|465104674|FG002|Run-in Period|Study Ended by Sponsor|0|||
128961772|NCT00318370|464145026|FG001|Period 3|Lack of Efficacy|0|||
128961773|NCT00318370|464145027|FG002|Period 3|Lack of Efficacy|24|||
128961774|NCT00318370|464145025|FG000|Period 3|Death|0|||
128961775|NCT00318370|464145026|FG001|Period 3|Death|0|||
128961776|NCT00318370|464145027|FG002|Period 3|Death|1|||
128961777|NCT00318370|464145025|FG000|Period 3|Physician Decision|0|||
128961778|NCT00318370|464145026|FG001|Period 3|Physician Decision|0|||
128961779|NCT00318370|464145027|FG002|Period 3|Physician Decision|1|||
128961780|NCT00318370|464145025|FG000|Period 3|Withdrawal by Subject|0|||
128961781|NCT00318370|464145026|FG001|Period 3|Withdrawal by Subject|0|||
128961782|NCT00318370|464145027|FG002|Period 3|Withdrawal by Subject|3|||
128961783|NCT00318370|464145025|FG000|Period 3|Other|0|||
128961784|NCT00318370|464145026|FG001|Period 3|Other|0|||
128961785|NCT00318370|464145027|FG002|Period 3|Other|3|||
128713177|NCT01472081|463246027|FG005|Overall Study|Subject request to discontinue treatment|0|||
128713178|NCT00847704|463246028|FG000|Overall Study|Withdrawal by Subject|1|||
128713179|NCT01962207|463246029|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
128961786|NCT01750840|464145028|FG000|Overall Study|Lost to Follow-up|4|||
128961787|NCT01576406|464145030|FG000|Overall Study|Lost to Follow-up|1|||
128961788|NCT01576406|464145031|FG001|Overall Study|Lost to Follow-up|2|||
128961789|NCT01576406|464145032|FG002|Overall Study|Lost to Follow-up|0|||
128961790|NCT01576406|464145033|FG003|Overall Study|Lost to Follow-up|0|||
128961791|NCT01576406|464145034|FG004|Overall Study|Lost to Follow-up|0|||
128961792|NCT01576406|464145035|FG005|Overall Study|Lost to Follow-up|0|||
128961793|NCT01576406|464145030|FG000|Overall Study|Death|3|||
128961794|NCT01576406|464145031|FG001|Overall Study|Death|4|||
128961795|NCT01576406|464145032|FG002|Overall Study|Death|8|||
128961796|NCT01576406|464145033|FG003|Overall Study|Death|5|||
128961797|NCT01576406|464145034|FG004|Overall Study|Death|7|||
128961798|NCT01576406|464145035|FG005|Overall Study|Death|9|||
128961799|NCT01576406|464145030|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
128961800|NCT01576406|464145031|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
128961801|NCT01576406|464145032|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
128961802|NCT01576406|464145033|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
128961803|NCT01576406|464145034|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
128961804|NCT01576406|464145035|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
128961805|NCT01576406|464145030|FG000|Overall Study|Withdrawal the consent|2|||
128961806|NCT01576406|464145031|FG001|Overall Study|Withdrawal the consent|2|||
128961807|NCT01576406|464145032|FG002|Overall Study|Withdrawal the consent|5|||
128961808|NCT01576406|464145033|FG003|Overall Study|Withdrawal the consent|1|||
128961809|NCT01576406|464145034|FG004|Overall Study|Withdrawal the consent|1|||
128961810|NCT01576406|464145035|FG005|Overall Study|Withdrawal the consent|3|||
128961811|NCT01576406|464145030|FG000|Overall Study|Other|0|||
128961812|NCT01576406|464145031|FG001|Overall Study|Other|0|||
128961813|NCT01576406|464145032|FG002|Overall Study|Other|2|||
128961814|NCT01576406|464145033|FG003|Overall Study|Other|2|||
128961815|NCT01576406|464145034|FG004|Overall Study|Other|0|||
128961816|NCT01576406|464145035|FG005|Overall Study|Other|0|||
128961817|NCT00669032|464145038|FG000|Overall Study|Lost to Follow-up|6|||
128961818|NCT00669032|464145039|FG001|Overall Study|Lost to Follow-up|5|||
128961819|NCT00669032|464145038|FG000|Overall Study|Lack of Efficacy|8|||
128961820|NCT00669032|464145039|FG001|Overall Study|Lack of Efficacy|19|||
128961821|NCT00669032|464145038|FG000|Overall Study|Withdrawal by Subject|12|||
128961822|NCT00669032|464145039|FG001|Overall Study|Withdrawal by Subject|13|||
128961823|NCT00669032|464145038|FG000|Overall Study|Adverse Event|12|||
128961824|NCT00669032|464145039|FG001|Overall Study|Adverse Event|16|||
128961825|NCT00669032|464145038|FG000|Overall Study|Physician Decision|1|||
128961826|NCT00669032|464145039|FG001|Overall Study|Physician Decision|1|||
128961827|NCT00669032|464145038|FG000|Overall Study|No fulfilment of the selection criteria|5|||
128961828|NCT00669032|464145039|FG001|Overall Study|No fulfilment of the selection criteria|5|||
128961829|NCT01607073|464145040|FG000|Overall Study|Adverse Event|1|||
128961830|NCT03627494|464145041|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
128961831|NCT03627494|464145042|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961832|NCT03627494|464145043|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
128961833|NCT03627494|464145044|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961834|NCT03627494|464145045|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961835|NCT03627494|464145046|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961836|NCT03627494|464145047|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961837|NCT03627494|464145048|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961838|NCT03627494|464145049|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961839|NCT03627494|464145050|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961840|NCT03627494|464145051|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961841|NCT03627494|464145052|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
128961842|NCT03627494|464145041|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961843|NCT03627494|464145042|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
128713180|NCT01962207|463246030|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
128713181|NCT01962207|463246031|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
128713182|NCT01962207|463246032|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
128713183|NCT01962207|463246029|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
128713184|NCT01962207|463246030|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
128771509|NCT04921969|463453721|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
128961844|NCT03627494|464145043|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961845|NCT03627494|464145044|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961846|NCT03627494|464145045|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
128771510|NCT04921969|463453722|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
128961847|NCT03627494|464145046|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961848|NCT03627494|464145047|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961849|NCT03627494|464145048|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961850|NCT03627494|464145049|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
128961851|NCT03627494|464145050|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961852|NCT03627494|464145051|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961853|NCT03627494|464145052|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
128961854|NCT03627494|464145041|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961855|NCT03627494|464145042|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961856|NCT03627494|464145043|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961857|NCT03627494|464145044|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961858|NCT03627494|464145045|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961859|NCT03627494|464145046|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961860|NCT03627494|464145047|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961861|NCT03627494|464145048|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961862|NCT03627494|464145049|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961863|NCT03627494|464145050|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
128961864|NCT03627494|464145051|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
128961865|NCT03627494|464145052|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
128961866|NCT00446641|464146962|FG000|Overall Study|Withdrawal by Subject|8|||
128961867|NCT00446641|464146963|FG001|Overall Study|Withdrawal by Subject|3|||
128961868|NCT00446641|464146962|FG000|Overall Study|poor compliance|8|||
128961869|NCT00446641|464146963|FG001|Overall Study|poor compliance|6|||
128961870|NCT00446641|464146962|FG000|Overall Study|Lost to Follow-up|1|||
128961871|NCT00446641|464146963|FG001|Overall Study|Lost to Follow-up|1|||
128961872|NCT03565991|464146964|FG000|Overall Study|Other|11|||
128961873|NCT03565991|464146965|FG001|Overall Study|Other|0|||
128961874|NCT03565991|464146964|FG000|Overall Study|Global deterioration of health status|14|||
128961875|NCT03565991|464146965|FG001|Overall Study|Global deterioration of health status|4|||
128961876|NCT03565991|464146964|FG000|Overall Study|Withdrawal by Subject|2|||
128961877|NCT03565991|464146965|FG001|Overall Study|Withdrawal by Subject|6|||
128961878|NCT03565991|464146964|FG000|Overall Study|Progressive disease|121|||
128961879|NCT03565991|464146965|FG001|Overall Study|Progressive disease|29|||
128961880|NCT03565991|464146964|FG000|Overall Study|Death|3|||
128961881|NCT03565991|464146965|FG001|Overall Study|Death|0|||
128961882|NCT03565991|464146964|FG000|Overall Study|Adverse Event|7|||
128961883|NCT03565991|464146965|FG001|Overall Study|Adverse Event|2|||
128961884|NCT00784459|464146966|FG000|Overall Study|Adverse Event|0|||
128961885|NCT00784459|464146967|FG001|Overall Study|Adverse Event|2|||
128961886|NCT00063986|464146968|FG000|Overall Study|Withdrawal by Subject|1|||
128961887|NCT00063986|464146968|FG000|Overall Study|Ineligible|1|||
128961888|NCT00063986|464146968|FG000|Overall Study|Intra-operatively ineligible|4|||
128961889|NCT04839393|464146977|FG000|Overall Study|Adverse Event|0|||
128961890|NCT04839393|464146978|FG001|Overall Study|Adverse Event|0|||
128961891|NCT04839393|464146979|FG002|Overall Study|Adverse Event|2|||
128961892|NCT04839393|464146977|FG000|Overall Study|Withdrawal by participant|0|||
128713185|NCT01962207|463246031|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
128713186|NCT01962207|463246032|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
128713187|NCT01962207|463246029|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
128961893|NCT04839393|464146978|FG001|Overall Study|Withdrawal by participant|0|||
128961894|NCT04839393|464146979|FG002|Overall Study|Withdrawal by participant|1|||
128961895|NCT00633893|464146984|FG000|Overall Study|Death|1|||
128961896|NCT00633893|464146985|FG001|Overall Study|Death|3|||
128961897|NCT00633893|464146986|FG002|Overall Study|Death|9|||
129127638|NCT02101853|464759358|FG001|Blinatumomab Salvage Therapy|Death|0|||
129127639|NCT02101853|464759359|FG002|Blinatumomab Salvage Therapy|Death|0|||
129127640|NCT02101853|464759360|FG003|Blinatumomab Salvage Therapy|Death|0|||
129127641|NCT02101853|464759361|FG004|Blinatumomab Salvage Therapy|Death|0|||
129127642|NCT02101853|464759362|FG005|Blinatumomab Salvage Therapy|Death|2|||
129127643|NCT02101853|464759357|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
128961898|NCT00633893|464146984|FG000|Overall Study|Adverse Event|65|||
128961899|NCT00633893|464146985|FG001|Overall Study|Adverse Event|58|||
128961900|NCT00633893|464146986|FG002|Overall Study|Adverse Event|126|||
128961901|NCT00633893|464146984|FG000|Overall Study|Withdrawal by Subject|7|||
128961902|NCT00633893|464146985|FG001|Overall Study|Withdrawal by Subject|12|||
128961903|NCT00633893|464146986|FG002|Overall Study|Withdrawal by Subject|6|||
128961904|NCT00633893|464146984|FG000|Overall Study|Lost to Follow-up|2|||
128961905|NCT00633893|464146985|FG001|Overall Study|Lost to Follow-up|4|||
128961906|NCT00633893|464146986|FG002|Overall Study|Lost to Follow-up|8|||
129127644|NCT02101853|464759358|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
128713188|NCT01962207|463246030|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
128713189|NCT01962207|463246031|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
128961907|NCT00633893|464146984|FG000|Overall Study|Poor/non-compliance|5|||
128961908|NCT00633893|464146985|FG001|Overall Study|Poor/non-compliance|12|||
128961909|NCT00633893|464146986|FG002|Overall Study|Poor/non-compliance|3|||
128961910|NCT00633893|464146984|FG000|Overall Study|Pregnancy|2|||
128961911|NCT00633893|464146985|FG001|Overall Study|Pregnancy|1|||
128961912|NCT00633893|464146986|FG002|Overall Study|Pregnancy|1|||
128961913|NCT00633893|464146984|FG000|Overall Study|Not meet/no longer meets criteria|4|||
128961914|NCT00633893|464146985|FG001|Overall Study|Not meet/no longer meets criteria|6|||
128961915|NCT00633893|464146986|FG002|Overall Study|Not meet/no longer meets criteria|4|||
128961916|NCT00633893|464146984|FG000|Overall Study|Other|28|||
128713190|NCT01962207|463246032|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
128713191|NCT01962207|463246029|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
128713192|NCT01962207|463246030|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
128961917|NCT00633893|464146985|FG001|Overall Study|Other|33|||
128961918|NCT00633893|464146986|FG002|Overall Study|Other|31|||
128961919|NCT02741310|464146987|FG000|Overall Study|Sponsor Decision|2|||
128961920|NCT02741310|464146988|FG001|Overall Study|Sponsor Decision|2|||
128961921|NCT05091918|464146989|FG000|Overall Study|Adverse Event|1|||
128961922|NCT05091918|464146989|FG000|Overall Study|Withdrawal by Subject|81|||
128961923|NCT00239356|464146990|FG000|Overall Study|Lack of Efficacy|1|||
128961924|NCT00239356|464146991|FG001|Overall Study|Lack of Efficacy|0|||
128961925|NCT00239356|464146990|FG000|Overall Study|Adverse Event|6|||
128961926|NCT00239356|464146991|FG001|Overall Study|Adverse Event|0|||
128961927|NCT00239356|464146990|FG000|Overall Study|Withdrawal by Subject|15|||
128961928|NCT00239356|464146991|FG001|Overall Study|Withdrawal by Subject|6|||
128961929|NCT00239356|464146990|FG000|Overall Study|Lost to Follow-up|3|||
128961930|NCT00239356|464146991|FG001|Overall Study|Lost to Follow-up|0|||
128961931|NCT00239356|464146990|FG000|Overall Study|poor/non-compliance|2|||
128961932|NCT00239356|464146991|FG001|Overall Study|poor/non-compliance|0|||
128961933|NCT00239356|464146990|FG000|Overall Study|Pregnancy|1|||
128961934|NCT00239356|464146991|FG001|Overall Study|Pregnancy|0|||
128961935|NCT00239356|464146990|FG000|Overall Study|Administrative reason|0|||
128961936|NCT00239356|464146991|FG001|Overall Study|Administrative reason|1|||
128961937|NCT00239356|464146990|FG000|Overall Study|Drug available on market|11|||
128961938|NCT00239356|464146991|FG001|Overall Study|Drug available on market|2|||
128961939|NCT02044822|464146992|FG000|Overall Study|Study Terminated by Sponsor|77|||
128961940|NCT02044822|464146992|FG000|Overall Study|Investigator's Discretion|10|||
128961941|NCT02044822|464146992|FG000|Overall Study|Withdrew Consent|3|||
128961942|NCT02044822|464146992|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
128961943|NCT02044822|464146992|FG000|Overall Study|Lost to Follow-up|1|||
128961944|NCT03417505|464146995|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
128961945|NCT03417505|464146996|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
128961946|NCT01237223|464147003|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
128961947|NCT01237223|464147004|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
128961948|NCT01237223|464147005|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
128961949|NCT01237223|464147006|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
128961950|NCT01237223|464147007|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
128961951|NCT01237223|464147008|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
128961952|NCT01237223|464147003|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
128961953|NCT01237223|464147004|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
128961954|NCT01237223|464147005|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
128961955|NCT01237223|464147006|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
128961956|NCT01237223|464147007|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
128961957|NCT01237223|464147008|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
128961958|NCT01237223|464147003|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
128961959|NCT01237223|464147004|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
128961960|NCT01237223|464147005|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
128961961|NCT01237223|464147006|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
128961962|NCT01237223|464147007|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
128961963|NCT01237223|464147008|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
128961964|NCT01237223|464147003|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
128961965|NCT01237223|464147004|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
128961966|NCT01237223|464147005|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
128961967|NCT01237223|464147006|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
128961968|NCT01237223|464147007|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
128961969|NCT01237223|464147008|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
128961970|NCT01237223|464147003|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
128961971|NCT01237223|464147004|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
129037066|NCT01522950|464426339|FG000|Overall Study|Protocol Violation|0|||
129037067|NCT01522950|464426340|FG001|Overall Study|Protocol Violation|0|||
129037068|NCT01522950|464426341|FG002|Overall Study|Protocol Violation|2|||
129037069|NCT01522950|464426339|FG000|Overall Study|Death|0|||
129037070|NCT01522950|464426340|FG001|Overall Study|Death|1|||
129037071|NCT01522950|464426341|FG002|Overall Study|Death|1|||
129037072|NCT01522950|464426339|FG000|Overall Study|Study Medication Sensitivity|0|||
129037073|NCT01522950|464426340|FG001|Overall Study|Study Medication Sensitivity|1|||
129037074|NCT01522950|464426341|FG002|Overall Study|Study Medication Sensitivity|0|||
129037075|NCT00298740|464426342|FG000|Overall Study|Lack of Efficacy|6|||
129037076|NCT00298740|464426342|FG000|Overall Study|Withdrawal by Subject|3|||
128713193|NCT01962207|463246031|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
129127645|NCT02101853|464759359|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129127646|NCT02101853|464759360|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129127647|NCT02101853|464759361|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129037077|NCT03136406|464426343|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
129037078|NCT02000531|464426348|FG000|Overall Study|Lost to Follow-up|1|||
129037079|NCT02000531|464426349|FG001|Overall Study|Lost to Follow-up|0|||
129037080|NCT02000531|464426348|FG000|Overall Study|Discontinued due to data cut-off|3|||
129037081|NCT02000531|464426349|FG001|Overall Study|Discontinued due to data cut-off|8|||
129037082|NCT01345318|464426352|FG000|Overall Study|Adverse Event|16|||
129037083|NCT01345318|464426352|FG000|Overall Study|Lack of Efficacy|17|||
129037084|NCT01345318|464426352|FG000|Overall Study|Lost to Follow-up|2|||
129037085|NCT01345318|464426352|FG000|Overall Study|Protocol Violation|1|||
129037086|NCT01345318|464426352|FG000|Overall Study|Withdrawal by Subject|41|||
129037087|NCT01345318|464426352|FG000|Overall Study|Other|3|||
129037088|NCT00317642|464426353|FG000|Overall Study|Not Received Either Study Drug|1|||
129037089|NCT00317642|464426354|FG001|Overall Study|Not Received Either Study Drug|3|||
129037090|NCT00317642|464426353|FG000|Overall Study|Physician Decision|15|||
129037091|NCT00317642|464426354|FG001|Overall Study|Physician Decision|7|||
129037092|NCT00317642|464426353|FG000|Overall Study|Participant declined treatment|14|||
129037093|NCT00317642|464426354|FG001|Overall Study|Participant declined treatment|3|||
129037094|NCT00317642|464426353|FG000|Overall Study|Adverse Event|17|||
129037095|NCT00317642|464426354|FG001|Overall Study|Adverse Event|5|||
129037096|NCT00317642|464426353|FG000|Overall Study|Treatment Failure|56|||
129037097|NCT00317642|464426354|FG001|Overall Study|Treatment Failure|102|||
129037098|NCT00317642|464426353|FG000|Overall Study|Disease Recurrence|1|||
129037099|NCT00317642|464426354|FG001|Overall Study|Disease Recurrence|2|||
129127648|NCT02101853|464759362|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
129127649|NCT02101853|464759357|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
129127650|NCT02101853|464759358|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
129127651|NCT02101853|464759359|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
129127652|NCT02101853|464759360|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
129127653|NCT02101853|464759361|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
128961972|NCT01237223|464147005|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
128961973|NCT01237223|464147006|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
128961974|NCT01237223|464147007|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
128961975|NCT01237223|464147008|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
128961976|NCT01237223|464147003|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
128961977|NCT01237223|464147004|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
128961978|NCT01237223|464147005|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
128961979|NCT01237223|464147006|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
128961980|NCT01237223|464147007|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
128961981|NCT01237223|464147008|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
128961982|NCT01237223|464147003|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
128961983|NCT01237223|464147004|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
128961984|NCT01237223|464147005|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
128961985|NCT01237223|464147006|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
128961986|NCT01237223|464147007|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
128961987|NCT01237223|464147008|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
128961988|NCT01237223|464147003|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
128961989|NCT01237223|464147004|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
128961990|NCT01237223|464147005|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
128961991|NCT01237223|464147006|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
128961992|NCT01237223|464147007|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
128961993|NCT01237223|464147008|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
128961994|NCT01237223|464147003|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
128961995|NCT01237223|464147004|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
128961996|NCT01237223|464147005|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
128961997|NCT01237223|464147006|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
128961998|NCT01237223|464147007|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
128961999|NCT01237223|464147008|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
128962000|NCT01237223|464147003|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
129037100|NCT00317642|464426353|FG000|Overall Study|Death|14|||
129037101|NCT00317642|464426354|FG001|Overall Study|Death|7|||
129037102|NCT00317642|464426353|FG000|Overall Study|Not Continue to Consolidation|2|||
129037103|NCT00317642|464426354|FG001|Overall Study|Not Continue to Consolidation|0|||
129127654|NCT02101853|464759362|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
129037104|NCT00317642|464426353|FG000|Overall Study|Withdrawal by Subject|0|||
129037105|NCT00317642|464426354|FG001|Overall Study|Withdrawal by Subject|1|||
128713194|NCT01962207|463246032|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
128713195|NCT01962207|463246029|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
128713196|NCT01962207|463246030|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
128962001|NCT01237223|464147004|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
128962002|NCT01237223|464147005|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
128962003|NCT01237223|464147006|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
128962004|NCT01237223|464147007|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
128962005|NCT01237223|464147008|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
128962006|NCT00407550|464147013|FG000|Overall Study|Adverse Event|0|||
128962007|NCT00407550|464147014|FG001|Overall Study|Adverse Event|1|||
128962008|NCT00407550|464147013|FG000|Overall Study|Withdrawal by Subject|0|||
128962009|NCT00407550|464147014|FG001|Overall Study|Withdrawal by Subject|2|||
128962010|NCT00407550|464147013|FG000|Overall Study|Death|1|||
128962011|NCT00407550|464147014|FG001|Overall Study|Death|0|||
128962012|NCT00407550|464147013|FG000|Overall Study|Insurance or Other medical condition|2|||
128962013|NCT00407550|464147014|FG001|Overall Study|Insurance or Other medical condition|1|||
128962014|NCT00443846|464147015|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
128962015|NCT00443846|464147016|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
128962016|NCT00443846|464147015|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
128962017|NCT00443846|464147016|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
128962018|NCT00443846|464147015|FG000|Overall Study|Adverse Event|0|||
128962019|NCT00443846|464147016|FG001|Overall Study|Adverse Event|1|||
128962020|NCT00443846|464147015|FG000|Overall Study|Personal reason|8|||
128962021|NCT00443846|464147016|FG001|Overall Study|Personal reason|3|||
128962022|NCT00443846|464147015|FG000|Overall Study|Lost to Follow-up|1|||
128962023|NCT00443846|464147016|FG001|Overall Study|Lost to Follow-up|2|||
128962024|NCT00641706|464147017|FG000|Overall Study|Adverse Event|2|||
128962025|NCT00641706|464147018|FG001|Overall Study|Adverse Event|1|||
128962026|NCT00641706|464147017|FG000|Overall Study|Withdrawal by Subject|6|||
128962027|NCT00641706|464147018|FG001|Overall Study|Withdrawal by Subject|1|||
128962028|NCT00641706|464147017|FG000|Overall Study|Clinical Decline|1|||
128962029|NCT00641706|464147018|FG001|Overall Study|Clinical Decline|0|||
128962030|NCT00641706|464147017|FG000|Overall Study|Lead Investigator Decision|0|||
128962031|NCT00641706|464147018|FG001|Overall Study|Lead Investigator Decision|1|||
128962032|NCT00282568|464147021|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
128962033|NCT00282568|464147021|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
128962034|NCT00282568|464147021|FG000|Extended Treatment Period|Adverse Event|17|||
128962035|NCT00282568|464147021|FG000|Extended Treatment Period|Non-compliance|4|||
128962036|NCT00282568|464147021|FG000|Extended Treatment Period|Physician Decision|1|||
128962037|NCT00282568|464147021|FG000|Extended Treatment Period|Lost to Follow-up|2|||
128962038|NCT01266070|464147022|FG000|Overall Study|Adverse Event|3|||
128962039|NCT01266070|464147022|FG000|Overall Study|Protocol Violation|1|||
128962040|NCT03006926|464147023|FG000|Overall Study|Adverse Event|0|||
128962041|NCT03006926|464147024|FG001|Overall Study|Adverse Event|27|||
128962042|NCT03006926|464147023|FG000|Overall Study|Withdrawal by Subject|0|||
128962043|NCT03006926|464147024|FG001|Overall Study|Withdrawal by Subject|1|||
128962044|NCT03006926|464147023|FG000|Overall Study|Radiological Disease Progression|0|||
128962045|NCT03006926|464147024|FG001|Overall Study|Radiological Disease Progression|52|||
128962046|NCT03006926|464147023|FG000|Overall Study|Clinical Disease Progression|0|||
128962047|NCT03006926|464147024|FG001|Overall Study|Clinical Disease Progression|10|||
128962048|NCT03006926|464147023|FG000|Overall Study|Other|0|||
128962049|NCT03006926|464147024|FG001|Overall Study|Other|8|||
128962050|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
128962051|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
128962052|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
128962053|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
128962054|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
128962055|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
128962056|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
128962057|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
128713197|NCT01962207|463246031|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
128713198|NCT01962207|463246032|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
128713199|NCT01962207|463246029|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
128713200|NCT01962207|463246030|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
128962058|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
128962059|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
128962060|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
128962061|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
128962062|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
128962063|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
128962064|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
129127655|NCT02101853|464759357|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
128962065|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
128962066|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
128962067|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
128962068|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
128962069|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
128962070|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
128962071|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
128962072|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
128962073|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
128962074|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
128962075|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
128962076|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
128962077|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
128962078|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
128962079|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
128962080|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
128962081|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
128962082|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
128962083|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
128962084|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
128962085|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
128962086|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
128962087|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
128962088|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
128962089|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
128962090|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
128962091|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
128962092|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
128962093|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
128962094|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
128962095|NCT03689972|464147025|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
128962096|NCT03689972|464147026|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
128962097|NCT03689972|464147027|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
128962098|NCT03689972|464147028|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
128962099|NCT03689972|464147029|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
128962100|NCT03689972|464147025|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
128962101|NCT03689972|464147026|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
128962102|NCT03689972|464147027|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
128962103|NCT03689972|464147028|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
128962104|NCT03689972|464147029|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
128962105|NCT03689972|464147025|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
128962106|NCT03689972|464147026|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
128962107|NCT03689972|464147027|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
128962108|NCT03689972|464147028|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
128962109|NCT03689972|464147029|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
128962110|NCT03689972|464147025|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
128962111|NCT03689972|464147026|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
128962112|NCT03689972|464147027|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
128962113|NCT03689972|464147028|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
128962114|NCT03689972|464147029|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
128962115|NCT03689972|464147025|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
128962116|NCT03689972|464147026|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
128962117|NCT03689972|464147027|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
128962118|NCT03689972|464147028|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
128962119|NCT03689972|464147029|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
128962120|NCT03689972|464147025|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
128962121|NCT03689972|464147026|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
128962122|NCT03689972|464147027|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
128962123|NCT03689972|464147028|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
128962124|NCT03689972|464147029|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
128962125|NCT03689972|464147025|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
128962126|NCT03689972|464147026|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
129127656|NCT02101853|464759358|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129037106|NCT00317642|464426353|FG000|Overall Study|Referred For Transplantation|1|||
129037107|NCT00317642|464426354|FG001|Overall Study|Referred For Transplantation|0|||
129037108|NCT00317642|464426353|FG000|Overall Study|AML Not Centrally Confirmed|1|||
129037109|NCT00317642|464426354|FG001|Overall Study|AML Not Centrally Confirmed|5|||
129037110|NCT01239472|464426359|FG000|Overall Study|Withdrawal by Subject|5|||
129037111|NCT01239472|464426360|FG001|Overall Study|Withdrawal by Subject|1|||
129037112|NCT01239472|464426359|FG000|Overall Study|Adverse Event|0|||
129037113|NCT01239472|464426360|FG001|Overall Study|Adverse Event|1|||
129037114|NCT01239472|464426359|FG000|Overall Study|Lack of Efficacy|0|||
129037115|NCT01239472|464426360|FG001|Overall Study|Lack of Efficacy|1|||
129037116|NCT01049412|464426364|FG000|Period I|Withdrawal by Subject|4|||
129037117|NCT01049412|464426365|FG001|Period I|Withdrawal by Subject|6|||
129037118|NCT01049412|464426364|FG000|Period I|Lost to Follow-up|2|||
129037119|NCT01049412|464426365|FG001|Period I|Lost to Follow-up|2|||
129037120|NCT01049412|464426364|FG000|Period I|Physician Decision|0|||
129037121|NCT01049412|464426365|FG001|Period I|Physician Decision|3|||
129037122|NCT01049412|464426364|FG000|Period I|Protocol Violation|1|||
129037123|NCT01049412|464426365|FG001|Period I|Protocol Violation|2|||
129037124|NCT01049412|464426364|FG000|Period I|Adverse Event|1|||
129037125|NCT01049412|464426365|FG001|Period I|Adverse Event|0|||
129037126|NCT01049412|464426364|FG000|Period II|Withdrawal by Subject|2|||
129037127|NCT01049412|464426365|FG001|Period II|Withdrawal by Subject|3|||
129037128|NCT01049412|464426364|FG000|Period II|Adverse Event|1|||
129037129|NCT01049412|464426365|FG001|Period II|Adverse Event|0|||
129037130|NCT01049412|464426364|FG000|Period II|Lost to Follow-up|1|||
129037131|NCT01049412|464426365|FG001|Period II|Lost to Follow-up|0|||
129037132|NCT05966090|464426366|FG000|Overall Study|Lost to Follow-up|6|||
129037133|NCT05966090|464426367|FG001|Overall Study|Lost to Follow-up|6|||
129037134|NCT05966090|464426366|FG000|Overall Study|Adverse Event|1|||
129037135|NCT05966090|464426367|FG001|Overall Study|Adverse Event|1|||
129037136|NCT05966090|464426366|FG000|Overall Study|Withdrawal by Subject|1|||
129037137|NCT05966090|464426367|FG001|Overall Study|Withdrawal by Subject|1|||
129037138|NCT05966090|464426366|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129037139|NCT05966090|464426367|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129037140|NCT05966090|464426366|FG000|Overall Study|Other|1|||
129037141|NCT05966090|464426367|FG001|Overall Study|Other|1|||
129037142|NCT03756883|464426368|FG000|Overall Study|Adverse Event|2|||
129037143|NCT03756883|464426369|FG001|Overall Study|Adverse Event|2|||
129037144|NCT03756883|464426370|FG002|Overall Study|Adverse Event|2|||
129037145|NCT03756883|464426368|FG000|Overall Study|Lack of Efficacy|0|||
129037146|NCT03756883|464426369|FG001|Overall Study|Lack of Efficacy|1|||
129037147|NCT03756883|464426370|FG002|Overall Study|Lack of Efficacy|2|||
129037148|NCT03756883|464426368|FG000|Overall Study|Lost to Follow-up|3|||
129037149|NCT03756883|464426369|FG001|Overall Study|Lost to Follow-up|3|||
129037150|NCT03756883|464426370|FG002|Overall Study|Lost to Follow-up|0|||
129037151|NCT03756883|464426368|FG000|Overall Study|Protocol Violation|2|||
129037152|NCT03756883|464426369|FG001|Overall Study|Protocol Violation|0|||
129037153|NCT03756883|464426370|FG002|Overall Study|Protocol Violation|1|||
129037154|NCT03756883|464426368|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
129037155|NCT03756883|464426369|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
129037156|NCT03756883|464426370|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
129037157|NCT03756883|464426368|FG000|Overall Study|Withdrawal by Subject|4|||
129037158|NCT03756883|464426369|FG001|Overall Study|Withdrawal by Subject|1|||
129037159|NCT03756883|464426370|FG002|Overall Study|Withdrawal by Subject|0|||
129037160|NCT03756883|464426368|FG000|Overall Study|Other Reasons|2|||
129037161|NCT03756883|464426369|FG001|Overall Study|Other Reasons|4|||
129037162|NCT03756883|464426370|FG002|Overall Study|Other Reasons|0|||
129037163|NCT00337428|464426371|FG000|Overall Study|Withdrawal by Subject|1|||
129037164|NCT00337428|464426372|FG001|Overall Study|Withdrawal by Subject|2|||
129037165|NCT00337428|464426371|FG000|Overall Study|Lack of Time|1|||
129037166|NCT00337428|464426372|FG001|Overall Study|Lack of Time|1|||
129037167|NCT00337428|464426371|FG000|Overall Study|Unwilling to Continue|1|||
129219986|NCT02908672|465104675|FG003|Run-in Period|Study Ended by Sponsor|0|||
128771511|NCT04921969|463453723|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
129037168|NCT00337428|464426372|FG001|Overall Study|Unwilling to Continue|0|||
129037169|NCT00337428|464426371|FG000|Overall Study|Anorexia|1|||
129037170|NCT00337428|464426372|FG001|Overall Study|Anorexia|0|||
129037171|NCT00263887|464426380|FG000|Overall Study|Withdrawal by Subject|1|||
129037172|NCT00263887|464426381|FG001|Overall Study|Withdrawal by Subject|1|||
129037173|NCT00263887|464426380|FG000|Overall Study|Lung transplantation|1|||
129037174|NCT00263887|464426381|FG001|Overall Study|Lung transplantation|2|||
129037175|NCT00263887|464426380|FG000|Overall Study|Too ill to attend visit|1|||
129037176|NCT00263887|464426381|FG001|Overall Study|Too ill to attend visit|0|||
129037177|NCT00263887|464426380|FG000|Overall Study|Adverse Event|0|||
129037178|NCT00263887|464426381|FG001|Overall Study|Adverse Event|2|||
129037179|NCT00263887|464426380|FG000|Overall Study|Disease progression|0|||
129037180|NCT00263887|464426381|FG001|Overall Study|Disease progression|1|||
129037181|NCT00263887|464426380|FG000|Overall Study|Lack of Efficacy|0|||
128962127|NCT03689972|464147027|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
128962128|NCT03689972|464147028|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
128962129|NCT03689972|464147029|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
128962130|NCT03689972|464147025|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
128962131|NCT03689972|464147026|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
128962132|NCT03689972|464147027|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
128962133|NCT03689972|464147028|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
128962134|NCT03689972|464147029|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
128962135|NCT03689972|464147025|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
128962136|NCT03689972|464147026|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
128962137|NCT03689972|464147027|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
128962138|NCT03689972|464147028|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
128962139|NCT03689972|464147029|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
128962140|NCT03689972|464147025|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
128962141|NCT03689972|464147026|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
128962142|NCT03689972|464147027|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
128962143|NCT03689972|464147028|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
128962144|NCT03689972|464147029|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
128962145|NCT01838213|464147030|FG000|Overall Study|Ineligible|166|||
128962146|NCT01838213|464147031|FG001|Overall Study|Ineligible|191|||
128962147|NCT00990249|464147038|FG000|Overall Study|Disease Progression|8|||
128962148|NCT00990249|464147038|FG000|Overall Study|Non-Compliance|1|||
128962149|NCT00990249|464147038|FG000|Overall Study|Death|2|||
128962150|NCT00990249|464147038|FG000|Overall Study|Not treated|2|||
128962151|NCT01548417|464147039|FG000|Overall Study|Withdrawal by Subject|0|||
128962152|NCT01548417|464147040|FG001|Overall Study|Withdrawal by Subject|2|||
128962153|NCT03725293|464147043|FG000|Overall Study|Physician Decision|9|||
128962154|NCT03725293|464147044|FG001|Overall Study|Physician Decision|6|||
128962155|NCT03725293|464147043|FG000|Overall Study|alternative vascular access needs|1|||
128962156|NCT03725293|464147044|FG001|Overall Study|alternative vascular access needs|2|||
128962157|NCT03725293|464147043|FG000|Overall Study|venous anatomy screen failures|2|||
128962158|NCT03725293|464147044|FG001|Overall Study|venous anatomy screen failures|1|||
128962159|NCT04583969|464147045|FG000|Overall Study|Death|31|||
128962160|NCT04583969|464147046|FG001|Overall Study|Death|38|||
128962161|NCT04583969|464147045|FG000|Overall Study|Lost to Follow-up|16|||
128962162|NCT04583969|464147046|FG001|Overall Study|Lost to Follow-up|13|||
128962163|NCT04583969|464147045|FG000|Overall Study|Protocol Violation|1|||
128962164|NCT04583969|464147046|FG001|Overall Study|Protocol Violation|0|||
128962165|NCT04583969|464147045|FG000|Overall Study|Withdrawal by Subject|3|||
128962166|NCT04583969|464147046|FG001|Overall Study|Withdrawal by Subject|3|||
128962167|NCT04583969|464147045|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
128962168|NCT04583969|464147046|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
128962169|NCT04583969|464147045|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
128962170|NCT04583969|464147046|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
128962171|NCT04583969|464147045|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
128962172|NCT04583969|464147046|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
128962173|NCT04583969|464147045|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
128962174|NCT04583969|464147046|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
128962175|NCT04583969|464147045|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
128962176|NCT04583969|464147046|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
128962177|NCT04397796|464147047|FG000|Overall Study|Death|3|||
128962178|NCT04397796|464147048|FG001|Overall Study|Death|1|||
128962179|NCT02640755|464147049|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
128962180|NCT02640755|464147050|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
128962181|NCT02640755|464147049|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
128962182|NCT02640755|464147050|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
128962183|NCT02640755|464147049|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
128962184|NCT02640755|464147050|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
128962185|NCT00770224|464147062|FG000|Step 1: Induction|Adverse Event|3|||
128962186|NCT00770224|464147063|FG001|Step 1: Induction|Adverse Event|0|||
128962187|NCT00770224|464147062|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
128962188|NCT00770224|464147063|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
128962189|NCT00770224|464147062|FG000|Step 1: Induction|Other reason not protocol specified|2|||
128962190|NCT00770224|464147063|FG001|Step 1: Induction|Other reason not protocol specified|0|||
128962191|NCT00770224|464147062|FG000|Step 1: Induction|Ineligible|2|||
128962192|NCT00770224|464147063|FG001|Step 1: Induction|Ineligible|0|||
128962193|NCT00770224|464147062|FG000|Step 1: Induction|No protocol treatment given|1|||
128962194|NCT00770224|464147063|FG001|Step 1: Induction|No protocol treatment given|0|||
128962195|NCT00770224|464147062|FG000|Step 2: Maintenance|Adverse Event|0|||
128962196|NCT00770224|464147063|FG001|Step 2: Maintenance|Adverse Event|10|||
129127657|NCT02101853|464759359|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129127658|NCT02101853|464759360|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129127659|NCT02101853|464759361|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129127660|NCT02101853|464759362|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
129127661|NCT04409002|464759363|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
129127662|NCT06481579|464759364|FG000|Overall Study|Death|1|||
128962197|NCT00770224|464147062|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
128962198|NCT00770224|464147063|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
128962199|NCT00770224|464147062|FG000|Step 2: Maintenance|Progression/relapse|0|||
128962200|NCT00770224|464147063|FG001|Step 2: Maintenance|Progression/relapse|1|||
128962201|NCT00770224|464147062|FG000|Step 2: Maintenance|Death|0|||
128962202|NCT00770224|464147063|FG001|Step 2: Maintenance|Death|2|||
128962203|NCT00770224|464147062|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
128962204|NCT00770224|464147063|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
128962205|NCT00770224|464147062|FG000|Step 2: Maintenance|Ineligible|0|||
128962206|NCT00770224|464147063|FG001|Step 2: Maintenance|Ineligible|2|||
128962207|NCT01484561|464147064|FG000|Overall Study|Lack of Efficacy|3|||
128962208|NCT01484561|464147065|FG001|Overall Study|Lack of Efficacy|1|||
128962209|NCT01484561|464147064|FG000|Overall Study|Lost to Follow-up|1|||
128962210|NCT01484561|464147065|FG001|Overall Study|Lost to Follow-up|0|||
128962211|NCT01484561|464147064|FG000|Overall Study|Withdrawal by Subject|3|||
128962212|NCT01484561|464147065|FG001|Overall Study|Withdrawal by Subject|0|||
128962213|NCT01484561|464147064|FG000|Overall Study|Other|1|||
128962214|NCT01484561|464147065|FG001|Overall Study|Other|1|||
128962215|NCT01484561|464147064|FG000|Overall Study|Adverse Event|1|||
128962216|NCT01484561|464147065|FG001|Overall Study|Adverse Event|4|||
128962217|NCT03371251|464147074|FG000|Overall Study|Withdrawal by Subject|1|||
128962218|NCT03371251|464147075|FG001|Overall Study|Withdrawal by Subject|0|||
128962219|NCT03371251|464147076|FG002|Overall Study|Withdrawal by Subject|1|||
128962220|NCT03371251|464147077|FG003|Overall Study|Withdrawal by Subject|0|||
128962221|NCT03371251|464147078|FG004|Overall Study|Withdrawal by Subject|2|||
128962222|NCT03371251|464147079|FG005|Overall Study|Withdrawal by Subject|2|||
128962223|NCT03371251|464147074|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
128962224|NCT03371251|464147075|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
128962225|NCT03371251|464147076|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
128962226|NCT03371251|464147077|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
128962227|NCT03371251|464147078|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
128962228|NCT03371251|464147079|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
128962229|NCT03371251|464147074|FG000|Overall Study|Adverse Event|0|||
128962230|NCT03371251|464147075|FG001|Overall Study|Adverse Event|0|||
128962231|NCT03371251|464147076|FG002|Overall Study|Adverse Event|0|||
128962232|NCT03371251|464147077|FG003|Overall Study|Adverse Event|0|||
128962233|NCT03371251|464147078|FG004|Overall Study|Adverse Event|1|||
128962234|NCT03371251|464147079|FG005|Overall Study|Adverse Event|0|||
128962235|NCT03371251|464147074|FG000|Overall Study|Decision by Sponsor|0|||
128962236|NCT03371251|464147075|FG001|Overall Study|Decision by Sponsor|0|||
128962237|NCT03371251|464147076|FG002|Overall Study|Decision by Sponsor|0|||
128962238|NCT03371251|464147077|FG003|Overall Study|Decision by Sponsor|0|||
128962239|NCT03371251|464147078|FG004|Overall Study|Decision by Sponsor|2|||
128962240|NCT03371251|464147079|FG005|Overall Study|Decision by Sponsor|0|||
128962241|NCT00114218|464147080|FG000|Overall Study|Wrong Cell Type|2|||
128962242|NCT00114218|464147080|FG000|Overall Study|Wrong Primary|1|||
128962243|NCT00114218|464147080|FG000|Overall Study|Never Treated|1|||
128962244|NCT01505114|464147081|FG000|Overall Study|Withdrawal by Subject|5|||
128962245|NCT01505114|464147082|FG001|Overall Study|Withdrawal by Subject|4|||
128962246|NCT01505114|464147083|FG002|Overall Study|Withdrawal by Subject|4|||
128962247|NCT01505114|464147084|FG003|Overall Study|Withdrawal by Subject|7|||
128962248|NCT01505114|464147081|FG000|Overall Study|Death|1|||
128962249|NCT01505114|464147082|FG001|Overall Study|Death|0|||
129127663|NCT06481579|464759365|FG001|Overall Study|Death|0|||
129127664|NCT06481579|464759364|FG000|Overall Study|Withdrawal by Subject|3|||
129127665|NCT06481579|464759365|FG001|Overall Study|Withdrawal by Subject|0|||
129127666|NCT06481579|464759364|FG000|Overall Study|Other|1|||
129127667|NCT06481579|464759365|FG001|Overall Study|Other|1|||
128962250|NCT01505114|464147083|FG002|Overall Study|Death|0|||
128962251|NCT01505114|464147084|FG003|Overall Study|Death|1|||
128962252|NCT01505114|464147081|FG000|Overall Study|unable to adhere to visit schedule|3|||
128962253|NCT01505114|464147082|FG001|Overall Study|unable to adhere to visit schedule|2|||
128962254|NCT01505114|464147083|FG002|Overall Study|unable to adhere to visit schedule|3|||
128962255|NCT01505114|464147084|FG003|Overall Study|unable to adhere to visit schedule|3|||
128962256|NCT01505114|464147081|FG000|Overall Study|Lost to Follow-up|11|||
129127668|NCT05032196|464759366|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
129127669|NCT05032196|464759367|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
129127670|NCT05032196|464759368|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128962257|NCT01505114|464147082|FG001|Overall Study|Lost to Follow-up|5|||
128962258|NCT01505114|464147083|FG002|Overall Study|Lost to Follow-up|8|||
128962259|NCT01505114|464147084|FG003|Overall Study|Lost to Follow-up|7|||
128962260|NCT01505114|464147081|FG000|Overall Study|relocated|4|||
128962261|NCT01505114|464147082|FG001|Overall Study|relocated|2|||
128962262|NCT01505114|464147083|FG002|Overall Study|relocated|2|||
128962263|NCT01505114|464147084|FG003|Overall Study|relocated|3|||
128962264|NCT01505114|464147081|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
128962265|NCT01505114|464147082|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
128962266|NCT01505114|464147083|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
128962267|NCT01505114|464147084|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
128962268|NCT01505114|464147081|FG000|Overall Study|staff safety concerns|0|||
128962269|NCT01505114|464147082|FG001|Overall Study|staff safety concerns|0|||
128962270|NCT01505114|464147083|FG002|Overall Study|staff safety concerns|0|||
128962271|NCT01505114|464147084|FG003|Overall Study|staff safety concerns|1|||
128962272|NCT01505114|464147081|FG000|Overall Study|investigator decision|1|||
128962273|NCT01505114|464147082|FG001|Overall Study|investigator decision|0|||
128962274|NCT01505114|464147083|FG002|Overall Study|investigator decision|1|||
128962275|NCT01505114|464147084|FG003|Overall Study|investigator decision|0|||
128962276|NCT03168555|464147085|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
128962277|NCT03168555|464147085|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
128962278|NCT03168555|464147085|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
128962279|NCT03168555|464147085|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
128962280|NCT01040845|464147086|FG000|Overall Study|Withdrawal by Subject|1|||
128962281|NCT01040845|464147087|FG001|Overall Study|Withdrawal by Subject|1|||
128962282|NCT01040845|464147086|FG000|Overall Study|Physician Decision|1|||
128962283|NCT01040845|464147087|FG001|Overall Study|Physician Decision|0|||
128962284|NCT02260388|464147092|FG000|Overall Study|Lost to Follow-up|2|||
128962285|NCT02260388|464147093|FG001|Overall Study|Lost to Follow-up|8|||
128962286|NCT02260388|464147094|FG002|Overall Study|Lost to Follow-up|3|||
128962287|NCT02260388|464147095|FG003|Overall Study|Lost to Follow-up|4|||
128962288|NCT04445688|464147096|FG000|Washout (One Week)|Adverse Event|2|||
128962289|NCT04445688|464147096|FG000|Washout (One Week)|Withdrawal by Subject|1|||
128962290|NCT01235507|464147098|FG000|Overall Study|Adverse Event|1|||
128962291|NCT01235507|464147098|FG000|Overall Study|Withdrawal by Subject|1|||
128962292|NCT02565615|464147104|FG000|Overall Study|Death|0|||
128962293|NCT02565615|464147105|FG001|Overall Study|Death|1|||
128962294|NCT02565615|464147106|FG002|Overall Study|Death|0|||
128962295|NCT02565615|464147107|FG003|Overall Study|Death|0|||
128962296|NCT02565615|464147108|FG004|Overall Study|Death|4|||
128962297|NCT02565615|464147104|FG000|Overall Study|Not willing to participate in study|2|||
128962298|NCT02565615|464147105|FG001|Overall Study|Not willing to participate in study|21|||
128962299|NCT02565615|464147106|FG002|Overall Study|Not willing to participate in study|0|||
128962300|NCT02565615|464147107|FG003|Overall Study|Not willing to participate in study|1|||
128962301|NCT02565615|464147108|FG004|Overall Study|Not willing to participate in study|169|||
128962302|NCT02565615|464147104|FG000|Overall Study|Lost to Follow-up|0|||
128962303|NCT02565615|464147105|FG001|Overall Study|Lost to Follow-up|4|||
128962304|NCT02565615|464147106|FG002|Overall Study|Lost to Follow-up|0|||
128962305|NCT02565615|464147107|FG003|Overall Study|Lost to Follow-up|1|||
128962306|NCT02565615|464147108|FG004|Overall Study|Lost to Follow-up|765|||
128962307|NCT02565615|464147104|FG000|Overall Study|Not meeting eligibility criteria|0|||
129037182|NCT00263887|464426381|FG001|Overall Study|Lack of Efficacy|1|||
129037183|NCT00779402|464426382|FG000|Treatment Phase 1|Disease Progression|1|||
129037184|NCT00779402|464426383|FG001|Treatment Phase 1|Disease Progression|0|||
129037185|NCT00779402|464426382|FG000|Treatment Phase 1|Adverse Event|2|||
129037186|NCT00779402|464426383|FG001|Treatment Phase 1|Adverse Event|0|||
129037187|NCT00779402|464426382|FG000|Treatment Phase 1|Protocol Violation|1|||
129037188|NCT00779402|464426383|FG001|Treatment Phase 1|Protocol Violation|0|||
129037189|NCT00779402|464426382|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
128713201|NCT01962207|463246031|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
128713202|NCT01962207|463246032|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
128713203|NCT03036072|463246035|FG000|Overall Study|Death|0|||
128713204|NCT03036072|463246036|FG001|Overall Study|Death|1|||
128962308|NCT02565615|464147105|FG001|Overall Study|Not meeting eligibility criteria|7|||
128962309|NCT02565615|464147106|FG002|Overall Study|Not meeting eligibility criteria|0|||
128962310|NCT02565615|464147107|FG003|Overall Study|Not meeting eligibility criteria|0|||
128962311|NCT02565615|464147108|FG004|Overall Study|Not meeting eligibility criteria|25|||
128962312|NCT02565615|464147104|FG000|Overall Study|Reason not defined|0|||
128962313|NCT02565615|464147105|FG001|Overall Study|Reason not defined|2|||
129037190|NCT00779402|464426383|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
129037191|NCT00779402|464426382|FG000|Treatment Phase 1|Lost to Follow-up|0|||
128713205|NCT03036072|463246035|FG000|Overall Study|Withdrawal by Subject|0|||
128962314|NCT02565615|464147106|FG002|Overall Study|Reason not defined|0|||
128962315|NCT02565615|464147107|FG003|Overall Study|Reason not defined|1|||
128962316|NCT02565615|464147108|FG004|Overall Study|Reason not defined|62|||
128962317|NCT02565615|464147104|FG000|Overall Study|Adverse Event|1|||
128962318|NCT02565615|464147105|FG001|Overall Study|Adverse Event|1|||
128962319|NCT02565615|464147106|FG002|Overall Study|Adverse Event|0|||
128962320|NCT02565615|464147107|FG003|Overall Study|Adverse Event|0|||
128962321|NCT02565615|464147108|FG004|Overall Study|Adverse Event|9|||
128962322|NCT02565615|464147104|FG000|Overall Study|Untreated|0|||
128962323|NCT02565615|464147105|FG001|Overall Study|Untreated|0|||
128962324|NCT02565615|464147106|FG002|Overall Study|Untreated|0|||
128962325|NCT02565615|464147107|FG003|Overall Study|Untreated|0|||
128962326|NCT02565615|464147108|FG004|Overall Study|Untreated|567|||
128962327|NCT01998399|464147115|FG000|Overall Study|Lost to Follow-up|1|||
128962328|NCT01998399|464147116|FG001|Overall Study|Lost to Follow-up|3|||
128962329|NCT01998399|464147115|FG000|Overall Study|Death|4|||
128962330|NCT01998399|464147116|FG001|Overall Study|Death|2|||
128962331|NCT01998399|464147115|FG000|Overall Study|Study stopped before dosing completed|3|||
128962332|NCT01998399|464147116|FG001|Overall Study|Study stopped before dosing completed|3|||
128962333|NCT01998399|464147115|FG000|Overall Study|Withdrawal by Subject|0|||
128962334|NCT01998399|464147116|FG001|Overall Study|Withdrawal by Subject|1|||
128962335|NCT04114539|464147120|FG000|Overall Study|Adverse Event|14|||
128962336|NCT04114539|464147120|FG000|Overall Study|Lost to Follow-up|2|||
128962337|NCT04114539|464147120|FG000|Overall Study|Non-compliance with Protocol|2|||
128962338|NCT04114539|464147120|FG000|Overall Study|Non-compliance with Study Drug|1|||
128962339|NCT04114539|464147120|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
128962340|NCT04114539|464147120|FG000|Overall Study|Withdrew consent|10|||
128962341|NCT04114539|464147120|FG000|Overall Study|Others not specified|5|||
128962342|NCT04114539|464147120|FG000|Overall Study|Investigator Decision|2|||
128962343|NCT01072448|464147129|FG000|Overall Study|Adverse Event|9|||
128962344|NCT01072448|464147130|FG001|Overall Study|Adverse Event|10|||
128962345|NCT01072448|464147129|FG000|Overall Study|Subject withdrew consent|4|||
128962346|NCT01072448|464147130|FG001|Overall Study|Subject withdrew consent|9|||
128962347|NCT01072448|464147129|FG000|Overall Study|Protocol deviation|3|||
128962348|NCT01072448|464147130|FG001|Overall Study|Protocol deviation|4|||
128962349|NCT01072448|464147129|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128962350|NCT01072448|464147130|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128962351|NCT01072448|464147129|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128962352|NCT01072448|464147130|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
128962353|NCT01072448|464147129|FG000|Overall Study|Lost to Follow-up|1|||
128962354|NCT01072448|464147130|FG001|Overall Study|Lost to Follow-up|1|||
128962355|NCT01072448|464147129|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128962356|NCT01072448|464147130|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128962357|NCT01072448|464147129|FG000|Overall Study|Death|0|||
128962358|NCT01072448|464147130|FG001|Overall Study|Death|2|||
128962359|NCT01400139|464147131|FG000|HYD Core Study|Adverse Event|210|||
128962360|NCT01400139|464147131|FG000|HYD Core Study|Lack of Efficacy|59|||
128962361|NCT01400139|464147131|FG000|HYD Core Study|Withdrawal by Subject|114|||
128962362|NCT01400139|464147131|FG000|HYD Core Study|Lost to Follow-up|39|||
128962363|NCT01400139|464147131|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
128962364|NCT01400139|464147131|FG000|HYD Core Study|Administrative|56|||
128962365|NCT01400139|464147131|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
128962366|NCT01400139|464147131|FG000|HYD Extension Period|Adverse Event|8|||
128962367|NCT01400139|464147131|FG000|HYD Extension Period|Withdrawal by Subject|5|||
128962368|NCT01400139|464147131|FG000|HYD Extension Period|Administrative|10|||
128962369|NCT00249795|464147132|FG000|Overall Study|Not treated|16|||
128962370|NCT00249795|464147133|FG001|Overall Study|Not treated|14|||
128962371|NCT00249795|464147132|FG000|Overall Study|Symptomatic hypotension|127|||
128962372|NCT00249795|464147133|FG001|Overall Study|Symptomatic hypotension|64|||
128962373|NCT00249795|464147132|FG000|Overall Study|Other Serious Adverse Event|84|||
128962374|NCT00249795|464147133|FG001|Overall Study|Other Serious Adverse Event|93|||
129037192|NCT00779402|464426383|FG001|Treatment Phase 1|Lost to Follow-up|1|||
128962375|NCT00249795|464147132|FG000|Overall Study|Qualifying condition not present|26|||
128962376|NCT00249795|464147133|FG001|Overall Study|Qualifying condition not present|29|||
128962377|NCT00249795|464147132|FG000|Overall Study|Withdrawal by Subject|678|||
128962378|NCT00249795|464147133|FG001|Overall Study|Withdrawal by Subject|742|||
128962379|NCT00249795|464147132|FG000|Overall Study|Thromboembolic / outcome event|39|||
128962380|NCT00249795|464147133|FG001|Overall Study|Thromboembolic / outcome event|45|||
129037193|NCT00779402|464426382|FG000|Treatment Phase 1|Death|0|||
129037194|NCT00779402|464426383|FG001|Treatment Phase 1|Death|1|||
128962381|NCT00249795|464147132|FG000|Overall Study|Oral anticoagulant required|2|||
128962382|NCT00249795|464147133|FG001|Overall Study|Oral anticoagulant required|0|||
128962383|NCT00249795|464147132|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
128962384|NCT00249795|464147133|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
128962385|NCT00249795|464147132|FG000|Overall Study|Non-compliance|71|||
128962386|NCT00249795|464147133|FG001|Overall Study|Non-compliance|69|||
128962387|NCT00249795|464147132|FG000|Overall Study|Study drug intolerance|3|||
128962388|NCT00249795|464147133|FG001|Overall Study|Study drug intolerance|3|||
128962389|NCT00249795|464147132|FG000|Overall Study|Other adverse events (non-serious)|188|||
129037195|NCT00779402|464426382|FG000|Treatment Phase 1|Intercurrent Illness|1|||
129037196|NCT00779402|464426383|FG001|Treatment Phase 1|Intercurrent Illness|1|||
128771512|NCT04921969|463453724|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
128771513|NCT01091428|463455271|FG000|Phase 1|Progressive Disease|24|||
128771514|NCT01091428|463455272|FG001|Phase 1|Progressive Disease|8|||
128771515|NCT01091428|463455273|FG002|Phase 1|Progressive Disease|0|||
128771516|NCT01091428|463455274|FG003|Phase 1|Progressive Disease|0|||
128771517|NCT01091428|463455271|FG000|Phase 1|Symptomatic Deterioration|3|||
128771518|NCT01091428|463455272|FG001|Phase 1|Symptomatic Deterioration|2|||
128771519|NCT01091428|463455273|FG002|Phase 1|Symptomatic Deterioration|0|||
128771520|NCT01091428|463455274|FG003|Phase 1|Symptomatic Deterioration|0|||
128771521|NCT01091428|463455271|FG000|Phase 1|Adverse Event|2|||
128771522|NCT01091428|463455272|FG001|Phase 1|Adverse Event|0|||
128771523|NCT01091428|463455273|FG002|Phase 1|Adverse Event|0|||
128771524|NCT01091428|463455274|FG003|Phase 1|Adverse Event|0|||
128771525|NCT01091428|463455271|FG000|Phase 1|Withdrawal by Subject|7|||
128771526|NCT01091428|463455272|FG001|Phase 1|Withdrawal by Subject|0|||
128771527|NCT01091428|463455273|FG002|Phase 1|Withdrawal by Subject|0|||
128771528|NCT01091428|463455274|FG003|Phase 1|Withdrawal by Subject|0|||
128771529|NCT01091428|463455271|FG000|Phase 1|Reason not specified|0|||
128771530|NCT01091428|463455272|FG001|Phase 1|Reason not specified|1|||
128771531|NCT01091428|463455273|FG002|Phase 1|Reason not specified|0|||
128771532|NCT01091428|463455274|FG003|Phase 1|Reason not specified|0|||
128771533|NCT01091428|463455271|FG000|Phase 1|Single-Patient IND|2|||
128771534|NCT01091428|463455272|FG001|Phase 1|Single-Patient IND|0|||
128962390|NCT00249795|464147133|FG001|Overall Study|Other adverse events (non-serious)|159|||
128962391|NCT00249795|464147132|FG000|Overall Study|Physician withdrew consent|71|||
128962392|NCT00249795|464147133|FG001|Overall Study|Physician withdrew consent|63|||
128962393|NCT00249795|464147132|FG000|Overall Study|Surgery / procedure|4|||
128962394|NCT00249795|464147133|FG001|Overall Study|Surgery / procedure|5|||
128962395|NCT00249795|464147132|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
128962396|NCT00249795|464147133|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
128962397|NCT00249795|464147132|FG000|Overall Study|Lightheadedness / dizziness|15|||
128962398|NCT00249795|464147133|FG001|Overall Study|Lightheadedness / dizziness|11|||
128962399|NCT00249795|464147132|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
128962400|NCT00249795|464147133|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
128962401|NCT00249795|464147132|FG000|Overall Study|Other contraindicated medication|1|||
128962402|NCT00249795|464147133|FG001|Overall Study|Other contraindicated medication|1|||
128962403|NCT00249795|464147132|FG000|Overall Study|Event related to cardiac condition|17|||
128962404|NCT00249795|464147133|FG001|Overall Study|Event related to cardiac condition|16|||
128962405|NCT00249795|464147132|FG000|Overall Study|Patient not wish to continue after May08|4|||
128962406|NCT00249795|464147133|FG001|Overall Study|Patient not wish to continue after May08|6|||
128962407|NCT00249795|464147132|FG000|Overall Study|Site not agree to continue after May08|1|||
128962408|NCT00249795|464147133|FG001|Overall Study|Site not agree to continue after May08|1|||
128962409|NCT00249795|464147132|FG000|Overall Study|Lost to Follow-up|0|||
128962410|NCT00249795|464147133|FG001|Overall Study|Lost to Follow-up|2|||
128962411|NCT00249795|464147132|FG000|Overall Study|Missing|0|||
128962412|NCT00249795|464147133|FG001|Overall Study|Missing|1|||
128962413|NCT02460978|464147135|FG000|Overall Study|Adverse Event|17|||
128962414|NCT02460978|464147136|FG001|Overall Study|Adverse Event|11|||
128962415|NCT02460978|464147137|FG002|Overall Study|Adverse Event|11|||
128962416|NCT02460978|464147135|FG000|Overall Study|Withdrawal by Subject|5|||
128962417|NCT02460978|464147136|FG001|Overall Study|Withdrawal by Subject|5|||
128962418|NCT02460978|464147137|FG002|Overall Study|Withdrawal by Subject|14|||
128962419|NCT02460978|464147135|FG000|Overall Study|Lost to Follow-up|2|||
128962420|NCT02460978|464147136|FG001|Overall Study|Lost to Follow-up|3|||
128962421|NCT02460978|464147137|FG002|Overall Study|Lost to Follow-up|1|||
128962422|NCT02460978|464147135|FG000|Overall Study|Protocol Violation|1|||
128962423|NCT02460978|464147136|FG001|Overall Study|Protocol Violation|1|||
128962424|NCT02460978|464147137|FG002|Overall Study|Protocol Violation|1|||
128962425|NCT02460978|464147135|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
128962426|NCT02460978|464147136|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
128962427|NCT02460978|464147137|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
128962428|NCT02460978|464147135|FG000|Overall Study|Pregnancy|0|||
128962429|NCT02460978|464147136|FG001|Overall Study|Pregnancy|0|||
128771535|NCT01091428|463455273|FG002|Phase 1|Single-Patient IND|0|||
128771536|NCT01091428|463455274|FG003|Phase 1|Single-Patient IND|0|||
128962430|NCT02460978|464147137|FG002|Overall Study|Pregnancy|2|||
128962431|NCT03549429|464147140|FG000|Overall Study|Protocol Violation|5|||
128962432|NCT03549429|464147141|FG001|Overall Study|Protocol Violation|3|||
128962433|NCT03906136|464149273|FG000|Overall Study|Adverse Event|1|||
128962434|NCT03906136|464149274|FG001|Overall Study|Adverse Event|0|||
128962435|NCT03906136|464149273|FG000|Overall Study|Lost to Follow-up|7|||
128962436|NCT03906136|464149274|FG001|Overall Study|Lost to Follow-up|4|||
128962437|NCT03906136|464149273|FG000|Overall Study|Physician Decision|1|||
128771537|NCT01091428|463455271|FG000|Phase 2|Progressive Disease|0|||
128771538|NCT01091428|463455272|FG001|Phase 2|Progressive Disease|0|||
128771539|NCT01091428|463455273|FG002|Phase 2|Progressive Disease|44|||
128771540|NCT01091428|463455274|FG003|Phase 2|Progressive Disease|46|||
128962438|NCT03906136|464149274|FG001|Overall Study|Physician Decision|0|||
128962439|NCT03906136|464149273|FG000|Overall Study|Withdrawal by Subject|3|||
128962440|NCT03906136|464149274|FG001|Overall Study|Withdrawal by Subject|7|||
128962441|NCT02371980|464149278|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
128962442|NCT02371980|464149279|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
128962443|NCT02371980|464149280|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
128962444|NCT02371980|464149281|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
128962445|NCT02371980|464149282|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
128962446|NCT02371980|464149278|FG000|Open-label Period|Significant Protocol Deviation|19|||
128962447|NCT02371980|464149279|FG001|Open-label Period|Significant Protocol Deviation|0|||
128962448|NCT02371980|464149280|FG002|Open-label Period|Significant Protocol Deviation|0|||
128962449|NCT02371980|464149281|FG003|Open-label Period|Significant Protocol Deviation|0|||
128962450|NCT02371980|464149282|FG004|Open-label Period|Significant Protocol Deviation|0|||
128962451|NCT02371980|464149278|FG000|Open-label Period|Noncompliance with Study Drug|10|||
128962452|NCT02371980|464149279|FG001|Open-label Period|Noncompliance with Study Drug|0|||
128962453|NCT02371980|464149280|FG002|Open-label Period|Noncompliance with Study Drug|0|||
128962454|NCT02371980|464149281|FG003|Open-label Period|Noncompliance with Study Drug|0|||
128962455|NCT02371980|464149282|FG004|Open-label Period|Noncompliance with Study Drug|0|||
128962456|NCT02371980|464149278|FG000|Open-label Period|Lost to Follow-up|55|||
128962457|NCT02371980|464149279|FG001|Open-label Period|Lost to Follow-up|0|||
128962458|NCT02371980|464149280|FG002|Open-label Period|Lost to Follow-up|0|||
128962459|NCT02371980|464149281|FG003|Open-label Period|Lost to Follow-up|0|||
128962460|NCT02371980|464149282|FG004|Open-label Period|Lost to Follow-up|0|||
128962461|NCT02371980|464149278|FG000|Open-label Period|Voluntary Withdrawal|91|||
128962462|NCT02371980|464149279|FG001|Open-label Period|Voluntary Withdrawal|0|||
128962463|NCT02371980|464149280|FG002|Open-label Period|Voluntary Withdrawal|0|||
128962464|NCT02371980|464149281|FG003|Open-label Period|Voluntary Withdrawal|0|||
128962465|NCT02371980|464149282|FG004|Open-label Period|Voluntary Withdrawal|0|||
128962466|NCT02371980|464149278|FG000|Open-label Period|Pregnancy|1|||
128962467|NCT02371980|464149279|FG001|Open-label Period|Pregnancy|0|||
128962468|NCT02371980|464149280|FG002|Open-label Period|Pregnancy|0|||
128962469|NCT02371980|464149281|FG003|Open-label Period|Pregnancy|0|||
128962470|NCT02371980|464149282|FG004|Open-label Period|Pregnancy|0|||
128962471|NCT02371980|464149278|FG000|Open-label Period|Lack of Efficacy|116|||
128962472|NCT02371980|464149279|FG001|Open-label Period|Lack of Efficacy|0|||
128962473|NCT02371980|464149280|FG002|Open-label Period|Lack of Efficacy|0|||
128962474|NCT02371980|464149281|FG003|Open-label Period|Lack of Efficacy|0|||
128962475|NCT02371980|464149282|FG004|Open-label Period|Lack of Efficacy|0|||
128962476|NCT02371980|464149278|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
128962477|NCT02371980|464149279|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
128962478|NCT02371980|464149280|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
128962479|NCT02371980|464149281|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
128962480|NCT02371980|464149282|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
128962481|NCT02371980|464149278|FG000|Open-label Period|Reason not Specified|9|||
128962482|NCT02371980|464149279|FG001|Open-label Period|Reason not Specified|0|||
128962483|NCT02371980|464149280|FG002|Open-label Period|Reason not Specified|0|||
128962484|NCT02371980|464149281|FG003|Open-label Period|Reason not Specified|0|||
128962485|NCT02371980|464149282|FG004|Open-label Period|Reason not Specified|0|||
128962486|NCT02371980|464149278|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
128962487|NCT02371980|464149279|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
128962488|NCT02371980|464149280|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
128962489|NCT02371980|464149281|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
128962490|NCT02371980|464149282|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
128962491|NCT02371980|464149278|FG000|Double-blind Period|Significant Protocol Deviation|0|||
128962492|NCT02371980|464149279|FG001|Double-blind Period|Significant Protocol Deviation|2|||
128962493|NCT02371980|464149280|FG002|Double-blind Period|Significant Protocol Deviation|7|||
128962494|NCT02371980|464149281|FG003|Double-blind Period|Significant Protocol Deviation|3|||
128962495|NCT02371980|464149282|FG004|Double-blind Period|Significant Protocol Deviation|3|||
128962496|NCT02371980|464149278|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
128962497|NCT02371980|464149279|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
128962498|NCT02371980|464149280|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
129037197|NCT00779402|464426382|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
129037198|NCT00779402|464426383|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
128962499|NCT02371980|464149281|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
128962500|NCT02371980|464149282|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
128962501|NCT02371980|464149278|FG000|Double-blind Period|Lost to Follow-up|0|||
128962502|NCT02371980|464149279|FG001|Double-blind Period|Lost to Follow-up|8|||
128962503|NCT02371980|464149280|FG002|Double-blind Period|Lost to Follow-up|8|||
128962504|NCT02371980|464149281|FG003|Double-blind Period|Lost to Follow-up|6|||
128962505|NCT02371980|464149282|FG004|Double-blind Period|Lost to Follow-up|5|||
128962506|NCT02371980|464149278|FG000|Double-blind Period|Voluntary Withdrawal|0|||
128962507|NCT02371980|464149279|FG001|Double-blind Period|Voluntary Withdrawal|12|||
129037199|NCT00779402|464426382|FG000|Treatment Phase 1|Other|4|||
128962508|NCT02371980|464149280|FG002|Double-blind Period|Voluntary Withdrawal|8|||
128962509|NCT02371980|464149281|FG003|Double-blind Period|Voluntary Withdrawal|9|||
128962510|NCT02371980|464149282|FG004|Double-blind Period|Voluntary Withdrawal|11|||
128962511|NCT02371980|464149278|FG000|Double-blind Period|Relapse|0|||
128962512|NCT02371980|464149279|FG001|Double-blind Period|Relapse|50|||
128962513|NCT02371980|464149280|FG002|Double-blind Period|Relapse|25|||
128962514|NCT02371980|464149281|FG003|Double-blind Period|Relapse|25|||
128962515|NCT02371980|464149282|FG004|Double-blind Period|Relapse|26|||
128962516|NCT02371980|464149278|FG000|Double-blind Period|Reason not Specified|0|||
128962517|NCT02371980|464149279|FG001|Double-blind Period|Reason not Specified|3|||
128962518|NCT02371980|464149280|FG002|Double-blind Period|Reason not Specified|3|||
128962519|NCT02371980|464149281|FG003|Double-blind Period|Reason not Specified|2|||
128962520|NCT02371980|464149282|FG004|Double-blind Period|Reason not Specified|1|||
128962521|NCT02371980|464149278|FG000|Double-blind Period|Missing|0|||
128962522|NCT02371980|464149279|FG001|Double-blind Period|Missing|1|||
128962523|NCT02371980|464149280|FG002|Double-blind Period|Missing|0|||
128962524|NCT02371980|464149281|FG003|Double-blind Period|Missing|0|||
128962525|NCT02371980|464149282|FG004|Double-blind Period|Missing|0|||
128962526|NCT01826448|464149284|FG000|Overall Study|Adverse Event|1|||
128962527|NCT01826448|464149285|FG001|Overall Study|Adverse Event|3|||
128962528|NCT01826448|464149284|FG000|Overall Study|Disease progression|2|||
128962529|NCT01826448|464149285|FG001|Overall Study|Disease progression|4|||
128962530|NCT01826448|464149284|FG000|Overall Study|Withdrawal by Subject|1|||
128962531|NCT01826448|464149285|FG001|Overall Study|Withdrawal by Subject|0|||
128962532|NCT01826448|464149284|FG000|Overall Study|Physician Decision|0|||
128962533|NCT01826448|464149285|FG001|Overall Study|Physician Decision|1|||
128962534|NCT01826448|464149284|FG000|Overall Study|2 active cancers|0|||
128962535|NCT01826448|464149285|FG001|Overall Study|2 active cancers|1|||
128962536|NCT00790218|464149286|FG000|Overall Study|Death|1|||
128962537|NCT00790218|464149287|FG001|Overall Study|Death|0|||
128962538|NCT00790218|464149288|FG002|Overall Study|Death|0|||
128962539|NCT03424044|464149290|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962540|NCT03424044|464149291|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962541|NCT03424044|464149292|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
128962542|NCT03424044|464149293|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962543|NCT03424044|464149294|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962544|NCT03424044|464149295|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962545|NCT03424044|464149296|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962546|NCT03424044|464149297|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962547|NCT03424044|464149298|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
128962548|NCT03424044|464149290|FG000|First Intervention (76 Hours)|Adverse Event|0|||
128962549|NCT03424044|464149291|FG001|First Intervention (76 Hours)|Adverse Event|0|||
128962550|NCT03424044|464149292|FG002|First Intervention (76 Hours)|Adverse Event|0|||
128962551|NCT03424044|464149293|FG003|First Intervention (76 Hours)|Adverse Event|0|||
128962552|NCT03424044|464149294|FG004|First Intervention (76 Hours)|Adverse Event|1|||
128962553|NCT03424044|464149295|FG005|First Intervention (76 Hours)|Adverse Event|0|||
128962554|NCT03424044|464149296|FG006|First Intervention (76 Hours)|Adverse Event|0|||
128962555|NCT03424044|464149297|FG007|First Intervention (76 Hours)|Adverse Event|0|||
129037200|NCT00779402|464426383|FG001|Treatment Phase 1|Other|2|||
129037201|NCT00779402|464426382|FG000|Treatment Phase 1|Closure of Study|3|||
129037202|NCT00779402|464426383|FG001|Treatment Phase 1|Closure of Study|2|||
129037203|NCT00779402|464426382|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
129037204|NCT00779402|464426383|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
129037205|NCT00779402|464426382|FG000|Surveillance Phase|Protocol Violation|0|||
129037206|NCT00779402|464426383|FG001|Surveillance Phase|Protocol Violation|1|||
129037207|NCT00779402|464426382|FG000|Surveillance Phase|Patient refused to continue|22|||
129037208|NCT00779402|464426383|FG001|Surveillance Phase|Patient refused to continue|14|||
129037209|NCT00779402|464426382|FG000|Surveillance Phase|Lost to Follow-up|2|||
129037210|NCT00779402|464426383|FG001|Surveillance Phase|Lost to Follow-up|1|||
129037211|NCT00779402|464426382|FG000|Surveillance Phase|Death|0|||
129037212|NCT00779402|464426383|FG001|Surveillance Phase|Death|1|||
129037213|NCT00779402|464426382|FG000|Surveillance Phase|Intercurrent Illness|2|||
129037214|NCT00779402|464426383|FG001|Surveillance Phase|Intercurrent Illness|0|||
129037215|NCT00779402|464426382|FG000|Surveillance Phase|Other|5|||
129037216|NCT00779402|464426383|FG001|Surveillance Phase|Other|5|||
129037217|NCT00779402|464426382|FG000|Surveillance Phase|Withdrawal by Subject|4|||
129037218|NCT00779402|464426383|FG001|Surveillance Phase|Withdrawal by Subject|1|||
129037219|NCT00779402|464426382|FG000|Surveillance Phase|Closure of study|5|||
129037220|NCT00779402|464426383|FG001|Surveillance Phase|Closure of study|6|||
129037221|NCT00779402|464426382|FG000|Surveillance Phase|Completed Protocol Visits|3|||
129037222|NCT00779402|464426383|FG001|Surveillance Phase|Completed Protocol Visits|2|||
129037223|NCT00779402|464426382|FG000|Long-term Follow-up|Patient refused to continue|2|||
129037224|NCT00779402|464426383|FG001|Long-term Follow-up|Patient refused to continue|0|||
129037225|NCT00779402|464426382|FG000|Long-term Follow-up|Other|5|||
129037226|NCT00779402|464426383|FG001|Long-term Follow-up|Other|0|||
128962556|NCT03424044|464149298|FG008|First Intervention (76 Hours)|Adverse Event|0|||
128962557|NCT03424044|464149290|FG000|First Intervention (76 Hours)|device issues|0|||
128962558|NCT03424044|464149291|FG001|First Intervention (76 Hours)|device issues|0|||
128962559|NCT03424044|464149292|FG002|First Intervention (76 Hours)|device issues|0|||
128962560|NCT03424044|464149293|FG003|First Intervention (76 Hours)|device issues|0|||
128962561|NCT03424044|464149294|FG004|First Intervention (76 Hours)|device issues|0|||
128962562|NCT03424044|464149295|FG005|First Intervention (76 Hours)|device issues|0|||
128962563|NCT03424044|464149296|FG006|First Intervention (76 Hours)|device issues|1|||
128962564|NCT03424044|464149297|FG007|First Intervention (76 Hours)|device issues|1|||
128962565|NCT03424044|464149298|FG008|First Intervention (76 Hours)|device issues|1|||
128962566|NCT03424044|464149290|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
128962567|NCT03424044|464149291|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
128962568|NCT03424044|464149292|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
128962569|NCT03424044|464149293|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
128962570|NCT03424044|464149294|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
128962571|NCT03424044|464149295|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
128962572|NCT03424044|464149296|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
128962573|NCT03424044|464149297|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
128962574|NCT03424044|464149298|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
128962575|NCT03424044|464149290|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962576|NCT03424044|464149291|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962577|NCT03424044|464149292|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962578|NCT03424044|464149293|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
128962579|NCT03424044|464149294|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962580|NCT03424044|464149295|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962581|NCT03424044|464149296|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962582|NCT03424044|464149297|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962583|NCT03424044|464149298|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
128962584|NCT02971007|464149301|FG000|Overall Study|Adverse Event|1|||
128962585|NCT02971007|464149302|FG001|Overall Study|Adverse Event|0|||
128962586|NCT02971007|464149303|FG002|Overall Study|Adverse Event|0|||
128962587|NCT02971007|464149301|FG000|Overall Study|Lost to Follow-up|0|||
128962588|NCT02971007|464149302|FG001|Overall Study|Lost to Follow-up|1|||
128962589|NCT02971007|464149303|FG002|Overall Study|Lost to Follow-up|1|||
128962590|NCT02971007|464149301|FG000|Overall Study|Withdrawal by Subject|0|||
128962591|NCT02971007|464149302|FG001|Overall Study|Withdrawal by Subject|1|||
128962592|NCT02971007|464149303|FG002|Overall Study|Withdrawal by Subject|0|||
128962593|NCT02971007|464149301|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
128962594|NCT02971007|464149302|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
128962595|NCT02971007|464149303|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
128962596|NCT02971007|464149301|FG000|Overall Study|Patient discontinued study drug|0|||
128962597|NCT02971007|464149302|FG001|Overall Study|Patient discontinued study drug|1|||
128962598|NCT02971007|464149303|FG002|Overall Study|Patient discontinued study drug|0|||
128962599|NCT00402285|464149306|FG000|Overall Study|insufficient RNA quality|7|||
128962600|NCT00402285|464149307|FG001|Overall Study|insufficient RNA quality|6|||
128962601|NCT00402285|464149308|FG002|Overall Study|insufficient RNA quality|2|||
128962602|NCT02431702|464149311|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
128962603|NCT02431702|464149312|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
128962604|NCT02431702|464149313|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
128962605|NCT02431702|464149314|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
128962606|NCT02431702|464149315|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
128962607|NCT02431702|464149316|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
128962608|NCT02431702|464149317|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
128962609|NCT02431702|464149311|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
128962610|NCT02431702|464149312|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
128962611|NCT02431702|464149313|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
128962612|NCT02431702|464149314|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
128962613|NCT02431702|464149315|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
128962614|NCT02431702|464149316|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
128962615|NCT02431702|464149317|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
128962616|NCT02431702|464149311|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
128962617|NCT02431702|464149312|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
128962618|NCT02431702|464149313|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
128962619|NCT02431702|464149314|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
128962620|NCT02431702|464149315|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
128962621|NCT02431702|464149316|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
128962622|NCT02431702|464149317|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
128962623|NCT02431702|464149311|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
128962624|NCT02431702|464149312|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
129037227|NCT00779402|464426382|FG000|Long-term Follow-up|Closure of Study|8|||
128962625|NCT02431702|464149313|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
128962626|NCT02431702|464149314|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
128962627|NCT02431702|464149315|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
128962628|NCT02431702|464149316|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
128962629|NCT02431702|464149317|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
128962630|NCT02431702|464149311|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
128962631|NCT02431702|464149312|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
128962632|NCT02431702|464149313|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
128962633|NCT02431702|464149314|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
128962634|NCT02431702|464149315|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
128962635|NCT02431702|464149316|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
128962636|NCT02431702|464149317|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
128962637|NCT02431702|464149311|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
128962638|NCT02431702|464149312|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
128962639|NCT02431702|464149313|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
128962640|NCT02431702|464149314|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
128962641|NCT02431702|464149315|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
128962642|NCT02431702|464149316|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
128962643|NCT02431702|464149317|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
128962644|NCT02431702|464149311|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
128962645|NCT02431702|464149312|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
128962646|NCT02431702|464149313|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
128962647|NCT02431702|464149314|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
128962648|NCT02431702|464149315|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
128962649|NCT02431702|464149316|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
128962650|NCT02431702|464149317|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
128962651|NCT02431702|464149311|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
128962652|NCT02431702|464149312|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
128962653|NCT02431702|464149313|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
128962654|NCT02431702|464149314|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
128962655|NCT02431702|464149315|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
128962656|NCT02431702|464149316|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
128962657|NCT02431702|464149317|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
128962658|NCT02431702|464149311|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
128962659|NCT02431702|464149312|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
128962660|NCT02431702|464149313|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
128962661|NCT02431702|464149314|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
128962662|NCT02431702|464149315|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
128962663|NCT02431702|464149316|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
128962664|NCT02431702|464149317|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
128962665|NCT02431702|464149311|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
128962666|NCT02431702|464149312|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
128962667|NCT02431702|464149313|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
128962668|NCT02431702|464149314|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
128962669|NCT02431702|464149315|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
128962670|NCT02431702|464149316|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
128962671|NCT02431702|464149317|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
128962672|NCT02431702|464149311|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
128962673|NCT02431702|464149312|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
128962674|NCT02431702|464149313|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
128962675|NCT02431702|464149314|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
128962676|NCT02431702|464149315|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
128962677|NCT02431702|464149316|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
128962678|NCT02431702|464149317|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
128962679|NCT02431702|464149311|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
128962680|NCT02431702|464149312|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
128962681|NCT02431702|464149313|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
128962682|NCT02431702|464149314|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
128962683|NCT02431702|464149315|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
128962684|NCT02431702|464149316|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
129037228|NCT00779402|464426383|FG001|Long-term Follow-up|Closure of Study|4|||
129219987|NCT02908672|465104672|FG000|Run-in Period|Withdrawal by Subject|3|||
129219988|NCT02908672|465104673|FG001|Run-in Period|Withdrawal by Subject|9|||
128962685|NCT02431702|464149317|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
128962686|NCT02431702|464149311|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
128962687|NCT02431702|464149312|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
128962688|NCT02431702|464149313|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
128962689|NCT02431702|464149314|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
128962690|NCT02431702|464149315|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
128962691|NCT02431702|464149316|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
128962692|NCT02431702|464149317|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
128962693|NCT02431702|464149311|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
128962694|NCT02431702|464149312|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
128962695|NCT02431702|464149313|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
128962696|NCT02431702|464149314|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
128962697|NCT02431702|464149315|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
128962698|NCT02431702|464149316|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
128962699|NCT02431702|464149317|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
128962700|NCT02431702|464149311|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
128962701|NCT02431702|464149312|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
128962702|NCT02431702|464149313|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
128962703|NCT02431702|464149314|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
128962704|NCT02431702|464149315|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
128962705|NCT02431702|464149316|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
128962706|NCT02431702|464149317|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
128962707|NCT02009930|464149318|FG000|Overall Study|withdrawn|5|||
128962708|NCT02959970|464149324|FG000|Overall Study|Adverse Event|1|||
128962709|NCT02959970|464149325|FG001|Overall Study|Adverse Event|0|||
128962710|NCT02959970|464149324|FG000|Overall Study|Withdrawal by Subject|0|||
128962711|NCT02959970|464149325|FG001|Overall Study|Withdrawal by Subject|2|||
128962712|NCT02959970|464149324|FG000|Overall Study|Lost to Follow-up|1|||
128962713|NCT02959970|464149325|FG001|Overall Study|Lost to Follow-up|5|||
128962714|NCT00693420|464149328|FG000|Overall Study|Adverse Event|4|||
128962715|NCT00693420|464149329|FG001|Overall Study|Adverse Event|4|||
128962716|NCT00693420|464149328|FG000|Overall Study|Lost to Follow-up|0|||
128962717|NCT00693420|464149329|FG001|Overall Study|Lost to Follow-up|3|||
128962718|NCT00693420|464149328|FG000|Overall Study|Withdrawal by Subject|1|||
128962719|NCT00693420|464149329|FG001|Overall Study|Withdrawal by Subject|0|||
128962720|NCT00693420|464149328|FG000|Overall Study|Protocol Violation|0|||
128962721|NCT00693420|464149329|FG001|Overall Study|Protocol Violation|2|||
128962722|NCT00693420|464149328|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
128962723|NCT00693420|464149329|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
128962724|NCT00693420|464149328|FG000|Overall Study|Personal Reasons|1|||
128962725|NCT00693420|464149329|FG001|Overall Study|Personal Reasons|4|||
128962726|NCT03250624|464149335|FG000|Overall Study|Lack of Efficacy|1|||
128962727|NCT03250624|464149336|FG001|Overall Study|Lack of Efficacy|4|||
128962728|NCT03250624|464149335|FG000|Overall Study|Adverse Event|0|||
128962729|NCT03250624|464149336|FG001|Overall Study|Adverse Event|1|||
128962730|NCT03250624|464149335|FG000|Overall Study|Other|1|||
128962731|NCT03250624|464149336|FG001|Overall Study|Other|2|||
128962732|NCT00509028|464149340|FG000|Overall Study|Adverse Event|2|||
128962733|NCT00509028|464149341|FG001|Overall Study|Adverse Event|0|||
128962734|NCT00509028|464149340|FG000|Overall Study|Withdrawal by Subject|4|||
128962735|NCT00509028|464149341|FG001|Overall Study|Withdrawal by Subject|3|||
128962736|NCT00509028|464149340|FG000|Overall Study|Lost to Follow-up|0|||
128962737|NCT00509028|464149341|FG001|Overall Study|Lost to Follow-up|1|||
128962738|NCT00509028|464149340|FG000|Overall Study|Protocol Violation|4|||
128962739|NCT00509028|464149341|FG001|Overall Study|Protocol Violation|2|||
128962740|NCT00509028|464149340|FG000|Overall Study|Non-compliance|2|||
128962741|NCT00509028|464149341|FG001|Overall Study|Non-compliance|1|||
128962742|NCT00948428|464149342|FG000|Overall Study|Withdrawal by Subject|6|||
128962743|NCT00948428|464149343|FG001|Overall Study|Withdrawal by Subject|12|||
128962744|NCT00948428|464149344|FG002|Overall Study|Withdrawal by Subject|7|||
128962745|NCT00948428|464149342|FG000|Overall Study|Adverse Event|6|||
128962746|NCT00948428|464149343|FG001|Overall Study|Adverse Event|3|||
128962747|NCT00948428|464149344|FG002|Overall Study|Adverse Event|0|||
128962748|NCT00948428|464149342|FG000|Overall Study|Lost to Follow-up|2|||
128962749|NCT00948428|464149343|FG001|Overall Study|Lost to Follow-up|1|||
128962750|NCT00948428|464149344|FG002|Overall Study|Lost to Follow-up|1|||
128962751|NCT00948428|464149342|FG000|Overall Study|Death|2|||
128962752|NCT00948428|464149343|FG001|Overall Study|Death|0|||
128962753|NCT00948428|464149344|FG002|Overall Study|Death|0|||
129219989|NCT02908672|465104674|FG002|Run-in Period|Withdrawal by Subject|0|||
129219990|NCT02908672|465104675|FG003|Run-in Period|Withdrawal by Subject|0|||
128962754|NCT00948428|464149342|FG000|Overall Study|Intercurrent Illness|1|||
128962755|NCT00948428|464149343|FG001|Overall Study|Intercurrent Illness|0|||
128962756|NCT00948428|464149344|FG002|Overall Study|Intercurrent Illness|0|||
129219991|NCT02908672|465104672|FG000|Triple Combination Period|Death|0|||
128713206|NCT03036072|463246036|FG001|Overall Study|Withdrawal by Subject|1|||
128713207|NCT03036072|463246035|FG000|Overall Study|Physician Decision|0|||
128713208|NCT03036072|463246036|FG001|Overall Study|Physician Decision|1|||
128962757|NCT00948428|464149342|FG000|Overall Study|Non-compliance|1|||
128962758|NCT00948428|464149343|FG001|Overall Study|Non-compliance|2|||
128962759|NCT00948428|464149344|FG002|Overall Study|Non-compliance|0|||
128962760|NCT02408484|464149345|FG000|Overall Study|Withdrawal by Subject|3|||
128962761|NCT02408484|464149345|FG000|Overall Study|Not treated during study period|1|||
128962762|NCT02471586|464149346|FG000|Overall Study|Lost to Follow-up|3|||
128962763|NCT02471586|464149347|FG001|Overall Study|Lost to Follow-up|8|||
128962764|NCT02471586|464149348|FG002|Overall Study|Lost to Follow-up|4|||
128962765|NCT02471586|464149346|FG000|Overall Study|Death|2|||
128962766|NCT02471586|464149347|FG001|Overall Study|Death|2|||
128962767|NCT02471586|464149348|FG002|Overall Study|Death|0|||
128962768|NCT00441727|464149351|FG000|Overall Study|Protocol Violation|19|||
128962769|NCT00441727|464149352|FG001|Overall Study|Protocol Violation|28|||
128962770|NCT00441727|464149353|FG002|Overall Study|Protocol Violation|32|||
128962771|NCT00441727|464149351|FG000|Overall Study|Adverse Event|26|||
128962772|NCT00441727|464149352|FG001|Overall Study|Adverse Event|33|||
128962773|NCT00441727|464149353|FG002|Overall Study|Adverse Event|28|||
128962774|NCT00441727|464149351|FG000|Overall Study|Lack of Efficacy|7|||
128962775|NCT00441727|464149352|FG001|Overall Study|Lack of Efficacy|8|||
128962776|NCT00441727|464149353|FG002|Overall Study|Lack of Efficacy|48|||
128962777|NCT00441727|464149351|FG000|Overall Study|Withdrawal by Subject|40|||
128962778|NCT00441727|464149352|FG001|Overall Study|Withdrawal by Subject|34|||
128962779|NCT00441727|464149353|FG002|Overall Study|Withdrawal by Subject|47|||
128962780|NCT00441727|464149351|FG000|Overall Study|Lost to Follow-up|5|||
128962781|NCT00441727|464149352|FG001|Overall Study|Lost to Follow-up|6|||
128962782|NCT00441727|464149353|FG002|Overall Study|Lost to Follow-up|5|||
128962783|NCT00441727|464149351|FG000|Overall Study|Safety Reasons|3|||
128962784|NCT00441727|464149352|FG001|Overall Study|Safety Reasons|1|||
128962785|NCT00441727|464149353|FG002|Overall Study|Safety Reasons|3|||
128962786|NCT00441727|464149351|FG000|Overall Study|Various reason specified|6|||
128962787|NCT00441727|464149352|FG001|Overall Study|Various reason specified|8|||
128962788|NCT00441727|464149353|FG002|Overall Study|Various reason specified|5|||
128962789|NCT03235726|464149356|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962790|NCT03235726|464149357|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962791|NCT03235726|464149358|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962792|NCT03235726|464149359|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962793|NCT03235726|464149360|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
128962794|NCT03235726|464149361|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962795|NCT03235726|464149362|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962796|NCT03235726|464149363|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962797|NCT03235726|464149364|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962798|NCT03235726|464149365|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
128962799|NCT03235726|464149356|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962800|NCT03235726|464149357|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962801|NCT03235726|464149358|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962802|NCT03235726|464149359|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962803|NCT03235726|464149360|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
128962804|NCT03235726|464149361|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962805|NCT03235726|464149362|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962806|NCT03235726|464149363|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962807|NCT03235726|464149364|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962808|NCT03235726|464149365|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
128962809|NCT03135262|464149369|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
128962810|NCT03135262|464149370|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
128962811|NCT03135262|464149371|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
128962812|NCT03135262|464149372|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
128962813|NCT03135262|464149373|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
128962814|NCT03135262|464149369|FG000|Overall Study|Progression of disease|0|||
128962815|NCT03135262|464149370|FG001|Overall Study|Progression of disease|0|||
128962816|NCT03135262|464149371|FG002|Overall Study|Progression of disease|0|||
128962817|NCT03135262|464149372|FG003|Overall Study|Progression of disease|1|||
128962818|NCT03135262|464149373|FG004|Overall Study|Progression of disease|0|||
129127671|NCT05032196|464759369|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128962819|NCT03135262|464149369|FG000|Overall Study|Death|6|||
128962820|NCT03135262|464149370|FG001|Overall Study|Death|2|||
128962821|NCT03135262|464149371|FG002|Overall Study|Death|2|||
128962822|NCT03135262|464149372|FG003|Overall Study|Death|2|||
128962823|NCT03135262|464149373|FG004|Overall Study|Death|0|||
128962824|NCT03135262|464149369|FG000|Overall Study|Withdrawal by Subject|0|||
128962825|NCT03135262|464149370|FG001|Overall Study|Withdrawal by Subject|0|||
128962826|NCT03135262|464149371|FG002|Overall Study|Withdrawal by Subject|1|||
128962827|NCT03135262|464149372|FG003|Overall Study|Withdrawal by Subject|0|||
128962828|NCT03135262|464149373|FG004|Overall Study|Withdrawal by Subject|1|||
128962829|NCT03135262|464149369|FG000|Overall Study|Study terminated by sponsor|2|||
128962830|NCT03135262|464149370|FG001|Overall Study|Study terminated by sponsor|4|||
128962831|NCT03135262|464149371|FG002|Overall Study|Study terminated by sponsor|4|||
128962832|NCT03135262|464149372|FG003|Overall Study|Study terminated by sponsor|3|||
128962833|NCT03135262|464149373|FG004|Overall Study|Study terminated by sponsor|0|||
128962834|NCT01675141|464149374|FG000|Overall Study|Lenalidomide outside NIH|3|||
128962835|NCT01675141|464149374|FG000|Overall Study|Withdrawal by Subject|3|||
128962836|NCT01675141|464149374|FG000|Overall Study|Physician Decision|4|||
128962837|NCT01675141|464149374|FG000|Overall Study|No treatment, per protocol|1|||
128962838|NCT01599806|464149379|FG000|Overall Study|Lost to Follow-up|20|||
128962839|NCT01599806|464149380|FG001|Overall Study|Lost to Follow-up|20|||
128962840|NCT01599806|464149379|FG000|Overall Study|Withdrawal by Subject|12|||
128962841|NCT01599806|464149380|FG001|Overall Study|Withdrawal by Subject|12|||
128962842|NCT01599806|464149379|FG000|Overall Study|Other Eligibility criteria|11|||
128962843|NCT01599806|464149380|FG001|Overall Study|Other Eligibility criteria|9|||
128962844|NCT00391807|464149383|FG000|Overall Study|Did not receive study medication|23|||
128962845|NCT00391807|464149383|FG000|Overall Study|Adverse Event|177|||
128962846|NCT00391807|464149383|FG000|Overall Study|Pregnancy|25|||
128962847|NCT00391807|464149383|FG000|Overall Study|Lost to Follow-up|227|||
128962848|NCT00391807|464149383|FG000|Overall Study|Withdrawal by Subject|147|||
128962849|NCT00391807|464149383|FG000|Overall Study|Protocol Violation|20|||
128962850|NCT00391807|464149383|FG000|Overall Study|Various|96|||
128962851|NCT02417064|464149392|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
128962852|NCT02417064|464149393|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
128962853|NCT02417064|464149394|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
128962854|NCT02417064|464149392|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
128962855|NCT02417064|464149393|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
128962856|NCT02417064|464149394|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
128962857|NCT02417064|464149392|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
128962858|NCT02417064|464149393|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
128962859|NCT02417064|464149394|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
128962860|NCT02417064|464149392|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
128962861|NCT02417064|464149393|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
128962862|NCT02417064|464149394|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
128962863|NCT02417064|464149392|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
128962864|NCT02417064|464149393|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
128962865|NCT02417064|464149394|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
128962866|NCT02417064|464149392|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
128962867|NCT02417064|464149393|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
128962868|NCT02417064|464149394|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
128962869|NCT02417064|464149392|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
128962870|NCT02417064|464149393|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
128962871|NCT02417064|464149394|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
128962872|NCT02417064|464149392|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
128962873|NCT02417064|464149393|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
128962874|NCT02417064|464149394|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
128962875|NCT02417064|464149392|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
128962876|NCT02417064|464149393|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
128962877|NCT02417064|464149394|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
128962878|NCT02417064|464149392|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
128962879|NCT02417064|464149393|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
128962880|NCT02417064|464149394|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
128962881|NCT02417064|464149392|FG000|Follow-up Phase (24 Weeks)|Other|2|||
128962882|NCT02417064|464149393|FG001|Follow-up Phase (24 Weeks)|Other|2|||
128962883|NCT02417064|464149394|FG002|Follow-up Phase (24 Weeks)|Other|3|||
128962884|NCT01585168|464149395|FG000|Overall Study|Lost to Follow-up|3|||
128962885|NCT01585168|464149396|FG001|Overall Study|Lost to Follow-up|1|||
128962886|NCT01585168|464149397|FG002|Overall Study|Lost to Follow-up|1|||
128962887|NCT01585168|464149398|FG003|Overall Study|Lost to Follow-up|1|||
128962888|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
128962889|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
128962890|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
128713209|NCT02484729|463246037|FG000|Overall Study|Failure of IntelliCap Error|0|||
128962891|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
128962892|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
128962893|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
128713210|NCT02484729|463246038|FG001|Overall Study|Failure of IntelliCap Error|0|||
128962894|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
128962895|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
128962896|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
128962897|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
128962898|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
128962899|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
128962900|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
128962901|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
128962902|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
128962903|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
128962904|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
128962905|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
128962906|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
128962907|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
128962908|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
128962909|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
128962910|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
128962911|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
128962912|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Other|0|||
128962913|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Other|1|||
128962914|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Other|0|||
128962915|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Other|0|||
128962916|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
128962917|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
128962918|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
128962919|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
128962920|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
128962921|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
128962922|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
128962923|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
128962924|NCT01194414|464149399|FG000|24 Weeks Double Blind Period|Death|0|||
128962925|NCT01194414|464149400|FG001|24 Weeks Double Blind Period|Death|1|||
128962926|NCT01194414|464149401|FG002|24 Weeks Double Blind Period|Death|0|||
128962927|NCT01194414|464149402|FG003|24 Weeks Double Blind Period|Death|0|||
128962928|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
128962929|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
128962930|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
128962931|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
128962932|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
128962933|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
128962934|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
128962935|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
128962936|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
128962937|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
128962938|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
128962939|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
128962940|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
128962941|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
128962942|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
128962943|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
128962944|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
128962945|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
128962946|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
128962947|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
128962948|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
128962949|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
128962950|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
128962951|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
128962952|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Other|2|||
128962953|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Other|1|||
128962954|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Other|0|||
128962955|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Other|0|||
128962956|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
129037229|NCT00779402|464426382|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
129037230|NCT00779402|464426383|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
129037231|NCT01519947|464426388|FG000|Overall Study|Death|0|||
129037232|NCT01519947|464426389|FG001|Overall Study|Death|0|||
129037233|NCT01519947|464426390|FG002|Overall Study|Death|0|||
128962957|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
128962958|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
128962959|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
128962960|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
128962961|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
128962962|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
128962963|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
128962964|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
128962965|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
128962966|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
128962967|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
128962968|NCT01194414|464149399|FG000|72 Weeks Open Label Extension|Death|1|||
128962969|NCT01194414|464149400|FG001|72 Weeks Open Label Extension|Death|2|||
128962970|NCT01194414|464149401|FG002|72 Weeks Open Label Extension|Death|0|||
128962971|NCT01194414|464149402|FG003|72 Weeks Open Label Extension|Death|2|||
128962972|NCT02017704|464149405|FG000|Overall Study|Withdrawal by Subject|2|||
128962973|NCT02017704|464149406|FG001|Overall Study|Withdrawal by Subject|0|||
128962974|NCT01587274|464149407|FG000|Overall Study|Lost to Follow-up|4|||
128962975|NCT01587274|464149408|FG001|Overall Study|Lost to Follow-up|5|||
128962976|NCT01587274|464149409|FG002|Overall Study|Lost to Follow-up|3|||
128962977|NCT00918346|464149410|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
128962978|NCT00918346|464149411|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
128962979|NCT02475629|464149412|FG000|Overall Study|Adverse Event|1|||
128962980|NCT02475629|464149412|FG000|Overall Study|Death|4|||
128962981|NCT02475629|464149412|FG000|Overall Study|Physician Decision|1|||
128962982|NCT02475629|464149412|FG000|Overall Study|Withdrawal by Subject|1|||
128962983|NCT02475629|464149412|FG000|Overall Study|Lost to Follow-up|1|||
128962984|NCT02475629|464149412|FG000|Overall Study|Subject non-compliance|1|||
128962985|NCT01451398|464149421|FG000|Overall Study|Adverse Event|7|||
128962986|NCT01451398|464149422|FG001|Overall Study|Adverse Event|9|||
128962987|NCT01451398|464149421|FG000|Overall Study|Protocol Violation|1|||
128962988|NCT01451398|464149422|FG001|Overall Study|Protocol Violation|2|||
128962989|NCT01451398|464149421|FG000|Overall Study|Physician Decision|1|||
128962990|NCT01451398|464149422|FG001|Overall Study|Physician Decision|1|||
128962991|NCT01451398|464149421|FG000|Overall Study|Withdrawal by Subject|10|||
128962992|NCT01451398|464149422|FG001|Overall Study|Withdrawal by Subject|14|||
128962993|NCT01451398|464149421|FG000|Overall Study|Lost to Follow-up|6|||
128962994|NCT01451398|464149422|FG001|Overall Study|Lost to Follow-up|4|||
128962995|NCT01451398|464149421|FG000|Overall Study|Non-compliance with study drug|1|||
128962996|NCT01451398|464149422|FG001|Overall Study|Non-compliance with study drug|3|||
128962997|NCT01451398|464149421|FG000|Overall Study|Non-compliance with protocol|1|||
128962998|NCT01451398|464149422|FG001|Overall Study|Non-compliance with protocol|1|||
128962999|NCT01451398|464149421|FG000|Overall Study|Moved out of country|0|||
128963000|NCT01451398|464149422|FG001|Overall Study|Moved out of country|1|||
128963001|NCT01451398|464149421|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
128963002|NCT01451398|464149422|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
128963003|NCT01451398|464149421|FG000|Overall Study|Lack of Efficacy|0|||
128963004|NCT01451398|464149422|FG001|Overall Study|Lack of Efficacy|1|||
128963005|NCT01000025|464149425|FG000|Overall Study|Adverse Event|43|||
128963006|NCT01000025|464149426|FG001|Overall Study|Adverse Event|2|||
128963007|NCT01000025|464149425|FG000|Overall Study|Withdrawal by Subject|13|||
128963008|NCT01000025|464149426|FG001|Overall Study|Withdrawal by Subject|8|||
128963009|NCT01000025|464149425|FG000|Overall Study|Death|23|||
128963010|NCT01000025|464149426|FG001|Overall Study|Death|13|||
128963011|NCT01000025|464149425|FG000|Overall Study|Lack of Efficacy|363|||
128963012|NCT01000025|464149426|FG001|Overall Study|Lack of Efficacy|208|||
128963013|NCT01000025|464149425|FG000|Overall Study|Intercurrent Illness|26|||
128963014|NCT01000025|464149426|FG001|Overall Study|Intercurrent Illness|7|||
128963015|NCT04423757|464149427|FG000|Overall Study|Adverse Event|2|||
128963016|NCT04423757|464149428|FG001|Overall Study|Adverse Event|0|||
128963017|NCT04423757|464149427|FG000|Overall Study|Not treated|1|||
128963018|NCT04423757|464149428|FG001|Overall Study|Not treated|1|||
128963019|NCT00422669|464149429|FG000|Overall Study|The study was terminated early.|98|||
128963020|NCT00422669|464149430|FG001|Overall Study|The study was terminated early.|100|||
128963021|NCT00422669|464149431|FG002|Overall Study|The study was terminated early.|7|||
128963022|NCT02709109|464149432|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
128963023|NCT02709109|464149433|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
128963024|NCT02709109|464149434|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
128963025|NCT02709109|464149435|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
128963026|NCT02709109|464149432|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
128963027|NCT02709109|464149433|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
128963028|NCT02709109|464149434|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
128963029|NCT02709109|464149435|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
128771541|NCT01091428|463455271|FG000|Phase 2|Symptomatic Deterioration|0|||
128963030|NCT02709109|464149432|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
128963031|NCT02709109|464149433|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
128963032|NCT02709109|464149434|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
128963033|NCT02709109|464149435|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
128963034|NCT02709109|464149432|FG000|Washout Period (28 Days)|Other|2|||
128963035|NCT02709109|464149433|FG001|Washout Period (28 Days)|Other|2|||
128963036|NCT02709109|464149434|FG002|Washout Period (28 Days)|Other|3|||
128963037|NCT02709109|464149435|FG003|Washout Period (28 Days)|Other|0|||
128963038|NCT02709109|464149432|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
128963039|NCT02709109|464149433|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
128963040|NCT02709109|464149434|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
128963041|NCT02709109|464149435|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
128963042|NCT02709109|464149432|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
128963043|NCT02709109|464149433|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
128963044|NCT02709109|464149434|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
128963045|NCT02709109|464149435|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
128963046|NCT02709109|464149432|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
128963047|NCT02709109|464149433|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
128963048|NCT02709109|464149434|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
128963049|NCT02709109|464149435|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
128963050|NCT02709109|464149432|FG000|Treatment Period 2 (28 Days)|Other|0|||
128963051|NCT02709109|464149433|FG001|Treatment Period 2 (28 Days)|Other|0|||
128963052|NCT02709109|464149434|FG002|Treatment Period 2 (28 Days)|Other|1|||
128963053|NCT02709109|464149435|FG003|Treatment Period 2 (28 Days)|Other|0|||
128963054|NCT00996593|464149436|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
128963055|NCT00996593|464149436|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
128963056|NCT00996593|464149436|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
128963057|NCT00996593|464149436|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
128963058|NCT00996593|464149436|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
128963059|NCT00996593|464149436|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
128963060|NCT00996593|464149436|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
128963061|NCT00996593|464149436|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
128963062|NCT00996593|464149436|FG000|Long-Term Follow-Up|Site Closed|1|||
128963063|NCT02738580|464149437|FG000|Overall Study|Adverse Event|1|||
128963064|NCT02738580|464149438|FG001|Overall Study|Adverse Event|0|||
128963065|NCT02738580|464149437|FG000|Overall Study|Lack of Efficacy|3|||
128963066|NCT02738580|464149438|FG001|Overall Study|Lack of Efficacy|2|||
128963067|NCT02738580|464149437|FG000|Overall Study|Withdrawal by Subject|0|||
128963068|NCT02738580|464149438|FG001|Overall Study|Withdrawal by Subject|1|||
128963069|NCT02738580|464149437|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
128963070|NCT02738580|464149438|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
128963071|NCT01250756|464149439|FG000|Infant Series|Withdrawal by Subject|4|||
128963072|NCT01250756|464149440|FG001|Infant Series|Withdrawal by Subject|5|||
128963073|NCT01250756|464149439|FG000|Infant Series|Randomized, Not Vaccinated|2|||
128963074|NCT01250756|464149440|FG001|Infant Series|Randomized, Not Vaccinated|2|||
128963075|NCT01250756|464149439|FG000|Infant Series|Other|22|||
128963076|NCT01250756|464149440|FG001|Infant Series|Other|0|||
128963077|NCT01250756|464149439|FG000|After Infant Series|Adverse Event|5|||
128963078|NCT01250756|464149440|FG001|After Infant Series|Adverse Event|2|||
128963079|NCT01250756|464149439|FG000|After Infant Series|Withdrawal by Subject|4|||
128963080|NCT01250756|464149440|FG001|After Infant Series|Withdrawal by Subject|1|||
128963081|NCT01250756|464149439|FG000|After Infant Series|Other|2|||
128963082|NCT01250756|464149440|FG001|After Infant Series|Other|1|||
128963083|NCT01250756|464149439|FG000|Toddler Dose|Adverse Event|0|||
128963084|NCT01250756|464149440|FG001|Toddler Dose|Adverse Event|1|||
128963085|NCT01250756|464149439|FG000|After Toddler Dose|Adverse Event|0|||
128963086|NCT01250756|464149440|FG001|After Toddler Dose|Adverse Event|1|||
128963087|NCT01815580|464149443|FG000|Overall Study|Lost to Follow-up|4|||
128963088|NCT01815580|464149444|FG001|Overall Study|Lost to Follow-up|7|||
128963089|NCT01815580|464149443|FG000|Overall Study|Withdrawal by Subject|3|||
128963090|NCT01815580|464149444|FG001|Overall Study|Withdrawal by Subject|4|||
128963091|NCT01815580|464149443|FG000|Overall Study|Excluded from analysis|5|||
128963092|NCT01815580|464149444|FG001|Overall Study|Excluded from analysis|4|||
128963093|NCT02228564|464149445|FG000|Overall Study|Withdrawal by Subject|10|||
128963094|NCT02228564|464149445|FG000|Overall Study|Death|11|||
128963095|NCT02228564|464149445|FG000|Overall Study|Physician Decision|5|||
128963096|NCT02228564|464149445|FG000|Overall Study|Lost to Follow-up|17|||
128963097|NCT02228564|464149445|FG000|Overall Study|Other|6|||
128963098|NCT02142504|464149446|FG000|Overall Study|Protocol Violation|2|||
128963099|NCT02142504|464149447|FG001|Overall Study|Protocol Violation|1|||
128963100|NCT02142504|464149448|FG002|Overall Study|Protocol Violation|2|||
128963101|NCT02142504|464149446|FG000|Overall Study|Adverse Event|2|||
128963102|NCT02142504|464149447|FG001|Overall Study|Adverse Event|3|||
128963103|NCT02142504|464149448|FG002|Overall Study|Adverse Event|4|||
128713211|NCT02484729|463246039|FG002|Overall Study|Failure of IntelliCap Error|0|||
128963104|NCT02142504|464149446|FG000|Overall Study|Lost to Follow-up|12|||
128963105|NCT02142504|464149447|FG001|Overall Study|Lost to Follow-up|19|||
128963106|NCT02142504|464149448|FG002|Overall Study|Lost to Follow-up|17|||
128963107|NCT02142504|464149446|FG000|Overall Study|Withdrawal by Subject|7|||
128963108|NCT02142504|464149447|FG001|Overall Study|Withdrawal by Subject|9|||
128963109|NCT02142504|464149448|FG002|Overall Study|Withdrawal by Subject|11|||
128963110|NCT02142504|464149446|FG000|Overall Study|Pregnancy|4|||
128963111|NCT02142504|464149447|FG001|Overall Study|Pregnancy|4|||
128963112|NCT02142504|464149448|FG002|Overall Study|Pregnancy|2|||
128963113|NCT02142504|464149446|FG000|Overall Study|Physician Decision|0|||
128963114|NCT02142504|464149447|FG001|Overall Study|Physician Decision|1|||
128963115|NCT02142504|464149448|FG002|Overall Study|Physician Decision|3|||
128963116|NCT02142504|464149446|FG000|Overall Study|Reason Not Specified|4|||
128963117|NCT02142504|464149447|FG001|Overall Study|Reason Not Specified|5|||
128963118|NCT02142504|464149448|FG002|Overall Study|Reason Not Specified|4|||
128963119|NCT00617591|464149449|FG000|Overall Study|Withdrew consent during Induction|4|||
128963120|NCT00617591|464149449|FG000|Overall Study|Withdrew consent during Maintenance|6|||
128713212|NCT02484729|463246040|FG003|Overall Study|Failure of IntelliCap Error|0|||
128713213|NCT02484729|463246041|FG004|Overall Study|Failure of IntelliCap Error|0|||
128713214|NCT02484729|463246042|FG005|Overall Study|Failure of IntelliCap Error|0|||
128713215|NCT02484729|463246043|FG006|Overall Study|Failure of IntelliCap Error|0|||
128713216|NCT02484729|463246044|FG007|Overall Study|Failure of IntelliCap Error|0|||
128713217|NCT02484729|463246045|FG008|Overall Study|Failure of IntelliCap Error|0|||
128713218|NCT02484729|463246046|FG009|Overall Study|Failure of IntelliCap Error|1|||
128963121|NCT00376246|464149450|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
128963122|NCT00376246|464149451|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
128963123|NCT00376246|464149450|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
128963124|NCT00376246|464149451|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
128963125|NCT00376246|464149450|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
128963126|NCT00376246|464149451|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
128963127|NCT00588523|464149455|FG000|Overall Study|Not treated|3|||
128963128|NCT03032510|464149456|FG000|Overall Study|Adverse Event|5|||
128963129|NCT03032510|464149457|FG001|Overall Study|Adverse Event|2|||
128963130|NCT03032510|464149456|FG000|Overall Study|Lost to Follow-up|8|||
128963131|NCT03032510|464149457|FG001|Overall Study|Lost to Follow-up|7|||
128963132|NCT03032510|464149456|FG000|Overall Study|Withdrawal by Subject|8|||
128963133|NCT03032510|464149457|FG001|Overall Study|Withdrawal by Subject|7|||
128963134|NCT03032510|464149456|FG000|Overall Study|Subject noncompliance|4|||
128963135|NCT03032510|464149457|FG001|Overall Study|Subject noncompliance|2|||
128963136|NCT03032510|464149456|FG000|Overall Study|Physician Decision|2|||
128963137|NCT03032510|464149457|FG001|Overall Study|Physician Decision|0|||
128963138|NCT01731990|464150927|FG000|Overall Study|Adverse Event|1|||
128963139|NCT01731990|464150928|FG001|Overall Study|Adverse Event|5|||
128963140|NCT01731990|464150927|FG000|Overall Study|Withdrawal by Subject|1|||
128963141|NCT01731990|464150928|FG001|Overall Study|Withdrawal by Subject|1|||
128963142|NCT01731990|464150927|FG000|Overall Study|Protocol deviation|1|||
128963143|NCT01731990|464150928|FG001|Overall Study|Protocol deviation|2|||
128963144|NCT01731990|464150927|FG000|Overall Study|Death|1|||
128963145|NCT01731990|464150928|FG001|Overall Study|Death|0|||
128963146|NCT01280812|464150929|FG000|Overall Study|Withdrawal by Subject|2|||
128963147|NCT01280812|464150930|FG001|Overall Study|Withdrawal by Subject|1|||
128963148|NCT01280812|464150931|FG002|Overall Study|Withdrawal by Subject|0|||
128963149|NCT01280812|464150929|FG000|Overall Study|Lost to Follow-up|1|||
128963150|NCT01280812|464150930|FG001|Overall Study|Lost to Follow-up|1|||
128963151|NCT01280812|464150931|FG002|Overall Study|Lost to Follow-up|1|||
128963152|NCT04483544|464150932|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
128963153|NCT04483544|464150932|FG000|Post-Treatment|Admitted to hospice|2|||
128963154|NCT04483544|464150932|FG000|Post-Treatment|Study terminated|3|||
129037234|NCT01519947|464426391|FG003|Overall Study|Death|1|||
129037235|NCT01519947|464426388|FG000|Overall Study|Protocol Violation|0|||
128713219|NCT02111850|463246049|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128963155|NCT01131078|464150939|FG000|Overall Study|Adverse Event|22|||
129037236|NCT01519947|464426389|FG001|Overall Study|Protocol Violation|0|||
128963156|NCT01131078|464150940|FG001|Overall Study|Adverse Event|12|||
128963157|NCT01131078|464150941|FG002|Overall Study|Adverse Event|17|||
128963158|NCT01131078|464150939|FG000|Overall Study|Progressive Disease|58|||
128963159|NCT01131078|464150940|FG001|Overall Study|Progressive Disease|77|||
128963160|NCT01131078|464150941|FG002|Overall Study|Progressive Disease|71|||
128963161|NCT01131078|464150939|FG000|Overall Study|Protocol Violation|1|||
128963162|NCT01131078|464150940|FG001|Overall Study|Protocol Violation|0|||
128963163|NCT01131078|464150941|FG002|Overall Study|Protocol Violation|0|||
128963164|NCT01131078|464150939|FG000|Overall Study|Lost to Follow-up|1|||
128963165|NCT01131078|464150940|FG001|Overall Study|Lost to Follow-up|1|||
128963166|NCT01131078|464150941|FG002|Overall Study|Lost to Follow-up|1|||
128963167|NCT01131078|464150939|FG000|Overall Study|Withdrawal by Subject|2|||
128963168|NCT01131078|464150940|FG001|Overall Study|Withdrawal by Subject|4|||
129037237|NCT01519947|464426390|FG002|Overall Study|Protocol Violation|2|||
128963169|NCT01131078|464150941|FG002|Overall Study|Withdrawal by Subject|3|||
128963170|NCT01131078|464150939|FG000|Overall Study|Non-compliance|3|||
128963171|NCT01131078|464150940|FG001|Overall Study|Non-compliance|0|||
128963172|NCT01131078|464150941|FG002|Overall Study|Non-compliance|0|||
128963173|NCT01131078|464150939|FG000|Overall Study|Physician Decision|10|||
128963174|NCT01131078|464150940|FG001|Overall Study|Physician Decision|6|||
128963175|NCT01131078|464150941|FG002|Overall Study|Physician Decision|8|||
128963176|NCT01131078|464150939|FG000|Overall Study|Death|4|||
128963177|NCT01131078|464150940|FG001|Overall Study|Death|0|||
128963178|NCT01131078|464150941|FG002|Overall Study|Death|2|||
128963179|NCT01131078|464150939|FG000|Overall Study|Other|0|||
128963180|NCT01131078|464150940|FG001|Overall Study|Other|1|||
128963181|NCT01131078|464150941|FG002|Overall Study|Other|0|||
128963182|NCT01685060|464150947|FG000|Overall Study|Rollover patients|16|||
128963183|NCT01685060|464150947|FG000|Overall Study|Adverse Event|12|||
128963184|NCT01685060|464150947|FG000|Overall Study|Progressive disease|69|||
128963185|NCT01685060|464150947|FG000|Overall Study|Physician Decision|14|||
128963186|NCT01685060|464150947|FG000|Overall Study|Subject/guardian decision|20|||
128963187|NCT01685060|464150947|FG000|Overall Study|Lost to Follow-up|1|||
128963188|NCT01685060|464150947|FG000|Overall Study|Death|8|||
128963189|NCT03597503|464150948|FG000|Overall Study|Withdrawal by Subject|0|||
128963190|NCT03597503|464150949|FG001|Overall Study|Withdrawal by Subject|2|||
128963191|NCT03597503|464150948|FG000|Overall Study|Lost to Follow-up|1|||
128963192|NCT03597503|464150949|FG001|Overall Study|Lost to Follow-up|2|||
128963193|NCT03597503|464150948|FG000|Overall Study|Protocol Violation|1|||
128963194|NCT03597503|464150949|FG001|Overall Study|Protocol Violation|0|||
128963195|NCT00405275|464150952|FG000|Overall Study|Death|1|||
128963196|NCT00405275|464150953|FG001|Overall Study|Death|0|||
128963197|NCT00405275|464150952|FG000|Overall Study|Lost to Follow-up|5|||
128963198|NCT00405275|464150953|FG001|Overall Study|Lost to Follow-up|1|||
128963199|NCT00405275|464150952|FG000|Overall Study|Withdrawal by Subject|7|||
128963200|NCT00405275|464150953|FG001|Overall Study|Withdrawal by Subject|9|||
128963201|NCT00405275|464150952|FG000|Overall Study|Unwilling to continue|10|||
128963202|NCT00405275|464150953|FG001|Overall Study|Unwilling to continue|9|||
128963203|NCT02809118|464150956|FG000|Overall Study|Withdrawal by Subject|0|||
128963204|NCT02809118|464150957|FG001|Overall Study|Withdrawal by Subject|1|||
128963205|NCT02809118|464150958|FG002|Overall Study|Withdrawal by Subject|1|||
128963206|NCT01235338|464150959|FG000|Overall Study|Adverse Event|3|||
129037238|NCT01519947|464426391|FG003|Overall Study|Protocol Violation|1|||
129037239|NCT01519947|464426388|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
129037240|NCT01519947|464426389|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
129037241|NCT01519947|464426390|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
129037242|NCT01519947|464426391|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
129037243|NCT01519947|464426388|FG000|Overall Study|Development of Anemia|0|||
129037244|NCT01519947|464426389|FG001|Overall Study|Development of Anemia|1|||
129037245|NCT01519947|464426390|FG002|Overall Study|Development of Anemia|0|||
129037246|NCT01519947|464426391|FG003|Overall Study|Development of Anemia|1|||
129037247|NCT01519947|464426388|FG000|Overall Study|Blood Transfusion|0|||
129037248|NCT01519947|464426389|FG001|Overall Study|Blood Transfusion|1|||
129037249|NCT01519947|464426390|FG002|Overall Study|Blood Transfusion|1|||
129037250|NCT01519947|464426391|FG003|Overall Study|Blood Transfusion|0|||
129037251|NCT01519947|464426388|FG000|Overall Study|Withdrawal by Subject|0|||
129037252|NCT01519947|464426389|FG001|Overall Study|Withdrawal by Subject|1|||
129037253|NCT01519947|464426390|FG002|Overall Study|Withdrawal by Subject|0|||
129037254|NCT01519947|464426391|FG003|Overall Study|Withdrawal by Subject|1|||
129037255|NCT01519947|464426388|FG000|Overall Study|Lost to Follow-up|0|||
128963207|NCT01235338|464150960|FG001|Overall Study|Adverse Event|2|||
128963208|NCT01235338|464150959|FG000|Overall Study|Protocol Violation|1|||
128963209|NCT01235338|464150960|FG001|Overall Study|Protocol Violation|1|||
129037256|NCT01519947|464426389|FG001|Overall Study|Lost to Follow-up|0|||
129037257|NCT01519947|464426390|FG002|Overall Study|Lost to Follow-up|3|||
129127672|NCT05032196|464759370|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
129127673|NCT05032196|464759371|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
128963210|NCT01235338|464150959|FG000|Overall Study|Withdrawal by Subject|5|||
128963211|NCT01235338|464150960|FG001|Overall Study|Withdrawal by Subject|0|||
129037258|NCT01519947|464426391|FG003|Overall Study|Lost to Follow-up|2|||
129037259|NCT01519947|464426388|FG000|Overall Study|Poor Response|1|||
129037260|NCT01519947|464426389|FG001|Overall Study|Poor Response|0|||
128963212|NCT01235338|464150959|FG000|Overall Study|Exclusion criteria violations|1|||
128963213|NCT01235338|464150960|FG001|Overall Study|Exclusion criteria violations|1|||
128963214|NCT01235338|464150959|FG000|Overall Study|Positive drug screen|0|||
128963215|NCT01235338|464150960|FG001|Overall Study|Positive drug screen|1|||
128963216|NCT01235338|464150959|FG000|Overall Study|Prohibited meds|1|||
128963217|NCT01235338|464150960|FG001|Overall Study|Prohibited meds|0|||
128963218|NCT05283499|464150964|FG000|Overall Study|Did not receive intervention|1|||
128963219|NCT05283499|464150965|FG001|Overall Study|Did not receive intervention|2|||
129037261|NCT01519947|464426390|FG002|Overall Study|Poor Response|0|||
129037262|NCT01519947|464426391|FG003|Overall Study|Poor Response|1|||
129037263|NCT01519947|464426388|FG000|Overall Study|Adverse Event|1|||
128963220|NCT03805971|464150972|FG000|Overall Study|Withdrawal by Subject|1|||
128963221|NCT03805971|464150972|FG000|Overall Study|Protocol Violation|2|||
128963222|NCT00517413|464150975|FG000|Overall Study|Adverse Event|7|||
128963223|NCT00517413|464150975|FG000|Overall Study|Death|13|||
128963224|NCT00517413|464150975|FG000|Overall Study|Protocol Violation|15|||
128963225|NCT00517413|464150975|FG000|Overall Study|Withdrawal by Subject|2|||
128963226|NCT00517413|464150975|FG000|Overall Study|Failure to return|1|||
128963227|NCT00517413|464150975|FG000|Overall Study|Other-Reasons|23|||
128963228|NCT00446797|464150976|FG000|Overall Study|Lack of Efficacy|0|||
128963229|NCT00446797|464150977|FG001|Overall Study|Lack of Efficacy|2|||
128963230|NCT00446797|464150976|FG000|Overall Study|Lost to Follow-up|5|||
128963231|NCT00446797|464150977|FG001|Overall Study|Lost to Follow-up|3|||
128963232|NCT00446797|464150976|FG000|Overall Study|Withdrawal by Subject|2|||
128963233|NCT00446797|464150977|FG001|Overall Study|Withdrawal by Subject|2|||
128963234|NCT00446797|464150976|FG000|Overall Study|Protocol Violation|1|||
128963235|NCT00446797|464150977|FG001|Overall Study|Protocol Violation|3|||
128963236|NCT00446797|464150976|FG000|Overall Study|subject entered at another site|0|||
128963237|NCT00446797|464150977|FG001|Overall Study|subject entered at another site|1|||
128963238|NCT00446797|464150976|FG000|Overall Study|did not meet entrance criteria|0|||
128963239|NCT00446797|464150977|FG001|Overall Study|did not meet entrance criteria|1|||
128963240|NCT02498392|464150982|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
128963241|NCT02498392|464150983|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
128963242|NCT02498392|464150982|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
128963243|NCT02498392|464150983|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
128963244|NCT02498392|464150982|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
128963245|NCT02498392|464150983|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
128963246|NCT02498392|464150982|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
128963247|NCT02498392|464150983|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
128963248|NCT02498392|464150982|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
128963249|NCT02498392|464150983|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
128963250|NCT02498392|464150982|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
128963251|NCT02498392|464150983|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
128963252|NCT02873208|464150984|FG000|Overall Study|Withdrawal by Subject|36|||
128963253|NCT02873208|464150984|FG000|Overall Study|Lost to Follow-up|22|||
128963254|NCT02873208|464150984|FG000|Overall Study|Adverse Event|15|||
128963255|NCT02873208|464150984|FG000|Overall Study|Non-compliance with study drug|12|||
128963256|NCT02873208|464150984|FG000|Overall Study|Protocol Violation|8|||
128963257|NCT02873208|464150984|FG000|Overall Study|Pregnancy|2|||
128963258|NCT02873208|464150984|FG000|Overall Study|Incarceration|1|||
128963259|NCT02873208|464150984|FG000|Overall Study|Lack of Efficacy|1|||
128963260|NCT02873208|464150984|FG000|Overall Study|Physician Decision|1|||
128963261|NCT04080752|464150985|FG000|Overall Study|Adverse Event|2|||
128963262|NCT04080752|464150986|FG001|Overall Study|Adverse Event|3|||
128963263|NCT04080752|464150985|FG000|Overall Study|Lack of Efficacy|1|||
128963264|NCT04080752|464150986|FG001|Overall Study|Lack of Efficacy|0|||
128963265|NCT04080752|464150985|FG000|Overall Study|Lost to Follow-up|1|||
128963266|NCT04080752|464150986|FG001|Overall Study|Lost to Follow-up|0|||
128963267|NCT04080752|464150985|FG000|Overall Study|Pregnancy|0|||
128963268|NCT04080752|464150986|FG001|Overall Study|Pregnancy|1|||
128963269|NCT04080752|464150985|FG000|Overall Study|Withdrawal by Subject|7|||
128963270|NCT04080752|464150986|FG001|Overall Study|Withdrawal by Subject|0|||
128963271|NCT04080752|464150985|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128963272|NCT04080752|464150986|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128963273|NCT04080752|464150985|FG000|Overall Study|Other|2|||
128963274|NCT04080752|464150986|FG001|Overall Study|Other|1|||
128963275|NCT01192100|464150987|FG000|Overall Study|Withdrawal by Subject|0|||
128963276|NCT01192100|464150988|FG001|Overall Study|Withdrawal by Subject|0|||
128963277|NCT01192100|464150989|FG002|Overall Study|Withdrawal by Subject|0|||
128963278|NCT01192100|464150990|FG003|Overall Study|Withdrawal by Subject|0|||
128963279|NCT01192100|464150991|FG004|Overall Study|Withdrawal by Subject|1|||
128963280|NCT01192100|464150992|FG005|Overall Study|Withdrawal by Subject|0|||
128963281|NCT01192100|464150987|FG000|Overall Study|Protocol Violation|0|||
128963282|NCT01192100|464150988|FG001|Overall Study|Protocol Violation|0|||
128963283|NCT01192100|464150989|FG002|Overall Study|Protocol Violation|0|||
128963284|NCT01192100|464150990|FG003|Overall Study|Protocol Violation|1|||
128963285|NCT01192100|464150991|FG004|Overall Study|Protocol Violation|0|||
128963286|NCT01192100|464150992|FG005|Overall Study|Protocol Violation|0|||
128963287|NCT04685538|464150994|FG000|Overall Study|Adverse Event|0|||
128963288|NCT04685538|464150995|FG001|Overall Study|Adverse Event|1|||
128963289|NCT04685538|464150994|FG000|Overall Study|Lost to Follow-up|0|||
128963290|NCT04685538|464150995|FG001|Overall Study|Lost to Follow-up|2|||
128963291|NCT04737759|464150996|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
128963292|NCT04737759|464150997|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
128963293|NCT04737759|464150996|FG000|Overall Study|Death|2|||
128963294|NCT04737759|464150997|FG001|Overall Study|Death|0|||
128963295|NCT04737759|464150996|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
128963296|NCT04737759|464150997|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
128963297|NCT04737759|464150996|FG000|Overall Study|Lost to Follow-up|4|||
129127674|NCT05032196|464759366|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129037264|NCT01519947|464426389|FG001|Overall Study|Adverse Event|0|||
129037265|NCT01519947|464426390|FG002|Overall Study|Adverse Event|1|||
129037266|NCT01519947|464426391|FG003|Overall Study|Adverse Event|1|||
129037267|NCT02274948|464426396|FG000|Overall Study|Lost to Follow-up|28|||
129037268|NCT02274948|464426397|FG001|Overall Study|Lost to Follow-up|25|||
129037269|NCT02274948|464426396|FG000|Overall Study|Withdrawal by Subject|64|||
129037270|NCT02274948|464426397|FG001|Overall Study|Withdrawal by Subject|58|||
129037271|NCT02274948|464426396|FG000|Overall Study|Stopped on family Practitioner advice|2|||
129037272|NCT02274948|464426397|FG001|Overall Study|Stopped on family Practitioner advice|5|||
128963298|NCT04737759|464150997|FG001|Overall Study|Lost to Follow-up|12|||
128963299|NCT01421069|464150999|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
128963300|NCT01421069|464150999|FG000|Parent Study|Failed to return|3|||
128963301|NCT01421069|464150999|FG000|Parent Study|Withdrawal by Subject|1|||
128963302|NCT01421069|464150999|FG000|Parent Study|Lost to Follow-up|2|||
128963303|NCT01421069|464150999|FG000|Parent Study|Lack of Efficacy|1|||
128963304|NCT01421069|464150999|FG000|Overall Period for Extension Study|Other|2|||
128963305|NCT01421069|464150999|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
128963306|NCT01421069|464150999|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
128963307|NCT01421069|464150999|FG000|Overall Period for Extension Study|Pregnancy|1|||
128713220|NCT02111850|463246050|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128963308|NCT01421069|464150999|FG000|Overall Period for Extension Study|Adverse Event|1|||
129037273|NCT02274948|464426396|FG000|Overall Study|Left the area|4|||
129037274|NCT02274948|464426397|FG001|Overall Study|Left the area|3|||
129037275|NCT00707434|464426398|FG000|Overall Study|Adverse Event|1|||
129037276|NCT01386125|464426399|FG000|Overall Study|Lost to Follow-up|3|||
129037277|NCT01386125|464426400|FG001|Overall Study|Lost to Follow-up|9|||
129037278|NCT01386125|464426399|FG000|Overall Study|Physician Decision|0|||
129037279|NCT01386125|464426400|FG001|Overall Study|Physician Decision|1|||
129037280|NCT01386125|464426399|FG000|Overall Study|Protocol Violation|5|||
129037281|NCT01386125|464426400|FG001|Overall Study|Protocol Violation|7|||
129037282|NCT01386125|464426399|FG000|Overall Study|Disease Progress|1|||
129037283|NCT01386125|464426400|FG001|Overall Study|Disease Progress|2|||
129037284|NCT01386125|464426399|FG000|Overall Study|Withdrawal by Subject|13|||
129037285|NCT01386125|464426400|FG001|Overall Study|Withdrawal by Subject|12|||
129037286|NCT01386125|464426399|FG000|Overall Study|Adverse Event|2|||
129037287|NCT01386125|464426400|FG001|Overall Study|Adverse Event|5|||
129037288|NCT01386125|464426399|FG000|Overall Study|Lack of Efficacy|0|||
129037289|NCT01386125|464426400|FG001|Overall Study|Lack of Efficacy|1|||
129037290|NCT01386125|464426399|FG000|Overall Study|Participant Leaving Country|1|||
129037291|NCT01386125|464426400|FG001|Overall Study|Participant Leaving Country|0|||
129037292|NCT01928615|464426402|FG000|Overall Study|Study Terminated by Sponsor|2|||
129037293|NCT00676494|464426406|FG000|Overall Study|Missed Visit|8|||
129037294|NCT00676494|464426406|FG000|Overall Study|Withdrawal by Subject|6|||
129037295|NCT00732160|464426407|FG000|Overall Study|Adverse Event|1|||
129037296|NCT00732160|464426408|FG001|Overall Study|Adverse Event|0|||
129037297|NCT00732160|464426409|FG002|Overall Study|Adverse Event|1|||
129037298|NCT00732160|464426410|FG003|Overall Study|Adverse Event|1|||
129037299|NCT00732160|464426407|FG000|Overall Study|scheduling|4|||
128963309|NCT01421069|464150999|FG000|Overall Period for Extension Study|Protocol Violation|1|||
128963310|NCT01421069|464150999|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
129037300|NCT00732160|464426408|FG001|Overall Study|scheduling|4|||
129037301|NCT00732160|464426409|FG002|Overall Study|scheduling|2|||
129037302|NCT00732160|464426410|FG003|Overall Study|scheduling|1|||
129037303|NCT01256060|464426414|FG000|Overall Study|Lost to Follow-up|0|||
129037304|NCT01256060|464426415|FG001|Overall Study|Lost to Follow-up|1|||
128963311|NCT01421069|464150999|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
128963312|NCT01421069|464150999|FG000|Active Treatment Period|Other|1|||
129037305|NCT01256060|464426416|FG002|Overall Study|Lost to Follow-up|0|||
129037306|NCT01256060|464426417|FG003|Overall Study|Lost to Follow-up|0|||
129127675|NCT05032196|464759367|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129127676|NCT05032196|464759368|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129127677|NCT05032196|464759369|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
129037307|NCT00985231|464426418|FG000|Overall Study|ineligible|1|||
129037308|NCT00985231|464426419|FG001|Overall Study|ineligible|0|||
129037309|NCT00985231|464426418|FG000|Overall Study|Protocol Violation|1|||
129037310|NCT00985231|464426419|FG001|Overall Study|Protocol Violation|0|||
129037311|NCT00985231|464426418|FG000|Overall Study|Withdrawal by Subject|1|||
129037312|NCT00985231|464426419|FG001|Overall Study|Withdrawal by Subject|0|||
129037313|NCT00985231|464426418|FG000|Overall Study|Lost to Follow-up|0|||
129037314|NCT00985231|464426419|FG001|Overall Study|Lost to Follow-up|1|||
129037315|NCT00985231|464426418|FG000|Overall Study|Study related symptoms & complaints|0|||
129037316|NCT00985231|464426419|FG001|Overall Study|Study related symptoms & complaints|2|||
128963313|NCT01421069|464150999|FG000|Active Treatment Period|No longer willing to participate in study|8|||
128963314|NCT01421069|464150999|FG000|Active Treatment Period|Insufficient clinical response|1|||
128963315|NCT01421069|464150999|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
128963316|NCT01421069|464150999|FG000|Active Treatment Period|Pregnancy|1|||
128963317|NCT01421069|464150999|FG000|Active Treatment Period|Adverse Event|1|||
128963318|NCT01421069|464150999|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
128963319|NCT01421069|464150999|FG000|Active Treatment Period|Enrolled in observational period|29|||
128963320|NCT01421069|464150999|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
128963321|NCT01421069|464150999|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
128963322|NCT01421069|464150999|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
128963323|NCT01421069|464150999|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
128963324|NCT01421069|464150999|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
128963325|NCT01421069|464150999|FG000|2b. Retreatment Period|Protocol Violation|1|||
128963326|NCT01421069|464150999|FG000|Observational Period|Other|1|||
128963327|NCT01421069|464150999|FG000|Observational Period|No longer willing to participate in study|4|||
128963328|NCT01421069|464150999|FG000|Observational Period|Lost to Follow-up|3|||
128963329|NCT01641081|464151000|FG000|Period 1|Sponsor request (potential unblinding)|0|||
128963330|NCT01641081|464151001|FG001|Period 1|Sponsor request (potential unblinding)|0|||
128963331|NCT01641081|464151002|FG002|Period 1|Sponsor request (potential unblinding)|0|||
128963332|NCT01641081|464151003|FG003|Period 1|Sponsor request (potential unblinding)|0|||
128963333|NCT01641081|464151004|FG004|Period 1|Sponsor request (potential unblinding)|0|||
128963334|NCT01641081|464151005|FG005|Period 1|Sponsor request (potential unblinding)|0|||
128963335|NCT01641081|464151006|FG006|Period 1|Sponsor request (potential unblinding)|1|||
128963336|NCT01641081|464151007|FG007|Period 1|Sponsor request (potential unblinding)|0|||
128963337|NCT01641081|464151008|FG008|Period 1|Sponsor request (potential unblinding)|0|||
128963338|NCT01641081|464151009|FG009|Period 1|Sponsor request (potential unblinding)|0|||
128963339|NCT01641081|464151000|FG000|Period 1|Protocol Violation|0|||
128963340|NCT01641081|464151001|FG001|Period 1|Protocol Violation|0|||
128963341|NCT01641081|464151002|FG002|Period 1|Protocol Violation|0|||
128963342|NCT01641081|464151003|FG003|Period 1|Protocol Violation|0|||
128963343|NCT01641081|464151004|FG004|Period 1|Protocol Violation|1|||
128963344|NCT01641081|464151005|FG005|Period 1|Protocol Violation|0|||
128963345|NCT01641081|464151006|FG006|Period 1|Protocol Violation|0|||
128963346|NCT01641081|464151007|FG007|Period 1|Protocol Violation|1|||
128963347|NCT01641081|464151008|FG008|Period 1|Protocol Violation|0|||
128963348|NCT01641081|464151009|FG009|Period 1|Protocol Violation|0|||
128963349|NCT01641081|464151000|FG000|Period 1|Adverse Event|1|||
128963350|NCT01641081|464151001|FG001|Period 1|Adverse Event|0|||
128963351|NCT01641081|464151002|FG002|Period 1|Adverse Event|0|||
128963352|NCT01641081|464151003|FG003|Period 1|Adverse Event|0|||
128963353|NCT01641081|464151004|FG004|Period 1|Adverse Event|0|||
128963354|NCT01641081|464151005|FG005|Period 1|Adverse Event|0|||
128963355|NCT01641081|464151006|FG006|Period 1|Adverse Event|0|||
128963356|NCT01641081|464151007|FG007|Period 1|Adverse Event|2|||
128963357|NCT01641081|464151008|FG008|Period 1|Adverse Event|0|||
128963358|NCT01641081|464151009|FG009|Period 1|Adverse Event|0|||
128963359|NCT01641081|464151000|FG000|Period 2|Adverse Event|0|||
128963360|NCT01641081|464151001|FG001|Period 2|Adverse Event|0|||
128963361|NCT01641081|464151002|FG002|Period 2|Adverse Event|0|||
128963362|NCT01641081|464151003|FG003|Period 2|Adverse Event|0|||
128963363|NCT01641081|464151004|FG004|Period 2|Adverse Event|0|||
128963364|NCT01641081|464151005|FG005|Period 2|Adverse Event|1|||
128963365|NCT01641081|464151006|FG006|Period 2|Adverse Event|0|||
128963366|NCT01641081|464151007|FG007|Period 2|Adverse Event|0|||
128963367|NCT01641081|464151008|FG008|Period 2|Adverse Event|0|||
128963368|NCT01641081|464151009|FG009|Period 2|Adverse Event|0|||
128963369|NCT01641081|464151000|FG000|Period 2|Withdrawal by Subject|0|||
128963370|NCT01641081|464151001|FG001|Period 2|Withdrawal by Subject|0|||
128963371|NCT01641081|464151002|FG002|Period 2|Withdrawal by Subject|0|||
128963372|NCT01641081|464151003|FG003|Period 2|Withdrawal by Subject|1|||
128963373|NCT01641081|464151004|FG004|Period 2|Withdrawal by Subject|0|||
128963374|NCT01641081|464151005|FG005|Period 2|Withdrawal by Subject|0|||
128963375|NCT01641081|464151006|FG006|Period 2|Withdrawal by Subject|2|||
128963376|NCT01641081|464151007|FG007|Period 2|Withdrawal by Subject|0|||
128963377|NCT01641081|464151008|FG008|Period 2|Withdrawal by Subject|0|||
128963378|NCT01641081|464151009|FG009|Period 2|Withdrawal by Subject|0|||
128963379|NCT01641081|464151000|FG000|Period 2|Protocol Violation|1|||
128963380|NCT01641081|464151001|FG001|Period 2|Protocol Violation|0|||
128963381|NCT01641081|464151002|FG002|Period 2|Protocol Violation|0|||
128963382|NCT01641081|464151003|FG003|Period 2|Protocol Violation|0|||
128963383|NCT01641081|464151004|FG004|Period 2|Protocol Violation|0|||
128963384|NCT01641081|464151005|FG005|Period 2|Protocol Violation|0|||
128963385|NCT01641081|464151006|FG006|Period 2|Protocol Violation|0|||
128963386|NCT01641081|464151007|FG007|Period 2|Protocol Violation|0|||
128963387|NCT01641081|464151008|FG008|Period 2|Protocol Violation|0|||
128963388|NCT01641081|464151009|FG009|Period 2|Protocol Violation|0|||
128963389|NCT01641081|464151000|FG000|Period 3|Adverse Event|0|||
128963390|NCT01641081|464151001|FG001|Period 3|Adverse Event|0|||
129219992|NCT02908672|465104673|FG001|Triple Combination Period|Death|0|||
129219993|NCT02908672|465104674|FG002|Triple Combination Period|Death|150|||
129219994|NCT02908672|465104675|FG003|Triple Combination Period|Death|127|||
129219995|NCT02908672|465104672|FG000|Triple Combination Period|Lost to Follow-up|0|||
129219996|NCT02908672|465104673|FG001|Triple Combination Period|Lost to Follow-up|0|||
128771542|NCT01091428|463455272|FG001|Phase 2|Symptomatic Deterioration|0|||
128771543|NCT01091428|463455273|FG002|Phase 2|Symptomatic Deterioration|1|||
128963391|NCT01641081|464151002|FG002|Period 3|Adverse Event|1|||
128963392|NCT01641081|464151003|FG003|Period 3|Adverse Event|0|||
128963393|NCT01641081|464151004|FG004|Period 3|Adverse Event|0|||
128963394|NCT01641081|464151005|FG005|Period 3|Adverse Event|0|||
128963395|NCT01641081|464151006|FG006|Period 3|Adverse Event|0|||
128963396|NCT01641081|464151007|FG007|Period 3|Adverse Event|0|||
128963397|NCT01641081|464151008|FG008|Period 3|Adverse Event|0|||
128963398|NCT01641081|464151009|FG009|Period 3|Adverse Event|0|||
128963399|NCT01641081|464151000|FG000|Period 3|Withdrawal by Subject|0|||
128963400|NCT01641081|464151001|FG001|Period 3|Withdrawal by Subject|0|||
128963401|NCT01641081|464151002|FG002|Period 3|Withdrawal by Subject|0|||
128963402|NCT01641081|464151003|FG003|Period 3|Withdrawal by Subject|0|||
128963403|NCT01641081|464151004|FG004|Period 3|Withdrawal by Subject|0|||
128963404|NCT01641081|464151005|FG005|Period 3|Withdrawal by Subject|0|||
128963405|NCT01641081|464151006|FG006|Period 3|Withdrawal by Subject|0|||
128963406|NCT01641081|464151007|FG007|Period 3|Withdrawal by Subject|0|||
128963407|NCT01641081|464151008|FG008|Period 3|Withdrawal by Subject|1|||
128963408|NCT01641081|464151009|FG009|Period 3|Withdrawal by Subject|0|||
128963409|NCT01641081|464151000|FG000|Period 4|Adverse Event|0|||
128963410|NCT01641081|464151001|FG001|Period 4|Adverse Event|1|||
128963411|NCT01641081|464151002|FG002|Period 4|Adverse Event|0|||
128963412|NCT01641081|464151003|FG003|Period 4|Adverse Event|1|||
128963413|NCT01641081|464151004|FG004|Period 4|Adverse Event|0|||
128963414|NCT01641081|464151005|FG005|Period 4|Adverse Event|0|||
128963415|NCT01641081|464151006|FG006|Period 4|Adverse Event|0|||
128963416|NCT01641081|464151007|FG007|Period 4|Adverse Event|0|||
128963417|NCT01641081|464151008|FG008|Period 4|Adverse Event|0|||
128963418|NCT01641081|464151009|FG009|Period 4|Adverse Event|0|||
128963419|NCT01641081|464151000|FG000|Period 5|Adverse Event|0|||
128963420|NCT01641081|464151001|FG001|Period 5|Adverse Event|0|||
128963421|NCT01641081|464151002|FG002|Period 5|Adverse Event|2|||
128963422|NCT01641081|464151003|FG003|Period 5|Adverse Event|0|||
128963423|NCT01641081|464151004|FG004|Period 5|Adverse Event|0|||
128963424|NCT01641081|464151005|FG005|Period 5|Adverse Event|0|||
128963425|NCT01641081|464151006|FG006|Period 5|Adverse Event|0|||
128963426|NCT01641081|464151007|FG007|Period 5|Adverse Event|0|||
128963427|NCT01641081|464151008|FG008|Period 5|Adverse Event|0|||
128963428|NCT01641081|464151009|FG009|Period 5|Adverse Event|0|||
128963429|NCT01095666|464151010|FG000|Overall Study|Lack of Efficacy|0|||
128963430|NCT01095666|464151011|FG001|Overall Study|Lack of Efficacy|0|||
128963431|NCT01095666|464151012|FG002|Overall Study|Lack of Efficacy|1|||
128963432|NCT01095666|464151010|FG000|Overall Study|Adverse Event|2|||
128963433|NCT01095666|464151011|FG001|Overall Study|Adverse Event|1|||
128963434|NCT01095666|464151012|FG002|Overall Study|Adverse Event|3|||
129037317|NCT00761176|464426420|FG000|Overall Study|Death|1|||
129037318|NCT00761176|464426421|FG001|Overall Study|Death|0|||
129037319|NCT00761176|464426420|FG000|Overall Study|Withdrawal by Subject|1|||
129037320|NCT00761176|464426421|FG001|Overall Study|Withdrawal by Subject|1|||
129037321|NCT00109850|464426422|FG000|Overall Study|Adverse Event|1|||
129037322|NCT00109850|464426422|FG000|Overall Study|Death|2|||
129037323|NCT00109850|464426422|FG000|Overall Study|Ineligible|1|||
129037324|NCT00476593|464426423|FG000|Overall Study|Lost to Follow-up|10|||
129037325|NCT00476593|464426424|FG001|Overall Study|Lost to Follow-up|2|||
129037326|NCT00476593|464426425|FG002|Overall Study|Lost to Follow-up|8|||
129037327|NCT00476593|464426426|FG003|Overall Study|Lost to Follow-up|22|||
129037328|NCT03430011|464426427|FG000|Pre-Treatment|Death|1|||
129037329|NCT03430011|464426428|FG001|Pre-Treatment|Death|0|||
129037330|NCT03430011|464426429|FG002|Pre-Treatment|Death|0|||
128963435|NCT01095666|464151010|FG000|Overall Study|Lost to Follow-up|2|||
128963436|NCT01095666|464151011|FG001|Overall Study|Lost to Follow-up|2|||
128963437|NCT01095666|464151012|FG002|Overall Study|Lost to Follow-up|0|||
128963438|NCT01095666|464151010|FG000|Overall Study|Withdrawal by Subject|6|||
128963439|NCT01095666|464151011|FG001|Overall Study|Withdrawal by Subject|6|||
128963440|NCT01095666|464151012|FG002|Overall Study|Withdrawal by Subject|1|||
128963441|NCT01095666|464151010|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
128963442|NCT01095666|464151011|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
128963443|NCT01095666|464151012|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
128963444|NCT01749800|464151016|FG000|Overall Study|not meeting inclusion criteria|3|||
128963445|NCT01749800|464151017|FG001|Overall Study|not meeting inclusion criteria|0|||
129037331|NCT03430011|464426430|FG003|Pre-Treatment|Death|0|||
129037332|NCT03430011|464426431|FG004|Pre-Treatment|Death|1|||
129037333|NCT03430011|464426432|FG005|Pre-Treatment|Death|0|||
129037334|NCT03430011|464426433|FG006|Pre-Treatment|Death|1|||
129037335|NCT03430011|464426434|FG007|Pre-Treatment|Death|0|||
129219997|NCT02908672|465104674|FG002|Triple Combination Period|Lost to Follow-up|6|||
129127678|NCT05032196|464759370|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129127679|NCT05032196|464759371|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129127680|NCT05032196|464759366|FG000|Period 2 (Multidose)|Physician Decision|0|||
129127681|NCT05032196|464759367|FG001|Period 2 (Multidose)|Physician Decision|0|||
129127682|NCT05032196|464759368|FG002|Period 2 (Multidose)|Physician Decision|0|||
129127683|NCT05032196|464759369|FG003|Period 2 (Multidose)|Physician Decision|0|||
128963446|NCT01749800|464151018|FG002|Overall Study|not meeting inclusion criteria|0|||
128963447|NCT01749800|464151016|FG000|Overall Study|Withdrawal by Subject|0|||
128963448|NCT01749800|464151017|FG001|Overall Study|Withdrawal by Subject|1|||
128963449|NCT01749800|464151018|FG002|Overall Study|Withdrawal by Subject|0|||
128963450|NCT02810951|464151025|FG000|Overall Study|Adverse Event|1|||
128963451|NCT01928082|464151026|FG000|Overall Study|Study terminated.|1|||
128963452|NCT05563714|464151027|FG000|Overall Study|Death|2|||
128963453|NCT05563714|464151028|FG001|Overall Study|Death|2|||
128963454|NCT05563714|464151029|FG002|Overall Study|Death|0|||
128963455|NCT05563714|464151030|FG003|Overall Study|Death|0|||
128963456|NCT05563714|464151027|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
128963457|NCT05563714|464151028|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
128963458|NCT05563714|464151029|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
128963459|NCT05563714|464151030|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
128963460|NCT05563714|464151027|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
128963461|NCT05563714|464151028|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
128963462|NCT05563714|464151029|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
128963463|NCT05563714|464151030|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
128963464|NCT05563714|464151027|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
128963465|NCT05563714|464151028|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
128963466|NCT05563714|464151029|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
128963467|NCT05563714|464151030|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
128963468|NCT05563714|464151027|FG000|Overall Study|Lost to Follow-up|22|||
128963469|NCT05563714|464151028|FG001|Overall Study|Lost to Follow-up|19|||
128963470|NCT05563714|464151029|FG002|Overall Study|Lost to Follow-up|0|||
128963471|NCT05563714|464151030|FG003|Overall Study|Lost to Follow-up|0|||
128963472|NCT01610206|464151039|FG000|Overall Study|Adverse Event|10|||
128963473|NCT01610206|464151040|FG001|Overall Study|Adverse Event|30|||
128963474|NCT00166517|464151041|FG000|Overall Study|Lost to Follow-up|1|||
128963475|NCT00166517|464151042|FG001|Overall Study|Lost to Follow-up|0|||
128963476|NCT00166517|464151041|FG000|Overall Study|Protocol Violation|4|||
128963477|NCT00166517|464151042|FG001|Overall Study|Protocol Violation|1|||
128963478|NCT00166517|464151041|FG000|Overall Study|Withdrawal by Subject|0|||
128963479|NCT00166517|464151042|FG001|Overall Study|Withdrawal by Subject|1|||
128963480|NCT02186561|464151043|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
128963481|NCT02186561|464151043|FG000|Enrollment|Enrollment Cap Reached|5|||
128963482|NCT02186561|464151043|FG000|Enrollment|Insurance Denial|2|||
128963483|NCT02186561|464151043|FG000|Enrollment|Withdrawal by Subject|2|||
128963484|NCT02186561|464151043|FG000|Enrollment|Investigator Withdrew Consent|1|||
128963485|NCT02186561|464151043|FG000|30-Day Post Index Procedure Visit|Death|1|||
128963486|NCT02186561|464151043|FG000|1- Year Post Index Procedure Visit|Death|1|||
128963487|NCT02186561|464151043|FG000|1- Year Post Index Procedure Visit|Missed|1|||
128963488|NCT04285853|464151044|FG000|Overall Study|Withdrawal by Subject|1|||
128963489|NCT04285853|464151045|FG001|Overall Study|Withdrawal by Subject|0|||
128963490|NCT04285853|464151044|FG000|Overall Study|Lost to Follow-up|9|||
128963491|NCT04285853|464151045|FG001|Overall Study|Lost to Follow-up|5|||
128963492|NCT02917629|464151046|FG000|Overall Study|Withdrawal by Subject|0|||
128963493|NCT02917629|464151047|FG001|Overall Study|Withdrawal by Subject|1|||
128963494|NCT00718523|464151048|FG000|Overall Study|Withdrawal by Subject|5|||
128963495|NCT00718523|464151049|FG001|Overall Study|Withdrawal by Subject|7|||
128963496|NCT00718523|464151048|FG000|Overall Study|Death|13|||
128963497|NCT00718523|464151049|FG001|Overall Study|Death|17|||
128963498|NCT03136484|464151050|FG000|Overall Study|Withdrawal by Subject|19|||
128963499|NCT03136484|464151051|FG001|Overall Study|Withdrawal by Subject|14|||
129127684|NCT05032196|464759370|FG004|Period 2 (Multidose)|Physician Decision|1|||
129127685|NCT05032196|464759371|FG005|Period 2 (Multidose)|Physician Decision|0|||
129127686|NCT05260008|464759372|FG000|Overall Study|Physician Decision|0|||
129219998|NCT02908672|465104675|FG003|Triple Combination Period|Lost to Follow-up|8|||
129219999|NCT02908672|465104672|FG000|Triple Combination Period|Reason Not Specified|0|||
129220000|NCT02908672|465104673|FG001|Triple Combination Period|Reason Not Specified|0|||
129220001|NCT02908672|465104674|FG002|Triple Combination Period|Reason Not Specified|0|||
128963500|NCT03136484|464151050|FG000|Overall Study|Lost to Follow-up|7|||
128963501|NCT03136484|464151051|FG001|Overall Study|Lost to Follow-up|8|||
128963502|NCT03136484|464151050|FG000|Overall Study|Death|1|||
128963503|NCT03136484|464151051|FG001|Overall Study|Death|0|||
129127687|NCT05260008|464759373|FG001|Overall Study|Physician Decision|1|||
129127688|NCT05260008|464759374|FG002|Overall Study|Physician Decision|0|||
128963504|NCT05041062|464151054|FG000|Overall Study|Adverse Event|2|||
128963505|NCT01802515|464151060|FG000|Overall Study|Withdrawal by Subject|3|||
128963506|NCT01802515|464151061|FG001|Overall Study|Withdrawal by Subject|0|||
128963507|NCT01802515|464151062|FG002|Overall Study|Withdrawal by Subject|0|||
128963508|NCT01176240|464151065|FG000|Study 306A|Lack of Efficacy|2|||
128963509|NCT01176240|464151066|FG001|Study 306A|Lack of Efficacy|1|||
128963510|NCT01176240|464151065|FG000|Study 306A|Protocol Violation|0|||
128963511|NCT01176240|464151066|FG001|Study 306A|Protocol Violation|1|||
128963512|NCT01176240|464151065|FG000|Study 306A|Withdrawal by Subject|0|||
128963513|NCT01176240|464151066|FG001|Study 306A|Withdrawal by Subject|1|||
128963514|NCT01176240|464151065|FG000|Study 306A|Stop due to diverse problems|1|||
128963515|NCT01176240|464151066|FG001|Study 306A|Stop due to diverse problems|0|||
128963516|NCT01176240|464151065|FG000|Study 306B|Lack of Efficacy|5|||
128963517|NCT01176240|464151066|FG001|Study 306B|Lack of Efficacy|3|||
128963518|NCT01176240|464151065|FG000|Study 306B|Adverse Event|10|||
128963519|NCT01176240|464151066|FG001|Study 306B|Adverse Event|5|||
128963520|NCT01176240|464151065|FG000|Study 306B|Protocol Violation|2|||
128963521|NCT01176240|464151066|FG001|Study 306B|Protocol Violation|3|||
128963522|NCT01176240|464151065|FG000|Study 306B|Withdrawal by Subject|4|||
128963523|NCT01176240|464151066|FG001|Study 306B|Withdrawal by Subject|1|||
128963524|NCT01176240|464151065|FG000|Study 306B|Physician Decision|2|||
128963525|NCT01176240|464151066|FG001|Study 306B|Physician Decision|1|||
128963526|NCT01176240|464151065|FG000|Study 306B|Supine Hypertension|1|||
128963527|NCT01176240|464151066|FG001|Study 306B|Supine Hypertension|2|||
128963528|NCT01176240|464151065|FG000|Study 306B|Lost to Follow-up|0|||
128963529|NCT01176240|464151066|FG001|Study 306B|Lost to Follow-up|1|||
128963530|NCT01176240|464151065|FG000|Study 306B|withdrew prior to dosing|2|||
128963531|NCT01176240|464151066|FG001|Study 306B|withdrew prior to dosing|1|||
128963532|NCT00807014|464151072|FG000|Overall Study|Participant Considered Disease Cured|13|||
128963533|NCT00807014|464151073|FG001|Overall Study|Participant Considered Disease Cured|2|||
128963534|NCT00807014|464151072|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
128963535|NCT00807014|464151073|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
128963536|NCT00807014|464151072|FG000|Overall Study|Protocol Violation|2|||
128963537|NCT00807014|464151073|FG001|Overall Study|Protocol Violation|8|||
128963538|NCT00807014|464151072|FG000|Overall Study|Adverse Event|0|||
128963539|NCT00807014|464151073|FG001|Overall Study|Adverse Event|2|||
128963540|NCT00807014|464151072|FG000|Overall Study|Lost to Follow-up|9|||
128963541|NCT00807014|464151073|FG001|Overall Study|Lost to Follow-up|7|||
128963542|NCT00807014|464151072|FG000|Overall Study|Recovery|1|||
128963543|NCT00807014|464151073|FG001|Overall Study|Recovery|0|||
128963544|NCT00807014|464151072|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
128963545|NCT00807014|464151073|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
128963546|NCT00651313|464151074|FG000|Overall Study|Adverse Event|0|||
128963547|NCT00651313|464151075|FG001|Overall Study|Adverse Event|1|||
128963548|NCT00651313|464151074|FG000|Overall Study|Withdrawal by Subject|3|||
128963549|NCT00651313|464151075|FG001|Overall Study|Withdrawal by Subject|1|||
128963550|NCT00651313|464151074|FG000|Overall Study|Lost to Follow-up|1|||
128963551|NCT00651313|464151075|FG001|Overall Study|Lost to Follow-up|1|||
128963552|NCT00651313|464151074|FG000|Overall Study|Adminstrative Discontinuation|2|||
128963553|NCT00651313|464151075|FG001|Overall Study|Adminstrative Discontinuation|3|||
128963554|NCT02650895|464151076|FG000|Overall Study|Withdrawal by Subject|0|||
128963555|NCT02650895|464151077|FG001|Overall Study|Withdrawal by Subject|1|||
129127689|NCT05260008|464759375|FG003|Overall Study|Physician Decision|0|||
129127690|NCT05696847|464760290|FG000|Overall Study|Withdrawal by Subject|1|||
129127691|NCT05696847|464760291|FG001|Overall Study|Withdrawal by Subject|0|||
129127692|NCT05696847|464760292|FG002|Overall Study|Withdrawal by Subject|0|||
129127693|NCT05696847|464760293|FG003|Overall Study|Withdrawal by Subject|0|||
128963556|NCT02650895|464151078|FG002|Overall Study|Withdrawal by Subject|0|||
129127694|NCT05696847|464760294|FG004|Overall Study|Withdrawal by Subject|0|||
129127695|NCT05696847|464760295|FG005|Overall Study|Withdrawal by Subject|0|||
129127696|NCT05696847|464760290|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129127697|NCT05696847|464760291|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129127698|NCT05696847|464760292|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129127699|NCT05696847|464760293|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128963557|NCT02650895|464151079|FG003|Overall Study|Withdrawal by Subject|0|||
128963558|NCT02650895|464151080|FG004|Overall Study|Withdrawal by Subject|0|||
128963559|NCT02650895|464151081|FG005|Overall Study|Withdrawal by Subject|0|||
128963560|NCT00981682|464151086|FG000|Overall Study|Adverse Event|48|||
128963561|NCT00981682|464151086|FG000|Overall Study|Withdrawal by Subject|52|||
128963562|NCT00981682|464151086|FG000|Overall Study|Lost to Follow-up|14|||
128963563|NCT00981682|464151086|FG000|Overall Study|Lack of Efficacy|13|||
128963564|NCT00981682|464151086|FG000|Overall Study|Protocol Violation|6|||
128963565|NCT00981682|464151086|FG000|Overall Study|administrative|9|||
128963566|NCT03038672|464153335|FG000|Initial Treatment|Unacceptable chemistry|0|||
128963567|NCT03038672|464153336|FG001|Initial Treatment|Unacceptable chemistry|1|||
129127700|NCT05696847|464760294|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129127701|NCT05696847|464760295|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129127702|NCT05696847|464760290|FG000|Overall Study|Adverse Event|0|||
129127703|NCT05696847|464760291|FG001|Overall Study|Adverse Event|0|||
129127704|NCT05696847|464760292|FG002|Overall Study|Adverse Event|0|||
129127705|NCT05696847|464760293|FG003|Overall Study|Adverse Event|0|||
129127706|NCT05696847|464760294|FG004|Overall Study|Adverse Event|0|||
129127707|NCT05696847|464760295|FG005|Overall Study|Adverse Event|1|||
129127708|NCT05696847|464760290|FG000|Overall Study|Sponsor Decision|0|||
129127709|NCT05696847|464760291|FG001|Overall Study|Sponsor Decision|0|||
129127710|NCT05696847|464760292|FG002|Overall Study|Sponsor Decision|0|||
129127711|NCT05696847|464760293|FG003|Overall Study|Sponsor Decision|1|||
129127712|NCT05696847|464760294|FG004|Overall Study|Sponsor Decision|0|||
129127713|NCT05696847|464760295|FG005|Overall Study|Sponsor Decision|0|||
129127714|NCT03323502|464760296|FG000|Overall Study|Resident could not be linked to CMS data|594|||
129127715|NCT03323502|464760297|FG001|Overall Study|Resident could not be linked to CMS data|435|||
129127716|NCT03323502|464760296|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
129127717|NCT03323502|464760297|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
129127718|NCT03323502|464760296|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
129127719|NCT03323502|464760297|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
128963568|NCT03038672|464153335|FG000|Initial Treatment|Progression prior to treatment|1|||
128963569|NCT03038672|464153336|FG001|Initial Treatment|Progression prior to treatment|0|||
128963570|NCT03038672|464153335|FG000|Initial Treatment|No treatment per protocol|1|||
128963571|NCT03038672|464153336|FG001|Initial Treatment|No treatment per protocol|0|||
128963572|NCT02712008|464153337|FG000|Baseline (Day 1) up to Week 12|Death|3|||
128963573|NCT02712008|464153338|FG001|Baseline (Day 1) up to Week 12|Death|0|||
128963574|NCT02712008|464153339|FG002|Baseline (Day 1) up to Week 12|Death|0|||
128963575|NCT02712008|464153340|FG003|Baseline (Day 1) up to Week 12|Death|0|||
128963576|NCT02712008|464153341|FG004|Baseline (Day 1) up to Week 12|Death|0|||
128963577|NCT02712008|464153342|FG005|Baseline (Day 1) up to Week 12|Death|0|||
128963578|NCT02712008|464153343|FG006|Baseline (Day 1) up to Week 12|Death|0|||
128963579|NCT02712008|464153344|FG007|Baseline (Day 1) up to Week 12|Death|0|||
128963580|NCT02712008|464153337|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128963581|NCT02712008|464153338|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
128963582|NCT02712008|464153339|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
128963583|NCT02712008|464153340|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128963584|NCT02712008|464153341|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128963585|NCT02712008|464153342|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128963586|NCT02712008|464153343|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128963587|NCT02712008|464153344|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
128963588|NCT02712008|464153337|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
128963589|NCT02712008|464153338|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128963590|NCT02712008|464153339|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
128963591|NCT02712008|464153340|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128963592|NCT02712008|464153341|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128963593|NCT02712008|464153342|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128963594|NCT02712008|464153343|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128963595|NCT02712008|464153344|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
128963596|NCT02712008|464153337|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
128963597|NCT02712008|464153338|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
128963598|NCT02712008|464153339|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
128963599|NCT02712008|464153340|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
128963600|NCT02712008|464153341|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
128963601|NCT02712008|464153342|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129127720|NCT03323502|464760296|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
129127721|NCT03323502|464760297|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
129127722|NCT03323502|464760296|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
129127723|NCT03323502|464760297|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
128963602|NCT02712008|464153343|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
128963603|NCT02712008|464153344|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
128963604|NCT02712008|464153337|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
128963605|NCT02712008|464153338|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
128963606|NCT02712008|464153339|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
128963607|NCT02712008|464153340|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
128963608|NCT02712008|464153341|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129127724|NCT04092777|464760298|FG000|Overall Study|Lost to Follow-up|28|||
128963609|NCT02712008|464153342|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129127725|NCT04092777|464760299|FG001|Overall Study|Lost to Follow-up|46|||
128963610|NCT02712008|464153343|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
128963611|NCT02712008|464153344|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
128963612|NCT02712008|464153337|FG000|From Week 12 up to Week 36|Adverse Event|0|||
128963613|NCT02712008|464153338|FG001|From Week 12 up to Week 36|Adverse Event|0|||
128963614|NCT02712008|464153339|FG002|From Week 12 up to Week 36|Adverse Event|0|||
128963615|NCT02712008|464153340|FG003|From Week 12 up to Week 36|Adverse Event|0|||
128963616|NCT02712008|464153341|FG004|From Week 12 up to Week 36|Adverse Event|1|||
128963617|NCT02712008|464153342|FG005|From Week 12 up to Week 36|Adverse Event|0|||
128963618|NCT02712008|464153343|FG006|From Week 12 up to Week 36|Adverse Event|0|||
128963619|NCT02712008|464153344|FG007|From Week 12 up to Week 36|Adverse Event|2|||
128963620|NCT02712008|464153337|FG000|From Week 12 up to Week 36|Death|1|||
128963621|NCT02712008|464153338|FG001|From Week 12 up to Week 36|Death|0|||
128963622|NCT02712008|464153339|FG002|From Week 12 up to Week 36|Death|0|||
128963623|NCT02712008|464153340|FG003|From Week 12 up to Week 36|Death|0|||
128963624|NCT02712008|464153341|FG004|From Week 12 up to Week 36|Death|0|||
128963625|NCT02712008|464153342|FG005|From Week 12 up to Week 36|Death|0|||
128963626|NCT02712008|464153343|FG006|From Week 12 up to Week 36|Death|1|||
128963627|NCT02712008|464153344|FG007|From Week 12 up to Week 36|Death|0|||
128963628|NCT02712008|464153337|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
128963629|NCT02712008|464153338|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
128963630|NCT02712008|464153339|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
128963631|NCT02712008|464153340|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
128963632|NCT02712008|464153341|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
128963633|NCT02712008|464153342|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
128963634|NCT02712008|464153343|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
128963635|NCT02712008|464153344|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
128963636|NCT02712008|464153337|FG000|From Week 12 up to Week 36|Physician Decision|0|||
128963637|NCT02712008|464153338|FG001|From Week 12 up to Week 36|Physician Decision|0|||
128963638|NCT02712008|464153339|FG002|From Week 12 up to Week 36|Physician Decision|0|||
128963639|NCT02712008|464153340|FG003|From Week 12 up to Week 36|Physician Decision|1|||
128963640|NCT02712008|464153341|FG004|From Week 12 up to Week 36|Physician Decision|1|||
128963641|NCT02712008|464153342|FG005|From Week 12 up to Week 36|Physician Decision|0|||
128963642|NCT02712008|464153343|FG006|From Week 12 up to Week 36|Physician Decision|0|||
128963643|NCT02712008|464153344|FG007|From Week 12 up to Week 36|Physician Decision|0|||
128963644|NCT02712008|464153337|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
128963645|NCT02712008|464153338|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
128963646|NCT02712008|464153339|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
128963647|NCT02712008|464153340|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
128963648|NCT02712008|464153341|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
128963649|NCT02712008|464153342|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
128963650|NCT02712008|464153343|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
128963651|NCT02712008|464153344|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
128963652|NCT00959894|464153345|FG000|Overall Study|Lost to Follow-up|10|||
128963653|NCT00959894|464153345|FG000|Overall Study|Adverse Event|3|||
128963654|NCT00959894|464153345|FG000|Overall Study|Withdrawal by Subject|1|||
128963655|NCT00959894|464153345|FG000|Overall Study|Need for contraindicated medication|1|||
128963656|NCT00959894|464153345|FG000|Overall Study|Subject moved out of town|1|||
128963657|NCT00653068|464153346|FG000|Overall Study|Death|9|||
128963658|NCT00653068|464153346|FG000|Overall Study|Lack of Efficacy|34|||
128963659|NCT00653068|464153346|FG000|Overall Study|Physician Decision|4|||
128963660|NCT00653068|464153346|FG000|Overall Study|Withdrawal by Subject|1|||
128963661|NCT00653068|464153346|FG000|Overall Study|Ineligible|2|||
128963662|NCT01305941|464153347|FG000|Overall Study|Adverse Event|6|||
128963663|NCT01305941|464153347|FG000|Overall Study|Clinical decline|2|||
128963664|NCT01305941|464153347|FG000|Overall Study|Withdrawal by Subject|1|||
128963665|NCT01305941|464153347|FG000|Overall Study|Death|1|||
128963666|NCT00608244|464153348|FG000|Overall Study|Adverse Event|1|||
128963667|NCT00608244|464153348|FG000|Overall Study|Low trough levels|1|||
128963668|NCT02944513|464153353|FG000|Overall Study|Withdrawal by Subject|4|||
128963669|NCT02944513|464153354|FG001|Overall Study|Withdrawal by Subject|1|||
128963670|NCT00937326|464153358|FG000|Overall Study|Adverse Event|0|||
128963671|NCT00937326|464153359|FG001|Overall Study|Adverse Event|3|||
129127726|NCT04092777|464760298|FG000|Overall Study|Withdrawal by Subject|8|||
128963672|NCT00937326|464153360|FG002|Overall Study|Adverse Event|1|||
129127727|NCT04092777|464760299|FG001|Overall Study|Withdrawal by Subject|5|||
129127728|NCT01081951|464760300|FG000|Overall Study|Death|54|||
129127729|NCT01081951|464760301|FG001|Overall Study|Death|47|||
128963673|NCT00937326|464153361|FG003|Overall Study|Adverse Event|1|||
128963674|NCT00937326|464153362|FG004|Overall Study|Adverse Event|2|||
128963675|NCT00937326|464153358|FG000|Overall Study|Death|0|||
128963676|NCT00937326|464153359|FG001|Overall Study|Death|0|||
129127730|NCT01081951|464760300|FG000|Overall Study|Withdrawal by Subject|2|||
128963677|NCT00937326|464153360|FG002|Overall Study|Death|1|||
128963678|NCT00937326|464153361|FG003|Overall Study|Death|0|||
128963679|NCT00937326|464153362|FG004|Overall Study|Death|0|||
128963680|NCT00937326|464153358|FG000|Overall Study|Withdrawal by Subject|3|||
129127731|NCT01081951|464760301|FG001|Overall Study|Withdrawal by Subject|6|||
128963681|NCT00937326|464153359|FG001|Overall Study|Withdrawal by Subject|4|||
128963682|NCT00937326|464153360|FG002|Overall Study|Withdrawal by Subject|1|||
128963683|NCT00937326|464153361|FG003|Overall Study|Withdrawal by Subject|4|||
128963684|NCT00937326|464153362|FG004|Overall Study|Withdrawal by Subject|3|||
128963685|NCT00937326|464153358|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
128963686|NCT00937326|464153359|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
128963687|NCT00937326|464153360|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
128963688|NCT00937326|464153361|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
128963689|NCT00937326|464153362|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
128963690|NCT02578992|464153363|FG000|Overall Study|equipment not available or malfunction|3|||
128963691|NCT02578992|464153364|FG001|Overall Study|equipment not available or malfunction|3|||
128963692|NCT00086385|464153367|FG000|Overall Study|Death|2|||
128963693|NCT00086385|464153368|FG001|Overall Study|Death|2|||
128963694|NCT00086385|464153369|FG002|Overall Study|Death|1|||
128963695|NCT00086385|464153370|FG003|Overall Study|Death|1|||
128963696|NCT00880100|464153375|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
128963697|NCT00880100|464153375|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
128963698|NCT00880100|464153375|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
128963699|NCT00731666|464153377|FG000|Overall Study|Adverse Event|2|||
128963700|NCT00731666|464153377|FG000|Overall Study|Lost to Follow-up|8|||
128963701|NCT00731666|464153377|FG000|Overall Study|Withdrawal by Subject|2|||
128963702|NCT02853123|464153378|FG000|Treatment Period 1|Adverse Event|0|||
128963703|NCT02853123|464153379|FG001|Treatment Period 1|Adverse Event|3|||
128963704|NCT02853123|464153378|FG000|Washout Period|Worsening of COPD|0|||
128963705|NCT02853123|464153379|FG001|Washout Period|Worsening of COPD|3|||
128963706|NCT02853123|464153378|FG000|Washout Period|Adverse Event|1|||
128963707|NCT02853123|464153379|FG001|Washout Period|Adverse Event|0|||
128963708|NCT05516134|464153381|FG000|Overall Study|Lost to Follow-up|1|||
128963709|NCT05516134|464153382|FG001|Overall Study|Lost to Follow-up|0|||
128963710|NCT05516134|464153383|FG002|Overall Study|Lost to Follow-up|0|||
128963711|NCT00254163|464153384|FG000|Overall Study|Adverse Event|29|||
128963712|NCT00254163|464153385|FG001|Overall Study|Adverse Event|26|||
128963713|NCT00254163|464153384|FG000|Overall Study|Patient request/withdrew consent|6|||
128963714|NCT00254163|464153385|FG001|Overall Study|Patient request/withdrew consent|4|||
128963715|NCT00254163|464153384|FG000|Overall Study|Investigator request|1|||
128963716|NCT00254163|464153385|FG001|Overall Study|Investigator request|3|||
128963717|NCT00254163|464153384|FG000|Overall Study|Failed entry|1|||
128963718|NCT00254163|464153385|FG001|Overall Study|Failed entry|3|||
128963719|NCT00254163|464153384|FG000|Overall Study|Progressive disease|0|||
128963720|NCT00254163|464153385|FG001|Overall Study|Progressive disease|1|||
128963721|NCT00254163|464153384|FG000|Overall Study|Death|0|||
128963722|NCT00254163|464153385|FG001|Overall Study|Death|1|||
128963723|NCT00254163|464153384|FG000|Overall Study|Other|8|||
128963724|NCT00254163|464153385|FG001|Overall Study|Other|8|||
128963725|NCT01510028|464153389|FG000|Overall Study|Lack of Efficacy|1|||
128963726|NCT01510028|464153390|FG001|Overall Study|Lack of Efficacy|0|||
128963727|NCT01510028|464153391|FG002|Overall Study|Lack of Efficacy|0|||
128963728|NCT01510028|464153392|FG003|Overall Study|Lack of Efficacy|0|||
128963729|NCT01355497|464153393|FG000|Overall Study|Death|19|||
128963730|NCT01355497|464153394|FG001|Overall Study|Death|18|||
128963731|NCT01355497|464153393|FG000|Overall Study|Lost to Follow-up|3|||
128963732|NCT01355497|464153394|FG001|Overall Study|Lost to Follow-up|0|||
128963733|NCT01355497|464153393|FG000|Overall Study|Protocol Violation|0|||
128963734|NCT01355497|464153394|FG001|Overall Study|Protocol Violation|1|||
128963735|NCT01355497|464153393|FG000|Overall Study|other-not provided|9|||
128963736|NCT01355497|464153394|FG001|Overall Study|other-not provided|4|||
128963737|NCT01355497|464153393|FG000|Overall Study|Withdrawal by Subject|12|||
128963738|NCT01355497|464153394|FG001|Overall Study|Withdrawal by Subject|20|||
128963739|NCT01355497|464153393|FG000|Overall Study|noncompliance|1|||
128963740|NCT01355497|464153394|FG001|Overall Study|noncompliance|2|||
128963741|NCT01355497|464153393|FG000|Overall Study|progressive disease|11|||
128963742|NCT01355497|464153394|FG001|Overall Study|progressive disease|8|||
128963743|NCT01355497|464153393|FG000|Overall Study|Adverse Event|11|||
128963744|NCT01355497|464153394|FG001|Overall Study|Adverse Event|10|||
128963745|NCT01784211|464153402|FG000|Part A (Days 1-15)|Adverse Event|1|||
128963746|NCT01784211|464153403|FG001|Part A (Days 1-15)|Adverse Event|1|||
128963747|NCT01784211|464153404|FG002|Part A (Days 1-15)|Adverse Event|0|||
128963748|NCT01784211|464153405|FG003|Part A (Days 1-15)|Adverse Event|0|||
129127732|NCT01081951|464760300|FG000|Overall Study|Allocated treatment but did not take it|0|||
129127733|NCT01081951|464760301|FG001|Overall Study|Allocated treatment but did not take it|1|||
128963749|NCT01784211|464153406|FG004|Part A (Days 1-15)|Adverse Event|0|||
128963750|NCT01784211|464153407|FG005|Part A (Days 1-15)|Adverse Event|0|||
128963751|NCT01784211|464153402|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
128963752|NCT01784211|464153403|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
128963753|NCT01784211|464153404|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
128963754|NCT01784211|464153405|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
128963755|NCT01784211|464153406|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
128963756|NCT01784211|464153407|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
128963757|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
128963758|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
128963759|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
128963760|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
128963761|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
128963762|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
128963763|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
128963764|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
128963765|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
128963766|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
128963767|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
128963768|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
128963769|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
128963770|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
128963771|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
128963772|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
128963773|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
128963774|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
128963775|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
128963776|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
128963777|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
128963778|NCT01001572|464153408|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
128963779|NCT01001572|464153409|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
128963780|NCT01001572|464153410|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
128963781|NCT01001572|464153408|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
128963782|NCT01001572|464153409|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
128963783|NCT01001572|464153410|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
128963784|NCT01001572|464153408|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
128963785|NCT01001572|464153409|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
128963786|NCT01001572|464153410|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
128963787|NCT01001572|464153408|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
128963788|NCT01001572|464153409|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
128963789|NCT01001572|464153410|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
128963790|NCT01001572|464153408|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
128963791|NCT01001572|464153409|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
128963792|NCT01001572|464153410|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
128963793|NCT01001572|464153408|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
128963794|NCT01001572|464153409|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
128963795|NCT01001572|464153410|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
128963796|NCT01001572|464153408|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128963797|NCT01001572|464153409|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128963798|NCT01001572|464153410|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
128963799|NCT01094808|464153411|FG000|Overall Study|Withdrawal by Subject|1|||
128963800|NCT01094808|464153412|FG001|Overall Study|Withdrawal by Subject|1|||
128963801|NCT01094808|464153413|FG002|Overall Study|Withdrawal by Subject|0|||
128963802|NCT00369278|464153414|FG000|Overall Study|Adverse Event|14|||
128963803|NCT00369278|464153415|FG001|Overall Study|Adverse Event|11|||
128963804|NCT00369278|464153414|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
128963805|NCT00369278|464153415|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
128963806|NCT00369278|464153414|FG000|Overall Study|Protocol Violation|2|||
128963807|NCT00369278|464153415|FG001|Overall Study|Protocol Violation|1|||
128963808|NCT00369278|464153414|FG000|Overall Study|Withdrawal by Subject|2|||
128963809|NCT00369278|464153415|FG001|Overall Study|Withdrawal by Subject|2|||
128963810|NCT00369278|464153414|FG000|Overall Study|Lost to Follow-up|1|||
128963811|NCT00369278|464153415|FG001|Overall Study|Lost to Follow-up|0|||
128963812|NCT00369278|464153414|FG000|Overall Study|Graft loss|1|||
128963813|NCT00369278|464153415|FG001|Overall Study|Graft loss|2|||
129037336|NCT03430011|464426427|FG000|Pre-Treatment|Screen Fail|0|||
129037337|NCT03430011|464426428|FG001|Pre-Treatment|Screen Fail|0|||
129037338|NCT03430011|464426429|FG002|Pre-Treatment|Screen Fail|0|||
129037339|NCT03430011|464426430|FG003|Pre-Treatment|Screen Fail|0|||
129037340|NCT03430011|464426431|FG004|Pre-Treatment|Screen Fail|1|||
129037341|NCT03430011|464426432|FG005|Pre-Treatment|Screen Fail|0|||
129037342|NCT03430011|464426433|FG006|Pre-Treatment|Screen Fail|0|||
129037343|NCT03430011|464426434|FG007|Pre-Treatment|Screen Fail|0|||
129037344|NCT03430011|464426427|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
129037345|NCT03430011|464426428|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
129037346|NCT03430011|464426429|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
129037347|NCT03430011|464426430|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
129037348|NCT03430011|464426431|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
129127734|NCT01081951|464760300|FG000|Overall Study|Lost to Follow-up|0|||
129127735|NCT01081951|464760301|FG001|Overall Study|Lost to Follow-up|1|||
128963814|NCT01224106|464153416|FG000|Double-Blind Treatment Phase|Death|3|||
128963815|NCT01224106|464153417|FG001|Double-Blind Treatment Phase|Death|0|||
128963816|NCT01224106|464153418|FG002|Double-Blind Treatment Phase|Death|0|||
128963817|NCT01224106|464153419|FG003|Double-Blind Treatment Phase|Death|0|||
128963818|NCT01224106|464153420|FG004|Double-Blind Treatment Phase|Death|0|||
128963819|NCT01224106|464153416|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
128963820|NCT01224106|464153417|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
128963821|NCT01224106|464153418|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
128963822|NCT01224106|464153419|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
128963823|NCT01224106|464153420|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
128963824|NCT01224106|464153416|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
128963825|NCT01224106|464153417|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
128963826|NCT01224106|464153418|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
128963827|NCT01224106|464153419|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
128963828|NCT01224106|464153420|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
128963829|NCT01224106|464153416|FG000|Double-Blind Treatment Phase|Other|0|||
128963830|NCT01224106|464153417|FG001|Double-Blind Treatment Phase|Other|0|||
128963831|NCT01224106|464153418|FG002|Double-Blind Treatment Phase|Other|1|||
128963832|NCT01224106|464153419|FG003|Double-Blind Treatment Phase|Other|0|||
128963833|NCT01224106|464153420|FG004|Double-Blind Treatment Phase|Other|0|||
128963834|NCT01224106|464153416|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
128963835|NCT01224106|464153417|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
128963836|NCT01224106|464153418|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
128963837|NCT01224106|464153419|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
128963838|NCT01224106|464153420|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
128963839|NCT01224106|464153416|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
128963840|NCT01224106|464153417|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
128963841|NCT01224106|464153418|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
128963842|NCT01224106|464153419|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
128963843|NCT01224106|464153420|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
128963844|NCT01224106|464153416|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
128963845|NCT01224106|464153417|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128963846|NCT01224106|464153418|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
128963847|NCT01224106|464153419|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128963848|NCT01224106|464153420|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128963849|NCT01224106|464153416|FG000|Open-Label Extension (OLE) Phase|Death|0|||
128963850|NCT01224106|464153417|FG001|Open-Label Extension (OLE) Phase|Death|0|||
128963851|NCT01224106|464153418|FG002|Open-Label Extension (OLE) Phase|Death|0|||
128963852|NCT01224106|464153419|FG003|Open-Label Extension (OLE) Phase|Death|1|||
128963853|NCT01224106|464153420|FG004|Open-Label Extension (OLE) Phase|Death|3|||
128963854|NCT01224106|464153416|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
128963855|NCT01224106|464153417|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
128963856|NCT01224106|464153418|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
128963857|NCT01224106|464153419|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
128963858|NCT01224106|464153420|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
128963859|NCT01224106|464153416|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
128963860|NCT01224106|464153417|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
128963861|NCT01224106|464153418|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
128963862|NCT01224106|464153419|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
128963863|NCT01224106|464153420|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
129037349|NCT03430011|464426432|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
129037350|NCT03430011|464426433|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
129037351|NCT03430011|464426434|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
129037352|NCT03430011|464426427|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
129037353|NCT03430011|464426428|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
129037354|NCT03430011|464426429|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
129037355|NCT03430011|464426430|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
129037356|NCT03430011|464426431|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
129037357|NCT03430011|464426432|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
128963864|NCT01224106|464153416|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
128963865|NCT01224106|464153417|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
128963866|NCT01224106|464153418|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
128963867|NCT01224106|464153419|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
128963868|NCT01224106|464153420|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
128963869|NCT01224106|464153416|FG000|Open-Label Extension (OLE) Phase|Other|0|||
129037358|NCT03430011|464426433|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
129127736|NCT04896385|464760307|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
128963870|NCT01224106|464153417|FG001|Open-Label Extension (OLE) Phase|Other|0|||
128963871|NCT01224106|464153418|FG002|Open-Label Extension (OLE) Phase|Other|0|||
128963872|NCT01224106|464153419|FG003|Open-Label Extension (OLE) Phase|Other|5|||
128963873|NCT01224106|464153420|FG004|Open-Label Extension (OLE) Phase|Other|3|||
128963874|NCT03551626|464153427|FG000|Overall Study|Adverse Event|88|||
128963875|NCT03551626|464153427|FG000|Overall Study|Disease relapse|18|||
128963876|NCT03551626|464153427|FG000|Overall Study|Withdrawal of informed consent|6|||
128963877|NCT03551626|464153427|FG000|Overall Study|Patient decision|5|||
128963878|NCT03551626|464153427|FG000|Overall Study|Physician Decision|4|||
128963879|NCT03551626|464153427|FG000|Overall Study|Lost to Follow-up|3|||
128963880|NCT03551626|464153427|FG000|Overall Study|Pregnancy|1|||
128963881|NCT03551626|464153427|FG000|Overall Study|Protocol deviation|1|||
128963882|NCT03551626|464153427|FG000|Overall Study|Technical problems|1|||
128963883|NCT02133001|464153428|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
128963884|NCT02133001|464153429|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
128963885|NCT02133001|464153428|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
128963886|NCT02133001|464153429|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
128963887|NCT02133001|464153428|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
128963888|NCT02133001|464153429|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
128963889|NCT02133001|464153428|FG000|Double Blind (Day 1-25)|Other|2|||
128963890|NCT02133001|464153429|FG001|Double Blind (Day 1-25)|Other|2|||
128963891|NCT02133001|464153428|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
128963892|NCT02133001|464153429|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
128963893|NCT02133001|464153428|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
128963894|NCT02133001|464153429|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
128963895|NCT02133001|464153428|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
128963896|NCT02133001|464153429|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
128963897|NCT02133001|464153428|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
128963898|NCT02133001|464153429|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
128963899|NCT04211961|464153430|FG000|Overall Study|Death|0|||
128963900|NCT04211961|464153431|FG001|Overall Study|Death|1|||
128963901|NCT04211961|464153430|FG000|Overall Study|Lost to Follow-up|0|||
128963902|NCT04211961|464153431|FG001|Overall Study|Lost to Follow-up|1|||
128963903|NCT04211961|464153430|FG000|Overall Study|Withdrawal by Subject|0|||
128963904|NCT04211961|464153431|FG001|Overall Study|Withdrawal by Subject|1|||
128963905|NCT05784129|464153432|FG000|Overall Study|Study terminated by sponsor|2|||
128963906|NCT05784129|464153433|FG001|Overall Study|Study terminated by sponsor|2|||
128963907|NCT01156363|464153434|FG000|Overall Study|Adverse Event|6|||
128963908|NCT01156363|464153434|FG000|Overall Study|Insufficient Therapeutic Response|5|||
128963909|NCT01156363|464153434|FG000|Overall Study|Failure to Return|1|||
128963910|NCT01156363|464153434|FG000|Overall Study|Refused Treatment|4|||
128963911|NCT01156363|464153434|FG000|Overall Study|Other|6|||
128963912|NCT04882072|464153435|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
128963913|NCT04882072|464153436|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
128963914|NCT04882072|464153435|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
128963915|NCT04882072|464153436|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
128963916|NCT04882072|464153435|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
128963917|NCT04882072|464153436|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
128963918|NCT03097133|464153437|FG000|Overall Study|Lost to Follow-up|3|||
128963919|NCT03097133|464153438|FG001|Overall Study|Lost to Follow-up|2|||
128963920|NCT03097133|464153437|FG000|Overall Study|Withdrawal by Subject|2|||
128963921|NCT03097133|464153438|FG001|Overall Study|Withdrawal by Subject|5|||
128963922|NCT03097133|464153437|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
128963923|NCT03097133|464153438|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
128963924|NCT03097133|464153437|FG000|Overall Study|Other|3|||
128963925|NCT03097133|464153438|FG001|Overall Study|Other|2|||
128963926|NCT03097133|464153437|FG000|Overall Study|Adverse Event|1|||
128963927|NCT03097133|464153438|FG001|Overall Study|Adverse Event|0|||
128963928|NCT00841672|464153444|FG000|Overall Study|Adverse Event|7|||
129037359|NCT03430011|464426434|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
128963929|NCT00841672|464153445|FG001|Overall Study|Adverse Event|16|||
128963930|NCT00841672|464153444|FG000|Overall Study|Abnormal test procedure result(s)|0|||
128963931|NCT00841672|464153445|FG001|Overall Study|Abnormal test procedure result(s)|1|||
128963932|NCT00841672|464153444|FG000|Overall Study|Subject withdrew consent|2|||
129037360|NCT03430011|464426427|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
128963933|NCT00841672|464153445|FG001|Overall Study|Subject withdrew consent|4|||
128963934|NCT00841672|464153444|FG000|Overall Study|Lost to Follow-up|1|||
128963935|NCT00841672|464153445|FG001|Overall Study|Lost to Follow-up|1|||
128963936|NCT00841672|464153444|FG000|Overall Study|Administrative problems|9|||
128963937|NCT00841672|464153445|FG001|Overall Study|Administrative problems|9|||
128963938|NCT00841672|464153444|FG000|Overall Study|Misrandomized|1|||
128963939|NCT00841672|464153445|FG001|Overall Study|Misrandomized|0|||
128963940|NCT00841672|464153444|FG000|Overall Study|Protocol Deviation|0|||
129037361|NCT03430011|464426428|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
128963941|NCT00841672|464153445|FG001|Overall Study|Protocol Deviation|1|||
128963942|NCT00741260|464153450|FG000|Overall Study|Disease Progression|3|||
128963943|NCT00741260|464153451|FG001|Overall Study|Disease Progression|5|||
128963944|NCT00741260|464153452|FG002|Overall Study|Disease Progression|3|||
128963945|NCT00741260|464153453|FG003|Overall Study|Disease Progression|3|||
128963946|NCT00741260|464153454|FG004|Overall Study|Disease Progression|5|||
128963947|NCT00741260|464153455|FG005|Overall Study|Disease Progression|37|||
128963948|NCT00741260|464153456|FG006|Overall Study|Disease Progression|4|||
128963949|NCT00741260|464153450|FG000|Overall Study|Death|0|||
128963950|NCT00741260|464153451|FG001|Overall Study|Death|1|||
128963951|NCT00741260|464153452|FG002|Overall Study|Death|0|||
128963952|NCT00741260|464153453|FG003|Overall Study|Death|1|||
128963953|NCT00741260|464153454|FG004|Overall Study|Death|2|||
128963954|NCT00741260|464153455|FG005|Overall Study|Death|2|||
128963955|NCT00741260|464153456|FG006|Overall Study|Death|1|||
128963956|NCT00741260|464153450|FG000|Overall Study|Withdrawal by Subject|0|||
128963957|NCT00741260|464153451|FG001|Overall Study|Withdrawal by Subject|0|||
128963958|NCT00741260|464153452|FG002|Overall Study|Withdrawal by Subject|0|||
128963959|NCT00741260|464153453|FG003|Overall Study|Withdrawal by Subject|0|||
128963960|NCT00741260|464153454|FG004|Overall Study|Withdrawal by Subject|1|||
128963961|NCT00741260|464153455|FG005|Overall Study|Withdrawal by Subject|3|||
128963962|NCT00741260|464153456|FG006|Overall Study|Withdrawal by Subject|1|||
128963963|NCT00741260|464153450|FG000|Overall Study|Physician Decision|1|||
128963964|NCT00741260|464153451|FG001|Overall Study|Physician Decision|1|||
128963965|NCT00741260|464153452|FG002|Overall Study|Physician Decision|0|||
128963966|NCT00741260|464153453|FG003|Overall Study|Physician Decision|0|||
128713221|NCT02111850|463246051|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713222|NCT02111850|463246052|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713223|NCT02111850|463246053|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
128963967|NCT00741260|464153454|FG004|Overall Study|Physician Decision|0|||
128963968|NCT00741260|464153455|FG005|Overall Study|Physician Decision|0|||
128963969|NCT00741260|464153456|FG006|Overall Study|Physician Decision|0|||
128963970|NCT00741260|464153450|FG000|Overall Study|Other|2|||
128963971|NCT00741260|464153451|FG001|Overall Study|Other|1|||
128963972|NCT00741260|464153452|FG002|Overall Study|Other|1|||
128963973|NCT00741260|464153453|FG003|Overall Study|Other|2|||
128963974|NCT00741260|464153454|FG004|Overall Study|Other|1|||
128963975|NCT00741260|464153455|FG005|Overall Study|Other|3|||
128963976|NCT00741260|464153456|FG006|Overall Study|Other|1|||
128963977|NCT02427100|464153457|FG000|Overall Study|Lost to Follow-up|0|||
128963978|NCT02427100|464153458|FG001|Overall Study|Lost to Follow-up|2|||
128963979|NCT02120352|464153459|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
128963980|NCT02120352|464153460|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
128963981|NCT02120352|464153461|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
128963982|NCT02120352|464153462|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
128963983|NCT02120352|464153463|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
128963984|NCT02120352|464153464|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
128963985|NCT02120352|464153465|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
128963986|NCT02120352|464153459|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
128963987|NCT02120352|464153460|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
128963988|NCT02120352|464153461|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
128963989|NCT02120352|464153462|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
128963990|NCT02120352|464153463|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
128963991|NCT02120352|464153464|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
128963992|NCT02120352|464153465|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
128963993|NCT02120352|464153459|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
128963994|NCT02120352|464153460|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
128963995|NCT02120352|464153461|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
128963996|NCT02120352|464153462|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
128963997|NCT02120352|464153463|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
128963998|NCT02120352|464153464|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
128963999|NCT02120352|464153465|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
128964000|NCT02120352|464153459|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
128964001|NCT02120352|464153460|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
128964002|NCT02120352|464153461|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
128964003|NCT02120352|464153462|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
128964004|NCT02120352|464153463|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
128964005|NCT02120352|464153464|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
128964006|NCT02120352|464153465|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
128964007|NCT02120352|464153459|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
128964008|NCT02120352|464153460|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
128964009|NCT02120352|464153461|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
128964010|NCT02120352|464153462|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
128964011|NCT02120352|464153463|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
128964012|NCT02120352|464153464|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
129220002|NCT02908672|465104675|FG003|Triple Combination Period|Reason Not Specified|1|||
129220003|NCT02908672|465104672|FG000|Triple Combination Period|Physician Decision|0|||
128964013|NCT02120352|464153465|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
128964014|NCT02120352|464153459|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
128964015|NCT02120352|464153460|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
128964016|NCT02120352|464153461|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
128964017|NCT02120352|464153462|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
128964018|NCT02120352|464153463|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
128964019|NCT02120352|464153464|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
128964020|NCT02120352|464153465|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
128964021|NCT02120352|464153459|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
128964022|NCT02120352|464153460|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
128964023|NCT02120352|464153461|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
128964024|NCT02120352|464153462|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
128964025|NCT02120352|464153463|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
128964026|NCT02120352|464153464|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
128964027|NCT02120352|464153465|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
128964028|NCT02120352|464153459|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
128964029|NCT02120352|464153460|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
128964030|NCT02120352|464153461|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
128964031|NCT02120352|464153462|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
128964032|NCT02120352|464153463|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
128964033|NCT02120352|464153464|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
128964034|NCT02120352|464153465|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
128964035|NCT02120352|464153459|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
128964036|NCT02120352|464153460|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
128964037|NCT02120352|464153461|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
128964038|NCT02120352|464153462|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
128964039|NCT02120352|464153463|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
128964040|NCT02120352|464153464|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
128964041|NCT02120352|464153465|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
128964042|NCT02120352|464153459|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
128964043|NCT02120352|464153460|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
128964044|NCT02120352|464153461|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
128964045|NCT02120352|464153462|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
128964046|NCT02120352|464153463|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
128964047|NCT02120352|464153464|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
128964048|NCT02120352|464153465|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
128964049|NCT02120352|464153459|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
128964050|NCT02120352|464153460|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
128964051|NCT02120352|464153461|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
128964052|NCT02120352|464153462|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
128964053|NCT02120352|464153463|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
128964054|NCT02120352|464153464|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
128964055|NCT02120352|464153465|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
128964056|NCT02120352|464153459|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
128964057|NCT02120352|464153460|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
128964058|NCT02120352|464153461|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
128964059|NCT02120352|464153462|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
128964060|NCT02120352|464153463|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
128964061|NCT02120352|464153464|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
128964062|NCT02120352|464153465|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
128964063|NCT02120352|464153459|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
129037362|NCT03430011|464426429|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
129037363|NCT03430011|464426430|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
129037364|NCT03430011|464426431|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
129037365|NCT03430011|464426432|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
129037366|NCT03430011|464426433|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
129037367|NCT03430011|464426434|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
129037368|NCT03430011|464426427|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
129037369|NCT03430011|464426428|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
129037370|NCT03430011|464426429|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
129037371|NCT03430011|464426430|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
129037372|NCT03430011|464426431|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
128964064|NCT02120352|464153460|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
128964065|NCT02120352|464153461|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
128964066|NCT02120352|464153462|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
128964067|NCT02120352|464153463|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
128964068|NCT02120352|464153464|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
128964069|NCT02120352|464153465|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
128964070|NCT02120352|464153459|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
128964071|NCT02120352|464153460|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
128964072|NCT02120352|464153461|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
128964073|NCT02120352|464153462|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
128964074|NCT02120352|464153463|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
128964075|NCT02120352|464153464|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
128964076|NCT02120352|464153465|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
128964077|NCT02120352|464153459|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
128964078|NCT02120352|464153460|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
128964079|NCT02120352|464153461|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
128964080|NCT02120352|464153462|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
128964081|NCT02120352|464153463|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
128964082|NCT02120352|464153464|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
128964083|NCT02120352|464153465|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
128964084|NCT02120352|464153459|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
128964085|NCT02120352|464153460|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
128964086|NCT02120352|464153461|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
128964087|NCT02120352|464153462|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
128964088|NCT02120352|464153463|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
128964089|NCT02120352|464153464|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
128964090|NCT02120352|464153465|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
128964091|NCT02120352|464153459|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
128964092|NCT02120352|464153460|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
128964093|NCT02120352|464153461|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
128964094|NCT02120352|464153462|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
128964095|NCT02120352|464153463|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
128964096|NCT02120352|464153464|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
128964097|NCT02120352|464153465|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
128964098|NCT02120352|464153459|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
128964099|NCT02120352|464153460|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
128964100|NCT02120352|464153461|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
128964101|NCT02120352|464153462|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
128964102|NCT02120352|464153463|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
128964103|NCT02120352|464153464|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
128964104|NCT02120352|464153465|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
128964105|NCT02120352|464153459|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
128964106|NCT02120352|464153460|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
128964107|NCT02120352|464153461|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
128964108|NCT02120352|464153462|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
128964109|NCT02120352|464153463|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
128964110|NCT02120352|464153464|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
128964111|NCT02120352|464153465|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
129037373|NCT03430011|464426432|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
129037374|NCT03430011|464426433|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
129037375|NCT03430011|464426434|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
129037376|NCT03430011|464426427|FG000|JCARH125 Treatment|Death|4|||
129037377|NCT03430011|464426428|FG001|JCARH125 Treatment|Death|19|||
129037378|NCT03430011|464426429|FG002|JCARH125 Treatment|Death|10|||
129037379|NCT03430011|464426430|FG003|JCARH125 Treatment|Death|8|||
129037380|NCT03430011|464426431|FG004|JCARH125 Treatment|Death|5|||
129037381|NCT03430011|464426432|FG005|JCARH125 Treatment|Death|3|||
129037382|NCT03430011|464426433|FG006|JCARH125 Treatment|Death|4|||
129037383|NCT03430011|464426434|FG007|JCARH125 Treatment|Death|2|||
129037384|NCT03430011|464426427|FG000|JCARH125 Treatment|Other reasons|1|||
129037385|NCT03430011|464426428|FG001|JCARH125 Treatment|Other reasons|0|||
129037386|NCT03430011|464426429|FG002|JCARH125 Treatment|Other reasons|4|||
129037387|NCT03430011|464426430|FG003|JCARH125 Treatment|Other reasons|2|||
129037388|NCT03430011|464426431|FG004|JCARH125 Treatment|Other reasons|2|||
129037389|NCT03430011|464426432|FG005|JCARH125 Treatment|Other reasons|1|||
129037390|NCT03430011|464426433|FG006|JCARH125 Treatment|Other reasons|3|||
129037391|NCT03430011|464426434|FG007|JCARH125 Treatment|Other reasons|2|||
129037392|NCT00084799|464426435|FG000|Overall Study|Disease Progression|1|||
129037393|NCT00084799|464426436|FG001|Overall Study|Disease Progression|0|||
129037394|NCT01235442|464426437|FG000|Overall Study|Lost to Follow-up|12|||
129037395|NCT01235442|464426438|FG001|Overall Study|Lost to Follow-up|10|||
129037396|NCT01235442|464426437|FG000|Overall Study|Death|0|||
129037397|NCT01235442|464426438|FG001|Overall Study|Death|2|||
128964112|NCT02120352|464153459|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
128964113|NCT02120352|464153460|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
128964114|NCT02120352|464153461|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
128964115|NCT02120352|464153462|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
128964116|NCT02120352|464153463|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
128964117|NCT02120352|464153464|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
128964118|NCT02120352|464153465|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
128964119|NCT02120352|464153459|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
128964120|NCT02120352|464153460|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
128964121|NCT02120352|464153461|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
128964122|NCT02120352|464153462|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
128964123|NCT02120352|464153463|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
128964124|NCT02120352|464153464|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
128964125|NCT02120352|464153465|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
128964126|NCT02120352|464153459|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
128964127|NCT02120352|464153460|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
128964128|NCT02120352|464153461|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
128964129|NCT02120352|464153462|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
128964130|NCT02120352|464153463|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
128964131|NCT02120352|464153464|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
128964132|NCT02120352|464153465|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
128964133|NCT00842361|464153467|FG000|Overall Study|Protocol Violation|1|||
128964134|NCT00842361|464153468|FG001|Overall Study|Protocol Violation|0|||
128964135|NCT00842361|464153467|FG000|Overall Study|Unclassified|0|||
128964136|NCT00842361|464153468|FG001|Overall Study|Unclassified|2|||
128964137|NCT03094611|464153469|FG000|Overall Study|Lack of Efficacy|1|||
128964138|NCT03094611|464153469|FG000|Overall Study|Stem Cell Transplant|1|||
128964139|NCT02023112|464153479|FG000|Overall Study|Withdrawal by Subject|2|||
128964140|NCT02023112|464153480|FG001|Overall Study|Withdrawal by Subject|1|||
128964141|NCT00981747|464153482|FG000|Losartan|Withdrawal by Subject|1|||
128964142|NCT00981747|464153482|FG000|Losartan|Death|1|||
128964143|NCT00981747|464153482|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
128964144|NCT01814826|464153483|FG000|Overall Study|Other|3|||
128964145|NCT01814826|464153484|FG001|Overall Study|Other|5|||
128964146|NCT01814826|464153485|FG002|Overall Study|Other|0|||
128964147|NCT01814826|464153483|FG000|Overall Study|Death|29|||
128964148|NCT01814826|464153484|FG001|Overall Study|Death|24|||
128964149|NCT01814826|464153485|FG002|Overall Study|Death|3|||
128964150|NCT03339401|464153486|FG000|Overall Study|Death|2|||
128964151|NCT03339401|464153487|FG001|Overall Study|Death|1|||
128964152|NCT03339401|464153486|FG000|Overall Study|Withdrawal by Subject|2|||
128964153|NCT03339401|464153487|FG001|Overall Study|Withdrawal by Subject|0|||
128964154|NCT03339401|464153486|FG000|Overall Study|Study terminated|4|||
128964155|NCT03339401|464153487|FG001|Overall Study|Study terminated|3|||
128964156|NCT03339401|464153486|FG000|Overall Study|Investigator Decision|1|||
128964157|NCT03339401|464153487|FG001|Overall Study|Investigator Decision|0|||
128964158|NCT03271307|464153488|FG000|Overall Study|Lost to Follow-up|0|||
128964159|NCT03271307|464153489|FG001|Overall Study|Lost to Follow-up|0|||
128964160|NCT03271307|464153490|FG002|Overall Study|Lost to Follow-up|0|||
128964161|NCT03271307|464153491|FG003|Overall Study|Lost to Follow-up|28|||
128964162|NCT03271307|464153492|FG004|Overall Study|Lost to Follow-up|91|||
128964163|NCT03365947|464153493|FG000|Overall Study|Lost to Follow-up|0|||
128964164|NCT03365947|464153494|FG001|Overall Study|Lost to Follow-up|0|||
128964165|NCT03365947|464153495|FG002|Overall Study|Lost to Follow-up|0|||
128964166|NCT03365947|464153496|FG003|Overall Study|Lost to Follow-up|0|||
128964167|NCT03365947|464153497|FG004|Overall Study|Lost to Follow-up|0|||
128964168|NCT03365947|464153498|FG005|Overall Study|Lost to Follow-up|1|||
128964169|NCT03365947|464153499|FG006|Overall Study|Lost to Follow-up|0|||
128964170|NCT03365947|464153500|FG007|Overall Study|Lost to Follow-up|0|||
128964171|NCT03365947|464153501|FG008|Overall Study|Lost to Follow-up|0|||
128964172|NCT03365947|464153502|FG009|Overall Study|Lost to Follow-up|0|||
128964173|NCT03365947|464153503|FG010|Overall Study|Lost to Follow-up|0|||
128964174|NCT03365947|464153504|FG011|Overall Study|Lost to Follow-up|0|||
128964175|NCT03365947|464153505|FG012|Overall Study|Lost to Follow-up|0|||
129037398|NCT01235442|464426437|FG000|Overall Study|Pregnancy|1|||
128964176|NCT03365947|464153506|FG013|Overall Study|Lost to Follow-up|0|||
128964177|NCT03365947|464153507|FG014|Overall Study|Lost to Follow-up|0|||
128964178|NCT03365947|464153508|FG015|Overall Study|Lost to Follow-up|0|||
128964179|NCT03365947|464153509|FG016|Overall Study|Lost to Follow-up|0|||
128964180|NCT03365947|464153510|FG017|Overall Study|Lost to Follow-up|0|||
128964181|NCT03365947|464153511|FG018|Overall Study|Lost to Follow-up|0|||
128964182|NCT01042938|464153512|FG000|Overall Study|Withdrawal by Subject|1|||
128964183|NCT01042938|464153513|FG001|Overall Study|Withdrawal by Subject|1|||
128964184|NCT01042938|464153512|FG000|Overall Study|Protocol Violation|1|||
128964185|NCT01042938|464153513|FG001|Overall Study|Protocol Violation|1|||
128964186|NCT01042938|464153512|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
128964187|NCT01042938|464153513|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
128964188|NCT03997760|464153516|FG000|Overall Study|Protocol Deviation|0|||
128964189|NCT03997760|464153517|FG001|Overall Study|Protocol Deviation|1|||
128964190|NCT03997760|464153518|FG002|Overall Study|Protocol Deviation|0|||
128964191|NCT03997760|464153519|FG003|Overall Study|Protocol Deviation|0|||
128964192|NCT00856986|464153520|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
128964193|NCT00856986|464153521|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
128964194|NCT00856986|464153522|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
128964195|NCT00856986|464153523|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
128964196|NCT00856986|464153524|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
128964197|NCT00856986|464153520|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
128964198|NCT00856986|464153521|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
128964199|NCT00856986|464153522|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
128964200|NCT00856986|464153523|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
128964201|NCT00856986|464153524|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
128964202|NCT00856986|464153520|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
128964203|NCT00856986|464153521|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
128964204|NCT00856986|464153522|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
128964205|NCT00856986|464153523|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
128964206|NCT00856986|464153524|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
128964207|NCT00856986|464153520|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
128964208|NCT00856986|464153521|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
128964209|NCT00856986|464153522|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
128964210|NCT00856986|464153523|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
128964211|NCT00856986|464153524|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
128964212|NCT00856986|464153520|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
128964213|NCT00856986|464153521|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
128964214|NCT00856986|464153522|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
128964215|NCT00856986|464153523|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
128964216|NCT00856986|464153524|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
128964217|NCT00856986|464153520|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
128964218|NCT00856986|464153521|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
128964219|NCT00856986|464153522|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
128964220|NCT00856986|464153523|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
128964221|NCT00856986|464153524|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
128964222|NCT00856986|464153520|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
128964223|NCT00856986|464153521|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
128964224|NCT00856986|464153522|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
128964225|NCT00856986|464153523|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
128964226|NCT00856986|464153524|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
128964227|NCT00856986|464153520|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
128964228|NCT00856986|464153521|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
128964229|NCT00856986|464153522|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
128964230|NCT00856986|464153523|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
128964231|NCT00856986|464153524|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
128964232|NCT00856986|464153520|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
128964233|NCT00856986|464153521|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
128964234|NCT00856986|464153522|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
128964235|NCT00856986|464153523|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
128964236|NCT00856986|464153524|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
128964237|NCT00856986|464153520|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
128964238|NCT00856986|464153521|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
128964239|NCT00856986|464153522|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
128964240|NCT00856986|464153523|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
128964241|NCT00856986|464153524|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
128964242|NCT00856986|464153520|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
128964243|NCT00856986|464153521|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
128964244|NCT00856986|464153522|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
128964245|NCT00856986|464153523|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
128964246|NCT00856986|464153524|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
128964247|NCT00856986|464153520|FG000|Main Period, Weeks 0-26|Unclassified|7|||
128964248|NCT00856986|464153521|FG001|Main Period, Weeks 0-26|Unclassified|6|||
128964249|NCT00856986|464153522|FG002|Main Period, Weeks 0-26|Unclassified|7|||
128964250|NCT00856986|464153523|FG003|Main Period, Weeks 0-26|Unclassified|0|||
128964251|NCT00856986|464153524|FG004|Main Period, Weeks 0-26|Unclassified|0|||
128964252|NCT00856986|464153520|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
128964253|NCT00856986|464153521|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
128964254|NCT00856986|464153522|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
128964255|NCT00856986|464153523|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
128964256|NCT00856986|464153524|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
128964257|NCT00856986|464153520|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
128964258|NCT00856986|464153521|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
128964259|NCT00856986|464153522|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
128964260|NCT00856986|464153523|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
128964261|NCT00856986|464153524|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
128964262|NCT00856986|464153520|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
128964263|NCT00856986|464153521|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
128964264|NCT00856986|464153522|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
128964265|NCT00856986|464153523|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
128964266|NCT00856986|464153524|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
128964267|NCT00856986|464153520|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
128964268|NCT00856986|464153521|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
128964269|NCT00856986|464153522|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
128964270|NCT00856986|464153523|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
128964271|NCT00856986|464153524|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
128964272|NCT00856986|464153520|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
128964273|NCT00856986|464153521|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
128964274|NCT00856986|464153522|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
128964275|NCT00856986|464153523|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
128964276|NCT00856986|464153524|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
128964277|NCT00856986|464153520|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
128964278|NCT00856986|464153521|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
128964279|NCT00856986|464153522|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
128964280|NCT00856986|464153523|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
128964281|NCT00856986|464153524|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
128964282|NCT01915095|464153525|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
128964283|NCT01915095|464153526|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
128964284|NCT01915095|464153527|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
128964285|NCT01915095|464153528|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
128964286|NCT01915095|464153529|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
128964287|NCT02067533|464153532|FG000|Overall Study|Lost to Follow-up|4|||
128964288|NCT02067533|464153533|FG001|Overall Study|Lost to Follow-up|2|||
128964289|NCT02999191|464153535|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
128964290|NCT02999191|464153536|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
128964291|NCT02999191|464153537|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
128964292|NCT02896192|464153539|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
128964293|NCT02896192|464153539|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
128964294|NCT02896192|464153539|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
128964295|NCT01696396|464155739|FG000|Overall Study|Withdrawal by Subject|19|||
128964296|NCT01696396|464155740|FG001|Overall Study|Withdrawal by Subject|5|||
128964297|NCT01696396|464155741|FG002|Overall Study|Withdrawal by Subject|19|||
129127737|NCT04896385|464760308|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
129127738|NCT04896385|464760309|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
129127739|NCT04896385|464760310|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
129127740|NCT04896385|464760307|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
129127741|NCT04896385|464760308|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
129127742|NCT04896385|464760309|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129127743|NCT04896385|464760310|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129127744|NCT04896385|464760307|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129127745|NCT04896385|464760308|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129127746|NCT04896385|464760309|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
129127747|NCT04896385|464760310|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
129127748|NCT04896385|464760307|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129127749|NCT04896385|464760308|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129220004|NCT02908672|465104673|FG001|Triple Combination Period|Physician Decision|0|||
129220005|NCT02908672|465104674|FG002|Triple Combination Period|Physician Decision|1|||
129220006|NCT02908672|465104675|FG003|Triple Combination Period|Physician Decision|1|||
129220007|NCT02908672|465104672|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
129220008|NCT02908672|465104673|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
129220009|NCT02908672|465104674|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
129220010|NCT02908672|465104675|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
129220011|NCT02908672|465104672|FG000|Triple Combination Period|Withdrawal by Subject|0|||
129220012|NCT02908672|465104673|FG001|Triple Combination Period|Withdrawal by Subject|0|||
129220013|NCT02908672|465104674|FG002|Triple Combination Period|Withdrawal by Subject|13|||
129220014|NCT02908672|465104675|FG003|Triple Combination Period|Withdrawal by Subject|16|||
129220015|NCT01185080|465104676|FG000|Overall Study|Adverse Event|1|||
128964298|NCT01696396|464155742|FG003|Overall Study|Withdrawal by Subject|11|||
129220016|NCT01185080|465104677|FG001|Overall Study|Adverse Event|1|||
128964299|NCT01696396|464155739|FG000|Overall Study|Decision by Sponsor|3|||
128964300|NCT01696396|464155740|FG001|Overall Study|Decision by Sponsor|1|||
129220017|NCT01185080|465104678|FG002|Overall Study|Adverse Event|0|||
128964301|NCT01696396|464155741|FG002|Overall Study|Decision by Sponsor|2|||
128964302|NCT01696396|464155742|FG003|Overall Study|Decision by Sponsor|2|||
128713224|NCT02111850|463246054|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713225|NCT02111850|463246055|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713226|NCT02111850|463246056|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713227|NCT02111850|463246057|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713228|NCT02111850|463246058|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713229|NCT02111850|463246059|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
128713230|NCT00665847|463246060|FG000|Overall Study|Adverse Event|8|||
128713231|NCT00665847|463246060|FG000|Overall Study|Withdrawal by Subject|2|||
128964303|NCT01696396|464155739|FG000|Overall Study|Lost to Follow-up|9|||
128964304|NCT01696396|464155740|FG001|Overall Study|Lost to Follow-up|1|||
128964305|NCT01696396|464155741|FG002|Overall Study|Lost to Follow-up|4|||
128964306|NCT01696396|464155742|FG003|Overall Study|Lost to Follow-up|1|||
129220018|NCT01185080|465104676|FG000|Overall Study|Personal reasons|0|||
128713232|NCT00665847|463246060|FG000|Overall Study|Subject non-compliant|8|||
128713233|NCT00665847|463246060|FG000|Overall Study|Subject reached a virologic endpoint|4|||
128713234|NCT00665847|463246060|FG000|Overall Study|Resistance to TMC125|1|||
128964307|NCT01696396|464155739|FG000|Overall Study|Death|0|||
128964308|NCT01696396|464155740|FG001|Overall Study|Death|0|||
128964309|NCT01696396|464155741|FG002|Overall Study|Death|1|||
128964310|NCT01696396|464155742|FG003|Overall Study|Death|0|||
128964311|NCT02892734|464155749|FG000|Treatment on Study|Progressive Disease|2|||
128964312|NCT02892734|464155749|FG000|Follow up for 2 Years|Death|2|||
128964313|NCT02892734|464155749|FG000|Follow up for 2 Years|Study closed early|1|||
128964314|NCT02043509|464155750|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
128964315|NCT02043509|464155751|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
128964316|NCT02043509|464155750|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
128964317|NCT02043509|464155751|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
128713235|NCT00665847|463246060|FG000|Overall Study|Subject ineligible to continue the trial|1|||
128964318|NCT02043509|464155750|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
128964319|NCT02043509|464155751|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
128964320|NCT02043509|464155750|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
128964321|NCT02043509|464155751|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
128964322|NCT02443155|464155758|FG000|Overall Study|Adverse Event|3|||
128964323|NCT02443155|464155759|FG001|Overall Study|Adverse Event|4|||
128964324|NCT02443155|464155760|FG002|Overall Study|Adverse Event|1|||
128964325|NCT02443155|464155761|FG003|Overall Study|Adverse Event|2|||
128964326|NCT02443155|464155758|FG000|Overall Study|Unclassified|0|||
128964327|NCT02443155|464155759|FG001|Overall Study|Unclassified|0|||
128964328|NCT02443155|464155760|FG002|Overall Study|Unclassified|2|||
128964329|NCT02443155|464155761|FG003|Overall Study|Unclassified|1|||
128964330|NCT02443155|464155758|FG000|Overall Study|Withdrawal by Subject|4|||
128964331|NCT02443155|464155759|FG001|Overall Study|Withdrawal by Subject|7|||
128964332|NCT02443155|464155760|FG002|Overall Study|Withdrawal by Subject|3|||
128713236|NCT00665847|463246060|FG000|Overall Study|Switch to Commercial Medication|1|||
128713237|NCT00492115|463246065|FG000|Overall Study|Withdrawal by Subject|3|||
128713238|NCT00492115|463246066|FG001|Overall Study|Withdrawal by Subject|4|||
128713239|NCT03564145|463246067|FG000|Overall Study|Adverse Event|4|||
128964333|NCT02443155|464155761|FG003|Overall Study|Withdrawal by Subject|9|||
128964334|NCT02443155|464155758|FG000|Overall Study|Pregnancy|3|||
128964335|NCT02443155|464155759|FG001|Overall Study|Pregnancy|1|||
128964336|NCT02443155|464155760|FG002|Overall Study|Pregnancy|1|||
128964337|NCT02443155|464155761|FG003|Overall Study|Pregnancy|2|||
128964338|NCT02443155|464155758|FG000|Overall Study|Lost to Follow-up|1|||
128964339|NCT02443155|464155759|FG001|Overall Study|Lost to Follow-up|2|||
128964340|NCT02443155|464155760|FG002|Overall Study|Lost to Follow-up|0|||
128964341|NCT02443155|464155761|FG003|Overall Study|Lost to Follow-up|1|||
128964342|NCT02443155|464155758|FG000|Overall Study|Protocol Violation|1|||
128713240|NCT03564145|463246067|FG000|Overall Study|Lost to Follow-up|21|||
128964343|NCT02443155|464155759|FG001|Overall Study|Protocol Violation|0|||
128964344|NCT02443155|464155760|FG002|Overall Study|Protocol Violation|1|||
128964345|NCT02443155|464155761|FG003|Overall Study|Protocol Violation|1|||
128964346|NCT02443155|464155758|FG000|Overall Study|Death|0|||
128964347|NCT02443155|464155759|FG001|Overall Study|Death|0|||
128964348|NCT02443155|464155760|FG002|Overall Study|Death|1|||
128964349|NCT02443155|464155761|FG003|Overall Study|Death|0|||
128964350|NCT02000219|464155762|FG000|14-Week Study Period|Physician Decision|1|||
128964351|NCT02000219|464155762|FG000|14-Week Study Period|Adverse Event|1|||
128964352|NCT02000219|464155762|FG000|14-Week Study Period|Underwent transplantation|1|||
128964353|NCT02000219|464155762|FG000|Continuation Period|Withdrawal by Subject|1|||
128964354|NCT02000219|464155762|FG000|Continuation Period|Had liver transplant|2|||
128964355|NCT02000219|464155762|FG000|Continuation Period|Non-compliance with study drug|2|||
128964356|NCT00608894|464155765|FG000|Overall Study|Withdrawal by Subject|0|||
128964357|NCT00608894|464155766|FG001|Overall Study|Withdrawal by Subject|2|||
128964358|NCT00106249|464155767|FG000|Overall Study|Lost to Follow-up|3|||
128964359|NCT00106249|464155768|FG001|Overall Study|Lost to Follow-up|2|||
129220019|NCT01185080|465104677|FG001|Overall Study|Personal reasons|0|||
129037399|NCT01235442|464426438|FG001|Overall Study|Pregnancy|1|||
129037400|NCT01235442|464426437|FG000|Overall Study|Ineligibility determined|5|||
129037401|NCT01235442|464426438|FG001|Overall Study|Ineligibility determined|4|||
129037402|NCT01235442|464426437|FG000|Overall Study|Protocol Violation|3|||
129037403|NCT01235442|464426438|FG001|Overall Study|Protocol Violation|3|||
129037404|NCT01235442|464426437|FG000|Overall Study|Adverse Event|4|||
129037405|NCT01235442|464426438|FG001|Overall Study|Adverse Event|6|||
129220020|NCT01185080|465104678|FG002|Overall Study|Personal reasons|1|||
129220021|NCT01705509|465106441|FG000|Inclusion CPET|Screen Failure|5|||
129220022|NCT01705509|465106441|FG000|Inclusion CPET|Withdrawal by Subject|2|||
129220023|NCT01705509|465106441|FG000|CPET w/ Ranexa|Screen Failure|2|||
129220024|NCT01227018|465106442|FG000|Overall Study|Disease progression|9|||
129220025|NCT01227018|465106442|FG000|Overall Study|Toxicity|2|||
129220026|NCT01227018|465106442|FG000|Overall Study|Withdrew after beginning treatment|4|||
129220027|NCT00753649|465106443|FG000|Overall Study|Migrated/moved from study area|1|||
129220028|NCT00753649|465106444|FG001|Overall Study|Migrated/moved from study area|0|||
129220029|NCT00753649|465106443|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
129220030|NCT00753649|465106444|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
129220031|NCT00753649|465106443|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
129220032|NCT00753649|465106444|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
129220033|NCT00753649|465106443|FG000|Overall Study|Protocol Violation|2|||
129220034|NCT00753649|465106444|FG001|Overall Study|Protocol Violation|0|||
129220035|NCT03252925|465106445|FG000|Overall Study|Withdrawal by Subject|1|||
129220036|NCT03252925|465106446|FG001|Overall Study|Withdrawal by Subject|0|||
129220037|NCT03252925|465106445|FG000|Overall Study|Protocol Violation|6|||
129220038|NCT03252925|465106446|FG001|Overall Study|Protocol Violation|0|||
129220039|NCT03252925|465106445|FG000|Overall Study|Adverse Event|1|||
129220040|NCT03252925|465106446|FG001|Overall Study|Adverse Event|0|||
129220041|NCT03252925|465106445|FG000|Overall Study|Lost to Follow-up|6|||
129220042|NCT03252925|465106446|FG001|Overall Study|Lost to Follow-up|6|||
129220043|NCT00123422|465106447|FG000|Overall Study|Physician Decision|2|||
129220044|NCT00123422|465106448|FG001|Overall Study|Physician Decision|2|||
129220045|NCT00123422|465106449|FG002|Overall Study|Physician Decision|6|||
129220046|NCT00123422|465106447|FG000|Overall Study|Withdrawal by Subject|1|||
129220047|NCT00123422|465106448|FG001|Overall Study|Withdrawal by Subject|2|||
129220048|NCT00123422|465106449|FG002|Overall Study|Withdrawal by Subject|2|||
129220049|NCT00123422|465106447|FG000|Overall Study|Lost to Follow-up|1|||
129220050|NCT00123422|465106448|FG001|Overall Study|Lost to Follow-up|2|||
128964360|NCT01495689|464155776|FG000|Overall Study|Death|0|||
128964361|NCT01495689|464155777|FG001|Overall Study|Death|1|||
128964362|NCT01495689|464155776|FG000|Overall Study|Withdrawal by Subject|3|||
128964363|NCT01495689|464155777|FG001|Overall Study|Withdrawal by Subject|0|||
128964364|NCT01495689|464155776|FG000|Overall Study|Lost to Follow-up|7|||
128964365|NCT01495689|464155777|FG001|Overall Study|Lost to Follow-up|6|||
128964366|NCT00524043|464155778|FG000|Overall Study|Lack of Efficacy|15|||
128964367|NCT00524043|464155779|FG001|Overall Study|Lack of Efficacy|13|||
128964368|NCT00524043|464155780|FG002|Overall Study|Lack of Efficacy|14|||
128964369|NCT00524043|464155778|FG000|Overall Study|Withdrawal by Subject|5|||
128964370|NCT00524043|464155779|FG001|Overall Study|Withdrawal by Subject|7|||
128964371|NCT00524043|464155780|FG002|Overall Study|Withdrawal by Subject|7|||
128964372|NCT00524043|464155778|FG000|Overall Study|Adverse Event|5|||
128964373|NCT00524043|464155779|FG001|Overall Study|Adverse Event|2|||
128964374|NCT00524043|464155780|FG002|Overall Study|Adverse Event|7|||
128964375|NCT00524043|464155778|FG000|Overall Study|Lost to Follow-up|3|||
128964376|NCT00524043|464155779|FG001|Overall Study|Lost to Follow-up|5|||
128964377|NCT00524043|464155780|FG002|Overall Study|Lost to Follow-up|3|||
128964378|NCT00524043|464155778|FG000|Overall Study|Various (eg, incarceration)|2|||
128964379|NCT00524043|464155779|FG001|Overall Study|Various (eg, incarceration)|1|||
128964380|NCT00524043|464155780|FG002|Overall Study|Various (eg, incarceration)|0|||
128964381|NCT01843205|464155785|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
128964382|NCT01843205|464155786|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
128964383|NCT00606177|464155787|FG000|Overall Study|Adverse Event|9|||
128964384|NCT00606177|464155788|FG001|Overall Study|Adverse Event|5|||
128964385|NCT00606177|464155787|FG000|Overall Study|Lack of Efficacy|3|||
128964386|NCT00606177|464155788|FG001|Overall Study|Lack of Efficacy|7|||
129037406|NCT01235442|464426437|FG000|Overall Study|Withdrawal by Subject|15|||
129037407|NCT01235442|464426438|FG001|Overall Study|Withdrawal by Subject|9|||
129220051|NCT00123422|465106449|FG002|Overall Study|Lost to Follow-up|2|||
128964387|NCT00606177|464155787|FG000|Overall Study|Physician Decision|1|||
128964388|NCT00606177|464155788|FG001|Overall Study|Physician Decision|0|||
128964389|NCT00606177|464155787|FG000|Overall Study|Protocol Violation|1|||
128964390|NCT00606177|464155788|FG001|Overall Study|Protocol Violation|4|||
128964391|NCT00606177|464155787|FG000|Overall Study|Withdrawal by Subject|5|||
128964392|NCT00606177|464155788|FG001|Overall Study|Withdrawal by Subject|6|||
128964393|NCT00606177|464155787|FG000|Overall Study|Progression to depressive phase|6|||
128964394|NCT00606177|464155788|FG001|Overall Study|Progression to depressive phase|1|||
129037408|NCT01235442|464426437|FG000|Overall Study|Lack of Efficacy|1|||
129037409|NCT01235442|464426438|FG001|Overall Study|Lack of Efficacy|3|||
128964395|NCT00606177|464155787|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
128964396|NCT00606177|464155788|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
128964397|NCT00606177|464155787|FG000|Overall Study|Change of residence or other commitments|1|||
128964398|NCT00606177|464155788|FG001|Overall Study|Change of residence or other commitments|1|||
128964399|NCT00136357|464155789|FG000|Overall Study|Withdrawal by Subject|3|||
128964400|NCT00136357|464155790|FG001|Overall Study|Withdrawal by Subject|2|||
128964401|NCT00216086|464155796|FG000|Overall Study|Protocol Violation|1|||
128964402|NCT00216086|464155796|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
128964403|NCT00216086|464155796|FG000|Overall Study|Social Reasons|2|||
128964404|NCT02025530|464155797|FG000|Overall Study|No longer met elligibility criteria|5|||
128964405|NCT02025530|464155798|FG001|Overall Study|No longer met elligibility criteria|1|||
128964406|NCT01017549|464155801|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
128964407|NCT01017549|464155801|FG000|One-year Follow-up|Lost to Follow-up|2|||
128964408|NCT01017549|464155801|FG000|One-year Follow-up|Withdrawal by Subject|5|||
128964409|NCT01017549|464155801|FG000|5 Year Follow-up|Lost to Follow-up|9|||
128964410|NCT01017549|464155801|FG000|5 Year Follow-up|Mastectomy|3|||
128964411|NCT02728206|464155803|FG000|Overall Study|Death|1|||
128964412|NCT02773368|464155806|FG000|Overall Study|Lost to Follow-up|4|||
128964413|NCT02773368|464155807|FG001|Overall Study|Lost to Follow-up|1|||
128964414|NCT02773368|464155806|FG000|Overall Study|Withdrawal by Subject|5|||
128964415|NCT02773368|464155807|FG001|Overall Study|Withdrawal by Subject|1|||
128964416|NCT02773368|464155806|FG000|Overall Study|Unclassified|1|||
128964417|NCT02773368|464155807|FG001|Overall Study|Unclassified|1|||
128964418|NCT02773368|464155806|FG000|Overall Study|Missing|0|||
128964419|NCT02773368|464155807|FG001|Overall Study|Missing|1|||
128964420|NCT01929018|464155810|FG000|Overall Study|Lost to Follow-up|1|||
128964421|NCT01929018|464155811|FG001|Overall Study|Lost to Follow-up|0|||
128964422|NCT01929018|464155810|FG000|Overall Study|Hospitalization|0|||
128964423|NCT01929018|464155811|FG001|Overall Study|Hospitalization|1|||
128964424|NCT02635867|464155814|FG000|Overall Study|Lost to Follow-up|4|||
128964425|NCT02635867|464155815|FG001|Overall Study|Lost to Follow-up|3|||
128964426|NCT02635867|464155816|FG002|Overall Study|Lost to Follow-up|3|||
128964427|NCT02635867|464155817|FG003|Overall Study|Lost to Follow-up|4|||
128964428|NCT02635867|464155818|FG004|Overall Study|Lost to Follow-up|1|||
128964429|NCT02918318|464155819|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
128964430|NCT02918318|464155820|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
128964431|NCT02918318|464155821|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
128964432|NCT02918318|464155822|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
128964433|NCT02918318|464155823|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
128964434|NCT02918318|464155819|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
128964435|NCT02918318|464155820|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
128964436|NCT02918318|464155821|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
128964437|NCT02918318|464155822|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
128964438|NCT02918318|464155823|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
128964439|NCT02918318|464155819|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
128964440|NCT02918318|464155820|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
128964441|NCT02918318|464155821|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
128964442|NCT02918318|464155822|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
128964443|NCT02918318|464155823|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
128964444|NCT02918318|464155819|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
128964445|NCT02918318|464155820|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
128964446|NCT02918318|464155821|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
128964447|NCT02918318|464155822|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
128964448|NCT02918318|464155823|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
128964449|NCT02918318|464155819|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
128964450|NCT02918318|464155820|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
128964451|NCT02918318|464155821|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
129037410|NCT01235442|464426437|FG000|Overall Study|Noncompliance|1|||
129037411|NCT01235442|464426438|FG001|Overall Study|Noncompliance|2|||
128713241|NCT03564145|463246067|FG000|Overall Study|Protocol Violation|2|||
128713242|NCT03564145|463246067|FG000|Overall Study|Withdrawal by Subject|48|||
128713243|NCT03564145|463246067|FG000|Overall Study|Study Terminated by Sponsor|146|||
128713244|NCT03564145|463246067|FG000|Overall Study|Physician Decision|1|||
128713245|NCT03564145|463246067|FG000|Overall Study|Other Than Specified|1|||
128713246|NCT03564145|463246067|FG000|Overall Study|Pregnancy|1|||
128964452|NCT02918318|464155822|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
128964453|NCT02918318|464155823|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
128964454|NCT02918318|464155819|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
128964455|NCT02918318|464155820|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
129220052|NCT01255436|465106454|FG000|Overall Study|Lost to Follow-up|178|||
128713247|NCT01853826|463248110|FG000|Overall Study|Patients who switched to commercial drug|11|||
128713248|NCT01853826|463248110|FG000|Overall Study|Patient refused to continue medication|21|||
128964456|NCT02918318|464155821|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
128964457|NCT02918318|464155822|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
128964458|NCT02918318|464155823|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
128964459|NCT02918318|464155819|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
128964460|NCT02918318|464155820|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
128964461|NCT02918318|464155821|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
128964462|NCT02918318|464155822|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
128964463|NCT02918318|464155823|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
128964464|NCT02918318|464155819|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
128964465|NCT02918318|464155820|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
128964466|NCT02918318|464155821|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
128964467|NCT02918318|464155822|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
129127750|NCT04896385|464760309|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
129127751|NCT04896385|464760310|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
129127752|NCT04896385|464760307|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
128964468|NCT02918318|464155823|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
128964469|NCT02918318|464155819|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
128964470|NCT02918318|464155820|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
128964471|NCT02918318|464155821|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
128964472|NCT02918318|464155822|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
128964473|NCT02918318|464155823|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
128964474|NCT02918318|464155819|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
128964475|NCT02918318|464155820|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
128964476|NCT02918318|464155821|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
128964477|NCT02918318|464155822|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
128964478|NCT02918318|464155823|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
128964479|NCT02918318|464155819|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
128964480|NCT02918318|464155820|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
128964481|NCT02918318|464155821|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
128964482|NCT02918318|464155822|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
128964483|NCT02918318|464155823|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
128964484|NCT02918318|464155819|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
128964485|NCT02918318|464155820|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
128964486|NCT02918318|464155821|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
128964487|NCT02918318|464155822|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
128964488|NCT02918318|464155823|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
128964489|NCT01782885|464155824|FG000|Overall Study|Lost to Follow-up|4|||
128964490|NCT01782885|464155825|FG001|Overall Study|Lost to Follow-up|6|||
128964491|NCT03447821|464155826|FG000|Overall Study|Withdrawal by Subject|1|||
128964492|NCT03447821|464155827|FG001|Overall Study|Withdrawal by Subject|1|||
128964493|NCT03447821|464155828|FG002|Overall Study|Withdrawal by Subject|0|||
128964494|NCT03447821|464155826|FG000|Overall Study|Lost to Follow-up|0|||
128964495|NCT03447821|464155827|FG001|Overall Study|Lost to Follow-up|0|||
128964496|NCT03447821|464155828|FG002|Overall Study|Lost to Follow-up|1|||
128964497|NCT00329784|464155831|FG000|Overall Study|Lost to Follow-up|0|||
129127753|NCT04896385|464760308|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
129127754|NCT04896385|464760309|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
129127755|NCT04896385|464760310|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
129127756|NCT04896385|464760307|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
129127757|NCT04896385|464760308|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
129127758|NCT04896385|464760309|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
129127759|NCT04896385|464760310|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
129127760|NCT01931098|464760313|FG000|Overall Study|Withdrawal by Subject|0|||
129127761|NCT01931098|464760314|FG001|Overall Study|Withdrawal by Subject|1|||
129127762|NCT01931098|464760313|FG000|Overall Study|Enrolled in different protocol|0|||
129127763|NCT01931098|464760314|FG001|Overall Study|Enrolled in different protocol|1|||
129127764|NCT01931098|464760313|FG000|Overall Study|Unable to begin trmt:active infection|0|||
129127765|NCT01931098|464760314|FG001|Overall Study|Unable to begin trmt:active infection|1|||
129127766|NCT01931098|464760313|FG000|Overall Study|Refused further treatment|0|||
129127767|NCT01931098|464760314|FG001|Overall Study|Refused further treatment|1|||
128771544|NCT01091428|463455274|FG003|Phase 2|Symptomatic Deterioration|6|||
128771545|NCT01091428|463455271|FG000|Phase 2|Adverse Event|0|||
128771546|NCT01091428|463455272|FG001|Phase 2|Adverse Event|0|||
128771547|NCT01091428|463455273|FG002|Phase 2|Adverse Event|12|||
128771548|NCT01091428|463455274|FG003|Phase 2|Adverse Event|5|||
128771549|NCT01091428|463455271|FG000|Phase 2|Withdrawal by Subject|0|||
128771550|NCT01091428|463455272|FG001|Phase 2|Withdrawal by Subject|0|||
128964498|NCT00329784|464155832|FG001|Overall Study|Lost to Follow-up|1|||
128964499|NCT00329784|464155833|FG002|Overall Study|Lost to Follow-up|0|||
128771551|NCT01091428|463455273|FG002|Phase 2|Withdrawal by Subject|9|||
128771552|NCT01091428|463455274|FG003|Phase 2|Withdrawal by Subject|8|||
128964500|NCT00329784|464155834|FG003|Overall Study|Lost to Follow-up|0|||
128964501|NCT00329784|464155831|FG000|Overall Study|Withdrawal by Subject|4|||
128964502|NCT00329784|464155832|FG001|Overall Study|Withdrawal by Subject|2|||
128964503|NCT00329784|464155833|FG002|Overall Study|Withdrawal by Subject|0|||
129127768|NCT02278354|464760315|FG000|Overall Study|Lost to Follow-up|2|||
129127769|NCT02278354|464760316|FG001|Overall Study|Lost to Follow-up|2|||
129127770|NCT02278354|464760315|FG000|Overall Study|Withdrawal by Subject|0|||
129127771|NCT02278354|464760316|FG001|Overall Study|Withdrawal by Subject|1|||
129127772|NCT02278354|464760315|FG000|Overall Study|<10 professional fights|2|||
129127773|NCT02278354|464760316|FG001|Overall Study|<10 professional fights|0|||
128713249|NCT01853826|463248110|FG000|Overall Study|Lost to Follow-up|2|||
128713250|NCT01853826|463248110|FG000|Overall Study|Non-compliant with protocol|4|||
128713251|NCT01853826|463248110|FG000|Overall Study|Other adverse events (AE)|62|||
128713252|NCT01853826|463248110|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
128964504|NCT00329784|464155834|FG003|Overall Study|Withdrawal by Subject|0|||
128964505|NCT00329784|464155831|FG000|Overall Study|Other|1|||
128964506|NCT00329784|464155832|FG001|Overall Study|Other|2|||
128964507|NCT00329784|464155833|FG002|Overall Study|Other|0|||
128964508|NCT00329784|464155834|FG003|Overall Study|Other|0|||
128964509|NCT00045630|464155842|FG000|Overall Study|Adverse Event|1|||
128964510|NCT00045630|464155842|FG000|Overall Study|Refusal unrelated to adverse event|1|||
128964511|NCT00045630|464155842|FG000|Overall Study|Progression/relapse|1|||
128964512|NCT00045630|464155842|FG000|Overall Study|Death|1|||
128964513|NCT00045630|464155842|FG000|Overall Study|Ineligible|2|||
128964514|NCT00924729|464155843|FG000|Overall Study|insufficient volume for analysis|1|||
128964515|NCT00924729|464155844|FG001|Overall Study|insufficient volume for analysis|0|||
128964516|NCT00924729|464155843|FG000|Overall Study|Protocol Violation|1|||
128964517|NCT00924729|464155844|FG001|Overall Study|Protocol Violation|0|||
128964518|NCT03034057|464155849|FG000|Overall Study|Withdrawal by Subject|10|||
128964519|NCT03034057|464155849|FG000|Overall Study|Protocol Violation|1|||
128964520|NCT03034057|464155849|FG000|Overall Study|Not defined|2|||
128964521|NCT03034057|464155849|FG000|Overall Study|Lost to Follow-up|19|||
128964522|NCT03034057|464155849|FG000|Overall Study|Adverse Event|22|||
128964523|NCT03034057|464155849|FG000|Overall Study|Medication error without associated AE|1|||
128964524|NCT01929707|464155850|FG000|Intervention Period 1|Lost to Follow-up|0|||
128964525|NCT01929707|464155851|FG001|Intervention Period 1|Lost to Follow-up|0|||
128964526|NCT01929707|464155852|FG002|Intervention Period 1|Lost to Follow-up|0|||
128964527|NCT01929707|464155853|FG003|Intervention Period 1|Lost to Follow-up|1|||
128964528|NCT01929707|464155854|FG004|Intervention Period 1|Lost to Follow-up|0|||
128964529|NCT01929707|464155855|FG005|Intervention Period 1|Lost to Follow-up|0|||
128964530|NCT01929707|464155856|FG006|Intervention Period 1|Lost to Follow-up|0|||
128964531|NCT01929707|464155857|FG007|Intervention Period 1|Lost to Follow-up|0|||
128964532|NCT01929707|464155850|FG000|Intervention Period 1|Withdrawal by Subject|0|||
128964533|NCT01929707|464155851|FG001|Intervention Period 1|Withdrawal by Subject|0|||
128964534|NCT01929707|464155852|FG002|Intervention Period 1|Withdrawal by Subject|0|||
128964535|NCT01929707|464155853|FG003|Intervention Period 1|Withdrawal by Subject|2|||
128964536|NCT01929707|464155854|FG004|Intervention Period 1|Withdrawal by Subject|0|||
128964537|NCT01929707|464155855|FG005|Intervention Period 1|Withdrawal by Subject|0|||
128964538|NCT01929707|464155856|FG006|Intervention Period 1|Withdrawal by Subject|0|||
128964539|NCT01929707|464155857|FG007|Intervention Period 1|Withdrawal by Subject|0|||
128964540|NCT01929707|464155850|FG000|Intervention Period 2|Withdrawal by Subject|0|||
128964541|NCT01929707|464155851|FG001|Intervention Period 2|Withdrawal by Subject|0|||
128964542|NCT01929707|464155852|FG002|Intervention Period 2|Withdrawal by Subject|0|||
128964543|NCT01929707|464155853|FG003|Intervention Period 2|Withdrawal by Subject|0|||
128964544|NCT01929707|464155854|FG004|Intervention Period 2|Withdrawal by Subject|0|||
128964545|NCT01929707|464155855|FG005|Intervention Period 2|Withdrawal by Subject|2|||
128964546|NCT01929707|464155856|FG006|Intervention Period 2|Withdrawal by Subject|0|||
128964547|NCT01929707|464155857|FG007|Intervention Period 2|Withdrawal by Subject|0|||
128964548|NCT00437203|464155858|FG000|Overall Study|Death|0|||
129127774|NCT01901562|464760317|FG000|Overall Study|Protocol Violation|5|||
129127775|NCT01901562|464760317|FG000|Overall Study|Excluded intraoperatively|4|||
128713253|NCT01853826|463248110|FG000|Overall Study|Progressive disease|342|||
128713254|NCT01853826|463248110|FG000|Overall Study|Other than listed|13|||
128713255|NCT01853826|463248110|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
128713256|NCT00982488|463248112|FG000|Overall Study|Administrative reason by sponsor|81|||
128964549|NCT00437203|464155859|FG001|Overall Study|Death|0|||
128964550|NCT00437203|464155860|FG002|Overall Study|Death|1|||
128964551|NCT00437203|464155861|FG003|Overall Study|Death|0|||
128964552|NCT00437203|464155862|FG004|Overall Study|Death|0|||
128964553|NCT00437203|464155863|FG005|Overall Study|Death|0|||
128964554|NCT00437203|464155864|FG006|Overall Study|Death|0|||
128964555|NCT00437203|464155865|FG007|Overall Study|Death|1|||
128964556|NCT00437203|464155866|FG008|Overall Study|Death|0|||
128964557|NCT00437203|464155867|FG009|Overall Study|Death|1|||
128964558|NCT00437203|464155858|FG000|Overall Study|Adverse Event|1|||
128964559|NCT00437203|464155859|FG001|Overall Study|Adverse Event|1|||
128964560|NCT00437203|464155860|FG002|Overall Study|Adverse Event|0|||
128713257|NCT00982488|463248113|FG001|Overall Study|Administrative reason by sponsor|3|||
128713258|NCT00982488|463248114|FG002|Overall Study|Administrative reason by sponsor|11|||
128713259|NCT00982488|463248115|FG003|Overall Study|Administrative reason by sponsor|0|||
128713260|NCT00982488|463248116|FG004|Overall Study|Administrative reason by sponsor|0|||
128713261|NCT00982488|463248112|FG000|Overall Study|Adverse event unrelated to study drug|5|||
128713262|NCT00982488|463248113|FG001|Overall Study|Adverse event unrelated to study drug|1|||
128713263|NCT00982488|463248114|FG002|Overall Study|Adverse event unrelated to study drug|0|||
128713264|NCT00982488|463248115|FG003|Overall Study|Adverse event unrelated to study drug|0|||
128713265|NCT00982488|463248116|FG004|Overall Study|Adverse event unrelated to study drug|0|||
128713266|NCT00982488|463248112|FG000|Overall Study|Death|11|||
128713267|NCT00982488|463248113|FG001|Overall Study|Death|0|||
128713268|NCT00982488|463248114|FG002|Overall Study|Death|2|||
128713269|NCT00982488|463248115|FG003|Overall Study|Death|0|||
128713270|NCT00982488|463248116|FG004|Overall Study|Death|0|||
128713271|NCT00982488|463248112|FG000|Overall Study|Disease progression|30|||
128713272|NCT00982488|463248113|FG001|Overall Study|Disease progression|5|||
128713273|NCT00982488|463248114|FG002|Overall Study|Disease progression|10|||
128713274|NCT00982488|463248115|FG003|Overall Study|Disease progression|1|||
128713275|NCT00982488|463248116|FG004|Overall Study|Disease progression|1|||
128713276|NCT00982488|463248112|FG000|Overall Study|Lost to Follow-up|1|||
128713277|NCT00982488|463248113|FG001|Overall Study|Lost to Follow-up|0|||
128713278|NCT00982488|463248114|FG002|Overall Study|Lost to Follow-up|0|||
128713279|NCT00982488|463248115|FG003|Overall Study|Lost to Follow-up|0|||
128713280|NCT00982488|463248116|FG004|Overall Study|Lost to Follow-up|0|||
128713281|NCT00982488|463248112|FG000|Overall Study|Maximum clinical benefit|1|||
128713282|NCT00982488|463248113|FG001|Overall Study|Maximum clinical benefit|1|||
128713283|NCT00982488|463248114|FG002|Overall Study|Maximum clinical benefit|1|||
128713284|NCT00982488|463248115|FG003|Overall Study|Maximum clinical benefit|0|||
128713285|NCT00982488|463248116|FG004|Overall Study|Maximum clinical benefit|0|||
128713286|NCT00982488|463248112|FG000|Overall Study|Other|15|||
128713287|NCT00982488|463248113|FG001|Overall Study|Other|1|||
128713288|NCT00982488|463248114|FG002|Overall Study|Other|3|||
128713289|NCT00982488|463248115|FG003|Overall Study|Other|1|||
128713290|NCT00982488|463248116|FG004|Overall Study|Other|0|||
128713291|NCT00982488|463248112|FG000|Overall Study|Poor compliance/noncompliance|0|||
128713292|NCT00982488|463248113|FG001|Overall Study|Poor compliance/noncompliance|1|||
128713293|NCT00982488|463248114|FG002|Overall Study|Poor compliance/noncompliance|0|||
128713294|NCT00982488|463248115|FG003|Overall Study|Poor compliance/noncompliance|0|||
128713295|NCT00982488|463248116|FG004|Overall Study|Poor compliance/noncompliance|0|||
128713296|NCT00982488|463248112|FG000|Overall Study|Stem cell transplant|2|||
128713297|NCT00982488|463248113|FG001|Overall Study|Stem cell transplant|0|||
128713298|NCT00982488|463248114|FG002|Overall Study|Stem cell transplant|0|||
128713299|NCT00982488|463248115|FG003|Overall Study|Stem cell transplant|1|||
128713300|NCT00982488|463248116|FG004|Overall Study|Stem cell transplant|0|||
128713301|NCT00982488|463248112|FG000|Overall Study|Study drug toxicity|34|||
128713302|NCT00982488|463248113|FG001|Overall Study|Study drug toxicity|1|||
128713303|NCT00982488|463248114|FG002|Overall Study|Study drug toxicity|6|||
128713304|NCT00982488|463248115|FG003|Overall Study|Study drug toxicity|0|||
128713305|NCT00982488|463248116|FG004|Overall Study|Study drug toxicity|0|||
128713306|NCT00982488|463248112|FG000|Overall Study|Withdrawal by Subject|5|||
128713307|NCT00982488|463248113|FG001|Overall Study|Withdrawal by Subject|1|||
128713308|NCT00982488|463248114|FG002|Overall Study|Withdrawal by Subject|1|||
128713309|NCT00982488|463248115|FG003|Overall Study|Withdrawal by Subject|0|||
128713310|NCT00982488|463248116|FG004|Overall Study|Withdrawal by Subject|0|||
128771553|NCT01091428|463455271|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
128771554|NCT01091428|463455272|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
128771555|NCT01091428|463455273|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
128964561|NCT00437203|464155861|FG003|Overall Study|Adverse Event|0|||
128964562|NCT00437203|464155862|FG004|Overall Study|Adverse Event|0|||
128964563|NCT00437203|464155863|FG005|Overall Study|Adverse Event|0|||
128964564|NCT00437203|464155864|FG006|Overall Study|Adverse Event|0|||
128964565|NCT00437203|464155865|FG007|Overall Study|Adverse Event|1|||
128964566|NCT00437203|464155866|FG008|Overall Study|Adverse Event|0|||
128964567|NCT00437203|464155867|FG009|Overall Study|Adverse Event|1|||
129220053|NCT01255436|465106455|FG001|Overall Study|Lost to Follow-up|191|||
128713311|NCT04244786|463248117|FG000|Overall Study|Adverse Event|0|||
128713312|NCT04244786|463248118|FG001|Overall Study|Adverse Event|0|||
128713313|NCT04244786|463248119|FG002|Overall Study|Adverse Event|2|||
128713314|NCT04244786|463248117|FG000|Overall Study|Withdrawal by Subject|0|||
128713315|NCT04244786|463248118|FG001|Overall Study|Withdrawal by Subject|0|||
128713316|NCT04244786|463248119|FG002|Overall Study|Withdrawal by Subject|5|||
128713317|NCT00613938|463248126|FG000|Overall Study|Withdrawal by Subject|2|||
128713318|NCT00613938|463248127|FG001|Overall Study|Withdrawal by Subject|4|||
128713319|NCT00613938|463248128|FG002|Overall Study|Withdrawal by Subject|9|||
128713320|NCT00613938|463248129|FG003|Overall Study|Withdrawal by Subject|9|||
128713321|NCT00613938|463248126|FG000|Overall Study|Adverse Event|1|||
128964568|NCT00437203|464155858|FG000|Overall Study|Study terminated by sponsor|0|||
129127776|NCT00569127|464760318|FG000|Overall Study|Adverse Event|57|||
129127777|NCT00569127|464760319|FG001|Overall Study|Adverse Event|47|||
129127778|NCT00569127|464760318|FG000|Overall Study|Withdrawal by Subject|13|||
129127779|NCT00569127|464760319|FG001|Overall Study|Withdrawal by Subject|27|||
129127780|NCT00569127|464760318|FG000|Overall Study|Progression|99|||
129127781|NCT00569127|464760319|FG001|Overall Study|Progression|100|||
129127782|NCT00569127|464760318|FG000|Overall Study|Death|4|||
129127783|NCT00569127|464760319|FG001|Overall Study|Death|3|||
129127784|NCT00569127|464760318|FG000|Overall Study|Other|20|||
129127785|NCT00569127|464760319|FG001|Overall Study|Other|19|||
129127786|NCT00569127|464760318|FG000|Overall Study|Lost to Follow-up|0|||
129127787|NCT00569127|464760319|FG001|Overall Study|Lost to Follow-up|3|||
129127788|NCT00569127|464760318|FG000|Overall Study|Not Eligible|14|||
129127789|NCT00569127|464760319|FG001|Overall Study|Not Eligible|11|||
129127790|NCT00569127|464760318|FG000|Overall Study|Still on Treatment|7|||
129127791|NCT00569127|464760319|FG001|Overall Study|Still on Treatment|3|||
129127792|NCT03036254|464760322|FG000|Overall Study|Adverse Event|6|||
129127793|NCT03036254|464760323|FG001|Overall Study|Adverse Event|4|||
129127794|NCT03036254|464760322|FG000|Overall Study|Death|3|||
129127795|NCT03036254|464760323|FG001|Overall Study|Death|1|||
129127796|NCT03036254|464760322|FG000|Overall Study|Lack of Efficacy|5|||
129127797|NCT03036254|464760323|FG001|Overall Study|Lack of Efficacy|1|||
129127798|NCT03036254|464760322|FG000|Overall Study|Withdrawal by Subject|3|||
129127799|NCT03036254|464760323|FG001|Overall Study|Withdrawal by Subject|5|||
129127800|NCT06354257|464760324|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129127801|NCT06354257|464760324|FG000|Treatment Period 2|Adverse Event|1|||
129127802|NCT03168672|464760325|FG000|Overall Study|Withdrawal by Subject|13|||
129127803|NCT03168672|464760325|FG000|Overall Study|Death|3|||
129127804|NCT03168672|464760325|FG000|Overall Study|Investigator's Decision|137|||
129127805|NCT03168672|464760325|FG000|Overall Study|Adverse Event|1|||
129127806|NCT03168672|464760325|FG000|Overall Study|Other|2|||
129127807|NCT03168672|464760325|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
129127808|NCT01757847|464760326|FG000|Overall Study|Withdrawal by Subject|3|||
129127809|NCT01757847|464760327|FG001|Overall Study|Withdrawal by Subject|4|||
129127810|NCT05436613|464760330|FG000|Overall Study|Lost to Follow-up|9|||
129127811|NCT05436613|464760330|FG000|Overall Study|Withdrawal by Subject|3|||
129127812|NCT05350202|464760333|FG000|Visit 1 - Baseline|Not-treated|18|||
129127813|NCT05350202|464760334|FG001|Visit 1 - Baseline|Not-treated|0|||
129127814|NCT05350202|464760333|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
129127815|NCT05350202|464760334|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
129127816|NCT05350202|464760333|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
129127817|NCT05350202|464760334|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
129127818|NCT05350202|464760333|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
129127819|NCT05350202|464760334|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
129127820|NCT05350202|464760333|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
129127821|NCT05350202|464760334|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
129127822|NCT05350202|464760333|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
129127823|NCT05350202|464760334|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
129127824|NCT05350202|464760333|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
129127825|NCT05350202|464760334|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
129127826|NCT04635423|464760335|FG000|Overall Study|Ongoing|493|||
129127827|NCT04635423|464760336|FG001|Overall Study|Ongoing|501|||
129127828|NCT04635423|464760335|FG000|Overall Study|Withdrawal by Subject|36|||
129127829|NCT04635423|464760336|FG001|Overall Study|Withdrawal by Subject|29|||
129127830|NCT05119569|464760351|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
129127831|NCT05119569|464760352|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
129127832|NCT05119569|464760353|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129127833|NCT05119569|464760354|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129127834|NCT05119569|464760351|FG000|Double Blind Treatment Phase|Adverse Event|6|||
129127835|NCT05119569|464760352|FG001|Double Blind Treatment Phase|Adverse Event|0|||
129127836|NCT05119569|464760353|FG002|Double Blind Treatment Phase|Adverse Event|0|||
129127837|NCT05119569|464760354|FG003|Double Blind Treatment Phase|Adverse Event|0|||
129127838|NCT05119569|464760351|FG000|Open Label Extension Phase|Ongoing in the study|0|||
129127839|NCT05119569|464760352|FG001|Open Label Extension Phase|Ongoing in the study|0|||
129127840|NCT05119569|464760353|FG002|Open Label Extension Phase|Ongoing in the study|65|||
129127841|NCT05119569|464760354|FG003|Open Label Extension Phase|Ongoing in the study|34|||
129127842|NCT03683030|464760355|FG000|Overall Study|Enrolled but screen failures|12|||
129127843|NCT03683030|464760356|FG001|Overall Study|Enrolled but screen failures|7|||
129127844|NCT03683030|464760355|FG000|Overall Study|Enrolled but no catheter inserted|11|||
129127845|NCT03683030|464760356|FG001|Overall Study|Enrolled but no catheter inserted|13|||
129127846|NCT03683030|464760355|FG000|Overall Study|Withdrawal by Subject|0|||
129127847|NCT03683030|464760356|FG001|Overall Study|Withdrawal by Subject|2|||
129127848|NCT03683030|464760355|FG000|Overall Study|Early termination by subject|1|||
129127849|NCT03683030|464760356|FG001|Overall Study|Early termination by subject|0|||
129127850|NCT03683030|464760355|FG000|Overall Study|Lost to Follow-up|0|||
129127851|NCT03683030|464760356|FG001|Overall Study|Lost to Follow-up|6|||
129127852|NCT03683030|464760355|FG000|Overall Study|Death|0|||
129127853|NCT03683030|464760356|FG001|Overall Study|Death|2|||
129127854|NCT03683030|464760355|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
129127855|NCT03683030|464760356|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
129127856|NCT02390284|464760357|FG000|Overall Study|Physician Decision|0|||
129127857|NCT02390284|464760358|FG001|Overall Study|Physician Decision|0|||
129127858|NCT02390284|464760359|FG002|Overall Study|Physician Decision|9|||
129127859|NCT03980223|464760360|FG000|Overall Study|Lost to Follow-up|3|||
129127860|NCT03980223|464760361|FG001|Overall Study|Lost to Follow-up|7|||
128964569|NCT00437203|464155859|FG001|Overall Study|Study terminated by sponsor|0|||
128964570|NCT00437203|464155860|FG002|Overall Study|Study terminated by sponsor|0|||
128964571|NCT00437203|464155861|FG003|Overall Study|Study terminated by sponsor|0|||
128964572|NCT00437203|464155862|FG004|Overall Study|Study terminated by sponsor|0|||
128964573|NCT00437203|464155863|FG005|Overall Study|Study terminated by sponsor|0|||
128964574|NCT00437203|464155864|FG006|Overall Study|Study terminated by sponsor|0|||
128964575|NCT00437203|464155865|FG007|Overall Study|Study terminated by sponsor|0|||
128964576|NCT00437203|464155866|FG008|Overall Study|Study terminated by sponsor|1|||
128964577|NCT00437203|464155867|FG009|Overall Study|Study terminated by sponsor|0|||
128964578|NCT00437203|464155858|FG000|Overall Study|Objective progression or relapse|5|||
128964579|NCT00437203|464155859|FG001|Overall Study|Objective progression or relapse|6|||
128964580|NCT00437203|464155860|FG002|Overall Study|Objective progression or relapse|2|||
128964581|NCT00437203|464155861|FG003|Overall Study|Objective progression or relapse|3|||
128964582|NCT00437203|464155862|FG004|Overall Study|Objective progression or relapse|3|||
128964583|NCT00437203|464155863|FG005|Overall Study|Objective progression or relapse|3|||
128964584|NCT00437203|464155864|FG006|Overall Study|Objective progression or relapse|6|||
128964585|NCT00437203|464155865|FG007|Overall Study|Objective progression or relapse|1|||
128964586|NCT00437203|464155866|FG008|Overall Study|Objective progression or relapse|2|||
128964587|NCT00437203|464155867|FG009|Overall Study|Objective progression or relapse|2|||
128964588|NCT00437203|464155858|FG000|Overall Study|Other|0|||
128964589|NCT00437203|464155859|FG001|Overall Study|Other|1|||
128964590|NCT00437203|464155860|FG002|Overall Study|Other|0|||
128964591|NCT00437203|464155861|FG003|Overall Study|Other|0|||
128964592|NCT00437203|464155862|FG004|Overall Study|Other|0|||
128964593|NCT00437203|464155863|FG005|Overall Study|Other|0|||
128964594|NCT00437203|464155864|FG006|Overall Study|Other|1|||
128964595|NCT00437203|464155865|FG007|Overall Study|Other|0|||
128964596|NCT00437203|464155866|FG008|Overall Study|Other|0|||
128964597|NCT00437203|464155867|FG009|Overall Study|Other|0|||
128964598|NCT01449955|464155868|FG000|Overall Study|Withdrawal by Subject|1|||
128964599|NCT01449955|464155869|FG001|Overall Study|Withdrawal by Subject|2|||
128964600|NCT04018612|464155870|FG000|Overall Study|Withdrawal by Subject|1|||
128964601|NCT04018612|464155871|FG001|Overall Study|Withdrawal by Subject|0|||
128964602|NCT04018612|464155872|FG002|Overall Study|Withdrawal by Subject|1|||
128964603|NCT02671760|464155873|FG000|Overall Study|Lost to Follow-up|0|||
128964604|NCT02671760|464155874|FG001|Overall Study|Lost to Follow-up|1|||
128964605|NCT02671760|464155875|FG002|Overall Study|Lost to Follow-up|0|||
128964606|NCT01906476|464155876|FG000|Overall Study|Lost to Follow-up|17|||
128964607|NCT01906476|464155877|FG001|Overall Study|Lost to Follow-up|16|||
128964608|NCT01993667|464155878|FG000|Overall Study|Insufficient data to analyze|16|||
128964609|NCT01993667|464155879|FG001|Overall Study|Insufficient data to analyze|16|||
128964610|NCT01993667|464155878|FG000|Overall Study|Insufficient altitude reached|3|||
128964611|NCT01993667|464155879|FG001|Overall Study|Insufficient altitude reached|1|||
128964612|NCT01993667|464155878|FG000|Overall Study|Lost to Follow-up|2|||
128964613|NCT01993667|464155879|FG001|Overall Study|Lost to Follow-up|2|||
128964614|NCT00479167|464155883|FG000|Overall Study|Withdrawal by Subject|1|||
128964615|NCT01997281|464155888|FG000|Overall Study|Withdrawal by Subject|1|||
128964616|NCT01997281|464155889|FG001|Overall Study|Withdrawal by Subject|0|||
128964617|NCT00560794|464155890|FG000|Overall Study|Adverse Event|2|||
128964618|NCT00560794|464155890|FG000|Overall Study|Patient was not Compliant|1|||
129127861|NCT03980223|464760362|FG002|Overall Study|Lost to Follow-up|10|||
129220054|NCT01255436|465106454|FG000|Overall Study|Death, stroke, or MI|4|||
129220055|NCT01255436|465106455|FG001|Overall Study|Death, stroke, or MI|3|||
129220056|NCT01229267|465106456|FG000|Overall Study|Adverse Event|4|||
128964619|NCT00560794|464155890|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
128964620|NCT00560794|464155890|FG000|Overall Study|Hematological Relapse|1|||
128964621|NCT00560794|464155890|FG000|Overall Study|Received Bone Marrow Transplant|6|||
128964622|NCT04857892|464155891|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
128964623|NCT04857892|464155892|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
128964624|NCT04857892|464155893|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
128964625|NCT04857892|464155894|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
128964626|NCT04857892|464155895|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
129127862|NCT03980223|464760363|FG003|Overall Study|Lost to Follow-up|8|||
129127863|NCT03980223|464760360|FG000|Overall Study|Withdrawal by Subject|0|||
129127864|NCT03980223|464760361|FG001|Overall Study|Withdrawal by Subject|0|||
129127865|NCT03980223|464760362|FG002|Overall Study|Withdrawal by Subject|1|||
129127866|NCT03980223|464760363|FG003|Overall Study|Withdrawal by Subject|2|||
129127867|NCT03980223|464760360|FG000|Overall Study|Physician Decision|0|||
129127868|NCT03980223|464760361|FG001|Overall Study|Physician Decision|0|||
129127869|NCT03980223|464760362|FG002|Overall Study|Physician Decision|1|||
129127870|NCT03980223|464760363|FG003|Overall Study|Physician Decision|0|||
129127871|NCT03980223|464760360|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
129127872|NCT03980223|464760361|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
129127873|NCT03980223|464760362|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
129127874|NCT03980223|464760363|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
129127875|NCT06239610|464760364|FG000|Overall Study|no usable migration data for minimum of one day|11|||
129127876|NCT01922934|464760368|FG000|Eligible Patients|Death|0|||
129127877|NCT01922934|464760369|FG001|Eligible Patients|Death|7|||
129127878|NCT01922934|464760368|FG000|Eligible Patients|Physician Decision|17|||
129127879|NCT01922934|464760369|FG001|Eligible Patients|Physician Decision|0|||
129127880|NCT01922934|464760368|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
129127881|NCT01922934|464760369|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
128964627|NCT04857892|464155891|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
128964628|NCT04857892|464155892|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
128964629|NCT04857892|464155893|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
128964630|NCT04857892|464155894|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
128964631|NCT04857892|464155895|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
128964632|NCT04857892|464155891|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
128964633|NCT04857892|464155892|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
128964634|NCT04857892|464155893|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
128964635|NCT04857892|464155894|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
128964636|NCT04857892|464155895|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
128964637|NCT02384993|464155900|FG000|Overall Study|Adverse Event|0|||
128964638|NCT02384993|464155901|FG001|Overall Study|Adverse Event|1|||
128964639|NCT01199198|464157806|FG000|Overall Study|Adverse Event|3|||
128964640|NCT01199198|464157807|FG001|Overall Study|Adverse Event|0|||
128964641|NCT01199198|464157806|FG000|Overall Study|Lost to Follow-up|1|||
128964642|NCT01199198|464157807|FG001|Overall Study|Lost to Follow-up|5|||
128964643|NCT01199198|464157806|FG000|Overall Study|Withdrawal by Subject|1|||
128964644|NCT01199198|464157807|FG001|Overall Study|Withdrawal by Subject|2|||
128964645|NCT01199198|464157806|FG000|Overall Study|ICU Transfer|1|||
128964646|NCT01199198|464157807|FG001|Overall Study|ICU Transfer|2|||
128964647|NCT01199198|464157806|FG000|Overall Study|Hospice-care transfer|1|||
128964648|NCT01199198|464157807|FG001|Overall Study|Hospice-care transfer|2|||
128964649|NCT01376388|464157817|FG000|Overall Study|Adverse Event|13|||
128964650|NCT01376388|464157817|FG000|Overall Study|Lack of Efficacy|2|||
128964651|NCT01376388|464157817|FG000|Overall Study|Withdrawal by Subject|3|||
129127882|NCT01922934|464760368|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
129127883|NCT01922934|464760369|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
129127884|NCT01922934|464760368|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
128964652|NCT03938636|464157825|FG000|Overall Study|Protocol Violation|0|||
128964653|NCT03938636|464157826|FG001|Overall Study|Protocol Violation|1|||
129127885|NCT01922934|464760369|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
129127886|NCT01922934|464760368|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
129127887|NCT01922934|464760369|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
129127888|NCT05166876|464760372|FG000|Overall Study|Withdrawal by Subject|1|||
129127889|NCT05166876|464760373|FG001|Overall Study|Withdrawal by Subject|0|||
129127890|NCT05166876|464760374|FG002|Overall Study|Withdrawal by Subject|0|||
129127891|NCT00658528|464760375|FG000|Overall Study|Adverse Event|5|||
129127892|NCT00658528|464760376|FG001|Overall Study|Adverse Event|7|||
129127893|NCT00658528|464760375|FG000|Overall Study|Lost to Follow-up|14|||
129127894|NCT00658528|464760376|FG001|Overall Study|Lost to Follow-up|22|||
129127895|NCT00658528|464760375|FG000|Overall Study|Withdrawal by Subject|8|||
129127896|NCT00658528|464760376|FG001|Overall Study|Withdrawal by Subject|6|||
129127897|NCT00658528|464760375|FG000|Overall Study|Withdrawal of consent|5|||
128964654|NCT03938636|464157827|FG002|Overall Study|Protocol Violation|1|||
128964655|NCT03938636|464157825|FG000|Overall Study|Subject withdrew due to death in family|0|||
129127898|NCT00658528|464760376|FG001|Overall Study|Withdrawal of consent|6|||
129127899|NCT00658528|464760375|FG000|Overall Study|Other|8|||
129127900|NCT00658528|464760376|FG001|Overall Study|Other|4|||
129127901|NCT01937299|464760377|FG000|Overall Study|Adverse Event|13|||
129127902|NCT01937299|464760378|FG001|Overall Study|Adverse Event|0|||
128964656|NCT03938636|464157826|FG001|Overall Study|Subject withdrew due to death in family|1|||
128964657|NCT03938636|464157827|FG002|Overall Study|Subject withdrew due to death in family|0|||
129127903|NCT01937299|464760377|FG000|Overall Study|Lack of Efficacy|0|||
129127904|NCT01937299|464760378|FG001|Overall Study|Lack of Efficacy|4|||
129127905|NCT01937299|464760377|FG000|Overall Study|Withdrawal by Subject|1|||
129127906|NCT01937299|464760378|FG001|Overall Study|Withdrawal by Subject|0|||
129220057|NCT01229267|465106457|FG001|Overall Study|Adverse Event|6|||
129220058|NCT01229267|465106458|FG002|Overall Study|Adverse Event|3|||
128713322|NCT00613938|463248127|FG001|Overall Study|Adverse Event|4|||
128713323|NCT00613938|463248128|FG002|Overall Study|Adverse Event|8|||
128713324|NCT00613938|463248129|FG003|Overall Study|Adverse Event|5|||
128713325|NCT00613938|463248126|FG000|Overall Study|Lack of Efficacy|16|||
128713326|NCT00613938|463248127|FG001|Overall Study|Lack of Efficacy|18|||
128713327|NCT00613938|463248128|FG002|Overall Study|Lack of Efficacy|5|||
128713328|NCT00613938|463248129|FG003|Overall Study|Lack of Efficacy|9|||
128713329|NCT00613938|463248126|FG000|Overall Study|Other|1|||
128713330|NCT00613938|463248127|FG001|Overall Study|Other|2|||
128713331|NCT00613938|463248128|FG002|Overall Study|Other|1|||
128713332|NCT00613938|463248129|FG003|Overall Study|Other|3|||
128713333|NCT02636868|463248130|FG000|Overall Study|Death|0|||
128713334|NCT02636868|463248131|FG001|Overall Study|Death|1|||
128713335|NCT02636868|463248132|FG002|Overall Study|Death|2|||
128713336|NCT03220217|463248133|FG000|Overall Study|Withdrawal by Subject|0|||
128713337|NCT03220217|463248134|FG001|Overall Study|Withdrawal by Subject|1|||
128713338|NCT03220217|463248135|FG002|Overall Study|Withdrawal by Subject|0|||
128713339|NCT03220217|463248133|FG000|Overall Study|Subject Missed Procedure|0|||
128713340|NCT03220217|463248134|FG001|Overall Study|Subject Missed Procedure|0|||
128713341|NCT03220217|463248135|FG002|Overall Study|Subject Missed Procedure|1|||
128964658|NCT03938636|464157825|FG000|Overall Study|Missed visit|0|||
128964659|NCT03938636|464157826|FG001|Overall Study|Missed visit|1|||
128964660|NCT03938636|464157827|FG002|Overall Study|Missed visit|0|||
128964661|NCT03938636|464157825|FG000|Overall Study|Adverse Event|0|||
128964662|NCT03938636|464157826|FG001|Overall Study|Adverse Event|0|||
128964663|NCT03938636|464157827|FG002|Overall Study|Adverse Event|1|||
128964664|NCT03938636|464157825|FG000|Overall Study|Lost to Follow-up|0|||
128964665|NCT03938636|464157826|FG001|Overall Study|Lost to Follow-up|0|||
128964666|NCT03938636|464157827|FG002|Overall Study|Lost to Follow-up|1|||
128964667|NCT01100658|464157828|FG000|Overall Study|Withdrawal by Subject|1|||
128964668|NCT00711412|464157829|FG000|Induction Treatment|Death|2|||
128964669|NCT00711412|464157829|FG000|Induction Treatment|Adverse Event|1|||
128964670|NCT00711412|464157829|FG000|Induction Treatment|Other|1|||
128964671|NCT00711412|464157829|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
128964672|NCT00711412|464157829|FG000|Evaluated for Combination Treatment|Death|1|||
128964673|NCT00711412|464157829|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
128964674|NCT00711412|464157829|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
128964675|NCT00711412|464157829|FG000|Combination Treatment|Progressive Disease|1|||
128964676|NCT00711412|464157829|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
128964677|NCT00711412|464157829|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
128964678|NCT00711412|464157829|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
128964679|NCT00711412|464157829|FG000|Evaluation for Response and Surgery|Death|1|||
128964680|NCT00711412|464157829|FG000|Survival Follow up Until Death|Other|12|||
128964681|NCT00420342|464157833|FG000|Overall Study|Lost to Follow-up|1|||
128964682|NCT00420342|464157834|FG001|Overall Study|Lost to Follow-up|0|||
128964683|NCT00420342|464157835|FG002|Overall Study|Lost to Follow-up|1|||
129037412|NCT01235442|464426437|FG000|Overall Study|Administrative decision|1|||
128964684|NCT00420342|464157833|FG000|Overall Study|Withdrawal by Subject|0|||
128964685|NCT00420342|464157834|FG001|Overall Study|Withdrawal by Subject|2|||
128964686|NCT00420342|464157835|FG002|Overall Study|Withdrawal by Subject|0|||
128964687|NCT04072575|464157836|FG000|Overall Study|Physician Decision|1|||
129037413|NCT01235442|464426438|FG001|Overall Study|Administrative decision|2|||
129037414|NCT01235442|464426437|FG000|Overall Study|Other unspecified|1|||
129037415|NCT01235442|464426438|FG001|Overall Study|Other unspecified|2|||
129037416|NCT04314843|464426441|FG000|Overall Study|Death|2|||
129037417|NCT04314843|464426442|FG001|Overall Study|Death|2|||
129037418|NCT04314843|464426441|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
129037419|NCT04314843|464426442|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
128964688|NCT04072575|464157836|FG000|Overall Study|Adverse Event|7|||
128964689|NCT04072575|464157836|FG000|Overall Study|Withdrawal by Subject|14|||
128964690|NCT04072575|464157836|FG000|Overall Study|Other|2|||
129037420|NCT01083680|464426443|FG000|Overall Study|Lost to Follow-up|2758|||
129037421|NCT01083680|464426443|FG000|Overall Study|Withdrawal by Subject|1086|||
129037422|NCT03840382|464426444|FG000|Overall Study|Lost to Follow-up|11|||
129037423|NCT00802178|464427989|FG000|Overall Study|Lack of Efficacy|36|||
128713342|NCT03025542|463248136|FG000|Overall Study|Adverse Event|0|||
128713343|NCT03025542|463248137|FG001|Overall Study|Adverse Event|2|||
128713344|NCT03025542|463248136|FG000|Overall Study|Lost to Follow-up|1|||
128713345|NCT03025542|463248137|FG001|Overall Study|Lost to Follow-up|0|||
128713346|NCT03025542|463248136|FG000|Overall Study|Withdrawal by Subject|1|||
128771556|NCT01091428|463455274|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
128713347|NCT03025542|463248137|FG001|Overall Study|Withdrawal by Subject|0|||
128713348|NCT03745937|463248139|FG000|Overall Study|Withdrawal by Subject|0|||
128713349|NCT03745937|463248140|FG001|Overall Study|Withdrawal by Subject|0|||
128964691|NCT02473289|464157837|FG000|Overall Study|Adverse Event|2|||
128964692|NCT02473289|464157838|FG001|Overall Study|Adverse Event|3|||
128964693|NCT02473289|464157837|FG000|Overall Study|Lost to Follow-up|1|||
128964694|NCT02473289|464157838|FG001|Overall Study|Lost to Follow-up|1|||
128964695|NCT02473289|464157837|FG000|Overall Study|Protocol Violation|0|||
128964696|NCT02473289|464157838|FG001|Overall Study|Protocol Violation|1|||
128964697|NCT02473289|464157837|FG000|Overall Study|Withdrawal of consent|6|||
128964698|NCT02473289|464157838|FG001|Overall Study|Withdrawal of consent|7|||
128964699|NCT02473289|464157837|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
128964700|NCT02473289|464157838|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
128964701|NCT02473289|464157837|FG000|Overall Study|Other|2|||
128964702|NCT02473289|464157838|FG001|Overall Study|Other|0|||
128964703|NCT00429572|464157842|FG000|Overall Study|Disease progression|1|||
128964704|NCT01366534|464157843|FG000|Overall Study|Lost to Follow-up|1|||
128964705|NCT01366534|464157844|FG001|Overall Study|Lost to Follow-up|0|||
128964706|NCT01366534|464157845|FG002|Overall Study|Lost to Follow-up|0|||
128964707|NCT01366534|464157843|FG000|Overall Study|Migrated|1|||
128964708|NCT01366534|464157844|FG001|Overall Study|Migrated|1|||
128964709|NCT01366534|464157845|FG002|Overall Study|Migrated|0|||
128964710|NCT01366534|464157843|FG000|Overall Study|Declined challenged|0|||
128964711|NCT01366534|464157844|FG001|Overall Study|Declined challenged|1|||
128964712|NCT01366534|464157845|FG002|Overall Study|Declined challenged|0|||
128964713|NCT02565576|464157846|FG000|Overall Study|abnormal lab value|2|||
128964714|NCT02565576|464157847|FG001|Overall Study|abnormal lab value|0|||
128964715|NCT02565576|464157846|FG000|Overall Study|subject / guardian decision|1|||
128964716|NCT02565576|464157847|FG001|Overall Study|subject / guardian decision|3|||
128964717|NCT02565576|464157846|FG000|Overall Study|Lost to Follow-up|1|||
128964718|NCT02565576|464157847|FG001|Overall Study|Lost to Follow-up|0|||
128964719|NCT02565576|464157846|FG000|Overall Study|Death|0|||
128964720|NCT02565576|464157847|FG001|Overall Study|Death|2|||
128964721|NCT02565576|464157846|FG000|Overall Study|Adverse Event|1|||
128964722|NCT02565576|464157847|FG001|Overall Study|Adverse Event|0|||
128964723|NCT03345342|464157848|FG000|Open-Label Phase|Adverse Event|30|||
128964724|NCT03345342|464157849|FG001|Open-Label Phase|Adverse Event|0|||
128964725|NCT03345342|464157850|FG002|Open-Label Phase|Adverse Event|0|||
128964726|NCT03345342|464157851|FG003|Open-Label Phase|Adverse Event|0|||
128964727|NCT03345342|464157852|FG004|Open-Label Phase|Adverse Event|0|||
128964728|NCT03345342|464157848|FG000|Open-Label Phase|Death|1|||
128964729|NCT03345342|464157849|FG001|Open-Label Phase|Death|0|||
128964730|NCT03345342|464157850|FG002|Open-Label Phase|Death|0|||
128964731|NCT03345342|464157851|FG003|Open-Label Phase|Death|0|||
128964732|NCT03345342|464157852|FG004|Open-Label Phase|Death|0|||
128964733|NCT03345342|464157848|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
128964734|NCT03345342|464157849|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
128964735|NCT03345342|464157850|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
129127907|NCT00385840|464760379|FG000|Overall Study|Adverse Event|1|||
129127908|NCT00385840|464760380|FG001|Overall Study|Adverse Event|1|||
129127909|NCT00385840|464760379|FG000|Overall Study|Lost to Follow-up|3|||
129127910|NCT00385840|464760380|FG001|Overall Study|Lost to Follow-up|13|||
129127911|NCT01706328|464760382|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
129127912|NCT01706328|464760383|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129127913|NCT01706328|464760384|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129127914|NCT01706328|464760382|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
129127915|NCT01706328|464760383|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129127916|NCT01706328|464760384|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129127917|NCT01706328|464760382|FG000|2-week Run-in Period|Physician Decision|4|||
129127918|NCT01706328|464760383|FG001|2-week Run-in Period|Physician Decision|0|||
129127919|NCT01706328|464760384|FG002|2-week Run-in Period|Physician Decision|0|||
129127920|NCT01706328|464760382|FG000|2-week Run-in Period|Adverse Event|4|||
129127921|NCT01706328|464760383|FG001|2-week Run-in Period|Adverse Event|0|||
129127922|NCT01706328|464760384|FG002|2-week Run-in Period|Adverse Event|0|||
129127923|NCT01706328|464760382|FG000|2-week Run-in Period|Lost to Follow-up|2|||
129127924|NCT01706328|464760383|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129127925|NCT01706328|464760384|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129127926|NCT01706328|464760382|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
129127927|NCT01706328|464760383|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
129127928|NCT01706328|464760384|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
128964736|NCT03345342|464157851|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
128964737|NCT03345342|464157852|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
128964738|NCT03345342|464157848|FG000|Open-Label Phase|Lack of Efficacy|6|||
128964739|NCT03345342|464157849|FG001|Open-Label Phase|Lack of Efficacy|0|||
128964740|NCT03345342|464157850|FG002|Open-Label Phase|Lack of Efficacy|0|||
128964741|NCT03345342|464157851|FG003|Open-Label Phase|Lack of Efficacy|0|||
128964742|NCT03345342|464157852|FG004|Open-Label Phase|Lack of Efficacy|0|||
128964743|NCT03345342|464157848|FG000|Open-Label Phase|Lost to Follow-up|9|||
128964744|NCT03345342|464157849|FG001|Open-Label Phase|Lost to Follow-up|0|||
128964745|NCT03345342|464157850|FG002|Open-Label Phase|Lost to Follow-up|0|||
128964746|NCT03345342|464157851|FG003|Open-Label Phase|Lost to Follow-up|0|||
128964747|NCT03345342|464157852|FG004|Open-Label Phase|Lost to Follow-up|0|||
129220059|NCT01229267|465106459|FG003|Overall Study|Adverse Event|2|||
129127929|NCT01706328|464760382|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
129127930|NCT01706328|464760383|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
129127931|NCT01706328|464760384|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
129127932|NCT01706328|464760382|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
129127933|NCT01706328|464760383|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
129127934|NCT01706328|464760384|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
129127935|NCT01706328|464760382|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
129127936|NCT01706328|464760383|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
129127937|NCT01706328|464760384|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
129127938|NCT01706328|464760382|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
129127939|NCT01706328|464760383|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
129127940|NCT01706328|464760384|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
129127941|NCT01706328|464760382|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
129127942|NCT01706328|464760383|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
129127943|NCT01706328|464760384|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
129127944|NCT01706328|464760382|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129127945|NCT01706328|464760383|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
129127946|NCT01706328|464760384|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
129127947|NCT03018938|464760387|FG000|Overall Study|Death|0|||
129127948|NCT03018938|464760388|FG001|Overall Study|Death|1|||
129127949|NCT03018938|464760387|FG000|Overall Study|Lost to Follow-up|21|||
129127950|NCT03018938|464760388|FG001|Overall Study|Lost to Follow-up|32|||
129127951|NCT03018938|464760387|FG000|Overall Study|Withdrawal by Subject|38|||
129127952|NCT03018938|464760388|FG001|Overall Study|Withdrawal by Subject|45|||
129127953|NCT03018938|464760387|FG000|Overall Study|Physician Decision|3|||
129127954|NCT03018938|464760388|FG001|Overall Study|Physician Decision|2|||
129127955|NCT03018938|464760387|FG000|Overall Study|Sponsor Decision|0|||
129127956|NCT03018938|464760388|FG001|Overall Study|Sponsor Decision|1|||
129127957|NCT03018938|464760387|FG000|Overall Study|Screen failure-After randomization|4|||
128713350|NCT03745937|463248141|FG002|Overall Study|Withdrawal by Subject|0|||
128713351|NCT03745937|463248142|FG003|Overall Study|Withdrawal by Subject|1|||
128713352|NCT03745937|463248139|FG000|Overall Study|Not-specifed|0|||
128713353|NCT03745937|463248140|FG001|Overall Study|Not-specifed|1|||
128713354|NCT03745937|463248141|FG002|Overall Study|Not-specifed|0|||
129127958|NCT03018938|464760388|FG001|Overall Study|Screen failure-After randomization|2|||
128713355|NCT03745937|463248142|FG003|Overall Study|Not-specifed|1|||
128713356|NCT00696696|463248148|FG000|Overall Study|Adverse Event|5|||
128713357|NCT00696696|463248148|FG000|Overall Study|Withdrawal by Subject|8|||
128713358|NCT00696696|463248148|FG000|Overall Study|Physician Decision|2|||
128713359|NCT00696696|463248148|FG000|Overall Study|Death|3|||
128713360|NCT02507505|463248149|FG000|Overall Study|Withdrawal by Subject|13|||
128713361|NCT02507505|463248150|FG001|Overall Study|Withdrawal by Subject|11|||
128713362|NCT02507505|463248149|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
128713363|NCT02507505|463248150|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
128713364|NCT02507505|463248149|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
128713365|NCT02507505|463248150|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
128713366|NCT02507505|463248149|FG000|Overall Study|Death before receipt of anesthesia|0|||
128713367|NCT02507505|463248150|FG001|Overall Study|Death before receipt of anesthesia|1|||
128713368|NCT03182829|463248151|FG000|Overall Study|Protocol Violation|12|||
128713369|NCT03182829|463248152|FG001|Overall Study|Protocol Violation|12|||
128713370|NCT03182829|463248151|FG000|Overall Study|Other|4|||
128713371|NCT03182829|463248152|FG001|Overall Study|Other|3|||
128964748|NCT03345342|464157848|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
128964749|NCT03345342|464157849|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
129127959|NCT03018938|464760387|FG000|Overall Study|Not recorded|0|||
129127960|NCT03018938|464760388|FG001|Overall Study|Not recorded|2|||
129127961|NCT02916771|464760395|FG000|Overall Study|Withdrawal by Subject|9|||
129127962|NCT02916771|464760395|FG000|Overall Study|Physician Decision|1|||
128713372|NCT00254540|463248153|FG000|Overall Study|Adverse Event|6|||
128713373|NCT00254540|463248154|FG001|Overall Study|Adverse Event|7|||
128713374|NCT00254540|463248153|FG000|Overall Study|Lack of Efficacy|13|||
128713375|NCT00254540|463248154|FG001|Overall Study|Lack of Efficacy|13|||
128713376|NCT00254540|463248153|FG000|Overall Study|Death|0|||
128964750|NCT03345342|464157850|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
129127963|NCT02916771|464760395|FG000|Overall Study|Began treatment for another active malignancy|1|||
129127964|NCT05759338|464760396|FG000|Overall Study|Withdrawal by Subject|3|||
128713377|NCT00254540|463248154|FG001|Overall Study|Death|1|||
128713378|NCT00254540|463248153|FG000|Overall Study|Laboratory Test Abnormality|0|||
128713379|NCT00254540|463248154|FG001|Overall Study|Laboratory Test Abnormality|1|||
128713380|NCT00225251|463248155|FG000|Overall Study|Withdrawal by Subject|1|||
128713381|NCT00225251|463248156|FG001|Overall Study|Withdrawal by Subject|1|||
128713382|NCT03045328|463248157|FG000|Overall Study|Withdrawal by Subject|2|||
129127965|NCT02924376|464760397|FG000|Overall Study|Progressive Disease|4|||
129127966|NCT02924376|464760398|FG001|Overall Study|Progressive Disease|0|||
129127967|NCT02924376|464760399|FG002|Overall Study|Progressive Disease|1|||
129127968|NCT02924376|464760400|FG003|Overall Study|Progressive Disease|0|||
129127969|NCT02924376|464760397|FG000|Overall Study|Death|73|||
129127970|NCT02924376|464760398|FG001|Overall Study|Death|18|||
129127971|NCT02924376|464760399|FG002|Overall Study|Death|15|||
129127972|NCT02924376|464760400|FG003|Overall Study|Death|2|||
129127973|NCT02924376|464760397|FG000|Overall Study|Lost to Follow-up|3|||
129220060|NCT01229267|465106460|FG004|Overall Study|Adverse Event|10|||
129220061|NCT01229267|465106456|FG000|Overall Study|Death|40|||
129220062|NCT01229267|465106457|FG001|Overall Study|Death|37|||
129220063|NCT01229267|465106458|FG002|Overall Study|Death|35|||
129220064|NCT01229267|465106459|FG003|Overall Study|Death|13|||
129220065|NCT01229267|465106460|FG004|Overall Study|Death|103|||
129220066|NCT01229267|465106456|FG000|Overall Study|Withdrawal by Subject|23|||
129127974|NCT02924376|464760398|FG001|Overall Study|Lost to Follow-up|0|||
129127975|NCT02924376|464760399|FG002|Overall Study|Lost to Follow-up|0|||
129127976|NCT02924376|464760400|FG003|Overall Study|Lost to Follow-up|0|||
129127977|NCT02924376|464760397|FG000|Overall Study|Study Terminated by Sponsor|19|||
129127978|NCT02924376|464760398|FG001|Overall Study|Study Terminated by Sponsor|0|||
129127979|NCT02924376|464760399|FG002|Overall Study|Study Terminated by Sponsor|0|||
129127980|NCT02924376|464760400|FG003|Overall Study|Study Terminated by Sponsor|0|||
129127981|NCT02924376|464760397|FG000|Overall Study|Physician Decision|1|||
129127982|NCT02924376|464760398|FG001|Overall Study|Physician Decision|0|||
129127983|NCT02924376|464760399|FG002|Overall Study|Physician Decision|0|||
129127984|NCT02924376|464760400|FG003|Overall Study|Physician Decision|0|||
129127985|NCT02924376|464760397|FG000|Overall Study|Withdrawal by Subject|7|||
129127986|NCT02924376|464760398|FG001|Overall Study|Withdrawal by Subject|2|||
129127987|NCT02924376|464760399|FG002|Overall Study|Withdrawal by Subject|1|||
129127988|NCT02924376|464760400|FG003|Overall Study|Withdrawal by Subject|0|||
129127989|NCT02924376|464760397|FG000|Overall Study|Rolled Over to Another Study|1|||
129127990|NCT02924376|464760398|FG001|Overall Study|Rolled Over to Another Study|0|||
129127991|NCT02924376|464760399|FG002|Overall Study|Rolled Over to Another Study|0|||
129127992|NCT02924376|464760400|FG003|Overall Study|Rolled Over to Another Study|0|||
129127993|NCT06455111|464760402|FG000|Overall Study|Withdrawal by Subject|11|||
129127994|NCT06455111|464760403|FG001|Overall Study|Withdrawal by Subject|4|||
129127995|NCT05977868|464761572|FG000|Overall Study|Withdrawal by Subject|1|||
129127996|NCT05977868|464761573|FG001|Overall Study|Withdrawal by Subject|2|||
129127997|NCT05977868|464761572|FG000|Overall Study|Transitioned to comfort care|1|||
129127998|NCT05977868|464761573|FG001|Overall Study|Transitioned to comfort care|0|||
128964751|NCT03345342|464157851|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
128964752|NCT03345342|464157852|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
128964753|NCT03345342|464157848|FG000|Open-Label Phase|Physician Decision|4|||
128964754|NCT03345342|464157849|FG001|Open-Label Phase|Physician Decision|0|||
128964755|NCT03345342|464157850|FG002|Open-Label Phase|Physician Decision|0|||
128964756|NCT03345342|464157851|FG003|Open-Label Phase|Physician Decision|0|||
128964757|NCT03345342|464157852|FG004|Open-Label Phase|Physician Decision|0|||
128964758|NCT03345342|464157848|FG000|Open-Label Phase|Protocol Violation|8|||
128964759|NCT03345342|464157849|FG001|Open-Label Phase|Protocol Violation|0|||
128964760|NCT03345342|464157850|FG002|Open-Label Phase|Protocol Violation|0|||
128964761|NCT03345342|464157851|FG003|Open-Label Phase|Protocol Violation|0|||
128964762|NCT03345342|464157852|FG004|Open-Label Phase|Protocol Violation|0|||
128964763|NCT03345342|464157848|FG000|Open-Label Phase|Withdrawal by Subject|57|||
128964764|NCT03345342|464157849|FG001|Open-Label Phase|Withdrawal by Subject|0|||
128964765|NCT03345342|464157850|FG002|Open-Label Phase|Withdrawal by Subject|0|||
128964766|NCT03345342|464157851|FG003|Open-Label Phase|Withdrawal by Subject|0|||
128964767|NCT03345342|464157852|FG004|Open-Label Phase|Withdrawal by Subject|0|||
129127999|NCT00975923|464761578|FG000|Overall Study|Withdrawal by Subject|0|||
129128000|NCT00975923|464761579|FG001|Overall Study|Withdrawal by Subject|1|||
129128001|NCT05291689|464761580|FG000|Overall Study|Adverse Event|3|||
129128002|NCT05291689|464761580|FG000|Overall Study|Lack of Efficacy|10|||
129128003|NCT05291689|464761580|FG000|Overall Study|Withdrawal by Subject|4|||
129220067|NCT01229267|465106457|FG001|Overall Study|Withdrawal by Subject|22|||
129220068|NCT01229267|465106458|FG002|Overall Study|Withdrawal by Subject|32|||
129220069|NCT01229267|465106459|FG003|Overall Study|Withdrawal by Subject|14|||
128713383|NCT01313767|463248163|FG000|Overall Study|Adverse Event|1|||
129128004|NCT02612155|464761582|FG000|Overall Study|Death|1|||
128964768|NCT03345342|464157848|FG000|Open-Label Phase|Other|15|||
128964769|NCT03345342|464157849|FG001|Open-Label Phase|Other|0|||
128964770|NCT03345342|464157850|FG002|Open-Label Phase|Other|0|||
128964771|NCT03345342|464157851|FG003|Open-Label Phase|Other|0|||
128964772|NCT03345342|464157852|FG004|Open-Label Phase|Other|0|||
129128005|NCT02612155|464761583|FG001|Overall Study|Death|1|||
129128006|NCT02612155|464761582|FG000|Overall Study|Lost to Follow-up|2|||
129128007|NCT02612155|464761583|FG001|Overall Study|Lost to Follow-up|2|||
129220070|NCT01229267|465106460|FG004|Overall Study|Withdrawal by Subject|59|||
129220071|NCT01229267|465106456|FG000|Overall Study|Protocol Violation|0|||
129128008|NCT02572167|464761586|FG000|Overall Study|Withdrawal by Subject|0|||
129128009|NCT02572167|464761587|FG001|Overall Study|Withdrawal by Subject|3|||
129128010|NCT02572167|464761588|FG002|Overall Study|Withdrawal by Subject|0|||
129128011|NCT02572167|464761586|FG000|Overall Study|Lost to Follow-up|2|||
129128012|NCT02572167|464761587|FG001|Overall Study|Lost to Follow-up|5|||
129128013|NCT02572167|464761588|FG002|Overall Study|Lost to Follow-up|3|||
129128014|NCT02572167|464761586|FG000|Overall Study|Death|0|||
129128015|NCT02572167|464761587|FG001|Overall Study|Death|8|||
129128016|NCT02572167|464761588|FG002|Overall Study|Death|3|||
129128017|NCT02572167|464761586|FG000|Overall Study|Did not meet inclusion criteria|0|||
129128018|NCT02572167|464761587|FG001|Overall Study|Did not meet inclusion criteria|0|||
129128019|NCT02572167|464761588|FG002|Overall Study|Did not meet inclusion criteria|1|||
129128020|NCT02572167|464761586|FG000|Overall Study|Study closure by Sponsor|4|||
129128021|NCT02572167|464761587|FG001|Overall Study|Study closure by Sponsor|40|||
129128022|NCT02572167|464761588|FG002|Overall Study|Study closure by Sponsor|24|||
129128023|NCT00005047|464761589|FG000|Overall Study|Withdrawal by Subject|12|||
129128024|NCT00005047|464761590|FG001|Overall Study|Withdrawal by Subject|0|||
129128025|NCT00005047|464761591|FG002|Overall Study|Withdrawal by Subject|0|||
129128026|NCT00005047|464761592|FG003|Overall Study|Withdrawal by Subject|0|||
129128027|NCT00005047|464761589|FG000|Overall Study|Adverse Event|5|||
129128028|NCT00005047|464761590|FG001|Overall Study|Adverse Event|0|||
129128029|NCT00005047|464761591|FG002|Overall Study|Adverse Event|0|||
129128030|NCT00005047|464761592|FG003|Overall Study|Adverse Event|0|||
129128031|NCT00005047|464761589|FG000|Overall Study|Lost to Follow-up|1|||
129128032|NCT00005047|464761590|FG001|Overall Study|Lost to Follow-up|0|||
129128033|NCT00005047|464761591|FG002|Overall Study|Lost to Follow-up|0|||
129128034|NCT00005047|464761592|FG003|Overall Study|Lost to Follow-up|0|||
129128035|NCT00005047|464761589|FG000|Overall Study|Lack of Efficacy|1|||
129128036|NCT00005047|464761590|FG001|Overall Study|Lack of Efficacy|0|||
129128037|NCT00005047|464761591|FG002|Overall Study|Lack of Efficacy|0|||
129128038|NCT00005047|464761592|FG003|Overall Study|Lack of Efficacy|0|||
129128039|NCT00098475|464761600|FG000|Step 1|Progressive disease|33|||
129128040|NCT00098475|464761601|FG001|Step 1|Progressive disease|35|||
129128041|NCT00098475|464761602|FG002|Step 1|Progressive disease|2|||
129128042|NCT00098475|464761603|FG003|Step 1|Progressive disease|1|||
129128043|NCT00098475|464761600|FG000|Step 1|Adverse Event|56|||
129128044|NCT00098475|464761601|FG001|Step 1|Adverse Event|37|||
129128045|NCT00098475|464761602|FG002|Step 1|Adverse Event|0|||
129128046|NCT00098475|464761603|FG003|Step 1|Adverse Event|1|||
129128047|NCT00098475|464761600|FG000|Step 1|Death|8|||
129128048|NCT00098475|464761601|FG001|Step 1|Death|5|||
129128049|NCT00098475|464761602|FG002|Step 1|Death|0|||
129128050|NCT00098475|464761603|FG003|Step 1|Death|1|||
129128051|NCT00098475|464761600|FG000|Step 1|Withdrawal by Subject|14|||
129128052|NCT00098475|464761601|FG001|Step 1|Withdrawal by Subject|11|||
129128053|NCT00098475|464761602|FG002|Step 1|Withdrawal by Subject|0|||
129128054|NCT00098475|464761603|FG003|Step 1|Withdrawal by Subject|0|||
129128055|NCT00098475|464761600|FG000|Step 1|Physician Decision|5|||
128964773|NCT03345342|464157848|FG000|Double-Blind Phase|Adverse Event|0|||
128964774|NCT03345342|464157849|FG001|Double-Blind Phase|Adverse Event|1|||
128964775|NCT03345342|464157850|FG002|Double-Blind Phase|Adverse Event|6|||
128964776|NCT03345342|464157851|FG003|Double-Blind Phase|Adverse Event|0|||
128964777|NCT03345342|464157852|FG004|Double-Blind Phase|Adverse Event|0|||
128964778|NCT03345342|464157848|FG000|Double-Blind Phase|Death|0|||
128964779|NCT03345342|464157849|FG001|Double-Blind Phase|Death|2|||
128964780|NCT03345342|464157850|FG002|Double-Blind Phase|Death|1|||
128964781|NCT03345342|464157851|FG003|Double-Blind Phase|Death|0|||
128964782|NCT03345342|464157852|FG004|Double-Blind Phase|Death|0|||
129128056|NCT00098475|464761601|FG001|Step 1|Physician Decision|2|||
129128057|NCT00098475|464761602|FG002|Step 1|Physician Decision|0|||
129128058|NCT00098475|464761603|FG003|Step 1|Physician Decision|0|||
129128059|NCT00098475|464761600|FG000|Step 1|Alternative therapy|31|||
129128060|NCT00098475|464761601|FG001|Step 1|Alternative therapy|43|||
129128061|NCT00098475|464761602|FG002|Step 1|Alternative therapy|1|||
128964783|NCT03345342|464157848|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
129128062|NCT00098475|464761603|FG003|Step 1|Alternative therapy|0|||
128713384|NCT01313767|463248164|FG001|Overall Study|Adverse Event|0|||
128964784|NCT03345342|464157849|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
128964785|NCT03345342|464157850|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
128964786|NCT03345342|464157851|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
129128063|NCT00098475|464761600|FG000|Step 1|Other disease|2|||
129128064|NCT00098475|464761601|FG001|Step 1|Other disease|1|||
129128065|NCT00098475|464761602|FG002|Step 1|Other disease|1|||
129128066|NCT00098475|464761603|FG003|Step 1|Other disease|0|||
129128067|NCT00098475|464761600|FG000|Step 1|Never started treatment|0|||
129128068|NCT00098475|464761601|FG001|Step 1|Never started treatment|2|||
129128069|NCT00098475|464761602|FG002|Step 1|Never started treatment|0|||
129128070|NCT00098475|464761603|FG003|Step 1|Never started treatment|0|||
129128071|NCT00098475|464761600|FG000|Step 1|Still on treatment as of this analysis|14|||
129128072|NCT00098475|464761601|FG001|Step 1|Still on treatment as of this analysis|27|||
129128073|NCT00098475|464761602|FG002|Step 1|Still on treatment as of this analysis|0|||
129128074|NCT00098475|464761603|FG003|Step 1|Still on treatment as of this analysis|0|||
129128075|NCT00098475|464761600|FG000|Step 1|Knee surgery|1|||
129128076|NCT00098475|464761601|FG001|Step 1|Knee surgery|0|||
129128077|NCT00098475|464761602|FG002|Step 1|Knee surgery|0|||
129128078|NCT00098475|464761603|FG003|Step 1|Knee surgery|0|||
129128079|NCT00098475|464761600|FG000|Step 1|Complications|1|||
129128080|NCT00098475|464761601|FG001|Step 1|Complications|0|||
129128081|NCT00098475|464761602|FG002|Step 1|Complications|0|||
129128082|NCT00098475|464761603|FG003|Step 1|Complications|0|||
129128083|NCT00098475|464761600|FG000|Step 1|Cannot comply due to other tx|0|||
129128084|NCT00098475|464761601|FG001|Step 1|Cannot comply due to other tx|1|||
129128085|NCT00098475|464761602|FG002|Step 1|Cannot comply due to other tx|0|||
129128086|NCT00098475|464761603|FG003|Step 1|Cannot comply due to other tx|0|||
129128087|NCT00098475|464761600|FG000|Step 1|Both patient and physician's decision|2|||
129128088|NCT00098475|464761601|FG001|Step 1|Both patient and physician's decision|1|||
129128089|NCT00098475|464761602|FG002|Step 1|Both patient and physician's decision|0|||
129128090|NCT00098475|464761603|FG003|Step 1|Both patient and physician's decision|0|||
129128091|NCT00098475|464761600|FG000|Step 1|Incorrect disease assessment|2|||
129128092|NCT00098475|464761601|FG001|Step 1|Incorrect disease assessment|0|||
129128093|NCT00098475|464761602|FG002|Step 1|Incorrect disease assessment|0|||
129128094|NCT00098475|464761603|FG003|Step 1|Incorrect disease assessment|0|||
129128095|NCT00098475|464761600|FG000|Step 1|Off treatment for > specified timeframe|1|||
129128096|NCT00098475|464761601|FG001|Step 1|Off treatment for > specified timeframe|1|||
129128097|NCT00098475|464761602|FG002|Step 1|Off treatment for > specified timeframe|0|||
129128098|NCT00098475|464761603|FG003|Step 1|Off treatment for > specified timeframe|0|||
129128099|NCT00098475|464761600|FG000|Step 1|Declining performance status|0|||
129128100|NCT00098475|464761601|FG001|Step 1|Declining performance status|1|||
129128101|NCT00098475|464761602|FG002|Step 1|Declining performance status|0|||
129128102|NCT00098475|464761603|FG003|Step 1|Declining performance status|0|||
129128103|NCT00098475|464761600|FG000|Step 1|Insurance issue|0|||
129128104|NCT00098475|464761601|FG001|Step 1|Insurance issue|1|||
129128105|NCT00098475|464761602|FG002|Step 1|Insurance issue|0|||
129128106|NCT00098475|464761603|FG003|Step 1|Insurance issue|0|||
129128107|NCT00098475|464761600|FG000|Step 1|Rising paraprotein|0|||
129128108|NCT00098475|464761601|FG001|Step 1|Rising paraprotein|1|||
129128109|NCT00098475|464761602|FG002|Step 1|Rising paraprotein|0|||
129128110|NCT00098475|464761603|FG003|Step 1|Rising paraprotein|0|||
129128111|NCT00098475|464761600|FG000|Step 1|Referred to other physicians|0|||
129128112|NCT00098475|464761601|FG001|Step 1|Referred to other physicians|1|||
129128113|NCT00098475|464761602|FG002|Step 1|Referred to other physicians|0|||
129128114|NCT00098475|464761603|FG003|Step 1|Referred to other physicians|0|||
129128115|NCT00098475|464761600|FG000|Step 1|Criteria to continue treatment not met|0|||
129128116|NCT00098475|464761601|FG001|Step 1|Criteria to continue treatment not met|1|||
129128117|NCT00098475|464761602|FG002|Step 1|Criteria to continue treatment not met|0|||
129128118|NCT00098475|464761603|FG003|Step 1|Criteria to continue treatment not met|0|||
129128119|NCT00098475|464761600|FG000|Step 1|Misinterpretation of lab data|0|||
129128120|NCT00098475|464761601|FG001|Step 1|Misinterpretation of lab data|1|||
129128121|NCT00098475|464761602|FG002|Step 1|Misinterpretation of lab data|0|||
129128122|NCT00098475|464761603|FG003|Step 1|Misinterpretation of lab data|0|||
129128123|NCT00098475|464761600|FG000|Step 1|Patient fell with fracture|1|||
129128124|NCT00098475|464761601|FG001|Step 1|Patient fell with fracture|0|||
129128125|NCT00098475|464761602|FG002|Step 1|Patient fell with fracture|0|||
129128126|NCT00098475|464761603|FG003|Step 1|Patient fell with fracture|0|||
129128127|NCT00098475|464761600|FG000|Step 1|Not documented|0|||
129128128|NCT00098475|464761601|FG001|Step 1|Not documented|1|||
128771557|NCT01091428|463455271|FG000|Phase 2|Reason not specified|0|||
128964787|NCT03345342|464157852|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
128964788|NCT03345342|464157848|FG000|Double-Blind Phase|Lost to Follow-up|0|||
128964789|NCT03345342|464157849|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129128129|NCT00098475|464761602|FG002|Step 1|Not documented|0|||
129128130|NCT00098475|464761603|FG003|Step 1|Not documented|0|||
129128131|NCT00098475|464761600|FG000|Step 2|Disease progression|1|||
129128132|NCT00098475|464761601|FG001|Step 2|Disease progression|4|||
128964790|NCT03345342|464157850|FG002|Double-Blind Phase|Lost to Follow-up|7|||
129128133|NCT00098475|464761602|FG002|Step 2|Disease progression|0|||
129128134|NCT00098475|464761603|FG003|Step 2|Disease progression|0|||
129128135|NCT00098475|464761600|FG000|Step 2|Adverse Event|2|||
129128136|NCT00098475|464761601|FG001|Step 2|Adverse Event|0|||
129128137|NCT00098475|464761602|FG002|Step 2|Adverse Event|0|||
129128138|NCT00098475|464761603|FG003|Step 2|Adverse Event|0|||
129128139|NCT00098475|464761600|FG000|Step 2|Withdrawal by Subject|0|||
129128140|NCT00098475|464761601|FG001|Step 2|Withdrawal by Subject|2|||
129128141|NCT00098475|464761602|FG002|Step 2|Withdrawal by Subject|0|||
129128142|NCT00098475|464761603|FG003|Step 2|Withdrawal by Subject|0|||
129128143|NCT00098475|464761600|FG000|Step 2|Physician Decision|0|||
129128144|NCT00098475|464761601|FG001|Step 2|Physician Decision|1|||
129128145|NCT00098475|464761602|FG002|Step 2|Physician Decision|0|||
128964791|NCT03345342|464157851|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129128146|NCT00098475|464761603|FG003|Step 2|Physician Decision|0|||
128964792|NCT03345342|464157852|FG004|Double-Blind Phase|Lost to Follow-up|0|||
128964793|NCT03345342|464157848|FG000|Double-Blind Phase|Physician Decision|0|||
128964794|NCT03345342|464157849|FG001|Double-Blind Phase|Physician Decision|1|||
128964795|NCT03345342|464157850|FG002|Double-Blind Phase|Physician Decision|4|||
128964796|NCT03345342|464157851|FG003|Double-Blind Phase|Physician Decision|0|||
128964797|NCT03345342|464157852|FG004|Double-Blind Phase|Physician Decision|0|||
129220072|NCT01229267|465106457|FG001|Overall Study|Protocol Violation|1|||
129220073|NCT01229267|465106458|FG002|Overall Study|Protocol Violation|0|||
129220074|NCT01229267|465106459|FG003|Overall Study|Protocol Violation|0|||
129220075|NCT01229267|465106460|FG004|Overall Study|Protocol Violation|0|||
129220076|NCT01229267|465106456|FG000|Overall Study|Progressive disease|0|||
129220077|NCT01229267|465106457|FG001|Overall Study|Progressive disease|0|||
129220078|NCT01229267|465106458|FG002|Overall Study|Progressive disease|0|||
129220079|NCT01229267|465106459|FG003|Overall Study|Progressive disease|0|||
129220080|NCT01229267|465106460|FG004|Overall Study|Progressive disease|1|||
129220081|NCT01229267|465106456|FG000|Overall Study|Physician Decision|8|||
129220082|NCT01229267|465106457|FG001|Overall Study|Physician Decision|11|||
129220083|NCT01229267|465106458|FG002|Overall Study|Physician Decision|8|||
129220084|NCT01229267|465106459|FG003|Overall Study|Physician Decision|3|||
129220085|NCT01229267|465106460|FG004|Overall Study|Physician Decision|25|||
129220086|NCT01229267|465106456|FG000|Overall Study|Lost to Follow-up|6|||
129220087|NCT01229267|465106457|FG001|Overall Study|Lost to Follow-up|5|||
129220088|NCT01229267|465106458|FG002|Overall Study|Lost to Follow-up|8|||
129220089|NCT01229267|465106459|FG003|Overall Study|Lost to Follow-up|3|||
129220090|NCT01229267|465106460|FG004|Overall Study|Lost to Follow-up|22|||
129220091|NCT01864603|465106470|FG000|Stage 2|DSMB design modification|86056|||
129220092|NCT01864603|465106471|FG001|Stage 2|DSMB design modification|92558|||
129220093|NCT04050202|465106472|FG000|Overall Study|Lost to Follow-up|2|||
129220094|NCT01499277|465106477|FG000|Overall Study|Adverse Event|3|||
129220095|NCT01499277|465106478|FG001|Overall Study|Adverse Event|6|||
129220096|NCT01499277|465106477|FG000|Overall Study|Death|3|||
129220097|NCT01499277|465106478|FG001|Overall Study|Death|2|||
129220098|NCT01499277|465106477|FG000|Overall Study|Lost to Follow-up|15|||
129220099|NCT01499277|465106478|FG001|Overall Study|Lost to Follow-up|8|||
128771558|NCT01091428|463455272|FG001|Phase 2|Reason not specified|0|||
128964798|NCT03345342|464157848|FG000|Double-Blind Phase|Protocol Violation|0|||
128964799|NCT03345342|464157849|FG001|Double-Blind Phase|Protocol Violation|0|||
129037424|NCT00802178|464427989|FG000|Overall Study|Insufficient tolerability (IT)|17|||
129037425|NCT00802178|464427989|FG000|Overall Study|Withdrawal by Subject|18|||
129037426|NCT00802178|464427989|FG000|Overall Study|Other|32|||
129037427|NCT00802178|464427989|FG000|Overall Study|Lack of efficacy and patient wish|1|||
129037428|NCT00802178|464427989|FG000|Overall Study|IT and patient wish|8|||
129037429|NCT00802178|464427989|FG000|Overall Study|Patients wish and other reason|1|||
129037430|NCT02211014|464427991|FG000|Overall Study|Adverse Event|0|||
129037431|NCT02211014|464427992|FG001|Overall Study|Adverse Event|2|||
129037432|NCT02211014|464427991|FG000|Overall Study|Physician Decision|1|||
129037433|NCT02211014|464427992|FG001|Overall Study|Physician Decision|2|||
129037434|NCT02211014|464427991|FG000|Overall Study|Started another cancer therapy|1|||
129037435|NCT02211014|464427992|FG001|Overall Study|Started another cancer therapy|0|||
129037436|NCT02211014|464427991|FG000|Overall Study|Withdrawal by Subject|0|||
129037437|NCT02211014|464427992|FG001|Overall Study|Withdrawal by Subject|1|||
129037438|NCT02211014|464427991|FG000|Overall Study|In agreement with patient, no benefit|0|||
129037439|NCT02211014|464427992|FG001|Overall Study|In agreement with patient, no benefit|1|||
129037440|NCT01844531|464427993|FG000|Overall Study|Withdrawal by Subject|0|||
129037441|NCT01844531|464427994|FG001|Overall Study|Withdrawal by Subject|1|||
129037442|NCT01844531|464427995|FG002|Overall Study|Withdrawal by Subject|0|||
129037443|NCT01844531|464427996|FG003|Overall Study|Withdrawal by Subject|0|||
129037444|NCT02744755|464427997|FG000|Study Period 1|Protocol Violation|2|||
129037445|NCT02744755|464427998|FG001|Study Period 1|Protocol Violation|1|||
129037446|NCT02744755|464427997|FG000|Study Period 1|not defined|0|||
129037447|NCT02744755|464427998|FG001|Study Period 1|not defined|1|||
129037448|NCT02744755|464427997|FG000|Study Period 1|Pregnancy|1|||
129037449|NCT02744755|464427998|FG001|Study Period 1|Pregnancy|0|||
129037450|NCT02744755|464427997|FG000|Study Period 1|Adverse Event|1|||
129220100|NCT01499277|465106477|FG000|Overall Study|Protocol Violation|2|||
129037451|NCT02744755|464427998|FG001|Study Period 1|Adverse Event|1|||
129037452|NCT02744755|464427997|FG000|Study Period 1|Lost to Follow-up|1|||
129037453|NCT02744755|464427998|FG001|Study Period 1|Lost to Follow-up|1|||
129037454|NCT02744755|464427997|FG000|Study Period 1|Lack of Efficacy|1|||
129037455|NCT02744755|464427998|FG001|Study Period 1|Lack of Efficacy|0|||
129037456|NCT02744755|464427997|FG000|Study Period 1|Withdrawal by Subject|8|||
129220101|NCT01499277|465106478|FG001|Overall Study|Protocol Violation|3|||
129220102|NCT01499277|465106477|FG000|Overall Study|Withdrawal by Subject|16|||
129220103|NCT01499277|465106478|FG001|Overall Study|Withdrawal by Subject|6|||
129220104|NCT01499277|465106477|FG000|Overall Study|Lack of therapeutic response and other|8|||
128964800|NCT03345342|464157850|FG002|Double-Blind Phase|Protocol Violation|1|||
129037457|NCT02744755|464427998|FG001|Study Period 1|Withdrawal by Subject|4|||
129220105|NCT01499277|465106478|FG001|Overall Study|Lack of therapeutic response and other|7|||
128964801|NCT03345342|464157851|FG003|Double-Blind Phase|Protocol Violation|0|||
128964802|NCT03345342|464157852|FG004|Double-Blind Phase|Protocol Violation|0|||
129128147|NCT00098475|464761600|FG000|Step 2|Alternative therapy|1|||
129128148|NCT00098475|464761601|FG001|Step 2|Alternative therapy|2|||
129128149|NCT00098475|464761602|FG002|Step 2|Alternative therapy|0|||
129128150|NCT00098475|464761603|FG003|Step 2|Alternative therapy|0|||
129128151|NCT00098475|464761600|FG000|Step 2|Never started treatment|1|||
129128152|NCT00098475|464761601|FG001|Step 2|Never started treatment|1|||
129128153|NCT00098475|464761602|FG002|Step 2|Never started treatment|0|||
129128154|NCT00098475|464761603|FG003|Step 2|Never started treatment|0|||
129128155|NCT04132050|464761604|FG000|Period I (Double-blind Period)|Adverse Event|3|||
129128156|NCT04132050|464761605|FG001|Period I (Double-blind Period)|Adverse Event|0|||
128964803|NCT03345342|464157848|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
128964804|NCT03345342|464157849|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
128964805|NCT03345342|464157850|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
128964806|NCT03345342|464157851|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
128964807|NCT03345342|464157852|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
128964808|NCT03345342|464157848|FG000|Double-Blind Phase|Other|0|||
128964809|NCT03345342|464157849|FG001|Double-Blind Phase|Other|1|||
128964810|NCT03345342|464157850|FG002|Double-Blind Phase|Other|3|||
128964811|NCT03345342|464157851|FG003|Double-Blind Phase|Other|0|||
128964812|NCT03345342|464157852|FG004|Double-Blind Phase|Other|0|||
128964813|NCT03345342|464157848|FG000|Follow-Up Phase|Adverse Event|0|||
128964814|NCT03345342|464157849|FG001|Follow-Up Phase|Adverse Event|0|||
128964815|NCT03345342|464157850|FG002|Follow-Up Phase|Adverse Event|0|||
128964816|NCT03345342|464157851|FG003|Follow-Up Phase|Adverse Event|0|||
128964817|NCT03345342|464157852|FG004|Follow-Up Phase|Adverse Event|4|||
129128157|NCT04132050|464761604|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
129128158|NCT04132050|464761605|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
129128159|NCT04132050|464761604|FG000|R788 Treatment Period|Adverse Event|5|||
128964818|NCT03345342|464157848|FG000|Follow-Up Phase|Lost to Follow-up|0|||
128964819|NCT03345342|464157849|FG001|Follow-Up Phase|Lost to Follow-up|0|||
128964820|NCT03345342|464157850|FG002|Follow-Up Phase|Lost to Follow-up|0|||
128964821|NCT03345342|464157851|FG003|Follow-Up Phase|Lost to Follow-up|0|||
128964822|NCT03345342|464157852|FG004|Follow-Up Phase|Lost to Follow-up|6|||
128964823|NCT03345342|464157848|FG000|Follow-Up Phase|Physician Decision|0|||
128964824|NCT03345342|464157849|FG001|Follow-Up Phase|Physician Decision|0|||
128964825|NCT03345342|464157850|FG002|Follow-Up Phase|Physician Decision|0|||
128964826|NCT03345342|464157851|FG003|Follow-Up Phase|Physician Decision|0|||
128964827|NCT03345342|464157852|FG004|Follow-Up Phase|Physician Decision|5|||
128964828|NCT03345342|464157848|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
128964829|NCT03345342|464157849|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
128964830|NCT03345342|464157850|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
128964831|NCT03345342|464157851|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
128964832|NCT03345342|464157852|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
128964833|NCT03345342|464157848|FG000|Follow-Up Phase|Other|0|||
128964834|NCT03345342|464157849|FG001|Follow-Up Phase|Other|0|||
128964835|NCT03345342|464157850|FG002|Follow-Up Phase|Other|0|||
128964836|NCT03345342|464157851|FG003|Follow-Up Phase|Other|3|||
128964837|NCT03345342|464157852|FG004|Follow-Up Phase|Other|1|||
128964838|NCT02782104|464157857|FG000|Overall Study|Other|215|||
128964839|NCT02782104|464157857|FG000|Overall Study|Induction Day 28 Non Responder|9|||
128964840|NCT02782104|464157857|FG000|Overall Study|Non-Compliance with Study Drug|2|||
128964841|NCT02782104|464157857|FG000|Overall Study|Death|8|||
128964842|NCT02782104|464157857|FG000|Overall Study|Pregnancy|6|||
128964843|NCT02782104|464157857|FG000|Overall Study|Withdrawal by Subject|63|||
128964844|NCT02782104|464157857|FG000|Overall Study|Protocol Violation|7|||
128964845|NCT02782104|464157857|FG000|Overall Study|Lack of Efficacy|61|||
128713385|NCT01313767|463248163|FG000|Overall Study|Lost to Follow-up|1|||
129128160|NCT04132050|464761605|FG001|R788 Treatment Period|Adverse Event|0|||
129128161|NCT04132050|464761604|FG000|R788 Treatment Period|Lack of Efficacy|5|||
129128162|NCT04132050|464761605|FG001|R788 Treatment Period|Lack of Efficacy|0|||
129128163|NCT04132050|464761604|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
129128164|NCT04132050|464761605|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
128713386|NCT01313767|463248164|FG001|Overall Study|Lost to Follow-up|0|||
129128165|NCT00433537|464761606|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
129128166|NCT00433537|464761607|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
128964846|NCT02782104|464157857|FG000|Overall Study|Lost to Follow-up|23|||
128964847|NCT02782104|464157857|FG000|Overall Study|Adverse Event|74|||
128964848|NCT03185819|464157858|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
128964849|NCT03185819|464157859|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
128713387|NCT01313767|463248163|FG000|Overall Study|Withdrawal by Subject|2|||
128964850|NCT03185819|464157860|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
128964851|NCT03185819|464157861|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
128964852|NCT03185819|464157858|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
128964853|NCT03185819|464157859|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
128964854|NCT03185819|464157860|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
128713388|NCT01313767|463248164|FG001|Overall Study|Withdrawal by Subject|1|||
128713389|NCT01313767|463248163|FG000|Overall Study|Protocol Violation|3|||
128713390|NCT01313767|463248164|FG001|Overall Study|Protocol Violation|1|||
128713391|NCT01287897|463248165|FG000|Overall Study|Adverse Event|5|||
128713392|NCT01287897|463248166|FG001|Overall Study|Adverse Event|3|||
128713393|NCT01287897|463248167|FG002|Overall Study|Adverse Event|6|||
128713394|NCT01287897|463248168|FG003|Overall Study|Adverse Event|4|||
128713395|NCT01287897|463248165|FG000|Overall Study|Lack of Efficacy|2|||
128713396|NCT01287897|463248166|FG001|Overall Study|Lack of Efficacy|0|||
128713397|NCT01287897|463248167|FG002|Overall Study|Lack of Efficacy|0|||
128713398|NCT01287897|463248168|FG003|Overall Study|Lack of Efficacy|0|||
128713399|NCT01287897|463248165|FG000|Overall Study|Protocol Violation|1|||
128713400|NCT01287897|463248166|FG001|Overall Study|Protocol Violation|1|||
128713401|NCT01287897|463248167|FG002|Overall Study|Protocol Violation|0|||
128713402|NCT01287897|463248168|FG003|Overall Study|Protocol Violation|1|||
128713403|NCT01287897|463248165|FG000|Overall Study|Lost to Follow-up|0|||
128713404|NCT01287897|463248166|FG001|Overall Study|Lost to Follow-up|0|||
128713405|NCT01287897|463248167|FG002|Overall Study|Lost to Follow-up|2|||
128713406|NCT01287897|463248168|FG003|Overall Study|Lost to Follow-up|0|||
128713407|NCT01287897|463248165|FG000|Overall Study|Withdrawal by Subject|1|||
128713408|NCT01287897|463248166|FG001|Overall Study|Withdrawal by Subject|5|||
128713409|NCT01287897|463248167|FG002|Overall Study|Withdrawal by Subject|3|||
128713410|NCT01287897|463248168|FG003|Overall Study|Withdrawal by Subject|2|||
128713411|NCT01287897|463248165|FG000|Overall Study|Not consented properly|0|||
128713412|NCT01287897|463248166|FG001|Overall Study|Not consented properly|1|||
128713413|NCT01287897|463248167|FG002|Overall Study|Not consented properly|0|||
128713414|NCT01287897|463248168|FG003|Overall Study|Not consented properly|0|||
128713415|NCT01287897|463248165|FG000|Overall Study|Not meeting entrance criteria|1|||
128713416|NCT01287897|463248166|FG001|Overall Study|Not meeting entrance criteria|1|||
128713417|NCT01287897|463248167|FG002|Overall Study|Not meeting entrance criteria|0|||
128964855|NCT03185819|464157861|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
128964856|NCT03185819|464157858|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
128964857|NCT03185819|464157859|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
128964858|NCT03185819|464157860|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
128964859|NCT03185819|464157861|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
128964860|NCT03185819|464157858|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
128964861|NCT03185819|464157859|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
128964862|NCT03185819|464157860|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
128964863|NCT03185819|464157861|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
128964864|NCT03185819|464157858|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
128964865|NCT03185819|464157859|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
128964866|NCT03185819|464157860|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
128964867|NCT03185819|464157861|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
128964868|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
128964869|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
128964870|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
128964871|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
128964872|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
129220106|NCT02974543|465106479|FG000|Overall Study|Withdrawal by Subject|1|||
129220107|NCT02974543|465106480|FG001|Overall Study|Withdrawal by Subject|0|||
129220108|NCT01237899|465106481|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
129220109|NCT01237899|465106482|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
129220110|NCT01237899|465106483|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
129220111|NCT01237899|465106484|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
129220112|NCT01237899|465106485|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
129220113|NCT01237899|465106486|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
129220114|NCT01237899|465106487|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
129220115|NCT01237899|465106488|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
129220116|NCT01237899|465106489|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
129220117|NCT01237899|465106490|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
129220118|NCT01237899|465106491|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
129220119|NCT02141438|465106493|FG000|Overall Study|Death|1308|||
129220120|NCT02141438|465106493|FG000|Overall Study|Lost to Follow-up|84|||
129220121|NCT02141438|465106493|FG000|Overall Study|Withdrawal by Subject|52|||
129220122|NCT02141438|465106493|FG000|Overall Study|Physician Decision|1|||
128713418|NCT01287897|463248168|FG003|Overall Study|Not meeting entrance criteria|0|||
128713419|NCT01287897|463248165|FG000|Overall Study|Other|1|||
128713420|NCT01287897|463248166|FG001|Overall Study|Other|0|||
128713421|NCT01287897|463248167|FG002|Overall Study|Other|1|||
128713422|NCT01287897|463248168|FG003|Overall Study|Other|0|||
128713423|NCT00065507|463248169|FG000|Overall Study|Death|16|||
128713424|NCT00065507|463248170|FG001|Overall Study|Death|17|||
129128167|NCT00433537|464761608|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
129128168|NCT00433537|464761606|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
129128169|NCT00433537|464761607|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
129128170|NCT00433537|464761608|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
129128171|NCT00433537|464761606|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
129128172|NCT00433537|464761607|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
129128173|NCT00433537|464761608|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
129128174|NCT00433537|464761606|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
129128175|NCT00433537|464761607|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
129128176|NCT00433537|464761608|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
129128177|NCT00433537|464761606|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
129128178|NCT00433537|464761607|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
129128179|NCT00433537|464761608|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
129128180|NCT00433537|464761606|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
129128181|NCT00433537|464761607|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
129128182|NCT00433537|464761608|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
129128183|NCT00433537|464761606|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
129128184|NCT00433537|464761607|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
129128185|NCT00433537|464761608|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
129128186|NCT00433537|464761606|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
129128187|NCT00433537|464761607|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
129128188|NCT00433537|464761608|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
129128189|NCT00433537|464761606|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
129128190|NCT00433537|464761607|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
129128191|NCT00433537|464761608|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
129128192|NCT00831844|464761609|FG000|Overall Study|Adverse Event|2|||
129128193|NCT00831844|464761610|FG001|Overall Study|Adverse Event|0|||
129128194|NCT00831844|464761611|FG002|Overall Study|Adverse Event|0|||
129128195|NCT00831844|464761612|FG003|Overall Study|Adverse Event|0|||
129128196|NCT00831844|464761613|FG004|Overall Study|Adverse Event|1|||
129128197|NCT00831844|464761614|FG005|Overall Study|Adverse Event|1|||
129128198|NCT00831844|464761615|FG006|Overall Study|Adverse Event|2|||
129128199|NCT00831844|464761616|FG007|Overall Study|Adverse Event|0|||
129128200|NCT00831844|464761617|FG008|Overall Study|Adverse Event|0|||
129128201|NCT00831844|464761618|FG009|Overall Study|Adverse Event|0|||
129128202|NCT00831844|464761609|FG000|Overall Study|Death|0|||
129128203|NCT00831844|464761610|FG001|Overall Study|Death|0|||
129128204|NCT00831844|464761611|FG002|Overall Study|Death|0|||
129128205|NCT00831844|464761612|FG003|Overall Study|Death|1|||
129128206|NCT00831844|464761613|FG004|Overall Study|Death|0|||
129128207|NCT00831844|464761614|FG005|Overall Study|Death|0|||
129128208|NCT00831844|464761615|FG006|Overall Study|Death|0|||
129128209|NCT00831844|464761616|FG007|Overall Study|Death|0|||
129128210|NCT00831844|464761617|FG008|Overall Study|Death|0|||
129128211|NCT00831844|464761618|FG009|Overall Study|Death|0|||
129128212|NCT00831844|464761609|FG000|Overall Study|Lack of Efficacy|8|||
129128213|NCT00831844|464761610|FG001|Overall Study|Lack of Efficacy|10|||
129128214|NCT00831844|464761611|FG002|Overall Study|Lack of Efficacy|15|||
129128215|NCT00831844|464761612|FG003|Overall Study|Lack of Efficacy|8|||
129128216|NCT00831844|464761613|FG004|Overall Study|Lack of Efficacy|11|||
129128217|NCT00831844|464761614|FG005|Overall Study|Lack of Efficacy|17|||
129128218|NCT00831844|464761615|FG006|Overall Study|Lack of Efficacy|8|||
129128219|NCT00831844|464761616|FG007|Overall Study|Lack of Efficacy|9|||
129128220|NCT00831844|464761617|FG008|Overall Study|Lack of Efficacy|7|||
129220123|NCT02141438|465106493|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
128964873|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
128964874|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
128964875|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
128964876|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
128964877|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
128964878|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
128964879|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
128964880|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
128964881|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
128978131|NCT00939094|464205321|FG001|Overall Study|Severe non-compliance to protocol|1|||
129128221|NCT00831844|464761618|FG009|Overall Study|Lack of Efficacy|0|||
129128222|NCT00831844|464761609|FG000|Overall Study|Physician Decision|0|||
129128223|NCT00831844|464761610|FG001|Overall Study|Physician Decision|1|||
129128224|NCT00831844|464761611|FG002|Overall Study|Physician Decision|3|||
129128225|NCT00831844|464761612|FG003|Overall Study|Physician Decision|1|||
129128226|NCT00831844|464761613|FG004|Overall Study|Physician Decision|1|||
129128227|NCT00831844|464761614|FG005|Overall Study|Physician Decision|1|||
129128228|NCT00831844|464761615|FG006|Overall Study|Physician Decision|0|||
129128229|NCT00831844|464761616|FG007|Overall Study|Physician Decision|0|||
129128230|NCT00831844|464761617|FG008|Overall Study|Physician Decision|1|||
129128231|NCT00831844|464761618|FG009|Overall Study|Physician Decision|0|||
129128232|NCT00831844|464761609|FG000|Overall Study|Withdrawal by Subject|0|||
129128233|NCT00831844|464761610|FG001|Overall Study|Withdrawal by Subject|0|||
129128234|NCT00831844|464761611|FG002|Overall Study|Withdrawal by Subject|1|||
129128235|NCT00831844|464761612|FG003|Overall Study|Withdrawal by Subject|0|||
129128236|NCT00831844|464761613|FG004|Overall Study|Withdrawal by Subject|0|||
129128237|NCT00831844|464761614|FG005|Overall Study|Withdrawal by Subject|0|||
129128238|NCT00831844|464761615|FG006|Overall Study|Withdrawal by Subject|0|||
129128239|NCT00831844|464761616|FG007|Overall Study|Withdrawal by Subject|1|||
129128240|NCT00831844|464761617|FG008|Overall Study|Withdrawal by Subject|1|||
129128241|NCT00831844|464761618|FG009|Overall Study|Withdrawal by Subject|0|||
129128242|NCT00831844|464761609|FG000|Overall Study|Ineligible|0|||
129128243|NCT00831844|464761610|FG001|Overall Study|Ineligible|1|||
129128244|NCT00831844|464761611|FG002|Overall Study|Ineligible|1|||
129128245|NCT00831844|464761612|FG003|Overall Study|Ineligible|0|||
129128246|NCT00831844|464761613|FG004|Overall Study|Ineligible|1|||
129128247|NCT00831844|464761614|FG005|Overall Study|Ineligible|0|||
129128248|NCT00831844|464761615|FG006|Overall Study|Ineligible|0|||
129128249|NCT00831844|464761616|FG007|Overall Study|Ineligible|0|||
129128250|NCT00831844|464761617|FG008|Overall Study|Ineligible|0|||
129128251|NCT00831844|464761618|FG009|Overall Study|Ineligible|0|||
129128252|NCT00843882|464761619|FG000|Step 1|Lack of Efficacy|14|||
129128253|NCT00843882|464761620|FG001|Step 1|Lack of Efficacy|10|||
129128254|NCT00843882|464761621|FG002|Step 1|Lack of Efficacy|21|||
129128255|NCT00843882|464761619|FG000|Step 1|Adverse Event|8|||
129220124|NCT04329806|465106494|FG000|Overall Study|Physician Decision|3|||
128771559|NCT01091428|463455273|FG002|Phase 2|Reason not specified|4|||
128771560|NCT01091428|463455274|FG003|Phase 2|Reason not specified|3|||
128771561|NCT01091428|463455271|FG000|Phase 2|Physician Decision|0|||
128771562|NCT01091428|463455272|FG001|Phase 2|Physician Decision|0|||
128771563|NCT01091428|463455273|FG002|Phase 2|Physician Decision|2|||
128771564|NCT01091428|463455274|FG003|Phase 2|Physician Decision|0|||
128771565|NCT03518658|463455277|FG000|Overall Study|Other|51|||
128771566|NCT03518658|463455278|FG001|Overall Study|Other|0|||
128964882|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
128964883|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
128964884|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
128964885|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
128771567|NCT02531295|463455279|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
128771568|NCT02531295|463455280|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
128771569|NCT02531295|463455281|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
128771570|NCT02531295|463455282|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
128771571|NCT02531295|463455283|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
128771572|NCT02531295|463455284|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
128771573|NCT04424290|463455286|FG000|Overall Study|Not treated|0|||
128771574|NCT04424290|463455287|FG001|Overall Study|Not treated|0|||
128771575|NCT04424290|463455288|FG002|Overall Study|Not treated|1|||
128771576|NCT04424290|463455289|FG003|Overall Study|Not treated|0|||
128771577|NCT04424290|463455290|FG004|Overall Study|Not treated|1|||
128771578|NCT04424290|463455286|FG000|Overall Study|Adverse Event|0|||
128771579|NCT04424290|463455287|FG001|Overall Study|Adverse Event|0|||
128771580|NCT04424290|463455288|FG002|Overall Study|Adverse Event|0|||
128771581|NCT04424290|463455289|FG003|Overall Study|Adverse Event|2|||
128771582|NCT04424290|463455290|FG004|Overall Study|Adverse Event|0|||
128964886|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
128964887|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
128964888|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
128964889|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
128964890|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
128771583|NCT04424290|463455286|FG000|Overall Study|Withdrawal by Subject|0|||
128771584|NCT04424290|463455287|FG001|Overall Study|Withdrawal by Subject|0|||
128964891|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
129128256|NCT00843882|464761620|FG001|Step 1|Adverse Event|17|||
129128257|NCT00843882|464761621|FG002|Step 1|Adverse Event|20|||
128771585|NCT04424290|463455288|FG002|Overall Study|Withdrawal by Subject|0|||
128771586|NCT04424290|463455289|FG003|Overall Study|Withdrawal by Subject|0|||
129128258|NCT00843882|464761619|FG000|Step 1|Death|1|||
129128259|NCT00843882|464761620|FG001|Step 1|Death|2|||
129128260|NCT00843882|464761621|FG002|Step 1|Death|4|||
129128261|NCT00843882|464761619|FG000|Step 1|Withdrawal by Subject|6|||
129128262|NCT00843882|464761620|FG001|Step 1|Withdrawal by Subject|12|||
129128263|NCT00843882|464761621|FG002|Step 1|Withdrawal by Subject|9|||
129128264|NCT00843882|464761619|FG000|Step 1|Physician Decision|0|||
129128265|NCT00843882|464761620|FG001|Step 1|Physician Decision|5|||
129128266|NCT00843882|464761621|FG002|Step 1|Physician Decision|1|||
129128267|NCT00843882|464761619|FG000|Step 1|Patient and physician's decision|0|||
129128268|NCT00843882|464761620|FG001|Step 1|Patient and physician's decision|0|||
129128269|NCT00843882|464761621|FG002|Step 1|Patient and physician's decision|1|||
129128270|NCT00843882|464761619|FG000|Step 1|Other complicating disease|1|||
129128271|NCT00843882|464761620|FG001|Step 1|Other complicating disease|3|||
129128272|NCT00843882|464761621|FG002|Step 1|Other complicating disease|4|||
128964892|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
128964893|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
128964894|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
128964895|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
128964896|NCT03185819|464157858|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
128964897|NCT03185819|464157859|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
128964898|NCT03185819|464157860|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
128964899|NCT03185819|464157861|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
128964900|NCT02438787|464157862|FG000|Overall Study|Adverse Event|1|||
128964901|NCT02438787|464157863|FG001|Overall Study|Adverse Event|0|||
128964902|NCT02438787|464157864|FG002|Overall Study|Adverse Event|2|||
128964903|NCT02438787|464157862|FG000|Overall Study|Lack of Efficacy|1|||
128964904|NCT02438787|464157863|FG001|Overall Study|Lack of Efficacy|2|||
128964905|NCT02438787|464157864|FG002|Overall Study|Lack of Efficacy|0|||
128964906|NCT02438787|464157862|FG000|Overall Study|Lost to Follow-up|0|||
129128273|NCT00843882|464761619|FG000|Step 1|Alternative therapy|0|||
129128274|NCT00843882|464761620|FG001|Step 1|Alternative therapy|1|||
129128275|NCT00843882|464761621|FG002|Step 1|Alternative therapy|1|||
129128276|NCT00843882|464761619|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
129128277|NCT00843882|464761620|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
129128278|NCT00843882|464761621|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
129128279|NCT00843882|464761619|FG000|Step 1|Off treatment reason unknown|0|||
129128280|NCT00843882|464761620|FG001|Step 1|Off treatment reason unknown|1|||
129128281|NCT00843882|464761621|FG002|Step 1|Off treatment reason unknown|4|||
129128282|NCT00843882|464761619|FG000|Step 1|Never started treatment|2|||
129128283|NCT00843882|464761620|FG001|Step 1|Never started treatment|0|||
129128284|NCT00843882|464761621|FG002|Step 1|Never started treatment|0|||
129128285|NCT00843882|464761619|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
129128286|NCT00843882|464761620|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
129128287|NCT00843882|464761621|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
129128288|NCT00843882|464761619|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
129128289|NCT00843882|464761620|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
128713425|NCT00065507|463248169|FG000|Overall Study|Adverse Event|4|||
128713426|NCT00065507|463248170|FG001|Overall Study|Adverse Event|3|||
128713427|NCT00065507|463248169|FG000|Overall Study|Lack of Efficacy|0|||
128713428|NCT00065507|463248170|FG001|Overall Study|Lack of Efficacy|6|||
128713429|NCT00065507|463248169|FG000|Overall Study|Poor/Non-compliance|3|||
128713430|NCT00065507|463248170|FG001|Overall Study|Poor/Non-compliance|2|||
128713431|NCT00065507|463248169|FG000|Overall Study|Lost to Follow-up|3|||
128713432|NCT00065507|463248170|FG001|Overall Study|Lost to Follow-up|0|||
128713433|NCT00065507|463248169|FG000|Overall Study|Subject Withdrew Consent|2|||
128713434|NCT00065507|463248170|FG001|Overall Study|Subject Withdrew Consent|1|||
128713435|NCT00065507|463248169|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
128713436|NCT00065507|463248170|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
128713437|NCT02169739|463248171|FG000|Overall Study|Lost to Follow-up|0|||
128713438|NCT02169739|463248172|FG001|Overall Study|Lost to Follow-up|4|||
128713439|NCT03635957|463248173|FG000|Run-In Period|Lost to Follow-up|1|||
128713440|NCT03635957|463248173|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
128713441|NCT00350636|463248174|FG000|Overall Study|Adverse Event|19|||
128713442|NCT00350636|463248175|FG001|Overall Study|Adverse Event|13|||
128713443|NCT00350636|463248174|FG000|Overall Study|Protocol Violation|1|||
128713444|NCT00350636|463248175|FG001|Overall Study|Protocol Violation|3|||
128713445|NCT00350636|463248174|FG000|Overall Study|Withdrawal by Subject|13|||
128713446|NCT00350636|463248175|FG001|Overall Study|Withdrawal by Subject|17|||
128713447|NCT00350636|463248174|FG000|Overall Study|Lost to Follow-up|9|||
128713448|NCT00350636|463248175|FG001|Overall Study|Lost to Follow-up|8|||
128713449|NCT00350636|463248174|FG000|Overall Study|Physician Decision|0|||
129128290|NCT00843882|464761621|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
128713450|NCT00350636|463248175|FG001|Overall Study|Physician Decision|2|||
128713451|NCT00350636|463248174|FG000|Overall Study|Other|1|||
128964907|NCT02438787|464157863|FG001|Overall Study|Lost to Follow-up|1|||
128964908|NCT02438787|464157864|FG002|Overall Study|Lost to Follow-up|0|||
128964909|NCT02438787|464157862|FG000|Overall Study|Protocol Violation|0|||
129128291|NCT00843882|464761619|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
129128292|NCT00843882|464761620|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
128713452|NCT00350636|463248175|FG001|Overall Study|Other|2|||
128713453|NCT01042236|463248180|FG000|Treatment Period 1|Adverse Event|0|||
128713454|NCT01042236|463248181|FG001|Treatment Period 1|Adverse Event|1|||
128771587|NCT04424290|463455290|FG004|Overall Study|Withdrawal by Subject|1|||
128771588|NCT04424290|463455286|FG000|Overall Study|Other than listed|0|||
128771589|NCT04424290|463455287|FG001|Overall Study|Other than listed|0|||
128771590|NCT04424290|463455288|FG002|Overall Study|Other than listed|0|||
128771591|NCT04424290|463455289|FG003|Overall Study|Other than listed|1|||
128771592|NCT04424290|463455290|FG004|Overall Study|Other than listed|0|||
128771593|NCT04249336|463455293|FG000|Overall Study|Lost to Follow-up|3|||
128771594|NCT04249336|463455294|FG001|Overall Study|Lost to Follow-up|3|||
129128293|NCT00843882|464761621|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
129128294|NCT00843882|464761619|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
129128295|NCT00843882|464761620|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
129128296|NCT00843882|464761621|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
129128297|NCT00843882|464761619|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
129128298|NCT00843882|464761620|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
128771595|NCT04249336|463455295|FG002|Overall Study|Lost to Follow-up|3|||
129128299|NCT00843882|464761621|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
129128300|NCT00843882|464761619|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
129128301|NCT00843882|464761620|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
129128302|NCT00843882|464761621|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
129128303|NCT00843882|464761619|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
129128304|NCT00843882|464761620|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
129128305|NCT00843882|464761621|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
129128306|NCT05317546|464761622|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
129128307|NCT05317546|464761623|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
129128308|NCT03331250|464761624|FG000|Overall Study|Withdrawal by Subject|1|||
129128309|NCT04590963|464761625|FG000|Overall Study|Death|118|||
129128310|NCT04590963|464761626|FG001|Overall Study|Death|59|||
129128311|NCT04590963|464761625|FG000|Overall Study|Lost to Follow-up|1|||
129128312|NCT04590963|464761626|FG001|Overall Study|Lost to Follow-up|1|||
129128313|NCT04590963|464761625|FG000|Overall Study|Progressive disease|0|||
129128314|NCT04590963|464761626|FG001|Overall Study|Progressive disease|1|||
129128315|NCT04590963|464761625|FG000|Overall Study|Study terminated by sponsor|103|||
129128316|NCT04590963|464761626|FG001|Overall Study|Study terminated by sponsor|50|||
129128317|NCT04590963|464761625|FG000|Overall Study|Withdrawal by Subject|15|||
129128318|NCT04590963|464761626|FG001|Overall Study|Withdrawal by Subject|8|||
129128319|NCT04590963|464761625|FG000|Overall Study|Ongoing at data cut-off|9|||
129128320|NCT04590963|464761626|FG001|Overall Study|Ongoing at data cut-off|4|||
129128321|NCT04590963|464761625|FG000|Overall Study|Screen failure|1|||
129128322|NCT04590963|464761626|FG001|Overall Study|Screen failure|0|||
129128323|NCT04057365|464761627|FG000|Overall Study|Withdrawal by Subject|2|||
129128324|NCT04057365|464761628|FG001|Overall Study|Withdrawal by Subject|0|||
129128325|NCT04738487|464761629|FG000|Overall Study|Participant Ongoing in Study|298|||
129128326|NCT04738487|464761630|FG001|Overall Study|Participant Ongoing in Study|297|||
129128327|NCT04738487|464761629|FG000|Overall Study|Withdrawal by Subject|7|||
129128328|NCT04738487|464761630|FG001|Overall Study|Withdrawal by Subject|9|||
129128329|NCT04738487|464761629|FG000|Overall Study|Lost to Follow-up|2|||
129128330|NCT04738487|464761630|FG001|Overall Study|Lost to Follow-up|0|||
129128331|NCT04738487|464761629|FG000|Overall Study|Death|287|||
129128332|NCT04738487|464761630|FG001|Overall Study|Death|306|||
129128333|NCT03976375|464761631|FG000|Overall Study|Death|158|||
129128334|NCT03976375|464761632|FG001|Overall Study|Death|160|||
129128335|NCT03976375|464761633|FG002|Overall Study|Death|42|||
129128336|NCT03976375|464761631|FG000|Overall Study|Lost to Follow-up|2|||
129128337|NCT03976375|464761632|FG001|Overall Study|Lost to Follow-up|1|||
129128338|NCT03976375|464761633|FG002|Overall Study|Lost to Follow-up|1|||
129128339|NCT03976375|464761631|FG000|Overall Study|Withdrawal by Subject|5|||
129128340|NCT03976375|464761632|FG001|Overall Study|Withdrawal by Subject|9|||
129128341|NCT03976375|464761633|FG002|Overall Study|Withdrawal by Subject|4|||
129128342|NCT03976375|464761631|FG000|Overall Study|Sponsor decision|20|||
129128343|NCT03976375|464761632|FG001|Overall Study|Sponsor decision|19|||
129220125|NCT04329806|465106495|FG001|Overall Study|Physician Decision|4|||
129220126|NCT02636595|465106498|FG000|Overall Study|Lost to Follow-up|1|||
129128344|NCT03976375|464761633|FG002|Overall Study|Sponsor decision|1|||
129128345|NCT01063114|464761634|FG000|Overall Study|Lost to Follow-up|1|||
129220127|NCT02636595|465106498|FG000|Overall Study|Other|1|||
129220128|NCT04730271|465106499|FG000|Overall Study|Adverse Event|0|||
128771596|NCT04249336|463455296|FG003|Overall Study|Lost to Follow-up|3|||
128771597|NCT01242176|463455297|FG000|Washout Period of 7 Days|Adverse Event|0|||
129128346|NCT05020743|464761635|FG000|Overall Study|Enrollment in Interventional Study|2|||
129128347|NCT05020743|464761636|FG001|Overall Study|Enrollment in Interventional Study|9|||
129128348|NCT05020743|464761637|FG002|Overall Study|Enrollment in Interventional Study|0|||
128771598|NCT01242176|463455298|FG001|Washout Period of 7 Days|Adverse Event|2|||
129128349|NCT05020743|464761635|FG000|Overall Study|Withdrawal by Subject|0|||
129128350|NCT05020743|464761636|FG001|Overall Study|Withdrawal by Subject|3|||
129220129|NCT04730271|465106500|FG001|Overall Study|Adverse Event|2|||
128771599|NCT01242176|463455297|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
129128351|NCT05020743|464761637|FG002|Overall Study|Withdrawal by Subject|1|||
129128352|NCT05020743|464761635|FG000|Overall Study|Lost to Follow-up|1|||
129128353|NCT05020743|464761636|FG001|Overall Study|Lost to Follow-up|0|||
129128354|NCT05020743|464761637|FG002|Overall Study|Lost to Follow-up|0|||
129128355|NCT05020743|464761635|FG000|Overall Study|Study Termination by Sponsor|10|||
129128356|NCT05020743|464761636|FG001|Overall Study|Study Termination by Sponsor|11|||
129128357|NCT05020743|464761637|FG002|Overall Study|Study Termination by Sponsor|10|||
129128358|NCT03488524|464761638|FG000|Overall Study|Withdrawal by Subject|51|||
129128359|NCT03488524|464761638|FG000|Overall Study|Death|19|||
129128360|NCT03488524|464761638|FG000|Overall Study|Study Sponsor|11|||
129128361|NCT03488524|464761638|FG000|Overall Study|Physician Decision|4|||
129128362|NCT03488524|464761638|FG000|Overall Study|Lost to Follow-up|3|||
129128363|NCT01913353|464761641|FG000|Overall Study|Adverse Event|2|||
128964910|NCT02438787|464157863|FG001|Overall Study|Protocol Violation|0|||
128964911|NCT02438787|464157864|FG002|Overall Study|Protocol Violation|1|||
128964912|NCT02438787|464157862|FG000|Overall Study|Withdrawal by Subject|15|||
128964913|NCT02438787|464157863|FG001|Overall Study|Withdrawal by Subject|7|||
128964914|NCT02438787|464157864|FG002|Overall Study|Withdrawal by Subject|10|||
128964915|NCT02438787|464157862|FG000|Overall Study|Study discontinued by sponsor|64|||
129128364|NCT01913353|464761642|FG001|Overall Study|Adverse Event|0|||
129128365|NCT01913353|464761641|FG000|Overall Study|Physician Decision|0|||
129128366|NCT01913353|464761642|FG001|Overall Study|Physician Decision|2|||
129128367|NCT01913353|464761641|FG000|Overall Study|Withdrawal by Subject|20|||
129128368|NCT01913353|464761642|FG001|Overall Study|Withdrawal by Subject|6|||
129128369|NCT01913353|464761641|FG000|Overall Study|multiple reasons|10|||
129128370|NCT01913353|464761642|FG001|Overall Study|multiple reasons|7|||
129128371|NCT04017962|464761643|FG000|Overall Study|Death|2|||
129128372|NCT04017962|464761644|FG001|Overall Study|Death|0|||
129128373|NCT04017962|464761643|FG000|Overall Study|Lost to Follow-up|2|||
129128374|NCT04017962|464761644|FG001|Overall Study|Lost to Follow-up|0|||
129128375|NCT04017962|464761643|FG000|Overall Study|Physician Decision|1|||
129128376|NCT04017962|464761644|FG001|Overall Study|Physician Decision|0|||
129128377|NCT04017962|464761643|FG000|Overall Study|Discontinued LTV|5|||
129128378|NCT04017962|464761644|FG001|Overall Study|Discontinued LTV|0|||
129128379|NCT01260948|464761652|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
129128380|NCT01260948|464761653|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
129128381|NCT01260948|464761652|FG000|Second Intervention|Emesis|0|||
129128382|NCT01260948|464761653|FG001|Second Intervention|Emesis|1|||
129128383|NCT00462462|464761654|FG000|Overall Study|Physician Decision|0|||
129128384|NCT00462462|464761655|FG001|Overall Study|Physician Decision|1|||
129128385|NCT01163617|464761656|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129128386|NCT01163617|464761657|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
129128387|NCT01163617|464761658|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129128388|NCT01163617|464761659|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129128389|NCT01163617|464761660|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129128390|NCT01163617|464761661|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129128391|NCT01163617|464761662|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129128392|NCT01163617|464761663|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129128393|NCT01163617|464761656|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129128394|NCT01163617|464761657|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
129128395|NCT01163617|464761658|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129128396|NCT01163617|464761659|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129128397|NCT01163617|464761660|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129128398|NCT01163617|464761661|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129128399|NCT01163617|464761662|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129128400|NCT01163617|464761663|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129128401|NCT01163617|464761656|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129128402|NCT01163617|464761657|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129128403|NCT01163617|464761658|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
129128404|NCT01163617|464761659|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129128405|NCT01163617|464761660|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129128406|NCT01163617|464761661|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
128771600|NCT01242176|463455298|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
128964916|NCT02438787|464157863|FG001|Overall Study|Study discontinued by sponsor|72|||
128964917|NCT02438787|464157864|FG002|Overall Study|Study discontinued by sponsor|69|||
129128407|NCT01163617|464761662|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129128408|NCT01163617|464761663|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129128409|NCT02394756|464761664|FG000|Period 1|Lens Discomfort|0|||
128771601|NCT03390036|463455299|FG000|Overall Study|Lost to Follow-up|1|||
128964918|NCT02438787|464157862|FG000|Overall Study|Other|0|||
129128410|NCT02394756|464761665|FG001|Period 1|Lens Discomfort|0|||
129128411|NCT02394756|464761666|FG002|Period 1|Lens Discomfort|0|||
129128412|NCT02394756|464761667|FG003|Period 1|Lens Discomfort|0|||
129128413|NCT02394756|464761668|FG004|Period 1|Lens Discomfort|0|||
129128414|NCT02394756|464761669|FG005|Period 1|Lens Discomfort|1|||
129128415|NCT02394756|464761664|FG000|Period 1|Withdrawal by Subject|0|||
129128416|NCT02394756|464761665|FG001|Period 1|Withdrawal by Subject|1|||
129128417|NCT02394756|464761666|FG002|Period 1|Withdrawal by Subject|1|||
129128418|NCT02394756|464761667|FG003|Period 1|Withdrawal by Subject|1|||
129128419|NCT02394756|464761668|FG004|Period 1|Withdrawal by Subject|0|||
129128420|NCT02394756|464761669|FG005|Period 1|Withdrawal by Subject|0|||
129128421|NCT02394756|464761664|FG000|Period 2|Unsatisfactory Visual Response|0|||
129128422|NCT02394756|464761665|FG001|Period 2|Unsatisfactory Visual Response|0|||
129128423|NCT02394756|464761666|FG002|Period 2|Unsatisfactory Visual Response|0|||
129128424|NCT02394756|464761667|FG003|Period 2|Unsatisfactory Visual Response|0|||
129128425|NCT02394756|464761668|FG004|Period 2|Unsatisfactory Visual Response|1|||
129128426|NCT02394756|464761669|FG005|Period 2|Unsatisfactory Visual Response|0|||
129128427|NCT02335944|464761670|FG000|Treatment Phase|Progressive Disease|2|||
129128428|NCT02335944|464761671|FG001|Treatment Phase|Progressive Disease|5|||
129128429|NCT02335944|464761672|FG002|Treatment Phase|Progressive Disease|2|||
129128430|NCT02335944|464761673|FG003|Treatment Phase|Progressive Disease|11|||
129128431|NCT02335944|464761674|FG004|Treatment Phase|Progressive Disease|4|||
129128432|NCT02335944|464761675|FG005|Treatment Phase|Progressive Disease|25|||
129128433|NCT02335944|464761676|FG006|Treatment Phase|Progressive Disease|2|||
129128434|NCT02335944|464761677|FG007|Treatment Phase|Progressive Disease|30|||
129128435|NCT02335944|464761678|FG008|Treatment Phase|Progressive Disease|27|||
129128436|NCT02335944|464761679|FG009|Treatment Phase|Progressive Disease|0|||
129128437|NCT02335944|464761670|FG000|Treatment Phase|Adverse Event|2|||
129128438|NCT02335944|464761671|FG001|Treatment Phase|Adverse Event|0|||
129128439|NCT02335944|464761672|FG002|Treatment Phase|Adverse Event|0|||
129128440|NCT02335944|464761673|FG003|Treatment Phase|Adverse Event|2|||
129128441|NCT02335944|464761674|FG004|Treatment Phase|Adverse Event|1|||
129128442|NCT02335944|464761675|FG005|Treatment Phase|Adverse Event|15|||
129128443|NCT02335944|464761676|FG006|Treatment Phase|Adverse Event|0|||
129128444|NCT02335944|464761677|FG007|Treatment Phase|Adverse Event|5|||
129128445|NCT02335944|464761678|FG008|Treatment Phase|Adverse Event|7|||
129128446|NCT02335944|464761679|FG009|Treatment Phase|Adverse Event|0|||
129128447|NCT02335944|464761670|FG000|Treatment Phase|Physician Decision|0|||
129128448|NCT02335944|464761671|FG001|Treatment Phase|Physician Decision|0|||
129128449|NCT02335944|464761672|FG002|Treatment Phase|Physician Decision|0|||
129128450|NCT02335944|464761673|FG003|Treatment Phase|Physician Decision|1|||
129128451|NCT02335944|464761674|FG004|Treatment Phase|Physician Decision|0|||
129128452|NCT02335944|464761675|FG005|Treatment Phase|Physician Decision|6|||
129128453|NCT02335944|464761676|FG006|Treatment Phase|Physician Decision|1|||
129128454|NCT02335944|464761677|FG007|Treatment Phase|Physician Decision|2|||
129128455|NCT02335944|464761678|FG008|Treatment Phase|Physician Decision|1|||
129128456|NCT02335944|464761679|FG009|Treatment Phase|Physician Decision|0|||
129128457|NCT02335944|464761670|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
129128458|NCT02335944|464761671|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
129128459|NCT02335944|464761672|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
129128460|NCT02335944|464761673|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
129128461|NCT02335944|464761674|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
129128462|NCT02335944|464761675|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
129128463|NCT02335944|464761676|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
129128464|NCT02335944|464761677|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
129128465|NCT02335944|464761678|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
129128466|NCT02335944|464761679|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
129128467|NCT02335944|464761670|FG000|Treatment Phase|Subject/Guardian Decision|0|||
129128468|NCT02335944|464761671|FG001|Treatment Phase|Subject/Guardian Decision|0|||
129128469|NCT02335944|464761672|FG002|Treatment Phase|Subject/Guardian Decision|1|||
129128470|NCT02335944|464761673|FG003|Treatment Phase|Subject/Guardian Decision|0|||
129128471|NCT02335944|464761674|FG004|Treatment Phase|Subject/Guardian Decision|0|||
129128472|NCT02335944|464761675|FG005|Treatment Phase|Subject/Guardian Decision|1|||
129128473|NCT02335944|464761676|FG006|Treatment Phase|Subject/Guardian Decision|0|||
129128474|NCT02335944|464761677|FG007|Treatment Phase|Subject/Guardian Decision|4|||
128964919|NCT02438787|464157863|FG001|Overall Study|Other|1|||
128964920|NCT02438787|464157864|FG002|Overall Study|Other|0|||
128964921|NCT02438787|464157862|FG000|Overall Study|Site terminated by sponsor|0|||
129128475|NCT02335944|464761678|FG008|Treatment Phase|Subject/Guardian Decision|0|||
129128476|NCT02335944|464761679|FG009|Treatment Phase|Subject/Guardian Decision|0|||
129128477|NCT02335944|464761670|FG000|Post-treatment Follow-up|Progressive Disease|0|||
128964922|NCT02438787|464157863|FG001|Overall Study|Site terminated by sponsor|0|||
129128478|NCT02335944|464761671|FG001|Post-treatment Follow-up|Progressive Disease|0|||
129128479|NCT02335944|464761672|FG002|Post-treatment Follow-up|Progressive Disease|0|||
129128480|NCT02335944|464761673|FG003|Post-treatment Follow-up|Progressive Disease|1|||
129128481|NCT02335944|464761674|FG004|Post-treatment Follow-up|Progressive Disease|0|||
129128482|NCT02335944|464761675|FG005|Post-treatment Follow-up|Progressive Disease|9|||
129128483|NCT02335944|464761676|FG006|Post-treatment Follow-up|Progressive Disease|0|||
129128484|NCT02335944|464761677|FG007|Post-treatment Follow-up|Progressive Disease|2|||
129128485|NCT02335944|464761678|FG008|Post-treatment Follow-up|Progressive Disease|3|||
129128486|NCT02335944|464761679|FG009|Post-treatment Follow-up|Progressive Disease|0|||
129128487|NCT02335944|464761670|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129128488|NCT02335944|464761671|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129220130|NCT04730271|465106499|FG000|Overall Study|Withdrawal by Subject|1|||
129220131|NCT04730271|465106500|FG001|Overall Study|Withdrawal by Subject|1|||
129220132|NCT04730271|465106499|FG000|Overall Study|Protocol Violation|7|||
129220133|NCT04730271|465106500|FG001|Overall Study|Protocol Violation|13|||
129220134|NCT04730271|465106499|FG000|Overall Study|Lost to Follow-up|3|||
129220135|NCT04730271|465106500|FG001|Overall Study|Lost to Follow-up|3|||
129220136|NCT04730271|465106499|FG000|Overall Study|Death|1|||
129220137|NCT04730271|465106500|FG001|Overall Study|Death|0|||
129220138|NCT05782179|465106503|FG000|Overall Study|Adverse Event|0|||
129220139|NCT05782179|465106504|FG001|Overall Study|Adverse Event|0|||
129220140|NCT05782179|465106505|FG002|Overall Study|Adverse Event|2|||
129220141|NCT05782179|465106506|FG003|Overall Study|Adverse Event|0|||
129220142|NCT05782179|465106507|FG004|Overall Study|Adverse Event|0|||
129220143|NCT05782179|465106508|FG005|Overall Study|Adverse Event|0|||
129220144|NCT03682770|465106509|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129220145|NCT03682770|465106510|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
129220146|NCT03682770|465106511|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129220147|NCT03682770|465106512|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129220148|NCT03682770|465106513|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129220149|NCT03682770|465106514|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129220150|NCT03682770|465106515|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129220151|NCT03682770|465106509|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
129220152|NCT03682770|465106510|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
129220153|NCT03682770|465106511|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129220154|NCT03682770|465106512|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129220155|NCT03682770|465106513|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129220156|NCT03682770|465106514|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129220157|NCT03682770|465106515|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129220158|NCT03682770|465106509|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129128489|NCT02335944|464761672|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128964923|NCT02438787|464157864|FG002|Overall Study|Site terminated by sponsor|1|||
128964924|NCT03375203|464157865|FG000|Overall Study|Protocol Violation|0|||
128964925|NCT03375203|464157866|FG001|Overall Study|Protocol Violation|0|||
128964926|NCT03375203|464157867|FG002|Overall Study|Protocol Violation|1|||
128964927|NCT03375203|464157868|FG003|Overall Study|Protocol Violation|0|||
128964928|NCT03375203|464157869|FG004|Overall Study|Protocol Violation|0|||
128964929|NCT03375203|464157865|FG000|Overall Study|Adverse Event|2|||
128964930|NCT03375203|464157866|FG001|Overall Study|Adverse Event|3|||
128964931|NCT03375203|464157867|FG002|Overall Study|Adverse Event|0|||
129128490|NCT02335944|464761673|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129128491|NCT02335944|464761674|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129128492|NCT02335944|464761675|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
129128493|NCT02335944|464761676|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129128494|NCT02335944|464761677|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129128495|NCT02335944|464761678|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
128713455|NCT01042236|463248182|FG002|Treatment Period 1|Adverse Event|0|||
128964932|NCT03375203|464157868|FG003|Overall Study|Adverse Event|2|||
128964933|NCT03375203|464157869|FG004|Overall Study|Adverse Event|2|||
128964934|NCT03375203|464157865|FG000|Overall Study|Withdrawal by Subject|3|||
128964935|NCT03375203|464157866|FG001|Overall Study|Withdrawal by Subject|0|||
128964936|NCT03375203|464157867|FG002|Overall Study|Withdrawal by Subject|1|||
128964937|NCT03375203|464157868|FG003|Overall Study|Withdrawal by Subject|0|||
129128496|NCT02335944|464761679|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129128497|NCT02335944|464761670|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
129128498|NCT02335944|464761671|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
128713456|NCT01042236|463248183|FG003|Treatment Period 1|Adverse Event|0|||
129128499|NCT02335944|464761672|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
128713457|NCT01042236|463248184|FG004|Treatment Period 1|Adverse Event|1|||
128713458|NCT01042236|463248185|FG005|Treatment Period 1|Adverse Event|0|||
128964938|NCT03375203|464157869|FG004|Overall Study|Withdrawal by Subject|2|||
128964939|NCT03375203|464157865|FG000|Overall Study|Non-compliance with study drug|1|||
128964940|NCT03375203|464157866|FG001|Overall Study|Non-compliance with study drug|0|||
128713459|NCT01042236|463248180|FG000|Treatment Period 3|Adverse Event|0|||
128713460|NCT01042236|463248181|FG001|Treatment Period 3|Adverse Event|0|||
128964941|NCT03375203|464157867|FG002|Overall Study|Non-compliance with study drug|0|||
129128500|NCT02335944|464761673|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
129128501|NCT02335944|464761674|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
129128502|NCT02335944|464761675|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
129128503|NCT02335944|464761676|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
129128504|NCT02335944|464761677|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
129128505|NCT02335944|464761678|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
129128506|NCT02335944|464761679|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
129128507|NCT02335944|464761670|FG000|Post-treatment Follow-up|Adverse Event|0|||
129128508|NCT02335944|464761671|FG001|Post-treatment Follow-up|Adverse Event|0|||
129128509|NCT02335944|464761672|FG002|Post-treatment Follow-up|Adverse Event|0|||
129128510|NCT02335944|464761673|FG003|Post-treatment Follow-up|Adverse Event|0|||
129128511|NCT02335944|464761674|FG004|Post-treatment Follow-up|Adverse Event|0|||
129128512|NCT02335944|464761675|FG005|Post-treatment Follow-up|Adverse Event|1|||
129128513|NCT02335944|464761676|FG006|Post-treatment Follow-up|Adverse Event|0|||
129128514|NCT02335944|464761677|FG007|Post-treatment Follow-up|Adverse Event|0|||
129128515|NCT02335944|464761678|FG008|Post-treatment Follow-up|Adverse Event|0|||
129128516|NCT02335944|464761679|FG009|Post-treatment Follow-up|Adverse Event|0|||
129128517|NCT02335944|464761670|FG000|Post-treatment Follow-up|Death|0|||
129128518|NCT02335944|464761671|FG001|Post-treatment Follow-up|Death|0|||
129128519|NCT02335944|464761672|FG002|Post-treatment Follow-up|Death|0|||
129128520|NCT02335944|464761673|FG003|Post-treatment Follow-up|Death|1|||
129128521|NCT02335944|464761674|FG004|Post-treatment Follow-up|Death|0|||
129128522|NCT02335944|464761675|FG005|Post-treatment Follow-up|Death|1|||
129128523|NCT02335944|464761676|FG006|Post-treatment Follow-up|Death|0|||
129128524|NCT02335944|464761677|FG007|Post-treatment Follow-up|Death|0|||
129128525|NCT02335944|464761678|FG008|Post-treatment Follow-up|Death|0|||
129128526|NCT02335944|464761679|FG009|Post-treatment Follow-up|Death|0|||
129128527|NCT02335944|464761670|FG000|Post-treatment Follow-up|Physician Decision|1|||
129128528|NCT02335944|464761671|FG001|Post-treatment Follow-up|Physician Decision|0|||
129128529|NCT02335944|464761672|FG002|Post-treatment Follow-up|Physician Decision|0|||
129128530|NCT02335944|464761673|FG003|Post-treatment Follow-up|Physician Decision|0|||
129128531|NCT02335944|464761674|FG004|Post-treatment Follow-up|Physician Decision|0|||
129128532|NCT02335944|464761675|FG005|Post-treatment Follow-up|Physician Decision|0|||
129128533|NCT02335944|464761676|FG006|Post-treatment Follow-up|Physician Decision|0|||
129128534|NCT02335944|464761677|FG007|Post-treatment Follow-up|Physician Decision|1|||
129128535|NCT02335944|464761678|FG008|Post-treatment Follow-up|Physician Decision|0|||
129128536|NCT02335944|464761679|FG009|Post-treatment Follow-up|Physician Decision|0|||
129128537|NCT00832975|464761680|FG000|Overall Study|Lost to Follow-up|7|||
129128538|NCT00832975|464761680|FG000|Overall Study|Protocol Violation|6|||
129128539|NCT00832975|464761680|FG000|Overall Study|Death|5|||
129128540|NCT00832975|464761680|FG000|Overall Study|Physician Decision|4|||
129128541|NCT00832975|464761680|FG000|Overall Study|Withdrawal by Subject|3|||
129128542|NCT00832975|464761680|FG000|Overall Study|Other reasons|14|||
129128543|NCT02811159|464761681|FG000|Treatment Course 1|Lost to Follow-up|1|||
129128544|NCT01371981|464761682|FG000|Overall Study|Adverse Event|12|||
129128545|NCT01371981|464761683|FG001|Overall Study|Adverse Event|17|||
129128546|NCT01371981|464761684|FG002|Overall Study|Adverse Event|0|||
129128547|NCT01371981|464761685|FG003|Overall Study|Adverse Event|4|||
129128548|NCT01371981|464761686|FG004|Overall Study|Adverse Event|1|||
129128549|NCT01371981|464761687|FG005|Overall Study|Adverse Event|0|||
129128550|NCT01371981|464761682|FG000|Overall Study|Death|22|||
129128551|NCT01371981|464761683|FG001|Overall Study|Death|16|||
129128552|NCT01371981|464761684|FG002|Overall Study|Death|0|||
129128553|NCT01371981|464761685|FG003|Overall Study|Death|0|||
129128554|NCT01371981|464761686|FG004|Overall Study|Death|2|||
129128555|NCT01371981|464761687|FG005|Overall Study|Death|2|||
129128556|NCT01371981|464761682|FG000|Overall Study|Lack of Efficacy|69|||
129128557|NCT01371981|464761683|FG001|Overall Study|Lack of Efficacy|61|||
129128558|NCT01371981|464761684|FG002|Overall Study|Lack of Efficacy|4|||
129128559|NCT01371981|464761685|FG003|Overall Study|Lack of Efficacy|8|||
129128560|NCT01371981|464761686|FG004|Overall Study|Lack of Efficacy|5|||
129128561|NCT01371981|464761687|FG005|Overall Study|Lack of Efficacy|0|||
129128562|NCT01371981|464761682|FG000|Overall Study|Physician Decision|48|||
129128563|NCT01371981|464761683|FG001|Overall Study|Physician Decision|63|||
129128564|NCT01371981|464761684|FG002|Overall Study|Physician Decision|1|||
129128565|NCT01371981|464761685|FG003|Overall Study|Physician Decision|7|||
129128566|NCT01371981|464761686|FG004|Overall Study|Physician Decision|14|||
129128567|NCT01371981|464761687|FG005|Overall Study|Physician Decision|3|||
129128568|NCT01371981|464761682|FG000|Overall Study|Withdrawal by Subject|12|||
129128569|NCT01371981|464761683|FG001|Overall Study|Withdrawal by Subject|19|||
129128570|NCT01371981|464761684|FG002|Overall Study|Withdrawal by Subject|1|||
129128571|NCT01371981|464761685|FG003|Overall Study|Withdrawal by Subject|2|||
129128572|NCT01371981|464761686|FG004|Overall Study|Withdrawal by Subject|10|||
129128573|NCT01371981|464761687|FG005|Overall Study|Withdrawal by Subject|3|||
129128574|NCT01371981|464761682|FG000|Overall Study|Ineligible|19|||
129128575|NCT01371981|464761683|FG001|Overall Study|Ineligible|13|||
129128576|NCT01371981|464761684|FG002|Overall Study|Ineligible|0|||
128771602|NCT03390036|463455300|FG001|Overall Study|Lost to Follow-up|0|||
129037458|NCT02744755|464427997|FG000|Study Period 2|Adverse Event|5|||
129037459|NCT02744755|464427998|FG001|Study Period 2|Adverse Event|0|||
129037460|NCT02744755|464427997|FG000|Study Period 2|Protocol Violation|1|||
129037461|NCT02744755|464427998|FG001|Study Period 2|Protocol Violation|0|||
129037462|NCT02744755|464427997|FG000|Study Period 2|not defined|3|||
129037463|NCT02744755|464427998|FG001|Study Period 2|not defined|2|||
129037464|NCT02744755|464427997|FG000|Study Period 2|Lost to Follow-up|0|||
129037465|NCT02744755|464427998|FG001|Study Period 2|Lost to Follow-up|2|||
129037466|NCT02744755|464427997|FG000|Study Period 2|Withdrawal by Subject|2|||
129037467|NCT02744755|464427998|FG001|Study Period 2|Withdrawal by Subject|2|||
129037468|NCT02744755|464427997|FG000|Study Period 2|Lack of Efficacy|3|||
129037469|NCT02744755|464427998|FG001|Study Period 2|Lack of Efficacy|2|||
129037470|NCT01280617|464428001|FG000|Overall Study|Adverse Event|0|||
129037471|NCT01280617|464428002|FG001|Overall Study|Adverse Event|1|||
129037472|NCT02001051|464428003|FG000|Overall Study|Deemed not eligible following enrollment|0|||
129037473|NCT02001051|464428004|FG001|Overall Study|Deemed not eligible following enrollment|1|||
129037474|NCT00529217|464428007|FG000|Overall Study|Lack of Efficacy|2|||
129037475|NCT00529217|464428007|FG000|Overall Study|Unable to adhere to study schedule|2|||
129037476|NCT01999894|464428008|FG000|Overall Study|Adverse Event|9|||
129037477|NCT01999894|464428008|FG000|Overall Study|Lack of Efficacy|5|||
129037478|NCT01999894|464428008|FG000|Overall Study|Protocol Violation|1|||
129037479|NCT01999894|464428008|FG000|Overall Study|Withdrawal by Subject|7|||
129037480|NCT01999894|464428008|FG000|Overall Study|Lost to Follow-up|10|||
129037481|NCT01999894|464428008|FG000|Overall Study|Other Reason|3|||
129037482|NCT01999894|464428008|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
129037483|NCT01098110|464428009|FG000|Overall Study|Withdrawal by Subject|14|||
129037484|NCT01098110|464428010|FG001|Overall Study|Withdrawal by Subject|24|||
129037485|NCT01098110|464428011|FG002|Overall Study|Withdrawal by Subject|19|||
129037486|NCT01098110|464428009|FG000|Overall Study|Adverse Event|30|||
129037487|NCT01098110|464428010|FG001|Overall Study|Adverse Event|32|||
129037488|NCT01098110|464428011|FG002|Overall Study|Adverse Event|43|||
129037489|NCT01098110|464428009|FG000|Overall Study|Lack of Efficacy|13|||
129037490|NCT01098110|464428010|FG001|Overall Study|Lack of Efficacy|9|||
129037491|NCT01098110|464428011|FG002|Overall Study|Lack of Efficacy|27|||
129037492|NCT01098110|464428009|FG000|Overall Study|Other|4|||
129037493|NCT01098110|464428010|FG001|Overall Study|Other|7|||
129037494|NCT01098110|464428011|FG002|Overall Study|Other|5|||
129037495|NCT01098110|464428009|FG000|Overall Study|Untreated|1|||
129037496|NCT01098110|464428010|FG001|Overall Study|Untreated|1|||
129037497|NCT01098110|464428011|FG002|Overall Study|Untreated|0|||
129037498|NCT02147587|464428012|FG000|Overall Study|Adverse Event|9|||
129037499|NCT02147587|464428013|FG001|Overall Study|Adverse Event|4|||
129037500|NCT02147587|464428012|FG000|Overall Study|Lack of Efficacy|2|||
129037501|NCT02147587|464428013|FG001|Overall Study|Lack of Efficacy|1|||
129037502|NCT00530348|464428016|FG000|Overall Study|Adverse Event|5|||
129037503|NCT00530348|464428017|FG001|Overall Study|Adverse Event|1|||
129037504|NCT00530348|464428016|FG000|Overall Study|Death|0|||
129037505|NCT00530348|464428017|FG001|Overall Study|Death|1|||
129037506|NCT00530348|464428016|FG000|Overall Study|Lack of Efficacy|2|||
129037507|NCT00530348|464428017|FG001|Overall Study|Lack of Efficacy|0|||
129037508|NCT00530348|464428016|FG000|Overall Study|Lost to Follow-up|0|||
129037509|NCT00530348|464428017|FG001|Overall Study|Lost to Follow-up|2|||
129037510|NCT00530348|464428016|FG000|Overall Study|Physician Decision|1|||
129037511|NCT00530348|464428017|FG001|Overall Study|Physician Decision|2|||
129037512|NCT00530348|464428016|FG000|Overall Study|Pregnancy|1|||
129037513|NCT00530348|464428017|FG001|Overall Study|Pregnancy|0|||
129037514|NCT00530348|464428016|FG000|Overall Study|Withdrawal by Subject|12|||
129037515|NCT00530348|464428017|FG001|Overall Study|Withdrawal by Subject|12|||
129037516|NCT00530348|464428016|FG000|Overall Study|Randomised in error|1|||
129037517|NCT00530348|464428017|FG001|Overall Study|Randomised in error|0|||
129037518|NCT00530348|464428016|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
129037519|NCT00530348|464428017|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
129037520|NCT04364763|464428018|FG000|Overall Study|Death|1|||
129037521|NCT04364763|464428019|FG001|Overall Study|Death|2|||
129037522|NCT04364763|464428018|FG000|Overall Study|Lost to Follow-up|1|||
129037523|NCT04364763|464428019|FG001|Overall Study|Lost to Follow-up|0|||
129037524|NCT02359864|464428020|FG000|Overall Study|Withdrawal by Subject|1|||
129037525|NCT02359864|464428021|FG001|Overall Study|Withdrawal by Subject|0|||
129037526|NCT01740791|464428022|FG000|Overall Study|Randomized but never treated|5|||
129037527|NCT01740791|464428023|FG001|Overall Study|Randomized but never treated|3|||
129037528|NCT01740791|464428024|FG002|Overall Study|Randomized but never treated|2|||
129037529|NCT01740791|464428025|FG003|Overall Study|Randomized but never treated|2|||
129037530|NCT01740791|464428026|FG004|Overall Study|Randomized but never treated|1|||
129037531|NCT01740791|464428027|FG005|Overall Study|Randomized but never treated|3|||
129037532|NCT01740791|464428022|FG000|Overall Study|Lost to Follow-up|2|||
129037533|NCT01740791|464428023|FG001|Overall Study|Lost to Follow-up|0|||
129037534|NCT01740791|464428024|FG002|Overall Study|Lost to Follow-up|2|||
129037535|NCT01740791|464428025|FG003|Overall Study|Lost to Follow-up|3|||
129128577|NCT01371981|464761685|FG003|Overall Study|Ineligible|0|||
129128578|NCT01371981|464761686|FG004|Overall Study|Ineligible|0|||
129128579|NCT01371981|464761687|FG005|Overall Study|Ineligible|4|||
129128580|NCT01371981|464761682|FG000|Overall Study|Did not start treatment|2|||
129128581|NCT01371981|464761683|FG001|Overall Study|Did not start treatment|3|||
129128582|NCT01371981|464761684|FG002|Overall Study|Did not start treatment|0|||
129128583|NCT01371981|464761685|FG003|Overall Study|Did not start treatment|0|||
129128584|NCT01371981|464761686|FG004|Overall Study|Did not start treatment|0|||
128964942|NCT03375203|464157868|FG003|Overall Study|Non-compliance with study drug|0|||
128964943|NCT03375203|464157869|FG004|Overall Study|Non-compliance with study drug|0|||
128964944|NCT03375203|464157865|FG000|Overall Study|Randomized, not treated.|0|||
128964945|NCT03375203|464157866|FG001|Overall Study|Randomized, not treated.|1|||
128964946|NCT03375203|464157867|FG002|Overall Study|Randomized, not treated.|0|||
128964947|NCT03375203|464157868|FG003|Overall Study|Randomized, not treated.|0|||
128964948|NCT03375203|464157869|FG004|Overall Study|Randomized, not treated.|0|||
128964949|NCT03321526|464157870|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
128964950|NCT03321526|464157871|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
128964951|NCT03321526|464157870|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
128964952|NCT03321526|464157871|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
128964953|NCT03321526|464157870|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
128964954|NCT03321526|464157871|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
128964955|NCT03321526|464157870|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
128964956|NCT03321526|464157871|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
128964957|NCT03321526|464157870|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
128964958|NCT03321526|464157871|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
128964959|NCT03321526|464157870|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
128964960|NCT03321526|464157871|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
128964961|NCT03321526|464157870|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
128964962|NCT03321526|464157871|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
128964963|NCT03321526|464157870|FG000|Follow-up Phase (2 Weeks)|Other|24|||
128964964|NCT03321526|464157871|FG001|Follow-up Phase (2 Weeks)|Other|24|||
128964965|NCT00732641|464157875|FG000|Overall Study|Relapse or Progressive Disease|65|||
129128585|NCT01371981|464761687|FG005|Overall Study|Did not start treatment|2|||
129128586|NCT05253807|464761688|FG000|Overall Study|Death|1|||
129128587|NCT05253807|464761689|FG001|Overall Study|Death|4|||
129128588|NCT05253807|464761688|FG000|Overall Study|Withdrawal by Subject|1|||
129128589|NCT05253807|464761689|FG001|Overall Study|Withdrawal by Subject|0|||
129128590|NCT05253807|464761688|FG000|Overall Study|Study Terminated by Sponsor|1|||
129128591|NCT05253807|464761689|FG001|Overall Study|Study Terminated by Sponsor|1|||
129128592|NCT04611126|464761690|FG000|Overall Study|TIL expansion unsuccessful|1|||
129128593|NCT04611126|464761691|FG001|Overall Study|TIL expansion unsuccessful|0|||
129128594|NCT03459846|464761696|FG000|Overall Study|Death|52|||
129128595|NCT03459846|464761697|FG001|Overall Study|Death|46|||
129128596|NCT03459846|464761696|FG000|Overall Study|Study terminated by sponsor|24|||
129128597|NCT03459846|464761697|FG001|Overall Study|Study terminated by sponsor|28|||
129128598|NCT03459846|464761696|FG000|Overall Study|Withdrawal by Subject|2|||
129128599|NCT03459846|464761697|FG001|Overall Study|Withdrawal by Subject|2|||
129128600|NCT05578872|464761702|FG000|Overall Study|Withdrawal by Subject|2|||
129128601|NCT05578872|464761703|FG001|Overall Study|Withdrawal by Subject|1|||
129128602|NCT05578872|464761702|FG000|Overall Study|Adverse Event|1|||
129128603|NCT05578872|464761703|FG001|Overall Study|Adverse Event|1|||
129128604|NCT05578872|464761702|FG000|Overall Study|Physician Decision|1|||
129128605|NCT05578872|464761703|FG001|Overall Study|Physician Decision|2|||
129128606|NCT05578872|464761702|FG000|Overall Study|Progressive disease|10|||
129128607|NCT05578872|464761703|FG001|Overall Study|Progressive disease|9|||
129128608|NCT05578872|464761702|FG000|Overall Study|Sponsor decision|0|||
129128609|NCT05578872|464761703|FG001|Overall Study|Sponsor decision|1|||
128771603|NCT03390036|463455301|FG002|Overall Study|Lost to Follow-up|0|||
128771604|NCT03390036|463455299|FG000|Overall Study|Lack of Efficacy|1|||
128964966|NCT00732641|464157876|FG001|Overall Study|Relapse or Progressive Disease|101|||
128964967|NCT00732641|464157875|FG000|Overall Study|Serious Adverse Events|12|||
128964968|NCT00732641|464157876|FG001|Overall Study|Serious Adverse Events|3|||
128964969|NCT00732641|464157875|FG000|Overall Study|Physician Decision|6|||
128964970|NCT00732641|464157876|FG001|Overall Study|Physician Decision|0|||
128964971|NCT00732641|464157875|FG000|Overall Study|Withdrawal by Subject|4|||
129128610|NCT05578872|464761702|FG000|Overall Study|Toxicity and Patient's decision|0|||
129128611|NCT05578872|464761703|FG001|Overall Study|Toxicity and Patient's decision|1|||
129128612|NCT05556057|464762297|FG000|Overall Study|Lost to Follow-up|5|||
129128613|NCT05556057|464762298|FG001|Overall Study|Lost to Follow-up|4|||
129128614|NCT05556057|464762297|FG000|Overall Study|Withdrawal by Subject|0|||
129128615|NCT05556057|464762298|FG001|Overall Study|Withdrawal by Subject|2|||
129128616|NCT02466971|464762302|FG000|Overall Study|eligible and never treated|14|||
129128617|NCT02466971|464762303|FG001|Overall Study|eligible and never treated|20|||
129128618|NCT02466971|464762302|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
129128619|NCT02466971|464762303|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
129128620|NCT02466971|464762302|FG000|Overall Study|ineligible and treated|1|||
129128621|NCT02466971|464762303|FG001|Overall Study|ineligible and treated|0|||
129128622|NCT02466971|464762302|FG000|Overall Study|ineligible and never treated|0|||
129128623|NCT02466971|464762303|FG001|Overall Study|ineligible and never treated|1|||
129128624|NCT04818112|464762308|FG000|Overall Study|Withdrawal by Subject|54|||
129128625|NCT04818112|464762309|FG001|Overall Study|Withdrawal by Subject|12|||
129128626|NCT04818112|464762308|FG000|Overall Study|Lost to Follow-up|38|||
129128627|NCT04818112|464762309|FG001|Overall Study|Lost to Follow-up|10|||
129128628|NCT06187909|464762310|FG000|Overall Study|Withdrawal by Subject|2|||
129128629|NCT06187909|464762311|FG001|Overall Study|Withdrawal by Subject|2|||
129128630|NCT04603066|464762312|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
129128631|NCT04603066|464762313|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
129128632|NCT02406612|464762314|FG000|Overall Study|Screening Failure|3|||
129128633|NCT02406612|464762315|FG001|Overall Study|Screening Failure|0|||
129128634|NCT02406612|464762314|FG000|Overall Study|Intra-procedural Exclusion|1|||
129128635|NCT02406612|464762315|FG001|Overall Study|Intra-procedural Exclusion|3|||
129128636|NCT02406612|464762314|FG000|Overall Study|Guidewire Failure|0|||
129128637|NCT02406612|464762315|FG001|Overall Study|Guidewire Failure|1|||
129128638|NCT00632359|464762322|FG000|Overall Study|Withdrawal by Subject|2|||
129128639|NCT06717399|464762323|FG000|Overall Study|Death|1|||
129128640|NCT05763875|464762328|FG000|Overall Study|Subject decision|5|||
129128641|NCT05763875|464762329|FG001|Overall Study|Subject decision|2|||
129128642|NCT05763875|464762330|FG002|Overall Study|Subject decision|1|||
129128643|NCT05763875|464762328|FG000|Overall Study|Lost to Follow-up|4|||
129128644|NCT05763875|464762329|FG001|Overall Study|Lost to Follow-up|1|||
129128645|NCT05763875|464762330|FG002|Overall Study|Lost to Follow-up|2|||
129128646|NCT05763875|464762328|FG000|Overall Study|Adverse Event|1|||
129128647|NCT05763875|464762329|FG001|Overall Study|Adverse Event|0|||
129128648|NCT05763875|464762330|FG002|Overall Study|Adverse Event|0|||
129128649|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
129128650|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
129128651|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
129128652|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
129128653|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
129128654|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
129128655|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
129128656|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
129128657|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
129128658|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
129128659|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
129128660|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
129128661|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
129128662|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
128964972|NCT00732641|464157876|FG001|Overall Study|Withdrawal by Subject|2|||
128964973|NCT00732641|464157875|FG000|Overall Study|Unable to Complete|1|||
128964974|NCT00732641|464157876|FG001|Overall Study|Unable to Complete|1|||
128964975|NCT00732641|464157875|FG000|Overall Study|Other|18|||
128964976|NCT00732641|464157876|FG001|Overall Study|Other|5|||
128964977|NCT00732238|464157877|FG000|Overall Study|Bacteremia|4|||
128964978|NCT00732238|464157878|FG001|Overall Study|Bacteremia|1|||
128964979|NCT00732238|464157877|FG000|Overall Study|Asymptomatic bacteriuria|1|||
128964980|NCT00732238|464157878|FG001|Overall Study|Asymptomatic bacteriuria|0|||
128964981|NCT02280096|464157879|FG000|Overall Study|Pregnancy|1|||
128964982|NCT02280096|464157880|FG001|Overall Study|Pregnancy|0|||
128964983|NCT02280096|464157879|FG000|Overall Study|Functional neurological disorder|1|||
128964984|NCT02280096|464157880|FG001|Overall Study|Functional neurological disorder|0|||
128964985|NCT02280096|464157879|FG000|Overall Study|Lack of attachment|0|||
128964986|NCT02280096|464157880|FG001|Overall Study|Lack of attachment|1|||
128964987|NCT02939976|464157883|FG000|Overall Study|Lost to Follow-up|7|||
128964988|NCT02939976|464157884|FG001|Overall Study|Lost to Follow-up|1|||
128964989|NCT02939976|464157885|FG002|Overall Study|Lost to Follow-up|1|||
128964990|NCT02939976|464157886|FG003|Overall Study|Lost to Follow-up|2|||
128964991|NCT02939976|464157883|FG000|Overall Study|Withdrawal by Subject|4|||
128964992|NCT02939976|464157884|FG001|Overall Study|Withdrawal by Subject|0|||
128964993|NCT02939976|464157885|FG002|Overall Study|Withdrawal by Subject|2|||
128964994|NCT02939976|464157886|FG003|Overall Study|Withdrawal by Subject|4|||
128964995|NCT02939976|464157883|FG000|Overall Study|Due to early study closure|4|||
128964996|NCT02939976|464157884|FG001|Overall Study|Due to early study closure|3|||
128964997|NCT02939976|464157885|FG002|Overall Study|Due to early study closure|2|||
128964998|NCT02939976|464157886|FG003|Overall Study|Due to early study closure|3|||
128964999|NCT00246376|464157887|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
128965000|NCT00246376|464157888|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
128965001|NCT00246376|464157889|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
129128663|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
129128664|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
129128665|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
129128666|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
129128667|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
129128668|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
129128669|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
129128670|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
129128671|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
129128672|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
129128673|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
129128674|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
129128675|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
129128676|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
129128677|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
129128678|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
129128679|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
129128680|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
129128681|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
129128682|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
129128683|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
129128684|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
129128685|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
129128686|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
129128687|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
129128688|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
129128689|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
129128690|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
129128691|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
129128692|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
129128693|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
129128694|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
129128695|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
129128696|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
129128697|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
129128698|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
129128699|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
129128700|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
129128701|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
129128702|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
129128703|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
129128704|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
129128705|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
129128706|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
129128707|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
129128708|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
129128709|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
129128710|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
129128711|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
129128712|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
129128713|NCT00217737|464762331|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
129128714|NCT00217737|464762332|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
129128715|NCT00217737|464762333|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
129128716|NCT00217737|464762334|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
129128717|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
129128718|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
129128719|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
129128720|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
129128721|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
129128722|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
129128723|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
129128724|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
129128725|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Study suspension|0|||
129128726|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Study suspension|45|||
129128727|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Study suspension|0|||
129128728|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Study suspension|0|||
129128729|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
129128730|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
129128731|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
129128732|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
129128733|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Death|2|||
129128734|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Death|3|||
129128735|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Death|0|||
129128736|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Death|0|||
129128737|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
129128738|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
129128739|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
129128740|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
129128741|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
129128742|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
129128743|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
129128744|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
129128745|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
129128746|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
129128747|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
129128748|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
129128749|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
129128750|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
129128751|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
129128752|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
129128753|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
129128754|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
129128755|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
129128756|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
129128757|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
129128758|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
129128759|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
129128760|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
129128761|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
129128762|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
129128763|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
129128764|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
129128765|NCT00217737|464762331|FG000|Step 2 Randomization/Registration|Other|1|||
129128766|NCT00217737|464762332|FG001|Step 2 Randomization/Registration|Other|2|||
129128767|NCT00217737|464762333|FG002|Step 2 Randomization/Registration|Other|0|||
129128768|NCT00217737|464762334|FG003|Step 2 Randomization/Registration|Other|0|||
129128769|NCT02145390|464762335|FG000|Overall Study|Withdrawal by Subject|1|||
129128770|NCT01732783|464763265|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
129128771|NCT01732783|464763266|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
129128772|NCT01732783|464763267|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
129128773|NCT01732783|464763265|FG000|Overall Study|Death|13|||
129128774|NCT01732783|464763266|FG001|Overall Study|Death|4|||
129128775|NCT01732783|464763267|FG002|Overall Study|Death|1|||
129128776|NCT01732783|464763265|FG000|Overall Study|Lost to Follow-up|7|||
129128777|NCT01732783|464763266|FG001|Overall Study|Lost to Follow-up|1|||
129128778|NCT01732783|464763267|FG002|Overall Study|Lost to Follow-up|1|||
129128779|NCT01732783|464763265|FG000|Overall Study|Administrative Decision|8|||
129128780|NCT01732783|464763266|FG001|Overall Study|Administrative Decision|2|||
129128781|NCT01732783|464763267|FG002|Overall Study|Administrative Decision|1|||
128965002|NCT00246376|464157890|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
129128782|NCT01732783|464763265|FG000|Overall Study|Withdrawal by Subject|1|||
129128783|NCT01732783|464763266|FG001|Overall Study|Withdrawal by Subject|0|||
129128784|NCT01732783|464763267|FG002|Overall Study|Withdrawal by Subject|0|||
129128785|NCT03506477|464763268|FG000|Overall Study|Withdrawal by Subject|1|||
128713461|NCT01042236|463248182|FG002|Treatment Period 3|Adverse Event|0|||
128713462|NCT01042236|463248183|FG003|Treatment Period 3|Adverse Event|1|||
128713463|NCT01042236|463248184|FG004|Treatment Period 3|Adverse Event|0|||
128713464|NCT01042236|463248185|FG005|Treatment Period 3|Adverse Event|0|||
128713465|NCT01042236|463248180|FG000|Treatment Period 3|Protocol Violation|0|||
128713466|NCT01042236|463248181|FG001|Treatment Period 3|Protocol Violation|0|||
128713467|NCT01042236|463248182|FG002|Treatment Period 3|Protocol Violation|0|||
128713468|NCT01042236|463248183|FG003|Treatment Period 3|Protocol Violation|1|||
128713469|NCT01042236|463248184|FG004|Treatment Period 3|Protocol Violation|0|||
129128786|NCT03506477|464763269|FG001|Overall Study|Withdrawal by Subject|0|||
129128787|NCT02717611|464763270|FG000|Overall Study|Death|13|||
129128788|NCT02717611|464763270|FG000|Overall Study|Withdrawal by Subject|6|||
129128789|NCT02717611|464763270|FG000|Overall Study|Active, not recruiting|40|||
129128790|NCT02717611|464763270|FG000|Overall Study|Complicating disease|1|||
129128791|NCT00325416|464763271|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
129128792|NCT00325416|464763272|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
129128793|NCT00325416|464763271|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
129128794|NCT00325416|464763272|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
129128795|NCT00325416|464763271|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
129128796|NCT00325416|464763272|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
129128797|NCT00325416|464763271|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
129128798|NCT00325416|464763272|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
129128799|NCT00325416|464763271|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
129128800|NCT00325416|464763272|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
129128801|NCT00325416|464763271|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
129128802|NCT00325416|464763272|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
129128803|NCT04589650|464763273|FG000|Overall Study|Subject decision|6|||
129128804|NCT04589650|464763274|FG001|Overall Study|Subject decision|2|||
129128805|NCT04589650|464763275|FG002|Overall Study|Subject decision|2|||
129128806|NCT04589650|464763276|FG003|Overall Study|Subject decision|0|||
129128807|NCT04589650|464763277|FG004|Overall Study|Subject decision|0|||
129128808|NCT04589650|464763278|FG005|Overall Study|Subject decision|0|||
129128809|NCT04589650|464763273|FG000|Overall Study|Adverse Event|3|||
129128810|NCT04589650|464763274|FG001|Overall Study|Adverse Event|1|||
129128811|NCT04589650|464763275|FG002|Overall Study|Adverse Event|1|||
129128812|NCT04589650|464763276|FG003|Overall Study|Adverse Event|1|||
129128813|NCT04589650|464763277|FG004|Overall Study|Adverse Event|0|||
129128814|NCT04589650|464763278|FG005|Overall Study|Adverse Event|1|||
129128815|NCT04589650|464763273|FG000|Overall Study|Physician Decision|1|||
129128816|NCT04589650|464763274|FG001|Overall Study|Physician Decision|1|||
129128817|NCT04589650|464763275|FG002|Overall Study|Physician Decision|0|||
129128818|NCT04589650|464763276|FG003|Overall Study|Physician Decision|0|||
129128819|NCT04589650|464763277|FG004|Overall Study|Physician Decision|0|||
129128820|NCT04589650|464763278|FG005|Overall Study|Physician Decision|0|||
129128821|NCT04589650|464763273|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129128822|NCT04589650|464763274|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129128823|NCT04589650|464763275|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129128824|NCT04589650|464763276|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129128825|NCT04589650|464763277|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
129128826|NCT04589650|464763278|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
129128827|NCT04589650|464763273|FG000|Overall Study|Death|0|||
129128828|NCT04589650|464763274|FG001|Overall Study|Death|0|||
129128829|NCT04589650|464763275|FG002|Overall Study|Death|0|||
129128830|NCT04589650|464763276|FG003|Overall Study|Death|1|||
129128831|NCT04589650|464763277|FG004|Overall Study|Death|0|||
129128832|NCT04589650|464763278|FG005|Overall Study|Death|0|||
129128833|NCT04589650|464763273|FG000|Overall Study|Guardian Decision|0|||
129128834|NCT04589650|464763274|FG001|Overall Study|Guardian Decision|0|||
129128835|NCT04589650|464763275|FG002|Overall Study|Guardian Decision|0|||
129128836|NCT04589650|464763276|FG003|Overall Study|Guardian Decision|1|||
129128837|NCT04589650|464763277|FG004|Overall Study|Guardian Decision|0|||
129128838|NCT04589650|464763278|FG005|Overall Study|Guardian Decision|0|||
129128839|NCT02324153|464763279|FG000|Overall Study|Withdrawal by Subject|4|||
129128840|NCT02324153|464763280|FG001|Overall Study|Withdrawal by Subject|1|||
129128841|NCT02324153|464763279|FG000|Overall Study|Surgery postponed after randomization|3|||
129128842|NCT02324153|464763280|FG001|Overall Study|Surgery postponed after randomization|0|||
128771605|NCT03390036|463455300|FG001|Overall Study|Lack of Efficacy|0|||
129128843|NCT02324153|464763279|FG000|Overall Study|Developed delirium preoperatively|1|||
129128844|NCT02324153|464763280|FG001|Overall Study|Developed delirium preoperatively|0|||
129128845|NCT03122106|464763283|FG000|Overall Study|Not enough tissue|1|||
129128846|NCT03122106|464763283|FG000|Overall Study|Disease progression during screening|2|||
129128847|NCT03122106|464763283|FG000|Overall Study|Poor RNA quality for vaccine|1|||
129128848|NCT01147458|464763286|FG000|First Intervention|Study terminated by sponsor|8|||
129128849|NCT01147458|464763287|FG001|First Intervention|Study terminated by sponsor|8|||
129128850|NCT01147458|464763288|FG002|First Intervention|Study terminated by sponsor|7|||
129128851|NCT01147458|464763289|FG003|First Intervention|Study terminated by sponsor|8|||
129128852|NCT01147458|464763286|FG000|First Intervention|Protocol Violation|2|||
129128853|NCT01147458|464763287|FG001|First Intervention|Protocol Violation|3|||
129128854|NCT01147458|464763288|FG002|First Intervention|Protocol Violation|2|||
129128855|NCT01147458|464763289|FG003|First Intervention|Protocol Violation|3|||
129128856|NCT01147458|464763286|FG000|First Intervention|Withdrawal by Subject|3|||
129128857|NCT01147458|464763287|FG001|First Intervention|Withdrawal by Subject|0|||
129128858|NCT01147458|464763288|FG002|First Intervention|Withdrawal by Subject|1|||
129128859|NCT01147458|464763289|FG003|First Intervention|Withdrawal by Subject|0|||
129128860|NCT01147458|464763286|FG000|First Intervention|Adverse Event|0|||
129128861|NCT01147458|464763287|FG001|First Intervention|Adverse Event|3|||
129128862|NCT01147458|464763288|FG002|First Intervention|Adverse Event|2|||
129128863|NCT01147458|464763289|FG003|First Intervention|Adverse Event|3|||
129128864|NCT01147458|464763286|FG000|First Intervention|Other|1|||
129128865|NCT01147458|464763287|FG001|First Intervention|Other|2|||
129128866|NCT01147458|464763288|FG002|First Intervention|Other|0|||
129128867|NCT01147458|464763289|FG003|First Intervention|Other|0|||
129128868|NCT01147458|464763286|FG000|Second Intervention|Study terminated by sponsor|7|||
129128869|NCT01147458|464763287|FG001|Second Intervention|Study terminated by sponsor|5|||
129128870|NCT01147458|464763288|FG002|Second Intervention|Study terminated by sponsor|5|||
129128871|NCT01147458|464763289|FG003|Second Intervention|Study terminated by sponsor|3|||
129128872|NCT01147458|464763286|FG000|Second Intervention|Protocol Violation|0|||
129128873|NCT01147458|464763287|FG001|Second Intervention|Protocol Violation|1|||
129128874|NCT01147458|464763288|FG002|Second Intervention|Protocol Violation|1|||
129128875|NCT01147458|464763289|FG003|Second Intervention|Protocol Violation|0|||
129128876|NCT01147458|464763286|FG000|Second Intervention|Withdrawal by Subject|0|||
129128877|NCT01147458|464763287|FG001|Second Intervention|Withdrawal by Subject|1|||
129128878|NCT01147458|464763288|FG002|Second Intervention|Withdrawal by Subject|0|||
129128879|NCT01147458|464763289|FG003|Second Intervention|Withdrawal by Subject|0|||
129128880|NCT01147458|464763286|FG000|Second Intervention|Adverse Event|2|||
129128881|NCT01147458|464763287|FG001|Second Intervention|Adverse Event|0|||
129128882|NCT01147458|464763288|FG002|Second Intervention|Adverse Event|1|||
129128883|NCT01147458|464763289|FG003|Second Intervention|Adverse Event|1|||
129128884|NCT01147458|464763286|FG000|Second Intervention|Other|0|||
129128885|NCT01147458|464763287|FG001|Second Intervention|Other|0|||
129128886|NCT01147458|464763288|FG002|Second Intervention|Other|1|||
129128887|NCT01147458|464763289|FG003|Second Intervention|Other|0|||
129128888|NCT03550209|464763290|FG000|Overall Study|Lost to Follow-up|1|||
129128889|NCT03550209|464763291|FG001|Overall Study|Lost to Follow-up|0|||
129128890|NCT03550209|464763292|FG002|Overall Study|Lost to Follow-up|1|||
129128891|NCT03550209|464763293|FG003|Overall Study|Lost to Follow-up|0|||
129128892|NCT03550209|464763290|FG000|Overall Study|Withdrawal by Subject|0|||
129128893|NCT03550209|464763291|FG001|Overall Study|Withdrawal by Subject|3|||
129128894|NCT03550209|464763292|FG002|Overall Study|Withdrawal by Subject|1|||
128713470|NCT01042236|463248185|FG005|Treatment Period 3|Protocol Violation|0|||
128713471|NCT00227903|463248186|FG000|Overall Study|Withdrawal by Subject|2|||
129128895|NCT03550209|464763293|FG003|Overall Study|Withdrawal by Subject|2|||
129128896|NCT03550209|464763290|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
129128897|NCT03550209|464763291|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
129128898|NCT03550209|464763292|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
129128899|NCT03550209|464763293|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
129128900|NCT02555878|464763294|FG000|Overall Study|Lost to Follow-up|2|||
129128901|NCT02555878|464763295|FG001|Overall Study|Lost to Follow-up|3|||
129128902|NCT02555878|464763294|FG000|Overall Study|Withdrawal by Subject|48|||
129128903|NCT02555878|464763295|FG001|Overall Study|Withdrawal by Subject|48|||
129128904|NCT02555878|464763294|FG000|Overall Study|Adverse Event|12|||
129128905|NCT02555878|464763295|FG001|Overall Study|Adverse Event|8|||
129128906|NCT02555878|464763294|FG000|Overall Study|Death|74|||
129128907|NCT02555878|464763295|FG001|Overall Study|Death|59|||
129128908|NCT02555878|464763294|FG000|Overall Study|Protocol Violation|1|||
129128909|NCT02555878|464763295|FG001|Overall Study|Protocol Violation|2|||
129128910|NCT02555878|464763294|FG000|Overall Study|Physician Decision|12|||
129128911|NCT02555878|464763295|FG001|Overall Study|Physician Decision|13|||
129128912|NCT02555878|464763294|FG000|Overall Study|Other|17|||
129128913|NCT02555878|464763295|FG001|Overall Study|Other|17|||
129128914|NCT00765076|464763296|FG000|Overall Study|Adverse Event|1|||
129128915|NCT00765076|464763297|FG001|Overall Study|Adverse Event|0|||
129128916|NCT00765076|464763298|FG002|Overall Study|Adverse Event|0|||
129128917|NCT00765076|464763296|FG000|Overall Study|Withdrawal by Subject|0|||
129128918|NCT00765076|464763297|FG001|Overall Study|Withdrawal by Subject|0|||
129128919|NCT00765076|464763298|FG002|Overall Study|Withdrawal by Subject|1|||
128713472|NCT00227903|463248187|FG001|Overall Study|Withdrawal by Subject|5|||
129128920|NCT02875080|464763299|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
129128921|NCT02875080|464763300|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
128713473|NCT00227903|463248186|FG000|Overall Study|Subject moved out of area|1|||
129128922|NCT02875080|464763301|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
129128923|NCT00768053|464763302|FG000|Overall Study|Adverse Event|10|||
129128924|NCT00768053|464763302|FG000|Overall Study|Lost to Follow-up|1|||
129220159|NCT03682770|465106510|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129128925|NCT01164475|464763303|FG000|Overall Study|Lack of Efficacy|1|||
129128926|NCT01164475|464763304|FG001|Overall Study|Lack of Efficacy|0|||
129128927|NCT01164475|464763303|FG000|Overall Study|Other|0|||
129128928|NCT01164475|464763304|FG001|Overall Study|Other|1|||
129128929|NCT01164475|464763303|FG000|Overall Study|Progressive disease|0|||
129128930|NCT01164475|464763304|FG001|Overall Study|Progressive disease|1|||
129128931|NCT01164475|464763303|FG000|Overall Study|Protocol Violation|1|||
129128932|NCT01164475|464763304|FG001|Overall Study|Protocol Violation|0|||
129128933|NCT03244189|464763306|FG000|Overall Study|Death|0|||
129128934|NCT03244189|464763307|FG001|Overall Study|Death|2|||
129128935|NCT03244189|464763306|FG000|Overall Study|Lost to Follow-up|92|||
129128936|NCT03244189|464763307|FG001|Overall Study|Lost to Follow-up|107|||
129128937|NCT03244189|464763306|FG000|Overall Study|Physician Decision|4|||
129128938|NCT03244189|464763307|FG001|Overall Study|Physician Decision|2|||
129128939|NCT03244189|464763306|FG000|Overall Study|Pregnancy|7|||
129128940|NCT03244189|464763307|FG001|Overall Study|Pregnancy|5|||
129128941|NCT03244189|464763306|FG000|Overall Study|Protocol Violation|0|||
129128942|NCT03244189|464763307|FG001|Overall Study|Protocol Violation|2|||
129128943|NCT03244189|464763306|FG000|Overall Study|Withdrawal by Subject|45|||
129128944|NCT03244189|464763307|FG001|Overall Study|Withdrawal by Subject|23|||
129128945|NCT03244189|464763306|FG000|Overall Study|Technical Problems|2|||
129128946|NCT03244189|464763307|FG001|Overall Study|Technical Problems|0|||
129128947|NCT06170827|464763308|FG000|Overall Study|Withdrawal by Subject|1|||
129128948|NCT06170827|464763309|FG001|Overall Study|Withdrawal by Subject|1|||
129128949|NCT03421808|464763314|FG000|Overall Study|COVID related problems|2|||
129128950|NCT03421808|464763315|FG001|Overall Study|COVID related problems|0|||
129128951|NCT03421808|464763314|FG000|Overall Study|Withdrawal by Subject|1|||
129128952|NCT03421808|464763315|FG001|Overall Study|Withdrawal by Subject|0|||
129128953|NCT03421808|464763314|FG000|Overall Study|Protocol Violation|0|||
129128954|NCT03421808|464763315|FG001|Overall Study|Protocol Violation|1|||
129128955|NCT02180867|464763316|FG000|Overall Study|Adverse Event|3|||
129128956|NCT02180867|464763317|FG001|Overall Study|Adverse Event|4|||
129128957|NCT02180867|464763318|FG002|Overall Study|Adverse Event|1|||
129128958|NCT02180867|464763319|FG003|Overall Study|Adverse Event|5|||
129128959|NCT02180867|464763320|FG004|Overall Study|Adverse Event|0|||
129128960|NCT02180867|464763321|FG005|Overall Study|Adverse Event|0|||
129128961|NCT02180867|464763322|FG006|Overall Study|Adverse Event|0|||
129128962|NCT02180867|464763316|FG000|Overall Study|Death|0|||
129128963|NCT02180867|464763317|FG001|Overall Study|Death|0|||
129128964|NCT02180867|464763318|FG002|Overall Study|Death|0|||
129128965|NCT02180867|464763319|FG003|Overall Study|Death|0|||
129128966|NCT02180867|464763320|FG004|Overall Study|Death|1|||
129128967|NCT02180867|464763321|FG005|Overall Study|Death|0|||
129128968|NCT02180867|464763322|FG006|Overall Study|Death|0|||
129128969|NCT02180867|464763316|FG000|Overall Study|Lack of Efficacy|0|||
129128970|NCT02180867|464763317|FG001|Overall Study|Lack of Efficacy|2|||
128965003|NCT00246376|464157891|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
128965004|NCT00246376|464157887|FG000|Overall Study|Adverse Event|2|||
128965005|NCT00246376|464157888|FG001|Overall Study|Adverse Event|3|||
129128971|NCT02180867|464763318|FG002|Overall Study|Lack of Efficacy|0|||
129128972|NCT02180867|464763319|FG003|Overall Study|Lack of Efficacy|1|||
129128973|NCT02180867|464763320|FG004|Overall Study|Lack of Efficacy|6|||
129128974|NCT02180867|464763321|FG005|Overall Study|Lack of Efficacy|0|||
129128975|NCT02180867|464763322|FG006|Overall Study|Lack of Efficacy|1|||
129128976|NCT02180867|464763316|FG000|Overall Study|Physician Decision|1|||
129128977|NCT02180867|464763317|FG001|Overall Study|Physician Decision|3|||
129128978|NCT02180867|464763318|FG002|Overall Study|Physician Decision|1|||
129128979|NCT02180867|464763319|FG003|Overall Study|Physician Decision|10|||
129128980|NCT02180867|464763320|FG004|Overall Study|Physician Decision|9|||
129128981|NCT02180867|464763321|FG005|Overall Study|Physician Decision|3|||
129128982|NCT02180867|464763322|FG006|Overall Study|Physician Decision|4|||
129128983|NCT02180867|464763316|FG000|Overall Study|Withdrawal by Subject|0|||
129128984|NCT02180867|464763317|FG001|Overall Study|Withdrawal by Subject|0|||
129128985|NCT02180867|464763318|FG002|Overall Study|Withdrawal by Subject|0|||
129128986|NCT02180867|464763319|FG003|Overall Study|Withdrawal by Subject|1|||
129128987|NCT02180867|464763320|FG004|Overall Study|Withdrawal by Subject|1|||
129128988|NCT02180867|464763321|FG005|Overall Study|Withdrawal by Subject|0|||
129128989|NCT02180867|464763322|FG006|Overall Study|Withdrawal by Subject|0|||
129128990|NCT02180867|464763316|FG000|Overall Study|Ineligible|1|||
129128991|NCT02180867|464763317|FG001|Overall Study|Ineligible|2|||
129128992|NCT02180867|464763318|FG002|Overall Study|Ineligible|0|||
129128993|NCT02180867|464763319|FG003|Overall Study|Ineligible|3|||
129128994|NCT02180867|464763320|FG004|Overall Study|Ineligible|5|||
129128995|NCT02180867|464763321|FG005|Overall Study|Ineligible|0|||
129128996|NCT02180867|464763322|FG006|Overall Study|Ineligible|0|||
129128997|NCT02180867|464763316|FG000|Overall Study|Repeat Eligibility Studies|0|||
129128998|NCT02180867|464763317|FG001|Overall Study|Repeat Eligibility Studies|0|||
129128999|NCT02180867|464763318|FG002|Overall Study|Repeat Eligibility Studies|0|||
129129000|NCT02180867|464763319|FG003|Overall Study|Repeat Eligibility Studies|0|||
129129001|NCT02180867|464763320|FG004|Overall Study|Repeat Eligibility Studies|1|||
129129002|NCT02180867|464763321|FG005|Overall Study|Repeat Eligibility Studies|0|||
129129003|NCT02180867|464763322|FG006|Overall Study|Repeat Eligibility Studies|0|||
129129004|NCT02180867|464763316|FG000|Overall Study|Refusal of further protocol therapy|1|||
128965006|NCT00246376|464157889|FG002|Overall Study|Adverse Event|1|||
129129005|NCT02180867|464763317|FG001|Overall Study|Refusal of further protocol therapy|0|||
129129006|NCT02180867|464763318|FG002|Overall Study|Refusal of further protocol therapy|2|||
129129007|NCT02180867|464763319|FG003|Overall Study|Refusal of further protocol therapy|6|||
129220160|NCT03682770|465106511|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
129220161|NCT03682770|465106512|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
129220162|NCT03682770|465106513|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129220163|NCT03682770|465106514|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129220164|NCT03682770|465106515|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129220165|NCT03682770|465106509|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129220166|NCT03682770|465106510|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129220167|NCT03682770|465106511|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129220168|NCT03682770|465106512|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
129037536|NCT01740791|464428026|FG004|Overall Study|Lost to Follow-up|2|||
129037537|NCT01740791|464428027|FG005|Overall Study|Lost to Follow-up|3|||
129037538|NCT01740791|464428022|FG000|Overall Study|Withdrew Consent|4|||
129037539|NCT01740791|464428023|FG001|Overall Study|Withdrew Consent|0|||
129220169|NCT03682770|465106513|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129220170|NCT03682770|465106514|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129220171|NCT03682770|465106515|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129220172|NCT03682770|465106509|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129220173|NCT03682770|465106510|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129220174|NCT03682770|465106511|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
129220175|NCT03682770|465106512|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
129220176|NCT03682770|465106513|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129220177|NCT03682770|465106514|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129220178|NCT03682770|465106515|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129220179|NCT03682770|465106509|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129220180|NCT03682770|465106510|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129220181|NCT03682770|465106511|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
129220182|NCT03682770|465106512|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129220183|NCT03682770|465106513|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129220184|NCT03682770|465106514|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129220185|NCT03682770|465106515|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129220186|NCT03682770|465106509|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129220187|NCT03682770|465106510|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129220188|NCT03682770|465106511|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
129220189|NCT03682770|465106512|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129220190|NCT03682770|465106513|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129220191|NCT03682770|465106514|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129220192|NCT03682770|465106515|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129220193|NCT03682770|465106509|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129220194|NCT03682770|465106510|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129220195|NCT03682770|465106511|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129220196|NCT03682770|465106512|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
129220197|NCT03682770|465106513|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129220198|NCT03682770|465106514|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129220199|NCT03682770|465106515|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129220200|NCT03682770|465106509|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
129220201|NCT03682770|465106510|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
128713474|NCT00227903|463248187|FG001|Overall Study|Subject moved out of area|2|||
128713475|NCT00227903|463248186|FG000|Overall Study|Lost to Follow-up|1|||
128713476|NCT00227903|463248187|FG001|Overall Study|Lost to Follow-up|3|||
128713477|NCT00227903|463248186|FG000|Overall Study|Miscarriage|1|||
129037540|NCT01740791|464428024|FG002|Overall Study|Withdrew Consent|1|||
129037541|NCT01740791|464428025|FG003|Overall Study|Withdrew Consent|2|||
129037542|NCT01740791|464428026|FG004|Overall Study|Withdrew Consent|0|||
129037543|NCT01740791|464428027|FG005|Overall Study|Withdrew Consent|3|||
129037544|NCT01740791|464428022|FG000|Overall Study|Investigator's discretion|1|||
129037545|NCT01740791|464428023|FG001|Overall Study|Investigator's discretion|0|||
129037546|NCT01740791|464428024|FG002|Overall Study|Investigator's discretion|1|||
129037547|NCT01740791|464428025|FG003|Overall Study|Investigator's discretion|0|||
129037548|NCT01740791|464428026|FG004|Overall Study|Investigator's discretion|0|||
129037549|NCT01740791|464428027|FG005|Overall Study|Investigator's discretion|1|||
129037550|NCT01740791|464428022|FG000|Overall Study|Adverse Event|0|||
129037551|NCT01740791|464428023|FG001|Overall Study|Adverse Event|0|||
129037552|NCT01740791|464428024|FG002|Overall Study|Adverse Event|0|||
129037553|NCT01740791|464428025|FG003|Overall Study|Adverse Event|0|||
129037554|NCT01740791|464428026|FG004|Overall Study|Adverse Event|0|||
129037555|NCT01740791|464428027|FG005|Overall Study|Adverse Event|1|||
129037556|NCT01808248|464428028|FG000|Overall Study|Lack of Efficacy|3|||
128713478|NCT00227903|463248187|FG001|Overall Study|Miscarriage|0|||
129037557|NCT01808248|464428028|FG000|Overall Study|Withdrawal by Subject|1|||
129037558|NCT01808248|464428028|FG000|Overall Study|Lost to Follow-up|1|||
129129008|NCT02180867|464763320|FG004|Overall Study|Refusal of further protocol therapy|4|||
129129009|NCT02180867|464763321|FG005|Overall Study|Refusal of further protocol therapy|0|||
129129010|NCT02180867|464763322|FG006|Overall Study|Refusal of further protocol therapy|0|||
129129011|NCT02337686|464763323|FG000|Overall Study|Adverse Event|1|||
129129012|NCT00177671|464764081|FG000|Overall Study|Withdrawal by Subject|5|||
129129013|NCT00177671|464764082|FG001|Overall Study|Withdrawal by Subject|6|||
129129014|NCT00177671|464764081|FG000|Overall Study|medical complications|2|||
129129015|NCT00177671|464764082|FG001|Overall Study|medical complications|0|||
129129016|NCT00177671|464764081|FG000|Overall Study|Adverse Event|6|||
129129017|NCT00177671|464764082|FG001|Overall Study|Adverse Event|0|||
129129018|NCT00177671|464764081|FG000|Overall Study|Physician Decision|12|||
129129019|NCT00177671|464764082|FG001|Overall Study|Physician Decision|8|||
129129020|NCT02293499|464764083|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
129129021|NCT02293499|464764084|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
129129022|NCT02293499|464764085|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
129129023|NCT02293499|464764083|FG000|Intervention - Camp|Withdrawal by Subject|3|||
129129024|NCT02293499|464764084|FG001|Intervention - Camp|Withdrawal by Subject|6|||
129129025|NCT02293499|464764085|FG002|Intervention - Camp|Withdrawal by Subject|2|||
129129026|NCT02293499|464764083|FG000|Intervention - Camp|these are those not showing up at camp|24|||
129129027|NCT02293499|464764084|FG001|Intervention - Camp|these are those not showing up at camp|28|||
129129028|NCT02293499|464764085|FG002|Intervention - Camp|these are those not showing up at camp|4|||
129129029|NCT02293499|464764083|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
129129030|NCT02293499|464764084|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
129129031|NCT02293499|464764085|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
129129032|NCT02293499|464764083|FG000|3 Month Follow Up|Lost to Follow-up|14|||
129129033|NCT02293499|464764084|FG001|3 Month Follow Up|Lost to Follow-up|15|||
129129034|NCT02293499|464764085|FG002|3 Month Follow Up|Lost to Follow-up|6|||
129129035|NCT02293499|464764083|FG000|6 Month Follow Up|Lost to Follow-up|17|||
129129036|NCT02293499|464764084|FG001|6 Month Follow Up|Lost to Follow-up|27|||
129129037|NCT02293499|464764085|FG002|6 Month Follow Up|Lost to Follow-up|6|||
129129038|NCT02293499|464764083|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
129129039|NCT02293499|464764084|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
128713479|NCT01475331|463248188|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
128713480|NCT01475331|463248189|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
129129040|NCT02293499|464764085|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
129129041|NCT02293499|464764083|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
129129042|NCT02293499|464764084|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
129129043|NCT02293499|464764085|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
129129044|NCT02293499|464764083|FG000|9 Month Follow Up|Lost to Follow-up|24|||
129129045|NCT02293499|464764084|FG001|9 Month Follow Up|Lost to Follow-up|28|||
129129046|NCT02293499|464764085|FG002|9 Month Follow Up|Lost to Follow-up|4|||
129129047|NCT02293499|464764083|FG000|12 Month Follow Up|Lost to Follow-up|26|||
129129048|NCT02293499|464764084|FG001|12 Month Follow Up|Lost to Follow-up|25|||
129129049|NCT02293499|464764085|FG002|12 Month Follow Up|Lost to Follow-up|6|||
129129050|NCT02293499|464764083|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
129129051|NCT02293499|464764084|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
129129052|NCT02293499|464764085|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
129129053|NCT02293499|464764083|FG000|15 Month Follow Up|Lost to Follow-up|22|||
129129054|NCT02293499|464764084|FG001|15 Month Follow Up|Lost to Follow-up|22|||
129129055|NCT02293499|464764085|FG002|15 Month Follow Up|Lost to Follow-up|7|||
129129056|NCT01847209|464764088|FG000|Overall Study|Withdrawal by Subject|1|||
129129057|NCT01847209|464764088|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
129129058|NCT02737618|464764110|FG000|Overall Study|Withdrawal by Subject|9|||
129129059|NCT01879852|464764114|FG000|Overall Study|Withdrawal by Subject|2|||
129129060|NCT01879852|464764115|FG001|Overall Study|Withdrawal by Subject|0|||
129129061|NCT02696616|464764116|FG000|Overall Study|Adverse Event|0|||
129129062|NCT02696616|464764117|FG001|Overall Study|Adverse Event|1|||
129129063|NCT02696616|464764118|FG002|Overall Study|Adverse Event|0|||
129129064|NCT02696616|464764119|FG003|Overall Study|Adverse Event|0|||
129220202|NCT03682770|465106511|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
129220203|NCT03682770|465106512|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
128713481|NCT01475331|463248188|FG000|Overall Study|excessive main duct communication|1|||
128713482|NCT01475331|463248189|FG001|Overall Study|excessive main duct communication|1|||
128713483|NCT01475331|463248188|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
129129065|NCT02696616|464764120|FG004|Overall Study|Adverse Event|0|||
129129066|NCT02696616|464764121|FG005|Overall Study|Adverse Event|0|||
129129067|NCT02696616|464764122|FG006|Overall Study|Adverse Event|0|||
129129068|NCT01500083|464764125|FG000|Overall Study|Adverse Event|4|||
129129069|NCT01500083|464764126|FG001|Overall Study|Adverse Event|17|||
129129070|NCT01500083|464764125|FG000|Overall Study|Death|0|||
129129071|NCT01500083|464764126|FG001|Overall Study|Death|2|||
128713484|NCT01475331|463248189|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
129129072|NCT01500083|464764125|FG000|Overall Study|Lost to Follow-up|1|||
129129073|NCT01500083|464764126|FG001|Overall Study|Lost to Follow-up|0|||
129129074|NCT01500083|464764125|FG000|Overall Study|Withdrawal of Consent|0|||
129129075|NCT01500083|464764126|FG001|Overall Study|Withdrawal of Consent|1|||
129129076|NCT01500083|464764125|FG000|Overall Study|Disease Progression|2|||
129129077|NCT01500083|464764126|FG001|Overall Study|Disease Progression|10|||
129129078|NCT01500083|464764125|FG000|Overall Study|Investigator Discretion|3|||
129129079|NCT01500083|464764126|FG001|Overall Study|Investigator Discretion|8|||
129129080|NCT01500083|464764125|FG000|Overall Study|Other Reasons|2|||
129129081|NCT01500083|464764126|FG001|Overall Study|Other Reasons|5|||
129129082|NCT01555931|464764127|FG000|Overall Study|Lost to Follow-up|2|||
129129083|NCT01555931|464764128|FG001|Overall Study|Lost to Follow-up|5|||
129129084|NCT02299167|464764131|FG000|Overall Study|patients were excluded from the study|11|||
129129085|NCT04598828|464764132|FG000|Overall Study|Physician Decision|1|||
129129086|NCT04598828|464764133|FG001|Overall Study|Physician Decision|0|||
129129087|NCT04598828|464764132|FG000|Overall Study|Withdrawal by Subject|0|||
129129088|NCT04598828|464764133|FG001|Overall Study|Withdrawal by Subject|1|||
129129089|NCT04598828|464764132|FG000|Overall Study|Withdrawal by Subject|0|||
129129090|NCT04598828|464764133|FG001|Overall Study|Withdrawal by Subject|1|||
129129091|NCT02676973|464764134|FG000|Overall Study|Withdrawal by Subject|9|||
129129092|NCT02676973|464764135|FG001|Overall Study|Withdrawal by Subject|8|||
129129093|NCT02676973|464764136|FG002|Overall Study|Withdrawal by Subject|11|||
129129094|NCT02676973|464764134|FG000|Overall Study|Lost to Follow-up|8|||
129129095|NCT02676973|464764135|FG001|Overall Study|Lost to Follow-up|12|||
129129096|NCT02676973|464764136|FG002|Overall Study|Lost to Follow-up|8|||
129129097|NCT02676973|464764134|FG000|Overall Study|Death|2|||
129129098|NCT02676973|464764135|FG001|Overall Study|Death|1|||
129129099|NCT02676973|464764136|FG002|Overall Study|Death|5|||
129129100|NCT01078662|464764138|FG000|Overall Study|Death|41|||
129129101|NCT01078662|464764139|FG001|Overall Study|Death|103|||
129129102|NCT01078662|464764140|FG002|Overall Study|Death|18|||
129129103|NCT01078662|464764141|FG003|Overall Study|Death|5|||
129129104|NCT01078662|464764142|FG004|Overall Study|Death|8|||
129129105|NCT01078662|464764138|FG000|Overall Study|Patients reached data cut-off|12|||
129129106|NCT01078662|464764139|FG001|Overall Study|Patients reached data cut-off|53|||
129129107|NCT01078662|464764140|FG002|Overall Study|Patients reached data cut-off|2|||
129129108|NCT01078662|464764141|FG003|Overall Study|Patients reached data cut-off|2|||
129129109|NCT01078662|464764142|FG004|Overall Study|Patients reached data cut-off|3|||
129129110|NCT01078662|464764138|FG000|Overall Study|Withdrawal by Subject|4|||
129129111|NCT01078662|464764139|FG001|Overall Study|Withdrawal by Subject|11|||
129129112|NCT01078662|464764140|FG002|Overall Study|Withdrawal by Subject|1|||
129129113|NCT01078662|464764141|FG003|Overall Study|Withdrawal by Subject|0|||
129129114|NCT01078662|464764142|FG004|Overall Study|Withdrawal by Subject|0|||
129129115|NCT01078662|464764138|FG000|Overall Study|Protocol Violation|0|||
129129116|NCT01078662|464764139|FG001|Overall Study|Protocol Violation|1|||
129129117|NCT01078662|464764140|FG002|Overall Study|Protocol Violation|0|||
129129118|NCT01078662|464764141|FG003|Overall Study|Protocol Violation|0|||
129129119|NCT01078662|464764142|FG004|Overall Study|Protocol Violation|0|||
129129120|NCT01078662|464764138|FG000|Overall Study|Lost to Follow-up|1|||
129129121|NCT01078662|464764139|FG001|Overall Study|Lost to Follow-up|0|||
129129122|NCT01078662|464764140|FG002|Overall Study|Lost to Follow-up|0|||
129129123|NCT01078662|464764141|FG003|Overall Study|Lost to Follow-up|0|||
129129124|NCT01078662|464764142|FG004|Overall Study|Lost to Follow-up|0|||
129129125|NCT00700635|464764143|FG000|Overall Study|Adverse Event|1|||
129129126|NCT00700635|464764144|FG001|Overall Study|Adverse Event|0|||
129129127|NCT00700635|464764145|FG002|Overall Study|Adverse Event|0|||
128713485|NCT01475331|463248188|FG000|Overall Study|Sign of malignancy during the procedure|2|||
128713486|NCT01475331|463248189|FG001|Overall Study|Sign of malignancy during the procedure|0|||
128713487|NCT01475331|463248188|FG000|Overall Study|cyst found to be prohibitively small|0|||
128713488|NCT01475331|463248189|FG001|Overall Study|cyst found to be prohibitively small|1|||
128713489|NCT03683758|463248192|FG000|Overall Study|Non-study commitment conflict|1|||
129129128|NCT00700635|464764143|FG000|Overall Study|Lost to Follow-up|1|||
128713490|NCT03683758|463248193|FG001|Overall Study|Non-study commitment conflict|3|||
128713491|NCT03683758|463248192|FG000|Overall Study|Illness preventing participation|1|||
129129129|NCT00700635|464764144|FG001|Overall Study|Lost to Follow-up|3|||
129129130|NCT00700635|464764145|FG002|Overall Study|Lost to Follow-up|0|||
128713492|NCT03683758|463248193|FG001|Overall Study|Illness preventing participation|0|||
129129131|NCT00700635|464764143|FG000|Overall Study|Protocol Violation|2|||
129129132|NCT00700635|464764144|FG001|Overall Study|Protocol Violation|2|||
129129133|NCT00700635|464764145|FG002|Overall Study|Protocol Violation|0|||
129129134|NCT00700635|464764143|FG000|Overall Study|Withdrawal by Subject|7|||
129129135|NCT00700635|464764144|FG001|Overall Study|Withdrawal by Subject|3|||
129129136|NCT00700635|464764145|FG002|Overall Study|Withdrawal by Subject|1|||
129129137|NCT04937387|464764148|FG000|Overall Study|Adverse Event|1|||
129129138|NCT04937387|464764149|FG001|Overall Study|Adverse Event|0|||
129129139|NCT04937387|464764150|FG002|Overall Study|Adverse Event|2|||
129129140|NCT04937387|464764151|FG003|Overall Study|Adverse Event|0|||
129129141|NCT04937387|464764148|FG000|Overall Study|Lack of Efficacy|1|||
128965007|NCT00246376|464157890|FG003|Overall Study|Adverse Event|3|||
128965008|NCT00246376|464157891|FG004|Overall Study|Adverse Event|1|||
128965009|NCT00246376|464157887|FG000|Overall Study|Lost to Follow-up|2|||
128965010|NCT00246376|464157888|FG001|Overall Study|Lost to Follow-up|11|||
128965011|NCT00246376|464157889|FG002|Overall Study|Lost to Follow-up|11|||
128965012|NCT00246376|464157890|FG003|Overall Study|Lost to Follow-up|16|||
128965013|NCT00246376|464157891|FG004|Overall Study|Lost to Follow-up|13|||
128965014|NCT01872897|464157892|FG000|Overall Study|Withdrawal by Subject|1|||
128965015|NCT01872897|464157893|FG001|Overall Study|Withdrawal by Subject|0|||
128965016|NCT02418585|464157896|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
128965017|NCT02418585|464157897|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
128965018|NCT02418585|464157896|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
128965019|NCT02418585|464157897|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
128965020|NCT02418585|464157896|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
128965021|NCT02418585|464157897|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
128965022|NCT02418585|464157896|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
128965023|NCT02418585|464157897|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
128965024|NCT02418585|464157896|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
128965025|NCT02418585|464157897|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
128965026|NCT02418585|464157896|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
128965027|NCT02418585|464157897|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
128965028|NCT02418585|464157896|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
128965029|NCT02418585|464157897|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
128965030|NCT02418585|464157896|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
128965031|NCT02418585|464157897|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
128965032|NCT02418585|464157896|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
128965033|NCT02418585|464157897|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
129037559|NCT00220727|464428030|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
129037560|NCT00220727|464428031|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
129037561|NCT02020967|464428032|FG000|Overall Study|Withdrawal by Subject|51|||
129037562|NCT03507686|464428033|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
129037563|NCT03507686|464428034|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
129037564|NCT03507686|464428033|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
129037565|NCT03507686|464428034|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
129037566|NCT03507686|464428033|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
129037567|NCT03507686|464428034|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
129037568|NCT03507686|464428033|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
129037569|NCT03507686|464428034|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
129037570|NCT03507686|464428033|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
129037571|NCT03507686|464428034|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
129037572|NCT03507686|464428033|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
129037573|NCT03507686|464428034|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
129037574|NCT02508116|464428035|FG000|Overall Study|Lost to Follow-up|2|||
129037575|NCT02508116|464428036|FG001|Overall Study|Lost to Follow-up|3|||
129037576|NCT02508116|464428035|FG000|Overall Study|Withdrawal by Subject|3|||
129037577|NCT02508116|464428036|FG001|Overall Study|Withdrawal by Subject|2|||
129037578|NCT02508116|464428035|FG000|Overall Study|Protocol Violation|1|||
129037579|NCT02508116|464428036|FG001|Overall Study|Protocol Violation|2|||
128965034|NCT02418585|464157896|FG000|Follow-up Phase (24 Weeks)|Other|3|||
129037580|NCT02508116|464428035|FG000|Overall Study|Physician Decision|2|||
129037581|NCT02508116|464428036|FG001|Overall Study|Physician Decision|0|||
129037582|NCT00983528|464428039|FG000|Overall Study|Death|4|||
129037583|NCT00983528|464428039|FG000|Overall Study|Lost to Follow-up|1|||
129037584|NCT00983528|464428039|FG000|Overall Study|Study Terminated|1|||
129037585|NCT00575380|464428040|FG000|Overall Study|Withdrawal by Subject|1|||
129037586|NCT00575380|464428041|FG001|Overall Study|Withdrawal by Subject|0|||
129037587|NCT00575380|464428040|FG000|Overall Study|Adverse Event|0|||
129037588|NCT00575380|464428041|FG001|Overall Study|Adverse Event|1|||
129037589|NCT00575380|464428040|FG000|Overall Study|Various|0|||
129037590|NCT00575380|464428041|FG001|Overall Study|Various|2|||
129037591|NCT00559364|464428042|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
129037592|NCT00559364|464428043|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
128965035|NCT02418585|464157897|FG001|Follow-up Phase (24 Weeks)|Other|2|||
128965036|NCT02040857|464157898|FG000|Overall Study|Adverse Event|14|||
128965037|NCT02040857|464157898|FG000|Overall Study|Physician Decision|5|||
128965038|NCT02040857|464157898|FG000|Overall Study|Withdrawal by Subject|31|||
129037593|NCT00330460|464428050|FG000|Overall Study|Physician Decision|1|||
128965039|NCT02040857|464157898|FG000|Overall Study|patient non-compliance|3|||
128965040|NCT02040857|464157898|FG000|Overall Study|Lost to Follow-up|2|||
129037594|NCT00330460|464428051|FG001|Overall Study|Physician Decision|0|||
129037595|NCT00330460|464428050|FG000|Overall Study|Adverse Event|10|||
129037596|NCT00330460|464428051|FG001|Overall Study|Adverse Event|8|||
129129142|NCT04937387|464764149|FG001|Overall Study|Lack of Efficacy|0|||
129129143|NCT04937387|464764150|FG002|Overall Study|Lack of Efficacy|0|||
129129144|NCT04937387|464764151|FG003|Overall Study|Lack of Efficacy|1|||
129129145|NCT04937387|464764148|FG000|Overall Study|Withdrawal by Subject|1|||
129129146|NCT04937387|464764149|FG001|Overall Study|Withdrawal by Subject|0|||
129129147|NCT04937387|464764150|FG002|Overall Study|Withdrawal by Subject|1|||
129129148|NCT04937387|464764151|FG003|Overall Study|Withdrawal by Subject|1|||
129129149|NCT04937387|464764148|FG000|Overall Study|Randomized in error|0|||
129129150|NCT04937387|464764149|FG001|Overall Study|Randomized in error|0|||
129129151|NCT04937387|464764150|FG002|Overall Study|Randomized in error|0|||
129129152|NCT04937387|464764151|FG003|Overall Study|Randomized in error|1|||
129129153|NCT02872714|464764157|FG000|Overall Study|Progressive Disease|1|||
129129154|NCT02872714|464764158|FG001|Overall Study|Progressive Disease|2|||
129129155|NCT02872714|464764159|FG002|Overall Study|Progressive Disease|0|||
129129156|NCT02872714|464764160|FG003|Overall Study|Progressive Disease|0|||
129129157|NCT02872714|464764161|FG004|Overall Study|Progressive Disease|0|||
129129158|NCT02872714|464764157|FG000|Overall Study|Death|87|||
129129159|NCT02872714|464764158|FG001|Overall Study|Death|36|||
129129160|NCT02872714|464764159|FG002|Overall Study|Death|8|||
129129161|NCT02872714|464764160|FG003|Overall Study|Death|81|||
129129162|NCT02872714|464764161|FG004|Overall Study|Death|2|||
129129163|NCT02872714|464764157|FG000|Overall Study|Lost to Follow-up|2|||
129129164|NCT02872714|464764158|FG001|Overall Study|Lost to Follow-up|1|||
129129165|NCT02872714|464764159|FG002|Overall Study|Lost to Follow-up|0|||
129129166|NCT02872714|464764160|FG003|Overall Study|Lost to Follow-up|3|||
129129167|NCT02872714|464764161|FG004|Overall Study|Lost to Follow-up|0|||
129129168|NCT02872714|464764157|FG000|Overall Study|Physician Decision|0|||
128965041|NCT02040857|464157898|FG000|Overall Study|recurrence|4|||
128965042|NCT02040857|464157898|FG000|Overall Study|ineligible|1|||
128965043|NCT04159701|464157899|FG000|Period 1: Treatment Period|Pregnancy|1|||
128965044|NCT04159701|464157900|FG001|Period 1: Treatment Period|Pregnancy|0|||
128965045|NCT04159701|464157899|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
128965046|NCT04159701|464157900|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
128965047|NCT04159701|464157899|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
128965048|NCT04159701|464157900|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
128965049|NCT04159701|464157899|FG000|Washout Period|site terminated by sponsor|0|||
128965050|NCT04159701|464157900|FG001|Washout Period|site terminated by sponsor|1|||
128965051|NCT04159701|464157899|FG000|Washout Period|study terminated by sponsor|10|||
128965052|NCT04159701|464157900|FG001|Washout Period|study terminated by sponsor|3|||
128965053|NCT04159701|464157899|FG000|Washout Period|Withdrawal by Subject|1|||
128965054|NCT04159701|464157900|FG001|Washout Period|Withdrawal by Subject|0|||
128965055|NCT04159701|464157899|FG000|Washout Period|Inadvertent Enrollment|1|||
128965056|NCT04159701|464157900|FG001|Washout Period|Inadvertent Enrollment|0|||
128965057|NCT04159701|464157899|FG000|Washout Period|Miscellaneous|1|||
128965058|NCT04159701|464157900|FG001|Washout Period|Miscellaneous|0|||
128965059|NCT04159701|464157899|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
129129169|NCT02872714|464764158|FG001|Overall Study|Physician Decision|0|||
129129170|NCT02872714|464764159|FG002|Overall Study|Physician Decision|0|||
129129171|NCT02872714|464764160|FG003|Overall Study|Physician Decision|1|||
129129172|NCT02872714|464764161|FG004|Overall Study|Physician Decision|0|||
129129173|NCT02872714|464764157|FG000|Overall Study|Withdrawal by Subject|1|||
129129174|NCT02872714|464764158|FG001|Overall Study|Withdrawal by Subject|3|||
129129175|NCT02872714|464764159|FG002|Overall Study|Withdrawal by Subject|0|||
128965060|NCT04159701|464157900|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
128965061|NCT04159701|464157899|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
128965062|NCT04159701|464157900|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
128965063|NCT04159701|464157899|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
128965064|NCT04159701|464157900|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
128965065|NCT04159701|464157899|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
129129176|NCT02872714|464764160|FG003|Overall Study|Withdrawal by Subject|2|||
129129177|NCT02872714|464764161|FG004|Overall Study|Withdrawal by Subject|0|||
129129178|NCT02872714|464764157|FG000|Overall Study|Captured as Other|2|||
129129179|NCT02872714|464764158|FG001|Overall Study|Captured as Other|0|||
129129180|NCT02872714|464764159|FG002|Overall Study|Captured as Other|0|||
129129181|NCT02872714|464764160|FG003|Overall Study|Captured as Other|1|||
129129182|NCT02872714|464764161|FG004|Overall Study|Captured as Other|0|||
129129183|NCT00690898|464765062|FG000|SCREENING|Screen failure|18|||
129129184|NCT00690898|464765062|FG000|TREATMENT|Adverse Event|3|||
129129185|NCT00690898|464765062|FG000|TREATMENT|Lack of Efficacy|18|||
129129186|NCT00690898|464765062|FG000|TREATMENT|Withdrawal by Subject|4|||
129129187|NCT00690898|464765062|FG000|TREATMENT|Other (not otherwise specified)|1|||
129129188|NCT02008370|464765065|FG000|Overall Study|Lost to Follow-up|7|||
129129189|NCT03317496|464765066|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
129129190|NCT03317496|464765067|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
129129191|NCT03317496|464765068|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
129129192|NCT03317496|464765069|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
129129193|NCT03317496|464765070|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
129129194|NCT03317496|464765066|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
128965066|NCT04159701|464157900|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
129129195|NCT03317496|464765067|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
129129196|NCT03317496|464765068|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
129129197|NCT03317496|464765069|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
129129198|NCT03317496|464765070|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
129129199|NCT03317496|464765066|FG000|Phase 1b Lead-in: Treatment|Death|0|||
129129200|NCT03317496|464765067|FG001|Phase 1b Lead-in: Treatment|Death|0|||
129129201|NCT03317496|464765068|FG002|Phase 1b Lead-in: Treatment|Death|1|||
129129202|NCT03317496|464765069|FG003|Phase 1b Lead-in: Treatment|Death|0|||
129129203|NCT03317496|464765070|FG004|Phase 1b Lead-in: Treatment|Death|0|||
129129204|NCT03317496|464765066|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
129129205|NCT03317496|464765067|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
129129206|NCT03317496|464765068|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
129129207|NCT03317496|464765069|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
129129208|NCT03317496|464765070|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
129129209|NCT03317496|464765066|FG000|Phase 1b Lead-in: Treatment|Other|2|||
129129210|NCT03317496|464765067|FG001|Phase 1b Lead-in: Treatment|Other|1|||
129129211|NCT03317496|464765068|FG002|Phase 1b Lead-in: Treatment|Other|0|||
129129212|NCT03317496|464765069|FG003|Phase 1b Lead-in: Treatment|Other|0|||
129129213|NCT03317496|464765070|FG004|Phase 1b Lead-in: Treatment|Other|0|||
129129214|NCT03317496|464765066|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129129215|NCT03317496|464765067|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129129216|NCT03317496|464765068|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
129129217|NCT03317496|464765069|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129129218|NCT03317496|464765070|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129129219|NCT03317496|464765066|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
128713493|NCT03683758|463248192|FG000|Overall Study|Adverse Event|1|||
128965067|NCT04159701|464157899|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
129129220|NCT03317496|464765067|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
129129221|NCT03317496|464765068|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
129129222|NCT03317496|464765069|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
129129223|NCT03317496|464765070|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
129129224|NCT03317496|464765066|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
129129225|NCT03317496|464765067|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
129129226|NCT03317496|464765068|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
129129227|NCT03317496|464765069|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
129129228|NCT03317496|464765070|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
129129229|NCT03317496|464765066|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
129129230|NCT03317496|464765067|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129129231|NCT03317496|464765068|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129129232|NCT03317496|464765069|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129129233|NCT03317496|464765070|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129129234|NCT03317496|464765066|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129129235|NCT03317496|464765067|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129129236|NCT03317496|464765068|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
129129237|NCT03317496|464765069|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129129238|NCT03317496|464765070|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129129239|NCT03317496|464765066|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
129129240|NCT03317496|464765067|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
129129241|NCT03317496|464765068|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
129129242|NCT03317496|464765069|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
129129243|NCT03317496|464765070|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
129129244|NCT03317496|464765066|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
129129245|NCT03317496|464765067|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
128713494|NCT03683758|463248193|FG001|Overall Study|Adverse Event|0|||
129129246|NCT03317496|464765068|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
129129247|NCT03317496|464765069|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
129129248|NCT03317496|464765070|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
129129249|NCT03317496|464765066|FG000|Phase 2: Treatment|Adverse Event|0|||
129129250|NCT03317496|464765067|FG001|Phase 2: Treatment|Adverse Event|0|||
129129251|NCT03317496|464765068|FG002|Phase 2: Treatment|Adverse Event|0|||
128965068|NCT04159701|464157900|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
128965069|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
129129252|NCT03317496|464765069|FG003|Phase 2: Treatment|Adverse Event|0|||
129129253|NCT03317496|464765070|FG004|Phase 2: Treatment|Adverse Event|6|||
129129254|NCT03317496|464765066|FG000|Phase 2: Treatment|Progressive disease|0|||
129129255|NCT03317496|464765067|FG001|Phase 2: Treatment|Progressive disease|0|||
129129256|NCT03317496|464765068|FG002|Phase 2: Treatment|Progressive disease|0|||
129129257|NCT03317496|464765069|FG003|Phase 2: Treatment|Progressive disease|0|||
129129258|NCT03317496|464765070|FG004|Phase 2: Treatment|Progressive disease|22|||
129129259|NCT03317496|464765066|FG000|Phase 2: Treatment|Other|0|||
129129260|NCT03317496|464765067|FG001|Phase 2: Treatment|Other|0|||
128713495|NCT00723892|463248194|FG000|Overall Study|Participant not tracked|33|||
129129261|NCT03317496|464765068|FG002|Phase 2: Treatment|Other|0|||
129129262|NCT03317496|464765069|FG003|Phase 2: Treatment|Other|0|||
129129263|NCT03317496|464765070|FG004|Phase 2: Treatment|Other|4|||
128965070|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
128965071|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
128965072|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
128965073|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
128965074|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
128965075|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
128965076|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
128965077|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
128965078|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
128965079|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
128965080|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
128965081|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
128965082|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
128965083|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
128965084|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
128965085|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
128965086|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
128965087|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
128965088|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
128965089|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
128965090|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
128965091|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
128965092|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
128965093|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
128965094|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
128965095|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
128965096|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
128965097|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
128965098|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
128965099|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
128965100|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
128965101|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
128965102|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
128965103|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
128965104|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
128965105|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
128965106|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
128965107|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
128965108|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
128965109|NCT03605836|464157901|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
128965110|NCT03605836|464157902|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
128965111|NCT03605836|464157903|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
128965112|NCT03605836|464157904|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
128965113|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
128965114|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
128965115|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
128965116|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
128965117|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
128965118|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
128965119|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
128965120|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
128965121|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
128965122|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
128965123|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
128965124|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
128965125|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
128965126|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
128965127|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
128965128|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
129129264|NCT03317496|464765066|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
129129265|NCT03317496|464765067|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
129129266|NCT03317496|464765068|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
129129267|NCT03317496|464765069|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
129129268|NCT03317496|464765070|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
129129269|NCT03317496|464765066|FG000|Phase 2: Treatment|Physician Decision|0|||
129129270|NCT03317496|464765067|FG001|Phase 2: Treatment|Physician Decision|0|||
129129271|NCT03317496|464765068|FG002|Phase 2: Treatment|Physician Decision|0|||
129129272|NCT03317496|464765069|FG003|Phase 2: Treatment|Physician Decision|0|||
129129273|NCT03317496|464765070|FG004|Phase 2: Treatment|Physician Decision|1|||
129129274|NCT03317496|464765066|FG000|Phase 2: Treatment|Death|0|||
129129275|NCT03317496|464765067|FG001|Phase 2: Treatment|Death|0|||
128965129|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
128965130|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
128965131|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
128965132|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
128965133|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
129129276|NCT03317496|464765068|FG002|Phase 2: Treatment|Death|0|||
129129277|NCT03317496|464765069|FG003|Phase 2: Treatment|Death|0|||
129129278|NCT03317496|464765070|FG004|Phase 2: Treatment|Death|1|||
128965134|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
128965135|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
128965136|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
128965137|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
128965138|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
128965139|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
128965140|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
128965141|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
128965142|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
128965143|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
128965144|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
128965145|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
128965146|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
128965147|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
128965148|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
128965149|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
128965150|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
128965151|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
128965152|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
128965153|NCT03605836|464157901|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
129129279|NCT03317496|464765066|FG000|Phase 2: Follow-up|Death|0|||
129129280|NCT03317496|464765067|FG001|Phase 2: Follow-up|Death|0|||
129129281|NCT03317496|464765068|FG002|Phase 2: Follow-up|Death|0|||
129129282|NCT03317496|464765069|FG003|Phase 2: Follow-up|Death|0|||
129129283|NCT03317496|464765070|FG004|Phase 2: Follow-up|Death|24|||
129129284|NCT03317496|464765066|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
129129285|NCT03317496|464765067|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
129129286|NCT03317496|464765068|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
129129287|NCT03317496|464765069|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
129129288|NCT03317496|464765070|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
129129289|NCT03317496|464765066|FG000|Phase 2: Follow-up|Other|0|||
129129290|NCT03317496|464765067|FG001|Phase 2: Follow-up|Other|0|||
129129291|NCT03317496|464765068|FG002|Phase 2: Follow-up|Other|0|||
129129292|NCT03317496|464765069|FG003|Phase 2: Follow-up|Other|0|||
129129293|NCT03317496|464765070|FG004|Phase 2: Follow-up|Other|1|||
129129294|NCT03317496|464765066|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
129129295|NCT03317496|464765067|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
129129296|NCT03317496|464765068|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
129129297|NCT03317496|464765069|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
129129298|NCT03317496|464765070|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
129129299|NCT01001104|464765075|FG000|Overall Study|Adverse Event|2|||
129129300|NCT01001104|464765076|FG001|Overall Study|Adverse Event|1|||
129129301|NCT01001104|464765077|FG002|Overall Study|Adverse Event|0|||
129129302|NCT01001104|464765078|FG003|Overall Study|Adverse Event|0|||
129129303|NCT01001104|464765075|FG000|Overall Study|Lost to Follow-up|0|||
129129304|NCT01001104|464765076|FG001|Overall Study|Lost to Follow-up|0|||
129129305|NCT01001104|464765077|FG002|Overall Study|Lost to Follow-up|1|||
129129306|NCT01001104|464765078|FG003|Overall Study|Lost to Follow-up|0|||
129129307|NCT01001104|464765075|FG000|Overall Study|Entry Criteria Not Met|0|||
129129308|NCT01001104|464765076|FG001|Overall Study|Entry Criteria Not Met|0|||
129129309|NCT01001104|464765077|FG002|Overall Study|Entry Criteria Not Met|0|||
129129310|NCT01001104|464765078|FG003|Overall Study|Entry Criteria Not Met|1|||
129129311|NCT01001104|464765075|FG000|Overall Study|Withdrawal by Subject|0|||
128771606|NCT03390036|463455301|FG002|Overall Study|Lack of Efficacy|0|||
128965154|NCT03605836|464157902|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
128965155|NCT03605836|464157903|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
128965156|NCT03605836|464157904|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
128965157|NCT00481988|464157906|FG000|Overall Study|Withdrawal by Subject|1|||
128965158|NCT00481988|464157907|FG001|Overall Study|Withdrawal by Subject|1|||
128965159|NCT00654420|464157908|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
128965160|NCT00654420|464157909|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
128965161|NCT00654420|464157910|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
128965162|NCT00654420|464157911|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
128965163|NCT00654420|464157908|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
128965164|NCT00654420|464157909|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
128965165|NCT00654420|464157910|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
128965166|NCT00654420|464157911|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
128965167|NCT00654420|464157908|FG000|Phase II|Adverse Event|0|||
128965168|NCT00654420|464157909|FG001|Phase II|Adverse Event|0|||
128965169|NCT00654420|464157910|FG002|Phase II|Adverse Event|3|||
128965170|NCT00654420|464157911|FG003|Phase II|Adverse Event|3|||
128965171|NCT00654420|464157908|FG000|Phase II|Lost to Follow-up|0|||
128965172|NCT00654420|464157909|FG001|Phase II|Lost to Follow-up|0|||
128965173|NCT00654420|464157910|FG002|Phase II|Lost to Follow-up|0|||
128965174|NCT00654420|464157911|FG003|Phase II|Lost to Follow-up|1|||
128965175|NCT00654420|464157908|FG000|Phase II|Physician Decision|0|||
128965176|NCT00654420|464157909|FG001|Phase II|Physician Decision|0|||
128965177|NCT00654420|464157910|FG002|Phase II|Physician Decision|0|||
128965178|NCT00654420|464157911|FG003|Phase II|Physician Decision|4|||
128965179|NCT00654420|464157908|FG000|Phase II|Progressive Disease|0|||
128965180|NCT00654420|464157909|FG001|Phase II|Progressive Disease|0|||
128965181|NCT00654420|464157910|FG002|Phase II|Progressive Disease|29|||
128965182|NCT00654420|464157911|FG003|Phase II|Progressive Disease|29|||
128965183|NCT00654420|464157908|FG000|Phase II|Withdrawal by Subject|0|||
128965184|NCT00654420|464157909|FG001|Phase II|Withdrawal by Subject|0|||
128965185|NCT00654420|464157910|FG002|Phase II|Withdrawal by Subject|4|||
128965186|NCT00654420|464157911|FG003|Phase II|Withdrawal by Subject|1|||
128965187|NCT00654420|464157908|FG000|Phase II|Missing Disposition Record|0|||
128965188|NCT00654420|464157909|FG001|Phase II|Missing Disposition Record|0|||
128965189|NCT00654420|464157910|FG002|Phase II|Missing Disposition Record|1|||
128965190|NCT00654420|464157911|FG003|Phase II|Missing Disposition Record|0|||
128965191|NCT00471276|464157913|FG000|Overall Study|Death|2|||
128965192|NCT00471276|464157913|FG000|Overall Study|Adverse Event|16|||
128965193|NCT00471276|464157913|FG000|Overall Study|Protocol Violation|1|||
128965194|NCT00471276|464157913|FG000|Overall Study|Objective progression or relapse|54|||
128965195|NCT00471276|464157913|FG000|Overall Study|Global deterioration of health status|1|||
128965196|NCT00471276|464157913|FG000|Overall Study|Other|3|||
128965197|NCT00471276|464157913|FG000|Overall Study|Refused treatment|6|||
128965198|NCT00701103|464157914|FG000|Overall Study|Adverse Event|0|||
128965199|NCT00701103|464157915|FG001|Overall Study|Adverse Event|0|||
128965200|NCT00701103|464157916|FG002|Overall Study|Adverse Event|1|||
128965201|NCT00701103|464157917|FG003|Overall Study|Adverse Event|1|||
128965202|NCT00701103|464157918|FG004|Overall Study|Adverse Event|0|||
128965203|NCT00701103|464157919|FG005|Overall Study|Adverse Event|1|||
128965204|NCT00701103|464157920|FG006|Overall Study|Adverse Event|1|||
128965205|NCT00701103|464157921|FG007|Overall Study|Adverse Event|0|||
128965206|NCT00701103|464157922|FG008|Overall Study|Adverse Event|0|||
128965207|NCT00701103|464157923|FG009|Overall Study|Adverse Event|2|||
128965208|NCT00701103|464157924|FG010|Overall Study|Adverse Event|0|||
128965209|NCT00701103|464157914|FG000|Overall Study|Progressive Disease|5|||
128965210|NCT00701103|464157915|FG001|Overall Study|Progressive Disease|2|||
128965211|NCT00701103|464157916|FG002|Overall Study|Progressive Disease|6|||
128965212|NCT00701103|464157917|FG003|Overall Study|Progressive Disease|5|||
128965213|NCT00701103|464157918|FG004|Overall Study|Progressive Disease|6|||
128965214|NCT00701103|464157919|FG005|Overall Study|Progressive Disease|5|||
128965215|NCT00701103|464157920|FG006|Overall Study|Progressive Disease|7|||
128965216|NCT00701103|464157921|FG007|Overall Study|Progressive Disease|7|||
128965217|NCT00701103|464157922|FG008|Overall Study|Progressive Disease|8|||
128965218|NCT00701103|464157923|FG009|Overall Study|Progressive Disease|8|||
128965219|NCT00701103|464157924|FG010|Overall Study|Progressive Disease|11|||
128965220|NCT00701103|464157914|FG000|Overall Study|Withdrawal by Subject|0|||
128965221|NCT00701103|464157915|FG001|Overall Study|Withdrawal by Subject|1|||
128965222|NCT00701103|464157916|FG002|Overall Study|Withdrawal by Subject|1|||
128965223|NCT00701103|464157917|FG003|Overall Study|Withdrawal by Subject|0|||
128965224|NCT00701103|464157918|FG004|Overall Study|Withdrawal by Subject|0|||
128965225|NCT00701103|464157919|FG005|Overall Study|Withdrawal by Subject|0|||
128965226|NCT00701103|464157920|FG006|Overall Study|Withdrawal by Subject|0|||
128965227|NCT00701103|464157921|FG007|Overall Study|Withdrawal by Subject|0|||
128965228|NCT00701103|464157922|FG008|Overall Study|Withdrawal by Subject|0|||
128965229|NCT00701103|464157923|FG009|Overall Study|Withdrawal by Subject|0|||
128965230|NCT00701103|464157924|FG010|Overall Study|Withdrawal by Subject|0|||
128965231|NCT00701103|464157914|FG000|Overall Study|Other|0|||
128965232|NCT00701103|464157915|FG001|Overall Study|Other|0|||
128965233|NCT00701103|464157916|FG002|Overall Study|Other|0|||
128965234|NCT00701103|464157917|FG003|Overall Study|Other|0|||
128965235|NCT00701103|464157918|FG004|Overall Study|Other|0|||
128965236|NCT00701103|464157919|FG005|Overall Study|Other|0|||
128965237|NCT00701103|464157920|FG006|Overall Study|Other|0|||
128965238|NCT00701103|464157921|FG007|Overall Study|Other|0|||
128965239|NCT00701103|464157922|FG008|Overall Study|Other|1|||
128965240|NCT00701103|464157923|FG009|Overall Study|Other|1|||
128965241|NCT00701103|464157924|FG010|Overall Study|Other|0|||
128965242|NCT00179517|464157925|FG000|Overall Study|Withdrawal by Subject|2|||
128965243|NCT00179517|464157926|FG001|Overall Study|Withdrawal by Subject|1|||
128965244|NCT00431496|464157933|FG000|Overall Study|Adverse Event|3|||
128965245|NCT00431496|464157933|FG000|Overall Study|Lost to Follow-up|1|||
128965246|NCT00431496|464157933|FG000|Overall Study|Withdrawal by Subject|2|||
128965247|NCT00431496|464157933|FG000|Overall Study|Protocol-specified criteria|5|||
128965248|NCT00361218|464157934|FG000|Overall Study|Lost to Follow-up|11|||
128965249|NCT00361218|464157934|FG000|Overall Study|Personal Reasons|7|||
129037597|NCT00330460|464428050|FG000|Overall Study|Withdrawal by Subject|18|||
129037598|NCT00330460|464428051|FG001|Overall Study|Withdrawal by Subject|17|||
129037599|NCT00330460|464428050|FG000|Overall Study|Death|1|||
129037600|NCT00330460|464428051|FG001|Overall Study|Death|1|||
129037601|NCT00330460|464428050|FG000|Overall Study|Ineligibility determined|1|||
129037602|NCT00330460|464428051|FG001|Overall Study|Ineligibility determined|3|||
129037603|NCT00330460|464428050|FG000|Overall Study|Lost to Follow-up|8|||
129037604|NCT00330460|464428051|FG001|Overall Study|Lost to Follow-up|3|||
129037605|NCT00330460|464428050|FG000|Overall Study|Noncompliance|2|||
129037606|NCT00330460|464428051|FG001|Overall Study|Noncompliance|1|||
129037607|NCT00330460|464428050|FG000|Overall Study|Other|1|||
129037608|NCT00330460|464428051|FG001|Overall Study|Other|0|||
129037609|NCT02663882|464428052|FG000|Overall Study|Lost to Follow-up|4|||
129037610|NCT02663882|464428053|FG001|Overall Study|Lost to Follow-up|2|||
129037611|NCT00388037|464428054|FG000|Overall Study|Protocol Violation|1|||
129037612|NCT00602537|464428055|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
129037613|NCT00602537|464428056|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
129037614|NCT00602537|464428055|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
129037615|NCT00602537|464428056|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
129037616|NCT00602537|464428055|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
129037617|NCT00602537|464428056|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
129037618|NCT00602537|464428055|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
129037619|NCT00602537|464428056|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
129037620|NCT00602537|464428055|FG000|Follow Up Study Comparison|Adverse Event|1|||
129037621|NCT00602537|464428056|FG001|Follow Up Study Comparison|Adverse Event|0|||
129037622|NCT00602537|464428055|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
129037623|NCT00602537|464428056|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
129037624|NCT00602537|464428055|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
129037625|NCT00602537|464428056|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
129037626|NCT00869440|464428063|FG000|Overall Study|Withdrawal by Subject|1|||
129037627|NCT00869440|464428064|FG001|Overall Study|Withdrawal by Subject|0|||
129037628|NCT00869440|464428065|FG002|Overall Study|Withdrawal by Subject|0|||
129037629|NCT00869440|464428066|FG003|Overall Study|Withdrawal by Subject|0|||
129037630|NCT00869440|464428063|FG000|Overall Study|Physician Decision|1|||
129037631|NCT00869440|464428064|FG001|Overall Study|Physician Decision|1|||
129037632|NCT00869440|464428065|FG002|Overall Study|Physician Decision|0|||
129037633|NCT00869440|464428066|FG003|Overall Study|Physician Decision|0|||
129037634|NCT00613730|464428067|FG000|Overall Study|Disease progression|2|||
129037635|NCT00613730|464428067|FG000|Overall Study|Administrative decision|1|||
129037636|NCT00479388|464428068|FG000|Overall Study|Adverse Event|90|||
129037637|NCT00479388|464428069|FG001|Overall Study|Adverse Event|45|||
129037638|NCT00479388|464428068|FG000|Overall Study|Lost to Follow-up|0|||
129037639|NCT00479388|464428069|FG001|Overall Study|Lost to Follow-up|2|||
129037640|NCT00479388|464428068|FG000|Overall Study|Protocol Violation|10|||
129037641|NCT00479388|464428069|FG001|Overall Study|Protocol Violation|9|||
129037642|NCT00479388|464428068|FG000|Overall Study|Withdrawal by Subject|32|||
129037643|NCT00479388|464428069|FG001|Overall Study|Withdrawal by Subject|17|||
129129312|NCT01001104|464765076|FG001|Overall Study|Withdrawal by Subject|0|||
128965250|NCT00361218|464157934|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
128965251|NCT02566109|464157935|FG000|Overall Study|Withdrawal by Subject|1|||
128965252|NCT01931150|464157936|FG000|Overall Study|Withdrawal by Subject|1|||
128965253|NCT01931150|464157937|FG001|Overall Study|Withdrawal by Subject|2|||
129037644|NCT01876368|464428072|FG000|Overall Study|Adverse Event|2|||
129037645|NCT01876368|464428073|FG001|Overall Study|Adverse Event|5|||
128965254|NCT01570309|464157940|FG000|Overall Study|Withdrawal by Subject|3|||
128965255|NCT01570309|464157941|FG001|Overall Study|Withdrawal by Subject|3|||
129037646|NCT01876368|464428072|FG000|Overall Study|Lack of Efficacy|1|||
129037647|NCT01876368|464428073|FG001|Overall Study|Lack of Efficacy|0|||
129037648|NCT01876368|464428072|FG000|Overall Study|Lost to Follow-up|0|||
129037649|NCT01876368|464428073|FG001|Overall Study|Lost to Follow-up|1|||
129129313|NCT01001104|464765077|FG002|Overall Study|Withdrawal by Subject|0|||
129129314|NCT01001104|464765078|FG003|Overall Study|Withdrawal by Subject|2|||
129129315|NCT02397837|464765079|FG000|Overall Study|Withdrawal by Subject|6|||
129129316|NCT02397837|464765080|FG001|Overall Study|Withdrawal by Subject|5|||
129129317|NCT02397837|464765079|FG000|Overall Study|Physician Decision|1|||
129129318|NCT02397837|464765080|FG001|Overall Study|Physician Decision|1|||
129129319|NCT00599313|464765082|FG000|Overall Study|Adverse Event|19|||
129129320|NCT00599313|464765082|FG000|Overall Study|Disease Progression|12|||
129129321|NCT00599313|464765082|FG000|Overall Study|Patient Request|4|||
129129322|NCT00599313|464765082|FG000|Overall Study|Ineligible|1|||
129129323|NCT02536794|464765083|FG000|Reached 1st Response Assessment|Adverse Event|2|||
129129324|NCT02536794|464765083|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
129129325|NCT02536794|464765083|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
129129326|NCT02536794|464765083|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
129129327|NCT02536794|464765083|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
129129328|NCT02536794|464765083|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
129129329|NCT00898807|464765096|FG000|Overall Study|Withdrawal by Subject|5|||
129129330|NCT00898807|464765097|FG001|Overall Study|Withdrawal by Subject|3|||
129129331|NCT00898807|464765096|FG000|Overall Study|Family pressure to discontinue|2|||
129129332|NCT00898807|464765097|FG001|Overall Study|Family pressure to discontinue|2|||
129129333|NCT00898807|464765096|FG000|Overall Study|Lost to Follow-up|1|||
129129334|NCT00898807|464765097|FG001|Overall Study|Lost to Follow-up|3|||
129129335|NCT00898807|464765096|FG000|Overall Study|Death|0|||
129129336|NCT00898807|464765097|FG001|Overall Study|Death|1|||
129129337|NCT00817063|464765098|FG000|Overall Study|Adverse Event|32|||
129129338|NCT00817063|464765099|FG001|Overall Study|Adverse Event|13|||
129129339|NCT00817063|464765098|FG000|Overall Study|Death|1|||
129129340|NCT00817063|464765099|FG001|Overall Study|Death|1|||
129129341|NCT00817063|464765098|FG000|Overall Study|Lack of Efficacy|33|||
129129342|NCT00817063|464765099|FG001|Overall Study|Lack of Efficacy|86|||
129129343|NCT00817063|464765098|FG000|Overall Study|Failure to Return|13|||
129129344|NCT00817063|464765099|FG001|Overall Study|Failure to Return|12|||
129129345|NCT00817063|464765098|FG000|Overall Study|Violation of Selection at Entry|7|||
129129346|NCT00817063|464765099|FG001|Overall Study|Violation of Selection at Entry|4|||
129129347|NCT00817063|464765098|FG000|Overall Study|Protocol Violation|3|||
129129348|NCT00817063|464765099|FG001|Overall Study|Protocol Violation|8|||
128965256|NCT01390038|464157942|FG000|Overall Study|Death|1|||
128965257|NCT01390038|464157942|FG000|Overall Study|Lost to Follow-up|1|||
128965258|NCT01390038|464157942|FG000|Overall Study|Withdrawal by Subject|4|||
128965259|NCT01390038|464157942|FG000|Overall Study|Simpliciti System Removal|2|||
128965260|NCT00368472|464157945|FG000|Overall Study|Adverse Event|22|||
128965261|NCT00368472|464157945|FG000|Overall Study|Medication non-compliance|4|||
128965262|NCT00368472|464157945|FG000|Overall Study|Protocol Violation|2|||
128965263|NCT00368472|464157945|FG000|Overall Study|Request of Investigator or Sponsor|3|||
129129349|NCT00817063|464765098|FG000|Overall Study|Withdrawal by Subject|17|||
129129350|NCT00817063|464765099|FG001|Overall Study|Withdrawal by Subject|37|||
129129351|NCT00817063|464765098|FG000|Overall Study|Early Improvement|19|||
128965264|NCT00368472|464157945|FG000|Overall Study|Withdrawal by Subject|40|||
128965265|NCT00368472|464157945|FG000|Overall Study|Diary non-compliance|1|||
128965266|NCT00368472|464157945|FG000|Overall Study|Other|32|||
128965267|NCT00368472|464157945|FG000|Overall Study|Missing Final Disposition Date|1|||
128965268|NCT03619837|464157949|FG000|Screening|received organs from HCV-negative donors|47|||
128965269|NCT03619837|464157949|FG000|Screening|died on the wait-list|2|||
128965270|NCT03619837|464157949|FG000|Screening|remained on the wait list|40|||
128965271|NCT03619837|464157949|FG000|Screening|didn't meet eligibility criteria|3|||
129129352|NCT00817063|464765099|FG001|Overall Study|Early Improvement|4|||
129129353|NCT00817063|464765098|FG000|Overall Study|Administrative|10|||
128965272|NCT03619837|464157949|FG000|Screening|withdrew consent|2|||
129129354|NCT00817063|464765099|FG001|Overall Study|Administrative|4|||
129129355|NCT00817063|464765098|FG000|Overall Study|Abnormality of Laboratory Test|2|||
129129356|NCT00817063|464765099|FG001|Overall Study|Abnormality of Laboratory Test|1|||
129129357|NCT01496456|464765100|FG000|Overall Study|Protocol Violation|1|||
129129358|NCT01496456|464765100|FG000|Overall Study|Lost to Follow-up|7|||
128965273|NCT03619837|464157949|FG000|Screening|never listed for HCV-viremic donor|1|||
129129359|NCT04919161|464765101|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
129129360|NCT04919161|464765102|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
129129361|NCT04919161|464765101|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
129129362|NCT04919161|464765102|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
129129363|NCT04919161|464765101|FG000|Overall Study|Acute ankle sprain after session 1|0|||
129129364|NCT04919161|464765102|FG001|Overall Study|Acute ankle sprain after session 1|1|||
129129365|NCT02489773|464765103|FG000|Overall Study|Lost to Follow-up|4|||
128965274|NCT03619837|464157949|FG000|Screening|developed exclusion criteria|2|||
128965275|NCT03619837|464157949|FG000|Screening|excluded by the investigator due to non-compliance|1|||
128965276|NCT04095793|464157950|FG000|Overall Study|Adverse Event|3|||
129129366|NCT02489773|464765104|FG001|Overall Study|Lost to Follow-up|1|||
129129367|NCT02489773|464765103|FG000|Overall Study|Physician Decision|1|||
129129368|NCT02489773|464765104|FG001|Overall Study|Physician Decision|0|||
129129369|NCT02489773|464765103|FG000|Overall Study|Withdrawal by Subject|1|||
129129370|NCT02489773|464765104|FG001|Overall Study|Withdrawal by Subject|0|||
129129371|NCT02489773|464765103|FG000|Overall Study|Leave the country or the state|1|||
129129372|NCT02489773|464765104|FG001|Overall Study|Leave the country or the state|1|||
129129373|NCT00712920|464765105|FG000|Overall Study|Adverse Event|3|||
129129374|NCT00712920|464765106|FG001|Overall Study|Adverse Event|4|||
129129375|NCT00712920|464765107|FG002|Overall Study|Adverse Event|7|||
129129376|NCT00712920|464765105|FG000|Overall Study|Withdrawal by Subject|4|||
129129377|NCT00712920|464765106|FG001|Overall Study|Withdrawal by Subject|2|||
129129378|NCT00712920|464765107|FG002|Overall Study|Withdrawal by Subject|1|||
129129379|NCT00712920|464765105|FG000|Overall Study|Lost to Follow-up|1|||
129129380|NCT00712920|464765106|FG001|Overall Study|Lost to Follow-up|4|||
129129381|NCT00712920|464765107|FG002|Overall Study|Lost to Follow-up|0|||
129129382|NCT00712920|464765105|FG000|Overall Study|Lack of Efficacy|1|||
129129383|NCT00712920|464765106|FG001|Overall Study|Lack of Efficacy|0|||
129129384|NCT00712920|464765107|FG002|Overall Study|Lack of Efficacy|1|||
129129385|NCT00712920|464765105|FG000|Overall Study|Other|5|||
129129386|NCT00712920|464765106|FG001|Overall Study|Other|7|||
128965277|NCT04095793|464157950|FG000|Overall Study|Study Terminated by Sponsor|103|||
128965278|NCT04095793|464157950|FG000|Overall Study|Withdrawal by Subject|4|||
128965279|NCT00044213|464157951|FG000|Overall Study|Withdrawal by Subject|50|||
128965280|NCT00044213|464157952|FG001|Overall Study|Withdrawal by Subject|65|||
128965281|NCT00044213|464157953|FG002|Overall Study|Withdrawal by Subject|91|||
128965282|NCT00044213|464157954|FG003|Overall Study|Withdrawal by Subject|83|||
128965283|NCT00044213|464157951|FG000|Overall Study|Death|42|||
128965284|NCT00044213|464157952|FG001|Overall Study|Death|42|||
128965285|NCT00044213|464157953|FG002|Overall Study|Death|42|||
128965286|NCT00044213|464157954|FG003|Overall Study|Death|49|||
128965287|NCT00044213|464157951|FG000|Overall Study|Lost to Follow-up|8|||
128965288|NCT00044213|464157952|FG001|Overall Study|Lost to Follow-up|5|||
128965289|NCT00044213|464157953|FG002|Overall Study|Lost to Follow-up|5|||
128965290|NCT00044213|464157954|FG003|Overall Study|Lost to Follow-up|4|||
128965291|NCT01927068|464157959|FG000|Overall Study|Death|37|||
128965292|NCT01927068|464157960|FG001|Overall Study|Death|3|||
128965293|NCT01927068|464157959|FG000|Overall Study|Withdrawal by Subject|50|||
128965294|NCT01927068|464157960|FG001|Overall Study|Withdrawal by Subject|3|||
128965295|NCT01927068|464157959|FG000|Overall Study|Lost to Follow-up|10|||
128965296|NCT01927068|464157960|FG001|Overall Study|Lost to Follow-up|2|||
128965297|NCT01927068|464157959|FG000|Overall Study|Physician Decision|9|||
128965298|NCT01927068|464157960|FG001|Overall Study|Physician Decision|0|||
128965299|NCT01927068|464157959|FG000|Overall Study|Missed last follow-up visit|2|||
128965300|NCT01927068|464157960|FG001|Overall Study|Missed last follow-up visit|0|||
128965301|NCT00880607|464157961|FG000|Overall Study|Physician Decision|2|||
128965302|NCT00880607|464157962|FG001|Overall Study|Physician Decision|2|||
128965303|NCT00880607|464157961|FG000|Overall Study|Protocol Violation|2|||
128965304|NCT00880607|464157962|FG001|Overall Study|Protocol Violation|1|||
128965305|NCT00880607|464157961|FG000|Overall Study|surgery did not extend past L1 level|3|||
128965306|NCT00880607|464157962|FG001|Overall Study|surgery did not extend past L1 level|0|||
128965307|NCT02963766|464157964|FG000|Double-Blind Period|Adverse Event|1|||
128965308|NCT02963766|464157965|FG001|Double-Blind Period|Adverse Event|0|||
128965309|NCT02963766|464157966|FG002|Double-Blind Period|Adverse Event|1|||
128965310|NCT02963766|464157964|FG000|Double-Blind Period|Physician Decision|1|||
128965311|NCT02963766|464157965|FG001|Double-Blind Period|Physician Decision|0|||
128965312|NCT02963766|464157966|FG002|Double-Blind Period|Physician Decision|0|||
128965313|NCT02963766|464157964|FG000|Double-Blind Period|Withdrawal by Subject|1|||
128965314|NCT02963766|464157965|FG001|Double-Blind Period|Withdrawal by Subject|1|||
128965315|NCT02963766|464157966|FG002|Double-Blind Period|Withdrawal by Subject|0|||
128965316|NCT02963766|464157964|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
129129387|NCT00712920|464765107|FG002|Overall Study|Other|3|||
128965317|NCT02963766|464157965|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
128965318|NCT02963766|464157966|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
128965319|NCT02963766|464157964|FG000|Double-Blind Period|Protocol Violation|1|||
129129388|NCT00712920|464765105|FG000|Overall Study|Non-compliance|3|||
129129389|NCT00712920|464765106|FG001|Overall Study|Non-compliance|0|||
129129390|NCT00712920|464765107|FG002|Overall Study|Non-compliance|0|||
128965320|NCT02963766|464157965|FG001|Double-Blind Period|Protocol Violation|0|||
128965321|NCT02963766|464157966|FG002|Double-Blind Period|Protocol Violation|0|||
128965322|NCT02963766|464157964|FG000|Double-Blind Period|Lost to Follow-up|0|||
128965323|NCT02963766|464157965|FG001|Double-Blind Period|Lost to Follow-up|1|||
128965324|NCT02963766|464157966|FG002|Double-Blind Period|Lost to Follow-up|0|||
128965325|NCT02963766|464157964|FG000|Open Label Extension (OLE)|Physician Decision|1|||
128965326|NCT02963766|464157965|FG001|Open Label Extension (OLE)|Physician Decision|2|||
128965327|NCT02963766|464157966|FG002|Open Label Extension (OLE)|Physician Decision|2|||
129129391|NCT02362451|464765110|FG000|Overall Study|Withdrawal by Subject|0|||
129129392|NCT02362451|464765111|FG001|Overall Study|Withdrawal by Subject|1|||
129129393|NCT02362451|464765110|FG000|Overall Study|Lack of Efficacy|2|||
128965328|NCT02963766|464157964|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
128965329|NCT02963766|464157965|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
128965330|NCT02963766|464157966|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
128965331|NCT00499460|464157967|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
129220204|NCT03682770|465106513|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
129220205|NCT03682770|465106514|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
129220206|NCT03682770|465106515|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
129220207|NCT03682770|465106509|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129220208|NCT03682770|465106510|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129220209|NCT03682770|465106511|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129220210|NCT03682770|465106512|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
128965332|NCT00499460|464157968|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
128965333|NCT00499460|464157967|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
128965334|NCT00499460|464157968|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
128965335|NCT00499460|464157967|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
128965336|NCT00499460|464157968|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
128965337|NCT00814307|464157969|FG000|Overall Study|Randomized but not treated|1|||
128965338|NCT00814307|464157970|FG001|Overall Study|Randomized but not treated|0|||
128965339|NCT00814307|464157971|FG002|Overall Study|Randomized but not treated|0|||
128965340|NCT00814307|464157972|FG003|Overall Study|Randomized but not treated|0|||
129037650|NCT01876368|464428072|FG000|Overall Study|Non-compliance with study treatment|0|||
129037651|NCT01876368|464428073|FG001|Overall Study|Non-compliance with study treatment|1|||
129037652|NCT01876368|464428072|FG000|Overall Study|Physician Decision|0|||
129037653|NCT01876368|464428073|FG001|Overall Study|Physician Decision|2|||
129037654|NCT01876368|464428072|FG000|Overall Study|Protocol deviation|3|||
129037655|NCT01876368|464428073|FG001|Overall Study|Protocol deviation|3|||
129037656|NCT01876368|464428072|FG000|Overall Study|Subject/guardian decision|3|||
129037657|NCT01876368|464428073|FG001|Overall Study|Subject/guardian decision|1|||
129037658|NCT01955044|464428074|FG000|Overall Study|Death|1|||
129037659|NCT01955044|464428075|FG001|Overall Study|Death|1|||
129037660|NCT01955044|464428076|FG002|Overall Study|Death|0|||
129037661|NCT01644149|464428077|FG000|Overall Study|Withdrawal by Subject|1|||
129037662|NCT01644149|464428078|FG001|Overall Study|Withdrawal by Subject|0|||
129037663|NCT01644149|464428077|FG000|Overall Study|Lost to Follow-up|3|||
129037664|NCT01644149|464428078|FG001|Overall Study|Lost to Follow-up|1|||
129037665|NCT05766787|464428079|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
129037666|NCT05766787|464428080|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
129037667|NCT05766787|464428079|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
129037668|NCT05766787|464428080|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
129037669|NCT05766787|464428079|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
129037670|NCT05766787|464428080|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
129037671|NCT01378962|464428081|FG000|Overall Study|Death|14|||
129037672|NCT01378962|464428081|FG000|Overall Study|Lost to Follow-up|1|||
129037673|NCT01378962|464428081|FG000|Overall Study|Other|2|||
129037674|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
129037675|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
129037676|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
129037677|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
129037678|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
129037679|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
129037680|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
129037681|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
129037682|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
129037683|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
129037684|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
128713496|NCT00723892|463248195|FG001|Overall Study|Participant not tracked|35|||
128713497|NCT00723892|463248194|FG000|Overall Study|Virological criterion|24|||
128713498|NCT00723892|463248195|FG001|Overall Study|Virological criterion|9|||
128713499|NCT00723892|463248194|FG000|Overall Study|Withdrawal by Subject|6|||
128713500|NCT00723892|463248195|FG001|Overall Study|Withdrawal by Subject|9|||
128713501|NCT00723892|463248194|FG000|Overall Study|End planned|11|||
128713502|NCT00723892|463248195|FG001|Overall Study|End planned|7|||
128771607|NCT00358215|463455302|FG000|Overall Study|Ineligibility determined|4|||
128965341|NCT00814307|464157969|FG000|Overall Study|Adverse Event|3|||
128965342|NCT00814307|464157970|FG001|Overall Study|Adverse Event|9|||
129037685|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
129037686|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
129037687|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
129037688|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
128713503|NCT00723892|463248194|FG000|Overall Study|Bad tolerance|5|||
128713504|NCT00723892|463248195|FG001|Overall Study|Bad tolerance|5|||
128713505|NCT00723892|463248194|FG000|Overall Study|Multiple reasons|17|||
129129394|NCT02362451|464765111|FG001|Overall Study|Lack of Efficacy|0|||
129129395|NCT02362451|464765110|FG000|Overall Study|Progression|1|||
129129396|NCT02362451|464765111|FG001|Overall Study|Progression|0|||
129129397|NCT02362451|464765110|FG000|Overall Study|Participant chose other therapy.|1|||
129129398|NCT02362451|464765111|FG001|Overall Study|Participant chose other therapy.|0|||
129129399|NCT02115386|464765112|FG000|Overall Study|Protocol Violation|1|||
129129400|NCT02115386|464765112|FG000|Overall Study|Administrative - trial was terminated|6|||
129129401|NCT02493855|464765113|FG000|Overall Study|Non-compliance|1|||
129129402|NCT02493855|464765114|FG001|Overall Study|Non-compliance|0|||
129129403|NCT02493855|464765115|FG002|Overall Study|Non-compliance|0|||
129129404|NCT02493855|464765113|FG000|Overall Study|Adverse Event|0|||
129129405|NCT02493855|464765114|FG001|Overall Study|Adverse Event|1|||
129129406|NCT02493855|464765115|FG002|Overall Study|Adverse Event|0|||
129129407|NCT02493855|464765113|FG000|Overall Study|Withdrawal by Subject|1|||
129129408|NCT02493855|464765114|FG001|Overall Study|Withdrawal by Subject|0|||
129129409|NCT02493855|464765115|FG002|Overall Study|Withdrawal by Subject|0|||
129129410|NCT02453048|464765116|FG000|Overall Study|Only part of initial 6 mo. study|0|||
129129411|NCT02453048|464765117|FG001|Overall Study|Only part of initial 6 mo. study|0|||
129129412|NCT02453048|464765118|FG002|Overall Study|Only part of initial 6 mo. study|0|||
129129413|NCT02453048|464765119|FG003|Overall Study|Only part of initial 6 mo. study|0|||
129129414|NCT02453048|464765120|FG004|Overall Study|Only part of initial 6 mo. study|6|||
129129415|NCT02453048|464765116|FG000|Overall Study|Lost to Follow-up|0|||
129129416|NCT02453048|464765117|FG001|Overall Study|Lost to Follow-up|1|||
129129417|NCT02453048|464765118|FG002|Overall Study|Lost to Follow-up|2|||
129129418|NCT02453048|464765119|FG003|Overall Study|Lost to Follow-up|0|||
129129419|NCT02453048|464765120|FG004|Overall Study|Lost to Follow-up|0|||
129129420|NCT03600428|464765122|FG000|Overall Study|Not eligible|0|||
129129421|NCT03600428|464765123|FG001|Overall Study|Not eligible|1|||
129129422|NCT03600428|464765122|FG000|Overall Study|Lost to Follow-up|5|||
129129423|NCT03600428|464765123|FG001|Overall Study|Lost to Follow-up|4|||
129129424|NCT01695746|464765127|FG000|Overall Study|Adverse Event|1|||
129129425|NCT01695746|464765127|FG000|Overall Study|Non-compliance by the participant|3|||
129129426|NCT01695746|464765127|FG000|Overall Study|Protocol Violation|5|||
129129427|NCT01695746|464765127|FG000|Overall Study|Participant not willing to participate|3|||
129129428|NCT04615507|464765128|FG000|Period 1|Covid-19 exposure|2|||
129129429|NCT04615507|464765129|FG001|Period 1|Covid-19 exposure|1|||
129129430|NCT04615507|464765128|FG000|Period 2|Covid-19 exposure|0|||
129129431|NCT04615507|464765129|FG001|Period 2|Covid-19 exposure|1|||
129129432|NCT04615507|464765128|FG000|Period 2|Protocol Violation|1|||
129129433|NCT04615507|464765129|FG001|Period 2|Protocol Violation|0|||
129129434|NCT04615507|464765128|FG000|Period 2|Withdrawal by Subject|1|||
129129435|NCT04615507|464765129|FG001|Period 2|Withdrawal by Subject|0|||
129129436|NCT04615507|464765128|FG000|Period 2|Adverse Event|0|||
129129437|NCT04615507|464765129|FG001|Period 2|Adverse Event|1|||
129129438|NCT04615507|464765128|FG000|Period 3|Covid-19 exposure|0|||
129129439|NCT04615507|464765129|FG001|Period 3|Covid-19 exposure|1|||
129129440|NCT05172570|464765131|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
129129441|NCT05172570|464765132|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
129129442|NCT05172570|464765133|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
129129443|NCT05172570|464765131|FG000|Overall Study|PI Decision due to equipment shortages|0|||
129129444|NCT05172570|464765132|FG001|Overall Study|PI Decision due to equipment shortages|0|||
129129445|NCT05172570|464765133|FG002|Overall Study|PI Decision due to equipment shortages|1|||
129129446|NCT01202591|464765134|FG000|Overall Study|Adverse Event|2|||
129129447|NCT01202591|464765135|FG001|Overall Study|Adverse Event|1|||
129129448|NCT01202591|464765136|FG002|Overall Study|Adverse Event|4|||
129129449|NCT01202591|464765137|FG003|Overall Study|Adverse Event|4|||
129129450|NCT01202591|464765138|FG004|Overall Study|Adverse Event|0|||
129129451|NCT01202591|464765139|FG005|Overall Study|Adverse Event|0|||
129129452|NCT01202591|464765134|FG000|Overall Study|Other reason as per investigator|3|||
129220211|NCT03682770|465106513|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
129220212|NCT03682770|465106514|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129220213|NCT03682770|465106515|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129129453|NCT01202591|464765135|FG001|Overall Study|Other reason as per investigator|4|||
129129454|NCT01202591|464765136|FG002|Overall Study|Other reason as per investigator|7|||
129129455|NCT01202591|464765137|FG003|Overall Study|Other reason as per investigator|3|||
129129456|NCT01202591|464765138|FG004|Overall Study|Other reason as per investigator|1|||
129129457|NCT01202591|464765139|FG005|Overall Study|Other reason as per investigator|3|||
129129458|NCT01202591|464765134|FG000|Overall Study|Withdrawal by Subject|0|||
129129459|NCT01202591|464765135|FG001|Overall Study|Withdrawal by Subject|0|||
129129460|NCT01202591|464765136|FG002|Overall Study|Withdrawal by Subject|0|||
129129461|NCT01202591|464765137|FG003|Overall Study|Withdrawal by Subject|0|||
129129462|NCT01202591|464765138|FG004|Overall Study|Withdrawal by Subject|2|||
129129463|NCT01202591|464765139|FG005|Overall Study|Withdrawal by Subject|1|||
129129464|NCT01202591|464765134|FG000|Overall Study|Objective Disease Progression|0|||
128965343|NCT00814307|464157971|FG002|Overall Study|Adverse Event|3|||
128965344|NCT00814307|464157972|FG003|Overall Study|Adverse Event|2|||
128965345|NCT00814307|464157969|FG000|Overall Study|Lack of Efficacy|1|||
128965346|NCT00814307|464157970|FG001|Overall Study|Lack of Efficacy|1|||
128965347|NCT00814307|464157971|FG002|Overall Study|Lack of Efficacy|3|||
128965348|NCT00814307|464157972|FG003|Overall Study|Lack of Efficacy|4|||
128965349|NCT00814307|464157969|FG000|Overall Study|Other|1|||
128965350|NCT00814307|464157970|FG001|Overall Study|Other|2|||
128965351|NCT00814307|464157971|FG002|Overall Study|Other|0|||
128965352|NCT00814307|464157972|FG003|Overall Study|Other|1|||
128965353|NCT00814307|464157969|FG000|Overall Study|Protocol Violation|2|||
128965354|NCT00814307|464157970|FG001|Overall Study|Protocol Violation|8|||
128965355|NCT00814307|464157971|FG002|Overall Study|Protocol Violation|1|||
128965356|NCT00814307|464157972|FG003|Overall Study|Protocol Violation|1|||
128965357|NCT00814307|464157969|FG000|Overall Study|Withdrawal by Subject|4|||
129037689|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
129037690|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
129037691|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
129037692|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
129037693|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
129037694|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
129037695|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
129037696|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
129037697|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
129037698|NCT01435928|464428082|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
129037699|NCT01435928|464428083|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
129037700|NCT01435928|464428084|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
129037701|NCT01435928|464428082|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
129037702|NCT01435928|464428083|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
129037703|NCT01435928|464428084|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
129037704|NCT01435928|464428082|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
129037705|NCT01435928|464428083|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
129037706|NCT01435928|464428084|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
129037707|NCT01435928|464428082|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
129037708|NCT01435928|464428083|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
129037709|NCT01435928|464428084|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
129037710|NCT01435928|464428082|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
129037711|NCT01435928|464428083|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
129037712|NCT01435928|464428084|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
129037713|NCT01435928|464428082|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
129037714|NCT01435928|464428083|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
129037715|NCT01435928|464428084|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
129037716|NCT01435928|464428082|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
129037717|NCT01435928|464428083|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
129037718|NCT01435928|464428084|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
129037719|NCT01435928|464428082|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
129037720|NCT01435928|464428083|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
129037721|NCT01435928|464428084|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
129037722|NCT00292227|464428086|FG000|Patch Period|Adverse Event|1|||
129037723|NCT00292227|464428087|FG001|Patch Period|Adverse Event|0|||
129037724|NCT00292227|464428088|FG002|Patch Period|Adverse Event|2|||
129037725|NCT00292227|464428086|FG000|Patch Period|Withdrawal by Subject|0|||
129037726|NCT00292227|464428087|FG001|Patch Period|Withdrawal by Subject|0|||
129037727|NCT00292227|464428088|FG002|Patch Period|Withdrawal by Subject|1|||
129037728|NCT02093923|464428089|FG000|Overall Study|Lost to Follow-up|0|||
129037729|NCT02093923|464428090|FG001|Overall Study|Lost to Follow-up|0|||
129037730|NCT02093923|464428091|FG002|Overall Study|Lost to Follow-up|0|||
129037731|NCT02093923|464428092|FG003|Overall Study|Lost to Follow-up|1|||
129037732|NCT02093923|464428093|FG004|Overall Study|Lost to Follow-up|0|||
129037733|NCT02093923|464428089|FG000|Overall Study|Screen failure after randomization|0|||
129037734|NCT02093923|464428090|FG001|Overall Study|Screen failure after randomization|0|||
129037735|NCT02093923|464428091|FG002|Overall Study|Screen failure after randomization|0|||
129037736|NCT02093923|464428092|FG003|Overall Study|Screen failure after randomization|1|||
129037737|NCT02093923|464428093|FG004|Overall Study|Screen failure after randomization|0|||
129037738|NCT00442546|464428096|FG000|Overall Study|Adverse Event|11|||
129037739|NCT00442546|464428097|FG001|Overall Study|Adverse Event|17|||
129037740|NCT00442546|464428098|FG002|Overall Study|Adverse Event|13|||
129037741|NCT00442546|464428096|FG000|Overall Study|Lost to Follow-up|1|||
129037742|NCT00442546|464428097|FG001|Overall Study|Lost to Follow-up|2|||
128965358|NCT00814307|464157970|FG001|Overall Study|Withdrawal by Subject|6|||
128965359|NCT00814307|464157971|FG002|Overall Study|Withdrawal by Subject|0|||
128965360|NCT00814307|464157972|FG003|Overall Study|Withdrawal by Subject|2|||
129129465|NCT01202591|464765135|FG001|Overall Study|Objective Disease Progression|0|||
129129466|NCT01202591|464765136|FG002|Overall Study|Objective Disease Progression|0|||
129129467|NCT01202591|464765137|FG003|Overall Study|Objective Disease Progression|0|||
129129468|NCT01202591|464765138|FG004|Overall Study|Objective Disease Progression|2|||
129129469|NCT01202591|464765139|FG005|Overall Study|Objective Disease Progression|0|||
129129470|NCT02830087|464765142|FG000|Overall Study|No study staff to follow-up patients|4|||
129129471|NCT02830087|464765143|FG001|Overall Study|No study staff to follow-up patients|4|||
129129472|NCT02830087|464765144|FG002|Overall Study|No study staff to follow-up patients|4|||
129129473|NCT02830087|464765145|FG003|Overall Study|No study staff to follow-up patients|3|||
129129474|NCT02830087|464765146|FG004|Overall Study|No study staff to follow-up patients|3|||
129129475|NCT02830087|464765147|FG005|Overall Study|No study staff to follow-up patients|3|||
129129476|NCT02583269|464765148|FG000|Overall Study|Patient hospitalized prior to start|1|||
129129477|NCT02583269|464765149|FG001|Overall Study|Patient hospitalized prior to start|0|||
129129478|NCT02583269|464765150|FG002|Overall Study|Patient hospitalized prior to start|0|||
129129479|NCT02583269|464765151|FG003|Overall Study|Patient hospitalized prior to start|0|||
129129480|NCT02583269|464765152|FG004|Overall Study|Patient hospitalized prior to start|0|||
129129481|NCT03611946|464765156|FG000|Overall Study|Withdrawal by Subject|0|||
129129482|NCT03611946|464765157|FG001|Overall Study|Withdrawal by Subject|0|||
129129483|NCT03611946|464765158|FG002|Overall Study|Withdrawal by Subject|1|||
129129484|NCT03611946|464765159|FG003|Overall Study|Withdrawal by Subject|0|||
129129485|NCT02207608|464765160|FG000|Overall Study|Adverse Event|1|||
129129486|NCT02207608|464765161|FG001|Overall Study|Adverse Event|0|||
129129487|NCT00980460|464765162|FG000|Overall Study|Death|0|||
129129488|NCT00980460|464765163|FG001|Overall Study|Death|0|||
129129489|NCT00980460|464765164|FG002|Overall Study|Death|1|||
129220214|NCT03682770|465106509|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129220215|NCT03682770|465106510|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129220216|NCT03682770|465106511|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129220217|NCT03682770|465106512|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129220218|NCT03682770|465106513|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129220219|NCT03682770|465106514|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
129220220|NCT03682770|465106515|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129220221|NCT03682770|465106509|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129220222|NCT03682770|465106510|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129220223|NCT03682770|465106511|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129220224|NCT03682770|465106512|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129220225|NCT03682770|465106513|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129220226|NCT03682770|465106514|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
129220227|NCT03682770|465106515|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
129220228|NCT02362282|465106516|FG000|Overall Study|Withdrawal by Subject|1|||
129220229|NCT02362282|465106517|FG001|Overall Study|Withdrawal by Subject|0|||
129220230|NCT01470326|465106518|FG000|Overall Study|Protocol Violation|32|||
129220231|NCT01470326|465106518|FG000|Overall Study|No Drug Administration Information|2|||
129220232|NCT01470326|465106518|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
129220233|NCT01166282|465106519|FG000|Open-label Period|Adverse Event|0|||
129220234|NCT01166282|465106520|FG001|Open-label Period|Adverse Event|0|||
129220235|NCT01166282|465106521|FG002|Open-label Period|Adverse Event|6|||
129220236|NCT01166282|465106519|FG000|Open-label Period|Withdrawal by Subject|0|||
129220237|NCT01166282|465106520|FG001|Open-label Period|Withdrawal by Subject|0|||
129220238|NCT01166282|465106521|FG002|Open-label Period|Withdrawal by Subject|4|||
129220239|NCT01166282|465106519|FG000|Open-label Period|Lack of Efficacy|0|||
129220240|NCT01166282|465106520|FG001|Open-label Period|Lack of Efficacy|0|||
129220241|NCT01166282|465106521|FG002|Open-label Period|Lack of Efficacy|2|||
129220242|NCT01166282|465106519|FG000|Open-label Period|Remission|0|||
129220243|NCT01166282|465106520|FG001|Open-label Period|Remission|0|||
129220244|NCT01166282|465106521|FG002|Open-label Period|Remission|4|||
129220245|NCT01166282|465106519|FG000|Open-label Period|Irregular Compliance|0|||
129220246|NCT01166282|465106520|FG001|Open-label Period|Irregular Compliance|0|||
129220247|NCT01166282|465106521|FG002|Open-label Period|Irregular Compliance|1|||
129220248|NCT00380367|465106526|FG000|Overall Study|Lost to Follow-up|1|||
128965361|NCT00814307|464157969|FG000|Overall Study|Death|0|||
129129490|NCT00980460|464765165|FG003|Overall Study|Death|2|||
129129491|NCT00980460|464765166|FG004|Overall Study|Death|1|||
129129492|NCT00980460|464765162|FG000|Overall Study|Lack of Efficacy|0|||
129129493|NCT00980460|464765163|FG001|Overall Study|Lack of Efficacy|0|||
129129494|NCT00980460|464765164|FG002|Overall Study|Lack of Efficacy|10|||
129129495|NCT00980460|464765165|FG003|Overall Study|Lack of Efficacy|6|||
129129496|NCT00980460|464765166|FG004|Overall Study|Lack of Efficacy|8|||
129129497|NCT00980460|464765162|FG000|Overall Study|Lost to Follow-up|0|||
129129498|NCT00980460|464765163|FG001|Overall Study|Lost to Follow-up|0|||
129129499|NCT00980460|464765164|FG002|Overall Study|Lost to Follow-up|0|||
129129500|NCT00980460|464765165|FG003|Overall Study|Lost to Follow-up|1|||
129220249|NCT00380367|465106526|FG000|Overall Study|Withdrawal by Subject|1|||
129129501|NCT00980460|464765166|FG004|Overall Study|Lost to Follow-up|0|||
129129502|NCT00980460|464765162|FG000|Overall Study|Physician Decision|0|||
129129503|NCT00980460|464765163|FG001|Overall Study|Physician Decision|0|||
129129504|NCT00980460|464765164|FG002|Overall Study|Physician Decision|11|||
129129505|NCT00980460|464765165|FG003|Overall Study|Physician Decision|5|||
129129506|NCT00980460|464765166|FG004|Overall Study|Physician Decision|3|||
129129507|NCT00980460|464765162|FG000|Overall Study|Withdrawal by Subject|0|||
129129508|NCT00980460|464765163|FG001|Overall Study|Withdrawal by Subject|0|||
129129509|NCT00980460|464765164|FG002|Overall Study|Withdrawal by Subject|1|||
129129510|NCT00980460|464765165|FG003|Overall Study|Withdrawal by Subject|0|||
129129511|NCT00980460|464765166|FG004|Overall Study|Withdrawal by Subject|0|||
129129512|NCT00980460|464765162|FG000|Overall Study|Ineligible|0|||
129129513|NCT00980460|464765163|FG001|Overall Study|Ineligible|2|||
129129514|NCT00980460|464765164|FG002|Overall Study|Ineligible|3|||
129129515|NCT00980460|464765165|FG003|Overall Study|Ineligible|1|||
129129516|NCT00980460|464765166|FG004|Overall Study|Ineligible|4|||
129129517|NCT00980460|464765162|FG000|Overall Study|Refusal of further therapy|0|||
129129518|NCT00980460|464765163|FG001|Overall Study|Refusal of further therapy|2|||
129129519|NCT00980460|464765164|FG002|Overall Study|Refusal of further therapy|3|||
129129520|NCT00980460|464765165|FG003|Overall Study|Refusal of further therapy|2|||
129129521|NCT00980460|464765166|FG004|Overall Study|Refusal of further therapy|0|||
129129522|NCT00980460|464765162|FG000|Overall Study|No therapy within 42 days of resection|0|||
129129523|NCT00980460|464765163|FG001|Overall Study|No therapy within 42 days of resection|0|||
129129524|NCT00980460|464765164|FG002|Overall Study|No therapy within 42 days of resection|3|||
129129525|NCT00980460|464765165|FG003|Overall Study|No therapy within 42 days of resection|1|||
129129526|NCT00980460|464765166|FG004|Overall Study|No therapy within 42 days of resection|0|||
129129527|NCT00980460|464765162|FG000|Overall Study|No transplant by protocol timepoints|0|||
129129528|NCT00980460|464765163|FG001|Overall Study|No transplant by protocol timepoints|0|||
129129529|NCT00980460|464765164|FG002|Overall Study|No transplant by protocol timepoints|3|||
129129530|NCT00980460|464765165|FG003|Overall Study|No transplant by protocol timepoints|0|||
129129531|NCT00980460|464765166|FG004|Overall Study|No transplant by protocol timepoints|0|||
129129532|NCT00876395|464766402|FG000|Overall Study|Untreated|8|||
129129533|NCT00876395|464766403|FG001|Overall Study|Untreated|1|||
129129534|NCT00876395|464766402|FG000|Overall Study|Adverse Event|63|||
129129535|NCT00876395|464766403|FG001|Overall Study|Adverse Event|11|||
129129536|NCT00876395|464766402|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129129537|NCT00876395|464766403|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129129538|NCT00876395|464766402|FG000|Overall Study|Disease progression|259|||
129129539|NCT00876395|464766403|FG001|Overall Study|Disease progression|162|||
129129540|NCT00876395|464766402|FG000|Overall Study|New cancer therapy|25|||
129129541|NCT00876395|464766403|FG001|Overall Study|New cancer therapy|7|||
129129542|NCT00876395|464766402|FG000|Overall Study|Protocol Violation|5|||
129129543|NCT00876395|464766403|FG001|Overall Study|Protocol Violation|2|||
129129544|NCT00876395|464766402|FG000|Overall Study|Withdrawal by Subject|66|||
129129545|NCT00876395|464766403|FG001|Overall Study|Withdrawal by Subject|33|||
129129546|NCT00876395|464766402|FG000|Overall Study|Lost to Follow-up|2|||
129129547|NCT00876395|464766403|FG001|Overall Study|Lost to Follow-up|0|||
129129548|NCT00876395|464766402|FG000|Overall Study|Administrative problems|39|||
129129549|NCT00876395|464766403|FG001|Overall Study|Administrative problems|23|||
129129550|NCT00876395|464766402|FG000|Overall Study|Death|12|||
129129551|NCT00876395|464766403|FG001|Overall Study|Death|0|||
129129552|NCT03807843|464766404|FG000|Overall Study|Lost to Follow-up|1|||
129129553|NCT03807843|464766405|FG001|Overall Study|Lost to Follow-up|0|||
129129554|NCT01312129|464766406|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
129129555|NCT01312129|464766407|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
128713506|NCT00723892|463248195|FG001|Overall Study|Multiple reasons|12|||
128713507|NCT00723892|463248194|FG000|Overall Study|Other|6|||
128713508|NCT00723892|463248195|FG001|Overall Study|Other|3|||
128713509|NCT00723892|463248194|FG000|Overall Study|Study end|1|||
128713510|NCT00723892|463248195|FG001|Overall Study|Study end|3|||
129129556|NCT00924651|464766410|FG000|Overall Study|Chemo started too soon|2|||
129129557|NCT00924651|464766411|FG001|Overall Study|Chemo started too soon|3|||
129129558|NCT00924651|464766410|FG000|Overall Study|No Reason|3|||
129129559|NCT00924651|464766411|FG001|Overall Study|No Reason|7|||
129129560|NCT00924651|464766410|FG000|Overall Study|Overwhelmed|6|||
129129561|NCT00924651|464766411|FG001|Overall Study|Overwhelmed|6|||
129129562|NCT00924651|464766410|FG000|Overall Study|Noncompliant|1|||
129129563|NCT00924651|464766411|FG001|Overall Study|Noncompliant|4|||
129129564|NCT00924651|464766410|FG000|Overall Study|Medical|1|||
129129565|NCT00924651|464766411|FG001|Overall Study|Medical|3|||
128713511|NCT00723892|463248194|FG000|Overall Study|Weight loss|1|||
128713512|NCT00723892|463248195|FG001|Overall Study|Weight loss|3|||
129129566|NCT00924651|464766410|FG000|Overall Study|Changed Mind|10|||
129129567|NCT00924651|464766411|FG001|Overall Study|Changed Mind|1|||
129129568|NCT00924651|464766410|FG000|Overall Study|Incomplete Form|2|||
129129569|NCT00924651|464766411|FG001|Overall Study|Incomplete Form|1|||
129129570|NCT01991314|464766412|FG000|Overall Study|Adverse Event|5|||
129129571|NCT01991314|464766413|FG001|Overall Study|Adverse Event|1|||
129129572|NCT01991314|464766412|FG000|Overall Study|Lost to Follow-up|6|||
129129573|NCT01991314|464766413|FG001|Overall Study|Lost to Follow-up|10|||
129129574|NCT00970944|464766414|FG000|Overall Study|Death|1|||
129129575|NCT00970944|464766415|FG001|Overall Study|Death|0|||
129129576|NCT00970944|464766414|FG000|Overall Study|Physician Decision|0|||
129129577|NCT00970944|464766415|FG001|Overall Study|Physician Decision|2|||
129129578|NCT00662259|464766416|FG000|Overall Study|Adverse Event|2|||
129129579|NCT00662259|464766417|FG001|Overall Study|Adverse Event|0|||
129129580|NCT01033942|464766418|FG000|Overall Study|Withdrawal by Subject|1|||
129129581|NCT01033942|464766419|FG001|Overall Study|Withdrawal by Subject|1|||
129129582|NCT01033942|464766420|FG002|Overall Study|Withdrawal by Subject|1|||
129129583|NCT01033942|464766418|FG000|Overall Study|Lost to Follow-up|1|||
129129584|NCT01033942|464766419|FG001|Overall Study|Lost to Follow-up|0|||
129129585|NCT01033942|464766420|FG002|Overall Study|Lost to Follow-up|0|||
129129586|NCT01033942|464766418|FG000|Overall Study|Enrolled in Extension Study|0|||
129129587|NCT01033942|464766419|FG001|Overall Study|Enrolled in Extension Study|3|||
129129588|NCT01033942|464766420|FG002|Overall Study|Enrolled in Extension Study|0|||
129129589|NCT02693418|464766421|FG000|Overall Study|Lost to Follow-up|1|||
129129590|NCT02693418|464766422|FG001|Overall Study|Lost to Follow-up|2|||
129129591|NCT02693418|464766423|FG002|Overall Study|Lost to Follow-up|0|||
129129592|NCT02693418|464766424|FG003|Overall Study|Lost to Follow-up|0|||
129129593|NCT02693418|464766425|FG004|Overall Study|Lost to Follow-up|0|||
129129594|NCT02693418|464766421|FG000|Overall Study|Menses during study period|0|||
129129595|NCT02693418|464766422|FG001|Overall Study|Menses during study period|0|||
129129596|NCT02693418|464766423|FG002|Overall Study|Menses during study period|2|||
129129597|NCT02693418|464766424|FG003|Overall Study|Menses during study period|0|||
129129598|NCT02693418|464766425|FG004|Overall Study|Menses during study period|0|||
129129599|NCT01750346|464766427|FG000|Overall Study|Adverse Event|1|||
129129600|NCT01750346|464766428|FG001|Overall Study|Adverse Event|0|||
129129601|NCT01750346|464766429|FG002|Overall Study|Adverse Event|0|||
129129602|NCT02260986|464766430|FG000|Overall Study|Adverse Event|24|||
129129603|NCT02260986|464766431|FG001|Overall Study|Adverse Event|0|||
129129604|NCT02260986|464766432|FG002|Overall Study|Adverse Event|11|||
129129605|NCT02260986|464766430|FG000|Overall Study|Lack of Efficacy|27|||
129129606|NCT02260986|464766431|FG001|Overall Study|Lack of Efficacy|3|||
129129607|NCT02260986|464766432|FG002|Overall Study|Lack of Efficacy|0|||
129129608|NCT02260986|464766430|FG000|Overall Study|Protocol Violation|14|||
129129609|NCT02260986|464766431|FG001|Overall Study|Protocol Violation|5|||
129129610|NCT02260986|464766432|FG002|Overall Study|Protocol Violation|16|||
129129611|NCT02260986|464766430|FG000|Overall Study|Car accident|0|||
129129612|NCT02260986|464766431|FG001|Overall Study|Car accident|0|||
129129613|NCT02260986|464766432|FG002|Overall Study|Car accident|1|||
129129614|NCT02260986|464766430|FG000|Overall Study|Withdrawal by Subject|17|||
129129615|NCT02260986|464766431|FG001|Overall Study|Withdrawal by Subject|4|||
129129616|NCT02260986|464766432|FG002|Overall Study|Withdrawal by Subject|9|||
129129617|NCT02260986|464766430|FG000|Overall Study|Incorrect randomization|0|||
129129618|NCT02260986|464766431|FG001|Overall Study|Incorrect randomization|1|||
129129619|NCT02260986|464766432|FG002|Overall Study|Incorrect randomization|0|||
129129620|NCT02260986|464766430|FG000|Overall Study|Lack of investigation product supply|2|||
129129621|NCT02260986|464766431|FG001|Overall Study|Lack of investigation product supply|0|||
129129622|NCT02260986|464766432|FG002|Overall Study|Lack of investigation product supply|1|||
129129623|NCT02260986|464766430|FG000|Overall Study|Lost to Follow-up|4|||
129129624|NCT02260986|464766431|FG001|Overall Study|Lost to Follow-up|0|||
129129625|NCT02260986|464766432|FG002|Overall Study|Lost to Follow-up|3|||
129129626|NCT02260986|464766430|FG000|Overall Study|Pregnancy|2|||
129129627|NCT02260986|464766431|FG001|Overall Study|Pregnancy|0|||
129129628|NCT02260986|464766432|FG002|Overall Study|Pregnancy|0|||
129129629|NCT02782468|464766435|FG000|Overall Study|Progressive Disease|2|||
129129630|NCT02782468|464766436|FG001|Overall Study|Progressive Disease|5|||
129129631|NCT02782468|464766437|FG002|Overall Study|Progressive Disease|0|||
129129632|NCT02782468|464766438|FG003|Overall Study|Progressive Disease|4|||
129129633|NCT02782468|464766435|FG000|Overall Study|Adverse Event|0|||
128965362|NCT00814307|464157970|FG001|Overall Study|Death|1|||
128965363|NCT00814307|464157971|FG002|Overall Study|Death|0|||
128965364|NCT00814307|464157972|FG003|Overall Study|Death|0|||
129129634|NCT02782468|464766436|FG001|Overall Study|Adverse Event|2|||
129129635|NCT02782468|464766437|FG002|Overall Study|Adverse Event|2|||
129129636|NCT02782468|464766438|FG003|Overall Study|Adverse Event|3|||
129129637|NCT02782468|464766435|FG000|Overall Study|Other|0|||
129129638|NCT02782468|464766436|FG001|Overall Study|Other|0|||
129129639|NCT02782468|464766437|FG002|Overall Study|Other|1|||
129129640|NCT02782468|464766438|FG003|Overall Study|Other|1|||
128965365|NCT02290340|464157974|FG000|Overall Study|Lost to Follow-up|0|||
129129641|NCT02782468|464766435|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
129129642|NCT02782468|464766436|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
129129643|NCT02782468|464766437|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
129129644|NCT02782468|464766438|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
129129645|NCT02782468|464766435|FG000|Overall Study|Symptomatic Deterioration|0|||
129129646|NCT02782468|464766436|FG001|Overall Study|Symptomatic Deterioration|0|||
129129647|NCT02782468|464766437|FG002|Overall Study|Symptomatic Deterioration|0|||
128965366|NCT02290340|464157975|FG001|Overall Study|Lost to Follow-up|0|||
128965367|NCT02290340|464157976|FG002|Overall Study|Lost to Follow-up|0|||
128965368|NCT02290340|464157977|FG003|Overall Study|Lost to Follow-up|1|||
129129648|NCT02782468|464766438|FG003|Overall Study|Symptomatic Deterioration|1|||
128965369|NCT02290340|464157974|FG000|Overall Study|Withdrawal by Subject|1|||
128965370|NCT02290340|464157975|FG001|Overall Study|Withdrawal by Subject|0|||
128965371|NCT02290340|464157976|FG002|Overall Study|Withdrawal by Subject|0|||
128965372|NCT02290340|464157977|FG003|Overall Study|Withdrawal by Subject|0|||
128965373|NCT02290340|464157974|FG000|Overall Study|Other|1|||
128965374|NCT02290340|464157975|FG001|Overall Study|Other|0|||
128965375|NCT02290340|464157976|FG002|Overall Study|Other|0|||
128965376|NCT02290340|464157977|FG003|Overall Study|Other|1|||
128965377|NCT01594749|464160008|FG000|Overall Study|Adverse Event|2|||
128965378|NCT01594749|464160009|FG001|Overall Study|Adverse Event|1|||
128965379|NCT01594749|464160008|FG000|Overall Study|Withdrawal by Subject|2|||
128965380|NCT01594749|464160009|FG001|Overall Study|Withdrawal by Subject|2|||
128965381|NCT01594749|464160008|FG000|Overall Study|Protocol Violation|2|||
129129649|NCT02782468|464766435|FG000|Overall Study|Withdrawal by Subject|1|||
129129650|NCT02782468|464766436|FG001|Overall Study|Withdrawal by Subject|0|||
129129651|NCT02782468|464766437|FG002|Overall Study|Withdrawal by Subject|0|||
129129652|NCT02782468|464766438|FG003|Overall Study|Withdrawal by Subject|0|||
129129653|NCT00356590|464766439|FG000|Overall Study|Adverse Event|54|||
129129654|NCT00356590|464766439|FG000|Overall Study|Death|10|||
129129655|NCT00356590|464766439|FG000|Overall Study|Lost to Follow-up|35|||
129129656|NCT00356590|464766439|FG000|Overall Study|Physician Decision|46|||
129129657|NCT00356590|464766439|FG000|Overall Study|Withdrawal by Subject|41|||
129129658|NCT00356590|464766439|FG000|Overall Study|Completed month 12 only|2|||
129129659|NCT00356590|464766439|FG000|Overall Study|Protocol issues|6|||
129129660|NCT00356590|464766439|FG000|Overall Study|Response status|28|||
129129661|NCT00356590|464766439|FG000|Overall Study|Other|52|||
129129662|NCT03086343|464766442|FG000|Period 1|Adverse Event|7|||
129129663|NCT03086343|464766443|FG001|Period 1|Adverse Event|7|||
129129664|NCT03086343|464766444|FG002|Period 1|Adverse Event|0|||
129129665|NCT03086343|464766445|FG003|Period 1|Adverse Event|1|||
129129666|NCT03086343|464766442|FG000|Period 1|Withdrawal by Subject|6|||
129129667|NCT03086343|464766443|FG001|Period 1|Withdrawal by Subject|10|||
129129668|NCT03086343|464766444|FG002|Period 1|Withdrawal by Subject|0|||
129129669|NCT03086343|464766445|FG003|Period 1|Withdrawal by Subject|0|||
129129670|NCT03086343|464766442|FG000|Period 1|Lost to Follow-up|1|||
129129671|NCT03086343|464766443|FG001|Period 1|Lost to Follow-up|3|||
129129672|NCT03086343|464766444|FG002|Period 1|Lost to Follow-up|1|||
129129673|NCT03086343|464766445|FG003|Period 1|Lost to Follow-up|0|||
129129674|NCT03086343|464766442|FG000|Period 1|Other, Not Specified|10|||
129129675|NCT03086343|464766443|FG001|Period 1|Other, Not Specified|12|||
129129676|NCT03086343|464766444|FG002|Period 1|Other, Not Specified|2|||
129129677|NCT03086343|464766445|FG003|Period 1|Other, Not Specified|1|||
129129678|NCT03086343|464766442|FG000|Period 1|Missing|1|||
129129679|NCT03086343|464766443|FG001|Period 1|Missing|0|||
129129680|NCT03086343|464766444|FG002|Period 1|Missing|0|||
129129681|NCT03086343|464766445|FG003|Period 1|Missing|0|||
129129682|NCT03086343|464766442|FG000|Period 2|Adverse Event|20|||
129129683|NCT03086343|464766443|FG001|Period 2|Adverse Event|11|||
129129684|NCT03086343|464766444|FG002|Period 2|Adverse Event|1|||
129129685|NCT03086343|464766445|FG003|Period 2|Adverse Event|2|||
129129686|NCT03086343|464766442|FG000|Period 2|Withdrawal by Subject|15|||
129129687|NCT03086343|464766443|FG001|Period 2|Withdrawal by Subject|25|||
129129688|NCT03086343|464766444|FG002|Period 2|Withdrawal by Subject|2|||
129129689|NCT03086343|464766445|FG003|Period 2|Withdrawal by Subject|2|||
128965382|NCT01594749|464160009|FG001|Overall Study|Protocol Violation|0|||
128965383|NCT01594749|464160008|FG000|Overall Study|Physician Decision|1|||
129129690|NCT03086343|464766442|FG000|Period 2|Lost to Follow-up|6|||
129129691|NCT03086343|464766443|FG001|Period 2|Lost to Follow-up|11|||
129129692|NCT03086343|464766444|FG002|Period 2|Lost to Follow-up|1|||
129129693|NCT03086343|464766445|FG003|Period 2|Lost to Follow-up|0|||
129129694|NCT03086343|464766442|FG000|Period 2|COVID-19 Infection|5|||
128965384|NCT01594749|464160009|FG001|Overall Study|Physician Decision|1|||
128965385|NCT01594749|464160008|FG000|Overall Study|Non-compliance with Protocol|0|||
128965386|NCT01594749|464160009|FG001|Overall Study|Non-compliance with Protocol|1|||
128965387|NCT01594749|464160008|FG000|Overall Study|Lost to Follow-up|1|||
128965388|NCT01594749|464160009|FG001|Overall Study|Lost to Follow-up|0|||
128965389|NCT01594749|464160008|FG000|Overall Study|Death|9|||
128965390|NCT01594749|464160009|FG001|Overall Study|Death|3|||
129129695|NCT03086343|464766443|FG001|Period 2|COVID-19 Infection|0|||
129129696|NCT03086343|464766444|FG002|Period 2|COVID-19 Infection|0|||
129129697|NCT03086343|464766445|FG003|Period 2|COVID-19 Infection|0|||
129129698|NCT03086343|464766442|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
129129699|NCT03086343|464766443|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
129129700|NCT03086343|464766444|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
129129701|NCT03086343|464766445|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
129129702|NCT03086343|464766442|FG000|Period 2|Other, Not Specified|23|||
129129703|NCT03086343|464766443|FG001|Period 2|Other, Not Specified|22|||
128965391|NCT01594749|464160008|FG000|Overall Study|Not Treated|4|||
128965392|NCT01594749|464160009|FG001|Overall Study|Not Treated|10|||
128713513|NCT00723892|463248194|FG000|Overall Study|Alcohol abuse|0|||
128713514|NCT00723892|463248195|FG001|Overall Study|Alcohol abuse|1|||
128713515|NCT00723892|463248194|FG000|Overall Study|Intercurrent infection|2|||
128713516|NCT00723892|463248195|FG001|Overall Study|Intercurrent infection|0|||
128713517|NCT00723892|463248194|FG000|Overall Study|Drug addiction|1|||
128713518|NCT00723892|463248195|FG001|Overall Study|Drug addiction|0|||
128713519|NCT01172847|463248196|FG000|Overall Study|Withdrawal by Subject|3|||
128713520|NCT01163279|463248200|FG000|Overall Study|Withdrawal by Subject|2|||
128713521|NCT01163279|463248201|FG001|Overall Study|Withdrawal by Subject|0|||
128713522|NCT02411292|463248202|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
128713523|NCT02411292|463248202|FG000|Overall Study|Death|2|||
128713524|NCT02411292|463248202|FG000|Overall Study|Lost to Follow-up|3|||
128713525|NCT02232425|463248203|FG000|Overall Study|Lost to Follow-up|6|||
128713526|NCT02232425|463248204|FG001|Overall Study|Lost to Follow-up|2|||
128713527|NCT02232425|463248203|FG000|Overall Study|Adverse Event|2|||
128713528|NCT02232425|463248204|FG001|Overall Study|Adverse Event|0|||
128713529|NCT02232425|463248203|FG000|Overall Study|Withdrawal by Subject|5|||
128713530|NCT02232425|463248204|FG001|Overall Study|Withdrawal by Subject|6|||
128713531|NCT02232425|463248203|FG000|Overall Study|Lack of Efficacy|1|||
128713532|NCT02232425|463248204|FG001|Overall Study|Lack of Efficacy|0|||
128713533|NCT00665353|463248205|FG000|Study Step 1|Adverse Event|1|||
128713534|NCT00665353|463248205|FG000|Study Step 1|Withdrawal by Subject|2|||
128713535|NCT00665353|463248205|FG000|Study Step 2|Lost to Follow-up|2|||
128965393|NCT01594749|464160008|FG000|Overall Study|Lost Source Documentation|1|||
128965394|NCT01594749|464160009|FG001|Overall Study|Lost Source Documentation|0|||
128965395|NCT00922974|464160010|FG000|Phase II Component|Protocol Violation|2|||
128965396|NCT00922974|464160011|FG001|Phase II Component|Protocol Violation|0|||
128965397|NCT00922974|464160010|FG000|Phase II Component|Not evaluable for treatment review|5|||
128965398|NCT00922974|464160011|FG001|Phase II Component|Not evaluable for treatment review|0|||
128965399|NCT00922974|464160010|FG000|Phase III Component|Protocol Violation|8|||
128965400|NCT00922974|464160011|FG001|Phase III Component|Protocol Violation|6|||
128965401|NCT03950440|464160012|FG000|Overall Study|Death|8|||
128965402|NCT03950440|464160013|FG001|Overall Study|Death|2|||
128965403|NCT03950440|464160014|FG002|Overall Study|Death|1|||
128965404|NCT00430027|464160015|FG000|Overall Study|Study terminated|8|||
128965405|NCT01957215|464160016|FG000|Overall Study|Adverse Event|2|||
128965406|NCT01957215|464160017|FG001|Overall Study|Adverse Event|2|||
128965407|NCT01957215|464160016|FG000|Overall Study|Lost to Follow-up|3|||
128965408|NCT01957215|464160017|FG001|Overall Study|Lost to Follow-up|3|||
128965409|NCT01957215|464160016|FG000|Overall Study|Protocol Violation|1|||
128965410|NCT01957215|464160017|FG001|Overall Study|Protocol Violation|2|||
128965411|NCT01957215|464160016|FG000|Overall Study|Withdrawal by Subject|7|||
128965412|NCT01957215|464160017|FG001|Overall Study|Withdrawal by Subject|5|||
128965413|NCT00634751|464160022|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
128965414|NCT00634751|464160023|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
128965415|NCT00634751|464160024|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
128965416|NCT00634751|464160025|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
128965417|NCT00634751|464160022|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
128965418|NCT00634751|464160023|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
128965419|NCT00634751|464160024|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
128965420|NCT00634751|464160025|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
128965421|NCT00634751|464160022|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
128965422|NCT00634751|464160023|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
128965423|NCT00634751|464160024|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
128965424|NCT00634751|464160025|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
128965425|NCT00088595|464160028|FG000|Overall Study|Adverse Event|11|||
128965426|NCT00088595|464160028|FG000|Overall Study|Withdrawal by Subject|8|||
128965427|NCT00088595|464160028|FG000|Overall Study|Ongoing (After Core)|7|||
128965428|NCT00088595|464160028|FG000|Overall Study|New Cancer Therapy|2|||
128965429|NCT01308853|464160034|FG000|Overall Study|Adverse Event|1|||
128965430|NCT01308853|464160034|FG000|Overall Study|Lost to Follow-up|2|||
128965431|NCT01308853|464160034|FG000|Overall Study|Insertion of permanent implants|1|||
128965432|NCT01119963|464160036|FG000|Overall Study|Lost to Follow-up|1|||
128965433|NCT01119963|464160037|FG001|Overall Study|Lost to Follow-up|1|||
128965434|NCT02603172|464160038|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
128965435|NCT02603172|464160039|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129129704|NCT03086343|464766444|FG002|Period 2|Other, Not Specified|2|||
128965436|NCT02603172|464160040|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
129129705|NCT03086343|464766445|FG003|Period 2|Other, Not Specified|4|||
129129706|NCT01922011|464766446|FG000|Overall Study|Protocol Violation|0|||
128713536|NCT00665353|463248205|FG000|Study Step 2|Lack of Efficacy|12|||
128713537|NCT01601626|463248206|FG000|Overall Study|Death|1|||
128713538|NCT01601626|463248207|FG001|Overall Study|Death|1|||
128713539|NCT01601626|463248208|FG002|Overall Study|Death|1|||
128713540|NCT01601626|463248206|FG000|Overall Study|Lost to Follow-up|1|||
128713541|NCT01601626|463248207|FG001|Overall Study|Lost to Follow-up|2|||
129129707|NCT01922011|464766447|FG001|Overall Study|Protocol Violation|1|||
129129708|NCT01922011|464766446|FG000|Overall Study|Physician Decision|0|||
129129709|NCT01922011|464766447|FG001|Overall Study|Physician Decision|1|||
129129710|NCT01922011|464766446|FG000|Overall Study|Parent/Guardian Decision|3|||
129129711|NCT01922011|464766447|FG001|Overall Study|Parent/Guardian Decision|0|||
129129712|NCT01922011|464766446|FG000|Overall Study|Lost to Follow-up|0|||
129129713|NCT01922011|464766447|FG001|Overall Study|Lost to Follow-up|1|||
129129714|NCT01922011|464766446|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
129129715|NCT01922011|464766447|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
129129716|NCT01922011|464766446|FG000|Overall Study|Not Treated|1|||
129129717|NCT01922011|464766447|FG001|Overall Study|Not Treated|0|||
129129718|NCT01922011|464766446|FG000|Overall Study|Lack of willing home health agency|1|||
129129719|NCT01922011|464766447|FG001|Overall Study|Lack of willing home health agency|0|||
129129720|NCT01922011|464766446|FG000|Overall Study|Randomized in error|1|||
129129721|NCT01922011|464766447|FG001|Overall Study|Randomized in error|0|||
129129722|NCT00153920|464766449|FG000|Overall Study|Adverse Event|9|||
129129723|NCT00153920|464766449|FG000|Overall Study|Progressive Disease|9|||
129129724|NCT00153920|464766449|FG000|Overall Study|Physician Decision|3|||
129129725|NCT00153920|464766449|FG000|Overall Study|Lack of Response|3|||
129129726|NCT00153920|464766449|FG000|Overall Study|Death|2|||
129129727|NCT00153920|464766449|FG000|Overall Study|Withdrawal by Subject|1|||
129129728|NCT00153920|464766449|FG000|Overall Study|Non-Protocol Therapy|1|||
129129729|NCT00153920|464766449|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
129129730|NCT00153920|464766449|FG000|Overall Study|Progressive Disease before Trt|1|||
129129731|NCT01666652|464766452|FG000|Overall Study|Serious Adverse Event|0|||
129129732|NCT01666652|464766453|FG001|Overall Study|Serious Adverse Event|0|||
129129733|NCT01666652|464766454|FG002|Overall Study|Serious Adverse Event|0|||
129129734|NCT01666652|464766455|FG003|Overall Study|Serious Adverse Event|1|||
129129735|NCT01666652|464766456|FG004|Overall Study|Serious Adverse Event|0|||
129129736|NCT01666652|464766452|FG000|Overall Study|Withdrawal by Subject|0|||
129129737|NCT01666652|464766453|FG001|Overall Study|Withdrawal by Subject|0|||
129129738|NCT01666652|464766454|FG002|Overall Study|Withdrawal by Subject|0|||
129129739|NCT01666652|464766455|FG003|Overall Study|Withdrawal by Subject|0|||
129129740|NCT01666652|464766456|FG004|Overall Study|Withdrawal by Subject|1|||
129129741|NCT01666652|464766452|FG000|Overall Study|Moved from study area|1|||
129129742|NCT01666652|464766453|FG001|Overall Study|Moved from study area|0|||
129129743|NCT01666652|464766454|FG002|Overall Study|Moved from study area|0|||
129129744|NCT01666652|464766455|FG003|Overall Study|Moved from study area|2|||
129129745|NCT01666652|464766456|FG004|Overall Study|Moved from study area|0|||
129129746|NCT01666652|464766452|FG000|Overall Study|Lost to Follow-up|1|||
129129747|NCT01666652|464766453|FG001|Overall Study|Lost to Follow-up|1|||
129129748|NCT01666652|464766454|FG002|Overall Study|Lost to Follow-up|1|||
129129749|NCT01666652|464766455|FG003|Overall Study|Lost to Follow-up|1|||
129129750|NCT01666652|464766456|FG004|Overall Study|Lost to Follow-up|0|||
129129751|NCT01018979|464766457|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
129129752|NCT01018979|464766458|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
129129753|NCT01018979|464766457|FG000|Overall Study|Not received at least one dose|0|||
129129754|NCT01018979|464766458|FG001|Overall Study|Not received at least one dose|1|||
129129755|NCT03010501|464766461|FG000|Study Week 1|Withdrawal by Subject|2|||
129129756|NCT03010501|464766462|FG001|Study Week 1|Withdrawal by Subject|1|||
129129757|NCT03010501|464766463|FG002|Study Week 1|Withdrawal by Subject|0|||
129129758|NCT03010501|464766464|FG003|Study Week 1|Withdrawal by Subject|2|||
129129759|NCT03010501|464766465|FG004|Study Week 1|Withdrawal by Subject|0|||
129129760|NCT03010501|464766466|FG005|Study Week 1|Withdrawal by Subject|0|||
129129761|NCT03010501|464766461|FG000|Study Week 3|Withdrawal by Subject|0|||
129129762|NCT03010501|464766462|FG001|Study Week 3|Withdrawal by Subject|0|||
128965437|NCT02603172|464160041|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
128965438|NCT02603172|464160042|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
128965439|NCT02603172|464160043|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129129763|NCT03010501|464766463|FG002|Study Week 3|Withdrawal by Subject|0|||
129129764|NCT03010501|464766464|FG003|Study Week 3|Withdrawal by Subject|1|||
128965440|NCT02603172|464160044|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
128965441|NCT02603172|464160045|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
128965442|NCT02244619|464160046|FG000|Overall Study|Did not receive study intervention|8|||
129129765|NCT03010501|464766465|FG004|Study Week 3|Withdrawal by Subject|0|||
129129766|NCT03010501|464766466|FG005|Study Week 3|Withdrawal by Subject|0|||
129129767|NCT00640289|464766467|FG000|Overall Study|Death|3|||
128965443|NCT02244619|464160047|FG001|Overall Study|Did not receive study intervention|21|||
128965444|NCT03285490|464160049|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
129129768|NCT00640289|464766467|FG000|Overall Study|Withdrawal by Subject|1|||
129129769|NCT00640289|464766467|FG000|Overall Study|Lost to Follow-up|1|||
129129770|NCT00640289|464766467|FG000|Overall Study|Data collected under different amendment|2|||
129129771|NCT00640289|464766467|FG000|Overall Study|Transferred to another center|1|||
129129772|NCT00640289|464766467|FG000|Overall Study|Missing status|5|||
129129773|NCT00544882|464766470|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
129129774|NCT00544882|464766471|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
129129775|NCT00544882|464766472|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
129129776|NCT00544882|464766470|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
129129777|NCT00544882|464766471|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
129129778|NCT00544882|464766472|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
129129779|NCT00544882|464766470|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
129129780|NCT00544882|464766471|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
129129781|NCT00544882|464766472|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
129129782|NCT00544882|464766470|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
129129783|NCT00544882|464766471|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
129129784|NCT00544882|464766472|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
129129785|NCT00544882|464766470|FG000|Cycle 3: Follow-up|Noncompliance|0|||
129129786|NCT00544882|464766471|FG001|Cycle 3: Follow-up|Noncompliance|1|||
129129787|NCT00544882|464766472|FG002|Cycle 3: Follow-up|Noncompliance|0|||
129129788|NCT00544882|464766470|FG000|Cycle 3: Follow-up|Pregnancy|0|||
129129789|NCT00544882|464766471|FG001|Cycle 3: Follow-up|Pregnancy|1|||
129129790|NCT00544882|464766472|FG002|Cycle 3: Follow-up|Pregnancy|0|||
128771608|NCT00358215|463455303|FG001|Overall Study|Ineligibility determined|3|||
128771609|NCT00358215|463455302|FG000|Overall Study|Adverse Event|83|||
128771610|NCT00358215|463455303|FG001|Overall Study|Adverse Event|65|||
128771611|NCT00358215|463455302|FG000|Overall Study|Withdrawal by Subject|111|||
128771612|NCT00358215|463455303|FG001|Overall Study|Withdrawal by Subject|102|||
128771613|NCT00358215|463455302|FG000|Overall Study|Participant request|65|||
128771614|NCT00358215|463455303|FG001|Overall Study|Participant request|64|||
128771615|NCT00358215|463455302|FG000|Overall Study|Physician Decision|47|||
128771616|NCT00358215|463455303|FG001|Overall Study|Physician Decision|39|||
128771617|NCT00358215|463455302|FG000|Overall Study|Lost to Follow-up|16|||
128771618|NCT00358215|463455303|FG001|Overall Study|Lost to Follow-up|22|||
128771619|NCT00358215|463455302|FG000|Overall Study|Death|265|||
128771620|NCT00358215|463455303|FG001|Overall Study|Death|281|||
128771621|NCT00358215|463455302|FG000|Overall Study|Protocol Violation|64|||
128771622|NCT00358215|463455303|FG001|Overall Study|Protocol Violation|59|||
128771623|NCT00358215|463455302|FG000|Overall Study|Pregnancy|1|||
128771624|NCT00358215|463455303|FG001|Overall Study|Pregnancy|0|||
128771625|NCT00358215|463455302|FG000|Overall Study|Other|21|||
128771626|NCT00358215|463455303|FG001|Overall Study|Other|14|||
128771627|NCT00358215|463455302|FG000|Overall Study|Did not receive investigational product|2|||
128771628|NCT00358215|463455303|FG001|Overall Study|Did not receive investigational product|3|||
128771629|NCT04329104|463455310|FG000|Efficacy Study|Withdrawal by Subject|0|||
128771630|NCT04329104|463455311|FG001|Efficacy Study|Withdrawal by Subject|0|||
128771631|NCT04329104|463455312|FG002|Efficacy Study|Withdrawal by Subject|0|||
128771632|NCT04329104|463455313|FG003|Efficacy Study|Withdrawal by Subject|5|||
128771633|NCT04329104|463455314|FG004|Efficacy Study|Withdrawal by Subject|6|||
128771634|NCT04329104|463455315|FG005|Efficacy Study|Withdrawal by Subject|8|||
128771635|NCT03884231|463455316|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
128771636|NCT03884231|463455316|FG000|Overall Study|Subject Withdrew Consent|1|||
128771637|NCT03884231|463455316|FG000|Overall Study|MRI Scan Not Performed|1|||
128771638|NCT01853254|463455317|FG000|Overall Study|Abnormal Laboratory Test|1|||
128771639|NCT01853254|463455317|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
128771640|NCT01853254|463455317|FG000|Overall Study|Death|1|||
128771641|NCT01853254|463455317|FG000|Overall Study|Failure to Return|43|||
128771642|NCT01853254|463455317|FG000|Overall Study|Insufficient Therapeutic Response|22|||
128965445|NCT03285490|464160050|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
128965446|NCT03285490|464160049|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
128965447|NCT03285490|464160050|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
129129791|NCT03043573|464766473|FG000|Overall Study|Lost to Follow-up|3|||
129129792|NCT03043573|464766474|FG001|Overall Study|Lost to Follow-up|3|||
129129793|NCT03043573|464766473|FG000|Overall Study|Physician Decision|0|||
129129794|NCT03043573|464766474|FG001|Overall Study|Physician Decision|5|||
129129795|NCT03043573|464766473|FG000|Overall Study|Withdrawal by Subject|0|||
129129796|NCT03043573|464766474|FG001|Overall Study|Withdrawal by Subject|4|||
129129797|NCT03599713|464766480|FG000|Overall Study|Death|38|||
129129798|NCT03599713|464766481|FG001|Overall Study|Death|3|||
129220250|NCT00392769|465106529|FG000|Overall Study|Clinical Deterioration|9|||
129220251|NCT00392769|465106529|FG000|Overall Study|Adverse Event|1|||
128965448|NCT03745989|464160051|FG000|Overall Study|Death|3|||
128771643|NCT01853254|463455317|FG000|Overall Study|Refusal of Treatment|1|||
128771644|NCT01853254|463455317|FG000|Overall Study|Other Protocol Violation|1|||
128771645|NCT01853254|463455317|FG000|Overall Study|Withdrawal of Consent|16|||
128965449|NCT03745989|464160052|FG001|Overall Study|Death|7|||
128771646|NCT01853254|463455317|FG000|Overall Study|Administrative/Other|16|||
128771647|NCT01017120|463455323|FG000|Overall Study|Adverse Event|9|||
128771648|NCT01017120|463455324|FG001|Overall Study|Adverse Event|0|||
129129799|NCT03599713|464766480|FG000|Overall Study|Withdrawal by Subject|17|||
129129800|NCT03599713|464766481|FG001|Overall Study|Withdrawal by Subject|0|||
129129801|NCT03599713|464766480|FG000|Overall Study|Lost to Follow-up|4|||
128713542|NCT01601626|463248208|FG002|Overall Study|Lost to Follow-up|0|||
128713543|NCT01601626|463248206|FG000|Overall Study|Unable to Get to Clinic|0|||
128713544|NCT01601626|463248207|FG001|Overall Study|Unable to Get to Clinic|1|||
128713545|NCT01601626|463248208|FG002|Overall Study|Unable to Get to Clinic|0|||
128965450|NCT03745989|464160053|FG002|Overall Study|Death|4|||
128965451|NCT03745989|464160051|FG000|Overall Study|Lost to Follow-up|0|||
128965452|NCT03745989|464160052|FG001|Overall Study|Lost to Follow-up|2|||
128965453|NCT03745989|464160053|FG002|Overall Study|Lost to Follow-up|0|||
128965454|NCT03745989|464160051|FG000|Overall Study|Sponsor Decision|0|||
128965455|NCT03745989|464160052|FG001|Overall Study|Sponsor Decision|2|||
128965456|NCT03745989|464160053|FG002|Overall Study|Sponsor Decision|8|||
128965457|NCT03745989|464160051|FG000|Overall Study|Withdrawal by Subject|0|||
128965458|NCT03745989|464160052|FG001|Overall Study|Withdrawal by Subject|1|||
128965459|NCT03745989|464160053|FG002|Overall Study|Withdrawal by Subject|3|||
129037743|NCT00442546|464428098|FG002|Overall Study|Lost to Follow-up|1|||
129037744|NCT00442546|464428096|FG000|Overall Study|Other|4|||
129037745|NCT00442546|464428097|FG001|Overall Study|Other|9|||
129037746|NCT00442546|464428098|FG002|Overall Study|Other|6|||
129037747|NCT00442546|464428096|FG000|Overall Study|Withdrawal by Subject|5|||
129037748|NCT00442546|464428097|FG001|Overall Study|Withdrawal by Subject|5|||
129037749|NCT00442546|464428098|FG002|Overall Study|Withdrawal by Subject|7|||
129037750|NCT00442546|464428096|FG000|Overall Study|Randomized But Not Treated|5|||
129037751|NCT00442546|464428097|FG001|Overall Study|Randomized But Not Treated|4|||
129037752|NCT00442546|464428098|FG002|Overall Study|Randomized But Not Treated|6|||
129037753|NCT00248170|464428099|FG000|Overall Study|Withdrawal by Subject|71|||
129037754|NCT00248170|464428100|FG001|Overall Study|Withdrawal by Subject|79|||
129037755|NCT00248170|464428099|FG000|Overall Study|Protocol Violation|35|||
129037756|NCT00248170|464428100|FG001|Overall Study|Protocol Violation|30|||
129037757|NCT00248170|464428099|FG000|Overall Study|Lost to Follow-up|28|||
129037758|NCT00248170|464428100|FG001|Overall Study|Lost to Follow-up|35|||
129037759|NCT00248170|464428099|FG000|Overall Study|Disease progression|196|||
129037760|NCT00248170|464428100|FG001|Overall Study|Disease progression|216|||
129037761|NCT00248170|464428099|FG000|Overall Study|Death|28|||
129037762|NCT00248170|464428100|FG001|Overall Study|Death|47|||
129037763|NCT00248170|464428099|FG000|Overall Study|Adverse Event|311|||
129037764|NCT00248170|464428100|FG001|Overall Study|Adverse Event|296|||
129037765|NCT00248170|464428099|FG000|Overall Study|Administrative problems|22|||
129037766|NCT00248170|464428100|FG001|Overall Study|Administrative problems|25|||
129037767|NCT00248170|464428099|FG000|Overall Study|Abnormal test procedure(s) result|49|||
129037768|NCT00248170|464428100|FG001|Overall Study|Abnormal test procedure(s) result|61|||
129037769|NCT00248170|464428099|FG000|Overall Study|Abnormal laboratory values|4|||
129037770|NCT00248170|464428100|FG001|Overall Study|Abnormal laboratory values|0|||
129037771|NCT00248170|464428099|FG000|Overall Study|Protocol deviation|17|||
129037772|NCT00248170|464428100|FG001|Overall Study|Protocol deviation|19|||
129037773|NCT01557582|464428101|FG000|Overall Study|Protocol Violation|4|||
129037774|NCT01557582|464428101|FG000|Overall Study|Operator error|2|||
129037775|NCT02843659|464428102|FG000|Overall Study|Subject Withdrew Consent|0|||
129037776|NCT02843659|464428103|FG001|Overall Study|Subject Withdrew Consent|0|||
129037777|NCT02843659|464428104|FG002|Overall Study|Subject Withdrew Consent|1|||
129037778|NCT02843659|464428102|FG000|Overall Study|Administrative Reason by Sponsor|4|||
129037779|NCT02843659|464428103|FG001|Overall Study|Administrative Reason by Sponsor|5|||
129037780|NCT02843659|464428104|FG002|Overall Study|Administrative Reason by Sponsor|4|||
129037781|NCT02843659|464428102|FG000|Overall Study|Adverse Event|0|||
129037782|NCT02843659|464428103|FG001|Overall Study|Adverse Event|1|||
129037783|NCT02843659|464428104|FG002|Overall Study|Adverse Event|0|||
129037784|NCT02413294|464428108|FG000|Overall Study|Withdrawal by Subject|1|||
129037785|NCT01253317|464428118|FG000|Overall Study|Adverse Event|2|||
129037786|NCT00831233|464430467|FG000|Overall Study|Adverse Event|0|||
129037787|NCT00831233|464430468|FG001|Overall Study|Adverse Event|1|||
129037788|NCT00831233|464430467|FG000|Overall Study|Protocol Violation|1|||
129037789|NCT00831233|464430468|FG001|Overall Study|Protocol Violation|0|||
129037790|NCT00831233|464430467|FG000|Overall Study|Selection Criteria Not Met|2|||
129037791|NCT00831233|464430468|FG001|Overall Study|Selection Criteria Not Met|0|||
129037792|NCT01796964|464430483|FG000|Overall Study|Adverse Event|1|||
129037793|NCT01796964|464430484|FG001|Overall Study|Adverse Event|1|||
129037794|NCT01796964|464430483|FG000|Overall Study|Death|1|||
129037795|NCT01796964|464430484|FG001|Overall Study|Death|0|||
129037796|NCT01796964|464430483|FG000|Overall Study|Protocol Violation|0|||
129037797|NCT01796964|464430484|FG001|Overall Study|Protocol Violation|1|||
129037798|NCT01796964|464430483|FG000|Overall Study|Withdrawal by Subject|1|||
129037799|NCT01796964|464430484|FG001|Overall Study|Withdrawal by Subject|1|||
129037800|NCT04025684|464430485|FG000|Overall Study|Withdrawal by Subject|1|||
129037801|NCT04025684|464430486|FG001|Overall Study|Withdrawal by Subject|1|||
129037802|NCT04025684|464430487|FG002|Overall Study|Withdrawal by Subject|0|||
129037803|NCT04025684|464430488|FG003|Overall Study|Withdrawal by Subject|0|||
129037804|NCT04025684|464430485|FG000|Overall Study|Multiple reasons|1|||
128713546|NCT01601626|463248206|FG000|Overall Study|Withdrawal by Subject|0|||
128713547|NCT01601626|463248207|FG001|Overall Study|Withdrawal by Subject|1|||
128965460|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
128713548|NCT01601626|463248208|FG002|Overall Study|Withdrawal by Subject|1|||
128713549|NCT01601626|463248206|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
128713550|NCT01601626|463248207|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
128713551|NCT01601626|463248208|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
128713552|NCT00498602|463248209|FG000|Overall Study|Death|0|||
128713553|NCT00498602|463248210|FG001|Overall Study|Death|0|||
128713554|NCT00498602|463248211|FG002|Overall Study|Death|0|||
128713555|NCT00498602|463248212|FG003|Overall Study|Death|0|||
128713556|NCT00498602|463248213|FG004|Overall Study|Death|0|||
128965461|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
128965462|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
128965463|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
128965464|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
128965465|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
128965466|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
128965467|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
128965468|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
128965469|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
128965470|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
128965471|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
128965472|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
128965473|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
128965474|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
128965475|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
129037805|NCT04025684|464430486|FG001|Overall Study|Multiple reasons|3|||
129037806|NCT04025684|464430487|FG002|Overall Study|Multiple reasons|0|||
129037807|NCT04025684|464430488|FG003|Overall Study|Multiple reasons|1|||
129037808|NCT02070757|464430489|FG000|Overall Study|Adverse Event|107|||
129037809|NCT02070757|464430490|FG001|Overall Study|Adverse Event|99|||
129037810|NCT02070757|464430489|FG000|Overall Study|Lost to Follow-up|7|||
129037811|NCT02070757|464430490|FG001|Overall Study|Lost to Follow-up|4|||
129037812|NCT02070757|464430489|FG000|Overall Study|Protocol Violation|0|||
129037813|NCT02070757|464430490|FG001|Overall Study|Protocol Violation|4|||
129037814|NCT02070757|464430489|FG000|Overall Study|Withdrawal by Subject|1|||
129037815|NCT02070757|464430490|FG001|Overall Study|Withdrawal by Subject|3|||
129037816|NCT02070757|464430489|FG000|Overall Study|Investigator Decision|0|||
129037817|NCT02070757|464430490|FG001|Overall Study|Investigator Decision|2|||
129037818|NCT02070757|464430489|FG000|Overall Study|Discharged from Study Hospital|2|||
129037819|NCT02070757|464430490|FG001|Overall Study|Discharged from Study Hospital|2|||
129037820|NCT01546922|464430491|FG000|First Period of 10 Weeks|Protocol Violation|3|||
129037821|NCT01546922|464430492|FG001|First Period of 10 Weeks|Protocol Violation|1|||
129037822|NCT01546922|464430491|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
129037823|NCT01546922|464430492|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
129037824|NCT01546922|464430491|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
129037825|NCT01546922|464430492|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
129037826|NCT01546922|464430491|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
129037827|NCT01546922|464430492|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
129037828|NCT01546922|464430491|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
129037829|NCT01546922|464430492|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
129037830|NCT01613378|464430496|FG000|Overall Study|Lack of Efficacy|13|||
129037831|NCT01613378|464430496|FG000|Overall Study|Adverse Event|11|||
129037832|NCT01613378|464430496|FG000|Overall Study|Withdrawal by Subject|8|||
129037833|NCT01613378|464430496|FG000|Overall Study|Death|2|||
129037834|NCT01613378|464430496|FG000|Overall Study|Lost to Follow-up|1|||
129037835|NCT01613378|464430496|FG000|Overall Study|Other Reason|4|||
129037836|NCT00792623|464430506|FG000|Overall Study|Adverse Event|2|||
129037837|NCT00792623|464430506|FG000|Overall Study|Withdrawal by Subject|5|||
129037838|NCT00880087|464430507|FG000|Overall Study|Lost to Follow-up|0|||
129037839|NCT00880087|464430508|FG001|Overall Study|Lost to Follow-up|2|||
129037840|NCT02916693|464430509|FG000|Overall Study|Lost to Follow-up|7|||
129037841|NCT04205162|464430514|FG000|Overall Study|Lost to Follow-up|1|||
129037842|NCT04205162|464430515|FG001|Overall Study|Lost to Follow-up|0|||
129037843|NCT04205162|464430514|FG000|Overall Study|Withdrawal by Subject|2|||
129037844|NCT04205162|464430515|FG001|Overall Study|Withdrawal by Subject|0|||
129037845|NCT04205162|464430514|FG000|Overall Study|University closure due to COVID-19|1|||
128713557|NCT00498602|463248214|FG005|Overall Study|Death|1|||
128713558|NCT00498602|463248215|FG006|Overall Study|Death|0|||
128713559|NCT00498602|463248209|FG000|Overall Study|Lack of Efficacy|1|||
128713560|NCT00498602|463248210|FG001|Overall Study|Lack of Efficacy|0|||
129037846|NCT04205162|464430515|FG001|Overall Study|University closure due to COVID-19|0|||
129037847|NCT01011556|464430516|FG000|Overall Study|Adverse Event|1|||
129037848|NCT01011556|464430517|FG001|Overall Study|Adverse Event|3|||
129129802|NCT03599713|464766481|FG001|Overall Study|Lost to Follow-up|0|||
129129803|NCT03599713|464766480|FG000|Overall Study|Discontinued Due to End of Study|42|||
129129804|NCT03599713|464766481|FG001|Overall Study|Discontinued Due to End of Study|3|||
129129805|NCT05800145|464766482|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
129129806|NCT05800145|464766483|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129129807|NCT05800145|464766484|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129129808|NCT05800145|464766485|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
129129809|NCT05800145|464766486|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129129810|NCT05800145|464766487|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129129811|NCT05800145|464766482|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
129129812|NCT05800145|464766483|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129129813|NCT05800145|464766484|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129129814|NCT05800145|464766485|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
129129815|NCT05800145|464766486|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129129816|NCT05800145|464766487|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129129817|NCT05800145|464766482|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
129129818|NCT05800145|464766483|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
129129819|NCT05800145|464766484|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
129129820|NCT05800145|464766485|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
129129821|NCT05800145|464766486|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
129129822|NCT05800145|464766487|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
129129823|NCT02850406|464766488|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
129129824|NCT02850406|464766489|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
129129825|NCT02850406|464766490|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
129129826|NCT02850406|464766491|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
128965476|NCT01291511|464160054|FG000|Cross-Titration and Stabilization Phase|Death|1|||
129129827|NCT02850406|464766492|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
129129828|NCT02850406|464766493|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
129129829|NCT02850406|464766494|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
128965477|NCT01291511|464160055|FG001|Cross-Titration and Stabilization Phase|Death|0|||
129129830|NCT02850406|464766495|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
129129831|NCT02850406|464766488|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129129832|NCT02850406|464766489|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129129833|NCT02850406|464766490|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
129129834|NCT02850406|464766491|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
129129835|NCT02850406|464766492|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129129836|NCT02850406|464766493|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129129837|NCT02850406|464766494|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129129838|NCT02850406|464766495|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129129839|NCT02850406|464766488|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129129840|NCT02850406|464766489|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129129841|NCT02850406|464766490|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
129129842|NCT02850406|464766491|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129129843|NCT02850406|464766492|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129129844|NCT02850406|464766493|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129129845|NCT02850406|464766494|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129129846|NCT02850406|464766495|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129129847|NCT02850406|464766488|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
129129848|NCT02850406|464766489|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
129129849|NCT02850406|464766490|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
129129850|NCT02850406|464766491|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
129129851|NCT02850406|464766492|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
129220252|NCT02304367|465106536|FG000|Overall Study|Lack of Response to Bruosumab|1|||
129220253|NCT02304367|465106536|FG000|Overall Study|Sponsor Decision|3|||
129220254|NCT02304367|465106536|FG000|Overall Study|Death|2|||
129220255|NCT02304367|465106536|FG000|Overall Study|Physician Decision|1|||
129220256|NCT02304367|465106536|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
129220257|NCT00318643|465106537|FG000|Overall Study|Adverse Event|0|||
128713561|NCT00498602|463248211|FG002|Overall Study|Lack of Efficacy|0|||
128713562|NCT00498602|463248212|FG003|Overall Study|Lack of Efficacy|0|||
128713563|NCT00498602|463248213|FG004|Overall Study|Lack of Efficacy|0|||
128713564|NCT00498602|463248214|FG005|Overall Study|Lack of Efficacy|0|||
128713565|NCT00498602|463248215|FG006|Overall Study|Lack of Efficacy|0|||
128713566|NCT00498602|463248209|FG000|Overall Study|Lost to Follow-up|0|||
128713567|NCT00498602|463248210|FG001|Overall Study|Lost to Follow-up|2|||
128713568|NCT00498602|463248211|FG002|Overall Study|Lost to Follow-up|0|||
128713569|NCT00498602|463248212|FG003|Overall Study|Lost to Follow-up|2|||
128713570|NCT00498602|463248213|FG004|Overall Study|Lost to Follow-up|0|||
128713571|NCT00498602|463248214|FG005|Overall Study|Lost to Follow-up|0|||
128713572|NCT00498602|463248215|FG006|Overall Study|Lost to Follow-up|0|||
128713573|NCT00498602|463248209|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
128713574|NCT00498602|463248210|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
128965478|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
128965479|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
128965480|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
128965481|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
128965482|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
128965483|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
128965484|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
128965485|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
128965486|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
128965487|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
128965488|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
128965489|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
128965490|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
128965491|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
128965492|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
128965493|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
128965494|NCT01291511|464160054|FG000|Double-blind Relapse Prevention Phase|Death|1|||
128965495|NCT01291511|464160055|FG001|Double-blind Relapse Prevention Phase|Death|0|||
128965496|NCT00047008|464160057|FG000|Overall Study|Withdrawn consent|2|||
128965497|NCT00047008|464160058|FG001|Overall Study|Withdrawn consent|3|||
128965498|NCT00047008|464160057|FG000|Overall Study|Ineligible|9|||
128965499|NCT00047008|464160058|FG001|Overall Study|Ineligible|8|||
128965500|NCT01047436|464160061|FG000|Overall Study|Protocol Violation|1|||
128965501|NCT01047436|464160062|FG001|Overall Study|Protocol Violation|0|||
128965502|NCT01408732|464160063|FG000|Overall Study|Withdrawal by Subject|2|||
128965503|NCT01408732|464160064|FG001|Overall Study|Withdrawal by Subject|2|||
128965504|NCT00424099|464160065|FG000|Overall Study|Adverse Event|0|||
128965505|NCT00424099|464160066|FG001|Overall Study|Adverse Event|1|||
128965506|NCT00424099|464160067|FG002|Overall Study|Adverse Event|1|||
128965507|NCT00424099|464160068|FG003|Overall Study|Adverse Event|0|||
128965508|NCT00424099|464160065|FG000|Overall Study|Death|0|||
128965509|NCT00424099|464160066|FG001|Overall Study|Death|1|||
128965510|NCT00424099|464160067|FG002|Overall Study|Death|0|||
128965511|NCT00424099|464160068|FG003|Overall Study|Death|0|||
128965512|NCT00424099|464160065|FG000|Overall Study|Illness|2|||
128965513|NCT00424099|464160066|FG001|Overall Study|Illness|0|||
129129852|NCT02850406|464766493|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
129129853|NCT02850406|464766494|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
129129854|NCT02850406|464766495|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
129129855|NCT02850406|464766488|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
129129856|NCT02850406|464766489|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
129129857|NCT02850406|464766490|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
129129858|NCT02850406|464766491|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
129129859|NCT02850406|464766492|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
129129860|NCT02850406|464766493|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
129129861|NCT02850406|464766494|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
129129862|NCT02850406|464766495|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
129129863|NCT02850406|464766488|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129864|NCT02850406|464766489|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129865|NCT02850406|464766490|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129866|NCT02850406|464766491|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129867|NCT02850406|464766492|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
129129868|NCT02850406|464766493|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
129129869|NCT02850406|464766494|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129870|NCT02850406|464766495|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129871|NCT02850406|464766488|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
128713575|NCT00498602|463248211|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
128713576|NCT00498602|463248212|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
128713577|NCT00498602|463248213|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
128965514|NCT00424099|464160067|FG002|Overall Study|Illness|1|||
128965515|NCT00424099|464160068|FG003|Overall Study|Illness|4|||
128965516|NCT00424099|464160065|FG000|Overall Study|Lost to Follow-up|0|||
129129872|NCT02850406|464766489|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
128713578|NCT00498602|463248214|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
129129873|NCT02850406|464766490|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
129129874|NCT02850406|464766491|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
129129875|NCT02850406|464766492|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
129129876|NCT02850406|464766493|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
128771649|NCT01017120|463455323|FG000|Overall Study|Lost to Follow-up|13|||
128965517|NCT00424099|464160066|FG001|Overall Study|Lost to Follow-up|0|||
128965518|NCT00424099|464160067|FG002|Overall Study|Lost to Follow-up|3|||
128965519|NCT00424099|464160068|FG003|Overall Study|Lost to Follow-up|0|||
128965520|NCT00424099|464160065|FG000|Overall Study|Hospitalized|1|||
128965521|NCT00424099|464160066|FG001|Overall Study|Hospitalized|2|||
128965522|NCT00424099|464160067|FG002|Overall Study|Hospitalized|1|||
128965523|NCT00424099|464160068|FG003|Overall Study|Hospitalized|3|||
128965524|NCT00424099|464160065|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
128965525|NCT00424099|464160066|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
128965526|NCT00424099|464160067|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
128965527|NCT00424099|464160068|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
128965528|NCT00424099|464160065|FG000|Overall Study|Withdrawal by Subject|1|||
128965529|NCT00424099|464160066|FG001|Overall Study|Withdrawal by Subject|9|||
128965530|NCT00424099|464160067|FG002|Overall Study|Withdrawal by Subject|4|||
128965531|NCT00424099|464160068|FG003|Overall Study|Withdrawal by Subject|6|||
128965532|NCT00424099|464160065|FG000|Overall Study|Physician Decision|0|||
128965533|NCT00424099|464160066|FG001|Overall Study|Physician Decision|0|||
128965534|NCT00424099|464160067|FG002|Overall Study|Physician Decision|1|||
128965535|NCT00424099|464160068|FG003|Overall Study|Physician Decision|0|||
128965536|NCT00424099|464160065|FG000|Overall Study|Missing|0|||
128965537|NCT00424099|464160066|FG001|Overall Study|Missing|0|||
128965538|NCT00424099|464160067|FG002|Overall Study|Missing|1|||
128965539|NCT00424099|464160068|FG003|Overall Study|Missing|0|||
128965540|NCT00796003|464160069|FG000|Overall Study|Disease Progression|2|||
128965541|NCT00796003|464160070|FG001|Overall Study|Disease Progression|13|||
128965542|NCT00796003|464160069|FG000|Overall Study|Adverse Event|1|||
128965543|NCT00796003|464160070|FG001|Overall Study|Adverse Event|7|||
128965544|NCT00796003|464160069|FG000|Overall Study|Specified organ function not met|0|||
128965545|NCT00796003|464160070|FG001|Overall Study|Specified organ function not met|1|||
128965546|NCT00796003|464160069|FG000|Overall Study|Physician Decision|0|||
128965547|NCT00796003|464160070|FG001|Overall Study|Physician Decision|4|||
128965548|NCT00796003|464160069|FG000|Overall Study|Withdrawal by Subject|0|||
128965549|NCT00796003|464160070|FG001|Overall Study|Withdrawal by Subject|1|||
128965550|NCT00796003|464160069|FG000|Overall Study|Other|0|||
128965551|NCT00796003|464160070|FG001|Overall Study|Other|1|||
128965552|NCT00796003|464160069|FG000|Overall Study|Participants Not treated|0|||
128965553|NCT00796003|464160070|FG001|Overall Study|Participants Not treated|2|||
128965554|NCT02437162|464160071|FG000|Overall Study|Protocol Violation|0|||
128965555|NCT02437162|464160072|FG001|Overall Study|Protocol Violation|1|||
128965556|NCT02437162|464160073|FG002|Overall Study|Protocol Violation|0|||
128965557|NCT02437162|464160071|FG000|Overall Study|Randomized but not treated|0|||
128965558|NCT02437162|464160072|FG001|Overall Study|Randomized but not treated|0|||
128965559|NCT02437162|464160073|FG002|Overall Study|Randomized but not treated|1|||
128965560|NCT02437162|464160071|FG000|Overall Study|Study discontinued by Sponsor|93|||
128965561|NCT02437162|464160072|FG001|Overall Study|Study discontinued by Sponsor|98|||
128965562|NCT02437162|464160073|FG002|Overall Study|Study discontinued by Sponsor|97|||
128965563|NCT02437162|464160071|FG000|Overall Study|Withdrawal by Subject|13|||
128965564|NCT02437162|464160072|FG001|Overall Study|Withdrawal by Subject|7|||
128965565|NCT02437162|464160073|FG002|Overall Study|Withdrawal by Subject|9|||
128965566|NCT02437162|464160071|FG000|Overall Study|Adverse Event|0|||
128965567|NCT02437162|464160072|FG001|Overall Study|Adverse Event|1|||
128965568|NCT02437162|464160073|FG002|Overall Study|Adverse Event|0|||
128965569|NCT02437162|464160071|FG000|Overall Study|Lost to Follow-up|1|||
128965570|NCT02437162|464160072|FG001|Overall Study|Lost to Follow-up|0|||
128965571|NCT02437162|464160073|FG002|Overall Study|Lost to Follow-up|1|||
128965572|NCT02437162|464160071|FG000|Overall Study|Death|0|||
128965573|NCT02437162|464160072|FG001|Overall Study|Death|1|||
128965574|NCT02437162|464160073|FG002|Overall Study|Death|0|||
128965575|NCT02437162|464160071|FG000|Overall Study|Other|0|||
128965576|NCT02437162|464160072|FG001|Overall Study|Other|0|||
128965577|NCT02437162|464160073|FG002|Overall Study|Other|1|||
128965578|NCT03981744|464160074|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
128965579|NCT03981744|464160075|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
128965580|NCT03981744|464160076|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
128965581|NCT03981744|464160077|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
128965582|NCT03981744|464160074|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
128965583|NCT03981744|464160075|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
129129877|NCT02850406|464766494|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
128965584|NCT03981744|464160076|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
128965585|NCT03981744|464160077|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
128965586|NCT03981744|464160074|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
128965587|NCT03981744|464160075|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
128965588|NCT03981744|464160076|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
128965589|NCT03981744|464160077|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
128965590|NCT04338321|464160078|FG000|Overall Study|Adverse Event|4|||
128965591|NCT04338321|464160079|FG001|Overall Study|Adverse Event|10|||
128965592|NCT04338321|464160078|FG000|Overall Study|Death|1|||
128965593|NCT04338321|464160079|FG001|Overall Study|Death|1|||
128965594|NCT04338321|464160078|FG000|Overall Study|Lost to Follow-up|4|||
129129878|NCT02850406|464766495|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
129129879|NCT02850406|464766488|FG000|Part C (Up to 52 Weeks)|Other|0|||
129129880|NCT02850406|464766489|FG001|Part C (Up to 52 Weeks)|Other|0|||
129129881|NCT02850406|464766490|FG002|Part C (Up to 52 Weeks)|Other|0|||
129129882|NCT02850406|464766491|FG003|Part C (Up to 52 Weeks)|Other|0|||
129129883|NCT02850406|464766492|FG004|Part C (Up to 52 Weeks)|Other|1|||
128965595|NCT04338321|464160079|FG001|Overall Study|Lost to Follow-up|9|||
128965596|NCT04338321|464160078|FG000|Overall Study|Withdrawal by Subject|45|||
128965597|NCT04338321|464160079|FG001|Overall Study|Withdrawal by Subject|69|||
128965598|NCT04338321|464160078|FG000|Overall Study|Physician Decision|5|||
128965599|NCT04338321|464160079|FG001|Overall Study|Physician Decision|9|||
128965600|NCT04338321|464160078|FG000|Overall Study|Other|3|||
128965601|NCT04338321|464160079|FG001|Overall Study|Other|10|||
128965602|NCT03107793|464160080|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
128965603|NCT03107793|464160081|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
128965604|NCT03107793|464160082|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
128965605|NCT03107793|464160083|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
128965606|NCT03107793|464160084|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
128965607|NCT03107793|464160080|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
128965608|NCT03107793|464160081|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
128965609|NCT03107793|464160082|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
128965610|NCT03107793|464160083|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
128965611|NCT03107793|464160084|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
128965612|NCT03107793|464160080|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
128965613|NCT03107793|464160081|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
129129884|NCT02850406|464766493|FG005|Part C (Up to 52 Weeks)|Other|3|||
129129885|NCT02850406|464766494|FG006|Part C (Up to 52 Weeks)|Other|0|||
129129886|NCT02850406|464766495|FG007|Part C (Up to 52 Weeks)|Other|0|||
129129887|NCT02850406|464766488|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
129129888|NCT02850406|464766489|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
129129889|NCT02850406|464766490|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
129129890|NCT02850406|464766491|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
129129891|NCT02850406|464766492|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
129129892|NCT02850406|464766493|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
129129893|NCT02850406|464766494|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
129129894|NCT02850406|464766495|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
129129895|NCT02850406|464766488|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129896|NCT02850406|464766489|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129897|NCT02850406|464766490|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129898|NCT02850406|464766491|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129899|NCT02850406|464766492|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129900|NCT02850406|464766493|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129901|NCT02850406|464766494|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129129902|NCT02850406|464766495|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
129129903|NCT02850406|464766488|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
129129904|NCT02850406|464766489|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
129129905|NCT02850406|464766490|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
129129906|NCT02850406|464766491|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
129129907|NCT02850406|464766492|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
129129908|NCT02850406|464766493|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
129129909|NCT02850406|464766494|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
129129910|NCT02850406|464766495|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
129129911|NCT02850406|464766488|FG000|Part D (Up to 52 Weeks)|Other|0|||
129129912|NCT02850406|464766489|FG001|Part D (Up to 52 Weeks)|Other|0|||
129129913|NCT02850406|464766490|FG002|Part D (Up to 52 Weeks)|Other|0|||
129129914|NCT02850406|464766491|FG003|Part D (Up to 52 Weeks)|Other|0|||
129129915|NCT02850406|464766492|FG004|Part D (Up to 52 Weeks)|Other|0|||
129129916|NCT02850406|464766493|FG005|Part D (Up to 52 Weeks)|Other|0|||
128771650|NCT01017120|463455324|FG001|Overall Study|Lost to Follow-up|11|||
128771651|NCT01017120|463455323|FG000|Overall Study|Lack of Efficacy|1|||
128965614|NCT03107793|464160082|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
128965615|NCT03107793|464160083|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
128965616|NCT03107793|464160084|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
128965617|NCT03107793|464160080|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
128965618|NCT03107793|464160081|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129129917|NCT02850406|464766494|FG006|Part D (Up to 52 Weeks)|Other|0|||
129129918|NCT02850406|464766495|FG007|Part D (Up to 52 Weeks)|Other|1|||
129129919|NCT01373229|464767763|FG000|Overall Study|Death|3|||
129129920|NCT01373229|464767763|FG000|Overall Study|Physician Decision|3|||
129129921|NCT00143507|464767764|FG000|Overall Study|Death|572|||
129129922|NCT00143507|464767765|FG001|Overall Study|Death|547|||
129129923|NCT00143507|464767764|FG000|Overall Study|Withdrawal by Subject|114|||
128965619|NCT03107793|464160082|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128965620|NCT03107793|464160083|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128965621|NCT03107793|464160084|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129129924|NCT00143507|464767765|FG001|Overall Study|Withdrawal by Subject|102|||
129129925|NCT00143507|464767764|FG000|Overall Study|Lost to Follow-up|1|||
129129926|NCT00143507|464767765|FG001|Overall Study|Lost to Follow-up|0|||
129129927|NCT00143507|464767764|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
129129928|NCT00143507|464767765|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
129129929|NCT00587457|464767766|FG000|Overall Study|Adverse Event|1|||
129129930|NCT00587457|464767767|FG001|Overall Study|Adverse Event|2|||
129129931|NCT00587457|464767768|FG002|Overall Study|Adverse Event|1|||
129129932|NCT00587457|464767766|FG000|Overall Study|Disease progression|2|||
129129933|NCT00587457|464767767|FG001|Overall Study|Disease progression|0|||
129129934|NCT00587457|464767768|FG002|Overall Study|Disease progression|2|||
129129935|NCT00587457|464767766|FG000|Overall Study|Initiation of alternative therapy|0|||
129129936|NCT00587457|464767767|FG001|Overall Study|Initiation of alternative therapy|1|||
129129937|NCT00587457|464767768|FG002|Overall Study|Initiation of alternative therapy|0|||
129129938|NCT00587457|464767766|FG000|Overall Study|Undefined|0|||
129129939|NCT00587457|464767767|FG001|Overall Study|Undefined|0|||
129129940|NCT00587457|464767768|FG002|Overall Study|Undefined|1|||
129129941|NCT00587457|464767766|FG000|Overall Study|Development of neutralizing Abs|0|||
129129942|NCT00587457|464767767|FG001|Overall Study|Development of neutralizing Abs|0|||
129129943|NCT00587457|464767768|FG002|Overall Study|Development of neutralizing Abs|1|||
129129944|NCT03234881|464767769|FG000|Overall Study|Lost to Follow-up|9|||
129129945|NCT03234881|464767770|FG001|Overall Study|Lost to Follow-up|3|||
129129946|NCT00729586|464767771|FG000|Overall Study|Ineligible|0|||
129129947|NCT00729586|464767772|FG001|Overall Study|Ineligible|1|||
129129948|NCT00729586|464767771|FG000|Overall Study|never treated|1|||
129129949|NCT00729586|464767772|FG001|Overall Study|never treated|0|||
129129950|NCT00972738|464767774|FG000|Overall Study|Adverse Event|7|||
129129951|NCT00972738|464767775|FG001|Overall Study|Adverse Event|1|||
129129952|NCT00972738|464767776|FG002|Overall Study|Adverse Event|8|||
129129953|NCT00972738|464767774|FG000|Overall Study|Protocol Violation|2|||
129129954|NCT00972738|464767775|FG001|Overall Study|Protocol Violation|1|||
129129955|NCT00972738|464767776|FG002|Overall Study|Protocol Violation|3|||
129129956|NCT00972738|464767774|FG000|Overall Study|Lost to Follow-up|1|||
129129957|NCT00972738|464767775|FG001|Overall Study|Lost to Follow-up|0|||
129129958|NCT00972738|464767776|FG002|Overall Study|Lost to Follow-up|1|||
129129959|NCT00972738|464767774|FG000|Overall Study|Lack of Efficacy|5|||
129129960|NCT00972738|464767775|FG001|Overall Study|Lack of Efficacy|1|||
129129961|NCT00972738|464767776|FG002|Overall Study|Lack of Efficacy|11|||
129129962|NCT00972738|464767774|FG000|Overall Study|Withdrawal by Subject|5|||
129129963|NCT00972738|464767775|FG001|Overall Study|Withdrawal by Subject|1|||
129129964|NCT00972738|464767776|FG002|Overall Study|Withdrawal by Subject|4|||
129129965|NCT00972738|464767774|FG000|Overall Study|Moved|0|||
128771652|NCT01017120|463455324|FG001|Overall Study|Lack of Efficacy|0|||
128771653|NCT01017120|463455323|FG000|Overall Study|Withdrawal by Subject|39|||
128965622|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129129966|NCT00972738|464767775|FG001|Overall Study|Moved|0|||
129129967|NCT00972738|464767776|FG002|Overall Study|Moved|1|||
129129968|NCT00972738|464767774|FG000|Overall Study|Other|1|||
129129969|NCT00972738|464767775|FG001|Overall Study|Other|2|||
129129970|NCT00972738|464767776|FG002|Overall Study|Other|1|||
129129971|NCT03915067|464767777|FG000|Overall Study|Adverse Event|0|||
129129972|NCT03915067|464767778|FG001|Overall Study|Adverse Event|0|||
129129973|NCT03915067|464767779|FG002|Overall Study|Adverse Event|1|||
129129974|NCT03915067|464767777|FG000|Overall Study|Withdrawal by Subject|4|||
128965623|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
128965624|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
128965625|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
128965626|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
128965627|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
128965628|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
128965629|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
128965630|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
128965631|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129129975|NCT03915067|464767778|FG001|Overall Study|Withdrawal by Subject|3|||
128965632|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
128965633|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
128965634|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
129220258|NCT00318643|465106538|FG001|Overall Study|Adverse Event|0|||
128771654|NCT01017120|463455324|FG001|Overall Study|Withdrawal by Subject|21|||
128965635|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
129129976|NCT03915067|464767779|FG002|Overall Study|Withdrawal by Subject|0|||
129129977|NCT03915067|464767777|FG000|Overall Study|Lost to Follow-up|3|||
129129978|NCT03915067|464767778|FG001|Overall Study|Lost to Follow-up|2|||
129129979|NCT03915067|464767779|FG002|Overall Study|Lost to Follow-up|0|||
129129980|NCT03915067|464767777|FG000|Overall Study|Protocol Deviation|0|||
129129981|NCT03915067|464767778|FG001|Overall Study|Protocol Deviation|0|||
129129982|NCT03915067|464767779|FG002|Overall Study|Protocol Deviation|1|||
128965636|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
129129983|NCT03915067|464767777|FG000|Overall Study|Covid-19 Related Issues|2|||
129129984|NCT03915067|464767778|FG001|Overall Study|Covid-19 Related Issues|4|||
129129985|NCT03915067|464767779|FG002|Overall Study|Covid-19 Related Issues|4|||
129129986|NCT03915067|464767777|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
129129987|NCT03915067|464767778|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
129129988|NCT03915067|464767779|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
129129989|NCT02034591|464767786|FG000|Overall Study|Withdrawal by Subject|0|||
129129990|NCT02034591|464767787|FG001|Overall Study|Withdrawal by Subject|0|||
129129991|NCT02034591|464767788|FG002|Overall Study|Withdrawal by Subject|0|||
129129992|NCT02034591|464767789|FG003|Overall Study|Withdrawal by Subject|0|||
129129993|NCT02034591|464767790|FG004|Overall Study|Withdrawal by Subject|1|||
129129994|NCT02034591|464767791|FG005|Overall Study|Withdrawal by Subject|0|||
129129995|NCT01793935|464767794|FG000|Overall Study|Pregnancy|1|||
129129996|NCT01793935|464767795|FG001|Overall Study|Pregnancy|0|||
129129997|NCT01793935|464767794|FG000|Overall Study|Protocol Violation|2|||
129129998|NCT01793935|464767795|FG001|Overall Study|Protocol Violation|1|||
129129999|NCT01793935|464767794|FG000|Overall Study|Adverse Event|2|||
129130000|NCT01793935|464767795|FG001|Overall Study|Adverse Event|0|||
129130001|NCT01793935|464767794|FG000|Overall Study|Patient did not take study medication|1|||
129130002|NCT01793935|464767795|FG001|Overall Study|Patient did not take study medication|1|||
129130003|NCT01793935|464767794|FG000|Overall Study|Lost to Follow-up|0|||
129130004|NCT01793935|464767795|FG001|Overall Study|Lost to Follow-up|1|||
129130005|NCT01121926|464767796|FG000|First Intervention Period|Adverse Event|1|||
129130006|NCT01121926|464767797|FG001|First Intervention Period|Adverse Event|0|||
129130007|NCT01121926|464767796|FG000|Washout Period|Adverse Event|0|||
129130008|NCT01121926|464767797|FG001|Washout Period|Adverse Event|1|||
129130009|NCT01121926|464767796|FG000|Washout Period|Positive pregnancy test|0|||
129130010|NCT01121926|464767797|FG001|Washout Period|Positive pregnancy test|1|||
129130011|NCT00416949|464767799|FG000|Overall Study|Patients refused to participate|5|||
129130012|NCT00313170|464767800|FG000|Overall Study|Death|2|||
129130013|NCT00313170|464767801|FG001|Overall Study|Death|4|||
129130014|NCT00313170|464767802|FG002|Overall Study|Death|2|||
129130015|NCT00313170|464767800|FG000|Overall Study|Adverse Event|1|||
129130016|NCT00313170|464767801|FG001|Overall Study|Adverse Event|2|||
129130017|NCT00313170|464767802|FG002|Overall Study|Adverse Event|0|||
129130018|NCT00313170|464767800|FG000|Overall Study|Disease progression|31|||
129130019|NCT00313170|464767801|FG001|Overall Study|Disease progression|26|||
129130020|NCT00313170|464767802|FG002|Overall Study|Disease progression|27|||
129130021|NCT00313170|464767800|FG000|Overall Study|Withdrawal by Subject|1|||
129130022|NCT00313170|464767801|FG001|Overall Study|Withdrawal by Subject|0|||
129130023|NCT00313170|464767802|FG002|Overall Study|Withdrawal by Subject|1|||
129130024|NCT00313170|464767800|FG000|Overall Study|Incorrect enrollment|0|||
129130025|NCT00313170|464767801|FG001|Overall Study|Incorrect enrollment|2|||
129130026|NCT00313170|464767802|FG002|Overall Study|Incorrect enrollment|1|||
129130027|NCT00313170|464767800|FG000|Overall Study|Lost to Follow-up|0|||
129130028|NCT00313170|464767801|FG001|Overall Study|Lost to Follow-up|0|||
129130029|NCT00313170|464767802|FG002|Overall Study|Lost to Follow-up|1|||
129130030|NCT00313170|464767800|FG000|Overall Study|Progression (investigators opinion)|1|||
129130031|NCT00313170|464767801|FG001|Overall Study|Progression (investigators opinion)|0|||
129130032|NCT00313170|464767802|FG002|Overall Study|Progression (investigators opinion)|0|||
129130033|NCT01410604|464767804|FG000|Overall Study|Adverse Event|2|||
129130034|NCT01410604|464767805|FG001|Overall Study|Adverse Event|1|||
129130035|NCT01410604|464767804|FG000|Overall Study|Lost to Follow-up|1|||
129130036|NCT01410604|464767805|FG001|Overall Study|Lost to Follow-up|0|||
129130037|NCT01410604|464767804|FG000|Overall Study|Physician Decision|0|||
129130038|NCT01410604|464767805|FG001|Overall Study|Physician Decision|1|||
129130039|NCT00529035|464767807|FG000|Overall Study|Withdrawal by Subject|1|||
129130040|NCT03439514|464767808|FG000|Double-Blind Treatment Period|Other|4|||
129130041|NCT03439514|464767809|FG001|Double-Blind Treatment Period|Other|1|||
129130042|NCT03439514|464767808|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
129130043|NCT03439514|464767809|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
128965637|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129130044|NCT03439514|464767808|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
129130045|NCT03439514|464767809|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
129130046|NCT03439514|464767808|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
129130047|NCT03439514|464767809|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
129130048|NCT03439514|464767808|FG000|Double-Blind Treatment Period|Death|1|||
129130049|NCT03439514|464767809|FG001|Double-Blind Treatment Period|Death|2|||
129130050|NCT02175758|464767810|FG000|Treatment Phase|Lost to Follow-up|0|||
129130051|NCT02175758|464767811|FG001|Treatment Phase|Lost to Follow-up|1|||
129130052|NCT02175758|464767812|FG002|Treatment Phase|Lost to Follow-up|0|||
129130053|NCT02175758|464767813|FG003|Treatment Phase|Lost to Follow-up|0|||
129130054|NCT02175758|464767814|FG004|Treatment Phase|Lost to Follow-up|0|||
129130055|NCT02175758|464767815|FG005|Treatment Phase|Lost to Follow-up|0|||
128965638|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
128965639|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
128965640|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
128965641|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
128965642|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
128965643|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
129130056|NCT02175758|464767810|FG000|Treatment Phase|Adverse Event|0|||
129130057|NCT02175758|464767811|FG001|Treatment Phase|Adverse Event|0|||
129130058|NCT02175758|464767812|FG002|Treatment Phase|Adverse Event|0|||
129130059|NCT02175758|464767813|FG003|Treatment Phase|Adverse Event|0|||
128965644|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
128965645|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
128965646|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
128965647|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
128965648|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
128965649|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
128965650|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
128965651|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
129130060|NCT02175758|464767814|FG004|Treatment Phase|Adverse Event|1|||
129130061|NCT02175758|464767815|FG005|Treatment Phase|Adverse Event|0|||
129130062|NCT01482221|464767818|FG000|Overall Study|Lack of Efficacy|1|||
129130063|NCT01482221|464767819|FG001|Overall Study|Lack of Efficacy|0|||
128965652|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
128965653|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
128965654|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
128965655|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
128965656|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
128965657|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
128965658|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
128965659|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
128965660|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
128965661|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
128965662|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
128965663|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
129130064|NCT01482221|464767820|FG002|Overall Study|Lack of Efficacy|1|||
129130065|NCT01482221|464767818|FG000|Overall Study|Lost to Follow-up|3|||
129130066|NCT01482221|464767819|FG001|Overall Study|Lost to Follow-up|2|||
129130067|NCT01482221|464767820|FG002|Overall Study|Lost to Follow-up|1|||
129130068|NCT01482221|464767818|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
128965664|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
128965665|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
128965666|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
128965667|NCT03107793|464160080|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
128965668|NCT03107793|464160081|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
129130069|NCT01482221|464767819|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
129130070|NCT01482221|464767820|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
129130071|NCT01482221|464767818|FG000|Overall Study|Condition under Investigation Worsened|3|||
129130072|NCT01482221|464767819|FG001|Overall Study|Condition under Investigation Worsened|2|||
129130073|NCT01482221|464767820|FG002|Overall Study|Condition under Investigation Worsened|4|||
129130074|NCT01482221|464767818|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
129130075|NCT01482221|464767819|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
129130076|NCT01482221|464767820|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
129130077|NCT01482221|464767818|FG000|Overall Study|Adverse Event|1|||
129130078|NCT01482221|464767819|FG001|Overall Study|Adverse Event|7|||
129130079|NCT01482221|464767820|FG002|Overall Study|Adverse Event|3|||
129130080|NCT01482221|464767818|FG000|Overall Study|Withdrawal by Subject|10|||
129130081|NCT01482221|464767819|FG001|Overall Study|Withdrawal by Subject|7|||
129130082|NCT01482221|464767820|FG002|Overall Study|Withdrawal by Subject|12|||
128965669|NCT03107793|464160082|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
129130083|NCT01482221|464767818|FG000|Overall Study|Incorrect randomization|0|||
129130084|NCT01482221|464767819|FG001|Overall Study|Incorrect randomization|1|||
129130085|NCT01482221|464767820|FG002|Overall Study|Incorrect randomization|0|||
129130086|NCT01482221|464767818|FG000|Overall Study|Physician Decision|0|||
129130087|NCT01482221|464767819|FG001|Overall Study|Physician Decision|1|||
129130088|NCT01482221|464767820|FG002|Overall Study|Physician Decision|0|||
129130089|NCT01047501|464767822|FG000|Overall Study|Adverse Event|7|||
129130090|NCT01047501|464767823|FG001|Overall Study|Adverse Event|8|||
129130091|NCT01047501|464767824|FG002|Overall Study|Adverse Event|5|||
129130092|NCT01047501|464767822|FG000|Overall Study|Withdrew Consent|6|||
129130093|NCT01047501|464767823|FG001|Overall Study|Withdrew Consent|2|||
129130094|NCT01047501|464767824|FG002|Overall Study|Withdrew Consent|4|||
129130095|NCT01047501|464767822|FG000|Overall Study|Lost to Follow-up|0|||
129130096|NCT01047501|464767823|FG001|Overall Study|Lost to Follow-up|1|||
129130097|NCT01047501|464767824|FG002|Overall Study|Lost to Follow-up|1|||
129130098|NCT01047501|464767822|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
129130099|NCT01047501|464767823|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
129130100|NCT01047501|464767824|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
129130101|NCT01047501|464767822|FG000|Overall Study|Death|1|||
129130102|NCT01047501|464767823|FG001|Overall Study|Death|0|||
129130103|NCT01047501|464767824|FG002|Overall Study|Death|0|||
129130104|NCT01047501|464767822|FG000|Overall Study|Other discontinuation|1|||
129130105|NCT01047501|464767823|FG001|Overall Study|Other discontinuation|0|||
129130106|NCT01047501|464767824|FG002|Overall Study|Other discontinuation|1|||
129130107|NCT01047501|464767822|FG000|Overall Study|Investigator judgement|0|||
129130108|NCT01047501|464767823|FG001|Overall Study|Investigator judgement|0|||
129130109|NCT01047501|464767824|FG002|Overall Study|Investigator judgement|1|||
129130110|NCT00741611|464767825|FG000|Overall Study|Death|0|||
129130111|NCT00741611|464767826|FG001|Overall Study|Death|0|||
129130112|NCT00741611|464767827|FG002|Overall Study|Death|1|||
129130113|NCT00741611|464767825|FG000|Overall Study|Withdrawal by Subject|0|||
129130114|NCT00741611|464767826|FG001|Overall Study|Withdrawal by Subject|2|||
129130115|NCT00741611|464767827|FG002|Overall Study|Withdrawal by Subject|2|||
129130116|NCT05607043|464767828|FG000|Overall Study|Lost to Follow-up|2|||
129130117|NCT00800540|464767834|FG000|Period One: 6 Weeks|Noncompliance|1|||
129130118|NCT00800540|464767835|FG001|Period One: 6 Weeks|Noncompliance|0|||
129130119|NCT00800540|464767834|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
129130120|NCT00800540|464767835|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
129130121|NCT00800540|464767834|FG000|Period 2: 6 Weeks|Adverse Event|0|||
129130122|NCT00800540|464767835|FG001|Period 2: 6 Weeks|Adverse Event|1|||
129130123|NCT00429299|464767840|FG000|Overall Study|Disease Progression|1|||
129130124|NCT00429299|464767841|FG001|Overall Study|Disease Progression|1|||
129130125|NCT00429299|464767842|FG002|Overall Study|Disease Progression|0|||
129130126|NCT00429299|464767840|FG000|Overall Study|Adverse Event|2|||
129130127|NCT00429299|464767841|FG001|Overall Study|Adverse Event|5|||
129130128|NCT00429299|464767842|FG002|Overall Study|Adverse Event|1|||
129130129|NCT00429299|464767840|FG000|Overall Study|Protocol Violation|1|||
129130130|NCT00429299|464767841|FG001|Overall Study|Protocol Violation|0|||
129130131|NCT00429299|464767842|FG002|Overall Study|Protocol Violation|0|||
129130132|NCT00429299|464767840|FG000|Overall Study|Withdrawal by Subject|0|||
129130133|NCT00429299|464767841|FG001|Overall Study|Withdrawal by Subject|1|||
129130134|NCT00429299|464767842|FG002|Overall Study|Withdrawal by Subject|3|||
129130135|NCT01510756|464767843|FG000|Overall Study|Death|1|||
129130136|NCT01510756|464767843|FG000|Overall Study|Lack of Efficacy|2|||
129130137|NCT01510756|464767843|FG000|Overall Study|Physician Decision|1|||
128713579|NCT00498602|463248215|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
128713580|NCT00498602|463248209|FG000|Overall Study|AE not related to Study Drug|1|||
128713581|NCT00498602|463248210|FG001|Overall Study|AE not related to Study Drug|3|||
128713582|NCT00498602|463248211|FG002|Overall Study|AE not related to Study Drug|0|||
128965670|NCT03107793|464160083|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
128965671|NCT03107793|464160084|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129130138|NCT03927157|464767844|FG000|Overall Study|Adverse Event|1|||
129130139|NCT03927157|464767845|FG001|Overall Study|Adverse Event|3|||
129130140|NCT03927157|464767844|FG000|Overall Study|Protocol Violation|1|||
129130141|NCT03927157|464767845|FG001|Overall Study|Protocol Violation|2|||
129130142|NCT03927157|464767844|FG000|Overall Study|Withdrawal by Subject|8|||
129130143|NCT03927157|464767845|FG001|Overall Study|Withdrawal by Subject|21|||
129130144|NCT03927157|464767844|FG000|Overall Study|Due to COVID-19 pandemic|5|||
129130145|NCT03927157|464767845|FG001|Overall Study|Due to COVID-19 pandemic|2|||
129130146|NCT03927157|464767844|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
129130147|NCT03927157|464767845|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
129130148|NCT03927157|464767844|FG000|Overall Study|Other than above|0|||
129130149|NCT03927157|464767845|FG001|Overall Study|Other than above|1|||
129130150|NCT04871113|464767846|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130151|NCT04871113|464767847|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130152|NCT04871113|464767848|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130153|NCT04871113|464767849|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130154|NCT04871113|464767850|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130155|NCT04871113|464767851|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
129130156|NCT04871113|464767852|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130157|NCT04871113|464767853|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
128713583|NCT00498602|463248212|FG003|Overall Study|AE not related to Study Drug|0|||
129130158|NCT04871113|464767854|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130159|NCT04871113|464767855|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129130160|NCT04871113|464767846|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129130161|NCT04871113|464767847|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129130162|NCT04871113|464767848|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
128771655|NCT01017120|463455323|FG000|Overall Study|Pregnancy|1|||
128771656|NCT01017120|463455324|FG001|Overall Study|Pregnancy|1|||
128771657|NCT01017120|463455323|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
128771658|NCT01017120|463455324|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
128771659|NCT01017120|463455323|FG000|Overall Study|Relocated Out of Town|0|||
128771660|NCT01017120|463455324|FG001|Overall Study|Relocated Out of Town|2|||
128771661|NCT01017120|463455323|FG000|Overall Study|Protocol Violation|1|||
128771662|NCT01017120|463455324|FG001|Overall Study|Protocol Violation|0|||
128771663|NCT01017120|463455323|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
128771664|NCT01017120|463455324|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
128771665|NCT01087723|463455326|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
128771666|NCT01087723|463455327|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
128771667|NCT01087723|463455326|FG000|Overall Study|Withdrawal by Subject|10|||
128771668|NCT01087723|463455327|FG001|Overall Study|Withdrawal by Subject|13|||
128771669|NCT01087723|463455326|FG000|Overall Study|Physician Decision|2|||
128771670|NCT01087723|463455327|FG001|Overall Study|Physician Decision|0|||
128771671|NCT01087723|463455326|FG000|Overall Study|Lost to Follow-up|1|||
128771672|NCT01087723|463455327|FG001|Overall Study|Lost to Follow-up|4|||
128771673|NCT01087723|463455326|FG000|Overall Study|Reason Not Specified|1|||
128771674|NCT01087723|463455327|FG001|Overall Study|Reason Not Specified|2|||
128771675|NCT00806624|463455328|FG000|Overall Study|Adverse Event|2|||
128771676|NCT00806624|463455329|FG001|Overall Study|Adverse Event|8|||
128771677|NCT00806624|463455330|FG002|Overall Study|Adverse Event|0|||
128771678|NCT00806624|463455328|FG000|Overall Study|Death|0|||
128771679|NCT00806624|463455329|FG001|Overall Study|Death|1|||
128771680|NCT00806624|463455330|FG002|Overall Study|Death|1|||
128771681|NCT00806624|463455328|FG000|Overall Study|Lost to Follow-up|1|||
128771682|NCT00806624|463455329|FG001|Overall Study|Lost to Follow-up|0|||
129130163|NCT04871113|464767849|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129130164|NCT04871113|464767850|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129130165|NCT04871113|464767851|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129130166|NCT04871113|464767852|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
129130167|NCT04871113|464767853|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
129130168|NCT04871113|464767854|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129130169|NCT04871113|464767855|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129130170|NCT02447029|464767856|FG000|Overall Study|Withdrawal by Subject|3|||
129130171|NCT02447029|464767857|FG001|Overall Study|Withdrawal by Subject|2|||
129130172|NCT00726557|464767858|FG000|Overall Study|Screening failure|4|||
129130173|NCT00726557|464767858|FG000|Overall Study|No end of treatment documentation|37|||
129130174|NCT00726557|464767858|FG000|Overall Study|No follow-up documentation available|55|||
129130175|NCT00726557|464767858|FG000|Overall Study|Treatment less than 3 months|17|||
129130176|NCT00726557|464767858|FG000|Overall Study|Inclusion criteria not met|15|||
129130177|NCT01239745|464767859|FG000|Overall Study|Study terminated by sponsor|45|||
129130178|NCT01239745|464767859|FG000|Overall Study|Adverse Event|1|||
129130179|NCT01257542|464767862|FG000|Overall Study|Protocol Violation|3|||
129130180|NCT01257542|464767863|FG001|Overall Study|Protocol Violation|5|||
129130181|NCT01257542|464767862|FG000|Overall Study|Withdrawal by Subject|0|||
129130182|NCT01257542|464767863|FG001|Overall Study|Withdrawal by Subject|2|||
129130183|NCT04398134|464767869|FG000|Overall Study|Adverse Event|0|||
129130184|NCT04398134|464767870|FG001|Overall Study|Adverse Event|0|||
129130185|NCT04398134|464767871|FG002|Overall Study|Adverse Event|1|||
129130186|NCT04398134|464767872|FG003|Overall Study|Adverse Event|0|||
129130187|NCT04398134|464767869|FG000|Overall Study|Withdrawal by Subject|2|||
129130188|NCT04398134|464767870|FG001|Overall Study|Withdrawal by Subject|0|||
129130189|NCT04398134|464767871|FG002|Overall Study|Withdrawal by Subject|0|||
129130190|NCT04398134|464767872|FG003|Overall Study|Withdrawal by Subject|1|||
129220259|NCT00318643|465106539|FG002|Overall Study|Adverse Event|0|||
129220260|NCT00318643|465106540|FG003|Overall Study|Adverse Event|0|||
129220261|NCT00318643|465106541|FG004|Overall Study|Adverse Event|1|||
129220262|NCT00318643|465106537|FG000|Overall Study|Participant's Decision|0|||
129220263|NCT00318643|465106538|FG001|Overall Study|Participant's Decision|0|||
129220264|NCT00318643|465106539|FG002|Overall Study|Participant's Decision|0|||
129220265|NCT00318643|465106540|FG003|Overall Study|Participant's Decision|0|||
129220266|NCT00318643|465106541|FG004|Overall Study|Participant's Decision|1|||
128771683|NCT00806624|463455330|FG002|Overall Study|Lost to Follow-up|1|||
128771684|NCT00806624|463455328|FG000|Overall Study|Withdrawal by Subject|6|||
128771685|NCT00806624|463455329|FG001|Overall Study|Withdrawal by Subject|3|||
128771686|NCT00806624|463455330|FG002|Overall Study|Withdrawal by Subject|3|||
128771687|NCT00806624|463455328|FG000|Overall Study|discontinued before start of treatment|0|||
128771688|NCT00806624|463455329|FG001|Overall Study|discontinued before start of treatment|0|||
128771689|NCT00806624|463455330|FG002|Overall Study|discontinued before start of treatment|1|||
128771690|NCT01702428|463455332|FG000|Overall Study|Adverse Event|2|||
129130191|NCT04398134|464767869|FG000|Overall Study|Study Terminated by Sponsor|30|||
129130192|NCT04398134|464767870|FG001|Overall Study|Study Terminated by Sponsor|11|||
129220267|NCT00318643|465106537|FG000|Overall Study|Investigator's Decision|0|||
129130193|NCT04398134|464767871|FG002|Overall Study|Study Terminated by Sponsor|32|||
129130194|NCT04398134|464767872|FG003|Overall Study|Study Terminated by Sponsor|11|||
129130195|NCT02202616|464767873|FG000|Overall Study|Screen failed|24|||
129130196|NCT02202616|464767873|FG000|Overall Study|Adverse Event|32|||
129130197|NCT02202616|464767873|FG000|Overall Study|Protocol deviation|18|||
129130198|NCT02202616|464767873|FG000|Overall Study|Patient withdrew consent|12|||
129130199|NCT02202616|464767873|FG000|Overall Study|Lost to Follow-up|6|||
129130200|NCT02202616|464767873|FG000|Overall Study|Administrative problems|6|||
129130201|NCT02202616|464767873|FG000|Overall Study|Abnormal test procedure result|1|||
129130202|NCT02202616|464767873|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129130203|NCT01334515|464767874|FG000|Overall Study|Adverse Event|1|||
129130204|NCT01334515|464767875|FG001|Overall Study|Adverse Event|6|||
129130205|NCT01334515|464767874|FG000|Overall Study|Death|1|||
129130206|NCT01334515|464767875|FG001|Overall Study|Death|0|||
129130207|NCT01334515|464767874|FG000|Overall Study|Lack of Efficacy|8|||
129130208|NCT01334515|464767875|FG001|Overall Study|Lack of Efficacy|21|||
129130209|NCT01334515|464767874|FG000|Overall Study|Physician Decision|1|||
129130210|NCT01334515|464767875|FG001|Overall Study|Physician Decision|1|||
129130211|NCT01334515|464767874|FG000|Overall Study|Withdrawal by Subject|1|||
129130212|NCT01334515|464767875|FG001|Overall Study|Withdrawal by Subject|1|||
129130213|NCT04327271|464767876|FG000|Overall Study|Death|1|||
129130214|NCT04327271|464767877|FG001|Overall Study|Death|0|||
129130215|NCT04327271|464767876|FG000|Overall Study|Withdrawal by Subject|1|||
129130216|NCT04327271|464767877|FG001|Overall Study|Withdrawal by Subject|0|||
129130217|NCT04327271|464767876|FG000|Overall Study|randomization error (data capture)|4|||
129130218|NCT04327271|464767877|FG001|Overall Study|randomization error (data capture)|3|||
129130219|NCT01479530|464767879|FG000|Overall Study|Adverse Event|5|||
129130220|NCT01479530|464767880|FG001|Overall Study|Adverse Event|6|||
129130221|NCT01479530|464767879|FG000|Overall Study|Lack of Efficacy|0|||
129130222|NCT01479530|464767880|FG001|Overall Study|Lack of Efficacy|1|||
129130223|NCT01479530|464767879|FG000|Overall Study|Protocol Violation|2|||
129130224|NCT01479530|464767880|FG001|Overall Study|Protocol Violation|3|||
129130225|NCT01479530|464767879|FG000|Overall Study|Withdrawal of Consent|3|||
129130226|NCT01479530|464767880|FG001|Overall Study|Withdrawal of Consent|2|||
129130227|NCT00303628|464767881|FG000|Overall Study|Disease progression|0|||
129130228|NCT00303628|464767882|FG001|Overall Study|Disease progression|1|||
129130229|NCT00303628|464767881|FG000|Overall Study|Adverse Event|26|||
129130230|NCT00303628|464767882|FG001|Overall Study|Adverse Event|36|||
129130231|NCT00303628|464767881|FG000|Overall Study|Death|0|||
129130232|NCT00303628|464767882|FG001|Overall Study|Death|1|||
129130233|NCT00303628|464767881|FG000|Overall Study|Withdrawal by Subject|11|||
129130234|NCT00303628|464767882|FG001|Overall Study|Withdrawal by Subject|20|||
129130235|NCT00303628|464767881|FG000|Overall Study|Alternative therapy|2|||
129130236|NCT00303628|464767882|FG001|Overall Study|Alternative therapy|0|||
129130237|NCT00303628|464767881|FG000|Overall Study|Other complicating disease|0|||
129130238|NCT00303628|464767882|FG001|Overall Study|Other complicating disease|1|||
129130239|NCT00303628|464767881|FG000|Overall Study|Not start protocol therapy|3|||
129130240|NCT00303628|464767882|FG001|Overall Study|Not start protocol therapy|5|||
129130241|NCT00303628|464767881|FG000|Overall Study|Other|8|||
129130242|NCT00303628|464767882|FG001|Overall Study|Other|9|||
129130243|NCT00776997|464767883|FG000|Overall Study|Adverse Event|2|||
128713584|NCT00498602|463248213|FG004|Overall Study|AE not related to Study Drug|2|||
128713585|NCT00498602|463248214|FG005|Overall Study|AE not related to Study Drug|2|||
128965672|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
128965673|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
128965674|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
129130244|NCT03487445|464767884|FG000|Randomization|Not treated for administrative reasons|1|||
129130245|NCT03487445|464767885|FG001|Randomization|Not treated for administrative reasons|0|||
129130246|NCT03301714|464767886|FG000|Overall Study|Lost to Follow-up|10|||
129130247|NCT03301714|464767887|FG001|Overall Study|Lost to Follow-up|4|||
129130248|NCT03301714|464767888|FG002|Overall Study|Lost to Follow-up|4|||
129130249|NCT03301714|464767886|FG000|Overall Study|Did not receive allocated intervention|0|||
129130250|NCT03301714|464767887|FG001|Overall Study|Did not receive allocated intervention|2|||
129130251|NCT03301714|464767888|FG002|Overall Study|Did not receive allocated intervention|3|||
128713586|NCT00498602|463248215|FG006|Overall Study|AE not related to Study Drug|1|||
129130252|NCT03580928|464767893|FG000|Overall Study|Death|0|||
129130253|NCT03580928|464767894|FG001|Overall Study|Death|3|||
129130254|NCT03580928|464767893|FG000|Overall Study|Withdrawal by Subject|2|||
129130255|NCT03580928|464767894|FG001|Overall Study|Withdrawal by Subject|1|||
129130256|NCT03580928|464767893|FG000|Overall Study|Lost to Follow-up|2|||
129130257|NCT03580928|464767894|FG001|Overall Study|Lost to Follow-up|0|||
129130258|NCT03580928|464767893|FG000|Overall Study|Progressive Disease|0|||
129130259|NCT03580928|464767894|FG001|Overall Study|Progressive Disease|1|||
129130260|NCT00003456|464768723|FG000|Overall Study|Not evaluable|8|||
129130261|NCT00479232|464768724|FG000|Overall Study|Adverse Event|0|||
129130262|NCT00479232|464768725|FG001|Overall Study|Adverse Event|0|||
129130263|NCT00479232|464768726|FG002|Overall Study|Adverse Event|5|||
129130264|NCT00479232|464768727|FG003|Overall Study|Adverse Event|0|||
128965675|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
128965676|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
128965677|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
128965678|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
128965679|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
128965680|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
129130265|NCT00479232|464768728|FG004|Overall Study|Adverse Event|0|||
129130266|NCT00479232|464768729|FG005|Overall Study|Adverse Event|10|||
129130267|NCT00479232|464768724|FG000|Overall Study|Deviation from Protocol|0|||
129130268|NCT00479232|464768725|FG001|Overall Study|Deviation from Protocol|0|||
129130269|NCT00479232|464768726|FG002|Overall Study|Deviation from Protocol|1|||
129130270|NCT00479232|464768727|FG003|Overall Study|Deviation from Protocol|0|||
129130271|NCT00479232|464768728|FG004|Overall Study|Deviation from Protocol|0|||
129130272|NCT00479232|464768729|FG005|Overall Study|Deviation from Protocol|0|||
129130273|NCT00479232|464768724|FG000|Overall Study|Lack of Efficacy|0|||
129130274|NCT00479232|464768725|FG001|Overall Study|Lack of Efficacy|0|||
129130275|NCT00479232|464768726|FG002|Overall Study|Lack of Efficacy|2|||
129130276|NCT00479232|464768727|FG003|Overall Study|Lack of Efficacy|0|||
129130277|NCT00479232|464768728|FG004|Overall Study|Lack of Efficacy|0|||
129130278|NCT00479232|464768729|FG005|Overall Study|Lack of Efficacy|4|||
129130279|NCT00479232|464768724|FG000|Overall Study|Physician Decision|0|||
129130280|NCT00479232|464768725|FG001|Overall Study|Physician Decision|0|||
129130281|NCT00479232|464768726|FG002|Overall Study|Physician Decision|2|||
129130282|NCT00479232|464768727|FG003|Overall Study|Physician Decision|0|||
129130283|NCT00479232|464768728|FG004|Overall Study|Physician Decision|0|||
129130284|NCT00479232|464768729|FG005|Overall Study|Physician Decision|1|||
129130285|NCT00479232|464768724|FG000|Overall Study|Progressive Disease|3|||
129130286|NCT00479232|464768725|FG001|Overall Study|Progressive Disease|1|||
129130287|NCT00479232|464768726|FG002|Overall Study|Progressive Disease|12|||
129130288|NCT00479232|464768727|FG003|Overall Study|Progressive Disease|3|||
129130289|NCT00479232|464768728|FG004|Overall Study|Progressive Disease|3|||
129130290|NCT00479232|464768729|FG005|Overall Study|Progressive Disease|12|||
129130291|NCT00479232|464768724|FG000|Overall Study|Withdrew Consent|0|||
129130292|NCT00479232|464768725|FG001|Overall Study|Withdrew Consent|2|||
129130293|NCT00479232|464768726|FG002|Overall Study|Withdrew Consent|6|||
129130294|NCT00479232|464768727|FG003|Overall Study|Withdrew Consent|0|||
129130295|NCT00479232|464768728|FG004|Overall Study|Withdrew Consent|1|||
129130296|NCT00479232|464768729|FG005|Overall Study|Withdrew Consent|3|||
129130297|NCT05399771|464768730|FG000|Overall Study|Physician Decision|3|||
129130298|NCT05399771|464768730|FG000|Overall Study|Adverse Event|1|||
129130299|NCT00484159|464768731|FG000|Overall Study|Lost to Follow-up|1|||
129130300|NCT00484159|464768732|FG001|Overall Study|Lost to Follow-up|1|||
129130301|NCT00484159|464768733|FG002|Overall Study|Lost to Follow-up|0|||
129130302|NCT03720847|464768734|FG000|Washout|Physician Decision|1|||
129130303|NCT03720847|464768735|FG001|Washout|Physician Decision|2|||
128965681|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
128965682|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
128965683|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
128965684|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
128965685|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
128965686|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
128965687|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Death|0|||
128965688|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Death|0|||
128965689|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Death|0|||
128965690|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Death|0|||
128965691|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Death|1|||
128965692|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
128965693|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
128965694|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
128965695|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
128965696|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
128965697|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
128965698|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
129130304|NCT00081458|464768736|FG000|Overall Study|Adverse Event|1|||
128771691|NCT01702428|463455333|FG001|Overall Study|Adverse Event|0|||
128771692|NCT01702428|463455334|FG002|Overall Study|Adverse Event|0|||
128965699|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
129130305|NCT00081458|464768737|FG001|Overall Study|Adverse Event|5|||
129130306|NCT00081458|464768738|FG002|Overall Study|Adverse Event|2|||
129130307|NCT00081458|464768736|FG000|Overall Study|Withdrawal by Subject|0|||
129130308|NCT00081458|464768737|FG001|Overall Study|Withdrawal by Subject|3|||
129130309|NCT00081458|464768738|FG002|Overall Study|Withdrawal by Subject|1|||
129130310|NCT00081458|464768736|FG000|Overall Study|Randomized but not dosed|0|||
129130311|NCT00081458|464768737|FG001|Overall Study|Randomized but not dosed|0|||
129130312|NCT00081458|464768738|FG002|Overall Study|Randomized but not dosed|1|||
128965700|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
128965701|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
128965702|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
128965703|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
128965704|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
128965705|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
128965706|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
128965707|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
128965708|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
128965709|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
128965710|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
128965711|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
128965712|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
128965713|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
128965714|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
128965715|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
128965716|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
128965717|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Other|0|||
128965718|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Other|0|||
128965719|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Other|0|||
128965720|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Other|1|||
128965721|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Other|3|||
128965722|NCT03107793|464160080|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
128965723|NCT03107793|464160081|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
128965724|NCT03107793|464160082|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
128965725|NCT03107793|464160083|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
128965726|NCT03107793|464160084|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
128965727|NCT01989572|464160085|FG000|Overall Study|Lack of Efficacy|35|||
128965728|NCT01989572|464160086|FG001|Overall Study|Lack of Efficacy|48|||
128965729|NCT01989572|464160087|FG002|Overall Study|Lack of Efficacy|48|||
128965730|NCT01989572|464160088|FG003|Overall Study|Lack of Efficacy|43|||
128965731|NCT01989572|464160089|FG004|Overall Study|Lack of Efficacy|71|||
128965732|NCT01989572|464160090|FG005|Overall Study|Lack of Efficacy|79|||
128965733|NCT01989572|464160085|FG000|Overall Study|Adverse Event|2|||
128965734|NCT01989572|464160086|FG001|Overall Study|Adverse Event|1|||
128965735|NCT01989572|464160087|FG002|Overall Study|Adverse Event|3|||
128965736|NCT01989572|464160088|FG003|Overall Study|Adverse Event|0|||
128965737|NCT01989572|464160089|FG004|Overall Study|Adverse Event|3|||
128965738|NCT01989572|464160090|FG005|Overall Study|Adverse Event|0|||
128965739|NCT01989572|464160085|FG000|Overall Study|Death|0|||
128965740|NCT01989572|464160086|FG001|Overall Study|Death|0|||
128965741|NCT01989572|464160087|FG002|Overall Study|Death|0|||
128965742|NCT01989572|464160088|FG003|Overall Study|Death|0|||
128965743|NCT01989572|464160089|FG004|Overall Study|Death|1|||
128965744|NCT01989572|464160090|FG005|Overall Study|Death|0|||
128965745|NCT01989572|464160085|FG000|Overall Study|Withdrawal by Subject|4|||
128965746|NCT01989572|464160086|FG001|Overall Study|Withdrawal by Subject|1|||
128965747|NCT01989572|464160087|FG002|Overall Study|Withdrawal by Subject|5|||
128965748|NCT01989572|464160088|FG003|Overall Study|Withdrawal by Subject|1|||
128965749|NCT01989572|464160089|FG004|Overall Study|Withdrawal by Subject|12|||
128965750|NCT01989572|464160090|FG005|Overall Study|Withdrawal by Subject|4|||
128965751|NCT01989572|464160085|FG000|Overall Study|complicating disease|1|||
128965752|NCT01989572|464160086|FG001|Overall Study|complicating disease|1|||
128965753|NCT01989572|464160087|FG002|Overall Study|complicating disease|2|||
128965754|NCT01989572|464160088|FG003|Overall Study|complicating disease|0|||
128965755|NCT01989572|464160089|FG004|Overall Study|complicating disease|1|||
128965756|NCT01989572|464160090|FG005|Overall Study|complicating disease|0|||
128965757|NCT01989572|464160085|FG000|Overall Study|error|2|||
128965758|NCT01989572|464160086|FG001|Overall Study|error|1|||
128965759|NCT01989572|464160087|FG002|Overall Study|error|1|||
128965760|NCT01989572|464160088|FG003|Overall Study|error|1|||
128965761|NCT01989572|464160089|FG004|Overall Study|error|1|||
128965762|NCT01989572|464160090|FG005|Overall Study|error|1|||
128965763|NCT01989572|464160085|FG000|Overall Study|maximum dose reached|0|||
128965764|NCT01989572|464160086|FG001|Overall Study|maximum dose reached|1|||
128965765|NCT01989572|464160087|FG002|Overall Study|maximum dose reached|0|||
128965766|NCT01989572|464160088|FG003|Overall Study|maximum dose reached|0|||
128965767|NCT01989572|464160089|FG004|Overall Study|maximum dose reached|1|||
128965768|NCT01989572|464160090|FG005|Overall Study|maximum dose reached|0|||
128965769|NCT01989572|464160085|FG000|Overall Study|unknown/not specify|3|||
128965770|NCT01989572|464160086|FG001|Overall Study|unknown/not specify|4|||
128965771|NCT01989572|464160087|FG002|Overall Study|unknown/not specify|1|||
128965772|NCT01989572|464160088|FG003|Overall Study|unknown/not specify|3|||
128965773|NCT01989572|464160089|FG004|Overall Study|unknown/not specify|3|||
128965774|NCT01989572|464160090|FG005|Overall Study|unknown/not specify|5|||
128965775|NCT01989572|464160085|FG000|Overall Study|not start protocol therapy|5|||
128965776|NCT01989572|464160086|FG001|Overall Study|not start protocol therapy|1|||
128965777|NCT01989572|464160087|FG002|Overall Study|not start protocol therapy|2|||
128965778|NCT01989572|464160088|FG003|Overall Study|not start protocol therapy|3|||
128965779|NCT01989572|464160089|FG004|Overall Study|not start protocol therapy|4|||
128965780|NCT01989572|464160090|FG005|Overall Study|not start protocol therapy|18|||
128965781|NCT01989572|464160085|FG000|Overall Study|alternative therapy|3|||
128965782|NCT01989572|464160086|FG001|Overall Study|alternative therapy|0|||
128965783|NCT01989572|464160087|FG002|Overall Study|alternative therapy|0|||
128965784|NCT01989572|464160088|FG003|Overall Study|alternative therapy|0|||
128965785|NCT01989572|464160089|FG004|Overall Study|alternative therapy|1|||
128965786|NCT01989572|464160090|FG005|Overall Study|alternative therapy|3|||
128965787|NCT02910089|464160091|FG000|Overall Study|Lost insurance eligibility|22|||
128965788|NCT02910089|464160092|FG001|Overall Study|Lost insurance eligibility|16|||
128965789|NCT02057068|464160099|FG000|Overall Study|Withdrawal by Subject|2|||
128965790|NCT02057068|464160100|FG001|Overall Study|Withdrawal by Subject|2|||
128965791|NCT02057068|464160099|FG000|Overall Study|Caregiver (CG) Health|0|||
128965792|NCT02057068|464160100|FG001|Overall Study|Caregiver (CG) Health|2|||
128965793|NCT02057068|464160099|FG000|Overall Study|Carepartner (CP) Health|4|||
128965794|NCT02057068|464160100|FG001|Overall Study|Carepartner (CP) Health|2|||
128965795|NCT02057068|464160099|FG000|Overall Study|Lost to Follow-up|2|||
128965796|NCT02057068|464160100|FG001|Overall Study|Lost to Follow-up|2|||
128965797|NCT00865046|464160101|FG000|Overall Study|Lost to Follow-up|1|||
128965798|NCT00865046|464160102|FG001|Overall Study|Lost to Follow-up|4|||
128965799|NCT00865046|464160103|FG002|Overall Study|Lost to Follow-up|0|||
128965800|NCT00865046|464160101|FG000|Overall Study|Death|0|||
128965801|NCT00865046|464160102|FG001|Overall Study|Death|1|||
128965802|NCT00865046|464160103|FG002|Overall Study|Death|1|||
128965803|NCT00865046|464160101|FG000|Overall Study|Withdrawal by Subject|5|||
128965804|NCT00865046|464160102|FG001|Overall Study|Withdrawal by Subject|0|||
128965805|NCT00865046|464160103|FG002|Overall Study|Withdrawal by Subject|0|||
128965806|NCT02977507|464160105|FG000|Overall Study|Protocol Deviation|1|||
128965807|NCT02977507|464160106|FG001|Overall Study|Protocol Deviation|0|||
128965808|NCT02977507|464160105|FG000|Overall Study|Lost to Follow-up|1|||
128965809|NCT02977507|464160106|FG001|Overall Study|Lost to Follow-up|0|||
128965810|NCT00633360|464160107|FG000|Overall Study|Lost to Follow-up|1|||
128965811|NCT00633360|464160108|FG001|Overall Study|Lost to Follow-up|1|||
128965812|NCT00633360|464160107|FG000|Overall Study|Adverse Event|3|||
128965813|NCT00633360|464160108|FG001|Overall Study|Adverse Event|1|||
128965814|NCT00633360|464160107|FG000|Overall Study|Protocol Violation|0|||
128965815|NCT00633360|464160108|FG001|Overall Study|Protocol Violation|1|||
128965816|NCT00610207|464160111|FG000|Overall Study|Lost to Follow-up|3|||
128965817|NCT02465489|464160114|FG000|Overall Study|Adverse Event|5|||
128965818|NCT01594411|464160115|FG000|Overall Study|Lost to Follow-up|2|||
128965819|NCT04449276|464160116|FG000|Overall Study|Adverse Event|1|||
128965820|NCT04449276|464160117|FG001|Overall Study|Adverse Event|2|||
128965821|NCT04449276|464160118|FG002|Overall Study|Adverse Event|0|||
128965822|NCT04449276|464160119|FG003|Overall Study|Adverse Event|0|||
128965823|NCT04449276|464160120|FG004|Overall Study|Adverse Event|2|||
128965824|NCT04449276|464160121|FG005|Overall Study|Adverse Event|0|||
128965825|NCT04449276|464160122|FG006|Overall Study|Adverse Event|0|||
128965826|NCT04449276|464160123|FG007|Overall Study|Adverse Event|1|||
128965827|NCT04449276|464160116|FG000|Overall Study|Withdrawal by Subject|2|||
128965828|NCT04449276|464160117|FG001|Overall Study|Withdrawal by Subject|0|||
128965829|NCT04449276|464160118|FG002|Overall Study|Withdrawal by Subject|0|||
128965830|NCT04449276|464160119|FG003|Overall Study|Withdrawal by Subject|1|||
128965831|NCT04449276|464160120|FG004|Overall Study|Withdrawal by Subject|0|||
128965832|NCT04449276|464160121|FG005|Overall Study|Withdrawal by Subject|0|||
128965833|NCT04449276|464160122|FG006|Overall Study|Withdrawal by Subject|0|||
128965834|NCT04449276|464160123|FG007|Overall Study|Withdrawal by Subject|0|||
128965835|NCT04449276|464160116|FG000|Overall Study|Other|0|||
128965836|NCT04449276|464160117|FG001|Overall Study|Other|2|||
128965837|NCT04449276|464160118|FG002|Overall Study|Other|3|||
128965838|NCT04449276|464160119|FG003|Overall Study|Other|2|||
128965839|NCT04449276|464160120|FG004|Overall Study|Other|0|||
128965840|NCT04449276|464160121|FG005|Overall Study|Other|0|||
128965841|NCT04449276|464160122|FG006|Overall Study|Other|0|||
128965842|NCT04449276|464160123|FG007|Overall Study|Other|1|||
129220268|NCT00318643|465106538|FG001|Overall Study|Investigator's Decision|0|||
129220269|NCT00318643|465106539|FG002|Overall Study|Investigator's Decision|0|||
128965843|NCT01614795|464160124|FG000|Overall Study|Adverse Event|0|||
128965844|NCT01614795|464160125|FG001|Overall Study|Adverse Event|0|||
128965845|NCT01614795|464160126|FG002|Overall Study|Adverse Event|1|||
129220270|NCT00318643|465106540|FG003|Overall Study|Investigator's Decision|0|||
128965846|NCT01614795|464160127|FG003|Overall Study|Adverse Event|1|||
128965847|NCT01614795|464160124|FG000|Overall Study|Lack of Efficacy|10|||
128965848|NCT01614795|464160125|FG001|Overall Study|Lack of Efficacy|10|||
128965849|NCT01614795|464160126|FG002|Overall Study|Lack of Efficacy|9|||
128965850|NCT01614795|464160127|FG003|Overall Study|Lack of Efficacy|8|||
128965851|NCT01614795|464160124|FG000|Overall Study|Physician Decision|1|||
128965852|NCT01614795|464160125|FG001|Overall Study|Physician Decision|0|||
128965853|NCT01614795|464160126|FG002|Overall Study|Physician Decision|1|||
128965854|NCT01614795|464160127|FG003|Overall Study|Physician Decision|1|||
128965855|NCT01614795|464160124|FG000|Overall Study|Withdrawal by Subject|0|||
128965856|NCT01614795|464160125|FG001|Overall Study|Withdrawal by Subject|1|||
128965857|NCT01614795|464160126|FG002|Overall Study|Withdrawal by Subject|0|||
128965858|NCT01614795|464160127|FG003|Overall Study|Withdrawal by Subject|2|||
128965859|NCT01614795|464160124|FG000|Overall Study|Ineligible|0|||
128965860|NCT01614795|464160125|FG001|Overall Study|Ineligible|1|||
128965861|NCT01614795|464160126|FG002|Overall Study|Ineligible|0|||
128965862|NCT01614795|464160127|FG003|Overall Study|Ineligible|0|||
128965863|NCT00910728|464160128|FG000|Overall Study|Lack of Efficacy|2|||
128965864|NCT00910728|464160129|FG001|Overall Study|Lack of Efficacy|3|||
128965865|NCT00910728|464160130|FG002|Overall Study|Lack of Efficacy|1|||
128965866|NCT00910728|464160131|FG003|Overall Study|Lack of Efficacy|2|||
128965867|NCT00910728|464160132|FG004|Overall Study|Lack of Efficacy|1|||
128965868|NCT00910728|464160133|FG005|Overall Study|Lack of Efficacy|0|||
128965869|NCT00910728|464160134|FG006|Overall Study|Lack of Efficacy|2|||
128965870|NCT00910728|464160135|FG007|Overall Study|Lack of Efficacy|2|||
128965871|NCT00910728|464160136|FG008|Overall Study|Lack of Efficacy|2|||
128965872|NCT00910728|464160128|FG000|Overall Study|Withdrawal by Subject|0|||
128965873|NCT00910728|464160129|FG001|Overall Study|Withdrawal by Subject|0|||
128965874|NCT00910728|464160130|FG002|Overall Study|Withdrawal by Subject|0|||
128965875|NCT00910728|464160131|FG003|Overall Study|Withdrawal by Subject|0|||
128965876|NCT00910728|464160132|FG004|Overall Study|Withdrawal by Subject|3|||
128965877|NCT00910728|464160133|FG005|Overall Study|Withdrawal by Subject|1|||
128965878|NCT00910728|464160134|FG006|Overall Study|Withdrawal by Subject|2|||
128965879|NCT00910728|464160135|FG007|Overall Study|Withdrawal by Subject|0|||
128965880|NCT00910728|464160136|FG008|Overall Study|Withdrawal by Subject|0|||
128965881|NCT00910728|464160128|FG000|Overall Study|(not specified)|2|||
128965882|NCT00910728|464160129|FG001|Overall Study|(not specified)|0|||
128965883|NCT00910728|464160130|FG002|Overall Study|(not specified)|1|||
128965884|NCT00910728|464160131|FG003|Overall Study|(not specified)|0|||
128965885|NCT00910728|464160132|FG004|Overall Study|(not specified)|1|||
128965886|NCT00910728|464160133|FG005|Overall Study|(not specified)|0|||
128965887|NCT00910728|464160134|FG006|Overall Study|(not specified)|0|||
128965888|NCT00910728|464160135|FG007|Overall Study|(not specified)|0|||
128965889|NCT00910728|464160136|FG008|Overall Study|(not specified)|0|||
128965890|NCT00910728|464160128|FG000|Overall Study|Adverse Event|2|||
128965891|NCT00910728|464160129|FG001|Overall Study|Adverse Event|0|||
128965892|NCT00910728|464160130|FG002|Overall Study|Adverse Event|1|||
128965893|NCT00910728|464160131|FG003|Overall Study|Adverse Event|1|||
128965894|NCT00910728|464160132|FG004|Overall Study|Adverse Event|0|||
128965895|NCT00910728|464160133|FG005|Overall Study|Adverse Event|0|||
128965896|NCT00910728|464160134|FG006|Overall Study|Adverse Event|2|||
128965897|NCT00910728|464160135|FG007|Overall Study|Adverse Event|1|||
128965898|NCT00910728|464160136|FG008|Overall Study|Adverse Event|1|||
128965899|NCT00023712|464160137|FG000|Overall Study|Not platinum sensitive|1|||
128965900|NCT00023712|464160138|FG001|Overall Study|Not platinum sensitive|0|||
128965901|NCT00023712|464160137|FG000|Overall Study|Never treated|1|||
128965902|NCT00023712|464160138|FG001|Overall Study|Never treated|1|||
128965903|NCT01810380|464160139|FG000|Overall Study|Randomised not treated|2|||
128965904|NCT01810380|464160140|FG001|Overall Study|Randomised not treated|1|||
128965905|NCT01810380|464160141|FG002|Overall Study|Randomised not treated|1|||
128965906|NCT01810380|464160139|FG000|Overall Study|Adverse Event|11|||
128965907|NCT01810380|464160140|FG001|Overall Study|Adverse Event|14|||
128965908|NCT01810380|464160141|FG002|Overall Study|Adverse Event|4|||
128965909|NCT01810380|464160139|FG000|Overall Study|Lack of Efficacy|24|||
128965910|NCT01810380|464160140|FG001|Overall Study|Lack of Efficacy|10|||
128965911|NCT01810380|464160141|FG002|Overall Study|Lack of Efficacy|11|||
128965912|NCT01810380|464160139|FG000|Overall Study|Protocol Violation|1|||
128965913|NCT01810380|464160140|FG001|Overall Study|Protocol Violation|0|||
128965914|NCT01810380|464160141|FG002|Overall Study|Protocol Violation|1|||
128965915|NCT01810380|464160139|FG000|Overall Study|Withdrawal by Subject|6|||
128965916|NCT01810380|464160140|FG001|Overall Study|Withdrawal by Subject|0|||
128965917|NCT01810380|464160141|FG002|Overall Study|Withdrawal by Subject|6|||
128965918|NCT01810380|464160139|FG000|Overall Study|Administrative or other reasons|11|||
128965919|NCT01810380|464160140|FG001|Overall Study|Administrative or other reasons|13|||
128965920|NCT01810380|464160141|FG002|Overall Study|Administrative or other reasons|9|||
128965921|NCT00251589|464160144|FG000|Overall Study|Adverse Event|5|||
128965922|NCT00251589|464160145|FG001|Overall Study|Adverse Event|1|||
129130313|NCT00549328|464768739|FG000|Overall Study|Adverse Event|2|||
128965923|NCT00251589|464160146|FG002|Overall Study|Adverse Event|2|||
128965924|NCT00251589|464160147|FG003|Overall Study|Adverse Event|1|||
128965925|NCT00251589|464160144|FG000|Overall Study|Withdrawal by Subject|1|||
128965926|NCT00251589|464160145|FG001|Overall Study|Withdrawal by Subject|1|||
128965927|NCT00251589|464160146|FG002|Overall Study|Withdrawal by Subject|0|||
128965928|NCT00251589|464160147|FG003|Overall Study|Withdrawal by Subject|0|||
128965929|NCT00251589|464160144|FG000|Overall Study|Discontinued due to progressive disease|9|||
128965930|NCT00251589|464160145|FG001|Overall Study|Discontinued due to progressive disease|1|||
128965931|NCT00251589|464160146|FG002|Overall Study|Discontinued due to progressive disease|0|||
128965932|NCT00251589|464160147|FG003|Overall Study|Discontinued due to progressive disease|1|||
128965933|NCT02571972|464160150|FG000|Overall Study|Protocol Violation|2|||
128965934|NCT02571972|464160150|FG000|Overall Study|Withdrawal by Subject|2|||
128965935|NCT03039192|464160153|FG000|Overall Study|Lost to Follow-up|4|||
128965936|NCT03039192|464160154|FG001|Overall Study|Lost to Follow-up|4|||
128965937|NCT03039192|464160153|FG000|Overall Study|Adverse event, serious fatal|0|||
128965938|NCT03039192|464160154|FG001|Overall Study|Adverse event, serious fatal|1|||
128965939|NCT03039192|464160153|FG000|Overall Study|Adverse event, non-fatal|0|||
128965940|NCT03039192|464160154|FG001|Overall Study|Adverse event, non-fatal|2|||
128965941|NCT03039192|464160153|FG000|Overall Study|Withdrawal by Subject|6|||
128965942|NCT03039192|464160154|FG001|Overall Study|Withdrawal by Subject|9|||
128965943|NCT03039192|464160153|FG000|Overall Study|Discontinued from treatment phase|19|||
128965944|NCT03039192|464160154|FG001|Overall Study|Discontinued from treatment phase|12|||
128965945|NCT03039192|464160153|FG000|Overall Study|Other|3|||
128965946|NCT03039192|464160154|FG001|Overall Study|Other|2|||
128965947|NCT02493868|464160155|FG000|Induction Phase: DE Participants|Adverse Event|22|||
128965948|NCT02493868|464160156|FG001|Induction Phase: DE Participants|Adverse Event|0|||
128965949|NCT02493868|464160155|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
128965950|NCT02493868|464160156|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
128965951|NCT02493868|464160155|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
128965952|NCT02493868|464160156|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
128965953|NCT02493868|464160155|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
128965954|NCT02493868|464160156|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
128965955|NCT02493868|464160155|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
128965956|NCT02493868|464160156|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
128965957|NCT02493868|464160155|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
128965958|NCT02493868|464160156|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
128965959|NCT02493868|464160155|FG000|Induction Phase: DE Participants|Other|8|||
128965960|NCT02493868|464160156|FG001|Induction Phase: DE Participants|Other|0|||
128965961|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
128965962|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
128965963|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
128965964|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
128965965|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
128965966|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
128965967|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
128965968|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
128965969|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
128965970|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
128965971|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
128965972|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
128965973|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
128965974|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
128965975|NCT02493868|464160155|FG000|Optimization Phase: DE+TE Participants|Other|10|||
128965976|NCT02493868|464160156|FG001|Optimization Phase: DE+TE Participants|Other|2|||
128965977|NCT02493868|464160155|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
128965978|NCT02493868|464160156|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
128965979|NCT02493868|464160155|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
128965980|NCT02493868|464160156|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
128965981|NCT02493868|464160155|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
128965982|NCT02493868|464160156|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
128965983|NCT02493868|464160155|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
128965984|NCT02493868|464160156|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
128965985|NCT02493868|464160155|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
128965986|NCT02493868|464160156|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
128965987|NCT02493868|464160155|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
128965988|NCT02493868|464160156|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
128965989|NCT02493868|464160155|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
128965990|NCT02493868|464160156|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
128965991|NCT02493868|464160155|FG000|Follow-up Phase|Lost to Follow-up|1|||
128965992|NCT02493868|464160156|FG001|Follow-up Phase|Lost to Follow-up|0|||
128965993|NCT02493868|464160155|FG000|Follow-up Phase|Withdrawal by Subject|3|||
128965994|NCT02493868|464160156|FG001|Follow-up Phase|Withdrawal by Subject|0|||
128965995|NCT02493868|464160155|FG000|Follow-up Phase|Investigator Decision|5|||
128965996|NCT02493868|464160156|FG001|Follow-up Phase|Investigator Decision|1|||
128965997|NCT02493868|464160155|FG000|Follow-up Phase|Other|2|||
128965998|NCT02493868|464160156|FG001|Follow-up Phase|Other|1|||
128965999|NCT02407236|464160157|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
128966000|NCT02407236|464160158|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
128966001|NCT02407236|464160159|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
128966002|NCT02407236|464160160|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
128966003|NCT02407236|464160161|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
128771693|NCT01702428|463455335|FG003|Overall Study|Adverse Event|0|||
128771694|NCT01702428|463455332|FG000|Overall Study|Lost to Follow-up|33|||
128771695|NCT01702428|463455333|FG001|Overall Study|Lost to Follow-up|41|||
128771696|NCT01702428|463455334|FG002|Overall Study|Lost to Follow-up|37|||
128771697|NCT01702428|463455335|FG003|Overall Study|Lost to Follow-up|44|||
128771698|NCT01702428|463455332|FG000|Overall Study|Parents cannot assist to site|1|||
128771699|NCT01702428|463455333|FG001|Overall Study|Parents cannot assist to site|0|||
128771700|NCT01702428|463455334|FG002|Overall Study|Parents cannot assist to site|1|||
128966004|NCT02407236|464160162|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
128966005|NCT02407236|464160163|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
128966006|NCT02407236|464160164|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
128966007|NCT02407236|464160165|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
128966008|NCT02407236|464160166|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
128966009|NCT02407236|464160167|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
128771701|NCT01702428|463455335|FG003|Overall Study|Parents cannot assist to site|0|||
128771702|NCT01702428|463455332|FG000|Overall Study|Lost Coverage|0|||
128771703|NCT01702428|463455333|FG001|Overall Study|Lost Coverage|0|||
128771704|NCT01702428|463455334|FG002|Overall Study|Lost Coverage|0|||
128771705|NCT01702428|463455335|FG003|Overall Study|Lost Coverage|1|||
128966010|NCT02407236|464160168|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
128966011|NCT02407236|464160169|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
128966012|NCT02407236|464160157|FG000|Induction Study (8 Weeks)|Death|0|||
128966013|NCT02407236|464160158|FG001|Induction Study (8 Weeks)|Death|0|||
128966014|NCT02407236|464160159|FG002|Induction Study (8 Weeks)|Death|1|||
128966015|NCT02407236|464160160|FG003|Induction Study (8 Weeks)|Death|0|||
128966016|NCT02407236|464160161|FG004|Induction Study (8 Weeks)|Death|0|||
128966017|NCT02407236|464160162|FG005|Induction Study (8 Weeks)|Death|0|||
128966018|NCT02407236|464160163|FG006|Induction Study (8 Weeks)|Death|0|||
128966019|NCT02407236|464160164|FG007|Induction Study (8 Weeks)|Death|0|||
128966020|NCT02407236|464160165|FG008|Induction Study (8 Weeks)|Death|0|||
128966021|NCT02407236|464160166|FG009|Induction Study (8 Weeks)|Death|0|||
128966022|NCT02407236|464160167|FG010|Induction Study (8 Weeks)|Death|0|||
128966023|NCT02407236|464160168|FG011|Induction Study (8 Weeks)|Death|0|||
128966024|NCT02407236|464160169|FG012|Induction Study (8 Weeks)|Death|0|||
128966025|NCT02407236|464160157|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
128966026|NCT02407236|464160158|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
128966027|NCT02407236|464160159|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
128966028|NCT02407236|464160160|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966029|NCT02407236|464160161|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966030|NCT02407236|464160162|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966031|NCT02407236|464160163|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966032|NCT02407236|464160164|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966033|NCT02407236|464160165|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966034|NCT02407236|464160166|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966035|NCT02407236|464160167|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966036|NCT02407236|464160168|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966037|NCT02407236|464160169|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
128966038|NCT02407236|464160157|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966039|NCT02407236|464160158|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966040|NCT02407236|464160159|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
128966041|NCT02407236|464160160|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966042|NCT02407236|464160161|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966043|NCT02407236|464160162|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966044|NCT02407236|464160163|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966045|NCT02407236|464160164|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966046|NCT02407236|464160165|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966047|NCT02407236|464160166|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128771706|NCT01702428|463455332|FG000|Overall Study|Lost Health Plan|3|||
128771707|NCT01702428|463455333|FG001|Overall Study|Lost Health Plan|5|||
128771708|NCT01702428|463455334|FG002|Overall Study|Lost Health Plan|0|||
128771709|NCT01702428|463455335|FG003|Overall Study|Lost Health Plan|2|||
128771710|NCT01702428|463455332|FG000|Overall Study|Mother transferred care|0|||
128966048|NCT02407236|464160167|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966049|NCT02407236|464160168|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966050|NCT02407236|464160169|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
128966051|NCT02407236|464160157|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
128771711|NCT01702428|463455333|FG001|Overall Study|Mother transferred care|1|||
128966052|NCT02407236|464160158|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
128966053|NCT02407236|464160159|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
128966054|NCT02407236|464160160|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
128966055|NCT02407236|464160161|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
128966056|NCT02407236|464160162|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
128966057|NCT02407236|464160163|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
128966058|NCT02407236|464160164|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
128966059|NCT02407236|464160165|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
128966060|NCT02407236|464160166|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
128966061|NCT02407236|464160167|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
128966062|NCT02407236|464160168|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
128966063|NCT02407236|464160169|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
128966064|NCT02407236|464160157|FG000|Induction Study (8 Weeks)|Other|2|||
128966065|NCT02407236|464160158|FG001|Induction Study (8 Weeks)|Other|1|||
128966066|NCT02407236|464160159|FG002|Induction Study (8 Weeks)|Other|5|||
128966067|NCT02407236|464160160|FG003|Induction Study (8 Weeks)|Other|0|||
128966068|NCT02407236|464160161|FG004|Induction Study (8 Weeks)|Other|0|||
128966069|NCT02407236|464160162|FG005|Induction Study (8 Weeks)|Other|0|||
128966070|NCT02407236|464160163|FG006|Induction Study (8 Weeks)|Other|0|||
128966071|NCT02407236|464160164|FG007|Induction Study (8 Weeks)|Other|0|||
128966072|NCT02407236|464160165|FG008|Induction Study (8 Weeks)|Other|0|||
128966073|NCT02407236|464160166|FG009|Induction Study (8 Weeks)|Other|0|||
128966074|NCT02407236|464160167|FG010|Induction Study (8 Weeks)|Other|0|||
128966075|NCT02407236|464160168|FG011|Induction Study (8 Weeks)|Other|0|||
128966076|NCT02407236|464160169|FG012|Induction Study (8 Weeks)|Other|0|||
128966077|NCT02407236|464160157|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966078|NCT02407236|464160158|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966079|NCT02407236|464160159|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966080|NCT02407236|464160160|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
128966081|NCT02407236|464160161|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
128966082|NCT02407236|464160162|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
128966083|NCT02407236|464160163|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
128966084|NCT02407236|464160164|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
128966085|NCT02407236|464160165|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966086|NCT02407236|464160166|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966087|NCT02407236|464160167|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966088|NCT02407236|464160168|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966089|NCT02407236|464160169|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
128966090|NCT02407236|464160157|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966091|NCT02407236|464160158|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966092|NCT02407236|464160159|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966093|NCT02407236|464160160|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
128966094|NCT02407236|464160161|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
128966095|NCT02407236|464160162|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
128966096|NCT02407236|464160163|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
128966097|NCT02407236|464160164|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
128966098|NCT02407236|464160165|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966099|NCT02407236|464160166|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966100|NCT02407236|464160167|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966101|NCT02407236|464160168|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966102|NCT02407236|464160169|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
128966103|NCT02407236|464160157|FG000|Maintenance Study (44 Weeks)|Other|0|||
128966104|NCT02407236|464160158|FG001|Maintenance Study (44 Weeks)|Other|0|||
128966105|NCT02407236|464160159|FG002|Maintenance Study (44 Weeks)|Other|0|||
128713587|NCT00498602|463248209|FG000|Overall Study|Caregiver Request|2|||
128966106|NCT02407236|464160160|FG003|Maintenance Study (44 Weeks)|Other|5|||
128966107|NCT02407236|464160161|FG004|Maintenance Study (44 Weeks)|Other|7|||
128966108|NCT02407236|464160162|FG005|Maintenance Study (44 Weeks)|Other|8|||
128966109|NCT02407236|464160163|FG006|Maintenance Study (44 Weeks)|Other|4|||
128966110|NCT02407236|464160164|FG007|Maintenance Study (44 Weeks)|Other|6|||
128966111|NCT02407236|464160165|FG008|Maintenance Study (44 Weeks)|Other|0|||
128966112|NCT02407236|464160166|FG009|Maintenance Study (44 Weeks)|Other|0|||
128966113|NCT02407236|464160167|FG010|Maintenance Study (44 Weeks)|Other|0|||
128966114|NCT02407236|464160168|FG011|Maintenance Study (44 Weeks)|Other|0|||
128713588|NCT00498602|463248210|FG001|Overall Study|Caregiver Request|2|||
128966115|NCT02407236|464160169|FG012|Maintenance Study (44 Weeks)|Other|0|||
128966116|NCT02407236|464160157|FG000|Maintenance Study (44 Weeks)|Death|0|||
128713589|NCT00498602|463248211|FG002|Overall Study|Caregiver Request|2|||
128713590|NCT00498602|463248212|FG003|Overall Study|Caregiver Request|0|||
128966117|NCT02407236|464160158|FG001|Maintenance Study (44 Weeks)|Death|0|||
128966118|NCT02407236|464160159|FG002|Maintenance Study (44 Weeks)|Death|0|||
128966119|NCT02407236|464160160|FG003|Maintenance Study (44 Weeks)|Death|0|||
128713591|NCT00498602|463248213|FG004|Overall Study|Caregiver Request|1|||
128966120|NCT02407236|464160161|FG004|Maintenance Study (44 Weeks)|Death|0|||
129037849|NCT01011556|464430518|FG002|Overall Study|Adverse Event|2|||
129037850|NCT01011556|464430519|FG003|Overall Study|Adverse Event|1|||
129037851|NCT01011556|464430516|FG000|Overall Study|Lost to Follow-up|1|||
129037852|NCT01011556|464430517|FG001|Overall Study|Lost to Follow-up|0|||
129037853|NCT01011556|464430518|FG002|Overall Study|Lost to Follow-up|0|||
129037854|NCT01011556|464430519|FG003|Overall Study|Lost to Follow-up|0|||
129037855|NCT01011556|464430516|FG000|Overall Study|Physician Decision|1|||
129037856|NCT01011556|464430517|FG001|Overall Study|Physician Decision|0|||
129037857|NCT01011556|464430518|FG002|Overall Study|Physician Decision|0|||
129037858|NCT01011556|464430519|FG003|Overall Study|Physician Decision|1|||
129037859|NCT01011556|464430516|FG000|Overall Study|Protocol Violation|0|||
129037860|NCT01011556|464430517|FG001|Overall Study|Protocol Violation|1|||
129037861|NCT01011556|464430518|FG002|Overall Study|Protocol Violation|0|||
129037862|NCT01011556|464430519|FG003|Overall Study|Protocol Violation|0|||
129037863|NCT01011556|464430516|FG000|Overall Study|Withdrawal by Subject|1|||
129037864|NCT01011556|464430517|FG001|Overall Study|Withdrawal by Subject|2|||
129037865|NCT01011556|464430518|FG002|Overall Study|Withdrawal by Subject|4|||
129037866|NCT01011556|464430519|FG003|Overall Study|Withdrawal by Subject|4|||
129037867|NCT01011556|464430516|FG000|Overall Study|Sponsor decision|0|||
129037868|NCT01011556|464430517|FG001|Overall Study|Sponsor decision|1|||
129037869|NCT01011556|464430518|FG002|Overall Study|Sponsor decision|1|||
129037870|NCT01011556|464430519|FG003|Overall Study|Sponsor decision|2|||
129037871|NCT01011556|464430516|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
129037872|NCT01011556|464430517|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
128713592|NCT00498602|463248214|FG005|Overall Study|Caregiver Request|2|||
128713593|NCT00498602|463248215|FG006|Overall Study|Caregiver Request|0|||
128713594|NCT00498602|463248209|FG000|Overall Study|Investigator Request|0|||
128966121|NCT02407236|464160162|FG005|Maintenance Study (44 Weeks)|Death|0|||
128966122|NCT02407236|464160163|FG006|Maintenance Study (44 Weeks)|Death|0|||
128966123|NCT02407236|464160164|FG007|Maintenance Study (44 Weeks)|Death|1|||
128966124|NCT02407236|464160165|FG008|Maintenance Study (44 Weeks)|Death|0|||
128966125|NCT02407236|464160166|FG009|Maintenance Study (44 Weeks)|Death|0|||
128966126|NCT02407236|464160167|FG010|Maintenance Study (44 Weeks)|Death|0|||
128966127|NCT02407236|464160168|FG011|Maintenance Study (44 Weeks)|Death|0|||
128966128|NCT02407236|464160169|FG012|Maintenance Study (44 Weeks)|Death|0|||
128966129|NCT02407236|464160157|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
128966130|NCT02407236|464160158|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
128966131|NCT02407236|464160159|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
128966132|NCT02407236|464160160|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
128966133|NCT02407236|464160161|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
128966134|NCT02407236|464160162|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
128713595|NCT00498602|463248210|FG001|Overall Study|Investigator Request|0|||
128713596|NCT00498602|463248211|FG002|Overall Study|Investigator Request|1|||
128713597|NCT00498602|463248212|FG003|Overall Study|Investigator Request|0|||
128713598|NCT00498602|463248213|FG004|Overall Study|Investigator Request|0|||
128713599|NCT00498602|463248214|FG005|Overall Study|Investigator Request|0|||
128713600|NCT00498602|463248215|FG006|Overall Study|Investigator Request|0|||
128713601|NCT00498602|463248209|FG000|Overall Study|Subject Request|3|||
128713602|NCT00498602|463248210|FG001|Overall Study|Subject Request|0|||
128713603|NCT00498602|463248211|FG002|Overall Study|Subject Request|1|||
128713604|NCT00498602|463248212|FG003|Overall Study|Subject Request|1|||
128713605|NCT00498602|463248213|FG004|Overall Study|Subject Request|1|||
128713606|NCT00498602|463248214|FG005|Overall Study|Subject Request|4|||
128713607|NCT00498602|463248215|FG006|Overall Study|Subject Request|1|||
128713608|NCT00498602|463248209|FG000|Overall Study|Other|2|||
128713609|NCT00498602|463248210|FG001|Overall Study|Other|3|||
128713610|NCT00498602|463248211|FG002|Overall Study|Other|1|||
128713611|NCT00498602|463248212|FG003|Overall Study|Other|0|||
128713612|NCT00498602|463248213|FG004|Overall Study|Other|0|||
128771712|NCT01702428|463455334|FG002|Overall Study|Mother transferred care|0|||
128771713|NCT01702428|463455335|FG003|Overall Study|Mother transferred care|0|||
128771714|NCT01702428|463455332|FG000|Overall Study|Parents too busy|1|||
128771715|NCT01702428|463455333|FG001|Overall Study|Parents too busy|0|||
129037873|NCT01011556|464430518|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
129037874|NCT01011556|464430519|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
129037875|NCT04220775|464430521|FG000|Overall Study|Adverse Event|1|||
128713613|NCT00498602|463248214|FG005|Overall Study|Other|3|||
128713614|NCT00498602|463248215|FG006|Overall Study|Other|0|||
128713615|NCT02632552|463248219|FG000|Overall Study|Lost to Follow-up|14|||
128713616|NCT02632552|463248220|FG001|Overall Study|Lost to Follow-up|8|||
128713617|NCT02632552|463248219|FG000|Overall Study|Withdrawal by Subject|2|||
128771716|NCT01702428|463455334|FG002|Overall Study|Parents too busy|0|||
128966135|NCT02407236|464160163|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129037876|NCT04220775|464430522|FG001|Overall Study|Adverse Event|0|||
129037877|NCT04220775|464430521|FG000|Overall Study|Disease Progression|1|||
129037878|NCT04220775|464430522|FG001|Overall Study|Disease Progression|0|||
129037879|NCT00089076|464430523|FG000|Overall Study|Alternate Therapy|1|||
129037880|NCT00089076|464430523|FG000|Overall Study|Withdrawal by Subject|2|||
129037881|NCT00089076|464430523|FG000|Overall Study|Progression|7|||
129037882|NCT00931463|464430524|FG000|Overall Study|Death|8|||
129037883|NCT00931463|464430525|FG001|Overall Study|Death|4|||
129037884|NCT00931463|464430524|FG000|Overall Study|Withdrawal by Subject|5|||
129037885|NCT00931463|464430525|FG001|Overall Study|Withdrawal by Subject|0|||
129037886|NCT00931463|464430524|FG000|Overall Study|Lost to Follow-up|4|||
129037887|NCT00931463|464430525|FG001|Overall Study|Lost to Follow-up|1|||
129037888|NCT03170869|464430526|FG000|Overall Study|Protocol Violation|5|||
129037889|NCT03170869|464430526|FG000|Overall Study|Early study termination|3|||
129037890|NCT01009515|464430527|FG000|Overall Study|Withdrawal by Subject|3|||
129037891|NCT00983476|464430533|FG000|Overall Study|Did not receive intervention|17|||
129037892|NCT00983476|464430534|FG001|Overall Study|Did not receive intervention|22|||
129037893|NCT00983476|464430535|FG002|Overall Study|Did not receive intervention|0|||
129037894|NCT01175473|464430537|FG000|Overall Study|Adverse Event|2|||
129037895|NCT01175473|464430538|FG001|Overall Study|Adverse Event|2|||
129037896|NCT02539368|464430541|FG000|Overall Study|Death|4|||
129037897|NCT02539368|464430542|FG001|Overall Study|Death|2|||
129037898|NCT02539368|464430543|FG002|Overall Study|Death|1|||
129037899|NCT02539368|464430544|FG003|Overall Study|Death|0|||
129037900|NCT02539368|464430545|FG004|Overall Study|Death|0|||
129037901|NCT02539368|464430541|FG000|Overall Study|Withdrawal by Subject|44|||
129037902|NCT02539368|464430542|FG001|Overall Study|Withdrawal by Subject|35|||
129037903|NCT02539368|464430543|FG002|Overall Study|Withdrawal by Subject|9|||
129037904|NCT02539368|464430544|FG003|Overall Study|Withdrawal by Subject|1|||
129037905|NCT02539368|464430545|FG004|Overall Study|Withdrawal by Subject|3|||
129037906|NCT02539368|464430541|FG000|Overall Study|Physician Decision|49|||
129037907|NCT02539368|464430542|FG001|Overall Study|Physician Decision|15|||
129037908|NCT02539368|464430543|FG002|Overall Study|Physician Decision|7|||
129037909|NCT02539368|464430544|FG003|Overall Study|Physician Decision|0|||
129037910|NCT02539368|464430545|FG004|Overall Study|Physician Decision|2|||
129037911|NCT02539368|464430541|FG000|Overall Study|Lost to Follow-up|96|||
129037912|NCT02539368|464430542|FG001|Overall Study|Lost to Follow-up|21|||
129037913|NCT02539368|464430543|FG002|Overall Study|Lost to Follow-up|16|||
129037914|NCT02539368|464430544|FG003|Overall Study|Lost to Follow-up|4|||
129037915|NCT02539368|464430545|FG004|Overall Study|Lost to Follow-up|3|||
129037916|NCT02539368|464430541|FG000|Overall Study|Adverse Event|44|||
129037917|NCT02539368|464430542|FG001|Overall Study|Adverse Event|5|||
129037918|NCT02539368|464430543|FG002|Overall Study|Adverse Event|9|||
129037919|NCT02539368|464430544|FG003|Overall Study|Adverse Event|0|||
129037920|NCT02539368|464430545|FG004|Overall Study|Adverse Event|3|||
129037921|NCT02539368|464430541|FG000|Overall Study|Participant Non-compliant|13|||
129037922|NCT02539368|464430542|FG001|Overall Study|Participant Non-compliant|2|||
129130314|NCT00549328|464768739|FG000|Overall Study|Disease Progression|10|||
129130315|NCT00549328|464768739|FG000|Overall Study|Death|1|||
128966136|NCT02407236|464160164|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
128966137|NCT02407236|464160165|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
128966138|NCT02407236|464160166|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
128966139|NCT02407236|464160167|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
128966140|NCT02407236|464160168|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
128966141|NCT02407236|464160169|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
128966142|NCT02407236|464160157|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966143|NCT02407236|464160158|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966144|NCT02407236|464160159|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966145|NCT02407236|464160160|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966146|NCT02407236|464160161|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966147|NCT02407236|464160162|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966148|NCT02407236|464160163|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966149|NCT02407236|464160164|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966150|NCT02407236|464160165|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966151|NCT02407236|464160166|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966152|NCT02407236|464160167|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
129130316|NCT00549328|464768739|FG000|Overall Study|Use of Prohibited Medication|1|||
129037923|NCT02539368|464430543|FG002|Overall Study|Participant Non-compliant|1|||
129037924|NCT02539368|464430544|FG003|Overall Study|Participant Non-compliant|1|||
129037925|NCT02539368|464430545|FG004|Overall Study|Participant Non-compliant|0|||
129037926|NCT02539368|464430541|FG000|Overall Study|Other|145|||
129037927|NCT02539368|464430542|FG001|Overall Study|Other|18|||
129037928|NCT02539368|464430543|FG002|Overall Study|Other|24|||
128966153|NCT02407236|464160168|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129037929|NCT02539368|464430544|FG003|Overall Study|Other|1|||
129037930|NCT02539368|464430545|FG004|Overall Study|Other|3|||
129037931|NCT02539368|464430541|FG000|Overall Study|Missing|10|||
129037932|NCT02539368|464430542|FG001|Overall Study|Missing|3|||
129037933|NCT02539368|464430543|FG002|Overall Study|Missing|0|||
129037934|NCT02539368|464430544|FG003|Overall Study|Missing|0|||
128966154|NCT02407236|464160169|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
128966155|NCT02407236|464160157|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966156|NCT02407236|464160158|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966157|NCT02407236|464160159|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966158|NCT02407236|464160160|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966159|NCT02407236|464160161|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966160|NCT02407236|464160162|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966161|NCT02407236|464160163|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966162|NCT02407236|464160164|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
128966163|NCT02407236|464160165|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
128966164|NCT02407236|464160166|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
128966165|NCT02407236|464160167|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
128966166|NCT02407236|464160168|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
128966167|NCT02407236|464160169|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
128966168|NCT02407236|464160157|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
128966169|NCT02407236|464160158|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
128966170|NCT02407236|464160159|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
128713618|NCT02632552|463248220|FG001|Overall Study|Withdrawal by Subject|0|||
128713619|NCT02632552|463248219|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
128966171|NCT02407236|464160160|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
128966172|NCT02407236|464160161|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
128966173|NCT02407236|464160162|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
128966174|NCT02407236|464160163|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
128966175|NCT02407236|464160164|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
128966176|NCT02407236|464160165|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
128966177|NCT02407236|464160166|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
128966178|NCT02407236|464160167|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
128966179|NCT02407236|464160168|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
128966180|NCT02407236|464160169|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
128966181|NCT00643448|464160171|FG000|Overall Study|Lack of Efficacy|2|||
128966182|NCT00643448|464160172|FG001|Overall Study|Lack of Efficacy|0|||
128966183|NCT00643448|464160173|FG002|Overall Study|Lack of Efficacy|4|||
128966184|NCT00643448|464160171|FG000|Overall Study|Adverse Event|2|||
128966185|NCT00643448|464160172|FG001|Overall Study|Adverse Event|2|||
128966186|NCT00643448|464160173|FG002|Overall Study|Adverse Event|2|||
128966187|NCT00643448|464160171|FG000|Overall Study|QTcF>550 ms|0|||
128966188|NCT00643448|464160172|FG001|Overall Study|QTcF>550 ms|3|||
128966189|NCT00643448|464160173|FG002|Overall Study|QTcF>550 ms|0|||
128966190|NCT05166603|464160174|FG000|Overall Study|Withdrawal by Subject|68|||
128966191|NCT05166603|464160175|FG001|Overall Study|Withdrawal by Subject|0|||
128966192|NCT04315298|464161993|FG000|Overall Study|Withdrawal by Subject|0|||
128966193|NCT04315298|464161994|FG001|Overall Study|Withdrawal by Subject|0|||
128966194|NCT04315298|464161995|FG002|Overall Study|Withdrawal by Subject|0|||
128966195|NCT04315298|464161996|FG003|Overall Study|Withdrawal by Subject|2|||
128966196|NCT04315298|464161997|FG004|Overall Study|Withdrawal by Subject|2|||
128966197|NCT04315298|464161998|FG005|Overall Study|Withdrawal by Subject|2|||
128966198|NCT04315298|464161999|FG006|Overall Study|Withdrawal by Subject|0|||
128966199|NCT04315298|464162000|FG007|Overall Study|Withdrawal by Subject|1|||
128966200|NCT04315298|464162001|FG008|Overall Study|Withdrawal by Subject|1|||
128966201|NCT04315298|464162002|FG009|Overall Study|Withdrawal by Subject|1|||
128966202|NCT04315298|464162003|FG010|Overall Study|Withdrawal by Subject|0|||
128966203|NCT04315298|464162004|FG011|Overall Study|Withdrawal by Subject|0|||
128966204|NCT04315298|464162005|FG012|Overall Study|Withdrawal by Subject|0|||
128966205|NCT04315298|464162006|FG013|Overall Study|Withdrawal by Subject|0|||
128966206|NCT04315298|464162007|FG014|Overall Study|Withdrawal by Subject|0|||
128966207|NCT04315298|464162008|FG015|Overall Study|Withdrawal by Subject|0|||
128966208|NCT04315298|464162009|FG016|Overall Study|Withdrawal by Subject|0|||
128966209|NCT04315298|464162010|FG017|Overall Study|Withdrawal by Subject|0|||
128966210|NCT04315298|464162011|FG018|Overall Study|Withdrawal by Subject|0|||
128966211|NCT04315298|464161993|FG000|Overall Study|Physician Decision|0|||
128966212|NCT04315298|464161994|FG001|Overall Study|Physician Decision|0|||
128966213|NCT04315298|464161995|FG002|Overall Study|Physician Decision|0|||
128966214|NCT04315298|464161996|FG003|Overall Study|Physician Decision|0|||
128713620|NCT02632552|463248220|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
128713621|NCT03103919|463248221|FG000|Overall Study|Adverse Event|2|||
128966215|NCT04315298|464161997|FG004|Overall Study|Physician Decision|1|||
128966216|NCT04315298|464161998|FG005|Overall Study|Physician Decision|0|||
128966217|NCT04315298|464161999|FG006|Overall Study|Physician Decision|0|||
128966218|NCT04315298|464162000|FG007|Overall Study|Physician Decision|0|||
128966219|NCT04315298|464162001|FG008|Overall Study|Physician Decision|0|||
128966220|NCT04315298|464162002|FG009|Overall Study|Physician Decision|0|||
128966221|NCT04315298|464162003|FG010|Overall Study|Physician Decision|0|||
128713622|NCT03103919|463248222|FG001|Overall Study|Adverse Event|2|||
128966222|NCT04315298|464162004|FG011|Overall Study|Physician Decision|0|||
128966223|NCT04315298|464162005|FG012|Overall Study|Physician Decision|0|||
128966224|NCT04315298|464162006|FG013|Overall Study|Physician Decision|0|||
128966225|NCT04315298|464162007|FG014|Overall Study|Physician Decision|0|||
128966226|NCT04315298|464162008|FG015|Overall Study|Physician Decision|0|||
128966227|NCT04315298|464162009|FG016|Overall Study|Physician Decision|0|||
128966228|NCT04315298|464162010|FG017|Overall Study|Physician Decision|0|||
128966229|NCT04315298|464162011|FG018|Overall Study|Physician Decision|0|||
128966230|NCT04315298|464161993|FG000|Overall Study|Lost to Follow-up|5|||
128966231|NCT04315298|464161994|FG001|Overall Study|Lost to Follow-up|10|||
128966232|NCT04315298|464161995|FG002|Overall Study|Lost to Follow-up|6|||
128966233|NCT04315298|464161996|FG003|Overall Study|Lost to Follow-up|8|||
128966234|NCT04315298|464161997|FG004|Overall Study|Lost to Follow-up|12|||
128966235|NCT04315298|464161998|FG005|Overall Study|Lost to Follow-up|13|||
128966236|NCT04315298|464161999|FG006|Overall Study|Lost to Follow-up|9|||
128966237|NCT04315298|464162000|FG007|Overall Study|Lost to Follow-up|16|||
128966238|NCT04315298|464162001|FG008|Overall Study|Lost to Follow-up|14|||
128966239|NCT04315298|464162002|FG009|Overall Study|Lost to Follow-up|0|||
128966240|NCT04315298|464162003|FG010|Overall Study|Lost to Follow-up|2|||
128966241|NCT04315298|464162004|FG011|Overall Study|Lost to Follow-up|1|||
128966242|NCT04315298|464162005|FG012|Overall Study|Lost to Follow-up|0|||
128966243|NCT04315298|464162006|FG013|Overall Study|Lost to Follow-up|0|||
128966244|NCT04315298|464162007|FG014|Overall Study|Lost to Follow-up|0|||
128966245|NCT04315298|464162008|FG015|Overall Study|Lost to Follow-up|2|||
128966246|NCT04315298|464162009|FG016|Overall Study|Lost to Follow-up|0|||
128966247|NCT04315298|464162010|FG017|Overall Study|Lost to Follow-up|0|||
128966248|NCT04315298|464162011|FG018|Overall Study|Lost to Follow-up|0|||
128966249|NCT04315298|464161993|FG000|Overall Study|Death|24|||
128966250|NCT04315298|464161994|FG001|Overall Study|Death|60|||
128966251|NCT04315298|464161995|FG002|Overall Study|Death|49|||
128966252|NCT04315298|464161996|FG003|Overall Study|Death|59|||
128966253|NCT04315298|464161997|FG004|Overall Study|Death|70|||
128966254|NCT04315298|464161998|FG005|Overall Study|Death|114|||
128966255|NCT04315298|464161999|FG006|Overall Study|Death|9|||
128966256|NCT04315298|464162000|FG007|Overall Study|Death|12|||
128966257|NCT04315298|464162001|FG008|Overall Study|Death|21|||
128966258|NCT04315298|464162002|FG009|Overall Study|Death|16|||
128966259|NCT04315298|464162003|FG010|Overall Study|Death|40|||
128966260|NCT04315298|464162004|FG011|Overall Study|Death|40|||
128966261|NCT04315298|464162005|FG012|Overall Study|Death|3|||
128966262|NCT04315298|464162006|FG013|Overall Study|Death|4|||
128966263|NCT04315298|464162007|FG014|Overall Study|Death|6|||
128966264|NCT04315298|464162008|FG015|Overall Study|Death|4|||
128966265|NCT04315298|464162009|FG016|Overall Study|Death|3|||
128966266|NCT04315298|464162010|FG017|Overall Study|Death|1|||
128966267|NCT04315298|464162011|FG018|Overall Study|Death|0|||
128966268|NCT00736385|464162012|FG000|Overall Study|Withdrawal by Subject|2|||
128966269|NCT00736385|464162013|FG001|Overall Study|Withdrawal by Subject|2|||
128966270|NCT00736385|464162012|FG000|Overall Study|Adverse Event|0|||
128966271|NCT00736385|464162013|FG001|Overall Study|Adverse Event|1|||
128713623|NCT02728895|463248223|FG000|Overall Study|Other|1|||
128713624|NCT02728895|463248224|FG001|Overall Study|Other|2|||
128713625|NCT02728895|463248223|FG000|Overall Study|Withdrawal by Subject|0|||
128713626|NCT02728895|463248224|FG001|Overall Study|Withdrawal by Subject|3|||
128713627|NCT01846507|463248225|FG000|Overall Study|Lost to Follow-up|4|||
128713628|NCT01846507|463248225|FG000|Overall Study|Protocol Violation|1|||
128713629|NCT01846507|463248225|FG000|Overall Study|Missing data|2|||
128966272|NCT03267511|464162014|FG000|Overall Study|Lost to Follow-up|0|||
128966273|NCT03267511|464162015|FG001|Overall Study|Lost to Follow-up|0|||
128966274|NCT03267511|464162016|FG002|Overall Study|Lost to Follow-up|0|||
128966275|NCT03267511|464162017|FG003|Overall Study|Lost to Follow-up|1|||
128966276|NCT02177786|464162018|FG000|Overall Study|Withdrew Consent|2|||
128966277|NCT02177786|464162019|FG001|Overall Study|Withdrew Consent|6|||
128966278|NCT02177786|464162020|FG002|Overall Study|Withdrew Consent|9|||
128966279|NCT02177786|464162021|FG003|Overall Study|Withdrew Consent|5|||
128966280|NCT02177786|464162018|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
128966281|NCT02177786|464162019|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
128966282|NCT02177786|464162020|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
128966283|NCT02177786|464162021|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
128966284|NCT02177786|464162018|FG000|Overall Study|Adverse Event|1|||
129037935|NCT02539368|464430545|FG004|Overall Study|Missing|0|||
128966285|NCT02177786|464162019|FG001|Overall Study|Adverse Event|1|||
128966286|NCT02177786|464162020|FG002|Overall Study|Adverse Event|2|||
128966287|NCT02177786|464162021|FG003|Overall Study|Adverse Event|3|||
129037936|NCT03558139|464430547|FG000|Overall Study|Consent Withdrawn|1|||
129037937|NCT03558139|464430548|FG001|Overall Study|Consent Withdrawn|1|||
128966288|NCT02177786|464162018|FG000|Overall Study|Death|1|||
128966289|NCT02177786|464162019|FG001|Overall Study|Death|1|||
128966290|NCT02177786|464162020|FG002|Overall Study|Death|1|||
128966291|NCT02177786|464162021|FG003|Overall Study|Death|1|||
128966292|NCT02177786|464162018|FG000|Overall Study|Lost to Follow-up|0|||
128966293|NCT02177786|464162019|FG001|Overall Study|Lost to Follow-up|0|||
128966294|NCT02177786|464162020|FG002|Overall Study|Lost to Follow-up|2|||
128966295|NCT02177786|464162021|FG003|Overall Study|Lost to Follow-up|2|||
128966296|NCT02177786|464162018|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128966297|NCT02177786|464162019|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128966298|NCT02177786|464162020|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128966299|NCT02177786|464162021|FG003|Overall Study|Non-Compliance with Study Drug|1|||
128966300|NCT02177786|464162018|FG000|Overall Study|Protocol Violation|0|||
128966301|NCT02177786|464162019|FG001|Overall Study|Protocol Violation|0|||
128966302|NCT02177786|464162020|FG002|Overall Study|Protocol Violation|2|||
128966303|NCT02177786|464162021|FG003|Overall Study|Protocol Violation|0|||
128966304|NCT02177786|464162018|FG000|Overall Study|Progressive Disease|0|||
128966305|NCT02177786|464162019|FG001|Overall Study|Progressive Disease|1|||
128966306|NCT02177786|464162020|FG002|Overall Study|Progressive Disease|0|||
128966307|NCT02177786|464162021|FG003|Overall Study|Progressive Disease|0|||
128966308|NCT02177786|464162018|FG000|Overall Study|Missing study completion status|0|||
128966309|NCT02177786|464162019|FG001|Overall Study|Missing study completion status|1|||
128966310|NCT02177786|464162020|FG002|Overall Study|Missing study completion status|0|||
128966311|NCT02177786|464162021|FG003|Overall Study|Missing study completion status|0|||
128966312|NCT00439309|464162022|FG000|Follow-Up|Death|1|||
128966313|NCT00439309|464162023|FG001|Follow-Up|Death|0|||
128966314|NCT00439309|464162022|FG000|Follow-Up|Lost to Follow-up|2|||
128966315|NCT00439309|464162023|FG001|Follow-Up|Lost to Follow-up|0|||
128966316|NCT00439309|464162022|FG000|Follow-Up|Withdrawal by Subject|0|||
128966317|NCT00439309|464162023|FG001|Follow-Up|Withdrawal by Subject|1|||
128966318|NCT00439309|464162022|FG000|Follow-Up|Late response by subject|0|||
128966319|NCT00439309|464162023|FG001|Follow-Up|Late response by subject|1|||
128966320|NCT01977040|464162024|FG000|Overall Study|Vasa previa not confirmed|2|||
128966321|NCT04402385|464162026|FG000|Overall Study|Withdrawal by Subject|4|||
128966322|NCT04402385|464162027|FG001|Overall Study|Withdrawal by Subject|4|||
128966323|NCT04402385|464162026|FG000|Overall Study|Lost to Follow-up|1|||
128966324|NCT04402385|464162027|FG001|Overall Study|Lost to Follow-up|1|||
128966325|NCT04402385|464162026|FG000|Overall Study|Physician Decision|0|||
128966326|NCT04402385|464162027|FG001|Overall Study|Physician Decision|1|||
128966327|NCT01473355|464162030|FG000|Overall Study|Protocol Violation|2|||
128966328|NCT01473355|464162030|FG000|Overall Study|Adverse Event|2|||
128966329|NCT01473355|464162030|FG000|Overall Study|Lost to Follow-up|2|||
128966330|NCT02436915|464162033|FG000|Overall Study|Withdrawal by Subject|0|||
128966331|NCT02436915|464162034|FG001|Overall Study|Withdrawal by Subject|1|||
128966332|NCT00863317|464162041|FG000|Overall Study|Lost to Follow-up|8|||
128966333|NCT00863317|464162042|FG001|Overall Study|Lost to Follow-up|9|||
128966334|NCT00038142|464162045|FG000|Overall Study|Ineligible|1|||
128966335|NCT00038142|464162046|FG001|Overall Study|Ineligible|0|||
128966336|NCT00038142|464162045|FG000|Overall Study|Progressive Disease|11|||
128966337|NCT00038142|464162046|FG001|Overall Study|Progressive Disease|7|||
128966338|NCT00038142|464162045|FG000|Overall Study|Death|1|||
128966339|NCT00038142|464162046|FG001|Overall Study|Death|0|||
128966340|NCT00038142|464162045|FG000|Overall Study|Adverse Event|1|||
128966341|NCT00038142|464162046|FG001|Overall Study|Adverse Event|0|||
128966342|NCT00038142|464162045|FG000|Overall Study|Unknown Reason|8|||
128966343|NCT00038142|464162046|FG001|Overall Study|Unknown Reason|0|||
128966344|NCT00809614|464162053|FG000|Overall Study|Lack of Efficacy|2|||
128966345|NCT00809614|464162054|FG001|Overall Study|Lack of Efficacy|3|||
128966346|NCT00809614|464162053|FG000|Overall Study|Withdrawal by Subject|1|||
128966347|NCT00809614|464162054|FG001|Overall Study|Withdrawal by Subject|1|||
128966348|NCT01080625|464162055|FG000|Overall Study|Physician Decision|0|||
128966349|NCT01080625|464162056|FG001|Overall Study|Physician Decision|2|||
128966350|NCT01080625|464162057|FG002|Overall Study|Physician Decision|1|||
128966351|NCT00364832|464162061|FG000|Core Period|Early Withdrawals|2|||
128966352|NCT00364832|464162062|FG001|Core Period|Early Withdrawals|2|||
128966353|NCT00364832|464162063|FG002|Core Period|Early Withdrawals|1|||
128966354|NCT00364832|464162064|FG003|Core Period|Early Withdrawals|1|||
128966355|NCT00364832|464162065|FG004|Core Period|Early Withdrawals|0|||
128966356|NCT00364832|464162066|FG005|Core Period|Early Withdrawals|0|||
128966357|NCT00364832|464162067|FG006|Core Period|Early Withdrawals|4|||
128966358|NCT00364832|464162068|FG007|Core Period|Early Withdrawals|1|||
128966359|NCT00364832|464162069|FG008|Core Period|Early Withdrawals|0|||
128966360|NCT00364832|464162070|FG009|Core Period|Early Withdrawals|0|||
128966361|NCT00364832|464162071|FG010|Core Period|Early Withdrawals|0|||
128966362|NCT00364832|464162072|FG011|Core Period|Early Withdrawals|0|||
129037938|NCT03558139|464430549|FG002|Overall Study|Consent Withdrawn|4|||
128966363|NCT00364832|464162061|FG000|Extension Year 1|Early Withdrawals|0|||
128966364|NCT00364832|464162062|FG001|Extension Year 1|Early Withdrawals|0|||
128966365|NCT00364832|464162063|FG002|Extension Year 1|Early Withdrawals|0|||
128966366|NCT00364832|464162064|FG003|Extension Year 1|Early Withdrawals|0|||
128966367|NCT00364832|464162065|FG004|Extension Year 1|Early Withdrawals|0|||
128966368|NCT00364832|464162066|FG005|Extension Year 1|Early Withdrawals|0|||
128966369|NCT00364832|464162067|FG006|Extension Year 1|Early Withdrawals|0|||
128966370|NCT00364832|464162068|FG007|Extension Year 1|Early Withdrawals|0|||
128966371|NCT00364832|464162069|FG008|Extension Year 1|Early Withdrawals|0|||
128966372|NCT00364832|464162070|FG009|Extension Year 1|Early Withdrawals|4|||
128966373|NCT00364832|464162071|FG010|Extension Year 1|Early Withdrawals|2|||
128966374|NCT00364832|464162072|FG011|Extension Year 1|Early Withdrawals|10|||
128966375|NCT00364832|464162061|FG000|Extension Year 2|Early Withdrawals|0|||
128966376|NCT00364832|464162062|FG001|Extension Year 2|Early Withdrawals|0|||
128966377|NCT00364832|464162063|FG002|Extension Year 2|Early Withdrawals|0|||
128966378|NCT00364832|464162064|FG003|Extension Year 2|Early Withdrawals|0|||
128966379|NCT00364832|464162065|FG004|Extension Year 2|Early Withdrawals|0|||
128966380|NCT00364832|464162066|FG005|Extension Year 2|Early Withdrawals|0|||
128966381|NCT00364832|464162067|FG006|Extension Year 2|Early Withdrawals|0|||
128966382|NCT00364832|464162068|FG007|Extension Year 2|Early Withdrawals|0|||
128966383|NCT00364832|464162069|FG008|Extension Year 2|Early Withdrawals|0|||
128966384|NCT00364832|464162070|FG009|Extension Year 2|Early Withdrawals|5|||
128966385|NCT00364832|464162071|FG010|Extension Year 2|Early Withdrawals|5|||
128966386|NCT00364832|464162072|FG011|Extension Year 2|Early Withdrawals|3|||
128966387|NCT02658149|464162074|FG000|Overall Study|Physician Decision|1|||
128966388|NCT02658149|464162075|FG001|Overall Study|Physician Decision|0|||
128966389|NCT00068822|464162076|FG000|First Randomized Intervention|Lost to Follow-up|1|||
128966390|NCT00068822|464162077|FG001|First Randomized Intervention|Lost to Follow-up|2|||
128966391|NCT00735072|464162081|FG000|Overall Study|interrupted study med during ARV change|1|||
128966392|NCT00735072|464162082|FG001|Overall Study|interrupted study med during ARV change|0|||
128966393|NCT00735072|464162081|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
128966394|NCT00735072|464162082|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
128966395|NCT00911144|464162083|FG000|Overall Study|Withdrawal by Subject|16|||
128966396|NCT00911144|464162084|FG001|Overall Study|Withdrawal by Subject|5|||
128966397|NCT00939341|464162089|FG000|Overall Study|Adverse Event|15|||
128966398|NCT00939341|464162089|FG000|Overall Study|Pregnancy|1|||
128966399|NCT00939341|464162089|FG000|Overall Study|Lost to Follow-up|23|||
128966400|NCT00939341|464162089|FG000|Overall Study|Withdrawal by Subject|13|||
128966401|NCT00939341|464162089|FG000|Overall Study|Protocol Violation|6|||
128966402|NCT00939341|464162089|FG000|Overall Study|Incorrect enrolment|8|||
128966403|NCT03377452|464162090|FG000|Overall Study|Refused assessment|0|||
128966404|NCT03377452|464162091|FG001|Overall Study|Refused assessment|2|||
128966405|NCT03377452|464162090|FG000|Overall Study|Lost to Follow-up|5|||
128966406|NCT03377452|464162091|FG001|Overall Study|Lost to Follow-up|4|||
128966407|NCT05179057|464162093|FG000|Overall Study|Adverse Event|3|||
128966408|NCT05179057|464162094|FG001|Overall Study|Adverse Event|2|||
128966409|NCT05179057|464162093|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
128966410|NCT05179057|464162094|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
128966411|NCT05179057|464162093|FG000|Overall Study|Study terminated|13|||
128966412|NCT05179057|464162094|FG001|Overall Study|Study terminated|7|||
128966413|NCT05179057|464162093|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
128966414|NCT05179057|464162094|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
128966415|NCT05179057|464162093|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
128966416|NCT05179057|464162094|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
128966417|NCT03146403|464162095|FG000|Overall Study|Withdrawal by Subject|0|||
128966418|NCT03146403|464162096|FG001|Overall Study|Withdrawal by Subject|3|||
128966419|NCT03146403|464162095|FG000|Overall Study|Lost to Follow-up|2|||
128966420|NCT03146403|464162096|FG001|Overall Study|Lost to Follow-up|0|||
128966421|NCT01024920|464162097|FG000|Overall Study|Progressive disease|47|||
128966422|NCT01024920|464162098|FG001|Overall Study|Progressive disease|25|||
128966423|NCT01024920|464162097|FG000|Overall Study|Adverse Event|8|||
128966424|NCT01024920|464162098|FG001|Overall Study|Adverse Event|4|||
128966425|NCT01024920|464162097|FG000|Overall Study|Lost to Follow-up|0|||
128966426|NCT01024920|464162098|FG001|Overall Study|Lost to Follow-up|1|||
128966427|NCT01024920|464162097|FG000|Overall Study|Patient refusal to continue|4|||
128966428|NCT01024920|464162098|FG001|Overall Study|Patient refusal to continue|0|||
128966429|NCT01024920|464162097|FG000|Overall Study|Other than listed|5|||
128966430|NCT01024920|464162098|FG001|Overall Study|Other than listed|1|||
128966431|NCT01024920|464162097|FG000|Overall Study|Not treated|3|||
128966432|NCT01024920|464162098|FG001|Overall Study|Not treated|0|||
128966433|NCT01024920|464162097|FG000|Overall Study|Protocol Violation|0|||
128966434|NCT01024920|464162098|FG001|Overall Study|Protocol Violation|1|||
128966435|NCT01098032|464162100|FG000|Overall Study|Withdrawal by Subject|1|||
128966436|NCT01098032|464162101|FG001|Overall Study|Withdrawal by Subject|1|||
128966437|NCT00693693|464162106|FG000|Overall Study|Lost to Follow-up|1|||
128966438|NCT00693693|464162107|FG001|Overall Study|Lost to Follow-up|1|||
128966439|NCT00693693|464162108|FG002|Overall Study|Lost to Follow-up|2|||
128966440|NCT02972593|464162109|FG000|Overall Study|Lost to Follow-up|19|||
128966441|NCT02972593|464162110|FG001|Overall Study|Lost to Follow-up|15|||
128966442|NCT02972593|464162109|FG000|Overall Study|Protocol Violation|1|||
128966443|NCT02972593|464162110|FG001|Overall Study|Protocol Violation|0|||
128966444|NCT04599972|464162115|FG000|Overall Study|Withdrawal by Subject|6|||
128966445|NCT04599972|464162116|FG001|Overall Study|Withdrawal by Subject|1|||
128966446|NCT04599972|464162115|FG000|Overall Study|Adverse Event|1|||
128966447|NCT04599972|464162116|FG001|Overall Study|Adverse Event|1|||
128966448|NCT04599972|464162115|FG000|Overall Study|Lost to Follow-up|1|||
128966449|NCT04599972|464162116|FG001|Overall Study|Lost to Follow-up|6|||
128966450|NCT04599972|464162115|FG000|Overall Study|Protocol Violation|1|||
128966451|NCT04599972|464162116|FG001|Overall Study|Protocol Violation|0|||
128966452|NCT04599972|464162115|FG000|Overall Study|Other reason|1|||
128966453|NCT04599972|464162116|FG001|Overall Study|Other reason|0|||
128966454|NCT00638690|464162123|FG000|Overall Study|Death|655|||
128966455|NCT00638690|464162124|FG001|Overall Study|Death|335|||
128966456|NCT00638690|464162123|FG000|Overall Study|Withdrawal by Subject|22|||
128966457|NCT00638690|464162124|FG001|Overall Study|Withdrawal by Subject|5|||
128966458|NCT00638690|464162123|FG000|Overall Study|Lost to Follow-up|4|||
128966459|NCT00638690|464162124|FG001|Overall Study|Lost to Follow-up|2|||
128966460|NCT00621244|464162130|FG000|Overall Study|Withdrawal by Subject|7|||
128966461|NCT00621244|464162131|FG001|Overall Study|Withdrawal by Subject|3|||
128966462|NCT00621244|464162132|FG002|Overall Study|Withdrawal by Subject|3|||
128966463|NCT00621244|464162133|FG003|Overall Study|Withdrawal by Subject|3|||
128966464|NCT00621244|464162130|FG000|Overall Study|Disease progression|44|||
128966465|NCT00621244|464162131|FG001|Overall Study|Disease progression|20|||
128966466|NCT00621244|464162132|FG002|Overall Study|Disease progression|20|||
128966467|NCT00621244|464162133|FG003|Overall Study|Disease progression|15|||
128966468|NCT00621244|464162130|FG000|Overall Study|Death|3|||
128966469|NCT00621244|464162131|FG001|Overall Study|Death|3|||
128966470|NCT00621244|464162132|FG002|Overall Study|Death|1|||
128966471|NCT00621244|464162133|FG003|Overall Study|Death|1|||
128966472|NCT00621244|464162130|FG000|Overall Study|Adverse Event|27|||
128966473|NCT00621244|464162131|FG001|Overall Study|Adverse Event|7|||
128966474|NCT00621244|464162132|FG002|Overall Study|Adverse Event|9|||
128966475|NCT00621244|464162133|FG003|Overall Study|Adverse Event|2|||
128966476|NCT00621244|464162130|FG000|Overall Study|Administrative problems|5|||
128966477|NCT00621244|464162131|FG001|Overall Study|Administrative problems|1|||
128966478|NCT00621244|464162132|FG002|Overall Study|Administrative problems|0|||
128966479|NCT00621244|464162133|FG003|Overall Study|Administrative problems|2|||
128966480|NCT00565812|464162146|FG000|Overall Study|Death|2|||
128966481|NCT00565812|464162147|FG001|Overall Study|Death|1|||
128966482|NCT00565812|464162148|FG002|Overall Study|Death|3|||
128966483|NCT00565812|464162146|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
128966484|NCT00565812|464162147|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
128966485|NCT00565812|464162148|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
128966486|NCT00565812|464162146|FG000|Overall Study|Lost to Follow-up|10|||
128966487|NCT00565812|464162147|FG001|Overall Study|Lost to Follow-up|8|||
128966488|NCT00565812|464162148|FG002|Overall Study|Lost to Follow-up|8|||
128966489|NCT00565812|464162146|FG000|Overall Study|Withdrawal by Subject|58|||
128966490|NCT00565812|464162147|FG001|Overall Study|Withdrawal by Subject|47|||
128966491|NCT00565812|464162148|FG002|Overall Study|Withdrawal by Subject|48|||
128966492|NCT00565812|464162146|FG000|Overall Study|Work Schedule|5|||
128966493|NCT00565812|464162147|FG001|Overall Study|Work Schedule|3|||
128966494|NCT00565812|464162148|FG002|Overall Study|Work Schedule|1|||
128966495|NCT00565812|464162146|FG000|Overall Study|Protocol Violation|2|||
128966496|NCT00565812|464162147|FG001|Overall Study|Protocol Violation|6|||
128966497|NCT00565812|464162148|FG002|Overall Study|Protocol Violation|4|||
128966498|NCT00565812|464162146|FG000|Overall Study|Adverse Event|41|||
129037939|NCT03558139|464430547|FG000|Overall Study|Death|5|||
129037940|NCT03558139|464430548|FG001|Overall Study|Death|3|||
129037941|NCT03558139|464430549|FG002|Overall Study|Death|8|||
129037942|NCT03558139|464430547|FG000|Overall Study|Lost to Follow-up|0|||
128966499|NCT00565812|464162147|FG001|Overall Study|Adverse Event|54|||
128966500|NCT00565812|464162148|FG002|Overall Study|Adverse Event|40|||
128966501|NCT00565812|464162146|FG000|Overall Study|Jury Duty|1|||
128966502|NCT00565812|464162147|FG001|Overall Study|Jury Duty|0|||
128966503|NCT00565812|464162148|FG002|Overall Study|Jury Duty|0|||
128966504|NCT00565812|464162146|FG000|Overall Study|Relocated Out of Area|5|||
129037943|NCT03558139|464430548|FG001|Overall Study|Lost to Follow-up|0|||
129037944|NCT03558139|464430549|FG002|Overall Study|Lost to Follow-up|3|||
129037945|NCT03558139|464430547|FG000|Overall Study|Study Ended Per Protocol|0|||
129037946|NCT03558139|464430548|FG001|Overall Study|Study Ended Per Protocol|3|||
129037947|NCT03558139|464430549|FG002|Overall Study|Study Ended Per Protocol|6|||
128966505|NCT00565812|464162147|FG001|Overall Study|Relocated Out of Area|8|||
128966506|NCT00565812|464162148|FG002|Overall Study|Relocated Out of Area|9|||
128966507|NCT00565812|464162146|FG000|Overall Study|Sponsor Decision|1|||
128966508|NCT00565812|464162147|FG001|Overall Study|Sponsor Decision|5|||
128966509|NCT00565812|464162148|FG002|Overall Study|Sponsor Decision|1|||
128966510|NCT00565812|464162146|FG000|Overall Study|Domestic Reasons|7|||
128966511|NCT00565812|464162147|FG001|Overall Study|Domestic Reasons|1|||
128966512|NCT00565812|464162148|FG002|Overall Study|Domestic Reasons|3|||
128966513|NCT00565812|464162146|FG000|Overall Study|Research Site Closure|6|||
128966514|NCT00565812|464162147|FG001|Overall Study|Research Site Closure|1|||
128966515|NCT00565812|464162148|FG002|Overall Study|Research Site Closure|8|||
129037948|NCT02752802|464430550|FG000|Overall Study|Contrast Volume Not Collected|1|||
129037949|NCT02752802|464430551|FG001|Overall Study|Contrast Volume Not Collected|0|||
128966516|NCT00565812|464162146|FG000|Overall Study|Surgical Intervention|0|||
128966517|NCT00565812|464162147|FG001|Overall Study|Surgical Intervention|1|||
128966518|NCT00565812|464162148|FG002|Overall Study|Surgical Intervention|2|||
128966519|NCT00565812|464162146|FG000|Overall Study|Low Compliance|1|||
128966520|NCT00565812|464162147|FG001|Overall Study|Low Compliance|0|||
128966521|NCT00565812|464162148|FG002|Overall Study|Low Compliance|1|||
128966522|NCT00565812|464162146|FG000|Overall Study|Follow-up Visit Not Completed|2|||
128966523|NCT00565812|464162147|FG001|Overall Study|Follow-up Visit Not Completed|0|||
128966524|NCT00565812|464162148|FG002|Overall Study|Follow-up Visit Not Completed|1|||
128966525|NCT00565812|464162146|FG000|Overall Study|Physician Decision|2|||
128966526|NCT00565812|464162147|FG001|Overall Study|Physician Decision|0|||
128966527|NCT00565812|464162148|FG002|Overall Study|Physician Decision|0|||
128966528|NCT04968353|464162149|FG000|Overall Study|Non-compliance|1|||
128966529|NCT04968353|464162150|FG001|Overall Study|Non-compliance|0|||
128966530|NCT04968353|464162151|FG002|Overall Study|Non-compliance|2|||
128966531|NCT04968353|464162152|FG003|Overall Study|Non-compliance|0|||
128966532|NCT02033850|464162157|FG000|Overall Study|Death|1|||
128966533|NCT02033850|464162158|FG001|Overall Study|Death|0|||
128966534|NCT02033850|464162157|FG000|Overall Study|unrelated medical reason|1|||
128966535|NCT02033850|464162158|FG001|Overall Study|unrelated medical reason|1|||
128966536|NCT03215667|464162159|FG000|Overall Study|Physician Decision|4|||
128966537|NCT00614991|464162162|FG000|Overall Study|Adverse Event|3|||
128966538|NCT00614991|464162163|FG001|Overall Study|Adverse Event|3|||
128966539|NCT00614991|464162164|FG002|Overall Study|Adverse Event|0|||
128966540|NCT00614991|464162165|FG003|Overall Study|Adverse Event|0|||
128966541|NCT00614991|464162166|FG004|Overall Study|Adverse Event|1|||
128966542|NCT00614991|464162167|FG005|Overall Study|Adverse Event|0|||
128966543|NCT03209362|464162170|FG000|Overall Study|Adverse Event|0|||
128966544|NCT03209362|464162171|FG001|Overall Study|Adverse Event|1|||
128966545|NCT03209362|464162170|FG000|Overall Study|Lost to Follow-up|0|||
128966546|NCT03209362|464162171|FG001|Overall Study|Lost to Follow-up|1|||
128966547|NCT03209362|464162170|FG000|Overall Study|Withdrawal by Subject|2|||
128966548|NCT03209362|464162171|FG001|Overall Study|Withdrawal by Subject|0|||
128966549|NCT03209362|464162170|FG000|Overall Study|Other|0|||
128966550|NCT03209362|464162171|FG001|Overall Study|Other|1|||
128966551|NCT00777257|464164007|FG000|Overall Study|Adverse Event|3|||
128966552|NCT00777257|464164008|FG001|Overall Study|Adverse Event|1|||
128966553|NCT00777257|464164009|FG002|Overall Study|Adverse Event|0|||
128966554|NCT00777257|464164007|FG000|Overall Study|Lost to Follow-up|3|||
128966555|NCT00777257|464164008|FG001|Overall Study|Lost to Follow-up|3|||
128966556|NCT00777257|464164009|FG002|Overall Study|Lost to Follow-up|2|||
128966557|NCT00777257|464164007|FG000|Overall Study|Protocol Violation|2|||
128966558|NCT00777257|464164008|FG001|Overall Study|Protocol Violation|2|||
128966559|NCT00777257|464164009|FG002|Overall Study|Protocol Violation|2|||
128966560|NCT00777257|464164007|FG000|Overall Study|Withdrawal by Subject|3|||
128966561|NCT00777257|464164008|FG001|Overall Study|Withdrawal by Subject|6|||
128966562|NCT00777257|464164009|FG002|Overall Study|Withdrawal by Subject|5|||
128966563|NCT00098865|464164010|FG000|Overall Study|Progressive Disease|6|||
128966564|NCT00098865|464164010|FG000|Overall Study|Adverse Event|2|||
128966565|NCT00098865|464164010|FG000|Overall Study|Alternative Therapy|1|||
128966566|NCT01183104|464164011|FG000|Overall Study|Adverse Event|8|||
128966567|NCT01183104|464164012|FG001|Overall Study|Adverse Event|6|||
128966568|NCT01183104|464164011|FG000|Overall Study|Death|0|||
128966569|NCT01183104|464164012|FG001|Overall Study|Death|1|||
128966570|NCT01183104|464164011|FG000|Overall Study|Lost to Follow-up|14|||
128966571|NCT01183104|464164012|FG001|Overall Study|Lost to Follow-up|7|||
128966572|NCT01183104|464164011|FG000|Overall Study|Physician Decision|5|||
128966573|NCT01183104|464164012|FG001|Overall Study|Physician Decision|8|||
128966574|NCT01183104|464164011|FG000|Overall Study|Withdrawal by Subject|6|||
128966575|NCT01183104|464164012|FG001|Overall Study|Withdrawal by Subject|11|||
128966576|NCT01183104|464164011|FG000|Overall Study|Nonparticipation in Extension Study|39|||
128966577|NCT01183104|464164012|FG001|Overall Study|Nonparticipation in Extension Study|50|||
128966578|NCT01183104|464164011|FG000|Overall Study|Did not receive study drug|5|||
128966579|NCT01183104|464164012|FG001|Overall Study|Did not receive study drug|9|||
128966580|NCT00364351|464164013|FG000|Overall Study|Adverse Event|90|||
128966581|NCT00364351|464164014|FG001|Overall Study|Adverse Event|44|||
128966582|NCT00364351|464164013|FG000|Overall Study|Condition under investigation worsened|469|||
128966583|NCT00364351|464164014|FG001|Overall Study|Condition under investigation worsened|497|||
128966584|NCT00364351|464164013|FG000|Overall Study|Prohibited concomitant medication|0|||
128966585|NCT00364351|464164014|FG001|Overall Study|Prohibited concomitant medication|2|||
128966586|NCT00364351|464164013|FG000|Overall Study|Lost to Follow-up|1|||
128966587|NCT00364351|464164014|FG001|Overall Study|Lost to Follow-up|1|||
128966588|NCT00364351|464164013|FG000|Overall Study|Withdrawal by Subject|30|||
128966589|NCT00364351|464164014|FG001|Overall Study|Withdrawal by Subject|29|||
128966590|NCT00364351|464164013|FG000|Overall Study|Incorrect enrollment|1|||
128966591|NCT00364351|464164014|FG001|Overall Study|Incorrect enrollment|1|||
128966592|NCT00364351|464164013|FG000|Overall Study|Sponsor decision|1|||
128966593|NCT00364351|464164014|FG001|Overall Study|Sponsor decision|0|||
128966594|NCT00364351|464164013|FG000|Overall Study|Poor treatment compliance|0|||
129037950|NCT02808819|464430552|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
129037951|NCT02808819|464430553|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
129037952|NCT02808819|464430552|FG000|Overall Study|Withdrawal by Subject|10|||
129037953|NCT02808819|464430553|FG001|Overall Study|Withdrawal by Subject|13|||
129037954|NCT02808819|464430552|FG000|Overall Study|Site terminated by sponsor|2|||
129037955|NCT02808819|464430553|FG001|Overall Study|Site terminated by sponsor|0|||
129037956|NCT02808819|464430552|FG000|Overall Study|Pregnancy|1|||
129037957|NCT02808819|464430553|FG001|Overall Study|Pregnancy|0|||
128966595|NCT00364351|464164014|FG001|Overall Study|Poor treatment compliance|3|||
128966596|NCT00364351|464164013|FG000|Overall Study|Investigator error|0|||
128966597|NCT00364351|464164014|FG001|Overall Study|Investigator error|2|||
128966598|NCT00364351|464164013|FG000|Overall Study|Patient could not travel to site|0|||
128966599|NCT00364351|464164014|FG001|Overall Study|Patient could not travel to site|1|||
128966600|NCT00364351|464164013|FG000|Overall Study|Randomised treatment not started|0|||
128966601|NCT00364351|464164014|FG001|Overall Study|Randomised treatment not started|3|||
128966602|NCT00688623|464164016|FG000|Overall Study|Adverse Event|22|||
128966603|NCT00688623|464164016|FG000|Overall Study|abnormal lab value|1|||
128966604|NCT00688623|464164016|FG000|Overall Study|Withdrawal by Subject|4|||
128966605|NCT00688623|464164016|FG000|Overall Study|Death|3|||
129037958|NCT02808819|464430552|FG000|Overall Study|Lost to Follow-up|1|||
128966606|NCT00688623|464164016|FG000|Overall Study|disease progression|23|||
128966607|NCT00688623|464164016|FG000|Overall Study|Protocol Violation|2|||
128966608|NCT02667236|464164017|FG000|Overall Study|Adverse Event|1|||
128966609|NCT02667236|464164018|FG001|Overall Study|Adverse Event|1|||
128966610|NCT02667236|464164017|FG000|Overall Study|Withdrawal by Subject|2|||
128966611|NCT02667236|464164018|FG001|Overall Study|Withdrawal by Subject|0|||
128966612|NCT00464620|464164019|FG000|Overall Study|Physician Decision|1|||
128966613|NCT00464620|464164020|FG001|Overall Study|Physician Decision|0|||
128966614|NCT00464620|464164021|FG002|Overall Study|Physician Decision|0|||
128966615|NCT00464620|464164019|FG000|Overall Study|Withdrawal by Subject|1|||
128966616|NCT00464620|464164020|FG001|Overall Study|Withdrawal by Subject|0|||
128966617|NCT00464620|464164021|FG002|Overall Study|Withdrawal by Subject|3|||
128966618|NCT00464620|464164019|FG000|Overall Study|Ineligible sarcoma subtype|0|||
129037959|NCT02808819|464430553|FG001|Overall Study|Lost to Follow-up|6|||
129037960|NCT02808819|464430552|FG000|Overall Study|Protocol Violation|0|||
129037961|NCT02808819|464430553|FG001|Overall Study|Protocol Violation|1|||
129037962|NCT02808819|464430552|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
129037963|NCT02808819|464430553|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
129037964|NCT02808819|464430552|FG000|Overall Study|Death|1|||
129037965|NCT02808819|464430553|FG001|Overall Study|Death|0|||
129037966|NCT02808819|464430552|FG000|Overall Study|Adverse Event|3|||
129037967|NCT02808819|464430553|FG001|Overall Study|Adverse Event|4|||
129037968|NCT03573817|464430554|FG000|Overall Study|Adverse Event|0|||
129037969|NCT03573817|464430555|FG001|Overall Study|Adverse Event|2|||
129220271|NCT00318643|465106541|FG004|Overall Study|Investigator's Decision|1|||
129220272|NCT01519921|465106544|FG000|Overall Study|Adverse Event|10|||
128713630|NCT02436356|463248226|FG000|Overall Study|Excluded by MRI Screening|0|||
128966619|NCT00464620|464164020|FG001|Overall Study|Ineligible sarcoma subtype|2|||
128966620|NCT00464620|464164021|FG002|Overall Study|Ineligible sarcoma subtype|2|||
128966621|NCT00464620|464164019|FG000|Overall Study|Use of prohibited concomitant medication|0|||
128966622|NCT00464620|464164020|FG001|Overall Study|Use of prohibited concomitant medication|0|||
128966623|NCT00464620|464164021|FG002|Overall Study|Use of prohibited concomitant medication|2|||
128966624|NCT04984876|464164022|FG000|Overall Study|Subject decision|2|||
128966625|NCT04984876|464164023|FG001|Overall Study|Subject decision|10|||
128966626|NCT04984876|464164024|FG002|Overall Study|Subject decision|3|||
128966627|NCT04984876|464164025|FG003|Overall Study|Subject decision|3|||
128966628|NCT04984876|464164026|FG004|Overall Study|Subject decision|3|||
128966629|NCT04984876|464164027|FG005|Overall Study|Subject decision|0|||
128966630|NCT04984876|464164022|FG000|Overall Study|Guardian decision|0|||
128966631|NCT04984876|464164023|FG001|Overall Study|Guardian decision|1|||
129037970|NCT03573817|464430554|FG000|Overall Study|Protocol Violation|0|||
128713631|NCT02436356|463248227|FG001|Overall Study|Excluded by MRI Screening|0|||
128713632|NCT02436356|463248228|FG002|Overall Study|Excluded by MRI Screening|2|||
129037971|NCT03573817|464430555|FG001|Overall Study|Protocol Violation|1|||
129037972|NCT03573817|464430554|FG000|Overall Study|Withdrawal by Subject|1|||
129220273|NCT01519921|465106545|FG001|Overall Study|Adverse Event|9|||
128713633|NCT02436356|463248226|FG000|Overall Study|Lost to Follow-up|0|||
128713634|NCT02436356|463248227|FG001|Overall Study|Lost to Follow-up|1|||
128966632|NCT04984876|464164024|FG002|Overall Study|Guardian decision|0|||
128966633|NCT04984876|464164025|FG003|Overall Study|Guardian decision|2|||
128966634|NCT04984876|464164026|FG004|Overall Study|Guardian decision|0|||
128966635|NCT04984876|464164027|FG005|Overall Study|Guardian decision|1|||
128966636|NCT04984876|464164022|FG000|Overall Study|Lost to Follow-up|0|||
128966637|NCT04984876|464164023|FG001|Overall Study|Lost to Follow-up|0|||
128966638|NCT04984876|464164024|FG002|Overall Study|Lost to Follow-up|1|||
128966639|NCT04984876|464164025|FG003|Overall Study|Lost to Follow-up|1|||
129220274|NCT01519921|465106544|FG000|Overall Study|Lack of Efficacy|4|||
129037973|NCT03573817|464430555|FG001|Overall Study|Withdrawal by Subject|1|||
128966640|NCT04984876|464164026|FG004|Overall Study|Lost to Follow-up|0|||
128966641|NCT04984876|464164027|FG005|Overall Study|Lost to Follow-up|0|||
128966642|NCT04984876|464164022|FG000|Overall Study|Physician Decision|1|||
128966643|NCT04984876|464164023|FG001|Overall Study|Physician Decision|0|||
128966644|NCT04984876|464164024|FG002|Overall Study|Physician Decision|0|||
128966645|NCT04984876|464164025|FG003|Overall Study|Physician Decision|1|||
128966646|NCT04984876|464164026|FG004|Overall Study|Physician Decision|0|||
128966647|NCT04984876|464164027|FG005|Overall Study|Physician Decision|0|||
128966648|NCT04984876|464164022|FG000|Overall Study|Adverse Event|0|||
128966649|NCT04984876|464164023|FG001|Overall Study|Adverse Event|0|||
128966650|NCT04984876|464164024|FG002|Overall Study|Adverse Event|1|||
128966651|NCT04984876|464164025|FG003|Overall Study|Adverse Event|0|||
128966652|NCT04984876|464164026|FG004|Overall Study|Adverse Event|0|||
128966653|NCT04984876|464164027|FG005|Overall Study|Adverse Event|0|||
128966654|NCT02204410|464164028|FG000|Overall Study|Lost to Follow-up|5|||
128966655|NCT02204410|464164028|FG000|Overall Study|Physician Decision|2|||
128966656|NCT02204410|464164028|FG000|Overall Study|Protocol Violation|1|||
128966657|NCT02204410|464164028|FG000|Overall Study|Withdrawal by Subject|3|||
128966658|NCT03654560|464164031|FG000|Overall Study|Death|3|||
128966659|NCT03654560|464164032|FG001|Overall Study|Death|1|||
128966660|NCT03654560|464164031|FG000|Overall Study|Lost to Follow-up|1|||
128966661|NCT03654560|464164032|FG001|Overall Study|Lost to Follow-up|0|||
128966662|NCT00209092|464164033|FG000|Overall Study|Progression of disease|7|||
128966663|NCT00209092|464164034|FG001|Overall Study|Progression of disease|1|||
128966664|NCT00209092|464164033|FG000|Overall Study|Adverse Event|0|||
128966665|NCT00209092|464164034|FG001|Overall Study|Adverse Event|1|||
128966666|NCT00209092|464164033|FG000|Overall Study|Withdrawal by Subject|1|||
128966667|NCT00209092|464164034|FG001|Overall Study|Withdrawal by Subject|0|||
128966668|NCT01117181|464164035|FG000|Overall Study|Lost to Follow-up|1|||
128966669|NCT01117181|464164036|FG001|Overall Study|Lost to Follow-up|0|||
128966670|NCT01117181|464164035|FG000|Overall Study|Withdrawal by Subject|0|||
128966671|NCT01117181|464164036|FG001|Overall Study|Withdrawal by Subject|2|||
128966672|NCT01518309|464164037|FG000|Overall Study|Adverse Event|6|||
128966673|NCT01518309|464164037|FG000|Overall Study|Death|6|||
128966674|NCT01518309|464164037|FG000|Overall Study|Lack of Efficacy|7|||
128966675|NCT01518309|464164037|FG000|Overall Study|Withdrawal by Subject|6|||
128966676|NCT01518309|464164037|FG000|Overall Study|Physician Decision|3|||
128966677|NCT01518309|464164037|FG000|Overall Study|Sponsor Decision|2|||
128966678|NCT01518309|464164037|FG000|Overall Study|Not in Predefined Categories|9|||
128966679|NCT02579863|464164038|FG000|Overall Study|Final Disposition Unknown|2|||
128966680|NCT02579863|464164039|FG001|Overall Study|Final Disposition Unknown|1|||
128966681|NCT02579863|464164038|FG000|Overall Study|Adverse Event|18|||
128966682|NCT02579863|464164039|FG001|Overall Study|Adverse Event|11|||
128966683|NCT02579863|464164038|FG000|Overall Study|Death|31|||
128966684|NCT02579863|464164039|FG001|Overall Study|Death|29|||
128966685|NCT02579863|464164038|FG000|Overall Study|Lost to Follow-up|2|||
128966686|NCT02579863|464164039|FG001|Overall Study|Lost to Follow-up|1|||
128966687|NCT02579863|464164038|FG000|Overall Study|Physician Decision|1|||
128966688|NCT02579863|464164039|FG001|Overall Study|Physician Decision|2|||
128966689|NCT02579863|464164038|FG000|Overall Study|Screen Failure|0|||
128966690|NCT02579863|464164039|FG001|Overall Study|Screen Failure|2|||
128966691|NCT02579863|464164038|FG000|Overall Study|Study Terminated at Selected Sites|82|||
128966692|NCT02579863|464164039|FG001|Overall Study|Study Terminated at Selected Sites|88|||
128966693|NCT02579863|464164038|FG000|Overall Study|Withdrawal by Subject|20|||
128966694|NCT02579863|464164039|FG001|Overall Study|Withdrawal by Subject|20|||
128966695|NCT03887052|464164050|FG000|Overall Study|Adverse Event|2|||
128966696|NCT03887052|464164050|FG000|Overall Study|Physician Decision|2|||
128966697|NCT03887052|464164050|FG000|Overall Study|Withdrawal by Subject|3|||
128966698|NCT03887052|464164050|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
128966699|NCT03887052|464164050|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
128966700|NCT01804842|464164051|FG000|Overall Study|Adverse Event|1|||
128966701|NCT01804842|464164052|FG001|Overall Study|Adverse Event|1|||
128966702|NCT01804842|464164053|FG002|Overall Study|Adverse Event|0|||
128966703|NCT01804842|464164051|FG000|Overall Study|Lost to Follow-up|1|||
128966704|NCT01804842|464164052|FG001|Overall Study|Lost to Follow-up|0|||
129037974|NCT02013531|464430556|FG000|Overall Study|Lost to Follow-up|3|||
129037975|NCT02013531|464430556|FG000|Overall Study|Met Withdrawal Criteria|1|||
129037976|NCT02013531|464430556|FG000|Overall Study|Withdrawal by Subject|1|||
128966705|NCT01804842|464164053|FG002|Overall Study|Lost to Follow-up|0|||
128966706|NCT01804842|464164051|FG000|Overall Study|Non-Compliance|1|||
128966707|NCT01804842|464164052|FG001|Overall Study|Non-Compliance|1|||
128966708|NCT01804842|464164053|FG002|Overall Study|Non-Compliance|0|||
128966709|NCT01804842|464164051|FG000|Overall Study|Personal Reason|0|||
128966710|NCT01804842|464164052|FG001|Overall Study|Personal Reason|0|||
128966711|NCT01804842|464164053|FG002|Overall Study|Personal Reason|1|||
128966712|NCT01440972|464164054|FG000|Overall Study|Withdrawal by Subject|3|||
128966713|NCT01440972|464164055|FG001|Overall Study|Withdrawal by Subject|2|||
128966714|NCT04222673|464164056|FG000|Overall Study|Lost to Follow-up|5|||
128966715|NCT02352090|464164057|FG000|Overall Study|general malaise|1|||
128771717|NCT01702428|463455335|FG003|Overall Study|Parents too busy|0|||
128771718|NCT01702428|463455332|FG000|Overall Study|Protocol Violation|3|||
128771719|NCT01702428|463455333|FG001|Overall Study|Protocol Violation|0|||
128966716|NCT02352090|464164058|FG001|Overall Study|general malaise|0|||
128966717|NCT02352090|464164059|FG002|Overall Study|general malaise|0|||
128966718|NCT02352090|464164057|FG000|Overall Study|non-specified mild side-effects|0|||
128966719|NCT02352090|464164058|FG001|Overall Study|non-specified mild side-effects|0|||
128966720|NCT02352090|464164059|FG002|Overall Study|non-specified mild side-effects|2|||
128966721|NCT01849562|464164060|FG000|Overall Study|Lost to Follow-up|1|||
128966722|NCT01849562|464164061|FG001|Overall Study|Lost to Follow-up|0|||
128966723|NCT01849562|464164062|FG002|Overall Study|Lost to Follow-up|0|||
128966724|NCT01849562|464164060|FG000|Overall Study|Non-compliance with Study Drug|1|||
128966725|NCT01849562|464164061|FG001|Overall Study|Non-compliance with Study Drug|0|||
128966726|NCT01849562|464164062|FG002|Overall Study|Non-compliance with Study Drug|0|||
128966727|NCT02182999|464164066|FG000|Overall Study|Adverse Event|4|||
128966728|NCT02182999|464164067|FG001|Overall Study|Adverse Event|3|||
128966729|NCT02182999|464164066|FG000|Overall Study|Physician Decision|1|||
128966730|NCT02182999|464164067|FG001|Overall Study|Physician Decision|0|||
128966731|NCT02252588|464164068|FG000|Overall Study|Withdrawal by Subject|4|||
128966732|NCT02252588|464164069|FG001|Overall Study|Withdrawal by Subject|0|||
128966733|NCT03039790|464164070|FG000|Overall Study|Lost to Follow-up|2|||
128966734|NCT03039790|464164071|FG001|Overall Study|Lost to Follow-up|0|||
128966735|NCT03039790|464164072|FG002|Overall Study|Lost to Follow-up|1|||
128966736|NCT03039790|464164073|FG003|Overall Study|Lost to Follow-up|1|||
128966737|NCT03039790|464164074|FG004|Overall Study|Lost to Follow-up|0|||
128966738|NCT03039790|464164075|FG005|Overall Study|Lost to Follow-up|1|||
128966739|NCT03039790|464164076|FG006|Overall Study|Lost to Follow-up|1|||
128966740|NCT03039790|464164077|FG007|Overall Study|Lost to Follow-up|1|||
128966741|NCT03039790|464164078|FG008|Overall Study|Lost to Follow-up|0|||
128966742|NCT03039790|464164079|FG009|Overall Study|Lost to Follow-up|1|||
128966743|NCT03039790|464164080|FG010|Overall Study|Lost to Follow-up|1|||
128966744|NCT03039790|464164081|FG011|Overall Study|Lost to Follow-up|0|||
128966745|NCT03039790|464164082|FG012|Overall Study|Lost to Follow-up|1|||
128966746|NCT03039790|464164083|FG013|Overall Study|Lost to Follow-up|0|||
128966747|NCT03039790|464164084|FG014|Overall Study|Lost to Follow-up|3|||
128966748|NCT03039790|464164085|FG015|Overall Study|Lost to Follow-up|1|||
128966749|NCT03039790|464164086|FG016|Overall Study|Lost to Follow-up|2|||
128966750|NCT03039790|464164087|FG017|Overall Study|Lost to Follow-up|2|||
128966751|NCT03039790|464164088|FG018|Overall Study|Lost to Follow-up|1|||
128966752|NCT03039790|464164089|FG019|Overall Study|Lost to Follow-up|3|||
128966753|NCT03039790|464164070|FG000|Overall Study|Withdrawal of Consent|1|||
128966754|NCT03039790|464164071|FG001|Overall Study|Withdrawal of Consent|0|||
128966755|NCT03039790|464164072|FG002|Overall Study|Withdrawal of Consent|0|||
128966756|NCT03039790|464164073|FG003|Overall Study|Withdrawal of Consent|1|||
128966757|NCT03039790|464164074|FG004|Overall Study|Withdrawal of Consent|0|||
128966758|NCT03039790|464164075|FG005|Overall Study|Withdrawal of Consent|0|||
128966759|NCT03039790|464164076|FG006|Overall Study|Withdrawal of Consent|0|||
128966760|NCT03039790|464164077|FG007|Overall Study|Withdrawal of Consent|0|||
128966761|NCT03039790|464164078|FG008|Overall Study|Withdrawal of Consent|0|||
128966762|NCT03039790|464164079|FG009|Overall Study|Withdrawal of Consent|1|||
128966763|NCT03039790|464164080|FG010|Overall Study|Withdrawal of Consent|0|||
128966764|NCT03039790|464164081|FG011|Overall Study|Withdrawal of Consent|0|||
128966765|NCT03039790|464164082|FG012|Overall Study|Withdrawal of Consent|2|||
128966766|NCT03039790|464164083|FG013|Overall Study|Withdrawal of Consent|0|||
128966767|NCT03039790|464164084|FG014|Overall Study|Withdrawal of Consent|1|||
128966768|NCT03039790|464164085|FG015|Overall Study|Withdrawal of Consent|5|||
128966769|NCT03039790|464164086|FG016|Overall Study|Withdrawal of Consent|3|||
128966770|NCT03039790|464164087|FG017|Overall Study|Withdrawal of Consent|0|||
128966771|NCT03039790|464164088|FG018|Overall Study|Withdrawal of Consent|2|||
128966772|NCT03039790|464164089|FG019|Overall Study|Withdrawal of Consent|5|||
128966773|NCT03039790|464164070|FG000|Overall Study|Death|0|||
128966774|NCT03039790|464164071|FG001|Overall Study|Death|0|||
128966775|NCT03039790|464164072|FG002|Overall Study|Death|0|||
128966776|NCT03039790|464164073|FG003|Overall Study|Death|0|||
128966777|NCT03039790|464164074|FG004|Overall Study|Death|0|||
128966778|NCT03039790|464164075|FG005|Overall Study|Death|0|||
128966779|NCT03039790|464164076|FG006|Overall Study|Death|0|||
128966780|NCT03039790|464164077|FG007|Overall Study|Death|0|||
128966781|NCT03039790|464164078|FG008|Overall Study|Death|0|||
128966782|NCT03039790|464164079|FG009|Overall Study|Death|0|||
128966783|NCT03039790|464164080|FG010|Overall Study|Death|0|||
128966784|NCT03039790|464164081|FG011|Overall Study|Death|0|||
128771720|NCT01702428|463455334|FG002|Overall Study|Protocol Violation|1|||
128966785|NCT03039790|464164082|FG012|Overall Study|Death|0|||
128966786|NCT03039790|464164083|FG013|Overall Study|Death|0|||
128966787|NCT03039790|464164084|FG014|Overall Study|Death|0|||
128966788|NCT03039790|464164085|FG015|Overall Study|Death|1|||
128771721|NCT01702428|463455335|FG003|Overall Study|Protocol Violation|0|||
128966789|NCT03039790|464164086|FG016|Overall Study|Death|3|||
128966790|NCT03039790|464164087|FG017|Overall Study|Death|0|||
128966791|NCT03039790|464164088|FG018|Overall Study|Death|2|||
128966792|NCT03039790|464164089|FG019|Overall Study|Death|0|||
128966793|NCT03039790|464164070|FG000|Overall Study|Reason, not Specified|1|||
128966794|NCT03039790|464164071|FG001|Overall Study|Reason, not Specified|0|||
128966795|NCT03039790|464164072|FG002|Overall Study|Reason, not Specified|0|||
128966796|NCT03039790|464164073|FG003|Overall Study|Reason, not Specified|0|||
128966797|NCT03039790|464164074|FG004|Overall Study|Reason, not Specified|0|||
128966798|NCT03039790|464164075|FG005|Overall Study|Reason, not Specified|0|||
128966799|NCT03039790|464164076|FG006|Overall Study|Reason, not Specified|0|||
128966800|NCT03039790|464164077|FG007|Overall Study|Reason, not Specified|0|||
128966801|NCT03039790|464164078|FG008|Overall Study|Reason, not Specified|0|||
128966802|NCT03039790|464164079|FG009|Overall Study|Reason, not Specified|0|||
128966803|NCT03039790|464164080|FG010|Overall Study|Reason, not Specified|0|||
128966804|NCT03039790|464164081|FG011|Overall Study|Reason, not Specified|0|||
128966805|NCT03039790|464164082|FG012|Overall Study|Reason, not Specified|0|||
128966806|NCT03039790|464164083|FG013|Overall Study|Reason, not Specified|0|||
128966807|NCT03039790|464164084|FG014|Overall Study|Reason, not Specified|0|||
128966808|NCT03039790|464164085|FG015|Overall Study|Reason, not Specified|0|||
128966809|NCT03039790|464164086|FG016|Overall Study|Reason, not Specified|2|||
128966810|NCT03039790|464164087|FG017|Overall Study|Reason, not Specified|0|||
128966811|NCT03039790|464164088|FG018|Overall Study|Reason, not Specified|1|||
128966812|NCT03039790|464164089|FG019|Overall Study|Reason, not Specified|0|||
128966813|NCT00498368|464164099|FG000|Overall Study|Withdrawal by Subject|3|||
128966814|NCT00498368|464164100|FG001|Overall Study|Withdrawal by Subject|2|||
128966815|NCT02266004|464164101|FG000|Overall Study|unrelated adverse event|1|||
128966816|NCT02266004|464164101|FG000|Overall Study|Physician Decision|1|||
128966817|NCT01347073|464164111|FG000|Overall Study|Adverse Event|1|||
128966818|NCT01347073|464164111|FG000|Overall Study|Liver Transplant|1|||
128966819|NCT01690988|464164118|FG000|Overall Study|Withdrawal by Subject|2|||
128966820|NCT01690988|464164119|FG001|Overall Study|Withdrawal by Subject|2|||
128966821|NCT01690988|464164120|FG002|Overall Study|Withdrawal by Subject|3|||
128966822|NCT01690988|464164118|FG000|Overall Study|Physician Decision|0|||
128966823|NCT01690988|464164119|FG001|Overall Study|Physician Decision|0|||
128966824|NCT01690988|464164120|FG002|Overall Study|Physician Decision|1|||
128966825|NCT01690988|464164118|FG000|Overall Study|Operation Cancelled|1|||
128966826|NCT01690988|464164119|FG001|Overall Study|Operation Cancelled|1|||
128966827|NCT01690988|464164120|FG002|Overall Study|Operation Cancelled|0|||
128966828|NCT01690988|464164118|FG000|Overall Study|Determined ineligible|1|||
128966829|NCT01690988|464164119|FG001|Overall Study|Determined ineligible|0|||
128966830|NCT01690988|464164120|FG002|Overall Study|Determined ineligible|0|||
128966831|NCT01690988|464164118|FG000|Overall Study|Death|1|||
128966832|NCT01690988|464164119|FG001|Overall Study|Death|1|||
128966833|NCT01690988|464164120|FG002|Overall Study|Death|1|||
128966834|NCT01690988|464164118|FG000|Overall Study|Sedated|1|||
128966835|NCT01690988|464164119|FG001|Overall Study|Sedated|1|||
128966836|NCT01690988|464164120|FG002|Overall Study|Sedated|2|||
128966837|NCT00372489|464164123|FG000|Overall Study|Adverse Event|18|||
128966838|NCT00372489|464164123|FG000|Overall Study|Lack of Efficacy|1|||
128966839|NCT00372489|464164123|FG000|Overall Study|Lost to Follow-up|3|||
128966840|NCT00372489|464164123|FG000|Overall Study|Physician Decision|3|||
128966841|NCT00372489|464164123|FG000|Overall Study|Withdrawal by Subject|5|||
128966842|NCT00372489|464164123|FG000|Overall Study|Patient Relocation|2|||
128966843|NCT00372489|464164123|FG000|Overall Study|Renal transplant|6|||
128966844|NCT00372489|464164123|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
128966845|NCT00552344|464164128|FG000|Overall Study|Lack of Efficacy|55|||
128966846|NCT00552344|464164128|FG000|Overall Study|Loss of efficacy|75|||
128966847|NCT00552344|464164128|FG000|Overall Study|Lost to Follow-up|8|||
128966848|NCT00552344|464164128|FG000|Overall Study|Withdrawal by Subject|48|||
128966849|NCT00552344|464164128|FG000|Overall Study|SAE, non-fatal|6|||
128966850|NCT00552344|464164128|FG000|Overall Study|AE, non-serious non-fatal|38|||
128966851|NCT00552344|464164128|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
128966852|NCT00552344|464164128|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
128966853|NCT00552344|464164128|FG000|Overall Study|Other Reason|22|||
128966854|NCT01662986|464164129|FG000|Overall Study|Adverse Event|5|||
128966855|NCT01662986|464164130|FG001|Overall Study|Adverse Event|4|||
128966856|NCT01662986|464164129|FG000|Overall Study|Protocol Violation|2|||
128966857|NCT01662986|464164130|FG001|Overall Study|Protocol Violation|3|||
128966858|NCT01662986|464164129|FG000|Overall Study|Lost to Follow-up|5|||
128966859|NCT01662986|464164130|FG001|Overall Study|Lost to Follow-up|4|||
128966860|NCT01662986|464164129|FG000|Overall Study|Withdrawal by Subject|2|||
128966861|NCT01662986|464164130|FG001|Overall Study|Withdrawal by Subject|2|||
128966862|NCT01662986|464164129|FG000|Overall Study|Not Treated|1|||
128966863|NCT01662986|464164130|FG001|Overall Study|Not Treated|0|||
128966864|NCT01662986|464164129|FG000|Overall Study|Other than stated above|3|||
128966865|NCT01662986|464164130|FG001|Overall Study|Other than stated above|0|||
128966866|NCT01512693|464164133|FG000|Overall Study|Withdrawal by Subject|0|||
128966867|NCT01512693|464164134|FG001|Overall Study|Withdrawal by Subject|1|||
129037977|NCT03546647|464430557|FG000|Overall Study|Adverse Event|1|||
128966868|NCT04731922|464164135|FG000|Overall Study|Adverse Event|0|||
128966869|NCT04731922|464164136|FG001|Overall Study|Adverse Event|0|||
128966870|NCT04731922|464164137|FG002|Overall Study|Adverse Event|0|||
128966871|NCT04731922|464164138|FG003|Overall Study|Adverse Event|0|||
128966872|NCT04731922|464164139|FG004|Overall Study|Adverse Event|0|||
128966873|NCT04731922|464164140|FG005|Overall Study|Adverse Event|0|||
128966874|NCT04731922|464164141|FG006|Overall Study|Adverse Event|0|||
128966875|NCT04731922|464164142|FG007|Overall Study|Adverse Event|0|||
128966876|NCT04731922|464164143|FG008|Overall Study|Adverse Event|0|||
128966877|NCT04731922|464164144|FG009|Overall Study|Adverse Event|0|||
128966878|NCT04731922|464164145|FG010|Overall Study|Adverse Event|1|||
128966879|NCT04731922|464164146|FG011|Overall Study|Adverse Event|0|||
128966880|NCT04731922|464164147|FG012|Overall Study|Adverse Event|0|||
128966881|NCT04731922|464164148|FG013|Overall Study|Adverse Event|0|||
128966882|NCT04731922|464164149|FG014|Overall Study|Adverse Event|0|||
128966883|NCT04731922|464164150|FG015|Overall Study|Adverse Event|0|||
128966884|NCT04731922|464164151|FG016|Overall Study|Adverse Event|0|||
128966885|NCT04731922|464164135|FG000|Overall Study|Lost to Follow-up|0|||
128966886|NCT04731922|464164136|FG001|Overall Study|Lost to Follow-up|0|||
128966887|NCT04731922|464164137|FG002|Overall Study|Lost to Follow-up|0|||
128966888|NCT04731922|464164138|FG003|Overall Study|Lost to Follow-up|1|||
128966889|NCT04731922|464164139|FG004|Overall Study|Lost to Follow-up|0|||
128966890|NCT04731922|464164140|FG005|Overall Study|Lost to Follow-up|1|||
128966891|NCT04731922|464164141|FG006|Overall Study|Lost to Follow-up|0|||
128966892|NCT04731922|464164142|FG007|Overall Study|Lost to Follow-up|0|||
128966893|NCT04731922|464164143|FG008|Overall Study|Lost to Follow-up|0|||
128966894|NCT04731922|464164144|FG009|Overall Study|Lost to Follow-up|0|||
128966895|NCT04731922|464164145|FG010|Overall Study|Lost to Follow-up|0|||
128966896|NCT04731922|464164146|FG011|Overall Study|Lost to Follow-up|0|||
128966897|NCT04731922|464164147|FG012|Overall Study|Lost to Follow-up|0|||
128966898|NCT04731922|464164148|FG013|Overall Study|Lost to Follow-up|0|||
128966899|NCT04731922|464164149|FG014|Overall Study|Lost to Follow-up|0|||
128966900|NCT04731922|464164150|FG015|Overall Study|Lost to Follow-up|0|||
128966901|NCT04731922|464164151|FG016|Overall Study|Lost to Follow-up|0|||
128966902|NCT04731922|464164135|FG000|Overall Study|Withdrawal by Subject|1|||
128966903|NCT04731922|464164136|FG001|Overall Study|Withdrawal by Subject|0|||
128966904|NCT04731922|464164137|FG002|Overall Study|Withdrawal by Subject|0|||
128966905|NCT04731922|464164138|FG003|Overall Study|Withdrawal by Subject|0|||
128966906|NCT04731922|464164139|FG004|Overall Study|Withdrawal by Subject|1|||
128966907|NCT04731922|464164140|FG005|Overall Study|Withdrawal by Subject|0|||
128966908|NCT04731922|464164141|FG006|Overall Study|Withdrawal by Subject|1|||
128966909|NCT04731922|464164142|FG007|Overall Study|Withdrawal by Subject|0|||
128966910|NCT04731922|464164143|FG008|Overall Study|Withdrawal by Subject|0|||
128966911|NCT04731922|464164144|FG009|Overall Study|Withdrawal by Subject|0|||
128966912|NCT04731922|464164145|FG010|Overall Study|Withdrawal by Subject|0|||
128966913|NCT04731922|464164146|FG011|Overall Study|Withdrawal by Subject|0|||
128966914|NCT04731922|464164147|FG012|Overall Study|Withdrawal by Subject|0|||
128966915|NCT04731922|464164148|FG013|Overall Study|Withdrawal by Subject|1|||
128966916|NCT04731922|464164149|FG014|Overall Study|Withdrawal by Subject|0|||
128966917|NCT04731922|464164150|FG015|Overall Study|Withdrawal by Subject|0|||
128966918|NCT04731922|464164151|FG016|Overall Study|Withdrawal by Subject|0|||
128966919|NCT04731922|464164135|FG000|Overall Study|Other|0|||
128966920|NCT04731922|464164136|FG001|Overall Study|Other|0|||
128966921|NCT04731922|464164137|FG002|Overall Study|Other|0|||
128966922|NCT04731922|464164138|FG003|Overall Study|Other|0|||
128966923|NCT04731922|464164139|FG004|Overall Study|Other|0|||
128966924|NCT04731922|464164140|FG005|Overall Study|Other|0|||
128966925|NCT04731922|464164141|FG006|Overall Study|Other|1|||
128966926|NCT04731922|464164142|FG007|Overall Study|Other|0|||
128966927|NCT04731922|464164143|FG008|Overall Study|Other|0|||
128966928|NCT04731922|464164144|FG009|Overall Study|Other|0|||
128713635|NCT02436356|463248228|FG002|Overall Study|Lost to Follow-up|0|||
128713636|NCT02436356|463248226|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
128966929|NCT04731922|464164145|FG010|Overall Study|Other|0|||
128966930|NCT04731922|464164146|FG011|Overall Study|Other|0|||
128966931|NCT04731922|464164147|FG012|Overall Study|Other|0|||
128966932|NCT04731922|464164148|FG013|Overall Study|Other|0|||
128713637|NCT02436356|463248227|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
128713638|NCT02436356|463248228|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
128966933|NCT04731922|464164149|FG014|Overall Study|Other|0|||
128966934|NCT04731922|464164150|FG015|Overall Study|Other|0|||
128966935|NCT04731922|464164151|FG016|Overall Study|Other|0|||
128966936|NCT00845845|464164152|FG000|Overall Study|Lost to Follow-up|0|||
128966937|NCT00845845|464164153|FG001|Overall Study|Lost to Follow-up|4|||
128966938|NCT02820038|464164155|FG000|Overall Study|Lost to Follow-up|7|||
128966939|NCT02820038|464164156|FG001|Overall Study|Lost to Follow-up|11|||
128966940|NCT02820038|464164157|FG002|Overall Study|Lost to Follow-up|2|||
128966941|NCT02820038|464164158|FG003|Overall Study|Lost to Follow-up|9|||
128966942|NCT02820038|464164155|FG000|Overall Study|Withdrawal by Subject|3|||
128966943|NCT02820038|464164156|FG001|Overall Study|Withdrawal by Subject|14|||
128966944|NCT02820038|464164157|FG002|Overall Study|Withdrawal by Subject|3|||
128966945|NCT02820038|464164158|FG003|Overall Study|Withdrawal by Subject|13|||
128966946|NCT02623699|464164159|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966947|NCT02623699|464164160|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
128966948|NCT02623699|464164161|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966949|NCT02623699|464164162|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966950|NCT02623699|464164163|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966951|NCT02623699|464164164|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966952|NCT02623699|464164165|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966953|NCT02623699|464164166|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966954|NCT02623699|464164167|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129220275|NCT01519921|465106545|FG001|Overall Study|Lack of Efficacy|3|||
128966955|NCT02623699|464164168|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966956|NCT02623699|464164169|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966957|NCT02623699|464164170|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
128966958|NCT02623699|464164159|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966959|NCT02623699|464164160|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966960|NCT02623699|464164161|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966961|NCT02623699|464164162|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966962|NCT02623699|464164163|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966963|NCT02623699|464164164|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966964|NCT02623699|464164165|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
128966965|NCT02623699|464164166|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966966|NCT02623699|464164167|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966967|NCT02623699|464164168|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966968|NCT02623699|464164169|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966969|NCT02623699|464164170|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
128966970|NCT02623699|464164159|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966971|NCT02623699|464164160|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966972|NCT02623699|464164161|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966973|NCT02623699|464164162|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966974|NCT02623699|464164163|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966975|NCT02623699|464164164|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
128966976|NCT02623699|464164165|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966977|NCT02623699|464164166|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966978|NCT02623699|464164167|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966979|NCT02623699|464164168|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966980|NCT02623699|464164169|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966981|NCT02623699|464164170|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
128966982|NCT02623699|464164159|FG000|Part B (Up to 289 Days)|Death|0|||
128966983|NCT02623699|464164160|FG001|Part B (Up to 289 Days)|Death|0|||
128966984|NCT02623699|464164161|FG002|Part B (Up to 289 Days)|Death|0|||
128966985|NCT02623699|464164162|FG003|Part B (Up to 289 Days)|Death|0|||
128966986|NCT02623699|464164163|FG004|Part B (Up to 289 Days)|Death|0|||
128966987|NCT02623699|464164164|FG005|Part B (Up to 289 Days)|Death|1|||
128966988|NCT02623699|464164165|FG006|Part B (Up to 289 Days)|Death|1|||
128966989|NCT02623699|464164166|FG007|Part B (Up to 289 Days)|Death|0|||
128966990|NCT02623699|464164167|FG008|Part B (Up to 289 Days)|Death|1|||
128966991|NCT02623699|464164168|FG009|Part B (Up to 289 Days)|Death|0|||
128966992|NCT02623699|464164169|FG010|Part B (Up to 289 Days)|Death|0|||
128966993|NCT02623699|464164170|FG011|Part B (Up to 289 Days)|Death|0|||
128966994|NCT02623699|464164159|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
128966995|NCT02623699|464164160|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
128966996|NCT02623699|464164161|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
128713639|NCT02436356|463248226|FG000|Overall Study|Excluded due to other medical conditions|3|||
128713640|NCT02436356|463248227|FG001|Overall Study|Excluded due to other medical conditions|0|||
128966997|NCT02623699|464164162|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
128966998|NCT02623699|464164163|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
128966999|NCT02623699|464164164|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
128967000|NCT02623699|464164165|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
128967001|NCT02623699|464164166|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
128967002|NCT02623699|464164167|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
128967003|NCT02623699|464164168|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
128967004|NCT02623699|464164169|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
128967005|NCT02623699|464164170|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
128967006|NCT02623699|464164159|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129220276|NCT01519921|465106544|FG000|Overall Study|Withdrawal by Subject|3|||
128713641|NCT02436356|463248228|FG002|Overall Study|Excluded due to other medical conditions|0|||
128967007|NCT02623699|464164160|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967008|NCT02623699|464164161|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967009|NCT02623699|464164162|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129220277|NCT01519921|465106545|FG001|Overall Study|Withdrawal by Subject|0|||
128713642|NCT02436356|463248226|FG000|Overall Study|Withdrawal by Subject|1|||
128967010|NCT02623699|464164163|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967011|NCT02623699|464164164|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967012|NCT02623699|464164165|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967013|NCT02623699|464164166|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967014|NCT02623699|464164167|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967015|NCT02623699|464164168|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
128967016|NCT02623699|464164169|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
128967017|NCT02623699|464164170|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
128967018|NCT02623699|464164159|FG000|Part C (Up to 236 Days)|Death|0|||
128967019|NCT02623699|464164160|FG001|Part C (Up to 236 Days)|Death|0|||
128967020|NCT02623699|464164161|FG002|Part C (Up to 236 Days)|Death|0|||
128967021|NCT02623699|464164162|FG003|Part C (Up to 236 Days)|Death|0|||
128967022|NCT02623699|464164163|FG004|Part C (Up to 236 Days)|Death|0|||
128967023|NCT02623699|464164164|FG005|Part C (Up to 236 Days)|Death|0|||
128967024|NCT02623699|464164165|FG006|Part C (Up to 236 Days)|Death|0|||
128967025|NCT02623699|464164166|FG007|Part C (Up to 236 Days)|Death|0|||
128967026|NCT02623699|464164167|FG008|Part C (Up to 236 Days)|Death|0|||
128967027|NCT02623699|464164168|FG009|Part C (Up to 236 Days)|Death|0|||
128967028|NCT02623699|464164169|FG010|Part C (Up to 236 Days)|Death|0|||
128967029|NCT02623699|464164170|FG011|Part C (Up to 236 Days)|Death|1|||
128967030|NCT02623699|464164159|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
128967031|NCT02623699|464164160|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
128967032|NCT02623699|464164161|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
128967033|NCT02623699|464164162|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
128967034|NCT02623699|464164163|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
128967035|NCT02623699|464164164|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
128967036|NCT02623699|464164165|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
128967037|NCT02623699|464164166|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
128967038|NCT02623699|464164167|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
128967039|NCT02623699|464164168|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
128967040|NCT02623699|464164169|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
128967041|NCT02623699|464164170|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
128771722|NCT01702428|463455332|FG000|Overall Study|Withdrawal by Subject|21|||
128771723|NCT01702428|463455333|FG001|Overall Study|Withdrawal by Subject|23|||
128967042|NCT03148795|464164171|FG000|Overall Study|Progressive Disease|1|||
128967043|NCT04973085|464164178|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
128967044|NCT04973085|464164179|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
128967045|NCT02224274|464164180|FG000|Overall Study|Death|1|||
128967046|NCT02224274|464164181|FG001|Overall Study|Death|0|||
128967047|NCT01976624|464164182|FG000|Overall Study|Participants contraindicated|2|||
128967048|NCT01976624|464164182|FG000|Overall Study|Participants age less than 19 years|12|||
128967049|NCT03074318|464164183|FG000|Overall Study|Adverse Event|0|||
128967050|NCT03074318|464164184|FG001|Overall Study|Adverse Event|1|||
128967051|NCT03074318|464164185|FG002|Overall Study|Adverse Event|1|||
128967052|NCT03074318|464164186|FG003|Overall Study|Adverse Event|1|||
128967053|NCT03074318|464164183|FG000|Overall Study|Death|1|||
128967054|NCT03074318|464164184|FG001|Overall Study|Death|0|||
128967055|NCT03074318|464164185|FG002|Overall Study|Death|0|||
128967056|NCT03074318|464164186|FG003|Overall Study|Death|0|||
128967057|NCT03074318|464164183|FG000|Overall Study|Withdrawal by Subject|1|||
128967058|NCT03074318|464164184|FG001|Overall Study|Withdrawal by Subject|2|||
128967059|NCT03074318|464164185|FG002|Overall Study|Withdrawal by Subject|2|||
128967060|NCT03074318|464164186|FG003|Overall Study|Withdrawal by Subject|4|||
128967061|NCT03074318|464164183|FG000|Overall Study|Trial Closure|2|||
128967062|NCT03074318|464164184|FG001|Overall Study|Trial Closure|2|||
128967063|NCT03074318|464164185|FG002|Overall Study|Trial Closure|3|||
128967064|NCT03074318|464164186|FG003|Overall Study|Trial Closure|11|||
128967065|NCT01627782|464164189|FG000|Overall Study|Adverse Event|1|||
128967066|NCT01627782|464164190|FG001|Overall Study|Adverse Event|2|||
128967067|NCT01627782|464164191|FG002|Overall Study|Adverse Event|0|||
128967068|NCT01627782|464164192|FG003|Overall Study|Adverse Event|1|||
128967069|NCT01627782|464164189|FG000|Overall Study|Lack of Efficacy|11|||
128967070|NCT01627782|464164190|FG001|Overall Study|Lack of Efficacy|1|||
128967071|NCT01627782|464164191|FG002|Overall Study|Lack of Efficacy|15|||
128967072|NCT01627782|464164192|FG003|Overall Study|Lack of Efficacy|2|||
128967073|NCT01627782|464164189|FG000|Overall Study|Protocol Violation|1|||
128967074|NCT01627782|464164190|FG001|Overall Study|Protocol Violation|0|||
129037978|NCT03546647|464430558|FG001|Overall Study|Adverse Event|0|||
129037979|NCT02400476|464430559|FG000|Overall Study|Adverse Event|57|||
128967075|NCT01627782|464164191|FG002|Overall Study|Protocol Violation|0|||
128967076|NCT01627782|464164192|FG003|Overall Study|Protocol Violation|0|||
128967077|NCT01627782|464164189|FG000|Overall Study|Withdrawal by Subject|2|||
128967078|NCT01627782|464164190|FG001|Overall Study|Withdrawal by Subject|1|||
128967079|NCT01627782|464164191|FG002|Overall Study|Withdrawal by Subject|0|||
128967080|NCT01627782|464164192|FG003|Overall Study|Withdrawal by Subject|0|||
128967081|NCT01627782|464164189|FG000|Overall Study|Other|0|||
128967082|NCT01627782|464164190|FG001|Overall Study|Other|2|||
128967083|NCT01627782|464164191|FG002|Overall Study|Other|0|||
128967084|NCT01627782|464164192|FG003|Overall Study|Other|3|||
128967085|NCT01627782|464164189|FG000|Overall Study|Randomized But Not Treated|1|||
129037980|NCT02400476|464430560|FG001|Overall Study|Adverse Event|10|||
128967086|NCT01627782|464164190|FG001|Overall Study|Randomized But Not Treated|0|||
128967087|NCT01627782|464164191|FG002|Overall Study|Randomized But Not Treated|0|||
128967088|NCT01627782|464164192|FG003|Overall Study|Randomized But Not Treated|0|||
128967089|NCT02177812|464164193|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
128967090|NCT02177812|464164194|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
128967091|NCT02177812|464164195|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
128967092|NCT02177812|464164196|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
128967093|NCT02177812|464164197|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
128967094|NCT02177812|464164198|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
128967095|NCT02177812|464164199|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
128967096|NCT02177812|464164200|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
128967097|NCT02177812|464164201|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
128967098|NCT02177812|464164193|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
128967099|NCT02177812|464164194|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
128967100|NCT02177812|464164195|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
128967101|NCT02177812|464164196|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
128967102|NCT02177812|464164197|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
128967103|NCT02177812|464164198|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
128967104|NCT02177812|464164199|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
128967105|NCT02177812|464164200|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
128967106|NCT02177812|464164201|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
128967107|NCT02177812|464164193|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
128967108|NCT02177812|464164194|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
128967109|NCT02177812|464164195|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
128967110|NCT02177812|464164196|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
128967111|NCT02177812|464164197|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
128967112|NCT02177812|464164198|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
128967113|NCT02177812|464164199|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
128967114|NCT02177812|464164200|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
128967115|NCT02177812|464164201|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
128967116|NCT00089999|464164202|FG000|Overall Study|Adverse Event|4|||
128967117|NCT00089999|464164203|FG001|Overall Study|Adverse Event|7|||
128967118|NCT00089999|464164202|FG000|Overall Study|Withdrawal by Subject|0|||
128967119|NCT00089999|464164203|FG001|Overall Study|Withdrawal by Subject|4|||
128967120|NCT00089999|464164202|FG000|Overall Study|Lost to Follow-up|2|||
128967121|NCT00089999|464164203|FG001|Overall Study|Lost to Follow-up|1|||
128967122|NCT00089999|464164202|FG000|Overall Study|Radiological Progression of Cancer|52|||
128967123|NCT00089999|464164203|FG001|Overall Study|Radiological Progression of Cancer|44|||
128967124|NCT00089999|464164202|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
128967125|NCT00089999|464164203|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
128967126|NCT00089999|464164202|FG000|Overall Study|Death|3|||
128967127|NCT00089999|464164203|FG001|Overall Study|Death|3|||
128967128|NCT00089999|464164202|FG000|Overall Study|Poor General Condition|1|||
128967129|NCT00089999|464164203|FG001|Overall Study|Poor General Condition|0|||
128967130|NCT00089999|464164202|FG000|Overall Study|Clinical Progression|1|||
128967131|NCT00089999|464164203|FG001|Overall Study|Clinical Progression|2|||
128967132|NCT00089999|464164202|FG000|Overall Study|Physician Decision|2|||
128967133|NCT00089999|464164203|FG001|Overall Study|Physician Decision|2|||
129037981|NCT02400476|464430561|FG002|Overall Study|Adverse Event|22|||
129037982|NCT02400476|464430562|FG003|Overall Study|Adverse Event|19|||
129037983|NCT02400476|464430563|FG004|Overall Study|Adverse Event|5|||
129037984|NCT02400476|464430564|FG005|Overall Study|Adverse Event|8|||
128967134|NCT00089999|464164202|FG000|Overall Study|Patient Underwent Surgery|2|||
128967135|NCT00089999|464164203|FG001|Overall Study|Patient Underwent Surgery|0|||
128967136|NCT00089999|464164202|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
128967137|NCT00089999|464164203|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
129037985|NCT02400476|464430559|FG000|Overall Study|Withdrawal by Subject|4|||
129037986|NCT02400476|464430560|FG001|Overall Study|Withdrawal by Subject|1|||
129037987|NCT02400476|464430561|FG002|Overall Study|Withdrawal by Subject|12|||
129037988|NCT02400476|464430562|FG003|Overall Study|Withdrawal by Subject|7|||
129037989|NCT02400476|464430563|FG004|Overall Study|Withdrawal by Subject|5|||
129220278|NCT01519921|465106544|FG000|Overall Study|Lost to Follow-up|2|||
128713643|NCT02436356|463248227|FG001|Overall Study|Withdrawal by Subject|0|||
128967138|NCT01167153|464164206|FG000|Overall Study|Non-effective therapy|1|||
129037990|NCT02400476|464430564|FG005|Overall Study|Withdrawal by Subject|5|||
129037991|NCT02400476|464430559|FG000|Overall Study|Lost to Follow-up|0|||
128967139|NCT01167153|464164207|FG001|Overall Study|Non-effective therapy|4|||
129037992|NCT02400476|464430560|FG001|Overall Study|Lost to Follow-up|0|||
129220279|NCT01519921|465106545|FG001|Overall Study|Lost to Follow-up|1|||
128967140|NCT01167153|464164206|FG000|Overall Study|AE including clinical laboratory AE|2|||
128713644|NCT02436356|463248228|FG002|Overall Study|Withdrawal by Subject|0|||
128713645|NCT04577118|463248229|FG000|Overall Study|Withdrawal by Subject|4|||
128967141|NCT01167153|464164207|FG001|Overall Study|AE including clinical laboratory AE|8|||
129037993|NCT02400476|464430561|FG002|Overall Study|Lost to Follow-up|0|||
129037994|NCT02400476|464430562|FG003|Overall Study|Lost to Follow-up|1|||
128967142|NCT01167153|464164206|FG000|Overall Study|Hypotension|1|||
128771724|NCT01702428|463455334|FG002|Overall Study|Withdrawal by Subject|14|||
128771725|NCT01702428|463455335|FG003|Overall Study|Withdrawal by Subject|10|||
128771726|NCT00154063|463455338|FG000|Overall Study|Adverse Event|4|||
128771727|NCT00154063|463455339|FG001|Overall Study|Adverse Event|8|||
128771728|NCT00154063|463455338|FG000|Overall Study|Protocol Violation|1|||
128771729|NCT00154063|463455339|FG001|Overall Study|Protocol Violation|1|||
128771730|NCT00154063|463455338|FG000|Overall Study|Investigator or Sponsor Request|0|||
128771731|NCT00154063|463455339|FG001|Overall Study|Investigator or Sponsor Request|1|||
128771732|NCT00154063|463455338|FG000|Overall Study|Withdrawal by Subject|4|||
128771733|NCT00154063|463455339|FG001|Overall Study|Withdrawal by Subject|9|||
128771734|NCT00154063|463455338|FG000|Overall Study|Other|3|||
128967143|NCT01167153|464164207|FG001|Overall Study|Hypotension|0|||
128967144|NCT01167153|464164206|FG000|Overall Study|Lost to Follow-up|7|||
128771735|NCT00154063|463455339|FG001|Overall Study|Other|3|||
128771736|NCT02091869|463455340|FG000|Overall Study|Withdrawal by Subject|0|||
128771737|NCT02091869|463455341|FG001|Overall Study|Withdrawal by Subject|3|||
128771738|NCT01804673|463455342|FG000|Overall Study|Adverse Event|4|||
128771739|NCT01804673|463455342|FG000|Overall Study|Withdrawal by Subject|1|||
128967145|NCT01167153|464164207|FG001|Overall Study|Lost to Follow-up|9|||
128967146|NCT01167153|464164206|FG000|Overall Study|Non-compliance to concomitant medication|0|||
128967147|NCT01167153|464164207|FG001|Overall Study|Non-compliance to concomitant medication|2|||
128967148|NCT01167153|464164206|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
128967149|NCT01167153|464164207|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
128967150|NCT01167153|464164206|FG000|Overall Study|Withdrawal consent|1|||
128967151|NCT01167153|464164207|FG001|Overall Study|Withdrawal consent|1|||
128967152|NCT01167153|464164206|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
128967153|NCT01167153|464164207|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
128771740|NCT01804673|463455342|FG000|Overall Study|Lack of Efficacy|9|||
128771741|NCT01804673|463455342|FG000|Overall Study|Change to Oral Therapy|37|||
128771742|NCT01804673|463455342|FG000|Overall Study|No Further Therapy Required|84|||
128771743|NCT01804673|463455342|FG000|Overall Study|Use of Prohibited Medication|1|||
128771744|NCT01804673|463455342|FG000|Overall Study|Other|4|||
128771745|NCT00451217|463455351|FG000|Overall Study|Lost to Follow-up|0|||
128771746|NCT00451217|463455352|FG001|Overall Study|Lost to Follow-up|1|||
128771747|NCT00451217|463455353|FG002|Overall Study|Lost to Follow-up|1|||
128771748|NCT00451217|463455354|FG003|Overall Study|Lost to Follow-up|1|||
128771749|NCT00451217|463455351|FG000|Overall Study|Withdrawal by Subject|1|||
128771750|NCT00451217|463455352|FG001|Overall Study|Withdrawal by Subject|0|||
128771751|NCT00451217|463455353|FG002|Overall Study|Withdrawal by Subject|0|||
128771752|NCT00451217|463455354|FG003|Overall Study|Withdrawal by Subject|0|||
128771753|NCT00451217|463455351|FG000|Overall Study|Not Treated|1|||
128771754|NCT00451217|463455352|FG001|Overall Study|Not Treated|1|||
128771755|NCT00451217|463455353|FG002|Overall Study|Not Treated|3|||
128771756|NCT00451217|463455354|FG003|Overall Study|Not Treated|4|||
128771757|NCT00467142|463455356|FG000|Overall Study|Withdrawal by Subject|1|||
128967154|NCT01462045|464165844|FG000|Overall Study|Family matter|0|||
128967155|NCT01462045|464165845|FG001|Overall Study|Family matter|1|||
128967156|NCT01462045|464165846|FG002|Overall Study|Family matter|0|||
128967157|NCT02828644|464165849|FG000|Overall Study|Lost to Follow-up|23|||
128967158|NCT02828644|464165850|FG001|Overall Study|Lost to Follow-up|22|||
128967159|NCT06048809|464165855|FG000|Overall Study|Adverse Event|2|||
128967160|NCT06048809|464165856|FG001|Overall Study|Adverse Event|0|||
128967161|NCT06048809|464165855|FG000|Overall Study|Withdrawal by Subject|1|||
128967162|NCT06048809|464165856|FG001|Overall Study|Withdrawal by Subject|1|||
128967163|NCT02158728|464165857|FG000|Overall Study|no procedure according to CIP done|3|||
128967164|NCT02158728|464165857|FG000|Overall Study|no qualified dataset|24|||
128967165|NCT03878160|464165863|FG000|Overall Study|Lost to Follow-up|1|||
128771758|NCT00467142|463455356|FG000|Overall Study|Adverse Event|1|||
128771759|NCT00467142|463455356|FG000|Overall Study|Protocol Violation|1|||
128771760|NCT02406261|463455357|FG000|Period 1|Lost to Follow-up|2|||
128771761|NCT02406261|463455358|FG001|Period 1|Lost to Follow-up|0|||
128771762|NCT02406261|463455357|FG000|Period 1|Adverse Event|1|||
128771763|NCT02406261|463455358|FG001|Period 1|Adverse Event|0|||
128771764|NCT02406261|463455357|FG000|Period 2|Physician Decision|0|||
129037995|NCT02400476|464430563|FG004|Overall Study|Lost to Follow-up|3|||
128771765|NCT02406261|463455358|FG001|Period 2|Physician Decision|1|||
128771766|NCT02406261|463455357|FG000|Period 2|Protocol Violation|0|||
128771767|NCT02406261|463455358|FG001|Period 2|Protocol Violation|1|||
128771768|NCT02406261|463455357|FG000|Period 2|Withdrawal by Subject|0|||
128771769|NCT02406261|463455358|FG001|Period 2|Withdrawal by Subject|1|||
128771770|NCT03632434|463455367|FG000|Overall Study|Withdrawal by Subject|2|||
128771771|NCT01751113|463455370|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
128771772|NCT01751113|463455371|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
128967166|NCT03878160|464165864|FG001|Overall Study|Lost to Follow-up|1|||
128967167|NCT03878160|464165865|FG002|Overall Study|Lost to Follow-up|1|||
128771773|NCT01751113|463455372|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129037996|NCT02400476|464430564|FG005|Overall Study|Lost to Follow-up|1|||
128967168|NCT03878160|464165863|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
128967169|NCT03878160|464165864|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
128967170|NCT03878160|464165865|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
128967171|NCT00589602|464165871|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
128967172|NCT03933215|464165878|FG000|Overall Study|Other|6|||
128967173|NCT03933215|464165878|FG000|Overall Study|Sponsor decision|5|||
128967174|NCT03933215|464165878|FG000|Overall Study|Protocol Violation|5|||
128967175|NCT03933215|464165878|FG000|Overall Study|Withdrawal by Subject|6|||
128967176|NCT03933215|464165878|FG000|Overall Study|Lost to Follow-up|6|||
128967177|NCT03933215|464165878|FG000|Overall Study|Enrolled but not treated|38|||
128967178|NCT04097028|464165879|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
128967179|NCT04097028|464165879|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
128967180|NCT04097028|464165879|FG000|Overall Study|Disease Progression prior to Surgery|2|||
128967181|NCT04097028|464165879|FG000|Overall Study|Adverse Event prior to Surgery|1|||
128967182|NCT01678313|464165880|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
128967183|NCT01678313|464165881|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
128967184|NCT01678313|464165880|FG000|Completed the 3-month Therapy|Physician Decision|3|||
128967185|NCT01678313|464165881|FG001|Completed the 3-month Therapy|Physician Decision|4|||
128967186|NCT01678313|464165880|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
128967187|NCT01678313|464165881|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
128967188|NCT01678313|464165880|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
128967189|NCT01678313|464165881|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
128967190|NCT00981292|464165884|FG000|Day 1|Protocol Violation|1|||
128967191|NCT00981292|464165885|FG001|Day 1|Protocol Violation|0|||
128967192|NCT00981292|464165886|FG002|Day 1|Protocol Violation|0|||
128967193|NCT00981292|464165887|FG003|Day 1|Protocol Violation|0|||
128967194|NCT00981292|464165888|FG004|Day 1|Protocol Violation|0|||
128967195|NCT00981292|464165889|FG005|Day 1|Protocol Violation|2|||
128967196|NCT00981292|464165884|FG000|Day 2|Protocol Violation|2|||
128967197|NCT00981292|464165885|FG001|Day 2|Protocol Violation|0|||
128967198|NCT00981292|464165886|FG002|Day 2|Protocol Violation|0|||
128967199|NCT00981292|464165887|FG003|Day 2|Protocol Violation|0|||
128967200|NCT00981292|464165888|FG004|Day 2|Protocol Violation|0|||
128967201|NCT00981292|464165889|FG005|Day 2|Protocol Violation|0|||
128967202|NCT00981292|464165884|FG000|Day 3|Protocol Violation|0|||
128967203|NCT00981292|464165885|FG001|Day 3|Protocol Violation|0|||
128967204|NCT00981292|464165886|FG002|Day 3|Protocol Violation|0|||
128967205|NCT00981292|464165887|FG003|Day 3|Protocol Violation|0|||
128967206|NCT00981292|464165888|FG004|Day 3|Protocol Violation|0|||
128967207|NCT00981292|464165889|FG005|Day 3|Protocol Violation|1|||
128967208|NCT01131130|464165890|FG000|Period 1 - Baseline|Pregnancy|1|||
128967209|NCT01131130|464165890|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
128967210|NCT03464136|464165891|FG000|Overall Study|Lost to Follow-up|5|||
128967211|NCT03464136|464165892|FG001|Overall Study|Lost to Follow-up|8|||
128967212|NCT03464136|464165891|FG000|Overall Study|Withdrawal by Subject|16|||
128967213|NCT03464136|464165892|FG001|Overall Study|Withdrawal by Subject|13|||
128967214|NCT03464136|464165891|FG000|Overall Study|Death|1|||
128967215|NCT03464136|464165892|FG001|Overall Study|Death|0|||
128967216|NCT03464136|464165891|FG000|Overall Study|Other|8|||
129037997|NCT02400476|464430559|FG000|Overall Study|Physician Decision|0|||
129037998|NCT02400476|464430560|FG001|Overall Study|Physician Decision|0|||
129037999|NCT02400476|464430561|FG002|Overall Study|Physician Decision|1|||
129038000|NCT02400476|464430562|FG003|Overall Study|Physician Decision|1|||
128713646|NCT00810407|463248230|FG000|Overall Study|Protocol Violation|3|||
128713647|NCT00810407|463248230|FG000|Overall Study|No Visit After First Day of Treatment|3|||
128713648|NCT03108027|463248232|FG000|Period 1|Subject/Guardian Decision|0|||
129038001|NCT02400476|464430563|FG004|Overall Study|Physician Decision|0|||
129038002|NCT02400476|464430564|FG005|Overall Study|Physician Decision|1|||
128713649|NCT03108027|463248233|FG001|Period 1|Subject/Guardian Decision|0|||
128713650|NCT03108027|463248234|FG002|Period 1|Subject/Guardian Decision|0|||
128967217|NCT03464136|464165892|FG001|Overall Study|Other|4|||
128967218|NCT03412565|464165893|FG000|Overall Study|Lost to Follow-up|0|||
128967219|NCT03412565|464165894|FG001|Overall Study|Lost to Follow-up|0|||
128967220|NCT03412565|464165895|FG002|Overall Study|Lost to Follow-up|1|||
128967221|NCT03412565|464165896|FG003|Overall Study|Lost to Follow-up|0|||
128967222|NCT03412565|464165893|FG000|Overall Study|Physician Decision|0|||
128967223|NCT03412565|464165894|FG001|Overall Study|Physician Decision|0|||
128967224|NCT03412565|464165895|FG002|Overall Study|Physician Decision|0|||
128967225|NCT03412565|464165896|FG003|Overall Study|Physician Decision|1|||
128967226|NCT03412565|464165893|FG000|Overall Study|Withdrawal by Subject|0|||
128967227|NCT03412565|464165894|FG001|Overall Study|Withdrawal by Subject|4|||
128967228|NCT03412565|464165895|FG002|Overall Study|Withdrawal by Subject|5|||
128967229|NCT03412565|464165896|FG003|Overall Study|Withdrawal by Subject|5|||
128967230|NCT03412565|464165893|FG000|Overall Study|Death|1|||
128967231|NCT03412565|464165894|FG001|Overall Study|Death|3|||
128967232|NCT03412565|464165895|FG002|Overall Study|Death|4|||
128967233|NCT03412565|464165896|FG003|Overall Study|Death|5|||
129038003|NCT02400476|464430559|FG000|Overall Study|Other, Disease Progression|0|||
128967234|NCT03412565|464165893|FG000|Overall Study|Data collection ended|0|||
128967235|NCT03412565|464165894|FG001|Overall Study|Data collection ended|41|||
128967236|NCT03412565|464165895|FG002|Overall Study|Data collection ended|41|||
128967237|NCT03412565|464165896|FG003|Overall Study|Data collection ended|40|||
128967238|NCT03277105|464165897|FG000|Overall Study|Death|129|||
128967239|NCT03277105|464165898|FG001|Overall Study|Death|124|||
128967240|NCT03277105|464165897|FG000|Overall Study|Lost to Follow-up|2|||
128967241|NCT03277105|464165898|FG001|Overall Study|Lost to Follow-up|4|||
128967242|NCT03277105|464165897|FG000|Overall Study|Withdrawal by Subject|10|||
128967243|NCT03277105|464165898|FG001|Overall Study|Withdrawal by Subject|10|||
128967244|NCT03277105|464165897|FG000|Overall Study|Other|118|||
128967245|NCT03277105|464165898|FG001|Overall Study|Other|125|||
128967246|NCT00537771|464165905|FG000|Overall Study|Withdrawal by Subject|6|||
128967247|NCT00537771|464165906|FG001|Overall Study|Withdrawal by Subject|23|||
128967248|NCT00537771|464165905|FG000|Overall Study|Adverse Event|8|||
128967249|NCT00537771|464165906|FG001|Overall Study|Adverse Event|15|||
128967250|NCT00537771|464165905|FG000|Overall Study|Lost to Follow-up|9|||
128967251|NCT00537771|464165906|FG001|Overall Study|Lost to Follow-up|15|||
128967252|NCT00537771|464165905|FG000|Overall Study|Protocol Violation|2|||
128967253|NCT00537771|464165906|FG001|Overall Study|Protocol Violation|6|||
128967254|NCT00537771|464165905|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
128967255|NCT00537771|464165906|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
128967256|NCT02736929|464165908|FG000|Main Study|Lost to Follow-up|7|||
128967257|NCT02736929|464165909|FG001|Main Study|Lost to Follow-up|1|||
128967258|NCT02736929|464165910|FG002|Main Study|Lost to Follow-up|0|||
128967259|NCT02736929|464165908|FG000|Main Study|Withdrawal by Subject|1|||
128967260|NCT02736929|464165909|FG001|Main Study|Withdrawal by Subject|1|||
128967261|NCT02736929|464165910|FG002|Main Study|Withdrawal by Subject|0|||
128967262|NCT02736929|464165908|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
128967263|NCT02736929|464165909|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
128967264|NCT02736929|464165910|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
128967265|NCT00285649|464165913|FG000|Overall Study|Lost to Follow-up|6|||
128967266|NCT00285649|464165914|FG001|Overall Study|Lost to Follow-up|4|||
128967267|NCT00285649|464165915|FG002|Overall Study|Lost to Follow-up|4|||
128967268|NCT00285649|464165913|FG000|Overall Study|Withdrawal by Subject|3|||
128967269|NCT00285649|464165914|FG001|Overall Study|Withdrawal by Subject|2|||
128967270|NCT00285649|464165915|FG002|Overall Study|Withdrawal by Subject|2|||
128967271|NCT03342404|464165916|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
128967272|NCT03342404|464165917|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
128967273|NCT03342404|464165916|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
128967274|NCT03342404|464165917|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
128967275|NCT03342404|464165916|FG000|Blinded Treatment Phase|Adverse Event|5|||
128967276|NCT03342404|464165917|FG001|Blinded Treatment Phase|Adverse Event|4|||
128967277|NCT03342404|464165916|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
128967278|NCT03342404|464165917|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
128967279|NCT03342404|464165916|FG000|Blinded Treatment Phase|Other reasons|1|||
128967280|NCT03342404|464165917|FG001|Blinded Treatment Phase|Other reasons|0|||
128967281|NCT03342404|464165916|FG000|Blinded Treatment Phase|Physician Decision|1|||
128967282|NCT03342404|464165917|FG001|Blinded Treatment Phase|Physician Decision|0|||
128967283|NCT03342404|464165916|FG000|Blinded Treatment Phase|Death|1|||
128967284|NCT03342404|464165917|FG001|Blinded Treatment Phase|Death|0|||
128967285|NCT03342404|464165916|FG000|Open-Label Phase|Lost to Follow-up|0|||
128967286|NCT03342404|464165917|FG001|Open-Label Phase|Lost to Follow-up|1|||
128967287|NCT03342404|464165916|FG000|Open-Label Phase|Other reasons|0|||
128967288|NCT03342404|464165917|FG001|Open-Label Phase|Other reasons|1|||
128967289|NCT03342404|464165916|FG000|Open-Label Phase|Adverse Event|0|||
128967290|NCT03342404|464165917|FG001|Open-Label Phase|Adverse Event|3|||
128967291|NCT03342404|464165916|FG000|Open-Label Phase|Withdrawal by Subject|0|||
128967292|NCT03342404|464165917|FG001|Open-Label Phase|Withdrawal by Subject|6|||
128967293|NCT01855425|464165918|FG000|Overall Study|Physician Decision|20|||
128967294|NCT00373880|464165919|FG000|Overall Study|Physician Decision|3|||
129038004|NCT02400476|464430560|FG001|Overall Study|Other, Disease Progression|1|||
129038005|NCT02400476|464430561|FG002|Overall Study|Other, Disease Progression|2|||
129038006|NCT02400476|464430562|FG003|Overall Study|Other, Disease Progression|1|||
129038007|NCT02400476|464430563|FG004|Overall Study|Other, Disease Progression|2|||
129220280|NCT01519921|465106544|FG000|Overall Study|Treatment refusal|2|||
129220281|NCT01519921|465106545|FG001|Overall Study|Treatment refusal|1|||
128967295|NCT00373880|464165919|FG000|Overall Study|Arrested|1|||
128967296|NCT00373880|464165919|FG000|Overall Study|Protocol Violation|14|||
128967297|NCT01634100|464165920|FG000|Overall Study|Withdrawal by Subject|1|||
128967298|NCT01634100|464165921|FG001|Overall Study|Withdrawal by Subject|0|||
128967299|NCT01634100|464165922|FG002|Overall Study|Withdrawal by Subject|1|||
128967300|NCT01634100|464165923|FG003|Overall Study|Withdrawal by Subject|0|||
128967301|NCT01634100|464165924|FG004|Overall Study|Withdrawal by Subject|0|||
128967302|NCT01634100|464165925|FG005|Overall Study|Withdrawal by Subject|0|||
128967303|NCT01975376|464165931|FG000|Overall Study|Adverse Event|5|||
128967304|NCT01975376|464165932|FG001|Overall Study|Adverse Event|5|||
128967305|NCT01975376|464165931|FG000|Overall Study|Death|65|||
128967306|NCT01975376|464165932|FG001|Overall Study|Death|72|||
128967307|NCT01975376|464165931|FG000|Overall Study|Lost to Follow-up|70|||
128967308|NCT01975376|464165932|FG001|Overall Study|Lost to Follow-up|66|||
128967309|NCT01975376|464165931|FG000|Overall Study|Withdrew consent|68|||
128967310|NCT01975376|464165932|FG001|Overall Study|Withdrew consent|62|||
128967311|NCT01975376|464165931|FG000|Overall Study|Other|2|||
128967312|NCT01975376|464165932|FG001|Overall Study|Other|4|||
128967313|NCT01975376|464165931|FG000|Overall Study|Randomized, Not Treated|16|||
128967314|NCT01975376|464165932|FG001|Overall Study|Randomized, Not Treated|8|||
128967315|NCT01819194|464165934|FG000|Overall Study|Loss of study articles|2|||
128967316|NCT02343952|464165937|FG000|Study Treatment|Disease Progression|23|||
128967317|NCT02343952|464165937|FG000|Study Treatment|Death|3|||
128967318|NCT02343952|464165937|FG000|Study Treatment|Adverse Event|19|||
128967319|NCT02343952|464165937|FG000|Study Treatment|Withdrawal by Subject|7|||
128967320|NCT02343952|464165937|FG000|Study Treatment|other complicating Diseases|1|||
128967321|NCT02343952|464165937|FG000|Follow up|Withdrawal by Subject|3|||
128967322|NCT02343952|464165937|FG000|Follow up|Death|33|||
128967323|NCT02343952|464165937|FG000|Follow up|Patient does not meet eligibility for study.|1|||
128967324|NCT02343952|464165937|FG000|Follow up|Research department closed by the practice.|5|||
128967325|NCT02343952|464165937|FG000|Follow up|Patient went home to Russia|1|||
128967326|NCT02343952|464165937|FG000|Follow up|Disease Progression|1|||
128967327|NCT02343952|464165937|FG000|Follow up|study terminated|1|||
128967328|NCT01448707|464165941|FG000|Overall Study|Adverse Event|3|||
128967329|NCT01448707|464165942|FG001|Overall Study|Adverse Event|1|||
128967330|NCT01448707|464165941|FG000|Overall Study|Lost to Follow-up|2|||
128967331|NCT01448707|464165942|FG001|Overall Study|Lost to Follow-up|6|||
128967332|NCT01448707|464165941|FG000|Overall Study|Withdrawal by Subject|6|||
128967333|NCT01448707|464165942|FG001|Overall Study|Withdrawal by Subject|7|||
128967334|NCT01448707|464165941|FG000|Overall Study|Other|7|||
128967335|NCT01448707|464165942|FG001|Overall Study|Other|4|||
128967336|NCT00899678|464165943|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
128967337|NCT00899678|464165944|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
128967338|NCT00899678|464165945|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
128967339|NCT00899678|464165943|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
128967340|NCT00899678|464165944|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
128967341|NCT00899678|464165945|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
128967342|NCT00899678|464165943|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
128967343|NCT00899678|464165944|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
128967344|NCT00899678|464165945|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
128967345|NCT00899678|464165943|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
128967346|NCT00899678|464165944|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
128967347|NCT00899678|464165945|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
128967348|NCT00899678|464165943|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
128967349|NCT00899678|464165944|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
128967350|NCT00899678|464165945|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
128967351|NCT00899678|464165943|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
128967352|NCT00899678|464165944|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
128967353|NCT00899678|464165945|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
128967354|NCT00899678|464165943|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
128967355|NCT00899678|464165944|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
128967356|NCT00899678|464165945|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
128967357|NCT00899678|464165943|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
128967358|NCT00899678|464165944|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
128967359|NCT00899678|464165945|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
128967360|NCT00899678|464165943|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
128967361|NCT00899678|464165944|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
128967362|NCT00899678|464165945|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
128967363|NCT00033371|464165946|FG000|Overall Study|Adverse Event|1|||
128713651|NCT03108027|463248235|FG003|Period 1|Subject/Guardian Decision|2|||
128713652|NCT03108027|463248236|FG004|Period 1|Subject/Guardian Decision|0|||
128713653|NCT03108027|463248237|FG005|Period 1|Subject/Guardian Decision|0|||
128713654|NCT03108027|463248232|FG000|Period 3|Adverse Event|0|||
128713655|NCT03108027|463248233|FG001|Period 3|Adverse Event|1|||
128713656|NCT03108027|463248234|FG002|Period 3|Adverse Event|0|||
128967364|NCT00033371|464165947|FG001|Overall Study|Adverse Event|5|||
128967365|NCT00033371|464165946|FG000|Overall Study|Lost to Follow-up|2|||
128967366|NCT00033371|464165947|FG001|Overall Study|Lost to Follow-up|1|||
128967367|NCT00033371|464165946|FG000|Overall Study|Withdrawal by Subject|3|||
128967368|NCT00033371|464165947|FG001|Overall Study|Withdrawal by Subject|3|||
128967369|NCT00033371|464165946|FG000|Overall Study|Disease Progression|0|||
128967370|NCT00033371|464165947|FG001|Overall Study|Disease Progression|1|||
128967371|NCT03796195|464165950|FG000|Overall Study|Study closed early|1|||
128967372|NCT03799627|464165955|FG000|Overall Study|Adverse Event|1|||
128967373|NCT03799627|464165956|FG001|Overall Study|Adverse Event|2|||
128713657|NCT03108027|463248235|FG003|Period 3|Adverse Event|0|||
128967374|NCT03799627|464165957|FG002|Overall Study|Adverse Event|0|||
128967375|NCT03799627|464165958|FG003|Overall Study|Adverse Event|0|||
128967376|NCT03799627|464165959|FG004|Overall Study|Adverse Event|2|||
128967377|NCT03799627|464165960|FG005|Overall Study|Adverse Event|5|||
128967378|NCT03799627|464165961|FG006|Overall Study|Adverse Event|0|||
128967379|NCT03799627|464165962|FG007|Overall Study|Adverse Event|2|||
128967380|NCT03799627|464165963|FG008|Overall Study|Adverse Event|0|||
128967381|NCT03799627|464165955|FG000|Overall Study|Physician Decision|2|||
128967382|NCT03799627|464165956|FG001|Overall Study|Physician Decision|2|||
128967383|NCT03799627|464165957|FG002|Overall Study|Physician Decision|0|||
128967384|NCT03799627|464165958|FG003|Overall Study|Physician Decision|0|||
128771774|NCT01751113|463455373|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
128771775|NCT01751113|463455374|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
128771776|NCT01751113|463455375|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
128771777|NCT01751113|463455370|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
128771778|NCT01751113|463455371|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
128771779|NCT01751113|463455372|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
128967385|NCT03799627|464165959|FG004|Overall Study|Physician Decision|2|||
128967386|NCT03799627|464165960|FG005|Overall Study|Physician Decision|2|||
128967387|NCT03799627|464165961|FG006|Overall Study|Physician Decision|0|||
128967388|NCT03799627|464165962|FG007|Overall Study|Physician Decision|0|||
128967389|NCT03799627|464165963|FG008|Overall Study|Physician Decision|0|||
128967390|NCT03799627|464165955|FG000|Overall Study|Withdrawal by Subject|1|||
128967391|NCT03799627|464165956|FG001|Overall Study|Withdrawal by Subject|1|||
128967392|NCT03799627|464165957|FG002|Overall Study|Withdrawal by Subject|0|||
128967393|NCT03799627|464165958|FG003|Overall Study|Withdrawal by Subject|2|||
128967394|NCT03799627|464165959|FG004|Overall Study|Withdrawal by Subject|0|||
128771780|NCT01751113|463455373|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
128771781|NCT01751113|463455374|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
128771782|NCT01751113|463455375|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
128771783|NCT01775930|463455376|FG000|Overall Study|Futility stopping boundary met|1|||
128771784|NCT01551303|463455378|FG000|Overall Study|failed awareness check on vision test|4|||
128771785|NCT01551303|463455379|FG001|Overall Study|failed awareness check on vision test|7|||
128771786|NCT02743793|463455389|FG000|Overall Study|Death|1|||
128771787|NCT02743793|463455390|FG001|Overall Study|Death|1|||
128771788|NCT02743793|463455389|FG000|Overall Study|Withdrawal by Subject|0|||
128771789|NCT02743793|463455390|FG001|Overall Study|Withdrawal by Subject|1|||
128771790|NCT02743793|463455389|FG000|Overall Study|Screen Failure|4|||
128771791|NCT02743793|463455390|FG001|Overall Study|Screen Failure|0|||
128771792|NCT02743793|463455389|FG000|Overall Study|No Primary Care Physician|0|||
128771793|NCT02743793|463455390|FG001|Overall Study|No Primary Care Physician|1|||
128771794|NCT02743793|463455389|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
128771795|NCT02743793|463455390|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
128771796|NCT02743793|463455389|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
128771797|NCT02743793|463455390|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
128771798|NCT01461993|463455395|FG000|Overall Study|Withdrawal by Subject|60|||
128771799|NCT01461993|463455396|FG001|Overall Study|Withdrawal by Subject|53|||
128771800|NCT01461993|463455397|FG002|Overall Study|Withdrawal by Subject|16|||
128771801|NCT01461993|463455395|FG000|Overall Study|Lost to Follow-up|44|||
128771802|NCT01461993|463455396|FG001|Overall Study|Lost to Follow-up|48|||
128771803|NCT01461993|463455397|FG002|Overall Study|Lost to Follow-up|22|||
128771804|NCT01461993|463455395|FG000|Overall Study|Protocol Violation|10|||
128771805|NCT01461993|463455396|FG001|Overall Study|Protocol Violation|9|||
128771806|NCT01461993|463455397|FG002|Overall Study|Protocol Violation|7|||
128771807|NCT01461993|463455395|FG000|Overall Study|Adverse Event|9|||
128771808|NCT01461993|463455396|FG001|Overall Study|Adverse Event|11|||
128771809|NCT01461993|463455397|FG002|Overall Study|Adverse Event|3|||
128771810|NCT01461993|463455395|FG000|Overall Study|No longer met eligibility criteria|13|||
128771811|NCT01461993|463455396|FG001|Overall Study|No longer met eligibility criteria|18|||
128771812|NCT01461993|463455397|FG002|Overall Study|No longer met eligibility criteria|10|||
128771813|NCT01461993|463455395|FG000|Overall Study|Did not meet entrance criteria|2|||
128771814|NCT01461993|463455396|FG001|Overall Study|Did not meet entrance criteria|3|||
128771815|NCT01461993|463455397|FG002|Overall Study|Did not meet entrance criteria|0|||
128771816|NCT01461993|463455395|FG000|Overall Study|Other|13|||
128771817|NCT01461993|463455396|FG001|Overall Study|Other|15|||
128771818|NCT01461993|463455397|FG002|Overall Study|Other|6|||
128771819|NCT00219141|463455399|FG000|Overall Study|Adverse Event|4|||
128771820|NCT00219141|463455400|FG001|Overall Study|Adverse Event|10|||
128771821|NCT00219141|463455401|FG002|Overall Study|Adverse Event|5|||
128771822|NCT00219141|463455399|FG000|Overall Study|Lack of Efficacy|3|||
128967395|NCT03799627|464165960|FG005|Overall Study|Withdrawal by Subject|3|||
128967396|NCT03799627|464165961|FG006|Overall Study|Withdrawal by Subject|0|||
128967397|NCT03799627|464165962|FG007|Overall Study|Withdrawal by Subject|0|||
128967398|NCT03799627|464165963|FG008|Overall Study|Withdrawal by Subject|0|||
128967399|NCT03799627|464165955|FG000|Overall Study|Lack of Efficacy|0|||
128967400|NCT03799627|464165956|FG001|Overall Study|Lack of Efficacy|0|||
128967401|NCT03799627|464165957|FG002|Overall Study|Lack of Efficacy|0|||
128967402|NCT03799627|464165958|FG003|Overall Study|Lack of Efficacy|1|||
128967403|NCT03799627|464165959|FG004|Overall Study|Lack of Efficacy|0|||
128967404|NCT03799627|464165960|FG005|Overall Study|Lack of Efficacy|0|||
128967405|NCT03799627|464165961|FG006|Overall Study|Lack of Efficacy|0|||
128967406|NCT03799627|464165962|FG007|Overall Study|Lack of Efficacy|0|||
128967407|NCT03799627|464165963|FG008|Overall Study|Lack of Efficacy|0|||
128967408|NCT03799627|464165955|FG000|Overall Study|Lost to Follow-up|0|||
128967409|NCT03799627|464165956|FG001|Overall Study|Lost to Follow-up|0|||
128967410|NCT03799627|464165957|FG002|Overall Study|Lost to Follow-up|0|||
128967411|NCT03799627|464165958|FG003|Overall Study|Lost to Follow-up|0|||
128967412|NCT03799627|464165959|FG004|Overall Study|Lost to Follow-up|0|||
128967413|NCT03799627|464165960|FG005|Overall Study|Lost to Follow-up|0|||
128967414|NCT03799627|464165961|FG006|Overall Study|Lost to Follow-up|1|||
128967415|NCT03799627|464165962|FG007|Overall Study|Lost to Follow-up|0|||
128967416|NCT03799627|464165963|FG008|Overall Study|Lost to Follow-up|1|||
128967417|NCT03799627|464165955|FG000|Overall Study|Death|0|||
128967418|NCT03799627|464165956|FG001|Overall Study|Death|0|||
128967419|NCT03799627|464165957|FG002|Overall Study|Death|0|||
128967420|NCT03799627|464165958|FG003|Overall Study|Death|1|||
128967421|NCT03799627|464165959|FG004|Overall Study|Death|0|||
128967422|NCT03799627|464165960|FG005|Overall Study|Death|0|||
128967423|NCT03799627|464165961|FG006|Overall Study|Death|0|||
128967424|NCT03799627|464165962|FG007|Overall Study|Death|0|||
128967425|NCT03799627|464165963|FG008|Overall Study|Death|0|||
128967426|NCT03799627|464165955|FG000|Overall Study|Study Drug Put on Hold|1|||
128967427|NCT03799627|464165956|FG001|Overall Study|Study Drug Put on Hold|0|||
128967428|NCT03799627|464165957|FG002|Overall Study|Study Drug Put on Hold|0|||
128967429|NCT03799627|464165958|FG003|Overall Study|Study Drug Put on Hold|0|||
128967430|NCT03799627|464165959|FG004|Overall Study|Study Drug Put on Hold|0|||
128967431|NCT03799627|464165960|FG005|Overall Study|Study Drug Put on Hold|0|||
128713658|NCT03108027|463248236|FG004|Period 3|Adverse Event|0|||
128713659|NCT03108027|463248237|FG005|Period 3|Adverse Event|0|||
128713660|NCT02426892|463248238|FG000|Overall Study|Adverse Event|2|||
128713661|NCT02426892|463248238|FG000|Overall Study|Lack of Efficacy|17|||
128713662|NCT02426892|463248238|FG000|Overall Study|Withdrawal by Subject|1|||
128713663|NCT02574247|463248239|FG000|Overall Study|Withdrawal by Subject|1|||
128713664|NCT02574247|463248240|FG001|Overall Study|Withdrawal by Subject|0|||
128713665|NCT02574247|463248241|FG002|Overall Study|Withdrawal by Subject|0|||
128713666|NCT02574247|463248239|FG000|Overall Study|Did not meet inclusion criteria|4|||
128713667|NCT02574247|463248240|FG001|Overall Study|Did not meet inclusion criteria|3|||
128713668|NCT02574247|463248241|FG002|Overall Study|Did not meet inclusion criteria|5|||
128713669|NCT00268996|463248242|FG000|Overall Study|Adverse Event|11|||
128713670|NCT00268996|463248243|FG001|Overall Study|Adverse Event|7|||
128713671|NCT00268996|463248242|FG000|Overall Study|Lost to Follow-up|3|||
128713672|NCT00268996|463248243|FG001|Overall Study|Lost to Follow-up|1|||
128713673|NCT00268996|463248242|FG000|Overall Study|Withdrawal by Subject|5|||
128713674|NCT00268996|463248243|FG001|Overall Study|Withdrawal by Subject|11|||
128713675|NCT00268996|463248242|FG000|Overall Study|Non-compliance|1|||
128713676|NCT00268996|463248243|FG001|Overall Study|Non-compliance|0|||
128713677|NCT00268996|463248242|FG000|Overall Study|Other|1|||
128713678|NCT00268996|463248243|FG001|Overall Study|Other|1|||
128713679|NCT00451321|463248248|FG000|Overall Study|Lost to Follow-up|3|||
128713680|NCT00451321|463248249|FG001|Overall Study|Lost to Follow-up|3|||
128713681|NCT00451321|463248250|FG002|Overall Study|Lost to Follow-up|1|||
128713682|NCT00451321|463248251|FG003|Overall Study|Lost to Follow-up|3|||
128713683|NCT00451321|463248252|FG004|Overall Study|Lost to Follow-up|0|||
128713684|NCT00451321|463248253|FG005|Overall Study|Lost to Follow-up|1|||
128713685|NCT00451321|463248254|FG006|Overall Study|Lost to Follow-up|0|||
128713686|NCT00451321|463248255|FG007|Overall Study|Lost to Follow-up|0|||
128713687|NCT00451321|463248248|FG000|Overall Study|Withdrawal by Subject|3|||
128713688|NCT00451321|463248249|FG001|Overall Study|Withdrawal by Subject|1|||
128713689|NCT00451321|463248250|FG002|Overall Study|Withdrawal by Subject|0|||
128713690|NCT00451321|463248251|FG003|Overall Study|Withdrawal by Subject|4|||
128713691|NCT00451321|463248252|FG004|Overall Study|Withdrawal by Subject|0|||
128713692|NCT00451321|463248253|FG005|Overall Study|Withdrawal by Subject|0|||
128713693|NCT00451321|463248254|FG006|Overall Study|Withdrawal by Subject|0|||
128713694|NCT00451321|463248255|FG007|Overall Study|Withdrawal by Subject|0|||
128967432|NCT03799627|464165961|FG006|Overall Study|Study Drug Put on Hold|0|||
128967433|NCT03799627|464165962|FG007|Overall Study|Study Drug Put on Hold|0|||
128967434|NCT03799627|464165963|FG008|Overall Study|Study Drug Put on Hold|0|||
129038008|NCT02400476|464430564|FG005|Overall Study|Other, Disease Progression|1|||
128713695|NCT00451321|463248248|FG000|Overall Study|Study closed/terminated|1|||
128967435|NCT03799627|464165955|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
128967436|NCT03799627|464165956|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
128967437|NCT03799627|464165957|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
128967438|NCT03799627|464165958|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
128967439|NCT03799627|464165959|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
128967440|NCT03799627|464165960|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
128967441|NCT03799627|464165961|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
128967442|NCT03799627|464165962|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
128967443|NCT03799627|464165963|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
128967444|NCT03799627|464165955|FG000|Overall Study|Kidney Transplantation|1|||
128967445|NCT03799627|464165956|FG001|Overall Study|Kidney Transplantation|0|||
128967446|NCT03799627|464165957|FG002|Overall Study|Kidney Transplantation|0|||
128967447|NCT03799627|464165958|FG003|Overall Study|Kidney Transplantation|1|||
128967448|NCT03799627|464165959|FG004|Overall Study|Kidney Transplantation|1|||
128967449|NCT03799627|464165960|FG005|Overall Study|Kidney Transplantation|0|||
128967450|NCT03799627|464165961|FG006|Overall Study|Kidney Transplantation|0|||
128967451|NCT03799627|464165962|FG007|Overall Study|Kidney Transplantation|0|||
129130317|NCT00770484|464768740|FG000|Overall Study|Withdrawal by Subject|1|||
128713696|NCT00451321|463248249|FG001|Overall Study|Study closed/terminated|1|||
128713697|NCT00451321|463248250|FG002|Overall Study|Study closed/terminated|17|||
128713698|NCT00451321|463248251|FG003|Overall Study|Study closed/terminated|5|||
128713699|NCT00451321|463248252|FG004|Overall Study|Study closed/terminated|7|||
128713700|NCT00451321|463248253|FG005|Overall Study|Study closed/terminated|7|||
128713701|NCT00451321|463248254|FG006|Overall Study|Study closed/terminated|5|||
128713702|NCT00451321|463248255|FG007|Overall Study|Study closed/terminated|3|||
128713703|NCT00451321|463248248|FG000|Overall Study|Sponsor decision to amend protocol|0|||
128713704|NCT00451321|463248249|FG001|Overall Study|Sponsor decision to amend protocol|0|||
128713705|NCT00451321|463248250|FG002|Overall Study|Sponsor decision to amend protocol|0|||
128713706|NCT00451321|463248251|FG003|Overall Study|Sponsor decision to amend protocol|0|||
128713707|NCT00451321|463248252|FG004|Overall Study|Sponsor decision to amend protocol|0|||
128713708|NCT00451321|463248253|FG005|Overall Study|Sponsor decision to amend protocol|1|||
128713709|NCT00451321|463248254|FG006|Overall Study|Sponsor decision to amend protocol|1|||
128713710|NCT00451321|463248255|FG007|Overall Study|Sponsor decision to amend protocol|3|||
128713711|NCT01528254|463248258|FG000|Overall Study|Administrative problems|96|||
128713712|NCT01528254|463248259|FG001|Overall Study|Administrative problems|94|||
128713713|NCT01528254|463248258|FG000|Overall Study|Adverse Event|28|||
128713714|NCT01528254|463248259|FG001|Overall Study|Adverse Event|44|||
128713715|NCT01528254|463248258|FG000|Overall Study|Lost to Follow-up|17|||
128713716|NCT01528254|463248259|FG001|Overall Study|Lost to Follow-up|24|||
128713717|NCT01528254|463248258|FG000|Overall Study|Death|13|||
128713718|NCT01528254|463248259|FG001|Overall Study|Death|9|||
128713719|NCT01528254|463248258|FG000|Overall Study|Protocol deviation|9|||
128713720|NCT01528254|463248259|FG001|Overall Study|Protocol deviation|19|||
128713721|NCT01528254|463248258|FG000|Overall Study|New therapy for study indication|8|||
128713722|NCT01528254|463248259|FG001|Overall Study|New therapy for study indication|6|||
128713723|NCT01528254|463248258|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
128713724|NCT01528254|463248259|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
128713725|NCT01528254|463248258|FG000|Overall Study|Withdrawal by Subject|5|||
128713726|NCT01528254|463248259|FG001|Overall Study|Withdrawal by Subject|4|||
128713727|NCT01528254|463248258|FG000|Overall Study|Abnormal laboratory value(s)|3|||
128713728|NCT01528254|463248259|FG001|Overall Study|Abnormal laboratory value(s)|7|||
128713729|NCT01528254|463248258|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128713730|NCT01528254|463248259|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128713731|NCT01528254|463248258|FG000|Overall Study|No longer requires study drug|1|||
128713732|NCT01528254|463248259|FG001|Overall Study|No longer requires study drug|1|||
128713733|NCT01166763|463248260|FG000|Overall Study|Withdrawal by Subject|3|||
128713734|NCT04339296|463248261|FG000|Overall Study|Refuse to participate after allocation|1|||
128713735|NCT04339296|463248262|FG001|Overall Study|Refuse to participate after allocation|1|||
128713736|NCT04339296|463248261|FG000|Overall Study|Withdrew after completion of baseline|2|||
128713737|NCT04339296|463248262|FG001|Overall Study|Withdrew after completion of baseline|1|||
128713738|NCT04339296|463248261|FG000|Overall Study|Lost to Follow-up|0|||
128713739|NCT04339296|463248262|FG001|Overall Study|Lost to Follow-up|4|||
128713740|NCT04339296|463248261|FG000|Overall Study|Discontinued intervention|5|||
128713741|NCT04339296|463248262|FG001|Overall Study|Discontinued intervention|3|||
128713742|NCT01909479|463248263|FG000|From Baseline to Week 26|Adverse Event|3|||
128771823|NCT00219141|463455400|FG001|Overall Study|Lack of Efficacy|2|||
128713743|NCT01909479|463248264|FG001|From Baseline to Week 26|Adverse Event|2|||
128713744|NCT01909479|463248263|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
128713745|NCT01909479|463248264|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
128713746|NCT01909479|463248263|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
128713747|NCT01909479|463248264|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
128713748|NCT01909479|463248263|FG000|26 - 52 Weeks|Adverse Event|0|||
128713749|NCT01909479|463248264|FG001|26 - 52 Weeks|Adverse Event|1|||
128713750|NCT01909479|463248263|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
128713751|NCT01909479|463248264|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
128713752|NCT01909479|463248263|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
128967452|NCT03799627|464165963|FG008|Overall Study|Kidney Transplantation|0|||
128967453|NCT03799627|464165955|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
128967454|NCT03799627|464165956|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
128967455|NCT03799627|464165957|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
128967456|NCT03799627|464165958|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
128967457|NCT03799627|464165959|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
128967458|NCT03799627|464165960|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
128967459|NCT03799627|464165961|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
128967460|NCT03799627|464165962|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
128967461|NCT03799627|464165963|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
128967462|NCT03799627|464165955|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
128967463|NCT03799627|464165956|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
128967464|NCT03799627|464165957|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
128967465|NCT03799627|464165958|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
128967466|NCT03799627|464165959|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
128967467|NCT03799627|464165960|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
128967468|NCT03799627|464165961|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
128967469|NCT03799627|464165962|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129038009|NCT02400476|464430559|FG000|Overall Study|Other, Decreased Quality of Life|0|||
129038010|NCT02400476|464430560|FG001|Overall Study|Other, Decreased Quality of Life|0|||
129038011|NCT02400476|464430561|FG002|Overall Study|Other, Decreased Quality of Life|2|||
129038012|NCT02400476|464430562|FG003|Overall Study|Other, Decreased Quality of Life|0|||
128713753|NCT01909479|463248264|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
128713754|NCT01909479|463248263|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
128713755|NCT01909479|463248264|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
128713756|NCT01909479|463248263|FG000|52 Weeks to End of Study|Adverse Event|2|||
128713757|NCT01909479|463248264|FG001|52 Weeks to End of Study|Adverse Event|1|||
128713758|NCT01909479|463248263|FG000|52 Weeks to End of Study|Death|0|||
128713759|NCT01909479|463248264|FG001|52 Weeks to End of Study|Death|1|||
128713760|NCT01909479|463248263|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
128713761|NCT01909479|463248264|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
128713762|NCT01909479|463248263|FG000|52 Weeks to End of Study|Protocol Violation|1|||
128713763|NCT01909479|463248264|FG001|52 Weeks to End of Study|Protocol Violation|0|||
128713764|NCT01909479|463248263|FG000|52 Weeks to End of Study|Progressive disease|1|||
128713765|NCT01909479|463248264|FG001|52 Weeks to End of Study|Progressive disease|1|||
128713766|NCT01909479|463248263|FG000|52 Weeks to End of Study|Personal reasons|2|||
128713767|NCT01909479|463248264|FG001|52 Weeks to End of Study|Personal reasons|1|||
128713768|NCT01909479|463248263|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
128713769|NCT01909479|463248264|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
128713770|NCT01909479|463248263|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
128713771|NCT01909479|463248264|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
128713772|NCT01909479|463248263|FG000|52 Weeks to End of Study|Lack of contact|1|||
128713773|NCT01909479|463248264|FG001|52 Weeks to End of Study|Lack of contact|0|||
128713774|NCT01909479|463248263|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
128713775|NCT01909479|463248264|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
128713776|NCT01909479|463248263|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
128713777|NCT01909479|463248264|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
128713778|NCT04446377|463248265|FG000|Overall Study|Withdrawal by Subject|6|||
128713779|NCT04446377|463248266|FG001|Overall Study|Withdrawal by Subject|1|||
128713780|NCT04446377|463248265|FG000|Overall Study|Physician Decision|1|||
128713781|NCT04446377|463248266|FG001|Overall Study|Physician Decision|1|||
128713782|NCT04446377|463248265|FG000|Overall Study|Lost to Follow-up|0|||
128713783|NCT04446377|463248266|FG001|Overall Study|Lost to Follow-up|2|||
128713784|NCT04446377|463248265|FG000|Overall Study|Not eligible|0|||
128713785|NCT04446377|463248266|FG001|Overall Study|Not eligible|1|||
128713786|NCT03557151|463248269|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
128713787|NCT03557151|463248270|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
128713788|NCT03557151|463248269|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
128713789|NCT03557151|463248270|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
128713790|NCT03557151|463248269|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
128713791|NCT03557151|463248270|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
128713792|NCT01414075|463248271|FG000|Overall Study|Adverse Event|1|||
128713793|NCT01414075|463248272|FG001|Overall Study|Adverse Event|0|||
128713794|NCT01414075|463248273|FG002|Overall Study|Adverse Event|1|||
128713795|NCT01414075|463248274|FG003|Overall Study|Adverse Event|0|||
128713796|NCT01414075|463248271|FG000|Overall Study|Death|1|||
128713797|NCT01414075|463248272|FG001|Overall Study|Death|0|||
128713798|NCT01414075|463248273|FG002|Overall Study|Death|0|||
128713799|NCT01414075|463248274|FG003|Overall Study|Death|1|||
128713800|NCT01414075|463248271|FG000|Overall Study|Withdrawal by Subject|0|||
128713801|NCT01414075|463248272|FG001|Overall Study|Withdrawal by Subject|0|||
128713802|NCT01414075|463248273|FG002|Overall Study|Withdrawal by Subject|0|||
128967470|NCT03799627|464165963|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
128967471|NCT03799627|464165955|FG000|Overall Study|Met Exclusion Criteria|0|||
128967472|NCT03799627|464165956|FG001|Overall Study|Met Exclusion Criteria|0|||
128967473|NCT03799627|464165957|FG002|Overall Study|Met Exclusion Criteria|0|||
128967474|NCT03799627|464165958|FG003|Overall Study|Met Exclusion Criteria|1|||
128967475|NCT03799627|464165959|FG004|Overall Study|Met Exclusion Criteria|0|||
128967476|NCT03799627|464165960|FG005|Overall Study|Met Exclusion Criteria|0|||
128967477|NCT03799627|464165961|FG006|Overall Study|Met Exclusion Criteria|0|||
128967478|NCT03799627|464165962|FG007|Overall Study|Met Exclusion Criteria|0|||
128967479|NCT03799627|464165963|FG008|Overall Study|Met Exclusion Criteria|0|||
128967480|NCT03799627|464165955|FG000|Overall Study|Investigational Product Noncompliance|0|||
128967481|NCT03799627|464165956|FG001|Overall Study|Investigational Product Noncompliance|0|||
128967482|NCT03799627|464165957|FG002|Overall Study|Investigational Product Noncompliance|0|||
128967483|NCT03799627|464165958|FG003|Overall Study|Investigational Product Noncompliance|1|||
128967484|NCT03799627|464165959|FG004|Overall Study|Investigational Product Noncompliance|0|||
128967485|NCT03799627|464165960|FG005|Overall Study|Investigational Product Noncompliance|0|||
128967486|NCT03799627|464165961|FG006|Overall Study|Investigational Product Noncompliance|0|||
128967487|NCT03799627|464165962|FG007|Overall Study|Investigational Product Noncompliance|0|||
128967488|NCT03799627|464165963|FG008|Overall Study|Investigational Product Noncompliance|0|||
128967489|NCT03799627|464165955|FG000|Overall Study|Participant Relocation|0|||
128967490|NCT03799627|464165956|FG001|Overall Study|Participant Relocation|0|||
128967491|NCT03799627|464165957|FG002|Overall Study|Participant Relocation|0|||
128967492|NCT03799627|464165958|FG003|Overall Study|Participant Relocation|1|||
128967493|NCT03799627|464165959|FG004|Overall Study|Participant Relocation|0|||
128967494|NCT03799627|464165960|FG005|Overall Study|Participant Relocation|1|||
128967495|NCT03799627|464165961|FG006|Overall Study|Participant Relocation|0|||
128967496|NCT03799627|464165962|FG007|Overall Study|Participant Relocation|0|||
128967497|NCT03799627|464165963|FG008|Overall Study|Participant Relocation|0|||
128967498|NCT03799627|464165955|FG000|Overall Study|Eurofin Issue|0|||
128967499|NCT03799627|464165956|FG001|Overall Study|Eurofin Issue|0|||
128967500|NCT03799627|464165957|FG002|Overall Study|Eurofin Issue|0|||
128967501|NCT03799627|464165958|FG003|Overall Study|Eurofin Issue|0|||
128967502|NCT03799627|464165959|FG004|Overall Study|Eurofin Issue|1|||
128967503|NCT03799627|464165960|FG005|Overall Study|Eurofin Issue|0|||
128967504|NCT03799627|464165961|FG006|Overall Study|Eurofin Issue|0|||
128967505|NCT03799627|464165962|FG007|Overall Study|Eurofin Issue|0|||
128967506|NCT03799627|464165963|FG008|Overall Study|Eurofin Issue|0|||
128967507|NCT03799627|464165955|FG000|Overall Study|Noncompliance with Site Instructions|0|||
128967508|NCT03799627|464165956|FG001|Overall Study|Noncompliance with Site Instructions|0|||
128967509|NCT03799627|464165957|FG002|Overall Study|Noncompliance with Site Instructions|0|||
128967510|NCT03799627|464165958|FG003|Overall Study|Noncompliance with Site Instructions|0|||
128967511|NCT03799627|464165959|FG004|Overall Study|Noncompliance with Site Instructions|1|||
128967512|NCT03799627|464165960|FG005|Overall Study|Noncompliance with Site Instructions|0|||
128967513|NCT03799627|464165961|FG006|Overall Study|Noncompliance with Site Instructions|0|||
128967514|NCT03799627|464165962|FG007|Overall Study|Noncompliance with Site Instructions|0|||
129038013|NCT02400476|464430563|FG004|Overall Study|Other, Decreased Quality of Life|0|||
129038014|NCT02400476|464430564|FG005|Overall Study|Other, Decreased Quality of Life|0|||
128713803|NCT01414075|463248274|FG003|Overall Study|Withdrawal by Subject|1|||
128713804|NCT01414075|463248271|FG000|Overall Study|Other than specified|1|||
128713805|NCT01414075|463248272|FG001|Overall Study|Other than specified|0|||
128771824|NCT00219141|463455401|FG002|Overall Study|Lack of Efficacy|0|||
128771825|NCT00219141|463455399|FG000|Overall Study|Administrative problems|0|||
128713806|NCT01414075|463248273|FG002|Overall Study|Other than specified|1|||
128713807|NCT01414075|463248274|FG003|Overall Study|Other than specified|0|||
128713808|NCT03266094|463248276|FG000|Overall Study|Lost to Follow-up|1|||
128713809|NCT03266094|463248276|FG000|Overall Study|Withdrawal by Subject|1|||
128713810|NCT02081690|463250646|FG000|Overall Study|Death|3|||
128713811|NCT02081690|463250646|FG000|Overall Study|Physician Decision|3|||
128713812|NCT02081690|463250646|FG000|Overall Study|Withdrawal by Subject|1|||
128713813|NCT03204981|463250648|FG000|Overall Study|Physician Decision|2|||
128713814|NCT03204981|463250648|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
128713815|NCT00397982|463250652|FG000|Overall Study|Withdrawal by Subject|1|||
128713816|NCT00397982|463250652|FG000|Overall Study|Adverse Event|1|||
128771826|NCT00219141|463455400|FG001|Overall Study|Administrative problems|1|||
128967515|NCT03799627|464165963|FG008|Overall Study|Noncompliance with Site Instructions|0|||
128967516|NCT03799627|464165955|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
128967517|NCT03799627|464165956|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
128967518|NCT03799627|464165957|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
128967519|NCT03799627|464165958|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129038015|NCT02400476|464430559|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
128713817|NCT00397982|463250652|FG000|Overall Study|noncompliance|1|||
128771827|NCT00219141|463455401|FG002|Overall Study|Administrative problems|0|||
128967520|NCT03799627|464165959|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
128967521|NCT03799627|464165960|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
128967522|NCT03799627|464165961|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
128967523|NCT03799627|464165962|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
128967524|NCT03799627|464165963|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
128967525|NCT03799627|464165955|FG000|Overall Study|Changes In Hemoglobin Values|1|||
128967526|NCT03799627|464165956|FG001|Overall Study|Changes In Hemoglobin Values|2|||
128967527|NCT03799627|464165957|FG002|Overall Study|Changes In Hemoglobin Values|1|||
128967528|NCT03799627|464165958|FG003|Overall Study|Changes In Hemoglobin Values|0|||
128967529|NCT03799627|464165959|FG004|Overall Study|Changes In Hemoglobin Values|0|||
128771828|NCT00219141|463455399|FG000|Overall Study|Lost to Follow-up|2|||
128771829|NCT00219141|463455400|FG001|Overall Study|Lost to Follow-up|4|||
128771830|NCT00219141|463455401|FG002|Overall Study|Lost to Follow-up|1|||
128771831|NCT00219141|463455399|FG000|Overall Study|Protocol Violation|3|||
128771832|NCT00219141|463455400|FG001|Overall Study|Protocol Violation|1|||
128771833|NCT00219141|463455401|FG002|Overall Study|Protocol Violation|1|||
128771834|NCT00219141|463455399|FG000|Overall Study|Withdrawal by Subject|1|||
128771835|NCT00219141|463455400|FG001|Overall Study|Withdrawal by Subject|3|||
128771836|NCT00219141|463455401|FG002|Overall Study|Withdrawal by Subject|5|||
128771837|NCT00219141|463455399|FG000|Overall Study|Condition no longer requires study drug|1|||
128771838|NCT00219141|463455400|FG001|Overall Study|Condition no longer requires study drug|0|||
128771839|NCT00219141|463455401|FG002|Overall Study|Condition no longer requires study drug|0|||
128771840|NCT01088529|463455402|FG000|Overall Study|Did not receive study treatment|0|||
128771841|NCT01088529|463455403|FG001|Overall Study|Did not receive study treatment|1|||
128771842|NCT02838628|463455405|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
128771843|NCT02838628|463455406|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
128771844|NCT02838628|463455405|FG000|Recurrence Follow-up Period|Adverse Event|1|||
128771845|NCT02838628|463455406|FG001|Recurrence Follow-up Period|Adverse Event|0|||
128771846|NCT02838628|463455405|FG000|Recurrence Follow-up Period|Non-compliance|0|||
128771847|NCT02838628|463455406|FG001|Recurrence Follow-up Period|Non-compliance|1|||
128771848|NCT02838628|463455405|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
128771849|NCT02838628|463455406|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
128771850|NCT02838628|463455405|FG000|Recurrence Follow-up Period|Other un-specified|1|||
128771851|NCT02838628|463455406|FG001|Recurrence Follow-up Period|Other un-specified|1|||
128771852|NCT02066532|463455409|FG000|Phase II|Withdrawal by Subject|1|||
128771853|NCT02066532|463455410|FG001|Phase II|Withdrawal by Subject|0|||
128771854|NCT02066532|463455411|FG002|Phase II|Withdrawal by Subject|0|||
128771855|NCT02066532|463455412|FG003|Phase II|Withdrawal by Subject|0|||
128771856|NCT01265823|463455413|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
128771857|NCT01265823|463455413|FG000|Overall Study|Failure to Return|4|||
128771858|NCT01265823|463455413|FG000|Overall Study|Protocol Violation|1|||
128771859|NCT01265823|463455413|FG000|Overall Study|Participant Request|1|||
128771860|NCT01018563|463455418|FG000|Overall Study|Termination of the study by Sponsor|2|||
128771861|NCT01018563|463455419|FG001|Overall Study|Termination of the study by Sponsor|1|||
128771862|NCT00514046|463455423|FG000|Overall Study|transferred to another protocol|2|||
128771863|NCT00514046|463455424|FG001|Overall Study|transferred to another protocol|1|||
128771864|NCT00514046|463455425|FG002|Overall Study|transferred to another protocol|3|||
128771865|NCT00514046|463455426|FG003|Overall Study|transferred to another protocol|0|||
128771866|NCT00514046|463455427|FG004|Overall Study|transferred to another protocol|1|||
128771867|NCT00514046|463455428|FG005|Overall Study|transferred to another protocol|0|||
128771868|NCT00514046|463455429|FG006|Overall Study|transferred to another protocol|0|||
128771869|NCT00514046|463455430|FG007|Overall Study|transferred to another protocol|0|||
128771870|NCT00514046|463455431|FG008|Overall Study|transferred to another protocol|0|||
128771871|NCT00514046|463455423|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
128771872|NCT00514046|463455424|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
128771873|NCT00514046|463455425|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
128771874|NCT00514046|463455426|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
128771875|NCT00514046|463455427|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
128771876|NCT00514046|463455428|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
128771877|NCT00514046|463455429|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
128771878|NCT00514046|463455430|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
128771879|NCT00514046|463455431|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
128771880|NCT00514046|463455423|FG000|Overall Study|Disease progression on study|0|||
128771881|NCT00514046|463455424|FG001|Overall Study|Disease progression on study|0|||
128771882|NCT00514046|463455425|FG002|Overall Study|Disease progression on study|2|||
128771883|NCT00514046|463455426|FG003|Overall Study|Disease progression on study|0|||
128771884|NCT00514046|463455427|FG004|Overall Study|Disease progression on study|0|||
128771885|NCT00514046|463455428|FG005|Overall Study|Disease progression on study|1|||
128771886|NCT00514046|463455429|FG006|Overall Study|Disease progression on study|0|||
128967530|NCT03799627|464165960|FG005|Overall Study|Changes In Hemoglobin Values|2|||
128967531|NCT03799627|464165961|FG006|Overall Study|Changes In Hemoglobin Values|1|||
128771887|NCT00514046|463455430|FG007|Overall Study|Disease progression on study|0|||
128771888|NCT00514046|463455431|FG008|Overall Study|Disease progression on study|0|||
128771889|NCT00383240|463455433|FG000|Overall Study|Adverse Event|4|||
128771890|NCT00383240|463455434|FG001|Overall Study|Adverse Event|6|||
128771891|NCT00383240|463455435|FG002|Overall Study|Adverse Event|9|||
128771892|NCT00383240|463455436|FG003|Overall Study|Adverse Event|7|||
128771893|NCT00383240|463455433|FG000|Overall Study|Treatment Failure|8|||
128771894|NCT00383240|463455434|FG001|Overall Study|Treatment Failure|13|||
128771895|NCT00383240|463455435|FG002|Overall Study|Treatment Failure|47|||
128771896|NCT00383240|463455436|FG003|Overall Study|Treatment Failure|46|||
128771897|NCT00383240|463455433|FG000|Overall Study|Lost to Follow-up|3|||
128771898|NCT00383240|463455434|FG001|Overall Study|Lost to Follow-up|0|||
128771899|NCT00383240|463455435|FG002|Overall Study|Lost to Follow-up|0|||
128771900|NCT00383240|463455436|FG003|Overall Study|Lost to Follow-up|2|||
128771901|NCT00383240|463455433|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
128771902|NCT00383240|463455434|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
128771903|NCT00383240|463455435|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
128771904|NCT00383240|463455436|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
128771905|NCT00383240|463455433|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
128771906|NCT00383240|463455434|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
128771907|NCT00383240|463455435|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
128771908|NCT00383240|463455436|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
128771909|NCT00383240|463455433|FG000|Overall Study|Protocol Violation|4|||
128771910|NCT00383240|463455434|FG001|Overall Study|Protocol Violation|5|||
128771911|NCT00383240|463455435|FG002|Overall Study|Protocol Violation|9|||
128771912|NCT00383240|463455436|FG003|Overall Study|Protocol Violation|6|||
128771913|NCT00383240|463455433|FG000|Overall Study|Did not meet protocol eligibility|9|||
128771914|NCT00383240|463455434|FG001|Overall Study|Did not meet protocol eligibility|4|||
128771915|NCT00383240|463455435|FG002|Overall Study|Did not meet protocol eligibility|9|||
128771916|NCT00383240|463455436|FG003|Overall Study|Did not meet protocol eligibility|3|||
128771917|NCT00383240|463455433|FG000|Overall Study|Administrative|1|||
128771918|NCT00383240|463455434|FG001|Overall Study|Administrative|1|||
128771919|NCT00383240|463455435|FG002|Overall Study|Administrative|0|||
128771920|NCT00383240|463455436|FG003|Overall Study|Administrative|0|||
128771921|NCT02023879|463455440|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
128771922|NCT02023879|463455441|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
128771923|NCT02023879|463455442|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
128771924|NCT02023879|463455440|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
128771925|NCT02023879|463455441|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
128771926|NCT02023879|463455442|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
128771927|NCT02023879|463455440|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
128771928|NCT02023879|463455441|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
128771929|NCT02023879|463455442|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
128771930|NCT02023879|463455440|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
128771931|NCT02023879|463455441|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
128771932|NCT02023879|463455442|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
128771933|NCT02023879|463455440|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
128771934|NCT02023879|463455441|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
128771935|NCT02023879|463455442|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
128771936|NCT02023879|463455440|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
128771937|NCT02023879|463455441|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
128771938|NCT02023879|463455442|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
128771939|NCT02023879|463455440|FG000|Extension Open Label Treatment|Adverse Event|1|||
128771940|NCT02023879|463455441|FG001|Extension Open Label Treatment|Adverse Event|7|||
128771941|NCT02023879|463455442|FG002|Extension Open Label Treatment|Adverse Event|3|||
128771942|NCT02023879|463455440|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
128771943|NCT02023879|463455441|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
128771944|NCT02023879|463455442|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
128771945|NCT02023879|463455440|FG000|Extension Open Label Treatment|Participant moved|1|||
128771946|NCT02023879|463455441|FG001|Extension Open Label Treatment|Participant moved|2|||
128771947|NCT02023879|463455442|FG002|Extension Open Label Treatment|Participant moved|0|||
128771948|NCT02023879|463455440|FG000|Extension Open Label Treatment|Other than specified above|2|||
128771949|NCT02023879|463455441|FG001|Extension Open Label Treatment|Other than specified above|7|||
128771950|NCT02023879|463455442|FG002|Extension Open Label Treatment|Other than specified above|2|||
128771951|NCT02924389|463455443|FG000|Overall Study|Lost to Follow-up|1|||
128771952|NCT02924389|463455444|FG001|Overall Study|Lost to Follow-up|0|||
128771953|NCT02924389|463455443|FG000|Overall Study|Physician Decision|2|||
128771954|NCT02924389|463455444|FG001|Overall Study|Physician Decision|0|||
128771955|NCT02924389|463455443|FG000|Overall Study|Withdrawal by Subject|3|||
128771956|NCT02924389|463455444|FG001|Overall Study|Withdrawal by Subject|0|||
128771957|NCT02924389|463455443|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
128771958|NCT02924389|463455444|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
128771959|NCT03918239|463457650|FG000|Overall Study|Lost to Follow-up|3|||
128771960|NCT03918239|463457651|FG001|Overall Study|Lost to Follow-up|1|||
128771961|NCT03918239|463457650|FG000|Overall Study|Pregnancy|0|||
128771962|NCT03918239|463457651|FG001|Overall Study|Pregnancy|2|||
128771963|NCT03918239|463457650|FG000|Overall Study|Withdrawal by Subject|3|||
128771964|NCT03918239|463457651|FG001|Overall Study|Withdrawal by Subject|3|||
128771965|NCT03918239|463457650|FG000|Overall Study|positive urine drug screening results|4|||
128771966|NCT03918239|463457651|FG001|Overall Study|positive urine drug screening results|1|||
128771967|NCT00593554|463457655|FG000|Overall Study|Death|1|||
128771968|NCT00593554|463457656|FG001|Overall Study|Death|2|||
128771969|NCT00593554|463457655|FG000|Overall Study|Physician Decision|0|||
128771970|NCT00593554|463457656|FG001|Overall Study|Physician Decision|1|||
128771971|NCT00593554|463457655|FG000|Overall Study|Withdrawal by Subject|1|||
128771972|NCT00593554|463457656|FG001|Overall Study|Withdrawal by Subject|0|||
128771973|NCT00593554|463457655|FG000|Overall Study|Disease Progression|1|||
128771974|NCT00593554|463457656|FG001|Overall Study|Disease Progression|2|||
128771975|NCT01024959|463457660|FG000|Overall Study|ineligible|12|||
128771976|NCT01024959|463457660|FG000|Overall Study|results not evaluable|12|||
128771977|NCT01024959|463457660|FG000|Overall Study|missing results required for analysis|17|||
128771978|NCT00636792|463457661|FG000|Overall Study|Adverse Event|16|||
128771979|NCT00636792|463457661|FG000|Overall Study|Physician Decision|7|||
128771980|NCT00636792|463457661|FG000|Overall Study|Progressive Disease|4|||
128771981|NCT00636792|463457661|FG000|Overall Study|Withdrawal by Subject|3|||
128771982|NCT00636792|463457661|FG000|Overall Study|Other|3|||
128771983|NCT01987596|463457664|FG000|Overall Study|Physician Decision|1|||
128771984|NCT01987596|463457665|FG001|Overall Study|Physician Decision|0|||
128771985|NCT01987596|463457664|FG000|Overall Study|Progressive Disease; missing all period|0|||
128771986|NCT01987596|463457665|FG001|Overall Study|Progressive Disease; missing all period|1|||
128771987|NCT00709592|463457666|FG000|Overall Study|Unable to proceed to transplant|0|||
128771988|NCT00709592|463457667|FG001|Overall Study|Unable to proceed to transplant|1|||
128771989|NCT01129336|463457668|FG000|Overall Study|Protocol Violation|1|||
128771990|NCT01129336|463457669|FG001|Overall Study|Protocol Violation|0|||
128771991|NCT01129336|463457668|FG000|Overall Study|Disease Progression|1|||
128771992|NCT01129336|463457669|FG001|Overall Study|Disease Progression|4|||
128771993|NCT01129336|463457668|FG000|Overall Study|Lost to Follow-up|1|||
128771994|NCT01129336|463457669|FG001|Overall Study|Lost to Follow-up|0|||
128771995|NCT01129336|463457668|FG000|Overall Study|Withdrawal by Subject|7|||
128771996|NCT01129336|463457669|FG001|Overall Study|Withdrawal by Subject|4|||
128771997|NCT01129336|463457668|FG000|Overall Study|Adverse Event|0|||
128771998|NCT01129336|463457669|FG001|Overall Study|Adverse Event|1|||
128771999|NCT01129336|463457668|FG000|Overall Study|Missing Study Completion Status|2|||
128772000|NCT01129336|463457669|FG001|Overall Study|Missing Study Completion Status|3|||
128772001|NCT01129336|463457668|FG000|Overall Study|Death|0|||
128772002|NCT01129336|463457669|FG001|Overall Study|Death|4|||
128772003|NCT00358150|463457670|FG000|Overall Study|Adverse Event|3|||
128772004|NCT00358150|463457670|FG000|Overall Study|Withdrawal by Subject|1|||
128772005|NCT00358150|463457670|FG000|Overall Study|Undefined|3|||
128772006|NCT04668989|463457671|FG000|First Intervention|Covid-19 related self-isolation|0|||
128772007|NCT04668989|463457672|FG001|First Intervention|Covid-19 related self-isolation|1|||
128772008|NCT04668989|463457671|FG000|Second Intervention|Adverse Event|0|||
128772009|NCT04668989|463457672|FG001|Second Intervention|Adverse Event|1|||
128772010|NCT00179010|463457676|FG000|Overall Study|Muscle probe defective|1|||
128772011|NCT00179010|463457677|FG001|Overall Study|Muscle probe defective|1|||
128772012|NCT00179010|463457676|FG000|Overall Study|Failure to place arterial line|0|||
128772013|NCT00179010|463457677|FG001|Overall Study|Failure to place arterial line|1|||
128772014|NCT01622348|463457678|FG000|Overall Study|Withdrawal by Subject|1|||
128772015|NCT01622348|463457679|FG001|Overall Study|Withdrawal by Subject|0|||
129038016|NCT02400476|464430560|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
128772016|NCT01622348|463457680|FG002|Overall Study|Withdrawal by Subject|1|||
128772017|NCT01592695|463457689|FG000|Overall Study|Lost to Follow-up|8|||
129038017|NCT02400476|464430561|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
128772018|NCT01592695|463457690|FG001|Overall Study|Lost to Follow-up|4|||
128772019|NCT00919893|463457697|FG000|Overall Study|Protocol Violation|19|||
128772020|NCT00919893|463457698|FG001|Overall Study|Protocol Violation|9|||
128772021|NCT01375959|463457704|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
128772022|NCT01375959|463457705|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
128772023|NCT01375959|463457704|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
128772024|NCT01375959|463457705|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
128772025|NCT01375959|463457704|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
128772026|NCT01375959|463457705|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
128772027|NCT00178256|463457706|FG000|Overall Study|Adverse Event|2|||
128772028|NCT00178256|463457707|FG001|Overall Study|Adverse Event|0|||
128713818|NCT00397982|463250652|FG000|Overall Study|Unrelated health issues|1|||
128713819|NCT02734810|463250655|FG000|Overall Study|Adverse Event|1|||
128713820|NCT02734810|463250656|FG001|Overall Study|Adverse Event|0|||
128713821|NCT02734810|463250655|FG000|Overall Study|Lack of Efficacy|1|||
128713822|NCT02734810|463250656|FG001|Overall Study|Lack of Efficacy|0|||
128713823|NCT00488345|463250657|FG000|Overall Study|Adverse Event|0|||
128713824|NCT00488345|463250658|FG001|Overall Study|Adverse Event|1|||
128713825|NCT00488345|463250659|FG002|Overall Study|Adverse Event|1|||
128713826|NCT00488345|463250657|FG000|Overall Study|Unable to administer antibiotics at home|0|||
128713827|NCT00488345|463250658|FG001|Overall Study|Unable to administer antibiotics at home|1|||
128713828|NCT00488345|463250659|FG002|Overall Study|Unable to administer antibiotics at home|0|||
128713829|NCT00488345|463250657|FG000|Overall Study|Institutional Review Board review|0|||
128713830|NCT00488345|463250658|FG001|Overall Study|Institutional Review Board review|0|||
128713831|NCT00488345|463250659|FG002|Overall Study|Institutional Review Board review|1|||
128713832|NCT00488345|463250657|FG000|Overall Study|Surgical team recommendation|0|||
128713833|NCT00488345|463250658|FG001|Overall Study|Surgical team recommendation|1|||
128713834|NCT00488345|463250659|FG002|Overall Study|Surgical team recommendation|0|||
128713835|NCT00488345|463250657|FG000|Overall Study|Parent/legal guardian request|0|||
128713836|NCT00488345|463250658|FG001|Overall Study|Parent/legal guardian request|1|||
128713837|NCT00488345|463250659|FG002|Overall Study|Parent/legal guardian request|1|||
128713838|NCT01104636|463250665|FG000|Overall Study|Lack of Efficacy|43|||
128713839|NCT01104636|463250665|FG000|Overall Study|Lost to Follow-up|24|||
128713840|NCT01104636|463250665|FG000|Overall Study|Withdrawal by Subject|4|||
128713841|NCT01104636|463250665|FG000|Overall Study|Other|43|||
128713842|NCT01104636|463250665|FG000|Overall Study|Study terminated by sponsor|1|||
128713843|NCT01104636|463250665|FG000|Overall Study|Pregnancy|2|||
128713844|NCT01104636|463250665|FG000|Overall Study|Adverse Event|40|||
128713845|NCT01104636|463250665|FG000|Overall Study|Ongoing|21|||
128713846|NCT01706003|463250666|FG000|Overall Study|Withdrawal by Subject|2|||
128713847|NCT01706003|463250667|FG001|Overall Study|Withdrawal by Subject|0|||
128713848|NCT01706003|463250666|FG000|Overall Study|Not scheduled|3|||
128713849|NCT01706003|463250667|FG001|Overall Study|Not scheduled|0|||
128713850|NCT01706003|463250666|FG000|Overall Study|Lost to Follow-up|6|||
128713851|NCT01706003|463250667|FG001|Overall Study|Lost to Follow-up|4|||
128713852|NCT00407563|463250668|FG000|Overall Study|Patient continues on treatment|1|||
128713853|NCT03055260|463250669|FG000|Overall Study|Withdrawal by Subject|1|||
128713854|NCT03055260|463250670|FG001|Overall Study|Withdrawal by Subject|0|||
128713855|NCT00592839|463250671|FG000|Overall Study|Withdrawal by Subject|1|||
128713856|NCT00592839|463250672|FG001|Overall Study|Withdrawal by Subject|1|||
128713857|NCT00592839|463250673|FG002|Overall Study|Withdrawal by Subject|3|||
128713858|NCT00592839|463250671|FG000|Overall Study|Protocol Violation|1|||
128713859|NCT00592839|463250672|FG001|Overall Study|Protocol Violation|1|||
128713860|NCT00592839|463250673|FG002|Overall Study|Protocol Violation|2|||
128713861|NCT00592839|463250671|FG000|Overall Study|Adverse Event|0|||
128713862|NCT00592839|463250672|FG001|Overall Study|Adverse Event|1|||
128713863|NCT00592839|463250673|FG002|Overall Study|Adverse Event|0|||
128713864|NCT00592839|463250671|FG000|Overall Study|Lost to Follow-up|0|||
128713865|NCT00592839|463250672|FG001|Overall Study|Lost to Follow-up|1|||
128713866|NCT00592839|463250673|FG002|Overall Study|Lost to Follow-up|1|||
128713867|NCT00249444|463250679|FG000|Overall Study|Lost to Follow-up|2|||
128713868|NCT00249444|463250680|FG001|Overall Study|Lost to Follow-up|2|||
128713869|NCT00249444|463250679|FG000|Overall Study|non-compliant|9|||
128713870|NCT00249444|463250680|FG001|Overall Study|non-compliant|11|||
128713871|NCT00249444|463250679|FG000|Overall Study|Adverse Event|1|||
128713872|NCT00249444|463250680|FG001|Overall Study|Adverse Event|1|||
128713873|NCT00249444|463250679|FG000|Overall Study|life event|0|||
128713874|NCT00249444|463250680|FG001|Overall Study|life event|1|||
128713875|NCT00936910|463250683|FG000|Overall Study|Lack of Efficacy|3|||
128713876|NCT00412854|463250684|FG000|Overall Study|Withdrawn due to adverse events|1|||
128713877|NCT00412854|463250685|FG001|Overall Study|Withdrawn due to adverse events|5|||
128713878|NCT00412854|463250684|FG000|Overall Study|Withdrawn for other reasons|13|||
128713879|NCT00412854|463250685|FG001|Overall Study|Withdrawn for other reasons|11|||
128713880|NCT04483011|463250689|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
128713881|NCT04483011|463250690|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
128713882|NCT03518073|463250691|FG000|Overall Study|Adverse Event|2|||
128713883|NCT03518073|463250692|FG001|Overall Study|Adverse Event|4|||
128713884|NCT03518073|463250693|FG002|Overall Study|Adverse Event|2|||
128713885|NCT03518073|463250691|FG000|Overall Study|Death|2|||
128967532|NCT03799627|464165962|FG007|Overall Study|Changes In Hemoglobin Values|0|||
128967533|NCT03799627|464165963|FG008|Overall Study|Changes In Hemoglobin Values|1|||
128713886|NCT03518073|463250692|FG001|Overall Study|Death|1|||
128713887|NCT03518073|463250693|FG002|Overall Study|Death|3|||
128713888|NCT03518073|463250691|FG000|Overall Study|Lost to Follow-up|1|||
128967534|NCT01922739|464165966|FG000|Titration/Adjustment Period|Adverse Event|3|||
128713889|NCT03518073|463250692|FG001|Overall Study|Lost to Follow-up|0|||
128713890|NCT03518073|463250693|FG002|Overall Study|Lost to Follow-up|1|||
128713891|NCT03518073|463250691|FG000|Overall Study|Physician Decision|5|||
128772029|NCT00178256|463457708|FG002|Overall Study|Adverse Event|0|||
128772030|NCT00178256|463457709|FG003|Overall Study|Adverse Event|0|||
128772031|NCT00178256|463457706|FG000|Overall Study|Death|0|||
128772032|NCT00178256|463457707|FG001|Overall Study|Death|1|||
128772033|NCT00178256|463457708|FG002|Overall Study|Death|0|||
128772034|NCT00178256|463457709|FG003|Overall Study|Death|1|||
128772035|NCT00178256|463457706|FG000|Overall Study|Cancer progression|2|||
128967535|NCT01922739|464165966|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
128967536|NCT01922739|464165966|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
128967537|NCT01922739|464165966|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
128967538|NCT01922739|464165966|FG000|Open-label Treatment Period|Adverse Event|6|||
128967539|NCT01922739|464165966|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
128967540|NCT01922739|464165966|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
128967541|NCT01922739|464165966|FG000|Open-label Treatment Period|Protocol Violation|5|||
128967542|NCT01922739|464165966|FG000|Open-label Treatment Period|Pregnancy|1|||
128967543|NCT01922739|464165966|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
128967544|NCT01922739|464165966|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
128967545|NCT01922739|464165966|FG000|Open-label Treatment Period|Physician Decision|1|||
128967546|NCT01922739|464165966|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
128772036|NCT00178256|463457707|FG001|Overall Study|Cancer progression|0|||
128772037|NCT00178256|463457708|FG002|Overall Study|Cancer progression|0|||
128772038|NCT00178256|463457709|FG003|Overall Study|Cancer progression|1|||
128772039|NCT01763788|463457710|FG000|Overall Study|Lost to Follow-up|0|||
128772040|NCT01763788|463457711|FG001|Overall Study|Lost to Follow-up|0|||
128772041|NCT01763788|463457712|FG002|Overall Study|Lost to Follow-up|1|||
128772042|NCT01763788|463457713|FG003|Overall Study|Lost to Follow-up|0|||
128772043|NCT03893825|463457714|FG000|Overall Study|Death|2|||
128772044|NCT03893825|463457715|FG001|Overall Study|Death|1|||
128772045|NCT03893825|463457714|FG000|Overall Study|Adverse Event|0|||
128772046|NCT03893825|463457715|FG001|Overall Study|Adverse Event|2|||
128772047|NCT03893825|463457714|FG000|Overall Study|Withdrawal by Subject|19|||
128772048|NCT03893825|463457715|FG001|Overall Study|Withdrawal by Subject|21|||
128772049|NCT03893825|463457714|FG000|Overall Study|Protocol deviation|1|||
128772050|NCT03893825|463457715|FG001|Overall Study|Protocol deviation|0|||
128772051|NCT03893825|463457714|FG000|Overall Study|Lost to Follow-up|10|||
128772052|NCT03893825|463457715|FG001|Overall Study|Lost to Follow-up|10|||
128772053|NCT03893825|463457714|FG000|Overall Study|Other than specified|7|||
128772054|NCT03893825|463457715|FG001|Overall Study|Other than specified|6|||
128772055|NCT02086552|463457718|FG000|Overall Study|Withdrawal by Subject|1|||
128772056|NCT00708305|463457719|FG000|Period 1|Protocol Violation|1|||
128772057|NCT00708305|463457720|FG001|Period 1|Protocol Violation|0|||
128772058|NCT00708305|463457721|FG002|Period 1|Protocol Violation|1|||
128772059|NCT00708305|463457722|FG003|Period 1|Protocol Violation|0|||
128772060|NCT00708305|463457719|FG000|Period 1|Other Reason|0|||
128772061|NCT00708305|463457720|FG001|Period 1|Other Reason|0|||
128772062|NCT00708305|463457721|FG002|Period 1|Other Reason|0|||
128772063|NCT00708305|463457722|FG003|Period 1|Other Reason|2|||
128772064|NCT00708305|463457719|FG000|Period 2|Lost to Follow-up|0|||
128772065|NCT00708305|463457720|FG001|Period 2|Lost to Follow-up|1|||
128772066|NCT00708305|463457721|FG002|Period 2|Lost to Follow-up|0|||
128772067|NCT00708305|463457722|FG003|Period 2|Lost to Follow-up|0|||
128772068|NCT00708305|463457719|FG000|Period 2|Protocol Violation|0|||
128772069|NCT00708305|463457720|FG001|Period 2|Protocol Violation|1|||
128772070|NCT00708305|463457721|FG002|Period 2|Protocol Violation|0|||
128772071|NCT00708305|463457722|FG003|Period 2|Protocol Violation|0|||
128772072|NCT00708305|463457719|FG000|Period 2|Other Reason|1|||
128772073|NCT00708305|463457720|FG001|Period 2|Other Reason|0|||
128772074|NCT00708305|463457721|FG002|Period 2|Other Reason|0|||
128772075|NCT00708305|463457722|FG003|Period 2|Other Reason|1|||
128772076|NCT00708305|463457719|FG000|Period 3|Protocol Violation|0|||
128772077|NCT00708305|463457720|FG001|Period 3|Protocol Violation|2|||
128772078|NCT00708305|463457721|FG002|Period 3|Protocol Violation|0|||
128772079|NCT00708305|463457722|FG003|Period 3|Protocol Violation|0|||
128772080|NCT00708305|463457719|FG000|Period 3|Other Reason|1|||
128772081|NCT00708305|463457720|FG001|Period 3|Other Reason|0|||
128772082|NCT00708305|463457721|FG002|Period 3|Other Reason|0|||
128772083|NCT00708305|463457722|FG003|Period 3|Other Reason|0|||
128772084|NCT02771210|463457727|FG000|Period 1|Adverse Event|5|||
128772085|NCT02771210|463457728|FG001|Period 1|Adverse Event|3|||
128772086|NCT02771210|463457727|FG000|Period 1|Lack of Efficacy|3|||
128772087|NCT02771210|463457728|FG001|Period 1|Lack of Efficacy|6|||
128772088|NCT02771210|463457727|FG000|Period 1|Lost to Follow-up|2|||
128772089|NCT02771210|463457728|FG001|Period 1|Lost to Follow-up|0|||
128772090|NCT02771210|463457727|FG000|Period 1|Physician Decision|0|||
128772091|NCT02771210|463457728|FG001|Period 1|Physician Decision|1|||
128772092|NCT02771210|463457727|FG000|Period 1|Withdrawal by Subject|0|||
128772093|NCT02771210|463457728|FG001|Period 1|Withdrawal by Subject|3|||
128772094|NCT02771210|463457727|FG000|Period 1|Withdrawal of informed consent|1|||
128772095|NCT02771210|463457728|FG001|Period 1|Withdrawal of informed consent|5|||
128772096|NCT02771210|463457727|FG000|Period 2|Adverse Event|1|||
128772097|NCT02771210|463457728|FG001|Period 2|Adverse Event|0|||
128772098|NCT02771210|463457727|FG000|Period 2|Lack of Efficacy|0|||
128772099|NCT02771210|463457728|FG001|Period 2|Lack of Efficacy|1|||
128772100|NCT02771210|463457727|FG000|Period 2|Withdrawal by Subject|1|||
128772101|NCT02771210|463457728|FG001|Period 2|Withdrawal by Subject|0|||
128772102|NCT02771210|463457727|FG000|Period 2|Withdrawal of informed consent|0|||
128772103|NCT02771210|463457728|FG001|Period 2|Withdrawal of informed consent|2|||
128772104|NCT04012814|463457731|FG000|Overall Study|Lost to Follow-up|4|||
128772105|NCT04012814|463457731|FG000|Overall Study|Withdrawal by Subject|2|||
128772106|NCT04012814|463457731|FG000|Overall Study|Protocol Violation|1|||
128772107|NCT04012814|463457731|FG000|Overall Study|Adverse Event|1|||
128772108|NCT04397523|463457732|FG000|Overall Study|Lost to Follow-up|3|||
128772109|NCT04397523|463457732|FG000|Overall Study|Transfer from/to other hospital|8|||
128772110|NCT01275196|463457733|FG000|Overall Study|Adverse Event|3|||
128772111|NCT01275196|463457734|FG001|Overall Study|Adverse Event|5|||
128772112|NCT01275196|463457733|FG000|Overall Study|Withdrawal by Subject|4|||
128772113|NCT01275196|463457734|FG001|Overall Study|Withdrawal by Subject|5|||
128772114|NCT01275196|463457733|FG000|Overall Study|Lost to Follow-up|1|||
128772115|NCT01275196|463457734|FG001|Overall Study|Lost to Follow-up|0|||
128772116|NCT01275196|463457733|FG000|Overall Study|Disease Progression|6|||
128772117|NCT01275196|463457734|FG001|Overall Study|Disease Progression|5|||
128772118|NCT01275196|463457733|FG000|Overall Study|Protocol Violation|1|||
128772119|NCT01275196|463457734|FG001|Overall Study|Protocol Violation|0|||
128772120|NCT01275196|463457733|FG000|Overall Study|Suboptimal response/treatment failure|5|||
128772121|NCT01275196|463457734|FG001|Overall Study|Suboptimal response/treatment failure|6|||
128772122|NCT00684762|463457760|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
128772123|NCT00684762|463457761|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
128772124|NCT02572817|463457762|FG000|Overall Study|Death|6|||
128772125|NCT02572817|463457763|FG001|Overall Study|Death|3|||
128772126|NCT02572817|463457762|FG000|Overall Study|Lost to Follow-up|3|||
128772127|NCT02572817|463457763|FG001|Overall Study|Lost to Follow-up|3|||
128772128|NCT02441946|463457766|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
128772129|NCT02441946|463457767|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
128772130|NCT02441946|463457768|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
128772131|NCT02441946|463457766|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
128772132|NCT02441946|463457767|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
128772133|NCT02441946|463457768|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
128772134|NCT02441946|463457766|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
128772135|NCT02441946|463457767|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
128772136|NCT02441946|463457768|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
128772137|NCT02441946|463457766|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
128772138|NCT02441946|463457767|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
128772139|NCT02441946|463457768|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
128772140|NCT02441946|463457766|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
128772141|NCT02441946|463457767|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
128772142|NCT02441946|463457768|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
128772143|NCT02441946|463457766|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
128772144|NCT02441946|463457767|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
128772145|NCT02441946|463457768|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
128967547|NCT00441012|464165969|FG000|Overall Study|Adverse Event|0|||
128967548|NCT00441012|464165970|FG001|Overall Study|Adverse Event|1|||
128967549|NCT00441012|464165969|FG000|Overall Study|Lost to Follow-up|3|||
128967550|NCT00441012|464165970|FG001|Overall Study|Lost to Follow-up|3|||
128772146|NCT02441946|463457766|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
128772147|NCT02441946|463457767|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
128772148|NCT02441946|463457768|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
128772149|NCT02441946|463457766|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
128772150|NCT02441946|463457767|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
128772151|NCT02441946|463457768|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
128772152|NCT02441946|463457766|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
128772153|NCT02441946|463457767|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
128772154|NCT02441946|463457768|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
128772155|NCT02441946|463457766|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
128772156|NCT02441946|463457767|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
128772157|NCT02441946|463457768|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
128772158|NCT02441946|463457766|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
128772159|NCT02441946|463457767|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
128772160|NCT02441946|463457768|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
128772161|NCT02111213|463457769|FG000|Overall Study|Withdrawal by Subject|3|||
128967551|NCT00441012|464165969|FG000|Overall Study|Protocol Violation|10|||
128967552|NCT00441012|464165970|FG001|Overall Study|Protocol Violation|9|||
128967553|NCT00441012|464165969|FG000|Overall Study|Withdrawal by Subject|4|||
128772162|NCT02111213|463457770|FG001|Overall Study|Withdrawal by Subject|2|||
128772163|NCT02111213|463457769|FG000|Overall Study|Lost to Follow-up|3|||
128772164|NCT02111213|463457770|FG001|Overall Study|Lost to Follow-up|4|||
128713892|NCT03518073|463250692|FG001|Overall Study|Physician Decision|0|||
128713893|NCT03518073|463250693|FG002|Overall Study|Physician Decision|2|||
128713894|NCT03518073|463250691|FG000|Overall Study|Progressive disease|1|||
128713895|NCT03518073|463250692|FG001|Overall Study|Progressive disease|1|||
128713896|NCT03518073|463250693|FG002|Overall Study|Progressive disease|1|||
128713897|NCT03518073|463250691|FG000|Overall Study|Protocol Violation|1|||
128713898|NCT03518073|463250692|FG001|Overall Study|Protocol Violation|0|||
128713899|NCT03518073|463250693|FG002|Overall Study|Protocol Violation|0|||
128713900|NCT03518073|463250691|FG000|Overall Study|Withdrawal by Subject|30|||
128713901|NCT03518073|463250692|FG001|Overall Study|Withdrawal by Subject|34|||
128713902|NCT03518073|463250693|FG002|Overall Study|Withdrawal by Subject|29|||
128713903|NCT03518073|463250691|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
128713904|NCT03518073|463250692|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
128713905|NCT03518073|463250693|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
128713906|NCT03518073|463250691|FG000|Overall Study|Covid-19|1|||
128713907|NCT03518073|463250692|FG001|Overall Study|Covid-19|2|||
128713908|NCT03518073|463250693|FG002|Overall Study|Covid-19|1|||
128713909|NCT03045081|463250694|FG000|Overall Study|Withdrawal by Subject|6|||
128713910|NCT03045081|463250695|FG001|Overall Study|Withdrawal by Subject|11|||
128713911|NCT01485640|463250696|FG000|Overall Study|Adverse Event|10|||
128713912|NCT01485640|463250696|FG000|Overall Study|Lack of Efficacy|2|||
128713913|NCT01485640|463250696|FG000|Overall Study|Protocol Violation|1|||
128713914|NCT01485640|463250696|FG000|Overall Study|Withdrawal by Subject|14|||
128713915|NCT01485640|463250696|FG000|Overall Study|Terminated by Sponsor|95|||
128713916|NCT01853046|463250697|FG000|Overall Study|Withdrawal by Subject|1|||
128713917|NCT01853046|463250698|FG001|Overall Study|Withdrawal by Subject|1|||
128713918|NCT01853046|463250697|FG000|Overall Study|Adverse Event|4|||
128713919|NCT01853046|463250698|FG001|Overall Study|Adverse Event|2|||
128713920|NCT01853046|463250697|FG000|Overall Study|Disease progression|13|||
128713921|NCT01853046|463250698|FG001|Overall Study|Disease progression|3|||
128713922|NCT02057198|463250704|FG000|Overall Study|Death|0|||
128713923|NCT02057198|463250705|FG001|Overall Study|Death|0|||
128713924|NCT02057198|463250706|FG002|Overall Study|Death|1|||
128713925|NCT02057198|463250704|FG000|Overall Study|Discharged early; lost to followup|0|||
128713926|NCT02057198|463250705|FG001|Overall Study|Discharged early; lost to followup|1|||
128713927|NCT02057198|463250706|FG002|Overall Study|Discharged early; lost to followup|0|||
128713928|NCT02489344|463250711|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
128713929|NCT02489344|463250711|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
128713930|NCT02489344|463250711|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
128713931|NCT02489344|463250711|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
128713932|NCT01119131|463250714|FG000|Overall Study|Adverse Event|1|||
128713933|NCT01119131|463250715|FG001|Overall Study|Adverse Event|1|||
128713934|NCT01119131|463250716|FG002|Overall Study|Adverse Event|1|||
128713935|NCT01119131|463250714|FG000|Overall Study|Non-Compliance|1|||
128713936|NCT01119131|463250715|FG001|Overall Study|Non-Compliance|0|||
128713937|NCT01119131|463250716|FG002|Overall Study|Non-Compliance|4|||
128713938|NCT01119131|463250714|FG000|Overall Study|Physician Decision|0|||
128713939|NCT01119131|463250715|FG001|Overall Study|Physician Decision|0|||
128713940|NCT01119131|463250716|FG002|Overall Study|Physician Decision|1|||
128713941|NCT00737282|463250720|FG000|Overall Study|Study prematurely terminated|175|||
128713942|NCT02810392|463250722|FG000|Overall Study|Subject too ill to continue|1|||
128713943|NCT02810392|463250723|FG001|Overall Study|Subject too ill to continue|0|||
128713944|NCT02810392|463250722|FG000|Overall Study|COVID 19 research restrictions|0|||
128713945|NCT02810392|463250723|FG001|Overall Study|COVID 19 research restrictions|1|||
128713946|NCT00840294|463250724|FG000|Overall Study|Withdrawal by Subject|2|||
128713947|NCT00840294|463250725|FG001|Overall Study|Withdrawal by Subject|1|||
128713948|NCT00840294|463250724|FG000|Overall Study|Protocol Violation|1|||
128713949|NCT00840294|463250725|FG001|Overall Study|Protocol Violation|3|||
128713950|NCT00840294|463250724|FG000|Overall Study|Illness|0|||
128713951|NCT00840294|463250725|FG001|Overall Study|Illness|1|||
128713952|NCT01187043|463250726|FG000|Overall Study|Adverse Event|0|||
128713953|NCT01187043|463250727|FG001|Overall Study|Adverse Event|0|||
128713954|NCT01187043|463250728|FG002|Overall Study|Adverse Event|0|||
128713955|NCT01187043|463250729|FG003|Overall Study|Adverse Event|0|||
128713956|NCT01187043|463250730|FG004|Overall Study|Adverse Event|1|||
128713957|NCT01187043|463250726|FG000|Overall Study|Unable to make scheduled visits|1|||
128713958|NCT01187043|463250727|FG001|Overall Study|Unable to make scheduled visits|0|||
128713959|NCT01187043|463250728|FG002|Overall Study|Unable to make scheduled visits|4|||
128713960|NCT01187043|463250729|FG003|Overall Study|Unable to make scheduled visits|0|||
128713961|NCT01187043|463250730|FG004|Overall Study|Unable to make scheduled visits|1|||
128713962|NCT03198234|463250732|FG000|Overall Study|Relapse of primary disease|0|||
128713963|NCT03198234|463250733|FG001|Overall Study|Relapse of primary disease|1|||
128713964|NCT03198234|463250734|FG002|Overall Study|Relapse of primary disease|0|||
128713965|NCT01340898|463250735|FG000|Primary Phase|Serious Adverse Events|0|||
128713966|NCT01340898|463250736|FG001|Primary Phase|Serious Adverse Events|0|||
128713967|NCT01340898|463250737|FG002|Primary Phase|Serious Adverse Events|1|||
128772165|NCT02761629|463457771|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
128772166|NCT02761629|463457772|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
128772167|NCT02761629|463457771|FG000|Overall Study|Insufficient Therapeutic Response|2|||
128772168|NCT02761629|463457772|FG001|Overall Study|Insufficient Therapeutic Response|7|||
128772169|NCT02761629|463457771|FG000|Overall Study|Failure to Return|2|||
128772170|NCT02761629|463457772|FG001|Overall Study|Failure to Return|4|||
128772171|NCT02761629|463457771|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
128772172|NCT02761629|463457772|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
128772173|NCT02761629|463457771|FG000|Overall Study|Protocol Violation|2|||
128772174|NCT02761629|463457772|FG001|Overall Study|Protocol Violation|2|||
128772175|NCT02761629|463457771|FG000|Overall Study|Withdrawal by Subject|0|||
128772176|NCT02761629|463457772|FG001|Overall Study|Withdrawal by Subject|3|||
128772177|NCT02761629|463457771|FG000|Overall Study|Other|0|||
128772178|NCT02761629|463457772|FG001|Overall Study|Other|2|||
128772179|NCT02761629|463457771|FG000|Overall Study|Lost to Follow-up|4|||
128772180|NCT02761629|463457772|FG001|Overall Study|Lost to Follow-up|1|||
128772181|NCT02761629|463457771|FG000|Overall Study|Randomized But Not Treated|8|||
128772182|NCT02761629|463457772|FG001|Overall Study|Randomized But Not Treated|4|||
128772183|NCT02001974|463457773|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
128772184|NCT02001974|463457774|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
128772185|NCT02001974|463457775|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
128772186|NCT02001974|463457773|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
128772187|NCT02001974|463457774|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
128772188|NCT02001974|463457775|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
128772189|NCT02001974|463457773|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
128772190|NCT02001974|463457774|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
128772191|NCT02001974|463457775|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
128772192|NCT02001974|463457773|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
128772193|NCT02001974|463457774|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
129130318|NCT00770484|464768741|FG001|Overall Study|Withdrawal by Subject|0|||
128772194|NCT02001974|463457775|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
128772195|NCT00210119|463457776|FG000|Overall Study|Protocol Violation|1|||
128772196|NCT00210119|463457776|FG000|Overall Study|Withdrawal by Subject|1|||
128772197|NCT01830881|463457777|FG000|Overall Study|Changed decision to have an abortion|0|||
128772198|NCT01830881|463457778|FG001|Overall Study|Changed decision to have an abortion|1|||
129130319|NCT03097315|464768746|FG000|Overall Study|Withdrawal by Subject|1|||
129130320|NCT01946802|464768747|FG000|Overall Study|Death|1|||
129130321|NCT01946802|464768747|FG000|Overall Study|Withdrawal by Subject|2|||
129130322|NCT01946802|464768747|FG000|Overall Study|Combined septic shock|1|||
129130323|NCT01946802|464768747|FG000|Overall Study|Protocol Violation|1|||
129130324|NCT03384966|464768748|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
129130325|NCT03384966|464768749|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
129130326|NCT03384966|464768750|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
129130327|NCT03384966|464768748|FG000|Follow-up Period|Adverse Event|1|||
129130328|NCT03384966|464768749|FG001|Follow-up Period|Adverse Event|0|||
129130329|NCT03384966|464768750|FG002|Follow-up Period|Adverse Event|0|||
129130330|NCT03637374|464768751|FG000|Overall Study|Death|2|||
129130331|NCT03637374|464768752|FG001|Overall Study|Death|0|||
129130332|NCT02836769|464768754|FG000|Overall Study|Lost to Follow-up|10|||
129130333|NCT02836769|464768754|FG000|Overall Study|Medical withdrawal|2|||
129130334|NCT02836769|464768754|FG000|Overall Study|Withdrawal by Subject|3|||
129130335|NCT00376506|464768763|FG000|Overall Study|Death|0|||
129130336|NCT00376506|464768764|FG001|Overall Study|Death|2|||
129130337|NCT02948400|464768767|FG000|Overall Study|Withdrawal by Subject|17|||
129130338|NCT02948400|464768768|FG001|Overall Study|Withdrawal by Subject|10|||
129130339|NCT02948400|464768767|FG000|Overall Study|failed to attend appointments|47|||
129130340|NCT02948400|464768768|FG001|Overall Study|failed to attend appointments|34|||
129130341|NCT02948400|464768767|FG000|Overall Study|COVID-related closure|6|||
129130342|NCT02948400|464768768|FG001|Overall Study|COVID-related closure|2|||
129130343|NCT02948400|464768767|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
129130344|NCT02948400|464768768|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
129130345|NCT02948400|464768767|FG000|Overall Study|motion sickness in virtual reality|2|||
129130346|NCT02948400|464768768|FG001|Overall Study|motion sickness in virtual reality|0|||
129130347|NCT02403271|464768769|FG000|Period 1|Other varied reasons|1|||
129130348|NCT02403271|464768770|FG001|Period 1|Other varied reasons|0|||
129130349|NCT02403271|464768769|FG000|Period 2|Withdrawal by Subject|0|||
128772199|NCT00119262|463457779|FG000|Overall Study|Lack of Efficacy|0|||
128967554|NCT00441012|464165970|FG001|Overall Study|Withdrawal by Subject|0|||
129130350|NCT02403271|464768770|FG001|Period 2|Withdrawal by Subject|14|||
129130351|NCT02403271|464768769|FG000|Period 2|Death|0|||
129130352|NCT02403271|464768770|FG001|Period 2|Death|84|||
129130353|NCT02403271|464768769|FG000|Period 2|Lost to Follow-up|0|||
129130354|NCT02403271|464768770|FG001|Period 2|Lost to Follow-up|2|||
128772200|NCT00119262|463457780|FG001|Overall Study|Lack of Efficacy|3|||
128772201|NCT00119262|463457779|FG000|Overall Study|Withdrawal by Subject|12|||
128772202|NCT00119262|463457780|FG001|Overall Study|Withdrawal by Subject|11|||
128772203|NCT00119262|463457779|FG000|Overall Study|Adverse Event|33|||
128772204|NCT00119262|463457780|FG001|Overall Study|Adverse Event|35|||
128772205|NCT00119262|463457779|FG000|Overall Study|other disease|0|||
128772206|NCT00119262|463457780|FG001|Overall Study|other disease|2|||
128772207|NCT00119262|463457779|FG000|Overall Study|ineligble|1|||
128772208|NCT00119262|463457780|FG001|Overall Study|ineligble|2|||
128772209|NCT00119262|463457779|FG000|Overall Study|others|0|||
128772210|NCT00119262|463457780|FG001|Overall Study|others|5|||
128772211|NCT00734214|463457781|FG000|Overall Study|Withdrawal by Subject|3|||
128772212|NCT00734214|463457782|FG001|Overall Study|Withdrawal by Subject|4|||
128772213|NCT00734214|463457781|FG000|Overall Study|MD withdrawal|1|||
128772214|NCT00734214|463457782|FG001|Overall Study|MD withdrawal|0|||
128772215|NCT02038764|463457783|FG000|Overall Study|Adverse Event|0|||
128772216|NCT02038764|463457784|FG001|Overall Study|Adverse Event|0|||
128772217|NCT02038764|463457785|FG002|Overall Study|Adverse Event|1|||
128772218|NCT02038764|463457786|FG003|Overall Study|Adverse Event|0|||
128772219|NCT02038764|463457787|FG004|Overall Study|Adverse Event|0|||
128772220|NCT02038764|463457783|FG000|Overall Study|Lost to Follow-up|0|||
128772221|NCT02038764|463457784|FG001|Overall Study|Lost to Follow-up|1|||
128772222|NCT02038764|463457785|FG002|Overall Study|Lost to Follow-up|0|||
128772223|NCT02038764|463457786|FG003|Overall Study|Lost to Follow-up|0|||
128772224|NCT02038764|463457787|FG004|Overall Study|Lost to Follow-up|0|||
128772225|NCT02038764|463457783|FG000|Overall Study|Withdrawal by Subject|0|||
128772226|NCT02038764|463457784|FG001|Overall Study|Withdrawal by Subject|0|||
128772227|NCT02038764|463457785|FG002|Overall Study|Withdrawal by Subject|0|||
128772228|NCT02038764|463457786|FG003|Overall Study|Withdrawal by Subject|0|||
128772229|NCT02038764|463457787|FG004|Overall Study|Withdrawal by Subject|1|||
128772230|NCT02038764|463457783|FG000|Overall Study|Other|1|||
128772231|NCT02038764|463457784|FG001|Overall Study|Other|0|||
128772232|NCT02038764|463457785|FG002|Overall Study|Other|1|||
128772233|NCT02038764|463457786|FG003|Overall Study|Other|0|||
128772234|NCT02038764|463457787|FG004|Overall Study|Other|0|||
128772235|NCT04844918|463457790|FG000|Overall Study|Adverse Event|7|||
128772236|NCT04844918|463457791|FG001|Overall Study|Adverse Event|8|||
128772237|NCT04844918|463457792|FG002|Overall Study|Adverse Event|5|||
128772238|NCT04844918|463457790|FG000|Overall Study|Physician Decision|0|||
128772239|NCT04844918|463457791|FG001|Overall Study|Physician Decision|1|||
128772240|NCT04844918|463457792|FG002|Overall Study|Physician Decision|0|||
128772241|NCT04844918|463457790|FG000|Overall Study|Withdrawal by Subject|6|||
128772242|NCT04844918|463457791|FG001|Overall Study|Withdrawal by Subject|3|||
128772243|NCT04844918|463457792|FG002|Overall Study|Withdrawal by Subject|3|||
128772244|NCT04844918|463457790|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
128772245|NCT04844918|463457791|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
128772246|NCT04844918|463457792|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
128772247|NCT00363896|463457801|FG000|Overall Study|Withdrawal by Subject|29|||
128772248|NCT00363896|463457802|FG001|Overall Study|Withdrawal by Subject|16|||
128772249|NCT00363896|463457801|FG000|Overall Study|Adverse Event|24|||
128772250|NCT00363896|463457802|FG001|Overall Study|Adverse Event|13|||
128772251|NCT00363896|463457801|FG000|Overall Study|COPD exacerbation|13|||
128772252|NCT00363896|463457802|FG001|Overall Study|COPD exacerbation|7|||
128772253|NCT00363896|463457801|FG000|Overall Study|Lack of Efficacy|12|||
128772254|NCT00363896|463457802|FG001|Overall Study|Lack of Efficacy|8|||
128772255|NCT00363896|463457801|FG000|Overall Study|Protocol Violation|6|||
128772256|NCT00363896|463457802|FG001|Overall Study|Protocol Violation|1|||
128772257|NCT00363896|463457801|FG000|Overall Study|Lost to Follow-up|3|||
128772258|NCT00363896|463457802|FG001|Overall Study|Lost to Follow-up|0|||
128772259|NCT00363896|463457801|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
128772260|NCT00363896|463457802|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
128772261|NCT00363896|463457801|FG000|Overall Study|Other|1|||
128772262|NCT00363896|463457802|FG001|Overall Study|Other|2|||
128772263|NCT00924469|463457807|FG000|Overall Study|Adverse Event|2|||
128772264|NCT00924469|463457808|FG001|Overall Study|Adverse Event|0|||
128772265|NCT00924469|463457807|FG000|Overall Study|Withdrawal by Subject|0|||
128967555|NCT00441012|464165969|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
128772266|NCT00924469|463457808|FG001|Overall Study|Withdrawal by Subject|1|||
128772267|NCT00924469|463457807|FG000|Overall Study|Lost to Follow-up|0|||
128772268|NCT00924469|463457808|FG001|Overall Study|Lost to Follow-up|1|||
128772269|NCT00630058|463457809|FG000|Overall Study|Adverse Event|1|||
128772270|NCT00630058|463457810|FG001|Overall Study|Adverse Event|1|||
128772271|NCT00630058|463457809|FG000|Overall Study|Withdrawal by Subject|0|||
128772272|NCT00630058|463457810|FG001|Overall Study|Withdrawal by Subject|1|||
128772273|NCT00630058|463457809|FG000|Overall Study|stopping criteria|3|||
128772274|NCT00630058|463457810|FG001|Overall Study|stopping criteria|2|||
128772275|NCT01651936|463457811|FG000|Base Study|Adverse Event|3|||
128772276|NCT01651936|463457812|FG001|Base Study|Adverse Event|0|||
128772277|NCT01651936|463457813|FG002|Base Study|Adverse Event|0|||
128772278|NCT01651936|463457811|FG000|Base Study|Withdrawal by Subject|1|||
128772279|NCT01651936|463457812|FG001|Base Study|Withdrawal by Subject|1|||
128772280|NCT01651936|463457813|FG002|Base Study|Withdrawal by Subject|0|||
128772281|NCT01651936|463457811|FG000|Base Study|Early Escape|2|||
128772282|NCT01651936|463457812|FG001|Base Study|Early Escape|8|||
128772283|NCT01651936|463457813|FG002|Base Study|Early Escape|0|||
128772284|NCT01651936|463457811|FG000|Base Study|Study terminated by sponsor|21|||
128772285|NCT01651936|463457812|FG001|Base Study|Study terminated by sponsor|16|||
128772286|NCT01651936|463457813|FG002|Base Study|Study terminated by sponsor|0|||
128772287|NCT01651936|463457811|FG000|Extension Study|Lack of Efficacy|0|||
128772288|NCT01651936|463457812|FG001|Extension Study|Lack of Efficacy|0|||
128772289|NCT01651936|463457813|FG002|Extension Study|Lack of Efficacy|1|||
128772290|NCT01651936|463457811|FG000|Extension Study|Study terminated by sponsor|0|||
128772291|NCT01651936|463457812|FG001|Extension Study|Study terminated by sponsor|0|||
128772292|NCT01651936|463457813|FG002|Extension Study|Study terminated by sponsor|13|||
128772293|NCT03044353|463457814|FG000|Overall Study|Adverse Event|0|||
128772294|NCT03044353|463457815|FG001|Overall Study|Adverse Event|1|||
128772295|NCT03044353|463457816|FG002|Overall Study|Adverse Event|0|||
128772296|NCT02141659|463457823|FG000|Overall Study|Major Protocol Deviation|0|||
128772297|NCT02141659|463457824|FG001|Overall Study|Major Protocol Deviation|1|||
128772298|NCT02141659|463457825|FG002|Overall Study|Major Protocol Deviation|0|||
128772299|NCT02141659|463457826|FG003|Overall Study|Major Protocol Deviation|0|||
128772300|NCT02141659|463457827|FG004|Overall Study|Major Protocol Deviation|0|||
128772301|NCT02141659|463457828|FG005|Overall Study|Major Protocol Deviation|0|||
128772302|NCT02141659|463457823|FG000|Overall Study|Lack of Efficacy|0|||
128772303|NCT02141659|463457824|FG001|Overall Study|Lack of Efficacy|0|||
128772304|NCT02141659|463457825|FG002|Overall Study|Lack of Efficacy|0|||
128772305|NCT02141659|463457826|FG003|Overall Study|Lack of Efficacy|0|||
128772306|NCT02141659|463457827|FG004|Overall Study|Lack of Efficacy|0|||
128772307|NCT02141659|463457828|FG005|Overall Study|Lack of Efficacy|1|||
128772308|NCT02141659|463457823|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
128772309|NCT02141659|463457824|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
128772310|NCT02141659|463457825|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
128967556|NCT00441012|464165970|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
128967557|NCT04489940|464165971|FG000|Overall Study|Other|2|||
128967558|NCT04489940|464165971|FG000|Overall Study|Withdrawal by Subject|2|||
128967559|NCT04489940|464165971|FG000|Overall Study|Death|5|||
128967560|NCT04489940|464165971|FG000|Overall Study|Lost to Follow-up|1|||
128967561|NCT02725268|464165972|FG000|Overall Study|Death|58|||
128967562|NCT02725268|464165973|FG001|Overall Study|Death|59|||
128967563|NCT02725268|464165974|FG002|Overall Study|Death|30|||
128967564|NCT02725268|464165975|FG003|Overall Study|Death|16|||
128967565|NCT02725268|464165972|FG000|Overall Study|Lost to Follow-up|4|||
128967566|NCT02725268|464165973|FG001|Overall Study|Lost to Follow-up|3|||
128967567|NCT02725268|464165974|FG002|Overall Study|Lost to Follow-up|0|||
128967568|NCT02725268|464165975|FG003|Overall Study|Lost to Follow-up|1|||
128967569|NCT02725268|464165972|FG000|Overall Study|Site Terminated by Sponsor|0|||
128967570|NCT02725268|464165973|FG001|Overall Study|Site Terminated by Sponsor|1|||
128967571|NCT02725268|464165974|FG002|Overall Study|Site Terminated by Sponsor|0|||
128967572|NCT02725268|464165975|FG003|Overall Study|Site Terminated by Sponsor|0|||
128967573|NCT02725268|464165972|FG000|Overall Study|Withdrawal by Subject|8|||
128967574|NCT02725268|464165973|FG001|Overall Study|Withdrawal by Subject|6|||
128967575|NCT02725268|464165974|FG002|Overall Study|Withdrawal by Subject|8|||
128967576|NCT02725268|464165975|FG003|Overall Study|Withdrawal by Subject|1|||
128967577|NCT02725268|464165972|FG000|Overall Study|Reason not Specified|2|||
128967578|NCT02725268|464165973|FG001|Overall Study|Reason not Specified|1|||
128967579|NCT02725268|464165974|FG002|Overall Study|Reason not Specified|0|||
128967580|NCT02725268|464165975|FG003|Overall Study|Reason not Specified|0|||
128967581|NCT04498468|464165976|FG000|Overall Study|Lost to Follow-up|3|||
128772311|NCT02141659|463457826|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
128772312|NCT02141659|463457827|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
128772313|NCT02141659|463457828|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
128772314|NCT05033080|463457832|FG000|Overall Study|Adverse Event|4|||
128772315|NCT05033080|463457833|FG001|Overall Study|Adverse Event|4|||
128772316|NCT05033080|463457832|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
128772317|NCT05033080|463457833|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
128772318|NCT05033080|463457832|FG000|Overall Study|Lost to Follow-up|1|||
128772319|NCT05033080|463457833|FG001|Overall Study|Lost to Follow-up|0|||
128772320|NCT05033080|463457832|FG000|Overall Study|Other non-compliance|0|||
128772321|NCT05033080|463457833|FG001|Overall Study|Other non-compliance|1|||
128967582|NCT00262314|464165981|FG000|Overall Study|Changing physicians|38|||
128967583|NCT00262314|464165981|FG000|Overall Study|Death|12|||
128772322|NCT05033080|463457832|FG000|Overall Study|Physician Decision|0|||
128772323|NCT05033080|463457833|FG001|Overall Study|Physician Decision|1|||
128772324|NCT05033080|463457832|FG000|Overall Study|Other|1|||
128772325|NCT05033080|463457833|FG001|Overall Study|Other|1|||
128772326|NCT01263106|463457834|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
128772327|NCT01263106|463457835|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
128772328|NCT01680458|463457836|FG000|Overall Study|Protocol Violation|3|||
128772329|NCT03012061|463457843|FG000|Overall Study|Withdrawal by Subject|1|||
128772330|NCT03012061|463457844|FG001|Overall Study|Withdrawal by Subject|5|||
128772331|NCT03012061|463457845|FG002|Overall Study|Withdrawal by Subject|4|||
128772332|NCT03012061|463457843|FG000|Overall Study|Investigator Site Closed|1|||
128772333|NCT03012061|463457844|FG001|Overall Study|Investigator Site Closed|2|||
128772334|NCT03012061|463457845|FG002|Overall Study|Investigator Site Closed|0|||
128772335|NCT03012061|463457843|FG000|Overall Study|Lost to Follow-up|2|||
128772336|NCT03012061|463457844|FG001|Overall Study|Lost to Follow-up|1|||
128772337|NCT03012061|463457845|FG002|Overall Study|Lost to Follow-up|0|||
128772338|NCT03012061|463457843|FG000|Overall Study|Study closed/ Terminated|0|||
128772339|NCT03012061|463457844|FG001|Overall Study|Study closed/ Terminated|0|||
128772340|NCT03012061|463457845|FG002|Overall Study|Study closed/ Terminated|1|||
128772341|NCT03012061|463457843|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
128772342|NCT03012061|463457844|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
128772343|NCT03012061|463457845|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
128772344|NCT03012061|463457843|FG000|Overall Study|Protocol Violation|0|||
128772345|NCT03012061|463457844|FG001|Overall Study|Protocol Violation|0|||
128772346|NCT03012061|463457845|FG002|Overall Study|Protocol Violation|2|||
128772347|NCT03012061|463457843|FG000|Overall Study|Lack of Efficacy|0|||
128772348|NCT03012061|463457844|FG001|Overall Study|Lack of Efficacy|1|||
128772349|NCT03012061|463457845|FG002|Overall Study|Lack of Efficacy|0|||
128772350|NCT03012061|463457843|FG000|Overall Study|Adverse Event|2|||
128772351|NCT03012061|463457844|FG001|Overall Study|Adverse Event|0|||
128772352|NCT03012061|463457845|FG002|Overall Study|Adverse Event|0|||
128772353|NCT02696902|463457846|FG000|Overall Study|Lost to Follow-up|0|||
128772354|NCT02696902|463457847|FG001|Overall Study|Lost to Follow-up|1|||
128772355|NCT02696902|463457848|FG002|Overall Study|Lost to Follow-up|1|||
128772356|NCT02696902|463457846|FG000|Overall Study|Withdrawal by Subject|0|||
128772357|NCT02696902|463457847|FG001|Overall Study|Withdrawal by Subject|0|||
128772358|NCT02696902|463457848|FG002|Overall Study|Withdrawal by Subject|1|||
128772359|NCT02696902|463457846|FG000|Overall Study|Death|19|||
128772360|NCT02696902|463457847|FG001|Overall Study|Death|3|||
128772361|NCT02696902|463457848|FG002|Overall Study|Death|24|||
128772362|NCT02696902|463457846|FG000|Overall Study|Participant not fit post-randomization|0|||
128772363|NCT02696902|463457847|FG001|Overall Study|Participant not fit post-randomization|0|||
128772364|NCT02696902|463457848|FG002|Overall Study|Participant not fit post-randomization|1|||
128772365|NCT02696902|463457846|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
128772366|NCT02696902|463457847|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
128772367|NCT02696902|463457848|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
128772368|NCT02696902|463457846|FG000|Overall Study|Principal investigator's decision|1|||
128772369|NCT02696902|463457847|FG001|Overall Study|Principal investigator's decision|0|||
128772370|NCT02696902|463457848|FG002|Overall Study|Principal investigator's decision|0|||
128772371|NCT02696902|463457846|FG000|Overall Study|Sponsor's decision|1|||
128772372|NCT02696902|463457847|FG001|Overall Study|Sponsor's decision|0|||
128772373|NCT02696902|463457848|FG002|Overall Study|Sponsor's decision|0|||
128967584|NCT00262314|464165981|FG000|Overall Study|Patient's decision|92|||
128967585|NCT00262314|464165981|FG000|Overall Study|Other|95|||
128967586|NCT00262314|464165981|FG000|Overall Study|Lost to Follow-up|70|||
128967587|NCT00262314|464165981|FG000|Overall Study|Administrative withdrawal|30|||
128967588|NCT05104749|464165982|FG000|Overall Study|Lost to Follow-up|2|||
128967589|NCT05104749|464165983|FG001|Overall Study|Lost to Follow-up|3|||
128967590|NCT03964493|464165984|FG000|Overall Study|Withdrawal by Subject|4|||
128967591|NCT03964493|464165985|FG001|Overall Study|Withdrawal by Subject|1|||
128967592|NCT03964493|464165984|FG000|Overall Study|Lost to Follow-up|13|||
128967593|NCT03964493|464165985|FG001|Overall Study|Lost to Follow-up|4|||
128967594|NCT02470429|464165986|FG000|Overall Study|Adverse Event|1|||
128967595|NCT02470429|464165987|FG001|Overall Study|Adverse Event|0|||
128967596|NCT02470429|464165986|FG000|Overall Study|Withdrawal by Subject|1|||
128967597|NCT02470429|464165987|FG001|Overall Study|Withdrawal by Subject|0|||
128967598|NCT01300767|464165988|FG000|Overall Study|Discomfort|2|||
128967599|NCT01300767|464165988|FG000|Overall Study|Biomicroscopy|1|||
128967600|NCT01300767|464165988|FG000|Overall Study|Unacceptable fit|1|||
128967601|NCT00398138|464165989|FG000|Overall Study|Adverse Event|2|||
128967602|NCT00117572|464165991|FG000|Overall Study|Site withdrew before starting treatment|2|||
128967603|NCT00117572|464165992|FG001|Overall Study|Site withdrew before starting treatment|3|||
128967604|NCT00117572|464165991|FG000|Overall Study|Withdrawal by Subject|3|||
128967605|NCT00117572|464165992|FG001|Overall Study|Withdrawal by Subject|3|||
128967606|NCT00117572|464165991|FG000|Overall Study|Protocol Violation|1|||
128967607|NCT00117572|464165992|FG001|Overall Study|Protocol Violation|0|||
128967608|NCT00887068|464165993|FG000|Overall Study|Withdrawal by Subject|2|||
128967609|NCT00887068|464165994|FG001|Overall Study|Withdrawal by Subject|0|||
128772374|NCT02696902|463457846|FG000|Overall Study|Transferred to other hospital|1|||
128967610|NCT00887068|464165993|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
128967611|NCT00887068|464165994|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
128967612|NCT01387594|464165995|FG000|Overall Study|Withdrawal by Subject|0|||
128967613|NCT01387594|464165996|FG001|Overall Study|Withdrawal by Subject|2|||
128967614|NCT01387594|464165995|FG000|Overall Study|Lost to Follow-up|0|||
128967615|NCT01387594|464165996|FG001|Overall Study|Lost to Follow-up|1|||
128967616|NCT04507360|464167387|FG000|Week 1|Lost to Follow-up|0|||
128967617|NCT04507360|464167388|FG001|Week 1|Lost to Follow-up|0|||
128967618|NCT04507360|464167389|FG002|Week 1|Lost to Follow-up|0|||
128967619|NCT04507360|464167390|FG003|Week 1|Lost to Follow-up|0|||
128967620|NCT04507360|464167391|FG004|Week 1|Lost to Follow-up|0|||
128967621|NCT04507360|464167392|FG005|Week 1|Lost to Follow-up|0|||
128967622|NCT04507360|464167393|FG006|Week 1|Lost to Follow-up|0|||
128967623|NCT04507360|464167394|FG007|Week 1|Lost to Follow-up|0|||
128967624|NCT04507360|464167395|FG008|Week 1|Lost to Follow-up|72|||
128967625|NCT04507360|464167396|FG009|Week 1|Lost to Follow-up|22|||
128967626|NCT04507360|464167397|FG010|Week 1|Lost to Follow-up|10|||
128967627|NCT04507360|464167387|FG000|Week 2|Lost to Follow-up|0|||
128967628|NCT04507360|464167388|FG001|Week 2|Lost to Follow-up|0|||
128967629|NCT04507360|464167389|FG002|Week 2|Lost to Follow-up|0|||
128967630|NCT04507360|464167390|FG003|Week 2|Lost to Follow-up|0|||
128967631|NCT04507360|464167391|FG004|Week 2|Lost to Follow-up|0|||
128967632|NCT04507360|464167392|FG005|Week 2|Lost to Follow-up|0|||
128967633|NCT04507360|464167393|FG006|Week 2|Lost to Follow-up|0|||
128967634|NCT04507360|464167394|FG007|Week 2|Lost to Follow-up|0|||
128967635|NCT04507360|464167395|FG008|Week 2|Lost to Follow-up|121|||
128967636|NCT04507360|464167396|FG009|Week 2|Lost to Follow-up|85|||
129220282|NCT01519921|465106544|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
128772375|NCT02696902|463457847|FG001|Overall Study|Transferred to other hospital|0|||
128772376|NCT02696902|463457848|FG002|Overall Study|Transferred to other hospital|0|||
128772377|NCT05822921|463457851|FG000|Overall Study|Lost to Follow-up|1|||
128772378|NCT05822921|463457852|FG001|Overall Study|Lost to Follow-up|1|||
128772379|NCT00544544|463457853|FG000|Overall Study|Withdrawal by Subject|1|||
128772380|NCT00544544|463457853|FG000|Overall Study|Adverse Event|1|||
128772381|NCT00544544|463457853|FG000|Overall Study|Lost to Follow-up|1|||
128772382|NCT03406702|463457854|FG000|Overall Study|Missed Day 27 Dosing|1|||
128772383|NCT01857622|463457859|FG000|Overall Study|Adverse Event|5|||
128772384|NCT01857622|463457860|FG001|Overall Study|Adverse Event|0|||
128772385|NCT01857622|463457861|FG002|Overall Study|Adverse Event|2|||
128772386|NCT01857622|463457859|FG000|Overall Study|Physician Decision|1|||
128772387|NCT01857622|463457860|FG001|Overall Study|Physician Decision|0|||
128772388|NCT01857622|463457861|FG002|Overall Study|Physician Decision|0|||
128772389|NCT01857622|463457859|FG000|Overall Study|Protocol Violation|4|||
128772390|NCT01857622|463457860|FG001|Overall Study|Protocol Violation|1|||
128772391|NCT01857622|463457861|FG002|Overall Study|Protocol Violation|0|||
128772392|NCT01857622|463457859|FG000|Overall Study|Withdrawal by Subject|1|||
128772393|NCT01857622|463457860|FG001|Overall Study|Withdrawal by Subject|0|||
128772394|NCT01857622|463457861|FG002|Overall Study|Withdrawal by Subject|0|||
128772395|NCT01040780|463459829|FG000|Overall Study|Protocol Violation|1|||
128772396|NCT01040780|463459830|FG001|Overall Study|Protocol Violation|3|||
128772397|NCT00802737|463459831|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
128772398|NCT00802737|463459832|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
128772399|NCT00802737|463459833|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
128772400|NCT00802737|463459831|FG000|Overall Study|Death|6|||
128772401|NCT00802737|463459832|FG001|Overall Study|Death|5|||
128772402|NCT00802737|463459833|FG002|Overall Study|Death|1|||
128772403|NCT00802737|463459831|FG000|Overall Study|Adverse Event|1|||
128772404|NCT00802737|463459832|FG001|Overall Study|Adverse Event|0|||
128772405|NCT00802737|463459833|FG002|Overall Study|Adverse Event|0|||
128772406|NCT00802737|463459831|FG000|Overall Study|Received Prohibited Therapy|1|||
128772407|NCT00802737|463459832|FG001|Overall Study|Received Prohibited Therapy|0|||
128772408|NCT00802737|463459833|FG002|Overall Study|Received Prohibited Therapy|0|||
128772409|NCT00802737|463459831|FG000|Overall Study|Ongoing CLL-Treatment|0|||
128772410|NCT00802737|463459832|FG001|Overall Study|Ongoing CLL-Treatment|1|||
128772411|NCT00802737|463459833|FG002|Overall Study|Ongoing CLL-Treatment|0|||
128772412|NCT00802737|463459831|FG000|Overall Study|Participant too Unwell|0|||
128772413|NCT00802737|463459832|FG001|Overall Study|Participant too Unwell|2|||
128772414|NCT00802737|463459833|FG002|Overall Study|Participant too Unwell|0|||
128772415|NCT03864926|463459841|FG000|Overall Study|Death|0|||
128772416|NCT03864926|463459842|FG001|Overall Study|Death|2|||
128772417|NCT00445601|463459843|FG000|Overall Study|Withdrawal by Subject|11|||
128772418|NCT00445601|463459844|FG001|Overall Study|Withdrawal by Subject|11|||
128772419|NCT00445601|463459843|FG000|Overall Study|TURBT Complication|12|||
128772420|NCT00445601|463459844|FG001|Overall Study|TURBT Complication|8|||
128967637|NCT04507360|464167397|FG010|Week 2|Lost to Follow-up|82|||
128967638|NCT04507360|464167387|FG000|Week 3|Lost to Follow-up|0|||
128967639|NCT04507360|464167388|FG001|Week 3|Lost to Follow-up|0|||
128967640|NCT04507360|464167389|FG002|Week 3|Lost to Follow-up|0|||
128967641|NCT04507360|464167390|FG003|Week 3|Lost to Follow-up|0|||
128967642|NCT04507360|464167391|FG004|Week 3|Lost to Follow-up|0|||
128967643|NCT04507360|464167392|FG005|Week 3|Lost to Follow-up|0|||
128967644|NCT04507360|464167393|FG006|Week 3|Lost to Follow-up|0|||
128967645|NCT04507360|464167394|FG007|Week 3|Lost to Follow-up|0|||
128967646|NCT04507360|464167395|FG008|Week 3|Lost to Follow-up|123|||
128967647|NCT04507360|464167396|FG009|Week 3|Lost to Follow-up|92|||
128967648|NCT04507360|464167397|FG010|Week 3|Lost to Follow-up|84|||
128967649|NCT04507360|464167387|FG000|Week 4|Lost to Follow-up|0|||
128967650|NCT04507360|464167388|FG001|Week 4|Lost to Follow-up|0|||
128967651|NCT04507360|464167389|FG002|Week 4|Lost to Follow-up|0|||
128967652|NCT04507360|464167390|FG003|Week 4|Lost to Follow-up|0|||
128967653|NCT04507360|464167391|FG004|Week 4|Lost to Follow-up|0|||
128967654|NCT04507360|464167392|FG005|Week 4|Lost to Follow-up|0|||
128967655|NCT04507360|464167393|FG006|Week 4|Lost to Follow-up|0|||
128772421|NCT00445601|463459843|FG000|Overall Study|Incorrect Disease Status|6|||
128772422|NCT00445601|463459844|FG001|Overall Study|Incorrect Disease Status|6|||
128772423|NCT00445601|463459843|FG000|Overall Study|Drug Delivery Issue|2|||
128772424|NCT00445601|463459844|FG001|Overall Study|Drug Delivery Issue|2|||
128772425|NCT00445601|463459843|FG000|Overall Study|Adverse Event|2|||
128772426|NCT00445601|463459844|FG001|Overall Study|Adverse Event|0|||
128772427|NCT00445601|463459843|FG000|Overall Study|Death prior to TURBT|0|||
128772428|NCT00445601|463459844|FG001|Overall Study|Death prior to TURBT|1|||
128772429|NCT02930122|463459852|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
128772430|NCT02930122|463459853|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
128772431|NCT01681368|463459854|FG000|Overall Study|Refused further treatment|1|||
128772432|NCT01681368|463459854|FG000|Overall Study|Refused further follow up|1|||
128772433|NCT01807221|463459855|FG000|Overall Study|Progressive disease|1|||
128772434|NCT01807221|463459856|FG001|Overall Study|Progressive disease|0|||
128772435|NCT01807221|463459857|FG002|Overall Study|Progressive disease|1|||
128772436|NCT01807221|463459858|FG003|Overall Study|Progressive disease|0|||
128772437|NCT01807221|463459859|FG004|Overall Study|Progressive disease|0|||
128772438|NCT01807221|463459860|FG005|Overall Study|Progressive disease|0|||
128772439|NCT01807221|463459855|FG000|Overall Study|Death|7|||
128772440|NCT01807221|463459856|FG001|Overall Study|Death|9|||
128772441|NCT01807221|463459857|FG002|Overall Study|Death|4|||
128967656|NCT04507360|464167394|FG007|Week 4|Lost to Follow-up|0|||
128967657|NCT04507360|464167395|FG008|Week 4|Lost to Follow-up|131|||
128967658|NCT04507360|464167396|FG009|Week 4|Lost to Follow-up|115|||
128772442|NCT01807221|463459858|FG003|Overall Study|Death|2|||
128772443|NCT01807221|463459859|FG004|Overall Study|Death|1|||
128772444|NCT01807221|463459860|FG005|Overall Study|Death|6|||
128772445|NCT01807221|463459855|FG000|Overall Study|Physician Decision|2|||
128772446|NCT01807221|463459856|FG001|Overall Study|Physician Decision|1|||
128772447|NCT01807221|463459857|FG002|Overall Study|Physician Decision|0|||
128772448|NCT01807221|463459858|FG003|Overall Study|Physician Decision|0|||
128772449|NCT01807221|463459859|FG004|Overall Study|Physician Decision|0|||
128772450|NCT01807221|463459860|FG005|Overall Study|Physician Decision|0|||
128772451|NCT01807221|463459855|FG000|Overall Study|Adverse Event|33|||
128772452|NCT01807221|463459856|FG001|Overall Study|Adverse Event|22|||
128772453|NCT01807221|463459857|FG002|Overall Study|Adverse Event|26|||
128772454|NCT01807221|463459858|FG003|Overall Study|Adverse Event|25|||
128772455|NCT01807221|463459859|FG004|Overall Study|Adverse Event|18|||
128772456|NCT01807221|463459860|FG005|Overall Study|Adverse Event|21|||
128772457|NCT01807221|463459855|FG000|Overall Study|Protocol Violation|0|||
128772458|NCT01807221|463459856|FG001|Overall Study|Protocol Violation|2|||
128772459|NCT01807221|463459857|FG002|Overall Study|Protocol Violation|1|||
128772460|NCT01807221|463459858|FG003|Overall Study|Protocol Violation|2|||
128772461|NCT01807221|463459859|FG004|Overall Study|Protocol Violation|0|||
128772462|NCT01807221|463459860|FG005|Overall Study|Protocol Violation|1|||
128772463|NCT01807221|463459855|FG000|Overall Study|Non-compliance|1|||
128772464|NCT01807221|463459856|FG001|Overall Study|Non-compliance|2|||
128772465|NCT01807221|463459857|FG002|Overall Study|Non-compliance|0|||
128772466|NCT01807221|463459858|FG003|Overall Study|Non-compliance|1|||
128772467|NCT01807221|463459859|FG004|Overall Study|Non-compliance|0|||
128772468|NCT01807221|463459860|FG005|Overall Study|Non-compliance|0|||
128772469|NCT01807221|463459855|FG000|Overall Study|Logistical difficulties|0|||
128772470|NCT01807221|463459856|FG001|Overall Study|Logistical difficulties|1|||
128772471|NCT01807221|463459857|FG002|Overall Study|Logistical difficulties|0|||
128772472|NCT01807221|463459858|FG003|Overall Study|Logistical difficulties|0|||
128772473|NCT01807221|463459859|FG004|Overall Study|Logistical difficulties|1|||
128772474|NCT01807221|463459860|FG005|Overall Study|Logistical difficulties|0|||
128772475|NCT01807221|463459855|FG000|Overall Study|Withdrawal by Subject|33|||
128772476|NCT01807221|463459856|FG001|Overall Study|Withdrawal by Subject|15|||
128772477|NCT01807221|463459857|FG002|Overall Study|Withdrawal by Subject|8|||
128772478|NCT01807221|463459858|FG003|Overall Study|Withdrawal by Subject|14|||
128772479|NCT01807221|463459859|FG004|Overall Study|Withdrawal by Subject|16|||
128772480|NCT01807221|463459860|FG005|Overall Study|Withdrawal by Subject|13|||
128772481|NCT01807221|463459855|FG000|Overall Study|Sponsor decision|2|||
128772482|NCT01807221|463459856|FG001|Overall Study|Sponsor decision|0|||
128772483|NCT01807221|463459857|FG002|Overall Study|Sponsor decision|1|||
128772484|NCT01807221|463459858|FG003|Overall Study|Sponsor decision|1|||
128967659|NCT04507360|464167397|FG010|Week 4|Lost to Follow-up|102|||
128967660|NCT04507360|464167387|FG000|Week 5|Lost to Follow-up|0|||
128967661|NCT04507360|464167388|FG001|Week 5|Lost to Follow-up|0|||
128772485|NCT01807221|463459859|FG004|Overall Study|Sponsor decision|0|||
128772486|NCT01807221|463459860|FG005|Overall Study|Sponsor decision|0|||
128772487|NCT01807221|463459855|FG000|Overall Study|Lost to Follow-up|1|||
128772488|NCT01807221|463459856|FG001|Overall Study|Lost to Follow-up|0|||
128772489|NCT01807221|463459857|FG002|Overall Study|Lost to Follow-up|2|||
128772490|NCT01807221|463459858|FG003|Overall Study|Lost to Follow-up|1|||
128772491|NCT01807221|463459859|FG004|Overall Study|Lost to Follow-up|0|||
128772492|NCT01807221|463459860|FG005|Overall Study|Lost to Follow-up|0|||
128772493|NCT02609659|463459861|FG000|Overall Study|Adverse Event|1|||
128772494|NCT02609659|463459861|FG000|Overall Study|Lost to Follow-up|6|||
128772495|NCT02609659|463459861|FG000|Overall Study|Other|1|||
128772496|NCT01004250|463459862|FG000|Induction Therapy Period|Adverse Event|10|||
128772497|NCT01004250|463459862|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
128772498|NCT01004250|463459862|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
128772499|NCT01004250|463459862|FG000|Induction Therapy Period|Physician Decision|2|||
128772500|NCT01004250|463459862|FG000|Maintenance Therapy Period|Adverse Event|15|||
128967662|NCT04507360|464167389|FG002|Week 5|Lost to Follow-up|0|||
128967663|NCT04507360|464167390|FG003|Week 5|Lost to Follow-up|0|||
128967664|NCT04507360|464167391|FG004|Week 5|Lost to Follow-up|0|||
128967665|NCT04507360|464167392|FG005|Week 5|Lost to Follow-up|0|||
128967666|NCT04507360|464167393|FG006|Week 5|Lost to Follow-up|0|||
128967667|NCT04507360|464167394|FG007|Week 5|Lost to Follow-up|0|||
128967668|NCT04507360|464167395|FG008|Week 5|Lost to Follow-up|103|||
128967669|NCT04507360|464167396|FG009|Week 5|Lost to Follow-up|135|||
128967670|NCT04507360|464167397|FG010|Week 5|Lost to Follow-up|143|||
128967671|NCT04507360|464167387|FG000|Week 8|Lost to Follow-up|0|||
128967672|NCT04507360|464167388|FG001|Week 8|Lost to Follow-up|0|||
128967673|NCT04507360|464167389|FG002|Week 8|Lost to Follow-up|0|||
128967674|NCT04507360|464167390|FG003|Week 8|Lost to Follow-up|0|||
128967675|NCT04507360|464167391|FG004|Week 8|Lost to Follow-up|0|||
128967676|NCT04507360|464167392|FG005|Week 8|Lost to Follow-up|0|||
128967677|NCT04507360|464167393|FG006|Week 8|Lost to Follow-up|0|||
128967678|NCT04507360|464167394|FG007|Week 8|Lost to Follow-up|0|||
128967679|NCT04507360|464167395|FG008|Week 8|Lost to Follow-up|139|||
128967680|NCT04507360|464167396|FG009|Week 8|Lost to Follow-up|145|||
129130355|NCT02403271|464768769|FG000|Period 2|Study Terminated by Sponsor|0|||
129130356|NCT02403271|464768770|FG001|Period 2|Study Terminated by Sponsor|14|||
129130357|NCT02403271|464768769|FG000|Period 2|Other varied reasons|0|||
129130358|NCT02403271|464768770|FG001|Period 2|Other varied reasons|10|||
129130359|NCT00221104|464768775|FG000|Overall Study|Adverse Event|1|||
129130360|NCT00221104|464768776|FG001|Overall Study|Adverse Event|0|||
129130361|NCT00221104|464768775|FG000|Overall Study|Physician Decision|1|||
129130362|NCT00221104|464768776|FG001|Overall Study|Physician Decision|0|||
129130363|NCT00221104|464768775|FG000|Overall Study|Protocol Violation|2|||
129130364|NCT00221104|464768776|FG001|Overall Study|Protocol Violation|0|||
129130365|NCT00221104|464768775|FG000|Overall Study|Withdrawal by Subject|42|||
129130366|NCT00221104|464768776|FG001|Overall Study|Withdrawal by Subject|29|||
129130367|NCT00221104|464768775|FG000|Overall Study|Others|37|||
129130368|NCT00221104|464768776|FG001|Overall Study|Others|47|||
129130369|NCT02989389|464768777|FG000|Period 1|Lost to Follow-up|0|||
129130370|NCT02989389|464768778|FG001|Period 1|Lost to Follow-up|1|||
129130371|NCT02989389|464768779|FG002|Period 1|Lost to Follow-up|0|||
129130372|NCT02989389|464768780|FG003|Period 1|Lost to Follow-up|0|||
129130373|NCT02989389|464768781|FG004|Period 1|Lost to Follow-up|0|||
129130374|NCT02989389|464768782|FG005|Period 1|Lost to Follow-up|0|||
129130375|NCT02989389|464768783|FG006|Period 1|Lost to Follow-up|0|||
129130376|NCT02989389|464768784|FG007|Period 1|Lost to Follow-up|0|||
129130377|NCT02989389|464768785|FG008|Period 1|Lost to Follow-up|0|||
129130378|NCT02989389|464768786|FG009|Period 1|Lost to Follow-up|0|||
129130379|NCT02989389|464768777|FG000|Period 1|Physician Decision|0|||
129130380|NCT02989389|464768778|FG001|Period 1|Physician Decision|0|||
129130381|NCT02989389|464768779|FG002|Period 1|Physician Decision|0|||
129130382|NCT02989389|464768780|FG003|Period 1|Physician Decision|0|||
128772501|NCT01004250|463459862|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
128772502|NCT01004250|463459862|FG000|Maintenance Therapy Period|Protocol Violation|1|||
128967681|NCT04507360|464167397|FG010|Week 8|Lost to Follow-up|152|||
128967682|NCT01004159|464167398|FG000|Overall Study|Adverse Event|2|||
128967683|NCT01004159|464167398|FG000|Overall Study|Disease Progression|18|||
128967684|NCT03050307|464167402|FG000|Overall Study|Adverse Event|4|||
128967685|NCT03050307|464167403|FG001|Overall Study|Adverse Event|2|||
128967686|NCT03050307|464167402|FG000|Overall Study|Significant Protocol Deviation|0|||
128967687|NCT03050307|464167403|FG001|Overall Study|Significant Protocol Deviation|1|||
128967688|NCT03050307|464167402|FG000|Overall Study|Lost to Follow-up|0|||
129130383|NCT02989389|464768781|FG004|Period 1|Physician Decision|0|||
129130384|NCT02989389|464768782|FG005|Period 1|Physician Decision|0|||
129130385|NCT02989389|464768783|FG006|Period 1|Physician Decision|0|||
129130386|NCT02989389|464768784|FG007|Period 1|Physician Decision|0|||
129130387|NCT02989389|464768785|FG008|Period 1|Physician Decision|1|||
129130388|NCT02989389|464768786|FG009|Period 1|Physician Decision|0|||
129130389|NCT04470427|464768787|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
129130390|NCT04470427|464768788|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
128967689|NCT03050307|464167403|FG001|Overall Study|Lost to Follow-up|1|||
128967690|NCT03050307|464167402|FG000|Overall Study|Voluntary Withdrawal|3|||
128967691|NCT03050307|464167403|FG001|Overall Study|Voluntary Withdrawal|4|||
128967692|NCT03050307|464167402|FG000|Overall Study|Reason not Specified|1|||
128967693|NCT03050307|464167403|FG001|Overall Study|Reason not Specified|1|||
128967694|NCT02973997|464167404|FG000|Overall Study|Withdrawal by Subject|4|||
128967695|NCT02973997|464167405|FG001|Overall Study|Withdrawal by Subject|0|||
128967696|NCT02973997|464167404|FG000|Overall Study|Adverse Event|4|||
128967697|NCT02973997|464167405|FG001|Overall Study|Adverse Event|1|||
128967698|NCT02973997|464167404|FG000|Overall Study|Disease Progression|11|||
128967699|NCT02973997|464167405|FG001|Overall Study|Disease Progression|20|||
128967700|NCT02973997|464167404|FG000|Overall Study|Alternative Therapy|3|||
128967701|NCT02973997|464167405|FG001|Overall Study|Alternative Therapy|0|||
128967702|NCT02973997|464167404|FG000|Overall Study|Other complicating disease|0|||
128772503|NCT01004250|463459862|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
128772504|NCT01004250|463459862|FG000|Maintenance Therapy Period|Physician Decision|4|||
128772505|NCT01004250|463459862|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
128772506|NCT00594906|463459863|FG000|Overall Study|Physician Decision|1|||
128772507|NCT00594906|463459864|FG001|Overall Study|Physician Decision|0|||
128772508|NCT00594906|463459863|FG000|Overall Study|Physician Decision|0|||
128772509|NCT00594906|463459864|FG001|Overall Study|Physician Decision|1|||
128772510|NCT00594906|463459863|FG000|Overall Study|Death|0|||
128772511|NCT00594906|463459864|FG001|Overall Study|Death|1|||
128772512|NCT00867490|463459865|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
128772513|NCT00867490|463459865|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
128772514|NCT00867490|463459865|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
128772515|NCT00867490|463459865|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
128772516|NCT00867490|463459865|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
128772517|NCT02823964|463459866|FG000|Overall Study|Adverse Event|2|||
128772518|NCT02823964|463459866|FG000|Overall Study|Physician Decision|1|||
128772519|NCT02823964|463459866|FG000|Overall Study|Lack of Efficacy|1|||
128772520|NCT02823964|463459866|FG000|Overall Study|Withdrawal by Subject|1|||
128772521|NCT00794820|463459870|FG000|Overall Study|Adverse Event|11|||
128772522|NCT00794820|463459870|FG000|Overall Study|Secondary Malignancies|2|||
128772523|NCT00794820|463459870|FG000|Overall Study|Resistant Disease|2|||
128772524|NCT00794820|463459870|FG000|Overall Study|Ineligible/Screen Failure|1|||
128772525|NCT02310126|463459872|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
128772526|NCT02310126|463459873|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
128772527|NCT02310126|463459872|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
128772528|NCT02310126|463459873|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
128772529|NCT03537261|463459881|FG000|Overall Study|Lost to Follow-up|4|||
128772530|NCT03537261|463459882|FG001|Overall Study|Lost to Follow-up|5|||
128772531|NCT03537261|463459881|FG000|Overall Study|Withdrawal by Subject|4|||
128772532|NCT03537261|463459882|FG001|Overall Study|Withdrawal by Subject|6|||
128772533|NCT03537261|463459881|FG000|Overall Study|Did not return study questionnaires|0|||
128772534|NCT03537261|463459882|FG001|Overall Study|Did not return study questionnaires|1|||
128772535|NCT01729728|463459883|FG000|Overall Study|Adverse Event|0|||
128772536|NCT01729728|463459884|FG001|Overall Study|Adverse Event|6|||
128772537|NCT01729728|463459885|FG002|Overall Study|Adverse Event|0|||
128967703|NCT02973997|464167405|FG001|Overall Study|Other complicating disease|1|||
128967704|NCT02973997|464167404|FG000|Overall Study|Death|0|||
128967705|NCT02973997|464167405|FG001|Overall Study|Death|1|||
128967706|NCT00444951|464167406|FG000|Overall Study|Lost to Follow-up|1|||
128967707|NCT00444951|464167407|FG001|Overall Study|Lost to Follow-up|1|||
128967708|NCT00444951|464167408|FG002|Overall Study|Lost to Follow-up|0|||
128967709|NCT00444951|464167406|FG000|Overall Study|Withdrawal by Subject|4|||
128772538|NCT01729728|463459883|FG000|Overall Study|Protocol Violation|1|||
128967710|NCT00444951|464167407|FG001|Overall Study|Withdrawal by Subject|5|||
128967711|NCT00444951|464167408|FG002|Overall Study|Withdrawal by Subject|3|||
128967712|NCT01998906|464167409|FG000|Overall Study|Participants ongoing in follow-up|77|||
128967713|NCT01998906|464167410|FG001|Overall Study|Participants ongoing in follow-up|60|||
128967714|NCT01998906|464167411|FG002|Overall Study|Participants ongoing in follow-up|58|||
129130391|NCT04470427|464768789|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
128772539|NCT01729728|463459884|FG001|Overall Study|Protocol Violation|0|||
128772540|NCT01729728|463459885|FG002|Overall Study|Protocol Violation|1|||
128772541|NCT02500979|463459886|FG000|Period 1|Hyperglycemia|1|||
128772542|NCT02500979|463459887|FG001|Period 1|Hyperglycemia|0|||
128772543|NCT02500979|463459886|FG000|Period 1|Severe non-compliance to protocol|0|||
128772544|NCT02500979|463459887|FG001|Period 1|Severe non-compliance to protocol|1|||
128772545|NCT02500979|463459886|FG000|Period 1|Adverse Event|1|||
128772546|NCT02500979|463459887|FG001|Period 1|Adverse Event|0|||
128772547|NCT02500979|463459886|FG000|Period 1|Subject decision|2|||
128967715|NCT01998906|464167409|FG000|Overall Study|Death|21|||
128967716|NCT01998906|464167410|FG001|Overall Study|Death|30|||
128967717|NCT01998906|464167411|FG002|Overall Study|Death|17|||
128967718|NCT01998906|464167409|FG000|Overall Study|Lack of Efficacy|10|||
128967719|NCT01998906|464167410|FG001|Overall Study|Lack of Efficacy|9|||
128967720|NCT01998906|464167411|FG002|Overall Study|Lack of Efficacy|8|||
128967721|NCT01998906|464167409|FG000|Overall Study|Failure to return|0|||
128967722|NCT01998906|464167410|FG001|Overall Study|Failure to return|2|||
128967723|NCT01998906|464167411|FG002|Overall Study|Failure to return|4|||
128967724|NCT01998906|464167409|FG000|Overall Study|Violation of Selection Criteria|0|||
128967725|NCT01998906|464167410|FG001|Overall Study|Violation of Selection Criteria|0|||
128967726|NCT01998906|464167411|FG002|Overall Study|Violation of Selection Criteria|1|||
128967727|NCT01998906|464167409|FG000|Overall Study|Withdrawal by Subject|1|||
128967728|NCT01998906|464167410|FG001|Overall Study|Withdrawal by Subject|4|||
129220283|NCT01519921|465106545|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
129220284|NCT04411667|465106548|FG000|Overall Study|Physician Decision|1|||
128713968|NCT01340898|463250735|FG000|Primary Phase|Withdrawal by Subject|8|||
128713969|NCT01340898|463250736|FG001|Primary Phase|Withdrawal by Subject|7|||
128713970|NCT01340898|463250737|FG002|Primary Phase|Withdrawal by Subject|5|||
128713971|NCT01340898|463250735|FG000|Primary Phase|Migrated/moved from study area|4|||
128713972|NCT01340898|463250736|FG001|Primary Phase|Migrated/moved from study area|1|||
128713973|NCT01340898|463250737|FG002|Primary Phase|Migrated/moved from study area|0|||
128713974|NCT01340898|463250735|FG000|Primary Phase|Lost to Follow-up|4|||
128713975|NCT01340898|463250736|FG001|Primary Phase|Lost to Follow-up|1|||
128713976|NCT01340898|463250737|FG002|Primary Phase|Lost to Follow-up|0|||
128713977|NCT01340898|463250735|FG000|Booster Phase|Withdrawal by Subject|3|||
128713978|NCT01340898|463250736|FG001|Booster Phase|Withdrawal by Subject|0|||
128713979|NCT01340898|463250737|FG002|Booster Phase|Withdrawal by Subject|4|||
128713980|NCT01340898|463250735|FG000|Booster Phase|Migrated/moved from study area|3|||
128713981|NCT01340898|463250736|FG001|Booster Phase|Migrated/moved from study area|0|||
128713982|NCT01340898|463250737|FG002|Booster Phase|Migrated/moved from study area|0|||
128713983|NCT01340898|463250735|FG000|Booster Phase|Lost to Follow-up|4|||
128713984|NCT01340898|463250736|FG001|Booster Phase|Lost to Follow-up|2|||
128713985|NCT01340898|463250737|FG002|Booster Phase|Lost to Follow-up|3|||
128713986|NCT01214629|463250739|FG000|Overall Study|Progressive Disease|1|||
128713987|NCT01214629|463250740|FG001|Overall Study|Progressive Disease|1|||
128713988|NCT01214629|463250741|FG002|Overall Study|Progressive Disease|0|||
128713989|NCT01214629|463250742|FG003|Overall Study|Progressive Disease|1|||
128713990|NCT01214629|463250743|FG004|Overall Study|Progressive Disease|2|||
128713991|NCT01214629|463250744|FG005|Overall Study|Progressive Disease|3|||
128713992|NCT01214629|463250745|FG006|Overall Study|Progressive Disease|1|||
128713993|NCT01214629|463250746|FG007|Overall Study|Progressive Disease|1|||
128713994|NCT01214629|463250747|FG008|Overall Study|Progressive Disease|1|||
128713995|NCT01214629|463250748|FG009|Overall Study|Progressive Disease|5|||
128713996|NCT01214629|463250749|FG010|Overall Study|Progressive Disease|1|||
128713997|NCT01214629|463250739|FG000|Overall Study|Adverse Event|0|||
128713998|NCT01214629|463250740|FG001|Overall Study|Adverse Event|0|||
128713999|NCT01214629|463250741|FG002|Overall Study|Adverse Event|0|||
128714000|NCT01214629|463250742|FG003|Overall Study|Adverse Event|1|||
128714001|NCT01214629|463250743|FG004|Overall Study|Adverse Event|0|||
128714002|NCT01214629|463250744|FG005|Overall Study|Adverse Event|1|||
128714003|NCT01214629|463250745|FG006|Overall Study|Adverse Event|0|||
128714004|NCT01214629|463250746|FG007|Overall Study|Adverse Event|0|||
128714005|NCT01214629|463250747|FG008|Overall Study|Adverse Event|0|||
128714006|NCT01214629|463250748|FG009|Overall Study|Adverse Event|1|||
128714007|NCT01214629|463250749|FG010|Overall Study|Adverse Event|0|||
128714008|NCT01214629|463250739|FG000|Overall Study|Physician Decision|0|||
128714009|NCT01214629|463250740|FG001|Overall Study|Physician Decision|0|||
128714010|NCT01214629|463250741|FG002|Overall Study|Physician Decision|0|||
128714011|NCT01214629|463250742|FG003|Overall Study|Physician Decision|0|||
128714012|NCT01214629|463250743|FG004|Overall Study|Physician Decision|0|||
128714013|NCT01214629|463250744|FG005|Overall Study|Physician Decision|0|||
128714014|NCT01214629|463250745|FG006|Overall Study|Physician Decision|0|||
128714015|NCT01214629|463250746|FG007|Overall Study|Physician Decision|0|||
128714016|NCT01214629|463250747|FG008|Overall Study|Physician Decision|0|||
128714017|NCT01214629|463250748|FG009|Overall Study|Physician Decision|0|||
128714018|NCT01214629|463250749|FG010|Overall Study|Physician Decision|1|||
128714019|NCT01214629|463250739|FG000|Overall Study|Withdrawal by Subject|0|||
128714020|NCT01214629|463250740|FG001|Overall Study|Withdrawal by Subject|0|||
128714021|NCT01214629|463250741|FG002|Overall Study|Withdrawal by Subject|0|||
128714022|NCT01214629|463250742|FG003|Overall Study|Withdrawal by Subject|0|||
128714023|NCT01214629|463250743|FG004|Overall Study|Withdrawal by Subject|0|||
128714024|NCT01214629|463250744|FG005|Overall Study|Withdrawal by Subject|0|||
128967729|NCT01998906|464167411|FG002|Overall Study|Withdrawal by Subject|3|||
128967730|NCT01998906|464167409|FG000|Overall Study|Administrative/Other|2|||
129220285|NCT04411667|465106549|FG001|Overall Study|Physician Decision|0|||
128714025|NCT01214629|463250745|FG006|Overall Study|Withdrawal by Subject|0|||
128714026|NCT01214629|463250746|FG007|Overall Study|Withdrawal by Subject|0|||
128714027|NCT01214629|463250747|FG008|Overall Study|Withdrawal by Subject|0|||
128714028|NCT01214629|463250748|FG009|Overall Study|Withdrawal by Subject|1|||
128714029|NCT01214629|463250749|FG010|Overall Study|Withdrawal by Subject|0|||
128714030|NCT02157298|463250752|FG000|Overall Study|Adverse Event|1|||
128714031|NCT02157298|463250753|FG001|Overall Study|Adverse Event|0|||
128714032|NCT02157298|463250752|FG000|Overall Study|Subject no longer meets study criteria|1|||
128772548|NCT02500979|463459887|FG001|Period 1|Subject decision|0|||
128772549|NCT02500979|463459886|FG000|Period 2|Change in risk|1|||
128772550|NCT02500979|463459887|FG001|Period 2|Change in risk|0|||
128772551|NCT01380990|463459890|FG000|Overall Study|Treatment Failure|1|||
128967731|NCT01998906|464167410|FG001|Overall Study|Administrative/Other|1|||
128772552|NCT01380990|463459891|FG001|Overall Study|Treatment Failure|0|||
128772553|NCT01380990|463459890|FG000|Overall Study|Death|0|||
128772554|NCT01380990|463459891|FG001|Overall Study|Death|1|||
128772555|NCT00672958|463459892|FG000|Overall Study|Adverse Event|11|||
128772556|NCT00672958|463459893|FG001|Overall Study|Adverse Event|9|||
128772557|NCT00672958|463459892|FG000|Overall Study|Lack of Efficacy|6|||
128967732|NCT01998906|464167411|FG002|Overall Study|Administrative/Other|3|||
128967733|NCT01998906|464167409|FG000|Overall Study|Other|3|||
128967734|NCT01998906|464167410|FG001|Overall Study|Other|8|||
128967735|NCT01998906|464167411|FG002|Overall Study|Other|4|||
128967736|NCT02996110|464167418|FG000|Pre-Treatment|Other Reasons|0|||
128967737|NCT02996110|464167419|FG001|Pre-Treatment|Other Reasons|1|||
128967738|NCT02996110|464167420|FG002|Pre-Treatment|Other Reasons|0|||
128967739|NCT02996110|464167421|FG003|Pre-Treatment|Other Reasons|0|||
128967740|NCT02996110|464167422|FG004|Pre-Treatment|Other Reasons|1|||
128967741|NCT02996110|464167418|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
128967742|NCT02996110|464167419|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
128967743|NCT02996110|464167420|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
128967744|NCT02996110|464167421|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
128967745|NCT02996110|464167422|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
128967746|NCT02996110|464167418|FG000|Track 1|Disease Progression|15|||
128967747|NCT02996110|464167419|FG001|Track 1|Disease Progression|17|||
128967748|NCT02996110|464167420|FG002|Track 1|Disease Progression|0|||
128967749|NCT02996110|464167421|FG003|Track 1|Disease Progression|0|||
128772558|NCT00672958|463459893|FG001|Overall Study|Lack of Efficacy|11|||
128772559|NCT00672958|463459892|FG000|Overall Study|Non-compliance with study drug|2|||
128772560|NCT00672958|463459893|FG001|Overall Study|Non-compliance with study drug|3|||
128772561|NCT00672958|463459892|FG000|Overall Study|Protocol deviations|11|||
128772562|NCT00672958|463459893|FG001|Overall Study|Protocol deviations|5|||
128772563|NCT00672958|463459892|FG000|Overall Study|Voluntary withdrawal|12|||
128772564|NCT00672958|463459893|FG001|Overall Study|Voluntary withdrawal|8|||
128772565|NCT00672958|463459892|FG000|Overall Study|Lost to Follow-up|22|||
128772566|NCT00672958|463459893|FG001|Overall Study|Lost to Follow-up|17|||
128772567|NCT00672958|463459892|FG000|Overall Study|Reason not specified|0|||
128772568|NCT00672958|463459893|FG001|Overall Study|Reason not specified|3|||
128772569|NCT04267614|463459894|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
128772570|NCT04267614|463459894|FG000|Overall Study|Lost to Follow-up|115|||
128772571|NCT00988351|463459895|FG000|Overall Study|Withdrawal by Subject|8|||
128772572|NCT00988351|463459896|FG001|Overall Study|Withdrawal by Subject|0|||
128772573|NCT00988351|463459895|FG000|Overall Study|Lost to Follow-up|6|||
128772574|NCT00988351|463459896|FG001|Overall Study|Lost to Follow-up|9|||
128772575|NCT00988351|463459895|FG000|Overall Study|not using CPAP|5|||
128772576|NCT00988351|463459896|FG001|Overall Study|not using CPAP|3|||
128772577|NCT01927731|463459904|FG000|Overall Study|Graft Failure|1|||
128772578|NCT01927731|463459905|FG001|Overall Study|Graft Failure|2|||
128772579|NCT01927731|463459904|FG000|Overall Study|Physician Decision|2|||
128772580|NCT01927731|463459905|FG001|Overall Study|Physician Decision|3|||
128772581|NCT01927731|463459904|FG000|Overall Study|Withdrawal by Subject|0|||
128772582|NCT01927731|463459905|FG001|Overall Study|Withdrawal by Subject|2|||
128772583|NCT01927731|463459904|FG000|Overall Study|Death|0|||
128772584|NCT01927731|463459905|FG001|Overall Study|Death|3|||
128772585|NCT01388530|463459908|FG000|Overall Study|Lost to Follow-up|5|||
128772586|NCT02836613|463459911|FG000|Overall Study|Accidental drowning|1|||
128772587|NCT02836613|463459912|FG001|Overall Study|Accidental drowning|0|||
128772588|NCT02836613|463459911|FG000|Overall Study|Lost to Follow-up|0|||
128772589|NCT02836613|463459912|FG001|Overall Study|Lost to Follow-up|1|||
128772590|NCT02836613|463459911|FG000|Overall Study|Withdrawal by Subject|0|||
128772591|NCT02836613|463459912|FG001|Overall Study|Withdrawal by Subject|2|||
128772592|NCT03881059|463459913|FG000|Treatment Period - Part A|Adverse Event|1|||
128772593|NCT03881059|463459914|FG001|Treatment Period - Part A|Adverse Event|3|||
128772594|NCT03881059|463459915|FG002|Treatment Period - Part A|Adverse Event|4|||
128967750|NCT02996110|464167422|FG004|Track 1|Disease Progression|0|||
128772595|NCT03881059|463459913|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
128772596|NCT03881059|463459914|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
128772597|NCT03881059|463459915|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
128772598|NCT03881059|463459913|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
128772599|NCT03881059|463459914|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
128772600|NCT03881059|463459915|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
128772601|NCT03881059|463459913|FG000|Treatment Period - Part A|Other reasons|2|||
128967751|NCT02996110|464167418|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
128967752|NCT02996110|464167419|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
129038018|NCT02400476|464430562|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
128772602|NCT03881059|463459914|FG001|Treatment Period - Part A|Other reasons|1|||
128772603|NCT03881059|463459915|FG002|Treatment Period - Part A|Other reasons|0|||
128772604|NCT03881059|463459913|FG000|Treatment Period - Part B|Adverse Event|0|||
128772605|NCT03881059|463459914|FG001|Treatment Period - Part B|Adverse Event|0|||
128772606|NCT03881059|463459915|FG002|Treatment Period - Part B|Adverse Event|3|||
128772607|NCT03881059|463459913|FG000|Treatment Period - Part B|Death|0|||
128772608|NCT03881059|463459914|FG001|Treatment Period - Part B|Death|1|||
128772609|NCT03881059|463459915|FG002|Treatment Period - Part B|Death|1|||
128967753|NCT02996110|464167420|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
128967754|NCT02996110|464167421|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
128967755|NCT02996110|464167422|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
128967756|NCT02996110|464167418|FG000|Track 1|Study Drug Toxicity|5|||
128967757|NCT02996110|464167419|FG001|Track 1|Study Drug Toxicity|3|||
128967758|NCT02996110|464167420|FG002|Track 1|Study Drug Toxicity|0|||
128967759|NCT02996110|464167421|FG003|Track 1|Study Drug Toxicity|0|||
128967760|NCT02996110|464167422|FG004|Track 1|Study Drug Toxicity|0|||
128967761|NCT02996110|464167418|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
128772610|NCT03881059|463459913|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
128772611|NCT03881059|463459914|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
128772612|NCT03881059|463459915|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
128772613|NCT03881059|463459913|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
128772614|NCT03881059|463459914|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
128772615|NCT03881059|463459915|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
128772616|NCT03881059|463459913|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
128772617|NCT03881059|463459914|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
128772618|NCT03881059|463459915|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
128967762|NCT02996110|464167419|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
128967763|NCT02996110|464167420|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
128967764|NCT02996110|464167421|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
128967765|NCT02996110|464167422|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
128967766|NCT02996110|464167418|FG000|Track 1|Administrative Reason by Sponsor|0|||
128967767|NCT02996110|464167419|FG001|Track 1|Administrative Reason by Sponsor|1|||
128967768|NCT02996110|464167420|FG002|Track 1|Administrative Reason by Sponsor|0|||
128967769|NCT02996110|464167421|FG003|Track 1|Administrative Reason by Sponsor|0|||
128967770|NCT02996110|464167422|FG004|Track 1|Administrative Reason by Sponsor|0|||
128967771|NCT02996110|464167418|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
128967772|NCT02996110|464167419|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
128967773|NCT02996110|464167420|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
128967774|NCT02996110|464167421|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
128967775|NCT02996110|464167422|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
128967776|NCT02996110|464167418|FG000|Track 2|Disease Progression|33|||
128967777|NCT02996110|464167419|FG001|Track 2|Disease Progression|26|||
128967778|NCT02996110|464167420|FG002|Track 2|Disease Progression|19|||
128967779|NCT02996110|464167421|FG003|Track 2|Disease Progression|16|||
128967780|NCT02996110|464167422|FG004|Track 2|Disease Progression|15|||
128967781|NCT02996110|464167418|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
128967782|NCT02996110|464167419|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
128967783|NCT02996110|464167420|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
128967784|NCT02996110|464167421|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
128967785|NCT02996110|464167422|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
128967786|NCT02996110|464167418|FG000|Track 2|Death|0|||
128967787|NCT02996110|464167419|FG001|Track 2|Death|0|||
128967788|NCT02996110|464167420|FG002|Track 2|Death|1|||
128967789|NCT02996110|464167421|FG003|Track 2|Death|0|||
128967790|NCT02996110|464167422|FG004|Track 2|Death|1|||
128772619|NCT03881059|463459913|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
128772620|NCT03881059|463459914|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
128772621|NCT03881059|463459915|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
128772622|NCT03881059|463459913|FG000|Treatment Period - Part B|Other reasons|4|||
128772623|NCT03881059|463459914|FG001|Treatment Period - Part B|Other reasons|3|||
128772624|NCT03881059|463459915|FG002|Treatment Period - Part B|Other reasons|3|||
128772625|NCT05284019|463459916|FG000|Overall Study|Study terminated|2|||
128772626|NCT05284019|463459917|FG001|Overall Study|Study terminated|2|||
128772627|NCT05284019|463459918|FG002|Overall Study|Study terminated|2|||
128772628|NCT05284019|463459919|FG003|Overall Study|Study terminated|5|||
128967791|NCT02996110|464167418|FG000|Track 2|Study Drug Toxicity|4|||
128967792|NCT02996110|464167419|FG001|Track 2|Study Drug Toxicity|1|||
128967793|NCT02996110|464167420|FG002|Track 2|Study Drug Toxicity|4|||
128967794|NCT02996110|464167421|FG003|Track 2|Study Drug Toxicity|1|||
128967795|NCT02996110|464167422|FG004|Track 2|Study Drug Toxicity|0|||
128967796|NCT02996110|464167418|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
128967797|NCT02996110|464167419|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
128772629|NCT05284019|463459920|FG004|Overall Study|Study terminated|15|||
128772630|NCT05284019|463459916|FG000|Overall Study|Withdrawal by Subject|0|||
128772631|NCT05284019|463459917|FG001|Overall Study|Withdrawal by Subject|0|||
128772632|NCT05284019|463459918|FG002|Overall Study|Withdrawal by Subject|0|||
128967798|NCT02996110|464167420|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
128967799|NCT02996110|464167421|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
128967800|NCT02996110|464167422|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
128967801|NCT02996110|464167418|FG000|Track 2|Participant Withdrew Consent|1|||
128967802|NCT02996110|464167419|FG001|Track 2|Participant Withdrew Consent|2|||
128967803|NCT02996110|464167420|FG002|Track 2|Participant Withdrew Consent|3|||
128967804|NCT02996110|464167421|FG003|Track 2|Participant Withdrew Consent|1|||
128967805|NCT02996110|464167422|FG004|Track 2|Participant Withdrew Consent|1|||
128967806|NCT02996110|464167418|FG000|Track 2|Other Reasons|0|||
128967807|NCT02996110|464167419|FG001|Track 2|Other Reasons|0|||
128967808|NCT02996110|464167420|FG002|Track 2|Other Reasons|1|||
128967809|NCT02996110|464167421|FG003|Track 2|Other Reasons|0|||
128967810|NCT02996110|464167422|FG004|Track 2|Other Reasons|1|||
128967811|NCT01938391|464167423|FG000|6 Month Follow up|Withdrawal by Subject|1|||
128967812|NCT01938391|464167423|FG000|12 Month Follow up|Physician Decision|1|||
128967813|NCT01938391|464167423|FG000|12 Month Follow up|Withdrawal by Subject|1|||
128772633|NCT05284019|463459919|FG003|Overall Study|Withdrawal by Subject|1|||
128772634|NCT05284019|463459920|FG004|Overall Study|Withdrawal by Subject|1|||
128772635|NCT05284019|463459916|FG000|Overall Study|Lost to Follow-up|1|||
128772636|NCT05284019|463459917|FG001|Overall Study|Lost to Follow-up|0|||
128772637|NCT05284019|463459918|FG002|Overall Study|Lost to Follow-up|0|||
128772638|NCT05284019|463459919|FG003|Overall Study|Lost to Follow-up|2|||
128772639|NCT05284019|463459920|FG004|Overall Study|Lost to Follow-up|1|||
128772640|NCT02065570|463459921|FG000|Induction Study|Adverse Event|5|||
128772641|NCT02065570|463459922|FG001|Induction Study|Adverse Event|12|||
128772642|NCT02065570|463459923|FG002|Induction Study|Adverse Event|0|||
128772643|NCT02065570|463459924|FG003|Induction Study|Adverse Event|0|||
128772644|NCT02065570|463459921|FG000|Induction Study|Withdrawal by Subject|2|||
128772645|NCT02065570|463459922|FG001|Induction Study|Withdrawal by Subject|3|||
128772646|NCT02065570|463459923|FG002|Induction Study|Withdrawal by Subject|0|||
128967814|NCT01077193|464167424|FG000|Overall Study|Lost to Follow-up|1|||
128967815|NCT01077193|464167424|FG000|Overall Study|Withdrawal by Subject|2|||
128967816|NCT01077193|464167424|FG000|Overall Study|Lack of Efficacy|1|||
128967817|NCT01077193|464167424|FG000|Overall Study|Study Terminated by Sponsor|40|||
128967818|NCT01536418|464167435|FG000|Overall Study|Protocol Violation|2|||
128967819|NCT01536418|464167436|FG001|Overall Study|Protocol Violation|3|||
128967820|NCT01536418|464167435|FG000|Overall Study|Physician Decision|1|||
128967821|NCT01536418|464167436|FG001|Overall Study|Physician Decision|3|||
128967822|NCT01536418|464167435|FG000|Overall Study|Study closed/terminated|41|||
128967823|NCT01536418|464167436|FG001|Overall Study|Study closed/terminated|37|||
128967824|NCT01536418|464167435|FG000|Overall Study|Lack of Efficacy|10|||
128967825|NCT01536418|464167436|FG001|Overall Study|Lack of Efficacy|16|||
128967826|NCT01536418|464167435|FG000|Overall Study|Adverse Event|9|||
128967827|NCT01536418|464167436|FG001|Overall Study|Adverse Event|4|||
128967828|NCT01536418|464167435|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
128967829|NCT01536418|464167436|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
128967830|NCT01536418|464167435|FG000|Overall Study|Withdrawal by Subject|5|||
128967831|NCT01536418|464167436|FG001|Overall Study|Withdrawal by Subject|3|||
128967832|NCT03687827|464167437|FG000|Treatment Period 1|Death|0|||
128967833|NCT03687827|464167438|FG001|Treatment Period 1|Death|1|||
128967834|NCT03687827|464167437|FG000|Treatment Period 1|Lost to Follow-up|2|||
128967835|NCT03687827|464167438|FG001|Treatment Period 1|Lost to Follow-up|2|||
128967836|NCT03687827|464167437|FG000|Treatment Period 1|Physician Decision|5|||
128967837|NCT03687827|464167438|FG001|Treatment Period 1|Physician Decision|2|||
128967838|NCT03687827|464167437|FG000|Treatment Period 1|Withdrawal by Subject|7|||
128967839|NCT03687827|464167438|FG001|Treatment Period 1|Withdrawal by Subject|3|||
128967840|NCT03687827|464167437|FG000|Treatment Period 2|Physician Decision|4|||
128967841|NCT03687827|464167438|FG001|Treatment Period 2|Physician Decision|1|||
128967842|NCT03687827|464167437|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128772647|NCT02065570|463459924|FG003|Induction Study|Withdrawal by Subject|0|||
128772648|NCT02065570|463459921|FG000|Induction Study|Lost to Follow-up|1|||
128772649|NCT02065570|463459922|FG001|Induction Study|Lost to Follow-up|1|||
128772650|NCT02065570|463459923|FG002|Induction Study|Lost to Follow-up|0|||
128772651|NCT02065570|463459924|FG003|Induction Study|Lost to Follow-up|0|||
128772652|NCT02065570|463459921|FG000|Induction Study|Other, Not Specified|6|||
128772653|NCT02065570|463459922|FG001|Induction Study|Other, Not Specified|5|||
128772654|NCT02065570|463459923|FG002|Induction Study|Other, Not Specified|0|||
128772655|NCT02065570|463459924|FG003|Induction Study|Other, Not Specified|0|||
128772656|NCT02065570|463459921|FG000|Maintenance Study|Adverse Event|0|||
128772657|NCT02065570|463459922|FG001|Maintenance Study|Adverse Event|0|||
128967843|NCT03687827|464167438|FG001|Treatment Period 2|Withdrawal by Subject|2|||
128967844|NCT03748420|464167440|FG000|Overall Study|No 12 month medication adherence data available|0|||
128967845|NCT03748420|464167441|FG001|Overall Study|No 12 month medication adherence data available|1|||
128967846|NCT03748420|464167440|FG000|Overall Study|Death|24|||
128967847|NCT03748420|464167441|FG001|Overall Study|Death|28|||
128772658|NCT02065570|463459923|FG002|Maintenance Study|Adverse Event|8|||
128772659|NCT02065570|463459924|FG003|Maintenance Study|Adverse Event|8|||
128772660|NCT02065570|463459921|FG000|Maintenance Study|Withdrawal by Subject|0|||
128772661|NCT02065570|463459922|FG001|Maintenance Study|Withdrawal by Subject|0|||
128772662|NCT02065570|463459923|FG002|Maintenance Study|Withdrawal by Subject|1|||
128772663|NCT02065570|463459924|FG003|Maintenance Study|Withdrawal by Subject|4|||
128772664|NCT02065570|463459921|FG000|Maintenance Study|Lost to Follow-up|0|||
128772665|NCT02065570|463459922|FG001|Maintenance Study|Lost to Follow-up|0|||
128772666|NCT02065570|463459923|FG002|Maintenance Study|Lost to Follow-up|2|||
128772667|NCT02065570|463459924|FG003|Maintenance Study|Lost to Follow-up|2|||
128772668|NCT02065570|463459921|FG000|Maintenance Study|Other, Not Specified|0|||
128772669|NCT02065570|463459922|FG001|Maintenance Study|Other, Not Specified|0|||
128772670|NCT02065570|463459923|FG002|Maintenance Study|Other, Not Specified|11|||
128772671|NCT02065570|463459924|FG003|Maintenance Study|Other, Not Specified|5|||
128772672|NCT01266993|463459925|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
128772673|NCT01266993|463459926|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
128772674|NCT01266993|463459925|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
128772675|NCT01266993|463459926|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
128772676|NCT02293837|463459929|FG000|Overall Study|Lost to Follow-up|0|||
128772677|NCT02293837|463459930|FG001|Overall Study|Lost to Follow-up|2|||
128772678|NCT02293837|463459931|FG002|Overall Study|Lost to Follow-up|1|||
128772679|NCT02293837|463459932|FG003|Overall Study|Lost to Follow-up|0|||
128772680|NCT02293837|463459929|FG000|Overall Study|Withdrawal by Subject|2|||
128772681|NCT02293837|463459930|FG001|Overall Study|Withdrawal by Subject|1|||
128772682|NCT02293837|463459931|FG002|Overall Study|Withdrawal by Subject|2|||
128772683|NCT02293837|463459932|FG003|Overall Study|Withdrawal by Subject|1|||
128772684|NCT02293837|463459929|FG000|Overall Study|COVID-19 Related|1|||
128772685|NCT02293837|463459930|FG001|Overall Study|COVID-19 Related|1|||
128772686|NCT02293837|463459931|FG002|Overall Study|COVID-19 Related|0|||
128772687|NCT02293837|463459932|FG003|Overall Study|COVID-19 Related|0|||
128772688|NCT02293837|463459929|FG000|Overall Study|Participant ill and could not be infused|0|||
128772689|NCT02293837|463459930|FG001|Overall Study|Participant ill and could not be infused|0|||
128772690|NCT02293837|463459931|FG002|Overall Study|Participant ill and could not be infused|1|||
128772691|NCT02293837|463459932|FG003|Overall Study|Participant ill and could not be infused|0|||
128772692|NCT04779242|463459933|FG000|Overall Study|Adverse Event|1|||
128772693|NCT04779242|463459934|FG001|Overall Study|Adverse Event|1|||
128772694|NCT04779242|463459933|FG000|Overall Study|Lost to Follow-up|2|||
128772695|NCT04779242|463459934|FG001|Overall Study|Lost to Follow-up|4|||
128772696|NCT04779242|463459933|FG000|Overall Study|Withdrawal by Subject|7|||
128772697|NCT04779242|463459934|FG001|Overall Study|Withdrawal by Subject|9|||
128772698|NCT04779242|463459933|FG000|Overall Study|Death|6|||
128772699|NCT04779242|463459934|FG001|Overall Study|Death|6|||
128772700|NCT04779242|463459933|FG000|Overall Study|COVID-19 related reasons|2|||
128772701|NCT04779242|463459934|FG001|Overall Study|COVID-19 related reasons|1|||
128772702|NCT04779242|463459933|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
128772703|NCT04779242|463459934|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
128772704|NCT04779242|463459933|FG000|Overall Study|Martial Law in Ukraine|2|||
128772705|NCT04779242|463459934|FG001|Overall Study|Martial Law in Ukraine|3|||
128772706|NCT03382600|463459937|FG000|Overall Study|Adverse Event|3|||
128772707|NCT03382600|463459938|FG001|Overall Study|Adverse Event|3|||
128772708|NCT03382600|463459937|FG000|Overall Study|Clinical Disease Progression|2|||
128772709|NCT03382600|463459938|FG001|Overall Study|Clinical Disease Progression|4|||
128772710|NCT03382600|463459937|FG000|Overall Study|Radiological Progression|40|||
128772711|NCT03382600|463459938|FG001|Overall Study|Radiological Progression|31|||
128772712|NCT03382600|463459937|FG000|Overall Study|Withdrawal by Subject|0|||
128772713|NCT03382600|463459938|FG001|Overall Study|Withdrawal by Subject|1|||
128772714|NCT03382600|463459937|FG000|Overall Study|Other|9|||
128772715|NCT03382600|463459938|FG001|Overall Study|Other|7|||
128772716|NCT01448044|463459939|FG000|Treatment Period|Adverse Event|4|||
128772717|NCT01448044|463459940|FG001|Treatment Period|Adverse Event|3|||
128772718|NCT01448044|463459939|FG000|Treatment Period|Lack of Efficacy|5|||
128772719|NCT01448044|463459940|FG001|Treatment Period|Lack of Efficacy|12|||
128772720|NCT01448044|463459939|FG000|Treatment Period|Subject requested discontinue study drug|1|||
128772721|NCT01448044|463459940|FG001|Treatment Period|Subject requested discontinue study drug|0|||
128772722|NCT01448044|463459939|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
128772723|NCT01448044|463459940|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
128772724|NCT01448044|463459939|FG000|Treatment Period|Participant does not meet study criteria|1|||
128772725|NCT01448044|463459940|FG001|Treatment Period|Participant does not meet study criteria|0|||
128772726|NCT01448044|463459939|FG000|Treatment Period|Lost to Follow-up|2|||
128772727|NCT01448044|463459940|FG001|Treatment Period|Lost to Follow-up|1|||
128772728|NCT01448044|463459939|FG000|Treatment Period|Other reason|2|||
128772729|NCT01448044|463459940|FG001|Treatment Period|Other reason|0|||
128772730|NCT01448044|463459939|FG000|Follow Up Period|Withdrawal by Subject|1|||
128772731|NCT01448044|463459940|FG001|Follow Up Period|Withdrawal by Subject|1|||
128772732|NCT01448044|463459939|FG000|Follow Up Period|Lost to Follow-up|6|||
128772733|NCT01448044|463459940|FG001|Follow Up Period|Lost to Follow-up|2|||
128772734|NCT01448044|463459939|FG000|Follow Up Period|Other|5|||
128772735|NCT01448044|463459940|FG001|Follow Up Period|Other|11|||
128772736|NCT01000376|463459941|FG000|Cycle 1 Day 1|Adverse Event|1|||
128772737|NCT01000376|463459942|FG001|Cycle 1 Day 1|Adverse Event|0|||
128772738|NCT01000376|463459941|FG000|Cycle 1 Day 1|Progressive Disease|1|||
128967848|NCT03748420|464167440|FG000|Overall Study|Lost to Follow-up|231|||
128967849|NCT03748420|464167441|FG001|Overall Study|Lost to Follow-up|230|||
128772739|NCT01000376|463459942|FG001|Cycle 1 Day 1|Progressive Disease|0|||
128772740|NCT00896454|463459943|FG000|Overall Study|Death|10|||
128772741|NCT00896454|463459943|FG000|Overall Study|Adverse Event|8|||
128772742|NCT00896454|463459943|FG000|Overall Study|Disease Progression|5|||
128772743|NCT00896454|463459943|FG000|Overall Study|Other|4|||
128772744|NCT00896454|463459943|FG000|Overall Study|Requirement for alternative therapy|3|||
128967850|NCT01466062|464167443|FG000|Overall Study|Adverse Event|1|||
128967851|NCT01466062|464167443|FG000|Overall Study|Withdrawal by Subject|1|||
128967852|NCT02865928|464167444|FG000|Overall Study|Withdrawal by Subject|1|||
128967853|NCT02865928|464167445|FG001|Overall Study|Withdrawal by Subject|0|||
128967854|NCT02865928|464167444|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
128967855|NCT02865928|464167445|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
128967856|NCT02865928|464167444|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
128967857|NCT02865928|464167445|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
128967858|NCT03152110|464167452|FG000|Overall Study|Withdrawal by Subject|3|||
128967859|NCT01925014|464167453|FG000|Overall Study|Inappropriate enrollment|4|||
128967860|NCT01925014|464167454|FG001|Overall Study|Inappropriate enrollment|6|||
128967861|NCT01925014|464167453|FG000|Overall Study|Withdrawal by Subject|5|||
128967862|NCT01925014|464167454|FG001|Overall Study|Withdrawal by Subject|13|||
128967863|NCT03696576|464167462|FG000|Overall Study|Soreness of throat after therapy|1|||
128967864|NCT03696576|464167463|FG001|Overall Study|Soreness of throat after therapy|1|||
128967865|NCT03696576|464167462|FG000|Overall Study|Lost to Follow-up|2|||
128967866|NCT03696576|464167463|FG001|Overall Study|Lost to Follow-up|4|||
128967867|NCT00312728|464167464|FG000|Overall Study|Progressive disease|53|||
128967868|NCT00312728|464167464|FG000|Overall Study|Adverse Event|32|||
128967869|NCT00312728|464167464|FG000|Overall Study|Withdrawal by Subject|10|||
128967870|NCT00312728|464167464|FG000|Overall Study|Required non-protocol cancer treatment|2|||
128967871|NCT00312728|464167464|FG000|Overall Study|Protocol Violation|2|||
128967872|NCT00312728|464167464|FG000|Overall Study|Other|10|||
128967873|NCT00312728|464167464|FG000|Overall Study|Other|1|||
128967874|NCT00850135|464167465|FG000|Overall Study|Physician Decision|1|||
128967875|NCT01487863|464167470|FG000|Overall Study|Death|19|||
128967876|NCT01487863|464167471|FG001|Overall Study|Death|19|||
128967877|NCT04259346|464167472|FG000|Overall Study|Lost to Follow-up|1|||
128967878|NCT04259346|464167473|FG001|Overall Study|Lost to Follow-up|3|||
128967879|NCT04259346|464167472|FG000|Overall Study|Protocol Violation|1|||
128967880|NCT04259346|464167473|FG001|Overall Study|Protocol Violation|0|||
128967881|NCT04259346|464167472|FG000|Overall Study|Withdrawal by Subject|1|||
128967882|NCT04259346|464167473|FG001|Overall Study|Withdrawal by Subject|0|||
128967883|NCT04259346|464167472|FG000|Overall Study|Adverse Event|1|||
128967884|NCT04259346|464167473|FG001|Overall Study|Adverse Event|1|||
128967885|NCT00623766|464167477|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
128967886|NCT00623766|464167478|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
128967887|NCT00623766|464167477|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
128967888|NCT00623766|464167478|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
128967889|NCT00623766|464167477|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
128967890|NCT00623766|464167478|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
128967891|NCT00623766|464167477|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
128967892|NCT00623766|464167478|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
128967893|NCT00623766|464167477|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
128967894|NCT00623766|464167478|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
128967895|NCT00486889|464167479|FG000|Overall Study|Death|3|||
129130392|NCT04470427|464768790|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
128772745|NCT00896454|463459943|FG000|Overall Study|Ongoing in study|2|||
128772746|NCT00896454|463459943|FG000|Overall Study|Withdrawal by Subject|1|||
128772747|NCT03688711|463459944|FG000|Overall Study|Withdrawal by Subject|0|||
128772748|NCT03688711|463459945|FG001|Overall Study|Withdrawal by Subject|1|||
128967896|NCT00486889|464167479|FG000|Overall Study|Non-compliant|2|||
128967897|NCT00486889|464167479|FG000|Overall Study|Withdrawal by Subject|6|||
128967898|NCT00893763|464167480|FG000|Overall Study|extubated|110|||
128772749|NCT03560245|463459950|FG000|Overall Study|Withdrawal by Subject|3|||
128772750|NCT03560245|463459951|FG001|Overall Study|Withdrawal by Subject|2|||
128967899|NCT00893763|464167481|FG001|Overall Study|extubated|110|||
128967900|NCT00422903|464167493|FG000|Overall Study|Disease Progression|3|||
128772751|NCT03560245|463459950|FG000|Overall Study|Adverse Event|1|||
128772752|NCT03560245|463459951|FG001|Overall Study|Adverse Event|1|||
128772753|NCT03560245|463459950|FG000|Overall Study|Protocol Violation|1|||
128772754|NCT03560245|463459951|FG001|Overall Study|Protocol Violation|0|||
128967901|NCT00422903|464167494|FG001|Overall Study|Disease Progression|1|||
128967902|NCT00422903|464167493|FG000|Overall Study|Adverse Event|0|||
128967903|NCT00422903|464167494|FG001|Overall Study|Adverse Event|2|||
128967904|NCT00422903|464167493|FG000|Overall Study|Informed Consent Withdrawn|1|||
128967905|NCT00422903|464167494|FG001|Overall Study|Informed Consent Withdrawn|2|||
128967906|NCT00441480|464167498|FG000|Overall Study|Protocol Violation|1|||
128967907|NCT00441480|464167499|FG001|Overall Study|Protocol Violation|1|||
129220286|NCT00067002|465106550|FG000|Overall Study|Early Death|1|||
128714033|NCT02157298|463250753|FG001|Overall Study|Subject no longer meets study criteria|2|||
128714034|NCT02157298|463250752|FG000|Overall Study|Poor/Non-compliance|1|||
128772755|NCT03560245|463459950|FG000|Overall Study|Death|0|||
128772756|NCT03560245|463459951|FG001|Overall Study|Death|1|||
128772757|NCT03560245|463459950|FG000|Overall Study|Lost to Follow-up|0|||
128772758|NCT03560245|463459951|FG001|Overall Study|Lost to Follow-up|1|||
128772759|NCT03560245|463459950|FG000|Overall Study|Physician Decision|0|||
128772760|NCT03560245|463459951|FG001|Overall Study|Physician Decision|1|||
128772761|NCT03560245|463459950|FG000|Overall Study|Other|0|||
128772762|NCT03560245|463459951|FG001|Overall Study|Other|1|||
128772763|NCT02058290|463459969|FG000|Overall Study|Protocol Violation|2|||
128772764|NCT02058290|463459970|FG001|Overall Study|Protocol Violation|1|||
128772765|NCT02058290|463459969|FG000|Overall Study|Physician Decision|1|||
128772766|NCT02058290|463459970|FG001|Overall Study|Physician Decision|0|||
128772767|NCT02058290|463459969|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
128772768|NCT02058290|463459970|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
128772769|NCT02058290|463459969|FG000|Overall Study|Withdrawal by Subject|0|||
128772770|NCT02058290|463459970|FG001|Overall Study|Withdrawal by Subject|1|||
128772771|NCT01291225|463459971|FG000|Overall Study|Lost to Follow-up|85|||
128772772|NCT01291225|463459972|FG001|Overall Study|Lost to Follow-up|39|||
128772773|NCT01267253|463459973|FG000|Overall Study|Ineligible - required test not done|1|||
128772774|NCT01267253|463459973|FG000|Overall Study|Inevaluable-never received study treatme|2|||
128772775|NCT04318093|463459974|FG000|Overall Study|Adverse Event|2|||
128772776|NCT04318093|463459975|FG001|Overall Study|Adverse Event|2|||
128714035|NCT02157298|463250753|FG001|Overall Study|Poor/Non-compliance|0|||
128714036|NCT02157298|463250752|FG000|Overall Study|Withdrawal by Subject|1|||
128714037|NCT02157298|463250753|FG001|Overall Study|Withdrawal by Subject|0|||
128714038|NCT03171415|463250754|FG000|Overall Study|Lost to Follow-up|0|||
128714039|NCT03171415|463250755|FG001|Overall Study|Lost to Follow-up|0|||
128714040|NCT03171415|463250756|FG002|Overall Study|Lost to Follow-up|0|||
128714041|NCT03171415|463250757|FG003|Overall Study|Lost to Follow-up|0|||
128714042|NCT03171415|463250758|FG004|Overall Study|Lost to Follow-up|2|||
128714043|NCT04059094|463250759|FG000|Overall Study|Adverse Event|0|||
128714044|NCT04059094|463250760|FG001|Overall Study|Adverse Event|0|||
128714045|NCT04059094|463250761|FG002|Overall Study|Adverse Event|0|||
128714046|NCT04059094|463250762|FG003|Overall Study|Adverse Event|0|||
128714047|NCT04059094|463250763|FG004|Overall Study|Adverse Event|1|||
128714048|NCT04059094|463250759|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
128714049|NCT04059094|463250760|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
128714050|NCT04059094|463250761|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
128714051|NCT04059094|463250762|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
128714052|NCT04059094|463250763|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
128714053|NCT00883116|463250768|FG000|Overall Study|Adverse event unrelated to study drug|5|||
128714054|NCT00883116|463250769|FG001|Overall Study|Adverse event unrelated to study drug|10|||
128714055|NCT00883116|463250768|FG000|Overall Study|Death|6|||
128714056|NCT00883116|463250769|FG001|Overall Study|Death|2|||
128714057|NCT00883116|463250768|FG000|Overall Study|Disease progression|130|||
128714058|NCT00883116|463250769|FG001|Overall Study|Disease progression|128|||
128714059|NCT00883116|463250768|FG000|Overall Study|Lost to Follow-up|0|||
128714060|NCT00883116|463250769|FG001|Overall Study|Lost to Follow-up|1|||
128714061|NCT00883116|463250768|FG000|Overall Study|Maximum clinical benefit|13|||
128714062|NCT00883116|463250769|FG001|Overall Study|Maximum clinical benefit|46|||
128772777|NCT04318093|463459974|FG000|Overall Study|Participant withdrew consent|1|||
128772778|NCT04318093|463459975|FG001|Overall Study|Participant withdrew consent|0|||
128772779|NCT04318093|463459974|FG000|Overall Study|Other reasons|0|||
128772780|NCT04318093|463459975|FG001|Overall Study|Other reasons|1|||
128772781|NCT02855164|463459978|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
128967908|NCT00441480|464167498|FG000|Overall Study|Withdrawal by Subject|2|||
128967909|NCT00441480|464167499|FG001|Overall Study|Withdrawal by Subject|3|||
128967910|NCT02699125|464167500|FG000|Placebo|Lost to Follow-up|2|||
128714063|NCT00883116|463250768|FG000|Overall Study|Not identified|3|||
128714064|NCT00883116|463250769|FG001|Overall Study|Not identified|6|||
128714065|NCT00883116|463250768|FG000|Overall Study|Study drug toxicity|36|||
128714066|NCT00883116|463250769|FG001|Overall Study|Study drug toxicity|16|||
128714067|NCT00883116|463250768|FG000|Overall Study|Withdrawal by Subject|14|||
128714068|NCT00883116|463250769|FG001|Overall Study|Withdrawal by Subject|8|||
128714069|NCT00883116|463250768|FG000|Overall Study|No longer meets study criteria|2|||
128772782|NCT02855164|463459979|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
128772783|NCT02855164|463459980|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
128772784|NCT02855164|463459981|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
128772785|NCT02855164|463459982|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
128772786|NCT02855164|463459983|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
128772787|NCT02855164|463459984|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
128772788|NCT02855164|463459985|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
128772789|NCT02855164|463459978|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
128772790|NCT02855164|463459979|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
128772791|NCT02855164|463459980|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
128772792|NCT02855164|463459981|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
128772793|NCT02855164|463459982|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
128772794|NCT02855164|463459983|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
128772795|NCT02855164|463459984|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
128772796|NCT02855164|463459985|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
128772797|NCT02855164|463459978|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
128772798|NCT02855164|463459979|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
128772799|NCT02855164|463459980|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
128772800|NCT02855164|463459981|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
128772801|NCT02855164|463459982|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
128772802|NCT02855164|463459983|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
128772803|NCT02855164|463459984|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
128772804|NCT02855164|463459985|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
128772805|NCT02855164|463459978|FG000|Part C (Randomized Set)|Adverse Event|0|||
128772806|NCT02855164|463459979|FG001|Part C (Randomized Set)|Adverse Event|0|||
128772807|NCT02855164|463459980|FG002|Part C (Randomized Set)|Adverse Event|0|||
128772808|NCT02855164|463459981|FG003|Part C (Randomized Set)|Adverse Event|0|||
128772809|NCT02855164|463459982|FG004|Part C (Randomized Set)|Adverse Event|0|||
128772810|NCT02855164|463459983|FG005|Part C (Randomized Set)|Adverse Event|5|||
128772811|NCT02855164|463459984|FG006|Part C (Randomized Set)|Adverse Event|9|||
128772812|NCT02855164|463459985|FG007|Part C (Randomized Set)|Adverse Event|2|||
128772813|NCT02855164|463459978|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
128772814|NCT02855164|463459979|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
128772815|NCT02855164|463459980|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
128772816|NCT02855164|463459981|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
128772817|NCT02855164|463459982|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
128772818|NCT02855164|463459983|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
128772819|NCT02855164|463459984|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
128772820|NCT02855164|463459985|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
128772821|NCT02855164|463459978|FG000|Part C (Randomized Set)|Physician Decision|0|||
128772822|NCT02855164|463459979|FG001|Part C (Randomized Set)|Physician Decision|0|||
128772823|NCT02855164|463459980|FG002|Part C (Randomized Set)|Physician Decision|0|||
128772824|NCT02855164|463459981|FG003|Part C (Randomized Set)|Physician Decision|0|||
128772825|NCT02855164|463459982|FG004|Part C (Randomized Set)|Physician Decision|0|||
128772826|NCT02855164|463459983|FG005|Part C (Randomized Set)|Physician Decision|1|||
128772827|NCT02855164|463459984|FG006|Part C (Randomized Set)|Physician Decision|0|||
128772828|NCT02855164|463459985|FG007|Part C (Randomized Set)|Physician Decision|1|||
128772829|NCT02855164|463459978|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
128772830|NCT02855164|463459979|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
128772831|NCT02855164|463459980|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
128772832|NCT02855164|463459981|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
128772833|NCT02855164|463459982|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
128772834|NCT02855164|463459983|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
128772835|NCT02855164|463459984|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
128772836|NCT02855164|463459985|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
128772837|NCT00876460|463459986|FG000|Combination Therapy Phase|Progressive disease|2|||
128772838|NCT00876460|463459987|FG001|Combination Therapy Phase|Progressive disease|3|||
128772839|NCT00876460|463459988|FG002|Combination Therapy Phase|Progressive disease|3|||
128772840|NCT00876460|463459989|FG003|Combination Therapy Phase|Progressive disease|3|||
129220287|NCT00067002|465106551|FG001|Overall Study|Early Death|2|||
129220288|NCT00067002|465106550|FG000|Overall Study|Delayed|1|||
129220289|NCT00067002|465106551|FG001|Overall Study|Delayed|1|||
128772841|NCT00876460|463459990|FG004|Combination Therapy Phase|Progressive disease|3|||
128772842|NCT00876460|463459991|FG005|Combination Therapy Phase|Progressive disease|1|||
128772843|NCT00876460|463459992|FG006|Combination Therapy Phase|Progressive disease|1|||
128772844|NCT00876460|463459993|FG007|Combination Therapy Phase|Progressive disease|1|||
128772845|NCT00876460|463459986|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
128772846|NCT00876460|463459987|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
128772847|NCT00876460|463459988|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
128772848|NCT00876460|463459989|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
129220290|NCT00067002|465106550|FG000|Overall Study|Graft Failure|5|||
128772849|NCT00876460|463459990|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
128772850|NCT00876460|463459991|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
128772851|NCT00876460|463459992|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
128772852|NCT00876460|463459993|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
128772853|NCT00876460|463459986|FG000|Combination Therapy Phase|Adverse Event|0|||
128772854|NCT00876460|463459987|FG001|Combination Therapy Phase|Adverse Event|2|||
128772855|NCT00876460|463459988|FG002|Combination Therapy Phase|Adverse Event|0|||
128772856|NCT00876460|463459989|FG003|Combination Therapy Phase|Adverse Event|2|||
128772857|NCT00876460|463459990|FG004|Combination Therapy Phase|Adverse Event|2|||
128772858|NCT00876460|463459991|FG005|Combination Therapy Phase|Adverse Event|0|||
128772859|NCT00876460|463459992|FG006|Combination Therapy Phase|Adverse Event|3|||
128772860|NCT00876460|463459993|FG007|Combination Therapy Phase|Adverse Event|2|||
128772861|NCT00876460|463459986|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
128772862|NCT00876460|463459987|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
128714070|NCT00883116|463250769|FG001|Overall Study|No longer meets study criteria|2|||
128714071|NCT01361464|463250770|FG000|Overall Study|Death|1|||
128714072|NCT01361464|463250770|FG000|Overall Study|Withdrawal by Subject|2|||
128714073|NCT04501666|463250771|FG000|Overall Study|Physician Decision|0|||
128714074|NCT04501666|463250772|FG001|Overall Study|Physician Decision|1|||
128714075|NCT04501666|463250771|FG000|Overall Study|Adverse Event|12|||
128714076|NCT04501666|463250772|FG001|Overall Study|Adverse Event|4|||
128714077|NCT04501666|463250771|FG000|Overall Study|Subject's request|10|||
128714078|NCT04501666|463250772|FG001|Overall Study|Subject's request|6|||
128714079|NCT04501666|463250771|FG000|Overall Study|Protocol Deviation|2|||
128714080|NCT04501666|463250772|FG001|Overall Study|Protocol Deviation|1|||
128714081|NCT04501666|463250771|FG000|Overall Study|Other-- site permanently closing|0|||
128714082|NCT04501666|463250772|FG001|Overall Study|Other-- site permanently closing|1|||
128714083|NCT01106898|463250776|FG000|Overall Study|Adverse Event|6|||
128714084|NCT01722071|463250777|FG000|Overall Study|Protocol Violation|1|||
128714085|NCT01722071|463250778|FG001|Overall Study|Protocol Violation|0|||
128714086|NCT03021265|463250779|FG000|Overall Study|Adverse Event|29|||
128714087|NCT03021265|463250779|FG000|Overall Study|Lack of Efficacy|3|||
128714088|NCT03021265|463250779|FG000|Overall Study|Improved|17|||
128714089|NCT03021265|463250779|FG000|Overall Study|Lost to Follow-up|67|||
128714090|NCT03021265|463250779|FG000|Overall Study|No reason given|2|||
128714091|NCT03021265|463250779|FG000|Overall Study|No visit since the first visit|4|||
128714092|NCT01338493|463250780|FG000|Enrolled|Withdrawal by Subject|1|||
128714093|NCT01338493|463250780|FG000|Enrolled|Patient not implanted|4|||
128714094|NCT01338493|463250780|FG000|Discharge|Death|1|||
128714095|NCT01338493|463250780|FG000|Discharge|Missed visit|1|||
128714096|NCT01338493|463250780|FG000|6 Months Follow up|Lost to Follow-up|11|||
128714097|NCT01338493|463250780|FG000|6 Months Follow up|Missed visit|8|||
128714098|NCT01338493|463250780|FG000|12 Months Follow up|Lost to Follow-up|9|||
128714099|NCT00642941|463250781|FG000|Overall Study|Physician Decision|3|||
128714100|NCT00642941|463250782|FG001|Overall Study|Physician Decision|1|||
128714101|NCT00642941|463250783|FG002|Overall Study|Physician Decision|0|||
128714102|NCT00642941|463250784|FG003|Overall Study|Physician Decision|0|||
128714103|NCT00642941|463250785|FG004|Overall Study|Physician Decision|0|||
128714104|NCT00642941|463250786|FG005|Overall Study|Physician Decision|0|||
128714105|NCT00642941|463250787|FG006|Overall Study|Physician Decision|1|||
128714106|NCT00642941|463250788|FG007|Overall Study|Physician Decision|0|||
128714107|NCT00642941|463250789|FG008|Overall Study|Physician Decision|0|||
128714108|NCT00642941|463250790|FG009|Overall Study|Physician Decision|1|||
128714109|NCT00642941|463250791|FG010|Overall Study|Physician Decision|0|||
128714110|NCT00642941|463250792|FG011|Overall Study|Physician Decision|1|||
128714111|NCT00642941|463250781|FG000|Overall Study|Death|4|||
128714112|NCT00642941|463250782|FG001|Overall Study|Death|0|||
128772863|NCT00876460|463459988|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
128772864|NCT00876460|463459989|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
128772865|NCT00876460|463459990|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
128772866|NCT00876460|463459991|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
128967911|NCT02699125|464167501|FG001|Placebo|Lost to Follow-up|0|||
128967912|NCT02699125|464167500|FG000|Placebo|Protocol Violation|1|||
128714113|NCT00642941|463250783|FG002|Overall Study|Death|1|||
128714114|NCT00642941|463250784|FG003|Overall Study|Death|1|||
128714115|NCT00642941|463250785|FG004|Overall Study|Death|2|||
128772867|NCT00876460|463459992|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
128967913|NCT02699125|464167501|FG001|Placebo|Protocol Violation|0|||
128714116|NCT00642941|463250786|FG005|Overall Study|Death|1|||
128714117|NCT00642941|463250787|FG006|Overall Study|Death|0|||
128714118|NCT00642941|463250788|FG007|Overall Study|Death|0|||
128714119|NCT00642941|463250789|FG008|Overall Study|Death|0|||
128714120|NCT00642941|463250790|FG009|Overall Study|Death|0|||
128714121|NCT00642941|463250791|FG010|Overall Study|Death|0|||
128714122|NCT00642941|463250792|FG011|Overall Study|Death|1|||
128714123|NCT00642941|463250781|FG000|Overall Study|Study closed by Sponsor|0|||
128714124|NCT00642941|463250782|FG001|Overall Study|Study closed by Sponsor|1|||
128714125|NCT00642941|463250783|FG002|Overall Study|Study closed by Sponsor|0|||
128714126|NCT00642941|463250784|FG003|Overall Study|Study closed by Sponsor|0|||
129220291|NCT00067002|465106551|FG001|Overall Study|Graft Failure|6|||
129220292|NCT01354314|465106556|FG000|Overall Study|Lost to Follow-up|1|||
129220293|NCT01354314|465106557|FG001|Overall Study|Lost to Follow-up|0|||
129220294|NCT01354314|465106558|FG002|Overall Study|Lost to Follow-up|1|||
129220295|NCT01354314|465106559|FG003|Overall Study|Lost to Follow-up|1|||
129220296|NCT01354314|465106556|FG000|Overall Study|Withdrawal by Subject|0|||
129220297|NCT01354314|465106557|FG001|Overall Study|Withdrawal by Subject|0|||
129220298|NCT01354314|465106558|FG002|Overall Study|Withdrawal by Subject|1|||
129220299|NCT01354314|465106559|FG003|Overall Study|Withdrawal by Subject|0|||
129220300|NCT01354314|465106556|FG000|Overall Study|Adverse Event|0|||
129220301|NCT01354314|465106557|FG001|Overall Study|Adverse Event|0|||
129220302|NCT01354314|465106558|FG002|Overall Study|Adverse Event|0|||
129220303|NCT01354314|465106559|FG003|Overall Study|Adverse Event|1|||
129220304|NCT01354314|465106556|FG000|Overall Study|Protocol Violation|1|||
129220305|NCT01354314|465106557|FG001|Overall Study|Protocol Violation|1|||
129220306|NCT01354314|465106558|FG002|Overall Study|Protocol Violation|0|||
129220307|NCT01354314|465106559|FG003|Overall Study|Protocol Violation|0|||
129220308|NCT01354314|465106556|FG000|Overall Study|Less than 90% Adherence|4|||
129220309|NCT01354314|465106557|FG001|Overall Study|Less than 90% Adherence|2|||
129220310|NCT01354314|465106558|FG002|Overall Study|Less than 90% Adherence|6|||
129220311|NCT01354314|465106559|FG003|Overall Study|Less than 90% Adherence|4|||
129220312|NCT00714870|465106561|FG000|Overall Study|Lost to Follow-up|22|||
129220313|NCT00714870|465106562|FG001|Overall Study|Lost to Follow-up|5|||
129220314|NCT00714870|465106561|FG000|Overall Study|patient unable to come b/c back pain|1|||
129220315|NCT00714870|465106562|FG001|Overall Study|patient unable to come b/c back pain|0|||
129220316|NCT00714870|465106561|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
129220317|NCT00714870|465106562|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
129220318|NCT03399552|465106563|FG000|Overall Study|No evidence of disease|1|||
129220319|NCT03399552|465106563|FG000|Overall Study|Unevaluable|1|||
129220320|NCT02357368|465106564|FG000|Overall Study|Lost to Follow-up|0|||
129220321|NCT02357368|465106565|FG001|Overall Study|Lost to Follow-up|0|||
129220322|NCT02357368|465106566|FG002|Overall Study|Lost to Follow-up|0|||
129220323|NCT02357368|465106567|FG003|Overall Study|Lost to Follow-up|1|||
129220324|NCT02357368|465106564|FG000|Overall Study|Pregnancy|3|||
129220325|NCT02357368|465106565|FG001|Overall Study|Pregnancy|2|||
129220326|NCT02357368|465106566|FG002|Overall Study|Pregnancy|0|||
129220327|NCT02357368|465106567|FG003|Overall Study|Pregnancy|0|||
129220328|NCT02357368|465106564|FG000|Overall Study|Withdrawal by Subject|3|||
129220329|NCT02357368|465106565|FG001|Overall Study|Withdrawal by Subject|1|||
129220330|NCT02357368|465106566|FG002|Overall Study|Withdrawal by Subject|1|||
129220331|NCT02357368|465106567|FG003|Overall Study|Withdrawal by Subject|2|||
129220332|NCT02377817|465106568|FG000|Overall Study|Transportation/childcare barriers.|2|||
128714127|NCT00642941|463250785|FG004|Overall Study|Study closed by Sponsor|0|||
128714128|NCT00642941|463250786|FG005|Overall Study|Study closed by Sponsor|0|||
128714129|NCT00642941|463250787|FG006|Overall Study|Study closed by Sponsor|0|||
128714130|NCT00642941|463250788|FG007|Overall Study|Study closed by Sponsor|0|||
128714131|NCT00642941|463250789|FG008|Overall Study|Study closed by Sponsor|0|||
128714132|NCT00642941|463250790|FG009|Overall Study|Study closed by Sponsor|0|||
128714133|NCT00642941|463250791|FG010|Overall Study|Study closed by Sponsor|0|||
128714134|NCT00642941|463250792|FG011|Overall Study|Study closed by Sponsor|0|||
128714135|NCT00642941|463250781|FG000|Overall Study|Withdrawal by Subject|1|||
128714136|NCT00642941|463250782|FG001|Overall Study|Withdrawal by Subject|0|||
128714137|NCT00642941|463250783|FG002|Overall Study|Withdrawal by Subject|0|||
128714138|NCT00642941|463250784|FG003|Overall Study|Withdrawal by Subject|2|||
128714139|NCT00642941|463250785|FG004|Overall Study|Withdrawal by Subject|0|||
128714140|NCT00642941|463250786|FG005|Overall Study|Withdrawal by Subject|0|||
128714141|NCT00642941|463250787|FG006|Overall Study|Withdrawal by Subject|2|||
128714142|NCT00642941|463250788|FG007|Overall Study|Withdrawal by Subject|0|||
128714143|NCT00642941|463250789|FG008|Overall Study|Withdrawal by Subject|1|||
128714144|NCT00642941|463250790|FG009|Overall Study|Withdrawal by Subject|0|||
128714145|NCT00642941|463250791|FG010|Overall Study|Withdrawal by Subject|0|||
128714146|NCT00642941|463250792|FG011|Overall Study|Withdrawal by Subject|1|||
128714147|NCT00642941|463250781|FG000|Overall Study|Protocol Violation|0|||
128714148|NCT00642941|463250782|FG001|Overall Study|Protocol Violation|0|||
128714149|NCT00642941|463250783|FG002|Overall Study|Protocol Violation|0|||
128714150|NCT00642941|463250784|FG003|Overall Study|Protocol Violation|0|||
128714151|NCT00642941|463250785|FG004|Overall Study|Protocol Violation|0|||
129220333|NCT02377817|465106569|FG001|Overall Study|Transportation/childcare barriers.|0|||
129220334|NCT02377817|465106568|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
129220335|NCT02377817|465106569|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
129220336|NCT03895840|465106570|FG000|Overall Study|Withdrawal by Subject|21|||
129220337|NCT01931566|465106571|FG000|Overall Study|Randomized But Not Treated|6|||
129220338|NCT01931566|465106572|FG001|Overall Study|Randomized But Not Treated|9|||
128714152|NCT00642941|463250786|FG005|Overall Study|Protocol Violation|0|||
128714153|NCT00642941|463250787|FG006|Overall Study|Protocol Violation|1|||
128714154|NCT00642941|463250788|FG007|Overall Study|Protocol Violation|0|||
128714155|NCT00642941|463250789|FG008|Overall Study|Protocol Violation|0|||
128967914|NCT02699125|464167500|FG000|Placebo|Withdrawal by Subject|0|||
128967915|NCT02699125|464167501|FG001|Placebo|Withdrawal by Subject|4|||
128967916|NCT02699125|464167500|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
128967917|NCT02699125|464167501|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
128967918|NCT02092324|464167506|FG000|Overall Study|Adverse Event|1|||
128967919|NCT02092324|464167506|FG000|Overall Study|Lack of Efficacy|6|||
128967920|NCT02092324|464167506|FG000|Overall Study|Proceed to Transplant|3|||
128967921|NCT02092324|464167506|FG000|Overall Study|Physician Decision|7|||
128967922|NCT02092324|464167506|FG000|Overall Study|Misdiagnosis|2|||
128967923|NCT01039428|464167507|FG000|Overall Study|Protocol Violation|1|||
128967924|NCT01039428|464167508|FG001|Overall Study|Protocol Violation|0|||
128967925|NCT01039428|464167507|FG000|Overall Study|Withdrawal by Subject|1|||
128967926|NCT01039428|464167508|FG001|Overall Study|Withdrawal by Subject|0|||
128967927|NCT00422240|464167515|FG000|Overall Study|Lack of Efficacy|1|||
128967928|NCT00422240|464167516|FG001|Overall Study|Lack of Efficacy|2|||
128967929|NCT00422240|464167517|FG002|Overall Study|Lack of Efficacy|0|||
128967930|NCT00422240|464167518|FG003|Overall Study|Lack of Efficacy|1|||
128967931|NCT00422240|464167515|FG000|Overall Study|Adverse Event|11|||
128967932|NCT00422240|464167516|FG001|Overall Study|Adverse Event|4|||
128967933|NCT00422240|464167517|FG002|Overall Study|Adverse Event|5|||
128967934|NCT00422240|464167518|FG003|Overall Study|Adverse Event|2|||
128967935|NCT00422240|464167515|FG000|Overall Study|Subject request|21|||
128967936|NCT00422240|464167516|FG001|Overall Study|Subject request|17|||
128967937|NCT00422240|464167517|FG002|Overall Study|Subject request|18|||
128967938|NCT00422240|464167518|FG003|Overall Study|Subject request|30|||
128967939|NCT00422240|464167515|FG000|Overall Study|Protocol Violation|0|||
128967940|NCT00422240|464167516|FG001|Overall Study|Protocol Violation|1|||
128967941|NCT00422240|464167517|FG002|Overall Study|Protocol Violation|0|||
128967942|NCT00422240|464167518|FG003|Overall Study|Protocol Violation|1|||
128967943|NCT00422240|464167515|FG000|Overall Study|Lost to Follow-up|31|||
128967944|NCT00422240|464167516|FG001|Overall Study|Lost to Follow-up|32|||
128967945|NCT00422240|464167517|FG002|Overall Study|Lost to Follow-up|19|||
128967946|NCT00422240|464167518|FG003|Overall Study|Lost to Follow-up|34|||
128967947|NCT00422240|464167515|FG000|Overall Study|Other|1|||
128967948|NCT00422240|464167516|FG001|Overall Study|Other|0|||
128967949|NCT00422240|464167517|FG002|Overall Study|Other|0|||
128967950|NCT00422240|464167518|FG003|Overall Study|Other|1|||
128967951|NCT00422240|464167515|FG000|Overall Study|Pregnancy|3|||
128967952|NCT00422240|464167516|FG001|Overall Study|Pregnancy|1|||
128967953|NCT00422240|464167517|FG002|Overall Study|Pregnancy|1|||
128967954|NCT00422240|464167518|FG003|Overall Study|Pregnancy|2|||
128967955|NCT01188811|464167526|FG000|Overall Study|Withdrawal by Subject|0|||
128967956|NCT01188811|464167527|FG001|Overall Study|Withdrawal by Subject|2|||
128967957|NCT01188811|464167526|FG000|Overall Study|Adverse Event|6|||
128967958|NCT01188811|464167527|FG001|Overall Study|Adverse Event|0|||
128967959|NCT01602744|464167528|FG000|Overall Study|Death|17|||
128967960|NCT01602744|464167529|FG001|Overall Study|Death|15|||
128967961|NCT01602744|464167528|FG000|Overall Study|Lost to Follow-up|13|||
128967962|NCT01602744|464167529|FG001|Overall Study|Lost to Follow-up|8|||
128967963|NCT03418376|464167530|FG000|Overall Study|Musculoskeletal injury|1|||
128967964|NCT03418376|464167531|FG001|Overall Study|Musculoskeletal injury|2|||
129220339|NCT01931566|465106573|FG002|Overall Study|Randomized But Not Treated|14|||
129220340|NCT01931566|465106571|FG000|Overall Study|Adverse Event|37|||
129220341|NCT01931566|465106572|FG001|Overall Study|Adverse Event|167|||
128967965|NCT03418376|464167532|FG002|Overall Study|Musculoskeletal injury|1|||
128967966|NCT03418376|464167533|FG003|Overall Study|Musculoskeletal injury|0|||
128967967|NCT03418376|464167530|FG000|Overall Study|Personal reasons|0|||
128967968|NCT03418376|464167531|FG001|Overall Study|Personal reasons|2|||
128967969|NCT03418376|464167532|FG002|Overall Study|Personal reasons|2|||
128714156|NCT00642941|463250790|FG009|Overall Study|Protocol Violation|0|||
128967970|NCT03418376|464167533|FG003|Overall Study|Personal reasons|1|||
129220342|NCT01931566|465106573|FG002|Overall Study|Adverse Event|132|||
128714157|NCT00642941|463250791|FG010|Overall Study|Protocol Violation|0|||
128714158|NCT00642941|463250792|FG011|Overall Study|Protocol Violation|0|||
128714159|NCT00642941|463250781|FG000|Overall Study|Adverse Event|1|||
128714160|NCT00642941|463250782|FG001|Overall Study|Adverse Event|1|||
128714161|NCT00642941|463250783|FG002|Overall Study|Adverse Event|0|||
128714162|NCT00642941|463250784|FG003|Overall Study|Adverse Event|0|||
128714163|NCT00642941|463250785|FG004|Overall Study|Adverse Event|0|||
128714164|NCT00642941|463250786|FG005|Overall Study|Adverse Event|0|||
128714165|NCT00642941|463250787|FG006|Overall Study|Adverse Event|1|||
128714166|NCT00642941|463250788|FG007|Overall Study|Adverse Event|1|||
128967971|NCT03418376|464167530|FG000|Overall Study|Exacerbation|0|||
128967972|NCT03418376|464167531|FG001|Overall Study|Exacerbation|1|||
129220343|NCT01931566|465106571|FG000|Overall Study|Major Protocol Deviation|5|||
128714167|NCT00642941|463250789|FG008|Overall Study|Adverse Event|0|||
128714168|NCT00642941|463250790|FG009|Overall Study|Adverse Event|1|||
128714169|NCT00642941|463250791|FG010|Overall Study|Adverse Event|0|||
128967973|NCT03418376|464167532|FG002|Overall Study|Exacerbation|0|||
128967974|NCT03418376|464167533|FG003|Overall Study|Exacerbation|0|||
128967975|NCT04350372|464167538|FG000|Overall Study|Death|1|||
129220344|NCT01931566|465106572|FG001|Overall Study|Major Protocol Deviation|14|||
129220345|NCT01931566|465106573|FG002|Overall Study|Major Protocol Deviation|21|||
129220346|NCT01931566|465106571|FG000|Overall Study|Lost to Follow-up|3|||
129220347|NCT01931566|465106572|FG001|Overall Study|Lost to Follow-up|26|||
129220348|NCT01931566|465106573|FG002|Overall Study|Lost to Follow-up|23|||
128967976|NCT00412113|464167539|FG000|Overall Study|Adverse Event|11|||
128967977|NCT00412113|464167540|FG001|Overall Study|Adverse Event|15|||
128967978|NCT00412113|464167539|FG000|Overall Study|did not receive treatment|1|||
128967979|NCT00412113|464167540|FG001|Overall Study|did not receive treatment|0|||
128967980|NCT01190020|464167541|FG000|Overall Study|Adverse Event|2|||
128967981|NCT01190020|464167542|FG001|Overall Study|Adverse Event|0|||
128967982|NCT01190020|464167541|FG000|Overall Study|Lost to Follow-up|2|||
128967983|NCT01190020|464167542|FG001|Overall Study|Lost to Follow-up|0|||
128967984|NCT01190020|464167541|FG000|Overall Study|Withdrawal by Subject|3|||
128967985|NCT01190020|464167542|FG001|Overall Study|Withdrawal by Subject|0|||
128967986|NCT03573804|464167544|FG000|Overall Study|claustrophobia or MRI table problems|10|||
128967987|NCT01673373|464169943|FG000|Overall Study|Death|2|||
128967988|NCT05171816|464169944|FG000|Overall Study|Death|18|||
128967989|NCT05171816|464169945|FG001|Overall Study|Death|16|||
128967990|NCT02000622|464169946|FG000|Overall Study|Withdrawal by Subject|5|||
129220349|NCT01931566|465106571|FG000|Overall Study|Voluntary Withdrawal|78|||
129220350|NCT01931566|465106572|FG001|Overall Study|Voluntary Withdrawal|245|||
129220351|NCT01931566|465106573|FG002|Overall Study|Voluntary Withdrawal|225|||
129220352|NCT01931566|465106571|FG000|Overall Study|Study Termination|289|||
129220353|NCT01931566|465106572|FG001|Overall Study|Study Termination|968|||
129220354|NCT01931566|465106573|FG002|Overall Study|Study Termination|1037|||
129220355|NCT01931566|465106571|FG000|Overall Study|Reason Not Specified|11|||
129220356|NCT01931566|465106572|FG001|Overall Study|Reason Not Specified|47|||
129220357|NCT01931566|465106573|FG002|Overall Study|Reason Not Specified|53|||
129220358|NCT01931566|465106571|FG000|Overall Study|Missing|0|||
129220359|NCT01931566|465106572|FG001|Overall Study|Missing|0|||
129220360|NCT01931566|465106573|FG002|Overall Study|Missing|1|||
129220361|NCT00760617|465106577|FG000|Overall Study|Adverse Event|5|||
129220362|NCT00760617|465106578|FG001|Overall Study|Adverse Event|2|||
129220363|NCT00760617|465106579|FG002|Overall Study|Adverse Event|0|||
129220364|NCT00760617|465106577|FG000|Overall Study|Lost to Follow-up|0|||
129220365|NCT00760617|465106578|FG001|Overall Study|Lost to Follow-up|0|||
129220366|NCT00760617|465106579|FG002|Overall Study|Lost to Follow-up|5|||
129220367|NCT04625101|465106580|FG000|Overall Study|Withdrawal by Subject|0|||
129220368|NCT04625101|465106581|FG001|Overall Study|Withdrawal by Subject|1|||
129220369|NCT04625101|465106580|FG000|Overall Study|Protocol Deviation|1|||
129220370|NCT04625101|465106581|FG001|Overall Study|Protocol Deviation|0|||
129220371|NCT02817464|465106582|FG000|Overall Study|Lost to Follow-up|1|||
129220372|NCT02817464|465106583|FG001|Overall Study|Lost to Follow-up|0|||
129220373|NCT02817464|465106582|FG000|Overall Study|Discontinued early due to personal decision|1|||
129220374|NCT02817464|465106583|FG001|Overall Study|Discontinued early due to personal decision|1|||
129220375|NCT02453711|465106584|FG000|Overall Study|Withdrawal by Subject|5|||
129220376|NCT02453711|465106585|FG001|Overall Study|Withdrawal by Subject|4|||
129220377|NCT02453711|465106586|FG002|Overall Study|Withdrawal by Subject|6|||
129220378|NCT02453711|465106587|FG003|Overall Study|Withdrawal by Subject|4|||
129220379|NCT02453711|465106588|FG004|Overall Study|Withdrawal by Subject|1|||
129220380|NCT02453711|465106589|FG005|Overall Study|Withdrawal by Subject|1|||
129220381|NCT02453711|465106590|FG006|Overall Study|Withdrawal by Subject|0|||
128714170|NCT00642941|463250792|FG011|Overall Study|Adverse Event|0|||
128714171|NCT00642941|463250781|FG000|Overall Study|Other|1|||
128714172|NCT00642941|463250782|FG001|Overall Study|Other|1|||
128714173|NCT00642941|463250783|FG002|Overall Study|Other|1|||
128714174|NCT00642941|463250784|FG003|Overall Study|Other|1|||
128714175|NCT00642941|463250785|FG004|Overall Study|Other|0|||
128714176|NCT00642941|463250786|FG005|Overall Study|Other|1|||
128714177|NCT00642941|463250787|FG006|Overall Study|Other|0|||
128714178|NCT00642941|463250788|FG007|Overall Study|Other|1|||
128714179|NCT00642941|463250789|FG008|Overall Study|Other|0|||
128714180|NCT00642941|463250790|FG009|Overall Study|Other|0|||
128714181|NCT00642941|463250791|FG010|Overall Study|Other|0|||
128714182|NCT00642941|463250792|FG011|Overall Study|Other|1|||
128714183|NCT00642941|463250781|FG000|Overall Study|Disease progression|60|||
128967991|NCT02000622|464169947|FG001|Overall Study|Withdrawal by Subject|7|||
129220382|NCT02453711|465106591|FG007|Overall Study|Withdrawal by Subject|1|||
129220383|NCT02453711|465106592|FG008|Overall Study|Withdrawal by Subject|7|||
129220384|NCT02453711|465106584|FG000|Overall Study|Lost to Follow-up|5|||
128967992|NCT02000622|464169946|FG000|Overall Study|Lost to Follow-up|4|||
129220385|NCT02453711|465106585|FG001|Overall Study|Lost to Follow-up|3|||
129220386|NCT02453711|465106586|FG002|Overall Study|Lost to Follow-up|2|||
129220387|NCT02453711|465106587|FG003|Overall Study|Lost to Follow-up|3|||
128714184|NCT00642941|463250782|FG001|Overall Study|Disease progression|50|||
128714185|NCT00642941|463250783|FG002|Overall Study|Disease progression|5|||
128714186|NCT00642941|463250784|FG003|Overall Study|Disease progression|36|||
128967993|NCT02000622|464169947|FG001|Overall Study|Lost to Follow-up|0|||
129220388|NCT02453711|465106588|FG004|Overall Study|Lost to Follow-up|1|||
128967994|NCT02000622|464169946|FG000|Overall Study|Death|159|||
128967995|NCT02000622|464169947|FG001|Overall Study|Death|73|||
128967996|NCT02000622|464169946|FG000|Overall Study|Withdrawn due to site closure|1|||
128967997|NCT02000622|464169947|FG001|Overall Study|Withdrawn due to site closure|0|||
128967998|NCT01405027|464169951|FG000|Overall Study|Withdrawn consent|3|||
128967999|NCT01405027|464169952|FG001|Overall Study|Withdrawn consent|0|||
128968000|NCT01405027|464169951|FG000|Overall Study|Lost to Follow-up|16|||
128968001|NCT01405027|464169952|FG001|Overall Study|Lost to Follow-up|24|||
128968002|NCT01405027|464169951|FG000|Overall Study|Investigator judgement|0|||
128968003|NCT01405027|464169952|FG001|Overall Study|Investigator judgement|2|||
128968004|NCT01405027|464169951|FG000|Overall Study|Death|1|||
128968005|NCT01405027|464169952|FG001|Overall Study|Death|0|||
128968006|NCT01405027|464169951|FG000|Overall Study|Other or Unknown|12|||
128968007|NCT01405027|464169952|FG001|Overall Study|Other or Unknown|25|||
128968008|NCT01680991|464169954|FG000|Overall Study|Adverse Event|1|||
128968009|NCT01680991|464169955|FG001|Overall Study|Adverse Event|0|||
128968010|NCT01680991|464169956|FG002|Overall Study|Adverse Event|0|||
128968011|NCT01680991|464169954|FG000|Overall Study|Death|1|||
128968012|NCT01680991|464169955|FG001|Overall Study|Death|0|||
128968013|NCT01680991|464169956|FG002|Overall Study|Death|1|||
128968014|NCT01680991|464169954|FG000|Overall Study|Protocol Violation|0|||
128968015|NCT01680991|464169955|FG001|Overall Study|Protocol Violation|1|||
128968016|NCT01680991|464169956|FG002|Overall Study|Protocol Violation|0|||
128968017|NCT01680991|464169954|FG000|Overall Study|Withdrawal by Subject|5|||
128968018|NCT01680991|464169955|FG001|Overall Study|Withdrawal by Subject|1|||
128968019|NCT01680991|464169956|FG002|Overall Study|Withdrawal by Subject|0|||
128968020|NCT01680991|464169954|FG000|Overall Study|Progressive disease (PD)|0|||
128968021|NCT01680991|464169955|FG001|Overall Study|Progressive disease (PD)|10|||
128968022|NCT01680991|464169956|FG002|Overall Study|Progressive disease (PD)|0|||
128968023|NCT01680991|464169954|FG000|Overall Study|Physician Decision|0|||
128968024|NCT01680991|464169955|FG001|Overall Study|Physician Decision|7|||
128968025|NCT01680991|464169956|FG002|Overall Study|Physician Decision|2|||
128968026|NCT01680991|464169954|FG000|Overall Study|Bad physical condition|0|||
128968027|NCT01680991|464169955|FG001|Overall Study|Bad physical condition|0|||
128968028|NCT01680991|464169956|FG002|Overall Study|Bad physical condition|1|||
128968029|NCT01680991|464169954|FG000|Overall Study|PD confirmed in other hospital|1|||
128968030|NCT01680991|464169955|FG001|Overall Study|PD confirmed in other hospital|0|||
128968031|NCT01680991|464169956|FG002|Overall Study|PD confirmed in other hospital|0|||
128968032|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
128968033|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
128968034|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|Death|1|||
128968035|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|Death|1|||
128968036|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
128968037|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
128968038|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
128968039|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
128968040|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
128968041|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
128968042|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
128968043|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
128968044|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
128968045|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
128968046|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
128968047|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
128968048|NCT03728881|464169957|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
128968049|NCT03728881|464169958|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
128968050|NCT03728881|464169957|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
128968051|NCT03728881|464169958|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
128968052|NCT03728881|464169957|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
128968053|NCT03728881|464169958|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
128968054|NCT06073054|464169959|FG000|Overall Study|Withdrawal by Subject|2|||
128968055|NCT00413777|464169963|FG000|Fixed-dose Period|Lost to Follow-up|1|||
128968056|NCT00413777|464169964|FG001|Fixed-dose Period|Lost to Follow-up|1|||
128968057|NCT00413777|464169963|FG000|Fixed-dose Period|Adverse Event|2|||
128968058|NCT00413777|464169964|FG001|Fixed-dose Period|Adverse Event|1|||
128968059|NCT00413777|464169963|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
128968060|NCT00413777|464169964|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
128968061|NCT00413777|464169963|FG000|Fixed-dose Period|Withdrew Consent|0|||
128968062|NCT00413777|464169964|FG001|Fixed-dose Period|Withdrew Consent|1|||
128968063|NCT05505734|464169965|FG000|Overall Study|Withdrawal by Subject|51|||
128968064|NCT05505734|464169966|FG001|Overall Study|Withdrawal by Subject|64|||
128968065|NCT05505734|464169965|FG000|Overall Study|Adverse Event|6|||
128968066|NCT05505734|464169966|FG001|Overall Study|Adverse Event|20|||
128968067|NCT05505734|464169965|FG000|Overall Study|Protocol Violation|8|||
128968068|NCT05505734|464169966|FG001|Overall Study|Protocol Violation|15|||
128968069|NCT05505734|464169965|FG000|Overall Study|Lack of therapeutic response|0|||
128968070|NCT05505734|464169966|FG001|Overall Study|Lack of therapeutic response|1|||
128968071|NCT05505734|464169965|FG000|Overall Study|Lost to Follow-up|247|||
128968072|NCT05505734|464169966|FG001|Overall Study|Lost to Follow-up|237|||
128968073|NCT05505734|464169965|FG000|Overall Study|Physician Decision|22|||
128968074|NCT05505734|464169966|FG001|Overall Study|Physician Decision|13|||
128968075|NCT05505734|464169965|FG000|Overall Study|Death|2|||
128968076|NCT05505734|464169966|FG001|Overall Study|Death|1|||
128968077|NCT05505734|464169965|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128968078|NCT05505734|464169966|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128968079|NCT05505734|464169965|FG000|Overall Study|Pregnancy|1|||
128968080|NCT05505734|464169966|FG001|Overall Study|Pregnancy|0|||
128968081|NCT05505734|464169965|FG000|Overall Study|Other|17|||
128968082|NCT05505734|464169966|FG001|Overall Study|Other|13|||
128968083|NCT00764322|464169967|FG000|Overall Study|Withdrawal by Subject|11|||
128968084|NCT00764322|464169967|FG000|Overall Study|No CYP2D6 genotyping|9|||
128968085|NCT01600105|464169971|FG000|Total Participants|Withdrawal by Subject|1|||
128968086|NCT01600105|464169972|FG001|Total Participants|Withdrawal by Subject|0|||
128968087|NCT01600105|464169971|FG000|Total Participants|No images in PACS|10|||
128968088|NCT01600105|464169972|FG001|Total Participants|No images in PACS|0|||
128968089|NCT01600105|464169971|FG000|Total Participants|Insufficient image quality|30|||
128968090|NCT01600105|464169972|FG001|Total Participants|Insufficient image quality|10|||
128968091|NCT01600105|464169971|FG000|Sub Study I|Insufficient image quality|0|||
128968092|NCT01600105|464169972|FG001|Sub Study I|Insufficient image quality|10|||
128968093|NCT01600105|464169971|FG000|Sub Study II|Withdrawal by Subject|1|||
128968094|NCT01600105|464169972|FG001|Sub Study II|Withdrawal by Subject|0|||
128968095|NCT01600105|464169971|FG000|Sub Study II|No images in PACS|1|||
128968096|NCT01600105|464169972|FG001|Sub Study II|No images in PACS|0|||
128968097|NCT01600105|464169971|FG000|Sub Study II|Insufficient image quality|3|||
128968098|NCT01600105|464169972|FG001|Sub Study II|Insufficient image quality|0|||
128968099|NCT01600105|464169971|FG000|Sub Study III|Insufficient image quality|5|||
128968100|NCT01600105|464169972|FG001|Sub Study III|Insufficient image quality|0|||
128968101|NCT01600105|464169971|FG000|Sub Study V|Poor Image Quality|2|||
128968102|NCT01600105|464169972|FG001|Sub Study V|Poor Image Quality|0|||
128968103|NCT04007367|464169974|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
128968104|NCT04007367|464169975|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
128714187|NCT00642941|463250785|FG004|Overall Study|Disease progression|23|||
128714188|NCT00642941|463250786|FG005|Overall Study|Disease progression|39|||
128714189|NCT00642941|463250787|FG006|Overall Study|Disease progression|18|||
128714190|NCT00642941|463250788|FG007|Overall Study|Disease progression|12|||
128714191|NCT00642941|463250789|FG008|Overall Study|Disease progression|10|||
128714192|NCT00642941|463250790|FG009|Overall Study|Disease progression|7|||
128714193|NCT00642941|463250791|FG010|Overall Study|Disease progression|12|||
128714194|NCT00642941|463250792|FG011|Overall Study|Disease progression|7|||
128714195|NCT01705652|463250793|FG000|Overall Study|Adverse Event|1|||
128714196|NCT01705652|463250794|FG001|Overall Study|Adverse Event|0|||
128714197|NCT01705652|463250793|FG000|Overall Study|Withdrawal by Subject|1|||
128714198|NCT01705652|463250794|FG001|Overall Study|Withdrawal by Subject|2|||
128714199|NCT01705652|463250793|FG000|Overall Study|non-compliance|1|||
128714200|NCT01705652|463250794|FG001|Overall Study|non-compliance|1|||
128714201|NCT00541034|463250796|FG000|Overall Study|Non-Compliance|3|||
128714202|NCT00656474|463250797|FG000|Overall Study|Other Reason|1|||
128714203|NCT02062879|463250798|FG000|Overall Study|Withdrawal by Subject|4|||
128968105|NCT04007367|464169976|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
128968106|NCT04007367|464169974|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
128968107|NCT04007367|464169975|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
128968108|NCT04007367|464169976|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
128968109|NCT04007367|464169974|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
128968110|NCT04007367|464169975|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
128968111|NCT04007367|464169976|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
128968112|NCT04007367|464169974|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
128968113|NCT04007367|464169975|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
128968114|NCT04007367|464169976|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
128714204|NCT02062879|463250799|FG001|Overall Study|Withdrawal by Subject|1|||
128714205|NCT02289079|463250800|FG000|Overall Study|Physician Decision|2|||
128968115|NCT04007367|464169974|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
128968116|NCT04007367|464169975|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
128968117|NCT04007367|464169976|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
128968118|NCT01764022|464169977|FG000|Overall Study|Death|3|||
128968119|NCT01764022|464169978|FG001|Overall Study|Death|5|||
128968120|NCT01764022|464169977|FG000|Overall Study|Withdrawal by Subject|2|||
128714206|NCT02289079|463250801|FG001|Overall Study|Physician Decision|0|||
128714207|NCT02289079|463250800|FG000|Overall Study|Lost to Follow-up|0|||
128714208|NCT02289079|463250801|FG001|Overall Study|Lost to Follow-up|1|||
128714209|NCT00553150|463250802|FG000|Overall Study|Withdrawal by Subject|0|||
128968121|NCT01764022|464169978|FG001|Overall Study|Withdrawal by Subject|6|||
128968122|NCT01764022|464169977|FG000|Overall Study|Lack of Efficacy|0|||
128968123|NCT01764022|464169978|FG001|Overall Study|Lack of Efficacy|1|||
128968124|NCT01764022|464169977|FG000|Overall Study|Physician Decision|0|||
128968125|NCT01764022|464169978|FG001|Overall Study|Physician Decision|2|||
128968126|NCT01764022|464169977|FG000|Overall Study|Lost to Follow-up|2|||
128968127|NCT01764022|464169978|FG001|Overall Study|Lost to Follow-up|0|||
128968128|NCT01764022|464169977|FG000|Overall Study|Protocol Violation|1|||
128968129|NCT01764022|464169978|FG001|Overall Study|Protocol Violation|0|||
128968130|NCT01899768|464169979|FG000|Part A|Adverse Event|2|||
128968131|NCT01899768|464169979|FG000|Part A|Withdrawal by Subject|1|||
128968132|NCT01899768|464169979|FG000|Part B|Adverse Event|1|||
128968133|NCT01899768|464169979|FG000|Part B|Withdrawal by Subject|1|||
128968134|NCT04043416|464169981|FG000|Washout|Change in health condition|0|||
128968135|NCT04043416|464169982|FG001|Washout|Change in health condition|1|||
128968136|NCT02203916|464169983|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
128968137|NCT02203916|464169984|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
128968138|NCT02203916|464169985|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
128968139|NCT02203916|464169983|FG000|Overall Study|Major Protocol Deviation|1|||
128968140|NCT02203916|464169984|FG001|Overall Study|Major Protocol Deviation|1|||
128968141|NCT02203916|464169985|FG002|Overall Study|Major Protocol Deviation|0|||
128772868|NCT00876460|463459993|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
128772869|NCT00876460|463459986|FG000|Combination Therapy Phase|Other reason not defined above|0|||
128772870|NCT00876460|463459987|FG001|Combination Therapy Phase|Other reason not defined above|0|||
128772871|NCT00876460|463459988|FG002|Combination Therapy Phase|Other reason not defined above|0|||
128772872|NCT00876460|463459989|FG003|Combination Therapy Phase|Other reason not defined above|0|||
128772873|NCT00876460|463459990|FG004|Combination Therapy Phase|Other reason not defined above|0|||
128772874|NCT00876460|463459991|FG005|Combination Therapy Phase|Other reason not defined above|0|||
128772875|NCT00876460|463459992|FG006|Combination Therapy Phase|Other reason not defined above|1|||
128968142|NCT02203916|464169983|FG000|Overall Study|Lost to Follow-up|0|||
129220389|NCT02453711|465106589|FG005|Overall Study|Lost to Follow-up|5|||
129220390|NCT02453711|465106590|FG006|Overall Study|Lost to Follow-up|2|||
128772876|NCT00876460|463459993|FG007|Combination Therapy Phase|Other reason not defined above|2|||
128772877|NCT00876460|463459986|FG000|Combination Therapy Phase|Not treated|0|||
128772878|NCT00876460|463459987|FG001|Combination Therapy Phase|Not treated|0|||
128772879|NCT00876460|463459988|FG002|Combination Therapy Phase|Not treated|0|||
128772880|NCT00876460|463459989|FG003|Combination Therapy Phase|Not treated|0|||
128772881|NCT00876460|463459990|FG004|Combination Therapy Phase|Not treated|0|||
128772882|NCT00876460|463459991|FG005|Combination Therapy Phase|Not treated|0|||
128772883|NCT00876460|463459992|FG006|Combination Therapy Phase|Not treated|1|||
128772884|NCT00876460|463459993|FG007|Combination Therapy Phase|Not treated|0|||
128772885|NCT00876460|463459986|FG000|Mono Therapy Phase|Progressive disease|0|||
128772886|NCT00876460|463459987|FG001|Mono Therapy Phase|Progressive disease|0|||
128772887|NCT00876460|463459988|FG002|Mono Therapy Phase|Progressive disease|0|||
128772888|NCT00876460|463459989|FG003|Mono Therapy Phase|Progressive disease|0|||
128772889|NCT00876460|463459990|FG004|Mono Therapy Phase|Progressive disease|2|||
128772890|NCT00876460|463459991|FG005|Mono Therapy Phase|Progressive disease|0|||
128772891|NCT00876460|463459992|FG006|Mono Therapy Phase|Progressive disease|1|||
128772892|NCT00876460|463459993|FG007|Mono Therapy Phase|Progressive disease|3|||
128772893|NCT00876460|463459986|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
128772894|NCT00876460|463459987|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
128772895|NCT00876460|463459988|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
128772896|NCT00876460|463459989|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
128772897|NCT00876460|463459990|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
128772898|NCT00876460|463459991|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
128772899|NCT00876460|463459992|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
128968143|NCT02203916|464169984|FG001|Overall Study|Lost to Follow-up|1|||
128968144|NCT02203916|464169985|FG002|Overall Study|Lost to Follow-up|0|||
128968145|NCT02203916|464169983|FG000|Overall Study|Voluntary Withdrawal|3|||
128968146|NCT02203916|464169984|FG001|Overall Study|Voluntary Withdrawal|3|||
128968147|NCT02203916|464169985|FG002|Overall Study|Voluntary Withdrawal|8|||
128968148|NCT02203916|464169983|FG000|Overall Study|Lack of Efficacy|3|||
128968149|NCT02203916|464169984|FG001|Overall Study|Lack of Efficacy|0|||
128968150|NCT02203916|464169985|FG002|Overall Study|Lack of Efficacy|0|||
128968151|NCT02203916|464169983|FG000|Overall Study|Reason Not Specified|0|||
128968152|NCT02203916|464169984|FG001|Overall Study|Reason Not Specified|2|||
128968153|NCT02203916|464169985|FG002|Overall Study|Reason Not Specified|1|||
128968154|NCT03236506|464169986|FG000|Overall Study|Death|1|||
129220391|NCT02453711|465106591|FG007|Overall Study|Lost to Follow-up|6|||
128772900|NCT00876460|463459993|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
128772901|NCT00876460|463459986|FG000|Mono Therapy Phase|Adverse Event|0|||
128772902|NCT00876460|463459987|FG001|Mono Therapy Phase|Adverse Event|0|||
128968155|NCT03236506|464169987|FG001|Overall Study|Death|1|||
128968156|NCT03236506|464169988|FG002|Overall Study|Death|1|||
128968157|NCT03236506|464169986|FG000|Overall Study|Withdrawal by Subject|3|||
129038019|NCT02400476|464430563|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
128772903|NCT00876460|463459988|FG002|Mono Therapy Phase|Adverse Event|0|||
128772904|NCT00876460|463459989|FG003|Mono Therapy Phase|Adverse Event|1|||
128772905|NCT00876460|463459990|FG004|Mono Therapy Phase|Adverse Event|0|||
128968158|NCT03236506|464169987|FG001|Overall Study|Withdrawal by Subject|3|||
128968159|NCT03236506|464169988|FG002|Overall Study|Withdrawal by Subject|4|||
128968160|NCT03236506|464169986|FG000|Overall Study|Did not initiate treatment|2|||
128968161|NCT03236506|464169987|FG001|Overall Study|Did not initiate treatment|1|||
128968162|NCT03236506|464169988|FG002|Overall Study|Did not initiate treatment|2|||
128968163|NCT00414973|464169989|FG000|Overall Study|Withdrawal by Subject|14|||
128968164|NCT00414973|464169990|FG001|Overall Study|Withdrawal by Subject|4|||
128968165|NCT00414973|464169991|FG002|Overall Study|Withdrawal by Subject|1|||
128772906|NCT00876460|463459991|FG005|Mono Therapy Phase|Adverse Event|0|||
128772907|NCT00876460|463459992|FG006|Mono Therapy Phase|Adverse Event|0|||
128772908|NCT00876460|463459993|FG007|Mono Therapy Phase|Adverse Event|0|||
128772909|NCT00127413|463459995|FG000|Overall Study|Lost to Follow-up|6|||
128772910|NCT00127413|463459996|FG001|Overall Study|Lost to Follow-up|4|||
128772911|NCT00127413|463459997|FG002|Overall Study|Lost to Follow-up|8|||
128968166|NCT00414973|464169992|FG003|Overall Study|Withdrawal by Subject|0|||
128968167|NCT00414973|464169989|FG000|Overall Study|Adverse Event|10|||
128968168|NCT00414973|464169990|FG001|Overall Study|Adverse Event|0|||
128968169|NCT00414973|464169991|FG002|Overall Study|Adverse Event|1|||
128968170|NCT00414973|464169992|FG003|Overall Study|Adverse Event|0|||
128968171|NCT00414973|464169989|FG000|Overall Study|Protocol Violation|3|||
128968172|NCT00414973|464169990|FG001|Overall Study|Protocol Violation|4|||
128968173|NCT00414973|464169991|FG002|Overall Study|Protocol Violation|0|||
128968174|NCT00414973|464169992|FG003|Overall Study|Protocol Violation|0|||
128968175|NCT00414973|464169989|FG000|Overall Study|Lost to Follow-up|0|||
128968176|NCT00414973|464169990|FG001|Overall Study|Lost to Follow-up|2|||
128968177|NCT00414973|464169991|FG002|Overall Study|Lost to Follow-up|0|||
128968178|NCT00414973|464169992|FG003|Overall Study|Lost to Follow-up|0|||
128968179|NCT00414973|464169989|FG000|Overall Study|Sponsor Decision|1|||
128968180|NCT00414973|464169990|FG001|Overall Study|Sponsor Decision|0|||
128968181|NCT00414973|464169991|FG002|Overall Study|Sponsor Decision|0|||
128968182|NCT00414973|464169992|FG003|Overall Study|Sponsor Decision|0|||
129220392|NCT02453711|465106592|FG008|Overall Study|Lost to Follow-up|6|||
129220393|NCT02453711|465106584|FG000|Overall Study|Death|0|||
129220394|NCT02453711|465106585|FG001|Overall Study|Death|0|||
129220395|NCT02453711|465106586|FG002|Overall Study|Death|0|||
129220396|NCT02453711|465106587|FG003|Overall Study|Death|0|||
129220397|NCT02453711|465106588|FG004|Overall Study|Death|0|||
129220398|NCT02453711|465106589|FG005|Overall Study|Death|0|||
129220399|NCT02453711|465106590|FG006|Overall Study|Death|1|||
129220400|NCT02453711|465106591|FG007|Overall Study|Death|0|||
128772912|NCT00127413|463459998|FG003|Overall Study|Lost to Follow-up|2|||
128772913|NCT00547911|463460001|FG000|Overall Study|Adverse Event|0|||
128772914|NCT00547911|463460002|FG001|Overall Study|Adverse Event|0|||
128772915|NCT00547911|463460003|FG002|Overall Study|Adverse Event|0|||
128772916|NCT00547911|463460004|FG003|Overall Study|Adverse Event|1|||
128772917|NCT00547911|463460005|FG004|Overall Study|Adverse Event|0|||
128772918|NCT00547911|463460006|FG005|Overall Study|Adverse Event|0|||
128772919|NCT01644474|463460008|FG000|Overall Study|Poor compliance to protocol|1|||
128772920|NCT01644474|463460009|FG001|Overall Study|Poor compliance to protocol|0|||
128772921|NCT01644474|463460008|FG000|Overall Study|Consent withdrawn by participant|0|||
128772922|NCT01644474|463460009|FG001|Overall Study|Consent withdrawn by participant|1|||
128772923|NCT01644474|463460008|FG000|Overall Study|Participant moved|0|||
128772924|NCT01644474|463460009|FG001|Overall Study|Participant moved|1|||
128772925|NCT01644474|463460008|FG000|Overall Study|Adverse Event|4|||
128772926|NCT01644474|463460009|FG001|Overall Study|Adverse Event|5|||
128772927|NCT01644474|463460008|FG000|Overall Study|Site scheduling error|1|||
128772928|NCT01644474|463460009|FG001|Overall Study|Site scheduling error|1|||
128968183|NCT00414973|464169989|FG000|Overall Study|Death|0|||
128968184|NCT00414973|464169990|FG001|Overall Study|Death|0|||
128968185|NCT00414973|464169991|FG002|Overall Study|Death|1|||
128968186|NCT00414973|464169992|FG003|Overall Study|Death|0|||
128968187|NCT00338806|464169999|FG000|Acute Phase|Withdrawal by Subject|0|||
128968188|NCT00338806|464170000|FG001|Acute Phase|Withdrawal by Subject|1|||
128968189|NCT00338806|464169999|FG000|Follow-up|Lost to Follow-up|1|||
128968190|NCT00338806|464170000|FG001|Follow-up|Lost to Follow-up|3|||
129220401|NCT02453711|465106592|FG008|Overall Study|Death|0|||
129220402|NCT02453711|465106584|FG000|Overall Study|Unclassified|1|||
129220403|NCT02453711|465106585|FG001|Overall Study|Unclassified|0|||
128772929|NCT01644474|463460008|FG000|Overall Study|Protocol Violation|1|||
128772930|NCT01644474|463460009|FG001|Overall Study|Protocol Violation|0|||
128772931|NCT02044458|463460013|FG000|Overall Study|Protocol Violation|3|||
128968191|NCT00744991|464170001|FG000|Overall Study|Progressive Disease|11|||
128968192|NCT00744991|464170001|FG000|Overall Study|Withdrawal by Subject|8|||
128968193|NCT00744991|464170001|FG000|Overall Study|Physician Decision|3|||
128968194|NCT00744991|464170001|FG000|Overall Study|Adverse Event|2|||
128968195|NCT00744991|464170001|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
128968196|NCT03198728|464170007|FG000|Overall Study|Adverse Event|10|||
129220404|NCT02453711|465106586|FG002|Overall Study|Unclassified|1|||
128772932|NCT02044458|463460014|FG001|Overall Study|Protocol Violation|8|||
128772933|NCT02601937|463460015|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772934|NCT02601937|463460016|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772935|NCT02601937|463460017|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772936|NCT02601937|463460018|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772937|NCT02601937|463460019|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772938|NCT02601937|463460020|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
128772939|NCT02601937|463460021|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772940|NCT02601937|463460022|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772941|NCT02601937|463460023|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772942|NCT02601937|463460024|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772943|NCT02601937|463460025|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
128772944|NCT02601937|463460015|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
128772945|NCT02601937|463460016|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772946|NCT02601937|463460017|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772947|NCT02601937|463460018|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772948|NCT02601937|463460019|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772949|NCT02601937|463460020|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772950|NCT02601937|463460021|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
128968197|NCT03198728|464170008|FG001|Overall Study|Adverse Event|5|||
128968198|NCT03198728|464170007|FG000|Overall Study|Lost to Follow-up|21|||
128968199|NCT03198728|464170008|FG001|Overall Study|Lost to Follow-up|7|||
128968200|NCT03198728|464170007|FG000|Overall Study|Physician Decision|7|||
128968201|NCT03198728|464170008|FG001|Overall Study|Physician Decision|2|||
128968202|NCT03198728|464170007|FG000|Overall Study|Withdrawal by Subject|14|||
128772951|NCT02601937|463460022|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772952|NCT02601937|463460023|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772953|NCT02601937|463460024|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772954|NCT02601937|463460025|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
128772955|NCT02601937|463460015|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772956|NCT02601937|463460016|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772957|NCT02601937|463460017|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
128772958|NCT02601937|463460018|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772959|NCT02601937|463460019|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772960|NCT02601937|463460020|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772961|NCT02601937|463460021|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772962|NCT02601937|463460022|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772963|NCT02601937|463460023|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772964|NCT02601937|463460024|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772965|NCT02601937|463460025|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
128772966|NCT02601937|463460015|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
128772967|NCT02601937|463460016|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
128772968|NCT02601937|463460017|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
128772969|NCT02601937|463460018|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
128772970|NCT02601937|463460019|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
128772971|NCT02601937|463460020|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
128772972|NCT02601937|463460021|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
128772973|NCT02601937|463460022|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
128772974|NCT02601937|463460023|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
128772975|NCT02601937|463460024|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
128772976|NCT02601937|463460025|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
128772977|NCT02601937|463460015|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772978|NCT02601937|463460016|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772979|NCT02601937|463460017|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772980|NCT02601937|463460018|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772981|NCT02601937|463460019|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772982|NCT02601937|463460020|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772983|NCT02601937|463460021|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772984|NCT02601937|463460022|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772985|NCT02601937|463460023|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772986|NCT02601937|463460024|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
128772987|NCT02601937|463460025|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
128772988|NCT02601937|463460015|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128774790|NCT02555371|463468340|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
128968203|NCT03198728|464170008|FG001|Overall Study|Withdrawal by Subject|10|||
128968204|NCT04051944|464170012|FG000|Overall Study|Study ending|1|||
128968205|NCT04051944|464170013|FG001|Overall Study|Study ending|1|||
128968206|NCT04051944|464170012|FG000|Overall Study|Early study termination by participant|1|||
128968207|NCT04051944|464170013|FG001|Overall Study|Early study termination by participant|0|||
128968208|NCT04051944|464170012|FG000|Overall Study|Withdrawal by Subject|2|||
128968209|NCT04051944|464170013|FG001|Overall Study|Withdrawal by Subject|2|||
128968210|NCT04051944|464170012|FG000|Overall Study|Lack of Efficacy|3|||
128968211|NCT04051944|464170013|FG001|Overall Study|Lack of Efficacy|0|||
128968212|NCT04051944|464170012|FG000|Overall Study|Adverse event, non- fatal|1|||
128968213|NCT04051944|464170013|FG001|Overall Study|Adverse event, non- fatal|1|||
128968214|NCT02139280|464170014|FG000|Overall Study|No longer eligible|2|||
128968215|NCT02139280|464170015|FG001|Overall Study|No longer eligible|0|||
128968216|NCT00736450|464170016|FG000|Overall Study|Not ABC gene eligible|19|||
128968217|NCT00736450|464170016|FG000|Overall Study|Withdrawal by Subject|5|||
128968218|NCT00736450|464170016|FG000|Overall Study|Physician Decision|1|||
128968219|NCT04157751|464170017|FG000|Overall Study|Withdrawal by Subject|12|||
129220405|NCT02453711|465106587|FG003|Overall Study|Unclassified|0|||
128714210|NCT00553150|463250803|FG001|Overall Study|Withdrawal by Subject|0|||
128714211|NCT00553150|463250804|FG002|Overall Study|Withdrawal by Subject|0|||
128714212|NCT00553150|463250805|FG003|Overall Study|Withdrawal by Subject|2|||
128714213|NCT00553150|463250802|FG000|Overall Study|Protocol Violation|0|||
128714214|NCT00553150|463250803|FG001|Overall Study|Protocol Violation|0|||
128714215|NCT00553150|463250804|FG002|Overall Study|Protocol Violation|0|||
128714216|NCT00553150|463250805|FG003|Overall Study|Protocol Violation|1|||
128714217|NCT00553150|463250802|FG000|Overall Study|Ineligible|0|||
128714218|NCT00553150|463250803|FG001|Overall Study|Ineligible|0|||
128714219|NCT00553150|463250804|FG002|Overall Study|Ineligible|0|||
128714220|NCT00553150|463250805|FG003|Overall Study|Ineligible|1|||
128714221|NCT03061331|463250806|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
128714222|NCT03061331|463250807|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
128714223|NCT02625259|463250808|FG000|First Intervention (Day 1)|Other|0|||
128714224|NCT02625259|463250809|FG001|First Intervention (Day 1)|Other|0|||
128714225|NCT02625259|463250810|FG002|First Intervention (Day 1)|Other|1|||
128714226|NCT02625259|463250811|FG003|First Intervention (Day 1)|Other|0|||
128714227|NCT02625259|463250812|FG004|First Intervention (Day 1)|Other|0|||
128714228|NCT02625259|463250808|FG000|First Intervention (Day 1)|Adverse Event|2|||
128714229|NCT02625259|463250809|FG001|First Intervention (Day 1)|Adverse Event|1|||
128714230|NCT02625259|463250810|FG002|First Intervention (Day 1)|Adverse Event|0|||
128714231|NCT02625259|463250811|FG003|First Intervention (Day 1)|Adverse Event|0|||
128714232|NCT02625259|463250812|FG004|First Intervention (Day 1)|Adverse Event|0|||
128714233|NCT02625259|463250808|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
128714234|NCT02625259|463250809|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
128714235|NCT02625259|463250810|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
128714236|NCT02625259|463250811|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
128714237|NCT02625259|463250812|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
128714238|NCT01980875|463250813|FG000|Overall Study|Withdrew Consent|1|||
128714239|NCT01980875|463250814|FG001|Overall Study|Withdrew Consent|1|||
128714240|NCT01980875|463250815|FG002|Overall Study|Withdrew Consent|1|||
128714241|NCT01980875|463250813|FG000|Overall Study|Study Terminated by Sponsor|7|||
128714242|NCT01980875|463250814|FG001|Overall Study|Study Terminated by Sponsor|24|||
128714243|NCT01980875|463250815|FG002|Overall Study|Study Terminated by Sponsor|22|||
128714244|NCT01980875|463250813|FG000|Overall Study|Lost to Follow-up|0|||
128714245|NCT01980875|463250814|FG001|Overall Study|Lost to Follow-up|0|||
128714246|NCT01980875|463250815|FG002|Overall Study|Lost to Follow-up|1|||
128714247|NCT02998840|463250816|FG000|Overall Study|Lost to Follow-up|1|||
128714248|NCT02998840|463250817|FG001|Overall Study|Lost to Follow-up|1|||
128714249|NCT02998840|463250818|FG002|Overall Study|Lost to Follow-up|2|||
128714250|NCT02998840|463250819|FG003|Overall Study|Lost to Follow-up|3|||
128714251|NCT02998840|463250816|FG000|Overall Study|Withdrawal by Subject|1|||
128714252|NCT02998840|463250817|FG001|Overall Study|Withdrawal by Subject|1|||
128714253|NCT02998840|463250818|FG002|Overall Study|Withdrawal by Subject|0|||
128714254|NCT02998840|463250819|FG003|Overall Study|Withdrawal by Subject|1|||
128714255|NCT02998840|463250816|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
128714256|NCT02998840|463250817|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
128714257|NCT02998840|463250818|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
128714258|NCT02998840|463250819|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
128714259|NCT00513474|463250823|FG000|Overall Study|Death|6|||
128714260|NCT00513474|463250824|FG001|Overall Study|Death|9|||
128714261|NCT00513474|463250823|FG000|Overall Study|Participant Withdrew Consent|1|||
128714262|NCT00513474|463250824|FG001|Overall Study|Participant Withdrew Consent|0|||
129038020|NCT02400476|464430564|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
128714263|NCT01686633|463250825|FG000|Overall Study|Lack of Efficacy|33|||
128714264|NCT01686633|463250826|FG001|Overall Study|Lack of Efficacy|13|||
128714265|NCT01686633|463250827|FG002|Overall Study|Lack of Efficacy|11|||
128714266|NCT01686633|463250825|FG000|Overall Study|Withdrawal by Subject|8|||
128714267|NCT01686633|463250826|FG001|Overall Study|Withdrawal by Subject|8|||
128714268|NCT01686633|463250827|FG002|Overall Study|Withdrawal by Subject|5|||
128772989|NCT02601937|463460016|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772990|NCT02601937|463460017|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772991|NCT02601937|463460018|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772992|NCT02601937|463460019|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772993|NCT02601937|463460020|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772994|NCT02601937|463460021|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772995|NCT02601937|463460022|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
128772996|NCT02601937|463460023|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772997|NCT02601937|463460024|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772998|NCT02601937|463460025|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
128772999|NCT02601937|463460015|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773000|NCT02601937|463460016|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773001|NCT02601937|463460017|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773002|NCT02601937|463460018|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773003|NCT02601937|463460019|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773004|NCT02601937|463460020|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773005|NCT02601937|463460021|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773006|NCT02601937|463460022|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129220406|NCT02453711|465106588|FG004|Overall Study|Unclassified|0|||
129220407|NCT02453711|465106589|FG005|Overall Study|Unclassified|0|||
129220408|NCT02453711|465106590|FG006|Overall Study|Unclassified|0|||
129220409|NCT02453711|465106591|FG007|Overall Study|Unclassified|0|||
129220410|NCT02453711|465106592|FG008|Overall Study|Unclassified|0|||
129220411|NCT01273519|465106593|FG000|Overall Study|Adverse Event|3|||
129220412|NCT01273519|465106594|FG001|Overall Study|Adverse Event|0|||
129220413|NCT01273519|465106595|FG002|Overall Study|Adverse Event|0|||
128714269|NCT01686633|463250825|FG000|Overall Study|Physician Decision|3|||
128714270|NCT01686633|463250826|FG001|Overall Study|Physician Decision|4|||
128714271|NCT01686633|463250827|FG002|Overall Study|Physician Decision|4|||
128714272|NCT01686633|463250825|FG000|Overall Study|Adverse Event|4|||
128714273|NCT01686633|463250826|FG001|Overall Study|Adverse Event|3|||
128714274|NCT01686633|463250827|FG002|Overall Study|Adverse Event|3|||
128714275|NCT01686633|463250825|FG000|Overall Study|Protocol Violation|2|||
128714276|NCT01686633|463250826|FG001|Overall Study|Protocol Violation|3|||
128714277|NCT01686633|463250827|FG002|Overall Study|Protocol Violation|0|||
128714278|NCT01686633|463250825|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
128714279|NCT01686633|463250826|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
128714280|NCT01686633|463250827|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
128714281|NCT01686633|463250825|FG000|Overall Study|Lost to Follow-up|0|||
128714282|NCT01686633|463250826|FG001|Overall Study|Lost to Follow-up|1|||
128714283|NCT01686633|463250827|FG002|Overall Study|Lost to Follow-up|1|||
128714284|NCT00535223|463250833|FG000|Overall Study|Withdrawal by Subject|4|||
128714285|NCT00535223|463250834|FG001|Overall Study|Withdrawal by Subject|1|||
128714286|NCT02953314|463250835|FG000|Overall Study|Adverse Event|0|||
128714287|NCT02953314|463250836|FG001|Overall Study|Adverse Event|1|||
128714288|NCT02953314|463250835|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
128714289|NCT02953314|463250836|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
128714290|NCT01765153|463250837|FG000|Training Phase 1|Format of intervention differed|1|||
128714291|NCT01765153|463250838|FG001|Training Phase 1|Format of intervention differed|0|||
128714292|NCT01765153|463250837|FG000|Training Phase 1|Poor participation in intervention|0|||
128714293|NCT01765153|463250838|FG001|Training Phase 1|Poor participation in intervention|1|||
128714294|NCT01765153|463250837|FG000|Rest Phase 1|Withdrawal by Subject|0|||
128714295|NCT01765153|463250838|FG001|Rest Phase 1|Withdrawal by Subject|1|||
128714296|NCT01765153|463250837|FG000|Training Phase 2|Withdrawal by Subject|0|||
128714297|NCT01765153|463250838|FG001|Training Phase 2|Withdrawal by Subject|1|||
128714298|NCT01765153|463250837|FG000|Rest Phase 2|Lost to Follow-up|2|||
128714299|NCT01765153|463250838|FG001|Rest Phase 2|Lost to Follow-up|1|||
128714300|NCT02663674|463250839|FG000|Overall Study|Lost to Follow-up|5|||
128714301|NCT02663674|463250840|FG001|Overall Study|Lost to Follow-up|4|||
128714302|NCT02663674|463250839|FG000|Overall Study|Withdrawal by Subject|1|||
128714303|NCT02663674|463250840|FG001|Overall Study|Withdrawal by Subject|4|||
128714304|NCT02663674|463250839|FG000|Overall Study|Physician Decision|1|||
128714305|NCT02663674|463250840|FG001|Overall Study|Physician Decision|1|||
128714306|NCT02663674|463250839|FG000|Overall Study|Other Event (Health Related)|0|||
128714307|NCT02663674|463250840|FG001|Overall Study|Other Event (Health Related)|1|||
128714308|NCT02554812|463250841|FG000|Overall Study|Adverse Event|2|||
128714309|NCT02554812|463250842|FG001|Overall Study|Adverse Event|5|||
128714310|NCT02554812|463250843|FG002|Overall Study|Adverse Event|3|||
128714311|NCT02554812|463250844|FG003|Overall Study|Adverse Event|0|||
128714312|NCT02554812|463250845|FG004|Overall Study|Adverse Event|5|||
128714313|NCT02554812|463250846|FG005|Overall Study|Adverse Event|0|||
128773007|NCT02601937|463460023|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
128773008|NCT02601937|463460024|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
128968220|NCT04157751|464170018|FG001|Overall Study|Withdrawal by Subject|17|||
128968221|NCT04157751|464170017|FG000|Overall Study|Lost to Follow-up|6|||
128968222|NCT04157751|464170018|FG001|Overall Study|Lost to Follow-up|2|||
128968223|NCT04157751|464170017|FG000|Overall Study|Adverse Event|34|||
128968224|NCT04157751|464170018|FG001|Overall Study|Adverse Event|23|||
128968225|NCT04157751|464170017|FG000|Overall Study|Not treated|1|||
128968226|NCT04157751|464170018|FG001|Overall Study|Not treated|5|||
128968227|NCT04157751|464170017|FG000|Overall Study|Other reason not stated above|10|||
128968228|NCT04157751|464170018|FG001|Overall Study|Other reason not stated above|10|||
128968229|NCT01947894|464170031|FG000|Overall Study|Other|3|||
128968230|NCT01947894|464170032|FG001|Overall Study|Other|4|||
128968231|NCT01947894|464170033|FG002|Overall Study|Other|3|||
128968232|NCT01947894|464170031|FG000|Overall Study|Withdrawal by Subject|12|||
128968233|NCT01947894|464170032|FG001|Overall Study|Withdrawal by Subject|4|||
128968234|NCT01947894|464170033|FG002|Overall Study|Withdrawal by Subject|1|||
128968235|NCT01947894|464170031|FG000|Overall Study|Death|12|||
128968236|NCT01947894|464170032|FG001|Overall Study|Death|1|||
128968237|NCT01947894|464170033|FG002|Overall Study|Death|0|||
128968238|NCT01947894|464170031|FG000|Overall Study|Physician Decision|2|||
128968239|NCT01947894|464170032|FG001|Overall Study|Physician Decision|0|||
128968240|NCT01947894|464170033|FG002|Overall Study|Physician Decision|0|||
128968241|NCT01947894|464170031|FG000|Overall Study|Adverse Event|5|||
128968242|NCT01947894|464170032|FG001|Overall Study|Adverse Event|1|||
128968243|NCT01947894|464170033|FG002|Overall Study|Adverse Event|0|||
128968244|NCT01947894|464170031|FG000|Overall Study|Switched to other growth hormone brand|53|||
128968245|NCT01947894|464170032|FG001|Overall Study|Switched to other growth hormone brand|8|||
128968246|NCT01947894|464170033|FG002|Overall Study|Switched to other growth hormone brand|23|||
128968247|NCT01302691|464170034|FG000|Overall Study|Adverse Event|2|||
128968248|NCT01302691|464170035|FG001|Overall Study|Adverse Event|0|||
128968249|NCT01302691|464170034|FG000|Overall Study|Death|0|||
128968250|NCT01302691|464170035|FG001|Overall Study|Death|1|||
128968251|NCT01302691|464170034|FG000|Overall Study|Lost to Follow-up|1|||
128968252|NCT01302691|464170035|FG001|Overall Study|Lost to Follow-up|0|||
128968253|NCT01302691|464170034|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
128968254|NCT01302691|464170035|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
128968255|NCT01302691|464170034|FG000|Overall Study|Physician Decision|0|||
128968256|NCT01302691|464170035|FG001|Overall Study|Physician Decision|1|||
128968257|NCT01302691|464170034|FG000|Overall Study|Protocol Violation|1|||
128968258|NCT01302691|464170035|FG001|Overall Study|Protocol Violation|0|||
128968259|NCT03446612|464170036|FG000|Overall Study|Protocol defined stopping criteria|0|||
128968260|NCT03446612|464170037|FG001|Overall Study|Protocol defined stopping criteria|1|||
128968261|NCT01437267|464170039|FG000|Overall Study|Withdrawal by Subject|0|||
128968262|NCT01437267|464170040|FG001|Overall Study|Withdrawal by Subject|0|||
129130393|NCT04470427|464768791|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
129130394|NCT04470427|464768792|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
128773009|NCT02601937|463460025|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
128773010|NCT02601937|463460015|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
128773011|NCT02601937|463460016|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
128773012|NCT02601937|463460017|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
128773013|NCT02601937|463460018|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
128773014|NCT02601937|463460019|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
128773015|NCT02601937|463460020|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
128773016|NCT02601937|463460021|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
128773017|NCT02601937|463460022|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
128773018|NCT02601937|463460023|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
128968263|NCT01437267|464170041|FG002|Overall Study|Withdrawal by Subject|0|||
128968264|NCT01437267|464170042|FG003|Overall Study|Withdrawal by Subject|1|||
128968265|NCT01437267|464170043|FG004|Overall Study|Withdrawal by Subject|0|||
128968266|NCT01437267|464170044|FG005|Overall Study|Withdrawal by Subject|0|||
128968267|NCT01437267|464170039|FG000|Overall Study|Protocol Violation|0|||
128968268|NCT01437267|464170040|FG001|Overall Study|Protocol Violation|1|||
128968269|NCT01437267|464170041|FG002|Overall Study|Protocol Violation|0|||
128968270|NCT01437267|464170042|FG003|Overall Study|Protocol Violation|0|||
128968271|NCT01437267|464170043|FG004|Overall Study|Protocol Violation|0|||
128773019|NCT02601937|463460024|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
128968272|NCT01437267|464170044|FG005|Overall Study|Protocol Violation|0|||
128968273|NCT03934203|464170045|FG000|Overall Study|Adverse Event|0|||
128968274|NCT03934203|464170046|FG001|Overall Study|Adverse Event|0|||
128968275|NCT03934203|464170047|FG002|Overall Study|Adverse Event|1|||
128968276|NCT03934203|464170048|FG003|Overall Study|Adverse Event|0|||
128968277|NCT03934203|464170049|FG004|Overall Study|Adverse Event|1|||
128968278|NCT03934203|464170050|FG005|Overall Study|Adverse Event|0|||
128968279|NCT03934203|464170051|FG006|Overall Study|Adverse Event|2|||
128968280|NCT03934203|464170052|FG007|Overall Study|Adverse Event|0|||
128773020|NCT02601937|463460025|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
128773021|NCT02601937|463460015|FG000|Period 2: Dose Expansion Cohort|Other|0|||
128773022|NCT02601937|463460016|FG001|Period 2: Dose Expansion Cohort|Other|0|||
128773023|NCT02601937|463460017|FG002|Period 2: Dose Expansion Cohort|Other|0|||
128773024|NCT02601937|463460018|FG003|Period 2: Dose Expansion Cohort|Other|0|||
128773025|NCT02601937|463460019|FG004|Period 2: Dose Expansion Cohort|Other|0|||
128773026|NCT02601937|463460020|FG005|Period 2: Dose Expansion Cohort|Other|0|||
128773027|NCT02601937|463460021|FG006|Period 2: Dose Expansion Cohort|Other|0|||
128773028|NCT02601937|463460022|FG007|Period 2: Dose Expansion Cohort|Other|0|||
128773029|NCT02601937|463460023|FG008|Period 2: Dose Expansion Cohort|Other|2|||
128773030|NCT02601937|463460024|FG009|Period 2: Dose Expansion Cohort|Other|2|||
128773031|NCT02601937|463460025|FG010|Period 2: Dose Expansion Cohort|Other|0|||
128773032|NCT02601937|463460015|FG000|Period 2: Dose Expansion Cohort|Death|0|||
128773033|NCT02601937|463460016|FG001|Period 2: Dose Expansion Cohort|Death|0|||
128773034|NCT02601937|463460017|FG002|Period 2: Dose Expansion Cohort|Death|0|||
128773035|NCT02601937|463460018|FG003|Period 2: Dose Expansion Cohort|Death|0|||
128773036|NCT02601937|463460019|FG004|Period 2: Dose Expansion Cohort|Death|0|||
128773037|NCT02601937|463460020|FG005|Period 2: Dose Expansion Cohort|Death|0|||
128773038|NCT02601937|463460021|FG006|Period 2: Dose Expansion Cohort|Death|0|||
128773039|NCT02601937|463460022|FG007|Period 2: Dose Expansion Cohort|Death|0|||
128773040|NCT02601937|463460023|FG008|Period 2: Dose Expansion Cohort|Death|1|||
128773041|NCT02601937|463460024|FG009|Period 2: Dose Expansion Cohort|Death|0|||
128773042|NCT02601937|463460025|FG010|Period 2: Dose Expansion Cohort|Death|0|||
128773043|NCT01625910|463462185|FG000|Overall Study|Lost to Follow-up|3|||
128773044|NCT01625910|463462186|FG001|Overall Study|Lost to Follow-up|4|||
128773045|NCT02391038|463462187|FG000|Overall Study|Progressive disease|3|||
128773046|NCT02391038|463462188|FG001|Overall Study|Progressive disease|3|||
128773047|NCT02391038|463462189|FG002|Overall Study|Progressive disease|6|||
128773048|NCT02959138|463462190|FG000|Overall Study|Enrolled but Never Treated|0|||
128773049|NCT02959138|463462191|FG001|Overall Study|Enrolled but Never Treated|1|||
128773050|NCT02959138|463462192|FG002|Overall Study|Enrolled but Never Treated|0|||
128773051|NCT04213989|463462193|FG000|Overall Study|Withdrawal by Subject|3|||
128773052|NCT04213989|463462194|FG001|Overall Study|Withdrawal by Subject|2|||
128773053|NCT04213989|463462193|FG000|Overall Study|Physician Decision|1|||
128773054|NCT04213989|463462194|FG001|Overall Study|Physician Decision|0|||
128773055|NCT04213989|463462193|FG000|Overall Study|Lost to Follow-up|0|||
128773056|NCT04213989|463462194|FG001|Overall Study|Lost to Follow-up|4|||
128773057|NCT01189890|463462197|FG000|Overall Study|Adverse Event|3|||
128773058|NCT01189890|463462198|FG001|Overall Study|Adverse Event|4|||
128773059|NCT01189890|463462197|FG000|Overall Study|Lack of Efficacy|7|||
128773060|NCT01189890|463462198|FG001|Overall Study|Lack of Efficacy|2|||
128773061|NCT01189890|463462197|FG000|Overall Study|Lost to Follow-up|1|||
128773062|NCT01189890|463462198|FG001|Overall Study|Lost to Follow-up|7|||
128773063|NCT01189890|463462197|FG000|Overall Study|Protocol Violation|1|||
128773064|NCT01189890|463462198|FG001|Overall Study|Protocol Violation|5|||
128773065|NCT01189890|463462197|FG000|Overall Study|Withdrawal by Subject|15|||
128773066|NCT01189890|463462198|FG001|Overall Study|Withdrawal by Subject|11|||
128773067|NCT01189890|463462197|FG000|Overall Study|Non Compliance|0|||
128773068|NCT01189890|463462198|FG001|Overall Study|Non Compliance|1|||
128773069|NCT01189890|463462197|FG000|Overall Study|Physician Decision|5|||
128773070|NCT01189890|463462198|FG001|Overall Study|Physician Decision|4|||
128773071|NCT01189890|463462197|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
128773072|NCT01189890|463462198|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
128773073|NCT01155388|463462201|FG000|Overall Study|Adverse Event|1|||
128773074|NCT01155388|463462202|FG001|Overall Study|Adverse Event|0|||
128773075|NCT03943589|463462203|FG000|Overall Study|Death|1|||
128773076|NCT03943589|463462203|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
128773077|NCT00900627|463462204|FG000|Overall Study|Condition under investigation worsened|4|||
128773078|NCT00900627|463462205|FG001|Overall Study|Condition under investigation worsened|0|||
128773079|NCT00900627|463462206|FG002|Overall Study|Condition under investigation worsened|5|||
128773080|NCT00900627|463462207|FG003|Overall Study|Condition under investigation worsened|3|||
128773081|NCT00900627|463462208|FG004|Overall Study|Condition under investigation worsened|0|||
128773082|NCT00900627|463462209|FG005|Overall Study|Condition under investigation worsened|0|||
128773083|NCT00900627|463462204|FG000|Overall Study|Withdrawal by Subject|1|||
128773084|NCT00900627|463462205|FG001|Overall Study|Withdrawal by Subject|0|||
128773085|NCT00900627|463462206|FG002|Overall Study|Withdrawal by Subject|1|||
128773086|NCT00900627|463462207|FG003|Overall Study|Withdrawal by Subject|0|||
128773087|NCT00900627|463462208|FG004|Overall Study|Withdrawal by Subject|1|||
128773088|NCT00900627|463462209|FG005|Overall Study|Withdrawal by Subject|2|||
128773089|NCT00900627|463462204|FG000|Overall Study|Adverse Event|1|||
128773090|NCT00900627|463462205|FG001|Overall Study|Adverse Event|2|||
128773091|NCT00900627|463462206|FG002|Overall Study|Adverse Event|0|||
128773092|NCT00900627|463462207|FG003|Overall Study|Adverse Event|3|||
128773093|NCT00900627|463462208|FG004|Overall Study|Adverse Event|0|||
128773094|NCT00900627|463462209|FG005|Overall Study|Adverse Event|0|||
128773095|NCT00900627|463462204|FG000|Overall Study|Death|0|||
128773096|NCT00900627|463462205|FG001|Overall Study|Death|0|||
128773097|NCT00900627|463462206|FG002|Overall Study|Death|0|||
128773098|NCT00900627|463462207|FG003|Overall Study|Death|0|||
128773099|NCT00900627|463462208|FG004|Overall Study|Death|28|||
128773100|NCT00900627|463462209|FG005|Overall Study|Death|24|||
128773101|NCT00373295|463462210|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
128773102|NCT00373295|463462211|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
128773103|NCT00373295|463462212|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
128773104|NCT00373295|463462213|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
128773105|NCT00373295|463462214|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
128773106|NCT00373295|463462215|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
128773107|NCT00830947|463462216|FG000|Overall Study|Lost to Follow-up|4|||
128773108|NCT00830947|463462217|FG001|Overall Study|Lost to Follow-up|4|||
128773109|NCT00962585|463462224|FG000|Overall Study|Adverse Event|0|||
128773110|NCT00962585|463462225|FG001|Overall Study|Adverse Event|2|||
128773111|NCT00962585|463462226|FG002|Overall Study|Adverse Event|1|||
128773112|NCT00962585|463462227|FG003|Overall Study|Adverse Event|0|||
128773113|NCT00962585|463462224|FG000|Overall Study|Lost to Follow-up|3|||
128773114|NCT00962585|463462225|FG001|Overall Study|Lost to Follow-up|0|||
128773115|NCT00962585|463462226|FG002|Overall Study|Lost to Follow-up|1|||
128773116|NCT00962585|463462227|FG003|Overall Study|Lost to Follow-up|0|||
128773117|NCT00962585|463462224|FG000|Overall Study|Protocol Violation|0|||
128773118|NCT00962585|463462225|FG001|Overall Study|Protocol Violation|0|||
128773119|NCT00962585|463462226|FG002|Overall Study|Protocol Violation|1|||
128773120|NCT00962585|463462227|FG003|Overall Study|Protocol Violation|0|||
128773121|NCT00962585|463462224|FG000|Overall Study|Withdrawal by Subject|1|||
128773122|NCT00962585|463462225|FG001|Overall Study|Withdrawal by Subject|0|||
128968281|NCT03934203|464170053|FG008|Overall Study|Adverse Event|0|||
128968282|NCT03934203|464170054|FG009|Overall Study|Adverse Event|0|||
128968283|NCT03934203|464170055|FG010|Overall Study|Adverse Event|0|||
128968284|NCT03934203|464170056|FG011|Overall Study|Adverse Event|0|||
128968285|NCT03934203|464170057|FG012|Overall Study|Adverse Event|0|||
128968286|NCT03934203|464170058|FG013|Overall Study|Adverse Event|1|||
128968287|NCT03934203|464170059|FG014|Overall Study|Adverse Event|0|||
128968288|NCT04445051|464170060|FG000|Overall Study|Adverse Event|0|||
128714314|NCT02554812|463250847|FG006|Overall Study|Adverse Event|1|||
128714315|NCT02554812|463250848|FG007|Overall Study|Adverse Event|6|||
128714316|NCT02554812|463250849|FG008|Overall Study|Adverse Event|2|||
128714317|NCT02554812|463250850|FG009|Overall Study|Adverse Event|2|||
128714318|NCT02554812|463250851|FG010|Overall Study|Adverse Event|1|||
128714319|NCT02554812|463250852|FG011|Overall Study|Adverse Event|2|||
128714320|NCT02554812|463250853|FG012|Overall Study|Adverse Event|0|||
128714321|NCT02554812|463250854|FG013|Overall Study|Adverse Event|3|||
128714322|NCT02554812|463250855|FG014|Overall Study|Adverse Event|2|||
128714323|NCT02554812|463250856|FG015|Overall Study|Adverse Event|1|||
128714324|NCT02554812|463250857|FG016|Overall Study|Adverse Event|0|||
128714325|NCT02554812|463250858|FG017|Overall Study|Adverse Event|1|||
128714326|NCT02554812|463250859|FG018|Overall Study|Adverse Event|0|||
128714327|NCT02554812|463250860|FG019|Overall Study|Adverse Event|0|||
128714328|NCT02554812|463250861|FG020|Overall Study|Adverse Event|0|||
128714329|NCT02554812|463250862|FG021|Overall Study|Adverse Event|2|||
128714330|NCT02554812|463250863|FG022|Overall Study|Adverse Event|1|||
128714331|NCT02554812|463250864|FG023|Overall Study|Adverse Event|1|||
128714332|NCT02554812|463250865|FG024|Overall Study|Adverse Event|1|||
128714333|NCT02554812|463250866|FG025|Overall Study|Adverse Event|2|||
128714334|NCT02554812|463250867|FG026|Overall Study|Adverse Event|1|||
128714335|NCT02554812|463250841|FG000|Overall Study|Death|1|||
128714336|NCT02554812|463250842|FG001|Overall Study|Death|2|||
128714337|NCT02554812|463250843|FG002|Overall Study|Death|2|||
128714338|NCT02554812|463250844|FG003|Overall Study|Death|2|||
128714339|NCT02554812|463250845|FG004|Overall Study|Death|0|||
128714340|NCT02554812|463250846|FG005|Overall Study|Death|1|||
128714341|NCT02554812|463250847|FG006|Overall Study|Death|1|||
128714342|NCT02554812|463250848|FG007|Overall Study|Death|1|||
128773123|NCT00962585|463462226|FG002|Overall Study|Withdrawal by Subject|0|||
128773124|NCT00962585|463462227|FG003|Overall Study|Withdrawal by Subject|0|||
128773125|NCT00962585|463462224|FG000|Overall Study|Withdrew Consent|2|||
129130395|NCT04470427|464768787|FG000|Part B :Open-label|Other than specified|0|||
128714343|NCT02554812|463250849|FG008|Overall Study|Death|0|||
128714344|NCT02554812|463250850|FG009|Overall Study|Death|0|||
128714345|NCT02554812|463250851|FG010|Overall Study|Death|0|||
128714346|NCT02554812|463250852|FG011|Overall Study|Death|0|||
128714347|NCT02554812|463250853|FG012|Overall Study|Death|0|||
128714348|NCT02554812|463250854|FG013|Overall Study|Death|0|||
128714349|NCT02554812|463250855|FG014|Overall Study|Death|1|||
128714350|NCT02554812|463250856|FG015|Overall Study|Death|1|||
128773126|NCT00962585|463462225|FG001|Overall Study|Withdrew Consent|0|||
128773127|NCT00962585|463462226|FG002|Overall Study|Withdrew Consent|0|||
128773128|NCT00962585|463462227|FG003|Overall Study|Withdrew Consent|0|||
128773129|NCT02254421|463462230|FG000|Overall Study|Randomized but Not Treated|1|||
128968289|NCT04445051|464170061|FG001|Overall Study|Adverse Event|0|||
128773130|NCT02254421|463462231|FG001|Overall Study|Randomized but Not Treated|0|||
128773131|NCT02254421|463462230|FG000|Overall Study|Death|0|||
128773132|NCT02254421|463462231|FG001|Overall Study|Death|2|||
128773133|NCT02254421|463462230|FG000|Overall Study|Withdrew Consent|1|||
128773134|NCT02254421|463462231|FG001|Overall Study|Withdrew Consent|1|||
128773135|NCT00839917|463462235|FG000|Overall Study|Lost to Follow-up|1|||
128773136|NCT00839917|463462236|FG001|Overall Study|Lost to Follow-up|0|||
128773137|NCT00839917|463462235|FG000|Overall Study|Did not receive vaccine|0|||
128773138|NCT00839917|463462236|FG001|Overall Study|Did not receive vaccine|1|||
128773139|NCT01254565|463462237|FG000|Overall Study|Non-compliance to Study Procedures|0|||
128773140|NCT01254565|463462238|FG001|Overall Study|Non-compliance to Study Procedures|0|||
128773141|NCT01254565|463462239|FG002|Overall Study|Non-compliance to Study Procedures|0|||
128773142|NCT01254565|463462240|FG003|Overall Study|Non-compliance to Study Procedures|0|||
128773143|NCT01254565|463462241|FG004|Overall Study|Non-compliance to Study Procedures|1|||
128773144|NCT01254565|463462242|FG005|Overall Study|Non-compliance to Study Procedures|0|||
128968290|NCT04445051|464170062|FG002|Overall Study|Adverse Event|1|||
128714351|NCT02554812|463250857|FG016|Overall Study|Death|1|||
128773145|NCT01254565|463462237|FG000|Overall Study|Did not Receive Treatment|1|||
128773146|NCT01254565|463462238|FG001|Overall Study|Did not Receive Treatment|1|||
128968291|NCT04445051|464170063|FG003|Overall Study|Adverse Event|0|||
128968292|NCT04445051|464170064|FG004|Overall Study|Adverse Event|0|||
128968293|NCT04445051|464170065|FG005|Overall Study|Adverse Event|0|||
128968294|NCT01624467|464170066|FG000|Overall Study|Withdrawal by Subject|2|||
128968295|NCT01624467|464170066|FG000|Overall Study|Lost to Follow-up|1|||
128968296|NCT01624467|464170066|FG000|Overall Study|Adverse Event|7|||
128968297|NCT01624467|464170066|FG000|Overall Study|Progressive Disease|19|||
128968298|NCT01624467|464170066|FG000|Overall Study|Per Sponsor Requirement|1|||
129130396|NCT04470427|464768788|FG001|Part B :Open-label|Other than specified|0|||
128714352|NCT02554812|463250858|FG017|Overall Study|Death|0|||
128714353|NCT02554812|463250859|FG018|Overall Study|Death|1|||
128714354|NCT02554812|463250860|FG019|Overall Study|Death|2|||
128714355|NCT02554812|463250861|FG020|Overall Study|Death|0|||
128714356|NCT02554812|463250862|FG021|Overall Study|Death|1|||
128714357|NCT02554812|463250863|FG022|Overall Study|Death|1|||
128714358|NCT02554812|463250864|FG023|Overall Study|Death|0|||
128714359|NCT02554812|463250865|FG024|Overall Study|Death|0|||
128714360|NCT02554812|463250866|FG025|Overall Study|Death|0|||
128714361|NCT02554812|463250867|FG026|Overall Study|Death|0|||
128714362|NCT02554812|463250841|FG000|Overall Study|Lost to Follow-up|0|||
128714363|NCT02554812|463250842|FG001|Overall Study|Lost to Follow-up|1|||
128714364|NCT02554812|463250843|FG002|Overall Study|Lost to Follow-up|0|||
128714365|NCT02554812|463250844|FG003|Overall Study|Lost to Follow-up|0|||
128714366|NCT02554812|463250845|FG004|Overall Study|Lost to Follow-up|0|||
128714367|NCT02554812|463250846|FG005|Overall Study|Lost to Follow-up|0|||
128714368|NCT02554812|463250847|FG006|Overall Study|Lost to Follow-up|0|||
128714369|NCT02554812|463250848|FG007|Overall Study|Lost to Follow-up|0|||
128714370|NCT02554812|463250849|FG008|Overall Study|Lost to Follow-up|0|||
128714371|NCT02554812|463250850|FG009|Overall Study|Lost to Follow-up|0|||
128714372|NCT02554812|463250851|FG010|Overall Study|Lost to Follow-up|0|||
128714373|NCT02554812|463250852|FG011|Overall Study|Lost to Follow-up|0|||
128714374|NCT02554812|463250853|FG012|Overall Study|Lost to Follow-up|0|||
128714375|NCT02554812|463250854|FG013|Overall Study|Lost to Follow-up|0|||
128714376|NCT02554812|463250855|FG014|Overall Study|Lost to Follow-up|0|||
128714377|NCT02554812|463250856|FG015|Overall Study|Lost to Follow-up|0|||
128714378|NCT02554812|463250857|FG016|Overall Study|Lost to Follow-up|0|||
128714379|NCT02554812|463250858|FG017|Overall Study|Lost to Follow-up|0|||
128714380|NCT02554812|463250859|FG018|Overall Study|Lost to Follow-up|0|||
128714381|NCT02554812|463250860|FG019|Overall Study|Lost to Follow-up|0|||
128714382|NCT02554812|463250861|FG020|Overall Study|Lost to Follow-up|0|||
128714383|NCT02554812|463250862|FG021|Overall Study|Lost to Follow-up|0|||
129130397|NCT04470427|464768789|FG002|Part B :Open-label|Other than specified|788|||
128714384|NCT02554812|463250863|FG022|Overall Study|Lost to Follow-up|0|||
128773147|NCT01254565|463462239|FG002|Overall Study|Did not Receive Treatment|0|||
128773148|NCT01254565|463462240|FG003|Overall Study|Did not Receive Treatment|0|||
128773149|NCT01254565|463462241|FG004|Overall Study|Did not Receive Treatment|3|||
128773150|NCT01254565|463462242|FG005|Overall Study|Did not Receive Treatment|4|||
128773151|NCT01254565|463462237|FG000|Overall Study|Other|0|||
128968299|NCT01624467|464170066|FG000|Overall Study|Subject Withdrew from Treatment|1|||
128714385|NCT02554812|463250864|FG023|Overall Study|Lost to Follow-up|0|||
128714386|NCT02554812|463250865|FG024|Overall Study|Lost to Follow-up|0|||
128714387|NCT02554812|463250866|FG025|Overall Study|Lost to Follow-up|0|||
128714388|NCT02554812|463250867|FG026|Overall Study|Lost to Follow-up|0|||
128714389|NCT02554812|463250841|FG000|Overall Study|Global deterioration of health status|4|||
128714390|NCT02554812|463250842|FG001|Overall Study|Global deterioration of health status|3|||
128714391|NCT02554812|463250843|FG002|Overall Study|Global deterioration of health status|3|||
128714392|NCT02554812|463250844|FG003|Overall Study|Global deterioration of health status|2|||
128714393|NCT02554812|463250845|FG004|Overall Study|Global deterioration of health status|5|||
128773152|NCT01254565|463462238|FG001|Overall Study|Other|0|||
128773153|NCT01254565|463462239|FG002|Overall Study|Other|0|||
128968300|NCT02201472|464170067|FG000|Overall Study|Lack of Efficacy|2|||
128773154|NCT01254565|463462240|FG003|Overall Study|Other|1|||
128773155|NCT01254565|463462241|FG004|Overall Study|Other|0|||
128773156|NCT01254565|463462242|FG005|Overall Study|Other|0|||
128773157|NCT00472186|463462243|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
128773158|NCT00472186|463462244|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
128773159|NCT03354637|463462245|FG000|Double-blind Period|Protocol Violation|2|||
128968301|NCT00901394|464170072|FG000|Overall Study|Physician Decision|1|||
128968302|NCT00901394|464170073|FG001|Overall Study|Physician Decision|1|||
128968303|NCT00901394|464170074|FG002|Overall Study|Physician Decision|2|||
128968304|NCT03864627|464170077|FG000|Overall Study|Adverse Event|0|||
128968305|NCT03864627|464170078|FG001|Overall Study|Adverse Event|1|||
128968306|NCT03864627|464170077|FG000|Overall Study|Lack of Efficacy|0|||
128968307|NCT03864627|464170078|FG001|Overall Study|Lack of Efficacy|1|||
128968308|NCT03864627|464170077|FG000|Overall Study|Lost to Follow-up|0|||
128968309|NCT03864627|464170078|FG001|Overall Study|Lost to Follow-up|1|||
128968310|NCT03864627|464170077|FG000|Overall Study|Withdrawal by Subject|4|||
128968311|NCT03864627|464170078|FG001|Overall Study|Withdrawal by Subject|8|||
128968312|NCT03864627|464170077|FG000|Overall Study|Study terminated by sponsor|0|||
128968313|NCT03864627|464170078|FG001|Overall Study|Study terminated by sponsor|1|||
128968314|NCT01388491|464170080|FG000|Overall Study|Adverse Event|10|||
128968315|NCT01388491|464170081|FG001|Overall Study|Adverse Event|9|||
128968316|NCT01388491|464170080|FG000|Overall Study|Sponsor Request|9|||
128968317|NCT01388491|464170081|FG001|Overall Study|Sponsor Request|7|||
128968318|NCT01388491|464170080|FG000|Overall Study|Withdrawal by Subject|6|||
128968319|NCT01388491|464170081|FG001|Overall Study|Withdrawal by Subject|10|||
128968320|NCT01388491|464170080|FG000|Overall Study|Lost to Follow-up|4|||
128968321|NCT01388491|464170081|FG001|Overall Study|Lost to Follow-up|3|||
128968322|NCT01388491|464170080|FG000|Overall Study|Protocol Violation|2|||
128968323|NCT01388491|464170081|FG001|Overall Study|Protocol Violation|0|||
128968324|NCT01388491|464170080|FG000|Overall Study|Noncompliance|2|||
128968325|NCT01388491|464170081|FG001|Overall Study|Noncompliance|0|||
128968326|NCT01388491|464170080|FG000|Overall Study|Pregnancy|1|||
128968327|NCT01388491|464170081|FG001|Overall Study|Pregnancy|0|||
128773160|NCT03354637|463462246|FG001|Double-blind Period|Protocol Violation|0|||
128773161|NCT03354637|463462247|FG002|Double-blind Period|Protocol Violation|0|||
128773162|NCT03354637|463462245|FG000|Double-blind Period|Adverse Event|1|||
128773163|NCT03354637|463462246|FG001|Double-blind Period|Adverse Event|2|||
128773164|NCT03354637|463462247|FG002|Double-blind Period|Adverse Event|0|||
128773165|NCT03354637|463462245|FG000|Double-blind Period|Lost to Follow-up|3|||
128773166|NCT03354637|463462246|FG001|Double-blind Period|Lost to Follow-up|4|||
128773167|NCT03354637|463462247|FG002|Double-blind Period|Lost to Follow-up|3|||
128773168|NCT03354637|463462245|FG000|Double-blind Period|Withdrawal by Subject|10|||
128773169|NCT03354637|463462246|FG001|Double-blind Period|Withdrawal by Subject|6|||
128968328|NCT00796224|464170087|FG000|Overall Study|Adverse Event|1|||
128968329|NCT00796224|464170088|FG001|Overall Study|Adverse Event|0|||
128773170|NCT03354637|463462247|FG002|Double-blind Period|Withdrawal by Subject|4|||
128773171|NCT03354637|463462245|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
128968330|NCT00796224|464170087|FG000|Overall Study|Protocol Violation|0|||
128773172|NCT03354637|463462246|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
128773173|NCT03354637|463462247|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
128773174|NCT03354637|463462245|FG000|Open Label Extension|Adverse Event|0|||
128773175|NCT03354637|463462246|FG001|Open Label Extension|Adverse Event|0|||
128773176|NCT03354637|463462247|FG002|Open Label Extension|Adverse Event|1|||
128773177|NCT03354637|463462245|FG000|Open Label Extension|Lost to Follow-up|0|||
128773178|NCT03354637|463462246|FG001|Open Label Extension|Lost to Follow-up|0|||
128773179|NCT03354637|463462247|FG002|Open Label Extension|Lost to Follow-up|2|||
128773180|NCT03354637|463462245|FG000|Open Label Extension|Withdrawal by Subject|0|||
128773181|NCT03354637|463462246|FG001|Open Label Extension|Withdrawal by Subject|0|||
128773182|NCT03354637|463462247|FG002|Open Label Extension|Withdrawal by Subject|5|||
128773183|NCT03354637|463462245|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
128773184|NCT03354637|463462246|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
128773185|NCT03354637|463462247|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
128773186|NCT03354637|463462245|FG000|Open Label Extension|Subject Noncompliance|0|||
128773187|NCT03354637|463462246|FG001|Open Label Extension|Subject Noncompliance|0|||
128773188|NCT03354637|463462247|FG002|Open Label Extension|Subject Noncompliance|1|||
128773189|NCT03354637|463462245|FG000|Open Label Extension|Lack of Efficacy|0|||
128968331|NCT00796224|464170088|FG001|Overall Study|Protocol Violation|1|||
128968332|NCT02569398|464170089|FG000|Overall Study|Adverse Event|0|||
128968333|NCT02569398|464170090|FG001|Overall Study|Adverse Event|1|||
128968334|NCT02569398|464170091|FG002|Overall Study|Adverse Event|6|||
128968335|NCT02569398|464170089|FG000|Overall Study|Withdrawal by Subject|43|||
128968336|NCT02569398|464170090|FG001|Overall Study|Withdrawal by Subject|43|||
128968337|NCT02569398|464170091|FG002|Overall Study|Withdrawal by Subject|30|||
128968338|NCT02569398|464170089|FG000|Overall Study|Study terminated by sponsor|130|||
128968339|NCT02569398|464170090|FG001|Overall Study|Study terminated by sponsor|131|||
128968340|NCT02569398|464170091|FG002|Overall Study|Study terminated by sponsor|134|||
128968341|NCT02569398|464170089|FG000|Overall Study|Other|12|||
128968342|NCT02569398|464170090|FG001|Overall Study|Other|14|||
128968343|NCT02569398|464170091|FG002|Overall Study|Other|13|||
128968344|NCT02116361|464170094|FG000|Overall Study|Pregnancy|0|||
128773190|NCT03354637|463462246|FG001|Open Label Extension|Lack of Efficacy|0|||
128773191|NCT03354637|463462247|FG002|Open Label Extension|Lack of Efficacy|1|||
128773192|NCT03354637|463462245|FG000|Open Label Extension|Physician Decision|0|||
128773193|NCT03354637|463462246|FG001|Open Label Extension|Physician Decision|0|||
128773194|NCT03354637|463462247|FG002|Open Label Extension|Physician Decision|1|||
128773195|NCT02726399|463462248|FG000|Overall Study|Participant Non-Compliance|1|||
128773196|NCT02726399|463462248|FG000|Overall Study|Adverse Event|2|||
128773197|NCT02726399|463462248|FG000|Overall Study|Progression of disease|4|||
128773198|NCT02564055|463462249|FG000|Overall Study|Adverse Event|1|||
128773199|NCT02564055|463462250|FG001|Overall Study|Adverse Event|0|||
128773200|NCT02564055|463462251|FG002|Overall Study|Adverse Event|4|||
128773201|NCT02564055|463462252|FG003|Overall Study|Adverse Event|1|||
128773202|NCT02564055|463462253|FG004|Overall Study|Adverse Event|4|||
128968345|NCT02116361|464170095|FG001|Overall Study|Pregnancy|0|||
128773203|NCT02564055|463462254|FG005|Overall Study|Adverse Event|1|||
128773204|NCT02564055|463462249|FG000|Overall Study|Protocol Violation|1|||
128773205|NCT02564055|463462250|FG001|Overall Study|Protocol Violation|0|||
128773206|NCT02564055|463462251|FG002|Overall Study|Protocol Violation|0|||
128773207|NCT02564055|463462252|FG003|Overall Study|Protocol Violation|0|||
128773208|NCT02564055|463462253|FG004|Overall Study|Protocol Violation|0|||
128773209|NCT02564055|463462254|FG005|Overall Study|Protocol Violation|0|||
128773210|NCT02564055|463462249|FG000|Overall Study|Reached stopping criteria|0|||
128773211|NCT02564055|463462250|FG001|Overall Study|Reached stopping criteria|0|||
128773212|NCT02564055|463462251|FG002|Overall Study|Reached stopping criteria|0|||
128773213|NCT02564055|463462252|FG003|Overall Study|Reached stopping criteria|0|||
128773214|NCT02564055|463462253|FG004|Overall Study|Reached stopping criteria|0|||
128773215|NCT02564055|463462254|FG005|Overall Study|Reached stopping criteria|1|||
128773216|NCT02564055|463462249|FG000|Overall Study|Lost to Follow-up|0|||
128773217|NCT02564055|463462250|FG001|Overall Study|Lost to Follow-up|1|||
128773218|NCT02564055|463462251|FG002|Overall Study|Lost to Follow-up|4|||
128773219|NCT02564055|463462252|FG003|Overall Study|Lost to Follow-up|2|||
128773220|NCT02564055|463462253|FG004|Overall Study|Lost to Follow-up|1|||
128773221|NCT02564055|463462254|FG005|Overall Study|Lost to Follow-up|0|||
128773222|NCT02564055|463462249|FG000|Overall Study|Physician Decision|0|||
128773223|NCT02564055|463462250|FG001|Overall Study|Physician Decision|0|||
128773224|NCT02564055|463462251|FG002|Overall Study|Physician Decision|1|||
128773225|NCT02564055|463462252|FG003|Overall Study|Physician Decision|0|||
128773226|NCT02564055|463462253|FG004|Overall Study|Physician Decision|0|||
128773227|NCT02564055|463462254|FG005|Overall Study|Physician Decision|0|||
128773228|NCT02564055|463462249|FG000|Overall Study|Withdrawal by Subject|4|||
128773229|NCT02564055|463462250|FG001|Overall Study|Withdrawal by Subject|4|||
128773230|NCT02564055|463462251|FG002|Overall Study|Withdrawal by Subject|3|||
128773231|NCT02564055|463462252|FG003|Overall Study|Withdrawal by Subject|3|||
128773232|NCT02564055|463462253|FG004|Overall Study|Withdrawal by Subject|10|||
128773233|NCT02564055|463462254|FG005|Overall Study|Withdrawal by Subject|10|||
128773234|NCT04747275|463462255|FG000|Overall Study|Study terminated|0|||
128773235|NCT04747275|463462256|FG001|Overall Study|Study terminated|1|||
128773236|NCT03268590|463462260|FG000|Overall Study|Previously unknown exclusion criteria|1|||
128773237|NCT00531011|463462261|FG000|Overall Study|Withdrawal by Subject|2|||
128773238|NCT00531011|463462262|FG001|Overall Study|Withdrawal by Subject|4|||
128773239|NCT00531011|463462261|FG000|Overall Study|Death|1|||
128773240|NCT00531011|463462262|FG001|Overall Study|Death|0|||
128773241|NCT00531011|463462261|FG000|Overall Study|Lost to Follow-up|1|||
128773242|NCT00531011|463462262|FG001|Overall Study|Lost to Follow-up|0|||
128773243|NCT00531011|463462261|FG000|Overall Study|Physician Decision|0|||
128773244|NCT00531011|463462262|FG001|Overall Study|Physician Decision|3|||
128773245|NCT02139982|463462265|FG000|Overall Study|Lack of Efficacy|0|||
128773246|NCT02139982|463462266|FG001|Overall Study|Lack of Efficacy|1|||
128773247|NCT02139982|463462267|FG002|Overall Study|Lack of Efficacy|0|||
128773248|NCT02139982|463462268|FG003|Overall Study|Lack of Efficacy|1|||
128773249|NCT02139982|463462269|FG004|Overall Study|Lack of Efficacy|0|||
128773250|NCT02139982|463462270|FG005|Overall Study|Lack of Efficacy|0|||
128968346|NCT02116361|464170096|FG002|Overall Study|Pregnancy|0|||
128968347|NCT02116361|464170097|FG003|Overall Study|Pregnancy|1|||
128968348|NCT02116361|464170094|FG000|Overall Study|Protocol Violation|1|||
128773251|NCT02139982|463462271|FG006|Overall Study|Lack of Efficacy|0|||
128773252|NCT02139982|463462272|FG007|Overall Study|Lack of Efficacy|0|||
128773253|NCT02139982|463462273|FG008|Overall Study|Lack of Efficacy|0|||
128773254|NCT02139982|463462274|FG009|Overall Study|Lack of Efficacy|0|||
128773255|NCT04254679|463462307|FG000|Overall Study|Protocol Violation|1|||
128773256|NCT04254679|463462308|FG001|Overall Study|Protocol Violation|1|||
128773257|NCT04254679|463462307|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
128773258|NCT04254679|463462308|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
128968349|NCT02116361|464170095|FG001|Overall Study|Protocol Violation|0|||
128773259|NCT02206152|463462313|FG000|Pre-Randomization|Withdrawal by Subject|2|||
128773260|NCT00478608|463462314|FG000|Overall Study|Adverse Event|1|||
128773261|NCT00478608|463462314|FG000|Overall Study|Serious Adverse Event|14|||
128773262|NCT00478608|463462314|FG000|Overall Study|Withdrawal by Subject|2|||
128773263|NCT00478608|463462314|FG000|Overall Study|Protocol Violation|3|||
128773264|NCT02080520|463462316|FG000|Overall Study|Self-reported symptoms|5|||
128773265|NCT02080520|463462317|FG001|Overall Study|Self-reported symptoms|6|||
128773266|NCT02080520|463462316|FG000|Overall Study|Unable to contact|2|||
128773267|NCT02080520|463462317|FG001|Overall Study|Unable to contact|1|||
128773268|NCT02080520|463462316|FG000|Overall Study|Initiated aspirin|2|||
128773269|NCT02080520|463462317|FG001|Overall Study|Initiated aspirin|0|||
128773270|NCT02080520|463462316|FG000|Overall Study|Atrial fibrillation|1|||
128773271|NCT02080520|463462317|FG001|Overall Study|Atrial fibrillation|1|||
128773272|NCT02080520|463462316|FG000|Overall Study|Cancer|1|||
128773273|NCT02080520|463462317|FG001|Overall Study|Cancer|2|||
128773274|NCT02080520|463462316|FG000|Overall Study|Not interested in study|1|||
128773275|NCT02080520|463462317|FG001|Overall Study|Not interested in study|3|||
128773276|NCT02080520|463462316|FG000|Overall Study|Too busy|1|||
128773277|NCT02080520|463462317|FG001|Overall Study|Too busy|1|||
128773278|NCT02080520|463462316|FG000|Overall Study|Work-related injury|1|||
128773279|NCT02080520|463462317|FG001|Overall Study|Work-related injury|0|||
128773280|NCT02080520|463462316|FG000|Overall Study|Personal reasons|0|||
128773281|NCT02080520|463462317|FG001|Overall Study|Personal reasons|3|||
128773282|NCT00390455|463462319|FG000|Overall Study|Adverse Event|17|||
128773283|NCT00390455|463462320|FG001|Overall Study|Adverse Event|3|||
128773284|NCT00390455|463462319|FG000|Overall Study|Withdrawal by Subject|8|||
128773285|NCT00390455|463462320|FG001|Overall Study|Withdrawal by Subject|8|||
128773286|NCT00390455|463462319|FG000|Overall Study|Alternate Treatment|0|||
128773287|NCT00390455|463462320|FG001|Overall Study|Alternate Treatment|1|||
128773288|NCT00390455|463462319|FG000|Overall Study|Other Medical Reasons|7|||
128773289|NCT00390455|463462320|FG001|Overall Study|Other Medical Reasons|11|||
128773290|NCT04076020|463462323|FG000|Overall Study|Death|4|||
128773291|NCT04076020|463462324|FG001|Overall Study|Death|6|||
128773292|NCT04076020|463462323|FG000|Overall Study|Withdrawal by Subject|12|||
128773293|NCT04076020|463462324|FG001|Overall Study|Withdrawal by Subject|8|||
128773294|NCT01394250|463462325|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
128773295|NCT01394250|463462326|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
128773296|NCT01394250|463462325|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
128773297|NCT01394250|463462326|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
128773298|NCT03237013|463462333|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
128773299|NCT03237013|463462334|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
128773300|NCT03237013|463462335|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
128773301|NCT00502996|463462338|FG000|Overall Study|Lost to Follow-up|9|||
128773302|NCT00502996|463462338|FG000|Overall Study|Protocol Violation|2|||
128773303|NCT00502996|463462338|FG000|Overall Study|Treatment failure|25|||
128773304|NCT00502996|463462338|FG000|Overall Study|Withdrawal Informed Consent|6|||
128773305|NCT00502996|463462338|FG000|Overall Study|Adverse Event|2|||
128773306|NCT02374593|463462339|FG000|Overall Study|non-compliant|2|||
128773307|NCT02374593|463462340|FG001|Overall Study|non-compliant|0|||
128773308|NCT00579982|463462342|FG000|Overall Study|Adverse Event|4|||
128773309|NCT00579982|463462342|FG000|Overall Study|Protocol Violation|4|||
128773310|NCT04827134|463462343|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
128773311|NCT04827134|463462344|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
128773312|NCT04827134|463462345|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
128773313|NCT04827134|463462346|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
128773314|NCT01313923|463462355|FG000|Overall Study|Physician Decision|3|||
128773315|NCT02471404|463462356|FG000|Overall Study|Adverse Event|7|||
128773316|NCT02471404|463462357|FG001|Overall Study|Adverse Event|1|||
128773317|NCT02471404|463462358|FG002|Overall Study|Adverse Event|2|||
128773318|NCT02471404|463462356|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
128773319|NCT02471404|463462357|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
128773320|NCT02471404|463462358|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
128773321|NCT02471404|463462356|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
128773322|NCT02471404|463462357|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
128773323|NCT02471404|463462358|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
128968350|NCT02116361|464170096|FG002|Overall Study|Protocol Violation|0|||
128968351|NCT02116361|464170097|FG003|Overall Study|Protocol Violation|2|||
128773324|NCT02471404|463462356|FG000|Overall Study|Lost to Follow-up|1|||
128773325|NCT02471404|463462357|FG001|Overall Study|Lost to Follow-up|1|||
128773326|NCT02471404|463462358|FG002|Overall Study|Lost to Follow-up|3|||
128773327|NCT02471404|463462356|FG000|Overall Study|Protocol Violation|1|||
128773328|NCT02471404|463462357|FG001|Overall Study|Protocol Violation|0|||
128773329|NCT02471404|463462358|FG002|Overall Study|Protocol Violation|0|||
128773330|NCT02471404|463462356|FG000|Overall Study|Withdrawal by Subject|8|||
128773331|NCT02471404|463462357|FG001|Overall Study|Withdrawal by Subject|4|||
128773332|NCT02471404|463462358|FG002|Overall Study|Withdrawal by Subject|5|||
128773333|NCT02471404|463462356|FG000|Overall Study|Other reasons not specified|10|||
128773334|NCT02471404|463462357|FG001|Overall Study|Other reasons not specified|7|||
128773335|NCT02471404|463462358|FG002|Overall Study|Other reasons not specified|12|||
128773336|NCT00305864|463462359|FG000|Overall Study|Ineligible / No protocol treatment|0|||
128773337|NCT00305864|463462360|FG001|Overall Study|Ineligible / No protocol treatment|1|||
128773338|NCT00305864|463462361|FG002|Overall Study|Ineligible / No protocol treatment|1|||
128773339|NCT00305864|463462362|FG003|Overall Study|Ineligible / No protocol treatment|13|||
128773340|NCT00287469|463462363|FG000|Overall Study|serious adverse event|1|||
128773341|NCT00287469|463462364|FG001|Overall Study|serious adverse event|6|||
128773342|NCT00287469|463462363|FG000|Overall Study|Adverse Event|1|||
128773343|NCT00287469|463462364|FG001|Overall Study|Adverse Event|1|||
128773344|NCT00287469|463462363|FG000|Overall Study|moved from area|144|||
128773345|NCT00287469|463462364|FG001|Overall Study|moved from area|138|||
128773346|NCT00287469|463462363|FG000|Overall Study|Lost to Follow-up|74|||
128773347|NCT00287469|463462364|FG001|Overall Study|Lost to Follow-up|69|||
128773348|NCT03285113|463462365|FG000|Overall Study|Unable to implant leads|2|||
128773349|NCT00849680|463462368|FG000|Overall Study|Adverse Event|0|||
128773350|NCT00849680|463462369|FG001|Overall Study|Adverse Event|0|||
128773351|NCT00849680|463462370|FG002|Overall Study|Adverse Event|0|||
128773352|NCT00849680|463462371|FG003|Overall Study|Adverse Event|0|||
128773353|NCT00849680|463462372|FG004|Overall Study|Adverse Event|0|||
128773354|NCT00849680|463462373|FG005|Overall Study|Adverse Event|0|||
128773355|NCT00849680|463462374|FG006|Overall Study|Adverse Event|2|||
128773356|NCT00849680|463462375|FG007|Overall Study|Adverse Event|0|||
128773357|NCT00849680|463462368|FG000|Overall Study|Lost to Follow-up|7|||
128773358|NCT00849680|463462369|FG001|Overall Study|Lost to Follow-up|3|||
128773359|NCT00849680|463462370|FG002|Overall Study|Lost to Follow-up|12|||
128773360|NCT00849680|463462371|FG003|Overall Study|Lost to Follow-up|11|||
128773361|NCT00849680|463462372|FG004|Overall Study|Lost to Follow-up|8|||
128968352|NCT02116361|464170094|FG000|Overall Study|Physician Decision|2|||
128968353|NCT02116361|464170095|FG001|Overall Study|Physician Decision|3|||
128968354|NCT02116361|464170096|FG002|Overall Study|Physician Decision|0|||
128968355|NCT02116361|464170097|FG003|Overall Study|Physician Decision|0|||
129220414|NCT01273519|465106593|FG000|Overall Study|Lost to Follow-up|2|||
128773362|NCT00849680|463462373|FG005|Overall Study|Lost to Follow-up|11|||
128773363|NCT00849680|463462374|FG006|Overall Study|Lost to Follow-up|12|||
128773364|NCT00849680|463462375|FG007|Overall Study|Lost to Follow-up|5|||
128773365|NCT00849680|463462368|FG000|Overall Study|Subject moved|1|||
128773366|NCT00849680|463462369|FG001|Overall Study|Subject moved|0|||
128773367|NCT00849680|463462370|FG002|Overall Study|Subject moved|3|||
128773368|NCT00849680|463462371|FG003|Overall Study|Subject moved|1|||
128773369|NCT00849680|463462372|FG004|Overall Study|Subject moved|0|||
128773370|NCT00849680|463462373|FG005|Overall Study|Subject moved|2|||
128773371|NCT00849680|463462374|FG006|Overall Study|Subject moved|2|||
128773372|NCT00849680|463462375|FG007|Overall Study|Subject moved|2|||
128773373|NCT00849680|463462368|FG000|Overall Study|Withdrawal by Subject|2|||
128773374|NCT00849680|463462369|FG001|Overall Study|Withdrawal by Subject|0|||
128773375|NCT00849680|463462370|FG002|Overall Study|Withdrawal by Subject|0|||
128773376|NCT00849680|463462371|FG003|Overall Study|Withdrawal by Subject|2|||
128773377|NCT00849680|463462372|FG004|Overall Study|Withdrawal by Subject|2|||
128773378|NCT00849680|463462373|FG005|Overall Study|Withdrawal by Subject|2|||
128773379|NCT00849680|463462374|FG006|Overall Study|Withdrawal by Subject|1|||
128773380|NCT00849680|463462375|FG007|Overall Study|Withdrawal by Subject|1|||
128773381|NCT00849680|463462368|FG000|Overall Study|Subject unable to comply with protocol|1|||
128773382|NCT00849680|463462369|FG001|Overall Study|Subject unable to comply with protocol|0|||
128773383|NCT00849680|463462370|FG002|Overall Study|Subject unable to comply with protocol|0|||
128773384|NCT00849680|463462371|FG003|Overall Study|Subject unable to comply with protocol|0|||
128773385|NCT00849680|463462372|FG004|Overall Study|Subject unable to comply with protocol|0|||
128773386|NCT00849680|463462373|FG005|Overall Study|Subject unable to comply with protocol|0|||
128773387|NCT00849680|463462374|FG006|Overall Study|Subject unable to comply with protocol|0|||
128773388|NCT00849680|463462375|FG007|Overall Study|Subject unable to comply with protocol|0|||
128773389|NCT02942004|463462378|FG000|Overall Study|Withdrawal by Subject|0|||
128773390|NCT02942004|463462379|FG001|Overall Study|Withdrawal by Subject|2|||
128773391|NCT02942004|463462380|FG002|Overall Study|Withdrawal by Subject|3|||
128773392|NCT02942004|463462378|FG000|Overall Study|Lost to Follow-up|1|||
128773393|NCT02942004|463462379|FG001|Overall Study|Lost to Follow-up|1|||
128773394|NCT02942004|463462380|FG002|Overall Study|Lost to Follow-up|2|||
128773395|NCT02942004|463462378|FG000|Overall Study|Randomized but not dosed|3|||
128773396|NCT02942004|463462379|FG001|Overall Study|Randomized but not dosed|9|||
128773397|NCT02942004|463462380|FG002|Overall Study|Randomized but not dosed|4|||
128773398|NCT00507026|463462383|FG000|Overall Study|Lack of Efficacy|6|||
128773399|NCT00507026|463462384|FG001|Overall Study|Lack of Efficacy|4|||
128773400|NCT00507026|463462385|FG002|Overall Study|Lack of Efficacy|21|||
128773401|NCT00507026|463462383|FG000|Overall Study|Withdrawal by Subject|2|||
128773402|NCT00507026|463462384|FG001|Overall Study|Withdrawal by Subject|0|||
128968356|NCT02116361|464170094|FG000|Overall Study|Adverse Event|1|||
128773403|NCT00507026|463462385|FG002|Overall Study|Withdrawal by Subject|0|||
128773404|NCT00507026|463462383|FG000|Overall Study|Investigator Decision|1|||
128773405|NCT00507026|463462384|FG001|Overall Study|Investigator Decision|0|||
128773406|NCT00507026|463462385|FG002|Overall Study|Investigator Decision|0|||
128773407|NCT00507026|463462383|FG000|Overall Study|Adverse Event|2|||
128773408|NCT00507026|463462384|FG001|Overall Study|Adverse Event|0|||
128773409|NCT00507026|463462385|FG002|Overall Study|Adverse Event|0|||
128773410|NCT00507026|463462383|FG000|Overall Study|Protocol Violation|1|||
128773411|NCT00507026|463462384|FG001|Overall Study|Protocol Violation|0|||
128773412|NCT00507026|463462385|FG002|Overall Study|Protocol Violation|0|||
128773413|NCT00507026|463462383|FG000|Overall Study|Other|1|||
128773414|NCT00507026|463462384|FG001|Overall Study|Other|0|||
128773415|NCT00507026|463462385|FG002|Overall Study|Other|0|||
128773416|NCT02372058|463462386|FG000|Overall Study|Withdrawal by Subject|3|||
128773417|NCT02061761|463462389|FG000|Overall Study|Disease progression|2|||
128773418|NCT02061761|463462390|FG001|Overall Study|Disease progression|8|||
128773419|NCT02061761|463462391|FG002|Overall Study|Disease progression|4|||
128773420|NCT02061761|463462392|FG003|Overall Study|Disease progression|5|||
128773421|NCT02061761|463462393|FG004|Overall Study|Disease progression|9|||
128773422|NCT02061761|463462394|FG005|Overall Study|Disease progression|3|||
128773423|NCT02061761|463462395|FG006|Overall Study|Disease progression|1|||
128773424|NCT02061761|463462396|FG007|Overall Study|Disease progression|2|||
128773425|NCT02061761|463462397|FG008|Overall Study|Disease progression|28|||
128773426|NCT02061761|463462389|FG000|Overall Study|Study Drug toxicity|0|||
128773427|NCT02061761|463462390|FG001|Overall Study|Study Drug toxicity|0|||
128773428|NCT02061761|463462391|FG002|Overall Study|Study Drug toxicity|0|||
128773429|NCT02061761|463462392|FG003|Overall Study|Study Drug toxicity|0|||
128773430|NCT02061761|463462393|FG004|Overall Study|Study Drug toxicity|0|||
128773431|NCT02061761|463462394|FG005|Overall Study|Study Drug toxicity|1|||
128773432|NCT02061761|463462395|FG006|Overall Study|Study Drug toxicity|0|||
128773433|NCT02061761|463462396|FG007|Overall Study|Study Drug toxicity|2|||
128773434|NCT02061761|463462397|FG008|Overall Study|Study Drug toxicity|6|||
128773435|NCT02061761|463462389|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
128773436|NCT02061761|463462390|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
128773437|NCT02061761|463462391|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
128773438|NCT02061761|463462392|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
128773439|NCT02061761|463462393|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
128773440|NCT02061761|463462394|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
128773441|NCT02061761|463462395|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
128773442|NCT02061761|463462396|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
128773443|NCT02061761|463462397|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
128773444|NCT02061761|463462389|FG000|Overall Study|Participant request to discontinue study treatment|0|||
128773445|NCT02061761|463462390|FG001|Overall Study|Participant request to discontinue study treatment|0|||
128773446|NCT02061761|463462391|FG002|Overall Study|Participant request to discontinue study treatment|2|||
128773447|NCT02061761|463462392|FG003|Overall Study|Participant request to discontinue study treatment|2|||
128773448|NCT02061761|463462393|FG004|Overall Study|Participant request to discontinue study treatment|0|||
128773449|NCT02061761|463462394|FG005|Overall Study|Participant request to discontinue study treatment|1|||
128773450|NCT02061761|463462395|FG006|Overall Study|Participant request to discontinue study treatment|0|||
128773451|NCT02061761|463462396|FG007|Overall Study|Participant request to discontinue study treatment|0|||
128773452|NCT02061761|463462397|FG008|Overall Study|Participant request to discontinue study treatment|2|||
128773453|NCT02061761|463462389|FG000|Overall Study|Withdrawal by Subject|0|||
128773454|NCT02061761|463462390|FG001|Overall Study|Withdrawal by Subject|0|||
128773455|NCT02061761|463462391|FG002|Overall Study|Withdrawal by Subject|0|||
128773456|NCT02061761|463462392|FG003|Overall Study|Withdrawal by Subject|0|||
128773457|NCT02061761|463462393|FG004|Overall Study|Withdrawal by Subject|0|||
128773458|NCT02061761|463462394|FG005|Overall Study|Withdrawal by Subject|0|||
128773459|NCT02061761|463462395|FG006|Overall Study|Withdrawal by Subject|0|||
128773460|NCT02061761|463462396|FG007|Overall Study|Withdrawal by Subject|0|||
128773461|NCT02061761|463462397|FG008|Overall Study|Withdrawal by Subject|2|||
128773462|NCT02061761|463462389|FG000|Overall Study|Maximum clinical benefit|0|||
128773463|NCT02061761|463462390|FG001|Overall Study|Maximum clinical benefit|0|||
128773464|NCT02061761|463462391|FG002|Overall Study|Maximum clinical benefit|0|||
128773465|NCT02061761|463462392|FG003|Overall Study|Maximum clinical benefit|1|||
128773466|NCT02061761|463462393|FG004|Overall Study|Maximum clinical benefit|0|||
128773467|NCT02061761|463462394|FG005|Overall Study|Maximum clinical benefit|0|||
128773468|NCT02061761|463462395|FG006|Overall Study|Maximum clinical benefit|0|||
128773469|NCT02061761|463462396|FG007|Overall Study|Maximum clinical benefit|0|||
128773470|NCT02061761|463462397|FG008|Overall Study|Maximum clinical benefit|6|||
128773471|NCT02061761|463462389|FG000|Overall Study|Participant no longer meets study criteria|0|||
128773472|NCT02061761|463462390|FG001|Overall Study|Participant no longer meets study criteria|0|||
128773473|NCT02061761|463462391|FG002|Overall Study|Participant no longer meets study criteria|0|||
128773474|NCT02061761|463462392|FG003|Overall Study|Participant no longer meets study criteria|0|||
128773475|NCT02061761|463462393|FG004|Overall Study|Participant no longer meets study criteria|0|||
128773476|NCT02061761|463462394|FG005|Overall Study|Participant no longer meets study criteria|0|||
128773477|NCT02061761|463462395|FG006|Overall Study|Participant no longer meets study criteria|0|||
128773478|NCT02061761|463462396|FG007|Overall Study|Participant no longer meets study criteria|0|||
128773479|NCT02061761|463462397|FG008|Overall Study|Participant no longer meets study criteria|1|||
128773480|NCT02061761|463462389|FG000|Overall Study|Other reasons|0|||
128773481|NCT02061761|463462390|FG001|Overall Study|Other reasons|0|||
128773482|NCT02061761|463462391|FG002|Overall Study|Other reasons|0|||
128773483|NCT02061761|463462392|FG003|Overall Study|Other reasons|0|||
128773484|NCT02061761|463462393|FG004|Overall Study|Other reasons|2|||
128773485|NCT02061761|463462394|FG005|Overall Study|Other reasons|0|||
128773486|NCT02061761|463462395|FG006|Overall Study|Other reasons|0|||
128773487|NCT02061761|463462396|FG007|Overall Study|Other reasons|0|||
128773488|NCT02061761|463462397|FG008|Overall Study|Other reasons|6|||
128773489|NCT00581113|463464016|FG000|Overall Study|Withdrawal by Subject|0|||
128773490|NCT00581113|463464017|FG001|Overall Study|Withdrawal by Subject|1|||
128773491|NCT00619476|463464018|FG000|Overall Study|Adverse Event|12|||
128773492|NCT00619476|463464019|FG001|Overall Study|Adverse Event|6|||
128773493|NCT00619476|463464020|FG002|Overall Study|Adverse Event|12|||
128773494|NCT00619476|463464021|FG003|Overall Study|Adverse Event|16|||
128773495|NCT00619476|463464018|FG000|Overall Study|Lack of Efficacy|6|||
128773496|NCT00619476|463464019|FG001|Overall Study|Lack of Efficacy|1|||
128773497|NCT00619476|463464020|FG002|Overall Study|Lack of Efficacy|1|||
128773498|NCT00619476|463464021|FG003|Overall Study|Lack of Efficacy|4|||
128773499|NCT00619476|463464018|FG000|Overall Study|Protocol Violation|5|||
128773500|NCT00619476|463464019|FG001|Overall Study|Protocol Violation|4|||
128773501|NCT00619476|463464020|FG002|Overall Study|Protocol Violation|4|||
128773502|NCT00619476|463464021|FG003|Overall Study|Protocol Violation|9|||
128773503|NCT00619476|463464018|FG000|Overall Study|Lost to Follow-up|1|||
128773504|NCT00619476|463464019|FG001|Overall Study|Lost to Follow-up|2|||
128773505|NCT00619476|463464020|FG002|Overall Study|Lost to Follow-up|0|||
128773506|NCT00619476|463464021|FG003|Overall Study|Lost to Follow-up|1|||
128773507|NCT00619476|463464018|FG000|Overall Study|Investigator Discretion|2|||
128773508|NCT00619476|463464019|FG001|Overall Study|Investigator Discretion|2|||
128773509|NCT00619476|463464020|FG002|Overall Study|Investigator Discretion|2|||
128773510|NCT00619476|463464021|FG003|Overall Study|Investigator Discretion|0|||
128773511|NCT00619476|463464018|FG000|Overall Study|Withdrawal by Subject|5|||
128773512|NCT00619476|463464019|FG001|Overall Study|Withdrawal by Subject|7|||
128773513|NCT00619476|463464020|FG002|Overall Study|Withdrawal by Subject|5|||
128773514|NCT00619476|463464021|FG003|Overall Study|Withdrawal by Subject|4|||
128773515|NCT01811563|463464022|FG000|Overall Study|Lost to Follow-up|5|||
128773516|NCT01811563|463464023|FG001|Overall Study|Lost to Follow-up|2|||
128773517|NCT01811563|463464022|FG000|Overall Study|Incorrect Randomization procedure|0|||
128773518|NCT01811563|463464023|FG001|Overall Study|Incorrect Randomization procedure|1|||
128773519|NCT01327547|463464024|FG000|Overall Study|Adverse Event|4|||
128773520|NCT01327547|463464025|FG001|Overall Study|Adverse Event|1|||
128773521|NCT01327547|463464024|FG000|Overall Study|Death|1|||
128773522|NCT01327547|463464025|FG001|Overall Study|Death|2|||
128773523|NCT01327547|463464024|FG000|Overall Study|Lost to Follow-up|6|||
128773524|NCT01327547|463464025|FG001|Overall Study|Lost to Follow-up|6|||
128773525|NCT01327547|463464024|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
128773526|NCT01327547|463464025|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
128773527|NCT01327547|463464024|FG000|Overall Study|Withdrawal by Subject|3|||
128773528|NCT01327547|463464025|FG001|Overall Study|Withdrawal by Subject|7|||
128773529|NCT01327547|463464024|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
128773530|NCT01327547|463464025|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
128773531|NCT01327547|463464024|FG000|Overall Study|Protocol Violation|1|||
128773532|NCT01327547|463464025|FG001|Overall Study|Protocol Violation|0|||
128773533|NCT01327547|463464024|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
128773534|NCT01327547|463464025|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
128773535|NCT01327547|463464024|FG000|Overall Study|Required prohibited medication|2|||
128773536|NCT01327547|463464025|FG001|Overall Study|Required prohibited medication|0|||
128773537|NCT01327547|463464024|FG000|Overall Study|Non-compliance with study procedures|1|||
128773538|NCT01327547|463464025|FG001|Overall Study|Non-compliance with study procedures|0|||
128773539|NCT01327547|463464024|FG000|Overall Study|By investigator in subject's interest|0|||
128773540|NCT01327547|463464025|FG001|Overall Study|By investigator in subject's interest|1|||
128773541|NCT00329719|463464026|FG000|Overall Study|Lost to Follow-up|0|||
128773542|NCT00329719|463464027|FG001|Overall Study|Lost to Follow-up|0|||
128773543|NCT00329719|463464028|FG002|Overall Study|Lost to Follow-up|0|||
128773544|NCT00329719|463464029|FG003|Overall Study|Lost to Follow-up|1|||
128773545|NCT02462083|463464032|FG000|Overall Study|Sponsor request|39|||
128773546|NCT02462083|463464032|FG000|Overall Study|Withdrawal by Subject|87|||
128773547|NCT02462083|463464032|FG000|Overall Study|Lost to Follow-up|41|||
128773548|NCT02462083|463464032|FG000|Overall Study|Lack of Efficacy|151|||
128773549|NCT02462083|463464032|FG000|Overall Study|Pregnancy|1|||
128773550|NCT02462083|463464032|FG000|Overall Study|Protocol Violation|6|||
128773551|NCT02462083|463464032|FG000|Overall Study|Adverse Event|33|||
128773552|NCT02462083|463464032|FG000|Overall Study|Worsening condition|16|||
128773553|NCT02462083|463464032|FG000|Overall Study|Other than specified|45|||
128773554|NCT02291289|463464033|FG000|Induction Treatment|Withdrawal by Subject|0|||
128773555|NCT02291289|463464034|FG001|Induction Treatment|Withdrawal by Subject|0|||
128773556|NCT02291289|463464035|FG002|Induction Treatment|Withdrawal by Subject|0|||
128773557|NCT02291289|463464036|FG003|Induction Treatment|Withdrawal by Subject|24|||
128968357|NCT02116361|464170095|FG001|Overall Study|Adverse Event|0|||
128968358|NCT02116361|464170096|FG002|Overall Study|Adverse Event|0|||
128968359|NCT02116361|464170097|FG003|Overall Study|Adverse Event|3|||
128968360|NCT02116361|464170094|FG000|Overall Study|Other Reasons|3|||
128968361|NCT02116361|464170095|FG001|Overall Study|Other Reasons|3|||
128968362|NCT02116361|464170096|FG002|Overall Study|Other Reasons|3|||
128968363|NCT02116361|464170097|FG003|Overall Study|Other Reasons|3|||
128968364|NCT02116361|464170094|FG000|Overall Study|Lack of Efficacy|5|||
128968365|NCT02116361|464170095|FG001|Overall Study|Lack of Efficacy|7|||
128968366|NCT02116361|464170096|FG002|Overall Study|Lack of Efficacy|4|||
128968367|NCT02116361|464170097|FG003|Overall Study|Lack of Efficacy|3|||
128968368|NCT02116361|464170094|FG000|Overall Study|Lost to Follow-up|4|||
128968369|NCT02116361|464170095|FG001|Overall Study|Lost to Follow-up|5|||
128968370|NCT02116361|464170096|FG002|Overall Study|Lost to Follow-up|7|||
128968371|NCT02116361|464170097|FG003|Overall Study|Lost to Follow-up|5|||
128968372|NCT02116361|464170094|FG000|Overall Study|Personal Reasons|6|||
128968373|NCT02116361|464170095|FG001|Overall Study|Personal Reasons|6|||
128968374|NCT02116361|464170096|FG002|Overall Study|Personal Reasons|4|||
128968375|NCT02116361|464170097|FG003|Overall Study|Personal Reasons|9|||
128968376|NCT02116361|464170094|FG000|Overall Study|Investigator Decision - Relapse|9|||
128968377|NCT02116361|464170095|FG001|Overall Study|Investigator Decision - Relapse|7|||
128968378|NCT02116361|464170096|FG002|Overall Study|Investigator Decision - Relapse|8|||
128968379|NCT02116361|464170097|FG003|Overall Study|Investigator Decision - Relapse|5|||
128968380|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
128968381|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
128968382|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
128968383|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
129130398|NCT04470427|464768790|FG003|Part B :Open-label|Other than specified|0|||
128714394|NCT02554812|463250846|FG005|Overall Study|Global deterioration of health status|0|||
128714395|NCT02554812|463250847|FG006|Overall Study|Global deterioration of health status|2|||
128714396|NCT02554812|463250848|FG007|Overall Study|Global deterioration of health status|1|||
128714397|NCT02554812|463250849|FG008|Overall Study|Global deterioration of health status|1|||
128714398|NCT02554812|463250850|FG009|Overall Study|Global deterioration of health status|1|||
128714399|NCT02554812|463250851|FG010|Overall Study|Global deterioration of health status|2|||
128714400|NCT02554812|463250852|FG011|Overall Study|Global deterioration of health status|1|||
128714401|NCT02554812|463250853|FG012|Overall Study|Global deterioration of health status|0|||
128714402|NCT02554812|463250854|FG013|Overall Study|Global deterioration of health status|0|||
128714403|NCT02554812|463250855|FG014|Overall Study|Global deterioration of health status|0|||
128714404|NCT02554812|463250856|FG015|Overall Study|Global deterioration of health status|1|||
128714405|NCT02554812|463250857|FG016|Overall Study|Global deterioration of health status|0|||
128714406|NCT02554812|463250858|FG017|Overall Study|Global deterioration of health status|0|||
128714407|NCT02554812|463250859|FG018|Overall Study|Global deterioration of health status|0|||
128714408|NCT02554812|463250860|FG019|Overall Study|Global deterioration of health status|0|||
128714409|NCT02554812|463250861|FG020|Overall Study|Global deterioration of health status|0|||
128773558|NCT02291289|463464037|FG004|Induction Treatment|Withdrawal by Subject|0|||
128773559|NCT02291289|463464038|FG005|Induction Treatment|Withdrawal by Subject|0|||
128773560|NCT02291289|463464039|FG006|Induction Treatment|Withdrawal by Subject|0|||
128773561|NCT02291289|463464040|FG007|Induction Treatment|Withdrawal by Subject|0|||
128773562|NCT02291289|463464041|FG008|Induction Treatment|Withdrawal by Subject|0|||
128773563|NCT02291289|463464042|FG009|Induction Treatment|Withdrawal by Subject|18|||
128773564|NCT02291289|463464043|FG010|Induction Treatment|Withdrawal by Subject|0|||
128773565|NCT02291289|463464044|FG011|Induction Treatment|Withdrawal by Subject|0|||
128773566|NCT02291289|463464045|FG012|Induction Treatment|Withdrawal by Subject|0|||
128773567|NCT02291289|463464033|FG000|Induction Treatment|Adverse Event|0|||
128773568|NCT02291289|463464034|FG001|Induction Treatment|Adverse Event|0|||
128968384|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
128968385|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
128968386|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
128968387|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
128968388|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
128968389|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
128968390|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
128968391|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
128714410|NCT02554812|463250862|FG021|Overall Study|Global deterioration of health status|0|||
128968392|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
129130399|NCT04470427|464768791|FG004|Part B :Open-label|Other than specified|523|||
128773569|NCT02291289|463464035|FG002|Induction Treatment|Adverse Event|0|||
128968393|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128968394|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128968395|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
128968396|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
128968397|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
128968398|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
128968399|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
128773570|NCT02291289|463464036|FG003|Induction Treatment|Adverse Event|3|||
128773571|NCT02291289|463464037|FG004|Induction Treatment|Adverse Event|0|||
128773572|NCT02291289|463464038|FG005|Induction Treatment|Adverse Event|0|||
128773573|NCT02291289|463464039|FG006|Induction Treatment|Adverse Event|0|||
128773574|NCT02291289|463464040|FG007|Induction Treatment|Adverse Event|0|||
128773575|NCT02291289|463464041|FG008|Induction Treatment|Adverse Event|0|||
128773576|NCT02291289|463464042|FG009|Induction Treatment|Adverse Event|1|||
128773577|NCT02291289|463464043|FG010|Induction Treatment|Adverse Event|0|||
128773578|NCT02291289|463464044|FG011|Induction Treatment|Adverse Event|0|||
128773579|NCT02291289|463464045|FG012|Induction Treatment|Adverse Event|0|||
128773580|NCT02291289|463464033|FG000|Induction Treatment|Death|25|||
128773581|NCT02291289|463464034|FG001|Induction Treatment|Death|0|||
128773582|NCT02291289|463464035|FG002|Induction Treatment|Death|0|||
128773583|NCT02291289|463464036|FG003|Induction Treatment|Death|111|||
128773584|NCT02291289|463464037|FG004|Induction Treatment|Death|0|||
128773585|NCT02291289|463464038|FG005|Induction Treatment|Death|0|||
128773586|NCT02291289|463464039|FG006|Induction Treatment|Death|1|||
128773587|NCT02291289|463464040|FG007|Induction Treatment|Death|0|||
128773588|NCT02291289|463464041|FG008|Induction Treatment|Death|0|||
128773589|NCT02291289|463464042|FG009|Induction Treatment|Death|82|||
128773590|NCT02291289|463464043|FG010|Induction Treatment|Death|0|||
128773591|NCT02291289|463464044|FG011|Induction Treatment|Death|0|||
128773592|NCT02291289|463464045|FG012|Induction Treatment|Death|0|||
128773593|NCT02291289|463464033|FG000|Induction Treatment|Lost to Follow-up|1|||
128773594|NCT02291289|463464034|FG001|Induction Treatment|Lost to Follow-up|0|||
128773595|NCT02291289|463464035|FG002|Induction Treatment|Lost to Follow-up|0|||
128773596|NCT02291289|463464036|FG003|Induction Treatment|Lost to Follow-up|12|||
128773597|NCT02291289|463464037|FG004|Induction Treatment|Lost to Follow-up|0|||
128773598|NCT02291289|463464038|FG005|Induction Treatment|Lost to Follow-up|0|||
128773599|NCT02291289|463464039|FG006|Induction Treatment|Lost to Follow-up|0|||
128773600|NCT02291289|463464040|FG007|Induction Treatment|Lost to Follow-up|0|||
128773601|NCT02291289|463464041|FG008|Induction Treatment|Lost to Follow-up|0|||
128773602|NCT02291289|463464042|FG009|Induction Treatment|Lost to Follow-up|9|||
128773603|NCT02291289|463464043|FG010|Induction Treatment|Lost to Follow-up|0|||
128773604|NCT02291289|463464044|FG011|Induction Treatment|Lost to Follow-up|0|||
128773605|NCT02291289|463464045|FG012|Induction Treatment|Lost to Follow-up|0|||
128773606|NCT02291289|463464033|FG000|Induction Treatment|Non-Compliance|0|||
128773607|NCT02291289|463464034|FG001|Induction Treatment|Non-Compliance|0|||
128773608|NCT02291289|463464035|FG002|Induction Treatment|Non-Compliance|0|||
128773609|NCT02291289|463464036|FG003|Induction Treatment|Non-Compliance|1|||
128773610|NCT02291289|463464037|FG004|Induction Treatment|Non-Compliance|0|||
128773611|NCT02291289|463464038|FG005|Induction Treatment|Non-Compliance|0|||
128773612|NCT02291289|463464039|FG006|Induction Treatment|Non-Compliance|0|||
128773613|NCT02291289|463464040|FG007|Induction Treatment|Non-Compliance|0|||
128773614|NCT02291289|463464041|FG008|Induction Treatment|Non-Compliance|0|||
128773615|NCT02291289|463464042|FG009|Induction Treatment|Non-Compliance|1|||
128773616|NCT02291289|463464043|FG010|Induction Treatment|Non-Compliance|0|||
128773617|NCT02291289|463464044|FG011|Induction Treatment|Non-Compliance|0|||
128773618|NCT02291289|463464045|FG012|Induction Treatment|Non-Compliance|0|||
128773619|NCT02291289|463464033|FG000|Induction Treatment|Reason Not Specified|0|||
128773620|NCT02291289|463464034|FG001|Induction Treatment|Reason Not Specified|0|||
128773621|NCT02291289|463464035|FG002|Induction Treatment|Reason Not Specified|0|||
128773622|NCT02291289|463464036|FG003|Induction Treatment|Reason Not Specified|4|||
128773623|NCT02291289|463464037|FG004|Induction Treatment|Reason Not Specified|0|||
128773624|NCT02291289|463464038|FG005|Induction Treatment|Reason Not Specified|0|||
128968400|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
128968401|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
128968402|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
128773625|NCT02291289|463464039|FG006|Induction Treatment|Reason Not Specified|0|||
128773626|NCT02291289|463464040|FG007|Induction Treatment|Reason Not Specified|0|||
128773627|NCT02291289|463464041|FG008|Induction Treatment|Reason Not Specified|0|||
128773628|NCT02291289|463464042|FG009|Induction Treatment|Reason Not Specified|7|||
128773629|NCT02291289|463464043|FG010|Induction Treatment|Reason Not Specified|0|||
128773630|NCT02291289|463464044|FG011|Induction Treatment|Reason Not Specified|0|||
128773631|NCT02291289|463464045|FG012|Induction Treatment|Reason Not Specified|0|||
128773632|NCT02291289|463464033|FG000|Induction Treatment|Physician Decision|0|||
128773633|NCT02291289|463464034|FG001|Induction Treatment|Physician Decision|0|||
128773634|NCT02291289|463464035|FG002|Induction Treatment|Physician Decision|0|||
128968403|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
128968404|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
128968405|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
128968406|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
128968407|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
128968408|NCT03227224|464170098|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
128968409|NCT03227224|464170099|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
128968410|NCT03227224|464170100|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
128968411|NCT03227224|464170101|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
128968412|NCT03227224|464170098|FG000|Follow-up Phase (2 Weeks)|Other|4|||
128968413|NCT03227224|464170099|FG001|Follow-up Phase (2 Weeks)|Other|4|||
128968414|NCT03227224|464170100|FG002|Follow-up Phase (2 Weeks)|Other|6|||
128968415|NCT03227224|464170101|FG003|Follow-up Phase (2 Weeks)|Other|3|||
128968416|NCT04195750|464170102|FG000|Overall Study|Death|245|||
128968417|NCT04195750|464170103|FG001|Overall Study|Death|253|||
128968418|NCT04195750|464170104|FG002|Overall Study|Death|5|||
128968419|NCT04195750|464170102|FG000|Overall Study|Physician Decision|0|||
128968420|NCT04195750|464170103|FG001|Overall Study|Physician Decision|1|||
128968421|NCT04195750|464170104|FG002|Overall Study|Physician Decision|0|||
128968422|NCT04195750|464170102|FG000|Overall Study|Withdrawal by Subject|9|||
128968423|NCT04195750|464170103|FG001|Overall Study|Withdrawal by Subject|8|||
128968424|NCT04195750|464170104|FG002|Overall Study|Withdrawal by Subject|0|||
128968425|NCT04195750|464170102|FG000|Overall Study|Ongoing|120|||
128968426|NCT04195750|464170103|FG001|Overall Study|Ongoing|110|||
128968427|NCT04195750|464170104|FG002|Overall Study|Ongoing|4|||
128968428|NCT02406027|464170105|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
128968429|NCT02406027|464170106|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
128968430|NCT02406027|464170107|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
128714411|NCT02554812|463250863|FG022|Overall Study|Global deterioration of health status|0|||
128714412|NCT02554812|463250864|FG023|Overall Study|Global deterioration of health status|0|||
128714413|NCT02554812|463250865|FG024|Overall Study|Global deterioration of health status|0|||
128714414|NCT02554812|463250866|FG025|Overall Study|Global deterioration of health status|0|||
128714415|NCT02554812|463250867|FG026|Overall Study|Global deterioration of health status|0|||
128714416|NCT02554812|463250841|FG000|Overall Study|Progressive disease|20|||
128714417|NCT02554812|463250842|FG001|Overall Study|Progressive disease|16|||
128714418|NCT02554812|463250843|FG002|Overall Study|Progressive disease|19|||
128714419|NCT02554812|463250844|FG003|Overall Study|Progressive disease|18|||
128714420|NCT02554812|463250845|FG004|Overall Study|Progressive disease|21|||
128714421|NCT02554812|463250846|FG005|Overall Study|Progressive disease|15|||
128714422|NCT02554812|463250847|FG006|Overall Study|Progressive disease|6|||
128714423|NCT02554812|463250848|FG007|Overall Study|Progressive disease|13|||
128714424|NCT02554812|463250849|FG008|Overall Study|Progressive disease|6|||
128714425|NCT02554812|463250850|FG009|Overall Study|Progressive disease|6|||
128714426|NCT02554812|463250851|FG010|Overall Study|Progressive disease|8|||
128714427|NCT02554812|463250852|FG011|Overall Study|Progressive disease|8|||
128714428|NCT02554812|463250853|FG012|Overall Study|Progressive disease|6|||
128714429|NCT02554812|463250854|FG013|Overall Study|Progressive disease|10|||
128714430|NCT02554812|463250855|FG014|Overall Study|Progressive disease|20|||
128714431|NCT02554812|463250856|FG015|Overall Study|Progressive disease|6|||
128714432|NCT02554812|463250857|FG016|Overall Study|Progressive disease|3|||
128714433|NCT02554812|463250858|FG017|Overall Study|Progressive disease|3|||
128714434|NCT02554812|463250859|FG018|Overall Study|Progressive disease|11|||
128714435|NCT02554812|463250860|FG019|Overall Study|Progressive disease|7|||
128714436|NCT02554812|463250861|FG020|Overall Study|Progressive disease|11|||
128714437|NCT02554812|463250862|FG021|Overall Study|Progressive disease|6|||
128714438|NCT02554812|463250863|FG022|Overall Study|Progressive disease|9|||
128714439|NCT02554812|463250864|FG023|Overall Study|Progressive disease|9|||
128714440|NCT02554812|463250865|FG024|Overall Study|Progressive disease|4|||
128714441|NCT02554812|463250866|FG025|Overall Study|Progressive disease|5|||
128714442|NCT02554812|463250867|FG026|Overall Study|Progressive disease|5|||
128714443|NCT02554812|463250841|FG000|Overall Study|Other|0|||
128714444|NCT02554812|463250842|FG001|Overall Study|Other|0|||
128714445|NCT02554812|463250843|FG002|Overall Study|Other|2|||
128714446|NCT02554812|463250844|FG003|Overall Study|Other|3|||
128714447|NCT02554812|463250845|FG004|Overall Study|Other|2|||
128714448|NCT02554812|463250846|FG005|Overall Study|Other|1|||
128714449|NCT02554812|463250847|FG006|Overall Study|Other|0|||
128714450|NCT02554812|463250848|FG007|Overall Study|Other|0|||
128714451|NCT02554812|463250849|FG008|Overall Study|Other|1|||
128714452|NCT02554812|463250850|FG009|Overall Study|Other|1|||
128714453|NCT02554812|463250851|FG010|Overall Study|Other|0|||
128714454|NCT02554812|463250852|FG011|Overall Study|Other|0|||
128714455|NCT02554812|463250853|FG012|Overall Study|Other|1|||
128714456|NCT02554812|463250854|FG013|Overall Study|Other|0|||
128714457|NCT02554812|463250855|FG014|Overall Study|Other|1|||
128714458|NCT02554812|463250856|FG015|Overall Study|Other|0|||
128714459|NCT02554812|463250857|FG016|Overall Study|Other|0|||
128968431|NCT02406027|464170108|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
128968432|NCT02406027|464170109|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
128968433|NCT02406027|464170110|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
128968434|NCT02406027|464170111|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
128714460|NCT02554812|463250858|FG017|Overall Study|Other|0|||
128714461|NCT02554812|463250859|FG018|Overall Study|Other|0|||
128714462|NCT02554812|463250860|FG019|Overall Study|Other|0|||
128714463|NCT02554812|463250861|FG020|Overall Study|Other|0|||
128714464|NCT02554812|463250862|FG021|Overall Study|Other|2|||
128714465|NCT02554812|463250863|FG022|Overall Study|Other|0|||
128714466|NCT02554812|463250864|FG023|Overall Study|Other|0|||
128714467|NCT02554812|463250865|FG024|Overall Study|Other|0|||
128714468|NCT02554812|463250866|FG025|Overall Study|Other|0|||
128714469|NCT02554812|463250867|FG026|Overall Study|Other|0|||
128714470|NCT02554812|463250841|FG000|Overall Study|Withdrawal by Subject|1|||
128714471|NCT02554812|463250842|FG001|Overall Study|Withdrawal by Subject|0|||
128714472|NCT02554812|463250843|FG002|Overall Study|Withdrawal by Subject|0|||
128714473|NCT02554812|463250844|FG003|Overall Study|Withdrawal by Subject|2|||
128714474|NCT02554812|463250845|FG004|Overall Study|Withdrawal by Subject|2|||
128714475|NCT02554812|463250846|FG005|Overall Study|Withdrawal by Subject|3|||
128714476|NCT02554812|463250847|FG006|Overall Study|Withdrawal by Subject|0|||
128714477|NCT02554812|463250848|FG007|Overall Study|Withdrawal by Subject|0|||
128714478|NCT02554812|463250849|FG008|Overall Study|Withdrawal by Subject|1|||
128714479|NCT02554812|463250850|FG009|Overall Study|Withdrawal by Subject|1|||
128714480|NCT02554812|463250851|FG010|Overall Study|Withdrawal by Subject|0|||
128714481|NCT02554812|463250852|FG011|Overall Study|Withdrawal by Subject|1|||
128714482|NCT02554812|463250853|FG012|Overall Study|Withdrawal by Subject|1|||
128714483|NCT02554812|463250854|FG013|Overall Study|Withdrawal by Subject|1|||
128714484|NCT02554812|463250855|FG014|Overall Study|Withdrawal by Subject|1|||
128714485|NCT02554812|463250856|FG015|Overall Study|Withdrawal by Subject|1|||
128714486|NCT02554812|463250857|FG016|Overall Study|Withdrawal by Subject|3|||
128714487|NCT02554812|463250858|FG017|Overall Study|Withdrawal by Subject|1|||
128714488|NCT02554812|463250859|FG018|Overall Study|Withdrawal by Subject|0|||
128714489|NCT02554812|463250860|FG019|Overall Study|Withdrawal by Subject|2|||
128714490|NCT02554812|463250861|FG020|Overall Study|Withdrawal by Subject|0|||
128714491|NCT02554812|463250862|FG021|Overall Study|Withdrawal by Subject|1|||
128714492|NCT02554812|463250863|FG022|Overall Study|Withdrawal by Subject|0|||
128714493|NCT02554812|463250864|FG023|Overall Study|Withdrawal by Subject|1|||
128714494|NCT02554812|463250865|FG024|Overall Study|Withdrawal by Subject|0|||
128714495|NCT02554812|463250866|FG025|Overall Study|Withdrawal by Subject|0|||
128714496|NCT02554812|463250867|FG026|Overall Study|Withdrawal by Subject|1|||
128714497|NCT02554812|463250841|FG000|Overall Study|Physician Decision|1|||
128714498|NCT02554812|463250842|FG001|Overall Study|Physician Decision|0|||
128714499|NCT02554812|463250843|FG002|Overall Study|Physician Decision|0|||
128714500|NCT02554812|463250844|FG003|Overall Study|Physician Decision|1|||
128714501|NCT02554812|463250845|FG004|Overall Study|Physician Decision|0|||
128714502|NCT02554812|463250846|FG005|Overall Study|Physician Decision|1|||
128714503|NCT02554812|463250847|FG006|Overall Study|Physician Decision|0|||
128714504|NCT02554812|463250848|FG007|Overall Study|Physician Decision|0|||
128714505|NCT02554812|463250849|FG008|Overall Study|Physician Decision|0|||
128714506|NCT02554812|463250850|FG009|Overall Study|Physician Decision|0|||
128714507|NCT02554812|463250851|FG010|Overall Study|Physician Decision|1|||
128714508|NCT02554812|463250852|FG011|Overall Study|Physician Decision|0|||
128714509|NCT02554812|463250853|FG012|Overall Study|Physician Decision|0|||
128714510|NCT02554812|463250854|FG013|Overall Study|Physician Decision|0|||
128714511|NCT02554812|463250855|FG014|Overall Study|Physician Decision|0|||
128714512|NCT02554812|463250856|FG015|Overall Study|Physician Decision|0|||
128714513|NCT02554812|463250857|FG016|Overall Study|Physician Decision|1|||
128714514|NCT02554812|463250858|FG017|Overall Study|Physician Decision|1|||
128714515|NCT02554812|463250859|FG018|Overall Study|Physician Decision|0|||
128714516|NCT02554812|463250860|FG019|Overall Study|Physician Decision|1|||
128714517|NCT02554812|463250861|FG020|Overall Study|Physician Decision|1|||
128714518|NCT02554812|463250862|FG021|Overall Study|Physician Decision|0|||
128714519|NCT02554812|463250863|FG022|Overall Study|Physician Decision|1|||
128714520|NCT02554812|463250864|FG023|Overall Study|Physician Decision|0|||
128714521|NCT02554812|463250865|FG024|Overall Study|Physician Decision|0|||
128714522|NCT02554812|463250866|FG025|Overall Study|Physician Decision|0|||
128714523|NCT02554812|463250867|FG026|Overall Study|Physician Decision|0|||
128714524|NCT02554812|463250841|FG000|Overall Study|Study terminated by sponsor|0|||
128968435|NCT02406027|464170105|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
128714525|NCT02554812|463250842|FG001|Overall Study|Study terminated by sponsor|0|||
128714526|NCT02554812|463250843|FG002|Overall Study|Study terminated by sponsor|0|||
128714527|NCT02554812|463250844|FG003|Overall Study|Study terminated by sponsor|0|||
128714528|NCT02554812|463250845|FG004|Overall Study|Study terminated by sponsor|0|||
128714529|NCT02554812|463250846|FG005|Overall Study|Study terminated by sponsor|0|||
128714530|NCT02554812|463250847|FG006|Overall Study|Study terminated by sponsor|0|||
128714531|NCT02554812|463250848|FG007|Overall Study|Study terminated by sponsor|0|||
128714532|NCT02554812|463250849|FG008|Overall Study|Study terminated by sponsor|0|||
128714533|NCT02554812|463250850|FG009|Overall Study|Study terminated by sponsor|0|||
128968436|NCT02406027|464170106|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
128968437|NCT02406027|464170107|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
128968438|NCT02406027|464170108|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
128968439|NCT02406027|464170109|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
128773635|NCT02291289|463464036|FG003|Induction Treatment|Physician Decision|3|||
128773636|NCT02291289|463464037|FG004|Induction Treatment|Physician Decision|0|||
128773637|NCT02291289|463464038|FG005|Induction Treatment|Physician Decision|0|||
128773638|NCT02291289|463464039|FG006|Induction Treatment|Physician Decision|0|||
128773639|NCT02291289|463464040|FG007|Induction Treatment|Physician Decision|0|||
128773640|NCT02291289|463464041|FG008|Induction Treatment|Physician Decision|0|||
128968440|NCT02406027|464170110|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
128968441|NCT02406027|464170111|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
128968442|NCT02406027|464170105|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
128968443|NCT02406027|464170106|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
128968444|NCT02406027|464170107|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
128968445|NCT02406027|464170108|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
128968446|NCT02406027|464170109|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
128968447|NCT02406027|464170110|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
128968448|NCT02406027|464170111|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
128968449|NCT02406027|464170105|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
128968450|NCT02406027|464170106|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
128968451|NCT02406027|464170107|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
128968452|NCT02406027|464170108|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
128968453|NCT02406027|464170109|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
128968454|NCT02406027|464170110|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
128968455|NCT02406027|464170111|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
128968456|NCT02406027|464170105|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
128968457|NCT02406027|464170106|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
128968458|NCT02406027|464170107|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
128968459|NCT02406027|464170108|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
128968460|NCT02406027|464170109|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
128968461|NCT02406027|464170110|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
128968462|NCT02406027|464170111|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
128968463|NCT02406027|464170105|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
128968464|NCT02406027|464170106|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
128968465|NCT02406027|464170107|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
128968466|NCT02406027|464170108|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
128968467|NCT02406027|464170109|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
128968468|NCT02406027|464170110|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
128968469|NCT02406027|464170111|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
128968470|NCT02406027|464170105|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
128968471|NCT02406027|464170106|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
128773641|NCT02291289|463464042|FG009|Induction Treatment|Physician Decision|1|||
128773642|NCT02291289|463464043|FG010|Induction Treatment|Physician Decision|0|||
128773643|NCT02291289|463464044|FG011|Induction Treatment|Physician Decision|0|||
128773644|NCT02291289|463464045|FG012|Induction Treatment|Physician Decision|0|||
128773645|NCT02291289|463464033|FG000|Induction Treatment|Protocol Violation|0|||
128773646|NCT02291289|463464034|FG001|Induction Treatment|Protocol Violation|0|||
128773647|NCT02291289|463464035|FG002|Induction Treatment|Protocol Violation|0|||
128773648|NCT02291289|463464036|FG003|Induction Treatment|Protocol Violation|3|||
128773649|NCT02291289|463464037|FG004|Induction Treatment|Protocol Violation|0|||
128773650|NCT02291289|463464038|FG005|Induction Treatment|Protocol Violation|0|||
128773651|NCT02291289|463464039|FG006|Induction Treatment|Protocol Violation|0|||
128773652|NCT02291289|463464040|FG007|Induction Treatment|Protocol Violation|0|||
128773653|NCT02291289|463464041|FG008|Induction Treatment|Protocol Violation|0|||
128773654|NCT02291289|463464042|FG009|Induction Treatment|Protocol Violation|2|||
128773655|NCT02291289|463464043|FG010|Induction Treatment|Protocol Violation|0|||
128773656|NCT02291289|463464044|FG011|Induction Treatment|Protocol Violation|0|||
128773657|NCT02291289|463464045|FG012|Induction Treatment|Protocol Violation|0|||
128773658|NCT02291289|463464033|FG000|Induction Treatment|Missing|4|||
128773659|NCT02291289|463464034|FG001|Induction Treatment|Missing|0|||
128968472|NCT02406027|464170107|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
128968473|NCT02406027|464170108|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
128773660|NCT02291289|463464035|FG002|Induction Treatment|Missing|0|||
128773661|NCT02291289|463464036|FG003|Induction Treatment|Missing|14|||
128773662|NCT02291289|463464037|FG004|Induction Treatment|Missing|0|||
128773663|NCT02291289|463464038|FG005|Induction Treatment|Missing|0|||
128773664|NCT02291289|463464039|FG006|Induction Treatment|Missing|0|||
128773665|NCT02291289|463464040|FG007|Induction Treatment|Missing|0|||
128968474|NCT02406027|464170109|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
128968475|NCT02406027|464170110|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
128968476|NCT02406027|464170111|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
128968477|NCT02406027|464170105|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
128968478|NCT02406027|464170106|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
128968479|NCT02406027|464170107|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
128714534|NCT02554812|463250851|FG010|Overall Study|Study terminated by sponsor|0|||
128714535|NCT02554812|463250852|FG011|Overall Study|Study terminated by sponsor|0|||
128714536|NCT02554812|463250853|FG012|Overall Study|Study terminated by sponsor|0|||
128714537|NCT02554812|463250854|FG013|Overall Study|Study terminated by sponsor|0|||
128714538|NCT02554812|463250855|FG014|Overall Study|Study terminated by sponsor|0|||
128714539|NCT02554812|463250856|FG015|Overall Study|Study terminated by sponsor|0|||
128714540|NCT02554812|463250857|FG016|Overall Study|Study terminated by sponsor|0|||
128714541|NCT02554812|463250858|FG017|Overall Study|Study terminated by sponsor|0|||
128714542|NCT02554812|463250859|FG018|Overall Study|Study terminated by sponsor|0|||
128714543|NCT02554812|463250860|FG019|Overall Study|Study terminated by sponsor|0|||
128714544|NCT02554812|463250861|FG020|Overall Study|Study terminated by sponsor|0|||
128714545|NCT02554812|463250862|FG021|Overall Study|Study terminated by sponsor|0|||
128714546|NCT02554812|463250863|FG022|Overall Study|Study terminated by sponsor|0|||
128714547|NCT02554812|463250864|FG023|Overall Study|Study terminated by sponsor|0|||
128714548|NCT02554812|463250865|FG024|Overall Study|Study terminated by sponsor|1|||
128714549|NCT02554812|463250866|FG025|Overall Study|Study terminated by sponsor|0|||
128714550|NCT02554812|463250867|FG026|Overall Study|Study terminated by sponsor|0|||
128714551|NCT02554812|463250841|FG000|Overall Study|No longer meets eligibility criteria|0|||
128714552|NCT02554812|463250842|FG001|Overall Study|No longer meets eligibility criteria|1|||
128714553|NCT02554812|463250843|FG002|Overall Study|No longer meets eligibility criteria|0|||
128714554|NCT02554812|463250844|FG003|Overall Study|No longer meets eligibility criteria|0|||
128714555|NCT02554812|463250845|FG004|Overall Study|No longer meets eligibility criteria|0|||
128714556|NCT02554812|463250846|FG005|Overall Study|No longer meets eligibility criteria|0|||
128714557|NCT02554812|463250847|FG006|Overall Study|No longer meets eligibility criteria|0|||
128714558|NCT02554812|463250848|FG007|Overall Study|No longer meets eligibility criteria|0|||
128714559|NCT02554812|463250849|FG008|Overall Study|No longer meets eligibility criteria|0|||
128714560|NCT02554812|463250850|FG009|Overall Study|No longer meets eligibility criteria|0|||
128714561|NCT02554812|463250851|FG010|Overall Study|No longer meets eligibility criteria|0|||
128714562|NCT02554812|463250852|FG011|Overall Study|No longer meets eligibility criteria|0|||
128714563|NCT02554812|463250853|FG012|Overall Study|No longer meets eligibility criteria|0|||
128714564|NCT02554812|463250854|FG013|Overall Study|No longer meets eligibility criteria|0|||
128714565|NCT02554812|463250855|FG014|Overall Study|No longer meets eligibility criteria|0|||
128714566|NCT02554812|463250856|FG015|Overall Study|No longer meets eligibility criteria|0|||
128714567|NCT02554812|463250857|FG016|Overall Study|No longer meets eligibility criteria|0|||
128714568|NCT02554812|463250858|FG017|Overall Study|No longer meets eligibility criteria|0|||
128714569|NCT02554812|463250859|FG018|Overall Study|No longer meets eligibility criteria|0|||
128714570|NCT02554812|463250860|FG019|Overall Study|No longer meets eligibility criteria|0|||
128714571|NCT02554812|463250861|FG020|Overall Study|No longer meets eligibility criteria|0|||
128714572|NCT02554812|463250862|FG021|Overall Study|No longer meets eligibility criteria|0|||
128714573|NCT02554812|463250863|FG022|Overall Study|No longer meets eligibility criteria|0|||
128714574|NCT02554812|463250864|FG023|Overall Study|No longer meets eligibility criteria|0|||
128714575|NCT02554812|463250865|FG024|Overall Study|No longer meets eligibility criteria|0|||
128714576|NCT02554812|463250866|FG025|Overall Study|No longer meets eligibility criteria|0|||
128714577|NCT02554812|463250867|FG026|Overall Study|No longer meets eligibility criteria|0|||
128714578|NCT00312494|463252255|FG000|Overall Study|Randomized; not treated with study drug|9|||
128714579|NCT00312494|463252256|FG001|Overall Study|Randomized; not treated with study drug|10|||
128714580|NCT00312494|463252257|FG002|Overall Study|Randomized; not treated with study drug|5|||
128714581|NCT00312494|463252255|FG000|Overall Study|Adverse Event|33|||
128714582|NCT00312494|463252256|FG001|Overall Study|Adverse Event|15|||
128714583|NCT00312494|463252257|FG002|Overall Study|Adverse Event|11|||
128714584|NCT00312494|463252255|FG000|Overall Study|Lack of Efficacy|4|||
128714585|NCT00312494|463252256|FG001|Overall Study|Lack of Efficacy|6|||
128714586|NCT00312494|463252257|FG002|Overall Study|Lack of Efficacy|8|||
128714587|NCT00312494|463252255|FG000|Overall Study|Laboratory abnormality|1|||
128714588|NCT00312494|463252256|FG001|Overall Study|Laboratory abnormality|0|||
128714589|NCT00312494|463252257|FG002|Overall Study|Laboratory abnormality|0|||
128714590|NCT00312494|463252255|FG000|Overall Study|Lost to Follow-up|8|||
128714591|NCT00312494|463252256|FG001|Overall Study|Lost to Follow-up|8|||
128714592|NCT00312494|463252257|FG002|Overall Study|Lost to Follow-up|8|||
128714593|NCT00312494|463252255|FG000|Overall Study|Withdrawal by Subject|6|||
128714594|NCT00312494|463252256|FG001|Overall Study|Withdrawal by Subject|9|||
128714595|NCT00312494|463252257|FG002|Overall Study|Withdrawal by Subject|10|||
128714596|NCT00312494|463252255|FG000|Overall Study|Other|10|||
128714597|NCT00312494|463252256|FG001|Overall Study|Other|10|||
128714598|NCT00312494|463252257|FG002|Overall Study|Other|1|||
128773666|NCT02291289|463464041|FG008|Induction Treatment|Missing|0|||
128773667|NCT02291289|463464042|FG009|Induction Treatment|Missing|54|||
128773668|NCT02291289|463464043|FG010|Induction Treatment|Missing|0|||
128773669|NCT02291289|463464044|FG011|Induction Treatment|Missing|0|||
128773670|NCT02291289|463464045|FG012|Induction Treatment|Missing|0|||
128773671|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773672|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773673|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773674|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773675|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
128773676|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
128773677|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773678|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773679|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773680|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773681|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
128773682|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
128773683|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128773684|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Death|0|||
128773685|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Death|29|||
128773686|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Death|16|||
128773687|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Death|0|||
128773688|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Death|188|||
128773689|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Death|107|||
128773690|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Death|0|||
128773691|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Death|1|||
128773692|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Death|1|||
128773693|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Death|0|||
128773694|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Death|46|||
128773695|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Death|19|||
128773696|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Death|0|||
128773697|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Adverse Event|0|||
128773698|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Adverse Event|0|||
128773699|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Adverse Event|0|||
128773700|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Adverse Event|0|||
128773701|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Adverse Event|1|||
128773702|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Adverse Event|1|||
128773703|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Adverse Event|0|||
128773704|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Adverse Event|0|||
128968480|NCT02406027|464170108|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
128968481|NCT02406027|464170109|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
128968482|NCT02406027|464170110|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
128968483|NCT02406027|464170111|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
128968484|NCT02406027|464170105|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
128968485|NCT02406027|464170106|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
128968486|NCT02406027|464170107|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
128968487|NCT02406027|464170108|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
128968488|NCT02406027|464170109|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
128968489|NCT02406027|464170110|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
128968490|NCT02406027|464170111|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
128968491|NCT02406027|464170105|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
128968492|NCT02406027|464170106|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
128968493|NCT02406027|464170107|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
128968494|NCT02406027|464170108|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
128968495|NCT02406027|464170109|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
128968496|NCT02406027|464170110|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
128968497|NCT02406027|464170111|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
128968498|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
128968499|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
128968500|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
128968501|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
128968502|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Other|13|||
128773705|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Adverse Event|0|||
128968503|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
128968504|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
128773706|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Adverse Event|0|||
128773707|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Adverse Event|0|||
128773708|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Adverse Event|0|||
128773709|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Adverse Event|0|||
128773710|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
128773711|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
128968505|NCT02497287|464170112|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
128968506|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
128968507|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
128968508|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
128968509|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
128968510|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
128968511|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
128968512|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
128968513|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
128968514|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
128968515|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
128968516|NCT02497287|464170112|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
128968517|NCT02497287|464170112|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
128968518|NCT02497287|464170112|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
128968519|NCT02497287|464170112|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
128968520|NCT02497287|464170112|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
128968521|NCT02497287|464170112|FG000|Follow-up Phase (4 Week)|Other|1|||
128968522|NCT03782376|464170113|FG000|Overall Study|Lost to Follow-up|2|||
128968523|NCT03782376|464170114|FG001|Overall Study|Lost to Follow-up|2|||
128968524|NCT03782376|464170113|FG000|Overall Study|Withdrawal by Subject|7|||
128773712|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
128968525|NCT03782376|464170114|FG001|Overall Study|Withdrawal by Subject|11|||
128968526|NCT03782376|464170113|FG000|Overall Study|Death|1|||
128968527|NCT03782376|464170114|FG001|Overall Study|Death|0|||
128968528|NCT03782376|464170113|FG000|Overall Study|Other|16|||
128968529|NCT03782376|464170114|FG001|Overall Study|Other|17|||
128968530|NCT03559192|464170115|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
128968531|NCT03559192|464170116|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
128968532|NCT03559192|464170117|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
128968533|NCT03559192|464170115|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
128968534|NCT03559192|464170116|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
128968535|NCT03559192|464170117|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
128968536|NCT03559192|464170115|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
128968537|NCT03559192|464170116|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
128968538|NCT03559192|464170117|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
128968539|NCT03559192|464170115|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
128968540|NCT03559192|464170116|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
128968541|NCT03559192|464170117|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
128968542|NCT03559192|464170115|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
128968543|NCT03559192|464170116|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
128968544|NCT03559192|464170117|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
128968545|NCT03559192|464170115|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
128968546|NCT03559192|464170116|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
128968547|NCT03559192|464170117|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
128968548|NCT03559192|464170115|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
128968549|NCT03559192|464170116|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
128968550|NCT03559192|464170117|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
128968551|NCT03559192|464170115|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
128968552|NCT03559192|464170116|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
128968553|NCT03559192|464170117|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
128968554|NCT03559192|464170115|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
128773713|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
128773714|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
128773715|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
128968555|NCT03559192|464170116|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
128968556|NCT03559192|464170117|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
128968557|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
128968558|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
128968559|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Death|0|||
128968560|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Death|4|||
128968561|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
128968562|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
128968563|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
128968564|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
128968565|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
128968566|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
128968567|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
128968568|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
128968569|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
128773716|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
128773717|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
128773718|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
128773719|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
128773720|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
128773721|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
128773722|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
128773723|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
128773724|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
128773725|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
128773726|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
128773727|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
128773728|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
128773729|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
128773730|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
128773731|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
128773732|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
128773733|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
128773734|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
128773735|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
128773736|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Physician Decision|0|||
128773737|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Physician Decision|2|||
128773738|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Physician Decision|0|||
128773739|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Physician Decision|0|||
128773740|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Physician Decision|3|||
128773741|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Physician Decision|0|||
128773742|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Physician Decision|0|||
128773743|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Physician Decision|0|||
128773744|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Physician Decision|0|||
128968570|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
128968571|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Other|4|||
128968572|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Other|3|||
128968573|NCT03517722|464170118|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
128968574|NCT03517722|464170119|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
128968575|NCT03517722|464170118|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
128968576|NCT03517722|464170119|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
128968577|NCT03517722|464170118|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
128968578|NCT03517722|464170119|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
128968579|NCT03517722|464170118|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
128968580|NCT03517722|464170119|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
128968581|NCT03517722|464170118|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
128968582|NCT03517722|464170119|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
128968583|NCT02422186|464170120|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
128968584|NCT02422186|464170121|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
128968585|NCT02422186|464170120|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
128968586|NCT02422186|464170121|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
128968587|NCT02422186|464170120|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
128968588|NCT02422186|464170121|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
128968589|NCT02422186|464170120|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
128968590|NCT02422186|464170121|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
128968591|NCT02422186|464170120|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
128968592|NCT02422186|464170121|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
128968593|NCT02422186|464170120|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
128968594|NCT02422186|464170121|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
128968595|NCT02422186|464170120|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
128968596|NCT02422186|464170121|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
128968597|NCT02422186|464170120|FG000|Follow-up Phase (2 Weeks)|Other|3|||
128968598|NCT02422186|464170121|FG001|Follow-up Phase (2 Weeks)|Other|0|||
128968599|NCT03277794|464170126|FG000|Overall Study|Lost to Follow-up|2|||
128968600|NCT03277794|464170127|FG001|Overall Study|Lost to Follow-up|4|||
128968601|NCT03277794|464170126|FG000|Overall Study|Withdrew due to high acuity|1|||
128968602|NCT03277794|464170127|FG001|Overall Study|Withdrew due to high acuity|0|||
128968603|NCT03039569|464170131|FG000|Overall Study|Lost to Follow-up|5|||
128968604|NCT03039569|464170132|FG001|Overall Study|Lost to Follow-up|4|||
129220415|NCT01273519|465106594|FG001|Overall Study|Lost to Follow-up|1|||
129220416|NCT01273519|465106595|FG002|Overall Study|Lost to Follow-up|3|||
128773745|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Physician Decision|0|||
129220417|NCT01273519|465106593|FG000|Overall Study|Lack of Efficacy|8|||
128773746|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Physician Decision|1|||
128968605|NCT02254304|464170133|FG000|Overall Study|Adverse Event|2|||
128968606|NCT02254304|464170134|FG001|Overall Study|Adverse Event|1|||
128968607|NCT02254304|464170133|FG000|Overall Study|Lost to Follow-up|2|||
128968608|NCT02254304|464170134|FG001|Overall Study|Lost to Follow-up|2|||
128968609|NCT02254304|464170133|FG000|Overall Study|Protocol Violation|1|||
128968610|NCT02254304|464170134|FG001|Overall Study|Protocol Violation|0|||
128968611|NCT02254304|464170133|FG000|Overall Study|Withdrawal by Subject|3|||
128968612|NCT02254304|464170134|FG001|Overall Study|Withdrawal by Subject|0|||
128968613|NCT02254304|464170133|FG000|Overall Study|Injection site pain and Injection fear|1|||
128968614|NCT02254304|464170134|FG001|Overall Study|Injection site pain and Injection fear|0|||
128968615|NCT02254304|464170133|FG000|Overall Study|Personal causes|4|||
128968616|NCT02254304|464170134|FG001|Overall Study|Personal causes|1|||
128968617|NCT02254304|464170133|FG000|Overall Study|Personal decision|1|||
128968618|NCT02254304|464170134|FG001|Overall Study|Personal decision|0|||
128968619|NCT01226472|464170135|FG000|Overall Study|Progressive Disease|1|||
128968620|NCT00952419|464170136|FG000|Overall Study|Adverse Event|2|||
128968621|NCT00952419|464170137|FG001|Overall Study|Adverse Event|0|||
128968622|NCT00952419|464170138|FG002|Overall Study|Adverse Event|0|||
128968623|NCT00952419|464170136|FG000|Overall Study|Protocol Violation|3|||
128968624|NCT00952419|464170137|FG001|Overall Study|Protocol Violation|7|||
128968625|NCT00952419|464170138|FG002|Overall Study|Protocol Violation|0|||
128968626|NCT00952419|464170136|FG000|Overall Study|Withdrawal by Subject|1|||
128968627|NCT00952419|464170137|FG001|Overall Study|Withdrawal by Subject|3|||
128968628|NCT00952419|464170138|FG002|Overall Study|Withdrawal by Subject|0|||
128968629|NCT03399786|464170139|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
128968630|NCT03399786|464170140|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
128968631|NCT03399786|464170141|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
128968632|NCT03399786|464170142|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
128968633|NCT03399786|464170139|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
128968634|NCT03399786|464170140|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
128968635|NCT03399786|464170141|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
128968636|NCT03399786|464170142|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
128968637|NCT03399786|464170139|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
128968638|NCT03399786|464170140|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
128968639|NCT03399786|464170141|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
128968640|NCT03399786|464170142|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
128968641|NCT04888507|464171736|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
128968642|NCT00636155|464171737|FG000|Overall Study|Adverse Event|8|||
128968643|NCT00636155|464171737|FG000|Overall Study|Lack of Efficacy|1|||
128968644|NCT00636155|464171737|FG000|Overall Study|Withdrawal by Subject|3|||
128968645|NCT00636155|464171737|FG000|Overall Study|Stem cell transplant|1|||
128968646|NCT00636155|464171737|FG000|Overall Study|Physician Decision|5|||
128968647|NCT00400946|464171738|FG000|Overall Study|Ineligible|0|||
128968648|NCT00400946|464171739|FG001|Overall Study|Ineligible|0|||
128968649|NCT00400946|464171740|FG002|Overall Study|Ineligible|0|||
128968650|NCT00400946|464171741|FG003|Overall Study|Ineligible|5|||
128968651|NCT00400946|464171742|FG004|Overall Study|Ineligible|1|||
128968652|NCT00400946|464171738|FG000|Overall Study|Induction Failure|0|||
128968653|NCT00400946|464171739|FG001|Overall Study|Induction Failure|0|||
128968654|NCT00400946|464171740|FG002|Overall Study|Induction Failure|0|||
128968655|NCT00400946|464171741|FG003|Overall Study|Induction Failure|11|||
128968656|NCT00400946|464171742|FG004|Overall Study|Induction Failure|8|||
128968657|NCT00400946|464171738|FG000|Overall Study|Induction Death|0|||
128968658|NCT00400946|464171739|FG001|Overall Study|Induction Death|0|||
128968659|NCT00400946|464171740|FG002|Overall Study|Induction Death|0|||
128968660|NCT00400946|464171741|FG003|Overall Study|Induction Death|13|||
128968661|NCT00400946|464171742|FG004|Overall Study|Induction Death|3|||
128968662|NCT00400946|464171738|FG000|Overall Study|Lost to Follow-up|1|||
128968663|NCT00400946|464171739|FG001|Overall Study|Lost to Follow-up|1|||
128968664|NCT00400946|464171740|FG002|Overall Study|Lost to Follow-up|0|||
128714599|NCT00903617|463252258|FG000|Overall Study|Adverse Event|0|||
128968665|NCT00400946|464171741|FG003|Overall Study|Lost to Follow-up|0|||
128968666|NCT00400946|464171742|FG004|Overall Study|Lost to Follow-up|1|||
128968667|NCT00400946|464171738|FG000|Overall Study|Remission Death|1|||
128968668|NCT00400946|464171739|FG001|Overall Study|Remission Death|1|||
128968669|NCT00400946|464171740|FG002|Overall Study|Remission Death|0|||
128968670|NCT00400946|464171741|FG003|Overall Study|Remission Death|0|||
128968671|NCT00400946|464171742|FG004|Overall Study|Remission Death|1|||
128968672|NCT00400946|464171738|FG000|Overall Study|Relapse|9|||
128968673|NCT00400946|464171739|FG001|Overall Study|Relapse|2|||
128968674|NCT00400946|464171740|FG002|Overall Study|Relapse|1|||
128968675|NCT00400946|464171741|FG003|Overall Study|Relapse|1|||
128968676|NCT00400946|464171742|FG004|Overall Study|Relapse|5|||
128968677|NCT00400946|464171738|FG000|Overall Study|Transplant in CR1|0|||
128968678|NCT00400946|464171739|FG001|Overall Study|Transplant in CR1|0|||
128968679|NCT00400946|464171740|FG002|Overall Study|Transplant in CR1|0|||
128968680|NCT00400946|464171741|FG003|Overall Study|Transplant in CR1|10|||
128968681|NCT00400946|464171742|FG004|Overall Study|Transplant in CR1|1|||
128968682|NCT00400946|464171738|FG000|Overall Study|Withdrawal by Subject|2|||
128968683|NCT00400946|464171739|FG001|Overall Study|Withdrawal by Subject|5|||
128968684|NCT00400946|464171740|FG002|Overall Study|Withdrawal by Subject|1|||
128968685|NCT00400946|464171741|FG003|Overall Study|Withdrawal by Subject|5|||
128968686|NCT00400946|464171742|FG004|Overall Study|Withdrawal by Subject|8|||
128968687|NCT00400946|464171738|FG000|Overall Study|Clinical|1|||
128968688|NCT00400946|464171739|FG001|Overall Study|Clinical|2|||
128968689|NCT00400946|464171740|FG002|Overall Study|Clinical|0|||
128968690|NCT00400946|464171741|FG003|Overall Study|Clinical|2|||
128968691|NCT00400946|464171742|FG004|Overall Study|Clinical|9|||
128968692|NCT00400946|464171738|FG000|Overall Study|Other|0|||
128968693|NCT00400946|464171739|FG001|Overall Study|Other|0|||
128968694|NCT00400946|464171740|FG002|Overall Study|Other|0|||
128968695|NCT00400946|464171741|FG003|Overall Study|Other|0|||
128968696|NCT00400946|464171742|FG004|Overall Study|Other|1|||
128968697|NCT05643170|464171743|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
128968698|NCT05643170|464171743|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
128968699|NCT01432756|464171744|FG000|Overall Study|Lost to Follow-up|1|||
128968700|NCT01432756|464171745|FG001|Overall Study|Lost to Follow-up|0|||
128968701|NCT01432756|464171746|FG002|Overall Study|Lost to Follow-up|2|||
128968702|NCT01432756|464171747|FG003|Overall Study|Lost to Follow-up|1|||
128968703|NCT05426460|464171757|FG000|Overall Study|Protocol Violation|1|||
128968704|NCT05426460|464171758|FG001|Overall Study|Protocol Violation|1|||
128968705|NCT05426460|464171759|FG002|Overall Study|Protocol Violation|1|||
128968706|NCT05426460|464171760|FG003|Overall Study|Protocol Violation|0|||
128968707|NCT01431521|464171764|FG000|Overall Study|Withdrawal by Subject|0|||
128968708|NCT01431521|464171765|FG001|Overall Study|Withdrawal by Subject|0|||
128968709|NCT01431521|464171766|FG002|Overall Study|Withdrawal by Subject|1|||
128968710|NCT01431521|464171767|FG003|Overall Study|Withdrawal by Subject|0|||
128968711|NCT01572844|464171768|FG000|Overall Study|Physician Decision|1|||
128968712|NCT01572844|464171769|FG001|Overall Study|Physician Decision|1|||
128968713|NCT00366444|464171771|FG000|Overall Study|Withdrawal by Subject|1|||
128968714|NCT00366444|464171772|FG001|Overall Study|Withdrawal by Subject|1|||
128968715|NCT00366444|464171771|FG000|Overall Study|Lack of Efficacy|0|||
128968716|NCT00366444|464171772|FG001|Overall Study|Lack of Efficacy|1|||
128968717|NCT04667949|464171773|FG000|Overall Study|Adverse Event|0|||
128968718|NCT04667949|464171774|FG001|Overall Study|Adverse Event|2|||
128968719|NCT04667949|464171773|FG000|Overall Study|Lost to Follow-up|0|||
128968720|NCT04667949|464171774|FG001|Overall Study|Lost to Follow-up|1|||
128968721|NCT04667949|464171773|FG000|Overall Study|Physician Decision|0|||
128968722|NCT04667949|464171774|FG001|Overall Study|Physician Decision|2|||
128773747|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Physician Decision|3|||
128773748|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Physician Decision|0|||
128773749|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Not Treated|0|||
128773750|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Not Treated|0|||
128773751|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Not Treated|2|||
128773752|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Not Treated|0|||
128773753|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Not Treated|0|||
128773754|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Not Treated|0|||
128773755|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Not Treated|0|||
128773756|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Not Treated|0|||
128773757|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Not Treated|0|||
128773758|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Not Treated|0|||
128773759|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Not Treated|0|||
128773760|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Not Treated|0|||
128968723|NCT04667949|464171773|FG000|Overall Study|Subject decision|1|||
128968724|NCT04667949|464171774|FG001|Overall Study|Subject decision|7|||
128968725|NCT01320033|464171777|FG000|Overall Study|Lack of Efficacy|0|||
128968726|NCT01320033|464171778|FG001|Overall Study|Lack of Efficacy|0|||
128968727|NCT01320033|464171779|FG002|Overall Study|Lack of Efficacy|1|||
128968728|NCT01320033|464171777|FG000|Overall Study|Adverse Event|9|||
128968729|NCT01320033|464171778|FG001|Overall Study|Adverse Event|7|||
128968730|NCT01320033|464171779|FG002|Overall Study|Adverse Event|8|||
128968731|NCT01320033|464171777|FG000|Overall Study|Withdrawal by Subject|22|||
128968732|NCT01320033|464171778|FG001|Overall Study|Withdrawal by Subject|23|||
128968733|NCT01320033|464171779|FG002|Overall Study|Withdrawal by Subject|23|||
128968734|NCT01320033|464171777|FG000|Overall Study|Protocol Violation|3|||
128968735|NCT01320033|464171778|FG001|Overall Study|Protocol Violation|5|||
128968736|NCT01320033|464171779|FG002|Overall Study|Protocol Violation|3|||
128968737|NCT01320033|464171777|FG000|Overall Study|Lost to Follow-up|22|||
128968738|NCT01320033|464171778|FG001|Overall Study|Lost to Follow-up|26|||
128773761|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Not Treated|0|||
128968739|NCT01320033|464171779|FG002|Overall Study|Lost to Follow-up|17|||
128968740|NCT01320033|464171777|FG000|Overall Study|Other|2|||
128968741|NCT01320033|464171778|FG001|Overall Study|Other|3|||
128968742|NCT01320033|464171779|FG002|Overall Study|Other|1|||
128968743|NCT00963469|464171780|FG000|Overall Study|Adverse Event|15|||
128968744|NCT00963469|464171781|FG001|Overall Study|Adverse Event|11|||
128773762|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773763|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
128773764|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773765|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773766|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773767|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773768|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773769|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773770|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773771|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128968745|NCT00963469|464171782|FG002|Overall Study|Adverse Event|1|||
128968746|NCT00963469|464171780|FG000|Overall Study|Lack of Efficacy|10|||
128968747|NCT00963469|464171781|FG001|Overall Study|Lack of Efficacy|7|||
128968748|NCT00963469|464171782|FG002|Overall Study|Lack of Efficacy|2|||
128968749|NCT00963469|464171780|FG000|Overall Study|Lost to Follow-up|1|||
128968750|NCT00963469|464171781|FG001|Overall Study|Lost to Follow-up|1|||
128968751|NCT00963469|464171782|FG002|Overall Study|Lost to Follow-up|0|||
128968752|NCT00963469|464171780|FG000|Overall Study|Protocol Violation|5|||
128968753|NCT00963469|464171781|FG001|Overall Study|Protocol Violation|5|||
128968754|NCT00963469|464171782|FG002|Overall Study|Protocol Violation|3|||
128773772|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773773|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773774|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
128773775|NCT02291289|463464033|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
128773776|NCT02291289|463464034|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
128773777|NCT02291289|463464035|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
128773778|NCT02291289|463464036|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
128773779|NCT02291289|463464037|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
128773780|NCT02291289|463464038|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
128773781|NCT02291289|463464039|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
128773782|NCT02291289|463464040|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
128773783|NCT02291289|463464041|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
128773784|NCT02291289|463464042|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
128773785|NCT02291289|463464043|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
128773786|NCT02291289|463464044|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
128773787|NCT02291289|463464045|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
128773788|NCT02291289|463464033|FG000|Early Disease Progression|Death|0|||
128773789|NCT02291289|463464034|FG001|Early Disease Progression|Death|0|||
128773790|NCT02291289|463464035|FG002|Early Disease Progression|Death|0|||
128773791|NCT02291289|463464036|FG003|Early Disease Progression|Death|0|||
128773792|NCT02291289|463464037|FG004|Early Disease Progression|Death|0|||
128773793|NCT02291289|463464038|FG005|Early Disease Progression|Death|0|||
128773794|NCT02291289|463464039|FG006|Early Disease Progression|Death|0|||
128773795|NCT02291289|463464040|FG007|Early Disease Progression|Death|0|||
128773796|NCT02291289|463464041|FG008|Early Disease Progression|Death|0|||
128773797|NCT02291289|463464042|FG009|Early Disease Progression|Death|0|||
128773798|NCT02291289|463464043|FG010|Early Disease Progression|Death|0|||
128773799|NCT02291289|463464044|FG011|Early Disease Progression|Death|0|||
128773800|NCT02291289|463464045|FG012|Early Disease Progression|Death|10|||
128773801|NCT02291289|463464033|FG000|Early Disease Progression|Lost to Follow-up|0|||
128773802|NCT02291289|463464034|FG001|Early Disease Progression|Lost to Follow-up|0|||
128773803|NCT02291289|463464035|FG002|Early Disease Progression|Lost to Follow-up|0|||
128773804|NCT02291289|463464036|FG003|Early Disease Progression|Lost to Follow-up|0|||
128773805|NCT02291289|463464037|FG004|Early Disease Progression|Lost to Follow-up|0|||
128773806|NCT02291289|463464038|FG005|Early Disease Progression|Lost to Follow-up|0|||
128773807|NCT02291289|463464039|FG006|Early Disease Progression|Lost to Follow-up|0|||
128773808|NCT02291289|463464040|FG007|Early Disease Progression|Lost to Follow-up|0|||
128773809|NCT02291289|463464041|FG008|Early Disease Progression|Lost to Follow-up|0|||
128773810|NCT02291289|463464042|FG009|Early Disease Progression|Lost to Follow-up|0|||
128773811|NCT02291289|463464043|FG010|Early Disease Progression|Lost to Follow-up|0|||
128773812|NCT02291289|463464044|FG011|Early Disease Progression|Lost to Follow-up|0|||
128773813|NCT02291289|463464045|FG012|Early Disease Progression|Lost to Follow-up|1|||
128773814|NCT01642186|463464048|FG000|Overall Study|Death|0|||
128773815|NCT01642186|463464049|FG001|Overall Study|Death|2|||
128968755|NCT00963469|464171780|FG000|Overall Study|Withdrawal by Subject|4|||
128968756|NCT00963469|464171781|FG001|Overall Study|Withdrawal by Subject|1|||
128773816|NCT01642186|463464050|FG002|Overall Study|Death|2|||
128773817|NCT01642186|463464048|FG000|Overall Study|Lost to Follow-up|0|||
128773818|NCT01642186|463464049|FG001|Overall Study|Lost to Follow-up|0|||
128773819|NCT01642186|463464050|FG002|Overall Study|Lost to Follow-up|1|||
128968757|NCT00963469|464171782|FG002|Overall Study|Withdrawal by Subject|1|||
128968758|NCT00963469|464171780|FG000|Overall Study|Pre-randomization Adverse Event|1|||
128968759|NCT00963469|464171781|FG001|Overall Study|Pre-randomization Adverse Event|2|||
129038021|NCT00003531|464430565|FG000|Overall Study|Not evaluable|10|||
128968760|NCT00963469|464171782|FG002|Overall Study|Pre-randomization Adverse Event|0|||
128968761|NCT00963469|464171780|FG000|Overall Study|Moved|1|||
128968762|NCT00963469|464171781|FG001|Overall Study|Moved|0|||
128968763|NCT00963469|464171782|FG002|Overall Study|Moved|0|||
128968764|NCT00963469|464171780|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
128968765|NCT00963469|464171781|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
128968766|NCT00963469|464171782|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
128968767|NCT04960202|464171801|FG000|Overall Study|Other|5|||
128968768|NCT04960202|464171802|FG001|Overall Study|Other|0|||
128968769|NCT04960202|464171801|FG000|Overall Study|Withdrawal by Subject|37|||
128968770|NCT04960202|464171802|FG001|Overall Study|Withdrawal by Subject|43|||
128968771|NCT04960202|464171801|FG000|Overall Study|Lost to Follow-up|20|||
128968772|NCT04960202|464171802|FG001|Overall Study|Lost to Follow-up|16|||
128968773|NCT04960202|464171801|FG000|Overall Study|Death|0|||
128968774|NCT04960202|464171802|FG001|Overall Study|Death|15|||
128968775|NCT03558828|464171806|FG000|Overall Study|Lost to Follow-up|4|||
128968776|NCT03558828|464171807|FG001|Overall Study|Lost to Follow-up|3|||
128968777|NCT03558828|464171808|FG002|Overall Study|Lost to Follow-up|3|||
128773820|NCT00506285|463464057|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
128968778|NCT03558828|464171809|FG003|Overall Study|Lost to Follow-up|5|||
128968779|NCT03558828|464171810|FG004|Overall Study|Lost to Follow-up|2|||
128968780|NCT03558828|464171811|FG005|Overall Study|Lost to Follow-up|3|||
128968781|NCT03558828|464171806|FG000|Overall Study|dropped before the intervention|1|||
128968782|NCT03558828|464171807|FG001|Overall Study|dropped before the intervention|1|||
128968783|NCT03558828|464171808|FG002|Overall Study|dropped before the intervention|0|||
128773821|NCT00506285|463464058|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
128773822|NCT00506285|463464057|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
128773823|NCT00506285|463464058|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
128968784|NCT03558828|464171809|FG003|Overall Study|dropped before the intervention|0|||
128968785|NCT03558828|464171810|FG004|Overall Study|dropped before the intervention|0|||
128968786|NCT03558828|464171811|FG005|Overall Study|dropped before the intervention|0|||
128968787|NCT00378534|464171812|FG000|Overall Study|Participants did not receive transplant|3|||
128968788|NCT00378534|464171813|FG001|Overall Study|Participants did not receive transplant|0|||
128968789|NCT03671148|464171819|FG000|Overall Study|Adverse Event|3|||
128968790|NCT03671148|464171820|FG001|Overall Study|Adverse Event|2|||
128968791|NCT03671148|464171819|FG000|Overall Study|Withdrawal by Subject|8|||
128968792|NCT03671148|464171820|FG001|Overall Study|Withdrawal by Subject|2|||
128968793|NCT03671148|464171819|FG000|Overall Study|Lost to Follow-up|1|||
128968794|NCT03671148|464171820|FG001|Overall Study|Lost to Follow-up|2|||
128968795|NCT03671148|464171819|FG000|Overall Study|Lack of Efficacy|7|||
128968796|NCT03671148|464171820|FG001|Overall Study|Lack of Efficacy|2|||
128968797|NCT03671148|464171819|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
128968798|NCT03671148|464171820|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
128968799|NCT03671148|464171819|FG000|Overall Study|Other|1|||
128968800|NCT03671148|464171820|FG001|Overall Study|Other|0|||
128968801|NCT03671148|464171819|FG000|Overall Study|Incomplete Randomization Visit|1|||
128968802|NCT03671148|464171820|FG001|Overall Study|Incomplete Randomization Visit|0|||
128968803|NCT00673816|464171823|FG000|Overall Study|Adverse Event|1|||
128968804|NCT00673816|464171823|FG000|Overall Study|Withdrawal by Subject|1|||
128968805|NCT02234050|464171825|FG000|Overall Study|Lack of Efficacy|38|||
128968806|NCT02234050|464171826|FG001|Overall Study|Lack of Efficacy|22|||
128968807|NCT02234050|464171825|FG000|Overall Study|Adverse Event|13|||
128968808|NCT02234050|464171826|FG001|Overall Study|Adverse Event|1|||
128968809|NCT02234050|464171825|FG000|Overall Study|Withdrawal by Subject|4|||
128968810|NCT02234050|464171826|FG001|Overall Study|Withdrawal by Subject|2|||
128773824|NCT00506285|463464057|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
128773825|NCT00506285|463464058|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
128773826|NCT00506285|463464057|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
128773827|NCT00506285|463464058|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
128968811|NCT02234050|464171825|FG000|Overall Study|Sponsor's decision|6|||
128968812|NCT02234050|464171826|FG001|Overall Study|Sponsor's decision|0|||
128968813|NCT02365506|464171828|FG000|Overall Study|Investigator's Discretion|0|||
128968814|NCT02365506|464171829|FG001|Overall Study|Investigator's Discretion|0|||
128968815|NCT02365506|464171830|FG002|Overall Study|Investigator's Discretion|1|||
128968816|NCT01852591|464171831|FG000|Overall Study|Withdrawal by Subject|2|||
128968817|NCT01852591|464171831|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
128968818|NCT03774875|464171832|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
128968819|NCT03774875|464171833|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
128968820|NCT03774875|464171832|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
128968821|NCT03774875|464171833|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
128968822|NCT03774875|464171832|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
128968823|NCT03774875|464171833|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
128968824|NCT03774875|464171832|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
128968825|NCT03774875|464171833|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
128968826|NCT03774875|464171832|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
128968827|NCT03774875|464171833|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
128968828|NCT03774875|464171832|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
128968829|NCT03774875|464171833|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
128968830|NCT03774875|464171832|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
128968831|NCT03774875|464171833|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
128968832|NCT03774875|464171832|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
128968833|NCT03774875|464171833|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
128968834|NCT03774875|464171832|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
128968835|NCT03774875|464171833|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
128968836|NCT03774875|464171832|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
128968837|NCT03774875|464171833|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
128968838|NCT03774875|464171832|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
128968839|NCT03774875|464171833|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
128968840|NCT03774875|464171832|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
128968841|NCT03774875|464171833|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
128968842|NCT03774875|464171832|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
128968843|NCT03774875|464171833|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
128968844|NCT03149029|464171834|FG000|Overall Study|Adverse Event|2|||
128968845|NCT03149029|464171835|FG001|Overall Study|Adverse Event|0|||
128968846|NCT04088331|464171837|FG000|Overall Study|Lost to Follow-up|3|||
128968847|NCT04088331|464171837|FG000|Overall Study|Withdrawal by Subject|7|||
128968848|NCT04088331|464171837|FG000|Overall Study|Adverse Event|4|||
128968849|NCT03233308|464171842|FG000|Overall Study|Adverse Event|1|||
128968850|NCT03233308|464171842|FG000|Overall Study|Protocol Violation|1|||
128968851|NCT00976963|464171849|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
128968852|NCT00976963|464171850|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
128968853|NCT00976963|464171849|FG000|Overall Study|administrative error|1|||
128968854|NCT00976963|464171850|FG001|Overall Study|administrative error|0|||
128968855|NCT00976963|464171849|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
128968856|NCT00976963|464171850|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
128968857|NCT02756845|464171853|FG000|Overall Study|Death|12|||
128968858|NCT02756845|464171854|FG001|Overall Study|Death|2|||
128968859|NCT02756845|464171853|FG000|Overall Study|Withdrawal by Subject|1|||
128968860|NCT02756845|464171854|FG001|Overall Study|Withdrawal by Subject|0|||
128968861|NCT01688999|464171857|FG000|Overall Study|Withdrawal by Subject|5|||
128968862|NCT01688999|464171858|FG001|Overall Study|Withdrawal by Subject|1|||
128968863|NCT01688999|464171859|FG002|Overall Study|Withdrawal by Subject|1|||
128968864|NCT01688999|464171857|FG000|Overall Study|Adverse Event|2|||
128968865|NCT01688999|464171858|FG001|Overall Study|Adverse Event|0|||
128968866|NCT01688999|464171859|FG002|Overall Study|Adverse Event|2|||
128968867|NCT01688999|464171857|FG000|Overall Study|Ineligible/Not treated|1|||
128968868|NCT01688999|464171858|FG001|Overall Study|Ineligible/Not treated|0|||
128968869|NCT01688999|464171859|FG002|Overall Study|Ineligible/Not treated|0|||
128968870|NCT02768103|464171860|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
128968871|NCT03369704|464171879|FG000|Treatment Epoch|technical problems|1|||
128968872|NCT03369704|464171880|FG001|Treatment Epoch|technical problems|0|||
128968873|NCT03369704|464171879|FG000|Treatment Epoch|Protocol Violation|1|||
128968874|NCT03369704|464171880|FG001|Treatment Epoch|Protocol Violation|0|||
128968875|NCT03369704|464171879|FG000|Treatment Epoch|Lost to Follow-up|0|||
128968876|NCT03369704|464171880|FG001|Treatment Epoch|Lost to Follow-up|1|||
128968877|NCT03369704|464171879|FG000|Treatment Epoch|Lack of Efficacy|0|||
128968878|NCT03369704|464171880|FG001|Treatment Epoch|Lack of Efficacy|2|||
128968879|NCT03369704|464171879|FG000|Treatment Epoch|Adverse Event|2|||
128968880|NCT03369704|464171880|FG001|Treatment Epoch|Adverse Event|0|||
128968881|NCT03369704|464171879|FG000|Follow-up Epoch|Lost to Follow-up|1|||
128968882|NCT03369704|464171880|FG001|Follow-up Epoch|Lost to Follow-up|0|||
128968883|NCT02348840|464171884|FG000|Overall Study|Withdrawal by Subject|2|||
128968884|NCT02348840|464171885|FG001|Overall Study|Withdrawal by Subject|1|||
128968885|NCT02348840|464171886|FG002|Overall Study|Withdrawal by Subject|0|||
128968886|NCT02348840|464171887|FG003|Overall Study|Withdrawal by Subject|0|||
128714600|NCT00903617|463252259|FG001|Overall Study|Adverse Event|1|||
128968887|NCT02148952|464171888|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
128968888|NCT02148952|464171889|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
128968889|NCT02148952|464171888|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
128968890|NCT02148952|464171889|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
128968891|NCT02148952|464171888|FG000|Follow-Up|Lost to Follow-up|219|||
128968892|NCT02148952|464171889|FG001|Follow-Up|Lost to Follow-up|231|||
128968893|NCT02148952|464171888|FG000|Follow-Up|Withdrawal by Subject|46|||
128968894|NCT02148952|464171889|FG001|Follow-Up|Withdrawal by Subject|48|||
128968895|NCT01025232|464171890|FG000|Overall Study|Study drug no longer available|3|||
128968896|NCT01025232|464171891|FG001|Overall Study|Study drug no longer available|6|||
128968897|NCT01263444|464171892|FG000|Overall Study|Adverse Event|8|||
128968898|NCT01263444|464171892|FG000|Overall Study|Withdrawal by Subject|1|||
128968899|NCT01263444|464171892|FG000|Overall Study|Protocol Violation|1|||
128968900|NCT00085644|464171893|FG000|Double-Blind Period|Adverse Event|5|||
128968901|NCT00085644|464171894|FG001|Double-Blind Period|Adverse Event|2|||
128968902|NCT00085644|464171895|FG002|Double-Blind Period|Adverse Event|0|||
128968903|NCT00085644|464171893|FG000|Double-Blind Period|Withdrawal by Subject|3|||
128968904|NCT00085644|464171894|FG001|Double-Blind Period|Withdrawal by Subject|0|||
128968905|NCT00085644|464171895|FG002|Double-Blind Period|Withdrawal by Subject|0|||
128968906|NCT00085644|464171893|FG000|Double-Blind Period|Lost to Follow-up|2|||
128968907|NCT00085644|464171894|FG001|Double-Blind Period|Lost to Follow-up|1|||
128968908|NCT00085644|464171895|FG002|Double-Blind Period|Lost to Follow-up|0|||
128968909|NCT00085644|464171893|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
128968910|NCT00085644|464171894|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
128968911|NCT00085644|464171895|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
128968912|NCT00085644|464171893|FG000|Double-Blind Period|Contemplating pregnancy|1|||
128968913|NCT00085644|464171894|FG001|Double-Blind Period|Contemplating pregnancy|0|||
128968914|NCT00085644|464171895|FG002|Double-Blind Period|Contemplating pregnancy|0|||
128968915|NCT00085644|464171893|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
128968916|NCT00085644|464171894|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
128968917|NCT00085644|464171895|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
128968918|NCT00085644|464171893|FG000|Open-Label Period|Adverse Event|0|||
128968919|NCT00085644|464171894|FG001|Open-Label Period|Adverse Event|0|||
128968920|NCT00085644|464171895|FG002|Open-Label Period|Adverse Event|38|||
128968921|NCT00085644|464171893|FG000|Open-Label Period|Withdrawal by Subject|0|||
128968922|NCT00085644|464171894|FG001|Open-Label Period|Withdrawal by Subject|0|||
128968923|NCT00085644|464171895|FG002|Open-Label Period|Withdrawal by Subject|29|||
129220418|NCT01273519|465106594|FG001|Overall Study|Lack of Efficacy|3|||
128968924|NCT00085644|464171893|FG000|Open-Label Period|Lost to Follow-up|0|||
128968925|NCT00085644|464171894|FG001|Open-Label Period|Lost to Follow-up|0|||
128968926|NCT00085644|464171895|FG002|Open-Label Period|Lost to Follow-up|13|||
128968927|NCT00085644|464171893|FG000|Open-Label Period|Lack of Efficacy|0|||
128968928|NCT00085644|464171894|FG001|Open-Label Period|Lack of Efficacy|0|||
128968929|NCT00085644|464171895|FG002|Open-Label Period|Lack of Efficacy|15|||
129220419|NCT01273519|465106595|FG002|Overall Study|Lack of Efficacy|4|||
128968930|NCT00085644|464171893|FG000|Open-Label Period|Pregnancy|0|||
128714601|NCT00903617|463252260|FG002|Overall Study|Adverse Event|1|||
128714602|NCT00903617|463252261|FG003|Overall Study|Adverse Event|0|||
128714603|NCT00903617|463252258|FG000|Overall Study|Protocol-defined stopping criteria|0|||
128714604|NCT00903617|463252259|FG001|Overall Study|Protocol-defined stopping criteria|2|||
128714605|NCT00903617|463252260|FG002|Overall Study|Protocol-defined stopping criteria|0|||
128714606|NCT00903617|463252261|FG003|Overall Study|Protocol-defined stopping criteria|0|||
128714607|NCT00903617|463252258|FG000|Overall Study|Lost to Follow-up|2|||
128714608|NCT00903617|463252259|FG001|Overall Study|Lost to Follow-up|0|||
128714609|NCT00903617|463252260|FG002|Overall Study|Lost to Follow-up|1|||
128714610|NCT00903617|463252261|FG003|Overall Study|Lost to Follow-up|1|||
128714611|NCT00903617|463252258|FG000|Overall Study|Withdrawal by Subject|1|||
128714612|NCT00903617|463252259|FG001|Overall Study|Withdrawal by Subject|2|||
128714613|NCT00903617|463252260|FG002|Overall Study|Withdrawal by Subject|3|||
128714614|NCT00903617|463252261|FG003|Overall Study|Withdrawal by Subject|0|||
128714615|NCT02355691|463252266|FG000|Overall Study|Loss of Research Personnel|7|||
128714616|NCT02355691|463252267|FG001|Overall Study|Loss of Research Personnel|9|||
128714617|NCT02345811|463252270|FG000|First Intervention|Withdrawal by Subject|1|||
128714618|NCT02345811|463252271|FG001|First Intervention|Withdrawal by Subject|1|||
128714619|NCT00462761|463252272|FG000|Overall Study|Adverse Event|6|||
128714620|NCT00462761|463252272|FG000|Overall Study|Withdrawal by Subject|9|||
128714621|NCT00462761|463252272|FG000|Overall Study|Physician Decision|5|||
128714622|NCT00462761|463252272|FG000|Overall Study|Disease progression|43|||
128714623|NCT00462761|463252272|FG000|Overall Study|Death|12|||
128714624|NCT00462761|463252272|FG000|Overall Study|Other|1|||
128714625|NCT02522286|463252273|FG000|Overall Study|Withdrawal by Subject|3|||
128714626|NCT02522286|463252274|FG001|Overall Study|Withdrawal by Subject|0|||
128714627|NCT02522286|463252275|FG002|Overall Study|Withdrawal by Subject|0|||
128714628|NCT02522286|463252276|FG003|Overall Study|Withdrawal by Subject|3|||
128714629|NCT02877082|463252277|FG000|Overall Study|Trial was closed early|5|||
128714630|NCT03480750|463252278|FG000|Overall Study|Withdrawal by Subject|0|||
128968931|NCT00085644|464171894|FG001|Open-Label Period|Pregnancy|0|||
128968932|NCT00085644|464171895|FG002|Open-Label Period|Pregnancy|3|||
128968933|NCT00085644|464171893|FG000|Open-Label Period|Contemplating pregnancy|0|||
128714631|NCT03480750|463252279|FG001|Overall Study|Withdrawal by Subject|1|||
128714632|NCT03480750|463252280|FG002|Overall Study|Withdrawal by Subject|0|||
128714633|NCT03480750|463252281|FG003|Overall Study|Withdrawal by Subject|0|||
128714634|NCT03480750|463252282|FG004|Overall Study|Withdrawal by Subject|0|||
128968934|NCT00085644|464171894|FG001|Open-Label Period|Contemplating pregnancy|0|||
129220420|NCT01273519|465106593|FG000|Overall Study|Other|6|||
128968935|NCT00085644|464171895|FG002|Open-Label Period|Contemplating pregnancy|3|||
128968936|NCT00085644|464171893|FG000|Open-Label Period|Protocol Violation|0|||
128968937|NCT00085644|464171894|FG001|Open-Label Period|Protocol Violation|0|||
128968938|NCT00085644|464171895|FG002|Open-Label Period|Protocol Violation|4|||
128968939|NCT00085644|464171893|FG000|Open-Label Period|Personal reason|0|||
128968940|NCT00085644|464171894|FG001|Open-Label Period|Personal reason|0|||
128968941|NCT00085644|464171895|FG002|Open-Label Period|Personal reason|4|||
128968942|NCT03330106|464171896|FG000|Part A|Withdrawal by Subject|1|||
128968943|NCT03330106|464171897|FG001|Part A|Withdrawal by Subject|1|||
128968944|NCT03330106|464171898|FG002|Part A|Withdrawal by Subject|0|||
128968945|NCT03330106|464171899|FG003|Part A|Withdrawal by Subject|0|||
128968946|NCT03330106|464171896|FG000|Part A|Death|2|||
128968947|NCT03330106|464171897|FG001|Part A|Death|1|||
128968948|NCT03330106|464171898|FG002|Part A|Death|0|||
128968949|NCT03330106|464171899|FG003|Part A|Death|0|||
128968950|NCT03330106|464171896|FG000|Part A|Adverse Event|0|||
128968951|NCT03330106|464171897|FG001|Part A|Adverse Event|1|||
128714635|NCT03480750|463252283|FG005|Overall Study|Withdrawal by Subject|0|||
128714636|NCT03480750|463252278|FG000|Overall Study|The interruption in Trientine shippment|0|||
128714637|NCT03480750|463252279|FG001|Overall Study|The interruption in Trientine shippment|0|||
128714638|NCT03480750|463252280|FG002|Overall Study|The interruption in Trientine shippment|0|||
128714639|NCT03480750|463252281|FG003|Overall Study|The interruption in Trientine shippment|0|||
128714640|NCT03480750|463252282|FG004|Overall Study|The interruption in Trientine shippment|0|||
128714641|NCT03480750|463252283|FG005|Overall Study|The interruption in Trientine shippment|1|||
128714642|NCT00605813|463252284|FG000|Overall Study|Protocol Violation|25|||
128714643|NCT01132482|463252285|FG000|Overall Study|Adverse Event|1|||
128714644|NCT01132482|463252286|FG001|Overall Study|Adverse Event|0|||
128714645|NCT00573755|463252291|FG000|Overall Study|Still receiving treatment|1|||
128714646|NCT00573755|463252292|FG001|Overall Study|Still receiving treatment|0|||
128714647|NCT00546637|463252295|FG000|Overall Study|Adverse Event|46|||
128714648|NCT00546637|463252296|FG001|Overall Study|Adverse Event|20|||
128714649|NCT00546637|463252295|FG000|Overall Study|Lack of Efficacy|5|||
128714650|NCT00546637|463252296|FG001|Overall Study|Lack of Efficacy|5|||
128714651|NCT00546637|463252295|FG000|Overall Study|Lost to Follow-up|2|||
128714652|NCT00546637|463252296|FG001|Overall Study|Lost to Follow-up|2|||
128714653|NCT00546637|463252295|FG000|Overall Study|Other|10|||
128714654|NCT00546637|463252296|FG001|Overall Study|Other|12|||
128714655|NCT00546637|463252295|FG000|Overall Study|Withdrawal by Subject|7|||
128714656|NCT00546637|463252296|FG001|Overall Study|Withdrawal by Subject|9|||
128714657|NCT00546637|463252295|FG000|Overall Study|Randomized, but not treated|3|||
128714658|NCT00546637|463252296|FG001|Overall Study|Randomized, but not treated|1|||
128714659|NCT03274440|463252297|FG000|Overall Study|Time commitment too great|1|||
128714660|NCT03274440|463252298|FG001|Overall Study|Time commitment too great|0|||
128714661|NCT03274440|463252299|FG002|Overall Study|Time commitment too great|0|||
128714662|NCT03274440|463252300|FG003|Overall Study|Time commitment too great|1|||
128714663|NCT03274440|463252301|FG004|Overall Study|Time commitment too great|0|||
128714664|NCT03274440|463252302|FG005|Overall Study|Time commitment too great|0|||
128714665|NCT01074450|463252303|FG000|First Intervention|Emesis in Dosing Interval|0|||
128714666|NCT01074450|463252304|FG001|First Intervention|Emesis in Dosing Interval|2|||
128714667|NCT01074450|463252303|FG000|Second Intervention|Protocol Violation|1|||
128714668|NCT01074450|463252304|FG001|Second Intervention|Protocol Violation|0|||
128714669|NCT01074450|463252303|FG000|Second Intervention|Physician Decision|0|||
128714670|NCT01074450|463252304|FG001|Second Intervention|Physician Decision|1|||
128714671|NCT00450450|463252305|FG000|Overall Study|Death|1|||
128714672|NCT00450450|463252306|FG001|Overall Study|Death|3|||
128714673|NCT00450450|463252305|FG000|Overall Study|Relapse|2|||
128714674|NCT00450450|463252306|FG001|Overall Study|Relapse|0|||
128714675|NCT00450450|463252305|FG000|Overall Study|Missing Data|2|||
128714676|NCT00450450|463252306|FG001|Overall Study|Missing Data|0|||
128714677|NCT04984993|463252307|FG000|Overall Study|Withdrawal by Subject|8|||
128714678|NCT04984993|463252308|FG001|Overall Study|Withdrawal by Subject|2|||
128714679|NCT04984993|463252307|FG000|Overall Study|Lost to Follow-up|2|||
128714680|NCT04984993|463252308|FG001|Overall Study|Lost to Follow-up|2|||
128714681|NCT04984993|463252307|FG000|Overall Study|Both patients moved to another country|4|||
128714682|NCT04984993|463252308|FG001|Overall Study|Both patients moved to another country|0|||
128714683|NCT02865187|463252311|FG000|Overall Study|Lost to Follow-up|12|||
128714684|NCT02865187|463252312|FG001|Overall Study|Lost to Follow-up|7|||
128714685|NCT02865187|463252311|FG000|Overall Study|Adverse Event|1|||
128714686|NCT02865187|463252312|FG001|Overall Study|Adverse Event|0|||
128714687|NCT01110707|463252313|FG000|Overall Study|Protocol Violation|0|||
128714688|NCT01110707|463252314|FG001|Overall Study|Protocol Violation|3|||
128714689|NCT02968563|463252319|FG000|Overall Study|Adverse Event|0|||
128714690|NCT02968563|463252320|FG001|Overall Study|Adverse Event|6|||
128968952|NCT03330106|464171898|FG002|Part A|Adverse Event|0|||
128968953|NCT03330106|464171899|FG003|Part A|Adverse Event|0|||
128968954|NCT03330106|464171896|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
128978132|NCT00939094|464205320|FG000|Overall Study|Study stopped by sponsor|0|||
128978133|NCT00939094|464205321|FG001|Overall Study|Study stopped by sponsor|2|||
128968955|NCT03330106|464171897|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
128968956|NCT03330106|464171898|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
128968957|NCT03330106|464171899|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
128968958|NCT03330106|464171896|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
128968959|NCT03330106|464171897|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
128968960|NCT03330106|464171898|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
128968961|NCT03330106|464171899|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
128968962|NCT03330106|464171896|FG000|Part A|Progressive Disease|0|||
128968963|NCT03330106|464171897|FG001|Part A|Progressive Disease|1|||
128968964|NCT03330106|464171898|FG002|Part A|Progressive Disease|0|||
128968965|NCT03330106|464171899|FG003|Part A|Progressive Disease|0|||
128968966|NCT03330106|464171896|FG000|Part B|Lost to Follow-up|0|||
128968967|NCT03330106|464171897|FG001|Part B|Lost to Follow-up|0|||
128968968|NCT03330106|464171898|FG002|Part B|Lost to Follow-up|0|||
128968969|NCT03330106|464171899|FG003|Part B|Lost to Follow-up|1|||
128968970|NCT03330106|464171896|FG000|Part B|Withdrawal by Subject|0|||
128968971|NCT03330106|464171897|FG001|Part B|Withdrawal by Subject|0|||
128968972|NCT03330106|464171898|FG002|Part B|Withdrawal by Subject|4|||
128968973|NCT03330106|464171899|FG003|Part B|Withdrawal by Subject|0|||
128968974|NCT03330106|464171896|FG000|Part B|Death|0|||
128968975|NCT03330106|464171897|FG001|Part B|Death|0|||
128968976|NCT03330106|464171898|FG002|Part B|Death|2|||
128968977|NCT03330106|464171899|FG003|Part B|Death|0|||
128968978|NCT03330106|464171896|FG000|Part B|Clinical Progression|0|||
128968979|NCT03330106|464171897|FG001|Part B|Clinical Progression|0|||
128968980|NCT03330106|464171898|FG002|Part B|Clinical Progression|1|||
128968981|NCT03330106|464171899|FG003|Part B|Clinical Progression|1|||
128773828|NCT00506285|463464057|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
128773829|NCT00506285|463464058|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
128773830|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
128773831|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
128773832|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
128773833|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
128773834|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
128773835|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
128773836|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
128968982|NCT03330106|464171896|FG000|Part B|Symptomatic Deterioration|0|||
128968983|NCT03330106|464171897|FG001|Part B|Symptomatic Deterioration|0|||
128968984|NCT03330106|464171898|FG002|Part B|Symptomatic Deterioration|0|||
128968985|NCT03330106|464171899|FG003|Part B|Symptomatic Deterioration|1|||
128968986|NCT03330106|464171896|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
128968987|NCT03330106|464171897|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
128968988|NCT03330106|464171898|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
128968989|NCT03330106|464171899|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
128968990|NCT03330106|464171896|FG000|Part B|Progressive Disease|0|||
128968991|NCT03330106|464171897|FG001|Part B|Progressive Disease|0|||
128968992|NCT03330106|464171898|FG002|Part B|Progressive Disease|11|||
128968993|NCT03330106|464171899|FG003|Part B|Progressive Disease|4|||
128968994|NCT02324049|464171901|FG000|Part C|Study terminated|11|||
128968995|NCT00423592|464171903|FG000|Overall Study|Adverse Event (through Week 12)|2|||
128968996|NCT00423592|464171903|FG000|Overall Study|Adverse Event (post Week 12)|5|||
128968997|NCT00333970|464171906|FG000|Overall Study|Withdrawal by Subject|13|||
128968998|NCT00333970|464171907|FG001|Overall Study|Withdrawal by Subject|7|||
128968999|NCT00608842|464171908|FG000|Overall Study|Participant's Request|0|||
128969000|NCT00608842|464171909|FG001|Overall Study|Participant's Request|1|||
128969001|NCT00608842|464171910|FG002|Overall Study|Participant's Request|2|||
128969002|NCT00608842|464171911|FG003|Overall Study|Participant's Request|1|||
128969003|NCT00608842|464171908|FG000|Overall Study|Lost to Follow-up|1|||
128969004|NCT00608842|464171909|FG001|Overall Study|Lost to Follow-up|0|||
128969005|NCT00608842|464171910|FG002|Overall Study|Lost to Follow-up|0|||
128969006|NCT00608842|464171911|FG003|Overall Study|Lost to Follow-up|0|||
128969007|NCT02358863|464173858|FG000|Overall Study|Physician Decision|3|||
129220421|NCT01273519|465106594|FG001|Overall Study|Other|1|||
128969008|NCT02531633|464173861|FG000|Part A (52 Weeks)|Sponsor request|24|||
128969009|NCT02531633|464173862|FG001|Part A (52 Weeks)|Sponsor request|24|||
129220422|NCT01273519|465106595|FG002|Overall Study|Other|1|||
128969010|NCT02531633|464173863|FG002|Part A (52 Weeks)|Sponsor request|18|||
128773837|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
128773838|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
128969011|NCT02531633|464173864|FG003|Part A (52 Weeks)|Sponsor request|18|||
128969012|NCT02531633|464173865|FG004|Part A (52 Weeks)|Sponsor request|19|||
128969013|NCT02531633|464173866|FG005|Part A (52 Weeks)|Sponsor request|0|||
128969014|NCT02531633|464173867|FG006|Part A (52 Weeks)|Sponsor request|0|||
128969015|NCT02531633|464173868|FG007|Part A (52 Weeks)|Sponsor request|0|||
128969016|NCT02531633|464173869|FG008|Part A (52 Weeks)|Sponsor request|0|||
128969017|NCT02531633|464173870|FG009|Part A (52 Weeks)|Sponsor request|0|||
128969018|NCT02531633|464173861|FG000|Part A (52 Weeks)|Protocol Violation|1|||
128969019|NCT02531633|464173862|FG001|Part A (52 Weeks)|Protocol Violation|0|||
128969020|NCT02531633|464173863|FG002|Part A (52 Weeks)|Protocol Violation|0|||
128969021|NCT02531633|464173864|FG003|Part A (52 Weeks)|Protocol Violation|0|||
128969022|NCT02531633|464173865|FG004|Part A (52 Weeks)|Protocol Violation|0|||
128969023|NCT02531633|464173866|FG005|Part A (52 Weeks)|Protocol Violation|0|||
128969024|NCT02531633|464173867|FG006|Part A (52 Weeks)|Protocol Violation|0|||
128969025|NCT02531633|464173868|FG007|Part A (52 Weeks)|Protocol Violation|0|||
128969026|NCT02531633|464173869|FG008|Part A (52 Weeks)|Protocol Violation|0|||
128969027|NCT02531633|464173870|FG009|Part A (52 Weeks)|Protocol Violation|0|||
128969028|NCT02531633|464173861|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
128969029|NCT02531633|464173862|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
128969030|NCT02531633|464173863|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
128969031|NCT02531633|464173864|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
128969032|NCT02531633|464173865|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
128969033|NCT02531633|464173866|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
128969034|NCT02531633|464173867|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
128969035|NCT02531633|464173868|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
128969036|NCT02531633|464173869|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
128969037|NCT02531633|464173870|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
128969038|NCT02531633|464173861|FG000|Part A (52 Weeks)|Physician Decision|1|||
128969039|NCT02531633|464173862|FG001|Part A (52 Weeks)|Physician Decision|4|||
128969040|NCT02531633|464173863|FG002|Part A (52 Weeks)|Physician Decision|3|||
128969041|NCT02531633|464173864|FG003|Part A (52 Weeks)|Physician Decision|1|||
128969042|NCT02531633|464173865|FG004|Part A (52 Weeks)|Physician Decision|0|||
128969043|NCT02531633|464173866|FG005|Part A (52 Weeks)|Physician Decision|0|||
128969044|NCT02531633|464173867|FG006|Part A (52 Weeks)|Physician Decision|0|||
128969045|NCT02531633|464173868|FG007|Part A (52 Weeks)|Physician Decision|0|||
128969046|NCT02531633|464173869|FG008|Part A (52 Weeks)|Physician Decision|0|||
128969047|NCT02531633|464173870|FG009|Part A (52 Weeks)|Physician Decision|0|||
128969048|NCT02531633|464173861|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
128969049|NCT02531633|464173862|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
128969050|NCT02531633|464173863|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
128969051|NCT02531633|464173864|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
128969052|NCT02531633|464173865|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
128969053|NCT02531633|464173866|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
128969054|NCT02531633|464173867|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
128969055|NCT02531633|464173868|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
128969056|NCT02531633|464173869|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
128969057|NCT02531633|464173870|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
128969058|NCT02531633|464173861|FG000|Part A (52 Weeks)|Other|2|||
128969059|NCT02531633|464173862|FG001|Part A (52 Weeks)|Other|0|||
128969060|NCT02531633|464173863|FG002|Part A (52 Weeks)|Other|0|||
128969061|NCT02531633|464173864|FG003|Part A (52 Weeks)|Other|0|||
128969062|NCT02531633|464173865|FG004|Part A (52 Weeks)|Other|0|||
128969063|NCT02531633|464173866|FG005|Part A (52 Weeks)|Other|0|||
128969064|NCT02531633|464173867|FG006|Part A (52 Weeks)|Other|0|||
128969065|NCT02531633|464173868|FG007|Part A (52 Weeks)|Other|0|||
128969066|NCT02531633|464173869|FG008|Part A (52 Weeks)|Other|0|||
128969067|NCT02531633|464173870|FG009|Part A (52 Weeks)|Other|0|||
128969068|NCT02531633|464173861|FG000|Part B (104 Weeks)|Sponsor request|0|||
128969069|NCT02531633|464173862|FG001|Part B (104 Weeks)|Sponsor request|0|||
128969070|NCT02531633|464173863|FG002|Part B (104 Weeks)|Sponsor request|0|||
128969071|NCT02531633|464173864|FG003|Part B (104 Weeks)|Sponsor request|0|||
128969072|NCT02531633|464173865|FG004|Part B (104 Weeks)|Sponsor request|0|||
128969073|NCT02531633|464173866|FG005|Part B (104 Weeks)|Sponsor request|8|||
128969074|NCT02531633|464173867|FG006|Part B (104 Weeks)|Sponsor request|5|||
128969075|NCT02531633|464173868|FG007|Part B (104 Weeks)|Sponsor request|3|||
128969076|NCT02531633|464173869|FG008|Part B (104 Weeks)|Sponsor request|5|||
128969077|NCT02531633|464173870|FG009|Part B (104 Weeks)|Sponsor request|4|||
128969078|NCT02531633|464173861|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
128969079|NCT02531633|464173862|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
128969080|NCT02531633|464173863|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
128969081|NCT02531633|464173864|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
128969082|NCT02531633|464173865|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
128969083|NCT02531633|464173866|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
128969084|NCT02531633|464173867|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
128969085|NCT02531633|464173868|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
128969086|NCT02531633|464173869|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
128969087|NCT02531633|464173870|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
128969088|NCT04969900|464173871|FG000|Overall Study|Physician Decision|1|||
128969089|NCT04969900|464173872|FG001|Overall Study|Physician Decision|1|||
128969090|NCT04969900|464173871|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
128969091|NCT04969900|464173872|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
128969092|NCT02155712|464173876|FG000|Overall Study|Death|12|||
128969093|NCT02155712|464173877|FG001|Overall Study|Death|0|||
128773839|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
128773840|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
128773841|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
128773842|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
128773843|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
128773844|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
128773845|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
128969094|NCT02155712|464173876|FG000|Overall Study|Lost to Follow-up|37|||
128773846|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
128773847|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
128773848|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
128773849|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
128969095|NCT02155712|464173877|FG001|Overall Study|Lost to Follow-up|22|||
128969096|NCT02155712|464173876|FG000|Overall Study|Revision of device|4|||
128969097|NCT02155712|464173877|FG001|Overall Study|Revision of device|3|||
128969098|NCT02155712|464173876|FG000|Overall Study|Withdrawal by Subject|39|||
128969099|NCT02155712|464173877|FG001|Overall Study|Withdrawal by Subject|21|||
128969100|NCT02155712|464173876|FG000|Overall Study|Site termination|77|||
128969101|NCT02155712|464173877|FG001|Overall Study|Site termination|19|||
128969102|NCT02155712|464173876|FG000|Overall Study|Sponsor terminated study early|150|||
128969103|NCT02155712|464173877|FG001|Overall Study|Sponsor terminated study early|0|||
128969104|NCT02155712|464173876|FG000|Overall Study|Missed final 5-year protocol visit|0|||
128969105|NCT02155712|464173877|FG001|Overall Study|Missed final 5-year protocol visit|32|||
128969106|NCT02155712|464173876|FG000|Overall Study|Censored because surgery cancelled|6|||
128969107|NCT02155712|464173877|FG001|Overall Study|Censored because surgery cancelled|10|||
128969108|NCT02155712|464173876|FG000|Overall Study|Censored because study device was not implanted|61|||
128969109|NCT02155712|464173877|FG001|Overall Study|Censored because study device was not implanted|66|||
128969110|NCT02155712|464173876|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
128969111|NCT02155712|464173877|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
128969112|NCT05016037|464173878|FG000|Overall Study|Lost to Follow-up|2|||
128969113|NCT03797144|464173886|FG000|Enrollment|Protocol Violation|4|||
128969114|NCT03797144|464173887|FG001|Enrollment|Protocol Violation|1|||
128969115|NCT03797144|464173886|FG000|Surgery|Protocol Violation|1|||
128969116|NCT03797144|464173887|FG001|Surgery|Protocol Violation|0|||
128969117|NCT03797144|464173886|FG000|3 Month|Early termination cut-off date|2|||
128969118|NCT03797144|464173887|FG001|3 Month|Early termination cut-off date|0|||
128969119|NCT03797144|464173886|FG000|12 Month|Early termination cut-off date|8|||
128969120|NCT03797144|464173887|FG001|12 Month|Early termination cut-off date|9|||
128969121|NCT03797144|464173886|FG000|24 Month|Early termination cut-off date|1|||
128969122|NCT03797144|464173887|FG001|24 Month|Early termination cut-off date|1|||
128969123|NCT00606229|464173888|FG000|Overall Study|Adverse Event|11|||
128969124|NCT00606229|464173888|FG000|Overall Study|Lack of Efficacy|1|||
128969125|NCT00606229|464173888|FG000|Overall Study|Withdrawal by Subject|4|||
128969126|NCT00606229|464173888|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
128969127|NCT00606229|464173888|FG000|Overall Study|change of residence or other commitments|2|||
128969128|NCT01526928|464173889|FG000|Overall Study|Progressive Disease|35|||
128969129|NCT01526928|464173890|FG001|Overall Study|Progressive Disease|17|||
128969130|NCT01526928|464173891|FG002|Overall Study|Progressive Disease|150|||
128969131|NCT01526928|464173892|FG003|Overall Study|Progressive Disease|182|||
128969132|NCT01526928|464173893|FG004|Overall Study|Progressive Disease|76|||
128969133|NCT01526928|464173894|FG005|Overall Study|Progressive Disease|4|||
128969134|NCT01526928|464173889|FG000|Overall Study|Adverse Event|2|||
128969135|NCT01526928|464173890|FG001|Overall Study|Adverse Event|1|||
128969136|NCT01526928|464173891|FG002|Overall Study|Adverse Event|29|||
128969137|NCT01526928|464173892|FG003|Overall Study|Adverse Event|40|||
128969138|NCT01526928|464173893|FG004|Overall Study|Adverse Event|13|||
128969139|NCT01526928|464173894|FG005|Overall Study|Adverse Event|2|||
128969140|NCT01526928|464173889|FG000|Overall Study|Death|0|||
128969141|NCT01526928|464173890|FG001|Overall Study|Death|0|||
128969142|NCT01526928|464173891|FG002|Overall Study|Death|3|||
128969143|NCT01526928|464173892|FG003|Overall Study|Death|0|||
128969144|NCT01526928|464173893|FG004|Overall Study|Death|0|||
128969145|NCT01526928|464173894|FG005|Overall Study|Death|0|||
129130400|NCT04470427|464768792|FG005|Part B :Open-label|Other than specified|0|||
129130401|NCT04470427|464768787|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
128969146|NCT01526928|464173889|FG000|Overall Study|Withdrawal by Subject|1|||
128969147|NCT01526928|464173890|FG001|Overall Study|Withdrawal by Subject|0|||
128969148|NCT01526928|464173891|FG002|Overall Study|Withdrawal by Subject|13|||
128969149|NCT01526928|464173892|FG003|Overall Study|Withdrawal by Subject|11|||
128969150|NCT01526928|464173893|FG004|Overall Study|Withdrawal by Subject|3|||
128969151|NCT01526928|464173894|FG005|Overall Study|Withdrawal by Subject|0|||
128969152|NCT01526928|464173889|FG000|Overall Study|Physician Decision|0|||
128969153|NCT01526928|464173890|FG001|Overall Study|Physician Decision|0|||
128969154|NCT01526928|464173891|FG002|Overall Study|Physician Decision|2|||
128969155|NCT01526928|464173892|FG003|Overall Study|Physician Decision|5|||
128969156|NCT01526928|464173893|FG004|Overall Study|Physician Decision|0|||
128969157|NCT01526928|464173894|FG005|Overall Study|Physician Decision|0|||
128969158|NCT01526928|464173889|FG000|Overall Study|Other Reason|0|||
128969159|NCT01526928|464173890|FG001|Overall Study|Other Reason|1|||
128969160|NCT01526928|464173891|FG002|Overall Study|Other Reason|11|||
128969161|NCT01526928|464173892|FG003|Overall Study|Other Reason|4|||
129130402|NCT04470427|464768788|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
129130403|NCT04470427|464768789|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
129130404|NCT04470427|464768790|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
129130405|NCT04470427|464768791|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
129130406|NCT04470427|464768792|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
129130407|NCT04470427|464768787|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
129130408|NCT04470427|464768788|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
129130409|NCT04470427|464768789|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
129130410|NCT04470427|464768790|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
129130411|NCT04470427|464768791|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
129130412|NCT04470427|464768792|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
129130413|NCT03412890|464768799|FG000|Overall Study|Adverse Event|5|||
129130414|NCT03412890|464768800|FG001|Overall Study|Adverse Event|5|||
128969162|NCT01526928|464173893|FG004|Overall Study|Other Reason|1|||
128969163|NCT01526928|464173894|FG005|Overall Study|Other Reason|0|||
128969164|NCT01526928|464173889|FG000|Overall Study|Lost to Follow-up|0|||
128969165|NCT01526928|464173890|FG001|Overall Study|Lost to Follow-up|0|||
128969166|NCT01526928|464173891|FG002|Overall Study|Lost to Follow-up|0|||
128969167|NCT01526928|464173892|FG003|Overall Study|Lost to Follow-up|1|||
128969168|NCT01526928|464173893|FG004|Overall Study|Lost to Follow-up|0|||
128969169|NCT01526928|464173894|FG005|Overall Study|Lost to Follow-up|0|||
128969170|NCT01526928|464173889|FG000|Overall Study|Protocol Deviation|0|||
128969171|NCT01526928|464173890|FG001|Overall Study|Protocol Deviation|0|||
128969172|NCT01526928|464173891|FG002|Overall Study|Protocol Deviation|0|||
128969173|NCT01526928|464173892|FG003|Overall Study|Protocol Deviation|2|||
128969174|NCT01526928|464173893|FG004|Overall Study|Protocol Deviation|0|||
128969175|NCT01526928|464173894|FG005|Overall Study|Protocol Deviation|0|||
128969176|NCT01526928|464173889|FG000|Overall Study|Missing|0|||
128969177|NCT01526928|464173890|FG001|Overall Study|Missing|0|||
128969178|NCT01526928|464173891|FG002|Overall Study|Missing|1|||
128969179|NCT01526928|464173892|FG003|Overall Study|Missing|0|||
128969180|NCT01526928|464173893|FG004|Overall Study|Missing|2|||
128969181|NCT01526928|464173894|FG005|Overall Study|Missing|0|||
128969182|NCT02829775|464173897|FG000|Overall Study|Death|1|||
128969183|NCT02829775|464173897|FG000|Overall Study|Withdrawal by Subject|3|||
128969184|NCT02829775|464173897|FG000|Overall Study|Disease remission|1|||
128969185|NCT01249157|464173898|FG000|Overall Study|Withdrawal by Subject|1|||
128969186|NCT00062647|464173899|FG000|Overall Study|Death|2|||
128969187|NCT00062647|464173900|FG001|Overall Study|Death|2|||
128969188|NCT00062647|464173899|FG000|Overall Study|Adverse Event|1|||
128969189|NCT00062647|464173900|FG001|Overall Study|Adverse Event|1|||
128969190|NCT00062647|464173899|FG000|Overall Study|Withdrawal by Subject|2|||
128969191|NCT00062647|464173900|FG001|Overall Study|Withdrawal by Subject|1|||
128969192|NCT00062647|464173899|FG000|Overall Study|Protocol Violation|1|||
128969193|NCT00062647|464173900|FG001|Overall Study|Protocol Violation|0|||
128969194|NCT00062647|464173899|FG000|Overall Study|Lost to Follow-up|1|||
128969195|NCT00062647|464173900|FG001|Overall Study|Lost to Follow-up|2|||
128969196|NCT00062647|464173899|FG000|Overall Study|Failed continuation criteria|4|||
128969197|NCT00062647|464173900|FG001|Overall Study|Failed continuation criteria|2|||
128969198|NCT00062647|464173899|FG000|Overall Study|Other|4|||
128969199|NCT00062647|464173900|FG001|Overall Study|Other|4|||
128969200|NCT00062647|464173899|FG000|Overall Study|Never received study treatment|1|||
129130415|NCT03412890|464768801|FG002|Overall Study|Adverse Event|9|||
129130416|NCT03412890|464768799|FG000|Overall Study|Protocol deviation|2|||
128969201|NCT00062647|464173900|FG001|Overall Study|Never received study treatment|1|||
128969202|NCT02392468|464173908|FG000|Overall Study|Adverse Event|0|||
128969203|NCT02392468|464173909|FG001|Overall Study|Adverse Event|1|||
129130417|NCT03412890|464768800|FG001|Overall Study|Protocol deviation|1|||
128714691|NCT02968563|463252319|FG000|Overall Study|Death|1|||
128969204|NCT02392468|464173910|FG002|Overall Study|Adverse Event|0|||
128969205|NCT02392468|464173911|FG003|Overall Study|Adverse Event|0|||
128969206|NCT02392468|464173912|FG004|Overall Study|Adverse Event|0|||
128969207|NCT02392468|464173913|FG005|Overall Study|Adverse Event|1|||
128969208|NCT01313039|464173914|FG000|Overall Study|Physician Decision|1|||
128969209|NCT01313039|464173914|FG000|Overall Study|Adverse Event|1|||
128969210|NCT05083949|464173920|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
128969211|NCT05083949|464173921|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
128969212|NCT05083949|464173920|FG000|Period 1|Adverse Event|1|||
128969213|NCT05083949|464173921|FG001|Period 1|Adverse Event|1|||
128969214|NCT05083949|464173920|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
129130418|NCT03412890|464768801|FG002|Overall Study|Protocol deviation|2|||
129130419|NCT03412890|464768799|FG000|Overall Study|Lost to Follow-up|7|||
128773850|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
128773851|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
128773852|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
128773853|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
128773854|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
128773855|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
128773856|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
128773857|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
128773858|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
128773859|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
128773860|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
128773861|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
128773862|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
128773863|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
128773864|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
128773865|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
128773866|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
128773867|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
128773868|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
128773869|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
128773870|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
128773871|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
128773872|NCT01089556|463464059|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
128773873|NCT01089556|463464060|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
128773874|NCT01089556|463464061|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
128773875|NCT01089556|463464062|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
128773876|NCT01089556|463464063|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
128773877|NCT01089556|463464064|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
128773878|NCT01089556|463464059|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
128773879|NCT01089556|463464060|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
128773880|NCT01089556|463464061|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
128773881|NCT01089556|463464062|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
128773882|NCT01089556|463464063|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
128773883|NCT01089556|463464064|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
128773884|NCT01089556|463464059|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
128773885|NCT01089556|463464060|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
128773886|NCT01089556|463464061|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
128773887|NCT01089556|463464062|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
128773888|NCT01089556|463464063|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
128773889|NCT01089556|463464064|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
128773890|NCT01089556|463464059|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
128773891|NCT01089556|463464060|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
128773892|NCT01089556|463464061|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
128773893|NCT01089556|463464062|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
128773894|NCT01089556|463464063|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
128773895|NCT01089556|463464064|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
128773896|NCT01089556|463464059|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
128773897|NCT01089556|463464060|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
128773898|NCT01089556|463464061|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
129130420|NCT03412890|464768800|FG001|Overall Study|Lost to Follow-up|10|||
129130421|NCT03412890|464768801|FG002|Overall Study|Lost to Follow-up|10|||
129130422|NCT03412890|464768799|FG000|Overall Study|Withdrawal by Subject|9|||
129130423|NCT03412890|464768800|FG001|Overall Study|Withdrawal by Subject|12|||
129130424|NCT03412890|464768801|FG002|Overall Study|Withdrawal by Subject|11|||
129130425|NCT03412890|464768799|FG000|Overall Study|Lack of Efficacy|2|||
129130426|NCT03412890|464768800|FG001|Overall Study|Lack of Efficacy|7|||
129130427|NCT03412890|464768801|FG002|Overall Study|Lack of Efficacy|5|||
129130428|NCT03412890|464768799|FG000|Overall Study|Other|5|||
129130429|NCT03412890|464768800|FG001|Overall Study|Other|6|||
128969215|NCT05083949|464173921|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
128969216|NCT05083949|464173920|FG000|Period 2|Adverse Event|0|||
128969217|NCT05083949|464173921|FG001|Period 2|Adverse Event|2|||
128969218|NCT01678560|464173922|FG000|Overall Study|Physician Decision|4|||
128969219|NCT01678560|464173923|FG001|Overall Study|Physician Decision|4|||
128969220|NCT01678560|464173922|FG000|Overall Study|Death|0|||
128969221|NCT01678560|464173923|FG001|Overall Study|Death|1|||
128969222|NCT01678560|464173922|FG000|Overall Study|Withdrawal by Subject|0|||
128969223|NCT01678560|464173923|FG001|Overall Study|Withdrawal by Subject|1|||
128969224|NCT00322387|464173927|FG000|Treatment Period|Adverse Event|0|||
129130430|NCT03412890|464768801|FG002|Overall Study|Other|5|||
129130431|NCT03412890|464768799|FG000|Overall Study|Participants who did not receive any study drug|0|||
129220423|NCT02302339|465106596|FG000|Overall Study|Lost to Follow-up|1|||
129130432|NCT03412890|464768800|FG001|Overall Study|Participants who did not receive any study drug|1|||
129130433|NCT03412890|464768801|FG002|Overall Study|Participants who did not receive any study drug|0|||
128969225|NCT00322387|464173928|FG001|Treatment Period|Adverse Event|1|||
128969226|NCT00322387|464173927|FG000|Follow-up Period|Final assessment not done|1|||
128969227|NCT00322387|464173928|FG001|Follow-up Period|Final assessment not done|3|||
128969228|NCT00322387|464173927|FG000|Follow-up Period|Death|1|||
128969229|NCT00322387|464173928|FG001|Follow-up Period|Death|0|||
128969230|NCT00090766|464173933|FG000|Overall Study|Nephrectomy Planned|0|||
128969231|NCT00090766|464173934|FG001|Overall Study|Nephrectomy Planned|0|||
128969232|NCT00090766|464173935|FG002|Overall Study|Nephrectomy Planned|1|||
128969233|NCT00090766|464173933|FG000|Overall Study|Death|1|||
128969234|NCT00090766|464173934|FG001|Overall Study|Death|0|||
128969235|NCT00090766|464173935|FG002|Overall Study|Death|0|||
128969236|NCT00090766|464173933|FG000|Overall Study|Admin|0|||
128969237|NCT00090766|464173934|FG001|Overall Study|Admin|2|||
128969238|NCT00090766|464173935|FG002|Overall Study|Admin|0|||
128969239|NCT00090766|464173933|FG000|Overall Study|Lost to Follow-up|2|||
128969240|NCT00090766|464173934|FG001|Overall Study|Lost to Follow-up|0|||
128969241|NCT00090766|464173935|FG002|Overall Study|Lost to Follow-up|2|||
128969242|NCT00654368|464173936|FG000|Overall Study|Ineligibility determined|6|||
128969243|NCT00654368|464173937|FG001|Overall Study|Ineligibility determined|0|||
128969244|NCT00654368|464173938|FG002|Overall Study|Ineligibility determined|0|||
128969245|NCT00654368|464173936|FG000|Overall Study|Protocol deviation|3|||
128969246|NCT00654368|464173937|FG001|Overall Study|Protocol deviation|2|||
128969247|NCT00654368|464173938|FG002|Overall Study|Protocol deviation|1|||
128969248|NCT00654368|464173936|FG000|Overall Study|Non-compliance|2|||
128969249|NCT00654368|464173937|FG001|Overall Study|Non-compliance|1|||
128969250|NCT00654368|464173938|FG002|Overall Study|Non-compliance|2|||
128969251|NCT00654368|464173936|FG000|Overall Study|Withdrawal by Subject|5|||
128969252|NCT00654368|464173937|FG001|Overall Study|Withdrawal by Subject|2|||
128969253|NCT00654368|464173938|FG002|Overall Study|Withdrawal by Subject|2|||
128969254|NCT00654368|464173936|FG000|Overall Study|Disease progression|21|||
128969255|NCT00654368|464173937|FG001|Overall Study|Disease progression|31|||
128969256|NCT00654368|464173938|FG002|Overall Study|Disease progression|13|||
128969257|NCT00654368|464173936|FG000|Overall Study|Requirement for alternative therapy|1|||
128969258|NCT00654368|464173937|FG001|Overall Study|Requirement for alternative therapy|1|||
128969259|NCT00654368|464173938|FG002|Overall Study|Requirement for alternative therapy|1|||
128969260|NCT00654368|464173936|FG000|Overall Study|Physician Decision|0|||
128969261|NCT00654368|464173937|FG001|Overall Study|Physician Decision|0|||
128969262|NCT00654368|464173938|FG002|Overall Study|Physician Decision|2|||
128969263|NCT00654368|464173936|FG000|Overall Study|Death|1|||
128969264|NCT00654368|464173937|FG001|Overall Study|Death|0|||
128969265|NCT00654368|464173938|FG002|Overall Study|Death|0|||
128969266|NCT00654368|464173936|FG000|Overall Study|Pregnancy|0|||
128969267|NCT00654368|464173937|FG001|Overall Study|Pregnancy|0|||
128969268|NCT00654368|464173938|FG002|Overall Study|Pregnancy|2|||
128969269|NCT00654368|464173936|FG000|Overall Study|Other|0|||
128969270|NCT00654368|464173937|FG001|Overall Study|Other|2|||
128969271|NCT00654368|464173938|FG002|Overall Study|Other|3|||
128969272|NCT00654368|464173936|FG000|Overall Study|Adverse Event|14|||
128969273|NCT00654368|464173937|FG001|Overall Study|Adverse Event|9|||
129130434|NCT00021255|464768802|FG000|Overall Study|Death|1|||
128969274|NCT00654368|464173938|FG002|Overall Study|Adverse Event|6|||
128969275|NCT00804986|464173945|FG000|Overall Study|Adverse Event|0|||
128969276|NCT00804986|464173946|FG001|Overall Study|Adverse Event|1|||
128969277|NCT00804986|464173947|FG002|Overall Study|Adverse Event|2|||
128969278|NCT00804986|464173948|FG003|Overall Study|Adverse Event|1|||
128969279|NCT00804986|464173949|FG004|Overall Study|Adverse Event|3|||
128969280|NCT00804986|464173950|FG005|Overall Study|Adverse Event|0|||
128969281|NCT00804986|464173945|FG000|Overall Study|Lack of Efficacy|0|||
128969282|NCT00804986|464173946|FG001|Overall Study|Lack of Efficacy|0|||
128969283|NCT00804986|464173947|FG002|Overall Study|Lack of Efficacy|0|||
128969284|NCT00804986|464173948|FG003|Overall Study|Lack of Efficacy|1|||
128969285|NCT00804986|464173949|FG004|Overall Study|Lack of Efficacy|0|||
128969286|NCT00804986|464173950|FG005|Overall Study|Lack of Efficacy|3|||
128969287|NCT00804986|464173945|FG000|Overall Study|Lost to Follow-up|0|||
128969288|NCT00804986|464173946|FG001|Overall Study|Lost to Follow-up|0|||
128969289|NCT00804986|464173947|FG002|Overall Study|Lost to Follow-up|0|||
128969290|NCT00804986|464173948|FG003|Overall Study|Lost to Follow-up|1|||
128969291|NCT00804986|464173949|FG004|Overall Study|Lost to Follow-up|1|||
128969292|NCT00804986|464173950|FG005|Overall Study|Lost to Follow-up|3|||
128969293|NCT00804986|464173945|FG000|Overall Study|Protocol Violation|0|||
128969294|NCT00804986|464173946|FG001|Overall Study|Protocol Violation|1|||
128969295|NCT00804986|464173947|FG002|Overall Study|Protocol Violation|0|||
128969296|NCT00804986|464173948|FG003|Overall Study|Protocol Violation|1|||
128969297|NCT00804986|464173949|FG004|Overall Study|Protocol Violation|0|||
128969298|NCT00804986|464173950|FG005|Overall Study|Protocol Violation|0|||
128969299|NCT00804986|464173945|FG000|Overall Study|Withdrawal by Subject|0|||
128969300|NCT00804986|464173946|FG001|Overall Study|Withdrawal by Subject|3|||
128969301|NCT00804986|464173947|FG002|Overall Study|Withdrawal by Subject|0|||
129130435|NCT00021255|464768803|FG001|Overall Study|Death|0|||
129130436|NCT00021255|464768804|FG002|Overall Study|Death|2|||
129130437|NCT00021255|464768802|FG000|Overall Study|Breast cancer relapse|5|||
129130438|NCT00021255|464768803|FG001|Overall Study|Breast cancer relapse|18|||
129130439|NCT00021255|464768804|FG002|Overall Study|Breast cancer relapse|11|||
129130440|NCT00021255|464768802|FG000|Overall Study|Second primary malignancy|0|||
129130441|NCT00021255|464768803|FG001|Overall Study|Second primary malignancy|4|||
129130442|NCT00021255|464768804|FG002|Overall Study|Second primary malignancy|1|||
129130443|NCT00021255|464768802|FG000|Overall Study|Withdrawal by Subject|41|||
129130444|NCT00021255|464768803|FG001|Overall Study|Withdrawal by Subject|64|||
129130445|NCT00021255|464768804|FG002|Overall Study|Withdrawal by Subject|26|||
129130446|NCT00021255|464768802|FG000|Overall Study|Lost to Follow-up|0|||
129130447|NCT00021255|464768803|FG001|Overall Study|Lost to Follow-up|2|||
129130448|NCT00021255|464768804|FG002|Overall Study|Lost to Follow-up|3|||
129130449|NCT00021255|464768802|FG000|Overall Study|Cardiac toxicity|0|||
129130450|NCT00021255|464768803|FG001|Overall Study|Cardiac toxicity|61|||
129130451|NCT00021255|464768804|FG002|Overall Study|Cardiac toxicity|32|||
129130452|NCT00021255|464768802|FG000|Overall Study|Herceptin toxicity|0|||
129130453|NCT00021255|464768803|FG001|Overall Study|Herceptin toxicity|22|||
129130454|NCT00021255|464768804|FG002|Overall Study|Herceptin toxicity|6|||
129130455|NCT00021255|464768802|FG000|Overall Study|Adverse Event|46|||
129130456|NCT00021255|464768803|FG001|Overall Study|Adverse Event|30|||
129130457|NCT00021255|464768804|FG002|Overall Study|Adverse Event|18|||
129130458|NCT00021255|464768802|FG000|Overall Study|Protocol Violation|0|||
129130459|NCT00021255|464768803|FG001|Overall Study|Protocol Violation|2|||
129130460|NCT00021255|464768804|FG002|Overall Study|Protocol Violation|0|||
129130461|NCT00021255|464768802|FG000|Overall Study|Other than specified above|0|||
129130462|NCT00021255|464768803|FG001|Overall Study|Other than specified above|38|||
129130463|NCT00021255|464768804|FG002|Overall Study|Other than specified above|19|||
129130464|NCT00021255|464768802|FG000|Overall Study|Missing|0|||
129130465|NCT00021255|464768803|FG001|Overall Study|Missing|27|||
129130466|NCT00021255|464768804|FG002|Overall Study|Missing|13|||
129130467|NCT00021255|464768802|FG000|Overall Study|Randomized but not treated|28|||
129130468|NCT00021255|464768803|FG001|Overall Study|Randomized but not treated|2|||
129130469|NCT00021255|464768804|FG002|Overall Study|Randomized but not treated|18|||
129130470|NCT01132755|464768807|FG000|Overall Study|Procedure not done due to medical reason|23|||
129130471|NCT01132755|464768807|FG000|Overall Study|Protocol Violation|15|||
129130472|NCT01132755|464768807|FG000|Overall Study|Withdrawal by Subject|4|||
129130473|NCT02232698|464768808|FG000|Overall Study|Pregnancy|1|||
129130474|NCT02232698|464768809|FG001|Overall Study|Pregnancy|1|||
128773899|NCT01089556|463464062|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
128773900|NCT01089556|463464063|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
128969302|NCT00804986|464173948|FG003|Overall Study|Withdrawal by Subject|3|||
128969303|NCT00804986|464173949|FG004|Overall Study|Withdrawal by Subject|5|||
128969304|NCT00804986|464173950|FG005|Overall Study|Withdrawal by Subject|3|||
128969305|NCT00804986|464173945|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
128969306|NCT00804986|464173946|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
128969307|NCT00804986|464173947|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
128969308|NCT00804986|464173948|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
128969309|NCT00804986|464173949|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
128969310|NCT00804986|464173950|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
128969311|NCT00804986|464173945|FG000|Overall Study|Sponsor Decision|0|||
128969312|NCT00804986|464173946|FG001|Overall Study|Sponsor Decision|1|||
128969313|NCT00804986|464173947|FG002|Overall Study|Sponsor Decision|0|||
128969314|NCT00804986|464173948|FG003|Overall Study|Sponsor Decision|0|||
128969315|NCT00804986|464173949|FG004|Overall Study|Sponsor Decision|0|||
128969316|NCT00804986|464173950|FG005|Overall Study|Sponsor Decision|0|||
128969317|NCT00804986|464173945|FG000|Overall Study|Physician Decision|1|||
128969318|NCT00804986|464173946|FG001|Overall Study|Physician Decision|0|||
128969319|NCT00804986|464173947|FG002|Overall Study|Physician Decision|0|||
129130475|NCT02232698|464768808|FG000|Overall Study|Met exclusion criteria|1|||
129220424|NCT02302339|465106597|FG001|Overall Study|Lost to Follow-up|0|||
129220425|NCT02302339|465106598|FG002|Overall Study|Lost to Follow-up|0|||
128969320|NCT00804986|464173948|FG003|Overall Study|Physician Decision|0|||
128969321|NCT00804986|464173949|FG004|Overall Study|Physician Decision|0|||
129130476|NCT02232698|464768809|FG001|Overall Study|Met exclusion criteria|1|||
129220426|NCT02302339|465106599|FG003|Overall Study|Lost to Follow-up|0|||
128773901|NCT01089556|463464064|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
128969322|NCT00804986|464173950|FG005|Overall Study|Physician Decision|0|||
129130477|NCT02232698|464768808|FG000|Overall Study|Had device-associated symptoms|7|||
129130478|NCT02232698|464768809|FG001|Overall Study|Had device-associated symptoms|0|||
129130479|NCT02232698|464768808|FG000|Overall Study|Non-compliance with study device|1|||
129130480|NCT02232698|464768809|FG001|Overall Study|Non-compliance with study device|4|||
129130481|NCT02232698|464768808|FG000|Overall Study|Allocated to control group|0|||
129130482|NCT02232698|464768809|FG001|Overall Study|Allocated to control group|3|||
129130483|NCT02232698|464768808|FG000|Overall Study|Withdrawal by Subject|0|||
129130484|NCT02232698|464768809|FG001|Overall Study|Withdrawal by Subject|11|||
129130485|NCT02393755|464768810|FG000|Overall Study|Withdrawal by Subject|0|||
128969323|NCT00959699|464173955|FG000|Treatment Period|Adverse Event|3|||
128969324|NCT00959699|464173956|FG001|Treatment Period|Adverse Event|13|||
128969325|NCT00959699|464173955|FG000|Treatment Period|Lack of Efficacy|15|||
128969326|NCT00959699|464173956|FG001|Treatment Period|Lack of Efficacy|6|||
128969327|NCT00959699|464173955|FG000|Treatment Period|Lost to Follow-up|0|||
128969328|NCT00959699|464173956|FG001|Treatment Period|Lost to Follow-up|1|||
128969329|NCT00959699|464173955|FG000|Treatment Period|Withdrawal by Subject|1|||
128969330|NCT00959699|464173956|FG001|Treatment Period|Withdrawal by Subject|3|||
128969331|NCT00959699|464173955|FG000|Treatment Period|Non-Compliance with Protocol|0|||
128969332|NCT00959699|464173956|FG001|Treatment Period|Non-Compliance with Protocol|1|||
128969333|NCT00959699|464173955|FG000|Treatment Period|Did not receive treatment|0|||
128969334|NCT00959699|464173956|FG001|Treatment Period|Did not receive treatment|1|||
128969335|NCT00959699|464173955|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
128969336|NCT00959699|464173956|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
128969337|NCT00959699|464173955|FG000|Follow-up Period|Lost to Follow-up|3|||
128969338|NCT00959699|464173956|FG001|Follow-up Period|Lost to Follow-up|2|||
128969339|NCT00959699|464173955|FG000|Follow-up Period|Withdrawal by Subject|3|||
128969340|NCT00959699|464173956|FG001|Follow-up Period|Withdrawal by Subject|4|||
128969341|NCT04228445|464173957|FG000|Overall Study|Lost to Follow-up|1|||
128969342|NCT04228445|464173958|FG001|Overall Study|Lost to Follow-up|1|||
128969343|NCT04228445|464173957|FG000|Overall Study|Physician Decision|1|||
128969344|NCT04228445|464173958|FG001|Overall Study|Physician Decision|2|||
128969345|NCT04228445|464173957|FG000|Overall Study|Withdrawal by Subject|0|||
128969346|NCT04228445|464173958|FG001|Overall Study|Withdrawal by Subject|1|||
128969347|NCT04228445|464173957|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
128969348|NCT04228445|464173958|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
128969349|NCT00606294|464173965|FG000|Overall Study|Withdrawal by Subject|36|||
128969350|NCT00606294|464173966|FG001|Overall Study|Withdrawal by Subject|0|||
128969351|NCT03924427|464173967|FG000|Overall Study|Adverse Event|4|||
128969352|NCT03924427|464173967|FG000|Overall Study|Lack of Efficacy|1|||
128969353|NCT03924427|464173967|FG000|Overall Study|Withdrawal by Subject|1|||
128969354|NCT01316380|464173968|FG000|Overall Study|Adverse Event|0|||
128969355|NCT01316380|464173969|FG001|Overall Study|Adverse Event|2|||
128969356|NCT01316380|464173970|FG002|Overall Study|Adverse Event|1|||
128969357|NCT01316380|464173968|FG000|Overall Study|Protocol Violation|0|||
128969358|NCT01316380|464173969|FG001|Overall Study|Protocol Violation|0|||
128969359|NCT01316380|464173970|FG002|Overall Study|Protocol Violation|1|||
128969360|NCT01316380|464173968|FG000|Overall Study|Withdrawal by Subject|1|||
128969361|NCT01316380|464173969|FG001|Overall Study|Withdrawal by Subject|2|||
128969362|NCT01316380|464173970|FG002|Overall Study|Withdrawal by Subject|0|||
128969363|NCT01316380|464173968|FG000|Overall Study|Other|0|||
128969364|NCT01316380|464173969|FG001|Overall Study|Other|1|||
128969365|NCT01316380|464173970|FG002|Overall Study|Other|1|||
128969366|NCT01316380|464173968|FG000|Overall Study|Not treated|1|||
128969367|NCT01316380|464173969|FG001|Overall Study|Not treated|0|||
128969368|NCT01316380|464173970|FG002|Overall Study|Not treated|0|||
128969369|NCT00149890|464173974|FG000|Overall Study|Adverse Event|1|||
128969370|NCT00149890|464173975|FG001|Overall Study|Adverse Event|8|||
128969371|NCT00149890|464173974|FG000|Overall Study|Lack of Efficacy|8|||
128969372|NCT00149890|464173975|FG001|Overall Study|Lack of Efficacy|9|||
128969373|NCT00149890|464173974|FG000|Overall Study|Protocol Violation|1|||
128969374|NCT00149890|464173975|FG001|Overall Study|Protocol Violation|0|||
128969375|NCT00149890|464173974|FG000|Overall Study|Lost to Follow-up|1|||
128969376|NCT00149890|464173975|FG001|Overall Study|Lost to Follow-up|0|||
128969377|NCT00149890|464173974|FG000|Overall Study|Graft Loss|2|||
128969378|NCT00149890|464173975|FG001|Overall Study|Graft Loss|1|||
128969379|NCT01894776|464173976|FG000|Overall Study|Withdrawal by Subject|1|||
129130486|NCT02393755|464768811|FG001|Overall Study|Withdrawal by Subject|3|||
129130487|NCT02393755|464768810|FG000|Overall Study|Adverse Event|0|||
129130488|NCT02393755|464768811|FG001|Overall Study|Adverse Event|2|||
128969380|NCT02332876|464173977|FG000|Overall Study|Lost to Follow-up|1|||
128969381|NCT02332876|464173978|FG001|Overall Study|Lost to Follow-up|1|||
128969382|NCT02485860|464173979|FG000|Overall Study|Lost to Follow-up|4|||
128969383|NCT02485860|464173980|FG001|Overall Study|Lost to Follow-up|1|||
128969384|NCT02485860|464173979|FG000|Overall Study|Physician Decision|1|||
128969385|NCT02485860|464173980|FG001|Overall Study|Physician Decision|2|||
128969386|NCT02485860|464173979|FG000|Overall Study|Health context (COVID-19)|1|||
128969387|NCT02485860|464173980|FG001|Overall Study|Health context (COVID-19)|0|||
128969388|NCT02415595|464173982|FG000|Overall Study|Administrative reason by sponsor|39|||
128969389|NCT02415595|464173983|FG001|Overall Study|Administrative reason by sponsor|40|||
128969390|NCT02415595|464173984|FG002|Overall Study|Administrative reason by sponsor|41|||
128969391|NCT02415595|464173985|FG003|Overall Study|Administrative reason by sponsor|39|||
128969392|NCT02415595|464173982|FG000|Overall Study|Adverse Event|1|||
128969393|NCT02415595|464173983|FG001|Overall Study|Adverse Event|3|||
128969394|NCT02415595|464173984|FG002|Overall Study|Adverse Event|5|||
129130489|NCT02393755|464768810|FG000|Overall Study|Physician Decision|0|||
129130490|NCT02393755|464768811|FG001|Overall Study|Physician Decision|2|||
129130491|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
129130492|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
129130493|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
129130494|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
129130495|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
129130496|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
129130497|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
129130498|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
129130499|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
129130500|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
129130501|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
129130502|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
129130503|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
129130504|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
129130505|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
129130506|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
129130507|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
129130508|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
129130509|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
129130510|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
129130511|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
129130512|NCT02337946|464768812|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
129130513|NCT02337946|464768813|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
129130514|NCT02337946|464768814|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
129130515|NCT02337946|464768812|FG000|In-between Period|Without Informed Consent|1|||
129130516|NCT02337946|464768813|FG001|In-between Period|Without Informed Consent|0|||
129130517|NCT02337946|464768814|FG002|In-between Period|Without Informed Consent|0|||
129130518|NCT02337946|464768812|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
129130519|NCT02337946|464768813|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
129130520|NCT02337946|464768814|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
129130521|NCT02337946|464768812|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
129220427|NCT02302339|465106596|FG000|Overall Study|Withdrawal by Subject|0|||
129220428|NCT02302339|465106597|FG001|Overall Study|Withdrawal by Subject|2|||
128714692|NCT02968563|463252320|FG001|Overall Study|Death|1|||
128714693|NCT02968563|463252319|FG000|Overall Study|Lost to Follow-up|0|||
128969395|NCT02415595|464173985|FG003|Overall Study|Adverse Event|10|||
128969396|NCT02415595|464173982|FG000|Overall Study|Lack of Efficacy|4|||
128969397|NCT02415595|464173983|FG001|Overall Study|Lack of Efficacy|4|||
128969398|NCT02415595|464173984|FG002|Overall Study|Lack of Efficacy|0|||
128969399|NCT02415595|464173985|FG003|Overall Study|Lack of Efficacy|0|||
128969400|NCT02415595|464173982|FG000|Overall Study|Lost to Follow-up|1|||
128969401|NCT02415595|464173983|FG001|Overall Study|Lost to Follow-up|3|||
128969402|NCT02415595|464173984|FG002|Overall Study|Lost to Follow-up|1|||
128969403|NCT02415595|464173985|FG003|Overall Study|Lost to Follow-up|1|||
128969404|NCT02415595|464173982|FG000|Overall Study|Poor/Non-compliance|1|||
128969405|NCT02415595|464173983|FG001|Overall Study|Poor/Non-compliance|0|||
128969406|NCT02415595|464173984|FG002|Overall Study|Poor/Non-compliance|1|||
128969407|NCT02415595|464173985|FG003|Overall Study|Poor/Non-compliance|0|||
128969408|NCT02415595|464173982|FG000|Overall Study|Reached stopping criteria|0|||
128969409|NCT02415595|464173983|FG001|Overall Study|Reached stopping criteria|1|||
128969410|NCT02415595|464173984|FG002|Overall Study|Reached stopping criteria|1|||
128969411|NCT02415595|464173985|FG003|Overall Study|Reached stopping criteria|0|||
128969412|NCT02415595|464173982|FG000|Overall Study|Withdrawal by Subject|4|||
128969413|NCT02415595|464173983|FG001|Overall Study|Withdrawal by Subject|0|||
128969414|NCT02415595|464173984|FG002|Overall Study|Withdrawal by Subject|1|||
128969415|NCT02415595|464173985|FG003|Overall Study|Withdrawal by Subject|3|||
128969416|NCT02415595|464173982|FG000|Overall Study|Other|0|||
128969417|NCT02415595|464173983|FG001|Overall Study|Other|1|||
128969418|NCT02415595|464173984|FG002|Overall Study|Other|1|||
128969419|NCT02415595|464173985|FG003|Overall Study|Other|0|||
128969420|NCT03325010|464173988|FG000|Overall Study|Adverse Event|3|||
128969421|NCT03325010|464173989|FG001|Overall Study|Adverse Event|8|||
128969422|NCT03325010|464173988|FG000|Overall Study|Protocol Violation|1|||
128969423|NCT03325010|464173989|FG001|Overall Study|Protocol Violation|8|||
128969424|NCT03325010|464173988|FG000|Overall Study|Withdrawal by Subject|1|||
128969425|NCT03325010|464173989|FG001|Overall Study|Withdrawal by Subject|3|||
128969426|NCT03325010|464173988|FG000|Overall Study|Lost to Follow-up|1|||
128969427|NCT03325010|464173989|FG001|Overall Study|Lost to Follow-up|0|||
129220429|NCT02302339|465106598|FG002|Overall Study|Withdrawal by Subject|1|||
128969428|NCT03325010|464173988|FG000|Overall Study|Physician Decision|1|||
128969429|NCT03325010|464173989|FG001|Overall Study|Physician Decision|1|||
129130522|NCT02337946|464768813|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
129130523|NCT02337946|464768814|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
129130524|NCT02337946|464768812|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
129130525|NCT02337946|464768813|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
129130526|NCT02337946|464768814|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
129130527|NCT02337946|464768812|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
129130528|NCT02337946|464768813|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
129130529|NCT02337946|464768814|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
129130530|NCT02337946|464768812|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
128969430|NCT03325010|464173988|FG000|Overall Study|Lack of Efficacy|2|||
128969431|NCT03325010|464173989|FG001|Overall Study|Lack of Efficacy|0|||
128969432|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
128969433|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
128969434|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
128969435|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
128969436|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
128969437|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
128969438|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
128969439|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
128969440|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
128969441|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
128969442|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
128969443|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
128969444|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
128969445|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
128969446|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
128969447|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
128969448|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
128969449|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
128969450|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
128969451|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
128969452|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
128969453|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
128969454|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
128969455|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
128969456|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Screen failure|0|||
128969457|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Screen failure|1|||
128969458|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Screen failure|2|||
128969459|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Screen failure|0|||
128969460|NCT02614261|464173990|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
128969461|NCT02614261|464173991|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
128969462|NCT02614261|464173992|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
128969463|NCT02614261|464173993|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
128969464|NCT02614261|464173990|FG000|Open-Label Extension Phase|Adverse Event|23|||
128969465|NCT02614261|464173991|FG001|Open-Label Extension Phase|Adverse Event|12|||
128969466|NCT02614261|464173992|FG002|Open-Label Extension Phase|Adverse Event|11|||
128969467|NCT02614261|464173993|FG003|Open-Label Extension Phase|Adverse Event|0|||
128969468|NCT02614261|464173990|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
128969469|NCT02614261|464173991|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
128969470|NCT02614261|464173992|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
128969471|NCT02614261|464173993|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
128969472|NCT02614261|464173990|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
128969473|NCT02614261|464173991|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
128969474|NCT02614261|464173992|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
128969475|NCT02614261|464173993|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
128969476|NCT02614261|464173990|FG000|Open-Label Extension Phase|Physician Decision|2|||
128969477|NCT02614261|464173991|FG001|Open-Label Extension Phase|Physician Decision|0|||
128969478|NCT02614261|464173992|FG002|Open-Label Extension Phase|Physician Decision|0|||
128969479|NCT02614261|464173993|FG003|Open-Label Extension Phase|Physician Decision|0|||
128969480|NCT02614261|464173990|FG000|Open-Label Extension Phase|Pregnancy|1|||
128969481|NCT02614261|464173991|FG001|Open-Label Extension Phase|Pregnancy|2|||
128969482|NCT02614261|464173992|FG002|Open-Label Extension Phase|Pregnancy|1|||
128969483|NCT02614261|464173993|FG003|Open-Label Extension Phase|Pregnancy|0|||
128969484|NCT02614261|464173990|FG000|Open-Label Extension Phase|Protocol Violation|3|||
128969485|NCT02614261|464173991|FG001|Open-Label Extension Phase|Protocol Violation|4|||
128969486|NCT02614261|464173992|FG002|Open-Label Extension Phase|Protocol Violation|1|||
128969487|NCT02614261|464173993|FG003|Open-Label Extension Phase|Protocol Violation|0|||
128969488|NCT02614261|464173990|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
128969489|NCT02614261|464173991|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
128969490|NCT02614261|464173992|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
129130531|NCT02337946|464768813|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
129130532|NCT02337946|464768814|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
128969491|NCT02614261|464173993|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
128773902|NCT01089556|463464059|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
128773903|NCT01089556|463464060|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
128773904|NCT01089556|463464061|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
128773905|NCT01089556|463464062|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
128773906|NCT01089556|463464063|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
128773907|NCT01089556|463464064|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
129130533|NCT02337946|464768812|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
128773908|NCT01089556|463464059|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
128773909|NCT01089556|463464060|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
128773910|NCT01089556|463464061|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
128773911|NCT01089556|463464062|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
128773912|NCT01089556|463464063|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
128773913|NCT01089556|463464064|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
128773914|NCT01089556|463464059|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
128773915|NCT01089556|463464060|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
128773916|NCT01089556|463464061|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
128773917|NCT01089556|463464062|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
128773918|NCT01089556|463464063|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
128773919|NCT01089556|463464064|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
128773920|NCT01238575|463464065|FG000|Overall Study|Lack of Efficacy|2|||
128773921|NCT01238575|463464066|FG001|Overall Study|Lack of Efficacy|4|||
128773922|NCT01238575|463464065|FG000|Overall Study|Adverse Event|2|||
128773923|NCT01238575|463464066|FG001|Overall Study|Adverse Event|0|||
128773924|NCT01950273|463464069|FG000|Overall Study|Protocol Violation|1|||
128773925|NCT01950273|463464070|FG001|Overall Study|Protocol Violation|0|||
128773926|NCT01950273|463464069|FG000|Overall Study|Withdrawal by Subject|2|||
128773927|NCT01950273|463464070|FG001|Overall Study|Withdrawal by Subject|0|||
128773928|NCT01950273|463464069|FG000|Overall Study|Other not defined above|1|||
128773929|NCT01950273|463464070|FG001|Overall Study|Other not defined above|0|||
128773930|NCT00432679|463464075|FG000|Overall Study|Adverse Event|2|||
128773931|NCT00432679|463464076|FG001|Overall Study|Adverse Event|1|||
128773932|NCT00432679|463464075|FG000|Overall Study|Withdrawal by Subject|3|||
128773933|NCT00432679|463464076|FG001|Overall Study|Withdrawal by Subject|2|||
128773934|NCT01177813|463464081|FG000|Overall Study|Adverse Event|8|||
128773935|NCT01177813|463464082|FG001|Overall Study|Adverse Event|2|||
128773936|NCT01177813|463464083|FG002|Overall Study|Adverse Event|4|||
128773937|NCT01177813|463464084|FG003|Overall Study|Adverse Event|6|||
129130534|NCT02337946|464768813|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
129130535|NCT02337946|464768814|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
129130536|NCT05324371|464768816|FG000|Overall Study|Withdrawal by Subject|1|||
129130537|NCT05324371|464768816|FG000|Overall Study|Death|1|||
129130538|NCT02949934|464768818|FG000|Natural Drinking Period|Adverse Event|1|||
129130539|NCT02949934|464768819|FG001|Natural Drinking Period|Adverse Event|0|||
129130540|NCT02949934|464768820|FG002|Natural Drinking Period|Adverse Event|0|||
129130541|NCT02949934|464768821|FG003|Natural Drinking Period|Adverse Event|1|||
129130542|NCT02949934|464768822|FG004|Natural Drinking Period|Adverse Event|0|||
129130543|NCT02949934|464768823|FG005|Natural Drinking Period|Adverse Event|0|||
129130544|NCT02949934|464768818|FG000|Natural Drinking Period|Lost to Follow-up|0|||
129130545|NCT02949934|464768819|FG001|Natural Drinking Period|Lost to Follow-up|0|||
129130546|NCT02949934|464768820|FG002|Natural Drinking Period|Lost to Follow-up|0|||
129130547|NCT02949934|464768821|FG003|Natural Drinking Period|Lost to Follow-up|0|||
129130548|NCT02949934|464768822|FG004|Natural Drinking Period|Lost to Follow-up|1|||
129130549|NCT02949934|464768823|FG005|Natural Drinking Period|Lost to Follow-up|0|||
129130550|NCT02949934|464768818|FG000|Neuroimaging|Protocol Violation|2|||
129130551|NCT02949934|464768819|FG001|Neuroimaging|Protocol Violation|0|||
129130552|NCT02949934|464768820|FG002|Neuroimaging|Protocol Violation|0|||
129130553|NCT02949934|464768821|FG003|Neuroimaging|Protocol Violation|0|||
129130554|NCT02949934|464768822|FG004|Neuroimaging|Protocol Violation|1|||
129130555|NCT02949934|464768823|FG005|Neuroimaging|Protocol Violation|0|||
129130556|NCT02949934|464768818|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
129130557|NCT02949934|464768819|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
128773938|NCT01177813|463464085|FG004|Overall Study|Adverse Event|3|||
128773939|NCT01177813|463464081|FG000|Overall Study|Lack of Efficacy|1|||
129130558|NCT02949934|464768820|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
129130559|NCT02949934|464768821|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
128773940|NCT01177813|463464082|FG001|Overall Study|Lack of Efficacy|0|||
128773941|NCT01177813|463464083|FG002|Overall Study|Lack of Efficacy|0|||
128773942|NCT01177813|463464084|FG003|Overall Study|Lack of Efficacy|0|||
128773943|NCT01177813|463464085|FG004|Overall Study|Lack of Efficacy|0|||
128773944|NCT01177813|463464081|FG000|Overall Study|Protocol Violation|3|||
129130560|NCT02949934|464768822|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
129130561|NCT02949934|464768823|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
129130562|NCT02949934|464768818|FG000|Neuroimaging|Not scanned|0|||
129130563|NCT02949934|464768819|FG001|Neuroimaging|Not scanned|0|||
129130564|NCT02949934|464768820|FG002|Neuroimaging|Not scanned|1|||
129130565|NCT02949934|464768821|FG003|Neuroimaging|Not scanned|0|||
129130566|NCT02949934|464768822|FG004|Neuroimaging|Not scanned|0|||
129130567|NCT02949934|464768823|FG005|Neuroimaging|Not scanned|2|||
129130568|NCT02949934|464768818|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
129130569|NCT02949934|464768819|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
129130570|NCT02949934|464768820|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
129130571|NCT02949934|464768821|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
129130572|NCT02949934|464768822|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
129130573|NCT02949934|464768823|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
129130574|NCT02949934|464768818|FG000|Bar Laboratory|Adverse Event|1|||
129130575|NCT02949934|464768819|FG001|Bar Laboratory|Adverse Event|0|||
129130576|NCT02949934|464768820|FG002|Bar Laboratory|Adverse Event|2|||
129130577|NCT02949934|464768821|FG003|Bar Laboratory|Adverse Event|0|||
129130578|NCT02949934|464768822|FG004|Bar Laboratory|Adverse Event|1|||
129130579|NCT02949934|464768823|FG005|Bar Laboratory|Adverse Event|0|||
129130580|NCT02949934|464768818|FG000|Bar Laboratory|Protocol Violation|0|||
129130581|NCT02949934|464768819|FG001|Bar Laboratory|Protocol Violation|0|||
129130582|NCT02949934|464768820|FG002|Bar Laboratory|Protocol Violation|0|||
129130583|NCT02949934|464768821|FG003|Bar Laboratory|Protocol Violation|1|||
129130584|NCT02949934|464768822|FG004|Bar Laboratory|Protocol Violation|0|||
129130585|NCT02949934|464768823|FG005|Bar Laboratory|Protocol Violation|0|||
129130586|NCT01251861|464768827|FG000|Overall Study|Disease progression|6|||
129130587|NCT01251861|464768828|FG001|Overall Study|Disease progression|6|||
129130588|NCT01251861|464768827|FG000|Overall Study|Adverse Event|2|||
129130589|NCT01251861|464768828|FG001|Overall Study|Adverse Event|17|||
129130590|NCT01251861|464768827|FG000|Overall Study|Withdrawal by Subject|2|||
129130591|NCT01251861|464768828|FG001|Overall Study|Withdrawal by Subject|2|||
129130592|NCT01251861|464768827|FG000|Overall Study|Alternative therapy|1|||
129130593|NCT01251861|464768828|FG001|Overall Study|Alternative therapy|0|||
129130594|NCT01251861|464768827|FG000|Overall Study|Other complicating disease|0|||
129130595|NCT01251861|464768828|FG001|Overall Study|Other complicating disease|1|||
129130596|NCT01251861|464768827|FG000|Overall Study|Physician Decision|1|||
129130597|NCT01251861|464768828|FG001|Overall Study|Physician Decision|0|||
129130598|NCT01251861|464768827|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
129130599|NCT01251861|464768828|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
129130600|NCT01251861|464768827|FG000|Overall Study|Other|1|||
129130601|NCT01251861|464768828|FG001|Overall Study|Other|0|||
129130602|NCT01251861|464768827|FG000|Overall Study|Never started therapy|4|||
129130603|NCT01251861|464768828|FG001|Overall Study|Never started therapy|1|||
129130604|NCT01251861|464768827|FG000|Overall Study|Potential interaction of drugs|0|||
129130605|NCT01251861|464768828|FG001|Overall Study|Potential interaction of drugs|1|||
129130606|NCT05643794|464769617|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
129130607|NCT05643794|464769618|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
129130608|NCT05643794|464769619|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129130609|NCT05643794|464769617|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129130610|NCT05643794|464769618|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129130611|NCT05643794|464769619|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129130612|NCT05643794|464769617|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
129130613|NCT05643794|464769618|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
129130614|NCT05643794|464769619|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
129130615|NCT05643794|464769617|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129130616|NCT05643794|464769618|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129130617|NCT05643794|464769619|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129130618|NCT05643794|464769617|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
129130619|NCT05643794|464769618|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
128969492|NCT02614261|464173990|FG000|Follow-up Phase|Adverse Event|2|||
128969493|NCT02614261|464173991|FG001|Follow-up Phase|Adverse Event|0|||
128969494|NCT02614261|464173992|FG002|Follow-up Phase|Adverse Event|1|||
128969495|NCT02614261|464173993|FG003|Follow-up Phase|Adverse Event|0|||
128969496|NCT02614261|464173990|FG000|Follow-up Phase|Lost to Follow-up|12|||
128969497|NCT02614261|464173991|FG001|Follow-up Phase|Lost to Follow-up|5|||
128969498|NCT02614261|464173992|FG002|Follow-up Phase|Lost to Follow-up|2|||
128969499|NCT02614261|464173993|FG003|Follow-up Phase|Lost to Follow-up|0|||
128969500|NCT02614261|464173990|FG000|Follow-up Phase|Physician Decision|5|||
128969501|NCT02614261|464173991|FG001|Follow-up Phase|Physician Decision|1|||
128969502|NCT02614261|464173992|FG002|Follow-up Phase|Physician Decision|0|||
128969503|NCT02614261|464173993|FG003|Follow-up Phase|Physician Decision|0|||
129130620|NCT05643794|464769619|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
129130621|NCT05643794|464769617|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
129130622|NCT05643794|464769618|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
129130623|NCT05643794|464769619|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
129130624|NCT04167670|464769622|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
128969504|NCT02614261|464173990|FG000|Follow-up Phase|Pregnancy|0|||
128969505|NCT02614261|464173991|FG001|Follow-up Phase|Pregnancy|1|||
128969506|NCT02614261|464173992|FG002|Follow-up Phase|Pregnancy|0|||
129130625|NCT04167670|464769623|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
129130626|NCT04167670|464769624|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
129130627|NCT04167670|464769622|FG000|Overall Study|Significant protocol deviation|3|||
129130628|NCT04167670|464769623|FG001|Overall Study|Significant protocol deviation|1|||
129130629|NCT04167670|464769624|FG002|Overall Study|Significant protocol deviation|0|||
129130630|NCT04167670|464769622|FG000|Overall Study|Lost to Follow-up|0|||
129130631|NCT04167670|464769623|FG001|Overall Study|Lost to Follow-up|3|||
129130632|NCT04167670|464769624|FG002|Overall Study|Lost to Follow-up|3|||
129130633|NCT04167670|464769622|FG000|Overall Study|Voluntary Withdrawal|0|||
129130634|NCT04167670|464769623|FG001|Overall Study|Voluntary Withdrawal|1|||
129130635|NCT04167670|464769624|FG002|Overall Study|Voluntary Withdrawal|1|||
129130636|NCT04167670|464769622|FG000|Overall Study|Withdrawal of Consent|4|||
129130637|NCT04167670|464769623|FG001|Overall Study|Withdrawal of Consent|1|||
129130638|NCT04167670|464769624|FG002|Overall Study|Withdrawal of Consent|3|||
129130639|NCT04167670|464769622|FG000|Overall Study|Miscellaneous|7|||
129130640|NCT04167670|464769623|FG001|Overall Study|Miscellaneous|5|||
129130641|NCT04167670|464769624|FG002|Overall Study|Miscellaneous|3|||
129130642|NCT01127061|464769627|FG000|Overall Study|Lost to Follow-up|7|||
129130643|NCT01127061|464769628|FG001|Overall Study|Lost to Follow-up|10|||
129130644|NCT01127061|464769627|FG000|Overall Study|Physician Decision|3|||
129130645|NCT01127061|464769628|FG001|Overall Study|Physician Decision|3|||
129130646|NCT04827446|464769629|FG000|Overall Study|Lost to Follow-up|1|||
129130647|NCT04827446|464769630|FG001|Overall Study|Lost to Follow-up|1|||
129130648|NCT04827446|464769629|FG000|Overall Study|Death|2|||
129130649|NCT04827446|464769630|FG001|Overall Study|Death|0|||
129130650|NCT04827446|464769629|FG000|Overall Study|Withdrawal by Subject|2|||
129130651|NCT04827446|464769630|FG001|Overall Study|Withdrawal by Subject|2|||
129130652|NCT01239680|464769636|FG000|Overall Study|Withdrawal by Subject|2|||
129130653|NCT01239680|464769637|FG001|Overall Study|Withdrawal by Subject|0|||
129130654|NCT03033901|464769638|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
129130655|NCT03033901|464769638|FG000|Overall Study|Refused PSG|23|||
129130656|NCT03033901|464769638|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
129130657|NCT03033901|464769638|FG000|Overall Study|Missing Oximetry Data|3|||
129130658|NCT02513199|464769645|FG000|Treatment|Death|1|||
129130659|NCT02513199|464769645|FG000|Treatment|Lost to Follow-up|1|||
129130660|NCT02513199|464769645|FG000|Follow-Up|Death|11|||
129130661|NCT01771913|464769652|FG000|Overall Study|Withdrawal by Subject|1|||
129220430|NCT02302339|465106599|FG003|Overall Study|Withdrawal by Subject|0|||
129220431|NCT01104311|465106600|FG000|Overall Study|Withdrawal by Subject|6|||
128714694|NCT02968563|463252320|FG001|Overall Study|Lost to Follow-up|1|||
128714695|NCT02369341|463252321|FG000|Overall Study|Migrated/moved from study area|1|||
128714696|NCT02369341|463252322|FG001|Overall Study|Migrated/moved from study area|0|||
128714697|NCT03287804|463252323|FG000|Overall Study|Death|1|||
128714698|NCT03287804|463252323|FG000|Overall Study|Physician Decision|2|||
128714699|NCT03287804|463252323|FG000|Overall Study|Progressive disease|8|||
128714700|NCT02710045|463252325|FG000|Overall Study|Death|1|||
128714701|NCT02710045|463252326|FG001|Overall Study|Death|2|||
128714702|NCT02710045|463252327|FG002|Overall Study|Death|0|||
128714703|NCT02710045|463252325|FG000|Overall Study|Withdrawal by Subject|6|||
128714704|NCT02710045|463252326|FG001|Overall Study|Withdrawal by Subject|6|||
128714705|NCT02710045|463252327|FG002|Overall Study|Withdrawal by Subject|2|||
128714706|NCT02710045|463252325|FG000|Overall Study|Protocol Violation|1|||
128714707|NCT02710045|463252326|FG001|Overall Study|Protocol Violation|2|||
128714708|NCT02710045|463252327|FG002|Overall Study|Protocol Violation|3|||
128714709|NCT02710045|463252325|FG000|Overall Study|Lost to Follow-up|3|||
128714710|NCT02710045|463252326|FG001|Overall Study|Lost to Follow-up|6|||
128714711|NCT02710045|463252327|FG002|Overall Study|Lost to Follow-up|7|||
128714712|NCT02710045|463252325|FG000|Overall Study|Physician Decision|0|||
128714713|NCT02710045|463252326|FG001|Overall Study|Physician Decision|0|||
129220432|NCT01104311|465106601|FG001|Overall Study|Withdrawal by Subject|6|||
128714714|NCT02710045|463252327|FG002|Overall Study|Physician Decision|1|||
128714715|NCT02710045|463252325|FG000|Overall Study|Poor Attendance|0|||
128714716|NCT02710045|463252326|FG001|Overall Study|Poor Attendance|1|||
128714717|NCT02710045|463252327|FG002|Overall Study|Poor Attendance|0|||
128714718|NCT03178773|463252328|FG000|Overall Study|Death|0|||
128714719|NCT03178773|463252329|FG001|Overall Study|Death|1|||
128714720|NCT03178773|463252328|FG000|Overall Study|Lost to Follow-up|29|||
128714721|NCT03178773|463252329|FG001|Overall Study|Lost to Follow-up|25|||
128969507|NCT02614261|464173993|FG003|Follow-up Phase|Pregnancy|0|||
129130662|NCT01771913|464769653|FG001|Overall Study|Withdrawal by Subject|0|||
129130663|NCT04307394|464769654|FG000|Overall Study|Lost to Follow-up|3|||
129130664|NCT04307394|464769654|FG000|Overall Study|Withdrawal by Subject|2|||
129130665|NCT00407511|464769662|FG000|Overall Study|Adverse Event|9|||
129130666|NCT00407511|464769662|FG000|Overall Study|Lost to Follow-up|4|||
129130667|NCT00407511|464769662|FG000|Overall Study|Other|5|||
129130668|NCT00407511|464769662|FG000|Overall Study|Withdrawal by Subject|4|||
129038022|NCT00588731|464430568|FG000|Overall Study|Withdrawal by Subject|3|||
129038023|NCT00588731|464430569|FG001|Overall Study|Withdrawal by Subject|2|||
129038024|NCT00251316|464430570|FG000|Overall Study|Physician Decision|2|||
129038025|NCT00251316|464430571|FG001|Overall Study|Physician Decision|3|||
129038026|NCT00612677|464430574|FG000|Overall Study|study closed before treatment started|1|||
129038027|NCT03417830|464430575|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
129038028|NCT03417830|464430576|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
129038029|NCT04569786|464430585|FG000|Overall Study|Lost to Follow-up|1|||
129038030|NCT04569786|464430586|FG001|Overall Study|Lost to Follow-up|0|||
129038031|NCT04569786|464430587|FG002|Overall Study|Lost to Follow-up|4|||
129038032|NCT04569786|464430588|FG003|Overall Study|Lost to Follow-up|1|||
129038033|NCT04569786|464430589|FG004|Overall Study|Lost to Follow-up|0|||
129038034|NCT04569786|464430585|FG000|Overall Study|Withdrawal by Subject|0|||
129038035|NCT04569786|464430586|FG001|Overall Study|Withdrawal by Subject|0|||
129038036|NCT04569786|464430587|FG002|Overall Study|Withdrawal by Subject|0|||
129130669|NCT01521364|464769663|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
129130670|NCT01521364|464769663|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
129130671|NCT02636283|464769664|FG000|Overall Study|Adverse Event|2|||
129130672|NCT02636283|464769665|FG001|Overall Study|Adverse Event|0|||
129130673|NCT02636283|464769664|FG000|Overall Study|Trial Terminated Prematurely|0|||
128714722|NCT03178773|463252328|FG000|Overall Study|Withdrawal by Subject|10|||
128714723|NCT03178773|463252329|FG001|Overall Study|Withdrawal by Subject|14|||
128714724|NCT01382446|463252330|FG000|Overall Study|Withdrawal by Subject|0|||
128714725|NCT01382446|463252331|FG001|Overall Study|Withdrawal by Subject|1|||
128714726|NCT01382446|463252330|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
128714727|NCT01382446|463252331|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
128714728|NCT02707991|463252333|FG000|Overall Study|Protocol Violation|1|||
128714729|NCT02707991|463252334|FG001|Overall Study|Protocol Violation|0|||
128714730|NCT02707991|463252333|FG000|Overall Study|Became ineligible|0|||
128714731|NCT02707991|463252334|FG001|Overall Study|Became ineligible|1|||
128714732|NCT02733991|463252335|FG000|Overall Study|Adverse Event|1|||
128714733|NCT02733991|463252336|FG001|Overall Study|Adverse Event|0|||
128714734|NCT02733991|463252335|FG000|Overall Study|Withdrawal by Subject|0|||
128714735|NCT02733991|463252336|FG001|Overall Study|Withdrawal by Subject|5|||
128714736|NCT02604212|463252339|FG000|Overall Study|Study Terminated by Sponsor|2|||
128714737|NCT02604212|463252340|FG001|Overall Study|Study Terminated by Sponsor|1|||
128714738|NCT02604212|463252341|FG002|Overall Study|Study Terminated by Sponsor|3|||
128714739|NCT02604212|463252342|FG003|Overall Study|Study Terminated by Sponsor|3|||
128714740|NCT02604212|463252339|FG000|Overall Study|Withdrawal by Subject|0|||
128714741|NCT02604212|463252340|FG001|Overall Study|Withdrawal by Subject|0|||
128714742|NCT02604212|463252341|FG002|Overall Study|Withdrawal by Subject|1|||
128714743|NCT02604212|463252342|FG003|Overall Study|Withdrawal by Subject|0|||
128714744|NCT03721276|463252343|FG000|Overall Study|Lost to Follow-up|5|||
128714745|NCT03721276|463252344|FG001|Overall Study|Lost to Follow-up|3|||
128714746|NCT03721276|463252343|FG000|Overall Study|Adverse Event|0|||
128714747|NCT03721276|463252344|FG001|Overall Study|Adverse Event|1|||
128714748|NCT00416078|463252345|FG000|Overall Study|Death|3|||
128714749|NCT00416078|463252346|FG001|Overall Study|Death|4|||
128714750|NCT00416078|463252345|FG000|Overall Study|Withdrawal by Subject|3|||
128714751|NCT00416078|463252346|FG001|Overall Study|Withdrawal by Subject|2|||
128714752|NCT00416078|463252345|FG000|Overall Study|Physician Decision|1|||
128714753|NCT00416078|463252346|FG001|Overall Study|Physician Decision|0|||
128714754|NCT00416078|463252345|FG000|Overall Study|Lost to Follow-up|4|||
128714755|NCT00416078|463252346|FG001|Overall Study|Lost to Follow-up|2|||
128714756|NCT01829230|463252347|FG000|Overall Study|Protocol Violation|0|||
128714757|NCT01829230|463252348|FG001|Overall Study|Protocol Violation|2|||
128714758|NCT01829230|463252347|FG000|Overall Study|Withdrawal by Subject|0|||
128714759|NCT01829230|463252348|FG001|Overall Study|Withdrawal by Subject|1|||
128714760|NCT01829230|463252347|FG000|Overall Study|Lost to Follow-up|1|||
128714761|NCT01829230|463252348|FG001|Overall Study|Lost to Follow-up|1|||
128773945|NCT01177813|463464082|FG001|Overall Study|Protocol Violation|2|||
128773946|NCT01177813|463464083|FG002|Overall Study|Protocol Violation|2|||
129038037|NCT04569786|464430588|FG003|Overall Study|Withdrawal by Subject|5|||
129038038|NCT04569786|464430589|FG004|Overall Study|Withdrawal by Subject|1|||
129130674|NCT02636283|464769665|FG001|Overall Study|Trial Terminated Prematurely|3|||
129130675|NCT04900272|464769666|FG000|Overall Study|Lost to Follow-up|2|||
128714762|NCT00461682|463252352|FG000|Overall Study|Protocol Violation|1|||
128714763|NCT04128267|463252356|FG000|Overall Study|Withdrawal by Subject|6|||
129130676|NCT04900272|464769666|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
128714764|NCT04128267|463252356|FG000|Overall Study|Death|2|||
128714765|NCT04128267|463252356|FG000|Overall Study|Disease progression|1|||
128773947|NCT01177813|463464084|FG003|Overall Study|Protocol Violation|0|||
129038039|NCT04569786|464430585|FG000|Overall Study|Physician Decision|0|||
128714766|NCT04128267|463252356|FG000|Overall Study|Participant had other medical issues|4|||
128773948|NCT01177813|463464085|FG004|Overall Study|Protocol Violation|1|||
129038040|NCT04569786|464430586|FG001|Overall Study|Physician Decision|0|||
129130677|NCT04900272|464769666|FG000|Overall Study|Withdrawal by Subject|1|||
128714767|NCT04128267|463252356|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
128714768|NCT01698801|463252359|FG000|Treatment Phase|Adverse Event|4|||
128714769|NCT01698801|463252359|FG000|Treatment Phase|Protocol Violation|1|||
128714770|NCT01698801|463252359|FG000|Treatment Phase|Other|4|||
128714771|NCT01698801|463252359|FG000|Treatment Phase|Withdrawal by Subject|1|||
128714772|NCT01698801|463252359|FG000|Treatment Phase|Disease progression|1|||
129038041|NCT04569786|464430587|FG002|Overall Study|Physician Decision|0|||
128714773|NCT01698801|463252359|FG000|Follow Up Phase|Withdrawal by Subject|1|||
128714774|NCT01698801|463252359|FG000|Follow Up Phase|Death|4|||
128714775|NCT01614067|463252361|FG000|Overall Study|Pregnancy|1|||
128714776|NCT01614067|463252362|FG001|Overall Study|Pregnancy|0|||
128714777|NCT01614067|463252361|FG000|Overall Study|Physician Decision|6|||
128714778|NCT01614067|463252362|FG001|Overall Study|Physician Decision|5|||
128714779|NCT01614067|463252361|FG000|Overall Study|Withdrawal by Subject|0|||
128714780|NCT01614067|463252362|FG001|Overall Study|Withdrawal by Subject|1|||
128714781|NCT01614067|463252361|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
128714782|NCT01614067|463252362|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
128714783|NCT01505868|463252363|FG000|Overall Study|Withdrawal by Subject|1|||
128714784|NCT01505868|463252364|FG001|Overall Study|Withdrawal by Subject|0|||
128714785|NCT01505868|463252365|FG002|Overall Study|Withdrawal by Subject|0|||
128714786|NCT01505868|463252366|FG003|Overall Study|Withdrawal by Subject|0|||
128714787|NCT01505868|463252367|FG004|Overall Study|Withdrawal by Subject|0|||
128714788|NCT00680043|463252368|FG000|Overall Study|Withdrawal by Subject|1|||
128714789|NCT00680043|463252369|FG001|Overall Study|Withdrawal by Subject|0|||
128714790|NCT00680043|463252370|FG002|Overall Study|Withdrawal by Subject|0|||
128714791|NCT00680043|463252368|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
128714792|NCT00680043|463252369|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
129038042|NCT04569786|464430588|FG003|Overall Study|Physician Decision|1|||
129038043|NCT04569786|464430589|FG004|Overall Study|Physician Decision|0|||
129038044|NCT01684878|464430593|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
129038045|NCT01684878|464430594|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
129038046|NCT01684878|464430595|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
129038047|NCT01684878|464430596|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
129038048|NCT01684878|464430593|FG000|Part 1: Safety Run in Phase|Death|15|||
129038049|NCT01684878|464430594|FG001|Part 1: Safety Run in Phase|Death|20|||
129038050|NCT01684878|464430595|FG002|Part 1: Safety Run in Phase|Death|0|||
129038051|NCT01684878|464430596|FG003|Part 1: Safety Run in Phase|Death|0|||
129038052|NCT01684878|464430593|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
129038053|NCT01684878|464430594|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
129038054|NCT01684878|464430595|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
129038055|NCT01684878|464430596|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
129038056|NCT01684878|464430593|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
129038057|NCT01684878|464430594|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
129038058|NCT01684878|464430595|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
129038059|NCT01684878|464430596|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
129038060|NCT01684878|464430593|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
129038061|NCT01684878|464430594|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
129038062|NCT01684878|464430595|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
129038063|NCT01684878|464430596|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
129038064|NCT01684878|464430593|FG000|Part 2: Randomized Phase|Death|0|||
129038065|NCT01684878|464430594|FG001|Part 2: Randomized Phase|Death|0|||
129038066|NCT01684878|464430595|FG002|Part 2: Randomized Phase|Death|62|||
129038067|NCT01684878|464430596|FG003|Part 2: Randomized Phase|Death|68|||
129038068|NCT01684878|464430593|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
129038069|NCT01684878|464430594|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
129038070|NCT01684878|464430595|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
129038071|NCT01684878|464430596|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
129038072|NCT01684878|464430593|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
129038073|NCT01684878|464430594|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
129038074|NCT01684878|464430595|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
129038075|NCT01684878|464430596|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
129038076|NCT02692482|464430597|FG000|Overall Study|Death|2|||
129038077|NCT02692482|464430598|FG001|Overall Study|Death|2|||
129038078|NCT02692482|464430597|FG000|Overall Study|Withdrawal by Subject|1|||
129038079|NCT02692482|464430598|FG001|Overall Study|Withdrawal by Subject|2|||
129038080|NCT01435031|464430599|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
128714793|NCT00680043|463252370|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
128714794|NCT00680043|463252368|FG000|Overall Study|Renal Transplant|1|||
128714795|NCT00680043|463252369|FG001|Overall Study|Renal Transplant|0|||
128714796|NCT00680043|463252370|FG002|Overall Study|Renal Transplant|4|||
129038081|NCT01435031|464430599|FG000|ITT at 1 Month|Death|1|||
129038082|NCT01435031|464430599|FG000|ITT at 1 Month|Lost to Follow-up|4|||
129038083|NCT01435031|464430599|FG000|ITT at 6 Months|Death|2|||
128773949|NCT01177813|463464081|FG000|Overall Study|Lost to Follow-up|12|||
128773950|NCT01177813|463464082|FG001|Overall Study|Lost to Follow-up|5|||
128773951|NCT01177813|463464083|FG002|Overall Study|Lost to Follow-up|6|||
128773952|NCT01177813|463464084|FG003|Overall Study|Lost to Follow-up|3|||
128773953|NCT01177813|463464085|FG004|Overall Study|Lost to Follow-up|0|||
128773954|NCT01177813|463464081|FG000|Overall Study|Withdrawal by Subject|12|||
128773955|NCT01177813|463464082|FG001|Overall Study|Withdrawal by Subject|7|||
128773956|NCT01177813|463464083|FG002|Overall Study|Withdrawal by Subject|6|||
128773957|NCT01177813|463464084|FG003|Overall Study|Withdrawal by Subject|5|||
128773958|NCT01177813|463464085|FG004|Overall Study|Withdrawal by Subject|3|||
128773959|NCT01177813|463464081|FG000|Overall Study|Other reason not defined above|5|||
128773960|NCT01177813|463464082|FG001|Overall Study|Other reason not defined above|2|||
128773961|NCT01177813|463464083|FG002|Overall Study|Other reason not defined above|2|||
128773962|NCT01177813|463464084|FG003|Overall Study|Other reason not defined above|3|||
128773963|NCT01177813|463464085|FG004|Overall Study|Other reason not defined above|2|||
128773964|NCT00109928|463464088|FG000|Overall Study|Adverse Event|2|||
128773965|NCT00109928|463464088|FG000|Overall Study|Progression|6|||
128773966|NCT00109928|463464088|FG000|Overall Study|Death|2|||
128773967|NCT00109928|463464088|FG000|Overall Study|not protocol specified|2|||
128773968|NCT00109928|463464088|FG000|Overall Study|not eligible|1|||
128773969|NCT01196104|463464089|FG000|Overall Study|Lost to Follow-up|1|||
128773970|NCT01196104|463464090|FG001|Overall Study|Lost to Follow-up|0|||
128773971|NCT01196104|463464089|FG000|Overall Study|Physician Decision|0|||
128773972|NCT01196104|463464090|FG001|Overall Study|Physician Decision|1|||
128773973|NCT01196104|463464089|FG000|Overall Study|Withdrawal by Subject|3|||
128773974|NCT01196104|463464090|FG001|Overall Study|Withdrawal by Subject|3|||
128773975|NCT01196104|463464089|FG000|Overall Study|Various|0|||
128773976|NCT01196104|463464090|FG001|Overall Study|Various|1|||
128773977|NCT00610675|463464091|FG000|Overall Study|Untreated|4|||
128773978|NCT00610675|463464091|FG000|Overall Study|Adverse Event|67|||
128773979|NCT00610675|463464091|FG000|Overall Study|Insufficient Effect|31|||
128773980|NCT00610675|463464091|FG000|Overall Study|Withdrawal by Subject|28|||
128773981|NCT00610675|463464091|FG000|Overall Study|Reasons unrelated to trial|27|||
128773982|NCT00610675|463464091|FG000|Overall Study|Lack of Compliance|7|||
128773983|NCT00610675|463464091|FG000|Overall Study|Lost to Follow-up|31|||
128773984|NCT00610675|463464091|FG000|Overall Study|Other reason (not specified)|25|||
128773985|NCT01316692|463464094|FG000|Overall Study|Adverse Event|5|||
128773986|NCT01316692|463464094|FG000|Overall Study|Disease Progression|7|||
128773987|NCT03772314|463464101|FG000|Overall Study|Adverse Event|7|||
128773988|NCT03772314|463464102|FG001|Overall Study|Adverse Event|2|||
128773989|NCT01536145|463464103|FG000|Overall Study|Progressive disease|3|||
128773990|NCT01536145|463464104|FG001|Overall Study|Progressive disease|4|||
128773991|NCT01536145|463464105|FG002|Overall Study|Progressive disease|1|||
128773992|NCT01536145|463464106|FG003|Overall Study|Progressive disease|2|||
128773993|NCT01536145|463464107|FG004|Overall Study|Progressive disease|1|||
128773994|NCT01536145|463464108|FG005|Overall Study|Progressive disease|2|||
128773995|NCT01536145|463464109|FG006|Overall Study|Progressive disease|1|||
128773996|NCT01536145|463464110|FG007|Overall Study|Progressive disease|2|||
128773997|NCT01536145|463464111|FG008|Overall Study|Progressive disease|1|||
128773998|NCT01536145|463464112|FG009|Overall Study|Progressive disease|3|||
128773999|NCT01536145|463464113|FG010|Overall Study|Progressive disease|3|||
128774000|NCT01536145|463464103|FG000|Overall Study|Withdrawal by Subject|0|||
128774001|NCT01536145|463464104|FG001|Overall Study|Withdrawal by Subject|0|||
129038084|NCT01435031|464430599|FG000|ITT at 6 Months|Lost to Follow-up|3|||
129038085|NCT01435031|464430599|FG000|ITT at 1 Year|Death|1|||
128774002|NCT01536145|463464105|FG002|Overall Study|Withdrawal by Subject|1|||
128774003|NCT01536145|463464106|FG003|Overall Study|Withdrawal by Subject|0|||
128774004|NCT01536145|463464107|FG004|Overall Study|Withdrawal by Subject|0|||
128774005|NCT01536145|463464108|FG005|Overall Study|Withdrawal by Subject|1|||
128774006|NCT01536145|463464109|FG006|Overall Study|Withdrawal by Subject|0|||
128774007|NCT01536145|463464110|FG007|Overall Study|Withdrawal by Subject|0|||
128774008|NCT01536145|463464111|FG008|Overall Study|Withdrawal by Subject|2|||
128774009|NCT01536145|463464112|FG009|Overall Study|Withdrawal by Subject|0|||
128774010|NCT01536145|463464113|FG010|Overall Study|Withdrawal by Subject|2|||
128774011|NCT01536145|463464103|FG000|Overall Study|Other|0|||
128774012|NCT01536145|463464104|FG001|Overall Study|Other|0|||
128774013|NCT01536145|463464105|FG002|Overall Study|Other|0|||
128774014|NCT01536145|463464106|FG003|Overall Study|Other|0|||
128774015|NCT01536145|463464107|FG004|Overall Study|Other|1|||
128774016|NCT01536145|463464108|FG005|Overall Study|Other|0|||
128774017|NCT01536145|463464109|FG006|Overall Study|Other|0|||
128774018|NCT01536145|463464110|FG007|Overall Study|Other|0|||
128774019|NCT01536145|463464111|FG008|Overall Study|Other|0|||
128774020|NCT01536145|463464112|FG009|Overall Study|Other|3|||
128774021|NCT01536145|463464113|FG010|Overall Study|Other|2|||
128774022|NCT01536145|463464103|FG000|Overall Study|Death|0|||
128774023|NCT01536145|463464104|FG001|Overall Study|Death|0|||
128774024|NCT01536145|463464105|FG002|Overall Study|Death|0|||
128774025|NCT01536145|463464106|FG003|Overall Study|Death|0|||
128774026|NCT01536145|463464107|FG004|Overall Study|Death|0|||
129130678|NCT05059080|464769667|FG000|Overall Study|Withdrawal by Subject|3|||
129130679|NCT05059080|464769667|FG000|Overall Study|Study Terminated by Sponsor|64|||
129130680|NCT00195429|464769671|FG000|Overall Study|Adverse Event|2|||
129130681|NCT00195429|464769672|FG001|Overall Study|Adverse Event|4|||
129130682|NCT00195429|464769671|FG000|Overall Study|Lack of Efficacy|2|||
129130683|NCT00195429|464769672|FG001|Overall Study|Lack of Efficacy|1|||
129130684|NCT00195429|464769671|FG000|Overall Study|Lost to Follow-up|1|||
129130685|NCT00195429|464769672|FG001|Overall Study|Lost to Follow-up|0|||
129130686|NCT02541903|464769673|FG000|Overall Study|Death|1|||
129130687|NCT04795323|464769676|FG000|Overall Study|Did not interact with TARA|1|||
129130688|NCT04795323|464769677|FG001|Overall Study|Did not interact with TARA|0|||
128774027|NCT01536145|463464108|FG005|Overall Study|Death|0|||
128774028|NCT01536145|463464109|FG006|Overall Study|Death|1|||
128774029|NCT01536145|463464110|FG007|Overall Study|Death|0|||
128774030|NCT01536145|463464111|FG008|Overall Study|Death|0|||
128774031|NCT01536145|463464112|FG009|Overall Study|Death|0|||
128774032|NCT01536145|463464113|FG010|Overall Study|Death|0|||
129130689|NCT03142750|464769679|FG000|Overall Study|Lost to Follow-up|4|||
129130690|NCT03142750|464769680|FG001|Overall Study|Lost to Follow-up|1|||
129130691|NCT04925934|464769681|FG000|Overall Study|Adverse Event|1|||
129130692|NCT04925934|464769682|FG001|Overall Study|Adverse Event|0|||
128774033|NCT01536145|463464103|FG000|Overall Study|Adverse Event|0|||
128969508|NCT02614261|464173990|FG000|Follow-up Phase|Protocol Violation|1|||
129130693|NCT04925934|464769683|FG002|Overall Study|Adverse Event|0|||
129130694|NCT04925934|464769681|FG000|Overall Study|Lost to Follow-up|2|||
129130695|NCT04925934|464769682|FG001|Overall Study|Lost to Follow-up|0|||
129130696|NCT04925934|464769683|FG002|Overall Study|Lost to Follow-up|1|||
129130697|NCT04925934|464769681|FG000|Overall Study|Death|0|||
129130698|NCT04925934|464769682|FG001|Overall Study|Death|1|||
129130699|NCT04925934|464769683|FG002|Overall Study|Death|0|||
129130700|NCT04925934|464769681|FG000|Overall Study|Withdrawal by Subject|8|||
129130701|NCT04925934|464769682|FG001|Overall Study|Withdrawal by Subject|5|||
129130702|NCT04925934|464769683|FG002|Overall Study|Withdrawal by Subject|9|||
129130703|NCT04925934|464769681|FG000|Overall Study|Other|2|||
129130704|NCT04925934|464769682|FG001|Overall Study|Other|2|||
129130705|NCT04925934|464769683|FG002|Overall Study|Other|2|||
129130706|NCT04925934|464769681|FG000|Overall Study|Eastern European Conflict|7|||
129130707|NCT04925934|464769682|FG001|Overall Study|Eastern European Conflict|3|||
129130708|NCT04925934|464769683|FG002|Overall Study|Eastern European Conflict|2|||
129130709|NCT03158688|464769684|FG000|Overall Study|Withdrawal by Subject|14|||
129130710|NCT03158688|464769685|FG001|Overall Study|Withdrawal by Subject|28|||
129220433|NCT01104311|465106600|FG000|Overall Study|Protocol Violation|0|||
129220434|NCT01104311|465106601|FG001|Overall Study|Protocol Violation|1|||
128774034|NCT01536145|463464104|FG001|Overall Study|Adverse Event|0|||
128969509|NCT02614261|464173991|FG001|Follow-up Phase|Protocol Violation|0|||
128969510|NCT02614261|464173992|FG002|Follow-up Phase|Protocol Violation|0|||
128969511|NCT02614261|464173993|FG003|Follow-up Phase|Protocol Violation|0|||
128969512|NCT02614261|464173990|FG000|Follow-up Phase|Withdrawal by Subject|12|||
128969513|NCT02614261|464173991|FG001|Follow-up Phase|Withdrawal by Subject|4|||
128969514|NCT02614261|464173992|FG002|Follow-up Phase|Withdrawal by Subject|11|||
128969515|NCT02614261|464173993|FG003|Follow-up Phase|Withdrawal by Subject|0|||
128969516|NCT02614261|464173990|FG000|Israel Addendum|Withdrawal by Subject|0|||
128969517|NCT02614261|464173991|FG001|Israel Addendum|Withdrawal by Subject|0|||
128969518|NCT02614261|464173992|FG002|Israel Addendum|Withdrawal by Subject|0|||
128969519|NCT02614261|464173993|FG003|Israel Addendum|Withdrawal by Subject|4|||
128969520|NCT03073200|464174002|FG000|Double Blind Treatment Period|Protocol Violation|1|||
128969521|NCT03073200|464174003|FG001|Double Blind Treatment Period|Protocol Violation|0|||
128969522|NCT03073200|464174004|FG002|Double Blind Treatment Period|Protocol Violation|0|||
128969523|NCT03073200|464174005|FG003|Double Blind Treatment Period|Protocol Violation|0|||
128969524|NCT03073200|464174006|FG004|Double Blind Treatment Period|Protocol Violation|0|||
128969525|NCT03073200|464174007|FG005|Double Blind Treatment Period|Protocol Violation|0|||
128969526|NCT03073200|464174008|FG006|Double Blind Treatment Period|Protocol Violation|0|||
128969527|NCT03073200|464174009|FG007|Double Blind Treatment Period|Protocol Violation|0|||
128969528|NCT03073200|464174010|FG008|Double Blind Treatment Period|Protocol Violation|0|||
128969529|NCT03073200|464174011|FG009|Double Blind Treatment Period|Protocol Violation|0|||
128969530|NCT03073200|464174012|FG010|Double Blind Treatment Period|Protocol Violation|0|||
129220435|NCT01104311|465106600|FG000|Overall Study|Physician Decision|2|||
128774035|NCT01536145|463464105|FG002|Overall Study|Adverse Event|0|||
128774036|NCT01536145|463464106|FG003|Overall Study|Adverse Event|0|||
129130711|NCT03158688|464769684|FG000|Overall Study|Decision by sponsor|13|||
129130712|NCT03158688|464769685|FG001|Overall Study|Decision by sponsor|37|||
129130713|NCT03158688|464769684|FG000|Overall Study|Lost to Follow-up|4|||
129130714|NCT03158688|464769685|FG001|Overall Study|Lost to Follow-up|3|||
129130715|NCT03158688|464769684|FG000|Overall Study|Death|74|||
129130716|NCT03158688|464769685|FG001|Overall Study|Death|142|||
129130717|NCT00374868|464769689|FG000|Overall Study|Adverse Event|12|||
129130718|NCT00374868|464769689|FG000|Overall Study|Progressive Disease|7|||
129130719|NCT00374868|464769689|FG000|Overall Study|Physician Decision|13|||
129220436|NCT01104311|465106601|FG001|Overall Study|Physician Decision|2|||
129130720|NCT00374868|464769689|FG000|Overall Study|Lost to Follow-up|1|||
129130721|NCT00374868|464769689|FG000|Overall Study|Death|2|||
129130722|NCT00374868|464769689|FG000|Overall Study|Other - Not Specified|1|||
129130723|NCT03188185|464769690|FG000|Stage 1|Adverse Event|4|||
129130724|NCT03188185|464769691|FG001|Stage 1|Adverse Event|12|||
129130725|NCT03188185|464769692|FG002|Stage 1|Adverse Event|0|||
129130726|NCT03188185|464769693|FG003|Stage 1|Adverse Event|0|||
129130727|NCT03188185|464769690|FG000|Stage 1|Lack of Efficacy|0|||
129130728|NCT03188185|464769691|FG001|Stage 1|Lack of Efficacy|2|||
129130729|NCT03188185|464769692|FG002|Stage 1|Lack of Efficacy|0|||
129130730|NCT03188185|464769693|FG003|Stage 1|Lack of Efficacy|0|||
129130731|NCT03188185|464769690|FG000|Stage 1|Lost to Follow-up|6|||
129130732|NCT03188185|464769691|FG001|Stage 1|Lost to Follow-up|1|||
129130733|NCT03188185|464769692|FG002|Stage 1|Lost to Follow-up|0|||
129130734|NCT03188185|464769693|FG003|Stage 1|Lost to Follow-up|0|||
129130735|NCT03188185|464769690|FG000|Stage 1|Withdrawal by Subject|9|||
129130736|NCT03188185|464769691|FG001|Stage 1|Withdrawal by Subject|0|||
129130737|NCT03188185|464769692|FG002|Stage 1|Withdrawal by Subject|0|||
129130738|NCT03188185|464769693|FG003|Stage 1|Withdrawal by Subject|0|||
128714797|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Adverse Event|82|||
128714798|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Death|6|||
128714799|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
128714800|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
128714801|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
128714802|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
128714803|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
128714804|NCT00195676|463252372|FG000|Period O - Open-label Treatment|Other reasons|68|||
128714805|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
128714806|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
128714807|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
128714808|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
128714809|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
128969531|NCT03073200|464174013|FG011|Double Blind Treatment Period|Protocol Violation|0|||
128969532|NCT03073200|464174014|FG012|Double Blind Treatment Period|Protocol Violation|0|||
128969533|NCT03073200|464174015|FG013|Double Blind Treatment Period|Protocol Violation|0|||
128969534|NCT03073200|464174016|FG014|Double Blind Treatment Period|Protocol Violation|0|||
128969535|NCT03073200|464174002|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969536|NCT03073200|464174003|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
128969537|NCT03073200|464174004|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969538|NCT03073200|464174005|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969539|NCT03073200|464174006|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969540|NCT03073200|464174007|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969541|NCT03073200|464174008|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969542|NCT03073200|464174009|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969543|NCT03073200|464174010|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969544|NCT03073200|464174011|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969545|NCT03073200|464174012|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969546|NCT03073200|464174013|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969547|NCT03073200|464174014|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969548|NCT03073200|464174015|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969549|NCT03073200|464174016|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
128969550|NCT03073200|464174002|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
128969551|NCT03073200|464174003|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969552|NCT03073200|464174004|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969553|NCT03073200|464174005|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969554|NCT03073200|464174006|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969555|NCT03073200|464174007|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
128714810|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
128969556|NCT03073200|464174008|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969557|NCT03073200|464174009|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969558|NCT03073200|464174010|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969559|NCT03073200|464174011|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969560|NCT03073200|464174012|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969561|NCT03073200|464174013|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
129130739|NCT03188185|464769690|FG000|Stage 1|Identified as a professional patient|0|||
129130740|NCT03188185|464769691|FG001|Stage 1|Identified as a professional patient|1|||
129130741|NCT03188185|464769692|FG002|Stage 1|Identified as a professional patient|0|||
129130742|NCT03188185|464769693|FG003|Stage 1|Identified as a professional patient|0|||
129130743|NCT03188185|464769690|FG000|Stage 2|Adverse Event|0|||
129130744|NCT03188185|464769691|FG001|Stage 2|Adverse Event|0|||
128714811|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
128969562|NCT03073200|464174014|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969563|NCT03073200|464174015|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969564|NCT03073200|464174016|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
128969565|NCT03073200|464174002|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969566|NCT03073200|464174003|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969567|NCT03073200|464174004|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969568|NCT03073200|464174005|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
128969569|NCT03073200|464174006|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
128969570|NCT03073200|464174007|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969571|NCT03073200|464174008|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969572|NCT03073200|464174009|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969573|NCT03073200|464174010|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969574|NCT03073200|464174011|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969575|NCT03073200|464174012|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969576|NCT03073200|464174013|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969577|NCT03073200|464174014|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969578|NCT03073200|464174015|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969579|NCT03073200|464174016|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
128969580|NCT03073200|464174002|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
128969581|NCT03073200|464174003|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
128969582|NCT03073200|464174004|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
128969583|NCT03073200|464174005|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
128969584|NCT03073200|464174006|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
128969585|NCT03073200|464174007|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
128969586|NCT03073200|464174008|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
128969587|NCT03073200|464174009|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
128969588|NCT03073200|464174010|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
128969589|NCT03073200|464174011|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
128969590|NCT03073200|464174012|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
128969591|NCT03073200|464174013|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
128969592|NCT03073200|464174014|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
128969593|NCT03073200|464174015|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
128969594|NCT03073200|464174016|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
128969595|NCT03073200|464174002|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969596|NCT03073200|464174003|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969597|NCT03073200|464174004|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969598|NCT03073200|464174005|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969599|NCT03073200|464174006|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
128969600|NCT03073200|464174007|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969601|NCT03073200|464174008|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969602|NCT03073200|464174009|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969603|NCT03073200|464174010|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969604|NCT03073200|464174011|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969605|NCT03073200|464174012|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969606|NCT03073200|464174013|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969607|NCT03073200|464174014|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969608|NCT03073200|464174015|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969609|NCT03073200|464174016|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
128969610|NCT03073200|464174002|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969611|NCT03073200|464174003|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969612|NCT03073200|464174004|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969613|NCT03073200|464174005|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
128969614|NCT03073200|464174006|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
128969615|NCT03073200|464174007|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969616|NCT03073200|464174008|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969617|NCT03073200|464174009|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969618|NCT03073200|464174010|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969619|NCT03073200|464174011|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969620|NCT03073200|464174012|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969621|NCT03073200|464174013|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969622|NCT03073200|464174014|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
128969623|NCT03073200|464174015|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129130745|NCT03188185|464769692|FG002|Stage 2|Adverse Event|2|||
129130746|NCT03188185|464769693|FG003|Stage 2|Adverse Event|4|||
128969624|NCT03073200|464174016|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129130747|NCT03188185|464769690|FG000|Stage 2|Lack of Efficacy|0|||
128714812|NCT00195676|463252372|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
128714813|NCT00195676|463252372|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
128714814|NCT00195676|463252372|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
128969625|NCT03073200|464174002|FG000|Extension Period|Lost to Follow-up|0|||
128969626|NCT03073200|464174003|FG001|Extension Period|Lost to Follow-up|0|||
128969627|NCT03073200|464174004|FG002|Extension Period|Lost to Follow-up|0|||
128969628|NCT03073200|464174005|FG003|Extension Period|Lost to Follow-up|0|||
128969629|NCT03073200|464174006|FG004|Extension Period|Lost to Follow-up|0|||
128969630|NCT03073200|464174007|FG005|Extension Period|Lost to Follow-up|0|||
128969631|NCT03073200|464174008|FG006|Extension Period|Lost to Follow-up|1|||
128969632|NCT03073200|464174009|FG007|Extension Period|Lost to Follow-up|1|||
128969633|NCT03073200|464174010|FG008|Extension Period|Lost to Follow-up|0|||
128969634|NCT03073200|464174011|FG009|Extension Period|Lost to Follow-up|0|||
128969635|NCT03073200|464174012|FG010|Extension Period|Lost to Follow-up|0|||
128969636|NCT03073200|464174013|FG011|Extension Period|Lost to Follow-up|0|||
128969637|NCT03073200|464174014|FG012|Extension Period|Lost to Follow-up|0|||
128969638|NCT03073200|464174015|FG013|Extension Period|Lost to Follow-up|0|||
128969639|NCT03073200|464174016|FG014|Extension Period|Lost to Follow-up|0|||
128969640|NCT03073200|464174002|FG000|Extension Period|Sponsor Decision|0|||
128969641|NCT03073200|464174003|FG001|Extension Period|Sponsor Decision|0|||
128969642|NCT03073200|464174004|FG002|Extension Period|Sponsor Decision|0|||
128969643|NCT03073200|464174005|FG003|Extension Period|Sponsor Decision|0|||
128969644|NCT03073200|464174006|FG004|Extension Period|Sponsor Decision|0|||
128969645|NCT03073200|464174007|FG005|Extension Period|Sponsor Decision|0|||
128969646|NCT03073200|464174008|FG006|Extension Period|Sponsor Decision|0|||
128969647|NCT03073200|464174009|FG007|Extension Period|Sponsor Decision|0|||
128969648|NCT03073200|464174010|FG008|Extension Period|Sponsor Decision|1|||
128969649|NCT03073200|464174011|FG009|Extension Period|Sponsor Decision|0|||
128969650|NCT03073200|464174012|FG010|Extension Period|Sponsor Decision|0|||
128969651|NCT03073200|464174013|FG011|Extension Period|Sponsor Decision|0|||
128969652|NCT03073200|464174014|FG012|Extension Period|Sponsor Decision|0|||
128969653|NCT03073200|464174015|FG013|Extension Period|Sponsor Decision|0|||
128969654|NCT03073200|464174016|FG014|Extension Period|Sponsor Decision|0|||
128969655|NCT03073200|464174002|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
128969656|NCT03073200|464174003|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
128969657|NCT03073200|464174004|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
128969658|NCT03073200|464174005|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
129038086|NCT01435031|464430599|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
129038087|NCT01435031|464430599|FG000|ITT at 1 Year|Lost to Follow-up|6|||
129038088|NCT01435031|464430599|FG000|ITT at 2 Years|Death|7|||
129038089|NCT01435031|464430599|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
129038090|NCT01435031|464430599|FG000|ITT at 2 Years|Lost to Follow-up|4|||
129038091|NCT01435031|464430599|FG000|ITT at 3 Years|Death|5|||
129038092|NCT01435031|464430599|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
129038093|NCT01435031|464430599|FG000|ITT at 3 Years|Lost to Follow-up|4|||
129038094|NCT01435031|464430599|FG000|ITT at 4 Years|Death|4|||
129038095|NCT01435031|464430599|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
129038096|NCT01435031|464430599|FG000|ITT at 4 Years|Lost to Follow-up|1|||
129038097|NCT02927834|464430600|FG000|Overall Study|Lost to Follow-up|1|||
129038098|NCT02927834|464430601|FG001|Overall Study|Lost to Follow-up|2|||
129038099|NCT02927834|464430602|FG002|Overall Study|Lost to Follow-up|2|||
129038100|NCT01867606|464430603|FG000|Overall Study|Withdrawal by Subject|10|||
129038101|NCT01867606|464430604|FG001|Overall Study|Withdrawal by Subject|14|||
129038102|NCT01867606|464430603|FG000|Overall Study|Protocol Violation|0|||
129038103|NCT01867606|464430604|FG001|Overall Study|Protocol Violation|1|||
129038104|NCT01662362|464430616|FG000|Overall Study|Lost to Follow-up|38|||
129038105|NCT01181531|464430621|FG000|Overall Study|Other|17|||
129038106|NCT01181531|464430622|FG001|Overall Study|Other|12|||
129038107|NCT01181531|464430621|FG000|Overall Study|Partial consent by subject withdrawn|0|||
129038108|NCT01181531|464430622|FG001|Overall Study|Partial consent by subject withdrawn|1|||
129038109|NCT01181531|464430621|FG000|Overall Study|Physician Decision|3|||
129038110|NCT01181531|464430622|FG001|Overall Study|Physician Decision|1|||
129038111|NCT01181531|464430621|FG000|Overall Study|Noncompliance|2|||
129038112|NCT01181531|464430622|FG001|Overall Study|Noncompliance|2|||
129038113|NCT01181531|464430621|FG000|Overall Study|Ineligibility determined|1|||
129038114|NCT01181531|464430622|FG001|Overall Study|Ineligibility determined|2|||
129038115|NCT01181531|464430621|FG000|Overall Study|Protocol Specified Criteria|15|||
129038116|NCT01181531|464430622|FG001|Overall Study|Protocol Specified Criteria|8|||
128969659|NCT03073200|464174006|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
128969660|NCT03073200|464174007|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
128969661|NCT03073200|464174008|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
129038117|NCT01181531|464430621|FG000|Overall Study|Pregnancy|0|||
129038118|NCT01181531|464430622|FG001|Overall Study|Pregnancy|1|||
129038119|NCT01181531|464430621|FG000|Overall Study|Withdrawal by Subject|8|||
129038120|NCT01181531|464430622|FG001|Overall Study|Withdrawal by Subject|7|||
129038121|NCT01181531|464430621|FG000|Overall Study|Protocol Violation|6|||
129038122|NCT01181531|464430622|FG001|Overall Study|Protocol Violation|6|||
129038123|NCT01181531|464430621|FG000|Overall Study|Death|9|||
129220437|NCT01104311|465106600|FG000|Overall Study|low compliance|1|||
128714815|NCT00195676|463252372|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
128969662|NCT03073200|464174009|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
128969663|NCT03073200|464174010|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
128969664|NCT03073200|464174011|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
128969665|NCT03073200|464174012|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
128969666|NCT03073200|464174013|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
128969667|NCT03073200|464174014|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
128969668|NCT03073200|464174015|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
128969669|NCT03073200|464174016|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
128969670|NCT03073200|464174002|FG000|Extension Period|Withdrawal by Subject|0|||
128969671|NCT03073200|464174003|FG001|Extension Period|Withdrawal by Subject|0|||
128969672|NCT03073200|464174004|FG002|Extension Period|Withdrawal by Subject|0|||
128969673|NCT03073200|464174005|FG003|Extension Period|Withdrawal by Subject|0|||
128969674|NCT03073200|464174006|FG004|Extension Period|Withdrawal by Subject|0|||
128969675|NCT03073200|464174007|FG005|Extension Period|Withdrawal by Subject|0|||
128969676|NCT03073200|464174008|FG006|Extension Period|Withdrawal by Subject|1|||
128969677|NCT03073200|464174009|FG007|Extension Period|Withdrawal by Subject|2|||
128969678|NCT03073200|464174010|FG008|Extension Period|Withdrawal by Subject|0|||
128969679|NCT03073200|464174011|FG009|Extension Period|Withdrawal by Subject|0|||
128969680|NCT03073200|464174012|FG010|Extension Period|Withdrawal by Subject|0|||
128969681|NCT03073200|464174013|FG011|Extension Period|Withdrawal by Subject|0|||
128969682|NCT03073200|464174014|FG012|Extension Period|Withdrawal by Subject|0|||
128969683|NCT03073200|464174015|FG013|Extension Period|Withdrawal by Subject|0|||
128969684|NCT03073200|464174016|FG014|Extension Period|Withdrawal by Subject|0|||
128969685|NCT03073200|464174002|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969686|NCT03073200|464174003|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969687|NCT03073200|464174004|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969688|NCT03073200|464174005|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969689|NCT03073200|464174006|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969690|NCT03073200|464174007|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969691|NCT03073200|464174008|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969692|NCT03073200|464174009|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969693|NCT03073200|464174010|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969694|NCT03073200|464174011|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969695|NCT03073200|464174012|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969696|NCT03073200|464174013|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
128969697|NCT03073200|464174014|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969698|NCT03073200|464174015|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969699|NCT03073200|464174016|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
128969700|NCT03073200|464174002|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969701|NCT03073200|464174003|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969702|NCT03073200|464174004|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969703|NCT03073200|464174005|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969704|NCT03073200|464174006|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969705|NCT03073200|464174007|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969706|NCT03073200|464174008|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969707|NCT03073200|464174009|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969708|NCT03073200|464174010|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969709|NCT03073200|464174011|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969710|NCT03073200|464174012|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969711|NCT03073200|464174013|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
128969712|NCT03073200|464174014|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969713|NCT03073200|464174015|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
128969714|NCT03073200|464174016|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129038124|NCT01181531|464430622|FG001|Overall Study|Death|12|||
129038125|NCT01181531|464430621|FG000|Overall Study|Adverse Event|0|||
129038126|NCT01181531|464430622|FG001|Overall Study|Adverse Event|1|||
129038127|NCT00987831|464430623|FG000|Overall Study|Never flared in 12 months|1|||
129038128|NCT00987831|464430624|FG001|Overall Study|Never flared in 12 months|0|||
129038129|NCT00987831|464430625|FG002|Overall Study|Never flared in 12 months|0|||
129038130|NCT00987831|464430623|FG000|Overall Study|Lost to Follow-up|0|||
129038131|NCT00987831|464430624|FG001|Overall Study|Lost to Follow-up|3|||
129038132|NCT00987831|464430625|FG002|Overall Study|Lost to Follow-up|0|||
129038133|NCT00810602|464430627|FG000|Overall Study|Withdrawal by Subject|8|||
129038134|NCT00810602|464430628|FG001|Overall Study|Withdrawal by Subject|3|||
129038135|NCT02792218|464430629|FG000|Overall Study|Patient/guardian decision|15|||
129038136|NCT02792218|464430630|FG001|Overall Study|Patient/guardian decision|42|||
129038137|NCT02792218|464430629|FG000|Overall Study|Adverse Event|15|||
129038138|NCT02792218|464430630|FG001|Overall Study|Adverse Event|14|||
128969715|NCT03073200|464174002|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969716|NCT03073200|464174003|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969717|NCT03073200|464174004|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969718|NCT03073200|464174005|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969719|NCT03073200|464174006|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969720|NCT03073200|464174007|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969721|NCT03073200|464174008|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969722|NCT03073200|464174009|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969723|NCT03073200|464174010|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969724|NCT03073200|464174011|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969725|NCT03073200|464174012|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
128969726|NCT03073200|464174013|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
128969727|NCT03073200|464174014|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969728|NCT03073200|464174015|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969729|NCT03073200|464174016|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
128969730|NCT03073200|464174002|FG000|Randomized Withdrawal Period|Adverse Event|0|||
128969731|NCT03073200|464174003|FG001|Randomized Withdrawal Period|Adverse Event|0|||
128969732|NCT03073200|464174004|FG002|Randomized Withdrawal Period|Adverse Event|0|||
128969733|NCT03073200|464174005|FG003|Randomized Withdrawal Period|Adverse Event|0|||
128969734|NCT03073200|464174006|FG004|Randomized Withdrawal Period|Adverse Event|0|||
128969735|NCT03073200|464174007|FG005|Randomized Withdrawal Period|Adverse Event|0|||
128969736|NCT03073200|464174008|FG006|Randomized Withdrawal Period|Adverse Event|0|||
128969737|NCT03073200|464174009|FG007|Randomized Withdrawal Period|Adverse Event|0|||
128969738|NCT03073200|464174010|FG008|Randomized Withdrawal Period|Adverse Event|0|||
128969739|NCT03073200|464174011|FG009|Randomized Withdrawal Period|Adverse Event|0|||
128969740|NCT03073200|464174012|FG010|Randomized Withdrawal Period|Adverse Event|1|||
128969741|NCT03073200|464174013|FG011|Randomized Withdrawal Period|Adverse Event|0|||
128969742|NCT03073200|464174014|FG012|Randomized Withdrawal Period|Adverse Event|0|||
128969743|NCT03073200|464174015|FG013|Randomized Withdrawal Period|Adverse Event|0|||
128969744|NCT03073200|464174016|FG014|Randomized Withdrawal Period|Adverse Event|0|||
128969745|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969746|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969747|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969748|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969749|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969750|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969751|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969752|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969753|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969754|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969755|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969756|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969757|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969758|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
128969759|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
128969760|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969761|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969762|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969763|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969764|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969765|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969766|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969767|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969768|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969769|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969770|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969771|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969772|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969773|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
128969774|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
128969775|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969776|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969777|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969778|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969779|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969780|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969781|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129130748|NCT03188185|464769691|FG001|Stage 2|Lack of Efficacy|0|||
129130749|NCT03188185|464769692|FG002|Stage 2|Lack of Efficacy|3|||
129130750|NCT03188185|464769693|FG003|Stage 2|Lack of Efficacy|0|||
129130751|NCT03188185|464769690|FG000|Stage 2|Lost to Follow-up|0|||
129130752|NCT03188185|464769691|FG001|Stage 2|Lost to Follow-up|0|||
129130753|NCT03188185|464769692|FG002|Stage 2|Lost to Follow-up|1|||
129130754|NCT03188185|464769693|FG003|Stage 2|Lost to Follow-up|0|||
129130755|NCT03188185|464769690|FG000|Stage 2|Physician Decision|0|||
129130756|NCT03188185|464769691|FG001|Stage 2|Physician Decision|0|||
129130757|NCT03188185|464769692|FG002|Stage 2|Physician Decision|0|||
128969782|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969783|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969784|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969785|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969786|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969787|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969788|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
128969789|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
128969790|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969791|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969792|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969793|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969794|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969795|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969796|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969797|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969798|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969799|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969800|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969801|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969802|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969803|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
128969804|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
128969805|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969806|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969807|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969808|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969809|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969810|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969811|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969812|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969813|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969814|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969815|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969816|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969817|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969818|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
128969819|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
128969820|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969821|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969822|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969823|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969824|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969825|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969826|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969827|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969828|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969829|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969830|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969831|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129130758|NCT03188185|464769693|FG003|Stage 2|Physician Decision|1|||
128714816|NCT00195676|463252372|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
128969832|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969833|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
129130759|NCT03188185|464769690|FG000|Stage 2|Withdrawal by Subject|0|||
129130760|NCT03188185|464769691|FG001|Stage 2|Withdrawal by Subject|0|||
129130761|NCT03188185|464769692|FG002|Stage 2|Withdrawal by Subject|3|||
128714817|NCT00195676|463252372|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
128969834|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
128969835|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969836|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969837|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969838|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969839|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969840|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969841|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969842|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969843|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969844|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969845|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969846|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969847|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969848|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
128969849|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128969850|NCT03073200|464174002|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969851|NCT03073200|464174003|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969852|NCT03073200|464174004|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969853|NCT03073200|464174005|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969854|NCT03073200|464174006|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969855|NCT03073200|464174007|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969856|NCT03073200|464174008|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969857|NCT03073200|464174009|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969858|NCT03073200|464174010|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969859|NCT03073200|464174011|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969860|NCT03073200|464174012|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969861|NCT03073200|464174013|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969862|NCT03073200|464174014|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969863|NCT03073200|464174015|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
128969864|NCT03073200|464174016|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
128969865|NCT03512275|464174017|FG000|Overall Study|Withdrawal by Subject|1|||
128969866|NCT03512275|464174018|FG001|Overall Study|Withdrawal by Subject|3|||
128969867|NCT03512275|464174017|FG000|Overall Study|Physician Decision|0|||
128969868|NCT03512275|464174018|FG001|Overall Study|Physician Decision|1|||
128969869|NCT03512275|464174017|FG000|Overall Study|Lost to Follow-up|0|||
128969870|NCT03512275|464174018|FG001|Overall Study|Lost to Follow-up|3|||
128969871|NCT03512275|464174017|FG000|Overall Study|Other|1|||
128969872|NCT03512275|464174018|FG001|Overall Study|Other|0|||
128969873|NCT04757376|464174019|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
128969874|NCT04757376|464174020|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
128969875|NCT04757376|464174021|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
128969876|NCT04757376|464174022|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
128969877|NCT04757376|464174023|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
128969878|NCT04757376|464174019|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
128969879|NCT04757376|464174020|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
128969880|NCT04757376|464174021|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
129038139|NCT02792218|464430629|FG000|Overall Study|Lost to Follow-up|10|||
129038140|NCT02792218|464430630|FG001|Overall Study|Lost to Follow-up|5|||
129038141|NCT02792218|464430629|FG000|Overall Study|Lack of Efficacy|1|||
129038142|NCT02792218|464430630|FG001|Overall Study|Lack of Efficacy|12|||
129038143|NCT02792218|464430629|FG000|Overall Study|Physician Decision|4|||
129038144|NCT02792218|464430630|FG001|Overall Study|Physician Decision|4|||
129038145|NCT02792218|464430629|FG000|Overall Study|Protocol deviation|3|||
129038146|NCT02792218|464430630|FG001|Overall Study|Protocol deviation|2|||
129038147|NCT02792218|464430629|FG000|Overall Study|New therapy for study indication|0|||
129038148|NCT02792218|464430630|FG001|Overall Study|New therapy for study indication|1|||
129038149|NCT02792218|464430629|FG000|Overall Study|Non-compliance with study treatment|0|||
129038150|NCT02792218|464430630|FG001|Overall Study|Non-compliance with study treatment|1|||
129038151|NCT02792218|464430629|FG000|Overall Study|Pregnancy|1|||
129038152|NCT02792218|464430630|FG001|Overall Study|Pregnancy|0|||
129038153|NCT00824369|464430631|FG000|Overall Study|Nolonger willing to participate in study|1|||
129038154|NCT00824369|464430632|FG001|Overall Study|Nolonger willing to participate in study|0|||
128969881|NCT04757376|464174022|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
129038155|NCT00824369|464430633|FG002|Overall Study|Nolonger willing to participate in study|1|||
129038156|NCT00824369|464430634|FG003|Overall Study|Nolonger willing to participate in study|2|||
129038157|NCT00824369|464430635|FG004|Overall Study|Nolonger willing to participate in study|0|||
128969882|NCT04757376|464174023|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
128969883|NCT04757376|464174019|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
128969884|NCT04757376|464174020|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
128969885|NCT04757376|464174021|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
128969886|NCT04757376|464174022|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
128969887|NCT04757376|464174023|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
128969888|NCT04757376|464174019|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
128969889|NCT04757376|464174020|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
128969890|NCT04757376|464174021|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
128969891|NCT04757376|464174022|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
128969892|NCT04757376|464174023|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
128969893|NCT04757376|464174019|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
128969894|NCT04757376|464174020|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
128969895|NCT04757376|464174021|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
128969896|NCT04757376|464174022|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
128969897|NCT04757376|464174023|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
128969898|NCT04757376|464174019|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
128969899|NCT04757376|464174020|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
128969900|NCT04757376|464174021|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
128969901|NCT04757376|464174022|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
128969902|NCT04757376|464174023|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
128969903|NCT04757376|464174019|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
128969904|NCT04757376|464174020|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
128969905|NCT04757376|464174021|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
128969906|NCT04757376|464174022|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
128969907|NCT04757376|464174023|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
128969908|NCT04757376|464174019|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
128969909|NCT04757376|464174020|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
128969910|NCT04757376|464174021|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
128969911|NCT04757376|464174022|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
128969912|NCT04757376|464174023|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
128969913|NCT00609167|464174024|FG000|Overall Study|Withdrawal by Subject|1|||
128969914|NCT00609167|464174025|FG001|Overall Study|Withdrawal by Subject|0|||
128969915|NCT00609167|464174024|FG000|Overall Study|Lack of Efficacy|1|||
128969916|NCT00609167|464174025|FG001|Overall Study|Lack of Efficacy|0|||
128969917|NCT00609167|464174024|FG000|Overall Study|Adverse Event|5|||
128969918|NCT00609167|464174025|FG001|Overall Study|Adverse Event|1|||
128969919|NCT00609167|464174024|FG000|Overall Study|Disease Progression|1|||
128969920|NCT00609167|464174025|FG001|Overall Study|Disease Progression|0|||
128969921|NCT00609167|464174024|FG000|Overall Study|Stem Cell Transplant|0|||
128969922|NCT00609167|464174025|FG001|Overall Study|Stem Cell Transplant|6|||
128969923|NCT01307046|464174026|FG000|Overall Study|Adverse Event|3|||
128969924|NCT01307046|464174027|FG001|Overall Study|Adverse Event|3|||
128969925|NCT01307046|464174026|FG000|Overall Study|Lack of Efficacy|0|||
128969926|NCT01307046|464174027|FG001|Overall Study|Lack of Efficacy|2|||
128969927|NCT01307046|464174026|FG000|Overall Study|Physician Decision|2|||
128969928|NCT01307046|464174027|FG001|Overall Study|Physician Decision|0|||
128969929|NCT01307046|464174026|FG000|Overall Study|Withdrawal by Subject|1|||
128969930|NCT01307046|464174027|FG001|Overall Study|Withdrawal by Subject|1|||
128969931|NCT01307046|464174026|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
128969932|NCT01307046|464174027|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
128969933|NCT01307046|464174026|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
128969934|NCT01307046|464174027|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
128969935|NCT02574520|464174028|FG000|Overall Study|Not dosed|2|||
128969936|NCT02574520|464174029|FG001|Overall Study|Not dosed|0|||
128969937|NCT02574520|464174030|FG002|Overall Study|Not dosed|5|||
128969938|NCT02574520|464174031|FG003|Overall Study|Not dosed|4|||
128969939|NCT02574520|464174028|FG000|Overall Study|Adverse Event|0|||
128714818|NCT01189812|463252373|FG000|Overall Study|Withdrawal by Subject|2|||
128714819|NCT01189812|463252374|FG001|Overall Study|Withdrawal by Subject|3|||
128714820|NCT01189812|463252373|FG000|Overall Study|Adverse Event|1|||
128969940|NCT02574520|464174029|FG001|Overall Study|Adverse Event|0|||
128714821|NCT01189812|463252374|FG001|Overall Study|Adverse Event|0|||
128714822|NCT01189812|463252373|FG000|Overall Study|Out of Window|4|||
128714823|NCT01189812|463252374|FG001|Overall Study|Out of Window|3|||
129130762|NCT03188185|464769693|FG003|Stage 2|Withdrawal by Subject|1|||
129130763|NCT02315625|464769697|FG000|First Intervention|Disease Progression|1|||
129130764|NCT02315625|464769698|FG001|First Intervention|Disease Progression|0|||
128969941|NCT02574520|464174030|FG002|Overall Study|Adverse Event|0|||
128969942|NCT02574520|464174031|FG003|Overall Study|Adverse Event|1|||
128969943|NCT02574520|464174028|FG000|Overall Study|Withdrawal by Subject|0|||
128969944|NCT02574520|464174029|FG001|Overall Study|Withdrawal by Subject|0|||
128969945|NCT02574520|464174030|FG002|Overall Study|Withdrawal by Subject|0|||
128969946|NCT02574520|464174031|FG003|Overall Study|Withdrawal by Subject|1|||
128969947|NCT02574520|464174028|FG000|Overall Study|Other|0|||
128969948|NCT02574520|464174029|FG001|Overall Study|Other|0|||
128969949|NCT02574520|464174030|FG002|Overall Study|Other|0|||
128969950|NCT02574520|464174031|FG003|Overall Study|Other|2|||
128969951|NCT01365091|464174034|FG000|Period 1|Adverse Event|1|||
128969952|NCT01365091|464174035|FG001|Period 1|Adverse Event|0|||
128969953|NCT01365091|464174036|FG002|Period 1|Adverse Event|2|||
128969954|NCT01365091|464174037|FG003|Period 1|Adverse Event|3|||
128969955|NCT01365091|464174034|FG000|Period 1|Positive test result for drugs of abuse|1|||
128969956|NCT01365091|464174035|FG001|Period 1|Positive test result for drugs of abuse|0|||
128969957|NCT01365091|464174036|FG002|Period 1|Positive test result for drugs of abuse|0|||
128969958|NCT01365091|464174037|FG003|Period 1|Positive test result for drugs of abuse|0|||
128969959|NCT01365091|464174034|FG000|Period 1|No longer met study criteria|0|||
128969960|NCT01365091|464174035|FG001|Period 1|No longer met study criteria|1|||
128969961|NCT01365091|464174036|FG002|Period 1|No longer met study criteria|0|||
128969962|NCT01365091|464174037|FG003|Period 1|No longer met study criteria|0|||
128969963|NCT01365091|464174034|FG000|Period 1|Withdrawal by Subject|0|||
128969964|NCT01365091|464174035|FG001|Period 1|Withdrawal by Subject|1|||
128969965|NCT01365091|464174036|FG002|Period 1|Withdrawal by Subject|0|||
128969966|NCT01365091|464174037|FG003|Period 1|Withdrawal by Subject|0|||
128969967|NCT01365091|464174034|FG000|Period 1|Personal reasons|0|||
128969968|NCT01365091|464174035|FG001|Period 1|Personal reasons|0|||
128969969|NCT01365091|464174036|FG002|Period 1|Personal reasons|1|||
128969970|NCT01365091|464174037|FG003|Period 1|Personal reasons|0|||
128969971|NCT01365091|464174034|FG000|Period 2|Withdrawal by Subject|1|||
128969972|NCT01365091|464174035|FG001|Period 2|Withdrawal by Subject|0|||
128969973|NCT01365091|464174036|FG002|Period 2|Withdrawal by Subject|0|||
128969974|NCT01365091|464174037|FG003|Period 2|Withdrawal by Subject|0|||
128969975|NCT01365091|464174034|FG000|Period 2|Adverse Event|0|||
128969976|NCT01365091|464174035|FG001|Period 2|Adverse Event|0|||
128969977|NCT01365091|464174036|FG002|Period 2|Adverse Event|1|||
128969978|NCT01365091|464174037|FG003|Period 2|Adverse Event|0|||
128969979|NCT05116683|464174038|FG000|Overall Study|Physician Decision|4|||
128969980|NCT03935594|464174040|FG000|Overall Study|Physician Decision|3|||
128969981|NCT01435122|464174041|FG000|Overall Study|Early withdrawal due to toxicity|8|||
128969982|NCT03695471|464175319|FG000|Overall Study|Cancellation|1|||
128969983|NCT02859558|464175320|FG000|Step 1|Not Eligible|0|||
128969984|NCT02859558|464175321|FG001|Step 1|Not Eligible|0|||
128969985|NCT02859558|464175322|FG002|Step 1|Not Eligible|0|||
128969986|NCT02859558|464175323|FG003|Step 1|Not Eligible|0|||
128969987|NCT02859558|464175324|FG004|Step 1|Not Eligible|3|||
128969988|NCT02859558|464175320|FG000|Step 1|Lost to Follow-up|1|||
128969989|NCT02859558|464175321|FG001|Step 1|Lost to Follow-up|3|||
128969990|NCT02859558|464175322|FG002|Step 1|Lost to Follow-up|3|||
128969991|NCT02859558|464175323|FG003|Step 1|Lost to Follow-up|0|||
128969992|NCT02859558|464175324|FG004|Step 1|Lost to Follow-up|0|||
128969993|NCT02859558|464175320|FG000|Step 1|Did Not Return to Clinic|2|||
128969994|NCT02859558|464175321|FG001|Step 1|Did Not Return to Clinic|3|||
128969995|NCT02859558|464175322|FG002|Step 1|Did Not Return to Clinic|4|||
128969996|NCT02859558|464175323|FG003|Step 1|Did Not Return to Clinic|0|||
128969997|NCT02859558|464175324|FG004|Step 1|Did Not Return to Clinic|0|||
128969998|NCT02859558|464175320|FG000|Step 1|Moved|0|||
128969999|NCT02859558|464175321|FG001|Step 1|Moved|1|||
128970000|NCT02859558|464175322|FG002|Step 1|Moved|1|||
128970001|NCT02859558|464175323|FG003|Step 1|Moved|0|||
128970002|NCT02859558|464175324|FG004|Step 1|Moved|0|||
128970003|NCT02859558|464175320|FG000|Step 1|Withdrawal By Participant|1|||
128970004|NCT02859558|464175321|FG001|Step 1|Withdrawal By Participant|2|||
128970005|NCT02859558|464175322|FG002|Step 1|Withdrawal By Participant|1|||
128970006|NCT02859558|464175323|FG003|Step 1|Withdrawal By Participant|0|||
128970007|NCT02859558|464175324|FG004|Step 1|Withdrawal By Participant|0|||
128970008|NCT02859558|464175320|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
128970009|NCT02859558|464175321|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
128970010|NCT02859558|464175322|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
128970011|NCT02859558|464175323|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
129130765|NCT02315625|464769697|FG000|Second Intervention|Physician Decision|2|||
128970012|NCT02859558|464175324|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
128970013|NCT02859558|464175320|FG000|Step 1|Incarceration|0|||
128970014|NCT02859558|464175321|FG001|Step 1|Incarceration|1|||
128970015|NCT02859558|464175322|FG002|Step 1|Incarceration|0|||
128970016|NCT02859558|464175323|FG003|Step 1|Incarceration|0|||
128970017|NCT02859558|464175324|FG004|Step 1|Incarceration|0|||
129130766|NCT02315625|464769698|FG001|Second Intervention|Physician Decision|1|||
128970018|NCT02859558|464175320|FG000|Step 1|Non-Adherence to Study Drug|2|||
128970019|NCT02859558|464175321|FG001|Step 1|Non-Adherence to Study Drug|0|||
128970020|NCT02859558|464175322|FG002|Step 1|Non-Adherence to Study Drug|1|||
128970021|NCT02859558|464175323|FG003|Step 1|Non-Adherence to Study Drug|0|||
128970022|NCT02859558|464175324|FG004|Step 1|Non-Adherence to Study Drug|0|||
128970023|NCT02859558|464175320|FG000|Step 1|Non-Adherence to Study Requirements|3|||
128970024|NCT02859558|464175321|FG001|Step 1|Non-Adherence to Study Requirements|1|||
128970025|NCT02859558|464175322|FG002|Step 1|Non-Adherence to Study Requirements|0|||
128970026|NCT02859558|464175323|FG003|Step 1|Non-Adherence to Study Requirements|0|||
128970027|NCT02859558|464175324|FG004|Step 1|Non-Adherence to Study Requirements|0|||
128970028|NCT02859558|464175320|FG000|Step 1|Virologic Failure|2|||
128970029|NCT02859558|464175321|FG001|Step 1|Virologic Failure|1|||
128970030|NCT02859558|464175322|FG002|Step 1|Virologic Failure|1|||
128970031|NCT02859558|464175323|FG003|Step 1|Virologic Failure|0|||
128970032|NCT02859558|464175324|FG004|Step 1|Virologic Failure|0|||
128970033|NCT02859558|464175320|FG000|Step 2|Lost to Follow-up|3|||
128970034|NCT02859558|464175321|FG001|Step 2|Lost to Follow-up|3|||
128970035|NCT02859558|464175322|FG002|Step 2|Lost to Follow-up|1|||
128970036|NCT02859558|464175323|FG003|Step 2|Lost to Follow-up|0|||
128970037|NCT02859558|464175324|FG004|Step 2|Lost to Follow-up|0|||
128970038|NCT02859558|464175320|FG000|Step 2|Withdrawal by Subject|0|||
128970039|NCT02859558|464175321|FG001|Step 2|Withdrawal by Subject|1|||
128970040|NCT02859558|464175322|FG002|Step 2|Withdrawal by Subject|1|||
128970041|NCT02859558|464175323|FG003|Step 2|Withdrawal by Subject|0|||
128970042|NCT02859558|464175324|FG004|Step 2|Withdrawal by Subject|0|||
128970043|NCT02859558|464175320|FG000|Step 2|Unexpected Closure of Site|0|||
128970044|NCT02859558|464175321|FG001|Step 2|Unexpected Closure of Site|1|||
128970045|NCT02859558|464175322|FG002|Step 2|Unexpected Closure of Site|1|||
128970046|NCT02859558|464175323|FG003|Step 2|Unexpected Closure of Site|0|||
128970047|NCT02859558|464175324|FG004|Step 2|Unexpected Closure of Site|0|||
128970048|NCT02859558|464175320|FG000|Step 2|Death|1|||
128970049|NCT02859558|464175321|FG001|Step 2|Death|0|||
128970050|NCT02859558|464175322|FG002|Step 2|Death|0|||
128970051|NCT02859558|464175323|FG003|Step 2|Death|0|||
128970052|NCT02859558|464175324|FG004|Step 2|Death|0|||
128970053|NCT02859558|464175320|FG000|Step 2|Incarceration|0|||
128970054|NCT02859558|464175321|FG001|Step 2|Incarceration|0|||
128970055|NCT02859558|464175322|FG002|Step 2|Incarceration|1|||
128970056|NCT02859558|464175323|FG003|Step 2|Incarceration|0|||
128970057|NCT02859558|464175324|FG004|Step 2|Incarceration|0|||
128970058|NCT05665595|464175325|FG000|Overall Study|Ongoing|692|||
128970059|NCT05665595|464175326|FG001|Overall Study|Ongoing|698|||
128970060|NCT05665595|464175325|FG000|Overall Study|Withdrawal by Subject|2|||
128970061|NCT05665595|464175326|FG001|Overall Study|Withdrawal by Subject|2|||
128970062|NCT05665595|464175325|FG000|Overall Study|Lost to Follow-up|1|||
128970063|NCT05665595|464175326|FG001|Overall Study|Lost to Follow-up|0|||
128970064|NCT05665595|464175325|FG000|Overall Study|Death|6|||
128970065|NCT05665595|464175326|FG001|Overall Study|Death|1|||
128970066|NCT00766142|464175327|FG000|Overall Study|Protocol Violation|4|||
128970067|NCT04076579|464175343|FG000|Overall Study|Adverse Event|2|||
128970068|NCT04076579|464175344|FG001|Overall Study|Adverse Event|0|||
128970069|NCT04076579|464175343|FG000|Overall Study|discontinued due to toxicity|1|||
128970070|NCT04076579|464175344|FG001|Overall Study|discontinued due to toxicity|0|||
128970071|NCT04076579|464175343|FG000|Overall Study|Physician Decision|1|||
128970072|NCT04076579|464175344|FG001|Overall Study|Physician Decision|0|||
128970073|NCT04076579|464175343|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
128970074|NCT04076579|464175344|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
128970075|NCT04076579|464175343|FG000|Overall Study|Noncompliance|0|||
129130767|NCT02315625|464769697|FG000|Second Intervention|Study closure|1|||
129130768|NCT02315625|464769698|FG001|Second Intervention|Study closure|0|||
129130769|NCT02315625|464769697|FG000|Second Intervention|Disease Progression|1|||
129130770|NCT02315625|464769698|FG001|Second Intervention|Disease Progression|0|||
129130771|NCT04822194|464769701|FG000|Overall Study|Withdrawal by Subject|5|||
129130772|NCT04822194|464769702|FG001|Overall Study|Withdrawal by Subject|4|||
128970076|NCT04076579|464175344|FG001|Overall Study|Noncompliance|1|||
128970077|NCT04076579|464175343|FG000|Overall Study|Withdrawal by Subject|0|||
128970078|NCT04076579|464175344|FG001|Overall Study|Withdrawal by Subject|2|||
128970079|NCT03793010|464175345|FG000|Overall Study|Withdrawal by Subject|5|||
128970080|NCT03793010|464175346|FG001|Overall Study|Withdrawal by Subject|7|||
128970081|NCT03793010|464175345|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
128970082|NCT03793010|464175346|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
128970083|NCT03793010|464175345|FG000|Overall Study|Lost to Follow-up|1|||
128970084|NCT03793010|464175346|FG001|Overall Study|Lost to Follow-up|2|||
128970085|NCT03793010|464175345|FG000|Overall Study|Patient couldn't sit still for injection|1|||
128970086|NCT03793010|464175346|FG001|Overall Study|Patient couldn't sit still for injection|0|||
128970087|NCT03793010|464175345|FG000|Overall Study|Withdrew to pursue other treatment|1|||
128970088|NCT03793010|464175346|FG001|Overall Study|Withdrew to pursue other treatment|0|||
128970089|NCT03793010|464175345|FG000|Overall Study|Did not meet eligibility criteria|1|||
129130773|NCT04822194|464769701|FG000|Overall Study|Technical issues with MR scanner|1|||
129130774|NCT04822194|464769702|FG001|Overall Study|Technical issues with MR scanner|0|||
129130775|NCT04822194|464769701|FG000|Overall Study|Lost to Follow-up|5|||
128714824|NCT01189812|463252373|FG000|Overall Study|Moved out of State|1|||
128970090|NCT03793010|464175346|FG001|Overall Study|Did not meet eligibility criteria|0|||
128970091|NCT02903966|464175347|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
128970092|NCT02903966|464175348|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
128970093|NCT02903966|464175347|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
128970094|NCT02903966|464175348|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
128970095|NCT02903966|464175347|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
128970096|NCT02903966|464175348|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
128970097|NCT04924114|464175349|FG000|Overall Study|Withdrawal by Subject|0|||
128970098|NCT04924114|464175350|FG001|Overall Study|Withdrawal by Subject|2|||
128970099|NCT04924114|464175351|FG002|Overall Study|Withdrawal by Subject|2|||
128970100|NCT04924114|464175352|FG003|Overall Study|Withdrawal by Subject|0|||
128970101|NCT04924114|464175353|FG004|Overall Study|Withdrawal by Subject|2|||
128970102|NCT04423718|464175354|FG000|Main Study|Adverse Event|9|||
128970103|NCT04423718|464175355|FG001|Main Study|Adverse Event|5|||
128970104|NCT04423718|464175356|FG002|Main Study|Adverse Event|8|||
128970105|NCT04423718|464175354|FG000|Main Study|Physician Decision|3|||
128970106|NCT04423718|464175355|FG001|Main Study|Physician Decision|3|||
128970107|NCT04423718|464175356|FG002|Main Study|Physician Decision|2|||
128970108|NCT04423718|464175354|FG000|Main Study|Protocol Violation|0|||
128970109|NCT04423718|464175355|FG001|Main Study|Protocol Violation|0|||
128970110|NCT04423718|464175356|FG002|Main Study|Protocol Violation|1|||
128970111|NCT04423718|464175354|FG000|Main Study|Lost to Follow-up|3|||
128970112|NCT04423718|464175355|FG001|Main Study|Lost to Follow-up|3|||
128970113|NCT04423718|464175356|FG002|Main Study|Lost to Follow-up|4|||
128970114|NCT04423718|464175354|FG000|Main Study|Lack of Efficacy|2|||
128970115|NCT04423718|464175355|FG001|Main Study|Lack of Efficacy|1|||
128970116|NCT04423718|464175356|FG002|Main Study|Lack of Efficacy|0|||
128970117|NCT04423718|464175354|FG000|Main Study|Withdrawal by Subject|14|||
128970118|NCT04423718|464175355|FG001|Main Study|Withdrawal by Subject|20|||
128970119|NCT04423718|464175356|FG002|Main Study|Withdrawal by Subject|20|||
128970120|NCT04423718|464175354|FG000|Main Study|Death|10|||
128970121|NCT04423718|464175355|FG001|Main Study|Death|7|||
128970122|NCT04423718|464175356|FG002|Main Study|Death|7|||
128970123|NCT04423718|464175354|FG000|Main Study|COVID-19 pandemic|2|||
128970124|NCT04423718|464175355|FG001|Main Study|COVID-19 pandemic|2|||
128970125|NCT04423718|464175356|FG002|Main Study|COVID-19 pandemic|2|||
128970126|NCT04423718|464175354|FG000|Main Study|Other|7|||
128970127|NCT04423718|464175355|FG001|Main Study|Other|3|||
128970128|NCT04423718|464175356|FG002|Main Study|Other|2|||
128970129|NCT04423718|464175354|FG000|Extension Phase|Other|1|||
128970130|NCT04423718|464175355|FG001|Extension Phase|Other|0|||
128970131|NCT04423718|464175356|FG002|Extension Phase|Other|0|||
128970132|NCT04423718|464175354|FG000|Extension Phase|Logistical problems|0|||
128970133|NCT04423718|464175355|FG001|Extension Phase|Logistical problems|1|||
128970134|NCT04423718|464175356|FG002|Extension Phase|Logistical problems|1|||
128970135|NCT04423718|464175354|FG000|Extension Phase|Physician Decision|1|||
128970136|NCT04423718|464175355|FG001|Extension Phase|Physician Decision|0|||
128970137|NCT04423718|464175356|FG002|Extension Phase|Physician Decision|1|||
128970138|NCT04423718|464175354|FG000|Extension Phase|Lack of Efficacy|2|||
128970139|NCT04423718|464175355|FG001|Extension Phase|Lack of Efficacy|0|||
128970140|NCT04423718|464175356|FG002|Extension Phase|Lack of Efficacy|1|||
128970141|NCT04423718|464175354|FG000|Extension Phase|Lost to Follow-up|0|||
128970142|NCT04423718|464175355|FG001|Extension Phase|Lost to Follow-up|2|||
128970143|NCT04423718|464175356|FG002|Extension Phase|Lost to Follow-up|3|||
128970144|NCT04423718|464175354|FG000|Extension Phase|Adverse Event|2|||
128714825|NCT01189812|463252374|FG001|Overall Study|Moved out of State|2|||
128970145|NCT04423718|464175355|FG001|Extension Phase|Adverse Event|3|||
128970146|NCT04423718|464175356|FG002|Extension Phase|Adverse Event|1|||
128970147|NCT04423718|464175354|FG000|Extension Phase|Death|4|||
128970148|NCT04423718|464175355|FG001|Extension Phase|Death|7|||
128970149|NCT04423718|464175356|FG002|Extension Phase|Death|2|||
128714826|NCT00415909|463253591|FG000|Overall Study|Withdrawal by Subject|2|||
128970150|NCT04423718|464175354|FG000|Extension Phase|Withdrawal by Subject|11|||
128970151|NCT04423718|464175355|FG001|Extension Phase|Withdrawal by Subject|11|||
128970152|NCT04423718|464175356|FG002|Extension Phase|Withdrawal by Subject|7|||
128714827|NCT00415909|463253591|FG000|Overall Study|Death|1|||
128714828|NCT00174915|463253592|FG000|Overall Study|Lost to Follow-up|19|||
128970153|NCT00425945|464175357|FG000|Overall Study|Concern about Supplement|2|||
128970154|NCT00425945|464175358|FG001|Overall Study|Concern about Supplement|0|||
128970155|NCT00425945|464175357|FG000|Overall Study|Inconvenience|0|||
128970156|NCT00425945|464175358|FG001|Overall Study|Inconvenience|2|||
128970157|NCT00425945|464175357|FG000|Overall Study|Lost to Follow-up|0|||
128970158|NCT00425945|464175358|FG001|Overall Study|Lost to Follow-up|2|||
128970159|NCT00425945|464175357|FG000|Overall Study|Began hypertension medication|1|||
128970160|NCT00425945|464175358|FG001|Overall Study|Began hypertension medication|0|||
128970161|NCT00425945|464175357|FG000|Overall Study|Began cancer treatments|1|||
128970162|NCT00425945|464175358|FG001|Overall Study|Began cancer treatments|0|||
129038158|NCT00824369|464430636|FG005|Overall Study|Nolonger willing to participate in study|1|||
129038159|NCT00824369|464430631|FG000|Overall Study|Lost to Follow-up|0|||
129038160|NCT00824369|464430632|FG001|Overall Study|Lost to Follow-up|0|||
129038161|NCT00824369|464430633|FG002|Overall Study|Lost to Follow-up|0|||
129038162|NCT00824369|464430634|FG003|Overall Study|Lost to Follow-up|0|||
129038163|NCT00824369|464430635|FG004|Overall Study|Lost to Follow-up|1|||
129038164|NCT00824369|464430636|FG005|Overall Study|Lost to Follow-up|0|||
129038165|NCT01619579|464433128|FG000|Overall Study|Withdrawal by Subject|0|||
129038166|NCT01619579|464433129|FG001|Overall Study|Withdrawal by Subject|3|||
129038167|NCT02124902|464433130|FG000|Overall Study|Adverse Event|7|||
129038168|NCT02124902|464433131|FG001|Overall Study|Adverse Event|2|||
129038169|NCT02124902|464433130|FG000|Overall Study|Went to alternative treatment|4|||
129038170|NCT02124902|464433131|FG001|Overall Study|Went to alternative treatment|0|||
129038171|NCT02124902|464433130|FG000|Overall Study|Withdrawal by Subject|2|||
129038172|NCT02124902|464433131|FG001|Overall Study|Withdrawal by Subject|1|||
129038173|NCT02124902|464433130|FG000|Overall Study|Physician Decision|2|||
129038174|NCT02124902|464433131|FG001|Overall Study|Physician Decision|0|||
129038175|NCT02124902|464433130|FG000|Overall Study|Not eligible|1|||
129038176|NCT02124902|464433131|FG001|Overall Study|Not eligible|0|||
129038177|NCT02124902|464433130|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
129038178|NCT02124902|464433131|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
129038179|NCT02012452|464433135|FG000|Overall Study|Lost to Follow-up|2|||
129038180|NCT02012452|464433136|FG001|Overall Study|Lost to Follow-up|1|||
129038181|NCT02012452|464433135|FG000|Overall Study|Withdrawal by Subject|4|||
129038182|NCT02012452|464433136|FG001|Overall Study|Withdrawal by Subject|0|||
129038183|NCT02688387|464433137|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038184|NCT02688387|464433138|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038185|NCT02688387|464433139|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
129038186|NCT02688387|464433140|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038187|NCT02688387|464433141|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038188|NCT02688387|464433142|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038189|NCT02688387|464433143|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038190|NCT02688387|464433144|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038191|NCT02688387|464433145|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038192|NCT02688387|464433146|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038193|NCT02688387|464433147|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038194|NCT02688387|464433148|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038195|NCT02688387|464433149|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038196|NCT02688387|464433150|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038197|NCT02688387|464433151|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038198|NCT02688387|464433152|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038199|NCT02688387|464433153|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038200|NCT02688387|464433154|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038201|NCT02688387|464433155|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038202|NCT02688387|464433156|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038203|NCT02688387|464433157|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038204|NCT02688387|464433158|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129038205|NCT02688387|464433137|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038206|NCT02688387|464433138|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038207|NCT02688387|464433139|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038208|NCT02688387|464433140|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
129038209|NCT02688387|464433141|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038210|NCT02688387|464433142|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038211|NCT02688387|464433143|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038212|NCT02688387|464433144|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038213|NCT02688387|464433145|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038214|NCT02688387|464433146|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038215|NCT02688387|464433147|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038216|NCT02688387|464433148|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038217|NCT02688387|464433149|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038218|NCT02688387|464433150|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038219|NCT02688387|464433151|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038220|NCT02688387|464433152|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038221|NCT02688387|464433153|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038222|NCT02688387|464433154|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038223|NCT02688387|464433155|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038224|NCT02688387|464433156|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038225|NCT02688387|464433157|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038226|NCT02688387|464433158|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038227|NCT02688387|464433137|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129130776|NCT04822194|464769702|FG001|Overall Study|Lost to Follow-up|7|||
128970163|NCT00425945|464175357|FG000|Overall Study|Moved from area|0|||
128970164|NCT00425945|464175358|FG001|Overall Study|Moved from area|1|||
128970165|NCT02881151|464175359|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
128970166|NCT04284787|464175360|FG000|Overall Study|Disease Progression|9|||
128970167|NCT04284787|464175361|FG001|Overall Study|Disease Progression|12|||
128970168|NCT04284787|464175360|FG000|Overall Study|Physician Decision|12|||
128970169|NCT04284787|464175361|FG001|Overall Study|Physician Decision|7|||
128970170|NCT04284787|464175360|FG000|Overall Study|Transplant|5|||
128970171|NCT04284787|464175361|FG001|Overall Study|Transplant|4|||
128970172|NCT04284787|464175360|FG000|Overall Study|Death|1|||
128970173|NCT04284787|464175361|FG001|Overall Study|Death|2|||
128970174|NCT04284787|464175360|FG000|Overall Study|Adverse Event|0|||
128970175|NCT04284787|464175361|FG001|Overall Study|Adverse Event|4|||
128970176|NCT04284787|464175360|FG000|Overall Study|Non-adherence|2|||
128970177|NCT04284787|464175361|FG001|Overall Study|Non-adherence|0|||
128970178|NCT04284787|464175360|FG000|Overall Study|Lack of Efficacy|2|||
128970179|NCT04284787|464175361|FG001|Overall Study|Lack of Efficacy|0|||
128970180|NCT04992507|464175364|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
128970181|NCT04992507|464175365|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
128970182|NCT04992507|464175364|FG000|Overall Study|Death|0|||
128970183|NCT04992507|464175365|FG001|Overall Study|Death|1|||
128970184|NCT03287830|464175366|FG000|Overall Study|Withdrawal by Subject|1|||
128970185|NCT03287830|464175367|FG001|Overall Study|Withdrawal by Subject|1|||
128970186|NCT03287830|464175366|FG000|Overall Study|not meeting inclusion criteria|5|||
128970187|NCT03287830|464175367|FG001|Overall Study|not meeting inclusion criteria|12|||
128970188|NCT02974621|464175368|FG000|Overall Study|Didn't receive study treatment|1|||
128970189|NCT02974621|464175369|FG001|Overall Study|Didn't receive study treatment|10|||
128970190|NCT03083470|464175370|FG000|Overall Study|Lost to Follow-up|0|||
128970191|NCT03083470|464175371|FG001|Overall Study|Lost to Follow-up|0|||
128970192|NCT03083470|464175372|FG002|Overall Study|Lost to Follow-up|0|||
128970193|NCT03083470|464175373|FG003|Overall Study|Lost to Follow-up|0|||
128970194|NCT03083470|464175374|FG004|Overall Study|Lost to Follow-up|1|||
128970195|NCT03083470|464175370|FG000|Overall Study|Withdrawal by Subject|0|||
128970196|NCT03083470|464175371|FG001|Overall Study|Withdrawal by Subject|0|||
128970197|NCT03083470|464175372|FG002|Overall Study|Withdrawal by Subject|0|||
128970198|NCT03083470|464175373|FG003|Overall Study|Withdrawal by Subject|0|||
128970199|NCT03083470|464175374|FG004|Overall Study|Withdrawal by Subject|1|||
128970200|NCT03077711|464175375|FG000|Overall Study|Lost to Follow-up|2|||
128970201|NCT03077711|464175376|FG001|Overall Study|Lost to Follow-up|2|||
128970202|NCT03077711|464175375|FG000|Overall Study|noncompliant taking medication|2|||
128970203|NCT03077711|464175376|FG001|Overall Study|noncompliant taking medication|0|||
128970204|NCT01108068|464175377|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
128970205|NCT01108068|464175378|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
128970206|NCT00836953|464175379|FG000|Overall Study|Withdrawal by Subject|1|||
128970207|NCT00836953|464175379|FG000|Overall Study|Lost to Follow-up|1|||
128970208|NCT00376675|464175380|FG000|Overall Study|Withdrawal by Subject|9|||
128970209|NCT00376675|464175381|FG001|Overall Study|Withdrawal by Subject|2|||
128970210|NCT00376675|464175380|FG000|Overall Study|Adverse Event|10|||
128970211|NCT00376675|464175381|FG001|Overall Study|Adverse Event|5|||
128970212|NCT00376675|464175380|FG000|Overall Study|Other Reason|1|||
128970213|NCT00376675|464175381|FG001|Overall Study|Other Reason|7|||
128970214|NCT02943668|464175383|FG000|Overall Study|Disease Progression|1|||
128970215|NCT00255008|464175384|FG000|Overall Study|Adverse Event|1|||
128970216|NCT00255008|464175385|FG001|Overall Study|Adverse Event|1|||
128970217|NCT00255008|464175386|FG002|Overall Study|Adverse Event|2|||
128970218|NCT00255008|464175387|FG003|Overall Study|Adverse Event|0|||
128970219|NCT00255008|464175384|FG000|Overall Study|Lost to Follow-up|1|||
128970220|NCT00255008|464175385|FG001|Overall Study|Lost to Follow-up|0|||
128970221|NCT00255008|464175386|FG002|Overall Study|Lost to Follow-up|1|||
128970222|NCT00255008|464175387|FG003|Overall Study|Lost to Follow-up|2|||
128970223|NCT00255008|464175384|FG000|Overall Study|Did not meet viral reduction criteria|4|||
128970224|NCT00255008|464175385|FG001|Overall Study|Did not meet viral reduction criteria|5|||
128970225|NCT00255008|464175386|FG002|Overall Study|Did not meet viral reduction criteria|0|||
128970226|NCT00255008|464175387|FG003|Overall Study|Did not meet viral reduction criteria|1|||
128970227|NCT00255008|464175384|FG000|Overall Study|Withdrew consent|0|||
129130777|NCT03442569|464769706|FG000|Overall Study|Subject was ineligible after enrollment|1|||
129130778|NCT01363076|464770889|FG000|Overall Study|Withdrawal by Subject|0|||
128970228|NCT00255008|464175385|FG001|Overall Study|Withdrew consent|0|||
128970229|NCT00255008|464175386|FG002|Overall Study|Withdrew consent|2|||
128970230|NCT00255008|464175387|FG003|Overall Study|Withdrew consent|0|||
128970231|NCT00255008|464175384|FG000|Overall Study|Sponsor request|18|||
128970232|NCT00255008|464175385|FG001|Overall Study|Sponsor request|3|||
128970233|NCT00255008|464175386|FG002|Overall Study|Sponsor request|8|||
128970234|NCT00255008|464175387|FG003|Overall Study|Sponsor request|17|||
128970235|NCT00255008|464175384|FG000|Overall Study|Adverse lab experience|1|||
129130779|NCT01363076|464770890|FG001|Overall Study|Withdrawal by Subject|1|||
129130780|NCT04706403|464770891|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
129130781|NCT04706403|464770892|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
129130782|NCT04706403|464770893|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
129130783|NCT04706403|464770894|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
129130784|NCT04706403|464770895|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
129130785|NCT00182637|464770896|FG000|Overall Study|Adverse Event|2|||
128714829|NCT00174915|463253593|FG001|Overall Study|Lost to Follow-up|17|||
128970236|NCT00255008|464175385|FG001|Overall Study|Adverse lab experience|0|||
128970237|NCT00255008|464175386|FG002|Overall Study|Adverse lab experience|0|||
128970238|NCT00255008|464175387|FG003|Overall Study|Adverse lab experience|0|||
128970239|NCT00255008|464175384|FG000|Overall Study|Other|7|||
128970240|NCT00255008|464175385|FG001|Overall Study|Other|0|||
128970241|NCT00255008|464175386|FG002|Overall Study|Other|3|||
128970242|NCT00255008|464175387|FG003|Overall Study|Other|2|||
128970243|NCT02996500|464175388|FG000|Overall Study|Adverse Event|1|||
128970244|NCT02996500|464175389|FG001|Overall Study|Adverse Event|1|||
128970245|NCT02996500|464175390|FG002|Overall Study|Adverse Event|4|||
128970246|NCT02996500|464175391|FG003|Overall Study|Adverse Event|3|||
128970247|NCT02996500|464175392|FG004|Overall Study|Adverse Event|1|||
128970248|NCT02996500|464175393|FG005|Overall Study|Adverse Event|2|||
128970249|NCT02996500|464175388|FG000|Overall Study|Lack of Efficacy|0|||
128970250|NCT02996500|464175389|FG001|Overall Study|Lack of Efficacy|0|||
128970251|NCT02996500|464175390|FG002|Overall Study|Lack of Efficacy|0|||
128970252|NCT02996500|464175391|FG003|Overall Study|Lack of Efficacy|0|||
128970253|NCT02996500|464175392|FG004|Overall Study|Lack of Efficacy|2|||
128970254|NCT02996500|464175393|FG005|Overall Study|Lack of Efficacy|0|||
128970255|NCT02996500|464175388|FG000|Overall Study|Lost to Follow-up|1|||
128970256|NCT02996500|464175389|FG001|Overall Study|Lost to Follow-up|0|||
128970257|NCT02996500|464175390|FG002|Overall Study|Lost to Follow-up|0|||
128970258|NCT02996500|464175391|FG003|Overall Study|Lost to Follow-up|0|||
128970259|NCT02996500|464175392|FG004|Overall Study|Lost to Follow-up|0|||
128970260|NCT02996500|464175393|FG005|Overall Study|Lost to Follow-up|1|||
128970261|NCT02996500|464175388|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
128970262|NCT02996500|464175389|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
128970263|NCT02996500|464175390|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
128970264|NCT02996500|464175391|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
128970265|NCT02996500|464175392|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
128970266|NCT02996500|464175393|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
128970267|NCT02996500|464175388|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128970268|NCT02996500|464175389|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128970269|NCT02996500|464175390|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128970270|NCT02996500|464175391|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128970271|NCT02996500|464175392|FG004|Overall Study|Non-Compliance With Study Drug|0|||
128970272|NCT02996500|464175393|FG005|Overall Study|Non-Compliance With Study Drug|1|||
128970273|NCT02996500|464175388|FG000|Overall Study|Progressive Disease|1|||
128970274|NCT02996500|464175389|FG001|Overall Study|Progressive Disease|0|||
128970275|NCT02996500|464175390|FG002|Overall Study|Progressive Disease|0|||
128970276|NCT02996500|464175391|FG003|Overall Study|Progressive Disease|0|||
128970277|NCT02996500|464175392|FG004|Overall Study|Progressive Disease|0|||
128970278|NCT02996500|464175393|FG005|Overall Study|Progressive Disease|0|||
128970279|NCT02996500|464175388|FG000|Overall Study|Other|2|||
128970280|NCT02996500|464175389|FG001|Overall Study|Other|0|||
128970281|NCT02996500|464175390|FG002|Overall Study|Other|2|||
128970282|NCT02996500|464175391|FG003|Overall Study|Other|0|||
128970283|NCT02996500|464175392|FG004|Overall Study|Other|0|||
129130786|NCT00182637|464770896|FG000|Overall Study|Disease Progression|1|||
129130787|NCT04766333|464770898|FG000|Overall Study|Lost to Follow-up|40|||
129130788|NCT04766333|464770899|FG001|Overall Study|Lost to Follow-up|826|||
129130789|NCT00639379|464770900|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
128714830|NCT00174915|463253594|FG002|Overall Study|Lost to Follow-up|9|||
128970284|NCT02996500|464175393|FG005|Overall Study|Other|0|||
129130790|NCT00639379|464770901|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
129130791|NCT00639379|464770900|FG000|Period 1 - 2 Weeks|lens issue|3|||
129130792|NCT00639379|464770901|FG001|Period 1 - 2 Weeks|lens issue|0|||
128970285|NCT02996500|464175388|FG000|Overall Study|Protocol Violation|0|||
128970286|NCT02996500|464175389|FG001|Overall Study|Protocol Violation|0|||
128970287|NCT02996500|464175390|FG002|Overall Study|Protocol Violation|0|||
128970288|NCT02996500|464175391|FG003|Overall Study|Protocol Violation|1|||
128970289|NCT02996500|464175392|FG004|Overall Study|Protocol Violation|0|||
128970290|NCT02996500|464175393|FG005|Overall Study|Protocol Violation|0|||
128970291|NCT02996500|464175388|FG000|Overall Study|Withdrawal by Subject|3|||
128970292|NCT02996500|464175389|FG001|Overall Study|Withdrawal by Subject|0|||
128970293|NCT02996500|464175390|FG002|Overall Study|Withdrawal by Subject|3|||
128970294|NCT02996500|464175391|FG003|Overall Study|Withdrawal by Subject|0|||
129038228|NCT02688387|464433138|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
129038229|NCT02688387|464433139|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038230|NCT02688387|464433140|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038231|NCT02688387|464433141|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038232|NCT02688387|464433142|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038233|NCT02688387|464433143|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038234|NCT02688387|464433144|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038235|NCT02688387|464433145|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038236|NCT02688387|464433146|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
128774037|NCT01536145|463464107|FG004|Overall Study|Adverse Event|0|||
128774038|NCT01536145|463464108|FG005|Overall Study|Adverse Event|0|||
128774039|NCT01536145|463464109|FG006|Overall Study|Adverse Event|0|||
128774040|NCT01536145|463464110|FG007|Overall Study|Adverse Event|2|||
128774041|NCT01536145|463464111|FG008|Overall Study|Adverse Event|0|||
128774042|NCT01536145|463464112|FG009|Overall Study|Adverse Event|0|||
129038237|NCT02688387|464433147|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038238|NCT02688387|464433148|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038239|NCT02688387|464433149|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
128774043|NCT01536145|463464113|FG010|Overall Study|Adverse Event|3|||
128774044|NCT01284140|463464116|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
128774045|NCT01284140|463464117|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
128774046|NCT01284140|463464116|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
128774047|NCT01284140|463464117|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
128774048|NCT00088205|463464118|FG000|Overall Study|Adverse Event|4|||
128774049|NCT00088205|463464118|FG000|Overall Study|Progressive Disease|51|||
128774050|NCT00088205|463464118|FG000|Overall Study|Physician Decision|1|||
128774051|NCT00088205|463464118|FG000|Overall Study|Death Due to Study Disease|4|||
128774052|NCT03192215|463464119|FG000|Overall Study|Death|28|||
128774053|NCT03192215|463464120|FG001|Overall Study|Death|23|||
128774054|NCT03192215|463464119|FG000|Overall Study|Lost to Follow-up|10|||
128774055|NCT03192215|463464120|FG001|Overall Study|Lost to Follow-up|15|||
128774056|NCT03192215|463464119|FG000|Overall Study|Withdrawal by Subject|49|||
128774057|NCT03192215|463464120|FG001|Overall Study|Withdrawal by Subject|48|||
128774058|NCT03192215|463464119|FG000|Overall Study|Other as reported in analysis|4|||
128774059|NCT03192215|463464120|FG001|Overall Study|Other as reported in analysis|1|||
128774060|NCT05199233|463464123|FG000|Overall Study|Lack of Efficacy|1|||
128774061|NCT02443103|463464130|FG000|Overall Study|Adverse Event|2|||
128774062|NCT02443103|463464130|FG000|Overall Study|Noncompliance|1|||
128774063|NCT01630590|463464131|FG000|Overall Study|Adverse Event|9|||
128774064|NCT01630590|463464131|FG000|Overall Study|Lack of Efficacy|37|||
128774065|NCT01630590|463464131|FG000|Overall Study|Withdrawal by Subject|4|||
129038240|NCT02688387|464433150|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038241|NCT02688387|464433151|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038242|NCT02688387|464433152|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038243|NCT02688387|464433153|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038244|NCT02688387|464433154|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038245|NCT02688387|464433155|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038246|NCT02688387|464433156|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038247|NCT02688387|464433157|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038248|NCT02688387|464433158|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129038249|NCT02688387|464433137|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038250|NCT02688387|464433138|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038251|NCT02688387|464433139|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
128774066|NCT01630590|463464131|FG000|Overall Study|2nd primary tumor|2|||
128774067|NCT01630590|463464131|FG000|Overall Study|Automobile accident|1|||
128774068|NCT01630590|463464131|FG000|Overall Study|Maximum benefit|4|||
128774069|NCT02366936|463464132|FG000|Overall Study|Withdrawal by Subject|2|||
128774070|NCT02366936|463464132|FG000|Overall Study|Lost to Follow-up|4|||
128774071|NCT02366936|463464132|FG000|Overall Study|Physician Decision|2|||
128774072|NCT03358329|463464135|FG000|Overall Study|Lost to Follow-up|2|||
128774073|NCT03358329|463464135|FG000|Overall Study|Withdrawal by Subject|2|||
128774074|NCT02982720|463464136|FG000|Overall Study|Adverse Event|3|||
128774075|NCT02982720|463464136|FG000|Overall Study|Death|1|||
128774076|NCT00065468|463464141|FG000|Overall Study|Death|172|||
128774077|NCT00065468|463464142|FG001|Overall Study|Death|169|||
128774078|NCT00065468|463464143|FG002|Overall Study|Death|171|||
128774079|NCT00065468|463464141|FG000|Overall Study|Withdrawal by Subject|3|||
128774080|NCT00065468|463464142|FG001|Overall Study|Withdrawal by Subject|4|||
128774081|NCT00065468|463464143|FG002|Overall Study|Withdrawal by Subject|5|||
128970295|NCT02996500|464175392|FG004|Overall Study|Withdrawal by Subject|2|||
128970296|NCT02996500|464175393|FG005|Overall Study|Withdrawal by Subject|0|||
128970297|NCT00707486|464175394|FG000|Overall Study|Withdrawal by Subject|1|||
129220438|NCT01104311|465106601|FG001|Overall Study|low compliance|1|||
129220439|NCT01104311|465106600|FG000|Overall Study|Adverse Event|1|||
129220440|NCT01104311|465106601|FG001|Overall Study|Adverse Event|2|||
129220441|NCT03207763|465108083|FG000|Overall Study|Lost to Follow-up|1|||
129220442|NCT03207763|465108084|FG001|Overall Study|Lost to Follow-up|0|||
129220443|NCT02605122|465108085|FG000|Overall Study|Withdrawal by Subject|4|||
128714831|NCT00174915|463253595|FG003|Overall Study|Lost to Follow-up|17|||
128714832|NCT00174915|463253596|FG004|Overall Study|Lost to Follow-up|10|||
128714833|NCT00174915|463253592|FG000|Overall Study|Adverse Event|18|||
128714834|NCT00174915|463253593|FG001|Overall Study|Adverse Event|16|||
128970298|NCT00126425|464175400|FG000|Overall Study|Withdrawal by Subject|17|||
128970299|NCT00126425|464175401|FG001|Overall Study|Withdrawal by Subject|1|||
128970300|NCT00126425|464175400|FG000|Overall Study|Lost to Follow-up|8|||
128970301|NCT00126425|464175401|FG001|Overall Study|Lost to Follow-up|4|||
128970302|NCT00126425|464175400|FG000|Overall Study|Protocol Violation|9|||
128970303|NCT00126425|464175401|FG001|Overall Study|Protocol Violation|6|||
128970304|NCT00126425|464175400|FG000|Overall Study|Adverse Event|1|||
128970305|NCT00126425|464175401|FG001|Overall Study|Adverse Event|0|||
128970306|NCT00126425|464175400|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
128970307|NCT00126425|464175401|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
128970308|NCT00126425|464175400|FG000|Overall Study|Other|5|||
128970309|NCT00126425|464175401|FG001|Overall Study|Other|0|||
128970310|NCT02774291|464175402|FG000|Overall Study|Lost to Follow-up|1|||
128970311|NCT00471315|464175403|FG000|Overall Study|Adverse Event|7|||
128970312|NCT00471315|464175403|FG000|Overall Study|Withdrawal by Subject|1|||
128970313|NCT04474366|464175404|FG000|Overall Study|Lost to Follow-up|2|||
128714835|NCT00174915|463253594|FG002|Overall Study|Adverse Event|11|||
128714836|NCT00174915|463253595|FG003|Overall Study|Adverse Event|18|||
128714837|NCT00174915|463253596|FG004|Overall Study|Adverse Event|5|||
128714838|NCT00174915|463253592|FG000|Overall Study|Personal Reason(s)|16|||
128714839|NCT00174915|463253593|FG001|Overall Study|Personal Reason(s)|16|||
128714840|NCT00174915|463253594|FG002|Overall Study|Personal Reason(s)|9|||
128714841|NCT00174915|463253595|FG003|Overall Study|Personal Reason(s)|9|||
128714842|NCT00174915|463253596|FG004|Overall Study|Personal Reason(s)|9|||
128714843|NCT00174915|463253592|FG000|Overall Study|Other|15|||
128714844|NCT00174915|463253593|FG001|Overall Study|Other|8|||
128714845|NCT00174915|463253594|FG002|Overall Study|Other|6|||
128714846|NCT00174915|463253595|FG003|Overall Study|Other|5|||
128714847|NCT00174915|463253596|FG004|Overall Study|Other|3|||
128714848|NCT00174915|463253592|FG000|Overall Study|Gout Flare|13|||
128714849|NCT00174915|463253593|FG001|Overall Study|Gout Flare|6|||
128714850|NCT00174915|463253594|FG002|Overall Study|Gout Flare|8|||
128714851|NCT00174915|463253595|FG003|Overall Study|Gout Flare|1|||
128714852|NCT00174915|463253596|FG004|Overall Study|Gout Flare|0|||
128714853|NCT00174915|463253592|FG000|Overall Study|Protocol Violation|6|||
128714854|NCT00174915|463253593|FG001|Overall Study|Protocol Violation|3|||
128714855|NCT00174915|463253594|FG002|Overall Study|Protocol Violation|3|||
128714856|NCT00174915|463253595|FG003|Overall Study|Protocol Violation|6|||
128714857|NCT00174915|463253596|FG004|Overall Study|Protocol Violation|3|||
128970314|NCT04474366|464175405|FG001|Overall Study|Lost to Follow-up|5|||
128970315|NCT00320190|464175406|FG000|First 12 Months|Completed but did not enter extension|5|||
128970316|NCT00320190|464175407|FG001|First 12 Months|Completed but did not enter extension|3|||
128970317|NCT00320190|464175406|FG000|First 12 Months|Sponsor terminated study|2|||
129038252|NCT02688387|464433140|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038253|NCT02688387|464433141|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
129038254|NCT02688387|464433142|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038255|NCT02688387|464433143|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038256|NCT02688387|464433144|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038257|NCT02688387|464433145|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038258|NCT02688387|464433146|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038259|NCT02688387|464433147|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038260|NCT02688387|464433148|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038261|NCT02688387|464433149|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038262|NCT02688387|464433150|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038263|NCT02688387|464433151|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129220444|NCT02605122|465108086|FG001|Overall Study|Withdrawal by Subject|1|||
129220445|NCT02605122|465108085|FG000|Overall Study|Lost to Follow-up|1|||
129220446|NCT02605122|465108086|FG001|Overall Study|Lost to Follow-up|1|||
128714858|NCT00174915|463253592|FG000|Overall Study|Therapeutic Failure|6|||
128714859|NCT00174915|463253593|FG001|Overall Study|Therapeutic Failure|3|||
128714860|NCT00174915|463253594|FG002|Overall Study|Therapeutic Failure|2|||
128714861|NCT00174915|463253595|FG003|Overall Study|Therapeutic Failure|1|||
128714862|NCT00174915|463253596|FG004|Overall Study|Therapeutic Failure|3|||
128774082|NCT00065468|463464141|FG000|Overall Study|Lost to Follow-up|5|||
128774083|NCT00065468|463464142|FG001|Overall Study|Lost to Follow-up|3|||
128774084|NCT00065468|463464143|FG002|Overall Study|Lost to Follow-up|2|||
128774085|NCT00065468|463464141|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
128774086|NCT00065468|463464142|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
128774087|NCT00065468|463464143|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
128774088|NCT00065468|463464141|FG000|Overall Study|Disease progression|0|||
128774089|NCT00065468|463464142|FG001|Overall Study|Disease progression|0|||
128774090|NCT00065468|463464143|FG002|Overall Study|Disease progression|1|||
128774091|NCT00065468|463464141|FG000|Overall Study|Other|14|||
128774092|NCT00065468|463464142|FG001|Overall Study|Other|24|||
128774093|NCT00065468|463464143|FG002|Overall Study|Other|18|||
128774094|NCT01225835|463464144|FG000|Overall Study|Completed protocol|2|||
128774095|NCT01225835|463464145|FG001|Overall Study|Completed protocol|1|||
128774096|NCT01225835|463464144|FG000|Overall Study|Did not meet hCG criterion|2|||
128774097|NCT01225835|463464145|FG001|Overall Study|Did not meet hCG criterion|0|||
128774098|NCT01225835|463464144|FG000|Overall Study|Adverse Event|2|||
128774099|NCT01225835|463464145|FG001|Overall Study|Adverse Event|1|||
128774100|NCT01225835|463464144|FG000|Overall Study|Other|1|||
128774101|NCT01225835|463464145|FG001|Overall Study|Other|1|||
128774102|NCT02589392|463464146|FG000|Overall Study|Adverse Event|1|||
128774103|NCT02589392|463464147|FG001|Overall Study|Adverse Event|1|||
128774104|NCT02589392|463464146|FG000|Overall Study|Withdrawal by Subject|1|||
128774105|NCT02589392|463464147|FG001|Overall Study|Withdrawal by Subject|2|||
129130793|NCT02582632|464770905|FG000|Overall Study|Other|1|||
129130794|NCT03298061|464770906|FG000|Overall Study|Adverse Event|3|||
128774106|NCT02589392|463464146|FG000|Overall Study|Protocol Violation|1|||
128774107|NCT02589392|463464147|FG001|Overall Study|Protocol Violation|1|||
128774108|NCT02589392|463464146|FG000|Overall Study|Lost to Follow-up|2|||
128774109|NCT02589392|463464147|FG001|Overall Study|Lost to Follow-up|2|||
129130795|NCT03298061|464770906|FG000|Overall Study|Lack of Efficacy|6|||
128774110|NCT02589392|463464146|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
129130796|NCT03298061|464770906|FG000|Overall Study|Protocol Violation|1|||
129130797|NCT03298061|464770906|FG000|Overall Study|Physician Decision|7|||
129038264|NCT02688387|464433152|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038265|NCT02688387|464433153|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038266|NCT02688387|464433154|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038267|NCT02688387|464433155|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038268|NCT02688387|464433156|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038269|NCT02688387|464433157|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038270|NCT02688387|464433158|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129038271|NCT02688387|464433137|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
129038272|NCT02688387|464433138|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038273|NCT02688387|464433139|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038274|NCT02688387|464433140|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038275|NCT02688387|464433141|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038276|NCT02688387|464433142|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038277|NCT02688387|464433143|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038278|NCT02688387|464433144|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038279|NCT02688387|464433145|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038280|NCT02688387|464433146|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038281|NCT02688387|464433147|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038282|NCT02688387|464433148|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038283|NCT02688387|464433149|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038284|NCT02688387|464433150|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038285|NCT02688387|464433151|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038286|NCT02688387|464433152|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038287|NCT02688387|464433153|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038288|NCT02688387|464433154|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038289|NCT02688387|464433155|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038290|NCT02688387|464433156|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038291|NCT02688387|464433157|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038292|NCT02688387|464433158|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129038293|NCT02688387|464433137|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129130798|NCT03298061|464770906|FG000|Overall Study|Withdrawal by Subject|10|||
129130799|NCT02383173|464770907|FG000|Overall Study|Palliative Care Team withdrew|0|||
128774111|NCT02589392|463464147|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
128774112|NCT02207374|463464152|FG000|Overall Study|Withdrawal by Subject|5|||
128774113|NCT02207374|463464153|FG001|Overall Study|Withdrawal by Subject|9|||
128774114|NCT02207374|463464154|FG002|Overall Study|Withdrawal by Subject|4|||
128774115|NCT02207374|463464152|FG000|Overall Study|Death|1|||
128774116|NCT02207374|463464153|FG001|Overall Study|Death|0|||
129130800|NCT02383173|464770908|FG001|Overall Study|Palliative Care Team withdrew|2|||
129130801|NCT01297244|464770909|FG000|Overall Study|Progressive disease|22|||
129130802|NCT01297244|464770910|FG001|Overall Study|Progressive disease|3|||
129130803|NCT01297244|464770909|FG000|Overall Study|Adverse Event|9|||
129130804|NCT01297244|464770910|FG001|Overall Study|Adverse Event|1|||
129130805|NCT01297244|464770909|FG000|Overall Study|Death|1|||
129130806|NCT01297244|464770910|FG001|Overall Study|Death|1|||
129130807|NCT01297244|464770909|FG000|Overall Study|Clinical progression|1|||
129130808|NCT01297244|464770910|FG001|Overall Study|Clinical progression|1|||
129130809|NCT01297244|464770909|FG000|Overall Study|Withdrawal by Subject|2|||
129130810|NCT01297244|464770910|FG001|Overall Study|Withdrawal by Subject|0|||
129130811|NCT03677401|464770911|FG000|Overall Study|Adverse Event|4|||
129130812|NCT03677401|464770912|FG001|Overall Study|Adverse Event|14|||
129130813|NCT03677401|464770911|FG000|Overall Study|Lack of Efficacy|3|||
129130814|NCT03677401|464770912|FG001|Overall Study|Lack of Efficacy|1|||
129130815|NCT03677401|464770911|FG000|Overall Study|Withdrawal by Subject|2|||
129130816|NCT03677401|464770912|FG001|Overall Study|Withdrawal by Subject|2|||
129130817|NCT03677401|464770911|FG000|Overall Study|Sponsor decision|0|||
129130818|NCT03677401|464770912|FG001|Overall Study|Sponsor decision|1|||
129130819|NCT03677401|464770911|FG000|Overall Study|Reason Unspecified|1|||
129130820|NCT03677401|464770912|FG001|Overall Study|Reason Unspecified|0|||
129130821|NCT01177410|464770913|FG000|Overall Study|Adverse Event|0|||
129130822|NCT01177410|464770914|FG001|Overall Study|Adverse Event|2|||
129130823|NCT01177410|464770915|FG002|Overall Study|Adverse Event|2|||
129130824|NCT01177410|464770913|FG000|Overall Study|Withdrawal by Subject|1|||
129130825|NCT01177410|464770914|FG001|Overall Study|Withdrawal by Subject|4|||
129130826|NCT01177410|464770915|FG002|Overall Study|Withdrawal by Subject|3|||
129130827|NCT01177410|464770913|FG000|Overall Study|Lost to Follow-up|0|||
129130828|NCT01177410|464770914|FG001|Overall Study|Lost to Follow-up|1|||
129130829|NCT01177410|464770915|FG002|Overall Study|Lost to Follow-up|0|||
129130830|NCT00875667|464770919|FG000|Overall Study|Adverse Event|29|||
129130831|NCT00875667|464770920|FG001|Overall Study|Adverse Event|10|||
129130832|NCT00875667|464770919|FG000|Overall Study|Withdrawal by Subject|17|||
129130833|NCT00875667|464770920|FG001|Overall Study|Withdrawal by Subject|5|||
129130834|NCT00875667|464770919|FG000|Overall Study|Death|7|||
129130835|NCT00875667|464770920|FG001|Overall Study|Death|2|||
129130836|NCT00875667|464770919|FG000|Overall Study|Protocol Violation|2|||
129130837|NCT00875667|464770920|FG001|Overall Study|Protocol Violation|0|||
129130838|NCT00875667|464770919|FG000|Overall Study|Disease Progression|100|||
129130839|NCT00875667|464770920|FG001|Overall Study|Disease Progression|49|||
128714863|NCT03060447|463253601|FG000|Overall Study|Withdrawal by Subject|2|||
128714864|NCT03060447|463253602|FG001|Overall Study|Withdrawal by Subject|0|||
128714865|NCT02132767|463253605|FG000|Overall Study|Death|3|||
128714866|NCT02132767|463253606|FG001|Overall Study|Death|2|||
128714867|NCT02132767|463253605|FG000|Overall Study|Withdrawal by Subject|10|||
128714868|NCT02132767|463253606|FG001|Overall Study|Withdrawal by Subject|9|||
128970318|NCT00320190|464175407|FG001|First 12 Months|Sponsor terminated study|2|||
128970319|NCT00320190|464175406|FG000|First 12 Months|Lost to Follow-up|0|||
128970320|NCT00320190|464175407|FG001|First 12 Months|Lost to Follow-up|1|||
128970321|NCT00320190|464175406|FG000|First 12 Months|Enrollment failure|0|||
128970322|NCT00320190|464175407|FG001|First 12 Months|Enrollment failure|1|||
128970323|NCT00320190|464175406|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
128970324|NCT00320190|464175407|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
128970325|NCT00320190|464175406|FG000|First 12 Months|Investigator request|0|||
128970326|NCT00320190|464175407|FG001|First 12 Months|Investigator request|1|||
128970327|NCT00320190|464175406|FG000|First 12 Months|Study drug toxicity|0|||
128970328|NCT00320190|464175407|FG001|First 12 Months|Study drug toxicity|1|||
128970329|NCT00320190|464175406|FG000|First 12 Months|Withdrawal by Subject|0|||
128970330|NCT00320190|464175407|FG001|First 12 Months|Withdrawal by Subject|1|||
128970331|NCT00320190|464175406|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
128970332|NCT00320190|464175407|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
128970333|NCT00320190|464175406|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
128970334|NCT00320190|464175407|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
128970335|NCT00320190|464175406|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
128970336|NCT00320190|464175407|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
129130840|NCT00875667|464770919|FG000|Overall Study|Miscellaneous|12|||
129130841|NCT00875667|464770920|FG001|Overall Study|Miscellaneous|6|||
129130842|NCT00875667|464770919|FG000|Overall Study|Randomized but no Study Drug Given|3|||
129130843|NCT00875667|464770920|FG001|Overall Study|Randomized but no Study Drug Given|1|||
129130844|NCT00894647|464770921|FG000|Overall Study|Adverse Event|5|||
129130845|NCT00894647|464770922|FG001|Overall Study|Adverse Event|4|||
129130846|NCT00894647|464770921|FG000|Overall Study|Withdrawal by Subject|4|||
129130847|NCT00894647|464770922|FG001|Overall Study|Withdrawal by Subject|4|||
129130848|NCT00894647|464770921|FG000|Overall Study|Lost to Follow-up|0|||
129130849|NCT00894647|464770922|FG001|Overall Study|Lost to Follow-up|2|||
129130850|NCT00894647|464770921|FG000|Overall Study|Non-compliance with study procedures|0|||
129130851|NCT00894647|464770922|FG001|Overall Study|Non-compliance with study procedures|2|||
128774117|NCT02207374|463464154|FG002|Overall Study|Death|1|||
128970337|NCT00712270|464175408|FG000|Overall Study|Withdrawal by Subject|11|||
128970338|NCT00712270|464175408|FG000|Overall Study|Screen Failure|3|||
128970339|NCT01474889|464175417|FG000|Overall Study|Physician Decision|1|||
128970340|NCT01474889|464175418|FG001|Overall Study|Physician Decision|0|||
128970341|NCT01474889|464175419|FG002|Overall Study|Physician Decision|0|||
128970342|NCT01474889|464175417|FG000|Overall Study|Did not meet inclusion|1|||
128970343|NCT01474889|464175418|FG001|Overall Study|Did not meet inclusion|0|||
128970344|NCT01474889|464175419|FG002|Overall Study|Did not meet inclusion|0|||
128970345|NCT01474889|464175417|FG000|Overall Study|Withdrawal by Subject|0|||
128970346|NCT01474889|464175418|FG001|Overall Study|Withdrawal by Subject|1|||
128970347|NCT01474889|464175419|FG002|Overall Study|Withdrawal by Subject|0|||
128970348|NCT03954704|464175425|FG000|Overall Study|Death|1|||
128970349|NCT03954704|464175426|FG001|Overall Study|Death|1|||
128970350|NCT03954704|464175427|FG002|Overall Study|Death|1|||
128970351|NCT03954704|464175428|FG003|Overall Study|Death|3|||
128970352|NCT03954704|464175429|FG004|Overall Study|Death|2|||
128970353|NCT03954704|464175430|FG005|Overall Study|Death|2|||
128970354|NCT03954704|464175431|FG006|Overall Study|Death|0|||
128970355|NCT03954704|464175425|FG000|Overall Study|Withdrew Consent|0|||
128970356|NCT03954704|464175426|FG001|Overall Study|Withdrew Consent|0|||
128970357|NCT03954704|464175427|FG002|Overall Study|Withdrew Consent|1|||
128970358|NCT03954704|464175428|FG003|Overall Study|Withdrew Consent|0|||
128970359|NCT03954704|464175429|FG004|Overall Study|Withdrew Consent|0|||
128970360|NCT03954704|464175430|FG005|Overall Study|Withdrew Consent|1|||
128970361|NCT03954704|464175431|FG006|Overall Study|Withdrew Consent|0|||
128970362|NCT03954704|464175425|FG000|Overall Study|Lost to Follow-up|0|||
128970363|NCT03954704|464175426|FG001|Overall Study|Lost to Follow-up|0|||
128970364|NCT03954704|464175427|FG002|Overall Study|Lost to Follow-up|0|||
128970365|NCT03954704|464175428|FG003|Overall Study|Lost to Follow-up|0|||
128970366|NCT03954704|464175429|FG004|Overall Study|Lost to Follow-up|0|||
128970367|NCT03954704|464175430|FG005|Overall Study|Lost to Follow-up|0|||
128970368|NCT03954704|464175431|FG006|Overall Study|Lost to Follow-up|1|||
128970369|NCT03954704|464175425|FG000|Overall Study|Study Terminated by Sponsor|0|||
128970370|NCT03954704|464175426|FG001|Overall Study|Study Terminated by Sponsor|0|||
128970371|NCT03954704|464175427|FG002|Overall Study|Study Terminated by Sponsor|1|||
128970372|NCT03954704|464175428|FG003|Overall Study|Study Terminated by Sponsor|0|||
128970373|NCT03954704|464175429|FG004|Overall Study|Study Terminated by Sponsor|1|||
128970374|NCT03954704|464175430|FG005|Overall Study|Study Terminated by Sponsor|4|||
128970375|NCT03954704|464175431|FG006|Overall Study|Study Terminated by Sponsor|2|||
128970376|NCT03954704|464175425|FG000|Overall Study|Enrolled but not Treated|0|||
128970377|NCT03954704|464175426|FG001|Overall Study|Enrolled but not Treated|0|||
128970378|NCT03954704|464175427|FG002|Overall Study|Enrolled but not Treated|0|||
128970379|NCT03954704|464175428|FG003|Overall Study|Enrolled but not Treated|0|||
128970380|NCT03954704|464175429|FG004|Overall Study|Enrolled but not Treated|0|||
128970381|NCT03954704|464175430|FG005|Overall Study|Enrolled but not Treated|1|||
128970382|NCT03954704|464175431|FG006|Overall Study|Enrolled but not Treated|0|||
128970383|NCT04412668|464175432|FG000|Overall Study|Death - multiple comorbidities|2|||
128970384|NCT04412668|464175433|FG001|Overall Study|Death - multiple comorbidities|0|||
128970385|NCT04412668|464175434|FG002|Overall Study|Death - multiple comorbidities|0|||
128970386|NCT04412668|464175432|FG000|Overall Study|Withdrawal by Subject|3|||
128970387|NCT04412668|464175433|FG001|Overall Study|Withdrawal by Subject|0|||
128970388|NCT04412668|464175434|FG002|Overall Study|Withdrawal by Subject|0|||
129038294|NCT02688387|464433138|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
128970389|NCT04412668|464175432|FG000|Overall Study|Other than Specified|2|||
128970390|NCT04412668|464175433|FG001|Overall Study|Other than Specified|0|||
128970391|NCT04412668|464175434|FG002|Overall Study|Other than Specified|0|||
129038295|NCT02688387|464433139|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038296|NCT02688387|464433140|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038297|NCT02688387|464433141|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038298|NCT02688387|464433142|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038299|NCT02688387|464433143|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038300|NCT02688387|464433144|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038301|NCT02688387|464433145|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038302|NCT02688387|464433146|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038303|NCT02688387|464433147|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
129038304|NCT02688387|464433148|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038305|NCT02688387|464433149|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038306|NCT02688387|464433150|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
128970392|NCT00102804|464175435|FG000|Overall Study|Progressive Disease (PD)|307|||
129038307|NCT02688387|464433151|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
128970393|NCT00102804|464175436|FG001|Overall Study|Progressive Disease (PD)|196|||
129220447|NCT00807001|465108094|FG000|Overall Study|Non-compliance|0|||
128970394|NCT00102804|464175435|FG000|Overall Study|Withdrawal by Subject|46|||
128970395|NCT00102804|464175436|FG001|Overall Study|Withdrawal by Subject|7|||
128970396|NCT00102804|464175435|FG000|Overall Study|Adverse Event|37|||
128970397|NCT00102804|464175436|FG001|Overall Study|Adverse Event|3|||
128714869|NCT02132767|463253605|FG000|Overall Study|Lost to Follow-up|4|||
128970398|NCT00102804|464175435|FG000|Overall Study|Physician Decision|24|||
128970399|NCT00102804|464175436|FG001|Overall Study|Physician Decision|6|||
128970400|NCT00102804|464175435|FG000|Overall Study|Death|5|||
128970401|NCT00102804|464175436|FG001|Overall Study|Death|6|||
128970402|NCT00102804|464175435|FG000|Overall Study|Enrollment Criteria Not Met|6|||
128970403|NCT00102804|464175436|FG001|Overall Study|Enrollment Criteria Not Met|0|||
128970404|NCT00102804|464175435|FG000|Overall Study|Lost to Follow-up|4|||
128970405|NCT00102804|464175436|FG001|Overall Study|Lost to Follow-up|1|||
128970406|NCT00102804|464175435|FG000|Overall Study|Protocol Violation|2|||
128970407|NCT00102804|464175436|FG001|Overall Study|Protocol Violation|1|||
128970408|NCT00102804|464175435|FG000|Overall Study|Satisfactory Response|2|||
128970409|NCT00102804|464175436|FG001|Overall Study|Satisfactory Response|0|||
128970410|NCT00102804|464175435|FG000|Overall Study|Sponsor Decision|1|||
128970411|NCT00102804|464175436|FG001|Overall Study|Sponsor Decision|0|||
128970412|NCT00102804|464175435|FG000|Overall Study|Alive, Receiving Treatment|7|||
128970413|NCT00102804|464175436|FG001|Overall Study|Alive, Receiving Treatment|2|||
128970414|NCT00683774|464175442|FG000|Overall Study|Withdrawal by Subject|0|||
128970415|NCT00683774|464175443|FG001|Overall Study|Withdrawal by Subject|1|||
128970416|NCT00683774|464175442|FG000|Overall Study|Physician Decision|3|||
128970417|NCT00683774|464175443|FG001|Overall Study|Physician Decision|0|||
128970418|NCT00691054|464175444|FG000|Overall Study|Withdrawal by Subject|1|||
128970419|NCT00397891|464175445|FG000|Overall Study|Withdrawal by Subject|1|||
128970420|NCT00397891|464175446|FG001|Overall Study|Withdrawal by Subject|0|||
128970421|NCT00397891|464175447|FG002|Overall Study|Withdrawal by Subject|0|||
128970422|NCT00397891|464175448|FG003|Overall Study|Withdrawal by Subject|0|||
128970423|NCT00397891|464175449|FG004|Overall Study|Withdrawal by Subject|1|||
128970424|NCT04964557|464175450|FG000|Overall Study|Withdrawal by Subject|3|||
128970425|NCT04964557|464175451|FG001|Overall Study|Withdrawal by Subject|2|||
128970426|NCT04964557|464175450|FG000|Overall Study|Lost to Follow-up|1|||
128970427|NCT04964557|464175451|FG001|Overall Study|Lost to Follow-up|2|||
128970428|NCT04964557|464175450|FG000|Overall Study|Physician Decision|2|||
128970429|NCT04964557|464175451|FG001|Overall Study|Physician Decision|0|||
128970430|NCT04964557|464175450|FG000|Overall Study|Death|3|||
128970431|NCT04964557|464175451|FG001|Overall Study|Death|0|||
128970432|NCT04964557|464175450|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
128970433|NCT04964557|464175451|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
128970434|NCT02632344|464177331|FG000|Overall Study|Adverse Event|3|||
128970435|NCT02632344|464177331|FG000|Overall Study|Lack of Efficacy|3|||
128970436|NCT02632344|464177331|FG000|Overall Study|Withdrawal by Subject|2|||
128970437|NCT03991936|464177335|FG000|Overall Study|Lost to Follow-up|1|||
128970438|NCT03991936|464177336|FG001|Overall Study|Lost to Follow-up|1|||
128970439|NCT03991936|464177337|FG002|Overall Study|Lost to Follow-up|1|||
128970440|NCT03991936|464177338|FG003|Overall Study|Lost to Follow-up|1|||
128970441|NCT03991936|464177339|FG004|Overall Study|Lost to Follow-up|1|||
128970442|NCT00939055|464177340|FG000|Overall Study|Discontinuation prior to procedure|4|||
128970443|NCT00939055|464177341|FG001|Overall Study|Discontinuation prior to procedure|0|||
128970444|NCT00584987|464177344|FG000|Overall Study|Protocol Violation|1|||
128970445|NCT00584987|464177345|FG001|Overall Study|Protocol Violation|1|||
128970446|NCT00584987|464177346|FG002|Overall Study|Protocol Violation|1|||
128970447|NCT00584987|464177347|FG003|Overall Study|Protocol Violation|0|||
128970448|NCT00584987|464177344|FG000|Overall Study|Adverse Event|0|||
128970449|NCT00584987|464177345|FG001|Overall Study|Adverse Event|0|||
128970450|NCT00584987|464177346|FG002|Overall Study|Adverse Event|0|||
128970451|NCT00584987|464177347|FG003|Overall Study|Adverse Event|1|||
128970452|NCT03225833|464177348|FG000|Overall Study|Adverse Event|0|||
128714870|NCT02132767|463253606|FG001|Overall Study|Lost to Follow-up|4|||
128714871|NCT00778700|463253609|FG000|Overall Study|Adverse Event|6|||
128970453|NCT03225833|464177349|FG001|Overall Study|Adverse Event|1|||
128970454|NCT03225833|464177350|FG002|Overall Study|Adverse Event|2|||
128970455|NCT03225833|464177351|FG003|Overall Study|Adverse Event|0|||
128970456|NCT03225833|464177352|FG004|Overall Study|Adverse Event|0|||
128970457|NCT03225833|464177353|FG005|Overall Study|Adverse Event|2|||
128970458|NCT03225833|464177348|FG000|Overall Study|Withdrawal by Subject|1|||
128970459|NCT03225833|464177349|FG001|Overall Study|Withdrawal by Subject|0|||
128970460|NCT03225833|464177350|FG002|Overall Study|Withdrawal by Subject|0|||
128970461|NCT03225833|464177351|FG003|Overall Study|Withdrawal by Subject|0|||
128970462|NCT03225833|464177352|FG004|Overall Study|Withdrawal by Subject|1|||
128970463|NCT03225833|464177353|FG005|Overall Study|Withdrawal by Subject|0|||
128970464|NCT03225833|464177348|FG000|Overall Study|Termination of Study by Sponsor|4|||
128970465|NCT03225833|464177349|FG001|Overall Study|Termination of Study by Sponsor|0|||
128970466|NCT03225833|464177350|FG002|Overall Study|Termination of Study by Sponsor|0|||
128970467|NCT03225833|464177351|FG003|Overall Study|Termination of Study by Sponsor|0|||
128970468|NCT03225833|464177352|FG004|Overall Study|Termination of Study by Sponsor|0|||
128970469|NCT03225833|464177353|FG005|Overall Study|Termination of Study by Sponsor|7|||
129038308|NCT02688387|464433152|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038309|NCT02688387|464433153|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129130852|NCT00894647|464770921|FG000|Overall Study|Other, not due to AE|1|||
129130853|NCT00894647|464770922|FG001|Overall Study|Other, not due to AE|2|||
129130854|NCT01913470|464770923|FG000|Overall Study|Lost to Follow-up|0|||
128774118|NCT02207374|463464152|FG000|Overall Study|Missing follow-up information|0|||
128774119|NCT02207374|463464153|FG001|Overall Study|Missing follow-up information|1|||
128774120|NCT02207374|463464154|FG002|Overall Study|Missing follow-up information|1|||
128970470|NCT03225833|464177348|FG000|Overall Study|Sponsor Decision|0|||
128970471|NCT03225833|464177349|FG001|Overall Study|Sponsor Decision|0|||
129130855|NCT01913470|464770924|FG001|Overall Study|Lost to Follow-up|1|||
129130856|NCT01913470|464770923|FG000|Overall Study|Physician Decision|0|||
128970472|NCT03225833|464177350|FG002|Overall Study|Sponsor Decision|0|||
128970473|NCT03225833|464177351|FG003|Overall Study|Sponsor Decision|0|||
128970474|NCT03225833|464177352|FG004|Overall Study|Sponsor Decision|0|||
128970475|NCT03225833|464177353|FG005|Overall Study|Sponsor Decision|1|||
128774127|NCT02087150|463464157|FG000|Overall Study|Death|0|||
128774128|NCT02087150|463464158|FG001|Overall Study|Death|1|||
128774129|NCT02087150|463464159|FG002|Overall Study|Death|0|||
128774130|NCT02087150|463464157|FG000|Overall Study|Lost to Follow-up|6|||
128774131|NCT02087150|463464158|FG001|Overall Study|Lost to Follow-up|13|||
128774132|NCT02087150|463464159|FG002|Overall Study|Lost to Follow-up|7|||
128774133|NCT02087150|463464157|FG000|Overall Study|Withdrawal by Subject|2|||
128774134|NCT02087150|463464158|FG001|Overall Study|Withdrawal by Subject|5|||
128774135|NCT02087150|463464159|FG002|Overall Study|Withdrawal by Subject|3|||
128774136|NCT02087150|463464157|FG000|Overall Study|Physician Decision|0|||
128774137|NCT02087150|463464158|FG001|Overall Study|Physician Decision|1|||
128774138|NCT02087150|463464159|FG002|Overall Study|Physician Decision|0|||
128774139|NCT02087150|463464157|FG000|Overall Study|Procedure not done|1|||
128774140|NCT02087150|463464158|FG001|Overall Study|Procedure not done|13|||
128774141|NCT02087150|463464159|FG002|Overall Study|Procedure not done|0|||
128774142|NCT02087150|463464157|FG000|Overall Study|F/U not completed w/in study window|0|||
128774143|NCT02087150|463464158|FG001|Overall Study|F/U not completed w/in study window|0|||
128774144|NCT02087150|463464159|FG002|Overall Study|F/U not completed w/in study window|1|||
128774145|NCT02087150|463464157|FG000|Overall Study|Other|1|||
128774146|NCT02087150|463464158|FG001|Overall Study|Other|0|||
128774147|NCT02087150|463464159|FG002|Overall Study|Other|0|||
128774148|NCT02087150|463464157|FG000|Overall Study|Pt moved out of town|0|||
128774149|NCT02087150|463464158|FG001|Overall Study|Pt moved out of town|1|||
128774150|NCT02087150|463464159|FG002|Overall Study|Pt moved out of town|0|||
128774151|NCT00972179|463464164|FG000|Overall Study|Noncompliance|1|||
128774152|NCT00972179|463464165|FG001|Overall Study|Noncompliance|0|||
128774153|NCT00972179|463464166|FG002|Overall Study|Noncompliance|0|||
128774154|NCT00972179|463464167|FG003|Overall Study|Noncompliance|0|||
128774155|NCT00972179|463464168|FG004|Overall Study|Noncompliance|1|||
128774156|NCT00972179|463464169|FG005|Overall Study|Noncompliance|0|||
128774157|NCT00972179|463464170|FG006|Overall Study|Noncompliance|1|||
128774158|NCT00972179|463464164|FG000|Overall Study|Withdrawal by Subject|0|||
128970476|NCT03258593|464177355|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
128970477|NCT03258593|464177356|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
128970478|NCT03258593|464177357|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
128970479|NCT03258593|464177358|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
128970480|NCT03258593|464177355|FG000|Run-In Maintenance Phase|Disease progression|3|||
128970481|NCT03258593|464177356|FG001|Run-In Maintenance Phase|Disease progression|0|||
128970482|NCT03258593|464177357|FG002|Run-In Maintenance Phase|Disease progression|0|||
128970483|NCT03258593|464177358|FG003|Run-In Maintenance Phase|Disease progression|0|||
128970484|NCT03258593|464177355|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
128970485|NCT03258593|464177356|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
128970486|NCT03258593|464177357|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
128970487|NCT03258593|464177358|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
128970488|NCT03258593|464177355|FG000|Expansion Maintenance Phase|Physician Decision|0|||
128970489|NCT03258593|464177356|FG001|Expansion Maintenance Phase|Physician Decision|1|||
128970490|NCT03258593|464177357|FG002|Expansion Maintenance Phase|Physician Decision|0|||
129130857|NCT01913470|464770924|FG001|Overall Study|Physician Decision|1|||
129130858|NCT01913470|464770923|FG000|Overall Study|Withdrawal by Subject|0|||
128774159|NCT00972179|463464165|FG001|Overall Study|Withdrawal by Subject|3|||
128774160|NCT00972179|463464166|FG002|Overall Study|Withdrawal by Subject|0|||
128970491|NCT03258593|464177358|FG003|Expansion Maintenance Phase|Physician Decision|0|||
128970492|NCT05318183|464177362|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
128970493|NCT05318183|464177363|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
129130859|NCT01913470|464770924|FG001|Overall Study|Withdrawal by Subject|1|||
128774161|NCT00972179|463464167|FG003|Overall Study|Withdrawal by Subject|1|||
128774162|NCT00972179|463464168|FG004|Overall Study|Withdrawal by Subject|0|||
128774163|NCT00972179|463464169|FG005|Overall Study|Withdrawal by Subject|0|||
128774164|NCT00972179|463464170|FG006|Overall Study|Withdrawal by Subject|2|||
128774165|NCT00972179|463464164|FG000|Overall Study|Administrative Decision|0|||
128774166|NCT00972179|463464165|FG001|Overall Study|Administrative Decision|0|||
129130860|NCT00923702|464770930|FG000|Overall Study|Ongoing enrollment|0|||
129130861|NCT00923702|464770931|FG001|Overall Study|Ongoing enrollment|0|||
129130862|NCT00923702|464770932|FG002|Overall Study|Ongoing enrollment|0|||
129130863|NCT00923702|464770933|FG003|Overall Study|Ongoing enrollment|0|||
129130864|NCT00923702|464770934|FG004|Overall Study|Ongoing enrollment|354|||
129130865|NCT00367458|464770935|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
128970494|NCT05318183|464177362|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
128970495|NCT05318183|464177363|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
128970496|NCT03657576|464177364|FG000|Overall Study|Death|0|||
128970497|NCT03657576|464177365|FG001|Overall Study|Death|1|||
128970498|NCT03657576|464177366|FG002|Overall Study|Death|1|||
129130866|NCT00367458|464770936|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
129130867|NCT02942407|464770943|FG000|Overall Study|Lost to Follow-up|3|||
129130868|NCT02942407|464770944|FG001|Overall Study|Lost to Follow-up|2|||
129130869|NCT02942407|464770943|FG000|Overall Study|Withdrawal by Subject|7|||
129130870|NCT02942407|464770944|FG001|Overall Study|Withdrawal by Subject|9|||
129130871|NCT02942407|464770943|FG000|Overall Study|Death|16|||
128714872|NCT00778700|463253610|FG001|Overall Study|Adverse Event|1|||
128714873|NCT00778700|463253611|FG002|Overall Study|Adverse Event|3|||
128714874|NCT00778700|463253612|FG003|Overall Study|Adverse Event|5|||
128714875|NCT00778700|463253609|FG000|Overall Study|Protocol Violation|1|||
128714876|NCT00778700|463253610|FG001|Overall Study|Protocol Violation|1|||
128714877|NCT00778700|463253611|FG002|Overall Study|Protocol Violation|0|||
128714878|NCT00778700|463253612|FG003|Overall Study|Protocol Violation|0|||
128714879|NCT00778700|463253609|FG000|Overall Study|Subject Withdrew Consent|6|||
128714880|NCT00778700|463253610|FG001|Overall Study|Subject Withdrew Consent|4|||
128714881|NCT00778700|463253611|FG002|Overall Study|Subject Withdrew Consent|1|||
128714882|NCT00778700|463253612|FG003|Overall Study|Subject Withdrew Consent|4|||
128714883|NCT00778700|463253609|FG000|Overall Study|Lost to Follow-up|3|||
128714884|NCT00778700|463253610|FG001|Overall Study|Lost to Follow-up|1|||
128714885|NCT00778700|463253611|FG002|Overall Study|Lost to Follow-up|0|||
128714886|NCT00778700|463253612|FG003|Overall Study|Lost to Follow-up|1|||
128714887|NCT00778700|463253609|FG000|Overall Study|Reason not Specified|2|||
128714888|NCT00778700|463253610|FG001|Overall Study|Reason not Specified|0|||
128714889|NCT00778700|463253611|FG002|Overall Study|Reason not Specified|1|||
128714890|NCT00778700|463253612|FG003|Overall Study|Reason not Specified|3|||
128714891|NCT00778700|463253609|FG000|Overall Study|Other|0|||
128714892|NCT00778700|463253610|FG001|Overall Study|Other|0|||
128714893|NCT00778700|463253611|FG002|Overall Study|Other|1|||
128714894|NCT00778700|463253612|FG003|Overall Study|Other|0|||
128714895|NCT01275833|463253618|FG000|Overall Study|Study terminated|1|||
128714896|NCT01275833|463253619|FG001|Overall Study|Study terminated|1|||
128714897|NCT00003901|463253622|FG000|Overall Study|Adverse Event|1|||
128714898|NCT00003901|463253622|FG000|Overall Study|Withdrawal by Subject|1|||
128714899|NCT00003901|463253622|FG000|Overall Study|Ineligible|6|||
128714900|NCT00003901|463253622|FG000|Overall Study|CT Scan not within protocol requirement|2|||
128714901|NCT00003901|463253622|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
128714902|NCT00003901|463253622|FG000|Overall Study|Medical problems|6|||
128714903|NCT00680745|463253627|FG000|Overall Study|Withdrawal by Subject|8|||
128714904|NCT00680745|463253628|FG001|Overall Study|Withdrawal by Subject|3|||
128714905|NCT00680745|463253629|FG002|Overall Study|Withdrawal by Subject|2|||
128714906|NCT00680745|463253630|FG003|Overall Study|Withdrawal by Subject|8|||
128714907|NCT00680745|463253627|FG000|Overall Study|Lost to Follow-up|0|||
128714908|NCT00680745|463253628|FG001|Overall Study|Lost to Follow-up|1|||
128714909|NCT00680745|463253629|FG002|Overall Study|Lost to Follow-up|1|||
128714910|NCT00680745|463253630|FG003|Overall Study|Lost to Follow-up|0|||
128714911|NCT00680745|463253627|FG000|Overall Study|Death|1|||
128714912|NCT00680745|463253628|FG001|Overall Study|Death|0|||
128714913|NCT00680745|463253629|FG002|Overall Study|Death|1|||
128714914|NCT00680745|463253630|FG003|Overall Study|Death|0|||
128774167|NCT00972179|463464166|FG002|Overall Study|Administrative Decision|0|||
128970499|NCT03657576|464177367|FG003|Overall Study|Death|0|||
128970500|NCT03657576|464177368|FG004|Overall Study|Death|0|||
128970501|NCT03657576|464177369|FG005|Overall Study|Death|0|||
128970502|NCT03657576|464177364|FG000|Overall Study|Withdrawal by Subject|0|||
129130872|NCT02942407|464770944|FG001|Overall Study|Death|13|||
128714915|NCT00680745|463253627|FG000|Overall Study|Adverse Event|5|||
128714916|NCT00680745|463253628|FG001|Overall Study|Adverse Event|3|||
128714917|NCT00680745|463253629|FG002|Overall Study|Adverse Event|3|||
128970503|NCT03657576|464177365|FG001|Overall Study|Withdrawal by Subject|0|||
128714918|NCT00680745|463253630|FG003|Overall Study|Adverse Event|3|||
128714919|NCT00680745|463253627|FG000|Overall Study|Poor/Non-compliance|0|||
128714920|NCT00680745|463253628|FG001|Overall Study|Poor/Non-compliance|3|||
128714921|NCT00680745|463253629|FG002|Overall Study|Poor/Non-compliance|0|||
128714922|NCT00680745|463253630|FG003|Overall Study|Poor/Non-compliance|0|||
128714923|NCT00680745|463253627|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
128970504|NCT03657576|464177366|FG002|Overall Study|Withdrawal by Subject|0|||
129130873|NCT01716156|464770946|FG000|Overall Study|Protocol Violation|1|||
129130874|NCT01716156|464770947|FG001|Overall Study|Protocol Violation|0|||
129130875|NCT01716156|464770948|FG002|Overall Study|Protocol Violation|0|||
129130876|NCT01716156|464770946|FG000|Overall Study|Withdrawal by Subject|0|||
128970505|NCT03657576|464177367|FG003|Overall Study|Withdrawal by Subject|1|||
128970506|NCT03657576|464177368|FG004|Overall Study|Withdrawal by Subject|0|||
128970507|NCT03657576|464177369|FG005|Overall Study|Withdrawal by Subject|0|||
128970508|NCT03657576|464177364|FG000|Overall Study|Screen Fail|0|||
128970509|NCT03657576|464177365|FG001|Overall Study|Screen Fail|0|||
128970510|NCT03657576|464177366|FG002|Overall Study|Screen Fail|0|||
128970511|NCT03657576|464177367|FG003|Overall Study|Screen Fail|0|||
128970512|NCT03657576|464177368|FG004|Overall Study|Screen Fail|0|||
128970513|NCT03657576|464177369|FG005|Overall Study|Screen Fail|5|||
128970514|NCT03657576|464177364|FG000|Overall Study|Disease Progression|1|||
128970515|NCT03657576|464177365|FG001|Overall Study|Disease Progression|1|||
128970516|NCT03657576|464177366|FG002|Overall Study|Disease Progression|0|||
128970517|NCT03657576|464177367|FG003|Overall Study|Disease Progression|5|||
128970518|NCT03657576|464177368|FG004|Overall Study|Disease Progression|0|||
128970519|NCT03657576|464177369|FG005|Overall Study|Disease Progression|0|||
128970520|NCT03657576|464177364|FG000|Overall Study|Insurance Coverage|0|||
128970521|NCT03657576|464177365|FG001|Overall Study|Insurance Coverage|0|||
128970522|NCT03657576|464177366|FG002|Overall Study|Insurance Coverage|0|||
128970523|NCT03657576|464177367|FG003|Overall Study|Insurance Coverage|1|||
128970524|NCT03657576|464177368|FG004|Overall Study|Insurance Coverage|0|||
128970525|NCT03657576|464177369|FG005|Overall Study|Insurance Coverage|0|||
128970526|NCT03381274|464177372|FG000|Overall Study|Death|2|||
128970527|NCT03381274|464177373|FG001|Overall Study|Death|9|||
128970528|NCT03381274|464177374|FG002|Overall Study|Death|3|||
128970529|NCT03381274|464177375|FG003|Overall Study|Death|2|||
128970530|NCT03381274|464177376|FG004|Overall Study|Death|3|||
128970531|NCT03381274|464177372|FG000|Overall Study|Lost to Follow-up|0|||
128970532|NCT03381274|464177373|FG001|Overall Study|Lost to Follow-up|0|||
128970533|NCT03381274|464177374|FG002|Overall Study|Lost to Follow-up|0|||
128970534|NCT03381274|464177375|FG003|Overall Study|Lost to Follow-up|1|||
128970535|NCT03381274|464177376|FG004|Overall Study|Lost to Follow-up|0|||
128970536|NCT03381274|464177372|FG000|Overall Study|Withdrawal by Subject|2|||
128970537|NCT03381274|464177373|FG001|Overall Study|Withdrawal by Subject|1|||
128970538|NCT03381274|464177374|FG002|Overall Study|Withdrawal by Subject|3|||
128970539|NCT03381274|464177375|FG003|Overall Study|Withdrawal by Subject|1|||
128970540|NCT03381274|464177376|FG004|Overall Study|Withdrawal by Subject|0|||
128970541|NCT03381274|464177372|FG000|Overall Study|Other|1|||
128970542|NCT03381274|464177373|FG001|Overall Study|Other|11|||
128970543|NCT03381274|464177374|FG002|Overall Study|Other|0|||
128970544|NCT03381274|464177375|FG003|Overall Study|Other|2|||
128970545|NCT03381274|464177376|FG004|Overall Study|Other|2|||
128970546|NCT01874353|464177377|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
128970547|NCT01874353|464177378|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
128970548|NCT01874353|464177379|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
128970549|NCT01874353|464177380|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
128970550|NCT01874353|464177377|FG000|Overall Study|Lost to Follow-up|2|||
128970551|NCT01874353|464177378|FG001|Overall Study|Lost to Follow-up|2|||
128970552|NCT01874353|464177379|FG002|Overall Study|Lost to Follow-up|2|||
128970553|NCT01874353|464177380|FG003|Overall Study|Lost to Follow-up|0|||
128970554|NCT01874353|464177377|FG000|Overall Study|Death|110|||
128970555|NCT01874353|464177378|FG001|Overall Study|Death|60|||
128970556|NCT01874353|464177379|FG002|Overall Study|Death|13|||
128970557|NCT01874353|464177380|FG003|Overall Study|Death|7|||
128970558|NCT01874353|464177377|FG000|Overall Study|Withdrawal by Subject|13|||
128970559|NCT01874353|464177378|FG001|Overall Study|Withdrawal by Subject|11|||
128970560|NCT01874353|464177379|FG002|Overall Study|Withdrawal by Subject|0|||
128970561|NCT01874353|464177380|FG003|Overall Study|Withdrawal by Subject|0|||
128970562|NCT04392154|464177381|FG000|Overall Study|Adverse Event|3|||
128970563|NCT04392154|464177382|FG001|Overall Study|Adverse Event|46|||
128970564|NCT04392154|464177381|FG000|Overall Study|Due to epidemic/pandemic|0|||
128970565|NCT04392154|464177382|FG001|Overall Study|Due to epidemic/pandemic|1|||
128970566|NCT04392154|464177381|FG000|Overall Study|Lack of Efficacy|1|||
128970567|NCT04392154|464177382|FG001|Overall Study|Lack of Efficacy|47|||
129130877|NCT01716156|464770947|FG001|Overall Study|Withdrawal by Subject|1|||
129130878|NCT01716156|464770948|FG002|Overall Study|Withdrawal by Subject|2|||
129130879|NCT01716156|464770946|FG000|Overall Study|Lost to Follow-up|1|||
128970568|NCT04392154|464177381|FG000|Overall Study|Lost to Follow-up|11|||
128970569|NCT04392154|464177382|FG001|Overall Study|Lost to Follow-up|61|||
128970570|NCT04392154|464177381|FG000|Overall Study|Geopolitical conflict|1|||
128970571|NCT04392154|464177382|FG001|Overall Study|Geopolitical conflict|1|||
128970572|NCT04392154|464177381|FG000|Overall Study|Physician Decision|1|||
128970573|NCT04392154|464177382|FG001|Overall Study|Physician Decision|5|||
129130880|NCT01716156|464770947|FG001|Overall Study|Lost to Follow-up|0|||
128970574|NCT04392154|464177381|FG000|Overall Study|Pregnancy|1|||
128970575|NCT04392154|464177382|FG001|Overall Study|Pregnancy|8|||
128970576|NCT04392154|464177381|FG000|Overall Study|Protocol deviation|1|||
128970577|NCT04392154|464177382|FG001|Overall Study|Protocol deviation|12|||
128970578|NCT04392154|464177381|FG000|Overall Study|Withdrawal by Subject|18|||
129130881|NCT01716156|464770948|FG002|Overall Study|Lost to Follow-up|0|||
129220448|NCT00807001|465108095|FG001|Overall Study|Non-compliance|1|||
128970579|NCT04392154|464177382|FG001|Overall Study|Withdrawal by Subject|138|||
128970580|NCT04392154|464177381|FG000|Overall Study|Sponsor Decision|1|||
128970581|NCT04392154|464177382|FG001|Overall Study|Sponsor Decision|14|||
128970582|NCT04392154|464177381|FG000|Overall Study|Site Closure|0|||
128970583|NCT04392154|464177382|FG001|Overall Study|Site Closure|4|||
128970584|NCT05180721|464177383|FG000|Overall Study|Lost to Follow-up|4|||
128970585|NCT01996865|464177385|FG000|Induction Period|Protocol Violation|1|||
128970586|NCT01996865|464177386|FG001|Induction Period|Protocol Violation|0|||
128970587|NCT01996865|464177387|FG002|Induction Period|Protocol Violation|0|||
128970588|NCT01996865|464177385|FG000|Induction Period|Progressive Disease|4|||
128970589|NCT01996865|464177386|FG001|Induction Period|Progressive Disease|0|||
128970590|NCT01996865|464177387|FG002|Induction Period|Progressive Disease|0|||
128970591|NCT01996865|464177385|FG000|Induction Period|Lost to Follow-up|10|||
128970592|NCT01996865|464177386|FG001|Induction Period|Lost to Follow-up|0|||
128970593|NCT01996865|464177387|FG002|Induction Period|Lost to Follow-up|0|||
128970594|NCT01996865|464177385|FG000|Induction Period|Other Reasons|13|||
128970595|NCT01996865|464177386|FG001|Induction Period|Other Reasons|0|||
128970596|NCT01996865|464177387|FG002|Induction Period|Other Reasons|0|||
128970597|NCT01996865|464177385|FG000|Induction Period|Adverse Event|20|||
128970598|NCT01996865|464177386|FG001|Induction Period|Adverse Event|0|||
128970599|NCT01996865|464177387|FG002|Induction Period|Adverse Event|0|||
128970600|NCT01996865|464177385|FG000|Induction Period|Withdrawal by Subject|60|||
128970601|NCT01996865|464177386|FG001|Induction Period|Withdrawal by Subject|0|||
128970602|NCT01996865|464177387|FG002|Induction Period|Withdrawal by Subject|0|||
128970603|NCT01996865|464177385|FG000|Induction Period|Death|111|||
128970604|NCT01996865|464177386|FG001|Induction Period|Death|0|||
128970605|NCT01996865|464177387|FG002|Induction Period|Death|0|||
128970606|NCT01996865|464177385|FG000|Maintenance Period|Protocol Violation|0|||
128970607|NCT01996865|464177386|FG001|Maintenance Period|Protocol Violation|1|||
128970608|NCT01996865|464177387|FG002|Maintenance Period|Protocol Violation|1|||
128970609|NCT01996865|464177385|FG000|Maintenance Period|Other reasons|0|||
128970610|NCT01996865|464177386|FG001|Maintenance Period|Other reasons|8|||
128970611|NCT01996865|464177387|FG002|Maintenance Period|Other reasons|5|||
128970612|NCT01996865|464177385|FG000|Maintenance Period|Progressive Disease|0|||
128970613|NCT01996865|464177386|FG001|Maintenance Period|Progressive Disease|6|||
128970614|NCT01996865|464177387|FG002|Maintenance Period|Progressive Disease|23|||
128970615|NCT01996865|464177385|FG000|Maintenance Period|Withdrawal by Subject|0|||
128970616|NCT01996865|464177386|FG001|Maintenance Period|Withdrawal by Subject|18|||
128970617|NCT01996865|464177387|FG002|Maintenance Period|Withdrawal by Subject|4|||
128970618|NCT01996865|464177385|FG000|Maintenance Period|Adverse Event|0|||
128970619|NCT01996865|464177386|FG001|Maintenance Period|Adverse Event|7|||
128970620|NCT01996865|464177387|FG002|Maintenance Period|Adverse Event|7|||
128970621|NCT01996865|464177385|FG000|Maintenance Period|Death|0|||
128970622|NCT01996865|464177386|FG001|Maintenance Period|Death|15|||
128970623|NCT01996865|464177387|FG002|Maintenance Period|Death|3|||
128970624|NCT01996865|464177385|FG000|Maintenance Period|Lost to Follow-up|0|||
128970625|NCT01996865|464177386|FG001|Maintenance Period|Lost to Follow-up|2|||
128970626|NCT01996865|464177387|FG002|Maintenance Period|Lost to Follow-up|0|||
128970627|NCT03575351|464177390|FG000|Overall Study|Adverse Event|1|||
128970628|NCT03575351|464177391|FG001|Overall Study|Adverse Event|0|||
128970629|NCT03575351|464177390|FG000|Overall Study|Death|2|||
128970630|NCT03575351|464177391|FG001|Overall Study|Death|2|||
128970631|NCT03575351|464177390|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
128970632|NCT03575351|464177391|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
128970633|NCT03575351|464177390|FG000|Overall Study|Lack of Efficacy|28|||
128970634|NCT03575351|464177391|FG001|Overall Study|Lack of Efficacy|0|||
128970635|NCT03575351|464177390|FG000|Overall Study|Withdrawal by Subject|1|||
128970636|NCT03575351|464177391|FG001|Overall Study|Withdrawal by Subject|1|||
128970637|NCT03575351|464177390|FG000|Overall Study|Physician Decision|3|||
128970638|NCT03575351|464177391|FG001|Overall Study|Physician Decision|0|||
128970639|NCT03575351|464177390|FG000|Overall Study|Disease relapse|15|||
128970640|NCT03575351|464177391|FG001|Overall Study|Disease relapse|6|||
128774168|NCT00972179|463464167|FG003|Overall Study|Administrative Decision|0|||
128970641|NCT03575351|464177390|FG000|Overall Study|Study drug manufacturing failure|0|||
128970642|NCT03575351|464177391|FG001|Overall Study|Study drug manufacturing failure|1|||
128970643|NCT03575351|464177390|FG000|Overall Study|other reasons|5|||
128970644|NCT03575351|464177391|FG001|Overall Study|other reasons|0|||
128970645|NCT04288089|464177397|FG000|Overall Study|Ongoing Treatment|2|||
128970646|NCT04288089|464177398|FG001|Overall Study|Ongoing Treatment|1|||
128970647|NCT04288089|464177399|FG002|Overall Study|Ongoing Treatment|1|||
128970648|NCT04288089|464177400|FG003|Overall Study|Ongoing Treatment|4|||
128970649|NCT03715205|464177401|FG000|Overall Study|Death|13|||
128970650|NCT03715205|464177401|FG000|Overall Study|Lost to Follow-up|2|||
128970651|NCT03715205|464177401|FG000|Overall Study|Physician Decision|93|||
128970652|NCT03715205|464177401|FG000|Overall Study|Withdrawal by Subject|26|||
128970653|NCT00557323|464177403|FG000|Overall Study|Death|3|||
128970654|NCT00557323|464177403|FG000|Overall Study|Withdrawal by Subject|2|||
128970655|NCT00557323|464177403|FG000|Overall Study|Administrative change|2|||
128970656|NCT01196091|464177408|FG000|Overall Study|Adverse Event|22|||
129130882|NCT03925220|464770949|FG000|Overall Study|Withdrawal by Subject|4|||
129130883|NCT03925220|464770950|FG001|Overall Study|Withdrawal by Subject|4|||
129130884|NCT03925220|464770951|FG002|Overall Study|Withdrawal by Subject|4|||
128774169|NCT00972179|463464168|FG004|Overall Study|Administrative Decision|1|||
128774170|NCT00972179|463464169|FG005|Overall Study|Administrative Decision|0|||
128774171|NCT00972179|463464170|FG006|Overall Study|Administrative Decision|0|||
128774172|NCT00972179|463464164|FG000|Overall Study|Lost to Follow-up|0|||
128774173|NCT00972179|463464165|FG001|Overall Study|Lost to Follow-up|0|||
128970657|NCT01196091|464177409|FG001|Overall Study|Adverse Event|27|||
128970658|NCT01196091|464177410|FG002|Overall Study|Adverse Event|26|||
128970659|NCT01196091|464177408|FG000|Overall Study|Death|3|||
128970660|NCT01196091|464177409|FG001|Overall Study|Death|2|||
128970661|NCT01196091|464177410|FG002|Overall Study|Death|2|||
128970662|NCT01196091|464177408|FG000|Overall Study|Entry Criteria Not Met|11|||
128970663|NCT01196091|464177409|FG001|Overall Study|Entry Criteria Not Met|11|||
128970664|NCT01196091|464177410|FG002|Overall Study|Entry Criteria Not Met|10|||
128970665|NCT01196091|464177408|FG000|Overall Study|Lack of Efficacy|15|||
128970666|NCT01196091|464177409|FG001|Overall Study|Lack of Efficacy|12|||
128970667|NCT01196091|464177410|FG002|Overall Study|Lack of Efficacy|17|||
128970668|NCT01196091|464177408|FG000|Overall Study|Lost to Follow-up|5|||
128970669|NCT01196091|464177409|FG001|Overall Study|Lost to Follow-up|5|||
128970670|NCT01196091|464177410|FG002|Overall Study|Lost to Follow-up|6|||
128970671|NCT01196091|464177408|FG000|Overall Study|Parent/Caregiver Decision|0|||
128970672|NCT01196091|464177409|FG001|Overall Study|Parent/Caregiver Decision|0|||
128970673|NCT01196091|464177410|FG002|Overall Study|Parent/Caregiver Decision|1|||
128970674|NCT01196091|464177408|FG000|Overall Study|Withdrawal by Subject|16|||
128970675|NCT01196091|464177409|FG001|Overall Study|Withdrawal by Subject|19|||
128970676|NCT01196091|464177410|FG002|Overall Study|Withdrawal by Subject|22|||
128970677|NCT01196091|464177408|FG000|Overall Study|Physician Decision|3|||
128970678|NCT01196091|464177409|FG001|Overall Study|Physician Decision|3|||
128970679|NCT01196091|464177410|FG002|Overall Study|Physician Decision|4|||
128970680|NCT01196091|464177408|FG000|Overall Study|Protocol Violation|1|||
128970681|NCT01196091|464177409|FG001|Overall Study|Protocol Violation|3|||
128970682|NCT01196091|464177410|FG002|Overall Study|Protocol Violation|3|||
128970683|NCT01196091|464177408|FG000|Overall Study|Sponsor Decision|6|||
128970684|NCT01196091|464177409|FG001|Overall Study|Sponsor Decision|5|||
128970685|NCT01196091|464177410|FG002|Overall Study|Sponsor Decision|4|||
128970686|NCT01196091|464177408|FG000|Overall Study|Excluded Site|5|||
128970687|NCT01196091|464177409|FG001|Overall Study|Excluded Site|11|||
128970688|NCT01196091|464177410|FG002|Overall Study|Excluded Site|8|||
128970689|NCT01196091|464177408|FG000|Overall Study|Randomized, No Study Drug Received|1|||
128970690|NCT01196091|464177409|FG001|Overall Study|Randomized, No Study Drug Received|0|||
128970691|NCT01196091|464177410|FG002|Overall Study|Randomized, No Study Drug Received|1|||
129038310|NCT02688387|464433154|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038311|NCT02688387|464433155|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038312|NCT02688387|464433156|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038313|NCT02688387|464433157|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038314|NCT02688387|464433158|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129038315|NCT02688387|464433137|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038316|NCT02688387|464433138|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038317|NCT02688387|464433139|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038318|NCT02688387|464433140|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038319|NCT02688387|464433141|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038320|NCT02688387|464433142|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038321|NCT02688387|464433143|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038322|NCT02688387|464433144|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038323|NCT02688387|464433145|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038324|NCT02688387|464433146|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038325|NCT02688387|464433147|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038326|NCT02688387|464433148|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038327|NCT02688387|464433149|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038328|NCT02688387|464433150|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038329|NCT02688387|464433151|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
129038330|NCT02688387|464433152|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038331|NCT02688387|464433153|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038332|NCT02688387|464433154|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038333|NCT02688387|464433155|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038334|NCT02688387|464433156|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129130885|NCT03925220|464770952|FG003|Overall Study|Withdrawal by Subject|4|||
128970692|NCT03733249|464177411|FG000|Overall Study|Death|7|||
128774174|NCT00972179|463464166|FG002|Overall Study|Lost to Follow-up|1|||
128970693|NCT03733249|464177411|FG000|Overall Study|Disease relapse|16|||
128970694|NCT03733249|464177411|FG000|Overall Study|Lost to Follow-up|4|||
128970695|NCT03733249|464177411|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
129130886|NCT03925220|464770949|FG000|Overall Study|Lost to Follow-up|40|||
129130887|NCT03925220|464770950|FG001|Overall Study|Lost to Follow-up|46|||
128970696|NCT03733249|464177411|FG000|Overall Study|Withdrawal by Subject|1|||
128970697|NCT02253992|464177412|FG000|Overall Study|Study drug toxicity|1|||
128970698|NCT02253992|464177413|FG001|Overall Study|Study drug toxicity|0|||
128970699|NCT02253992|464177414|FG002|Overall Study|Study drug toxicity|10|||
128970700|NCT02253992|464177412|FG000|Overall Study|Disease progression|4|||
128970701|NCT02253992|464177413|FG001|Overall Study|Disease progression|3|||
128970702|NCT02253992|464177414|FG002|Overall Study|Disease progression|98|||
128970703|NCT02253992|464177412|FG000|Overall Study|Withdrawal by Subject|0|||
128970704|NCT02253992|464177413|FG001|Overall Study|Withdrawal by Subject|0|||
128970705|NCT02253992|464177414|FG002|Overall Study|Withdrawal by Subject|3|||
128970706|NCT02253992|464177412|FG000|Overall Study|Adverse Event|0|||
128970707|NCT02253992|464177413|FG001|Overall Study|Adverse Event|0|||
128970708|NCT02253992|464177414|FG002|Overall Study|Adverse Event|8|||
128970709|NCT02253992|464177412|FG000|Overall Study|Death|0|||
128970710|NCT02253992|464177413|FG001|Overall Study|Death|0|||
128970711|NCT02253992|464177414|FG002|Overall Study|Death|1|||
128970712|NCT02253992|464177412|FG000|Overall Study|Subject discontinued study drug|1|||
128970713|NCT02253992|464177413|FG001|Overall Study|Subject discontinued study drug|0|||
128970714|NCT02253992|464177414|FG002|Overall Study|Subject discontinued study drug|1|||
128970715|NCT02253992|464177412|FG000|Overall Study|Completed treatment as per protocol|0|||
128970716|NCT02253992|464177413|FG001|Overall Study|Completed treatment as per protocol|1|||
128970717|NCT02253992|464177414|FG002|Overall Study|Completed treatment as per protocol|22|||
128970718|NCT02253992|464177412|FG000|Overall Study|Other|0|||
128970719|NCT02253992|464177413|FG001|Overall Study|Other|0|||
128970720|NCT02253992|464177414|FG002|Overall Study|Other|1|||
128970721|NCT00772889|464177415|FG000|Overall Study|Adverse Event|7|||
128970722|NCT00772889|464177416|FG001|Overall Study|Adverse Event|4|||
128970723|NCT00772889|464177417|FG002|Overall Study|Adverse Event|0|||
128970724|NCT00772889|464177415|FG000|Overall Study|Withdrawal by Subject|9|||
128970725|NCT00772889|464177416|FG001|Overall Study|Withdrawal by Subject|8|||
128970726|NCT00772889|464177417|FG002|Overall Study|Withdrawal by Subject|9|||
128970727|NCT00772889|464177415|FG000|Overall Study|Lost to Follow-up|6|||
128970728|NCT00772889|464177416|FG001|Overall Study|Lost to Follow-up|6|||
128970729|NCT00772889|464177417|FG002|Overall Study|Lost to Follow-up|7|||
128970730|NCT03323086|464177418|FG000|Overall Study|Lost to Follow-up|3|||
128970731|NCT03323086|464177419|FG001|Overall Study|Lost to Follow-up|2|||
128970732|NCT04247828|464177428|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
128970733|NCT02159365|464177429|FG000|Overall Study|Disease Progression|23|||
128970734|NCT02159365|464177429|FG000|Overall Study|Other reasons|11|||
128970735|NCT02159365|464177429|FG000|Overall Study|Administrative reason by Sponsor|9|||
128970736|NCT02159365|464177429|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
128970737|NCT02159365|464177429|FG000|Overall Study|Study drug toxicity|7|||
128970738|NCT02159365|464177429|FG000|Overall Study|Maximum clinical benefit|3|||
128970739|NCT02159365|464177429|FG000|Overall Study|Subject request to discontinue treatment|3|||
128970740|NCT02159365|464177429|FG000|Overall Study|Subject withdrew consent|3|||
128970741|NCT02159365|464177429|FG000|Overall Study|Death|1|||
128970742|NCT02159365|464177429|FG000|Overall Study|Lost to Follow-up|1|||
128970743|NCT00796549|464177430|FG000|Overall Study|Adverse Event|11|||
128970744|NCT00796549|464177430|FG000|Overall Study|not entered|149|||
128970745|NCT00796549|464177430|FG000|Overall Study|Other|2|||
129130888|NCT03925220|464770951|FG002|Overall Study|Lost to Follow-up|37|||
129130889|NCT03925220|464770952|FG003|Overall Study|Lost to Follow-up|38|||
129130890|NCT05221866|464770953|FG000|Overall Study|Withdrawal by Subject|5|||
129130891|NCT05221866|464770954|FG001|Overall Study|Withdrawal by Subject|7|||
129130892|NCT05221866|464770955|FG002|Overall Study|Withdrawal by Subject|6|||
129130893|NCT05221866|464770956|FG003|Overall Study|Withdrawal by Subject|4|||
129130894|NCT05221866|464770953|FG000|Overall Study|Physician Decision|3|||
129130895|NCT05221866|464770954|FG001|Overall Study|Physician Decision|2|||
128714924|NCT00680745|463253628|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
128714925|NCT00680745|463253629|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
128714926|NCT00680745|463253630|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
128714927|NCT00680745|463253627|FG000|Overall Study|False Treatment|0|||
128714928|NCT00680745|463253628|FG001|Overall Study|False Treatment|1|||
128714929|NCT00680745|463253629|FG002|Overall Study|False Treatment|3|||
129130896|NCT05221866|464770955|FG002|Overall Study|Physician Decision|1|||
128714930|NCT00680745|463253630|FG003|Overall Study|False Treatment|0|||
128970746|NCT00796549|464177430|FG000|Overall Study|Progressive disease|56|||
128970747|NCT01878175|464177432|FG000|Overall Study|Developed contraindicated health problem|2|||
128970748|NCT02201251|464177433|FG000|Overall Study|Adverse Event|1|||
128970749|NCT02201251|464177434|FG001|Overall Study|Adverse Event|1|||
128970750|NCT02201251|464177433|FG000|Overall Study|Protocol Violation|1|||
128970751|NCT02201251|464177434|FG001|Overall Study|Protocol Violation|0|||
128970752|NCT02201251|464177433|FG000|Overall Study|Noncompliance with Study Drug|0|||
129130897|NCT05221866|464770956|FG003|Overall Study|Physician Decision|4|||
129130898|NCT05221866|464770953|FG000|Overall Study|Lost to Follow-up|12|||
129130899|NCT05221866|464770954|FG001|Overall Study|Lost to Follow-up|17|||
129038335|NCT02688387|464433157|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038336|NCT02688387|464433158|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129038337|NCT02688387|464433137|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038338|NCT02688387|464433138|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038339|NCT02688387|464433139|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038340|NCT02688387|464433140|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038341|NCT02688387|464433141|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038342|NCT02688387|464433142|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038343|NCT02688387|464433143|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038344|NCT02688387|464433144|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038345|NCT02688387|464433145|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038346|NCT02688387|464433146|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038347|NCT02688387|464433147|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038348|NCT02688387|464433148|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038349|NCT02688387|464433149|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038350|NCT02688387|464433150|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038351|NCT02688387|464433151|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038352|NCT02688387|464433152|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038353|NCT02688387|464433153|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038354|NCT02688387|464433154|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038355|NCT02688387|464433155|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038356|NCT02688387|464433156|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038357|NCT02688387|464433157|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
129038358|NCT02688387|464433158|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129038359|NCT02688387|464433137|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038360|NCT02688387|464433138|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038361|NCT02688387|464433139|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038362|NCT02688387|464433140|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038363|NCT02688387|464433141|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038364|NCT02688387|464433142|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038365|NCT02688387|464433143|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038366|NCT02688387|464433144|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038367|NCT02688387|464433145|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038368|NCT02688387|464433146|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038369|NCT02688387|464433147|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038370|NCT02688387|464433148|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038371|NCT02688387|464433149|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038372|NCT02688387|464433150|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038373|NCT02688387|464433151|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038374|NCT02688387|464433152|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038375|NCT02688387|464433153|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038376|NCT02688387|464433154|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038377|NCT02688387|464433155|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
129038378|NCT02688387|464433156|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038379|NCT02688387|464433157|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
129038380|NCT02688387|464433158|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129038381|NCT02688387|464433137|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038382|NCT02688387|464433138|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038383|NCT02688387|464433139|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038384|NCT02688387|464433140|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038385|NCT02688387|464433141|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038386|NCT02688387|464433142|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038387|NCT02688387|464433143|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038388|NCT02688387|464433144|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038389|NCT02688387|464433145|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038390|NCT02688387|464433146|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038391|NCT02688387|464433147|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038392|NCT02688387|464433148|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038393|NCT02688387|464433149|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038394|NCT02688387|464433150|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038395|NCT02688387|464433151|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038396|NCT02688387|464433152|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038397|NCT02688387|464433153|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038398|NCT02688387|464433154|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038399|NCT02688387|464433155|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038400|NCT02688387|464433156|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
129038401|NCT02688387|464433157|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038402|NCT02688387|464433158|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129038403|NCT02938442|464433161|FG000|Overall Study|Death|0|||
129038404|NCT02938442|464433162|FG001|Overall Study|Death|1|||
129038405|NCT02938442|464433161|FG000|Overall Study|Lost to Follow-up|0|||
128714931|NCT02612428|463253631|FG000|VTL-308|Death|14|||
128714932|NCT02612428|463253632|FG001|VTL-308|Death|16|||
128714933|NCT02612428|463253631|FG000|VTL-308|Withdrawal by Subject|0|||
128714934|NCT02612428|463253632|FG001|VTL-308|Withdrawal by Subject|1|||
128714935|NCT02612428|463253631|FG000|VTL-308E|Death|9|||
128714936|NCT02612428|463253632|FG001|VTL-308E|Death|7|||
128714937|NCT02612428|463253631|FG000|VTL-308E|Lost to Follow-up|2|||
128714938|NCT02612428|463253632|FG001|VTL-308E|Lost to Follow-up|0|||
128714939|NCT00742001|463253633|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
128714940|NCT00742001|463253634|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
128714941|NCT00742001|463253635|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
128714942|NCT00137423|463253636|FG000|Overall Study|Adverse Event|7|||
128714943|NCT00137423|463253637|FG001|Overall Study|Adverse Event|9|||
128714944|NCT00137423|463253636|FG000|Overall Study|consent withdrawn|1|||
128714945|NCT00137423|463253637|FG001|Overall Study|consent withdrawn|1|||
128714946|NCT00137423|463253636|FG000|Overall Study|Lack of Efficacy|31|||
128714947|NCT00137423|463253637|FG001|Overall Study|Lack of Efficacy|33|||
128714948|NCT00137423|463253636|FG000|Overall Study|Death|0|||
128714949|NCT00137423|463253637|FG001|Overall Study|Death|1|||
128714950|NCT01928329|463253638|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
128714951|NCT01928329|463253639|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
128714952|NCT01928329|463253638|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
128714953|NCT01928329|463253639|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
128714954|NCT01928329|463253638|FG000|Overall Study|Adverse Event|5|||
128714955|NCT01928329|463253639|FG001|Overall Study|Adverse Event|3|||
128714956|NCT01928329|463253638|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
128714957|NCT01928329|463253639|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
128714958|NCT01928329|463253638|FG000|Overall Study|Withdrawal by Subject|1|||
128714959|NCT01928329|463253639|FG001|Overall Study|Withdrawal by Subject|5|||
128714960|NCT01928329|463253638|FG000|Overall Study|Physician Decision|1|||
128714961|NCT01928329|463253639|FG001|Overall Study|Physician Decision|1|||
128714962|NCT03187262|463253641|FG000|Induction|Lack of Efficacy|2|||
128714963|NCT03187262|463253641|FG000|Induction|Progressive Disease|4|||
128714964|NCT03187262|463253641|FG000|Consolidation|Progressive Disease|5|||
128714965|NCT02617511|463253642|FG000|Overall Study|Withdrawal by Subject|1|||
128714966|NCT02617511|463253643|FG001|Overall Study|Withdrawal by Subject|0|||
128714967|NCT02141997|463253644|FG000|Overall Study|Adverse Event|0|||
128714968|NCT02141997|463253645|FG001|Overall Study|Adverse Event|2|||
128714969|NCT02141997|463253646|FG002|Overall Study|Adverse Event|0|||
128714970|NCT02141997|463253647|FG003|Overall Study|Adverse Event|1|||
128714971|NCT02141997|463253644|FG000|Overall Study|Participant noncompliance|1|||
128714972|NCT02141997|463253645|FG001|Overall Study|Participant noncompliance|0|||
128714973|NCT02141997|463253646|FG002|Overall Study|Participant noncompliance|0|||
128714974|NCT02141997|463253647|FG003|Overall Study|Participant noncompliance|0|||
128714975|NCT02141997|463253644|FG000|Overall Study|Withdrew consent|1|||
128714976|NCT02141997|463253645|FG001|Overall Study|Withdrew consent|0|||
128714977|NCT02141997|463253646|FG002|Overall Study|Withdrew consent|3|||
128714978|NCT02141997|463253647|FG003|Overall Study|Withdrew consent|0|||
128714979|NCT02141997|463253644|FG000|Overall Study|Other|1|||
128714980|NCT02141997|463253645|FG001|Overall Study|Other|4|||
128714981|NCT02141997|463253646|FG002|Overall Study|Other|0|||
128714982|NCT02141997|463253647|FG003|Overall Study|Other|0|||
128714983|NCT04105998|463253650|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
128970753|NCT02201251|464177434|FG001|Overall Study|Noncompliance with Study Drug|1|||
128970754|NCT02201251|464177433|FG000|Overall Study|Withdrawal by Subject|2|||
128970755|NCT02201251|464177434|FG001|Overall Study|Withdrawal by Subject|1|||
128970756|NCT02877134|464177436|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970757|NCT02877134|464177437|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
128970758|NCT02877134|464177438|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970759|NCT02877134|464177439|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970760|NCT02877134|464177440|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970761|NCT02877134|464177441|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
128970762|NCT02877134|464177442|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970763|NCT02877134|464177443|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970764|NCT02877134|464177444|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970765|NCT02877134|464177445|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
128714984|NCT04105998|463253651|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
128714985|NCT01050257|463253654|FG000|Overall Study|Adverse Event|4|||
128970766|NCT02877134|464177446|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970767|NCT02877134|464177447|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
128970768|NCT02877134|464177436|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129038406|NCT02938442|464433162|FG001|Overall Study|Lost to Follow-up|1|||
128774175|NCT00972179|463464167|FG003|Overall Study|Lost to Follow-up|0|||
128774176|NCT00972179|463464168|FG004|Overall Study|Lost to Follow-up|0|||
128774177|NCT00972179|463464169|FG005|Overall Study|Lost to Follow-up|3|||
128774178|NCT00972179|463464170|FG006|Overall Study|Lost to Follow-up|1|||
128774179|NCT02500316|463464172|FG000|Overall Study|Adverse Event|3|||
128774180|NCT02500316|463464172|FG000|Overall Study|Lost to Follow-up|2|||
128774181|NCT02500316|463464172|FG000|Overall Study|Protocol Violation|1|||
128774182|NCT02500316|463464172|FG000|Overall Study|Withdrawal by Subject|15|||
128774183|NCT02500316|463464172|FG000|Overall Study|Final height achieved|5|||
128774184|NCT02500316|463464172|FG000|Overall Study|Due to war activity|1|||
128774185|NCT02611830|463464174|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
128774186|NCT02611830|463464175|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
128774187|NCT02611830|463464176|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
128774188|NCT02611830|463464177|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
128774189|NCT02611830|463464174|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
128774190|NCT02611830|463464175|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
128774191|NCT02611830|463464176|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
128774192|NCT02611830|463464177|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
129130900|NCT05221866|464770955|FG002|Overall Study|Lost to Follow-up|14|||
128774193|NCT02611830|463464174|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
128774194|NCT02611830|463464175|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
128774195|NCT02611830|463464176|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
128774196|NCT02611830|463464177|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
128774197|NCT02611830|463464174|FG000|OL Induction Phase|Lack of Efficacy|9|||
128774198|NCT02611830|463464175|FG001|OL Induction Phase|Lack of Efficacy|0|||
128774199|NCT02611830|463464176|FG002|OL Induction Phase|Lack of Efficacy|0|||
128774200|NCT02611830|463464177|FG003|OL Induction Phase|Lack of Efficacy|0|||
128774201|NCT02611830|463464174|FG000|OL Induction Phase|Reason not specified|3|||
128774202|NCT02611830|463464175|FG001|OL Induction Phase|Reason not specified|0|||
128774203|NCT02611830|463464176|FG002|OL Induction Phase|Reason not specified|0|||
128774204|NCT02611830|463464177|FG003|OL Induction Phase|Reason not specified|0|||
128774205|NCT02611830|463464174|FG000|Maintenance Phase|Lack of Efficacy|0|||
128774206|NCT02611830|463464175|FG001|Maintenance Phase|Lack of Efficacy|29|||
128774207|NCT02611830|463464176|FG002|Maintenance Phase|Lack of Efficacy|18|||
128774208|NCT02611830|463464177|FG003|Maintenance Phase|Lack of Efficacy|6|||
128774209|NCT02611830|463464174|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
128774210|NCT02611830|463464175|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
128774211|NCT02611830|463464176|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
128774212|NCT02611830|463464177|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
128774213|NCT02611830|463464174|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
128774214|NCT02611830|463464175|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
128774215|NCT02611830|463464176|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
128774216|NCT02611830|463464177|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
128774217|NCT02611830|463464174|FG000|Maintenance Phase|Lost to Follow-up|0|||
128774218|NCT02611830|463464175|FG001|Maintenance Phase|Lost to Follow-up|0|||
128774219|NCT02611830|463464176|FG002|Maintenance Phase|Lost to Follow-up|0|||
128774220|NCT02611830|463464177|FG003|Maintenance Phase|Lost to Follow-up|1|||
128774221|NCT02611830|463464174|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
128774222|NCT02611830|463464175|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
128774223|NCT02611830|463464176|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
128970769|NCT02877134|464177437|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
128970770|NCT02877134|464177438|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
128970771|NCT02877134|464177439|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
128970772|NCT02877134|464177440|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
128970773|NCT02877134|464177441|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
128970774|NCT02877134|464177442|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
128970775|NCT02877134|464177443|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
128970776|NCT02877134|464177444|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129130901|NCT05221866|464770956|FG003|Overall Study|Lost to Follow-up|14|||
128774224|NCT02611830|463464177|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
128774225|NCT02611830|463464174|FG000|Maintenance Phase|Pregnancy|0|||
128774226|NCT02611830|463464175|FG001|Maintenance Phase|Pregnancy|0|||
128774227|NCT02611830|463464176|FG002|Maintenance Phase|Pregnancy|1|||
128774228|NCT02611830|463464177|FG003|Maintenance Phase|Pregnancy|0|||
128774229|NCT02611830|463464174|FG000|Maintenance Phase|Reason not specified|0|||
128774230|NCT02611830|463464175|FG001|Maintenance Phase|Reason not specified|1|||
128774231|NCT02611830|463464176|FG002|Maintenance Phase|Reason not specified|4|||
128774232|NCT02611830|463464177|FG003|Maintenance Phase|Reason not specified|0|||
128774233|NCT00903786|463464183|FG000|Overall Study|Physician Decision|6|||
128774234|NCT00903786|463464183|FG000|Overall Study|Lack of Efficacy|5|||
128774235|NCT00903786|463464183|FG000|Overall Study|Reason other than lack of efficacy|4|||
128774236|NCT01163747|463464188|FG000|Overall Study|Adverse Event|0|||
128774237|NCT01163747|463464189|FG001|Overall Study|Adverse Event|5|||
128970777|NCT02877134|464177445|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
128970778|NCT02877134|464177446|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
128970779|NCT02877134|464177447|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
128970780|NCT02877134|464177436|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
128970781|NCT02877134|464177437|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
128970782|NCT02877134|464177438|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
128970783|NCT02877134|464177439|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
128970784|NCT02877134|464177440|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
128970785|NCT02877134|464177441|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
128970786|NCT02877134|464177442|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
128970787|NCT02877134|464177443|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
128970788|NCT02877134|464177444|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
128970789|NCT02877134|464177445|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
128970790|NCT02877134|464177446|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
128970791|NCT02877134|464177447|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
128970792|NCT02877134|464177436|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
128970793|NCT02877134|464177437|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
128970794|NCT02877134|464177438|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
128970795|NCT02877134|464177439|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
128970796|NCT02877134|464177440|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
128970797|NCT02877134|464177441|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
128970798|NCT02877134|464177442|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
128970799|NCT02877134|464177443|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
128970800|NCT02877134|464177444|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
128970801|NCT02877134|464177445|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
128970802|NCT02877134|464177446|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
128970803|NCT02877134|464177447|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
128970804|NCT02877134|464177436|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970805|NCT02877134|464177437|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970806|NCT02877134|464177438|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970807|NCT02877134|464177439|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970808|NCT02877134|464177440|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970809|NCT02877134|464177441|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970810|NCT02877134|464177442|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970811|NCT02877134|464177443|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970812|NCT02877134|464177444|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
128970813|NCT02877134|464177445|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970814|NCT02877134|464177446|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970815|NCT02877134|464177447|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
128970816|NCT02877134|464177436|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
128774238|NCT01163747|463464188|FG000|Overall Study|Insufficient Therapeutic Response|0|||
128774239|NCT01163747|463464189|FG001|Overall Study|Insufficient Therapeutic Response|1|||
128774240|NCT01163747|463464188|FG000|Overall Study|Protocol Violation|0|||
128774241|NCT01163747|463464189|FG001|Overall Study|Protocol Violation|1|||
128774242|NCT01163747|463464188|FG000|Overall Study|Refused Treatment|6|||
128774243|NCT01163747|463464189|FG001|Overall Study|Refused Treatment|4|||
128774244|NCT03363659|463464190|FG000|Overall Study|Adverse Event|1|||
128774245|NCT03363659|463464190|FG000|Overall Study|Screen fail|1|||
128774246|NCT03363659|463464190|FG000|Overall Study|Withdrawal by Subject|1|||
128774247|NCT03872388|463464191|FG000|Overall Study|Disease Progression|0|||
128774248|NCT03872388|463464192|FG001|Overall Study|Disease Progression|0|||
128774249|NCT03872388|463464193|FG002|Overall Study|Disease Progression|0|||
128774250|NCT03872388|463464194|FG003|Overall Study|Disease Progression|0|||
128774251|NCT03872388|463464195|FG004|Overall Study|Disease Progression|0|||
128774252|NCT03872388|463464196|FG005|Overall Study|Disease Progression|0|||
128774253|NCT03872388|463464197|FG006|Overall Study|Disease Progression|1|||
128774254|NCT03872388|463464198|FG007|Overall Study|Disease Progression|1|||
128774255|NCT03681639|463466481|FG000|Overall Study|Death|4|||
128774256|NCT03681639|463466481|FG000|Overall Study|Lost to Follow-up|2|||
128774257|NCT03681639|463466481|FG000|Overall Study|Withdrawal by Subject|1|||
128774258|NCT03681639|463466481|FG000|Overall Study|Adverse Event|2|||
128774259|NCT00654940|463466482|FG000|Period 1|Adverse Event|0|||
128970817|NCT02877134|464177437|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129038407|NCT02938442|464433161|FG000|Overall Study|Physician Decision|0|||
129038408|NCT02938442|464433162|FG001|Overall Study|Physician Decision|1|||
129038409|NCT02938442|464433161|FG000|Overall Study|Withdrawal by Subject|2|||
129220449|NCT00807001|465108096|FG002|Overall Study|Non-compliance|0|||
128774260|NCT00654940|463466483|FG001|Period 1|Adverse Event|1|||
128774261|NCT00654940|463466482|FG000|Period 1|Intolerable Pain Level|1|||
128774262|NCT00654940|463466483|FG001|Period 1|Intolerable Pain Level|0|||
128774263|NCT04714216|463466484|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
129220450|NCT00807001|465108097|FG003|Overall Study|Non-compliance|0|||
129220451|NCT00807001|465108098|FG004|Overall Study|Non-compliance|0|||
128714986|NCT01050257|463253655|FG001|Overall Study|Adverse Event|4|||
128714987|NCT01050257|463253656|FG002|Overall Study|Adverse Event|2|||
128714988|NCT01050257|463253654|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
128714989|NCT01050257|463253655|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
128714990|NCT01050257|463253656|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
128714991|NCT01050257|463253654|FG000|Overall Study|Withdrawal by Subject|0|||
128714992|NCT01050257|463253655|FG001|Overall Study|Withdrawal by Subject|3|||
128714993|NCT01050257|463253656|FG002|Overall Study|Withdrawal by Subject|0|||
128714994|NCT01050257|463253654|FG000|Overall Study|No reason specified|0|||
128714995|NCT01050257|463253655|FG001|Overall Study|No reason specified|0|||
128714996|NCT01050257|463253656|FG002|Overall Study|No reason specified|2|||
128714997|NCT01050257|463253654|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
128714998|NCT01050257|463253655|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
128714999|NCT01050257|463253656|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
128715000|NCT01050257|463253654|FG000|Overall Study|Violation criteria|0|||
128715001|NCT01050257|463253655|FG001|Overall Study|Violation criteria|1|||
128715002|NCT01050257|463253656|FG002|Overall Study|Violation criteria|0|||
128715003|NCT01050257|463253654|FG000|Overall Study|Failure to return|0|||
128715004|NCT01050257|463253655|FG001|Overall Study|Failure to return|2|||
128715005|NCT01050257|463253656|FG002|Overall Study|Failure to return|0|||
128715006|NCT01050257|463253654|FG000|Overall Study|Death|0|||
128715007|NCT01050257|463253655|FG001|Overall Study|Death|0|||
128715008|NCT01050257|463253656|FG002|Overall Study|Death|1|||
128715009|NCT00278109|463253658|FG000|Overall Study|Adverse Event|3|||
128715010|NCT00278109|463253658|FG000|Overall Study|social circumstances|1|||
128715011|NCT02580357|463253659|FG000|Overall Study|Lost to Follow-up|2|||
128715012|NCT02580357|463253660|FG001|Overall Study|Lost to Follow-up|0|||
128715013|NCT02580357|463253661|FG002|Overall Study|Lost to Follow-up|0|||
128715014|NCT02580357|463253659|FG000|Overall Study|Protocol Violation|1|||
128715015|NCT02580357|463253660|FG001|Overall Study|Protocol Violation|0|||
128715016|NCT02580357|463253661|FG002|Overall Study|Protocol Violation|0|||
128715017|NCT02064166|463253662|FG000|Overall Study|Adverse Event|1|||
128715018|NCT02064166|463253663|FG001|Overall Study|Adverse Event|0|||
128715019|NCT00909389|463253666|FG000|Overall Study|Adverse Event|6|||
128715020|NCT00909389|463253666|FG000|Overall Study|Death|4|||
128715021|NCT00909389|463253666|FG000|Overall Study|Poor Compliance|16|||
128715022|NCT00909389|463253666|FG000|Overall Study|Lost to Follow-up|4|||
128715023|NCT00909389|463253666|FG000|Overall Study|No Information|103|||
128715024|NCT00003492|463253667|FG000|Overall Study|Not evaluable|6|||
128715025|NCT00597766|463253670|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
128715026|NCT00597766|463253671|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
128715027|NCT00597766|463253672|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
128715028|NCT00597766|463253670|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
128715029|NCT00597766|463253671|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
128715030|NCT00597766|463253672|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
128715031|NCT00383149|463253674|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
128715032|NCT00383149|463253674|FG000|Overall Study|Death|2|||
128715033|NCT00383149|463253674|FG000|Overall Study|Disease Progression|38|||
128715034|NCT00383149|463253674|FG000|Overall Study|Lost to Follow-up|1|||
128715035|NCT00383149|463253674|FG000|Overall Study|Other|1|||
128715036|NCT00383149|463253674|FG000|Overall Study|Study Drug Toxicity|4|||
128715037|NCT00383149|463253674|FG000|Overall Study|Request to Discontinue Treatment|4|||
128715038|NCT00383149|463253674|FG000|Overall Study|Participant Withdrew Consent|1|||
128715039|NCT00453544|463253685|FG000|Overall Study|Withdrawal by Subject|1|||
128715040|NCT00453544|463253686|FG001|Overall Study|Withdrawal by Subject|0|||
128715041|NCT00453544|463253687|FG002|Overall Study|Withdrawal by Subject|0|||
128715042|NCT00453544|463253688|FG003|Overall Study|Withdrawal by Subject|0|||
128715043|NCT00453544|463253685|FG000|Overall Study|Primary outcome measure not completed|1|||
128715044|NCT00453544|463253686|FG001|Overall Study|Primary outcome measure not completed|1|||
128715045|NCT00453544|463253687|FG002|Overall Study|Primary outcome measure not completed|0|||
128715046|NCT00453544|463253688|FG003|Overall Study|Primary outcome measure not completed|1|||
128715047|NCT02457910|463253689|FG000|Overall Study|Withdrawal by Subject|0|||
128715048|NCT02457910|463253690|FG001|Overall Study|Withdrawal by Subject|0|||
128715049|NCT02457910|463253691|FG002|Overall Study|Withdrawal by Subject|0|||
128715050|NCT02457910|463253692|FG003|Overall Study|Withdrawal by Subject|0|||
128715051|NCT02457910|463253693|FG004|Overall Study|Withdrawal by Subject|0|||
128715052|NCT02457910|463253694|FG005|Overall Study|Withdrawal by Subject|1|||
128715053|NCT02457910|463253689|FG000|Overall Study|Adverse Event|0|||
128715054|NCT02457910|463253690|FG001|Overall Study|Adverse Event|2|||
128715055|NCT02457910|463253691|FG002|Overall Study|Adverse Event|1|||
128715056|NCT02457910|463253692|FG003|Overall Study|Adverse Event|1|||
128715057|NCT02457910|463253693|FG004|Overall Study|Adverse Event|1|||
128715058|NCT02457910|463253694|FG005|Overall Study|Adverse Event|3|||
128715059|NCT02457910|463253689|FG000|Overall Study|Disease progression|3|||
128715060|NCT02457910|463253690|FG001|Overall Study|Disease progression|3|||
128774264|NCT04714216|463466484|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
128774265|NCT01818141|463466485|FG000|Overall Study|Withdrawal by Subject|2|||
128774266|NCT01818141|463466486|FG001|Overall Study|Withdrawal by Subject|0|||
128774267|NCT01818141|463466485|FG000|Overall Study|No baseline C.diff colonies|1|||
128774268|NCT01818141|463466486|FG001|Overall Study|No baseline C.diff colonies|1|||
128774269|NCT01818141|463466485|FG000|Overall Study|Lost to Follow-up|0|||
128774270|NCT01818141|463466486|FG001|Overall Study|Lost to Follow-up|2|||
128774271|NCT04834362|463466490|FG000|Overall Study|Death|1|||
128774272|NCT04834362|463466491|FG001|Overall Study|Death|2|||
128774273|NCT00513019|463466495|FG000|Overall Study|Adverse Event|1|||
128774274|NCT00513019|463466496|FG001|Overall Study|Adverse Event|0|||
128774275|NCT00513019|463466495|FG000|Overall Study|Withdrawal by Subject|4|||
128774276|NCT00513019|463466496|FG001|Overall Study|Withdrawal by Subject|5|||
128774277|NCT01755689|463466497|FG000|Overall Study|Withdrawal by Subject|1|||
128774278|NCT01755689|463466498|FG001|Overall Study|Withdrawal by Subject|3|||
128774279|NCT01755689|463466499|FG002|Overall Study|Withdrawal by Subject|2|||
128774280|NCT01755689|463466500|FG003|Overall Study|Withdrawal by Subject|1|||
128774281|NCT01755689|463466501|FG004|Overall Study|Withdrawal by Subject|1|||
128774282|NCT01755689|463466497|FG000|Overall Study|Migrated/moved from study area|0|||
128774283|NCT01755689|463466498|FG001|Overall Study|Migrated/moved from study area|1|||
128774284|NCT01755689|463466499|FG002|Overall Study|Migrated/moved from study area|1|||
128774285|NCT01755689|463466500|FG003|Overall Study|Migrated/moved from study area|1|||
128774286|NCT01755689|463466501|FG004|Overall Study|Migrated/moved from study area|1|||
128774287|NCT01755689|463466497|FG000|Overall Study|Lost to Follow-up|1|||
128774288|NCT01755689|463466498|FG001|Overall Study|Lost to Follow-up|0|||
128774289|NCT01755689|463466499|FG002|Overall Study|Lost to Follow-up|1|||
128774290|NCT01755689|463466500|FG003|Overall Study|Lost to Follow-up|0|||
128774291|NCT01755689|463466501|FG004|Overall Study|Lost to Follow-up|2|||
128774292|NCT01755689|463466497|FG000|Overall Study|Pregnancy|1|||
128774293|NCT01755689|463466498|FG001|Overall Study|Pregnancy|1|||
128774294|NCT01755689|463466499|FG002|Overall Study|Pregnancy|2|||
128774295|NCT01755689|463466500|FG003|Overall Study|Pregnancy|4|||
128774296|NCT01755689|463466501|FG004|Overall Study|Pregnancy|2|||
128774297|NCT01995357|463466502|FG000|Period 5|Lack of Efficacy|1|||
128774298|NCT01995357|463466503|FG001|Period 5|Lack of Efficacy|0|||
128774299|NCT01995357|463466504|FG002|Period 5|Lack of Efficacy|0|||
128774300|NCT01995357|463466505|FG003|Period 5|Lack of Efficacy|0|||
128774301|NCT01995357|463466506|FG004|Period 5|Lack of Efficacy|0|||
128774302|NCT01995357|463466507|FG005|Period 5|Lack of Efficacy|0|||
128774303|NCT01995357|463466502|FG000|Period 5|Adverse Event|1|||
128774304|NCT01995357|463466503|FG001|Period 5|Adverse Event|0|||
128774305|NCT01995357|463466504|FG002|Period 5|Adverse Event|1|||
128774306|NCT01995357|463466505|FG003|Period 5|Adverse Event|0|||
128774307|NCT01995357|463466506|FG004|Period 5|Adverse Event|0|||
128774308|NCT01995357|463466507|FG005|Period 5|Adverse Event|0|||
129130902|NCT05221866|464770953|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
129130903|NCT05221866|464770954|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
129130904|NCT05221866|464770955|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
129130905|NCT05221866|464770956|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
129130906|NCT05561140|464770957|FG000|Randomized Treatment Period|Adverse Event|1|||
128774309|NCT02955277|463466508|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
128774310|NCT02955277|463466509|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
128774311|NCT02955277|463466508|FG000|Post to Follow-up|Lost to Follow-up|8|||
129130907|NCT05561140|464770958|FG001|Randomized Treatment Period|Adverse Event|0|||
129130908|NCT05561140|464770957|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
129130909|NCT05561140|464770958|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
129130910|NCT05561140|464770957|FG000|Open Label Treatment Period|Adverse Event|6|||
129130911|NCT05561140|464770958|FG001|Open Label Treatment Period|Adverse Event|4|||
129130912|NCT05561140|464770957|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
129130913|NCT05561140|464770958|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
129130914|NCT05561140|464770957|FG000|Open Label Treatment Period|Physician Decision|0|||
129130915|NCT05561140|464770958|FG001|Open Label Treatment Period|Physician Decision|1|||
128774312|NCT02955277|463466509|FG001|Post to Follow-up|Lost to Follow-up|11|||
129130916|NCT05561140|464770957|FG000|Open Label Treatment Period|Pregnancy|1|||
129130917|NCT05561140|464770958|FG001|Open Label Treatment Period|Pregnancy|0|||
128774313|NCT01668147|463466516|FG000|Overall Study|Withdrawal by Subject|6|||
128774314|NCT01809210|463466517|FG000|Overall Study|Withdrawal by Subject|0|||
128774315|NCT01809210|463466518|FG001|Overall Study|Withdrawal by Subject|0|||
128774316|NCT01809210|463466519|FG002|Overall Study|Withdrawal by Subject|1|||
128774317|NCT01809210|463466520|FG003|Overall Study|Withdrawal by Subject|1|||
128774318|NCT01809210|463466521|FG004|Overall Study|Withdrawal by Subject|1|||
128774319|NCT01809210|463466522|FG005|Overall Study|Withdrawal by Subject|0|||
128774320|NCT01809210|463466523|FG006|Overall Study|Withdrawal by Subject|4|||
128774321|NCT01809210|463466517|FG000|Overall Study|Death|1|||
128774322|NCT01809210|463466518|FG001|Overall Study|Death|1|||
129130918|NCT05561140|464770957|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
129130919|NCT05561140|464770958|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
129130920|NCT05561140|464770957|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
129130921|NCT05561140|464770958|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
129130922|NCT05561140|464770957|FG000|Open Label Treatment Period|Other|1|||
129130923|NCT05561140|464770958|FG001|Open Label Treatment Period|Other|0|||
129130924|NCT01944774|464770959|FG000|Overall Study|Withdrawal by Subject|2|||
129130925|NCT01944774|464770960|FG001|Overall Study|Withdrawal by Subject|3|||
129130926|NCT01944774|464770961|FG002|Overall Study|Withdrawal by Subject|3|||
129130927|NCT01944774|464770959|FG000|Overall Study|Adverse Event|3|||
129130928|NCT01944774|464770960|FG001|Overall Study|Adverse Event|2|||
129130929|NCT01944774|464770961|FG002|Overall Study|Adverse Event|3|||
129130930|NCT01944774|464770959|FG000|Overall Study|Lack of Efficacy|1|||
129130931|NCT01944774|464770960|FG001|Overall Study|Lack of Efficacy|2|||
129130932|NCT01944774|464770961|FG002|Overall Study|Lack of Efficacy|2|||
129130933|NCT01944774|464770959|FG000|Overall Study|Lost to Follow-up|0|||
128774323|NCT01809210|463466519|FG002|Overall Study|Death|2|||
128774324|NCT01809210|463466520|FG003|Overall Study|Death|0|||
128774325|NCT01809210|463466521|FG004|Overall Study|Death|1|||
128774326|NCT01809210|463466522|FG005|Overall Study|Death|3|||
129130934|NCT01944774|464770960|FG001|Overall Study|Lost to Follow-up|1|||
129130935|NCT01944774|464770961|FG002|Overall Study|Lost to Follow-up|0|||
128774327|NCT01809210|463466523|FG006|Overall Study|Death|1|||
128774328|NCT00590980|463466524|FG000|Overall Study|Did not meet all inclusion criteria|10|||
128774329|NCT03699124|463466525|FG000|Overall Study|Adverse Event|6|||
128774330|NCT03699124|463466526|FG001|Overall Study|Adverse Event|5|||
128774331|NCT03699124|463466527|FG002|Overall Study|Adverse Event|2|||
128774332|NCT03699124|463466525|FG000|Overall Study|Death|0|||
128774333|NCT03699124|463466526|FG001|Overall Study|Death|2|||
128774334|NCT03699124|463466527|FG002|Overall Study|Death|0|||
128774335|NCT03699124|463466525|FG000|Overall Study|Lost to Follow-up|20|||
128774336|NCT03699124|463466526|FG001|Overall Study|Lost to Follow-up|16|||
128774337|NCT03699124|463466527|FG002|Overall Study|Lost to Follow-up|15|||
128774338|NCT03699124|463466525|FG000|Overall Study|Protocol Violation|1|||
128774339|NCT03699124|463466526|FG001|Overall Study|Protocol Violation|0|||
128774340|NCT03699124|463466527|FG002|Overall Study|Protocol Violation|0|||
128774341|NCT03699124|463466525|FG000|Overall Study|Withdrawal by Subject|13|||
128774342|NCT03699124|463466526|FG001|Overall Study|Withdrawal by Subject|14|||
128774343|NCT03699124|463466527|FG002|Overall Study|Withdrawal by Subject|13|||
128774344|NCT03699124|463466525|FG000|Overall Study|Other reasons|5|||
128774345|NCT03699124|463466526|FG001|Overall Study|Other reasons|3|||
128774346|NCT03699124|463466527|FG002|Overall Study|Other reasons|10|||
128774347|NCT01118962|463466528|FG000|Overall Study|Adverse Event|2|||
128774348|NCT01118962|463466528|FG000|Overall Study|Lack of Efficacy|1|||
128970818|NCT02877134|464177438|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129130936|NCT03325439|464770963|FG000|Overall Study|Ineligibility|3|||
129130937|NCT00774748|464770964|FG000|Overall Study|Lost to Follow-up|3|||
129130938|NCT02503865|464770965|FG000|Overall Study|Moved out of area|1|||
129130939|NCT02503865|464770966|FG001|Overall Study|Moved out of area|8|||
129130940|NCT02503865|464770967|FG002|Overall Study|Moved out of area|0|||
129130941|NCT02503865|464770965|FG000|Overall Study|Refused treatment|4|||
129130942|NCT02503865|464770966|FG001|Overall Study|Refused treatment|39|||
129130943|NCT02503865|464770967|FG002|Overall Study|Refused treatment|2|||
129130944|NCT05073315|464770968|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
129130945|NCT05073315|464770969|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
129130946|NCT05073315|464770970|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
128774349|NCT01118962|463466528|FG000|Overall Study|Protocol Violation|1|||
128970819|NCT02877134|464177439|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
128970820|NCT02877134|464177440|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
128970821|NCT02877134|464177441|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
128970822|NCT02877134|464177442|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
128970823|NCT02877134|464177443|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
128970824|NCT02877134|464177444|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
128970825|NCT02877134|464177445|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
128970826|NCT02877134|464177446|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
128970827|NCT02877134|464177447|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
128970828|NCT02877134|464177436|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128970829|NCT02877134|464177437|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128774350|NCT01118962|463466528|FG000|Overall Study|Withdrawal by Subject|4|||
128774351|NCT01118962|463466528|FG000|Overall Study|Pregnancy|1|||
129130947|NCT05073315|464770968|FG000|Period 1 (Lead-in Period)|Death|1|||
128774352|NCT01118962|463466528|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
129130948|NCT05073315|464770969|FG001|Period 1 (Lead-in Period)|Death|0|||
128774353|NCT00262743|463466529|FG000|Overall Study|Adverse Event|0|||
128774354|NCT00262743|463466530|FG001|Overall Study|Adverse Event|9|||
129130949|NCT05073315|464770970|FG002|Period 1 (Lead-in Period)|Death|0|||
129130950|NCT05073315|464770968|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
128774355|NCT00262743|463466529|FG000|Overall Study|Disease progression|0|||
128970830|NCT02877134|464177438|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128774356|NCT00262743|463466530|FG001|Overall Study|Disease progression|3|||
128970831|NCT02877134|464177439|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128970832|NCT02877134|464177440|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128970833|NCT02877134|464177441|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128970834|NCT02877134|464177442|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128970835|NCT02877134|464177443|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
128970836|NCT02877134|464177444|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
128970837|NCT02877134|464177445|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
128970838|NCT02877134|464177446|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128970839|NCT02877134|464177447|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
128970840|NCT02877134|464177436|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
128970841|NCT02877134|464177437|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
128970842|NCT02877134|464177438|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
128970843|NCT02877134|464177439|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
128970844|NCT02877134|464177440|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
128970845|NCT02877134|464177441|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
128970846|NCT02877134|464177442|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
128970847|NCT02877134|464177443|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
128970848|NCT02877134|464177444|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
128970849|NCT02877134|464177445|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
128970850|NCT02877134|464177446|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
128970851|NCT02877134|464177447|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
128970852|NCT01332851|464177448|FG000|Overall Study|Withdrawal by Subject|4|||
128970853|NCT01332851|464177449|FG001|Overall Study|Withdrawal by Subject|2|||
128970854|NCT01332851|464177448|FG000|Overall Study|Lost to Follow-up|7|||
128970855|NCT01332851|464177449|FG001|Overall Study|Lost to Follow-up|11|||
128970856|NCT01197794|464177452|FG000|Overall Study|Adverse Event|3|||
128970857|NCT01197794|464177453|FG001|Overall Study|Adverse Event|2|||
128970858|NCT01197794|464177454|FG002|Overall Study|Adverse Event|4|||
128970859|NCT01197794|464177455|FG003|Overall Study|Adverse Event|4|||
128970860|NCT01197794|464177456|FG004|Overall Study|Adverse Event|4|||
128970861|NCT01197794|464177457|FG005|Overall Study|Adverse Event|2|||
128970862|NCT01197794|464177458|FG006|Overall Study|Adverse Event|3|||
128970863|NCT01197794|464177452|FG000|Overall Study|Protocol Violation|0|||
128970864|NCT01197794|464177453|FG001|Overall Study|Protocol Violation|0|||
128970865|NCT01197794|464177454|FG002|Overall Study|Protocol Violation|0|||
128970866|NCT01197794|464177455|FG003|Overall Study|Protocol Violation|0|||
128970867|NCT01197794|464177456|FG004|Overall Study|Protocol Violation|2|||
128970868|NCT01197794|464177457|FG005|Overall Study|Protocol Violation|0|||
128970869|NCT01197794|464177458|FG006|Overall Study|Protocol Violation|1|||
128970870|NCT01197794|464177452|FG000|Overall Study|Development of study withdrawal criteria|3|||
128970871|NCT01197794|464177453|FG001|Overall Study|Development of study withdrawal criteria|0|||
128970872|NCT01197794|464177454|FG002|Overall Study|Development of study withdrawal criteria|0|||
128970873|NCT01197794|464177455|FG003|Overall Study|Development of study withdrawal criteria|1|||
128970874|NCT01197794|464177456|FG004|Overall Study|Development of study withdrawal criteria|0|||
128970875|NCT01197794|464177457|FG005|Overall Study|Development of study withdrawal criteria|0|||
128970876|NCT01197794|464177458|FG006|Overall Study|Development of study withdrawal criteria|1|||
128970877|NCT01197794|464177452|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
128970878|NCT01197794|464177453|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
128970879|NCT01197794|464177454|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
128970880|NCT01197794|464177455|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
128970881|NCT01197794|464177456|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
128970882|NCT01197794|464177457|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
128970883|NCT01197794|464177458|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
128970884|NCT01197794|464177452|FG000|Overall Study|Withdrawal by Subject|3|||
128970885|NCT01197794|464177453|FG001|Overall Study|Withdrawal by Subject|3|||
128970886|NCT01197794|464177454|FG002|Overall Study|Withdrawal by Subject|4|||
128970887|NCT01197794|464177455|FG003|Overall Study|Withdrawal by Subject|1|||
128970888|NCT01197794|464177456|FG004|Overall Study|Withdrawal by Subject|1|||
128970889|NCT01197794|464177457|FG005|Overall Study|Withdrawal by Subject|5|||
128970890|NCT01197794|464177458|FG006|Overall Study|Withdrawal by Subject|6|||
128970891|NCT01197794|464177452|FG000|Overall Study|Lost to Follow-up|1|||
128970892|NCT01197794|464177453|FG001|Overall Study|Lost to Follow-up|1|||
128970893|NCT01197794|464177454|FG002|Overall Study|Lost to Follow-up|0|||
128970894|NCT01197794|464177455|FG003|Overall Study|Lost to Follow-up|1|||
128970895|NCT01197794|464177456|FG004|Overall Study|Lost to Follow-up|0|||
128970896|NCT01197794|464177457|FG005|Overall Study|Lost to Follow-up|1|||
128970897|NCT01197794|464177458|FG006|Overall Study|Lost to Follow-up|0|||
128970898|NCT01197794|464177452|FG000|Overall Study|Other|1|||
128774357|NCT04430335|463466535|FG000|Overall Study|Withdrawal by Subject|1|||
128970899|NCT01197794|464177453|FG001|Overall Study|Other|1|||
128970900|NCT01197794|464177454|FG002|Overall Study|Other|3|||
128774358|NCT01591460|463466552|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
128970901|NCT01197794|464177455|FG003|Overall Study|Other|0|||
128970902|NCT01197794|464177456|FG004|Overall Study|Other|2|||
128970903|NCT01197794|464177457|FG005|Overall Study|Other|2|||
128970904|NCT01197794|464177458|FG006|Overall Study|Other|4|||
128970905|NCT01055457|464177459|FG000|Overall Study|Lost to Follow-up|0|||
128970906|NCT01055457|464177460|FG001|Overall Study|Lost to Follow-up|1|||
128970907|NCT01055457|464177461|FG002|Overall Study|Lost to Follow-up|0|||
128970908|NCT01055457|464177462|FG003|Overall Study|Lost to Follow-up|0|||
128970909|NCT01055457|464177463|FG004|Overall Study|Lost to Follow-up|0|||
128970910|NCT01055457|464177464|FG005|Overall Study|Lost to Follow-up|1|||
128970911|NCT01055457|464177465|FG006|Overall Study|Lost to Follow-up|0|||
128970912|NCT01055457|464177466|FG007|Overall Study|Lost to Follow-up|0|||
128970913|NCT01055457|464177467|FG008|Overall Study|Lost to Follow-up|0|||
128970914|NCT01055457|464177468|FG009|Overall Study|Lost to Follow-up|0|||
128970915|NCT01055457|464177459|FG000|Overall Study|Protocol Violation|0|||
128970916|NCT01055457|464177460|FG001|Overall Study|Protocol Violation|0|||
128970917|NCT01055457|464177461|FG002|Overall Study|Protocol Violation|1|||
128970918|NCT01055457|464177462|FG003|Overall Study|Protocol Violation|1|||
128970919|NCT01055457|464177463|FG004|Overall Study|Protocol Violation|1|||
128970920|NCT01055457|464177464|FG005|Overall Study|Protocol Violation|2|||
128970921|NCT01055457|464177465|FG006|Overall Study|Protocol Violation|1|||
128970922|NCT01055457|464177466|FG007|Overall Study|Protocol Violation|0|||
128970923|NCT01055457|464177467|FG008|Overall Study|Protocol Violation|0|||
128970924|NCT01055457|464177468|FG009|Overall Study|Protocol Violation|1|||
128970925|NCT01055457|464177459|FG000|Overall Study|Subject Disinterest|0|||
128970926|NCT01055457|464177460|FG001|Overall Study|Subject Disinterest|0|||
128970927|NCT01055457|464177461|FG002|Overall Study|Subject Disinterest|0|||
128970928|NCT01055457|464177462|FG003|Overall Study|Subject Disinterest|0|||
128970929|NCT01055457|464177463|FG004|Overall Study|Subject Disinterest|0|||
128970930|NCT01055457|464177464|FG005|Overall Study|Subject Disinterest|0|||
128970931|NCT01055457|464177465|FG006|Overall Study|Subject Disinterest|0|||
128970932|NCT01055457|464177466|FG007|Overall Study|Subject Disinterest|1|||
128970933|NCT01055457|464177467|FG008|Overall Study|Subject Disinterest|0|||
128970934|NCT01055457|464177468|FG009|Overall Study|Subject Disinterest|0|||
128970935|NCT01055457|464177459|FG000|Overall Study|Subject Ineligible|1|||
128970936|NCT01055457|464177460|FG001|Overall Study|Subject Ineligible|0|||
128970937|NCT01055457|464177461|FG002|Overall Study|Subject Ineligible|1|||
128970938|NCT01055457|464177462|FG003|Overall Study|Subject Ineligible|0|||
128970939|NCT01055457|464177463|FG004|Overall Study|Subject Ineligible|1|||
128970940|NCT01055457|464177464|FG005|Overall Study|Subject Ineligible|0|||
128970941|NCT01055457|464177465|FG006|Overall Study|Subject Ineligible|0|||
128970942|NCT01055457|464177466|FG007|Overall Study|Subject Ineligible|0|||
128970943|NCT01055457|464177467|FG008|Overall Study|Subject Ineligible|0|||
128970944|NCT01055457|464177468|FG009|Overall Study|Subject Ineligible|0|||
128970945|NCT01055457|464177459|FG000|Overall Study|Discomfort|0|||
128970946|NCT01055457|464177460|FG001|Overall Study|Discomfort|0|||
128970947|NCT01055457|464177461|FG002|Overall Study|Discomfort|0|||
128970948|NCT01055457|464177462|FG003|Overall Study|Discomfort|0|||
128970949|NCT01055457|464177463|FG004|Overall Study|Discomfort|1|||
128970950|NCT01055457|464177464|FG005|Overall Study|Discomfort|0|||
128970951|NCT01055457|464177465|FG006|Overall Study|Discomfort|0|||
128970952|NCT01055457|464177466|FG007|Overall Study|Discomfort|0|||
128970953|NCT01055457|464177467|FG008|Overall Study|Discomfort|0|||
128970954|NCT01055457|464177468|FG009|Overall Study|Discomfort|0|||
128970955|NCT01055457|464177459|FG000|Overall Study|Pregnancy|0|||
128970956|NCT01055457|464177460|FG001|Overall Study|Pregnancy|0|||
128970957|NCT01055457|464177461|FG002|Overall Study|Pregnancy|0|||
129038410|NCT02938442|464433162|FG001|Overall Study|Withdrawal by Subject|0|||
129038411|NCT04403399|464433164|FG000|Period 2|Physician Decision|0|||
129038412|NCT04403399|464433165|FG001|Period 2|Physician Decision|1|||
129038413|NCT01606228|464433166|FG000|Overall Study|Lost to Follow-up|20|||
129038414|NCT01606228|464433166|FG000|Overall Study|Withdrawal by Subject|3|||
129038415|NCT01606228|464433166|FG000|Overall Study|Non-compliant|3|||
129038416|NCT01606228|464433166|FG000|Overall Study|Lack of Efficacy|2|||
129038417|NCT01606228|464433166|FG000|Overall Study|Adverse Event|1|||
129038418|NCT04100096|464433168|FG000|Overall Study|Adverse Event|19|||
129038419|NCT04100096|464433169|FG001|Overall Study|Adverse Event|7|||
129038420|NCT04100096|464433168|FG000|Overall Study|Lack of Efficacy|0|||
129038421|NCT04100096|464433169|FG001|Overall Study|Lack of Efficacy|1|||
129038422|NCT04100096|464433168|FG000|Overall Study|Lost to Follow-up|13|||
129038423|NCT04100096|464433169|FG001|Overall Study|Lost to Follow-up|11|||
128970958|NCT01055457|464177462|FG003|Overall Study|Pregnancy|1|||
128970959|NCT01055457|464177463|FG004|Overall Study|Pregnancy|0|||
128970960|NCT01055457|464177464|FG005|Overall Study|Pregnancy|0|||
128970961|NCT01055457|464177465|FG006|Overall Study|Pregnancy|0|||
128970962|NCT01055457|464177466|FG007|Overall Study|Pregnancy|0|||
128970963|NCT01055457|464177467|FG008|Overall Study|Pregnancy|0|||
128970964|NCT01055457|464177468|FG009|Overall Study|Pregnancy|0|||
128970965|NCT01055457|464177459|FG000|Overall Study|Adverse Event|0|||
129038424|NCT04100096|464433168|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129038425|NCT04100096|464433169|FG001|Overall Study|Non-Compliance With Study Drug|3|||
128970966|NCT01055457|464177460|FG001|Overall Study|Adverse Event|0|||
128970967|NCT01055457|464177461|FG002|Overall Study|Adverse Event|0|||
128970968|NCT01055457|464177462|FG003|Overall Study|Adverse Event|1|||
128970969|NCT01055457|464177463|FG004|Overall Study|Adverse Event|0|||
128970970|NCT01055457|464177464|FG005|Overall Study|Adverse Event|0|||
128970971|NCT01055457|464177465|FG006|Overall Study|Adverse Event|0|||
128970972|NCT01055457|464177466|FG007|Overall Study|Adverse Event|0|||
128970973|NCT01055457|464177467|FG008|Overall Study|Adverse Event|0|||
128970974|NCT01055457|464177468|FG009|Overall Study|Adverse Event|0|||
128970975|NCT03630016|464177477|FG000|Overall Study|Poor Sensor Placement|1|||
128970976|NCT00002981|464177478|FG000|Overall Study|Inevaluable|6|||
128970977|NCT01833806|464177479|FG000|Overall Study|Alternative treatment|2|||
128970978|NCT01833806|464177479|FG000|Overall Study|Death|5|||
128970979|NCT01833806|464177479|FG000|Overall Study|Physician Decision|1|||
128970980|NCT01833806|464177479|FG000|Overall Study|Lost to Follow-up|1|||
128970981|NCT03457636|464177480|FG000|Overall Study|Lost to Follow-up|2|||
128970982|NCT02724111|464177481|FG000|Overall Study|Protocol Violation|2|||
128970983|NCT02724111|464177482|FG001|Overall Study|Protocol Violation|5|||
128970984|NCT01828567|464177483|FG000|Overall Study|Lost to Follow-up|27|||
128970985|NCT01828567|464177484|FG001|Overall Study|Lost to Follow-up|9|||
129130951|NCT05073315|464770969|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
129130952|NCT05073315|464770970|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
129130953|NCT05073315|464770968|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
129130954|NCT05073315|464770969|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
129130955|NCT05073315|464770970|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
128970986|NCT01828567|464177483|FG000|Overall Study|Excluded - did not meet criteria|4|||
128970987|NCT01828567|464177484|FG001|Overall Study|Excluded - did not meet criteria|1|||
128970988|NCT01885104|464177485|FG000|Overall Study|Withdrawal of Consent|1|||
128970989|NCT01885104|464177486|FG001|Overall Study|Withdrawal of Consent|0|||
128970990|NCT01885104|464177485|FG000|Overall Study|Lost to Follow-up|0|||
128970991|NCT01885104|464177486|FG001|Overall Study|Lost to Follow-up|1|||
129130956|NCT05073315|464770968|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
128970992|NCT01885104|464177485|FG000|Overall Study|Physician Decision|1|||
129130957|NCT05073315|464770969|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
129130958|NCT05073315|464770970|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
128715061|NCT02457910|463253691|FG002|Overall Study|Disease progression|1|||
128715062|NCT02457910|463253692|FG003|Overall Study|Disease progression|1|||
128715063|NCT02457910|463253693|FG004|Overall Study|Disease progression|4|||
128715064|NCT02457910|463253694|FG005|Overall Study|Disease progression|6|||
128715065|NCT02457910|463253689|FG000|Overall Study|Other complicating illness|0|||
128715066|NCT02457910|463253690|FG001|Overall Study|Other complicating illness|0|||
128715067|NCT02457910|463253691|FG002|Overall Study|Other complicating illness|0|||
128715068|NCT02457910|463253692|FG003|Overall Study|Other complicating illness|0|||
128715069|NCT02457910|463253693|FG004|Overall Study|Other complicating illness|0|||
128715070|NCT02457910|463253694|FG005|Overall Study|Other complicating illness|1|||
128715071|NCT02457910|463253689|FG000|Overall Study|Death|0|||
128715072|NCT02457910|463253690|FG001|Overall Study|Death|0|||
128715073|NCT02457910|463253691|FG002|Overall Study|Death|1|||
128715074|NCT02457910|463253692|FG003|Overall Study|Death|0|||
128715075|NCT02457910|463253693|FG004|Overall Study|Death|0|||
128715076|NCT02457910|463253694|FG005|Overall Study|Death|0|||
128715077|NCT00619801|463253695|FG000|Overall Study|Lack of Efficacy|0|||
128715078|NCT00619801|463253696|FG001|Overall Study|Lack of Efficacy|1|||
128715079|NCT00619801|463253695|FG000|Overall Study|Withdrawal by Subject|1|||
128715080|NCT00619801|463253696|FG001|Overall Study|Withdrawal by Subject|1|||
128715081|NCT00619801|463253695|FG000|Overall Study|Loss of efficacy|0|||
128715082|NCT00619801|463253696|FG001|Overall Study|Loss of efficacy|1|||
128715083|NCT00450333|463253699|FG000|Overall Study|Study terminated|47|||
128715084|NCT00450333|463253700|FG001|Overall Study|Study terminated|54|||
128715085|NCT00450333|463253701|FG002|Overall Study|Study terminated|16|||
128715086|NCT00450333|463253702|FG003|Overall Study|Study terminated|21|||
128715087|NCT00450333|463253699|FG000|Overall Study|Adverse Event|1|||
128970993|NCT01885104|464177486|FG001|Overall Study|Physician Decision|0|||
128970994|NCT04063865|464177487|FG000|Overall Study|Physician Decision|1|||
128970995|NCT04063865|464177488|FG001|Overall Study|Physician Decision|3|||
128970996|NCT04063865|464177487|FG000|Overall Study|Study Closed Prior to Completion|4|||
128970997|NCT04063865|464177488|FG001|Overall Study|Study Closed Prior to Completion|4|||
128970998|NCT04063865|464177487|FG000|Overall Study|Withdrawal by Subject|1|||
128970999|NCT04063865|464177488|FG001|Overall Study|Withdrawal by Subject|1|||
129130959|NCT05073315|464770968|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
128715088|NCT00450333|463253700|FG001|Overall Study|Adverse Event|7|||
128715089|NCT00450333|463253701|FG002|Overall Study|Adverse Event|2|||
128971000|NCT03898323|464177489|FG000|Overall Study|Physician Decision|1|||
128971001|NCT00374127|464177497|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
128715090|NCT00450333|463253702|FG003|Overall Study|Adverse Event|2|||
128715091|NCT00450333|463253699|FG000|Overall Study|Protocol Violation|1|||
128715092|NCT00450333|463253700|FG001|Overall Study|Protocol Violation|0|||
128715093|NCT00450333|463253701|FG002|Overall Study|Protocol Violation|1|||
129130960|NCT05073315|464770969|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
129130961|NCT05073315|464770970|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
129130962|NCT05073315|464770968|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
129130963|NCT05073315|464770969|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
129130964|NCT05073315|464770970|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
129130965|NCT05073315|464770968|FG000|Period 2|Adverse Event|0|||
129130966|NCT05073315|464770969|FG001|Period 2|Adverse Event|3|||
129130967|NCT05073315|464770970|FG002|Period 2|Adverse Event|6|||
129130968|NCT05073315|464770968|FG000|Period 2|Lost to Follow-up|0|||
129130969|NCT05073315|464770969|FG001|Period 2|Lost to Follow-up|5|||
129130970|NCT05073315|464770970|FG002|Period 2|Lost to Follow-up|5|||
129130971|NCT05073315|464770968|FG000|Period 2|Withdrawal by Subject|0|||
129130972|NCT05073315|464770969|FG001|Period 2|Withdrawal by Subject|4|||
129130973|NCT05073315|464770970|FG002|Period 2|Withdrawal by Subject|9|||
129130974|NCT05073315|464770968|FG000|Period 2|Protocol Violation|0|||
129130975|NCT05073315|464770969|FG001|Period 2|Protocol Violation|0|||
129130976|NCT05073315|464770970|FG002|Period 2|Protocol Violation|1|||
129130977|NCT01529268|464770971|FG000|Overall Study|Lost to Follow-up|9|||
129130978|NCT01529268|464770972|FG001|Overall Study|Lost to Follow-up|3|||
129130979|NCT01529268|464770971|FG000|Overall Study|Moved|3|||
129130980|NCT01529268|464770972|FG001|Overall Study|Moved|0|||
129220452|NCT00854113|465108099|FG000|Overall Study|Adverse Event|0|||
129220453|NCT00854113|465108100|FG001|Overall Study|Adverse Event|0|||
128715094|NCT00450333|463253702|FG003|Overall Study|Protocol Violation|0|||
128971002|NCT00374127|464177497|FG000|Overall Study|Blood could not be drawn.|2|||
128971003|NCT00374127|464177497|FG000|Overall Study|Protocol Violation|5|||
128971004|NCT00374127|464177497|FG000|Overall Study|Pregnancy|1|||
128971005|NCT04035473|464177502|FG000|Screening/Baseline|Death|0|||
128971006|NCT04035473|464177503|FG001|Screening/Baseline|Death|1|||
128971007|NCT04035473|464177502|FG000|Screening/Baseline|Adverse Event|0|||
128971008|NCT04035473|464177503|FG001|Screening/Baseline|Adverse Event|1|||
128971009|NCT04035473|464177502|FG000|Follow-up Period|Adverse Event|2|||
128971010|NCT04035473|464177503|FG001|Follow-up Period|Adverse Event|0|||
128971011|NCT00112840|464177504|FG000|Overall Study|Physician Decision|1|||
128971012|NCT00112840|464177505|FG001|Overall Study|Physician Decision|0|||
128971013|NCT00112840|464177506|FG002|Overall Study|Physician Decision|0|||
128971014|NCT00112840|464177504|FG000|Overall Study|Withdrawal by Subject|1|||
128971015|NCT00112840|464177505|FG001|Overall Study|Withdrawal by Subject|0|||
128971016|NCT00112840|464177506|FG002|Overall Study|Withdrawal by Subject|1|||
128971017|NCT00112840|464177504|FG000|Overall Study|Protocol Violation|0|||
128971018|NCT00112840|464177505|FG001|Overall Study|Protocol Violation|0|||
128971019|NCT00112840|464177506|FG002|Overall Study|Protocol Violation|5|||
128971020|NCT02875366|464177507|FG000|Overall Study|Adverse Event|0|||
128971021|NCT02875366|464177508|FG001|Overall Study|Adverse Event|2|||
128971022|NCT02875366|464177507|FG000|Overall Study|Noncompliance|0|||
128971023|NCT02875366|464177508|FG001|Overall Study|Noncompliance|1|||
128971024|NCT02735044|464177510|FG000|Overall Study|Adverse Event|3|||
128971025|NCT02735044|464177511|FG001|Overall Study|Adverse Event|3|||
128971026|NCT02735044|464177510|FG000|Overall Study|Lack of Efficacy|1|||
128971027|NCT02735044|464177511|FG001|Overall Study|Lack of Efficacy|0|||
128971028|NCT02735044|464177510|FG000|Overall Study|Poor compliance to protocol|7|||
128971029|NCT02735044|464177511|FG001|Overall Study|Poor compliance to protocol|7|||
128971030|NCT02735044|464177510|FG000|Overall Study|Randomized and not treated|0|||
129130981|NCT04069520|464770978|FG000|Overall Study|Lost to Follow-up|0|||
129130982|NCT04069520|464770979|FG001|Overall Study|Lost to Follow-up|2|||
129130983|NCT04069520|464770978|FG000|Overall Study|Withdrawal by Subject|0|||
129130984|NCT04069520|464770979|FG001|Overall Study|Withdrawal by Subject|1|||
129130985|NCT04069520|464770978|FG000|Overall Study|Prior Injury|1|||
129130986|NCT04069520|464770979|FG001|Overall Study|Prior Injury|0|||
129130987|NCT04069520|464770978|FG000|Overall Study|Orthodontia|1|||
129130988|NCT04069520|464770979|FG001|Overall Study|Orthodontia|0|||
129130989|NCT04069520|464770978|FG000|Overall Study|Cut from team|0|||
129130990|NCT04069520|464770979|FG001|Overall Study|Cut from team|2|||
128971031|NCT02735044|464177511|FG001|Overall Study|Randomized and not treated|2|||
128971032|NCT02735044|464177510|FG000|Overall Study|Other, not specified above|5|||
128971033|NCT02735044|464177511|FG001|Overall Study|Other, not specified above|11|||
128971034|NCT02141854|464177513|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
128971035|NCT02141854|464177514|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128971036|NCT02141854|464177515|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128971037|NCT02141854|464177516|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129130991|NCT01068912|464770980|FG000|Overall Study|Adverse Event|2|||
129130992|NCT01068912|464770981|FG001|Overall Study|Adverse Event|3|||
129130993|NCT01068912|464770982|FG002|Overall Study|Adverse Event|2|||
128971038|NCT02141854|464177517|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129130994|NCT01068912|464770980|FG000|Overall Study|Withdrawal by Subject|5|||
128715095|NCT00450333|463253699|FG000|Overall Study|Withdrawal by Subject|1|||
129130995|NCT01068912|464770981|FG001|Overall Study|Withdrawal by Subject|6|||
129130996|NCT01068912|464770982|FG002|Overall Study|Withdrawal by Subject|6|||
129220454|NCT00854113|465108101|FG002|Overall Study|Adverse Event|0|||
128774359|NCT01591460|463466552|FG000|Overall Study|Futility Rule (Week 12)|7|||
128774360|NCT01591460|463466552|FG000|Overall Study|Futility Rule (Week 24)|3|||
128774361|NCT01591460|463466552|FG000|Overall Study|Rebound or Breakthrough|3|||
128774362|NCT01591460|463466552|FG000|Overall Study|Treatment Discontinued by Error|1|||
128774363|NCT01591460|463466552|FG000|Overall Study|Lost to Follow-up|1|||
128774364|NCT01591460|463466552|FG000|Overall Study|Noncompliance|1|||
128774365|NCT01591460|463466552|FG000|Overall Study|Participant Refusal|3|||
128774366|NCT01591460|463466552|FG000|Overall Study|Withdrawal by Subject|1|||
128774367|NCT01591460|463466552|FG000|Overall Study|Protocol Violation|1|||
128774368|NCT03230864|463466553|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
128774369|NCT03230864|463466554|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
128774370|NCT03230864|463466555|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
128774371|NCT03230864|463466556|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
128774372|NCT03230864|463466553|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
128774373|NCT03230864|463466554|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
128774374|NCT03230864|463466555|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
128774375|NCT03230864|463466556|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
128774376|NCT03230864|463466553|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
128774377|NCT03230864|463466554|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
128774378|NCT03230864|463466555|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
128774379|NCT03230864|463466556|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
128774380|NCT03230864|463466553|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
128774381|NCT03230864|463466554|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
128774382|NCT03230864|463466555|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
128774383|NCT03230864|463466556|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
128774384|NCT03230864|463466553|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
128774385|NCT03230864|463466554|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
128774386|NCT03230864|463466555|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
128774387|NCT03230864|463466556|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
128774388|NCT03230864|463466553|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
128774389|NCT03230864|463466554|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
128774390|NCT03230864|463466555|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
128774391|NCT03230864|463466556|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
128774392|NCT03230864|463466553|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
128774393|NCT03230864|463466554|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
128774394|NCT03230864|463466555|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
128774395|NCT03230864|463466556|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
128774396|NCT03230864|463466553|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
128774397|NCT03230864|463466554|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
128774398|NCT03230864|463466555|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
128774399|NCT03230864|463466556|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
128774400|NCT03230864|463466553|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
128774401|NCT03230864|463466554|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
128774402|NCT03230864|463466555|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
128774403|NCT03230864|463466556|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
128774404|NCT03230864|463466553|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
128774405|NCT03230864|463466554|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
128774406|NCT03230864|463466555|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
128774407|NCT03230864|463466556|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
128774408|NCT01744496|463466563|FG000|Titration Period|Adverse Event|2|||
128774409|NCT01744496|463466564|FG001|Titration Period|Adverse Event|1|||
128774410|NCT01744496|463466563|FG000|Titration Period|Personal reasons|0|||
128715096|NCT00450333|463253700|FG001|Overall Study|Withdrawal by Subject|0|||
128715097|NCT00450333|463253701|FG002|Overall Study|Withdrawal by Subject|3|||
128715098|NCT00450333|463253702|FG003|Overall Study|Withdrawal by Subject|0|||
128715099|NCT00450333|463253699|FG000|Overall Study|Kidney transplant|1|||
128715100|NCT00450333|463253700|FG001|Overall Study|Kidney transplant|0|||
128715101|NCT00450333|463253701|FG002|Overall Study|Kidney transplant|1|||
128715102|NCT00450333|463253702|FG003|Overall Study|Kidney transplant|3|||
128715103|NCT00450333|463253699|FG000|Overall Study|Death|3|||
128715104|NCT00450333|463253700|FG001|Overall Study|Death|2|||
128715105|NCT00450333|463253701|FG002|Overall Study|Death|2|||
128715106|NCT00450333|463253702|FG003|Overall Study|Death|2|||
128715107|NCT00969150|463253713|FG000|Overall Study|Adverse Event|4|||
128774411|NCT01744496|463466564|FG001|Titration Period|Personal reasons|1|||
128774412|NCT01744496|463466563|FG000|Maintenance Period|Adverse Event|1|||
128774413|NCT01744496|463466564|FG001|Maintenance Period|Adverse Event|3|||
128715108|NCT00969150|463253714|FG001|Overall Study|Adverse Event|14|||
128715109|NCT00969150|463253713|FG000|Overall Study|Lack of Efficacy|1|||
128715110|NCT00969150|463253714|FG001|Overall Study|Lack of Efficacy|1|||
129130997|NCT01068912|464770980|FG000|Overall Study|Lost to Follow-up|3|||
129130998|NCT01068912|464770981|FG001|Overall Study|Lost to Follow-up|7|||
129130999|NCT01068912|464770982|FG002|Overall Study|Lost to Follow-up|3|||
129131000|NCT01068912|464770980|FG000|Overall Study|Protocol Violation|0|||
129131001|NCT01068912|464770981|FG001|Overall Study|Protocol Violation|2|||
129131002|NCT01068912|464770982|FG002|Overall Study|Protocol Violation|0|||
129131003|NCT01068912|464770980|FG000|Overall Study|aggravation influenza|1|||
128715111|NCT00969150|463253713|FG000|Overall Study|Protocol Violation|9|||
128715112|NCT00969150|463253714|FG001|Overall Study|Protocol Violation|12|||
128715113|NCT00969150|463253713|FG000|Overall Study|Withdrawal by Subject|13|||
128715114|NCT00969150|463253714|FG001|Overall Study|Withdrawal by Subject|9|||
128715115|NCT00969150|463253713|FG000|Overall Study|Lost to Follow-up|5|||
128715116|NCT00969150|463253714|FG001|Overall Study|Lost to Follow-up|4|||
128715117|NCT00969150|463253713|FG000|Overall Study|Other reasons|1|||
128715118|NCT00969150|463253714|FG001|Overall Study|Other reasons|0|||
128715119|NCT00056407|463253718|FG000|Overall Study|Adverse Event|282|||
128715120|NCT00056407|463253719|FG001|Overall Study|Adverse Event|364|||
128715121|NCT00056407|463253718|FG000|Overall Study|Withdrawal by Subject|377|||
128715122|NCT00056407|463253719|FG001|Overall Study|Withdrawal by Subject|361|||
128715123|NCT00056407|463253718|FG000|Overall Study|Lost to Follow-up|123|||
128715124|NCT00056407|463253719|FG001|Overall Study|Lost to Follow-up|113|||
128715125|NCT00056407|463253718|FG000|Overall Study|Protocol Violation|104|||
128715126|NCT00056407|463253719|FG001|Overall Study|Protocol Violation|95|||
128715127|NCT00056407|463253718|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
128715128|NCT00056407|463253719|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
128715129|NCT00056407|463253718|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
128715130|NCT00056407|463253719|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
128715131|NCT00056407|463253718|FG000|Overall Study|Missing|25|||
128715132|NCT00056407|463253719|FG001|Overall Study|Missing|34|||
128715133|NCT00616655|463253720|FG000|Overall Study|Adverse Event|10|||
128715134|NCT00616655|463253721|FG001|Overall Study|Adverse Event|7|||
128715135|NCT00616655|463253722|FG002|Overall Study|Adverse Event|12|||
128715136|NCT00616655|463253720|FG000|Overall Study|Lack of Efficacy|5|||
128715137|NCT00616655|463253721|FG001|Overall Study|Lack of Efficacy|5|||
128715138|NCT00616655|463253722|FG002|Overall Study|Lack of Efficacy|5|||
128715139|NCT00616655|463253720|FG000|Overall Study|Lost to Follow-up|3|||
128715140|NCT00616655|463253721|FG001|Overall Study|Lost to Follow-up|12|||
128715141|NCT00616655|463253722|FG002|Overall Study|Lost to Follow-up|10|||
128715142|NCT00616655|463253720|FG000|Overall Study|Protocol Violation|2|||
128715143|NCT00616655|463253721|FG001|Overall Study|Protocol Violation|4|||
128715144|NCT00616655|463253722|FG002|Overall Study|Protocol Violation|3|||
128715145|NCT00616655|463253720|FG000|Overall Study|Withdrawal by Subject|9|||
128715146|NCT00616655|463253721|FG001|Overall Study|Withdrawal by Subject|7|||
128715147|NCT00616655|463253722|FG002|Overall Study|Withdrawal by Subject|11|||
128715148|NCT00616655|463253720|FG000|Overall Study|Does not meet in/ex criteria|0|||
128715149|NCT00616655|463253721|FG001|Overall Study|Does not meet in/ex criteria|0|||
128715150|NCT00616655|463253722|FG002|Overall Study|Does not meet in/ex criteria|2|||
128715151|NCT00616655|463253720|FG000|Overall Study|Other|6|||
128715152|NCT00616655|463253721|FG001|Overall Study|Other|6|||
128715153|NCT00616655|463253722|FG002|Overall Study|Other|5|||
128715154|NCT03761147|463253723|FG000|Overall Study|Withdrawal by Subject|6|||
128715155|NCT03761147|463253724|FG001|Overall Study|Withdrawal by Subject|1|||
128715156|NCT03761147|463253723|FG000|Overall Study|Adverse Event|1|||
128715157|NCT03761147|463253724|FG001|Overall Study|Adverse Event|3|||
128715158|NCT00309842|463253726|FG000|Overall Study|Lost to Follow-up|1|||
128715159|NCT04958785|463255130|FG000|Overall Study|Study Terminated by Sponsor|4|||
128715160|NCT04958785|463255131|FG001|Overall Study|Study Terminated by Sponsor|10|||
128715161|NCT04958785|463255132|FG002|Overall Study|Study Terminated by Sponsor|7|||
128715162|NCT04958785|463255133|FG003|Overall Study|Study Terminated by Sponsor|6|||
128715163|NCT04958785|463255134|FG004|Overall Study|Study Terminated by Sponsor|34|||
128715164|NCT04958785|463255130|FG000|Overall Study|Death|2|||
128715165|NCT04958785|463255131|FG001|Overall Study|Death|3|||
128715166|NCT04958785|463255132|FG002|Overall Study|Death|4|||
128715167|NCT04958785|463255133|FG003|Overall Study|Death|5|||
128715168|NCT04958785|463255134|FG004|Overall Study|Death|5|||
128715169|NCT04958785|463255130|FG000|Overall Study|Withdrew consent|2|||
128715170|NCT04958785|463255131|FG001|Overall Study|Withdrew consent|0|||
128715171|NCT04958785|463255132|FG002|Overall Study|Withdrew consent|3|||
128715172|NCT04958785|463255133|FG003|Overall Study|Withdrew consent|1|||
128715173|NCT04958785|463255134|FG004|Overall Study|Withdrew consent|0|||
128715174|NCT04958785|463255130|FG000|Overall Study|Investigator's discretion|0|||
128715175|NCT04958785|463255131|FG001|Overall Study|Investigator's discretion|1|||
128715176|NCT04958785|463255132|FG002|Overall Study|Investigator's discretion|0|||
128715177|NCT04958785|463255133|FG003|Overall Study|Investigator's discretion|1|||
128715178|NCT04958785|463255134|FG004|Overall Study|Investigator's discretion|2|||
128715179|NCT04958785|463255130|FG000|Overall Study|Adverse Event|0|||
129131004|NCT01068912|464770981|FG001|Overall Study|aggravation influenza|1|||
128715180|NCT04958785|463255131|FG001|Overall Study|Adverse Event|0|||
129131005|NCT01068912|464770982|FG002|Overall Study|aggravation influenza|1|||
129131006|NCT01068912|464770980|FG000|Overall Study|other underlying illness|0|||
129131007|NCT01068912|464770981|FG001|Overall Study|other underlying illness|3|||
129131008|NCT01068912|464770982|FG002|Overall Study|other underlying illness|3|||
129131009|NCT01947933|464770983|FG000|Overall Study|Withdrawal by Subject|0|||
129131010|NCT01947933|464770984|FG001|Overall Study|Withdrawal by Subject|0|||
129131011|NCT01947933|464770985|FG002|Overall Study|Withdrawal by Subject|1|||
129131012|NCT01947933|464770986|FG003|Overall Study|Withdrawal by Subject|0|||
129131013|NCT01947933|464770987|FG004|Overall Study|Withdrawal by Subject|0|||
129131014|NCT01947933|464770988|FG005|Overall Study|Withdrawal by Subject|0|||
129131015|NCT01947933|464770989|FG006|Overall Study|Withdrawal by Subject|0|||
129131016|NCT01947933|464770990|FG007|Overall Study|Withdrawal by Subject|0|||
129131017|NCT01947933|464770991|FG008|Overall Study|Withdrawal by Subject|0|||
129131018|NCT01947933|464770983|FG000|Overall Study|Lost to Follow-up|0|||
129131019|NCT01947933|464770984|FG001|Overall Study|Lost to Follow-up|0|||
129131020|NCT01947933|464770985|FG002|Overall Study|Lost to Follow-up|0|||
129131021|NCT01947933|464770986|FG003|Overall Study|Lost to Follow-up|0|||
129131022|NCT01947933|464770987|FG004|Overall Study|Lost to Follow-up|0|||
129131023|NCT01947933|464770988|FG005|Overall Study|Lost to Follow-up|0|||
129131024|NCT01947933|464770989|FG006|Overall Study|Lost to Follow-up|0|||
129131025|NCT01947933|464770990|FG007|Overall Study|Lost to Follow-up|0|||
129131026|NCT01947933|464770991|FG008|Overall Study|Lost to Follow-up|1|||
129131027|NCT00294398|464770992|FG000|Overall Study|Lost to Follow-up|21|||
129131028|NCT00294398|464770993|FG001|Overall Study|Lost to Follow-up|26|||
129131029|NCT02965833|464770994|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
128971039|NCT02141854|464177518|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128971040|NCT02141854|464177513|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
128971041|NCT02141854|464177514|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128971042|NCT02141854|464177515|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128971043|NCT02141854|464177516|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128971044|NCT02141854|464177517|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128971045|NCT02141854|464177518|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128971046|NCT02141854|464177513|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
128971047|NCT02141854|464177514|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128971048|NCT02141854|464177515|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128971049|NCT02141854|464177516|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128971050|NCT02141854|464177517|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128971051|NCT02141854|464177518|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128971052|NCT02141854|464177513|FG000|Run-In Period (Pre-assignment)|Other|14|||
128971053|NCT02141854|464177514|FG001|Run-In Period (Pre-assignment)|Other|0|||
128971054|NCT02141854|464177515|FG002|Run-In Period (Pre-assignment)|Other|0|||
128971055|NCT02141854|464177516|FG003|Run-In Period (Pre-assignment)|Other|0|||
128971056|NCT02141854|464177517|FG004|Run-In Period (Pre-assignment)|Other|0|||
128971057|NCT02141854|464177518|FG005|Run-In Period (Pre-assignment)|Other|0|||
128971058|NCT02141854|464177513|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
128971059|NCT02141854|464177514|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
128971060|NCT02141854|464177515|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
128971061|NCT02141854|464177516|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
128971062|NCT02141854|464177517|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
128971063|NCT02141854|464177518|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
128971064|NCT02141854|464177513|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
128971065|NCT02141854|464177514|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128971066|NCT02141854|464177515|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128971067|NCT02141854|464177516|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128971068|NCT02141854|464177517|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128971069|NCT02141854|464177518|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128971070|NCT02141854|464177513|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
128971071|NCT02141854|464177514|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128971072|NCT02141854|464177515|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128971073|NCT02141854|464177516|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128971074|NCT02141854|464177517|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129131030|NCT02965833|464770995|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
129131031|NCT02965833|464770994|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129220455|NCT00854113|465108102|FG003|Overall Study|Adverse Event|0|||
128971075|NCT02141854|464177518|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128971076|NCT02141854|464177513|FG000|Treatment Period|Protocol Violation|0|||
128971077|NCT02141854|464177514|FG001|Treatment Period|Protocol Violation|1|||
129131032|NCT02965833|464770995|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129131033|NCT02965833|464770994|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
129220456|NCT00854113|465108103|FG004|Overall Study|Adverse Event|0|||
129220457|NCT00854113|465108104|FG005|Overall Study|Adverse Event|0|||
129220458|NCT00854113|465108105|FG006|Overall Study|Adverse Event|0|||
129220459|NCT00854113|465108106|FG007|Overall Study|Adverse Event|2|||
129131034|NCT02965833|464770995|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
129131035|NCT02965833|464770994|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
129131036|NCT02965833|464770995|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
129131037|NCT02965833|464770994|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
129131038|NCT02965833|464770995|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
129131039|NCT00118287|464770999|FG000|Overall Study|Intracranial haemorrhage|1|||
129131040|NCT00118287|464770999|FG000|Overall Study|Muscle pain|1|||
129131041|NCT03407482|464771000|FG000|Overall Study|Adverse Event|12|||
129131042|NCT03407482|464771000|FG000|Overall Study|Disease Relapse|1|||
129131043|NCT03407482|464771000|FG000|Overall Study|Lost to Follow-up|1|||
129131044|NCT03407482|464771000|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129131045|NCT03407482|464771000|FG000|Overall Study|Pregnancy|2|||
129131046|NCT03407482|464771000|FG000|Overall Study|Protocol Violation|1|||
129131047|NCT03407482|464771000|FG000|Overall Study|Study Terminated By Sponsor|106|||
129131048|NCT03407482|464771000|FG000|Overall Study|Withdrawal by Subject|6|||
129131049|NCT03407482|464771000|FG000|Overall Study|Data Entry Error|1|||
129131050|NCT05089357|464771003|FG000|Overall Study|Withdrawal by Subject|23|||
129131051|NCT05089357|464771003|FG000|Overall Study|Lost to Follow-up|6|||
129131052|NCT05089357|464771003|FG000|Overall Study|Medical reason|1|||
128971078|NCT02141854|464177515|FG002|Treatment Period|Protocol Violation|0|||
128971079|NCT02141854|464177516|FG003|Treatment Period|Protocol Violation|2|||
128971080|NCT02141854|464177517|FG004|Treatment Period|Protocol Violation|2|||
128971081|NCT02141854|464177518|FG005|Treatment Period|Protocol Violation|1|||
128971082|NCT02141854|464177513|FG000|Treatment Period|Noncompliance|0|||
128971083|NCT02141854|464177514|FG001|Treatment Period|Noncompliance|0|||
128971084|NCT02141854|464177515|FG002|Treatment Period|Noncompliance|0|||
128971085|NCT02141854|464177516|FG003|Treatment Period|Noncompliance|1|||
128971086|NCT02141854|464177517|FG004|Treatment Period|Noncompliance|0|||
128971087|NCT02141854|464177518|FG005|Treatment Period|Noncompliance|0|||
128971088|NCT02141854|464177513|FG000|Treatment Period|Lack of Efficacy|0|||
128971089|NCT02141854|464177514|FG001|Treatment Period|Lack of Efficacy|0|||
128971090|NCT02141854|464177515|FG002|Treatment Period|Lack of Efficacy|0|||
128971091|NCT02141854|464177516|FG003|Treatment Period|Lack of Efficacy|1|||
128971092|NCT02141854|464177517|FG004|Treatment Period|Lack of Efficacy|1|||
128971093|NCT02141854|464177518|FG005|Treatment Period|Lack of Efficacy|7|||
128971094|NCT02141854|464177513|FG000|Treatment Period|Pregnancy|0|||
128971095|NCT02141854|464177514|FG001|Treatment Period|Pregnancy|1|||
128971096|NCT02141854|464177515|FG002|Treatment Period|Pregnancy|0|||
128971097|NCT02141854|464177516|FG003|Treatment Period|Pregnancy|0|||
128971098|NCT02141854|464177517|FG004|Treatment Period|Pregnancy|0|||
128971099|NCT02141854|464177518|FG005|Treatment Period|Pregnancy|0|||
128971100|NCT02141854|464177513|FG000|Treatment Period|Other|0|||
128971101|NCT02141854|464177514|FG001|Treatment Period|Other|1|||
128971102|NCT02141854|464177515|FG002|Treatment Period|Other|2|||
128971103|NCT02141854|464177516|FG003|Treatment Period|Other|0|||
128971104|NCT02141854|464177517|FG004|Treatment Period|Other|1|||
128971105|NCT02141854|464177518|FG005|Treatment Period|Other|2|||
128971106|NCT02141854|464177513|FG000|Treatment Period|Adverse Event|0|||
128971107|NCT02141854|464177514|FG001|Treatment Period|Adverse Event|2|||
128971108|NCT02141854|464177515|FG002|Treatment Period|Adverse Event|2|||
128971109|NCT02141854|464177516|FG003|Treatment Period|Adverse Event|0|||
128971110|NCT02141854|464177517|FG004|Treatment Period|Adverse Event|2|||
128971111|NCT02141854|464177518|FG005|Treatment Period|Adverse Event|2|||
128971112|NCT02141854|464177513|FG000|Treatment Period|Withdrawal by Subject|0|||
128971113|NCT02141854|464177514|FG001|Treatment Period|Withdrawal by Subject|2|||
128971114|NCT02141854|464177515|FG002|Treatment Period|Withdrawal by Subject|3|||
128971115|NCT02141854|464177516|FG003|Treatment Period|Withdrawal by Subject|3|||
128971116|NCT02141854|464177517|FG004|Treatment Period|Withdrawal by Subject|4|||
128971117|NCT02141854|464177518|FG005|Treatment Period|Withdrawal by Subject|7|||
128971118|NCT02141854|464177513|FG000|Treatment Period|Disease progression|0|||
128971119|NCT02141854|464177514|FG001|Treatment Period|Disease progression|2|||
128971120|NCT02141854|464177515|FG002|Treatment Period|Disease progression|1|||
128971121|NCT02141854|464177516|FG003|Treatment Period|Disease progression|3|||
128971122|NCT02141854|464177517|FG004|Treatment Period|Disease progression|0|||
128971123|NCT02141854|464177518|FG005|Treatment Period|Disease progression|18|||
128971124|NCT02141854|464177513|FG000|Treatment Period|Lost to Follow-up|0|||
128971125|NCT02141854|464177514|FG001|Treatment Period|Lost to Follow-up|1|||
128971126|NCT02141854|464177515|FG002|Treatment Period|Lost to Follow-up|1|||
129131053|NCT05089357|464771003|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
128971127|NCT02141854|464177516|FG003|Treatment Period|Lost to Follow-up|1|||
128971128|NCT02141854|464177517|FG004|Treatment Period|Lost to Follow-up|0|||
128971129|NCT02141854|464177518|FG005|Treatment Period|Lost to Follow-up|1|||
128971130|NCT01868594|464177519|FG000|Overall Study|Do not meet inclusion criteria|4|||
128971131|NCT01868594|464177520|FG001|Overall Study|Do not meet inclusion criteria|3|||
128971132|NCT01201967|464177523|FG000|Overall Study|Lost to Follow-up|6|||
128971133|NCT01201967|464177524|FG001|Overall Study|Lost to Follow-up|5|||
128971134|NCT02659098|464177525|FG000|Overall Study|Withdrawal by Subject|7|||
129131054|NCT05089357|464771003|FG000|Overall Study|Pregnancy|2|||
129131055|NCT05537571|464771004|FG000|Overall Study|Withdrawal by Subject|1|||
129131056|NCT05537571|464771005|FG001|Overall Study|Withdrawal by Subject|1|||
128715181|NCT04958785|463255132|FG002|Overall Study|Adverse Event|0|||
128715182|NCT04958785|463255133|FG003|Overall Study|Adverse Event|0|||
128715183|NCT04958785|463255134|FG004|Overall Study|Adverse Event|1|||
128715184|NCT04958785|463255130|FG000|Overall Study|Lost to Follow-up|0|||
128715185|NCT04958785|463255131|FG001|Overall Study|Lost to Follow-up|0|||
128715186|NCT04958785|463255132|FG002|Overall Study|Lost to Follow-up|0|||
128715187|NCT04958785|463255133|FG003|Overall Study|Lost to Follow-up|0|||
128715188|NCT04958785|463255134|FG004|Overall Study|Lost to Follow-up|1|||
128715189|NCT03232281|463255143|FG000|Overall Study|Adverse Event|1|||
128715190|NCT03232281|463255144|FG001|Overall Study|Adverse Event|1|||
128715191|NCT03232281|463255143|FG000|Overall Study|Withdrawal by Subject|5|||
128715192|NCT03232281|463255144|FG001|Overall Study|Withdrawal by Subject|4|||
128715193|NCT03232281|463255143|FG000|Overall Study|Protocol Deviation|1|||
128715194|NCT03232281|463255144|FG001|Overall Study|Protocol Deviation|1|||
128715195|NCT04267133|463255156|FG000|Overall Study|Withdrawal by Subject|1|||
128715196|NCT04267133|463255156|FG000|Overall Study|Adverse Event|4|||
128715197|NCT05104476|463255157|FG000|Overall Study|Randomized But Not Treated|1|||
128715198|NCT05104476|463255158|FG001|Overall Study|Randomized But Not Treated|2|||
128715199|NCT05104476|463255157|FG000|Overall Study|Adverse Event|2|||
128715200|NCT05104476|463255158|FG001|Overall Study|Adverse Event|2|||
128715201|NCT05104476|463255157|FG000|Overall Study|Withdrawal by Subject|3|||
128715202|NCT05104476|463255158|FG001|Overall Study|Withdrawal by Subject|3|||
128715203|NCT05104476|463255157|FG000|Overall Study|Other Than Specified|0|||
128715204|NCT05104476|463255158|FG001|Overall Study|Other Than Specified|3|||
128715205|NCT04008030|463255159|FG000|Pre-Treatment|Withdrawal by Subject|0|||
128715206|NCT04008030|463255160|FG001|Pre-Treatment|Withdrawal by Subject|0|||
128715207|NCT04008030|463255161|FG002|Pre-Treatment|Withdrawal by Subject|9|||
128715208|NCT04008030|463255159|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
128715209|NCT04008030|463255160|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
128715210|NCT04008030|463255161|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
128715211|NCT04008030|463255159|FG000|Pre-Treatment|Other reasons|0|||
128715212|NCT04008030|463255160|FG001|Pre-Treatment|Other reasons|1|||
128715213|NCT04008030|463255161|FG002|Pre-Treatment|Other reasons|6|||
128715214|NCT04008030|463255159|FG000|Treatment|Withdrawal by Subject|1|||
128715215|NCT04008030|463255160|FG001|Treatment|Withdrawal by Subject|1|||
128715216|NCT04008030|463255161|FG002|Treatment|Withdrawal by Subject|1|||
128715217|NCT04008030|463255159|FG000|Treatment|Death|2|||
128715218|NCT04008030|463255160|FG001|Treatment|Death|4|||
128715219|NCT04008030|463255161|FG002|Treatment|Death|0|||
128715220|NCT04008030|463255159|FG000|Treatment|Pregnancy|0|||
128715221|NCT04008030|463255160|FG001|Treatment|Pregnancy|1|||
128715222|NCT04008030|463255161|FG002|Treatment|Pregnancy|0|||
128715223|NCT04008030|463255159|FG000|Treatment|Participant no longer meets study criteria|0|||
128715224|NCT04008030|463255160|FG001|Treatment|Participant no longer meets study criteria|1|||
128715225|NCT04008030|463255161|FG002|Treatment|Participant no longer meets study criteria|0|||
128715226|NCT04008030|463255159|FG000|Treatment|Other reasons|5|||
128715227|NCT04008030|463255160|FG001|Treatment|Other reasons|13|||
128715228|NCT04008030|463255161|FG002|Treatment|Other reasons|6|||
128715229|NCT04008030|463255159|FG000|Treatment|Disease Progression|137|||
128715230|NCT04008030|463255160|FG001|Treatment|Disease Progression|82|||
128715231|NCT04008030|463255161|FG002|Treatment|Disease Progression|85|||
128715232|NCT04008030|463255159|FG000|Treatment|Study drug toxicity|28|||
128715233|NCT04008030|463255160|FG001|Treatment|Study drug toxicity|48|||
128715234|NCT04008030|463255161|FG002|Treatment|Study drug toxicity|8|||
128715235|NCT04008030|463255159|FG000|Treatment|Adverse Event unrelated to study drug|28|||
128715236|NCT04008030|463255160|FG001|Treatment|Adverse Event unrelated to study drug|22|||
128715237|NCT04008030|463255161|FG002|Treatment|Adverse Event unrelated to study drug|6|||
128715238|NCT04008030|463255159|FG000|Treatment|Maximum Clinical Benefit|0|||
128715239|NCT04008030|463255160|FG001|Treatment|Maximum Clinical Benefit|1|||
128715240|NCT04008030|463255161|FG002|Treatment|Maximum Clinical Benefit|9|||
128715241|NCT04008030|463255159|FG000|Treatment|On-going treatment|13|||
128715242|NCT04008030|463255160|FG001|Treatment|On-going treatment|20|||
128715243|NCT04008030|463255161|FG002|Treatment|On-going treatment|0|||
128715244|NCT04191499|463255165|FG000|Overall Study|Adverse Event|1|||
128715245|NCT04191499|463255166|FG001|Overall Study|Adverse Event|0|||
128715246|NCT04191499|463255165|FG000|Overall Study|Death|42|||
128715247|NCT04191499|463255166|FG001|Overall Study|Death|55|||
128715248|NCT04191499|463255165|FG000|Overall Study|Lost to Follow-up|4|||
128715249|NCT04191499|463255166|FG001|Overall Study|Lost to Follow-up|1|||
128715250|NCT04191499|463255165|FG000|Overall Study|Physician Decision|1|||
128715251|NCT04191499|463255166|FG001|Overall Study|Physician Decision|0|||
128715252|NCT04191499|463255165|FG000|Overall Study|Progressive Disease|1|||
128715253|NCT04191499|463255166|FG001|Overall Study|Progressive Disease|0|||
128715254|NCT04191499|463255165|FG000|Overall Study|Symptomatic Deterioration|1|||
128715255|NCT04191499|463255166|FG001|Overall Study|Symptomatic Deterioration|0|||
128715256|NCT04191499|463255165|FG000|Overall Study|Withdrawal by Subject|7|||
128774414|NCT01744496|463466563|FG000|Maintenance Period|Protocol Violation|1|||
128774415|NCT01744496|463466564|FG001|Maintenance Period|Protocol Violation|0|||
128774416|NCT01744496|463466563|FG000|Maintenance Period|Withdrawal by Subject|1|||
128774417|NCT01744496|463466564|FG001|Maintenance Period|Withdrawal by Subject|1|||
128774418|NCT01744496|463466563|FG000|Maintenance Period|Subject left town|1|||
128774419|NCT01744496|463466564|FG001|Maintenance Period|Subject left town|0|||
128774420|NCT01567163|463466565|FG000|Overall Study|Progressive Disease|2|||
128774421|NCT01567163|463466565|FG000|Overall Study|Lost to Follow-up|2|||
128774422|NCT03405662|463466566|FG000|Overall Study|COVID-19 restriction|1|||
128774423|NCT03405662|463466567|FG001|Overall Study|COVID-19 restriction|0|||
128774424|NCT03405662|463466566|FG000|Overall Study|unblinding|0|||
128774425|NCT03405662|463466567|FG001|Overall Study|unblinding|1|||
128774426|NCT03405662|463466566|FG000|Overall Study|placement in memory care facility|0|||
128774427|NCT03405662|463466567|FG001|Overall Study|placement in memory care facility|2|||
128774428|NCT00983619|463466568|FG000|Overall Study|Lost to Follow-up|0|||
128774429|NCT00983619|463466569|FG001|Overall Study|Lost to Follow-up|1|||
128774430|NCT00983619|463466570|FG002|Overall Study|Lost to Follow-up|0|||
128774431|NCT00983619|463466571|FG003|Overall Study|Lost to Follow-up|0|||
128774432|NCT00983619|463466572|FG004|Overall Study|Lost to Follow-up|0|||
128774433|NCT00983619|463466573|FG005|Overall Study|Lost to Follow-up|2|||
128774434|NCT00983619|463466574|FG006|Overall Study|Lost to Follow-up|0|||
128774435|NCT00983619|463466575|FG007|Overall Study|Lost to Follow-up|0|||
129038426|NCT04100096|464433168|FG000|Overall Study|Protocol Deviation|1|||
129038427|NCT04100096|464433169|FG001|Overall Study|Protocol Deviation|1|||
129220460|NCT00854113|465108107|FG008|Overall Study|Adverse Event|0|||
128774436|NCT00983619|463466576|FG008|Overall Study|Lost to Follow-up|0|||
128774437|NCT00983619|463466577|FG009|Overall Study|Lost to Follow-up|0|||
128774438|NCT00983619|463466578|FG010|Overall Study|Lost to Follow-up|0|||
128774439|NCT00983619|463466579|FG011|Overall Study|Lost to Follow-up|2|||
128774440|NCT00983619|463466568|FG000|Overall Study|Withdrawal by Subject|2|||
128774441|NCT00983619|463466569|FG001|Overall Study|Withdrawal by Subject|1|||
128774442|NCT00983619|463466570|FG002|Overall Study|Withdrawal by Subject|1|||
128774443|NCT00983619|463466571|FG003|Overall Study|Withdrawal by Subject|3|||
128774444|NCT00983619|463466572|FG004|Overall Study|Withdrawal by Subject|1|||
128774445|NCT00983619|463466573|FG005|Overall Study|Withdrawal by Subject|23|||
128774446|NCT00983619|463466574|FG006|Overall Study|Withdrawal by Subject|0|||
128774447|NCT00983619|463466575|FG007|Overall Study|Withdrawal by Subject|0|||
128774448|NCT00983619|463466576|FG008|Overall Study|Withdrawal by Subject|0|||
128774449|NCT00983619|463466577|FG009|Overall Study|Withdrawal by Subject|0|||
128774450|NCT00983619|463466578|FG010|Overall Study|Withdrawal by Subject|1|||
128774451|NCT00983619|463466579|FG011|Overall Study|Withdrawal by Subject|1|||
128774452|NCT00983619|463466568|FG000|Overall Study|Death|0|||
128774453|NCT00983619|463466569|FG001|Overall Study|Death|2|||
128774454|NCT00983619|463466570|FG002|Overall Study|Death|2|||
128774455|NCT00983619|463466571|FG003|Overall Study|Death|1|||
128774456|NCT00983619|463466572|FG004|Overall Study|Death|2|||
128774457|NCT00983619|463466573|FG005|Overall Study|Death|30|||
128774458|NCT00983619|463466574|FG006|Overall Study|Death|1|||
128774459|NCT00983619|463466575|FG007|Overall Study|Death|0|||
128774460|NCT00983619|463466576|FG008|Overall Study|Death|1|||
128774461|NCT00983619|463466577|FG009|Overall Study|Death|2|||
128774462|NCT00983619|463466578|FG010|Overall Study|Death|9|||
128774463|NCT00983619|463466579|FG011|Overall Study|Death|8|||
128774464|NCT00983619|463466568|FG000|Overall Study|Other|1|||
128774465|NCT00983619|463466569|FG001|Overall Study|Other|0|||
129038428|NCT04100096|464433168|FG000|Overall Study|Withdrawal by Participant|13|||
129038429|NCT04100096|464433169|FG001|Overall Study|Withdrawal by Participant|15|||
129038430|NCT01647711|464433170|FG000|Overall Study|Progressive disease|6|||
129038431|NCT01647711|464433171|FG001|Overall Study|Progressive disease|2|||
129038432|NCT01647711|464433172|FG002|Overall Study|Progressive disease|6|||
129038433|NCT01647711|464433173|FG003|Overall Study|Progressive disease|8|||
129038434|NCT01647711|464433174|FG004|Overall Study|Progressive disease|2|||
129038435|NCT01647711|464433170|FG000|Overall Study|Other adverse event|0|||
129038436|NCT01647711|464433171|FG001|Overall Study|Other adverse event|0|||
129038437|NCT01647711|464433172|FG002|Overall Study|Other adverse event|2|||
129038438|NCT01647711|464433173|FG003|Overall Study|Other adverse event|0|||
128774466|NCT00983619|463466570|FG002|Overall Study|Other|0|||
128774467|NCT00983619|463466571|FG003|Overall Study|Other|1|||
128774468|NCT00983619|463466572|FG004|Overall Study|Other|0|||
128774469|NCT00983619|463466573|FG005|Overall Study|Other|12|||
128774470|NCT00983619|463466574|FG006|Overall Study|Other|2|||
128774471|NCT00983619|463466575|FG007|Overall Study|Other|2|||
128774472|NCT00983619|463466576|FG008|Overall Study|Other|0|||
128774473|NCT00983619|463466577|FG009|Overall Study|Other|1|||
128774474|NCT00983619|463466578|FG010|Overall Study|Other|1|||
128774475|NCT00983619|463466579|FG011|Overall Study|Other|0|||
128774476|NCT00750893|463466580|FG000|Overall Study|Adverse Event|5|||
128774477|NCT00750893|463466580|FG000|Overall Study|Withdrawal by Subject|10|||
128774478|NCT00750893|463466580|FG000|Overall Study|Lost to Follow-up|510|||
129038439|NCT01647711|464433174|FG004|Overall Study|Other adverse event|2|||
129038440|NCT01647711|464433170|FG000|Overall Study|Protocol Violation|0|||
128971135|NCT04363944|464177526|FG000|Overall Study|Withdrawal by Subject|2|||
128971136|NCT04363944|464177527|FG001|Overall Study|Withdrawal by Subject|0|||
128971137|NCT01693562|464179539|FG000|Escalation Phase|Withdrawal by Subject|0|||
128971138|NCT01693562|464179540|FG001|Escalation Phase|Withdrawal by Subject|1|||
128971139|NCT01693562|464179541|FG002|Escalation Phase|Withdrawal by Subject|0|||
128971140|NCT01693562|464179542|FG003|Escalation Phase|Withdrawal by Subject|0|||
128971141|NCT01693562|464179543|FG004|Escalation Phase|Withdrawal by Subject|0|||
128715257|NCT04191499|463255166|FG001|Overall Study|Withdrawal by Subject|11|||
128715258|NCT04191499|463255165|FG000|Overall Study|Ongoing in the study|104|||
128715259|NCT04191499|463255166|FG001|Overall Study|Ongoing in the study|97|||
128715260|NCT01496313|463255167|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
128715261|NCT01496313|463255168|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
128715262|NCT01496313|463255169|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
128715263|NCT01496313|463255170|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
128715264|NCT01496313|463255171|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
128715265|NCT01496313|463255172|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
128715266|NCT01496313|463255167|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
128715267|NCT01496313|463255168|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
128715268|NCT01496313|463255169|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
128715269|NCT01496313|463255170|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
128715270|NCT01496313|463255171|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
128715271|NCT01496313|463255172|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
128715272|NCT01496313|463255167|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
128715273|NCT01496313|463255168|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
128715274|NCT01496313|463255169|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
128715275|NCT01496313|463255170|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
128715276|NCT01496313|463255171|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
128715277|NCT01496313|463255172|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
128715278|NCT01496313|463255167|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
128715279|NCT01496313|463255168|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
128715280|NCT01496313|463255169|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
128715281|NCT01496313|463255170|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
128715282|NCT01496313|463255171|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
128715283|NCT01496313|463255172|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
128715284|NCT01496313|463255167|FG000|Randomized Period (up to 14 Months)|Other|1|||
128715285|NCT01496313|463255168|FG001|Randomized Period (up to 14 Months)|Other|2|||
128715286|NCT01496313|463255169|FG002|Randomized Period (up to 14 Months)|Other|0|||
128715287|NCT01496313|463255170|FG003|Randomized Period (up to 14 Months)|Other|0|||
128715288|NCT01496313|463255171|FG004|Randomized Period (up to 14 Months)|Other|0|||
128715289|NCT01496313|463255172|FG005|Randomized Period (up to 14 Months)|Other|0|||
128715290|NCT01496313|463255167|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
128715291|NCT01496313|463255168|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
128715292|NCT01496313|463255169|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
128715293|NCT01496313|463255170|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
128715294|NCT01496313|463255171|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
128715295|NCT01496313|463255172|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
128715296|NCT01496313|463255167|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
128715297|NCT01496313|463255168|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
128715298|NCT01496313|463255169|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
128715299|NCT01496313|463255170|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
128715300|NCT01496313|463255171|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
128715301|NCT01496313|463255172|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
128715302|NCT01496313|463255167|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
128715303|NCT01496313|463255168|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
128715304|NCT01496313|463255169|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
128715305|NCT01496313|463255170|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
128715306|NCT01496313|463255171|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
128715307|NCT01496313|463255172|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
128715308|NCT04519645|463255173|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
128715309|NCT04519645|463255174|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
128774479|NCT00750893|463466580|FG000|Overall Study|Other|17|||
128971142|NCT01693562|464179544|FG005|Escalation Phase|Withdrawal by Subject|2|||
128971143|NCT01693562|464179545|FG006|Escalation Phase|Withdrawal by Subject|0|||
128971144|NCT01693562|464179546|FG007|Escalation Phase|Withdrawal by Subject|0|||
128971145|NCT01693562|464179547|FG008|Escalation Phase|Withdrawal by Subject|0|||
129131057|NCT05537571|464771006|FG002|Overall Study|Withdrawal by Subject|0|||
129131058|NCT05537571|464771007|FG003|Overall Study|Withdrawal by Subject|0|||
129131059|NCT05537571|464771008|FG004|Overall Study|Withdrawal by Subject|0|||
129131060|NCT05537571|464771004|FG000|Overall Study|Adverse Event|2|||
129131061|NCT05537571|464771005|FG001|Overall Study|Adverse Event|0|||
129131062|NCT05537571|464771006|FG002|Overall Study|Adverse Event|0|||
129131063|NCT05537571|464771007|FG003|Overall Study|Adverse Event|0|||
129131064|NCT05537571|464771008|FG004|Overall Study|Adverse Event|0|||
129131065|NCT05537571|464771004|FG000|Overall Study|Hepatitis A screening result|2|||
128971146|NCT01693562|464179548|FG009|Escalation Phase|Withdrawal by Subject|0|||
128971147|NCT01693562|464179549|FG010|Escalation Phase|Withdrawal by Subject|0|||
128971148|NCT01693562|464179550|FG011|Escalation Phase|Withdrawal by Subject|0|||
128971149|NCT01693562|464179551|FG012|Escalation Phase|Withdrawal by Subject|0|||
128971150|NCT01693562|464179552|FG013|Escalation Phase|Withdrawal by Subject|0|||
128971151|NCT01693562|464179553|FG014|Escalation Phase|Withdrawal by Subject|0|||
128971152|NCT01693562|464179554|FG015|Escalation Phase|Withdrawal by Subject|0|||
128971153|NCT01693562|464179555|FG016|Escalation Phase|Withdrawal by Subject|0|||
128971154|NCT01693562|464179556|FG017|Escalation Phase|Withdrawal by Subject|0|||
128971155|NCT01693562|464179557|FG018|Escalation Phase|Withdrawal by Subject|0|||
128971156|NCT01693562|464179558|FG019|Escalation Phase|Withdrawal by Subject|0|||
128971157|NCT01693562|464179559|FG020|Escalation Phase|Withdrawal by Subject|0|||
128971158|NCT01693562|464179560|FG021|Escalation Phase|Withdrawal by Subject|0|||
128971159|NCT01693562|464179561|FG022|Escalation Phase|Withdrawal by Subject|0|||
129131066|NCT05537571|464771005|FG001|Overall Study|Hepatitis A screening result|0|||
129131067|NCT05537571|464771006|FG002|Overall Study|Hepatitis A screening result|0|||
129131068|NCT05537571|464771007|FG003|Overall Study|Hepatitis A screening result|0|||
129131069|NCT05537571|464771008|FG004|Overall Study|Hepatitis A screening result|0|||
129131070|NCT05537571|464771004|FG000|Overall Study|Lost to Follow-up|0|||
129131071|NCT05537571|464771005|FG001|Overall Study|Lost to Follow-up|0|||
129131072|NCT05537571|464771006|FG002|Overall Study|Lost to Follow-up|1|||
129220461|NCT00854113|465108108|FG009|Overall Study|Adverse Event|0|||
129220462|NCT00854113|465108109|FG010|Overall Study|Adverse Event|0|||
129131073|NCT05537571|464771007|FG003|Overall Study|Lost to Follow-up|0|||
129220463|NCT00854113|465108099|FG000|Overall Study|Withdrawal by Subject|0|||
129220464|NCT00854113|465108100|FG001|Overall Study|Withdrawal by Subject|0|||
128971160|NCT01693562|464179539|FG000|Escalation Phase|Death|4|||
128971161|NCT01693562|464179540|FG001|Escalation Phase|Death|2|||
128971162|NCT01693562|464179541|FG002|Escalation Phase|Death|0|||
128971163|NCT01693562|464179542|FG003|Escalation Phase|Death|3|||
128971164|NCT01693562|464179543|FG004|Escalation Phase|Death|6|||
128971165|NCT01693562|464179544|FG005|Escalation Phase|Death|4|||
128971166|NCT01693562|464179545|FG006|Escalation Phase|Death|0|||
128971167|NCT01693562|464179546|FG007|Escalation Phase|Death|0|||
128971168|NCT01693562|464179547|FG008|Escalation Phase|Death|0|||
128971169|NCT01693562|464179548|FG009|Escalation Phase|Death|0|||
128971170|NCT01693562|464179549|FG010|Escalation Phase|Death|0|||
128971171|NCT01693562|464179550|FG011|Escalation Phase|Death|0|||
129131074|NCT05537571|464771008|FG004|Overall Study|Lost to Follow-up|1|||
129131075|NCT05752487|464771013|FG000|Overall Study|Enrolled, not treated|9|||
129220465|NCT00854113|465108101|FG002|Overall Study|Withdrawal by Subject|0|||
128774480|NCT02420327|463466581|FG000|Overall Study|Adverse Event|7|||
128774481|NCT02420327|463466581|FG000|Overall Study|Pregnancy|1|||
128774482|NCT02420327|463466581|FG000|Overall Study|Withdrawal by Subject|6|||
128774483|NCT02420327|463466581|FG000|Overall Study|Lost to Follow-up|1|||
128774484|NCT02420327|463466581|FG000|Overall Study|Protocol Violation|1|||
128774485|NCT00393094|463466583|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
128774486|NCT00393094|463466583|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
128774487|NCT04285229|463466584|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
128774488|NCT04285229|463466585|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129131076|NCT05752487|464771013|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
129131077|NCT05752487|464771013|FG000|Overall Study|Withdrawal by Subject|2|||
129131078|NCT03091439|464771014|FG000|Overall Study|Study Terminated by the Sponsor|1|||
129131079|NCT03091439|464771015|FG001|Overall Study|Study Terminated by the Sponsor|0|||
129131080|NCT01860989|464771016|FG000|Overall Study|Unsatisfactory therapeutic|5|||
129220466|NCT00854113|465108102|FG003|Overall Study|Withdrawal by Subject|0|||
128774489|NCT04285229|463466586|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128774490|NCT04285229|463466587|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128774491|NCT04285229|463466588|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129220467|NCT00854113|465108103|FG004|Overall Study|Withdrawal by Subject|0|||
128774492|NCT04285229|463466589|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128971172|NCT01693562|464179551|FG012|Escalation Phase|Death|0|||
128971173|NCT01693562|464179552|FG013|Escalation Phase|Death|0|||
128971174|NCT01693562|464179553|FG014|Escalation Phase|Death|0|||
128971175|NCT01693562|464179554|FG015|Escalation Phase|Death|0|||
128971176|NCT01693562|464179555|FG016|Escalation Phase|Death|0|||
128971177|NCT01693562|464179556|FG017|Escalation Phase|Death|0|||
128971178|NCT01693562|464179557|FG018|Escalation Phase|Death|0|||
129220468|NCT00854113|465108104|FG005|Overall Study|Withdrawal by Subject|0|||
129220469|NCT00854113|465108105|FG006|Overall Study|Withdrawal by Subject|0|||
129220470|NCT00854113|465108106|FG007|Overall Study|Withdrawal by Subject|1|||
129220471|NCT00854113|465108107|FG008|Overall Study|Withdrawal by Subject|1|||
129220472|NCT00854113|465108108|FG009|Overall Study|Withdrawal by Subject|0|||
129220473|NCT00854113|465108109|FG010|Overall Study|Withdrawal by Subject|0|||
128774493|NCT04285229|463466584|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
128774494|NCT04285229|463466585|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
128774495|NCT04285229|463466586|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
128774496|NCT04285229|463466587|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
128774497|NCT04285229|463466588|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
128774498|NCT04285229|463466589|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
128774499|NCT04285229|463466584|FG000|Extended Treatment Period|Adverse Event|0|||
128971179|NCT01693562|464179558|FG019|Escalation Phase|Death|0|||
128971180|NCT01693562|464179559|FG020|Escalation Phase|Death|0|||
128971181|NCT01693562|464179560|FG021|Escalation Phase|Death|0|||
128971182|NCT01693562|464179561|FG022|Escalation Phase|Death|0|||
128971183|NCT01693562|464179539|FG000|Escalation Phase|Lost to Follow-up|0|||
128971184|NCT01693562|464179540|FG001|Escalation Phase|Lost to Follow-up|1|||
128971185|NCT01693562|464179541|FG002|Escalation Phase|Lost to Follow-up|1|||
128971186|NCT01693562|464179542|FG003|Escalation Phase|Lost to Follow-up|0|||
128971187|NCT01693562|464179543|FG004|Escalation Phase|Lost to Follow-up|0|||
128971188|NCT01693562|464179544|FG005|Escalation Phase|Lost to Follow-up|0|||
128971189|NCT01693562|464179545|FG006|Escalation Phase|Lost to Follow-up|0|||
128971190|NCT01693562|464179546|FG007|Escalation Phase|Lost to Follow-up|0|||
128971191|NCT01693562|464179547|FG008|Escalation Phase|Lost to Follow-up|0|||
128971192|NCT01693562|464179548|FG009|Escalation Phase|Lost to Follow-up|0|||
128971193|NCT01693562|464179549|FG010|Escalation Phase|Lost to Follow-up|0|||
128971194|NCT01693562|464179550|FG011|Escalation Phase|Lost to Follow-up|0|||
128971195|NCT01693562|464179551|FG012|Escalation Phase|Lost to Follow-up|0|||
128971196|NCT01693562|464179552|FG013|Escalation Phase|Lost to Follow-up|0|||
128971197|NCT01693562|464179553|FG014|Escalation Phase|Lost to Follow-up|0|||
128971198|NCT01693562|464179554|FG015|Escalation Phase|Lost to Follow-up|0|||
128971199|NCT01693562|464179555|FG016|Escalation Phase|Lost to Follow-up|0|||
128971200|NCT01693562|464179556|FG017|Escalation Phase|Lost to Follow-up|0|||
128971201|NCT01693562|464179557|FG018|Escalation Phase|Lost to Follow-up|0|||
128971202|NCT01693562|464179558|FG019|Escalation Phase|Lost to Follow-up|0|||
128971203|NCT01693562|464179559|FG020|Escalation Phase|Lost to Follow-up|0|||
128971204|NCT01693562|464179560|FG021|Escalation Phase|Lost to Follow-up|0|||
128971205|NCT01693562|464179561|FG022|Escalation Phase|Lost to Follow-up|0|||
128971206|NCT01693562|464179539|FG000|Escalation Phase|Other|0|||
128971207|NCT01693562|464179540|FG001|Escalation Phase|Other|0|||
128971208|NCT01693562|464179541|FG002|Escalation Phase|Other|2|||
128971209|NCT01693562|464179542|FG003|Escalation Phase|Other|0|||
128971210|NCT01693562|464179543|FG004|Escalation Phase|Other|0|||
128971211|NCT01693562|464179544|FG005|Escalation Phase|Other|1|||
128971212|NCT01693562|464179545|FG006|Escalation Phase|Other|0|||
128971213|NCT01693562|464179546|FG007|Escalation Phase|Other|0|||
128971214|NCT01693562|464179547|FG008|Escalation Phase|Other|0|||
128971215|NCT01693562|464179548|FG009|Escalation Phase|Other|0|||
128971216|NCT01693562|464179549|FG010|Escalation Phase|Other|0|||
128971217|NCT01693562|464179550|FG011|Escalation Phase|Other|0|||
128971218|NCT01693562|464179551|FG012|Escalation Phase|Other|0|||
128971219|NCT01693562|464179552|FG013|Escalation Phase|Other|0|||
128971220|NCT01693562|464179553|FG014|Escalation Phase|Other|0|||
128971221|NCT01693562|464179554|FG015|Escalation Phase|Other|0|||
128971222|NCT01693562|464179555|FG016|Escalation Phase|Other|0|||
128971223|NCT01693562|464179556|FG017|Escalation Phase|Other|0|||
128971224|NCT01693562|464179557|FG018|Escalation Phase|Other|0|||
128971225|NCT01693562|464179558|FG019|Escalation Phase|Other|0|||
128971226|NCT01693562|464179559|FG020|Escalation Phase|Other|0|||
128971227|NCT01693562|464179560|FG021|Escalation Phase|Other|0|||
128971228|NCT01693562|464179561|FG022|Escalation Phase|Other|0|||
128971229|NCT01693562|464179539|FG000|Exploration Phase|Withdrawal by Subject|0|||
129220474|NCT02273596|465108113|FG000|24-Week Treatment Period|Adverse Event|3|||
128774500|NCT04285229|463466585|FG001|Extended Treatment Period|Adverse Event|0|||
128774501|NCT04285229|463466586|FG002|Extended Treatment Period|Adverse Event|0|||
128774502|NCT04285229|463466587|FG003|Extended Treatment Period|Adverse Event|1|||
128971230|NCT01693562|464179540|FG001|Exploration Phase|Withdrawal by Subject|0|||
128971231|NCT01693562|464179541|FG002|Exploration Phase|Withdrawal by Subject|0|||
128971232|NCT01693562|464179542|FG003|Exploration Phase|Withdrawal by Subject|0|||
128971233|NCT01693562|464179543|FG004|Exploration Phase|Withdrawal by Subject|0|||
128971234|NCT01693562|464179544|FG005|Exploration Phase|Withdrawal by Subject|0|||
128971235|NCT01693562|464179545|FG006|Exploration Phase|Withdrawal by Subject|2|||
128971236|NCT01693562|464179546|FG007|Exploration Phase|Withdrawal by Subject|0|||
128971237|NCT01693562|464179547|FG008|Exploration Phase|Withdrawal by Subject|0|||
128971238|NCT01693562|464179548|FG009|Exploration Phase|Withdrawal by Subject|0|||
128971239|NCT01693562|464179549|FG010|Exploration Phase|Withdrawal by Subject|0|||
128971240|NCT01693562|464179550|FG011|Exploration Phase|Withdrawal by Subject|0|||
128971241|NCT01693562|464179551|FG012|Exploration Phase|Withdrawal by Subject|0|||
128971242|NCT01693562|464179552|FG013|Exploration Phase|Withdrawal by Subject|0|||
128971243|NCT01693562|464179553|FG014|Exploration Phase|Withdrawal by Subject|0|||
128971244|NCT01693562|464179554|FG015|Exploration Phase|Withdrawal by Subject|0|||
128971245|NCT01693562|464179555|FG016|Exploration Phase|Withdrawal by Subject|0|||
128971246|NCT01693562|464179556|FG017|Exploration Phase|Withdrawal by Subject|0|||
128971247|NCT01693562|464179557|FG018|Exploration Phase|Withdrawal by Subject|0|||
128971248|NCT01693562|464179558|FG019|Exploration Phase|Withdrawal by Subject|0|||
128971249|NCT01693562|464179559|FG020|Exploration Phase|Withdrawal by Subject|0|||
128971250|NCT01693562|464179560|FG021|Exploration Phase|Withdrawal by Subject|0|||
128971251|NCT01693562|464179561|FG022|Exploration Phase|Withdrawal by Subject|0|||
128971252|NCT01693562|464179539|FG000|Exploration Phase|Death|0|||
128971253|NCT01693562|464179540|FG001|Exploration Phase|Death|0|||
128971254|NCT01693562|464179541|FG002|Exploration Phase|Death|0|||
128971255|NCT01693562|464179542|FG003|Exploration Phase|Death|0|||
128971256|NCT01693562|464179543|FG004|Exploration Phase|Death|0|||
128971257|NCT01693562|464179544|FG005|Exploration Phase|Death|0|||
128971258|NCT01693562|464179545|FG006|Exploration Phase|Death|17|||
128971259|NCT01693562|464179546|FG007|Exploration Phase|Death|0|||
129038441|NCT01647711|464433171|FG001|Overall Study|Protocol Violation|0|||
129038442|NCT01647711|464433172|FG002|Overall Study|Protocol Violation|0|||
129038443|NCT01647711|464433173|FG003|Overall Study|Protocol Violation|0|||
129038444|NCT01647711|464433174|FG004|Overall Study|Protocol Violation|1|||
129038445|NCT01647711|464433170|FG000|Overall Study|Refused to continue taking medication|0|||
129038446|NCT01647711|464433171|FG001|Overall Study|Refused to continue taking medication|0|||
129038447|NCT01647711|464433172|FG002|Overall Study|Refused to continue taking medication|0|||
129038448|NCT01647711|464433173|FG003|Overall Study|Refused to continue taking medication|2|||
129038449|NCT01647711|464433174|FG004|Overall Study|Refused to continue taking medication|1|||
129038450|NCT01647711|464433170|FG000|Overall Study|Other reason not defined|0|||
129038451|NCT01647711|464433171|FG001|Overall Study|Other reason not defined|1|||
129038452|NCT01647711|464433172|FG002|Overall Study|Other reason not defined|1|||
129038453|NCT01647711|464433173|FG003|Overall Study|Other reason not defined|1|||
129038454|NCT01647711|464433174|FG004|Overall Study|Other reason not defined|0|||
129038455|NCT01470417|464433179|FG000|Overall Study|Disease progression|0|||
129038456|NCT01470417|464433180|FG001|Overall Study|Disease progression|2|||
129038457|NCT02973321|464433181|FG000|Overall Study|Other than specified|0|||
129038458|NCT02973321|464433182|FG001|Overall Study|Other than specified|5|||
129038459|NCT02973321|464433183|FG002|Overall Study|Other than specified|3|||
129038460|NCT02973321|464433184|FG003|Overall Study|Other than specified|3|||
129038461|NCT02973321|464433185|FG004|Overall Study|Other than specified|1|||
129038462|NCT02973321|464433181|FG000|Overall Study|Lack of Efficacy|0|||
129038463|NCT02973321|464433182|FG001|Overall Study|Lack of Efficacy|0|||
129038464|NCT02973321|464433183|FG002|Overall Study|Lack of Efficacy|0|||
129220475|NCT02273596|465108113|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
129220476|NCT02273596|465108113|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
129220477|NCT02273596|465108113|FG000|24-Week Treatment Period|Physician Decision|1|||
129220478|NCT02273596|465108113|FG000|24-Week Treatment Period|Protocol Deviation|1|||
129220479|NCT02273596|465108113|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
129220480|NCT02273596|465108113|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
129220481|NCT02273596|465108113|FG000|Extension Period|Lost to Follow-up|1|||
129220482|NCT02273596|465108113|FG000|Extension Period|Protocol Deviation|1|||
129220483|NCT02604160|465108114|FG000|Overall Study|Protocol Violation|0|||
129220484|NCT02604160|465108115|FG001|Overall Study|Protocol Violation|1|||
129220485|NCT02604160|465108114|FG000|Overall Study|Physician Decision|0|||
129220486|NCT02604160|465108115|FG001|Overall Study|Physician Decision|1|||
129220487|NCT01596062|465108116|FG000|Overall Study|Adverse Event|1|||
129220488|NCT01596062|465108117|FG001|Overall Study|Adverse Event|0|||
129220489|NCT01596062|465108118|FG002|Overall Study|Adverse Event|2|||
129220490|NCT01596062|465108116|FG000|Overall Study|Lack of Efficacy|0|||
129220491|NCT01596062|465108117|FG001|Overall Study|Lack of Efficacy|0|||
129220492|NCT01596062|465108118|FG002|Overall Study|Lack of Efficacy|1|||
129220493|NCT02139592|465108119|FG000|Overall Study|Case Report Forms Uncollected|8|||
129220494|NCT02687191|465108120|FG000|Overall Study|Death|0|||
129220495|NCT02687191|465108121|FG001|Overall Study|Death|1|||
129220496|NCT02687191|465108122|FG002|Overall Study|Death|1|||
129220497|NCT02687191|465108123|FG003|Overall Study|Death|0|||
129220498|NCT02687191|465108124|FG004|Overall Study|Death|1|||
129220499|NCT02687191|465108125|FG005|Overall Study|Death|1|||
129220500|NCT02687191|465108120|FG000|Overall Study|Withdrawal by Subject|0|||
129220501|NCT02687191|465108121|FG001|Overall Study|Withdrawal by Subject|0|||
129220502|NCT02687191|465108122|FG002|Overall Study|Withdrawal by Subject|0|||
129220503|NCT02687191|465108123|FG003|Overall Study|Withdrawal by Subject|1|||
128971260|NCT01693562|464179547|FG008|Exploration Phase|Death|0|||
128971261|NCT01693562|464179548|FG009|Exploration Phase|Death|0|||
128971262|NCT01693562|464179549|FG010|Exploration Phase|Death|0|||
128971263|NCT01693562|464179550|FG011|Exploration Phase|Death|0|||
128971264|NCT01693562|464179551|FG012|Exploration Phase|Death|0|||
128971265|NCT01693562|464179552|FG013|Exploration Phase|Death|0|||
129131081|NCT01685437|464771019|FG000|Overall Study|Withdrawal by Subject|22|||
129131082|NCT01685437|464771019|FG000|Overall Study|Lost to Follow-up|3|||
128971266|NCT01693562|464179553|FG014|Exploration Phase|Death|0|||
128971267|NCT01693562|464179554|FG015|Exploration Phase|Death|0|||
128971268|NCT01693562|464179555|FG016|Exploration Phase|Death|0|||
128971269|NCT01693562|464179556|FG017|Exploration Phase|Death|0|||
128971270|NCT01693562|464179557|FG018|Exploration Phase|Death|0|||
128971271|NCT01693562|464179558|FG019|Exploration Phase|Death|0|||
128971272|NCT01693562|464179559|FG020|Exploration Phase|Death|0|||
128971273|NCT01693562|464179560|FG021|Exploration Phase|Death|0|||
128971274|NCT01693562|464179561|FG022|Exploration Phase|Death|0|||
128971275|NCT01693562|464179539|FG000|Exploration Phase|Other|0|||
128971276|NCT01693562|464179540|FG001|Exploration Phase|Other|0|||
128971277|NCT01693562|464179541|FG002|Exploration Phase|Other|0|||
128971278|NCT01693562|464179542|FG003|Exploration Phase|Other|0|||
128971279|NCT01693562|464179543|FG004|Exploration Phase|Other|0|||
128971280|NCT01693562|464179544|FG005|Exploration Phase|Other|0|||
128971281|NCT01693562|464179545|FG006|Exploration Phase|Other|2|||
128971282|NCT01693562|464179546|FG007|Exploration Phase|Other|0|||
128971283|NCT01693562|464179547|FG008|Exploration Phase|Other|0|||
129131083|NCT01685437|464771019|FG000|Overall Study|Adverse Event|1|||
129131084|NCT01685437|464771019|FG000|Overall Study|Protocol Violation|4|||
129131085|NCT01685437|464771019|FG000|Overall Study|Unable to make visits due to work|1|||
129131086|NCT01214720|464771022|FG000|Overall Study|Alive and still on treatment|34|||
129131087|NCT01214720|464771023|FG001|Overall Study|Alive and still on treatment|18|||
129131088|NCT01214720|464771022|FG000|Overall Study|Alive and in follow-up|45|||
129131089|NCT01214720|464771023|FG001|Overall Study|Alive and in follow-up|48|||
129131090|NCT01214720|464771022|FG000|Overall Study|Lost to Follow-up|6|||
129131091|NCT01214720|464771023|FG001|Overall Study|Lost to Follow-up|2|||
129131092|NCT02347787|464771024|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
129131093|NCT02347787|464771025|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
129131094|NCT02347787|464771024|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
129131095|NCT02347787|464771025|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
129131096|NCT02347787|464771024|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
129131097|NCT02347787|464771025|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
129131098|NCT02347787|464771024|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
129131099|NCT02347787|464771025|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
129131100|NCT03770455|464771032|FG000|Overall Study|Screen failures|3|||
129131101|NCT01039675|464771035|FG000|Overall Study|Adverse Event|0|||
129131102|NCT01039675|464771036|FG001|Overall Study|Adverse Event|2|||
129131103|NCT01039675|464771035|FG000|Overall Study|Lack of Efficacy|0|||
129131104|NCT01039675|464771036|FG001|Overall Study|Lack of Efficacy|2|||
128971284|NCT01693562|464179548|FG009|Exploration Phase|Other|0|||
129131105|NCT01039675|464771035|FG000|Overall Study|Withdrawal by Subject|0|||
129131106|NCT01039675|464771036|FG001|Overall Study|Withdrawal by Subject|1|||
129131107|NCT01039675|464771035|FG000|Overall Study|Lost to Follow-up|0|||
129131108|NCT01039675|464771036|FG001|Overall Study|Lost to Follow-up|1|||
129131109|NCT01039675|464771035|FG000|Overall Study|Physician Decision|0|||
129131110|NCT01039675|464771036|FG001|Overall Study|Physician Decision|1|||
128971285|NCT01693562|464179549|FG010|Exploration Phase|Other|0|||
128971286|NCT01693562|464179550|FG011|Exploration Phase|Other|0|||
129131111|NCT00992836|464772734|FG000|Overall Study|Lost to Follow-up|1|||
129131112|NCT00992836|464772734|FG000|Overall Study|Withdrawal by Subject|2|||
129131113|NCT00992836|464772734|FG000|Overall Study|Protocol Violation|2|||
128971287|NCT01693562|464179551|FG012|Exploration Phase|Other|0|||
128971288|NCT01693562|464179552|FG013|Exploration Phase|Other|0|||
128971289|NCT01693562|464179553|FG014|Exploration Phase|Other|0|||
128971290|NCT01693562|464179554|FG015|Exploration Phase|Other|0|||
129131114|NCT01617967|464772738|FG000|Overall Study|Protocol Violation|0|||
128971291|NCT01693562|464179555|FG016|Exploration Phase|Other|0|||
128971292|NCT01693562|464179556|FG017|Exploration Phase|Other|0|||
128971293|NCT01693562|464179557|FG018|Exploration Phase|Other|0|||
128971294|NCT01693562|464179558|FG019|Exploration Phase|Other|0|||
129131115|NCT01617967|464772739|FG001|Overall Study|Protocol Violation|0|||
129131116|NCT01617967|464772740|FG002|Overall Study|Protocol Violation|0|||
129131117|NCT01617967|464772741|FG003|Overall Study|Protocol Violation|1|||
129131118|NCT01617967|464772742|FG004|Overall Study|Protocol Violation|0|||
129131119|NCT01617967|464772743|FG005|Overall Study|Protocol Violation|0|||
129131120|NCT01617967|464772738|FG000|Overall Study|Withdrawal by Subject|0|||
129131121|NCT01617967|464772739|FG001|Overall Study|Withdrawal by Subject|0|||
129131122|NCT01617967|464772740|FG002|Overall Study|Withdrawal by Subject|0|||
129131123|NCT01617967|464772741|FG003|Overall Study|Withdrawal by Subject|0|||
129131124|NCT01617967|464772742|FG004|Overall Study|Withdrawal by Subject|0|||
129131125|NCT01617967|464772743|FG005|Overall Study|Withdrawal by Subject|1|||
129131126|NCT01617967|464772738|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
129131127|NCT01617967|464772739|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
129131128|NCT01617967|464772740|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
129131129|NCT01617967|464772741|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
129131130|NCT01617967|464772742|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
129131131|NCT01617967|464772743|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
128971295|NCT01693562|464179559|FG020|Exploration Phase|Other|0|||
128971296|NCT01693562|464179560|FG021|Exploration Phase|Other|0|||
128971297|NCT01693562|464179561|FG022|Exploration Phase|Other|0|||
128971298|NCT01693562|464179539|FG000|Expansion Phase|Withdrawal by Subject|0|||
128971299|NCT01693562|464179540|FG001|Expansion Phase|Withdrawal by Subject|0|||
128971300|NCT01693562|464179541|FG002|Expansion Phase|Withdrawal by Subject|0|||
128971301|NCT01693562|464179542|FG003|Expansion Phase|Withdrawal by Subject|0|||
128971302|NCT01693562|464179543|FG004|Expansion Phase|Withdrawal by Subject|0|||
128971303|NCT01693562|464179544|FG005|Expansion Phase|Withdrawal by Subject|0|||
128971304|NCT01693562|464179545|FG006|Expansion Phase|Withdrawal by Subject|0|||
128971305|NCT01693562|464179546|FG007|Expansion Phase|Withdrawal by Subject|16|||
128971306|NCT01693562|464179547|FG008|Expansion Phase|Withdrawal by Subject|2|||
128971307|NCT01693562|464179548|FG009|Expansion Phase|Withdrawal by Subject|54|||
128971308|NCT01693562|464179549|FG010|Expansion Phase|Withdrawal by Subject|2|||
128971309|NCT01693562|464179550|FG011|Expansion Phase|Withdrawal by Subject|2|||
128971310|NCT01693562|464179551|FG012|Expansion Phase|Withdrawal by Subject|3|||
128971311|NCT01693562|464179552|FG013|Expansion Phase|Withdrawal by Subject|5|||
128971312|NCT01693562|464179553|FG014|Expansion Phase|Withdrawal by Subject|16|||
128971313|NCT01693562|464179554|FG015|Expansion Phase|Withdrawal by Subject|7|||
128971314|NCT01693562|464179555|FG016|Expansion Phase|Withdrawal by Subject|40|||
128971315|NCT01693562|464179556|FG017|Expansion Phase|Withdrawal by Subject|4|||
128971316|NCT01693562|464179557|FG018|Expansion Phase|Withdrawal by Subject|8|||
128971317|NCT01693562|464179558|FG019|Expansion Phase|Withdrawal by Subject|3|||
128971318|NCT01693562|464179559|FG020|Expansion Phase|Withdrawal by Subject|1|||
128971319|NCT01693562|464179560|FG021|Expansion Phase|Withdrawal by Subject|8|||
128971320|NCT01693562|464179561|FG022|Expansion Phase|Withdrawal by Subject|1|||
128971321|NCT01693562|464179539|FG000|Expansion Phase|Death|0|||
128971322|NCT01693562|464179540|FG001|Expansion Phase|Death|0|||
128971323|NCT01693562|464179541|FG002|Expansion Phase|Death|0|||
128971324|NCT01693562|464179542|FG003|Expansion Phase|Death|0|||
128971325|NCT01693562|464179543|FG004|Expansion Phase|Death|0|||
128971326|NCT01693562|464179544|FG005|Expansion Phase|Death|0|||
128971327|NCT01693562|464179545|FG006|Expansion Phase|Death|0|||
128971328|NCT01693562|464179546|FG007|Expansion Phase|Death|42|||
128971329|NCT01693562|464179547|FG008|Expansion Phase|Death|17|||
128971330|NCT01693562|464179548|FG009|Expansion Phase|Death|208|||
128971331|NCT01693562|464179549|FG010|Expansion Phase|Death|30|||
128971332|NCT01693562|464179550|FG011|Expansion Phase|Death|8|||
128971333|NCT01693562|464179551|FG012|Expansion Phase|Death|19|||
128971334|NCT01693562|464179552|FG013|Expansion Phase|Death|42|||
128971335|NCT01693562|464179553|FG014|Expansion Phase|Death|23|||
128971336|NCT01693562|464179554|FG015|Expansion Phase|Death|23|||
128971337|NCT01693562|464179555|FG016|Expansion Phase|Death|128|||
128971338|NCT01693562|464179556|FG017|Expansion Phase|Death|16|||
128971339|NCT01693562|464179557|FG018|Expansion Phase|Death|36|||
128971340|NCT01693562|464179558|FG019|Expansion Phase|Death|16|||
128774503|NCT04285229|463466588|FG004|Extended Treatment Period|Adverse Event|0|||
128774504|NCT04285229|463466589|FG005|Extended Treatment Period|Adverse Event|0|||
128774505|NCT04285229|463466584|FG000|Extended Treatment Period|Physician Decision|0|||
128774506|NCT04285229|463466585|FG001|Extended Treatment Period|Physician Decision|0|||
128774507|NCT04285229|463466586|FG002|Extended Treatment Period|Physician Decision|1|||
128774508|NCT04285229|463466587|FG003|Extended Treatment Period|Physician Decision|0|||
128774509|NCT04285229|463466588|FG004|Extended Treatment Period|Physician Decision|0|||
128774510|NCT04285229|463466589|FG005|Extended Treatment Period|Physician Decision|0|||
128774511|NCT04285229|463466584|FG000|Follow-up Period|Adverse Event|0|||
128774512|NCT04285229|463466585|FG001|Follow-up Period|Adverse Event|0|||
128774513|NCT04285229|463466586|FG002|Follow-up Period|Adverse Event|0|||
128774514|NCT04285229|463466587|FG003|Follow-up Period|Adverse Event|0|||
128774515|NCT04285229|463466588|FG004|Follow-up Period|Adverse Event|1|||
128971341|NCT01693562|464179559|FG020|Expansion Phase|Death|17|||
128971342|NCT01693562|464179560|FG021|Expansion Phase|Death|35|||
128971343|NCT01693562|464179561|FG022|Expansion Phase|Death|7|||
128971344|NCT01693562|464179539|FG000|Expansion Phase|Lost to Follow-up|0|||
129220504|NCT02687191|465108124|FG004|Overall Study|Withdrawal by Subject|0|||
129220505|NCT02687191|465108125|FG005|Overall Study|Withdrawal by Subject|0|||
129220506|NCT03180840|465108126|FG000|Overall Study|Withdrawal by Subject|1|||
128774516|NCT04285229|463466589|FG005|Follow-up Period|Adverse Event|4|||
128774517|NCT04285229|463466584|FG000|Follow-up Period|Withdrawal by Subject|0|||
128774518|NCT04285229|463466585|FG001|Follow-up Period|Withdrawal by Subject|0|||
128971345|NCT01693562|464179540|FG001|Expansion Phase|Lost to Follow-up|0|||
128971346|NCT01693562|464179541|FG002|Expansion Phase|Lost to Follow-up|0|||
128971347|NCT01693562|464179542|FG003|Expansion Phase|Lost to Follow-up|0|||
128971348|NCT01693562|464179543|FG004|Expansion Phase|Lost to Follow-up|0|||
128971349|NCT01693562|464179544|FG005|Expansion Phase|Lost to Follow-up|0|||
128971350|NCT01693562|464179545|FG006|Expansion Phase|Lost to Follow-up|0|||
128971351|NCT01693562|464179546|FG007|Expansion Phase|Lost to Follow-up|1|||
128971352|NCT01693562|464179547|FG008|Expansion Phase|Lost to Follow-up|2|||
128971353|NCT01693562|464179548|FG009|Expansion Phase|Lost to Follow-up|10|||
128971354|NCT01693562|464179549|FG010|Expansion Phase|Lost to Follow-up|4|||
129220507|NCT01788358|465108127|FG000|Overall Study|Other|11|||
128971355|NCT01693562|464179550|FG011|Expansion Phase|Lost to Follow-up|4|||
128971356|NCT01693562|464179551|FG012|Expansion Phase|Lost to Follow-up|1|||
128971357|NCT01693562|464179552|FG013|Expansion Phase|Lost to Follow-up|3|||
128715310|NCT04519645|463255175|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
128715311|NCT04519645|463255173|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
128971358|NCT01693562|464179553|FG014|Expansion Phase|Lost to Follow-up|0|||
128971359|NCT01693562|464179554|FG015|Expansion Phase|Lost to Follow-up|1|||
128971360|NCT01693562|464179555|FG016|Expansion Phase|Lost to Follow-up|1|||
128971361|NCT01693562|464179556|FG017|Expansion Phase|Lost to Follow-up|0|||
128971362|NCT01693562|464179557|FG018|Expansion Phase|Lost to Follow-up|2|||
128971363|NCT01693562|464179558|FG019|Expansion Phase|Lost to Follow-up|1|||
128971364|NCT01693562|464179559|FG020|Expansion Phase|Lost to Follow-up|2|||
128971365|NCT01693562|464179560|FG021|Expansion Phase|Lost to Follow-up|2|||
128971366|NCT01693562|464179561|FG022|Expansion Phase|Lost to Follow-up|1|||
128971367|NCT01693562|464179539|FG000|Expansion Phase|Other|0|||
128971368|NCT01693562|464179540|FG001|Expansion Phase|Other|0|||
128971369|NCT01693562|464179541|FG002|Expansion Phase|Other|0|||
128971370|NCT01693562|464179542|FG003|Expansion Phase|Other|0|||
128971371|NCT01693562|464179543|FG004|Expansion Phase|Other|0|||
128971372|NCT01693562|464179544|FG005|Expansion Phase|Other|0|||
128971373|NCT01693562|464179545|FG006|Expansion Phase|Other|0|||
128715312|NCT04519645|463255174|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
128715313|NCT04519645|463255175|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
128715314|NCT04519645|463255173|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
128715315|NCT04519645|463255174|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
128715316|NCT04519645|463255175|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
128715317|NCT04519645|463255173|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
128715318|NCT04519645|463255174|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
128715319|NCT04519645|463255175|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
128715320|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
128715321|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
128715322|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
128715323|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
128715324|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
128715325|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
128715326|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
128715327|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
128715328|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
128715329|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
128715330|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
128715331|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
128715332|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
128715333|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
128715334|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
128715335|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
128715336|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
128715337|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
128715338|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
128715339|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
128715340|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
128715341|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
128715342|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
128715343|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
128715344|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
128715345|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
128715346|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
128715347|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
128715348|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
128715349|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
128971374|NCT01693562|464179546|FG007|Expansion Phase|Other|3|||
129131132|NCT05276804|464772750|FG000|Overall Study|screen failure|23|||
129131133|NCT05276804|464772751|FG001|Overall Study|screen failure|0|||
129131134|NCT02827708|464772752|FG000|Overall Study|Lost to Follow-up|3|||
128774519|NCT04285229|463466586|FG002|Follow-up Period|Withdrawal by Subject|0|||
128774520|NCT04285229|463466587|FG003|Follow-up Period|Withdrawal by Subject|0|||
128971375|NCT01693562|464179547|FG008|Expansion Phase|Other|1|||
128971376|NCT01693562|464179548|FG009|Expansion Phase|Other|28|||
128971377|NCT01693562|464179549|FG010|Expansion Phase|Other|4|||
128971378|NCT01693562|464179550|FG011|Expansion Phase|Other|7|||
128971379|NCT01693562|464179551|FG012|Expansion Phase|Other|0|||
128971380|NCT01693562|464179552|FG013|Expansion Phase|Other|1|||
129131135|NCT02827708|464772753|FG001|Overall Study|Lost to Follow-up|1|||
128774521|NCT04285229|463466588|FG004|Follow-up Period|Withdrawal by Subject|0|||
128774522|NCT04285229|463466589|FG005|Follow-up Period|Withdrawal by Subject|5|||
128774523|NCT04285229|463466584|FG000|Follow-up Period|Covid-19|0|||
128774524|NCT04285229|463466585|FG001|Follow-up Period|Covid-19|0|||
128774525|NCT04285229|463466586|FG002|Follow-up Period|Covid-19|0|||
128774526|NCT04285229|463466587|FG003|Follow-up Period|Covid-19|0|||
128774527|NCT04285229|463466588|FG004|Follow-up Period|Covid-19|0|||
128774528|NCT04285229|463466589|FG005|Follow-up Period|Covid-19|2|||
128774529|NCT04285229|463466584|FG000|Follow-up Period|Physician Decision|0|||
128774530|NCT04285229|463466585|FG001|Follow-up Period|Physician Decision|0|||
128774531|NCT04285229|463466586|FG002|Follow-up Period|Physician Decision|0|||
128774532|NCT04285229|463466587|FG003|Follow-up Period|Physician Decision|0|||
128774533|NCT04285229|463466588|FG004|Follow-up Period|Physician Decision|0|||
128774534|NCT04285229|463466589|FG005|Follow-up Period|Physician Decision|1|||
128774535|NCT01556763|463466591|FG000|Overall Study|Withdrawal by Subject|0|||
128774536|NCT01556763|463466592|FG001|Overall Study|Withdrawal by Subject|1|||
128774537|NCT01556763|463466593|FG002|Overall Study|Withdrawal by Subject|0|||
128774538|NCT04170296|463466594|FG000|Overall Study|Adverse Event|1|||
128774539|NCT04170296|463466595|FG001|Overall Study|Adverse Event|0|||
128774540|NCT04170296|463466594|FG000|Overall Study|Withdrawal by Subject|3|||
128774541|NCT04170296|463466595|FG001|Overall Study|Withdrawal by Subject|2|||
128774542|NCT04170296|463466594|FG000|Overall Study|Lost to Follow-up|4|||
128774543|NCT04170296|463466595|FG001|Overall Study|Lost to Follow-up|2|||
128774544|NCT02138747|463466596|FG000|Treatment Period 1|Adverse Event|10|||
128774545|NCT02138747|463466597|FG001|Treatment Period 1|Adverse Event|14|||
128774546|NCT02138747|463466598|FG002|Treatment Period 1|Adverse Event|2|||
128774547|NCT02138747|463466599|FG003|Treatment Period 1|Adverse Event|1|||
128774548|NCT02138747|463466596|FG000|Treatment Period 1|Lost to Follow-up|0|||
128774549|NCT02138747|463466597|FG001|Treatment Period 1|Lost to Follow-up|1|||
128774550|NCT02138747|463466598|FG002|Treatment Period 1|Lost to Follow-up|1|||
128774551|NCT02138747|463466599|FG003|Treatment Period 1|Lost to Follow-up|0|||
128774552|NCT02138747|463466596|FG000|Treatment Period 1|Protocol Violation|0|||
128774553|NCT02138747|463466597|FG001|Treatment Period 1|Protocol Violation|2|||
128774554|NCT02138747|463466598|FG002|Treatment Period 1|Protocol Violation|0|||
128774555|NCT02138747|463466599|FG003|Treatment Period 1|Protocol Violation|0|||
128774556|NCT02138747|463466596|FG000|Treatment Period 1|Withdrawal by Subject|8|||
128774557|NCT02138747|463466597|FG001|Treatment Period 1|Withdrawal by Subject|4|||
128774558|NCT02138747|463466598|FG002|Treatment Period 1|Withdrawal by Subject|1|||
128774559|NCT02138747|463466599|FG003|Treatment Period 1|Withdrawal by Subject|3|||
128774560|NCT02138747|463466596|FG000|Treatment Period 1|Other - Miscellaneous|2|||
128774561|NCT02138747|463466597|FG001|Treatment Period 1|Other - Miscellaneous|4|||
128774562|NCT02138747|463466598|FG002|Treatment Period 1|Other - Miscellaneous|0|||
128774563|NCT02138747|463466599|FG003|Treatment Period 1|Other - Miscellaneous|0|||
128774564|NCT02138747|463466596|FG000|Treatment Period 2|Adverse Event|6|||
128774565|NCT02138747|463466597|FG001|Treatment Period 2|Adverse Event|3|||
128774566|NCT02138747|463466598|FG002|Treatment Period 2|Adverse Event|1|||
128774567|NCT02138747|463466599|FG003|Treatment Period 2|Adverse Event|1|||
128774568|NCT02138747|463466596|FG000|Treatment Period 2|Lost to Follow-up|2|||
128774569|NCT02138747|463466597|FG001|Treatment Period 2|Lost to Follow-up|0|||
128774570|NCT02138747|463466598|FG002|Treatment Period 2|Lost to Follow-up|0|||
128774571|NCT02138747|463466599|FG003|Treatment Period 2|Lost to Follow-up|0|||
128774572|NCT02138747|463466596|FG000|Treatment Period 2|Protocol Violation|1|||
128774573|NCT02138747|463466597|FG001|Treatment Period 2|Protocol Violation|0|||
129131136|NCT02827708|464772752|FG000|Overall Study|Withdrawal by Subject|1|||
128774574|NCT02138747|463466598|FG002|Treatment Period 2|Protocol Violation|0|||
128774575|NCT02138747|463466599|FG003|Treatment Period 2|Protocol Violation|0|||
128774576|NCT02138747|463466596|FG000|Treatment Period 2|Withdrawal by Subject|5|||
128774577|NCT02138747|463466597|FG001|Treatment Period 2|Withdrawal by Subject|4|||
128774578|NCT02138747|463466598|FG002|Treatment Period 2|Withdrawal by Subject|1|||
128774579|NCT02138747|463466599|FG003|Treatment Period 2|Withdrawal by Subject|2|||
128774580|NCT02138747|463466596|FG000|Treatment Period 2|Other - Miscellaneous|3|||
128774581|NCT02138747|463466597|FG001|Treatment Period 2|Other - Miscellaneous|0|||
128774582|NCT02138747|463466598|FG002|Treatment Period 2|Other - Miscellaneous|0|||
128774583|NCT02138747|463466599|FG003|Treatment Period 2|Other - Miscellaneous|0|||
129131137|NCT02827708|464772753|FG001|Overall Study|Withdrawal by Subject|2|||
129131138|NCT02827708|464772752|FG000|Overall Study|Death|1|||
128774584|NCT03567993|463466600|FG000|Overall Study|Lost to Follow-up|4|||
128774585|NCT03567993|463466601|FG001|Overall Study|Lost to Follow-up|2|||
128774586|NCT03567993|463466600|FG000|Overall Study|Death|1|||
128774587|NCT03567993|463466601|FG001|Overall Study|Death|1|||
128774588|NCT03567993|463466600|FG000|Overall Study|Withdrawal by Subject|1|||
128774589|NCT03567993|463466601|FG001|Overall Study|Withdrawal by Subject|0|||
128774590|NCT02285595|463466602|FG000|Overall Study|Lost to Follow-up|14|||
128774591|NCT02285595|463466602|FG000|Overall Study|Withdrawal by Subject|1|||
128774592|NCT00195715|463466603|FG000|Overall Study|Adverse Event|122|||
128774593|NCT00195715|463466603|FG000|Overall Study|Withdrawal by Subject|58|||
128774594|NCT00195715|463466603|FG000|Overall Study|Lost to Follow-up|27|||
128774595|NCT00195715|463466603|FG000|Overall Study|Protocol Violation|13|||
128774596|NCT00195715|463466603|FG000|Overall Study|Lack of Efficacy|93|||
128774597|NCT00195715|463466603|FG000|Overall Study|Pregnancy|14|||
128774598|NCT00195715|463466603|FG000|Overall Study|Investigative site closure|8|||
128774599|NCT00195715|463466603|FG000|Overall Study|Subject moved/relocated|7|||
128774600|NCT00195715|463466603|FG000|Overall Study|Subject non-compliance|6|||
128774601|NCT00195715|463466603|FG000|Overall Study|Subject started commercial Humira|5|||
128774602|NCT00195715|463466603|FG000|Overall Study|Subject choice|3|||
128774603|NCT00195715|463466603|FG000|Overall Study|Loss of response/no improvement|3|||
128774604|NCT00195715|463466603|FG000|Overall Study|Sponsor stopped study|1|||
128774605|NCT00195715|463466603|FG000|Overall Study|Administrative reasons|2|||
128774606|NCT00195715|463466603|FG000|Overall Study|Investigator's decision|2|||
128774607|NCT00195715|463466603|FG000|Overall Study|Subject wants to get pregnant|4|||
128774608|NCT00195715|463466603|FG000|Overall Study|Use of prohibited medication|2|||
128774609|NCT00195715|463466603|FG000|Overall Study|Planned surgery|2|||
128774610|NCT00195715|463466603|FG000|Overall Study|Increased infection rate|1|||
128774611|NCT00195715|463466603|FG000|Overall Study|Ineligible|1|||
128774612|NCT00195715|463466603|FG000|Overall Study|Colonic stricture|1|||
128774613|NCT00195715|463466603|FG000|Overall Study|Sponsor discontinued trial|1|||
128774614|NCT00195715|463466603|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
128774615|NCT00845871|463466608|FG000|Assessment Period|Adverse Event|2|||
128774616|NCT00845871|463466608|FG000|Assessment Period|Abnormal laboratory values|1|||
128774617|NCT00845871|463466608|FG000|Assessment Period|Abnormal test procedure results|1|||
128774618|NCT00845871|463466608|FG000|Assessment Period|Patient withdrew consent|3|||
128774619|NCT00064025|463466618|FG000|Overall Study|Ineligible|4|||
129220508|NCT01788358|465108127|FG000|Overall Study|Logistical difficulties|1|||
129220509|NCT01788358|465108127|FG000|Overall Study|Lost to Follow-up|5|||
129220510|NCT01788358|465108127|FG000|Overall Study|Protocol Violation|3|||
129220511|NCT01788358|465108127|FG000|Overall Study|Withdrawal by Subject|26|||
129220512|NCT01788358|465108127|FG000|Overall Study|Lack of Efficacy|1|||
129220513|NCT01788358|465108127|FG000|Overall Study|Adverse Event|51|||
129220514|NCT02873702|465108130|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
129220515|NCT02873702|465108131|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
129220516|NCT02873702|465108132|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
129220517|NCT02873702|465108133|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
129220518|NCT02873702|465108130|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
129220519|NCT02873702|465108131|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
129220520|NCT02873702|465108132|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
129220521|NCT02873702|465108133|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
129220522|NCT02873702|465108130|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
129220523|NCT02873702|465108131|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
129220524|NCT02873702|465108132|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
129220525|NCT02873702|465108133|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
129220526|NCT02873702|465108130|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
129220527|NCT02873702|465108131|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
129220528|NCT02873702|465108132|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
129220529|NCT02873702|465108133|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
129220530|NCT02873702|465108130|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
129220531|NCT02873702|465108131|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
129220532|NCT02873702|465108132|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
129220533|NCT02873702|465108133|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
128715350|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
128715351|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
128715352|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
128715353|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
128715354|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
128715355|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
128715356|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
128715357|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
128715358|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
128774620|NCT00064025|463466618|FG000|Overall Study|Inevaluable|3|||
128774621|NCT02468934|463466621|FG000|Overall Study|Withdrawal by Subject|4|||
128774622|NCT02468934|463466621|FG000|Overall Study|Screen Failure|3|||
128774623|NCT01370603|463466622|FG000|Period 1|Adverse Event|5|||
128774624|NCT01370603|463466623|FG001|Period 1|Adverse Event|3|||
128971381|NCT01693562|464179553|FG014|Expansion Phase|Other|1|||
128971382|NCT01693562|464179554|FG015|Expansion Phase|Other|0|||
128971383|NCT01693562|464179555|FG016|Expansion Phase|Other|28|||
128971384|NCT01693562|464179556|FG017|Expansion Phase|Other|0|||
129220534|NCT01413204|465108143|FG000|Overall Study|Adverse Event|1|||
129220535|NCT01413204|465108144|FG001|Overall Study|Adverse Event|2|||
129220536|NCT01413204|465108145|FG002|Overall Study|Adverse Event|2|||
128715359|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
128971385|NCT01693562|464179557|FG018|Expansion Phase|Other|1|||
128971386|NCT01693562|464179558|FG019|Expansion Phase|Other|0|||
128971387|NCT01693562|464179559|FG020|Expansion Phase|Other|1|||
128971388|NCT01693562|464179560|FG021|Expansion Phase|Other|17|||
128971389|NCT01693562|464179561|FG022|Expansion Phase|Other|1|||
128971390|NCT05618808|464179566|FG000|Overall Study|Withdrawal by Subject|3|||
128971391|NCT05618808|464179567|FG001|Overall Study|Withdrawal by Subject|1|||
128971392|NCT05618808|464179568|FG002|Overall Study|Withdrawal by Subject|3|||
128971393|NCT05298774|464179575|FG000|Overall Study|Physician Decision|3|||
128971394|NCT05298774|464179575|FG000|Overall Study|Withdrawal by Subject|2|||
128971395|NCT05298774|464179575|FG000|Overall Study|Lost to Follow-up|3|||
128971396|NCT05298774|464179575|FG000|Overall Study|Screen failure|1|||
128971397|NCT06048367|464179584|FG000|Overall Study|Withdrawal by Subject|0|||
128971398|NCT06048367|464179585|FG001|Overall Study|Withdrawal by Subject|1|||
128971399|NCT06048367|464179586|FG002|Overall Study|Withdrawal by Subject|0|||
128971400|NCT06048367|464179587|FG003|Overall Study|Withdrawal by Subject|0|||
128971401|NCT06048367|464179588|FG004|Overall Study|Withdrawal by Subject|0|||
128971402|NCT06048367|464179584|FG000|Overall Study|Withdrawal by Subject|0|||
128971403|NCT06048367|464179585|FG001|Overall Study|Withdrawal by Subject|0|||
128971404|NCT06048367|464179586|FG002|Overall Study|Withdrawal by Subject|1|||
128971405|NCT06048367|464179587|FG003|Overall Study|Withdrawal by Subject|0|||
128971406|NCT06048367|464179588|FG004|Overall Study|Withdrawal by Subject|0|||
128971407|NCT06048367|464179584|FG000|Overall Study|Withdrawal by Subject|0|||
128971408|NCT06048367|464179585|FG001|Overall Study|Withdrawal by Subject|0|||
129220537|NCT01413204|465108143|FG000|Overall Study|Physician Decision|3|||
128715360|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
128715361|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
128715362|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
128715363|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
128715364|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
128715365|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
128715366|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
128715367|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
128715368|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
128715369|NCT03742037|463255176|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
128715370|NCT03742037|463255177|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
128715371|NCT03742037|463255178|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
128715372|NCT03742037|463255179|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
128715373|NCT03742037|463255180|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
128715374|NCT03742037|463255181|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
128715375|NCT03742037|463255182|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
128715376|NCT03742037|463255176|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
128715377|NCT03742037|463255177|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
128715378|NCT03742037|463255178|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
128715379|NCT03742037|463255179|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
128715380|NCT03742037|463255180|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
128715381|NCT03742037|463255181|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
128715382|NCT03742037|463255182|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
128715383|NCT03742037|463255176|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
128715384|NCT03742037|463255177|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
128715385|NCT03742037|463255178|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
128715386|NCT03742037|463255179|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
128715387|NCT03742037|463255180|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
128715388|NCT03742037|463255181|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
128715389|NCT03742037|463255182|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
128715390|NCT03742037|463255176|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
128715391|NCT03742037|463255177|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
128715392|NCT03742037|463255178|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
128715393|NCT03742037|463255179|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
128715394|NCT03742037|463255180|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
128715395|NCT03742037|463255181|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
128715396|NCT03742037|463255182|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
128715397|NCT03742037|463255176|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
128971409|NCT06048367|464179586|FG002|Overall Study|Withdrawal by Subject|0|||
128971410|NCT06048367|464179587|FG003|Overall Study|Withdrawal by Subject|1|||
128971411|NCT06048367|464179588|FG004|Overall Study|Withdrawal by Subject|0|||
129220538|NCT01413204|465108144|FG001|Overall Study|Physician Decision|0|||
128971412|NCT06048367|464179584|FG000|Overall Study|Withdrawal by Subject|0|||
128774625|NCT01370603|463466622|FG000|Period 1|Lost to Follow-up|2|||
128774626|NCT01370603|463466623|FG001|Period 1|Lost to Follow-up|0|||
128774627|NCT01370603|463466622|FG000|Period 1|Protocol Violation|2|||
128971413|NCT06048367|464179585|FG001|Overall Study|Withdrawal by Subject|0|||
128971414|NCT06048367|464179586|FG002|Overall Study|Withdrawal by Subject|0|||
128971415|NCT06048367|464179587|FG003|Overall Study|Withdrawal by Subject|1|||
128971416|NCT06048367|464179588|FG004|Overall Study|Withdrawal by Subject|0|||
128971417|NCT01327573|464179589|FG000|Overall Study|Physician Decision|3|||
128971418|NCT01327573|464179590|FG001|Overall Study|Physician Decision|1|||
128971419|NCT02136134|464179591|FG000|Overall Study|Death|170|||
128971420|NCT02136134|464179592|FG001|Overall Study|Death|148|||
128971421|NCT02136134|464179591|FG000|Overall Study|Withdrawal by Subject|19|||
128971422|NCT02136134|464179592|FG001|Overall Study|Withdrawal by Subject|10|||
128971423|NCT02136134|464179591|FG000|Overall Study|Lost to Follow-up|3|||
128971424|NCT02136134|464179592|FG001|Overall Study|Lost to Follow-up|3|||
128971425|NCT02136134|464179591|FG000|Overall Study|Uspecified|55|||
128971426|NCT02136134|464179592|FG001|Overall Study|Uspecified|90|||
128971427|NCT03070119|464179595|FG000|Overall Study|Adverse Event|0|||
128971428|NCT03070119|464179596|FG001|Overall Study|Adverse Event|0|||
128971429|NCT03070119|464179597|FG002|Overall Study|Adverse Event|1|||
128971430|NCT03070119|464179595|FG000|Overall Study|Lost to Follow-up|0|||
128971431|NCT03070119|464179596|FG001|Overall Study|Lost to Follow-up|1|||
128971432|NCT03070119|464179597|FG002|Overall Study|Lost to Follow-up|0|||
128971433|NCT03070119|464179595|FG000|Overall Study|Consent Withdrawn|6|||
128971434|NCT03070119|464179596|FG001|Overall Study|Consent Withdrawn|5|||
128971435|NCT03070119|464179597|FG002|Overall Study|Consent Withdrawn|3|||
128971436|NCT03070119|464179595|FG000|Overall Study|Investigator Decision|0|||
128971437|NCT03070119|464179596|FG001|Overall Study|Investigator Decision|0|||
128971438|NCT03070119|464179597|FG002|Overall Study|Investigator Decision|1|||
128971439|NCT03070119|464179595|FG000|Overall Study|Death|7|||
128971440|NCT03070119|464179596|FG001|Overall Study|Death|14|||
128971441|NCT03070119|464179597|FG002|Overall Study|Death|5|||
128971442|NCT03070119|464179595|FG000|Overall Study|Disease Progression|5|||
128971443|NCT03070119|464179596|FG001|Overall Study|Disease Progression|7|||
128971444|NCT03070119|464179597|FG002|Overall Study|Disease Progression|7|||
128971445|NCT03070119|464179595|FG000|Overall Study|Reason not Specified|2|||
128971446|NCT03070119|464179596|FG001|Overall Study|Reason not Specified|2|||
128971447|NCT03070119|464179597|FG002|Overall Study|Reason not Specified|1|||
128971448|NCT00732472|464179598|FG000|Overall Study|Adverse Event|0|||
128971449|NCT00732472|464179599|FG001|Overall Study|Adverse Event|1|||
128971450|NCT00732472|464179600|FG002|Overall Study|Adverse Event|1|||
128971451|NCT00732472|464179601|FG003|Overall Study|Adverse Event|1|||
128971452|NCT00732472|464179598|FG000|Overall Study|Protocol Violation|0|||
128971453|NCT00732472|464179599|FG001|Overall Study|Protocol Violation|0|||
128971454|NCT00732472|464179600|FG002|Overall Study|Protocol Violation|0|||
128971455|NCT00732472|464179601|FG003|Overall Study|Protocol Violation|1|||
128971456|NCT00732472|464179598|FG000|Overall Study|Withdrawal by Subject|0|||
128971457|NCT00732472|464179599|FG001|Overall Study|Withdrawal by Subject|2|||
128971458|NCT00732472|464179600|FG002|Overall Study|Withdrawal by Subject|0|||
128971459|NCT00732472|464179601|FG003|Overall Study|Withdrawal by Subject|1|||
128971460|NCT01058395|464179603|FG000|Overall Study|Death|2|||
128971461|NCT01058395|464179604|FG001|Overall Study|Death|1|||
128971462|NCT01058395|464179603|FG000|Overall Study|Lost to Follow-up|1|||
128971463|NCT01058395|464179604|FG001|Overall Study|Lost to Follow-up|0|||
128971464|NCT01266876|464179605|FG000|Overall Study|Adverse Event|0|||
128971465|NCT01266876|464179606|FG001|Overall Study|Adverse Event|0|||
128971466|NCT01266876|464179607|FG002|Overall Study|Adverse Event|0|||
128774628|NCT01370603|463466623|FG001|Period 1|Protocol Violation|2|||
128774629|NCT01370603|463466622|FG000|Period 1|Withdrawal by Subject|5|||
128774630|NCT01370603|463466623|FG001|Period 1|Withdrawal by Subject|5|||
128774631|NCT01370603|463466622|FG000|Crossover Washout|Adverse Event|2|||
128774632|NCT01370603|463466623|FG001|Crossover Washout|Adverse Event|1|||
128774633|NCT01370603|463466622|FG000|Crossover Washout|Lost to Follow-up|2|||
128774634|NCT01370603|463466623|FG001|Crossover Washout|Lost to Follow-up|0|||
128971467|NCT01266876|464179608|FG003|Overall Study|Adverse Event|1|||
128971468|NCT01266876|464179609|FG004|Overall Study|Adverse Event|0|||
128971469|NCT04083781|464179610|FG000|Main Part|Physician Decision|0|||
128971470|NCT04083781|464179611|FG001|Main Part|Physician Decision|1|||
128971471|NCT04083781|464179612|FG002|Main Part|Physician Decision|2|||
128971472|NCT04083781|464179613|FG003|Main Part|Physician Decision|0|||
128971473|NCT04083781|464179610|FG000|Main Part|Death|1|||
128971474|NCT04083781|464179611|FG001|Main Part|Death|3|||
128971475|NCT04083781|464179612|FG002|Main Part|Death|1|||
128971476|NCT04083781|464179613|FG003|Main Part|Death|0|||
128971477|NCT04083781|464179610|FG000|Main Part|Withdrawal by Subject|5|||
128971478|NCT04083781|464179611|FG001|Main Part|Withdrawal by Subject|2|||
128971479|NCT04083781|464179612|FG002|Main Part|Withdrawal by Subject|3|||
128971480|NCT04083781|464179613|FG003|Main Part|Withdrawal by Subject|7|||
128971481|NCT04083781|464179610|FG000|Extension Part|Physician Decision|0|||
128971482|NCT04083781|464179611|FG001|Extension Part|Physician Decision|0|||
128971483|NCT04083781|464179612|FG002|Extension Part|Physician Decision|0|||
128774635|NCT01370603|463466622|FG000|Crossover Washout|Protocol Violation|1|||
128774636|NCT01370603|463466623|FG001|Crossover Washout|Protocol Violation|0|||
128774637|NCT01370603|463466622|FG000|Crossover Washout|Withdrawal by Subject|4|||
128774638|NCT01370603|463466623|FG001|Crossover Washout|Withdrawal by Subject|1|||
128774639|NCT01370603|463466622|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
128774640|NCT01370603|463466623|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
128774641|NCT01370603|463466622|FG000|Period 2|Adverse Event|1|||
128774642|NCT01370603|463466623|FG001|Period 2|Adverse Event|4|||
128774643|NCT01370603|463466622|FG000|Period 2|Lost to Follow-up|1|||
128774644|NCT01370603|463466623|FG001|Period 2|Lost to Follow-up|0|||
129220539|NCT01413204|465108145|FG002|Overall Study|Physician Decision|2|||
128774645|NCT01370603|463466622|FG000|Period 2|Withdrawal by Subject|1|||
128774646|NCT01370603|463466623|FG001|Period 2|Withdrawal by Subject|0|||
128774647|NCT02218489|463466630|FG000|Overall Study|Withdrawal by Subject|4|||
128774648|NCT02218489|463466631|FG001|Overall Study|Withdrawal by Subject|3|||
128774649|NCT02218489|463466630|FG000|Overall Study|Lost to Follow-up|1|||
128774650|NCT02218489|463466631|FG001|Overall Study|Lost to Follow-up|0|||
128774651|NCT05221749|463466632|FG000|Overall Study|Lost to Follow-up|2|||
128774652|NCT05221749|463466633|FG001|Overall Study|Lost to Follow-up|3|||
129220540|NCT01413204|465108143|FG000|Overall Study|Withdrawal by Subject|1|||
129220541|NCT01413204|465108144|FG001|Overall Study|Withdrawal by Subject|4|||
129220542|NCT01413204|465108145|FG002|Overall Study|Withdrawal by Subject|4|||
129220543|NCT01413204|465108143|FG000|Overall Study|Clearly not eligible for the study|0|||
129220544|NCT01413204|465108144|FG001|Overall Study|Clearly not eligible for the study|0|||
128715398|NCT03742037|463255177|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
128715399|NCT03742037|463255178|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
128715400|NCT03742037|463255179|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
128715401|NCT03742037|463255180|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
128715402|NCT03742037|463255181|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
128715403|NCT03742037|463255182|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
128715404|NCT03742037|463255176|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
128715405|NCT03742037|463255177|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
128715406|NCT03742037|463255178|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
128715407|NCT03742037|463255179|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
128715408|NCT03742037|463255180|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
128715409|NCT03742037|463255181|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
128715410|NCT03742037|463255182|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
128715411|NCT03742037|463255176|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
128715412|NCT03742037|463255177|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
128715413|NCT03742037|463255178|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
128715414|NCT03742037|463255179|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
128715415|NCT03742037|463255180|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
128715416|NCT03742037|463255181|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
128715417|NCT03742037|463255182|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
128715418|NCT03742037|463255176|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
128715419|NCT03742037|463255177|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
128715420|NCT03742037|463255178|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
128715421|NCT03742037|463255179|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
128715422|NCT03742037|463255180|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
128715423|NCT03742037|463255181|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
128715424|NCT03742037|463255182|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
128715425|NCT04447755|463255183|FG000|Overall Study|Death|9|||
128715426|NCT04447755|463255184|FG001|Overall Study|Death|16|||
128715427|NCT04447755|463255185|FG002|Overall Study|Death|8|||
128715428|NCT04447755|463255186|FG003|Overall Study|Death|9|||
128715429|NCT04447755|463255187|FG004|Overall Study|Death|8|||
128715430|NCT04447755|463255188|FG005|Overall Study|Death|9|||
128715431|NCT04447755|463255189|FG006|Overall Study|Death|55|||
128715432|NCT04447755|463255183|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128774653|NCT02404493|463466634|FG000|Overall Study|Adverse Event|1|||
128774654|NCT02404493|463466635|FG001|Overall Study|Adverse Event|1|||
128774655|NCT02388074|463466636|FG000|Overall Study|Lost in Transit|2|||
128774656|NCT02388074|463466636|FG000|Overall Study|Sample Not Returned|1|||
129220545|NCT01413204|465108145|FG002|Overall Study|Clearly not eligible for the study|1|||
128774657|NCT00003458|463466639|FG000|Overall Study|Not evaluable|4|||
128774658|NCT02133924|463466640|FG000|Overall Study|Death|38|||
128774659|NCT02133924|463466640|FG000|Overall Study|Physician Decision|1|||
128774660|NCT02133924|463466640|FG000|Overall Study|Withdrawal by Subject|3|||
128774661|NCT01254890|463466641|FG000|Overall Study|Ineligible|0|||
128774662|NCT01254890|463466642|FG001|Overall Study|Ineligible|3|||
128774663|NCT01254890|463466641|FG000|Overall Study|Withdrawal by Subject|1|||
128774664|NCT01254890|463466642|FG001|Overall Study|Withdrawal by Subject|2|||
128774665|NCT01254890|463466641|FG000|Overall Study|Disease Progression|0|||
128774666|NCT01254890|463466642|FG001|Overall Study|Disease Progression|5|||
128774667|NCT04039503|463466647|FG000|Overall Study|Adverse Event|3|||
128774668|NCT04039503|463466648|FG001|Overall Study|Adverse Event|0|||
128774669|NCT04039503|463466649|FG002|Overall Study|Adverse Event|2|||
128774670|NCT04039503|463466650|FG003|Overall Study|Adverse Event|0|||
128774671|NCT04039503|463466647|FG000|Overall Study|Lost to Follow-up|0|||
128774672|NCT04039503|463466648|FG001|Overall Study|Lost to Follow-up|0|||
128774673|NCT04039503|463466649|FG002|Overall Study|Lost to Follow-up|1|||
128774674|NCT04039503|463466650|FG003|Overall Study|Lost to Follow-up|0|||
128774675|NCT04039503|463466647|FG000|Overall Study|Protocol Violation|0|||
128774676|NCT04039503|463466648|FG001|Overall Study|Protocol Violation|1|||
128774677|NCT04039503|463466649|FG002|Overall Study|Protocol Violation|2|||
128774678|NCT04039503|463466650|FG003|Overall Study|Protocol Violation|1|||
128774679|NCT04039503|463466647|FG000|Overall Study|Withdrawal by Subject|4|||
128774680|NCT04039503|463466648|FG001|Overall Study|Withdrawal by Subject|3|||
128774681|NCT04039503|463466649|FG002|Overall Study|Withdrawal by Subject|5|||
128774682|NCT04039503|463466650|FG003|Overall Study|Withdrawal by Subject|2|||
128774683|NCT04157686|463466652|FG000|Overall Study|Adverse Event|1|||
128774684|NCT04157686|463466653|FG001|Overall Study|Adverse Event|0|||
128774685|NCT04157686|463466654|FG002|Overall Study|Adverse Event|1|||
128774686|NCT04157686|463466655|FG003|Overall Study|Adverse Event|0|||
128774687|NCT04157686|463466656|FG004|Overall Study|Adverse Event|1|||
128774688|NCT04157686|463466657|FG005|Overall Study|Adverse Event|0|||
128774689|NCT04157686|463466658|FG006|Overall Study|Adverse Event|0|||
128774690|NCT04157686|463466659|FG007|Overall Study|Adverse Event|0|||
128774691|NCT04157686|463466652|FG000|Overall Study|Pregnancy|0|||
128774692|NCT04157686|463466653|FG001|Overall Study|Pregnancy|1|||
128774693|NCT04157686|463466654|FG002|Overall Study|Pregnancy|3|||
128715433|NCT04447755|463255184|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
128715434|NCT04447755|463255185|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128715435|NCT04447755|463255186|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128715436|NCT04447755|463255187|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
128715437|NCT04447755|463255188|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
128715438|NCT04447755|463255189|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
128715439|NCT04447755|463255183|FG000|Overall Study|Sponsor Decision|0|||
128715440|NCT04447755|463255184|FG001|Overall Study|Sponsor Decision|0|||
128715441|NCT04447755|463255185|FG002|Overall Study|Sponsor Decision|0|||
128715442|NCT04447755|463255186|FG003|Overall Study|Sponsor Decision|0|||
128715443|NCT04447755|463255187|FG004|Overall Study|Sponsor Decision|1|||
128715444|NCT04447755|463255188|FG005|Overall Study|Sponsor Decision|0|||
128715445|NCT04447755|463255189|FG006|Overall Study|Sponsor Decision|10|||
128715446|NCT04447755|463255183|FG000|Overall Study|Lost to Follow-up|0|||
128715447|NCT04447755|463255184|FG001|Overall Study|Lost to Follow-up|0|||
128715448|NCT04447755|463255185|FG002|Overall Study|Lost to Follow-up|0|||
128715449|NCT04447755|463255186|FG003|Overall Study|Lost to Follow-up|0|||
128715450|NCT04447755|463255187|FG004|Overall Study|Lost to Follow-up|0|||
128715451|NCT04447755|463255188|FG005|Overall Study|Lost to Follow-up|0|||
128715452|NCT04447755|463255189|FG006|Overall Study|Lost to Follow-up|1|||
128715453|NCT02375113|463255192|FG000|Overall Study|Undisclosed Reason(s).|1|||
128715454|NCT02375113|463255193|FG001|Overall Study|Undisclosed Reason(s).|1|||
128715455|NCT02375113|463255192|FG000|Overall Study|Poor adherence (<70%).|1|||
128715456|NCT02375113|463255193|FG001|Overall Study|Poor adherence (<70%).|0|||
128715457|NCT02375113|463255192|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
128715458|NCT02375113|463255193|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
128715459|NCT04387435|463255207|FG000|Overall Study|Physician Decision|1|||
128715460|NCT03855280|463255208|FG000|Treatment Phase|Adverse Event|1|||
128715461|NCT03855280|463255208|FG000|Treatment Phase|Withdrawal by Subject|1|||
128715462|NCT03855280|463255208|FG000|Continuation Phase|Protocol Violation|1|||
128774694|NCT04157686|463466655|FG003|Overall Study|Pregnancy|0|||
128774695|NCT04157686|463466656|FG004|Overall Study|Pregnancy|0|||
128774696|NCT04157686|463466657|FG005|Overall Study|Pregnancy|0|||
128774697|NCT04157686|463466658|FG006|Overall Study|Pregnancy|3|||
128715463|NCT03855280|463255208|FG000|Continuation Phase|Adverse Event|1|||
128715464|NCT03855280|463255208|FG000|Continuation Phase|Sponsor Concluded Study|1|||
128715465|NCT03338855|463255209|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
128715466|NCT03338855|463255210|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
128715467|NCT00511667|463255211|FG000|Overall Study|Adverse Event|1|||
128715468|NCT00511667|463255212|FG001|Overall Study|Adverse Event|0|||
128715469|NCT00511667|463255211|FG000|Overall Study|Protocol Violation|1|||
128774698|NCT04157686|463466659|FG007|Overall Study|Pregnancy|0|||
128774699|NCT04157686|463466652|FG000|Overall Study|Lost to Follow-up|1|||
128774700|NCT04157686|463466653|FG001|Overall Study|Lost to Follow-up|2|||
128774701|NCT04157686|463466654|FG002|Overall Study|Lost to Follow-up|8|||
128774702|NCT04157686|463466655|FG003|Overall Study|Lost to Follow-up|6|||
128774703|NCT04157686|463466656|FG004|Overall Study|Lost to Follow-up|6|||
128774704|NCT04157686|463466657|FG005|Overall Study|Lost to Follow-up|3|||
128774705|NCT04157686|463466658|FG006|Overall Study|Lost to Follow-up|7|||
128774706|NCT04157686|463466659|FG007|Overall Study|Lost to Follow-up|9|||
128774707|NCT04157686|463466652|FG000|Overall Study|Lack of Efficacy|0|||
128774708|NCT04157686|463466653|FG001|Overall Study|Lack of Efficacy|0|||
128774709|NCT04157686|463466654|FG002|Overall Study|Lack of Efficacy|0|||
128774710|NCT04157686|463466655|FG003|Overall Study|Lack of Efficacy|0|||
128774711|NCT04157686|463466656|FG004|Overall Study|Lack of Efficacy|0|||
128774712|NCT04157686|463466657|FG005|Overall Study|Lack of Efficacy|2|||
128774713|NCT04157686|463466658|FG006|Overall Study|Lack of Efficacy|0|||
128774714|NCT04157686|463466659|FG007|Overall Study|Lack of Efficacy|1|||
128774715|NCT04157686|463466652|FG000|Overall Study|Withdrawal by Subject|10|||
128774716|NCT04157686|463466653|FG001|Overall Study|Withdrawal by Subject|10|||
128774717|NCT04157686|463466654|FG002|Overall Study|Withdrawal by Subject|12|||
128715470|NCT00511667|463255212|FG001|Overall Study|Protocol Violation|1|||
128715471|NCT00511667|463255211|FG000|Overall Study|Withdrawal by Subject|2|||
128715472|NCT00511667|463255212|FG001|Overall Study|Withdrawal by Subject|0|||
128715473|NCT00511667|463255211|FG000|Overall Study|Site terminated|6|||
128715474|NCT00511667|463255212|FG001|Overall Study|Site terminated|1|||
128715475|NCT00511667|463255211|FG000|Overall Study|Other|2|||
128715476|NCT00511667|463255212|FG001|Overall Study|Other|1|||
128715477|NCT01026792|463255213|FG000|Overall Study|Protocol Violation|1|||
128715478|NCT00423150|463255214|FG000|Overall Study|Adverse Event|11|||
128715479|NCT00423150|463255214|FG000|Overall Study|Progression of disease being studied|69|||
128715480|NCT00423150|463255214|FG000|Overall Study|Withdrawal by Subject|1|||
128715481|NCT00423150|463255214|FG000|Overall Study|Non-compliance with protocol|1|||
128715482|NCT00423150|463255214|FG000|Overall Study|Administrative|4|||
128715483|NCT03204305|463255215|FG000|Overall Study|Lost to Follow-up|6|||
128715484|NCT03204305|463255216|FG001|Overall Study|Lost to Follow-up|4|||
128715485|NCT03204305|463255217|FG002|Overall Study|Lost to Follow-up|0|||
128715486|NCT03204305|463255218|FG003|Overall Study|Lost to Follow-up|0|||
128715487|NCT03204305|463255215|FG000|Overall Study|Physician Decision|1|||
128715488|NCT03204305|463255216|FG001|Overall Study|Physician Decision|0|||
128715489|NCT03204305|463255217|FG002|Overall Study|Physician Decision|0|||
128715490|NCT03204305|463255218|FG003|Overall Study|Physician Decision|0|||
128715491|NCT03204305|463255215|FG000|Overall Study|failure to place arterial line|2|||
128715492|NCT03204305|463255216|FG001|Overall Study|failure to place arterial line|1|||
128715493|NCT03204305|463255217|FG002|Overall Study|failure to place arterial line|0|||
128715494|NCT03204305|463255218|FG003|Overall Study|failure to place arterial line|0|||
128715495|NCT03204305|463255215|FG000|Overall Study|Withdrawal by Subject|2|||
128715496|NCT03204305|463255216|FG001|Overall Study|Withdrawal by Subject|0|||
128715497|NCT03204305|463255217|FG002|Overall Study|Withdrawal by Subject|0|||
128715498|NCT03204305|463255218|FG003|Overall Study|Withdrawal by Subject|0|||
128715499|NCT02335099|463255219|FG000|Treatment|Withdrawal by Subject|1|||
128715500|NCT02335099|463255220|FG001|Treatment|Withdrawal by Subject|3|||
128715501|NCT02335099|463255219|FG000|Treatment|Lost to Follow-up|2|||
128715502|NCT02335099|463255220|FG001|Treatment|Lost to Follow-up|0|||
128715503|NCT02335099|463255219|FG000|Treatment|Death|1|||
128715504|NCT02335099|463255220|FG001|Treatment|Death|0|||
128715505|NCT02335099|463255219|FG000|Treatment|Adverse Event|1|||
128715506|NCT02335099|463255220|FG001|Treatment|Adverse Event|2|||
128715507|NCT02335099|463255219|FG000|Follow-up|Death|0|||
128715508|NCT02335099|463255220|FG001|Follow-up|Death|1|||
128715509|NCT02045797|463255221|FG000|Overall Study|Adverse Event|3|||
128715510|NCT02045797|463255222|FG001|Overall Study|Adverse Event|1|||
128715511|NCT02045797|463255223|FG002|Overall Study|Adverse Event|0|||
128715512|NCT02045797|463255221|FG000|Overall Study|Lack of Efficacy|1|||
128715513|NCT02045797|463255222|FG001|Overall Study|Lack of Efficacy|0|||
128715514|NCT02045797|463255223|FG002|Overall Study|Lack of Efficacy|0|||
128715515|NCT02045797|463255221|FG000|Overall Study|Lost to Follow-up|2|||
128715516|NCT02045797|463255222|FG001|Overall Study|Lost to Follow-up|3|||
128715517|NCT02045797|463255223|FG002|Overall Study|Lost to Follow-up|1|||
128715518|NCT02045797|463255221|FG000|Overall Study|Physician Decision|0|||
128715519|NCT02045797|463255222|FG001|Overall Study|Physician Decision|1|||
128715520|NCT02045797|463255223|FG002|Overall Study|Physician Decision|0|||
128715521|NCT02045797|463255221|FG000|Overall Study|Withdrawal by Subject|1|||
128715522|NCT02045797|463255222|FG001|Overall Study|Withdrawal by Subject|2|||
129131139|NCT02827708|464772753|FG001|Overall Study|Death|2|||
129131140|NCT01137812|464772754|FG000|Overall Study|Adverse Event|21|||
129131141|NCT01137812|464772755|FG001|Overall Study|Adverse Event|14|||
129131142|NCT01137812|464772754|FG000|Overall Study|Lost to Follow-up|6|||
129131143|NCT01137812|464772755|FG001|Overall Study|Lost to Follow-up|8|||
129131144|NCT01137812|464772754|FG000|Overall Study|Physician Decision|25|||
129131145|NCT01137812|464772755|FG001|Overall Study|Physician Decision|17|||
129131146|NCT01137812|464772754|FG000|Overall Study|Protocol Violation|5|||
129131147|NCT01137812|464772755|FG001|Overall Study|Protocol Violation|4|||
129131148|NCT01137812|464772754|FG000|Overall Study|Withdrawal by Subject|5|||
128715523|NCT02045797|463255223|FG002|Overall Study|Withdrawal by Subject|0|||
128774718|NCT04157686|463466655|FG003|Overall Study|Withdrawal by Subject|20|||
128971484|NCT04083781|464179613|FG003|Extension Part|Physician Decision|1|||
128971485|NCT04083781|464179610|FG000|Extension Part|Death|0|||
128971486|NCT04083781|464179611|FG001|Extension Part|Death|1|||
128971487|NCT04083781|464179612|FG002|Extension Part|Death|0|||
128971488|NCT04083781|464179613|FG003|Extension Part|Death|1|||
128971489|NCT04083781|464179610|FG000|Extension Part|Withdrawal by Subject|0|||
128971490|NCT04083781|464179611|FG001|Extension Part|Withdrawal by Subject|1|||
128971491|NCT04083781|464179612|FG002|Extension Part|Withdrawal by Subject|0|||
128971492|NCT04083781|464179613|FG003|Extension Part|Withdrawal by Subject|0|||
128971493|NCT04083781|464179610|FG000|Extension Part|Ongoing|13|||
128971494|NCT04083781|464179611|FG001|Extension Part|Ongoing|25|||
128971495|NCT04083781|464179612|FG002|Extension Part|Ongoing|15|||
128971496|NCT04083781|464179613|FG003|Extension Part|Ongoing|51|||
128971497|NCT05245071|464179614|FG000|Overall Study|Progressive disease|18|||
128971498|NCT05245071|464179614|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
128971499|NCT05245071|464179614|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
128971500|NCT05304611|464179615|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971501|NCT05304611|464179616|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971502|NCT05304611|464179617|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971503|NCT05304611|464179618|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971504|NCT05304611|464179619|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971505|NCT05304611|464179620|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971506|NCT05304611|464179621|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
128971507|NCT05304611|464179622|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971508|NCT05304611|464179623|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
128971509|NCT05304611|464179624|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971510|NCT05304611|464179625|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971511|NCT05304611|464179626|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
128971512|NCT05304611|464179615|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
128971513|NCT05304611|464179616|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
128971514|NCT05304611|464179617|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
128971515|NCT05304611|464179618|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
128971516|NCT05304611|464179619|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
128971517|NCT05304611|464179620|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
128971518|NCT05304611|464179621|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
128971519|NCT05304611|464179622|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
128971520|NCT05304611|464179623|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
128971521|NCT05304611|464179624|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
128971522|NCT05304611|464179625|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
128971523|NCT05304611|464179626|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
128971524|NCT05304611|464179615|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
129131149|NCT01137812|464772755|FG001|Overall Study|Withdrawal by Subject|13|||
129131150|NCT01137812|464772754|FG000|Overall Study|Death|2|||
129131151|NCT01137812|464772755|FG001|Overall Study|Death|0|||
129131152|NCT01137812|464772754|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
129131153|NCT01137812|464772755|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
129131154|NCT01137812|464772754|FG000|Overall Study|Other|19|||
129131155|NCT01137812|464772755|FG001|Overall Study|Other|27|||
129131156|NCT04621760|464772759|FG000|Overall Study|Lost to Follow-up|2|||
129131157|NCT04621760|464772760|FG001|Overall Study|Lost to Follow-up|4|||
129131158|NCT04621760|464772759|FG000|Overall Study|Withdrawal by Subject|1|||
129131159|NCT04621760|464772760|FG001|Overall Study|Withdrawal by Subject|0|||
129131160|NCT04602000|464772763|FG000|Overall Study|Withdrawal by Subject|3|||
129131161|NCT04602000|464772764|FG001|Overall Study|Withdrawal by Subject|6|||
129131162|NCT04602000|464772765|FG002|Overall Study|Withdrawal by Subject|3|||
129131163|NCT04602000|464772766|FG003|Overall Study|Withdrawal by Subject|27|||
129131164|NCT04602000|464772767|FG004|Overall Study|Withdrawal by Subject|39|||
129131165|NCT04602000|464772763|FG000|Overall Study|Physician Decision|1|||
129131166|NCT04602000|464772764|FG001|Overall Study|Physician Decision|0|||
129131167|NCT04602000|464772765|FG002|Overall Study|Physician Decision|0|||
129131168|NCT04602000|464772766|FG003|Overall Study|Physician Decision|2|||
129131169|NCT04602000|464772767|FG004|Overall Study|Physician Decision|2|||
129131170|NCT04602000|464772763|FG000|Overall Study|Death|0|||
129131171|NCT04602000|464772764|FG001|Overall Study|Death|1|||
129131172|NCT04602000|464772765|FG002|Overall Study|Death|0|||
128971525|NCT05304611|464179616|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
128971526|NCT05304611|464179617|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
128971527|NCT05304611|464179618|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
129131173|NCT04602000|464772766|FG003|Overall Study|Death|1|||
128971528|NCT05304611|464179619|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
128971529|NCT05304611|464179620|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
128971530|NCT05304611|464179621|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
128971531|NCT05304611|464179622|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
128971532|NCT05304611|464179623|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
129131174|NCT04602000|464772767|FG004|Overall Study|Death|2|||
129220546|NCT01413204|465108143|FG000|Overall Study|Fasting plasma glucose level increased|1|||
129131175|NCT04602000|464772763|FG000|Overall Study|Lost to Follow-up|0|||
129131176|NCT04602000|464772764|FG001|Overall Study|Lost to Follow-up|0|||
129131177|NCT04602000|464772765|FG002|Overall Study|Lost to Follow-up|0|||
128971533|NCT05304611|464179624|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
128971534|NCT05304611|464179625|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
128971535|NCT05304611|464179626|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
128971536|NCT02354690|464179627|FG000|Overall Study|Physician Decision|1|||
128971537|NCT00963820|464179628|FG000|Dose Escalation Phase|Progressive Disease|3|||
128971538|NCT00963820|464179629|FG001|Dose Escalation Phase|Progressive Disease|3|||
128971539|NCT00963820|464179630|FG002|Dose Escalation Phase|Progressive Disease|3|||
128971540|NCT00963820|464179631|FG003|Dose Escalation Phase|Progressive Disease|3|||
128971541|NCT00963820|464179632|FG004|Dose Escalation Phase|Progressive Disease|4|||
128971542|NCT00963820|464179633|FG005|Dose Escalation Phase|Progressive Disease|3|||
128971543|NCT00963820|464179634|FG006|Dose Escalation Phase|Progressive Disease|3|||
128971544|NCT00963820|464179635|FG007|Dose Escalation Phase|Progressive Disease|2|||
128971545|NCT00963820|464179636|FG008|Dose Escalation Phase|Progressive Disease|0|||
128971546|NCT00963820|464179637|FG009|Dose Escalation Phase|Progressive Disease|0|||
128971547|NCT00963820|464179638|FG010|Dose Escalation Phase|Progressive Disease|0|||
128971548|NCT00963820|464179639|FG011|Dose Escalation Phase|Progressive Disease|0|||
128971549|NCT00963820|464179628|FG000|Dose Escalation Phase|Adverse Event|0|||
128971550|NCT00963820|464179629|FG001|Dose Escalation Phase|Adverse Event|0|||
128971551|NCT00963820|464179630|FG002|Dose Escalation Phase|Adverse Event|0|||
128971552|NCT00963820|464179631|FG003|Dose Escalation Phase|Adverse Event|0|||
128971553|NCT00963820|464179632|FG004|Dose Escalation Phase|Adverse Event|0|||
128971554|NCT00963820|464179633|FG005|Dose Escalation Phase|Adverse Event|0|||
128971555|NCT00963820|464179634|FG006|Dose Escalation Phase|Adverse Event|3|||
128971556|NCT00963820|464179635|FG007|Dose Escalation Phase|Adverse Event|1|||
128971557|NCT00963820|464179636|FG008|Dose Escalation Phase|Adverse Event|0|||
128971558|NCT00963820|464179637|FG009|Dose Escalation Phase|Adverse Event|0|||
128971559|NCT00963820|464179638|FG010|Dose Escalation Phase|Adverse Event|0|||
128971560|NCT00963820|464179639|FG011|Dose Escalation Phase|Adverse Event|0|||
128971561|NCT00963820|464179628|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
128971562|NCT00963820|464179629|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
128971563|NCT00963820|464179630|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
128971564|NCT00963820|464179631|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
128971565|NCT00963820|464179632|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
128971566|NCT00963820|464179633|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
128971567|NCT00963820|464179634|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
128971568|NCT00963820|464179635|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
128971569|NCT00963820|464179636|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
128971570|NCT00963820|464179637|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
128971571|NCT00963820|464179638|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
128971572|NCT00963820|464179639|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
128971573|NCT00963820|464179628|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971574|NCT00963820|464179629|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971575|NCT00963820|464179630|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971576|NCT00963820|464179631|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971577|NCT00963820|464179632|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971578|NCT00963820|464179633|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971579|NCT00963820|464179634|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
128971580|NCT00963820|464179635|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971581|NCT00963820|464179636|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971582|NCT00963820|464179637|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971583|NCT00963820|464179638|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971584|NCT00963820|464179639|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
128971585|NCT00963820|464179628|FG000|Expansion Phase|Progressive Disease|0|||
128971586|NCT00963820|464179629|FG001|Expansion Phase|Progressive Disease|0|||
128971587|NCT00963820|464179630|FG002|Expansion Phase|Progressive Disease|0|||
128971588|NCT00963820|464179631|FG003|Expansion Phase|Progressive Disease|0|||
128971589|NCT00963820|464179632|FG004|Expansion Phase|Progressive Disease|0|||
129131178|NCT04602000|464772766|FG003|Overall Study|Lost to Follow-up|3|||
128971590|NCT00963820|464179633|FG005|Expansion Phase|Progressive Disease|0|||
128971591|NCT00963820|464179634|FG006|Expansion Phase|Progressive Disease|0|||
128971592|NCT00963820|464179635|FG007|Expansion Phase|Progressive Disease|0|||
128971593|NCT00963820|464179636|FG008|Expansion Phase|Progressive Disease|8|||
128971594|NCT00963820|464179637|FG009|Expansion Phase|Progressive Disease|6|||
128971595|NCT00963820|464179638|FG010|Expansion Phase|Progressive Disease|4|||
128971596|NCT00963820|464179639|FG011|Expansion Phase|Progressive Disease|2|||
129131179|NCT04602000|464772767|FG004|Overall Study|Lost to Follow-up|4|||
129131180|NCT04602000|464772763|FG000|Overall Study|Other|4|||
128971597|NCT00963820|464179628|FG000|Expansion Phase|Adverse Event|0|||
128971598|NCT00963820|464179629|FG001|Expansion Phase|Adverse Event|0|||
129131181|NCT04602000|464772764|FG001|Overall Study|Other|1|||
128971599|NCT00963820|464179630|FG002|Expansion Phase|Adverse Event|0|||
128971600|NCT00963820|464179631|FG003|Expansion Phase|Adverse Event|0|||
128971601|NCT00963820|464179632|FG004|Expansion Phase|Adverse Event|0|||
128971602|NCT00963820|464179633|FG005|Expansion Phase|Adverse Event|0|||
128971603|NCT00963820|464179634|FG006|Expansion Phase|Adverse Event|0|||
128971604|NCT00963820|464179635|FG007|Expansion Phase|Adverse Event|0|||
128971605|NCT00963820|464179636|FG008|Expansion Phase|Adverse Event|1|||
128971606|NCT00963820|464179637|FG009|Expansion Phase|Adverse Event|3|||
128971607|NCT00963820|464179638|FG010|Expansion Phase|Adverse Event|0|||
128971608|NCT00963820|464179639|FG011|Expansion Phase|Adverse Event|0|||
128971609|NCT00963820|464179628|FG000|Expansion Phase|Withdrawal by Subject|0|||
128971610|NCT00963820|464179629|FG001|Expansion Phase|Withdrawal by Subject|0|||
128971611|NCT00963820|464179630|FG002|Expansion Phase|Withdrawal by Subject|0|||
128971612|NCT00963820|464179631|FG003|Expansion Phase|Withdrawal by Subject|0|||
128971613|NCT00963820|464179632|FG004|Expansion Phase|Withdrawal by Subject|0|||
128971614|NCT00963820|464179633|FG005|Expansion Phase|Withdrawal by Subject|0|||
128971615|NCT00963820|464179634|FG006|Expansion Phase|Withdrawal by Subject|0|||
128971616|NCT00963820|464179635|FG007|Expansion Phase|Withdrawal by Subject|0|||
128971617|NCT00963820|464179636|FG008|Expansion Phase|Withdrawal by Subject|1|||
128971618|NCT00963820|464179637|FG009|Expansion Phase|Withdrawal by Subject|0|||
128971619|NCT00963820|464179638|FG010|Expansion Phase|Withdrawal by Subject|1|||
128971620|NCT00963820|464179639|FG011|Expansion Phase|Withdrawal by Subject|1|||
128971621|NCT00963820|464179628|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971622|NCT00963820|464179629|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971623|NCT00963820|464179630|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971624|NCT00963820|464179631|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971625|NCT00963820|464179632|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971626|NCT00963820|464179633|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971627|NCT00963820|464179634|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971628|NCT00963820|464179635|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971629|NCT00963820|464179636|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971630|NCT00963820|464179637|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971631|NCT00963820|464179638|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
128971632|NCT00963820|464179639|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
128971633|NCT05549505|464179647|FG000|Overall Study|Lost to Follow-up|2|||
128971634|NCT05549505|464179648|FG001|Overall Study|Lost to Follow-up|0|||
128971635|NCT05549505|464179647|FG000|Overall Study|Withdrawal by Subject|3|||
128971636|NCT05549505|464179648|FG001|Overall Study|Withdrawal by Subject|3|||
128971637|NCT05549505|464179647|FG000|Overall Study|Other: Miscellaneous|3|||
128971638|NCT05549505|464179648|FG001|Overall Study|Other: Miscellaneous|6|||
128971639|NCT01602822|464179651|FG000|Overall Study|Adverse Event|11|||
128971640|NCT05492877|464179655|FG000|Overall Study|Adverse Event|11|||
128971641|NCT05492877|464179656|FG001|Overall Study|Adverse Event|7|||
128971642|NCT05492877|464179655|FG000|Overall Study|Death|1|||
128971643|NCT05492877|464179656|FG001|Overall Study|Death|0|||
128971644|NCT05492877|464179655|FG000|Overall Study|Lost to Follow-up|1|||
128971645|NCT05492877|464179656|FG001|Overall Study|Lost to Follow-up|1|||
128971646|NCT05492877|464179655|FG000|Overall Study|Physician Decision|1|||
128971647|NCT05492877|464179656|FG001|Overall Study|Physician Decision|2|||
128971648|NCT05492877|464179655|FG000|Overall Study|Protocol Violation|1|||
128971649|NCT05492877|464179656|FG001|Overall Study|Protocol Violation|1|||
128971650|NCT05492877|464179655|FG000|Overall Study|Withdrawal by Subject|3|||
128971651|NCT05492877|464179656|FG001|Overall Study|Withdrawal by Subject|7|||
128971652|NCT05492877|464179655|FG000|Overall Study|Reason not specified|6|||
128971653|NCT05492877|464179656|FG001|Overall Study|Reason not specified|4|||
128971654|NCT02286089|464179657|FG000|Overall Study|Ongoing in Study|1|||
128971655|NCT02286089|464179658|FG001|Overall Study|Ongoing in Study|1|||
128971656|NCT02286089|464179659|FG002|Overall Study|Ongoing in Study|4|||
128971657|NCT02286089|464179660|FG003|Overall Study|Ongoing in Study|10|||
128971658|NCT02286089|464179657|FG000|Overall Study|Withdrawal by Subject|0|||
128971659|NCT02286089|464179658|FG001|Overall Study|Withdrawal by Subject|0|||
128971660|NCT02286089|464179659|FG002|Overall Study|Withdrawal by Subject|2|||
128971661|NCT02286089|464179660|FG003|Overall Study|Withdrawal by Subject|2|||
128971662|NCT00129376|464179661|FG000|Overall Study|Adverse Event|1|||
128971663|NCT00129376|464179661|FG000|Overall Study|Lack of Efficacy|1|||
128971664|NCT03218826|464179662|FG000|Overall Study|Non-compliance with protocol|1|||
128971665|NCT03218826|464179663|FG001|Overall Study|Non-compliance with protocol|0|||
128971666|NCT03218826|464179664|FG002|Overall Study|Non-compliance with protocol|2|||
128971667|NCT03218826|464179665|FG003|Overall Study|Non-compliance with protocol|1|||
128971668|NCT03218826|464179666|FG004|Overall Study|Non-compliance with protocol|1|||
128971669|NCT01426009|464179667|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
128971670|NCT01426009|464179667|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
128971671|NCT01426009|464179667|FG000|Washout 1|Withdrawal by Subject|1|||
128971672|NCT01426009|464179667|FG000|Washout 1|Personal Reasons|1|||
128971673|NCT01426009|464179667|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
129220547|NCT01413204|465108144|FG001|Overall Study|Fasting plasma glucose level increased|0|||
129220548|NCT01413204|465108145|FG002|Overall Study|Fasting plasma glucose level increased|10|||
129220549|NCT01039376|465108146|FG000|Overall Study|Lost to Follow-up|5|||
129220550|NCT01039376|465108147|FG001|Overall Study|Lost to Follow-up|12|||
129220551|NCT01039376|465108146|FG000|Overall Study|Physician Decision|15|||
129220552|NCT01039376|465108147|FG001|Overall Study|Physician Decision|10|||
129220553|NCT01039376|465108146|FG000|Overall Study|Withdrawal by Subject|20|||
129220554|NCT01039376|465108147|FG001|Overall Study|Withdrawal by Subject|32|||
129220555|NCT01039376|465108146|FG000|Overall Study|Study terminated by Sponsor|90|||
129220556|NCT01039376|465108147|FG001|Overall Study|Study terminated by Sponsor|72|||
129220557|NCT04555616|465108148|FG000|Overall Study|Death|1|||
129220558|NCT04555616|465108149|FG001|Overall Study|Death|0|||
129220559|NCT04555616|465108150|FG002|Overall Study|Death|1|||
129220560|NCT04555616|465108148|FG000|Overall Study|Withdrawal by Subject|2|||
129220561|NCT04555616|465108149|FG001|Overall Study|Withdrawal by Subject|1|||
129220562|NCT04555616|465108150|FG002|Overall Study|Withdrawal by Subject|0|||
129220563|NCT04816669|465108151|FG000|Part 1|Adverse Event|1|||
129220564|NCT04816669|465108152|FG001|Part 1|Adverse Event|1|||
129220565|NCT04816669|465108153|FG002|Part 1|Adverse Event|0|||
129220566|NCT04816669|465108154|FG003|Part 1|Adverse Event|0|||
129220567|NCT04816669|465108151|FG000|Part 1|Lost to Follow-up|2|||
129220568|NCT04816669|465108152|FG001|Part 1|Lost to Follow-up|2|||
129220569|NCT04816669|465108153|FG002|Part 1|Lost to Follow-up|0|||
129220570|NCT04816669|465108154|FG003|Part 1|Lost to Follow-up|0|||
129220571|NCT04816669|465108151|FG000|Part 1|Protocol Violation|0|||
129220572|NCT04816669|465108152|FG001|Part 1|Protocol Violation|1|||
129220573|NCT04816669|465108153|FG002|Part 1|Protocol Violation|0|||
129220574|NCT04816669|465108154|FG003|Part 1|Protocol Violation|0|||
129220575|NCT04816669|465108151|FG000|Part 1|Withdrawal by Subject|1|||
129220576|NCT04816669|465108152|FG001|Part 1|Withdrawal by Subject|2|||
129220577|NCT04816669|465108153|FG002|Part 1|Withdrawal by Subject|0|||
129220578|NCT04816669|465108154|FG003|Part 1|Withdrawal by Subject|0|||
129220579|NCT04816669|465108151|FG000|Part 2|Other|0|||
129220580|NCT04816669|465108152|FG001|Part 2|Other|0|||
129220581|NCT04816669|465108153|FG002|Part 2|Other|1|||
129220582|NCT04816669|465108154|FG003|Part 2|Other|0|||
129220583|NCT04816669|465108151|FG000|Part 2|Withdrawal by Subject|0|||
129220584|NCT04816669|465108152|FG001|Part 2|Withdrawal by Subject|0|||
129220585|NCT04816669|465108153|FG002|Part 2|Withdrawal by Subject|0|||
129220586|NCT04816669|465108154|FG003|Part 2|Withdrawal by Subject|1|||
129220587|NCT04816669|465108151|FG000|Part 2|Lost to Follow-up|0|||
129220588|NCT04816669|465108152|FG001|Part 2|Lost to Follow-up|0|||
129220589|NCT04816669|465108153|FG002|Part 2|Lost to Follow-up|1|||
129220590|NCT04816669|465108154|FG003|Part 2|Lost to Follow-up|0|||
129220591|NCT02446899|465108157|FG000|Overall Study|Adverse Event|4|||
129220592|NCT02446899|465108158|FG001|Overall Study|Adverse Event|7|||
129220593|NCT02446899|465108157|FG000|Overall Study|Condition Under Investigation Worsened|1|||
128715524|NCT00484939|463255226|FG000|Overall Study|Death|9|||
129220594|NCT02446899|465108158|FG001|Overall Study|Condition Under Investigation Worsened|4|||
129220595|NCT02446899|465108157|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
129220596|NCT02446899|465108158|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
129220597|NCT02446899|465108157|FG000|Overall Study|Lack of Efficacy|2|||
129220598|NCT02446899|465108158|FG001|Overall Study|Lack of Efficacy|8|||
129220599|NCT02446899|465108157|FG000|Overall Study|Lost to Follow-up|1|||
129220600|NCT02446899|465108158|FG001|Overall Study|Lost to Follow-up|3|||
129220601|NCT02446899|465108157|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
129220602|NCT02446899|465108158|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
128715525|NCT00484939|463255227|FG001|Overall Study|Death|13|||
128715526|NCT00484939|463255226|FG000|Overall Study|Adverse Event|22|||
128715527|NCT00484939|463255227|FG001|Overall Study|Adverse Event|12|||
128715528|NCT00484939|463255226|FG000|Overall Study|Patient Withdrew Consent|19|||
128715529|NCT00484939|463255227|FG001|Overall Study|Patient Withdrew Consent|10|||
128715530|NCT00484939|463255226|FG000|Overall Study|Protocol Violation|3|||
128715531|NCT00484939|463255227|FG001|Overall Study|Protocol Violation|3|||
128715532|NCT00484939|463255226|FG000|Overall Study|Lost to Follow-up|0|||
128715533|NCT00484939|463255227|FG001|Overall Study|Lost to Follow-up|3|||
128715534|NCT00484939|463255226|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
129220603|NCT02446899|465108157|FG000|Overall Study|Withdrawal by Subject|11|||
128715535|NCT00484939|463255227|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
128715536|NCT00484939|463255226|FG000|Overall Study|Disease progression|67|||
129220604|NCT02446899|465108158|FG001|Overall Study|Withdrawal by Subject|19|||
129220605|NCT02446899|465108157|FG000|Overall Study|Miscellaneous|5|||
129220606|NCT02446899|465108158|FG001|Overall Study|Miscellaneous|4|||
129220607|NCT02446899|465108157|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129220608|NCT02446899|465108158|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
129220609|NCT00742235|465108159|FG000|Overall Study|Lost to Follow-up|0|||
129220610|NCT00742235|465108160|FG001|Overall Study|Lost to Follow-up|31|||
129220611|NCT02194985|465108163|FG000|Overall Study|Adverse Event|1|||
129220612|NCT02194985|465108163|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
129220613|NCT02194985|465108163|FG000|Overall Study|Physician Decision|4|||
129220614|NCT02194985|465108163|FG000|Overall Study|Lost to Follow-up|1|||
129220615|NCT02194985|465108163|FG000|Overall Study|Withdrawal by Subject|2|||
129220616|NCT02561832|465108164|FG000|Overall Study|Withdrawal by Subject|1|||
129220617|NCT02561832|465108165|FG001|Overall Study|Withdrawal by Subject|1|||
128715537|NCT00484939|463255227|FG001|Overall Study|Disease progression|88|||
129220618|NCT02561832|465108164|FG000|Overall Study|Adverse Event|3|||
129220619|NCT02561832|465108165|FG001|Overall Study|Adverse Event|0|||
129220620|NCT02561832|465108164|FG000|Overall Study|Disease progression|3|||
129220621|NCT02561832|465108165|FG001|Overall Study|Disease progression|3|||
129220622|NCT01262989|465108166|FG000|Period 1|Lost to Follow-up|1|||
129220623|NCT01262989|465108167|FG001|Period 1|Lost to Follow-up|1|||
129220624|NCT01262989|465108166|FG000|Period 1|Intercurrent disease|0|||
129220625|NCT01262989|465108167|FG001|Period 1|Intercurrent disease|1|||
129220626|NCT01262989|465108166|FG000|Period 1|Positive answer for exclusion criteria|0|||
129220627|NCT01262989|465108167|FG001|Period 1|Positive answer for exclusion criteria|1|||
129220628|NCT01262989|465108166|FG000|Period 2|Intercurrent disease|0|||
129220629|NCT01262989|465108167|FG001|Period 2|Intercurrent disease|1|||
129220630|NCT03599089|465108168|FG000|Overall Study|Lost to Follow-up|1|||
129220631|NCT03599089|465108169|FG001|Overall Study|Lost to Follow-up|0|||
129131182|NCT04602000|464772765|FG002|Overall Study|Other|2|||
129131183|NCT04602000|464772766|FG003|Overall Study|Other|5|||
129131184|NCT04602000|464772767|FG004|Overall Study|Other|4|||
129131185|NCT04602000|464772763|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129131186|NCT04602000|464772764|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129131187|NCT04602000|464772765|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
129131188|NCT04602000|464772766|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129131189|NCT04602000|464772767|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129131190|NCT00471354|464772768|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
129131191|NCT00471354|464772768|FG000|Overall Study|Adverse Event|13|||
129131192|NCT00471354|464772768|FG000|Overall Study|Protocol Violation|12|||
129131193|NCT00471354|464772768|FG000|Overall Study|Withdrawal by Subject|1|||
129131194|NCT00471354|464772768|FG000|Overall Study|Physician Decision|4|||
129220632|NCT03599089|465108170|FG002|Overall Study|Lost to Follow-up|0|||
129220633|NCT03599089|465108171|FG003|Overall Study|Lost to Follow-up|0|||
129220634|NCT03599089|465108168|FG000|Overall Study|Withdrawal by Subject|2|||
128715538|NCT00484939|463255226|FG000|Overall Study|Screen Failure|2|||
128715539|NCT00484939|463255227|FG001|Overall Study|Screen Failure|2|||
128715540|NCT00484939|463255226|FG000|Overall Study|Reason Not Specified|11|||
128715541|NCT00484939|463255227|FG001|Overall Study|Reason Not Specified|6|||
128715542|NCT00101907|463255231|FG000|Overall Study|Adverse Event|1|||
128715543|NCT00101907|463255232|FG001|Overall Study|Adverse Event|0|||
128715544|NCT00101907|463255233|FG002|Overall Study|Adverse Event|0|||
128715545|NCT00101907|463255234|FG003|Overall Study|Adverse Event|0|||
128715546|NCT00101907|463255235|FG004|Overall Study|Adverse Event|0|||
128715547|NCT00101907|463255236|FG005|Overall Study|Adverse Event|0|||
128715548|NCT00101907|463255231|FG000|Overall Study|Death|0|||
128715549|NCT00101907|463255232|FG001|Overall Study|Death|1|||
128715550|NCT00101907|463255233|FG002|Overall Study|Death|0|||
128715551|NCT00101907|463255234|FG003|Overall Study|Death|0|||
128715552|NCT00101907|463255235|FG004|Overall Study|Death|3|||
128715553|NCT00101907|463255236|FG005|Overall Study|Death|0|||
128715554|NCT00101907|463255231|FG000|Overall Study|Physician Decision|0|||
128715555|NCT00101907|463255232|FG001|Overall Study|Physician Decision|0|||
128715556|NCT00101907|463255233|FG002|Overall Study|Physician Decision|0|||
128715557|NCT00101907|463255234|FG003|Overall Study|Physician Decision|1|||
128715558|NCT00101907|463255235|FG004|Overall Study|Physician Decision|1|||
128715559|NCT00101907|463255236|FG005|Overall Study|Physician Decision|0|||
128715560|NCT00101907|463255231|FG000|Overall Study|Withdrawal by Subject|1|||
128715561|NCT00101907|463255232|FG001|Overall Study|Withdrawal by Subject|0|||
128715562|NCT00101907|463255233|FG002|Overall Study|Withdrawal by Subject|1|||
128715563|NCT00101907|463255234|FG003|Overall Study|Withdrawal by Subject|0|||
128715564|NCT00101907|463255235|FG004|Overall Study|Withdrawal by Subject|1|||
128715565|NCT00101907|463255236|FG005|Overall Study|Withdrawal by Subject|0|||
128715566|NCT01474876|463255239|FG000|Overall Study|Adverse Event|11|||
128715567|NCT01474876|463255240|FG001|Overall Study|Adverse Event|5|||
128715568|NCT01474876|463255241|FG002|Overall Study|Adverse Event|0|||
128715569|NCT01474876|463255239|FG000|Overall Study|Serious Adverse Event|2|||
128715570|NCT01474876|463255240|FG001|Overall Study|Serious Adverse Event|3|||
128715571|NCT01474876|463255241|FG002|Overall Study|Serious Adverse Event|0|||
128715572|NCT01474876|463255239|FG000|Overall Study|Lost to Follow-up|5|||
128971674|NCT01426009|464179667|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
129131195|NCT00471354|464772768|FG000|Overall Study|Sponsor Decision|1|||
129131196|NCT00471354|464772768|FG000|Overall Study|Lost to Follow-up|3|||
129220635|NCT03599089|465108169|FG001|Overall Study|Withdrawal by Subject|1|||
129220636|NCT03599089|465108170|FG002|Overall Study|Withdrawal by Subject|0|||
129220637|NCT03599089|465108171|FG003|Overall Study|Withdrawal by Subject|0|||
128715573|NCT01474876|463255240|FG001|Overall Study|Lost to Follow-up|4|||
129220638|NCT03599089|465108168|FG000|Overall Study|Lack of Efficacy|0|||
129220639|NCT03599089|465108169|FG001|Overall Study|Lack of Efficacy|0|||
129220640|NCT03599089|465108170|FG002|Overall Study|Lack of Efficacy|1|||
129220641|NCT03599089|465108171|FG003|Overall Study|Lack of Efficacy|2|||
129220642|NCT03214666|465108172|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129220643|NCT03214666|465108173|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129220644|NCT03214666|465108174|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129220645|NCT03214666|465108175|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129220646|NCT03214666|465108176|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
129220647|NCT03214666|465108177|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129220648|NCT00470275|465108178|FG000|Overall Study|Death|1|||
129220649|NCT00470275|465108178|FG000|Overall Study|Lack of Efficacy|7|||
129220650|NCT00470275|465108178|FG000|Overall Study|Withdrawal by Subject|2|||
128715574|NCT01474876|463255241|FG002|Overall Study|Lost to Follow-up|0|||
129131197|NCT00471354|464772768|FG000|Overall Study|Lack of Efficacy|5|||
129131198|NCT00471354|464772768|FG000|Overall Study|Patient/Caregiver Decision|12|||
129131199|NCT02573467|464772772|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
129131200|NCT02573467|464772773|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
129131201|NCT02573467|464772774|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
129131202|NCT02573467|464772775|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
129131203|NCT02573467|464772772|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
129131204|NCT02573467|464772773|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
129131205|NCT02573467|464772774|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
129131206|NCT02573467|464772775|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
129131207|NCT02573467|464772772|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
129131208|NCT02573467|464772773|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
129131209|NCT02573467|464772774|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
129131210|NCT02573467|464772775|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
129131211|NCT02573467|464772772|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
129131212|NCT02573467|464772773|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
129131213|NCT02573467|464772774|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
129131214|NCT02573467|464772775|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
129131215|NCT02573467|464772772|FG000|Post-treatment Follow up Epoch|Death|1|||
129131216|NCT02573467|464772773|FG001|Post-treatment Follow up Epoch|Death|1|||
129131217|NCT02573467|464772774|FG002|Post-treatment Follow up Epoch|Death|0|||
129131218|NCT02573467|464772775|FG003|Post-treatment Follow up Epoch|Death|1|||
129131219|NCT02573467|464772772|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
129131220|NCT02573467|464772773|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
129131221|NCT02573467|464772774|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
129131222|NCT02573467|464772775|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
129131223|NCT02573467|464772772|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
129131224|NCT02573467|464772773|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
129131225|NCT02573467|464772774|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
129131226|NCT02573467|464772775|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
129131227|NCT02153827|464772776|FG000|Overall Study|Lost to Follow-up|3|||
129131228|NCT02153827|464772777|FG001|Overall Study|Lost to Follow-up|9|||
129131229|NCT02143778|464772778|FG000|Overall Study|Withdrawal by Subject|2|||
129131230|NCT02143778|464772778|FG000|Overall Study|Device malfunction|1|||
129131231|NCT00625378|464772780|FG000|Overall Study|Adverse Event|22|||
129131232|NCT00625378|464772781|FG001|Overall Study|Adverse Event|0|||
129131233|NCT00625378|464772780|FG000|Overall Study|Withdrawal by Subject|16|||
129131234|NCT00625378|464772781|FG001|Overall Study|Withdrawal by Subject|0|||
129131235|NCT00625378|464772780|FG000|Overall Study|Death|38|||
129131236|NCT00625378|464772781|FG001|Overall Study|Death|0|||
129131237|NCT00625378|464772780|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
129131238|NCT00625378|464772781|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
129131239|NCT00625378|464772780|FG000|Overall Study|Lost to Follow-up|17|||
129131240|NCT00625378|464772781|FG001|Overall Study|Lost to Follow-up|0|||
129131241|NCT00625378|464772780|FG000|Overall Study|Non-compliant with study medication|3|||
129131242|NCT00625378|464772781|FG001|Overall Study|Non-compliant with study medication|0|||
129131243|NCT00625378|464772780|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
129131244|NCT00625378|464772781|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
129131245|NCT00625378|464772780|FG000|Overall Study|Medical decision|1|||
129131246|NCT00625378|464772781|FG001|Overall Study|Medical decision|0|||
129131247|NCT00625378|464772780|FG000|Overall Study|Multiple toxicities|1|||
129131248|NCT00625378|464772781|FG001|Overall Study|Multiple toxicities|0|||
129131249|NCT00625378|464772780|FG000|Overall Study|New cancer|1|||
129131250|NCT00625378|464772781|FG001|Overall Study|New cancer|0|||
129131251|NCT00625378|464772780|FG000|Overall Study|PTA program|2|||
129131252|NCT00625378|464772781|FG001|Overall Study|PTA program|0|||
129131253|NCT00625378|464772780|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
129220651|NCT03048578|465108179|FG000|Overall Study|Withdrawal by Subject|5|||
129220652|NCT03048578|465108180|FG001|Overall Study|Withdrawal by Subject|6|||
128971675|NCT01426009|464179667|FG000|Washout 2|electrive surgery|1|||
128971676|NCT01426009|464179667|FG000|Washout 3|personal reasons|1|||
128971677|NCT01426009|464179667|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
128971678|NCT01426009|464179667|FG000|Washout 4|Lost to Follow-up|1|||
128971679|NCT00515099|464179674|FG000|Overall Study|Lost to Follow-up|0|||
128971680|NCT00515099|464179675|FG001|Overall Study|Lost to Follow-up|4|||
128971681|NCT00515099|464179674|FG000|Overall Study|Withdrawal by Subject|2|||
128971682|NCT00515099|464179675|FG001|Overall Study|Withdrawal by Subject|0|||
128971683|NCT00515099|464179674|FG000|Overall Study|IRB Recommendation|1|||
128971684|NCT00515099|464179675|FG001|Overall Study|IRB Recommendation|0|||
128971685|NCT04476108|464179676|FG000|Overall Study|Adverse Event|4|||
128971686|NCT04476108|464179677|FG001|Overall Study|Adverse Event|1|||
128971687|NCT04476108|464179676|FG000|Overall Study|Lost to Follow-up|1|||
128971688|NCT04476108|464179677|FG001|Overall Study|Lost to Follow-up|0|||
128971689|NCT04476108|464179676|FG000|Overall Study|Inadvertent Enrollment|1|||
128971690|NCT04476108|464179677|FG001|Overall Study|Inadvertent Enrollment|0|||
128971691|NCT04476108|464179676|FG000|Overall Study|Protocol Violation|1|||
128971692|NCT04476108|464179677|FG001|Overall Study|Protocol Violation|1|||
128971693|NCT04476108|464179676|FG000|Overall Study|Withdrawal by Subject|1|||
128971694|NCT04476108|464179677|FG001|Overall Study|Withdrawal by Subject|1|||
128971695|NCT00355615|464179678|FG000|Randomized Double Blind Period|Adverse Event|1|||
128971696|NCT00355615|464179679|FG001|Randomized Double Blind Period|Adverse Event|0|||
128971697|NCT00355615|464179680|FG002|Randomized Double Blind Period|Adverse Event|0|||
128971698|NCT00355615|464179681|FG003|Randomized Double Blind Period|Adverse Event|0|||
128971699|NCT00355615|464179682|FG004|Randomized Double Blind Period|Adverse Event|0|||
128971700|NCT00355615|464179678|FG000|Randomized Double Blind Period|Protocol Violation|0|||
128971701|NCT00355615|464179679|FG001|Randomized Double Blind Period|Protocol Violation|0|||
128971702|NCT00355615|464179680|FG002|Randomized Double Blind Period|Protocol Violation|1|||
128971703|NCT00355615|464179681|FG003|Randomized Double Blind Period|Protocol Violation|1|||
128971704|NCT00355615|464179682|FG004|Randomized Double Blind Period|Protocol Violation|0|||
128971705|NCT00355615|464179678|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
128971706|NCT00355615|464179679|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
128971707|NCT00355615|464179680|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
128971708|NCT00355615|464179681|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
128971709|NCT00355615|464179682|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
128971710|NCT00355615|464179678|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
128971711|NCT00355615|464179679|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
128971712|NCT00355615|464179680|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
128971713|NCT00355615|464179681|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
128971714|NCT00355615|464179682|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
128971715|NCT00355615|464179678|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
128971716|NCT00355615|464179679|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
128971717|NCT00355615|464179680|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
128971718|NCT00355615|464179681|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
128971719|NCT00355615|464179682|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
128971720|NCT00355615|464179678|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
128971721|NCT00355615|464179679|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
128971722|NCT00355615|464179680|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
128971723|NCT00355615|464179681|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
128971724|NCT00355615|464179682|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
128971725|NCT03523715|464179683|FG000|Overall Study|Lost to Follow-up|11|||
128971726|NCT03523715|464179684|FG001|Overall Study|Lost to Follow-up|14|||
128971727|NCT03523715|464179683|FG000|Overall Study|Did not meet inclusion criteria|1|||
128971728|NCT03523715|464179684|FG001|Overall Study|Did not meet inclusion criteria|0|||
128971729|NCT03523715|464179683|FG000|Overall Study|Internally inconsistent reporting|0|||
128971730|NCT03523715|464179684|FG001|Overall Study|Internally inconsistent reporting|2|||
129220653|NCT03048578|465108179|FG000|Overall Study|Lost to Follow-up|22|||
129220654|NCT03048578|465108180|FG001|Overall Study|Lost to Follow-up|10|||
129220655|NCT03048578|465108179|FG000|Overall Study|Adverse Event|1|||
129220656|NCT03048578|465108180|FG001|Overall Study|Adverse Event|2|||
129220657|NCT03048578|465108179|FG000|Overall Study|Terminated|3|||
128971731|NCT04430036|464179685|FG000|Safety Run in Phase|Progression of disease|2|||
128971732|NCT01842334|464179686|FG000|Overall Study|Withdrawal by Subject|3|||
128971733|NCT01842334|464179687|FG001|Overall Study|Withdrawal by Subject|3|||
128971734|NCT01842334|464179686|FG000|Overall Study|Moved away mid-study|0|||
128971735|NCT01842334|464179687|FG001|Overall Study|Moved away mid-study|1|||
128971736|NCT03299166|464179697|FG000|Overall Study|Adverse Event|9|||
128971737|NCT03299166|464179698|FG001|Overall Study|Adverse Event|4|||
128971738|NCT03299166|464179697|FG000|Overall Study|Withdrawal by Subject|6|||
128971739|NCT03299166|464179698|FG001|Overall Study|Withdrawal by Subject|5|||
128971740|NCT03299166|464179697|FG000|Overall Study|Physician Decision|1|||
129220658|NCT03048578|465108180|FG001|Overall Study|Terminated|2|||
128715575|NCT01474876|463255239|FG000|Overall Study|Investigator's decision|28|||
128715576|NCT01474876|463255240|FG001|Overall Study|Investigator's decision|6|||
128715577|NCT01474876|463255241|FG002|Overall Study|Investigator's decision|0|||
128715578|NCT01474876|463255239|FG000|Overall Study|Patient's request|19|||
128715579|NCT01474876|463255240|FG001|Overall Study|Patient's request|5|||
128715580|NCT01474876|463255241|FG002|Overall Study|Patient's request|0|||
128715581|NCT01474876|463255239|FG000|Overall Study|Investigator's decision and pt request|1|||
128715582|NCT01474876|463255240|FG001|Overall Study|Investigator's decision and pt request|0|||
128715583|NCT01474876|463255241|FG002|Overall Study|Investigator's decision and pt request|0|||
128715584|NCT01523886|463255242|FG000|Overall Study|surgery cancelled|0|||
128715585|NCT01523886|463255243|FG001|Overall Study|surgery cancelled|1|||
128715586|NCT01173718|463255253|FG000|Overall Study|Death|17|||
128715587|NCT01173718|463255253|FG000|Overall Study|Abandonment of study graft|27|||
128715588|NCT01367158|463255254|FG000|Overall Study|Withdrew consent|0|||
128715589|NCT01367158|463255255|FG001|Overall Study|Withdrew consent|2|||
128715590|NCT01367158|463255256|FG002|Overall Study|Withdrew consent|1|||
128715591|NCT01367158|463255257|FG003|Overall Study|Withdrew consent|0|||
128715592|NCT01367158|463255258|FG004|Overall Study|Withdrew consent|2|||
128715593|NCT01367158|463255259|FG005|Overall Study|Withdrew consent|0|||
128715594|NCT01367158|463255260|FG006|Overall Study|Withdrew consent|0|||
128715595|NCT01367158|463255261|FG007|Overall Study|Withdrew consent|1|||
128715596|NCT01367158|463255262|FG008|Overall Study|Withdrew consent|0|||
128715597|NCT01367158|463255263|FG009|Overall Study|Withdrew consent|0|||
128715598|NCT01367158|463255264|FG010|Overall Study|Withdrew consent|0|||
128715599|NCT01367158|463255254|FG000|Overall Study|Lost to Follow-up|0|||
128715600|NCT01367158|463255255|FG001|Overall Study|Lost to Follow-up|0|||
128715601|NCT01367158|463255256|FG002|Overall Study|Lost to Follow-up|0|||
128715602|NCT01367158|463255257|FG003|Overall Study|Lost to Follow-up|1|||
128715603|NCT01367158|463255258|FG004|Overall Study|Lost to Follow-up|0|||
128971741|NCT03299166|464179698|FG001|Overall Study|Physician Decision|1|||
128971742|NCT03299166|464179697|FG000|Overall Study|Sponsor Decision|3|||
128971743|NCT03299166|464179698|FG001|Overall Study|Sponsor Decision|0|||
128971744|NCT03299166|464179697|FG000|Overall Study|Lost to Follow-up|2|||
128971745|NCT03299166|464179698|FG001|Overall Study|Lost to Follow-up|4|||
128971746|NCT03299166|464179697|FG000|Overall Study|Randomization Error|0|||
128971747|NCT03299166|464179698|FG001|Overall Study|Randomization Error|1|||
128971748|NCT03299166|464179697|FG000|Overall Study|Subject unable to return due to COVID|1|||
128971749|NCT03299166|464179698|FG001|Overall Study|Subject unable to return due to COVID|0|||
128971750|NCT03299166|464179697|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
128971751|NCT03299166|464179698|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
128971752|NCT04055844|464179699|FG000|Overall Study|Adverse Event|12|||
128971753|NCT04055844|464179699|FG000|Overall Study|Poor Performance|1|||
128971754|NCT04055844|464179699|FG000|Overall Study|Death|1|||
128971755|NCT00572728|464179700|FG000|Overall Study|Withdrawal by Subject|10|||
128971756|NCT00572728|464179700|FG000|Overall Study|Ineligible|3|||
128971757|NCT00572728|464179700|FG000|Overall Study|Enrolled under Amendment 4|5|||
128971758|NCT00572728|464179700|FG000|Overall Study|Offstudy due to complicating disease|1|||
128971759|NCT00572728|464179700|FG000|Overall Study|FLT1 not completed|4|||
128971760|NCT00572728|464179700|FG000|Overall Study|First Chemotherapy not initiated|2|||
128971761|NCT00572728|464179700|FG000|Overall Study|FLT2 not completed|5|||
128971762|NCT00572728|464179700|FG000|Overall Study|Second chemotherapy not initiated|1|||
128971763|NCT00572728|464179700|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
128971764|NCT00572728|464179700|FG000|Overall Study|Pathology missing|1|||
128971765|NCT00113555|464179703|FG000|Overall Study|Baseline Failure|59|||
128971766|NCT00113555|464179703|FG000|Overall Study|Permanently Explanted|7|||
128971767|NCT00113555|464179703|FG000|Overall Study|Death|1|||
128971768|NCT00113555|464179703|FG000|Overall Study|Missed Followup|4|||
128971769|NCT00113555|464179703|FG000|Overall Study|Lost to Follow-up|8|||
128971770|NCT03595176|464179704|FG000|Overall Study|Death|0|||
128971771|NCT03595176|464179705|FG001|Overall Study|Death|2|||
128971772|NCT03595176|464179704|FG000|Overall Study|Lost to Follow-up|0|||
128971773|NCT03595176|464179705|FG001|Overall Study|Lost to Follow-up|1|||
128971774|NCT03128307|464179714|FG000|Overall Study|Lost to Follow-up|29|||
128971775|NCT03128307|464179714|FG000|Overall Study|Withdrawal by Subject|5|||
128715604|NCT01367158|463255259|FG005|Overall Study|Lost to Follow-up|2|||
128715605|NCT01367158|463255260|FG006|Overall Study|Lost to Follow-up|0|||
128715606|NCT01367158|463255261|FG007|Overall Study|Lost to Follow-up|1|||
128971776|NCT01888965|464181504|FG000|Overall Study|Adverse Event|5|||
128971777|NCT01888965|464181504|FG000|Overall Study|Lack of Efficacy|4|||
128971778|NCT00887822|464181506|FG000|Overall Study|Insufficient therapeutic response|53|||
128971779|NCT00887822|464181507|FG001|Overall Study|Insufficient therapeutic response|55|||
128971780|NCT00887822|464181506|FG000|Overall Study|Adverse Event|14|||
128971781|NCT00887822|464181507|FG001|Overall Study|Adverse Event|17|||
128971782|NCT00887822|464181506|FG000|Overall Study|Failure to return|11|||
128715607|NCT01367158|463255262|FG008|Overall Study|Lost to Follow-up|0|||
128715608|NCT01367158|463255263|FG009|Overall Study|Lost to Follow-up|0|||
128715609|NCT01367158|463255264|FG010|Overall Study|Lost to Follow-up|1|||
128715610|NCT01367158|463255254|FG000|Overall Study|Protocol Violation|0|||
129220659|NCT00526071|465108181|FG000|Overall Study|Adverse Event|1|||
129220660|NCT00526071|465108181|FG000|Overall Study|Withdrawal by Subject|1|||
129220661|NCT00526071|465108181|FG000|Overall Study|Lack of Response to Study Drug|4|||
129220662|NCT02500797|465108186|FG000|Overall Study|Cancel (rapid disease progression)|0|||
129220663|NCT02500797|465108187|FG001|Overall Study|Cancel (rapid disease progression)|0|||
129220664|NCT02500797|465108188|FG002|Overall Study|Cancel (rapid disease progression)|0|||
129220665|NCT02500797|465108189|FG003|Overall Study|Cancel (rapid disease progression)|0|||
129220666|NCT02500797|465108190|FG004|Overall Study|Cancel (rapid disease progression)|1|||
129220667|NCT02500797|465108191|FG005|Overall Study|Cancel (rapid disease progression)|1|||
129220668|NCT02500797|465108192|FG006|Overall Study|Cancel (rapid disease progression)|0|||
129220669|NCT02500797|465108193|FG007|Overall Study|Cancel (rapid disease progression)|0|||
129220670|NCT02500797|465108186|FG000|Overall Study|Withdrawal by Subject|1|||
129220671|NCT02500797|465108187|FG001|Overall Study|Withdrawal by Subject|0|||
128971783|NCT00887822|464181507|FG001|Overall Study|Failure to return|11|||
128971784|NCT00887822|464181506|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
128971785|NCT00887822|464181507|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
128971786|NCT00887822|464181506|FG000|Overall Study|Administrative/Other than specified|5|||
128971787|NCT00887822|464181507|FG001|Overall Study|Administrative/Other than specified|4|||
128971788|NCT00887822|464181506|FG000|Overall Study|Death|2|||
128971789|NCT00887822|464181507|FG001|Overall Study|Death|3|||
128971790|NCT00887822|464181506|FG000|Overall Study|Protocol Violation|0|||
128971791|NCT00887822|464181507|FG001|Overall Study|Protocol Violation|1|||
128971792|NCT00887822|464181506|FG000|Overall Study|Randomized but not treated|0|||
128971793|NCT00887822|464181507|FG001|Overall Study|Randomized but not treated|1|||
128971794|NCT02987205|464181508|FG000|Overall Study|Adverse Event|1|||
128971795|NCT02987205|464181508|FG000|Overall Study|Withdrawal by Subject|3|||
128971796|NCT04167514|464181509|FG000|Overall Study|Adverse event, not serious|0|||
128971797|NCT04167514|464181510|FG001|Overall Study|Adverse event, not serious|1|||
128971798|NCT04167514|464181509|FG000|Overall Study|Lost to Follow-up|1|||
128971799|NCT04167514|464181510|FG001|Overall Study|Lost to Follow-up|0|||
128971800|NCT04167514|464181509|FG000|Overall Study|Participant Decision|2|||
128971801|NCT04167514|464181510|FG001|Overall Study|Participant Decision|4|||
128971802|NCT04167514|464181509|FG000|Overall Study|Physician Decision|3|||
128971803|NCT04167514|464181510|FG001|Overall Study|Physician Decision|2|||
128971804|NCT04167514|464181509|FG000|Overall Study|Death|14|||
128971805|NCT04167514|464181510|FG001|Overall Study|Death|18|||
128971806|NCT04167514|464181509|FG000|Overall Study|Enrolled but treatment not administered|2|||
128971807|NCT04167514|464181510|FG001|Overall Study|Enrolled but treatment not administered|0|||
128971808|NCT04167514|464181509|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
128971809|NCT04167514|464181510|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
128971810|NCT04167514|464181509|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
128971811|NCT04167514|464181510|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
128971812|NCT03345849|464181511|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
128971813|NCT03345849|464181512|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
128971814|NCT03345849|464181513|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
128971815|NCT03345849|464181514|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
128971816|NCT03345849|464181511|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
128971817|NCT03345849|464181512|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
128971818|NCT03345849|464181513|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
128971819|NCT03345849|464181514|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
128971820|NCT03345849|464181511|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
128971821|NCT03345849|464181512|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
128971822|NCT03345849|464181513|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
128971823|NCT03345849|464181514|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
128971824|NCT03345849|464181511|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
128971825|NCT03345849|464181512|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
128971826|NCT03345849|464181513|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
128971827|NCT03345849|464181514|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
128971828|NCT03345849|464181511|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
128971829|NCT03345849|464181512|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
128971830|NCT03345849|464181513|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
129220672|NCT02500797|465108188|FG002|Overall Study|Withdrawal by Subject|0|||
129220673|NCT02500797|465108189|FG003|Overall Study|Withdrawal by Subject|0|||
129220674|NCT02500797|465108190|FG004|Overall Study|Withdrawal by Subject|0|||
128971831|NCT03345849|464181514|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
129220675|NCT02500797|465108191|FG005|Overall Study|Withdrawal by Subject|0|||
129038465|NCT02973321|464433184|FG003|Overall Study|Lack of Efficacy|0|||
129220676|NCT02500797|465108192|FG006|Overall Study|Withdrawal by Subject|0|||
129220677|NCT02500797|465108193|FG007|Overall Study|Withdrawal by Subject|0|||
129220678|NCT01415882|465108196|FG000|Overall Study|Ineligible|1|||
128971832|NCT03345849|464181511|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
128971833|NCT03345849|464181512|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
128971834|NCT03345849|464181513|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
128971835|NCT03345849|464181514|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
128971836|NCT03345849|464181511|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
128971837|NCT03345849|464181512|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
128971838|NCT03345849|464181513|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
128971839|NCT03345849|464181514|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
128971840|NCT03345849|464181511|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
128971841|NCT03345849|464181512|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
128971842|NCT03345849|464181513|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
128971843|NCT03345849|464181514|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
128971844|NCT03345849|464181511|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
128971845|NCT03345849|464181512|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
128971846|NCT03345849|464181513|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
128971847|NCT03345849|464181514|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
128971848|NCT03345849|464181511|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
128971849|NCT03345849|464181512|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
128971850|NCT03345849|464181513|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
128971851|NCT03345849|464181514|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
128971852|NCT03345849|464181511|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
128971853|NCT03345849|464181512|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
128971854|NCT03345849|464181513|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
128971855|NCT03345849|464181514|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
128971856|NCT04437511|464181517|FG000|Overall Study|Adverse Event|50|||
128971857|NCT04437511|464181518|FG001|Overall Study|Adverse Event|21|||
128971858|NCT04437511|464181517|FG000|Overall Study|Death|15|||
128971859|NCT04437511|464181518|FG001|Overall Study|Death|10|||
128971860|NCT04437511|464181517|FG000|Overall Study|Lost to Follow-up|11|||
128971861|NCT04437511|464181518|FG001|Overall Study|Lost to Follow-up|11|||
128971862|NCT04437511|464181517|FG000|Overall Study|Physician Decision|19|||
128971863|NCT04437511|464181518|FG001|Overall Study|Physician Decision|10|||
128971864|NCT04437511|464181517|FG000|Overall Study|Progressive Disease|4|||
128971865|NCT04437511|464181518|FG001|Overall Study|Progressive Disease|7|||
128971866|NCT04437511|464181517|FG000|Overall Study|Withdrawal by Subject|111|||
128971867|NCT04437511|464181518|FG001|Overall Study|Withdrawal by Subject|94|||
128971868|NCT04437511|464181517|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
128971869|NCT04437511|464181518|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
128971870|NCT04437511|464181517|FG000|Overall Study|Continuing Study|7|||
128971871|NCT04437511|464181518|FG001|Overall Study|Continuing Study|5|||
128971872|NCT03093350|464181523|FG000|Overall Study|Death|1|||
128971873|NCT03093350|464181523|FG000|Overall Study|Signed consent, never began treartment|1|||
128971874|NCT04517253|464181539|FG000|Primary Treatment Period|Adverse Event|1|||
128971875|NCT04517253|464181540|FG001|Primary Treatment Period|Adverse Event|0|||
128971876|NCT04517253|464181541|FG002|Primary Treatment Period|Adverse Event|0|||
128971877|NCT04517253|464181539|FG000|Primary Treatment Period|Death|0|||
128971878|NCT04517253|464181540|FG001|Primary Treatment Period|Death|1|||
128971879|NCT04517253|464181541|FG002|Primary Treatment Period|Death|0|||
128971880|NCT04517253|464181539|FG000|Maintenance Period|Withdrawal by Subject|1|||
128971881|NCT04517253|464181540|FG001|Maintenance Period|Withdrawal by Subject|0|||
128971882|NCT04517253|464181541|FG002|Maintenance Period|Withdrawal by Subject|0|||
128971883|NCT04517253|464181539|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
128971884|NCT04517253|464181540|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
128971885|NCT04517253|464181541|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
128971886|NCT05564039|464181544|FG000|Overall Study|Adverse Event|1|||
128971887|NCT05564039|464181545|FG001|Overall Study|Adverse Event|0|||
128971888|NCT05564039|464181544|FG000|Overall Study|Death|1|||
128971889|NCT05564039|464181545|FG001|Overall Study|Death|1|||
128971890|NCT05564039|464181544|FG000|Overall Study|Lost to Follow-up|3|||
128971891|NCT05564039|464181545|FG001|Overall Study|Lost to Follow-up|2|||
128971892|NCT05564039|464181544|FG000|Overall Study|Withdrawal by Subject|2|||
128971893|NCT05564039|464181545|FG001|Overall Study|Withdrawal by Subject|0|||
128971894|NCT05564039|464181544|FG000|Overall Study|Inadvertent enrollment|3|||
128971895|NCT05564039|464181545|FG001|Overall Study|Inadvertent enrollment|6|||
128971896|NCT04785144|464181546|FG000|Overall Study|Withdrawal by Subject|4|||
128971897|NCT04785144|464181547|FG001|Overall Study|Withdrawal by Subject|1|||
128971898|NCT04785144|464181548|FG002|Overall Study|Withdrawal by Subject|0|||
128971899|NCT04785144|464181549|FG003|Overall Study|Withdrawal by Subject|0|||
128715611|NCT01367158|463255255|FG001|Overall Study|Protocol Violation|1|||
128971900|NCT04785144|464181550|FG004|Overall Study|Withdrawal by Subject|0|||
128971901|NCT04785144|464181551|FG005|Overall Study|Withdrawal by Subject|2|||
128971902|NCT04785144|464181552|FG006|Overall Study|Withdrawal by Subject|2|||
128971903|NCT04785144|464181553|FG007|Overall Study|Withdrawal by Subject|0|||
128971904|NCT04785144|464181554|FG008|Overall Study|Withdrawal by Subject|1|||
128971905|NCT04785144|464181555|FG009|Overall Study|Withdrawal by Subject|0|||
128971906|NCT04785144|464181546|FG000|Overall Study|Lost to Follow-up|1|||
128971907|NCT04785144|464181547|FG001|Overall Study|Lost to Follow-up|0|||
128971908|NCT04785144|464181548|FG002|Overall Study|Lost to Follow-up|0|||
128971909|NCT04785144|464181549|FG003|Overall Study|Lost to Follow-up|0|||
128971910|NCT04785144|464181550|FG004|Overall Study|Lost to Follow-up|1|||
128971911|NCT04785144|464181551|FG005|Overall Study|Lost to Follow-up|2|||
128971912|NCT04785144|464181552|FG006|Overall Study|Lost to Follow-up|1|||
128971913|NCT04785144|464181553|FG007|Overall Study|Lost to Follow-up|2|||
128971914|NCT04785144|464181554|FG008|Overall Study|Lost to Follow-up|4|||
128971915|NCT04785144|464181555|FG009|Overall Study|Lost to Follow-up|1|||
128971916|NCT04785144|464181546|FG000|Overall Study|Protocol Violation|0|||
128971917|NCT04785144|464181547|FG001|Overall Study|Protocol Violation|0|||
128971918|NCT04785144|464181548|FG002|Overall Study|Protocol Violation|0|||
128971919|NCT04785144|464181549|FG003|Overall Study|Protocol Violation|0|||
128971920|NCT04785144|464181550|FG004|Overall Study|Protocol Violation|0|||
128971921|NCT04785144|464181551|FG005|Overall Study|Protocol Violation|0|||
128971922|NCT04785144|464181552|FG006|Overall Study|Protocol Violation|1|||
128971923|NCT04785144|464181553|FG007|Overall Study|Protocol Violation|0|||
128971924|NCT04785144|464181554|FG008|Overall Study|Protocol Violation|0|||
128971925|NCT04785144|464181555|FG009|Overall Study|Protocol Violation|0|||
128971926|NCT04785144|464181546|FG000|Overall Study|Physician Decision|0|||
128971927|NCT04785144|464181547|FG001|Overall Study|Physician Decision|0|||
128971928|NCT04785144|464181548|FG002|Overall Study|Physician Decision|0|||
128971929|NCT04785144|464181549|FG003|Overall Study|Physician Decision|0|||
128971930|NCT04785144|464181550|FG004|Overall Study|Physician Decision|0|||
128971931|NCT04785144|464181551|FG005|Overall Study|Physician Decision|0|||
128971932|NCT04785144|464181552|FG006|Overall Study|Physician Decision|0|||
128971933|NCT04785144|464181553|FG007|Overall Study|Physician Decision|0|||
128971934|NCT04785144|464181554|FG008|Overall Study|Physician Decision|0|||
128971935|NCT04785144|464181555|FG009|Overall Study|Physician Decision|1|||
128971936|NCT04785144|464181546|FG000|Overall Study|Unable to continue due to work schedule|0|||
128971937|NCT04785144|464181547|FG001|Overall Study|Unable to continue due to work schedule|0|||
128971938|NCT04785144|464181548|FG002|Overall Study|Unable to continue due to work schedule|0|||
128971939|NCT04785144|464181549|FG003|Overall Study|Unable to continue due to work schedule|0|||
128971940|NCT04785144|464181550|FG004|Overall Study|Unable to continue due to work schedule|0|||
128971941|NCT04785144|464181551|FG005|Overall Study|Unable to continue due to work schedule|0|||
128971942|NCT04785144|464181552|FG006|Overall Study|Unable to continue due to work schedule|0|||
128971943|NCT04785144|464181553|FG007|Overall Study|Unable to continue due to work schedule|0|||
128971944|NCT04785144|464181554|FG008|Overall Study|Unable to continue due to work schedule|0|||
128971945|NCT04785144|464181555|FG009|Overall Study|Unable to continue due to work schedule|1|||
128971946|NCT01263470|464181558|FG000|Overall Study|Adverse Event|2|||
128971947|NCT01263470|464181559|FG001|Overall Study|Adverse Event|2|||
128971948|NCT01263470|464181560|FG002|Overall Study|Adverse Event|1|||
128971949|NCT01263470|464181561|FG003|Overall Study|Adverse Event|1|||
128971950|NCT01263470|464181562|FG004|Overall Study|Adverse Event|2|||
128971951|NCT01263470|464181563|FG005|Overall Study|Adverse Event|2|||
128971952|NCT01263470|464181558|FG000|Overall Study|Protocol Violation|0|||
128971953|NCT01263470|464181559|FG001|Overall Study|Protocol Violation|1|||
128971954|NCT01263470|464181560|FG002|Overall Study|Protocol Violation|0|||
128971955|NCT01263470|464181561|FG003|Overall Study|Protocol Violation|0|||
128971956|NCT01263470|464181562|FG004|Overall Study|Protocol Violation|0|||
128971957|NCT01263470|464181563|FG005|Overall Study|Protocol Violation|1|||
128971958|NCT01263470|464181558|FG000|Overall Study|Withdrawal by Subject|0|||
128971959|NCT01263470|464181559|FG001|Overall Study|Withdrawal by Subject|1|||
128971960|NCT01263470|464181560|FG002|Overall Study|Withdrawal by Subject|1|||
129220679|NCT01415882|465108197|FG001|Overall Study|Ineligible|0|||
129220680|NCT01415882|465108198|FG002|Overall Study|Ineligible|0|||
129220681|NCT01415882|465108199|FG003|Overall Study|Ineligible|3|||
129220682|NCT01415882|465108200|FG004|Overall Study|Ineligible|0|||
129220683|NCT01415882|465108196|FG000|Overall Study|Withdrawal by Subject|0|||
128715612|NCT01367158|463255256|FG002|Overall Study|Protocol Violation|0|||
129220684|NCT01415882|465108197|FG001|Overall Study|Withdrawal by Subject|1|||
129220685|NCT01415882|465108198|FG002|Overall Study|Withdrawal by Subject|0|||
128971961|NCT01263470|464181561|FG003|Overall Study|Withdrawal by Subject|2|||
128971962|NCT01263470|464181562|FG004|Overall Study|Withdrawal by Subject|0|||
128971963|NCT01263470|464181563|FG005|Overall Study|Withdrawal by Subject|2|||
128971964|NCT01263470|464181558|FG000|Overall Study|Lack of Efficacy|0|||
128971965|NCT01263470|464181559|FG001|Overall Study|Lack of Efficacy|0|||
128971966|NCT01263470|464181560|FG002|Overall Study|Lack of Efficacy|2|||
128971967|NCT01263470|464181561|FG003|Overall Study|Lack of Efficacy|0|||
128971968|NCT01263470|464181562|FG004|Overall Study|Lack of Efficacy|0|||
128971969|NCT01263470|464181563|FG005|Overall Study|Lack of Efficacy|0|||
128971970|NCT01263470|464181558|FG000|Overall Study|Participant Unavailability|0|||
129038466|NCT02973321|464433185|FG004|Overall Study|Lack of Efficacy|1|||
128971971|NCT01263470|464181559|FG001|Overall Study|Participant Unavailability|1|||
128971972|NCT01263470|464181560|FG002|Overall Study|Participant Unavailability|0|||
128971973|NCT01263470|464181561|FG003|Overall Study|Participant Unavailability|0|||
128971974|NCT01263470|464181562|FG004|Overall Study|Participant Unavailability|0|||
128971975|NCT01263470|464181563|FG005|Overall Study|Participant Unavailability|0|||
128971976|NCT01263470|464181558|FG000|Overall Study|Study Drug Non-compliance|0|||
128971977|NCT01263470|464181559|FG001|Overall Study|Study Drug Non-compliance|0|||
128971978|NCT01263470|464181560|FG002|Overall Study|Study Drug Non-compliance|0|||
128971979|NCT01263470|464181561|FG003|Overall Study|Study Drug Non-compliance|0|||
128971980|NCT01263470|464181562|FG004|Overall Study|Study Drug Non-compliance|1|||
128971981|NCT01263470|464181563|FG005|Overall Study|Study Drug Non-compliance|0|||
128971982|NCT00610714|464181564|FG000|Overall Study|Adverse Event|3|||
128971983|NCT00610714|464181565|FG001|Overall Study|Adverse Event|1|||
128971984|NCT00610714|464181564|FG000|Overall Study|Death|12|||
128971985|NCT00610714|464181565|FG001|Overall Study|Death|18|||
128971986|NCT00610714|464181564|FG000|Overall Study|Withdrawal by Subject|9|||
128971987|NCT00610714|464181565|FG001|Overall Study|Withdrawal by Subject|3|||
128971988|NCT00610714|464181564|FG000|Overall Study|Study completion at 120 PFS events|2|||
128971989|NCT00610714|464181565|FG001|Overall Study|Study completion at 120 PFS events|2|||
128971990|NCT00712712|464181566|FG000|Overall Study|Protocol Violation|11|||
128971991|NCT00712712|464181566|FG000|Overall Study|Radiofrequency not done|3|||
128971992|NCT00712712|464181566|FG000|Overall Study|Death|8|||
128971993|NCT00712712|464181566|FG000|Overall Study|Withdrawal by Subject|1|||
128971994|NCT03598140|464181567|FG000|Overall Study|enrolled but didn't start|1|||
128971995|NCT03598140|464181568|FG001|Overall Study|enrolled but didn't start|0|||
128971996|NCT01029691|464181569|FG000|Continued APAP to Delivery|Death|0|||
128971997|NCT01029691|464181570|FG001|Continued APAP to Delivery|Death|0|||
128971998|NCT01029691|464181571|FG002|Continued APAP to Delivery|Death|1|||
128971999|NCT01023516|464181573|FG000|Overall Study|Voluntary discontinuation|7|||
128972000|NCT01023516|464181574|FG001|Overall Study|Voluntary discontinuation|5|||
128972001|NCT01023516|464181573|FG000|Overall Study|Adverse Event|9|||
128972002|NCT01023516|464181574|FG001|Overall Study|Adverse Event|6|||
128972003|NCT01023516|464181573|FG000|Overall Study|Safety reason|0|||
128972004|NCT01023516|464181574|FG001|Overall Study|Safety reason|3|||
128972005|NCT01023516|464181573|FG000|Overall Study|Study-specific criteria|4|||
128972006|NCT01023516|464181574|FG001|Overall Study|Study-specific criteria|2|||
128972007|NCT01023516|464181573|FG000|Overall Study|Incorrect enrolment|4|||
128972008|NCT01023516|464181574|FG001|Overall Study|Incorrect enrolment|2|||
128972009|NCT04556175|464181577|FG000|Overall Study|Study terminated due to COVID-19|8|||
128972010|NCT04556175|464181578|FG001|Overall Study|Study terminated due to COVID-19|8|||
128972011|NCT02723019|464181586|FG000|Overall Study|Death|17|||
128972012|NCT02723019|464181587|FG001|Overall Study|Death|13|||
128972013|NCT02723019|464181586|FG000|Overall Study|Withdrawal by Subject|11|||
128972014|NCT02723019|464181587|FG001|Overall Study|Withdrawal by Subject|7|||
128972015|NCT02723019|464181586|FG000|Overall Study|Lost to Follow-up|57|||
128972016|NCT02723019|464181587|FG001|Overall Study|Lost to Follow-up|70|||
128972017|NCT00592072|464181590|FG000|Wash Out Period|Lost to Follow-up|1|||
128972018|NCT00592072|464181591|FG001|Wash Out Period|Lost to Follow-up|1|||
128972019|NCT05333289|464181593|FG000|Overall Study|Other|1|||
128972020|NCT05333289|464181594|FG001|Overall Study|Other|0|||
128972021|NCT05333289|464181595|FG002|Overall Study|Other|0|||
128972022|NCT05333289|464181596|FG003|Overall Study|Other|1|||
128972023|NCT05333289|464181597|FG004|Overall Study|Other|1|||
128972024|NCT05333289|464181598|FG005|Overall Study|Other|2|||
128972025|NCT05333289|464181599|FG006|Overall Study|Other|2|||
128715613|NCT01367158|463255257|FG003|Overall Study|Protocol Violation|0|||
128972026|NCT05333289|464181600|FG007|Overall Study|Other|0|||
129131254|NCT00625378|464772781|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
129131255|NCT00625378|464772780|FG000|Overall Study|Sponsor decision|1|||
129131256|NCT00625378|464772781|FG001|Overall Study|Sponsor decision|0|||
129131257|NCT00625378|464772780|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
128715614|NCT01367158|463255258|FG004|Overall Study|Protocol Violation|0|||
128715615|NCT01367158|463255259|FG005|Overall Study|Protocol Violation|0|||
128715616|NCT01367158|463255260|FG006|Overall Study|Protocol Violation|0|||
128715617|NCT01367158|463255261|FG007|Overall Study|Protocol Violation|0|||
128715618|NCT01367158|463255262|FG008|Overall Study|Protocol Violation|0|||
128972027|NCT05333289|464181593|FG000|Overall Study|Withdrawal by Subject|1|||
128972028|NCT05333289|464181594|FG001|Overall Study|Withdrawal by Subject|2|||
128972029|NCT05333289|464181595|FG002|Overall Study|Withdrawal by Subject|2|||
128972030|NCT05333289|464181596|FG003|Overall Study|Withdrawal by Subject|1|||
128972031|NCT05333289|464181597|FG004|Overall Study|Withdrawal by Subject|1|||
128972032|NCT05333289|464181598|FG005|Overall Study|Withdrawal by Subject|2|||
128972033|NCT05333289|464181599|FG006|Overall Study|Withdrawal by Subject|1|||
128972034|NCT05333289|464181600|FG007|Overall Study|Withdrawal by Subject|3|||
128972035|NCT05333289|464181593|FG000|Overall Study|Protocol Violation|1|||
128972036|NCT05333289|464181594|FG001|Overall Study|Protocol Violation|0|||
128715619|NCT01367158|463255263|FG009|Overall Study|Protocol Violation|0|||
128972037|NCT05333289|464181595|FG002|Overall Study|Protocol Violation|0|||
128715620|NCT01367158|463255264|FG010|Overall Study|Protocol Violation|0|||
128715621|NCT02226003|463255265|FG000|Overall Study|Lost to Follow-up|2|||
128715622|NCT02226003|463255266|FG001|Overall Study|Lost to Follow-up|1|||
128715623|NCT02226003|463255267|FG002|Overall Study|Lost to Follow-up|3|||
128715624|NCT02226003|463255265|FG000|Overall Study|Withdrawal by Subject|0|||
128715625|NCT02226003|463255266|FG001|Overall Study|Withdrawal by Subject|0|||
128715626|NCT02226003|463255267|FG002|Overall Study|Withdrawal by Subject|3|||
128715627|NCT04219891|463255274|FG000|Overall Study|Lost to Follow-up|3|||
128972038|NCT05333289|464181596|FG003|Overall Study|Protocol Violation|0|||
128972039|NCT05333289|464181597|FG004|Overall Study|Protocol Violation|0|||
128972040|NCT05333289|464181598|FG005|Overall Study|Protocol Violation|0|||
128972041|NCT05333289|464181599|FG006|Overall Study|Protocol Violation|0|||
128972042|NCT05333289|464181600|FG007|Overall Study|Protocol Violation|0|||
128972043|NCT05333289|464181593|FG000|Overall Study|Physician Decision|0|||
128972044|NCT05333289|464181594|FG001|Overall Study|Physician Decision|0|||
128972045|NCT05333289|464181595|FG002|Overall Study|Physician Decision|1|||
128972046|NCT05333289|464181596|FG003|Overall Study|Physician Decision|0|||
128972047|NCT05333289|464181597|FG004|Overall Study|Physician Decision|0|||
128972048|NCT05333289|464181598|FG005|Overall Study|Physician Decision|2|||
129131258|NCT00625378|464772781|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
129131259|NCT00625378|464772780|FG000|Overall Study|Switch to commercial drug|6|||
129131260|NCT00625378|464772781|FG001|Overall Study|Switch to commercial drug|1|||
129131261|NCT00625378|464772780|FG000|Overall Study|Missing|2|||
129131262|NCT00625378|464772781|FG001|Overall Study|Missing|0|||
128972049|NCT05333289|464181599|FG006|Overall Study|Physician Decision|0|||
128972050|NCT05333289|464181600|FG007|Overall Study|Physician Decision|0|||
128972051|NCT05333289|464181593|FG000|Overall Study|Lost to Follow-up|6|||
128972052|NCT05333289|464181594|FG001|Overall Study|Lost to Follow-up|0|||
128972053|NCT05333289|464181595|FG002|Overall Study|Lost to Follow-up|1|||
128972054|NCT05333289|464181596|FG003|Overall Study|Lost to Follow-up|6|||
128972055|NCT05333289|464181597|FG004|Overall Study|Lost to Follow-up|3|||
128972056|NCT05333289|464181598|FG005|Overall Study|Lost to Follow-up|3|||
128972057|NCT05333289|464181599|FG006|Overall Study|Lost to Follow-up|2|||
128972058|NCT05333289|464181600|FG007|Overall Study|Lost to Follow-up|1|||
128972059|NCT05333289|464181593|FG000|Overall Study|Death|1|||
128972060|NCT05333289|464181594|FG001|Overall Study|Death|0|||
128972061|NCT05333289|464181595|FG002|Overall Study|Death|0|||
128972062|NCT05333289|464181596|FG003|Overall Study|Death|0|||
128972063|NCT05333289|464181597|FG004|Overall Study|Death|0|||
128972064|NCT05333289|464181598|FG005|Overall Study|Death|0|||
128972065|NCT05333289|464181599|FG006|Overall Study|Death|0|||
128972066|NCT05333289|464181600|FG007|Overall Study|Death|0|||
128972067|NCT03685643|464181605|FG000|Overall Study|Lost to Follow-up|14|||
128972068|NCT03685643|464181606|FG001|Overall Study|Lost to Follow-up|22|||
128972069|NCT01347840|464181612|FG000|Overall Study|Withdrawal by Subject|1|||
128972070|NCT01060124|464181614|FG000|Overall Study|Other|16|||
128972071|NCT01060124|464181614|FG000|Overall Study|Adverse Event|14|||
128972072|NCT01060124|464181614|FG000|Overall Study|Withdrawal by Subject|7|||
128972073|NCT05307523|464181616|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
128972074|NCT05307523|464181617|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
129131263|NCT00625378|464772780|FG000|Overall Study|End of treatment not available|2|||
129131264|NCT00625378|464772781|FG001|Overall Study|End of treatment not available|0|||
129131265|NCT00625378|464772780|FG000|Overall Study|Never treated|2|||
129131266|NCT00625378|464772781|FG001|Overall Study|Never treated|0|||
129131267|NCT02639559|464772783|FG000|Overall Study|Mobilization failure|0|||
129131268|NCT02639559|464772784|FG001|Overall Study|Mobilization failure|3|||
128715628|NCT04219891|463255274|FG000|Overall Study|Withdrawal by Subject|2|||
128715629|NCT00587561|463255783|FG000|Overall Study|Lost to Follow-up|6|||
128715630|NCT00587561|463255784|FG001|Overall Study|Lost to Follow-up|4|||
128715631|NCT04734652|463255786|FG000|Overall Study|Withdrawal by Subject|2|||
128972075|NCT05307523|464181616|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
128972076|NCT05307523|464181617|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
129131269|NCT02639559|464772783|FG000|Overall Study|Issues with vascular acess|1|||
129131270|NCT02639559|464772784|FG001|Overall Study|Issues with vascular acess|0|||
129131271|NCT03880565|464772785|FG000|Overall Study|Withdrawal by Subject|1|||
129131272|NCT03880565|464772786|FG001|Overall Study|Withdrawal by Subject|0|||
129220686|NCT01415882|465108199|FG003|Overall Study|Withdrawal by Subject|1|||
129220687|NCT01415882|465108200|FG004|Overall Study|Withdrawal by Subject|0|||
128972077|NCT03858686|464181619|FG000|Period 1|Adverse Event|1|||
128972078|NCT03858686|464181620|FG001|Period 1|Adverse Event|1|||
128972079|NCT03858686|464181619|FG000|Period 1|Lack of compliance|0|||
129131273|NCT02969018|464772791|FG000|Overall Study|Adverse Event|2|||
129131274|NCT02969018|464772792|FG001|Overall Study|Adverse Event|4|||
128715632|NCT04734652|463255787|FG001|Overall Study|Withdrawal by Subject|0|||
128715633|NCT04734652|463255786|FG000|Overall Study|Death|0|||
128972080|NCT03858686|464181620|FG001|Period 1|Lack of compliance|1|||
128972081|NCT03858686|464181619|FG000|Period 1|Adverse Event|0|||
128972082|NCT03858686|464181620|FG001|Period 1|Adverse Event|1|||
128972083|NCT03858686|464181619|FG000|Period 2|Adverse Event|0|||
128972084|NCT03858686|464181620|FG001|Period 2|Adverse Event|1|||
128972085|NCT03231228|464181622|FG000|Overall Study|Lost to Follow-up|2|||
128972086|NCT03231228|464181623|FG001|Overall Study|Lost to Follow-up|0|||
128972087|NCT03231228|464181622|FG000|Overall Study|Physician Decision|1|||
128972088|NCT03231228|464181623|FG001|Overall Study|Physician Decision|0|||
128972089|NCT02299206|464181624|FG000|Overall Study|Lost to Follow-up|1|||
128972090|NCT02299206|464181624|FG000|Overall Study|Withdrawal by Subject|1|||
128972091|NCT01682759|464181626|FG000|Overall Study|Death|2|||
128972092|NCT01682759|464181627|FG001|Overall Study|Death|1|||
128972093|NCT01682759|464181626|FG000|Overall Study|Lost to Follow-up|10|||
128972094|NCT01682759|464181627|FG001|Overall Study|Lost to Follow-up|13|||
128972095|NCT01682759|464181626|FG000|Overall Study|Physician Decision|1|||
128972096|NCT01682759|464181627|FG001|Overall Study|Physician Decision|1|||
128972097|NCT01682759|464181626|FG000|Overall Study|Withdrawal by Subject|56|||
128972098|NCT01682759|464181627|FG001|Overall Study|Withdrawal by Subject|55|||
128972099|NCT04191096|464181628|FG000|Overall Study|Death|102|||
128972100|NCT04191096|464181629|FG001|Overall Study|Death|89|||
128972101|NCT04191096|464181628|FG000|Overall Study|Lost to Follow-up|1|||
128972102|NCT04191096|464181629|FG001|Overall Study|Lost to Follow-up|1|||
128972103|NCT04191096|464181628|FG000|Overall Study|Withdrawal by Subject|5|||
128972104|NCT04191096|464181629|FG001|Overall Study|Withdrawal by Subject|5|||
128972105|NCT04191096|464181628|FG000|Overall Study|Participants Ongoing|518|||
128972106|NCT04191096|464181629|FG001|Overall Study|Participants Ongoing|530|||
128972107|NCT02683668|464181633|FG000|Period 2|Withdrawal by Subject|0|||
128972108|NCT02683668|464181634|FG001|Period 2|Withdrawal by Subject|1|||
128972109|NCT02683668|464181635|FG002|Period 2|Withdrawal by Subject|0|||
128972110|NCT03893630|464181636|FG000|Overall Study|Lost to Follow-up|5|||
128972111|NCT03893630|464181637|FG001|Overall Study|Lost to Follow-up|4|||
128972112|NCT03893630|464181638|FG002|Overall Study|Lost to Follow-up|2|||
128972113|NCT03893630|464181636|FG000|Overall Study|Withdrawal by Subject|3|||
128972114|NCT03893630|464181637|FG001|Overall Study|Withdrawal by Subject|6|||
128972115|NCT03893630|464181638|FG002|Overall Study|Withdrawal by Subject|3|||
128972116|NCT03893630|464181636|FG000|Overall Study|Discontinued Intervention|0|||
128972117|NCT03893630|464181637|FG001|Overall Study|Discontinued Intervention|4|||
128972118|NCT03893630|464181638|FG002|Overall Study|Discontinued Intervention|2|||
128972119|NCT03650387|464182959|FG000|Overall Study|Withdrawal by Subject|13|||
128972120|NCT03650387|464182959|FG000|Overall Study|Lost to Follow-up|12|||
128972121|NCT03650387|464182959|FG000|Overall Study|Adverse Event (Not related)|1|||
128972122|NCT03650387|464182959|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
128972123|NCT05815758|464182960|FG000|Overall Study|Adverse Event|6|||
128972124|NCT05815758|464182961|FG001|Overall Study|Adverse Event|2|||
128972125|NCT05815758|464182960|FG000|Overall Study|Lost to Follow-up|14|||
128972126|NCT05815758|464182961|FG001|Overall Study|Lost to Follow-up|1|||
128972127|NCT05815758|464182960|FG000|Overall Study|Withdrawal by Subject|6|||
128972128|NCT05815758|464182961|FG001|Overall Study|Withdrawal by Subject|6|||
128972129|NCT05815758|464182960|FG000|Overall Study|Protocol Violation|1|||
128972130|NCT05815758|464182961|FG001|Overall Study|Protocol Violation|1|||
128972131|NCT05815758|464182960|FG000|Overall Study|Discontinued|4|||
128972132|NCT05815758|464182961|FG001|Overall Study|Discontinued|4|||
128972133|NCT03661983|464182962|FG000|Open Label Stabilization Phase|Adverse Event|5|||
128972134|NCT03661983|464182963|FG001|Open Label Stabilization Phase|Adverse Event|0|||
128972135|NCT03661983|464182964|FG002|Open Label Stabilization Phase|Adverse Event|0|||
128972136|NCT03661983|464182965|FG003|Open Label Stabilization Phase|Adverse Event|0|||
128972137|NCT03661983|464182962|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
128972138|NCT03661983|464182963|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
128972139|NCT03661983|464182964|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
128972140|NCT03661983|464182965|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
128972141|NCT03661983|464182962|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
128972142|NCT03661983|464182963|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
128972143|NCT03661983|464182964|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
128972144|NCT03661983|464182965|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
128972145|NCT03661983|464182962|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
128972146|NCT03661983|464182963|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
128972147|NCT03661983|464182964|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
128972148|NCT03661983|464182965|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
128972149|NCT03661983|464182962|FG000|Double-blind Randomized Phase|Adverse Event|0|||
128972150|NCT03661983|464182963|FG001|Double-blind Randomized Phase|Adverse Event|1|||
128972151|NCT03661983|464182964|FG002|Double-blind Randomized Phase|Adverse Event|0|||
128972152|NCT03661983|464182965|FG003|Double-blind Randomized Phase|Adverse Event|0|||
128972153|NCT03661983|464182962|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
128972154|NCT03661983|464182963|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
129131275|NCT02969018|464772793|FG002|Overall Study|Adverse Event|1|||
129131276|NCT02969018|464772794|FG003|Overall Study|Adverse Event|2|||
129131277|NCT02969018|464772795|FG004|Overall Study|Adverse Event|0|||
129131278|NCT02969018|464772796|FG005|Overall Study|Adverse Event|1|||
129131279|NCT02969018|464772797|FG006|Overall Study|Adverse Event|2|||
128972155|NCT03661983|464182964|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
128972156|NCT03661983|464182965|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
128972157|NCT03661983|464182962|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
128972158|NCT03661983|464182963|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
128972159|NCT03661983|464182964|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
128972160|NCT03661983|464182965|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
128972161|NCT03661983|464182962|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
128972162|NCT03661983|464182963|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
128972163|NCT03661983|464182964|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
128972164|NCT03661983|464182965|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
128972165|NCT02045979|464182966|FG000|Overall Study|Informed Consent Withdrawn|2|||
128972166|NCT02045979|464182967|FG001|Overall Study|Informed Consent Withdrawn|0|||
128972167|NCT02045979|464182968|FG002|Overall Study|Informed Consent Withdrawn|1|||
128972168|NCT02045979|464182966|FG000|Overall Study|not specified above|0|||
128972169|NCT02045979|464182967|FG001|Overall Study|not specified above|1|||
128972170|NCT02045979|464182968|FG002|Overall Study|not specified above|0|||
128972171|NCT02425891|464182969|FG000|Overall Study|Death|333|||
128972172|NCT02425891|464182970|FG001|Overall Study|Death|314|||
128972173|NCT02425891|464182969|FG000|Overall Study|Lost to Follow-up|4|||
128972174|NCT02425891|464182970|FG001|Overall Study|Lost to Follow-up|6|||
128972175|NCT02425891|464182969|FG000|Overall Study|Non-Compliance|1|||
128972176|NCT02425891|464182970|FG001|Overall Study|Non-Compliance|1|||
128972177|NCT02425891|464182969|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
128972178|NCT02425891|464182970|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
128972179|NCT02425891|464182969|FG000|Overall Study|Physician Decision|0|||
128972180|NCT02425891|464182970|FG001|Overall Study|Physician Decision|1|||
128972181|NCT02425891|464182969|FG000|Overall Study|Protocol Violation|1|||
129131280|NCT02969018|464772798|FG007|Overall Study|Adverse Event|0|||
129131281|NCT02969018|464772791|FG000|Overall Study|Lack of Efficacy|0|||
129131282|NCT02969018|464772792|FG001|Overall Study|Lack of Efficacy|1|||
129131283|NCT02969018|464772793|FG002|Overall Study|Lack of Efficacy|0|||
129131284|NCT02969018|464772794|FG003|Overall Study|Lack of Efficacy|0|||
129131285|NCT02969018|464772795|FG004|Overall Study|Lack of Efficacy|1|||
129131286|NCT02969018|464772796|FG005|Overall Study|Lack of Efficacy|1|||
129131287|NCT02969018|464772797|FG006|Overall Study|Lack of Efficacy|1|||
129131288|NCT02969018|464772798|FG007|Overall Study|Lack of Efficacy|1|||
129131289|NCT02969018|464772791|FG000|Overall Study|Lost to Follow-up|1|||
129131290|NCT02969018|464772792|FG001|Overall Study|Lost to Follow-up|2|||
129131291|NCT02969018|464772793|FG002|Overall Study|Lost to Follow-up|2|||
129131292|NCT02969018|464772794|FG003|Overall Study|Lost to Follow-up|0|||
129131293|NCT02969018|464772795|FG004|Overall Study|Lost to Follow-up|1|||
129131294|NCT02969018|464772796|FG005|Overall Study|Lost to Follow-up|1|||
129131295|NCT02969018|464772797|FG006|Overall Study|Lost to Follow-up|0|||
129131296|NCT02969018|464772798|FG007|Overall Study|Lost to Follow-up|1|||
129131297|NCT02969018|464772791|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129131298|NCT02969018|464772792|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129131299|NCT02969018|464772793|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129131300|NCT02969018|464772794|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129131301|NCT02969018|464772795|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
129131302|NCT02969018|464772796|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129131303|NCT02969018|464772797|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
129131304|NCT02969018|464772798|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129131305|NCT02969018|464772791|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129131306|NCT02969018|464772792|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129131307|NCT02969018|464772793|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129131308|NCT02969018|464772794|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129131309|NCT02969018|464772795|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129131310|NCT02969018|464772796|FG005|Overall Study|Non-Compliance With Study Drug|0|||
129131311|NCT02969018|464772797|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129131312|NCT02969018|464772798|FG007|Overall Study|Non-Compliance With Study Drug|0|||
129131313|NCT02969018|464772791|FG000|Overall Study|Other|0|||
129131314|NCT02969018|464772792|FG001|Overall Study|Other|0|||
129131315|NCT02969018|464772793|FG002|Overall Study|Other|0|||
129131316|NCT02969018|464772794|FG003|Overall Study|Other|1|||
129131317|NCT02969018|464772795|FG004|Overall Study|Other|0|||
129131318|NCT02969018|464772796|FG005|Overall Study|Other|0|||
129131319|NCT02969018|464772797|FG006|Overall Study|Other|0|||
129131320|NCT02969018|464772798|FG007|Overall Study|Other|2|||
129131321|NCT02969018|464772791|FG000|Overall Study|Pregnancy|0|||
129131322|NCT02969018|464772792|FG001|Overall Study|Pregnancy|0|||
129131323|NCT02969018|464772793|FG002|Overall Study|Pregnancy|0|||
129131324|NCT02969018|464772794|FG003|Overall Study|Pregnancy|0|||
129131325|NCT02969018|464772795|FG004|Overall Study|Pregnancy|0|||
129131326|NCT02969018|464772796|FG005|Overall Study|Pregnancy|1|||
129131327|NCT02969018|464772797|FG006|Overall Study|Pregnancy|0|||
129131328|NCT02969018|464772798|FG007|Overall Study|Pregnancy|0|||
129131329|NCT02969018|464772791|FG000|Overall Study|Protocol Violation|0|||
129131330|NCT02969018|464772792|FG001|Overall Study|Protocol Violation|0|||
129131331|NCT02969018|464772793|FG002|Overall Study|Protocol Violation|1|||
129131332|NCT02969018|464772794|FG003|Overall Study|Protocol Violation|1|||
128972182|NCT02425891|464182970|FG001|Overall Study|Protocol Violation|1|||
128972183|NCT02425891|464182969|FG000|Overall Study|Study Terminated By Sponsor|85|||
128972184|NCT02425891|464182970|FG001|Overall Study|Study Terminated By Sponsor|95|||
128972185|NCT02425891|464182969|FG000|Overall Study|Withdrawal by Subject|27|||
128972186|NCT02425891|464182970|FG001|Overall Study|Withdrawal by Subject|32|||
128972187|NCT04124952|464182971|FG000|Overall Study|Lost to Follow-up|1|||
128972188|NCT02094612|464182972|FG000|Overall Study|Lost to Follow-up|47|||
128972189|NCT02094612|464182973|FG001|Overall Study|Lost to Follow-up|47|||
128972190|NCT02094612|464182972|FG000|Overall Study|Never started ADHD medication|32|||
128972191|NCT02094612|464182973|FG001|Overall Study|Never started ADHD medication|23|||
128972192|NCT03261037|464182976|FG000|Overall Study|Withdrawal by Subject|2|||
128972193|NCT03261037|464182977|FG001|Overall Study|Withdrawal by Subject|13|||
128972194|NCT03261037|464182978|FG002|Overall Study|Withdrawal by Subject|0|||
128972195|NCT03261037|464182979|FG003|Overall Study|Withdrawal by Subject|18|||
128972196|NCT03261037|464182976|FG000|Overall Study|Non-compliance with study procedures|0|||
128972197|NCT03261037|464182977|FG001|Overall Study|Non-compliance with study procedures|2|||
128972198|NCT03261037|464182978|FG002|Overall Study|Non-compliance with study procedures|0|||
128972199|NCT03261037|464182979|FG003|Overall Study|Non-compliance with study procedures|6|||
128972200|NCT03261037|464182976|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
128972201|NCT03261037|464182977|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
128972202|NCT03261037|464182978|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
128972203|NCT03261037|464182979|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
128972204|NCT03261037|464182976|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
128972205|NCT03261037|464182977|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
128972206|NCT03261037|464182978|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
128972207|NCT03261037|464182979|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
128972208|NCT03261037|464182976|FG000|Overall Study|Diagnosed but protocol deviation|1|||
128972209|NCT03261037|464182977|FG001|Overall Study|Diagnosed but protocol deviation|0|||
128972210|NCT03261037|464182978|FG002|Overall Study|Diagnosed but protocol deviation|0|||
128972211|NCT03261037|464182979|FG003|Overall Study|Diagnosed but protocol deviation|0|||
128972212|NCT03261037|464182976|FG000|Overall Study|Participant did not want to continue the study|0|||
128972213|NCT03261037|464182977|FG001|Overall Study|Participant did not want to continue the study|1|||
128972214|NCT03261037|464182978|FG002|Overall Study|Participant did not want to continue the study|0|||
128972215|NCT03261037|464182979|FG003|Overall Study|Participant did not want to continue the study|0|||
128972216|NCT03261037|464182976|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
128972217|NCT03261037|464182977|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
128972218|NCT03261037|464182978|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
128972219|NCT03261037|464182979|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
128972220|NCT03261037|464182976|FG000|Overall Study|Participant presented clinical improvement|0|||
128972221|NCT03261037|464182977|FG001|Overall Study|Participant presented clinical improvement|2|||
128972222|NCT03261037|464182978|FG002|Overall Study|Participant presented clinical improvement|0|||
128972223|NCT03261037|464182979|FG003|Overall Study|Participant presented clinical improvement|0|||
128972224|NCT03261037|464182976|FG000|Overall Study|Technical difficulties|0|||
128972225|NCT03261037|464182977|FG001|Overall Study|Technical difficulties|0|||
128972226|NCT03261037|464182978|FG002|Overall Study|Technical difficulties|0|||
128972227|NCT03261037|464182979|FG003|Overall Study|Technical difficulties|1|||
128972228|NCT03261037|464182976|FG000|Overall Study|Equipment failed to work|0|||
128972229|NCT03261037|464182977|FG001|Overall Study|Equipment failed to work|0|||
128972230|NCT03261037|464182978|FG002|Overall Study|Equipment failed to work|0|||
128972231|NCT03261037|464182979|FG003|Overall Study|Equipment failed to work|1|||
128972232|NCT03261037|464182976|FG000|Overall Study|End of study for participant and no follow up|0|||
128972233|NCT03261037|464182977|FG001|Overall Study|End of study for participant and no follow up|0|||
128972234|NCT03261037|464182978|FG002|Overall Study|End of study for participant and no follow up|0|||
128972235|NCT03261037|464182979|FG003|Overall Study|End of study for participant and no follow up|1|||
128972236|NCT03261037|464182976|FG000|Overall Study|Participant was too weak to continue in study|1|||
128972237|NCT03261037|464182977|FG001|Overall Study|Participant was too weak to continue in study|0|||
128972238|NCT03261037|464182978|FG002|Overall Study|Participant was too weak to continue in study|0|||
128972239|NCT03261037|464182979|FG003|Overall Study|Participant was too weak to continue in study|0|||
129131333|NCT02969018|464772795|FG004|Overall Study|Protocol Violation|0|||
129131334|NCT02969018|464772796|FG005|Overall Study|Protocol Violation|0|||
129131335|NCT02969018|464772797|FG006|Overall Study|Protocol Violation|0|||
129131336|NCT02969018|464772798|FG007|Overall Study|Protocol Violation|0|||
129131337|NCT02969018|464772791|FG000|Overall Study|Withdrawal by Subject|0|||
129131338|NCT02969018|464772792|FG001|Overall Study|Withdrawal by Subject|1|||
129220688|NCT00357006|465108201|FG000|Overall Study|Lost to Follow-up|1|||
129220689|NCT00357006|465108202|FG001|Overall Study|Lost to Follow-up|2|||
129220690|NCT00357006|465108203|FG002|Overall Study|Lost to Follow-up|1|||
129220691|NCT00357006|465108201|FG000|Overall Study|Withdrawal by Subject|1|||
129220692|NCT00357006|465108202|FG001|Overall Study|Withdrawal by Subject|3|||
129220693|NCT00357006|465108203|FG002|Overall Study|Withdrawal by Subject|2|||
129220694|NCT00976560|465108204|FG000|Overall Study|Adverse Event|5|||
129220695|NCT00976560|465108205|FG001|Overall Study|Adverse Event|5|||
129220696|NCT00976560|465108204|FG000|Overall Study|Lack of Efficacy|3|||
129220697|NCT00976560|465108205|FG001|Overall Study|Lack of Efficacy|5|||
129220698|NCT00976560|465108204|FG000|Overall Study|Protocol Violation|1|||
129220699|NCT00976560|465108205|FG001|Overall Study|Protocol Violation|0|||
129220700|NCT00976560|465108204|FG000|Overall Study|Lost to Follow-up|1|||
129220701|NCT00976560|465108205|FG001|Overall Study|Lost to Follow-up|0|||
129220702|NCT00976560|465108204|FG000|Overall Study|Physician Decision|2|||
129220703|NCT00976560|465108205|FG001|Overall Study|Physician Decision|0|||
129220704|NCT00976560|465108204|FG000|Overall Study|Withdrawal by Subject|2|||
129220705|NCT00976560|465108205|FG001|Overall Study|Withdrawal by Subject|3|||
129220706|NCT03710161|465108206|FG000|Overall Study|Study halted due to COVID pandemic|3|||
129220707|NCT03710161|465108207|FG001|Overall Study|Study halted due to COVID pandemic|2|||
129220708|NCT03339219|465108215|FG000|Overall Study|Death|12|||
129220709|NCT03339219|465108215|FG000|Overall Study|Site Terminated by Sponsor|22|||
129220710|NCT03339219|465108215|FG000|Overall Study|Withdrawal by Subject|1|||
129220711|NCT01932437|465108217|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129220712|NCT01932437|465108218|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129220713|NCT01932437|465108219|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129220714|NCT01932437|465108220|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129131339|NCT02969018|464772793|FG002|Overall Study|Withdrawal by Subject|2|||
129131340|NCT02969018|464772794|FG003|Overall Study|Withdrawal by Subject|1|||
129131341|NCT02969018|464772795|FG004|Overall Study|Withdrawal by Subject|0|||
129131342|NCT02969018|464772796|FG005|Overall Study|Withdrawal by Subject|4|||
129131343|NCT02969018|464772797|FG006|Overall Study|Withdrawal by Subject|4|||
129131344|NCT02969018|464772798|FG007|Overall Study|Withdrawal by Subject|3|||
129131345|NCT04790201|464772802|FG000|Overall Study|Lost to Follow-up|0|||
129131346|NCT04790201|464772803|FG001|Overall Study|Lost to Follow-up|0|||
129131347|NCT04790201|464772804|FG002|Overall Study|Lost to Follow-up|2|||
129131348|NCT04790201|464772802|FG000|Overall Study|Death|0|||
129220715|NCT01932437|465108221|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129220716|NCT01932437|465108222|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
129220717|NCT00074490|465108223|FG000|Overall Study|Progressive malignancy|0|||
129220718|NCT00074490|465108224|FG001|Overall Study|Progressive malignancy|7|||
129220719|NCT00074490|465108225|FG002|Overall Study|Progressive malignancy|0|||
129220720|NCT00074490|465108226|FG003|Overall Study|Progressive malignancy|0|||
129220721|NCT00074490|465108227|FG004|Overall Study|Progressive malignancy|3|||
129220722|NCT00074490|465108228|FG005|Overall Study|Progressive malignancy|0|||
129220723|NCT00467753|465108234|FG000|Overall Study|Lost to Follow-up|1|||
129220724|NCT00467753|465108235|FG001|Overall Study|Lost to Follow-up|2|||
129220725|NCT00467753|465108234|FG000|Overall Study|Adverse Event|2|||
129220726|NCT00467753|465108235|FG001|Overall Study|Adverse Event|0|||
129220727|NCT02175030|465108236|FG000|Overall Study|Failed screen after consent|7|||
129220728|NCT02175030|465108237|FG001|Overall Study|Failed screen after consent|6|||
129220729|NCT02175030|465108236|FG000|Overall Study|Failed IUD Insertion|20|||
129220730|NCT02175030|465108237|FG001|Overall Study|Failed IUD Insertion|21|||
129220731|NCT02175030|465108236|FG000|Overall Study|Physician Decision|1|||
128774719|NCT04157686|463466656|FG004|Overall Study|Withdrawal by Subject|12|||
128972240|NCT04654468|464182986|FG000|Overall Study|Death|1|||
128972241|NCT04654468|464182986|FG000|Overall Study|Ongoing in the Study|50|||
128972242|NCT00081263|464182987|FG000|Overall Study|clerical error|1|||
128972243|NCT00081263|464182988|FG001|Overall Study|clerical error|0|||
129131349|NCT04790201|464772803|FG001|Overall Study|Death|1|||
128774720|NCT04157686|463466657|FG005|Overall Study|Withdrawal by Subject|11|||
128972244|NCT00081263|464182987|FG000|Overall Study|wrong cell type|7|||
128972245|NCT00081263|464182988|FG001|Overall Study|wrong cell type|5|||
128972246|NCT00081263|464182987|FG000|Overall Study|improper pre-protocol therapy|0|||
128972247|NCT00081263|464182988|FG001|Overall Study|improper pre-protocol therapy|1|||
129131350|NCT04790201|464772804|FG002|Overall Study|Death|0|||
129220732|NCT02175030|465108237|FG001|Overall Study|Physician Decision|1|||
129220733|NCT02175030|465108236|FG000|Overall Study|Lost to Follow-up|6|||
129220734|NCT02175030|465108237|FG001|Overall Study|Lost to Follow-up|6|||
129220735|NCT02175030|465108236|FG000|Overall Study|Withdrawal by Subject|1|||
129220736|NCT02175030|465108237|FG001|Overall Study|Withdrawal by Subject|4|||
129220737|NCT03695367|465108240|FG000|Overall Study|Missed the Day 28 visit.|1|||
129220738|NCT03695367|465108241|FG001|Overall Study|Missed the Day 28 visit.|0|||
128972248|NCT00081263|464182987|FG000|Overall Study|Inadequate pathology|0|||
129131351|NCT04790201|464772802|FG000|Overall Study|Protocol Violation|1|||
129131352|NCT04790201|464772803|FG001|Overall Study|Protocol Violation|0|||
129220739|NCT03695367|465108240|FG000|Overall Study|Lost to Follow-up|0|||
128972249|NCT00081263|464182988|FG001|Overall Study|Inadequate pathology|1|||
128972250|NCT00081263|464182987|FG000|Overall Study|Never treated|4|||
128972251|NCT00081263|464182988|FG001|Overall Study|Never treated|5|||
128972252|NCT00081263|464182987|FG000|Overall Study|Inadequate data|5|||
128972253|NCT00081263|464182988|FG001|Overall Study|Inadequate data|10|||
128972254|NCT04564027|464182993|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
128972255|NCT04564027|464182994|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
128972256|NCT04564027|464182995|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
128972257|NCT04564027|464182996|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
128972258|NCT00777036|464182997|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
128972259|NCT00777036|464182998|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
128972260|NCT00777036|464182999|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
128972261|NCT00777036|464183000|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
128972262|NCT00777036|464182997|FG000|On Treatment|Administrative Reason By Sponsor|1|||
128972263|NCT00777036|464182998|FG001|On Treatment|Administrative Reason By Sponsor|0|||
128972264|NCT00777036|464182999|FG002|On Treatment|Administrative Reason By Sponsor|9|||
128972265|NCT00777036|464183000|FG003|On Treatment|Administrative Reason By Sponsor|0|||
128972266|NCT00777036|464182997|FG000|On Treatment|Failure to Meet Study Criteria|0|||
128972267|NCT00777036|464182998|FG001|On Treatment|Failure to Meet Study Criteria|1|||
128972268|NCT00777036|464182999|FG002|On Treatment|Failure to Meet Study Criteria|4|||
128972269|NCT00777036|464183000|FG003|On Treatment|Failure to Meet Study Criteria|0|||
128972270|NCT00777036|464182997|FG000|On Treatment|Pregnancy|1|||
128972271|NCT00777036|464182998|FG001|On Treatment|Pregnancy|0|||
128972272|NCT00777036|464182999|FG002|On Treatment|Pregnancy|1|||
128972273|NCT00777036|464183000|FG003|On Treatment|Pregnancy|0|||
128972274|NCT00777036|464182997|FG000|On Treatment|Non-compliance with Study Drug|1|||
128972275|NCT00777036|464182998|FG001|On Treatment|Non-compliance with Study Drug|0|||
128972276|NCT00777036|464182999|FG002|On Treatment|Non-compliance with Study Drug|1|||
128972277|NCT00777036|464183000|FG003|On Treatment|Non-compliance with Study Drug|0|||
128972278|NCT00777036|464182997|FG000|On Treatment|Maximum Clinical Benefit|2|||
128972279|NCT00777036|464182998|FG001|On Treatment|Maximum Clinical Benefit|0|||
128972280|NCT00777036|464182999|FG002|On Treatment|Maximum Clinical Benefit|5|||
128972281|NCT00777036|464183000|FG003|On Treatment|Maximum Clinical Benefit|0|||
128972282|NCT00777036|464182997|FG000|On Treatment|Withdrawal by Subject|0|||
128972283|NCT00777036|464182998|FG001|On Treatment|Withdrawal by Subject|2|||
128972284|NCT00777036|464182999|FG002|On Treatment|Withdrawal by Subject|2|||
128972285|NCT00777036|464183000|FG003|On Treatment|Withdrawal by Subject|0|||
128972286|NCT00777036|464182997|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
128972287|NCT00777036|464182998|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
128972288|NCT00777036|464182999|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
128972289|NCT00777036|464183000|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
128972290|NCT00777036|464182997|FG000|On Treatment|Death|0|||
128972291|NCT00777036|464182998|FG001|On Treatment|Death|2|||
128972292|NCT00777036|464182999|FG002|On Treatment|Death|0|||
128972293|NCT00777036|464183000|FG003|On Treatment|Death|0|||
128972294|NCT00777036|464182997|FG000|On Treatment|Study Drug Toxicity|1|||
128972295|NCT00777036|464182998|FG001|On Treatment|Study Drug Toxicity|0|||
128972296|NCT00777036|464182999|FG002|On Treatment|Study Drug Toxicity|4|||
128972297|NCT00777036|464183000|FG003|On Treatment|Study Drug Toxicity|0|||
128972298|NCT00777036|464182997|FG000|On Treatment|Progressive Disease|6|||
128972299|NCT00777036|464182998|FG001|On Treatment|Progressive Disease|4|||
128972300|NCT00777036|464182999|FG002|On Treatment|Progressive Disease|7|||
128972301|NCT00777036|464183000|FG003|On Treatment|Progressive Disease|0|||
128972302|NCT00777036|464182997|FG000|On Treatment|Not Reported|0|||
128972303|NCT00777036|464182998|FG001|On Treatment|Not Reported|0|||
128972304|NCT00777036|464182999|FG002|On Treatment|Not Reported|2|||
128972305|NCT00777036|464183000|FG003|On Treatment|Not Reported|0|||
128972306|NCT00777036|464182997|FG000|On Treatment|Site Closed|0|||
128972307|NCT00777036|464182998|FG001|On Treatment|Site Closed|1|||
128972308|NCT00777036|464182999|FG002|On Treatment|Site Closed|1|||
128972309|NCT00777036|464183000|FG003|On Treatment|Site Closed|0|||
128972310|NCT00777036|464182997|FG000|Follow-Up|Withdrawal by Subject|0|||
128972311|NCT00777036|464182998|FG001|Follow-Up|Withdrawal by Subject|0|||
128972312|NCT00777036|464182999|FG002|Follow-Up|Withdrawal by Subject|5|||
128972313|NCT00777036|464183000|FG003|Follow-Up|Withdrawal by Subject|0|||
128972314|NCT00777036|464182997|FG000|Follow-Up|Death|1|||
128972315|NCT00777036|464182998|FG001|Follow-Up|Death|9|||
128972316|NCT00777036|464182999|FG002|Follow-Up|Death|0|||
128972317|NCT00777036|464183000|FG003|Follow-Up|Death|0|||
128972318|NCT00777036|464182997|FG000|Follow-Up|Lost to Follow-up|3|||
128972319|NCT00777036|464182998|FG001|Follow-Up|Lost to Follow-up|0|||
128972320|NCT00777036|464182999|FG002|Follow-Up|Lost to Follow-up|0|||
128972321|NCT00777036|464183000|FG003|Follow-Up|Lost to Follow-up|0|||
128972322|NCT00777036|464182997|FG000|Follow-Up|Reason Not Specified|4|||
128972323|NCT00777036|464182998|FG001|Follow-Up|Reason Not Specified|0|||
128972324|NCT00777036|464182999|FG002|Follow-Up|Reason Not Specified|13|||
128972325|NCT00777036|464183000|FG003|Follow-Up|Reason Not Specified|0|||
128715634|NCT04734652|463255787|FG001|Overall Study|Death|1|||
128972326|NCT00777036|464182997|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
128972327|NCT00777036|464182998|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
128972328|NCT00777036|464182999|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
128972329|NCT00777036|464183000|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
128972330|NCT01267955|464183001|FG000|Stage 1 (6 Months)|Death|3|||
128972331|NCT01267955|464183001|FG000|Stage 2 (6 Months)|Death|5|||
128972332|NCT01267955|464183001|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
128972333|NCT05827978|464183002|FG000|Overall Study|Adverse Event|1|||
128972334|NCT05827978|464183003|FG001|Overall Study|Adverse Event|0|||
128972335|NCT05827978|464183004|FG002|Overall Study|Adverse Event|0|||
128972336|NCT05827978|464183005|FG003|Overall Study|Adverse Event|1|||
128972337|NCT05827978|464183006|FG004|Overall Study|Adverse Event|0|||
128972338|NCT05827978|464183007|FG005|Overall Study|Adverse Event|0|||
128972339|NCT05827978|464183002|FG000|Overall Study|Death|1|||
128972340|NCT05827978|464183003|FG001|Overall Study|Death|5|||
128972341|NCT05827978|464183004|FG002|Overall Study|Death|2|||
128972342|NCT05827978|464183005|FG003|Overall Study|Death|3|||
128972343|NCT05827978|464183006|FG004|Overall Study|Death|1|||
128972344|NCT05827978|464183007|FG005|Overall Study|Death|3|||
128972345|NCT05827978|464183002|FG000|Overall Study|Lost to Follow-up|57|||
128972346|NCT05827978|464183003|FG001|Overall Study|Lost to Follow-up|88|||
128972347|NCT05827978|464183004|FG002|Overall Study|Lost to Follow-up|54|||
128972348|NCT05827978|464183005|FG003|Overall Study|Lost to Follow-up|47|||
128972349|NCT05827978|464183006|FG004|Overall Study|Lost to Follow-up|25|||
128972350|NCT05827978|464183007|FG005|Overall Study|Lost to Follow-up|10|||
128972351|NCT05827978|464183002|FG000|Overall Study|Noncompliance with Study Procedures|0|||
128972352|NCT05827978|464183003|FG001|Overall Study|Noncompliance with Study Procedures|1|||
128972353|NCT05827978|464183004|FG002|Overall Study|Noncompliance with Study Procedures|1|||
128972354|NCT05827978|464183005|FG003|Overall Study|Noncompliance with Study Procedures|1|||
128972355|NCT05827978|464183006|FG004|Overall Study|Noncompliance with Study Procedures|1|||
128972356|NCT05827978|464183007|FG005|Overall Study|Noncompliance with Study Procedures|0|||
128972357|NCT05827978|464183002|FG000|Overall Study|Physician Decision|2|||
128972358|NCT05827978|464183003|FG001|Overall Study|Physician Decision|0|||
128972359|NCT05827978|464183004|FG002|Overall Study|Physician Decision|1|||
128972360|NCT05827978|464183005|FG003|Overall Study|Physician Decision|2|||
128972361|NCT05827978|464183006|FG004|Overall Study|Physician Decision|1|||
128972362|NCT05827978|464183007|FG005|Overall Study|Physician Decision|1|||
128972363|NCT05827978|464183002|FG000|Overall Study|Protocol Violation|5|||
128972364|NCT05827978|464183003|FG001|Overall Study|Protocol Violation|2|||
128972365|NCT05827978|464183004|FG002|Overall Study|Protocol Violation|0|||
128972366|NCT05827978|464183005|FG003|Overall Study|Protocol Violation|0|||
128972367|NCT05827978|464183006|FG004|Overall Study|Protocol Violation|0|||
128715635|NCT05407675|463255788|FG000|Overall Study|Withdrawal by Subject|0|||
128972368|NCT05827978|464183007|FG005|Overall Study|Protocol Violation|0|||
128972369|NCT05827978|464183002|FG000|Overall Study|Withdrawal by Subject|17|||
128972370|NCT05827978|464183003|FG001|Overall Study|Withdrawal by Subject|16|||
128972371|NCT05827978|464183004|FG002|Overall Study|Withdrawal by Subject|10|||
128972372|NCT05827978|464183005|FG003|Overall Study|Withdrawal by Subject|12|||
128972373|NCT05827978|464183006|FG004|Overall Study|Withdrawal by Subject|10|||
128972374|NCT05827978|464183007|FG005|Overall Study|Withdrawal by Subject|9|||
128972375|NCT05827978|464183002|FG000|Overall Study|Other Than Specified|0|||
128972376|NCT05827978|464183003|FG001|Overall Study|Other Than Specified|0|||
129038467|NCT02973321|464433181|FG000|Overall Study|Adverse Event|1|||
129038468|NCT02973321|464433182|FG001|Overall Study|Adverse Event|10|||
129038469|NCT02973321|464433183|FG002|Overall Study|Adverse Event|11|||
129038470|NCT02973321|464433184|FG003|Overall Study|Adverse Event|13|||
129038471|NCT02973321|464433185|FG004|Overall Study|Adverse Event|3|||
129038472|NCT01790113|464433192|FG000|Overall Study|Adverse Event|2|||
129038473|NCT01790113|464433193|FG001|Overall Study|Adverse Event|7|||
129038474|NCT01790113|464433192|FG000|Overall Study|Study ended due to FDA clearance|1|||
129038475|NCT01790113|464433193|FG001|Overall Study|Study ended due to FDA clearance|68|||
129038476|NCT00194792|464433194|FG000|Overall Study|Withdrawal by Subject|1|||
129038477|NCT01714739|464433195|FG000|Overall Study|Disease progression|3|||
129038478|NCT01714739|464433196|FG001|Overall Study|Disease progression|5|||
129038479|NCT01714739|464433197|FG002|Overall Study|Disease progression|5|||
129038480|NCT01714739|464433198|FG003|Overall Study|Disease progression|204|||
129038481|NCT01714739|464433199|FG004|Overall Study|Disease progression|1|||
129038482|NCT01714739|464433200|FG005|Overall Study|Disease progression|3|||
129038483|NCT01714739|464433201|FG006|Overall Study|Disease progression|5|||
129038484|NCT01714739|464433195|FG000|Overall Study|Study drug toxicity|1|||
129038485|NCT01714739|464433196|FG001|Overall Study|Study drug toxicity|1|||
129038486|NCT01714739|464433197|FG002|Overall Study|Study drug toxicity|1|||
129038487|NCT01714739|464433198|FG003|Overall Study|Study drug toxicity|15|||
129038488|NCT01714739|464433199|FG004|Overall Study|Study drug toxicity|0|||
129038489|NCT01714739|464433200|FG005|Overall Study|Study drug toxicity|0|||
129038490|NCT01714739|464433201|FG006|Overall Study|Study drug toxicity|5|||
129038491|NCT01714739|464433195|FG000|Overall Study|Death|0|||
129220740|NCT03695367|465108241|FG001|Overall Study|Lost to Follow-up|1|||
129220741|NCT03695367|465108240|FG000|Overall Study|Withdrawal by Subject|0|||
129220742|NCT03695367|465108241|FG001|Overall Study|Withdrawal by Subject|1|||
129220743|NCT03695367|465108240|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
129220744|NCT03695367|465108241|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
129220745|NCT01077050|465110052|FG000|Overall Study|Subjects signed ICF could not be located|1|||
129220746|NCT01077050|465110052|FG000|Overall Study|Screen failure|8|||
129220747|NCT00684060|465110053|FG000|Overall Study|Lost to Follow-up|1|||
129220748|NCT00684060|465110054|FG001|Overall Study|Lost to Follow-up|0|||
129220749|NCT00684060|465110053|FG000|Overall Study|New stenosis identified|1|||
129220750|NCT00684060|465110054|FG001|Overall Study|New stenosis identified|0|||
129220751|NCT00684060|465110053|FG000|Overall Study|Unable to collect MRI|1|||
129220752|NCT00684060|465110054|FG001|Overall Study|Unable to collect MRI|2|||
129220753|NCT00684060|465110053|FG000|Overall Study|Death|0|||
129220754|NCT00684060|465110054|FG001|Overall Study|Death|1|||
129220755|NCT00702715|465110059|FG000|Overall Study|Lost to Follow-up|1|||
129220756|NCT00702715|465110060|FG001|Overall Study|Lost to Follow-up|0|||
129220757|NCT03751657|465110061|FG000|Overall Study|Physician Decision|0|||
129220758|NCT03751657|465110062|FG001|Overall Study|Physician Decision|1|||
129220759|NCT03751657|465110061|FG000|Overall Study|Withdrawal by Subject|1|||
129220760|NCT03751657|465110062|FG001|Overall Study|Withdrawal by Subject|1|||
129220761|NCT03751657|465110061|FG000|Overall Study|Lost to Follow-up|2|||
129220762|NCT03751657|465110062|FG001|Overall Study|Lost to Follow-up|1|||
129220763|NCT02736890|465110066|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
129220764|NCT02736890|465110067|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
129220765|NCT02736890|465110066|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
129220766|NCT02736890|465110067|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
129220767|NCT02904954|465110068|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
129220768|NCT02904954|465110069|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
129220769|NCT02904954|465110068|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
129220770|NCT02904954|465110069|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
129220771|NCT02904954|465110068|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
129220772|NCT02904954|465110069|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
129220773|NCT02904954|465110068|FG000|Adjuvant Durvalumab|Recurrence|2|||
129220774|NCT02904954|465110069|FG001|Adjuvant Durvalumab|Recurrence|0|||
129220775|NCT02904954|465110068|FG000|Adjuvant Durvalumab|Adverse Event|2|||
129220776|NCT02904954|465110069|FG001|Adjuvant Durvalumab|Adverse Event|6|||
129220777|NCT02904954|465110068|FG000|Adjuvant Durvalumab|Participant wishes|12|||
129220778|NCT02904954|465110069|FG001|Adjuvant Durvalumab|Participant wishes|7|||
129220779|NCT02904954|465110068|FG000|Adjuvant Durvalumab|Physician Decision|2|||
129220780|NCT02904954|465110069|FG001|Adjuvant Durvalumab|Physician Decision|1|||
129220781|NCT02904954|465110068|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
129220782|NCT02904954|465110069|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
129220783|NCT02904954|465110068|FG000|Adjuvant Durvalumab|Death|0|||
129220784|NCT02904954|465110069|FG001|Adjuvant Durvalumab|Death|1|||
129220785|NCT02904954|465110068|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
129220786|NCT02904954|465110069|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
129220787|NCT05097963|465110070|FG000|Overall Study|Protocol Violation|13|||
129220788|NCT05097963|465110070|FG000|Overall Study|Withdrawal by Subject|21|||
129220789|NCT02948634|465110071|FG000|Overall Study|Lack of efficacy and study suspended|10|||
129220790|NCT02948634|465110072|FG001|Overall Study|Lack of efficacy and study suspended|2|||
129220791|NCT03830892|465110073|FG000|Overall Study|Physician Decision|2|||
129220792|NCT03830892|465110074|FG001|Overall Study|Physician Decision|3|||
129220793|NCT03830892|465110073|FG000|Overall Study|Study terminated due to COVID|4|||
129220794|NCT03830892|465110074|FG001|Overall Study|Study terminated due to COVID|0|||
129220795|NCT03830892|465110073|FG000|Overall Study|Protocol Violation|0|||
129220796|NCT03830892|465110074|FG001|Overall Study|Protocol Violation|1|||
129220797|NCT03830892|465110073|FG000|Overall Study|Withdrawal by Subject|0|||
129131353|NCT04790201|464772804|FG002|Overall Study|Protocol Violation|1|||
129131354|NCT05762679|464772807|FG000|Overall Study|Withdrawal by Subject|1|||
129131355|NCT05762679|464772807|FG000|Overall Study|No analyzable imaging data|1|||
129131356|NCT03670628|464772808|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
129131357|NCT03670628|464772809|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
129131358|NCT03670628|464772808|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
129131359|NCT03670628|464772809|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
129131360|NCT04339972|464772810|FG000|Overall Study|Scheduling Issues|3|||
129131361|NCT04339972|464772811|FG001|Overall Study|Scheduling Issues|3|||
129220798|NCT03830892|465110074|FG001|Overall Study|Withdrawal by Subject|2|||
129220799|NCT03675321|465110075|FG000|Overall Study|Lack of Efficacy|2|||
129220800|NCT03675321|465110076|FG001|Overall Study|Lack of Efficacy|2|||
129220801|NCT03675321|465110075|FG000|Overall Study|Withdrawal by Subject|1|||
129220802|NCT03675321|465110076|FG001|Overall Study|Withdrawal by Subject|3|||
129220803|NCT01491607|465110082|FG000|Overall Study|Lost to Follow-up|7|||
129220804|NCT01491607|465110082|FG000|Overall Study|Withdrawal by Subject|3|||
129220805|NCT01317277|465110083|FG000|Overall Study|Lost to Follow-up|3|||
129220806|NCT01317277|465110084|FG001|Overall Study|Lost to Follow-up|1|||
129220807|NCT01317277|465110083|FG000|Overall Study|Lost MEMS|1|||
129220808|NCT01317277|465110084|FG001|Overall Study|Lost MEMS|1|||
129220809|NCT01317277|465110083|FG000|Overall Study|Unable to comply with intervention|1|||
129220810|NCT01317277|465110084|FG001|Overall Study|Unable to comply with intervention|0|||
129220811|NCT01317277|465110083|FG000|Overall Study|Withdrawal by Subject|1|||
129220812|NCT01317277|465110084|FG001|Overall Study|Withdrawal by Subject|0|||
129220813|NCT01317277|465110083|FG000|Overall Study|Adverse Event|1|||
129220814|NCT01317277|465110084|FG001|Overall Study|Adverse Event|0|||
129220815|NCT00774566|465110085|FG000|Overall Study|Protocol Violation|18|||
129220816|NCT00774566|465110086|FG001|Overall Study|Protocol Violation|15|||
129220817|NCT02999672|465110093|FG000|Overall Study|Death|0|||
129220818|NCT02999672|465110094|FG001|Overall Study|Death|1|||
129220819|NCT02999672|465110093|FG000|Overall Study|Study Terminated by Sponsor|0|||
129220820|NCT02999672|465110094|FG001|Overall Study|Study Terminated by Sponsor|1|||
129220821|NCT02999672|465110093|FG000|Overall Study|Progressive Disease|9|||
129220822|NCT02999672|465110094|FG001|Overall Study|Progressive Disease|5|||
129220823|NCT02999672|465110093|FG000|Overall Study|Adverse Event|4|||
129220824|NCT02999672|465110094|FG001|Overall Study|Adverse Event|0|||
129220825|NCT03565497|465110095|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
129220826|NCT03565497|465110096|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
129220827|NCT03565497|465110097|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
129220828|NCT03565497|465110095|FG000|Overall Study|Lost to Follow-up|1|||
129220829|NCT03565497|465110096|FG001|Overall Study|Lost to Follow-up|1|||
129220830|NCT03565497|465110097|FG002|Overall Study|Lost to Follow-up|2|||
129220831|NCT03565497|465110095|FG000|Overall Study|Withdrawal by Subject|1|||
129220832|NCT03565497|465110096|FG001|Overall Study|Withdrawal by Subject|1|||
129220833|NCT03565497|465110097|FG002|Overall Study|Withdrawal by Subject|1|||
129220834|NCT01075685|465110098|FG000|Overall Study|Protocol Violation|9|||
129220835|NCT01075685|465110099|FG001|Overall Study|Protocol Violation|1|||
129220836|NCT01075685|465110098|FG000|Overall Study|Withdrawal by Subject|20|||
129220837|NCT01075685|465110099|FG001|Overall Study|Withdrawal by Subject|5|||
129220838|NCT01075685|465110098|FG000|Overall Study|Lost to Follow-up|563|||
129220839|NCT01075685|465110099|FG001|Overall Study|Lost to Follow-up|220|||
129220840|NCT02858362|465110102|FG000|Overall Study|Protocol Violation|0|||
129220841|NCT02858362|465110103|FG001|Overall Study|Protocol Violation|1|||
129220842|NCT02858362|465110104|FG002|Overall Study|Protocol Violation|0|||
129220843|NCT02858362|465110102|FG000|Overall Study|Withdrawal by Subject|1|||
129220844|NCT02858362|465110103|FG001|Overall Study|Withdrawal by Subject|0|||
129220845|NCT02858362|465110104|FG002|Overall Study|Withdrawal by Subject|0|||
129220846|NCT02858362|465110102|FG000|Overall Study|Early Study Termination|0|||
129220847|NCT02858362|465110103|FG001|Overall Study|Early Study Termination|0|||
129220848|NCT02858362|465110104|FG002|Overall Study|Early Study Termination|3|||
129220849|NCT02858362|465110102|FG000|Overall Study|Lost to Follow-up|1|||
129220850|NCT02858362|465110103|FG001|Overall Study|Lost to Follow-up|0|||
129220851|NCT02858362|465110104|FG002|Overall Study|Lost to Follow-up|0|||
129220852|NCT01301027|465110106|FG000|Overall Study|Physician Decision|2|||
129220853|NCT01301027|465110107|FG001|Overall Study|Physician Decision|0|||
129220854|NCT01301027|465110106|FG000|Overall Study|Withdrawal by Subject|2|||
128715636|NCT05407675|463255789|FG001|Overall Study|Withdrawal by Subject|2|||
129038492|NCT01714739|464433196|FG001|Overall Study|Death|0|||
129038493|NCT01714739|464433197|FG002|Overall Study|Death|0|||
129038494|NCT01714739|464433198|FG003|Overall Study|Death|1|||
129038495|NCT01714739|464433199|FG004|Overall Study|Death|0|||
129038496|NCT01714739|464433200|FG005|Overall Study|Death|0|||
129038497|NCT01714739|464433201|FG006|Overall Study|Death|0|||
129038498|NCT01714739|464433195|FG000|Overall Study|Adverse Event unrelated to drug|0|||
129038499|NCT01714739|464433196|FG001|Overall Study|Adverse Event unrelated to drug|0|||
129038500|NCT01714739|464433197|FG002|Overall Study|Adverse Event unrelated to drug|3|||
129038501|NCT01714739|464433198|FG003|Overall Study|Adverse Event unrelated to drug|21|||
129038502|NCT01714739|464433199|FG004|Overall Study|Adverse Event unrelated to drug|0|||
129038503|NCT01714739|464433200|FG005|Overall Study|Adverse Event unrelated to drug|0|||
129038504|NCT01714739|464433201|FG006|Overall Study|Adverse Event unrelated to drug|0|||
129038505|NCT01714739|464433195|FG000|Overall Study|Participant request to stop therapy|0|||
129038506|NCT01714739|464433196|FG001|Overall Study|Participant request to stop therapy|1|||
129038507|NCT01714739|464433197|FG002|Overall Study|Participant request to stop therapy|0|||
129038508|NCT01714739|464433198|FG003|Overall Study|Participant request to stop therapy|6|||
129038509|NCT01714739|464433199|FG004|Overall Study|Participant request to stop therapy|0|||
129038510|NCT01714739|464433200|FG005|Overall Study|Participant request to stop therapy|0|||
129038511|NCT01714739|464433201|FG006|Overall Study|Participant request to stop therapy|0|||
129038512|NCT01714739|464433195|FG000|Overall Study|Participant withdrew consent|0|||
129038513|NCT01714739|464433196|FG001|Overall Study|Participant withdrew consent|1|||
128972377|NCT05827978|464183004|FG002|Overall Study|Other Than Specified|1|||
128972378|NCT05827978|464183005|FG003|Overall Study|Other Than Specified|0|||
128972379|NCT05827978|464183006|FG004|Overall Study|Other Than Specified|2|||
128972380|NCT05827978|464183007|FG005|Overall Study|Other Than Specified|0|||
128972381|NCT04651777|464183008|FG000|Overall Study|Adverse Event|1|||
128972382|NCT04651777|464183008|FG000|Overall Study|Withdrawal by Subject|2|||
128972383|NCT04566445|464183009|FG000|Overall Study|Death|4|||
128972384|NCT04566445|464183010|FG001|Overall Study|Death|1|||
128972385|NCT04566445|464183011|FG002|Overall Study|Death|1|||
128972386|NCT04566445|464183009|FG000|Overall Study|Lost to Follow-up|3|||
128972387|NCT04566445|464183010|FG001|Overall Study|Lost to Follow-up|1|||
128972388|NCT04566445|464183011|FG002|Overall Study|Lost to Follow-up|1|||
128972389|NCT04566445|464183009|FG000|Overall Study|Study terminated by sponsor|11|||
128972390|NCT04566445|464183010|FG001|Overall Study|Study terminated by sponsor|17|||
128972391|NCT04566445|464183011|FG002|Overall Study|Study terminated by sponsor|32|||
128972392|NCT04566445|464183009|FG000|Overall Study|Withdrawal by Subject|12|||
128972393|NCT04566445|464183010|FG001|Overall Study|Withdrawal by Subject|14|||
128972394|NCT04566445|464183011|FG002|Overall Study|Withdrawal by Subject|13|||
128972395|NCT04566445|464183009|FG000|Overall Study|Randomized but not treated due to AE|2|||
128972396|NCT04566445|464183010|FG001|Overall Study|Randomized but not treated due to AE|1|||
128972397|NCT04566445|464183011|FG002|Overall Study|Randomized but not treated due to AE|0|||
128972398|NCT04566445|464183009|FG000|Overall Study|Adverse Event|1|||
128972399|NCT04566445|464183010|FG001|Overall Study|Adverse Event|1|||
128972400|NCT04566445|464183011|FG002|Overall Study|Adverse Event|0|||
128972401|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
128972402|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
128972403|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
128972404|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
128972405|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Death|38|||
128972406|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Death|10|||
128972407|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
128972408|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
128972409|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
128972410|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
128972411|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
128972412|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
128972413|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
128972414|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
128972415|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
128972416|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
128972417|NCT02421939|464183012|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
128972418|NCT02421939|464183013|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
128972419|NCT02421939|464183012|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
128972420|NCT02421939|464183013|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
128972421|NCT02421939|464183012|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
128972422|NCT02421939|464183013|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
128972423|NCT02421939|464183012|FG000|Long Term Follow up: up to 3 Years|Death|118|||
128972424|NCT02421939|464183013|FG001|Long Term Follow up: up to 3 Years|Death|65|||
128972425|NCT02421939|464183012|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
128972426|NCT02421939|464183013|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
128972427|NCT00729560|464183014|FG000|Overall Study|Withdrawal by Subject|3|||
128972428|NCT00103207|464183015|FG000|Overall Study|Adverse Event|3|||
128972429|NCT00103207|464183015|FG000|Overall Study|Death|1|||
128972430|NCT00103207|464183015|FG000|Overall Study|Withdrawal by Subject|2|||
128972431|NCT00103207|464183015|FG000|Overall Study|Other complicating disease|1|||
128972432|NCT00103207|464183015|FG000|Overall Study|Ineligible|4|||
128972433|NCT00103207|464183015|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
128972434|NCT03662789|464183016|FG000|Overall Study|Lost to Follow-up|1|||
128972435|NCT03662789|464183017|FG001|Overall Study|Lost to Follow-up|2|||
128972436|NCT03662789|464183016|FG000|Overall Study|Could not perform treadmill test|4|||
128972437|NCT03662789|464183017|FG001|Overall Study|Could not perform treadmill test|4|||
128972438|NCT03662789|464183016|FG000|Overall Study|Death|0|||
128972439|NCT03662789|464183017|FG001|Overall Study|Death|1|||
129220855|NCT01301027|465110107|FG001|Overall Study|Withdrawal by Subject|3|||
129220856|NCT01301027|465110106|FG000|Overall Study|Adverse Event|0|||
129220857|NCT01301027|465110107|FG001|Overall Study|Adverse Event|2|||
128972440|NCT02559115|464183018|FG000|Overall Study|Withdrawal by Subject|3|||
128972441|NCT02060903|464183021|FG000|Overall Study|Lost to Follow-up|4|||
128972442|NCT02060903|464183022|FG001|Overall Study|Lost to Follow-up|0|||
128972443|NCT02060903|464183021|FG000|Overall Study|Withdrawal by Subject|0|||
128972444|NCT02060903|464183022|FG001|Overall Study|Withdrawal by Subject|7|||
128972445|NCT00137267|464183023|FG000|Overall Study|Lost to Follow-up|15|||
128972446|NCT00137267|464183024|FG001|Overall Study|Lost to Follow-up|21|||
128972447|NCT00638989|464183025|FG000|Overall Study|Lost to Follow-up|0|||
128972448|NCT00638989|464183026|FG001|Overall Study|Lost to Follow-up|0|||
128972449|NCT00638989|464183027|FG002|Overall Study|Lost to Follow-up|1|||
128972450|NCT02871791|464183033|FG000|Phase 1b|Death|0|||
128972451|NCT02871791|464183034|FG001|Phase 1b|Death|1|||
128972452|NCT02871791|464183033|FG000|Phase 1b|progressive disease|6|||
128972453|NCT02871791|464183034|FG001|Phase 1b|progressive disease|2|||
128972454|NCT02871791|464183033|FG000|Phase 2|Death|1|||
128972455|NCT02871791|464183034|FG001|Phase 2|Death|0|||
128972456|NCT02871791|464183033|FG000|Phase 2|Lost to Follow-up|2|||
128972457|NCT02871791|464183034|FG001|Phase 2|Lost to Follow-up|0|||
128972458|NCT04005755|464183035|FG000|Overall Study|Adverse Event|6|||
128972459|NCT04005755|464183035|FG000|Overall Study|Physician Decision|3|||
128972460|NCT04005755|464183035|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
128972461|NCT04005755|464183035|FG000|Overall Study|Withdrawal by Subject|3|||
128972462|NCT04005755|464183035|FG000|Overall Study|Lost to Follow-up|1|||
128972463|NCT02750501|464183036|FG000|Overall Study|Adverse Event|4|||
128972464|NCT02750501|464183036|FG000|Overall Study|Physician Decision|1|||
128972465|NCT02750501|464183036|FG000|Overall Study|Protocol Violation|1|||
128972466|NCT02750501|464183036|FG000|Overall Study|G-tube came out|1|||
128972467|NCT02750501|464183036|FG000|Overall Study|Non-compliant use of PERT|1|||
128972468|NCT01738594|464183037|FG000|Registration and Treatment Start|Adverse Event|0|||
128972469|NCT01738594|464183038|FG001|Registration and Treatment Start|Adverse Event|1|||
128972470|NCT01738594|464183039|FG002|Registration and Treatment Start|Adverse Event|0|||
128972471|NCT01738594|464183040|FG003|Registration and Treatment Start|Adverse Event|0|||
128972472|NCT01738594|464183041|FG004|Registration and Treatment Start|Adverse Event|0|||
128972473|NCT01738594|464183042|FG005|Registration and Treatment Start|Adverse Event|0|||
128972474|NCT01738594|464183043|FG006|Registration and Treatment Start|Adverse Event|0|||
128972475|NCT01738594|464183044|FG007|Registration and Treatment Start|Adverse Event|0|||
128972476|NCT01738594|464183037|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
128972477|NCT01738594|464183038|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
128972478|NCT01738594|464183039|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
128972479|NCT01738594|464183040|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
128972480|NCT01738594|464183041|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
128972481|NCT01738594|464183042|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
128972482|NCT01738594|464183043|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
128972483|NCT01738594|464183044|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
128972484|NCT01738594|464183037|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
128972485|NCT01738594|464183038|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
128972486|NCT01738594|464183039|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
128972487|NCT01738594|464183040|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
128972488|NCT01738594|464183041|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
128972489|NCT01738594|464183042|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
128972490|NCT01738594|464183043|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
128972491|NCT01738594|464183044|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
128972492|NCT01738594|464183037|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
128972493|NCT01738594|464183038|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
128972494|NCT01738594|464183039|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
128972495|NCT01738594|464183040|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
128972496|NCT01738594|464183041|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
128972497|NCT01738594|464183042|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
128972498|NCT01738594|464183043|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
128972499|NCT01738594|464183044|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
128972500|NCT01738594|464183037|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
128972501|NCT01738594|464183038|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
128972502|NCT01738594|464183039|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
128972503|NCT01738594|464183040|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
128972504|NCT01738594|464183041|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129220858|NCT01301027|465110106|FG000|Overall Study|Fracture|1|||
129220859|NCT01301027|465110107|FG001|Overall Study|Fracture|3|||
129220860|NCT01301027|465110106|FG000|Overall Study|Transplant|0|||
129220861|NCT01301027|465110107|FG001|Overall Study|Transplant|2|||
129220862|NCT01301027|465110106|FG000|Overall Study|Volume Overload|3|||
129220863|NCT01301027|465110107|FG001|Overall Study|Volume Overload|0|||
128972505|NCT01738594|464183042|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
128972506|NCT01738594|464183043|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
128972507|NCT01738594|464183044|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
128972508|NCT01738594|464183037|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
128972509|NCT01738594|464183038|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
128972510|NCT01738594|464183039|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
128972511|NCT01738594|464183040|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129220864|NCT02023697|465110108|FG000|Treatment Period|Radiological progression|13|||
129220865|NCT02023697|465110109|FG001|Treatment Period|Radiological progression|17|||
129220866|NCT02023697|465110110|FG002|Treatment Period|Radiological progression|26|||
129220867|NCT02023697|465110108|FG000|Treatment Period|Never Treated|5|||
129220868|NCT02023697|465110109|FG001|Treatment Period|Never Treated|6|||
129220869|NCT02023697|465110110|FG002|Treatment Period|Never Treated|10|||
129220870|NCT02023697|465110108|FG000|Treatment Period|Adverse Event|13|||
129220871|NCT02023697|465110109|FG001|Treatment Period|Adverse Event|25|||
129220872|NCT02023697|465110110|FG002|Treatment Period|Adverse Event|23|||
129220873|NCT02023697|465110108|FG000|Treatment Period|Logistical difficulties|1|||
129220874|NCT02023697|465110109|FG001|Treatment Period|Logistical difficulties|1|||
129220875|NCT02023697|465110110|FG002|Treatment Period|Logistical difficulties|1|||
129220876|NCT02023697|465110108|FG000|Treatment Period|Clinical progression|10|||
128972512|NCT01738594|464183041|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
128972513|NCT01738594|464183042|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
128972514|NCT01738594|464183043|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
128972515|NCT01738594|464183044|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
128972516|NCT01738594|464183037|FG000|Follow up for 1 Year|Death|0|||
128972517|NCT01738594|464183038|FG001|Follow up for 1 Year|Death|0|||
128972518|NCT01738594|464183039|FG002|Follow up for 1 Year|Death|0|||
128972519|NCT01738594|464183040|FG003|Follow up for 1 Year|Death|0|||
128972520|NCT01738594|464183041|FG004|Follow up for 1 Year|Death|0|||
128972521|NCT01738594|464183042|FG005|Follow up for 1 Year|Death|1|||
128972522|NCT01738594|464183043|FG006|Follow up for 1 Year|Death|0|||
128972523|NCT01738594|464183044|FG007|Follow up for 1 Year|Death|0|||
128972524|NCT01738594|464183037|FG000|Follow up for 1 Year|Other|0|||
128972525|NCT01738594|464183038|FG001|Follow up for 1 Year|Other|0|||
128972526|NCT01738594|464183039|FG002|Follow up for 1 Year|Other|0|||
128972527|NCT01738594|464183040|FG003|Follow up for 1 Year|Other|0|||
128972528|NCT01738594|464183041|FG004|Follow up for 1 Year|Other|0|||
128972529|NCT01738594|464183042|FG005|Follow up for 1 Year|Other|2|||
128972530|NCT01738594|464183043|FG006|Follow up for 1 Year|Other|0|||
128972531|NCT01738594|464183044|FG007|Follow up for 1 Year|Other|0|||
128972532|NCT00403390|464183045|FG000|Overall Study|Withdrawal by Subject|1|||
128972533|NCT00403390|464183046|FG001|Overall Study|Withdrawal by Subject|0|||
128972534|NCT00403390|464183045|FG000|Overall Study|samples lost|1|||
128972535|NCT00403390|464183046|FG001|Overall Study|samples lost|0|||
128972536|NCT00403390|464183045|FG000|Overall Study|non-compliant|1|||
128972537|NCT00403390|464183046|FG001|Overall Study|non-compliant|0|||
128972538|NCT03117309|464183047|FG000|Overall Study|Not meeting inclusion criteria|0|||
128972539|NCT03117309|464183048|FG001|Overall Study|Not meeting inclusion criteria|1|||
128972540|NCT01010776|464183054|FG000|Main Phase|Withdrawal by Subject|14|||
128972541|NCT01010776|464183054|FG000|Main Phase|Lack of Efficacy|8|||
128972542|NCT01010776|464183054|FG000|Main Phase|Adverse Event|7|||
128972543|NCT01010776|464183054|FG000|Main Phase|Lost to Follow-up|6|||
128972544|NCT01010776|464183054|FG000|Main Phase|Non-compliance to study medication|5|||
128972545|NCT01010776|464183054|FG000|Main Phase|Selection failure|2|||
128972546|NCT01010776|464183054|FG000|Main Phase|Inform consent withdrawal|1|||
128972547|NCT01010776|464183054|FG000|Main Phase|Other|1|||
128972548|NCT01010776|464183054|FG000|Main Phase|Did not received study medication|5|||
128972549|NCT01010776|464183054|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
128972550|NCT01010776|464183054|FG000|Extension Phase|Other|3|||
128972551|NCT02583711|464183058|FG000|Overall Study|Withdrawal by Subject|0|||
128972552|NCT02583711|464183059|FG001|Overall Study|Withdrawal by Subject|10|||
128972553|NCT02583711|464183060|FG002|Overall Study|Withdrawal by Subject|0|||
128972554|NCT01012037|464183061|FG000|Overall Study|Adverse Event|0|||
128972555|NCT01012037|464183062|FG001|Overall Study|Adverse Event|8|||
128972556|NCT01012037|464183063|FG002|Overall Study|Adverse Event|3|||
128972557|NCT01012037|464183061|FG000|Overall Study|Protocol Violation|0|||
128972558|NCT01012037|464183062|FG001|Overall Study|Protocol Violation|3|||
128972559|NCT01012037|464183063|FG002|Overall Study|Protocol Violation|5|||
129220877|NCT02023697|465110109|FG001|Treatment Period|Clinical progression|8|||
129220878|NCT02023697|465110110|FG002|Treatment Period|Clinical progression|28|||
129220879|NCT02023697|465110108|FG000|Treatment Period|Withdrawal by Subject|4|||
128972560|NCT01012037|464183061|FG000|Overall Study|Withdrawal by Subject|0|||
128972561|NCT01012037|464183062|FG001|Overall Study|Withdrawal by Subject|4|||
129220880|NCT02023697|465110109|FG001|Treatment Period|Withdrawal by Subject|5|||
129220881|NCT02023697|465110110|FG002|Treatment Period|Withdrawal by Subject|13|||
129220882|NCT02023697|465110108|FG000|Treatment Period|Safety outcome reached|0|||
128972562|NCT01012037|464183063|FG002|Overall Study|Withdrawal by Subject|1|||
128972563|NCT01012037|464183061|FG000|Overall Study|Other reason (not specified)|1|||
128972564|NCT01012037|464183062|FG001|Overall Study|Other reason (not specified)|1|||
128972565|NCT01012037|464183063|FG002|Overall Study|Other reason (not specified)|1|||
128972566|NCT01708915|464183070|FG000|Overall Study|Adverse Event|1|||
128972567|NCT01708915|464183071|FG001|Overall Study|Adverse Event|0|||
128972568|NCT01708915|464183072|FG002|Overall Study|Adverse Event|9|||
128972569|NCT01708915|464183073|FG003|Overall Study|Adverse Event|13|||
128972570|NCT01708915|464183070|FG000|Overall Study|Lack of Efficacy|84|||
128972571|NCT01708915|464183071|FG001|Overall Study|Lack of Efficacy|60|||
128972572|NCT01708915|464183072|FG002|Overall Study|Lack of Efficacy|35|||
128972573|NCT01708915|464183073|FG003|Overall Study|Lack of Efficacy|15|||
128972574|NCT01708915|464183070|FG000|Overall Study|Protocol Violation|0|||
128972575|NCT01708915|464183071|FG001|Overall Study|Protocol Violation|0|||
128972576|NCT01708915|464183072|FG002|Overall Study|Protocol Violation|0|||
128972577|NCT01708915|464183073|FG003|Overall Study|Protocol Violation|1|||
128972578|NCT01708915|464183070|FG000|Overall Study|Withdrawal by Subject|0|||
128972579|NCT01708915|464183071|FG001|Overall Study|Withdrawal by Subject|1|||
128972580|NCT01708915|464183072|FG002|Overall Study|Withdrawal by Subject|2|||
128972581|NCT01708915|464183073|FG003|Overall Study|Withdrawal by Subject|2|||
128972582|NCT01708915|464183070|FG000|Overall Study|Other reasons than stated above|1|||
128972583|NCT01708915|464183071|FG001|Overall Study|Other reasons than stated above|1|||
128972584|NCT01708915|464183072|FG002|Overall Study|Other reasons than stated above|0|||
128972585|NCT01708915|464183073|FG003|Overall Study|Other reasons than stated above|2|||
128972586|NCT01432938|464183074|FG000|First Intervention|Protocol Violation|1|||
128972587|NCT01432938|464183075|FG001|First Intervention|Protocol Violation|0|||
128972588|NCT01432938|464183074|FG000|First Intervention|Physician Decision|1|||
128972589|NCT01432938|464183075|FG001|First Intervention|Physician Decision|0|||
128972590|NCT01432938|464183074|FG000|Second Intervention|Adverse Event|1|||
128972591|NCT01432938|464183075|FG001|Second Intervention|Adverse Event|0|||
128972592|NCT04223778|464183076|FG000|Overall Study|Death|1|||
128972593|NCT04223778|464183077|FG001|Overall Study|Death|1|||
128972594|NCT04223778|464183076|FG000|Overall Study|Lost to Follow-up|4|||
128972595|NCT04223778|464183077|FG001|Overall Study|Lost to Follow-up|5|||
128972596|NCT04223778|464183076|FG000|Overall Study|Physician Decision|10|||
128972597|NCT04223778|464183077|FG001|Overall Study|Physician Decision|6|||
128972598|NCT04223778|464183076|FG000|Overall Study|Withdrawal by Subject|35|||
128972599|NCT04223778|464183077|FG001|Overall Study|Withdrawal by Subject|17|||
128972600|NCT04223778|464183076|FG000|Overall Study|Not Reported|7|||
128972601|NCT04223778|464183077|FG001|Overall Study|Not Reported|8|||
128972602|NCT01855919|464184585|FG000|Overall Study|Adverse Event|16|||
128972603|NCT01855919|464184586|FG001|Overall Study|Adverse Event|8|||
128972604|NCT01855919|464184585|FG000|Overall Study|Lack of Efficacy|1|||
128972605|NCT01855919|464184586|FG001|Overall Study|Lack of Efficacy|3|||
128972606|NCT01855919|464184585|FG000|Overall Study|Withdrawal by Subject|4|||
128972607|NCT01855919|464184586|FG001|Overall Study|Withdrawal by Subject|10|||
128972608|NCT01855919|464184585|FG000|Overall Study|Entry Criteria Not Met|1|||
128972609|NCT01855919|464184586|FG001|Overall Study|Entry Criteria Not Met|1|||
128972610|NCT01855919|464184585|FG000|Overall Study|Protocol Violation|1|||
128972611|NCT01855919|464184586|FG001|Overall Study|Protocol Violation|4|||
128972612|NCT04459416|464184587|FG000|Overall Study|Lost to Follow-up|2|||
128972613|NCT04459416|464184588|FG001|Overall Study|Lost to Follow-up|0|||
128972614|NCT04459416|464184587|FG000|Overall Study|Withdrawal by Subject|8|||
128972615|NCT04459416|464184588|FG001|Overall Study|Withdrawal by Subject|10|||
128972616|NCT04459416|464184587|FG000|Overall Study|Disease progression|0|||
128972617|NCT04459416|464184588|FG001|Overall Study|Disease progression|3|||
128972618|NCT04418427|464184589|FG000|Overall Study|Death|0|||
128972619|NCT04418427|464184590|FG001|Overall Study|Death|1|||
128972620|NCT04418427|464184591|FG002|Overall Study|Death|0|||
128972621|NCT04418427|464184589|FG000|Overall Study|Lost to Follow-up|0|||
128972622|NCT04418427|464184590|FG001|Overall Study|Lost to Follow-up|2|||
128972623|NCT04418427|464184591|FG002|Overall Study|Lost to Follow-up|2|||
128972624|NCT04418427|464184589|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
128972625|NCT04418427|464184590|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
128972626|NCT04418427|464184591|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
128972627|NCT04418427|464184589|FG000|Overall Study|Pre-existing medical condition|0|||
128972628|NCT04418427|464184590|FG001|Overall Study|Pre-existing medical condition|1|||
128972629|NCT04418427|464184591|FG002|Overall Study|Pre-existing medical condition|0|||
128972630|NCT02554721|464184594|FG000|Overall Study|Adverse Event|1|||
128972631|NCT02554721|464184595|FG001|Overall Study|Adverse Event|0|||
128972632|NCT02554721|464184596|FG002|Overall Study|Adverse Event|0|||
128972633|NCT02554721|464184597|FG003|Overall Study|Adverse Event|0|||
128972634|NCT02554721|464184598|FG004|Overall Study|Adverse Event|1|||
129220883|NCT02023697|465110109|FG001|Treatment Period|Safety outcome reached|1|||
129220884|NCT02023697|465110110|FG002|Treatment Period|Safety outcome reached|0|||
128972635|NCT02554721|464184594|FG000|Overall Study|Noncompliance|0|||
128972636|NCT02554721|464184595|FG001|Overall Study|Noncompliance|0|||
128972637|NCT02554721|464184596|FG002|Overall Study|Noncompliance|0|||
128972638|NCT02554721|464184597|FG003|Overall Study|Noncompliance|0|||
128972639|NCT02554721|464184598|FG004|Overall Study|Noncompliance|1|||
128972640|NCT00908895|464184599|FG000|Overall Study|Lost to Follow-up|1|||
128972641|NCT00908895|464184600|FG001|Overall Study|Lost to Follow-up|3|||
128972642|NCT00908895|464184599|FG000|Overall Study|algodystrophy|2|||
128972643|NCT00908895|464184600|FG001|Overall Study|algodystrophy|2|||
128972644|NCT00908895|464184599|FG000|Overall Study|Adverse Event|1|||
128972645|NCT00908895|464184600|FG001|Overall Study|Adverse Event|1|||
128972646|NCT02059174|464184602|FG000|Period 1|Withdrawal by Subject|0|||
128972647|NCT02059174|464184603|FG001|Period 1|Withdrawal by Subject|2|||
128972648|NCT02059174|464184602|FG000|Period 2|Withdrawal by Subject|0|||
128972649|NCT02059174|464184603|FG001|Period 2|Withdrawal by Subject|2|||
128972650|NCT02059174|464184602|FG000|Period 2|Protocol Violation|1|||
128972651|NCT02059174|464184603|FG001|Period 2|Protocol Violation|0|||
128972652|NCT02059174|464184602|FG000|Period 3|Physician Decision|1|||
128972653|NCT02059174|464184603|FG001|Period 3|Physician Decision|0|||
128972654|NCT02306148|464184604|FG000|Overall Study|Adverse Event|12|||
128972655|NCT02306148|464184605|FG001|Overall Study|Adverse Event|6|||
128972656|NCT02306148|464184604|FG000|Overall Study|Lost to Follow-up|1|||
128972657|NCT02306148|464184605|FG001|Overall Study|Lost to Follow-up|4|||
128972658|NCT00087594|464184606|FG000|Overall Study|Adverse Event|2|||
129131362|NCT04339972|464772810|FG000|Overall Study|dropout|1|||
129131363|NCT04339972|464772811|FG001|Overall Study|dropout|1|||
129131364|NCT04339972|464772810|FG000|Overall Study|Technical issues|1|||
129131365|NCT04339972|464772811|FG001|Overall Study|Technical issues|0|||
129131366|NCT04339972|464772810|FG000|Overall Study|Claustraphobia|0|||
129131367|NCT04339972|464772811|FG001|Overall Study|Claustraphobia|1|||
129131368|NCT02691663|464772812|FG000|Overall Study|Screen failure after baseline|2|||
129131369|NCT02691663|464772813|FG001|Overall Study|Screen failure after baseline|2|||
129131370|NCT02691663|464772812|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
129131371|NCT02691663|464772813|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
129131372|NCT02691663|464772812|FG000|Overall Study|Withdrawn after Follow up 2|1|||
129131373|NCT02691663|464772813|FG001|Overall Study|Withdrawn after Follow up 2|1|||
129131374|NCT02691663|464772812|FG000|Overall Study|Lost to Follow-up|3|||
129131375|NCT02691663|464772813|FG001|Overall Study|Lost to Follow-up|2|||
129131376|NCT06377488|464772816|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
129131377|NCT06377488|464772816|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
129131378|NCT06377488|464772816|FG000|Overall Study|Protocol Violation|1|||
129131379|NCT06377488|464772816|FG000|Overall Study|Lost to Follow-up|1|||
129131380|NCT06377488|464772816|FG000|Overall Study|Incorrect Lens Dispensed|2|||
129131381|NCT01179516|464772821|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
129131382|NCT01179516|464772822|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
129131383|NCT01179516|464772823|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
129131384|NCT01179516|464772821|FG000|Overall Study|Lack of Efficacy|4|||
129131385|NCT01179516|464772822|FG001|Overall Study|Lack of Efficacy|2|||
129131386|NCT01179516|464772823|FG002|Overall Study|Lack of Efficacy|0|||
128715637|NCT05407675|463255790|FG002|Overall Study|Withdrawal by Subject|3|||
128715638|NCT05407675|463255791|FG003|Overall Study|Withdrawal by Subject|5|||
128715639|NCT05407675|463255792|FG004|Overall Study|Withdrawal by Subject|0|||
128715640|NCT05407675|463255793|FG005|Overall Study|Withdrawal by Subject|2|||
128715641|NCT05407675|463255794|FG006|Overall Study|Withdrawal by Subject|0|||
128715642|NCT05407675|463255795|FG007|Overall Study|Withdrawal by Subject|0|||
128715643|NCT05407675|463255796|FG008|Overall Study|Withdrawal by Subject|2|||
128715644|NCT05407675|463255797|FG009|Overall Study|Withdrawal by Subject|0|||
128972659|NCT00087594|464184607|FG001|Overall Study|Adverse Event|3|||
128972660|NCT00087594|464184606|FG000|Overall Study|Lost to Follow-up|0|||
128972661|NCT00087594|464184607|FG001|Overall Study|Lost to Follow-up|2|||
129220885|NCT02023697|465110108|FG000|Treatment Period|Physician Decision|0|||
129220886|NCT02023697|465110109|FG001|Treatment Period|Physician Decision|0|||
129220887|NCT02023697|465110110|FG002|Treatment Period|Physician Decision|1|||
129220888|NCT02023697|465110108|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
129220889|NCT02023697|465110109|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
129220890|NCT02023697|465110110|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
129220891|NCT02023697|465110108|FG000|Active Follow-up Period|Lost to Follow-up|1|||
129220892|NCT02023697|465110109|FG001|Active Follow-up Period|Lost to Follow-up|1|||
129220893|NCT02023697|465110110|FG002|Active Follow-up Period|Lost to Follow-up|1|||
129131387|NCT01179516|464772821|FG000|Overall Study|Noncompliance with Study Drug|2|||
128715645|NCT05407675|463255798|FG010|Overall Study|Withdrawal by Subject|1|||
128715646|NCT05407675|463255799|FG011|Overall Study|Withdrawal by Subject|0|||
128715647|NCT05407675|463255800|FG012|Overall Study|Withdrawal by Subject|0|||
128715648|NCT05407675|463255788|FG000|Overall Study|Site terminated by sponsor|0|||
128715649|NCT05407675|463255789|FG001|Overall Study|Site terminated by sponsor|0|||
128715650|NCT05407675|463255790|FG002|Overall Study|Site terminated by sponsor|1|||
128715651|NCT05407675|463255791|FG003|Overall Study|Site terminated by sponsor|0|||
128715652|NCT05407675|463255792|FG004|Overall Study|Site terminated by sponsor|2|||
128715653|NCT05407675|463255793|FG005|Overall Study|Site terminated by sponsor|0|||
128715654|NCT05407675|463255794|FG006|Overall Study|Site terminated by sponsor|1|||
128774721|NCT04157686|463466658|FG006|Overall Study|Withdrawal by Subject|18|||
128972662|NCT00087594|464184606|FG000|Overall Study|Withdrawal by Subject|4|||
128972663|NCT00087594|464184607|FG001|Overall Study|Withdrawal by Subject|2|||
128972664|NCT00087594|464184606|FG000|Overall Study|Lack of Efficacy|2|||
129220894|NCT02023697|465110108|FG000|Active Follow-up Period|Deterioration of general condition|1|||
129220895|NCT02023697|465110109|FG001|Active Follow-up Period|Deterioration of general condition|1|||
128972665|NCT00087594|464184607|FG001|Overall Study|Lack of Efficacy|5|||
129131388|NCT01179516|464772822|FG001|Overall Study|Noncompliance with Study Drug|0|||
128972666|NCT01952041|464184608|FG000|Overall Study|Lost to Follow-up|9|||
128972667|NCT01952041|464184609|FG001|Overall Study|Lost to Follow-up|16|||
128972668|NCT01952041|464184608|FG000|Overall Study|Withdrawal by Subject|7|||
128972669|NCT01952041|464184609|FG001|Overall Study|Withdrawal by Subject|5|||
128972670|NCT01952041|464184608|FG000|Overall Study|Death|1|||
128972671|NCT01952041|464184609|FG001|Overall Study|Death|0|||
128972672|NCT00186121|464184610|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
128972673|NCT00186121|464184610|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
128972674|NCT00186121|464184610|FG000|Overall Study|Not eligible (no treatment)|1|||
128972675|NCT01569568|464184611|FG000|Overall Study|Physician Decision|0|||
128972676|NCT01569568|464184612|FG001|Overall Study|Physician Decision|2|||
128972677|NCT01370499|464184613|FG000|Overall Study|Adverse Event|38|||
128972678|NCT01370499|464184614|FG001|Overall Study|Adverse Event|12|||
128972679|NCT01370499|464184613|FG000|Overall Study|Lack of Efficacy|4|||
128972680|NCT01370499|464184614|FG001|Overall Study|Lack of Efficacy|2|||
128972681|NCT01370499|464184613|FG000|Overall Study|Lost to Follow-up|2|||
128972682|NCT01370499|464184614|FG001|Overall Study|Lost to Follow-up|1|||
128972683|NCT01370499|464184613|FG000|Overall Study|Physician Decision|3|||
128972684|NCT01370499|464184614|FG001|Overall Study|Physician Decision|3|||
128972685|NCT01370499|464184613|FG000|Overall Study|Protocol Violation|5|||
128972686|NCT01370499|464184614|FG001|Overall Study|Protocol Violation|4|||
128972687|NCT01370499|464184613|FG000|Overall Study|Withdrawal by Subject|18|||
128972688|NCT01370499|464184614|FG001|Overall Study|Withdrawal by Subject|7|||
128972689|NCT01370499|464184613|FG000|Overall Study|Sponsor Decision|41|||
128972690|NCT01370499|464184614|FG001|Overall Study|Sponsor Decision|15|||
128972691|NCT01654224|464184618|FG000|Overall Study|Lost to Follow-up|2|||
128972692|NCT01654224|464184619|FG001|Overall Study|Lost to Follow-up|2|||
128972693|NCT01654224|464184618|FG000|Overall Study|Did not receive allocation|1|||
128972694|NCT01654224|464184619|FG001|Overall Study|Did not receive allocation|8|||
128972695|NCT01654224|464184618|FG000|Overall Study|Insufficient blood sample|3|||
128972696|NCT01654224|464184619|FG001|Overall Study|Insufficient blood sample|2|||
128972697|NCT00166504|464184621|FG000|Overall Study|Adverse Event|3|||
128972698|NCT00166504|464184622|FG001|Overall Study|Adverse Event|3|||
128972699|NCT00166504|464184621|FG000|Overall Study|Lost to Follow-up|1|||
128972700|NCT00166504|464184622|FG001|Overall Study|Lost to Follow-up|1|||
128972701|NCT00166504|464184621|FG000|Overall Study|Withdrawal by Subject|1|||
128972702|NCT00166504|464184622|FG001|Overall Study|Withdrawal by Subject|0|||
128972703|NCT03558503|464184623|FG000|Overall Study|Adverse Event|1|||
128972704|NCT03558503|464184623|FG000|Overall Study|Death|1|||
128972705|NCT03558503|464184623|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
128972706|NCT02145429|464184624|FG000|Overall Study|Death|4|||
128972707|NCT02145429|464184625|FG001|Overall Study|Death|5|||
128972708|NCT02145429|464184624|FG000|Overall Study|Lost to Follow-up|4|||
128972709|NCT02145429|464184625|FG001|Overall Study|Lost to Follow-up|3|||
128972710|NCT02145429|464184624|FG000|Overall Study|Withdrawal by Subject|8|||
128972711|NCT02145429|464184625|FG001|Overall Study|Withdrawal by Subject|3|||
128972712|NCT02943577|464184626|FG000|Overall Study|Protocol Violation|0|||
128972713|NCT02943577|464184627|FG001|Overall Study|Protocol Violation|1|||
128972714|NCT02943577|464184626|FG000|Overall Study|Adverse Event|3|||
128972715|NCT02943577|464184627|FG001|Overall Study|Adverse Event|2|||
128972716|NCT02943577|464184626|FG000|Overall Study|Lost to Follow-up|0|||
128972717|NCT02943577|464184627|FG001|Overall Study|Lost to Follow-up|1|||
129220896|NCT02023697|465110110|FG002|Active Follow-up Period|Deterioration of general condition|1|||
129220897|NCT02023697|465110108|FG000|Active Follow-up Period|Other unspecified|2|||
129220898|NCT02023697|465110109|FG001|Active Follow-up Period|Other unspecified|0|||
128972718|NCT02943577|464184626|FG000|Overall Study|Withdrawal by Subject|1|||
128972719|NCT02943577|464184627|FG001|Overall Study|Withdrawal by Subject|1|||
128972720|NCT02943577|464184626|FG000|Overall Study|Pregnancy|1|||
128972721|NCT02943577|464184627|FG001|Overall Study|Pregnancy|0|||
128972722|NCT01944462|464184628|FG000|PPPP Educational Program|Lost to Follow-up|60|||
128972723|NCT01222767|464184629|FG000|Overall Study|Progressive disease|13|||
128972724|NCT01222767|464184629|FG000|Overall Study|Adverse Event|2|||
128972725|NCT01222767|464184629|FG000|Overall Study|Surgical resection|1|||
128972726|NCT01222767|464184629|FG000|Overall Study|Never treated|1|||
129220899|NCT02023697|465110110|FG002|Active Follow-up Period|Other unspecified|1|||
128972727|NCT01553591|464184631|FG000|Overall Study|Voluntarily withdrew|94|||
128972728|NCT01553591|464184632|FG001|Overall Study|Voluntarily withdrew|79|||
128972729|NCT01553591|464184633|FG002|Overall Study|Voluntarily withdrew|96|||
128972730|NCT01553591|464184631|FG000|Overall Study|Adverse Event|36|||
129220900|NCT02023697|465110108|FG000|Active Follow-up Period|Clinical progression|0|||
128972731|NCT01553591|464184632|FG001|Overall Study|Adverse Event|45|||
128972732|NCT01553591|464184633|FG002|Overall Study|Adverse Event|16|||
128972733|NCT01553591|464184631|FG000|Overall Study|Lost to Follow-up|25|||
128972734|NCT01553591|464184632|FG001|Overall Study|Lost to Follow-up|23|||
128972735|NCT01553591|464184633|FG002|Overall Study|Lost to Follow-up|16|||
128972736|NCT01553591|464184631|FG000|Overall Study|Physician decision: other|11|||
128972737|NCT01553591|464184632|FG001|Overall Study|Physician decision: other|14|||
128972738|NCT01553591|464184633|FG002|Overall Study|Physician decision: other|16|||
128972739|NCT01553591|464184631|FG000|Overall Study|Physician decision: lack of efficacy|2|||
128972740|NCT01553591|464184632|FG001|Overall Study|Physician decision: lack of efficacy|3|||
128972741|NCT01553591|464184633|FG002|Overall Study|Physician decision: lack of efficacy|7|||
128972742|NCT01553591|464184631|FG000|Overall Study|Protocol Violation|3|||
128972743|NCT01553591|464184632|FG001|Overall Study|Protocol Violation|4|||
128972744|NCT01553591|464184633|FG002|Overall Study|Protocol Violation|4|||
128972745|NCT01553591|464184631|FG000|Overall Study|Sponsor decision|1|||
128972746|NCT01553591|464184632|FG001|Overall Study|Sponsor decision|0|||
128972747|NCT01553591|464184633|FG002|Overall Study|Sponsor decision|3|||
128972748|NCT01553591|464184631|FG000|Overall Study|Randomized and never dispensed drug|0|||
128972749|NCT01553591|464184632|FG001|Overall Study|Randomized and never dispensed drug|1|||
129131389|NCT01179516|464772823|FG002|Overall Study|Noncompliance with Study Drug|1|||
129131390|NCT01179516|464772821|FG000|Overall Study|Protocol Deviations|4|||
129131391|NCT01179516|464772822|FG001|Overall Study|Protocol Deviations|3|||
129131392|NCT01179516|464772823|FG002|Overall Study|Protocol Deviations|3|||
129131393|NCT01179516|464772821|FG000|Overall Study|Withdrawal of Consent|2|||
129131394|NCT01179516|464772822|FG001|Overall Study|Withdrawal of Consent|6|||
129131395|NCT01179516|464772823|FG002|Overall Study|Withdrawal of Consent|10|||
129131396|NCT01179516|464772821|FG000|Overall Study|Lost to Follow-up|7|||
129131397|NCT01179516|464772822|FG001|Overall Study|Lost to Follow-up|7|||
129131398|NCT01179516|464772823|FG002|Overall Study|Lost to Follow-up|3|||
129131399|NCT01179516|464772821|FG000|Overall Study|Other|2|||
129131400|NCT01179516|464772822|FG001|Overall Study|Other|0|||
129131401|NCT01179516|464772823|FG002|Overall Study|Other|2|||
129131402|NCT02112552|464772826|FG000|Overall Study|Withdrawal by Subject|1|||
129131403|NCT02112552|464772826|FG000|Overall Study|Adverse Event|1|||
129131404|NCT00866320|464772827|FG000|Overall Study|Withdrawal by Subject|4|||
129131405|NCT00866320|464772827|FG000|Overall Study|Death|2|||
129131406|NCT03349515|464772828|FG000|Overall Study|Lack of Efficacy|2|||
129131407|NCT03349515|464772829|FG001|Overall Study|Lack of Efficacy|0|||
129131408|NCT03349515|464772828|FG000|Overall Study|Physician Decision|3|||
129131409|NCT03349515|464772829|FG001|Overall Study|Physician Decision|1|||
129131410|NCT02965456|464772830|FG000|Overall Study|Lost to Follow-up|40|||
129131411|NCT02965456|464772831|FG001|Overall Study|Lost to Follow-up|18|||
129131412|NCT02965456|464772830|FG000|Overall Study|Subject Request|22|||
129131413|NCT02965456|464772831|FG001|Overall Study|Subject Request|13|||
129131414|NCT02965456|464772830|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
129131415|NCT02965456|464772831|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
129131416|NCT02965456|464772830|FG000|Overall Study|Adverse Event|3|||
129131417|NCT02965456|464772831|FG001|Overall Study|Adverse Event|0|||
129131418|NCT02965456|464772830|FG000|Overall Study|Noncompliance with Study Drug|1|||
129131419|NCT02965456|464772831|FG001|Overall Study|Noncompliance with Study Drug|1|||
129131420|NCT02965456|464772830|FG000|Overall Study|Worsening Condition|0|||
129131421|NCT02965456|464772831|FG001|Overall Study|Worsening Condition|2|||
129131422|NCT02965456|464772830|FG000|Overall Study|Lack of Efficacy|1|||
129131423|NCT02965456|464772831|FG001|Overall Study|Lack of Efficacy|0|||
129131424|NCT02965456|464772830|FG000|Overall Study|Physician Decision|0|||
129131425|NCT02965456|464772831|FG001|Overall Study|Physician Decision|1|||
129131426|NCT02965456|464772830|FG000|Overall Study|Pregnancy|1|||
129131427|NCT02965456|464772831|FG001|Overall Study|Pregnancy|0|||
129131428|NCT02965456|464772830|FG000|Overall Study|Protocol Violation|0|||
129131429|NCT02965456|464772831|FG001|Overall Study|Protocol Violation|1|||
129131430|NCT02965456|464772830|FG000|Overall Study|Participant ran out of study drug|0|||
129131431|NCT02965456|464772831|FG001|Overall Study|Participant ran out of study drug|1|||
129131432|NCT00303953|464772832|FG000|Overall Study|Ineligible|1|||
129131433|NCT00303953|464772832|FG000|Overall Study|Death|1|||
129131434|NCT00303953|464772832|FG000|Overall Study|Adverse Event|4|||
129131435|NCT00303953|464772832|FG000|Overall Study|Lack of Efficacy|12|||
129131436|NCT00303953|464772832|FG000|Overall Study|Physician Decision|1|||
129131437|NCT04465955|464772833|FG000|Overall Study|Withdrew consent|6|||
129131438|NCT04465955|464772834|FG001|Overall Study|Withdrew consent|10|||
129131439|NCT04465955|464772835|FG002|Overall Study|Withdrew consent|7|||
129131440|NCT04465955|464772833|FG000|Overall Study|Adverse Event|6|||
129131441|NCT04465955|464772834|FG001|Overall Study|Adverse Event|5|||
129131442|NCT04465955|464772835|FG002|Overall Study|Adverse Event|1|||
128972750|NCT01553591|464184633|FG002|Overall Study|Randomized and never dispensed drug|0|||
128972751|NCT02477800|464184636|FG000|Placebo-Controlled Period|Adverse Event|16|||
129131443|NCT04465955|464772833|FG000|Overall Study|Lost to Follow-up|2|||
129131444|NCT04465955|464772834|FG001|Overall Study|Lost to Follow-up|0|||
129131445|NCT04465955|464772835|FG002|Overall Study|Lost to Follow-up|3|||
129131446|NCT04465955|464772833|FG000|Overall Study|Other|1|||
129131447|NCT04465955|464772834|FG001|Overall Study|Other|1|||
128972752|NCT02477800|464184637|FG001|Placebo-Controlled Period|Adverse Event|25|||
129131448|NCT04465955|464772835|FG002|Overall Study|Other|3|||
129131449|NCT00387127|464772838|FG000|Overall Study|Lost to Follow-up|0|||
129131450|NCT00387127|464772839|FG001|Overall Study|Lost to Follow-up|4|||
129131451|NCT00387127|464772838|FG000|Overall Study|Death|16|||
129131452|NCT00387127|464772839|FG001|Overall Study|Death|16|||
129131453|NCT00387127|464772838|FG000|Overall Study|Physician Decision|0|||
129220901|NCT02023697|465110109|FG001|Active Follow-up Period|Clinical progression|2|||
129220902|NCT02023697|465110110|FG002|Active Follow-up Period|Clinical progression|1|||
129220903|NCT02023697|465110108|FG000|Active Follow-up Period|Radiological progression|0|||
129220904|NCT02023697|465110109|FG001|Active Follow-up Period|Radiological progression|0|||
129220905|NCT02023697|465110110|FG002|Active Follow-up Period|Radiological progression|1|||
129220906|NCT02023697|465110108|FG000|Active Follow-up Period|Death|83|||
129220907|NCT02023697|465110109|FG001|Active Follow-up Period|Death|82|||
129220908|NCT02023697|465110110|FG002|Active Follow-up Period|Death|87|||
129220909|NCT02023697|465110108|FG000|Long-term Follow-up Period|Death|9|||
129220910|NCT02023697|465110109|FG001|Long-term Follow-up Period|Death|6|||
129220911|NCT02023697|465110110|FG002|Long-term Follow-up Period|Death|4|||
129220912|NCT02023697|465110108|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
129220913|NCT02023697|465110109|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
129220914|NCT02023697|465110110|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
129220915|NCT02023697|465110108|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
129220916|NCT02023697|465110109|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
129220917|NCT02023697|465110110|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
128715655|NCT05407675|463255795|FG007|Overall Study|Site terminated by sponsor|0|||
128715656|NCT05407675|463255796|FG008|Overall Study|Site terminated by sponsor|0|||
128715657|NCT05407675|463255797|FG009|Overall Study|Site terminated by sponsor|2|||
128715658|NCT05407675|463255798|FG010|Overall Study|Site terminated by sponsor|2|||
128715659|NCT05407675|463255799|FG011|Overall Study|Site terminated by sponsor|2|||
128715660|NCT05407675|463255800|FG012|Overall Study|Site terminated by sponsor|1|||
128715661|NCT05407675|463255788|FG000|Overall Study|Disease Progression|0|||
128715662|NCT05407675|463255789|FG001|Overall Study|Disease Progression|0|||
128715663|NCT05407675|463255790|FG002|Overall Study|Disease Progression|0|||
128715664|NCT05407675|463255791|FG003|Overall Study|Disease Progression|0|||
128715665|NCT05407675|463255792|FG004|Overall Study|Disease Progression|0|||
128715666|NCT05407675|463255793|FG005|Overall Study|Disease Progression|0|||
128715667|NCT05407675|463255794|FG006|Overall Study|Disease Progression|0|||
128715668|NCT05407675|463255795|FG007|Overall Study|Disease Progression|0|||
128715669|NCT05407675|463255796|FG008|Overall Study|Disease Progression|0|||
128715670|NCT05407675|463255797|FG009|Overall Study|Disease Progression|0|||
128715671|NCT05407675|463255798|FG010|Overall Study|Disease Progression|1|||
128715672|NCT05407675|463255799|FG011|Overall Study|Disease Progression|0|||
128715673|NCT05407675|463255800|FG012|Overall Study|Disease Progression|0|||
128715674|NCT05407675|463255788|FG000|Overall Study|Physician Decision|0|||
128715675|NCT05407675|463255789|FG001|Overall Study|Physician Decision|0|||
128715676|NCT05407675|463255790|FG002|Overall Study|Physician Decision|0|||
128715677|NCT05407675|463255791|FG003|Overall Study|Physician Decision|0|||
128715678|NCT05407675|463255792|FG004|Overall Study|Physician Decision|0|||
128715679|NCT05407675|463255793|FG005|Overall Study|Physician Decision|0|||
128715680|NCT05407675|463255794|FG006|Overall Study|Physician Decision|0|||
128715681|NCT05407675|463255795|FG007|Overall Study|Physician Decision|0|||
128715682|NCT05407675|463255796|FG008|Overall Study|Physician Decision|0|||
128715683|NCT05407675|463255797|FG009|Overall Study|Physician Decision|0|||
128715684|NCT05407675|463255798|FG010|Overall Study|Physician Decision|1|||
128715685|NCT05407675|463255799|FG011|Overall Study|Physician Decision|0|||
128715686|NCT05407675|463255800|FG012|Overall Study|Physician Decision|0|||
128715687|NCT05407675|463255788|FG000|Overall Study|Other reasons|0|||
128715688|NCT05407675|463255789|FG001|Overall Study|Other reasons|0|||
128715689|NCT05407675|463255790|FG002|Overall Study|Other reasons|0|||
128715690|NCT05407675|463255791|FG003|Overall Study|Other reasons|0|||
128715691|NCT05407675|463255792|FG004|Overall Study|Other reasons|0|||
128715692|NCT05407675|463255793|FG005|Overall Study|Other reasons|0|||
128715693|NCT05407675|463255794|FG006|Overall Study|Other reasons|0|||
128715694|NCT05407675|463255795|FG007|Overall Study|Other reasons|0|||
128715695|NCT05407675|463255796|FG008|Overall Study|Other reasons|1|||
128715696|NCT05407675|463255797|FG009|Overall Study|Other reasons|1|||
128715697|NCT05407675|463255798|FG010|Overall Study|Other reasons|1|||
128715698|NCT05407675|463255799|FG011|Overall Study|Other reasons|1|||
128715699|NCT05407675|463255800|FG012|Overall Study|Other reasons|0|||
128715700|NCT05407675|463255788|FG000|Overall Study|Death|3|||
128715701|NCT05407675|463255789|FG001|Overall Study|Death|4|||
128715702|NCT05407675|463255790|FG002|Overall Study|Death|3|||
128715703|NCT05407675|463255791|FG003|Overall Study|Death|6|||
128715704|NCT05407675|463255792|FG004|Overall Study|Death|0|||
128715705|NCT05407675|463255793|FG005|Overall Study|Death|2|||
128715706|NCT05407675|463255794|FG006|Overall Study|Death|4|||
128715707|NCT05407675|463255795|FG007|Overall Study|Death|2|||
128715708|NCT05407675|463255796|FG008|Overall Study|Death|2|||
128715709|NCT05407675|463255797|FG009|Overall Study|Death|4|||
128715710|NCT05407675|463255798|FG010|Overall Study|Death|2|||
128715711|NCT05407675|463255799|FG011|Overall Study|Death|1|||
128715712|NCT05407675|463255800|FG012|Overall Study|Death|0|||
128715713|NCT05407675|463255788|FG000|Overall Study|Adverse Event|0|||
128715714|NCT05407675|463255789|FG001|Overall Study|Adverse Event|0|||
128715715|NCT05407675|463255790|FG002|Overall Study|Adverse Event|0|||
129038514|NCT01714739|464433197|FG002|Overall Study|Participant withdrew consent|0|||
129038515|NCT01714739|464433198|FG003|Overall Study|Participant withdrew consent|8|||
129038516|NCT01714739|464433199|FG004|Overall Study|Participant withdrew consent|0|||
129038517|NCT01714739|464433200|FG005|Overall Study|Participant withdrew consent|0|||
129038518|NCT01714739|464433201|FG006|Overall Study|Participant withdrew consent|0|||
129038519|NCT01714739|464433195|FG000|Overall Study|Lost to Follow-up|0|||
129038520|NCT01714739|464433196|FG001|Overall Study|Lost to Follow-up|0|||
129038521|NCT01714739|464433197|FG002|Overall Study|Lost to Follow-up|0|||
129038522|NCT01714739|464433198|FG003|Overall Study|Lost to Follow-up|1|||
129038523|NCT01714739|464433199|FG004|Overall Study|Lost to Follow-up|0|||
129038524|NCT01714739|464433200|FG005|Overall Study|Lost to Follow-up|0|||
129038525|NCT01714739|464433201|FG006|Overall Study|Lost to Follow-up|0|||
129038526|NCT01714739|464433195|FG000|Overall Study|Maximum clinical benefit|0|||
129038527|NCT01714739|464433196|FG001|Overall Study|Maximum clinical benefit|1|||
129038528|NCT01714739|464433197|FG002|Overall Study|Maximum clinical benefit|1|||
129038529|NCT01714739|464433198|FG003|Overall Study|Maximum clinical benefit|3|||
129038530|NCT01714739|464433199|FG004|Overall Study|Maximum clinical benefit|0|||
129038531|NCT01714739|464433200|FG005|Overall Study|Maximum clinical benefit|0|||
129038532|NCT01714739|464433201|FG006|Overall Study|Maximum clinical benefit|0|||
129131454|NCT00387127|464772839|FG001|Overall Study|Physician Decision|1|||
129131455|NCT00387127|464772838|FG000|Overall Study|Withdrawal by Subject|3|||
129131456|NCT00387127|464772839|FG001|Overall Study|Withdrawal by Subject|2|||
129131457|NCT00387127|464772838|FG000|Overall Study|Required by Protocol Amendment #4|12|||
129131458|NCT00387127|464772839|FG001|Overall Study|Required by Protocol Amendment #4|10|||
128715716|NCT05407675|463255791|FG003|Overall Study|Adverse Event|0|||
128715717|NCT05407675|463255792|FG004|Overall Study|Adverse Event|1|||
128715718|NCT05407675|463255793|FG005|Overall Study|Adverse Event|0|||
128715719|NCT05407675|463255794|FG006|Overall Study|Adverse Event|0|||
128715720|NCT05407675|463255795|FG007|Overall Study|Adverse Event|0|||
128715721|NCT05407675|463255796|FG008|Overall Study|Adverse Event|0|||
128715722|NCT05407675|463255797|FG009|Overall Study|Adverse Event|0|||
128715723|NCT05407675|463255798|FG010|Overall Study|Adverse Event|0|||
128715724|NCT05407675|463255799|FG011|Overall Study|Adverse Event|1|||
128715725|NCT05407675|463255800|FG012|Overall Study|Adverse Event|0|||
128715726|NCT05407675|463255788|FG000|Overall Study|Ongoing Treatment|0|||
128715727|NCT05407675|463255789|FG001|Overall Study|Ongoing Treatment|0|||
128715728|NCT05407675|463255790|FG002|Overall Study|Ongoing Treatment|0|||
128715729|NCT05407675|463255791|FG003|Overall Study|Ongoing Treatment|0|||
128715730|NCT05407675|463255792|FG004|Overall Study|Ongoing Treatment|0|||
128715731|NCT05407675|463255793|FG005|Overall Study|Ongoing Treatment|0|||
128715732|NCT05407675|463255794|FG006|Overall Study|Ongoing Treatment|0|||
128715733|NCT05407675|463255795|FG007|Overall Study|Ongoing Treatment|0|||
128715734|NCT05407675|463255796|FG008|Overall Study|Ongoing Treatment|1|||
128715735|NCT05407675|463255797|FG009|Overall Study|Ongoing Treatment|0|||
128715736|NCT05407675|463255798|FG010|Overall Study|Ongoing Treatment|0|||
128715737|NCT05407675|463255799|FG011|Overall Study|Ongoing Treatment|0|||
128715738|NCT05407675|463255800|FG012|Overall Study|Ongoing Treatment|0|||
128715739|NCT01499563|463255808|FG000|Overall Study|Withdrawal by Subject|10|||
128715740|NCT01499563|463255809|FG001|Overall Study|Withdrawal by Subject|11|||
128715741|NCT01499563|463255810|FG002|Overall Study|Withdrawal by Subject|7|||
128715742|NCT01499563|463255811|FG003|Overall Study|Withdrawal by Subject|8|||
128715743|NCT01499563|463255808|FG000|Overall Study|Physician Decision|2|||
128715744|NCT01499563|463255809|FG001|Overall Study|Physician Decision|1|||
128715745|NCT01499563|463255810|FG002|Overall Study|Physician Decision|3|||
128715746|NCT01499563|463255811|FG003|Overall Study|Physician Decision|0|||
128715747|NCT01499563|463255808|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
128715748|NCT01499563|463255809|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
128715749|NCT01499563|463255810|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
128715750|NCT01499563|463255811|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
128715751|NCT01499563|463255808|FG000|Overall Study|Adverse Event|2|||
128715752|NCT01499563|463255809|FG001|Overall Study|Adverse Event|0|||
128715753|NCT01499563|463255810|FG002|Overall Study|Adverse Event|1|||
128715754|NCT01499563|463255811|FG003|Overall Study|Adverse Event|3|||
128715755|NCT01499563|463255808|FG000|Overall Study|Lack of Efficacy|0|||
128715756|NCT01499563|463255809|FG001|Overall Study|Lack of Efficacy|1|||
128715757|NCT01499563|463255810|FG002|Overall Study|Lack of Efficacy|6|||
128715758|NCT01499563|463255811|FG003|Overall Study|Lack of Efficacy|3|||
128715759|NCT01499563|463255808|FG000|Overall Study|Other|8|||
128715760|NCT01499563|463255809|FG001|Overall Study|Other|6|||
128715761|NCT01499563|463255810|FG002|Overall Study|Other|6|||
128715762|NCT01499563|463255811|FG003|Overall Study|Other|4|||
128715763|NCT03279692|463255812|FG000|Overall Study|Withdrawal by Subject|1|||
128715764|NCT02472795|463255814|FG000|Overall Study|Adverse Event|0|||
128715765|NCT02472795|463255815|FG001|Overall Study|Adverse Event|1|||
128715766|NCT02472795|463255816|FG002|Overall Study|Adverse Event|0|||
128715767|NCT02472795|463255817|FG003|Overall Study|Adverse Event|0|||
128715768|NCT02472795|463255818|FG004|Overall Study|Adverse Event|2|||
129038533|NCT01714739|464433195|FG000|Overall Study|Poor/non-comliance|0|||
128715769|NCT02472795|463255814|FG000|Overall Study|Withdrawal by Subject|0|||
129038534|NCT01714739|464433196|FG001|Overall Study|Poor/non-comliance|1|||
128972753|NCT02477800|464184638|FG002|Placebo-Controlled Period|Adverse Event|28|||
128972754|NCT02477800|464184639|FG003|Placebo-Controlled Period|Adverse Event|0|||
128972755|NCT02477800|464184640|FG004|Placebo-Controlled Period|Adverse Event|0|||
128972756|NCT02477800|464184641|FG005|Placebo-Controlled Period|Adverse Event|0|||
128972757|NCT02477800|464184642|FG006|Placebo-Controlled Period|Adverse Event|0|||
128972758|NCT02477800|464184636|FG000|Placebo-Controlled Period|Change of Treatment|1|||
128972759|NCT02477800|464184637|FG001|Placebo-Controlled Period|Change of Treatment|2|||
128972760|NCT02477800|464184638|FG002|Placebo-Controlled Period|Change of Treatment|1|||
128972761|NCT02477800|464184639|FG003|Placebo-Controlled Period|Change of Treatment|0|||
128972762|NCT02477800|464184640|FG004|Placebo-Controlled Period|Change of Treatment|0|||
128972763|NCT02477800|464184641|FG005|Placebo-Controlled Period|Change of Treatment|0|||
128972764|NCT02477800|464184642|FG006|Placebo-Controlled Period|Change of Treatment|0|||
128972765|NCT02477800|464184636|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
128972766|NCT02477800|464184637|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
128972767|NCT02477800|464184638|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
128972768|NCT02477800|464184639|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
128972769|NCT02477800|464184640|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
128972770|NCT02477800|464184641|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
128972771|NCT02477800|464184642|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
128972772|NCT02477800|464184636|FG000|Placebo-Controlled Period|Death|0|||
128972773|NCT02477800|464184637|FG001|Placebo-Controlled Period|Death|3|||
128972774|NCT02477800|464184638|FG002|Placebo-Controlled Period|Death|2|||
128972775|NCT02477800|464184639|FG003|Placebo-Controlled Period|Death|0|||
128972776|NCT02477800|464184640|FG004|Placebo-Controlled Period|Death|0|||
128972777|NCT02477800|464184641|FG005|Placebo-Controlled Period|Death|0|||
128972778|NCT02477800|464184642|FG006|Placebo-Controlled Period|Death|0|||
128972779|NCT02477800|464184636|FG000|Placebo-Controlled Period|Disease Progression|1|||
128972780|NCT02477800|464184637|FG001|Placebo-Controlled Period|Disease Progression|0|||
128972781|NCT02477800|464184638|FG002|Placebo-Controlled Period|Disease Progression|1|||
128972782|NCT02477800|464184639|FG003|Placebo-Controlled Period|Disease Progression|0|||
128972783|NCT02477800|464184640|FG004|Placebo-Controlled Period|Disease Progression|0|||
128972784|NCT02477800|464184641|FG005|Placebo-Controlled Period|Disease Progression|0|||
128972785|NCT02477800|464184642|FG006|Placebo-Controlled Period|Disease Progression|0|||
128972786|NCT02477800|464184636|FG000|Placebo-Controlled Period|Investigator Decision|3|||
128972787|NCT02477800|464184637|FG001|Placebo-Controlled Period|Investigator Decision|2|||
128972788|NCT02477800|464184638|FG002|Placebo-Controlled Period|Investigator Decision|1|||
128972789|NCT02477800|464184639|FG003|Placebo-Controlled Period|Investigator Decision|0|||
128972790|NCT02477800|464184640|FG004|Placebo-Controlled Period|Investigator Decision|0|||
128972791|NCT02477800|464184641|FG005|Placebo-Controlled Period|Investigator Decision|0|||
128972792|NCT02477800|464184642|FG006|Placebo-Controlled Period|Investigator Decision|0|||
128972793|NCT02477800|464184636|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
128972794|NCT02477800|464184637|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
128972795|NCT02477800|464184638|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
128972796|NCT02477800|464184639|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
128972797|NCT02477800|464184640|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
128972798|NCT02477800|464184641|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
128972799|NCT02477800|464184642|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
128972800|NCT02477800|464184636|FG000|Placebo-Controlled Period|Relocation|2|||
128972801|NCT02477800|464184637|FG001|Placebo-Controlled Period|Relocation|0|||
128972802|NCT02477800|464184638|FG002|Placebo-Controlled Period|Relocation|0|||
128972803|NCT02477800|464184639|FG003|Placebo-Controlled Period|Relocation|0|||
128972804|NCT02477800|464184640|FG004|Placebo-Controlled Period|Relocation|0|||
128972805|NCT02477800|464184641|FG005|Placebo-Controlled Period|Relocation|0|||
128972806|NCT02477800|464184642|FG006|Placebo-Controlled Period|Relocation|0|||
128972807|NCT02477800|464184636|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
128972808|NCT02477800|464184637|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
128972809|NCT02477800|464184638|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
128972810|NCT02477800|464184639|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
128972811|NCT02477800|464184640|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
128972812|NCT02477800|464184641|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
128972813|NCT02477800|464184642|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
128972814|NCT02477800|464184636|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
128972815|NCT02477800|464184637|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
128972816|NCT02477800|464184638|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
128972817|NCT02477800|464184639|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
128972818|NCT02477800|464184640|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
128972819|NCT02477800|464184641|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
128972820|NCT02477800|464184642|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
128972821|NCT02477800|464184636|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
128972822|NCT02477800|464184637|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
128972823|NCT02477800|464184638|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
129220918|NCT02023697|465110108|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
129220919|NCT02023697|465110109|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
129220920|NCT02023697|465110110|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
129220921|NCT02023697|465110108|FG000|Long-term Follow-up Period|Technical problems|0|||
129220922|NCT02023697|465110109|FG001|Long-term Follow-up Period|Technical problems|0|||
129220923|NCT02023697|465110110|FG002|Long-term Follow-up Period|Technical problems|1|||
129220924|NCT02023697|465110108|FG000|Long-term Follow-up Period|Other unspecified|6|||
129220925|NCT02023697|465110109|FG001|Long-term Follow-up Period|Other unspecified|3|||
129220926|NCT02023697|465110110|FG002|Long-term Follow-up Period|Other unspecified|5|||
129220927|NCT00845897|465110111|FG000|Overall Study|Lost to Follow-up|1|||
129220928|NCT00845897|465110112|FG001|Overall Study|Lost to Follow-up|1|||
129220929|NCT00845897|465110113|FG002|Overall Study|Lost to Follow-up|0|||
129220930|NCT00845897|465110111|FG000|Overall Study|Withdrawal by Subject|0|||
129220931|NCT00845897|465110112|FG001|Overall Study|Withdrawal by Subject|3|||
129220932|NCT00845897|465110113|FG002|Overall Study|Withdrawal by Subject|2|||
129220933|NCT00845897|465110111|FG000|Overall Study|Ulcer did not heal|1|||
129220934|NCT00845897|465110112|FG001|Overall Study|Ulcer did not heal|0|||
129220935|NCT00845897|465110113|FG002|Overall Study|Ulcer did not heal|1|||
129220936|NCT00845897|465110111|FG000|Overall Study|Too ill to participate|0|||
129220937|NCT00845897|465110112|FG001|Overall Study|Too ill to participate|1|||
129220938|NCT00845897|465110113|FG002|Overall Study|Too ill to participate|0|||
129220939|NCT02722499|465110114|FG000|Overall Study|Lost to Follow-up|2|||
129220940|NCT02722499|465110115|FG001|Overall Study|Lost to Follow-up|0|||
129220941|NCT02722499|465110116|FG002|Overall Study|Lost to Follow-up|1|||
129220942|NCT03566485|465110126|FG000|Overall Study|Disease progression|5|||
128972824|NCT02477800|464184639|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
128972825|NCT02477800|464184640|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
128972826|NCT02477800|464184641|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
128972827|NCT02477800|464184642|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
128972828|NCT02477800|464184636|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
128972829|NCT02477800|464184637|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
128972830|NCT02477800|464184638|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
128972831|NCT02477800|464184639|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128972832|NCT02477800|464184640|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128972833|NCT02477800|464184641|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128972834|NCT02477800|464184642|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128972835|NCT02477800|464184636|FG000|Placebo-Controlled Period|Reason not Specified|161|||
128972836|NCT02477800|464184637|FG001|Placebo-Controlled Period|Reason not Specified|161|||
128972837|NCT02477800|464184638|FG002|Placebo-Controlled Period|Reason not Specified|189|||
128972838|NCT02477800|464184639|FG003|Placebo-Controlled Period|Reason not Specified|0|||
128972839|NCT02477800|464184640|FG004|Placebo-Controlled Period|Reason not Specified|0|||
128972840|NCT02477800|464184641|FG005|Placebo-Controlled Period|Reason not Specified|0|||
128972841|NCT02477800|464184642|FG006|Placebo-Controlled Period|Reason not Specified|0|||
128972842|NCT02477800|464184636|FG000|Long Term Extension Period|Adverse Event|0|||
128972843|NCT02477800|464184637|FG001|Long Term Extension Period|Adverse Event|0|||
128972844|NCT02477800|464184638|FG002|Long Term Extension Period|Adverse Event|0|||
128972845|NCT02477800|464184639|FG003|Long Term Extension Period|Adverse Event|6|||
128972846|NCT02477800|464184640|FG004|Long Term Extension Period|Adverse Event|2|||
128972847|NCT02477800|464184641|FG005|Long Term Extension Period|Adverse Event|4|||
128972848|NCT02477800|464184642|FG006|Long Term Extension Period|Adverse Event|3|||
128972849|NCT02477800|464184636|FG000|Long Term Extension Period|Death|0|||
128972850|NCT02477800|464184637|FG001|Long Term Extension Period|Death|0|||
128972851|NCT02477800|464184638|FG002|Long Term Extension Period|Death|0|||
128972852|NCT02477800|464184639|FG003|Long Term Extension Period|Death|1|||
128972853|NCT02477800|464184640|FG004|Long Term Extension Period|Death|1|||
128972854|NCT02477800|464184641|FG005|Long Term Extension Period|Death|1|||
128972855|NCT02477800|464184642|FG006|Long Term Extension Period|Death|2|||
128972856|NCT02477800|464184636|FG000|Long Term Extension Period|Consent Withdrawn|0|||
128972857|NCT02477800|464184637|FG001|Long Term Extension Period|Consent Withdrawn|0|||
128972858|NCT02477800|464184638|FG002|Long Term Extension Period|Consent Withdrawn|0|||
128972859|NCT02477800|464184639|FG003|Long Term Extension Period|Consent Withdrawn|10|||
128972860|NCT02477800|464184640|FG004|Long Term Extension Period|Consent Withdrawn|4|||
129220943|NCT03566485|465110127|FG001|Overall Study|Disease progression|4|||
129220944|NCT03566485|465110126|FG000|Overall Study|Clinical progression|0|||
129220945|NCT03566485|465110127|FG001|Overall Study|Clinical progression|1|||
129220946|NCT03566485|465110126|FG000|Overall Study|Toxicity|0|||
128715770|NCT02472795|463255815|FG001|Overall Study|Withdrawal by Subject|0|||
128715771|NCT02472795|463255816|FG002|Overall Study|Withdrawal by Subject|0|||
128972861|NCT02477800|464184641|FG005|Long Term Extension Period|Consent Withdrawn|13|||
128972862|NCT02477800|464184642|FG006|Long Term Extension Period|Consent Withdrawn|16|||
128972863|NCT02477800|464184636|FG000|Long Term Extension Period|Disease Progression|0|||
129220947|NCT03566485|465110127|FG001|Overall Study|Toxicity|2|||
129220948|NCT04999852|465110128|FG000|Overall Study|Withdrawal by Subject|11|||
129131459|NCT00387127|464772838|FG000|Overall Study|Serious Adverse Event|1|||
129131460|NCT00387127|464772839|FG001|Overall Study|Serious Adverse Event|1|||
129131461|NCT00387127|464772838|FG000|Overall Study|Sponsor Unblinded|1|||
129131462|NCT00387127|464772839|FG001|Overall Study|Sponsor Unblinded|0|||
129131463|NCT00812097|464772840|FG000|Overall Study|Death|3|||
129131464|NCT00812097|464772841|FG001|Overall Study|Death|10|||
129131465|NCT00812097|464772842|FG002|Overall Study|Death|3|||
129131466|NCT00812097|464772843|FG003|Overall Study|Death|3|||
129131467|NCT00812097|464772840|FG000|Overall Study|Withdrawal by Subject|14|||
129131468|NCT00812097|464772841|FG001|Overall Study|Withdrawal by Subject|12|||
129131469|NCT00812097|464772842|FG002|Overall Study|Withdrawal by Subject|8|||
128715772|NCT02472795|463255817|FG003|Overall Study|Withdrawal by Subject|0|||
128972864|NCT02477800|464184637|FG001|Long Term Extension Period|Disease Progression|0|||
128972865|NCT02477800|464184638|FG002|Long Term Extension Period|Disease Progression|0|||
128972866|NCT02477800|464184639|FG003|Long Term Extension Period|Disease Progression|3|||
128972867|NCT02477800|464184640|FG004|Long Term Extension Period|Disease Progression|1|||
128972868|NCT02477800|464184641|FG005|Long Term Extension Period|Disease Progression|1|||
128972869|NCT02477800|464184642|FG006|Long Term Extension Period|Disease Progression|0|||
128972870|NCT02477800|464184636|FG000|Long Term Extension Period|Investigator Decision|0|||
128972871|NCT02477800|464184637|FG001|Long Term Extension Period|Investigator Decision|0|||
128972872|NCT02477800|464184638|FG002|Long Term Extension Period|Investigator Decision|0|||
128972873|NCT02477800|464184639|FG003|Long Term Extension Period|Investigator Decision|0|||
128972874|NCT02477800|464184640|FG004|Long Term Extension Period|Investigator Decision|0|||
128972875|NCT02477800|464184641|FG005|Long Term Extension Period|Investigator Decision|0|||
128972876|NCT02477800|464184642|FG006|Long Term Extension Period|Investigator Decision|2|||
128972877|NCT02477800|464184636|FG000|Long Term Extension Period|Lost to Follow-up|0|||
128972878|NCT02477800|464184637|FG001|Long Term Extension Period|Lost to Follow-up|0|||
128972879|NCT02477800|464184638|FG002|Long Term Extension Period|Lost to Follow-up|0|||
128972880|NCT02477800|464184639|FG003|Long Term Extension Period|Lost to Follow-up|0|||
128972881|NCT02477800|464184640|FG004|Long Term Extension Period|Lost to Follow-up|1|||
128972882|NCT02477800|464184641|FG005|Long Term Extension Period|Lost to Follow-up|3|||
128972883|NCT02477800|464184642|FG006|Long Term Extension Period|Lost to Follow-up|0|||
128972884|NCT02477800|464184636|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
128972885|NCT02477800|464184637|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
128972886|NCT02477800|464184638|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
128972887|NCT02477800|464184639|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
128972888|NCT02477800|464184640|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
128972889|NCT02477800|464184641|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
128972890|NCT02477800|464184642|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
128972891|NCT02477800|464184636|FG000|Long Term Extension Period|Study Visit Burden|0|||
128972892|NCT02477800|464184637|FG001|Long Term Extension Period|Study Visit Burden|0|||
128972893|NCT02477800|464184638|FG002|Long Term Extension Period|Study Visit Burden|0|||
128972894|NCT02477800|464184639|FG003|Long Term Extension Period|Study Visit Burden|3|||
128972895|NCT02477800|464184640|FG004|Long Term Extension Period|Study Visit Burden|0|||
128972896|NCT02477800|464184641|FG005|Long Term Extension Period|Study Visit Burden|2|||
128972897|NCT02477800|464184642|FG006|Long Term Extension Period|Study Visit Burden|2|||
128972898|NCT02477800|464184636|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
128972899|NCT02477800|464184637|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
128972900|NCT02477800|464184638|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
128972901|NCT02477800|464184639|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
128972902|NCT02477800|464184640|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
128972903|NCT02477800|464184641|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
128972904|NCT02477800|464184642|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
128972905|NCT02477800|464184636|FG000|Long Term Extension Period|Reason not Specified|0|||
128972906|NCT02477800|464184637|FG001|Long Term Extension Period|Reason not Specified|0|||
128972907|NCT02477800|464184638|FG002|Long Term Extension Period|Reason not Specified|0|||
128972908|NCT02477800|464184639|FG003|Long Term Extension Period|Reason not Specified|126|||
128972909|NCT02477800|464184640|FG004|Long Term Extension Period|Reason not Specified|140|||
128972910|NCT02477800|464184641|FG005|Long Term Extension Period|Reason not Specified|270|||
128972911|NCT02477800|464184642|FG006|Long Term Extension Period|Reason not Specified|224|||
128972912|NCT00958191|464184645|FG000|Overall Study|Death|4|||
128972913|NCT00958191|464184645|FG000|Overall Study|Lost to Follow-up|5|||
128972914|NCT00958191|464184645|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
128972915|NCT00958191|464184645|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
129131470|NCT00812097|464772843|FG003|Overall Study|Withdrawal by Subject|2|||
129131471|NCT00812097|464772840|FG000|Overall Study|Lost to Follow-up|90|||
128972916|NCT00958191|464184645|FG000|Overall Study|Revision of study device|4|||
128972917|NCT00958191|464184645|FG000|Overall Study|Site termination|11|||
128972918|NCT00958191|464184645|FG000|Overall Study|No 5 yr x-rays|56|||
129131472|NCT00812097|464772841|FG001|Overall Study|Lost to Follow-up|14|||
129131473|NCT00812097|464772842|FG002|Overall Study|Lost to Follow-up|17|||
128715773|NCT02472795|463255818|FG004|Overall Study|Withdrawal by Subject|1|||
128972919|NCT00611767|464184646|FG000|Overall Study|Withdrawal by Subject|4|||
128972920|NCT00611767|464184647|FG001|Overall Study|Withdrawal by Subject|1|||
128972921|NCT00611767|464184646|FG000|Overall Study|Thiopental not available|3|||
128972922|NCT00611767|464184647|FG001|Overall Study|Thiopental not available|0|||
128972923|NCT00611767|464184646|FG000|Overall Study|didn't like the medication|1|||
128972924|NCT00611767|464184647|FG001|Overall Study|didn't like the medication|1|||
128972925|NCT00611767|464184646|FG000|Overall Study|Physician Decision|1|||
128972926|NCT00611767|464184647|FG001|Overall Study|Physician Decision|0|||
128972927|NCT01818765|464184648|FG000|Overall Study|Death|2|||
128972928|NCT02010567|464184649|FG000|Overall Study|Adverse Event|0|||
128972929|NCT02010567|464184650|FG001|Overall Study|Adverse Event|0|||
128972930|NCT02010567|464184651|FG002|Overall Study|Adverse Event|1|||
128972931|NCT02010567|464184652|FG003|Overall Study|Adverse Event|0|||
128972932|NCT02010567|464184653|FG004|Overall Study|Adverse Event|1|||
128972933|NCT02005211|464184654|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
128972934|NCT02005211|464184655|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
128972935|NCT02005211|464184656|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
128972936|NCT02005211|464184657|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
128972937|NCT02005211|464184658|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
128972938|NCT02005211|464184659|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
128972939|NCT02005211|464184660|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
128972940|NCT00397631|464184663|FG000|Overall Study|Adverse Event|5|||
128972941|NCT00397631|464184664|FG001|Overall Study|Adverse Event|6|||
128972942|NCT00397631|464184663|FG000|Overall Study|Lack of Efficacy|7|||
128972943|NCT00397631|464184664|FG001|Overall Study|Lack of Efficacy|10|||
128972944|NCT00397631|464184663|FG000|Overall Study|Lost to Follow-up|8|||
128972945|NCT00397631|464184664|FG001|Overall Study|Lost to Follow-up|9|||
128972946|NCT00397631|464184663|FG000|Overall Study|Physician Decision|2|||
128972947|NCT00397631|464184664|FG001|Overall Study|Physician Decision|0|||
128972948|NCT00397631|464184663|FG000|Overall Study|Protocol Violation|0|||
128972949|NCT00397631|464184664|FG001|Overall Study|Protocol Violation|1|||
128972950|NCT00397631|464184663|FG000|Overall Study|Withdrawal by Subject|7|||
128972951|NCT00397631|464184664|FG001|Overall Study|Withdrawal by Subject|14|||
128972952|NCT00397631|464184663|FG000|Overall Study|protocol discontinuation criteria|1|||
128972953|NCT00397631|464184664|FG001|Overall Study|protocol discontinuation criteria|4|||
128972954|NCT02202161|464184665|FG000|Overall Study|Adverse Event|1|||
128972955|NCT02202161|464184666|FG001|Overall Study|Adverse Event|1|||
128972956|NCT02202161|464184667|FG002|Overall Study|Adverse Event|0|||
128972957|NCT02202161|464184668|FG003|Overall Study|Adverse Event|0|||
128972958|NCT02202161|464184669|FG004|Overall Study|Adverse Event|0|||
128972959|NCT02202161|464184670|FG005|Overall Study|Adverse Event|1|||
129038535|NCT01714739|464433197|FG002|Overall Study|Poor/non-comliance|0|||
129038536|NCT01714739|464433198|FG003|Overall Study|Poor/non-comliance|1|||
129038537|NCT01714739|464433199|FG004|Overall Study|Poor/non-comliance|0|||
129038538|NCT01714739|464433200|FG005|Overall Study|Poor/non-comliance|0|||
129038539|NCT01714739|464433201|FG006|Overall Study|Poor/non-comliance|0|||
129038540|NCT01714739|464433195|FG000|Overall Study|No longer meets study criteria|0|||
129038541|NCT01714739|464433196|FG001|Overall Study|No longer meets study criteria|0|||
129038542|NCT01714739|464433197|FG002|Overall Study|No longer meets study criteria|0|||
129038543|NCT01714739|464433198|FG003|Overall Study|No longer meets study criteria|1|||
129038544|NCT01714739|464433199|FG004|Overall Study|No longer meets study criteria|0|||
129038545|NCT01714739|464433200|FG005|Overall Study|No longer meets study criteria|0|||
129038546|NCT01714739|464433201|FG006|Overall Study|No longer meets study criteria|0|||
129038547|NCT01714739|464433195|FG000|Overall Study|Other reason|0|||
129038548|NCT01714739|464433196|FG001|Overall Study|Other reason|0|||
129038549|NCT01714739|464433197|FG002|Overall Study|Other reason|0|||
129038550|NCT01714739|464433198|FG003|Overall Study|Other reason|3|||
129038551|NCT01714739|464433199|FG004|Overall Study|Other reason|1|||
129038552|NCT01714739|464433200|FG005|Overall Study|Other reason|0|||
129038553|NCT01714739|464433201|FG006|Overall Study|Other reason|0|||
129038554|NCT03585959|464433202|FG000|Overall Study|Physician Decision|1|||
129038555|NCT03585959|464433202|FG000|Overall Study|Unsuccessful Procedure|2|||
129038556|NCT00865514|464433203|FG000|Overall Study|Infusion cost exceeded funding|2|||
129038557|NCT03920280|464433204|FG000|Overall Study|Adverse Event|2|||
129038558|NCT03920280|464433205|FG001|Overall Study|Adverse Event|3|||
129038559|NCT03920280|464433204|FG000|Overall Study|Lost to Follow-up|0|||
129038560|NCT03920280|464433205|FG001|Overall Study|Lost to Follow-up|1|||
128972960|NCT02202161|464184671|FG006|Overall Study|Adverse Event|0|||
128972961|NCT02202161|464184672|FG007|Overall Study|Adverse Event|0|||
128972962|NCT02202161|464184665|FG000|Overall Study|Did not meet continuation criteria|0|||
128972963|NCT02202161|464184666|FG001|Overall Study|Did not meet continuation criteria|0|||
129038561|NCT03920280|464433204|FG000|Overall Study|Withdrawal by Subject|1|||
129038562|NCT03920280|464433205|FG001|Overall Study|Withdrawal by Subject|1|||
129038563|NCT03920280|464433204|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
128972964|NCT02202161|464184667|FG002|Overall Study|Did not meet continuation criteria|0|||
128972965|NCT02202161|464184668|FG003|Overall Study|Did not meet continuation criteria|0|||
129038564|NCT03920280|464433205|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
129038565|NCT01463982|464433206|FG000|Overall Study|Withdrawal by Subject|0|||
129038566|NCT01463982|464433207|FG001|Overall Study|Withdrawal by Subject|1|||
129038567|NCT01463982|464433208|FG002|Overall Study|Withdrawal by Subject|1|||
129038568|NCT01463982|464433209|FG003|Overall Study|Withdrawal by Subject|0|||
129038569|NCT01463982|464433206|FG000|Overall Study|Treatment delay over 5 week|0|||
129038570|NCT01463982|464433207|FG001|Overall Study|Treatment delay over 5 week|0|||
129038571|NCT01463982|464433208|FG002|Overall Study|Treatment delay over 5 week|1|||
129038572|NCT01463982|464433209|FG003|Overall Study|Treatment delay over 5 week|0|||
129038573|NCT01857206|464433212|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
129038574|NCT01857206|464433213|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
129038575|NCT01857206|464433212|FG000|Overall Study|Lost to Follow-up|9|||
129038576|NCT01857206|464433213|FG001|Overall Study|Lost to Follow-up|6|||
129038577|NCT01857206|464433212|FG000|Overall Study|Unclassified|3|||
129038578|NCT01857206|464433213|FG001|Overall Study|Unclassified|3|||
129220949|NCT04999852|465110129|FG001|Overall Study|Withdrawal by Subject|1|||
129220950|NCT04999852|465110128|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
129220951|NCT04999852|465110129|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
129220952|NCT04638660|465110130|FG000|Overall Study|Withdrawal by Subject|2|||
129220953|NCT04638660|465110131|FG001|Overall Study|Withdrawal by Subject|0|||
129220954|NCT04638660|465110130|FG000|Overall Study|Lost to Follow-up|1|||
129220955|NCT04638660|465110131|FG001|Overall Study|Lost to Follow-up|0|||
129220956|NCT03610269|465110133|FG000|Overall Study|Physician Decision|10|||
129220957|NCT03610269|465110133|FG000|Overall Study|Protocol Violation|1|||
129220958|NCT03610269|465110133|FG000|Overall Study|Unable to draw blood|1|||
129220959|NCT03610269|465110133|FG000|Overall Study|Screen fail|4|||
129220960|NCT00478023|465110134|FG000|Overall Study|Adverse Event|11|||
129220961|NCT00478023|465110135|FG001|Overall Study|Adverse Event|7|||
129220962|NCT00478023|465110136|FG002|Overall Study|Adverse Event|8|||
129220963|NCT00478023|465110137|FG003|Overall Study|Adverse Event|14|||
129220964|NCT00478023|465110138|FG004|Overall Study|Adverse Event|6|||
129220965|NCT00478023|465110134|FG000|Overall Study|Death|1|||
129220966|NCT00478023|465110135|FG001|Overall Study|Death|0|||
129220967|NCT00478023|465110136|FG002|Overall Study|Death|0|||
129220968|NCT00478023|465110137|FG003|Overall Study|Death|0|||
129038579|NCT01857206|464433212|FG000|Overall Study|Withdrawal by Subject|1|||
129038580|NCT01857206|464433213|FG001|Overall Study|Withdrawal by Subject|0|||
129038581|NCT01857973|464433214|FG000|Overall Study|Subject did not meet required BG range|3|||
129038582|NCT01857973|464433214|FG000|Overall Study|drop out after 3 failed attempts|1|||
129038583|NCT01857973|464433214|FG000|Overall Study|Physician Decision|1|||
129038584|NCT00129116|464433219|FG000|Primary Phase|Lost to Follow-up|1|||
129220969|NCT00478023|465110138|FG004|Overall Study|Death|0|||
129220970|NCT00478023|465110134|FG000|Overall Study|Lack of Efficacy|11|||
129220971|NCT00478023|465110135|FG001|Overall Study|Lack of Efficacy|10|||
129220972|NCT00478023|465110136|FG002|Overall Study|Lack of Efficacy|4|||
129220973|NCT00478023|465110137|FG003|Overall Study|Lack of Efficacy|5|||
129220974|NCT00478023|465110138|FG004|Overall Study|Lack of Efficacy|41|||
129220975|NCT00478023|465110134|FG000|Overall Study|Lost to Follow-up|3|||
129038585|NCT00129116|464433220|FG001|Primary Phase|Lost to Follow-up|1|||
129038586|NCT00129116|464433221|FG002|Primary Phase|Lost to Follow-up|0|||
129038587|NCT00129116|464433222|FG003|Primary Phase|Lost to Follow-up|1|||
129038588|NCT00129116|464433223|FG004|Primary Phase|Lost to Follow-up|1|||
129038589|NCT00129116|464433219|FG000|Primary Phase|Protocol Violation|0|||
129038590|NCT00129116|464433220|FG001|Primary Phase|Protocol Violation|1|||
129038591|NCT00129116|464433221|FG002|Primary Phase|Protocol Violation|0|||
129038592|NCT00129116|464433222|FG003|Primary Phase|Protocol Violation|0|||
129038593|NCT00129116|464433223|FG004|Primary Phase|Protocol Violation|0|||
129038594|NCT00129116|464433219|FG000|Primary Phase|Adverse Event|1|||
129038595|NCT00129116|464433220|FG001|Primary Phase|Adverse Event|1|||
129038596|NCT00129116|464433221|FG002|Primary Phase|Adverse Event|0|||
129038597|NCT00129116|464433222|FG003|Primary Phase|Adverse Event|0|||
129038598|NCT00129116|464433223|FG004|Primary Phase|Adverse Event|0|||
129038599|NCT00129116|464433219|FG000|Primary Phase|Withdrawal by Subject|0|||
129038600|NCT00129116|464433220|FG001|Primary Phase|Withdrawal by Subject|1|||
129038601|NCT00129116|464433221|FG002|Primary Phase|Withdrawal by Subject|0|||
129038602|NCT00129116|464433222|FG003|Primary Phase|Withdrawal by Subject|0|||
129038603|NCT00129116|464433223|FG004|Primary Phase|Withdrawal by Subject|0|||
129038604|NCT00129116|464433219|FG000|Primary Phase|Other|0|||
129038605|NCT00129116|464433220|FG001|Primary Phase|Other|0|||
129038606|NCT00129116|464433221|FG002|Primary Phase|Other|1|||
129220976|NCT00478023|465110135|FG001|Overall Study|Lost to Follow-up|1|||
129038607|NCT00129116|464433222|FG003|Primary Phase|Other|0|||
129038608|NCT00129116|464433223|FG004|Primary Phase|Other|0|||
129038609|NCT00129116|464433219|FG000|Booster Phase|Lost to Follow-up|2|||
129220977|NCT00478023|465110136|FG002|Overall Study|Lost to Follow-up|1|||
129038610|NCT00129116|464433220|FG001|Booster Phase|Lost to Follow-up|0|||
129220978|NCT00478023|465110137|FG003|Overall Study|Lost to Follow-up|1|||
129220979|NCT00478023|465110138|FG004|Overall Study|Lost to Follow-up|0|||
129220980|NCT00478023|465110134|FG000|Overall Study|Withdrawal by Subject|2|||
128972966|NCT02202161|464184669|FG004|Overall Study|Did not meet continuation criteria|0|||
128972967|NCT02202161|464184670|FG005|Overall Study|Did not meet continuation criteria|0|||
128972968|NCT02202161|464184671|FG006|Overall Study|Did not meet continuation criteria|0|||
128972969|NCT02202161|464184672|FG007|Overall Study|Did not meet continuation criteria|3|||
128972970|NCT02202161|464184665|FG000|Overall Study|Physician Decision|0|||
128972971|NCT02202161|464184666|FG001|Overall Study|Physician Decision|0|||
128972972|NCT02202161|464184667|FG002|Overall Study|Physician Decision|0|||
128972973|NCT02202161|464184668|FG003|Overall Study|Physician Decision|0|||
128972974|NCT02202161|464184669|FG004|Overall Study|Physician Decision|0|||
128972975|NCT02202161|464184670|FG005|Overall Study|Physician Decision|0|||
128972976|NCT02202161|464184671|FG006|Overall Study|Physician Decision|0|||
128972977|NCT02202161|464184672|FG007|Overall Study|Physician Decision|3|||
128972978|NCT02202161|464184665|FG000|Overall Study|Withdrawal by Subject|0|||
128972979|NCT02202161|464184666|FG001|Overall Study|Withdrawal by Subject|0|||
128972980|NCT02202161|464184667|FG002|Overall Study|Withdrawal by Subject|0|||
128972981|NCT02202161|464184668|FG003|Overall Study|Withdrawal by Subject|0|||
128972982|NCT02202161|464184669|FG004|Overall Study|Withdrawal by Subject|1|||
128972983|NCT02202161|464184670|FG005|Overall Study|Withdrawal by Subject|0|||
128972984|NCT02202161|464184671|FG006|Overall Study|Withdrawal by Subject|0|||
128972985|NCT02202161|464184672|FG007|Overall Study|Withdrawal by Subject|0|||
128972986|NCT00832091|464184673|FG000|Overall Study|Adverse Event|1|||
128972987|NCT00832091|464184674|FG001|Overall Study|Adverse Event|1|||
128972988|NCT00832091|464184673|FG000|Overall Study|Protocol Violation|1|||
128972989|NCT00832091|464184674|FG001|Overall Study|Protocol Violation|0|||
128972990|NCT00832091|464184673|FG000|Overall Study|Withdrawal by Subject|2|||
128972991|NCT00832091|464184674|FG001|Overall Study|Withdrawal by Subject|1|||
128972992|NCT00832091|464184673|FG000|Overall Study|Prohibited Medication|1|||
128972993|NCT00832091|464184674|FG001|Overall Study|Prohibited Medication|0|||
128972994|NCT00942422|464184675|FG000|Overall Study|Withdrawal by Subject|1|||
128972995|NCT00942422|464184675|FG000|Overall Study|Death|1|||
128972996|NCT00942422|464184675|FG000|Overall Study|Progressive diease|1|||
128972997|NCT02711553|464184678|FG000|Overall Study|Withdrawal by Subject|2|||
128972998|NCT02711553|464184679|FG001|Overall Study|Withdrawal by Subject|1|||
128972999|NCT02711553|464184680|FG002|Overall Study|Withdrawal by Subject|1|||
128973000|NCT02711553|464184681|FG003|Overall Study|Withdrawal by Subject|0|||
128973001|NCT02711553|464184678|FG000|Overall Study|Lost to Follow-up|3|||
128973002|NCT02711553|464184679|FG001|Overall Study|Lost to Follow-up|3|||
128973003|NCT02711553|464184680|FG002|Overall Study|Lost to Follow-up|6|||
128973004|NCT02711553|464184681|FG003|Overall Study|Lost to Follow-up|3|||
128973005|NCT02711553|464184678|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
128973006|NCT02711553|464184679|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
128973007|NCT02711553|464184680|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
128973008|NCT02711553|464184681|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
128973009|NCT05559203|464184682|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
128973010|NCT04048876|464184683|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
128973011|NCT04048876|464184684|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
128973012|NCT04048876|464184685|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
128973013|NCT04048876|464184686|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
128973014|NCT04048876|464184683|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
128973015|NCT04048876|464184684|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
128973016|NCT04048876|464184685|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
128973017|NCT04048876|464184686|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
128973018|NCT04048876|464184683|FG000|Placebo Controlled Phase|Adverse Event|0|||
128973019|NCT04048876|464184684|FG001|Placebo Controlled Phase|Adverse Event|1|||
128973020|NCT04048876|464184685|FG002|Placebo Controlled Phase|Adverse Event|0|||
128973021|NCT04048876|464184686|FG003|Placebo Controlled Phase|Adverse Event|0|||
128973022|NCT04048876|464184683|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
128973023|NCT04048876|464184684|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
128973024|NCT04048876|464184685|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
128973025|NCT04048876|464184686|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
128973026|NCT02187224|464184687|FG000|Overall Study|Did not show up for test day|1|||
128973027|NCT02187224|464184688|FG001|Overall Study|Did not show up for test day|0|||
128973028|NCT00415623|464184692|FG000|Overall Study|Adverse Event|3|||
128973029|NCT00415623|464184693|FG001|Overall Study|Adverse Event|4|||
129131474|NCT00812097|464772843|FG003|Overall Study|Lost to Follow-up|5|||
128774722|NCT04157686|463466659|FG007|Overall Study|Withdrawal by Subject|24|||
128973030|NCT00415623|464184692|FG000|Overall Study|Death|1|||
128973031|NCT00415623|464184693|FG001|Overall Study|Death|0|||
128973032|NCT00415623|464184692|FG000|Overall Study|Withdrawal by Subject|1|||
128973033|NCT00415623|464184693|FG001|Overall Study|Withdrawal by Subject|1|||
128973034|NCT00542425|464184694|FG000|Initial 24 Weeks|Administrative reasons|0|||
128973035|NCT00542425|464184695|FG001|Initial 24 Weeks|Administrative reasons|0|||
128973036|NCT00542425|464184696|FG002|Initial 24 Weeks|Administrative reasons|1|||
128973037|NCT00542425|464184697|FG003|Initial 24 Weeks|Administrative reasons|1|||
128715774|NCT04166513|463255819|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
128715775|NCT04166513|463255820|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
129038611|NCT00129116|464433221|FG002|Booster Phase|Lost to Follow-up|0|||
129038612|NCT00129116|464433222|FG003|Booster Phase|Lost to Follow-up|0|||
129038613|NCT00129116|464433223|FG004|Booster Phase|Lost to Follow-up|1|||
129038614|NCT00346164|464433224|FG000|Overall Study|Adverse Event|0|||
129038615|NCT00346164|464433225|FG001|Overall Study|Adverse Event|0|||
129038616|NCT00346164|464433226|FG002|Overall Study|Adverse Event|0|||
128715776|NCT04166513|463255821|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
129038617|NCT00346164|464433227|FG003|Overall Study|Adverse Event|1|||
129038618|NCT00346164|464433224|FG000|Overall Study|Lack of Efficacy|0|||
129038619|NCT00346164|464433225|FG001|Overall Study|Lack of Efficacy|1|||
129038620|NCT00346164|464433226|FG002|Overall Study|Lack of Efficacy|7|||
129038621|NCT00346164|464433227|FG003|Overall Study|Lack of Efficacy|25|||
129038622|NCT00346164|464433224|FG000|Overall Study|Physician Decision|0|||
129038623|NCT00346164|464433225|FG001|Overall Study|Physician Decision|1|||
129038624|NCT00346164|464433226|FG002|Overall Study|Physician Decision|2|||
129038625|NCT00346164|464433227|FG003|Overall Study|Physician Decision|27|||
129038626|NCT00346164|464433224|FG000|Overall Study|Protocol Violation|6|||
129038627|NCT00346164|464433225|FG001|Overall Study|Protocol Violation|2|||
129038628|NCT00346164|464433226|FG002|Overall Study|Protocol Violation|10|||
128715777|NCT04166513|463255822|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
128715778|NCT04166513|463255819|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
128715779|NCT04166513|463255820|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
128715780|NCT04166513|463255821|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
128715781|NCT04166513|463255822|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
128715782|NCT04166513|463255819|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
128715783|NCT04166513|463255820|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
128715784|NCT04166513|463255821|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
128715785|NCT04166513|463255822|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
128715786|NCT04166513|463255819|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
128715787|NCT04166513|463255820|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
128715788|NCT04166513|463255821|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
128715789|NCT04166513|463255822|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
128715790|NCT04166513|463255819|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
128715791|NCT04166513|463255820|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
128715792|NCT04166513|463255821|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
128715793|NCT04166513|463255822|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
128715794|NCT00597012|463255827|FG000|Overall Study|Death|1|||
128715795|NCT00597012|463255828|FG001|Overall Study|Death|1|||
128715796|NCT00597012|463255827|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
128715797|NCT00597012|463255828|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
128715798|NCT00597012|463255827|FG000|Overall Study|Withdrawal by Subject|7|||
128715799|NCT00597012|463255828|FG001|Overall Study|Withdrawal by Subject|4|||
128715800|NCT00597012|463255827|FG000|Overall Study|Ineligible|2|||
128715801|NCT00597012|463255828|FG001|Overall Study|Ineligible|0|||
128715802|NCT00597012|463255827|FG000|Overall Study|Lost to Follow-up|0|||
128715803|NCT00597012|463255828|FG001|Overall Study|Lost to Follow-up|2|||
128715804|NCT03274687|463256606|FG000|Overall Study|Protocol Violation|1|||
128715805|NCT03274687|463256607|FG001|Overall Study|Protocol Violation|1|||
128715806|NCT04568590|463256614|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
128715807|NCT00202644|463256615|FG000|Overall Study|Adverse Event|12|||
128715808|NCT00202644|463256616|FG001|Overall Study|Adverse Event|13|||
128715809|NCT00202644|463256615|FG000|Overall Study|Withdrawal by Subject|8|||
128715810|NCT00202644|463256616|FG001|Overall Study|Withdrawal by Subject|6|||
128715811|NCT00202644|463256615|FG000|Overall Study|Lack of Efficacy|6|||
128715812|NCT00202644|463256616|FG001|Overall Study|Lack of Efficacy|6|||
128715813|NCT00202644|463256615|FG000|Overall Study|Lost to Follow-up|0|||
128715814|NCT00202644|463256616|FG001|Overall Study|Lost to Follow-up|1|||
128715815|NCT00202644|463256615|FG000|Overall Study|Other|9|||
128715816|NCT00202644|463256616|FG001|Overall Study|Other|1|||
128715817|NCT01851720|463256623|FG000|Overall Study|Lost to Follow-up|0|||
128715818|NCT01851720|463256624|FG001|Overall Study|Lost to Follow-up|1|||
128715819|NCT01870583|463256627|FG000|Overall Study|Protocol Violation|0|||
128715820|NCT01870583|463256628|FG001|Overall Study|Protocol Violation|5|||
128715821|NCT01870583|463256629|FG002|Overall Study|Protocol Violation|3|||
128715822|NCT01870583|463256627|FG000|Overall Study|Lost to Follow-up|11|||
129038629|NCT00346164|464433227|FG003|Overall Study|Protocol Violation|4|||
129131475|NCT00812097|464772840|FG000|Overall Study|Explantation of study device(s)|27|||
128715823|NCT01870583|463256628|FG001|Overall Study|Lost to Follow-up|13|||
128715824|NCT01870583|463256629|FG002|Overall Study|Lost to Follow-up|5|||
128715825|NCT00937157|463256630|FG000|Overall Study|Pregnancy|1|||
128715826|NCT00937157|463256630|FG000|Overall Study|Lost to Follow-up|3|||
128715827|NCT02024867|463256631|FG000|Overall Study|Protocol Violation|3|||
128715828|NCT02024867|463256632|FG001|Overall Study|Protocol Violation|3|||
128715829|NCT02024867|463256631|FG000|Overall Study|Lost to Follow-up|6|||
128715830|NCT02024867|463256632|FG001|Overall Study|Lost to Follow-up|4|||
129038630|NCT00346164|464433224|FG000|Overall Study|Withdrawal by Subject|0|||
129220981|NCT00478023|465110135|FG001|Overall Study|Withdrawal by Subject|3|||
129220982|NCT00478023|465110136|FG002|Overall Study|Withdrawal by Subject|2|||
129220983|NCT00478023|465110137|FG003|Overall Study|Withdrawal by Subject|4|||
129220984|NCT00478023|465110138|FG004|Overall Study|Withdrawal by Subject|5|||
129220985|NCT00478023|465110134|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
129220986|NCT00478023|465110135|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
129220987|NCT00478023|465110136|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
129220988|NCT00478023|465110137|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
129220989|NCT00478023|465110138|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
129220990|NCT00611026|465110140|FG000|Randomized to Double-blind Treatment|Not treated|2|||
129220991|NCT00611026|465110141|FG001|Randomized to Double-blind Treatment|Not treated|1|||
129220992|NCT00611026|465110142|FG002|Randomized to Double-blind Treatment|Not treated|3|||
129220993|NCT00611026|465110140|FG000|Double-blind Treatment Period|Death|1|||
129220994|NCT00611026|465110141|FG001|Double-blind Treatment Period|Death|0|||
129220995|NCT00611026|465110142|FG002|Double-blind Treatment Period|Death|0|||
129220996|NCT00611026|465110140|FG000|Double-blind Treatment Period|Adverse Event|9|||
129220997|NCT00611026|465110141|FG001|Double-blind Treatment Period|Adverse Event|28|||
129220998|NCT00611026|465110142|FG002|Double-blind Treatment Period|Adverse Event|46|||
129220999|NCT00611026|465110140|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
129221000|NCT00611026|465110141|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
129221001|NCT00611026|465110142|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
129221002|NCT00611026|465110140|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
129221003|NCT00611026|465110141|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
129221004|NCT00611026|465110142|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
129221005|NCT00611026|465110140|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
129221006|NCT00611026|465110141|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
129221007|NCT00611026|465110142|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
129221008|NCT00611026|465110140|FG000|Double-blind Treatment Period|Other|13|||
129221009|NCT00611026|465110141|FG001|Double-blind Treatment Period|Other|20|||
129221010|NCT00611026|465110142|FG002|Double-blind Treatment Period|Other|18|||
129221011|NCT05019521|465110143|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
129221012|NCT05019521|465110144|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
129221013|NCT05019521|465110145|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
129221014|NCT05019521|465110146|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
129221015|NCT05019521|465110147|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
129221016|NCT05019521|465110148|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
129221017|NCT05019521|465110149|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
129131476|NCT00812097|464772841|FG001|Overall Study|Explantation of study device(s)|29|||
129131477|NCT00812097|464772842|FG002|Overall Study|Explantation of study device(s)|14|||
129131478|NCT00812097|464772843|FG003|Overall Study|Explantation of study device(s)|20|||
129131479|NCT00812097|464772840|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
129131480|NCT00812097|464772841|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
129131481|NCT00812097|464772842|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
129131482|NCT00812097|464772843|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
129131483|NCT01786109|464772844|FG000|Overall Study|fail manometry barostat tube placement|1|||
129131484|NCT01786109|464772845|FG001|Overall Study|fail manometry barostat tube placement|0|||
128715831|NCT03251079|463256635|FG000|Overall Study|Withdrawal by Subject|1|||
128715832|NCT00455429|463256641|FG000|Overall Study|Study Terminated by Sponsor|0|||
128715833|NCT00455429|463256642|FG001|Overall Study|Study Terminated by Sponsor|0|||
128715834|NCT00455429|463256643|FG002|Overall Study|Study Terminated by Sponsor|0|||
129131485|NCT01786109|464772846|FG002|Overall Study|fail manometry barostat tube placement|0|||
128715835|NCT00455429|463256644|FG003|Overall Study|Study Terminated by Sponsor|3|||
128715836|NCT00455429|463256641|FG000|Overall Study|Lost to Follow-up|1|||
128715837|NCT00455429|463256642|FG001|Overall Study|Lost to Follow-up|0|||
128715838|NCT00455429|463256643|FG002|Overall Study|Lost to Follow-up|0|||
128715839|NCT00455429|463256644|FG003|Overall Study|Lost to Follow-up|3|||
128715840|NCT00455429|463256641|FG000|Overall Study|Withdrawal by Subject|0|||
128715841|NCT00455429|463256642|FG001|Overall Study|Withdrawal by Subject|1|||
129131486|NCT01786109|464772844|FG000|Overall Study|unrelated illness|0|||
129131487|NCT01786109|464772845|FG001|Overall Study|unrelated illness|0|||
129221018|NCT05019521|465110143|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129221019|NCT05019521|465110144|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129221020|NCT05019521|465110145|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129131488|NCT01786109|464772846|FG002|Overall Study|unrelated illness|1|||
129221021|NCT05019521|465110146|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
129221022|NCT05019521|465110147|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129131489|NCT01786109|464772844|FG000|Overall Study|adverse effects colon preparation|0|||
129131490|NCT01786109|464772845|FG001|Overall Study|adverse effects colon preparation|0|||
129221023|NCT05019521|465110148|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
128715842|NCT00455429|463256643|FG002|Overall Study|Withdrawal by Subject|1|||
128973038|NCT00542425|464184698|FG004|Initial 24 Weeks|Administrative reasons|0|||
128973039|NCT00542425|464184694|FG000|Initial 24 Weeks|Adverse Event|0|||
128973040|NCT00542425|464184695|FG001|Initial 24 Weeks|Adverse Event|1|||
128973041|NCT00542425|464184696|FG002|Initial 24 Weeks|Adverse Event|1|||
128973042|NCT00542425|464184697|FG003|Initial 24 Weeks|Adverse Event|3|||
128973043|NCT00542425|464184698|FG004|Initial 24 Weeks|Adverse Event|2|||
128973044|NCT00542425|464184694|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
128973045|NCT00542425|464184695|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
128973046|NCT00542425|464184696|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
128973047|NCT00542425|464184697|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
128973048|NCT00542425|464184698|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
128973049|NCT00542425|464184694|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
128973050|NCT00542425|464184695|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
128973051|NCT00542425|464184696|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
128973052|NCT00542425|464184697|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
128973053|NCT00542425|464184698|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
128973054|NCT00542425|464184694|FG000|Initial 24 Weeks|Non-compliance|0|||
128973055|NCT00542425|464184695|FG001|Initial 24 Weeks|Non-compliance|0|||
128973056|NCT00542425|464184696|FG002|Initial 24 Weeks|Non-compliance|0|||
128973057|NCT00542425|464184697|FG003|Initial 24 Weeks|Non-compliance|1|||
128973058|NCT00542425|464184698|FG004|Initial 24 Weeks|Non-compliance|1|||
128973059|NCT00542425|464184694|FG000|Initial 24 Weeks|Protocol Violation|0|||
128973060|NCT00542425|464184695|FG001|Initial 24 Weeks|Protocol Violation|0|||
128973061|NCT00542425|464184696|FG002|Initial 24 Weeks|Protocol Violation|0|||
128973062|NCT00542425|464184697|FG003|Initial 24 Weeks|Protocol Violation|1|||
128973063|NCT00542425|464184698|FG004|Initial 24 Weeks|Protocol Violation|0|||
128973064|NCT00542425|464184694|FG000|Initial 24 Weeks|Refusal of treatment|2|||
128973065|NCT00542425|464184695|FG001|Initial 24 Weeks|Refusal of treatment|2|||
128973066|NCT00542425|464184696|FG002|Initial 24 Weeks|Refusal of treatment|1|||
128973067|NCT00542425|464184697|FG003|Initial 24 Weeks|Refusal of treatment|4|||
128973068|NCT00542425|464184698|FG004|Initial 24 Weeks|Refusal of treatment|1|||
128973069|NCT00542425|464184694|FG000|Initial 24 Weeks|Other|0|||
128973070|NCT00542425|464184695|FG001|Initial 24 Weeks|Other|2|||
128973071|NCT00542425|464184696|FG002|Initial 24 Weeks|Other|1|||
128973072|NCT00542425|464184697|FG003|Initial 24 Weeks|Other|0|||
128973073|NCT00542425|464184698|FG004|Initial 24 Weeks|Other|0|||
128973074|NCT00542425|464184694|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
128973075|NCT00542425|464184695|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
128973076|NCT00542425|464184696|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
128973077|NCT00542425|464184697|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
128973078|NCT00542425|464184698|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
128973079|NCT00542425|464184694|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
128973080|NCT00542425|464184695|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
128973081|NCT00542425|464184696|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
128973082|NCT00542425|464184697|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
128973083|NCT00542425|464184698|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
128973084|NCT00542425|464184694|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
128973085|NCT00542425|464184695|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
128973086|NCT00542425|464184696|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
128973087|NCT00542425|464184697|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
128973088|NCT00542425|464184698|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
128973089|NCT00542425|464184694|FG000|Extended 24 Weeks of Treatment|Other|1|||
128973090|NCT00542425|464184695|FG001|Extended 24 Weeks of Treatment|Other|1|||
128973091|NCT00542425|464184696|FG002|Extended 24 Weeks of Treatment|Other|0|||
128973092|NCT00542425|464184697|FG003|Extended 24 Weeks of Treatment|Other|0|||
128973093|NCT00542425|464184698|FG004|Extended 24 Weeks of Treatment|Other|1|||
128973094|NCT01601873|464184699|FG000|Overall Study|Lost to Follow-up|2|||
128973095|NCT01601873|464184700|FG001|Overall Study|Lost to Follow-up|3|||
128973096|NCT02096471|464184701|FG000|Overall Study|Adverse Event|1|||
128973097|NCT02096471|464184701|FG000|Overall Study|Lack of Efficacy|7|||
128973098|NCT02096471|464184701|FG000|Overall Study|Withdrawal by Subject|3|||
128973099|NCT02096471|464184701|FG000|Overall Study|Non-Compliant|2|||
128973100|NCT02449915|464184702|FG000|Overall Study|Exclusion criteria - drug use|1|||
128973101|NCT02449915|464184703|FG001|Overall Study|Exclusion criteria - drug use|0|||
128973102|NCT02449915|464184702|FG000|Overall Study|Withdrawal by Subject|0|||
128973103|NCT02449915|464184703|FG001|Overall Study|Withdrawal by Subject|2|||
128973104|NCT02449915|464184702|FG000|Overall Study|Intraoperative surgical findings|1|||
128973105|NCT02449915|464184703|FG001|Overall Study|Intraoperative surgical findings|1|||
128973106|NCT02449915|464184702|FG000|Overall Study|Abnormal preop lab|0|||
128973107|NCT02449915|464184703|FG001|Overall Study|Abnormal preop lab|1|||
128973108|NCT03455530|464186884|FG000|Overall Study|Withdrawal by Subject|9|||
128973109|NCT03455530|464186885|FG001|Overall Study|Withdrawal by Subject|1|||
128774723|NCT04157686|463466652|FG000|Overall Study|Physician Decision|0|||
128973110|NCT03455530|464186886|FG002|Overall Study|Withdrawal by Subject|3|||
128973111|NCT03455530|464186887|FG003|Overall Study|Withdrawal by Subject|3|||
128973112|NCT01592773|464186892|FG000|Overall Study|Study Terminated by Sponsor|582|||
128973113|NCT01592773|464186892|FG000|Overall Study|Withdrawal by Subject|35|||
128973114|NCT01592773|464186892|FG000|Overall Study|Lost to Follow-up|19|||
128973115|NCT01592773|464186892|FG000|Overall Study|Adverse Event|17|||
128973116|NCT01592773|464186892|FG000|Overall Study|Lack of Efficacy|9|||
128973117|NCT01592773|464186892|FG000|Overall Study|Protocol Violation|2|||
128973118|NCT01592773|464186892|FG000|Overall Study|Inclusion/exclusion not meet|1|||
128973119|NCT01592773|464186892|FG000|Overall Study|Other Reason|1|||
128973120|NCT00740116|464186897|FG000|Overall Study|Withdrawal by Subject|1|||
128973121|NCT00740116|464186898|FG001|Overall Study|Withdrawal by Subject|1|||
128973122|NCT00740116|464186897|FG000|Overall Study|Protocol Violation|1|||
128973123|NCT00740116|464186898|FG001|Overall Study|Protocol Violation|4|||
128973124|NCT03037489|464186899|FG000|Overall Study|Adverse Event|4|||
128973125|NCT03037489|464186900|FG001|Overall Study|Adverse Event|0|||
128973126|NCT03037489|464186899|FG000|Overall Study|Withdrawal by Subject|3|||
128973127|NCT03037489|464186900|FG001|Overall Study|Withdrawal by Subject|0|||
128973128|NCT00121485|464186901|FG000|Overall Study|Not implanted|1|||
128973129|NCT00121485|464186902|FG001|Overall Study|Not implanted|5|||
128973130|NCT00121485|464186901|FG000|Overall Study|Crossover|0|||
128973131|NCT00121485|464186902|FG001|Overall Study|Crossover|2|||
128973132|NCT00724243|464186905|FG000|Overall Study|Lack of Efficacy|10|||
128973133|NCT00724243|464186905|FG000|Overall Study|Adverse Event|5|||
128973134|NCT03031327|464186906|FG000|Overall Study|Withdrawal by Subject|0|||
128973135|NCT03031327|464186907|FG001|Overall Study|Withdrawal by Subject|1|||
128973136|NCT03031327|464186908|FG002|Overall Study|Withdrawal by Subject|1|||
128973137|NCT01004861|464186909|FG000|Overall Study|Disease progression|3|||
128973138|NCT01004861|464186910|FG001|Overall Study|Disease progression|4|||
128973139|NCT01004861|464186911|FG002|Overall Study|Disease progression|5|||
128973140|NCT01004861|464186912|FG003|Overall Study|Disease progression|4|||
128973141|NCT01004861|464186913|FG004|Overall Study|Disease progression|4|||
128973142|NCT01004861|464186914|FG005|Overall Study|Disease progression|4|||
128973143|NCT01004861|464186915|FG006|Overall Study|Disease progression|5|||
128973144|NCT01004861|464186916|FG007|Overall Study|Disease progression|1|||
128973145|NCT01004861|464186917|FG008|Overall Study|Disease progression|4|||
128973146|NCT01004861|464186918|FG009|Overall Study|Disease progression|7|||
128973147|NCT01004861|464186919|FG010|Overall Study|Disease progression|6|||
128973148|NCT01004861|464186920|FG011|Overall Study|Disease progression|3|||
128973149|NCT01004861|464186921|FG012|Overall Study|Disease progression|8|||
128973150|NCT01004861|464186909|FG000|Overall Study|Physician Decision|0|||
128973151|NCT01004861|464186910|FG001|Overall Study|Physician Decision|2|||
128973152|NCT01004861|464186911|FG002|Overall Study|Physician Decision|1|||
128973153|NCT01004861|464186912|FG003|Overall Study|Physician Decision|1|||
128973154|NCT01004861|464186913|FG004|Overall Study|Physician Decision|1|||
128973155|NCT01004861|464186914|FG005|Overall Study|Physician Decision|0|||
128973156|NCT01004861|464186915|FG006|Overall Study|Physician Decision|0|||
128973157|NCT01004861|464186916|FG007|Overall Study|Physician Decision|1|||
128973158|NCT01004861|464186917|FG008|Overall Study|Physician Decision|0|||
128973159|NCT01004861|464186918|FG009|Overall Study|Physician Decision|0|||
128973160|NCT01004861|464186919|FG010|Overall Study|Physician Decision|0|||
128973161|NCT01004861|464186920|FG011|Overall Study|Physician Decision|0|||
128973162|NCT01004861|464186921|FG012|Overall Study|Physician Decision|3|||
128973163|NCT01004861|464186909|FG000|Overall Study|Adverse Event|0|||
128973164|NCT01004861|464186910|FG001|Overall Study|Adverse Event|0|||
128973165|NCT01004861|464186911|FG002|Overall Study|Adverse Event|0|||
128973166|NCT01004861|464186912|FG003|Overall Study|Adverse Event|1|||
128973167|NCT01004861|464186913|FG004|Overall Study|Adverse Event|0|||
128973168|NCT01004861|464186914|FG005|Overall Study|Adverse Event|2|||
128973169|NCT01004861|464186915|FG006|Overall Study|Adverse Event|1|||
128973170|NCT01004861|464186916|FG007|Overall Study|Adverse Event|1|||
128973171|NCT01004861|464186917|FG008|Overall Study|Adverse Event|13|||
129038631|NCT00346164|464433225|FG001|Overall Study|Withdrawal by Subject|0|||
129038632|NCT00346164|464433226|FG002|Overall Study|Withdrawal by Subject|2|||
129038633|NCT00346164|464433227|FG003|Overall Study|Withdrawal by Subject|0|||
129038634|NCT00346164|464433224|FG000|Overall Study|Ineligible|11|||
129038635|NCT00346164|464433225|FG001|Overall Study|Ineligible|2|||
129038636|NCT00346164|464433226|FG002|Overall Study|Ineligible|2|||
129038637|NCT00346164|464433227|FG003|Overall Study|Ineligible|23|||
129038638|NCT00346164|464433224|FG000|Overall Study|Refusal of further protocol therapy|0|||
128973172|NCT01004861|464186918|FG009|Overall Study|Adverse Event|1|||
128973173|NCT01004861|464186919|FG010|Overall Study|Adverse Event|1|||
128973174|NCT01004861|464186920|FG011|Overall Study|Adverse Event|0|||
128973175|NCT01004861|464186921|FG012|Overall Study|Adverse Event|2|||
128973176|NCT01004861|464186909|FG000|Overall Study|Protocol Violation|0|||
128973177|NCT01004861|464186910|FG001|Overall Study|Protocol Violation|0|||
128973178|NCT01004861|464186911|FG002|Overall Study|Protocol Violation|0|||
128973179|NCT01004861|464186912|FG003|Overall Study|Protocol Violation|0|||
128973180|NCT01004861|464186913|FG004|Overall Study|Protocol Violation|1|||
128973181|NCT01004861|464186914|FG005|Overall Study|Protocol Violation|0|||
128973182|NCT01004861|464186915|FG006|Overall Study|Protocol Violation|0|||
129038639|NCT00346164|464433225|FG001|Overall Study|Refusal of further protocol therapy|1|||
128973183|NCT01004861|464186916|FG007|Overall Study|Protocol Violation|0|||
128973184|NCT01004861|464186917|FG008|Overall Study|Protocol Violation|0|||
128973185|NCT01004861|464186918|FG009|Overall Study|Protocol Violation|0|||
128973186|NCT01004861|464186919|FG010|Overall Study|Protocol Violation|0|||
128973187|NCT01004861|464186920|FG011|Overall Study|Protocol Violation|0|||
128973188|NCT01004861|464186921|FG012|Overall Study|Protocol Violation|0|||
128973189|NCT01004861|464186909|FG000|Overall Study|Lost to Follow-up|0|||
128973190|NCT01004861|464186910|FG001|Overall Study|Lost to Follow-up|0|||
128973191|NCT01004861|464186911|FG002|Overall Study|Lost to Follow-up|0|||
128973192|NCT01004861|464186912|FG003|Overall Study|Lost to Follow-up|0|||
128973193|NCT01004861|464186913|FG004|Overall Study|Lost to Follow-up|0|||
128973194|NCT01004861|464186914|FG005|Overall Study|Lost to Follow-up|0|||
128973195|NCT01004861|464186915|FG006|Overall Study|Lost to Follow-up|0|||
128973196|NCT01004861|464186916|FG007|Overall Study|Lost to Follow-up|1|||
128973197|NCT01004861|464186917|FG008|Overall Study|Lost to Follow-up|3|||
128973198|NCT01004861|464186918|FG009|Overall Study|Lost to Follow-up|0|||
128973199|NCT01004861|464186919|FG010|Overall Study|Lost to Follow-up|0|||
128973200|NCT01004861|464186920|FG011|Overall Study|Lost to Follow-up|1|||
128973201|NCT01004861|464186921|FG012|Overall Study|Lost to Follow-up|0|||
128973202|NCT01004861|464186909|FG000|Overall Study|Non-compliance|0|||
128973203|NCT01004861|464186910|FG001|Overall Study|Non-compliance|0|||
128973204|NCT01004861|464186911|FG002|Overall Study|Non-compliance|0|||
128973205|NCT01004861|464186912|FG003|Overall Study|Non-compliance|0|||
128973206|NCT01004861|464186913|FG004|Overall Study|Non-compliance|0|||
128973207|NCT01004861|464186914|FG005|Overall Study|Non-compliance|0|||
128973208|NCT01004861|464186915|FG006|Overall Study|Non-compliance|0|||
128973209|NCT01004861|464186916|FG007|Overall Study|Non-compliance|0|||
128973210|NCT01004861|464186917|FG008|Overall Study|Non-compliance|5|||
128973211|NCT01004861|464186918|FG009|Overall Study|Non-compliance|0|||
128973212|NCT01004861|464186919|FG010|Overall Study|Non-compliance|0|||
128973213|NCT01004861|464186920|FG011|Overall Study|Non-compliance|0|||
128973214|NCT01004861|464186921|FG012|Overall Study|Non-compliance|1|||
128973215|NCT01004861|464186909|FG000|Overall Study|Other|0|||
128973216|NCT01004861|464186910|FG001|Overall Study|Other|0|||
128973217|NCT01004861|464186911|FG002|Overall Study|Other|0|||
128973218|NCT01004861|464186912|FG003|Overall Study|Other|0|||
128973219|NCT01004861|464186913|FG004|Overall Study|Other|0|||
128973220|NCT01004861|464186914|FG005|Overall Study|Other|0|||
128973221|NCT01004861|464186915|FG006|Overall Study|Other|0|||
128973222|NCT01004861|464186916|FG007|Overall Study|Other|0|||
128973223|NCT01004861|464186917|FG008|Overall Study|Other|0|||
128973224|NCT01004861|464186918|FG009|Overall Study|Other|2|||
128973225|NCT01004861|464186919|FG010|Overall Study|Other|1|||
128973226|NCT01004861|464186920|FG011|Overall Study|Other|2|||
128973227|NCT01004861|464186921|FG012|Overall Study|Other|3|||
128973228|NCT01004861|464186909|FG000|Overall Study|Patient decision|0|||
128973229|NCT01004861|464186910|FG001|Overall Study|Patient decision|0|||
128973230|NCT01004861|464186911|FG002|Overall Study|Patient decision|0|||
128973231|NCT01004861|464186912|FG003|Overall Study|Patient decision|0|||
128973232|NCT01004861|464186913|FG004|Overall Study|Patient decision|1|||
128973233|NCT01004861|464186914|FG005|Overall Study|Patient decision|0|||
128973234|NCT01004861|464186915|FG006|Overall Study|Patient decision|1|||
128973235|NCT01004861|464186916|FG007|Overall Study|Patient decision|0|||
128973236|NCT01004861|464186917|FG008|Overall Study|Patient decision|7|||
128973237|NCT01004861|464186918|FG009|Overall Study|Patient decision|1|||
128973238|NCT01004861|464186919|FG010|Overall Study|Patient decision|1|||
128973239|NCT01004861|464186920|FG011|Overall Study|Patient decision|2|||
128973240|NCT01004861|464186921|FG012|Overall Study|Patient decision|3|||
128973241|NCT01004861|464186909|FG000|Overall Study|Transitioned to Phase 4 study|0|||
128973242|NCT01004861|464186910|FG001|Overall Study|Transitioned to Phase 4 study|0|||
128973243|NCT01004861|464186911|FG002|Overall Study|Transitioned to Phase 4 study|0|||
128973244|NCT01004861|464186912|FG003|Overall Study|Transitioned to Phase 4 study|0|||
128973245|NCT01004861|464186913|FG004|Overall Study|Transitioned to Phase 4 study|0|||
128973246|NCT01004861|464186914|FG005|Overall Study|Transitioned to Phase 4 study|0|||
128973247|NCT01004861|464186915|FG006|Overall Study|Transitioned to Phase 4 study|0|||
128973248|NCT01004861|464186916|FG007|Overall Study|Transitioned to Phase 4 study|0|||
128973249|NCT01004861|464186917|FG008|Overall Study|Transitioned to Phase 4 study|2|||
128774724|NCT04157686|463466653|FG001|Overall Study|Physician Decision|0|||
128973250|NCT01004861|464186918|FG009|Overall Study|Transitioned to Phase 4 study|0|||
128973251|NCT01004861|464186919|FG010|Overall Study|Transitioned to Phase 4 study|0|||
128973252|NCT01004861|464186920|FG011|Overall Study|Transitioned to Phase 4 study|0|||
128973253|NCT01004861|464186921|FG012|Overall Study|Transitioned to Phase 4 study|0|||
128973254|NCT01004861|464186909|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973255|NCT01004861|464186910|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973256|NCT01004861|464186911|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973257|NCT01004861|464186912|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973258|NCT01004861|464186913|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973259|NCT01004861|464186914|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973260|NCT01004861|464186915|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973261|NCT01004861|464186916|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973262|NCT01004861|464186917|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
128973263|NCT01004861|464186918|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973264|NCT01004861|464186919|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973265|NCT01004861|464186920|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973266|NCT01004861|464186921|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
128973267|NCT01004861|464186909|FG000|Overall Study|Patient withdrew|0|||
128973268|NCT01004861|464186910|FG001|Overall Study|Patient withdrew|0|||
128973269|NCT01004861|464186911|FG002|Overall Study|Patient withdrew|0|||
128973270|NCT01004861|464186912|FG003|Overall Study|Patient withdrew|0|||
128973271|NCT01004861|464186913|FG004|Overall Study|Patient withdrew|0|||
128973272|NCT01004861|464186914|FG005|Overall Study|Patient withdrew|0|||
128973273|NCT01004861|464186915|FG006|Overall Study|Patient withdrew|0|||
128973274|NCT01004861|464186916|FG007|Overall Study|Patient withdrew|0|||
128973275|NCT01004861|464186917|FG008|Overall Study|Patient withdrew|1|||
128973276|NCT01004861|464186918|FG009|Overall Study|Patient withdrew|0|||
128973277|NCT01004861|464186919|FG010|Overall Study|Patient withdrew|0|||
128973278|NCT01004861|464186920|FG011|Overall Study|Patient withdrew|0|||
128973279|NCT01004861|464186921|FG012|Overall Study|Patient withdrew|0|||
128973280|NCT01004861|464186909|FG000|Overall Study|Surgical resection|0|||
128973281|NCT01004861|464186910|FG001|Overall Study|Surgical resection|0|||
128973282|NCT01004861|464186911|FG002|Overall Study|Surgical resection|0|||
128973283|NCT01004861|464186912|FG003|Overall Study|Surgical resection|0|||
128973284|NCT01004861|464186913|FG004|Overall Study|Surgical resection|0|||
128973285|NCT01004861|464186914|FG005|Overall Study|Surgical resection|0|||
128973286|NCT01004861|464186915|FG006|Overall Study|Surgical resection|0|||
128973287|NCT01004861|464186916|FG007|Overall Study|Surgical resection|0|||
128973288|NCT01004861|464186917|FG008|Overall Study|Surgical resection|1|||
128973289|NCT01004861|464186918|FG009|Overall Study|Surgical resection|0|||
128973290|NCT01004861|464186919|FG010|Overall Study|Surgical resection|0|||
128973291|NCT01004861|464186920|FG011|Overall Study|Surgical resection|0|||
128973292|NCT01004861|464186921|FG012|Overall Study|Surgical resection|0|||
128973293|NCT01004861|464186909|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973294|NCT01004861|464186910|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973295|NCT01004861|464186911|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973296|NCT01004861|464186912|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973297|NCT01004861|464186913|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973298|NCT01004861|464186914|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973299|NCT01004861|464186915|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973300|NCT01004861|464186916|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973301|NCT01004861|464186917|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
128973302|NCT01004861|464186918|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973303|NCT01004861|464186919|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973304|NCT01004861|464186920|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973305|NCT01004861|464186921|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
128973306|NCT01004861|464186909|FG000|Overall Study|Study termination by Sponsor|0|||
128973307|NCT01004861|464186910|FG001|Overall Study|Study termination by Sponsor|0|||
128973308|NCT01004861|464186911|FG002|Overall Study|Study termination by Sponsor|0|||
128973309|NCT01004861|464186912|FG003|Overall Study|Study termination by Sponsor|0|||
128973310|NCT01004861|464186913|FG004|Overall Study|Study termination by Sponsor|0|||
128973311|NCT01004861|464186914|FG005|Overall Study|Study termination by Sponsor|0|||
128973312|NCT01004861|464186915|FG006|Overall Study|Study termination by Sponsor|0|||
128973313|NCT01004861|464186916|FG007|Overall Study|Study termination by Sponsor|0|||
128973314|NCT01004861|464186917|FG008|Overall Study|Study termination by Sponsor|1|||
128973315|NCT01004861|464186918|FG009|Overall Study|Study termination by Sponsor|0|||
128973316|NCT01004861|464186919|FG010|Overall Study|Study termination by Sponsor|0|||
128973317|NCT01004861|464186920|FG011|Overall Study|Study termination by Sponsor|0|||
128973318|NCT01004861|464186921|FG012|Overall Study|Study termination by Sponsor|0|||
128973319|NCT00686699|464186923|FG000|Treatment Period 1|Adverse Event|0|||
128973320|NCT00686699|464186924|FG001|Treatment Period 1|Adverse Event|2|||
128973321|NCT04610827|464186925|FG000|Overall Study|Withdrawal by Subject|1|||
128973322|NCT04610827|464186926|FG001|Overall Study|Withdrawal by Subject|1|||
128973323|NCT04610827|464186927|FG002|Overall Study|Withdrawal by Subject|0|||
128973324|NCT04657003|464186956|FG000|Overall Study|Adverse Event|5|||
128973325|NCT04657003|464186957|FG001|Overall Study|Adverse Event|1|||
128973326|NCT04657003|464186958|FG002|Overall Study|Adverse Event|5|||
129221024|NCT05019521|465110149|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129221025|NCT05019521|465110143|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
129221026|NCT05019521|465110144|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
129221027|NCT05019521|465110145|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
129221028|NCT05019521|465110146|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
129221029|NCT05019521|465110147|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129221030|NCT05019521|465110148|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129221031|NCT05019521|465110149|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129221032|NCT05019521|465110143|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
129221033|NCT05019521|465110144|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
128715843|NCT00455429|463256644|FG003|Overall Study|Withdrawal by Subject|0|||
129038640|NCT00346164|464433226|FG002|Overall Study|Refusal of further protocol therapy|3|||
129038641|NCT00346164|464433227|FG003|Overall Study|Refusal of further protocol therapy|15|||
129038642|NCT00346164|464433224|FG000|Overall Study|Inability to start week 16 tx on time|0|||
129038643|NCT00346164|464433225|FG001|Overall Study|Inability to start week 16 tx on time|0|||
129038644|NCT00346164|464433226|FG002|Overall Study|Inability to start week 16 tx on time|0|||
129038645|NCT00346164|464433227|FG003|Overall Study|Inability to start week 16 tx on time|11|||
129038646|NCT01198873|464433228|FG000|Overall Study|Adverse Event|4|||
128715844|NCT00455429|463256641|FG000|Overall Study|Lack of Efficacy|0|||
128715845|NCT00455429|463256642|FG001|Overall Study|Lack of Efficacy|1|||
128973327|NCT04657003|464186956|FG000|Overall Study|Death|0|||
128973328|NCT04657003|464186957|FG001|Overall Study|Death|2|||
128973329|NCT04657003|464186958|FG002|Overall Study|Death|0|||
128973330|NCT04657003|464186956|FG000|Overall Study|Lost to Follow-up|8|||
128973331|NCT04657003|464186957|FG001|Overall Study|Lost to Follow-up|4|||
128973332|NCT04657003|464186958|FG002|Overall Study|Lost to Follow-up|10|||
128973333|NCT04657003|464186956|FG000|Overall Study|Other - As Reported by Investigator|3|||
128973334|NCT04657003|464186957|FG001|Overall Study|Other - As Reported by Investigator|2|||
128973335|NCT04657003|464186958|FG002|Overall Study|Other - As Reported by Investigator|2|||
128973336|NCT04657003|464186956|FG000|Overall Study|Pregnancy|2|||
128973337|NCT04657003|464186957|FG001|Overall Study|Pregnancy|0|||
128973338|NCT04657003|464186958|FG002|Overall Study|Pregnancy|2|||
128973339|NCT04657003|464186956|FG000|Overall Study|Withdrawal by Subject|16|||
128973340|NCT04657003|464186957|FG001|Overall Study|Withdrawal by Subject|7|||
128973341|NCT04657003|464186958|FG002|Overall Study|Withdrawal by Subject|10|||
128973342|NCT01736176|464186959|FG000|Overall Study|Adverse Event|3|||
128973343|NCT01736176|464186959|FG000|Overall Study|Withdrawal by Subject|4|||
128973344|NCT01736176|464186959|FG000|Overall Study|Lack of Efficacy|3|||
128973345|NCT01736176|464186959|FG000|Overall Study|Unable to Complete PEG Placement|1|||
128973346|NCT00934791|464186960|FG000|Overall Study|Withdrawal by Subject|1|||
128973347|NCT00934791|464186961|FG001|Overall Study|Withdrawal by Subject|0|||
128973348|NCT02646891|464186963|FG000|Overall Study|Adverse Event|0|||
129038647|NCT01198873|464433229|FG001|Overall Study|Adverse Event|7|||
129038648|NCT01198873|464433228|FG000|Overall Study|Study closure|29|||
129038649|NCT01198873|464433229|FG001|Overall Study|Study closure|23|||
129038650|NCT01198873|464433228|FG000|Overall Study|Other than above|4|||
128715846|NCT00455429|463256643|FG002|Overall Study|Lack of Efficacy|0|||
128715847|NCT00455429|463256644|FG003|Overall Study|Lack of Efficacy|1|||
128715848|NCT00455429|463256641|FG000|Overall Study|Adverse Event|0|||
128715849|NCT00455429|463256642|FG001|Overall Study|Adverse Event|1|||
128715850|NCT00455429|463256643|FG002|Overall Study|Adverse Event|0|||
128715851|NCT00455429|463256644|FG003|Overall Study|Adverse Event|3|||
128715852|NCT00455429|463256641|FG000|Overall Study|Randomly assigned but not treated|0|||
128715853|NCT00455429|463256642|FG001|Overall Study|Randomly assigned but not treated|0|||
128715854|NCT00455429|463256643|FG002|Overall Study|Randomly assigned but not treated|0|||
128715855|NCT00455429|463256644|FG003|Overall Study|Randomly assigned but not treated|2|||
128715856|NCT00455429|463256641|FG000|Overall Study|Personal Reason|1|||
128715857|NCT00455429|463256642|FG001|Overall Study|Personal Reason|0|||
128715858|NCT00455429|463256643|FG002|Overall Study|Personal Reason|0|||
128715859|NCT00455429|463256644|FG003|Overall Study|Personal Reason|0|||
128715860|NCT00455429|463256641|FG000|Overall Study|Non-compliance|0|||
128715861|NCT00455429|463256642|FG001|Overall Study|Non-compliance|0|||
128973349|NCT02646891|464186964|FG001|Overall Study|Adverse Event|1|||
128973350|NCT02646891|464186965|FG002|Overall Study|Adverse Event|0|||
129038651|NCT01198873|464433229|FG001|Overall Study|Other than above|2|||
128715862|NCT00455429|463256643|FG002|Overall Study|Non-compliance|0|||
128715863|NCT00455429|463256644|FG003|Overall Study|Non-compliance|1|||
128973351|NCT02646891|464186966|FG003|Overall Study|Adverse Event|0|||
128973352|NCT02646891|464186967|FG004|Overall Study|Adverse Event|0|||
128973353|NCT02646891|464186968|FG005|Overall Study|Adverse Event|0|||
128715864|NCT00455429|463256641|FG000|Overall Study|Other|0|||
128715865|NCT00455429|463256642|FG001|Overall Study|Other|2|||
128715866|NCT00455429|463256643|FG002|Overall Study|Other|0|||
128715867|NCT00455429|463256644|FG003|Overall Study|Other|1|||
128973354|NCT02646891|464186969|FG006|Overall Study|Adverse Event|0|||
129038652|NCT03139240|464433230|FG000|Overall Study|Lost to Follow-up|0|||
128715868|NCT01165554|463256645|FG000|Overall Study|Withdrawal by Subject|23|||
128715869|NCT02951156|463256652|FG000|Overall Study|Death|3|||
128715870|NCT02951156|463256653|FG001|Overall Study|Death|8|||
129131491|NCT01786109|464772846|FG002|Overall Study|adverse effects colon preparation|1|||
129131492|NCT00317369|464772847|FG000|Overall Study|Adverse Event|2|||
129131493|NCT00317369|464772848|FG001|Overall Study|Adverse Event|1|||
129131494|NCT00317369|464772849|FG002|Overall Study|Adverse Event|0|||
128973355|NCT02646891|464186970|FG007|Overall Study|Adverse Event|0|||
128973356|NCT02646891|464186971|FG008|Overall Study|Adverse Event|0|||
128973357|NCT02646891|464186972|FG009|Overall Study|Adverse Event|0|||
128973358|NCT02646891|464186963|FG000|Overall Study|Lost to Follow-up|0|||
128973359|NCT02646891|464186964|FG001|Overall Study|Lost to Follow-up|0|||
128973360|NCT02646891|464186965|FG002|Overall Study|Lost to Follow-up|0|||
128973361|NCT02646891|464186966|FG003|Overall Study|Lost to Follow-up|0|||
128973362|NCT02646891|464186967|FG004|Overall Study|Lost to Follow-up|0|||
128973363|NCT02646891|464186968|FG005|Overall Study|Lost to Follow-up|0|||
128973364|NCT02646891|464186969|FG006|Overall Study|Lost to Follow-up|2|||
128973365|NCT02646891|464186970|FG007|Overall Study|Lost to Follow-up|2|||
128973366|NCT02646891|464186971|FG008|Overall Study|Lost to Follow-up|2|||
128973367|NCT02646891|464186972|FG009|Overall Study|Lost to Follow-up|2|||
128973368|NCT02646891|464186963|FG000|Overall Study|Protocol Violation|0|||
128973369|NCT02646891|464186964|FG001|Overall Study|Protocol Violation|0|||
128973370|NCT02646891|464186965|FG002|Overall Study|Protocol Violation|0|||
128973371|NCT02646891|464186966|FG003|Overall Study|Protocol Violation|0|||
128973372|NCT02646891|464186967|FG004|Overall Study|Protocol Violation|0|||
128973373|NCT02646891|464186968|FG005|Overall Study|Protocol Violation|0|||
128973374|NCT02646891|464186969|FG006|Overall Study|Protocol Violation|1|||
128973375|NCT02646891|464186970|FG007|Overall Study|Protocol Violation|1|||
128973376|NCT02646891|464186971|FG008|Overall Study|Protocol Violation|0|||
128973377|NCT02646891|464186972|FG009|Overall Study|Protocol Violation|0|||
128973378|NCT02646891|464186963|FG000|Overall Study|Withdrawal by Subject|2|||
128973379|NCT02646891|464186964|FG001|Overall Study|Withdrawal by Subject|0|||
128973380|NCT02646891|464186965|FG002|Overall Study|Withdrawal by Subject|1|||
128973381|NCT02646891|464186966|FG003|Overall Study|Withdrawal by Subject|0|||
128973382|NCT02646891|464186967|FG004|Overall Study|Withdrawal by Subject|0|||
128973383|NCT02646891|464186968|FG005|Overall Study|Withdrawal by Subject|0|||
128973384|NCT02646891|464186969|FG006|Overall Study|Withdrawal by Subject|5|||
128973385|NCT02646891|464186970|FG007|Overall Study|Withdrawal by Subject|9|||
128973386|NCT02646891|464186971|FG008|Overall Study|Withdrawal by Subject|7|||
128973387|NCT02646891|464186972|FG009|Overall Study|Withdrawal by Subject|3|||
128973388|NCT02646891|464186963|FG000|Overall Study|Death|0|||
128973389|NCT02646891|464186964|FG001|Overall Study|Death|0|||
128973390|NCT02646891|464186965|FG002|Overall Study|Death|0|||
128973391|NCT02646891|464186966|FG003|Overall Study|Death|0|||
128973392|NCT02646891|464186967|FG004|Overall Study|Death|0|||
128973393|NCT02646891|464186968|FG005|Overall Study|Death|0|||
128973394|NCT02646891|464186969|FG006|Overall Study|Death|1|||
128973395|NCT02646891|464186970|FG007|Overall Study|Death|1|||
128973396|NCT02646891|464186971|FG008|Overall Study|Death|1|||
128973397|NCT02646891|464186972|FG009|Overall Study|Death|0|||
128973398|NCT00723489|464186973|FG000|Overall Study|Physician Decision|0|||
129131495|NCT00317369|464772847|FG000|Overall Study|Lack of Efficacy|0|||
129131496|NCT00317369|464772848|FG001|Overall Study|Lack of Efficacy|1|||
129131497|NCT00317369|464772849|FG002|Overall Study|Lack of Efficacy|1|||
129131498|NCT00317369|464772847|FG000|Overall Study|Withdrawal by Subject|0|||
128973399|NCT00723489|464186974|FG001|Overall Study|Physician Decision|1|||
128973400|NCT00723489|464186975|FG002|Overall Study|Physician Decision|0|||
128973401|NCT00723489|464186976|FG003|Overall Study|Physician Decision|0|||
128973402|NCT00723489|464186973|FG000|Overall Study|Pregnancy|0|||
128973403|NCT00723489|464186974|FG001|Overall Study|Pregnancy|0|||
128973404|NCT00723489|464186975|FG002|Overall Study|Pregnancy|0|||
128973405|NCT00723489|464186976|FG003|Overall Study|Pregnancy|1|||
128973406|NCT00723489|464186973|FG000|Overall Study|Withdrawal by Subject|0|||
128973407|NCT00723489|464186974|FG001|Overall Study|Withdrawal by Subject|0|||
128973408|NCT00723489|464186975|FG002|Overall Study|Withdrawal by Subject|0|||
128973409|NCT00723489|464186976|FG003|Overall Study|Withdrawal by Subject|1|||
128973410|NCT00723489|464186973|FG000|Overall Study|Seropositive at baseline|1|||
128973411|NCT00723489|464186974|FG001|Overall Study|Seropositive at baseline|0|||
128973412|NCT00723489|464186975|FG002|Overall Study|Seropositive at baseline|0|||
128973413|NCT00723489|464186976|FG003|Overall Study|Seropositive at baseline|0|||
128973414|NCT00723489|464186973|FG000|Overall Study|Prohibited Medication|0|||
128973415|NCT00723489|464186974|FG001|Overall Study|Prohibited Medication|0|||
128973416|NCT00723489|464186975|FG002|Overall Study|Prohibited Medication|0|||
128973417|NCT00723489|464186976|FG003|Overall Study|Prohibited Medication|1|||
129131499|NCT00317369|464772848|FG001|Overall Study|Withdrawal by Subject|0|||
129131500|NCT00317369|464772849|FG002|Overall Study|Withdrawal by Subject|1|||
128973418|NCT00723489|464186973|FG000|Overall Study|Samples Collected Out of Window|0|||
128973419|NCT00723489|464186974|FG001|Overall Study|Samples Collected Out of Window|3|||
128715871|NCT02951156|463256654|FG002|Overall Study|Death|5|||
128715872|NCT02951156|463256652|FG000|Overall Study|Progressive disease|1|||
128973420|NCT00723489|464186975|FG002|Overall Study|Samples Collected Out of Window|0|||
128973421|NCT00723489|464186976|FG003|Overall Study|Samples Collected Out of Window|0|||
128973422|NCT02274311|464186977|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
128973423|NCT01599585|464186978|FG000|Overall Study|Withdrawal by Subject|16|||
128973424|NCT01599585|464186979|FG001|Overall Study|Withdrawal by Subject|9|||
128973425|NCT01599585|464186978|FG000|Overall Study|Lost to Follow-up|3|||
128973426|NCT01599585|464186979|FG001|Overall Study|Lost to Follow-up|5|||
128973427|NCT01599585|464186978|FG000|Overall Study|randomized did not start treatment|3|||
128973428|NCT01599585|464186979|FG001|Overall Study|randomized did not start treatment|3|||
128973429|NCT00853112|464186980|FG000|Overall Study|Randomized but not treated|0|||
128973430|NCT00853112|464186981|FG001|Overall Study|Randomized but not treated|1|||
128973431|NCT00853112|464186982|FG002|Overall Study|Randomized but not treated|0|||
128973432|NCT00853112|464186983|FG003|Overall Study|Randomized but not treated|2|||
128973433|NCT00853112|464186984|FG004|Overall Study|Randomized but not treated|0|||
128973434|NCT00853112|464186985|FG005|Overall Study|Randomized but not treated|0|||
128973435|NCT00853112|464186986|FG006|Overall Study|Randomized but not treated|1|||
128973436|NCT00811395|464186991|FG000|Extension Treatment|Adverse Event|1|||
128973437|NCT00811395|464186992|FG001|Extension Treatment|Adverse Event|2|||
128973438|NCT00811395|464186993|FG002|Extension Treatment|Adverse Event|2|||
128973439|NCT00811395|464186994|FG003|Extension Treatment|Adverse Event|2|||
128973440|NCT00811395|464186995|FG004|Extension Treatment|Adverse Event|0|||
128973441|NCT00811395|464186996|FG005|Extension Treatment|Adverse Event|1|||
128973442|NCT00811395|464186991|FG000|Extension Treatment|Progressive disease|1|||
128973443|NCT00811395|464186992|FG001|Extension Treatment|Progressive disease|1|||
128973444|NCT00811395|464186993|FG002|Extension Treatment|Progressive disease|0|||
128973445|NCT00811395|464186994|FG003|Extension Treatment|Progressive disease|0|||
128973446|NCT00811395|464186995|FG004|Extension Treatment|Progressive disease|0|||
128973447|NCT00811395|464186996|FG005|Extension Treatment|Progressive disease|0|||
128973448|NCT00811395|464186991|FG000|Extension Treatment|Participant did not wish to continue|0|||
128973449|NCT00811395|464186992|FG001|Extension Treatment|Participant did not wish to continue|3|||
128973450|NCT00811395|464186993|FG002|Extension Treatment|Participant did not wish to continue|0|||
128973451|NCT00811395|464186994|FG003|Extension Treatment|Participant did not wish to continue|1|||
128973452|NCT00811395|464186995|FG004|Extension Treatment|Participant did not wish to continue|0|||
128973453|NCT00811395|464186996|FG005|Extension Treatment|Participant did not wish to continue|1|||
128973454|NCT00811395|464186991|FG000|Extension Treatment|Other than above|0|||
128973455|NCT00811395|464186992|FG001|Extension Treatment|Other than above|0|||
128973456|NCT00811395|464186993|FG002|Extension Treatment|Other than above|1|||
128973457|NCT00811395|464186994|FG003|Extension Treatment|Other than above|0|||
128973458|NCT00811395|464186995|FG004|Extension Treatment|Other than above|0|||
128973459|NCT00811395|464186996|FG005|Extension Treatment|Other than above|0|||
128973460|NCT00170846|464187003|FG000|Overall Study|Subject withdrew Informed Consent|5|||
128973461|NCT00170846|464187004|FG001|Overall Study|Subject withdrew Informed Consent|12|||
128973462|NCT00170846|464187005|FG002|Overall Study|Subject withdrew Informed Consent|8|||
128973463|NCT00170846|464187003|FG000|Overall Study|Lost to Follow-up|6|||
128973464|NCT00170846|464187004|FG001|Overall Study|Lost to Follow-up|3|||
128973465|NCT00170846|464187005|FG002|Overall Study|Lost to Follow-up|2|||
128973466|NCT00170846|464187003|FG000|Overall Study|Death|0|||
128973467|NCT00170846|464187004|FG001|Overall Study|Death|3|||
128973468|NCT00170846|464187005|FG002|Overall Study|Death|3|||
128973469|NCT00170846|464187003|FG000|Overall Study|Reason Missing|0|||
128973470|NCT00170846|464187004|FG001|Overall Study|Reason Missing|1|||
128973471|NCT00170846|464187005|FG002|Overall Study|Reason Missing|0|||
128973472|NCT00118040|464187006|FG000|Overall Study|Adverse Event|0|||
128973473|NCT00118040|464187007|FG001|Overall Study|Adverse Event|1|||
128973474|NCT00118040|464187008|FG002|Overall Study|Adverse Event|0|||
128973475|NCT00118040|464187006|FG000|Overall Study|Withdrawal by Subject|0|||
128973476|NCT00118040|464187007|FG001|Overall Study|Withdrawal by Subject|0|||
128973477|NCT00118040|464187008|FG002|Overall Study|Withdrawal by Subject|2|||
128973478|NCT00118040|464187006|FG000|Overall Study|Medical Contraindication|0|||
128973479|NCT00118040|464187007|FG001|Overall Study|Medical Contraindication|0|||
128973480|NCT00118040|464187008|FG002|Overall Study|Medical Contraindication|1|||
128973481|NCT00118040|464187006|FG000|Overall Study|Non-Compliant Participant|1|||
128973482|NCT00118040|464187007|FG001|Overall Study|Non-Compliant Participant|1|||
128973483|NCT00118040|464187008|FG002|Overall Study|Non-Compliant Participant|2|||
129131501|NCT00825175|464772852|FG000|Overall Study|Withdrawal by Subject|0|||
129131502|NCT00825175|464772853|FG001|Overall Study|Withdrawal by Subject|5|||
128973484|NCT00118040|464187006|FG000|Overall Study|Other|0|||
128973485|NCT00118040|464187007|FG001|Overall Study|Other|0|||
128973486|NCT00118040|464187008|FG002|Overall Study|Other|1|||
128973487|NCT02607865|464187011|FG000|Overall Study|Lost to Follow-up|9|||
128973488|NCT02607865|464187012|FG001|Overall Study|Lost to Follow-up|7|||
128973489|NCT02607865|464187013|FG002|Overall Study|Lost to Follow-up|7|||
128973490|NCT02607865|464187014|FG003|Overall Study|Lost to Follow-up|5|||
128973491|NCT02607865|464187011|FG000|Overall Study|Withdrawal by Subject|18|||
128973492|NCT02607865|464187012|FG001|Overall Study|Withdrawal by Subject|18|||
128774725|NCT04157686|463466654|FG002|Overall Study|Physician Decision|1|||
128973493|NCT02607865|464187013|FG002|Overall Study|Withdrawal by Subject|17|||
128973494|NCT02607865|464187014|FG003|Overall Study|Withdrawal by Subject|8|||
128973495|NCT02607865|464187011|FG000|Overall Study|Death|5|||
128973496|NCT02607865|464187012|FG001|Overall Study|Death|4|||
128973497|NCT02607865|464187013|FG002|Overall Study|Death|1|||
128973498|NCT02607865|464187014|FG003|Overall Study|Death|3|||
128973499|NCT02607865|464187011|FG000|Overall Study|Unclassified|1|||
128973500|NCT02607865|464187012|FG001|Overall Study|Unclassified|1|||
128973501|NCT02607865|464187013|FG002|Overall Study|Unclassified|2|||
128973502|NCT02607865|464187014|FG003|Overall Study|Unclassified|0|||
128973503|NCT00528840|464187015|FG000|Overall Study|Lost to Follow-up|10|||
128973504|NCT00528840|464187015|FG000|Overall Study|Adverse Event|1|||
128973505|NCT00528840|464187015|FG000|Overall Study|Withdrawal by Subject|17|||
128973506|NCT00528840|464187015|FG000|Overall Study|Death|2|||
128973507|NCT00528840|464187015|FG000|Overall Study|Administrative Reasons|1|||
128973508|NCT00528840|464187015|FG000|Overall Study|Other|2|||
128973509|NCT01970540|464187016|FG000|Overall Study|Non-treatment-related AE|0|||
128973510|NCT01970540|464187017|FG001|Overall Study|Non-treatment-related AE|0|||
128973511|NCT01970540|464187018|FG002|Overall Study|Non-treatment-related AE|1|||
128973512|NCT01970540|464187016|FG000|Overall Study|Progressive disease|55|||
128973513|NCT01970540|464187017|FG001|Overall Study|Progressive disease|23|||
128973514|NCT01970540|464187018|FG002|Overall Study|Progressive disease|10|||
128973515|NCT01970540|464187016|FG000|Overall Study|Treatment delay over protocol|0|||
128973516|NCT01970540|464187017|FG001|Overall Study|Treatment delay over protocol|0|||
128973517|NCT01970540|464187018|FG002|Overall Study|Treatment delay over protocol|1|||
128973518|NCT01970540|464187016|FG000|Overall Study|Physician Decision|7|||
128973519|NCT01970540|464187017|FG001|Overall Study|Physician Decision|2|||
128973520|NCT01970540|464187018|FG002|Overall Study|Physician Decision|0|||
128973521|NCT01970540|464187016|FG000|Overall Study|Clinical progression|0|||
128973522|NCT01970540|464187017|FG001|Overall Study|Clinical progression|1|||
128973523|NCT01970540|464187018|FG002|Overall Study|Clinical progression|1|||
128973524|NCT01970540|464187016|FG000|Overall Study|End of study|2|||
128973525|NCT01970540|464187017|FG001|Overall Study|End of study|0|||
128973526|NCT01970540|464187018|FG002|Overall Study|End of study|2|||
128973527|NCT01970540|464187016|FG000|Overall Study|Adverse Event|0|||
128973528|NCT01970540|464187017|FG001|Overall Study|Adverse Event|2|||
128973529|NCT01970540|464187018|FG002|Overall Study|Adverse Event|1|||
128973530|NCT01970540|464187016|FG000|Overall Study|Treatment-related AE|4|||
128973531|NCT01970540|464187017|FG001|Overall Study|Treatment-related AE|0|||
128973532|NCT01970540|464187018|FG002|Overall Study|Treatment-related AE|2|||
128973533|NCT01970540|464187016|FG000|Overall Study|Withdrawal by Subject|4|||
128973534|NCT01970540|464187017|FG001|Overall Study|Withdrawal by Subject|0|||
128973535|NCT01970540|464187018|FG002|Overall Study|Withdrawal by Subject|1|||
128973536|NCT01970540|464187016|FG000|Overall Study|Clinical deterioration|1|||
128973537|NCT01970540|464187017|FG001|Overall Study|Clinical deterioration|0|||
128973538|NCT01970540|464187018|FG002|Overall Study|Clinical deterioration|0|||
128973539|NCT01756833|464187027|FG000|Overall Study|Withdrawal by Subject|4|||
128973540|NCT01756833|464187028|FG001|Overall Study|Withdrawal by Subject|3|||
128973541|NCT00952588|464187029|FG000|Overall Study|Death|28|||
128973542|NCT00952588|464187030|FG001|Overall Study|Death|13|||
128973543|NCT00952588|464187029|FG000|Overall Study|Withdrawal by Subject|2|||
128973544|NCT00952588|464187030|FG001|Overall Study|Withdrawal by Subject|5|||
128973545|NCT00952588|464187029|FG000|Overall Study|Adverse Event|2|||
128973546|NCT00952588|464187030|FG001|Overall Study|Adverse Event|3|||
128973547|NCT00952588|464187029|FG000|Overall Study|Lost to Follow-up|2|||
129038653|NCT03139240|464433231|FG001|Overall Study|Lost to Follow-up|1|||
129038654|NCT03139240|464433232|FG002|Overall Study|Lost to Follow-up|1|||
129038655|NCT03139240|464433233|FG003|Overall Study|Lost to Follow-up|0|||
129038656|NCT00823199|464433234|FG000|Overall Study|Withdrawal by Subject|2|||
129038657|NCT01998243|464433235|FG000|Overall Study|Pregnancy|0|||
129038658|NCT01998243|464433236|FG001|Overall Study|Pregnancy|1|||
129038659|NCT01998243|464433235|FG000|Overall Study|Protocol Violation|5|||
129038660|NCT01998243|464433236|FG001|Overall Study|Protocol Violation|2|||
129038661|NCT01998243|464433235|FG000|Overall Study|Withdrawal by Subject|3|||
128973548|NCT00952588|464187030|FG001|Overall Study|Lost to Follow-up|0|||
128973549|NCT00952588|464187029|FG000|Overall Study|Physician Decision|0|||
128973550|NCT00952588|464187030|FG001|Overall Study|Physician Decision|1|||
128973551|NCT00952588|464187029|FG000|Overall Study|Lack of Efficacy|2|||
128973552|NCT00952588|464187030|FG001|Overall Study|Lack of Efficacy|2|||
128973553|NCT01796106|464187031|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
128973554|NCT01796106|464187032|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
128973555|NCT01766401|464187033|FG000|Overall Study|Adverse Event|7|||
128973556|NCT01766401|464187034|FG001|Overall Study|Adverse Event|22|||
129038662|NCT01998243|464433236|FG001|Overall Study|Withdrawal by Subject|4|||
129131503|NCT00699751|464772858|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
128973557|NCT01766401|464187033|FG000|Overall Study|Lack of Efficacy|1|||
129038663|NCT00268892|464433237|FG000|Overall Study|Adverse Event|14|||
128715873|NCT02951156|463256653|FG001|Overall Study|Progressive disease|0|||
128973558|NCT01766401|464187034|FG001|Overall Study|Lack of Efficacy|2|||
128973559|NCT01766401|464187033|FG000|Overall Study|Protocol Violation|3|||
128973560|NCT01766401|464187034|FG001|Overall Study|Protocol Violation|8|||
128973561|NCT01766401|464187033|FG000|Overall Study|Withdrawal by Subject|15|||
128973562|NCT01766401|464187034|FG001|Overall Study|Withdrawal by Subject|12|||
128973563|NCT01766401|464187033|FG000|Overall Study|Lost to Follow-up|10|||
128973564|NCT01766401|464187034|FG001|Overall Study|Lost to Follow-up|11|||
128973565|NCT01766401|464187033|FG000|Overall Study|Pregnancy|1|||
128973566|NCT01766401|464187034|FG001|Overall Study|Pregnancy|1|||
128973567|NCT02795182|464187038|FG000|Overall Study|Death|5|||
128973568|NCT02795182|464187039|FG001|Overall Study|Death|4|||
128973569|NCT02795182|464187040|FG002|Overall Study|Death|4|||
128973570|NCT02795182|464187041|FG003|Overall Study|Death|18|||
128973571|NCT02795182|464187038|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
128973572|NCT02795182|464187039|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
128973573|NCT02795182|464187040|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
128973574|NCT02795182|464187041|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
128973575|NCT02795182|464187038|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
128973576|NCT02795182|464187039|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
128973577|NCT02795182|464187040|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
128973578|NCT02795182|464187041|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
128973579|NCT02795182|464187038|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
128973580|NCT02795182|464187039|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
128973581|NCT02795182|464187040|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
128973582|NCT02795182|464187041|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
128973583|NCT02795182|464187038|FG000|Overall Study|Withdrawal by Subject|4|||
128973584|NCT02795182|464187039|FG001|Overall Study|Withdrawal by Subject|0|||
128973585|NCT02795182|464187040|FG002|Overall Study|Withdrawal by Subject|0|||
128973586|NCT02795182|464187041|FG003|Overall Study|Withdrawal by Subject|3|||
128973587|NCT02795182|464187038|FG000|Overall Study|Lost to Follow-up|0|||
128973588|NCT02795182|464187039|FG001|Overall Study|Lost to Follow-up|0|||
128973589|NCT02795182|464187040|FG002|Overall Study|Lost to Follow-up|1|||
128973590|NCT02795182|464187041|FG003|Overall Study|Lost to Follow-up|1|||
128973591|NCT02795182|464187038|FG000|Overall Study|Roll Over to Long Term Extension|3|||
128973592|NCT02795182|464187039|FG001|Overall Study|Roll Over to Long Term Extension|3|||
128973593|NCT02795182|464187040|FG002|Overall Study|Roll Over to Long Term Extension|2|||
128973594|NCT02795182|464187041|FG003|Overall Study|Roll Over to Long Term Extension|5|||
128973595|NCT02795182|464187038|FG000|Overall Study|Progressive Disease|0|||
128973596|NCT02795182|464187039|FG001|Overall Study|Progressive Disease|1|||
128973597|NCT02795182|464187040|FG002|Overall Study|Progressive Disease|0|||
128973598|NCT02795182|464187041|FG003|Overall Study|Progressive Disease|4|||
128973599|NCT02795182|464187038|FG000|Overall Study|Physician Decision|0|||
128973600|NCT02795182|464187039|FG001|Overall Study|Physician Decision|0|||
128973601|NCT02795182|464187040|FG002|Overall Study|Physician Decision|0|||
128973602|NCT02795182|464187041|FG003|Overall Study|Physician Decision|1|||
128973603|NCT00398086|464187043|FG000|Overall Study|Unacceptable Toxicity|2|||
128973604|NCT00398086|464187044|FG001|Overall Study|Unacceptable Toxicity|8|||
128973605|NCT00398086|464187045|FG002|Overall Study|Unacceptable Toxicity|2|||
128973606|NCT00398086|464187043|FG000|Overall Study|Adverse Event|1|||
128973607|NCT00398086|464187044|FG001|Overall Study|Adverse Event|4|||
128973608|NCT00398086|464187045|FG002|Overall Study|Adverse Event|0|||
128973609|NCT00398086|464187043|FG000|Overall Study|Physician Decision|1|||
128973610|NCT00398086|464187044|FG001|Overall Study|Physician Decision|4|||
128973611|NCT00398086|464187045|FG002|Overall Study|Physician Decision|0|||
128973612|NCT00398086|464187043|FG000|Overall Study|Withdrawal by Subject|5|||
128973613|NCT00398086|464187044|FG001|Overall Study|Withdrawal by Subject|7|||
128973614|NCT00398086|464187045|FG002|Overall Study|Withdrawal by Subject|0|||
128973615|NCT01021553|464187046|FG000|Overall Study|Adverse Event|1|||
128973616|NCT01021553|464187047|FG001|Overall Study|Adverse Event|0|||
128973617|NCT01021553|464187048|FG002|Overall Study|Adverse Event|0|||
128973618|NCT01021553|464187046|FG000|Overall Study|Lack of Efficacy|2|||
128973619|NCT01021553|464187047|FG001|Overall Study|Lack of Efficacy|2|||
128973620|NCT01021553|464187048|FG002|Overall Study|Lack of Efficacy|0|||
128973621|NCT01021553|464187046|FG000|Overall Study|Protocol Violation|0|||
128973622|NCT01021553|464187047|FG001|Overall Study|Protocol Violation|2|||
128973623|NCT01021553|464187048|FG002|Overall Study|Protocol Violation|2|||
128973624|NCT01021553|464187046|FG000|Overall Study|Lost to Follow-up|0|||
128973625|NCT01021553|464187047|FG001|Overall Study|Lost to Follow-up|0|||
128973626|NCT01021553|464187048|FG002|Overall Study|Lost to Follow-up|1|||
128973627|NCT01021553|464187046|FG000|Overall Study|Withdrawal by Subject|1|||
128973628|NCT01021553|464187047|FG001|Overall Study|Withdrawal by Subject|1|||
128973629|NCT01021553|464187048|FG002|Overall Study|Withdrawal by Subject|0|||
128973630|NCT01950364|464187049|FG000|Overall Study|Adverse Event|3|||
128774726|NCT04157686|463466655|FG003|Overall Study|Physician Decision|0|||
128973631|NCT01950364|464187050|FG001|Overall Study|Adverse Event|0|||
128973632|NCT01950364|464187049|FG000|Overall Study|Stem Cell Transplant|2|||
128973633|NCT01950364|464187050|FG001|Overall Study|Stem Cell Transplant|6|||
128973634|NCT01950364|464187049|FG000|Overall Study|Disease Progression|5|||
128973635|NCT01950364|464187050|FG001|Overall Study|Disease Progression|2|||
128973636|NCT01950364|464187049|FG000|Overall Study|Withdrawal by Subject|0|||
128973637|NCT01950364|464187050|FG001|Overall Study|Withdrawal by Subject|1|||
128973638|NCT01950364|464187049|FG000|Overall Study|Protocol Violation|0|||
128973639|NCT01950364|464187050|FG001|Overall Study|Protocol Violation|1|||
128973640|NCT00033293|464187051|FG000|Overall Study|Death|0|||
128973641|NCT00033293|464187052|FG001|Overall Study|Death|1|||
128973642|NCT00033293|464187051|FG000|Overall Study|Lack of Efficacy|5|||
128973643|NCT00033293|464187052|FG001|Overall Study|Lack of Efficacy|8|||
128973644|NCT00033293|464187051|FG000|Overall Study|Lost to Follow-up|0|||
128973645|NCT00033293|464187052|FG001|Overall Study|Lost to Follow-up|1|||
128973646|NCT00033293|464187051|FG000|Overall Study|Physician Decision|3|||
128973647|NCT00033293|464187052|FG001|Overall Study|Physician Decision|1|||
128973648|NCT00033293|464187051|FG000|Overall Study|Withdrawal by Subject|1|||
128973649|NCT00033293|464187052|FG001|Overall Study|Withdrawal by Subject|0|||
128973650|NCT00033293|464187051|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
128973651|NCT00033293|464187052|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
128973652|NCT00033293|464187051|FG000|Overall Study|Treatment refused|0|||
128973653|NCT00033293|464187052|FG001|Overall Study|Treatment refused|6|||
128973654|NCT00935701|464187053|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
128973655|NCT01700140|464187054|FG000|Overall Study|Use of rescue drugs|3|||
128973656|NCT01700140|464187055|FG001|Overall Study|Use of rescue drugs|3|||
128973657|NCT01700140|464187056|FG002|Overall Study|Use of rescue drugs|1|||
128973658|NCT01700140|464187054|FG000|Overall Study|Discontinuation of radiotherapy|1|||
128973659|NCT01700140|464187055|FG001|Overall Study|Discontinuation of radiotherapy|0|||
128973660|NCT01700140|464187056|FG002|Overall Study|Discontinuation of radiotherapy|0|||
128973661|NCT01700140|464187054|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
128973662|NCT01700140|464187055|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
128973663|NCT01700140|464187056|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
128973664|NCT01700140|464187054|FG000|Overall Study|Aggravation of symptoms|1|||
128973665|NCT01700140|464187055|FG001|Overall Study|Aggravation of symptoms|0|||
128973666|NCT01700140|464187056|FG002|Overall Study|Aggravation of symptoms|0|||
128973667|NCT01700140|464187054|FG000|Overall Study|Adverse Event|0|||
128973668|NCT01700140|464187055|FG001|Overall Study|Adverse Event|1|||
128973669|NCT01700140|464187056|FG002|Overall Study|Adverse Event|0|||
128973670|NCT01700140|464187054|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
128973671|NCT01700140|464187055|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
128973672|NCT01700140|464187056|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
128973673|NCT02573012|464187057|FG000|Overall Study|Adverse Event|5|||
128973674|NCT02573012|464187058|FG001|Overall Study|Adverse Event|5|||
128973675|NCT02573012|464187057|FG000|Overall Study|Lack of Efficacy|5|||
128973676|NCT02573012|464187058|FG001|Overall Study|Lack of Efficacy|4|||
128973677|NCT02573012|464187057|FG000|Overall Study|Non-compliance|1|||
128973678|NCT02573012|464187058|FG001|Overall Study|Non-compliance|2|||
128973679|NCT02573012|464187057|FG000|Overall Study|Withdrawal by Subject|2|||
128973680|NCT02573012|464187058|FG001|Overall Study|Withdrawal by Subject|2|||
128973681|NCT02573012|464187057|FG000|Overall Study|Study Ended per Protocol|1|||
128973682|NCT02573012|464187058|FG001|Overall Study|Study Ended per Protocol|0|||
128973683|NCT02573012|464187057|FG000|Overall Study|Physician Decision|1|||
128973684|NCT02573012|464187058|FG001|Overall Study|Physician Decision|2|||
128973685|NCT01610414|464187059|FG000|Study Start - Month 13|Serious Adverse Event|65|||
128973686|NCT01610414|464187060|FG001|Study Start - Month 13|Serious Adverse Event|67|||
128973687|NCT01610414|464187059|FG000|Study Start - Month 13|Adverse Event|14|||
128973688|NCT01610414|464187060|FG001|Study Start - Month 13|Adverse Event|14|||
128973689|NCT01610414|464187059|FG000|Study Start - Month 13|Protocol Violation|3|||
128973690|NCT01610414|464187060|FG001|Study Start - Month 13|Protocol Violation|1|||
128973691|NCT01610414|464187059|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
128973692|NCT01610414|464187060|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
128973693|NCT01610414|464187059|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
128973694|NCT01610414|464187060|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
129038664|NCT00268892|464433238|FG001|Overall Study|Adverse Event|17|||
129038665|NCT00268892|464433239|FG002|Overall Study|Adverse Event|20|||
129038666|NCT00268892|464433237|FG000|Overall Study|Lack of Efficacy|1|||
129038667|NCT00268892|464433238|FG001|Overall Study|Lack of Efficacy|3|||
129038668|NCT00268892|464433239|FG002|Overall Study|Lack of Efficacy|0|||
129038669|NCT00268892|464433237|FG000|Overall Study|Withdrawal by Subject|14|||
129038670|NCT00268892|464433238|FG001|Overall Study|Withdrawal by Subject|15|||
129038671|NCT00268892|464433239|FG002|Overall Study|Withdrawal by Subject|13|||
129038672|NCT00268892|464433237|FG000|Overall Study|Physician Decision|0|||
129038673|NCT00268892|464433238|FG001|Overall Study|Physician Decision|1|||
129038674|NCT00268892|464433239|FG002|Overall Study|Physician Decision|0|||
128774727|NCT04157686|463466656|FG004|Overall Study|Physician Decision|1|||
128973695|NCT01610414|464187059|FG000|Study Start - Month 13|Lost to Follow-up|4|||
128973696|NCT01610414|464187060|FG001|Study Start - Month 13|Lost to Follow-up|6|||
128973697|NCT01610414|464187059|FG000|Study Start - Month 13|Suspected HZ episode|1|||
128973698|NCT01610414|464187060|FG001|Study Start - Month 13|Suspected HZ episode|3|||
128973699|NCT01610414|464187059|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
128973700|NCT01610414|464187060|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
128973701|NCT01610414|464187059|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
128973702|NCT01610414|464187060|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
128973703|NCT01610414|464187059|FG000|Month 13 - Month 25|Adverse Event|8|||
128973704|NCT01610414|464187060|FG001|Month 13 - Month 25|Adverse Event|4|||
128973705|NCT01610414|464187059|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
128973706|NCT01610414|464187060|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
128973707|NCT01610414|464187059|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
128973708|NCT01610414|464187060|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
128973709|NCT01610414|464187059|FG000|Month 13 - Month 25|Protocol Violation|0|||
128973710|NCT01610414|464187060|FG001|Month 13 - Month 25|Protocol Violation|2|||
128973711|NCT01610414|464187059|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
128973712|NCT01610414|464187060|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
128973713|NCT01610414|464187059|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
128973714|NCT01610414|464187060|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
128973715|NCT01610414|464187059|FG000|After Month 25|Study end not reached|48|||
128973716|NCT01610414|464187060|FG001|After Month 25|Study end not reached|53|||
128973717|NCT02736474|464187061|FG000|Overall Study|Lost to Follow-up|0|||
128973718|NCT02736474|464187062|FG001|Overall Study|Lost to Follow-up|1|||
128973719|NCT02483611|464187063|FG000|Overall Study|Protocol Violation|0|||
128973720|NCT02483611|464187064|FG001|Overall Study|Protocol Violation|0|||
128973721|NCT02483611|464187065|FG002|Overall Study|Protocol Violation|1|||
128973722|NCT00518336|464187066|FG000|Year 7|Lost to Follow-up|2|||
128973723|NCT00518336|464187067|FG001|Year 7|Lost to Follow-up|0|||
128973724|NCT00518336|464187066|FG000|Year 7|Could not attend in time|0|||
128973725|NCT00518336|464187067|FG001|Year 7|Could not attend in time|3|||
128973726|NCT00518336|464187066|FG000|Year 8|Lost to Follow-up|1|||
128973727|NCT00518336|464187067|FG001|Year 8|Lost to Follow-up|1|||
128973728|NCT00518336|464187066|FG000|Year 8|Could not attend in time|0|||
128973729|NCT00518336|464187067|FG001|Year 8|Could not attend in time|1|||
128973730|NCT00518336|464187066|FG000|Year 9|Migrated/moved from study area|1|||
128973731|NCT00518336|464187067|FG001|Year 9|Migrated/moved from study area|1|||
128973732|NCT00518336|464187066|FG000|Year 9|Lost to Follow-up|3|||
128973733|NCT00518336|464187067|FG001|Year 9|Lost to Follow-up|0|||
128973734|NCT00518336|464187066|FG000|Year 9|Personal reasons|1|||
128973735|NCT00518336|464187067|FG001|Year 9|Personal reasons|0|||
128973736|NCT00125268|464187068|FG000|Overall Study|Withdrawal by Subject|1|||
128973737|NCT00125268|464187069|FG001|Overall Study|Withdrawal by Subject|1|||
128973738|NCT00286156|464187070|FG000|Overall Study|Missed 12 month visit|0|||
128973739|NCT00286156|464187071|FG001|Overall Study|Missed 12 month visit|0|||
128973740|NCT00286156|464187072|FG002|Overall Study|Missed 12 month visit|1|||
128973741|NCT00286156|464187070|FG000|Overall Study|AE: pulmonary embolus|0|||
128973742|NCT00286156|464187071|FG001|Overall Study|AE: pulmonary embolus|1|||
128973743|NCT00286156|464187072|FG002|Overall Study|AE: pulmonary embolus|0|||
128973744|NCT00286156|464187070|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
128973745|NCT00286156|464187071|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
128973746|NCT00286156|464187072|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
128973747|NCT00286156|464187070|FG000|Overall Study|AE: pneumonia|1|||
128973748|NCT00286156|464187071|FG001|Overall Study|AE: pneumonia|0|||
128973749|NCT00286156|464187072|FG002|Overall Study|AE: pneumonia|0|||
128973750|NCT00621764|464188388|FG000|Overall Study|Protocol Violation|0|||
128973751|NCT00621764|464188389|FG001|Overall Study|Protocol Violation|0|||
128973752|NCT00621764|464188390|FG002|Overall Study|Protocol Violation|0|||
128973753|NCT00621764|464188391|FG003|Overall Study|Protocol Violation|1|||
128973754|NCT02499172|464188392|FG000|Overall Study|Financial reason|0|||
129038675|NCT00268892|464433237|FG000|Overall Study|Lost to Follow-up|5|||
129038676|NCT00268892|464433238|FG001|Overall Study|Lost to Follow-up|2|||
129038677|NCT00268892|464433239|FG002|Overall Study|Lost to Follow-up|4|||
129038678|NCT00268892|464433237|FG000|Overall Study|Protocol Violation|0|||
129038679|NCT00268892|464433238|FG001|Overall Study|Protocol Violation|1|||
129038680|NCT00268892|464433239|FG002|Overall Study|Protocol Violation|0|||
129038681|NCT00268892|464433237|FG000|Overall Study|Disease Progression|1|||
129038682|NCT00268892|464433238|FG001|Overall Study|Disease Progression|1|||
129038683|NCT00268892|464433239|FG002|Overall Study|Disease Progression|0|||
129038684|NCT00268892|464433237|FG000|Overall Study|Trial Site Closed|4|||
129038685|NCT00268892|464433238|FG001|Overall Study|Trial Site Closed|2|||
128973755|NCT02499172|464188393|FG001|Overall Study|Financial reason|0|||
128973756|NCT02499172|464188394|FG002|Overall Study|Financial reason|523|||
128973757|NCT02499172|464188395|FG003|Overall Study|Financial reason|436|||
128973758|NCT02499172|464188392|FG000|Overall Study|Lost to Follow-up|65|||
128973759|NCT02499172|464188393|FG001|Overall Study|Lost to Follow-up|64|||
129038686|NCT00268892|464433239|FG002|Overall Study|Trial Site Closed|2|||
128715874|NCT02951156|463256654|FG002|Overall Study|Progressive disease|1|||
128973760|NCT02499172|464188394|FG002|Overall Study|Lost to Follow-up|0|||
128973761|NCT02499172|464188395|FG003|Overall Study|Lost to Follow-up|0|||
128973762|NCT01293123|464188396|FG000|Overall Study|Lost to Follow-up|0|||
128973763|NCT01293123|464188397|FG001|Overall Study|Lost to Follow-up|1|||
128973764|NCT00211536|464188400|FG000|Overall Study|Withdrawal by Subject|2|||
128973765|NCT00211536|464188401|FG001|Overall Study|Withdrawal by Subject|2|||
128973766|NCT00211536|464188400|FG000|Overall Study|Physician Decision|0|||
128973767|NCT00211536|464188401|FG001|Overall Study|Physician Decision|5|||
128973768|NCT00211536|464188400|FG000|Overall Study|Adverse Event|2|||
128973769|NCT00211536|464188401|FG001|Overall Study|Adverse Event|0|||
128973770|NCT00003389|464188402|FG000|Overall Study|Disease progression|6|||
128973771|NCT00003389|464188403|FG001|Overall Study|Disease progression|1|||
128973772|NCT00003389|464188402|FG000|Overall Study|Adverse Event|13|||
128973773|NCT00003389|464188403|FG001|Overall Study|Adverse Event|2|||
128973774|NCT00003389|464188402|FG000|Overall Study|Death|0|||
128973775|NCT00003389|464188403|FG001|Overall Study|Death|3|||
128973776|NCT00003389|464188402|FG000|Overall Study|Withdrawal by Subject|12|||
128973777|NCT00003389|464188403|FG001|Overall Study|Withdrawal by Subject|5|||
128973778|NCT00003389|464188402|FG000|Overall Study|Alternative therapy|2|||
128973779|NCT00003389|464188403|FG001|Overall Study|Alternative therapy|1|||
128973780|NCT00003389|464188402|FG000|Overall Study|Complicating disease|1|||
128973781|NCT00003389|464188403|FG001|Overall Study|Complicating disease|0|||
128973782|NCT00003389|464188402|FG000|Overall Study|Off-treatment reason missing|31|||
128973783|NCT00003389|464188403|FG001|Overall Study|Off-treatment reason missing|21|||
128973784|NCT00003389|464188402|FG000|Overall Study|Ineligible|33|||
128973785|NCT00003389|464188403|FG001|Overall Study|Ineligible|27|||
128973786|NCT01997892|464188406|FG000|Overall Study|Physician Decision|2|||
128973787|NCT01997892|464188406|FG000|Overall Study|Lost to Follow-up|6|||
128973788|NCT01997892|464188406|FG000|Overall Study|Death|14|||
128973789|NCT01997892|464188406|FG000|Overall Study|Renal transplant|8|||
128973790|NCT01997892|464188406|FG000|Overall Study|Other|3|||
128973791|NCT01997892|464188406|FG000|Overall Study|Study completion data not recorded|35|||
128973792|NCT02710422|464188407|FG000|Overall Study|Termination of study|9|||
128973793|NCT02710422|464188408|FG001|Overall Study|Termination of study|9|||
128973794|NCT02608099|464188409|FG000|Overall Study|Ablation procedure not initiated|3|||
128973795|NCT02608099|464188410|FG001|Overall Study|Ablation procedure not initiated|2|||
128973796|NCT00417248|464188411|FG000|Overall Study|Study Terminated|6|||
128973797|NCT00417248|464188411|FG000|Overall Study|Death|1|||
128973798|NCT00417248|464188411|FG000|Overall Study|Lack of Efficacy|1|||
128973799|NCT03763942|464188412|FG000|Overall Study|Lost to Follow-up|114|||
128973800|NCT03763942|464188413|FG001|Overall Study|Lost to Follow-up|54|||
128973801|NCT03763942|464188412|FG000|Overall Study|Protocol Violation|1|||
128973802|NCT03763942|464188413|FG001|Overall Study|Protocol Violation|0|||
128973803|NCT03763942|464188412|FG000|Overall Study|Withdrawal by Subject|2|||
128973804|NCT03763942|464188413|FG001|Overall Study|Withdrawal by Subject|0|||
128973805|NCT03763942|464188412|FG000|Overall Study|Other|2|||
128973806|NCT03763942|464188413|FG001|Overall Study|Other|3|||
128973807|NCT01108263|464188420|FG000|Overall Study|Adverse Event|0|||
128973808|NCT01108263|464188421|FG001|Overall Study|Adverse Event|1|||
128973809|NCT01685372|464188422|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
128973810|NCT01685372|464188423|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
128973811|NCT01488994|464188424|FG000|Overall Study|Withdrawal by Subject|0|||
128973812|NCT01488994|464188425|FG001|Overall Study|Withdrawal by Subject|1|||
128973813|NCT00829010|464188428|FG000|Overall Study|Adverse Event|1|||
128973814|NCT00829010|464188429|FG001|Overall Study|Adverse Event|0|||
128973815|NCT00829010|464188430|FG002|Overall Study|Adverse Event|0|||
128973816|NCT00829010|464188431|FG003|Overall Study|Adverse Event|0|||
128973817|NCT00829010|464188432|FG004|Overall Study|Adverse Event|0|||
128973818|NCT00829010|464188428|FG000|Overall Study|Withdrawal by Subject|0|||
128715875|NCT02951156|463256652|FG000|Overall Study|Withdrawal by Subject|0|||
128715876|NCT02951156|463256653|FG001|Overall Study|Withdrawal by Subject|0|||
128973819|NCT00829010|464188429|FG001|Overall Study|Withdrawal by Subject|1|||
128973820|NCT00829010|464188430|FG002|Overall Study|Withdrawal by Subject|1|||
128973821|NCT00829010|464188431|FG003|Overall Study|Withdrawal by Subject|0|||
128973822|NCT00829010|464188432|FG004|Overall Study|Withdrawal by Subject|2|||
128973823|NCT00829010|464188428|FG000|Overall Study|Lost to Follow-up|1|||
128973824|NCT00829010|464188429|FG001|Overall Study|Lost to Follow-up|0|||
128973825|NCT00829010|464188430|FG002|Overall Study|Lost to Follow-up|2|||
128973826|NCT00829010|464188431|FG003|Overall Study|Lost to Follow-up|0|||
128973827|NCT00829010|464188432|FG004|Overall Study|Lost to Follow-up|0|||
128973828|NCT00829010|464188428|FG000|Overall Study|Fatality|5|||
128973829|NCT00829010|464188429|FG001|Overall Study|Fatality|4|||
128973830|NCT00829010|464188430|FG002|Overall Study|Fatality|0|||
128973831|NCT00829010|464188431|FG003|Overall Study|Fatality|3|||
128973832|NCT00829010|464188432|FG004|Overall Study|Fatality|0|||
128973833|NCT00829010|464188428|FG000|Overall Study|Migrated/Moved from study area|3|||
128973834|NCT00829010|464188429|FG001|Overall Study|Migrated/Moved from study area|4|||
128973835|NCT00829010|464188430|FG002|Overall Study|Migrated/Moved from study area|0|||
128973836|NCT00829010|464188431|FG003|Overall Study|Migrated/Moved from study area|5|||
128973837|NCT00829010|464188432|FG004|Overall Study|Migrated/Moved from study area|0|||
128973838|NCT00474539|464188435|FG000|Infant Series|Withdrawal by Subject|3|||
128973839|NCT00474539|464188436|FG001|Infant Series|Withdrawal by Subject|4|||
128973840|NCT00474539|464188435|FG000|Infant Series|Randomization error|5|||
128973841|NCT00474539|464188436|FG001|Infant Series|Randomization error|0|||
128973842|NCT00474539|464188435|FG000|Infant Series|Lost to Follow-up|2|||
128973843|NCT00474539|464188436|FG001|Infant Series|Lost to Follow-up|1|||
128973844|NCT00474539|464188435|FG000|Infant Series|Protocol Violation|0|||
128973845|NCT00474539|464188436|FG001|Infant Series|Protocol Violation|1|||
128973846|NCT00474539|464188435|FG000|After Infant Series|Lost to Follow-up|3|||
128973847|NCT00474539|464188436|FG001|After Infant Series|Lost to Follow-up|0|||
128973848|NCT00474539|464188435|FG000|After Infant Series|Withdrawal by Subject|1|||
128973849|NCT00474539|464188436|FG001|After Infant Series|Withdrawal by Subject|0|||
128973850|NCT00474539|464188435|FG000|Toddler Dose|Protocol Violation|1|||
128973851|NCT00474539|464188436|FG001|Toddler Dose|Protocol Violation|0|||
128973852|NCT02061540|464188437|FG000|Overall Study|Adverse Event|2|||
128973853|NCT02061540|464188437|FG000|Overall Study|Withdrawal by Subject|2|||
128973854|NCT02289833|464188439|FG000|Overall Study|Study discontinuation|0|||
128973855|NCT02289833|464188440|FG001|Overall Study|Study discontinuation|1|||
128973856|NCT02289833|464188439|FG000|Overall Study|Lost to Follow-up|4|||
128973857|NCT02289833|464188440|FG001|Overall Study|Lost to Follow-up|0|||
128973858|NCT02289833|464188439|FG000|Overall Study|Death|23|||
128973859|NCT02289833|464188440|FG001|Overall Study|Death|16|||
128973860|NCT01227252|464188441|FG000|Overall Study|Sponsor Decision|0|||
128973861|NCT01227252|464188442|FG001|Overall Study|Sponsor Decision|1|||
128973862|NCT01227252|464188443|FG002|Overall Study|Sponsor Decision|0|||
128973863|NCT01227252|464188444|FG003|Overall Study|Sponsor Decision|0|||
128973864|NCT01227252|464188441|FG000|Overall Study|Lost to Follow-up|0|||
128973865|NCT01227252|464188442|FG001|Overall Study|Lost to Follow-up|1|||
128973866|NCT01227252|464188443|FG002|Overall Study|Lost to Follow-up|0|||
128973867|NCT01227252|464188444|FG003|Overall Study|Lost to Follow-up|0|||
128973868|NCT01227252|464188441|FG000|Overall Study|Withdrawal by Subject|0|||
128973869|NCT01227252|464188442|FG001|Overall Study|Withdrawal by Subject|1|||
128973870|NCT01227252|464188443|FG002|Overall Study|Withdrawal by Subject|0|||
128973871|NCT01227252|464188444|FG003|Overall Study|Withdrawal by Subject|0|||
128973872|NCT02561273|464188451|FG000|Overall Study|Protocol Violation|1|||
128973873|NCT02561273|464188452|FG001|Overall Study|Protocol Violation|0|||
128973874|NCT03442595|464188453|FG000|Overall Study|Lost to Follow-up|94|||
128973875|NCT03442595|464188454|FG001|Overall Study|Lost to Follow-up|0|||
128973876|NCT04107935|464188455|FG000|Overall Study|Death|1|||
128973877|NCT04107935|464188456|FG001|Overall Study|Death|0|||
128973878|NCT00998985|464188460|FG000|Overall Study|Withdrawal by Subject|0|||
128973879|NCT00998985|464188461|FG001|Overall Study|Withdrawal by Subject|0|||
128973880|NCT00998985|464188462|FG002|Overall Study|Withdrawal by Subject|0|||
128973881|NCT00998985|464188463|FG003|Overall Study|Withdrawal by Subject|0|||
128973882|NCT00998985|464188464|FG004|Overall Study|Withdrawal by Subject|0|||
128973883|NCT00998985|464188465|FG005|Overall Study|Withdrawal by Subject|0|||
128973884|NCT00998985|464188466|FG006|Overall Study|Withdrawal by Subject|0|||
128973885|NCT00998985|464188467|FG007|Overall Study|Withdrawal by Subject|0|||
128973886|NCT00998985|464188468|FG008|Overall Study|Withdrawal by Subject|1|||
128973887|NCT00998985|464188469|FG009|Overall Study|Withdrawal by Subject|0|||
128973888|NCT00998985|464188470|FG010|Overall Study|Withdrawal by Subject|0|||
128973889|NCT00998985|464188471|FG011|Overall Study|Withdrawal by Subject|0|||
128973890|NCT00998985|464188472|FG012|Overall Study|Withdrawal by Subject|0|||
128973891|NCT00998985|464188473|FG013|Overall Study|Withdrawal by Subject|0|||
128973892|NCT00998985|464188460|FG000|Overall Study|Protocol Violation|0|||
128973893|NCT00998985|464188461|FG001|Overall Study|Protocol Violation|0|||
128973894|NCT00998985|464188462|FG002|Overall Study|Protocol Violation|0|||
128973895|NCT00998985|464188463|FG003|Overall Study|Protocol Violation|0|||
128973896|NCT00998985|464188464|FG004|Overall Study|Protocol Violation|0|||
128973897|NCT00998985|464188465|FG005|Overall Study|Protocol Violation|1|||
128973898|NCT00998985|464188466|FG006|Overall Study|Protocol Violation|0|||
129038687|NCT01640184|464433240|FG000|Overall Study|Death|1|||
129038688|NCT01640184|464433241|FG001|Overall Study|Death|0|||
129038689|NCT01640184|464433242|FG002|Overall Study|Death|0|||
129038690|NCT01640184|464433240|FG000|Overall Study|Lost to Follow-up|4|||
129038691|NCT01640184|464433241|FG001|Overall Study|Lost to Follow-up|1|||
129038692|NCT01640184|464433242|FG002|Overall Study|Lost to Follow-up|0|||
129038693|NCT01640184|464433240|FG000|Overall Study|Physician Decision|3|||
129038694|NCT01640184|464433241|FG001|Overall Study|Physician Decision|0|||
129038695|NCT01640184|464433242|FG002|Overall Study|Physician Decision|0|||
129038696|NCT01640184|464433240|FG000|Overall Study|Withdrawal by Subject|0|||
129038697|NCT01640184|464433241|FG001|Overall Study|Withdrawal by Subject|1|||
128973899|NCT00998985|464188467|FG007|Overall Study|Protocol Violation|0|||
128973900|NCT00998985|464188468|FG008|Overall Study|Protocol Violation|0|||
129038698|NCT01640184|464433242|FG002|Overall Study|Withdrawal by Subject|1|||
128973901|NCT00998985|464188469|FG009|Overall Study|Protocol Violation|0|||
129038699|NCT01640184|464433240|FG000|Overall Study|Protocol Violation|0|||
128973902|NCT00998985|464188470|FG010|Overall Study|Protocol Violation|0|||
128973903|NCT00998985|464188471|FG011|Overall Study|Protocol Violation|0|||
128973904|NCT00998985|464188472|FG012|Overall Study|Protocol Violation|0|||
128973905|NCT00998985|464188473|FG013|Overall Study|Protocol Violation|0|||
128973906|NCT01040728|464188475|FG000|Overall Study|Adverse Event|4|||
128973907|NCT01040728|464188476|FG001|Overall Study|Adverse Event|8|||
128973908|NCT01040728|464188477|FG002|Overall Study|Adverse Event|0|||
128973909|NCT01040728|464188478|FG003|Overall Study|Adverse Event|4|||
128973910|NCT01040728|464188475|FG000|Overall Study|Withdrawal by Subject|0|||
128973911|NCT01040728|464188476|FG001|Overall Study|Withdrawal by Subject|1|||
128973912|NCT01040728|464188477|FG002|Overall Study|Withdrawal by Subject|1|||
128973913|NCT01040728|464188478|FG003|Overall Study|Withdrawal by Subject|0|||
128973914|NCT01040728|464188475|FG000|Overall Study|Protocol Violation|0|||
128973915|NCT01040728|464188476|FG001|Overall Study|Protocol Violation|0|||
128973916|NCT01040728|464188477|FG002|Overall Study|Protocol Violation|0|||
128973917|NCT01040728|464188478|FG003|Overall Study|Protocol Violation|1|||
128973918|NCT01040728|464188475|FG000|Overall Study|Lack of Efficacy|0|||
128973919|NCT01040728|464188476|FG001|Overall Study|Lack of Efficacy|1|||
128973920|NCT01040728|464188477|FG002|Overall Study|Lack of Efficacy|0|||
128973921|NCT01040728|464188478|FG003|Overall Study|Lack of Efficacy|1|||
128973922|NCT01040728|464188475|FG000|Overall Study|Other reasons not listed above|0|||
128973923|NCT01040728|464188476|FG001|Overall Study|Other reasons not listed above|1|||
128973924|NCT01040728|464188477|FG002|Overall Study|Other reasons not listed above|0|||
128973925|NCT01040728|464188478|FG003|Overall Study|Other reasons not listed above|0|||
128973926|NCT01875874|464188481|FG000|Overall Study|Death|3|||
128973927|NCT00590031|464188482|FG000|Overall Study|Adverse Event|3|||
128973928|NCT00590031|464188482|FG000|Overall Study|Withdrawal by Subject|1|||
128973929|NCT00590031|464188482|FG000|Overall Study|Metastatic Disease|1|||
128973930|NCT00590031|464188482|FG000|Overall Study|Admin Hold|1|||
128973931|NCT00826540|464188489|FG000|Overall Study|ineligible|3|||
128973932|NCT00826540|464188489|FG000|Overall Study|Withdrawal by Subject|1|||
128973933|NCT01166386|464188490|FG000|Overall Study|Withdrawal by Subject|3|||
128973934|NCT01166386|464188491|FG001|Overall Study|Withdrawal by Subject|5|||
128973935|NCT02382276|464188492|FG000|Overall Study|Withdrawal by Subject|4|||
128973936|NCT02382276|464188493|FG001|Overall Study|Withdrawal by Subject|8|||
128973937|NCT02382276|464188494|FG002|Overall Study|Withdrawal by Subject|5|||
128973938|NCT02382276|464188492|FG000|Overall Study|Adverse Event|7|||
128973939|NCT02382276|464188493|FG001|Overall Study|Adverse Event|2|||
128973940|NCT02382276|464188494|FG002|Overall Study|Adverse Event|32|||
128973941|NCT02382276|464188492|FG000|Overall Study|Physician Decision|0|||
128973942|NCT02382276|464188493|FG001|Overall Study|Physician Decision|0|||
128973943|NCT02382276|464188494|FG002|Overall Study|Physician Decision|2|||
128973944|NCT01222416|464188495|FG000|Overall Study|ineligible;metastasis|3|||
128973945|NCT01222416|464188496|FG001|Overall Study|ineligible;metastasis|0|||
128973946|NCT01222416|464188495|FG000|Overall Study|Adverse Event|4|||
128973947|NCT01222416|464188496|FG001|Overall Study|Adverse Event|0|||
128973948|NCT01222416|464188495|FG000|Overall Study|Withdrawal by Subject|5|||
128973949|NCT01222416|464188496|FG001|Overall Study|Withdrawal by Subject|0|||
128973950|NCT01222416|464188495|FG000|Overall Study|scheduling|6|||
128973951|NCT01222416|464188496|FG001|Overall Study|scheduling|0|||
128973952|NCT01222416|464188495|FG000|Overall Study|missed view/scan|1|||
128973953|NCT01222416|464188496|FG001|Overall Study|missed view/scan|0|||
128973954|NCT01222416|464188495|FG000|Overall Study|Death|1|||
128973955|NCT01222416|464188496|FG001|Overall Study|Death|0|||
128973956|NCT02178592|464188499|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
128973957|NCT02178592|464188500|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
128973958|NCT02178592|464188499|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
128973959|NCT02178592|464188500|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
128973960|NCT02178592|464188499|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
128973961|NCT02178592|464188500|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
128973962|NCT02178592|464188499|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
128973963|NCT02178592|464188500|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
128973964|NCT02178592|464188499|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
128973965|NCT02178592|464188500|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
128973966|NCT02178592|464188499|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
128973967|NCT02178592|464188500|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
128973968|NCT02178592|464188499|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
128973969|NCT02178592|464188500|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
128973970|NCT02178592|464188499|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
128973971|NCT02178592|464188500|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
128973972|NCT02178592|464188499|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
128973973|NCT02178592|464188500|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
128973974|NCT02178592|464188499|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
128973975|NCT02178592|464188500|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
128973976|NCT02178592|464188499|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
129131504|NCT00699751|464772859|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
129131505|NCT00699751|464772858|FG000|Period 1: Without/Before Drug Switch|Death|28|||
129131506|NCT00699751|464772859|FG001|Period 1: Without/Before Drug Switch|Death|29|||
129131507|NCT00699751|464772858|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
129131508|NCT00699751|464772859|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
129131509|NCT00699751|464772858|FG000|Period 1: Without/Before Drug Switch|Other|30|||
129131510|NCT00699751|464772859|FG001|Period 1: Without/Before Drug Switch|Other|20|||
129131511|NCT00699751|464772858|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
129131512|NCT00699751|464772859|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
129131513|NCT00699751|464772858|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
129131514|NCT00699751|464772859|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
129131515|NCT00699751|464772858|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
129131516|NCT00699751|464772859|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
129131517|NCT00699751|464772858|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
129131518|NCT00699751|464772859|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
128973977|NCT02178592|464188500|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
128973978|NCT02178592|464188499|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
128973979|NCT02178592|464188500|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
128973980|NCT02520141|464188503|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
128973981|NCT00703781|464188504|FG000|Overall Study|Withdrawal by Subject|1|||
128973982|NCT00703781|464188505|FG001|Overall Study|Withdrawal by Subject|2|||
128973983|NCT00703781|464188504|FG000|Overall Study|Cancelled surgery|1|||
128973984|NCT00703781|464188505|FG001|Overall Study|Cancelled surgery|0|||
128973985|NCT03452397|464188508|FG000|Overall Study|Adverse Event|1|||
128973986|NCT03452397|464188509|FG001|Overall Study|Adverse Event|0|||
128973987|NCT03452397|464188510|FG002|Overall Study|Adverse Event|0|||
128973988|NCT03452397|464188511|FG003|Overall Study|Adverse Event|0|||
128973989|NCT03452397|464188508|FG000|Overall Study|Administrative reason|0|||
128973990|NCT03452397|464188509|FG001|Overall Study|Administrative reason|0|||
128973991|NCT03452397|464188510|FG002|Overall Study|Administrative reason|1|||
128973992|NCT03452397|464188511|FG003|Overall Study|Administrative reason|1|||
128973993|NCT03452397|464188508|FG000|Overall Study|Withdrawal by Subject|0|||
128973994|NCT03452397|464188509|FG001|Overall Study|Withdrawal by Subject|0|||
128973995|NCT03452397|464188510|FG002|Overall Study|Withdrawal by Subject|1|||
128973996|NCT03452397|464188511|FG003|Overall Study|Withdrawal by Subject|0|||
128973997|NCT02691468|464188513|FG000|Overall Study|Bronchial blocker use|2|||
128973998|NCT02691468|464188514|FG001|Overall Study|Bronchial blocker use|1|||
128973999|NCT02691468|464188513|FG000|Overall Study|Lost to Follow-up|2|||
128974000|NCT02691468|464188514|FG001|Overall Study|Lost to Follow-up|1|||
128974001|NCT02691468|464188513|FG000|Overall Study|Failure to advance FOB|2|||
128974002|NCT02691468|464188514|FG001|Overall Study|Failure to advance FOB|0|||
128974003|NCT06334055|464188515|FG000|Overall Study|Adverse Event|4|||
128974004|NCT06334055|464188515|FG000|Overall Study|Disqualified|72|||
128974005|NCT02545049|464188516|FG000|Overall Study|Withdrawal by Subject|1|||
128974006|NCT02545049|464188517|FG001|Overall Study|Withdrawal by Subject|7|||
128974007|NCT02545049|464188516|FG000|Overall Study|Lost to Follow-up|4|||
128974008|NCT02545049|464188517|FG001|Overall Study|Lost to Follow-up|6|||
128974009|NCT02545049|464188516|FG000|Overall Study|GCP violations|37|||
128974010|NCT02545049|464188517|FG001|Overall Study|GCP violations|48|||
128974011|NCT02972658|464189928|FG000|Overall Study|Adverse Event|0|||
128974012|NCT02972658|464189929|FG001|Overall Study|Adverse Event|3|||
128974013|NCT02972658|464189930|FG002|Overall Study|Adverse Event|0|||
128974014|NCT02972658|464189931|FG003|Overall Study|Adverse Event|2|||
128974015|NCT02972658|464189928|FG000|Overall Study|Other-determined by Investigator|1|||
128974016|NCT02972658|464189929|FG001|Overall Study|Other-determined by Investigator|1|||
128974017|NCT02972658|464189930|FG002|Overall Study|Other-determined by Investigator|0|||
128974018|NCT02972658|464189931|FG003|Overall Study|Other-determined by Investigator|0|||
128974019|NCT02972658|464189928|FG000|Overall Study|Death|0|||
128974020|NCT02972658|464189929|FG001|Overall Study|Death|0|||
128974021|NCT02972658|464189930|FG002|Overall Study|Death|0|||
128974022|NCT02972658|464189931|FG003|Overall Study|Death|1|||
128974023|NCT02972658|464189928|FG000|Overall Study|Lost to Follow-up|0|||
128974024|NCT02972658|464189929|FG001|Overall Study|Lost to Follow-up|1|||
128974025|NCT02972658|464189930|FG002|Overall Study|Lost to Follow-up|1|||
128974026|NCT02972658|464189931|FG003|Overall Study|Lost to Follow-up|2|||
128974027|NCT02972658|464189928|FG000|Overall Study|Progressive Disease|0|||
128974028|NCT02972658|464189929|FG001|Overall Study|Progressive Disease|1|||
128974029|NCT02972658|464189930|FG002|Overall Study|Progressive Disease|0|||
128974030|NCT02972658|464189931|FG003|Overall Study|Progressive Disease|1|||
128974031|NCT02972658|464189928|FG000|Overall Study|Withdrawal by Subject|4|||
128974032|NCT02972658|464189929|FG001|Overall Study|Withdrawal by Subject|4|||
128974033|NCT02972658|464189930|FG002|Overall Study|Withdrawal by Subject|1|||
128974034|NCT02972658|464189931|FG003|Overall Study|Withdrawal by Subject|6|||
128974035|NCT02972658|464189928|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
128974036|NCT02972658|464189929|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
128974037|NCT02972658|464189930|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
128974038|NCT02972658|464189931|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
128974039|NCT02972658|464189928|FG000|Overall Study|Sponsor Decision|70|||
128974040|NCT02972658|464189929|FG001|Overall Study|Sponsor Decision|127|||
128974041|NCT02972658|464189930|FG002|Overall Study|Sponsor Decision|72|||
128974042|NCT02972658|464189931|FG003|Overall Study|Sponsor Decision|119|||
128974043|NCT03958149|464189932|FG000|Overall Study|Withdrawal by Subject|0|||
128974044|NCT03958149|464189933|FG001|Overall Study|Withdrawal by Subject|1|||
128974045|NCT02785588|464189934|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
128974046|NCT02785588|464189934|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
128974047|NCT00768040|464189938|FG000|Overall Study|Adverse Event|3|||
128974048|NCT00768040|464189939|FG001|Overall Study|Adverse Event|2|||
128974049|NCT00768040|464189938|FG000|Overall Study|Abnormal laboratory value|1|||
128974050|NCT00768040|464189939|FG001|Overall Study|Abnormal laboratory value|1|||
128974051|NCT02185040|464189941|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
128974052|NCT02185040|464189942|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
128974053|NCT02185040|464189943|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
128974054|NCT02185040|464189944|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
128974055|NCT02185040|464189945|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
128974056|NCT02185040|464189946|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
128974057|NCT02185040|464189947|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
128974058|NCT02185040|464189941|FG000|Part 1 Treatment Phase|Adverse Event|1|||
128974059|NCT02185040|464189942|FG001|Part 1 Treatment Phase|Adverse Event|0|||
128974060|NCT02185040|464189943|FG002|Part 1 Treatment Phase|Adverse Event|0|||
128974061|NCT02185040|464189944|FG003|Part 1 Treatment Phase|Adverse Event|2|||
128974062|NCT02185040|464189945|FG004|Part 1 Treatment Phase|Adverse Event|3|||
128974063|NCT02185040|464189946|FG005|Part 1 Treatment Phase|Adverse Event|0|||
128974064|NCT02185040|464189947|FG006|Part 1 Treatment Phase|Adverse Event|0|||
128974065|NCT02185040|464189941|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
128974066|NCT02185040|464189942|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
128974067|NCT02185040|464189943|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
128974068|NCT02185040|464189944|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
128974069|NCT02185040|464189945|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
128974070|NCT02185040|464189946|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
128974071|NCT02185040|464189947|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
128974072|NCT02185040|464189941|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
128974073|NCT02185040|464189942|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
128974074|NCT02185040|464189943|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
128974075|NCT02185040|464189944|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
128974076|NCT02185040|464189945|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
128974077|NCT02185040|464189946|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
128974078|NCT02185040|464189947|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
128974079|NCT02185040|464189941|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
128974080|NCT02185040|464189942|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
128974081|NCT02185040|464189943|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
128974082|NCT02185040|464189944|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
128974083|NCT02185040|464189945|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
128974084|NCT02185040|464189946|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
128974085|NCT02185040|464189947|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
128974086|NCT02185040|464189941|FG000|Active Treatment Extension Phase|Adverse Event|0|||
128974087|NCT02185040|464189942|FG001|Active Treatment Extension Phase|Adverse Event|0|||
128974088|NCT02185040|464189943|FG002|Active Treatment Extension Phase|Adverse Event|0|||
128974089|NCT02185040|464189944|FG003|Active Treatment Extension Phase|Adverse Event|0|||
128974090|NCT02185040|464189945|FG004|Active Treatment Extension Phase|Adverse Event|0|||
128974091|NCT02185040|464189946|FG005|Active Treatment Extension Phase|Adverse Event|1|||
128974092|NCT02185040|464189947|FG006|Active Treatment Extension Phase|Adverse Event|4|||
128974093|NCT02185040|464189941|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
128974094|NCT02185040|464189942|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
128974095|NCT02185040|464189943|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
128974096|NCT02185040|464189944|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
128974097|NCT02185040|464189945|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
128974098|NCT02185040|464189946|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
128974099|NCT02185040|464189947|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
128974100|NCT02185040|464189941|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
128974101|NCT02185040|464189942|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
128974102|NCT02185040|464189943|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
129221034|NCT05019521|465110145|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
128974103|NCT02185040|464189944|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
128974104|NCT02185040|464189945|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
128974105|NCT02185040|464189946|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
128974106|NCT02185040|464189947|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
128974107|NCT03347279|464189948|FG000|Overall Study|Withdrawal by Subject|8|||
128974108|NCT03347279|464189949|FG001|Overall Study|Withdrawal by Subject|15|||
128974109|NCT03347279|464189948|FG000|Overall Study|Death|0|||
128974110|NCT03347279|464189949|FG001|Overall Study|Death|2|||
128974111|NCT03347279|464189948|FG000|Overall Study|Lost to Follow-up|5|||
128974112|NCT03347279|464189949|FG001|Overall Study|Lost to Follow-up|2|||
128974113|NCT03347279|464189948|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
128974114|NCT03347279|464189949|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
128974115|NCT03818399|464189952|FG000|Overall Study|Lost to Follow-up|11|||
128974116|NCT03818399|464189952|FG000|Overall Study|Withdrawal by Subject|1|||
128974117|NCT03818399|464189952|FG000|Overall Study|Protocol Violation|2|||
128974118|NCT03557801|464189955|FG000|Overall Study|Protocol Violation|1|||
128974119|NCT03557801|464189956|FG001|Overall Study|Protocol Violation|0|||
128974120|NCT03557801|464189957|FG002|Overall Study|Protocol Violation|0|||
128974121|NCT03557801|464189955|FG000|Overall Study|Withdrawal by Subject|1|||
128974122|NCT03557801|464189956|FG001|Overall Study|Withdrawal by Subject|0|||
128974123|NCT03557801|464189957|FG002|Overall Study|Withdrawal by Subject|3|||
128974124|NCT03557801|464189955|FG000|Overall Study|Lost to Follow-up|0|||
128974125|NCT03557801|464189956|FG001|Overall Study|Lost to Follow-up|1|||
128974126|NCT03557801|464189957|FG002|Overall Study|Lost to Follow-up|0|||
128974127|NCT00141297|464189958|FG000|Overall Study|Adverse Event|0|||
128974128|NCT00141297|464189959|FG001|Overall Study|Adverse Event|0|||
128974129|NCT00141297|464189960|FG002|Overall Study|Adverse Event|1|||
128974130|NCT00141297|464189961|FG003|Overall Study|Adverse Event|0|||
128974131|NCT00141297|464189962|FG004|Overall Study|Adverse Event|1|||
128974132|NCT00141297|464189963|FG005|Overall Study|Adverse Event|1|||
128974133|NCT00141297|464189964|FG006|Overall Study|Adverse Event|0|||
128974134|NCT00141297|464189965|FG007|Overall Study|Adverse Event|1|||
128974135|NCT00141297|464189966|FG008|Overall Study|Adverse Event|1|||
128974136|NCT00141297|464189967|FG009|Overall Study|Adverse Event|0|||
128974137|NCT00141297|464189958|FG000|Overall Study|Death|1|||
128974138|NCT00141297|464189959|FG001|Overall Study|Death|0|||
128974139|NCT00141297|464189960|FG002|Overall Study|Death|0|||
128974140|NCT00141297|464189961|FG003|Overall Study|Death|0|||
128974141|NCT00141297|464189962|FG004|Overall Study|Death|0|||
128974142|NCT00141297|464189963|FG005|Overall Study|Death|0|||
128974143|NCT00141297|464189964|FG006|Overall Study|Death|0|||
128974144|NCT00141297|464189965|FG007|Overall Study|Death|0|||
128974145|NCT00141297|464189966|FG008|Overall Study|Death|1|||
128974146|NCT00141297|464189967|FG009|Overall Study|Death|0|||
128974147|NCT00141297|464189958|FG000|Overall Study|Withdrawal by Subject|0|||
128974148|NCT00141297|464189959|FG001|Overall Study|Withdrawal by Subject|0|||
128974149|NCT00141297|464189960|FG002|Overall Study|Withdrawal by Subject|0|||
128974150|NCT00141297|464189961|FG003|Overall Study|Withdrawal by Subject|0|||
128974151|NCT00141297|464189962|FG004|Overall Study|Withdrawal by Subject|0|||
128974152|NCT00141297|464189963|FG005|Overall Study|Withdrawal by Subject|0|||
128974153|NCT00141297|464189964|FG006|Overall Study|Withdrawal by Subject|0|||
128974154|NCT00141297|464189965|FG007|Overall Study|Withdrawal by Subject|0|||
128974155|NCT00141297|464189966|FG008|Overall Study|Withdrawal by Subject|1|||
128974156|NCT00141297|464189967|FG009|Overall Study|Withdrawal by Subject|0|||
128974157|NCT00141297|464189958|FG000|Overall Study|Other|0|||
128974158|NCT00141297|464189959|FG001|Overall Study|Other|0|||
128974159|NCT00141297|464189960|FG002|Overall Study|Other|0|||
128974160|NCT00141297|464189961|FG003|Overall Study|Other|1|||
128974161|NCT00141297|464189962|FG004|Overall Study|Other|5|||
128974162|NCT00141297|464189963|FG005|Overall Study|Other|0|||
128974163|NCT00141297|464189964|FG006|Overall Study|Other|0|||
128974164|NCT00141297|464189965|FG007|Overall Study|Other|0|||
128974165|NCT00141297|464189966|FG008|Overall Study|Other|2|||
128974166|NCT00141297|464189967|FG009|Overall Study|Other|0|||
128974167|NCT00141297|464189958|FG000|Overall Study|Progressive Disease|2|||
128974168|NCT00141297|464189959|FG001|Overall Study|Progressive Disease|3|||
128974169|NCT00141297|464189960|FG002|Overall Study|Progressive Disease|6|||
128974170|NCT00141297|464189961|FG003|Overall Study|Progressive Disease|2|||
128974171|NCT00141297|464189962|FG004|Overall Study|Progressive Disease|15|||
128974172|NCT00141297|464189963|FG005|Overall Study|Progressive Disease|2|||
128974173|NCT00141297|464189964|FG006|Overall Study|Progressive Disease|3|||
128974174|NCT00141297|464189965|FG007|Overall Study|Progressive Disease|3|||
128715877|NCT02951156|463256654|FG002|Overall Study|Withdrawal by Subject|1|||
128715878|NCT02951156|463256652|FG000|Overall Study|Study terminated by sponsor|0|||
128974175|NCT00141297|464189966|FG008|Overall Study|Progressive Disease|15|||
128974176|NCT00141297|464189967|FG009|Overall Study|Progressive Disease|6|||
128974177|NCT00141297|464189958|FG000|Overall Study|Transitioned|0|||
129131519|NCT00985790|464772862|FG000|Overall Study|Withdrawal by Subject|1|||
129131520|NCT00985790|464772863|FG001|Overall Study|Withdrawal by Subject|1|||
129131521|NCT00985790|464772862|FG000|Overall Study|Lost to Follow-up|6|||
128974178|NCT00141297|464189959|FG001|Overall Study|Transitioned|0|||
128974179|NCT00141297|464189960|FG002|Overall Study|Transitioned|0|||
129131522|NCT00985790|464772863|FG001|Overall Study|Lost to Follow-up|7|||
129221035|NCT05019521|465110146|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129221036|NCT05019521|465110147|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129221037|NCT05019521|465110148|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129221038|NCT05019521|465110149|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129221039|NCT05019521|465110143|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
129221040|NCT05019521|465110144|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
129221041|NCT05019521|465110145|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
129221042|NCT05019521|465110146|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
129221043|NCT05019521|465110147|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
129221044|NCT05019521|465110148|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
129221045|NCT05019521|465110149|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
129221046|NCT05019521|465110143|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
129221047|NCT05019521|465110144|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221048|NCT05019521|465110145|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221049|NCT05019521|465110146|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221050|NCT05019521|465110147|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221051|NCT05019521|465110148|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221052|NCT05019521|465110149|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221053|NCT05019521|465110143|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129221054|NCT05019521|465110144|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129221055|NCT05019521|465110145|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129221056|NCT05019521|465110146|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
129221057|NCT05019521|465110147|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129221058|NCT05019521|465110148|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129221059|NCT05019521|465110149|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129221060|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
129221061|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
129221062|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
129221063|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
129221064|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
129221065|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
129221066|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
129221067|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129221068|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
129221069|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129221070|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129221071|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129221072|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129221073|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129221074|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
129221075|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129221076|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129221077|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129221078|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
129221079|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
129221080|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
129221081|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129221082|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
129221083|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
129221084|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129221085|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129221086|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
128715879|NCT02951156|463256653|FG001|Overall Study|Study terminated by sponsor|0|||
129038700|NCT01640184|464433241|FG001|Overall Study|Protocol Violation|0|||
129038701|NCT01640184|464433242|FG002|Overall Study|Protocol Violation|1|||
129038702|NCT02260258|464433245|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
129038703|NCT02260258|464433246|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
129038704|NCT02563769|464433247|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
129038705|NCT02563769|464433248|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
129038706|NCT02563769|464433249|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
129221087|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
128715880|NCT02951156|463256654|FG002|Overall Study|Study terminated by sponsor|1|||
128715881|NCT02951156|463256652|FG000|Overall Study|Other|5|||
129038707|NCT00690482|464433250|FG000|Overall Study|Adverse Event|2|||
129038708|NCT00690482|464433251|FG001|Overall Study|Adverse Event|1|||
129038709|NCT00690482|464433250|FG000|Overall Study|Incorrect enrolment|0|||
129221088|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
129221089|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
129221090|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
129221091|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
129221092|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
129038710|NCT00690482|464433251|FG001|Overall Study|Incorrect enrolment|1|||
129038711|NCT00690482|464433250|FG000|Overall Study|Study-specific discontinuation criteria|1|||
129038712|NCT00690482|464433251|FG001|Overall Study|Study-specific discontinuation criteria|0|||
129038713|NCT00690482|464433250|FG000|Overall Study|Intake of prohibited medicine|1|||
129038714|NCT00690482|464433251|FG001|Overall Study|Intake of prohibited medicine|0|||
129038715|NCT00690482|464433250|FG000|Overall Study|withdrew consent at rand.day|0|||
129038716|NCT00690482|464433251|FG001|Overall Study|withdrew consent at rand.day|1|||
129038717|NCT01610063|464433254|FG000|Overall Study|Lost to Follow-up|42|||
129038718|NCT01610063|464433255|FG001|Overall Study|Lost to Follow-up|20|||
129038719|NCT04405739|464433256|FG000|Overall Study|Adverse Event|0|||
129038720|NCT04405739|464433257|FG001|Overall Study|Adverse Event|1|||
129131523|NCT04124965|464772864|FG000|Overall Study|Adverse event, non-fatal|3|||
129131524|NCT04124965|464772865|FG001|Overall Study|Adverse event, non-fatal|1|||
129131525|NCT04124965|464772864|FG000|Overall Study|Withdrawal by Subject|1|||
129131526|NCT04124965|464772865|FG001|Overall Study|Withdrawal by Subject|1|||
129131527|NCT04124965|464772864|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
129131528|NCT04124965|464772865|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
129131529|NCT04124965|464772864|FG000|Overall Study|Pregnancy|1|||
129131530|NCT04124965|464772865|FG001|Overall Study|Pregnancy|0|||
129131531|NCT04124965|464772864|FG000|Overall Study|Sponsor and participant decision|0|||
129131532|NCT04124965|464772865|FG001|Overall Study|Sponsor and participant decision|1|||
129131533|NCT04124965|464772864|FG000|Overall Study|Personal surgery|0|||
129131534|NCT04124965|464772865|FG001|Overall Study|Personal surgery|1|||
129131535|NCT04124965|464772864|FG000|Overall Study|Physician Decision|0|||
129131536|NCT04124965|464772865|FG001|Overall Study|Physician Decision|1|||
129131537|NCT02184156|464772866|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
129131538|NCT02184156|464772867|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
129131539|NCT02184156|464772866|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
129131540|NCT02184156|464772867|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
129131541|NCT00002874|464772868|FG000|Overall Study|Withdrawal by Subject|1|||
129131542|NCT00002874|464772869|FG001|Overall Study|Withdrawal by Subject|1|||
129131543|NCT00002874|464772868|FG000|Overall Study|Protocol Violation|44|||
129131544|NCT00002874|464772869|FG001|Overall Study|Protocol Violation|34|||
129131545|NCT01397747|464772870|FG000|Overall Study|Multitarget DNA test excluded|689|||
129131546|NCT01397747|464772870|FG000|Overall Study|Colonoscopy excluded|304|||
129131547|NCT01397747|464772870|FG000|Overall Study|FIT excluded|34|||
129131548|NCT03828383|464772871|FG000|Overall Study|Lost to Follow-up|3|||
129131549|NCT03828383|464772872|FG001|Overall Study|Lost to Follow-up|2|||
129131550|NCT03828383|464772871|FG000|Overall Study|Withdrawal by Subject|4|||
129131551|NCT03828383|464772872|FG001|Overall Study|Withdrawal by Subject|5|||
129131552|NCT00308685|464772874|FG000|Overall Study|Lost to Follow-up|1|||
129131553|NCT00308685|464772875|FG001|Overall Study|Lost to Follow-up|0|||
129131554|NCT00308685|464772874|FG000|Overall Study|Need to administer prohibited medication|1|||
129131555|NCT00308685|464772875|FG001|Overall Study|Need to administer prohibited medication|2|||
129131556|NCT00308685|464772874|FG000|Overall Study|Other than specified|1|||
129131557|NCT00308685|464772875|FG001|Overall Study|Other than specified|3|||
129131558|NCT03158311|464772878|FG000|Overall Study|Subject/Guardian Decision|10|||
129131559|NCT03158311|464772879|FG001|Overall Study|Subject/Guardian Decision|6|||
129131560|NCT03158311|464772880|FG002|Overall Study|Subject/Guardian Decision|11|||
129131561|NCT03158311|464772878|FG000|Overall Study|Adverse Event|5|||
129131562|NCT03158311|464772879|FG001|Overall Study|Adverse Event|3|||
129131563|NCT03158311|464772880|FG002|Overall Study|Adverse Event|3|||
129131564|NCT03158311|464772878|FG000|Overall Study|Techinical Problems|3|||
129131565|NCT03158311|464772879|FG001|Overall Study|Techinical Problems|1|||
129131566|NCT03158311|464772880|FG002|Overall Study|Techinical Problems|5|||
129131567|NCT03158311|464772878|FG000|Overall Study|Physician Decision|2|||
129131568|NCT03158311|464772879|FG001|Overall Study|Physician Decision|3|||
129131569|NCT03158311|464772880|FG002|Overall Study|Physician Decision|7|||
129131570|NCT03158311|464772878|FG000|Overall Study|Lost to Follow-up|1|||
129131571|NCT03158311|464772879|FG001|Overall Study|Lost to Follow-up|1|||
129131572|NCT03158311|464772880|FG002|Overall Study|Lost to Follow-up|1|||
129131573|NCT03158311|464772878|FG000|Overall Study|Sponsor decision|1|||
129131574|NCT03158311|464772879|FG001|Overall Study|Sponsor decision|0|||
129131575|NCT03158311|464772880|FG002|Overall Study|Sponsor decision|0|||
129131576|NCT03158311|464772878|FG000|Overall Study|Pregnancy|0|||
129221093|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
129131577|NCT03158311|464772879|FG001|Overall Study|Pregnancy|2|||
129038721|NCT04405739|464433258|FG002|Overall Study|Adverse Event|0|||
129038722|NCT04405739|464433259|FG003|Overall Study|Adverse Event|0|||
129038723|NCT04405739|464433256|FG000|Overall Study|Lost to Follow-up|0|||
129221094|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
129221095|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221096|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221097|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221098|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221099|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221100|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
129221101|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129221102|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129221103|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
129221104|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129221105|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129221106|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129221107|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
129221108|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129221109|NCT05019521|465110143|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
129221110|NCT05019521|465110144|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
129221111|NCT05019521|465110145|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
129221112|NCT05019521|465110146|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
129221113|NCT05019521|465110147|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
129221114|NCT05019521|465110148|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
129221115|NCT05019521|465110149|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
129221116|NCT01147874|465110151|FG000|Overall Study|Adverse Event|5|||
129221117|NCT01147874|465110151|FG000|Overall Study|Investigator's Request|1|||
129221118|NCT01147874|465110151|FG000|Overall Study|Lost to Follow-up|25|||
129221119|NCT01147874|465110151|FG000|Overall Study|Other|5|||
129221120|NCT01147874|465110151|FG000|Overall Study|Protocol Violation|5|||
129221121|NCT01147874|465110151|FG000|Overall Study|Sponsor's Decision|2|||
129221122|NCT01147874|465110151|FG000|Overall Study|Withdrawal by Subject|24|||
129221123|NCT02533453|465110159|FG000|Overall Study|Adverse Event|6|||
129221124|NCT02533453|465110159|FG000|Overall Study|Protocol Violation|1|||
129221125|NCT02533453|465110159|FG000|Overall Study|Withdrawal by Subject|2|||
129221126|NCT00885534|465110160|FG000|Overall Study|Patient deemed ineligible|1|||
129221127|NCT04292899|465110162|FG000|Overall Study|Death|21|||
129221128|NCT04292899|465110163|FG001|Overall Study|Death|28|||
129221129|NCT04292899|465110164|FG002|Overall Study|Death|188|||
129221130|NCT04292899|465110165|FG003|Overall Study|Death|371|||
129221131|NCT04292899|465110162|FG000|Overall Study|Lost to Follow-up|8|||
129221132|NCT04292899|465110163|FG001|Overall Study|Lost to Follow-up|4|||
129221133|NCT04292899|465110164|FG002|Overall Study|Lost to Follow-up|22|||
129221134|NCT04292899|465110165|FG003|Overall Study|Lost to Follow-up|235|||
129221135|NCT04292899|465110162|FG000|Overall Study|Withdrew consent|1|||
129221136|NCT04292899|465110163|FG001|Overall Study|Withdrew consent|0|||
129221137|NCT04292899|465110164|FG002|Overall Study|Withdrew consent|11|||
129221138|NCT04292899|465110165|FG003|Overall Study|Withdrew consent|32|||
129221139|NCT04292899|465110162|FG000|Overall Study|Adverse Event|2|||
129221140|NCT04292899|465110163|FG001|Overall Study|Adverse Event|1|||
129221141|NCT04292899|465110164|FG002|Overall Study|Adverse Event|2|||
129221142|NCT04292899|465110165|FG003|Overall Study|Adverse Event|2|||
129221143|NCT04292899|465110162|FG000|Overall Study|Investigator's Discretion|0|||
129221144|NCT04292899|465110163|FG001|Overall Study|Investigator's Discretion|0|||
129221145|NCT04292899|465110164|FG002|Overall Study|Investigator's Discretion|0|||
129221146|NCT04292899|465110165|FG003|Overall Study|Investigator's Discretion|3|||
129221147|NCT04292899|465110162|FG000|Overall Study|Non-compliance With Study Drug|0|||
129221148|NCT04292899|465110163|FG001|Overall Study|Non-compliance With Study Drug|0|||
129221149|NCT04292899|465110164|FG002|Overall Study|Non-compliance With Study Drug|0|||
129221150|NCT04292899|465110165|FG003|Overall Study|Non-compliance With Study Drug|1|||
129038724|NCT04405739|464433257|FG001|Overall Study|Lost to Follow-up|2|||
129038725|NCT04405739|464433258|FG002|Overall Study|Lost to Follow-up|1|||
129038726|NCT04405739|464433259|FG003|Overall Study|Lost to Follow-up|3|||
129038727|NCT04405739|464433256|FG000|Overall Study|Withdrawal by Subject|0|||
129038728|NCT04405739|464433257|FG001|Overall Study|Withdrawal by Subject|2|||
129038729|NCT04405739|464433258|FG002|Overall Study|Withdrawal by Subject|1|||
129038730|NCT04405739|464433259|FG003|Overall Study|Withdrawal by Subject|1|||
129038731|NCT04405739|464433256|FG000|Overall Study|Death|0|||
129038732|NCT04405739|464433257|FG001|Overall Study|Death|0|||
129221151|NCT04292899|465110162|FG000|Overall Study|Protocol Violation|0|||
129221152|NCT04292899|465110163|FG001|Overall Study|Protocol Violation|0|||
129221153|NCT04292899|465110164|FG002|Overall Study|Protocol Violation|0|||
128974180|NCT00141297|464189961|FG003|Overall Study|Transitioned|0|||
128974181|NCT00141297|464189962|FG004|Overall Study|Transitioned|1|||
128974182|NCT00141297|464189963|FG005|Overall Study|Transitioned|0|||
128974183|NCT00141297|464189964|FG006|Overall Study|Transitioned|0|||
128974184|NCT00141297|464189965|FG007|Overall Study|Transitioned|0|||
128974185|NCT00141297|464189966|FG008|Overall Study|Transitioned|0|||
128974186|NCT00141297|464189967|FG009|Overall Study|Transitioned|0|||
128974187|NCT02200510|464189968|FG000|Overall Study|Death|1|||
128974188|NCT02200510|464189969|FG001|Overall Study|Death|1|||
128974189|NCT02200510|464189968|FG000|Overall Study|Protocol Violation|0|||
128974190|NCT02200510|464189969|FG001|Overall Study|Protocol Violation|1|||
128974191|NCT02200510|464189968|FG000|Overall Study|Lost to Follow-up|7|||
128974192|NCT02200510|464189969|FG001|Overall Study|Lost to Follow-up|1|||
128974193|NCT02200510|464189968|FG000|Overall Study|potential COI - joined study team|1|||
128974194|NCT02200510|464189969|FG001|Overall Study|potential COI - joined study team|0|||
128974195|NCT00290355|464189970|FG000|Overall Study|Serious adverse event|7|||
128974196|NCT00290355|464189971|FG001|Overall Study|Serious adverse event|4|||
128974197|NCT00290355|464189970|FG000|Overall Study|Study product reactogenicity|1|||
128974198|NCT00290355|464189971|FG001|Overall Study|Study product reactogenicity|0|||
128974199|NCT00290355|464189970|FG000|Overall Study|Protocol Violation|1|||
128974200|NCT00290355|464189971|FG001|Overall Study|Protocol Violation|0|||
128974201|NCT00290355|464189970|FG000|Overall Study|Withdrawal by Subject|2|||
128974202|NCT00290355|464189971|FG001|Overall Study|Withdrawal by Subject|0|||
128974203|NCT00290355|464189970|FG000|Overall Study|Migrated / moved from the study area|1|||
128974204|NCT00290355|464189971|FG001|Overall Study|Migrated / moved from the study area|0|||
128974205|NCT00290355|464189970|FG000|Overall Study|Lost to Follow-up|3|||
128974206|NCT00290355|464189971|FG001|Overall Study|Lost to Follow-up|1|||
128974207|NCT00290355|464189970|FG000|Overall Study|Other|2|||
128974208|NCT00290355|464189971|FG001|Overall Study|Other|0|||
128974209|NCT01542632|464189972|FG000|Overall Study|Withdrawal of Consent|0|||
128974210|NCT01542632|464189973|FG001|Overall Study|Withdrawal of Consent|0|||
128974211|NCT01542632|464189974|FG002|Overall Study|Withdrawal of Consent|0|||
128974212|NCT01542632|464189975|FG003|Overall Study|Withdrawal of Consent|2|||
128974213|NCT01542632|464189976|FG004|Overall Study|Withdrawal of Consent|3|||
128974214|NCT01542632|464189977|FG005|Overall Study|Withdrawal of Consent|0|||
128974215|NCT01542632|464189972|FG000|Overall Study|Adverse Event|0|||
128974216|NCT01542632|464189973|FG001|Overall Study|Adverse Event|0|||
128974217|NCT01542632|464189974|FG002|Overall Study|Adverse Event|1|||
128974218|NCT01542632|464189975|FG003|Overall Study|Adverse Event|0|||
128974219|NCT01542632|464189976|FG004|Overall Study|Adverse Event|0|||
128974220|NCT01542632|464189977|FG005|Overall Study|Adverse Event|0|||
128974221|NCT01542632|464189972|FG000|Overall Study|Lost to Follow-up|0|||
128974222|NCT01542632|464189973|FG001|Overall Study|Lost to Follow-up|1|||
128974223|NCT01542632|464189974|FG002|Overall Study|Lost to Follow-up|0|||
128974224|NCT01542632|464189975|FG003|Overall Study|Lost to Follow-up|0|||
128974225|NCT01542632|464189976|FG004|Overall Study|Lost to Follow-up|0|||
128974226|NCT01542632|464189977|FG005|Overall Study|Lost to Follow-up|0|||
128974227|NCT01542632|464189972|FG000|Overall Study|Sponsor/Investigator Decision|0|||
128974228|NCT01542632|464189973|FG001|Overall Study|Sponsor/Investigator Decision|0|||
128974229|NCT01542632|464189974|FG002|Overall Study|Sponsor/Investigator Decision|0|||
128974230|NCT01542632|464189975|FG003|Overall Study|Sponsor/Investigator Decision|0|||
128974231|NCT01542632|464189976|FG004|Overall Study|Sponsor/Investigator Decision|1|||
128974232|NCT01542632|464189977|FG005|Overall Study|Sponsor/Investigator Decision|0|||
128974233|NCT00033514|464189978|FG000|Overall Study|Lost to Follow-up|1|||
128974234|NCT00033514|464189979|FG001|Overall Study|Lost to Follow-up|1|||
128974235|NCT00033514|464189978|FG000|Overall Study|Withdrawal by Subject|0|||
128974236|NCT00033514|464189979|FG001|Overall Study|Withdrawal by Subject|3|||
128974237|NCT01072500|464189985|FG000|Overall Study|Death|2|||
128974238|NCT01072500|464189986|FG001|Overall Study|Death|2|||
128974239|NCT01072500|464189985|FG000|Overall Study|Lost to Follow-up|5|||
128974240|NCT01072500|464189986|FG001|Overall Study|Lost to Follow-up|2|||
128974241|NCT01072500|464189985|FG000|Overall Study|Withdrawal by Subject|17|||
128974242|NCT01072500|464189986|FG001|Overall Study|Withdrawal by Subject|10|||
128974243|NCT03798366|464189987|FG000|Overall Study|Lost to Follow-up|0|||
128974244|NCT03798366|464189988|FG001|Overall Study|Lost to Follow-up|1|||
128974245|NCT01642004|464189989|FG000|Randomization|Adverse Event unrelated to study drug|1|||
128974246|NCT01642004|464189990|FG001|Randomization|Adverse Event unrelated to study drug|0|||
129038733|NCT04405739|464433258|FG002|Overall Study|Death|1|||
129038734|NCT04405739|464433259|FG003|Overall Study|Death|0|||
129038735|NCT04405739|464433256|FG000|Overall Study|Transferred to rehab|0|||
128974247|NCT01642004|464189989|FG000|Randomization|Participant withdrew consent|1|||
128974248|NCT01642004|464189990|FG001|Randomization|Participant withdrew consent|6|||
128974249|NCT01642004|464189989|FG000|Randomization|No longer meets study criteria|2|||
128974250|NCT01642004|464189990|FG001|Randomization|No longer meets study criteria|2|||
128974251|NCT01642004|464189989|FG000|Treatment|Disease progression|95|||
128974252|NCT01642004|464189990|FG001|Treatment|Disease progression|79|||
128974253|NCT01642004|464189989|FG000|Treatment|Study drug toxicity|10|||
128974254|NCT01642004|464189990|FG001|Treatment|Study drug toxicity|13|||
128974255|NCT01642004|464189989|FG000|Treatment|Death|1|||
128974256|NCT01642004|464189990|FG001|Treatment|Death|1|||
128974257|NCT01642004|464189989|FG000|Treatment|Adverse event unrelated to study drug|9|||
128974258|NCT01642004|464189990|FG001|Treatment|Adverse event unrelated to study drug|13|||
128974259|NCT01642004|464189989|FG000|Treatment|Maximum clinical benefit|1|||
128974260|NCT01642004|464189990|FG001|Treatment|Maximum clinical benefit|9|||
128974261|NCT01642004|464189989|FG000|Treatment|Poor/non-compliance|1|||
128974262|NCT01642004|464189990|FG001|Treatment|Poor/non-compliance|0|||
128974263|NCT01642004|464189989|FG000|Treatment|No longer meets study criteria|1|||
128974264|NCT01642004|464189990|FG001|Treatment|No longer meets study criteria|2|||
128974265|NCT01642004|464189989|FG000|Treatment|Other reasons|2|||
128974266|NCT01642004|464189990|FG001|Treatment|Other reasons|0|||
128974267|NCT01642004|464189989|FG000|Treatment|Not reported|0|||
128974268|NCT01642004|464189990|FG001|Treatment|Not reported|3|||
128974269|NCT01642004|464189989|FG000|Treatment|Participant request to discontinue study treatment|6|||
128974270|NCT01642004|464189990|FG001|Treatment|Participant request to discontinue study treatment|4|||
128974271|NCT01642004|464189989|FG000|Treatment|Participant withdrew consent|5|||
128715882|NCT02951156|463256653|FG001|Overall Study|Other|1|||
128715883|NCT02951156|463256654|FG002|Overall Study|Other|2|||
128715884|NCT04351087|463256655|FG000|Overall Study|Lost to Follow-up|7|||
128715885|NCT04351087|463256656|FG001|Overall Study|Lost to Follow-up|3|||
128974272|NCT01642004|464189990|FG001|Treatment|Participant withdrew consent|5|||
128974273|NCT02192190|464189995|FG000|Overall Study|Adverse Event|1|||
128974274|NCT02192190|464189996|FG001|Overall Study|Adverse Event|1|||
128974275|NCT02192190|464189997|FG002|Overall Study|Adverse Event|0|||
128974276|NCT02192190|464189998|FG003|Overall Study|Adverse Event|0|||
128974277|NCT02192190|464189999|FG004|Overall Study|Adverse Event|0|||
128974278|NCT02192190|464190000|FG005|Overall Study|Adverse Event|0|||
128974279|NCT02192190|464189995|FG000|Overall Study|Lost to Follow-up|3|||
128974280|NCT02192190|464189996|FG001|Overall Study|Lost to Follow-up|3|||
128974281|NCT02192190|464189997|FG002|Overall Study|Lost to Follow-up|2|||
128974282|NCT02192190|464189998|FG003|Overall Study|Lost to Follow-up|1|||
128974283|NCT02192190|464189999|FG004|Overall Study|Lost to Follow-up|4|||
128974284|NCT02192190|464190000|FG005|Overall Study|Lost to Follow-up|3|||
128974285|NCT02192190|464189995|FG000|Overall Study|Physician Decision|2|||
128974286|NCT02192190|464189996|FG001|Overall Study|Physician Decision|0|||
128974287|NCT02192190|464189997|FG002|Overall Study|Physician Decision|0|||
128715886|NCT04351087|463256655|FG000|Overall Study|Withdrawal by Subject|3|||
128715887|NCT04351087|463256656|FG001|Overall Study|Withdrawal by Subject|4|||
128715888|NCT04351087|463256655|FG000|Overall Study|Lack of Efficacy|3|||
128715889|NCT04351087|463256656|FG001|Overall Study|Lack of Efficacy|2|||
128715890|NCT03519347|463256659|FG000|Interventional Crossover Period 1|Death|0|||
128715891|NCT03519347|463256660|FG001|Interventional Crossover Period 1|Death|0|||
128715892|NCT03519347|463256661|FG002|Interventional Crossover Period 1|Death|0|||
128715893|NCT03519347|463256662|FG003|Interventional Crossover Period 1|Death|1|||
128715894|NCT05517382|463256663|FG000|Overall Study|Lost to Follow-up|0|||
128715895|NCT05517382|463256664|FG001|Overall Study|Lost to Follow-up|1|||
128715896|NCT01641692|463256665|FG000|Treatment Period 1|Adverse Event|1|||
128715897|NCT01641692|463256666|FG001|Treatment Period 1|Adverse Event|0|||
128715898|NCT01641692|463256667|FG002|Treatment Period 1|Adverse Event|0|||
128715899|NCT01641692|463256668|FG003|Treatment Period 1|Adverse Event|0|||
128715900|NCT01641692|463256669|FG004|Treatment Period 1|Adverse Event|0|||
128715901|NCT01641692|463256670|FG005|Treatment Period 1|Adverse Event|0|||
128715902|NCT01641692|463256671|FG006|Treatment Period 1|Adverse Event|0|||
128715903|NCT01641692|463256672|FG007|Treatment Period 1|Adverse Event|0|||
128715904|NCT01641692|463256665|FG000|Treatment Period 1|Lack of Efficacy|0|||
128715905|NCT01641692|463256666|FG001|Treatment Period 1|Lack of Efficacy|0|||
128715906|NCT01641692|463256667|FG002|Treatment Period 1|Lack of Efficacy|0|||
128715907|NCT01641692|463256668|FG003|Treatment Period 1|Lack of Efficacy|0|||
128715908|NCT01641692|463256669|FG004|Treatment Period 1|Lack of Efficacy|0|||
128715909|NCT01641692|463256670|FG005|Treatment Period 1|Lack of Efficacy|0|||
128715910|NCT01641692|463256671|FG006|Treatment Period 1|Lack of Efficacy|0|||
128715911|NCT01641692|463256672|FG007|Treatment Period 1|Lack of Efficacy|1|||
128715912|NCT01641692|463256665|FG000|Treatment Period 1|Protocol Violation|1|||
128715913|NCT01641692|463256666|FG001|Treatment Period 1|Protocol Violation|0|||
128715914|NCT01641692|463256667|FG002|Treatment Period 1|Protocol Violation|0|||
128715915|NCT01641692|463256668|FG003|Treatment Period 1|Protocol Violation|0|||
128715916|NCT01641692|463256669|FG004|Treatment Period 1|Protocol Violation|2|||
128715917|NCT01641692|463256670|FG005|Treatment Period 1|Protocol Violation|0|||
128974288|NCT02192190|464189998|FG003|Overall Study|Physician Decision|0|||
128974289|NCT02192190|464189999|FG004|Overall Study|Physician Decision|0|||
128974290|NCT02192190|464190000|FG005|Overall Study|Physician Decision|0|||
128715918|NCT01641692|463256671|FG006|Treatment Period 1|Protocol Violation|0|||
128974291|NCT02192190|464189995|FG000|Overall Study|Terminated by Sponsor|43|||
128974292|NCT02192190|464189996|FG001|Overall Study|Terminated by Sponsor|23|||
128974293|NCT02192190|464189997|FG002|Overall Study|Terminated by Sponsor|20|||
128974294|NCT02192190|464189998|FG003|Overall Study|Terminated by Sponsor|23|||
129131578|NCT03158311|464772880|FG002|Overall Study|Pregnancy|0|||
128974295|NCT02192190|464189999|FG004|Overall Study|Terminated by Sponsor|21|||
128974296|NCT02192190|464190000|FG005|Overall Study|Terminated by Sponsor|23|||
128974297|NCT02192190|464189995|FG000|Overall Study|Withdrawal by Subject|4|||
128974298|NCT02192190|464189996|FG001|Overall Study|Withdrawal by Subject|1|||
128974299|NCT02192190|464189997|FG002|Overall Study|Withdrawal by Subject|2|||
128974300|NCT02192190|464189998|FG003|Overall Study|Withdrawal by Subject|1|||
128974301|NCT02192190|464189999|FG004|Overall Study|Withdrawal by Subject|5|||
128974302|NCT02192190|464190000|FG005|Overall Study|Withdrawal by Subject|3|||
128974303|NCT02192190|464189995|FG000|Overall Study|Could not Keep Visit Schedule|1|||
128974304|NCT02192190|464189996|FG001|Overall Study|Could not Keep Visit Schedule|0|||
128974305|NCT02192190|464189997|FG002|Overall Study|Could not Keep Visit Schedule|0|||
128974306|NCT02192190|464189998|FG003|Overall Study|Could not Keep Visit Schedule|0|||
128974307|NCT02192190|464189999|FG004|Overall Study|Could not Keep Visit Schedule|0|||
128974308|NCT02192190|464190000|FG005|Overall Study|Could not Keep Visit Schedule|0|||
128974309|NCT02192190|464189995|FG000|Overall Study|Positive Drug Screen|0|||
128974310|NCT02192190|464189996|FG001|Overall Study|Positive Drug Screen|0|||
128974311|NCT02192190|464189997|FG002|Overall Study|Positive Drug Screen|0|||
128974312|NCT02192190|464189998|FG003|Overall Study|Positive Drug Screen|1|||
128974313|NCT02192190|464189999|FG004|Overall Study|Positive Drug Screen|0|||
128974314|NCT02192190|464190000|FG005|Overall Study|Positive Drug Screen|0|||
128974315|NCT02192190|464189995|FG000|Overall Study|Inadequate Pain Relief|0|||
128974316|NCT02192190|464189996|FG001|Overall Study|Inadequate Pain Relief|1|||
128974317|NCT02192190|464189997|FG002|Overall Study|Inadequate Pain Relief|1|||
128974318|NCT02192190|464189998|FG003|Overall Study|Inadequate Pain Relief|0|||
128974319|NCT02192190|464189999|FG004|Overall Study|Inadequate Pain Relief|0|||
128974320|NCT02192190|464190000|FG005|Overall Study|Inadequate Pain Relief|0|||
128974321|NCT03227692|464190001|FG000|Overall Study|Protocol Violation|1|||
128974322|NCT03227692|464190002|FG001|Overall Study|Protocol Violation|1|||
128974323|NCT03227692|464190001|FG000|Overall Study|Lost to Follow-up|4|||
128974324|NCT03227692|464190002|FG001|Overall Study|Lost to Follow-up|2|||
128974325|NCT03227692|464190001|FG000|Overall Study|Adverse Event|0|||
128974326|NCT03227692|464190002|FG001|Overall Study|Adverse Event|2|||
128974327|NCT01657253|464190003|FG000|Overall Study|Lost to Follow-up|6|||
128974328|NCT01657253|464190004|FG001|Overall Study|Lost to Follow-up|5|||
128974329|NCT01657253|464190003|FG000|Overall Study|Withdrawal by Subject|11|||
128974330|NCT01657253|464190004|FG001|Overall Study|Withdrawal by Subject|12|||
128974331|NCT01657253|464190003|FG000|Overall Study|Adverse Event|0|||
128974332|NCT01657253|464190004|FG001|Overall Study|Adverse Event|1|||
128974333|NCT01603628|464190007|FG000|Overall Study|Personal Reasons|1|||
128974334|NCT01603628|464190008|FG001|Overall Study|Personal Reasons|1|||
128974335|NCT01603628|464190009|FG002|Overall Study|Personal Reasons|2|||
128974336|NCT01603628|464190007|FG000|Overall Study|Protocol Violation|1|||
128974337|NCT01603628|464190008|FG001|Overall Study|Protocol Violation|1|||
128974338|NCT01603628|464190009|FG002|Overall Study|Protocol Violation|0|||
128974339|NCT01603628|464190007|FG000|Overall Study|Lost to Follow-up|0|||
128974340|NCT01603628|464190008|FG001|Overall Study|Lost to Follow-up|1|||
128974341|NCT01603628|464190009|FG002|Overall Study|Lost to Follow-up|0|||
128974342|NCT01603628|464190007|FG000|Overall Study|Other Miscellaneous Reason|1|||
128974343|NCT01603628|464190008|FG001|Overall Study|Other Miscellaneous Reason|0|||
128974344|NCT01603628|464190009|FG002|Overall Study|Other Miscellaneous Reason|0|||
128974345|NCT00890201|464190011|FG000|Overall Study|Protocol Violation|5|||
128974346|NCT00890201|464190012|FG001|Overall Study|Protocol Violation|56|||
128974347|NCT02087241|464190013|FG000|Overall Study|Death|2|||
128974348|NCT02087241|464190014|FG001|Overall Study|Death|1|||
128974349|NCT02087241|464190015|FG002|Overall Study|Death|1|||
128974350|NCT02087241|464190016|FG003|Overall Study|Death|1|||
128974351|NCT02087241|464190013|FG000|Overall Study|Withdrawal by Subject|1|||
128974352|NCT02087241|464190014|FG001|Overall Study|Withdrawal by Subject|0|||
128974353|NCT02087241|464190015|FG002|Overall Study|Withdrawal by Subject|0|||
128974354|NCT02087241|464190016|FG003|Overall Study|Withdrawal by Subject|1|||
128974355|NCT02087241|464190013|FG000|Overall Study|Progressive Disease|0|||
128974356|NCT02087241|464190014|FG001|Overall Study|Progressive Disease|0|||
128974357|NCT02087241|464190015|FG002|Overall Study|Progressive Disease|0|||
128974358|NCT02087241|464190016|FG003|Overall Study|Progressive Disease|1|||
128974359|NCT02087241|464190013|FG000|Overall Study|Study Terminated by Sponsor|0|||
128974360|NCT02087241|464190014|FG001|Overall Study|Study Terminated by Sponsor|2|||
128974361|NCT02087241|464190015|FG002|Overall Study|Study Terminated by Sponsor|0|||
128974362|NCT02087241|464190016|FG003|Overall Study|Study Terminated by Sponsor|4|||
128974363|NCT02181504|464190017|FG000|Overall Study|Adverse Event|1|||
128974364|NCT02181504|464190018|FG001|Overall Study|Adverse Event|1|||
128974365|NCT02181504|464190019|FG002|Overall Study|Adverse Event|1|||
128974366|NCT01289028|464190024|FG000|Overall Study|Progressive Disease|49|||
128974367|NCT01289028|464190024|FG000|Overall Study|Adverse Event|14|||
128974368|NCT01289028|464190024|FG000|Overall Study|Withdrawal by Subject|6|||
128974369|NCT01289028|464190024|FG000|Overall Study|Death|4|||
128974370|NCT01289028|464190024|FG000|Overall Study|Lack of Efficacy|2|||
128974371|NCT01289028|464190024|FG000|Overall Study|No longer required|2|||
128974372|NCT01289028|464190024|FG000|Overall Study|Lost to Follow-up|2|||
129221154|NCT04292899|465110165|FG003|Overall Study|Protocol Violation|1|||
129221155|NCT01209325|465110169|FG000|Overall Study|Lost to Follow-up|24|||
129221156|NCT01209325|465110169|FG000|Overall Study|Adverse Event|1|||
129221157|NCT01209325|465110169|FG000|Overall Study|Relocated|3|||
129221158|NCT01209325|465110169|FG000|Overall Study|Refusal after starting therapy|8|||
129221159|NCT01209325|465110169|FG000|Overall Study|Protocol Violation|4|||
129221160|NCT01209325|465110169|FG000|Overall Study|Refusal prior to therapy|1|||
129221161|NCT01209325|465110169|FG000|Overall Study|Incarceration|2|||
129221162|NCT00396253|465110170|FG000|Overall Study|Protocol Violation|1|||
129221163|NCT00396253|465110170|FG000|Overall Study|Withdrawal by Subject|7|||
129221164|NCT00396253|465110170|FG000|Overall Study|Death|3|||
129221165|NCT00396253|465110170|FG000|Overall Study|Physician Decision|1|||
129038736|NCT04405739|464433257|FG001|Overall Study|Transferred to rehab|0|||
129038737|NCT04405739|464433258|FG002|Overall Study|Transferred to rehab|0|||
129038738|NCT04405739|464433259|FG003|Overall Study|Transferred to rehab|1|||
129038739|NCT04405739|464433256|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
129038740|NCT04405739|464433257|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
129038741|NCT04405739|464433258|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
129038742|NCT04405739|464433259|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
129038743|NCT01436643|464433260|FG000|2-week Pre-treatment|Abnormal test result|0|||
129038744|NCT01436643|464433261|FG001|2-week Pre-treatment|Abnormal test result|0|||
129038745|NCT01436643|464433262|FG002|2-week Pre-treatment|Abnormal test result|0|||
129038746|NCT01436643|464433263|FG003|2-week Pre-treatment|Abnormal test result|1|||
129038747|NCT01436643|464433260|FG000|2-week Pre-treatment|Adverse Event|0|||
129038748|NCT01436643|464433261|FG001|2-week Pre-treatment|Adverse Event|0|||
129038749|NCT01436643|464433262|FG002|2-week Pre-treatment|Adverse Event|0|||
129038750|NCT01436643|464433263|FG003|2-week Pre-treatment|Adverse Event|5|||
129038751|NCT01436643|464433260|FG000|2-week Pre-treatment|Protocol Violation|0|||
129221166|NCT00396253|465110170|FG000|Overall Study|Change in eligibility status|1|||
129221167|NCT05340478|465110174|FG000|Overall Study|Scheduling Issues|10|||
129221168|NCT05340478|465110175|FG001|Overall Study|Scheduling Issues|4|||
129221169|NCT05340478|465110174|FG000|Overall Study|Neither member of dyad started treatment|2|||
129221170|NCT05340478|465110175|FG001|Overall Study|Neither member of dyad started treatment|2|||
129038752|NCT01436643|464433261|FG001|2-week Pre-treatment|Protocol Violation|0|||
129038753|NCT01436643|464433262|FG002|2-week Pre-treatment|Protocol Violation|0|||
129221171|NCT05340478|465110174|FG000|Overall Study|Withdrawn from study|2|||
129221172|NCT05340478|465110175|FG001|Overall Study|Withdrawn from study|2|||
129221173|NCT05340478|465110174|FG000|Overall Study|Lost to Follow-up|1|||
129221174|NCT05340478|465110175|FG001|Overall Study|Lost to Follow-up|4|||
129038754|NCT01436643|464433263|FG003|2-week Pre-treatment|Protocol Violation|4|||
129038755|NCT01436643|464433260|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
129038756|NCT01436643|464433261|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
129038757|NCT01436643|464433262|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
129221175|NCT02116205|465110179|FG000|Overall Study|Withdrawal by Subject|2|||
129221176|NCT02116205|465110180|FG001|Overall Study|Withdrawal by Subject|4|||
129221177|NCT02116205|465110181|FG002|Overall Study|Withdrawal by Subject|1|||
129221178|NCT02116205|465110182|FG003|Overall Study|Withdrawal by Subject|3|||
129221179|NCT02116205|465110179|FG000|Overall Study|Lost to Follow-up|0|||
129221180|NCT02116205|465110180|FG001|Overall Study|Lost to Follow-up|2|||
129221181|NCT02116205|465110181|FG002|Overall Study|Lost to Follow-up|1|||
129221182|NCT02116205|465110182|FG003|Overall Study|Lost to Follow-up|2|||
129221183|NCT02116205|465110179|FG000|Overall Study|Physician Decision|0|||
129221184|NCT02116205|465110180|FG001|Overall Study|Physician Decision|1|||
129221185|NCT02116205|465110181|FG002|Overall Study|Physician Decision|1|||
129221186|NCT02116205|465110182|FG003|Overall Study|Physician Decision|1|||
129221187|NCT02116205|465110179|FG000|Overall Study|Exclusion criteria|0|||
129221188|NCT02116205|465110180|FG001|Overall Study|Exclusion criteria|0|||
129221189|NCT02116205|465110181|FG002|Overall Study|Exclusion criteria|1|||
129221190|NCT02116205|465110182|FG003|Overall Study|Exclusion criteria|0|||
129221191|NCT02541604|465110183|FG000|Overall Study|Death|6|||
129221192|NCT02541604|465110184|FG001|Overall Study|Death|5|||
129221193|NCT02541604|465110185|FG002|Overall Study|Death|7|||
129221194|NCT02541604|465110186|FG003|Overall Study|Death|2|||
129038758|NCT01436643|464433263|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
129038759|NCT01436643|464433260|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
129221195|NCT02541604|465110187|FG004|Overall Study|Death|9|||
129221196|NCT02541604|465110188|FG005|Overall Study|Death|8|||
129221197|NCT02541604|465110189|FG006|Overall Study|Death|9|||
129221198|NCT02541604|465110190|FG007|Overall Study|Death|9|||
129221199|NCT02541604|465110191|FG008|Overall Study|Death|3|||
129221200|NCT02541604|465110192|FG009|Overall Study|Death|4|||
129221201|NCT02541604|465110193|FG010|Overall Study|Death|2|||
129221202|NCT02541604|465110194|FG011|Overall Study|Death|3|||
129221203|NCT02541604|465110183|FG000|Overall Study|Lost to Follow-up|2|||
129038760|NCT01436643|464433261|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
129221204|NCT02541604|465110184|FG001|Overall Study|Lost to Follow-up|0|||
129221205|NCT02541604|465110185|FG002|Overall Study|Lost to Follow-up|1|||
129221206|NCT02541604|465110186|FG003|Overall Study|Lost to Follow-up|0|||
129221207|NCT02541604|465110187|FG004|Overall Study|Lost to Follow-up|0|||
129221208|NCT02541604|465110188|FG005|Overall Study|Lost to Follow-up|1|||
129221209|NCT02541604|465110189|FG006|Overall Study|Lost to Follow-up|1|||
129221210|NCT02541604|465110190|FG007|Overall Study|Lost to Follow-up|0|||
129221211|NCT02541604|465110191|FG008|Overall Study|Lost to Follow-up|0|||
129221212|NCT02541604|465110192|FG009|Overall Study|Lost to Follow-up|0|||
129221213|NCT02541604|465110193|FG010|Overall Study|Lost to Follow-up|0|||
129221214|NCT02541604|465110194|FG011|Overall Study|Lost to Follow-up|0|||
129221215|NCT02541604|465110183|FG000|Overall Study|Withdrawal by Subject|2|||
129221216|NCT02541604|465110184|FG001|Overall Study|Withdrawal by Subject|0|||
129221217|NCT02541604|465110185|FG002|Overall Study|Withdrawal by Subject|1|||
129221218|NCT02541604|465110186|FG003|Overall Study|Withdrawal by Subject|0|||
129221219|NCT02541604|465110187|FG004|Overall Study|Withdrawal by Subject|1|||
129221220|NCT02541604|465110188|FG005|Overall Study|Withdrawal by Subject|1|||
129221221|NCT02541604|465110189|FG006|Overall Study|Withdrawal by Subject|0|||
129221222|NCT02541604|465110190|FG007|Overall Study|Withdrawal by Subject|0|||
129221223|NCT02541604|465110191|FG008|Overall Study|Withdrawal by Subject|1|||
129221224|NCT02541604|465110192|FG009|Overall Study|Withdrawal by Subject|0|||
129221225|NCT02541604|465110193|FG010|Overall Study|Withdrawal by Subject|0|||
129221226|NCT02541604|465110194|FG011|Overall Study|Withdrawal by Subject|0|||
129221227|NCT02541604|465110183|FG000|Overall Study|Study Terminated by Sponsor|1|||
129221228|NCT02541604|465110184|FG001|Overall Study|Study Terminated by Sponsor|4|||
129221229|NCT02541604|465110185|FG002|Overall Study|Study Terminated by Sponsor|2|||
129221230|NCT02541604|465110186|FG003|Overall Study|Study Terminated by Sponsor|1|||
129221231|NCT02541604|465110187|FG004|Overall Study|Study Terminated by Sponsor|0|||
129221232|NCT02541604|465110188|FG005|Overall Study|Study Terminated by Sponsor|0|||
129221233|NCT02541604|465110189|FG006|Overall Study|Study Terminated by Sponsor|0|||
129221234|NCT02541604|465110190|FG007|Overall Study|Study Terminated by Sponsor|0|||
129131579|NCT03158311|464772878|FG000|Overall Study|Randomized in error|0|||
129131580|NCT03158311|464772879|FG001|Overall Study|Randomized in error|0|||
129131581|NCT03158311|464772880|FG002|Overall Study|Randomized in error|1|||
129131582|NCT01018953|464772881|FG000|Overall Study|Adverse Event|2|||
129131583|NCT01018953|464772881|FG000|Overall Study|Withdrawal by Subject|1|||
128974373|NCT01289028|464190024|FG000|Overall Study|New Cancer Therapy|2|||
128974374|NCT01289028|464190024|FG000|Overall Study|Abnormal Lab Value|1|||
128974375|NCT01289028|464190024|FG000|Overall Study|Missing reason for discon|1|||
128974376|NCT02120469|464190025|FG000|Overall Study|HER-2/neu-amplified|1|||
128974377|NCT02120469|464190026|FG001|Overall Study|HER-2/neu-amplified|0|||
128974378|NCT02120469|464190027|FG002|Overall Study|HER-2/neu-amplified|1|||
129131584|NCT01018953|464772881|FG000|Overall Study|Study termination by sponsor|5|||
129131585|NCT02665455|464772882|FG000|Overall Study|Withdrawal by Subject|6|||
129131586|NCT02665455|464772882|FG000|Overall Study|Lost to Follow-up|1|||
129131587|NCT02665455|464772882|FG000|Overall Study|Adverse Event|1|||
129131588|NCT02665455|464772882|FG000|Overall Study|Protocol Violation|1|||
129131589|NCT02642679|464774880|FG000|Overall Study|Withdrawal by Subject|1|||
129131590|NCT02642679|464774880|FG000|Overall Study|Physician Decision|1|||
129131591|NCT02642679|464774880|FG000|Overall Study|Physician Decision|1|||
129131592|NCT01112267|464774882|FG000|Overall Study|Adverse Event|24|||
129131593|NCT01112267|464774883|FG001|Overall Study|Adverse Event|6|||
129131594|NCT01112267|464774882|FG000|Overall Study|Withdrawal by Subject|3|||
129131595|NCT01112267|464774883|FG001|Overall Study|Withdrawal by Subject|5|||
129131596|NCT01112267|464774882|FG000|Overall Study|Protocol Violation|5|||
129131597|NCT01112267|464774883|FG001|Overall Study|Protocol Violation|3|||
129131598|NCT01112267|464774882|FG000|Overall Study|Participants not compliant|1|||
129131599|NCT01112267|464774883|FG001|Overall Study|Participants not compliant|2|||
129131600|NCT01112267|464774882|FG000|Overall Study|Participants not receive any study drug|1|||
129131601|NCT01112267|464774883|FG001|Overall Study|Participants not receive any study drug|2|||
129131602|NCT05638737|464774886|FG000|Overall Study|Withdrawal by Subject|4|||
129131603|NCT05638737|464774887|FG001|Overall Study|Withdrawal by Subject|7|||
129131604|NCT03641924|464774890|FG000|Overall Study|Withdrawal by Subject|26|||
129131605|NCT03641924|464774890|FG000|Overall Study|Lost to Follow-up|16|||
129131606|NCT03641924|464774890|FG000|Overall Study|Protocol Violation|10|||
129131607|NCT04333498|464774891|FG000|Overall Study|Lost to Follow-up|1|||
129131608|NCT04333498|464774892|FG001|Overall Study|Lost to Follow-up|0|||
129131609|NCT04333498|464774891|FG000|Overall Study|Lost to Follow-up|0|||
129131610|NCT04333498|464774892|FG001|Overall Study|Lost to Follow-up|1|||
129131611|NCT01565694|464774893|FG000|Dose-Titration Period|Adverse Event|4|||
129131612|NCT01565694|464774893|FG000|Dose-Titration Period|Protocol Violation|10|||
129131613|NCT01565694|464774893|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
129131614|NCT00134719|464774899|FG000|Primary Vaccination Phase|Adverse Event|4|||
129221235|NCT02541604|465110191|FG008|Overall Study|Study Terminated by Sponsor|0|||
129221236|NCT02541604|465110192|FG009|Overall Study|Study Terminated by Sponsor|0|||
129221237|NCT02541604|465110193|FG010|Overall Study|Study Terminated by Sponsor|0|||
129221238|NCT02541604|465110194|FG011|Overall Study|Study Terminated by Sponsor|0|||
129221239|NCT02541604|465110183|FG000|Overall Study|Medical condition may jeopardize safety|0|||
129131615|NCT00134719|464774900|FG001|Primary Vaccination Phase|Adverse Event|0|||
129221240|NCT02541604|465110184|FG001|Overall Study|Medical condition may jeopardize safety|0|||
129221241|NCT02541604|465110185|FG002|Overall Study|Medical condition may jeopardize safety|0|||
129221242|NCT02541604|465110186|FG003|Overall Study|Medical condition may jeopardize safety|0|||
129221243|NCT02541604|465110187|FG004|Overall Study|Medical condition may jeopardize safety|0|||
129221244|NCT02541604|465110188|FG005|Overall Study|Medical condition may jeopardize safety|0|||
129221245|NCT02541604|465110189|FG006|Overall Study|Medical condition may jeopardize safety|0|||
129221246|NCT02541604|465110190|FG007|Overall Study|Medical condition may jeopardize safety|1|||
129221247|NCT02541604|465110191|FG008|Overall Study|Medical condition may jeopardize safety|0|||
129221248|NCT02541604|465110192|FG009|Overall Study|Medical condition may jeopardize safety|0|||
129221249|NCT02541604|465110193|FG010|Overall Study|Medical condition may jeopardize safety|0|||
129221250|NCT02541604|465110194|FG011|Overall Study|Medical condition may jeopardize safety|0|||
129221251|NCT02752165|465110201|FG000|Overall Study|Withdrawal by Subject|6|||
129221252|NCT02752165|465110202|FG001|Overall Study|Withdrawal by Subject|6|||
129221253|NCT02752165|465110201|FG000|Overall Study|Protocol Violation|6|||
129221254|NCT02752165|465110202|FG001|Overall Study|Protocol Violation|5|||
129221255|NCT02752165|465110201|FG000|Overall Study|Lost to Follow-up|33|||
129221256|NCT02752165|465110202|FG001|Overall Study|Lost to Follow-up|38|||
129221257|NCT01704599|465110204|FG000|Overall Study|Adverse Event|1|||
129221258|NCT02840461|465110205|FG000|Overall Study|Adverse Event|1|||
129221259|NCT02840461|465110206|FG001|Overall Study|Adverse Event|5|||
129221260|NCT02840461|465110207|FG002|Overall Study|Adverse Event|3|||
129221261|NCT02840461|465110205|FG000|Overall Study|Lost to Follow-up|10|||
129221262|NCT02840461|465110206|FG001|Overall Study|Lost to Follow-up|7|||
129221263|NCT02840461|465110207|FG002|Overall Study|Lost to Follow-up|6|||
129221264|NCT02840461|465110205|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
129221265|NCT02840461|465110206|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
129221266|NCT02840461|465110207|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
129221267|NCT02840461|465110205|FG000|Overall Study|Protocol Violation|2|||
129221268|NCT02840461|465110206|FG001|Overall Study|Protocol Violation|3|||
129221269|NCT02840461|465110207|FG002|Overall Study|Protocol Violation|1|||
129221270|NCT02840461|465110205|FG000|Overall Study|Withdrawal by Subject|10|||
129221271|NCT02840461|465110206|FG001|Overall Study|Withdrawal by Subject|6|||
129221272|NCT02840461|465110207|FG002|Overall Study|Withdrawal by Subject|2|||
129221273|NCT02840461|465110205|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
129221274|NCT02840461|465110206|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
129221275|NCT02840461|465110207|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
129221276|NCT01737502|465110210|FG000|Phase I|Disease progression|2|||
129221277|NCT01737502|465110211|FG001|Phase I|Disease progression|3|||
129221278|NCT01737502|465110210|FG000|Phase I|Complicating disease|1|||
129221279|NCT01737502|465110211|FG001|Phase I|Complicating disease|0|||
129221280|NCT01737502|465110210|FG000|Phase II|Adverse Event|0|||
129221281|NCT01737502|465110211|FG001|Phase II|Adverse Event|3|||
129038761|NCT01436643|464433262|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
129038762|NCT01436643|464433263|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
129038763|NCT01436643|464433260|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
129038764|NCT01436643|464433261|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
129038765|NCT01436643|464433262|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
129038766|NCT01436643|464433263|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
129038767|NCT03718117|464433264|FG000|Overall Study|Death|12|||
129038768|NCT03718117|464433265|FG001|Overall Study|Death|11|||
129038769|NCT03718117|464433266|FG002|Overall Study|Death|0|||
129038770|NCT03718117|464433264|FG000|Overall Study|Other|0|||
129221282|NCT01737502|465110210|FG000|Phase II|Disease progression|0|||
129221283|NCT01737502|465110211|FG001|Phase II|Disease progression|18|||
129221284|NCT01737502|465110210|FG000|Phase II|Death|0|||
129221285|NCT01737502|465110211|FG001|Phase II|Death|1|||
129221286|NCT01737502|465110210|FG000|Phase II|Transition to hospice care|0|||
129038771|NCT03718117|464433265|FG001|Overall Study|Other|1|||
129038772|NCT03718117|464433266|FG002|Overall Study|Other|0|||
129038773|NCT03718117|464433264|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
129038774|NCT03718117|464433265|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
129038775|NCT03718117|464433266|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
129038776|NCT03718117|464433264|FG000|Overall Study|Participant not met eligibility criteria|0|||
129038777|NCT03718117|464433265|FG001|Overall Study|Participant not met eligibility criteria|0|||
129038778|NCT03718117|464433266|FG002|Overall Study|Participant not met eligibility criteria|2|||
129038779|NCT02056652|464433272|FG000|Overall Study|Withdrawal by Subject|1|||
129038780|NCT02056652|464433273|FG001|Overall Study|Withdrawal by Subject|0|||
129038781|NCT02056652|464433272|FG000|Overall Study|Lost to Follow-up|0|||
129038782|NCT02056652|464433273|FG001|Overall Study|Lost to Follow-up|3|||
129038783|NCT04232540|464433276|FG000|Overall Study|Lost to Follow-up|1|||
129038784|NCT04232540|464433277|FG001|Overall Study|Lost to Follow-up|0|||
129038785|NCT03234608|464433278|FG000|Overall Study|Lost to Follow-up|23|||
129038786|NCT03234608|464433279|FG001|Overall Study|Lost to Follow-up|21|||
129038787|NCT02105701|464433280|FG000|Overall Study|Lost to Follow-up|1|||
129038788|NCT02105701|464433281|FG001|Overall Study|Lost to Follow-up|0|||
129038789|NCT02105701|464433282|FG002|Overall Study|Lost to Follow-up|2|||
129038790|NCT02105701|464433283|FG003|Overall Study|Lost to Follow-up|1|||
129131616|NCT00134719|464774901|FG002|Primary Vaccination Phase|Adverse Event|0|||
129131617|NCT00134719|464774899|FG000|Primary Vaccination Phase|Protocol Violation|1|||
129131618|NCT00134719|464774900|FG001|Primary Vaccination Phase|Protocol Violation|0|||
129131619|NCT00134719|464774901|FG002|Primary Vaccination Phase|Protocol Violation|0|||
129131620|NCT00134719|464774899|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
129131621|NCT00134719|464774900|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
129131622|NCT00134719|464774901|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
129131623|NCT00134719|464774899|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
129131624|NCT00134719|464774900|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
129131625|NCT00134719|464774901|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
129131626|NCT00134719|464774899|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
129131627|NCT00134719|464774900|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
129131628|NCT00134719|464774901|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
128715919|NCT01641692|463256672|FG007|Treatment Period 1|Protocol Violation|0|||
128715920|NCT01641692|463256665|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
128715921|NCT01641692|463256666|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
128974379|NCT03267576|464190029|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
128974380|NCT03267576|464190030|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
128974381|NCT03267576|464190029|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
128974382|NCT03267576|464190030|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
128974383|NCT01369069|464190031|FG000|Overall Study|Lost to Follow-up|8|||
128974384|NCT01369069|464190032|FG001|Overall Study|Lost to Follow-up|9|||
128974385|NCT01369069|464190031|FG000|Overall Study|Withdrawal by Subject|9|||
128974386|NCT01369069|464190032|FG001|Overall Study|Withdrawal by Subject|7|||
128974387|NCT00882362|464190033|FG000|Overall Study|Adverse Event|13|||
128974388|NCT00882362|464190034|FG001|Overall Study|Adverse Event|10|||
128974389|NCT00882362|464190033|FG000|Overall Study|Withdrawal by Subject|13|||
128974390|NCT00882362|464190034|FG001|Overall Study|Withdrawal by Subject|10|||
128974391|NCT00882362|464190033|FG000|Overall Study|Lack of Efficacy|3|||
128974392|NCT00882362|464190034|FG001|Overall Study|Lack of Efficacy|0|||
128974393|NCT00882362|464190033|FG000|Overall Study|Protocol Violation|7|||
128974394|NCT00882362|464190034|FG001|Overall Study|Protocol Violation|2|||
128974395|NCT00882362|464190033|FG000|Overall Study|Pregnancy|1|||
128974396|NCT00882362|464190034|FG001|Overall Study|Pregnancy|0|||
128974397|NCT00882362|464190033|FG000|Overall Study|Physician Decision|5|||
128974398|NCT00882362|464190034|FG001|Overall Study|Physician Decision|1|||
128974399|NCT00882362|464190033|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
128974400|NCT00882362|464190034|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
128974401|NCT00882362|464190033|FG000|Overall Study|change of residence or other commitments|5|||
128974402|NCT00882362|464190034|FG001|Overall Study|change of residence or other commitments|0|||
128974403|NCT01846208|464190035|FG000|Overall Study|Withdrew prior to treatment|1|||
128974404|NCT01846208|464190036|FG001|Overall Study|Withdrew prior to treatment|1|||
128974405|NCT01846208|464190037|FG002|Overall Study|Withdrew prior to treatment|1|||
128974406|NCT01846208|464190035|FG000|Overall Study|Dosing Symptoms|1|||
128974407|NCT01846208|464190036|FG001|Overall Study|Dosing Symptoms|2|||
128974408|NCT01846208|464190037|FG002|Overall Study|Dosing Symptoms|6|||
128974409|NCT01846208|464190035|FG000|Overall Study|Withdrawal by Subject|5|||
128974410|NCT01846208|464190036|FG001|Overall Study|Withdrawal by Subject|0|||
128974411|NCT01846208|464190037|FG002|Overall Study|Withdrawal by Subject|0|||
128974412|NCT01846208|464190035|FG000|Overall Study|Non-compliance|1|||
128974413|NCT01846208|464190036|FG001|Overall Study|Non-compliance|1|||
128974414|NCT01846208|464190037|FG002|Overall Study|Non-compliance|0|||
129131629|NCT00134719|464774899|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
129131630|NCT00134719|464774900|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
129131631|NCT00134719|464774901|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
129131632|NCT00541229|464774902|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
128974415|NCT01846208|464190035|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
128974416|NCT01846208|464190036|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
128974417|NCT01846208|464190037|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
128974418|NCT01846208|464190035|FG000|Overall Study|Refused SU OFC|0|||
128974419|NCT01846208|464190036|FG001|Overall Study|Refused SU OFC|0|||
128974420|NCT01846208|464190037|FG002|Overall Study|Refused SU OFC|1|||
128974421|NCT01268514|464190038|FG000|Overall Study|Adverse Event|20|||
128974422|NCT01268514|464190038|FG000|Overall Study|Death|8|||
128974423|NCT01268514|464190038|FG000|Overall Study|Lost to Follow-up|5|||
128974424|NCT01268514|464190038|FG000|Overall Study|Withdrawal by Subject|3|||
128974425|NCT01268514|464190038|FG000|Overall Study|Withdrawal by Surgeon|5|||
128974426|NCT01424306|464190039|FG000|Overall Study|Protocol Violation|0|||
128974427|NCT01424306|464190040|FG001|Overall Study|Protocol Violation|0|||
128974428|NCT01424306|464190041|FG002|Overall Study|Protocol Violation|0|||
128974429|NCT01424306|464190042|FG003|Overall Study|Protocol Violation|0|||
128974430|NCT01424306|464190043|FG004|Overall Study|Protocol Violation|1|||
128974431|NCT01424306|464190044|FG005|Overall Study|Protocol Violation|0|||
128974432|NCT01809327|464190050|FG000|Overall Study|Lost to Follow-up|5|||
129038791|NCT02105701|464433280|FG000|Overall Study|Protocol Violation|0|||
129038792|NCT02105701|464433281|FG001|Overall Study|Protocol Violation|0|||
129038793|NCT02105701|464433282|FG002|Overall Study|Protocol Violation|1|||
129038794|NCT02105701|464433283|FG003|Overall Study|Protocol Violation|0|||
129038795|NCT02105701|464433280|FG000|Overall Study|Withdrawal by Subject|2|||
129038796|NCT02105701|464433281|FG001|Overall Study|Withdrawal by Subject|1|||
129038797|NCT02105701|464433282|FG002|Overall Study|Withdrawal by Subject|0|||
129038798|NCT02105701|464433283|FG003|Overall Study|Withdrawal by Subject|1|||
129038799|NCT02105701|464433280|FG000|Overall Study|Death|1|||
129038800|NCT02105701|464433281|FG001|Overall Study|Death|0|||
129038801|NCT02105701|464433282|FG002|Overall Study|Death|0|||
129038802|NCT02105701|464433283|FG003|Overall Study|Death|0|||
129038803|NCT02148445|464433284|FG000|Overall Study|Death|1|||
129038804|NCT02148445|464433285|FG001|Overall Study|Death|3|||
129038805|NCT03450629|464433286|FG000|Overall Study|Adverse Event|15|||
129038806|NCT03450629|464433287|FG001|Overall Study|Adverse Event|14|||
129038807|NCT03450629|464433286|FG000|Overall Study|Physician Decision|2|||
129038808|NCT03450629|464433287|FG001|Overall Study|Physician Decision|2|||
129038809|NCT03450629|464433286|FG000|Overall Study|Lack of Efficacy|2|||
129038810|NCT03450629|464433287|FG001|Overall Study|Lack of Efficacy|0|||
129038811|NCT03450629|464433286|FG000|Overall Study|Lost to Follow-up|4|||
129038812|NCT03450629|464433287|FG001|Overall Study|Lost to Follow-up|2|||
129038813|NCT03450629|464433286|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129038814|NCT03450629|464433287|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
129038815|NCT03450629|464433286|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129038816|NCT03450629|464433287|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129038817|NCT03450629|464433286|FG000|Overall Study|Protocol Violation|11|||
129038818|NCT03450629|464433287|FG001|Overall Study|Protocol Violation|8|||
129038819|NCT03450629|464433286|FG000|Overall Study|Withdrawal by Subject|12|||
129038820|NCT03450629|464433287|FG001|Overall Study|Withdrawal by Subject|6|||
129038821|NCT04230876|464433288|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
129221287|NCT01737502|465110211|FG001|Phase II|Transition to hospice care|1|||
129221288|NCT04672655|465110215|FG000|Overall Study|Lost to Follow-up|12|||
129221289|NCT04672655|465110216|FG001|Overall Study|Lost to Follow-up|17|||
129038822|NCT04230876|464433289|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
129038823|NCT03438006|464433293|FG000|Overall Study|Adverse Event|1|||
129038824|NCT03438006|464433293|FG000|Overall Study|Lost to Follow-up|67|||
129038825|NCT03438006|464433293|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
129038826|NCT03438006|464433293|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
129038827|NCT00739973|464433304|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
129038828|NCT00739973|464433305|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038829|NCT00739973|464433306|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038830|NCT00739973|464433307|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038831|NCT00739973|464433308|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038832|NCT00739973|464433309|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038833|NCT00739973|464433310|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038834|NCT00739973|464433311|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038835|NCT00739973|464433312|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129038836|NCT00739973|464433304|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
129038837|NCT00739973|464433305|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038838|NCT00739973|464433306|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038839|NCT00739973|464433307|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038840|NCT00739973|464433308|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038841|NCT00739973|464433309|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038842|NCT00739973|464433310|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038843|NCT00739973|464433311|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038844|NCT00739973|464433312|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129038845|NCT00739973|464433304|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
129038846|NCT00739973|464433305|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038847|NCT00739973|464433306|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038848|NCT00739973|464433307|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038849|NCT00739973|464433308|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038850|NCT00739973|464433309|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038851|NCT00739973|464433310|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038852|NCT00739973|464433311|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038853|NCT00739973|464433312|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129038854|NCT00739973|464433304|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
129038855|NCT00739973|464433305|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129221290|NCT04672655|465110215|FG000|Overall Study|Withdrawal by Subject|1|||
129221291|NCT04672655|465110216|FG001|Overall Study|Withdrawal by Subject|0|||
128974433|NCT01809327|464190051|FG001|Overall Study|Lost to Follow-up|2|||
128974434|NCT01809327|464190052|FG002|Overall Study|Lost to Follow-up|4|||
128974435|NCT01809327|464190053|FG003|Overall Study|Lost to Follow-up|2|||
128974436|NCT01809327|464190054|FG004|Overall Study|Lost to Follow-up|3|||
128974437|NCT01809327|464190050|FG000|Overall Study|Withdrawal by Subject|6|||
128974438|NCT01809327|464190051|FG001|Overall Study|Withdrawal by Subject|4|||
128974439|NCT01809327|464190052|FG002|Overall Study|Withdrawal by Subject|4|||
128974440|NCT01809327|464190053|FG003|Overall Study|Withdrawal by Subject|2|||
128974441|NCT01809327|464190054|FG004|Overall Study|Withdrawal by Subject|5|||
128974442|NCT01809327|464190050|FG000|Overall Study|Adverse Event|4|||
128974443|NCT01809327|464190051|FG001|Overall Study|Adverse Event|3|||
128974444|NCT01809327|464190052|FG002|Overall Study|Adverse Event|7|||
128974445|NCT01809327|464190053|FG003|Overall Study|Adverse Event|4|||
128974446|NCT01809327|464190054|FG004|Overall Study|Adverse Event|8|||
128974447|NCT01809327|464190050|FG000|Overall Study|Death|1|||
128974448|NCT01809327|464190051|FG001|Overall Study|Death|0|||
128974449|NCT01809327|464190052|FG002|Overall Study|Death|0|||
128974450|NCT01809327|464190053|FG003|Overall Study|Death|0|||
128974451|NCT01809327|464190054|FG004|Overall Study|Death|0|||
128974452|NCT01809327|464190050|FG000|Overall Study|Protocol Violation|0|||
128974453|NCT01809327|464190051|FG001|Overall Study|Protocol Violation|1|||
128974454|NCT01809327|464190052|FG002|Overall Study|Protocol Violation|0|||
128974455|NCT01809327|464190053|FG003|Overall Study|Protocol Violation|0|||
128974456|NCT01809327|464190054|FG004|Overall Study|Protocol Violation|0|||
128974457|NCT01809327|464190050|FG000|Overall Study|Physician Decision|1|||
128974458|NCT01809327|464190051|FG001|Overall Study|Physician Decision|1|||
128974459|NCT01809327|464190052|FG002|Overall Study|Physician Decision|0|||
128974460|NCT01809327|464190053|FG003|Overall Study|Physician Decision|0|||
128974461|NCT01809327|464190054|FG004|Overall Study|Physician Decision|0|||
128974462|NCT01809327|464190050|FG000|Overall Study|Pregnancy|1|||
128974463|NCT01809327|464190051|FG001|Overall Study|Pregnancy|0|||
128974464|NCT01809327|464190052|FG002|Overall Study|Pregnancy|0|||
128974465|NCT01809327|464190053|FG003|Overall Study|Pregnancy|0|||
129131633|NCT00541229|464774903|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
129131634|NCT00541229|464774904|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
129131635|NCT00541229|464774905|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
129131636|NCT00541229|464774906|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
129131637|NCT00541229|464774907|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
129131638|NCT00541229|464774902|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129131639|NCT00541229|464774903|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129131640|NCT00541229|464774904|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129131641|NCT00541229|464774905|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129131642|NCT00541229|464774906|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129131643|NCT00541229|464774907|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
129131644|NCT00541229|464774902|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129131645|NCT00541229|464774903|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129131646|NCT00541229|464774904|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129131647|NCT00541229|464774905|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129131648|NCT00541229|464774906|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129131649|NCT00541229|464774907|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
129131650|NCT00541229|464774902|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
129131651|NCT00541229|464774903|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
129131652|NCT00541229|464774904|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
129131653|NCT00541229|464774905|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
129131654|NCT00541229|464774906|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
129131655|NCT00541229|464774907|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
129131656|NCT00541229|464774902|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
129131657|NCT00541229|464774903|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
129131658|NCT00541229|464774904|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
129131659|NCT00541229|464774905|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
129131660|NCT00541229|464774906|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
128974466|NCT01809327|464190054|FG004|Overall Study|Pregnancy|0|||
129131661|NCT00541229|464774907|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
129131662|NCT00541229|464774902|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
129131663|NCT00541229|464774903|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
129131664|NCT00541229|464774904|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
129131665|NCT00541229|464774905|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
129131666|NCT00541229|464774906|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
129131667|NCT00541229|464774907|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
129131668|NCT00541229|464774902|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
128974467|NCT01809327|464190050|FG000|Overall Study|Other|14|||
129221292|NCT04672655|465110215|FG000|Overall Study|Withdrawal by Study|1|||
128974468|NCT01809327|464190051|FG001|Overall Study|Other|15|||
128974469|NCT01809327|464190052|FG002|Overall Study|Other|7|||
128974470|NCT01809327|464190053|FG003|Overall Study|Other|4|||
128974471|NCT01809327|464190054|FG004|Overall Study|Other|9|||
129131669|NCT00541229|464774903|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
129131670|NCT00541229|464774904|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
128974472|NCT03344562|464190055|FG000|Overall Study|Withdrawal by Subject|2|||
128974473|NCT03344562|464190056|FG001|Overall Study|Withdrawal by Subject|0|||
128974474|NCT02463331|464190068|FG000|Overall Study|Adverse Event|4|||
128715922|NCT01641692|463256667|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
128715923|NCT01641692|463256668|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
128715924|NCT01641692|463256669|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
128715925|NCT01641692|463256670|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
128715926|NCT01641692|463256671|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
128715927|NCT01641692|463256672|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
128715928|NCT01641692|463256665|FG000|Treatment Period 1|Lost to Follow-up|0|||
128715929|NCT01641692|463256666|FG001|Treatment Period 1|Lost to Follow-up|0|||
128715930|NCT01641692|463256667|FG002|Treatment Period 1|Lost to Follow-up|1|||
128715931|NCT01641692|463256668|FG003|Treatment Period 1|Lost to Follow-up|0|||
128715932|NCT01641692|463256669|FG004|Treatment Period 1|Lost to Follow-up|0|||
128715933|NCT01641692|463256670|FG005|Treatment Period 1|Lost to Follow-up|0|||
128715934|NCT01641692|463256671|FG006|Treatment Period 1|Lost to Follow-up|0|||
128715935|NCT01641692|463256672|FG007|Treatment Period 1|Lost to Follow-up|0|||
128715936|NCT01641692|463256665|FG000|Treatment Period 1|Physician Decision|0|||
128715937|NCT01641692|463256666|FG001|Treatment Period 1|Physician Decision|0|||
128715938|NCT01641692|463256667|FG002|Treatment Period 1|Physician Decision|0|||
128715939|NCT01641692|463256668|FG003|Treatment Period 1|Physician Decision|0|||
128715940|NCT01641692|463256669|FG004|Treatment Period 1|Physician Decision|1|||
128715941|NCT01641692|463256670|FG005|Treatment Period 1|Physician Decision|0|||
128715942|NCT01641692|463256671|FG006|Treatment Period 1|Physician Decision|0|||
128715943|NCT01641692|463256672|FG007|Treatment Period 1|Physician Decision|0|||
128715944|NCT01641692|463256665|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128715945|NCT01641692|463256666|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128715946|NCT01641692|463256667|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128715947|NCT01641692|463256668|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128715948|NCT01641692|463256669|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128974475|NCT02463331|464190069|FG001|Overall Study|Adverse Event|2|||
128974476|NCT02463331|464190068|FG000|Overall Study|Lost to Follow-up|1|||
128974477|NCT02463331|464190069|FG001|Overall Study|Lost to Follow-up|1|||
128974478|NCT02463331|464190068|FG000|Overall Study|Pregnancy|2|||
128974479|NCT02463331|464190069|FG001|Overall Study|Pregnancy|3|||
128974480|NCT02463331|464190068|FG000|Overall Study|Lack of Efficacy|6|||
128974481|NCT02463331|464190069|FG001|Overall Study|Lack of Efficacy|0|||
128974482|NCT02463331|464190068|FG000|Overall Study|Physician Decision|3|||
128974483|NCT02463331|464190069|FG001|Overall Study|Physician Decision|0|||
128974484|NCT02390362|464190072|FG000|Overall Study|Withdrawal by Subject|0|||
128974485|NCT02390362|464190073|FG001|Overall Study|Withdrawal by Subject|1|||
128974486|NCT04009824|464190074|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
128974487|NCT04009824|464190075|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
128974488|NCT04009824|464190076|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
128974489|NCT04009824|464190077|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
128974490|NCT04009824|464190078|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
128974491|NCT01024946|464190079|FG000|Overall Study|Screen Failure|3|||
128974492|NCT01024946|464190079|FG000|Overall Study|Withdrawal by Subject|1|||
128974493|NCT01024946|464190079|FG000|Overall Study|Adverse Event|1|||
128974494|NCT02274766|464190080|FG000|Overall Study|Withdrawal by Subject|3|||
128974495|NCT02274766|464190081|FG001|Overall Study|Withdrawal by Subject|6|||
128974496|NCT02274766|464190080|FG000|Overall Study|Did Not Receive Study Drug|1|||
128974497|NCT02274766|464190081|FG001|Overall Study|Did Not Receive Study Drug|1|||
128974498|NCT02274766|464190080|FG000|Overall Study|Subject Unwilling to Proceed|0|||
128974499|NCT02274766|464190081|FG001|Overall Study|Subject Unwilling to Proceed|1|||
128974500|NCT02274766|464190080|FG000|Overall Study|Adverse Event|0|||
128974501|NCT02274766|464190081|FG001|Overall Study|Adverse Event|1|||
128974502|NCT02583399|464191832|FG000|Overall Study|Able to be discharged|3|||
128974503|NCT02583399|464191832|FG000|Overall Study|Wanted to use a restricted medication|3|||
128974504|NCT02759939|464191837|FG000|Overall Study|Missing data on first outcome assessed|11|||
128974505|NCT02759939|464191838|FG001|Overall Study|Missing data on first outcome assessed|2|||
128974506|NCT02759939|464191839|FG002|Overall Study|Missing data on first outcome assessed|5|||
129131671|NCT00541229|464774905|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
129131672|NCT00541229|464774906|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
129131673|NCT00541229|464774907|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
129131674|NCT00541229|464774902|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
128974507|NCT02759939|464191840|FG003|Overall Study|Missing data on first outcome assessed|2|||
128974508|NCT02759939|464191837|FG000|Overall Study|Ineligible for T2 and T3|310|||
128974509|NCT02759939|464191838|FG001|Overall Study|Ineligible for T2 and T3|179|||
129131675|NCT00541229|464774903|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
128715949|NCT01641692|463256670|FG005|Treatment Period 1|Withdrawal by Subject|2|||
128974510|NCT02759939|464191839|FG002|Overall Study|Ineligible for T2 and T3|366|||
128974511|NCT02759939|464191840|FG003|Overall Study|Ineligible for T2 and T3|391|||
128974512|NCT02759939|464191837|FG000|Overall Study|Lost to Follow-up|735|||
128974513|NCT02759939|464191838|FG001|Overall Study|Lost to Follow-up|791|||
128974514|NCT02759939|464191839|FG002|Overall Study|Lost to Follow-up|783|||
128974515|NCT02759939|464191840|FG003|Overall Study|Lost to Follow-up|650|||
128974516|NCT04397757|464191842|FG000|Overall Study|Death|3|||
128974517|NCT04397757|464191843|FG001|Overall Study|Death|11|||
128974518|NCT04397757|464191842|FG000|Overall Study|Withdrawal by Subject|2|||
128974519|NCT04397757|464191843|FG001|Overall Study|Withdrawal by Subject|0|||
128974520|NCT04397757|464191842|FG000|Overall Study|Lost to Follow-up|4|||
128974521|NCT04397757|464191843|FG001|Overall Study|Lost to Follow-up|3|||
128974522|NCT00535236|464191846|FG000|Overall Study|Adverse Event|1|||
128974523|NCT00535236|464191847|FG001|Overall Study|Adverse Event|0|||
128974524|NCT00535236|464191848|FG002|Overall Study|Adverse Event|9|||
128974525|NCT00535236|464191849|FG003|Overall Study|Adverse Event|3|||
128974526|NCT00535236|464191850|FG004|Overall Study|Adverse Event|3|||
128974527|NCT00535236|464191851|FG005|Overall Study|Adverse Event|0|||
128974528|NCT00535236|464191852|FG006|Overall Study|Adverse Event|5|||
128974529|NCT00535236|464191853|FG007|Overall Study|Adverse Event|1|||
128974530|NCT00535236|464191854|FG008|Overall Study|Adverse Event|2|||
128974531|NCT00535236|464191855|FG009|Overall Study|Adverse Event|1|||
128974532|NCT00535236|464191846|FG000|Overall Study|Lost to Follow-up|1|||
128974533|NCT00535236|464191847|FG001|Overall Study|Lost to Follow-up|2|||
128974534|NCT00535236|464191848|FG002|Overall Study|Lost to Follow-up|0|||
128974535|NCT00535236|464191849|FG003|Overall Study|Lost to Follow-up|0|||
128974536|NCT00535236|464191850|FG004|Overall Study|Lost to Follow-up|2|||
128974537|NCT00535236|464191851|FG005|Overall Study|Lost to Follow-up|0|||
128974538|NCT00535236|464191852|FG006|Overall Study|Lost to Follow-up|0|||
128974539|NCT00535236|464191853|FG007|Overall Study|Lost to Follow-up|0|||
128974540|NCT00535236|464191854|FG008|Overall Study|Lost to Follow-up|6|||
128974541|NCT00535236|464191855|FG009|Overall Study|Lost to Follow-up|1|||
128974542|NCT00535236|464191846|FG000|Overall Study|Physician Decision|0|||
128974543|NCT00535236|464191847|FG001|Overall Study|Physician Decision|0|||
128974544|NCT00535236|464191848|FG002|Overall Study|Physician Decision|0|||
128974545|NCT00535236|464191849|FG003|Overall Study|Physician Decision|0|||
128974546|NCT00535236|464191850|FG004|Overall Study|Physician Decision|1|||
128974547|NCT00535236|464191851|FG005|Overall Study|Physician Decision|0|||
128974548|NCT00535236|464191852|FG006|Overall Study|Physician Decision|1|||
128974549|NCT00535236|464191853|FG007|Overall Study|Physician Decision|0|||
128974550|NCT00535236|464191854|FG008|Overall Study|Physician Decision|0|||
128974551|NCT00535236|464191855|FG009|Overall Study|Physician Decision|0|||
128974552|NCT00535236|464191846|FG000|Overall Study|Protocol Violation|2|||
128974553|NCT00535236|464191847|FG001|Overall Study|Protocol Violation|0|||
128974554|NCT00535236|464191848|FG002|Overall Study|Protocol Violation|1|||
128974555|NCT00535236|464191849|FG003|Overall Study|Protocol Violation|0|||
128974556|NCT00535236|464191850|FG004|Overall Study|Protocol Violation|0|||
128974557|NCT00535236|464191851|FG005|Overall Study|Protocol Violation|0|||
128974558|NCT00535236|464191852|FG006|Overall Study|Protocol Violation|0|||
128974559|NCT00535236|464191853|FG007|Overall Study|Protocol Violation|0|||
128974560|NCT00535236|464191854|FG008|Overall Study|Protocol Violation|1|||
128974561|NCT00535236|464191855|FG009|Overall Study|Protocol Violation|0|||
128974562|NCT00535236|464191846|FG000|Overall Study|Withdrawal by Subject|3|||
128974563|NCT00535236|464191847|FG001|Overall Study|Withdrawal by Subject|0|||
128974564|NCT00535236|464191848|FG002|Overall Study|Withdrawal by Subject|2|||
128974565|NCT00535236|464191849|FG003|Overall Study|Withdrawal by Subject|1|||
128974566|NCT00535236|464191850|FG004|Overall Study|Withdrawal by Subject|6|||
128974567|NCT00535236|464191851|FG005|Overall Study|Withdrawal by Subject|1|||
129131676|NCT00541229|464774904|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
129131677|NCT00541229|464774905|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
129131678|NCT00541229|464774906|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
129131679|NCT00541229|464774907|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
129131680|NCT00541229|464774902|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
129131681|NCT00541229|464774903|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
129131682|NCT00541229|464774904|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
129131683|NCT00541229|464774905|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
129131684|NCT00541229|464774906|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
129131685|NCT00541229|464774907|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
129131686|NCT00541229|464774902|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
128715950|NCT01641692|463256671|FG006|Treatment Period 1|Withdrawal by Subject|0|||
128974568|NCT00535236|464191852|FG006|Overall Study|Withdrawal by Subject|5|||
128974569|NCT00535236|464191853|FG007|Overall Study|Withdrawal by Subject|0|||
128974570|NCT00535236|464191854|FG008|Overall Study|Withdrawal by Subject|4|||
128974571|NCT00535236|464191855|FG009|Overall Study|Withdrawal by Subject|2|||
128974572|NCT03288987|464191857|FG000|Overall Study|Protocol Violation|10|||
128974573|NCT03288987|464191858|FG001|Overall Study|Protocol Violation|4|||
128974574|NCT04905563|464191859|FG000|Overall Study|Withdrawal by Subject|1|||
128974575|NCT04905563|464191860|FG001|Overall Study|Withdrawal by Subject|0|||
129038856|NCT00739973|464433306|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129038857|NCT00739973|464433307|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129038858|NCT00739973|464433308|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129038859|NCT00739973|464433309|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129038860|NCT00739973|464433310|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129038861|NCT00739973|464433311|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129038862|NCT00739973|464433312|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129038863|NCT00739973|464433304|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
129038864|NCT00739973|464433305|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038865|NCT00739973|464433306|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038866|NCT00739973|464433307|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038867|NCT00739973|464433308|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038868|NCT00739973|464433309|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038869|NCT00739973|464433310|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038870|NCT00739973|464433311|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038871|NCT00739973|464433312|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129038872|NCT00739973|464433304|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
129038873|NCT00739973|464433305|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129038874|NCT00739973|464433306|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129038875|NCT00739973|464433307|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129038876|NCT00739973|464433308|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129038877|NCT00739973|464433309|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129038878|NCT00739973|464433310|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129038879|NCT00739973|464433311|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129038880|NCT00739973|464433312|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
128715951|NCT01641692|463256672|FG007|Treatment Period 1|Withdrawal by Subject|1|||
128715952|NCT01641692|463256665|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
128715953|NCT01641692|463256666|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
128974576|NCT04905563|464191859|FG000|Overall Study|Standard of care orders entered by resident|1|||
128974577|NCT04905563|464191860|FG001|Overall Study|Standard of care orders entered by resident|0|||
128974578|NCT04905563|464191859|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
128974579|NCT04905563|464191860|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
128974580|NCT04905563|464191859|FG000|Overall Study|Withdrawal by Subject|0|||
128974581|NCT04905563|464191860|FG001|Overall Study|Withdrawal by Subject|1|||
128974582|NCT02447952|464191871|FG000|Overall Study|Adverse Event|2|||
128974583|NCT02447952|464191871|FG000|Overall Study|Physician Decision|1|||
128974584|NCT02447952|464191871|FG000|Overall Study|Withdrawal by Subject|4|||
128974585|NCT04554394|464191872|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
128974586|NCT04554394|464191873|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
128974587|NCT04554394|464191872|FG000|Overall Study|Withdrawal by Subject|2|||
128974588|NCT04554394|464191873|FG001|Overall Study|Withdrawal by Subject|2|||
128974589|NCT04554394|464191872|FG000|Overall Study|Lost to Follow-up|2|||
128974590|NCT04554394|464191873|FG001|Overall Study|Lost to Follow-up|2|||
128974591|NCT04554394|464191872|FG000|Overall Study|Physician Decision|1|||
128974592|NCT04554394|464191873|FG001|Overall Study|Physician Decision|1|||
128974593|NCT00886587|464191874|FG000|Overall Study|Adverse Event|2|||
128974594|NCT00886587|464191875|FG001|Overall Study|Adverse Event|1|||
128974595|NCT00886587|464191874|FG000|Overall Study|Protocol Violation|2|||
128974596|NCT00886587|464191875|FG001|Overall Study|Protocol Violation|0|||
128974597|NCT00886587|464191874|FG000|Overall Study|Withdrawal by Subject|0|||
128974598|NCT00886587|464191875|FG001|Overall Study|Withdrawal by Subject|1|||
128974599|NCT02584660|464191879|FG000|Overall Study|Adverse Event|4|||
128974600|NCT02584660|464191880|FG001|Overall Study|Adverse Event|0|||
128974601|NCT02584660|464191879|FG000|Overall Study|Lost to Follow-up|3|||
128974602|NCT02584660|464191880|FG001|Overall Study|Lost to Follow-up|4|||
128974603|NCT02584660|464191879|FG000|Overall Study|Protocol Violation|0|||
128974604|NCT02584660|464191880|FG001|Overall Study|Protocol Violation|1|||
128974605|NCT02584660|464191879|FG000|Overall Study|Withdrawal by Subject|0|||
129038881|NCT00739973|464433304|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
129038882|NCT00739973|464433305|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129038883|NCT00739973|464433306|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129038884|NCT00739973|464433307|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
128715954|NCT01641692|463256667|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
128774728|NCT04157686|463466657|FG005|Overall Study|Physician Decision|0|||
128974606|NCT02584660|464191880|FG001|Overall Study|Withdrawal by Subject|2|||
128974607|NCT02584660|464191879|FG000|Overall Study|Other|0|||
128974608|NCT02584660|464191880|FG001|Overall Study|Other|1|||
128974609|NCT00374452|464191881|FG000|Overall Study|Left clinic before intervention started|4|||
128974610|NCT00374452|464191882|FG001|Overall Study|Left clinic before intervention started|1|||
128974611|NCT00374452|464191881|FG000|Overall Study|Change in job role before intervention|0|||
128974612|NCT00374452|464191882|FG001|Overall Study|Change in job role before intervention|1|||
128974613|NCT00374452|464191881|FG000|Overall Study|Left clinic after intervention started|1|||
128974614|NCT00374452|464191882|FG001|Overall Study|Left clinic after intervention started|1|||
128974615|NCT00374452|464191881|FG000|Overall Study|Withdrawal by Subject|0|||
128974616|NCT00374452|464191882|FG001|Overall Study|Withdrawal by Subject|2|||
128974617|NCT03099304|464191884|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
128974618|NCT03099304|464191885|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
128974619|NCT03099304|464191886|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
128974620|NCT03099304|464191887|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
128974621|NCT03099304|464191888|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
128974622|NCT03099304|464191889|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
128974623|NCT03099304|464191884|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
128974624|NCT03099304|464191885|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
128974625|NCT03099304|464191886|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
128974626|NCT03099304|464191887|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
128974627|NCT03099304|464191888|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
128974628|NCT03099304|464191889|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
128974629|NCT03099304|464191884|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
128974630|NCT03099304|464191885|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
128974631|NCT03099304|464191886|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
128974632|NCT03099304|464191887|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
128974633|NCT03099304|464191888|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
128974634|NCT03099304|464191889|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
128974635|NCT03099304|464191884|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
128974636|NCT03099304|464191885|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
128974637|NCT03099304|464191886|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
128974638|NCT03099304|464191887|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
128974639|NCT03099304|464191888|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
128974640|NCT03099304|464191889|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
128974641|NCT03099304|464191884|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
128974642|NCT03099304|464191885|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
128974643|NCT03099304|464191886|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
128974644|NCT03099304|464191887|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
128974645|NCT03099304|464191888|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
128974646|NCT03099304|464191889|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
128974647|NCT03099304|464191884|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
128974648|NCT03099304|464191885|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
128974649|NCT03099304|464191886|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
128974650|NCT03099304|464191887|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
128974651|NCT03099304|464191888|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
128974652|NCT03099304|464191889|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
128974653|NCT03099304|464191884|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
128974654|NCT03099304|464191885|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
128974655|NCT03099304|464191886|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
128974656|NCT03099304|464191887|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
128974657|NCT03099304|464191888|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
128974658|NCT03099304|464191889|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
128974659|NCT03099304|464191884|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
128974660|NCT03099304|464191885|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
128974661|NCT03099304|464191886|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
128974662|NCT03099304|464191887|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
128974663|NCT03099304|464191888|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
128974664|NCT03099304|464191889|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
128974665|NCT03099304|464191884|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
128974666|NCT03099304|464191885|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
128974667|NCT03099304|464191886|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
128974668|NCT03099304|464191887|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
129038885|NCT00739973|464433308|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129038886|NCT00739973|464433309|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129038887|NCT00739973|464433310|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129038888|NCT00739973|464433311|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129221293|NCT04672655|465110216|FG001|Overall Study|Withdrawal by Study|0|||
128774729|NCT04157686|463466658|FG006|Overall Study|Physician Decision|3|||
128974669|NCT03099304|464191888|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
128974670|NCT03099304|464191889|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
128974671|NCT03099304|464191884|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
128974672|NCT03099304|464191885|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
128974673|NCT03099304|464191886|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
128974674|NCT03099304|464191887|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
128974675|NCT03099304|464191888|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
128974676|NCT03099304|464191889|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
128974677|NCT03099304|464191884|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
128974678|NCT03099304|464191885|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
128974679|NCT03099304|464191886|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
128974680|NCT03099304|464191887|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
128974681|NCT03099304|464191888|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
128974682|NCT03099304|464191889|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
128974683|NCT03099304|464191884|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
128974684|NCT03099304|464191885|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
128974685|NCT03099304|464191886|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
128974686|NCT03099304|464191887|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
128974687|NCT03099304|464191888|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
128974688|NCT03099304|464191889|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
128974689|NCT03099304|464191884|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
128974690|NCT03099304|464191885|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
128974691|NCT03099304|464191886|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
128974692|NCT03099304|464191887|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
128974693|NCT03099304|464191888|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
128974694|NCT03099304|464191889|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
128974695|NCT03099304|464191884|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
128974696|NCT03099304|464191885|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
128974697|NCT03099304|464191886|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
128974698|NCT03099304|464191887|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
128974699|NCT03099304|464191888|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
128974700|NCT03099304|464191889|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
128974701|NCT03099304|464191884|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
128974702|NCT03099304|464191885|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
128974703|NCT03099304|464191886|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
128974704|NCT03099304|464191887|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
128974705|NCT03099304|464191888|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
128974706|NCT03099304|464191889|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
128974707|NCT03099304|464191884|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
128974708|NCT03099304|464191885|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
128974709|NCT03099304|464191886|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
128974710|NCT03099304|464191887|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
128974711|NCT03099304|464191888|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
128974712|NCT03099304|464191889|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
128974713|NCT03099304|464191884|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
128974714|NCT03099304|464191885|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
128974715|NCT03099304|464191886|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
128974716|NCT03099304|464191887|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
128974717|NCT03099304|464191888|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
128974718|NCT03099304|464191889|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
128974719|NCT03196973|464191895|FG000|Overall Study|Adverse Event|1|||
128974720|NCT03196973|464191896|FG001|Overall Study|Adverse Event|1|||
128974721|NCT03196973|464191897|FG002|Overall Study|Adverse Event|2|||
128974722|NCT03196973|464191895|FG000|Overall Study|Lack of Efficacy|2|||
128974723|NCT03196973|464191896|FG001|Overall Study|Lack of Efficacy|6|||
128974724|NCT03196973|464191897|FG002|Overall Study|Lack of Efficacy|1|||
128974725|NCT03196973|464191895|FG000|Overall Study|Lost to Follow-up|4|||
128974726|NCT03196973|464191896|FG001|Overall Study|Lost to Follow-up|3|||
128974727|NCT03196973|464191897|FG002|Overall Study|Lost to Follow-up|2|||
128974728|NCT03196973|464191895|FG000|Overall Study|Consent withdrawn|2|||
128974729|NCT03196973|464191896|FG001|Overall Study|Consent withdrawn|1|||
128974730|NCT03196973|464191897|FG002|Overall Study|Consent withdrawn|0|||
128974731|NCT03196973|464191895|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
129038889|NCT00739973|464433312|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129038890|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
129038891|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
129038892|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
128974732|NCT03196973|464191896|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
128974733|NCT03196973|464191897|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
128974734|NCT01142791|464191898|FG000|Overall Study|Alternative Treatment|1|||
129038893|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
128715955|NCT01641692|463256668|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
128974735|NCT01142791|464191899|FG001|Overall Study|Alternative Treatment|0|||
128974736|NCT01142791|464191898|FG000|Overall Study|Lost to Follow-up|1|||
128974737|NCT01142791|464191899|FG001|Overall Study|Lost to Follow-up|0|||
129038894|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
129038895|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
129038896|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
129038897|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
129038898|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
129038899|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129038900|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129038901|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129038902|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129038903|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
129038904|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129038905|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129038906|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
129038907|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129038908|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
129038909|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
129038910|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129038911|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129038912|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129038913|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129038914|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129038915|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129038916|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129038917|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
129038918|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
129038919|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
129038920|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
129038921|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
129038922|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
129038923|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
129038924|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
129038925|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
129038926|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038927|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038928|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
129038929|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038930|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038931|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038932|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038933|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038934|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129038935|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129038936|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
129038937|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129038938|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
129038939|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129038940|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129038941|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
129038942|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
129038943|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129038944|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
129038945|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
129038946|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
129038947|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
129038948|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
129038949|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
129038950|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
129038951|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
129221294|NCT00494676|465110217|FG000|Allocation|Withdrawal by Subject|2|||
128974738|NCT01142791|464191898|FG000|Overall Study|Withdrawal by Subject|5|||
128974739|NCT01142791|464191899|FG001|Overall Study|Withdrawal by Subject|0|||
128974740|NCT01142791|464191898|FG000|Overall Study|Received only 1 sonication|0|||
128974741|NCT01142791|464191899|FG001|Overall Study|Received only 1 sonication|6|||
128974742|NCT02590406|464191900|FG000|Overall Study|Adverse Event|1|||
128974743|NCT02590406|464191901|FG001|Overall Study|Adverse Event|0|||
128974744|NCT02590406|464191900|FG000|Overall Study|Saturometer malfunction|0|||
128974745|NCT02590406|464191901|FG001|Overall Study|Saturometer malfunction|1|||
128974746|NCT03032523|464191902|FG000|Overall Study|Withdrawal by Subject|2|||
128974747|NCT03032523|464191903|FG001|Overall Study|Withdrawal by Subject|2|||
128974748|NCT03032523|464191902|FG000|Overall Study|Physician Decision|1|||
128974749|NCT03032523|464191903|FG001|Overall Study|Physician Decision|0|||
128974750|NCT00957723|464191906|FG000|Overall Study|Death|3|||
128974751|NCT00957723|464191906|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
128974752|NCT00957723|464191906|FG000|Overall Study|Lost to Follow-up|8|||
128974753|NCT00957723|464191906|FG000|Overall Study|Withdrawal by Subject|24|||
128974754|NCT00957723|464191906|FG000|Overall Study|Investigative Site Terminated|61|||
128974755|NCT00957723|464191906|FG000|Overall Study|Intercurrent Illness|2|||
128974756|NCT00957723|464191906|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
128974757|NCT05375838|464191907|FG000|Overall Study|Other|0|||
128974758|NCT05375838|464191908|FG001|Overall Study|Other|0|||
128974759|NCT05375838|464191909|FG002|Overall Study|Other|0|||
128974760|NCT05375838|464191910|FG003|Overall Study|Other|1|||
128974761|NCT05375838|464191911|FG004|Overall Study|Other|1|||
128974762|NCT05375838|464191912|FG005|Overall Study|Other|0|||
128974763|NCT05375838|464191907|FG000|Overall Study|Withdrawal by Subject|2|||
128974764|NCT05375838|464191908|FG001|Overall Study|Withdrawal by Subject|1|||
128974765|NCT05375838|464191909|FG002|Overall Study|Withdrawal by Subject|3|||
128974766|NCT05375838|464191910|FG003|Overall Study|Withdrawal by Subject|2|||
128974767|NCT05375838|464191911|FG004|Overall Study|Withdrawal by Subject|2|||
128974768|NCT05375838|464191912|FG005|Overall Study|Withdrawal by Subject|0|||
128974769|NCT05375838|464191907|FG000|Overall Study|Protocol Violation|0|||
128974770|NCT05375838|464191908|FG001|Overall Study|Protocol Violation|0|||
128974771|NCT05375838|464191909|FG002|Overall Study|Protocol Violation|0|||
128974772|NCT05375838|464191910|FG003|Overall Study|Protocol Violation|0|||
128974773|NCT05375838|464191911|FG004|Overall Study|Protocol Violation|1|||
128974774|NCT05375838|464191912|FG005|Overall Study|Protocol Violation|0|||
128974775|NCT05375838|464191907|FG000|Overall Study|Physician Decision|0|||
128974776|NCT05375838|464191908|FG001|Overall Study|Physician Decision|1|||
128974777|NCT05375838|464191909|FG002|Overall Study|Physician Decision|0|||
128974778|NCT05375838|464191910|FG003|Overall Study|Physician Decision|0|||
128974779|NCT05375838|464191911|FG004|Overall Study|Physician Decision|0|||
128974780|NCT05375838|464191912|FG005|Overall Study|Physician Decision|1|||
128974781|NCT05375838|464191907|FG000|Overall Study|Lost to Follow-up|2|||
128974782|NCT05375838|464191908|FG001|Overall Study|Lost to Follow-up|7|||
128974783|NCT05375838|464191909|FG002|Overall Study|Lost to Follow-up|0|||
128974784|NCT05375838|464191910|FG003|Overall Study|Lost to Follow-up|4|||
128974785|NCT05375838|464191911|FG004|Overall Study|Lost to Follow-up|2|||
128974786|NCT05375838|464191912|FG005|Overall Study|Lost to Follow-up|3|||
128974787|NCT00984009|464191913|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
128974788|NCT00281528|464191914|FG000|Overall Study|Progressive Disease|28|||
128974789|NCT00281528|464191915|FG001|Overall Study|Progressive Disease|18|||
128974790|NCT00281528|464191916|FG002|Overall Study|Progressive Disease|27|||
128974791|NCT00281528|464191914|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
128974792|NCT00281528|464191915|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
128974793|NCT00281528|464191916|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
128974794|NCT00281528|464191914|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
128974795|NCT00281528|464191915|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
128974796|NCT00281528|464191916|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
128974797|NCT00281528|464191914|FG000|Overall Study|Physician Decision|11|||
128974798|NCT00281528|464191915|FG001|Overall Study|Physician Decision|4|||
128774730|NCT04157686|463466659|FG007|Overall Study|Physician Decision|0|||
128774731|NCT04157686|463466652|FG000|Overall Study|Death|0|||
128974799|NCT00281528|464191916|FG002|Overall Study|Physician Decision|5|||
128974800|NCT00281528|464191914|FG000|Overall Study|Protocol Violation|1|||
128974801|NCT00281528|464191915|FG001|Overall Study|Protocol Violation|0|||
128974802|NCT00281528|464191916|FG002|Overall Study|Protocol Violation|1|||
128974803|NCT00281528|464191914|FG000|Overall Study|Withdrawal by Subject|5|||
128974804|NCT00281528|464191915|FG001|Overall Study|Withdrawal by Subject|5|||
128974805|NCT00281528|464191916|FG002|Overall Study|Withdrawal by Subject|7|||
128974806|NCT00281528|464191914|FG000|Overall Study|Other|6|||
128974807|NCT00281528|464191915|FG001|Overall Study|Other|3|||
128974808|NCT00281528|464191916|FG002|Overall Study|Other|5|||
128974809|NCT02036476|464191928|FG000|Overall Study|Withdrawal by Subject|2|||
128974810|NCT02036476|464191928|FG000|Overall Study|Progressive Disease|4|||
128974811|NCT02036476|464191928|FG000|Overall Study|Unacceptable Toxicity|2|||
128974812|NCT02168816|464191929|FG000|Overall Study|Lost to Follow-up|2|||
128974813|NCT02168816|464191930|FG001|Overall Study|Lost to Follow-up|2|||
128974814|NCT01984294|464191933|FG000|Overall Study|Randomized but Never Treated|0|||
128974815|NCT01984294|464191934|FG001|Overall Study|Randomized but Never Treated|0|||
128974816|NCT01984294|464191935|FG002|Overall Study|Randomized but Never Treated|1|||
128974817|NCT01984294|464191933|FG000|Overall Study|Lack of Efficacy|4|||
128974818|NCT01984294|464191934|FG001|Overall Study|Lack of Efficacy|2|||
128974819|NCT01984294|464191935|FG002|Overall Study|Lack of Efficacy|6|||
128974820|NCT01984294|464191933|FG000|Overall Study|Adverse Event|0|||
128974821|NCT01984294|464191934|FG001|Overall Study|Adverse Event|1|||
128974822|NCT01984294|464191935|FG002|Overall Study|Adverse Event|0|||
128974823|NCT02993783|464191938|FG000|Overall Study|Reason not Specified|6|||
128974824|NCT02993783|464191939|FG001|Overall Study|Reason not Specified|9|||
128974825|NCT01987609|464191940|FG000|Overall Study|Adverse Event|1|||
128974826|NCT02610231|464191941|FG000|Overall Study|Withdrawal by Subject|27|||
128974827|NCT02610231|464191941|FG000|Overall Study|Adverse Event|20|||
128974828|NCT02610231|464191941|FG000|Overall Study|Death|5|||
128974829|NCT02610231|464191941|FG000|Overall Study|Surgery|2|||
128974830|NCT02610231|464191941|FG000|Overall Study|Physician Decision|1|||
128974831|NCT02610231|464191941|FG000|Overall Study|Non Compliance|2|||
128974832|NCT02610231|464191941|FG000|Overall Study|Other|3|||
128974833|NCT00806494|464191942|FG000|Overall Study|Adverse Event|29|||
128974834|NCT00806494|464191942|FG000|Overall Study|Lack of Efficacy|6|||
128974835|NCT00806494|464191942|FG000|Overall Study|Lost to Follow-up|10|||
128974836|NCT00806494|464191942|FG000|Overall Study|Other|30|||
128974837|NCT00806494|464191942|FG000|Overall Study|Withdrawal by Subject|5|||
128974838|NCT01279954|464191943|FG000|Overall Study|Lack of Efficacy|3|||
128974839|NCT01279954|464191944|FG001|Overall Study|Lack of Efficacy|4|||
128974840|NCT02709889|464191945|FG000|Overall Study|Withdrawal by Subject|11|||
128974841|NCT02709889|464191946|FG001|Overall Study|Withdrawal by Subject|10|||
128974842|NCT02709889|464191947|FG002|Overall Study|Withdrawal by Subject|2|||
128974843|NCT02709889|464191948|FG003|Overall Study|Withdrawal by Subject|12|||
128974844|NCT02709889|464191945|FG000|Overall Study|Death|25|||
128974845|NCT02709889|464191946|FG001|Overall Study|Death|38|||
128974846|NCT02709889|464191947|FG002|Overall Study|Death|4|||
128974847|NCT02709889|464191948|FG003|Overall Study|Death|44|||
128974848|NCT02709889|464191945|FG000|Overall Study|Physician Decision|1|||
128974849|NCT02709889|464191946|FG001|Overall Study|Physician Decision|2|||
128974850|NCT02709889|464191947|FG002|Overall Study|Physician Decision|3|||
128974851|NCT02709889|464191948|FG003|Overall Study|Physician Decision|5|||
128974852|NCT02709889|464191945|FG000|Overall Study|Lost to Follow-up|2|||
128974853|NCT02709889|464191946|FG001|Overall Study|Lost to Follow-up|0|||
128974854|NCT02709889|464191947|FG002|Overall Study|Lost to Follow-up|0|||
128974855|NCT02709889|464191948|FG003|Overall Study|Lost to Follow-up|4|||
128974856|NCT02709889|464191945|FG000|Overall Study|Study Terminated by Sponsor|4|||
128974857|NCT02709889|464191946|FG001|Overall Study|Study Terminated by Sponsor|6|||
128974858|NCT02709889|464191947|FG002|Overall Study|Study Terminated by Sponsor|2|||
128974859|NCT02709889|464191948|FG003|Overall Study|Study Terminated by Sponsor|17|||
128974860|NCT02709889|464191945|FG000|Overall Study|Other, Not Specified|0|||
128974861|NCT02709889|464191946|FG001|Overall Study|Other, Not Specified|1|||
128974862|NCT02709889|464191947|FG002|Overall Study|Other, Not Specified|1|||
128974863|NCT02709889|464191948|FG003|Overall Study|Other, Not Specified|6|||
128974864|NCT03258762|464191949|FG000|Overall Study|Lost to Follow-up|0|||
128974865|NCT03258762|464191950|FG001|Overall Study|Lost to Follow-up|1|||
128974866|NCT01711359|464191951|FG000|Treatment Period|Withdrawal by Subject|18|||
128974867|NCT01711359|464191952|FG001|Treatment Period|Withdrawal by Subject|7|||
128974868|NCT01711359|464191953|FG002|Treatment Period|Withdrawal by Subject|13|||
129038952|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
129038953|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129038954|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129038955|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129038956|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129038957|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129038958|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129038959|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
129038960|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129131687|NCT00541229|464774903|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
128974869|NCT01711359|464191951|FG000|Treatment Period|Lack of Efficacy|13|||
128974870|NCT01711359|464191952|FG001|Treatment Period|Lack of Efficacy|2|||
128974871|NCT01711359|464191953|FG002|Treatment Period|Lack of Efficacy|2|||
128974872|NCT01711359|464191951|FG000|Treatment Period|Adverse Event|8|||
128974873|NCT01711359|464191952|FG001|Treatment Period|Adverse Event|10|||
128974874|NCT01711359|464191953|FG002|Treatment Period|Adverse Event|24|||
128974875|NCT01711359|464191951|FG000|Treatment Period|Physician Decision|4|||
128974876|NCT01711359|464191952|FG001|Treatment Period|Physician Decision|3|||
128974877|NCT01711359|464191953|FG002|Treatment Period|Physician Decision|2|||
128974878|NCT01711359|464191951|FG000|Treatment Period|Death|3|||
128974879|NCT01711359|464191952|FG001|Treatment Period|Death|0|||
128974880|NCT01711359|464191953|FG002|Treatment Period|Death|0|||
128974881|NCT01711359|464191951|FG000|Treatment Period|Entry Criteria Not Met|1|||
128974882|NCT01711359|464191952|FG001|Treatment Period|Entry Criteria Not Met|0|||
128974883|NCT01711359|464191953|FG002|Treatment Period|Entry Criteria Not Met|0|||
128974884|NCT01711359|464191951|FG000|Treatment Period|Sponsor Decision|1|||
128974885|NCT01711359|464191952|FG001|Treatment Period|Sponsor Decision|0|||
128974886|NCT01711359|464191953|FG002|Treatment Period|Sponsor Decision|0|||
128974887|NCT01711359|464191951|FG000|Treatment Period|Lost to Follow-up|1|||
128974888|NCT01711359|464191952|FG001|Treatment Period|Lost to Follow-up|1|||
128974889|NCT01711359|464191953|FG002|Treatment Period|Lost to Follow-up|1|||
128974890|NCT01711359|464191951|FG000|Treatment Period|Randomized, Not Treated|3|||
128974891|NCT01711359|464191952|FG001|Treatment Period|Randomized, Not Treated|1|||
128974892|NCT01711359|464191953|FG002|Treatment Period|Randomized, Not Treated|0|||
128974893|NCT02698176|464191954|FG000|Overall Study|Progressive disease|4|||
128974894|NCT02698176|464191955|FG001|Overall Study|Progressive disease|3|||
128974895|NCT02698176|464191956|FG002|Overall Study|Progressive disease|1|||
128974896|NCT02698176|464191957|FG003|Overall Study|Progressive disease|0|||
128974897|NCT02698176|464191954|FG000|Overall Study|Adverse Event|2|||
128974898|NCT02698176|464191955|FG001|Overall Study|Adverse Event|0|||
128974899|NCT02698176|464191956|FG002|Overall Study|Adverse Event|0|||
128974900|NCT02698176|464191957|FG003|Overall Study|Adverse Event|0|||
128974901|NCT02698176|464191954|FG000|Overall Study|Clinical progression|3|||
128974902|NCT02698176|464191955|FG001|Overall Study|Clinical progression|0|||
128974903|NCT02698176|464191956|FG002|Overall Study|Clinical progression|0|||
128974904|NCT02698176|464191957|FG003|Overall Study|Clinical progression|0|||
128974905|NCT02561572|464191960|FG000|Overall Study|Inadequate time before surgery|2|||
128974906|NCT02561572|464191961|FG001|Overall Study|Inadequate time before surgery|1|||
128974907|NCT02561572|464191960|FG000|Overall Study|Protocol Violation|0|||
128974908|NCT02561572|464191961|FG001|Overall Study|Protocol Violation|1|||
128974909|NCT00795717|464191962|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
128974910|NCT00795717|464191963|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
128974911|NCT00795717|464191962|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
128974912|NCT00795717|464191963|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
128974913|NCT00795717|464191962|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
128974914|NCT00795717|464191963|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
128974915|NCT00795717|464191962|FG000|Phase II|too busy|0|||
128974916|NCT00795717|464191963|FG001|Phase II|too busy|1|||
128974917|NCT02985684|464191969|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
128974918|NCT02985684|464191969|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
128974919|NCT02985684|464191969|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
128974920|NCT00424463|464191970|FG000|Overall Study|Adverse Event|2|||
128974921|NCT00424463|464191971|FG001|Overall Study|Adverse Event|3|||
128974922|NCT00424463|464191972|FG002|Overall Study|Adverse Event|2|||
128974923|NCT00424463|464191970|FG000|Overall Study|Physician Decision|0|||
128974924|NCT00424463|464191971|FG001|Overall Study|Physician Decision|2|||
128974925|NCT00424463|464191972|FG002|Overall Study|Physician Decision|2|||
128974926|NCT00424463|464191970|FG000|Overall Study|Withdrawal by Subject|4|||
128974927|NCT00424463|464191971|FG001|Overall Study|Withdrawal by Subject|2|||
128974928|NCT00424463|464191972|FG002|Overall Study|Withdrawal by Subject|5|||
128974929|NCT00424463|464191970|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
128974930|NCT00424463|464191971|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
128974931|NCT00424463|464191972|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
128974932|NCT00424463|464191970|FG000|Overall Study|Patient's convenience|0|||
128974933|NCT00424463|464191971|FG001|Overall Study|Patient's convenience|0|||
128974934|NCT00424463|464191972|FG002|Overall Study|Patient's convenience|1|||
129038961|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129038962|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
129038963|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
129038964|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
129038965|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
129038966|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
129038967|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
129038968|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
129038969|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
129038970|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
129038971|NCT00739973|464433304|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
128974935|NCT01436357|464191973|FG000|Overall Study|Death|5|||
128974936|NCT01436357|464191974|FG001|Overall Study|Death|1|||
129038972|NCT00739973|464433305|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
129221295|NCT00494676|465110218|FG001|Allocation|Withdrawal by Subject|4|||
128974937|NCT01436357|464191973|FG000|Overall Study|Enrolled but not vaccinated|1|||
128974938|NCT01436357|464191974|FG001|Overall Study|Enrolled but not vaccinated|1|||
128974939|NCT01436357|464191973|FG000|Overall Study|Incarceration|18|||
128974940|NCT01436357|464191974|FG001|Overall Study|Incarceration|20|||
128974941|NCT01436357|464191973|FG000|Overall Study|Lost to Follow-up|67|||
128974942|NCT01436357|464191974|FG001|Overall Study|Lost to Follow-up|61|||
128974943|NCT01436357|464191973|FG000|Overall Study|Protocol Violation|1|||
128974944|NCT01436357|464191974|FG001|Overall Study|Protocol Violation|0|||
128974945|NCT01436357|464191973|FG000|Overall Study|Withdrawal by Subject|26|||
128974946|NCT01436357|464191974|FG001|Overall Study|Withdrawal by Subject|38|||
128974947|NCT01436357|464191973|FG000|Overall Study|Physician Decision|3|||
128974948|NCT01436357|464191974|FG001|Overall Study|Physician Decision|4|||
128974949|NCT01436357|464191973|FG000|Overall Study|Moved out of area|1|||
128974950|NCT01436357|464191974|FG001|Overall Study|Moved out of area|2|||
128974951|NCT01436357|464191973|FG000|Overall Study|Subject in rehab|0|||
128974952|NCT01436357|464191974|FG001|Overall Study|Subject in rehab|1|||
128974953|NCT00656799|464191975|FG000|Overall Study|Death|2|||
128974954|NCT05281094|464191976|FG000|Overall Study|Adverse Event|1|||
128974955|NCT05281094|464191977|FG001|Overall Study|Adverse Event|0|||
128974956|NCT05281094|464191976|FG000|Overall Study|Lost to Follow-up|29|||
128974957|NCT05281094|464191977|FG001|Overall Study|Lost to Follow-up|22|||
128974958|NCT05281094|464191976|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
128974959|NCT05281094|464191977|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
128974960|NCT05281094|464191976|FG000|Overall Study|Death|1|||
128974961|NCT05281094|464191977|FG001|Overall Study|Death|2|||
128974962|NCT05281094|464191976|FG000|Overall Study|Not pre-specified reason|8|||
128974963|NCT05281094|464191977|FG001|Overall Study|Not pre-specified reason|5|||
128974964|NCT00631969|464191982|FG000|Overall Study|Adverse Event|3|||
128974965|NCT00631969|464191983|FG001|Overall Study|Adverse Event|1|||
128974966|NCT00631969|464191982|FG000|Overall Study|Lack of Efficacy|2|||
128974967|NCT00631969|464191983|FG001|Overall Study|Lack of Efficacy|8|||
128974968|NCT00631969|464191982|FG000|Overall Study|Lost to Follow-up|2|||
128974969|NCT00631969|464191983|FG001|Overall Study|Lost to Follow-up|1|||
128974970|NCT00631969|464191982|FG000|Overall Study|Protocol Violation|1|||
128974971|NCT00631969|464191983|FG001|Overall Study|Protocol Violation|1|||
128974972|NCT00631969|464191982|FG000|Overall Study|Consent Withdrawn|5|||
128974973|NCT00631969|464191983|FG001|Overall Study|Consent Withdrawn|7|||
128974974|NCT00631969|464191982|FG000|Overall Study|Noncompliant With Study Medication|0|||
128974975|NCT00631969|464191983|FG001|Overall Study|Noncompliant With Study Medication|1|||
128974976|NCT00631969|464191982|FG000|Overall Study|No Drug Exposure|2|||
128974977|NCT00631969|464191983|FG001|Overall Study|No Drug Exposure|2|||
128974978|NCT05315297|464191984|FG000|Overall Study|Lost to Follow-up|6|||
128974979|NCT05315297|464191985|FG001|Overall Study|Lost to Follow-up|4|||
128974980|NCT05315297|464191984|FG000|Overall Study|Withdrawal by Subject|0|||
128974981|NCT05315297|464191985|FG001|Overall Study|Withdrawal by Subject|1|||
128974982|NCT03053180|464193919|FG000|Overall Study|Failure to Return|1|||
128974983|NCT04144140|464193924|FG000|Overall Study|Other|0|||
128974984|NCT04144140|464193925|FG001|Overall Study|Other|0|||
128974985|NCT04144140|464193926|FG002|Overall Study|Other|0|||
128974986|NCT04144140|464193927|FG003|Overall Study|Other|0|||
128974987|NCT04144140|464193928|FG004|Overall Study|Other|0|||
128974988|NCT04144140|464193929|FG005|Overall Study|Other|1|||
128974989|NCT04144140|464193930|FG006|Overall Study|Other|0|||
128974990|NCT01465958|464193931|FG000|Run-in Phase|Protocol Violation|1|||
128974991|NCT01465958|464193932|FG001|Run-in Phase|Protocol Violation|0|||
128974992|NCT01465958|464193931|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
128974993|NCT01465958|464193932|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
128974994|NCT00669240|464193941|FG000|Overall Study|Lack of Efficacy|33|||
128974995|NCT00669240|464193941|FG000|Overall Study|Withdrawal by Subject|42|||
128974996|NCT00669240|464193941|FG000|Overall Study|Lost to Follow-up|34|||
128974997|NCT00669240|464193941|FG000|Overall Study|Adverse Event|21|||
128974998|NCT00669240|464193941|FG000|Overall Study|Other|19|||
128974999|NCT00669240|464193941|FG000|Overall Study|Enrolled but not treated|15|||
129221296|NCT00494676|465110217|FG000|First Intervention|Withdrawal by Subject|1|||
129221297|NCT00494676|465110218|FG001|First Intervention|Withdrawal by Subject|3|||
129221298|NCT00494676|465110217|FG000|Second Intervention|Withdrawal by Subject|1|||
129221299|NCT00494676|465110218|FG001|Second Intervention|Withdrawal by Subject|1|||
129221300|NCT05767749|465110222|FG000|Overall Study|Withdrawal by Subject|0|||
129221301|NCT05767749|465110223|FG001|Overall Study|Withdrawal by Subject|0|||
128715956|NCT01641692|463256669|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
128975000|NCT00669240|464193941|FG000|Overall Study|Enrolled but no dosing record|1|||
128975001|NCT00959192|464193946|FG000|Overall Study|Adverse Event|1|||
129221302|NCT05767749|465110224|FG002|Overall Study|Withdrawal by Subject|2|||
128975002|NCT00959192|464193947|FG001|Overall Study|Adverse Event|1|||
128975003|NCT00959192|464193948|FG002|Overall Study|Adverse Event|1|||
128975004|NCT00959192|464193949|FG003|Overall Study|Adverse Event|0|||
128975005|NCT00959192|464193946|FG000|Overall Study|Investigator Request|1|||
128975006|NCT00959192|464193947|FG001|Overall Study|Investigator Request|0|||
128975007|NCT00959192|464193948|FG002|Overall Study|Investigator Request|0|||
128975008|NCT00959192|464193949|FG003|Overall Study|Investigator Request|0|||
128975009|NCT00959192|464193946|FG000|Overall Study|Caregiver Request|0|||
128975010|NCT00959192|464193947|FG001|Overall Study|Caregiver Request|0|||
128975011|NCT00959192|464193948|FG002|Overall Study|Caregiver Request|2|||
128975012|NCT00959192|464193949|FG003|Overall Study|Caregiver Request|1|||
128975013|NCT00532441|464193950|FG000|Overall Study|Death|1|||
128975014|NCT00532441|464193951|FG001|Overall Study|Death|0|||
128975015|NCT01967134|464193952|FG000|Overall Study|Lost to Follow-up|0|||
128975016|NCT01967134|464193953|FG001|Overall Study|Lost to Follow-up|1|||
128975017|NCT01967134|464193954|FG002|Overall Study|Lost to Follow-up|0|||
128975018|NCT00443534|464193955|FG000|Overall Study|Lack of Efficacy|67|||
128975019|NCT00443534|464193955|FG000|Overall Study|Adverse Event|16|||
128975020|NCT00443534|464193955|FG000|Overall Study|Death|9|||
128975021|NCT00443534|464193955|FG000|Overall Study|Withdrawal by Subject|8|||
128975022|NCT00443534|464193955|FG000|Overall Study|Study Terminated by Sponsor|12|||
128975023|NCT00443534|464193955|FG000|Overall Study|Other|10|||
128975024|NCT00443534|464193955|FG000|Overall Study|Enrolled, Not Treated|1|||
128975025|NCT00364611|464193957|FG000|Overall Study|Did not receive study medication|0|||
128975026|NCT00364611|464193958|FG001|Overall Study|Did not receive study medication|1|||
128975027|NCT00364611|464193957|FG000|Overall Study|Adverse Event|7|||
128975028|NCT00364611|464193958|FG001|Overall Study|Adverse Event|4|||
128975029|NCT00364611|464193957|FG000|Overall Study|Participant's Request|3|||
128975030|NCT00364611|464193958|FG001|Overall Study|Participant's Request|4|||
128975031|NCT00364611|464193957|FG000|Overall Study|Disease Progression|38|||
128975032|NCT00364611|464193958|FG001|Overall Study|Disease Progression|8|||
128975033|NCT00364611|464193957|FG000|Overall Study|Investigator decision|2|||
128975034|NCT00364611|464193958|FG001|Overall Study|Investigator decision|2|||
128975035|NCT00364611|464193957|FG000|Overall Study|Found Ineligible|1|||
128975036|NCT00364611|464193958|FG001|Overall Study|Found Ineligible|0|||
128975037|NCT00364611|464193957|FG000|Overall Study|Presumed CR on Study|0|||
128975038|NCT00364611|464193958|FG001|Overall Study|Presumed CR on Study|1|||
128975039|NCT00364611|464193957|FG000|Overall Study|Receiving Liver Ablation|0|||
128975040|NCT00364611|464193958|FG001|Overall Study|Receiving Liver Ablation|1|||
128975041|NCT05466240|464193959|FG000|Overall Study|Adverse Event|1|||
128975042|NCT05466240|464193960|FG001|Overall Study|Adverse Event|0|||
128975043|NCT05466240|464193959|FG000|Overall Study|Withdrawal by Subject|1|||
128975044|NCT05466240|464193960|FG001|Overall Study|Withdrawal by Subject|0|||
128975045|NCT00305773|464193961|FG000|Overall Study|Death|3|||
128975046|NCT00305773|464193962|FG001|Overall Study|Death|2|||
129131688|NCT00541229|464774904|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
128715957|NCT01641692|463256670|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
128715958|NCT01641692|463256671|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
128715959|NCT01641692|463256672|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
128715960|NCT01641692|463256665|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128715961|NCT01641692|463256666|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128715962|NCT01641692|463256667|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128715963|NCT01641692|463256668|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128715964|NCT01641692|463256669|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128715965|NCT01641692|463256670|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128715966|NCT01641692|463256671|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
128715967|NCT01641692|463256672|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128715968|NCT01641692|463256665|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
128715969|NCT01641692|463256666|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128715970|NCT01641692|463256667|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
128715971|NCT01641692|463256668|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
128715972|NCT01641692|463256669|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
128715973|NCT01641692|463256670|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128715974|NCT01641692|463256671|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128715975|NCT01641692|463256672|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
128715976|NCT01641692|463256665|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
128715977|NCT01641692|463256666|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
128715978|NCT01641692|463256667|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128715979|NCT01641692|463256668|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
128715980|NCT01641692|463256669|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
128715981|NCT01641692|463256670|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128715982|NCT01641692|463256671|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
128715983|NCT01641692|463256672|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128715984|NCT01641692|463256665|FG000|Treatment Period 2|Lack of Efficacy|1|||
128715985|NCT01641692|463256666|FG001|Treatment Period 2|Lack of Efficacy|0|||
128715986|NCT01641692|463256667|FG002|Treatment Period 2|Lack of Efficacy|0|||
128715987|NCT01641692|463256668|FG003|Treatment Period 2|Lack of Efficacy|0|||
128975047|NCT00305773|464193961|FG000|Overall Study|Adverse Event|1|||
128975048|NCT00305773|464193962|FG001|Overall Study|Adverse Event|2|||
128975049|NCT00305773|464193961|FG000|Overall Study|Alternative Treatment|4|||
128975050|NCT00305773|464193962|FG001|Overall Study|Alternative Treatment|4|||
128975051|NCT00305773|464193961|FG000|Overall Study|Physician Decision|1|||
129131689|NCT00541229|464774905|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
129038973|NCT00739973|464433306|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129038974|NCT00739973|464433307|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129038975|NCT00739973|464433308|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129038976|NCT00739973|464433309|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129038977|NCT00739973|464433310|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
129038978|NCT00739973|464433311|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129038979|NCT00739973|464433312|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129038980|NCT03078478|464433313|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
129131690|NCT00541229|464774906|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
129131691|NCT00541229|464774907|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
129131692|NCT00541229|464774902|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
129131693|NCT00541229|464774903|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
129131694|NCT00541229|464774904|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
129131695|NCT00541229|464774905|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
129131696|NCT00541229|464774906|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
129131697|NCT00541229|464774907|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
129131698|NCT00541229|464774902|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129131699|NCT00541229|464774903|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129131700|NCT00541229|464774904|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
128975052|NCT00305773|464193962|FG001|Overall Study|Physician Decision|1|||
128975053|NCT00305773|464193961|FG000|Overall Study|Withdrawal by Subject|1|||
128975054|NCT00305773|464193962|FG001|Overall Study|Withdrawal by Subject|4|||
128975055|NCT00305773|464193961|FG000|Overall Study|Disease Progression|1|||
128975056|NCT00305773|464193962|FG001|Overall Study|Disease Progression|3|||
128975057|NCT00305773|464193961|FG000|Overall Study|All other reasons|3|||
128975058|NCT00305773|464193962|FG001|Overall Study|All other reasons|2|||
128975059|NCT04097925|464193963|FG000|Overall Study|Withdrawal by Subject|1|||
128975060|NCT02679222|464193964|FG000|Overall Study|No time for project|1|||
128975061|NCT04735432|464193968|FG000|Overall Study|Other - due to personal reason|1|||
128975062|NCT04735432|464193969|FG001|Overall Study|Other - due to personal reason|0|||
128975063|NCT04735432|464193968|FG000|Overall Study|Adverse Event|2|||
128975064|NCT04735432|464193969|FG001|Overall Study|Adverse Event|0|||
128975065|NCT01823991|464193974|FG000|Overall Study|Withdrawal by Subject|8|||
128975066|NCT01823991|464193975|FG001|Overall Study|Withdrawal by Subject|5|||
128975067|NCT05158244|464193976|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
128975068|NCT05158244|464193977|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
128975069|NCT05158244|464193978|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
128975070|NCT05158244|464193979|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
128975071|NCT05158244|464193980|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
128975072|NCT05158244|464193976|FG000|Overall Study|Withdrawal by Subject|0|||
128975073|NCT05158244|464193977|FG001|Overall Study|Withdrawal by Subject|0|||
128975074|NCT05158244|464193978|FG002|Overall Study|Withdrawal by Subject|1|||
128975075|NCT05158244|464193979|FG003|Overall Study|Withdrawal by Subject|0|||
128975076|NCT05158244|464193980|FG004|Overall Study|Withdrawal by Subject|0|||
128975077|NCT01066819|464193982|FG000|Overall Study|Adverse Event|18|||
128975078|NCT01066819|464193983|FG001|Overall Study|Adverse Event|1|||
128975079|NCT01066819|464193984|FG002|Overall Study|Adverse Event|6|||
128975080|NCT01066819|464193985|FG003|Overall Study|Adverse Event|0|||
128975081|NCT01066819|464193986|FG004|Overall Study|Adverse Event|0|||
128975082|NCT01066819|464193987|FG005|Overall Study|Adverse Event|0|||
128975083|NCT01066819|464193982|FG000|Overall Study|Death|5|||
128975084|NCT01066819|464193983|FG001|Overall Study|Death|0|||
128975085|NCT01066819|464193984|FG002|Overall Study|Death|1|||
128975086|NCT01066819|464193985|FG003|Overall Study|Death|0|||
128975087|NCT01066819|464193986|FG004|Overall Study|Death|0|||
128975088|NCT01066819|464193987|FG005|Overall Study|Death|0|||
129038981|NCT03078478|464433314|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
129131701|NCT00541229|464774905|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129131702|NCT00541229|464774906|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
129131703|NCT00541229|464774907|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
128975089|NCT01066819|464193982|FG000|Overall Study|Lack of Efficacy|22|||
128975090|NCT01066819|464193983|FG001|Overall Study|Lack of Efficacy|1|||
128975091|NCT01066819|464193984|FG002|Overall Study|Lack of Efficacy|2|||
128975092|NCT01066819|464193985|FG003|Overall Study|Lack of Efficacy|1|||
128975093|NCT01066819|464193986|FG004|Overall Study|Lack of Efficacy|0|||
128975094|NCT01066819|464193987|FG005|Overall Study|Lack of Efficacy|0|||
128975095|NCT01066819|464193982|FG000|Overall Study|Physician Decision|6|||
128975096|NCT01066819|464193983|FG001|Overall Study|Physician Decision|2|||
128975097|NCT01066819|464193984|FG002|Overall Study|Physician Decision|3|||
128975098|NCT01066819|464193985|FG003|Overall Study|Physician Decision|0|||
128975099|NCT01066819|464193986|FG004|Overall Study|Physician Decision|0|||
128975100|NCT01066819|464193987|FG005|Overall Study|Physician Decision|0|||
128975101|NCT01066819|464193982|FG000|Overall Study|Protocol Violation|12|||
128975102|NCT01066819|464193983|FG001|Overall Study|Protocol Violation|6|||
128975103|NCT01066819|464193984|FG002|Overall Study|Protocol Violation|0|||
128975104|NCT01066819|464193985|FG003|Overall Study|Protocol Violation|0|||
128975105|NCT01066819|464193986|FG004|Overall Study|Protocol Violation|0|||
128975106|NCT01066819|464193987|FG005|Overall Study|Protocol Violation|0|||
128975107|NCT01066819|464193982|FG000|Overall Study|Withdrawal by Subject|29|||
128975108|NCT01066819|464193983|FG001|Overall Study|Withdrawal by Subject|11|||
128975109|NCT01066819|464193984|FG002|Overall Study|Withdrawal by Subject|6|||
128975110|NCT01066819|464193985|FG003|Overall Study|Withdrawal by Subject|0|||
128975111|NCT01066819|464193986|FG004|Overall Study|Withdrawal by Subject|0|||
128975112|NCT01066819|464193987|FG005|Overall Study|Withdrawal by Subject|0|||
128975113|NCT01066819|464193982|FG000|Overall Study|Administrative|6|||
128975114|NCT01066819|464193983|FG001|Overall Study|Administrative|4|||
128975115|NCT01066819|464193984|FG002|Overall Study|Administrative|2|||
128975116|NCT01066819|464193985|FG003|Overall Study|Administrative|0|||
128975117|NCT01066819|464193986|FG004|Overall Study|Administrative|0|||
128975118|NCT01066819|464193987|FG005|Overall Study|Administrative|0|||
128975119|NCT01066819|464193982|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
128975120|NCT01066819|464193983|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
128975121|NCT01066819|464193984|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
128975122|NCT01066819|464193985|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
128975123|NCT01066819|464193986|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
128975124|NCT01066819|464193987|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
128975125|NCT01066819|464193982|FG000|Overall Study|Early termination|2|||
128975126|NCT01066819|464193983|FG001|Overall Study|Early termination|0|||
128975127|NCT01066819|464193984|FG002|Overall Study|Early termination|0|||
128975128|NCT01066819|464193985|FG003|Overall Study|Early termination|0|||
128975129|NCT01066819|464193986|FG004|Overall Study|Early termination|0|||
128975130|NCT01066819|464193987|FG005|Overall Study|Early termination|0|||
128975131|NCT01066819|464193982|FG000|Overall Study|Failed to return|298|||
128975132|NCT01066819|464193983|FG001|Overall Study|Failed to return|107|||
128975133|NCT01066819|464193984|FG002|Overall Study|Failed to return|68|||
128975134|NCT01066819|464193985|FG003|Overall Study|Failed to return|7|||
128975135|NCT01066819|464193986|FG004|Overall Study|Failed to return|2|||
128975136|NCT01066819|464193987|FG005|Overall Study|Failed to return|3|||
128975137|NCT01066819|464193982|FG000|Overall Study|Lab test not done|9|||
128975138|NCT01066819|464193983|FG001|Overall Study|Lab test not done|0|||
128975139|NCT01066819|464193984|FG002|Overall Study|Lab test not done|2|||
128975140|NCT01066819|464193985|FG003|Overall Study|Lab test not done|1|||
128975141|NCT01066819|464193986|FG004|Overall Study|Lab test not done|0|||
128975142|NCT01066819|464193987|FG005|Overall Study|Lab test not done|0|||
128975143|NCT01066819|464193982|FG000|Overall Study|Miscellaneous|28|||
128975144|NCT01066819|464193983|FG001|Overall Study|Miscellaneous|10|||
128975145|NCT01066819|464193984|FG002|Overall Study|Miscellaneous|18|||
128975146|NCT01066819|464193985|FG003|Overall Study|Miscellaneous|1|||
128975147|NCT01066819|464193986|FG004|Overall Study|Miscellaneous|0|||
128975148|NCT01066819|464193987|FG005|Overall Study|Miscellaneous|0|||
128975149|NCT01066819|464193982|FG000|Overall Study|Non responders|123|||
128975150|NCT01066819|464193983|FG001|Overall Study|Non responders|2|||
128975151|NCT01066819|464193984|FG002|Overall Study|Non responders|7|||
128975152|NCT01066819|464193985|FG003|Overall Study|Non responders|2|||
128975153|NCT01066819|464193986|FG004|Overall Study|Non responders|0|||
128975154|NCT01066819|464193987|FG005|Overall Study|Non responders|1|||
128975155|NCT01066819|464193982|FG000|Overall Study|Not categorised|9|||
128975156|NCT01066819|464193983|FG001|Overall Study|Not categorised|2|||
128975157|NCT01066819|464193984|FG002|Overall Study|Not categorised|6|||
128975158|NCT01066819|464193985|FG003|Overall Study|Not categorised|1|||
128975159|NCT01066819|464193986|FG004|Overall Study|Not categorised|0|||
128975160|NCT01066819|464193987|FG005|Overall Study|Not categorised|0|||
128975161|NCT01066819|464193982|FG000|Overall Study|Relapse|16|||
128975162|NCT01066819|464193983|FG001|Overall Study|Relapse|4|||
128975163|NCT01066819|464193984|FG002|Overall Study|Relapse|3|||
128975164|NCT01066819|464193985|FG003|Overall Study|Relapse|0|||
128975165|NCT01066819|464193986|FG004|Overall Study|Relapse|0|||
128975166|NCT01066819|464193987|FG005|Overall Study|Relapse|0|||
128975167|NCT01066819|464193982|FG000|Overall Study|Results not available|1|||
128975168|NCT01066819|464193983|FG001|Overall Study|Results not available|0|||
129038982|NCT03078478|464433313|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
129038983|NCT03078478|464433314|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
128975169|NCT01066819|464193984|FG002|Overall Study|Results not available|0|||
128975170|NCT01066819|464193985|FG003|Overall Study|Results not available|0|||
128975171|NCT01066819|464193986|FG004|Overall Study|Results not available|0|||
128975172|NCT01066819|464193987|FG005|Overall Study|Results not available|0|||
129038984|NCT03078478|464433313|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
128975173|NCT01066819|464193982|FG000|Overall Study|Screen failure|1|||
128975174|NCT01066819|464193983|FG001|Overall Study|Screen failure|0|||
128975175|NCT01066819|464193984|FG002|Overall Study|Screen failure|0|||
129038985|NCT03078478|464433314|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
129038986|NCT03078478|464433313|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
129038987|NCT03078478|464433314|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
129038988|NCT03078478|464433313|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
129038989|NCT03078478|464433314|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
129038990|NCT03078478|464433313|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
129038991|NCT03078478|464433314|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
129038992|NCT03078478|464433313|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
129038993|NCT03078478|464433314|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
129038994|NCT03078478|464433313|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
129038995|NCT03078478|464433314|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
129038996|NCT03253094|464433316|FG000|Overall Study|Adverse Event|2|||
129038997|NCT03253094|464433317|FG001|Overall Study|Adverse Event|0|||
129038998|NCT03253094|464433318|FG002|Overall Study|Adverse Event|0|||
129038999|NCT03253094|464433319|FG003|Overall Study|Adverse Event|0|||
129039000|NCT03253094|464433320|FG004|Overall Study|Adverse Event|0|||
129039001|NCT03253094|464433321|FG005|Overall Study|Adverse Event|0|||
129039002|NCT03253094|464433316|FG000|Overall Study|Lack of Efficacy|0|||
129039003|NCT03253094|464433317|FG001|Overall Study|Lack of Efficacy|0|||
129039004|NCT03253094|464433318|FG002|Overall Study|Lack of Efficacy|2|||
129039005|NCT03253094|464433319|FG003|Overall Study|Lack of Efficacy|1|||
129039006|NCT03253094|464433320|FG004|Overall Study|Lack of Efficacy|2|||
129039007|NCT03253094|464433321|FG005|Overall Study|Lack of Efficacy|1|||
129039008|NCT03253094|464433316|FG000|Overall Study|Lost to Follow-up|0|||
129039009|NCT03253094|464433317|FG001|Overall Study|Lost to Follow-up|0|||
129039010|NCT03253094|464433318|FG002|Overall Study|Lost to Follow-up|1|||
129039011|NCT03253094|464433319|FG003|Overall Study|Lost to Follow-up|1|||
129039012|NCT03253094|464433320|FG004|Overall Study|Lost to Follow-up|0|||
129039013|NCT03253094|464433321|FG005|Overall Study|Lost to Follow-up|1|||
129039014|NCT03253094|464433316|FG000|Overall Study|Physician Decision|1|||
129039015|NCT03253094|464433317|FG001|Overall Study|Physician Decision|0|||
129039016|NCT03253094|464433318|FG002|Overall Study|Physician Decision|0|||
129039017|NCT03253094|464433319|FG003|Overall Study|Physician Decision|1|||
129039018|NCT03253094|464433320|FG004|Overall Study|Physician Decision|0|||
129039019|NCT03253094|464433321|FG005|Overall Study|Physician Decision|2|||
129039020|NCT03253094|464433316|FG000|Overall Study|Withdrawal by Subject|1|||
129039021|NCT03253094|464433317|FG001|Overall Study|Withdrawal by Subject|2|||
129039022|NCT03253094|464433318|FG002|Overall Study|Withdrawal by Subject|1|||
129039023|NCT03253094|464433319|FG003|Overall Study|Withdrawal by Subject|0|||
129039024|NCT03253094|464433320|FG004|Overall Study|Withdrawal by Subject|3|||
129039025|NCT03253094|464433321|FG005|Overall Study|Withdrawal by Subject|0|||
129039026|NCT03253094|464433316|FG000|Overall Study|Other|0|||
129039027|NCT03253094|464433317|FG001|Overall Study|Other|1|||
129039028|NCT03253094|464433318|FG002|Overall Study|Other|2|||
129039029|NCT03253094|464433319|FG003|Overall Study|Other|1|||
129039030|NCT03253094|464433320|FG004|Overall Study|Other|0|||
129039031|NCT03253094|464433321|FG005|Overall Study|Other|0|||
129039032|NCT02339090|464433322|FG000|Overall Study|Adverse Event|1|||
129039033|NCT02339090|464433323|FG001|Overall Study|Adverse Event|0|||
129039034|NCT02339090|464433322|FG000|Overall Study|Lost to Follow-up|0|||
129221303|NCT05767749|465110225|FG003|Overall Study|Withdrawal by Subject|2|||
129039035|NCT02339090|464433323|FG001|Overall Study|Lost to Follow-up|1|||
129039036|NCT02339090|464433322|FG000|Overall Study|Non-compliance With Study Drug|0|||
129039037|NCT02339090|464433323|FG001|Overall Study|Non-compliance With Study Drug|1|||
129039038|NCT02339090|464433322|FG000|Overall Study|Withdrawal by Subject|2|||
129039039|NCT02339090|464433323|FG001|Overall Study|Withdrawal by Subject|1|||
129039040|NCT02339090|464433322|FG000|Overall Study|Poor Growth|3|||
129039041|NCT02339090|464433323|FG001|Overall Study|Poor Growth|0|||
129039042|NCT02339090|464433322|FG000|Overall Study|Randomized but not treated|0|||
129039043|NCT02339090|464433323|FG001|Overall Study|Randomized but not treated|2|||
129039044|NCT02737592|464433326|FG000|Overall Study|Withdrawal by Subject|1|||
129039045|NCT00576303|464433327|FG000|Dose Titration Period|Early withdrawal|17|||
129039046|NCT00576303|464433327|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
129039047|NCT00576303|464433327|FG000|Long Term Safety Period|Early withdrawal|16|||
129039048|NCT00955721|464433328|FG000|Overall Study|Physician Decision|1|||
129039049|NCT00955721|464433329|FG001|Overall Study|Physician Decision|0|||
129039050|NCT00955721|464433328|FG000|Overall Study|Death|1|||
129039051|NCT00955721|464433329|FG001|Overall Study|Death|0|||
129039052|NCT00955721|464433328|FG000|Overall Study|Withdrawal by Subject|1|||
129039053|NCT00955721|464433329|FG001|Overall Study|Withdrawal by Subject|0|||
129039054|NCT00749411|464433334|FG000|Overall Study|Adverse Event|0|||
129039055|NCT00749411|464433335|FG001|Overall Study|Adverse Event|2|||
129039056|NCT00749411|464433334|FG000|Overall Study|Lack of Efficacy|0|||
129039057|NCT00749411|464433335|FG001|Overall Study|Lack of Efficacy|1|||
129039058|NCT00749411|464433334|FG000|Overall Study|Protocol Violation|1|||
129039059|NCT00749411|464433335|FG001|Overall Study|Protocol Violation|1|||
129039060|NCT00749411|464433334|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129221304|NCT05767749|465110226|FG004|Overall Study|Withdrawal by Subject|2|||
129131704|NCT00541229|464774902|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
129131705|NCT00541229|464774903|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
129131706|NCT00541229|464774904|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
129131707|NCT00541229|464774905|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
128975176|NCT01066819|464193985|FG003|Overall Study|Screen failure|0|||
128975177|NCT01066819|464193986|FG004|Overall Study|Screen failure|0|||
128975178|NCT01066819|464193987|FG005|Overall Study|Screen failure|0|||
128975179|NCT01066819|464193982|FG000|Overall Study|Spontaneous cure|1|||
128975180|NCT01066819|464193983|FG001|Overall Study|Spontaneous cure|0|||
128975181|NCT01066819|464193984|FG002|Overall Study|Spontaneous cure|0|||
128975182|NCT01066819|464193985|FG003|Overall Study|Spontaneous cure|0|||
128975183|NCT01066819|464193986|FG004|Overall Study|Spontaneous cure|0|||
128975184|NCT01066819|464193987|FG005|Overall Study|Spontaneous cure|0|||
128975185|NCT01066819|464193982|FG000|Overall Study|Treatment never started|85|||
128975186|NCT01066819|464193983|FG001|Overall Study|Treatment never started|19|||
128975187|NCT01066819|464193984|FG002|Overall Study|Treatment never started|19|||
128975188|NCT01066819|464193985|FG003|Overall Study|Treatment never started|3|||
128975189|NCT01066819|464193986|FG004|Overall Study|Treatment never started|2|||
128975190|NCT01066819|464193987|FG005|Overall Study|Treatment never started|2|||
128975191|NCT01066819|464193982|FG000|Overall Study|Treatment stopped|12|||
128975192|NCT01066819|464193983|FG001|Overall Study|Treatment stopped|1|||
128975193|NCT01066819|464193984|FG002|Overall Study|Treatment stopped|2|||
128975194|NCT01066819|464193985|FG003|Overall Study|Treatment stopped|1|||
128975195|NCT01066819|464193986|FG004|Overall Study|Treatment stopped|0|||
128975196|NCT01066819|464193987|FG005|Overall Study|Treatment stopped|0|||
128975197|NCT01066819|464193982|FG000|Overall Study|Other|5|||
128975198|NCT01066819|464193983|FG001|Overall Study|Other|1|||
128975199|NCT01066819|464193984|FG002|Overall Study|Other|1|||
128975200|NCT01066819|464193985|FG003|Overall Study|Other|0|||
128975201|NCT01066819|464193986|FG004|Overall Study|Other|0|||
128975202|NCT01066819|464193987|FG005|Overall Study|Other|0|||
128975203|NCT00805194|464193988|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
128975204|NCT00805194|464193989|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
128975205|NCT00805194|464193988|FG000|Overall Study|Worsening or AE of underlying disease|64|||
128975206|NCT00805194|464193989|FG001|Overall Study|Worsening or AE of underlying disease|70|||
128975207|NCT00805194|464193988|FG000|Overall Study|Other AE|84|||
128975208|NCT00805194|464193989|FG001|Overall Study|Other AE|73|||
128975209|NCT00805194|464193988|FG000|Overall Study|Protocol Violation|9|||
128975210|NCT00805194|464193989|FG001|Overall Study|Protocol Violation|9|||
128975211|NCT00805194|464193988|FG000|Overall Study|Lost to Follow-up|5|||
128975212|NCT00805194|464193989|FG001|Overall Study|Lost to Follow-up|5|||
128975213|NCT00805194|464193988|FG000|Overall Study|Withdrawal by Subject|60|||
128975214|NCT00805194|464193989|FG001|Overall Study|Withdrawal by Subject|42|||
128975215|NCT00805194|464193988|FG000|Overall Study|Not treated|3|||
128975216|NCT00805194|464193989|FG001|Overall Study|Not treated|4|||
128975217|NCT00805194|464193988|FG000|Overall Study|Reasons other than stated above|20|||
128975218|NCT00805194|464193989|FG001|Overall Study|Reasons other than stated above|16|||
129131708|NCT00541229|464774906|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
129131709|NCT00541229|464774907|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
129131710|NCT00541229|464774902|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
129131711|NCT00541229|464774903|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
129131712|NCT00541229|464774904|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
129131713|NCT00541229|464774905|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
129131714|NCT00541229|464774906|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
129131715|NCT00541229|464774907|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
129131716|NCT00541229|464774902|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129131717|NCT00541229|464774903|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129131718|NCT00541229|464774904|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
128975219|NCT00696774|464194000|FG000|Period II|Adverse Event|0|||
128975220|NCT00696774|464194001|FG001|Period II|Adverse Event|0|||
128975221|NCT00696774|464194002|FG002|Period II|Adverse Event|15|||
128975222|NCT00696774|464194000|FG000|Period II|Lost to Follow-up|0|||
128975223|NCT00696774|464194001|FG001|Period II|Lost to Follow-up|0|||
128975224|NCT00696774|464194002|FG002|Period II|Lost to Follow-up|4|||
128975225|NCT00696774|464194000|FG000|Period II|Protocol Violation|0|||
128975226|NCT00696774|464194001|FG001|Period II|Protocol Violation|0|||
128774732|NCT04157686|463466653|FG001|Overall Study|Death|0|||
128774733|NCT04157686|463466654|FG002|Overall Study|Death|0|||
128975227|NCT00696774|464194002|FG002|Period II|Protocol Violation|11|||
128975228|NCT00696774|464194000|FG000|Period II|Withdrawal by Subject|0|||
128975229|NCT00696774|464194001|FG001|Period II|Withdrawal by Subject|0|||
128975230|NCT00696774|464194002|FG002|Period II|Withdrawal by Subject|4|||
128975231|NCT00696774|464194000|FG000|Period II|Sponsor Decision|0|||
128975232|NCT00696774|464194001|FG001|Period II|Sponsor Decision|0|||
128975233|NCT00696774|464194002|FG002|Period II|Sponsor Decision|0|||
128975234|NCT00696774|464194000|FG000|Period II|Lack of Efficacy|0|||
128975235|NCT00696774|464194001|FG001|Period II|Lack of Efficacy|0|||
128975236|NCT00696774|464194002|FG002|Period II|Lack of Efficacy|2|||
128975237|NCT00696774|464194000|FG000|Period III|Adverse Event|1|||
128975238|NCT00696774|464194001|FG001|Period III|Adverse Event|1|||
128975239|NCT00696774|464194002|FG002|Period III|Adverse Event|0|||
128975240|NCT00696774|464194000|FG000|Period III|Lost to Follow-up|2|||
128975241|NCT00696774|464194001|FG001|Period III|Lost to Follow-up|1|||
128975242|NCT00696774|464194002|FG002|Period III|Lost to Follow-up|0|||
128975243|NCT00696774|464194000|FG000|Period III|Protocol Violation|1|||
128975244|NCT00696774|464194001|FG001|Period III|Protocol Violation|1|||
128975245|NCT00696774|464194002|FG002|Period III|Protocol Violation|0|||
128975246|NCT00696774|464194000|FG000|Period III|Withdrawal by Subject|1|||
128975247|NCT00696774|464194001|FG001|Period III|Withdrawal by Subject|2|||
128975248|NCT00696774|464194002|FG002|Period III|Withdrawal by Subject|0|||
128975249|NCT00696774|464194000|FG000|Period III|Sponsor Decision|2|||
128975250|NCT00696774|464194001|FG001|Period III|Sponsor Decision|0|||
128975251|NCT00696774|464194002|FG002|Period III|Sponsor Decision|0|||
128975252|NCT00696774|464194000|FG000|Period III|Lack of Efficacy|0|||
128975253|NCT00696774|464194001|FG001|Period III|Lack of Efficacy|2|||
128975254|NCT00696774|464194002|FG002|Period III|Lack of Efficacy|0|||
128975255|NCT03490734|464194003|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
128975256|NCT03490734|464194004|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
128975257|NCT03490734|464194005|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
128975258|NCT03490734|464194006|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
128975259|NCT03490734|464194003|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
128975260|NCT03490734|464194004|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
128975261|NCT03490734|464194005|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
128975262|NCT03490734|464194006|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
128975263|NCT03490734|464194003|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
128975264|NCT03490734|464194004|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
128975265|NCT03490734|464194005|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
128975266|NCT03490734|464194006|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
128975267|NCT03490734|464194003|FG000|Post-intervention Scan Visit|Adverse Event|2|||
129131719|NCT00541229|464774905|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129131720|NCT00541229|464774906|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129131721|NCT00541229|464774907|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
129131722|NCT00541229|464774902|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129131723|NCT00541229|464774903|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129131724|NCT00541229|464774904|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
129131725|NCT00541229|464774905|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129131726|NCT00541229|464774906|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129131727|NCT00541229|464774907|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129131728|NCT03439839|464774908|FG000|Overall Study|Death|3|||
129131729|NCT03439839|464774909|FG001|Overall Study|Death|0|||
129131730|NCT01807520|464774910|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129131731|NCT01807520|464774911|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
129131732|NCT01807520|464774912|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
129131733|NCT01807520|464774913|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129131734|NCT01807520|464774914|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129131735|NCT01807520|464774915|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129131736|NCT01807520|464774916|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129131737|NCT01807520|464774910|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
129131738|NCT01807520|464774911|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129131739|NCT01807520|464774912|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
129131740|NCT01807520|464774913|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129131741|NCT01807520|464774914|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129131742|NCT01807520|464774915|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129131743|NCT01807520|464774916|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
128975268|NCT03490734|464194004|FG001|Post-intervention Scan Visit|Adverse Event|0|||
128975269|NCT03490734|464194005|FG002|Post-intervention Scan Visit|Adverse Event|0|||
128975270|NCT03490734|464194006|FG003|Post-intervention Scan Visit|Adverse Event|0|||
128975271|NCT03490734|464194003|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
128975272|NCT03490734|464194004|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
129131744|NCT01807520|464774910|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129131745|NCT01807520|464774911|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
128975273|NCT03490734|464194005|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
128975274|NCT03490734|464194006|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
128975275|NCT03490734|464194003|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
128975276|NCT03490734|464194004|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
128975277|NCT03490734|464194005|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
128975278|NCT03490734|464194006|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
129039061|NCT00749411|464433335|FG001|Overall Study|Protocol-defined stopping criteria|1|||
129039062|NCT03183141|464433336|FG000|Overall Study|Withdrawal by Subject|2|||
129039063|NCT03183141|464433337|FG001|Overall Study|Withdrawal by Subject|4|||
129039064|NCT03183141|464433336|FG000|Overall Study|Death|0|||
129039065|NCT03183141|464433337|FG001|Overall Study|Death|8|||
129039066|NCT02756637|464433339|FG000|Overall Study|Not eligible for initial SWOG study|10|||
129039067|NCT02756637|464433340|FG001|Overall Study|Not eligible for initial SWOG study|10|||
129039068|NCT02756637|464433339|FG000|Overall Study|No available NLR value|44|||
129039069|NCT02756637|464433340|FG001|Overall Study|No available NLR value|44|||
129039070|NCT02756637|464433339|FG000|Overall Study|Did not complete curative therapy|33|||
129039071|NCT02756637|464433340|FG001|Overall Study|Did not complete curative therapy|0|||
129039072|NCT04034355|464433343|FG000|Overall Study|Study terminated by Sponsor|10|||
129039073|NCT04034355|464433344|FG001|Overall Study|Study terminated by Sponsor|17|||
129039074|NCT04034355|464433343|FG000|Overall Study|Withdrawal by Subject|12|||
129039075|NCT04034355|464433344|FG001|Overall Study|Withdrawal by Subject|11|||
129039076|NCT04034355|464433343|FG000|Overall Study|Site terminated by Sponsor|4|||
129039077|NCT04034355|464433344|FG001|Overall Study|Site terminated by Sponsor|5|||
129039078|NCT04034355|464433343|FG000|Overall Study|Adverse Event|2|||
129039079|NCT04034355|464433344|FG001|Overall Study|Adverse Event|0|||
129039080|NCT04034355|464433343|FG000|Overall Study|Death|1|||
129039081|NCT04034355|464433344|FG001|Overall Study|Death|1|||
129039082|NCT04034355|464433343|FG000|Overall Study|Not reported|2|||
129039083|NCT04034355|464433344|FG001|Overall Study|Not reported|0|||
129039084|NCT04034355|464433343|FG000|Overall Study|Lost to Follow-up|1|||
129039085|NCT04034355|464433344|FG001|Overall Study|Lost to Follow-up|0|||
129039086|NCT04034355|464433343|FG000|Overall Study|Physician Decision|1|||
129039087|NCT04034355|464433344|FG001|Overall Study|Physician Decision|0|||
129039088|NCT04034355|464433343|FG000|Overall Study|Protocol Violation|0|||
129039089|NCT04034355|464433344|FG001|Overall Study|Protocol Violation|1|||
129039090|NCT04034355|464433343|FG000|Overall Study|Progressive disease|1|||
129039091|NCT04034355|464433344|FG001|Overall Study|Progressive disease|0|||
129040327|NCT00544817|464440116|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
129040328|NCT00544817|464440116|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
129040329|NCT01131299|464440117|FG000|Overall Study|Withdrawal by Subject|4|||
129040330|NCT01131299|464440118|FG001|Overall Study|Withdrawal by Subject|7|||
129040331|NCT01221090|464440119|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
129040332|NCT01221090|464440120|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
129040333|NCT01221090|464440121|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
129040334|NCT01221090|464440122|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
129040335|NCT01221090|464440119|FG000|Overall Study|Withdrawal by Subject|0|||
129040336|NCT01221090|464440120|FG001|Overall Study|Withdrawal by Subject|22|||
129040337|NCT01221090|464440121|FG002|Overall Study|Withdrawal by Subject|27|||
129040338|NCT01221090|464440122|FG003|Overall Study|Withdrawal by Subject|2|||
129040339|NCT00708708|464440123|FG000|Overall Study|Another therapy instead of Enbrel|141|||
129040340|NCT00708708|464440123|FG000|Overall Study|Lost to Follow-up|52|||
129040341|NCT00708708|464440123|FG000|Overall Study|Withdrawal by Subject|51|||
129040342|NCT00708708|464440123|FG000|Overall Study|Intolerance|42|||
129040343|NCT00708708|464440123|FG000|Overall Study|Another therapy along with Enbrel|15|||
129040344|NCT00708708|464440123|FG000|Overall Study|Other unspecified|11|||
129040345|NCT00708708|464440123|FG000|Overall Study|Good effectiveness|9|||
129040346|NCT00708708|464440123|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
129040347|NCT00708708|464440123|FG000|Overall Study|Administrative reasons|7|||
129040348|NCT00708708|464440123|FG000|Overall Study|Lack of effectiveness|4|||
129040349|NCT00708708|464440123|FG000|Overall Study|Lack of compliance|3|||
129040350|NCT00708708|464440123|FG000|Overall Study|Pregnancy|3|||
129040351|NCT00708708|464440123|FG000|Overall Study|Adverse Event|3|||
129040352|NCT00708708|464440123|FG000|Overall Study|Missing values|392|||
129040353|NCT04776746|464440130|FG000|Overall Study|Study terminated by sponsor|61|||
129040354|NCT04776746|464440130|FG000|Overall Study|Adverse Event|5|||
129040355|NCT04776746|464440130|FG000|Overall Study|Death|4|||
129040356|NCT04776746|464440130|FG000|Overall Study|Lack of Efficacy|3|||
129040357|NCT04776746|464440130|FG000|Overall Study|Noncompliance with study drug|2|||
129040358|NCT04776746|464440130|FG000|Overall Study|Not related to COVID-19|2|||
129040359|NCT00440466|464440131|FG000|Overall Study|Death|3|||
129040360|NCT00440466|464440132|FG001|Overall Study|Death|2|||
129040361|NCT00440466|464440133|FG002|Overall Study|Death|9|||
129040362|NCT00440466|464440131|FG000|Overall Study|Adverse Event|3|||
129040363|NCT00440466|464440132|FG001|Overall Study|Adverse Event|4|||
129040364|NCT00440466|464440133|FG002|Overall Study|Adverse Event|11|||
129040365|NCT00440466|464440131|FG000|Overall Study|Lost to Follow-up|1|||
129040366|NCT00440466|464440132|FG001|Overall Study|Lost to Follow-up|0|||
129040367|NCT00440466|464440133|FG002|Overall Study|Lost to Follow-up|2|||
129040368|NCT00440466|464440131|FG000|Overall Study|Physician Decision|2|||
129040369|NCT00440466|464440132|FG001|Overall Study|Physician Decision|0|||
129040370|NCT00440466|464440133|FG002|Overall Study|Physician Decision|1|||
129040371|NCT00440466|464440131|FG000|Overall Study|Protocol Violation|2|||
129040372|NCT00440466|464440132|FG001|Overall Study|Protocol Violation|0|||
129040373|NCT00440466|464440133|FG002|Overall Study|Protocol Violation|4|||
129131746|NCT01807520|464774912|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
129131747|NCT01807520|464774913|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129131748|NCT01807520|464774914|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129131749|NCT01807520|464774915|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129131750|NCT01807520|464774916|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129131751|NCT01807520|464774910|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
129131752|NCT01807520|464774911|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129131753|NCT01807520|464774912|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129131754|NCT01807520|464774913|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129131755|NCT01807520|464774914|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129131756|NCT01807520|464774915|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129131757|NCT01807520|464774916|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129131758|NCT01807520|464774910|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129131759|NCT01807520|464774911|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129131760|NCT01807520|464774912|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
129131761|NCT01807520|464774913|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129131762|NCT01807520|464774914|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129131763|NCT01807520|464774915|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129131764|NCT01807520|464774916|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129131765|NCT01807520|464774910|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
129131766|NCT01807520|464774911|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129131767|NCT01807520|464774912|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129131768|NCT01807520|464774913|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129131769|NCT01807520|464774914|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129131770|NCT01807520|464774915|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129131771|NCT01807520|464774916|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129131772|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
129131773|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
129131774|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129131775|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129131776|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
129131777|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129131778|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129131779|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129131780|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129131781|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129131782|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
129131783|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129131784|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129131785|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129131786|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
129131787|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129131788|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129131789|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129131790|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129131791|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129131792|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129131793|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129131794|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
129131795|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129131796|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129131797|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129131798|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129131799|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129131800|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
129131801|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129131802|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129131803|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
129131804|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129131805|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129131806|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129131807|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
129131808|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
129131809|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129131810|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129131811|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
128774734|NCT04157686|463466655|FG003|Overall Study|Death|2|||
128975279|NCT00887913|464194009|FG000|Overall Study|Withdrawal by Subject|6|||
128975280|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
128975281|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
128975282|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
128975283|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
129131812|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129131813|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129131814|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
129131815|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
129131816|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129131817|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
129131818|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129131819|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129131820|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129131821|NCT01807520|464774910|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
129131822|NCT01807520|464774911|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
129131823|NCT01807520|464774912|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
129131824|NCT01807520|464774913|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
129131825|NCT01807520|464774914|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
129131826|NCT01807520|464774915|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
129131827|NCT01807520|464774916|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
129131828|NCT01807520|464774910|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129131829|NCT01807520|464774911|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129131830|NCT01807520|464774912|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129131831|NCT01807520|464774913|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129131832|NCT01807520|464774914|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129131833|NCT01807520|464774915|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
129131834|NCT01807520|464774916|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129131835|NCT01807520|464774910|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129131836|NCT01807520|464774911|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129131837|NCT01807520|464774912|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129131838|NCT01807520|464774913|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129131839|NCT01807520|464774914|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129131840|NCT01807520|464774915|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
129131841|NCT01807520|464774916|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129131842|NCT01807520|464774910|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129131843|NCT01807520|464774911|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129131844|NCT01807520|464774912|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129131845|NCT01807520|464774913|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129131846|NCT01807520|464774914|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
128715988|NCT01641692|463256669|FG004|Treatment Period 2|Lack of Efficacy|0|||
128715989|NCT01641692|463256670|FG005|Treatment Period 2|Lack of Efficacy|0|||
128715990|NCT01641692|463256671|FG006|Treatment Period 2|Lack of Efficacy|0|||
128715991|NCT01641692|463256672|FG007|Treatment Period 2|Lack of Efficacy|0|||
128715992|NCT01641692|463256665|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
128715993|NCT01641692|463256666|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
128715994|NCT01641692|463256667|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
128715995|NCT01641692|463256668|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
128715996|NCT01641692|463256669|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
128715997|NCT01641692|463256670|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
128715998|NCT01641692|463256671|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
128715999|NCT01641692|463256672|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
128716000|NCT01641692|463256665|FG000|Treatment Period 2|Lost to Follow-up|0|||
128716001|NCT01641692|463256666|FG001|Treatment Period 2|Lost to Follow-up|0|||
128716002|NCT01641692|463256667|FG002|Treatment Period 2|Lost to Follow-up|0|||
128716003|NCT01641692|463256668|FG003|Treatment Period 2|Lost to Follow-up|0|||
128716004|NCT01641692|463256669|FG004|Treatment Period 2|Lost to Follow-up|0|||
128716005|NCT01641692|463256670|FG005|Treatment Period 2|Lost to Follow-up|1|||
128716006|NCT01641692|463256671|FG006|Treatment Period 2|Lost to Follow-up|0|||
128716007|NCT01641692|463256672|FG007|Treatment Period 2|Lost to Follow-up|0|||
128716008|NCT01641692|463256665|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128716009|NCT01641692|463256666|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128716010|NCT01641692|463256667|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128716011|NCT01641692|463256668|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128975284|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
129131847|NCT01807520|464774915|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
128716012|NCT01641692|463256669|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128716013|NCT01641692|463256670|FG005|Treatment Period 2|Withdrawal by Subject|1|||
128716014|NCT01641692|463256671|FG006|Treatment Period 2|Withdrawal by Subject|0|||
128716015|NCT01641692|463256672|FG007|Treatment Period 2|Withdrawal by Subject|1|||
129131848|NCT01807520|464774916|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
129131849|NCT01797185|464774922|FG000|Overall Study|Adverse Event|5|||
129131850|NCT01797185|464774923|FG001|Overall Study|Adverse Event|15|||
129131851|NCT01797185|464774924|FG002|Overall Study|Adverse Event|6|||
129131852|NCT01797185|464774922|FG000|Overall Study|Withdrawal by Subject|6|||
129131853|NCT01797185|464774923|FG001|Overall Study|Withdrawal by Subject|9|||
129131854|NCT01797185|464774924|FG002|Overall Study|Withdrawal by Subject|5|||
129131855|NCT01797185|464774922|FG000|Overall Study|Site terminated|8|||
129131856|NCT01797185|464774923|FG001|Overall Study|Site terminated|4|||
129131857|NCT01797185|464774924|FG002|Overall Study|Site terminated|0|||
129131858|NCT01797185|464774922|FG000|Overall Study|Lost to Follow-up|2|||
129131859|NCT01797185|464774923|FG001|Overall Study|Lost to Follow-up|6|||
129131860|NCT01797185|464774924|FG002|Overall Study|Lost to Follow-up|1|||
129131861|NCT01797185|464774922|FG000|Overall Study|Withdrawn per sponsor|5|||
129131862|NCT01797185|464774923|FG001|Overall Study|Withdrawn per sponsor|0|||
129131863|NCT01797185|464774924|FG002|Overall Study|Withdrawn per sponsor|0|||
129131864|NCT01797185|464774922|FG000|Overall Study|Physician Decision|1|||
129131865|NCT01797185|464774923|FG001|Overall Study|Physician Decision|3|||
129131866|NCT01797185|464774924|FG002|Overall Study|Physician Decision|0|||
129131867|NCT01797185|464774922|FG000|Overall Study|Protocol Violation|1|||
129131868|NCT01797185|464774923|FG001|Overall Study|Protocol Violation|1|||
129131869|NCT01797185|464774924|FG002|Overall Study|Protocol Violation|0|||
129131870|NCT00723944|464774925|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
129131871|NCT00723944|464774926|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
129131872|NCT00723944|464774925|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
129131873|NCT00723944|464774926|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
129131874|NCT00723944|464774925|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
129131875|NCT00723944|464774926|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
129131876|NCT05177094|464774927|FG000|Overall Study|Adverse Event|5|||
129131877|NCT05177094|464774928|FG001|Overall Study|Adverse Event|5|||
129131878|NCT05177094|464774927|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
129131879|NCT05177094|464774928|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
129131880|NCT05177094|464774927|FG000|Overall Study|Protocol Deviation|3|||
129131881|NCT05177094|464774928|FG001|Overall Study|Protocol Deviation|0|||
129131882|NCT05177094|464774927|FG000|Overall Study|Withdrawal by Subject|6|||
129131883|NCT05177094|464774928|FG001|Overall Study|Withdrawal by Subject|3|||
129131884|NCT05177094|464774927|FG000|Overall Study|Participant could not tolerate long study visits|1|||
129131885|NCT05177094|464774928|FG001|Overall Study|Participant could not tolerate long study visits|0|||
129131886|NCT02400736|464774929|FG000|Overall Study|Lost to Follow-up|6|||
129131887|NCT02400736|464774930|FG001|Overall Study|Lost to Follow-up|6|||
129131888|NCT02400736|464774929|FG000|Overall Study|Withdrawal by Subject|2|||
129131889|NCT02400736|464774930|FG001|Overall Study|Withdrawal by Subject|1|||
129131890|NCT02400736|464774929|FG000|Overall Study|Moved from the area|3|||
129131891|NCT02400736|464774930|FG001|Overall Study|Moved from the area|1|||
129131892|NCT01875237|464774931|FG000|Overall Study|GVDH before DLI|1|||
129131893|NCT01875237|464774932|FG001|Overall Study|GVDH before DLI|0|||
129131894|NCT01875237|464774931|FG000|Overall Study|DLI cells could not be produced|1|||
129131895|NCT01875237|464774932|FG001|Overall Study|DLI cells could not be produced|0|||
129131896|NCT03558672|464774933|FG000|Overall Study|Study Early Termination|10|||
129131897|NCT00421733|464774935|FG000|Overall Study|Adverse Event|4|||
129131898|NCT00421733|464774936|FG001|Overall Study|Adverse Event|9|||
129131899|NCT00421733|464774937|FG002|Overall Study|Adverse Event|2|||
129131900|NCT00421733|464774935|FG000|Overall Study|Lost to Follow-up|1|||
129131901|NCT00421733|464774936|FG001|Overall Study|Lost to Follow-up|2|||
129131902|NCT00421733|464774937|FG002|Overall Study|Lost to Follow-up|4|||
129131903|NCT00421733|464774935|FG000|Overall Study|Withdrawal by Subject|1|||
129131904|NCT00421733|464774936|FG001|Overall Study|Withdrawal by Subject|2|||
129131905|NCT00421733|464774937|FG002|Overall Study|Withdrawal by Subject|7|||
129131906|NCT00421733|464774935|FG000|Overall Study|Death|0|||
128975285|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
128975286|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
128975287|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
129131907|NCT00421733|464774936|FG001|Overall Study|Death|3|||
129131908|NCT00421733|464774937|FG002|Overall Study|Death|0|||
129131909|NCT00421733|464774935|FG000|Overall Study|Required dialysis|1|||
128975288|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Death|0|||
129131910|NCT00421733|464774936|FG001|Overall Study|Required dialysis|0|||
129131911|NCT00421733|464774937|FG002|Overall Study|Required dialysis|0|||
129131912|NCT00421733|464774935|FG000|Overall Study|Administrative|2|||
129131913|NCT00421733|464774936|FG001|Overall Study|Administrative|0|||
129131914|NCT00421733|464774937|FG002|Overall Study|Administrative|0|||
129131915|NCT00421733|464774935|FG000|Overall Study|Did not satisfy entry criteria|1|||
129131916|NCT00421733|464774936|FG001|Overall Study|Did not satisfy entry criteria|3|||
129131917|NCT00421733|464774937|FG002|Overall Study|Did not satisfy entry criteria|2|||
129131918|NCT00421733|464774935|FG000|Overall Study|Sponsor request|1|||
128975289|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Death|0|||
129131919|NCT00421733|464774936|FG001|Overall Study|Sponsor request|0|||
129131920|NCT00421733|464774937|FG002|Overall Study|Sponsor request|3|||
129131921|NCT00421733|464774935|FG000|Overall Study|Protocol deviation|4|||
129131922|NCT00421733|464774936|FG001|Overall Study|Protocol deviation|7|||
129131923|NCT00421733|464774937|FG002|Overall Study|Protocol deviation|2|||
129131924|NCT02265744|464774942|FG000|Overall Study|Poor/Non-compliance|1|||
129131925|NCT02265744|464774943|FG001|Overall Study|Poor/Non-compliance|1|||
129131926|NCT02265744|464774944|FG002|Overall Study|Poor/Non-compliance|0|||
129131927|NCT02265744|464774945|FG003|Overall Study|Poor/Non-compliance|0|||
129131928|NCT02265744|464774946|FG004|Overall Study|Poor/Non-compliance|2|||
129131929|NCT02265744|464774942|FG000|Overall Study|Lost to Follow-up|0|||
129131930|NCT02265744|464774943|FG001|Overall Study|Lost to Follow-up|0|||
129131931|NCT02265744|464774944|FG002|Overall Study|Lost to Follow-up|0|||
129131932|NCT02265744|464774945|FG003|Overall Study|Lost to Follow-up|1|||
129131933|NCT02265744|464774946|FG004|Overall Study|Lost to Follow-up|0|||
129131934|NCT02265744|464774942|FG000|Overall Study|Death|0|||
129131935|NCT02265744|464774943|FG001|Overall Study|Death|0|||
129131936|NCT02265744|464774944|FG002|Overall Study|Death|0|||
129131937|NCT02265744|464774945|FG003|Overall Study|Death|2|||
129131938|NCT02265744|464774946|FG004|Overall Study|Death|0|||
129131939|NCT02265744|464774942|FG000|Overall Study|Withdrawal by Subject|2|||
129131940|NCT02265744|464774943|FG001|Overall Study|Withdrawal by Subject|0|||
129131941|NCT02265744|464774944|FG002|Overall Study|Withdrawal by Subject|0|||
129131942|NCT02265744|464774945|FG003|Overall Study|Withdrawal by Subject|2|||
129131943|NCT02265744|464774946|FG004|Overall Study|Withdrawal by Subject|0|||
129131944|NCT02265744|464774942|FG000|Overall Study|Participant request to discontinue|2|||
129131945|NCT02265744|464774943|FG001|Overall Study|Participant request to discontinue|2|||
129131946|NCT02265744|464774944|FG002|Overall Study|Participant request to discontinue|2|||
129131947|NCT02265744|464774945|FG003|Overall Study|Participant request to discontinue|0|||
129131948|NCT02265744|464774946|FG004|Overall Study|Participant request to discontinue|0|||
129131949|NCT02265744|464774942|FG000|Overall Study|Adverse Event|8|||
129131950|NCT02265744|464774943|FG001|Overall Study|Adverse Event|4|||
129131951|NCT02265744|464774944|FG002|Overall Study|Adverse Event|9|||
129131952|NCT02265744|464774945|FG003|Overall Study|Adverse Event|8|||
129131953|NCT02265744|464774946|FG004|Overall Study|Adverse Event|2|||
129131954|NCT02265744|464774942|FG000|Overall Study|Lack of Efficacy|2|||
129131955|NCT02265744|464774943|FG001|Overall Study|Lack of Efficacy|4|||
129131956|NCT02265744|464774944|FG002|Overall Study|Lack of Efficacy|3|||
129131957|NCT02265744|464774945|FG003|Overall Study|Lack of Efficacy|4|||
129131958|NCT02265744|464774946|FG004|Overall Study|Lack of Efficacy|5|||
129131959|NCT02265744|464774942|FG000|Overall Study|Reason not provided by Investigator|1|||
129131960|NCT02265744|464774943|FG001|Overall Study|Reason not provided by Investigator|0|||
129131961|NCT02265744|464774944|FG002|Overall Study|Reason not provided by Investigator|0|||
129131962|NCT02265744|464774945|FG003|Overall Study|Reason not provided by Investigator|2|||
129131963|NCT02265744|464774946|FG004|Overall Study|Reason not provided by Investigator|0|||
129131964|NCT02265744|464774942|FG000|Overall Study|Administrative reason by sponsor|3|||
129131965|NCT02265744|464774943|FG001|Overall Study|Administrative reason by sponsor|2|||
129131966|NCT02265744|464774944|FG002|Overall Study|Administrative reason by sponsor|2|||
129131967|NCT02265744|464774945|FG003|Overall Study|Administrative reason by sponsor|3|||
129131968|NCT02265744|464774946|FG004|Overall Study|Administrative reason by sponsor|3|||
129131969|NCT02265744|464774942|FG000|Overall Study|Subject no longer meets study criteria|0|||
129131970|NCT02265744|464774943|FG001|Overall Study|Subject no longer meets study criteria|0|||
129131971|NCT02265744|464774944|FG002|Overall Study|Subject no longer meets study criteria|0|||
129131972|NCT02265744|464774945|FG003|Overall Study|Subject no longer meets study criteria|0|||
129131973|NCT02265744|464774946|FG004|Overall Study|Subject no longer meets study criteria|1|||
129131974|NCT02265744|464774942|FG000|Overall Study|Pregnancy|1|||
129131975|NCT02265744|464774943|FG001|Overall Study|Pregnancy|2|||
129131976|NCT02265744|464774944|FG002|Overall Study|Pregnancy|1|||
129131977|NCT02265744|464774945|FG003|Overall Study|Pregnancy|1|||
129131978|NCT02265744|464774946|FG004|Overall Study|Pregnancy|0|||
129131979|NCT05161936|464774949|FG000|Overall Study|Study terminated by Sponsor|1|||
129131980|NCT05161936|464774950|FG001|Overall Study|Study terminated by Sponsor|0|||
129131981|NCT05161936|464774951|FG002|Overall Study|Study terminated by Sponsor|0|||
129131982|NCT05161936|464774949|FG000|Overall Study|Withdrawal by Subject|0|||
129131983|NCT05161936|464774950|FG001|Overall Study|Withdrawal by Subject|0|||
129131984|NCT05161936|464774951|FG002|Overall Study|Withdrawal by Subject|1|||
129131985|NCT01158404|464774954|FG000|Overall Study|Withdrawal by Subject|0|||
129131986|NCT01158404|464774955|FG001|Overall Study|Withdrawal by Subject|1|||
129131987|NCT01158404|464774956|FG002|Overall Study|Withdrawal by Subject|0|||
129131988|NCT01158404|464774957|FG003|Overall Study|Withdrawal by Subject|0|||
128716016|NCT01641692|463256665|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129131989|NCT01158404|464774958|FG004|Overall Study|Withdrawal by Subject|3|||
129131990|NCT01158404|464774959|FG005|Overall Study|Withdrawal by Subject|1|||
129131991|NCT01158404|464774960|FG006|Overall Study|Withdrawal by Subject|0|||
129131992|NCT01158404|464774961|FG007|Overall Study|Withdrawal by Subject|1|||
129131993|NCT01158404|464774954|FG000|Overall Study|Physician Decision|0|||
129131994|NCT01158404|464774955|FG001|Overall Study|Physician Decision|0|||
129131995|NCT01158404|464774956|FG002|Overall Study|Physician Decision|0|||
129131996|NCT01158404|464774957|FG003|Overall Study|Physician Decision|0|||
129131997|NCT01158404|464774958|FG004|Overall Study|Physician Decision|0|||
129131998|NCT01158404|464774959|FG005|Overall Study|Physician Decision|0|||
129131999|NCT01158404|464774960|FG006|Overall Study|Physician Decision|0|||
129132000|NCT01158404|464774961|FG007|Overall Study|Physician Decision|1|||
129132001|NCT01158404|464774954|FG000|Overall Study|Progressive Disease|0|||
129132002|NCT01158404|464774955|FG001|Overall Study|Progressive Disease|0|||
129132003|NCT01158404|464774956|FG002|Overall Study|Progressive Disease|0|||
129132004|NCT01158404|464774957|FG003|Overall Study|Progressive Disease|0|||
129132005|NCT01158404|464774958|FG004|Overall Study|Progressive Disease|0|||
129132006|NCT01158404|464774959|FG005|Overall Study|Progressive Disease|0|||
129132007|NCT01158404|464774960|FG006|Overall Study|Progressive Disease|1|||
129132008|NCT01158404|464774961|FG007|Overall Study|Progressive Disease|0|||
129132009|NCT02384460|464774965|FG000|Overall Study|Protocol Violation|0|||
129132010|NCT02384460|464774966|FG001|Overall Study|Protocol Violation|1|||
129132011|NCT02384460|464774965|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
129132012|NCT02384460|464774966|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
129132013|NCT02384460|464774965|FG000|Overall Study|Adverse Event|5|||
129132014|NCT02384460|464774966|FG001|Overall Study|Adverse Event|2|||
129132015|NCT02384460|464774965|FG000|Overall Study|Withdrawal by Subject|0|||
129132016|NCT02384460|464774966|FG001|Overall Study|Withdrawal by Subject|3|||
129132017|NCT02384460|464774965|FG000|Overall Study|Elective medical treatment|1|||
129132018|NCT02384460|464774966|FG001|Overall Study|Elective medical treatment|0|||
129132019|NCT02384460|464774965|FG000|Overall Study|Non-compliance|1|||
129132020|NCT02384460|464774966|FG001|Overall Study|Non-compliance|0|||
129132021|NCT01060111|464774967|FG000|Overall Study|Adverse Event|9|||
129132022|NCT01060111|464774968|FG001|Overall Study|Adverse Event|5|||
129132023|NCT01060111|464774969|FG002|Overall Study|Adverse Event|18|||
129132024|NCT01060111|464774967|FG000|Overall Study|Lack of Efficacy|2|||
129132025|NCT01060111|464774968|FG001|Overall Study|Lack of Efficacy|1|||
129132026|NCT01060111|464774969|FG002|Overall Study|Lack of Efficacy|0|||
129132027|NCT01060111|464774967|FG000|Overall Study|Inappropriate participant|5|||
129132028|NCT01060111|464774968|FG001|Overall Study|Inappropriate participant|4|||
129132029|NCT01060111|464774969|FG002|Overall Study|Inappropriate participant|5|||
129132030|NCT01060111|464774967|FG000|Overall Study|Participants' evasion for hospital visit|0|||
129132031|NCT01060111|464774968|FG001|Overall Study|Participants' evasion for hospital visit|3|||
129132032|NCT01060111|464774969|FG002|Overall Study|Participants' evasion for hospital visit|2|||
129132033|NCT01060111|464774967|FG000|Overall Study|Participants' non-cooperation|8|||
129132034|NCT01060111|464774968|FG001|Overall Study|Participants' non-cooperation|6|||
129132035|NCT01060111|464774969|FG002|Overall Study|Participants' non-cooperation|6|||
129132036|NCT01060111|464774967|FG000|Overall Study|Adverse event and insufficient effect|0|||
129132037|NCT01060111|464774968|FG001|Overall Study|Adverse event and insufficient effect|1|||
129132038|NCT01060111|464774969|FG002|Overall Study|Adverse event and insufficient effect|0|||
129132039|NCT01060111|464774967|FG000|Overall Study|Participants' non-cooperation|1|||
129132040|NCT01060111|464774968|FG001|Overall Study|Participants' non-cooperation|0|||
129132041|NCT01060111|464774969|FG002|Overall Study|Participants' non-cooperation|0|||
129132042|NCT01060111|464774967|FG000|Overall Study|Other|2|||
129132043|NCT01060111|464774968|FG001|Overall Study|Other|3|||
129132044|NCT01060111|464774969|FG002|Overall Study|Other|4|||
129132045|NCT04999020|464774972|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
129132046|NCT04999020|464774973|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
129132047|NCT04999020|464774974|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
129132048|NCT04999020|464774975|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
129132049|NCT04999020|464774972|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
129132050|NCT04999020|464774973|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
129132051|NCT04999020|464774974|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
129132052|NCT04999020|464774975|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
129132053|NCT04999020|464774972|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
129132054|NCT04999020|464774973|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
129132055|NCT04999020|464774974|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
129132056|NCT04999020|464774975|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
129132057|NCT04999020|464774972|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129132058|NCT04999020|464774973|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129132059|NCT04999020|464774974|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
129132060|NCT04999020|464774975|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
129132061|NCT04999020|464774972|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
129132062|NCT04999020|464774973|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
129132063|NCT04999020|464774974|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
129132064|NCT04999020|464774975|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
129132065|NCT04999020|464774972|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
129132066|NCT04999020|464774973|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
129132067|NCT04999020|464774974|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
129132068|NCT04999020|464774975|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
129132069|NCT04999020|464774972|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
129132070|NCT04999020|464774973|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
129132071|NCT04999020|464774974|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
129132072|NCT04999020|464774975|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
129132073|NCT04999020|464774972|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
129132074|NCT04999020|464774973|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
129132075|NCT04999020|464774974|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
129132076|NCT04999020|464774975|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
129132077|NCT02448043|464774976|FG000|Overall Study|Withdrawal by Subject|2|||
129132078|NCT02448043|464774977|FG001|Overall Study|Withdrawal by Subject|2|||
129132079|NCT02448043|464774976|FG000|Overall Study|Protocol Violation|1|||
129132080|NCT02448043|464774977|FG001|Overall Study|Protocol Violation|2|||
129132081|NCT00997126|464774978|FG000|Overall Study|Physician Decision|7|||
129132082|NCT00997126|464774979|FG001|Overall Study|Physician Decision|11|||
129132083|NCT02583477|464774984|FG000|Overall Study|Adverse Event|0|||
129132084|NCT02583477|464774985|FG001|Overall Study|Adverse Event|2|||
129132085|NCT02583477|464774984|FG000|Overall Study|Death|1|||
129132086|NCT02583477|464774985|FG001|Overall Study|Death|16|||
129132087|NCT02583477|464774984|FG000|Overall Study|Study terminated|2|||
129132088|NCT02583477|464774985|FG001|Overall Study|Study terminated|2|||
129132089|NCT01327703|464774988|FG000|Second Treatment Period|Adverse Event|1|||
129132090|NCT01327703|464774989|FG001|Second Treatment Period|Adverse Event|1|||
129132091|NCT01327703|464774988|FG000|Second Treatment Period|Protocol Violation|0|||
129132092|NCT01327703|464774989|FG001|Second Treatment Period|Protocol Violation|1|||
129132093|NCT01131585|464774990|FG000|Overall Study|Adverse Event|0|||
129132094|NCT01131585|464774991|FG001|Overall Study|Adverse Event|2|||
129132095|NCT01131585|464774990|FG000|Overall Study|Abnormal laboratory value|1|||
129132096|NCT01131585|464774991|FG001|Overall Study|Abnormal laboratory value|0|||
129132097|NCT01131585|464774990|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129132098|NCT01131585|464774991|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129132099|NCT01131585|464774990|FG000|Overall Study|Protocol Violation|2|||
129132100|NCT01131585|464774991|FG001|Overall Study|Protocol Violation|1|||
129132101|NCT01131585|464774990|FG000|Overall Study|Withdrawal by Subject|3|||
129132102|NCT01131585|464774991|FG001|Overall Study|Withdrawal by Subject|3|||
129132103|NCT01131585|464774990|FG000|Overall Study|Lost to Follow-up|0|||
129132104|NCT01131585|464774991|FG001|Overall Study|Lost to Follow-up|1|||
129132105|NCT01131585|464774990|FG000|Overall Study|Administrative problems|1|||
129132106|NCT01131585|464774991|FG001|Overall Study|Administrative problems|1|||
129132107|NCT01131585|464774990|FG000|Overall Study|Study termination|78|||
129132108|NCT01131585|464774991|FG001|Overall Study|Study termination|32|||
129132109|NCT00927082|464774992|FG000|Overall Study|Lost to Follow-up|9|||
129132110|NCT00927082|464774993|FG001|Overall Study|Lost to Follow-up|8|||
129132111|NCT00927082|464774994|FG002|Overall Study|Lost to Follow-up|12|||
129132112|NCT00927082|464774995|FG003|Overall Study|Lost to Follow-up|16|||
129132113|NCT00927082|464774992|FG000|Overall Study|Withdrawal by Subject|3|||
128716017|NCT01641692|463256666|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128716018|NCT01641692|463256667|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128716019|NCT01641692|463256668|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128716020|NCT01641692|463256669|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
128975290|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Death|0|||
128975291|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Death|1|||
128975292|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Death|1|||
128975293|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Death|0|||
128975294|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Death|2|||
128975295|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Death|0|||
128975296|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
128975297|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
128975298|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
128975299|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
128975300|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
128975301|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
128975302|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
128975303|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
128975304|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
128975305|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
128975306|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
128975307|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
128975308|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
128975309|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
128975310|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
128975311|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
128975312|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
129132114|NCT00927082|464774993|FG001|Overall Study|Withdrawal by Subject|2|||
129132115|NCT00927082|464774994|FG002|Overall Study|Withdrawal by Subject|7|||
129132116|NCT00927082|464774995|FG003|Overall Study|Withdrawal by Subject|2|||
129132117|NCT00927082|464774992|FG000|Overall Study|Death|0|||
129132118|NCT00927082|464774993|FG001|Overall Study|Death|0|||
129132119|NCT00927082|464774994|FG002|Overall Study|Death|1|||
129132120|NCT00927082|464774995|FG003|Overall Study|Death|0|||
129132121|NCT00927082|464774992|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
129132122|NCT00927082|464774993|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
129132123|NCT00927082|464774994|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
129132124|NCT00927082|464774995|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
129132125|NCT01860404|464774997|FG000|Overall Study|Lost to Follow-up|3|||
129132126|NCT01860404|464774998|FG001|Overall Study|Lost to Follow-up|4|||
129132127|NCT01860404|464774999|FG002|Overall Study|Lost to Follow-up|1|||
129132128|NCT01860404|464775000|FG003|Overall Study|Lost to Follow-up|6|||
129132129|NCT01860404|464775001|FG004|Overall Study|Lost to Follow-up|4|||
129132130|NCT01860404|464774997|FG000|Overall Study|Withdrawal by Subject|0|||
129132131|NCT01860404|464774998|FG001|Overall Study|Withdrawal by Subject|0|||
129132132|NCT01860404|464774999|FG002|Overall Study|Withdrawal by Subject|4|||
129132133|NCT01860404|464775000|FG003|Overall Study|Withdrawal by Subject|0|||
129132134|NCT01860404|464775001|FG004|Overall Study|Withdrawal by Subject|0|||
128716021|NCT01641692|463256670|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128716022|NCT01641692|463256671|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
128716023|NCT01641692|463256672|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
128716024|NCT01641692|463256665|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128716025|NCT01641692|463256666|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128716026|NCT01641692|463256667|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
128716027|NCT01641692|463256668|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128716028|NCT01641692|463256669|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128716029|NCT01641692|463256670|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
128716030|NCT01641692|463256671|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128716031|NCT01641692|463256672|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
128716032|NCT01641692|463256665|FG000|Treatment Period 3|Adverse Event|0|||
128716033|NCT01641692|463256666|FG001|Treatment Period 3|Adverse Event|0|||
128716034|NCT01641692|463256667|FG002|Treatment Period 3|Adverse Event|0|||
128716035|NCT01641692|463256668|FG003|Treatment Period 3|Adverse Event|0|||
128716036|NCT01641692|463256669|FG004|Treatment Period 3|Adverse Event|0|||
128716037|NCT01641692|463256670|FG005|Treatment Period 3|Adverse Event|0|||
128716038|NCT01641692|463256671|FG006|Treatment Period 3|Adverse Event|1|||
128716039|NCT01641692|463256672|FG007|Treatment Period 3|Adverse Event|0|||
128716040|NCT01641692|463256665|FG000|Treatment Period 3|Protocol Violation|0|||
128716041|NCT01641692|463256666|FG001|Treatment Period 3|Protocol Violation|0|||
128716042|NCT01641692|463256667|FG002|Treatment Period 3|Protocol Violation|1|||
128716043|NCT01641692|463256668|FG003|Treatment Period 3|Protocol Violation|0|||
128716044|NCT01641692|463256669|FG004|Treatment Period 3|Protocol Violation|0|||
128716045|NCT01641692|463256670|FG005|Treatment Period 3|Protocol Violation|0|||
128716046|NCT01641692|463256671|FG006|Treatment Period 3|Protocol Violation|0|||
128716047|NCT01641692|463256672|FG007|Treatment Period 3|Protocol Violation|0|||
128716048|NCT01641692|463256665|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
128716049|NCT01641692|463256666|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
128716050|NCT01641692|463256667|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
128716051|NCT01641692|463256668|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
128716052|NCT01641692|463256669|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
128716053|NCT01641692|463256670|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
128716054|NCT01641692|463256671|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
128716055|NCT01641692|463256672|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
128716056|NCT01641692|463256665|FG000|Treatment Period 3|Lost to Follow-up|0|||
128716057|NCT01641692|463256666|FG001|Treatment Period 3|Lost to Follow-up|1|||
128716058|NCT01641692|463256667|FG002|Treatment Period 3|Lost to Follow-up|0|||
128716059|NCT01641692|463256668|FG003|Treatment Period 3|Lost to Follow-up|0|||
128716060|NCT01641692|463256669|FG004|Treatment Period 3|Lost to Follow-up|0|||
128716061|NCT01641692|463256670|FG005|Treatment Period 3|Lost to Follow-up|0|||
128716062|NCT01641692|463256671|FG006|Treatment Period 3|Lost to Follow-up|0|||
128716063|NCT01641692|463256672|FG007|Treatment Period 3|Lost to Follow-up|0|||
128716064|NCT01641692|463256665|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
128716065|NCT01641692|463256666|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
128716066|NCT01641692|463256667|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
128716067|NCT01641692|463256668|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
128716068|NCT01641692|463256669|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
129132135|NCT00849472|464775002|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
129132136|NCT00849472|464775002|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
129132137|NCT00849472|464775002|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
129132138|NCT00849472|464775002|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
129132139|NCT00849472|464775002|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
129132140|NCT00849472|464775002|FG000|Weekly Paclitaxel|Disease Progression|1|||
129132141|NCT00849472|464775002|FG000|Weekly Paclitaxel|Adverse Event|11|||
129132142|NCT00849472|464775002|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
129132143|NCT00849472|464775002|FG000|Weekly Paclitaxel|Physician Decision|3|||
129132144|NCT00849472|464775002|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
128975313|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
128975314|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
128975315|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
128975316|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
128975317|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
128975318|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
128975319|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
128975320|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
128975321|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
128975322|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
128975323|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
128975324|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
128975325|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
128975326|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
128975327|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
128975328|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
128975329|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
129132145|NCT00849472|464775002|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
129132146|NCT00849472|464775002|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
129132147|NCT00849472|464775002|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
129132148|NCT00849472|464775002|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
129132149|NCT00849472|464775002|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
129132150|NCT00849472|464775002|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
129132151|NCT00849472|464775002|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
129132152|NCT02762604|464775003|FG000|Overall Study|Lost to Follow-up|2|||
129132153|NCT02762604|464775004|FG001|Overall Study|Lost to Follow-up|7|||
129132154|NCT02762604|464775003|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
129132155|NCT02762604|464775004|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
129132156|NCT02691572|464775006|FG000|Overall Study|Withdrawal by Subject|1|||
129132157|NCT02691572|464775007|FG001|Overall Study|Withdrawal by Subject|0|||
129132158|NCT02691572|464775006|FG000|Overall Study|Protocol Violation|0|||
129132159|NCT02691572|464775007|FG001|Overall Study|Protocol Violation|1|||
129132160|NCT03370302|464775011|FG000|Dose Escalation Phase|Other|0|||
129132161|NCT03370302|464775012|FG001|Dose Escalation Phase|Other|1|||
129132162|NCT03370302|464775013|FG002|Dose Escalation Phase|Other|1|||
129132163|NCT03370302|464775014|FG003|Dose Escalation Phase|Other|0|||
129132164|NCT03370302|464775015|FG004|Dose Escalation Phase|Other|0|||
129132165|NCT03370302|464775016|FG005|Dose Escalation Phase|Other|0|||
129132166|NCT03370302|464775011|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
129132167|NCT03370302|464775012|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
129132168|NCT03370302|464775013|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
129132169|NCT03370302|464775014|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129132170|NCT03370302|464775015|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
129132171|NCT03370302|464775016|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
129132172|NCT03370302|464775011|FG000|Dose Escalation Phase|Adverse Event|1|||
129132173|NCT03370302|464775012|FG001|Dose Escalation Phase|Adverse Event|0|||
129221305|NCT05767749|465110227|FG005|Overall Study|Withdrawal by Subject|2|||
129221306|NCT03894813|465111362|FG000|Overall Study|Adverse Event|1|||
129221307|NCT03894813|465111363|FG001|Overall Study|Adverse Event|1|||
129221308|NCT03894813|465111362|FG000|Overall Study|Lack of Efficacy|3|||
129221309|NCT03894813|465111363|FG001|Overall Study|Lack of Efficacy|3|||
129221310|NCT03894813|465111362|FG000|Overall Study|Lost to Follow-up|1|||
129221311|NCT03894813|465111363|FG001|Overall Study|Lost to Follow-up|0|||
129221312|NCT03894813|465111362|FG000|Overall Study|Pregnancy|2|||
128975330|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
128975331|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
128975332|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
129132174|NCT03370302|464775013|FG002|Dose Escalation Phase|Adverse Event|2|||
129132175|NCT03370302|464775014|FG003|Dose Escalation Phase|Adverse Event|0|||
129132176|NCT03370302|464775015|FG004|Dose Escalation Phase|Adverse Event|0|||
129132177|NCT03370302|464775016|FG005|Dose Escalation Phase|Adverse Event|0|||
129221313|NCT03894813|465111363|FG001|Overall Study|Pregnancy|1|||
129221314|NCT03894813|465111362|FG000|Overall Study|Protocol Violation|3|||
129221315|NCT03894813|465111363|FG001|Overall Study|Protocol Violation|7|||
129132178|NCT03370302|464775011|FG000|Dose Escalation Phase|Progressive Disease|2|||
129132179|NCT03370302|464775012|FG001|Dose Escalation Phase|Progressive Disease|4|||
129132180|NCT03370302|464775013|FG002|Dose Escalation Phase|Progressive Disease|2|||
128975333|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
128975334|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
128975335|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
128975336|NCT02442765|464194010|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
129132181|NCT03370302|464775014|FG003|Dose Escalation Phase|Progressive Disease|0|||
129132182|NCT03370302|464775015|FG004|Dose Escalation Phase|Progressive Disease|3|||
129132183|NCT03370302|464775016|FG005|Dose Escalation Phase|Progressive Disease|1|||
129132184|NCT03370302|464775011|FG000|Dose Expansion Phase|Progressive Disease|0|||
129132185|NCT03370302|464775012|FG001|Dose Expansion Phase|Progressive Disease|0|||
129132186|NCT03370302|464775013|FG002|Dose Expansion Phase|Progressive Disease|0|||
129132187|NCT03370302|464775014|FG003|Dose Expansion Phase|Progressive Disease|6|||
129132188|NCT03370302|464775015|FG004|Dose Expansion Phase|Progressive Disease|0|||
129132189|NCT03370302|464775016|FG005|Dose Expansion Phase|Progressive Disease|0|||
129132190|NCT01428128|464775017|FG000|Overall Study|Withdrawal by Subject|4|||
129132191|NCT01428128|464775017|FG000|Overall Study|Screen failure by p53|10|||
129132192|NCT01428128|464775017|FG000|Overall Study|Received Neulasta in one cycle|2|||
129132193|NCT01428128|464775017|FG000|Overall Study|Adverse Event|1|||
129132194|NCT05259033|464775024|FG000|Overall Study|Withdrawal by Subject|10|||
129132195|NCT05259033|464775025|FG001|Overall Study|Withdrawal by Subject|5|||
129132196|NCT05259033|464775024|FG000|Overall Study|Lost to Follow-up|1|||
129132197|NCT05259033|464775025|FG001|Overall Study|Lost to Follow-up|0|||
129132198|NCT05259033|464775024|FG000|Overall Study|Death|2|||
129132199|NCT05259033|464775025|FG001|Overall Study|Death|0|||
129132200|NCT04180696|464775026|FG000|Overall Study|Death|5|||
129132201|NCT04180696|464775027|FG001|Overall Study|Death|6|||
129132202|NCT04180696|464775026|FG000|Overall Study|Lost to Follow-up|1|||
129132203|NCT04180696|464775027|FG001|Overall Study|Lost to Follow-up|0|||
128975337|NCT02442765|464194011|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
128975338|NCT02442765|464194012|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
128975339|NCT02442765|464194013|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
128975340|NCT02442765|464194014|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
128975341|NCT02442765|464194015|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
128975342|NCT02442765|464194016|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
128975343|NCT02442765|464194017|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
128975344|NCT01200758|464194018|FG000|Stage I|Death|0|||
128975345|NCT01200758|464194019|FG001|Stage I|Death|1|||
128975346|NCT01200758|464194020|FG002|Stage I|Death|0|||
128975347|NCT01200758|464194021|FG003|Stage I|Death|0|||
128975348|NCT01200758|464194018|FG000|Stage I|Physician Decision|1|||
128975349|NCT01200758|464194019|FG001|Stage I|Physician Decision|1|||
128975350|NCT01200758|464194020|FG002|Stage I|Physician Decision|0|||
128975351|NCT01200758|464194021|FG003|Stage I|Physician Decision|0|||
128975352|NCT01200758|464194018|FG000|Stage I|Lack of Efficacy|2|||
128975353|NCT01200758|464194019|FG001|Stage I|Lack of Efficacy|1|||
128975354|NCT01200758|464194020|FG002|Stage I|Lack of Efficacy|0|||
128975355|NCT01200758|464194021|FG003|Stage I|Lack of Efficacy|0|||
128975356|NCT01200758|464194018|FG000|Stage I|Adverse Event|5|||
128975357|NCT01200758|464194019|FG001|Stage I|Adverse Event|5|||
128975358|NCT01200758|464194020|FG002|Stage I|Adverse Event|0|||
128975359|NCT01200758|464194021|FG003|Stage I|Adverse Event|0|||
128975360|NCT01200758|464194018|FG000|Stage I|Withdrawal by Subject|1|||
128975361|NCT01200758|464194019|FG001|Stage I|Withdrawal by Subject|2|||
128975362|NCT01200758|464194020|FG002|Stage I|Withdrawal by Subject|0|||
129132204|NCT04180696|464775026|FG000|Overall Study|Withdrawal by Subject|0|||
129132205|NCT04180696|464775027|FG001|Overall Study|Withdrawal by Subject|1|||
129132206|NCT04210375|464775028|FG000|Overall Study|Death|0|||
129132207|NCT04210375|464775029|FG001|Overall Study|Death|1|||
128774735|NCT04157686|463466656|FG004|Overall Study|Death|0|||
128975363|NCT01200758|464194021|FG003|Stage I|Withdrawal by Subject|0|||
128975364|NCT01200758|464194018|FG000|Stage I|Disease Progression|9|||
128975365|NCT01200758|464194019|FG001|Stage I|Disease Progression|7|||
128975366|NCT01200758|464194020|FG002|Stage I|Disease Progression|0|||
128975367|NCT01200758|464194021|FG003|Stage I|Disease Progression|0|||
128975368|NCT01200758|464194018|FG000|Stage 2|Disease Progression|0|||
128975369|NCT01200758|464194019|FG001|Stage 2|Disease Progression|0|||
128975370|NCT01200758|464194020|FG002|Stage 2|Disease Progression|16|||
128975371|NCT01200758|464194021|FG003|Stage 2|Disease Progression|21|||
128975372|NCT01200758|464194018|FG000|Stage 2|Lack of Efficacy|0|||
128975373|NCT01200758|464194019|FG001|Stage 2|Lack of Efficacy|0|||
128975374|NCT01200758|464194020|FG002|Stage 2|Lack of Efficacy|4|||
128975375|NCT01200758|464194021|FG003|Stage 2|Lack of Efficacy|2|||
128975376|NCT01200758|464194018|FG000|Stage 2|Physician Decision|0|||
129132208|NCT04210375|464775030|FG002|Overall Study|Death|0|||
129132209|NCT04210375|464775031|FG003|Overall Study|Death|0|||
129132210|NCT00424008|464775032|FG000|Overall Study|Adverse Event|8|||
129132211|NCT00424008|464775033|FG001|Overall Study|Adverse Event|6|||
129132212|NCT00424008|464775032|FG000|Overall Study|Lack of Efficacy|40|||
129132213|NCT00424008|464775033|FG001|Overall Study|Lack of Efficacy|34|||
128975377|NCT01200758|464194019|FG001|Stage 2|Physician Decision|0|||
128975378|NCT01200758|464194020|FG002|Stage 2|Physician Decision|5|||
128975379|NCT01200758|464194021|FG003|Stage 2|Physician Decision|7|||
128975380|NCT01200758|464194018|FG000|Stage 2|Adverse Event|0|||
128975381|NCT01200758|464194019|FG001|Stage 2|Adverse Event|0|||
128975382|NCT01200758|464194020|FG002|Stage 2|Adverse Event|5|||
128975383|NCT01200758|464194021|FG003|Stage 2|Adverse Event|9|||
128975384|NCT01200758|464194018|FG000|Stage 2|Withdrawal by Subject|0|||
128975385|NCT01200758|464194019|FG001|Stage 2|Withdrawal by Subject|0|||
128975386|NCT01200758|464194020|FG002|Stage 2|Withdrawal by Subject|4|||
128975387|NCT01200758|464194021|FG003|Stage 2|Withdrawal by Subject|1|||
128975388|NCT01200758|464194018|FG000|Stage 2|Lost to Follow-up|0|||
128975389|NCT01200758|464194019|FG001|Stage 2|Lost to Follow-up|0|||
128975390|NCT01200758|464194020|FG002|Stage 2|Lost to Follow-up|3|||
128975391|NCT01200758|464194021|FG003|Stage 2|Lost to Follow-up|1|||
128975392|NCT01200758|464194018|FG000|Stage 2|Protocol Violation|0|||
128975393|NCT01200758|464194019|FG001|Stage 2|Protocol Violation|0|||
128975394|NCT01200758|464194020|FG002|Stage 2|Protocol Violation|1|||
128975395|NCT01200758|464194021|FG003|Stage 2|Protocol Violation|4|||
128975396|NCT01200758|464194018|FG000|Stage 2|Death|0|||
128975397|NCT01200758|464194019|FG001|Stage 2|Death|0|||
128975398|NCT01200758|464194020|FG002|Stage 2|Death|3|||
128975399|NCT01200758|464194021|FG003|Stage 2|Death|5|||
128975400|NCT01371721|464194022|FG000|Overall Study|Adverse Event|5|||
128975401|NCT01371721|464194023|FG001|Overall Study|Adverse Event|4|||
128975402|NCT01371721|464194024|FG002|Overall Study|Adverse Event|5|||
128975403|NCT01371721|464194022|FG000|Overall Study|Protocol Violation|6|||
128975404|NCT01371721|464194023|FG001|Overall Study|Protocol Violation|4|||
128975405|NCT01371721|464194024|FG002|Overall Study|Protocol Violation|5|||
128975406|NCT01371721|464194022|FG000|Overall Study|Lost to Follow-up|8|||
128975407|NCT01371721|464194023|FG001|Overall Study|Lost to Follow-up|2|||
128975408|NCT01371721|464194024|FG002|Overall Study|Lost to Follow-up|6|||
128975409|NCT01371721|464194022|FG000|Overall Study|Withdrawal by Subject|5|||
128975410|NCT01371721|464194023|FG001|Overall Study|Withdrawal by Subject|7|||
128975411|NCT01371721|464194024|FG002|Overall Study|Withdrawal by Subject|11|||
128975412|NCT01371721|464194022|FG000|Overall Study|Other|2|||
128975413|NCT01371721|464194023|FG001|Overall Study|Other|3|||
128975414|NCT01371721|464194024|FG002|Overall Study|Other|0|||
128975415|NCT01371721|464194022|FG000|Overall Study|Lack of Efficacy|2|||
128975416|NCT01371721|464194023|FG001|Overall Study|Lack of Efficacy|4|||
128975417|NCT01371721|464194024|FG002|Overall Study|Lack of Efficacy|3|||
128975418|NCT01371721|464194022|FG000|Overall Study|Randomized but not treated|1|||
128975419|NCT01371721|464194023|FG001|Overall Study|Randomized but not treated|0|||
128975420|NCT01371721|464194024|FG002|Overall Study|Randomized but not treated|0|||
128975421|NCT00545584|464194025|FG000|Overall Study|Only one reason for discontinuation|62|||
128975422|NCT00545584|464194026|FG001|Overall Study|Only one reason for discontinuation|61|||
128975423|NCT00545584|464194027|FG002|Overall Study|Only one reason for discontinuation|48|||
128975424|NCT00545584|464194025|FG000|Overall Study|Two or more reasons for discontinuation|17|||
128975425|NCT00545584|464194026|FG001|Overall Study|Two or more reasons for discontinuation|19|||
128975426|NCT00545584|464194027|FG002|Overall Study|Two or more reasons for discontinuation|8|||
128975427|NCT03525613|464194030|FG000|Overall Study|Adverse Event|11|||
128975428|NCT03525613|464194031|FG001|Overall Study|Adverse Event|8|||
128975429|NCT03525613|464194032|FG002|Overall Study|Adverse Event|3|||
128975430|NCT03525613|464194033|FG003|Overall Study|Adverse Event|3|||
128975431|NCT03525613|464194030|FG000|Overall Study|Lost to Follow-up|4|||
128975432|NCT03525613|464194031|FG001|Overall Study|Lost to Follow-up|5|||
128975433|NCT03525613|464194032|FG002|Overall Study|Lost to Follow-up|3|||
128975434|NCT03525613|464194033|FG003|Overall Study|Lost to Follow-up|2|||
128975435|NCT03525613|464194030|FG000|Overall Study|Physician Decision|0|||
128975436|NCT03525613|464194031|FG001|Overall Study|Physician Decision|1|||
128975437|NCT03525613|464194032|FG002|Overall Study|Physician Decision|0|||
128975438|NCT03525613|464194033|FG003|Overall Study|Physician Decision|1|||
128975439|NCT03525613|464194030|FG000|Overall Study|Consent Withdrawal|25|||
128975440|NCT03525613|464194031|FG001|Overall Study|Consent Withdrawal|16|||
128975441|NCT03525613|464194032|FG002|Overall Study|Consent Withdrawal|12|||
128975442|NCT03525613|464194033|FG003|Overall Study|Consent Withdrawal|9|||
128975443|NCT03525613|464194030|FG000|Overall Study|Death|20|||
128975444|NCT03525613|464194031|FG001|Overall Study|Death|9|||
128975445|NCT03525613|464194032|FG002|Overall Study|Death|7|||
128975446|NCT03525613|464194033|FG003|Overall Study|Death|1|||
128975447|NCT03525613|464194030|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
128975448|NCT03525613|464194031|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
128975449|NCT03525613|464194032|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
128975450|NCT03525613|464194033|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
128975451|NCT00461552|464194034|FG000|Overall Study|Drug Dispensing error|0|||
128975452|NCT00461552|464194035|FG001|Overall Study|Drug Dispensing error|2|||
128975453|NCT00523744|464194036|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
128975454|NCT00523744|464194036|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
128975455|NCT00523744|464194036|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
128975456|NCT00523744|464194036|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
128975457|NCT00523744|464194036|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
128975458|NCT00523744|464194036|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
128975459|NCT00715949|464194041|FG000|Overall Study|could not finish first test|4|||
128975460|NCT02608892|464194053|FG000|Overall Study|Lost to Follow-up|1|||
128975461|NCT02608892|464194054|FG001|Overall Study|Lost to Follow-up|0|||
128975462|NCT00537810|464194058|FG000|Overall Study|Withdrawal by Subject|4|||
128975463|NCT00537810|464194059|FG001|Overall Study|Withdrawal by Subject|11|||
128975464|NCT00537810|464194060|FG002|Overall Study|Withdrawal by Subject|4|||
128975465|NCT00537810|464194061|FG003|Overall Study|Withdrawal by Subject|3|||
128975466|NCT00537810|464194058|FG000|Overall Study|Medically withdrawn|2|||
128975467|NCT00537810|464194059|FG001|Overall Study|Medically withdrawn|2|||
128975468|NCT00537810|464194060|FG002|Overall Study|Medically withdrawn|0|||
128975469|NCT00537810|464194061|FG003|Overall Study|Medically withdrawn|1|||
128975470|NCT01066546|464194062|FG000|Overall Study|Study terminated by sponsor|5|||
128975471|NCT00554840|464194071|FG000|Overall Study|Physician Decision|0|||
128975472|NCT00554840|464194072|FG001|Overall Study|Physician Decision|1|||
128975473|NCT01385098|464194073|FG000|Overall Study|Adverse Event|10|||
128975474|NCT01385098|464194073|FG000|Overall Study|Lost to Follow-up|4|||
128975475|NCT00925522|464194074|FG000|Overall Study|study closed -- business decision|20|||
128975476|NCT00410514|464194079|FG000|Overall Study|Adverse Event|2|||
128975477|NCT00410514|464194080|FG001|Overall Study|Adverse Event|2|||
128975478|NCT00410514|464194081|FG002|Overall Study|Adverse Event|2|||
128975479|NCT00410514|464194079|FG000|Overall Study|Protocol Violation|0|||
128975480|NCT00410514|464194080|FG001|Overall Study|Protocol Violation|1|||
128975481|NCT00410514|464194081|FG002|Overall Study|Protocol Violation|1|||
128975482|NCT00410514|464194079|FG000|Overall Study|Lost to Follow-up|0|||
128975483|NCT00410514|464194080|FG001|Overall Study|Lost to Follow-up|0|||
128975484|NCT00410514|464194081|FG002|Overall Study|Lost to Follow-up|2|||
128975485|NCT00410514|464194079|FG000|Overall Study|Non-compliant with study procedures|0|||
128975486|NCT00410514|464194080|FG001|Overall Study|Non-compliant with study procedures|0|||
128975487|NCT00410514|464194081|FG002|Overall Study|Non-compliant with study procedures|2|||
128975488|NCT02390167|464195792|FG000|Overall Study|Lost to Follow-up|1|||
128975489|NCT02033369|464195793|FG000|Overall Study|Physician Decision|1|||
128975490|NCT02033369|464195794|FG001|Overall Study|Physician Decision|2|||
128975491|NCT02033369|464195793|FG000|Overall Study|Not a good demographic match|0|||
128975492|NCT02033369|464195794|FG001|Overall Study|Not a good demographic match|2|||
128975493|NCT02033369|464195793|FG000|Overall Study|Withdrawal by Subject|1|||
128975494|NCT02033369|464195794|FG001|Overall Study|Withdrawal by Subject|1|||
128975495|NCT02033369|464195793|FG000|Overall Study|Lost to Follow-up|1|||
128975496|NCT02033369|464195794|FG001|Overall Study|Lost to Follow-up|0|||
129039092|NCT02190279|464435267|FG000|Overall Study|Withdrawal consent|1|||
128975497|NCT02033369|464195793|FG000|Overall Study|Protocol Violation|2|||
128975498|NCT02033369|464195794|FG001|Overall Study|Protocol Violation|0|||
128975499|NCT01265719|464195800|FG000|Overall Study|Does not meet entrance criteria|0|||
129039093|NCT02190279|464435268|FG001|Overall Study|Withdrawal consent|0|||
129039094|NCT02190279|464435269|FG002|Overall Study|Withdrawal consent|1|||
129039095|NCT02190279|464435267|FG000|Overall Study|Lost to Follow-up|2|||
129039096|NCT02190279|464435268|FG001|Overall Study|Lost to Follow-up|0|||
129039097|NCT02190279|464435269|FG002|Overall Study|Lost to Follow-up|0|||
129039098|NCT02190279|464435267|FG000|Overall Study|Refused further treatment|0|||
129039099|NCT02190279|464435268|FG001|Overall Study|Refused further treatment|0|||
129039100|NCT02190279|464435269|FG002|Overall Study|Refused further treatment|1|||
129039101|NCT02190279|464435267|FG000|Overall Study|Screening failure|0|||
129039102|NCT02190279|464435268|FG001|Overall Study|Screening failure|0|||
129039103|NCT02190279|464435269|FG002|Overall Study|Screening failure|1|||
129039104|NCT00546910|464435270|FG000|Overall Study|Adverse Event|2|||
129039105|NCT00546910|464435271|FG001|Overall Study|Adverse Event|3|||
129039106|NCT00546910|464435270|FG000|Overall Study|Lack of Efficacy|5|||
129039107|NCT00546910|464435271|FG001|Overall Study|Lack of Efficacy|7|||
129039108|NCT00546910|464435270|FG000|Overall Study|Physician Decision|0|||
129039109|NCT00546910|464435271|FG001|Overall Study|Physician Decision|1|||
129039110|NCT00546910|464435270|FG000|Overall Study|Withdrawal by Subject|2|||
129039111|NCT00546910|464435271|FG001|Overall Study|Withdrawal by Subject|0|||
129039112|NCT01115855|464435272|FG000|Overall Study|Adverse Event|16|||
129039113|NCT01115855|464435273|FG001|Overall Study|Adverse Event|18|||
129039114|NCT01115855|464435272|FG000|Overall Study|Death|6|||
129039115|NCT01115855|464435273|FG001|Overall Study|Death|5|||
129039116|NCT01115855|464435272|FG000|Overall Study|Lab Abnormality|1|||
129039117|NCT01115855|464435273|FG001|Overall Study|Lab Abnormality|1|||
129039118|NCT01115855|464435272|FG000|Overall Study|Protocol Violation|0|||
129039119|NCT01115855|464435273|FG001|Overall Study|Protocol Violation|1|||
129132214|NCT00424008|464775032|FG000|Overall Study|Lost to Follow-up|1|||
129132215|NCT00424008|464775033|FG001|Overall Study|Lost to Follow-up|2|||
129039120|NCT01115855|464435272|FG000|Overall Study|Withdrawal by Subject|5|||
129039121|NCT01115855|464435273|FG001|Overall Study|Withdrawal by Subject|5|||
129039122|NCT01115855|464435272|FG000|Overall Study|Other|8|||
129039123|NCT01115855|464435273|FG001|Overall Study|Other|6|||
129132216|NCT00424008|464775032|FG000|Overall Study|Withdrawal by Subject|5|||
128975500|NCT01265719|464195801|FG001|Overall Study|Does not meet entrance criteria|3|||
128975501|NCT01265719|464195800|FG000|Overall Study|Other reasons|2|||
128975502|NCT01265719|464195801|FG001|Overall Study|Other reasons|0|||
128975503|NCT01265719|464195800|FG000|Overall Study|Withdrawal by Subject|8|||
128975504|NCT01265719|464195801|FG001|Overall Study|Withdrawal by Subject|3|||
128975505|NCT01265719|464195800|FG000|Overall Study|Lost to Follow-up|2|||
128975506|NCT01265719|464195801|FG001|Overall Study|Lost to Follow-up|7|||
128975507|NCT01265719|464195800|FG000|Overall Study|Adverse Event|2|||
129132217|NCT00424008|464775033|FG001|Overall Study|Withdrawal by Subject|8|||
129132218|NCT00424008|464775032|FG000|Overall Study|Noncompliance with protocol|13|||
129132219|NCT00424008|464775033|FG001|Overall Study|Noncompliance with protocol|7|||
129132220|NCT00424008|464775032|FG000|Overall Study|Did not meet protocol eligibility|16|||
129132221|NCT00424008|464775033|FG001|Overall Study|Did not meet protocol eligibility|21|||
129132222|NCT00424008|464775032|FG000|Overall Study|Administrative|266|||
129132223|NCT00424008|464775033|FG001|Overall Study|Administrative|257|||
129132224|NCT02593864|464775036|FG000|Overall Study|Withdrawal by Subject|3|||
129132225|NCT02593864|464775036|FG000|Overall Study|Lost to Follow-up|3|||
129132226|NCT01928771|464775043|FG000|Overall Study|Adverse Event|6|||
129132227|NCT01928771|464775044|FG001|Overall Study|Adverse Event|5|||
129132228|NCT01928771|464775045|FG002|Overall Study|Adverse Event|1|||
129132229|NCT01928771|464775043|FG000|Overall Study|Death|2|||
129132230|NCT01928771|464775044|FG001|Overall Study|Death|2|||
129132231|NCT01928771|464775045|FG002|Overall Study|Death|2|||
128975508|NCT01265719|464195801|FG001|Overall Study|Adverse Event|0|||
128975509|NCT04335929|464195802|FG000|Overall Study|Lost to Follow-up|10|||
128975510|NCT00413231|464195803|FG000|0 to 30-day Post Treatment|Death|5|||
128975511|NCT00413231|464195803|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
128975512|NCT00413231|464195803|FG000|30-day to 365-day Post Treatment|Death|13|||
128975513|NCT00413231|464195803|FG000|365-day to 60-month Post Treatment|Death|36|||
128975514|NCT00413231|464195803|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
128975515|NCT00413231|464195803|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
128975516|NCT00413231|464195803|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
128975517|NCT00626327|464195804|FG000|Overall Study|Withdrawal by Subject|21|||
128975518|NCT00626327|464195805|FG001|Overall Study|Withdrawal by Subject|29|||
128975519|NCT00626327|464195806|FG002|Overall Study|Withdrawal by Subject|30|||
128975520|NCT00626327|464195804|FG000|Overall Study|Adverse Event|1|||
128975521|NCT00626327|464195805|FG001|Overall Study|Adverse Event|0|||
128975522|NCT00626327|464195806|FG002|Overall Study|Adverse Event|0|||
128975523|NCT00626327|464195804|FG000|Overall Study|Lost to Follow-up|24|||
128975524|NCT00626327|464195805|FG001|Overall Study|Lost to Follow-up|21|||
128975525|NCT00626327|464195806|FG002|Overall Study|Lost to Follow-up|23|||
128975526|NCT00626327|464195804|FG000|Overall Study|Inappropriate enrollment|4|||
128975527|NCT00626327|464195805|FG001|Overall Study|Inappropriate enrollment|5|||
128975528|NCT00626327|464195806|FG002|Overall Study|Inappropriate enrollment|3|||
128975529|NCT00626327|464195804|FG000|Overall Study|Administrative Reason|2|||
128975530|NCT00626327|464195805|FG001|Overall Study|Administrative Reason|0|||
128975531|NCT00626327|464195806|FG002|Overall Study|Administrative Reason|6|||
128975532|NCT00626327|464195804|FG000|Overall Study|Protocol Violation|26|||
129221316|NCT03894813|465111362|FG000|Overall Study|Withdrawal by Subject|1|||
129221317|NCT03894813|465111363|FG001|Overall Study|Withdrawal by Subject|3|||
129221318|NCT03894813|465111362|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
129221319|NCT03894813|465111363|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
129221320|NCT03773796|465111364|FG000|Overall Study|Adverse Event|1|||
129221321|NCT03773796|465111364|FG000|Overall Study|Withdrawal by Subject|1|||
129221322|NCT03773796|465111364|FG000|Overall Study|Lack of Efficacy|1|||
129221323|NCT03805659|465111365|FG000|Overall Study|Withdrawal by Subject|0|||
129221324|NCT03805659|465111366|FG001|Overall Study|Withdrawal by Subject|1|||
129221325|NCT01250145|465111368|FG000|Overall Study|Adverse Event|2|||
129221326|NCT01250145|465111369|FG001|Overall Study|Adverse Event|1|||
129221327|NCT01250145|465111368|FG000|Overall Study|Withdrawal by Subject|0|||
129221328|NCT01250145|465111369|FG001|Overall Study|Withdrawal by Subject|4|||
128975533|NCT00626327|464195805|FG001|Overall Study|Protocol Violation|4|||
128975534|NCT00626327|464195806|FG002|Overall Study|Protocol Violation|26|||
129132232|NCT01928771|464775043|FG000|Overall Study|Lost to Follow-up|5|||
128975535|NCT00945945|464195807|FG000|Overall Study|Adverse Event|15|||
128975536|NCT00945945|464195808|FG001|Overall Study|Adverse Event|35|||
128975537|NCT00945945|464195807|FG000|Overall Study|Withdrawal by Subject|7|||
128975538|NCT00945945|464195808|FG001|Overall Study|Withdrawal by Subject|10|||
128975539|NCT00945945|464195807|FG000|Overall Study|Lost to Follow-up|4|||
128975540|NCT00945945|464195808|FG001|Overall Study|Lost to Follow-up|5|||
129132233|NCT01928771|464775044|FG001|Overall Study|Lost to Follow-up|6|||
129132234|NCT01928771|464775045|FG002|Overall Study|Lost to Follow-up|3|||
129132235|NCT01928771|464775043|FG000|Overall Study|Withdrawal by Subject|20|||
129132236|NCT01928771|464775044|FG001|Overall Study|Withdrawal by Subject|15|||
129132237|NCT01928771|464775045|FG002|Overall Study|Withdrawal by Subject|17|||
129132238|NCT01928771|464775043|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
128975541|NCT00945945|464195807|FG000|Overall Study|Lack of Efficacy|6|||
128975542|NCT00945945|464195808|FG001|Overall Study|Lack of Efficacy|2|||
128975543|NCT00945945|464195807|FG000|Overall Study|Protocol Violation|4|||
128975544|NCT00945945|464195808|FG001|Overall Study|Protocol Violation|2|||
128975545|NCT00945945|464195807|FG000|Overall Study|Entry Criteria Not Met|0|||
128975546|NCT00945945|464195808|FG001|Overall Study|Entry Criteria Not Met|1|||
128975547|NCT02408016|464195809|FG000|Overall Study|Death|6|||
128975548|NCT02408016|464195810|FG001|Overall Study|Death|1|||
128975549|NCT02408016|464195811|FG002|Overall Study|Death|0|||
128975550|NCT02408016|464195809|FG000|Overall Study|Physician Decision|0|||
128975551|NCT02408016|464195810|FG001|Overall Study|Physician Decision|2|||
128975552|NCT02408016|464195811|FG002|Overall Study|Physician Decision|0|||
128975553|NCT02275052|464195812|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129221329|NCT01069900|465111372|FG000|Overall Study|Technical problems|0|||
129221330|NCT01069900|465111373|FG001|Overall Study|Technical problems|1|||
129221331|NCT01069900|465111372|FG000|Overall Study|Lost to Follow-up|7|||
129221332|NCT01069900|465111373|FG001|Overall Study|Lost to Follow-up|1|||
129221333|NCT01069900|465111372|FG000|Overall Study|Withdrawal by Subject|6|||
129221334|NCT01069900|465111373|FG001|Overall Study|Withdrawal by Subject|1|||
129221335|NCT01069900|465111372|FG000|Overall Study|Protocol Violation|4|||
129221336|NCT01069900|465111373|FG001|Overall Study|Protocol Violation|1|||
129221337|NCT01069900|465111372|FG000|Overall Study|Insufficient Therapeutic effect|1|||
129221338|NCT01069900|465111373|FG001|Overall Study|Insufficient Therapeutic effect|0|||
128975554|NCT02275052|464195813|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
128975555|NCT02275052|464195814|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128975556|NCT02275052|464195815|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128975557|NCT02275052|464195812|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
128975558|NCT02275052|464195813|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
128975559|NCT02275052|464195814|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
128975560|NCT02275052|464195815|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
128975561|NCT02275052|464195812|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
128975562|NCT02275052|464195813|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
128975563|NCT02275052|464195814|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
128975564|NCT02275052|464195815|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
128975565|NCT02275052|464195812|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
128975566|NCT02275052|464195813|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
128975567|NCT02275052|464195814|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
128975568|NCT02275052|464195815|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
128975569|NCT02275052|464195812|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
128975570|NCT02275052|464195813|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
128975571|NCT02275052|464195814|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
128975572|NCT02275052|464195815|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
128975573|NCT02275052|464195812|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
128975574|NCT02275052|464195813|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
129039124|NCT01467479|464435274|FG000|Overall Study|No Study Medication|1|||
129221339|NCT01675544|465111374|FG000|Overall Study|Withdrawal by Subject|2|||
129221340|NCT02813577|465111376|FG000|Overall Study|Study terminated|4|||
129221341|NCT02067676|465111377|FG000|Overall Study|Withdrawal by Subject|1|||
129221342|NCT02067676|465111378|FG001|Overall Study|Withdrawal by Subject|0|||
128774736|NCT04157686|463466657|FG005|Overall Study|Death|0|||
129039125|NCT01467479|464435275|FG001|Overall Study|No Study Medication|0|||
129039126|NCT01467479|464435276|FG002|Overall Study|No Study Medication|2|||
129039127|NCT01467479|464435274|FG000|Overall Study|Adverse Event|1|||
129039128|NCT01467479|464435275|FG001|Overall Study|Adverse Event|2|||
129039129|NCT01467479|464435276|FG002|Overall Study|Adverse Event|0|||
129039130|NCT01467479|464435274|FG000|Overall Study|Death|0|||
129039131|NCT01467479|464435275|FG001|Overall Study|Death|0|||
129039132|NCT01467479|464435276|FG002|Overall Study|Death|1|||
129039133|NCT01467479|464435274|FG000|Overall Study|Lost to Follow-up|2|||
129039134|NCT01467479|464435275|FG001|Overall Study|Lost to Follow-up|5|||
129039135|NCT01467479|464435276|FG002|Overall Study|Lost to Follow-up|3|||
129039136|NCT01467479|464435274|FG000|Overall Study|Withdrawal of Consent|3|||
129039137|NCT01467479|464435275|FG001|Overall Study|Withdrawal of Consent|7|||
129039138|NCT01467479|464435276|FG002|Overall Study|Withdrawal of Consent|7|||
129039139|NCT01467479|464435274|FG000|Overall Study|Study Terminated by Sponsor|1|||
129039140|NCT01467479|464435275|FG001|Overall Study|Study Terminated by Sponsor|3|||
129039141|NCT01467479|464435276|FG002|Overall Study|Study Terminated by Sponsor|3|||
129039142|NCT01467479|464435274|FG000|Overall Study|Other|1|||
129039143|NCT01467479|464435275|FG001|Overall Study|Other|0|||
129039144|NCT01467479|464435276|FG002|Overall Study|Other|0|||
129039145|NCT02284347|464435286|FG000|Overall Study|Lost to Follow-up|2|||
129221343|NCT02067676|465111379|FG002|Overall Study|Withdrawal by Subject|0|||
128774737|NCT04157686|463466658|FG006|Overall Study|Death|0|||
129221344|NCT02067676|465111380|FG003|Overall Study|Withdrawal by Subject|0|||
128975575|NCT02275052|464195814|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
128975576|NCT02275052|464195815|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
128975577|NCT02275052|464195812|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
128975578|NCT02275052|464195813|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
128975579|NCT02275052|464195814|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
128975580|NCT02275052|464195815|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
128975581|NCT02275052|464195812|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
128975582|NCT02275052|464195813|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
128975583|NCT02275052|464195814|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
128975584|NCT02275052|464195815|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
128975585|NCT02275052|464195812|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128975586|NCT02275052|464195813|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128975587|NCT02275052|464195814|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128975588|NCT02275052|464195815|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
128975589|NCT02275052|464195812|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
128975590|NCT02275052|464195813|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
128975591|NCT02275052|464195814|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
128975592|NCT02275052|464195815|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
128975593|NCT02275052|464195812|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
128975594|NCT02275052|464195813|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
128975595|NCT02275052|464195814|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
128975596|NCT02275052|464195815|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
128975597|NCT02807376|464195818|FG000|Overall Study|Intra-operative exclusion criteria|3|||
128975598|NCT02807376|464195819|FG001|Overall Study|Intra-operative exclusion criteria|0|||
128975599|NCT02807376|464195818|FG000|Overall Study|Lost to Follow-up|0|||
128975600|NCT02807376|464195819|FG001|Overall Study|Lost to Follow-up|1|||
128975601|NCT00846027|464195820|FG000|Overall Study|Death|3|||
128975602|NCT00846027|464195820|FG000|Overall Study|Disease Progression|30|||
128975603|NCT00846027|464195820|FG000|Overall Study|Toxicity|12|||
128975604|NCT00846027|464195820|FG000|Overall Study|Patient Decision|7|||
128975605|NCT00846027|464195820|FG000|Overall Study|Investigator Discretion|29|||
128975606|NCT00846027|464195820|FG000|Overall Study|Protocol Violation|2|||
128975607|NCT00846027|464195820|FG000|Overall Study|Subject Not Treated|7|||
128975608|NCT00808028|464195821|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
128975609|NCT00808028|464195822|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
128975610|NCT00808028|464195823|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
128975611|NCT00808028|464195824|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
128975612|NCT00808028|464195821|FG000|Stage 1 (6 Months)|Other|1|||
128975613|NCT00808028|464195822|FG001|Stage 1 (6 Months)|Other|0|||
128975614|NCT00808028|464195823|FG002|Stage 1 (6 Months)|Other|2|||
128975615|NCT00808028|464195824|FG003|Stage 1 (6 Months)|Other|4|||
128975616|NCT00808028|464195821|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
128975617|NCT00808028|464195822|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
128975618|NCT00808028|464195823|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
128975619|NCT00808028|464195824|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
128975620|NCT00808028|464195821|FG000|Stage 1 (6 Months)|Adverse Event|0|||
128975621|NCT00808028|464195822|FG001|Stage 1 (6 Months)|Adverse Event|0|||
128975622|NCT00808028|464195823|FG002|Stage 1 (6 Months)|Adverse Event|1|||
128975623|NCT00808028|464195824|FG003|Stage 1 (6 Months)|Adverse Event|2|||
128975624|NCT00808028|464195821|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
128975625|NCT00808028|464195822|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
128975626|NCT00808028|464195823|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
128975627|NCT00808028|464195824|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
128975628|NCT00808028|464195821|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
128975629|NCT00808028|464195822|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
128975630|NCT00808028|464195823|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
128774738|NCT04157686|463466659|FG007|Overall Study|Death|0|||
128975631|NCT00808028|464195824|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
128975632|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
128975633|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
128975634|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
129039146|NCT02284347|464435286|FG000|Overall Study|Withdrawn prior to treatment|1|||
129039147|NCT01915940|464435290|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
129039148|NCT01915940|464435291|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
129039149|NCT01915940|464435292|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
129039150|NCT01915940|464435290|FG000|Treatment Period|Decision of Participant|0|||
129039151|NCT01915940|464435291|FG001|Treatment Period|Decision of Participant|1|||
129039152|NCT01915940|464435292|FG002|Treatment Period|Decision of Participant|3|||
129039153|NCT01915940|464435290|FG000|Treatment Period|Adverse Event|0|||
129039154|NCT01915940|464435291|FG001|Treatment Period|Adverse Event|9|||
129039155|NCT01915940|464435292|FG002|Treatment Period|Adverse Event|1|||
128975635|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
128975636|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
128975637|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
128975638|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
128975639|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
128975640|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
128975641|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
128975642|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
128975643|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
128975644|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
128975645|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
128975646|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
128975647|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
128975648|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
128975649|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
128975650|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
128975651|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
128975652|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
128975653|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
128975654|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
128975655|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
128975656|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
128975657|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
128975658|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
128975659|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
128975660|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
128975661|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
128975662|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
128975663|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
128975664|NCT00808028|464195821|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
128975665|NCT00808028|464195822|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
128975666|NCT00808028|464195823|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
128975667|NCT00808028|464195824|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
128975668|NCT01797302|464195825|FG000|Overall Study|Lost to Follow-up|16|||
128975669|NCT01797302|464195826|FG001|Overall Study|Lost to Follow-up|23|||
128975670|NCT01797302|464195827|FG002|Overall Study|Lost to Follow-up|22|||
128975671|NCT01797302|464195825|FG000|Overall Study|Withdrawal by Subject|1|||
128975672|NCT01797302|464195826|FG001|Overall Study|Withdrawal by Subject|3|||
128975673|NCT01797302|464195827|FG002|Overall Study|Withdrawal by Subject|4|||
128975674|NCT03228836|464195828|FG000|Overall Study|Adverse Event|3|||
128975675|NCT03228836|464195828|FG000|Overall Study|Withdrawal by Subject|1|||
128975676|NCT03228836|464195828|FG000|Overall Study|Death|1|||
128975677|NCT03228836|464195828|FG000|Overall Study|Physician Decision|1|||
128975678|NCT03228836|464195828|FG000|Overall Study|Disease Progression|7|||
128975679|NCT03228836|464195828|FG000|Overall Study|Other|4|||
128975680|NCT02773849|464195830|FG000|Overall Study|Lost to Follow-up|11|||
128975681|NCT02773849|464195830|FG000|Overall Study|Death|26|||
128975682|NCT02773849|464195830|FG000|Overall Study|Withdrawal by Subject|5|||
128975683|NCT02773849|464195830|FG000|Overall Study|Withdrawal of Consent|9|||
128975684|NCT02773849|464195830|FG000|Overall Study|Other: not due to lack of tolerability|11|||
128975685|NCT00948389|464195831|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
128975686|NCT00948389|464195832|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
128975687|NCT00948389|464195833|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
129132239|NCT01928771|464775044|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129132240|NCT01928771|464775045|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
129132241|NCT01928771|464775043|FG000|Overall Study|Other Reasons|9|||
129132242|NCT01928771|464775044|FG001|Overall Study|Other Reasons|9|||
129132243|NCT01928771|464775045|FG002|Overall Study|Other Reasons|14|||
129132244|NCT01928771|464775043|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
129132245|NCT01928771|464775044|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
128716069|NCT01641692|463256670|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
128716070|NCT01641692|463256671|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
128716071|NCT01641692|463256672|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
128716072|NCT01641692|463256665|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
128975688|NCT00948389|464195834|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
128975689|NCT00948389|464195835|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
128975690|NCT00948389|464195831|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
128975691|NCT00948389|464195832|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
128975692|NCT00948389|464195833|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
129132246|NCT01928771|464775045|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
129132247|NCT03932331|464775046|FG000|Overall Study|Death|0|||
129132248|NCT03932331|464775047|FG001|Overall Study|Death|7|||
128975693|NCT00948389|464195834|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
128975694|NCT00948389|464195835|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
128975695|NCT00948389|464195831|FG000|Overall Study|Both Progression and Toxicity|1|||
128975696|NCT00948389|464195832|FG001|Overall Study|Both Progression and Toxicity|0|||
128975697|NCT00948389|464195833|FG002|Overall Study|Both Progression and Toxicity|0|||
128975698|NCT00948389|464195834|FG003|Overall Study|Both Progression and Toxicity|0|||
128975699|NCT00948389|464195835|FG004|Overall Study|Both Progression and Toxicity|0|||
128975700|NCT02418000|464195840|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
128975701|NCT02418000|464195841|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975702|NCT02418000|464195842|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975703|NCT02418000|464195843|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975704|NCT02418000|464195844|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975705|NCT02418000|464195840|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
128975706|NCT02418000|464195841|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
128975707|NCT02418000|464195842|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
128975708|NCT02418000|464195843|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
128975709|NCT02418000|464195844|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
128975710|NCT02418000|464195840|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
128975711|NCT02418000|464195841|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
128975712|NCT02418000|464195842|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
128975713|NCT02418000|464195843|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
128975714|NCT02418000|464195844|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
128975715|NCT02418000|464195840|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975716|NCT02418000|464195841|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
128975717|NCT02418000|464195842|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975718|NCT02418000|464195843|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975719|NCT02418000|464195844|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
128975720|NCT02418000|464195840|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
128975721|NCT02418000|464195841|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
128975722|NCT02418000|464195842|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
128975723|NCT02418000|464195843|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
128975724|NCT02418000|464195844|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
128975725|NCT02418000|464195840|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975726|NCT02418000|464195841|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975727|NCT02418000|464195842|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
128975728|NCT02418000|464195843|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975729|NCT02418000|464195844|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975730|NCT02418000|464195840|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975731|NCT02418000|464195841|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975732|NCT02418000|464195842|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975733|NCT02418000|464195843|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
128975734|NCT02418000|464195844|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975735|NCT02418000|464195840|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
128975736|NCT02418000|464195841|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
128975737|NCT02418000|464195842|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
128975738|NCT02418000|464195843|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
128975739|NCT02418000|464195844|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
128975740|NCT02418000|464195840|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975741|NCT02418000|464195841|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975742|NCT02418000|464195842|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975743|NCT02418000|464195843|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
128975744|NCT02418000|464195844|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
128975745|NCT00508001|464195845|FG000|Overall Study|Adverse Event|2|||
128975746|NCT00508001|464195846|FG001|Overall Study|Adverse Event|0|||
128975747|NCT00508001|464195847|FG002|Overall Study|Adverse Event|4|||
128975748|NCT00508001|464195845|FG000|Overall Study|condition under investigation worsened|13|||
128975749|NCT00508001|464195846|FG001|Overall Study|condition under investigation worsened|7|||
128975750|NCT00508001|464195847|FG002|Overall Study|condition under investigation worsened|1|||
128975751|NCT00508001|464195845|FG000|Overall Study|Death|0|||
128975752|NCT00508001|464195846|FG001|Overall Study|Death|1|||
128975753|NCT00508001|464195847|FG002|Overall Study|Death|1|||
128975754|NCT00508001|464195845|FG000|Overall Study|Withdrawal by Subject|4|||
128975755|NCT00508001|464195846|FG001|Overall Study|Withdrawal by Subject|4|||
128975756|NCT00508001|464195847|FG002|Overall Study|Withdrawal by Subject|1|||
128975757|NCT01051856|464195869|FG000|Overall Study|Withdrawal by Subject|1|||
128975758|NCT01051856|464195870|FG001|Overall Study|Withdrawal by Subject|0|||
128975759|NCT02381795|464195871|FG000|Overall Study|Withdrawal by Subject|1|||
128975760|NCT02381795|464195871|FG000|Overall Study|Study Terminated|2|||
129221345|NCT02067676|465111381|FG004|Overall Study|Withdrawal by Subject|0|||
129221346|NCT02067676|465111382|FG005|Overall Study|Withdrawal by Subject|0|||
129221347|NCT00996333|465111383|FG000|Overall Study|Screen failure|1|||
129221348|NCT00996333|465111383|FG000|Overall Study|Withdrawal by Subject|1|||
129221349|NCT00996333|465111383|FG000|Overall Study|Death|4|||
129221350|NCT00996333|465111383|FG000|Overall Study|Adverse Event|1|||
129221351|NCT00996333|465111383|FG000|Overall Study|Physician Decision|1|||
129221352|NCT00996333|465111383|FG000|Overall Study|Other|5|||
129221353|NCT04939415|465111391|FG000|Overall Study|Withdrawal by Subject|1|||
129221354|NCT04939415|465111392|FG001|Overall Study|Withdrawal by Subject|3|||
129221355|NCT04939415|465111391|FG000|Overall Study|Lost to Follow-up|0|||
129221356|NCT04939415|465111392|FG001|Overall Study|Lost to Follow-up|2|||
129221357|NCT00369265|465111393|FG000|Overall Study|Study terminated|4|||
129221358|NCT00369265|465111394|FG001|Overall Study|Study terminated|7|||
129221359|NCT00068419|465111397|FG000|Overall Study|Adverse Event|3|||
129221360|NCT00068419|465111397|FG000|Overall Study|Lack of Efficacy|24|||
129221361|NCT00068419|465111397|FG000|Overall Study|Lost to Follow-up|1|||
129221362|NCT00068419|465111397|FG000|Overall Study|Physician Decision|7|||
129221363|NCT00068419|465111397|FG000|Overall Study|Withdrawal by Subject|14|||
129221364|NCT00068419|465111397|FG000|Overall Study|Ineligible|11|||
129221365|NCT02506244|465111400|FG000|Overall Study|Did not undergo active monitoring|458|||
129221366|NCT02506244|465111401|FG001|Overall Study|Did not undergo active monitoring|459|||
129221367|NCT02506244|465111402|FG002|Overall Study|Did not undergo active monitoring|0|||
129221368|NCT01160822|465111403|FG000|Overall Study|Adverse Event|0|||
129221369|NCT01160822|465111404|FG001|Overall Study|Adverse Event|0|||
129221370|NCT01160822|465111405|FG002|Overall Study|Adverse Event|0|||
129221371|NCT01160822|465111406|FG003|Overall Study|Adverse Event|0|||
129221372|NCT01160822|465111407|FG004|Overall Study|Adverse Event|1|||
129221373|NCT01160822|465111408|FG005|Overall Study|Adverse Event|2|||
129221374|NCT01160822|465111409|FG006|Overall Study|Adverse Event|5|||
129221375|NCT01160822|465111403|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129221376|NCT01160822|465111404|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129221377|NCT01160822|465111405|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129221378|NCT01160822|465111406|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129221379|NCT01160822|465111407|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
129221380|NCT01160822|465111408|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
129221381|NCT01160822|465111409|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
129221382|NCT01160822|465111403|FG000|Overall Study|Withdrawal by Subject|0|||
129221383|NCT01160822|465111404|FG001|Overall Study|Withdrawal by Subject|0|||
129221384|NCT01160822|465111405|FG002|Overall Study|Withdrawal by Subject|0|||
129221385|NCT01160822|465111406|FG003|Overall Study|Withdrawal by Subject|0|||
129221386|NCT01160822|465111407|FG004|Overall Study|Withdrawal by Subject|0|||
128975761|NCT02176226|464195874|FG000|Overall Study|Lost to Follow-up|3|||
128975762|NCT02176226|464195874|FG000|Overall Study|Withdrew prior to treatment|6|||
128975763|NCT02908841|464195879|FG000|Overall Study|Physician Decision|4|||
128975764|NCT02908841|464195880|FG001|Overall Study|Physician Decision|0|||
128975765|NCT01611558|464195881|FG000|Induction Phase|Study drug toxicity|15|||
128975766|NCT01611558|464195881|FG000|Induction Phase|Disease progression|18|||
128975767|NCT01611558|464195881|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
128975768|NCT01611558|464195881|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
128975769|NCT01611558|464195881|FG000|Induction Phase|Death|1|||
128975770|NCT01611558|464195881|FG000|Maintenance Phase|Withdrawal by Subject|1|||
128975771|NCT01611558|464195881|FG000|Maintenance Phase|Elevated Uric acid|1|||
128975772|NCT01412333|464195888|FG000|Overall Study|Adverse Event|40|||
129221387|NCT01160822|465111408|FG005|Overall Study|Withdrawal by Subject|0|||
128975773|NCT01412333|464195889|FG001|Overall Study|Adverse Event|42|||
129221388|NCT01160822|465111409|FG006|Overall Study|Withdrawal by Subject|1|||
129221389|NCT01160822|465111403|FG000|Overall Study|Lost to Follow-up|0|||
129221390|NCT01160822|465111404|FG001|Overall Study|Lost to Follow-up|0|||
129221391|NCT01160822|465111405|FG002|Overall Study|Lost to Follow-up|0|||
129221392|NCT01160822|465111406|FG003|Overall Study|Lost to Follow-up|0|||
129221393|NCT01160822|465111407|FG004|Overall Study|Lost to Follow-up|1|||
129221394|NCT01160822|465111408|FG005|Overall Study|Lost to Follow-up|0|||
129221395|NCT01160822|465111409|FG006|Overall Study|Lost to Follow-up|0|||
128975774|NCT01412333|464195888|FG000|Overall Study|Death|5|||
128975775|NCT01412333|464195889|FG001|Overall Study|Death|6|||
128975776|NCT01412333|464195888|FG000|Overall Study|Lack of Efficacy|22|||
129221396|NCT01160822|465111403|FG000|Overall Study|Administrative problems|0|||
129221397|NCT01160822|465111404|FG001|Overall Study|Administrative problems|0|||
129221398|NCT01160822|465111405|FG002|Overall Study|Administrative problems|0|||
129221399|NCT01160822|465111406|FG003|Overall Study|Administrative problems|0|||
129221400|NCT01160822|465111407|FG004|Overall Study|Administrative problems|1|||
129221401|NCT01160822|465111408|FG005|Overall Study|Administrative problems|0|||
129221402|NCT01160822|465111409|FG006|Overall Study|Administrative problems|0|||
128975777|NCT01412333|464195889|FG001|Overall Study|Lack of Efficacy|10|||
129221403|NCT01160822|465111403|FG000|Overall Study|Protocol deviation|0|||
129221404|NCT01160822|465111404|FG001|Overall Study|Protocol deviation|0|||
128975778|NCT01412333|464195888|FG000|Overall Study|Lost to Follow-up|15|||
128975779|NCT01412333|464195889|FG001|Overall Study|Lost to Follow-up|12|||
128975780|NCT01412333|464195888|FG000|Overall Study|Non-Compliance|3|||
128975781|NCT01412333|464195889|FG001|Overall Study|Non-Compliance|7|||
128975782|NCT01412333|464195888|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128975783|NCT01412333|464195889|FG001|Overall Study|Non-Compliance With Study Drug|1|||
128975784|NCT01412333|464195888|FG000|Overall Study|Other|30|||
128975785|NCT01412333|464195889|FG001|Overall Study|Other|33|||
128975786|NCT01412333|464195888|FG000|Overall Study|Physician Decision|11|||
128975787|NCT01412333|464195889|FG001|Overall Study|Physician Decision|16|||
128975788|NCT01412333|464195888|FG000|Overall Study|Pregnancy|6|||
128975789|NCT01412333|464195889|FG001|Overall Study|Pregnancy|4|||
128975790|NCT01412333|464195888|FG000|Overall Study|Protocol Violation|1|||
128975791|NCT01412333|464195889|FG001|Overall Study|Protocol Violation|2|||
128975792|NCT01412333|464195888|FG000|Overall Study|Study Terminated By Sponsor|3|||
128975793|NCT01412333|464195889|FG001|Overall Study|Study Terminated By Sponsor|2|||
128975794|NCT01412333|464195888|FG000|Overall Study|Withdrawal by Subject|51|||
128975795|NCT01412333|464195889|FG001|Overall Study|Withdrawal by Subject|54|||
129039156|NCT01915940|464435290|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
129039157|NCT01915940|464435291|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
129039158|NCT01915940|464435292|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
129039159|NCT02960438|464435293|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
129039160|NCT02960438|464435294|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
128716073|NCT01641692|463256666|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
128716074|NCT01641692|463256667|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
128716075|NCT01641692|463256668|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
128716076|NCT01641692|463256669|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
128716077|NCT01641692|463256670|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
128716078|NCT01641692|463256671|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
128716079|NCT01641692|463256672|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
128716080|NCT04948450|463256677|FG000|Overall Study|Return home|1|||
128716081|NCT04948450|463256678|FG001|Overall Study|Return home|3|||
128716082|NCT05198843|463256681|FG000|Overall Study|Lack of Efficacy|1|||
128716083|NCT01786629|463258142|FG000|Overall Study|Lack of Efficacy|0|||
128716084|NCT01786629|463258143|FG001|Overall Study|Lack of Efficacy|4|||
128716085|NCT01786629|463258142|FG000|Overall Study|Adverse Event|0|||
128716086|NCT01786629|463258143|FG001|Overall Study|Adverse Event|1|||
128716087|NCT00410761|463258144|FG000|Randomized Treatment Period|Adverse Event|34|||
128716088|NCT00410761|463258145|FG001|Randomized Treatment Period|Adverse Event|3|||
128716089|NCT00410761|463258144|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
128716090|NCT00410761|463258145|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
128716091|NCT00410761|463258144|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
128716092|NCT00410761|463258145|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
128975796|NCT01412333|464195888|FG000|Overall Study|Missing|1|||
128975797|NCT01412333|464195889|FG001|Overall Study|Missing|3|||
128975798|NCT04005885|464195890|FG000|First Intervention|Withdrawal by Subject|1|||
129039161|NCT02960438|464435295|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
129039162|NCT02960438|464435296|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
129039163|NCT02960438|464435293|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
129039164|NCT02960438|464435294|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
129039165|NCT02960438|464435295|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
129039166|NCT02960438|464435296|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
129039167|NCT02960438|464435293|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
129039168|NCT02960438|464435294|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
129039169|NCT02960438|464435295|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
129039170|NCT02960438|464435296|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
129039171|NCT02960438|464435293|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
129039172|NCT02960438|464435294|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
129039173|NCT02960438|464435295|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
129039174|NCT02960438|464435296|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
129039175|NCT02960438|464435293|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
129039176|NCT02960438|464435294|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
129039177|NCT02960438|464435295|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
129039178|NCT02960438|464435296|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
129039179|NCT02960438|464435293|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
129039180|NCT02960438|464435294|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
129132249|NCT03932331|464775048|FG002|Overall Study|Death|2|||
128716093|NCT00410761|463258144|FG000|Randomized Treatment Period|Other|69|||
128975799|NCT04005885|464195891|FG001|First Intervention|Withdrawal by Subject|1|||
128975800|NCT04005885|464195890|FG000|Second Intervention|Withdrawal by Subject|0|||
128975801|NCT04005885|464195891|FG001|Second Intervention|Withdrawal by Subject|2|||
128975802|NCT00750867|464195892|FG000|Overall Study|Adverse Event|2|||
128975803|NCT02718625|464195894|FG000|Overall Study|Adverse Event|0|||
128975804|NCT02718625|464195895|FG001|Overall Study|Adverse Event|1|||
129132250|NCT03932331|464775046|FG000|Overall Study|Withdrawal by Subject|0|||
129132251|NCT03932331|464775047|FG001|Overall Study|Withdrawal by Subject|3|||
128975805|NCT02718625|464195894|FG000|Overall Study|Termination of Study by Sponsor|0|||
128975806|NCT02718625|464195895|FG001|Overall Study|Termination of Study by Sponsor|1|||
128975807|NCT01947127|464195900|FG000|Overall Study|Protocol Violation|18|||
128975808|NCT01947127|464195901|FG001|Overall Study|Protocol Violation|38|||
128975809|NCT01947127|464195900|FG000|Overall Study|Withdrawal by Subject|1|||
128975810|NCT01947127|464195901|FG001|Overall Study|Withdrawal by Subject|1|||
128975811|NCT01947127|464195900|FG000|Overall Study|Data loss|4|||
128975812|NCT01947127|464195901|FG001|Overall Study|Data loss|4|||
128975813|NCT01836549|464195902|FG000|Overall Study|Did not receive study drug|0|||
128975814|NCT01836549|464195903|FG001|Overall Study|Did not receive study drug|0|||
128975815|NCT01836549|464195904|FG002|Overall Study|Did not receive study drug|1|||
128975816|NCT01836549|464195905|FG003|Overall Study|Did not receive study drug|0|||
128975817|NCT01836549|464195906|FG004|Overall Study|Did not receive study drug|0|||
128975818|NCT01836549|464195907|FG005|Overall Study|Did not receive study drug|0|||
128975819|NCT01836549|464195908|FG006|Overall Study|Did not receive study drug|0|||
128975820|NCT01836549|464195902|FG000|Overall Study|Patient declared ineligible|0|||
128975821|NCT01836549|464195903|FG001|Overall Study|Patient declared ineligible|0|||
128975822|NCT01836549|464195904|FG002|Overall Study|Patient declared ineligible|0|||
128975823|NCT01836549|464195905|FG003|Overall Study|Patient declared ineligible|1|||
128975824|NCT01836549|464195906|FG004|Overall Study|Patient declared ineligible|0|||
129132252|NCT03932331|464775048|FG002|Overall Study|Withdrawal by Subject|0|||
129132253|NCT03932331|464775046|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
129132254|NCT03932331|464775047|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
129132255|NCT03932331|464775048|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
129132256|NCT03932331|464775046|FG000|Overall Study|Progressive disease|3|||
129132257|NCT03932331|464775047|FG001|Overall Study|Progressive disease|0|||
129132258|NCT03932331|464775048|FG002|Overall Study|Progressive disease|0|||
128716094|NCT00410761|463258145|FG001|Randomized Treatment Period|Other|21|||
128716095|NCT00410761|463258144|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
128716096|NCT00410761|463258145|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
128975825|NCT01836549|464195907|FG005|Overall Study|Patient declared ineligible|0|||
128975826|NCT01836549|464195908|FG006|Overall Study|Patient declared ineligible|0|||
128975827|NCT01836549|464195902|FG000|Overall Study|Patient inevaluable to start therapy|0|||
128975828|NCT01836549|464195903|FG001|Overall Study|Patient inevaluable to start therapy|0|||
128975829|NCT01836549|464195904|FG002|Overall Study|Patient inevaluable to start therapy|0|||
128975830|NCT01836549|464195905|FG003|Overall Study|Patient inevaluable to start therapy|0|||
128975831|NCT01836549|464195906|FG004|Overall Study|Patient inevaluable to start therapy|0|||
128975832|NCT01836549|464195907|FG005|Overall Study|Patient inevaluable to start therapy|0|||
128975833|NCT01836549|464195908|FG006|Overall Study|Patient inevaluable to start therapy|1|||
129132259|NCT03932331|464775046|FG000|Overall Study|Lung infection|1|||
129132260|NCT03932331|464775047|FG001|Overall Study|Lung infection|0|||
128716097|NCT00410761|463258144|FG000|Open-Label Treatment Period|Adverse Event|13|||
128716098|NCT00410761|463258145|FG001|Open-Label Treatment Period|Adverse Event|15|||
128716099|NCT00410761|463258144|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
128716100|NCT00410761|463258145|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
128716101|NCT00410761|463258144|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
128716102|NCT00410761|463258145|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
128716103|NCT00410761|463258144|FG000|Open-Label Treatment Period|Other|18|||
128716104|NCT00410761|463258145|FG001|Open-Label Treatment Period|Other|9|||
128716105|NCT02926924|463258146|FG000|Overall Study|withdrawal - reason unknown|0|||
128716106|NCT02926924|463258147|FG001|Overall Study|withdrawal - reason unknown|1|||
128716107|NCT02750592|463258151|FG000|Overall Study|Adverse Event|3|||
128716108|NCT02750592|463258151|FG000|Overall Study|Lack of Efficacy|2|||
128716109|NCT02981342|463258154|FG000|Overall Study|Adverse Event|0|||
128716110|NCT02981342|463258155|FG001|Overall Study|Adverse Event|0|||
128716111|NCT02981342|463258156|FG002|Overall Study|Adverse Event|0|||
128716112|NCT02981342|463258157|FG003|Overall Study|Adverse Event|1|||
128716113|NCT02981342|463258154|FG000|Overall Study|Death|0|||
128716114|NCT02981342|463258155|FG001|Overall Study|Death|9|||
129132261|NCT03932331|464775048|FG002|Overall Study|Lung infection|0|||
129132262|NCT03932331|464775046|FG000|Overall Study|Other|0|||
129132263|NCT03932331|464775047|FG001|Overall Study|Other|0|||
129132264|NCT03932331|464775048|FG002|Overall Study|Other|58|||
128975834|NCT04652102|464195909|FG000|Overall Study|Adverse Event|14|||
128975835|NCT04652102|464195910|FG001|Overall Study|Adverse Event|13|||
128975836|NCT04652102|464195909|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
128975837|NCT04652102|464195910|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
128716115|NCT02981342|463258156|FG002|Overall Study|Death|9|||
128716116|NCT02981342|463258157|FG003|Overall Study|Death|4|||
129132265|NCT01937117|464775049|FG000|Overall Study|Disease Progression|7|||
129132266|NCT01937117|464775049|FG000|Overall Study|Physician Decision|4|||
129221405|NCT01160822|465111405|FG002|Overall Study|Protocol deviation|0|||
129221406|NCT01160822|465111406|FG003|Overall Study|Protocol deviation|0|||
129221407|NCT01160822|465111407|FG004|Overall Study|Protocol deviation|2|||
129221408|NCT01160822|465111408|FG005|Overall Study|Protocol deviation|0|||
129221409|NCT01160822|465111409|FG006|Overall Study|Protocol deviation|0|||
128975838|NCT04652102|464195909|FG000|Overall Study|Physician Decision|78|||
128975839|NCT04652102|464195910|FG001|Overall Study|Physician Decision|40|||
128975840|NCT04652102|464195909|FG000|Overall Study|Study Ended by Sponsor|64|||
128975841|NCT04652102|464195910|FG001|Overall Study|Study Ended by Sponsor|17|||
128975842|NCT04652102|464195909|FG000|Overall Study|Withdrawal by Subject|4625|||
128975843|NCT04652102|464195910|FG001|Overall Study|Withdrawal by Subject|5594|||
128975844|NCT04652102|464195909|FG000|Overall Study|Lost to Follow-up|2019|||
128975845|NCT04652102|464195910|FG001|Overall Study|Lost to Follow-up|1082|||
129221410|NCT00092443|465111410|FG000|Overall Study|Adverse Event|9|||
129221411|NCT00092443|465111411|FG001|Overall Study|Adverse Event|13|||
129221412|NCT00092443|465111410|FG000|Overall Study|Lost to Follow-up|7|||
129221413|NCT00092443|465111411|FG001|Overall Study|Lost to Follow-up|3|||
129221414|NCT00092443|465111410|FG000|Overall Study|Protocol Violation|11|||
129221415|NCT00092443|465111411|FG001|Overall Study|Protocol Violation|9|||
129221416|NCT00092443|465111410|FG000|Overall Study|Withdrawal by Subject|9|||
129221417|NCT00092443|465111411|FG001|Overall Study|Withdrawal by Subject|11|||
129221418|NCT00092443|465111410|FG000|Overall Study|Moved|5|||
129221419|NCT00092443|465111411|FG001|Overall Study|Moved|5|||
129221420|NCT00092443|465111410|FG000|Overall Study|Other|17|||
129221421|NCT00092443|465111411|FG001|Overall Study|Other|13|||
129221422|NCT00314795|465111415|FG000|Overall Study|Adverse Event|8|||
129221423|NCT00314795|465111415|FG000|Overall Study|Death|4|||
129221424|NCT00314795|465111415|FG000|Overall Study|Reason not Specified|3|||
129221425|NCT00314795|465111415|FG000|Overall Study|Renal Transplant|3|||
129221426|NCT00314795|465111415|FG000|Overall Study|Participants Withdrew Consent|2|||
129221427|NCT04717336|465111417|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
129221428|NCT04717336|465111418|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
129221429|NCT04717336|465111417|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
128975846|NCT04652102|464195909|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
128975847|NCT04652102|464195910|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
129221430|NCT04717336|465111418|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
129221431|NCT01500720|465111425|FG000|Overall Study|Randomized But Not Treated|1|||
129221432|NCT01500720|465111426|FG001|Overall Study|Randomized But Not Treated|1|||
129221433|NCT01500720|465111425|FG000|Overall Study|Other|4|||
129221434|NCT01500720|465111426|FG001|Overall Study|Other|8|||
129221435|NCT02527421|465111427|FG000|Overall Study|Withdrawal by Subject|1|||
129221436|NCT02527421|465111428|FG001|Overall Study|Withdrawal by Subject|0|||
129221437|NCT00806819|465111429|FG000|Overall Study|progressive disease (modified RECIST )|217|||
129221438|NCT00806819|465111430|FG001|Overall Study|progressive disease (modified RECIST )|216|||
129221439|NCT00806819|465111429|FG000|Overall Study|Worsening or AE of underlying disease|18|||
129221440|NCT00806819|465111430|FG001|Overall Study|Worsening or AE of underlying disease|25|||
129221441|NCT00806819|465111429|FG000|Overall Study|Other AE|38|||
129221442|NCT00806819|465111430|FG001|Overall Study|Other AE|40|||
129221443|NCT00806819|465111429|FG000|Overall Study|Protocol Violation|9|||
129221444|NCT00806819|465111430|FG001|Overall Study|Protocol Violation|4|||
129221445|NCT00806819|465111429|FG000|Overall Study|Lost to Follow-up|1|||
129221446|NCT00806819|465111430|FG001|Overall Study|Lost to Follow-up|0|||
129221447|NCT00806819|465111429|FG000|Overall Study|Withdrawal by Subject|32|||
129221448|NCT00806819|465111430|FG001|Overall Study|Withdrawal by Subject|29|||
129221449|NCT00806819|465111429|FG000|Overall Study|Not treated|6|||
129221450|NCT00806819|465111430|FG001|Overall Study|Not treated|3|||
129221451|NCT00806819|465111429|FG000|Overall Study|Reasons other than stated above|25|||
129221452|NCT00806819|465111430|FG001|Overall Study|Reasons other than stated above|41|||
129221453|NCT01615029|465111436|FG000|Overall Study|Adverse Event|0|||
128975848|NCT04652102|464195909|FG000|Overall Study|Miscellaneous|80|||
128975849|NCT04652102|464195910|FG001|Overall Study|Miscellaneous|64|||
128975850|NCT02516306|464195911|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
129221454|NCT01615029|465111437|FG001|Overall Study|Adverse Event|0|||
128975851|NCT02516306|464195912|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
128975852|NCT01969565|464195916|FG000|Overall Study|Withdrawal by Subject|1|||
128975853|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Adverse Event|30|||
128975854|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Adverse Event|25|||
128975855|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Adverse Event|23|||
128975856|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Adverse Event|14|||
129221455|NCT01615029|465111438|FG002|Overall Study|Adverse Event|0|||
129221456|NCT01615029|465111439|FG003|Overall Study|Adverse Event|0|||
128975857|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Death|0|||
128975858|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Death|0|||
129221457|NCT01615029|465111440|FG004|Overall Study|Adverse Event|1|||
129221458|NCT01615029|465111436|FG000|Overall Study|Death|0|||
129221459|NCT01615029|465111437|FG001|Overall Study|Death|0|||
128975859|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Death|1|||
128975860|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Death|0|||
129221460|NCT01615029|465111438|FG002|Overall Study|Death|0|||
129221461|NCT01615029|465111439|FG003|Overall Study|Death|0|||
129221462|NCT01615029|465111440|FG004|Overall Study|Death|1|||
129221463|NCT01615029|465111436|FG000|Overall Study|Lost to Follow-up|0|||
129221464|NCT01615029|465111437|FG001|Overall Study|Lost to Follow-up|0|||
129221465|NCT01615029|465111438|FG002|Overall Study|Lost to Follow-up|0|||
129221466|NCT01615029|465111439|FG003|Overall Study|Lost to Follow-up|0|||
129221467|NCT01615029|465111440|FG004|Overall Study|Lost to Follow-up|1|||
129221468|NCT01615029|465111436|FG000|Overall Study|Progressive disease|2|||
129221469|NCT01615029|465111437|FG001|Overall Study|Progressive disease|1|||
129221470|NCT01615029|465111438|FG002|Overall Study|Progressive disease|1|||
129221471|NCT01615029|465111439|FG003|Overall Study|Progressive disease|1|||
129221472|NCT01615029|465111440|FG004|Overall Study|Progressive disease|5|||
129221473|NCT01615029|465111436|FG000|Overall Study|Physician Decision|0|||
128716117|NCT02981342|463258154|FG000|Overall Study|Withdrawal by Subject|0|||
128716118|NCT02981342|463258155|FG001|Overall Study|Withdrawal by Subject|0|||
128716119|NCT02981342|463258156|FG002|Overall Study|Withdrawal by Subject|3|||
128716120|NCT02981342|463258157|FG003|Overall Study|Withdrawal by Subject|1|||
128716121|NCT02981342|463258154|FG000|Overall Study|Study closed by sponsor|0|||
128716122|NCT02981342|463258155|FG001|Overall Study|Study closed by sponsor|0|||
128716123|NCT02981342|463258156|FG002|Overall Study|Study closed by sponsor|1|||
128716124|NCT02981342|463258157|FG003|Overall Study|Study closed by sponsor|1|||
128716125|NCT02981342|463258154|FG000|Overall Study|Randomized, Never Treated|0|||
128716126|NCT02981342|463258155|FG001|Overall Study|Randomized, Never Treated|1|||
128716127|NCT02981342|463258156|FG002|Overall Study|Randomized, Never Treated|0|||
128716128|NCT02981342|463258157|FG003|Overall Study|Randomized, Never Treated|7|||
128716129|NCT02981342|463258154|FG000|Overall Study|Lost to Follow-up|0|||
128716130|NCT02981342|463258155|FG001|Overall Study|Lost to Follow-up|1|||
128716131|NCT02981342|463258156|FG002|Overall Study|Lost to Follow-up|0|||
128716132|NCT02981342|463258157|FG003|Overall Study|Lost to Follow-up|0|||
128716133|NCT05333900|463258158|FG000|Overall Study|Protocol Violation|0|||
128716134|NCT05333900|463258159|FG001|Overall Study|Protocol Violation|1|||
128716135|NCT05333900|463258158|FG000|Overall Study|Withdrawal by Subject|0|||
128716136|NCT05333900|463258159|FG001|Overall Study|Withdrawal by Subject|1|||
128716137|NCT05333900|463258158|FG000|Overall Study|COVID-19 Pandemic|1|||
128716138|NCT05333900|463258159|FG001|Overall Study|COVID-19 Pandemic|1|||
128716139|NCT03724812|463258160|FG000|Overall Study|Missed Visit|1|||
128716140|NCT03724812|463258160|FG000|Overall Study|Death|2|||
128716141|NCT03724812|463258160|FG000|Overall Study|Withdrawal by Subject|1|||
128716142|NCT01394523|463258161|FG000|Overall Study|Unable to place block|1|||
128716143|NCT01394523|463258162|FG001|Overall Study|Unable to place block|0|||
128716144|NCT01394523|463258163|FG002|Overall Study|Unable to place block|0|||
128716145|NCT03525574|463258164|FG000|Overall Study|Adverse Event|15|||
128716146|NCT03525574|463258165|FG001|Overall Study|Adverse Event|0|||
128716147|NCT03525574|463258164|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
128716148|NCT03525574|463258165|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
128716149|NCT03525574|463258164|FG000|Overall Study|Lost to Follow-up|4|||
128716150|NCT03525574|463258165|FG001|Overall Study|Lost to Follow-up|0|||
128716151|NCT03525574|463258164|FG000|Overall Study|Commercial drug is Available for participant|48|||
128716152|NCT03525574|463258165|FG001|Overall Study|Commercial drug is Available for participant|0|||
128716153|NCT03525574|463258164|FG000|Overall Study|Death|1|||
128716154|NCT03525574|463258165|FG001|Overall Study|Death|0|||
128716155|NCT03525574|463258164|FG000|Overall Study|Other non-compliance|2|||
128716156|NCT03525574|463258165|FG001|Overall Study|Other non-compliance|0|||
128716157|NCT03525574|463258164|FG000|Overall Study|Physician Decision|6|||
128716158|NCT03525574|463258165|FG001|Overall Study|Physician Decision|0|||
128716159|NCT03525574|463258164|FG000|Overall Study|Other|58|||
128716160|NCT03525574|463258165|FG001|Overall Study|Other|0|||
128716161|NCT03525574|463258164|FG000|Overall Study|Enrolled but never dosed|1|||
128716162|NCT03525574|463258165|FG001|Overall Study|Enrolled but never dosed|0|||
128716163|NCT03525574|463258164|FG000|Overall Study|Not enrolled in 105 study|0|||
129221474|NCT01615029|465111437|FG001|Overall Study|Physician Decision|0|||
129221475|NCT01615029|465111438|FG002|Overall Study|Physician Decision|0|||
129221476|NCT01615029|465111439|FG003|Overall Study|Physician Decision|0|||
128716164|NCT03525574|463258165|FG001|Overall Study|Not enrolled in 105 study|3|||
128716165|NCT04741074|463258168|FG000|Overall Study|Withdrawal by Subject|1|||
128716166|NCT04741074|463258169|FG001|Overall Study|Withdrawal by Subject|1|||
128716167|NCT04741074|463258168|FG000|Overall Study|Study terminated prematurely|1|||
128716168|NCT04741074|463258169|FG001|Overall Study|Study terminated prematurely|0|||
128716169|NCT02432846|463258170|FG000|Overall Study (4 Arms/Strata)|Death|3|||
128716170|NCT02432846|463258171|FG001|Overall Study (4 Arms/Strata)|Death|2|||
128716171|NCT02432846|463258172|FG002|Overall Study (4 Arms/Strata)|Death|4|||
128716172|NCT02432846|463258173|FG003|Overall Study (4 Arms/Strata)|Death|3|||
129221477|NCT01615029|465111440|FG004|Overall Study|Physician Decision|1|||
129221478|NCT01615029|465111436|FG000|Overall Study|Ongoing|1|||
129221479|NCT01615029|465111437|FG001|Overall Study|Ongoing|2|||
128716173|NCT02432846|463258174|FG004|Overall Study (4 Arms/Strata)|Death|0|||
129221480|NCT01615029|465111438|FG002|Overall Study|Ongoing|3|||
128975861|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Physician Decision|0|||
128975862|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Physician Decision|1|||
128975863|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Physician Decision|0|||
128975864|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Physician Decision|1|||
128975865|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
128975866|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
128716174|NCT02432846|463258175|FG005|Overall Study (4 Arms/Strata)|Death|0|||
128716175|NCT02432846|463258170|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
128716176|NCT02432846|463258171|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
128716177|NCT02432846|463258172|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
128716178|NCT02432846|463258173|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
128716179|NCT02432846|463258174|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
128716180|NCT02432846|463258175|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
128716181|NCT02432846|463258170|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
128716182|NCT02432846|463258171|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
128716183|NCT02432846|463258172|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
128716184|NCT02432846|463258173|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
128716185|NCT02432846|463258174|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
128716186|NCT02432846|463258175|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
128716187|NCT02432846|463258170|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
128716188|NCT02432846|463258171|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
128716189|NCT02432846|463258172|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
128716190|NCT02432846|463258173|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
128716191|NCT02432846|463258174|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
128716192|NCT02432846|463258175|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
128716193|NCT02432846|463258170|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
128716194|NCT02432846|463258171|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
128716195|NCT02432846|463258172|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
128716196|NCT02432846|463258173|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
128716197|NCT02432846|463258174|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
128716198|NCT02432846|463258175|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
128716199|NCT02432846|463258170|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
128716200|NCT02432846|463258171|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
128716201|NCT02432846|463258172|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
128716202|NCT02432846|463258173|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
128716203|NCT02432846|463258174|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
128716204|NCT02432846|463258175|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
128716205|NCT02432846|463258170|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
128716206|NCT02432846|463258171|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
128716207|NCT02432846|463258172|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
128716208|NCT02432846|463258173|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
128716209|NCT02432846|463258174|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
128716210|NCT02432846|463258175|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
128716211|NCT02432846|463258170|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
128716212|NCT02432846|463258171|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
128716213|NCT02432846|463258172|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
128716214|NCT02432846|463258173|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
128716215|NCT02432846|463258174|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
128716216|NCT02432846|463258175|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
128716217|NCT02432846|463258170|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
128716218|NCT02432846|463258171|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
128716219|NCT02432846|463258172|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
128716220|NCT02432846|463258173|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
128716221|NCT02432846|463258174|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
128716222|NCT02432846|463258175|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
128716223|NCT02432846|463258170|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
128716224|NCT02432846|463258171|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
128716225|NCT02432846|463258172|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
128716226|NCT02432846|463258173|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
128716227|NCT02432846|463258174|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
128716228|NCT02432846|463258175|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
128716229|NCT02432846|463258170|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
128716230|NCT02432846|463258171|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
128716231|NCT02432846|463258172|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
128716232|NCT02432846|463258173|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
128975867|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
128975868|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
129221481|NCT01615029|465111439|FG003|Overall Study|Ongoing|2|||
129221482|NCT01615029|465111440|FG004|Overall Study|Ongoing|23|||
129221483|NCT00802945|465111446|FG000|Overall Study|Death|27|||
129221484|NCT00802945|465111447|FG001|Overall Study|Death|23|||
129221485|NCT00802945|465111446|FG000|Overall Study|Terminated by sponsor|8|||
129221486|NCT00802945|465111447|FG001|Overall Study|Terminated by sponsor|12|||
129221487|NCT03843541|465111448|FG000|Overall Study|Adverse Event|4|||
129221488|NCT03843541|465111449|FG001|Overall Study|Adverse Event|2|||
129221489|NCT03843541|465111450|FG002|Overall Study|Adverse Event|3|||
129221490|NCT03843541|465111448|FG000|Overall Study|Death|1|||
129221491|NCT03843541|465111449|FG001|Overall Study|Death|0|||
129221492|NCT03843541|465111450|FG002|Overall Study|Death|0|||
129221493|NCT03843541|465111448|FG000|Overall Study|Lack of adherence to study medication|0|||
129221494|NCT03843541|465111449|FG001|Overall Study|Lack of adherence to study medication|0|||
128975869|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Other|6|||
128975870|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Other|1|||
128975871|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Other|0|||
128975872|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Other|2|||
129221495|NCT03843541|465111450|FG002|Overall Study|Lack of adherence to study medication|1|||
129221496|NCT03843541|465111448|FG000|Overall Study|Physician Decision|1|||
129221497|NCT03843541|465111449|FG001|Overall Study|Physician Decision|2|||
129221498|NCT03843541|465111450|FG002|Overall Study|Physician Decision|2|||
129221499|NCT03843541|465111448|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
129221500|NCT03843541|465111449|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
128716233|NCT02432846|463258174|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
128975873|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
128975874|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
128975875|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
128975876|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
128975877|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
128975878|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
128975879|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
129039181|NCT02960438|464435295|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
129039182|NCT02960438|464435296|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
129039183|NCT02960438|464435293|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
129039184|NCT02960438|464435294|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
129039185|NCT02960438|464435295|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
129039186|NCT02960438|464435296|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
129039187|NCT02960438|464435293|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
129039188|NCT02960438|464435294|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
129039189|NCT02960438|464435295|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
129039190|NCT02960438|464435296|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
129039191|NCT02960438|464435293|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
129039192|NCT02960438|464435294|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
129039193|NCT02960438|464435295|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
129039194|NCT02960438|464435296|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
129039195|NCT02960438|464435293|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
129039196|NCT02960438|464435294|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
129039197|NCT02960438|464435295|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
129039198|NCT02960438|464435296|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
129039199|NCT02960438|464435293|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
129039200|NCT02960438|464435294|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
129039201|NCT02960438|464435295|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
129039202|NCT02960438|464435296|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
129039203|NCT02960438|464435293|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
129039204|NCT02960438|464435294|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
129039205|NCT02960438|464435295|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
129039206|NCT02960438|464435296|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
129039207|NCT02999984|464435300|FG000|Overall Study|Treatment Failure|1|||
129039208|NCT01316419|464435301|FG000|Overall Study|Not treated|103|||
129039209|NCT01316419|464435301|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
129039210|NCT01316419|464435301|FG000|Overall Study|Lost to Follow-up|19|||
129039211|NCT00754013|464435304|FG000|Overall Study|Lost to Follow-up|1|||
129039212|NCT00754013|464435305|FG001|Overall Study|Lost to Follow-up|1|||
129039213|NCT00754013|464435304|FG000|Overall Study|didn't return after study termed|3|||
129039214|NCT00754013|464435305|FG001|Overall Study|didn't return after study termed|4|||
129221501|NCT03843541|465111450|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
129221502|NCT03843541|465111448|FG000|Overall Study|Withdrawal by Subject|6|||
129221503|NCT03843541|465111449|FG001|Overall Study|Withdrawal by Subject|9|||
129221504|NCT03843541|465111450|FG002|Overall Study|Withdrawal by Subject|7|||
129039215|NCT04039919|464435306|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129039216|NCT04039919|464435307|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129039217|NCT04039919|464435308|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129039218|NCT04039919|464435309|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129039219|NCT04039919|464435310|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129039220|NCT04039919|464435306|FG000|Treatment Period 1|Sponsor's decision|0|||
129132267|NCT01937117|464775049|FG000|Overall Study|Adverse Event|2|||
129132268|NCT01407367|464775054|FG000|Overall Study|Death|24|||
129132269|NCT01407367|464775055|FG001|Overall Study|Death|32|||
129132270|NCT01407367|464775054|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
129132271|NCT01407367|464775055|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
129132272|NCT01407367|464775054|FG000|Overall Study|Withdrawal by Subject|4|||
129132273|NCT01407367|464775055|FG001|Overall Study|Withdrawal by Subject|15|||
129132274|NCT01407367|464775054|FG000|Overall Study|Lost to Follow-up|0|||
129132275|NCT01407367|464775055|FG001|Overall Study|Lost to Follow-up|2|||
129132276|NCT01452347|464775056|FG000|Overall Study|Adverse Event|2|||
129132277|NCT01452347|464775057|FG001|Overall Study|Adverse Event|1|||
129132278|NCT01452347|464775056|FG000|Overall Study|Non compliance protocol|2|||
129132279|NCT01452347|464775057|FG001|Overall Study|Non compliance protocol|0|||
129132280|NCT01452347|464775056|FG000|Overall Study|Lost to Follow-up|2|||
129132281|NCT01452347|464775057|FG001|Overall Study|Lost to Follow-up|0|||
129132282|NCT01452347|464775056|FG000|Overall Study|Withdrawal by Subject|3|||
129132283|NCT01452347|464775057|FG001|Overall Study|Withdrawal by Subject|3|||
129132284|NCT01452347|464775056|FG000|Overall Study|Not treated|6|||
129132285|NCT01452347|464775057|FG001|Overall Study|Not treated|3|||
129132286|NCT01452347|464775056|FG000|Overall Study|Other reason not defined above|2|||
129132287|NCT01452347|464775057|FG001|Overall Study|Other reason not defined above|0|||
129132288|NCT03921541|464776590|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
129132289|NCT03921541|464776591|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
129132290|NCT01653262|464776592|FG000|Overall Study|Lack of Efficacy|1|||
129132291|NCT01653262|464776592|FG000|Overall Study|SAE, non-fatal|1|||
129132292|NCT01653262|464776592|FG000|Overall Study|AE, non-serious non-fatal|1|||
129132293|NCT00420407|464776594|FG000|Overall Study|Lost to Follow-up|0|||
129132294|NCT00420407|464776595|FG001|Overall Study|Lost to Follow-up|3|||
129132295|NCT00420407|464776594|FG000|Overall Study|Physician Decision|2|||
129132296|NCT00420407|464776595|FG001|Overall Study|Physician Decision|1|||
129132297|NCT00420407|464776594|FG000|Overall Study|subject identified as detainee|1|||
129132298|NCT00420407|464776595|FG001|Overall Study|subject identified as detainee|0|||
129132299|NCT00420407|464776594|FG000|Overall Study|subject identified as Jehovah's witness|1|||
129132300|NCT00420407|464776595|FG001|Overall Study|subject identified as Jehovah's witness|0|||
129132301|NCT00420407|464776594|FG000|Overall Study|Withdrawal by Subject|0|||
129132302|NCT00420407|464776595|FG001|Overall Study|Withdrawal by Subject|2|||
129132303|NCT04633447|464776596|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
129132304|NCT04633447|464776597|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
129132305|NCT04633447|464776596|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
129132306|NCT04633447|464776597|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
129132307|NCT04633447|464776596|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
129132308|NCT04633447|464776597|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
129132309|NCT04633447|464776596|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
129132310|NCT04633447|464776597|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
129132311|NCT04633447|464776596|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
129132312|NCT04633447|464776597|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
129132313|NCT04633447|464776596|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
129132314|NCT04633447|464776597|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
129132315|NCT05417113|464776599|FG000|Overall Study|Lost to Follow-up|2|||
129132316|NCT05417113|464776600|FG001|Overall Study|Lost to Follow-up|2|||
129132317|NCT01022580|464776601|FG000|Overall Study|Death|18|||
129132318|NCT01022580|464776602|FG001|Overall Study|Death|22|||
129132319|NCT01500096|464776605|FG000|Overall Study|Lost to Follow-up|1|||
129132320|NCT01500096|464776606|FG001|Overall Study|Lost to Follow-up|0|||
129132321|NCT01500096|464776607|FG002|Overall Study|Lost to Follow-up|0|||
129132322|NCT01500096|464776608|FG003|Overall Study|Lost to Follow-up|2|||
129132323|NCT01734928|464776609|FG000|Randomization|Physician Decision|0|||
129132324|NCT01734928|464776610|FG001|Randomization|Physician Decision|1|||
129132325|NCT01734928|464776609|FG000|Randomization|clinical progression|0|||
129039221|NCT04039919|464435307|FG001|Treatment Period 1|Sponsor's decision|0|||
129039222|NCT04039919|464435308|FG002|Treatment Period 1|Sponsor's decision|0|||
129039223|NCT04039919|464435309|FG003|Treatment Period 1|Sponsor's decision|0|||
129132326|NCT01734928|464776610|FG001|Randomization|clinical progression|1|||
129132327|NCT01734928|464776609|FG000|Randomization|progressive disease|0|||
129132328|NCT01734928|464776610|FG001|Randomization|progressive disease|2|||
129132329|NCT01734928|464776609|FG000|Randomization|Withdrew informed consent|0|||
129132330|NCT01734928|464776610|FG001|Randomization|Withdrew informed consent|4|||
129132331|NCT01734928|464776609|FG000|Randomization|Death|1|||
129039224|NCT04039919|464435310|FG004|Treatment Period 1|Sponsor's decision|16|||
129221505|NCT03843541|465111448|FG000|Overall Study|Administration of rescue mucolytic|0|||
129221506|NCT03843541|465111449|FG001|Overall Study|Administration of rescue mucolytic|0|||
129221507|NCT03843541|465111450|FG002|Overall Study|Administration of rescue mucolytic|1|||
129221508|NCT03843541|465111448|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
129221509|NCT03843541|465111449|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
129221510|NCT03843541|465111450|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
129221511|NCT05307692|465111454|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
129221512|NCT05307692|465111455|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
129221513|NCT05307692|465111456|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
129221514|NCT05307692|465111457|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
129221515|NCT05307692|465111454|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
129221516|NCT05307692|465111455|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
129221517|NCT05307692|465111456|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
129221518|NCT05307692|465111457|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
129221519|NCT05307692|465111454|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
129221520|NCT05307692|465111455|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
129221521|NCT05307692|465111456|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
129221522|NCT05307692|465111457|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
129221523|NCT05307692|465111454|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
129221524|NCT05307692|465111455|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
129221525|NCT05307692|465111456|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
129221526|NCT05307692|465111457|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
129221527|NCT05307692|465111454|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
128975880|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
128975881|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
128975882|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
129221528|NCT05307692|465111455|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
129221529|NCT05307692|465111456|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
129221530|NCT05307692|465111457|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
128975883|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
128975884|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
128975885|NCT00242710|464195917|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
128975886|NCT00242710|464195918|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
128975887|NCT00242710|464195919|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
128975888|NCT00242710|464195920|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
128975889|NCT00242710|464195917|FG000|Period Between Core Study and Extension|Adverse Event|2|||
128975890|NCT00242710|464195918|FG001|Period Between Core Study and Extension|Adverse Event|3|||
128975891|NCT00242710|464195919|FG002|Period Between Core Study and Extension|Adverse Event|5|||
128975892|NCT00242710|464195920|FG003|Period Between Core Study and Extension|Adverse Event|2|||
128975893|NCT00242710|464195917|FG000|Period Between Core Study and Extension|Physician Decision|1|||
128975894|NCT00242710|464195918|FG001|Period Between Core Study and Extension|Physician Decision|1|||
128975895|NCT00242710|464195919|FG002|Period Between Core Study and Extension|Physician Decision|0|||
128975896|NCT00242710|464195920|FG003|Period Between Core Study and Extension|Physician Decision|0|||
128975897|NCT00242710|464195917|FG000|Period Between Core Study and Extension|Other|24|||
128975898|NCT00242710|464195918|FG001|Period Between Core Study and Extension|Other|24|||
128975899|NCT00242710|464195919|FG002|Period Between Core Study and Extension|Other|9|||
128975900|NCT00242710|464195920|FG003|Period Between Core Study and Extension|Other|11|||
128975901|NCT00242710|464195917|FG000|Period Between Core Study and Extension|Extension not Available|17|||
128975902|NCT00242710|464195918|FG001|Period Between Core Study and Extension|Extension not Available|21|||
128975903|NCT00242710|464195919|FG002|Period Between Core Study and Extension|Extension not Available|8|||
128975904|NCT00242710|464195920|FG003|Period Between Core Study and Extension|Extension not Available|7|||
128975905|NCT00242710|464195917|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
128975906|NCT00242710|464195918|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
128975907|NCT00242710|464195919|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
128975908|NCT00242710|464195920|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
128975909|NCT00242710|464195917|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
128975910|NCT00242710|464195918|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
128975911|NCT00242710|464195919|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
128975912|NCT00242710|464195920|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
128975913|NCT00242710|464195917|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
128975914|NCT00242710|464195918|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
129039225|NCT04039919|464435306|FG000|Treatment Period 5|Withdrawal by Subject|1|||
128975915|NCT00242710|464195919|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
128975916|NCT00242710|464195920|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
128975917|NCT00242710|464195917|FG000|Study Extension (up to Year 2)|Death|0|||
128975918|NCT00242710|464195918|FG001|Study Extension (up to Year 2)|Death|0|||
128975919|NCT00242710|464195919|FG002|Study Extension (up to Year 2)|Death|0|||
128975920|NCT00242710|464195920|FG003|Study Extension (up to Year 2)|Death|1|||
128975921|NCT00242710|464195917|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
128975922|NCT00242710|464195918|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
129132332|NCT01734928|464776610|FG001|Randomization|Death|0|||
129132333|NCT01734928|464776609|FG000|Randomization|Randomization error|1|||
129132334|NCT01734928|464776610|FG001|Randomization|Randomization error|0|||
129132335|NCT01734928|464776609|FG000|Randomization|Lost to Follow-up|1|||
129132336|NCT01734928|464776610|FG001|Randomization|Lost to Follow-up|0|||
129132337|NCT01734928|464776609|FG000|Treatment Period|Lost to Follow-up|0|||
129132338|NCT01734928|464776610|FG001|Treatment Period|Lost to Follow-up|2|||
129132339|NCT01734928|464776609|FG000|Treatment Period|Progressive Disease|167|||
129132340|NCT01734928|464776610|FG001|Treatment Period|Progressive Disease|165|||
129132341|NCT01734928|464776609|FG000|Treatment Period|Adverse Event|39|||
129132342|NCT01734928|464776610|FG001|Treatment Period|Adverse Event|52|||
129132343|NCT01734928|464776609|FG000|Treatment Period|Withdrawal of Consent|25|||
129132344|NCT01734928|464776610|FG001|Treatment Period|Withdrawal of Consent|22|||
129132345|NCT01734928|464776609|FG000|Treatment Period|Death|20|||
129132346|NCT01734928|464776610|FG001|Treatment Period|Death|9|||
129132347|NCT01734928|464776609|FG000|Treatment Period|Other Reasons|27|||
129132348|NCT01734928|464776610|FG001|Treatment Period|Other Reasons|19|||
129132349|NCT01734928|464776609|FG000|Treatment Period|Pregnancy|0|||
129132350|NCT01734928|464776610|FG001|Treatment Period|Pregnancy|1|||
129132351|NCT01778985|464776611|FG000|Overall Study|Lost to Follow-up|1|||
129132352|NCT01778985|464776612|FG001|Overall Study|Lost to Follow-up|0|||
129132353|NCT01778985|464776611|FG000|Overall Study|Physician Decision|2|||
129132354|NCT01778985|464776612|FG001|Overall Study|Physician Decision|2|||
129132355|NCT01778985|464776611|FG000|Overall Study|Protocol Violation|4|||
129132356|NCT01778985|464776612|FG001|Overall Study|Protocol Violation|1|||
129132357|NCT03600350|464776613|FG000|Overall Study|Death|1|||
129132358|NCT03600350|464776613|FG000|Overall Study|On Follow Up|18|||
129132359|NCT02323334|464776614|FG000|Period 3|Lost to Follow-up|0|||
129132360|NCT02323334|464776615|FG001|Period 3|Lost to Follow-up|0|||
129132361|NCT02323334|464776616|FG002|Period 3|Lost to Follow-up|1|||
129132362|NCT02323334|464776617|FG003|Period 3|Lost to Follow-up|0|||
129132363|NCT02323334|464776618|FG004|Period 3|Lost to Follow-up|0|||
128975923|NCT00242710|464195919|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
129132364|NCT02323334|464776619|FG005|Period 3|Lost to Follow-up|0|||
129132365|NCT02323334|464776620|FG006|Period 3|Lost to Follow-up|0|||
129132366|NCT02323334|464776621|FG007|Period 3|Lost to Follow-up|0|||
129132367|NCT02323334|464776622|FG008|Period 3|Lost to Follow-up|0|||
129132368|NCT02323334|464776623|FG009|Period 3|Lost to Follow-up|0|||
129132369|NCT02323334|464776624|FG010|Period 3|Lost to Follow-up|0|||
129132370|NCT02323334|464776625|FG011|Period 3|Lost to Follow-up|0|||
129132371|NCT02323334|464776626|FG012|Period 3|Lost to Follow-up|0|||
129132372|NCT02323334|464776627|FG013|Period 3|Lost to Follow-up|0|||
129132373|NCT02323334|464776628|FG014|Period 3|Lost to Follow-up|0|||
129132374|NCT02323334|464776629|FG015|Period 3|Lost to Follow-up|0|||
129132375|NCT02323334|464776630|FG016|Period 3|Lost to Follow-up|0|||
129132376|NCT02323334|464776614|FG000|Period 3|Withdrawal by Subject|1|||
129132377|NCT02323334|464776615|FG001|Period 3|Withdrawal by Subject|0|||
129132378|NCT02323334|464776616|FG002|Period 3|Withdrawal by Subject|0|||
129132379|NCT02323334|464776617|FG003|Period 3|Withdrawal by Subject|0|||
129132380|NCT02323334|464776618|FG004|Period 3|Withdrawal by Subject|0|||
129132381|NCT02323334|464776619|FG005|Period 3|Withdrawal by Subject|0|||
129132382|NCT02323334|464776620|FG006|Period 3|Withdrawal by Subject|0|||
129132383|NCT02323334|464776621|FG007|Period 3|Withdrawal by Subject|0|||
129132384|NCT02323334|464776622|FG008|Period 3|Withdrawal by Subject|0|||
129132385|NCT02323334|464776623|FG009|Period 3|Withdrawal by Subject|0|||
128774739|NCT04157686|463466652|FG000|Overall Study|Protocol Violation|0|||
128975924|NCT00242710|464195920|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
128975925|NCT00242710|464195917|FG000|Study Extension (up to Year 2)|Other|3|||
129132386|NCT02323334|464776624|FG010|Period 3|Withdrawal by Subject|0|||
129132387|NCT02323334|464776625|FG011|Period 3|Withdrawal by Subject|0|||
129132388|NCT02323334|464776626|FG012|Period 3|Withdrawal by Subject|0|||
129132389|NCT02323334|464776627|FG013|Period 3|Withdrawal by Subject|0|||
129132390|NCT02323334|464776628|FG014|Period 3|Withdrawal by Subject|0|||
129132391|NCT02323334|464776629|FG015|Period 3|Withdrawal by Subject|0|||
129132392|NCT02323334|464776630|FG016|Period 3|Withdrawal by Subject|0|||
129132393|NCT00552058|464776631|FG000|Overall Study|Adverse Event|8|||
129132394|NCT00552058|464776632|FG001|Overall Study|Adverse Event|7|||
129132395|NCT00552058|464776631|FG000|Overall Study|Lack of Efficacy|1|||
128975926|NCT00242710|464195918|FG001|Study Extension (up to Year 2)|Other|5|||
129132396|NCT00552058|464776632|FG001|Overall Study|Lack of Efficacy|5|||
129132397|NCT00552058|464776631|FG000|Overall Study|Lost to Follow-up|1|||
129132398|NCT00552058|464776632|FG001|Overall Study|Lost to Follow-up|0|||
128975927|NCT00242710|464195919|FG002|Study Extension (up to Year 2)|Other|4|||
129221531|NCT05307692|465111454|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
129221532|NCT05307692|465111455|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
129221533|NCT05307692|465111456|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
129221534|NCT05307692|465111457|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
129221535|NCT05307692|465111454|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
129221536|NCT05307692|465111455|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
129221537|NCT05307692|465111456|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
129221538|NCT05307692|465111457|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
129221539|NCT05307692|465111454|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
129221540|NCT05307692|465111455|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
129221541|NCT05307692|465111456|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
129221542|NCT05307692|465111457|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
129221543|NCT02003924|465111460|FG000|Double-blind Phase|Lost to Follow-up|2|||
129221544|NCT02003924|465111461|FG001|Double-blind Phase|Lost to Follow-up|1|||
129221545|NCT02003924|465111462|FG002|Double-blind Phase|Lost to Follow-up|0|||
129221546|NCT02003924|465111460|FG000|Double-blind Phase|Protocol Violation|1|||
129221547|NCT02003924|465111461|FG001|Double-blind Phase|Protocol Violation|2|||
129221548|NCT02003924|465111462|FG002|Double-blind Phase|Protocol Violation|0|||
129221549|NCT02003924|465111460|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
129221550|NCT02003924|465111461|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
129221551|NCT02003924|465111462|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
129221552|NCT02003924|465111460|FG000|Double-blind Phase|Disease Progression|229|||
129221553|NCT02003924|465111461|FG001|Double-blind Phase|Disease Progression|247|||
129221554|NCT02003924|465111462|FG002|Double-blind Phase|Disease Progression|0|||
129221555|NCT02003924|465111460|FG000|Double-blind Phase|Adverse Event|120|||
129221556|NCT02003924|465111461|FG001|Double-blind Phase|Adverse Event|31|||
129221557|NCT02003924|465111462|FG002|Double-blind Phase|Adverse Event|0|||
129221558|NCT02003924|465111460|FG000|Double-blind Phase|Randomized But not Treated|3|||
129221559|NCT02003924|465111461|FG001|Double-blind Phase|Randomized But not Treated|3|||
129221560|NCT02003924|465111462|FG002|Double-blind Phase|Randomized But not Treated|0|||
129221561|NCT02003924|465111460|FG000|Double-blind Phase|Other|29|||
129221562|NCT02003924|465111461|FG001|Double-blind Phase|Other|50|||
129221563|NCT02003924|465111462|FG002|Double-blind Phase|Other|0|||
129221564|NCT02003924|465111460|FG000|Open-label Phase|Lost to Follow-up|0|||
129221565|NCT02003924|465111461|FG001|Open-label Phase|Lost to Follow-up|0|||
129221566|NCT02003924|465111462|FG002|Open-label Phase|Lost to Follow-up|1|||
129221567|NCT02003924|465111460|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
129221568|NCT02003924|465111461|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
129221569|NCT02003924|465111462|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
129221570|NCT02003924|465111460|FG000|Open-label Phase|Disease Progression|59|||
129221571|NCT02003924|465111461|FG001|Open-label Phase|Disease Progression|0|||
129221572|NCT02003924|465111462|FG002|Open-label Phase|Disease Progression|5|||
129221573|NCT02003924|465111460|FG000|Open-label Phase|Adverse Event|25|||
129221574|NCT02003924|465111461|FG001|Open-label Phase|Adverse Event|0|||
128975928|NCT00242710|464195920|FG003|Study Extension (up to Year 2)|Other|3|||
128975929|NCT00242710|464195917|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
129132399|NCT00552058|464776631|FG000|Overall Study|Withdrawal by Subject|4|||
129132400|NCT00552058|464776632|FG001|Overall Study|Withdrawal by Subject|4|||
129132401|NCT00552058|464776631|FG000|Overall Study|Other: Protocol Violation|0|||
129132402|NCT00552058|464776632|FG001|Overall Study|Other: Protocol Violation|1|||
129132403|NCT00552058|464776631|FG000|Overall Study|Other: Non Compliance|1|||
129132404|NCT00552058|464776632|FG001|Overall Study|Other: Non Compliance|2|||
129132405|NCT00552058|464776631|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
129132406|NCT00552058|464776632|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
129132407|NCT00552058|464776631|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
129132408|NCT00552058|464776632|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
129132409|NCT00552058|464776631|FG000|Overall Study|Other: Positive Stool Result|0|||
129132410|NCT00552058|464776632|FG001|Overall Study|Other: Positive Stool Result|1|||
129132411|NCT00552058|464776631|FG000|Overall Study|Other: Randomized in error|0|||
129132412|NCT00552058|464776632|FG001|Overall Study|Other: Randomized in error|1|||
129132413|NCT00552058|464776631|FG000|Overall Study|Other: Sponsors Decision|0|||
129132414|NCT00552058|464776632|FG001|Overall Study|Other: Sponsors Decision|1|||
129132415|NCT00552058|464776631|FG000|Overall Study|Other: Early Roll Over|1|||
129132416|NCT00552058|464776632|FG001|Overall Study|Other: Early Roll Over|0|||
129132417|NCT03520569|464776633|FG000|Overall Study|Withdrawal by Subject|1|||
129132418|NCT03418675|464776636|FG000|Overall Study|Lost to Follow-up|13|||
129221575|NCT02003924|465111462|FG002|Open-label Phase|Adverse Event|10|||
129221576|NCT02003924|465111460|FG000|Open-label Phase|Other|7|||
129221577|NCT02003924|465111461|FG001|Open-label Phase|Other|0|||
128774740|NCT04157686|463466653|FG001|Overall Study|Protocol Violation|0|||
129221578|NCT02003924|465111462|FG002|Open-label Phase|Other|0|||
129221579|NCT02003924|465111460|FG000|Long-term Follow-up Phase|Death|288|||
129221580|NCT02003924|465111461|FG001|Long-term Follow-up Phase|Death|174|||
129221581|NCT02003924|465111462|FG002|Long-term Follow-up Phase|Death|4|||
129221582|NCT02003924|465111460|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
129221583|NCT02003924|465111461|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
129221584|NCT02003924|465111462|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
129221585|NCT02003924|465111460|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
129221586|NCT02003924|465111461|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
129221587|NCT02003924|465111462|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
129221588|NCT02003924|465111460|FG000|Long-term Follow-up Phase|Other|5|||
129221589|NCT02003924|465111461|FG001|Long-term Follow-up Phase|Other|2|||
129221590|NCT02003924|465111462|FG002|Long-term Follow-up Phase|Other|1|||
129221591|NCT00560352|465111467|FG000|Overall Study|Adverse event unrelated to study drug|2|||
129221592|NCT00560352|465111468|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129221593|NCT00560352|465111469|FG002|Overall Study|Adverse event unrelated to study drug|1|||
129221594|NCT00560352|465111467|FG000|Overall Study|Study drug toxicity|3|||
129221595|NCT00560352|465111468|FG001|Overall Study|Study drug toxicity|0|||
129221596|NCT00560352|465111469|FG002|Overall Study|Study drug toxicity|1|||
129221597|NCT00560352|465111467|FG000|Overall Study|Disease progression|0|||
129221598|NCT00560352|465111468|FG001|Overall Study|Disease progression|1|||
129221599|NCT00560352|465111469|FG002|Overall Study|Disease progression|1|||
129221600|NCT00560352|465111467|FG000|Overall Study|Withdrawal by Subject|1|||
129221601|NCT00560352|465111468|FG001|Overall Study|Withdrawal by Subject|1|||
129221602|NCT00560352|465111469|FG002|Overall Study|Withdrawal by Subject|1|||
129221603|NCT00560352|465111467|FG000|Overall Study|Maximum clinical benefit|1|||
129221604|NCT00560352|465111468|FG001|Overall Study|Maximum clinical benefit|0|||
129221605|NCT00560352|465111469|FG002|Overall Study|Maximum clinical benefit|0|||
129221606|NCT03083873|465113250|FG000|Overall Study|Death|6|||
129221607|NCT03083873|465113251|FG001|Overall Study|Death|15|||
129221608|NCT03083873|465113252|FG002|Overall Study|Death|13|||
129221609|NCT03083873|465113253|FG003|Overall Study|Death|9|||
129221610|NCT03083873|465113254|FG004|Overall Study|Death|0|||
129221611|NCT03083873|465113250|FG000|Overall Study|Sponsor Terminated Study|0|||
129221612|NCT03083873|465113251|FG001|Overall Study|Sponsor Terminated Study|1|||
129221613|NCT03083873|465113252|FG002|Overall Study|Sponsor Terminated Study|2|||
129221614|NCT03083873|465113253|FG003|Overall Study|Sponsor Terminated Study|3|||
129221615|NCT03083873|465113254|FG004|Overall Study|Sponsor Terminated Study|0|||
129221616|NCT03083873|465113250|FG000|Overall Study|Lost to Follow-up|0|||
129221617|NCT03083873|465113251|FG001|Overall Study|Lost to Follow-up|1|||
129221618|NCT03083873|465113252|FG002|Overall Study|Lost to Follow-up|1|||
129221619|NCT03083873|465113253|FG003|Overall Study|Lost to Follow-up|0|||
129221620|NCT03083873|465113254|FG004|Overall Study|Lost to Follow-up|0|||
129221621|NCT03083873|465113250|FG000|Overall Study|Withdrawal by Subject|2|||
129221622|NCT03083873|465113251|FG001|Overall Study|Withdrawal by Subject|0|||
129221623|NCT03083873|465113252|FG002|Overall Study|Withdrawal by Subject|0|||
129221624|NCT03083873|465113253|FG003|Overall Study|Withdrawal by Subject|0|||
129221625|NCT03083873|465113254|FG004|Overall Study|Withdrawal by Subject|0|||
129221626|NCT03083873|465113250|FG000|Overall Study|Did Not Receive TIL|2|||
129221627|NCT03083873|465113251|FG001|Overall Study|Did Not Receive TIL|5|||
129221628|NCT03083873|465113252|FG002|Overall Study|Did Not Receive TIL|3|||
129221629|NCT03083873|465113253|FG003|Overall Study|Did Not Receive TIL|1|||
129221630|NCT03083873|465113254|FG004|Overall Study|Did Not Receive TIL|0|||
129221631|NCT01677377|465113255|FG000|Overall Study|Protocol Violation|1|||
129221632|NCT01677377|465113256|FG001|Overall Study|Protocol Violation|0|||
129221633|NCT01677377|465113257|FG002|Overall Study|Protocol Violation|0|||
129221634|NCT01677377|465113255|FG000|Overall Study|Lost to Follow-up|0|||
129221635|NCT01677377|465113256|FG001|Overall Study|Lost to Follow-up|1|||
129221636|NCT01677377|465113257|FG002|Overall Study|Lost to Follow-up|1|||
129221637|NCT01677377|465113255|FG000|Overall Study|Withdrawal by Subject|0|||
129221638|NCT01677377|465113256|FG001|Overall Study|Withdrawal by Subject|0|||
129221639|NCT01677377|465113257|FG002|Overall Study|Withdrawal by Subject|3|||
129221640|NCT01677377|465113255|FG000|Overall Study|Lack of Efficacy|0|||
129221641|NCT01677377|465113256|FG001|Overall Study|Lack of Efficacy|0|||
129221642|NCT01677377|465113257|FG002|Overall Study|Lack of Efficacy|1|||
129221643|NCT01677377|465113255|FG000|Overall Study|Pregnancy|0|||
129221644|NCT01677377|465113256|FG001|Overall Study|Pregnancy|0|||
129221645|NCT01677377|465113257|FG002|Overall Study|Pregnancy|1|||
129221646|NCT02656693|465113271|FG000|Overall Study|Pregnancy|1|||
129221647|NCT02656693|465113272|FG001|Overall Study|Pregnancy|1|||
129221648|NCT02656693|465113273|FG002|Overall Study|Pregnancy|1|||
129221649|NCT02656693|465113271|FG000|Overall Study|Bariatric surgery|0|||
129221650|NCT02656693|465113272|FG001|Overall Study|Bariatric surgery|1|||
129221651|NCT02656693|465113273|FG002|Overall Study|Bariatric surgery|2|||
129221652|NCT02269267|465113275|FG000|Overall Study|Death|5|||
129221653|NCT00796419|465113277|FG000|Overall Study|Death|0|||
129221654|NCT00796419|465113278|FG001|Overall Study|Death|1|||
129221655|NCT01193257|465113282|FG000|Overall Study|Death|202|||
129221656|NCT01193257|465113283|FG001|Overall Study|Death|391|||
129221657|NCT01193257|465113282|FG000|Overall Study|Study termination by sponsor|0|||
129132419|NCT03418675|464776637|FG001|Overall Study|Lost to Follow-up|10|||
129132420|NCT03418675|464776636|FG000|Overall Study|Adverse Event|2|||
129132421|NCT03418675|464776637|FG001|Overall Study|Adverse Event|0|||
129132422|NCT03422718|464776638|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
129132423|NCT03422718|464776639|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
129132424|NCT03422718|464776640|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
129132425|NCT03422718|464776641|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
129132426|NCT03422718|464776642|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
129132427|NCT03422718|464776643|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
129132428|NCT03422718|464776644|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
129132429|NCT03422718|464776645|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
129132430|NCT03422718|464776638|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
129132431|NCT03422718|464776639|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
129132432|NCT03422718|464776640|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
129132433|NCT03422718|464776641|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
129132434|NCT03422718|464776642|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
129132435|NCT03422718|464776643|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
129132436|NCT03422718|464776644|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
129132437|NCT03422718|464776645|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
129132438|NCT03422718|464776638|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
129132439|NCT03422718|464776639|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
129132440|NCT03422718|464776640|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
129132441|NCT03422718|464776641|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
129132442|NCT03422718|464776642|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
129132443|NCT03422718|464776643|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
129132444|NCT03422718|464776644|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
129132445|NCT03422718|464776645|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
129132446|NCT03422718|464776638|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129132447|NCT03422718|464776639|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
129132448|NCT03422718|464776640|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129132449|NCT03422718|464776641|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129132450|NCT03422718|464776642|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
129132451|NCT03422718|464776643|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
129132452|NCT03422718|464776644|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129132453|NCT03422718|464776645|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129132454|NCT03422718|464776638|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
129132455|NCT03422718|464776639|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
129132456|NCT03422718|464776640|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
129132457|NCT03422718|464776641|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
129132458|NCT03422718|464776642|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
129132459|NCT03422718|464776643|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
129132460|NCT03422718|464776644|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
129132461|NCT03422718|464776645|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
129132462|NCT03422718|464776638|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
129132463|NCT03422718|464776639|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
129132464|NCT03422718|464776640|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
129132465|NCT03422718|464776641|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
129132466|NCT03422718|464776642|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
129132467|NCT03422718|464776643|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
129132468|NCT03422718|464776644|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
129132469|NCT03422718|464776645|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
129132470|NCT01178411|464776646|FG000|Overall Study|Adverse Event|5|||
129132471|NCT01178411|464776646|FG000|Overall Study|Withdrawal by Subject|4|||
129132472|NCT01178411|464776646|FG000|Overall Study|Protocol Violation|1|||
129132473|NCT01178411|464776646|FG000|Overall Study|Progressive disease per RECIST|32|||
129132474|NCT01178411|464776646|FG000|Overall Study|Progressive disease per clinician|9|||
129132475|NCT01178411|464776646|FG000|Overall Study|Physician Decision|6|||
129132476|NCT01178411|464776646|FG000|Overall Study|Death|1|||
129132477|NCT01178411|464776646|FG000|Overall Study|No reason provided|1|||
129132478|NCT01178411|464776646|FG000|Overall Study|Drug manufacturing ended|1|||
129132479|NCT01129284|464776647|FG000|Overall Study|Adverse Event|2|||
129132480|NCT01129284|464776648|FG001|Overall Study|Adverse Event|0|||
129132481|NCT01129284|464776649|FG002|Overall Study|Adverse Event|1|||
129132482|NCT00845182|464776657|FG000|Overall Study|Lost to Follow-up|3|||
128716234|NCT02432846|463258175|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
129132483|NCT00845182|464776658|FG001|Overall Study|Lost to Follow-up|3|||
129132484|NCT00845182|464776659|FG002|Overall Study|Lost to Follow-up|4|||
129132485|NCT00845182|464776657|FG000|Overall Study|Adverse Event|0|||
128975930|NCT00242710|464195918|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
128975931|NCT00242710|464195919|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
128975932|NCT00242710|464195920|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
128975933|NCT00242710|464195917|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
128975934|NCT00242710|464195918|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
128975935|NCT00242710|464195919|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
128975936|NCT00242710|464195920|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
128975937|NCT00579527|464195921|FG000|Overall Study|Death|4|||
128975938|NCT03961529|464195922|FG000|Overall Study|Adverse Event|13|||
128975939|NCT03961529|464195923|FG001|Overall Study|Adverse Event|5|||
128975940|NCT03961529|464195924|FG002|Overall Study|Adverse Event|2|||
128975941|NCT03961529|464195922|FG000|Overall Study|Withdrawal by Subject|17|||
128975942|NCT03961529|464195923|FG001|Overall Study|Withdrawal by Subject|2|||
128975943|NCT03961529|464195924|FG002|Overall Study|Withdrawal by Subject|1|||
128975944|NCT03961529|464195922|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128975945|NCT03961529|464195923|FG001|Overall Study|Withdrawal by parent/guardian|7|||
128975946|NCT03961529|464195924|FG002|Overall Study|Withdrawal by parent/guardian|0|||
128975947|NCT03961529|464195922|FG000|Overall Study|Physician Decision|2|||
128975948|NCT03961529|464195923|FG001|Overall Study|Physician Decision|1|||
128975949|NCT03961529|464195924|FG002|Overall Study|Physician Decision|1|||
128975950|NCT03961529|464195922|FG000|Overall Study|Lost to Follow-up|2|||
128975951|NCT03961529|464195923|FG001|Overall Study|Lost to Follow-up|1|||
128975952|NCT03961529|464195924|FG002|Overall Study|Lost to Follow-up|0|||
128975953|NCT03961529|464195922|FG000|Overall Study|Lack of Efficacy|2|||
128975954|NCT03961529|464195923|FG001|Overall Study|Lack of Efficacy|0|||
128975955|NCT03961529|464195924|FG002|Overall Study|Lack of Efficacy|1|||
128975956|NCT03961529|464195922|FG000|Overall Study|Other|6|||
128975957|NCT03961529|464195923|FG001|Overall Study|Other|1|||
128975958|NCT03961529|464195924|FG002|Overall Study|Other|0|||
128975959|NCT03644173|464195927|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
128975960|NCT03644173|464195927|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
128975961|NCT03644173|464195927|FG000|Participants at the 1-month Follow up|Death|2|||
128975962|NCT03644173|464195927|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
128975963|NCT00381706|464195928|FG000|Overall Study|Never treated|7|||
128975964|NCT00381706|464195929|FG001|Overall Study|Never treated|2|||
128975965|NCT00381706|464195930|FG002|Overall Study|Never treated|1|||
128975966|NCT00472043|464195947|FG000|Overall Study|Withdrawal by Subject|1|||
128975967|NCT00472043|464195948|FG001|Overall Study|Withdrawal by Subject|0|||
128975968|NCT00472043|464195947|FG000|Overall Study|Death|1|||
128975969|NCT00472043|464195948|FG001|Overall Study|Death|0|||
128975970|NCT03922711|464195949|FG000|Overall Study|Adverse Event|3|||
128975971|NCT03922711|464195950|FG001|Overall Study|Adverse Event|2|||
128975972|NCT03922711|464195951|FG002|Overall Study|Adverse Event|2|||
128975973|NCT03922711|464195949|FG000|Overall Study|Protocol Violation|1|||
128975974|NCT03922711|464195950|FG001|Overall Study|Protocol Violation|0|||
128975975|NCT03922711|464195951|FG002|Overall Study|Protocol Violation|0|||
128975976|NCT03922711|464195949|FG000|Overall Study|Withdrawal by Subject|0|||
128975977|NCT03922711|464195950|FG001|Overall Study|Withdrawal by Subject|3|||
128975978|NCT03922711|464195951|FG002|Overall Study|Withdrawal by Subject|1|||
128975979|NCT03922711|464195949|FG000|Overall Study|Not further specified|0|||
128975980|NCT03922711|464195950|FG001|Overall Study|Not further specified|0|||
128975981|NCT03922711|464195951|FG002|Overall Study|Not further specified|1|||
128975982|NCT00877890|464195956|FG000|Overall Study|Adverse Event|6|||
128975983|NCT00877890|464195957|FG001|Overall Study|Adverse Event|6|||
128975984|NCT00877890|464195956|FG000|Overall Study|Lost to Follow-up|5|||
128975985|NCT00877890|464195957|FG001|Overall Study|Lost to Follow-up|5|||
128975986|NCT00877890|464195956|FG000|Overall Study|Protocol Violation|0|||
128716235|NCT02432846|463258170|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
128975987|NCT00877890|464195957|FG001|Overall Study|Protocol Violation|1|||
128975988|NCT00877890|464195956|FG000|Overall Study|Withdrawal of Consent|6|||
128975989|NCT00877890|464195957|FG001|Overall Study|Withdrawal of Consent|12|||
128975990|NCT00877890|464195956|FG000|Overall Study|Investigator Decision|0|||
128975991|NCT00877890|464195957|FG001|Overall Study|Investigator Decision|2|||
128975992|NCT00877890|464195956|FG000|Overall Study|Loss of Glucose Control|3|||
128975993|NCT00877890|464195957|FG001|Overall Study|Loss of Glucose Control|4|||
128975994|NCT03049852|464195960|FG000|Overall Study|Lost to Follow-up|0|||
128975995|NCT03049852|464195961|FG001|Overall Study|Lost to Follow-up|1|||
128975996|NCT03049852|464195962|FG002|Overall Study|Lost to Follow-up|0|||
129132486|NCT00845182|464776658|FG001|Overall Study|Adverse Event|1|||
128716236|NCT02432846|463258171|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
128975997|NCT04728815|464195968|FG000|Overall Study|Lost to Follow-up|3|||
128975998|NCT04728815|464195969|FG001|Overall Study|Lost to Follow-up|0|||
128975999|NCT04728815|464195970|FG002|Overall Study|Lost to Follow-up|0|||
128976000|NCT04728815|464195971|FG003|Overall Study|Lost to Follow-up|1|||
128976001|NCT04728815|464195972|FG004|Overall Study|Lost to Follow-up|1|||
128976002|NCT04728815|464195973|FG005|Overall Study|Lost to Follow-up|0|||
128976003|NCT04728815|464195974|FG006|Overall Study|Lost to Follow-up|2|||
129132487|NCT00845182|464776659|FG002|Overall Study|Adverse Event|1|||
129132488|NCT00845182|464776657|FG000|Overall Study|Physician Decision|0|||
129132489|NCT00845182|464776658|FG001|Overall Study|Physician Decision|0|||
129132490|NCT00845182|464776659|FG002|Overall Study|Physician Decision|1|||
128716237|NCT02432846|463258172|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
128716238|NCT02432846|463258173|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
128716239|NCT02432846|463258174|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
128716240|NCT02432846|463258175|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
128716241|NCT02432846|463258170|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
128716242|NCT02432846|463258171|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
128716243|NCT02432846|463258172|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
128716244|NCT02432846|463258173|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
128716245|NCT02432846|463258174|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
128716246|NCT02432846|463258175|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
128716247|NCT02432846|463258170|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
128716248|NCT02432846|463258171|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
128716249|NCT02432846|463258172|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
128976004|NCT04728815|464195975|FG007|Overall Study|Lost to Follow-up|0|||
128976005|NCT04728815|464195968|FG000|Overall Study|Physician Decision|0|||
128976006|NCT04728815|464195969|FG001|Overall Study|Physician Decision|0|||
128976007|NCT04728815|464195970|FG002|Overall Study|Physician Decision|1|||
128716250|NCT02432846|463258173|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
128716251|NCT02432846|463258174|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
128774741|NCT04157686|463466654|FG002|Overall Study|Protocol Violation|0|||
128976008|NCT04728815|464195971|FG003|Overall Study|Physician Decision|0|||
128976009|NCT04728815|464195972|FG004|Overall Study|Physician Decision|0|||
128976010|NCT04728815|464195973|FG005|Overall Study|Physician Decision|0|||
128976011|NCT04728815|464195974|FG006|Overall Study|Physician Decision|0|||
128976012|NCT04728815|464195975|FG007|Overall Study|Physician Decision|0|||
128976013|NCT04728815|464195968|FG000|Overall Study|Treatment drop|0|||
128976014|NCT04728815|464195969|FG001|Overall Study|Treatment drop|2|||
128976015|NCT04728815|464195970|FG002|Overall Study|Treatment drop|1|||
128976016|NCT04728815|464195971|FG003|Overall Study|Treatment drop|0|||
128976017|NCT04728815|464195972|FG004|Overall Study|Treatment drop|3|||
128976018|NCT04728815|464195973|FG005|Overall Study|Treatment drop|1|||
128976019|NCT04728815|464195974|FG006|Overall Study|Treatment drop|3|||
128976020|NCT04728815|464195975|FG007|Overall Study|Treatment drop|0|||
128976021|NCT04728815|464195968|FG000|Overall Study|Study drop|0|||
128976022|NCT04728815|464195969|FG001|Overall Study|Study drop|3|||
128976023|NCT04728815|464195970|FG002|Overall Study|Study drop|3|||
129132491|NCT01625182|464776660|FG000|Overall Study|Administrative problems|1|||
129132492|NCT01625182|464776661|FG001|Overall Study|Administrative problems|0|||
129132493|NCT01625182|464776660|FG000|Overall Study|Protocol deviation|0|||
129132494|NCT01625182|464776661|FG001|Overall Study|Protocol deviation|2|||
129132495|NCT01625182|464776660|FG000|Overall Study|Adverse Event|2|||
129132496|NCT01625182|464776661|FG001|Overall Study|Adverse Event|0|||
129132497|NCT01625182|464776660|FG000|Overall Study|Withdrawal by Subject|5|||
129132498|NCT01625182|464776661|FG001|Overall Study|Withdrawal by Subject|1|||
129132499|NCT01625182|464776660|FG000|Overall Study|Lack of Efficacy|12|||
129132500|NCT01625182|464776661|FG001|Overall Study|Lack of Efficacy|8|||
129132501|NCT00447278|464776664|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
129132502|NCT00447278|464776665|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
129132503|NCT00447278|464776664|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
129132504|NCT00447278|464776665|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
129132505|NCT00447278|464776664|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
129132506|NCT00447278|464776665|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
129132507|NCT00447278|464776664|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
129132508|NCT00447278|464776665|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
129132509|NCT00447278|464776664|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
129132510|NCT00447278|464776665|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
129132511|NCT00447278|464776664|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
129132512|NCT00447278|464776665|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
129132513|NCT00447278|464776664|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
129132514|NCT00447278|464776665|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
129132515|NCT00447278|464776664|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
129132516|NCT00447278|464776665|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
129132517|NCT00447278|464776664|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
129132518|NCT00447278|464776665|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
129132519|NCT00447278|464776664|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
128976024|NCT04728815|464195971|FG003|Overall Study|Study drop|0|||
128976025|NCT04728815|464195972|FG004|Overall Study|Study drop|0|||
128976026|NCT04728815|464195973|FG005|Overall Study|Study drop|0|||
128976027|NCT04728815|464195974|FG006|Overall Study|Study drop|7|||
128976028|NCT04728815|464195975|FG007|Overall Study|Study drop|0|||
128976029|NCT00957034|464195976|FG000|Overall Study|Adverse Event|0|||
128976030|NCT00957034|464195977|FG001|Overall Study|Adverse Event|1|||
128976031|NCT00957034|464195978|FG002|Overall Study|Adverse Event|1|||
128976032|NCT00957034|464195976|FG000|Overall Study|Sponsor Terminated Study|6|||
128976033|NCT00957034|464195977|FG001|Overall Study|Sponsor Terminated Study|1|||
129132520|NCT00447278|464776665|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
129132521|NCT00447278|464776664|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
128716252|NCT02432846|463258175|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
128716253|NCT01770379|463258176|FG000|Overall Study|Technical issues|1|||
128716254|NCT01770379|463258177|FG001|Overall Study|Technical issues|0|||
128716255|NCT01770379|463258178|FG002|Overall Study|Technical issues|0|||
128716256|NCT01770379|463258176|FG000|Overall Study|Withdrawal by Subject|7|||
128716257|NCT01770379|463258177|FG001|Overall Study|Withdrawal by Subject|10|||
128716258|NCT01770379|463258178|FG002|Overall Study|Withdrawal by Subject|7|||
128716259|NCT01770379|463258176|FG000|Overall Study|study terminated by sponsor|22|||
128716260|NCT01770379|463258177|FG001|Overall Study|study terminated by sponsor|23|||
128716261|NCT01770379|463258178|FG002|Overall Study|study terminated by sponsor|22|||
128716262|NCT01770379|463258176|FG000|Overall Study|Protocol Violation|0|||
128716263|NCT01770379|463258177|FG001|Overall Study|Protocol Violation|1|||
128716264|NCT01770379|463258178|FG002|Overall Study|Protocol Violation|1|||
128716265|NCT01770379|463258176|FG000|Overall Study|Physician Decision|0|||
128716266|NCT01770379|463258177|FG001|Overall Study|Physician Decision|1|||
128716267|NCT01770379|463258178|FG002|Overall Study|Physician Decision|2|||
128716268|NCT01770379|463258176|FG000|Overall Study|Lost to Follow-up|0|||
128716269|NCT01770379|463258177|FG001|Overall Study|Lost to Follow-up|0|||
128716270|NCT01770379|463258178|FG002|Overall Study|Lost to Follow-up|2|||
128716271|NCT01770379|463258176|FG000|Overall Study|Lack of Efficacy|8|||
128716272|NCT01770379|463258177|FG001|Overall Study|Lack of Efficacy|6|||
128716273|NCT01770379|463258178|FG002|Overall Study|Lack of Efficacy|6|||
128716274|NCT01770379|463258176|FG000|Overall Study|Adverse Event|1|||
128716275|NCT01770379|463258177|FG001|Overall Study|Adverse Event|3|||
128716276|NCT01770379|463258178|FG002|Overall Study|Adverse Event|2|||
128716277|NCT03045887|463258179|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
128716278|NCT03045887|463258180|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716279|NCT03045887|463258181|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716280|NCT03045887|463258182|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716281|NCT03045887|463258183|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716282|NCT03045887|463258184|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716283|NCT03045887|463258185|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716284|NCT03045887|463258186|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716285|NCT03045887|463258187|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716286|NCT03045887|463258188|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
128716287|NCT03045887|463258179|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716288|NCT03045887|463258180|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716289|NCT03045887|463258181|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716290|NCT03045887|463258182|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
128716291|NCT03045887|463258183|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716292|NCT03045887|463258184|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716293|NCT03045887|463258185|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716294|NCT03045887|463258186|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716295|NCT03045887|463258187|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716296|NCT03045887|463258188|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
128716297|NCT03045887|463258179|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
128716298|NCT03045887|463258180|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716299|NCT03045887|463258181|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716300|NCT03045887|463258182|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716301|NCT03045887|463258183|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716302|NCT03045887|463258184|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
128976034|NCT00957034|464195978|FG002|Overall Study|Sponsor Terminated Study|5|||
128976035|NCT00957034|464195976|FG000|Overall Study|Withdrawal by Subject|0|||
128716303|NCT03045887|463258185|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716304|NCT03045887|463258186|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716305|NCT03045887|463258187|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716306|NCT03045887|463258188|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
128716307|NCT03045887|463258179|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128716308|NCT03045887|463258180|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128716309|NCT03045887|463258181|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
128716310|NCT03045887|463258182|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
128716311|NCT03045887|463258183|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128976036|NCT00957034|464195977|FG001|Overall Study|Withdrawal by Subject|2|||
128716312|NCT03045887|463258184|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128716313|NCT03045887|463258185|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128716314|NCT03045887|463258186|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128716315|NCT03045887|463258187|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128716316|NCT03045887|463258188|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
128716317|NCT03045887|463258179|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716318|NCT03045887|463258180|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716319|NCT03045887|463258181|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716320|NCT03045887|463258182|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
128716321|NCT03045887|463258183|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716322|NCT03045887|463258184|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716323|NCT03045887|463258185|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716324|NCT03045887|463258186|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716325|NCT03045887|463258187|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716326|NCT03045887|463258188|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
128716327|NCT01912287|463258190|FG000|Overall Study|Ineligible|1|||
128716328|NCT01912287|463258191|FG001|Overall Study|Ineligible|0|||
128716329|NCT01912287|463258192|FG002|Overall Study|Ineligible|1|||
128716330|NCT01912287|463258190|FG000|Overall Study|No-show|0|||
128716331|NCT01912287|463258191|FG001|Overall Study|No-show|0|||
129132522|NCT00447278|464776665|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
129132523|NCT00447278|464776664|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
129132524|NCT00447278|464776665|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
129132525|NCT00447278|464776664|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
129132526|NCT00447278|464776665|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
129132527|NCT00447278|464776664|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
128716332|NCT01912287|463258192|FG002|Overall Study|No-show|1|||
128716333|NCT01912287|463258190|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
128716334|NCT01912287|463258191|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
128716335|NCT01912287|463258192|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
129132528|NCT00447278|464776665|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
129132529|NCT01348698|464776666|FG000|Overall Study|Does not meet lesion size criteria|1|||
129132530|NCT01348698|464776666|FG000|Overall Study|Death|3|||
129132531|NCT01348698|464776666|FG000|Overall Study|PI decision to close study|68|||
129132532|NCT02595749|464776667|FG000|Overall Study|Withdrawal by Subject|12|||
129132533|NCT02595749|464776668|FG001|Overall Study|Withdrawal by Subject|7|||
129132534|NCT00263562|464776669|FG000|Overall Study|Protocol Violation|3|||
129132535|NCT00263562|464776670|FG001|Overall Study|Protocol Violation|0|||
129132536|NCT05427916|464776676|FG000|Overall Study|Adverse Event|3|||
129132537|NCT05427916|464776677|FG001|Overall Study|Adverse Event|0|||
128716336|NCT01912287|463258190|FG000|Overall Study|Felt treatment no longer needed|0|||
128716337|NCT01912287|463258191|FG001|Overall Study|Felt treatment no longer needed|1|||
129132538|NCT05427916|464776676|FG000|Overall Study|Lack of Efficacy|6|||
129221658|NCT01193257|465113283|FG001|Overall Study|Study termination by sponsor|3|||
129221659|NCT01193257|465113282|FG000|Overall Study|Withdrawal by Subject|26|||
128716338|NCT01912287|463258192|FG002|Overall Study|Felt treatment no longer needed|0|||
128716339|NCT01912287|463258190|FG000|Overall Study|Life circumstances|4|||
128716340|NCT01912287|463258191|FG001|Overall Study|Life circumstances|2|||
128716341|NCT01912287|463258192|FG002|Overall Study|Life circumstances|0|||
128716342|NCT01912287|463258190|FG000|Overall Study|Lost Interest|1|||
128716343|NCT01912287|463258191|FG001|Overall Study|Lost Interest|0|||
128716344|NCT01912287|463258192|FG002|Overall Study|Lost Interest|0|||
128716345|NCT01912287|463258190|FG000|Overall Study|Uknown reason - subject drop out|5|||
128716346|NCT01912287|463258191|FG001|Overall Study|Uknown reason - subject drop out|7|||
128716347|NCT01912287|463258192|FG002|Overall Study|Uknown reason - subject drop out|3|||
128716348|NCT01912287|463258190|FG000|Overall Study|Missed Assesment|1|||
128716349|NCT01912287|463258191|FG001|Overall Study|Missed Assesment|1|||
128716350|NCT01912287|463258192|FG002|Overall Study|Missed Assesment|1|||
128716351|NCT01912287|463258190|FG000|Overall Study|Scheduling/change in availability|17|||
128716352|NCT01912287|463258191|FG001|Overall Study|Scheduling/change in availability|10|||
128716353|NCT01912287|463258192|FG002|Overall Study|Scheduling/change in availability|8|||
128716354|NCT03914326|463258195|FG000|Overall Study|Withdrawal by Subject|27|||
128716355|NCT03914326|463258196|FG001|Overall Study|Withdrawal by Subject|34|||
128716356|NCT03914326|463258195|FG000|Overall Study|Lost to Follow-up|43|||
129221660|NCT01193257|465113283|FG001|Overall Study|Withdrawal by Subject|86|||
129221661|NCT01193257|465113282|FG000|Overall Study|Lost to Follow-up|2|||
129221662|NCT01193257|465113283|FG001|Overall Study|Lost to Follow-up|3|||
128716357|NCT03914326|463258196|FG001|Overall Study|Lost to Follow-up|51|||
128716358|NCT03914326|463258195|FG000|Overall Study|Randomised more than once|0|||
128716359|NCT03914326|463258196|FG001|Overall Study|Randomised more than once|1|||
128716360|NCT03226392|463258201|FG000|Overall Study|Protocol Deviation|1|||
128716361|NCT03226392|463258202|FG001|Overall Study|Protocol Deviation|0|||
128716362|NCT03226392|463258201|FG000|Overall Study|Physician Decision|1|||
128716363|NCT03226392|463258202|FG001|Overall Study|Physician Decision|0|||
128716364|NCT03226392|463258201|FG000|Overall Study|Lost to Follow-up|1|||
128716365|NCT03226392|463258202|FG001|Overall Study|Lost to Follow-up|0|||
128716366|NCT03226392|463258201|FG000|Overall Study|Adverse Event|1|||
128716367|NCT03226392|463258202|FG001|Overall Study|Adverse Event|0|||
128716368|NCT03226392|463258201|FG000|Overall Study|Technical Problems|0|||
128716369|NCT03226392|463258202|FG001|Overall Study|Technical Problems|2|||
128716370|NCT03226392|463258201|FG000|Overall Study|Subject/Guardian Decision|7|||
128716371|NCT03226392|463258202|FG001|Overall Study|Subject/Guardian Decision|6|||
128716372|NCT04788953|463258203|FG000|Overall Study|Adverse Event|1|||
128716373|NCT04788953|463258204|FG001|Overall Study|Adverse Event|1|||
128716374|NCT04788953|463258203|FG000|Overall Study|Withdrawal by Subject|1|||
128716375|NCT04788953|463258204|FG001|Overall Study|Withdrawal by Subject|0|||
128716376|NCT04788953|463258203|FG000|Overall Study|Protocol Violation|0|||
128716377|NCT04788953|463258204|FG001|Overall Study|Protocol Violation|1|||
128716378|NCT00469092|463258205|FG000|Overall Study|Adverse Event|5|||
128716379|NCT00469092|463258206|FG001|Overall Study|Adverse Event|4|||
128716380|NCT00469092|463258205|FG000|Overall Study|Lack of Efficacy|1|||
128716381|NCT00469092|463258206|FG001|Overall Study|Lack of Efficacy|0|||
128716382|NCT00469092|463258205|FG000|Overall Study|Lost to Follow-up|1|||
128716383|NCT00469092|463258206|FG001|Overall Study|Lost to Follow-up|2|||
128716384|NCT00469092|463258205|FG000|Overall Study|Protocol Violation|3|||
128716385|NCT00469092|463258206|FG001|Overall Study|Protocol Violation|3|||
128716386|NCT00469092|463258205|FG000|Overall Study|Withdrawal by Subject|4|||
128716387|NCT00469092|463258206|FG001|Overall Study|Withdrawal by Subject|4|||
128716388|NCT00469092|463258205|FG000|Overall Study|Withdrawal Criteria|3|||
128716389|NCT00469092|463258206|FG001|Overall Study|Withdrawal Criteria|4|||
128716390|NCT00469092|463258205|FG000|Overall Study|Incorrectly Randomised|4|||
128716391|NCT00469092|463258206|FG001|Overall Study|Incorrectly Randomised|3|||
128716392|NCT00469092|463258205|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
128716393|NCT00469092|463258206|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
128716394|NCT00469092|463258205|FG000|Overall Study|Use of lipid lowering drug|1|||
128976037|NCT00957034|464195978|FG002|Overall Study|Withdrawal by Subject|0|||
128976038|NCT02967562|464198493|FG000|Overall Study|Consent not obtained|1|||
128976039|NCT02967562|464198494|FG001|Overall Study|Consent not obtained|0|||
128976040|NCT02967562|464198493|FG000|Overall Study|High leak precluding analysis|1|||
128976041|NCT02967562|464198494|FG001|Overall Study|High leak precluding analysis|1|||
128976042|NCT00106626|464198495|FG000|Overall Study|Adverse Event|5|||
128716395|NCT00469092|463258206|FG001|Overall Study|Use of lipid lowering drug|0|||
128716396|NCT00469092|463258205|FG000|Overall Study|Hypoglycaemic Episodes|1|||
128716397|NCT00469092|463258206|FG001|Overall Study|Hypoglycaemic Episodes|1|||
128716398|NCT00469092|463258205|FG000|Overall Study|Abnormal lab value|1|||
128716399|NCT00469092|463258206|FG001|Overall Study|Abnormal lab value|0|||
128976043|NCT00106626|464198496|FG001|Overall Study|Adverse Event|4|||
128976044|NCT00106626|464198497|FG002|Overall Study|Adverse Event|3|||
128976045|NCT00106626|464198498|FG003|Overall Study|Adverse Event|3|||
128976046|NCT00106626|464198495|FG000|Overall Study|Progressive Disease|4|||
128976047|NCT00106626|464198496|FG001|Overall Study|Progressive Disease|1|||
128976048|NCT00106626|464198497|FG002|Overall Study|Progressive Disease|9|||
128976049|NCT00106626|464198498|FG003|Overall Study|Progressive Disease|10|||
128976050|NCT00106626|464198495|FG000|Overall Study|Received radiation on new therapy|1|||
128976051|NCT00106626|464198496|FG001|Overall Study|Received radiation on new therapy|0|||
128976052|NCT00106626|464198497|FG002|Overall Study|Received radiation on new therapy|0|||
128976053|NCT00106626|464198498|FG003|Overall Study|Received radiation on new therapy|0|||
128976054|NCT00106626|464198495|FG000|Overall Study|> 14 day delay in therapy start|0|||
128976055|NCT00106626|464198496|FG001|Overall Study|> 14 day delay in therapy start|1|||
128976056|NCT00106626|464198497|FG002|Overall Study|> 14 day delay in therapy start|0|||
128976057|NCT00106626|464198498|FG003|Overall Study|> 14 day delay in therapy start|0|||
128976058|NCT00732199|464198499|FG000|Overall Study|Withdrawal by Subject|25|||
128976059|NCT00732199|464198500|FG001|Overall Study|Withdrawal by Subject|18|||
128976060|NCT00732199|464198499|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
128976061|NCT00732199|464198500|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
128976062|NCT02870348|464198505|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
128976063|NCT00672139|464198506|FG000|Overall Study|Death|14|||
128976064|NCT00672139|464198507|FG001|Overall Study|Death|23|||
128976065|NCT00672139|464198506|FG000|Overall Study|Withdrawal by Subject|2|||
128976066|NCT00672139|464198507|FG001|Overall Study|Withdrawal by Subject|11|||
128976067|NCT00672139|464198506|FG000|Overall Study|Adverse Event|4|||
128976068|NCT00672139|464198507|FG001|Overall Study|Adverse Event|7|||
128976069|NCT00672139|464198506|FG000|Overall Study|Physician Decision|2|||
128976070|NCT00672139|464198507|FG001|Overall Study|Physician Decision|0|||
128976071|NCT00672139|464198506|FG000|Overall Study|Lack of Efficacy|4|||
128976072|NCT00672139|464198507|FG001|Overall Study|Lack of Efficacy|1|||
128976073|NCT00672139|464198506|FG000|Overall Study|Protocol Violation|1|||
128716400|NCT00469092|463258205|FG000|Overall Study|Use of Corticosteroid|1|||
128774742|NCT04157686|463466655|FG003|Overall Study|Protocol Violation|0|||
128976074|NCT00672139|464198507|FG001|Overall Study|Protocol Violation|1|||
128976075|NCT00672139|464198506|FG000|Overall Study|hospice discharge, caregiver requests|3|||
128976076|NCT00672139|464198507|FG001|Overall Study|hospice discharge, caregiver requests|2|||
128716401|NCT00469092|463258206|FG001|Overall Study|Use of Corticosteroid|0|||
128716402|NCT00413192|463258208|FG000|Overall Study|Disease progression|26|||
128716403|NCT00413192|463258209|FG001|Overall Study|Disease progression|31|||
128716404|NCT00413192|463258210|FG002|Overall Study|Disease progression|16|||
128716405|NCT00413192|463258211|FG003|Overall Study|Disease progression|25|||
128716406|NCT00413192|463258208|FG000|Overall Study|Toxicity|3|||
128716407|NCT00413192|463258209|FG001|Overall Study|Toxicity|2|||
128716408|NCT00413192|463258210|FG002|Overall Study|Toxicity|2|||
128716409|NCT00413192|463258211|FG003|Overall Study|Toxicity|2|||
128716410|NCT00413192|463258208|FG000|Overall Study|Withdrawal by Subject|3|||
128716411|NCT00413192|463258209|FG001|Overall Study|Withdrawal by Subject|5|||
128716412|NCT00413192|463258210|FG002|Overall Study|Withdrawal by Subject|0|||
128716413|NCT00413192|463258211|FG003|Overall Study|Withdrawal by Subject|1|||
128716414|NCT00413192|463258208|FG000|Overall Study|Intercurrent illness|0|||
128716415|NCT00413192|463258209|FG001|Overall Study|Intercurrent illness|0|||
128716416|NCT00413192|463258210|FG002|Overall Study|Intercurrent illness|0|||
128716417|NCT00413192|463258211|FG003|Overall Study|Intercurrent illness|1|||
128716418|NCT00413192|463258208|FG000|Overall Study|Intercurrent death|0|||
128716419|NCT00413192|463258209|FG001|Overall Study|Intercurrent death|1|||
128716420|NCT00413192|463258210|FG002|Overall Study|Intercurrent death|0|||
128716421|NCT00413192|463258211|FG003|Overall Study|Intercurrent death|0|||
128976077|NCT01562327|464198514|FG000|Overall Study|Adverse Event|2|||
128976078|NCT01562327|464198514|FG000|Overall Study|Lack of Efficacy|1|||
128976079|NCT01562327|464198514|FG000|Overall Study|Participant drop-out|1|||
128976080|NCT01562327|464198514|FG000|Overall Study|Infusion not received at 6 month window|4|||
128976081|NCT00256204|464198515|FG000|Overall Study|Adverse Event|10|||
128976082|NCT00256204|464198516|FG001|Overall Study|Adverse Event|14|||
128976083|NCT00256204|464198517|FG002|Overall Study|Adverse Event|16|||
128976084|NCT00256204|464198518|FG003|Overall Study|Adverse Event|14|||
128976085|NCT00256204|464198515|FG000|Overall Study|Death|0|||
128976086|NCT00256204|464198516|FG001|Overall Study|Death|1|||
128976087|NCT00256204|464198517|FG002|Overall Study|Death|0|||
128976088|NCT00256204|464198518|FG003|Overall Study|Death|0|||
128976089|NCT00256204|464198515|FG000|Overall Study|Lost to Follow-up|1|||
128976090|NCT00256204|464198516|FG001|Overall Study|Lost to Follow-up|1|||
128976091|NCT00256204|464198517|FG002|Overall Study|Lost to Follow-up|1|||
128976092|NCT00256204|464198518|FG003|Overall Study|Lost to Follow-up|2|||
128976093|NCT00256204|464198515|FG000|Overall Study|Protocol Violation|1|||
128976094|NCT00256204|464198516|FG001|Overall Study|Protocol Violation|0|||
128976095|NCT00256204|464198517|FG002|Overall Study|Protocol Violation|2|||
128976096|NCT00256204|464198518|FG003|Overall Study|Protocol Violation|1|||
128976097|NCT00256204|464198515|FG000|Overall Study|Physician Decision|0|||
128976098|NCT00256204|464198516|FG001|Overall Study|Physician Decision|0|||
128976099|NCT00256204|464198517|FG002|Overall Study|Physician Decision|1|||
128976100|NCT00256204|464198518|FG003|Overall Study|Physician Decision|2|||
128976101|NCT00256204|464198515|FG000|Overall Study|Withdrawal by Subject|17|||
128976102|NCT00256204|464198516|FG001|Overall Study|Withdrawal by Subject|6|||
128976103|NCT00256204|464198517|FG002|Overall Study|Withdrawal by Subject|7|||
128976104|NCT00256204|464198518|FG003|Overall Study|Withdrawal by Subject|5|||
128976105|NCT00256204|464198515|FG000|Overall Study|Need for additional prohibited treatment|38|||
128976106|NCT00256204|464198516|FG001|Overall Study|Need for additional prohibited treatment|28|||
128976107|NCT00256204|464198517|FG002|Overall Study|Need for additional prohibited treatment|27|||
128976108|NCT00256204|464198518|FG003|Overall Study|Need for additional prohibited treatment|25|||
128976109|NCT00808132|464198521|FG000|Overall Study|Adverse Event|34|||
128976110|NCT00808132|464198522|FG001|Overall Study|Adverse Event|33|||
128976111|NCT00808132|464198523|FG002|Overall Study|Adverse Event|16|||
128976112|NCT00808132|464198524|FG003|Overall Study|Adverse Event|31|||
128976113|NCT00808132|464198525|FG004|Overall Study|Adverse Event|33|||
128976114|NCT00808132|464198521|FG000|Overall Study|Death|0|||
128976115|NCT00808132|464198522|FG001|Overall Study|Death|0|||
128976116|NCT00808132|464198523|FG002|Overall Study|Death|0|||
128976117|NCT00808132|464198524|FG003|Overall Study|Death|0|||
128976118|NCT00808132|464198525|FG004|Overall Study|Death|1|||
129039226|NCT04039919|464435307|FG001|Treatment Period 5|Withdrawal by Subject|0|||
129039227|NCT04039919|464435308|FG002|Treatment Period 5|Withdrawal by Subject|0|||
128716422|NCT00413192|463258208|FG000|Overall Study|Other|5|||
128716423|NCT00413192|463258209|FG001|Overall Study|Other|1|||
128716424|NCT00413192|463258210|FG002|Overall Study|Other|1|||
128716425|NCT00413192|463258211|FG003|Overall Study|Other|2|||
128716426|NCT00413192|463258208|FG000|Overall Study|Not treated|0|||
128716427|NCT00413192|463258209|FG001|Overall Study|Not treated|0|||
128774743|NCT04157686|463466656|FG004|Overall Study|Protocol Violation|1|||
128976119|NCT00808132|464198521|FG000|Overall Study|Physician Decision|0|||
128976120|NCT00808132|464198522|FG001|Overall Study|Physician Decision|1|||
128976121|NCT00808132|464198523|FG002|Overall Study|Physician Decision|0|||
128976122|NCT00808132|464198524|FG003|Overall Study|Physician Decision|0|||
128976123|NCT00808132|464198525|FG004|Overall Study|Physician Decision|0|||
128976124|NCT00808132|464198521|FG000|Overall Study|Lost to Follow-up|8|||
128976125|NCT00808132|464198522|FG001|Overall Study|Lost to Follow-up|10|||
128976126|NCT00808132|464198523|FG002|Overall Study|Lost to Follow-up|11|||
128976127|NCT00808132|464198524|FG003|Overall Study|Lost to Follow-up|8|||
128976128|NCT00808132|464198525|FG004|Overall Study|Lost to Follow-up|9|||
128976129|NCT00808132|464198521|FG000|Overall Study|Protocol Violation|8|||
128976130|NCT00808132|464198522|FG001|Overall Study|Protocol Violation|9|||
128976131|NCT00808132|464198523|FG002|Overall Study|Protocol Violation|4|||
128976132|NCT00808132|464198524|FG003|Overall Study|Protocol Violation|9|||
128716428|NCT00413192|463258210|FG002|Overall Study|Not treated|0|||
128716429|NCT00413192|463258211|FG003|Overall Study|Not treated|1|||
128716430|NCT01998633|463258212|FG000|Overall Study|Death|1|||
128716431|NCT02631850|463258213|FG000|Treatment Period|Lost to Follow-up|0|||
128716432|NCT02631850|463258214|FG001|Treatment Period|Lost to Follow-up|1|||
128716433|NCT02631850|463258215|FG002|Treatment Period|Lost to Follow-up|0|||
128716434|NCT02631850|463258216|FG003|Treatment Period|Lost to Follow-up|0|||
128716435|NCT02631850|463258213|FG000|Treatment Period|Protocol Violation|1|||
128716436|NCT02631850|463258214|FG001|Treatment Period|Protocol Violation|0|||
128716437|NCT02631850|463258215|FG002|Treatment Period|Protocol Violation|0|||
128716438|NCT02631850|463258216|FG003|Treatment Period|Protocol Violation|0|||
128716439|NCT02631850|463258213|FG000|Treatment Period|Withdrawal by Subject|0|||
128716440|NCT02631850|463258214|FG001|Treatment Period|Withdrawal by Subject|5|||
128716441|NCT02631850|463258215|FG002|Treatment Period|Withdrawal by Subject|2|||
128716442|NCT02631850|463258216|FG003|Treatment Period|Withdrawal by Subject|2|||
128716443|NCT02631850|463258213|FG000|Treatment Period|Adverse Event|1|||
128716444|NCT02631850|463258214|FG001|Treatment Period|Adverse Event|0|||
128716445|NCT02631850|463258215|FG002|Treatment Period|Adverse Event|2|||
128716446|NCT02631850|463258216|FG003|Treatment Period|Adverse Event|3|||
128716447|NCT02631850|463258213|FG000|Treatment Period|Family medical issue|1|||
128716448|NCT02631850|463258214|FG001|Treatment Period|Family medical issue|0|||
128716449|NCT02631850|463258215|FG002|Treatment Period|Family medical issue|0|||
128716450|NCT02631850|463258216|FG003|Treatment Period|Family medical issue|0|||
128716451|NCT02631850|463258213|FG000|6 Month Follow up|Lost to Follow-up|5|||
128716452|NCT02631850|463258214|FG001|6 Month Follow up|Lost to Follow-up|8|||
128716453|NCT02631850|463258215|FG002|6 Month Follow up|Lost to Follow-up|3|||
128716454|NCT02631850|463258216|FG003|6 Month Follow up|Lost to Follow-up|5|||
128716455|NCT02631850|463258213|FG000|6 Month Follow up|Withdrawal by Subject|1|||
128716456|NCT02631850|463258214|FG001|6 Month Follow up|Withdrawal by Subject|0|||
128716457|NCT02631850|463258215|FG002|6 Month Follow up|Withdrawal by Subject|0|||
128716458|NCT02631850|463258216|FG003|6 Month Follow up|Withdrawal by Subject|2|||
128716459|NCT02631850|463258213|FG000|6 Month Follow up|Adverse Event|1|||
128716460|NCT02631850|463258214|FG001|6 Month Follow up|Adverse Event|4|||
128716461|NCT02631850|463258215|FG002|6 Month Follow up|Adverse Event|1|||
128716462|NCT02631850|463258216|FG003|6 Month Follow up|Adverse Event|3|||
128716463|NCT02631850|463258213|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
128716464|NCT02631850|463258214|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
128716465|NCT02631850|463258215|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
128716466|NCT02631850|463258216|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
128716467|NCT03992781|463258217|FG000|Overall Study|Lost to Follow-up|5|||
128716468|NCT03992781|463258217|FG000|Overall Study|Adverse Event|1|||
128716469|NCT03992781|463258217|FG000|Overall Study|Lack of Efficacy|5|||
128716470|NCT02118012|463258222|FG000|Overall Study|Adverse Event|0|||
128716471|NCT02118012|463258223|FG001|Overall Study|Adverse Event|1|||
128716472|NCT02118012|463258222|FG000|Overall Study|Physician Decision|0|||
128716473|NCT02118012|463258223|FG001|Overall Study|Physician Decision|1|||
128716474|NCT02268864|463258224|FG000|Overall Study|Withdrawal by Subject|2|||
128716475|NCT02268864|463258225|FG001|Overall Study|Withdrawal by Subject|0|||
128716476|NCT02268864|463258226|FG002|Overall Study|Withdrawal by Subject|0|||
128716477|NCT02268864|463258224|FG000|Overall Study|Death|0|||
128716478|NCT02268864|463258225|FG001|Overall Study|Death|1|||
128716479|NCT02268864|463258226|FG002|Overall Study|Death|0|||
128716480|NCT00857220|463258227|FG000|Overall Study|Adverse Event|35|||
128716481|NCT00857220|463258227|FG000|Overall Study|Death|1|||
128716482|NCT00857220|463258227|FG000|Overall Study|Lack of Efficacy|11|||
128976133|NCT00808132|464198525|FG004|Overall Study|Protocol Violation|5|||
128716483|NCT00857220|463258227|FG000|Overall Study|Lost to Follow-up|30|||
128716484|NCT00857220|463258227|FG000|Overall Study|Physician Decision|4|||
128716485|NCT00857220|463258227|FG000|Overall Study|Protocol Violation|16|||
128716486|NCT00857220|463258227|FG000|Overall Study|Withdrawal by Subject|67|||
128716487|NCT00857220|463258227|FG000|Overall Study|Clinical Hold|6|||
128716488|NCT00857220|463258227|FG000|Overall Study|Site Closed|5|||
128716489|NCT00857220|463258227|FG000|Overall Study|Miscellaneous|8|||
128976134|NCT00808132|464198521|FG000|Overall Study|Withdrawal by Subject|27|||
128716490|NCT03698994|463258228|FG000|Overall Study|Adverse Event|2|||
128716491|NCT03698994|463258228|FG000|Overall Study|Death|1|||
128716492|NCT03698994|463258228|FG000|Overall Study|Physician Decision|1|||
128716493|NCT03698994|463258228|FG000|Overall Study|Withdrawal by Subject|3|||
128716494|NCT03698994|463258228|FG000|Overall Study|Progressive Disease|12|||
128976135|NCT00808132|464198522|FG001|Overall Study|Withdrawal by Subject|18|||
128976136|NCT00808132|464198523|FG002|Overall Study|Withdrawal by Subject|2|||
128976137|NCT00808132|464198524|FG003|Overall Study|Withdrawal by Subject|7|||
128976138|NCT00808132|464198525|FG004|Overall Study|Withdrawal by Subject|16|||
128976139|NCT00808132|464198521|FG000|Overall Study|Other|6|||
128976140|NCT00808132|464198522|FG001|Overall Study|Other|4|||
128976141|NCT00808132|464198523|FG002|Overall Study|Other|6|||
128976142|NCT00808132|464198524|FG003|Overall Study|Other|2|||
128976143|NCT00808132|464198525|FG004|Overall Study|Other|15|||
128976144|NCT00808132|464198521|FG000|Overall Study|Randomized, but not treated|10|||
128976145|NCT00808132|464198522|FG001|Overall Study|Randomized, but not treated|7|||
128976146|NCT00808132|464198523|FG002|Overall Study|Randomized, but not treated|9|||
128976147|NCT00808132|464198524|FG003|Overall Study|Randomized, but not treated|8|||
128976148|NCT00808132|464198525|FG004|Overall Study|Randomized, but not treated|9|||
128976149|NCT00808132|464198521|FG000|Overall Study|Unsatisfactory response|5|||
128976150|NCT00808132|464198522|FG001|Overall Study|Unsatisfactory response|6|||
128976151|NCT00808132|464198523|FG002|Overall Study|Unsatisfactory response|6|||
128976152|NCT00808132|464198524|FG003|Overall Study|Unsatisfactory response|4|||
128976153|NCT00808132|464198525|FG004|Overall Study|Unsatisfactory response|12|||
128976154|NCT00550615|464198526|FG000|Overall Study|Withdrawal by Subject|0|||
128976155|NCT00550615|464198527|FG001|Overall Study|Withdrawal by Subject|0|||
128976156|NCT00550615|464198528|FG002|Overall Study|Withdrawal by Subject|2|||
129132539|NCT05427916|464776677|FG001|Overall Study|Lack of Efficacy|0|||
129132540|NCT05427916|464776676|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
129132541|NCT05427916|464776677|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
129132542|NCT05558410|464776678|FG000|Overall Study|Adverse Event|1|||
129132543|NCT05558410|464776679|FG001|Overall Study|Adverse Event|2|||
129132544|NCT05558410|464776680|FG002|Overall Study|Adverse Event|0|||
129132545|NCT05558410|464776678|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
129132546|NCT05558410|464776679|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
128716495|NCT00171223|463258229|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
128716496|NCT00171223|463258230|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
128716497|NCT00171223|463258231|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
128716498|NCT00171223|463258229|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
128716499|NCT00171223|463258230|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
128716500|NCT00171223|463258231|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
128716501|NCT00171223|463258229|FG000|Overall Study|Abnormal Procedure|1|||
128976157|NCT00550615|464198529|FG003|Overall Study|Withdrawal by Subject|3|||
128976158|NCT00550615|464198526|FG000|Overall Study|Not evaluable|0|||
128976159|NCT00550615|464198527|FG001|Overall Study|Not evaluable|0|||
128976160|NCT00550615|464198528|FG002|Overall Study|Not evaluable|2|||
128976161|NCT00550615|464198529|FG003|Overall Study|Not evaluable|7|||
128976162|NCT02405091|464198530|FG000|Overall Study|Adverse Event|16|||
128976163|NCT02405091|464198531|FG001|Overall Study|Adverse Event|10|||
128976164|NCT02405091|464198532|FG002|Overall Study|Adverse Event|0|||
128976165|NCT02405091|464198530|FG000|Overall Study|Protocol Violation|1|||
128976166|NCT02405091|464198531|FG001|Overall Study|Protocol Violation|0|||
128976167|NCT02405091|464198532|FG002|Overall Study|Protocol Violation|0|||
128976168|NCT02405091|464198530|FG000|Overall Study|Noncompliance|1|||
128976169|NCT02405091|464198531|FG001|Overall Study|Noncompliance|6|||
128976170|NCT02405091|464198532|FG002|Overall Study|Noncompliance|2|||
128976171|NCT02405091|464198530|FG000|Overall Study|Withdrawal by Subject|4|||
128976172|NCT02405091|464198531|FG001|Overall Study|Withdrawal by Subject|8|||
128976173|NCT02405091|464198532|FG002|Overall Study|Withdrawal by Subject|0|||
128976174|NCT02405091|464198530|FG000|Overall Study|Death|0|||
128976175|NCT02405091|464198531|FG001|Overall Study|Death|1|||
128976176|NCT02405091|464198532|FG002|Overall Study|Death|0|||
128976177|NCT02405091|464198530|FG000|Overall Study|Lost to Follow-up|5|||
128976178|NCT02405091|464198531|FG001|Overall Study|Lost to Follow-up|6|||
128976179|NCT02405091|464198532|FG002|Overall Study|Lost to Follow-up|0|||
129132547|NCT05558410|464776680|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
129132548|NCT05558410|464776678|FG000|Overall Study|Lost to Follow-up|10|||
128976180|NCT02405091|464198530|FG000|Overall Study|Physician Decision|2|||
128976181|NCT02405091|464198531|FG001|Overall Study|Physician Decision|2|||
128976182|NCT02405091|464198532|FG002|Overall Study|Physician Decision|0|||
128976183|NCT01948791|464198539|FG000|Overall Study|Adverse Event|12|||
128976184|NCT01948791|464198539|FG000|Overall Study|Lack of Efficacy|3|||
128976185|NCT01948791|464198539|FG000|Overall Study|Protocol Violation|2|||
128976186|NCT01948791|464198539|FG000|Overall Study|Withdrawal by Subject|5|||
128976187|NCT01948791|464198539|FG000|Overall Study|Lost to Follow-up|6|||
129132549|NCT05558410|464776679|FG001|Overall Study|Lost to Follow-up|17|||
128976188|NCT01948791|464198539|FG000|Overall Study|Management issues|1|||
128976189|NCT01948791|464198539|FG000|Overall Study|Others|7|||
128976190|NCT01948791|464198539|FG000|Overall Study|Screening failure|35|||
128716502|NCT00171223|463258230|FG001|Overall Study|Abnormal Procedure|0|||
128976191|NCT01955005|464198551|FG000|Overall Study|Withdrawal by Subject|3|||
128976192|NCT01955005|464198552|FG001|Overall Study|Withdrawal by Subject|5|||
128976193|NCT02555722|464198557|FG000|Week 2|Adverse Event|0|||
128716503|NCT00171223|463258231|FG002|Overall Study|Abnormal Procedure|0|||
128716504|NCT00171223|463258229|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
128716505|NCT00171223|463258230|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
128716506|NCT00171223|463258231|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
128716507|NCT00171223|463258229|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
128716508|NCT00171223|463258230|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
128716509|NCT00171223|463258231|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
128716510|NCT00171223|463258229|FG000|Overall Study|Protocol Violation|2|||
128716511|NCT00171223|463258230|FG001|Overall Study|Protocol Violation|2|||
128716512|NCT00171223|463258231|FG002|Overall Study|Protocol Violation|3|||
128716513|NCT00171223|463258229|FG000|Overall Study|Participant Withdrew Consent|12|||
128716514|NCT00171223|463258230|FG001|Overall Study|Participant Withdrew Consent|21|||
128716515|NCT00171223|463258231|FG002|Overall Study|Participant Withdrew Consent|15|||
128716516|NCT00171223|463258229|FG000|Overall Study|Lost to Follow-up|5|||
128716517|NCT00171223|463258230|FG001|Overall Study|Lost to Follow-up|2|||
128716518|NCT00171223|463258231|FG002|Overall Study|Lost to Follow-up|3|||
128716519|NCT00171223|463258229|FG000|Overall Study|Administrative Problems|4|||
128716520|NCT00171223|463258230|FG001|Overall Study|Administrative Problems|7|||
128716521|NCT00171223|463258231|FG002|Overall Study|Administrative Problems|6|||
128716522|NCT00171223|463258229|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
128716523|NCT00171223|463258230|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
128976194|NCT02555722|464198558|FG001|Week 2|Adverse Event|1|||
128976195|NCT02555722|464198557|FG000|Week 2|Withdrawal by Subject|1|||
128976196|NCT02555722|464198558|FG001|Week 2|Withdrawal by Subject|0|||
128976197|NCT02555722|464198557|FG000|Month 1|Lens Discomfort|1|||
128976198|NCT02555722|464198558|FG001|Month 1|Lens Discomfort|0|||
128976199|NCT02555722|464198557|FG000|Month 2|Withdrawal by Subject|3|||
128976200|NCT02555722|464198558|FG001|Month 2|Withdrawal by Subject|0|||
128976201|NCT02555722|464198557|FG000|Month 2|Lost to Follow-up|1|||
128976202|NCT02555722|464198558|FG001|Month 2|Lost to Follow-up|0|||
128976203|NCT00352027|464198559|FG000|Overall Study|Progressive disease|3|||
128976204|NCT00702949|464198560|FG000|Overall Study|Refusal|3|||
128976205|NCT00702949|464198561|FG001|Overall Study|Refusal|2|||
128976206|NCT00702949|464198562|FG002|Overall Study|Refusal|2|||
128976207|NCT00702949|464198560|FG000|Overall Study|Adverse Event|1|||
128976208|NCT00702949|464198561|FG001|Overall Study|Adverse Event|6|||
128976209|NCT00702949|464198562|FG002|Overall Study|Adverse Event|3|||
128976210|NCT00702949|464198560|FG000|Overall Study|Other Medical Reason/unknown|1|||
128976211|NCT00702949|464198561|FG001|Overall Study|Other Medical Reason/unknown|1|||
128976212|NCT00702949|464198562|FG002|Overall Study|Other Medical Reason/unknown|3|||
128976213|NCT04491591|464198567|FG000|Overall Study|Accidently randomized|3|||
128976214|NCT04491591|464198568|FG001|Overall Study|Accidently randomized|1|||
128976215|NCT04491591|464198569|FG002|Overall Study|Accidently randomized|0|||
128976216|NCT04491591|464198567|FG000|Overall Study|Did not complete survey|28|||
128976217|NCT04491591|464198568|FG001|Overall Study|Did not complete survey|20|||
128976218|NCT04491591|464198569|FG002|Overall Study|Did not complete survey|3|||
128976219|NCT00135694|464198570|FG000|Overall Study|Adverse Event|17|||
128976220|NCT00135694|464198571|FG001|Overall Study|Adverse Event|4|||
128976221|NCT00135694|464198572|FG002|Overall Study|Adverse Event|0|||
128976222|NCT00135694|464198570|FG000|Overall Study|Death|14|||
128976223|NCT00135694|464198571|FG001|Overall Study|Death|1|||
128976224|NCT00135694|464198572|FG002|Overall Study|Death|2|||
129039228|NCT04039919|464435309|FG003|Treatment Period 5|Withdrawal by Subject|0|||
129039229|NCT04039919|464435310|FG004|Treatment Period 5|Withdrawal by Subject|0|||
129039230|NCT02310789|464435311|FG000|Overall Study|Adverse Event|1|||
129039231|NCT00983918|464435312|FG000|Overall Study|conversion to open cholecystectomy|0|||
129039232|NCT00983918|464435313|FG001|Overall Study|conversion to open cholecystectomy|2|||
129039233|NCT00983918|464435314|FG002|Overall Study|conversion to open cholecystectomy|2|||
129039234|NCT00983918|464435315|FG003|Overall Study|conversion to open cholecystectomy|2|||
129039235|NCT01197417|464435316|FG000|Overall Study|Physician Decision|3|||
129039236|NCT01197417|464435317|FG001|Overall Study|Physician Decision|2|||
129039237|NCT01197417|464435316|FG000|Overall Study|Withdrawal by Subject|2|||
129039238|NCT01197417|464435317|FG001|Overall Study|Withdrawal by Subject|4|||
129039239|NCT01197417|464435316|FG000|Overall Study|Site miscommunication|0|||
129039240|NCT01197417|464435317|FG001|Overall Study|Site miscommunication|1|||
129039241|NCT01197417|464435316|FG000|Overall Study|Subject transferred to intensive care|0|||
128716524|NCT00171223|463258231|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
128716525|NCT00171223|463258229|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
128716526|NCT00171223|463258230|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
128716527|NCT00171223|463258231|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
128976225|NCT00135694|464198570|FG000|Overall Study|Lost to Follow-up|8|||
128976226|NCT00135694|464198571|FG001|Overall Study|Lost to Follow-up|7|||
128976227|NCT00135694|464198572|FG002|Overall Study|Lost to Follow-up|1|||
128976228|NCT00135694|464198570|FG000|Overall Study|Withdrawal by Subject|41|||
129039242|NCT01197417|464435317|FG001|Overall Study|Subject transferred to intensive care|1|||
129132550|NCT05558410|464776680|FG002|Overall Study|Lost to Follow-up|19|||
128976229|NCT00135694|464198571|FG001|Overall Study|Withdrawal by Subject|7|||
128976230|NCT00135694|464198572|FG002|Overall Study|Withdrawal by Subject|4|||
128976231|NCT00135694|464198570|FG000|Overall Study|Protocol Violation|19|||
128976232|NCT00135694|464198571|FG001|Overall Study|Protocol Violation|1|||
128976233|NCT00135694|464198572|FG002|Overall Study|Protocol Violation|0|||
128976234|NCT00135694|464198570|FG000|Overall Study|Hepatitis C related reasons|39|||
128976235|NCT00135694|464198571|FG001|Overall Study|Hepatitis C related reasons|1|||
128976236|NCT00135694|464198572|FG002|Overall Study|Hepatitis C related reasons|0|||
128976237|NCT00135694|464198570|FG000|Overall Study|Ineligible for Random assignment|42|||
128976238|NCT00135694|464198571|FG001|Overall Study|Ineligible for Random assignment|0|||
128976239|NCT00135694|464198572|FG002|Overall Study|Ineligible for Random assignment|0|||
128976240|NCT02802735|464198574|FG000|Overall Study|Withdrawal by Subject|0|||
128976241|NCT02802735|464198575|FG001|Overall Study|Withdrawal by Subject|1|||
128976242|NCT02802735|464198576|FG002|Overall Study|Withdrawal by Subject|0|||
128976243|NCT02802735|464198577|FG003|Overall Study|Withdrawal by Subject|0|||
128976244|NCT02802735|464198578|FG004|Overall Study|Withdrawal by Subject|0|||
128976245|NCT00420212|464198579|FG000|Overall Study|Adverse Event|22|||
128976246|NCT00420212|464198580|FG001|Overall Study|Adverse Event|40|||
128976247|NCT00420212|464198581|FG002|Overall Study|Adverse Event|36|||
128976248|NCT00420212|464198579|FG000|Overall Study|Lost to Follow-up|9|||
128976249|NCT00420212|464198580|FG001|Overall Study|Lost to Follow-up|11|||
128976250|NCT00420212|464198581|FG002|Overall Study|Lost to Follow-up|11|||
128976251|NCT00420212|464198579|FG000|Overall Study|Withdrawal by Subject|31|||
128976252|NCT00420212|464198580|FG001|Overall Study|Withdrawal by Subject|22|||
128976253|NCT00420212|464198581|FG002|Overall Study|Withdrawal by Subject|19|||
128976254|NCT00420212|464198579|FG000|Overall Study|Physician Decision|4|||
128976255|NCT00420212|464198580|FG001|Overall Study|Physician Decision|4|||
128976256|NCT00420212|464198581|FG002|Overall Study|Physician Decision|3|||
128976257|NCT00420212|464198579|FG000|Overall Study|Protocol Violation|4|||
128976258|NCT00420212|464198580|FG001|Overall Study|Protocol Violation|4|||
128976259|NCT00420212|464198581|FG002|Overall Study|Protocol Violation|8|||
129132551|NCT05558410|464776678|FG000|Overall Study|Death|1|||
129132552|NCT05558410|464776679|FG001|Overall Study|Death|0|||
129132553|NCT05558410|464776680|FG002|Overall Study|Death|0|||
129132554|NCT05558410|464776678|FG000|Overall Study|Other non-compliance|0|||
129132555|NCT05558410|464776679|FG001|Overall Study|Other non-compliance|1|||
129132556|NCT05558410|464776680|FG002|Overall Study|Other non-compliance|2|||
129132557|NCT05558410|464776678|FG000|Overall Study|Sponsor Decision|1|||
129132558|NCT05558410|464776679|FG001|Overall Study|Sponsor Decision|0|||
129132559|NCT05558410|464776680|FG002|Overall Study|Sponsor Decision|0|||
129132560|NCT05558410|464776678|FG000|Overall Study|Other|1|||
129132561|NCT05558410|464776679|FG001|Overall Study|Other|0|||
129132562|NCT05558410|464776680|FG002|Overall Study|Other|1|||
129132563|NCT00933166|464776685|FG000|Overall Study|Lost to Follow-up|4|||
129132564|NCT00933166|464776685|FG000|Overall Study|Lack of Efficacy|9|||
129132565|NCT00933166|464776685|FG000|Overall Study|Unavailable|4|||
129132566|NCT00933166|464776685|FG000|Overall Study|Withdrawal by Subject|1|||
129132567|NCT03501277|464776689|FG000|Intervention Period 1 (4 Days)|Other|0|||
129132568|NCT03501277|464776690|FG001|Intervention Period 1 (4 Days)|Other|0|||
129132569|NCT03501277|464776691|FG002|Intervention Period 1 (4 Days)|Other|1|||
129132570|NCT03501277|464776692|FG003|Intervention Period 1 (4 Days)|Other|0|||
129132571|NCT03501277|464776689|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
129132572|NCT03501277|464776690|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
129132573|NCT03501277|464776691|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
129132574|NCT03501277|464776692|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
129132575|NCT03501277|464776689|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
129132576|NCT03501277|464776690|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
129132577|NCT03501277|464776691|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
129132578|NCT03501277|464776692|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
129132579|NCT03501277|464776689|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
129132580|NCT03501277|464776690|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
129132581|NCT03501277|464776691|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
129132582|NCT03501277|464776692|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
129132583|NCT06038643|464776696|FG000|Overall Study|Withdrawal by Subject|9|||
129132584|NCT06038643|464776697|FG001|Overall Study|Withdrawal by Subject|4|||
129132585|NCT06038643|464776696|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
129132586|NCT06038643|464776697|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
129132587|NCT01405911|464776704|FG000|Overall Study|Pre-treatment lab AE|0|||
129132588|NCT01405911|464776705|FG001|Overall Study|Pre-treatment lab AE|1|||
129132589|NCT01405911|464776706|FG002|Overall Study|Pre-treatment lab AE|0|||
128976260|NCT00420212|464198579|FG000|Overall Study|Death|0|||
128976261|NCT00420212|464198580|FG001|Overall Study|Death|0|||
128976262|NCT00420212|464198581|FG002|Overall Study|Death|1|||
128976263|NCT00420212|464198579|FG000|Overall Study|Other-Unspecified|21|||
128976264|NCT00420212|464198580|FG001|Overall Study|Other-Unspecified|14|||
128976265|NCT00420212|464198581|FG002|Overall Study|Other-Unspecified|18|||
128976266|NCT03147495|464198582|FG000|Overall Study|Physician Decision|0|||
128716528|NCT00730912|463258243|FG000|Overall Study|Discontinued|0|||
128716529|NCT00730912|463258244|FG001|Overall Study|Discontinued|0|||
128716530|NCT00730912|463258245|FG002|Overall Study|Discontinued|1|||
128716531|NCT04053023|463258250|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
128716532|NCT04053023|463258251|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
128716533|NCT03424265|463258252|FG000|Overall Study|screening failure|1|||
128716534|NCT03424265|463258253|FG001|Overall Study|screening failure|0|||
128716535|NCT03424265|463258252|FG000|Overall Study|Withdrawal by Subject|0|||
128716536|NCT03424265|463258253|FG001|Overall Study|Withdrawal by Subject|2|||
128716537|NCT00894322|463258257|FG000|Overall Study|Withdrawal by Subject|1|||
128716538|NCT00894322|463258258|FG001|Overall Study|Withdrawal by Subject|0|||
128716539|NCT00894322|463258259|FG002|Overall Study|Withdrawal by Subject|0|||
128716540|NCT07114198|463258261|FG000|Overall Study|Protocol Violation|1|||
128716541|NCT07114198|463258262|FG001|Overall Study|Protocol Violation|1|||
128716542|NCT01721330|463258263|FG000|Overall Study|Withdrawal by Subject|0|||
128716543|NCT01721330|463258264|FG001|Overall Study|Withdrawal by Subject|1|||
128716544|NCT00296374|463258265|FG000|Overall Study|Adverse Event|14|||
128716545|NCT00296374|463258266|FG001|Overall Study|Adverse Event|10|||
128716546|NCT00296374|463258267|FG002|Overall Study|Adverse Event|7|||
128716547|NCT00296374|463258265|FG000|Overall Study|Withdrawal by Subject|3|||
128976267|NCT03147495|464198583|FG001|Overall Study|Physician Decision|6|||
128976268|NCT00742391|464198586|FG000|Overall Study|Adverse Event|2|||
128976269|NCT00742391|464198587|FG001|Overall Study|Adverse Event|1|||
128976270|NCT00742391|464198586|FG000|Overall Study|Lost to Follow-up|1|||
128976271|NCT00742391|464198587|FG001|Overall Study|Lost to Follow-up|0|||
128976272|NCT00742391|464198586|FG000|Overall Study|Protocol Violation|1|||
128976273|NCT00742391|464198587|FG001|Overall Study|Protocol Violation|0|||
128976274|NCT02975206|464198594|FG000|Overall Study|Withdrawal by Subject|14|||
128976275|NCT02975206|464198595|FG001|Overall Study|Withdrawal by Subject|11|||
128976276|NCT02975206|464198596|FG002|Overall Study|Withdrawal by Subject|11|||
128976277|NCT02975206|464198594|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
128976278|NCT02975206|464198595|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
128976279|NCT02975206|464198596|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
128976280|NCT01981096|464198598|FG000|Overall Study|Parent illness|1|||
128976281|NCT01981096|464198599|FG001|Overall Study|Parent illness|0|||
128976282|NCT01981096|464198598|FG000|Overall Study|Withdrawal by Subject|0|||
128976283|NCT01981096|464198599|FG001|Overall Study|Withdrawal by Subject|1|||
128976284|NCT01981096|464198598|FG000|Overall Study|Lost to Follow-up|2|||
128976285|NCT01981096|464198599|FG001|Overall Study|Lost to Follow-up|0|||
129039243|NCT01197417|464435316|FG000|Overall Study|Not consented in time to receive drug|0|||
129039244|NCT01197417|464435317|FG001|Overall Study|Not consented in time to receive drug|1|||
129039245|NCT01197417|464435316|FG000|Overall Study|Hypotension|1|||
129039246|NCT01197417|464435317|FG001|Overall Study|Hypotension|2|||
129039247|NCT01197417|464435316|FG000|Overall Study|Found to be ineligible|2|||
129039248|NCT01197417|464435317|FG001|Overall Study|Found to be ineligible|5|||
129039249|NCT01197417|464435316|FG000|Overall Study|No 25-hour magnesium level|0|||
129039250|NCT01197417|464435317|FG001|Overall Study|No 25-hour magnesium level|2|||
129039251|NCT00794417|464435320|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
129039252|NCT00794417|464435321|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
129039253|NCT00794417|464435322|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
129039254|NCT00794417|464435323|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
129039255|NCT00794417|464435320|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
129039256|NCT00794417|464435321|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
129039257|NCT00794417|464435322|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
129039258|NCT00794417|464435323|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
129039259|NCT00794417|464435320|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
129039260|NCT00794417|464435321|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
129039261|NCT00794417|464435322|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
129039262|NCT00794417|464435323|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
129039263|NCT00794417|464435320|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
129039264|NCT00794417|464435321|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
129039265|NCT00794417|464435322|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
129039266|NCT00794417|464435323|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
129039267|NCT00794417|464435320|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
129039268|NCT00794417|464435321|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
129039269|NCT00794417|464435322|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
129039270|NCT00794417|464435323|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
129132590|NCT01405911|464776704|FG000|Overall Study|Lost to Follow-up|0|||
128716548|NCT00296374|463258266|FG001|Overall Study|Withdrawal by Subject|5|||
128716549|NCT00296374|463258267|FG002|Overall Study|Withdrawal by Subject|11|||
128716550|NCT00296374|463258265|FG000|Overall Study|Incorrect enrollment|3|||
128716551|NCT00296374|463258266|FG001|Overall Study|Incorrect enrollment|3|||
128716552|NCT00296374|463258267|FG002|Overall Study|Incorrect enrollment|4|||
128976286|NCT00866606|464198600|FG000|Overall Study|Lost to Follow-up|3|||
128976287|NCT00866606|464198600|FG000|Overall Study|Adverse Event|1|||
128976288|NCT01225211|464198601|FG000|Overall Study|Adverse Event|0|||
128716553|NCT00296374|463258265|FG000|Overall Study|Protocol Violation|1|||
128716554|NCT00296374|463258266|FG001|Overall Study|Protocol Violation|2|||
128716555|NCT00296374|463258267|FG002|Overall Study|Protocol Violation|3|||
128716556|NCT00296374|463258265|FG000|Overall Study|Lost to Follow-up|3|||
128716557|NCT00296374|463258266|FG001|Overall Study|Lost to Follow-up|1|||
128716558|NCT00296374|463258267|FG002|Overall Study|Lost to Follow-up|1|||
128716559|NCT00296374|463258265|FG000|Overall Study|Relocated to another state|1|||
128716560|NCT00296374|463258266|FG001|Overall Study|Relocated to another state|0|||
128716561|NCT00296374|463258267|FG002|Overall Study|Relocated to another state|0|||
128716562|NCT00296374|463258265|FG000|Overall Study|Stopped drug before end of study visit|0|||
128716563|NCT00296374|463258266|FG001|Overall Study|Stopped drug before end of study visit|1|||
128716564|NCT00296374|463258267|FG002|Overall Study|Stopped drug before end of study visit|0|||
128716565|NCT00296374|463258265|FG000|Overall Study|Nephrologist introduced ACE|0|||
128716566|NCT00296374|463258266|FG001|Overall Study|Nephrologist introduced ACE|1|||
128716567|NCT00296374|463258267|FG002|Overall Study|Nephrologist introduced ACE|0|||
128716568|NCT00296374|463258265|FG000|Overall Study|Pregnancy|0|||
128716569|NCT00296374|463258266|FG001|Overall Study|Pregnancy|0|||
128716570|NCT00296374|463258267|FG002|Overall Study|Pregnancy|2|||
128716571|NCT00296374|463258265|FG000|Overall Study|Other|0|||
128716572|NCT00296374|463258266|FG001|Overall Study|Other|0|||
128716573|NCT00296374|463258267|FG002|Overall Study|Other|1|||
128716574|NCT00670800|463260170|FG000|Overall Study|2 controls were insulin resistant|0|||
128716575|NCT00670800|463260171|FG001|Overall Study|2 controls were insulin resistant|2|||
128716576|NCT04736199|463260172|FG000|Overall Study|Adverse Event|28|||
128716577|NCT04736199|463260173|FG001|Overall Study|Adverse Event|22|||
128716578|NCT04736199|463260172|FG000|Overall Study|Death|9|||
128716579|NCT04736199|463260173|FG001|Overall Study|Death|3|||
128716580|NCT04736199|463260172|FG000|Overall Study|Lost to Follow-up|4|||
128716581|NCT04736199|463260173|FG001|Overall Study|Lost to Follow-up|1|||
128716582|NCT04736199|463260172|FG000|Overall Study|Physician Decision|5|||
128716583|NCT04736199|463260173|FG001|Overall Study|Physician Decision|9|||
128716584|NCT04736199|463260172|FG000|Overall Study|Withdrawal by Subject|21|||
128716585|NCT04736199|463260173|FG001|Overall Study|Withdrawal by Subject|9|||
128716586|NCT04736199|463260172|FG000|Overall Study|Progressive disease|120|||
128716587|NCT04736199|463260173|FG001|Overall Study|Progressive disease|101|||
128716588|NCT04736199|463260172|FG000|Overall Study|Subject decision|13|||
128716589|NCT04736199|463260173|FG001|Overall Study|Subject decision|13|||
128716590|NCT04736199|463260172|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
128716591|NCT04736199|463260173|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
128716592|NCT04736199|463260172|FG000|Overall Study|Additional primary malignancy|1|||
128716593|NCT04736199|463260173|FG001|Overall Study|Additional primary malignancy|0|||
128716594|NCT04736199|463260172|FG000|Overall Study|Non-compliance with study drug|0|||
128716595|NCT04736199|463260173|FG001|Overall Study|Non-compliance with study drug|1|||
128716596|NCT04736199|463260172|FG000|Overall Study|Other reason|0|||
128716597|NCT04736199|463260173|FG001|Overall Study|Other reason|1|||
128716598|NCT04736199|463260172|FG000|Overall Study|Ongoing with study drug|240|||
128716599|NCT04736199|463260173|FG001|Overall Study|Ongoing with study drug|63|||
128716600|NCT04736199|463260172|FG000|Overall Study|Study drug never administered|3|||
128716601|NCT04736199|463260173|FG001|Overall Study|Study drug never administered|0|||
128716602|NCT04318080|463260174|FG000|Overall Study|Study closed by sponsor|10|||
128716603|NCT04318080|463260175|FG001|Overall Study|Study closed by sponsor|22|||
128716604|NCT04318080|463260174|FG000|Overall Study|Death|3|||
128716605|NCT04318080|463260175|FG001|Overall Study|Death|9|||
128716606|NCT04318080|463260174|FG000|Overall Study|Withdrawal by Subject|1|||
128716607|NCT04318080|463260175|FG001|Overall Study|Withdrawal by Subject|0|||
128716608|NCT04318080|463260174|FG000|Overall Study|Protocol Deviation|1|||
128716609|NCT04318080|463260175|FG001|Overall Study|Protocol Deviation|0|||
128716610|NCT06308822|463260176|FG000|Overall Study|Mutation Status Not Confirmed|17|||
128716611|NCT06308822|463260176|FG000|Overall Study|Adverse Event|1|||
128976289|NCT01225211|464198602|FG001|Overall Study|Adverse Event|0|||
128976290|NCT01225211|464198603|FG002|Overall Study|Adverse Event|1|||
128976291|NCT01225211|464198604|FG003|Overall Study|Adverse Event|0|||
128716612|NCT06308822|463260176|FG000|Overall Study|Death|5|||
128716613|NCT06308822|463260176|FG000|Overall Study|Disease progression|8|||
128774744|NCT04157686|463466657|FG005|Overall Study|Protocol Violation|0|||
128774745|NCT04157686|463466658|FG006|Overall Study|Protocol Violation|0|||
128774746|NCT04157686|463466659|FG007|Overall Study|Protocol Violation|0|||
128774747|NCT04157686|463466652|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
128976292|NCT01225211|464198605|FG004|Overall Study|Adverse Event|0|||
128976293|NCT01225211|464198606|FG005|Overall Study|Adverse Event|0|||
129132591|NCT01405911|464776705|FG001|Overall Study|Lost to Follow-up|1|||
128716614|NCT06308822|463260176|FG000|Overall Study|Withdrawal by Subject|1|||
128716615|NCT06308822|463260176|FG000|Overall Study|Physician Decision|3|||
128774748|NCT04157686|463466653|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
129221663|NCT01193257|465113282|FG000|Overall Study|Unblinded due to futility|135|||
129221664|NCT01193257|465113283|FG001|Overall Study|Unblinded due to futility|251|||
129221665|NCT01027273|465113289|FG000|Overall Study|Lost to Follow-up|57|||
129221666|NCT01027273|465113290|FG001|Overall Study|Lost to Follow-up|31|||
129221667|NCT01027273|465113289|FG000|Overall Study|Death|2|||
129221668|NCT01027273|465113290|FG001|Overall Study|Death|2|||
129221669|NCT00337675|465113292|FG000|Overall Study|Adverse Event|10|||
129221670|NCT00337675|465113293|FG001|Overall Study|Adverse Event|9|||
129221671|NCT00337675|465113294|FG002|Overall Study|Adverse Event|19|||
129221672|NCT00337675|465113292|FG000|Overall Study|Lack of Efficacy|10|||
129221673|NCT00337675|465113293|FG001|Overall Study|Lack of Efficacy|7|||
129221674|NCT00337675|465113294|FG002|Overall Study|Lack of Efficacy|9|||
129221675|NCT00337675|465113292|FG000|Overall Study|Lost to Follow-up|22|||
129221676|NCT00337675|465113293|FG001|Overall Study|Lost to Follow-up|19|||
129221677|NCT00337675|465113294|FG002|Overall Study|Lost to Follow-up|17|||
129221678|NCT00337675|465113292|FG000|Overall Study|Physician Decision|9|||
129221679|NCT00337675|465113293|FG001|Overall Study|Physician Decision|17|||
129221680|NCT00337675|465113294|FG002|Overall Study|Physician Decision|14|||
129221681|NCT00337675|465113292|FG000|Overall Study|Protocol Violation|21|||
129221682|NCT00337675|465113293|FG001|Overall Study|Protocol Violation|24|||
129221683|NCT00337675|465113294|FG002|Overall Study|Protocol Violation|19|||
129221684|NCT00337675|465113292|FG000|Overall Study|Withdrawal by Subject|25|||
129221685|NCT00337675|465113293|FG001|Overall Study|Withdrawal by Subject|25|||
129221686|NCT00337675|465113294|FG002|Overall Study|Withdrawal by Subject|19|||
129221687|NCT00337675|465113292|FG000|Overall Study|Progressive Disease|0|||
129221688|NCT00337675|465113293|FG001|Overall Study|Progressive Disease|2|||
129221689|NCT00337675|465113294|FG002|Overall Study|Progressive Disease|0|||
129221690|NCT00337675|465113292|FG000|Overall Study|Trial Terminated|0|||
129221691|NCT00337675|465113293|FG001|Overall Study|Trial Terminated|0|||
129221692|NCT00337675|465113294|FG002|Overall Study|Trial Terminated|2|||
128976294|NCT01225211|464198607|FG006|Overall Study|Adverse Event|0|||
128976295|NCT01225211|464198608|FG007|Overall Study|Adverse Event|0|||
128976296|NCT01225211|464198609|FG008|Overall Study|Adverse Event|0|||
128774749|NCT04157686|463466654|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
128774750|NCT04157686|463466655|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
128774751|NCT04157686|463466656|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
128774752|NCT04157686|463466657|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
128774753|NCT04157686|463466658|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
128774754|NCT04157686|463466659|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
128774755|NCT01216293|463466660|FG000|Main Study|Adverse Event|1|||
128774756|NCT01216293|463466661|FG001|Main Study|Adverse Event|4|||
128774757|NCT01216293|463466662|FG002|Main Study|Adverse Event|2|||
128774758|NCT01216293|463466660|FG000|Main Study|Major Protocol Deviation|1|||
128774759|NCT01216293|463466661|FG001|Main Study|Major Protocol Deviation|0|||
128774760|NCT01216293|463466662|FG002|Main Study|Major Protocol Deviation|1|||
128774761|NCT01216293|463466660|FG000|Main Study|Lost to Follow-up|3|||
128774762|NCT01216293|463466661|FG001|Main Study|Lost to Follow-up|1|||
128774763|NCT01216293|463466662|FG002|Main Study|Lost to Follow-up|0|||
128716616|NCT03712904|463260177|FG000|Overall Study|Death|0|||
128716617|NCT03712904|463260178|FG001|Overall Study|Death|1|||
128716618|NCT03712904|463260177|FG000|Overall Study|Withdrawal by Subject|0|||
128716619|NCT03712904|463260178|FG001|Overall Study|Withdrawal by Subject|1|||
128716620|NCT03712904|463260177|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
128716621|NCT03712904|463260178|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
128716622|NCT01852942|463260179|FG000|Overall Study|Physician Decision|1|||
128716623|NCT01852942|463260180|FG001|Overall Study|Physician Decision|0|||
128716624|NCT01852942|463260179|FG000|Overall Study|Death|1|||
128716625|NCT01852942|463260180|FG001|Overall Study|Death|1|||
128716626|NCT01852942|463260179|FG000|Overall Study|Withdrawal by Subject|2|||
128716627|NCT01852942|463260180|FG001|Overall Study|Withdrawal by Subject|3|||
128716628|NCT01852942|463260179|FG000|Overall Study|Lost to Follow-up|1|||
129221693|NCT00441064|465113299|FG000|Overall Study|Adverse Event|1|||
129221694|NCT00441064|465113300|FG001|Overall Study|Adverse Event|0|||
128716629|NCT01852942|463260180|FG001|Overall Study|Lost to Follow-up|2|||
128716630|NCT01921179|463260181|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
128716631|NCT01921179|463260182|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
129221695|NCT00441064|465113299|FG000|Overall Study|Abnormal laboratory values|0|||
129221696|NCT00441064|465113300|FG001|Overall Study|Abnormal laboratory values|2|||
128716632|NCT01921179|463260181|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
128774764|NCT01216293|463466660|FG000|Main Study|Voluntary Withdrawal|2|||
128976297|NCT01225211|464198610|FG009|Overall Study|Adverse Event|1|||
129221697|NCT00441064|465113299|FG000|Overall Study|Abnormal test procedure results|0|||
128976298|NCT01225211|464198601|FG000|Overall Study|Withdrawal by Subject|0|||
129221698|NCT00441064|465113300|FG001|Overall Study|Abnormal test procedure results|1|||
129221699|NCT00441064|465113299|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129221700|NCT00441064|465113300|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129221701|NCT00441064|465113299|FG000|Overall Study|Protocol Deviation|3|||
129221702|NCT00441064|465113300|FG001|Overall Study|Protocol Deviation|2|||
129221703|NCT00441064|465113299|FG000|Overall Study|Patient withdrew consent|5|||
129221704|NCT00441064|465113300|FG001|Overall Study|Patient withdrew consent|2|||
129221705|NCT03962504|465113301|FG000|Overall Study|Other|11|||
129221706|NCT03962504|465113302|FG001|Overall Study|Other|32|||
129221707|NCT00048074|465113305|FG000|Overall Study|Adverse Event|46|||
129221708|NCT00048074|465113306|FG001|Overall Study|Adverse Event|41|||
129221709|NCT00048074|465113307|FG002|Overall Study|Adverse Event|53|||
129221710|NCT00048074|465113305|FG000|Overall Study|Death|3|||
129221711|NCT00048074|465113306|FG001|Overall Study|Death|3|||
129221712|NCT00048074|465113307|FG002|Overall Study|Death|2|||
129221713|NCT00048074|465113305|FG000|Overall Study|Lost to Follow-up|2|||
129221714|NCT00048074|465113306|FG001|Overall Study|Lost to Follow-up|6|||
129221715|NCT00048074|465113307|FG002|Overall Study|Lost to Follow-up|6|||
129221716|NCT00048074|465113305|FG000|Overall Study|Withdrawal by Subject|28|||
129221717|NCT00048074|465113306|FG001|Overall Study|Withdrawal by Subject|30|||
129221718|NCT00048074|465113307|FG002|Overall Study|Withdrawal by Subject|35|||
129221719|NCT00048074|465113305|FG000|Overall Study|Protocol Violation|1|||
129221720|NCT00048074|465113306|FG001|Overall Study|Protocol Violation|3|||
129221721|NCT00048074|465113307|FG002|Overall Study|Protocol Violation|0|||
129221722|NCT00048074|465113305|FG000|Overall Study|Study participation was terminated|0|||
129221723|NCT00048074|465113306|FG001|Overall Study|Study participation was terminated|1|||
129221724|NCT00048074|465113307|FG002|Overall Study|Study participation was terminated|0|||
129221725|NCT00048074|465113305|FG000|Overall Study|Husband ill|0|||
129221726|NCT00048074|465113306|FG001|Overall Study|Husband ill|1|||
129221727|NCT00048074|465113307|FG002|Overall Study|Husband ill|0|||
129221728|NCT00048074|465113305|FG000|Overall Study|Poor compliance|0|||
129221729|NCT00048074|465113306|FG001|Overall Study|Poor compliance|1|||
129221730|NCT00048074|465113307|FG002|Overall Study|Poor compliance|0|||
129221731|NCT00048074|465113305|FG000|Overall Study|Out of station|0|||
129221732|NCT00048074|465113306|FG001|Overall Study|Out of station|1|||
129221733|NCT00048074|465113307|FG002|Overall Study|Out of station|1|||
129221734|NCT00048074|465113305|FG000|Overall Study|Social reasons|1|||
129221735|NCT00048074|465113306|FG001|Overall Study|Social reasons|0|||
129221736|NCT00048074|465113307|FG002|Overall Study|Social reasons|0|||
129221737|NCT02873377|465113308|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
129221738|NCT02873377|465113309|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
129221739|NCT02873377|465113308|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
129221740|NCT02873377|465113309|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
129221741|NCT01032889|465113319|FG000|Overall Study|Adverse Event|2|||
129221742|NCT01032889|465113320|FG001|Overall Study|Adverse Event|2|||
129221743|NCT01032889|465113321|FG002|Overall Study|Adverse Event|0|||
129221744|NCT01032889|465113319|FG000|Overall Study|Withdrawal of Consent|1|||
128976299|NCT01225211|464198602|FG001|Overall Study|Withdrawal by Subject|0|||
128976300|NCT01225211|464198603|FG002|Overall Study|Withdrawal by Subject|0|||
128976301|NCT01225211|464198604|FG003|Overall Study|Withdrawal by Subject|0|||
129221745|NCT01032889|465113320|FG001|Overall Study|Withdrawal of Consent|2|||
129221746|NCT01032889|465113321|FG002|Overall Study|Withdrawal of Consent|1|||
129221747|NCT01032889|465113319|FG000|Overall Study|Patient Request|0|||
129221748|NCT01032889|465113320|FG001|Overall Study|Patient Request|1|||
129221749|NCT01032889|465113321|FG002|Overall Study|Patient Request|0|||
128716633|NCT01921179|463260182|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
128716634|NCT05608005|463260186|FG000|Overall Study|Adverse Event|2|||
128716635|NCT05608005|463260187|FG001|Overall Study|Adverse Event|1|||
128716636|NCT05608005|463260188|FG002|Overall Study|Adverse Event|3|||
128716637|NCT05608005|463260186|FG000|Overall Study|Protocol Violation|2|||
128716638|NCT05608005|463260187|FG001|Overall Study|Protocol Violation|3|||
128716639|NCT05608005|463260188|FG002|Overall Study|Protocol Violation|0|||
128716640|NCT05608005|463260186|FG000|Overall Study|Withdrawal by Subject|10|||
128716641|NCT05608005|463260187|FG001|Overall Study|Withdrawal by Subject|12|||
128716642|NCT05608005|463260188|FG002|Overall Study|Withdrawal by Subject|4|||
128716643|NCT05608005|463260186|FG000|Overall Study|Lost to Follow-up|25|||
128716644|NCT05608005|463260187|FG001|Overall Study|Lost to Follow-up|27|||
128716645|NCT05608005|463260188|FG002|Overall Study|Lost to Follow-up|15|||
128716646|NCT05608005|463260186|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
128716647|NCT05608005|463260187|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
128716648|NCT05608005|463260188|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
128976302|NCT01225211|464198605|FG004|Overall Study|Withdrawal by Subject|0|||
128976303|NCT01225211|464198606|FG005|Overall Study|Withdrawal by Subject|0|||
129221750|NCT01032889|465113319|FG000|Overall Study|Lost to Follow-up|1|||
129221751|NCT01032889|465113320|FG001|Overall Study|Lost to Follow-up|1|||
129221752|NCT01032889|465113321|FG002|Overall Study|Lost to Follow-up|0|||
129221753|NCT01032889|465113319|FG000|Overall Study|Lack of Submental Fat|2|||
129221754|NCT01032889|465113320|FG001|Overall Study|Lack of Submental Fat|8|||
128716649|NCT04708886|463260189|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
128716650|NCT04708886|463260189|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
128716651|NCT01372501|463260190|FG000|Overall Study|Adverse Event|4|||
128716652|NCT01372501|463260190|FG000|Overall Study|Device migration|1|||
128716653|NCT03989440|463260191|FG000|Overall Study|COVID-19 travel restrictions|0|||
128716654|NCT03989440|463260192|FG001|Overall Study|COVID-19 travel restrictions|0|||
128716655|NCT03989440|463260193|FG002|Overall Study|COVID-19 travel restrictions|1|||
128716656|NCT03989440|463260194|FG003|Overall Study|COVID-19 travel restrictions|0|||
128716657|NCT03989440|463260195|FG004|Overall Study|COVID-19 travel restrictions|0|||
128716658|NCT03989440|463260196|FG005|Overall Study|COVID-19 travel restrictions|0|||
128716659|NCT03989440|463260191|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
128716660|NCT03989440|463260192|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
129039271|NCT00794417|464435320|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
129039272|NCT00794417|464435321|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
129039273|NCT00794417|464435322|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
129039274|NCT00794417|464435323|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
129039275|NCT02065713|464435324|FG000|Overall Study|Adverse Event|0|||
129039276|NCT02065713|464435325|FG001|Overall Study|Adverse Event|1|||
129039277|NCT02065713|464435324|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129039278|NCT02065713|464435325|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129039279|NCT01652729|464435326|FG000|Overall Study|Withdrawal by Subject|14|||
129039280|NCT01652729|464435327|FG001|Overall Study|Withdrawal by Subject|7|||
129039281|NCT01652729|464435328|FG002|Overall Study|Withdrawal by Subject|7|||
129039282|NCT01652729|464435326|FG000|Overall Study|Adverse Event|4|||
129039283|NCT01652729|464435327|FG001|Overall Study|Adverse Event|0|||
129039284|NCT01652729|464435328|FG002|Overall Study|Adverse Event|3|||
129039285|NCT01652729|464435326|FG000|Overall Study|Physician Decision|1|||
129039286|NCT01652729|464435327|FG001|Overall Study|Physician Decision|0|||
129039287|NCT01652729|464435328|FG002|Overall Study|Physician Decision|1|||
129039288|NCT01652729|464435326|FG000|Overall Study|Protocol Violation|1|||
129039289|NCT01652729|464435327|FG001|Overall Study|Protocol Violation|0|||
129039290|NCT01652729|464435328|FG002|Overall Study|Protocol Violation|0|||
129039291|NCT01652729|464435326|FG000|Overall Study|Lost to Follow-up|6|||
129039292|NCT01652729|464435327|FG001|Overall Study|Lost to Follow-up|6|||
129039293|NCT01652729|464435328|FG002|Overall Study|Lost to Follow-up|3|||
129039294|NCT01652729|464435326|FG000|Overall Study|Administrative|1|||
129039295|NCT01652729|464435327|FG001|Overall Study|Administrative|0|||
129039296|NCT01652729|464435328|FG002|Overall Study|Administrative|0|||
129039297|NCT01223235|464435331|FG000|Overall Study|Withdrawal by Subject|1|||
129039298|NCT04364737|464435332|FG000|Overall Study|Withdrawal by Subject|4|||
129039299|NCT04364737|464435333|FG001|Overall Study|Withdrawal by Subject|9|||
129039300|NCT04364737|464435332|FG000|Overall Study|Lost to Follow-up|1|||
129039301|NCT04364737|464435333|FG001|Overall Study|Lost to Follow-up|1|||
129039302|NCT01220609|464435334|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
129039303|NCT01220609|464435334|FG000|Overall Study|Ineligible- Wrong cell type|1|||
129039304|NCT01220609|464435334|FG000|Overall Study|Ineligible-Never treated|1|||
129039305|NCT02225665|464435335|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
129039306|NCT02225665|464435336|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
129039307|NCT02225665|464435335|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
129039308|NCT02225665|464435336|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
129039309|NCT01311557|464435337|FG000|Overall Study|Serious adverse event|0|||
129039310|NCT01311557|464435338|FG001|Overall Study|Serious adverse event|1|||
129039311|NCT01311557|464435337|FG000|Overall Study|Protocol Violation|4|||
129039312|NCT01311557|464435338|FG001|Overall Study|Protocol Violation|2|||
129039313|NCT01311557|464435337|FG000|Overall Study|Lost to Follow-up|0|||
129039314|NCT01311557|464435338|FG001|Overall Study|Lost to Follow-up|1|||
129039315|NCT01311557|464435337|FG000|Overall Study|Withdrawal by Subject|1|||
129039316|NCT01311557|464435338|FG001|Overall Study|Withdrawal by Subject|2|||
129039317|NCT00804141|464435339|FG000|Overall Study|Adverse Event|157|||
129039318|NCT00804141|464435339|FG000|Overall Study|Death|4|||
129039319|NCT00804141|464435339|FG000|Overall Study|Failed to return|96|||
129039320|NCT00804141|464435339|FG000|Overall Study|Investigator request|8|||
129039321|NCT00804141|464435339|FG000|Overall Study|Protocol Violation|85|||
129039322|NCT00804141|464435339|FG000|Overall Study|Withdrawal by Subject|131|||
129132592|NCT01405911|464776706|FG002|Overall Study|Lost to Follow-up|0|||
128716661|NCT03989440|463260193|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
129039323|NCT00804141|464435339|FG000|Overall Study|Lack of Efficacy|46|||
129039324|NCT00804141|464435339|FG000|Overall Study|Other than specified|30|||
129039325|NCT00804141|464435339|FG000|Overall Study|Enrolled but not treated|6|||
129039326|NCT00572039|464435340|FG000|Overall Study|Withdrawal by Subject|9|||
129039327|NCT00572039|464435341|FG001|Overall Study|Withdrawal by Subject|6|||
129039328|NCT00572039|464435340|FG000|Overall Study|Death|2|||
129039329|NCT00572039|464435341|FG001|Overall Study|Death|3|||
129039330|NCT00572039|464435340|FG000|Overall Study|Ill|5|||
129039331|NCT00572039|464435341|FG001|Overall Study|Ill|1|||
129039332|NCT02418455|464435346|FG000|48-Week Treatment Period|Other- Not Specified|1|||
129039333|NCT02418455|464435346|FG000|Continuation Period|Sponsor Decision|7|||
129039334|NCT00614822|464435350|FG000|Overall Study|Adverse Event|3|||
129132593|NCT01405911|464776704|FG000|Overall Study|Protocol Violation|1|||
129221755|NCT01032889|465113321|FG002|Overall Study|Lack of Submental Fat|1|||
129221756|NCT01032889|465113319|FG000|Overall Study|Miscellaneous Reasons|2|||
129221757|NCT01032889|465113320|FG001|Overall Study|Miscellaneous Reasons|1|||
129221758|NCT01032889|465113321|FG002|Overall Study|Miscellaneous Reasons|1|||
129221759|NCT02039843|465113322|FG000|Randomization and Observation Period|Adverse Event|2|||
129221760|NCT02039843|465113323|FG001|Randomization and Observation Period|Adverse Event|0|||
129221761|NCT02039843|465113322|FG000|Randomization and Observation Period|Death|1|||
129221762|NCT02039843|465113323|FG001|Randomization and Observation Period|Death|0|||
129221763|NCT02039843|465113322|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
129221764|NCT02039843|465113323|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
129221765|NCT02039843|465113322|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
129221766|NCT02039843|465113323|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
129221767|NCT02039843|465113322|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
129221768|NCT02039843|465113323|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
129221769|NCT02039843|465113322|FG000|Pairing With a Study Dog|Death|1|||
129221770|NCT02039843|465113323|FG001|Pairing With a Study Dog|Death|0|||
129221771|NCT02039843|465113322|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
129221772|NCT02039843|465113323|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
129221773|NCT02039843|465113322|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
129221774|NCT02039843|465113323|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
129221775|NCT02039843|465113322|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
129221776|NCT02039843|465113323|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
129221777|NCT02624986|465113327|FG000|Overall Study|Death|0|||
129221778|NCT02624986|465113328|FG001|Overall Study|Death|1|||
129221779|NCT02624986|465113329|FG002|Overall Study|Death|2|||
129221780|NCT02624986|465113330|FG003|Overall Study|Death|2|||
129221781|NCT02624986|465113331|FG004|Overall Study|Death|2|||
129221782|NCT02624986|465113332|FG005|Overall Study|Death|0|||
129221783|NCT02624986|465113333|FG006|Overall Study|Death|0|||
129221784|NCT02624986|465113334|FG007|Overall Study|Death|1|||
129221785|NCT02624986|465113327|FG000|Overall Study|Study Terminated by Sponsor|1|||
129221786|NCT02624986|465113328|FG001|Overall Study|Study Terminated by Sponsor|1|||
129221787|NCT02624986|465113329|FG002|Overall Study|Study Terminated by Sponsor|0|||
129221788|NCT02624986|465113330|FG003|Overall Study|Study Terminated by Sponsor|1|||
129221789|NCT02624986|465113331|FG004|Overall Study|Study Terminated by Sponsor|2|||
129221790|NCT02624986|465113332|FG005|Overall Study|Study Terminated by Sponsor|2|||
129221791|NCT02624986|465113333|FG006|Overall Study|Study Terminated by Sponsor|4|||
129221792|NCT02624986|465113334|FG007|Overall Study|Study Terminated by Sponsor|3|||
129221793|NCT02624986|465113327|FG000|Overall Study|Progressive Disease|0|||
129221794|NCT02624986|465113328|FG001|Overall Study|Progressive Disease|1|||
129221795|NCT02624986|465113329|FG002|Overall Study|Progressive Disease|0|||
129221796|NCT02624986|465113330|FG003|Overall Study|Progressive Disease|0|||
129221797|NCT02624986|465113331|FG004|Overall Study|Progressive Disease|0|||
129221798|NCT02624986|465113332|FG005|Overall Study|Progressive Disease|0|||
129221799|NCT02624986|465113333|FG006|Overall Study|Progressive Disease|0|||
129221800|NCT02624986|465113334|FG007|Overall Study|Progressive Disease|0|||
129221801|NCT02624986|465113327|FG000|Overall Study|Protocol Violation|1|||
129221802|NCT02624986|465113328|FG001|Overall Study|Protocol Violation|0|||
129221803|NCT02624986|465113329|FG002|Overall Study|Protocol Violation|0|||
129221804|NCT02624986|465113330|FG003|Overall Study|Protocol Violation|0|||
129221805|NCT02624986|465113331|FG004|Overall Study|Protocol Violation|0|||
128716662|NCT03989440|463260194|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
128716663|NCT03989440|463260195|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
128716664|NCT03989440|463260196|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
129132594|NCT01405911|464776705|FG001|Overall Study|Protocol Violation|0|||
129132595|NCT01405911|464776706|FG002|Overall Study|Protocol Violation|0|||
129132596|NCT01405911|464776704|FG000|Overall Study|Withdrawal by Subject|3|||
129132597|NCT01405911|464776705|FG001|Overall Study|Withdrawal by Subject|1|||
129132598|NCT01405911|464776706|FG002|Overall Study|Withdrawal by Subject|1|||
129132599|NCT04739709|464776707|FG000|Overall Study|Physician Decision|1|||
129132600|NCT04739709|464776708|FG001|Overall Study|Physician Decision|0|||
128716665|NCT03970733|463260199|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
128716666|NCT03970733|463260200|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
128716667|NCT03970733|463260201|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
128716668|NCT03970733|463260202|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
128716669|NCT03970733|463260203|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
128716670|NCT03970733|463260199|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
128716671|NCT03970733|463260200|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
128716672|NCT03970733|463260201|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
129221806|NCT02624986|465113332|FG005|Overall Study|Protocol Violation|0|||
129221807|NCT02624986|465113333|FG006|Overall Study|Protocol Violation|0|||
129221808|NCT02624986|465113334|FG007|Overall Study|Protocol Violation|0|||
129132601|NCT02530242|464776718|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
129132602|NCT02530242|464776719|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
128716673|NCT03970733|463260202|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
128716674|NCT03970733|463260203|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
128716675|NCT03970733|463260199|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
128716676|NCT03970733|463260200|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
128716677|NCT03970733|463260201|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
128716678|NCT03970733|463260202|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
128716679|NCT03970733|463260203|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
128716680|NCT03970733|463260199|FG000|Main Study Phase (18 Months)|Other|1|||
128716681|NCT03970733|463260200|FG001|Main Study Phase (18 Months)|Other|1|||
128716682|NCT03970733|463260201|FG002|Main Study Phase (18 Months)|Other|0|||
128716683|NCT03970733|463260202|FG003|Main Study Phase (18 Months)|Other|0|||
128716684|NCT03970733|463260203|FG004|Main Study Phase (18 Months)|Other|0|||
128716685|NCT03970733|463260199|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
128716686|NCT03970733|463260200|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
128716687|NCT03970733|463260201|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
128716688|NCT03970733|463260202|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
128716689|NCT03970733|463260203|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
128716690|NCT02357901|463260204|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
128716691|NCT02357901|463260205|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
128716692|NCT02357901|463260206|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
128716693|NCT02357901|463260207|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
128716694|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
128716695|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
128716696|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
128716697|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
128716698|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
128716699|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
128716700|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
128716701|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
128716702|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
128716703|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
128716704|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
128716705|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
128716706|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
128716707|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
128716708|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
128716709|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
128716710|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
128716711|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
128716712|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
128716713|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
128716714|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
128716715|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
128716716|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
128716717|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
128716718|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
128716719|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
128716720|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
128716721|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
128716722|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
128716723|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
128716724|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
128716725|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
128716726|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
128716727|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
128716728|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
128716729|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
128716730|NCT02357901|463260204|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
128716731|NCT02357901|463260205|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
128716732|NCT02357901|463260206|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
128716733|NCT02357901|463260207|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
128716734|NCT00491387|463260211|FG000|Overall Study|study terminated|20|||
128716735|NCT01086540|463260219|FG000|Overall Study|Death|3|||
128716736|NCT01086540|463260220|FG001|Overall Study|Death|1|||
128716737|NCT01086540|463260219|FG000|Overall Study|Physician Decision|2|||
128716738|NCT01086540|463260220|FG001|Overall Study|Physician Decision|1|||
129221809|NCT02624986|465113327|FG000|Overall Study|Withdrawal by Subject|0|||
129221810|NCT02624986|465113328|FG001|Overall Study|Withdrawal by Subject|0|||
129221811|NCT02624986|465113329|FG002|Overall Study|Withdrawal by Subject|0|||
129221812|NCT02624986|465113330|FG003|Overall Study|Withdrawal by Subject|0|||
129221813|NCT02624986|465113331|FG004|Overall Study|Withdrawal by Subject|0|||
129221814|NCT02624986|465113332|FG005|Overall Study|Withdrawal by Subject|0|||
129221815|NCT02624986|465113333|FG006|Overall Study|Withdrawal by Subject|0|||
129221816|NCT02624986|465113334|FG007|Overall Study|Withdrawal by Subject|1|||
129221817|NCT00740857|465113336|FG000|Overall Study|Withdrawal by Subject|1|||
128976304|NCT01225211|464198607|FG006|Overall Study|Withdrawal by Subject|1|||
128976305|NCT01225211|464198608|FG007|Overall Study|Withdrawal by Subject|0|||
128976306|NCT01225211|464198609|FG008|Overall Study|Withdrawal by Subject|1|||
128976307|NCT01225211|464198610|FG009|Overall Study|Withdrawal by Subject|3|||
128976308|NCT01225211|464198601|FG000|Overall Study|Other|0|||
129132603|NCT00283959|464776720|FG000|Extension Period|Low Compliance|1|||
129132604|NCT05591755|464776721|FG000|Overall Study|Screen Failure|1|||
129132605|NCT05591755|464776722|FG001|Overall Study|Screen Failure|0|||
129132606|NCT05591755|464776723|FG002|Overall Study|Screen Failure|0|||
129132607|NCT05591755|464776724|FG003|Overall Study|Screen Failure|0|||
129132608|NCT05591755|464776721|FG000|Overall Study|Protocol Violation|0|||
129132609|NCT05591755|464776722|FG001|Overall Study|Protocol Violation|0|||
129132610|NCT05591755|464776723|FG002|Overall Study|Protocol Violation|2|||
129132611|NCT05591755|464776724|FG003|Overall Study|Protocol Violation|0|||
129132612|NCT05591755|464776721|FG000|Overall Study|Withdrawal by Subject|0|||
129132613|NCT05591755|464776722|FG001|Overall Study|Withdrawal by Subject|1|||
129132614|NCT05591755|464776723|FG002|Overall Study|Withdrawal by Subject|0|||
129132615|NCT05591755|464776724|FG003|Overall Study|Withdrawal by Subject|0|||
129132616|NCT00433290|464776725|FG000|Overall Study|Adverse Event|24|||
129132617|NCT00433290|464776726|FG001|Overall Study|Adverse Event|7|||
128716739|NCT01086540|463260219|FG000|Overall Study|Addition of new therapy for PAH|1|||
128716740|NCT01086540|463260220|FG001|Overall Study|Addition of new therapy for PAH|0|||
128716741|NCT03164928|463260221|FG000|Overall Study|Lost to Follow-up|1|||
128716742|NCT03164928|463260222|FG001|Overall Study|Lost to Follow-up|0|||
128716743|NCT02278263|463260223|FG000|Overall Study|Protocol Violation|7|||
128716744|NCT02278263|463260224|FG001|Overall Study|Protocol Violation|0|||
128716745|NCT02278263|463260225|FG002|Overall Study|Protocol Violation|9|||
128716746|NCT01998737|463260226|FG000|Overall Study|Corrupted database|23|||
128716747|NCT01998737|463260227|FG001|Overall Study|Corrupted database|0|||
128716748|NCT03997383|463260230|FG000|Double-blind Treatment Period|Adverse Event|4|||
128716749|NCT03997383|463260231|FG001|Double-blind Treatment Period|Adverse Event|3|||
128716750|NCT03997383|463260230|FG000|Double-blind Treatment Period|Death|4|||
128716751|NCT03997383|463260231|FG001|Double-blind Treatment Period|Death|4|||
128716752|NCT03997383|463260230|FG000|Double-blind Treatment Period|Physician Decision|2|||
128716753|NCT03997383|463260231|FG001|Double-blind Treatment Period|Physician Decision|0|||
128716754|NCT03997383|463260230|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
128716755|NCT03997383|463260231|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
128716756|NCT03997383|463260230|FG000|Open-label Extension Period|Ongoing|148|||
128716757|NCT03997383|463260231|FG001|Open-label Extension Period|Ongoing|151|||
128716758|NCT03997383|463260230|FG000|Open-label Extension Period|Adverse Event|4|||
128716759|NCT03997383|463260231|FG001|Open-label Extension Period|Adverse Event|1|||
128716760|NCT03997383|463260230|FG000|Open-label Extension Period|Death|8|||
128716761|NCT03997383|463260231|FG001|Open-label Extension Period|Death|9|||
128716762|NCT03997383|463260230|FG000|Open-label Extension Period|Physician Decision|1|||
128716763|NCT03997383|463260231|FG001|Open-label Extension Period|Physician Decision|1|||
128716764|NCT03997383|463260230|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
128716765|NCT03997383|463260231|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
128716766|NCT03997383|463260230|FG000|Open-label Extension Period|Reason Not Specified|2|||
128716767|NCT03997383|463260231|FG001|Open-label Extension Period|Reason Not Specified|0|||
128716768|NCT03880019|463260232|FG000|Overall Study|Competing disease|1|||
128716769|NCT00326950|463260233|FG000|Overall Study|Progressive Disease|1|||
128716770|NCT01266460|463260243|FG000|Overall Study|Adverse Event|3|||
128716771|NCT01266460|463260243|FG000|Overall Study|Withdrawal by Subject|5|||
128716772|NCT01266460|463260243|FG000|Overall Study|Disease Progression|18|||
128716773|NCT01266460|463260243|FG000|Overall Study|Not otherwise specified|8|||
128716774|NCT01132547|463260244|FG000|Overall Study|Withdrawal by Subject|3|||
129132618|NCT00433290|464776725|FG000|Overall Study|Lack of Efficacy|1|||
129132619|NCT00433290|464776726|FG001|Overall Study|Lack of Efficacy|5|||
129221818|NCT00740857|465113337|FG001|Overall Study|Withdrawal by Subject|0|||
128716775|NCT01132547|463260245|FG001|Overall Study|Withdrawal by Subject|1|||
128716776|NCT01132547|463260244|FG000|Overall Study|Death|1|||
128716777|NCT01132547|463260245|FG001|Overall Study|Death|0|||
128716778|NCT05811234|463260246|FG000|Overall Study|Loss of Effectiveness|2|||
128976309|NCT01225211|464198602|FG001|Overall Study|Other|0|||
128976310|NCT01225211|464198603|FG002|Overall Study|Other|0|||
128976311|NCT01225211|464198604|FG003|Overall Study|Other|0|||
128976312|NCT01225211|464198605|FG004|Overall Study|Other|0|||
129221819|NCT00740857|465113338|FG002|Overall Study|Withdrawal by Subject|0|||
129221820|NCT03532451|465113342|FG000|Overall Study|Withdrawal by Subject|0|||
129221821|NCT03532451|465113343|FG001|Overall Study|Withdrawal by Subject|1|||
129221822|NCT03532451|465113342|FG000|Overall Study|Did not undergo surgery|1|||
129221823|NCT03532451|465113343|FG001|Overall Study|Did not undergo surgery|1|||
129221824|NCT00912197|465113346|FG000|Overall Study|Withdrawal by Subject|3|||
129221825|NCT00912197|465113347|FG001|Overall Study|Withdrawal by Subject|3|||
129221826|NCT01326104|465113351|FG000|Overall Study|progressed prior to vaccine|0|||
129221827|NCT01326104|465113352|FG001|Overall Study|progressed prior to vaccine|2|||
129221828|NCT01326104|465113351|FG000|Overall Study|unable to make vaccine|0|||
129221829|NCT01326104|465113352|FG001|Overall Study|unable to make vaccine|2|||
129221830|NCT01287741|465113353|FG000|Overall Study|Withdrawal by Subject|35|||
129221831|NCT01287741|465113354|FG001|Overall Study|Withdrawal by Subject|38|||
129221832|NCT01287741|465113353|FG000|Overall Study|Protocol Violation|2|||
129221833|NCT01287741|465113354|FG001|Overall Study|Protocol Violation|0|||
129221834|NCT01287741|465113353|FG000|Overall Study|Physician Decision|15|||
129221835|NCT01287741|465113354|FG001|Overall Study|Physician Decision|23|||
129221836|NCT01287741|465113353|FG000|Overall Study|Non-compliance|8|||
129221837|NCT01287741|465113354|FG001|Overall Study|Non-compliance|6|||
129221838|NCT01287741|465113353|FG000|Overall Study|Lost to Follow-up|10|||
129221839|NCT01287741|465113354|FG001|Overall Study|Lost to Follow-up|8|||
129221840|NCT01287741|465113353|FG000|Overall Study|Death|32|||
129221841|NCT01287741|465113354|FG001|Overall Study|Death|44|||
129221842|NCT01287741|465113353|FG000|Overall Study|Adverse Event|4|||
129221843|NCT01287741|465113354|FG001|Overall Study|Adverse Event|6|||
129221844|NCT01287741|465113353|FG000|Overall Study|Study terminated by Sponsor|307|||
129221845|NCT01287741|465113354|FG001|Overall Study|Study terminated by Sponsor|315|||
129221846|NCT01287741|465113353|FG000|Overall Study|Progressive disease|190|||
129221847|NCT01287741|465113354|FG001|Overall Study|Progressive disease|166|||
128716779|NCT05811234|463260246|FG000|Overall Study|Adverse Event|4|||
128716780|NCT05811234|463260246|FG000|Overall Study|Pregnancy|1|||
128716781|NCT05811234|463260246|FG000|Overall Study|Disease progression|1|||
128716782|NCT05811234|463260246|FG000|Overall Study|Withdrawal by Subject|4|||
128716783|NCT05811234|463260246|FG000|Overall Study|Lost to Follow-up|13|||
128716784|NCT05811234|463260246|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
128716785|NCT04499781|463260247|FG000|Overall Study|Lost to Follow-up|2|||
128716786|NCT04499781|463260248|FG001|Overall Study|Lost to Follow-up|3|||
128716787|NCT04499781|463260247|FG000|Overall Study|Withdrawal by Subject|2|||
128716788|NCT04499781|463260248|FG001|Overall Study|Withdrawal by Subject|0|||
128716789|NCT00227305|463260249|FG000|Overall Study|Adverse Event|40|||
128716790|NCT00227305|463260249|FG000|Overall Study|Withdrawal by Subject|42|||
128716791|NCT00227305|463260249|FG000|Overall Study|Lost to Follow-up|33|||
128716792|NCT00227305|463260249|FG000|Overall Study|Study specific discontinuation|13|||
128716793|NCT00227305|463260249|FG000|Overall Study|MOVED OUT OF AREA|3|||
128716794|NCT00227305|463260249|FG000|Overall Study|Lack of Efficacy|7|||
128716795|NCT00227305|463260249|FG000|Overall Study|Physician Decision|3|||
128716796|NCT00227305|463260249|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
128716797|NCT00227305|463260249|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
128716798|NCT00227305|463260249|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
128716799|NCT00483379|463260250|FG000|Treatment Period|Adverse Event|1|||
128716800|NCT00483379|463260251|FG001|Treatment Period|Adverse Event|0|||
128716801|NCT00483379|463260250|FG000|Treatment Period|Withdrawal by Subject|1|||
128716802|NCT00483379|463260251|FG001|Treatment Period|Withdrawal by Subject|0|||
128716803|NCT03311659|463260258|FG000|Overall Study|Protocol Violation|1|||
128716804|NCT00071760|463260259|FG000|Overall Study|Adverse Event|2|||
128716805|NCT00071760|463260260|FG001|Overall Study|Adverse Event|1|||
128716806|NCT00071760|463260259|FG000|Overall Study|Lost to Follow-up|0|||
128716807|NCT00071760|463260260|FG001|Overall Study|Lost to Follow-up|3|||
128716808|NCT00071760|463260259|FG000|Overall Study|Protocol Violation|1|||
128716809|NCT00071760|463260260|FG001|Overall Study|Protocol Violation|0|||
128716810|NCT00071760|463260259|FG000|Overall Study|Withdrawal by Subject|0|||
128716811|NCT00071760|463260260|FG001|Overall Study|Withdrawal by Subject|1|||
128716812|NCT00071760|463260259|FG000|Overall Study|Insufficient Viral Load Response|1|||
128716813|NCT00071760|463260260|FG001|Overall Study|Insufficient Viral Load Response|1|||
128716814|NCT00071760|463260259|FG000|Overall Study|Lack of availability of RTV|1|||
129221848|NCT01287741|465113353|FG000|Overall Study|Reason not specified|23|||
128716815|NCT00071760|463260260|FG001|Overall Study|Lack of availability of RTV|0|||
128716816|NCT00071760|463260259|FG000|Overall Study|Physician Decision|2|||
128716817|NCT00071760|463260260|FG001|Overall Study|Physician Decision|1|||
129221849|NCT01287741|465113354|FG001|Overall Study|Reason not specified|9|||
129221850|NCT04421027|465113355|FG000|Treatment Period|Adverse Event|5|||
129221851|NCT04421027|465113356|FG001|Treatment Period|Adverse Event|3|||
129221852|NCT04421027|465113357|FG002|Treatment Period|Adverse Event|0|||
129221853|NCT04421027|465113358|FG003|Treatment Period|Adverse Event|0|||
129221854|NCT04421027|465113355|FG000|Treatment Period|Death|98|||
129221855|NCT04421027|465113356|FG001|Treatment Period|Death|61|||
128716818|NCT00071760|463260259|FG000|Overall Study|Relocation|0|||
129221856|NCT04421027|465113357|FG002|Treatment Period|Death|0|||
129221857|NCT04421027|465113358|FG003|Treatment Period|Death|0|||
129221858|NCT04421027|465113355|FG000|Treatment Period|Lost to Follow-up|22|||
129221859|NCT04421027|465113356|FG001|Treatment Period|Lost to Follow-up|20|||
129221860|NCT04421027|465113357|FG002|Treatment Period|Lost to Follow-up|0|||
129221861|NCT04421027|465113358|FG003|Treatment Period|Lost to Follow-up|0|||
129221862|NCT04421027|465113355|FG000|Treatment Period|Other-Unknown|15|||
129221863|NCT04421027|465113356|FG001|Treatment Period|Other-Unknown|9|||
129221864|NCT04421027|465113357|FG002|Treatment Period|Other-Unknown|0|||
129221865|NCT04421027|465113358|FG003|Treatment Period|Other-Unknown|0|||
129221866|NCT04421027|465113355|FG000|Treatment Period|Physician Decision|1|||
129221867|NCT04421027|465113356|FG001|Treatment Period|Physician Decision|1|||
129221868|NCT04421027|465113357|FG002|Treatment Period|Physician Decision|0|||
129221869|NCT04421027|465113358|FG003|Treatment Period|Physician Decision|0|||
129221870|NCT04421027|465113355|FG000|Treatment Period|Withdrawal by Subject|7|||
129221871|NCT04421027|465113356|FG001|Treatment Period|Withdrawal by Subject|12|||
129221872|NCT04421027|465113357|FG002|Treatment Period|Withdrawal by Subject|0|||
129221873|NCT04421027|465113358|FG003|Treatment Period|Withdrawal by Subject|0|||
129221874|NCT04421027|465113355|FG000|Treatment Period|Randomized Not Dosed|9|||
129221875|NCT04421027|465113356|FG001|Treatment Period|Randomized Not Dosed|14|||
129221876|NCT04421027|465113357|FG002|Treatment Period|Randomized Not Dosed|0|||
129221877|NCT04421027|465113358|FG003|Treatment Period|Randomized Not Dosed|0|||
129221878|NCT04421027|465113355|FG000|Follow-Up Period|Adverse Event|0|||
129221879|NCT04421027|465113356|FG001|Follow-Up Period|Adverse Event|0|||
129221880|NCT04421027|465113357|FG002|Follow-Up Period|Adverse Event|0|||
129221881|NCT04421027|465113358|FG003|Follow-Up Period|Adverse Event|3|||
129221882|NCT04421027|465113355|FG000|Follow-Up Period|Death|0|||
129221883|NCT04421027|465113356|FG001|Follow-Up Period|Death|0|||
129221884|NCT04421027|465113357|FG002|Follow-Up Period|Death|16|||
129221885|NCT04421027|465113358|FG003|Follow-Up Period|Death|17|||
129221886|NCT04421027|465113355|FG000|Follow-Up Period|Lost to Follow-up|0|||
129221887|NCT04421027|465113356|FG001|Follow-Up Period|Lost to Follow-up|0|||
129221888|NCT04421027|465113357|FG002|Follow-Up Period|Lost to Follow-up|7|||
129221889|NCT04421027|465113358|FG003|Follow-Up Period|Lost to Follow-up|7|||
129221890|NCT04421027|465113355|FG000|Follow-Up Period|Protocol Deviation|0|||
129221891|NCT04421027|465113356|FG001|Follow-Up Period|Protocol Deviation|0|||
129221892|NCT04421027|465113357|FG002|Follow-Up Period|Protocol Deviation|1|||
129221893|NCT04421027|465113358|FG003|Follow-Up Period|Protocol Deviation|0|||
129221894|NCT04421027|465113355|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
129221895|NCT04421027|465113356|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
129221896|NCT04421027|465113357|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
129221897|NCT04421027|465113358|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
129221898|NCT04421027|465113355|FG000|Follow-Up Period|Left message, participant did not call back|0|||
129221899|NCT04421027|465113356|FG001|Follow-Up Period|Left message, participant did not call back|0|||
129221900|NCT04421027|465113357|FG002|Follow-Up Period|Left message, participant did not call back|0|||
129221901|NCT04421027|465113358|FG003|Follow-Up Period|Left message, participant did not call back|1|||
129221902|NCT04421027|465113355|FG000|Follow-Up Period|Participant died|0|||
129221903|NCT04421027|465113356|FG001|Follow-Up Period|Participant died|0|||
129221904|NCT04421027|465113357|FG002|Follow-Up Period|Participant died|0|||
129221905|NCT04421027|465113358|FG003|Follow-Up Period|Participant died|1|||
129221906|NCT04421027|465113355|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
129221907|NCT04421027|465113356|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
129221908|NCT04421027|465113357|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
129221909|NCT04421027|465113358|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
129221910|NCT02930018|465113368|FG000|Overall Study|Lost to Follow-up|1|||
129221911|NCT02930018|465113369|FG001|Overall Study|Lost to Follow-up|1|||
129221912|NCT02930018|465113368|FG000|Overall Study|Withdrawal by Subject|5|||
129221913|NCT02930018|465113369|FG001|Overall Study|Withdrawal by Subject|2|||
129221914|NCT04434937|465113373|FG000|Overall Study|Death|4|||
129221915|NCT04434937|465113373|FG000|Overall Study|Withdrawal by Subject|1|||
129221916|NCT04434937|465113373|FG000|Overall Study|Transitioned to Rollover Study|19|||
129221917|NCT04434937|465113373|FG000|Overall Study|Progressive Disease|18|||
129221918|NCT00114517|465113374|FG000|Overall Study|Adverse Event|6|||
128976313|NCT01225211|464198606|FG005|Overall Study|Other|0|||
128976314|NCT01225211|464198607|FG006|Overall Study|Other|0|||
129221919|NCT00114517|465113375|FG001|Overall Study|Adverse Event|1|||
129221920|NCT00114517|465113376|FG002|Overall Study|Adverse Event|6|||
129221921|NCT00114517|465113377|FG003|Overall Study|Adverse Event|3|||
129221922|NCT00114517|465113374|FG000|Overall Study|Lost to Follow-up|2|||
129221923|NCT00114517|465113375|FG001|Overall Study|Lost to Follow-up|2|||
129221924|NCT00114517|465113376|FG002|Overall Study|Lost to Follow-up|2|||
129221925|NCT00114517|465113377|FG003|Overall Study|Lost to Follow-up|1|||
129221926|NCT00114517|465113374|FG000|Overall Study|Too busy|3|||
128976315|NCT01225211|464198608|FG007|Overall Study|Other|0|||
128976316|NCT01225211|464198609|FG008|Overall Study|Other|0|||
129221927|NCT00114517|465113375|FG001|Overall Study|Too busy|1|||
129221928|NCT00114517|465113376|FG002|Overall Study|Too busy|1|||
128716819|NCT00071760|463260260|FG001|Overall Study|Relocation|1|||
128716820|NCT01994629|463260261|FG000|Overall Study|Withdrawal by Subject|1|||
128716821|NCT01994629|463260262|FG001|Overall Study|Withdrawal by Subject|0|||
128716822|NCT01994629|463260261|FG000|Overall Study|Lost to Follow-up|0|||
128716823|NCT01994629|463260262|FG001|Overall Study|Lost to Follow-up|3|||
128716824|NCT04103892|463260263|FG000|Overall Study|Adverse Event|0|||
128716825|NCT04103892|463260264|FG001|Overall Study|Adverse Event|0|||
128716826|NCT04103892|463260265|FG002|Overall Study|Adverse Event|0|||
128716827|NCT04103892|463260266|FG003|Overall Study|Adverse Event|3|||
128716828|NCT04103892|463260263|FG000|Overall Study|Lost to Follow-up|0|||
128716829|NCT04103892|463260264|FG001|Overall Study|Lost to Follow-up|0|||
128716830|NCT04103892|463260265|FG002|Overall Study|Lost to Follow-up|2|||
128716831|NCT04103892|463260266|FG003|Overall Study|Lost to Follow-up|0|||
128716832|NCT04103892|463260263|FG000|Overall Study|Protocol Violation|0|||
128716833|NCT04103892|463260264|FG001|Overall Study|Protocol Violation|0|||
128716834|NCT04103892|463260265|FG002|Overall Study|Protocol Violation|1|||
128716835|NCT04103892|463260266|FG003|Overall Study|Protocol Violation|1|||
128716836|NCT04103892|463260263|FG000|Overall Study|Withdrawal by Subject|1|||
128716837|NCT04103892|463260264|FG001|Overall Study|Withdrawal by Subject|0|||
128716838|NCT04103892|463260265|FG002|Overall Study|Withdrawal by Subject|2|||
128716839|NCT04103892|463260266|FG003|Overall Study|Withdrawal by Subject|5|||
128716840|NCT04103892|463260263|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
128716841|NCT04103892|463260264|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
128716842|NCT04103892|463260265|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
128716843|NCT04103892|463260266|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
128716844|NCT01558752|463260267|FG000|Overall Study|Physician Decision|2|||
128716845|NCT01558752|463260268|FG001|Overall Study|Physician Decision|0|||
128716846|NCT03051607|463260279|FG000|Overall Study|Adverse Event|66|||
128716847|NCT03341533|463260281|FG000|Overall Study|Withdrawal by Subject|1|||
128716848|NCT03341533|463260282|FG001|Overall Study|Withdrawal by Subject|1|||
128716849|NCT03341533|463260281|FG000|Overall Study|Not eligible after randomization|2|||
128716850|NCT03341533|463260282|FG001|Overall Study|Not eligible after randomization|1|||
128716851|NCT02738450|463260290|FG000|Overall Study|Withdrawal by Subject|0|||
128716852|NCT02738450|463260291|FG001|Overall Study|Withdrawal by Subject|2|||
128716853|NCT02738450|463260292|FG002|Overall Study|Withdrawal by Subject|0|||
128716854|NCT01603459|463260296|FG000|Overall Study|Adverse Event|5|||
128716855|NCT01603459|463260296|FG000|Overall Study|Withdrawal by Subject|5|||
128716856|NCT01603459|463260296|FG000|Overall Study|Lost to Follow-up|3|||
128716857|NCT01603459|463260296|FG000|Overall Study|Predefined discontinuation criteria|3|||
128716858|NCT01603459|463260296|FG000|Overall Study|Non-compliance|1|||
128716859|NCT01603459|463260296|FG000|Overall Study|Administrative reason|1|||
128716860|NCT00399360|463260297|FG000|Overall Study|Lost to Follow-up|2|||
128716861|NCT00399360|463260298|FG001|Overall Study|Lost to Follow-up|1|||
128716862|NCT00399360|463260299|FG002|Overall Study|Lost to Follow-up|2|||
128716863|NCT00399360|463260300|FG003|Overall Study|Lost to Follow-up|4|||
128716864|NCT00399360|463260297|FG000|Overall Study|Adverse Event|0|||
128716865|NCT00399360|463260298|FG001|Overall Study|Adverse Event|0|||
128716866|NCT00399360|463260299|FG002|Overall Study|Adverse Event|1|||
128716867|NCT00399360|463260300|FG003|Overall Study|Adverse Event|0|||
128716868|NCT00399360|463260297|FG000|Overall Study|Withdrawal by Subject|0|||
128716869|NCT00399360|463260298|FG001|Overall Study|Withdrawal by Subject|2|||
128716870|NCT00399360|463260299|FG002|Overall Study|Withdrawal by Subject|0|||
128716871|NCT00399360|463260300|FG003|Overall Study|Withdrawal by Subject|2|||
128716872|NCT01412021|463260302|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
128716873|NCT01412021|463260302|FG000|Overall Study|Treatment Prior to Approval|3|||
128716874|NCT01412021|463260302|FG000|Overall Study|Transferred to Other Hospital|9|||
128716875|NCT01166178|463260303|FG000|Overall Study|Withdrawal by Subject|1|||
128716876|NCT01166178|463260304|FG001|Overall Study|Withdrawal by Subject|0|||
128716877|NCT01166178|463260303|FG000|Overall Study|Study was terminated|20|||
128716878|NCT01166178|463260304|FG001|Overall Study|Study was terminated|8|||
128716879|NCT02446990|463260311|FG000|Overall Study|Death|485|||
128716880|NCT02446990|463260312|FG001|Overall Study|Death|458|||
128716881|NCT02446990|463260311|FG000|Overall Study|Lost to Follow-up|3|||
128716882|NCT02446990|463260312|FG001|Overall Study|Lost to Follow-up|1|||
128716883|NCT02446990|463260311|FG000|Overall Study|Physician Decision|1|||
128716884|NCT02446990|463260312|FG001|Overall Study|Physician Decision|0|||
128716885|NCT02446990|463260311|FG000|Overall Study|Withdrawal by Subject|231|||
128774765|NCT01216293|463466661|FG001|Main Study|Voluntary Withdrawal|2|||
128774766|NCT01216293|463466662|FG002|Main Study|Voluntary Withdrawal|2|||
128716886|NCT02446990|463260312|FG001|Overall Study|Withdrawal by Subject|199|||
128716887|NCT03333044|463260313|FG000|Overall Study|Pregnancy|1|||
128716888|NCT03333044|463260314|FG001|Overall Study|Pregnancy|0|||
128716889|NCT03333044|463260315|FG002|Overall Study|Pregnancy|0|||
128716890|NCT03333044|463260313|FG000|Overall Study|Lost to Follow-up|0|||
128716891|NCT03333044|463260314|FG001|Overall Study|Lost to Follow-up|14|||
128716892|NCT03333044|463260315|FG002|Overall Study|Lost to Follow-up|6|||
128716893|NCT04537234|463260316|FG000|Overall Study|Withdrawal by Subject|2|||
128774767|NCT01216293|463466660|FG000|Main Study|Other Reason Not Specified|0|||
128716894|NCT04537234|463260317|FG001|Overall Study|Withdrawal by Subject|0|||
128716895|NCT05478252|463260318|FG000|Overall Study|Withdrawal by Subject|2|||
128716896|NCT05478252|463260319|FG001|Overall Study|Withdrawal by Subject|3|||
128716897|NCT05478252|463260318|FG000|Overall Study|Lost to Follow-up|4|||
128716898|NCT05478252|463260319|FG001|Overall Study|Lost to Follow-up|2|||
128716899|NCT05478252|463260318|FG000|Overall Study|Physician Decision|1|||
128716900|NCT05478252|463260319|FG001|Overall Study|Physician Decision|1|||
128716901|NCT05478252|463260318|FG000|Overall Study|Death|1|||
128716902|NCT05478252|463260319|FG001|Overall Study|Death|0|||
128716903|NCT00858442|463261847|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
128716904|NCT00858442|463261848|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
128716905|NCT01466348|463261851|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
128716906|NCT01466348|463261852|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
128716907|NCT02189473|463261856|FG000|Overall Study|Death|22|||
128716908|NCT02189473|463261857|FG001|Overall Study|Death|23|||
128716909|NCT02189473|463261856|FG000|Overall Study|Lost to Follow-up|1|||
128716910|NCT02189473|463261857|FG001|Overall Study|Lost to Follow-up|2|||
128716911|NCT01955161|463261858|FG000|Overall Study|Withdrawal before treatment|2|||
128716912|NCT01955161|463261859|FG001|Overall Study|Withdrawal before treatment|0|||
128716913|NCT01955161|463261860|FG002|Overall Study|Withdrawal before treatment|1|||
128716914|NCT01955161|463261858|FG000|Overall Study|Adverse Event|10|||
128716915|NCT01955161|463261859|FG001|Overall Study|Adverse Event|14|||
128716916|NCT01955161|463261860|FG002|Overall Study|Adverse Event|15|||
128716917|NCT01955161|463261858|FG000|Overall Study|Death|1|||
128716918|NCT01955161|463261859|FG001|Overall Study|Death|1|||
128716919|NCT01955161|463261860|FG002|Overall Study|Death|3|||
128716920|NCT01955161|463261858|FG000|Overall Study|Withdrawal by Subject|9|||
128716921|NCT01955161|463261859|FG001|Overall Study|Withdrawal by Subject|8|||
128716922|NCT01955161|463261860|FG002|Overall Study|Withdrawal by Subject|12|||
128716923|NCT01955161|463261858|FG000|Overall Study|Protocol Violation|2|||
128716924|NCT01955161|463261859|FG001|Overall Study|Protocol Violation|0|||
128716925|NCT01955161|463261860|FG002|Overall Study|Protocol Violation|0|||
128716926|NCT01955161|463261858|FG000|Overall Study|Other reason: physician decision|0|||
128716927|NCT01955161|463261859|FG001|Overall Study|Other reason: physician decision|1|||
128716928|NCT01955161|463261860|FG002|Overall Study|Other reason: physician decision|1|||
128716929|NCT01955161|463261858|FG000|Overall Study|Other reason: disallowed medication|1|||
128716930|NCT01955161|463261859|FG001|Overall Study|Other reason: disallowed medication|0|||
128716931|NCT01955161|463261860|FG002|Overall Study|Other reason: disallowed medication|1|||
128716932|NCT01955161|463261858|FG000|Overall Study|Other reason: caregiver unavailable|1|||
128716933|NCT01955161|463261859|FG001|Overall Study|Other reason: caregiver unavailable|0|||
128716934|NCT01955161|463261860|FG002|Overall Study|Other reason: caregiver unavailable|0|||
128716935|NCT01955161|463261858|FG000|Overall Study|Other reason: moved to nursing home|0|||
128716936|NCT01955161|463261859|FG001|Overall Study|Other reason: moved to nursing home|1|||
128716937|NCT01955161|463261860|FG002|Overall Study|Other reason: moved to nursing home|0|||
128716938|NCT01955161|463261858|FG000|Overall Study|Other reason: insufficient compliance|0|||
128716939|NCT01955161|463261859|FG001|Overall Study|Other reason: insufficient compliance|0|||
128716940|NCT01955161|463261860|FG002|Overall Study|Other reason: insufficient compliance|1|||
128716941|NCT01955161|463261858|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
128716942|NCT01955161|463261859|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
128716943|NCT01955161|463261860|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
128716944|NCT01955161|463261858|FG000|Overall Study|Other reason: patient's will|0|||
128716945|NCT01955161|463261859|FG001|Overall Study|Other reason: patient's will|0|||
128716946|NCT01955161|463261860|FG002|Overall Study|Other reason: patient's will|1|||
128716947|NCT02784821|463261863|FG000|Overall Study|Death|0|||
128716948|NCT02784821|463261864|FG001|Overall Study|Death|5|||
128716949|NCT02784821|463261865|FG002|Overall Study|Death|4|||
128716950|NCT02784821|463261866|FG003|Overall Study|Death|5|||
128716951|NCT01277523|463261867|FG000|Overall Study|Adverse Event|1|||
128716952|NCT01277523|463261868|FG001|Overall Study|Adverse Event|0|||
128716953|NCT01277523|463261869|FG002|Overall Study|Adverse Event|0|||
128716954|NCT01277523|463261867|FG000|Overall Study|Protocol Violation|2|||
128716955|NCT01277523|463261868|FG001|Overall Study|Protocol Violation|0|||
128716956|NCT01277523|463261869|FG002|Overall Study|Protocol Violation|0|||
128716957|NCT01277523|463261867|FG000|Overall Study|Other Reason not Defined|0|||
129132620|NCT00433290|464776725|FG000|Overall Study|Withdrawal by Subject|4|||
129132621|NCT00433290|464776726|FG001|Overall Study|Withdrawal by Subject|2|||
129132622|NCT00433290|464776725|FG000|Overall Study|Protocol Violation|3|||
128716958|NCT01277523|463261868|FG001|Overall Study|Other Reason not Defined|1|||
128716959|NCT01277523|463261869|FG002|Overall Study|Other Reason not Defined|0|||
128716960|NCT01030523|463261875|FG000|Initial Study (5 Years)|Death|1|||
128716961|NCT01030523|463261876|FG001|Initial Study (5 Years)|Death|0|||
128716962|NCT01030523|463261875|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
128716963|NCT01030523|463261876|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
128716964|NCT01030523|463261875|FG000|Initial Study (5 Years)|Implant failure|1|||
128716965|NCT01030523|463261876|FG001|Initial Study (5 Years)|Implant failure|0|||
128716966|NCT01030523|463261875|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
128716967|NCT01030523|463261876|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
128716968|NCT01030523|463261875|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
128976317|NCT01225211|464198610|FG009|Overall Study|Other|1|||
128976318|NCT01058356|464198631|FG000|Overall Study|Adverse Event|5|||
128976319|NCT01058356|464198631|FG000|Overall Study|Administration of contraindicated drugs|12|||
128976320|NCT01058356|464198631|FG000|Overall Study|Withdrawal by Subject|21|||
128976321|NCT01058356|464198631|FG000|Overall Study|Lost to Follow-up|4|||
128716969|NCT01030523|463261876|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
128716970|NCT01030523|463261875|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
128716971|NCT01030523|463261876|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
128716972|NCT02389998|463261881|FG000|Overall Study|car accident|1|||
128716973|NCT02389998|463261882|FG001|Overall Study|car accident|0|||
128716974|NCT02150954|463261887|FG000|Overall Study|Protocol Violation|1|||
128716975|NCT02150954|463261888|FG001|Overall Study|Protocol Violation|0|||
128716976|NCT03814746|463261889|FG000|Overall Study|Participant decision|9|||
128716977|NCT03814746|463261890|FG001|Overall Study|Participant decision|6|||
128716978|NCT03814746|463261891|FG002|Overall Study|Participant decision|15|||
128716979|NCT03814746|463261889|FG000|Overall Study|Physician Decision|2|||
128716980|NCT03814746|463261890|FG001|Overall Study|Physician Decision|2|||
128716981|NCT03814746|463261891|FG002|Overall Study|Physician Decision|4|||
128716982|NCT03814746|463261889|FG000|Overall Study|Death|2|||
128716983|NCT03814746|463261890|FG001|Overall Study|Death|2|||
128716984|NCT03814746|463261891|FG002|Overall Study|Death|2|||
128716985|NCT03814746|463261889|FG000|Overall Study|Adverse Event|2|||
128716986|NCT03814746|463261890|FG001|Overall Study|Adverse Event|2|||
128716987|NCT03814746|463261891|FG002|Overall Study|Adverse Event|1|||
128716988|NCT03814746|463261889|FG000|Overall Study|Lost to Follow-up|2|||
128716989|NCT03814746|463261890|FG001|Overall Study|Lost to Follow-up|1|||
128716990|NCT03814746|463261891|FG002|Overall Study|Lost to Follow-up|2|||
128716991|NCT03814746|463261889|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128716992|NCT03814746|463261890|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128716993|NCT03814746|463261891|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
128716994|NCT03814746|463261889|FG000|Overall Study|Pregnancy|0|||
128716995|NCT03814746|463261890|FG001|Overall Study|Pregnancy|1|||
128716996|NCT03814746|463261891|FG002|Overall Study|Pregnancy|1|||
128716997|NCT03814746|463261889|FG000|Overall Study|Protocol Violation|1|||
128716998|NCT03814746|463261890|FG001|Overall Study|Protocol Violation|0|||
128716999|NCT03814746|463261891|FG002|Overall Study|Protocol Violation|0|||
128717000|NCT00518323|463261894|FG000|Overall Study|Lack of Efficacy|14|||
128717001|NCT00518323|463261895|FG001|Overall Study|Lack of Efficacy|2|||
128717002|NCT00518323|463261896|FG002|Overall Study|Lack of Efficacy|4|||
128717003|NCT00518323|463261897|FG003|Overall Study|Lack of Efficacy|20|||
128717004|NCT00518323|463261894|FG000|Overall Study|Withdrawal by Subject|1|||
128717005|NCT00518323|463261895|FG001|Overall Study|Withdrawal by Subject|2|||
128717006|NCT00518323|463261896|FG002|Overall Study|Withdrawal by Subject|4|||
128717007|NCT00518323|463261897|FG003|Overall Study|Withdrawal by Subject|2|||
128717008|NCT00518323|463261894|FG000|Overall Study|Lost to Follow-up|0|||
128717009|NCT00518323|463261895|FG001|Overall Study|Lost to Follow-up|2|||
128717010|NCT00518323|463261896|FG002|Overall Study|Lost to Follow-up|1|||
128717011|NCT00518323|463261897|FG003|Overall Study|Lost to Follow-up|3|||
128717012|NCT00518323|463261894|FG000|Overall Study|Adverse Event|1|||
128717013|NCT00518323|463261895|FG001|Overall Study|Adverse Event|1|||
128717014|NCT00518323|463261896|FG002|Overall Study|Adverse Event|1|||
128717015|NCT00518323|463261897|FG003|Overall Study|Adverse Event|0|||
128717016|NCT00518323|463261894|FG000|Overall Study|Prohibited medication and others|3|||
128717017|NCT00518323|463261895|FG001|Overall Study|Prohibited medication and others|1|||
128717018|NCT00518323|463261896|FG002|Overall Study|Prohibited medication and others|1|||
128717019|NCT00518323|463261897|FG003|Overall Study|Prohibited medication and others|0|||
128717020|NCT00391274|463261898|FG000|Overall Study|Death Due to Study Disease|55|||
128717021|NCT00391274|463261899|FG001|Overall Study|Death Due to Study Disease|45|||
128717022|NCT00391274|463261898|FG000|Overall Study|Lost to Follow-up|0|||
128717023|NCT00391274|463261899|FG001|Overall Study|Lost to Follow-up|3|||
128976322|NCT00606021|464198638|FG000|Induction Phase|Death|73|||
128976323|NCT00606021|464198639|FG001|Induction Phase|Death|0|||
129132623|NCT00433290|464776726|FG001|Overall Study|Protocol Violation|2|||
128717024|NCT00391274|463261898|FG000|Overall Study|Physician Decision|4|||
128717025|NCT00391274|463261899|FG001|Overall Study|Physician Decision|2|||
128717026|NCT00391274|463261898|FG000|Overall Study|Withdrawal by Subject|0|||
128717027|NCT00391274|463261899|FG001|Overall Study|Withdrawal by Subject|3|||
128717028|NCT00391274|463261898|FG000|Overall Study|Death Due to Adverse Event|1|||
128717029|NCT00391274|463261899|FG001|Overall Study|Death Due to Adverse Event|3|||
128717030|NCT00391274|463261898|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
128717031|NCT00391274|463261899|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
128717032|NCT00391274|463261898|FG000|Overall Study|Death Not Study Related|0|||
128717033|NCT00391274|463261899|FG001|Overall Study|Death Not Study Related|1|||
128717034|NCT01519960|463261900|FG000|Overall Study|Withdrawal from the study|26|||
128976324|NCT00606021|464198640|FG002|Induction Phase|Death|0|||
128976325|NCT00606021|464198638|FG000|Induction Phase|Physician Decision|2|||
128976326|NCT00606021|464198639|FG001|Induction Phase|Physician Decision|0|||
128976327|NCT00606021|464198640|FG002|Induction Phase|Physician Decision|0|||
128976328|NCT00606021|464198638|FG000|Induction Phase|Withdrawal by Subject|2|||
128976329|NCT00606021|464198639|FG001|Induction Phase|Withdrawal by Subject|0|||
128976330|NCT00606021|464198640|FG002|Induction Phase|Withdrawal by Subject|0|||
128976331|NCT00606021|464198638|FG000|Induction Phase|Lost to Follow-up|10|||
128976332|NCT00606021|464198639|FG001|Induction Phase|Lost to Follow-up|0|||
128976333|NCT00606021|464198640|FG002|Induction Phase|Lost to Follow-up|0|||
128976334|NCT00606021|464198638|FG000|Maintenance Phase|Death|0|||
128976335|NCT00606021|464198639|FG001|Maintenance Phase|Death|17|||
128976336|NCT00606021|464198640|FG002|Maintenance Phase|Death|15|||
128976337|NCT00606021|464198638|FG000|Maintenance Phase|Physician Decision|0|||
128976338|NCT00606021|464198639|FG001|Maintenance Phase|Physician Decision|1|||
128976339|NCT00606021|464198640|FG002|Maintenance Phase|Physician Decision|0|||
128976340|NCT00606021|464198638|FG000|Maintenance Phase|Lost to Follow-up|0|||
128976341|NCT00606021|464198639|FG001|Maintenance Phase|Lost to Follow-up|5|||
128976342|NCT00606021|464198640|FG002|Maintenance Phase|Lost to Follow-up|2|||
128976343|NCT00392210|464198641|FG000|First Voiding Trial|Physician Decision|2|||
128976344|NCT00392210|464198642|FG001|First Voiding Trial|Physician Decision|2|||
128976345|NCT02067104|464198643|FG000|Overall Study|Study termination due to low accrual|4|||
128976346|NCT02067104|464198644|FG001|Overall Study|Study termination due to low accrual|5|||
128976347|NCT04815291|464198656|FG000|Overall Study|Lost to Follow-up|1|||
128976348|NCT04815291|464198656|FG000|Overall Study|Physician Decision|4|||
128976349|NCT04815291|464198656|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
128976350|NCT02140762|464198657|FG000|Overall Study|Adverse Event|1|||
128976351|NCT02140762|464198658|FG001|Overall Study|Adverse Event|1|||
129039335|NCT01557920|464435351|FG000|Overall Study|Withdrawal by Subject|2|||
129039336|NCT01557920|464435352|FG001|Overall Study|Withdrawal by Subject|3|||
128717035|NCT01519960|463261901|FG001|Overall Study|Withdrawal from the study|22|||
128717036|NCT01519960|463261902|FG002|Overall Study|Withdrawal from the study|5|||
128717037|NCT01387347|463261903|FG000|Overall Study|Lost to Follow-up|2|||
128717038|NCT01387347|463261904|FG001|Overall Study|Lost to Follow-up|1|||
128717039|NCT00561080|463261907|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
128717040|NCT00561080|463261908|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
128717041|NCT00561080|463261909|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
128717042|NCT00561080|463261907|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
128717043|NCT00561080|463261908|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
128717044|NCT00561080|463261909|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
128717045|NCT00561080|463261907|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
128717046|NCT00561080|463261908|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
128717047|NCT00561080|463261909|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
128717048|NCT00561080|463261907|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
128717049|NCT00561080|463261908|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
128717050|NCT00561080|463261909|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
128717051|NCT00561080|463261907|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
128717052|NCT00561080|463261908|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
128717053|NCT00561080|463261909|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
128717054|NCT00561080|463261907|FG000|Vaccination Period (up to Month 4)|Other|0|||
128717055|NCT00561080|463261908|FG001|Vaccination Period (up to Month 4)|Other|2|||
128717056|NCT00561080|463261909|FG002|Vaccination Period (up to Month 4)|Other|1|||
128717057|NCT00561080|463261907|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
128717058|NCT00561080|463261908|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
128717059|NCT00561080|463261909|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
128717060|NCT00561080|463261907|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
128717061|NCT00561080|463261908|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
128976352|NCT02140762|464198657|FG000|Overall Study|Lost to Follow-up|9|||
129039337|NCT01557920|464435351|FG000|Overall Study|Lack of Efficacy|1|||
129039338|NCT01557920|464435352|FG001|Overall Study|Lack of Efficacy|0|||
129039339|NCT02075606|464435355|FG000|Overall Study|Adverse Event|5|||
129039340|NCT02075606|464435355|FG000|Overall Study|Withdrawal by Subject|1|||
129039341|NCT02075606|464435355|FG000|Overall Study|Death|1|||
129039342|NCT02075606|464435355|FG000|Overall Study|Investigator's decision|1|||
129039343|NCT02075606|464435355|FG000|Overall Study|Symptom management|1|||
129039344|NCT02075606|464435355|FG000|Overall Study|Increasing Symptoms|1|||
128717062|NCT00561080|463261909|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
128717063|NCT00561080|463261907|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
128976353|NCT02140762|464198658|FG001|Overall Study|Lost to Follow-up|5|||
128976354|NCT02140762|464198657|FG000|Overall Study|Protocol Violation|1|||
128976355|NCT02140762|464198658|FG001|Overall Study|Protocol Violation|1|||
128976356|NCT02140762|464198657|FG000|Overall Study|Withdrawal by Subject|6|||
128976357|NCT02140762|464198658|FG001|Overall Study|Withdrawal by Subject|4|||
129039345|NCT02310763|464435360|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
129039346|NCT02310763|464435361|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
129039347|NCT02310763|464435362|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
128717064|NCT00561080|463261908|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
128717065|NCT00561080|463261909|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
128717066|NCT00561080|463261907|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
128717067|NCT00561080|463261908|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
128717068|NCT00561080|463261909|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
128717069|NCT05778786|463261919|FG000|Period 1|COVID-19 Related|3|||
128717070|NCT05778786|463261920|FG001|Period 1|COVID-19 Related|3|||
128717071|NCT05778786|463261919|FG000|Period 1|Withdrew Consent during Study|1|||
128717072|NCT05778786|463261920|FG001|Period 1|Withdrew Consent during Study|0|||
128717073|NCT05778786|463261919|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
128717074|NCT05778786|463261920|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
128717075|NCT05778786|463261919|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
128717076|NCT05778786|463261920|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
128717077|NCT01602380|463261921|FG000|Overall Study|Death|147|||
128717078|NCT01602380|463261922|FG001|Overall Study|Death|145|||
128717079|NCT01602380|463261921|FG000|Overall Study|Withdrawal by Subject|39|||
128717080|NCT01602380|463261922|FG001|Overall Study|Withdrawal by Subject|41|||
128717081|NCT01602380|463261921|FG000|Overall Study|Lost to Follow-up|15|||
128717082|NCT01602380|463261922|FG001|Overall Study|Lost to Follow-up|12|||
128717083|NCT01602380|463261921|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
128717084|NCT01602380|463261922|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
128717085|NCT01602380|463261921|FG000|Overall Study|Other|2|||
128717086|NCT01602380|463261922|FG001|Overall Study|Other|0|||
128717087|NCT03658538|463261924|FG000|Overall Study|Death|2|||
128717088|NCT03658538|463261925|FG001|Overall Study|Death|1|||
128717089|NCT03658538|463261924|FG000|Overall Study|Cancer diagnosis|1|||
129039348|NCT02310763|464435360|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
128717090|NCT03658538|463261925|FG001|Overall Study|Cancer diagnosis|0|||
129039349|NCT02310763|464435361|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
129039350|NCT02310763|464435362|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
129039351|NCT02310763|464435360|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
129039352|NCT02310763|464435361|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
129039353|NCT02310763|464435362|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
129039354|NCT02310763|464435360|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
129039355|NCT02310763|464435361|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
129039356|NCT02310763|464435362|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
129039357|NCT02310763|464435360|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
129039358|NCT02310763|464435361|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
129039359|NCT02310763|464435362|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
129039360|NCT01731886|464435368|FG000|Overall Study|Death|1|||
129039361|NCT01731886|464435369|FG001|Overall Study|Death|0|||
129039362|NCT01731886|464435368|FG000|Overall Study|Never started treatment|0|||
129039363|NCT01731886|464435369|FG001|Overall Study|Never started treatment|1|||
129039364|NCT01731886|464435368|FG000|Overall Study|Non-compliant|1|||
129039365|NCT01731886|464435369|FG001|Overall Study|Non-compliant|0|||
129039366|NCT00271024|464435370|FG000|Overall Study|Lost Interest|3|||
129039367|NCT00271024|464435371|FG001|Overall Study|Lost Interest|4|||
129039368|NCT00271024|464435372|FG002|Overall Study|Lost Interest|2|||
129039369|NCT00271024|464435373|FG003|Overall Study|Lost Interest|3|||
129039370|NCT00271024|464435370|FG000|Overall Study|Unknown/Unspecified|11|||
129039371|NCT00271024|464435371|FG001|Overall Study|Unknown/Unspecified|11|||
129039372|NCT00271024|464435372|FG002|Overall Study|Unknown/Unspecified|8|||
129039373|NCT00271024|464435373|FG003|Overall Study|Unknown/Unspecified|4|||
129039374|NCT00271024|464435370|FG000|Overall Study|Protocol Violation|1|||
129039375|NCT00271024|464435371|FG001|Overall Study|Protocol Violation|6|||
129039376|NCT00271024|464435372|FG002|Overall Study|Protocol Violation|5|||
129039377|NCT00271024|464435373|FG003|Overall Study|Protocol Violation|11|||
129039378|NCT00271024|464435370|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
129039379|NCT00271024|464435371|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
129039380|NCT00271024|464435372|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
129039381|NCT00271024|464435373|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
129039382|NCT00271024|464435370|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
129039383|NCT00271024|464435371|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
129039384|NCT00271024|464435372|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
129039385|NCT00271024|464435373|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
129039386|NCT01040793|464435374|FG000|Overall Study|Adverse Event|5|||
129039387|NCT01040793|464435375|FG001|Overall Study|Adverse Event|3|||
129039388|NCT01040793|464435376|FG002|Overall Study|Adverse Event|0|||
128717091|NCT03658538|463261924|FG000|Overall Study|Change residence|1|||
128717092|NCT03658538|463261925|FG001|Overall Study|Change residence|2|||
128717093|NCT03658538|463261924|FG000|Overall Study|Lost to Follow-up|3|||
128717094|NCT03658538|463261925|FG001|Overall Study|Lost to Follow-up|3|||
128717095|NCT03658538|463261924|FG000|Overall Study|Unblinded|2|||
128717096|NCT03658538|463261925|FG001|Overall Study|Unblinded|3|||
128717097|NCT03658538|463261924|FG000|Overall Study|Physician Decision|0|||
128717098|NCT03658538|463261925|FG001|Overall Study|Physician Decision|1|||
128717099|NCT03658538|463261924|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
128717100|NCT03658538|463261925|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
128717101|NCT03658538|463261924|FG000|Overall Study|Evicted from home|1|||
128717102|NCT03658538|463261925|FG001|Overall Study|Evicted from home|0|||
128717103|NCT01064401|463261926|FG000|Overall Study|Adverse Event|47|||
128717104|NCT01064401|463261927|FG001|Overall Study|Adverse Event|56|||
128717105|NCT01064401|463261926|FG000|Overall Study|Lack of Efficacy|46|||
128717106|NCT01064401|463261927|FG001|Overall Study|Lack of Efficacy|23|||
128717107|NCT01064401|463261926|FG000|Overall Study|Lost to Follow-up|12|||
128717108|NCT01064401|463261927|FG001|Overall Study|Lost to Follow-up|9|||
128717109|NCT01064401|463261926|FG000|Overall Study|Consent Withdrawn|98|||
128717110|NCT01064401|463261927|FG001|Overall Study|Consent Withdrawn|80|||
128717111|NCT01064401|463261926|FG000|Overall Study|Investigator Decision|4|||
128717112|NCT01064401|463261927|FG001|Overall Study|Investigator Decision|6|||
128717113|NCT01064401|463261926|FG000|Overall Study|Death|4|||
128717114|NCT01064401|463261927|FG001|Overall Study|Death|0|||
128717115|NCT01064401|463261926|FG000|Overall Study|Pregnancy|4|||
128717116|NCT01064401|463261927|FG001|Overall Study|Pregnancy|7|||
128717117|NCT01064401|463261926|FG000|Overall Study|Noncompliance|7|||
128717118|NCT01064401|463261927|FG001|Overall Study|Noncompliance|8|||
128717119|NCT01064401|463261926|FG000|Overall Study|Site Closure|4|||
128717120|NCT01064401|463261927|FG001|Overall Study|Site Closure|5|||
128717121|NCT01064401|463261926|FG000|Overall Study|Other|2|||
128717122|NCT01064401|463261927|FG001|Overall Study|Other|1|||
128717123|NCT03158051|463261928|FG000|Overall Study|Lost to Follow-up|41|||
128717124|NCT03158051|463261929|FG001|Overall Study|Lost to Follow-up|47|||
128717125|NCT03158051|463261928|FG000|Overall Study|Physician Decision|6|||
128717126|NCT03158051|463261929|FG001|Overall Study|Physician Decision|7|||
128717127|NCT03158051|463261928|FG000|Overall Study|Withdrawal by Subject|24|||
128717128|NCT03158051|463261929|FG001|Overall Study|Withdrawal by Subject|15|||
128717129|NCT03158051|463261928|FG000|Overall Study|Death|0|||
128717130|NCT03158051|463261929|FG001|Overall Study|Death|1|||
128717131|NCT02738151|463261930|FG000|Overall Study|Randomized but not treated|4|||
128717132|NCT02738151|463261931|FG001|Overall Study|Randomized but not treated|1|||
128717133|NCT02738151|463261930|FG000|Overall Study|Adverse Event|4|||
128717134|NCT02738151|463261931|FG001|Overall Study|Adverse Event|5|||
128717135|NCT02738151|463261930|FG000|Overall Study|Hypoglycemia|0|||
128717136|NCT02738151|463261931|FG001|Overall Study|Hypoglycemia|1|||
128717137|NCT02738151|463261930|FG000|Overall Study|Poor Compliance to Protocol|4|||
128717138|NCT02738151|463261931|FG001|Overall Study|Poor Compliance to Protocol|3|||
128717139|NCT02738151|463261930|FG000|Overall Study|Other than specified above|11|||
128717140|NCT02738151|463261931|FG001|Overall Study|Other than specified above|21|||
129039389|NCT01040793|464435377|FG003|Overall Study|Adverse Event|2|||
129039390|NCT01040793|464435378|FG004|Overall Study|Adverse Event|2|||
129039391|NCT01040793|464435379|FG005|Overall Study|Adverse Event|1|||
129039392|NCT01040793|464435374|FG000|Overall Study|Protocol Violation|1|||
129039393|NCT01040793|464435375|FG001|Overall Study|Protocol Violation|1|||
129039394|NCT01040793|464435376|FG002|Overall Study|Protocol Violation|1|||
129039395|NCT01040793|464435377|FG003|Overall Study|Protocol Violation|0|||
129039396|NCT01040793|464435378|FG004|Overall Study|Protocol Violation|1|||
129039397|NCT01040793|464435379|FG005|Overall Study|Protocol Violation|0|||
129039398|NCT01040793|464435374|FG000|Overall Study|Lost to Follow-up|0|||
129039399|NCT01040793|464435375|FG001|Overall Study|Lost to Follow-up|1|||
129039400|NCT01040793|464435376|FG002|Overall Study|Lost to Follow-up|1|||
129039401|NCT01040793|464435377|FG003|Overall Study|Lost to Follow-up|0|||
129132624|NCT00433290|464776725|FG000|Overall Study|Physician Decision|2|||
129132625|NCT00433290|464776726|FG001|Overall Study|Physician Decision|0|||
129132626|NCT00433290|464776725|FG000|Overall Study|Entry Criteria Not Met|0|||
129132627|NCT00433290|464776726|FG001|Overall Study|Entry Criteria Not Met|1|||
129132628|NCT00433290|464776725|FG000|Overall Study|Lost to Follow-up|1|||
129132629|NCT00433290|464776726|FG001|Overall Study|Lost to Follow-up|0|||
129132630|NCT01483651|464776727|FG000|Overall Study|Withdrawal by Subject|0|||
129132631|NCT01483651|464776728|FG001|Overall Study|Withdrawal by Subject|1|||
129132632|NCT01483651|464776729|FG002|Overall Study|Withdrawal by Subject|1|||
128717141|NCT02005250|463261932|FG000|Overall Study|Lost to Follow-up|15|||
128717142|NCT02005250|463261933|FG001|Overall Study|Lost to Follow-up|5|||
128717143|NCT02588833|463261934|FG000|Part 1|Withdrawal by Subject|1|||
128717144|NCT02588833|463261935|FG001|Part 1|Withdrawal by Subject|0|||
128717145|NCT02588833|463261934|FG000|Part 2A|Physician Decision|0|||
128717146|NCT02588833|463261935|FG001|Part 2A|Physician Decision|1|||
128717147|NCT02588833|463261934|FG000|Part 2A|Withdrawal by Subject|0|||
128717148|NCT02588833|463261935|FG001|Part 2A|Withdrawal by Subject|1|||
128717149|NCT02588833|463261934|FG000|Part 2B|Adverse Event|0|||
129039402|NCT01040793|464435378|FG004|Overall Study|Lost to Follow-up|0|||
129039403|NCT01040793|464435379|FG005|Overall Study|Lost to Follow-up|0|||
129039404|NCT01040793|464435374|FG000|Overall Study|Withdrawal by Subject|0|||
128717150|NCT02588833|463261935|FG001|Part 2B|Adverse Event|1|||
128717151|NCT02588833|463261934|FG000|Part 2C|Adverse Event|0|||
129039405|NCT01040793|464435375|FG001|Overall Study|Withdrawal by Subject|0|||
129039406|NCT01040793|464435376|FG002|Overall Study|Withdrawal by Subject|0|||
129039407|NCT01040793|464435377|FG003|Overall Study|Withdrawal by Subject|2|||
129039408|NCT01040793|464435378|FG004|Overall Study|Withdrawal by Subject|0|||
129039409|NCT01040793|464435379|FG005|Overall Study|Withdrawal by Subject|0|||
129039410|NCT01040793|464435374|FG000|Overall Study|Other reasons not listed above|0|||
129039411|NCT01040793|464435375|FG001|Overall Study|Other reasons not listed above|0|||
129039412|NCT01040793|464435376|FG002|Overall Study|Other reasons not listed above|1|||
129039413|NCT01040793|464435377|FG003|Overall Study|Other reasons not listed above|0|||
129039414|NCT01040793|464435378|FG004|Overall Study|Other reasons not listed above|1|||
129039415|NCT01040793|464435379|FG005|Overall Study|Other reasons not listed above|0|||
129221929|NCT00114517|465113377|FG003|Overall Study|Too busy|2|||
129221930|NCT00114517|465113374|FG000|Overall Study|Moved from area|0|||
129221931|NCT00114517|465113375|FG001|Overall Study|Moved from area|3|||
129221932|NCT00114517|465113376|FG002|Overall Study|Moved from area|2|||
129221933|NCT00114517|465113377|FG003|Overall Study|Moved from area|1|||
129221934|NCT00114517|465113374|FG000|Overall Study|Did not want estradiol|1|||
129221935|NCT00114517|465113375|FG001|Overall Study|Did not want estradiol|1|||
129221936|NCT00114517|465113376|FG002|Overall Study|Did not want estradiol|0|||
129221937|NCT00114517|465113377|FG003|Overall Study|Did not want estradiol|0|||
129221938|NCT00114517|465113374|FG000|Overall Study|Armed-services duty|0|||
129221939|NCT00114517|465113375|FG001|Overall Study|Armed-services duty|1|||
129221940|NCT00114517|465113376|FG002|Overall Study|Armed-services duty|0|||
129221941|NCT00114517|465113377|FG003|Overall Study|Armed-services duty|1|||
129221942|NCT00114517|465113374|FG000|Overall Study|Competing family issue|0|||
129221943|NCT00114517|465113375|FG001|Overall Study|Competing family issue|1|||
129221944|NCT00114517|465113376|FG002|Overall Study|Competing family issue|0|||
129221945|NCT00114517|465113377|FG003|Overall Study|Competing family issue|1|||
129221946|NCT00114517|465113374|FG000|Overall Study|Physician Decision|0|||
129221947|NCT00114517|465113375|FG001|Overall Study|Physician Decision|1|||
129221948|NCT00114517|465113376|FG002|Overall Study|Physician Decision|0|||
129039416|NCT00939627|464435388|FG000|Overall Study|Disease Progression|16|||
129039417|NCT00939627|464435389|FG001|Overall Study|Disease Progression|12|||
129039418|NCT00939627|464435390|FG002|Overall Study|Disease Progression|0|||
129039419|NCT00939627|464435388|FG000|Overall Study|Adverse Event|6|||
129039420|NCT00939627|464435389|FG001|Overall Study|Adverse Event|7|||
129039421|NCT00939627|464435390|FG002|Overall Study|Adverse Event|0|||
129039422|NCT00939627|464435388|FG000|Overall Study|Death|0|||
129039423|NCT00939627|464435389|FG001|Overall Study|Death|2|||
129132633|NCT01483651|464776730|FG003|Overall Study|Withdrawal by Subject|0|||
129132634|NCT01483651|464776731|FG004|Overall Study|Withdrawal by Subject|0|||
129132635|NCT01483651|464776732|FG005|Overall Study|Withdrawal by Subject|1|||
129132636|NCT00504309|464776742|FG000|Overall Study|Death|0|||
129132637|NCT00504309|464776743|FG001|Overall Study|Death|0|||
129132638|NCT00504309|464776744|FG002|Overall Study|Death|0|||
129132639|NCT00504309|464776745|FG003|Overall Study|Death|0|||
129132640|NCT00504309|464776746|FG004|Overall Study|Death|1|||
129132641|NCT00504309|464776747|FG005|Overall Study|Death|0|||
129132642|NCT00504309|464776742|FG000|Overall Study|Withdrawal by Subject|0|||
129132643|NCT00504309|464776743|FG001|Overall Study|Withdrawal by Subject|0|||
129132644|NCT00504309|464776744|FG002|Overall Study|Withdrawal by Subject|1|||
129132645|NCT00504309|464776745|FG003|Overall Study|Withdrawal by Subject|0|||
129132646|NCT00504309|464776746|FG004|Overall Study|Withdrawal by Subject|0|||
129132647|NCT00504309|464776747|FG005|Overall Study|Withdrawal by Subject|0|||
129132648|NCT03345095|464776748|FG000|Overall Study|Lack of Efficacy|184|||
129132649|NCT03345095|464776749|FG001|Overall Study|Lack of Efficacy|156|||
129132650|NCT03345095|464776748|FG000|Overall Study|Adverse Event|36|||
129132651|NCT03345095|464776749|FG001|Overall Study|Adverse Event|118|||
129039424|NCT00939627|464435390|FG002|Overall Study|Death|0|||
129039425|NCT00939627|464435388|FG000|Overall Study|Withdrawal by Subject|2|||
129039426|NCT00939627|464435389|FG001|Overall Study|Withdrawal by Subject|4|||
129039427|NCT00939627|464435390|FG002|Overall Study|Withdrawal by Subject|0|||
129039428|NCT00939627|464435388|FG000|Overall Study|Other complicating disease|1|||
129132652|NCT03345095|464776748|FG000|Overall Study|Withdrawal by Subject|22|||
129132653|NCT03345095|464776749|FG001|Overall Study|Withdrawal by Subject|59|||
129132654|NCT03345095|464776748|FG000|Overall Study|Physician Decision|3|||
129132655|NCT03345095|464776749|FG001|Overall Study|Physician Decision|18|||
129039429|NCT00939627|464435389|FG001|Overall Study|Other complicating disease|1|||
129039430|NCT00939627|464435390|FG002|Overall Study|Other complicating disease|0|||
129039431|NCT00939627|464435388|FG000|Overall Study|Not compliant|2|||
129039432|NCT00939627|464435389|FG001|Overall Study|Not compliant|0|||
129132656|NCT03345095|464776748|FG000|Overall Study|Death|2|||
129132657|NCT03345095|464776749|FG001|Overall Study|Death|4|||
129221949|NCT00114517|465113377|FG003|Overall Study|Physician Decision|0|||
129221950|NCT00114517|465113374|FG000|Overall Study|Lost interest|0|||
129221951|NCT00114517|465113375|FG001|Overall Study|Lost interest|0|||
129221952|NCT00114517|465113376|FG002|Overall Study|Lost interest|1|||
129221953|NCT00114517|465113377|FG003|Overall Study|Lost interest|0|||
129221954|NCT00114517|465113374|FG000|Overall Study|Weight increase|0|||
128976358|NCT02140762|464198657|FG000|Overall Study|Other|0|||
128976359|NCT02140762|464198658|FG001|Overall Study|Other|1|||
129132658|NCT03345095|464776748|FG000|Overall Study|Other reasons|2|||
129132659|NCT03345095|464776749|FG001|Overall Study|Other reasons|11|||
129132660|NCT03345095|464776748|FG000|Overall Study|Protocol Violation|0|||
129132661|NCT03345095|464776749|FG001|Overall Study|Protocol Violation|1|||
129132662|NCT01121575|464776750|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
129132663|NCT01121575|464776751|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
129132664|NCT01121575|464776752|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
129132665|NCT01121575|464776753|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
129132666|NCT01121575|464776754|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
129132667|NCT01121575|464776755|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
129132668|NCT01121575|464776750|FG000|Overall Study|Unspecified Reasons|8|||
129132669|NCT01121575|464776751|FG001|Overall Study|Unspecified Reasons|6|||
129132670|NCT01121575|464776752|FG002|Overall Study|Unspecified Reasons|7|||
129132671|NCT01121575|464776753|FG003|Overall Study|Unspecified Reasons|5|||
129132672|NCT01121575|464776754|FG004|Overall Study|Unspecified Reasons|13|||
129132673|NCT01121575|464776755|FG005|Overall Study|Unspecified Reasons|10|||
129132674|NCT01121575|464776750|FG000|Overall Study|Death|6|||
129132675|NCT01121575|464776751|FG001|Overall Study|Death|0|||
129132676|NCT01121575|464776752|FG002|Overall Study|Death|0|||
129132677|NCT01121575|464776753|FG003|Overall Study|Death|1|||
129132678|NCT01121575|464776754|FG004|Overall Study|Death|7|||
129132679|NCT01121575|464776755|FG005|Overall Study|Death|1|||
129132680|NCT00724503|464776757|FG000|Overall Study|Lost to Follow-up|4|||
129132681|NCT00724503|464776758|FG001|Overall Study|Lost to Follow-up|8|||
129132682|NCT00724503|464776757|FG000|Overall Study|Withdrawal by Subject|11|||
129132683|NCT00724503|464776758|FG001|Overall Study|Withdrawal by Subject|23|||
129132684|NCT00724503|464776757|FG000|Overall Study|Death|190|||
129132685|NCT00724503|464776758|FG001|Overall Study|Death|182|||
129132686|NCT00724503|464776757|FG000|Overall Study|Adverse Event|1|||
129132687|NCT00724503|464776758|FG001|Overall Study|Adverse Event|0|||
129132688|NCT00724503|464776757|FG000|Overall Study|Not otherwise specified|4|||
129132689|NCT00724503|464776758|FG001|Overall Study|Not otherwise specified|7|||
129132690|NCT01186419|464776761|FG000|Overall Study|Withdrawal by Subject|5|||
129132691|NCT01186419|464776762|FG001|Overall Study|Withdrawal by Subject|3|||
129132692|NCT01186419|464776761|FG000|Overall Study|Adverse Event|1|||
129132693|NCT01186419|464776762|FG001|Overall Study|Adverse Event|2|||
129132694|NCT01186419|464776761|FG000|Overall Study|Physician Decision|0|||
129132695|NCT01186419|464776762|FG001|Overall Study|Physician Decision|3|||
129132696|NCT01186419|464776761|FG000|Overall Study|Other|1|||
129132697|NCT01186419|464776762|FG001|Overall Study|Other|1|||
129132698|NCT01560416|464776766|FG000|Randomized Phase|Crossover Participants|7|||
129132699|NCT01560416|464776767|FG001|Randomized Phase|Crossover Participants|0|||
129132700|NCT00088881|464778490|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
129132701|NCT00088881|464778490|FG000|Step 1 - R-CHOP|Adverse Event|1|||
129132702|NCT00088881|464778490|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
129132703|NCT00088881|464778490|FG000|Step 1 - R-CHOP|Physician Decision|1|||
129132704|NCT00088881|464778490|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
129132705|NCT00088881|464778490|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
129132706|NCT00088881|464778490|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
129132707|NCT01631188|464778496|FG000|Overall Study|Physician Decision|75|||
129132708|NCT00835978|464778497|FG000|Overall Study|Death|33|||
129132709|NCT00835978|464778498|FG001|Overall Study|Death|40|||
129132710|NCT00835978|464778499|FG002|Overall Study|Death|49|||
129132711|NCT00835978|464778500|FG003|Overall Study|Death|4|||
129132712|NCT00835978|464778497|FG000|Overall Study|Lost to Follow-up|3|||
129132713|NCT00835978|464778498|FG001|Overall Study|Lost to Follow-up|4|||
129132714|NCT00835978|464778499|FG002|Overall Study|Lost to Follow-up|2|||
129132715|NCT00835978|464778500|FG003|Overall Study|Lost to Follow-up|1|||
129132716|NCT00835978|464778497|FG000|Overall Study|Other|5|||
129132717|NCT00835978|464778498|FG001|Overall Study|Other|1|||
129132718|NCT00835978|464778499|FG002|Overall Study|Other|8|||
129132719|NCT00835978|464778500|FG003|Overall Study|Other|0|||
129132720|NCT00835978|464778497|FG000|Overall Study|Objective progression or relapse|2|||
129132721|NCT00835978|464778498|FG001|Overall Study|Objective progression or relapse|0|||
129132722|NCT00835978|464778499|FG002|Overall Study|Objective progression or relapse|1|||
129132723|NCT00835978|464778500|FG003|Overall Study|Objective progression or relapse|0|||
129132724|NCT00835978|464778497|FG000|Overall Study|Adverse Event|1|||
129132725|NCT00835978|464778498|FG001|Overall Study|Adverse Event|0|||
129132726|NCT00835978|464778499|FG002|Overall Study|Adverse Event|1|||
129132727|NCT00835978|464778500|FG003|Overall Study|Adverse Event|0|||
129132728|NCT00835978|464778497|FG000|Overall Study|Withdrawal by Subject|0|||
129132729|NCT00835978|464778498|FG001|Overall Study|Withdrawal by Subject|3|||
129132730|NCT00835978|464778499|FG002|Overall Study|Withdrawal by Subject|0|||
128978134|NCT00939094|464205320|FG000|Overall Study|Abnormal ECG findings|1|||
129132731|NCT00835978|464778500|FG003|Overall Study|Withdrawal by Subject|5|||
129132732|NCT00835978|464778497|FG000|Overall Study|Study terminated by sponsor|12|||
129132733|NCT00835978|464778498|FG001|Overall Study|Study terminated by sponsor|8|||
128717152|NCT02588833|463261935|FG001|Part 2C|Adverse Event|1|||
128976360|NCT00989664|464198660|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
128976361|NCT00989664|464198660|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
128976362|NCT00989664|464198660|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
128976363|NCT00989664|464198660|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
129039433|NCT00939627|464435390|FG002|Overall Study|Not compliant|0|||
128717153|NCT02588833|463261934|FG000|Part 2C|Withdrawal by Subject|0|||
128976364|NCT00989664|464198660|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
128976365|NCT00989664|464198660|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
128976366|NCT00989664|464198660|FG000|Long-Term Follow-Up|Death|3|||
128976367|NCT00095836|464198661|FG000|Overall Study|Lost to Follow-up|1|||
128976368|NCT00095836|464198661|FG000|Overall Study|Adverse Event|1|||
128976369|NCT00095836|464198661|FG000|Overall Study|Death|2|||
128976370|NCT00962780|464198665|FG000|Overall Study|Death|0|||
128976371|NCT00962780|464198666|FG001|Overall Study|Death|1|||
128976372|NCT00962780|464198665|FG000|Overall Study|Protocol Violation|9|||
128976373|NCT00962780|464198666|FG001|Overall Study|Protocol Violation|4|||
128976374|NCT00962780|464198665|FG000|Overall Study|Withdrawal by Subject|1|||
128976375|NCT00962780|464198666|FG001|Overall Study|Withdrawal by Subject|8|||
128976376|NCT00962780|464198665|FG000|Overall Study|Other|0|||
128976377|NCT00962780|464198666|FG001|Overall Study|Other|1|||
128976378|NCT02363322|464198667|FG000|Overall Study|Lost to Follow-up|1|||
128976379|NCT02363322|464198668|FG001|Overall Study|Lost to Follow-up|0|||
128976380|NCT02055976|464198669|FG000|Overall Study|Other|0|||
128976381|NCT02055976|464198670|FG001|Overall Study|Other|0|||
128976382|NCT02055976|464198671|FG002|Overall Study|Other|1|||
128976383|NCT02055976|464198672|FG003|Overall Study|Other|0|||
128976384|NCT02055976|464198673|FG004|Overall Study|Other|0|||
128976385|NCT02055976|464198674|FG005|Overall Study|Other|0|||
128976386|NCT02055976|464198675|FG006|Overall Study|Other|0|||
128976387|NCT02055976|464198676|FG007|Overall Study|Other|0|||
128976388|NCT02055976|464198677|FG008|Overall Study|Other|0|||
128976389|NCT02055976|464198669|FG000|Overall Study|Adverse Event|0|||
128976390|NCT02055976|464198670|FG001|Overall Study|Adverse Event|0|||
128976391|NCT02055976|464198671|FG002|Overall Study|Adverse Event|0|||
128976392|NCT02055976|464198672|FG003|Overall Study|Adverse Event|0|||
128976393|NCT02055976|464198673|FG004|Overall Study|Adverse Event|0|||
128976394|NCT02055976|464198674|FG005|Overall Study|Adverse Event|1|||
128976395|NCT02055976|464198675|FG006|Overall Study|Adverse Event|1|||
128976396|NCT02055976|464198676|FG007|Overall Study|Adverse Event|0|||
128976397|NCT02055976|464198677|FG008|Overall Study|Adverse Event|0|||
128976398|NCT02055976|464198669|FG000|Overall Study|Does not meet entrance criteria|0|||
128976399|NCT02055976|464198670|FG001|Overall Study|Does not meet entrance criteria|0|||
128976400|NCT02055976|464198671|FG002|Overall Study|Does not meet entrance criteria|0|||
128976401|NCT02055976|464198672|FG003|Overall Study|Does not meet entrance criteria|0|||
128976402|NCT02055976|464198673|FG004|Overall Study|Does not meet entrance criteria|0|||
128976403|NCT02055976|464198674|FG005|Overall Study|Does not meet entrance criteria|0|||
128976404|NCT02055976|464198675|FG006|Overall Study|Does not meet entrance criteria|1|||
128976405|NCT02055976|464198676|FG007|Overall Study|Does not meet entrance criteria|0|||
128976406|NCT02055976|464198677|FG008|Overall Study|Does not meet entrance criteria|0|||
128976407|NCT02055976|464198669|FG000|Overall Study|Lost to Follow-up|0|||
128976408|NCT02055976|464198670|FG001|Overall Study|Lost to Follow-up|0|||
128976409|NCT02055976|464198671|FG002|Overall Study|Lost to Follow-up|0|||
128976410|NCT02055976|464198672|FG003|Overall Study|Lost to Follow-up|1|||
128976411|NCT02055976|464198673|FG004|Overall Study|Lost to Follow-up|0|||
128976412|NCT02055976|464198674|FG005|Overall Study|Lost to Follow-up|0|||
128976413|NCT02055976|464198675|FG006|Overall Study|Lost to Follow-up|0|||
128976414|NCT02055976|464198676|FG007|Overall Study|Lost to Follow-up|0|||
128976415|NCT02055976|464198677|FG008|Overall Study|Lost to Follow-up|0|||
128976416|NCT01230827|464198678|FG000|Overall Study|Lost to Follow-up|0|||
128976417|NCT01230827|464198679|FG001|Overall Study|Lost to Follow-up|0|||
128976418|NCT01230827|464198680|FG002|Overall Study|Lost to Follow-up|1|||
128976419|NCT01230827|464198681|FG003|Overall Study|Lost to Follow-up|3|||
128976420|NCT01230827|464198678|FG000|Overall Study|Withdrawal by Subject|1|||
128976421|NCT01230827|464198679|FG001|Overall Study|Withdrawal by Subject|0|||
129039434|NCT00939627|464435388|FG000|Overall Study|No off-tx reason given|0|||
129039435|NCT00939627|464435389|FG001|Overall Study|No off-tx reason given|2|||
129039436|NCT00939627|464435390|FG002|Overall Study|No off-tx reason given|0|||
129039437|NCT02487082|464435391|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
129039438|NCT02487082|464435392|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
129039439|NCT02487082|464435391|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
129039440|NCT02487082|464435392|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
129039441|NCT02492841|464435393|FG000|Overall Study|Lost to Follow-up|34|||
129039442|NCT02492841|464435394|FG001|Overall Study|Lost to Follow-up|31|||
129039443|NCT02492841|464435395|FG002|Overall Study|Lost to Follow-up|35|||
129039444|NCT00104247|464435406|FG000|Overall Study|Withdrawal by Subject|1|||
129039445|NCT00104247|464435407|FG001|Overall Study|Withdrawal by Subject|0|||
128717154|NCT02588833|463261935|FG001|Part 2C|Withdrawal by Subject|1|||
128717155|NCT02588833|463261934|FG000|Part 3 (Safety Follow-up)|Other|0|||
128717156|NCT02588833|463261935|FG001|Part 3 (Safety Follow-up)|Other|2|||
128717157|NCT03188094|463261945|FG000|Overall Study|Screen failure|1|||
128717158|NCT03188094|463261946|FG001|Overall Study|Screen failure|0|||
128717159|NCT03188094|463261947|FG002|Overall Study|Screen failure|0|||
128717160|NCT03188094|463261945|FG000|Overall Study|Pregnancy|3|||
128717161|NCT03188094|463261946|FG001|Overall Study|Pregnancy|0|||
128717162|NCT03188094|463261947|FG002|Overall Study|Pregnancy|0|||
128717163|NCT03188094|463261945|FG000|Overall Study|Ineligible|1|||
128717164|NCT03188094|463261946|FG001|Overall Study|Ineligible|0|||
128717165|NCT03188094|463261947|FG002|Overall Study|Ineligible|0|||
128717166|NCT03188094|463261945|FG000|Overall Study|Lost to Follow-up|0|||
128717167|NCT03188094|463261946|FG001|Overall Study|Lost to Follow-up|0|||
128976422|NCT01230827|464198680|FG002|Overall Study|Withdrawal by Subject|3|||
128717168|NCT03188094|463261947|FG002|Overall Study|Lost to Follow-up|17|||
128717169|NCT04007094|463261948|FG000|Overall Study|Lost to Follow-up|1|||
128717170|NCT04007094|463261949|FG001|Overall Study|Lost to Follow-up|1|||
128717171|NCT02921776|463261950|FG000|Overall Study|patient deterioration, fatigue|2|||
128717172|NCT02921776|463261951|FG001|Overall Study|patient deterioration, fatigue|6|||
128717173|NCT02921776|463261952|FG002|Overall Study|patient deterioration, fatigue|0|||
128717174|NCT02921776|463261953|FG003|Overall Study|patient deterioration, fatigue|0|||
128717175|NCT02921776|463261954|FG004|Overall Study|patient deterioration, fatigue|0|||
128717176|NCT02921776|463261955|FG005|Overall Study|patient deterioration, fatigue|0|||
128717177|NCT02921776|463261956|FG006|Overall Study|patient deterioration, fatigue|0|||
128717178|NCT02921776|463261957|FG007|Overall Study|patient deterioration, fatigue|0|||
128717179|NCT02921776|463261950|FG000|Overall Study|Withdrawal by Subject|0|||
128717180|NCT02921776|463261951|FG001|Overall Study|Withdrawal by Subject|2|||
128717181|NCT02921776|463261952|FG002|Overall Study|Withdrawal by Subject|0|||
128717182|NCT02921776|463261953|FG003|Overall Study|Withdrawal by Subject|1|||
128717183|NCT02921776|463261954|FG004|Overall Study|Withdrawal by Subject|1|||
128717184|NCT02921776|463261955|FG005|Overall Study|Withdrawal by Subject|0|||
128717185|NCT02921776|463261956|FG006|Overall Study|Withdrawal by Subject|8|||
128717186|NCT02921776|463261957|FG007|Overall Study|Withdrawal by Subject|1|||
128717187|NCT02921776|463261950|FG000|Overall Study|Death|0|||
128717188|NCT02921776|463261951|FG001|Overall Study|Death|0|||
128717189|NCT02921776|463261952|FG002|Overall Study|Death|0|||
128717190|NCT02921776|463261953|FG003|Overall Study|Death|2|||
128717191|NCT02921776|463261954|FG004|Overall Study|Death|0|||
128717192|NCT02921776|463261955|FG005|Overall Study|Death|0|||
128717193|NCT02921776|463261956|FG006|Overall Study|Death|0|||
128717194|NCT02921776|463261957|FG007|Overall Study|Death|0|||
128717195|NCT02921776|463261950|FG000|Overall Study|extubation or early discharge|0|||
128717196|NCT02921776|463261951|FG001|Overall Study|extubation or early discharge|0|||
128717197|NCT02921776|463261952|FG002|Overall Study|extubation or early discharge|0|||
128717198|NCT02921776|463261953|FG003|Overall Study|extubation or early discharge|5|||
128717199|NCT02921776|463261954|FG004|Overall Study|extubation or early discharge|5|||
128717200|NCT02921776|463261955|FG005|Overall Study|extubation or early discharge|0|||
128717201|NCT02921776|463261956|FG006|Overall Study|extubation or early discharge|0|||
128717202|NCT02921776|463261957|FG007|Overall Study|extubation or early discharge|0|||
128717203|NCT02921776|463261950|FG000|Overall Study|Lost to Follow-up|0|||
128717204|NCT02921776|463261951|FG001|Overall Study|Lost to Follow-up|0|||
128717205|NCT02921776|463261952|FG002|Overall Study|Lost to Follow-up|0|||
128717206|NCT02921776|463261953|FG003|Overall Study|Lost to Follow-up|0|||
128717207|NCT02921776|463261954|FG004|Overall Study|Lost to Follow-up|0|||
128717208|NCT02921776|463261955|FG005|Overall Study|Lost to Follow-up|2|||
128717209|NCT02921776|463261956|FG006|Overall Study|Lost to Follow-up|3|||
128717210|NCT02921776|463261957|FG007|Overall Study|Lost to Follow-up|6|||
128717211|NCT02070744|463261961|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
128717212|NCT02070744|463261962|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
128717213|NCT02070744|463261963|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
128717214|NCT02070744|463261964|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
128717215|NCT02070744|463261965|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
128717216|NCT02070744|463261961|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
128774768|NCT01216293|463466661|FG001|Main Study|Other Reason Not Specified|1|||
128717217|NCT02070744|463261962|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
128717218|NCT02070744|463261963|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
128717219|NCT02070744|463261964|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
128717220|NCT02070744|463261965|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
128717221|NCT02070744|463261961|FG000|OLE Phase (48 Weeks)|Other|0|||
128717222|NCT02070744|463261962|FG001|OLE Phase (48 Weeks)|Other|0|||
128717223|NCT02070744|463261963|FG002|OLE Phase (48 Weeks)|Other|0|||
128717224|NCT02070744|463261964|FG003|OLE Phase (48 Weeks)|Other|0|||
128717225|NCT02070744|463261965|FG004|OLE Phase (48 Weeks)|Other|1|||
128976423|NCT01230827|464198681|FG003|Overall Study|Withdrawal by Subject|2|||
128976424|NCT01230827|464198678|FG000|Overall Study|Lack of Efficacy|14|||
128976425|NCT01230827|464198679|FG001|Overall Study|Lack of Efficacy|1|||
128976426|NCT01230827|464198680|FG002|Overall Study|Lack of Efficacy|2|||
128717226|NCT04199117|463261966|FG000|Overall Study|Withdrawal by Subject|3|||
128717227|NCT04199117|463261967|FG001|Overall Study|Withdrawal by Subject|0|||
128717228|NCT04199117|463261968|FG002|Overall Study|Withdrawal by Subject|0|||
128717229|NCT04199117|463261969|FG003|Overall Study|Withdrawal by Subject|1|||
128717230|NCT04199117|463261970|FG004|Overall Study|Withdrawal by Subject|1|||
128717231|NCT04199117|463261971|FG005|Overall Study|Withdrawal by Subject|0|||
128717232|NCT04199117|463261972|FG006|Overall Study|Withdrawal by Subject|0|||
128717233|NCT04199117|463261973|FG007|Overall Study|Withdrawal by Subject|2|||
128717234|NCT04199117|463261974|FG008|Overall Study|Withdrawal by Subject|0|||
128717235|NCT04199117|463261975|FG009|Overall Study|Withdrawal by Subject|0|||
128717236|NCT04199117|463261976|FG010|Overall Study|Withdrawal by Subject|1|||
128717237|NCT04199117|463261977|FG011|Overall Study|Withdrawal by Subject|1|||
128717238|NCT04199117|463261978|FG012|Overall Study|Withdrawal by Subject|2|||
128717239|NCT04199117|463261979|FG013|Overall Study|Withdrawal by Subject|1|||
128717240|NCT04199117|463261980|FG014|Overall Study|Withdrawal by Subject|1|||
128717241|NCT04199117|463261981|FG015|Overall Study|Withdrawal by Subject|1|||
128717242|NCT04199117|463261966|FG000|Overall Study|Death|1|||
128717243|NCT04199117|463261967|FG001|Overall Study|Death|1|||
128717244|NCT04199117|463261968|FG002|Overall Study|Death|0|||
128717245|NCT04199117|463261969|FG003|Overall Study|Death|0|||
128717246|NCT04199117|463261970|FG004|Overall Study|Death|0|||
128717247|NCT04199117|463261971|FG005|Overall Study|Death|0|||
128717248|NCT04199117|463261972|FG006|Overall Study|Death|0|||
128717249|NCT04199117|463261973|FG007|Overall Study|Death|0|||
128717250|NCT04199117|463261974|FG008|Overall Study|Death|0|||
128717251|NCT04199117|463261975|FG009|Overall Study|Death|0|||
128717252|NCT04199117|463261976|FG010|Overall Study|Death|0|||
128717253|NCT04199117|463261977|FG011|Overall Study|Death|1|||
128717254|NCT04199117|463261978|FG012|Overall Study|Death|0|||
128717255|NCT04199117|463261979|FG013|Overall Study|Death|1|||
128717256|NCT04199117|463261980|FG014|Overall Study|Death|0|||
128717257|NCT04199117|463261981|FG015|Overall Study|Death|0|||
128717258|NCT04199117|463261966|FG000|Overall Study|Withdrawal by PI|0|||
128717259|NCT04199117|463261967|FG001|Overall Study|Withdrawal by PI|0|||
128717260|NCT04199117|463261968|FG002|Overall Study|Withdrawal by PI|0|||
128717261|NCT04199117|463261969|FG003|Overall Study|Withdrawal by PI|0|||
128717262|NCT04199117|463261970|FG004|Overall Study|Withdrawal by PI|0|||
128717263|NCT04199117|463261971|FG005|Overall Study|Withdrawal by PI|0|||
128717264|NCT04199117|463261972|FG006|Overall Study|Withdrawal by PI|0|||
128717265|NCT04199117|463261973|FG007|Overall Study|Withdrawal by PI|0|||
128717266|NCT04199117|463261974|FG008|Overall Study|Withdrawal by PI|0|||
128976427|NCT01230827|464198681|FG003|Overall Study|Lack of Efficacy|3|||
128976428|NCT01230827|464198678|FG000|Overall Study|Adverse Event|4|||
128976429|NCT01230827|464198679|FG001|Overall Study|Adverse Event|2|||
128976430|NCT01230827|464198680|FG002|Overall Study|Adverse Event|3|||
128976431|NCT01230827|464198681|FG003|Overall Study|Adverse Event|7|||
128976432|NCT01230827|464198678|FG000|Overall Study|Recovery|0|||
128976433|NCT01230827|464198679|FG001|Overall Study|Recovery|6|||
128976434|NCT01230827|464198680|FG002|Overall Study|Recovery|0|||
128976435|NCT01230827|464198681|FG003|Overall Study|Recovery|0|||
128976436|NCT01230827|464198678|FG000|Overall Study|Study terminated by Sponsor|0|||
128976437|NCT01230827|464198679|FG001|Overall Study|Study terminated by Sponsor|2|||
128976438|NCT01230827|464198680|FG002|Overall Study|Study terminated by Sponsor|56|||
128976439|NCT01230827|464198681|FG003|Overall Study|Study terminated by Sponsor|63|||
128976440|NCT00805142|464198682|FG000|Titration Period|Adverse Event|3|||
128976441|NCT00805142|464198683|FG001|Titration Period|Adverse Event|3|||
128976442|NCT00805142|464198682|FG000|Titration Period|Lack of Efficacy|1|||
128976443|NCT00805142|464198683|FG001|Titration Period|Lack of Efficacy|1|||
128976444|NCT00805142|464198682|FG000|Titration Period|Lost to Follow-up|0|||
128976445|NCT00805142|464198683|FG001|Titration Period|Lost to Follow-up|1|||
128976446|NCT00805142|464198682|FG000|Titration Period|Disease Progression|2|||
128976447|NCT00805142|464198683|FG001|Titration Period|Disease Progression|1|||
128976448|NCT00805142|464198682|FG000|Titration Period|Withdrawal of consent|0|||
128976449|NCT00805142|464198683|FG001|Titration Period|Withdrawal of consent|1|||
128976450|NCT00805142|464198682|FG000|Titration Period|Other|0|||
128976451|NCT00805142|464198683|FG001|Titration Period|Other|3|||
128717267|NCT04199117|463261975|FG009|Overall Study|Withdrawal by PI|0|||
128717268|NCT04199117|463261976|FG010|Overall Study|Withdrawal by PI|0|||
128717269|NCT04199117|463261977|FG011|Overall Study|Withdrawal by PI|0|||
128717270|NCT04199117|463261978|FG012|Overall Study|Withdrawal by PI|1|||
128717271|NCT04199117|463261979|FG013|Overall Study|Withdrawal by PI|0|||
128717272|NCT04199117|463261980|FG014|Overall Study|Withdrawal by PI|0|||
128717273|NCT04199117|463261981|FG015|Overall Study|Withdrawal by PI|0|||
128717274|NCT00702403|463263903|FG000|From Consent to Engraftment|Progressive leukemia|6|||
128717275|NCT00702403|463263903|FG000|From Consent to Engraftment|Critically ill|2|||
128717276|NCT00702403|463263903|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
128717277|NCT00702403|463263903|FG000|From Consent to Engraftment|Myocardial infarction|1|||
128717278|NCT00702403|463263903|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
128976452|NCT00805142|464198682|FG000|Maintenance Period|Adverse Event|0|||
128976453|NCT00805142|464198683|FG001|Maintenance Period|Adverse Event|1|||
129039446|NCT00104247|464435406|FG000|Overall Study|Noncompliant with dosing|0|||
129039447|NCT00104247|464435407|FG001|Overall Study|Noncompliant with dosing|1|||
129039448|NCT01917968|464435415|FG000|Overall Study|Death|3|||
129039449|NCT01917968|464435416|FG001|Overall Study|Death|2|||
129039450|NCT01917968|464435415|FG000|Overall Study|Lost to Follow-up|21|||
129039451|NCT01917968|464435416|FG001|Overall Study|Lost to Follow-up|39|||
129039452|NCT01917968|464435415|FG000|Overall Study|Physician Decision|1|||
129039453|NCT01917968|464435416|FG001|Overall Study|Physician Decision|2|||
129039454|NCT01917968|464435415|FG000|Overall Study|Withdrawal by Subject|20|||
129039455|NCT01917968|464435416|FG001|Overall Study|Withdrawal by Subject|35|||
129039456|NCT01917968|464435415|FG000|Overall Study|Subject Relocation|5|||
129039457|NCT01917968|464435416|FG001|Overall Study|Subject Relocation|1|||
129039458|NCT01917968|464435415|FG000|Overall Study|36M Missed Visit|3|||
129039459|NCT01917968|464435416|FG001|Overall Study|36M Missed Visit|2|||
129039460|NCT01917968|464435415|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
129039461|NCT01917968|464435416|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
129039462|NCT01917968|464435415|FG000|Overall Study|Change in Family Circumstances|0|||
129039463|NCT01917968|464435416|FG001|Overall Study|Change in Family Circumstances|1|||
129039464|NCT01917968|464435415|FG000|Overall Study|No Data Available|0|||
129039465|NCT01917968|464435416|FG001|Overall Study|No Data Available|2|||
129039466|NCT01507090|464435419|FG000|Overall Study|incomplete dataset|18|||
129039467|NCT03581188|464436681|FG000|Overall Study|Inclusion criteria not met|3|||
129039468|NCT03581188|464436682|FG001|Overall Study|Inclusion criteria not met|2|||
129039469|NCT03581188|464436681|FG000|Overall Study|Lost to Follow-up|5|||
129039470|NCT03581188|464436682|FG001|Overall Study|Lost to Follow-up|5|||
129039471|NCT03581188|464436681|FG000|Overall Study|Discontinued intervention|11|||
129039472|NCT03581188|464436682|FG001|Overall Study|Discontinued intervention|8|||
129039473|NCT03064438|464436687|FG000|Overall Study|Lost to Follow-up|1|||
129039474|NCT03064438|464436688|FG001|Overall Study|Lost to Follow-up|0|||
129039475|NCT03064438|464436687|FG000|Overall Study|Withdrawal by Subject|0|||
129039476|NCT03064438|464436688|FG001|Overall Study|Withdrawal by Subject|1|||
129039477|NCT01937351|464436689|FG000|Overall Study|Withdrawal by Subject|4|||
129039478|NCT01937351|464436690|FG001|Overall Study|Withdrawal by Subject|2|||
129039479|NCT01937351|464436689|FG000|Overall Study|Death|1|||
129039480|NCT01937351|464436690|FG001|Overall Study|Death|0|||
129039481|NCT01937351|464436689|FG000|Overall Study|Not treated w device, per protocol fail|4|||
129039482|NCT01937351|464436690|FG001|Overall Study|Not treated w device, per protocol fail|0|||
129039483|NCT01961687|464436691|FG000|Overall Study|Lost to Follow-up|19|||
129039484|NCT01961687|464436691|FG000|Overall Study|Re-operation|17|||
129039485|NCT01961687|464436691|FG000|Overall Study|Death|7|||
129039486|NCT01961687|464436691|FG000|Overall Study|Withdrawal by Subject|6|||
129039487|NCT01961687|464436691|FG000|Overall Study|Adverse Event|6|||
129039488|NCT01961687|464436691|FG000|Overall Study|Moved to area without study site|2|||
129039489|NCT01961687|464436691|FG000|Overall Study|Sponsor decision|2|||
129039490|NCT01961687|464436691|FG000|Overall Study|Physician Decision|1|||
129039491|NCT01961687|464436691|FG000|Overall Study|Unable to meet follow-up requirements|1|||
129039492|NCT03919448|464436696|FG000|Overall Study|Withdrawal by Subject|1|||
128976454|NCT00805142|464198682|FG000|Maintenance Period|Other|0|||
128976455|NCT00805142|464198683|FG001|Maintenance Period|Other|1|||
128976456|NCT01021423|464198685|FG000|Overall Study|Study terminated|4|||
128976457|NCT01021423|464198686|FG001|Overall Study|Study terminated|5|||
128976458|NCT02886338|464198687|FG000|Overall Study|Withdrawal by Subject|1|||
129132734|NCT00835978|464778499|FG002|Overall Study|Study terminated by sponsor|30|||
129132735|NCT00835978|464778500|FG003|Overall Study|Study terminated by sponsor|0|||
128717279|NCT00702403|463263903|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
128717280|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
128717281|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
128717282|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Non-compliance|2|||
128717283|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
128717284|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
128717285|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Suicide|1|||
128717286|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
128976459|NCT00122317|464198688|FG000|Overall Study|Death|3|||
128717287|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
128976460|NCT00122317|464198688|FG000|Overall Study|Adverse Event|4|||
128976461|NCT00122317|464198688|FG000|Overall Study|Physician Decision|2|||
129039493|NCT03919448|464436697|FG001|Overall Study|Withdrawal by Subject|0|||
129039494|NCT03919448|464436698|FG002|Overall Study|Withdrawal by Subject|0|||
129039495|NCT03438539|464436699|FG000|Overall Study|Lost to Follow-up|8|||
129039496|NCT03438539|464436700|FG001|Overall Study|Lost to Follow-up|4|||
129039497|NCT03438539|464436701|FG002|Overall Study|Lost to Follow-up|10|||
129039498|NCT03438539|464436702|FG003|Overall Study|Lost to Follow-up|9|||
129039499|NCT03438539|464436703|FG004|Overall Study|Lost to Follow-up|3|||
128976462|NCT00122317|464198688|FG000|Overall Study|patient non-compliance|1|||
128976463|NCT00122317|464198688|FG000|Overall Study|Withdrawal by Subject|1|||
129039500|NCT03438539|464436704|FG005|Overall Study|Lost to Follow-up|8|||
129039501|NCT04213209|464436705|FG000|Overall Study|Protocol Violation|1|||
129039502|NCT04213209|464436706|FG001|Overall Study|Protocol Violation|0|||
129039503|NCT04213209|464436707|FG002|Overall Study|Protocol Violation|0|||
129039504|NCT04213209|464436708|FG003|Overall Study|Protocol Violation|0|||
129039505|NCT04213209|464436709|FG004|Overall Study|Protocol Violation|0|||
129039506|NCT04213209|464436710|FG005|Overall Study|Protocol Violation|0|||
129039507|NCT00483548|464436715|FG000|Overall Study|Randomized; not treated with study drug|1|||
129039508|NCT00483548|464436716|FG001|Overall Study|Randomized; not treated with study drug|3|||
129039509|NCT00483548|464436715|FG000|Overall Study|Adverse Event|25|||
129039510|NCT00483548|464436716|FG001|Overall Study|Adverse Event|14|||
129039511|NCT00483548|464436715|FG000|Overall Study|Laboratory abnormality|1|||
129039512|NCT00483548|464436716|FG001|Overall Study|Laboratory abnormality|2|||
129039513|NCT00483548|464436715|FG000|Overall Study|Lack of Efficacy|4|||
129039514|NCT00483548|464436716|FG001|Overall Study|Lack of Efficacy|8|||
129039515|NCT00483548|464436715|FG000|Overall Study|Protocol Violation|11|||
129039516|NCT00483548|464436716|FG001|Overall Study|Protocol Violation|7|||
129039517|NCT00483548|464436715|FG000|Overall Study|Pregnancy|1|||
129039518|NCT00483548|464436716|FG001|Overall Study|Pregnancy|0|||
129039519|NCT00483548|464436715|FG000|Overall Study|Protocol required discontinuation|6|||
129039520|NCT00483548|464436716|FG001|Overall Study|Protocol required discontinuation|6|||
129039521|NCT00483548|464436715|FG000|Overall Study|Unable to comply with protocol schedule|1|||
129039522|NCT00483548|464436716|FG001|Overall Study|Unable to comply with protocol schedule|0|||
129039523|NCT00483548|464436715|FG000|Overall Study|Non-compliance with medication|2|||
129039524|NCT00483548|464436716|FG001|Overall Study|Non-compliance with medication|0|||
129039525|NCT00483548|464436715|FG000|Overall Study|Lost to Follow-up|3|||
129039526|NCT00483548|464436716|FG001|Overall Study|Lost to Follow-up|4|||
129039527|NCT00483548|464436715|FG000|Overall Study|Withdrawal by Subject|5|||
129039528|NCT00483548|464436716|FG001|Overall Study|Withdrawal by Subject|2|||
129039529|NCT00126126|464436717|FG000|Overall Study|Lost to Follow-up|0|||
129039530|NCT00126126|464436718|FG001|Overall Study|Lost to Follow-up|2|||
129039531|NCT02694549|464436719|FG000|Overall Study|screen failures|2|||
129039532|NCT01534078|464436720|FG000|Overall Study|Death|1|||
129039533|NCT01534078|464436720|FG000|Overall Study|Withdrawal by Subject|1|||
129039534|NCT02459665|464436721|FG000|Overall Study|Withdrawal by Subject|0|||
129039535|NCT02459665|464436722|FG001|Overall Study|Withdrawal by Subject|1|||
129039536|NCT02459665|464436723|FG002|Overall Study|Withdrawal by Subject|1|||
129039537|NCT02459665|464436724|FG003|Overall Study|Withdrawal by Subject|2|||
129039538|NCT00868296|464436728|FG000|Overall Study|Adverse Event|0|||
129039539|NCT00868296|464436729|FG001|Overall Study|Adverse Event|2|||
129039540|NCT00868296|464436728|FG000|Overall Study|Withdrawal by Subject|0|||
129039541|NCT00868296|464436729|FG001|Overall Study|Withdrawal by Subject|1|||
129039542|NCT00986570|464436734|FG000|Overall Study|Lost to Follow-up|6|||
129039543|NCT00986570|464436734|FG000|Overall Study|Potential bias for objective assessment|1|||
129039544|NCT01501110|464436735|FG000|Overall Study|Death|0|||
129039545|NCT01501110|464436736|FG001|Overall Study|Death|1|||
129039546|NCT02462486|464436741|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
129039547|NCT02462486|464436742|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
129039548|NCT02462486|464436743|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
129039549|NCT02462486|464436741|FG000|Overall Study|Adverse Event|53|||
129039550|NCT02462486|464436742|FG001|Overall Study|Adverse Event|48|||
129039551|NCT02462486|464436743|FG002|Overall Study|Adverse Event|21|||
129039552|NCT02462486|464436741|FG000|Overall Study|Lack of Efficacy|6|||
129039553|NCT02462486|464436742|FG001|Overall Study|Lack of Efficacy|12|||
129039554|NCT02462486|464436743|FG002|Overall Study|Lack of Efficacy|3|||
129039555|NCT02462486|464436741|FG000|Overall Study|Lost to Follow-up|3|||
129039556|NCT02462486|464436742|FG001|Overall Study|Lost to Follow-up|4|||
129039557|NCT02462486|464436743|FG002|Overall Study|Lost to Follow-up|2|||
129039558|NCT02462486|464436741|FG000|Overall Study|Withdrawal by Subject|25|||
129039559|NCT02462486|464436742|FG001|Overall Study|Withdrawal by Subject|22|||
129039560|NCT02462486|464436743|FG002|Overall Study|Withdrawal by Subject|19|||
129039561|NCT02462486|464436741|FG000|Overall Study|Protocol Violation|3|||
129039562|NCT02462486|464436742|FG001|Overall Study|Protocol Violation|1|||
129039563|NCT02462486|464436743|FG002|Overall Study|Protocol Violation|1|||
129039564|NCT02462486|464436741|FG000|Overall Study|Reason not Specified|3|||
129039565|NCT02462486|464436742|FG001|Overall Study|Reason not Specified|4|||
129039566|NCT02462486|464436743|FG002|Overall Study|Reason not Specified|3|||
129039567|NCT01439724|464436744|FG000|Overall Study|missing consultation|9|||
129039568|NCT01439724|464436745|FG001|Overall Study|missing consultation|8|||
129039569|NCT03877926|464436751|FG000|Overall Study|Adverse Event|1|||
129039570|NCT03877926|464436752|FG001|Overall Study|Adverse Event|0|||
129039571|NCT03877926|464436753|FG002|Overall Study|Adverse Event|0|||
129039572|NCT03877926|464436754|FG003|Overall Study|Adverse Event|0|||
129039573|NCT03877926|464436751|FG000|Overall Study|Death|2|||
129039574|NCT03877926|464436752|FG001|Overall Study|Death|2|||
129039575|NCT03877926|464436753|FG002|Overall Study|Death|2|||
129039576|NCT03877926|464436754|FG003|Overall Study|Death|0|||
129039577|NCT03877926|464436751|FG000|Overall Study|Lost to Follow-up|41|||
129039578|NCT03877926|464436752|FG001|Overall Study|Lost to Follow-up|52|||
129039579|NCT03877926|464436753|FG002|Overall Study|Lost to Follow-up|45|||
129039580|NCT03877926|464436754|FG003|Overall Study|Lost to Follow-up|17|||
129039581|NCT03877926|464436751|FG000|Overall Study|Physician Decision|2|||
129039582|NCT03877926|464436752|FG001|Overall Study|Physician Decision|0|||
129039583|NCT03877926|464436753|FG002|Overall Study|Physician Decision|2|||
129039584|NCT03877926|464436754|FG003|Overall Study|Physician Decision|0|||
129039585|NCT03877926|464436751|FG000|Overall Study|Withdrawal by Subject|18|||
129039586|NCT03877926|464436752|FG001|Overall Study|Withdrawal by Subject|21|||
129039587|NCT03877926|464436753|FG002|Overall Study|Withdrawal by Subject|12|||
129039588|NCT03877926|464436754|FG003|Overall Study|Withdrawal by Subject|4|||
129039589|NCT03877926|464436751|FG000|Overall Study|Other - Various|4|||
129039590|NCT03877926|464436752|FG001|Overall Study|Other - Various|1|||
129039591|NCT03877926|464436753|FG002|Overall Study|Other - Various|1|||
129039592|NCT03877926|464436754|FG003|Overall Study|Other - Various|0|||
129039593|NCT03877926|464436751|FG000|Overall Study|Not Treated|3|||
129039594|NCT03877926|464436752|FG001|Overall Study|Not Treated|1|||
129039595|NCT03877926|464436753|FG002|Overall Study|Not Treated|1|||
129221955|NCT00114517|465113375|FG001|Overall Study|Weight increase|0|||
129221956|NCT00114517|465113376|FG002|Overall Study|Weight increase|1|||
129221957|NCT00114517|465113377|FG003|Overall Study|Weight increase|0|||
129221958|NCT00114517|465113374|FG000|Overall Study|Concern about blood clots|0|||
129221959|NCT00114517|465113375|FG001|Overall Study|Concern about blood clots|0|||
129221960|NCT00114517|465113376|FG002|Overall Study|Concern about blood clots|1|||
129221961|NCT00114517|465113377|FG003|Overall Study|Concern about blood clots|0|||
129221962|NCT00114517|465113374|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
129039596|NCT03877926|464436754|FG003|Overall Study|Not Treated|0|||
129039597|NCT03554317|464436756|FG000|Overall Study|Withdrawal by Subject|1|||
129039598|NCT03554317|464436756|FG000|Overall Study|PSA Progression|3|||
129039599|NCT03554317|464436756|FG000|Overall Study|Radiographic Progression|4|||
129039600|NCT00124462|464436759|FG000|Overall Study|Lost to Follow-up|3|||
129039601|NCT00124462|464436760|FG001|Overall Study|Lost to Follow-up|3|||
129039602|NCT00124462|464436759|FG000|Overall Study|Physician Decision|3|||
129039603|NCT00124462|464436760|FG001|Overall Study|Physician Decision|4|||
129039604|NCT00124462|464436759|FG000|Overall Study|Withdrawal by Subject|4|||
129039605|NCT00124462|464436760|FG001|Overall Study|Withdrawal by Subject|5|||
129039606|NCT00124462|464436759|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
129039607|NCT00124462|464436760|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
129039608|NCT00537199|464436761|FG000|Overall Study|Study Terminated|1|||
129039609|NCT03297294|464436762|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
129039610|NCT03297294|464436763|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
129039611|NCT03297294|464436764|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129039612|NCT03297294|464436765|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129039613|NCT03297294|464436766|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129039614|NCT03297294|464436762|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
129039615|NCT03297294|464436763|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
129039616|NCT03297294|464436764|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129039617|NCT03297294|464436765|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129039618|NCT03297294|464436766|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129039619|NCT03297294|464436762|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
129039620|NCT03297294|464436763|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
129221963|NCT00114517|465113375|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
129221964|NCT00114517|465113376|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
129221965|NCT00114517|465113377|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
129221966|NCT04695977|465113378|FG000|Overall Study|Sponsor Decision|9|||
129221967|NCT04695977|465113379|FG001|Overall Study|Sponsor Decision|4|||
128717288|NCT00702403|463263903|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
128717289|NCT00380978|463263905|FG000|Overall Study|Refused allocated intervention|0|||
128717290|NCT00380978|463263906|FG001|Overall Study|Refused allocated intervention|6|||
128717291|NCT00380978|463263905|FG000|Overall Study|Wrong study envelope|0|||
128717292|NCT00380978|463263906|FG001|Overall Study|Wrong study envelope|2|||
129039621|NCT03297294|464436764|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129039622|NCT03297294|464436765|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129039623|NCT03297294|464436766|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129039624|NCT03297294|464436762|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
129221968|NCT04695977|465113378|FG000|Overall Study|Death|2|||
129221969|NCT04695977|465113379|FG001|Overall Study|Death|5|||
129221970|NCT03474965|465113380|FG000|Overall Study|Pregnancy|1|||
128717293|NCT00380978|463263905|FG000|Overall Study|Allocation prior to analgesia request|1|||
128717294|NCT00380978|463263906|FG001|Overall Study|Allocation prior to analgesia request|2|||
129039625|NCT03297294|464436763|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
129039626|NCT03297294|464436764|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129221971|NCT03474965|465113381|FG001|Overall Study|Pregnancy|0|||
129221972|NCT03474965|465113382|FG002|Overall Study|Pregnancy|0|||
129039627|NCT03297294|464436765|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129039628|NCT03297294|464436766|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129039629|NCT03297294|464436762|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129039630|NCT03297294|464436763|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129039631|NCT03297294|464436764|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129039632|NCT03297294|464436765|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
129039633|NCT03297294|464436766|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129039634|NCT02039063|464436769|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
129039635|NCT02039063|464436770|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
129039636|NCT02039063|464436771|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
129039637|NCT02039063|464436772|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
129039638|NCT02039063|464436769|FG000|Treatment Phase|Progression of disease|0|||
129039639|NCT02039063|464436770|FG001|Treatment Phase|Progression of disease|0|||
129039640|NCT02039063|464436771|FG002|Treatment Phase|Progression of disease|1|||
129039641|NCT02039063|464436772|FG003|Treatment Phase|Progression of disease|1|||
129039642|NCT02039063|464436769|FG000|Extension Phase|Inadequate therapeutic effect|0|||
129039643|NCT02039063|464436770|FG001|Extension Phase|Inadequate therapeutic effect|1|||
129039644|NCT02039063|464436771|FG002|Extension Phase|Inadequate therapeutic effect|2|||
129039645|NCT02039063|464436772|FG003|Extension Phase|Inadequate therapeutic effect|0|||
129039646|NCT02039063|464436769|FG000|Extension Phase|Progression of disease|0|||
129039647|NCT02039063|464436770|FG001|Extension Phase|Progression of disease|0|||
129039648|NCT02039063|464436771|FG002|Extension Phase|Progression of disease|0|||
129039649|NCT02039063|464436772|FG003|Extension Phase|Progression of disease|1|||
129039650|NCT02039063|464436769|FG000|Extension Phase|Adverse Event|0|||
129039651|NCT02039063|464436770|FG001|Extension Phase|Adverse Event|0|||
129039652|NCT02039063|464436771|FG002|Extension Phase|Adverse Event|1|||
129039653|NCT02039063|464436772|FG003|Extension Phase|Adverse Event|0|||
129039654|NCT00467831|464436773|FG000|Overall Study|Death|2|||
129039655|NCT00467831|464436773|FG000|Overall Study|Withdrawal by Subject|1|||
129039656|NCT02776553|464436778|FG000|Overall Study|Lost to Follow-up|1|||
129039657|NCT02776553|464436779|FG001|Overall Study|Lost to Follow-up|0|||
129039658|NCT02776553|464436778|FG000|Overall Study|got liver transplant|1|||
129039659|NCT02776553|464436779|FG001|Overall Study|got liver transplant|2|||
129039660|NCT02776553|464436778|FG000|Overall Study|had other surgery|1|||
129039661|NCT02776553|464436779|FG001|Overall Study|had other surgery|0|||
129039662|NCT02776553|464436778|FG000|Overall Study|Protocol Violation|0|||
129039663|NCT02776553|464436779|FG001|Overall Study|Protocol Violation|1|||
129039664|NCT00171340|464436781|FG000|Overall Study|Adverse Event|46|||
129039665|NCT00171340|464436782|FG001|Overall Study|Adverse Event|42|||
129039666|NCT00171340|464436781|FG000|Overall Study|Lack of Efficacy|29|||
129039667|NCT00171340|464436782|FG001|Overall Study|Lack of Efficacy|41|||
129039668|NCT00171340|464436781|FG000|Overall Study|Protocol Violation|7|||
129039669|NCT00171340|464436782|FG001|Overall Study|Protocol Violation|8|||
129039670|NCT00171340|464436781|FG000|Overall Study|Withdrawal by Subject|22|||
129039671|NCT00171340|464436782|FG001|Overall Study|Withdrawal by Subject|19|||
129039672|NCT00171340|464436781|FG000|Overall Study|Lost to Follow-up|0|||
129039673|NCT00171340|464436782|FG001|Overall Study|Lost to Follow-up|5|||
129039674|NCT00171340|464436781|FG000|Overall Study|Abnormal Laboratory Results|2|||
129039675|NCT00171340|464436782|FG001|Overall Study|Abnormal Laboratory Results|0|||
129039676|NCT00171340|464436781|FG000|Overall Study|Abnormal Test Procedure Results|6|||
129039677|NCT00171340|464436782|FG001|Overall Study|Abnormal Test Procedure Results|11|||
129039678|NCT00171340|464436781|FG000|Overall Study|No Longer Required Study Drug|1|||
129039679|NCT00171340|464436782|FG001|Overall Study|No Longer Required Study Drug|1|||
129039680|NCT00171340|464436781|FG000|Overall Study|Administrative Problems|5|||
129039681|NCT00171340|464436782|FG001|Overall Study|Administrative Problems|2|||
129039682|NCT00171340|464436781|FG000|Overall Study|Death|6|||
129039683|NCT00171340|464436782|FG001|Overall Study|Death|6|||
129039684|NCT01056640|464436783|FG000|Overall Study|Withdrawal by Subject|11|||
129039685|NCT01056640|464436784|FG001|Overall Study|Withdrawal by Subject|8|||
129039686|NCT01056640|464436783|FG000|Overall Study|Death|15|||
129221973|NCT03474965|465113383|FG003|Overall Study|Pregnancy|0|||
129039687|NCT01056640|464436784|FG001|Overall Study|Death|4|||
129039688|NCT02087176|464436785|FG000|Overall Study|Withdrawal by Subject|1|||
129039689|NCT02087176|464436785|FG000|Overall Study|Death|10|||
129039690|NCT02087176|464436785|FG000|Overall Study|Censored|19|||
129039691|NCT02087176|464436785|FG000|Overall Study|Study Terminated by Sponsor|2|||
129039692|NCT03648879|464436786|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
129039693|NCT03812991|464436787|FG000|Overall Study|Lost to Follow-up|3|||
129039694|NCT03812991|464436788|FG001|Overall Study|Lost to Follow-up|1|||
129221974|NCT03474965|465113380|FG000|Overall Study|Lost to Follow-up|0|||
129039695|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
129039696|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
129039697|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
129039698|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
129221975|NCT03474965|465113381|FG001|Overall Study|Lost to Follow-up|0|||
129039699|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
129039700|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
128717295|NCT00380978|463263905|FG000|Overall Study|Parous patient|1|||
128717296|NCT00380978|463263906|FG001|Overall Study|Parous patient|0|||
128717297|NCT04146545|463263907|FG000|Overall Study|deemed ineligible after randomization|1|||
128717298|NCT04146545|463263908|FG001|Overall Study|deemed ineligible after randomization|0|||
128717299|NCT01729754|463263909|FG000|Part 1|Adverse Event|2|||
128717300|NCT01729754|463263910|FG001|Part 1|Adverse Event|0|||
129039701|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
129039702|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
129039703|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
129039704|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
129039705|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
129039706|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
129039707|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
129039708|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
129039709|NCT04740931|464436789|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
129039710|NCT04740931|464436790|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
129039711|NCT04740931|464436789|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
129039712|NCT04740931|464436790|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
129039713|NCT04740931|464436789|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
129039714|NCT04740931|464436790|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
129039715|NCT04740931|464436789|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
129039716|NCT04740931|464436790|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
129039717|NCT04740931|464436789|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
129039718|NCT04740931|464436790|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
129039719|NCT04740931|464436789|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
129039720|NCT04740931|464436790|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
129039721|NCT04740931|464436789|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
129039722|NCT04740931|464436790|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
129039723|NCT04740931|464436789|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
129039724|NCT04740931|464436790|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
129039725|NCT04099641|464436793|FG000|Overall Study|Death|46|||
129039726|NCT04099641|464436794|FG001|Overall Study|Death|12|||
129039727|NCT04099641|464436793|FG000|Overall Study|Lost to Follow-up|1|||
129039728|NCT04099641|464436794|FG001|Overall Study|Lost to Follow-up|0|||
129039729|NCT04099641|464436793|FG000|Overall Study|Withdrawal by Subject|2|||
129039730|NCT04099641|464436794|FG001|Overall Study|Withdrawal by Subject|0|||
129039731|NCT00895037|464436795|FG000|Overall Study|Death|0|||
129132736|NCT03684057|464778501|FG000|Overall Study|Withdrawal by Subject|4|||
129132737|NCT03684057|464778502|FG001|Overall Study|Withdrawal by Subject|5|||
129132738|NCT01105130|464778503|FG000|Overall Study|Withdrawal by Subject|4|||
129132739|NCT01105130|464778504|FG001|Overall Study|Withdrawal by Subject|6|||
129132740|NCT01105130|464778505|FG002|Overall Study|Withdrawal by Subject|2|||
129132741|NCT01105130|464778503|FG000|Overall Study|Never Started|2|||
129132742|NCT01105130|464778504|FG001|Overall Study|Never Started|2|||
129132743|NCT01105130|464778505|FG002|Overall Study|Never Started|4|||
129132744|NCT01105130|464778503|FG000|Overall Study|Toxicity|1|||
129132745|NCT01105130|464778504|FG001|Overall Study|Toxicity|3|||
129132746|NCT01105130|464778505|FG002|Overall Study|Toxicity|2|||
129132747|NCT01105130|464778503|FG000|Overall Study|Multiple Reasons|3|||
128717301|NCT01729754|463263911|FG002|Part 1|Adverse Event|0|||
128717302|NCT01729754|463263912|FG003|Part 1|Adverse Event|1|||
128717303|NCT01729754|463263913|FG004|Part 1|Adverse Event|0|||
129039732|NCT00895037|464436796|FG001|Overall Study|Death|2|||
129039733|NCT00895037|464436797|FG002|Overall Study|Death|1|||
129039734|NCT04798482|464436813|FG000|Overall Study|Physician Decision|1|||
129039735|NCT04798482|464436813|FG000|Overall Study|Lost eligibility|1|||
129039736|NCT01192399|464436814|FG000|Overall Study|Lack of Efficacy|2|||
129039737|NCT01930175|464436815|FG000|Core Study|Lost to Follow-up|0|||
129039738|NCT01930175|464436816|FG001|Core Study|Lost to Follow-up|1|||
129221976|NCT03474965|465113382|FG002|Overall Study|Lost to Follow-up|1|||
129221977|NCT03474965|465113383|FG003|Overall Study|Lost to Follow-up|0|||
128717304|NCT01729754|463263914|FG005|Part 1|Adverse Event|0|||
128717305|NCT01729754|463263915|FG006|Part 1|Adverse Event|2|||
128717306|NCT01729754|463263916|FG007|Part 1|Adverse Event|0|||
128717307|NCT01729754|463263917|FG008|Part 1|Adverse Event|0|||
129039739|NCT01930175|464436817|FG002|Core Study|Lost to Follow-up|0|||
129039740|NCT01930175|464436815|FG000|Core Study|Adverse Event|0|||
129039741|NCT01930175|464436816|FG001|Core Study|Adverse Event|0|||
129039742|NCT01930175|464436817|FG002|Core Study|Adverse Event|1|||
129039743|NCT02820740|464436818|FG000|Overall Study|Did not have procedure|2|||
129039744|NCT00925301|464436821|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
129039745|NCT00925301|464436822|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
129039746|NCT00925301|464436823|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
129132748|NCT01105130|464778504|FG001|Overall Study|Multiple Reasons|0|||
129221978|NCT03474965|465113380|FG000|Overall Study|Death|1|||
129221979|NCT03474965|465113381|FG001|Overall Study|Death|0|||
129221980|NCT03474965|465113382|FG002|Overall Study|Death|0|||
129221981|NCT03474965|465113383|FG003|Overall Study|Death|0|||
129221982|NCT03474965|465113380|FG000|Overall Study|Adverse Event|1|||
129221983|NCT03474965|465113381|FG001|Overall Study|Adverse Event|0|||
129221984|NCT03474965|465113382|FG002|Overall Study|Adverse Event|0|||
129221985|NCT03474965|465113383|FG003|Overall Study|Adverse Event|1|||
129221986|NCT03474965|465113380|FG000|Overall Study|Physician Decision|3|||
129221987|NCT03474965|465113381|FG001|Overall Study|Physician Decision|1|||
129221988|NCT03474965|465113382|FG002|Overall Study|Physician Decision|2|||
129221989|NCT03474965|465113383|FG003|Overall Study|Physician Decision|0|||
129221990|NCT03474965|465113380|FG000|Overall Study|Participant Decision|7|||
129221991|NCT03474965|465113381|FG001|Overall Study|Participant Decision|0|||
129221992|NCT03474965|465113382|FG002|Overall Study|Participant Decision|1|||
129221993|NCT03474965|465113383|FG003|Overall Study|Participant Decision|0|||
129221994|NCT03474965|465113380|FG000|Overall Study|Guardian Decision|4|||
129221995|NCT03474965|465113381|FG001|Overall Study|Guardian Decision|2|||
129221996|NCT03474965|465113382|FG002|Overall Study|Guardian Decision|7|||
129221997|NCT03474965|465113383|FG003|Overall Study|Guardian Decision|2|||
129221998|NCT03821272|465115980|FG000|Overall Study|Death|1|||
129221999|NCT03821272|465115981|FG001|Overall Study|Death|0|||
129222000|NCT03821272|465115980|FG000|Overall Study|Physician Decision|1|||
129222001|NCT03821272|465115981|FG001|Overall Study|Physician Decision|0|||
129222002|NCT03821272|465115980|FG000|Overall Study|Withdrawal by Subject|1|||
129222003|NCT03821272|465115981|FG001|Overall Study|Withdrawal by Subject|0|||
129222004|NCT05904769|465115982|FG000|Overall Study|Physician Decision|0|||
129222005|NCT05904769|465115983|FG001|Overall Study|Physician Decision|6|||
129222006|NCT02255435|465115984|FG000|Overall Study|Patient's Limited Time Availability|0|||
129222007|NCT02255435|465115985|FG001|Overall Study|Patient's Limited Time Availability|0|||
129222008|NCT02255435|465115986|FG002|Overall Study|Patient's Limited Time Availability|0|||
129222009|NCT02255435|465115987|FG003|Overall Study|Patient's Limited Time Availability|0|||
129222010|NCT02255435|465115988|FG004|Overall Study|Patient's Limited Time Availability|0|||
129222011|NCT02255435|465115989|FG005|Overall Study|Patient's Limited Time Availability|0|||
129222012|NCT02255435|465115990|FG006|Overall Study|Patient's Limited Time Availability|0|||
129222013|NCT02255435|465115991|FG007|Overall Study|Patient's Limited Time Availability|1|||
129222014|NCT02255435|465115992|FG008|Overall Study|Patient's Limited Time Availability|0|||
129222015|NCT02255435|465115993|FG009|Overall Study|Patient's Limited Time Availability|0|||
129222016|NCT02255435|465115984|FG000|Overall Study|Withdrawal by Subject|0|||
129222017|NCT02255435|465115985|FG001|Overall Study|Withdrawal by Subject|0|||
129222018|NCT02255435|465115986|FG002|Overall Study|Withdrawal by Subject|0|||
129222019|NCT02255435|465115987|FG003|Overall Study|Withdrawal by Subject|0|||
129222020|NCT02255435|465115988|FG004|Overall Study|Withdrawal by Subject|0|||
129222021|NCT02255435|465115989|FG005|Overall Study|Withdrawal by Subject|0|||
129222022|NCT02255435|465115990|FG006|Overall Study|Withdrawal by Subject|0|||
129222023|NCT02255435|465115991|FG007|Overall Study|Withdrawal by Subject|0|||
129222024|NCT02255435|465115992|FG008|Overall Study|Withdrawal by Subject|1|||
129222025|NCT02255435|465115993|FG009|Overall Study|Withdrawal by Subject|4|||
129222026|NCT02255435|465115984|FG000|Overall Study|Administrative reasons|0|||
129222027|NCT02255435|465115985|FG001|Overall Study|Administrative reasons|0|||
129222028|NCT02255435|465115986|FG002|Overall Study|Administrative reasons|0|||
129222029|NCT02255435|465115987|FG003|Overall Study|Administrative reasons|0|||
129222030|NCT02255435|465115988|FG004|Overall Study|Administrative reasons|0|||
129222031|NCT02255435|465115989|FG005|Overall Study|Administrative reasons|0|||
129222032|NCT02255435|465115990|FG006|Overall Study|Administrative reasons|0|||
129222033|NCT02255435|465115991|FG007|Overall Study|Administrative reasons|0|||
129222034|NCT02255435|465115992|FG008|Overall Study|Administrative reasons|0|||
129222035|NCT02255435|465115993|FG009|Overall Study|Administrative reasons|2|||
129222036|NCT03595124|465115994|FG000|Overall Study|Physician Decision|1|||
129222037|NCT03595124|465115995|FG001|Overall Study|Physician Decision|1|||
129222038|NCT03595124|465115996|FG002|Overall Study|Physician Decision|1|||
129222039|NCT03595124|465115994|FG000|Overall Study|Ineligible|1|||
129222040|NCT03595124|465115995|FG001|Overall Study|Ineligible|1|||
129222041|NCT03595124|465115996|FG002|Overall Study|Ineligible|0|||
129222042|NCT03595124|465115994|FG000|Overall Study|Disease Progression|4|||
129222043|NCT03595124|465115995|FG001|Overall Study|Disease Progression|1|||
129222044|NCT03595124|465115996|FG002|Overall Study|Disease Progression|4|||
129222045|NCT05195489|465115997|FG000|Overall Study|Lost to Follow-up|1|||
129222046|NCT05195489|465115998|FG001|Overall Study|Lost to Follow-up|0|||
129222047|NCT05195489|465115997|FG000|Overall Study|Protocol Violation|0|||
129222048|NCT05195489|465115998|FG001|Overall Study|Protocol Violation|2|||
129222049|NCT05195489|465115997|FG000|Overall Study|Withdrawal by Subject|1|||
129222050|NCT05195489|465115998|FG001|Overall Study|Withdrawal by Subject|1|||
129222051|NCT05195489|465115997|FG000|Overall Study|Removed|0|||
129222052|NCT05195489|465115998|FG001|Overall Study|Removed|1|||
129222053|NCT04812548|465115999|FG000|Overall Study|Adverse Event|2|||
129222054|NCT04812548|465116000|FG001|Overall Study|Adverse Event|7|||
129222055|NCT04812548|465115999|FG000|Overall Study|HSCT Planned|2|||
129222056|NCT04812548|465116000|FG001|Overall Study|HSCT Planned|3|||
129039747|NCT00925301|464436824|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
129039748|NCT00925301|464436821|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
129039749|NCT00925301|464436822|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
129039750|NCT00925301|464436823|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
129039751|NCT00925301|464436824|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
129039752|NCT00925301|464436821|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
129039753|NCT00925301|464436822|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
129039754|NCT00925301|464436823|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
129039755|NCT00925301|464436824|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
129039756|NCT00925301|464436821|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
129039757|NCT00925301|464436822|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
129039758|NCT00925301|464436823|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
129039759|NCT00925301|464436824|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
129039760|NCT00925301|464436821|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
129039761|NCT00925301|464436822|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
129039762|NCT00925301|464436823|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
129039763|NCT00925301|464436824|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
129039764|NCT00925301|464436821|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
129039765|NCT00925301|464436822|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
129039766|NCT00925301|464436823|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
129039767|NCT00925301|464436824|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
129039768|NCT00925301|464436821|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129039769|NCT00925301|464436822|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129039770|NCT00925301|464436823|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129039771|NCT00925301|464436824|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
129039772|NCT03043560|464436825|FG000|Overall Study|Discontinued Intervention|1|||
129039773|NCT03043560|464436826|FG001|Overall Study|Discontinued Intervention|2|||
129039774|NCT03043560|464436825|FG000|Overall Study|Lost to Follow-up|0|||
129039775|NCT03043560|464436826|FG001|Overall Study|Lost to Follow-up|1|||
129039776|NCT01117766|464436827|FG000|First Intervention|Adverse Event|0|||
129039777|NCT01117766|464436828|FG001|First Intervention|Adverse Event|1|||
129039778|NCT01117766|464436827|FG000|First Intervention|Protocol Violation|1|||
129039779|NCT01117766|464436828|FG001|First Intervention|Protocol Violation|0|||
129039780|NCT01117766|464436827|FG000|Washout Period|Protocol Violation|0|||
129039781|NCT01117766|464436828|FG001|Washout Period|Protocol Violation|2|||
129039782|NCT01117766|464436827|FG000|Second Intervention|Lost to Follow-up|1|||
129039783|NCT01117766|464436828|FG001|Second Intervention|Lost to Follow-up|0|||
129039784|NCT01117766|464436827|FG000|Second Intervention|Other|1|||
129039785|NCT01117766|464436828|FG001|Second Intervention|Other|2|||
129039786|NCT01117766|464436827|FG000|Second Intervention|Adverse Event|0|||
129039787|NCT01117766|464436828|FG001|Second Intervention|Adverse Event|2|||
129039788|NCT01117766|464436827|FG000|Second Intervention|Withdrawal by Subject|0|||
129039789|NCT01117766|464436828|FG001|Second Intervention|Withdrawal by Subject|1|||
129039790|NCT00438659|464436829|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
129039791|NCT00438659|464436830|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
129039792|NCT00438659|464436829|FG000|Overall Study|Cancel|5|||
129039793|NCT00438659|464436830|FG001|Overall Study|Cancel|2|||
129039794|NCT01117987|464436831|FG000|Overall Study|Protocol deviation|0|||
129039795|NCT01117987|464436832|FG001|Overall Study|Protocol deviation|1|||
129039796|NCT01117987|464436831|FG000|Overall Study|Subject no longer requires study drug|1|||
129039797|NCT01117987|464436832|FG001|Overall Study|Subject no longer requires study drug|0|||
129039798|NCT01117987|464436831|FG000|Overall Study|Lost to Follow-up|1|||
129039799|NCT01117987|464436832|FG001|Overall Study|Lost to Follow-up|1|||
129039800|NCT01117987|464436831|FG000|Overall Study|Abnormal test procedure result|2|||
129039801|NCT01117987|464436832|FG001|Overall Study|Abnormal test procedure result|0|||
129039802|NCT01117987|464436831|FG000|Overall Study|Lack of Efficacy|3|||
129039803|NCT01117987|464436832|FG001|Overall Study|Lack of Efficacy|4|||
129039804|NCT01117987|464436831|FG000|Overall Study|Death|5|||
129039805|NCT01117987|464436832|FG001|Overall Study|Death|10|||
129039806|NCT01117987|464436831|FG000|Overall Study|Withdrawal by Subject|5|||
129132749|NCT01105130|464778505|FG002|Overall Study|Multiple Reasons|2|||
129132750|NCT02927145|464778507|FG000|Initial Recruitment|Withdrawal by Subject|0|||
129132751|NCT02927145|464778508|FG001|Initial Recruitment|Withdrawal by Subject|1|||
129132752|NCT02927145|464778509|FG002|Initial Recruitment|Withdrawal by Subject|1|||
129039807|NCT01117987|464436832|FG001|Overall Study|Withdrawal by Subject|10|||
129039808|NCT01117987|464436831|FG000|Overall Study|Adverse Event|19|||
129039809|NCT01117987|464436832|FG001|Overall Study|Adverse Event|26|||
129039810|NCT01117987|464436831|FG000|Overall Study|Administrative problems|25|||
129039811|NCT01117987|464436832|FG001|Overall Study|Administrative problems|22|||
129039812|NCT03069417|464436833|FG000|Overall Study|Lost to Follow-up|2|||
129039813|NCT03069417|464436834|FG001|Overall Study|Lost to Follow-up|0|||
129039814|NCT03069417|464436833|FG000|Overall Study|Reason Unknown|4|||
129039815|NCT03069417|464436834|FG001|Overall Study|Reason Unknown|7|||
129132753|NCT02927145|464778510|FG003|Initial Recruitment|Withdrawal by Subject|4|||
128717308|NCT01729754|463263918|FG009|Part 1|Adverse Event|5|||
128717309|NCT01729754|463263909|FG000|Part 1|Lack of Efficacy|1|||
128717310|NCT01729754|463263910|FG001|Part 1|Lack of Efficacy|0|||
128717311|NCT01729754|463263911|FG002|Part 1|Lack of Efficacy|0|||
128717312|NCT01729754|463263912|FG003|Part 1|Lack of Efficacy|0|||
128717313|NCT01729754|463263913|FG004|Part 1|Lack of Efficacy|0|||
128717314|NCT01729754|463263914|FG005|Part 1|Lack of Efficacy|0|||
128717315|NCT01729754|463263915|FG006|Part 1|Lack of Efficacy|2|||
128717316|NCT01729754|463263916|FG007|Part 1|Lack of Efficacy|0|||
128717317|NCT01729754|463263917|FG008|Part 1|Lack of Efficacy|0|||
128717318|NCT01729754|463263918|FG009|Part 1|Lack of Efficacy|0|||
128717319|NCT01729754|463263909|FG000|Part 1|Lost to Follow-up|1|||
128717320|NCT01729754|463263910|FG001|Part 1|Lost to Follow-up|0|||
128717321|NCT01729754|463263911|FG002|Part 1|Lost to Follow-up|0|||
128717322|NCT01729754|463263912|FG003|Part 1|Lost to Follow-up|2|||
128717323|NCT01729754|463263913|FG004|Part 1|Lost to Follow-up|0|||
128717324|NCT01729754|463263914|FG005|Part 1|Lost to Follow-up|0|||
128717325|NCT01729754|463263915|FG006|Part 1|Lost to Follow-up|3|||
128717326|NCT01729754|463263916|FG007|Part 1|Lost to Follow-up|0|||
128717327|NCT01729754|463263917|FG008|Part 1|Lost to Follow-up|0|||
128717328|NCT01729754|463263918|FG009|Part 1|Lost to Follow-up|3|||
128717329|NCT01729754|463263909|FG000|Part 1|Non-compliance with Study Drug|1|||
128717330|NCT01729754|463263910|FG001|Part 1|Non-compliance with Study Drug|0|||
128717331|NCT01729754|463263911|FG002|Part 1|Non-compliance with Study Drug|0|||
128717332|NCT01729754|463263912|FG003|Part 1|Non-compliance with Study Drug|0|||
128717333|NCT01729754|463263913|FG004|Part 1|Non-compliance with Study Drug|0|||
128717334|NCT01729754|463263914|FG005|Part 1|Non-compliance with Study Drug|0|||
128717335|NCT01729754|463263915|FG006|Part 1|Non-compliance with Study Drug|0|||
128717336|NCT01729754|463263916|FG007|Part 1|Non-compliance with Study Drug|0|||
128717337|NCT01729754|463263917|FG008|Part 1|Non-compliance with Study Drug|0|||
128717338|NCT01729754|463263918|FG009|Part 1|Non-compliance with Study Drug|0|||
128717339|NCT01729754|463263909|FG000|Part 1|Physician Decision|0|||
128717340|NCT01729754|463263910|FG001|Part 1|Physician Decision|0|||
128717341|NCT01729754|463263911|FG002|Part 1|Physician Decision|0|||
128717342|NCT01729754|463263912|FG003|Part 1|Physician Decision|0|||
128717343|NCT01729754|463263913|FG004|Part 1|Physician Decision|0|||
128717344|NCT01729754|463263914|FG005|Part 1|Physician Decision|0|||
128717345|NCT01729754|463263915|FG006|Part 1|Physician Decision|0|||
128717346|NCT01729754|463263916|FG007|Part 1|Physician Decision|0|||
128717347|NCT01729754|463263917|FG008|Part 1|Physician Decision|0|||
128717348|NCT01729754|463263918|FG009|Part 1|Physician Decision|4|||
128717349|NCT01729754|463263909|FG000|Part 1|Pregnancy|0|||
128717350|NCT01729754|463263910|FG001|Part 1|Pregnancy|0|||
128717351|NCT01729754|463263911|FG002|Part 1|Pregnancy|0|||
128717352|NCT01729754|463263912|FG003|Part 1|Pregnancy|1|||
128717353|NCT01729754|463263913|FG004|Part 1|Pregnancy|0|||
128717354|NCT01729754|463263914|FG005|Part 1|Pregnancy|0|||
128717355|NCT01729754|463263915|FG006|Part 1|Pregnancy|0|||
128976464|NCT00394654|464198689|FG000|Overall Study|Lost to Follow-up|1|||
128976465|NCT00394654|464198690|FG001|Overall Study|Lost to Follow-up|0|||
128976466|NCT00394654|464198689|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
128976467|NCT00394654|464198690|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
128976468|NCT03756285|464198691|FG000|Overall Study|Lost to Follow-up|0|||
128976469|NCT03756285|464198692|FG001|Overall Study|Lost to Follow-up|1|||
128976470|NCT03756285|464198691|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
128976471|NCT03756285|464198692|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
129132754|NCT02927145|464778511|FG004|Initial Recruitment|Withdrawal by Subject|1|||
129132755|NCT02927145|464778512|FG005|Initial Recruitment|Withdrawal by Subject|1|||
129132756|NCT02927145|464778513|FG006|Initial Recruitment|Withdrawal by Subject|0|||
129132757|NCT02927145|464778514|FG007|Initial Recruitment|Withdrawal by Subject|0|||
129132758|NCT02927145|464778515|FG008|Initial Recruitment|Withdrawal by Subject|2|||
129132759|NCT02927145|464778507|FG000|Initial Recruitment|Adverse Event|0|||
129132760|NCT02927145|464778508|FG001|Initial Recruitment|Adverse Event|0|||
129132761|NCT02927145|464778509|FG002|Initial Recruitment|Adverse Event|0|||
129132762|NCT02927145|464778510|FG003|Initial Recruitment|Adverse Event|0|||
129132763|NCT02927145|464778511|FG004|Initial Recruitment|Adverse Event|2|||
128717356|NCT01729754|463263916|FG007|Part 1|Pregnancy|0|||
128717357|NCT01729754|463263917|FG008|Part 1|Pregnancy|0|||
128717358|NCT01729754|463263918|FG009|Part 1|Pregnancy|1|||
128717359|NCT01729754|463263909|FG000|Part 1|Progressive Disease|0|||
128717360|NCT01729754|463263910|FG001|Part 1|Progressive Disease|0|||
128717361|NCT01729754|463263911|FG002|Part 1|Progressive Disease|0|||
128717362|NCT01729754|463263912|FG003|Part 1|Progressive Disease|0|||
128717363|NCT01729754|463263913|FG004|Part 1|Progressive Disease|0|||
128717364|NCT01729754|463263914|FG005|Part 1|Progressive Disease|0|||
128717365|NCT01729754|463263915|FG006|Part 1|Progressive Disease|0|||
128717366|NCT01729754|463263916|FG007|Part 1|Progressive Disease|0|||
128717367|NCT01729754|463263917|FG008|Part 1|Progressive Disease|0|||
128717368|NCT01729754|463263918|FG009|Part 1|Progressive Disease|1|||
128717369|NCT01729754|463263909|FG000|Part 1|Protocol Violation|2|||
128717370|NCT01729754|463263910|FG001|Part 1|Protocol Violation|0|||
128717371|NCT01729754|463263911|FG002|Part 1|Protocol Violation|0|||
128717372|NCT01729754|463263912|FG003|Part 1|Protocol Violation|1|||
129222057|NCT04812548|465115999|FG000|Overall Study|Progressive Disease|0|||
129222058|NCT04812548|465116000|FG001|Overall Study|Progressive Disease|2|||
128717373|NCT01729754|463263913|FG004|Part 1|Protocol Violation|0|||
128976472|NCT03756285|464198691|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
128976473|NCT03756285|464198692|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
128976474|NCT03458234|464198696|FG000|Overall Study|Withdrawal by Subject|1|||
128976475|NCT01021293|464198698|FG000|Overall Study|Serious Adverse Event|2|||
128976476|NCT01021293|464198699|FG001|Overall Study|Serious Adverse Event|1|||
128976477|NCT01021293|464198698|FG000|Overall Study|Adverse Event|2|||
128976478|NCT01021293|464198699|FG001|Overall Study|Adverse Event|1|||
128976479|NCT01021293|464198698|FG000|Overall Study|Withdrawal by Subject|1|||
128976480|NCT01021293|464198699|FG001|Overall Study|Withdrawal by Subject|3|||
128976481|NCT01021293|464198698|FG000|Overall Study|Migrated/moved from study area|6|||
128976482|NCT01021293|464198699|FG001|Overall Study|Migrated/moved from study area|18|||
128976483|NCT01021293|464198698|FG000|Overall Study|Lost to Follow-up|1|||
128976484|NCT01021293|464198699|FG001|Overall Study|Lost to Follow-up|1|||
128976485|NCT00027846|464200983|FG000|Overall Study|Lost to Follow-up|0|||
128976486|NCT00027846|464200984|FG001|Overall Study|Lost to Follow-up|41|||
128976487|NCT00027846|464200985|FG002|Overall Study|Lost to Follow-up|9|||
128976488|NCT00027846|464200983|FG000|Overall Study|Withdrawal by Subject|0|||
128976489|NCT00027846|464200984|FG001|Overall Study|Withdrawal by Subject|14|||
128976490|NCT00027846|464200985|FG002|Overall Study|Withdrawal by Subject|7|||
128976491|NCT00027846|464200983|FG000|Overall Study|Ineligible for study|2|||
128976492|NCT00027846|464200984|FG001|Overall Study|Ineligible for study|6|||
128976493|NCT00027846|464200985|FG002|Overall Study|Ineligible for study|14|||
128976494|NCT00027846|464200983|FG000|Overall Study|Entry into another COG therapeutic study|0|||
128976495|NCT00027846|464200984|FG001|Overall Study|Entry into another COG therapeutic study|5|||
128976496|NCT00027846|464200985|FG002|Overall Study|Entry into another COG therapeutic study|2|||
128976497|NCT00027846|464200983|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
128976498|NCT00027846|464200984|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
128976499|NCT00027846|464200985|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
128976500|NCT05604781|464200990|FG000|Overall Study|Lost to Follow-up|3|||
128976501|NCT05604781|464200990|FG000|Overall Study|Adverse Event|1|||
128976502|NCT02889861|464201001|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
128976503|NCT01864746|464201002|FG000|Overall Study|Disease recurrence|25|||
128976504|NCT01864746|464201003|FG001|Overall Study|Disease recurrence|40|||
128976505|NCT01864746|464201002|FG000|Overall Study|Second primary invasive nonbreast|2|||
128976506|NCT01864746|464201003|FG001|Overall Study|Second primary invasive nonbreast|3|||
128976507|NCT01864746|464201002|FG000|Overall Study|Death|2|||
128976508|NCT01864746|464201003|FG001|Overall Study|Death|1|||
128976509|NCT01864746|464201002|FG000|Overall Study|Adverse Event|33|||
128976510|NCT01864746|464201003|FG001|Overall Study|Adverse Event|5|||
128976511|NCT01864746|464201002|FG000|Overall Study|Withdrawal by Subject|56|||
128976512|NCT01864746|464201003|FG001|Overall Study|Withdrawal by Subject|41|||
128976513|NCT01864746|464201002|FG000|Overall Study|Physician Decision|5|||
128976514|NCT01864746|464201003|FG001|Overall Study|Physician Decision|6|||
128976515|NCT01005966|464201004|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
128976516|NCT01005966|464201005|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
128976517|NCT01005966|464201006|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
128976518|NCT01005966|464201007|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
129132764|NCT02927145|464778512|FG005|Initial Recruitment|Adverse Event|0|||
129132765|NCT02927145|464778513|FG006|Initial Recruitment|Adverse Event|0|||
129132766|NCT02927145|464778514|FG007|Initial Recruitment|Adverse Event|0|||
129132767|NCT02927145|464778515|FG008|Initial Recruitment|Adverse Event|0|||
129132768|NCT02927145|464778507|FG000|Invitation for Additional Challenge|Pregnancy|0|||
129132769|NCT02927145|464778508|FG001|Invitation for Additional Challenge|Pregnancy|0|||
129132770|NCT02927145|464778509|FG002|Invitation for Additional Challenge|Pregnancy|0|||
129132771|NCT02927145|464778510|FG003|Invitation for Additional Challenge|Pregnancy|0|||
129132772|NCT02927145|464778511|FG004|Invitation for Additional Challenge|Pregnancy|0|||
129132773|NCT02927145|464778512|FG005|Invitation for Additional Challenge|Pregnancy|0|||
129132774|NCT02927145|464778513|FG006|Invitation for Additional Challenge|Pregnancy|1|||
129132775|NCT02927145|464778514|FG007|Invitation for Additional Challenge|Pregnancy|0|||
129132776|NCT02927145|464778515|FG008|Invitation for Additional Challenge|Pregnancy|0|||
128976519|NCT01005966|464201008|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
128976520|NCT01005966|464201004|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
128976521|NCT01005966|464201005|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
128976522|NCT01005966|464201006|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
128976523|NCT01005966|464201007|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
128976524|NCT01005966|464201008|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
129222059|NCT04812548|465115999|FG000|Overall Study|Death|0|||
128717374|NCT01729754|463263914|FG005|Part 1|Protocol Violation|0|||
128976525|NCT01005966|464201004|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
128976526|NCT01005966|464201005|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
129222060|NCT04812548|465116000|FG001|Overall Study|Death|1|||
129039816|NCT02244424|464436835|FG000|Overall Study|Lost to Follow-up|20|||
129039817|NCT02244424|464436836|FG001|Overall Study|Lost to Follow-up|10|||
129039818|NCT04117945|464436837|FG000|Overall Study|Death|1|||
129039819|NCT04117945|464436838|FG001|Overall Study|Death|0|||
129039820|NCT04117945|464436837|FG000|Overall Study|Withdrawal by Subject|3|||
129039821|NCT04117945|464436838|FG001|Overall Study|Withdrawal by Subject|1|||
129039822|NCT04117945|464436837|FG000|Overall Study|Disease Progression|0|||
129039823|NCT04117945|464436838|FG001|Overall Study|Disease Progression|2|||
129039824|NCT04117945|464436837|FG000|Overall Study|Ineligible|8|||
129039825|NCT04117945|464436838|FG001|Overall Study|Ineligible|7|||
129039826|NCT00402025|464436839|FG000|Overall Study|Adverse Event|0|||
129039827|NCT00402025|464436840|FG001|Overall Study|Adverse Event|0|||
129039828|NCT00402025|464436841|FG002|Overall Study|Adverse Event|2|||
129039829|NCT00402025|464436839|FG000|Overall Study|Death|0|||
129039830|NCT00402025|464436840|FG001|Overall Study|Death|1|||
129039831|NCT00402025|464436841|FG002|Overall Study|Death|5|||
129039832|NCT00402025|464436839|FG000|Overall Study|Disease Progression|1|||
129039833|NCT00402025|464436840|FG001|Overall Study|Disease Progression|1|||
129039834|NCT00402025|464436841|FG002|Overall Study|Disease Progression|2|||
129039835|NCT00402025|464436839|FG000|Overall Study|Physician Decision|1|||
129039836|NCT00402025|464436840|FG001|Overall Study|Physician Decision|1|||
129039837|NCT00402025|464436841|FG002|Overall Study|Physician Decision|0|||
129039838|NCT00402025|464436839|FG000|Overall Study|Participant Decision|0|||
129039839|NCT00402025|464436840|FG001|Overall Study|Participant Decision|0|||
129039840|NCT00402025|464436841|FG002|Overall Study|Participant Decision|1|||
129039841|NCT04678817|464438674|FG000|Overall Study|Lost to Follow-up|28|||
129039842|NCT04678817|464438675|FG001|Overall Study|Lost to Follow-up|0|||
129039843|NCT04678817|464438676|FG002|Overall Study|Lost to Follow-up|0|||
129039844|NCT01730040|464438679|FG000|Overall Study|Randomized but not treated|0|||
129039845|NCT01730040|464438680|FG001|Overall Study|Randomized but not treated|0|||
129039846|NCT01730040|464438681|FG002|Overall Study|Randomized but not treated|0|||
129039847|NCT01730040|464438682|FG003|Overall Study|Randomized but not treated|0|||
129039848|NCT01730040|464438683|FG004|Overall Study|Randomized but not treated|0|||
129039849|NCT01730040|464438684|FG005|Overall Study|Randomized but not treated|1|||
129039850|NCT01730040|464438685|FG006|Overall Study|Randomized but not treated|0|||
129039851|NCT01730040|464438679|FG000|Overall Study|Subject moved|0|||
129039852|NCT01730040|464438680|FG001|Overall Study|Subject moved|0|||
129039853|NCT01730040|464438681|FG002|Overall Study|Subject moved|1|||
129039854|NCT01730040|464438682|FG003|Overall Study|Subject moved|0|||
129039855|NCT01730040|464438683|FG004|Overall Study|Subject moved|0|||
129039856|NCT01730040|464438684|FG005|Overall Study|Subject moved|0|||
129039857|NCT01730040|464438685|FG006|Overall Study|Subject moved|1|||
129039858|NCT01730040|464438679|FG000|Overall Study|Physician Decision|0|||
129039859|NCT01730040|464438680|FG001|Overall Study|Physician Decision|0|||
129039860|NCT01730040|464438681|FG002|Overall Study|Physician Decision|0|||
129039861|NCT01730040|464438682|FG003|Overall Study|Physician Decision|0|||
129039862|NCT01730040|464438683|FG004|Overall Study|Physician Decision|0|||
129039863|NCT01730040|464438684|FG005|Overall Study|Physician Decision|1|||
129039864|NCT01730040|464438685|FG006|Overall Study|Physician Decision|1|||
129039865|NCT01730040|464438679|FG000|Overall Study|Other than specified|7|||
129039866|NCT01730040|464438680|FG001|Overall Study|Other than specified|8|||
129039867|NCT01730040|464438681|FG002|Overall Study|Other than specified|5|||
129039868|NCT01730040|464438682|FG003|Overall Study|Other than specified|5|||
129039869|NCT01730040|464438683|FG004|Overall Study|Other than specified|5|||
129039870|NCT01730040|464438684|FG005|Overall Study|Other than specified|4|||
129039871|NCT01730040|464438685|FG006|Overall Study|Other than specified|4|||
129039872|NCT01730040|464438679|FG000|Overall Study|Adverse Event|4|||
129039873|NCT01730040|464438680|FG001|Overall Study|Adverse Event|3|||
129039874|NCT01730040|464438681|FG002|Overall Study|Adverse Event|5|||
129039875|NCT01730040|464438682|FG003|Overall Study|Adverse Event|3|||
129039876|NCT01730040|464438683|FG004|Overall Study|Adverse Event|1|||
129039877|NCT01730040|464438684|FG005|Overall Study|Adverse Event|1|||
129039878|NCT01730040|464438685|FG006|Overall Study|Adverse Event|2|||
129039879|NCT01730040|464438679|FG000|Overall Study|Poor compliance to protocol|2|||
129039880|NCT01730040|464438680|FG001|Overall Study|Poor compliance to protocol|4|||
129039881|NCT01730040|464438681|FG002|Overall Study|Poor compliance to protocol|0|||
129039882|NCT01730040|464438682|FG003|Overall Study|Poor compliance to protocol|0|||
129039883|NCT01730040|464438683|FG004|Overall Study|Poor compliance to protocol|0|||
129039884|NCT01730040|464438684|FG005|Overall Study|Poor compliance to protocol|0|||
129039885|NCT01730040|464438685|FG006|Overall Study|Poor compliance to protocol|1|||
129039886|NCT01684215|464438686|FG000|Phase 1, Part 1|Adverse Event|1|||
129039887|NCT01684215|464438687|FG001|Phase 1, Part 1|Adverse Event|0|||
129039888|NCT01684215|464438688|FG002|Phase 1, Part 1|Adverse Event|0|||
129039889|NCT01684215|464438689|FG003|Phase 1, Part 1|Adverse Event|0|||
129039890|NCT01684215|464438686|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
129039891|NCT01684215|464438687|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
129039892|NCT01684215|464438688|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
129039893|NCT01684215|464438689|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
129039894|NCT01684215|464438686|FG000|Phase 1, Part 2|Adverse Event|0|||
128717375|NCT01729754|463263915|FG006|Part 1|Protocol Violation|1|||
128717376|NCT01729754|463263916|FG007|Part 1|Protocol Violation|0|||
128717377|NCT01729754|463263917|FG008|Part 1|Protocol Violation|0|||
128717378|NCT01729754|463263918|FG009|Part 1|Protocol Violation|0|||
128717379|NCT01729754|463263909|FG000|Part 1|Withdrawal by Subject|5|||
128717380|NCT01729754|463263910|FG001|Part 1|Withdrawal by Subject|0|||
128717381|NCT01729754|463263911|FG002|Part 1|Withdrawal by Subject|0|||
128717382|NCT01729754|463263912|FG003|Part 1|Withdrawal by Subject|7|||
128717383|NCT01729754|463263913|FG004|Part 1|Withdrawal by Subject|0|||
128717384|NCT01729754|463263914|FG005|Part 1|Withdrawal by Subject|0|||
128717385|NCT01729754|463263915|FG006|Part 1|Withdrawal by Subject|5|||
128717386|NCT01729754|463263916|FG007|Part 1|Withdrawal by Subject|0|||
128717387|NCT01729754|463263917|FG008|Part 1|Withdrawal by Subject|0|||
128717388|NCT01729754|463263918|FG009|Part 1|Withdrawal by Subject|6|||
128717389|NCT01729754|463263909|FG000|Part 1|Other Protocol Specified Criteria|2|||
128717390|NCT01729754|463263910|FG001|Part 1|Other Protocol Specified Criteria|0|||
128717391|NCT01729754|463263911|FG002|Part 1|Other Protocol Specified Criteria|0|||
128717392|NCT01729754|463263912|FG003|Part 1|Other Protocol Specified Criteria|0|||
128717393|NCT01729754|463263913|FG004|Part 1|Other Protocol Specified Criteria|0|||
128717394|NCT01729754|463263914|FG005|Part 1|Other Protocol Specified Criteria|0|||
128717395|NCT01729754|463263915|FG006|Part 1|Other Protocol Specified Criteria|1|||
128717396|NCT01729754|463263916|FG007|Part 1|Other Protocol Specified Criteria|0|||
128717397|NCT01729754|463263917|FG008|Part 1|Other Protocol Specified Criteria|0|||
128717398|NCT01729754|463263918|FG009|Part 1|Other Protocol Specified Criteria|4|||
128717399|NCT01729754|463263909|FG000|Part 2|Adverse Event|2|||
128717400|NCT01729754|463263910|FG001|Part 2|Adverse Event|0|||
128717401|NCT01729754|463263911|FG002|Part 2|Adverse Event|0|||
128717402|NCT01729754|463263912|FG003|Part 2|Adverse Event|0|||
128717403|NCT01729754|463263913|FG004|Part 2|Adverse Event|0|||
128717404|NCT01729754|463263914|FG005|Part 2|Adverse Event|0|||
128717405|NCT01729754|463263915|FG006|Part 2|Adverse Event|0|||
128976527|NCT01005966|464201006|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
128976528|NCT01005966|464201007|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
128976529|NCT01005966|464201008|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
128976530|NCT01005966|464201004|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
128976531|NCT01005966|464201005|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
128976532|NCT01005966|464201006|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
128976533|NCT01005966|464201007|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
128976534|NCT01005966|464201008|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
128976535|NCT01005966|464201004|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
128976536|NCT01005966|464201005|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
128976537|NCT01005966|464201006|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
128976538|NCT01005966|464201007|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
128976539|NCT01005966|464201008|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
128976540|NCT01005966|464201004|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
128976541|NCT01005966|464201005|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
128976542|NCT01005966|464201006|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
128976543|NCT01005966|464201007|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
128976544|NCT01005966|464201008|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
128976545|NCT01005966|464201004|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
128976546|NCT01005966|464201005|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
129039895|NCT01684215|464438687|FG001|Phase 1, Part 2|Adverse Event|0|||
129039896|NCT01684215|464438688|FG002|Phase 1, Part 2|Adverse Event|1|||
129039897|NCT01684215|464438689|FG003|Phase 1, Part 2|Adverse Event|0|||
129039898|NCT01684215|464438686|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
129039899|NCT01684215|464438687|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
129039900|NCT01684215|464438688|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
129039901|NCT01684215|464438689|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
129039902|NCT01684215|464438686|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
129039903|NCT01684215|464438687|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
129039904|NCT01684215|464438688|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
129039905|NCT01684215|464438689|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
129039906|NCT01684215|464438686|FG000|Phase 2|Death|0|||
129039907|NCT01684215|464438687|FG001|Phase 2|Death|0|||
129039908|NCT01684215|464438688|FG002|Phase 2|Death|0|||
129039909|NCT01684215|464438689|FG003|Phase 2|Death|8|||
129039910|NCT01684215|464438686|FG000|Phase 2|Study terminated by sponsor|0|||
129039911|NCT01684215|464438687|FG001|Phase 2|Study terminated by sponsor|0|||
129039912|NCT01684215|464438688|FG002|Phase 2|Study terminated by sponsor|0|||
129039913|NCT01684215|464438689|FG003|Phase 2|Study terminated by sponsor|30|||
129039914|NCT01684215|464438686|FG000|Phase 2|Enrolled but not treated|0|||
128717406|NCT01729754|463263916|FG007|Part 2|Adverse Event|0|||
128717407|NCT01729754|463263917|FG008|Part 2|Adverse Event|1|||
128717408|NCT01729754|463263918|FG009|Part 2|Adverse Event|2|||
128717409|NCT01729754|463263909|FG000|Part 2|Lack of Efficacy|0|||
128717410|NCT01729754|463263910|FG001|Part 2|Lack of Efficacy|0|||
128717411|NCT01729754|463263911|FG002|Part 2|Lack of Efficacy|0|||
129222061|NCT04812548|465115999|FG000|Overall Study|Post Study Access to Treatment|0|||
129222062|NCT04812548|465116000|FG001|Overall Study|Post Study Access to Treatment|1|||
129222063|NCT04812548|465115999|FG000|Overall Study|Withdrawal by Subject|0|||
129222064|NCT04812548|465116000|FG001|Overall Study|Withdrawal by Subject|1|||
129222065|NCT04812548|465115999|FG000|Overall Study|Physician Decision|1|||
129222066|NCT04812548|465116000|FG001|Overall Study|Physician Decision|0|||
129222067|NCT03656562|465116001|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
129222068|NCT03656562|465116002|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
129222069|NCT03656562|465116003|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
129222070|NCT03656562|465116004|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
129222071|NCT03656562|465116001|FG000|Overall Study|Physician Decision|1|||
129222072|NCT03656562|465116002|FG001|Overall Study|Physician Decision|2|||
129222073|NCT03656562|465116003|FG002|Overall Study|Physician Decision|0|||
129222074|NCT03656562|465116004|FG003|Overall Study|Physician Decision|0|||
129222075|NCT03656562|465116001|FG000|Overall Study|Subject Decision|3|||
129222076|NCT03656562|465116002|FG001|Overall Study|Subject Decision|5|||
129222077|NCT03656562|465116003|FG002|Overall Study|Subject Decision|0|||
129222078|NCT03656562|465116004|FG003|Overall Study|Subject Decision|2|||
129222079|NCT04269265|465116012|FG000|Overall Study|Physician Decision|1|||
128717412|NCT01729754|463263912|FG003|Part 2|Lack of Efficacy|0|||
128717413|NCT01729754|463263913|FG004|Part 2|Lack of Efficacy|0|||
128717414|NCT01729754|463263914|FG005|Part 2|Lack of Efficacy|0|||
128717415|NCT01729754|463263915|FG006|Part 2|Lack of Efficacy|0|||
128717416|NCT01729754|463263916|FG007|Part 2|Lack of Efficacy|0|||
128717417|NCT01729754|463263917|FG008|Part 2|Lack of Efficacy|2|||
128717418|NCT01729754|463263918|FG009|Part 2|Lack of Efficacy|2|||
128976547|NCT01005966|464201006|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
128976548|NCT01005966|464201007|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
128976549|NCT01005966|464201008|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
128976550|NCT01005966|464201004|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
128976551|NCT01005966|464201005|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
128976552|NCT01005966|464201006|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
128976553|NCT01005966|464201007|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
128976554|NCT01005966|464201008|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
128976555|NCT01005966|464201004|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
128976556|NCT01005966|464201005|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
128976557|NCT01005966|464201006|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
128976558|NCT01005966|464201007|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
128976559|NCT01005966|464201008|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
128976560|NCT01451203|464201009|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
128976561|NCT01451203|464201010|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
128976562|NCT01451203|464201009|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
128976563|NCT01451203|464201010|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
128976564|NCT01451203|464201009|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
128976565|NCT01451203|464201010|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
128976566|NCT01451203|464201009|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
128976567|NCT01451203|464201010|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
128976568|NCT01451203|464201009|FG000|Double-blind Treatment Period|Adverse Event|6|||
128976569|NCT01451203|464201010|FG001|Double-blind Treatment Period|Adverse Event|9|||
128976570|NCT01451203|464201009|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
128976571|NCT01451203|464201010|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
128976572|NCT01451203|464201009|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
128976573|NCT01451203|464201010|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
128976574|NCT01451203|464201009|FG000|Double-blind Treatment Period|Investigator decision|2|||
128976575|NCT01451203|464201010|FG001|Double-blind Treatment Period|Investigator decision|0|||
128976576|NCT01451203|464201009|FG000|Post-treatment Period|Consent withdrawn|2|||
128976577|NCT01451203|464201010|FG001|Post-treatment Period|Consent withdrawn|4|||
128976578|NCT01451203|464201009|FG000|Post-treatment Period|Lack of Efficacy|12|||
128976579|NCT01451203|464201010|FG001|Post-treatment Period|Lack of Efficacy|28|||
128976580|NCT01451203|464201009|FG000|Post-treatment Period|Adverse Event|0|||
128976581|NCT01451203|464201010|FG001|Post-treatment Period|Adverse Event|1|||
128976582|NCT01451203|464201009|FG000|Post-treatment Period|Investigator decision|0|||
128976583|NCT01451203|464201010|FG001|Post-treatment Period|Investigator decision|1|||
128976584|NCT03890731|464201011|FG000|Overall Study|Progressive disease|1|||
128976585|NCT03890731|464201011|FG000|Overall Study|Patient's decision|1|||
128976586|NCT03890731|464201011|FG000|Overall Study|Adverse Event|4|||
129039915|NCT01684215|464438687|FG001|Phase 2|Enrolled but not treated|0|||
128976587|NCT00027027|464201015|FG000|Overall Study|Adverse Event|0|||
128976588|NCT00027027|464201016|FG001|Overall Study|Adverse Event|0|||
129039916|NCT01684215|464438688|FG002|Phase 2|Enrolled but not treated|0|||
129039917|NCT01684215|464438689|FG003|Phase 2|Enrolled but not treated|1|||
129222080|NCT04269265|465116012|FG000|Overall Study|Withdrawal by Subject|1|||
129222081|NCT04269265|465116012|FG000|Overall Study|Overenrolled (sample size reached)|4|||
129132777|NCT01363440|464778516|FG000|Overall Study|Adverse Event|5|||
129132778|NCT01363440|464778517|FG001|Overall Study|Adverse Event|4|||
129132779|NCT01363440|464778518|FG002|Overall Study|Adverse Event|4|||
129132780|NCT01363440|464778516|FG000|Overall Study|Death|3|||
129132781|NCT01363440|464778517|FG001|Overall Study|Death|7|||
129132782|NCT01363440|464778518|FG002|Overall Study|Death|5|||
129132783|NCT01363440|464778516|FG000|Overall Study|Withdrawal by Subject|9|||
129132784|NCT01363440|464778517|FG001|Overall Study|Withdrawal by Subject|11|||
129132785|NCT01363440|464778518|FG002|Overall Study|Withdrawal by Subject|11|||
129132786|NCT01363440|464778516|FG000|Overall Study|Lost to Follow-up|2|||
129132787|NCT01363440|464778517|FG001|Overall Study|Lost to Follow-up|4|||
128717419|NCT01729754|463263909|FG000|Part 2|Lost to Follow-up|0|||
128717420|NCT01729754|463263910|FG001|Part 2|Lost to Follow-up|0|||
128717421|NCT01729754|463263911|FG002|Part 2|Lost to Follow-up|0|||
128976589|NCT00027027|464201017|FG002|Overall Study|Adverse Event|1|||
128976590|NCT00027027|464201018|FG003|Overall Study|Adverse Event|0|||
128976591|NCT00027027|464201019|FG004|Overall Study|Adverse Event|1|||
128976592|NCT00027027|464201015|FG000|Overall Study|Admitted for Signs of PD|0|||
128976593|NCT00027027|464201016|FG001|Overall Study|Admitted for Signs of PD|0|||
128976594|NCT00027027|464201017|FG002|Overall Study|Admitted for Signs of PD|0|||
128976595|NCT00027027|464201018|FG003|Overall Study|Admitted for Signs of PD|0|||
128976596|NCT00027027|464201019|FG004|Overall Study|Admitted for Signs of PD|1|||
128976597|NCT00027027|464201015|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
128976598|NCT00027027|464201016|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
128976599|NCT00027027|464201017|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
128976600|NCT00027027|464201018|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
128976601|NCT00027027|464201019|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
128976602|NCT00027027|464201015|FG000|Overall Study|PD Requiring Surgery|0|||
128976603|NCT00027027|464201016|FG001|Overall Study|PD Requiring Surgery|0|||
128976604|NCT00027027|464201017|FG002|Overall Study|PD Requiring Surgery|1|||
128976605|NCT00027027|464201018|FG003|Overall Study|PD Requiring Surgery|0|||
128976606|NCT00027027|464201019|FG004|Overall Study|PD Requiring Surgery|0|||
128976607|NCT00027027|464201015|FG000|Overall Study|Physician Decision Due To PD|2|||
128976608|NCT00027027|464201016|FG001|Overall Study|Physician Decision Due To PD|3|||
128976609|NCT00027027|464201017|FG002|Overall Study|Physician Decision Due To PD|2|||
128976610|NCT00027027|464201018|FG003|Overall Study|Physician Decision Due To PD|3|||
128976611|NCT00027027|464201019|FG004|Overall Study|Physician Decision Due To PD|5|||
128976612|NCT00027027|464201015|FG000|Overall Study|Withdrawal by Subject|0|||
128976613|NCT00027027|464201016|FG001|Overall Study|Withdrawal by Subject|0|||
128976614|NCT00027027|464201017|FG002|Overall Study|Withdrawal by Subject|0|||
128976615|NCT00027027|464201018|FG003|Overall Study|Withdrawal by Subject|0|||
128976616|NCT00027027|464201019|FG004|Overall Study|Withdrawal by Subject|1|||
128976617|NCT02039687|464201025|FG000|Overall Study|Adverse Event|0|||
128976618|NCT02039687|464201026|FG001|Overall Study|Adverse Event|0|||
128976619|NCT02039687|464201027|FG002|Overall Study|Adverse Event|1|||
128976620|NCT02039687|464201028|FG003|Overall Study|Adverse Event|0|||
128976621|NCT02039687|464201025|FG000|Overall Study|Withdrawal by Subject|0|||
128976622|NCT02039687|464201026|FG001|Overall Study|Withdrawal by Subject|1|||
128976623|NCT02039687|464201027|FG002|Overall Study|Withdrawal by Subject|0|||
128976624|NCT02039687|464201028|FG003|Overall Study|Withdrawal by Subject|0|||
129039918|NCT01684215|464438686|FG000|Phase 2|Lost to Follow-up|0|||
129039919|NCT01684215|464438687|FG001|Phase 2|Lost to Follow-up|0|||
129039920|NCT01684215|464438688|FG002|Phase 2|Lost to Follow-up|0|||
129039921|NCT01684215|464438689|FG003|Phase 2|Lost to Follow-up|4|||
129039922|NCT01301482|464438690|FG000|Overall Study|Withdrawal by Subject|1|||
129039923|NCT00480324|464438691|FG000|Overall Study|Adverse Event|1|||
129039924|NCT00480324|464438692|FG001|Overall Study|Adverse Event|1|||
129132788|NCT01363440|464778518|FG002|Overall Study|Lost to Follow-up|5|||
129132789|NCT01363440|464778516|FG000|Overall Study|Other|4|||
129132790|NCT01363440|464778517|FG001|Overall Study|Other|5|||
129132791|NCT01363440|464778518|FG002|Overall Study|Other|2|||
129132792|NCT02506036|464778521|FG000|First Intervention (4-6 Weeks)|Death|1|||
129132793|NCT02506036|464778522|FG001|First Intervention (4-6 Weeks)|Death|0|||
129132794|NCT02506036|464778521|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
129132795|NCT02506036|464778522|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
129132796|NCT02506036|464778521|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
129132797|NCT02506036|464778522|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
129132798|NCT00758043|464778526|FG000|Overall Study|Adverse Event|1|||
128976625|NCT02039687|464201025|FG000|Overall Study|treatment assignment could not be confir|0|||
128976626|NCT02039687|464201026|FG001|Overall Study|treatment assignment could not be confir|0|||
128976627|NCT02039687|464201027|FG002|Overall Study|treatment assignment could not be confir|2|||
129039925|NCT00480324|464438691|FG000|Overall Study|Protocol Violation|0|||
129039926|NCT00480324|464438692|FG001|Overall Study|Protocol Violation|1|||
129132799|NCT00758043|464778527|FG001|Overall Study|Adverse Event|20|||
128717422|NCT01729754|463263912|FG003|Part 2|Lost to Follow-up|2|||
129132800|NCT00758043|464778528|FG002|Overall Study|Adverse Event|12|||
128976628|NCT02039687|464201028|FG003|Overall Study|treatment assignment could not be confir|0|||
129039927|NCT00480324|464438691|FG000|Overall Study|Withdrawal by Subject|14|||
129039928|NCT00480324|464438692|FG001|Overall Study|Withdrawal by Subject|5|||
129039929|NCT00480324|464438691|FG000|Overall Study|Lost to Follow-up|17|||
129039930|NCT00480324|464438692|FG001|Overall Study|Lost to Follow-up|8|||
129039931|NCT00480324|464438691|FG000|Overall Study|Subject's mother pregnant|0|||
129039932|NCT00480324|464438692|FG001|Overall Study|Subject's mother pregnant|1|||
129039933|NCT00784134|464438693|FG000|Overall Study|Lost to Follow-up|3|||
129039934|NCT00784134|464438694|FG001|Overall Study|Lost to Follow-up|6|||
129039935|NCT03785145|464438695|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
129039936|NCT03785145|464438696|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
129039937|NCT03785145|464438695|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
129039938|NCT03785145|464438696|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
129039939|NCT03785145|464438695|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
129039940|NCT03785145|464438696|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
129039941|NCT03785145|464438695|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
129039942|NCT03785145|464438696|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
129039943|NCT03785145|464438695|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
129039944|NCT03785145|464438696|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
128976629|NCT00303329|464201040|FG000|Overall Study|Adverse Event|7|||
128976630|NCT00303329|464201041|FG001|Overall Study|Adverse Event|14|||
128976631|NCT00303329|464201040|FG000|Overall Study|Abnormal Laboratory Values|0|||
128976632|NCT00303329|464201041|FG001|Overall Study|Abnormal Laboratory Values|1|||
128976633|NCT00303329|464201040|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
128976634|NCT00303329|464201041|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128976635|NCT00303329|464201040|FG000|Overall Study|Condition no longer requires study drug|0|||
128976636|NCT00303329|464201041|FG001|Overall Study|Condition no longer requires study drug|8|||
128976637|NCT00303329|464201040|FG000|Overall Study|Protocol Violation|3|||
128976638|NCT00303329|464201041|FG001|Overall Study|Protocol Violation|0|||
128976639|NCT00303329|464201040|FG000|Overall Study|Withdrawal by Subject|9|||
128976640|NCT00303329|464201041|FG001|Overall Study|Withdrawal by Subject|15|||
128976641|NCT00303329|464201040|FG000|Overall Study|Lost to Follow-up|0|||
128976642|NCT00303329|464201041|FG001|Overall Study|Lost to Follow-up|1|||
128976643|NCT00303329|464201040|FG000|Overall Study|Administrative problems|1|||
128976644|NCT00303329|464201041|FG001|Overall Study|Administrative problems|0|||
128976645|NCT00303329|464201040|FG000|Overall Study|Death|2|||
128976646|NCT00303329|464201041|FG001|Overall Study|Death|12|||
128976647|NCT00303329|464201040|FG000|Overall Study|Stopped at end of core|3|||
128976648|NCT00303329|464201041|FG001|Overall Study|Stopped at end of core|9|||
128976649|NCT00303329|464201040|FG000|Overall Study|Stopped at end of extension 1|1|||
128976650|NCT00303329|464201041|FG001|Overall Study|Stopped at end of extension 1|0|||
128976651|NCT03812224|464201042|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
128976652|NCT03812224|464201043|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
128976653|NCT03812224|464201042|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
128976654|NCT03812224|464201043|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
128976655|NCT03812224|464201042|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
128976656|NCT03812224|464201043|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
128976657|NCT03812224|464201042|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
128976658|NCT03812224|464201043|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
128976659|NCT02500901|464201044|FG000|Overall Study|Disease ProgressionDD|2|||
128976660|NCT03055806|464201048|FG000|Overall Study|Adverse Event|0|||
128976661|NCT03055806|464201049|FG001|Overall Study|Adverse Event|0|||
128976662|NCT03055806|464201050|FG002|Overall Study|Adverse Event|1|||
128976663|NCT03055806|464201051|FG003|Overall Study|Adverse Event|1|||
128976664|NCT03055806|464201048|FG000|Overall Study|Lost to Follow-up|0|||
128976665|NCT03055806|464201049|FG001|Overall Study|Lost to Follow-up|3|||
129039945|NCT03785145|464438695|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
129039946|NCT03785145|464438696|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
129039947|NCT03785145|464438695|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
129039948|NCT03785145|464438696|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
129039949|NCT03785145|464438695|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
129039950|NCT03785145|464438696|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
129039951|NCT03785145|464438695|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
129039952|NCT03785145|464438696|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
129039953|NCT03785145|464438695|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
128976666|NCT03055806|464201050|FG002|Overall Study|Lost to Follow-up|6|||
128976667|NCT03055806|464201051|FG003|Overall Study|Lost to Follow-up|7|||
128976668|NCT03055806|464201048|FG000|Overall Study|Physician Decision|1|||
128976669|NCT03055806|464201049|FG001|Overall Study|Physician Decision|0|||
129039954|NCT03785145|464438696|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
129132801|NCT00758043|464778529|FG003|Overall Study|Adverse Event|62|||
129132802|NCT00758043|464778526|FG000|Overall Study|Lack of Efficacy|0|||
129132803|NCT00758043|464778527|FG001|Overall Study|Lack of Efficacy|6|||
129222082|NCT04189445|465116013|FG000|Overall Study|Withdrawal of consent|8|||
128976670|NCT03055806|464201050|FG002|Overall Study|Physician Decision|0|||
128976671|NCT03055806|464201051|FG003|Overall Study|Physician Decision|1|||
128976672|NCT03055806|464201048|FG000|Overall Study|Protocol Violation|1|||
128976673|NCT03055806|464201049|FG001|Overall Study|Protocol Violation|0|||
128976674|NCT03055806|464201050|FG002|Overall Study|Protocol Violation|0|||
128976675|NCT03055806|464201051|FG003|Overall Study|Protocol Violation|0|||
128976676|NCT03055806|464201048|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
128976677|NCT03055806|464201049|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
128976678|NCT03055806|464201050|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
128976679|NCT03055806|464201051|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
128976680|NCT03055806|464201048|FG000|Overall Study|Withdrawal of consent to continue study|2|||
128976681|NCT03055806|464201049|FG001|Overall Study|Withdrawal of consent to continue study|3|||
128976682|NCT03055806|464201050|FG002|Overall Study|Withdrawal of consent to continue study|4|||
128976683|NCT03055806|464201051|FG003|Overall Study|Withdrawal of consent to continue study|6|||
128976684|NCT03055806|464201048|FG000|Overall Study|Partner not willing to try intercourse|1|||
128976685|NCT03055806|464201049|FG001|Overall Study|Partner not willing to try intercourse|0|||
128976686|NCT03055806|464201050|FG002|Overall Study|Partner not willing to try intercourse|0|||
128976687|NCT03055806|464201051|FG003|Overall Study|Partner not willing to try intercourse|0|||
128976688|NCT00125138|464201052|FG000|Overall Study|Adverse Event|1|||
128976689|NCT00125138|464201053|FG001|Overall Study|Adverse Event|0|||
128976690|NCT00125138|464201054|FG002|Overall Study|Adverse Event|3|||
128976691|NCT00125138|464201055|FG003|Overall Study|Adverse Event|2|||
128976692|NCT00125138|464201052|FG000|Overall Study|Withdrawal by Subject|2|||
128976693|NCT00125138|464201053|FG001|Overall Study|Withdrawal by Subject|3|||
128976694|NCT00125138|464201054|FG002|Overall Study|Withdrawal by Subject|1|||
128976695|NCT00125138|464201055|FG003|Overall Study|Withdrawal by Subject|1|||
128976696|NCT00125138|464201052|FG000|Overall Study|Lack of Efficacy|0|||
128976697|NCT00125138|464201053|FG001|Overall Study|Lack of Efficacy|0|||
128976698|NCT00125138|464201054|FG002|Overall Study|Lack of Efficacy|0|||
128976699|NCT00125138|464201055|FG003|Overall Study|Lack of Efficacy|1|||
128976700|NCT00125138|464201052|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
128976701|NCT00125138|464201053|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
128976702|NCT00125138|464201054|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
128976703|NCT00125138|464201055|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
128976704|NCT00783263|464201066|FG000|Overall Study|Adverse Event|3|||
128976705|NCT00783263|464201067|FG001|Overall Study|Adverse Event|0|||
128976706|NCT00783263|464201068|FG002|Overall Study|Adverse Event|2|||
128976707|NCT00783263|464201069|FG003|Overall Study|Adverse Event|1|||
128976708|NCT00783263|464201066|FG000|Overall Study|Lost to Follow-up|1|||
128976709|NCT00783263|464201067|FG001|Overall Study|Lost to Follow-up|1|||
128976710|NCT00783263|464201068|FG002|Overall Study|Lost to Follow-up|0|||
128976711|NCT00783263|464201069|FG003|Overall Study|Lost to Follow-up|0|||
128976712|NCT00783263|464201066|FG000|Overall Study|Withdrawal by Subject|0|||
128976713|NCT00783263|464201067|FG001|Overall Study|Withdrawal by Subject|1|||
128976714|NCT00783263|464201068|FG002|Overall Study|Withdrawal by Subject|1|||
128976715|NCT00783263|464201069|FG003|Overall Study|Withdrawal by Subject|2|||
128976716|NCT00405756|464201070|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
128976717|NCT00405756|464201071|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
128976718|NCT00405756|464201072|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
128976719|NCT00405756|464201070|FG000|Double-blind Treatment|Adverse Event|31|||
128976720|NCT00405756|464201071|FG001|Double-blind Treatment|Adverse Event|27|||
128976721|NCT00405756|464201072|FG002|Double-blind Treatment|Adverse Event|12|||
128976722|NCT00405756|464201070|FG000|Double-blind Treatment|Disease Progression|47|||
128976723|NCT00405756|464201071|FG001|Double-blind Treatment|Disease Progression|81|||
128976724|NCT00405756|464201072|FG002|Double-blind Treatment|Disease Progression|102|||
128976725|NCT00405756|464201070|FG000|Double-blind Treatment|Lack of Efficacy|1|||
128976726|NCT00405756|464201071|FG001|Double-blind Treatment|Lack of Efficacy|4|||
128976727|NCT00405756|464201072|FG002|Double-blind Treatment|Lack of Efficacy|2|||
128976728|NCT00405756|464201070|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
128976729|NCT00405756|464201071|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
128976730|NCT00405756|464201072|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
128976731|NCT00405756|464201070|FG000|Double-blind Treatment|Lost to Follow-up|1|||
128976732|NCT00405756|464201071|FG001|Double-blind Treatment|Lost to Follow-up|0|||
128976733|NCT00405756|464201072|FG002|Double-blind Treatment|Lost to Follow-up|0|||
128976734|NCT00405756|464201070|FG000|Double-blind Treatment|Death|4|||
128976735|NCT00405756|464201071|FG001|Double-blind Treatment|Death|4|||
128976736|NCT00405756|464201072|FG002|Double-blind Treatment|Death|4|||
128717423|NCT01729754|463263913|FG004|Part 2|Lost to Follow-up|0|||
128976737|NCT00405756|464201070|FG000|Double-blind Treatment|Protocol Violation|1|||
128976738|NCT00405756|464201071|FG001|Double-blind Treatment|Protocol Violation|0|||
128976739|NCT00405756|464201072|FG002|Double-blind Treatment|Protocol Violation|2|||
128976740|NCT00405756|464201070|FG000|Double-blind Treatment|Other|7|||
128976741|NCT00405756|464201071|FG001|Double-blind Treatment|Other|4|||
128717424|NCT01729754|463263914|FG005|Part 2|Lost to Follow-up|0|||
128717425|NCT01729754|463263915|FG006|Part 2|Lost to Follow-up|0|||
128717426|NCT01729754|463263916|FG007|Part 2|Lost to Follow-up|1|||
128717427|NCT01729754|463263917|FG008|Part 2|Lost to Follow-up|0|||
128717428|NCT01729754|463263918|FG009|Part 2|Lost to Follow-up|2|||
128717429|NCT01729754|463263909|FG000|Part 2|Non-Compliance with Study Drug|0|||
128717430|NCT01729754|463263910|FG001|Part 2|Non-Compliance with Study Drug|0|||
128976742|NCT00405756|464201072|FG002|Double-blind Treatment|Other|4|||
128976743|NCT00405756|464201070|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
128976744|NCT00405756|464201071|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
128976745|NCT00405756|464201072|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
128976746|NCT00405756|464201070|FG000|Open-label Extension|Adverse Event|1|||
128976747|NCT00405756|464201071|FG001|Open-label Extension|Adverse Event|3|||
128976748|NCT00405756|464201072|FG002|Open-label Extension|Adverse Event|7|||
128976749|NCT00405756|464201070|FG000|Open-label Extension|Disease Progression|8|||
128976750|NCT00405756|464201071|FG001|Open-label Extension|Disease Progression|23|||
128976751|NCT00405756|464201072|FG002|Open-label Extension|Disease Progression|26|||
128976752|NCT00405756|464201070|FG000|Open-label Extension|Withdrawal by Subject|2|||
128976753|NCT00405756|464201071|FG001|Open-label Extension|Withdrawal by Subject|3|||
128976754|NCT00405756|464201072|FG002|Open-label Extension|Withdrawal by Subject|3|||
128976755|NCT00405756|464201070|FG000|Open-label Extension|Death|1|||
128976756|NCT00405756|464201071|FG001|Open-label Extension|Death|2|||
128976757|NCT00405756|464201072|FG002|Open-label Extension|Death|4|||
128976758|NCT00405756|464201070|FG000|Open-label Extension|Other|0|||
128976759|NCT00405756|464201071|FG001|Open-label Extension|Other|1|||
128976760|NCT00405756|464201072|FG002|Open-label Extension|Other|7|||
128976761|NCT00405756|464201070|FG000|Follow-up|Ongoing in Follow-up Period|52|||
128976762|NCT00405756|464201071|FG001|Follow-up|Ongoing in Follow-up Period|51|||
128976763|NCT00405756|464201072|FG002|Follow-up|Ongoing in Follow-up Period|60|||
128976764|NCT00405756|464201070|FG000|Follow-up|Death|21|||
128976765|NCT00405756|464201071|FG001|Follow-up|Death|31|||
128976766|NCT00405756|464201072|FG002|Follow-up|Death|24|||
128976767|NCT00405756|464201070|FG000|Follow-up|Lost to Follow-up|2|||
128976768|NCT00405756|464201071|FG001|Follow-up|Lost to Follow-up|8|||
128976769|NCT00405756|464201072|FG002|Follow-up|Lost to Follow-up|4|||
128976770|NCT01038635|464201073|FG000|Overall Study|Disease Progression|2|||
128976771|NCT01038635|464201074|FG001|Overall Study|Disease Progression|0|||
128976772|NCT01038635|464201075|FG002|Overall Study|Disease Progression|0|||
128976773|NCT01038635|464201076|FG003|Overall Study|Disease Progression|0|||
128976774|NCT01038635|464201077|FG004|Overall Study|Disease Progression|0|||
128976775|NCT01038635|464201078|FG005|Overall Study|Disease Progression|0|||
128976776|NCT01038635|464201079|FG006|Overall Study|Disease Progression|1|||
128976777|NCT01038635|464201080|FG007|Overall Study|Disease Progression|4|||
128976778|NCT01038635|464201081|FG008|Overall Study|Disease Progression|0|||
128976779|NCT01038635|464201073|FG000|Overall Study|Death|0|||
128976780|NCT01038635|464201074|FG001|Overall Study|Death|0|||
128976781|NCT01038635|464201075|FG002|Overall Study|Death|0|||
128976782|NCT01038635|464201076|FG003|Overall Study|Death|0|||
128976783|NCT01038635|464201077|FG004|Overall Study|Death|1|||
128976784|NCT01038635|464201078|FG005|Overall Study|Death|0|||
128976785|NCT01038635|464201079|FG006|Overall Study|Death|1|||
128976786|NCT01038635|464201080|FG007|Overall Study|Death|1|||
128976787|NCT01038635|464201081|FG008|Overall Study|Death|2|||
128976788|NCT01060150|464201082|FG000|Overall Study|Adverse Event|6|||
128976789|NCT01060150|464201082|FG000|Overall Study|Lost to Follow-up|1|||
128976790|NCT01060150|464201082|FG000|Overall Study|Protocol Violation|6|||
128976791|NCT01060150|464201082|FG000|Overall Study|Withdrawal by Subject|8|||
128976792|NCT01060150|464201082|FG000|Overall Study|Enrolled, but not treated|2|||
128976793|NCT03018340|464201083|FG000|Overall Study|Adverse Event|1|||
128976794|NCT03018340|464201084|FG001|Overall Study|Adverse Event|2|||
128976795|NCT03018340|464201083|FG000|Overall Study|Withdrawal by Subject|0|||
128976796|NCT03018340|464201084|FG001|Overall Study|Withdrawal by Subject|8|||
128976797|NCT03018340|464201083|FG000|Overall Study|Lack of Efficacy|0|||
128976798|NCT03018340|464201084|FG001|Overall Study|Lack of Efficacy|1|||
128976799|NCT03018340|464201083|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
128976800|NCT03018340|464201084|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
128976801|NCT03018340|464201083|FG000|Overall Study|Lost to Follow-up|1|||
128976802|NCT03018340|464201084|FG001|Overall Study|Lost to Follow-up|7|||
128976803|NCT03018340|464201083|FG000|Overall Study|Protocol Violation|3|||
128976804|NCT03018340|464201084|FG001|Overall Study|Protocol Violation|7|||
128976805|NCT03018340|464201083|FG000|Overall Study|Not further specified|0|||
128976806|NCT03018340|464201084|FG001|Overall Study|Not further specified|1|||
128976807|NCT01683058|464201086|FG000|Overall Study|Lost to Follow-up|9|||
128976808|NCT01683058|464201086|FG000|Overall Study|Adverse Event|6|||
128717431|NCT01729754|463263911|FG002|Part 2|Non-Compliance with Study Drug|0|||
128976809|NCT01683058|464201086|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
128976810|NCT01683058|464201086|FG000|Overall Study|Withdrawal by Subject|7|||
128976811|NCT01683058|464201086|FG000|Overall Study|Lack of Efficacy|2|||
128976812|NCT04062240|464201090|FG000|Overall Study|equipment malfunction|1|||
128976813|NCT01957111|464201091|FG000|Overall Study|Withdrawal by Subject|1|||
128976814|NCT01957111|464201092|FG001|Overall Study|Withdrawal by Subject|1|||
128976815|NCT01057394|464201093|FG000|Overall Study|Not eligible|0|||
128976816|NCT01057394|464201094|FG001|Overall Study|Not eligible|2|||
128976817|NCT01195636|464201095|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
128976818|NCT01195636|464201096|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
128976819|NCT01195636|464201095|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
128976820|NCT01195636|464201096|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
128976821|NCT01195636|464201095|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
128976822|NCT01195636|464201096|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
128976823|NCT01195636|464201095|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
128976824|NCT01195636|464201096|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
128976825|NCT01195636|464201095|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
128976826|NCT01195636|464201096|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
128976827|NCT01195636|464201095|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
128976828|NCT01195636|464201096|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
128976829|NCT01195636|464201095|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
128976830|NCT01195636|464201096|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
128976831|NCT01195636|464201095|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
128976832|NCT01195636|464201096|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
128976833|NCT03500419|464201097|FG000|Overall Study|Withdrawal by Subject|2|||
128976834|NCT03500419|464201098|FG001|Overall Study|Withdrawal by Subject|25|||
128976835|NCT00203294|464201099|FG000|Overall Study|Withdrawal by Subject|8|||
128976836|NCT00203294|464201100|FG001|Overall Study|Withdrawal by Subject|13|||
128976837|NCT00082628|464201101|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
128976838|NCT00082628|464201102|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
128976839|NCT00082628|464201103|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
128976840|NCT00082628|464201104|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
128976841|NCT00082628|464201105|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
128976842|NCT00082628|464201101|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
128976843|NCT00082628|464201102|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
128976844|NCT00082628|464201103|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
128976845|NCT00082628|464201104|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
128976846|NCT00082628|464201105|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
128976847|NCT00082628|464201101|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
128976848|NCT00082628|464201102|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
128976849|NCT00082628|464201103|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
128976850|NCT00082628|464201104|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
128976851|NCT00082628|464201105|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
128976852|NCT00082628|464201101|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
128976853|NCT00082628|464201102|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
128976854|NCT00082628|464201103|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
128976855|NCT00082628|464201104|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
128976856|NCT00082628|464201105|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
128976857|NCT00082628|464201101|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
128976858|NCT00082628|464201102|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
128976859|NCT00082628|464201103|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
128976860|NCT00082628|464201104|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
128976861|NCT00082628|464201105|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
128976862|NCT00082628|464201101|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
128976863|NCT00082628|464201102|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
128976864|NCT00082628|464201103|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
128976865|NCT00082628|464201104|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
128976866|NCT00082628|464201105|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
128976867|NCT00082628|464201101|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
128976868|NCT00082628|464201102|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
128976869|NCT00082628|464201103|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
128976870|NCT00082628|464201104|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
128976871|NCT00082628|464201105|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
128976872|NCT01566981|464201106|FG000|Overall Study|Lost to Follow-up|5|||
128976873|NCT01566981|464201107|FG001|Overall Study|Lost to Follow-up|8|||
128976874|NCT03481634|464201111|FG000|Overall Study|Withdrawal by Subject|16|||
128976875|NCT03481634|464201112|FG001|Overall Study|Withdrawal by Subject|19|||
128976876|NCT03481634|464201113|FG002|Overall Study|Withdrawal by Subject|14|||
128976877|NCT03481634|464201111|FG000|Overall Study|Protocol Violation|1|||
128976878|NCT03481634|464201112|FG001|Overall Study|Protocol Violation|0|||
128976879|NCT03481634|464201113|FG002|Overall Study|Protocol Violation|1|||
128976880|NCT03481634|464201111|FG000|Overall Study|Progressive disease|0|||
128976881|NCT03481634|464201112|FG001|Overall Study|Progressive disease|1|||
128976882|NCT03481634|464201113|FG002|Overall Study|Progressive disease|0|||
128976883|NCT03481634|464201111|FG000|Overall Study|Physician Decision|3|||
128976884|NCT03481634|464201112|FG001|Overall Study|Physician Decision|0|||
128976885|NCT03481634|464201113|FG002|Overall Study|Physician Decision|1|||
128976886|NCT03481634|464201111|FG000|Overall Study|Lost to Follow-up|3|||
128976887|NCT03481634|464201112|FG001|Overall Study|Lost to Follow-up|4|||
128976888|NCT03481634|464201113|FG002|Overall Study|Lost to Follow-up|4|||
128976889|NCT03481634|464201111|FG000|Overall Study|Death|4|||
128976890|NCT03481634|464201112|FG001|Overall Study|Death|8|||
128976891|NCT03481634|464201113|FG002|Overall Study|Death|7|||
128976892|NCT03481634|464201111|FG000|Overall Study|Adverse Event|6|||
128976893|NCT03481634|464201112|FG001|Overall Study|Adverse Event|3|||
128976894|NCT03481634|464201113|FG002|Overall Study|Adverse Event|7|||
128976895|NCT00994890|464201116|FG000|Overall Study|Adverse Event|13|||
128976896|NCT00994890|464201117|FG001|Overall Study|Adverse Event|9|||
128976897|NCT00994890|464201118|FG002|Overall Study|Adverse Event|11|||
128976898|NCT00994890|464201116|FG000|Overall Study|Lack of Efficacy|0|||
128976899|NCT00994890|464201117|FG001|Overall Study|Lack of Efficacy|0|||
128976900|NCT00994890|464201118|FG002|Overall Study|Lack of Efficacy|1|||
128976901|NCT00994890|464201116|FG000|Overall Study|Lost to Follow-up|6|||
128976902|NCT00994890|464201117|FG001|Overall Study|Lost to Follow-up|1|||
128976903|NCT00994890|464201118|FG002|Overall Study|Lost to Follow-up|3|||
128976904|NCT00994890|464201116|FG000|Overall Study|No longer willing to participate|8|||
128976905|NCT00994890|464201117|FG001|Overall Study|No longer willing to participate|5|||
128976906|NCT00994890|464201118|FG002|Overall Study|No longer willing to participate|13|||
128976907|NCT00994890|464201116|FG000|Overall Study|Protocol Violation|2|||
128976908|NCT00994890|464201117|FG001|Overall Study|Protocol Violation|4|||
128976909|NCT00994890|464201118|FG002|Overall Study|Protocol Violation|0|||
128976910|NCT00994890|464201116|FG000|Overall Study|Study terminated by sponsor|199|||
128976911|NCT00994890|464201117|FG001|Overall Study|Study terminated by sponsor|201|||
128976912|NCT00994890|464201118|FG002|Overall Study|Study terminated by sponsor|197|||
128976913|NCT00994890|464201116|FG000|Overall Study|Randomized, but not treated|1|||
128976914|NCT00994890|464201117|FG001|Overall Study|Randomized, but not treated|0|||
128976915|NCT00994890|464201118|FG002|Overall Study|Randomized, but not treated|0|||
128976916|NCT00994890|464201116|FG000|Overall Study|Other|2|||
128976917|NCT00994890|464201117|FG001|Overall Study|Other|2|||
128976918|NCT00994890|464201118|FG002|Overall Study|Other|1|||
128976919|NCT03323385|464201123|FG000|Overall Study|Withdrawal by Subject|1|||
128976920|NCT03323385|464201124|FG001|Overall Study|Withdrawal by Subject|2|||
128976921|NCT03323385|464201123|FG000|Overall Study|Noncompliance|0|||
128976922|NCT03323385|464201124|FG001|Overall Study|Noncompliance|1|||
128976923|NCT00247962|464201125|FG000|Overall Study|Adverse Event|15|||
128976924|NCT00247962|464201126|FG001|Overall Study|Adverse Event|12|||
128976925|NCT00247962|464201125|FG000|Overall Study|Lost to Follow-up|3|||
128976926|NCT00247962|464201126|FG001|Overall Study|Lost to Follow-up|1|||
128976927|NCT00247962|464201125|FG000|Overall Study|Physician Decision|0|||
128976928|NCT00247962|464201126|FG001|Overall Study|Physician Decision|1|||
128976929|NCT00247962|464201125|FG000|Overall Study|Protocol Violation|1|||
128976930|NCT00247962|464201126|FG001|Overall Study|Protocol Violation|1|||
128976931|NCT00247962|464201125|FG000|Overall Study|Withdrawal by Subject|3|||
128976932|NCT00247962|464201126|FG001|Overall Study|Withdrawal by Subject|2|||
128976933|NCT00247962|464201125|FG000|Overall Study|Lack of Efficacy|4|||
128976934|NCT00247962|464201126|FG001|Overall Study|Lack of Efficacy|2|||
129039955|NCT03785145|464438695|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
129039956|NCT03785145|464438696|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
129039957|NCT01552369|464438697|FG000|Overall Study|Did not consent to extended follow up|8|||
129039958|NCT01552369|464438698|FG001|Overall Study|Did not consent to extended follow up|9|||
128976935|NCT01849289|464201127|FG000|Overall Study|Adverse Event|3|||
129039959|NCT03250299|464438702|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
128976936|NCT01849289|464201128|FG001|Overall Study|Adverse Event|3|||
128976937|NCT01849289|464201127|FG000|Overall Study|Protocol Violation|3|||
128976938|NCT01849289|464201128|FG001|Overall Study|Protocol Violation|3|||
128976939|NCT01849289|464201127|FG000|Overall Study|Withdrawal criteria|1|||
128976940|NCT01849289|464201128|FG001|Overall Study|Withdrawal criteria|0|||
128976941|NCT01849289|464201127|FG000|Overall Study|Unclassified|25|||
128976942|NCT01849289|464201128|FG001|Overall Study|Unclassified|18|||
128976943|NCT01469637|464201129|FG000|First Intervention|Unacceptable behavior|0|||
128976944|NCT01469637|464201130|FG001|First Intervention|Unacceptable behavior|1|||
128976945|NCT01469637|464201129|FG000|Second Intervention|Incarcerated|1|||
128976946|NCT01469637|464201130|FG001|Second Intervention|Incarcerated|0|||
128976947|NCT00598585|464201131|FG000|Overall Study|Lost to Follow-up|1|||
128976948|NCT00598585|464201132|FG001|Overall Study|Lost to Follow-up|0|||
128976949|NCT02607735|464201135|FG000|Primary Study|Randomized but Never Treated|1|||
128976950|NCT02607735|464201136|FG001|Primary Study|Randomized but Never Treated|0|||
129132804|NCT00758043|464778528|FG002|Overall Study|Lack of Efficacy|18|||
129132805|NCT00758043|464778529|FG003|Overall Study|Lack of Efficacy|12|||
129132806|NCT00758043|464778526|FG000|Overall Study|Refused Further Treatment|0|||
129132807|NCT00758043|464778527|FG001|Overall Study|Refused Further Treatment|11|||
129132808|NCT00758043|464778528|FG002|Overall Study|Refused Further Treatment|5|||
129132809|NCT00758043|464778529|FG003|Overall Study|Refused Further Treatment|8|||
129132810|NCT00758043|464778526|FG000|Overall Study|Lost to Follow-up|0|||
128976951|NCT02607735|464201137|FG002|Primary Study|Randomized but Never Treated|0|||
128976952|NCT02607735|464201135|FG000|Primary Study|Lost to Follow-up|4|||
128976953|NCT02607735|464201136|FG001|Primary Study|Lost to Follow-up|0|||
128976954|NCT02607735|464201137|FG002|Primary Study|Lost to Follow-up|0|||
128976955|NCT02607735|464201135|FG000|Primary Study|Withdrew Consent|2|||
128976956|NCT02607735|464201136|FG001|Primary Study|Withdrew Consent|0|||
128976957|NCT02607735|464201137|FG002|Primary Study|Withdrew Consent|0|||
128976958|NCT02607735|464201135|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
128976959|NCT02607735|464201136|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
128976960|NCT02607735|464201137|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
128976961|NCT02607735|464201135|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
128976962|NCT02607735|464201136|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
128976963|NCT02607735|464201137|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
128976964|NCT02394028|464201138|FG000|Induction Phase|Adverse Event|2|||
128976965|NCT02394028|464201139|FG001|Induction Phase|Adverse Event|4|||
128976966|NCT02394028|464201140|FG002|Induction Phase|Adverse Event|1|||
128976967|NCT02394028|464201141|FG003|Induction Phase|Adverse Event|2|||
128976968|NCT02394028|464201142|FG004|Induction Phase|Adverse Event|5|||
128976969|NCT02394028|464201143|FG005|Induction Phase|Adverse Event|2|||
128976970|NCT02394028|464201144|FG006|Induction Phase|Adverse Event|0|||
128976971|NCT02394028|464201145|FG007|Induction Phase|Adverse Event|0|||
128976972|NCT02394028|464201146|FG008|Induction Phase|Adverse Event|0|||
128976973|NCT02394028|464201147|FG009|Induction Phase|Adverse Event|0|||
128976974|NCT02394028|464201148|FG010|Induction Phase|Adverse Event|0|||
128976975|NCT02394028|464201138|FG000|Induction Phase|Lack of Efficacy|3|||
128976976|NCT02394028|464201139|FG001|Induction Phase|Lack of Efficacy|6|||
128976977|NCT02394028|464201140|FG002|Induction Phase|Lack of Efficacy|2|||
128976978|NCT02394028|464201141|FG003|Induction Phase|Lack of Efficacy|17|||
128976979|NCT02394028|464201142|FG004|Induction Phase|Lack of Efficacy|14|||
128976980|NCT02394028|464201143|FG005|Induction Phase|Lack of Efficacy|8|||
128976981|NCT02394028|464201144|FG006|Induction Phase|Lack of Efficacy|17|||
128976982|NCT02394028|464201145|FG007|Induction Phase|Lack of Efficacy|23|||
128976983|NCT02394028|464201146|FG008|Induction Phase|Lack of Efficacy|0|||
128976984|NCT02394028|464201147|FG009|Induction Phase|Lack of Efficacy|0|||
128976985|NCT02394028|464201148|FG010|Induction Phase|Lack of Efficacy|0|||
128976986|NCT02394028|464201138|FG000|Induction Phase|Lost to Follow-up|1|||
128976987|NCT02394028|464201139|FG001|Induction Phase|Lost to Follow-up|0|||
128976988|NCT02394028|464201140|FG002|Induction Phase|Lost to Follow-up|0|||
128976989|NCT02394028|464201141|FG003|Induction Phase|Lost to Follow-up|1|||
128976990|NCT02394028|464201142|FG004|Induction Phase|Lost to Follow-up|0|||
128976991|NCT02394028|464201143|FG005|Induction Phase|Lost to Follow-up|0|||
128976992|NCT02394028|464201144|FG006|Induction Phase|Lost to Follow-up|1|||
128976993|NCT02394028|464201145|FG007|Induction Phase|Lost to Follow-up|0|||
128976994|NCT02394028|464201146|FG008|Induction Phase|Lost to Follow-up|0|||
128976995|NCT02394028|464201147|FG009|Induction Phase|Lost to Follow-up|0|||
128976996|NCT02394028|464201148|FG010|Induction Phase|Lost to Follow-up|0|||
128976997|NCT02394028|464201138|FG000|Induction Phase|Non-compliance|0|||
128976998|NCT02394028|464201139|FG001|Induction Phase|Non-compliance|1|||
128976999|NCT02394028|464201140|FG002|Induction Phase|Non-compliance|3|||
128977000|NCT02394028|464201141|FG003|Induction Phase|Non-compliance|1|||
128977001|NCT02394028|464201142|FG004|Induction Phase|Non-compliance|3|||
128977002|NCT02394028|464201143|FG005|Induction Phase|Non-compliance|0|||
128977003|NCT02394028|464201144|FG006|Induction Phase|Non-compliance|1|||
128977004|NCT02394028|464201145|FG007|Induction Phase|Non-compliance|1|||
128977005|NCT02394028|464201146|FG008|Induction Phase|Non-compliance|0|||
128977006|NCT02394028|464201147|FG009|Induction Phase|Non-compliance|0|||
128977007|NCT02394028|464201148|FG010|Induction Phase|Non-compliance|0|||
128977008|NCT02394028|464201138|FG000|Induction Phase|Physician Decision|0|||
128977009|NCT02394028|464201139|FG001|Induction Phase|Physician Decision|0|||
128977010|NCT02394028|464201140|FG002|Induction Phase|Physician Decision|1|||
128977011|NCT02394028|464201141|FG003|Induction Phase|Physician Decision|4|||
128977012|NCT02394028|464201142|FG004|Induction Phase|Physician Decision|0|||
128977013|NCT02394028|464201143|FG005|Induction Phase|Physician Decision|2|||
129132811|NCT00758043|464778527|FG001|Overall Study|Lost to Follow-up|2|||
129132812|NCT00758043|464778528|FG002|Overall Study|Lost to Follow-up|2|||
128977014|NCT02394028|464201144|FG006|Induction Phase|Physician Decision|1|||
128977015|NCT02394028|464201145|FG007|Induction Phase|Physician Decision|0|||
128977016|NCT02394028|464201146|FG008|Induction Phase|Physician Decision|0|||
128977017|NCT02394028|464201147|FG009|Induction Phase|Physician Decision|0|||
128977018|NCT02394028|464201148|FG010|Induction Phase|Physician Decision|0|||
128977019|NCT02394028|464201138|FG000|Induction Phase|Protocol Violation|0|||
128977020|NCT02394028|464201139|FG001|Induction Phase|Protocol Violation|2|||
128977021|NCT02394028|464201140|FG002|Induction Phase|Protocol Violation|0|||
128977022|NCT02394028|464201141|FG003|Induction Phase|Protocol Violation|3|||
128977023|NCT02394028|464201142|FG004|Induction Phase|Protocol Violation|0|||
128977024|NCT02394028|464201143|FG005|Induction Phase|Protocol Violation|1|||
128977025|NCT02394028|464201144|FG006|Induction Phase|Protocol Violation|1|||
128977026|NCT02394028|464201145|FG007|Induction Phase|Protocol Violation|0|||
128977027|NCT02394028|464201146|FG008|Induction Phase|Protocol Violation|0|||
128977028|NCT02394028|464201147|FG009|Induction Phase|Protocol Violation|0|||
128977029|NCT02394028|464201148|FG010|Induction Phase|Protocol Violation|0|||
128977030|NCT02394028|464201138|FG000|Induction Phase|Withdrawal by Subject|1|||
128977031|NCT02394028|464201139|FG001|Induction Phase|Withdrawal by Subject|2|||
128977032|NCT02394028|464201140|FG002|Induction Phase|Withdrawal by Subject|4|||
128977033|NCT02394028|464201141|FG003|Induction Phase|Withdrawal by Subject|6|||
128977034|NCT02394028|464201142|FG004|Induction Phase|Withdrawal by Subject|7|||
128977035|NCT02394028|464201143|FG005|Induction Phase|Withdrawal by Subject|4|||
128977036|NCT02394028|464201144|FG006|Induction Phase|Withdrawal by Subject|3|||
128977037|NCT02394028|464201145|FG007|Induction Phase|Withdrawal by Subject|6|||
128977038|NCT02394028|464201146|FG008|Induction Phase|Withdrawal by Subject|0|||
128977039|NCT02394028|464201147|FG009|Induction Phase|Withdrawal by Subject|0|||
128977040|NCT02394028|464201148|FG010|Induction Phase|Withdrawal by Subject|0|||
128977041|NCT02394028|464201138|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977042|NCT02394028|464201139|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977043|NCT02394028|464201140|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977044|NCT02394028|464201141|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977045|NCT02394028|464201142|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977046|NCT02394028|464201143|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977047|NCT02394028|464201144|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
128977048|NCT02394028|464201145|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977049|NCT02394028|464201146|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977050|NCT02394028|464201147|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977051|NCT02394028|464201148|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
128977052|NCT02394028|464201138|FG000|Induction Phase|Sponsor decision|0|||
128977053|NCT02394028|464201139|FG001|Induction Phase|Sponsor decision|1|||
128977054|NCT02394028|464201140|FG002|Induction Phase|Sponsor decision|2|||
128977055|NCT02394028|464201141|FG003|Induction Phase|Sponsor decision|0|||
128977056|NCT02394028|464201142|FG004|Induction Phase|Sponsor decision|0|||
128977057|NCT02394028|464201143|FG005|Induction Phase|Sponsor decision|0|||
128977058|NCT02394028|464201144|FG006|Induction Phase|Sponsor decision|0|||
128977059|NCT02394028|464201145|FG007|Induction Phase|Sponsor decision|0|||
128977060|NCT02394028|464201146|FG008|Induction Phase|Sponsor decision|0|||
128977061|NCT02394028|464201147|FG009|Induction Phase|Sponsor decision|0|||
128977062|NCT02394028|464201148|FG010|Induction Phase|Sponsor decision|0|||
128977063|NCT02394028|464201138|FG000|Induction Phase|Technical reason|0|||
128977064|NCT02394028|464201139|FG001|Induction Phase|Technical reason|0|||
128977065|NCT02394028|464201140|FG002|Induction Phase|Technical reason|0|||
128977066|NCT02394028|464201141|FG003|Induction Phase|Technical reason|1|||
128977067|NCT02394028|464201142|FG004|Induction Phase|Technical reason|0|||
128977068|NCT02394028|464201143|FG005|Induction Phase|Technical reason|0|||
128977069|NCT02394028|464201144|FG006|Induction Phase|Technical reason|0|||
128977070|NCT02394028|464201145|FG007|Induction Phase|Technical reason|0|||
128977071|NCT02394028|464201146|FG008|Induction Phase|Technical reason|0|||
128977072|NCT02394028|464201147|FG009|Induction Phase|Technical reason|0|||
128977073|NCT02394028|464201148|FG010|Induction Phase|Technical reason|0|||
128977074|NCT02394028|464201138|FG000|Induction Phase|:ack of calculation|0|||
128977075|NCT02394028|464201139|FG001|Induction Phase|:ack of calculation|0|||
128977076|NCT02394028|464201140|FG002|Induction Phase|:ack of calculation|0|||
128977077|NCT02394028|464201141|FG003|Induction Phase|:ack of calculation|0|||
128977078|NCT02394028|464201142|FG004|Induction Phase|:ack of calculation|0|||
129039960|NCT03250299|464438703|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
129039961|NCT03250299|464438704|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
129039962|NCT03250299|464438705|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
129039963|NCT03250299|464438706|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
129039964|NCT03250299|464438702|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
128977079|NCT02394028|464201143|FG005|Induction Phase|:ack of calculation|0|||
128977080|NCT02394028|464201144|FG006|Induction Phase|:ack of calculation|0|||
128977081|NCT02394028|464201145|FG007|Induction Phase|:ack of calculation|1|||
128977082|NCT02394028|464201146|FG008|Induction Phase|:ack of calculation|0|||
128977083|NCT02394028|464201147|FG009|Induction Phase|:ack of calculation|0|||
128977084|NCT02394028|464201148|FG010|Induction Phase|:ack of calculation|0|||
128977085|NCT02394028|464201138|FG000|Maintenance Phase|Protocol Violation|0|||
128977086|NCT02394028|464201139|FG001|Maintenance Phase|Protocol Violation|0|||
128977087|NCT02394028|464201140|FG002|Maintenance Phase|Protocol Violation|0|||
129039965|NCT03250299|464438703|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
129039966|NCT03250299|464438704|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
128717432|NCT01729754|463263912|FG003|Part 2|Non-Compliance with Study Drug|0|||
128717433|NCT01729754|463263913|FG004|Part 2|Non-Compliance with Study Drug|0|||
128717434|NCT01729754|463263914|FG005|Part 2|Non-Compliance with Study Drug|0|||
128717435|NCT01729754|463263915|FG006|Part 2|Non-Compliance with Study Drug|0|||
128977088|NCT02394028|464201141|FG003|Maintenance Phase|Protocol Violation|0|||
128977089|NCT02394028|464201142|FG004|Maintenance Phase|Protocol Violation|0|||
128977090|NCT02394028|464201143|FG005|Maintenance Phase|Protocol Violation|0|||
128977091|NCT02394028|464201144|FG006|Maintenance Phase|Protocol Violation|0|||
128977092|NCT02394028|464201145|FG007|Maintenance Phase|Protocol Violation|0|||
128977093|NCT02394028|464201146|FG008|Maintenance Phase|Protocol Violation|0|||
128977094|NCT02394028|464201147|FG009|Maintenance Phase|Protocol Violation|0|||
128977095|NCT02394028|464201148|FG010|Maintenance Phase|Protocol Violation|1|||
128977096|NCT02394028|464201138|FG000|Maintenance Phase|Physician Decision|0|||
128977097|NCT02394028|464201139|FG001|Maintenance Phase|Physician Decision|0|||
128717436|NCT01729754|463263916|FG007|Part 2|Non-Compliance with Study Drug|0|||
128717437|NCT01729754|463263917|FG008|Part 2|Non-Compliance with Study Drug|0|||
128717438|NCT01729754|463263918|FG009|Part 2|Non-Compliance with Study Drug|1|||
128717439|NCT01729754|463263909|FG000|Part 2|Pregnancy|0|||
128717440|NCT01729754|463263910|FG001|Part 2|Pregnancy|0|||
128717441|NCT01729754|463263911|FG002|Part 2|Pregnancy|0|||
128717442|NCT01729754|463263912|FG003|Part 2|Pregnancy|1|||
128717443|NCT01729754|463263913|FG004|Part 2|Pregnancy|0|||
129222083|NCT04189445|465116014|FG001|Overall Study|Withdrawal of consent|1|||
129222084|NCT04189445|465116015|FG002|Overall Study|Withdrawal of consent|0|||
128977098|NCT02394028|464201140|FG002|Maintenance Phase|Physician Decision|0|||
128977099|NCT02394028|464201141|FG003|Maintenance Phase|Physician Decision|0|||
128977100|NCT02394028|464201142|FG004|Maintenance Phase|Physician Decision|0|||
128977101|NCT02394028|464201143|FG005|Maintenance Phase|Physician Decision|0|||
128977102|NCT02394028|464201144|FG006|Maintenance Phase|Physician Decision|0|||
128977103|NCT02394028|464201145|FG007|Maintenance Phase|Physician Decision|0|||
128977104|NCT02394028|464201146|FG008|Maintenance Phase|Physician Decision|1|||
128977105|NCT02394028|464201147|FG009|Maintenance Phase|Physician Decision|3|||
128977106|NCT02394028|464201148|FG010|Maintenance Phase|Physician Decision|2|||
128977107|NCT02394028|464201138|FG000|Maintenance Phase|Lack of Efficacy|0|||
128977108|NCT02394028|464201139|FG001|Maintenance Phase|Lack of Efficacy|0|||
128977109|NCT02394028|464201140|FG002|Maintenance Phase|Lack of Efficacy|0|||
128977110|NCT02394028|464201141|FG003|Maintenance Phase|Lack of Efficacy|0|||
128977111|NCT02394028|464201142|FG004|Maintenance Phase|Lack of Efficacy|0|||
128977112|NCT02394028|464201143|FG005|Maintenance Phase|Lack of Efficacy|0|||
128977113|NCT02394028|464201144|FG006|Maintenance Phase|Lack of Efficacy|0|||
128977114|NCT02394028|464201145|FG007|Maintenance Phase|Lack of Efficacy|0|||
128977115|NCT02394028|464201146|FG008|Maintenance Phase|Lack of Efficacy|7|||
128977116|NCT02394028|464201147|FG009|Maintenance Phase|Lack of Efficacy|25|||
128977117|NCT02394028|464201148|FG010|Maintenance Phase|Lack of Efficacy|33|||
128977118|NCT02394028|464201138|FG000|Maintenance Phase|Death|0|||
128977119|NCT02394028|464201139|FG001|Maintenance Phase|Death|0|||
128977120|NCT02394028|464201140|FG002|Maintenance Phase|Death|0|||
128977121|NCT02394028|464201141|FG003|Maintenance Phase|Death|0|||
128977122|NCT02394028|464201142|FG004|Maintenance Phase|Death|0|||
128977123|NCT02394028|464201143|FG005|Maintenance Phase|Death|0|||
128977124|NCT02394028|464201144|FG006|Maintenance Phase|Death|0|||
128977125|NCT02394028|464201145|FG007|Maintenance Phase|Death|0|||
128977126|NCT02394028|464201146|FG008|Maintenance Phase|Death|0|||
128977127|NCT02394028|464201147|FG009|Maintenance Phase|Death|0|||
128977128|NCT02394028|464201148|FG010|Maintenance Phase|Death|1|||
128977129|NCT02394028|464201138|FG000|Maintenance Phase|Adverse Event|0|||
128977130|NCT02394028|464201139|FG001|Maintenance Phase|Adverse Event|0|||
128977131|NCT02394028|464201140|FG002|Maintenance Phase|Adverse Event|0|||
128977132|NCT02394028|464201141|FG003|Maintenance Phase|Adverse Event|0|||
128977133|NCT02394028|464201142|FG004|Maintenance Phase|Adverse Event|0|||
128717444|NCT01729754|463263914|FG005|Part 2|Pregnancy|0|||
128717445|NCT01729754|463263915|FG006|Part 2|Pregnancy|0|||
128717446|NCT01729754|463263916|FG007|Part 2|Pregnancy|0|||
128717447|NCT01729754|463263917|FG008|Part 2|Pregnancy|0|||
128717448|NCT01729754|463263918|FG009|Part 2|Pregnancy|1|||
128717449|NCT01729754|463263909|FG000|Part 2|Withdrawal by Subject|3|||
128977134|NCT02394028|464201143|FG005|Maintenance Phase|Adverse Event|0|||
128977135|NCT02394028|464201144|FG006|Maintenance Phase|Adverse Event|0|||
128977136|NCT02394028|464201145|FG007|Maintenance Phase|Adverse Event|0|||
128977137|NCT02394028|464201146|FG008|Maintenance Phase|Adverse Event|1|||
128977138|NCT02394028|464201147|FG009|Maintenance Phase|Adverse Event|1|||
128977139|NCT02394028|464201148|FG010|Maintenance Phase|Adverse Event|3|||
128977140|NCT02394028|464201138|FG000|Maintenance Phase|Site closure|0|||
128977141|NCT02394028|464201139|FG001|Maintenance Phase|Site closure|0|||
129222085|NCT04189445|465116013|FG000|Overall Study|Study Terminated by Sponsor|25|||
129222086|NCT04189445|465116014|FG001|Overall Study|Study Terminated by Sponsor|3|||
128717450|NCT01729754|463263910|FG001|Part 2|Withdrawal by Subject|0|||
128717451|NCT01729754|463263911|FG002|Part 2|Withdrawal by Subject|0|||
128717452|NCT01729754|463263912|FG003|Part 2|Withdrawal by Subject|2|||
128717453|NCT01729754|463263913|FG004|Part 2|Withdrawal by Subject|0|||
129039967|NCT03250299|464438705|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
129039968|NCT03250299|464438706|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
129039969|NCT03250299|464438702|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129039970|NCT03250299|464438703|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129039971|NCT03250299|464438704|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
129039972|NCT03250299|464438705|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129039973|NCT03250299|464438706|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129039974|NCT03250299|464438702|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
129039975|NCT03250299|464438703|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
129039976|NCT03250299|464438704|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
129039977|NCT03250299|464438705|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
129039978|NCT03250299|464438706|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
129132813|NCT00758043|464778529|FG003|Overall Study|Lost to Follow-up|5|||
128977142|NCT02394028|464201140|FG002|Maintenance Phase|Site closure|0|||
128977143|NCT02394028|464201141|FG003|Maintenance Phase|Site closure|0|||
128977144|NCT02394028|464201142|FG004|Maintenance Phase|Site closure|0|||
128977145|NCT02394028|464201143|FG005|Maintenance Phase|Site closure|0|||
128977146|NCT02394028|464201144|FG006|Maintenance Phase|Site closure|0|||
128977147|NCT02394028|464201145|FG007|Maintenance Phase|Site closure|0|||
128977148|NCT02394028|464201146|FG008|Maintenance Phase|Site closure|0|||
128977149|NCT02394028|464201147|FG009|Maintenance Phase|Site closure|1|||
128977150|NCT02394028|464201148|FG010|Maintenance Phase|Site closure|0|||
128977151|NCT02394028|464201138|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128977152|NCT02394028|464201139|FG001|Maintenance Phase|Withdrawal by Subject|0|||
128977153|NCT02394028|464201140|FG002|Maintenance Phase|Withdrawal by Subject|0|||
128977154|NCT02394028|464201141|FG003|Maintenance Phase|Withdrawal by Subject|0|||
128977155|NCT02394028|464201142|FG004|Maintenance Phase|Withdrawal by Subject|0|||
128977156|NCT02394028|464201143|FG005|Maintenance Phase|Withdrawal by Subject|0|||
128977157|NCT02394028|464201144|FG006|Maintenance Phase|Withdrawal by Subject|0|||
128977158|NCT02394028|464201145|FG007|Maintenance Phase|Withdrawal by Subject|0|||
128977159|NCT02394028|464201146|FG008|Maintenance Phase|Withdrawal by Subject|3|||
128977160|NCT02394028|464201147|FG009|Maintenance Phase|Withdrawal by Subject|12|||
128977161|NCT02394028|464201148|FG010|Maintenance Phase|Withdrawal by Subject|12|||
128977162|NCT02355665|464201151|FG000|Overall Study|Adverse Event|16|||
128977163|NCT02355665|464201152|FG001|Overall Study|Adverse Event|24|||
128977164|NCT02355665|464201151|FG000|Overall Study|Protocol Violation|2|||
128977165|NCT02355665|464201152|FG001|Overall Study|Protocol Violation|0|||
128977166|NCT02355665|464201151|FG000|Overall Study|Withdrawal by Subject|90|||
128977167|NCT02355665|464201152|FG001|Overall Study|Withdrawal by Subject|100|||
128977168|NCT02355665|464201151|FG000|Overall Study|Lost to Follow-up|131|||
128977169|NCT02355665|464201152|FG001|Overall Study|Lost to Follow-up|103|||
128977170|NCT02355665|464201151|FG000|Overall Study|Death|4|||
128977171|NCT02355665|464201152|FG001|Overall Study|Death|2|||
128977172|NCT02355665|464201151|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
128977173|NCT02355665|464201152|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
128977174|NCT04129242|464201153|FG000|Overall Study|Physician Decision|1|||
128977175|NCT04129242|464201154|FG001|Overall Study|Physician Decision|1|||
128977176|NCT04129242|464201153|FG000|Overall Study|Protocol Violation|0|||
128977177|NCT04129242|464201154|FG001|Overall Study|Protocol Violation|1|||
128977178|NCT01775995|464201155|FG000|Overall Study|Lost to Follow-up|1|||
128977179|NCT01775995|464201156|FG001|Overall Study|Lost to Follow-up|1|||
128977180|NCT02918006|464201158|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
128977181|NCT02918006|464201159|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
128977182|NCT02918006|464201160|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
128977183|NCT02918006|464201158|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
128977184|NCT02918006|464201159|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
128977185|NCT02918006|464201160|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
128977186|NCT02918006|464201158|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
128977187|NCT02918006|464201159|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
128977188|NCT02918006|464201160|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
128977189|NCT02918006|464201158|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
128977190|NCT02918006|464201159|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
128977191|NCT02918006|464201160|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
128977192|NCT02918006|464201158|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
128977193|NCT02918006|464201159|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
128977194|NCT02918006|464201160|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
128977195|NCT02918006|464201158|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
128977196|NCT02918006|464201159|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
128977197|NCT02918006|464201160|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
128977198|NCT02918006|464201158|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
128977199|NCT02918006|464201159|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
128977200|NCT02918006|464201160|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
128977201|NCT02918006|464201158|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
128977202|NCT02918006|464201159|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
128717454|NCT01729754|463263914|FG005|Part 2|Withdrawal by Subject|0|||
128717455|NCT01729754|463263915|FG006|Part 2|Withdrawal by Subject|0|||
128717456|NCT01729754|463263916|FG007|Part 2|Withdrawal by Subject|1|||
128717457|NCT01729754|463263917|FG008|Part 2|Withdrawal by Subject|1|||
128717458|NCT01729754|463263918|FG009|Part 2|Withdrawal by Subject|4|||
128717459|NCT01729754|463263909|FG000|Part 2|Other Protocol Specified Criteria|1|||
128717460|NCT01729754|463263910|FG001|Part 2|Other Protocol Specified Criteria|0|||
128717461|NCT01729754|463263911|FG002|Part 2|Other Protocol Specified Criteria|0|||
128717462|NCT01729754|463263912|FG003|Part 2|Other Protocol Specified Criteria|0|||
128717463|NCT01729754|463263913|FG004|Part 2|Other Protocol Specified Criteria|0|||
128717464|NCT01729754|463263914|FG005|Part 2|Other Protocol Specified Criteria|0|||
128717465|NCT01729754|463263915|FG006|Part 2|Other Protocol Specified Criteria|0|||
128717466|NCT01729754|463263916|FG007|Part 2|Other Protocol Specified Criteria|1|||
128717467|NCT01729754|463263917|FG008|Part 2|Other Protocol Specified Criteria|0|||
128717468|NCT01729754|463263918|FG009|Part 2|Other Protocol Specified Criteria|0|||
128717469|NCT01729754|463263909|FG000|Part 3|Adverse Event|0|||
128717470|NCT01729754|463263910|FG001|Part 3|Adverse Event|0|||
128717471|NCT01729754|463263911|FG002|Part 3|Adverse Event|1|||
128717472|NCT01729754|463263912|FG003|Part 3|Adverse Event|0|||
128717473|NCT01729754|463263913|FG004|Part 3|Adverse Event|0|||
128717474|NCT01729754|463263914|FG005|Part 3|Adverse Event|5|||
128717475|NCT01729754|463263915|FG006|Part 3|Adverse Event|0|||
128717476|NCT01729754|463263916|FG007|Part 3|Adverse Event|0|||
128717477|NCT01729754|463263917|FG008|Part 3|Adverse Event|0|||
128717478|NCT01729754|463263918|FG009|Part 3|Adverse Event|3|||
128717479|NCT01729754|463263909|FG000|Part 3|Death|0|||
128717480|NCT01729754|463263910|FG001|Part 3|Death|0|||
128717481|NCT01729754|463263911|FG002|Part 3|Death|0|||
128717482|NCT01729754|463263912|FG003|Part 3|Death|0|||
128717483|NCT01729754|463263913|FG004|Part 3|Death|0|||
128717484|NCT01729754|463263914|FG005|Part 3|Death|2|||
128717485|NCT01729754|463263915|FG006|Part 3|Death|0|||
128717486|NCT01729754|463263916|FG007|Part 3|Death|0|||
128977203|NCT02918006|464201160|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
128977204|NCT02918006|464201158|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
128977205|NCT02918006|464201159|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
128977206|NCT02918006|464201160|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
128977207|NCT01084096|464203023|FG000|Overall Study|Lost to Follow-up|1501|||
128977208|NCT01084096|464203024|FG001|Overall Study|Lost to Follow-up|1833|||
128977209|NCT01084096|464203023|FG000|Overall Study|Withdrawal by Subject|3|||
128977210|NCT01084096|464203024|FG001|Overall Study|Withdrawal by Subject|0|||
128977211|NCT01084096|464203023|FG000|Overall Study|Woman had a miscarriage|21|||
128977212|NCT01084096|464203024|FG001|Overall Study|Woman had a miscarriage|17|||
128977213|NCT01354964|464203025|FG000|Overall Study|Lost to Follow-up|2|||
128977214|NCT01354964|464203026|FG001|Overall Study|Lost to Follow-up|0|||
128977215|NCT01354964|464203025|FG000|Overall Study|IV access issues|1|||
128977216|NCT01354964|464203026|FG001|Overall Study|IV access issues|1|||
128977217|NCT01354964|464203025|FG000|Overall Study|Physician Decision|1|||
128977218|NCT01354964|464203026|FG001|Overall Study|Physician Decision|0|||
128977219|NCT04450394|464203034|FG000|Overall Study|Adverse Event|2|||
128977220|NCT04450394|464203035|FG001|Overall Study|Adverse Event|0|||
128977221|NCT04450394|464203036|FG002|Overall Study|Adverse Event|0|||
128977222|NCT04450394|464203034|FG000|Overall Study|Death|0|||
128977223|NCT04450394|464203035|FG001|Overall Study|Death|1|||
128977224|NCT04450394|464203036|FG002|Overall Study|Death|0|||
128977225|NCT04450394|464203034|FG000|Overall Study|Lost to Follow-up|0|||
128977226|NCT04450394|464203035|FG001|Overall Study|Lost to Follow-up|3|||
129132814|NCT00758043|464778526|FG000|Overall Study|Withdrawal by Subject|0|||
128717487|NCT01729754|463263917|FG008|Part 3|Death|0|||
128717488|NCT01729754|463263918|FG009|Part 3|Death|0|||
128717489|NCT01729754|463263909|FG000|Part 3|Lack of Efficacy|0|||
128977227|NCT04450394|464203036|FG002|Overall Study|Lost to Follow-up|0|||
128977228|NCT04450394|464203034|FG000|Overall Study|Physician Decision|0|||
128717490|NCT01729754|463263910|FG001|Part 3|Lack of Efficacy|0|||
128717491|NCT01729754|463263911|FG002|Part 3|Lack of Efficacy|0|||
128717492|NCT01729754|463263912|FG003|Part 3|Lack of Efficacy|0|||
128717493|NCT01729754|463263913|FG004|Part 3|Lack of Efficacy|2|||
128717494|NCT01729754|463263914|FG005|Part 3|Lack of Efficacy|0|||
128774769|NCT01216293|463466662|FG002|Main Study|Other Reason Not Specified|1|||
128977229|NCT04450394|464203035|FG001|Overall Study|Physician Decision|1|||
128977230|NCT04450394|464203036|FG002|Overall Study|Physician Decision|0|||
129132815|NCT00758043|464778527|FG001|Overall Study|Withdrawal by Subject|1|||
128977231|NCT04450394|464203034|FG000|Overall Study|Protocol Violation|2|||
128977232|NCT04450394|464203035|FG001|Overall Study|Protocol Violation|0|||
128717495|NCT01729754|463263915|FG006|Part 3|Lack of Efficacy|0|||
128717496|NCT01729754|463263916|FG007|Part 3|Lack of Efficacy|0|||
128717497|NCT01729754|463263917|FG008|Part 3|Lack of Efficacy|0|||
128717498|NCT01729754|463263918|FG009|Part 3|Lack of Efficacy|4|||
128717499|NCT01729754|463263909|FG000|Part 3|Lost to Follow-up|0|||
128717500|NCT01729754|463263910|FG001|Part 3|Lost to Follow-up|1|||
128717501|NCT01729754|463263911|FG002|Part 3|Lost to Follow-up|2|||
128977233|NCT04450394|464203036|FG002|Overall Study|Protocol Violation|0|||
128977234|NCT04450394|464203034|FG000|Overall Study|Withdrawal by Subject|6|||
129222087|NCT04189445|465116015|FG002|Overall Study|Study Terminated by Sponsor|0|||
129039979|NCT03346070|464438707|FG000|Overall Study|Death|0|||
129039980|NCT03346070|464438708|FG001|Overall Study|Death|0|||
129039981|NCT03346070|464438709|FG002|Overall Study|Death|0|||
129039982|NCT03346070|464438710|FG003|Overall Study|Death|0|||
129039983|NCT03346070|464438711|FG004|Overall Study|Death|1|||
129039984|NCT03346070|464438707|FG000|Overall Study|Lost to Follow-up|0|||
129039985|NCT03346070|464438708|FG001|Overall Study|Lost to Follow-up|1|||
129039986|NCT03346070|464438709|FG002|Overall Study|Lost to Follow-up|2|||
129039987|NCT03346070|464438710|FG003|Overall Study|Lost to Follow-up|0|||
129039988|NCT03346070|464438711|FG004|Overall Study|Lost to Follow-up|0|||
129039989|NCT03346070|464438707|FG000|Overall Study|Physician Decision|0|||
129039990|NCT03346070|464438708|FG001|Overall Study|Physician Decision|0|||
129039991|NCT03346070|464438709|FG002|Overall Study|Physician Decision|0|||
129039992|NCT03346070|464438710|FG003|Overall Study|Physician Decision|1|||
129039993|NCT03346070|464438711|FG004|Overall Study|Physician Decision|1|||
129039994|NCT03346070|464438707|FG000|Overall Study|Withdrawal by Subject|1|||
129039995|NCT03346070|464438708|FG001|Overall Study|Withdrawal by Subject|0|||
129039996|NCT03346070|464438709|FG002|Overall Study|Withdrawal by Subject|0|||
129039997|NCT03346070|464438710|FG003|Overall Study|Withdrawal by Subject|1|||
129039998|NCT03346070|464438711|FG004|Overall Study|Withdrawal by Subject|0|||
129039999|NCT03346070|464438707|FG000|Overall Study|Study medication not received as planned|2|||
129040000|NCT03346070|464438708|FG001|Overall Study|Study medication not received as planned|3|||
129040001|NCT03346070|464438709|FG002|Overall Study|Study medication not received as planned|2|||
129040002|NCT03346070|464438710|FG003|Overall Study|Study medication not received as planned|3|||
129040003|NCT03346070|464438711|FG004|Overall Study|Study medication not received as planned|2|||
129040004|NCT03346070|464438707|FG000|Overall Study|Screen Failure|0|||
129040005|NCT03346070|464438708|FG001|Overall Study|Screen Failure|0|||
129040006|NCT03346070|464438709|FG002|Overall Study|Screen Failure|0|||
129040007|NCT03346070|464438710|FG003|Overall Study|Screen Failure|1|||
129040008|NCT03346070|464438711|FG004|Overall Study|Screen Failure|1|||
129040009|NCT00977548|464438717|FG000|Overall Study|Ineligible|4|||
129040010|NCT00977548|464438717|FG000|Overall Study|Adverse Event|8|||
129040011|NCT00977548|464438717|FG000|Overall Study|Withdrawal by Subject|1|||
129040012|NCT04086641|464438718|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
129040013|NCT04086641|464438719|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
129040014|NCT01042535|464438722|FG000|Overall Study|disease progression prior to treatment|3|||
129040015|NCT01042535|464438722|FG000|Overall Study|disease progression during treatment|3|||
129222088|NCT04189445|465116013|FG000|Overall Study|Death|54|||
129222089|NCT04189445|465116014|FG001|Overall Study|Death|24|||
129222090|NCT04189445|465116015|FG002|Overall Study|Death|0|||
129222091|NCT03184870|465116016|FG000|Initial Treatment|Death|6|||
129222092|NCT03184870|465116017|FG001|Initial Treatment|Death|6|||
128977235|NCT04450394|464203035|FG001|Overall Study|Withdrawal by Subject|9|||
128977236|NCT04450394|464203036|FG002|Overall Study|Withdrawal by Subject|0|||
128977237|NCT02155660|464203041|FG000|Overall Study|Other Reason|8|||
128977238|NCT02155660|464203042|FG001|Overall Study|Other Reason|6|||
128977239|NCT02155660|464203043|FG002|Overall Study|Other Reason|10|||
128977240|NCT02155660|464203044|FG003|Overall Study|Other Reason|10|||
128977241|NCT02155660|464203041|FG000|Overall Study|Study-specific withdrawal criteria|0|||
128977242|NCT02155660|464203042|FG001|Overall Study|Study-specific withdrawal criteria|1|||
128977243|NCT02155660|464203043|FG002|Overall Study|Study-specific withdrawal criteria|1|||
128977244|NCT02155660|464203044|FG003|Overall Study|Study-specific withdrawal criteria|1|||
128977245|NCT02155660|464203041|FG000|Overall Study|Severe non-compliance|0|||
128977246|NCT02155660|464203042|FG001|Overall Study|Severe non-compliance|4|||
128977247|NCT02155660|464203043|FG002|Overall Study|Severe non-compliance|0|||
128977248|NCT02155660|464203044|FG003|Overall Study|Severe non-compliance|1|||
128977249|NCT02155660|464203041|FG000|Overall Study|Adverse Event|2|||
128977250|NCT02155660|464203042|FG001|Overall Study|Adverse Event|6|||
128977251|NCT02155660|464203043|FG002|Overall Study|Adverse Event|3|||
128977252|NCT02155660|464203044|FG003|Overall Study|Adverse Event|1|||
128977253|NCT02155660|464203041|FG000|Overall Study|Lost to Follow-up|3|||
128977254|NCT02155660|464203042|FG001|Overall Study|Lost to Follow-up|6|||
128977255|NCT02155660|464203043|FG002|Overall Study|Lost to Follow-up|5|||
128977256|NCT02155660|464203044|FG003|Overall Study|Lost to Follow-up|8|||
128977257|NCT02155660|464203041|FG000|Overall Study|Death|17|||
128977258|NCT02155660|464203042|FG001|Overall Study|Death|19|||
128977259|NCT02155660|464203043|FG002|Overall Study|Death|17|||
128977260|NCT02155660|464203044|FG003|Overall Study|Death|19|||
128977261|NCT02155660|464203041|FG000|Overall Study|Withdrawal by Subject|28|||
128977262|NCT02155660|464203042|FG001|Overall Study|Withdrawal by Subject|31|||
129040016|NCT01042535|464438722|FG000|Overall Study|complications from other disease|2|||
129040017|NCT01546142|464438723|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
129040018|NCT01546142|464438724|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
129040019|NCT01546142|464438723|FG000|Overall Study|Subject Noncompliance|1|||
129040020|NCT01546142|464438724|FG001|Overall Study|Subject Noncompliance|1|||
129222093|NCT03184870|465116018|FG002|Initial Treatment|Death|8|||
129222094|NCT03184870|465116019|FG003|Initial Treatment|Death|8|||
128717502|NCT01729754|463263912|FG003|Part 3|Lost to Follow-up|0|||
128717503|NCT01729754|463263913|FG004|Part 3|Lost to Follow-up|0|||
128717504|NCT01729754|463263914|FG005|Part 3|Lost to Follow-up|3|||
128717505|NCT01729754|463263915|FG006|Part 3|Lost to Follow-up|0|||
128717506|NCT01729754|463263916|FG007|Part 3|Lost to Follow-up|0|||
128717507|NCT01729754|463263917|FG008|Part 3|Lost to Follow-up|1|||
128717508|NCT01729754|463263918|FG009|Part 3|Lost to Follow-up|0|||
128717509|NCT01729754|463263909|FG000|Part 3|Physician Decision|0|||
128717510|NCT01729754|463263910|FG001|Part 3|Physician Decision|0|||
128717511|NCT01729754|463263911|FG002|Part 3|Physician Decision|1|||
128717512|NCT01729754|463263912|FG003|Part 3|Physician Decision|0|||
128717513|NCT01729754|463263913|FG004|Part 3|Physician Decision|0|||
128717514|NCT01729754|463263914|FG005|Part 3|Physician Decision|0|||
128717515|NCT01729754|463263915|FG006|Part 3|Physician Decision|0|||
128717516|NCT01729754|463263916|FG007|Part 3|Physician Decision|0|||
128717517|NCT01729754|463263917|FG008|Part 3|Physician Decision|0|||
128717518|NCT01729754|463263918|FG009|Part 3|Physician Decision|0|||
128717519|NCT01729754|463263909|FG000|Part 3|Withdrawal by Subject|0|||
129040021|NCT01546142|464438723|FG000|Overall Study|Adverse Event|6|||
129040022|NCT01546142|464438724|FG001|Overall Study|Adverse Event|3|||
129040023|NCT01546142|464438723|FG000|Overall Study|Lost to Follow-up|20|||
129040024|NCT01546142|464438724|FG001|Overall Study|Lost to Follow-up|15|||
129040025|NCT01546142|464438723|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
129040026|NCT01546142|464438724|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
129040027|NCT01546142|464438723|FG000|Overall Study|Subject Randomized but Not Treated|1|||
129040028|NCT01546142|464438724|FG001|Overall Study|Subject Randomized but Not Treated|0|||
129040029|NCT00743509|464438731|FG000|Overall Study|Withdrawal by Subject|2|||
129040030|NCT00418522|464438737|FG000|Overall Study|Adverse Event|7|||
129040031|NCT00418522|464438738|FG001|Overall Study|Adverse Event|1|||
129040032|NCT00418522|464438737|FG000|Overall Study|Lack of Efficacy|1|||
129040033|NCT00418522|464438738|FG001|Overall Study|Lack of Efficacy|3|||
129040034|NCT00418522|464438737|FG000|Overall Study|Lost to Follow-up|10|||
129040035|NCT00418522|464438738|FG001|Overall Study|Lost to Follow-up|4|||
129040036|NCT00418522|464438737|FG000|Overall Study|Withdrawal by Subject|31|||
129040037|NCT00418522|464438738|FG001|Overall Study|Withdrawal by Subject|7|||
129040038|NCT00418522|464438737|FG000|Overall Study|Other|27|||
129040039|NCT00418522|464438738|FG001|Overall Study|Other|23|||
129040040|NCT00418522|464438737|FG000|Overall Study|Randomized but did not receive treatment|7|||
129040041|NCT00418522|464438738|FG001|Overall Study|Randomized but did not receive treatment|4|||
129040042|NCT02695719|464438739|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
129040043|NCT02695719|464438740|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
129040044|NCT02695719|464438739|FG000|Overall Study|Significant Protocol Deviation|0|||
129040045|NCT02695719|464438740|FG001|Overall Study|Significant Protocol Deviation|1|||
129040046|NCT02695719|464438739|FG000|Overall Study|Voluntary Withdrawal|1|||
129040047|NCT02695719|464438740|FG001|Overall Study|Voluntary Withdrawal|0|||
129040048|NCT00573170|464438742|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
129040049|NCT00573170|464438743|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
129040050|NCT00573170|464438744|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
129040051|NCT00573170|464438745|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
129040052|NCT00573170|464438746|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
129040053|NCT00573170|464438747|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
128717520|NCT01729754|463263910|FG001|Part 3|Withdrawal by Subject|4|||
128717521|NCT01729754|463263911|FG002|Part 3|Withdrawal by Subject|1|||
129040054|NCT00573170|464438742|FG000|First Washout Period|Adverse Event|1|||
129040055|NCT00573170|464438743|FG001|First Washout Period|Adverse Event|1|||
129040056|NCT00573170|464438744|FG002|First Washout Period|Adverse Event|0|||
129040057|NCT00573170|464438745|FG003|First Washout Period|Adverse Event|0|||
129040058|NCT00573170|464438746|FG004|First Washout Period|Adverse Event|0|||
129040059|NCT00573170|464438747|FG005|First Washout Period|Adverse Event|1|||
129040060|NCT00573170|464438742|FG000|First Washout Period|Lack of Efficacy|0|||
128717522|NCT01729754|463263912|FG003|Part 3|Withdrawal by Subject|0|||
128717523|NCT01729754|463263913|FG004|Part 3|Withdrawal by Subject|2|||
129040061|NCT00573170|464438743|FG001|First Washout Period|Lack of Efficacy|0|||
129040062|NCT00573170|464438744|FG002|First Washout Period|Lack of Efficacy|0|||
129040063|NCT00573170|464438745|FG003|First Washout Period|Lack of Efficacy|0|||
128717524|NCT01729754|463263914|FG005|Part 3|Withdrawal by Subject|1|||
128717525|NCT01729754|463263915|FG006|Part 3|Withdrawal by Subject|0|||
128717526|NCT01729754|463263916|FG007|Part 3|Withdrawal by Subject|2|||
129040064|NCT00573170|464438746|FG004|First Washout Period|Lack of Efficacy|0|||
129040065|NCT00573170|464438747|FG005|First Washout Period|Lack of Efficacy|1|||
129040066|NCT00573170|464438742|FG000|First Washout Period|Lost to Follow-up|1|||
129040067|NCT00573170|464438743|FG001|First Washout Period|Lost to Follow-up|1|||
128717527|NCT01729754|463263917|FG008|Part 3|Withdrawal by Subject|0|||
128717528|NCT01729754|463263918|FG009|Part 3|Withdrawal by Subject|0|||
128717529|NCT01729754|463263909|FG000|Part 3|Other Protocol Specified Criteria|0|||
128717530|NCT01729754|463263910|FG001|Part 3|Other Protocol Specified Criteria|0|||
128717531|NCT01729754|463263911|FG002|Part 3|Other Protocol Specified Criteria|0|||
129040068|NCT00573170|464438744|FG002|First Washout Period|Lost to Follow-up|0|||
129132816|NCT00758043|464778528|FG002|Overall Study|Withdrawal by Subject|1|||
129132817|NCT00758043|464778529|FG003|Overall Study|Withdrawal by Subject|4|||
128977263|NCT02155660|464203043|FG002|Overall Study|Withdrawal by Subject|24|||
128977264|NCT02155660|464203044|FG003|Overall Study|Withdrawal by Subject|21|||
128977265|NCT00303719|464203051|FG000|Overall Study|Not evaluable, prior therapies|0|||
128977266|NCT00303719|464203052|FG001|Overall Study|Not evaluable, prior therapies|30|||
128977267|NCT00303719|464203051|FG000|Overall Study|Lost to Follow-up|0|||
128977268|NCT00303719|464203052|FG001|Overall Study|Lost to Follow-up|7|||
128977269|NCT01641952|464203053|FG000|Overall Study|Lost to Follow-up|28|||
128977270|NCT01641952|464203053|FG000|Overall Study|Adverse Event|6|||
128977271|NCT00561912|464203063|FG000|Overall Study|ineligible|1|||
128977272|NCT02643420|464203064|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
128977273|NCT02643420|464203065|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
128977274|NCT02643420|464203064|FG000|Overall Study|Withdrawal by Subject|25|||
128977275|NCT02643420|464203065|FG001|Overall Study|Withdrawal by Subject|19|||
128977276|NCT02643420|464203064|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
128977277|NCT02643420|464203065|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
128977278|NCT02643420|464203064|FG000|Overall Study|Lost to Follow-up|6|||
128977279|NCT02643420|464203065|FG001|Overall Study|Lost to Follow-up|10|||
128977280|NCT02643420|464203064|FG000|Overall Study|Investigator Decision|2|||
128977281|NCT02643420|464203065|FG001|Overall Study|Investigator Decision|4|||
128977282|NCT02643420|464203064|FG000|Overall Study|Sponsor decision|1|||
128977283|NCT02643420|464203065|FG001|Overall Study|Sponsor decision|1|||
128977284|NCT02643420|464203064|FG000|Overall Study|Death|0|||
128977285|NCT02643420|464203065|FG001|Overall Study|Death|2|||
128977286|NCT02643420|464203064|FG000|Overall Study|Reason not Specified|8|||
128977287|NCT02643420|464203065|FG001|Overall Study|Reason not Specified|7|||
128977288|NCT00718887|464203071|FG000|Overall Study|Withdrawal by Subject|3|||
128977289|NCT00718887|464203072|FG001|Overall Study|Withdrawal by Subject|2|||
128977290|NCT00718887|464203071|FG000|Overall Study|Not identified|2|||
128977291|NCT00718887|464203072|FG001|Overall Study|Not identified|7|||
128977292|NCT05102734|464203074|FG000|Overall Study|Did not require vasopressors|1|||
128977293|NCT05102734|464203075|FG001|Overall Study|Did not require vasopressors|0|||
128977294|NCT05102734|464203074|FG000|Overall Study|Did not have functioning PA catheter|1|||
128977295|NCT05102734|464203075|FG001|Overall Study|Did not have functioning PA catheter|0|||
128977296|NCT05102734|464203074|FG000|Overall Study|Inadequate video quality|2|||
128977297|NCT05102734|464203075|FG001|Overall Study|Inadequate video quality|0|||
128977298|NCT04235959|464203076|FG000|Overall Study|Protocol Violation|0|||
128977299|NCT04235959|464203077|FG001|Overall Study|Protocol Violation|1|||
128977300|NCT04235959|464203078|FG002|Overall Study|Protocol Violation|0|||
128977301|NCT04235959|464203076|FG000|Overall Study|Adverse Event|1|||
128977302|NCT04235959|464203077|FG001|Overall Study|Adverse Event|0|||
128977303|NCT04235959|464203078|FG002|Overall Study|Adverse Event|0|||
128977304|NCT00608426|464203079|FG000|Overall Study|Death|32|||
128977305|NCT00608426|464203080|FG001|Overall Study|Death|36|||
128977306|NCT00608426|464203079|FG000|Overall Study|Lost to Follow-up|485|||
128977307|NCT00608426|464203080|FG001|Overall Study|Lost to Follow-up|521|||
128977308|NCT00608426|464203079|FG000|Overall Study|refused, health issues, wrong address|319|||
128977309|NCT00608426|464203080|FG001|Overall Study|refused, health issues, wrong address|348|||
128977310|NCT04601194|464203084|FG000|Overall Study|Lost to Follow-up|7|||
128977311|NCT02630459|464203085|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
128977312|NCT02630459|464203086|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
128977313|NCT02630459|464203087|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
128977314|NCT02630459|464203088|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
128977315|NCT02630459|464203089|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
128977316|NCT02630459|464203090|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
128977317|NCT02630459|464203091|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
128977318|NCT02630459|464203092|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
128977319|NCT02630459|464203085|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
128977320|NCT02630459|464203086|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
128977321|NCT02630459|464203087|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
128977322|NCT02630459|464203088|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
128977323|NCT02630459|464203089|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
128977324|NCT02630459|464203090|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
128977325|NCT02630459|464203091|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
128977326|NCT02630459|464203092|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
128977327|NCT02630459|464203085|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
128977328|NCT02630459|464203086|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
128977329|NCT02630459|464203087|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
128977330|NCT02630459|464203088|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
128977331|NCT02630459|464203089|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
128977332|NCT02630459|464203090|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
128977333|NCT02630459|464203091|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
128977334|NCT02630459|464203092|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
128977335|NCT02630459|464203085|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
128977336|NCT02630459|464203086|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
128977337|NCT02630459|464203087|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
128977338|NCT02630459|464203088|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
128977339|NCT02630459|464203089|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
128977340|NCT02630459|464203090|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
128977341|NCT02630459|464203091|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
128977342|NCT02630459|464203092|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
128977343|NCT02630459|464203085|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
128977344|NCT02630459|464203086|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
128977345|NCT02630459|464203087|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
128977346|NCT02630459|464203088|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
128977347|NCT02630459|464203089|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
128977348|NCT02630459|464203090|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
128977349|NCT02630459|464203091|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
128977350|NCT02630459|464203092|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
128977351|NCT02630459|464203085|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
128977352|NCT02630459|464203086|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
128977353|NCT02630459|464203087|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
128977354|NCT02630459|464203088|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
128977355|NCT02630459|464203089|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
128977356|NCT02630459|464203090|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
128977357|NCT02630459|464203091|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
128977358|NCT02630459|464203092|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
128977359|NCT02630459|464203085|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
128977360|NCT02630459|464203086|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
128977361|NCT02630459|464203087|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
128977362|NCT02630459|464203088|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
128977363|NCT02630459|464203089|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
128977364|NCT02630459|464203090|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
128977365|NCT02630459|464203091|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
128977366|NCT02630459|464203092|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
128977367|NCT00348686|464203095|FG000|Overall Study|Withdrawal by Subject|45|||
128977368|NCT00348686|464203095|FG000|Overall Study|Adverse Event|5|||
128977369|NCT00348686|464203095|FG000|Overall Study|Protocol Violation|6|||
128977370|NCT00348686|464203095|FG000|Overall Study|Lost to Follow-up|2|||
128977371|NCT00348686|464203095|FG000|Overall Study|Multiple Reasons|8|||
128977372|NCT01258738|464203096|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
128977373|NCT01258738|464203097|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
128977374|NCT01258738|464203096|FG000|Double-blind Period|Withdrawal by Subject|2|||
128977375|NCT01258738|464203097|FG001|Double-blind Period|Withdrawal by Subject|2|||
128977376|NCT01258738|464203096|FG000|Double-blind Period|Protocol Violation|1|||
128977377|NCT01258738|464203097|FG001|Double-blind Period|Protocol Violation|1|||
128977378|NCT01258738|464203096|FG000|Double-blind Period|Adverse Event|3|||
128977379|NCT01258738|464203097|FG001|Double-blind Period|Adverse Event|1|||
128977380|NCT01258738|464203096|FG000|Open-label Period|Did not meet inclusion criteria|0|||
128977381|NCT01258738|464203097|FG001|Open-label Period|Did not meet inclusion criteria|1|||
128977382|NCT01258738|464203096|FG000|Open-label Period|Insufficient clinical response|5|||
128977383|NCT01258738|464203097|FG001|Open-label Period|Insufficient clinical response|3|||
128977384|NCT01258738|464203096|FG000|Open-label Period|Lost to Follow-up|0|||
128977385|NCT01258738|464203097|FG001|Open-label Period|Lost to Follow-up|2|||
128977386|NCT01258738|464203096|FG000|Open-label Period|Withdrawal by Subject|5|||
128977387|NCT01258738|464203097|FG001|Open-label Period|Withdrawal by Subject|6|||
128977388|NCT01258738|464203096|FG000|Open-label Period|Protocol Violation|2|||
128977389|NCT01258738|464203097|FG001|Open-label Period|Protocol Violation|2|||
129040069|NCT00573170|464438745|FG003|First Washout Period|Lost to Follow-up|2|||
129040070|NCT00573170|464438746|FG004|First Washout Period|Lost to Follow-up|0|||
129040071|NCT00573170|464438747|FG005|First Washout Period|Lost to Follow-up|2|||
129040072|NCT00573170|464438742|FG000|First Washout Period|Withdrawal by Subject|2|||
129040073|NCT00573170|464438743|FG001|First Washout Period|Withdrawal by Subject|0|||
129040074|NCT00573170|464438744|FG002|First Washout Period|Withdrawal by Subject|0|||
129040075|NCT00573170|464438745|FG003|First Washout Period|Withdrawal by Subject|2|||
129040076|NCT00573170|464438746|FG004|First Washout Period|Withdrawal by Subject|3|||
128977390|NCT01258738|464203096|FG000|Open-label Period|Adverse Event|4|||
128977391|NCT01258738|464203097|FG001|Open-label Period|Adverse Event|5|||
128977392|NCT01258738|464203096|FG000|Open-label Period|Other Reasons|0|||
128977393|NCT01258738|464203097|FG001|Open-label Period|Other Reasons|1|||
128977394|NCT01258738|464203096|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
128977395|NCT01258738|464203097|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
128977396|NCT00689611|464203098|FG000|Overall Study|Death|6|||
128977397|NCT00689611|464203099|FG001|Overall Study|Death|9|||
128977398|NCT00689611|464203098|FG000|Overall Study|Withdrawal by Subject|8|||
128977399|NCT00689611|464203099|FG001|Overall Study|Withdrawal by Subject|9|||
128977400|NCT00689611|464203098|FG000|Overall Study|Lost to Follow-up|27|||
128977401|NCT00689611|464203099|FG001|Overall Study|Lost to Follow-up|28|||
128977402|NCT00568399|464203100|FG000|Overall Study|Death|2|||
128977403|NCT00568399|464203100|FG000|Overall Study|Adverse Event|5|||
128977404|NCT00568399|464203100|FG000|Overall Study|Withdrawal by Subject|8|||
128977405|NCT01904760|464203101|FG000|Overall Study|Protocol Violation|1|||
128977406|NCT01904760|464203102|FG001|Overall Study|Protocol Violation|0|||
128977407|NCT04249076|464203112|FG000|Overall Study|Adverse Event|1|||
128977408|NCT04249076|464203113|FG001|Overall Study|Adverse Event|1|||
128977409|NCT04249076|464203112|FG000|Overall Study|Protocol Violation|1|||
128977410|NCT04249076|464203113|FG001|Overall Study|Protocol Violation|2|||
128977411|NCT04249076|464203112|FG000|Overall Study|Lack of Efficacy|0|||
128977412|NCT04249076|464203113|FG001|Overall Study|Lack of Efficacy|1|||
128977413|NCT04249076|464203112|FG000|Overall Study|Withdrawal by Subject|0|||
128977414|NCT04249076|464203113|FG001|Overall Study|Withdrawal by Subject|1|||
128977415|NCT01117428|464203114|FG000|Overall Study|Lack of Efficacy|1|||
128977416|NCT01117428|464203115|FG001|Overall Study|Lack of Efficacy|0|||
128977417|NCT01117428|464203116|FG002|Overall Study|Lack of Efficacy|0|||
128977418|NCT01117428|464203117|FG003|Overall Study|Lack of Efficacy|0|||
128977419|NCT01117428|464203118|FG004|Overall Study|Lack of Efficacy|0|||
128977420|NCT01117428|464203119|FG005|Overall Study|Lack of Efficacy|0|||
128977421|NCT01117428|464203114|FG000|Overall Study|Adverse Event|4|||
128977422|NCT01117428|464203115|FG001|Overall Study|Adverse Event|0|||
128977423|NCT01117428|464203116|FG002|Overall Study|Adverse Event|0|||
128977424|NCT01117428|464203117|FG003|Overall Study|Adverse Event|0|||
128977425|NCT01117428|464203118|FG004|Overall Study|Adverse Event|1|||
128977426|NCT01117428|464203119|FG005|Overall Study|Adverse Event|2|||
128977427|NCT01117428|464203114|FG000|Overall Study|Death|0|||
128977428|NCT01117428|464203115|FG001|Overall Study|Death|1|||
128977429|NCT01117428|464203116|FG002|Overall Study|Death|2|||
128977430|NCT01117428|464203117|FG003|Overall Study|Death|0|||
128977431|NCT01117428|464203118|FG004|Overall Study|Death|0|||
128977432|NCT01117428|464203119|FG005|Overall Study|Death|1|||
128977433|NCT01117428|464203114|FG000|Overall Study|Physician Decision|0|||
128977434|NCT01117428|464203115|FG001|Overall Study|Physician Decision|1|||
128977435|NCT01117428|464203116|FG002|Overall Study|Physician Decision|0|||
128977436|NCT01117428|464203117|FG003|Overall Study|Physician Decision|0|||
128977437|NCT01117428|464203118|FG004|Overall Study|Physician Decision|0|||
128977438|NCT01117428|464203119|FG005|Overall Study|Physician Decision|0|||
128977439|NCT01117428|464203114|FG000|Overall Study|Withdrawal by Subject|0|||
128977440|NCT01117428|464203115|FG001|Overall Study|Withdrawal by Subject|0|||
128977441|NCT01117428|464203116|FG002|Overall Study|Withdrawal by Subject|1|||
128977442|NCT01117428|464203117|FG003|Overall Study|Withdrawal by Subject|0|||
128977443|NCT01117428|464203118|FG004|Overall Study|Withdrawal by Subject|0|||
128977444|NCT01117428|464203119|FG005|Overall Study|Withdrawal by Subject|0|||
128977445|NCT01117428|464203114|FG000|Overall Study|Progressive disease|15|||
128977446|NCT01117428|464203115|FG001|Overall Study|Progressive disease|27|||
128977447|NCT01117428|464203116|FG002|Overall Study|Progressive disease|10|||
128977448|NCT01117428|464203117|FG003|Overall Study|Progressive disease|12|||
128977449|NCT01117428|464203118|FG004|Overall Study|Progressive disease|16|||
128977450|NCT01117428|464203119|FG005|Overall Study|Progressive disease|17|||
128977451|NCT03018028|464203120|FG000|Overall Study|Withdrawal by Subject|3|||
128977452|NCT03018028|464203121|FG001|Overall Study|Withdrawal by Subject|0|||
128977453|NCT03018028|464203122|FG002|Overall Study|Withdrawal by Subject|1|||
128977454|NCT03018028|464203123|FG003|Overall Study|Withdrawal by Subject|2|||
128977455|NCT03018028|464203124|FG004|Overall Study|Withdrawal by Subject|0|||
128977456|NCT02519777|464203126|FG000|Overall Study|Death|1|||
128977457|NCT02519777|464203127|FG001|Overall Study|Death|0|||
128977458|NCT02519777|464203128|FG002|Overall Study|Death|0|||
129132818|NCT00758043|464778526|FG000|Overall Study|Required Prohibited Medication|0|||
129132819|NCT00758043|464778527|FG001|Overall Study|Required Prohibited Medication|0|||
128977459|NCT02519777|464203126|FG000|Overall Study|Lost to Follow-up|0|||
128977460|NCT02519777|464203127|FG001|Overall Study|Lost to Follow-up|4|||
128977461|NCT02519777|464203128|FG002|Overall Study|Lost to Follow-up|2|||
128977462|NCT02519777|464203126|FG000|Overall Study|Withdrawal by Subject|3|||
128977463|NCT02519777|464203127|FG001|Overall Study|Withdrawal by Subject|1|||
128977464|NCT02519777|464203128|FG002|Overall Study|Withdrawal by Subject|0|||
128977465|NCT02519777|464203126|FG000|Overall Study|Severe Debilitation|1|||
128977466|NCT02519777|464203127|FG001|Overall Study|Severe Debilitation|1|||
128977467|NCT02519777|464203128|FG002|Overall Study|Severe Debilitation|1|||
128977468|NCT02519777|464203126|FG000|Overall Study|Not able to get to clinic|1|||
128977469|NCT02519777|464203127|FG001|Overall Study|Not able to get to clinic|2|||
128977470|NCT02519777|464203128|FG002|Overall Study|Not able to get to clinic|1|||
128977471|NCT02195531|464203129|FG000|Overall Study|Withdrawal by Subject|1|||
128977472|NCT02195531|464203130|FG001|Overall Study|Withdrawal by Subject|1|||
128977473|NCT02195531|464203131|FG002|Overall Study|Withdrawal by Subject|1|||
128977474|NCT02543801|464203133|FG000|Overall Study|Protocol Violation|1|||
128977475|NCT02543801|464203134|FG001|Overall Study|Protocol Violation|2|||
128977476|NCT02543801|464203135|FG002|Overall Study|Protocol Violation|0|||
128977477|NCT02543801|464203136|FG003|Overall Study|Protocol Violation|0|||
128977478|NCT01034709|464203137|FG000|Overall Study|Protocol Violation|9|||
128977479|NCT01034709|464203138|FG001|Overall Study|Protocol Violation|16|||
128977480|NCT02364999|464203150|FG000|Overall Study|Death|136|||
128977481|NCT02364999|464203151|FG001|Overall Study|Death|138|||
128977482|NCT02364999|464203150|FG000|Overall Study|Lost to Follow-up|10|||
128977483|NCT02364999|464203151|FG001|Overall Study|Lost to Follow-up|15|||
128977484|NCT02364999|464203150|FG000|Overall Study|Protocol Violation|3|||
128977485|NCT02364999|464203151|FG001|Overall Study|Protocol Violation|2|||
128977486|NCT02364999|464203150|FG000|Overall Study|Withdrawal by Subject|14|||
128977487|NCT02364999|464203151|FG001|Overall Study|Withdrawal by Subject|14|||
128977488|NCT02364999|464203150|FG000|Overall Study|Other|0|||
128977489|NCT02364999|464203151|FG001|Overall Study|Other|1|||
128977490|NCT02364999|464203150|FG000|Overall Study|Randomized but did not receive treatment|2|||
128977491|NCT02364999|464203151|FG001|Overall Study|Randomized but did not receive treatment|3|||
128977492|NCT01234337|464203152|FG000|Overall Study|Adverse Event|58|||
128977493|NCT01234337|464203153|FG001|Overall Study|Adverse Event|21|||
128977494|NCT01234337|464203152|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
128977495|NCT01234337|464203153|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
128977496|NCT01234337|464203152|FG000|Overall Study|Investi. decision not protocol driven|5|||
128977497|NCT01234337|464203153|FG001|Overall Study|Investi. decision not protocol driven|6|||
128977498|NCT01234337|464203152|FG000|Overall Study|Non-compliant with study medication|3|||
128977499|NCT01234337|464203153|FG001|Overall Study|Non-compliant with study medication|2|||
128977500|NCT01234337|464203152|FG000|Overall Study|Randomized but not treated|6|||
128977501|NCT01234337|464203153|FG001|Overall Study|Randomized but not treated|4|||
128977502|NCT01234337|464203152|FG000|Overall Study|Lost to Follow-up|0|||
128977503|NCT01234337|464203153|FG001|Overall Study|Lost to Follow-up|1|||
128977504|NCT01234337|464203152|FG000|Overall Study|Protocol Violation|2|||
128977505|NCT01234337|464203153|FG001|Overall Study|Protocol Violation|3|||
128977506|NCT01234337|464203152|FG000|Overall Study|Withdrawal by Subject|11|||
128977507|NCT01234337|464203153|FG001|Overall Study|Withdrawal by Subject|9|||
128977508|NCT01234337|464203152|FG000|Overall Study|Death|0|||
128977509|NCT01234337|464203153|FG001|Overall Study|Death|1|||
128977510|NCT01234337|464203152|FG000|Overall Study|Switch to commercial drug|0|||
128977511|NCT01234337|464203153|FG001|Overall Study|Switch to commercial drug|1|||
128977512|NCT04118127|464203154|FG000|Overall Study|Trial terminated by sponsor|0|||
128977513|NCT04118127|464203155|FG001|Overall Study|Trial terminated by sponsor|12|||
128977514|NCT04118127|464203154|FG000|Overall Study|Adverse Event|1|||
128977515|NCT04118127|464203155|FG001|Overall Study|Adverse Event|2|||
128977516|NCT04118127|464203154|FG000|Overall Study|Physician Decision|0|||
128977517|NCT04118127|464203155|FG001|Overall Study|Physician Decision|1|||
128977518|NCT04118127|464203154|FG000|Overall Study|Withdrawal by Subject|2|||
128977519|NCT04118127|464203155|FG001|Overall Study|Withdrawal by Subject|1|||
128977520|NCT03480360|464203156|FG000|Overall Study|Death|2|||
128977521|NCT00660816|464203161|FG000|Overall Study|Adverse Event|1|||
128977522|NCT00660816|464203162|FG001|Overall Study|Adverse Event|2|||
128977523|NCT00660816|464203161|FG000|Overall Study|Withdrawal by Subject|1|||
128977524|NCT00660816|464203162|FG001|Overall Study|Withdrawal by Subject|0|||
128977525|NCT00660816|464203161|FG000|Overall Study|Death|0|||
128977526|NCT00660816|464203162|FG001|Overall Study|Death|2|||
128977527|NCT00660816|464203161|FG000|Overall Study|Lack of Efficacy|1|||
128977528|NCT00660816|464203162|FG001|Overall Study|Lack of Efficacy|0|||
128977529|NCT00660816|464203161|FG000|Overall Study|Physician Decision|0|||
128977530|NCT00660816|464203162|FG001|Overall Study|Physician Decision|2|||
128977531|NCT00660816|464203161|FG000|Overall Study|Protocol Violation|1|||
128977532|NCT00660816|464203162|FG001|Overall Study|Protocol Violation|0|||
128977533|NCT00660816|464203161|FG000|Overall Study|Disease Progression|16|||
128977534|NCT00660816|464203162|FG001|Overall Study|Disease Progression|12|||
128977535|NCT00660816|464203161|FG000|Overall Study|Complicating Disease|0|||
128977536|NCT00660816|464203162|FG001|Overall Study|Complicating Disease|1|||
128977537|NCT02692560|464203163|FG000|Overall Study|Withdrawal by Subject|0|||
128977538|NCT02692560|464203164|FG001|Overall Study|Withdrawal by Subject|6|||
128977539|NCT01326910|464203165|FG000|Overall Study|Withdrawal by Subject|3|||
128977540|NCT01326910|464203166|FG001|Overall Study|Withdrawal by Subject|2|||
128977541|NCT01326910|464203165|FG000|Overall Study|Protocol Violation|1|||
128977542|NCT01326910|464203166|FG001|Overall Study|Protocol Violation|1|||
128977543|NCT01681836|464203169|FG000|Second Intervention|Withdrawal by Subject|0|||
129132820|NCT00758043|464778528|FG002|Overall Study|Required Prohibited Medication|1|||
129132821|NCT00758043|464778529|FG003|Overall Study|Required Prohibited Medication|3|||
129132822|NCT00758043|464778526|FG000|Overall Study|Non-Compliant With study Drug|0|||
129132823|NCT00758043|464778527|FG001|Overall Study|Non-Compliant With study Drug|0|||
128717532|NCT01729754|463263912|FG003|Part 3|Other Protocol Specified Criteria|0|||
128717533|NCT01729754|463263913|FG004|Part 3|Other Protocol Specified Criteria|0|||
128717534|NCT01729754|463263914|FG005|Part 3|Other Protocol Specified Criteria|2|||
128717535|NCT01729754|463263915|FG006|Part 3|Other Protocol Specified Criteria|0|||
128717536|NCT01729754|463263916|FG007|Part 3|Other Protocol Specified Criteria|1|||
128717537|NCT01729754|463263917|FG008|Part 3|Other Protocol Specified Criteria|0|||
128717538|NCT01729754|463263918|FG009|Part 3|Other Protocol Specified Criteria|0|||
128717539|NCT00773292|463263919|FG000|Treatment 48 Weeks|Adverse Event|1|||
128717540|NCT00773292|463263919|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
128717541|NCT00542919|463263920|FG000|Overall Study|Adverse Event|1|||
128717542|NCT00542919|463263921|FG001|Overall Study|Adverse Event|5|||
128717543|NCT00542919|463263922|FG002|Overall Study|Adverse Event|1|||
128717544|NCT00542919|463263920|FG000|Overall Study|Withdrawal by Subject|1|||
128717545|NCT00542919|463263921|FG001|Overall Study|Withdrawal by Subject|0|||
128717546|NCT00542919|463263922|FG002|Overall Study|Withdrawal by Subject|3|||
128717547|NCT00542919|463263920|FG000|Overall Study|Physician Decision|2|||
128717548|NCT00542919|463263921|FG001|Overall Study|Physician Decision|2|||
128717549|NCT00542919|463263922|FG002|Overall Study|Physician Decision|1|||
128717550|NCT00542919|463263920|FG000|Overall Study|Sponsor Decision|1|||
128977544|NCT01681836|464203170|FG001|Second Intervention|Withdrawal by Subject|1|||
128977545|NCT01241318|464203173|FG000|Overall Study|Woman: false pregnancies|27|||
128977546|NCT01241318|464203174|FG001|Overall Study|Woman: false pregnancies|15|||
128977547|NCT01241318|464203173|FG000|Overall Study|Woman: miscarriage/abortion|46|||
128977548|NCT01241318|464203174|FG001|Overall Study|Woman: miscarriage/abortion|38|||
128977549|NCT01241318|464203173|FG000|Overall Study|Withdrawal by Subject|175|||
128977550|NCT01241318|464203174|FG001|Overall Study|Withdrawal by Subject|46|||
128977551|NCT01241318|464203173|FG000|Overall Study|Lost to Follow-up|740|||
128977552|NCT01241318|464203174|FG001|Overall Study|Lost to Follow-up|455|||
128717551|NCT00542919|463263921|FG001|Overall Study|Sponsor Decision|0|||
128717552|NCT00542919|463263922|FG002|Overall Study|Sponsor Decision|0|||
128717553|NCT00542919|463263920|FG000|Overall Study|Lost to Follow-up|2|||
128717554|NCT00542919|463263921|FG001|Overall Study|Lost to Follow-up|0|||
128717555|NCT00542919|463263922|FG002|Overall Study|Lost to Follow-up|1|||
128717556|NCT01881230|463263923|FG000|Overall Study|Death|2|||
128717557|NCT01881230|463263924|FG001|Overall Study|Death|0|||
128717558|NCT01881230|463263925|FG002|Overall Study|Death|1|||
128717559|NCT01881230|463263923|FG000|Overall Study|Adverse Event|9|||
128717560|NCT01881230|463263924|FG001|Overall Study|Adverse Event|13|||
128717561|NCT01881230|463263925|FG002|Overall Study|Adverse Event|12|||
128717562|NCT01881230|463263923|FG000|Overall Study|Progressive Disease|31|||
128717563|NCT01881230|463263924|FG001|Overall Study|Progressive Disease|35|||
128717564|NCT01881230|463263925|FG002|Overall Study|Progressive Disease|36|||
128717565|NCT01881230|463263923|FG000|Overall Study|Symptomatic Deterioration|3|||
128717566|NCT01881230|463263924|FG001|Overall Study|Symptomatic Deterioration|3|||
128717567|NCT01881230|463263925|FG002|Overall Study|Symptomatic Deterioration|1|||
128717568|NCT01881230|463263923|FG000|Overall Study|Withdrawal by Subject|6|||
128717569|NCT01881230|463263924|FG001|Overall Study|Withdrawal by Subject|4|||
128717570|NCT01881230|463263925|FG002|Overall Study|Withdrawal by Subject|6|||
128717571|NCT01881230|463263923|FG000|Overall Study|Physician Decision|4|||
128717572|NCT01881230|463263924|FG001|Overall Study|Physician Decision|3|||
128717573|NCT01881230|463263925|FG002|Overall Study|Physician Decision|6|||
128717574|NCT01881230|463263923|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128717575|NCT01881230|463263924|FG001|Overall Study|Non-Compliance with Study Drug|2|||
128717576|NCT01881230|463263925|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128717577|NCT01881230|463263923|FG000|Overall Study|Given Commercially Available Drug|0|||
128717578|NCT01881230|463263924|FG001|Overall Study|Given Commercially Available Drug|0|||
128717579|NCT01881230|463263925|FG002|Overall Study|Given Commercially Available Drug|2|||
128977553|NCT01241318|464203173|FG000|Overall Study|Death|2|||
128977554|NCT01241318|464203174|FG001|Overall Study|Death|4|||
128977555|NCT01241318|464203173|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
128717580|NCT01881230|463263923|FG000|Overall Study|Protocol Violation|1|||
129222095|NCT03184870|465116020|FG004|Initial Treatment|Death|6|||
128717581|NCT01881230|463263924|FG001|Overall Study|Protocol Violation|1|||
129222096|NCT03184870|465116021|FG005|Initial Treatment|Death|6|||
128717582|NCT01881230|463263925|FG002|Overall Study|Protocol Violation|0|||
128717583|NCT01881230|463263923|FG000|Overall Study|Miscellaneous|3|||
128717584|NCT01881230|463263924|FG001|Overall Study|Miscellaneous|3|||
128717585|NCT01881230|463263925|FG002|Overall Study|Miscellaneous|0|||
128717586|NCT01881230|463263923|FG000|Overall Study|Untreated: Other|0|||
128717587|NCT01881230|463263924|FG001|Overall Study|Untreated: Other|0|||
128717588|NCT01881230|463263925|FG002|Overall Study|Untreated: Other|1|||
128717589|NCT01881230|463263923|FG000|Overall Study|Untreated: Death|0|||
128717590|NCT01881230|463263924|FG001|Overall Study|Untreated: Death|0|||
128717591|NCT01881230|463263925|FG002|Overall Study|Untreated: Death|1|||
128977556|NCT01241318|464203174|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
128977557|NCT01241318|464203173|FG000|Overall Study|Woman: Stillborn infant|129|||
128717592|NCT01881230|463263923|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
129222097|NCT03184870|465116022|FG006|Initial Treatment|Death|6|||
129222098|NCT03184870|465116023|FG007|Initial Treatment|Death|7|||
128977558|NCT01241318|464203174|FG001|Overall Study|Woman: Stillborn infant|146|||
128977559|NCT02728804|464203184|FG000|Overall Study|Ineligible|3|||
128977560|NCT02728804|464203184|FG000|Overall Study|Did not complete baseline questionnaire|9|||
128977561|NCT02728804|464203184|FG000|Overall Study|Death|99|||
128977562|NCT01156012|464203191|FG000|Overall Study|Adverse Event|3|||
128977563|NCT01156012|464203192|FG001|Overall Study|Adverse Event|1|||
128977564|NCT01156012|464203191|FG000|Overall Study|Lost to Follow-up|1|||
128977565|NCT01156012|464203192|FG001|Overall Study|Lost to Follow-up|0|||
128977566|NCT01156012|464203191|FG000|Overall Study|Withdrawal by Subject|1|||
128977567|NCT01156012|464203192|FG001|Overall Study|Withdrawal by Subject|0|||
128977568|NCT01156012|464203191|FG000|Overall Study|use of commercial drug instead of study|0|||
128977569|NCT01156012|464203192|FG001|Overall Study|use of commercial drug instead of study|1|||
128977570|NCT01156012|464203191|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
128977571|NCT01156012|464203192|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
128977572|NCT02475564|464203193|FG000|Overall Study|Withdrawal by Subject|1|||
128977573|NCT02475564|464203194|FG001|Overall Study|Withdrawal by Subject|0|||
128977574|NCT02475564|464203193|FG000|Overall Study|Lost to Follow-up|2|||
128977575|NCT02475564|464203194|FG001|Overall Study|Lost to Follow-up|1|||
128977576|NCT02475564|464203193|FG000|Overall Study|Intense Menstrual bleeding|1|||
128977577|NCT02475564|464203194|FG001|Overall Study|Intense Menstrual bleeding|0|||
128977578|NCT02705755|464203196|FG000|Part A (6 Days)|Adverse Event|1|||
128977579|NCT02705755|464203197|FG001|Part A (6 Days)|Adverse Event|0|||
128977580|NCT02705755|464203198|FG002|Part A (6 Days)|Adverse Event|0|||
128977581|NCT02705755|464203199|FG003|Part A (6 Days)|Adverse Event|0|||
128977582|NCT02705755|464203196|FG000|Part A (6 Days)|Physician Decision|3|||
128977583|NCT02705755|464203197|FG001|Part A (6 Days)|Physician Decision|0|||
128977584|NCT02705755|464203198|FG002|Part A (6 Days)|Physician Decision|0|||
128977585|NCT02705755|464203199|FG003|Part A (6 Days)|Physician Decision|0|||
128977586|NCT02705755|464203196|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
128977587|NCT02705755|464203197|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
128977588|NCT02705755|464203198|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
128977589|NCT02705755|464203199|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
128977590|NCT02705755|464203196|FG000|Part C (20 Weeks)|Physician Decision|0|||
128977591|NCT02705755|464203197|FG001|Part C (20 Weeks)|Physician Decision|0|||
128977592|NCT02705755|464203198|FG002|Part C (20 Weeks)|Physician Decision|0|||
128977593|NCT02705755|464203199|FG003|Part C (20 Weeks)|Physician Decision|2|||
128977594|NCT02705755|464203196|FG000|Part C (20 Weeks)|Adverse Event|0|||
128977595|NCT02705755|464203197|FG001|Part C (20 Weeks)|Adverse Event|0|||
128977596|NCT02705755|464203198|FG002|Part C (20 Weeks)|Adverse Event|0|||
128977597|NCT02705755|464203199|FG003|Part C (20 Weeks)|Adverse Event|6|||
128977598|NCT02705755|464203196|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
128977599|NCT02705755|464203197|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
128977600|NCT02705755|464203198|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
128977601|NCT02705755|464203199|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
128977602|NCT01640353|464205125|FG000|Overall Study|Withdrew prior to treatment|10|||
128977603|NCT01640353|464205125|FG000|Overall Study|Withdrawn from analysis at term site|12|||
128977604|NCT01640353|464205125|FG000|Overall Study|Withdrawal by Subject|5|||
128977605|NCT01640353|464205125|FG000|Overall Study|Death|2|||
128977606|NCT01640353|464205125|FG000|Overall Study|Early site termination|3|||
128977607|NCT01640353|464205125|FG000|Overall Study|Lost to Follow-up|12|||
128977608|NCT01640353|464205125|FG000|Overall Study|Physician Decision|1|||
128977609|NCT03758612|464205130|FG000|Washout Period|Withdrawal by Subject|0|||
128977610|NCT03758612|464205131|FG001|Washout Period|Withdrawal by Subject|0|||
128977611|NCT03758612|464205132|FG002|Washout Period|Withdrawal by Subject|2|||
128977612|NCT03758612|464205133|FG003|Washout Period|Withdrawal by Subject|0|||
128977613|NCT03758612|464205134|FG004|Washout Period|Withdrawal by Subject|0|||
128977614|NCT03758612|464205135|FG005|Washout Period|Withdrawal by Subject|0|||
128977615|NCT03758612|464205136|FG006|Washout Period|Withdrawal by Subject|0|||
129040077|NCT00573170|464438747|FG005|First Washout Period|Withdrawal by Subject|3|||
129040078|NCT00573170|464438742|FG000|First Washout Period|Other|4|||
129040079|NCT00573170|464438743|FG001|First Washout Period|Other|0|||
129040080|NCT00573170|464438744|FG002|First Washout Period|Other|1|||
129040081|NCT00573170|464438745|FG003|First Washout Period|Other|1|||
129040082|NCT00573170|464438746|FG004|First Washout Period|Other|0|||
129040083|NCT00573170|464438747|FG005|First Washout Period|Other|0|||
129040084|NCT00573170|464438742|FG000|Second Washout Period|Adverse Event|1|||
129040085|NCT00573170|464438743|FG001|Second Washout Period|Adverse Event|0|||
129040086|NCT00573170|464438744|FG002|Second Washout Period|Adverse Event|0|||
129040087|NCT00573170|464438745|FG003|Second Washout Period|Adverse Event|0|||
129040088|NCT00573170|464438746|FG004|Second Washout Period|Adverse Event|1|||
129040089|NCT00573170|464438747|FG005|Second Washout Period|Adverse Event|0|||
129040090|NCT00573170|464438742|FG000|Second Washout Period|Protocol Violation|2|||
129040091|NCT00573170|464438743|FG001|Second Washout Period|Protocol Violation|1|||
129040092|NCT00573170|464438744|FG002|Second Washout Period|Protocol Violation|1|||
129040093|NCT00573170|464438745|FG003|Second Washout Period|Protocol Violation|0|||
129222099|NCT03184870|465116024|FG008|Initial Treatment|Death|1|||
128977616|NCT03758612|464205137|FG007|Washout Period|Withdrawal by Subject|0|||
128977617|NCT03758612|464205138|FG008|Washout Period|Withdrawal by Subject|0|||
128977618|NCT03758612|464205139|FG009|Washout Period|Withdrawal by Subject|0|||
128977619|NCT03758612|464205140|FG010|Washout Period|Withdrawal by Subject|0|||
128977620|NCT03758612|464205141|FG011|Washout Period|Withdrawal by Subject|0|||
128977621|NCT03758612|464205130|FG000|Period 2|Protocol Violation|0|||
128977622|NCT03758612|464205131|FG001|Period 2|Protocol Violation|0|||
128977623|NCT03758612|464205132|FG002|Period 2|Protocol Violation|0|||
128977624|NCT03758612|464205133|FG003|Period 2|Protocol Violation|0|||
128977625|NCT03758612|464205134|FG004|Period 2|Protocol Violation|1|||
128977626|NCT03758612|464205135|FG005|Period 2|Protocol Violation|0|||
128977627|NCT03758612|464205136|FG006|Period 2|Protocol Violation|0|||
128977628|NCT03758612|464205137|FG007|Period 2|Protocol Violation|0|||
128977629|NCT03758612|464205138|FG008|Period 2|Protocol Violation|0|||
128977630|NCT03758612|464205139|FG009|Period 2|Protocol Violation|0|||
128977631|NCT03758612|464205140|FG010|Period 2|Protocol Violation|0|||
128977632|NCT03758612|464205141|FG011|Period 2|Protocol Violation|0|||
128977633|NCT01603615|464205143|FG000|Overall Study|Did not Receive Treatment|7|||
128977634|NCT01603615|464205143|FG000|Overall Study|Lost to Follow-up|9|||
128977635|NCT01603615|464205143|FG000|Overall Study|Personal Reasons|17|||
128977636|NCT01603615|464205143|FG000|Overall Study|Other Miscellaneous|1|||
128977637|NCT03419741|464205144|FG000|Overall Study|Adverse Event|1|||
128977638|NCT03419741|464205145|FG001|Overall Study|Adverse Event|0|||
128977639|NCT03419741|464205144|FG000|Overall Study|Withdrawal by Subject|1|||
128977640|NCT03419741|464205145|FG001|Overall Study|Withdrawal by Subject|2|||
128977641|NCT04354870|464205146|FG000|Overall Study|Lost to Follow-up|32|||
128977642|NCT04354870|464205147|FG001|Overall Study|Lost to Follow-up|12|||
128977643|NCT04354870|464205146|FG000|Overall Study|Withdrawal by Subject|10|||
128977644|NCT04354870|464205147|FG001|Overall Study|Withdrawal by Subject|16|||
128977645|NCT04354870|464205146|FG000|Overall Study|Did not complete all study visits|6|||
128977646|NCT04354870|464205147|FG001|Overall Study|Did not complete all study visits|5|||
128977647|NCT03384316|464205148|FG000|Overall Study|Screen failure|0|||
128977648|NCT03384316|464205149|FG001|Overall Study|Screen failure|1|||
128977649|NCT02194699|464205160|FG000|Randomised|Did not receive treatment|1|||
128977650|NCT02194699|464205161|FG001|Randomised|Did not receive treatment|5|||
128977651|NCT02194699|464205160|FG000|Randomised|Without potential for 52 weeks of IP|5|||
128977652|NCT02194699|464205161|FG001|Randomised|Without potential for 52 weeks of IP|5|||
128977653|NCT02194699|464205160|FG000|Randomised|Duplicate patient|2|||
128977654|NCT02194699|464205161|FG001|Randomised|Duplicate patient|1|||
128977655|NCT02194699|464205160|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
128977656|NCT02194699|464205161|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
128977657|NCT02194699|464205160|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
128977658|NCT02194699|464205161|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
128977659|NCT02194699|464205160|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
128977660|NCT02194699|464205161|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
128977661|NCT02194699|464205160|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
128977662|NCT02194699|464205161|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
128977663|NCT02194699|464205160|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
128977664|NCT02194699|464205161|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
128977665|NCT02194699|464205160|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
128977666|NCT02194699|464205161|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
128977667|NCT02127970|464205171|FG000|Overall Study|Adverse Event|2|||
128977668|NCT02127970|464205172|FG001|Overall Study|Adverse Event|1|||
128977669|NCT02127970|464205171|FG000|Overall Study|Death|1|||
128977670|NCT02127970|464205172|FG001|Overall Study|Death|1|||
128977671|NCT02127970|464205171|FG000|Overall Study|Lost to Follow-up|14|||
128977672|NCT02127970|464205172|FG001|Overall Study|Lost to Follow-up|14|||
128977673|NCT02127970|464205171|FG000|Overall Study|Reason not Specified|4|||
128977674|NCT02127970|464205172|FG001|Overall Study|Reason not Specified|7|||
128977675|NCT02127970|464205171|FG000|Overall Study|Pregnancy|0|||
128977676|NCT02127970|464205172|FG001|Overall Study|Pregnancy|1|||
128977677|NCT02127970|464205171|FG000|Overall Study|Subject Withdrew Consent|5|||
128977678|NCT02127970|464205172|FG001|Overall Study|Subject Withdrew Consent|3|||
128977679|NCT01710709|464205173|FG000|Overall Study|Lost to Follow-up|29|||
128977680|NCT01710709|464205173|FG000|Overall Study|Adverse Event|48|||
129040094|NCT00573170|464438746|FG004|Second Washout Period|Protocol Violation|0|||
129040095|NCT00573170|464438747|FG005|Second Washout Period|Protocol Violation|0|||
129040096|NCT00573170|464438742|FG000|Second Washout Period|Withdrawal by Subject|1|||
129040097|NCT00573170|464438743|FG001|Second Washout Period|Withdrawal by Subject|1|||
129040098|NCT00573170|464438744|FG002|Second Washout Period|Withdrawal by Subject|2|||
129040099|NCT00573170|464438745|FG003|Second Washout Period|Withdrawal by Subject|0|||
129040100|NCT00573170|464438746|FG004|Second Washout Period|Withdrawal by Subject|1|||
129040101|NCT00573170|464438747|FG005|Second Washout Period|Withdrawal by Subject|0|||
129040102|NCT00573170|464438742|FG000|Second Washout Period|Lost to Follow-up|0|||
129040103|NCT00573170|464438743|FG001|Second Washout Period|Lost to Follow-up|0|||
129040104|NCT00573170|464438744|FG002|Second Washout Period|Lost to Follow-up|0|||
129040105|NCT00573170|464438745|FG003|Second Washout Period|Lost to Follow-up|1|||
129040106|NCT00573170|464438746|FG004|Second Washout Period|Lost to Follow-up|0|||
129040107|NCT00573170|464438747|FG005|Second Washout Period|Lost to Follow-up|0|||
129040108|NCT00573170|464438742|FG000|Second Washout Period|Other|1|||
129040109|NCT00573170|464438743|FG001|Second Washout Period|Other|2|||
129040110|NCT00573170|464438744|FG002|Second Washout Period|Other|1|||
129040111|NCT00573170|464438745|FG003|Second Washout Period|Other|4|||
129040112|NCT00573170|464438746|FG004|Second Washout Period|Other|6|||
129040113|NCT00573170|464438747|FG005|Second Washout Period|Other|2|||
129040114|NCT00573170|464438742|FG000|Third Treatment Period|Withdrawal by Subject|1|||
129040115|NCT00573170|464438743|FG001|Third Treatment Period|Withdrawal by Subject|0|||
129040116|NCT00573170|464438744|FG002|Third Treatment Period|Withdrawal by Subject|0|||
129040117|NCT00573170|464438745|FG003|Third Treatment Period|Withdrawal by Subject|0|||
129040118|NCT00573170|464438746|FG004|Third Treatment Period|Withdrawal by Subject|0|||
129040119|NCT00573170|464438747|FG005|Third Treatment Period|Withdrawal by Subject|0|||
129040120|NCT00573170|464438742|FG000|Third Treatment Period|Lost to Follow-up|0|||
129040121|NCT00573170|464438743|FG001|Third Treatment Period|Lost to Follow-up|0|||
129040122|NCT00573170|464438744|FG002|Third Treatment Period|Lost to Follow-up|0|||
129040123|NCT00573170|464438745|FG003|Third Treatment Period|Lost to Follow-up|0|||
129040124|NCT00573170|464438746|FG004|Third Treatment Period|Lost to Follow-up|0|||
129040125|NCT00573170|464438747|FG005|Third Treatment Period|Lost to Follow-up|2|||
129040126|NCT00608517|464438748|FG000|Overall Study|Death|1|||
129040127|NCT00608517|464438749|FG001|Overall Study|Death|0|||
129040128|NCT00608517|464438750|FG002|Overall Study|Death|0|||
129040129|NCT00493454|464438751|FG000|Overall Study|Withdrawal by Subject|1|||
129040130|NCT00103038|464438752|FG000|Overall Study|Withdrawal by Subject|8|||
129040131|NCT00103038|464438752|FG000|Overall Study|Screen failure|3|||
129040132|NCT00103038|464438752|FG000|Overall Study|Death|1|||
129040133|NCT00103038|464438752|FG000|Overall Study|Physician Decision|1|||
129040134|NCT03649412|464438759|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
129040135|NCT03649412|464438760|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
129040136|NCT03649412|464438759|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
129040137|NCT03649412|464438760|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
129040138|NCT03649412|464438759|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
129040139|NCT03649412|464438760|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129040140|NCT03649412|464438759|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
129040141|NCT03649412|464438760|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
129040142|NCT03649412|464438759|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
129040143|NCT03649412|464438760|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
129040144|NCT03649412|464438759|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
129040145|NCT03649412|464438760|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
129040146|NCT02865395|464438761|FG000|Overall Study|Physician Decision|6|||
129040147|NCT02865395|464438762|FG001|Overall Study|Physician Decision|10|||
129040148|NCT02865395|464438763|FG002|Overall Study|Physician Decision|7|||
129040149|NCT02674386|464438766|FG000|Overall Study|Lost to Follow-up|0|||
129040150|NCT02674386|464438767|FG001|Overall Study|Lost to Follow-up|1|||
129040151|NCT02674386|464438768|FG002|Overall Study|Lost to Follow-up|1|||
129040152|NCT02674386|464438766|FG000|Overall Study|Withdrawal by Subject|0|||
129040153|NCT02674386|464438767|FG001|Overall Study|Withdrawal by Subject|4|||
129040154|NCT02674386|464438768|FG002|Overall Study|Withdrawal by Subject|0|||
129040155|NCT02674386|464438766|FG000|Overall Study|Other|0|||
129040156|NCT02674386|464438767|FG001|Overall Study|Other|1|||
129040157|NCT02674386|464438768|FG002|Overall Study|Other|0|||
129040158|NCT02674386|464438766|FG000|Overall Study|Enrolled but not evaluated|0|||
129040159|NCT02674386|464438767|FG001|Overall Study|Enrolled but not evaluated|4|||
129040160|NCT02674386|464438768|FG002|Overall Study|Enrolled but not evaluated|0|||
129040161|NCT04019054|464438769|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
129040162|NCT04019054|464438770|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
129040163|NCT04019054|464438769|FG000|Overall Study|Withdrawal by Subject|3|||
129040164|NCT04019054|464438770|FG001|Overall Study|Withdrawal by Subject|1|||
129040165|NCT02094261|464438773|FG000|Overall Study|Death|24|||
129040166|NCT02094261|464438773|FG000|Overall Study|Lost to Follow-up|1|||
129040167|NCT02094261|464438773|FG000|Overall Study|Withdrawal by Subject|4|||
129040168|NCT02094261|464438773|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
129040169|NCT02363439|464438774|FG000|Overall Study|Lack of Efficacy|4|||
129040170|NCT01682148|464438777|FG000|Overall Study|Withdrawal by Subject|2|||
129040171|NCT01682148|464438778|FG001|Overall Study|Withdrawal by Subject|0|||
129040172|NCT01682148|464438777|FG000|Overall Study|Lost to Follow-up|1|||
129040173|NCT01682148|464438778|FG001|Overall Study|Lost to Follow-up|2|||
129040174|NCT01682148|464438777|FG000|Overall Study|Protocol Violation|1|||
129040175|NCT01682148|464438778|FG001|Overall Study|Protocol Violation|1|||
129040176|NCT03827018|464438781|FG000|Overall Study|Adverse Event|1|||
129040177|NCT03827018|464438782|FG001|Overall Study|Adverse Event|0|||
129040178|NCT03827018|464438781|FG000|Overall Study|Withdrawal by Subject|2|||
128717593|NCT01881230|463263924|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
128717594|NCT01881230|463263925|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
128717595|NCT02385266|463263926|FG000|Overall Study|Withdrawal by Subject|1|||
128717596|NCT02385266|463263927|FG001|Overall Study|Withdrawal by Subject|3|||
128717597|NCT00112502|463263928|FG000|Overall Study|Withdrawal by Subject|0|||
128717598|NCT00112502|463263929|FG001|Overall Study|Withdrawal by Subject|1|||
128977681|NCT01710709|464205173|FG000|Overall Study|Participant met withdrawal criteria|33|||
128977682|NCT01710709|464205173|FG000|Overall Study|Participant withdrawn by investigator|2|||
128977683|NCT01710709|464205173|FG000|Overall Study|Withdrawal by Subject|53|||
128977684|NCT01710709|464205173|FG000|Overall Study|Protocol Violation|5|||
128977685|NCT01710709|464205173|FG000|Overall Study|Lack of Efficacy|3|||
128977686|NCT01398176|464205175|FG000|Overall Study|Lost to Follow-up|1|||
128977687|NCT01398176|464205176|FG001|Overall Study|Lost to Follow-up|3|||
128977688|NCT01398176|464205175|FG000|Overall Study|Physician Decision|2|||
128977689|NCT01398176|464205176|FG001|Overall Study|Physician Decision|3|||
128977690|NCT00542321|464205177|FG000|Overall Study|Death|0|||
128977691|NCT00542321|464205178|FG001|Overall Study|Death|1|||
128977692|NCT00253747|464205185|FG000|Overall Study|Lost to Follow-up|13|||
128977693|NCT00253747|464205186|FG001|Overall Study|Lost to Follow-up|14|||
128977694|NCT00253747|464205185|FG000|Overall Study|Withdrawal by Subject|10|||
128977695|NCT00253747|464205186|FG001|Overall Study|Withdrawal by Subject|11|||
128977696|NCT00253747|464205185|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
128977697|NCT00253747|464205186|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
128977698|NCT01977651|464205187|FG000|4 Month Treatment Period|Adverse Event|34|||
128977699|NCT01977651|464205187|FG000|4 Month Treatment Period|Death|3|||
128977700|NCT01977651|464205187|FG000|4 Month Treatment Period|Progressive Disease|43|||
128977701|NCT01977651|464205187|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
128977702|NCT01977651|464205187|FG000|4 Month Treatment Period|Physician Decision|4|||
128977703|NCT01977651|464205187|FG000|1 Year Extension Period|Adverse Event|14|||
128977704|NCT01977651|464205187|FG000|1 Year Extension Period|Death|10|||
128977705|NCT01977651|464205187|FG000|1 Year Extension Period|Lost to Follow-up|2|||
128977706|NCT01977651|464205187|FG000|1 Year Extension Period|Progressive Disease|86|||
128977707|NCT01977651|464205187|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
128977708|NCT01977651|464205187|FG000|1 Year Extension Period|Physician Decision|6|||
128977709|NCT01977651|464205187|FG000|1 Year Extension Period|Miscellaneous|1|||
128977710|NCT01977651|464205187|FG000|Post 1 Year Extension Period|Adverse Event|5|||
128977711|NCT01977651|464205187|FG000|Post 1 Year Extension Period|Death|13|||
129040179|NCT03827018|464438782|FG001|Overall Study|Withdrawal by Subject|2|||
129040180|NCT03827018|464438781|FG000|Overall Study|Lack of Efficacy|0|||
129040181|NCT03827018|464438782|FG001|Overall Study|Lack of Efficacy|1|||
129040182|NCT01029392|464438784|FG000|Overall Study|Withdrawal by Subject|18|||
128717599|NCT00112502|463263930|FG002|Overall Study|Withdrawal by Subject|1|||
128717600|NCT00112502|463263931|FG003|Overall Study|Withdrawal by Subject|4|||
128717601|NCT00112502|463263932|FG004|Overall Study|Withdrawal by Subject|2|||
128717602|NCT00112502|463263933|FG005|Overall Study|Withdrawal by Subject|5|||
128717603|NCT00112502|463263934|FG006|Overall Study|Withdrawal by Subject|3|||
128717604|NCT00112502|463263935|FG007|Overall Study|Withdrawal by Subject|7|||
128717605|NCT01217060|463263940|FG000|Overall Study|Withdrawal by Subject|1|||
128717606|NCT03388138|463263944|FG000|Overall Study|Protocol Violation|1|||
128717607|NCT03388138|463263945|FG001|Overall Study|Protocol Violation|0|||
128717608|NCT01528072|463263948|FG000|Overall Study|Withdrawal by Subject|5|||
128717609|NCT01528072|463263948|FG000|Overall Study|Physician Decision|1|||
128717610|NCT01528072|463263948|FG000|Overall Study|Determined not eligible by AEAC|1|||
128717611|NCT01528072|463263948|FG000|Overall Study|Missed Visit|2|||
128717612|NCT01528072|463263948|FG000|Overall Study|Lost to Follow-up|5|||
128717613|NCT01528072|463263948|FG000|Overall Study|Explanted|2|||
128717614|NCT01528072|463263948|FG000|Overall Study|Site Closure|4|||
128717615|NCT01528072|463263948|FG000|Overall Study|Death|2|||
129040183|NCT01029392|464438785|FG001|Overall Study|Withdrawal by Subject|11|||
129040184|NCT01029392|464438784|FG000|Overall Study|Physician Decision|2|||
129040185|NCT01029392|464438785|FG001|Overall Study|Physician Decision|0|||
128717616|NCT01528072|463263948|FG000|Overall Study|Early Termination of Study|52|||
128717617|NCT01859494|463263951|FG000|Overall Study|Adverse Event|1|||
128717618|NCT02769247|463263956|FG000|Overall Study|Withdrawal by Subject|1|||
128717619|NCT02769247|463263957|FG001|Overall Study|Withdrawal by Subject|0|||
129040186|NCT00063882|464438786|FG000|Overall Study|Protocol Violation|3|||
128717620|NCT02769247|463263958|FG002|Overall Study|Withdrawal by Subject|0|||
128717621|NCT02769247|463263959|FG003|Overall Study|Withdrawal by Subject|1|||
128717622|NCT02769247|463263956|FG000|Overall Study|Protocol Violation|0|||
128717623|NCT02769247|463263957|FG001|Overall Study|Protocol Violation|0|||
128977712|NCT01977651|464205187|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
128977713|NCT01977651|464205187|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
128977714|NCT01977651|464205187|FG000|Post 1 Year Extension Period|Physician Decision|4|||
128977715|NCT01977651|464205187|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
128977716|NCT03287089|464205188|FG000|Overall Study|Lost to Follow-up|0|||
128977717|NCT03287089|464205189|FG001|Overall Study|Lost to Follow-up|2|||
129132824|NCT00758043|464778528|FG002|Overall Study|Non-Compliant With study Drug|0|||
129132825|NCT00758043|464778529|FG003|Overall Study|Non-Compliant With study Drug|1|||
129132826|NCT00758043|464778526|FG000|Overall Study|Other Reasons|0|||
129132827|NCT00758043|464778527|FG001|Overall Study|Other Reasons|1|||
129132828|NCT00758043|464778528|FG002|Overall Study|Other Reasons|0|||
129132829|NCT00758043|464778529|FG003|Overall Study|Other Reasons|5|||
129132830|NCT02400580|464778532|FG000|Overall Study|Withdrawal by Subject|1|||
129132831|NCT02400580|464778533|FG001|Overall Study|Withdrawal by Subject|1|||
129132832|NCT02400580|464778532|FG000|Overall Study|Adverse Event|1|||
129132833|NCT02400580|464778533|FG001|Overall Study|Adverse Event|0|||
129132834|NCT00965094|464778536|FG000|Overall Study|Adverse Event|5|||
129132835|NCT00965094|464778537|FG001|Overall Study|Adverse Event|0|||
129132836|NCT00965094|464778536|FG000|Overall Study|Lost to Follow-up|0|||
129132837|NCT00965094|464778537|FG001|Overall Study|Lost to Follow-up|1|||
129132838|NCT01336972|464778541|FG000|Overall Study|Adverse Event|1|||
129132839|NCT01336972|464778542|FG001|Overall Study|Adverse Event|1|||
129132840|NCT01336972|464778543|FG002|Overall Study|Adverse Event|0|||
129132841|NCT02441114|464778545|FG000|Washout2|Withdrawal by Subject|4|||
129132842|NCT03446573|464778546|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
129132843|NCT03446573|464778547|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
129132844|NCT03446573|464778546|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
129132845|NCT03446573|464778547|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
129132846|NCT03446573|464778546|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
129132847|NCT03446573|464778547|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
129132848|NCT03446573|464778546|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
129132849|NCT03446573|464778547|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
129132850|NCT03446573|464778546|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
129132851|NCT03446573|464778547|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
129132852|NCT03446573|464778546|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
129132853|NCT03446573|464778547|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
129132854|NCT03446573|464778546|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
129132855|NCT03446573|464778547|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
129132856|NCT03446573|464778546|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
129132857|NCT03446573|464778547|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
129132858|NCT03446573|464778546|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
129132859|NCT03446573|464778547|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
129132860|NCT03446573|464778546|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
129132861|NCT03446573|464778547|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
129132862|NCT03446573|464778546|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
129132863|NCT03446573|464778547|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
128717624|NCT02769247|463263958|FG002|Overall Study|Protocol Violation|1|||
128717625|NCT02769247|463263959|FG003|Overall Study|Protocol Violation|0|||
128717626|NCT02769247|463263956|FG000|Overall Study|Physician Decision|1|||
128717627|NCT02769247|463263957|FG001|Overall Study|Physician Decision|0|||
128717628|NCT02769247|463263958|FG002|Overall Study|Physician Decision|0|||
128717629|NCT02769247|463263959|FG003|Overall Study|Physician Decision|0|||
128717630|NCT05089682|463263960|FG000|Overall Study|Withdrawal by Subject|2|||
128717631|NCT01514760|463263961|FG000|Overall Study|Lost to Follow-up|2|||
128717632|NCT02092662|463263962|FG000|Overall Study|Lost to Follow-up|13|||
128717633|NCT02092662|463263963|FG001|Overall Study|Lost to Follow-up|0|||
128977718|NCT03287089|464205188|FG000|Overall Study|Physician Decision|0|||
128977719|NCT03287089|464205189|FG001|Overall Study|Physician Decision|2|||
128977720|NCT03287089|464205188|FG000|Overall Study|Withdrawal by Subject|0|||
128977721|NCT03287089|464205189|FG001|Overall Study|Withdrawal by Subject|2|||
128977722|NCT00661362|464205190|FG000|Overall Study|Adverse Event|5|||
128977723|NCT00661362|464205191|FG001|Overall Study|Adverse Event|4|||
128977724|NCT00661362|464205190|FG000|Overall Study|Incorrect enrollment|2|||
128977725|NCT00661362|464205191|FG001|Overall Study|Incorrect enrollment|0|||
128977726|NCT00661362|464205190|FG000|Overall Study|Study specific discontinuation criteria|4|||
128977727|NCT00661362|464205191|FG001|Overall Study|Study specific discontinuation criteria|11|||
128977728|NCT00661362|464205190|FG000|Overall Study|Withdrawal by Subject|13|||
128977729|NCT00661362|464205191|FG001|Overall Study|Withdrawal by Subject|23|||
129132864|NCT03446573|464778546|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
129132865|NCT03446573|464778547|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
129132866|NCT03446573|464778546|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
129132867|NCT03446573|464778547|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
129132868|NCT01371565|464778550|FG000|Overall Study|Withdrawal by Subject|1|||
129132869|NCT01371565|464778550|FG000|Overall Study|Death|1|||
128977730|NCT00661362|464205190|FG000|Overall Study|Lost to Follow-up|3|||
128977731|NCT00661362|464205191|FG001|Overall Study|Lost to Follow-up|1|||
128977732|NCT00661362|464205190|FG000|Overall Study|Severe non-compliance to protocol|0|||
128977733|NCT00661362|464205191|FG001|Overall Study|Severe non-compliance to protocol|1|||
129040187|NCT00063882|464438787|FG001|Overall Study|Protocol Violation|3|||
129040188|NCT00063882|464438786|FG000|Overall Study|Withdrawal by Subject|2|||
129040189|NCT00063882|464438787|FG001|Overall Study|Withdrawal by Subject|1|||
129040190|NCT01103479|464438788|FG000|Overall Study|Up to date with CRC screening|1|||
129040191|NCT01103479|464438789|FG001|Overall Study|Up to date with CRC screening|9|||
129040192|NCT01103479|464438790|FG002|Overall Study|Up to date with CRC screening|12|||
129040193|NCT01103479|464438788|FG000|Overall Study|Family history of CRC|1|||
129040194|NCT01103479|464438789|FG001|Overall Study|Family history of CRC|0|||
129040195|NCT01103479|464438790|FG002|Overall Study|Family history of CRC|2|||
129040196|NCT01103479|464438788|FG000|Overall Study|Active cancer|1|||
129040197|NCT01103479|464438789|FG001|Overall Study|Active cancer|0|||
129040198|NCT01103479|464438790|FG002|Overall Study|Active cancer|0|||
129040199|NCT01103479|464438788|FG000|Overall Study|Saw non-study physician|2|||
129040200|NCT01103479|464438789|FG001|Overall Study|Saw non-study physician|0|||
129040201|NCT01103479|464438790|FG002|Overall Study|Saw non-study physician|0|||
129040202|NCT00834899|464438791|FG000|Overall Study|Withdrawal by Subject|1|||
129040203|NCT00834899|464438792|FG001|Overall Study|Withdrawal by Subject|1|||
129040204|NCT01534637|464438793|FG000|Overall Study|Physician Decision|3|||
129040205|NCT01534637|464438793|FG000|Overall Study|Lack of Efficacy|3|||
129040206|NCT01534637|464438793|FG000|Overall Study|Withdrawal by Subject|1|||
129040207|NCT01534637|464438793|FG000|Overall Study|Adverse Event|1|||
129040208|NCT01534637|464438793|FG000|Overall Study|Liver Mets before treatment|1|||
129040209|NCT00605917|464438794|FG000|Overall Study|Protocol Violation|79|||
129040210|NCT00890552|464438796|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
129040211|NCT00890552|464438796|FG000|On-treatment|Early prog disease/ death|10|||
129040212|NCT03903159|464438797|FG000|Overall Study|Discharged with Staff Approval|2|||
129040213|NCT03903159|464438797|FG000|Overall Study|Discharged at Staff Request|2|||
129040214|NCT03903159|464438797|FG000|Overall Study|Discharged Against Staff Advice|1|||
129040215|NCT02443545|464438800|FG000|Overall Study|Adverse Event|1|||
129040216|NCT02443545|464438801|FG001|Overall Study|Adverse Event|1|||
129040217|NCT02443545|464438800|FG000|Overall Study|Lost to Follow-up|0|||
129040218|NCT02443545|464438801|FG001|Overall Study|Lost to Follow-up|2|||
129040219|NCT02443545|464438800|FG000|Overall Study|Physician Decision|3|||
129040220|NCT02443545|464438801|FG001|Overall Study|Physician Decision|0|||
129040221|NCT02443545|464438800|FG000|Overall Study|Protocol Violation|8|||
129040222|NCT02443545|464438801|FG001|Overall Study|Protocol Violation|1|||
129040223|NCT02443545|464438800|FG000|Overall Study|Pregnancy|1|||
129040224|NCT02443545|464438801|FG001|Overall Study|Pregnancy|1|||
129040225|NCT02443545|464438800|FG000|Overall Study|Withdrawal by Subject|6|||
129040226|NCT02443545|464438801|FG001|Overall Study|Withdrawal by Subject|3|||
129040227|NCT02443545|464438800|FG000|Overall Study|Termination of study|20|||
129040228|NCT02443545|464438801|FG001|Overall Study|Termination of study|11|||
129040229|NCT00724373|464438802|FG000|Overall Study|Adverse Event|41|||
129040230|NCT00724373|464438802|FG000|Overall Study|Lack of Efficacy|82|||
129040231|NCT00724373|464438802|FG000|Overall Study|Lost to Follow-up|7|||
129040232|NCT00724373|464438802|FG000|Overall Study|Non-compliance|2|||
129040233|NCT00724373|464438802|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
129040234|NCT00724373|464438802|FG000|Overall Study|Participant moved away|1|||
129040235|NCT00724373|464438802|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
129040236|NCT00724373|464438802|FG000|Overall Study|Only to have 24 week regimen|1|||
129040237|NCT00724373|464438802|FG000|Overall Study|Viral Relapse|1|||
129040238|NCT00724373|464438802|FG000|Overall Study|Acute HCV infection|1|||
129040239|NCT00724373|464438802|FG000|Overall Study|Drug Relapse|1|||
129040240|NCT00724373|464438802|FG000|Overall Study|Tolerability|23|||
129040241|NCT00536484|464438803|FG000|Overall Study|Adverse Event|21|||
129040242|NCT00536484|464438804|FG001|Overall Study|Adverse Event|34|||
129040243|NCT00536484|464438803|FG000|Overall Study|Withdrawal by Subject|11|||
129040244|NCT00536484|464438804|FG001|Overall Study|Withdrawal by Subject|11|||
129132870|NCT01371565|464778550|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
129132871|NCT04270760|464778551|FG000|Overall Study|Withdrawal by Subject|0|||
129132872|NCT04270760|464778552|FG001|Overall Study|Withdrawal by Subject|1|||
129132873|NCT04270760|464778553|FG002|Overall Study|Withdrawal by Subject|3|||
129040245|NCT00536484|464438803|FG000|Overall Study|Lost to Follow-up|8|||
129040246|NCT00536484|464438804|FG001|Overall Study|Lost to Follow-up|6|||
129040247|NCT00536484|464438803|FG000|Overall Study|Lack of Efficacy|16|||
129040248|NCT00536484|464438804|FG001|Overall Study|Lack of Efficacy|5|||
129040249|NCT00536484|464438803|FG000|Overall Study|Other|4|||
129040250|NCT00536484|464438804|FG001|Overall Study|Other|0|||
129132874|NCT04270760|464778554|FG003|Overall Study|Withdrawal by Subject|0|||
129040251|NCT01506908|464438805|FG000|Overall Study|Adverse Event|1|||
129040252|NCT01506908|464438806|FG001|Overall Study|Adverse Event|0|||
129040253|NCT03314662|464438807|FG000|Overall Study|Withdrawal by Subject|1|||
129040254|NCT03314662|464438808|FG001|Overall Study|Withdrawal by Subject|1|||
129040255|NCT03314662|464438809|FG002|Overall Study|Withdrawal by Subject|1|||
129040256|NCT03314662|464438807|FG000|Overall Study|Lost to Follow-up|5|||
129040257|NCT03314662|464438808|FG001|Overall Study|Lost to Follow-up|4|||
129040258|NCT03314662|464438809|FG002|Overall Study|Lost to Follow-up|4|||
128977734|NCT00661362|464205190|FG000|Overall Study|Safety reasons|1|||
128977735|NCT00661362|464205191|FG001|Overall Study|Safety reasons|0|||
128977736|NCT00661362|464205190|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
128977737|NCT00661362|464205191|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
128977738|NCT00775138|464205192|FG000|Overall Study|Withdrawal by Subject|0|||
128977739|NCT00775138|464205193|FG001|Overall Study|Withdrawal by Subject|0|||
128977740|NCT00775138|464205194|FG002|Overall Study|Withdrawal by Subject|2|||
128977741|NCT00775138|464205195|FG003|Overall Study|Withdrawal by Subject|2|||
128977742|NCT00775138|464205192|FG000|Overall Study|Adverse Event|0|||
128977743|NCT00775138|464205193|FG001|Overall Study|Adverse Event|0|||
128717646|NCT03329690|463263969|FG000|Overall Study|Progressive disease per RECIST|85|||
128717647|NCT03329690|463263970|FG001|Overall Study|Progressive disease per RECIST|44|||
128717648|NCT03329690|463263971|FG002|Overall Study|Progressive disease per RECIST|6|||
128717649|NCT03329690|463263972|FG003|Overall Study|Progressive disease per RECIST|16|||
128717650|NCT03329690|463263973|FG004|Overall Study|Progressive disease per RECIST|20|||
128717651|NCT03329690|463263969|FG000|Overall Study|Clinical progression|7|||
128717652|NCT03329690|463263970|FG001|Overall Study|Clinical progression|4|||
128717653|NCT03329690|463263971|FG002|Overall Study|Clinical progression|1|||
128717654|NCT03329690|463263972|FG003|Overall Study|Clinical progression|1|||
128717655|NCT03329690|463263973|FG004|Overall Study|Clinical progression|1|||
128717656|NCT03329690|463263969|FG000|Overall Study|Adverse Event|22|||
128717657|NCT03329690|463263970|FG001|Overall Study|Adverse Event|4|||
128717658|NCT03329690|463263971|FG002|Overall Study|Adverse Event|0|||
128717659|NCT03329690|463263972|FG003|Overall Study|Adverse Event|1|||
128717660|NCT03329690|463263973|FG004|Overall Study|Adverse Event|2|||
128717661|NCT03329690|463263969|FG000|Overall Study|Death|2|||
128717662|NCT03329690|463263970|FG001|Overall Study|Death|0|||
128717663|NCT03329690|463263971|FG002|Overall Study|Death|0|||
128717664|NCT03329690|463263972|FG003|Overall Study|Death|1|||
128717665|NCT03329690|463263973|FG004|Overall Study|Death|0|||
128717666|NCT03329690|463263969|FG000|Overall Study|Withdrawal by Subject|2|||
128717667|NCT03329690|463263970|FG001|Overall Study|Withdrawal by Subject|3|||
128717668|NCT03329690|463263971|FG002|Overall Study|Withdrawal by Subject|0|||
128717669|NCT03329690|463263972|FG003|Overall Study|Withdrawal by Subject|1|||
128717670|NCT03329690|463263973|FG004|Overall Study|Withdrawal by Subject|0|||
128717671|NCT03329690|463263969|FG000|Overall Study|Physician Decision|1|||
128717672|NCT03329690|463263970|FG001|Overall Study|Physician Decision|0|||
128717673|NCT03329690|463263971|FG002|Overall Study|Physician Decision|0|||
128717674|NCT03329690|463263972|FG003|Overall Study|Physician Decision|0|||
128717675|NCT03329690|463263973|FG004|Overall Study|Physician Decision|1|||
128717676|NCT03329690|463263969|FG000|Overall Study|Miscellaneous|6|||
128717677|NCT03329690|463263970|FG001|Overall Study|Miscellaneous|0|||
128717678|NCT03329690|463263971|FG002|Overall Study|Miscellaneous|0|||
128717679|NCT03329690|463263972|FG003|Overall Study|Miscellaneous|0|||
128717680|NCT03329690|463263973|FG004|Overall Study|Miscellaneous|0|||
128717681|NCT03329690|463263969|FG000|Overall Study|Did not receive treatment|1|||
128717682|NCT03329690|463263970|FG001|Overall Study|Did not receive treatment|0|||
128717683|NCT03329690|463263971|FG002|Overall Study|Did not receive treatment|0|||
128717684|NCT03329690|463263972|FG003|Overall Study|Did not receive treatment|1|||
128717685|NCT03329690|463263973|FG004|Overall Study|Did not receive treatment|0|||
128717686|NCT02418468|463263975|FG000|Overall Study|Adverse Event|1|||
128717687|NCT02418468|463263976|FG001|Overall Study|Adverse Event|0|||
128717688|NCT02418468|463263975|FG000|Overall Study|Withdrawal of informed consent|1|||
128717689|NCT02418468|463263976|FG001|Overall Study|Withdrawal of informed consent|1|||
128717690|NCT02914769|463263977|FG000|Overall Study|Protocol Violation|3|||
128717691|NCT02914769|463263978|FG001|Overall Study|Protocol Violation|2|||
128717692|NCT02914769|463263977|FG000|Overall Study|Withdrawal by Subject|0|||
128717693|NCT02914769|463263978|FG001|Overall Study|Withdrawal by Subject|1|||
128717694|NCT02337907|463263979|FG000|Overall Study|Other than listed|1|||
129132875|NCT04270760|464778555|FG004|Overall Study|Withdrawal by Subject|0|||
129132876|NCT04270760|464778551|FG000|Overall Study|Lost to Follow-up|1|||
128717695|NCT02337907|463263980|FG001|Overall Study|Other than listed|0|||
128717696|NCT02337907|463263981|FG002|Overall Study|Other than listed|0|||
128717697|NCT02337907|463263982|FG003|Overall Study|Other than listed|1|||
128717698|NCT02337907|463263983|FG004|Overall Study|Other than listed|1|||
128717699|NCT02337907|463263984|FG005|Overall Study|Other than listed|0|||
128717700|NCT02337907|463263979|FG000|Overall Study|Withdrawal by Subject|2|||
128717701|NCT02337907|463263980|FG001|Overall Study|Withdrawal by Subject|3|||
128717702|NCT02337907|463263981|FG002|Overall Study|Withdrawal by Subject|0|||
128717703|NCT02337907|463263982|FG003|Overall Study|Withdrawal by Subject|2|||
128717704|NCT02337907|463263983|FG004|Overall Study|Withdrawal by Subject|5|||
128717705|NCT02337907|463263984|FG005|Overall Study|Withdrawal by Subject|0|||
128717706|NCT02337907|463263979|FG000|Overall Study|Lost to Follow-up|0|||
129132877|NCT04270760|464778552|FG001|Overall Study|Lost to Follow-up|2|||
128717707|NCT02337907|463263980|FG001|Overall Study|Lost to Follow-up|0|||
128717708|NCT02337907|463263981|FG002|Overall Study|Lost to Follow-up|0|||
128717709|NCT02337907|463263982|FG003|Overall Study|Lost to Follow-up|0|||
128717710|NCT02337907|463263983|FG004|Overall Study|Lost to Follow-up|0|||
129222171|NCT03184870|465116024|FG008|Initial Treatment|Moved to crossover treatment|0|||
129222172|NCT03184870|465116025|FG009|Initial Treatment|Moved to crossover treatment|0|||
129222173|NCT03184870|465116026|FG010|Initial Treatment|Moved to crossover treatment|0|||
129222174|NCT03184870|465116027|FG011|Initial Treatment|Moved to crossover treatment|0|||
129222175|NCT03184870|465116028|FG012|Initial Treatment|Moved to crossover treatment|9|||
129222176|NCT03184870|465116029|FG013|Initial Treatment|Moved to crossover treatment|0|||
129222177|NCT03184870|465116030|FG014|Initial Treatment|Moved to crossover treatment|0|||
129222178|NCT03184870|465116031|FG015|Initial Treatment|Moved to crossover treatment|0|||
129222179|NCT03184870|465116032|FG016|Initial Treatment|Moved to crossover treatment|0|||
129222180|NCT03184870|465116033|FG017|Initial Treatment|Moved to crossover treatment|0|||
129222181|NCT03184870|465116016|FG000|Crossover Treatment|Other reasons|0|||
129222182|NCT03184870|465116017|FG001|Crossover Treatment|Other reasons|0|||
129222183|NCT03184870|465116018|FG002|Crossover Treatment|Other reasons|0|||
129222184|NCT03184870|465116019|FG003|Crossover Treatment|Other reasons|0|||
129222185|NCT03184870|465116020|FG004|Crossover Treatment|Other reasons|0|||
129222186|NCT03184870|465116021|FG005|Crossover Treatment|Other reasons|0|||
129222187|NCT03184870|465116022|FG006|Crossover Treatment|Other reasons|0|||
129222188|NCT03184870|465116023|FG007|Crossover Treatment|Other reasons|0|||
129222189|NCT03184870|465116024|FG008|Crossover Treatment|Other reasons|0|||
129222190|NCT03184870|465116025|FG009|Crossover Treatment|Other reasons|0|||
129222191|NCT03184870|465116026|FG010|Crossover Treatment|Other reasons|0|||
129222192|NCT03184870|465116027|FG011|Crossover Treatment|Other reasons|0|||
129222193|NCT03184870|465116028|FG012|Crossover Treatment|Other reasons|0|||
129222194|NCT03184870|465116029|FG013|Crossover Treatment|Other reasons|0|||
129222195|NCT03184870|465116030|FG014|Crossover Treatment|Other reasons|0|||
129222196|NCT03184870|465116031|FG015|Crossover Treatment|Other reasons|0|||
128978135|NCT00939094|464205321|FG001|Overall Study|Abnormal ECG findings|0|||
128978136|NCT01906489|464205322|FG000|Overall Study|Adverse Event|10|||
128978137|NCT01906489|464205323|FG001|Overall Study|Adverse Event|3|||
128978138|NCT01906489|464205322|FG000|Overall Study|Worsening of CKD|6|||
128978139|NCT01906489|464205323|FG001|Overall Study|Worsening of CKD|4|||
128978140|NCT01906489|464205322|FG000|Overall Study|Withdrawal by Subject|5|||
128978141|NCT01906489|464205323|FG001|Overall Study|Withdrawal by Subject|0|||
128978142|NCT01906489|464205322|FG000|Overall Study|Worsening of Anemia|1|||
128978143|NCT01906489|464205323|FG001|Overall Study|Worsening of Anemia|0|||
128978144|NCT01906489|464205322|FG000|Overall Study|Protocol Violation|0|||
128978145|NCT01906489|464205323|FG001|Overall Study|Protocol Violation|1|||
128978146|NCT01906489|464205322|FG000|Overall Study|Non- Compliance|1|||
128978147|NCT01906489|464205323|FG001|Overall Study|Non- Compliance|0|||
128978148|NCT01906489|464205322|FG000|Overall Study|Sponsor Decision|1|||
128978149|NCT01906489|464205323|FG001|Overall Study|Sponsor Decision|0|||
128978150|NCT01906489|464205322|FG000|Overall Study|Lost to Follow-up|1|||
128978151|NCT01906489|464205323|FG001|Overall Study|Lost to Follow-up|1|||
128978152|NCT01906489|464205322|FG000|Overall Study|Other|1|||
128978153|NCT01906489|464205323|FG001|Overall Study|Other|0|||
128978154|NCT02551874|464206945|FG000|Overall Study|Lost to Follow-up|0|||
128978155|NCT02551874|464206946|FG001|Overall Study|Lost to Follow-up|2|||
128978156|NCT02551874|464206945|FG000|Overall Study|Pregnancy|0|||
128978157|NCT02551874|464206946|FG001|Overall Study|Pregnancy|1|||
128978158|NCT02551874|464206945|FG000|Overall Study|Reason not reported|10|||
128978159|NCT02551874|464206946|FG001|Overall Study|Reason not reported|4|||
128978160|NCT02551874|464206945|FG000|Overall Study|Did not receive randomized treatment|0|||
128978161|NCT02551874|464206946|FG001|Overall Study|Did not receive randomized treatment|7|||
128978162|NCT02551874|464206945|FG000|Overall Study|Did not enter long-term study|18|||
128978163|NCT02551874|464206946|FG001|Overall Study|Did not enter long-term study|25|||
128978164|NCT01524900|464206947|FG000|Overall Study|Lost to Follow-up|3|||
128978165|NCT01524900|464206948|FG001|Overall Study|Lost to Follow-up|12|||
128978166|NCT01524900|464206949|FG002|Overall Study|Lost to Follow-up|1|||
128978167|NCT01524900|464206950|FG003|Overall Study|Lost to Follow-up|0|||
128978168|NCT01524900|464206951|FG004|Overall Study|Lost to Follow-up|0|||
128978169|NCT01524900|464206947|FG000|Overall Study|Other reason than stated above|1|||
128978170|NCT01524900|464206948|FG001|Overall Study|Other reason than stated above|1|||
128978171|NCT01524900|464206949|FG002|Overall Study|Other reason than stated above|0|||
128978172|NCT01524900|464206950|FG003|Overall Study|Other reason than stated above|0|||
128978173|NCT01524900|464206951|FG004|Overall Study|Other reason than stated above|0|||
128978174|NCT01524900|464206947|FG000|Overall Study|No reason documented|2|||
128978175|NCT01524900|464206948|FG001|Overall Study|No reason documented|1|||
128978176|NCT01524900|464206949|FG002|Overall Study|No reason documented|0|||
128978177|NCT01524900|464206950|FG003|Overall Study|No reason documented|1|||
128978178|NCT01524900|464206951|FG004|Overall Study|No reason documented|0|||
128978179|NCT00298766|464206952|FG000|Overall Study|Adverse Event|18|||
129222197|NCT03184870|465116032|FG016|Crossover Treatment|Other reasons|0|||
129222198|NCT03184870|465116033|FG017|Crossover Treatment|Other reasons|2|||
129222199|NCT03184870|465116016|FG000|Crossover Treatment|Death|0|||
129222200|NCT03184870|465116017|FG001|Crossover Treatment|Death|0|||
129222201|NCT03184870|465116018|FG002|Crossover Treatment|Death|0|||
129222202|NCT03184870|465116019|FG003|Crossover Treatment|Death|0|||
129222203|NCT03184870|465116020|FG004|Crossover Treatment|Death|0|||
129040376|NCT00440466|464440133|FG002|Overall Study|Withdrawal by Subject|9|||
129040377|NCT00440466|464440131|FG000|Overall Study|Began Dialysis|0|||
129040378|NCT00440466|464440132|FG001|Overall Study|Began Dialysis|0|||
129040379|NCT00440466|464440133|FG002|Overall Study|Began Dialysis|1|||
129040380|NCT00440466|464440131|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
129040381|NCT00440466|464440132|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
129040382|NCT00440466|464440133|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
129040383|NCT03768726|464440138|FG000|Treatment Phase|Adverse Event|2|||
129040384|NCT03768726|464440139|FG001|Treatment Phase|Adverse Event|2|||
129040385|NCT03768726|464440138|FG000|Treatment Phase|Lost to Follow-up|1|||
129040386|NCT03768726|464440139|FG001|Treatment Phase|Lost to Follow-up|0|||
129040387|NCT03768726|464440138|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
129040388|NCT03768726|464440139|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
129040389|NCT03768726|464440138|FG000|Treatment Phase|Withdrawal by Subject|3|||
129040390|NCT03768726|464440139|FG001|Treatment Phase|Withdrawal by Subject|1|||
129040391|NCT03768726|464440138|FG000|Follow-Up|Adverse Event|2|||
129040392|NCT03768726|464440139|FG001|Follow-Up|Adverse Event|2|||
129040393|NCT03768726|464440138|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
129040394|NCT03768726|464440139|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
129040395|NCT03768726|464440138|FG000|Follow-Up|Withdrawal by Subject|2|||
129040396|NCT03768726|464440139|FG001|Follow-Up|Withdrawal by Subject|0|||
129040397|NCT03768726|464440138|FG000|Follow-Up|Other|1|||
129040398|NCT03768726|464440139|FG001|Follow-Up|Other|0|||
129040399|NCT01286558|464440142|FG000|Overall Study|Adverse Event|1|||
129040400|NCT01286558|464440143|FG001|Overall Study|Adverse Event|1|||
129040401|NCT01286558|464440142|FG000|Overall Study|Withdrawal by Subject|0|||
129040402|NCT01286558|464440143|FG001|Overall Study|Withdrawal by Subject|1|||
129040403|NCT01787279|464440145|FG000|Overall Study|Lost to Follow-up|2|||
129040404|NCT01787279|464440145|FG000|Overall Study|Lack of Efficacy|1|||
129040405|NCT01005329|464440147|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
129040406|NCT04109313|464440152|FG000|Overall Study|Pregnancy|1|||
129040407|NCT04109313|464440152|FG000|Overall Study|Adverse Event|11|||
129040408|NCT04109313|464440152|FG000|Overall Study|Lack of Efficacy|11|||
129040409|NCT04109313|464440152|FG000|Overall Study|Lost to Follow-up|1|||
129040410|NCT04109313|464440152|FG000|Overall Study|Physician Decision|2|||
129040411|NCT04109313|464440152|FG000|Overall Study|Subject Decision|13|||
129040412|NCT04109313|464440152|FG000|Overall Study|Covid-19 situation|2|||
129040413|NCT01272921|464440153|FG000|Overall Study|Protocol Violation|2|||
129040414|NCT01272921|464440154|FG001|Overall Study|Protocol Violation|1|||
129040415|NCT01132664|464440155|FG000|Phase lb|Adverse Event|0|||
128717880|NCT02113956|463264076|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
128717881|NCT02113956|463264077|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
128717882|NCT02113956|463264076|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
128717883|NCT02113956|463264077|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
128717884|NCT02406651|463264078|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
128717885|NCT03649711|463264079|FG000|Overall Study|Adverse Event|0|||
129040416|NCT01132664|464440156|FG001|Phase lb|Adverse Event|1|||
129040417|NCT01132664|464440157|FG002|Phase lb|Adverse Event|0|||
129040418|NCT01132664|464440158|FG003|Phase lb|Adverse Event|0|||
129040419|NCT01132664|464440159|FG004|Phase lb|Adverse Event|0|||
129040420|NCT01132664|464440155|FG000|Phase lb|Withdrawal by Subject|1|||
129040421|NCT01132664|464440156|FG001|Phase lb|Withdrawal by Subject|2|||
128717886|NCT03649711|463264080|FG001|Overall Study|Adverse Event|1|||
128717887|NCT03649711|463264081|FG002|Overall Study|Adverse Event|0|||
128717888|NCT03649711|463264079|FG000|Overall Study|Kidney Transplant|1|||
129040422|NCT01132664|464440157|FG002|Phase lb|Withdrawal by Subject|0|||
129040423|NCT01132664|464440158|FG003|Phase lb|Withdrawal by Subject|0|||
129040424|NCT01132664|464440159|FG004|Phase lb|Withdrawal by Subject|0|||
129040425|NCT01132664|464440155|FG000|Phase lb|Disease Progression|4|||
129040426|NCT01132664|464440156|FG001|Phase lb|Disease Progression|9|||
128717889|NCT03649711|463264080|FG001|Overall Study|Kidney Transplant|0|||
128717890|NCT03649711|463264081|FG002|Overall Study|Kidney Transplant|0|||
128717891|NCT04439253|463265123|FG000|Overall Study|Adverse Event|1|||
128717892|NCT04439253|463265123|FG000|Overall Study|Disease progression|2|||
128717893|NCT04439253|463265123|FG000|Overall Study|Complicating disease|1|||
129222204|NCT03184870|465116021|FG005|Crossover Treatment|Death|0|||
129040427|NCT01132664|464440157|FG002|Phase lb|Disease Progression|0|||
129040428|NCT01132664|464440158|FG003|Phase lb|Disease Progression|0|||
129040429|NCT01132664|464440159|FG004|Phase lb|Disease Progression|0|||
129040430|NCT01132664|464440155|FG000|Phase ll|Death|0|||
129040431|NCT01132664|464440156|FG001|Phase ll|Death|0|||
129222205|NCT03184870|465116022|FG006|Crossover Treatment|Death|0|||
129040432|NCT01132664|464440157|FG002|Phase ll|Death|2|||
129040433|NCT01132664|464440158|FG003|Phase ll|Death|0|||
128717894|NCT02794103|463265124|FG000|Overall Study|Loss to follow up due to high sedation|3|||
129040434|NCT01132664|464440159|FG004|Phase ll|Death|0|||
129040435|NCT01132664|464440155|FG000|Phase ll|Adverse Event|0|||
129040436|NCT01132664|464440156|FG001|Phase ll|Adverse Event|0|||
129040437|NCT01132664|464440157|FG002|Phase ll|Adverse Event|10|||
129222206|NCT03184870|465116023|FG007|Crossover Treatment|Death|0|||
129040438|NCT01132664|464440158|FG003|Phase ll|Adverse Event|0|||
129040439|NCT01132664|464440159|FG004|Phase ll|Adverse Event|0|||
129040440|NCT01132664|464440155|FG000|Phase ll|Withdrawal by Subject|0|||
129040441|NCT01132664|464440156|FG001|Phase ll|Withdrawal by Subject|0|||
129040442|NCT01132664|464440157|FG002|Phase ll|Withdrawal by Subject|3|||
129040443|NCT01132664|464440158|FG003|Phase ll|Withdrawal by Subject|0|||
129040444|NCT01132664|464440159|FG004|Phase ll|Withdrawal by Subject|0|||
129040445|NCT01132664|464440155|FG000|Phase ll|Disease progression|0|||
129040446|NCT01132664|464440156|FG001|Phase ll|Disease progression|0|||
129040447|NCT01132664|464440157|FG002|Phase ll|Disease progression|35|||
129040448|NCT01132664|464440158|FG003|Phase ll|Disease progression|0|||
129040449|NCT01132664|464440159|FG004|Phase ll|Disease progression|0|||
129040450|NCT01132664|464440155|FG000|BM Cohort|Disease progression|0|||
129040451|NCT01132664|464440156|FG001|BM Cohort|Disease progression|0|||
129040452|NCT01132664|464440157|FG002|BM Cohort|Disease progression|0|||
129222207|NCT03184870|465116024|FG008|Crossover Treatment|Death|0|||
129222208|NCT03184870|465116025|FG009|Crossover Treatment|Death|0|||
129222209|NCT03184870|465116026|FG010|Crossover Treatment|Death|0|||
129222210|NCT03184870|465116027|FG011|Crossover Treatment|Death|0|||
129222211|NCT03184870|465116028|FG012|Crossover Treatment|Death|0|||
129222212|NCT03184870|465116029|FG013|Crossover Treatment|Death|0|||
129222213|NCT03184870|465116030|FG014|Crossover Treatment|Death|0|||
129222214|NCT03184870|465116031|FG015|Crossover Treatment|Death|0|||
129222215|NCT03184870|465116032|FG016|Crossover Treatment|Death|0|||
129222216|NCT03184870|465116033|FG017|Crossover Treatment|Death|7|||
129222217|NCT03959527|465116034|FG000|Overall Study|Withdrawal by Subject|8|||
129222218|NCT03959527|465116035|FG001|Overall Study|Withdrawal by Subject|3|||
129222219|NCT03959527|465116034|FG000|Overall Study|Lost to Follow-up|31|||
129222220|NCT03959527|465116035|FG001|Overall Study|Lost to Follow-up|15|||
129222221|NCT03959527|465116034|FG000|Overall Study|Did not meet eligibility criteria|1|||
129222222|NCT03959527|465116035|FG001|Overall Study|Did not meet eligibility criteria|1|||
129040453|NCT01132664|464440158|FG003|BM Cohort|Disease progression|3|||
129040454|NCT01132664|464440159|FG004|BM Cohort|Disease progression|4|||
129040455|NCT01132664|464440155|FG000|BM Cohort|Adverse Event|0|||
129040456|NCT01132664|464440156|FG001|BM Cohort|Adverse Event|0|||
129040457|NCT01132664|464440157|FG002|BM Cohort|Adverse Event|0|||
129040458|NCT01132664|464440158|FG003|BM Cohort|Adverse Event|0|||
129040459|NCT01132664|464440159|FG004|BM Cohort|Adverse Event|1|||
129040460|NCT01132664|464440155|FG000|BM Cohort|Withdrawal by Subject|0|||
129040461|NCT01132664|464440156|FG001|BM Cohort|Withdrawal by Subject|0|||
129040462|NCT01132664|464440157|FG002|BM Cohort|Withdrawal by Subject|0|||
129040463|NCT01132664|464440158|FG003|BM Cohort|Withdrawal by Subject|0|||
129040464|NCT01132664|464440159|FG004|BM Cohort|Withdrawal by Subject|1|||
129040465|NCT00892281|464440163|FG000|Overall Study|Adverse Event|65|||
129040466|NCT00892281|464440164|FG001|Overall Study|Adverse Event|8|||
129040467|NCT00892281|464440163|FG000|Overall Study|Lost to Follow-up|81|||
129040468|NCT00892281|464440164|FG001|Overall Study|Lost to Follow-up|8|||
129040469|NCT00892281|464440163|FG000|Overall Study|Pregnancy|1|||
128717895|NCT04608500|463265125|FG000|Overall Study|Adverse Event|2|||
129040470|NCT00892281|464440164|FG001|Overall Study|Pregnancy|0|||
129040471|NCT00892281|464440163|FG000|Overall Study|Protocol Violation|7|||
129040472|NCT00892281|464440164|FG001|Overall Study|Protocol Violation|2|||
129040473|NCT00892281|464440163|FG000|Overall Study|Withdrawal by Subject|86|||
129040474|NCT00892281|464440164|FG001|Overall Study|Withdrawal by Subject|14|||
129040475|NCT00892281|464440163|FG000|Overall Study|Subject failed to return for final visit|2|||
129040476|NCT00892281|464440164|FG001|Overall Study|Subject failed to return for final visit|0|||
129040477|NCT00892281|464440163|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
129040478|NCT00892281|464440164|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
129040479|NCT00892281|464440163|FG000|Overall Study|Final visit completed 4 weeks late|0|||
129040480|NCT00892281|464440164|FG001|Overall Study|Final visit completed 4 weeks late|1|||
129040481|NCT00892281|464440163|FG000|Overall Study|Subject completed day after study closed|1|||
129040482|NCT00892281|464440164|FG001|Overall Study|Subject completed day after study closed|0|||
129040483|NCT00892281|464440163|FG000|Overall Study|Family emergency|1|||
129040484|NCT00892281|464440164|FG001|Overall Study|Family emergency|0|||
129040485|NCT00892281|464440163|FG000|Overall Study|Last visit not done - death in family|1|||
129040486|NCT00892281|464440164|FG001|Overall Study|Last visit not done - death in family|0|||
129040487|NCT00892281|464440163|FG000|Overall Study|Did not meet incl/excl criteria|1|||
129040488|NCT00892281|464440164|FG001|Overall Study|Did not meet incl/excl criteria|0|||
129040489|NCT00892281|464440163|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
129040490|NCT00892281|464440164|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
129040491|NCT00892281|464440163|FG000|Overall Study|Unable to redeem the drug voucher|1|||
129040492|NCT00892281|464440164|FG001|Overall Study|Unable to redeem the drug voucher|0|||
129040493|NCT00892281|464440163|FG000|Overall Study|Subject not good candidate for study|1|||
129222223|NCT03959527|465116034|FG000|Overall Study|Protocol Violation|10|||
129222224|NCT03959527|465116035|FG001|Overall Study|Protocol Violation|5|||
129222225|NCT03404960|465116036|FG000|Overall Study|Adverse Event|0|||
129222226|NCT03404960|465116037|FG001|Overall Study|Adverse Event|2|||
129222227|NCT03404960|465116036|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
129132952|NCT04433975|464778575|FG001|12-month Follow Up|Lost to Follow-up|31|||
129132953|NCT04606771|464778576|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
129132954|NCT04606771|464778577|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
129132955|NCT04606771|464778576|FG000|Overall Study|Death|5|||
129132956|NCT04606771|464778577|FG001|Overall Study|Death|6|||
129132957|NCT04606771|464778576|FG000|Overall Study|Wrong randomisation|0|||
129132958|NCT04606771|464778577|FG001|Overall Study|Wrong randomisation|1|||
129132959|NCT04392635|464778578|FG000|Overall Study|Lost to Follow-up|0|||
129222228|NCT03404960|465116037|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
129222229|NCT03404960|465116036|FG000|Overall Study|Bowel obstruction|0|||
128978180|NCT00298766|464206952|FG000|Overall Study|Death|2|||
128978181|NCT00298766|464206952|FG000|Overall Study|Withdrawal by Subject|9|||
128978182|NCT00298766|464206952|FG000|Overall Study|Treatment ongoing|4|||
128978183|NCT00298766|464206952|FG000|Overall Study|Progression of amyloid markers|4|||
128978184|NCT00298766|464206952|FG000|Overall Study|Deterioration in KPS and organ function|1|||
128978185|NCT00298766|464206952|FG000|Overall Study|Subjects overall condition deterioration|4|||
128978186|NCT00298766|464206952|FG000|Overall Study|Other|4|||
128978187|NCT00386152|464206953|FG000|Overall Study|Adverse Event|6|||
128978188|NCT00386152|464206954|FG001|Overall Study|Adverse Event|5|||
128978189|NCT00386152|464206955|FG002|Overall Study|Adverse Event|4|||
128978190|NCT00386152|464206953|FG000|Overall Study|Chang from original chemo stratification|4|||
128978191|NCT00386152|464206954|FG001|Overall Study|Chang from original chemo stratification|5|||
128978192|NCT00386152|464206955|FG002|Overall Study|Chang from original chemo stratification|6|||
128978193|NCT00386152|464206953|FG000|Overall Study|Death|3|||
128978194|NCT00386152|464206954|FG001|Overall Study|Death|0|||
128978195|NCT00386152|464206955|FG002|Overall Study|Death|1|||
128978196|NCT00386152|464206953|FG000|Overall Study|Disease progression|7|||
128978197|NCT00386152|464206954|FG001|Overall Study|Disease progression|4|||
128978198|NCT00386152|464206955|FG002|Overall Study|Disease progression|5|||
128978199|NCT00386152|464206953|FG000|Overall Study|Physician Decision|13|||
128978200|NCT00386152|464206954|FG001|Overall Study|Physician Decision|10|||
128978201|NCT00386152|464206955|FG002|Overall Study|Physician Decision|4|||
128978202|NCT00386152|464206953|FG000|Overall Study|Lost to Follow-up|1|||
128978203|NCT00386152|464206954|FG001|Overall Study|Lost to Follow-up|0|||
128978204|NCT00386152|464206955|FG002|Overall Study|Lost to Follow-up|0|||
128978205|NCT00386152|464206953|FG000|Overall Study|Completed chemotherapy|4|||
128978206|NCT00386152|464206954|FG001|Overall Study|Completed chemotherapy|5|||
128978207|NCT00386152|464206955|FG002|Overall Study|Completed chemotherapy|1|||
128978208|NCT00386152|464206953|FG000|Overall Study|Protocol Violation|3|||
128978209|NCT00386152|464206954|FG001|Overall Study|Protocol Violation|5|||
128978210|NCT00386152|464206955|FG002|Overall Study|Protocol Violation|2|||
128978211|NCT00386152|464206953|FG000|Overall Study|Withdrawal by Subject|3|||
128978212|NCT00386152|464206954|FG001|Overall Study|Withdrawal by Subject|6|||
128978213|NCT00386152|464206955|FG002|Overall Study|Withdrawal by Subject|10|||
128978214|NCT03633461|464206963|FG000|Overall Study|Lost to Follow-up|0|||
128978215|NCT03633461|464206964|FG001|Overall Study|Lost to Follow-up|1|||
128978216|NCT03938857|464206965|FG000|Overall Study|Physician Decision|1|||
128978217|NCT03938857|464206966|FG001|Overall Study|Physician Decision|0|||
128978218|NCT03938857|464206967|FG002|Overall Study|Physician Decision|0|||
128978219|NCT03938857|464206968|FG003|Overall Study|Physician Decision|0|||
128978220|NCT02516605|464206969|FG000|Overall Study|Protocol Violation|0|||
128978221|NCT02516605|464206970|FG001|Overall Study|Protocol Violation|0|||
128978222|NCT02516605|464206971|FG002|Overall Study|Protocol Violation|0|||
128978223|NCT02516605|464206972|FG003|Overall Study|Protocol Violation|0|||
128978224|NCT02516605|464206973|FG004|Overall Study|Protocol Violation|1|||
128978225|NCT02516605|464206969|FG000|Overall Study|Withdrawal by Subject|0|||
128978226|NCT02516605|464206970|FG001|Overall Study|Withdrawal by Subject|0|||
128978227|NCT02516605|464206971|FG002|Overall Study|Withdrawal by Subject|0|||
128978228|NCT02516605|464206972|FG003|Overall Study|Withdrawal by Subject|1|||
128978229|NCT02516605|464206973|FG004|Overall Study|Withdrawal by Subject|0|||
128978230|NCT02577107|464206974|FG000|Overall Study|Protocol deviation|0|||
128978231|NCT02577107|464206975|FG001|Overall Study|Protocol deviation|1|||
128978232|NCT00577382|464206976|FG000|Overall Study|Adverse Event|0|||
128978233|NCT00577382|464206977|FG001|Overall Study|Adverse Event|6|||
128978234|NCT00577382|464206976|FG000|Overall Study|Withdrawal by Subject|0|||
128978235|NCT00577382|464206977|FG001|Overall Study|Withdrawal by Subject|1|||
128978236|NCT00577382|464206976|FG000|Overall Study|Progressive Disease|17|||
128978237|NCT00577382|464206977|FG001|Overall Study|Progressive Disease|19|||
128978238|NCT00577382|464206976|FG000|Overall Study|Intercurrent Illness|1|||
128978239|NCT00577382|464206977|FG001|Overall Study|Intercurrent Illness|2|||
128978240|NCT00577382|464206976|FG000|Overall Study|Death|1|||
128978241|NCT00577382|464206977|FG001|Overall Study|Death|1|||
128978242|NCT00577382|464206976|FG000|Overall Study|Lost to Follow-up|2|||
128978243|NCT00577382|464206977|FG001|Overall Study|Lost to Follow-up|2|||
128978244|NCT00508872|464206978|FG000|Overall Study|Lost to Follow-up|1|||
128978245|NCT00508872|464206978|FG000|Overall Study|Physician Decision|1|||
129132960|NCT04392635|464778579|FG001|Overall Study|Lost to Follow-up|1|||
129132961|NCT02030418|464778580|FG000|Overall Study|Death|78|||
129222230|NCT03404960|465116037|FG001|Overall Study|Bowel obstruction|1|||
129040494|NCT00892281|464440164|FG001|Overall Study|Subject not good candidate for study|0|||
129040495|NCT00892281|464440163|FG000|Overall Study|Subject did not return for any visits|1|||
129040496|NCT00892281|464440164|FG001|Overall Study|Subject did not return for any visits|0|||
129040497|NCT00892281|464440163|FG000|Overall Study|Subject missed several visits/lost meds|1|||
129040498|NCT00892281|464440164|FG001|Overall Study|Subject missed several visits/lost meds|0|||
129040499|NCT00892281|464440163|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
129040500|NCT00892281|464440164|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
129040501|NCT00892281|464440163|FG000|Overall Study|Scheduled for knee replacement|0|||
129040502|NCT00892281|464440164|FG001|Overall Study|Scheduled for knee replacement|1|||
129040503|NCT00892281|464440163|FG000|Overall Study|PI complained of inadequate compensation|3|||
129040504|NCT00892281|464440164|FG001|Overall Study|PI complained of inadequate compensation|0|||
129040505|NCT00892281|464440163|FG000|Overall Study|Subject lost interest in program|0|||
129040506|NCT00892281|464440164|FG001|Overall Study|Subject lost interest in program|1|||
129040507|NCT00892281|464440163|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
129040508|NCT00892281|464440164|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
129040509|NCT00892281|464440163|FG000|Overall Study|Death in family|1|||
129040510|NCT00892281|464440164|FG001|Overall Study|Death in family|0|||
129040511|NCT00892281|464440163|FG000|Overall Study|Lack of efficacy of study product|2|||
129040512|NCT00892281|464440164|FG001|Overall Study|Lack of efficacy of study product|0|||
129040513|NCT00892281|464440163|FG000|Overall Study|Subject not seen by PI at final visit|1|||
129040514|NCT00892281|464440164|FG001|Overall Study|Subject not seen by PI at final visit|0|||
129040515|NCT00892281|464440163|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
129040516|NCT00892281|464440164|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
129040517|NCT00892281|464440163|FG000|Overall Study|Missed multiple visits|1|||
129040518|NCT00892281|464440164|FG001|Overall Study|Missed multiple visits|0|||
129040519|NCT00892281|464440163|FG000|Overall Study|Missed visits rescheduled out of window|1|||
129040520|NCT00892281|464440164|FG001|Overall Study|Missed visits rescheduled out of window|0|||
129040521|NCT00892281|464440163|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
129040522|NCT00892281|464440164|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
129040523|NCT00892281|464440163|FG000|Overall Study|Subject had history of drug abuse|1|||
129040524|NCT00892281|464440164|FG001|Overall Study|Subject had history of drug abuse|0|||
129040525|NCT00892281|464440163|FG000|Overall Study|Rash on hand|1|||
129040526|NCT00892281|464440164|FG001|Overall Study|Rash on hand|0|||
129040527|NCT00892281|464440163|FG000|Overall Study|Visit 4 date out of window|1|||
129040528|NCT00892281|464440164|FG001|Overall Study|Visit 4 date out of window|0|||
129040529|NCT00655850|464440165|FG000|Overall Study|Death|2|||
129040530|NCT00655850|464440165|FG000|Overall Study|Withdrawal by Subject|1|||
129040531|NCT01567826|464440168|FG000|Overall Study|Lost to Follow-up|3|||
129040532|NCT01567826|464440169|FG001|Overall Study|Lost to Follow-up|2|||
129040533|NCT05212883|464440178|FG000|Overall Study|Invalid test result|125|||
129040534|NCT02502734|464440179|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
129040535|NCT02502734|464440180|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
129132962|NCT02030418|464778580|FG000|Overall Study|Missed 12-Month Visit|9|||
129132963|NCT02030418|464778580|FG000|Overall Study|Withdrawn|57|||
129132964|NCT06100250|464778581|FG000|Overall Study|Lost to Follow-up|5|||
129132965|NCT02021318|464778582|FG000|Overall Study|Adverse Event|2|||
129132966|NCT02021318|464778583|FG001|Overall Study|Adverse Event|1|||
129132967|NCT02021318|464778582|FG000|Overall Study|Death|33|||
129132968|NCT02021318|464778583|FG001|Overall Study|Death|34|||
129132969|NCT02021318|464778582|FG000|Overall Study|Lost to Follow-up|3|||
129132970|NCT02021318|464778583|FG001|Overall Study|Lost to Follow-up|3|||
129132971|NCT02021318|464778582|FG000|Overall Study|Progressive Disease|0|||
129132972|NCT02021318|464778583|FG001|Overall Study|Progressive Disease|1|||
129132973|NCT02021318|464778582|FG000|Overall Study|Withdrawal by Subject|30|||
129132974|NCT02021318|464778583|FG001|Overall Study|Withdrawal by Subject|18|||
129132975|NCT02021318|464778582|FG000|Overall Study|Physician Decision|3|||
129132976|NCT02021318|464778583|FG001|Overall Study|Physician Decision|3|||
129132977|NCT02021318|464778582|FG000|Overall Study|Miscellaneous|2|||
129132978|NCT02021318|464778583|FG001|Overall Study|Miscellaneous|3|||
129132979|NCT00421993|464778587|FG000|Overall Study|Withdrawal by Subject|22|||
129132980|NCT00421993|464778588|FG001|Overall Study|Withdrawal by Subject|23|||
129132981|NCT00421993|464778589|FG002|Overall Study|Withdrawal by Subject|23|||
129132982|NCT00421993|464778590|FG003|Overall Study|Withdrawal by Subject|24|||
129132983|NCT00421993|464778587|FG000|Overall Study|Lost to Follow-up|18|||
129132984|NCT00421993|464778588|FG001|Overall Study|Lost to Follow-up|19|||
129132985|NCT00421993|464778589|FG002|Overall Study|Lost to Follow-up|22|||
129222231|NCT03404960|465116036|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
129222232|NCT03404960|465116037|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
129040536|NCT02502734|464440179|FG000|Washout Period|Adverse Event|1|||
129040537|NCT02502734|464440180|FG001|Washout Period|Adverse Event|0|||
129132986|NCT00421993|464778590|FG003|Overall Study|Lost to Follow-up|20|||
129132987|NCT00421993|464778587|FG000|Overall Study|Adverse Event|11|||
129132988|NCT00421993|464778588|FG001|Overall Study|Adverse Event|1|||
129132989|NCT00421993|464778589|FG002|Overall Study|Adverse Event|6|||
129222233|NCT04838626|465116038|FG000|Overall Study|Adverse Event|2|||
129222234|NCT04838626|465116038|FG000|Overall Study|Physician Decision|6|||
129040538|NCT05444543|464440186|FG000|Overall Study|Withdrawal by Subject|1|||
129040539|NCT05444543|464440187|FG001|Overall Study|Withdrawal by Subject|0|||
129040540|NCT05444543|464440186|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
129040541|NCT05444543|464440187|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
129040542|NCT05444543|464440186|FG000|Overall Study|Adverse Event|0|||
129040543|NCT05444543|464440187|FG001|Overall Study|Adverse Event|1|||
129040544|NCT05444543|464440186|FG000|Overall Study|Family relocating at a distance from study site|0|||
129040545|NCT05444543|464440187|FG001|Overall Study|Family relocating at a distance from study site|1|||
129040546|NCT01261624|464440188|FG000|Week 0 to Week 12|Disease Progression|1|||
129040547|NCT01261624|464440189|FG001|Week 0 to Week 12|Disease Progression|1|||
129040548|NCT01261624|464440188|FG000|Week 0 to Week 12|Insufficient Response|0|||
129040549|NCT01261624|464440189|FG001|Week 0 to Week 12|Insufficient Response|2|||
129040550|NCT01261624|464440188|FG000|Week 13 to Week 24|Insufficient Response|0|||
129040551|NCT01261624|464440189|FG001|Week 13 to Week 24|Insufficient Response|1|||
129040552|NCT02280187|464440190|FG000|Overall Study|Lost to Follow-up|218|||
129040553|NCT04668274|464440191|FG000|Part 1 Study Period 1|Adverse Event|3|||
129040554|NCT04668274|464440192|FG001|Part 1 Study Period 1|Adverse Event|0|||
129040555|NCT04668274|464440193|FG002|Part 1 Study Period 1|Adverse Event|0|||
129040556|NCT04668274|464440194|FG003|Part 1 Study Period 1|Adverse Event|0|||
129040557|NCT04668274|464440191|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
129040558|NCT04668274|464440192|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
129040559|NCT04668274|464440193|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
129040560|NCT04668274|464440194|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
129040561|NCT04668274|464440191|FG000|Part 1 Study Period 2|Other|0|||
129040562|NCT04668274|464440192|FG001|Part 1 Study Period 2|Other|1|||
129040563|NCT04668274|464440193|FG002|Part 1 Study Period 2|Other|0|||
129040564|NCT04668274|464440194|FG003|Part 1 Study Period 2|Other|0|||
129040565|NCT04668274|464440191|FG000|Part 1 Study Period 3|Adverse Event|0|||
129040566|NCT04668274|464440192|FG001|Part 1 Study Period 3|Adverse Event|0|||
129040567|NCT04668274|464440193|FG002|Part 1 Study Period 3|Adverse Event|1|||
129040568|NCT04668274|464440194|FG003|Part 1 Study Period 3|Adverse Event|0|||
129040569|NCT04668274|464440191|FG000|Part 1 Study Period 3|Other|0|||
129040570|NCT04668274|464440192|FG001|Part 1 Study Period 3|Other|0|||
129040571|NCT04668274|464440193|FG002|Part 1 Study Period 3|Other|2|||
129040572|NCT04668274|464440194|FG003|Part 1 Study Period 3|Other|0|||
129040573|NCT04668274|464440191|FG000|Part 2 Study Period 4|Other|0|||
129222235|NCT04838626|465116038|FG000|Overall Study|Protocol Violation|3|||
129222236|NCT04838626|465116038|FG000|Overall Study|Withdrawal by Subject|9|||
129040574|NCT04668274|464440192|FG001|Part 2 Study Period 4|Other|0|||
129040575|NCT04668274|464440193|FG002|Part 2 Study Period 4|Other|0|||
129040576|NCT04668274|464440194|FG003|Part 2 Study Period 4|Other|1|||
129040577|NCT00508027|464440195|FG000|Dose Level 1|Lost to Follow-up|4|||
129132990|NCT00421993|464778590|FG003|Overall Study|Adverse Event|4|||
129132991|NCT00421993|464778587|FG000|Overall Study|Protocol Violation|2|||
129132992|NCT00421993|464778588|FG001|Overall Study|Protocol Violation|2|||
129132993|NCT00421993|464778589|FG002|Overall Study|Protocol Violation|0|||
129132994|NCT00421993|464778590|FG003|Overall Study|Protocol Violation|1|||
129132995|NCT00421993|464778587|FG000|Overall Study|Lack of Efficacy|0|||
129132996|NCT00421993|464778588|FG001|Overall Study|Lack of Efficacy|3|||
129132997|NCT00421993|464778589|FG002|Overall Study|Lack of Efficacy|0|||
129132998|NCT00421993|464778590|FG003|Overall Study|Lack of Efficacy|5|||
129132999|NCT00421993|464778587|FG000|Overall Study|Pregnancy|0|||
129133000|NCT00421993|464778588|FG001|Overall Study|Pregnancy|1|||
129133001|NCT00421993|464778589|FG002|Overall Study|Pregnancy|1|||
129133002|NCT00421993|464778590|FG003|Overall Study|Pregnancy|2|||
129133003|NCT00421993|464778587|FG000|Overall Study|Subject transportation issues|0|||
129133004|NCT00421993|464778588|FG001|Overall Study|Subject transportation issues|0|||
129133005|NCT00421993|464778589|FG002|Overall Study|Subject transportation issues|0|||
129133006|NCT00421993|464778590|FG003|Overall Study|Subject transportation issues|1|||
129133007|NCT01980888|464778591|FG000|Overall Study|Study Terminated by Sponsor|116|||
129133008|NCT01980888|464778592|FG001|Overall Study|Study Terminated by Sponsor|122|||
129222237|NCT04838626|465116038|FG000|Overall Study|Technical Problems|2|||
129222238|NCT01688466|465116039|FG000|Overall Study|Withdrawal by Subject|2|||
129040578|NCT00508027|464440195|FG000|Dose Level 1|Withdrawal by Subject|2|||
129040579|NCT00508027|464440195|FG000|Dose Level 1|Physician Decision|2|||
129040580|NCT00508027|464440195|FG000|Dose Level 2|Lost to Follow-up|2|||
129040581|NCT00508027|464440195|FG000|Dose Level 2|Withdrawal by Subject|2|||
129133009|NCT01980888|464778591|FG000|Overall Study|Withdrew Consent|17|||
129133010|NCT01980888|464778592|FG001|Overall Study|Withdrew Consent|6|||
129040582|NCT01719562|464440196|FG000|Overall Study|Lost to Follow-up|1|||
129040583|NCT01719562|464440197|FG001|Overall Study|Lost to Follow-up|0|||
129040584|NCT01719562|464440196|FG000|Overall Study|Death|1|||
129133011|NCT01980888|464778591|FG000|Overall Study|Investigator's Discretion|8|||
129133012|NCT01980888|464778592|FG001|Overall Study|Investigator's Discretion|3|||
129222239|NCT01688466|465116040|FG001|Overall Study|Withdrawal by Subject|1|||
129040585|NCT01719562|464440197|FG001|Overall Study|Death|0|||
129040586|NCT01719562|464440196|FG000|Overall Study|New cancer diagnosis|1|||
129040587|NCT01719562|464440197|FG001|Overall Study|New cancer diagnosis|0|||
129040588|NCT00860743|464440200|FG000|Overall Study|Withdrawal by Subject|3|||
129040589|NCT00860743|464440201|FG001|Overall Study|Withdrawal by Subject|0|||
129040590|NCT00941720|464440202|FG000|Overall Study|Withdrawal by Subject|1|||
129040591|NCT00941720|464440202|FG000|Overall Study|Insurance denied participation|11|||
129040592|NCT00941720|464440202|FG000|Overall Study|ineligible|2|||
129040593|NCT01202877|464440203|FG000|Overall Study|Disease Progression|0|||
129040594|NCT01202877|464440204|FG001|Overall Study|Disease Progression|1|||
129040595|NCT01202877|464440205|FG002|Overall Study|Disease Progression|2|||
129040596|NCT01202877|464440203|FG000|Overall Study|Adverse Event|0|||
129040597|NCT01202877|464440204|FG001|Overall Study|Adverse Event|0|||
129040598|NCT01202877|464440205|FG002|Overall Study|Adverse Event|2|||
129040599|NCT01202877|464440203|FG000|Overall Study|Withdrawal by Subject|0|||
129040600|NCT01202877|464440204|FG001|Overall Study|Withdrawal by Subject|0|||
129040601|NCT01202877|464440205|FG002|Overall Study|Withdrawal by Subject|1|||
129040602|NCT01202877|464440203|FG000|Overall Study|Death|0|||
129040603|NCT01202877|464440204|FG001|Overall Study|Death|0|||
129040604|NCT01202877|464440205|FG002|Overall Study|Death|1|||
129040605|NCT00396331|464440206|FG000|Overall Study|Failed to mobilize - no transplant|8|||
129040606|NCT00396331|464440206|FG000|Overall Study|Did not go on to transplant|5|||
129040607|NCT00396331|464440206|FG000|Overall Study|Lost to Follow-up|3|||
129040608|NCT00396331|464440206|FG000|Overall Study|Death|16|||
129040609|NCT00775528|464440207|FG000|Overall Study|Protocol Violation|1|||
129040610|NCT00350402|464440210|FG000|Overall Study|Lost to Follow-up|1|||
129040611|NCT00350402|464440211|FG001|Overall Study|Lost to Follow-up|1|||
129040612|NCT01884688|464440212|FG000|Overall Study|Screen Failure|2|||
129040613|NCT02549573|464440222|FG000|Overall Study|Withdrawal by Subject|0|||
129040614|NCT02549573|464440223|FG001|Overall Study|Withdrawal by Subject|2|||
129040615|NCT02549573|464440222|FG000|Overall Study|Protocol Violation|0|||
129040616|NCT02549573|464440223|FG001|Overall Study|Protocol Violation|1|||
129040617|NCT01382251|464440227|FG000|Overall Study|Surgeries cancelled or delayed|16|||
129040618|NCT01382251|464440228|FG001|Overall Study|Surgeries cancelled or delayed|16|||
129040619|NCT01382251|464440227|FG000|Overall Study|Lost to Follow-up|4|||
129040620|NCT01382251|464440228|FG001|Overall Study|Lost to Follow-up|4|||
129040621|NCT01382251|464440227|FG000|Overall Study|Contacted after study closed|1|||
129040622|NCT01382251|464440228|FG001|Overall Study|Contacted after study closed|1|||
129040623|NCT00562120|464440229|FG000|First Intervention Period|Adverse Event|1|||
129040624|NCT00562120|464440230|FG001|First Intervention Period|Adverse Event|0|||
129040625|NCT00562120|464440231|FG002|First Intervention Period|Adverse Event|0|||
129040626|NCT00562120|464440232|FG003|First Intervention Period|Adverse Event|0|||
129040627|NCT00562120|464440229|FG000|First Intervention Period|Randomized but not Treated|1|||
129040628|NCT00562120|464440230|FG001|First Intervention Period|Randomized but not Treated|0|||
129040629|NCT00562120|464440231|FG002|First Intervention Period|Randomized but not Treated|0|||
129040630|NCT00562120|464440232|FG003|First Intervention Period|Randomized but not Treated|0|||
129040631|NCT00545688|464440235|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
129040632|NCT00545688|464440236|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
129040633|NCT00545688|464440237|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
129040634|NCT00545688|464440238|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
129040635|NCT00545688|464440235|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
129040636|NCT00545688|464440236|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
129040637|NCT00545688|464440237|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
129040638|NCT00545688|464440238|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
129040639|NCT00545688|464440235|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
128717896|NCT04608500|463265126|FG001|Overall Study|Adverse Event|0|||
128717897|NCT04608500|463265125|FG000|Overall Study|Lost to Follow-up|15|||
128717898|NCT04608500|463265126|FG001|Overall Study|Lost to Follow-up|9|||
128717899|NCT04608500|463265125|FG000|Overall Study|Participant request|11|||
128717900|NCT04608500|463265126|FG001|Overall Study|Participant request|7|||
128717901|NCT04608500|463265125|FG000|Overall Study|Protocol Violation|1|||
128717902|NCT04608500|463265126|FG001|Overall Study|Protocol Violation|0|||
128717903|NCT04608500|463265125|FG000|Overall Study|Other|6|||
128717904|NCT04608500|463265126|FG001|Overall Study|Other|2|||
128717905|NCT02747420|463265127|FG000|Overall Study|Lost to Follow-up|4|||
129040640|NCT00545688|464440236|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
129040641|NCT00545688|464440237|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
129040642|NCT00545688|464440238|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
129040643|NCT00545688|464440235|FG000|Neo-Adjuvant Treatment Period|Death|0|||
129040644|NCT00545688|464440236|FG001|Neo-Adjuvant Treatment Period|Death|1|||
129040645|NCT00545688|464440237|FG002|Neo-Adjuvant Treatment Period|Death|0|||
129040646|NCT00545688|464440238|FG003|Neo-Adjuvant Treatment Period|Death|0|||
129040647|NCT00545688|464440235|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
128717906|NCT02747420|463265128|FG001|Overall Study|Lost to Follow-up|2|||
128717907|NCT02747420|463265127|FG000|Overall Study|Withdrawal by Subject|3|||
128717908|NCT02747420|463265128|FG001|Overall Study|Withdrawal by Subject|2|||
128978246|NCT03007472|464206979|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
128978247|NCT03007472|464206979|FG000|Overall Study|Death|2|||
128978248|NCT03007472|464206979|FG000|Overall Study|Loss to Follow Up|1|||
128978249|NCT02988115|464206983|FG000|Overall Study|Adverse Event|6|||
128978250|NCT02988115|464206984|FG001|Overall Study|Adverse Event|1|||
128978251|NCT02988115|464206983|FG000|Overall Study|Sponsor Decision|5|||
128978252|NCT02988115|464206984|FG001|Overall Study|Sponsor Decision|2|||
128978253|NCT02988115|464206983|FG000|Overall Study|Withdrawal by Subject|1|||
128978254|NCT02988115|464206984|FG001|Overall Study|Withdrawal by Subject|1|||
128978255|NCT02988115|464206983|FG000|Overall Study|Withdrawn by Mistake|1|||
128978256|NCT02988115|464206984|FG001|Overall Study|Withdrawn by Mistake|0|||
128978257|NCT02988115|464206983|FG000|Overall Study|Lost to Follow-up|1|||
128978258|NCT02988115|464206984|FG001|Overall Study|Lost to Follow-up|0|||
128978259|NCT01731951|464206985|FG000|Overall Study|Documented Disease Progression|1|||
128978260|NCT01731951|464206986|FG001|Overall Study|Documented Disease Progression|0|||
128978261|NCT01731951|464206987|FG002|Overall Study|Documented Disease Progression|0|||
128978262|NCT01731951|464206988|FG003|Overall Study|Documented Disease Progression|0|||
128978263|NCT01731951|464206989|FG004|Overall Study|Documented Disease Progression|0|||
128978264|NCT01731951|464206990|FG005|Overall Study|Documented Disease Progression|0|||
128978265|NCT01731951|464206985|FG000|Overall Study|Lost to Follow-up|2|||
128978266|NCT01731951|464206986|FG001|Overall Study|Lost to Follow-up|0|||
128978267|NCT01731951|464206987|FG002|Overall Study|Lost to Follow-up|0|||
128978268|NCT01731951|464206988|FG003|Overall Study|Lost to Follow-up|1|||
128978269|NCT01731951|464206989|FG004|Overall Study|Lost to Follow-up|3|||
128978270|NCT01731951|464206990|FG005|Overall Study|Lost to Follow-up|1|||
128978271|NCT01731951|464206985|FG000|Overall Study|Withdrawal of Consent|1|||
128978272|NCT01731951|464206986|FG001|Overall Study|Withdrawal of Consent|0|||
128978273|NCT01731951|464206987|FG002|Overall Study|Withdrawal of Consent|0|||
128978274|NCT01731951|464206988|FG003|Overall Study|Withdrawal of Consent|0|||
128978275|NCT01731951|464206989|FG004|Overall Study|Withdrawal of Consent|0|||
128978276|NCT01731951|464206990|FG005|Overall Study|Withdrawal of Consent|2|||
128978277|NCT01731951|464206985|FG000|Overall Study|Death|13|||
128978278|NCT01731951|464206986|FG001|Overall Study|Death|15|||
128978279|NCT01731951|464206987|FG002|Overall Study|Death|9|||
128978280|NCT01731951|464206988|FG003|Overall Study|Death|8|||
128978281|NCT01731951|464206989|FG004|Overall Study|Death|9|||
128978282|NCT01731951|464206990|FG005|Overall Study|Death|6|||
128978283|NCT01014442|464206991|FG000|Overall Study|Adverse Event|0|||
128978284|NCT01014442|464206992|FG001|Overall Study|Adverse Event|8|||
128978285|NCT01014442|464206991|FG000|Overall Study|Withdrawal by Subject|4|||
128978286|NCT01014442|464206992|FG001|Overall Study|Withdrawal by Subject|4|||
128978287|NCT01014442|464206991|FG000|Overall Study|Protocol Violation|2|||
128978288|NCT01014442|464206992|FG001|Overall Study|Protocol Violation|5|||
128978289|NCT01014442|464206991|FG000|Overall Study|Lack of Compliance|0|||
128978290|NCT01014442|464206992|FG001|Overall Study|Lack of Compliance|1|||
128978291|NCT01014442|464206991|FG000|Overall Study|Unspecified Reason|1|||
128978292|NCT01014442|464206992|FG001|Overall Study|Unspecified Reason|1|||
128978293|NCT01220024|464206999|FG000|Overall Study|Lost to Follow-up|1|||
128978294|NCT01220024|464207000|FG001|Overall Study|Lost to Follow-up|1|||
128978295|NCT00490815|464207001|FG000|Overall Study|Adverse Event|2|||
128978296|NCT00490815|464207002|FG001|Overall Study|Adverse Event|3|||
129222240|NCT01688466|465116039|FG000|Overall Study|Death|0|||
129222241|NCT01688466|465116040|FG001|Overall Study|Death|1|||
129222242|NCT01688466|465116039|FG000|Overall Study|Adverse Event|0|||
129222243|NCT01688466|465116040|FG001|Overall Study|Adverse Event|4|||
129222244|NCT01688466|465116039|FG000|Overall Study|Not evaluable|0|||
129222245|NCT01688466|465116040|FG001|Overall Study|Not evaluable|1|||
129222246|NCT06029959|465116042|FG000|Overall Study|Physician Decision|6|||
129222247|NCT03786783|465116043|FG000|Overall Study|Death|1|||
129222248|NCT03786783|465116043|FG000|Overall Study|Physician Decision|6|||
129222249|NCT03786783|465116043|FG000|Overall Study|Withdrawal by Subject|2|||
129222250|NCT03786783|465116043|FG000|Overall Study|Disease Progression|7|||
129222251|NCT03786783|465116043|FG000|Overall Study|Patient/Parent Refusal|4|||
129222252|NCT02867384|465116044|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
128978297|NCT00490815|464207001|FG000|Overall Study|Withdrawal by Subject|4|||
128978298|NCT00490815|464207002|FG001|Overall Study|Withdrawal by Subject|0|||
128978299|NCT00490815|464207001|FG000|Overall Study|Lost to Follow-up|1|||
128978300|NCT00490815|464207002|FG001|Overall Study|Lost to Follow-up|3|||
128978301|NCT00490815|464207001|FG000|Overall Study|Death|1|||
128978302|NCT00490815|464207002|FG001|Overall Study|Death|3|||
128978303|NCT01756846|464207004|FG000|Overall Study|Lost to Follow-up|5|||
128978304|NCT01756846|464207005|FG001|Overall Study|Lost to Follow-up|10|||
128978305|NCT01756846|464207004|FG000|Overall Study|Withdrawal by Subject|1|||
128978306|NCT01756846|464207005|FG001|Overall Study|Withdrawal by Subject|2|||
128978307|NCT01284127|464207008|FG000|Overall Study|Adverse Event|2|||
128978308|NCT01284127|464207008|FG000|Overall Study|Withdrawal by Subject|4|||
128978309|NCT01284127|464207008|FG000|Overall Study|Physician Decision|1|||
129222253|NCT02867384|465116045|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
129222254|NCT02867384|465116046|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
129222255|NCT02867384|465116044|FG000|Overall Study|Progression/ Relapse|15|||
129040648|NCT00545688|464440236|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
129040649|NCT00545688|464440237|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
129040650|NCT00545688|464440238|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
129040651|NCT00545688|464440235|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
129040652|NCT00545688|464440236|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
129040653|NCT00545688|464440237|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
129040654|NCT00545688|464440238|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
129040655|NCT00545688|464440235|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
129040656|NCT00545688|464440236|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
129040657|NCT00545688|464440237|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
129040658|NCT00545688|464440238|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
129040659|NCT00545688|464440235|FG000|Adjuvant Treatment Period|Disease Progression|3|||
128978310|NCT00545740|464207009|FG000|Overall Study|Lack of Efficacy|34|||
128978311|NCT00545740|464207010|FG001|Overall Study|Lack of Efficacy|35|||
128978312|NCT00545740|464207011|FG002|Overall Study|Lack of Efficacy|47|||
128978313|NCT00545740|464207012|FG003|Overall Study|Lack of Efficacy|36|||
128978314|NCT00545740|464207009|FG000|Overall Study|Withdrawal by Subject|17|||
128978315|NCT00545740|464207010|FG001|Overall Study|Withdrawal by Subject|15|||
128978316|NCT00545740|464207011|FG002|Overall Study|Withdrawal by Subject|16|||
128978317|NCT00545740|464207012|FG003|Overall Study|Withdrawal by Subject|18|||
129040660|NCT00545688|464440236|FG001|Adjuvant Treatment Period|Disease Progression|3|||
129040661|NCT00545688|464440237|FG002|Adjuvant Treatment Period|Disease Progression|0|||
129040662|NCT00545688|464440238|FG003|Adjuvant Treatment Period|Disease Progression|7|||
129040663|NCT00545688|464440235|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
129040664|NCT00545688|464440236|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
129040665|NCT00545688|464440237|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
129040666|NCT00545688|464440238|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
129040667|NCT00545688|464440235|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
129040668|NCT00545688|464440236|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
129040669|NCT00545688|464440237|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
129040670|NCT00545688|464440238|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
129040671|NCT00545688|464440235|FG000|Adjuvant Treatment Period|Adverse Event|0|||
129040672|NCT00545688|464440236|FG001|Adjuvant Treatment Period|Adverse Event|3|||
129040673|NCT00545688|464440237|FG002|Adjuvant Treatment Period|Adverse Event|2|||
129040674|NCT00545688|464440238|FG003|Adjuvant Treatment Period|Adverse Event|2|||
129040675|NCT00545688|464440235|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
129040676|NCT00545688|464440236|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
129040677|NCT00545688|464440237|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
129040678|NCT00545688|464440238|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
129040679|NCT00545688|464440235|FG000|Follow-Up Period|Death|4|||
129040680|NCT00545688|464440236|FG001|Follow-Up Period|Death|2|||
129040681|NCT00545688|464440237|FG002|Follow-Up Period|Death|2|||
129040682|NCT00545688|464440238|FG003|Follow-Up Period|Death|6|||
129040683|NCT00545688|464440235|FG000|Follow-Up Period|Disease Progression|6|||
129040684|NCT00545688|464440236|FG001|Follow-Up Period|Disease Progression|5|||
129040685|NCT00545688|464440237|FG002|Follow-Up Period|Disease Progression|9|||
129040686|NCT00545688|464440238|FG003|Follow-Up Period|Disease Progression|9|||
129040687|NCT00545688|464440235|FG000|Follow-Up Period|Refused Treatment|6|||
129040688|NCT00545688|464440236|FG001|Follow-Up Period|Refused Treatment|2|||
129040689|NCT00545688|464440237|FG002|Follow-Up Period|Refused Treatment|0|||
129040690|NCT00545688|464440238|FG003|Follow-Up Period|Refused Treatment|2|||
129040691|NCT00545688|464440235|FG000|Follow-Up Period|Lost to Follow-up|3|||
129040692|NCT00545688|464440236|FG001|Follow-Up Period|Lost to Follow-up|3|||
129040693|NCT00545688|464440237|FG002|Follow-Up Period|Lost to Follow-up|3|||
129040694|NCT00545688|464440238|FG003|Follow-Up Period|Lost to Follow-up|1|||
129040695|NCT00545688|464440235|FG000|Follow-Up Period|Unspecified Reason|2|||
129040696|NCT00545688|464440236|FG001|Follow-Up Period|Unspecified Reason|5|||
129040697|NCT00545688|464440237|FG002|Follow-Up Period|Unspecified Reason|6|||
129040698|NCT00545688|464440238|FG003|Follow-Up Period|Unspecified Reason|8|||
129040699|NCT00545688|464440235|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
129040700|NCT00545688|464440236|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
129040701|NCT00545688|464440237|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
129040702|NCT00545688|464440238|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
129040703|NCT00952276|464440241|FG000|Overall Study|Withdrawal by Subject|1|||
129040704|NCT00952276|464440242|FG001|Overall Study|Withdrawal by Subject|0|||
129040705|NCT00952276|464440243|FG002|Overall Study|Withdrawal by Subject|0|||
129040706|NCT00952276|464440244|FG003|Overall Study|Withdrawal by Subject|1|||
129040707|NCT00952276|464440245|FG004|Overall Study|Withdrawal by Subject|0|||
129040708|NCT01010126|464442003|FG000|Overall Study|Withdrawal by Subject|1|||
129040709|NCT01010126|464442004|FG001|Overall Study|Withdrawal by Subject|0|||
129040710|NCT01010126|464442005|FG002|Overall Study|Withdrawal by Subject|1|||
129040711|NCT01010126|464442006|FG003|Overall Study|Withdrawal by Subject|0|||
129040712|NCT01010126|464442007|FG004|Overall Study|Withdrawal by Subject|3|||
129040713|NCT01010126|464442008|FG005|Overall Study|Withdrawal by Subject|0|||
128978318|NCT00545740|464207009|FG000|Overall Study|Adverse Event|10|||
128978319|NCT00545740|464207010|FG001|Overall Study|Adverse Event|18|||
128978320|NCT00545740|464207011|FG002|Overall Study|Adverse Event|19|||
128978321|NCT00545740|464207012|FG003|Overall Study|Adverse Event|9|||
128978322|NCT00545740|464207009|FG000|Overall Study|Lost to Follow-up|7|||
128978323|NCT00545740|464207010|FG001|Overall Study|Lost to Follow-up|5|||
128978324|NCT00545740|464207011|FG002|Overall Study|Lost to Follow-up|5|||
128978325|NCT00545740|464207012|FG003|Overall Study|Lost to Follow-up|6|||
128978326|NCT00545740|464207009|FG000|Overall Study|Protocol Violation|1|||
128978327|NCT00545740|464207010|FG001|Overall Study|Protocol Violation|3|||
128978328|NCT00545740|464207011|FG002|Overall Study|Protocol Violation|1|||
128978329|NCT00545740|464207012|FG003|Overall Study|Protocol Violation|0|||
128978330|NCT00545740|464207009|FG000|Overall Study|Non-compliance|0|||
128978331|NCT00545740|464207010|FG001|Overall Study|Non-compliance|2|||
128978332|NCT00545740|464207011|FG002|Overall Study|Non-compliance|1|||
128978333|NCT00545740|464207012|FG003|Overall Study|Non-compliance|0|||
128978334|NCT00545740|464207009|FG000|Overall Study|Moved|2|||
128978335|NCT00545740|464207010|FG001|Overall Study|Moved|0|||
128978336|NCT00545740|464207011|FG002|Overall Study|Moved|1|||
128978337|NCT00545740|464207012|FG003|Overall Study|Moved|0|||
128978338|NCT00545740|464207009|FG000|Overall Study|Diverticulitis attack|0|||
128978339|NCT00545740|464207010|FG001|Overall Study|Diverticulitis attack|0|||
128978340|NCT00545740|464207011|FG002|Overall Study|Diverticulitis attack|1|||
128978341|NCT00545740|464207012|FG003|Overall Study|Diverticulitis attack|1|||
128978342|NCT00545740|464207009|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
128978343|NCT00545740|464207010|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
128978344|NCT00545740|464207011|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
128978345|NCT00545740|464207012|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
128978346|NCT00545740|464207009|FG000|Overall Study|Site closure|1|||
128978347|NCT00545740|464207010|FG001|Overall Study|Site closure|0|||
128978348|NCT00545740|464207011|FG002|Overall Study|Site closure|0|||
128978349|NCT00545740|464207012|FG003|Overall Study|Site closure|0|||
129040714|NCT00595335|464442011|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
129040715|NCT00595335|464442012|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
129040716|NCT00595335|464442011|FG000|Baseline to Six Months|Disease Progression|1|||
129040717|NCT00595335|464442012|FG001|Baseline to Six Months|Disease Progression|1|||
129040718|NCT00595335|464442011|FG000|Baseline to Six Months|Adverse Event|1|||
129040719|NCT00595335|464442012|FG001|Baseline to Six Months|Adverse Event|0|||
129040720|NCT00595335|464442011|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
129040721|NCT00595335|464442012|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
129040722|NCT00595335|464442011|FG000|Six Months to Twelve Months|Disease Progression|1|||
129040723|NCT00595335|464442012|FG001|Six Months to Twelve Months|Disease Progression|0|||
129040724|NCT01647958|464442018|FG000|Initial Study|Lost to Follow-up|2|||
129040725|NCT01647958|464442019|FG001|Initial Study|Lost to Follow-up|3|||
129040726|NCT01647958|464442018|FG000|Continuation Phase|treatment received during Overall Study|39|||
129040727|NCT01647958|464442019|FG001|Continuation Phase|treatment received during Overall Study|0|||
129040728|NCT01647958|464442018|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
129040729|NCT01647958|464442019|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
129040730|NCT03686150|464442026|FG000|Overall Study|Withdrawal by Subject|1|||
129040731|NCT03686150|464442027|FG001|Overall Study|Withdrawal by Subject|1|||
129222256|NCT02867384|465116045|FG001|Overall Study|Progression/ Relapse|19|||
129222257|NCT02867384|465116046|FG002|Overall Study|Progression/ Relapse|0|||
129222258|NCT02867384|465116044|FG000|Overall Study|Adverse Event|13|||
129222259|NCT02867384|465116045|FG001|Overall Study|Adverse Event|1|||
129222260|NCT02867384|465116046|FG002|Overall Study|Adverse Event|0|||
129222261|NCT02867384|465116044|FG000|Overall Study|Withdrawal by Subject|6|||
129222262|NCT02867384|465116045|FG001|Overall Study|Withdrawal by Subject|5|||
129222263|NCT02867384|465116046|FG002|Overall Study|Withdrawal by Subject|0|||
129222264|NCT02867384|465116044|FG000|Overall Study|Physician Decision|1|||
129222265|NCT02867384|465116045|FG001|Overall Study|Physician Decision|2|||
128978350|NCT00545740|464207009|FG000|Overall Study|Missed visit|1|||
128978351|NCT00545740|464207010|FG001|Overall Study|Missed visit|0|||
128978352|NCT00545740|464207011|FG002|Overall Study|Missed visit|0|||
129040732|NCT03686150|464442028|FG002|Overall Study|Withdrawal by Subject|1|||
129040733|NCT03686150|464442029|FG003|Overall Study|Withdrawal by Subject|0|||
129222266|NCT02867384|465116046|FG002|Overall Study|Physician Decision|0|||
129222267|NCT02867384|465116044|FG000|Overall Study|Patient compliance|1|||
128978353|NCT00545740|464207012|FG003|Overall Study|Missed visit|0|||
128978354|NCT00545740|464207009|FG000|Overall Study|Physician Decision|0|||
128978355|NCT00545740|464207010|FG001|Overall Study|Physician Decision|0|||
128978356|NCT00545740|464207011|FG002|Overall Study|Physician Decision|3|||
128978357|NCT00545740|464207012|FG003|Overall Study|Physician Decision|0|||
129222268|NCT02867384|465116045|FG001|Overall Study|Patient compliance|0|||
129222269|NCT02867384|465116046|FG002|Overall Study|Patient compliance|0|||
129040734|NCT03686150|464442030|FG004|Overall Study|Withdrawal by Subject|1|||
129040735|NCT03686150|464442031|FG005|Overall Study|Withdrawal by Subject|2|||
129040736|NCT03686150|464442026|FG000|Overall Study|Physician Decision|1|||
129040737|NCT03686150|464442027|FG001|Overall Study|Physician Decision|0|||
129040738|NCT03686150|464442028|FG002|Overall Study|Physician Decision|0|||
129040739|NCT03686150|464442029|FG003|Overall Study|Physician Decision|0|||
128717909|NCT03662542|463265129|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
128717910|NCT03662542|463265130|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717911|NCT03662542|463265131|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717912|NCT03662542|463265132|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717913|NCT03662542|463265133|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717914|NCT03662542|463265134|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717915|NCT03662542|463265135|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717916|NCT03662542|463265136|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717917|NCT03662542|463265137|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
128717918|NCT03662542|463265129|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717919|NCT03662542|463265130|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
128717920|NCT03662542|463265131|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717921|NCT03662542|463265132|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717922|NCT03662542|463265133|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717923|NCT03662542|463265134|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717924|NCT03662542|463265135|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717925|NCT03662542|463265136|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717926|NCT03662542|463265137|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
128717927|NCT03662542|463265129|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
128717928|NCT03662542|463265130|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
129222270|NCT02867384|465116044|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
129222271|NCT02867384|465116045|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
129222272|NCT02867384|465116046|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
129040740|NCT03686150|464442030|FG004|Overall Study|Physician Decision|0|||
129040741|NCT03686150|464442031|FG005|Overall Study|Physician Decision|1|||
129040742|NCT03686150|464442026|FG000|Overall Study|Lost to Follow-up|0|||
129040743|NCT03686150|464442027|FG001|Overall Study|Lost to Follow-up|1|||
129040744|NCT03686150|464442028|FG002|Overall Study|Lost to Follow-up|0|||
129040745|NCT03686150|464442029|FG003|Overall Study|Lost to Follow-up|0|||
129040746|NCT03686150|464442030|FG004|Overall Study|Lost to Follow-up|0|||
129040747|NCT03686150|464442031|FG005|Overall Study|Lost to Follow-up|0|||
129040748|NCT01213836|464442037|FG000|Period 1, First Intervention|Adverse Event|2|||
129040749|NCT01213836|464442038|FG001|Period 1, First Intervention|Adverse Event|1|||
129040750|NCT01213836|464442037|FG000|Period 1, First Intervention|Protocol Violation|0|||
129040751|NCT01213836|464442038|FG001|Period 1, First Intervention|Protocol Violation|1|||
129040752|NCT01213836|464442037|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
129040753|NCT01213836|464442038|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
129040754|NCT00255151|464442045|FG000|Overall Study|Adverse Event|10|||
129040755|NCT00255151|464442046|FG001|Overall Study|Adverse Event|6|||
129040756|NCT00255151|464442047|FG002|Overall Study|Adverse Event|9|||
129040757|NCT00255151|464442045|FG000|Overall Study|Lost to Follow-up|4|||
129040758|NCT00255151|464442046|FG001|Overall Study|Lost to Follow-up|3|||
129040759|NCT00255151|464442047|FG002|Overall Study|Lost to Follow-up|4|||
129040760|NCT00255151|464442045|FG000|Overall Study|Withdrawal by Subject|18|||
129040761|NCT00255151|464442046|FG001|Overall Study|Withdrawal by Subject|17|||
129040762|NCT00255151|464442047|FG002|Overall Study|Withdrawal by Subject|8|||
129040763|NCT00255151|464442045|FG000|Overall Study|Noncompliance|0|||
129040764|NCT00255151|464442046|FG001|Overall Study|Noncompliance|1|||
129040765|NCT00255151|464442047|FG002|Overall Study|Noncompliance|2|||
129040766|NCT00255151|464442045|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
129040767|NCT00255151|464442046|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
129040768|NCT00255151|464442047|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
129040769|NCT00255151|464442045|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
129040770|NCT00255151|464442046|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
129040771|NCT00255151|464442047|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
129040772|NCT00255151|464442045|FG000|Overall Study|Possible Barrett's Esophagus|1|||
128717929|NCT03662542|463265131|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
129040773|NCT00255151|464442046|FG001|Overall Study|Possible Barrett's Esophagus|3|||
129040774|NCT00255151|464442047|FG002|Overall Study|Possible Barrett's Esophagus|8|||
129040775|NCT00255151|464442045|FG000|Overall Study|Esophageal Stricture|0|||
129040776|NCT00255151|464442046|FG001|Overall Study|Esophageal Stricture|0|||
129040777|NCT00255151|464442047|FG002|Overall Study|Esophageal Stricture|1|||
129040778|NCT00255151|464442045|FG000|Overall Study|Therapeutic Failure|11|||
129040779|NCT00255151|464442046|FG001|Overall Study|Therapeutic Failure|2|||
129040780|NCT00255151|464442047|FG002|Overall Study|Therapeutic Failure|3|||
129040781|NCT02676284|464442048|FG000|Overall Study|Withdrawal by Subject|1|||
129040782|NCT01685073|464442049|FG000|Overall Study|Lost to Follow-up|6|||
129040783|NCT01685073|464442050|FG001|Overall Study|Lost to Follow-up|8|||
129040784|NCT01685073|464442049|FG000|Overall Study|Withdrawal by Subject|24|||
129040785|NCT01685073|464442050|FG001|Overall Study|Withdrawal by Subject|24|||
129040786|NCT00107042|464442055|FG000|Overall Study|Lost to Follow-up|9|||
129040787|NCT00107042|464442056|FG001|Overall Study|Lost to Follow-up|7|||
129040788|NCT00107042|464442055|FG000|Overall Study|Withdrawal by Subject|6|||
129040789|NCT00107042|464442056|FG001|Overall Study|Withdrawal by Subject|1|||
129040790|NCT00107042|464442055|FG000|Overall Study|Moved out of area|5|||
129040791|NCT00107042|464442056|FG001|Overall Study|Moved out of area|3|||
129040792|NCT00107042|464442055|FG000|Overall Study|Pregnancy|1|||
129040793|NCT00107042|464442056|FG001|Overall Study|Pregnancy|1|||
129040794|NCT00107042|464442055|FG000|Overall Study|Inadvertent enrollment|0|||
129040795|NCT00107042|464442056|FG001|Overall Study|Inadvertent enrollment|1|||
129040796|NCT00107042|464442055|FG000|Overall Study|vaccinated outside window|1|||
129040797|NCT00107042|464442056|FG001|Overall Study|vaccinated outside window|1|||
129040798|NCT00107042|464442055|FG000|Overall Study|Disallowed medications|0|||
129040799|NCT00107042|464442056|FG001|Overall Study|Disallowed medications|2|||
129040800|NCT00140413|464442058|FG000|Overall Study|Lost to Follow-up|1|||
129040801|NCT00140413|464442059|FG001|Overall Study|Lost to Follow-up|0|||
129040802|NCT00140413|464442058|FG000|Overall Study|Withdrawal by Subject|2|||
129040803|NCT00140413|464442059|FG001|Overall Study|Withdrawal by Subject|0|||
129040804|NCT00865098|464442060|FG000|Overall Study|Progressive disease|1|||
129040805|NCT01360866|464442068|FG000|Overall Study|Lost to Follow-up|11|||
129040806|NCT01360866|464442069|FG001|Overall Study|Lost to Follow-up|28|||
129040807|NCT01360866|464442070|FG002|Overall Study|Lost to Follow-up|41|||
129040808|NCT01360866|464442071|FG003|Overall Study|Lost to Follow-up|0|||
129040809|NCT01360866|464442068|FG000|Overall Study|Adverse Event|56|||
129040810|NCT01360866|464442069|FG001|Overall Study|Adverse Event|61|||
129040811|NCT01360866|464442070|FG002|Overall Study|Adverse Event|134|||
129040812|NCT01360866|464442071|FG003|Overall Study|Adverse Event|6|||
129040813|NCT01360866|464442068|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
129040814|NCT01360866|464442069|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
129040815|NCT01360866|464442070|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
129040816|NCT01360866|464442071|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
129040817|NCT01360866|464442068|FG000|Overall Study|Withdrawn by Investigator|9|||
129040818|NCT01360866|464442069|FG001|Overall Study|Withdrawn by Investigator|8|||
129040819|NCT01360866|464442070|FG002|Overall Study|Withdrawn by Investigator|31|||
129040820|NCT01360866|464442071|FG003|Overall Study|Withdrawn by Investigator|2|||
129040821|NCT01360866|464442068|FG000|Overall Study|Withdrawal by participant|79|||
129040822|NCT01360866|464442069|FG001|Overall Study|Withdrawal by participant|89|||
129040823|NCT01360866|464442070|FG002|Overall Study|Withdrawal by participant|168|||
129040824|NCT01360866|464442071|FG003|Overall Study|Withdrawal by participant|8|||
129040825|NCT01360866|464442068|FG000|Overall Study|Protocol Deviation|25|||
129040826|NCT01360866|464442069|FG001|Overall Study|Protocol Deviation|33|||
129040827|NCT01360866|464442070|FG002|Overall Study|Protocol Deviation|61|||
129040828|NCT01360866|464442071|FG003|Overall Study|Protocol Deviation|2|||
129040829|NCT01360866|464442068|FG000|Overall Study|Lack of Efficacy|30|||
129040830|NCT01360866|464442069|FG001|Overall Study|Lack of Efficacy|40|||
129040831|NCT01360866|464442070|FG002|Overall Study|Lack of Efficacy|30|||
129040832|NCT01360866|464442071|FG003|Overall Study|Lack of Efficacy|4|||
129040833|NCT03702049|464442075|FG000|Overall Study|Lost to Follow-up|4|||
129040834|NCT03702049|464442075|FG000|Overall Study|Physician Decision|1|||
129040835|NCT01304693|464442076|FG000|Overall Study|Adverse Event|0|||
129040836|NCT01304693|464442077|FG001|Overall Study|Adverse Event|0|||
129040837|NCT01304693|464442078|FG002|Overall Study|Adverse Event|0|||
129040838|NCT01304693|464442079|FG003|Overall Study|Adverse Event|0|||
129040839|NCT01304693|464442080|FG004|Overall Study|Adverse Event|1|||
129040840|NCT01304693|464442076|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
129040841|NCT01304693|464442077|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
129133013|NCT01980888|464778591|FG000|Overall Study|Non-Compliance with Study Drug|3|||
129133014|NCT01980888|464778592|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129133015|NCT05762744|464778598|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
129133016|NCT05762744|464778599|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
129133017|NCT05762744|464778598|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
129133018|NCT05762744|464778599|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
129133019|NCT01671059|464778600|FG000|Overall Study|Adverse Event|4|||
129040842|NCT01304693|464442078|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
129040843|NCT01304693|464442079|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
129040844|NCT01304693|464442080|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
129040845|NCT02129647|464442081|FG000|Overall Study|Adverse Event|2|||
129040846|NCT02129647|464442081|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
129040847|NCT01715896|464442084|FG000|Overall Study|Lost to Follow-up|0|||
129133020|NCT01671059|464778600|FG000|Overall Study|Lack of Efficacy|1|||
129222273|NCT02867384|465116044|FG000|Overall Study|Never start treatment|3|||
129222274|NCT02867384|465116045|FG001|Overall Study|Never start treatment|0|||
129222275|NCT02867384|465116046|FG002|Overall Study|Never start treatment|0|||
129222276|NCT04363801|465116050|FG000|Overall Study|Death|18|||
129222277|NCT04363801|465116051|FG001|Overall Study|Death|14|||
129222278|NCT04363801|465116052|FG002|Overall Study|Death|16|||
129222279|NCT04363801|465116053|FG003|Overall Study|Death|48|||
129222280|NCT04363801|465116054|FG004|Overall Study|Death|38|||
129222281|NCT04363801|465116050|FG000|Overall Study|Withdrawal by Subject|1|||
129222282|NCT04363801|465116051|FG001|Overall Study|Withdrawal by Subject|6|||
129222283|NCT04363801|465116052|FG002|Overall Study|Withdrawal by Subject|1|||
129222284|NCT04363801|465116053|FG003|Overall Study|Withdrawal by Subject|4|||
129222285|NCT04363801|465116054|FG004|Overall Study|Withdrawal by Subject|14|||
129222286|NCT04363801|465116050|FG000|Overall Study|Sponsor Decision|6|||
129222287|NCT04363801|465116051|FG001|Overall Study|Sponsor Decision|4|||
129222288|NCT04363801|465116052|FG002|Overall Study|Sponsor Decision|10|||
129222289|NCT04363801|465116053|FG003|Overall Study|Sponsor Decision|33|||
129222290|NCT04363801|465116054|FG004|Overall Study|Sponsor Decision|32|||
129222291|NCT04363801|465116050|FG000|Overall Study|Lost to Follow-up|0|||
129222292|NCT04363801|465116051|FG001|Overall Study|Lost to Follow-up|0|||
129222293|NCT04363801|465116052|FG002|Overall Study|Lost to Follow-up|1|||
129222294|NCT04363801|465116053|FG003|Overall Study|Lost to Follow-up|0|||
129222295|NCT04363801|465116054|FG004|Overall Study|Lost to Follow-up|1|||
129222296|NCT06336603|465116057|FG000|Overall Study|Withdrawal by Subject|1|||
129222297|NCT06336603|465116057|FG000|Overall Study|Lost to Follow-up|2|||
129222298|NCT04395001|465116058|FG000|Overall Study|Lost to Follow-up|8|||
129222299|NCT04395001|465116059|FG001|Overall Study|Lost to Follow-up|9|||
129222300|NCT04395001|465116060|FG002|Overall Study|Lost to Follow-up|5|||
128978358|NCT00545740|464207009|FG000|Overall Study|Accepted only monthly telephone calls|1|||
128978359|NCT00545740|464207010|FG001|Overall Study|Accepted only monthly telephone calls|0|||
128978360|NCT00545740|464207011|FG002|Overall Study|Accepted only monthly telephone calls|0|||
128978361|NCT00545740|464207012|FG003|Overall Study|Accepted only monthly telephone calls|0|||
128978362|NCT00545740|464207009|FG000|Overall Study|Sponsor decision|0|||
128978363|NCT00545740|464207010|FG001|Overall Study|Sponsor decision|1|||
128978364|NCT00545740|464207011|FG002|Overall Study|Sponsor decision|0|||
128978365|NCT00545740|464207012|FG003|Overall Study|Sponsor decision|0|||
128978366|NCT00545740|464207009|FG000|Overall Study|Lack of time|0|||
128978367|NCT00545740|464207010|FG001|Overall Study|Lack of time|1|||
128978368|NCT00545740|464207011|FG002|Overall Study|Lack of time|0|||
128978369|NCT00545740|464207012|FG003|Overall Study|Lack of time|0|||
128978370|NCT00545740|464207009|FG000|Overall Study|Non-adherence to visits|0|||
128978371|NCT00545740|464207010|FG001|Overall Study|Non-adherence to visits|1|||
128978372|NCT00545740|464207011|FG002|Overall Study|Non-adherence to visits|0|||
128978373|NCT00545740|464207012|FG003|Overall Study|Non-adherence to visits|0|||
128978374|NCT00545740|464207009|FG000|Overall Study|Patient difficulties|0|||
128978375|NCT00545740|464207010|FG001|Overall Study|Patient difficulties|1|||
128978376|NCT00545740|464207011|FG002|Overall Study|Patient difficulties|0|||
128978377|NCT00545740|464207012|FG003|Overall Study|Patient difficulties|0|||
128978378|NCT00545740|464207009|FG000|Overall Study|Husband against study|0|||
128978379|NCT00545740|464207010|FG001|Overall Study|Husband against study|0|||
128978380|NCT00545740|464207011|FG002|Overall Study|Husband against study|1|||
128978381|NCT00545740|464207012|FG003|Overall Study|Husband against study|0|||
128978382|NCT04212221|464207018|FG000|Overall Study|Remained on Treatment|0|||
128978383|NCT04212221|464207019|FG001|Overall Study|Remained on Treatment|0|||
128978384|NCT04212221|464207020|FG002|Overall Study|Remained on Treatment|0|||
128978385|NCT04212221|464207021|FG003|Overall Study|Remained on Treatment|1|||
128978386|NCT04212221|464207022|FG004|Overall Study|Remained on Treatment|0|||
128978387|NCT04212221|464207023|FG005|Overall Study|Remained on Treatment|0|||
128978388|NCT04212221|464207024|FG006|Overall Study|Remained on Treatment|3|||
128978389|NCT04212221|464207025|FG007|Overall Study|Remained on Treatment|9|||
129222301|NCT04395001|465116058|FG000|Overall Study|Withdrawal by Subject|3|||
128978390|NCT04212221|464207018|FG000|Overall Study|Adverse Event|0|||
128978391|NCT04212221|464207019|FG001|Overall Study|Adverse Event|0|||
128978392|NCT04212221|464207020|FG002|Overall Study|Adverse Event|0|||
129222302|NCT04395001|465116059|FG001|Overall Study|Withdrawal by Subject|1|||
129222303|NCT04395001|465116060|FG002|Overall Study|Withdrawal by Subject|3|||
129222304|NCT04395001|465116058|FG000|Overall Study|missed appointment|7|||
128978393|NCT04212221|464207021|FG003|Overall Study|Adverse Event|0|||
128978394|NCT04212221|464207022|FG004|Overall Study|Adverse Event|0|||
128978395|NCT04212221|464207023|FG005|Overall Study|Adverse Event|0|||
128978396|NCT04212221|464207024|FG006|Overall Study|Adverse Event|2|||
129222305|NCT04395001|465116059|FG001|Overall Study|missed appointment|4|||
129222306|NCT04395001|465116060|FG002|Overall Study|missed appointment|1|||
129222307|NCT04251156|465116064|FG000|Overall Study|Lost to Follow-up|1|||
129222308|NCT04251156|465116065|FG001|Overall Study|Lost to Follow-up|1|||
129222309|NCT04251156|465116064|FG000|Overall Study|Withdrawal by Subject|4|||
129222310|NCT04251156|465116065|FG001|Overall Study|Withdrawal by Subject|4|||
129222311|NCT03901469|465116066|FG000|Overall Study|Radiographic Progression|4|||
129040848|NCT01715896|464442085|FG001|Overall Study|Lost to Follow-up|2|||
129040849|NCT01715896|464442084|FG000|Overall Study|Withdrawal by Subject|1|||
129040850|NCT01715896|464442085|FG001|Overall Study|Withdrawal by Subject|4|||
129040851|NCT01715896|464442084|FG000|Overall Study|Other|2|||
129040852|NCT01715896|464442085|FG001|Overall Study|Other|5|||
129040853|NCT01833533|464442089|FG000|Overall Study|Adverse Event|0|||
129040854|NCT01833533|464442090|FG001|Overall Study|Adverse Event|1|||
129040855|NCT01833533|464442089|FG000|Overall Study|Lost to Follow-up|4|||
129040856|NCT01833533|464442090|FG001|Overall Study|Lost to Follow-up|9|||
129040857|NCT01833533|464442089|FG000|Overall Study|To Enter an Extension Study|0|||
129040858|NCT01833533|464442090|FG001|Overall Study|To Enter an Extension Study|4|||
129040859|NCT01833533|464442089|FG000|Overall Study|Other|2|||
129040860|NCT01833533|464442090|FG001|Overall Study|Other|7|||
129040861|NCT01048502|464442091|FG000|Overall Study|Lost to Follow-up|2|||
129040862|NCT01048502|464442092|FG001|Overall Study|Lost to Follow-up|0|||
129040863|NCT01048502|464442093|FG002|Overall Study|Lost to Follow-up|0|||
129040864|NCT01048502|464442094|FG003|Overall Study|Lost to Follow-up|0|||
129040865|NCT01048502|464442091|FG000|Overall Study|Adverse Event|1|||
129040866|NCT01048502|464442092|FG001|Overall Study|Adverse Event|0|||
129040867|NCT01048502|464442093|FG002|Overall Study|Adverse Event|0|||
129040868|NCT01048502|464442094|FG003|Overall Study|Adverse Event|0|||
129040869|NCT01048502|464442091|FG000|Overall Study|Withdrawal by Subject|1|||
129040870|NCT01048502|464442092|FG001|Overall Study|Withdrawal by Subject|4|||
129040871|NCT01048502|464442093|FG002|Overall Study|Withdrawal by Subject|5|||
129040872|NCT01048502|464442094|FG003|Overall Study|Withdrawal by Subject|3|||
129040873|NCT01048502|464442091|FG000|Overall Study|Physician Decision|0|||
129040874|NCT01048502|464442092|FG001|Overall Study|Physician Decision|3|||
129040875|NCT01048502|464442093|FG002|Overall Study|Physician Decision|0|||
129040876|NCT01048502|464442094|FG003|Overall Study|Physician Decision|1|||
129040877|NCT01138826|464442095|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
129040878|NCT01138826|464442096|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
129040879|NCT01138826|464442097|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
129040880|NCT01138826|464442098|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
129040881|NCT01138826|464442099|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
129040882|NCT01138826|464442100|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
129040883|NCT01333072|464442104|FG000|Overall Study|Lost to Follow-up|3|||
129040884|NCT01333072|464442105|FG001|Overall Study|Lost to Follow-up|0|||
129040885|NCT01333072|464442104|FG000|Overall Study|Adverse Event|2|||
129040886|NCT01333072|464442105|FG001|Overall Study|Adverse Event|4|||
129040887|NCT01333072|464442104|FG000|Overall Study|Physician Decision|1|||
129040888|NCT01333072|464442105|FG001|Overall Study|Physician Decision|0|||
129040889|NCT01557842|464442106|FG000|Overall Study|Lost to Follow-up|0|||
129040890|NCT01557842|464442107|FG001|Overall Study|Lost to Follow-up|1|||
129040891|NCT01557842|464442106|FG000|Overall Study|Death|1|||
129040892|NCT01557842|464442107|FG001|Overall Study|Death|0|||
129040893|NCT01557842|464442106|FG000|Overall Study|Lack of Efficacy|0|||
129040894|NCT01557842|464442107|FG001|Overall Study|Lack of Efficacy|1|||
129040895|NCT01557842|464442106|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
129040896|NCT01557842|464442107|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
129040897|NCT01557842|464442106|FG000|Overall Study|Study Terminated by Sponsor|3|||
129040898|NCT01557842|464442107|FG001|Overall Study|Study Terminated by Sponsor|4|||
129040899|NCT01557842|464442106|FG000|Overall Study|Not Ablated|2|||
129040900|NCT01557842|464442107|FG001|Overall Study|Not Ablated|0|||
129040901|NCT02457611|464442111|FG000|Overall Study|Lost to Follow-up|3|||
129040902|NCT00384293|464442112|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
129040903|NCT00384293|464442113|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
129040904|NCT00384293|464442114|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
129040905|NCT00384293|464442112|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
129040906|NCT00384293|464442113|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
129133021|NCT01030900|464778607|FG000|Overall Study|Not treated due to congestive heart failure|1|||
129133022|NCT01030900|464778607|FG000|Overall Study|Not treated due to rapid disease|1|||
129133023|NCT01179399|464778608|FG000|Overall Study|Adverse Event|1|||
129133024|NCT01179399|464778608|FG000|Overall Study|Lack of Efficacy|30|||
129040907|NCT00384293|464442114|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
129040908|NCT00384293|464442112|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
129133025|NCT01179399|464778608|FG000|Overall Study|Withdrawal by Subject|1|||
129133026|NCT00441896|464778609|FG000|Overall Study|Withdrawal by Subject|0|||
129040909|NCT00384293|464442113|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
129040910|NCT00384293|464442114|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
129040911|NCT00384293|464442112|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
129040912|NCT00384293|464442113|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
129040913|NCT00384293|464442114|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
129040914|NCT00384293|464442112|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
129133027|NCT00441896|464778610|FG001|Overall Study|Withdrawal by Subject|0|||
128717930|NCT03662542|463265132|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
128717931|NCT03662542|463265133|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
128717932|NCT03662542|463265134|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
129040915|NCT00384293|464442113|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
129040916|NCT00384293|464442114|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
129040917|NCT00384293|464442112|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
129040918|NCT00384293|464442113|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
129040919|NCT00384293|464442114|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
129040920|NCT00384293|464442112|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
129040921|NCT00384293|464442113|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
129040922|NCT00384293|464442114|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
129040923|NCT00384293|464442112|FG000|Post-randomization Period|Adverse Event|0|||
129040924|NCT00384293|464442113|FG001|Post-randomization Period|Adverse Event|23|||
129040925|NCT00384293|464442114|FG002|Post-randomization Period|Adverse Event|7|||
128717933|NCT03662542|463265135|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
129040926|NCT00384293|464442112|FG000|Post-randomization Period|Lost to Follow-up|0|||
129040927|NCT00384293|464442113|FG001|Post-randomization Period|Lost to Follow-up|2|||
129040928|NCT00384293|464442114|FG002|Post-randomization Period|Lost to Follow-up|1|||
129040929|NCT00384293|464442112|FG000|Post-randomization Period|Protocol Violation|0|||
129040930|NCT00384293|464442113|FG001|Post-randomization Period|Protocol Violation|1|||
129040931|NCT00384293|464442114|FG002|Post-randomization Period|Protocol Violation|0|||
129040932|NCT00384293|464442112|FG000|Post-randomization Period|Withdrawal by Subject|0|||
129040933|NCT00384293|464442113|FG001|Post-randomization Period|Withdrawal by Subject|8|||
129040934|NCT00384293|464442114|FG002|Post-randomization Period|Withdrawal by Subject|6|||
129040935|NCT00384293|464442112|FG000|Post-randomization Period|Trial Termination|0|||
129040936|NCT00384293|464442113|FG001|Post-randomization Period|Trial Termination|180|||
129040937|NCT00384293|464442114|FG002|Post-randomization Period|Trial Termination|204|||
129040938|NCT00384293|464442112|FG000|Post-randomization Period|Patient Randomized in Error|0|||
129040939|NCT00384293|464442113|FG001|Post-randomization Period|Patient Randomized in Error|0|||
129040940|NCT00384293|464442114|FG002|Post-randomization Period|Patient Randomized in Error|1|||
129040941|NCT03005067|464442115|FG000|Overall Study|Withdrawal by Subject|3|||
129040942|NCT03005067|464442116|FG001|Overall Study|Withdrawal by Subject|2|||
129040943|NCT03005067|464442115|FG000|Overall Study|Adverse Event|4|||
129040944|NCT03005067|464442116|FG001|Overall Study|Adverse Event|3|||
129040945|NCT03005067|464442115|FG000|Overall Study|Other (reason not specified)|3|||
129040946|NCT03005067|464442116|FG001|Overall Study|Other (reason not specified)|1|||
129040947|NCT03005067|464442115|FG000|Overall Study|Protocol Violation|0|||
129040948|NCT03005067|464442116|FG001|Overall Study|Protocol Violation|1|||
129040949|NCT00619359|464442121|FG000|Overall Study|Adverse Event|32|||
129040950|NCT00619359|464442122|FG001|Overall Study|Adverse Event|36|||
129040951|NCT00619359|464442121|FG000|Overall Study|Lost to Follow-up|12|||
129040952|NCT00619359|464442122|FG001|Overall Study|Lost to Follow-up|16|||
129040953|NCT00619359|464442121|FG000|Overall Study|Physician Decision|0|||
129040954|NCT00619359|464442122|FG001|Overall Study|Physician Decision|7|||
129040955|NCT00619359|464442121|FG000|Overall Study|Protocol Violation|1|||
129040956|NCT00619359|464442122|FG001|Overall Study|Protocol Violation|1|||
129040957|NCT00619359|464442121|FG000|Overall Study|Withdrawal by Subject|19|||
129040958|NCT00619359|464442122|FG001|Overall Study|Withdrawal by Subject|20|||
129040959|NCT00619359|464442121|FG000|Overall Study|Progressive Disease|3|||
129040960|NCT00619359|464442122|FG001|Overall Study|Progressive Disease|1|||
129040961|NCT01483625|464442124|FG000|Overall Study|Adverse Event|1|||
129040962|NCT01483625|464442125|FG001|Overall Study|Adverse Event|1|||
129040963|NCT01483625|464442124|FG000|Overall Study|Refused to continue medication|2|||
129040964|NCT01483625|464442125|FG001|Overall Study|Refused to continue medication|1|||
129040965|NCT01483625|464442124|FG000|Overall Study|Due to other reason|1|||
129040966|NCT01483625|464442125|FG001|Overall Study|Due to other reason|0|||
129040967|NCT03891329|464442138|FG000|Overall Study|Death|5|||
129040968|NCT03891329|464442138|FG000|Overall Study|Lost to Follow-up|4|||
129040969|NCT03891329|464442138|FG000|Overall Study|Physician Decision|4|||
129040970|NCT03891329|464442138|FG000|Overall Study|Device explanted|3|||
129040971|NCT03891329|464442138|FG000|Overall Study|No study device implanted|3|||
129040972|NCT01832402|464442141|FG000|Overall Study|Lost to Follow-up|2|||
129133028|NCT00441896|464778611|FG002|Overall Study|Withdrawal by Subject|0|||
129133029|NCT00441896|464778612|FG003|Overall Study|Withdrawal by Subject|1|||
128717934|NCT03662542|463265136|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
128717935|NCT03662542|463265137|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
129040973|NCT01832402|464442142|FG001|Overall Study|Lost to Follow-up|0|||
129040974|NCT01832402|464442141|FG000|Overall Study|Withdrawal by Subject|3|||
129040975|NCT01832402|464442142|FG001|Overall Study|Withdrawal by Subject|3|||
129040976|NCT01832402|464442141|FG000|Overall Study|Declining Performance status|2|||
128717936|NCT03662542|463265129|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
128717937|NCT03662542|463265130|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129040977|NCT01832402|464442142|FG001|Overall Study|Declining Performance status|1|||
129040978|NCT01803269|464442145|FG000|Overall Study|Withdrawal by Subject|3|||
129040979|NCT01803269|464442146|FG001|Overall Study|Withdrawal by Subject|0|||
129040980|NCT01803269|464442147|FG002|Overall Study|Withdrawal by Subject|0|||
129222312|NCT03901469|465116067|FG001|Overall Study|Radiographic Progression|6|||
129222313|NCT03901469|465116068|FG002|Overall Study|Radiographic Progression|3|||
129222314|NCT03901469|465116069|FG003|Overall Study|Radiographic Progression|30|||
129222315|NCT03901469|465116070|FG004|Overall Study|Radiographic Progression|7|||
129222316|NCT03901469|465116071|FG005|Overall Study|Radiographic Progression|2|||
129222317|NCT03901469|465116072|FG006|Overall Study|Radiographic Progression|11|||
129222318|NCT03901469|465116066|FG000|Overall Study|Clinical Progression|0|||
129222319|NCT03901469|465116067|FG001|Overall Study|Clinical Progression|2|||
129222320|NCT03901469|465116068|FG002|Overall Study|Clinical Progression|0|||
129222321|NCT03901469|465116069|FG003|Overall Study|Clinical Progression|7|||
129222322|NCT03901469|465116070|FG004|Overall Study|Clinical Progression|6|||
129222323|NCT03901469|465116071|FG005|Overall Study|Clinical Progression|0|||
129222324|NCT03901469|465116072|FG006|Overall Study|Clinical Progression|2|||
129222325|NCT03901469|465116066|FG000|Overall Study|Adverse Event|1|||
129222326|NCT03901469|465116067|FG001|Overall Study|Adverse Event|0|||
129222327|NCT03901469|465116068|FG002|Overall Study|Adverse Event|0|||
129222328|NCT03901469|465116069|FG003|Overall Study|Adverse Event|0|||
129222329|NCT03901469|465116070|FG004|Overall Study|Adverse Event|0|||
129222330|NCT03901469|465116071|FG005|Overall Study|Adverse Event|0|||
129222331|NCT03901469|465116072|FG006|Overall Study|Adverse Event|9|||
129222332|NCT03901469|465116066|FG000|Overall Study|Physician Decision|0|||
129222333|NCT03901469|465116067|FG001|Overall Study|Physician Decision|0|||
129222334|NCT03901469|465116068|FG002|Overall Study|Physician Decision|0|||
129222335|NCT03901469|465116069|FG003|Overall Study|Physician Decision|1|||
129222336|NCT03901469|465116070|FG004|Overall Study|Physician Decision|0|||
129222337|NCT03901469|465116071|FG005|Overall Study|Physician Decision|0|||
129222338|NCT03901469|465116072|FG006|Overall Study|Physician Decision|0|||
129222339|NCT03901469|465116066|FG000|Overall Study|Withdrawal by Subject|0|||
129222340|NCT03901469|465116067|FG001|Overall Study|Withdrawal by Subject|0|||
129222341|NCT03901469|465116068|FG002|Overall Study|Withdrawal by Subject|0|||
129222342|NCT03901469|465116069|FG003|Overall Study|Withdrawal by Subject|0|||
129222343|NCT03901469|465116070|FG004|Overall Study|Withdrawal by Subject|2|||
129222344|NCT03901469|465116071|FG005|Overall Study|Withdrawal by Subject|0|||
129222345|NCT03901469|465116072|FG006|Overall Study|Withdrawal by Subject|8|||
129222346|NCT03901469|465116066|FG000|Overall Study|Death|0|||
129222347|NCT03901469|465116067|FG001|Overall Study|Death|0|||
129222348|NCT03901469|465116068|FG002|Overall Study|Death|0|||
128978397|NCT04212221|464207025|FG007|Overall Study|Adverse Event|3|||
128978398|NCT04212221|464207018|FG000|Overall Study|Death|0|||
128978399|NCT04212221|464207019|FG001|Overall Study|Death|0|||
128978400|NCT04212221|464207020|FG002|Overall Study|Death|0|||
128978401|NCT04212221|464207021|FG003|Overall Study|Death|0|||
128978402|NCT04212221|464207022|FG004|Overall Study|Death|0|||
128978403|NCT04212221|464207023|FG005|Overall Study|Death|0|||
128978404|NCT04212221|464207024|FG006|Overall Study|Death|0|||
128978405|NCT04212221|464207025|FG007|Overall Study|Death|2|||
128978406|NCT04212221|464207018|FG000|Overall Study|Disease progression according to irRECIST|1|||
128978407|NCT04212221|464207019|FG001|Overall Study|Disease progression according to irRECIST|2|||
128978408|NCT04212221|464207020|FG002|Overall Study|Disease progression according to irRECIST|3|||
128978409|NCT04212221|464207021|FG003|Overall Study|Disease progression according to irRECIST|3|||
128978410|NCT04212221|464207022|FG004|Overall Study|Disease progression according to irRECIST|2|||
128978411|NCT04212221|464207023|FG005|Overall Study|Disease progression according to irRECIST|2|||
128978412|NCT04212221|464207024|FG006|Overall Study|Disease progression according to irRECIST|21|||
128978413|NCT04212221|464207025|FG007|Overall Study|Disease progression according to irRECIST|17|||
128978414|NCT04212221|464207018|FG000|Overall Study|Global Deterioration of Health Status|0|||
128978415|NCT04212221|464207019|FG001|Overall Study|Global Deterioration of Health Status|0|||
128978416|NCT04212221|464207020|FG002|Overall Study|Global Deterioration of Health Status|0|||
128978417|NCT04212221|464207021|FG003|Overall Study|Global Deterioration of Health Status|0|||
128978418|NCT04212221|464207022|FG004|Overall Study|Global Deterioration of Health Status|0|||
128978419|NCT04212221|464207023|FG005|Overall Study|Global Deterioration of Health Status|0|||
128978420|NCT04212221|464207024|FG006|Overall Study|Global Deterioration of Health Status|0|||
129040981|NCT01258101|464442153|FG000|Overall Study|Adverse Event|5|||
129222349|NCT03901469|465116069|FG003|Overall Study|Death|3|||
129222350|NCT03901469|465116070|FG004|Overall Study|Death|5|||
129222351|NCT03901469|465116071|FG005|Overall Study|Death|0|||
129222352|NCT03901469|465116072|FG006|Overall Study|Death|1|||
129222353|NCT03901469|465116066|FG000|Overall Study|Termination of study by sponsor|0|||
129222354|NCT03901469|465116067|FG001|Overall Study|Termination of study by sponsor|0|||
129222355|NCT03901469|465116068|FG002|Overall Study|Termination of study by sponsor|0|||
129222356|NCT03901469|465116069|FG003|Overall Study|Termination of study by sponsor|0|||
129222357|NCT03901469|465116070|FG004|Overall Study|Termination of study by sponsor|1|||
129222358|NCT03901469|465116071|FG005|Overall Study|Termination of study by sponsor|1|||
128717938|NCT03662542|463265131|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
128717939|NCT03662542|463265132|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
128978421|NCT04212221|464207025|FG007|Overall Study|Global Deterioration of Health Status|2|||
128978422|NCT04212221|464207018|FG000|Overall Study|Investigator's Decision|0|||
128978423|NCT04212221|464207019|FG001|Overall Study|Investigator's Decision|0|||
128978424|NCT04212221|464207020|FG002|Overall Study|Investigator's Decision|0|||
128978425|NCT04212221|464207021|FG003|Overall Study|Investigator's Decision|1|||
128978426|NCT04212221|464207022|FG004|Overall Study|Investigator's Decision|0|||
128978427|NCT04212221|464207023|FG005|Overall Study|Investigator's Decision|0|||
128978428|NCT04212221|464207024|FG006|Overall Study|Investigator's Decision|3|||
128978429|NCT04212221|464207025|FG007|Overall Study|Investigator's Decision|0|||
128978430|NCT04212221|464207018|FG000|Overall Study|Participant refused to continue treatment|0|||
128978431|NCT04212221|464207019|FG001|Overall Study|Participant refused to continue treatment|1|||
128978432|NCT04212221|464207020|FG002|Overall Study|Participant refused to continue treatment|0|||
128978433|NCT04212221|464207021|FG003|Overall Study|Participant refused to continue treatment|1|||
128978434|NCT04212221|464207022|FG004|Overall Study|Participant refused to continue treatment|1|||
128978435|NCT04212221|464207023|FG005|Overall Study|Participant refused to continue treatment|2|||
128978436|NCT04212221|464207024|FG006|Overall Study|Participant refused to continue treatment|4|||
128978437|NCT04212221|464207025|FG007|Overall Study|Participant refused to continue treatment|2|||
128978438|NCT04212221|464207018|FG000|Overall Study|Protocol Violation|0|||
128978439|NCT04212221|464207019|FG001|Overall Study|Protocol Violation|0|||
128978440|NCT04212221|464207020|FG002|Overall Study|Protocol Violation|0|||
128978441|NCT04212221|464207021|FG003|Overall Study|Protocol Violation|0|||
128978442|NCT04212221|464207022|FG004|Overall Study|Protocol Violation|0|||
128978443|NCT04212221|464207023|FG005|Overall Study|Protocol Violation|0|||
128978444|NCT04212221|464207024|FG006|Overall Study|Protocol Violation|0|||
128978445|NCT04212221|464207025|FG007|Overall Study|Protocol Violation|1|||
128978446|NCT03742271|464207030|FG000|Overall Study|Unsatisfactory Visual Response|1|||
128978447|NCT03742271|464207030|FG000|Overall Study|Withdrawal by Subject|3|||
128978448|NCT03742271|464207030|FG000|Overall Study|Lost to Follow-up|4|||
128978449|NCT03742271|464207030|FG000|Overall Study|Failed Insertion & removal|3|||
128978450|NCT03742271|464207030|FG000|Overall Study|Protocol Violation|1|||
128978451|NCT01624974|464207033|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
128978452|NCT01624974|464207034|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
128978453|NCT01624974|464207033|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
128978454|NCT01624974|464207034|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
128978455|NCT01624974|464207033|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
128978456|NCT01624974|464207034|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
128978457|NCT01624974|464207033|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
128978458|NCT01624974|464207034|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
128978459|NCT01624974|464207033|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
128978460|NCT01624974|464207034|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
128978461|NCT01624974|464207033|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
128978462|NCT01624974|464207034|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
128978463|NCT01624974|464207033|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
128978464|NCT01624974|464207034|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
128978465|NCT01624974|464207033|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
128978466|NCT01624974|464207034|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
128978467|NCT01624974|464207033|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
128978468|NCT01624974|464207034|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
128978469|NCT01624974|464207033|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
128978470|NCT01624974|464207034|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
128978471|NCT01624974|464207033|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
128978472|NCT01624974|464207034|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
128978473|NCT01624974|464207033|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
128978474|NCT01624974|464207034|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
128717940|NCT03662542|463265133|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
128978475|NCT01376908|464207035|FG000|Overall Study|Protocol Violation|1|||
128978476|NCT01376908|464207036|FG001|Overall Study|Protocol Violation|1|||
128978477|NCT01376908|464207035|FG000|Overall Study|Withdrawal by Subject|1|||
128978478|NCT01376908|464207036|FG001|Overall Study|Withdrawal by Subject|2|||
128978479|NCT01468844|464207037|FG000|Overall Study|Adverse Event|1|||
128978480|NCT01468844|464207038|FG001|Overall Study|Adverse Event|0|||
128978481|NCT01468844|464207037|FG000|Overall Study|Withdrawal by Subject|1|||
128978482|NCT01468844|464207038|FG001|Overall Study|Withdrawal by Subject|0|||
128978483|NCT02142712|464207039|FG000|Overall Study|Lost to Follow-up|1|||
128978484|NCT02142712|464207040|FG001|Overall Study|Lost to Follow-up|1|||
128978485|NCT02142712|464207041|FG002|Overall Study|Lost to Follow-up|1|||
128978486|NCT02142712|464207042|FG003|Overall Study|Lost to Follow-up|0|||
128978487|NCT01899729|464207043|FG000|Overall Study|Adverse Event|1|||
128978488|NCT01899729|464207044|FG001|Overall Study|Adverse Event|0|||
128978489|NCT01899729|464207045|FG002|Overall Study|Adverse Event|0|||
129222359|NCT03901469|465116072|FG006|Overall Study|Termination of study by sponsor|0|||
129222360|NCT03901469|465116066|FG000|Overall Study|Not Reported|1|||
129222361|NCT03901469|465116067|FG001|Overall Study|Not Reported|0|||
129222362|NCT03901469|465116068|FG002|Overall Study|Not Reported|0|||
129222363|NCT03901469|465116069|FG003|Overall Study|Not Reported|1|||
129222364|NCT03901469|465116070|FG004|Overall Study|Not Reported|0|||
129222365|NCT03901469|465116071|FG005|Overall Study|Not Reported|0|||
129222366|NCT03901469|465116072|FG006|Overall Study|Not Reported|1|||
129222367|NCT04776148|465116073|FG000|Overall Study|Death|249|||
129222368|NCT04776148|465116074|FG001|Overall Study|Death|260|||
128978490|NCT01899729|464207046|FG003|Overall Study|Adverse Event|0|||
128978491|NCT01899729|464207047|FG004|Overall Study|Adverse Event|1|||
128978492|NCT01899729|464207043|FG000|Overall Study|Withdrawal by Subject|1|||
128978493|NCT01899729|464207044|FG001|Overall Study|Withdrawal by Subject|2|||
128978494|NCT01899729|464207045|FG002|Overall Study|Withdrawal by Subject|0|||
128978495|NCT01899729|464207046|FG003|Overall Study|Withdrawal by Subject|0|||
129222369|NCT04776148|465116073|FG000|Overall Study|Lost to Follow-up|0|||
129222370|NCT04776148|465116074|FG001|Overall Study|Lost to Follow-up|1|||
129222371|NCT04776148|465116073|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129222372|NCT04776148|465116074|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129222373|NCT04776148|465116073|FG000|Overall Study|Withdrawal by Subject|3|||
129222374|NCT04776148|465116074|FG001|Overall Study|Withdrawal by Subject|4|||
128774791|NCT02555371|463468341|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
128774792|NCT02555371|463468342|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
128774793|NCT02555371|463468338|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
128978496|NCT01899729|464207047|FG004|Overall Study|Withdrawal by Subject|0|||
128978497|NCT01899729|464207043|FG000|Overall Study|Lack of Efficacy|0|||
128978498|NCT01899729|464207044|FG001|Overall Study|Lack of Efficacy|0|||
128978499|NCT01899729|464207045|FG002|Overall Study|Lack of Efficacy|2|||
128978500|NCT01899729|464207046|FG003|Overall Study|Lack of Efficacy|0|||
128978501|NCT01899729|464207047|FG004|Overall Study|Lack of Efficacy|1|||
128978502|NCT02853318|464207050|FG000|Overall Study|Withdrawal by Subject|1|||
128978503|NCT00252499|464207053|FG000|Overall Study|Lost to Follow-up|1|||
128978504|NCT00252499|464207054|FG001|Overall Study|Lost to Follow-up|0|||
128978505|NCT00252499|464207055|FG002|Overall Study|Lost to Follow-up|0|||
128978506|NCT02646332|464207061|FG000|Overall Study|Lost to Follow-up|0|||
128978507|NCT02646332|464207062|FG001|Overall Study|Lost to Follow-up|3|||
128978508|NCT04490499|464207063|FG000|Overall Study|Withdrawal by Subject|2|||
128978509|NCT01882439|464207064|FG000|Overall Study|Adverse event related to study drug|3|||
128978510|NCT01882439|464207065|FG001|Overall Study|Adverse event related to study drug|8|||
128978511|NCT01882439|464207066|FG002|Overall Study|Adverse event related to study drug|1|||
128978512|NCT01882439|464207067|FG003|Overall Study|Adverse event related to study drug|2|||
128978513|NCT01882439|464207064|FG000|Overall Study|Pregnancy|0|||
128978514|NCT01882439|464207065|FG001|Overall Study|Pregnancy|1|||
128978515|NCT01882439|464207066|FG002|Overall Study|Pregnancy|0|||
128978516|NCT01882439|464207067|FG003|Overall Study|Pregnancy|0|||
128978517|NCT01882439|464207064|FG000|Overall Study|Protocol Violation|2|||
129040982|NCT01258101|464442154|FG001|Overall Study|Adverse Event|6|||
129040983|NCT01258101|464442155|FG002|Overall Study|Adverse Event|0|||
129040984|NCT01258101|464442156|FG003|Overall Study|Adverse Event|0|||
129040985|NCT01258101|464442153|FG000|Overall Study|Extra exclusion criterion amended|2|||
129040986|NCT01258101|464442154|FG001|Overall Study|Extra exclusion criterion amended|1|||
129040987|NCT01258101|464442155|FG002|Overall Study|Extra exclusion criterion amended|1|||
129040988|NCT01258101|464442156|FG003|Overall Study|Extra exclusion criterion amended|1|||
129040989|NCT01258101|464442153|FG000|Overall Study|Informed consent has been withdrawn|2|||
129040990|NCT01258101|464442154|FG001|Overall Study|Informed consent has been withdrawn|2|||
129040991|NCT01258101|464442155|FG002|Overall Study|Informed consent has been withdrawn|1|||
129040992|NCT01258101|464442156|FG003|Overall Study|Informed consent has been withdrawn|1|||
129040993|NCT01258101|464442153|FG000|Overall Study|Patient is not able to attend visits|8|||
129040994|NCT01258101|464442154|FG001|Overall Study|Patient is not able to attend visits|9|||
129040995|NCT01258101|464442155|FG002|Overall Study|Patient is not able to attend visits|7|||
128978518|NCT01882439|464207065|FG001|Overall Study|Protocol Violation|2|||
129040996|NCT01258101|464442156|FG003|Overall Study|Patient is not able to attend visits|6|||
129040997|NCT01258101|464442153|FG000|Overall Study|Patient´s compliance|4|||
129040998|NCT01258101|464442154|FG001|Overall Study|Patient´s compliance|3|||
129040999|NCT01258101|464442155|FG002|Overall Study|Patient´s compliance|1|||
129041000|NCT01258101|464442156|FG003|Overall Study|Patient´s compliance|2|||
129041001|NCT01258101|464442153|FG000|Overall Study|Lost to Follow-up|5|||
129222375|NCT04776148|465116073|FG000|Overall Study|Sponsor Decision|30|||
128978519|NCT01882439|464207066|FG002|Overall Study|Protocol Violation|0|||
128978520|NCT01882439|464207067|FG003|Overall Study|Protocol Violation|1|||
129222376|NCT04776148|465116074|FG001|Overall Study|Sponsor Decision|15|||
129222377|NCT02563522|465116075|FG000|Overall Study|Adverse Event|2|||
129222378|NCT02563522|465116076|FG001|Overall Study|Adverse Event|3|||
129222379|NCT02563522|465116075|FG000|Overall Study|Lost to Follow-up|1|||
129222380|NCT02563522|465116076|FG001|Overall Study|Lost to Follow-up|0|||
128978521|NCT01882439|464207064|FG000|Overall Study|No longer willing to participate|1|||
128978522|NCT01882439|464207065|FG001|Overall Study|No longer willing to participate|4|||
128978523|NCT01882439|464207066|FG002|Overall Study|No longer willing to participate|2|||
128978524|NCT01882439|464207067|FG003|Overall Study|No longer willing to participate|3|||
128978525|NCT01882439|464207064|FG000|Overall Study|Medication error with no associated AE|0|||
128978526|NCT01882439|464207065|FG001|Overall Study|Medication error with no associated AE|0|||
128978527|NCT01882439|464207066|FG002|Overall Study|Medication error with no associated AE|2|||
128978528|NCT01882439|464207067|FG003|Overall Study|Medication error with no associated AE|0|||
128978529|NCT01882439|464207064|FG000|Overall Study|Insufficient clinical response|1|||
128978530|NCT01882439|464207065|FG001|Overall Study|Insufficient clinical response|4|||
128978531|NCT01882439|464207066|FG002|Overall Study|Insufficient clinical response|4|||
128978532|NCT01882439|464207067|FG003|Overall Study|Insufficient clinical response|2|||
128978533|NCT01882439|464207064|FG000|Overall Study|Adverse event unrelated to study drug|2|||
128978534|NCT01882439|464207065|FG001|Overall Study|Adverse event unrelated to study drug|2|||
128978535|NCT01882439|464207066|FG002|Overall Study|Adverse event unrelated to study drug|1|||
128978536|NCT01882439|464207067|FG003|Overall Study|Adverse event unrelated to study drug|1|||
128978537|NCT01997333|464207072|FG000|Randomization and Treatment|Disease Progression|70|||
128978538|NCT01997333|464207073|FG001|Randomization and Treatment|Disease Progression|159|||
128978539|NCT01997333|464207072|FG000|Randomization and Treatment|Adverse Event|10|||
128978540|NCT01997333|464207073|FG001|Randomization and Treatment|Adverse Event|32|||
128978541|NCT01997333|464207072|FG000|Randomization and Treatment|Physician Decision|0|||
128978542|NCT01997333|464207073|FG001|Randomization and Treatment|Physician Decision|4|||
128978543|NCT01997333|464207072|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
128978544|NCT01997333|464207073|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
128978545|NCT01997333|464207072|FG000|Randomization and Treatment|Did not receive treatment|17|||
128978546|NCT01997333|464207073|FG001|Randomization and Treatment|Did not receive treatment|5|||
128978547|NCT01997333|464207072|FG000|Survival Follow up|Withdrawal by Subject|15|||
128978548|NCT01997333|464207073|FG001|Survival Follow up|Withdrawal by Subject|6|||
128978549|NCT01997333|464207072|FG000|Survival Follow up|Lost to Follow-up|0|||
128978550|NCT01997333|464207073|FG001|Survival Follow up|Lost to Follow-up|6|||
128978551|NCT01997333|464207072|FG000|Survival Follow up|Various|1|||
128978552|NCT01997333|464207073|FG001|Survival Follow up|Various|2|||
128978553|NCT02269709|464207074|FG000|Time of Enrollment|Withdrawal by Subject|3|||
128978554|NCT02269709|464207074|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
128978555|NCT02269709|464207074|FG000|Six Month Follow-up|Lost to Follow-up|12|||
128978556|NCT02909504|464207075|FG000|Overall Study|Adverse Event|2|||
128978557|NCT02909504|464207075|FG000|Overall Study|Lack of Efficacy|3|||
128978558|NCT02909504|464207075|FG000|Overall Study|Withdrawal by Subject|4|||
128978559|NCT02909504|464207075|FG000|Overall Study|Pregnancy|1|||
128978560|NCT02909504|464207075|FG000|Overall Study|Subject moved|1|||
128978561|NCT02909504|464207075|FG000|Overall Study|Lost to Follow-up|1|||
128978562|NCT04411472|464207076|FG000|Overall Study|Adverse Event|5|||
128978563|NCT04411472|464207077|FG001|Overall Study|Adverse Event|10|||
128978564|NCT04411472|464207078|FG002|Overall Study|Adverse Event|1|||
128978565|NCT04411472|464207079|FG003|Overall Study|Adverse Event|0|||
128978566|NCT04411472|464207080|FG004|Overall Study|Adverse Event|0|||
128978567|NCT04411472|464207081|FG005|Overall Study|Adverse Event|0|||
128978568|NCT04411472|464207076|FG000|Overall Study|Protocol Violation|1|||
128978569|NCT04411472|464207077|FG001|Overall Study|Protocol Violation|0|||
128978570|NCT04411472|464207078|FG002|Overall Study|Protocol Violation|0|||
128978571|NCT04411472|464207079|FG003|Overall Study|Protocol Violation|0|||
128978572|NCT04411472|464207080|FG004|Overall Study|Protocol Violation|0|||
128978573|NCT04411472|464207081|FG005|Overall Study|Protocol Violation|0|||
128978574|NCT04411472|464207076|FG000|Overall Study|Withdrawal by Subject|0|||
128978575|NCT04411472|464207077|FG001|Overall Study|Withdrawal by Subject|1|||
128978576|NCT04411472|464207078|FG002|Overall Study|Withdrawal by Subject|0|||
128978577|NCT04411472|464207079|FG003|Overall Study|Withdrawal by Subject|1|||
128978578|NCT04411472|464207080|FG004|Overall Study|Withdrawal by Subject|0|||
128978579|NCT04411472|464207081|FG005|Overall Study|Withdrawal by Subject|0|||
128978580|NCT04411472|464207076|FG000|Overall Study|Physician Decision|1|||
129041002|NCT01258101|464442154|FG001|Overall Study|Lost to Follow-up|5|||
128978581|NCT04411472|464207077|FG001|Overall Study|Physician Decision|0|||
128978582|NCT04411472|464207078|FG002|Overall Study|Physician Decision|0|||
128978583|NCT04411472|464207079|FG003|Overall Study|Physician Decision|0|||
129041003|NCT01258101|464442155|FG002|Overall Study|Lost to Follow-up|0|||
128717941|NCT03662542|463265134|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
128717942|NCT03662542|463265135|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
128717943|NCT03662542|463265136|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
128717944|NCT03662542|463265137|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
128717945|NCT03662542|463265129|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
128978584|NCT04411472|464207080|FG004|Overall Study|Physician Decision|0|||
128978585|NCT04411472|464207081|FG005|Overall Study|Physician Decision|0|||
128978586|NCT04411472|464207076|FG000|Overall Study|Study terminated by sponsor|17|||
129041004|NCT01258101|464442156|FG003|Overall Study|Lost to Follow-up|6|||
129041005|NCT01258101|464442153|FG000|Overall Study|PCR positive at week 24|0|||
129041006|NCT01258101|464442154|FG001|Overall Study|PCR positive at week 24|0|||
129041007|NCT01258101|464442155|FG002|Overall Study|PCR positive at week 24|0|||
129041008|NCT01258101|464442156|FG003|Overall Study|PCR positive at week 24|1|||
129041009|NCT01258101|464442153|FG000|Overall Study|Other reason|7|||
129041010|NCT01258101|464442154|FG001|Overall Study|Other reason|8|||
129041011|NCT01258101|464442155|FG002|Overall Study|Other reason|1|||
129041012|NCT01258101|464442156|FG003|Overall Study|Other reason|8|||
129041013|NCT00303667|464442157|FG000|Overall Study|Death|0|||
129041014|NCT00303667|464442158|FG001|Overall Study|Death|4|||
129041015|NCT01807117|464442159|FG000|Overall Study|Physician Decision|2|||
129041016|NCT01807117|464442159|FG000|Overall Study|Disease diagnosis not a study disease|1|||
129041017|NCT01298778|464442160|FG000|Overall Study|Lost to Follow-up|2|||
129041018|NCT01298778|464442161|FG001|Overall Study|Lost to Follow-up|3|||
129041019|NCT01298778|464442160|FG000|Overall Study|Incorrect use of VAS|1|||
129041020|NCT01298778|464442161|FG001|Overall Study|Incorrect use of VAS|0|||
129041021|NCT01298778|464442160|FG000|Overall Study|Withdrawal by Subject|0|||
129041022|NCT01298778|464442161|FG001|Overall Study|Withdrawal by Subject|1|||
129041023|NCT01298778|464442160|FG000|Overall Study|Protocol Violation|0|||
129041024|NCT01298778|464442161|FG001|Overall Study|Protocol Violation|1|||
129041025|NCT01298778|464442160|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
129041026|NCT01298778|464442161|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
129041027|NCT04965389|464442162|FG000|Overall Study|Other reasons|1|||
129041028|NCT04965389|464442163|FG001|Overall Study|Other reasons|0|||
129041029|NCT04965389|464442164|FG002|Overall Study|Other reasons|0|||
128717946|NCT03662542|463265130|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
128717947|NCT03662542|463265131|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129041030|NCT04965389|464442165|FG003|Overall Study|Other reasons|0|||
129041031|NCT04965389|464442162|FG000|Overall Study|Participant withdrew consent|0|||
129133030|NCT00441896|464778613|FG004|Overall Study|Withdrawal by Subject|0|||
129133031|NCT00441896|464778614|FG005|Overall Study|Withdrawal by Subject|0|||
129133032|NCT00441896|464778615|FG006|Overall Study|Withdrawal by Subject|0|||
129133033|NCT00441896|464778616|FG007|Overall Study|Withdrawal by Subject|0|||
129133034|NCT00441896|464778617|FG008|Overall Study|Withdrawal by Subject|0|||
129133035|NCT00441896|464778618|FG009|Overall Study|Withdrawal by Subject|0|||
129133036|NCT00441896|464778609|FG000|Overall Study|Other|0|||
129133037|NCT00441896|464778610|FG001|Overall Study|Other|0|||
129133038|NCT00441896|464778611|FG002|Overall Study|Other|0|||
129133039|NCT00441896|464778612|FG003|Overall Study|Other|0|||
129133040|NCT00441896|464778613|FG004|Overall Study|Other|1|||
129133041|NCT00441896|464778614|FG005|Overall Study|Other|0|||
129133042|NCT00441896|464778615|FG006|Overall Study|Other|0|||
129133043|NCT00441896|464778616|FG007|Overall Study|Other|0|||
129133044|NCT00441896|464778617|FG008|Overall Study|Other|0|||
129133045|NCT00441896|464778618|FG009|Overall Study|Other|0|||
129133046|NCT03334175|464778619|FG000|Overall Study|Lost to Follow-up|0|||
129133047|NCT03334175|464778620|FG001|Overall Study|Lost to Follow-up|1|||
129133048|NCT01350973|464778621|FG000|Overall Study|Adverse Event|4|||
129133049|NCT01350973|464778622|FG001|Overall Study|Adverse Event|7|||
129133050|NCT01350973|464778623|FG002|Overall Study|Adverse Event|7|||
129133051|NCT01350973|464778621|FG000|Overall Study|Voluntary Withdrawal|2|||
129133052|NCT01350973|464778622|FG001|Overall Study|Voluntary Withdrawal|1|||
129133053|NCT01350973|464778623|FG002|Overall Study|Voluntary Withdrawal|1|||
129133054|NCT03738215|464778627|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
129133055|NCT03738215|464778628|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
129133056|NCT03738215|464778629|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
129133057|NCT03738215|464778627|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
129133058|NCT03738215|464778628|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
129133059|NCT03738215|464778629|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129133060|NCT03738215|464778627|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
128717948|NCT03662542|463265132|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
128717949|NCT03662542|463265133|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
128717950|NCT03662542|463265134|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
128717951|NCT03662542|463265135|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
128717952|NCT03662542|463265136|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
128717953|NCT03662542|463265137|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
128774794|NCT02555371|463468339|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129041032|NCT04965389|464442163|FG001|Overall Study|Participant withdrew consent|1|||
129041033|NCT04965389|464442164|FG002|Overall Study|Participant withdrew consent|0|||
129041034|NCT04965389|464442165|FG003|Overall Study|Participant withdrew consent|0|||
129041035|NCT04965389|464442162|FG000|Overall Study|Poor/Non-compliance|0|||
129133061|NCT03738215|464778628|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
129133062|NCT03738215|464778629|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
129133063|NCT03738215|464778627|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
129133064|NCT03738215|464778628|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
129041036|NCT04965389|464442163|FG001|Overall Study|Poor/Non-compliance|1|||
129041037|NCT04965389|464442164|FG002|Overall Study|Poor/Non-compliance|0|||
129041038|NCT04965389|464442165|FG003|Overall Study|Poor/Non-compliance|0|||
129041039|NCT02709486|464442168|FG000|Overall Study|Adverse Event|2|||
129041040|NCT02709486|464442169|FG001|Overall Study|Adverse Event|5|||
129041041|NCT02709486|464442170|FG002|Overall Study|Adverse Event|3|||
129041042|NCT02709486|464442168|FG000|Overall Study|Death|0|||
129041043|NCT02709486|464442169|FG001|Overall Study|Death|0|||
129041044|NCT02709486|464442170|FG002|Overall Study|Death|2|||
129041045|NCT02709486|464442168|FG000|Overall Study|Insufficient clinical response|7|||
129041046|NCT02709486|464442169|FG001|Overall Study|Insufficient clinical response|3|||
129041047|NCT02709486|464442170|FG002|Overall Study|Insufficient clinical response|3|||
129041048|NCT02709486|464442168|FG000|Overall Study|Lost to Follow-up|3|||
129041049|NCT02709486|464442169|FG001|Overall Study|Lost to Follow-up|2|||
129041050|NCT02709486|464442170|FG002|Overall Study|Lost to Follow-up|2|||
129041051|NCT02709486|464442168|FG000|Overall Study|Other|0|||
129041052|NCT02709486|464442169|FG001|Overall Study|Other|2|||
129041053|NCT02709486|464442170|FG002|Overall Study|Other|3|||
129041054|NCT02709486|464442168|FG000|Overall Study|Withdrawal by Subject|32|||
129041055|NCT02709486|464442169|FG001|Overall Study|Withdrawal by Subject|22|||
129041056|NCT02709486|464442170|FG002|Overall Study|Withdrawal by Subject|32|||
129041057|NCT02377921|464442174|FG000|Overall Study|Subject non-compliance|1|||
129041058|NCT02377921|464442175|FG001|Overall Study|Subject non-compliance|1|||
129041059|NCT00706355|464442181|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
129041060|NCT00706355|464442182|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
129041061|NCT00706355|464442183|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
129041062|NCT00706355|464442184|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
129041063|NCT00706355|464442181|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
129041064|NCT00706355|464442182|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
129133065|NCT03738215|464778629|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
129133066|NCT03738215|464778627|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
129133067|NCT03738215|464778628|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
128717954|NCT03662542|463265129|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
128717955|NCT03662542|463265130|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129041065|NCT00706355|464442183|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
129133068|NCT03738215|464778629|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
129133069|NCT03738215|464778627|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
129133070|NCT03738215|464778628|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
129133071|NCT03738215|464778629|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
129133072|NCT03738215|464778627|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
129133073|NCT03738215|464778628|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
129133074|NCT03738215|464778629|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
129133075|NCT03738215|464778627|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
129133076|NCT03738215|464778628|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
129133077|NCT03738215|464778629|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
129133078|NCT03738215|464778627|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
129133079|NCT03738215|464778628|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
129133080|NCT03738215|464778629|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
129133081|NCT03738215|464778627|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
129133082|NCT03738215|464778628|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
129133083|NCT03738215|464778629|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
129133084|NCT02638493|464778630|FG000|Overall Study|Inability to provide semen samples|2|||
129133085|NCT02638493|464778631|FG001|Overall Study|Inability to provide semen samples|0|||
129133086|NCT02638493|464778632|FG002|Overall Study|Inability to provide semen samples|0|||
129133087|NCT01033071|464778633|FG000|Overall Study|Adverse Event|28|||
129133088|NCT01033071|464778634|FG001|Overall Study|Adverse Event|51|||
129133089|NCT01033071|464778635|FG002|Overall Study|Adverse Event|26|||
129133090|NCT01033071|464778633|FG000|Overall Study|Protocol Violation|0|||
129133091|NCT01033071|464778634|FG001|Overall Study|Protocol Violation|2|||
129133092|NCT01033071|464778635|FG002|Overall Study|Protocol Violation|1|||
129133093|NCT01033071|464778633|FG000|Overall Study|Lost to Follow-up|4|||
129133094|NCT01033071|464778634|FG001|Overall Study|Lost to Follow-up|5|||
129133095|NCT01033071|464778635|FG002|Overall Study|Lost to Follow-up|5|||
129133096|NCT01033071|464778633|FG000|Overall Study|Withdrawal by Subject|17|||
129133097|NCT01033071|464778634|FG001|Overall Study|Withdrawal by Subject|14|||
128717956|NCT03662542|463265131|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129041066|NCT00706355|464442184|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
128717957|NCT03662542|463265132|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
129041067|NCT00706355|464442181|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
129041068|NCT00706355|464442182|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
129133098|NCT01033071|464778635|FG002|Overall Study|Withdrawal by Subject|11|||
129133099|NCT01033071|464778633|FG000|Overall Study|Lack of Efficacy|0|||
128978587|NCT04411472|464207077|FG001|Overall Study|Study terminated by sponsor|20|||
128978588|NCT04411472|464207078|FG002|Overall Study|Study terminated by sponsor|3|||
128978589|NCT04411472|464207079|FG003|Overall Study|Study terminated by sponsor|0|||
128978590|NCT04411472|464207080|FG004|Overall Study|Study terminated by sponsor|0|||
128978591|NCT04411472|464207081|FG005|Overall Study|Study terminated by sponsor|0|||
128978592|NCT05060003|464207083|FG000|Overall Study|ctDNA negative|7|||
128978593|NCT03969589|464207086|FG000|Overall Study|Lost to Follow-up|3|||
128978594|NCT03969589|464207087|FG001|Overall Study|Lost to Follow-up|2|||
128978595|NCT03969589|464207086|FG000|Overall Study|Declined Follow-Up|0|||
128978596|NCT03969589|464207087|FG001|Overall Study|Declined Follow-Up|1|||
128978597|NCT00517634|464207088|FG000|Second Treatment Period|Withdrawal by Subject|0|||
128978598|NCT00517634|464207089|FG001|Second Treatment Period|Withdrawal by Subject|0|||
128978599|NCT00517634|464207090|FG002|Second Treatment Period|Withdrawal by Subject|0|||
128978600|NCT00517634|464207091|FG003|Second Treatment Period|Withdrawal by Subject|0|||
128978601|NCT00517634|464207092|FG004|Second Treatment Period|Withdrawal by Subject|1|||
128978602|NCT00517634|464207093|FG005|Second Treatment Period|Withdrawal by Subject|0|||
128978603|NCT03091920|464207096|FG000|Overall Study|Adverse Event|0|||
128978604|NCT03091920|464207097|FG001|Overall Study|Adverse Event|1|||
128978605|NCT03091920|464207098|FG002|Overall Study|Adverse Event|0|||
128978606|NCT03143855|464207099|FG000|Overall Study|Withdrawal by Subject|4|||
128978607|NCT03143855|464207100|FG001|Overall Study|Withdrawal by Subject|3|||
128978608|NCT03143855|464207099|FG000|Overall Study|Protocol Violation|1|||
128978609|NCT03143855|464207100|FG001|Overall Study|Protocol Violation|0|||
128978610|NCT03143855|464207099|FG000|Overall Study|Participant experienced withdrawal|0|||
128978611|NCT03143855|464207100|FG001|Overall Study|Participant experienced withdrawal|1|||
128978612|NCT00453349|464207101|FG000|Randomized|Adverse Event|12|||
128978613|NCT00453349|464207102|FG001|Randomized|Adverse Event|11|||
128978614|NCT00453349|464207101|FG000|Randomized|Lack of Efficacy|2|||
128978615|NCT00453349|464207102|FG001|Randomized|Lack of Efficacy|1|||
128978616|NCT00453349|464207101|FG000|Randomized|Lost to Follow-up|7|||
128978617|NCT00453349|464207102|FG001|Randomized|Lost to Follow-up|5|||
128978618|NCT00453349|464207101|FG000|Randomized|Protocol Violation|1|||
128978619|NCT00453349|464207102|FG001|Randomized|Protocol Violation|1|||
128978620|NCT00453349|464207101|FG000|Randomized|Withdrawal by Subject|3|||
128978621|NCT00453349|464207102|FG001|Randomized|Withdrawal by Subject|5|||
128978622|NCT00453349|464207101|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
128978623|NCT00453349|464207102|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
128978624|NCT00453349|464207101|FG000|Completed Study|Adverse Event|12|||
128978625|NCT00453349|464207102|FG001|Completed Study|Adverse Event|11|||
128978626|NCT00453349|464207101|FG000|Completed Study|Lack of Efficacy|2|||
128978627|NCT00453349|464207102|FG001|Completed Study|Lack of Efficacy|1|||
128978628|NCT00453349|464207101|FG000|Completed Study|Lost to Follow-up|7|||
128978629|NCT00453349|464207102|FG001|Completed Study|Lost to Follow-up|5|||
128978630|NCT00453349|464207101|FG000|Completed Study|Protocol Violation|1|||
128978631|NCT00453349|464207102|FG001|Completed Study|Protocol Violation|1|||
128978632|NCT00453349|464207101|FG000|Completed Study|Withdrawal by Subject|3|||
128978633|NCT00453349|464207102|FG001|Completed Study|Withdrawal by Subject|5|||
128978634|NCT00453349|464207101|FG000|Completed Study|Lost to follow up after study treatment|2|||
128978635|NCT00453349|464207102|FG001|Completed Study|Lost to follow up after study treatment|11|||
128978636|NCT01503229|464209316|FG000|Overall Study|Withdrew consent|1|||
128978637|NCT01078389|464209317|FG000|Overall Study|Adverse Event|10|||
128978638|NCT01078389|464209318|FG001|Overall Study|Adverse Event|6|||
128978639|NCT01078389|464209317|FG000|Overall Study|Major Protocol Deviation|2|||
128978640|NCT01078389|464209318|FG001|Overall Study|Major Protocol Deviation|0|||
128978641|NCT01078389|464209317|FG000|Overall Study|Lost to Follow-up|23|||
128978642|NCT01078389|464209318|FG001|Overall Study|Lost to Follow-up|23|||
128978643|NCT01078389|464209317|FG000|Overall Study|Voluntary Withdrawal|20|||
128978644|NCT01078389|464209318|FG001|Overall Study|Voluntary Withdrawal|36|||
128978645|NCT01078389|464209317|FG000|Overall Study|Other|9|||
129041069|NCT00706355|464442183|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
129041070|NCT00706355|464442184|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
129041071|NCT00706355|464442181|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
129041072|NCT00706355|464442182|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
129041073|NCT00706355|464442183|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
129041074|NCT00706355|464442184|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
129133100|NCT01033071|464778634|FG001|Overall Study|Lack of Efficacy|1|||
129133101|NCT01033071|464778635|FG002|Overall Study|Lack of Efficacy|1|||
128978646|NCT01078389|464209318|FG001|Overall Study|Other|2|||
128978647|NCT01002573|464209319|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
128978648|NCT01002573|464209320|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
128978649|NCT02028182|464209321|FG000|Overall Study|Protocol Violation|2|||
128978650|NCT02198040|464209324|FG000|Overall Study|Work reasons|0|||
128978651|NCT02198040|464209325|FG001|Overall Study|Work reasons|1|||
128978652|NCT02198040|464209326|FG002|Overall Study|Work reasons|0|||
128978653|NCT02198040|464209324|FG000|Overall Study|Withdrawal by Subject|0|||
128978654|NCT02198040|464209325|FG001|Overall Study|Withdrawal by Subject|0|||
128978655|NCT02198040|464209326|FG002|Overall Study|Withdrawal by Subject|1|||
128978656|NCT04524663|464209327|FG000|Overall Study|Withdrawal by Subject|0|||
128978657|NCT04524663|464209328|FG001|Overall Study|Withdrawal by Subject|2|||
128978658|NCT00337935|464209329|FG000|Overall Study|Adverse Event|2|||
128978659|NCT00337935|464209330|FG001|Overall Study|Adverse Event|5|||
128978660|NCT00337935|464209329|FG000|Overall Study|Death|2|||
128978661|NCT00337935|464209330|FG001|Overall Study|Death|8|||
128978662|NCT00337935|464209329|FG000|Overall Study|Physician Decision|1|||
128978663|NCT00337935|464209330|FG001|Overall Study|Physician Decision|1|||
128978664|NCT00337935|464209329|FG000|Overall Study|Lost to Follow-up|0|||
128978665|NCT00337935|464209330|FG001|Overall Study|Lost to Follow-up|1|||
128978666|NCT00337935|464209329|FG000|Overall Study|Protocol Violation|4|||
128978667|NCT00337935|464209330|FG001|Overall Study|Protocol Violation|3|||
128978668|NCT00337935|464209329|FG000|Overall Study|Withdrawal by Subject|1|||
128978669|NCT00337935|464209330|FG001|Overall Study|Withdrawal by Subject|7|||
128978670|NCT00337935|464209329|FG000|Overall Study|Other|0|||
128978671|NCT00337935|464209330|FG001|Overall Study|Other|1|||
128978672|NCT00337935|464209329|FG000|Overall Study|Lack of Efficacy|0|||
128978673|NCT00337935|464209330|FG001|Overall Study|Lack of Efficacy|1|||
128978674|NCT01884675|464209331|FG000|Overall Study|Study closed/terminated|3|||
128978675|NCT01884675|464209332|FG001|Overall Study|Study closed/terminated|2|||
128978676|NCT02361307|464209333|FG000|Overall Study|Unstable medical condition.|0|||
128978677|NCT02361307|464209334|FG001|Overall Study|Unstable medical condition.|1|||
128978678|NCT00711009|464209335|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
128978679|NCT00711009|464209336|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
128978680|NCT00711009|464209335|FG000|Overall Study|Withdrawal by Subject|4|||
128978681|NCT00711009|464209336|FG001|Overall Study|Withdrawal by Subject|2|||
128978682|NCT00711009|464209335|FG000|Overall Study|Lost to Follow-up|3|||
128978683|NCT00711009|464209336|FG001|Overall Study|Lost to Follow-up|9|||
128978684|NCT00711009|464209335|FG000|Overall Study|Participant Noncompliant|0|||
128978685|NCT00711009|464209336|FG001|Overall Study|Participant Noncompliant|1|||
128978686|NCT00711009|464209335|FG000|Overall Study|Virologic Failure|2|||
128978687|NCT00711009|464209336|FG001|Overall Study|Virologic Failure|1|||
128978688|NCT00711009|464209335|FG000|Overall Study|Pregnancy|1|||
128978689|NCT00711009|464209336|FG001|Overall Study|Pregnancy|0|||
128978690|NCT00711009|464209335|FG000|Overall Study|Site closing|0|||
128978691|NCT00711009|464209336|FG001|Overall Study|Site closing|1|||
128978692|NCT00711009|464209335|FG000|Overall Study|Dose adjustment|1|||
128978693|NCT00711009|464209336|FG001|Overall Study|Dose adjustment|0|||
128978694|NCT03359811|464209337|FG000|Overall Study|Protocol Violation|2|||
128978695|NCT03359811|464209338|FG001|Overall Study|Protocol Violation|0|||
128978696|NCT01682876|464209339|FG000|Overall Study|Administrative reason|4|||
128978697|NCT01682876|464209340|FG001|Overall Study|Administrative reason|4|||
128978698|NCT01682876|464209341|FG002|Overall Study|Administrative reason|0|||
128978699|NCT01682876|464209342|FG003|Overall Study|Administrative reason|3|||
128978700|NCT01682876|464209339|FG000|Overall Study|Adverse Event|0|||
128978701|NCT01682876|464209340|FG001|Overall Study|Adverse Event|0|||
128978702|NCT01682876|464209341|FG002|Overall Study|Adverse Event|0|||
128978703|NCT01682876|464209342|FG003|Overall Study|Adverse Event|1|||
128978704|NCT01682876|464209339|FG000|Overall Study|Lost to Follow-up|11|||
128978705|NCT01682876|464209340|FG001|Overall Study|Lost to Follow-up|15|||
128978706|NCT01682876|464209341|FG002|Overall Study|Lost to Follow-up|9|||
128978707|NCT01682876|464209342|FG003|Overall Study|Lost to Follow-up|11|||
128978708|NCT01682876|464209339|FG000|Overall Study|Protocol Violation|1|||
128978709|NCT01682876|464209340|FG001|Overall Study|Protocol Violation|1|||
128978710|NCT01682876|464209341|FG002|Overall Study|Protocol Violation|1|||
128978711|NCT01682876|464209342|FG003|Overall Study|Protocol Violation|1|||
128978712|NCT01682876|464209339|FG000|Overall Study|Withdrawal by Subject|4|||
128978713|NCT01682876|464209340|FG001|Overall Study|Withdrawal by Subject|0|||
128978714|NCT01682876|464209341|FG002|Overall Study|Withdrawal by Subject|0|||
128978715|NCT01682876|464209342|FG003|Overall Study|Withdrawal by Subject|2|||
128978716|NCT01682876|464209339|FG000|Overall Study|Other|1|||
128978717|NCT01682876|464209340|FG001|Overall Study|Other|0|||
128978718|NCT01682876|464209341|FG002|Overall Study|Other|1|||
128978719|NCT01682876|464209342|FG003|Overall Study|Other|1|||
128978720|NCT02534324|464209344|FG000|Overall Study|Protocol Violation|4|||
128978721|NCT02534324|464209345|FG001|Overall Study|Protocol Violation|1|||
128978722|NCT02534324|464209344|FG000|Overall Study|Lost to Follow-up|20|||
128978723|NCT02534324|464209345|FG001|Overall Study|Lost to Follow-up|7|||
128978724|NCT02534324|464209344|FG000|Overall Study|Adverse Event|1|||
128978725|NCT02534324|464209345|FG001|Overall Study|Adverse Event|0|||
128978726|NCT01459016|464209348|FG000|Overall Study|Withdrawal by Subject|11|||
128978727|NCT01459016|464209348|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
128978728|NCT00303602|464209352|FG000|Overall Study|Adverse Event|2|||
128978729|NCT00303602|464209353|FG001|Overall Study|Adverse Event|2|||
128978730|NCT00303602|464209352|FG000|Overall Study|Withdrawal by Subject|5|||
128978731|NCT00303602|464209353|FG001|Overall Study|Withdrawal by Subject|6|||
128978732|NCT00303602|464209352|FG000|Overall Study|Lost to Follow-up|5|||
128978733|NCT00303602|464209353|FG001|Overall Study|Lost to Follow-up|2|||
129041075|NCT00706355|464442181|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
129041076|NCT00706355|464442182|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
129041077|NCT00706355|464442183|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
129041078|NCT00706355|464442184|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
129041079|NCT00706355|464442181|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
129041080|NCT00706355|464442182|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
129041081|NCT00706355|464442183|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
129041082|NCT00706355|464442184|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
129041083|NCT00706355|464442181|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
129041084|NCT00706355|464442182|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
129041085|NCT00706355|464442183|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
129041086|NCT00706355|464442184|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
129041087|NCT00706355|464442181|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
129041088|NCT00706355|464442182|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
129041089|NCT00706355|464442183|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
129041090|NCT00706355|464442184|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
129041091|NCT00706355|464442181|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
129041092|NCT00706355|464442182|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
129041093|NCT00706355|464442183|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
129041094|NCT00706355|464442184|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
129041095|NCT02139124|464442187|FG000|Overall Study|Adverse Event|2|||
129041096|NCT02139124|464442188|FG001|Overall Study|Adverse Event|0|||
129041097|NCT02139124|464442189|FG002|Overall Study|Adverse Event|1|||
129041098|NCT02139124|464442190|FG003|Overall Study|Adverse Event|2|||
129041099|NCT02139124|464442191|FG004|Overall Study|Adverse Event|5|||
129041100|NCT02139124|464442187|FG000|Overall Study|Withdrawal by Subject|2|||
129041101|NCT02139124|464442188|FG001|Overall Study|Withdrawal by Subject|2|||
129041102|NCT02139124|464442189|FG002|Overall Study|Withdrawal by Subject|2|||
129041103|NCT02139124|464442190|FG003|Overall Study|Withdrawal by Subject|2|||
129041104|NCT02139124|464442191|FG004|Overall Study|Withdrawal by Subject|3|||
129041105|NCT02139124|464442187|FG000|Overall Study|Protocol Violation|0|||
129041106|NCT02139124|464442188|FG001|Overall Study|Protocol Violation|0|||
129041107|NCT02139124|464442189|FG002|Overall Study|Protocol Violation|0|||
129041108|NCT02139124|464442190|FG003|Overall Study|Protocol Violation|1|||
129041109|NCT02139124|464442191|FG004|Overall Study|Protocol Violation|1|||
129041110|NCT02139124|464442187|FG000|Overall Study|non-compliant|1|||
129041111|NCT02139124|464442188|FG001|Overall Study|non-compliant|0|||
129041112|NCT02139124|464442189|FG002|Overall Study|non-compliant|0|||
129041113|NCT02139124|464442190|FG003|Overall Study|non-compliant|2|||
129041114|NCT02139124|464442191|FG004|Overall Study|non-compliant|0|||
129041115|NCT02139124|464442187|FG000|Overall Study|incarceration|0|||
129041116|NCT02139124|464442188|FG001|Overall Study|incarceration|0|||
129041117|NCT02139124|464442189|FG002|Overall Study|incarceration|1|||
129041118|NCT02139124|464442190|FG003|Overall Study|incarceration|0|||
129041119|NCT02139124|464442191|FG004|Overall Study|incarceration|0|||
129041120|NCT02139124|464442187|FG000|Overall Study|subject moved|1|||
129041121|NCT02139124|464442188|FG001|Overall Study|subject moved|0|||
129041122|NCT02139124|464442189|FG002|Overall Study|subject moved|0|||
129041123|NCT02139124|464442190|FG003|Overall Study|subject moved|0|||
129041124|NCT02139124|464442191|FG004|Overall Study|subject moved|0|||
129041125|NCT02139124|464442187|FG000|Overall Study|Lost to Follow-up|3|||
129041126|NCT02139124|464442188|FG001|Overall Study|Lost to Follow-up|2|||
129041127|NCT02139124|464442189|FG002|Overall Study|Lost to Follow-up|0|||
128717958|NCT03662542|463265133|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
128717959|NCT03662542|463265134|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
128717960|NCT03662542|463265135|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
128717961|NCT03662542|463265136|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
128717962|NCT03662542|463265137|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
128717963|NCT03662542|463265129|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
128717964|NCT03662542|463265130|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
128717965|NCT03662542|463265131|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
128717966|NCT03662542|463265132|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
128717967|NCT03662542|463265133|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
128717968|NCT03662542|463265134|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
129041128|NCT02139124|464442190|FG003|Overall Study|Lost to Follow-up|5|||
129041129|NCT02139124|464442191|FG004|Overall Study|Lost to Follow-up|4|||
129041130|NCT03465436|464442192|FG000|Period 1|Protocol Violation|0|||
129041131|NCT03465436|464442193|FG001|Period 1|Protocol Violation|0|||
129041132|NCT03465436|464442194|FG002|Period 1|Protocol Violation|1|||
129041133|NCT03465436|464442195|FG003|Period 1|Protocol Violation|0|||
129041134|NCT03465436|464442192|FG000|Period 2|Protocol Violation|0|||
129041135|NCT03465436|464442193|FG001|Period 2|Protocol Violation|1|||
129041136|NCT03465436|464442194|FG002|Period 2|Protocol Violation|0|||
129133102|NCT01033071|464778633|FG000|Overall Study|Other|6|||
129133103|NCT01033071|464778634|FG001|Overall Study|Other|4|||
129133104|NCT01033071|464778635|FG002|Overall Study|Other|3|||
129133105|NCT01695772|464778639|FG000|Overall Study|Withdrawal by Subject|18|||
129133106|NCT01695772|464778639|FG000|Overall Study|Progressive Disease|8|||
129133107|NCT01695772|464778639|FG000|Overall Study|Investigator Decision|5|||
129133108|NCT01695772|464778639|FG000|Overall Study|Lost to Follow-up|4|||
129133109|NCT01695772|464778639|FG000|Overall Study|Protocol Violation|2|||
129133110|NCT01695772|464778639|FG000|Overall Study|Unspecified Reason|1|||
129133111|NCT00004859|464778643|FG000|Overall Study|Lack of Efficacy|43|||
129133112|NCT00004859|464778644|FG001|Overall Study|Lack of Efficacy|113|||
129133113|NCT00004859|464778643|FG000|Overall Study|Adverse Event|31|||
129133114|NCT00004859|464778644|FG001|Overall Study|Adverse Event|93|||
129133115|NCT00004859|464778643|FG000|Overall Study|Death|5|||
129133116|NCT00004859|464778644|FG001|Overall Study|Death|5|||
129133117|NCT00004859|464778643|FG000|Overall Study|Withdrawal by Subject|7|||
129133118|NCT00004859|464778644|FG001|Overall Study|Withdrawal by Subject|33|||
129133119|NCT00004859|464778643|FG000|Overall Study|Protocol Violation|2|||
129133120|NCT00004859|464778644|FG001|Overall Study|Protocol Violation|2|||
129133121|NCT00004859|464778643|FG000|Overall Study|other disease|0|||
129133122|NCT00004859|464778644|FG001|Overall Study|other disease|3|||
129133123|NCT00004859|464778643|FG000|Overall Study|error|3|||
129133124|NCT00004859|464778644|FG001|Overall Study|error|1|||
129133125|NCT00004859|464778643|FG000|Overall Study|missing data|14|||
129133126|NCT00004859|464778644|FG001|Overall Study|missing data|11|||
129133127|NCT00004859|464778643|FG000|Overall Study|Other|13|||
129133128|NCT00004859|464778644|FG001|Overall Study|Other|21|||
129133129|NCT04073407|464778645|FG000|Part 1|Withdrawal by Subject|1|||
129133130|NCT04073407|464778646|FG001|Part 1|Withdrawal by Subject|0|||
129133131|NCT04073407|464778645|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
129133132|NCT04073407|464778646|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
129133133|NCT04073407|464778645|FG000|Part 2|Withdrawal by Subject|0|||
129133134|NCT04073407|464778646|FG001|Part 2|Withdrawal by Subject|1|||
129133135|NCT04941898|464781224|FG000|Overall Study|Protocol Violation|1|||
129133136|NCT02724644|464781225|FG000|Overall Study|Adverse Event|7|||
129133137|NCT02724644|464781226|FG001|Overall Study|Adverse Event|1|||
129133138|NCT02724644|464781225|FG000|Overall Study|Lost to Follow-up|6|||
129133139|NCT02724644|464781226|FG001|Overall Study|Lost to Follow-up|2|||
129133140|NCT02724644|464781225|FG000|Overall Study|Withdrawal by Subject|7|||
129222381|NCT02563522|465116075|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
129222382|NCT02563522|465116076|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
129222383|NCT02960893|465116080|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
129222384|NCT02960893|465116081|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
129222385|NCT02960893|465116082|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
129222386|NCT02960893|465116083|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
129222387|NCT02960893|465116080|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
129222388|NCT02960893|465116081|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
129222389|NCT02960893|465116082|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
129222390|NCT02960893|465116083|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
129222391|NCT02960893|465116080|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
129222392|NCT02960893|465116081|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
129222393|NCT02960893|465116082|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
129222394|NCT02960893|465116083|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
128717969|NCT03662542|463265135|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
128717970|NCT03662542|463265136|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
128717971|NCT03662542|463265137|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
128717972|NCT03662542|463265129|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
128717973|NCT03662542|463265130|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
128717974|NCT03662542|463265131|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
128717975|NCT03662542|463265132|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
128717976|NCT03662542|463265133|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
128717977|NCT03662542|463265134|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
128717978|NCT03662542|463265135|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
128717979|NCT03662542|463265136|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
128717980|NCT03662542|463265137|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
128774795|NCT02555371|463468340|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129133141|NCT02724644|464781226|FG001|Overall Study|Withdrawal by Subject|1|||
129133142|NCT02724644|464781225|FG000|Overall Study|Administrative|1|||
129133143|NCT02724644|464781226|FG001|Overall Study|Administrative|0|||
129133144|NCT03022630|464781227|FG000|Overall Study|Death|9|||
129133145|NCT03022630|464781228|FG001|Overall Study|Death|7|||
129133146|NCT03022630|464781227|FG000|Overall Study|Withdrawal by Subject|0|||
129133147|NCT03022630|464781228|FG001|Overall Study|Withdrawal by Subject|5|||
129222395|NCT02960893|465116080|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
129041137|NCT03465436|464442195|FG003|Period 2|Protocol Violation|0|||
129041138|NCT03465436|464442192|FG000|Period 3|Protocol Violation|1|||
129041139|NCT03465436|464442193|FG001|Period 3|Protocol Violation|1|||
129041140|NCT03465436|464442194|FG002|Period 3|Protocol Violation|0|||
129041141|NCT03465436|464442195|FG003|Period 3|Protocol Violation|0|||
129041142|NCT03465436|464442192|FG000|Period 4|Protocol Violation|0|||
129041143|NCT03465436|464442193|FG001|Period 4|Protocol Violation|0|||
129041144|NCT03465436|464442194|FG002|Period 4|Protocol Violation|1|||
129041145|NCT03465436|464442195|FG003|Period 4|Protocol Violation|0|||
129041146|NCT02813421|464444164|FG000|Overall Study|Withdrawal by Subject|1|||
129041147|NCT02813421|464444165|FG001|Overall Study|Withdrawal by Subject|2|||
129041148|NCT02813421|464444164|FG000|Overall Study|Lost to Follow-up|1|||
129041149|NCT02813421|464444165|FG001|Overall Study|Lost to Follow-up|1|||
129041150|NCT00706095|464444174|FG000|Overall Study|Progressive Disease|4|||
129041151|NCT00706095|464444175|FG001|Overall Study|Progressive Disease|5|||
129041152|NCT00706095|464444176|FG002|Overall Study|Progressive Disease|3|||
129041153|NCT00706095|464444174|FG000|Overall Study|Clinical Progression|1|||
129041154|NCT00706095|464444175|FG001|Overall Study|Clinical Progression|2|||
129041155|NCT00706095|464444176|FG002|Overall Study|Clinical Progression|2|||
129041156|NCT00706095|464444174|FG000|Overall Study|Withdrawal by Subject|1|||
129041157|NCT00706095|464444175|FG001|Overall Study|Withdrawal by Subject|0|||
129041158|NCT00706095|464444176|FG002|Overall Study|Withdrawal by Subject|0|||
129041159|NCT00856830|464444177|FG000|Irinotecan & Bendamustine|Death|0|||
129041160|NCT00856830|464444178|FG001|Irinotecan & Bendamustine|Death|0|||
129041161|NCT00856830|464444179|FG002|Irinotecan & Bendamustine|Death|0|||
129041162|NCT00856830|464444180|FG003|Irinotecan & Bendamustine|Death|2|||
129041163|NCT00856830|464444177|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
129041164|NCT00856830|464444178|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
129041165|NCT00856830|464444179|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
129041166|NCT00856830|464444180|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
129041167|NCT00918463|464444181|FG000|Overall Study|Death|1|||
129041168|NCT00918463|464444181|FG000|Overall Study|Lack of Efficacy|1|||
129041169|NCT01014624|464444186|FG000|Overall Study|Adverse Event|0|||
129041170|NCT01014624|464444187|FG001|Overall Study|Adverse Event|1|||
129041171|NCT01014624|464444186|FG000|Overall Study|Protocol Violation|1|||
129041172|NCT01014624|464444187|FG001|Overall Study|Protocol Violation|0|||
129041173|NCT01014624|464444186|FG000|Overall Study|Withdrawal by Subject|1|||
129041174|NCT01014624|464444187|FG001|Overall Study|Withdrawal by Subject|0|||
129041175|NCT02954159|464444188|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
129041176|NCT02954159|464444189|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
129041177|NCT02954159|464444188|FG000|Overall Study|Withdrawal by Subject|0|||
129041178|NCT02954159|464444189|FG001|Overall Study|Withdrawal by Subject|1|||
129041179|NCT01117337|464444193|FG000|Overall Study|Lost to Follow-up|4|||
129041180|NCT01117337|464444194|FG001|Overall Study|Lost to Follow-up|0|||
129041181|NCT03575871|464444195|FG000|Overall Study|Adverse Event|5|||
129041182|NCT03575871|464444196|FG001|Overall Study|Adverse Event|5|||
129041183|NCT03575871|464444197|FG002|Overall Study|Adverse Event|8|||
129041184|NCT03575871|464444195|FG000|Overall Study|Death|1|||
129041185|NCT03575871|464444196|FG001|Overall Study|Death|0|||
129041186|NCT03575871|464444197|FG002|Overall Study|Death|0|||
129041187|NCT03575871|464444195|FG000|Overall Study|Lack of Efficacy|5|||
128717981|NCT03662542|463265129|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
128717982|NCT03662542|463265130|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
128717983|NCT03662542|463265131|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129041188|NCT03575871|464444196|FG001|Overall Study|Lack of Efficacy|4|||
129041189|NCT03575871|464444197|FG002|Overall Study|Lack of Efficacy|7|||
129041190|NCT03575871|464444195|FG000|Overall Study|Lost to Follow-up|1|||
129041191|NCT03575871|464444196|FG001|Overall Study|Lost to Follow-up|1|||
129041192|NCT03575871|464444197|FG002|Overall Study|Lost to Follow-up|1|||
129041193|NCT03575871|464444195|FG000|Overall Study|Protocol Deviation|1|||
129041194|NCT03575871|464444196|FG001|Overall Study|Protocol Deviation|1|||
129041195|NCT03575871|464444197|FG002|Overall Study|Protocol Deviation|1|||
129041196|NCT03575871|464444195|FG000|Overall Study|Withdrawal by Subject|6|||
129041197|NCT03575871|464444196|FG001|Overall Study|Withdrawal by Subject|1|||
129041198|NCT03575871|464444197|FG002|Overall Study|Withdrawal by Subject|9|||
129041199|NCT03575871|464444195|FG000|Overall Study|Other than specified|2|||
128717984|NCT03662542|463265132|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129041200|NCT03575871|464444196|FG001|Overall Study|Other than specified|2|||
129041201|NCT03575871|464444197|FG002|Overall Study|Other than specified|0|||
129041202|NCT01744093|464444201|FG000|Overall Study|Withdrawal by Subject|6|||
129041203|NCT01744093|464444202|FG001|Overall Study|Withdrawal by Subject|1|||
129041204|NCT01570283|464444203|FG000|Cohort 1: Dose Level 1|Death|0|||
129041205|NCT01570283|464444204|FG001|Cohort 1: Dose Level 1|Death|1|||
129041206|NCT01570283|464444205|FG002|Cohort 1: Dose Level 1|Death|0|||
129133148|NCT00884949|464781229|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
129133149|NCT00884949|464781229|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
129041207|NCT01570283|464444206|FG003|Cohort 1: Dose Level 1|Death|0|||
129041208|NCT01570283|464444207|FG004|Cohort 1: Dose Level 1|Death|0|||
128978734|NCT00303602|464209352|FG000|Overall Study|Protocol entry criteria not met|2|||
128978735|NCT00303602|464209353|FG001|Overall Study|Protocol entry criteria not met|2|||
128978736|NCT00303602|464209352|FG000|Overall Study|Physician Decision|2|||
128978737|NCT00303602|464209353|FG001|Overall Study|Physician Decision|1|||
128978738|NCT00303602|464209352|FG000|Overall Study|Noncompliance|2|||
128978739|NCT00303602|464209353|FG001|Overall Study|Noncompliance|2|||
128978740|NCT00303602|464209352|FG000|Overall Study|Protocol Violation|1|||
128978741|NCT00303602|464209353|FG001|Overall Study|Protocol Violation|0|||
128978742|NCT00240331|464209356|FG000|Overall Study|Withdrawal by Subject|125|||
128978743|NCT00240331|464209357|FG001|Overall Study|Withdrawal by Subject|132|||
128978744|NCT00240331|464209356|FG000|Overall Study|Option selected by investigator|1|||
128978745|NCT00240331|464209357|FG001|Overall Study|Option selected by investigator|2|||
128978746|NCT00313716|464209360|FG000|Overall Study|Death|3|||
128978747|NCT00313716|464209361|FG001|Overall Study|Death|2|||
128978748|NCT00313716|464209362|FG002|Overall Study|Death|9|||
128978749|NCT00313716|464209363|FG003|Overall Study|Death|3|||
128978750|NCT00313716|464209364|FG004|Overall Study|Death|5|||
128978751|NCT00313716|464209365|FG005|Overall Study|Death|9|||
128978752|NCT00313716|464209360|FG000|Overall Study|Lost to Follow-up|2|||
128978753|NCT00313716|464209361|FG001|Overall Study|Lost to Follow-up|5|||
128978754|NCT00313716|464209362|FG002|Overall Study|Lost to Follow-up|2|||
128978755|NCT00313716|464209363|FG003|Overall Study|Lost to Follow-up|1|||
128978756|NCT00313716|464209364|FG004|Overall Study|Lost to Follow-up|0|||
128978757|NCT00313716|464209365|FG005|Overall Study|Lost to Follow-up|4|||
128978758|NCT00313716|464209360|FG000|Overall Study|Withdrawal by Subject|0|||
128978759|NCT00313716|464209361|FG001|Overall Study|Withdrawal by Subject|1|||
128978760|NCT00313716|464209362|FG002|Overall Study|Withdrawal by Subject|1|||
128978761|NCT00313716|464209363|FG003|Overall Study|Withdrawal by Subject|0|||
128978762|NCT00313716|464209364|FG004|Overall Study|Withdrawal by Subject|1|||
128978763|NCT00313716|464209365|FG005|Overall Study|Withdrawal by Subject|0|||
128978764|NCT02491463|464209366|FG000|Overall Study|Withdrawal by Subject|1|||
128978765|NCT02491463|464209367|FG001|Overall Study|Withdrawal by Subject|2|||
128978766|NCT02491463|464209368|FG002|Overall Study|Withdrawal by Subject|0|||
128978767|NCT02491463|464209369|FG003|Overall Study|Withdrawal by Subject|0|||
128978768|NCT02491463|464209366|FG000|Overall Study|Migrated/moved from study area|1|||
128978769|NCT02491463|464209367|FG001|Overall Study|Migrated/moved from study area|5|||
128978770|NCT02491463|464209368|FG002|Overall Study|Migrated/moved from study area|1|||
128978771|NCT02491463|464209369|FG003|Overall Study|Migrated/moved from study area|1|||
128978772|NCT02491463|464209366|FG000|Overall Study|Lost to Follow-up|0|||
128978773|NCT02491463|464209367|FG001|Overall Study|Lost to Follow-up|3|||
128978774|NCT02491463|464209368|FG002|Overall Study|Lost to Follow-up|3|||
128978775|NCT02491463|464209369|FG003|Overall Study|Lost to Follow-up|0|||
128978776|NCT01491802|464209370|FG000|Overall Study|Adverse Event|1|||
128978777|NCT01491802|464209371|FG001|Overall Study|Adverse Event|1|||
128978778|NCT01491802|464209370|FG000|Overall Study|Withdrawal by Subject|0|||
128978779|NCT01491802|464209371|FG001|Overall Study|Withdrawal by Subject|1|||
128978780|NCT00663208|464209374|FG000|Treatment Period|Lost to Follow-up|0|||
128978781|NCT00663208|464209375|FG001|Treatment Period|Lost to Follow-up|1|||
128978782|NCT00663208|464209376|FG002|Treatment Period|Lost to Follow-up|0|||
128978783|NCT00663208|464209377|FG003|Treatment Period|Lost to Follow-up|0|||
128978784|NCT00663208|464209378|FG004|Treatment Period|Lost to Follow-up|0|||
128978785|NCT00663208|464209379|FG005|Treatment Period|Lost to Follow-up|0|||
128978786|NCT00663208|464209380|FG006|Treatment Period|Lost to Follow-up|0|||
128978787|NCT00663208|464209374|FG000|Follow-up Period|Lost to Follow-up|2|||
128978788|NCT00663208|464209375|FG001|Follow-up Period|Lost to Follow-up|0|||
128978789|NCT00663208|464209376|FG002|Follow-up Period|Lost to Follow-up|3|||
128978790|NCT00663208|464209377|FG003|Follow-up Period|Lost to Follow-up|2|||
128978791|NCT00663208|464209378|FG004|Follow-up Period|Lost to Follow-up|0|||
128978792|NCT00663208|464209379|FG005|Follow-up Period|Lost to Follow-up|0|||
128978793|NCT00663208|464209380|FG006|Follow-up Period|Lost to Follow-up|0|||
128978794|NCT00663208|464209374|FG000|Follow-up Period|Other reason|1|||
128978795|NCT00663208|464209375|FG001|Follow-up Period|Other reason|0|||
128978796|NCT00663208|464209376|FG002|Follow-up Period|Other reason|0|||
128978797|NCT00663208|464209377|FG003|Follow-up Period|Other reason|0|||
128978798|NCT00663208|464209378|FG004|Follow-up Period|Other reason|0|||
128978799|NCT00663208|464209379|FG005|Follow-up Period|Other reason|0|||
129041209|NCT01570283|464444208|FG005|Cohort 1: Dose Level 1|Death|0|||
129041210|NCT01570283|464444203|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129041211|NCT01570283|464444204|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
128978800|NCT00663208|464209380|FG006|Follow-up Period|Other reason|1|||
128978801|NCT01249404|464209382|FG000|Overall Study|Study treatment not received|0|||
128978802|NCT01249404|464209383|FG001|Overall Study|Study treatment not received|1|||
128978803|NCT01249404|464209384|FG002|Overall Study|Study treatment not received|2|||
128978804|NCT01249404|464209382|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
128978805|NCT01249404|464209383|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
128978806|NCT01249404|464209384|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
129041212|NCT01570283|464444205|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129041213|NCT01570283|464444206|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129041214|NCT01570283|464444207|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129041215|NCT01570283|464444208|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129041216|NCT01570283|464444203|FG000|Cohort 2: Dose Level 2|Death|0|||
129041217|NCT01570283|464444204|FG001|Cohort 2: Dose Level 2|Death|0|||
129041218|NCT01570283|464444205|FG002|Cohort 2: Dose Level 2|Death|1|||
129041219|NCT01570283|464444206|FG003|Cohort 2: Dose Level 2|Death|0|||
129041220|NCT01570283|464444207|FG004|Cohort 2: Dose Level 2|Death|0|||
129041221|NCT01570283|464444208|FG005|Cohort 2: Dose Level 2|Death|0|||
129041222|NCT01570283|464444203|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129041223|NCT01570283|464444204|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129041224|NCT01570283|464444205|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129041225|NCT01570283|464444206|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
129041226|NCT01570283|464444207|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129041227|NCT01570283|464444208|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129041228|NCT01570283|464444203|FG000|Cohort 3: Dose Level 3|Death|0|||
129041229|NCT01570283|464444204|FG001|Cohort 3: Dose Level 3|Death|0|||
129041230|NCT01570283|464444205|FG002|Cohort 3: Dose Level 3|Death|0|||
129041231|NCT01570283|464444206|FG003|Cohort 3: Dose Level 3|Death|0|||
129041232|NCT01570283|464444207|FG004|Cohort 3: Dose Level 3|Death|0|||
129041233|NCT01570283|464444208|FG005|Cohort 3: Dose Level 3|Death|1|||
129041234|NCT01570283|464444203|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129041235|NCT01570283|464444204|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129041236|NCT01570283|464444205|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129041237|NCT01570283|464444206|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129041238|NCT01570283|464444207|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129041239|NCT01570283|464444208|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
129041240|NCT01173471|464444211|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129041241|NCT01173471|464444212|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129041242|NCT01173471|464444213|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129041243|NCT01173471|464444214|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129041244|NCT01173471|464444211|FG000|Overall Study|Condition under investigation worsened|2|||
129041245|NCT01173471|464444212|FG001|Overall Study|Condition under investigation worsened|0|||
129041246|NCT01173471|464444213|FG002|Overall Study|Condition under investigation worsened|0|||
129041247|NCT01173471|464444214|FG003|Overall Study|Condition under investigation worsened|0|||
129041248|NCT01173471|464444211|FG000|Overall Study|Lost to Follow-up|0|||
129041249|NCT01173471|464444212|FG001|Overall Study|Lost to Follow-up|0|||
129041250|NCT01173471|464444213|FG002|Overall Study|Lost to Follow-up|1|||
129041251|NCT01173471|464444214|FG003|Overall Study|Lost to Follow-up|0|||
129041252|NCT01173471|464444211|FG000|Overall Study|Reason given as Other|0|||
129041253|NCT01173471|464444212|FG001|Overall Study|Reason given as Other|0|||
129041254|NCT01173471|464444213|FG002|Overall Study|Reason given as Other|1|||
129041255|NCT01173471|464444214|FG003|Overall Study|Reason given as Other|0|||
129041256|NCT03028740|464444215|FG000|Overall Study|Did not Receive Study Drug|4|||
129041257|NCT03028740|464444216|FG001|Overall Study|Did not Receive Study Drug|5|||
129041258|NCT03028740|464444215|FG000|Overall Study|Adverse Event|8|||
129041259|NCT03028740|464444216|FG001|Overall Study|Adverse Event|26|||
129041260|NCT03028740|464444215|FG000|Overall Study|Lack of Efficacy|0|||
129041261|NCT03028740|464444216|FG001|Overall Study|Lack of Efficacy|1|||
129041262|NCT03028740|464444215|FG000|Overall Study|Withdrawal by Subject|48|||
129041263|NCT03028740|464444216|FG001|Overall Study|Withdrawal by Subject|101|||
129041264|NCT03028740|464444215|FG000|Overall Study|Lost to Follow-up|30|||
129041265|NCT03028740|464444216|FG001|Overall Study|Lost to Follow-up|54|||
129041266|NCT03028740|464444215|FG000|Overall Study|Physician Decision|4|||
129041267|NCT03028740|464444216|FG001|Overall Study|Physician Decision|11|||
129133150|NCT01567085|464781232|FG000|Overall Study|Death|6|||
128717985|NCT03662542|463265133|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
128717986|NCT03662542|463265134|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
128717987|NCT03662542|463265135|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
128717988|NCT03662542|463265136|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129041268|NCT03028740|464444215|FG000|Overall Study|Protocol Violation|4|||
129041269|NCT03028740|464444216|FG001|Overall Study|Protocol Violation|8|||
129041270|NCT03028740|464444215|FG000|Overall Study|Non-compliance with Study Drug|0|||
129041271|NCT03028740|464444216|FG001|Overall Study|Non-compliance with Study Drug|2|||
129041272|NCT03028740|464444215|FG000|Overall Study|Study Terminated by Sponsor|467|||
129133151|NCT01567085|464781232|FG000|Overall Study|Adverse Event|6|||
129133152|NCT01567085|464781232|FG000|Overall Study|Lost to Follow-up|3|||
129041273|NCT03028740|464444216|FG001|Overall Study|Study Terminated by Sponsor|917|||
129041274|NCT03028740|464444215|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
129041275|NCT03028740|464444216|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
129041276|NCT03028740|464444215|FG000|Overall Study|Reason not Specified|1|||
129133153|NCT01567085|464781232|FG000|Overall Study|Graft loss|2|||
128717989|NCT03662542|463265137|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
128978807|NCT01249404|464209382|FG000|Overall Study|Adverse Event|2|||
128978808|NCT01249404|464209383|FG001|Overall Study|Adverse Event|2|||
128978809|NCT01249404|464209384|FG002|Overall Study|Adverse Event|2|||
128978810|NCT01249404|464209382|FG000|Overall Study|Withdrawal by Subject|2|||
128978811|NCT01249404|464209383|FG001|Overall Study|Withdrawal by Subject|2|||
128978812|NCT01249404|464209384|FG002|Overall Study|Withdrawal by Subject|0|||
128978813|NCT01249404|464209382|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
128978814|NCT01249404|464209383|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
128978815|NCT01249404|464209384|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
128978816|NCT01249404|464209382|FG000|Overall Study|Non compliance to visit schedule|0|||
128978817|NCT01249404|464209383|FG001|Overall Study|Non compliance to visit schedule|1|||
128978818|NCT01249404|464209384|FG002|Overall Study|Non compliance to visit schedule|0|||
128978819|NCT04563845|464209385|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978820|NCT04563845|464209386|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978821|NCT04563845|464209387|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978822|NCT04563845|464209388|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978823|NCT04563845|464209389|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978824|NCT04563845|464209390|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978825|NCT04563845|464209391|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978826|NCT04563845|464209392|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
128978827|NCT04563845|464209393|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978828|NCT04563845|464209394|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978829|NCT04563845|464209395|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978830|NCT04563845|464209396|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978831|NCT04563845|464209397|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978832|NCT04563845|464209398|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
128978833|NCT04563845|464209385|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978834|NCT04563845|464209386|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978835|NCT04563845|464209387|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978836|NCT04563845|464209388|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978837|NCT04563845|464209389|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
128978838|NCT04563845|464209390|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978839|NCT04563845|464209391|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978840|NCT04563845|464209392|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978841|NCT04563845|464209393|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978842|NCT04563845|464209394|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978843|NCT04563845|464209395|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978844|NCT04563845|464209396|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978845|NCT04563845|464209397|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978846|NCT04563845|464209398|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
128978847|NCT02927990|464209399|FG000|Overall Study|Protocol Violation|4|||
128978848|NCT02927990|464209399|FG000|Overall Study|Physician Decision|9|||
128978849|NCT02927990|464209399|FG000|Overall Study|Room switched and therefore no study device available|15|||
128978850|NCT02927990|464209399|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
128978851|NCT00960323|464209400|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
128978852|NCT02146274|464209401|FG000|Overall Study|Protocol Violation|73|||
128978853|NCT03824704|464209407|FG000|Overall Study|Study Terminated by Sponsor|1|||
128978854|NCT02719028|464209409|FG000|Overall Study|Adverse Event|2|||
128978855|NCT02719028|464209410|FG001|Overall Study|Adverse Event|1|||
128978856|NCT02719028|464209411|FG002|Overall Study|Adverse Event|4|||
128978857|NCT02719028|464209412|FG003|Overall Study|Adverse Event|8|||
128978858|NCT02719028|464209409|FG000|Overall Study|Physician Decision|0|||
128978859|NCT02719028|464209410|FG001|Overall Study|Physician Decision|1|||
128978860|NCT02719028|464209411|FG002|Overall Study|Physician Decision|1|||
128978861|NCT02719028|464209412|FG003|Overall Study|Physician Decision|1|||
128978862|NCT02719028|464209409|FG000|Overall Study|Use of prohibited medication|0|||
128978863|NCT02719028|464209410|FG001|Overall Study|Use of prohibited medication|0|||
128978864|NCT02719028|464209411|FG002|Overall Study|Use of prohibited medication|1|||
128978865|NCT02719028|464209412|FG003|Overall Study|Use of prohibited medication|0|||
128978866|NCT02719028|464209409|FG000|Overall Study|Protocol Violation|0|||
128978867|NCT02719028|464209410|FG001|Overall Study|Protocol Violation|0|||
129222396|NCT02960893|465116081|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
128717990|NCT03662542|463265129|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
128717991|NCT03662542|463265130|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
128717992|NCT03662542|463265131|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
128717993|NCT03662542|463265132|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
128717994|NCT03662542|463265133|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
128717995|NCT03662542|463265134|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
128978868|NCT02719028|464209411|FG002|Overall Study|Protocol Violation|0|||
128978869|NCT02719028|464209412|FG003|Overall Study|Protocol Violation|1|||
128978870|NCT01539720|464209413|FG000|Overall Study|Screen Fail|15|||
128978871|NCT01539720|464209414|FG001|Overall Study|Screen Fail|3|||
128978872|NCT01539720|464209413|FG000|Overall Study|Lost to Follow-up|14|||
128978873|NCT01539720|464209414|FG001|Overall Study|Lost to Follow-up|7|||
128978874|NCT03287960|464209415|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
128978875|NCT03287960|464209415|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
128978876|NCT03730987|464209418|FG000|Overall Study|Lost to Follow-up|2|||
128978877|NCT03730987|464209419|FG001|Overall Study|Lost to Follow-up|0|||
128978878|NCT03730987|464209420|FG002|Overall Study|Lost to Follow-up|2|||
128774796|NCT02555371|463468341|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
128774797|NCT02555371|463468342|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
128774798|NCT02555371|463468338|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
128978879|NCT03730987|464209421|FG003|Overall Study|Lost to Follow-up|0|||
129041277|NCT03028740|464444216|FG001|Overall Study|Reason not Specified|5|||
128717996|NCT03662542|463265135|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
128717997|NCT03662542|463265136|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
128717998|NCT03662542|463265137|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
128717999|NCT03662542|463265129|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
128718000|NCT03662542|463265130|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
128718001|NCT03662542|463265131|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
128718002|NCT03662542|463265132|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
128718003|NCT03662542|463265133|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
128718004|NCT03662542|463265134|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
128718005|NCT03662542|463265135|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
128718006|NCT03662542|463265136|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
128718007|NCT03662542|463265137|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
128718008|NCT03662542|463265129|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
128718009|NCT03662542|463265130|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
128718010|NCT03662542|463265131|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
128718011|NCT03662542|463265132|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
128718012|NCT03662542|463265133|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
128718013|NCT03662542|463265134|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
128718014|NCT03662542|463265135|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
128718015|NCT03662542|463265136|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
128718016|NCT03662542|463265137|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
128718017|NCT03662542|463265129|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
128718018|NCT03662542|463265130|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
128718019|NCT03662542|463265131|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
128718020|NCT03662542|463265132|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
128718021|NCT03662542|463265133|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
128774799|NCT02555371|463468339|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
128774800|NCT02555371|463468340|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
128978880|NCT01667731|464209425|FG000|Overall Study|Enrolled but not treated|0|||
128978881|NCT01667731|464209426|FG001|Overall Study|Enrolled but not treated|0|||
128978882|NCT01667731|464209427|FG002|Overall Study|Enrolled but not treated|0|||
129041278|NCT00685802|464444224|FG000|Washout Period of 7 Days|Protocol Violation|2|||
129041279|NCT00685802|464444225|FG001|Washout Period of 7 Days|Protocol Violation|0|||
129041280|NCT00685802|464444224|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129041281|NCT00685802|464444225|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129041282|NCT03336242|464444229|FG000|Overall Study|Adverse Event|0|||
129041283|NCT03336242|464444230|FG001|Overall Study|Adverse Event|1|||
129041284|NCT02224573|464444232|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
129041285|NCT02224573|464444233|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
129041286|NCT02224573|464444232|FG000|Treatment Phase|Started on Other IMP|1|||
129041287|NCT02224573|464444233|FG001|Treatment Phase|Started on Other IMP|0|||
129041288|NCT02224573|464444232|FG000|Treatment Phase|Participant Discontinued IMP|0|||
129041289|NCT02224573|464444233|FG001|Treatment Phase|Participant Discontinued IMP|1|||
129041290|NCT02224573|464444232|FG000|Treatment Phase|Lack of Efficacy|15|||
129041291|NCT02224573|464444233|FG001|Treatment Phase|Lack of Efficacy|8|||
129041292|NCT02224573|464444232|FG000|Treatment Phase|Began Commercial Product|1|||
129041293|NCT02224573|464444233|FG001|Treatment Phase|Began Commercial Product|0|||
129041294|NCT02224573|464444232|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
129041295|NCT02224573|464444233|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
128718022|NCT03662542|463265134|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
128978883|NCT01667731|464209428|FG003|Overall Study|Enrolled but not treated|0|||
129041296|NCT02224573|464444232|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
129041297|NCT02224573|464444233|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
128718023|NCT03662542|463265135|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
128978884|NCT01667731|464209429|FG004|Overall Study|Enrolled but not treated|1|||
128978885|NCT01667731|464209425|FG000|Overall Study|Efficacy Failure|1|||
128978886|NCT01667731|464209426|FG001|Overall Study|Efficacy Failure|12|||
128978887|NCT01667731|464209427|FG002|Overall Study|Efficacy Failure|0|||
128978888|NCT01667731|464209428|FG003|Overall Study|Efficacy Failure|1|||
128978889|NCT01667731|464209429|FG004|Overall Study|Efficacy Failure|24|||
128978890|NCT01667731|464209425|FG000|Overall Study|Lost to Follow-up|2|||
129222397|NCT02960893|465116082|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
129222398|NCT02960893|465116083|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
129222399|NCT02960893|465116080|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
129222400|NCT02960893|465116081|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
129222401|NCT02960893|465116082|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
129222402|NCT02960893|465116083|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
129222403|NCT02960893|465116080|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
129222404|NCT02960893|465116081|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
129222405|NCT02960893|465116082|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
129222406|NCT02960893|465116083|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
129222407|NCT02960893|465116080|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
129222408|NCT02960893|465116081|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
129222409|NCT02960893|465116082|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
129222410|NCT02960893|465116083|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
129222411|NCT02960893|465116080|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
129222412|NCT02960893|465116081|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
129222413|NCT02960893|465116082|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
129222414|NCT02960893|465116083|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
129222415|NCT02960893|465116080|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
129222416|NCT02960893|465116081|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
129222417|NCT02960893|465116082|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
129222418|NCT02960893|465116083|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
129222419|NCT02960893|465116080|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
129222420|NCT02960893|465116081|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
129222421|NCT02960893|465116082|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
129222422|NCT02960893|465116083|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
129222423|NCT05754333|465116086|FG000|Overall Study|Miscellaneous|3|||
129222424|NCT05754333|465116087|FG001|Overall Study|Miscellaneous|0|||
129222425|NCT05754333|465116088|FG002|Overall Study|Miscellaneous|0|||
129222426|NCT05754333|465116089|FG003|Overall Study|Miscellaneous|0|||
129222427|NCT05754333|465116086|FG000|Overall Study|Lost to Follow-up|2|||
128978891|NCT01667731|464209426|FG001|Overall Study|Lost to Follow-up|3|||
128978892|NCT01667731|464209427|FG002|Overall Study|Lost to Follow-up|1|||
128978893|NCT01667731|464209428|FG003|Overall Study|Lost to Follow-up|1|||
129041298|NCT02224573|464444232|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
129041299|NCT02224573|464444233|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
129041300|NCT02224573|464444232|FG000|Treatment Phase|Continued Compassionate Use|1|||
129041301|NCT02224573|464444233|FG001|Treatment Phase|Continued Compassionate Use|0|||
129041302|NCT02224573|464444232|FG000|Treatment Phase|Lack of Efficiency|2|||
129041303|NCT02224573|464444233|FG001|Treatment Phase|Lack of Efficiency|1|||
129041304|NCT02224573|464444232|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
129041305|NCT02224573|464444233|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
129041306|NCT02224573|464444232|FG000|Treatment Phase|Participant Moved|2|||
129041307|NCT02224573|464444233|FG001|Treatment Phase|Participant Moved|0|||
129041308|NCT02224573|464444232|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
129041309|NCT02224573|464444233|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
129041310|NCT02224573|464444232|FG000|Treatment Phase|Refused Medication|1|||
129041311|NCT02224573|464444233|FG001|Treatment Phase|Refused Medication|1|||
129041312|NCT02224573|464444232|FG000|Treatment Phase|Adverse Event|26|||
129041313|NCT02224573|464444233|FG001|Treatment Phase|Adverse Event|38|||
129041314|NCT02224573|464444232|FG000|Treatment Phase|Placed in Group Home|0|||
129041315|NCT02224573|464444233|FG001|Treatment Phase|Placed in Group Home|1|||
129041316|NCT02224573|464444232|FG000|Treatment Phase|Pursued Other Trials|1|||
129041317|NCT02224573|464444233|FG001|Treatment Phase|Pursued Other Trials|0|||
129041318|NCT02224573|464444232|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
129041319|NCT02224573|464444233|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
129041320|NCT02224573|464444232|FG000|Treatment Phase|Lost to Follow-up|2|||
129041321|NCT02224573|464444233|FG001|Treatment Phase|Lost to Follow-up|1|||
129041322|NCT02224573|464444232|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
129041323|NCT02224573|464444233|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
129041324|NCT02224573|464444232|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
129041325|NCT02224573|464444233|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
129041326|NCT02224573|464444232|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
129222428|NCT05754333|465116087|FG001|Overall Study|Lost to Follow-up|1|||
129041327|NCT02224573|464444233|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
129041328|NCT02224573|464444232|FG000|Taper Phase|Adverse Event|1|||
129041329|NCT02224573|464444233|FG001|Taper Phase|Adverse Event|1|||
129041330|NCT02546362|464444234|FG000|4-week Treatment Period|Lost to Follow-up|1|||
129041331|NCT02546362|464444234|FG000|4-week Treatment Period|Change in medication|2|||
129041332|NCT02546362|464444234|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
129041333|NCT02546362|464444234|FG000|12-week Treatment Period|Lost to Follow-up|2|||
129041334|NCT02546362|464444234|FG000|12-week Treatment Period|Change in medication|1|||
129041335|NCT05206448|464444235|FG000|Overall Study|Lost to Follow-up|2|||
129041336|NCT05206448|464444236|FG001|Overall Study|Lost to Follow-up|2|||
129041337|NCT05206448|464444235|FG000|Overall Study|Withdrawal by Subject|2|||
129041338|NCT05206448|464444236|FG001|Overall Study|Withdrawal by Subject|0|||
129222429|NCT05754333|465116088|FG002|Overall Study|Lost to Follow-up|0|||
129222430|NCT05754333|465116089|FG003|Overall Study|Lost to Follow-up|1|||
129222431|NCT03738228|465116090|FG000|Overall Study|Never received study treatment|2|||
129222432|NCT03738228|465116091|FG001|Overall Study|Never received study treatment|2|||
129222433|NCT06170242|465116092|FG000|Overall Study|Lost to Follow-up|0|||
129222434|NCT06170242|465116093|FG001|Overall Study|Lost to Follow-up|0|||
129222435|NCT06170242|465116094|FG002|Overall Study|Lost to Follow-up|1|||
129222436|NCT06170242|465116095|FG003|Overall Study|Lost to Follow-up|1|||
129222437|NCT04874415|465116101|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222438|NCT04874415|465116102|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222439|NCT04874415|465116103|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222440|NCT04874415|465116104|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222441|NCT04874415|465116105|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222442|NCT04874415|465116106|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222443|NCT04874415|465116107|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129222444|NCT04874415|465116108|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222445|NCT04874415|465116109|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
129222446|NCT04874415|465116110|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129222447|NCT04874415|465116111|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222448|NCT04874415|465116112|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129222449|NCT04874415|465116113|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129222450|NCT04874415|465116114|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129222451|NCT04874415|465116115|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
129222452|NCT04874415|465116116|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129222453|NCT04874415|465116101|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222454|NCT04874415|465116102|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
129222455|NCT04874415|465116103|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
129222456|NCT04874415|465116104|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222457|NCT04874415|465116105|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
129222458|NCT04874415|465116106|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
129222459|NCT04874415|465116107|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222460|NCT04874415|465116108|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222461|NCT04874415|465116109|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
129222462|NCT04874415|465116110|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
129222463|NCT04874415|465116111|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222464|NCT04874415|465116112|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222465|NCT04874415|465116113|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222466|NCT04874415|465116114|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
129222467|NCT04874415|465116115|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
129222468|NCT04874415|465116116|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
129222469|NCT04874415|465116101|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222470|NCT04874415|465116102|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222471|NCT04874415|465116103|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222472|NCT04874415|465116104|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222473|NCT04874415|465116105|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
129222474|NCT04874415|465116106|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222475|NCT04874415|465116107|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222476|NCT04874415|465116108|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222477|NCT04874415|465116109|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222478|NCT04874415|465116110|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222479|NCT04874415|465116111|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129041339|NCT05206448|464444235|FG000|Overall Study|found ineligible after randomization|1|||
129041340|NCT05206448|464444236|FG001|Overall Study|found ineligible after randomization|1|||
129041341|NCT05206448|464444235|FG000|Overall Study|unable to complete study due to personal constraints|1|||
129041342|NCT05206448|464444236|FG001|Overall Study|unable to complete study due to personal constraints|0|||
129041343|NCT05206448|464444235|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
129041344|NCT05206448|464444236|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
129041345|NCT01661881|464444238|FG000|Overall Study|Disease Progression|1|||
129041346|NCT00949988|464444243|FG000|Overall Study|Withdrawal by Subject|3|||
129133154|NCT01567085|464781232|FG000|Overall Study|Renal transplantectomy|1|||
129133155|NCT01567085|464781232|FG000|Overall Study|Returned to chronic dialysis|1|||
129133156|NCT01567085|464781232|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
129133157|NCT00504231|464781236|FG000|Overall Study|Discrepant chart documentation re route|0|||
129133158|NCT00504231|464781237|FG001|Overall Study|Discrepant chart documentation re route|0|||
129133159|NCT00504231|464781238|FG002|Overall Study|Discrepant chart documentation re route|1|||
129133160|NCT00504231|464781239|FG003|Overall Study|Discrepant chart documentation re route|0|||
129133161|NCT03928704|464781241|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129133162|NCT03928704|464781242|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
128718024|NCT03662542|463265136|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
128718025|NCT03662542|463265137|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
128718026|NCT01462084|463265148|FG000|Overall Study|Withdrawal by Subject|1|||
128718027|NCT01462084|463265149|FG001|Overall Study|Withdrawal by Subject|0|||
128718028|NCT01462084|463265148|FG000|Overall Study|Protocol Violation|1|||
128718029|NCT01462084|463265149|FG001|Overall Study|Protocol Violation|1|||
128718030|NCT01996826|463265150|FG000|Overall Study|Lost to Follow-up|6|||
128718031|NCT01996826|463265151|FG001|Overall Study|Lost to Follow-up|2|||
128718032|NCT01996826|463265150|FG000|Overall Study|Physician Decision|1|||
128718033|NCT01996826|463265151|FG001|Overall Study|Physician Decision|1|||
128718034|NCT00695396|463265152|FG000|Overall Study|Study Closed Prematurely|5|||
128718035|NCT00695396|463265153|FG001|Overall Study|Study Closed Prematurely|6|||
128718036|NCT00695396|463265154|FG002|Overall Study|Study Closed Prematurely|8|||
128718037|NCT00695396|463265152|FG000|Overall Study|Withdrawal by Subject|2|||
128718038|NCT00695396|463265153|FG001|Overall Study|Withdrawal by Subject|2|||
128718039|NCT00695396|463265154|FG002|Overall Study|Withdrawal by Subject|0|||
128718040|NCT00371254|463265155|FG000|Overall Study|Disease progression|13|||
128718041|NCT00371254|463265156|FG001|Overall Study|Disease progression|13|||
128718042|NCT00371254|463265155|FG000|Overall Study|Study drug toxicity|3|||
128718043|NCT00371254|463265156|FG001|Overall Study|Study drug toxicity|5|||
128718044|NCT00371254|463265155|FG000|Overall Study|Subject request|5|||
128718045|NCT00371254|463265156|FG001|Overall Study|Subject request|0|||
128718046|NCT00371254|463265155|FG000|Overall Study|Investigator Decision|2|||
128718047|NCT00371254|463265156|FG001|Overall Study|Investigator Decision|0|||
128718048|NCT00371254|463265155|FG000|Overall Study|Adverse event unrelated to study drug|0|||
128718049|NCT00371254|463265156|FG001|Overall Study|Adverse event unrelated to study drug|1|||
128718050|NCT00371254|463265155|FG000|Overall Study|Lost to Follow-up|0|||
128718051|NCT00371254|463265156|FG001|Overall Study|Lost to Follow-up|1|||
128718052|NCT00371254|463265155|FG000|Overall Study|Withdrawal by Subject|0|||
128718053|NCT00371254|463265156|FG001|Overall Study|Withdrawal by Subject|1|||
128718054|NCT02246673|463265159|FG000|Overall Study|Sponsor Decision|1|||
128718055|NCT02246673|463265160|FG001|Overall Study|Sponsor Decision|0|||
128718056|NCT02246673|463265161|FG002|Overall Study|Sponsor Decision|0|||
128718057|NCT02246673|463265162|FG003|Overall Study|Sponsor Decision|0|||
128718058|NCT02246673|463265163|FG004|Overall Study|Sponsor Decision|0|||
128718059|NCT02246673|463265159|FG000|Overall Study|Withdrawal by Subject|0|||
128718060|NCT02246673|463265160|FG001|Overall Study|Withdrawal by Subject|0|||
128718061|NCT02246673|463265161|FG002|Overall Study|Withdrawal by Subject|0|||
128718062|NCT02246673|463265162|FG003|Overall Study|Withdrawal by Subject|0|||
128718063|NCT02246673|463265163|FG004|Overall Study|Withdrawal by Subject|1|||
128718064|NCT02246673|463265159|FG000|Overall Study|Lost to Follow-up|0|||
128718065|NCT02246673|463265160|FG001|Overall Study|Lost to Follow-up|0|||
128718066|NCT02246673|463265161|FG002|Overall Study|Lost to Follow-up|0|||
128718067|NCT02246673|463265162|FG003|Overall Study|Lost to Follow-up|1|||
128718068|NCT02246673|463265163|FG004|Overall Study|Lost to Follow-up|0|||
128718069|NCT02246673|463265159|FG000|Overall Study|Protocol Violation|0|||
128718070|NCT02246673|463265160|FG001|Overall Study|Protocol Violation|0|||
128718071|NCT02246673|463265161|FG002|Overall Study|Protocol Violation|0|||
128718072|NCT02246673|463265162|FG003|Overall Study|Protocol Violation|1|||
128718073|NCT02246673|463265163|FG004|Overall Study|Protocol Violation|0|||
128718074|NCT05413369|463265168|FG000|Overall Study|Adverse Event|1|||
128718075|NCT05413369|463265169|FG001|Overall Study|Adverse Event|1|||
128718076|NCT05413369|463265168|FG000|Overall Study|Withdrawal by Subject|13|||
128718077|NCT05413369|463265169|FG001|Overall Study|Withdrawal by Subject|4|||
128718078|NCT05413369|463265168|FG000|Overall Study|Non-compliance with study schedule|2|||
128718079|NCT05413369|463265169|FG001|Overall Study|Non-compliance with study schedule|1|||
128718080|NCT05413369|463265168|FG000|Overall Study|Other|1|||
128718081|NCT05413369|463265169|FG001|Overall Study|Other|1|||
128718082|NCT00720057|463265170|FG000|Overall Study|Lost to Follow-up|0|||
128718083|NCT00720057|463265171|FG001|Overall Study|Lost to Follow-up|2|||
129041347|NCT01144403|464444248|FG000|Overall Study|Lost to Follow-up|3|||
129041348|NCT01144403|464444248|FG000|Overall Study|Death|1|||
129041349|NCT01144403|464444248|FG000|Overall Study|Adverse Event|1|||
129041350|NCT03176784|464444249|FG000|Overall Study|Lost to Follow-up|77|||
129041351|NCT03176784|464444250|FG001|Overall Study|Lost to Follow-up|79|||
129041352|NCT03176784|464444251|FG002|Overall Study|Lost to Follow-up|79|||
129133163|NCT03928704|464781243|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129133164|NCT03928704|464781244|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129133165|NCT03928704|464781245|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129133166|NCT03928704|464781246|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129133167|NCT03928704|464781241|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
129133168|NCT03928704|464781242|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129133169|NCT03928704|464781243|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129133170|NCT03928704|464781244|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129133171|NCT03928704|464781245|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129133172|NCT03928704|464781246|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129133173|NCT03928704|464781241|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
129222480|NCT04874415|465116112|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129041353|NCT03176784|464444252|FG003|Overall Study|Lost to Follow-up|49|||
129041354|NCT03176784|464444249|FG000|Overall Study|Withdrawal by Subject|28|||
129222481|NCT04874415|465116113|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222482|NCT04874415|465116114|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222483|NCT04874415|465116115|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222484|NCT04874415|465116116|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129222485|NCT01312857|465116117|FG000|Overall Study|Adverse Event|1|||
129222486|NCT01312857|465116118|FG001|Overall Study|Adverse Event|1|||
129222487|NCT01312857|465116117|FG000|Overall Study|Lost to Follow-up|2|||
129222488|NCT01312857|465116118|FG001|Overall Study|Lost to Follow-up|0|||
129222489|NCT01312857|465116117|FG000|Overall Study|Physician Decision|3|||
129222490|NCT01312857|465116118|FG001|Overall Study|Physician Decision|0|||
129222491|NCT01312857|465116117|FG000|Overall Study|Withdrawal by Subject|2|||
129222492|NCT01312857|465116118|FG001|Overall Study|Withdrawal by Subject|0|||
129222493|NCT02455557|465116119|FG000|Overall Study|Withdrawal by Subject|2|||
129222494|NCT00807027|465116120|FG000|Overall Study|Withdrawal by Subject|13|||
129222495|NCT00807027|465116121|FG001|Overall Study|Withdrawal by Subject|14|||
129222496|NCT00807027|465116120|FG000|Overall Study|Protocol Violation|1|||
129222497|NCT00807027|465116121|FG001|Overall Study|Protocol Violation|1|||
129222498|NCT00807027|465116120|FG000|Overall Study|Adverse Event|2|||
129222499|NCT00807027|465116121|FG001|Overall Study|Adverse Event|2|||
129222500|NCT02586207|465116122|FG000|Overall Study|Physician Decision|1|||
129222501|NCT02586207|465116122|FG000|Overall Study|Withdrawal by Subject|1|||
129222502|NCT04896073|465116123|FG000|Overall Study|Screen failure|0|||
129222503|NCT04896073|465116124|FG001|Overall Study|Screen failure|2|||
129222504|NCT04896073|465116123|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
129222505|NCT04896073|465116124|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
129222506|NCT01385176|465116125|FG000|Randomization Phase|Death|1|||
129222507|NCT01385176|465116126|FG001|Randomization Phase|Death|2|||
129222508|NCT01385176|465116125|FG000|6-18 Month All VNS Active|Death|1|||
129222509|NCT01385176|465116126|FG001|6-18 Month All VNS Active|Death|2|||
129222510|NCT01385176|465116125|FG000|6-18 Month All VNS Active|Physician Decision|0|||
129222511|NCT01385176|465116126|FG001|6-18 Month All VNS Active|Physician Decision|1|||
129222512|NCT01385176|465116125|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
129222513|NCT01385176|465116126|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
129222514|NCT01385176|465116125|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
129222515|NCT01385176|465116126|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
129222516|NCT02306161|465116127|FG000|Overall Study|Death|1|||
129222517|NCT02306161|465116128|FG001|Overall Study|Death|3|||
129222518|NCT02306161|465116127|FG000|Overall Study|Lack of Efficacy|20|||
129222519|NCT02306161|465116128|FG001|Overall Study|Lack of Efficacy|43|||
129222520|NCT02306161|465116127|FG000|Overall Study|Physician Decision|30|||
129222521|NCT02306161|465116128|FG001|Overall Study|Physician Decision|18|||
129222522|NCT02306161|465116127|FG000|Overall Study|Withdrawal by Subject|4|||
129222523|NCT02306161|465116128|FG001|Overall Study|Withdrawal by Subject|0|||
129222524|NCT02306161|465116127|FG000|Overall Study|Ineligible|9|||
129222525|NCT02306161|465116128|FG001|Overall Study|Ineligible|5|||
129222526|NCT04995419|465116129|FG000|Overall Study|Withdrawal by Subject|3|||
129222527|NCT04995419|465116129|FG000|Overall Study|Progressive Disease|19|||
129222528|NCT04995419|465116129|FG000|Overall Study|Adverse Event|2|||
129222529|NCT04995419|465116129|FG000|Overall Study|Ongoing|16|||
129222530|NCT03306173|465116130|FG000|Overall Study|Lost to Follow-up|16|||
129222531|NCT03306173|465116131|FG001|Overall Study|Lost to Follow-up|23|||
129222532|NCT03306173|465116130|FG000|Overall Study|Withdrawal by Subject|4|||
128718084|NCT00720057|463265170|FG000|Overall Study|Protocol Violation|1|||
128774801|NCT02555371|463468341|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
128774802|NCT02555371|463468342|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
128774803|NCT02555371|463468338|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
128774804|NCT02555371|463468339|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
128774805|NCT02555371|463468340|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
128774806|NCT02555371|463468341|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
128774807|NCT02555371|463468342|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
128774808|NCT02555371|463468338|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
128774809|NCT02555371|463468339|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
128774810|NCT02555371|463468340|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
128774811|NCT02555371|463468341|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
128774812|NCT02555371|463468342|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
128774813|NCT02555371|463468338|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
128774814|NCT02555371|463468339|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
128774815|NCT02555371|463468340|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
128774816|NCT02555371|463468341|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
128774817|NCT02555371|463468342|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
128774818|NCT02555371|463468338|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
129041355|NCT03176784|464444250|FG001|Overall Study|Withdrawal by Subject|34|||
128774819|NCT02555371|463468339|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
128774820|NCT02555371|463468340|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
128774821|NCT02555371|463468341|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
128774822|NCT02555371|463468342|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
128774823|NCT02555371|463468338|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
128774824|NCT02555371|463468339|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
129041356|NCT03176784|464444251|FG002|Overall Study|Withdrawal by Subject|34|||
129041357|NCT03176784|464444252|FG003|Overall Study|Withdrawal by Subject|21|||
129041358|NCT01351350|464444255|FG000|Overall Study|Disease Progression|5|||
129041359|NCT01351350|464444256|FG001|Overall Study|Disease Progression|13|||
129041360|NCT01351350|464444257|FG002|Overall Study|Disease Progression|6|||
128774825|NCT02555371|463468340|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
128774826|NCT02555371|463468341|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
128774827|NCT02555371|463468342|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
128774828|NCT02555371|463468338|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
128774829|NCT02555371|463468339|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
128774830|NCT02555371|463468340|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
128774831|NCT02555371|463468341|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
128774832|NCT02555371|463468342|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
128774833|NCT02555371|463468338|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
128774834|NCT02555371|463468339|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
128774835|NCT02555371|463468340|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
128774836|NCT02555371|463468341|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
128774837|NCT02555371|463468342|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
128774838|NCT02555371|463468338|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
128774839|NCT02555371|463468339|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
128774840|NCT02555371|463468340|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
128774841|NCT02555371|463468341|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
128774842|NCT02555371|463468342|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
128774843|NCT02555371|463468338|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
128774844|NCT02555371|463468339|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
128774845|NCT02555371|463468340|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
128774846|NCT02555371|463468341|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
128774847|NCT02555371|463468342|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
128774848|NCT02555371|463468338|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
128774849|NCT02555371|463468339|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
128774850|NCT02555371|463468340|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
128774851|NCT02555371|463468341|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
128774852|NCT02555371|463468342|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
128774853|NCT02555371|463468338|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
128774854|NCT02555371|463468339|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
128774855|NCT02555371|463468340|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
128774856|NCT02555371|463468341|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
128774857|NCT02555371|463468342|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
128774858|NCT03095599|463468343|FG000|Overall Study|Withdrawal by Subject|1|||
128774859|NCT03095599|463468344|FG001|Overall Study|Withdrawal by Subject|0|||
128774860|NCT03095599|463468343|FG000|Overall Study|Lost to Follow-up|1|||
128774861|NCT03095599|463468344|FG001|Overall Study|Lost to Follow-up|0|||
128774862|NCT03095599|463468343|FG000|Overall Study|Withdrawal prior to vaccination|1|||
128774863|NCT03095599|463468344|FG001|Overall Study|Withdrawal prior to vaccination|0|||
128774864|NCT04781647|463468347|FG000|Overall Study|Study terminated by Sponsor|11|||
128774865|NCT04781647|463468348|FG001|Overall Study|Study terminated by Sponsor|9|||
128978894|NCT01667731|464209429|FG004|Overall Study|Lost to Follow-up|2|||
128978895|NCT01667731|464209425|FG000|Overall Study|Subject Withdrew Consent|2|||
128978896|NCT01667731|464209426|FG001|Overall Study|Subject Withdrew Consent|0|||
128774866|NCT04781647|463468349|FG002|Overall Study|Study terminated by Sponsor|9|||
128774867|NCT04781647|463468347|FG000|Overall Study|Withdrawal by Subject|1|||
128978897|NCT01667731|464209427|FG002|Overall Study|Subject Withdrew Consent|1|||
128978898|NCT01667731|464209428|FG003|Overall Study|Subject Withdrew Consent|0|||
128978899|NCT01667731|464209429|FG004|Overall Study|Subject Withdrew Consent|1|||
128978900|NCT01667731|464209425|FG000|Overall Study|Death|0|||
128978901|NCT01667731|464209426|FG001|Overall Study|Death|1|||
128978902|NCT01667731|464209427|FG002|Overall Study|Death|0|||
128978903|NCT01667731|464209428|FG003|Overall Study|Death|0|||
128978904|NCT01667731|464209429|FG004|Overall Study|Death|0|||
128978905|NCT01425268|464209430|FG000|Overall Study|Withdrawal by Subject|2|||
128978906|NCT01425268|464209431|FG001|Overall Study|Withdrawal by Subject|0|||
128978907|NCT01425268|464209430|FG000|Overall Study|Sponsor Decision|5|||
128978908|NCT01425268|464209431|FG001|Overall Study|Sponsor Decision|0|||
128978909|NCT01425268|464209430|FG000|Overall Study|Physician Decision|1|||
128978910|NCT01425268|464209431|FG001|Overall Study|Physician Decision|0|||
128978911|NCT02839330|464209432|FG000|Overall Study|Adverse Event|0|||
128978912|NCT02839330|464209433|FG001|Overall Study|Adverse Event|1|||
128978913|NCT02839330|464209434|FG002|Overall Study|Adverse Event|2|||
128978914|NCT02839330|464209435|FG003|Overall Study|Adverse Event|2|||
128978915|NCT02839330|464209432|FG000|Overall Study|Death|4|||
128978916|NCT02839330|464209433|FG001|Overall Study|Death|6|||
128978917|NCT02839330|464209434|FG002|Overall Study|Death|1|||
128978918|NCT02839330|464209435|FG003|Overall Study|Death|1|||
128978919|NCT02839330|464209432|FG000|Overall Study|Withdrawal by Subject|27|||
128978920|NCT02839330|464209433|FG001|Overall Study|Withdrawal by Subject|19|||
128978921|NCT02839330|464209434|FG002|Overall Study|Withdrawal by Subject|11|||
128978922|NCT02839330|464209435|FG003|Overall Study|Withdrawal by Subject|13|||
128978923|NCT02839330|464209432|FG000|Overall Study|Lost to Follow-up|22|||
128978924|NCT02839330|464209433|FG001|Overall Study|Lost to Follow-up|27|||
128978925|NCT02839330|464209434|FG002|Overall Study|Lost to Follow-up|29|||
128978926|NCT02839330|464209435|FG003|Overall Study|Lost to Follow-up|25|||
128978927|NCT02839330|464209432|FG000|Overall Study|Administrative Reason|0|||
128978928|NCT02839330|464209433|FG001|Overall Study|Administrative Reason|0|||
128978929|NCT02839330|464209434|FG002|Overall Study|Administrative Reason|0|||
128978930|NCT02839330|464209435|FG003|Overall Study|Administrative Reason|1|||
128978931|NCT02839330|464209432|FG000|Overall Study|Protocol Violation|1|||
128978932|NCT02839330|464209433|FG001|Overall Study|Protocol Violation|2|||
128978933|NCT02839330|464209434|FG002|Overall Study|Protocol Violation|2|||
128978934|NCT02839330|464209435|FG003|Overall Study|Protocol Violation|3|||
128978935|NCT02839330|464209432|FG000|Overall Study|Other reason, not specified|4|||
128978936|NCT02839330|464209433|FG001|Overall Study|Other reason, not specified|3|||
128978937|NCT02839330|464209434|FG002|Overall Study|Other reason, not specified|3|||
128978938|NCT02839330|464209435|FG003|Overall Study|Other reason, not specified|6|||
128978939|NCT01345162|464209440|FG000|Overall Study|Protocol Violation|2|||
128978940|NCT01345162|464209441|FG001|Overall Study|Protocol Violation|4|||
128978941|NCT00883896|464209443|FG000|Overall Study|Lost to Follow-up|0|||
128978942|NCT00883896|464209444|FG001|Overall Study|Lost to Follow-up|0|||
128978943|NCT00883896|464209445|FG002|Overall Study|Lost to Follow-up|0|||
128978944|NCT00883896|464209446|FG003|Overall Study|Lost to Follow-up|2|||
128978945|NCT00883896|464209443|FG000|Overall Study|Withdrawal by Subject|5|||
128978946|NCT00883896|464209444|FG001|Overall Study|Withdrawal by Subject|0|||
128978947|NCT00883896|464209445|FG002|Overall Study|Withdrawal by Subject|1|||
128978948|NCT00883896|464209446|FG003|Overall Study|Withdrawal by Subject|3|||
128978949|NCT00883896|464209443|FG000|Overall Study|Lack of Efficacy|0|||
128978950|NCT00883896|464209444|FG001|Overall Study|Lack of Efficacy|0|||
128978951|NCT00883896|464209445|FG002|Overall Study|Lack of Efficacy|0|||
129041361|NCT01351350|464444258|FG003|Overall Study|Disease Progression|8|||
128774868|NCT04781647|463468348|FG001|Overall Study|Withdrawal by Subject|2|||
128774869|NCT04781647|463468349|FG002|Overall Study|Withdrawal by Subject|0|||
128774870|NCT04781647|463468347|FG000|Overall Study|Adverse Event|0|||
128978952|NCT00883896|464209446|FG003|Overall Study|Lack of Efficacy|2|||
128978953|NCT00883896|464209443|FG000|Overall Study|Other|1|||
128978954|NCT00883896|464209444|FG001|Overall Study|Other|0|||
128978955|NCT00883896|464209445|FG002|Overall Study|Other|0|||
128978956|NCT00883896|464209446|FG003|Overall Study|Other|0|||
128978957|NCT00174460|464209451|FG000|Overall Study|Withdrawal by Subject|0|||
128774871|NCT04781647|463468348|FG001|Overall Study|Adverse Event|1|||
128978958|NCT00174460|464209452|FG001|Overall Study|Withdrawal by Subject|1|||
128978959|NCT00579059|464209455|FG000|Overall Study|Study Canceled at 1 Year|21|||
128978960|NCT00579059|464209456|FG001|Overall Study|Study Canceled at 1 Year|10|||
128978961|NCT00779506|464209458|FG000|Overall Study|Screening Failed|2|||
129041362|NCT01351350|464444259|FG004|Overall Study|Disease Progression|5|||
129041363|NCT01351350|464444255|FG000|Overall Study|Adverse Event|1|||
129041364|NCT01351350|464444256|FG001|Overall Study|Adverse Event|10|||
129041365|NCT01351350|464444257|FG002|Overall Study|Adverse Event|1|||
129041366|NCT01351350|464444258|FG003|Overall Study|Adverse Event|2|||
129041367|NCT01351350|464444259|FG004|Overall Study|Adverse Event|0|||
129041368|NCT01351350|464444255|FG000|Overall Study|Participant Decision|2|||
129041369|NCT01351350|464444256|FG001|Overall Study|Participant Decision|6|||
129133174|NCT03928704|464781242|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
128774872|NCT04781647|463468349|FG002|Overall Study|Adverse Event|1|||
128774873|NCT04781647|463468347|FG000|Overall Study|Protocol Violation|1|||
128774874|NCT04781647|463468348|FG001|Overall Study|Protocol Violation|0|||
128774875|NCT04781647|463468349|FG002|Overall Study|Protocol Violation|0|||
128774876|NCT04781647|463468347|FG000|Overall Study|Pregnancy|0|||
128774877|NCT04781647|463468348|FG001|Overall Study|Pregnancy|0|||
128774878|NCT04781647|463468349|FG002|Overall Study|Pregnancy|1|||
128774879|NCT04781647|463468347|FG000|Overall Study|Virology rebounded|1|||
128774880|NCT04781647|463468348|FG001|Overall Study|Virology rebounded|0|||
128774881|NCT04781647|463468349|FG002|Overall Study|Virology rebounded|0|||
128774882|NCT01474512|463468357|FG000|Induction Period|Adverse Event|6|||
128774883|NCT01474512|463468358|FG001|Induction Period|Adverse Event|10|||
128774884|NCT01474512|463468359|FG002|Induction Period|Adverse Event|10|||
129041370|NCT01351350|464444257|FG002|Overall Study|Participant Decision|3|||
129041371|NCT01351350|464444258|FG003|Overall Study|Participant Decision|3|||
129041372|NCT01351350|464444259|FG004|Overall Study|Participant Decision|2|||
129041373|NCT01351350|464444255|FG000|Overall Study|Enrolled but not Treated|0|||
129133175|NCT03928704|464781243|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129133176|NCT03928704|464781244|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129133177|NCT03928704|464781245|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129133178|NCT03928704|464781246|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129133179|NCT03928704|464781241|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
129133180|NCT03928704|464781242|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
129133181|NCT03928704|464781243|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129133182|NCT03928704|464781244|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129133183|NCT03928704|464781245|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129133184|NCT03928704|464781246|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129133185|NCT03928704|464781241|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129133186|NCT03928704|464781242|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129133187|NCT03928704|464781243|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
129133188|NCT03928704|464781244|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129133189|NCT03928704|464781245|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129133190|NCT03928704|464781246|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129133191|NCT03928704|464781241|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129133192|NCT03928704|464781242|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129133193|NCT03928704|464781243|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
129133194|NCT03928704|464781244|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
128774885|NCT01474512|463468360|FG003|Induction Period|Adverse Event|0|||
128774886|NCT01474512|463468361|FG004|Induction Period|Adverse Event|0|||
128774887|NCT01474512|463468362|FG005|Induction Period|Adverse Event|0|||
128774888|NCT01474512|463468363|FG006|Induction Period|Adverse Event|0|||
128774889|NCT01474512|463468364|FG007|Induction Period|Adverse Event|0|||
128774890|NCT01474512|463468365|FG008|Induction Period|Adverse Event|0|||
128774891|NCT01474512|463468366|FG009|Induction Period|Adverse Event|0|||
128774892|NCT01474512|463468367|FG010|Induction Period|Adverse Event|0|||
128774893|NCT01474512|463468368|FG011|Induction Period|Adverse Event|0|||
128774894|NCT01474512|463468369|FG012|Induction Period|Adverse Event|0|||
128774895|NCT01474512|463468370|FG013|Induction Period|Adverse Event|0|||
128774896|NCT01474512|463468371|FG014|Induction Period|Adverse Event|0|||
128774897|NCT01474512|463468372|FG015|Induction Period|Adverse Event|0|||
128774898|NCT01474512|463468373|FG016|Induction Period|Adverse Event|0|||
128774899|NCT01474512|463468374|FG017|Induction Period|Adverse Event|0|||
128774900|NCT01474512|463468357|FG000|Induction Period|Lack of Efficacy|7|||
128774901|NCT01474512|463468358|FG001|Induction Period|Lack of Efficacy|1|||
128774902|NCT01474512|463468359|FG002|Induction Period|Lack of Efficacy|0|||
128774903|NCT01474512|463468360|FG003|Induction Period|Lack of Efficacy|0|||
128774904|NCT01474512|463468361|FG004|Induction Period|Lack of Efficacy|0|||
128774905|NCT01474512|463468362|FG005|Induction Period|Lack of Efficacy|0|||
129041374|NCT01351350|464444256|FG001|Overall Study|Enrolled but not Treated|0|||
128774906|NCT01474512|463468363|FG006|Induction Period|Lack of Efficacy|0|||
128774907|NCT01474512|463468364|FG007|Induction Period|Lack of Efficacy|0|||
128774908|NCT01474512|463468365|FG008|Induction Period|Lack of Efficacy|0|||
128774909|NCT01474512|463468366|FG009|Induction Period|Lack of Efficacy|0|||
128774910|NCT01474512|463468367|FG010|Induction Period|Lack of Efficacy|0|||
128774911|NCT01474512|463468368|FG011|Induction Period|Lack of Efficacy|0|||
128774912|NCT01474512|463468369|FG012|Induction Period|Lack of Efficacy|0|||
128774913|NCT01474512|463468370|FG013|Induction Period|Lack of Efficacy|0|||
129041375|NCT01351350|464444257|FG002|Overall Study|Enrolled but not Treated|1|||
129041376|NCT01351350|464444258|FG003|Overall Study|Enrolled but not Treated|0|||
129041377|NCT01351350|464444259|FG004|Overall Study|Enrolled but not Treated|0|||
129041378|NCT04647383|464444260|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
129041379|NCT04647383|464444261|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
129041380|NCT04647383|464444262|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
129041381|NCT04647383|464444263|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
129041382|NCT00873119|464444271|FG000|Overall Study|Patient request|4|||
129041383|NCT00873119|464444272|FG001|Overall Study|Patient request|2|||
129041384|NCT00873119|464444271|FG000|Overall Study|Adverse Event|8|||
129041385|NCT00873119|464444272|FG001|Overall Study|Adverse Event|0|||
129133195|NCT03928704|464781245|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129133196|NCT03928704|464781246|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
128718085|NCT00720057|463265171|FG001|Overall Study|Protocol Violation|0|||
128718086|NCT00720057|463265170|FG000|Overall Study|Withdrawal by Subject|0|||
128718087|NCT00720057|463265171|FG001|Overall Study|Withdrawal by Subject|1|||
128718088|NCT02726074|463265175|FG000|Overall Study|Withdrawal by Subject|4|||
128718089|NCT02726074|463265175|FG000|Overall Study|Adverse Event|14|||
128718090|NCT02726074|463265175|FG000|Overall Study|Protocol Violation|3|||
128718091|NCT02726074|463265175|FG000|Overall Study|Lost to Follow-up|2|||
128718092|NCT02726074|463265175|FG000|Overall Study|Others|3|||
128718093|NCT03559257|463265184|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
128718094|NCT03559257|463265185|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
128718095|NCT03559257|463265184|FG000|Double Blind Treatment Period|Protocol Violation|1|||
128718096|NCT03559257|463265185|FG001|Double Blind Treatment Period|Protocol Violation|4|||
128718097|NCT03559257|463265184|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
128718098|NCT03559257|463265185|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
128718099|NCT03559257|463265184|FG000|Double Blind Treatment Period|Adverse Event|0|||
128718100|NCT03559257|463265185|FG001|Double Blind Treatment Period|Adverse Event|1|||
128718101|NCT03559257|463265184|FG000|Double Blind Treatment Period|Screen Failure|0|||
128718102|NCT03559257|463265185|FG001|Double Blind Treatment Period|Screen Failure|1|||
128718103|NCT03559257|463265184|FG000|Open-label Treatment Period|Adverse Event|1|||
128718104|NCT03559257|463265185|FG001|Open-label Treatment Period|Adverse Event|4|||
128718105|NCT03559257|463265184|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
128718106|NCT03559257|463265185|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
128718107|NCT03559257|463265184|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
128718108|NCT03559257|463265185|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
128718109|NCT03559257|463265184|FG000|Open-label Treatment Period|Protocol Violation|2|||
128718110|NCT03559257|463265185|FG001|Open-label Treatment Period|Protocol Violation|0|||
128718111|NCT03559257|463265184|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
128718112|NCT03559257|463265185|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
128718113|NCT03559257|463265184|FG000|Open-label Treatment Period|Physician Decision|0|||
128718114|NCT03559257|463265185|FG001|Open-label Treatment Period|Physician Decision|1|||
128718115|NCT01288287|463265186|FG000|Overall Study|Lost to Follow-up|8|||
128718116|NCT01288287|463265186|FG000|Overall Study|Withdrawal by Subject|4|||
128718117|NCT01288287|463265186|FG000|Overall Study|Lack of Efficacy|13|||
128718118|NCT01288287|463265186|FG000|Overall Study|Other Reason|13|||
128718119|NCT01288287|463265186|FG000|Overall Study|Unknown Reason|1|||
128718120|NCT01288287|463265186|FG000|Overall Study|Unknown Status|7|||
128718121|NCT03011307|463265189|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
128718122|NCT03011307|463265190|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
128718123|NCT03011307|463265189|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
128718124|NCT03011307|463265190|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
128718125|NCT03011307|463265189|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
128718126|NCT03011307|463265190|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
128718127|NCT00271947|463265191|FG000|Overall Study|Lost to Follow-up|1|||
128718128|NCT02466555|463265192|FG000|Overall Study|Lost to Follow-up|2|||
128718129|NCT02291055|463265193|FG000|Overall Study|Death|2|||
128718130|NCT02291055|463265194|FG001|Overall Study|Death|2|||
128718131|NCT02291055|463265195|FG002|Overall Study|Death|5|||
128718132|NCT02291055|463265196|FG003|Overall Study|Death|8|||
128718133|NCT02291055|463265197|FG004|Overall Study|Death|12|||
129041386|NCT00873119|464444271|FG000|Overall Study|Progressive disease|26|||
129041387|NCT00873119|464444272|FG001|Overall Study|Progressive disease|18|||
129041388|NCT00873119|464444271|FG000|Overall Study|Death|2|||
129041389|NCT00873119|464444272|FG001|Overall Study|Death|1|||
129041390|NCT00873119|464444271|FG000|Overall Study|Other|2|||
129041391|NCT00873119|464444272|FG001|Overall Study|Other|5|||
129041392|NCT00873119|464444271|FG000|Overall Study|Not treated|2|||
129133197|NCT03928704|464781241|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
128718134|NCT02291055|463265193|FG000|Overall Study|Lost to Follow-up|0|||
128718135|NCT02291055|463265194|FG001|Overall Study|Lost to Follow-up|0|||
128718136|NCT02291055|463265195|FG002|Overall Study|Lost to Follow-up|0|||
129041393|NCT00873119|464444272|FG001|Overall Study|Not treated|0|||
128978962|NCT00779506|464209458|FG000|Overall Study|Adverse Event|4|||
128978963|NCT00779506|464209458|FG000|Overall Study|Lack of Efficacy|11|||
128978964|NCT00779506|464209458|FG000|Overall Study|Protocol Violation|5|||
128978965|NCT00779506|464209458|FG000|Overall Study|Withdrawal by Subject|6|||
128978966|NCT00779506|464209458|FG000|Overall Study|Lost to Follow-up|1|||
128718137|NCT02291055|463265196|FG003|Overall Study|Lost to Follow-up|1|||
128718138|NCT02291055|463265197|FG004|Overall Study|Lost to Follow-up|2|||
128718139|NCT02291055|463265193|FG000|Overall Study|Withdrawal by Subject|3|||
128718140|NCT02291055|463265194|FG001|Overall Study|Withdrawal by Subject|1|||
128718141|NCT02291055|463265195|FG002|Overall Study|Withdrawal by Subject|1|||
128718142|NCT02291055|463265196|FG003|Overall Study|Withdrawal by Subject|5|||
128718143|NCT02291055|463265197|FG004|Overall Study|Withdrawal by Subject|10|||
128718144|NCT02291055|463265193|FG000|Overall Study|Progressive Disease|0|||
128718145|NCT02291055|463265194|FG001|Overall Study|Progressive Disease|0|||
128718146|NCT02291055|463265195|FG002|Overall Study|Progressive Disease|1|||
128718147|NCT02291055|463265196|FG003|Overall Study|Progressive Disease|4|||
128718148|NCT02291055|463265197|FG004|Overall Study|Progressive Disease|2|||
128718149|NCT02291055|463265193|FG000|Overall Study|Study Terminated by Sponsor|0|||
128718150|NCT02291055|463265194|FG001|Overall Study|Study Terminated by Sponsor|0|||
128718151|NCT02291055|463265195|FG002|Overall Study|Study Terminated by Sponsor|0|||
128718152|NCT02291055|463265196|FG003|Overall Study|Study Terminated by Sponsor|5|||
128718153|NCT02291055|463265197|FG004|Overall Study|Study Terminated by Sponsor|1|||
128718154|NCT02291055|463265193|FG000|Overall Study|Other|0|||
128718155|NCT02291055|463265194|FG001|Overall Study|Other|2|||
128978967|NCT04047472|464209459|FG000|Overall Study|Adverse Event|3|||
128978968|NCT04047472|464209460|FG001|Overall Study|Adverse Event|3|||
128978969|NCT04047472|464209459|FG000|Overall Study|Death|0|||
128978970|NCT04047472|464209460|FG001|Overall Study|Death|1|||
128978971|NCT04047472|464209459|FG000|Overall Study|Lost to Follow-up|1|||
128978972|NCT04047472|464209460|FG001|Overall Study|Lost to Follow-up|0|||
128978973|NCT04047472|464209459|FG000|Overall Study|Physician Decision|1|||
128978974|NCT04047472|464209460|FG001|Overall Study|Physician Decision|2|||
128978975|NCT04047472|464209459|FG000|Overall Study|Protocol Violation|1|||
128978976|NCT04047472|464209460|FG001|Overall Study|Protocol Violation|0|||
128978977|NCT04047472|464209459|FG000|Overall Study|Withdrawal by Subject|10|||
128978978|NCT04047472|464209460|FG001|Overall Study|Withdrawal by Subject|10|||
128978979|NCT02030067|464209461|FG000|Overall Study|Disease Progression|1|||
128978980|NCT02030067|464209462|FG001|Overall Study|Disease Progression|1|||
128978981|NCT02030067|464209463|FG002|Overall Study|Disease Progression|2|||
128978982|NCT02030067|464209464|FG003|Overall Study|Disease Progression|2|||
128978983|NCT02030067|464209465|FG004|Overall Study|Disease Progression|3|||
128978984|NCT02030067|464209466|FG005|Overall Study|Disease Progression|2|||
128978985|NCT02030067|464209467|FG006|Overall Study|Disease Progression|3|||
128978986|NCT02030067|464209468|FG007|Overall Study|Disease Progression|3|||
128978987|NCT02030067|464209469|FG008|Overall Study|Disease Progression|4|||
128978988|NCT02030067|464209470|FG009|Overall Study|Disease Progression|3|||
128978989|NCT02030067|464209471|FG010|Overall Study|Disease Progression|7|||
128978990|NCT02030067|464209472|FG011|Overall Study|Disease Progression|2|||
128978991|NCT02030067|464209473|FG012|Overall Study|Disease Progression|59|||
128978992|NCT02030067|464209461|FG000|Overall Study|Withdrawal by Subject|0|||
128978993|NCT02030067|464209462|FG001|Overall Study|Withdrawal by Subject|0|||
128978994|NCT02030067|464209463|FG002|Overall Study|Withdrawal by Subject|0|||
128978995|NCT02030067|464209464|FG003|Overall Study|Withdrawal by Subject|1|||
128978996|NCT02030067|464209465|FG004|Overall Study|Withdrawal by Subject|0|||
128978997|NCT02030067|464209466|FG005|Overall Study|Withdrawal by Subject|0|||
128978998|NCT02030067|464209467|FG006|Overall Study|Withdrawal by Subject|0|||
128978999|NCT02030067|464209468|FG007|Overall Study|Withdrawal by Subject|1|||
129041394|NCT00285584|464444273|FG000|Month 3|Lost to Follow-up|3|||
128718156|NCT02291055|463265195|FG002|Overall Study|Other|1|||
128718157|NCT02291055|463265196|FG003|Overall Study|Other|4|||
128718158|NCT02291055|463265197|FG004|Overall Study|Other|0|||
128718159|NCT03839212|463265199|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
128718160|NCT00679263|463265200|FG000|Visit 2/Dose 1|Adverse Event|1|||
128979000|NCT02030067|464209469|FG008|Overall Study|Withdrawal by Subject|0|||
128979001|NCT02030067|464209470|FG009|Overall Study|Withdrawal by Subject|0|||
129041395|NCT00285584|464444274|FG001|Month 3|Lost to Follow-up|3|||
128979002|NCT02030067|464209471|FG010|Overall Study|Withdrawal by Subject|3|||
128979003|NCT02030067|464209472|FG011|Overall Study|Withdrawal by Subject|0|||
128979004|NCT02030067|464209473|FG012|Overall Study|Withdrawal by Subject|6|||
128979005|NCT02030067|464209461|FG000|Overall Study|Physician Decision|0|||
128979006|NCT02030067|464209462|FG001|Overall Study|Physician Decision|0|||
128718161|NCT00679263|463265201|FG001|Visit 2/Dose 1|Adverse Event|0|||
128718162|NCT00679263|463265202|FG002|Visit 2/Dose 1|Adverse Event|0|||
128979007|NCT02030067|464209463|FG002|Overall Study|Physician Decision|0|||
128979008|NCT02030067|464209464|FG003|Overall Study|Physician Decision|0|||
129041396|NCT00285584|464444273|FG000|Month 3|Withdrawal by Subject|1|||
128979009|NCT02030067|464209465|FG004|Overall Study|Physician Decision|0|||
128718163|NCT00679263|463265200|FG000|Visit 2/Dose 1|subject not compliance|1|||
128979010|NCT02030067|464209466|FG005|Overall Study|Physician Decision|0|||
128774914|NCT01474512|463468371|FG014|Induction Period|Lack of Efficacy|0|||
128774915|NCT01474512|463468372|FG015|Induction Period|Lack of Efficacy|0|||
128774916|NCT01474512|463468373|FG016|Induction Period|Lack of Efficacy|0|||
128774917|NCT01474512|463468374|FG017|Induction Period|Lack of Efficacy|0|||
128774918|NCT01474512|463468357|FG000|Induction Period|Withdrawal by Subject|6|||
128774919|NCT01474512|463468358|FG001|Induction Period|Withdrawal by Subject|6|||
128774920|NCT01474512|463468359|FG002|Induction Period|Withdrawal by Subject|5|||
129133198|NCT03928704|464781242|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
128718164|NCT00679263|463265201|FG001|Visit 2/Dose 1|subject not compliance|1|||
128718165|NCT00679263|463265202|FG002|Visit 2/Dose 1|subject not compliance|0|||
128718166|NCT01464346|463265206|FG000|Overall Study|Withdrawal by Subject|0|||
128718167|NCT01464346|463265207|FG001|Overall Study|Withdrawal by Subject|0|||
128718168|NCT01464346|463265208|FG002|Overall Study|Withdrawal by Subject|1|||
128718169|NCT03999892|463265209|FG000|Overall Study|Lost to Follow-up|1|||
128718170|NCT02295995|463265210|FG000|Overall Study|Lost to Follow-up|5|||
128718171|NCT02295995|463265211|FG001|Overall Study|Lost to Follow-up|1|||
128718172|NCT01498458|463265212|FG000|Overall Study|Adverse Event|4|||
128718173|NCT01498458|463265212|FG000|Overall Study|Physician Decision|3|||
128718174|NCT00718328|463265213|FG000|Overall Study|Lost to Follow-up|1|||
128718175|NCT00718328|463265214|FG001|Overall Study|Lost to Follow-up|0|||
128718176|NCT02946047|463265220|FG000|Overall Study|Adverse Event|1|||
128718177|NCT02946047|463265221|FG001|Overall Study|Adverse Event|0|||
128718178|NCT02946047|463265222|FG002|Overall Study|Adverse Event|0|||
128718179|NCT02946047|463265223|FG003|Overall Study|Adverse Event|0|||
128718180|NCT01581307|463265224|FG000|Overall Study|Withdrawal by Subject|1|||
128718181|NCT00378209|463265227|FG000|Overall Study|Progressive disease|11|||
128718182|NCT00378209|463265227|FG000|Overall Study|Adverse Event|3|||
128718183|NCT00378209|463265227|FG000|Overall Study|Initiation of non-protocol therapy|3|||
128718184|NCT00378209|463265227|FG000|Overall Study|Physician Decision|3|||
128718185|NCT00378209|463265227|FG000|Overall Study|Death|1|||
128718186|NCT00378209|463265227|FG000|Overall Study|Treatment delay|1|||
128718187|NCT04814433|463265233|FG000|Overall Study|Survey not returned|4|||
128718188|NCT04814433|463265234|FG001|Overall Study|Survey not returned|8|||
128718189|NCT04814433|463265235|FG002|Overall Study|Survey not returned|4|||
128718190|NCT04814433|463265236|FG003|Overall Study|Survey not returned|5|||
128718191|NCT02496533|463265239|FG000|Overall Study|Lack of data on outcome|3|||
128718192|NCT02496533|463265240|FG001|Overall Study|Lack of data on outcome|0|||
128718193|NCT02496533|463265239|FG000|Overall Study|Patient did not complete all measures|0|||
128718194|NCT02496533|463265240|FG001|Overall Study|Patient did not complete all measures|4|||
128718195|NCT02496533|463265239|FG000|Overall Study|Late for radiologic testing|0|||
128718196|NCT02496533|463265240|FG001|Overall Study|Late for radiologic testing|2|||
128718197|NCT01816893|463265243|FG000|Washout Period|Withdrawal by Subject|2|||
128718198|NCT01816893|463265244|FG001|Washout Period|Withdrawal by Subject|0|||
128718199|NCT02016625|463267081|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
128718200|NCT02016625|463267082|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
128718201|NCT02016625|463267081|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
128718202|NCT02016625|463267082|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
128718203|NCT02016625|463267081|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
128718204|NCT02016625|463267082|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
128718205|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
128718206|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
128718207|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
128718208|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
128718209|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
128718210|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
128718211|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
128718212|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
128718213|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
128718214|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
128718215|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
128718216|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
128718217|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
128718218|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
128718219|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
128718220|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
128718221|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
128718222|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
128774921|NCT01474512|463468360|FG003|Induction Period|Withdrawal by Subject|0|||
128774922|NCT01474512|463468361|FG004|Induction Period|Withdrawal by Subject|0|||
128718223|NCT00887354|463267083|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
128718224|NCT00887354|463267084|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
128718225|NCT00887354|463267083|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
128718226|NCT00887354|463267084|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
128774923|NCT01474512|463468362|FG005|Induction Period|Withdrawal by Subject|0|||
128774924|NCT01474512|463468363|FG006|Induction Period|Withdrawal by Subject|0|||
128774925|NCT01474512|463468364|FG007|Induction Period|Withdrawal by Subject|0|||
128774926|NCT01474512|463468365|FG008|Induction Period|Withdrawal by Subject|0|||
128774927|NCT01474512|463468366|FG009|Induction Period|Withdrawal by Subject|0|||
128774928|NCT01474512|463468367|FG010|Induction Period|Withdrawal by Subject|0|||
128774929|NCT01474512|463468368|FG011|Induction Period|Withdrawal by Subject|0|||
128774930|NCT01474512|463468369|FG012|Induction Period|Withdrawal by Subject|0|||
128774931|NCT01474512|463468370|FG013|Induction Period|Withdrawal by Subject|0|||
128774932|NCT01474512|463468371|FG014|Induction Period|Withdrawal by Subject|0|||
128774933|NCT01474512|463468372|FG015|Induction Period|Withdrawal by Subject|0|||
128774934|NCT01474512|463468373|FG016|Induction Period|Withdrawal by Subject|0|||
128774935|NCT01474512|463468374|FG017|Induction Period|Withdrawal by Subject|0|||
128774936|NCT01474512|463468357|FG000|Induction Period|Protocol Violation|3|||
128774937|NCT01474512|463468358|FG001|Induction Period|Protocol Violation|6|||
128774938|NCT01474512|463468359|FG002|Induction Period|Protocol Violation|0|||
128774939|NCT01474512|463468360|FG003|Induction Period|Protocol Violation|0|||
128774940|NCT01474512|463468361|FG004|Induction Period|Protocol Violation|0|||
128774941|NCT01474512|463468362|FG005|Induction Period|Protocol Violation|0|||
128774942|NCT01474512|463468363|FG006|Induction Period|Protocol Violation|0|||
128774943|NCT01474512|463468364|FG007|Induction Period|Protocol Violation|0|||
128774944|NCT01474512|463468365|FG008|Induction Period|Protocol Violation|0|||
128774945|NCT01474512|463468366|FG009|Induction Period|Protocol Violation|0|||
128774946|NCT01474512|463468367|FG010|Induction Period|Protocol Violation|0|||
128774947|NCT01474512|463468368|FG011|Induction Period|Protocol Violation|0|||
128774948|NCT01474512|463468369|FG012|Induction Period|Protocol Violation|0|||
128774949|NCT01474512|463468370|FG013|Induction Period|Protocol Violation|0|||
128774950|NCT01474512|463468371|FG014|Induction Period|Protocol Violation|0|||
128774951|NCT01474512|463468372|FG015|Induction Period|Protocol Violation|0|||
128774952|NCT01474512|463468373|FG016|Induction Period|Protocol Violation|0|||
128774953|NCT01474512|463468374|FG017|Induction Period|Protocol Violation|0|||
128774954|NCT01474512|463468357|FG000|Induction Period|Sponsor Decision|1|||
128774955|NCT01474512|463468358|FG001|Induction Period|Sponsor Decision|1|||
128774956|NCT01474512|463468359|FG002|Induction Period|Sponsor Decision|1|||
128774957|NCT01474512|463468360|FG003|Induction Period|Sponsor Decision|0|||
128774958|NCT01474512|463468361|FG004|Induction Period|Sponsor Decision|0|||
128774959|NCT01474512|463468362|FG005|Induction Period|Sponsor Decision|0|||
128774960|NCT01474512|463468363|FG006|Induction Period|Sponsor Decision|0|||
128774961|NCT01474512|463468364|FG007|Induction Period|Sponsor Decision|0|||
128774962|NCT01474512|463468365|FG008|Induction Period|Sponsor Decision|0|||
128774963|NCT01474512|463468366|FG009|Induction Period|Sponsor Decision|0|||
128774964|NCT01474512|463468367|FG010|Induction Period|Sponsor Decision|0|||
128774965|NCT01474512|463468368|FG011|Induction Period|Sponsor Decision|0|||
128774966|NCT01474512|463468369|FG012|Induction Period|Sponsor Decision|0|||
128774967|NCT01474512|463468370|FG013|Induction Period|Sponsor Decision|0|||
128718227|NCT00887354|463267083|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
128718228|NCT00887354|463267084|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
128718229|NCT00887354|463267083|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
128718230|NCT00887354|463267084|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
128718231|NCT00887354|463267083|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
128718232|NCT00887354|463267084|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
128718233|NCT00887354|463267083|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
128718234|NCT00887354|463267084|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
128718235|NCT00914810|463267087|FG000|Overall Study|Withdrawal by Subject|1|||
128718236|NCT00914810|463267088|FG001|Overall Study|Withdrawal by Subject|0|||
128718237|NCT00914810|463267087|FG000|Overall Study|Relocated out of state|1|||
128718238|NCT00914810|463267088|FG001|Overall Study|Relocated out of state|0|||
128718239|NCT00914810|463267087|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
128718240|NCT00914810|463267088|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
128718241|NCT01465022|463267089|FG000|Overall Study|Lost to Follow-up|15|||
128774968|NCT01474512|463468371|FG014|Induction Period|Sponsor Decision|0|||
128774969|NCT01474512|463468372|FG015|Induction Period|Sponsor Decision|0|||
128774970|NCT01474512|463468373|FG016|Induction Period|Sponsor Decision|0|||
128774971|NCT01474512|463468374|FG017|Induction Period|Sponsor Decision|0|||
128774972|NCT01474512|463468357|FG000|Induction Period|Lost to Follow-up|1|||
128774973|NCT01474512|463468358|FG001|Induction Period|Lost to Follow-up|0|||
129041397|NCT00285584|464444274|FG001|Month 3|Withdrawal by Subject|0|||
129041398|NCT00285584|464444273|FG000|Month 6|Lost to Follow-up|0|||
128774974|NCT01474512|463468359|FG002|Induction Period|Lost to Follow-up|2|||
128774975|NCT01474512|463468360|FG003|Induction Period|Lost to Follow-up|0|||
128774976|NCT01474512|463468361|FG004|Induction Period|Lost to Follow-up|0|||
128774977|NCT01474512|463468362|FG005|Induction Period|Lost to Follow-up|0|||
128774978|NCT01474512|463468363|FG006|Induction Period|Lost to Follow-up|0|||
128774979|NCT01474512|463468364|FG007|Induction Period|Lost to Follow-up|0|||
128718242|NCT01465022|463267090|FG001|Overall Study|Lost to Follow-up|14|||
128774980|NCT01474512|463468365|FG008|Induction Period|Lost to Follow-up|0|||
128774981|NCT01474512|463468366|FG009|Induction Period|Lost to Follow-up|0|||
128774982|NCT01474512|463468367|FG010|Induction Period|Lost to Follow-up|0|||
128774983|NCT01474512|463468368|FG011|Induction Period|Lost to Follow-up|0|||
128774984|NCT01474512|463468369|FG012|Induction Period|Lost to Follow-up|0|||
128774985|NCT01474512|463468370|FG013|Induction Period|Lost to Follow-up|0|||
128774986|NCT01474512|463468371|FG014|Induction Period|Lost to Follow-up|0|||
128774987|NCT01474512|463468372|FG015|Induction Period|Lost to Follow-up|0|||
128774988|NCT01474512|463468373|FG016|Induction Period|Lost to Follow-up|0|||
128774989|NCT01474512|463468374|FG017|Induction Period|Lost to Follow-up|0|||
128774990|NCT01474512|463468357|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128774991|NCT01474512|463468358|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128774992|NCT01474512|463468359|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128774993|NCT01474512|463468360|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
128774994|NCT01474512|463468361|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
128774995|NCT01474512|463468362|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
128774996|NCT01474512|463468363|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
128774997|NCT01474512|463468364|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128774998|NCT01474512|463468365|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128774999|NCT01474512|463468366|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775000|NCT01474512|463468367|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775001|NCT01474512|463468368|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775002|NCT01474512|463468369|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775003|NCT01474512|463468370|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775004|NCT01474512|463468371|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775005|NCT01474512|463468372|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775006|NCT01474512|463468373|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775007|NCT01474512|463468374|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
128775008|NCT01474512|463468357|FG000|Maintenance Period|Adverse Event|0|||
128775009|NCT01474512|463468358|FG001|Maintenance Period|Adverse Event|0|||
128775010|NCT01474512|463468359|FG002|Maintenance Period|Adverse Event|0|||
128775011|NCT01474512|463468360|FG003|Maintenance Period|Adverse Event|4|||
128775012|NCT01474512|463468361|FG004|Maintenance Period|Adverse Event|2|||
128775013|NCT01474512|463468362|FG005|Maintenance Period|Adverse Event|7|||
128775014|NCT01474512|463468363|FG006|Maintenance Period|Adverse Event|0|||
128775015|NCT01474512|463468364|FG007|Maintenance Period|Adverse Event|19|||
128775016|NCT01474512|463468365|FG008|Maintenance Period|Adverse Event|1|||
128775017|NCT01474512|463468366|FG009|Maintenance Period|Adverse Event|3|||
128775018|NCT01474512|463468367|FG010|Maintenance Period|Adverse Event|0|||
128775019|NCT01474512|463468368|FG011|Maintenance Period|Adverse Event|0|||
128775020|NCT01474512|463468369|FG012|Maintenance Period|Adverse Event|0|||
128775021|NCT01474512|463468370|FG013|Maintenance Period|Adverse Event|0|||
128775022|NCT01474512|463468371|FG014|Maintenance Period|Adverse Event|0|||
128775023|NCT01474512|463468372|FG015|Maintenance Period|Adverse Event|0|||
128775024|NCT01474512|463468373|FG016|Maintenance Period|Adverse Event|0|||
128775025|NCT01474512|463468374|FG017|Maintenance Period|Adverse Event|0|||
128775026|NCT01474512|463468357|FG000|Maintenance Period|Withdrawal by Subject|0|||
128775027|NCT01474512|463468358|FG001|Maintenance Period|Withdrawal by Subject|0|||
128775028|NCT01474512|463468359|FG002|Maintenance Period|Withdrawal by Subject|0|||
128775029|NCT01474512|463468360|FG003|Maintenance Period|Withdrawal by Subject|6|||
128775030|NCT01474512|463468361|FG004|Maintenance Period|Withdrawal by Subject|2|||
128775031|NCT01474512|463468362|FG005|Maintenance Period|Withdrawal by Subject|3|||
128775032|NCT01474512|463468363|FG006|Maintenance Period|Withdrawal by Subject|1|||
128775033|NCT01474512|463468364|FG007|Maintenance Period|Withdrawal by Subject|6|||
128775034|NCT01474512|463468365|FG008|Maintenance Period|Withdrawal by Subject|3|||
128775035|NCT01474512|463468366|FG009|Maintenance Period|Withdrawal by Subject|1|||
128775036|NCT01474512|463468367|FG010|Maintenance Period|Withdrawal by Subject|0|||
128775037|NCT01474512|463468368|FG011|Maintenance Period|Withdrawal by Subject|0|||
128775038|NCT01474512|463468369|FG012|Maintenance Period|Withdrawal by Subject|0|||
128775039|NCT01474512|463468370|FG013|Maintenance Period|Withdrawal by Subject|0|||
128775040|NCT01474512|463468371|FG014|Maintenance Period|Withdrawal by Subject|0|||
128775041|NCT01474512|463468372|FG015|Maintenance Period|Withdrawal by Subject|0|||
128775042|NCT01474512|463468373|FG016|Maintenance Period|Withdrawal by Subject|0|||
128775043|NCT01474512|463468374|FG017|Maintenance Period|Withdrawal by Subject|0|||
128775044|NCT01474512|463468357|FG000|Maintenance Period|Lost to Follow-up|0|||
128775045|NCT01474512|463468358|FG001|Maintenance Period|Lost to Follow-up|0|||
128775046|NCT01474512|463468359|FG002|Maintenance Period|Lost to Follow-up|0|||
128775047|NCT01474512|463468360|FG003|Maintenance Period|Lost to Follow-up|3|||
128775048|NCT01474512|463468361|FG004|Maintenance Period|Lost to Follow-up|3|||
128775049|NCT01474512|463468362|FG005|Maintenance Period|Lost to Follow-up|0|||
129133199|NCT03928704|464781243|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
129133200|NCT03928704|464781244|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
129133201|NCT03928704|464781245|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
128775050|NCT01474512|463468363|FG006|Maintenance Period|Lost to Follow-up|0|||
128775051|NCT01474512|463468364|FG007|Maintenance Period|Lost to Follow-up|2|||
128775052|NCT01474512|463468365|FG008|Maintenance Period|Lost to Follow-up|1|||
129133202|NCT03928704|464781246|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
129133203|NCT03928704|464781241|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129133204|NCT03928704|464781242|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129133205|NCT03928704|464781243|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
129133206|NCT03928704|464781244|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129133207|NCT03928704|464781245|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129133208|NCT03928704|464781246|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129133209|NCT03928704|464781241|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129133210|NCT03928704|464781242|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129133211|NCT03928704|464781243|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129133212|NCT03928704|464781244|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129133213|NCT03928704|464781245|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129133214|NCT03928704|464781246|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
129133215|NCT03928704|464781241|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
129133216|NCT03928704|464781242|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
129133217|NCT03928704|464781243|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
129133218|NCT03928704|464781244|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
129133219|NCT03928704|464781245|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
129133220|NCT03928704|464781246|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
129133221|NCT04575324|464781249|FG000|Overall Study|Lost to Follow-up|29|||
129133222|NCT04575324|464781250|FG001|Overall Study|Lost to Follow-up|25|||
129133223|NCT04575324|464781249|FG000|Overall Study|Death|1|||
129133224|NCT04575324|464781250|FG001|Overall Study|Death|2|||
129133225|NCT04575324|464781249|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
129133226|NCT04575324|464781250|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
129133227|NCT01002105|464781254|FG000|Overall Study|Lost to Follow-up|10|||
129133228|NCT01002105|464781255|FG001|Overall Study|Lost to Follow-up|16|||
129133229|NCT01002105|464781254|FG000|Overall Study|non compliance|5|||
129133230|NCT01002105|464781255|FG001|Overall Study|non compliance|3|||
129133231|NCT01002105|464781254|FG000|Overall Study|condition worsened|4|||
129133232|NCT01002105|464781255|FG001|Overall Study|condition worsened|2|||
129133233|NCT00327171|464781259|FG000|Overall Study|Did not receive study medication|3|||
129133234|NCT00327171|464781260|FG001|Overall Study|Did not receive study medication|0|||
129133235|NCT00327171|464781259|FG000|Overall Study|Adverse Event|23|||
129133236|NCT00327171|464781260|FG001|Overall Study|Adverse Event|23|||
129133237|NCT00327171|464781259|FG000|Overall Study|Disease progression/lack of efficacy|68|||
129133238|NCT00327171|464781260|FG001|Overall Study|Disease progression/lack of efficacy|69|||
129133239|NCT00327171|464781259|FG000|Overall Study|Investigator/participant request|1|||
129133240|NCT00327171|464781260|FG001|Overall Study|Investigator/participant request|8|||
129133241|NCT00327171|464781259|FG000|Overall Study|Clinical progression|12|||
129133242|NCT00327171|464781260|FG001|Overall Study|Clinical progression|8|||
129133243|NCT00327171|464781259|FG000|Overall Study|Undisclosed history of ischemia|0|||
129133244|NCT00327171|464781260|FG001|Overall Study|Undisclosed history of ischemia|1|||
129133245|NCT00327171|464781259|FG000|Overall Study|Other|1|||
129133246|NCT00327171|464781260|FG001|Overall Study|Other|0|||
129133247|NCT00266812|464781261|FG000|Overall Study|Disease Progression|9|||
129133248|NCT00266812|464781262|FG001|Overall Study|Disease Progression|3|||
129133249|NCT00266812|464781261|FG000|Overall Study|Death|5|||
129133250|NCT00266812|464781262|FG001|Overall Study|Death|4|||
129222533|NCT03306173|465116131|FG001|Overall Study|Withdrawal by Subject|3|||
128718243|NCT01465022|463267091|FG002|Overall Study|Lost to Follow-up|0|||
128718244|NCT01465022|463267089|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
128718245|NCT01465022|463267090|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
128718246|NCT01465022|463267091|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
128718247|NCT01465022|463267089|FG000|Overall Study|Not Randomized|0|||
129133251|NCT00266812|464781261|FG000|Overall Study|Adverse Event|3|||
129133252|NCT00266812|464781262|FG001|Overall Study|Adverse Event|1|||
129133253|NCT00266812|464781261|FG000|Overall Study|Protocol Violation|0|||
129133254|NCT00266812|464781262|FG001|Overall Study|Protocol Violation|1|||
129133255|NCT00266812|464781261|FG000|Overall Study|Withdrawal by Subject|0|||
129133256|NCT00266812|464781262|FG001|Overall Study|Withdrawal by Subject|2|||
129133257|NCT00266812|464781261|FG000|Overall Study|Discontinued before starting study drug|4|||
129133258|NCT00266812|464781262|FG001|Overall Study|Discontinued before starting study drug|0|||
129133259|NCT03695094|464781263|FG000|Overall Study|Adverse Event|1|||
128718248|NCT01465022|463267090|FG001|Overall Study|Not Randomized|0|||
128718249|NCT01465022|463267091|FG002|Overall Study|Not Randomized|70|||
129133260|NCT03695094|464781264|FG001|Overall Study|Adverse Event|1|||
129133261|NCT03695094|464781263|FG000|Overall Study|Withdrawal by Subject|1|||
129133262|NCT03695094|464781264|FG001|Overall Study|Withdrawal by Subject|0|||
129133263|NCT00456612|464781265|FG000|Overall Study|Withdrawal by Subject|3|||
129133264|NCT00530075|464781268|FG000|Overall Study|Adverse Event|1|||
129133265|NCT00530075|464781268|FG000|Overall Study|Death|1|||
129222534|NCT03306173|465116130|FG000|Overall Study|Discontinued|4|||
128718250|NCT01327300|463267092|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
128718251|NCT01327300|463267093|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
128718252|NCT03257631|463267107|FG000|Overall Study|Death|1|||
128718253|NCT03257631|463267108|FG001|Overall Study|Death|0|||
128718254|NCT03257631|463267109|FG002|Overall Study|Death|1|||
128718255|NCT03257631|463267110|FG003|Overall Study|Death|1|||
128718256|NCT03257631|463267107|FG000|Overall Study|Progressive Disease|10|||
128718257|NCT03257631|463267108|FG001|Overall Study|Progressive Disease|9|||
128718258|NCT03257631|463267109|FG002|Overall Study|Progressive Disease|17|||
128718259|NCT03257631|463267110|FG003|Overall Study|Progressive Disease|8|||
128718260|NCT03257631|463267107|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128718261|NCT03257631|463267108|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128718262|NCT03257631|463267109|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
128718263|NCT03257631|463267110|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
128718264|NCT03257631|463267107|FG000|Overall Study|Adverse Event|0|||
128718265|NCT03257631|463267108|FG001|Overall Study|Adverse Event|0|||
128718266|NCT03257631|463267109|FG002|Overall Study|Adverse Event|2|||
128718267|NCT03257631|463267110|FG003|Overall Study|Adverse Event|0|||
128718268|NCT02529137|463267111|FG000|Overall Study|Discontinuation for different reasons|8|||
128718269|NCT01290666|463267115|FG000|Overall Study|Lost to Follow-up|11|||
128718270|NCT01290666|463267115|FG000|Overall Study|Withdrawal by Subject|23|||
128718271|NCT01290666|463267115|FG000|Overall Study|Early Termination of Study|4|||
128718272|NCT03036098|463267116|FG000|Pre-Treatment|Other Reasons|1|||
128718273|NCT03036098|463267117|FG001|Pre-Treatment|Other Reasons|2|||
128718274|NCT03036098|463267118|FG002|Pre-Treatment|Other Reasons|0|||
128718275|NCT03036098|463267119|FG003|Pre-Treatment|Other Reasons|5|||
128718276|NCT03036098|463267116|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
128718277|NCT03036098|463267117|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
128718278|NCT03036098|463267118|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
128718279|NCT03036098|463267119|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
128718280|NCT03036098|463267116|FG000|Pre-Treatment|Withdrawal by Subject|1|||
128718281|NCT03036098|463267117|FG001|Pre-Treatment|Withdrawal by Subject|14|||
128718282|NCT03036098|463267118|FG002|Pre-Treatment|Withdrawal by Subject|0|||
128718283|NCT03036098|463267119|FG003|Pre-Treatment|Withdrawal by Subject|5|||
128718284|NCT03036098|463267116|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
128718285|NCT03036098|463267117|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
128718286|NCT03036098|463267118|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
128718287|NCT03036098|463267119|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
128718288|NCT03036098|463267116|FG000|Treatment|Disease Progression|130|||
128718289|NCT03036098|463267117|FG001|Treatment|Disease Progression|77|||
128718290|NCT03036098|463267118|FG002|Treatment|Disease Progression|168|||
128718291|NCT03036098|463267119|FG003|Treatment|Disease Progression|50|||
128718292|NCT03036098|463267116|FG000|Treatment|Study Drug Toxicity|95|||
128718293|NCT03036098|463267117|FG001|Treatment|Study Drug Toxicity|45|||
128718294|NCT03036098|463267118|FG002|Treatment|Study Drug Toxicity|26|||
128718295|NCT03036098|463267119|FG003|Treatment|Study Drug Toxicity|22|||
128718296|NCT03036098|463267116|FG000|Treatment|Death|9|||
128718297|NCT03036098|463267117|FG001|Treatment|Death|3|||
128718298|NCT03036098|463267118|FG002|Treatment|Death|1|||
128718299|NCT03036098|463267119|FG003|Treatment|Death|2|||
128718300|NCT03036098|463267116|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
128718301|NCT03036098|463267117|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
128718302|NCT03036098|463267118|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
128718303|NCT03036098|463267119|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
128718304|NCT03036098|463267116|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
128718305|NCT03036098|463267117|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
128775053|NCT01474512|463468366|FG009|Maintenance Period|Lost to Follow-up|1|||
128775054|NCT01474512|463468367|FG010|Maintenance Period|Lost to Follow-up|0|||
128775055|NCT01474512|463468368|FG011|Maintenance Period|Lost to Follow-up|0|||
128775056|NCT01474512|463468369|FG012|Maintenance Period|Lost to Follow-up|0|||
128775057|NCT01474512|463468370|FG013|Maintenance Period|Lost to Follow-up|0|||
128718306|NCT03036098|463267118|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
128718307|NCT03036098|463267119|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
128718308|NCT03036098|463267116|FG000|Treatment|Withdrawal by Subject|2|||
128718309|NCT03036098|463267117|FG001|Treatment|Withdrawal by Subject|9|||
128718310|NCT03036098|463267118|FG002|Treatment|Withdrawal by Subject|2|||
128718311|NCT03036098|463267119|FG003|Treatment|Withdrawal by Subject|4|||
128718312|NCT03036098|463267116|FG000|Treatment|Maximum Clinical Benefit|6|||
128718313|NCT03036098|463267117|FG001|Treatment|Maximum Clinical Benefit|1|||
128718314|NCT03036098|463267118|FG002|Treatment|Maximum Clinical Benefit|6|||
128718315|NCT03036098|463267119|FG003|Treatment|Maximum Clinical Benefit|10|||
128718316|NCT03036098|463267116|FG000|Treatment|Poor/Non Compliance|1|||
128718317|NCT03036098|463267117|FG001|Treatment|Poor/Non Compliance|2|||
128718318|NCT03036098|463267118|FG002|Treatment|Poor/Non Compliance|0|||
128775058|NCT01474512|463468371|FG014|Maintenance Period|Lost to Follow-up|0|||
128775059|NCT01474512|463468372|FG015|Maintenance Period|Lost to Follow-up|0|||
128979011|NCT02030067|464209467|FG006|Overall Study|Physician Decision|0|||
128979012|NCT02030067|464209468|FG007|Overall Study|Physician Decision|0|||
128979013|NCT02030067|464209469|FG008|Overall Study|Physician Decision|0|||
128979014|NCT02030067|464209470|FG009|Overall Study|Physician Decision|0|||
128979015|NCT02030067|464209471|FG010|Overall Study|Physician Decision|1|||
128979016|NCT02030067|464209472|FG011|Overall Study|Physician Decision|0|||
128979017|NCT02030067|464209473|FG012|Overall Study|Physician Decision|3|||
128979018|NCT02030067|464209461|FG000|Overall Study|other reasons|0|||
128979019|NCT02030067|464209462|FG001|Overall Study|other reasons|0|||
128979020|NCT02030067|464209463|FG002|Overall Study|other reasons|0|||
128979021|NCT02030067|464209464|FG003|Overall Study|other reasons|0|||
128979022|NCT02030067|464209465|FG004|Overall Study|other reasons|0|||
128979023|NCT02030067|464209466|FG005|Overall Study|other reasons|1|||
128979024|NCT02030067|464209467|FG006|Overall Study|other reasons|0|||
128979025|NCT02030067|464209468|FG007|Overall Study|other reasons|0|||
128979026|NCT02030067|464209469|FG008|Overall Study|other reasons|2|||
128979027|NCT02030067|464209470|FG009|Overall Study|other reasons|0|||
128979028|NCT02030067|464209471|FG010|Overall Study|other reasons|0|||
128979029|NCT02030067|464209472|FG011|Overall Study|other reasons|0|||
128979030|NCT02030067|464209473|FG012|Overall Study|other reasons|4|||
128979031|NCT02030067|464209461|FG000|Overall Study|Adverse Event|0|||
128979032|NCT02030067|464209462|FG001|Overall Study|Adverse Event|0|||
128979033|NCT02030067|464209463|FG002|Overall Study|Adverse Event|0|||
128979034|NCT02030067|464209464|FG003|Overall Study|Adverse Event|0|||
128979035|NCT02030067|464209465|FG004|Overall Study|Adverse Event|0|||
128979036|NCT02030067|464209466|FG005|Overall Study|Adverse Event|0|||
128979037|NCT02030067|464209467|FG006|Overall Study|Adverse Event|0|||
128979038|NCT02030067|464209468|FG007|Overall Study|Adverse Event|0|||
128979039|NCT02030067|464209469|FG008|Overall Study|Adverse Event|0|||
128979040|NCT02030067|464209470|FG009|Overall Study|Adverse Event|0|||
128979041|NCT02030067|464209471|FG010|Overall Study|Adverse Event|0|||
128979042|NCT02030067|464209472|FG011|Overall Study|Adverse Event|1|||
128979043|NCT02030067|464209473|FG012|Overall Study|Adverse Event|8|||
129133266|NCT00530075|464781268|FG000|Overall Study|Lack of Efficacy|3|||
129133267|NCT00530075|464781268|FG000|Overall Study|Protocol Violation|1|||
129133268|NCT00530075|464781268|FG000|Overall Study|Withdrawal by Subject|1|||
129133269|NCT02316613|464781269|FG000|Overall Study|Death|63|||
129133270|NCT02316613|464781269|FG000|Overall Study|Lost to Follow-up|9|||
129133271|NCT02316613|464781269|FG000|Overall Study|Lymphoma transformation|2|||
129133272|NCT02316613|464781269|FG000|Overall Study|Participant moved/changed medical team|11|||
129133273|NCT02316613|464781269|FG000|Overall Study|No data and duplicate cases|5|||
129133274|NCT02316613|464781269|FG000|Overall Study|Did not met selection criteria|14|||
129133275|NCT01166945|464781270|FG000|Randomized|diagnosed with Group A strep|4|||
129133276|NCT01166945|464781271|FG001|Randomized|diagnosed with Group A strep|4|||
129133277|NCT01166945|464781270|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
129133278|NCT01166945|464781271|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
129133279|NCT01166945|464781270|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
129133280|NCT01166945|464781271|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
128979044|NCT01632345|464209474|FG000|Treatment: Part I|Adverse Event|1|||
129133281|NCT01166945|464781270|FG000|Day 30|Lost to Follow-up|4|||
128979045|NCT01632345|464209475|FG001|Treatment: Part I|Adverse Event|4|||
128979046|NCT01632345|464209476|FG002|Treatment: Part I|Adverse Event|2|||
128979047|NCT01632345|464209477|FG003|Treatment: Part I|Adverse Event|1|||
128979048|NCT01632345|464209478|FG004|Treatment: Part I|Adverse Event|3|||
128979049|NCT01632345|464209479|FG005|Treatment: Part I|Adverse Event|0|||
128979050|NCT01632345|464209480|FG006|Treatment: Part I|Adverse Event|0|||
128979051|NCT01632345|464209474|FG000|Treatment: Part I|Lack of Efficacy|0|||
129133282|NCT01166945|464781271|FG001|Day 30|Lost to Follow-up|3|||
129133283|NCT00784927|464781273|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
129133284|NCT00784927|464781273|FG000|Overall Study|Protocol Violation|1|||
129133285|NCT00784927|464781273|FG000|Overall Study|Ineligible|1|||
129133286|NCT00422461|464781280|FG000|Overall Study|Adverse Event|1|||
129133287|NCT00422461|464781281|FG001|Overall Study|Adverse Event|2|||
129133288|NCT00422461|464781282|FG002|Overall Study|Adverse Event|1|||
129133289|NCT00422461|464781283|FG003|Overall Study|Adverse Event|1|||
129133290|NCT00422461|464781280|FG000|Overall Study|Other|0|||
129133291|NCT00422461|464781281|FG001|Overall Study|Other|0|||
129133292|NCT00422461|464781282|FG002|Overall Study|Other|0|||
129133293|NCT00422461|464781283|FG003|Overall Study|Other|2|||
128979052|NCT01632345|464209475|FG001|Treatment: Part I|Lack of Efficacy|1|||
128979053|NCT01632345|464209476|FG002|Treatment: Part I|Lack of Efficacy|0|||
129133294|NCT00422461|464781280|FG000|Overall Study|Participants no longer willing to participate in study|1|||
128979054|NCT01632345|464209477|FG003|Treatment: Part I|Lack of Efficacy|1|||
128979055|NCT01632345|464209478|FG004|Treatment: Part I|Lack of Efficacy|1|||
128979056|NCT01632345|464209479|FG005|Treatment: Part I|Lack of Efficacy|0|||
128979057|NCT01632345|464209480|FG006|Treatment: Part I|Lack of Efficacy|0|||
128979058|NCT01632345|464209474|FG000|Treatment: Part I|Lost to Follow-up|3|||
128979059|NCT01632345|464209475|FG001|Treatment: Part I|Lost to Follow-up|2|||
128979060|NCT01632345|464209476|FG002|Treatment: Part I|Lost to Follow-up|1|||
129133295|NCT00422461|464781281|FG001|Overall Study|Participants no longer willing to participate in study|0|||
129133296|NCT00422461|464781282|FG002|Overall Study|Participants no longer willing to participate in study|0|||
129133297|NCT00422461|464781283|FG003|Overall Study|Participants no longer willing to participate in study|0|||
129133298|NCT00422461|464781280|FG000|Overall Study|Randomized but not treated|1|||
129133299|NCT00422461|464781281|FG001|Overall Study|Randomized but not treated|1|||
129222535|NCT03306173|465116131|FG001|Overall Study|Discontinued|4|||
128718319|NCT03036098|463267119|FG003|Treatment|Poor/Non Compliance|1|||
128718320|NCT03036098|463267116|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
128718321|NCT03036098|463267117|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
128718322|NCT03036098|463267118|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
128718323|NCT03036098|463267119|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
128718324|NCT03036098|463267116|FG000|Treatment|Administrative Reason by Sponsor|1|||
128718325|NCT03036098|463267117|FG001|Treatment|Administrative Reason by Sponsor|0|||
128718326|NCT03036098|463267118|FG002|Treatment|Administrative Reason by Sponsor|2|||
128718327|NCT03036098|463267119|FG003|Treatment|Administrative Reason by Sponsor|1|||
128718328|NCT03036098|463267116|FG000|Treatment|Other Reasons|31|||
128718329|NCT03036098|463267117|FG001|Treatment|Other Reasons|5|||
128718330|NCT03036098|463267118|FG002|Treatment|Other Reasons|21|||
128718331|NCT03036098|463267119|FG003|Treatment|Other Reasons|8|||
128718332|NCT03036098|463267116|FG000|Treatment|Ongoing Treatment|0|||
128718333|NCT03036098|463267117|FG001|Treatment|Ongoing Treatment|0|||
128718334|NCT03036098|463267118|FG002|Treatment|Ongoing Treatment|23|||
128718335|NCT03036098|463267119|FG003|Treatment|Ongoing Treatment|0|||
128718336|NCT02063854|463267120|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
128718337|NCT02063854|463267121|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
128718338|NCT02063854|463267122|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
128718339|NCT02063854|463267123|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
128718340|NCT02063854|463267124|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
128979061|NCT01632345|464209477|FG003|Treatment: Part I|Lost to Follow-up|3|||
128979062|NCT01632345|464209478|FG004|Treatment: Part I|Lost to Follow-up|4|||
128979063|NCT01632345|464209479|FG005|Treatment: Part I|Lost to Follow-up|0|||
128979064|NCT01632345|464209480|FG006|Treatment: Part I|Lost to Follow-up|0|||
128718341|NCT02063854|463267125|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
128979065|NCT01632345|464209474|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
128979066|NCT01632345|464209475|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
128718342|NCT02063854|463267126|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
128718343|NCT02063854|463267120|FG000|Overall Study|Major Protocol Deviation|0|||
128718344|NCT02063854|463267121|FG001|Overall Study|Major Protocol Deviation|0|||
128718345|NCT02063854|463267122|FG002|Overall Study|Major Protocol Deviation|3|||
128718346|NCT02063854|463267123|FG003|Overall Study|Major Protocol Deviation|0|||
128718347|NCT02063854|463267124|FG004|Overall Study|Major Protocol Deviation|0|||
128718348|NCT02063854|463267125|FG005|Overall Study|Major Protocol Deviation|0|||
128718349|NCT02063854|463267126|FG006|Overall Study|Major Protocol Deviation|0|||
128718350|NCT02063854|463267120|FG000|Overall Study|Voluntary Withdrawal|2|||
128718351|NCT02063854|463267121|FG001|Overall Study|Voluntary Withdrawal|0|||
128718352|NCT02063854|463267122|FG002|Overall Study|Voluntary Withdrawal|8|||
128718353|NCT02063854|463267123|FG003|Overall Study|Voluntary Withdrawal|1|||
128718354|NCT02063854|463267124|FG004|Overall Study|Voluntary Withdrawal|3|||
128718355|NCT02063854|463267125|FG005|Overall Study|Voluntary Withdrawal|6|||
128718356|NCT02063854|463267126|FG006|Overall Study|Voluntary Withdrawal|1|||
128718357|NCT02063854|463267120|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
128718358|NCT02063854|463267121|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
128718359|NCT02063854|463267122|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
128718360|NCT02063854|463267123|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
128718361|NCT02063854|463267124|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
128718362|NCT02063854|463267125|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
128718363|NCT02063854|463267126|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
128718364|NCT02063854|463267120|FG000|Overall Study|Reason Not Specified|1|||
128718365|NCT02063854|463267121|FG001|Overall Study|Reason Not Specified|0|||
128718366|NCT02063854|463267122|FG002|Overall Study|Reason Not Specified|0|||
128718367|NCT02063854|463267123|FG003|Overall Study|Reason Not Specified|0|||
128718368|NCT02063854|463267124|FG004|Overall Study|Reason Not Specified|0|||
128718369|NCT02063854|463267125|FG005|Overall Study|Reason Not Specified|0|||
128718370|NCT02063854|463267126|FG006|Overall Study|Reason Not Specified|0|||
128718371|NCT02063854|463267120|FG000|Overall Study|Did Not Receive Study Drug|0|||
128718372|NCT02063854|463267121|FG001|Overall Study|Did Not Receive Study Drug|0|||
128979067|NCT01632345|464209476|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
128718373|NCT02063854|463267122|FG002|Overall Study|Did Not Receive Study Drug|0|||
128718374|NCT02063854|463267123|FG003|Overall Study|Did Not Receive Study Drug|0|||
128718375|NCT02063854|463267124|FG004|Overall Study|Did Not Receive Study Drug|0|||
128718376|NCT02063854|463267125|FG005|Overall Study|Did Not Receive Study Drug|1|||
128718377|NCT02063854|463267126|FG006|Overall Study|Did Not Receive Study Drug|0|||
128979068|NCT01632345|464209477|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
128775060|NCT01474512|463468373|FG016|Maintenance Period|Lost to Follow-up|0|||
128775061|NCT01474512|463468374|FG017|Maintenance Period|Lost to Follow-up|0|||
128775062|NCT01474512|463468357|FG000|Maintenance Period|Death|0|||
128775063|NCT01474512|463468358|FG001|Maintenance Period|Death|0|||
128775064|NCT01474512|463468359|FG002|Maintenance Period|Death|0|||
128775065|NCT01474512|463468360|FG003|Maintenance Period|Death|0|||
128775066|NCT01474512|463468361|FG004|Maintenance Period|Death|0|||
128775067|NCT01474512|463468362|FG005|Maintenance Period|Death|2|||
128775068|NCT01474512|463468363|FG006|Maintenance Period|Death|0|||
128775069|NCT01474512|463468364|FG007|Maintenance Period|Death|0|||
128775070|NCT01474512|463468365|FG008|Maintenance Period|Death|0|||
128775071|NCT01474512|463468366|FG009|Maintenance Period|Death|0|||
128775072|NCT01474512|463468367|FG010|Maintenance Period|Death|0|||
128775073|NCT01474512|463468368|FG011|Maintenance Period|Death|0|||
128775074|NCT01474512|463468369|FG012|Maintenance Period|Death|0|||
128775075|NCT01474512|463468370|FG013|Maintenance Period|Death|0|||
128775076|NCT01474512|463468371|FG014|Maintenance Period|Death|0|||
128775077|NCT01474512|463468372|FG015|Maintenance Period|Death|0|||
128775078|NCT01474512|463468373|FG016|Maintenance Period|Death|0|||
128775079|NCT01474512|463468374|FG017|Maintenance Period|Death|0|||
128775080|NCT01474512|463468357|FG000|Maintenance Period|Physician Decision|0|||
128775081|NCT01474512|463468358|FG001|Maintenance Period|Physician Decision|0|||
128775082|NCT01474512|463468359|FG002|Maintenance Period|Physician Decision|0|||
128775083|NCT01474512|463468360|FG003|Maintenance Period|Physician Decision|0|||
128775084|NCT01474512|463468361|FG004|Maintenance Period|Physician Decision|0|||
128775085|NCT01474512|463468362|FG005|Maintenance Period|Physician Decision|1|||
128775086|NCT01474512|463468363|FG006|Maintenance Period|Physician Decision|0|||
128775087|NCT01474512|463468364|FG007|Maintenance Period|Physician Decision|2|||
128775088|NCT01474512|463468365|FG008|Maintenance Period|Physician Decision|0|||
128775089|NCT01474512|463468366|FG009|Maintenance Period|Physician Decision|0|||
128979069|NCT01632345|464209478|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
128979070|NCT01632345|464209479|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
128979071|NCT01632345|464209480|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
128979072|NCT01632345|464209474|FG000|Treatment: Part I|Physician Decision|2|||
128979073|NCT01632345|464209475|FG001|Treatment: Part I|Physician Decision|1|||
128979074|NCT01632345|464209476|FG002|Treatment: Part I|Physician Decision|0|||
128979075|NCT01632345|464209477|FG003|Treatment: Part I|Physician Decision|0|||
129041399|NCT00285584|464444274|FG001|Month 6|Lost to Follow-up|1|||
129041400|NCT00466726|464444275|FG000|Overall Study|Not evaluable for response|14|||
129041401|NCT01376310|464444276|FG000|Overall Study|Study closed/terminated|1|||
129041402|NCT01376310|464444277|FG001|Overall Study|Study closed/terminated|2|||
129041403|NCT01376310|464444276|FG000|Overall Study|Withdrawal by Subject|8|||
129041404|NCT01376310|464444277|FG001|Overall Study|Withdrawal by Subject|2|||
129041405|NCT01376310|464444276|FG000|Overall Study|Physician Decision|26|||
129041406|NCT01376310|464444277|FG001|Overall Study|Physician Decision|7|||
129041407|NCT01376310|464444276|FG000|Overall Study|Lost to Follow-up|1|||
129041408|NCT01376310|464444277|FG001|Overall Study|Lost to Follow-up|0|||
129041409|NCT00645944|464444280|FG000|Randomized|Withdrawal by Subject|1|||
129133300|NCT00422461|464781282|FG002|Overall Study|Randomized but not treated|0|||
129133301|NCT00422461|464781283|FG003|Overall Study|Randomized but not treated|0|||
129133302|NCT01471574|464781284|FG000|Treatment Period|Lack of Efficacy|12|||
129133303|NCT01471574|464781285|FG001|Treatment Period|Lack of Efficacy|4|||
129133304|NCT01471574|464781286|FG002|Treatment Period|Lack of Efficacy|14|||
129133305|NCT01471574|464781287|FG003|Treatment Period|Lack of Efficacy|1|||
129133306|NCT01471574|464781284|FG000|Treatment Period|Adverse Event|7|||
129133307|NCT01471574|464781285|FG001|Treatment Period|Adverse Event|3|||
129133308|NCT01471574|464781286|FG002|Treatment Period|Adverse Event|6|||
129133309|NCT01471574|464781287|FG003|Treatment Period|Adverse Event|1|||
129133310|NCT01471574|464781284|FG000|Treatment Period|Withdrawal by Subject|5|||
129133311|NCT01471574|464781285|FG001|Treatment Period|Withdrawal by Subject|1|||
129133312|NCT01471574|464781286|FG002|Treatment Period|Withdrawal by Subject|1|||
129041410|NCT00645944|464444281|FG001|Randomized|Withdrawal by Subject|2|||
129041411|NCT00645944|464444280|FG000|Received Medication|Adverse Event|2|||
129041412|NCT00645944|464444281|FG001|Received Medication|Adverse Event|1|||
129041413|NCT00645944|464444280|FG000|Received Medication|Withdrawal by Subject|1|||
129041414|NCT00645944|464444281|FG001|Received Medication|Withdrawal by Subject|1|||
129041415|NCT00645944|464444280|FG000|Received Medication|Lost to Follow-up|1|||
129133313|NCT01471574|464781287|FG003|Treatment Period|Withdrawal by Subject|0|||
129133314|NCT01471574|464781284|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
128775090|NCT01474512|463468367|FG010|Maintenance Period|Physician Decision|0|||
128775091|NCT01474512|463468368|FG011|Maintenance Period|Physician Decision|0|||
128775092|NCT01474512|463468369|FG012|Maintenance Period|Physician Decision|0|||
128775093|NCT01474512|463468370|FG013|Maintenance Period|Physician Decision|0|||
128775094|NCT01474512|463468371|FG014|Maintenance Period|Physician Decision|0|||
128775095|NCT01474512|463468372|FG015|Maintenance Period|Physician Decision|0|||
129041416|NCT00645944|464444281|FG001|Received Medication|Lost to Follow-up|0|||
129133315|NCT01471574|464781285|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
128775096|NCT01474512|463468373|FG016|Maintenance Period|Physician Decision|0|||
129041417|NCT00645944|464444280|FG000|Received Medication|Protocol Violation|2|||
129041418|NCT00645944|464444281|FG001|Received Medication|Protocol Violation|1|||
129041419|NCT02339740|464444282|FG000|Overall Study|Death|1|||
128718378|NCT03538158|463267127|FG000|Overall Study|Lost to Follow-up|13|||
128718379|NCT03538158|463267128|FG001|Overall Study|Lost to Follow-up|7|||
128718380|NCT03538158|463267127|FG000|Overall Study|Withdrawal by Subject|2|||
128718381|NCT03538158|463267128|FG001|Overall Study|Withdrawal by Subject|1|||
128718382|NCT02255981|463267130|FG000|Overall Study|Lost to Follow-up|3|||
128718383|NCT02255981|463267130|FG000|Overall Study|Withdrawal by Subject|1|||
128718384|NCT01046682|463267134|FG000|Overall Study|Adverse Event|2|||
128718385|NCT01046682|463267135|FG001|Overall Study|Adverse Event|0|||
128718386|NCT00772707|463267136|FG000|Overall Study|Withdrawn|3|||
128718387|NCT01454570|463267137|FG000|Overall Study|Withdrawal by Subject|2|||
128718388|NCT01454570|463267137|FG000|Overall Study|Screen Failure|7|||
128718389|NCT04356963|463267139|FG000|First Session|Withdrawal by Subject|1|||
128718390|NCT04356963|463267139|FG000|Second Session|Withdrawal by Subject|3|||
128718391|NCT04356963|463267139|FG000|Second Session|Lost to Follow-up|1|||
128718392|NCT04356963|463267139|FG000|Third Session|Lost to Follow-up|6|||
128718393|NCT04356963|463267139|FG000|Third Session|Withdrawal by Subject|1|||
128718394|NCT01679002|463267144|FG000|Overall Study|Adverse Event|1|||
128718395|NCT01679002|463267145|FG001|Overall Study|Adverse Event|1|||
128718396|NCT01679002|463267146|FG002|Overall Study|Adverse Event|0|||
128718397|NCT01179477|463267149|FG000|Overall Study|Death|542|||
128718398|NCT01179477|463267149|FG000|Overall Study|Unsuccessful implant|80|||
128718399|NCT01179477|463267149|FG000|Overall Study|Non-death withdrawal|438|||
128718400|NCT01179477|463267149|FG000|Overall Study|Did not complete final visit|27|||
128718401|NCT04256785|463267154|FG000|Overall Study|Adverse Event|8|||
128718402|NCT04256785|463267155|FG001|Overall Study|Adverse Event|6|||
128718403|NCT04256785|463267154|FG000|Overall Study|Lack of Efficacy|3|||
128718404|NCT04256785|463267155|FG001|Overall Study|Lack of Efficacy|4|||
128718405|NCT04256785|463267154|FG000|Overall Study|Lost to Follow-up|7|||
128718406|NCT04256785|463267155|FG001|Overall Study|Lost to Follow-up|7|||
128718407|NCT04256785|463267154|FG000|Overall Study|Protocol Violation|1|||
128718408|NCT04256785|463267155|FG001|Overall Study|Protocol Violation|0|||
128718409|NCT04256785|463267154|FG000|Overall Study|Withdrawal by Subject|4|||
128718410|NCT04256785|463267155|FG001|Overall Study|Withdrawal by Subject|1|||
128718411|NCT04256785|463267154|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
128718412|NCT04256785|463267155|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
128718413|NCT00975481|463267156|FG000|Second Intervention Period|Adverse Event|2|||
128718414|NCT00975481|463267157|FG001|Second Intervention Period|Adverse Event|1|||
128718415|NCT00975481|463267158|FG002|Second Intervention Period|Adverse Event|0|||
129041420|NCT02339740|464444283|FG001|Overall Study|Death|0|||
129041421|NCT02339740|464444282|FG000|Overall Study|Physician Decision|0|||
129041422|NCT02339740|464444283|FG001|Overall Study|Physician Decision|2|||
129041423|NCT02339740|464444282|FG000|Overall Study|Withdrawal by Subject|5|||
129041424|NCT02339740|464444283|FG001|Overall Study|Withdrawal by Subject|1|||
129041425|NCT02339740|464444282|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
129041426|NCT02339740|464444283|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
129041427|NCT02096588|464444284|FG000|Overall Study|Lack of Efficacy|2|||
129041428|NCT02096588|464444285|FG001|Overall Study|Lack of Efficacy|0|||
129041429|NCT02096588|464444284|FG000|Overall Study|Withdrawal by Subject|0|||
129041430|NCT02096588|464444285|FG001|Overall Study|Withdrawal by Subject|1|||
129041431|NCT01523587|464444286|FG000|Overall Study|Other than listed|5|||
129041432|NCT01523587|464444287|FG001|Overall Study|Other than listed|5|||
129041433|NCT01523587|464444286|FG000|Overall Study|Worsening of underlying cancer disease|19|||
129041434|NCT01523587|464444287|FG001|Overall Study|Worsening of underlying cancer disease|34|||
129041435|NCT01523587|464444286|FG000|Overall Study|Adverse Event|68|||
129041436|NCT01523587|464444287|FG001|Overall Study|Adverse Event|52|||
129041437|NCT01523587|464444286|FG000|Overall Study|Protocol Violation|5|||
129041438|NCT01523587|464444287|FG001|Overall Study|Protocol Violation|3|||
129041439|NCT01523587|464444286|FG000|Overall Study|Lost to Follow-up|2|||
129041440|NCT01523587|464444287|FG001|Overall Study|Lost to Follow-up|2|||
129041441|NCT01523587|464444286|FG000|Overall Study|Withdrawal by Subject|28|||
129041442|NCT01523587|464444287|FG001|Overall Study|Withdrawal by Subject|20|||
129041443|NCT01523587|464444286|FG000|Overall Study|Withdrew due to Progressive disease|265|||
129041444|NCT01523587|464444287|FG001|Overall Study|Withdrew due to Progressive disease|279|||
129041445|NCT01523587|464444286|FG000|Overall Study|Randomised but bot treated|6|||
129041446|NCT01523587|464444287|FG001|Overall Study|Randomised but bot treated|2|||
129041447|NCT01020799|464444303|FG000|Overall Study|Adverse Event|4|||
129041448|NCT01020799|464444304|FG001|Overall Study|Adverse Event|3|||
129041449|NCT01020799|464444305|FG002|Overall Study|Adverse Event|2|||
129041450|NCT01020799|464444303|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
129041451|NCT01020799|464444304|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
129041452|NCT01020799|464444305|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
128718416|NCT00975481|463267159|FG003|Second Intervention Period|Adverse Event|0|||
128718417|NCT00975481|463267160|FG004|Second Intervention Period|Adverse Event|0|||
129041453|NCT01020799|464444303|FG000|Overall Study|Protocol Violation|3|||
129041454|NCT01020799|464444304|FG001|Overall Study|Protocol Violation|2|||
128718418|NCT00975481|463267161|FG005|Second Intervention Period|Adverse Event|0|||
128718419|NCT00975481|463267156|FG000|Second Intervention Period|Withdrawal by Subject|0|||
128718420|NCT00975481|463267157|FG001|Second Intervention Period|Withdrawal by Subject|0|||
128718421|NCT00975481|463267158|FG002|Second Intervention Period|Withdrawal by Subject|1|||
128718422|NCT00975481|463267159|FG003|Second Intervention Period|Withdrawal by Subject|0|||
128718423|NCT00975481|463267160|FG004|Second Intervention Period|Withdrawal by Subject|0|||
128718424|NCT00975481|463267161|FG005|Second Intervention Period|Withdrawal by Subject|0|||
128718425|NCT00975481|463267156|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
128718426|NCT00975481|463267157|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
128718427|NCT00975481|463267158|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
128718428|NCT00975481|463267159|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
128718429|NCT00975481|463267160|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
128718430|NCT00975481|463267161|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
128718431|NCT00975481|463267156|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
128718432|NCT00975481|463267157|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
128718433|NCT00975481|463267158|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
128718434|NCT00975481|463267159|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
128718435|NCT00975481|463267160|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
128718436|NCT00975481|463267161|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
128718437|NCT00643682|463267162|FG000|Overall Study|did not keep appointment|522|||
128718438|NCT00643682|463267163|FG001|Overall Study|did not keep appointment|509|||
128718439|NCT03630120|463267167|FG000|Overall Study|Disease progression|0|||
128718440|NCT03630120|463267168|FG001|Overall Study|Disease progression|1|||
128718441|NCT03630120|463267169|FG002|Overall Study|Disease progression|1|||
128718442|NCT03630120|463267170|FG003|Overall Study|Disease progression|1|||
128718443|NCT03755414|463267172|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
128718444|NCT03755414|463267173|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
128718445|NCT03755414|463267174|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
128718446|NCT03755414|463267172|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
128718447|NCT03755414|463267173|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
128718448|NCT03755414|463267174|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
128718449|NCT03755414|463267172|FG000|Overall Study|Non-compliance|0|||
128718450|NCT03755414|463267173|FG001|Overall Study|Non-compliance|1|||
128718451|NCT03755414|463267174|FG002|Overall Study|Non-compliance|0|||
128718452|NCT02153112|463267175|FG000|Overall Study|Adverse Event|0|||
128718453|NCT02153112|463267176|FG001|Overall Study|Adverse Event|0|||
128718454|NCT02153112|463267177|FG002|Overall Study|Adverse Event|1|||
128718455|NCT02153112|463267178|FG003|Overall Study|Adverse Event|0|||
128718456|NCT02153112|463267179|FG004|Overall Study|Adverse Event|0|||
128979076|NCT01632345|464209478|FG004|Treatment: Part I|Physician Decision|1|||
128979077|NCT01632345|464209479|FG005|Treatment: Part I|Physician Decision|0|||
128979078|NCT01632345|464209480|FG006|Treatment: Part I|Physician Decision|0|||
128979079|NCT01632345|464209474|FG000|Treatment: Part I|Pregnancy|0|||
128979080|NCT01632345|464209475|FG001|Treatment: Part I|Pregnancy|1|||
128979081|NCT01632345|464209476|FG002|Treatment: Part I|Pregnancy|0|||
128979082|NCT01632345|464209477|FG003|Treatment: Part I|Pregnancy|0|||
128979083|NCT01632345|464209478|FG004|Treatment: Part I|Pregnancy|0|||
128979084|NCT01632345|464209479|FG005|Treatment: Part I|Pregnancy|0|||
128979085|NCT01632345|464209480|FG006|Treatment: Part I|Pregnancy|0|||
128979086|NCT01632345|464209474|FG000|Treatment: Part I|Protocol Deviation|0|||
128979087|NCT01632345|464209475|FG001|Treatment: Part I|Protocol Deviation|0|||
128979088|NCT01632345|464209476|FG002|Treatment: Part I|Protocol Deviation|1|||
128979089|NCT01632345|464209477|FG003|Treatment: Part I|Protocol Deviation|1|||
128979090|NCT01632345|464209478|FG004|Treatment: Part I|Protocol Deviation|0|||
128979091|NCT01632345|464209479|FG005|Treatment: Part I|Protocol Deviation|0|||
128979092|NCT01632345|464209480|FG006|Treatment: Part I|Protocol Deviation|0|||
128979093|NCT01632345|464209474|FG000|Treatment: Part I|Withdrawal by Subject|3|||
128979094|NCT01632345|464209475|FG001|Treatment: Part I|Withdrawal by Subject|4|||
128979095|NCT01632345|464209476|FG002|Treatment: Part I|Withdrawal by Subject|4|||
128979096|NCT01632345|464209477|FG003|Treatment: Part I|Withdrawal by Subject|1|||
128979097|NCT01632345|464209478|FG004|Treatment: Part I|Withdrawal by Subject|4|||
128979098|NCT01632345|464209479|FG005|Treatment: Part I|Withdrawal by Subject|0|||
128979099|NCT01632345|464209480|FG006|Treatment: Part I|Withdrawal by Subject|0|||
128718457|NCT02153112|463267180|FG005|Overall Study|Adverse Event|0|||
128718458|NCT02153112|463267181|FG006|Overall Study|Adverse Event|0|||
128718459|NCT02153112|463267182|FG007|Overall Study|Adverse Event|0|||
128979100|NCT01632345|464209474|FG000|Treatment: Part II|Adverse Event|0|||
128979101|NCT01632345|464209475|FG001|Treatment: Part II|Adverse Event|0|||
128979102|NCT01632345|464209476|FG002|Treatment: Part II|Adverse Event|0|||
128979103|NCT01632345|464209477|FG003|Treatment: Part II|Adverse Event|0|||
129041455|NCT01020799|464444305|FG002|Overall Study|Protocol Violation|0|||
129041456|NCT01020799|464444303|FG000|Overall Study|Withdrawal by Subject|2|||
129041457|NCT01020799|464444304|FG001|Overall Study|Withdrawal by Subject|2|||
128718460|NCT02153112|463267183|FG008|Overall Study|Adverse Event|0|||
128718461|NCT02153112|463267184|FG009|Overall Study|Adverse Event|0|||
128718462|NCT02153112|463267175|FG000|Overall Study|Lost to Follow-up|1|||
128718463|NCT02153112|463267176|FG001|Overall Study|Lost to Follow-up|1|||
128718464|NCT02153112|463267177|FG002|Overall Study|Lost to Follow-up|0|||
128718465|NCT02153112|463267178|FG003|Overall Study|Lost to Follow-up|0|||
128718466|NCT02153112|463267179|FG004|Overall Study|Lost to Follow-up|2|||
128718467|NCT02153112|463267180|FG005|Overall Study|Lost to Follow-up|1|||
128718468|NCT02153112|463267181|FG006|Overall Study|Lost to Follow-up|1|||
128718469|NCT02153112|463267182|FG007|Overall Study|Lost to Follow-up|0|||
128718470|NCT02153112|463267183|FG008|Overall Study|Lost to Follow-up|1|||
128718471|NCT02153112|463267184|FG009|Overall Study|Lost to Follow-up|1|||
128718472|NCT02153112|463267175|FG000|Overall Study|Withdrawal by Subject|3|||
128718473|NCT02153112|463267176|FG001|Overall Study|Withdrawal by Subject|1|||
128718474|NCT02153112|463267177|FG002|Overall Study|Withdrawal by Subject|2|||
128718475|NCT02153112|463267178|FG003|Overall Study|Withdrawal by Subject|2|||
128718476|NCT02153112|463267179|FG004|Overall Study|Withdrawal by Subject|1|||
128718477|NCT02153112|463267180|FG005|Overall Study|Withdrawal by Subject|1|||
128718478|NCT02153112|463267181|FG006|Overall Study|Withdrawal by Subject|7|||
128718479|NCT02153112|463267182|FG007|Overall Study|Withdrawal by Subject|2|||
128718480|NCT02153112|463267183|FG008|Overall Study|Withdrawal by Subject|13|||
128718481|NCT02153112|463267184|FG009|Overall Study|Withdrawal by Subject|12|||
128718482|NCT02153112|463267175|FG000|Overall Study|Reason not Specified|0|||
128718483|NCT02153112|463267176|FG001|Overall Study|Reason not Specified|0|||
128718484|NCT02153112|463267177|FG002|Overall Study|Reason not Specified|0|||
128718485|NCT02153112|463267178|FG003|Overall Study|Reason not Specified|0|||
128718486|NCT02153112|463267179|FG004|Overall Study|Reason not Specified|0|||
128718487|NCT02153112|463267180|FG005|Overall Study|Reason not Specified|0|||
128718488|NCT02153112|463267181|FG006|Overall Study|Reason not Specified|0|||
128718489|NCT02153112|463267182|FG007|Overall Study|Reason not Specified|0|||
128718490|NCT02153112|463267183|FG008|Overall Study|Reason not Specified|1|||
128718491|NCT02153112|463267184|FG009|Overall Study|Reason not Specified|1|||
128718492|NCT00741039|463267191|FG000|Overall Study|Patient non-compliance|2|||
128718493|NCT00741039|463267192|FG001|Overall Study|Patient non-compliance|0|||
128718494|NCT01092182|463267193|FG000|Overall Study|Death|0|||
128718495|NCT01092182|463267194|FG001|Overall Study|Death|5|||
128718496|NCT01092182|463267195|FG002|Overall Study|Death|3|||
128718497|NCT01092182|463267193|FG000|Overall Study|participant safety|1|||
128718498|NCT01092182|463267194|FG001|Overall Study|participant safety|2|||
128718499|NCT01092182|463267195|FG002|Overall Study|participant safety|0|||
128718500|NCT01092182|463267193|FG000|Overall Study|Physician Decision|0|||
128718501|NCT01092182|463267194|FG001|Overall Study|Physician Decision|6|||
128718502|NCT01092182|463267195|FG002|Overall Study|Physician Decision|0|||
128718503|NCT01092182|463267193|FG000|Overall Study|Did not meet criteria|0|||
128718504|NCT01092182|463267194|FG001|Overall Study|Did not meet criteria|0|||
128718505|NCT01092182|463267195|FG002|Overall Study|Did not meet criteria|25|||
128718506|NCT01092182|463267193|FG000|Overall Study|Non-compliance|0|||
128718507|NCT01092182|463267194|FG001|Overall Study|Non-compliance|3|||
128718508|NCT01092182|463267195|FG002|Overall Study|Non-compliance|0|||
128979104|NCT01632345|464209478|FG004|Treatment: Part II|Adverse Event|0|||
128979105|NCT01632345|464209479|FG005|Treatment: Part II|Adverse Event|3|||
128979106|NCT01632345|464209480|FG006|Treatment: Part II|Adverse Event|8|||
128979107|NCT01632345|464209474|FG000|Treatment: Part II|Lost to Follow-up|0|||
128979108|NCT01632345|464209475|FG001|Treatment: Part II|Lost to Follow-up|0|||
128979109|NCT01632345|464209476|FG002|Treatment: Part II|Lost to Follow-up|0|||
128979110|NCT01632345|464209477|FG003|Treatment: Part II|Lost to Follow-up|0|||
128979111|NCT01632345|464209478|FG004|Treatment: Part II|Lost to Follow-up|0|||
128979112|NCT01632345|464209479|FG005|Treatment: Part II|Lost to Follow-up|3|||
128979113|NCT01632345|464209480|FG006|Treatment: Part II|Lost to Follow-up|1|||
128979114|NCT01632345|464209474|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
128979115|NCT01632345|464209475|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
128979116|NCT01632345|464209476|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
128979117|NCT01632345|464209477|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
128979118|NCT01632345|464209478|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
128979119|NCT01632345|464209479|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
128979120|NCT01632345|464209480|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
128979121|NCT01632345|464209474|FG000|Treatment: Part II|Withdrawal by Subject|0|||
128979122|NCT01632345|464209475|FG001|Treatment: Part II|Withdrawal by Subject|0|||
128979123|NCT01632345|464209476|FG002|Treatment: Part II|Withdrawal by Subject|0|||
129222536|NCT01382706|465116132|FG000|Overall Study|Adverse Event|1|||
128718509|NCT01092182|463267193|FG000|Overall Study|Participant refused follow-up|0|||
128718510|NCT01092182|463267194|FG001|Overall Study|Participant refused follow-up|2|||
128718511|NCT01092182|463267195|FG002|Overall Study|Participant refused follow-up|0|||
128718512|NCT02515045|463267204|FG000|Overall Study|Adverse Event|0|||
128718513|NCT02515045|463267205|FG001|Overall Study|Adverse Event|3|||
128979124|NCT01632345|464209477|FG003|Treatment: Part II|Withdrawal by Subject|0|||
128979125|NCT01632345|464209478|FG004|Treatment: Part II|Withdrawal by Subject|0|||
128718514|NCT02515045|463267206|FG002|Overall Study|Adverse Event|3|||
128718515|NCT02515045|463267204|FG000|Overall Study|Lost to Follow-up|0|||
128718516|NCT02515045|463267205|FG001|Overall Study|Lost to Follow-up|1|||
128718517|NCT02515045|463267206|FG002|Overall Study|Lost to Follow-up|1|||
128718518|NCT02677987|463267209|FG000|Overall Study|Withdrawal by Subject|3|||
128718519|NCT02677987|463267210|FG001|Overall Study|Withdrawal by Subject|0|||
128718520|NCT02677987|463267209|FG000|Overall Study|Lost to Follow-up|1|||
128718521|NCT02677987|463267210|FG001|Overall Study|Lost to Follow-up|0|||
128718522|NCT01522365|463267213|FG000|Overall Study|Withdrawal by Subject|1|||
128718523|NCT01522365|463267214|FG001|Overall Study|Withdrawal by Subject|1|||
128718524|NCT01522365|463267213|FG000|Overall Study|Lost to Follow-up|1|||
128718525|NCT01522365|463267214|FG001|Overall Study|Lost to Follow-up|1|||
128718526|NCT00673179|463267215|FG000|Overall Study|Toxicity/Complications|3|||
128718527|NCT00673179|463267216|FG001|Overall Study|Toxicity/Complications|0|||
128718528|NCT01120756|463267217|FG000|Overall Study|Withdrawal by Subject|1|||
128718529|NCT01120756|463267218|FG001|Overall Study|Withdrawal by Subject|1|||
128718530|NCT03760146|463267224|FG000|Overall Study|Adverse Event|11|||
128718531|NCT03760146|463267225|FG001|Overall Study|Adverse Event|8|||
128718532|NCT03760146|463267226|FG002|Overall Study|Adverse Event|0|||
128718533|NCT03760146|463267227|FG003|Overall Study|Adverse Event|0|||
128718534|NCT03760146|463267228|FG004|Overall Study|Adverse Event|0|||
128718535|NCT03760146|463267229|FG005|Overall Study|Adverse Event|0|||
128718536|NCT03760146|463267224|FG000|Overall Study|Death|1|||
128718537|NCT03760146|463267225|FG001|Overall Study|Death|0|||
128718538|NCT03760146|463267226|FG002|Overall Study|Death|0|||
128718539|NCT03760146|463267227|FG003|Overall Study|Death|0|||
128718540|NCT03760146|463267228|FG004|Overall Study|Death|0|||
128718541|NCT03760146|463267229|FG005|Overall Study|Death|0|||
128718542|NCT03760146|463267224|FG000|Overall Study|Lost to Follow-up|41|||
128718543|NCT03760146|463267225|FG001|Overall Study|Lost to Follow-up|28|||
128718544|NCT03760146|463267226|FG002|Overall Study|Lost to Follow-up|9|||
128718545|NCT03760146|463267227|FG003|Overall Study|Lost to Follow-up|2|||
128718546|NCT03760146|463267228|FG004|Overall Study|Lost to Follow-up|14|||
128718547|NCT03760146|463267229|FG005|Overall Study|Lost to Follow-up|8|||
128718548|NCT03760146|463267224|FG000|Overall Study|No longer met eligibility criteria|3|||
128718549|NCT03760146|463267225|FG001|Overall Study|No longer met eligibility criteria|9|||
128718550|NCT03760146|463267226|FG002|Overall Study|No longer met eligibility criteria|0|||
128718551|NCT03760146|463267227|FG003|Overall Study|No longer met eligibility criteria|0|||
128718552|NCT03760146|463267228|FG004|Overall Study|No longer met eligibility criteria|1|||
128718553|NCT03760146|463267229|FG005|Overall Study|No longer met eligibility criteria|0|||
128718554|NCT03760146|463267224|FG000|Overall Study|Protocol Violation|21|||
128718555|NCT03760146|463267225|FG001|Overall Study|Protocol Violation|13|||
128718556|NCT03760146|463267226|FG002|Overall Study|Protocol Violation|1|||
128718557|NCT03760146|463267227|FG003|Overall Study|Protocol Violation|0|||
128718558|NCT03760146|463267228|FG004|Overall Study|Protocol Violation|1|||
128718559|NCT03760146|463267229|FG005|Overall Study|Protocol Violation|0|||
128718560|NCT03760146|463267224|FG000|Overall Study|Withdrawal by Subject|19|||
128718561|NCT03760146|463267225|FG001|Overall Study|Withdrawal by Subject|20|||
128718562|NCT03760146|463267226|FG002|Overall Study|Withdrawal by Subject|1|||
128718563|NCT03760146|463267227|FG003|Overall Study|Withdrawal by Subject|0|||
128718564|NCT03760146|463267228|FG004|Overall Study|Withdrawal by Subject|1|||
128718565|NCT03760146|463267229|FG005|Overall Study|Withdrawal by Subject|0|||
128718566|NCT03642717|463267230|FG000|Overall Study|Lost to Follow-up|2|||
128718567|NCT03642717|463267230|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
128718568|NCT03642717|463267230|FG000|Overall Study|Taken study drug prior to contract date|3|||
128979126|NCT01632345|464209479|FG005|Treatment: Part II|Withdrawal by Subject|2|||
128979127|NCT01632345|464209480|FG006|Treatment: Part II|Withdrawal by Subject|2|||
128979128|NCT00636506|464209488|FG000|Overall Study|Lost to Follow-up|8|||
128979129|NCT00636506|464209488|FG000|Overall Study|Explanted|1|||
128979130|NCT00636506|464209488|FG000|Overall Study|Withdrawal by Subject|6|||
128979131|NCT00636506|464209488|FG000|Overall Study|Procedure aborted|1|||
128979132|NCT03125902|464209489|FG000|Overall Study|Adverse Event|0|||
128979133|NCT03125902|464209490|FG001|Overall Study|Adverse Event|1|||
128979134|NCT03125902|464209489|FG000|Overall Study|Death|119|||
128979135|NCT03125902|464209490|FG001|Overall Study|Death|229|||
128979136|NCT03125902|464209489|FG000|Overall Study|Lost to Follow-up|4|||
128979137|NCT03125902|464209490|FG001|Overall Study|Lost to Follow-up|13|||
128979138|NCT03125902|464209489|FG000|Overall Study|Other|0|||
128979139|NCT03125902|464209490|FG001|Overall Study|Other|4|||
129222537|NCT01382706|465116132|FG000|Overall Study|Withdrawal by Subject|1|||
128718569|NCT01559012|463267233|FG000|Overall Study|Withdrawal by Subject|0|||
128718570|NCT01559012|463267234|FG001|Overall Study|Withdrawal by Subject|1|||
128718571|NCT00946712|463267235|FG000|Overall Study|Adverse Event|118|||
128718572|NCT00946712|463267236|FG001|Overall Study|Adverse Event|124|||
128718573|NCT00946712|463267235|FG000|Overall Study|Disease progression|308|||
128718574|NCT00946712|463267236|FG001|Overall Study|Disease progression|404|||
128718575|NCT00946712|463267235|FG000|Overall Study|Death|21|||
128979140|NCT03125902|464209489|FG000|Overall Study|Physician Decision|2|||
128979141|NCT03125902|464209490|FG001|Overall Study|Physician Decision|1|||
128979142|NCT03125902|464209489|FG000|Overall Study|Progressive Disease|0|||
128979143|NCT03125902|464209490|FG001|Overall Study|Progressive Disease|3|||
128979144|NCT03125902|464209489|FG000|Overall Study|Study Terminated By Sponsor|74|||
128979145|NCT03125902|464209490|FG001|Overall Study|Study Terminated By Sponsor|143|||
128979146|NCT03125902|464209489|FG000|Overall Study|Withdrawal by Subject|21|||
128979147|NCT03125902|464209490|FG001|Overall Study|Withdrawal by Subject|37|||
128979148|NCT01843933|464209491|FG000|Overall Study|Data lost|6|||
128979149|NCT01843933|464209492|FG001|Overall Study|Data lost|4|||
128979150|NCT01535638|464209493|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
129222538|NCT05559099|465116133|FG000|Overall Study|Death|5|||
129222539|NCT05559099|465116134|FG001|Overall Study|Death|4|||
129222540|NCT05559099|465116133|FG000|Overall Study|Lost to Follow-up|0|||
129222541|NCT05559099|465116134|FG001|Overall Study|Lost to Follow-up|2|||
129222542|NCT05559099|465116133|FG000|Overall Study|Adverse Event|1|||
129222543|NCT05559099|465116134|FG001|Overall Study|Adverse Event|1|||
129222544|NCT04018092|465116135|FG000|Overall Study|Withdrawal by Subject|1|||
129222545|NCT04018092|465116136|FG001|Overall Study|Withdrawal by Subject|1|||
129222546|NCT04018092|465116135|FG000|Overall Study|Withdrawal by Subject|1|||
129222547|NCT04018092|465116136|FG001|Overall Study|Withdrawal by Subject|1|||
129222548|NCT05508074|465116137|FG000|Overall Study|Death|2|||
129222549|NCT05508074|465116138|FG001|Overall Study|Death|5|||
128718576|NCT00946712|463267236|FG001|Overall Study|Death|22|||
128718577|NCT00946712|463267235|FG000|Overall Study|No treatment given|25|||
128718578|NCT00946712|463267236|FG001|Overall Study|No treatment given|29|||
128718579|NCT00946712|463267235|FG000|Overall Study|Other reasons|61|||
128718580|NCT00946712|463267236|FG001|Overall Study|Other reasons|73|||
128718581|NCT00946712|463267235|FG000|Overall Study|On Treatment|0|||
128718582|NCT00946712|463267236|FG001|Overall Study|On Treatment|4|||
129222550|NCT05508074|465116137|FG000|Overall Study|Withdrawal by Subject|1|||
129222551|NCT05508074|465116138|FG001|Overall Study|Withdrawal by Subject|2|||
128718583|NCT00946712|463267235|FG000|Overall Study|Ineligible|14|||
128718584|NCT00946712|463267236|FG001|Overall Study|Ineligible|6|||
128718585|NCT01848756|463267237|FG000|Overall Study|Adverse Event|1|||
128718586|NCT01848756|463267237|FG000|Overall Study|Withdrawal by Subject|1|||
128718587|NCT01848756|463267237|FG000|Overall Study|Enrolled in Error|1|||
128718588|NCT02075658|463267238|FG000|Overall Study|Physician Decision|2|||
128718589|NCT02075658|463267239|FG001|Overall Study|Physician Decision|2|||
128718590|NCT02865915|463267240|FG000|Overall Study|Pregnancy|1|||
128718591|NCT02865915|463267241|FG001|Overall Study|Pregnancy|0|||
128718592|NCT02865915|463267240|FG000|Overall Study|Withdrawal by Subject|1|||
128718593|NCT02865915|463267241|FG001|Overall Study|Withdrawal by Subject|1|||
128718594|NCT02865915|463267240|FG000|Overall Study|Adverse Event|0|||
128718595|NCT02865915|463267241|FG001|Overall Study|Adverse Event|4|||
128718596|NCT02865915|463267240|FG000|Overall Study|Lost to Follow-up|0|||
128718597|NCT02865915|463267241|FG001|Overall Study|Lost to Follow-up|1|||
128718598|NCT02865915|463267240|FG000|Overall Study|Protocol Violation|0|||
128718599|NCT02865915|463267241|FG001|Overall Study|Protocol Violation|1|||
128718600|NCT02865915|463267240|FG000|Overall Study|Study terminated by sponsor|23|||
128718601|NCT02865915|463267241|FG001|Overall Study|Study terminated by sponsor|18|||
128718602|NCT02865915|463267240|FG000|Overall Study|Dosing group discontinued|0|||
128718603|NCT02865915|463267241|FG001|Overall Study|Dosing group discontinued|5|||
128718604|NCT00663052|463267242|FG000|Overall Study|Adverse Event|6|||
128718605|NCT00663052|463267243|FG001|Overall Study|Adverse Event|3|||
128718606|NCT00663052|463267242|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
128718607|NCT00663052|463267243|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
128718608|NCT00663052|463267242|FG000|Overall Study|Protocol Violation|1|||
128718609|NCT00663052|463267243|FG001|Overall Study|Protocol Violation|0|||
128718610|NCT00663052|463267242|FG000|Overall Study|Withdrawal by Subject|2|||
128718611|NCT00663052|463267243|FG001|Overall Study|Withdrawal by Subject|5|||
128718612|NCT00663052|463267242|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
128718613|NCT00663052|463267243|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
128718614|NCT00663052|463267242|FG000|Overall Study|Other|0|||
128718615|NCT00663052|463267243|FG001|Overall Study|Other|1|||
128718616|NCT05760300|463267244|FG000|Overall Study|Adverse Event|0|||
128718617|NCT05760300|463267245|FG001|Overall Study|Adverse Event|0|||
128718618|NCT05760300|463267246|FG002|Overall Study|Adverse Event|1|||
128718619|NCT05760300|463267247|FG003|Overall Study|Adverse Event|0|||
128718620|NCT05760300|463267244|FG000|Overall Study|Participant Decision|1|||
128718621|NCT05760300|463267245|FG001|Overall Study|Participant Decision|0|||
128718622|NCT05760300|463267246|FG002|Overall Study|Participant Decision|0|||
128718623|NCT05760300|463267247|FG003|Overall Study|Participant Decision|0|||
128718624|NCT04350788|463267261|FG000|Overall Study|Lost to Follow-up|6|||
128718625|NCT04350788|463267262|FG001|Overall Study|Lost to Follow-up|2|||
128718626|NCT04350788|463267261|FG000|Overall Study|Withdrawal by Subject|2|||
129222552|NCT05508074|465116137|FG000|Overall Study|Adverse Event|0|||
129222553|NCT05508074|465116138|FG001|Overall Study|Adverse Event|1|||
128718627|NCT04350788|463267262|FG001|Overall Study|Withdrawal by Subject|4|||
128979151|NCT01535638|464209494|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
129222554|NCT05508074|465116137|FG000|Overall Study|Physician Decision|0|||
128979152|NCT01535638|464209495|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
128979153|NCT01535638|464209496|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
128979154|NCT01535638|464209497|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
128979155|NCT01535638|464209498|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
128979156|NCT01535638|464209493|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
128979157|NCT01535638|464209494|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
128979158|NCT01535638|464209495|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
128979159|NCT01535638|464209496|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
128979160|NCT01535638|464209497|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
128979161|NCT01535638|464209498|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
128979162|NCT03769753|464209499|FG000|Overall Study|Not Treated|6|||
128979163|NCT03769753|464209499|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
128979164|NCT01482598|464209500|FG000|Overall Study|Death|7|||
128979165|NCT01482598|464209501|FG001|Overall Study|Death|10|||
128979166|NCT01482598|464209500|FG000|Overall Study|Physician Decision|0|||
128979167|NCT01482598|464209501|FG001|Overall Study|Physician Decision|3|||
128979168|NCT01482598|464209500|FG000|Overall Study|Withdrawal by Subject|4|||
128979169|NCT01482598|464209501|FG001|Overall Study|Withdrawal by Subject|5|||
128979170|NCT01482598|464209500|FG000|Overall Study|Lost to Follow-up|5|||
128979171|NCT01482598|464209501|FG001|Overall Study|Lost to Follow-up|4|||
128979172|NCT01373294|464209502|FG000|Overall Study|Adverse Event|1|||
128979173|NCT01373294|464209503|FG001|Overall Study|Adverse Event|0|||
128979174|NCT03702166|464209504|FG000|Overall Study|Lost to Follow-up|1|||
128979175|NCT03702166|464209504|FG000|Overall Study|Withdrawal by Subject|1|||
128979176|NCT01657903|464209505|FG000|Overall Study|Lost to Follow-up|1|||
128979177|NCT01657903|464209505|FG000|Overall Study|Withdrawal by Subject|1|||
128979178|NCT01684930|464211616|FG000|Overall Study|Withdrawal by Subject|3|||
128979179|NCT01684930|464211617|FG001|Overall Study|Withdrawal by Subject|1|||
128979180|NCT01041027|464211625|FG000|Overall Study|Withdrawal by Subject|2|||
128979181|NCT01041027|464211625|FG000|Overall Study|Protocol Violation|1|||
128718628|NCT04350788|463267261|FG000|Overall Study|Protocol Violation|4|||
128718629|NCT04350788|463267262|FG001|Overall Study|Protocol Violation|0|||
128979182|NCT01041027|464211625|FG000|Overall Study|Delayed Radiation Therapy|1|||
128979183|NCT01041027|464211625|FG000|Overall Study|Adverse Event|4|||
129041458|NCT01020799|464444305|FG002|Overall Study|Withdrawal by Subject|3|||
129041459|NCT01020799|464444303|FG000|Overall Study|Lost to Follow-up|6|||
128718630|NCT01894581|463267263|FG000|Overall Study|Withdrawal by Subject|2|||
128718631|NCT01894581|463267264|FG001|Overall Study|Withdrawal by Subject|3|||
128718632|NCT01894581|463267263|FG000|Overall Study|Screen Failure|3|||
128718633|NCT01894581|463267264|FG001|Overall Study|Screen Failure|4|||
128718634|NCT03313804|463267265|FG000|Treatment|Death|5|||
128718635|NCT03313804|463267265|FG000|Treatment|still on treatment|2|||
128718636|NCT03313804|463267265|FG000|Follow Up|still on follow up|3|||
128718637|NCT01252940|463267266|FG000|Main Study Phase|Randomized but not treated|4|||
128718638|NCT01252940|463267267|FG001|Main Study Phase|Randomized but not treated|2|||
128718639|NCT01252940|463267266|FG000|Main Study Phase|Adverse Event|3|||
128718640|NCT01252940|463267267|FG001|Main Study Phase|Adverse Event|1|||
128718641|NCT01252940|463267266|FG000|Main Study Phase|Lack of Efficacy|1|||
128718642|NCT01252940|463267267|FG001|Main Study Phase|Lack of Efficacy|0|||
128718643|NCT01252940|463267266|FG000|Main Study Phase|Lost to Follow-up|6|||
128718644|NCT01252940|463267267|FG001|Main Study Phase|Lost to Follow-up|1|||
128718645|NCT01252940|463267266|FG000|Main Study Phase|Physician Decision|1|||
128718646|NCT01252940|463267267|FG001|Main Study Phase|Physician Decision|0|||
128718647|NCT01252940|463267266|FG000|Main Study Phase|Protocol Violation|4|||
128718648|NCT01252940|463267267|FG001|Main Study Phase|Protocol Violation|2|||
128718649|NCT01252940|463267266|FG000|Main Study Phase|Withdrawal by Subject|6|||
128718650|NCT01252940|463267267|FG001|Main Study Phase|Withdrawal by Subject|5|||
128718651|NCT01252940|463267266|FG000|Main Study Phase|Subject Non-compliance|1|||
128718652|NCT01252940|463267267|FG001|Main Study Phase|Subject Non-compliance|1|||
128718653|NCT01252940|463267266|FG000|Extension Phase|Adverse Event|2|||
128718654|NCT01252940|463267267|FG001|Extension Phase|Adverse Event|1|||
128979184|NCT01020812|464211626|FG000|Overall Study|Physician Decision|1|||
128979185|NCT01020812|464211626|FG000|Overall Study|Withdrawal by Subject|1|||
128979186|NCT01020812|464211626|FG000|Overall Study|Protocol Violation|1|||
128979187|NCT02528643|464211627|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
129041460|NCT01020799|464444304|FG001|Overall Study|Lost to Follow-up|4|||
129041461|NCT01020799|464444305|FG002|Overall Study|Lost to Follow-up|2|||
129041462|NCT04179019|464444306|FG000|Overall Study|Lost to Follow-up|2|||
128718655|NCT01252940|463267266|FG000|Extension Phase|Lack of Efficacy|1|||
128718656|NCT01252940|463267267|FG001|Extension Phase|Lack of Efficacy|0|||
128718657|NCT01252940|463267266|FG000|Extension Phase|Lost to Follow-up|5|||
128718658|NCT01252940|463267267|FG001|Extension Phase|Lost to Follow-up|0|||
128979188|NCT02528643|464211628|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
129041463|NCT04179019|464444306|FG000|Overall Study|Physician Decision|2|||
129041464|NCT04179019|464444306|FG000|Overall Study|Withdrawal by Subject|5|||
128718659|NCT01252940|463267266|FG000|Extension Phase|Physician Decision|0|||
128718660|NCT01252940|463267267|FG001|Extension Phase|Physician Decision|1|||
129041465|NCT04179019|464444306|FG000|Overall Study|Adverse Event|4|||
129041466|NCT02610816|464444307|FG000|Phase 1|Withdrawal by Subject|2|||
129041467|NCT02610816|464444308|FG001|Phase 1|Withdrawal by Subject|6|||
129041468|NCT02610816|464444309|FG002|Phase 1|Withdrawal by Subject|0|||
129041469|NCT02610816|464444310|FG003|Phase 1|Withdrawal by Subject|0|||
129041470|NCT02610816|464444307|FG000|Phase 1|Lost to Follow-up|2|||
129041471|NCT02610816|464444308|FG001|Phase 1|Lost to Follow-up|1|||
129041472|NCT02610816|464444309|FG002|Phase 1|Lost to Follow-up|0|||
129041473|NCT02610816|464444310|FG003|Phase 1|Lost to Follow-up|0|||
129041474|NCT02610816|464444307|FG000|Phase 1|Physician Decision|0|||
129041475|NCT02610816|464444308|FG001|Phase 1|Physician Decision|1|||
129041476|NCT02610816|464444309|FG002|Phase 1|Physician Decision|0|||
129041477|NCT02610816|464444310|FG003|Phase 1|Physician Decision|0|||
129041478|NCT02610816|464444307|FG000|Phase 2|Withdrawal by Subject|0|||
129041479|NCT02610816|464444308|FG001|Phase 2|Withdrawal by Subject|0|||
129041480|NCT02610816|464444309|FG002|Phase 2|Withdrawal by Subject|9|||
129041481|NCT02610816|464444310|FG003|Phase 2|Withdrawal by Subject|3|||
129041482|NCT02610816|464444307|FG000|Phase 2|Lost to Follow-up|0|||
129041483|NCT02610816|464444308|FG001|Phase 2|Lost to Follow-up|0|||
129041484|NCT02610816|464444309|FG002|Phase 2|Lost to Follow-up|2|||
129041485|NCT02610816|464444310|FG003|Phase 2|Lost to Follow-up|0|||
129041486|NCT02610816|464444307|FG000|Phase 2|Physician Decision|0|||
129041487|NCT02610816|464444308|FG001|Phase 2|Physician Decision|0|||
128979189|NCT02528643|464211627|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
128979190|NCT02528643|464211628|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
128979191|NCT02528643|464211627|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
128979192|NCT02528643|464211628|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
128979193|NCT02528643|464211627|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
128979194|NCT02528643|464211628|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
128979195|NCT02528643|464211627|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
128979196|NCT02528643|464211628|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
128979197|NCT02528643|464211627|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
128979198|NCT02528643|464211628|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
128979199|NCT02528643|464211627|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
128979200|NCT02528643|464211628|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
128979201|NCT01191190|464211629|FG000|Overall Study|Withdrawal by Subject|1|||
128979202|NCT01871870|464211633|FG000|Overall Study|Hardware issues|7|||
128979203|NCT01871870|464211633|FG000|Overall Study|hyperglycemia|2|||
128979204|NCT01856920|464211639|FG000|Overall Study|Disease Progression On Study|3|||
128979205|NCT01856920|464211640|FG001|Overall Study|Disease Progression On Study|4|||
128979206|NCT01856920|464211639|FG000|Overall Study|Disease Progression before Treatment|1|||
128979207|NCT01856920|464211640|FG001|Overall Study|Disease Progression before Treatment|0|||
128979208|NCT01856920|464211639|FG000|Overall Study|Ineligible|0|||
128979209|NCT01856920|464211640|FG001|Overall Study|Ineligible|1|||
128979210|NCT01856920|464211639|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
128979211|NCT01856920|464211640|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
128979212|NCT01856920|464211639|FG000|Overall Study|Refused further Treatment|5|||
128979213|NCT01856920|464211640|FG001|Overall Study|Refused further Treatment|1|||
128979214|NCT01856920|464211639|FG000|Overall Study|Other Reasons|0|||
128979215|NCT01856920|464211640|FG001|Overall Study|Other Reasons|1|||
128979216|NCT01856920|464211639|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
128979217|NCT01856920|464211640|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
128979218|NCT02545270|464211641|FG000|Overall Study|technical difficulties|0|||
128979219|NCT02545270|464211642|FG001|Overall Study|technical difficulties|1|||
128979220|NCT02545270|464211643|FG002|Overall Study|technical difficulties|0|||
128979221|NCT02545270|464211641|FG000|Overall Study|Videos being too similar to other|0|||
128979222|NCT02545270|464211642|FG001|Overall Study|Videos being too similar to other|0|||
128979223|NCT02545270|464211643|FG002|Overall Study|Videos being too similar to other|2|||
128979224|NCT00761891|464211644|FG000|Overall Study|Withdrawal by Subject|10|||
129222555|NCT05508074|465116138|FG001|Overall Study|Physician Decision|1|||
129222556|NCT05508074|465116137|FG000|Overall Study|wrongly randomized|0|||
128775097|NCT01474512|463468374|FG017|Maintenance Period|Physician Decision|0|||
128979225|NCT02074059|464211650|FG000|Overall Study|Death|0|||
128979226|NCT02074059|464211651|FG001|Overall Study|Death|0|||
128979227|NCT02074059|464211652|FG002|Overall Study|Death|0|||
129041488|NCT02610816|464444309|FG002|Phase 2|Physician Decision|0|||
129041489|NCT02610816|464444310|FG003|Phase 2|Physician Decision|2|||
129041490|NCT02610816|464444307|FG000|Phase 2|Pregnancy|0|||
129041491|NCT02610816|464444308|FG001|Phase 2|Pregnancy|0|||
129041492|NCT02610816|464444309|FG002|Phase 2|Pregnancy|0|||
129041493|NCT02610816|464444310|FG003|Phase 2|Pregnancy|1|||
129041494|NCT03438227|464444311|FG000|Overall Study|Withdrawal by Subject|10|||
129041495|NCT03438227|464444312|FG001|Overall Study|Withdrawal by Subject|5|||
129041496|NCT01855048|464444313|FG000|Overall Study|Withdrawal by Subject|0|||
129041497|NCT01855048|464444314|FG001|Overall Study|Withdrawal by Subject|1|||
129222557|NCT05508074|465116138|FG001|Overall Study|wrongly randomized|1|||
129041498|NCT01855048|464444315|FG002|Overall Study|Withdrawal by Subject|0|||
129041499|NCT01855048|464444316|FG003|Overall Study|Withdrawal by Subject|0|||
129041500|NCT01855048|464444317|FG004|Overall Study|Withdrawal by Subject|1|||
129041501|NCT01855048|464444318|FG005|Overall Study|Withdrawal by Subject|0|||
129041502|NCT02691741|464444319|FG000|Overall Study|Adverse Event|0|||
129041503|NCT02691741|464444320|FG001|Overall Study|Adverse Event|2|||
129041504|NCT02691741|464444319|FG000|Overall Study|Lost to Follow-up|1|||
129041505|NCT02691741|464444320|FG001|Overall Study|Lost to Follow-up|0|||
129041506|NCT02691741|464444319|FG000|Overall Study|Physician Decision|0|||
129041507|NCT02691741|464444320|FG001|Overall Study|Physician Decision|1|||
129041508|NCT02691741|464444319|FG000|Overall Study|Withdrawal by Subject|0|||
129041509|NCT02691741|464444320|FG001|Overall Study|Withdrawal by Subject|4|||
129222558|NCT05508074|465116137|FG000|Overall Study|non-compliance|0|||
129222559|NCT05508074|465116138|FG001|Overall Study|non-compliance|1|||
129041510|NCT01813071|464444321|FG000|Overall Study|Protocol Violation|0|||
129133316|NCT01471574|464781286|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
129133317|NCT01471574|464781287|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
129133318|NCT01471574|464781284|FG000|Treatment Period|Lost to Follow-up|1|||
129133319|NCT01471574|464781285|FG001|Treatment Period|Lost to Follow-up|2|||
129133320|NCT01471574|464781286|FG002|Treatment Period|Lost to Follow-up|2|||
129133321|NCT01471574|464781287|FG003|Treatment Period|Lost to Follow-up|0|||
129133322|NCT01471574|464781284|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
129133323|NCT01471574|464781285|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
129133324|NCT01471574|464781286|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
129133325|NCT01471574|464781287|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
129133326|NCT01471574|464781284|FG000|Treatment Period|Other|1|||
129133327|NCT01471574|464781285|FG001|Treatment Period|Other|0|||
129133328|NCT01471574|464781286|FG002|Treatment Period|Other|0|||
129133329|NCT01471574|464781287|FG003|Treatment Period|Other|0|||
129133330|NCT01471574|464781284|FG000|Follow-up Period|Withdrawal by Subject|3|||
129133331|NCT01471574|464781285|FG001|Follow-up Period|Withdrawal by Subject|0|||
129133332|NCT01471574|464781286|FG002|Follow-up Period|Withdrawal by Subject|3|||
129133333|NCT01471574|464781287|FG003|Follow-up Period|Withdrawal by Subject|1|||
129133334|NCT01471574|464781284|FG000|Follow-up Period|Lost to Follow-up|4|||
129133335|NCT01471574|464781285|FG001|Follow-up Period|Lost to Follow-up|1|||
129133336|NCT01471574|464781286|FG002|Follow-up Period|Lost to Follow-up|3|||
129133337|NCT01471574|464781287|FG003|Follow-up Period|Lost to Follow-up|2|||
129133338|NCT01471574|464781284|FG000|Follow-up Period|Death|0|||
129133339|NCT01471574|464781285|FG001|Follow-up Period|Death|0|||
129222560|NCT05218499|465116139|FG000|Overall Study|Not treated|1|||
129222561|NCT05218499|465116140|FG001|Overall Study|Not treated|1|||
128979228|NCT02074059|464211653|FG003|Overall Study|Death|0|||
128979229|NCT02074059|464211654|FG004|Overall Study|Death|1|||
128979230|NCT02074059|464211655|FG005|Overall Study|Death|1|||
128979231|NCT02764229|464211661|FG000|Overall Study|Withdrawal by Subject|15|||
128979232|NCT02764229|464211661|FG000|Overall Study|Adverse Event|9|||
128979233|NCT02764229|464211661|FG000|Overall Study|Physician Decision|5|||
128979234|NCT02764229|464211661|FG000|Overall Study|Lost to Follow-up|3|||
128979235|NCT02764229|464211661|FG000|Overall Study|Lack of Efficacy|1|||
128979236|NCT02764229|464211661|FG000|Overall Study|Study Stopped by Sponsor|69|||
128979237|NCT00265382|464211664|FG000|Overall Study|Adverse Event|21|||
128979238|NCT00265382|464211664|FG000|Overall Study|Laboratory Abnormality|1|||
128979239|NCT00265382|464211664|FG000|Overall Study|Lost to Follow-up|3|||
128979240|NCT00265382|464211664|FG000|Overall Study|Lack of Efficacy|6|||
128979241|NCT00265382|464211664|FG000|Overall Study|Miscellaneous|6|||
128979242|NCT00265382|464211664|FG000|Overall Study|Withdrawal by Subject|13|||
128979243|NCT00265382|464211664|FG000|Overall Study|Study terminated by sponsor|94|||
128979244|NCT00265382|464211664|FG000|Overall Study|Death|1|||
128979245|NCT01724021|464211667|FG000|Overall Study|Adverse Event|11|||
128979246|NCT01724021|464211668|FG001|Overall Study|Adverse Event|6|||
128979247|NCT01724021|464211667|FG000|Overall Study|Death|46|||
128979248|NCT01724021|464211668|FG001|Overall Study|Death|58|||
128979249|NCT01724021|464211667|FG000|Overall Study|Participant request/ Withdrew consent|18|||
128979250|NCT01724021|464211668|FG001|Overall Study|Participant request/ Withdrew consent|14|||
128979251|NCT01724021|464211667|FG000|Overall Study|Lost to Follow-up|15|||
128979252|NCT01724021|464211668|FG001|Overall Study|Lost to Follow-up|15|||
128979253|NCT01724021|464211667|FG000|Overall Study|Reason Not Specified|36|||
128979254|NCT01724021|464211668|FG001|Overall Study|Reason Not Specified|39|||
128979255|NCT01724021|464211667|FG000|Overall Study|Missing|1|||
128979256|NCT01724021|464211668|FG001|Overall Study|Missing|1|||
128979257|NCT00529152|464211669|FG000|Overall Study|Adverse Event|2|||
128979258|NCT00529152|464211669|FG000|Overall Study|Withdrawal by Subject|2|||
128979259|NCT00529152|464211669|FG000|Overall Study|Lost to Follow-up|1|||
129041511|NCT01813071|464444322|FG001|Overall Study|Protocol Violation|0|||
129133340|NCT01471574|464781286|FG002|Follow-up Period|Death|1|||
129133341|NCT01471574|464781287|FG003|Follow-up Period|Death|0|||
128979260|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
128979261|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
128718661|NCT01252940|463267266|FG000|Extension Phase|Subject Non-compliance|1|||
128718662|NCT01252940|463267267|FG001|Extension Phase|Subject Non-compliance|0|||
128718663|NCT01252940|463267266|FG000|Extension Phase|Withdrawal by Subject|1|||
128718664|NCT01252940|463267267|FG001|Extension Phase|Withdrawal by Subject|1|||
128718665|NCT03971695|463268794|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
128718666|NCT03971695|463268795|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
128718667|NCT03971695|463268796|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
128979262|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
128979263|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
128979264|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
128979265|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
128979266|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Death|1|||
128979267|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Death|1|||
128979268|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Death|1|||
128979269|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Death|0|||
128979270|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Death|0|||
128979271|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Death|0|||
128979272|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
128979273|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
128979274|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
128979275|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
128979276|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
128979277|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
128979278|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
128979279|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
128979280|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
128979281|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
128979282|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
128979283|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
128979284|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
128979285|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
128979286|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
128979287|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
128979288|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
128979289|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
128979290|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
128979291|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
128979292|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
128979293|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
128979294|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
128979295|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
128979296|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
128979297|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
128979298|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
128979299|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
128979300|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
128979301|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
128979302|NCT03370133|464211675|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
128979303|NCT03370133|464211676|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
128979304|NCT03370133|464211677|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
128979305|NCT03370133|464211678|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
128979306|NCT03370133|464211679|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
128979307|NCT03370133|464211680|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
128979308|NCT03370133|464211675|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
128979309|NCT03370133|464211676|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
128979310|NCT03370133|464211677|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
128979311|NCT03370133|464211678|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
128979312|NCT03370133|464211679|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
128979313|NCT03370133|464211680|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
128979314|NCT03370133|464211675|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
129041512|NCT01813071|464444323|FG002|Overall Study|Protocol Violation|0|||
129041513|NCT01813071|464444324|FG003|Overall Study|Protocol Violation|0|||
129041514|NCT01813071|464444325|FG004|Overall Study|Protocol Violation|1|||
128718668|NCT03971695|463268797|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
129041515|NCT01813071|464444326|FG005|Overall Study|Protocol Violation|4|||
129041516|NCT01813071|464444327|FG006|Overall Study|Protocol Violation|2|||
128979315|NCT03370133|464211676|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
129041517|NCT01813071|464444328|FG007|Overall Study|Protocol Violation|4|||
128775098|NCT01474512|463468357|FG000|Maintenance Period|Clinical Relapse|0|||
128775099|NCT01474512|463468358|FG001|Maintenance Period|Clinical Relapse|0|||
128775100|NCT01474512|463468359|FG002|Maintenance Period|Clinical Relapse|0|||
128775101|NCT01474512|463468360|FG003|Maintenance Period|Clinical Relapse|1|||
128775102|NCT01474512|463468361|FG004|Maintenance Period|Clinical Relapse|0|||
128775103|NCT01474512|463468362|FG005|Maintenance Period|Clinical Relapse|0|||
128775104|NCT01474512|463468363|FG006|Maintenance Period|Clinical Relapse|0|||
128775105|NCT01474512|463468364|FG007|Maintenance Period|Clinical Relapse|0|||
128775106|NCT01474512|463468365|FG008|Maintenance Period|Clinical Relapse|0|||
128775107|NCT01474512|463468366|FG009|Maintenance Period|Clinical Relapse|0|||
128775108|NCT01474512|463468367|FG010|Maintenance Period|Clinical Relapse|0|||
128775109|NCT01474512|463468368|FG011|Maintenance Period|Clinical Relapse|0|||
128775110|NCT01474512|463468369|FG012|Maintenance Period|Clinical Relapse|0|||
128775111|NCT01474512|463468370|FG013|Maintenance Period|Clinical Relapse|0|||
128775112|NCT01474512|463468371|FG014|Maintenance Period|Clinical Relapse|0|||
128775113|NCT01474512|463468372|FG015|Maintenance Period|Clinical Relapse|0|||
128775114|NCT01474512|463468373|FG016|Maintenance Period|Clinical Relapse|0|||
128775115|NCT01474512|463468374|FG017|Maintenance Period|Clinical Relapse|0|||
128775116|NCT01474512|463468357|FG000|Maintenance Period|Lack of Efficacy|0|||
128775117|NCT01474512|463468358|FG001|Maintenance Period|Lack of Efficacy|0|||
128775118|NCT01474512|463468359|FG002|Maintenance Period|Lack of Efficacy|0|||
128775119|NCT01474512|463468360|FG003|Maintenance Period|Lack of Efficacy|1|||
128775120|NCT01474512|463468361|FG004|Maintenance Period|Lack of Efficacy|0|||
128775121|NCT01474512|463468362|FG005|Maintenance Period|Lack of Efficacy|0|||
128775122|NCT01474512|463468363|FG006|Maintenance Period|Lack of Efficacy|0|||
128775123|NCT01474512|463468364|FG007|Maintenance Period|Lack of Efficacy|11|||
128775124|NCT01474512|463468365|FG008|Maintenance Period|Lack of Efficacy|11|||
128775125|NCT01474512|463468366|FG009|Maintenance Period|Lack of Efficacy|12|||
128775126|NCT01474512|463468367|FG010|Maintenance Period|Lack of Efficacy|0|||
128775127|NCT01474512|463468368|FG011|Maintenance Period|Lack of Efficacy|0|||
128775128|NCT01474512|463468369|FG012|Maintenance Period|Lack of Efficacy|0|||
128775129|NCT01474512|463468370|FG013|Maintenance Period|Lack of Efficacy|0|||
128775130|NCT01474512|463468371|FG014|Maintenance Period|Lack of Efficacy|0|||
128775131|NCT01474512|463468372|FG015|Maintenance Period|Lack of Efficacy|0|||
128775132|NCT01474512|463468373|FG016|Maintenance Period|Lack of Efficacy|0|||
128775133|NCT01474512|463468374|FG017|Maintenance Period|Lack of Efficacy|0|||
128775134|NCT01474512|463468357|FG000|Maintenance Period|Protocol Violation|0|||
128775135|NCT01474512|463468358|FG001|Maintenance Period|Protocol Violation|0|||
128775136|NCT01474512|463468359|FG002|Maintenance Period|Protocol Violation|0|||
128775137|NCT01474512|463468360|FG003|Maintenance Period|Protocol Violation|1|||
128775138|NCT01474512|463468361|FG004|Maintenance Period|Protocol Violation|0|||
128775139|NCT01474512|463468362|FG005|Maintenance Period|Protocol Violation|0|||
128979316|NCT03370133|464211677|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
128979317|NCT03370133|464211678|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
128979318|NCT03370133|464211679|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
128979319|NCT03370133|464211680|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
128979320|NCT03370133|464211675|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
128979321|NCT03370133|464211676|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
128979322|NCT03370133|464211677|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
128979323|NCT03370133|464211678|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
128775140|NCT01474512|463468363|FG006|Maintenance Period|Protocol Violation|0|||
128979324|NCT03370133|464211679|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
129133342|NCT01471574|464781284|FG000|Follow-up Period|Follow-up no longer required|0|||
129133343|NCT01471574|464781285|FG001|Follow-up Period|Follow-up no longer required|1|||
129133344|NCT01471574|464781286|FG002|Follow-up Period|Follow-up no longer required|0|||
129133345|NCT01471574|464781287|FG003|Follow-up Period|Follow-up no longer required|0|||
129133346|NCT01795937|464781288|FG000|Overall Study|Withdrawal by Subject|1|||
129133347|NCT01795937|464781289|FG001|Overall Study|Withdrawal by Subject|0|||
129133348|NCT01795937|464781290|FG002|Overall Study|Withdrawal by Subject|0|||
129133349|NCT01795937|464781288|FG000|Overall Study|Physician Decision|0|||
129133350|NCT01795937|464781289|FG001|Overall Study|Physician Decision|1|||
129133351|NCT01795937|464781290|FG002|Overall Study|Physician Decision|0|||
129133352|NCT04027946|464781291|FG000|Overall Study|Screen failures|3|||
129133353|NCT01028053|464781296|FG000|Overall Study|Screen Failure|113|||
129133354|NCT01028053|464781296|FG000|Overall Study|Patient Request|11|||
129133355|NCT01028053|464781296|FG000|Overall Study|Protocol Violation|1|||
129133356|NCT01028053|464781296|FG000|Overall Study|Physician Decision|2|||
129133357|NCT01028053|464781296|FG000|Overall Study|Technical Problem|1|||
129133358|NCT01028053|464781296|FG000|Overall Study|Terminated by Sponsor|1|||
129133359|NCT01028053|464781296|FG000|Overall Study|Various reasons|4|||
129133360|NCT00983957|464781298|FG000|Overall Study|Adverse Event|1|||
129133361|NCT00983957|464781298|FG000|Overall Study|Personal Reasons|1|||
129133362|NCT00986232|464781299|FG000|Overall Study|Adverse Event|1|||
129133363|NCT00986232|464781300|FG001|Overall Study|Adverse Event|2|||
129041518|NCT01813071|464444329|FG008|Overall Study|Protocol Violation|2|||
129041519|NCT01813071|464444321|FG000|Overall Study|Withdrawal by Subject|0|||
129041520|NCT01813071|464444322|FG001|Overall Study|Withdrawal by Subject|0|||
129041521|NCT01813071|464444323|FG002|Overall Study|Withdrawal by Subject|0|||
129041522|NCT01813071|464444324|FG003|Overall Study|Withdrawal by Subject|0|||
129041523|NCT01813071|464444325|FG004|Overall Study|Withdrawal by Subject|0|||
129041524|NCT01813071|464444326|FG005|Overall Study|Withdrawal by Subject|1|||
129041525|NCT01813071|464444327|FG006|Overall Study|Withdrawal by Subject|0|||
129041526|NCT01813071|464444328|FG007|Overall Study|Withdrawal by Subject|0|||
129041527|NCT01813071|464444329|FG008|Overall Study|Withdrawal by Subject|0|||
129041528|NCT01813071|464444321|FG000|Overall Study|Adverse Event|0|||
129041529|NCT01813071|464444322|FG001|Overall Study|Adverse Event|0|||
129041530|NCT01813071|464444323|FG002|Overall Study|Adverse Event|0|||
129041531|NCT01813071|464444324|FG003|Overall Study|Adverse Event|0|||
129041532|NCT01813071|464444325|FG004|Overall Study|Adverse Event|0|||
129041533|NCT01813071|464444326|FG005|Overall Study|Adverse Event|1|||
129041534|NCT01813071|464444327|FG006|Overall Study|Adverse Event|0|||
129041535|NCT01813071|464444328|FG007|Overall Study|Adverse Event|0|||
129041536|NCT01813071|464444329|FG008|Overall Study|Adverse Event|0|||
129041537|NCT01813071|464444321|FG000|Overall Study|Physician Decision|0|||
129133364|NCT00986232|464781301|FG002|Overall Study|Adverse Event|3|||
129133365|NCT00986232|464781302|FG003|Overall Study|Adverse Event|0|||
129133366|NCT00986232|464781299|FG000|Overall Study|Lost to Follow-up|19|||
128718669|NCT03971695|463268798|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
128718670|NCT03971695|463268799|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
128718671|NCT03971695|463268800|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
128718672|NCT03971695|463268801|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
128718673|NCT03971695|463268802|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
128718674|NCT03971695|463268803|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
128718675|NCT03971695|463268804|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
128718676|NCT03971695|463268805|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
128718677|NCT03971695|463268806|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
128718678|NCT02155738|463268814|FG000|Overall Study|Missing critical information|1|||
128718679|NCT02155738|463268815|FG001|Overall Study|Missing critical information|0|||
128718680|NCT02155738|463268816|FG002|Overall Study|Missing critical information|0|||
128718681|NCT02155738|463268817|FG003|Overall Study|Missing critical information|1|||
128718682|NCT01190254|463268818|FG000|Overall Study|Adverse Event|3|||
128718683|NCT01190254|463268819|FG001|Overall Study|Adverse Event|6|||
128718684|NCT01190254|463268820|FG002|Overall Study|Adverse Event|8|||
128718685|NCT01190254|463268818|FG000|Overall Study|Lack of Efficacy|7|||
128718686|NCT01190254|463268819|FG001|Overall Study|Lack of Efficacy|4|||
128718687|NCT01190254|463268820|FG002|Overall Study|Lack of Efficacy|5|||
128718688|NCT01190254|463268818|FG000|Overall Study|Lost to Follow-up|4|||
128718689|NCT01190254|463268819|FG001|Overall Study|Lost to Follow-up|2|||
128718690|NCT01190254|463268820|FG002|Overall Study|Lost to Follow-up|0|||
128718691|NCT01190254|463268818|FG000|Overall Study|Withdrawal by Subject|4|||
128718692|NCT01190254|463268819|FG001|Overall Study|Withdrawal by Subject|5|||
128718693|NCT01190254|463268820|FG002|Overall Study|Withdrawal by Subject|7|||
128718694|NCT01190254|463268818|FG000|Overall Study|Protocol Violation|2|||
128718695|NCT01190254|463268819|FG001|Overall Study|Protocol Violation|0|||
128718696|NCT01190254|463268820|FG002|Overall Study|Protocol Violation|2|||
128718697|NCT01190254|463268818|FG000|Overall Study|Did not meet protocol eligibility|1|||
128718698|NCT01190254|463268819|FG001|Overall Study|Did not meet protocol eligibility|0|||
128718699|NCT01190254|463268820|FG002|Overall Study|Did not meet protocol eligibility|0|||
128718700|NCT02356783|463268821|FG000|Overall Study|Lost to Follow-up|1|||
128718701|NCT02356783|463268822|FG001|Overall Study|Lost to Follow-up|3|||
128718702|NCT02603809|463268823|FG000|Overall Study|Withdrawal by Subject|4|||
128718703|NCT02603809|463268824|FG001|Overall Study|Withdrawal by Subject|1|||
128718704|NCT02603809|463268825|FG002|Overall Study|Withdrawal by Subject|2|||
128718705|NCT02603809|463268826|FG003|Overall Study|Withdrawal by Subject|3|||
128718706|NCT02603809|463268827|FG004|Overall Study|Withdrawal by Subject|3|||
128718707|NCT02603809|463268828|FG005|Overall Study|Withdrawal by Subject|4|||
128718708|NCT02603809|463268823|FG000|Overall Study|Lost to Follow-up|2|||
128718709|NCT02603809|463268824|FG001|Overall Study|Lost to Follow-up|3|||
128718710|NCT02603809|463268825|FG002|Overall Study|Lost to Follow-up|1|||
128718711|NCT02603809|463268826|FG003|Overall Study|Lost to Follow-up|4|||
129041538|NCT01813071|464444322|FG001|Overall Study|Physician Decision|0|||
129041539|NCT01813071|464444323|FG002|Overall Study|Physician Decision|0|||
129041540|NCT01813071|464444324|FG003|Overall Study|Physician Decision|0|||
129041541|NCT01813071|464444325|FG004|Overall Study|Physician Decision|0|||
129041542|NCT01813071|464444326|FG005|Overall Study|Physician Decision|0|||
129041543|NCT01813071|464444327|FG006|Overall Study|Physician Decision|1|||
129041544|NCT01813071|464444328|FG007|Overall Study|Physician Decision|0|||
129041545|NCT01813071|464444329|FG008|Overall Study|Physician Decision|0|||
128775141|NCT01474512|463468364|FG007|Maintenance Period|Protocol Violation|1|||
128775142|NCT01474512|463468365|FG008|Maintenance Period|Protocol Violation|0|||
128775143|NCT01474512|463468366|FG009|Maintenance Period|Protocol Violation|1|||
128775144|NCT01474512|463468367|FG010|Maintenance Period|Protocol Violation|0|||
128775145|NCT01474512|463468368|FG011|Maintenance Period|Protocol Violation|0|||
128775146|NCT01474512|463468369|FG012|Maintenance Period|Protocol Violation|0|||
128775147|NCT01474512|463468370|FG013|Maintenance Period|Protocol Violation|0|||
128775148|NCT01474512|463468371|FG014|Maintenance Period|Protocol Violation|0|||
128775149|NCT01474512|463468372|FG015|Maintenance Period|Protocol Violation|0|||
128775150|NCT01474512|463468373|FG016|Maintenance Period|Protocol Violation|0|||
128775151|NCT01474512|463468374|FG017|Maintenance Period|Protocol Violation|0|||
128775152|NCT01474512|463468357|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
128775153|NCT01474512|463468358|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
128775154|NCT01474512|463468359|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
128775155|NCT01474512|463468360|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
128775156|NCT01474512|463468361|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
128775157|NCT01474512|463468362|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
128775158|NCT01474512|463468363|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
128775159|NCT01474512|463468364|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
128775160|NCT01474512|463468365|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
128775161|NCT01474512|463468366|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
128775162|NCT01474512|463468367|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
128775163|NCT01474512|463468368|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
128775164|NCT01474512|463468369|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
128775165|NCT01474512|463468370|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
128775166|NCT01474512|463468371|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
128775167|NCT01474512|463468372|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
128775168|NCT01474512|463468373|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
128775169|NCT01474512|463468374|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
128775170|NCT01474512|463468357|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
128775171|NCT01474512|463468358|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
128775172|NCT01474512|463468359|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
128775173|NCT01474512|463468360|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
128775174|NCT01474512|463468361|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
128775175|NCT01474512|463468362|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
128775176|NCT01474512|463468363|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
128775177|NCT01474512|463468364|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
128775178|NCT01474512|463468365|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
128775179|NCT01474512|463468366|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
128775180|NCT01474512|463468367|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
128775181|NCT01474512|463468368|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
128775182|NCT01474512|463468369|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
128775183|NCT01474512|463468370|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
128775184|NCT01474512|463468371|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
128775185|NCT01474512|463468372|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
128775186|NCT01474512|463468373|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
128775187|NCT01474512|463468374|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
128775188|NCT01474512|463468357|FG000|Long-Term Extension Period|Adverse Event|0|||
128775189|NCT01474512|463468358|FG001|Long-Term Extension Period|Adverse Event|0|||
128775190|NCT01474512|463468359|FG002|Long-Term Extension Period|Adverse Event|0|||
128775191|NCT01474512|463468360|FG003|Long-Term Extension Period|Adverse Event|0|||
128775192|NCT01474512|463468361|FG004|Long-Term Extension Period|Adverse Event|0|||
128775193|NCT01474512|463468362|FG005|Long-Term Extension Period|Adverse Event|0|||
128775194|NCT01474512|463468363|FG006|Long-Term Extension Period|Adverse Event|0|||
128775195|NCT01474512|463468364|FG007|Long-Term Extension Period|Adverse Event|0|||
128775196|NCT01474512|463468365|FG008|Long-Term Extension Period|Adverse Event|0|||
128775197|NCT01474512|463468366|FG009|Long-Term Extension Period|Adverse Event|0|||
128775198|NCT01474512|463468367|FG010|Long-Term Extension Period|Adverse Event|0|||
128775199|NCT01474512|463468368|FG011|Long-Term Extension Period|Adverse Event|1|||
128775200|NCT01474512|463468369|FG012|Long-Term Extension Period|Adverse Event|57|||
128979325|NCT03370133|464211680|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
128775201|NCT01474512|463468370|FG013|Long-Term Extension Period|Adverse Event|58|||
128775202|NCT01474512|463468371|FG014|Long-Term Extension Period|Adverse Event|0|||
128775203|NCT01474512|463468372|FG015|Long-Term Extension Period|Adverse Event|0|||
128979326|NCT03370133|464211675|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
128775204|NCT01474512|463468373|FG016|Long-Term Extension Period|Adverse Event|0|||
128775205|NCT01474512|463468374|FG017|Long-Term Extension Period|Adverse Event|0|||
128775206|NCT01474512|463468357|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
128775207|NCT01474512|463468358|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
128775208|NCT01474512|463468359|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
128775209|NCT01474512|463468360|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
128718712|NCT02603809|463268827|FG004|Overall Study|Lost to Follow-up|2|||
128718713|NCT02603809|463268828|FG005|Overall Study|Lost to Follow-up|2|||
128718714|NCT02603809|463268823|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
128718715|NCT02603809|463268824|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
128979327|NCT03370133|464211676|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
128979328|NCT03370133|464211677|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
128979329|NCT03370133|464211678|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
128979330|NCT03370133|464211679|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
128979331|NCT03370133|464211680|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
128979332|NCT03370133|464211675|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
128979333|NCT03370133|464211676|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
128979334|NCT03370133|464211677|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
128979335|NCT03370133|464211678|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
128979336|NCT03370133|464211679|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
128979337|NCT03370133|464211680|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
128979338|NCT03370133|464211675|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
128979339|NCT03370133|464211676|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
128979340|NCT03370133|464211677|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
128979341|NCT03370133|464211678|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
128979342|NCT03370133|464211679|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
128979343|NCT03370133|464211680|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
128979344|NCT03370133|464211675|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
128979345|NCT03370133|464211676|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
128979346|NCT03370133|464211677|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
128979347|NCT03370133|464211678|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
128979348|NCT03370133|464211679|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
128979349|NCT03370133|464211680|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
128979350|NCT03524664|464211681|FG000|Overall Study|Withdrawal by Subject|1|||
128979351|NCT03524664|464211682|FG001|Overall Study|Withdrawal by Subject|2|||
128979352|NCT03524664|464211681|FG000|Overall Study|Lost to Follow-up|4|||
128979353|NCT03524664|464211682|FG001|Overall Study|Lost to Follow-up|13|||
128979354|NCT02694562|464211683|FG000|Overall Study|Death|8|||
128979355|NCT02694562|464211683|FG000|Overall Study|Protocol Violation|4|||
128979356|NCT02694562|464211683|FG000|Overall Study|Lost to Follow-up|3|||
128979357|NCT02694562|464211683|FG000|Overall Study|Screen Failure|2|||
128979358|NCT02694562|464211683|FG000|Overall Study|Physician Decision|1|||
128979359|NCT01333865|464211684|FG000|Overall Study|Adverse Event|2|||
128979360|NCT00684073|464211685|FG000|Selection|Selection/non-selection criteria|3|||
128979361|NCT00684073|464211685|FG000|Selection|Death|1|||
128979362|NCT00684073|464211685|FG000|Selection|noncompliance|1|||
128979363|NCT00684073|464211685|FG000|Selection|Lost to Follow-up|1|||
128979364|NCT00684073|464211685|FG000|Selection|request of the sponsor|1|||
128979365|NCT00684073|464211685|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
128979366|NCT00620815|464211688|FG000|Overall Study|Adverse Event|1|||
128979367|NCT00620815|464211689|FG001|Overall Study|Adverse Event|1|||
128979368|NCT00620815|464211690|FG002|Overall Study|Adverse Event|2|||
128979369|NCT00620815|464211688|FG000|Overall Study|Withdrawal by Subject|1|||
128979370|NCT00620815|464211689|FG001|Overall Study|Withdrawal by Subject|2|||
128979371|NCT00620815|464211690|FG002|Overall Study|Withdrawal by Subject|0|||
128979372|NCT00620815|464211688|FG000|Overall Study|Lost to Follow-up|1|||
128979373|NCT00620815|464211689|FG001|Overall Study|Lost to Follow-up|6|||
128979374|NCT00620815|464211690|FG002|Overall Study|Lost to Follow-up|3|||
128979375|NCT00620815|464211688|FG000|Overall Study|Inappropriate enrolment|0|||
128979376|NCT00620815|464211689|FG001|Overall Study|Inappropriate enrolment|0|||
128979377|NCT00620815|464211690|FG002|Overall Study|Inappropriate enrolment|1|||
128979378|NCT00620815|464211688|FG000|Overall Study|Protocol Violation|1|||
128979379|NCT00620815|464211689|FG001|Overall Study|Protocol Violation|2|||
128979380|NCT00620815|464211690|FG002|Overall Study|Protocol Violation|1|||
128979381|NCT01888367|464211691|FG000|Overall Study|Physician Decision|3|||
129041546|NCT01813071|464444321|FG000|Overall Study|Met inc/exc criteria|0|||
128718716|NCT02603809|463268825|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
128718717|NCT02603809|463268826|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
128718718|NCT02603809|463268827|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
128979382|NCT01888367|464211692|FG001|Overall Study|Physician Decision|4|||
128979383|NCT01888367|464211693|FG002|Overall Study|Physician Decision|2|||
128979384|NCT01888367|464211691|FG000|Overall Study|Death|2|||
128979385|NCT01888367|464211692|FG001|Overall Study|Death|0|||
128979386|NCT01888367|464211693|FG002|Overall Study|Death|1|||
128979387|NCT01888367|464211691|FG000|Overall Study|Withdrawal by Subject|1|||
129041547|NCT01813071|464444322|FG001|Overall Study|Met inc/exc criteria|0|||
128718719|NCT02603809|463268828|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
128718720|NCT02603809|463268823|FG000|Overall Study|Physician Decision|0|||
128718721|NCT02603809|463268824|FG001|Overall Study|Physician Decision|0|||
128979388|NCT01888367|464211692|FG001|Overall Study|Withdrawal by Subject|0|||
128979389|NCT01888367|464211693|FG002|Overall Study|Withdrawal by Subject|1|||
128979390|NCT01888367|464211691|FG000|Overall Study|Lost to Follow-up|1|||
128979391|NCT01888367|464211692|FG001|Overall Study|Lost to Follow-up|1|||
128979392|NCT01888367|464211693|FG002|Overall Study|Lost to Follow-up|0|||
128979393|NCT01888367|464211691|FG000|Overall Study|Protocol Violation|0|||
128979394|NCT01888367|464211692|FG001|Overall Study|Protocol Violation|0|||
128979395|NCT01888367|464211693|FG002|Overall Study|Protocol Violation|1|||
128979396|NCT01888367|464211691|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
128979397|NCT01888367|464211692|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
128979398|NCT01888367|464211693|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
128979399|NCT01920061|464211695|FG000|Overall Study|Death|1|||
128979400|NCT01920061|464211696|FG001|Overall Study|Death|1|||
128979401|NCT01920061|464211697|FG002|Overall Study|Death|0|||
128979402|NCT01920061|464211698|FG003|Overall Study|Death|1|||
128979403|NCT01920061|464211699|FG004|Overall Study|Death|1|||
128979404|NCT01920061|464211700|FG005|Overall Study|Death|0|||
128979405|NCT01920061|464211701|FG006|Overall Study|Death|0|||
128979406|NCT01920061|464211702|FG007|Overall Study|Death|1|||
128979407|NCT01920061|464211703|FG008|Overall Study|Death|0|||
128979408|NCT01920061|464211704|FG009|Overall Study|Death|1|||
128979409|NCT01920061|464211705|FG010|Overall Study|Death|0|||
128979410|NCT01920061|464211706|FG011|Overall Study|Death|1|||
128979411|NCT01920061|464211707|FG012|Overall Study|Death|0|||
128979412|NCT01920061|464211708|FG013|Overall Study|Death|2|||
128979413|NCT01920061|464211709|FG014|Overall Study|Death|0|||
128979414|NCT01920061|464211710|FG015|Overall Study|Death|0|||
128979415|NCT01920061|464211711|FG016|Overall Study|Death|0|||
128979416|NCT01920061|464211712|FG017|Overall Study|Death|0|||
128979417|NCT01920061|464211713|FG018|Overall Study|Death|1|||
128979418|NCT01920061|464211714|FG019|Overall Study|Death|0|||
128979419|NCT01920061|464211695|FG000|Overall Study|Lost to Follow-up|0|||
128979420|NCT01920061|464211696|FG001|Overall Study|Lost to Follow-up|2|||
128979421|NCT01920061|464211697|FG002|Overall Study|Lost to Follow-up|0|||
128979422|NCT01920061|464211698|FG003|Overall Study|Lost to Follow-up|0|||
128979423|NCT01920061|464211699|FG004|Overall Study|Lost to Follow-up|0|||
128979424|NCT01920061|464211700|FG005|Overall Study|Lost to Follow-up|0|||
128979425|NCT01920061|464211701|FG006|Overall Study|Lost to Follow-up|1|||
128979426|NCT01920061|464211702|FG007|Overall Study|Lost to Follow-up|0|||
128979427|NCT01920061|464211703|FG008|Overall Study|Lost to Follow-up|0|||
128979428|NCT01920061|464211704|FG009|Overall Study|Lost to Follow-up|0|||
128979429|NCT01920061|464211705|FG010|Overall Study|Lost to Follow-up|3|||
128979430|NCT01920061|464211706|FG011|Overall Study|Lost to Follow-up|0|||
128979431|NCT01920061|464211707|FG012|Overall Study|Lost to Follow-up|0|||
128979432|NCT01920061|464211708|FG013|Overall Study|Lost to Follow-up|0|||
128979433|NCT01920061|464211709|FG014|Overall Study|Lost to Follow-up|0|||
128979434|NCT01920061|464211710|FG015|Overall Study|Lost to Follow-up|0|||
128979435|NCT01920061|464211711|FG016|Overall Study|Lost to Follow-up|0|||
128979436|NCT01920061|464211712|FG017|Overall Study|Lost to Follow-up|1|||
128979437|NCT01920061|464211713|FG018|Overall Study|Lost to Follow-up|4|||
128979438|NCT01920061|464211714|FG019|Overall Study|Lost to Follow-up|3|||
128979439|NCT01920061|464211695|FG000|Overall Study|Other|1|||
128979440|NCT01920061|464211696|FG001|Overall Study|Other|1|||
128979441|NCT01920061|464211697|FG002|Overall Study|Other|2|||
128979442|NCT01920061|464211698|FG003|Overall Study|Other|1|||
128979443|NCT01920061|464211699|FG004|Overall Study|Other|0|||
128979444|NCT01920061|464211700|FG005|Overall Study|Other|1|||
128979445|NCT01920061|464211701|FG006|Overall Study|Other|0|||
128979446|NCT01920061|464211702|FG007|Overall Study|Other|0|||
128979447|NCT01920061|464211703|FG008|Overall Study|Other|0|||
128979448|NCT01920061|464211704|FG009|Overall Study|Other|1|||
128979449|NCT01920061|464211705|FG010|Overall Study|Other|1|||
128979450|NCT01920061|464211706|FG011|Overall Study|Other|2|||
128979451|NCT01920061|464211707|FG012|Overall Study|Other|1|||
128979452|NCT01920061|464211708|FG013|Overall Study|Other|4|||
128979453|NCT01920061|464211709|FG014|Overall Study|Other|0|||
128979454|NCT01920061|464211710|FG015|Overall Study|Other|1|||
128979455|NCT01920061|464211711|FG016|Overall Study|Other|1|||
128979456|NCT01920061|464211712|FG017|Overall Study|Other|0|||
128979457|NCT01920061|464211713|FG018|Overall Study|Other|1|||
128718722|NCT02603809|463268825|FG002|Overall Study|Physician Decision|0|||
128979458|NCT01920061|464211714|FG019|Overall Study|Other|1|||
128979459|NCT01920061|464211695|FG000|Overall Study|Participant refused further follow-up|0|||
128979460|NCT01920061|464211696|FG001|Overall Study|Participant refused further follow-up|0|||
128979461|NCT01920061|464211697|FG002|Overall Study|Participant refused further follow-up|0|||
128979462|NCT01920061|464211698|FG003|Overall Study|Participant refused further follow-up|0|||
128979463|NCT01920061|464211699|FG004|Overall Study|Participant refused further follow-up|1|||
128979464|NCT01920061|464211700|FG005|Overall Study|Participant refused further follow-up|1|||
128979465|NCT01920061|464211701|FG006|Overall Study|Participant refused further follow-up|0|||
128979466|NCT01920061|464211702|FG007|Overall Study|Participant refused further follow-up|0|||
129041548|NCT01813071|464444323|FG002|Overall Study|Met inc/exc criteria|0|||
129041549|NCT01813071|464444324|FG003|Overall Study|Met inc/exc criteria|0|||
128718723|NCT02603809|463268826|FG003|Overall Study|Physician Decision|1|||
128718724|NCT02603809|463268827|FG004|Overall Study|Physician Decision|2|||
128718725|NCT02603809|463268828|FG005|Overall Study|Physician Decision|1|||
128718726|NCT02603809|463268823|FG000|Overall Study|Adverse Event|3|||
128718727|NCT02603809|463268824|FG001|Overall Study|Adverse Event|0|||
128979467|NCT01920061|464211703|FG008|Overall Study|Participant refused further follow-up|1|||
128979468|NCT01920061|464211704|FG009|Overall Study|Participant refused further follow-up|0|||
128979469|NCT01920061|464211705|FG010|Overall Study|Participant refused further follow-up|1|||
128979470|NCT01920061|464211706|FG011|Overall Study|Participant refused further follow-up|0|||
128979471|NCT01920061|464211707|FG012|Overall Study|Participant refused further follow-up|1|||
128979472|NCT01920061|464211708|FG013|Overall Study|Participant refused further follow-up|0|||
128979473|NCT01920061|464211709|FG014|Overall Study|Participant refused further follow-up|1|||
128979474|NCT01920061|464211710|FG015|Overall Study|Participant refused further follow-up|2|||
128979475|NCT01920061|464211711|FG016|Overall Study|Participant refused further follow-up|1|||
128979476|NCT01920061|464211712|FG017|Overall Study|Participant refused further follow-up|1|||
128979477|NCT01920061|464211713|FG018|Overall Study|Participant refused further follow-up|0|||
128979478|NCT01920061|464211714|FG019|Overall Study|Participant refused further follow-up|0|||
128979479|NCT00877929|464211715|FG000|Overall Study|Adverse Event|11|||
128979480|NCT00877929|464211716|FG001|Overall Study|Adverse Event|20|||
128979481|NCT00877929|464211715|FG000|Overall Study|Protocol Violation|3|||
128979482|NCT00877929|464211716|FG001|Overall Study|Protocol Violation|3|||
128979483|NCT00877929|464211715|FG000|Overall Study|Lost to Follow-up|0|||
128979484|NCT00877929|464211716|FG001|Overall Study|Lost to Follow-up|1|||
128979485|NCT00877929|464211715|FG000|Overall Study|Withdrawal by Subject|4|||
128979486|NCT00877929|464211716|FG001|Overall Study|Withdrawal by Subject|4|||
128979487|NCT00877929|464211715|FG000|Overall Study|Lack of Efficacy|0|||
128979488|NCT00877929|464211716|FG001|Overall Study|Lack of Efficacy|1|||
128979489|NCT00877929|464211715|FG000|Overall Study|Other reason (not specified)|2|||
128979490|NCT00877929|464211716|FG001|Overall Study|Other reason (not specified)|6|||
128979491|NCT00689728|464211718|FG000|Double-Blind Treatment|Adverse Event|1|||
128979492|NCT00689728|464211719|FG001|Double-Blind Treatment|Adverse Event|0|||
128979493|NCT00689728|464211720|FG002|Double-Blind Treatment|Adverse Event|0|||
128979494|NCT00689728|464211718|FG000|Double-Blind Treatment|Protocol Violation|0|||
128979495|NCT00689728|464211719|FG001|Double-Blind Treatment|Protocol Violation|0|||
128979496|NCT00689728|464211720|FG002|Double-Blind Treatment|Protocol Violation|1|||
128979497|NCT00689728|464211718|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
128979498|NCT00689728|464211719|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
128979499|NCT00689728|464211720|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
128979500|NCT00689728|464211718|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
128979501|NCT00689728|464211719|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
128979502|NCT00689728|464211720|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
128979503|NCT00689728|464211718|FG000|Rescue|Adverse Event|0|||
128979504|NCT00689728|464211719|FG001|Rescue|Adverse Event|1|||
128979505|NCT00689728|464211720|FG002|Rescue|Adverse Event|0|||
128979506|NCT00689728|464211718|FG000|Rescue|Withdrawal by Subject|1|||
128718728|NCT02603809|463268825|FG002|Overall Study|Adverse Event|2|||
128718729|NCT02603809|463268826|FG003|Overall Study|Adverse Event|2|||
128718730|NCT02603809|463268827|FG004|Overall Study|Adverse Event|1|||
128718731|NCT02603809|463268828|FG005|Overall Study|Adverse Event|1|||
128718732|NCT02603809|463268823|FG000|Overall Study|Lack of Efficacy|0|||
128718733|NCT02603809|463268824|FG001|Overall Study|Lack of Efficacy|1|||
128718734|NCT02603809|463268825|FG002|Overall Study|Lack of Efficacy|0|||
128979507|NCT00689728|464211719|FG001|Rescue|Withdrawal by Subject|1|||
129041550|NCT01813071|464444325|FG004|Overall Study|Met inc/exc criteria|0|||
129041551|NCT01813071|464444326|FG005|Overall Study|Met inc/exc criteria|1|||
129041552|NCT01813071|464444327|FG006|Overall Study|Met inc/exc criteria|0|||
129041553|NCT01813071|464444328|FG007|Overall Study|Met inc/exc criteria|1|||
129041554|NCT01813071|464444329|FG008|Overall Study|Met inc/exc criteria|1|||
129041555|NCT01425528|464444330|FG000|Overall Study|Withdrawal by Subject|1|||
129133367|NCT00986232|464781300|FG001|Overall Study|Lost to Follow-up|12|||
128718735|NCT02603809|463268826|FG003|Overall Study|Lack of Efficacy|0|||
128718736|NCT02603809|463268827|FG004|Overall Study|Lack of Efficacy|0|||
128979508|NCT00689728|464211720|FG002|Rescue|Withdrawal by Subject|1|||
128979509|NCT00689728|464211718|FG000|Optional Follow-Up|Adverse Event|1|||
128718737|NCT02603809|463268828|FG005|Overall Study|Lack of Efficacy|1|||
128718738|NCT04729127|463268829|FG000|Overall Study|Suspended/Terminated EI Services|4|||
128979510|NCT00689728|464211719|FG001|Optional Follow-Up|Adverse Event|0|||
128979511|NCT00689728|464211720|FG002|Optional Follow-Up|Adverse Event|0|||
128979512|NCT00689728|464211718|FG000|Optional Follow-Up|Lack of Efficacy|0|||
128979513|NCT00689728|464211719|FG001|Optional Follow-Up|Lack of Efficacy|1|||
128979514|NCT00689728|464211720|FG002|Optional Follow-Up|Lack of Efficacy|1|||
129041556|NCT01425528|464444331|FG001|Overall Study|Withdrawal by Subject|1|||
129041557|NCT00842530|464444332|FG000|Overall Study|Serious adverse event|0|||
129133368|NCT00986232|464781301|FG002|Overall Study|Lost to Follow-up|12|||
129222562|NCT05218499|465116141|FG002|Overall Study|Not treated|8|||
129222563|NCT05218499|465116139|FG000|Overall Study|Death|2|||
128775210|NCT01474512|463468361|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
128775211|NCT01474512|463468362|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
128775212|NCT01474512|463468363|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
128775213|NCT01474512|463468364|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
128775214|NCT01474512|463468365|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
128775215|NCT01474512|463468366|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
128775216|NCT01474512|463468367|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
128775217|NCT01474512|463468368|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
128775218|NCT01474512|463468369|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
128775219|NCT01474512|463468370|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
128775220|NCT01474512|463468371|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
128775221|NCT01474512|463468372|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
128775222|NCT01474512|463468373|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
128775223|NCT01474512|463468374|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
128775224|NCT01474512|463468357|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
128775225|NCT01474512|463468358|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
128775226|NCT01474512|463468359|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
128775227|NCT01474512|463468360|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
128775228|NCT01474512|463468361|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
128775229|NCT01474512|463468362|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
128775230|NCT01474512|463468363|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
128979515|NCT00689728|464211718|FG000|Optional Follow-Up|Lost to Follow-up|0|||
128979516|NCT00689728|464211719|FG001|Optional Follow-Up|Lost to Follow-up|1|||
128979517|NCT00689728|464211720|FG002|Optional Follow-Up|Lost to Follow-up|1|||
128979518|NCT00689728|464211718|FG000|Optional Follow-Up|Protocol Violation|0|||
128979519|NCT00689728|464211719|FG001|Optional Follow-Up|Protocol Violation|0|||
128979520|NCT00689728|464211720|FG002|Optional Follow-Up|Protocol Violation|1|||
128979521|NCT00689728|464211718|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
128979522|NCT00689728|464211719|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
128979523|NCT00689728|464211720|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
128979524|NCT00842829|464211721|FG000|Dose Titration Period|Adverse Event|11|||
128979525|NCT00842829|464211722|FG001|Dose Titration Period|Adverse Event|10|||
128979526|NCT00842829|464211723|FG002|Dose Titration Period|Adverse Event|0|||
128979527|NCT00842829|464211721|FG000|Dose Titration Period|Lack of Efficacy|4|||
128979528|NCT00842829|464211722|FG001|Dose Titration Period|Lack of Efficacy|1|||
128979529|NCT00842829|464211723|FG002|Dose Titration Period|Lack of Efficacy|0|||
128979530|NCT00842829|464211721|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
128979531|NCT00842829|464211722|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
128979532|NCT00842829|464211723|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
128979533|NCT00842829|464211721|FG000|Dose Titration Period|Withdrawal by Subject|2|||
128979534|NCT00842829|464211722|FG001|Dose Titration Period|Withdrawal by Subject|6|||
128979535|NCT00842829|464211723|FG002|Dose Titration Period|Withdrawal by Subject|0|||
128979536|NCT00842829|464211721|FG000|Dose Titration Period|Other|5|||
128979537|NCT00842829|464211722|FG001|Dose Titration Period|Other|4|||
128979538|NCT00842829|464211723|FG002|Dose Titration Period|Other|0|||
128979539|NCT00842829|464211721|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
128979540|NCT00842829|464211722|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
128979541|NCT00842829|464211723|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
128979542|NCT00842829|464211721|FG000|Dose Titration Period|Non-compliance to study drug|2|||
128979543|NCT00842829|464211722|FG001|Dose Titration Period|Non-compliance to study drug|1|||
128979544|NCT00842829|464211723|FG002|Dose Titration Period|Non-compliance to study drug|0|||
128979545|NCT00842829|464211721|FG000|Treatment Period|Adverse Event|0|||
128979546|NCT00842829|464211722|FG001|Treatment Period|Adverse Event|0|||
128979547|NCT00842829|464211723|FG002|Treatment Period|Adverse Event|15|||
128979548|NCT00842829|464211721|FG000|Treatment Period|Lack of Efficacy|0|||
128979549|NCT00842829|464211722|FG001|Treatment Period|Lack of Efficacy|0|||
128979550|NCT00842829|464211723|FG002|Treatment Period|Lack of Efficacy|6|||
128979551|NCT00842829|464211721|FG000|Treatment Period|Unstable persistent cancer pain|0|||
128979552|NCT00842829|464211722|FG001|Treatment Period|Unstable persistent cancer pain|0|||
128979553|NCT00842829|464211723|FG002|Treatment Period|Unstable persistent cancer pain|5|||
128979554|NCT00842829|464211721|FG000|Treatment Period|Withdrawal by Subject|0|||
128979555|NCT00842829|464211722|FG001|Treatment Period|Withdrawal by Subject|0|||
128979556|NCT00842829|464211723|FG002|Treatment Period|Withdrawal by Subject|11|||
128979557|NCT00842829|464211721|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
128979558|NCT00842829|464211722|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
128979559|NCT00842829|464211723|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
128979560|NCT00842829|464211721|FG000|Treatment Period|Protocol Violation|0|||
128979561|NCT00842829|464211722|FG001|Treatment Period|Protocol Violation|0|||
128979562|NCT00842829|464211723|FG002|Treatment Period|Protocol Violation|2|||
128979563|NCT00842829|464211721|FG000|Treatment Period|Other|0|||
129222564|NCT05218499|465116140|FG001|Overall Study|Death|0|||
129133369|NCT00986232|464781302|FG003|Overall Study|Lost to Follow-up|7|||
129133370|NCT00986232|464781299|FG000|Overall Study|Protocol Violation|2|||
129133371|NCT00986232|464781300|FG001|Overall Study|Protocol Violation|3|||
129133372|NCT00986232|464781301|FG002|Overall Study|Protocol Violation|0|||
129133373|NCT00986232|464781302|FG003|Overall Study|Protocol Violation|1|||
129133374|NCT00986232|464781299|FG000|Overall Study|Withdrawal by Subject|13|||
129133375|NCT00986232|464781300|FG001|Overall Study|Withdrawal by Subject|16|||
129133376|NCT00986232|464781301|FG002|Overall Study|Withdrawal by Subject|12|||
129133377|NCT00986232|464781302|FG003|Overall Study|Withdrawal by Subject|3|||
129133378|NCT00986232|464781299|FG000|Overall Study|Missed one or more bleeds|13|||
129133379|NCT00986232|464781300|FG001|Overall Study|Missed one or more bleeds|10|||
129133380|NCT00986232|464781301|FG002|Overall Study|Missed one or more bleeds|6|||
129133381|NCT00986232|464781302|FG003|Overall Study|Missed one or more bleeds|7|||
129133382|NCT00986232|464781299|FG000|Overall Study|Incomplete safety follow-up|3|||
129133383|NCT00986232|464781300|FG001|Overall Study|Incomplete safety follow-up|7|||
129133384|NCT00986232|464781301|FG002|Overall Study|Incomplete safety follow-up|2|||
129133385|NCT00986232|464781302|FG003|Overall Study|Incomplete safety follow-up|2|||
129133386|NCT00790933|464781303|FG000|Overall Study|Adverse Event|94|||
129133387|NCT00790933|464781304|FG001|Overall Study|Adverse Event|119|||
129133388|NCT00790933|464781305|FG002|Overall Study|Adverse Event|65|||
129133389|NCT00790933|464781306|FG003|Overall Study|Adverse Event|5|||
129133390|NCT00790933|464781307|FG004|Overall Study|Adverse Event|69|||
129133391|NCT00790933|464781303|FG000|Overall Study|Protocol Violation(s)|8|||
128718739|NCT04729127|463268830|FG001|Overall Study|Suspended/Terminated EI Services|0|||
128718740|NCT04729127|463268831|FG002|Overall Study|Suspended/Terminated EI Services|4|||
128718741|NCT04729127|463268832|FG003|Overall Study|Suspended/Terminated EI Services|6|||
128718742|NCT04729127|463268833|FG004|Overall Study|Suspended/Terminated EI Services|0|||
128718743|NCT04729127|463268834|FG005|Overall Study|Suspended/Terminated EI Services|6|||
128718744|NCT04729127|463268835|FG006|Overall Study|Suspended/Terminated EI Services|2|||
128718745|NCT04729127|463268836|FG007|Overall Study|Suspended/Terminated EI Services|0|||
128718746|NCT04729127|463268837|FG008|Overall Study|Suspended/Terminated EI Services|2|||
128718747|NCT04729127|463268829|FG000|Overall Study|Withdrawal by Subject|1|||
128718748|NCT04729127|463268830|FG001|Overall Study|Withdrawal by Subject|0|||
128718749|NCT04729127|463268831|FG002|Overall Study|Withdrawal by Subject|1|||
128718750|NCT04729127|463268832|FG003|Overall Study|Withdrawal by Subject|0|||
128979564|NCT00842829|464211722|FG001|Treatment Period|Other|0|||
128979565|NCT00842829|464211723|FG002|Treatment Period|Other|18|||
128979566|NCT00842829|464211721|FG000|Treatment Period|Non-compliance to study procedures|0|||
128979567|NCT00842829|464211722|FG001|Treatment Period|Non-compliance to study procedures|0|||
128979568|NCT00842829|464211723|FG002|Treatment Period|Non-compliance to study procedures|4|||
128979569|NCT00842829|464211721|FG000|Treatment Period|Unclear completion status|0|||
128979570|NCT00842829|464211722|FG001|Treatment Period|Unclear completion status|0|||
128979571|NCT00842829|464211723|FG002|Treatment Period|Unclear completion status|1|||
128979572|NCT00842829|464211721|FG000|Continuation Period|Adverse Event|0|||
128979573|NCT00842829|464211722|FG001|Continuation Period|Adverse Event|0|||
128979574|NCT00842829|464211723|FG002|Continuation Period|Adverse Event|32|||
128979575|NCT00842829|464211721|FG000|Continuation Period|Lack of Efficacy|0|||
128979576|NCT00842829|464211722|FG001|Continuation Period|Lack of Efficacy|0|||
128979577|NCT00842829|464211723|FG002|Continuation Period|Lack of Efficacy|6|||
128979578|NCT00842829|464211721|FG000|Continuation Period|Unstable persistent cancer pain|0|||
128979579|NCT00842829|464211722|FG001|Continuation Period|Unstable persistent cancer pain|0|||
128979580|NCT00842829|464211723|FG002|Continuation Period|Unstable persistent cancer pain|3|||
128979581|NCT00842829|464211721|FG000|Continuation Period|Withdrawal by Subject|0|||
128979582|NCT00842829|464211722|FG001|Continuation Period|Withdrawal by Subject|0|||
128979583|NCT00842829|464211723|FG002|Continuation Period|Withdrawal by Subject|10|||
128979584|NCT00842829|464211721|FG000|Continuation Period|Other|0|||
128979585|NCT00842829|464211722|FG001|Continuation Period|Other|0|||
128979586|NCT00842829|464211723|FG002|Continuation Period|Other|7|||
128979587|NCT00842829|464211721|FG000|Continuation Period|Non-compliance to study procedures|0|||
128979588|NCT00842829|464211722|FG001|Continuation Period|Non-compliance to study procedures|0|||
128979589|NCT00842829|464211723|FG002|Continuation Period|Non-compliance to study procedures|2|||
128979590|NCT00842829|464211721|FG000|Continuation Period|Non-compliance to study drug|0|||
129133392|NCT00790933|464781304|FG001|Overall Study|Protocol Violation(s)|18|||
129133393|NCT00790933|464781305|FG002|Overall Study|Protocol Violation(s)|7|||
129133394|NCT00790933|464781306|FG003|Overall Study|Protocol Violation(s)|0|||
128718751|NCT04729127|463268833|FG004|Overall Study|Withdrawal by Subject|0|||
128718752|NCT04729127|463268834|FG005|Overall Study|Withdrawal by Subject|0|||
128979591|NCT00842829|464211722|FG001|Continuation Period|Non-compliance to study drug|0|||
128718753|NCT04729127|463268835|FG006|Overall Study|Withdrawal by Subject|0|||
128979592|NCT00842829|464211723|FG002|Continuation Period|Non-compliance to study drug|1|||
128979593|NCT03590613|464211727|FG000|Period 2, 4 Days|Physician Decision|0|||
129133395|NCT00790933|464781307|FG004|Overall Study|Protocol Violation(s)|12|||
129133396|NCT00790933|464781303|FG000|Overall Study|Lack of Efficacy|192|||
129133397|NCT00790933|464781304|FG001|Overall Study|Lack of Efficacy|176|||
129133398|NCT00790933|464781305|FG002|Overall Study|Lack of Efficacy|130|||
129041558|NCT00842530|464444333|FG001|Overall Study|Serious adverse event|6|||
129041559|NCT00842530|464444332|FG000|Overall Study|Other adverse event|6|||
129041560|NCT00842530|464444333|FG001|Overall Study|Other adverse event|1|||
129041561|NCT00842530|464444332|FG000|Overall Study|Protocol Violation|32|||
129041562|NCT00842530|464444333|FG001|Overall Study|Protocol Violation|14|||
129041563|NCT00842530|464444332|FG000|Overall Study|Lost to Follow-up|6|||
129041564|NCT00842530|464444333|FG001|Overall Study|Lost to Follow-up|8|||
129041565|NCT00842530|464444332|FG000|Overall Study|Withdrawal by Subject|73|||
129041566|NCT00842530|464444333|FG001|Overall Study|Withdrawal by Subject|28|||
129041567|NCT02939950|464444334|FG000|Overall Study|Lost to Follow-up|13|||
129041568|NCT02939950|464444335|FG001|Overall Study|Lost to Follow-up|16|||
128718754|NCT04729127|463268836|FG007|Overall Study|Withdrawal by Subject|0|||
128979594|NCT03590613|464211728|FG001|Period 2, 4 Days|Physician Decision|0|||
128979595|NCT03590613|464211729|FG002|Period 2, 4 Days|Physician Decision|0|||
128979596|NCT03590613|464211730|FG003|Period 2, 4 Days|Physician Decision|1|||
128979597|NCT04369742|464211731|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
128979598|NCT04369742|464211732|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
128979599|NCT04369742|464211731|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
128979600|NCT04369742|464211732|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
128979601|NCT00280059|464211733|FG000|Efficacy Assessment Phase|Death|2|||
128979602|NCT00280059|464211734|FG001|Efficacy Assessment Phase|Death|0|||
128979603|NCT00280059|464211733|FG000|Efficacy Assessment Phase|Adverse Event|33|||
128979604|NCT00280059|464211734|FG001|Efficacy Assessment Phase|Adverse Event|31|||
128979605|NCT00280059|464211733|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
128979606|NCT00280059|464211734|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
128979607|NCT00280059|464211733|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
128979608|NCT00280059|464211734|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
128979609|NCT00280059|464211733|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
128979610|NCT00280059|464211734|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
128979611|NCT00280059|464211733|FG000|Efficacy Assessment Phase|Other|7|||
128979612|NCT00280059|464211734|FG001|Efficacy Assessment Phase|Other|8|||
128979613|NCT00280059|464211733|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
128979614|NCT00280059|464211734|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
128979615|NCT01130831|464211739|FG000|Overall Study|Withdrawal by Subject|7|||
128979616|NCT01130831|464211739|FG000|Overall Study|Death|4|||
128979617|NCT01130831|464211739|FG000|Overall Study|Information was missing|3|||
128979618|NCT00951912|464211741|FG000|Overall Study|Lack of Efficacy|1|||
128979619|NCT00951912|464211742|FG001|Overall Study|Lack of Efficacy|0|||
128979620|NCT00951912|464211743|FG002|Overall Study|Lack of Efficacy|0|||
128979621|NCT00951912|464211741|FG000|Overall Study|Adverse Event|0|||
128979622|NCT00951912|464211742|FG001|Overall Study|Adverse Event|1|||
128979623|NCT00951912|464211743|FG002|Overall Study|Adverse Event|1|||
128979624|NCT00951912|464211741|FG000|Overall Study|Lost to Follow-up|2|||
128979625|NCT00951912|464211742|FG001|Overall Study|Lost to Follow-up|2|||
128979626|NCT00951912|464211743|FG002|Overall Study|Lost to Follow-up|0|||
129041569|NCT02939950|464444334|FG000|Overall Study|Positive slit lamp findings|0|||
129041570|NCT02939950|464444335|FG001|Overall Study|Positive slit lamp findings|1|||
129041571|NCT02939950|464444334|FG000|Overall Study|Chalazion upper lid|0|||
129041572|NCT02939950|464444335|FG001|Overall Study|Chalazion upper lid|1|||
129041573|NCT02939950|464444334|FG000|Overall Study|Lack of motivation|0|||
129041574|NCT02939950|464444335|FG001|Overall Study|Lack of motivation|2|||
129041575|NCT02939950|464444334|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
129041576|NCT02939950|464444335|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
129041577|NCT02939950|464444334|FG000|Overall Study|Military orders|1|||
129041578|NCT02939950|464444335|FG001|Overall Study|Military orders|0|||
129041579|NCT02939950|464444334|FG000|Overall Study|Participant Relocated|5|||
129041580|NCT02939950|464444335|FG001|Overall Study|Participant Relocated|3|||
129041581|NCT02939950|464444334|FG000|Overall Study|Study related symptoms|8|||
129041582|NCT02939950|464444335|FG001|Overall Study|Study related symptoms|8|||
129041583|NCT02939950|464444334|FG000|Overall Study|Unacceptable lens movement|2|||
129041584|NCT02939950|464444335|FG001|Overall Study|Unacceptable lens movement|0|||
129041585|NCT02939950|464444334|FG000|Overall Study|Protocol Violation|6|||
129041586|NCT02939950|464444335|FG001|Overall Study|Protocol Violation|3|||
129041587|NCT02939950|464444334|FG000|Overall Study|Physician Decision|2|||
129041588|NCT02939950|464444335|FG001|Overall Study|Physician Decision|0|||
129041589|NCT02939950|464444334|FG000|Overall Study|Pregnancy|6|||
129041590|NCT02939950|464444335|FG001|Overall Study|Pregnancy|7|||
129041591|NCT02939950|464444334|FG000|Overall Study|Withdrawal by Subject|12|||
129041592|NCT02939950|464444335|FG001|Overall Study|Withdrawal by Subject|28|||
129041593|NCT02939950|464444334|FG000|Overall Study|Adverse Event|7|||
129133399|NCT00790933|464781306|FG003|Overall Study|Lack of Efficacy|1|||
128979627|NCT00951912|464211741|FG000|Overall Study|Physician Decision|1|||
128979628|NCT00951912|464211742|FG001|Overall Study|Physician Decision|0|||
129041594|NCT02939950|464444335|FG001|Overall Study|Adverse Event|3|||
129041595|NCT02939950|464444334|FG000|Overall Study|Randomized, not dispensed|1|||
128979629|NCT00951912|464211743|FG002|Overall Study|Physician Decision|1|||
128979630|NCT00951912|464211741|FG000|Overall Study|Withdrawal by Subject|1|||
129222565|NCT05218499|465116141|FG002|Overall Study|Death|0|||
129222566|NCT05218499|465116139|FG000|Overall Study|Other than listed|3|||
129222567|NCT05218499|465116140|FG001|Overall Study|Other than listed|7|||
129222568|NCT05218499|465116141|FG002|Overall Study|Other than listed|10|||
129222569|NCT05218499|465116139|FG000|Overall Study|Protocol deviation|5|||
129222570|NCT05218499|465116140|FG001|Overall Study|Protocol deviation|6|||
129222571|NCT05218499|465116141|FG002|Overall Study|Protocol deviation|4|||
129222572|NCT05218499|465116139|FG000|Overall Study|Technical problems|0|||
129222573|NCT05218499|465116140|FG001|Overall Study|Technical problems|1|||
129222574|NCT05218499|465116141|FG002|Overall Study|Technical problems|0|||
129222575|NCT05218499|465116139|FG000|Overall Study|Burden of trial procedures|0|||
129222576|NCT05218499|465116140|FG001|Overall Study|Burden of trial procedures|1|||
129222577|NCT05218499|465116141|FG002|Overall Study|Burden of trial procedures|2|||
129222578|NCT05218499|465116139|FG000|Overall Study|Clinical disease progression|6|||
129222579|NCT05218499|465116140|FG001|Overall Study|Clinical disease progression|6|||
129222580|NCT05218499|465116141|FG002|Overall Study|Clinical disease progression|11|||
129222581|NCT05218499|465116139|FG000|Overall Study|Objective disease progression|44|||
129222582|NCT05218499|465116140|FG001|Overall Study|Objective disease progression|61|||
128979631|NCT00951912|464211742|FG001|Overall Study|Withdrawal by Subject|1|||
129041596|NCT02939950|464444335|FG001|Overall Study|Randomized, not dispensed|0|||
129041597|NCT02939950|464444334|FG000|Overall Study|Ineligible at Baseline|2|||
129041598|NCT02939950|464444335|FG001|Overall Study|Ineligible at Baseline|8|||
129041599|NCT02243293|464444339|FG000|Overall Study|Adverse Event|1|||
129041600|NCT02243293|464444340|FG001|Overall Study|Adverse Event|0|||
129041601|NCT02243293|464444341|FG002|Overall Study|Adverse Event|0|||
129041602|NCT02243293|464444342|FG003|Overall Study|Adverse Event|0|||
129041603|NCT02243293|464444343|FG004|Overall Study|Adverse Event|0|||
129041604|NCT02243293|464444344|FG005|Overall Study|Adverse Event|0|||
129041605|NCT02243293|464444345|FG006|Overall Study|Adverse Event|0|||
129041606|NCT02243293|464444346|FG007|Overall Study|Adverse Event|0|||
129041607|NCT02243293|464444347|FG008|Overall Study|Adverse Event|0|||
129041608|NCT02243293|464444348|FG009|Overall Study|Adverse Event|0|||
129041609|NCT02243293|464444349|FG010|Overall Study|Adverse Event|0|||
129041610|NCT02243293|464444350|FG011|Overall Study|Adverse Event|0|||
129041611|NCT02243293|464444351|FG012|Overall Study|Adverse Event|0|||
129041612|NCT02243293|464444352|FG013|Overall Study|Adverse Event|0|||
129041613|NCT02243293|464444353|FG014|Overall Study|Adverse Event|0|||
129041614|NCT02243293|464444354|FG015|Overall Study|Adverse Event|1|||
129041615|NCT02243293|464444355|FG016|Overall Study|Adverse Event|0|||
129041616|NCT02243293|464444356|FG017|Overall Study|Adverse Event|0|||
129041617|NCT02243293|464444357|FG018|Overall Study|Adverse Event|0|||
129041618|NCT02243293|464444358|FG019|Overall Study|Adverse Event|0|||
129041619|NCT02243293|464444359|FG020|Overall Study|Adverse Event|1|||
129041620|NCT02243293|464444360|FG021|Overall Study|Adverse Event|0|||
129041621|NCT02243293|464444339|FG000|Overall Study|Withdrawal by Subject|1|||
129041622|NCT02243293|464444340|FG001|Overall Study|Withdrawal by Subject|0|||
129041623|NCT02243293|464444341|FG002|Overall Study|Withdrawal by Subject|0|||
129222583|NCT05218499|465116141|FG002|Overall Study|Objective disease progression|42|||
129222584|NCT05218499|465116139|FG000|Overall Study|Adverse Event|11|||
128979632|NCT00951912|464211743|FG002|Overall Study|Withdrawal by Subject|0|||
128979633|NCT00951912|464211741|FG000|Overall Study|Other:Depression|1|||
128979634|NCT00951912|464211742|FG001|Overall Study|Other:Depression|0|||
128979635|NCT00951912|464211743|FG002|Overall Study|Other:Depression|0|||
128979636|NCT00951912|464211741|FG000|Overall Study|Other: Colon cancer|1|||
128979637|NCT00951912|464211742|FG001|Overall Study|Other: Colon cancer|0|||
128979638|NCT00951912|464211743|FG002|Overall Study|Other: Colon cancer|0|||
128979639|NCT00951912|464211741|FG000|Overall Study|Other: Stroke|0|||
128979640|NCT00951912|464211742|FG001|Overall Study|Other: Stroke|1|||
128979641|NCT00951912|464211743|FG002|Overall Study|Other: Stroke|0|||
128979642|NCT03417999|464211744|FG000|Overall Study|Withdrawal by Subject|1|||
128979643|NCT03417999|464211745|FG001|Overall Study|Withdrawal by Subject|0|||
128979644|NCT03417999|464211746|FG002|Overall Study|Withdrawal by Subject|0|||
128979645|NCT03417999|464211744|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
128979646|NCT03417999|464211745|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
129041624|NCT02243293|464444342|FG003|Overall Study|Withdrawal by Subject|0|||
129041625|NCT02243293|464444343|FG004|Overall Study|Withdrawal by Subject|0|||
129222585|NCT05218499|465116140|FG001|Overall Study|Adverse Event|36|||
129041626|NCT02243293|464444344|FG005|Overall Study|Withdrawal by Subject|0|||
129041627|NCT02243293|464444345|FG006|Overall Study|Withdrawal by Subject|0|||
129041628|NCT02243293|464444346|FG007|Overall Study|Withdrawal by Subject|0|||
129041629|NCT02243293|464444347|FG008|Overall Study|Withdrawal by Subject|0|||
129041630|NCT02243293|464444348|FG009|Overall Study|Withdrawal by Subject|1|||
129222586|NCT05218499|465116141|FG002|Overall Study|Adverse Event|9|||
129222587|NCT05218499|465116139|FG000|Overall Study|On treatment at time of snapshot|18|||
129222588|NCT05218499|465116140|FG001|Overall Study|On treatment at time of snapshot|29|||
129222589|NCT05218499|465116141|FG002|Overall Study|On treatment at time of snapshot|0|||
129041631|NCT02243293|464444349|FG010|Overall Study|Withdrawal by Subject|0|||
128775231|NCT01474512|463468364|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
128775232|NCT01474512|463468365|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
128775233|NCT01474512|463468366|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
128775234|NCT01474512|463468367|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
128775235|NCT01474512|463468368|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
128775236|NCT01474512|463468369|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
128775237|NCT01474512|463468370|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
128775238|NCT01474512|463468371|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
128775239|NCT01474512|463468372|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
128775240|NCT01474512|463468373|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
128775241|NCT01474512|463468374|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
128775242|NCT01474512|463468357|FG000|Long-Term Extension Period|Physician Decision|0|||
128775243|NCT01474512|463468358|FG001|Long-Term Extension Period|Physician Decision|0|||
128775244|NCT01474512|463468359|FG002|Long-Term Extension Period|Physician Decision|0|||
128775245|NCT01474512|463468360|FG003|Long-Term Extension Period|Physician Decision|0|||
128775246|NCT01474512|463468361|FG004|Long-Term Extension Period|Physician Decision|0|||
128775247|NCT01474512|463468362|FG005|Long-Term Extension Period|Physician Decision|0|||
128775248|NCT01474512|463468363|FG006|Long-Term Extension Period|Physician Decision|0|||
128775249|NCT01474512|463468364|FG007|Long-Term Extension Period|Physician Decision|0|||
128775250|NCT01474512|463468365|FG008|Long-Term Extension Period|Physician Decision|0|||
128775251|NCT01474512|463468366|FG009|Long-Term Extension Period|Physician Decision|0|||
128775252|NCT01474512|463468367|FG010|Long-Term Extension Period|Physician Decision|0|||
128775253|NCT01474512|463468368|FG011|Long-Term Extension Period|Physician Decision|0|||
128775254|NCT01474512|463468369|FG012|Long-Term Extension Period|Physician Decision|21|||
128775255|NCT01474512|463468370|FG013|Long-Term Extension Period|Physician Decision|21|||
128775256|NCT01474512|463468371|FG014|Long-Term Extension Period|Physician Decision|0|||
128775257|NCT01474512|463468372|FG015|Long-Term Extension Period|Physician Decision|0|||
128775258|NCT01474512|463468373|FG016|Long-Term Extension Period|Physician Decision|0|||
128775259|NCT01474512|463468374|FG017|Long-Term Extension Period|Physician Decision|0|||
128775260|NCT01474512|463468357|FG000|Long-Term Extension Period|Clinical Relapse|0|||
128775261|NCT01474512|463468358|FG001|Long-Term Extension Period|Clinical Relapse|0|||
128775262|NCT01474512|463468359|FG002|Long-Term Extension Period|Clinical Relapse|0|||
128775263|NCT01474512|463468360|FG003|Long-Term Extension Period|Clinical Relapse|0|||
128775264|NCT01474512|463468361|FG004|Long-Term Extension Period|Clinical Relapse|0|||
128775265|NCT01474512|463468362|FG005|Long-Term Extension Period|Clinical Relapse|0|||
128775266|NCT01474512|463468363|FG006|Long-Term Extension Period|Clinical Relapse|0|||
128775267|NCT01474512|463468364|FG007|Long-Term Extension Period|Clinical Relapse|0|||
128775268|NCT01474512|463468365|FG008|Long-Term Extension Period|Clinical Relapse|0|||
128775269|NCT01474512|463468366|FG009|Long-Term Extension Period|Clinical Relapse|0|||
128775270|NCT01474512|463468367|FG010|Long-Term Extension Period|Clinical Relapse|0|||
128775271|NCT01474512|463468368|FG011|Long-Term Extension Period|Clinical Relapse|0|||
128775272|NCT01474512|463468369|FG012|Long-Term Extension Period|Clinical Relapse|9|||
128775273|NCT01474512|463468370|FG013|Long-Term Extension Period|Clinical Relapse|9|||
128775274|NCT01474512|463468371|FG014|Long-Term Extension Period|Clinical Relapse|0|||
128775275|NCT01474512|463468372|FG015|Long-Term Extension Period|Clinical Relapse|0|||
128775276|NCT01474512|463468373|FG016|Long-Term Extension Period|Clinical Relapse|0|||
128775277|NCT01474512|463468374|FG017|Long-Term Extension Period|Clinical Relapse|0|||
128775278|NCT01474512|463468357|FG000|Long-Term Extension Period|Death|0|||
129222590|NCT04055090|465116142|FG000|Overall Study|screen failure|1|||
129222591|NCT04055090|465116143|FG001|Overall Study|screen failure|0|||
129222592|NCT04055090|465116142|FG000|Overall Study|Withdrawal by Subject|1|||
129222593|NCT04055090|465116143|FG001|Overall Study|Withdrawal by Subject|0|||
129222594|NCT03776812|465116144|FG000|Overall Study|Death|53|||
129222595|NCT03776812|465116145|FG001|Overall Study|Death|49|||
129222596|NCT03776812|465116146|FG002|Overall Study|Death|56|||
129222597|NCT03776812|465116144|FG000|Overall Study|Withdrawal by Subject|1|||
129222598|NCT03776812|465116145|FG001|Overall Study|Withdrawal by Subject|7|||
129222599|NCT03776812|465116146|FG002|Overall Study|Withdrawal by Subject|2|||
129222600|NCT03776812|465116144|FG000|Overall Study|Lost to Follow-up|1|||
129222601|NCT03776812|465116145|FG001|Overall Study|Lost to Follow-up|1|||
129222602|NCT03776812|465116146|FG002|Overall Study|Lost to Follow-up|0|||
129222603|NCT03776812|465116144|FG000|Overall Study|Did not enter long-term follow-up|3|||
129222604|NCT03776812|465116145|FG001|Overall Study|Did not enter long-term follow-up|3|||
129222605|NCT03776812|465116146|FG002|Overall Study|Did not enter long-term follow-up|2|||
129222606|NCT04572841|465116150|FG000|Overall Study|Adverse Event|1|||
129222607|NCT04572841|465116151|FG001|Overall Study|Adverse Event|1|||
129222608|NCT04572841|465116150|FG000|Overall Study|Withdrawal by Subject|2|||
128775279|NCT01474512|463468358|FG001|Long-Term Extension Period|Death|0|||
129222609|NCT04572841|465116151|FG001|Overall Study|Withdrawal by Subject|1|||
128775280|NCT01474512|463468359|FG002|Long-Term Extension Period|Death|0|||
128775281|NCT01474512|463468360|FG003|Long-Term Extension Period|Death|0|||
128775282|NCT01474512|463468361|FG004|Long-Term Extension Period|Death|0|||
129222610|NCT06469242|465116152|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
128979647|NCT03417999|464211746|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
128979648|NCT03417999|464211744|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
128979649|NCT03417999|464211745|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
128979650|NCT03417999|464211746|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
128979651|NCT03417999|464211744|FG000|Overall Study|Inadequate study staff available to process samples|0|||
128979652|NCT03417999|464211745|FG001|Overall Study|Inadequate study staff available to process samples|0|||
128979653|NCT03417999|464211746|FG002|Overall Study|Inadequate study staff available to process samples|1|||
128979654|NCT01513460|464211747|FG000|Overall Study|Death|0|||
128979655|NCT01513460|464211748|FG001|Overall Study|Death|0|||
128979656|NCT01513460|464211749|FG002|Overall Study|Death|1|||
128979657|NCT01513460|464211747|FG000|Overall Study|Lost to Follow-up|0|||
128979658|NCT01513460|464211748|FG001|Overall Study|Lost to Follow-up|0|||
128979659|NCT01513460|464211749|FG002|Overall Study|Lost to Follow-up|2|||
128979660|NCT01513460|464211747|FG000|Overall Study|Abnormal laboratory value|1|||
128979661|NCT01513460|464211748|FG001|Overall Study|Abnormal laboratory value|0|||
128979662|NCT01513460|464211749|FG002|Overall Study|Abnormal laboratory value|1|||
128979663|NCT01513460|464211747|FG000|Overall Study|Lack of Efficacy|1|||
128979664|NCT01513460|464211748|FG001|Overall Study|Lack of Efficacy|2|||
128979665|NCT01513460|464211749|FG002|Overall Study|Lack of Efficacy|5|||
128979666|NCT01513460|464211747|FG000|Overall Study|Protocol deviations|3|||
128979667|NCT01513460|464211748|FG001|Overall Study|Protocol deviations|4|||
128979668|NCT01513460|464211749|FG002|Overall Study|Protocol deviations|3|||
128979669|NCT01513460|464211747|FG000|Overall Study|Withdrawal by Subject|7|||
128979670|NCT01513460|464211748|FG001|Overall Study|Withdrawal by Subject|8|||
128979671|NCT01513460|464211749|FG002|Overall Study|Withdrawal by Subject|21|||
128979672|NCT01513460|464211747|FG000|Overall Study|Adverse Event|16|||
128979673|NCT01513460|464211748|FG001|Overall Study|Adverse Event|18|||
128979674|NCT01513460|464211749|FG002|Overall Study|Adverse Event|23|||
128979675|NCT01513460|464211747|FG000|Overall Study|Abnormal test procedure|1|||
128979676|NCT01513460|464211748|FG001|Overall Study|Abnormal test procedure|0|||
128979677|NCT01513460|464211749|FG002|Overall Study|Abnormal test procedure|0|||
128979678|NCT00489216|464211754|FG000|Overall Study|Adverse Event|1|||
128979679|NCT00422942|464211759|FG000|Overall Study|Study terminated by Sponsor|3|||
128979680|NCT02612194|464211760|FG000|Overall Study|Death|5|||
128979681|NCT02612194|464211761|FG001|Overall Study|Death|0|||
128979682|NCT02612194|464211762|FG002|Overall Study|Death|2|||
128979683|NCT02612194|464211760|FG000|Overall Study|Early Study Termination|1|||
128718755|NCT04729127|463268837|FG008|Overall Study|Withdrawal by Subject|0|||
128718756|NCT04729127|463268829|FG000|Overall Study|Switched Agency/Setting|1|||
128718757|NCT04729127|463268830|FG001|Overall Study|Switched Agency/Setting|0|||
128718758|NCT04729127|463268831|FG002|Overall Study|Switched Agency/Setting|1|||
128718759|NCT04729127|463268832|FG003|Overall Study|Switched Agency/Setting|1|||
128718760|NCT04729127|463268833|FG004|Overall Study|Switched Agency/Setting|0|||
128718761|NCT04729127|463268834|FG005|Overall Study|Switched Agency/Setting|1|||
128718762|NCT04729127|463268835|FG006|Overall Study|Switched Agency/Setting|1|||
128718763|NCT04729127|463268836|FG007|Overall Study|Switched Agency/Setting|0|||
128718764|NCT04729127|463268837|FG008|Overall Study|Switched Agency/Setting|1|||
128718765|NCT01365507|463268838|FG000|Overall Study|Withdrawal Criteria|8|||
128718766|NCT01365507|463268839|FG001|Overall Study|Withdrawal Criteria|5|||
128718767|NCT01365507|463268838|FG000|Overall Study|Unclassified|1|||
128718768|NCT01365507|463268839|FG001|Overall Study|Unclassified|4|||
128718769|NCT00192504|463268842|FG000|Overall Study|Lost to Follow-up|1|||
128718770|NCT00192504|463268843|FG001|Overall Study|Lost to Follow-up|0|||
128718771|NCT00192504|463268844|FG002|Overall Study|Lost to Follow-up|0|||
128979684|NCT02612194|464211761|FG001|Overall Study|Early Study Termination|0|||
128979685|NCT02612194|464211762|FG002|Overall Study|Early Study Termination|0|||
128979686|NCT02539160|464211763|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
128979687|NCT02539160|464211764|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
128979688|NCT02539160|464211765|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
128979689|NCT02539160|464211766|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
128979690|NCT02539160|464211763|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
129133400|NCT00790933|464781307|FG004|Overall Study|Lack of Efficacy|121|||
129133401|NCT00790933|464781303|FG000|Overall Study|Study Terminated by Sponsor|0|||
129133402|NCT00790933|464781304|FG001|Overall Study|Study Terminated by Sponsor|0|||
129133403|NCT00790933|464781305|FG002|Overall Study|Study Terminated by Sponsor|1|||
129133404|NCT00790933|464781306|FG003|Overall Study|Study Terminated by Sponsor|0|||
129133405|NCT00790933|464781307|FG004|Overall Study|Study Terminated by Sponsor|0|||
129133406|NCT00790933|464781303|FG000|Overall Study|Withdrawal by Subject|123|||
129133407|NCT00790933|464781304|FG001|Overall Study|Withdrawal by Subject|120|||
129133408|NCT00790933|464781305|FG002|Overall Study|Withdrawal by Subject|52|||
129133409|NCT00790933|464781306|FG003|Overall Study|Withdrawal by Subject|6|||
129133410|NCT00790933|464781307|FG004|Overall Study|Withdrawal by Subject|50|||
129133411|NCT00790933|464781303|FG000|Overall Study|Lost to Follow-up|13|||
129133412|NCT00790933|464781304|FG001|Overall Study|Lost to Follow-up|31|||
129133413|NCT00790933|464781305|FG002|Overall Study|Lost to Follow-up|10|||
129133414|NCT00790933|464781306|FG003|Overall Study|Lost to Follow-up|1|||
129133415|NCT00790933|464781307|FG004|Overall Study|Lost to Follow-up|15|||
129133416|NCT00790933|464781303|FG000|Overall Study|Reason Not Specified|8|||
129133417|NCT00790933|464781304|FG001|Overall Study|Reason Not Specified|16|||
129133418|NCT00790933|464781305|FG002|Overall Study|Reason Not Specified|4|||
129133419|NCT00790933|464781306|FG003|Overall Study|Reason Not Specified|1|||
128718772|NCT00192504|463268845|FG003|Overall Study|Lost to Follow-up|0|||
128718773|NCT00192504|463268842|FG000|Overall Study|Dosing window missed|0|||
128718774|NCT00192504|463268843|FG001|Overall Study|Dosing window missed|0|||
128718775|NCT00192504|463268844|FG002|Overall Study|Dosing window missed|1|||
128718776|NCT00192504|463268845|FG003|Overall Study|Dosing window missed|0|||
128718777|NCT01139450|463268846|FG000|Overall Study|Withdrawal by Subject|7|||
128718778|NCT01139450|463268847|FG001|Overall Study|Withdrawal by Subject|10|||
128718779|NCT01139450|463268848|FG002|Overall Study|Withdrawal by Subject|13|||
128718780|NCT01139450|463268846|FG000|Overall Study|Lack of Efficacy|3|||
128718781|NCT01139450|463268847|FG001|Overall Study|Lack of Efficacy|1|||
128718782|NCT01139450|463268848|FG002|Overall Study|Lack of Efficacy|8|||
128718783|NCT01139450|463268846|FG000|Overall Study|Protocol Violation|6|||
128718784|NCT01139450|463268847|FG001|Overall Study|Protocol Violation|5|||
128718785|NCT01139450|463268848|FG002|Overall Study|Protocol Violation|2|||
128718786|NCT01139450|463268846|FG000|Overall Study|Lost to Follow-up|9|||
128718787|NCT01139450|463268847|FG001|Overall Study|Lost to Follow-up|7|||
128718788|NCT01139450|463268848|FG002|Overall Study|Lost to Follow-up|11|||
128718789|NCT01139450|463268846|FG000|Overall Study|Administrative|0|||
128718790|NCT01139450|463268847|FG001|Overall Study|Administrative|0|||
128718791|NCT01139450|463268848|FG002|Overall Study|Administrative|1|||
128718792|NCT01139450|463268846|FG000|Overall Study|Adverse Event|2|||
128718793|NCT01139450|463268847|FG001|Overall Study|Adverse Event|2|||
128718794|NCT01139450|463268848|FG002|Overall Study|Adverse Event|3|||
128718795|NCT04782856|463268857|FG000|Overall Study|Withdrawal by Subject|0|||
128718796|NCT04782856|463268858|FG001|Overall Study|Withdrawal by Subject|1|||
128718797|NCT03020823|463268859|FG000|Overall Study|Physician Decision|4|||
128718798|NCT03020823|463268859|FG000|Overall Study|Lack of Efficacy|4|||
128718799|NCT03020823|463268859|FG000|Overall Study|Adverse Event|2|||
128718800|NCT03739112|463268860|FG000|Overall Study|Adverse Event|2|||
128718801|NCT03739112|463268861|FG001|Overall Study|Adverse Event|2|||
128718802|NCT03739112|463268860|FG000|Overall Study|Withdrawal by Subject|38|||
128718803|NCT03739112|463268861|FG001|Overall Study|Withdrawal by Subject|19|||
128718804|NCT03739112|463268860|FG000|Overall Study|Lost to Follow-up|31|||
128718805|NCT03739112|463268861|FG001|Overall Study|Lost to Follow-up|33|||
128718806|NCT03739112|463268860|FG000|Overall Study|Protocol Deviation|12|||
128718807|NCT03739112|463268861|FG001|Overall Study|Protocol Deviation|9|||
128718808|NCT03739112|463268860|FG000|Overall Study|Physician Decision|1|||
128718809|NCT03739112|463268861|FG001|Overall Study|Physician Decision|0|||
128718810|NCT03739112|463268860|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
128718811|NCT03739112|463268861|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
128718812|NCT03739112|463268860|FG000|Overall Study|Site went on hold|65|||
128718813|NCT03739112|463268861|FG001|Overall Study|Site went on hold|67|||
128718814|NCT03739112|463268860|FG000|Overall Study|Other than specified|8|||
128718815|NCT03739112|463268861|FG001|Overall Study|Other than specified|5|||
128718816|NCT03739112|463268860|FG000|Overall Study|Randomized but not vaccinated|31|||
128718817|NCT03739112|463268861|FG001|Overall Study|Randomized but not vaccinated|25|||
128718818|NCT04307446|463268862|FG000|Overall Study|Lost to Follow-up|2|||
128718819|NCT04307446|463268863|FG001|Overall Study|Lost to Follow-up|0|||
128718820|NCT01652664|463268864|FG000|Overall Study|Treatment Failure|5|||
128718821|NCT01652664|463268865|FG001|Overall Study|Treatment Failure|1|||
128718822|NCT01652664|463268864|FG000|Overall Study|Inadequate IOP control|1|||
128718823|NCT01652664|463268865|FG001|Overall Study|Inadequate IOP control|0|||
128718824|NCT00930579|463268869|FG000|Overall Study|Withdrawal by Subject|1|||
128718825|NCT00930579|463268869|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
128775283|NCT01474512|463468362|FG005|Long-Term Extension Period|Death|0|||
128775284|NCT01474512|463468363|FG006|Long-Term Extension Period|Death|0|||
128775285|NCT01474512|463468364|FG007|Long-Term Extension Period|Death|0|||
128718826|NCT02672423|463268870|FG000|Period 1|Adverse Event|0|||
128718827|NCT02672423|463268871|FG001|Period 1|Adverse Event|0|||
128718828|NCT02672423|463268872|FG002|Period 1|Adverse Event|0|||
128718829|NCT02672423|463268873|FG003|Period 1|Adverse Event|0|||
128718830|NCT02672423|463268874|FG004|Period 1|Adverse Event|1|||
128718831|NCT02672423|463268875|FG005|Period 1|Adverse Event|0|||
128718832|NCT02672423|463268876|FG006|Period 1|Adverse Event|0|||
128718833|NCT02672423|463268877|FG007|Period 1|Adverse Event|0|||
128718834|NCT02672423|463268878|FG008|Period 1|Adverse Event|0|||
128718835|NCT02672423|463268879|FG009|Period 1|Adverse Event|0|||
128718836|NCT02672423|463268870|FG000|Period 2|Withdrawal by Subject|0|||
128718837|NCT02672423|463268871|FG001|Period 2|Withdrawal by Subject|0|||
128718838|NCT02672423|463268872|FG002|Period 2|Withdrawal by Subject|1|||
128718839|NCT02672423|463268873|FG003|Period 2|Withdrawal by Subject|0|||
128775286|NCT01474512|463468365|FG008|Long-Term Extension Period|Death|0|||
129133420|NCT00790933|464781307|FG004|Overall Study|Reason Not Specified|9|||
128979691|NCT02539160|464211764|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
129133421|NCT00245570|464781310|FG000|Washout Between Periods III and IV|Adverse Event|0|||
128718840|NCT02672423|463268874|FG004|Period 2|Withdrawal by Subject|0|||
128718841|NCT02672423|463268875|FG005|Period 2|Withdrawal by Subject|0|||
128718842|NCT02672423|463268876|FG006|Period 2|Withdrawal by Subject|0|||
128718843|NCT02672423|463268877|FG007|Period 2|Withdrawal by Subject|0|||
128718844|NCT02672423|463268878|FG008|Period 2|Withdrawal by Subject|0|||
128718845|NCT02672423|463268879|FG009|Period 2|Withdrawal by Subject|0|||
128718846|NCT02672423|463268870|FG000|Period 3|Withdrawal by Subject|0|||
128718847|NCT02672423|463268871|FG001|Period 3|Withdrawal by Subject|0|||
128718848|NCT02672423|463268872|FG002|Period 3|Withdrawal by Subject|0|||
128718849|NCT02672423|463268873|FG003|Period 3|Withdrawal by Subject|0|||
128718850|NCT02672423|463268874|FG004|Period 3|Withdrawal by Subject|0|||
128718851|NCT02672423|463268875|FG005|Period 3|Withdrawal by Subject|0|||
128718852|NCT02672423|463268876|FG006|Period 3|Withdrawal by Subject|0|||
128718853|NCT02672423|463268877|FG007|Period 3|Withdrawal by Subject|1|||
128718854|NCT02672423|463268878|FG008|Period 3|Withdrawal by Subject|0|||
128718855|NCT02672423|463268879|FG009|Period 3|Withdrawal by Subject|0|||
128718856|NCT02672423|463268870|FG000|Period 3|Physician Decision|0|||
128718857|NCT02672423|463268871|FG001|Period 3|Physician Decision|0|||
128718858|NCT02672423|463268872|FG002|Period 3|Physician Decision|0|||
128979692|NCT02539160|464211765|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
128979693|NCT02539160|464211766|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
128979694|NCT02539160|464211763|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
128979695|NCT02539160|464211764|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
129133422|NCT00245570|464781311|FG001|Washout Between Periods III and IV|Adverse Event|1|||
129133423|NCT00245570|464781312|FG002|Washout Between Periods III and IV|Adverse Event|0|||
129133424|NCT00245570|464781313|FG003|Washout Between Periods III and IV|Adverse Event|0|||
128718859|NCT02672423|463268873|FG003|Period 3|Physician Decision|0|||
128979696|NCT02539160|464211765|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
128979697|NCT02539160|464211766|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
128979698|NCT01681004|464211769|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
128979699|NCT01681004|464211770|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
128979700|NCT01681004|464211769|FG000|Study Completion|Lost to Follow-up|8|||
128979701|NCT01681004|464211770|FG001|Study Completion|Lost to Follow-up|3|||
128979702|NCT01681004|464211769|FG000|Study Completion|Physician Decision|1|||
128979703|NCT01681004|464211770|FG001|Study Completion|Physician Decision|3|||
128979704|NCT01681004|464211769|FG000|Study Completion|Site Termination|2|||
128979705|NCT01681004|464211770|FG001|Study Completion|Site Termination|1|||
128979706|NCT01681004|464211769|FG000|Study Completion|Death|1|||
128979707|NCT01681004|464211770|FG001|Study Completion|Death|1|||
128979708|NCT00372905|464211771|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
128979709|NCT00372905|464211772|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
128979710|NCT00372905|464211773|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
128979711|NCT00372905|464211774|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
128979712|NCT00372905|464211771|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
128979713|NCT00372905|464211772|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
128979714|NCT00372905|464211773|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
128979715|NCT00372905|464211774|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
128979716|NCT00372905|464211771|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
128979717|NCT00372905|464211772|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
128979718|NCT00372905|464211773|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
128979719|NCT00372905|464211774|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
128979720|NCT00372905|464211771|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
128979721|NCT00372905|464211772|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
128979722|NCT00372905|464211773|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
128979723|NCT00372905|464211774|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
128979724|NCT00372905|464211771|FG000|Follow up Until Relapse or Progression|Study closed|0|||
128979725|NCT00372905|464211772|FG001|Follow up Until Relapse or Progression|Study closed|0|||
128979726|NCT00372905|464211773|FG002|Follow up Until Relapse or Progression|Study closed|0|||
128979727|NCT00372905|464211774|FG003|Follow up Until Relapse or Progression|Study closed|3|||
128979728|NCT00372905|464211771|FG000|Follow up Until Relapse or Progression|Other|0|||
128718860|NCT02672423|463268874|FG004|Period 3|Physician Decision|0|||
128979729|NCT00372905|464211772|FG001|Follow up Until Relapse or Progression|Other|1|||
128979730|NCT00372905|464211773|FG002|Follow up Until Relapse or Progression|Other|0|||
128979731|NCT00372905|464211774|FG003|Follow up Until Relapse or Progression|Other|0|||
129133425|NCT00245570|464781314|FG004|Washout Between Periods III and IV|Adverse Event|0|||
129133426|NCT00245570|464781315|FG005|Washout Between Periods III and IV|Adverse Event|0|||
128718861|NCT02672423|463268875|FG005|Period 3|Physician Decision|1|||
128718862|NCT02672423|463268876|FG006|Period 3|Physician Decision|0|||
128718863|NCT02672423|463268877|FG007|Period 3|Physician Decision|0|||
128718864|NCT02672423|463268878|FG008|Period 3|Physician Decision|0|||
128718865|NCT02672423|463268879|FG009|Period 3|Physician Decision|0|||
128718866|NCT00536107|463268882|FG000|Overall Study|Death|5|||
128718867|NCT00536107|463268883|FG001|Overall Study|Death|1|||
129041632|NCT02243293|464444350|FG011|Overall Study|Withdrawal by Subject|1|||
129041633|NCT02243293|464444351|FG012|Overall Study|Withdrawal by Subject|0|||
129041634|NCT02243293|464444352|FG013|Overall Study|Withdrawal by Subject|0|||
129041635|NCT02243293|464444353|FG014|Overall Study|Withdrawal by Subject|0|||
129041636|NCT02243293|464444354|FG015|Overall Study|Withdrawal by Subject|0|||
129041637|NCT02243293|464444355|FG016|Overall Study|Withdrawal by Subject|0|||
129041638|NCT02243293|464444356|FG017|Overall Study|Withdrawal by Subject|0|||
129041639|NCT02243293|464444357|FG018|Overall Study|Withdrawal by Subject|0|||
129041640|NCT02243293|464444358|FG019|Overall Study|Withdrawal by Subject|0|||
129041641|NCT02243293|464444359|FG020|Overall Study|Withdrawal by Subject|0|||
129041642|NCT02243293|464444360|FG021|Overall Study|Withdrawal by Subject|1|||
129041643|NCT02243293|464444339|FG000|Overall Study|Lost to Follow-up|0|||
129041644|NCT02243293|464444340|FG001|Overall Study|Lost to Follow-up|1|||
129041645|NCT02243293|464444341|FG002|Overall Study|Lost to Follow-up|1|||
129041646|NCT02243293|464444342|FG003|Overall Study|Lost to Follow-up|1|||
129041647|NCT02243293|464444343|FG004|Overall Study|Lost to Follow-up|0|||
129041648|NCT02243293|464444344|FG005|Overall Study|Lost to Follow-up|0|||
129041649|NCT02243293|464444345|FG006|Overall Study|Lost to Follow-up|3|||
129041650|NCT02243293|464444346|FG007|Overall Study|Lost to Follow-up|0|||
129041651|NCT02243293|464444347|FG008|Overall Study|Lost to Follow-up|0|||
129041652|NCT02243293|464444348|FG009|Overall Study|Lost to Follow-up|0|||
129041653|NCT02243293|464444349|FG010|Overall Study|Lost to Follow-up|0|||
129041654|NCT02243293|464444350|FG011|Overall Study|Lost to Follow-up|2|||
129041655|NCT02243293|464444351|FG012|Overall Study|Lost to Follow-up|0|||
129041656|NCT02243293|464444352|FG013|Overall Study|Lost to Follow-up|0|||
129041657|NCT02243293|464444353|FG014|Overall Study|Lost to Follow-up|0|||
129041658|NCT02243293|464444354|FG015|Overall Study|Lost to Follow-up|0|||
129041659|NCT02243293|464444355|FG016|Overall Study|Lost to Follow-up|3|||
129041660|NCT02243293|464444356|FG017|Overall Study|Lost to Follow-up|1|||
129041661|NCT02243293|464444357|FG018|Overall Study|Lost to Follow-up|0|||
129041662|NCT02243293|464444358|FG019|Overall Study|Lost to Follow-up|0|||
129041663|NCT02243293|464444359|FG020|Overall Study|Lost to Follow-up|1|||
129041664|NCT02243293|464444360|FG021|Overall Study|Lost to Follow-up|2|||
129041665|NCT02243293|464444339|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
129041666|NCT02243293|464444340|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
129041667|NCT02243293|464444341|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
129041668|NCT02243293|464444342|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
129041669|NCT02243293|464444343|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
129041670|NCT02243293|464444344|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
129041671|NCT02243293|464444345|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
129041672|NCT02243293|464444346|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
129041673|NCT02243293|464444347|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
129041674|NCT02243293|464444348|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
129041675|NCT02243293|464444349|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
129041676|NCT02243293|464444350|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
129041677|NCT02243293|464444351|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
129041678|NCT02243293|464444352|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
129041679|NCT02243293|464444353|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
129041680|NCT02243293|464444354|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
129041681|NCT02243293|464444355|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
129041682|NCT02243293|464444356|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
129041683|NCT02243293|464444357|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
129041684|NCT02243293|464444358|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
129041685|NCT02243293|464444359|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
129041686|NCT02243293|464444360|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
129041687|NCT02243293|464444339|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
129041688|NCT02243293|464444340|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
129133427|NCT01829165|464781316|FG000|Overall Study|Did not complete intervention|2|||
129133428|NCT01829165|464781317|FG001|Overall Study|Did not complete intervention|0|||
129133429|NCT04233580|464781338|FG000|Overall Study|Adverse Event|3|||
129133430|NCT04233580|464781339|FG001|Overall Study|Adverse Event|3|||
129133431|NCT04233580|464781338|FG000|Overall Study|Withdrawal by Subject|2|||
129133432|NCT04233580|464781339|FG001|Overall Study|Withdrawal by Subject|1|||
129041689|NCT02243293|464444341|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
129041690|NCT02243293|464444342|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
129041691|NCT02243293|464444343|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
129041692|NCT02243293|464444344|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
129041693|NCT02243293|464444345|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
129041694|NCT02243293|464444346|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
129041695|NCT02243293|464444347|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
129041696|NCT02243293|464444348|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
129041697|NCT02243293|464444349|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
129133433|NCT03954938|464781340|FG000|Overall Study|Withdrawal by Subject|2|||
129133434|NCT03954938|464781340|FG000|Overall Study|Adverse Event|1|||
129041698|NCT02243293|464444350|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
129041699|NCT02243293|464444351|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
129041700|NCT02243293|464444352|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
129041701|NCT02243293|464444353|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
129041702|NCT02243293|464444354|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
129041703|NCT02243293|464444355|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
129041704|NCT02243293|464444356|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
129041705|NCT02243293|464444357|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
129041706|NCT02243293|464444358|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
129041707|NCT02243293|464444359|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
129041708|NCT02243293|464444360|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
129041709|NCT04974619|464445903|FG000|Overall Study|Lost to Follow-up|0|||
129041710|NCT04974619|464445904|FG001|Overall Study|Lost to Follow-up|0|||
129041711|NCT04974619|464445905|FG002|Overall Study|Lost to Follow-up|1|||
129041712|NCT04974619|464445903|FG000|Overall Study|Withdrawal by Subject|0|||
129041713|NCT04974619|464445904|FG001|Overall Study|Withdrawal by Subject|0|||
129041714|NCT04974619|464445905|FG002|Overall Study|Withdrawal by Subject|1|||
129041715|NCT04974619|464445903|FG000|Overall Study|Protocol Violation|0|||
129041716|NCT04974619|464445904|FG001|Overall Study|Protocol Violation|1|||
129041717|NCT04974619|464445905|FG002|Overall Study|Protocol Violation|0|||
129041718|NCT02658487|464445906|FG000|Overall Study|Death|2|||
129041719|NCT02658487|464445906|FG000|Overall Study|Disease progression|10|||
129041720|NCT02658487|464445906|FG000|Overall Study|Alternative therapy|1|||
129041721|NCT02658487|464445906|FG000|Overall Study|Adverse Event|1|||
129041722|NCT02658487|464445906|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
129041723|NCT02658487|464445906|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
129041724|NCT00493779|464445907|FG000|Overall Study|Logistical issue at site|1|||
129041725|NCT01885182|464445908|FG000|Overall Study|Adverse Event|11|||
129041726|NCT01885182|464445909|FG001|Overall Study|Adverse Event|13|||
129041727|NCT01885182|464445908|FG000|Overall Study|Withdrawal by Subject|13|||
129041728|NCT01885182|464445909|FG001|Overall Study|Withdrawal by Subject|6|||
129041729|NCT01885182|464445908|FG000|Overall Study|Lost to Follow-up|2|||
129041730|NCT01885182|464445909|FG001|Overall Study|Lost to Follow-up|2|||
129041731|NCT01885182|464445908|FG000|Overall Study|Lack of Efficacy|8|||
129041732|NCT01885182|464445909|FG001|Overall Study|Lack of Efficacy|1|||
129041733|NCT00614926|464445916|FG000|Overall Study|Burden of travel|1|||
129041734|NCT00614926|464445917|FG001|Overall Study|Burden of travel|0|||
129041735|NCT00614926|464445916|FG000|Overall Study|Adverse Event|3|||
129041736|NCT00614926|464445917|FG001|Overall Study|Adverse Event|0|||
129041737|NCT01207440|464445918|FG000|Overall Study|Adverse Event|46|||
129041738|NCT01207440|464445919|FG001|Overall Study|Adverse Event|11|||
129041739|NCT01207440|464445920|FG002|Overall Study|Adverse Event|7|||
129041740|NCT01207440|464445921|FG003|Overall Study|Adverse Event|2|||
129041741|NCT01207440|464445922|FG004|Overall Study|Adverse Event|6|||
129041742|NCT01207440|464445923|FG005|Overall Study|Adverse Event|6|||
129041743|NCT01207440|464445924|FG006|Overall Study|Adverse Event|2|||
129041744|NCT01207440|464445918|FG000|Overall Study|Death|6|||
129041745|NCT01207440|464445919|FG001|Overall Study|Death|3|||
129041746|NCT01207440|464445920|FG002|Overall Study|Death|2|||
129041747|NCT01207440|464445921|FG003|Overall Study|Death|2|||
129041748|NCT01207440|464445922|FG004|Overall Study|Death|7|||
129041749|NCT01207440|464445923|FG005|Overall Study|Death|5|||
129041750|NCT01207440|464445924|FG006|Overall Study|Death|1|||
129041751|NCT01207440|464445918|FG000|Overall Study|Lack of Efficacy|13|||
129041752|NCT01207440|464445919|FG001|Overall Study|Lack of Efficacy|2|||
129041753|NCT01207440|464445920|FG002|Overall Study|Lack of Efficacy|5|||
129041754|NCT01207440|464445921|FG003|Overall Study|Lack of Efficacy|1|||
129041755|NCT01207440|464445922|FG004|Overall Study|Lack of Efficacy|2|||
129041756|NCT01207440|464445923|FG005|Overall Study|Lack of Efficacy|3|||
129041757|NCT01207440|464445924|FG006|Overall Study|Lack of Efficacy|0|||
129041758|NCT01207440|464445918|FG000|Overall Study|Lost to Follow-up|0|||
129041759|NCT01207440|464445919|FG001|Overall Study|Lost to Follow-up|0|||
129041760|NCT01207440|464445920|FG002|Overall Study|Lost to Follow-up|2|||
129041761|NCT01207440|464445921|FG003|Overall Study|Lost to Follow-up|1|||
129041762|NCT01207440|464445922|FG004|Overall Study|Lost to Follow-up|0|||
129041763|NCT01207440|464445923|FG005|Overall Study|Lost to Follow-up|0|||
129041764|NCT01207440|464445924|FG006|Overall Study|Lost to Follow-up|0|||
129041765|NCT01207440|464445918|FG000|Overall Study|Non-compliance with Study Drug|3|||
129041766|NCT01207440|464445919|FG001|Overall Study|Non-compliance with Study Drug|0|||
129041767|NCT01207440|464445920|FG002|Overall Study|Non-compliance with Study Drug|1|||
129041768|NCT01207440|464445921|FG003|Overall Study|Non-compliance with Study Drug|0|||
129041769|NCT01207440|464445922|FG004|Overall Study|Non-compliance with Study Drug|0|||
129041770|NCT01207440|464445923|FG005|Overall Study|Non-compliance with Study Drug|0|||
129041771|NCT01207440|464445924|FG006|Overall Study|Non-compliance with Study Drug|0|||
129041772|NCT01207440|464445918|FG000|Overall Study|Physician Decision|6|||
129041773|NCT01207440|464445919|FG001|Overall Study|Physician Decision|5|||
129041774|NCT01207440|464445920|FG002|Overall Study|Physician Decision|5|||
129041775|NCT01207440|464445921|FG003|Overall Study|Physician Decision|0|||
129041776|NCT01207440|464445922|FG004|Overall Study|Physician Decision|1|||
129041777|NCT01207440|464445923|FG005|Overall Study|Physician Decision|0|||
129041778|NCT01207440|464445924|FG006|Overall Study|Physician Decision|0|||
129041779|NCT01207440|464445918|FG000|Overall Study|Progressive Disease|19|||
129041780|NCT01207440|464445919|FG001|Overall Study|Progressive Disease|10|||
129041781|NCT01207440|464445920|FG002|Overall Study|Progressive Disease|19|||
129041782|NCT01207440|464445921|FG003|Overall Study|Progressive Disease|7|||
129041783|NCT01207440|464445922|FG004|Overall Study|Progressive Disease|23|||
129041784|NCT01207440|464445923|FG005|Overall Study|Progressive Disease|27|||
129041785|NCT01207440|464445924|FG006|Overall Study|Progressive Disease|0|||
129041786|NCT01207440|464445918|FG000|Overall Study|Protocol Violation|2|||
129041787|NCT01207440|464445919|FG001|Overall Study|Protocol Violation|0|||
129041788|NCT01207440|464445920|FG002|Overall Study|Protocol Violation|0|||
129041789|NCT01207440|464445921|FG003|Overall Study|Protocol Violation|0|||
129041790|NCT01207440|464445922|FG004|Overall Study|Protocol Violation|0|||
129041791|NCT01207440|464445923|FG005|Overall Study|Protocol Violation|0|||
129041792|NCT01207440|464445924|FG006|Overall Study|Protocol Violation|0|||
129041793|NCT01207440|464445918|FG000|Overall Study|Site Terminated by Sponsor|69|||
129041794|NCT01207440|464445919|FG001|Overall Study|Site Terminated by Sponsor|19|||
129041795|NCT01207440|464445920|FG002|Overall Study|Site Terminated by Sponsor|12|||
129041796|NCT01207440|464445921|FG003|Overall Study|Site Terminated by Sponsor|2|||
129041797|NCT01207440|464445922|FG004|Overall Study|Site Terminated by Sponsor|3|||
129041798|NCT01207440|464445923|FG005|Overall Study|Site Terminated by Sponsor|0|||
129041799|NCT01207440|464445924|FG006|Overall Study|Site Terminated by Sponsor|2|||
129041800|NCT01207440|464445918|FG000|Overall Study|Withdrawal by Subject|29|||
129041801|NCT01207440|464445919|FG001|Overall Study|Withdrawal by Subject|4|||
129041802|NCT01207440|464445920|FG002|Overall Study|Withdrawal by Subject|5|||
129041803|NCT01207440|464445921|FG003|Overall Study|Withdrawal by Subject|3|||
129041804|NCT01207440|464445922|FG004|Overall Study|Withdrawal by Subject|2|||
129041805|NCT01207440|464445923|FG005|Overall Study|Withdrawal by Subject|2|||
129041806|NCT01207440|464445924|FG006|Overall Study|Withdrawal by Subject|0|||
129041807|NCT01207440|464445918|FG000|Overall Study|Reason Not Specified|10|||
129041808|NCT01207440|464445919|FG001|Overall Study|Reason Not Specified|10|||
129041809|NCT01207440|464445920|FG002|Overall Study|Reason Not Specified|7|||
129041810|NCT01207440|464445921|FG003|Overall Study|Reason Not Specified|0|||
129041811|NCT01207440|464445922|FG004|Overall Study|Reason Not Specified|4|||
129041812|NCT01207440|464445923|FG005|Overall Study|Reason Not Specified|3|||
129041813|NCT01207440|464445924|FG006|Overall Study|Reason Not Specified|0|||
129041814|NCT03341000|464445925|FG000|Overall Study|Adverse Event|1|||
129041815|NCT02516410|464445928|FG000|Overall Study|Adverse Event|0|||
129041816|NCT02516410|464445929|FG001|Overall Study|Adverse Event|1|||
129041817|NCT02516410|464445928|FG000|Overall Study|Withdrawal by Subject|0|||
129041818|NCT02516410|464445929|FG001|Overall Study|Withdrawal by Subject|1|||
129041819|NCT01432574|464445930|FG000|Overall Study|Moved|2|||
129041820|NCT01432574|464445930|FG000|Overall Study|Not interested|1|||
129041821|NCT01475253|464445934|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
129041822|NCT01475253|464445935|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
129041823|NCT01475253|464445936|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
129041824|NCT01475253|464445937|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
129041825|NCT01475253|464445934|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
129041826|NCT01475253|464445935|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
129041827|NCT01475253|464445936|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
129041828|NCT01475253|464445937|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
129041829|NCT03135899|464445938|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
129041830|NCT03135899|464445939|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
129041831|NCT03135899|464445940|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
129041832|NCT03135899|464445941|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
128718868|NCT00536107|463268882|FG000|Overall Study|Incorrect enrolment|1|||
128718869|NCT00536107|463268883|FG001|Overall Study|Incorrect enrolment|0|||
128718870|NCT00536107|463268882|FG000|Overall Study|Withdrawal by Subject|0|||
128718871|NCT00536107|463268883|FG001|Overall Study|Withdrawal by Subject|1|||
129041833|NCT03135899|464445942|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
129041834|NCT03135899|464445943|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
128718872|NCT00536107|463268882|FG000|Overall Study|Study Termination|2|||
129041835|NCT03135899|464445944|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
129041836|NCT03135899|464445945|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
129041837|NCT03135899|464445938|FG000|Overall Study|Withdrawal by Subject|0|||
129041838|NCT03135899|464445939|FG001|Overall Study|Withdrawal by Subject|0|||
129041839|NCT03135899|464445940|FG002|Overall Study|Withdrawal by Subject|0|||
129041840|NCT03135899|464445941|FG003|Overall Study|Withdrawal by Subject|0|||
129041841|NCT03135899|464445942|FG004|Overall Study|Withdrawal by Subject|0|||
129041842|NCT03135899|464445943|FG005|Overall Study|Withdrawal by Subject|2|||
129041843|NCT03135899|464445944|FG006|Overall Study|Withdrawal by Subject|0|||
128979732|NCT02312934|464211775|FG000|Overall Study|Lost to Follow-up|1|||
128979733|NCT02312934|464211776|FG001|Overall Study|Lost to Follow-up|0|||
128979734|NCT02312934|464211775|FG000|Overall Study|Physician Decision|1|||
128979735|NCT02312934|464211776|FG001|Overall Study|Physician Decision|0|||
128979736|NCT00701064|464211778|FG000|Overall Study|Protocol Violation|1|||
128979737|NCT00701064|464211779|FG001|Overall Study|Protocol Violation|1|||
128979738|NCT00701064|464211778|FG000|Overall Study|Withdrawal by Subject|1|||
128979739|NCT00701064|464211779|FG001|Overall Study|Withdrawal by Subject|1|||
128979740|NCT00701064|464211778|FG000|Overall Study|initiated other PTSD treatment|2|||
128979741|NCT00701064|464211779|FG001|Overall Study|initiated other PTSD treatment|2|||
128979742|NCT00689299|464211780|FG000|Overall Study|Adverse Event|2|||
128979743|NCT00689299|464211781|FG001|Overall Study|Adverse Event|1|||
128979744|NCT00689299|464211782|FG002|Overall Study|Adverse Event|1|||
128979745|NCT00689299|464211780|FG000|Overall Study|Lost to Follow-up|0|||
128979746|NCT00689299|464211781|FG001|Overall Study|Lost to Follow-up|1|||
128979747|NCT00689299|464211782|FG002|Overall Study|Lost to Follow-up|1|||
128979748|NCT00689299|464211780|FG000|Overall Study|Withdrawal by Subject|4|||
128979749|NCT00689299|464211781|FG001|Overall Study|Withdrawal by Subject|1|||
128979750|NCT00689299|464211782|FG002|Overall Study|Withdrawal by Subject|3|||
128979751|NCT00689299|464211780|FG000|Overall Study|Protocol Violation|1|||
128979752|NCT00689299|464211781|FG001|Overall Study|Protocol Violation|0|||
128979753|NCT00689299|464211782|FG002|Overall Study|Protocol Violation|0|||
128979754|NCT02613910|464211785|FG000|Overall Study|Termination of study|1|||
128979755|NCT02098733|464211786|FG000|Overall Study|Data Not Available|5|||
128979756|NCT02098733|464211786|FG000|Overall Study|Lost to Follow-up|5|||
128979757|NCT00695318|464211787|FG000|Overall Study|Lost to Follow-up|1|||
128979758|NCT00695318|464211788|FG001|Overall Study|Lost to Follow-up|0|||
128979759|NCT00695318|464211787|FG000|Overall Study|Withdrawal by Subject|2|||
128979760|NCT00695318|464211788|FG001|Overall Study|Withdrawal by Subject|0|||
128979761|NCT00695318|464211787|FG000|Overall Study|Death|1|||
128979762|NCT00695318|464211788|FG001|Overall Study|Death|1|||
128979763|NCT00695318|464211787|FG000|Overall Study|Study Terminated|1|||
128979764|NCT00695318|464211788|FG001|Overall Study|Study Terminated|0|||
128979765|NCT03395704|464211789|FG000|Overall Study|Adverse Event|2|||
128979766|NCT03395704|464211790|FG001|Overall Study|Adverse Event|1|||
128979767|NCT03395704|464211789|FG000|Overall Study|Withdrawal by Subject|2|||
128979768|NCT03395704|464211790|FG001|Overall Study|Withdrawal by Subject|1|||
128979769|NCT03395704|464211789|FG000|Overall Study|Physician Decision|0|||
128979770|NCT03395704|464211790|FG001|Overall Study|Physician Decision|1|||
128979771|NCT04823494|464212953|FG000|Overall Study|Programming software malfunction.|1|||
128979772|NCT04823494|464212954|FG001|Overall Study|Programming software malfunction.|0|||
128979773|NCT04823494|464212953|FG000|Overall Study|Withdrawal by Subject|1|||
128979774|NCT04823494|464212954|FG001|Overall Study|Withdrawal by Subject|0|||
128979775|NCT04823494|464212953|FG000|Overall Study|Devices lost|0|||
128979776|NCT04823494|464212954|FG001|Overall Study|Devices lost|1|||
128979777|NCT03726320|464212955|FG000|Overall Study|Lost to Follow-up|2|||
128979778|NCT03726320|464212956|FG001|Overall Study|Lost to Follow-up|4|||
128979779|NCT03726320|464212957|FG002|Overall Study|Lost to Follow-up|0|||
128979780|NCT03726320|464212955|FG000|Overall Study|Time Constraints|4|||
128979781|NCT03726320|464212956|FG001|Overall Study|Time Constraints|1|||
128979782|NCT03726320|464212957|FG002|Overall Study|Time Constraints|0|||
128979783|NCT03726320|464212955|FG000|Overall Study|Ineligible after enrollment|3|||
128979784|NCT03726320|464212956|FG001|Overall Study|Ineligible after enrollment|3|||
128979785|NCT03726320|464212957|FG002|Overall Study|Ineligible after enrollment|0|||
128979786|NCT03726320|464212955|FG000|Overall Study|Clinic / insurance issue|2|||
128979787|NCT03726320|464212956|FG001|Overall Study|Clinic / insurance issue|0|||
128979788|NCT03726320|464212957|FG002|Overall Study|Clinic / insurance issue|0|||
128979789|NCT03726320|464212955|FG000|Overall Study|Language barrier|1|||
128979790|NCT03726320|464212956|FG001|Overall Study|Language barrier|0|||
128979791|NCT03726320|464212957|FG002|Overall Study|Language barrier|0|||
128979792|NCT03726320|464212955|FG000|Overall Study|Provider left the clinic|0|||
128979793|NCT03726320|464212956|FG001|Overall Study|Provider left the clinic|0|||
128979794|NCT03726320|464212957|FG002|Overall Study|Provider left the clinic|1|||
128979795|NCT03691831|464212960|FG000|Overall Study|Lost to Follow-up|16|||
128979796|NCT03691831|464212961|FG001|Overall Study|Lost to Follow-up|12|||
128979797|NCT03691831|464212960|FG000|Overall Study|Withdrawal by Subject|9|||
128979798|NCT03691831|464212961|FG001|Overall Study|Withdrawal by Subject|17|||
128979799|NCT03691831|464212960|FG000|Overall Study|Investigator Decision|2|||
128979800|NCT03691831|464212961|FG001|Overall Study|Investigator Decision|2|||
128979801|NCT03922945|464212962|FG000|Overall Study|Adverse Event|1|||
128979802|NCT03922945|464212963|FG001|Overall Study|Adverse Event|1|||
128979803|NCT03922945|464212964|FG002|Overall Study|Adverse Event|2|||
128979804|NCT03922945|464212962|FG000|Overall Study|Lost to Follow-up|13|||
128979805|NCT03922945|464212963|FG001|Overall Study|Lost to Follow-up|9|||
128979806|NCT03922945|464212964|FG002|Overall Study|Lost to Follow-up|20|||
128979807|NCT03922945|464212962|FG000|Overall Study|Lack of Efficacy|2|||
128979808|NCT03922945|464212963|FG001|Overall Study|Lack of Efficacy|0|||
128979809|NCT03922945|464212964|FG002|Overall Study|Lack of Efficacy|1|||
128718873|NCT00536107|463268883|FG001|Overall Study|Study Termination|4|||
128718874|NCT01176266|463268886|FG000|Overall Study|Death|6|||
128718875|NCT01176266|463268886|FG000|Overall Study|Withdrawal by Subject|3|||
128718876|NCT04829318|463268887|FG000|Overall Study|Adverse Event|6|||
128718877|NCT04829318|463268887|FG000|Overall Study|Death|1|||
128979810|NCT03922945|464212962|FG000|Overall Study|Protocol Non-Compliance|0|||
128979811|NCT03922945|464212963|FG001|Overall Study|Protocol Non-Compliance|0|||
128979812|NCT03922945|464212964|FG002|Overall Study|Protocol Non-Compliance|1|||
128979813|NCT03922945|464212962|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
128979814|NCT03922945|464212963|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
128979815|NCT03922945|464212964|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
128979816|NCT03922945|464212962|FG000|Overall Study|All Other Personal Reasons|1|||
128979817|NCT03922945|464212963|FG001|Overall Study|All Other Personal Reasons|1|||
128979818|NCT03922945|464212964|FG002|Overall Study|All Other Personal Reasons|2|||
128979819|NCT00039377|464212966|FG000|Initial Registration|Adverse Event|2|||
128979820|NCT00039377|464212967|FG001|Initial Registration|Adverse Event|0|||
128979821|NCT00039377|464212968|FG002|Initial Registration|Adverse Event|0|||
128979822|NCT00039377|464212969|FG003|Initial Registration|Adverse Event|0|||
128979823|NCT00039377|464212966|FG000|Initial Registration|Relapsed|6|||
128979824|NCT00039377|464212967|FG001|Initial Registration|Relapsed|0|||
128979825|NCT00039377|464212968|FG002|Initial Registration|Relapsed|0|||
128979826|NCT00039377|464212969|FG003|Initial Registration|Relapsed|0|||
128979827|NCT00039377|464212966|FG000|Initial Registration|Received non-protocol therapy|11|||
129041844|NCT03135899|464445945|FG007|Overall Study|Withdrawal by Subject|0|||
129041845|NCT04146363|464445946|FG000|Induction Period|Adverse Event|1|||
129041846|NCT04146363|464445947|FG001|Induction Period|Adverse Event|2|||
129041847|NCT04146363|464445948|FG002|Induction Period|Adverse Event|0|||
129041848|NCT04146363|464445949|FG003|Induction Period|Adverse Event|0|||
129041849|NCT04146363|464445950|FG004|Induction Period|Adverse Event|0|||
129041850|NCT04146363|464445951|FG005|Induction Period|Adverse Event|0|||
129041851|NCT04146363|464445952|FG006|Induction Period|Adverse Event|0|||
129041852|NCT04146363|464445953|FG007|Induction Period|Adverse Event|0|||
129041853|NCT04146363|464445954|FG008|Induction Period|Adverse Event|0|||
129041854|NCT04146363|464445955|FG009|Induction Period|Adverse Event|0|||
129041855|NCT04146363|464445956|FG010|Induction Period|Adverse Event|0|||
129041856|NCT04146363|464445946|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
129041857|NCT04146363|464445947|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
129041858|NCT04146363|464445948|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
129041859|NCT04146363|464445949|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
129041860|NCT04146363|464445950|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
129041861|NCT04146363|464445951|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
129041862|NCT04146363|464445952|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
129041863|NCT04146363|464445953|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
129041864|NCT04146363|464445954|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
129041865|NCT04146363|464445955|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
129041866|NCT04146363|464445956|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
129041867|NCT04146363|464445946|FG000|Induction Period|Lack of Efficacy|7|||
129041868|NCT04146363|464445947|FG001|Induction Period|Lack of Efficacy|2|||
129041869|NCT04146363|464445948|FG002|Induction Period|Lack of Efficacy|0|||
129041870|NCT04146363|464445949|FG003|Induction Period|Lack of Efficacy|0|||
129041871|NCT04146363|464445950|FG004|Induction Period|Lack of Efficacy|0|||
129041872|NCT04146363|464445951|FG005|Induction Period|Lack of Efficacy|0|||
129041873|NCT04146363|464445952|FG006|Induction Period|Lack of Efficacy|0|||
129041874|NCT04146363|464445953|FG007|Induction Period|Lack of Efficacy|0|||
129041875|NCT04146363|464445954|FG008|Induction Period|Lack of Efficacy|0|||
129133435|NCT02421510|464781341|FG000|Overall Study|Other|4|||
129133436|NCT02421510|464781342|FG001|Overall Study|Other|2|||
129133437|NCT02421510|464781343|FG002|Overall Study|Other|3|||
129133438|NCT02421510|464781341|FG000|Overall Study|Protocol Violation|1|||
129133439|NCT02421510|464781342|FG001|Overall Study|Protocol Violation|2|||
129133440|NCT02421510|464781343|FG002|Overall Study|Protocol Violation|0|||
129133441|NCT02421510|464781341|FG000|Overall Study|Death|1|||
129133442|NCT02421510|464781342|FG001|Overall Study|Death|0|||
128718878|NCT04829318|463268887|FG000|Overall Study|Lost to Follow-up|1|||
128979828|NCT00039377|464212967|FG001|Initial Registration|Received non-protocol therapy|0|||
128979829|NCT00039377|464212968|FG002|Initial Registration|Received non-protocol therapy|0|||
129041876|NCT04146363|464445955|FG009|Induction Period|Lack of Efficacy|0|||
129041877|NCT04146363|464445956|FG010|Induction Period|Lack of Efficacy|0|||
129041878|NCT04146363|464445946|FG000|Induction Period|Lost to Follow-up|1|||
129041879|NCT04146363|464445947|FG001|Induction Period|Lost to Follow-up|4|||
129041880|NCT04146363|464445948|FG002|Induction Period|Lost to Follow-up|0|||
129041881|NCT04146363|464445949|FG003|Induction Period|Lost to Follow-up|0|||
129041882|NCT04146363|464445950|FG004|Induction Period|Lost to Follow-up|0|||
129041883|NCT04146363|464445951|FG005|Induction Period|Lost to Follow-up|0|||
129041884|NCT04146363|464445952|FG006|Induction Period|Lost to Follow-up|0|||
129041885|NCT04146363|464445953|FG007|Induction Period|Lost to Follow-up|0|||
129133443|NCT02421510|464781343|FG002|Overall Study|Death|0|||
129133444|NCT02421510|464781341|FG000|Overall Study|Noncompliance with study drug|1|||
128979830|NCT00039377|464212969|FG003|Initial Registration|Received non-protocol therapy|0|||
128979831|NCT00039377|464212966|FG000|Initial Registration|Withdrawal by Subject|3|||
128979832|NCT00039377|464212967|FG001|Initial Registration|Withdrawal by Subject|0|||
128979833|NCT00039377|464212968|FG002|Initial Registration|Withdrawal by Subject|0|||
128979834|NCT00039377|464212969|FG003|Initial Registration|Withdrawal by Subject|0|||
128979835|NCT04067310|464212973|FG000|Overall Study|Physician Decision|2|||
128979836|NCT04067310|464212974|FG001|Overall Study|Physician Decision|6|||
128979837|NCT04067310|464212973|FG000|Overall Study|Lost to Follow-up|0|||
128979838|NCT04067310|464212974|FG001|Overall Study|Lost to Follow-up|1|||
128979839|NCT04067310|464212973|FG000|Overall Study|Withdrawal by Subject|3|||
128979840|NCT04067310|464212974|FG001|Overall Study|Withdrawal by Subject|0|||
128979841|NCT01347931|464212975|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
128979842|NCT02493712|464212976|FG000|Overall Study|Withdrawal by Subject|1|||
128979843|NCT02493712|464212977|FG001|Overall Study|Withdrawal by Subject|0|||
128979844|NCT02493712|464212978|FG002|Overall Study|Withdrawal by Subject|2|||
128979845|NCT02493712|464212976|FG000|Overall Study|Protocol Violation|0|||
128979846|NCT02493712|464212977|FG001|Overall Study|Protocol Violation|0|||
128979847|NCT02493712|464212978|FG002|Overall Study|Protocol Violation|1|||
128979848|NCT02493712|464212976|FG000|Overall Study|Lost to Follow-up|1|||
128979849|NCT02493712|464212977|FG001|Overall Study|Lost to Follow-up|0|||
128979850|NCT02493712|464212978|FG002|Overall Study|Lost to Follow-up|0|||
128979851|NCT02493712|464212976|FG000|Overall Study|Physician Decision|0|||
128979852|NCT02493712|464212977|FG001|Overall Study|Physician Decision|1|||
128979853|NCT02493712|464212978|FG002|Overall Study|Physician Decision|0|||
128979854|NCT02493712|464212976|FG000|Overall Study|Lack of Efficacy|0|||
128979855|NCT02493712|464212977|FG001|Overall Study|Lack of Efficacy|5|||
128979856|NCT02493712|464212978|FG002|Overall Study|Lack of Efficacy|3|||
128979857|NCT04120116|464212979|FG000|Overall Study|Lost to Follow-up|0|||
128979858|NCT04120116|464212980|FG001|Overall Study|Lost to Follow-up|1|||
128979859|NCT04120116|464212981|FG002|Overall Study|Lost to Follow-up|0|||
128979860|NCT04120116|464212982|FG003|Overall Study|Lost to Follow-up|2|||
128979861|NCT04120116|464212979|FG000|Overall Study|Withdrawal by Subject|1|||
128979862|NCT04120116|464212980|FG001|Overall Study|Withdrawal by Subject|0|||
128979863|NCT04120116|464212981|FG002|Overall Study|Withdrawal by Subject|1|||
128979864|NCT04120116|464212982|FG003|Overall Study|Withdrawal by Subject|1|||
128979865|NCT04120116|464212979|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
128979866|NCT04120116|464212980|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
128979867|NCT04120116|464212981|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
128979868|NCT04120116|464212982|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
128979869|NCT02087085|464212983|FG000|Overall Study|Adverse Event|10|||
128979870|NCT02087085|464212984|FG001|Overall Study|Adverse Event|14|||
128979871|NCT02087085|464212983|FG000|Overall Study|Lack of Efficacy|4|||
128979872|NCT02087085|464212984|FG001|Overall Study|Lack of Efficacy|3|||
128979873|NCT02087085|464212983|FG000|Overall Study|Lost to Follow-up|6|||
128979874|NCT02087085|464212984|FG001|Overall Study|Lost to Follow-up|4|||
128979875|NCT02087085|464212983|FG000|Overall Study|Withdrawal by Subject|9|||
128979876|NCT02087085|464212984|FG001|Overall Study|Withdrawal by Subject|11|||
128979877|NCT02087085|464212983|FG000|Overall Study|Protocol Violation|1|||
128979878|NCT02087085|464212984|FG001|Overall Study|Protocol Violation|0|||
128979879|NCT02087085|464212983|FG000|Overall Study|Study Terminated by Sponsor|87|||
128979880|NCT02087085|464212984|FG001|Overall Study|Study Terminated by Sponsor|80|||
128979881|NCT02087085|464212983|FG000|Overall Study|Other Miscellaneous Reasons|3|||
128979882|NCT02087085|464212984|FG001|Overall Study|Other Miscellaneous Reasons|4|||
128979883|NCT03339999|464212992|FG000|Overall Study|Adverse Event|1|||
128979884|NCT03339999|464212993|FG001|Overall Study|Adverse Event|2|||
128979885|NCT03339999|464212994|FG002|Overall Study|Adverse Event|2|||
128979886|NCT03339999|464212995|FG003|Overall Study|Adverse Event|1|||
128979887|NCT03339999|464212992|FG000|Overall Study|Lack of Efficacy|0|||
128979888|NCT03339999|464212993|FG001|Overall Study|Lack of Efficacy|1|||
128979889|NCT03339999|464212994|FG002|Overall Study|Lack of Efficacy|0|||
128979890|NCT03339999|464212995|FG003|Overall Study|Lack of Efficacy|0|||
128979891|NCT03339999|464212992|FG000|Overall Study|Lost to Follow-up|0|||
128979892|NCT03339999|464212993|FG001|Overall Study|Lost to Follow-up|0|||
128979893|NCT03339999|464212994|FG002|Overall Study|Lost to Follow-up|0|||
128979894|NCT03339999|464212995|FG003|Overall Study|Lost to Follow-up|1|||
128979895|NCT03339999|464212992|FG000|Overall Study|Study Terminated by Sponsor|6|||
128979896|NCT03339999|464212993|FG001|Overall Study|Study Terminated by Sponsor|3|||
128979897|NCT03339999|464212994|FG002|Overall Study|Study Terminated by Sponsor|4|||
129133445|NCT02421510|464781342|FG001|Overall Study|Noncompliance with study drug|0|||
128979898|NCT03339999|464212995|FG003|Overall Study|Study Terminated by Sponsor|3|||
128979899|NCT01729559|464213001|FG000|Overall Study|Protocol Violation|31|||
128979900|NCT01729559|464213002|FG001|Overall Study|Protocol Violation|28|||
128979901|NCT03764813|464213007|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
128979902|NCT03764813|464213008|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
129133446|NCT02421510|464781343|FG002|Overall Study|Noncompliance with study drug|0|||
129133447|NCT02421510|464781341|FG000|Overall Study|Physician Decision|1|||
129133448|NCT02421510|464781342|FG001|Overall Study|Physician Decision|1|||
129133449|NCT02421510|464781343|FG002|Overall Study|Physician Decision|3|||
129133450|NCT02421510|464781341|FG000|Overall Study|Adverse Event|9|||
129133451|NCT02421510|464781342|FG001|Overall Study|Adverse Event|10|||
129133452|NCT02421510|464781343|FG002|Overall Study|Adverse Event|18|||
129133453|NCT02421510|464781341|FG000|Overall Study|Pregnancy|1|||
129133454|NCT02421510|464781342|FG001|Overall Study|Pregnancy|1|||
129133455|NCT02421510|464781343|FG002|Overall Study|Pregnancy|0|||
129133456|NCT02421510|464781341|FG000|Overall Study|Withdrawal by Subject|14|||
129133457|NCT02421510|464781342|FG001|Overall Study|Withdrawal by Subject|18|||
129133458|NCT02421510|464781343|FG002|Overall Study|Withdrawal by Subject|12|||
129133459|NCT02421510|464781341|FG000|Overall Study|Lost to Follow-up|1|||
129133460|NCT02421510|464781342|FG001|Overall Study|Lost to Follow-up|1|||
129133461|NCT02421510|464781343|FG002|Overall Study|Lost to Follow-up|0|||
129133462|NCT00899847|464781344|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
129133463|NCT00724893|464781347|FG000|Overall Study|Adverse Event|76|||
129133464|NCT00724893|464781348|FG001|Overall Study|Adverse Event|142|||
129133465|NCT00724893|464781347|FG000|Overall Study|Withdrawal by Subject|0|||
129133466|NCT00724893|464781348|FG001|Overall Study|Withdrawal by Subject|1|||
129133467|NCT00724893|464781347|FG000|Overall Study|Lack of virologic response|94|||
128979903|NCT03764813|464213009|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
128979904|NCT03764813|464213010|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
128979905|NCT01716585|464213013|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
128979906|NCT01716585|464213014|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
128979907|NCT01716585|464213013|FG000|Double-blind Treatment|Adverse Event|2|||
128979908|NCT01716585|464213014|FG001|Double-blind Treatment|Adverse Event|1|||
128979909|NCT01716585|464213013|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
128979910|NCT01716585|464213014|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
128979911|NCT01716585|464213013|FG000|Double-blind Treatment|Lost to Follow-up|2|||
128979912|NCT01716585|464213014|FG001|Double-blind Treatment|Lost to Follow-up|0|||
128979913|NCT01716585|464213013|FG000|Double-blind Treatment|Subject Noncompliant|1|||
128979914|NCT01716585|464213014|FG001|Double-blind Treatment|Subject Noncompliant|0|||
128979915|NCT01716585|464213013|FG000|Double-blind Treatment|Other|1|||
128979916|NCT01716585|464213014|FG001|Double-blind Treatment|Other|0|||
128979917|NCT01716585|464213013|FG000|Open-label Treatment|Adverse Event|0|||
128979918|NCT01716585|464213014|FG001|Open-label Treatment|Adverse Event|2|||
128979919|NCT01716585|464213013|FG000|Open-label Treatment|Virologic Failure|0|||
128979920|NCT01716585|464213014|FG001|Open-label Treatment|Virologic Failure|2|||
128979921|NCT01716585|464213013|FG000|Open-label Treatment|Withdrawal by Subject|0|||
128979922|NCT01716585|464213014|FG001|Open-label Treatment|Withdrawal by Subject|3|||
128979923|NCT01707667|464213017|FG000|Period 1|expulsion of colonic sensor catheter|1|||
128979924|NCT01707667|464213018|FG001|Period 1|expulsion of colonic sensor catheter|0|||
128979925|NCT04382066|464213019|FG000|Overall Study|Adverse Event|1|||
128979926|NCT04382066|464213020|FG001|Overall Study|Adverse Event|0|||
128979927|NCT04382066|464213021|FG002|Overall Study|Adverse Event|0|||
128979928|NCT04382066|464213019|FG000|Overall Study|Death|1|||
128979929|NCT04382066|464213020|FG001|Overall Study|Death|0|||
128979930|NCT04382066|464213021|FG002|Overall Study|Death|1|||
128979931|NCT00504595|464213022|FG000|Overall Study|Lack of Efficacy|1|||
128979932|NCT00504595|464213023|FG001|Overall Study|Lack of Efficacy|0|||
128979933|NCT00504595|464213024|FG002|Overall Study|Lack of Efficacy|0|||
128979934|NCT00504595|464213025|FG003|Overall Study|Lack of Efficacy|0|||
128979935|NCT00504595|464213022|FG000|Overall Study|Other|0|||
128979936|NCT00504595|464213023|FG001|Overall Study|Other|0|||
128979937|NCT00504595|464213024|FG002|Overall Study|Other|2|||
128979938|NCT00504595|464213025|FG003|Overall Study|Other|0|||
128979939|NCT00779142|464213026|FG000|Overall Study|Screen Failures|3|||
128979940|NCT00851721|464213028|FG000|Overall Study|planned surgery|1|||
129133468|NCT00724893|464781348|FG001|Overall Study|Lack of virologic response|202|||
129133469|NCT00724893|464781347|FG000|Overall Study|Reason not specified|193|||
129133470|NCT00724893|464781348|FG001|Overall Study|Reason not specified|7|||
129133471|NCT00724893|464781347|FG000|Overall Study|Patient choice|0|||
128775287|NCT01474512|463468366|FG009|Long-Term Extension Period|Death|0|||
128979941|NCT00851721|464213029|FG001|Overall Study|planned surgery|0|||
128979942|NCT00851721|464213028|FG000|Overall Study|Death|1|||
129133472|NCT00724893|464781348|FG001|Overall Study|Patient choice|26|||
129133473|NCT00724893|464781347|FG000|Overall Study|Geographic reasons|0|||
129222611|NCT06469242|465116153|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
128979943|NCT00851721|464213029|FG001|Overall Study|Death|0|||
128979944|NCT00851721|464213028|FG000|Overall Study|Adverse Event|0|||
128979945|NCT00851721|464213029|FG001|Overall Study|Adverse Event|1|||
128979946|NCT03137433|464213031|FG000|Overall Study|Withdrawal by Subject|11|||
129133474|NCT00724893|464781348|FG001|Overall Study|Geographic reasons|11|||
129133475|NCT00724893|464781347|FG000|Overall Study|Incarceration|0|||
129133476|NCT00724893|464781348|FG001|Overall Study|Incarceration|9|||
128775288|NCT01474512|463468367|FG010|Long-Term Extension Period|Death|0|||
128979947|NCT03137433|464213032|FG001|Overall Study|Withdrawal by Subject|11|||
129041886|NCT04146363|464445954|FG008|Induction Period|Lost to Follow-up|0|||
129041887|NCT04146363|464445955|FG009|Induction Period|Lost to Follow-up|0|||
129041888|NCT04146363|464445956|FG010|Induction Period|Lost to Follow-up|0|||
129041889|NCT04146363|464445946|FG000|Induction Period|Positive quantiferon test|0|||
129041890|NCT04146363|464445947|FG001|Induction Period|Positive quantiferon test|1|||
129041891|NCT04146363|464445948|FG002|Induction Period|Positive quantiferon test|0|||
129041892|NCT04146363|464445949|FG003|Induction Period|Positive quantiferon test|0|||
129041893|NCT04146363|464445950|FG004|Induction Period|Positive quantiferon test|0|||
129041894|NCT04146363|464445951|FG005|Induction Period|Positive quantiferon test|0|||
129041895|NCT04146363|464445952|FG006|Induction Period|Positive quantiferon test|0|||
129041896|NCT04146363|464445953|FG007|Induction Period|Positive quantiferon test|0|||
129041897|NCT04146363|464445954|FG008|Induction Period|Positive quantiferon test|0|||
129133477|NCT00724893|464781347|FG000|Overall Study|Substance abuse|0|||
129133478|NCT00724893|464781348|FG001|Overall Study|Substance abuse|3|||
129133479|NCT00724893|464781347|FG000|Overall Study|Financial reasons|0|||
129133480|NCT00724893|464781348|FG001|Overall Study|Financial reasons|2|||
129133481|NCT00724893|464781347|FG000|Overall Study|Assigned shorter treatment|0|||
128718879|NCT04829318|463268887|FG000|Overall Study|Physician Decision|1|||
128718880|NCT04829318|463268887|FG000|Overall Study|Withdrawal by Subject|19|||
128718881|NCT04829318|463268887|FG000|Overall Study|Site terminated by sponsor|1|||
129133482|NCT00724893|464781348|FG001|Overall Study|Assigned shorter treatment|2|||
129133483|NCT00724893|464781347|FG000|Overall Study|Lost to Follow-up|0|||
129133484|NCT00724893|464781348|FG001|Overall Study|Lost to Follow-up|52|||
129133485|NCT00724893|464781347|FG000|Overall Study|Unknown, missing data|1|||
129133486|NCT00724893|464781348|FG001|Overall Study|Unknown, missing data|1|||
129133487|NCT01279200|464781351|FG000|Overall Study|Withdrawal by Subject|1|||
129133488|NCT01279200|464781352|FG001|Overall Study|Withdrawal by Subject|3|||
129133489|NCT01279200|464781351|FG000|Overall Study|Patient withdrawal due to high cost|0|||
129133490|NCT01279200|464781352|FG001|Overall Study|Patient withdrawal due to high cost|1|||
129133491|NCT01279200|464781351|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
129133492|NCT01279200|464781352|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
129133493|NCT01279200|464781351|FG000|Overall Study|ultrasound screening failure|0|||
129133494|NCT01279200|464781352|FG001|Overall Study|ultrasound screening failure|1|||
129133495|NCT01279200|464781351|FG000|Overall Study|Lost to Follow-up|0|||
129133496|NCT01279200|464781352|FG001|Overall Study|Lost to Follow-up|1|||
129133497|NCT01279200|464781351|FG000|Overall Study|Adverse Event|1|||
129133498|NCT01279200|464781352|FG001|Overall Study|Adverse Event|0|||
129133499|NCT01149538|464781357|FG000|Overall Study|Lost to Follow-up|0|||
129133500|NCT01149538|464781358|FG001|Overall Study|Lost to Follow-up|1|||
129133501|NCT01149538|464781357|FG000|Overall Study|Withdrawal by Subject|5|||
129133502|NCT01149538|464781358|FG001|Overall Study|Withdrawal by Subject|3|||
129133503|NCT00888849|464781359|FG000|Overall Study|Death|4|||
129133504|NCT00888849|464781360|FG001|Overall Study|Death|7|||
129133505|NCT00888849|464781359|FG000|Overall Study|Lost to Follow-up|1|||
129133506|NCT00888849|464781360|FG001|Overall Study|Lost to Follow-up|2|||
129133507|NCT00896233|464781365|FG000|Overall Study|Claustrophobia during MRI|1|||
129133508|NCT04280562|464781366|FG000|Study|Adverse Event|2|||
129133509|NCT04280562|464781367|FG001|Study|Adverse Event|0|||
129133510|NCT04280562|464781366|FG000|Study|Lost to Follow-up|3|||
129133511|NCT04280562|464781367|FG001|Study|Lost to Follow-up|3|||
129133512|NCT05507450|464781371|FG000|Overall Study|Death|0|||
129133513|NCT05507450|464781372|FG001|Overall Study|Death|0|||
129133514|NCT05507450|464781373|FG002|Overall Study|Death|1|||
129133515|NCT05507450|464781374|FG003|Overall Study|Death|0|||
129133516|NCT05507450|464781371|FG000|Overall Study|Lost to Follow-up|22|||
129133517|NCT05507450|464781372|FG001|Overall Study|Lost to Follow-up|20|||
129133518|NCT05507450|464781373|FG002|Overall Study|Lost to Follow-up|20|||
129133519|NCT05507450|464781374|FG003|Overall Study|Lost to Follow-up|7|||
129133520|NCT05507450|464781371|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129133521|NCT05507450|464781372|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
129133522|NCT05507450|464781373|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129133523|NCT05507450|464781374|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129133524|NCT05507450|464781371|FG000|Overall Study|Withdrawal by Subject|4|||
129133525|NCT05507450|464781372|FG001|Overall Study|Withdrawal by Subject|11|||
129133526|NCT05507450|464781373|FG002|Overall Study|Withdrawal by Subject|7|||
129133527|NCT05507450|464781374|FG003|Overall Study|Withdrawal by Subject|3|||
129133528|NCT05507450|464781371|FG000|Overall Study|Participant left the country|0|||
129133529|NCT05507450|464781372|FG001|Overall Study|Participant left the country|0|||
129133530|NCT05507450|464781373|FG002|Overall Study|Participant left the country|1|||
129133531|NCT05507450|464781374|FG003|Overall Study|Participant left the country|0|||
129133532|NCT00514917|464781378|FG000|Overall Study|Death|4|||
129133533|NCT00514917|464781379|FG001|Overall Study|Death|10|||
128718882|NCT04829318|463268887|FG000|Overall Study|Sponsor decision|5|||
129041898|NCT04146363|464445955|FG009|Induction Period|Positive quantiferon test|0|||
129041899|NCT04146363|464445956|FG010|Induction Period|Positive quantiferon test|0|||
129041900|NCT04146363|464445946|FG000|Induction Period|Protocol Deviation|5|||
129222612|NCT06469242|465116152|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
129222613|NCT06469242|465116153|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
129222614|NCT05040971|465116154|FG000|Overall Study|Withdrawal by Subject|0|||
128718883|NCT04829318|463268887|FG000|Overall Study|Other|1|||
129041901|NCT04146363|464445947|FG001|Induction Period|Protocol Deviation|6|||
129041902|NCT04146363|464445948|FG002|Induction Period|Protocol Deviation|0|||
129041903|NCT04146363|464445949|FG003|Induction Period|Protocol Deviation|0|||
129041904|NCT04146363|464445950|FG004|Induction Period|Protocol Deviation|0|||
129041905|NCT04146363|464445951|FG005|Induction Period|Protocol Deviation|0|||
129041906|NCT04146363|464445952|FG006|Induction Period|Protocol Deviation|0|||
129041907|NCT04146363|464445953|FG007|Induction Period|Protocol Deviation|0|||
129041908|NCT04146363|464445954|FG008|Induction Period|Protocol Deviation|0|||
129041909|NCT04146363|464445955|FG009|Induction Period|Protocol Deviation|0|||
129041910|NCT04146363|464445956|FG010|Induction Period|Protocol Deviation|0|||
129041911|NCT04146363|464445946|FG000|Induction Period|Withdrawal by Subject|6|||
129041912|NCT04146363|464445947|FG001|Induction Period|Withdrawal by Subject|3|||
129041913|NCT04146363|464445948|FG002|Induction Period|Withdrawal by Subject|0|||
129041914|NCT04146363|464445949|FG003|Induction Period|Withdrawal by Subject|0|||
129041915|NCT04146363|464445950|FG004|Induction Period|Withdrawal by Subject|0|||
129041916|NCT04146363|464445951|FG005|Induction Period|Withdrawal by Subject|0|||
129041917|NCT04146363|464445952|FG006|Induction Period|Withdrawal by Subject|0|||
129041918|NCT04146363|464445953|FG007|Induction Period|Withdrawal by Subject|0|||
129041919|NCT04146363|464445954|FG008|Induction Period|Withdrawal by Subject|0|||
129041920|NCT04146363|464445955|FG009|Induction Period|Withdrawal by Subject|0|||
129041921|NCT04146363|464445956|FG010|Induction Period|Withdrawal by Subject|0|||
129041922|NCT04146363|464445946|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041923|NCT04146363|464445947|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041924|NCT04146363|464445948|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041925|NCT04146363|464445949|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041926|NCT04146363|464445950|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041927|NCT04146363|464445951|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041928|NCT04146363|464445952|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
129041929|NCT04146363|464445953|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
129041930|NCT04146363|464445954|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041931|NCT04146363|464445955|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041932|NCT04146363|464445956|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
129041933|NCT04146363|464445946|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041934|NCT04146363|464445947|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041935|NCT04146363|464445948|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041936|NCT04146363|464445949|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041937|NCT04146363|464445950|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041938|NCT04146363|464445951|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041939|NCT04146363|464445952|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041940|NCT04146363|464445953|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
129041941|NCT04146363|464445954|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041942|NCT04146363|464445955|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041943|NCT04146363|464445956|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129041944|NCT04146363|464445946|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129041945|NCT04146363|464445947|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129041946|NCT04146363|464445948|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129041947|NCT04146363|464445949|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129041948|NCT04146363|464445950|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128718884|NCT05075850|463268893|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
128718885|NCT01265849|463268894|FG000|Overall Study|Randomized//Treatment not initiated|1|||
128718886|NCT01265849|463268895|FG001|Overall Study|Randomized//Treatment not initiated|4|||
128718887|NCT01265849|463268896|FG002|Overall Study|Randomized//Treatment not initiated|0|||
128718888|NCT01265849|463268894|FG000|Overall Study|Physician Decision|1|||
128718889|NCT01265849|463268895|FG001|Overall Study|Physician Decision|2|||
129041949|NCT04146363|464445951|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129041950|NCT04146363|464445952|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
129041951|NCT04146363|464445953|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
129222615|NCT05040971|465116155|FG001|Overall Study|Withdrawal by Subject|2|||
128718890|NCT01265849|463268896|FG002|Overall Study|Physician Decision|0|||
128718891|NCT01265849|463268894|FG000|Overall Study|Lost to Follow-up|18|||
128718892|NCT01265849|463268895|FG001|Overall Study|Lost to Follow-up|15|||
129041952|NCT04146363|464445954|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
128718893|NCT01265849|463268896|FG002|Overall Study|Lost to Follow-up|5|||
128718894|NCT01265849|463268894|FG000|Overall Study|Not otherwise specified|1|||
129041953|NCT04146363|464445955|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129041954|NCT04146363|464445956|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129133534|NCT00514917|464781378|FG000|Overall Study|Protocol Violation|1|||
128718895|NCT01265849|463268895|FG001|Overall Study|Not otherwise specified|6|||
128979948|NCT03137433|464213031|FG000|Overall Study|Lost to Follow-up|5|||
128979949|NCT03137433|464213032|FG001|Overall Study|Lost to Follow-up|6|||
128979950|NCT03137433|464213031|FG000|Overall Study|Physician Decision|2|||
128979951|NCT03137433|464213032|FG001|Overall Study|Physician Decision|0|||
128979952|NCT03137433|464213031|FG000|Overall Study|Moved out of study area|1|||
128979953|NCT03137433|464213032|FG001|Overall Study|Moved out of study area|0|||
128979954|NCT03137433|464213031|FG000|Overall Study|Too far out of window due to COVID|0|||
128979955|NCT03137433|464213032|FG001|Overall Study|Too far out of window due to COVID|1|||
128979956|NCT02132312|464213034|FG000|Overall Study|Adverse Event|2|||
128979957|NCT02132312|464213035|FG001|Overall Study|Adverse Event|0|||
128979958|NCT02132312|464213034|FG000|Overall Study|Physician Decision|1|||
128979959|NCT02132312|464213035|FG001|Overall Study|Physician Decision|1|||
128979960|NCT02132312|464213034|FG000|Overall Study|Protocol Violation|0|||
128979961|NCT02132312|464213035|FG001|Overall Study|Protocol Violation|1|||
128979962|NCT02132312|464213034|FG000|Overall Study|Withdrawal by Subject|1|||
128979963|NCT02132312|464213035|FG001|Overall Study|Withdrawal by Subject|0|||
128979964|NCT02132312|464213034|FG000|Overall Study|Lost to Follow-up|2|||
128979965|NCT02132312|464213035|FG001|Overall Study|Lost to Follow-up|1|||
128979966|NCT03258710|464213036|FG000|Overall Study|Adverse Event|1|||
128979967|NCT03258710|464213036|FG000|Overall Study|Protocol-defined stopping criteria|1|||
128979968|NCT03258710|464213036|FG000|Overall Study|Physician Decision|1|||
128979969|NCT02242305|464213037|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
128979970|NCT02242305|464213038|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
128979971|NCT02242305|464213037|FG000|Overall Study|Adverse Event|1|||
128979972|NCT02242305|464213038|FG001|Overall Study|Adverse Event|0|||
128979973|NCT02242305|464213037|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
128979974|NCT02242305|464213038|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
128979975|NCT02242305|464213037|FG000|Overall Study|Subject withdraws inform consent|0|||
128979976|NCT02242305|464213038|FG001|Overall Study|Subject withdraws inform consent|4|||
128979977|NCT02242305|464213037|FG000|Overall Study|Lost to Follow-up|2|||
128979978|NCT02242305|464213038|FG001|Overall Study|Lost to Follow-up|0|||
128979979|NCT03451630|464213039|FG000|Overall Study|Death|15|||
128979980|NCT03451630|464213040|FG001|Overall Study|Death|16|||
128979981|NCT03451630|464213041|FG002|Overall Study|Death|11|||
128979982|NCT03451630|464213039|FG000|Overall Study|Lost to Follow-up|9|||
128979983|NCT03451630|464213040|FG001|Overall Study|Lost to Follow-up|0|||
128979984|NCT03451630|464213041|FG002|Overall Study|Lost to Follow-up|4|||
128979985|NCT03451630|464213039|FG000|Overall Study|Withdrawal by Subject|0|||
128979986|NCT03451630|464213040|FG001|Overall Study|Withdrawal by Subject|3|||
128979987|NCT03451630|464213041|FG002|Overall Study|Withdrawal by Subject|0|||
128979988|NCT03451630|464213039|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
128979989|NCT03451630|464213040|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
128979990|NCT03451630|464213041|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
128979991|NCT02041533|464213045|FG000|Pre-Treatment Period|Disease Progression|1|||
128979992|NCT02041533|464213046|FG001|Pre-Treatment Period|Disease Progression|1|||
128979993|NCT02041533|464213045|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
128979994|NCT02041533|464213046|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
128979995|NCT02041533|464213045|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
128979996|NCT02041533|464213046|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
128979997|NCT02041533|464213045|FG000|Treatment Period|Disease progression|189|||
128979998|NCT02041533|464213046|FG001|Treatment Period|Disease progression|146|||
128979999|NCT02041533|464213045|FG000|Treatment Period|Study drug toxicity|30|||
128980000|NCT02041533|464213046|FG001|Treatment Period|Study drug toxicity|34|||
128980001|NCT02041533|464213045|FG000|Treatment Period|Death|1|||
128980002|NCT02041533|464213046|FG001|Treatment Period|Death|0|||
128980003|NCT02041533|464213045|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
128980004|NCT02041533|464213046|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
128980005|NCT02041533|464213045|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
128980006|NCT02041533|464213046|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
128980007|NCT02041533|464213045|FG000|Treatment Period|Participant withdrew consent|2|||
128980008|NCT02041533|464213046|FG001|Treatment Period|Participant withdrew consent|2|||
128980009|NCT02041533|464213045|FG000|Treatment Period|Maximum clinical benefit|0|||
128980010|NCT02041533|464213046|FG001|Treatment Period|Maximum clinical benefit|18|||
128980011|NCT02041533|464213045|FG000|Treatment Period|Poor/Non-compliance|1|||
128980012|NCT02041533|464213046|FG001|Treatment Period|Poor/Non-compliance|0|||
128980013|NCT02041533|464213045|FG000|Treatment Period|Administrative reason by sponsor|1|||
128980014|NCT02041533|464213046|FG001|Treatment Period|Administrative reason by sponsor|0|||
128718896|NCT01265849|463268896|FG002|Overall Study|Not otherwise specified|1|||
128980015|NCT02041533|464213045|FG000|Treatment Period|Other reasons|9|||
128980016|NCT02041533|464213046|FG001|Treatment Period|Other reasons|2|||
128718897|NCT01265849|463268894|FG000|Overall Study|Withdrawal by Subject|25|||
129133535|NCT00514917|464781379|FG001|Overall Study|Protocol Violation|0|||
129133536|NCT00514917|464781378|FG000|Overall Study|Lost to Follow-up|4|||
129133537|NCT00514917|464781379|FG001|Overall Study|Lost to Follow-up|3|||
129133538|NCT00514917|464781378|FG000|Overall Study|Withdrawal by Subject|18|||
129133539|NCT00514917|464781379|FG001|Overall Study|Withdrawal by Subject|16|||
129133540|NCT00514917|464781378|FG000|Overall Study|Discontinued due to study closure|88|||
128775289|NCT01474512|463468368|FG011|Long-Term Extension Period|Death|0|||
128980017|NCT02041533|464213045|FG000|Treatment Period|Not Reported|0|||
128980018|NCT02041533|464213046|FG001|Treatment Period|Not Reported|1|||
128980019|NCT01874288|464213047|FG000|Overall Study|Withdrawal by Subject|1|||
128980020|NCT01874288|464213048|FG001|Overall Study|Withdrawal by Subject|0|||
128980021|NCT01874288|464213049|FG002|Overall Study|Withdrawal by Subject|2|||
128980022|NCT01874288|464213050|FG003|Overall Study|Withdrawal by Subject|1|||
128980023|NCT01874288|464213051|FG004|Overall Study|Withdrawal by Subject|1|||
128980024|NCT01874288|464213047|FG000|Overall Study|Physician Decision|0|||
128980025|NCT01874288|464213048|FG001|Overall Study|Physician Decision|0|||
128980026|NCT01874288|464213049|FG002|Overall Study|Physician Decision|0|||
128980027|NCT01874288|464213050|FG003|Overall Study|Physician Decision|1|||
128980028|NCT01874288|464213051|FG004|Overall Study|Physician Decision|0|||
128980029|NCT01874288|464213047|FG000|Overall Study|Progressive disease|2|||
128980030|NCT01874288|464213048|FG001|Overall Study|Progressive disease|0|||
128980031|NCT01874288|464213049|FG002|Overall Study|Progressive disease|3|||
128980032|NCT01874288|464213050|FG003|Overall Study|Progressive disease|5|||
128980033|NCT01874288|464213051|FG004|Overall Study|Progressive disease|1|||
128980034|NCT00591786|464213052|FG000|Overall Study|Withdrawal of Informed Consent|0|||
128980035|NCT00591786|464213053|FG001|Overall Study|Withdrawal of Informed Consent|0|||
128980036|NCT00591786|464213054|FG002|Overall Study|Withdrawal of Informed Consent|1|||
128980037|NCT00591786|464213055|FG003|Overall Study|Withdrawal of Informed Consent|0|||
128980038|NCT00591786|464213056|FG004|Overall Study|Withdrawal of Informed Consent|0|||
128980039|NCT00591786|464213057|FG005|Overall Study|Withdrawal of Informed Consent|0|||
128980040|NCT00591786|464213058|FG006|Overall Study|Withdrawal of Informed Consent|0|||
128980041|NCT00591786|464213059|FG007|Overall Study|Withdrawal of Informed Consent|0|||
128980042|NCT00591786|464213060|FG008|Overall Study|Withdrawal of Informed Consent|0|||
128980043|NCT00591786|464213061|FG009|Overall Study|Withdrawal of Informed Consent|0|||
128980044|NCT01140646|464213062|FG000|Overall Study|Adverse Event|4|||
128980045|NCT01140646|464213062|FG000|Overall Study|Refused Further Treatment|5|||
128980046|NCT00784836|464213067|FG000|Overall Study|Early Study Termination|3|||
128980047|NCT00660829|464213068|FG000|Overall Study|Adverse Event|3|||
128980048|NCT00660829|464213069|FG001|Overall Study|Adverse Event|4|||
128980049|NCT00660829|464213068|FG000|Overall Study|Lack of Efficacy|2|||
128980050|NCT00660829|464213069|FG001|Overall Study|Lack of Efficacy|3|||
128980051|NCT00660829|464213068|FG000|Overall Study|Non-Compliance|0|||
128980052|NCT00660829|464213069|FG001|Overall Study|Non-Compliance|4|||
128980053|NCT00660829|464213068|FG000|Overall Study|Withdrawal by Subject|1|||
128980054|NCT00660829|464213069|FG001|Overall Study|Withdrawal by Subject|2|||
128980055|NCT00660829|464213068|FG000|Overall Study|Lost to Follow-up|3|||
128980056|NCT00660829|464213069|FG001|Overall Study|Lost to Follow-up|2|||
128980057|NCT00660829|464213068|FG000|Overall Study|Other|9|||
128980058|NCT00660829|464213069|FG001|Overall Study|Other|4|||
128980059|NCT02127931|464213070|FG000|Overall Study|Glitch in Game|1|||
128980060|NCT00434876|464213071|FG000|Overall Study|Lost to Follow-up|1|||
128980061|NCT00434876|464213072|FG001|Overall Study|Lost to Follow-up|1|||
128980062|NCT00758394|464213073|FG000|2nd Intervention Order|Lost to Follow-up|0|||
128980063|NCT00758394|464213074|FG001|2nd Intervention Order|Lost to Follow-up|1|||
128980064|NCT00758394|464213075|FG002|2nd Intervention Order|Lost to Follow-up|0|||
128980065|NCT00758394|464213076|FG003|2nd Intervention Order|Lost to Follow-up|0|||
128980066|NCT00758394|464213073|FG000|3rd Intervention|Lost to Follow-up|1|||
128980067|NCT00758394|464213074|FG001|3rd Intervention|Lost to Follow-up|0|||
128980068|NCT00758394|464213075|FG002|3rd Intervention|Lost to Follow-up|0|||
128980069|NCT00758394|464213076|FG003|3rd Intervention|Lost to Follow-up|1|||
128980070|NCT02058940|464214752|FG000|Overall Study|Discharged from Critical Care Unit|1|||
128980071|NCT05637515|464214753|FG000|Overall Study|Withdrawal by Subject|17|||
128980072|NCT05637515|464214754|FG001|Overall Study|Withdrawal by Subject|17|||
128980073|NCT00772031|464214756|FG000|Overall Study|Early termination of trial|12|||
128980074|NCT00772031|464214757|FG001|Overall Study|Early termination of trial|10|||
128980075|NCT00772031|464214756|FG000|Overall Study|Lost to Follow-up|20|||
128980076|NCT00772031|464214757|FG001|Overall Study|Lost to Follow-up|33|||
128980077|NCT00635804|464214758|FG000|Overall Study|Adverse Event|0|||
128980078|NCT00635804|464214759|FG001|Overall Study|Adverse Event|0|||
128980079|NCT00635804|464214760|FG002|Overall Study|Adverse Event|0|||
128980080|NCT00635804|464214761|FG003|Overall Study|Adverse Event|0|||
128980081|NCT00635804|464214762|FG004|Overall Study|Adverse Event|0|||
128980082|NCT00635804|464214763|FG005|Overall Study|Adverse Event|1|||
128980083|NCT00635804|464214764|FG006|Overall Study|Adverse Event|0|||
128980084|NCT00635804|464214765|FG007|Overall Study|Adverse Event|0|||
128980085|NCT00635804|464214758|FG000|Overall Study|Withdrawal by Subject|1|||
128980086|NCT00635804|464214759|FG001|Overall Study|Withdrawal by Subject|0|||
129222616|NCT05040971|465116154|FG000|Overall Study|Lost to Follow-up|8|||
129222617|NCT05040971|465116155|FG001|Overall Study|Lost to Follow-up|3|||
129222618|NCT05040971|465116154|FG000|Overall Study|Death|2|||
129222619|NCT05040971|465116155|FG001|Overall Study|Death|0|||
129222620|NCT01013649|465116158|FG000|First Step|Withdrawal by Subject|36|||
129222621|NCT01013649|465116159|FG001|First Step|Withdrawal by Subject|19|||
129222622|NCT01013649|465116160|FG002|First Step|Withdrawal by Subject|0|||
129222623|NCT01013649|465116161|FG003|First Step|Withdrawal by Subject|0|||
129222624|NCT01013649|465116158|FG000|First Step|Progression|58|||
129222625|NCT01013649|465116159|FG001|First Step|Progression|23|||
129222626|NCT01013649|465116160|FG002|First Step|Progression|0|||
129222627|NCT01013649|465116161|FG003|First Step|Progression|0|||
129222628|NCT01013649|465116158|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
129222629|NCT01013649|465116159|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
129222630|NCT01013649|465116160|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
129222631|NCT01013649|465116161|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
129222632|NCT01013649|465116158|FG000|First Step|Death|3|||
129222633|NCT01013649|465116159|FG001|First Step|Death|4|||
129222634|NCT01013649|465116160|FG002|First Step|Death|0|||
129222635|NCT01013649|465116161|FG003|First Step|Death|0|||
129222636|NCT01013649|465116158|FG000|First Step|Adverse Event|9|||
129222637|NCT01013649|465116159|FG001|First Step|Adverse Event|5|||
129222638|NCT01013649|465116160|FG002|First Step|Adverse Event|0|||
129222639|NCT01013649|465116161|FG003|First Step|Adverse Event|0|||
129222640|NCT01013649|465116158|FG000|First Step|Other|4|||
129222641|NCT01013649|465116159|FG001|First Step|Other|6|||
129222642|NCT01013649|465116160|FG002|First Step|Other|0|||
129222643|NCT01013649|465116161|FG003|First Step|Other|0|||
129222644|NCT04285567|465116165|FG000|Overall Study|Death|3|||
129222645|NCT04285567|465116166|FG001|Overall Study|Death|3|||
129222646|NCT04285567|465116165|FG000|Overall Study|Lost to Follow-up|1|||
129222647|NCT04285567|465116166|FG001|Overall Study|Lost to Follow-up|1|||
129222648|NCT04285567|465116165|FG000|Overall Study|Reason Not Specified|1|||
129222649|NCT04285567|465116166|FG001|Overall Study|Reason Not Specified|1|||
129222650|NCT04285567|465116165|FG000|Overall Study|Physician Decision|2|||
129222651|NCT04285567|465116166|FG001|Overall Study|Physician Decision|1|||
129222652|NCT04285567|465116165|FG000|Overall Study|Withdrawal by Subject|2|||
129222653|NCT04285567|465116166|FG001|Overall Study|Withdrawal by Subject|6|||
129222654|NCT04285567|465116165|FG000|Overall Study|Adverse Event|1|||
129222655|NCT04285567|465116166|FG001|Overall Study|Adverse Event|0|||
129222656|NCT04285567|465116165|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
129222657|NCT04285567|465116166|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
129222658|NCT04758637|465116167|FG000|Overall Study|Lost to Follow-up|0|||
129222659|NCT04758637|465116168|FG001|Overall Study|Lost to Follow-up|1|||
129222660|NCT04758637|465116169|FG002|Overall Study|Lost to Follow-up|0|||
129222661|NCT04758637|465116170|FG003|Overall Study|Lost to Follow-up|0|||
129222662|NCT04494256|465116172|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
129222663|NCT04494256|465116173|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
129222664|NCT04494256|465116174|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
129222665|NCT04494256|465116175|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
128980087|NCT00635804|464214760|FG002|Overall Study|Withdrawal by Subject|0|||
128980088|NCT00635804|464214761|FG003|Overall Study|Withdrawal by Subject|0|||
128980089|NCT00635804|464214762|FG004|Overall Study|Withdrawal by Subject|0|||
128980090|NCT00635804|464214763|FG005|Overall Study|Withdrawal by Subject|0|||
128980091|NCT00635804|464214764|FG006|Overall Study|Withdrawal by Subject|0|||
128980092|NCT00635804|464214765|FG007|Overall Study|Withdrawal by Subject|0|||
128980093|NCT02718131|464214766|FG000|Overall Study|Withdrawal by Subject|1|||
128980094|NCT02718131|464214767|FG001|Overall Study|Withdrawal by Subject|0|||
128980095|NCT02718131|464214766|FG000|Overall Study|Adverse Event|1|||
128980096|NCT02718131|464214767|FG001|Overall Study|Adverse Event|0|||
128980097|NCT02718131|464214766|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
128980098|NCT02718131|464214767|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
128980099|NCT01101321|464214768|FG000|Period 1|Withdrawal by Subject|1|||
128980100|NCT01101321|464214769|FG001|Period 1|Withdrawal by Subject|1|||
128980101|NCT01101321|464214768|FG000|Period 1|Adverse Event|3|||
128980102|NCT01101321|464214769|FG001|Period 1|Adverse Event|3|||
128980103|NCT00679354|464214776|FG000|Overall Study|Death|3|||
128980104|NCT00679354|464214776|FG000|Overall Study|Lack of Efficacy|22|||
128980105|NCT00679354|464214776|FG000|Overall Study|Physician Decision|4|||
128980106|NCT00679354|464214776|FG000|Overall Study|Ineligible|1|||
128980107|NCT01654666|464214781|FG000|Overall Study|Protocol Violation|7|||
128980108|NCT01654666|464214782|FG001|Overall Study|Protocol Violation|4|||
128980109|NCT01654666|464214783|FG002|Overall Study|Protocol Violation|8|||
129222666|NCT04494256|465116176|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
129222667|NCT04494256|465116177|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
129222668|NCT04494256|465116178|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
129222669|NCT04494256|465116172|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129222670|NCT04494256|465116173|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
128718898|NCT01265849|463268895|FG001|Overall Study|Withdrawal by Subject|34|||
128718899|NCT01265849|463268896|FG002|Overall Study|Withdrawal by Subject|13|||
128718900|NCT03194321|463268898|FG000|Overall Study|Withdrawal by Subject|1|||
128718901|NCT03194321|463268898|FG000|Overall Study|Lost to Follow-up|1|||
128718902|NCT03194321|463268898|FG000|Overall Study|Travel for Follow-up|1|||
128718903|NCT00271609|463268899|FG000|Overall Study|Adverse Event|11|||
128718904|NCT00271609|463268900|FG001|Overall Study|Adverse Event|3|||
128718905|NCT00271609|463268899|FG000|Overall Study|Withdrawal by Subject|2|||
128718906|NCT00271609|463268900|FG001|Overall Study|Withdrawal by Subject|0|||
128718907|NCT02188589|463268901|FG000|Overall Study|Withdrawal by Subject|5|||
128718908|NCT03659916|463268903|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
128718909|NCT03659916|463268904|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
128718910|NCT03659916|463268905|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
128718911|NCT03659916|463268903|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
128718912|NCT03659916|463268904|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
129041955|NCT04146363|464445946|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041956|NCT04146363|464445947|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041957|NCT04146363|464445948|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
129041958|NCT04146363|464445949|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041959|NCT04146363|464445950|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041960|NCT04146363|464445951|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
129041961|NCT04146363|464445952|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041962|NCT04146363|464445953|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041963|NCT04146363|464445954|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041964|NCT04146363|464445955|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041965|NCT04146363|464445956|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
129041966|NCT04146363|464445946|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129041967|NCT04146363|464445947|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129041968|NCT04146363|464445948|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129041969|NCT04146363|464445949|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129041970|NCT04146363|464445950|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
129041971|NCT04146363|464445951|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
129041972|NCT04146363|464445952|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
129041973|NCT04146363|464445953|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
129133541|NCT00514917|464781379|FG001|Overall Study|Discontinued due to study closure|81|||
128718913|NCT03659916|463268905|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
128718914|NCT03659916|463268903|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
128718915|NCT03659916|463268904|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
128718916|NCT03659916|463268905|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
128718917|NCT03659916|463268903|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
128718918|NCT03659916|463268904|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
128718919|NCT03659916|463268905|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
128718920|NCT03659916|463268903|FG000|Treatment Period (72 Weeks)|Other|1|||
129041974|NCT04146363|464445954|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129041975|NCT04146363|464445955|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129133542|NCT00514917|464781378|FG000|Overall Study|Undefined|11|||
129133543|NCT00514917|464781379|FG001|Overall Study|Undefined|5|||
129133544|NCT02697422|464781380|FG000|Overall Study|Declined exit survey|9|||
129133545|NCT02697422|464781381|FG001|Overall Study|Declined exit survey|2|||
129133546|NCT02697422|464781380|FG000|Overall Study|Lost to Follow-up|13|||
129133547|NCT02697422|464781381|FG001|Overall Study|Lost to Follow-up|8|||
129133548|NCT02697422|464781380|FG000|Overall Study|Death|2|||
129133549|NCT02697422|464781381|FG001|Overall Study|Death|1|||
129133550|NCT02697422|464781380|FG000|Overall Study|Withdrawal by Subject|0|||
129133551|NCT02697422|464781381|FG001|Overall Study|Withdrawal by Subject|1|||
129133552|NCT02697422|464781380|FG000|Overall Study|Physician Decision|1|||
129133553|NCT02697422|464781381|FG001|Overall Study|Physician Decision|1|||
129133554|NCT02697422|464781380|FG000|Overall Study|Exit survey data lost|1|||
129133555|NCT02697422|464781381|FG001|Overall Study|Exit survey data lost|0|||
129133556|NCT04149353|464781386|FG000|Overall Study|Study terminated|1|||
129133557|NCT01263028|464781389|FG000|Overall Study|Withdrawal by Subject|1|||
129133558|NCT01263028|464781389|FG000|Overall Study|Adverse Event|1|||
129133559|NCT01263028|464781389|FG000|Overall Study|Study terminated due to low enrollment.|4|||
129133560|NCT00309244|464781390|FG000|Overall Study|Adverse Event|29|||
129133561|NCT00309244|464781391|FG001|Overall Study|Adverse Event|12|||
129133562|NCT00309244|464781390|FG000|Overall Study|Lost to Follow-up|6|||
129133563|NCT00309244|464781391|FG001|Overall Study|Lost to Follow-up|22|||
129133564|NCT00309244|464781390|FG000|Overall Study|Physician Decision|5|||
128718921|NCT03659916|463268904|FG001|Treatment Period (72 Weeks)|Other|3|||
128718922|NCT03659916|463268905|FG002|Treatment Period (72 Weeks)|Other|9|||
128718923|NCT03659916|463268903|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
128718924|NCT03659916|463268904|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
128718925|NCT03659916|463268905|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
128980110|NCT01654666|464214781|FG000|Overall Study|Lost to Follow-up|4|||
128980111|NCT01654666|464214782|FG001|Overall Study|Lost to Follow-up|5|||
128980112|NCT01654666|464214783|FG002|Overall Study|Lost to Follow-up|5|||
128980113|NCT01654666|464214781|FG000|Overall Study|Withdrawal by Subject|4|||
128980114|NCT01654666|464214782|FG001|Overall Study|Withdrawal by Subject|4|||
128980115|NCT01654666|464214783|FG002|Overall Study|Withdrawal by Subject|1|||
128980116|NCT00535262|464214786|FG000|Overall Study|No funding|3|||
128980117|NCT02898662|464214787|FG000|Overall Study|Adverse Event|1|||
128980118|NCT02898662|464214788|FG001|Overall Study|Adverse Event|0|||
128980119|NCT02898662|464214787|FG000|Overall Study|Loss of asthma control|23|||
128980120|NCT02898662|464214788|FG001|Overall Study|Loss of asthma control|24|||
128980121|NCT02898662|464214787|FG000|Overall Study|Withdrawal by Subject|4|||
128980122|NCT02898662|464214788|FG001|Overall Study|Withdrawal by Subject|1|||
128980123|NCT02898662|464214787|FG000|Overall Study|Technical issue|0|||
128980124|NCT02898662|464214788|FG001|Overall Study|Technical issue|1|||
128980125|NCT02898662|464214787|FG000|Overall Study|Randomized in error|0|||
128980126|NCT02898662|464214788|FG001|Overall Study|Randomized in error|1|||
128980127|NCT02898662|464214787|FG000|Overall Study|Subject decision|1|||
128980128|NCT02898662|464214788|FG001|Overall Study|Subject decision|0|||
128980129|NCT02898662|464214787|FG000|Overall Study|Other|0|||
128980130|NCT02898662|464214788|FG001|Overall Study|Other|1|||
128980131|NCT03802331|464214789|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
128980132|NCT03802331|464214790|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
128980133|NCT00917553|464214791|FG000|Overall Study|Lost to Follow-up|2|||
128980134|NCT00917553|464214792|FG001|Overall Study|Lost to Follow-up|1|||
128980135|NCT01616173|464214793|FG000|Overall Study|Lost to Follow-up|0|||
128980136|NCT01616173|464214794|FG001|Overall Study|Lost to Follow-up|2|||
128980137|NCT01616173|464214795|FG002|Overall Study|Lost to Follow-up|0|||
128980138|NCT03432819|464214798|FG000|Overall Study|Lost to Follow-up|2|||
128980139|NCT03432819|464214799|FG001|Overall Study|Lost to Follow-up|2|||
128980140|NCT03432819|464214798|FG000|Overall Study|Withdrawal by Subject|5|||
128980141|NCT03432819|464214799|FG001|Overall Study|Withdrawal by Subject|3|||
128980142|NCT03326323|464214801|FG000|Overall Study|Unable to receive ANH protocol|3|||
128980143|NCT04225026|464214803|FG000|Overall Study|Withdrawal by Subject|4|||
128980144|NCT04225026|464214803|FG000|Overall Study|Adverse Event|1|||
128980145|NCT04225026|464214803|FG000|Overall Study|Other|1|||
128980146|NCT04225026|464214803|FG000|Overall Study|Death|11|||
128980147|NCT04225026|464214803|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
128980148|NCT00672490|464214806|FG000|Overall Study|Withdrawal by Subject|8|||
128980149|NCT00672490|464214807|FG001|Overall Study|Withdrawal by Subject|8|||
128980150|NCT00672490|464214806|FG000|Overall Study|Lack of Compliance|2|||
128980151|NCT00672490|464214807|FG001|Overall Study|Lack of Compliance|7|||
128980152|NCT00672490|464214806|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
128980153|NCT00672490|464214807|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
128980154|NCT00672490|464214806|FG000|Overall Study|Adverse Event|5|||
128980155|NCT00672490|464214807|FG001|Overall Study|Adverse Event|8|||
128980156|NCT00672490|464214806|FG000|Overall Study|Violation of Concomitant Medicine|1|||
128980157|NCT00672490|464214807|FG001|Overall Study|Violation of Concomitant Medicine|0|||
128980158|NCT00672490|464214806|FG000|Overall Study|Intolerance|0|||
128980159|NCT00672490|464214807|FG001|Overall Study|Intolerance|2|||
128980160|NCT00672490|464214806|FG000|Overall Study|Lost to Follow-up|1|||
128980161|NCT00672490|464214807|FG001|Overall Study|Lost to Follow-up|5|||
128980162|NCT00672490|464214806|FG000|Overall Study|No reason was provided|6|||
128980163|NCT00672490|464214807|FG001|Overall Study|No reason was provided|2|||
128980164|NCT04738123|464214810|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
128980165|NCT04738123|464214811|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
128980166|NCT04738123|464214810|FG000|Overall Study|Progressive Disease|0|||
128980167|NCT04738123|464214811|FG001|Overall Study|Progressive Disease|4|||
128980168|NCT04738123|464214810|FG000|Overall Study|Adverse Event|8|||
128980169|NCT04738123|464214811|FG001|Overall Study|Adverse Event|7|||
128980170|NCT04738123|464214810|FG000|Overall Study|Other Reasons|0|||
128980171|NCT04738123|464214811|FG001|Overall Study|Other Reasons|1|||
129041976|NCT04146363|464445956|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129041977|NCT04146363|464445946|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
128718926|NCT03659916|463268903|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
128775290|NCT01474512|463468369|FG012|Long-Term Extension Period|Death|9|||
129041978|NCT04146363|464445947|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129041979|NCT04146363|464445948|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
129041980|NCT04146363|464445949|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129041981|NCT04146363|464445950|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129041982|NCT04146363|464445951|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
129133565|NCT00309244|464781391|FG001|Overall Study|Physician Decision|8|||
128980172|NCT04738123|464214810|FG000|Overall Study|Suicidal or assaultive behavior|0|||
128980173|NCT04738123|464214811|FG001|Overall Study|Suicidal or assaultive behavior|2|||
128980174|NCT04738123|464214810|FG000|Overall Study|Protocol Violation|2|||
128980175|NCT04738123|464214811|FG001|Overall Study|Protocol Violation|2|||
128980176|NCT04738123|464214810|FG000|Overall Study|Consent Withdrawn|35|||
128980177|NCT04738123|464214811|FG001|Overall Study|Consent Withdrawn|22|||
128980178|NCT03604159|464214812|FG000|Overall Study|Lost to Follow-up|6|||
128980179|NCT03604159|464214813|FG001|Overall Study|Lost to Follow-up|7|||
128980180|NCT04533204|464214818|FG000|Overall Study|Unable to understand training instructions|1|||
128980181|NCT04533204|464214819|FG001|Overall Study|Unable to understand training instructions|1|||
128980182|NCT03982069|464214820|FG000|Overall Study|Lost to Follow-up|5|||
128980183|NCT03982069|464214821|FG001|Overall Study|Lost to Follow-up|5|||
128980184|NCT03982069|464214822|FG002|Overall Study|Lost to Follow-up|3|||
128980185|NCT03982069|464214823|FG003|Overall Study|Lost to Follow-up|5|||
128980186|NCT03982069|464214820|FG000|Overall Study|Physician Decision|0|||
128980187|NCT03982069|464214821|FG001|Overall Study|Physician Decision|1|||
128980188|NCT03982069|464214822|FG002|Overall Study|Physician Decision|0|||
128980189|NCT03982069|464214823|FG003|Overall Study|Physician Decision|0|||
128980190|NCT03982069|464214820|FG000|Overall Study|Withdrawal by Subject|2|||
128980191|NCT03982069|464214821|FG001|Overall Study|Withdrawal by Subject|1|||
128980192|NCT03982069|464214822|FG002|Overall Study|Withdrawal by Subject|5|||
128980193|NCT03982069|464214823|FG003|Overall Study|Withdrawal by Subject|2|||
128980194|NCT03982069|464214820|FG000|Overall Study|Specimen loss|3|||
128980195|NCT03982069|464214821|FG001|Overall Study|Specimen loss|3|||
128980196|NCT03982069|464214822|FG002|Overall Study|Specimen loss|1|||
128980197|NCT03982069|464214823|FG003|Overall Study|Specimen loss|1|||
128980198|NCT01218477|464214824|FG000|Overall Study|Disease progression|2|||
128980199|NCT01218477|464214825|FG001|Overall Study|Disease progression|3|||
128980200|NCT01218477|464214826|FG002|Overall Study|Disease progression|6|||
128980201|NCT01218477|464214827|FG003|Overall Study|Disease progression|2|||
128980202|NCT01218477|464214824|FG000|Overall Study|Study drug toxicity|0|||
128980203|NCT01218477|464214825|FG001|Overall Study|Study drug toxicity|2|||
128980204|NCT01218477|464214826|FG002|Overall Study|Study drug toxicity|5|||
128980205|NCT01218477|464214827|FG003|Overall Study|Study drug toxicity|0|||
128980206|NCT01218477|464214824|FG000|Overall Study|No longer meets study criteria|1|||
128980207|NCT01218477|464214825|FG001|Overall Study|No longer meets study criteria|0|||
128980208|NCT01218477|464214826|FG002|Overall Study|No longer meets study criteria|0|||
128980209|NCT01218477|464214827|FG003|Overall Study|No longer meets study criteria|0|||
128980210|NCT01218477|464214824|FG000|Overall Study|Withdrawal by Subject|0|||
128980211|NCT01218477|464214825|FG001|Overall Study|Withdrawal by Subject|0|||
128980212|NCT01218477|464214826|FG002|Overall Study|Withdrawal by Subject|1|||
128980213|NCT01218477|464214827|FG003|Overall Study|Withdrawal by Subject|0|||
128980214|NCT01218477|464214824|FG000|Overall Study|Prepared for cell transplantation|0|||
128980215|NCT01218477|464214825|FG001|Overall Study|Prepared for cell transplantation|1|||
128980216|NCT01218477|464214826|FG002|Overall Study|Prepared for cell transplantation|1|||
128980217|NCT01218477|464214827|FG003|Overall Study|Prepared for cell transplantation|0|||
128980218|NCT01218477|464214824|FG000|Overall Study|Administrative reason by sponsor|0|||
128980219|NCT01218477|464214825|FG001|Overall Study|Administrative reason by sponsor|0|||
128980220|NCT01218477|464214826|FG002|Overall Study|Administrative reason by sponsor|1|||
128980221|NCT01218477|464214827|FG003|Overall Study|Administrative reason by sponsor|0|||
128980222|NCT01218477|464214824|FG000|Overall Study|Maximum clinical benefit|0|||
128980223|NCT01218477|464214825|FG001|Overall Study|Maximum clinical benefit|2|||
128980224|NCT01218477|464214826|FG002|Overall Study|Maximum clinical benefit|0|||
128980225|NCT01218477|464214827|FG003|Overall Study|Maximum clinical benefit|0|||
128980226|NCT00787527|464214830|FG000|Overall Study|Toxicity|3|||
128980227|NCT00083616|464214831|FG000|Overall Study|Disease Progression|16|||
128980228|NCT00083616|464214831|FG000|Overall Study|Lost to Follow-up|1|||
128980229|NCT00083616|464214831|FG000|Overall Study|Physician Decision|2|||
128980230|NCT00083616|464214831|FG000|Overall Study|Withdrawal by Subject|3|||
128980231|NCT00083616|464214831|FG000|Overall Study|Ineligibility determined|2|||
128980232|NCT00083616|464214831|FG000|Overall Study|Non-compliance|1|||
128980233|NCT00083616|464214831|FG000|Overall Study|Other|6|||
128980234|NCT01474993|464214834|FG000|Overall Study|Lost to Follow-up|1|||
128980235|NCT01474993|464214835|FG001|Overall Study|Lost to Follow-up|2|||
128980236|NCT01474993|464214834|FG000|Overall Study|Adverse Event|0|||
128980237|NCT01474993|464214835|FG001|Overall Study|Adverse Event|1|||
128980238|NCT00760994|464214836|FG000|Overall Study|Lost to Follow-up|4|||
128980239|NCT00760994|464214837|FG001|Overall Study|Lost to Follow-up|4|||
129041983|NCT04146363|464445952|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
129041984|NCT04146363|464445953|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
129041985|NCT04146363|464445954|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129041986|NCT04146363|464445955|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129041987|NCT04146363|464445956|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129041988|NCT04146363|464445946|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041989|NCT04146363|464445947|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041990|NCT04146363|464445948|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041991|NCT04146363|464445949|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
128980240|NCT00760994|464214838|FG002|Overall Study|Lost to Follow-up|3|||
128980241|NCT01853397|464214839|FG000|Overall Study|Withdrawal by Subject|0|||
128980242|NCT01853397|464214840|FG001|Overall Study|Withdrawal by Subject|0|||
128980243|NCT01853397|464214841|FG002|Overall Study|Withdrawal by Subject|0|||
128980244|NCT01853397|464214842|FG003|Overall Study|Withdrawal by Subject|1|||
128980245|NCT01853397|464214839|FG000|Overall Study|Subject Noncompliance|0|||
128980246|NCT01853397|464214840|FG001|Overall Study|Subject Noncompliance|0|||
128980247|NCT01853397|464214841|FG002|Overall Study|Subject Noncompliance|0|||
128980248|NCT01853397|464214842|FG003|Overall Study|Subject Noncompliance|1|||
128980249|NCT00486720|464214843|FG000|Overall Study|Adverse Event|1|||
128980250|NCT00486720|464214844|FG001|Overall Study|Adverse Event|2|||
128980251|NCT00486720|464214843|FG000|Overall Study|Lack of Efficacy|4|||
128980252|NCT00486720|464214844|FG001|Overall Study|Lack of Efficacy|6|||
128980253|NCT00486720|464214843|FG000|Overall Study|Physician Decision|1|||
128980254|NCT00486720|464214844|FG001|Overall Study|Physician Decision|2|||
128980255|NCT00486720|464214843|FG000|Overall Study|Protocol Violation|1|||
128980256|NCT00486720|464214844|FG001|Overall Study|Protocol Violation|0|||
128980257|NCT00486720|464214843|FG000|Overall Study|Withdrawal by Subject|3|||
128980258|NCT00486720|464214844|FG001|Overall Study|Withdrawal by Subject|1|||
128980259|NCT00486720|464214843|FG000|Overall Study|Progressive Disease|0|||
128980260|NCT00486720|464214844|FG001|Overall Study|Progressive Disease|1|||
128980261|NCT02452892|464214845|FG000|Week 1 Initial Randommization|Adverse Event|1|||
128980262|NCT02452892|464214846|FG001|Week 1 Initial Randommization|Adverse Event|0|||
128980263|NCT02452892|464214847|FG002|Week 1 Initial Randommization|Adverse Event|0|||
128980264|NCT02452892|464214848|FG003|Week 1 Initial Randommization|Adverse Event|0|||
128980265|NCT02452892|464214845|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
128980266|NCT02452892|464214846|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
128980267|NCT02452892|464214847|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
128980268|NCT02452892|464214848|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
128980269|NCT02452892|464214845|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
128980270|NCT02452892|464214846|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
128980271|NCT02452892|464214847|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
128980272|NCT02452892|464214848|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
128980273|NCT02452892|464214845|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
128980274|NCT02452892|464214846|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
128980275|NCT02452892|464214847|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
128980276|NCT02452892|464214848|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
128980277|NCT02452892|464214845|FG000|Follow-up|Withdrawal by Subject|0|||
128980278|NCT02452892|464214846|FG001|Follow-up|Withdrawal by Subject|0|||
128980279|NCT02452892|464214847|FG002|Follow-up|Withdrawal by Subject|0|||
128980280|NCT02452892|464214848|FG003|Follow-up|Withdrawal by Subject|1|||
128980281|NCT02452892|464214845|FG000|Follow-up|Subject left town on Day 42|1|||
128980282|NCT02452892|464214846|FG001|Follow-up|Subject left town on Day 42|0|||
128980283|NCT02452892|464214847|FG002|Follow-up|Subject left town on Day 42|0|||
128980284|NCT02452892|464214848|FG003|Follow-up|Subject left town on Day 42|0|||
128980285|NCT00955682|464214849|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
128980286|NCT00955682|464214850|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
128980287|NCT02117024|464214851|FG000|Overall Study|Progressive Disease|26|||
128980288|NCT02117024|464214852|FG001|Overall Study|Progressive Disease|9|||
128980289|NCT02117024|464214851|FG000|Overall Study|Significant Clinical Progression|7|||
128980290|NCT02117024|464214852|FG001|Overall Study|Significant Clinical Progression|4|||
128980291|NCT02117024|464214851|FG000|Overall Study|Death|5|||
128980292|NCT02117024|464214852|FG001|Overall Study|Death|0|||
128980293|NCT02117024|464214851|FG000|Overall Study|Withdrawal by Subject|3|||
128980294|NCT02117024|464214852|FG001|Overall Study|Withdrawal by Subject|1|||
128980295|NCT02117024|464214851|FG000|Overall Study|Protocol Violation|1|||
128980296|NCT02117024|464214852|FG001|Overall Study|Protocol Violation|0|||
128980297|NCT02117024|464214851|FG000|Overall Study|Adverse Event|1|||
128980298|NCT02117024|464214852|FG001|Overall Study|Adverse Event|2|||
128980299|NCT02117024|464214851|FG000|Overall Study|Randomized in Error|1|||
128980300|NCT02117024|464214852|FG001|Overall Study|Randomized in Error|0|||
128980301|NCT02117024|464214851|FG000|Overall Study|Patient returned to primary oncologist|0|||
128980302|NCT02117024|464214852|FG001|Overall Study|Patient returned to primary oncologist|1|||
128718927|NCT03659916|463268904|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
128775291|NCT01474512|463468370|FG013|Long-Term Extension Period|Death|9|||
128980303|NCT02117024|464214851|FG000|Overall Study|Patient took treatment break|0|||
128980304|NCT02117024|464214852|FG001|Overall Study|Patient took treatment break|1|||
128980305|NCT02117024|464214851|FG000|Overall Study|Physician Decision|0|||
128980306|NCT02117024|464214852|FG001|Overall Study|Physician Decision|2|||
128980307|NCT00565721|464214855|FG000|Overall Study|Screen Failure|2|||
129041992|NCT04146363|464445950|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041993|NCT04146363|464445951|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041994|NCT04146363|464445952|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041995|NCT04146363|464445953|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041996|NCT04146363|464445954|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
129222671|NCT04494256|465116174|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129222672|NCT04494256|465116175|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129222673|NCT04494256|465116176|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
129222674|NCT04494256|465116177|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129222675|NCT04494256|465116178|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129222676|NCT04494256|465116172|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
129222677|NCT04494256|465116173|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
129222678|NCT04494256|465116174|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
129222679|NCT04494256|465116175|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
129222680|NCT04494256|465116176|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
129222681|NCT04494256|465116177|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
129222682|NCT04494256|465116178|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
129222683|NCT04494256|465116172|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222684|NCT04494256|465116173|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222685|NCT04494256|465116174|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222686|NCT04494256|465116175|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
129222687|NCT04494256|465116176|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
129222688|NCT04494256|465116177|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222689|NCT04494256|465116178|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222690|NCT04494256|465116172|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129222691|NCT04494256|465116173|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129222692|NCT04494256|465116174|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129222693|NCT04494256|465116175|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129222694|NCT04494256|465116176|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129222695|NCT04494256|465116177|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129222696|NCT04494256|465116178|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129222697|NCT04494256|465116172|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
129222698|NCT04494256|465116173|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
129222699|NCT04494256|465116174|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
129222700|NCT04494256|465116175|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
129222701|NCT04494256|465116176|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
129222702|NCT04494256|465116177|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
129222703|NCT04494256|465116178|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
129222704|NCT04494256|465116172|FG000|Part 2: Open Label Period|Death|0|||
129222705|NCT04494256|465116173|FG001|Part 2: Open Label Period|Death|0|||
129222706|NCT04494256|465116174|FG002|Part 2: Open Label Period|Death|0|||
129222707|NCT04494256|465116175|FG003|Part 2: Open Label Period|Death|0|||
129222708|NCT04494256|465116176|FG004|Part 2: Open Label Period|Death|0|||
129222709|NCT04494256|465116177|FG005|Part 2: Open Label Period|Death|4|||
129222710|NCT04494256|465116178|FG006|Part 2: Open Label Period|Death|2|||
129222711|NCT04494256|465116172|FG000|Part 2: Open Label Period|Adverse Event|0|||
129222712|NCT04494256|465116173|FG001|Part 2: Open Label Period|Adverse Event|0|||
129222713|NCT04494256|465116174|FG002|Part 2: Open Label Period|Adverse Event|0|||
129222714|NCT04494256|465116175|FG003|Part 2: Open Label Period|Adverse Event|0|||
129222715|NCT04494256|465116176|FG004|Part 2: Open Label Period|Adverse Event|0|||
129222716|NCT04494256|465116177|FG005|Part 2: Open Label Period|Adverse Event|0|||
129222717|NCT04494256|465116178|FG006|Part 2: Open Label Period|Adverse Event|2|||
129222718|NCT04494256|465116172|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129222719|NCT04494256|465116173|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129222720|NCT04494256|465116174|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129222721|NCT04494256|465116175|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129222722|NCT04494256|465116176|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129222723|NCT04494256|465116177|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
129222724|NCT04494256|465116178|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
129222725|NCT04494256|465116172|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129222726|NCT04494256|465116173|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129222727|NCT04494256|465116174|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129222728|NCT04494256|465116175|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129222729|NCT04494256|465116176|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
128718928|NCT03659916|463268905|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
128718929|NCT03659916|463268903|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
128775292|NCT01474512|463468371|FG014|Long-Term Extension Period|Death|0|||
128980308|NCT00565721|464214855|FG000|Overall Study|Lost to Follow-up|6|||
128980309|NCT00565721|464214855|FG000|Overall Study|Technical Problems|1|||
128980310|NCT00565721|464214855|FG000|Overall Study|Physician Decision|2|||
128980311|NCT00565721|464214855|FG000|Overall Study|Other reasons|6|||
128980312|NCT02813681|464214856|FG000|Overall Study|Physician Decision|5|||
128980313|NCT02813681|464214857|FG001|Overall Study|Physician Decision|5|||
128980314|NCT02813681|464214858|FG002|Overall Study|Physician Decision|0|||
128980315|NCT02813681|464214856|FG000|Overall Study|Lost to Follow-up|0|||
128980316|NCT02813681|464214857|FG001|Overall Study|Lost to Follow-up|1|||
128980317|NCT02813681|464214858|FG002|Overall Study|Lost to Follow-up|0|||
128980318|NCT02500706|464214859|FG000|Overall Study|Adverse Event|0|||
128980319|NCT02500706|464214860|FG001|Overall Study|Adverse Event|0|||
128980320|NCT02500706|464214861|FG002|Overall Study|Adverse Event|1|||
128980321|NCT02500706|464214859|FG000|Overall Study|Lost to Follow-up|0|||
129041997|NCT04146363|464445955|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
129041998|NCT04146363|464445956|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
129041999|NCT04146363|464445946|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042000|NCT04146363|464445947|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042001|NCT04146363|464445948|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042002|NCT04146363|464445949|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042003|NCT04146363|464445950|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042004|NCT04146363|464445951|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042005|NCT04146363|464445952|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042006|NCT04146363|464445953|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129042007|NCT04146363|464445954|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
129042008|NCT04146363|464445955|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
129042009|NCT04146363|464445956|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
129042010|NCT04146363|464445946|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042011|NCT04146363|464445947|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042012|NCT04146363|464445948|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042013|NCT04146363|464445949|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042014|NCT04146363|464445950|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042015|NCT04146363|464445951|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042016|NCT04146363|464445952|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042017|NCT04146363|464445953|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042018|NCT04146363|464445954|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
129042019|NCT04146363|464445955|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
129042020|NCT04146363|464445956|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129042021|NCT04146363|464445946|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042022|NCT04146363|464445947|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042023|NCT04146363|464445948|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042024|NCT04146363|464445949|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042025|NCT04146363|464445950|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042026|NCT04146363|464445951|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042027|NCT04146363|464445952|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042028|NCT04146363|464445953|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
129042029|NCT04146363|464445954|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
129042030|NCT04146363|464445955|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
129042031|NCT04146363|464445956|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
128980322|NCT02500706|464214860|FG001|Overall Study|Lost to Follow-up|1|||
128980323|NCT02500706|464214861|FG002|Overall Study|Lost to Follow-up|1|||
128980324|NCT02500706|464214859|FG000|Overall Study|Withdrawal by Subject|4|||
129042032|NCT04146363|464445946|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129042033|NCT04146363|464445947|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129042034|NCT04146363|464445948|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129042035|NCT04146363|464445949|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129042036|NCT04146363|464445950|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129133566|NCT00309244|464781390|FG000|Overall Study|Protocol Violation|6|||
129133567|NCT00309244|464781391|FG001|Overall Study|Protocol Violation|3|||
129133568|NCT00309244|464781390|FG000|Overall Study|Withdrawal by Subject|50|||
129133569|NCT00309244|464781391|FG001|Overall Study|Withdrawal by Subject|32|||
129133570|NCT00309244|464781390|FG000|Overall Study|Various|7|||
129133571|NCT00309244|464781391|FG001|Overall Study|Various|7|||
129133572|NCT00309244|464781390|FG000|Overall Study|Randomized but not dosed|11|||
129133573|NCT00309244|464781391|FG001|Overall Study|Randomized but not dosed|12|||
129133574|NCT00309244|464781390|FG000|Overall Study|Death|4|||
129133575|NCT00309244|464781391|FG001|Overall Study|Death|1|||
129133576|NCT03019588|464781392|FG000|Overall Study|Death|44|||
128980325|NCT02500706|464214860|FG001|Overall Study|Withdrawal by Subject|6|||
128980326|NCT02500706|464214861|FG002|Overall Study|Withdrawal by Subject|4|||
128980327|NCT02500706|464214859|FG000|Overall Study|Unclassified|0|||
129133577|NCT03019588|464781393|FG001|Overall Study|Death|46|||
128980328|NCT02500706|464214860|FG001|Overall Study|Unclassified|0|||
128775293|NCT01474512|463468372|FG015|Long-Term Extension Period|Death|0|||
128775294|NCT01474512|463468373|FG016|Long-Term Extension Period|Death|0|||
128980329|NCT02500706|464214861|FG002|Overall Study|Unclassified|1|||
128980330|NCT01497899|464214866|FG000|Double-Blind Phase|Randomized but not Treated|1|||
128980331|NCT01497899|464214867|FG001|Double-Blind Phase|Randomized but not Treated|0|||
128980332|NCT01497899|464214868|FG002|Double-Blind Phase|Randomized but not Treated|0|||
128980333|NCT01497899|464214869|FG003|Double-Blind Phase|Randomized but not Treated|0|||
128980334|NCT01497899|464214866|FG000|Double-Blind Phase|Adverse Event|1|||
128980335|NCT01497899|464214867|FG001|Double-Blind Phase|Adverse Event|0|||
128980336|NCT01497899|464214868|FG002|Double-Blind Phase|Adverse Event|0|||
128980337|NCT01497899|464214869|FG003|Double-Blind Phase|Adverse Event|0|||
128980338|NCT01497899|464214866|FG000|Double-Blind Phase|Lack of Efficacy|0|||
128980339|NCT01497899|464214867|FG001|Double-Blind Phase|Lack of Efficacy|1|||
128980340|NCT01497899|464214868|FG002|Double-Blind Phase|Lack of Efficacy|0|||
128980341|NCT01497899|464214869|FG003|Double-Blind Phase|Lack of Efficacy|0|||
128980342|NCT01497899|464214866|FG000|Double-Blind Phase|Investigator's Discretion|1|||
128980343|NCT01497899|464214867|FG001|Double-Blind Phase|Investigator's Discretion|0|||
128980344|NCT01497899|464214868|FG002|Double-Blind Phase|Investigator's Discretion|0|||
128980345|NCT01497899|464214869|FG003|Double-Blind Phase|Investigator's Discretion|0|||
128980346|NCT01497899|464214866|FG000|Double-Blind Phase|Withdrew Consent|0|||
128980347|NCT01497899|464214867|FG001|Double-Blind Phase|Withdrew Consent|1|||
128980348|NCT01497899|464214868|FG002|Double-Blind Phase|Withdrew Consent|0|||
128980349|NCT01497899|464214869|FG003|Double-Blind Phase|Withdrew Consent|0|||
128980350|NCT01497899|464214866|FG000|Double-Blind Phase|Lost to Follow-up|3|||
128980351|NCT01497899|464214867|FG001|Double-Blind Phase|Lost to Follow-up|2|||
128980352|NCT01497899|464214868|FG002|Double-Blind Phase|Lost to Follow-up|0|||
128980353|NCT01497899|464214869|FG003|Double-Blind Phase|Lost to Follow-up|0|||
128980354|NCT01497899|464214866|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
128980355|NCT01497899|464214867|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
128980356|NCT01497899|464214868|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
128980357|NCT01497899|464214869|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
128980358|NCT01497899|464214866|FG000|Open-Label Extension Phase|Adverse Event|1|||
128980359|NCT01497899|464214867|FG001|Open-Label Extension Phase|Adverse Event|0|||
128980360|NCT01497899|464214868|FG002|Open-Label Extension Phase|Adverse Event|0|||
128980361|NCT01497899|464214869|FG003|Open-Label Extension Phase|Adverse Event|0|||
128980362|NCT01497899|464214866|FG000|Open-Label Extension Phase|Death|1|||
128980363|NCT01497899|464214867|FG001|Open-Label Extension Phase|Death|0|||
128980364|NCT01497899|464214868|FG002|Open-Label Extension Phase|Death|0|||
128980365|NCT01497899|464214869|FG003|Open-Label Extension Phase|Death|0|||
128980366|NCT01497899|464214866|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
128980367|NCT01497899|464214867|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
128980368|NCT01497899|464214868|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
128980369|NCT01497899|464214869|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
128980370|NCT01497899|464214866|FG000|Open-Label Extension Phase|Pregnancy|0|||
128980371|NCT01497899|464214867|FG001|Open-Label Extension Phase|Pregnancy|1|||
128980372|NCT01497899|464214868|FG002|Open-Label Extension Phase|Pregnancy|1|||
128980373|NCT01497899|464214869|FG003|Open-Label Extension Phase|Pregnancy|0|||
128980374|NCT01497899|464214866|FG000|Open-Label Extension Phase|Protocol Violation|0|||
128980375|NCT01497899|464214867|FG001|Open-Label Extension Phase|Protocol Violation|0|||
128980376|NCT01497899|464214868|FG002|Open-Label Extension Phase|Protocol Violation|1|||
128980377|NCT01497899|464214869|FG003|Open-Label Extension Phase|Protocol Violation|0|||
128980378|NCT01497899|464214866|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
129042037|NCT04146363|464445951|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129042038|NCT04146363|464445952|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129042039|NCT04146363|464445953|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129042040|NCT04146363|464445954|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
129042041|NCT04146363|464445955|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
129042042|NCT04146363|464445956|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
129042043|NCT04146363|464445946|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042044|NCT04146363|464445947|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042045|NCT04146363|464445948|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042046|NCT04146363|464445949|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042047|NCT04146363|464445950|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042048|NCT04146363|464445951|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042049|NCT04146363|464445952|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042050|NCT04146363|464445953|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
128980379|NCT01497899|464214867|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
128980380|NCT01497899|464214868|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
128980381|NCT01497899|464214869|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
128980382|NCT05047601|464214871|FG000|Overall Study|Lost to Follow-up|9|||
128980383|NCT05047601|464214872|FG001|Overall Study|Lost to Follow-up|11|||
128980384|NCT05047601|464214873|FG002|Overall Study|Lost to Follow-up|7|||
128980385|NCT05047601|464214871|FG000|Overall Study|Withdrawal by Subject|25|||
129042051|NCT04146363|464445954|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042052|NCT04146363|464445955|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
129042053|NCT04146363|464445956|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
129042054|NCT04146363|464445946|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042055|NCT04146363|464445947|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042056|NCT04146363|464445948|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042057|NCT04146363|464445949|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042058|NCT04146363|464445950|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042059|NCT04146363|464445951|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042060|NCT04146363|464445952|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042061|NCT04146363|464445953|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042062|NCT04146363|464445954|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042063|NCT04146363|464445955|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
129042064|NCT04146363|464445956|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129042065|NCT02914236|464445957|FG000|Overall Study|Lost to Follow-up|1|||
129042066|NCT02148913|464445959|FG000|Overall Study|Death|0|||
129042067|NCT02148913|464445960|FG001|Overall Study|Death|1|||
129042068|NCT02148913|464445961|FG002|Overall Study|Death|0|||
129042069|NCT02148913|464445962|FG003|Overall Study|Death|0|||
129042070|NCT01045993|464445970|FG000|Overall Study|Treated-later found eligibility not met|0|||
129042071|NCT01045993|464445971|FG001|Overall Study|Treated-later found eligibility not met|1|||
129042072|NCT01045993|464445972|FG002|Overall Study|Treated-later found eligibility not met|0|||
129042073|NCT01045993|464445973|FG003|Overall Study|Treated-later found eligibility not met|0|||
129042074|NCT05506358|464445974|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
129042075|NCT05506358|464445975|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129042076|NCT05506358|464445976|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129042077|NCT05506358|464445977|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129042078|NCT05506358|464445978|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129042079|NCT05506358|464445974|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
129042080|NCT05506358|464445975|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129042081|NCT05506358|464445976|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129042082|NCT05506358|464445977|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129042083|NCT05506358|464445978|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129042084|NCT05506358|464445974|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129042085|NCT05506358|464445975|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129042086|NCT05506358|464445976|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129042087|NCT05506358|464445977|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
129042088|NCT05506358|464445978|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129042089|NCT05506358|464445974|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
129042090|NCT05506358|464445975|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
129042091|NCT05506358|464445976|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
129042092|NCT05506358|464445977|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
129042093|NCT05506358|464445978|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
129042094|NCT05506358|464445974|FG000|Overall Study|HbE trait|0|||
129042095|NCT05506358|464445975|FG001|Overall Study|HbE trait|0|||
129042096|NCT05506358|464445976|FG002|Overall Study|HbE trait|0|||
129042097|NCT05506358|464445977|FG003|Overall Study|HbE trait|1|||
129042098|NCT05506358|464445978|FG004|Overall Study|HbE trait|0|||
129042099|NCT01659736|464445979|FG000|Treatment Period|Adverse Event|1|||
129042100|NCT01659736|464445980|FG001|Treatment Period|Adverse Event|1|||
129042101|NCT01659736|464445979|FG000|Treatment Period|Protocol Violation|3|||
129042102|NCT01659736|464445980|FG001|Treatment Period|Protocol Violation|1|||
129042103|NCT01659736|464445979|FG000|Treatment Period|Withdrawal by Subject|1|||
129042104|NCT01659736|464445980|FG001|Treatment Period|Withdrawal by Subject|0|||
129042105|NCT01659736|464445979|FG000|3-month Follow-up|Lost to Follow-up|0|||
129042106|NCT01659736|464445980|FG001|3-month Follow-up|Lost to Follow-up|1|||
129042107|NCT00252174|464445988|FG000|Overall Study|Withdrawal by Subject|0|||
129042108|NCT00252174|464445989|FG001|Overall Study|Withdrawal by Subject|1|||
129042109|NCT00252174|464445990|FG002|Overall Study|Withdrawal by Subject|0|||
128718930|NCT03659916|463268904|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
128718931|NCT03659916|463268905|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
128718932|NCT03659916|463268903|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
128718933|NCT03659916|463268904|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
128718934|NCT03659916|463268905|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
128718935|NCT03659916|463268903|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
129042110|NCT02025010|464445991|FG000|Overall Study|Symptomatic or radiographic progression|36|||
128980386|NCT05047601|464214872|FG001|Overall Study|Withdrawal by Subject|36|||
128980387|NCT05047601|464214873|FG002|Overall Study|Withdrawal by Subject|23|||
128980388|NCT05047601|464214871|FG000|Overall Study|Other|10|||
128980389|NCT05047601|464214872|FG001|Overall Study|Other|6|||
128980390|NCT05047601|464214873|FG002|Overall Study|Other|5|||
128980391|NCT00286234|464214874|FG000|Overall Study|Protocol Violation|1|||
128980392|NCT00286234|464214875|FG001|Overall Study|Protocol Violation|2|||
128980393|NCT00286234|464214876|FG002|Overall Study|Protocol Violation|0|||
128980394|NCT00286234|464214877|FG003|Overall Study|Protocol Violation|1|||
128980395|NCT00286234|464214874|FG000|Overall Study|Physician Decision|1|||
128980396|NCT00286234|464214875|FG001|Overall Study|Physician Decision|0|||
128980397|NCT00286234|464214876|FG002|Overall Study|Physician Decision|0|||
128980398|NCT00286234|464214877|FG003|Overall Study|Physician Decision|1|||
128980399|NCT00286234|464214874|FG000|Overall Study|Adverse Event|0|||
128980400|NCT00286234|464214875|FG001|Overall Study|Adverse Event|0|||
128980401|NCT00286234|464214876|FG002|Overall Study|Adverse Event|0|||
128980402|NCT00286234|464214877|FG003|Overall Study|Adverse Event|1|||
128980403|NCT00286234|464214874|FG000|Overall Study|Adverse Event|0|||
128980404|NCT00286234|464214875|FG001|Overall Study|Adverse Event|0|||
128980405|NCT00286234|464214876|FG002|Overall Study|Adverse Event|0|||
128980406|NCT00286234|464214877|FG003|Overall Study|Adverse Event|1|||
128980407|NCT00283062|464214884|FG000|Overall Study|Did not receive any study medication|5|||
128980408|NCT00283062|464214885|FG001|Overall Study|Did not receive any study medication|4|||
128980409|NCT00283062|464214886|FG002|Overall Study|Did not receive any study medication|36|||
128980410|NCT00283062|464214887|FG003|Overall Study|Did not receive any study medication|45|||
128980411|NCT00283062|464214884|FG000|Overall Study|Adverse Event|2|||
128980412|NCT00283062|464214885|FG001|Overall Study|Adverse Event|0|||
128980413|NCT00283062|464214886|FG002|Overall Study|Adverse Event|1|||
128980414|NCT00283062|464214887|FG003|Overall Study|Adverse Event|0|||
128980415|NCT00283062|464214884|FG000|Overall Study|Lost to Follow-up|1|||
128980416|NCT00283062|464214885|FG001|Overall Study|Lost to Follow-up|0|||
128980417|NCT00283062|464214886|FG002|Overall Study|Lost to Follow-up|1|||
128980418|NCT00283062|464214887|FG003|Overall Study|Lost to Follow-up|0|||
128980419|NCT00283062|464214884|FG000|Overall Study|Progressive disease|0|||
128980420|NCT00283062|464214885|FG001|Overall Study|Progressive disease|0|||
128980421|NCT00283062|464214886|FG002|Overall Study|Progressive disease|1|||
128980422|NCT00283062|464214887|FG003|Overall Study|Progressive disease|0|||
128980423|NCT00283062|464214884|FG000|Overall Study|Participant did not wish to continue|3|||
129222730|NCT04494256|465116177|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129222731|NCT04494256|465116178|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
129222732|NCT04494256|465116172|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129222733|NCT04494256|465116173|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129222734|NCT04494256|465116174|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129222735|NCT04494256|465116175|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129222736|NCT04494256|465116176|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129222737|NCT04494256|465116177|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
129222738|NCT04494256|465116178|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
129222739|NCT04494256|465116172|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222740|NCT04494256|465116173|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222741|NCT04494256|465116174|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129222742|NCT04494256|465116175|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
128980424|NCT00283062|464214885|FG001|Overall Study|Participant did not wish to continue|2|||
128980425|NCT00283062|464214886|FG002|Overall Study|Participant did not wish to continue|1|||
128980426|NCT00283062|464214887|FG003|Overall Study|Participant did not wish to continue|0|||
128980427|NCT00283062|464214884|FG000|Overall Study|Undefined|0|||
128980428|NCT00283062|464214885|FG001|Overall Study|Undefined|1|||
128980429|NCT00283062|464214886|FG002|Overall Study|Undefined|1|||
128980430|NCT00283062|464214887|FG003|Overall Study|Undefined|4|||
128980431|NCT00283062|464214884|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
128980432|NCT00283062|464214885|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
128980433|NCT00283062|464214886|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
129042111|NCT02025010|464445991|FG000|Overall Study|Adverse Event|6|||
129042112|NCT02025010|464445991|FG000|Overall Study|Physician Decision|7|||
129042113|NCT02025010|464445991|FG000|Overall Study|Withdrawal by Subject|3|||
129042114|NCT02025010|464445991|FG000|Overall Study|Intercurrent illness|3|||
129042115|NCT02025010|464445991|FG000|Overall Study|Patients still on treatment|3|||
129042116|NCT02025010|464445991|FG000|Overall Study|Never initiate the treatment|2|||
129042117|NCT00484419|464445996|FG000|Overall Study|Adverse Event|3|||
129042118|NCT00484419|464445997|FG001|Overall Study|Adverse Event|0|||
129042119|NCT00484419|464445998|FG002|Overall Study|Adverse Event|0|||
129042120|NCT00484419|464445996|FG000|Overall Study|Lost to Follow-up|1|||
129042121|NCT00484419|464445997|FG001|Overall Study|Lost to Follow-up|0|||
129042122|NCT00484419|464445998|FG002|Overall Study|Lost to Follow-up|2|||
128980434|NCT00283062|464214887|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
128980435|NCT03137173|464214888|FG000|Overall Study|Withdrawal by Subject|8|||
128980436|NCT03137173|464214889|FG001|Overall Study|Withdrawal by Subject|13|||
128980437|NCT03137173|464214888|FG000|Overall Study|Death|1|||
128980438|NCT03137173|464214889|FG001|Overall Study|Death|3|||
128980439|NCT03137173|464214888|FG000|Overall Study|Physician Decision|1|||
128980440|NCT03137173|464214889|FG001|Overall Study|Physician Decision|0|||
128980441|NCT03137173|464214888|FG000|Overall Study|Lost to Follow-up|13|||
128980442|NCT03137173|464214889|FG001|Overall Study|Lost to Follow-up|18|||
128980443|NCT03137173|464214888|FG000|Overall Study|Other reasons|3|||
128980444|NCT03137173|464214889|FG001|Overall Study|Other reasons|2|||
128980445|NCT01365468|464214890|FG000|Overall Study|Physician Decision|1|||
128980446|NCT01365468|464214891|FG001|Overall Study|Physician Decision|0|||
128980447|NCT01365468|464214890|FG000|Overall Study|Disease progression|1|||
128980448|NCT01365468|464214891|FG001|Overall Study|Disease progression|0|||
128980449|NCT01365468|464214890|FG000|Overall Study|Lost to Follow-up|2|||
128980450|NCT01365468|464214891|FG001|Overall Study|Lost to Follow-up|0|||
128980451|NCT00423267|464214894|FG000|Period A|Withdrawal by Subject|0|||
128980452|NCT00423267|464214895|FG001|Period A|Withdrawal by Subject|1|||
128980453|NCT00423267|464214894|FG000|Period A|Non-compliance with protocol|1|||
128980454|NCT00423267|464214895|FG001|Period A|Non-compliance with protocol|0|||
128980455|NCT00423267|464214894|FG000|Period A|Administrative|1|||
128980456|NCT00423267|464214895|FG001|Period A|Administrative|0|||
128980457|NCT00827112|464214896|FG000|Overall Study|Adverse Event|2|||
128980458|NCT00827112|464214897|FG001|Overall Study|Adverse Event|0|||
128980459|NCT00827112|464214896|FG000|Overall Study|Lack of Efficacy|2|||
128980460|NCT00827112|464214897|FG001|Overall Study|Lack of Efficacy|0|||
128980461|NCT00827112|464214896|FG000|Overall Study|Lost to Follow-up|3|||
128980462|NCT00827112|464214897|FG001|Overall Study|Lost to Follow-up|2|||
128980463|NCT00827112|464214896|FG000|Overall Study|Pregnancy|0|||
128980464|NCT00827112|464214897|FG001|Overall Study|Pregnancy|1|||
128980465|NCT00827112|464214896|FG000|Overall Study|Protocol Violation|0|||
128980466|NCT00827112|464214897|FG001|Overall Study|Protocol Violation|2|||
128980467|NCT00827112|464214896|FG000|Overall Study|Withdrawal by Subject|2|||
128980468|NCT00827112|464214897|FG001|Overall Study|Withdrawal by Subject|1|||
128980469|NCT00827112|464214896|FG000|Overall Study|Randomized but not treated|5|||
128980470|NCT00827112|464214897|FG001|Overall Study|Randomized but not treated|3|||
128980471|NCT00827112|464214896|FG000|Overall Study|Other|1|||
128980472|NCT00827112|464214897|FG001|Overall Study|Other|3|||
128980473|NCT01475214|464214898|FG000|Overall Study|Lost to Follow-up|1|||
128980474|NCT01475214|464214899|FG001|Overall Study|Lost to Follow-up|0|||
128980475|NCT01475214|464214900|FG002|Overall Study|Lost to Follow-up|1|||
128980476|NCT01475214|464214898|FG000|Overall Study|Physician Decision|2|||
128980477|NCT01475214|464214899|FG001|Overall Study|Physician Decision|0|||
128980478|NCT01475214|464214900|FG002|Overall Study|Physician Decision|0|||
128980479|NCT01475214|464214898|FG000|Overall Study|Withdrawal by Subject|2|||
128980480|NCT01475214|464214899|FG001|Overall Study|Withdrawal by Subject|4|||
128980481|NCT01475214|464214900|FG002|Overall Study|Withdrawal by Subject|1|||
128980482|NCT00554229|464214905|FG000|Overall Study|Lost to Follow-up|3|||
128980483|NCT00554229|464214906|FG001|Overall Study|Lost to Follow-up|6|||
128980484|NCT00554229|464214905|FG000|Overall Study|Withdrawal by Subject|29|||
128980485|NCT00554229|464214906|FG001|Overall Study|Withdrawal by Subject|37|||
128980486|NCT00554229|464214905|FG000|Overall Study|Adverse Event|71|||
128980487|NCT00554229|464214906|FG001|Overall Study|Adverse Event|39|||
128980488|NCT00554229|464214905|FG000|Overall Study|Protocol Violation|3|||
128718936|NCT03659916|463268904|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
128718937|NCT03659916|463268905|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
128718938|NCT03659916|463268903|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
128980489|NCT00554229|464214906|FG001|Overall Study|Protocol Violation|3|||
128980490|NCT00554229|464214905|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
128980491|NCT00554229|464214906|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
128980492|NCT00554229|464214905|FG000|Overall Study|Randomised but no treatment received|1|||
128980493|NCT00554229|464214906|FG001|Overall Study|Randomised but no treatment received|0|||
128980494|NCT02828982|464214907|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
128980495|NCT02828982|464214908|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
128980496|NCT03044730|464214918|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
128718939|NCT03659916|463268904|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
128980497|NCT03044730|464214918|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
128980498|NCT03044730|464214918|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
128980499|NCT03044730|464214918|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
128980500|NCT03044730|464214918|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
128980501|NCT03044730|464214918|FG000|Cycles 4 and Beyond|Adverse Event|1|||
128980502|NCT03044730|464214918|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
128980503|NCT03044730|464214918|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
128980504|NCT03044730|464214918|FG000|On Follow-up for 2 Years|Death|17|||
128980505|NCT00690612|464216632|FG000|Overall Study|Adverse Event|1|||
128718940|NCT03659916|463268905|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
128718941|NCT00878709|463268906|FG000|Overall Study|Withdrawal by Subject|197|||
128718942|NCT00878709|463268907|FG001|Overall Study|Withdrawal by Subject|120|||
128718943|NCT00878709|463268906|FG000|Overall Study|Lost to Follow-up|35|||
128718944|NCT00878709|463268907|FG001|Overall Study|Lost to Follow-up|33|||
128718945|NCT00878709|463268906|FG000|Overall Study|Other Reasons|93|||
128718946|NCT00878709|463268907|FG001|Overall Study|Other Reasons|84|||
128718947|NCT03886220|463268910|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
128980506|NCT00690612|464216632|FG000|Overall Study|Withdrawal by Subject|2|||
128775295|NCT01474512|463468374|FG017|Long-Term Extension Period|Death|0|||
128980507|NCT00911508|464216637|FG000|Overall Study|Lost to Follow-up|27|||
128980508|NCT00911508|464216638|FG001|Overall Study|Lost to Follow-up|18|||
128980509|NCT00911508|464216637|FG000|Overall Study|Withdrawal by Subject|79|||
128980510|NCT00911508|464216638|FG001|Overall Study|Withdrawal by Subject|112|||
128980511|NCT01409382|464216639|FG000|Overall Study|Lost to Follow-up|1|||
129133578|NCT03019588|464781392|FG000|Overall Study|Study terminated by Sponsor|3|||
129133579|NCT03019588|464781393|FG001|Overall Study|Study terminated by Sponsor|1|||
129133580|NCT00887588|464781394|FG000|Core Period|Death|1|||
129133581|NCT00887588|464781395|FG001|Core Period|Death|1|||
129133582|NCT00887588|464781394|FG000|Core Period|Lost to Follow-up|3|||
129133583|NCT00887588|464781395|FG001|Core Period|Lost to Follow-up|1|||
129133584|NCT00887588|464781394|FG000|Core Period|Withdrawal by Subject|6|||
129133585|NCT00887588|464781395|FG001|Core Period|Withdrawal by Subject|8|||
129133586|NCT00887588|464781394|FG000|Core Period|Adverse Event|9|||
129133587|NCT00887588|464781395|FG001|Core Period|Adverse Event|11|||
129133588|NCT00887588|464781394|FG000|Extension Period|Adverse Event|4|||
129133589|NCT00887588|464781395|FG001|Extension Period|Adverse Event|4|||
129133590|NCT00887588|464781394|FG000|Extension Period|Death|0|||
129133591|NCT00887588|464781395|FG001|Extension Period|Death|1|||
129133592|NCT00887588|464781394|FG000|Extension Period|Protocol deviation|1|||
129133593|NCT00887588|464781395|FG001|Extension Period|Protocol deviation|0|||
129133594|NCT00887588|464781394|FG000|Extension Period|Lost to Follow-up|1|||
129133595|NCT00887588|464781395|FG001|Extension Period|Lost to Follow-up|0|||
129133596|NCT00366535|464781396|FG000|First Phase: 12 Weeks|Adverse Event|1|||
129133597|NCT00366535|464781397|FG001|First Phase: 12 Weeks|Adverse Event|3|||
129133598|NCT00366535|464781396|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
129133599|NCT00366535|464781397|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
129133600|NCT00366535|464781396|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
129133601|NCT00366535|464781397|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
129133602|NCT00366535|464781396|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
129133603|NCT00366535|464781397|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
129133604|NCT00250718|464781403|FG000|Overall Study|Death|1|||
129133605|NCT00250718|464781403|FG000|Overall Study|Adverse Event|1|||
129133606|NCT00250718|464781403|FG000|Overall Study|Withdrawal by Subject|1|||
129133607|NCT03753542|464781404|FG000|Overall Study|Lost to Follow-up|9|||
129133608|NCT03753542|464781405|FG001|Overall Study|Lost to Follow-up|14|||
129133609|NCT01301092|464781406|FG000|Overall Study|Lost to Follow-up|0|||
129133610|NCT01301092|464781407|FG001|Overall Study|Lost to Follow-up|0|||
129133611|NCT01301092|464781408|FG002|Overall Study|Lost to Follow-up|1|||
129133612|NCT00853047|464781409|FG000|Core Phase|Participant Request|0|||
129133613|NCT00853047|464781410|FG001|Core Phase|Participant Request|0|||
129133614|NCT00853047|464781411|FG002|Core Phase|Participant Request|0|||
129133615|NCT00853047|464781412|FG003|Core Phase|Participant Request|1|||
129133616|NCT00853047|464781413|FG004|Core Phase|Participant Request|0|||
129133617|NCT00853047|464781414|FG005|Core Phase|Participant Request|0|||
129133618|NCT00853047|464781409|FG000|Open-Label Extension Phase|Participant Request|0|||
129133619|NCT00853047|464781410|FG001|Open-Label Extension Phase|Participant Request|0|||
129133620|NCT00853047|464781411|FG002|Open-Label Extension Phase|Participant Request|0|||
129133621|NCT00853047|464781412|FG003|Open-Label Extension Phase|Participant Request|0|||
129133622|NCT00853047|464781413|FG004|Open-Label Extension Phase|Participant Request|0|||
129133623|NCT00853047|464781414|FG005|Open-Label Extension Phase|Participant Request|7|||
129133624|NCT00853047|464781409|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129133625|NCT00853047|464781410|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129133626|NCT00853047|464781411|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129133627|NCT00853047|464781412|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
129133628|NCT00853047|464781413|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
129133629|NCT00853047|464781414|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
129133630|NCT00853047|464781409|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129133631|NCT00853047|464781410|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129133632|NCT00853047|464781411|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129133633|NCT00853047|464781412|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129133634|NCT00853047|464781413|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129133635|NCT00853047|464781414|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
129133636|NCT00853047|464781409|FG000|Open-Label Extension Phase|Investigator Decision|0|||
129133637|NCT00853047|464781410|FG001|Open-Label Extension Phase|Investigator Decision|0|||
129133638|NCT00853047|464781411|FG002|Open-Label Extension Phase|Investigator Decision|0|||
128980512|NCT01409382|464216640|FG001|Overall Study|Lost to Follow-up|1|||
128980513|NCT01409382|464216639|FG000|Overall Study|Protocol Violation|0|||
128980514|NCT01409382|464216640|FG001|Overall Study|Protocol Violation|3|||
128980515|NCT01409382|464216639|FG000|Overall Study|Multiple pregnancy|2|||
128980516|NCT01409382|464216640|FG001|Overall Study|Multiple pregnancy|4|||
128980517|NCT01409382|464216639|FG000|Overall Study|Still pregnant when study ended|13|||
128980518|NCT01409382|464216640|FG001|Overall Study|Still pregnant when study ended|2|||
128980519|NCT01409382|464216639|FG000|Overall Study|Did not manage to get pregnant|64|||
128980520|NCT01409382|464216640|FG001|Overall Study|Did not manage to get pregnant|70|||
128980521|NCT01409382|464216639|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
128980522|NCT01409382|464216640|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
128980523|NCT01233076|464216641|FG000|Period 2, One Week|Lost to Follow-up|1|||
128980524|NCT01233076|464216642|FG001|Period 2, One Week|Lost to Follow-up|0|||
128980525|NCT01786707|464216644|FG000|Overall Study|Lost to Follow-up|1|||
128980526|NCT01786707|464216645|FG001|Overall Study|Lost to Follow-up|1|||
128980527|NCT01519700|464216646|FG000|Overall Study|Death|1|||
128980528|NCT01519700|464216647|FG001|Overall Study|Death|0|||
128980529|NCT01519700|464216648|FG002|Overall Study|Death|0|||
128980530|NCT01519700|464216649|FG003|Overall Study|Death|0|||
128980531|NCT01519700|464216646|FG000|Overall Study|Lost to Follow-up|0|||
128980532|NCT01519700|464216647|FG001|Overall Study|Lost to Follow-up|0|||
128980533|NCT01519700|464216648|FG002|Overall Study|Lost to Follow-up|1|||
128980534|NCT01519700|464216649|FG003|Overall Study|Lost to Follow-up|1|||
128980535|NCT01519700|464216646|FG000|Overall Study|Physician Decision|1|||
128980536|NCT01519700|464216647|FG001|Overall Study|Physician Decision|1|||
128980537|NCT01519700|464216648|FG002|Overall Study|Physician Decision|3|||
128980538|NCT01519700|464216649|FG003|Overall Study|Physician Decision|0|||
128980539|NCT01519700|464216646|FG000|Overall Study|Withdrawal by Subject|5|||
128980540|NCT01519700|464216647|FG001|Overall Study|Withdrawal by Subject|3|||
128980541|NCT01519700|464216648|FG002|Overall Study|Withdrawal by Subject|3|||
128980542|NCT01519700|464216649|FG003|Overall Study|Withdrawal by Subject|2|||
128980543|NCT01519700|464216646|FG000|Overall Study|Other Reason|2|||
128980544|NCT01519700|464216647|FG001|Overall Study|Other Reason|2|||
128980545|NCT01519700|464216648|FG002|Overall Study|Other Reason|0|||
128980546|NCT01519700|464216649|FG003|Overall Study|Other Reason|4|||
128980547|NCT00965458|464216655|FG000|Overall Study|Adverse Event|1|||
128980548|NCT00965458|464216656|FG001|Overall Study|Adverse Event|0|||
128980549|NCT00965458|464216655|FG000|Overall Study|Lost to Follow-up|1|||
128980550|NCT00965458|464216656|FG001|Overall Study|Lost to Follow-up|3|||
128980551|NCT00965458|464216655|FG000|Overall Study|Withdrawal by Subject|0|||
128980552|NCT00965458|464216656|FG001|Overall Study|Withdrawal by Subject|1|||
128980553|NCT03039686|464216660|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
128980554|NCT03039686|464216661|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
128980555|NCT03039686|464216662|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
128980556|NCT03039686|464216660|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
128980557|NCT03039686|464216661|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
128980558|NCT03039686|464216662|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
128980559|NCT03039686|464216660|FG000|Double-blind Period|Withdrawal by Subject|2|||
128980560|NCT03039686|464216661|FG001|Double-blind Period|Withdrawal by Subject|2|||
128980561|NCT03039686|464216662|FG002|Double-blind Period|Withdrawal by Subject|1|||
128980562|NCT03039686|464216660|FG000|Double-blind Period|Death|0|||
128980563|NCT03039686|464216661|FG001|Double-blind Period|Death|0|||
128980564|NCT03039686|464216662|FG002|Double-blind Period|Death|1|||
128980565|NCT03039686|464216660|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
128980566|NCT03039686|464216661|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
128980567|NCT03039686|464216662|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
128980568|NCT03039686|464216660|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
128980569|NCT03039686|464216661|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
128980570|NCT03039686|464216662|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
128980571|NCT03039686|464216660|FG000|Open Label Period|Withdrawal by Subject|0|||
128980572|NCT03039686|464216661|FG001|Open Label Period|Withdrawal by Subject|3|||
128980573|NCT03039686|464216662|FG002|Open Label Period|Withdrawal by Subject|1|||
128980574|NCT02158949|464216663|FG000|Overall Study|Withdrawal by Subject|1|||
128980575|NCT02158949|464216664|FG001|Overall Study|Withdrawal by Subject|0|||
128980576|NCT02158949|464216663|FG000|Overall Study|Lost to Follow-up|5|||
128980577|NCT02158949|464216664|FG001|Overall Study|Lost to Follow-up|11|||
128980578|NCT02181634|464216665|FG000|Overall Study|Lack of Efficacy|33|||
128980579|NCT02181634|464216665|FG000|Overall Study|Adverse Event|17|||
128980580|NCT02181634|464216665|FG000|Overall Study|Physician Decision|8|||
128980581|NCT02181634|464216665|FG000|Overall Study|Withdrawal by Subject|5|||
128980582|NCT02181634|464216665|FG000|Overall Study|Death|2|||
128980583|NCT02181634|464216665|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
129222743|NCT04494256|465116176|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
128980584|NCT02181634|464216665|FG000|Overall Study|Ineligible|1|||
128980585|NCT02181634|464216665|FG000|Overall Study|Max number of dose reduction|1|||
129042123|NCT00484419|464445996|FG000|Overall Study|Withdrawal by Subject|3|||
129042124|NCT00484419|464445997|FG001|Overall Study|Withdrawal by Subject|1|||
129042125|NCT00484419|464445998|FG002|Overall Study|Withdrawal by Subject|1|||
129042126|NCT00484419|464445996|FG000|Overall Study|subject met discontinuation criteria|2|||
129042127|NCT00484419|464445997|FG001|Overall Study|subject met discontinuation criteria|2|||
129042128|NCT00484419|464445998|FG002|Overall Study|subject met discontinuation criteria|4|||
129042129|NCT00484419|464445996|FG000|Overall Study|required restricted medication|1|||
129042130|NCT00484419|464445997|FG001|Overall Study|required restricted medication|0|||
129133639|NCT00853047|464781412|FG003|Open-Label Extension Phase|Investigator Decision|0|||
129133640|NCT00853047|464781413|FG004|Open-Label Extension Phase|Investigator Decision|0|||
129133641|NCT00853047|464781414|FG005|Open-Label Extension Phase|Investigator Decision|1|||
129133642|NCT00853047|464781409|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
129133643|NCT00853047|464781410|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
129133644|NCT00853047|464781411|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
129133645|NCT00853047|464781412|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
129133646|NCT00853047|464781413|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
129133647|NCT00853047|464781414|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
129133648|NCT00160615|464782893|FG000|Overall Study|Adverse Event|5|||
129133649|NCT00160615|464782894|FG001|Overall Study|Adverse Event|12|||
129133650|NCT00160615|464782893|FG000|Overall Study|Withdrawal by Subject|0|||
129133651|NCT00160615|464782894|FG001|Overall Study|Withdrawal by Subject|2|||
129133652|NCT00160615|464782893|FG000|Overall Study|Lack of Efficacy|11|||
129133653|NCT00160615|464782894|FG001|Overall Study|Lack of Efficacy|23|||
129133654|NCT00160615|464782893|FG000|Overall Study|Patient decision|1|||
129133655|NCT00160615|464782894|FG001|Overall Study|Patient decision|2|||
129133656|NCT00160615|464782893|FG000|Overall Study|Investigator decision|1|||
129133657|NCT00160615|464782894|FG001|Overall Study|Investigator decision|1|||
129133658|NCT00160615|464782893|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
129133659|NCT00160615|464782894|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
129133660|NCT00160615|464782893|FG000|Overall Study|Switch to surgical treatment|0|||
129133661|NCT00160615|464782894|FG001|Overall Study|Switch to surgical treatment|2|||
129133662|NCT00160615|464782893|FG000|Overall Study|Non-compliance was suspected|0|||
129133663|NCT00160615|464782894|FG001|Overall Study|Non-compliance was suspected|1|||
129133664|NCT00160615|464782893|FG000|Overall Study|Poor compliance|0|||
129133665|NCT00160615|464782894|FG001|Overall Study|Poor compliance|1|||
129133666|NCT03166631|464782895|FG000|Overall Study|Progressive disease|2|||
129133667|NCT03166631|464782896|FG001|Overall Study|Progressive disease|1|||
129133668|NCT03166631|464782897|FG002|Overall Study|Progressive disease|3|||
129133669|NCT03166631|464782898|FG003|Overall Study|Progressive disease|4|||
129133670|NCT03166631|464782899|FG004|Overall Study|Progressive disease|2|||
129133671|NCT03166631|464782900|FG005|Overall Study|Progressive disease|2|||
129133672|NCT03166631|464782901|FG006|Overall Study|Progressive disease|5|||
129133673|NCT03166631|464782902|FG007|Overall Study|Progressive disease|6|||
129133674|NCT03166631|464782903|FG008|Overall Study|Progressive disease|11|||
129133675|NCT03166631|464782904|FG009|Overall Study|Progressive disease|5|||
129133676|NCT03166631|464782905|FG010|Overall Study|Progressive disease|7|||
129133677|NCT03166631|464782895|FG000|Overall Study|Physician Decision|0|||
129133678|NCT03166631|464782896|FG001|Overall Study|Physician Decision|0|||
129133679|NCT03166631|464782897|FG002|Overall Study|Physician Decision|0|||
129133680|NCT03166631|464782898|FG003|Overall Study|Physician Decision|0|||
129133681|NCT03166631|464782899|FG004|Overall Study|Physician Decision|0|||
129133682|NCT03166631|464782900|FG005|Overall Study|Physician Decision|0|||
129133683|NCT03166631|464782901|FG006|Overall Study|Physician Decision|1|||
129133684|NCT03166631|464782902|FG007|Overall Study|Physician Decision|0|||
129133685|NCT03166631|464782903|FG008|Overall Study|Physician Decision|1|||
129133686|NCT03166631|464782904|FG009|Overall Study|Physician Decision|0|||
129133687|NCT03166631|464782905|FG010|Overall Study|Physician Decision|1|||
129133688|NCT03166631|464782895|FG000|Overall Study|Death|0|||
129133689|NCT03166631|464782896|FG001|Overall Study|Death|0|||
129133690|NCT03166631|464782897|FG002|Overall Study|Death|0|||
129133691|NCT03166631|464782898|FG003|Overall Study|Death|0|||
129133692|NCT03166631|464782899|FG004|Overall Study|Death|1|||
129133693|NCT03166631|464782900|FG005|Overall Study|Death|0|||
129133694|NCT03166631|464782901|FG006|Overall Study|Death|1|||
129133695|NCT03166631|464782902|FG007|Overall Study|Death|0|||
129133696|NCT03166631|464782903|FG008|Overall Study|Death|0|||
129133697|NCT03166631|464782904|FG009|Overall Study|Death|0|||
129133698|NCT03166631|464782905|FG010|Overall Study|Death|0|||
129133699|NCT03166631|464782895|FG000|Overall Study|Adverse Event|1|||
129133700|NCT03166631|464782896|FG001|Overall Study|Adverse Event|0|||
129133701|NCT03166631|464782897|FG002|Overall Study|Adverse Event|0|||
129133702|NCT03166631|464782898|FG003|Overall Study|Adverse Event|0|||
129133703|NCT03166631|464782899|FG004|Overall Study|Adverse Event|0|||
129133704|NCT03166631|464782900|FG005|Overall Study|Adverse Event|1|||
129133705|NCT03166631|464782901|FG006|Overall Study|Adverse Event|1|||
129133706|NCT03166631|464782902|FG007|Overall Study|Adverse Event|0|||
129133707|NCT03166631|464782903|FG008|Overall Study|Adverse Event|1|||
129133708|NCT03166631|464782904|FG009|Overall Study|Adverse Event|2|||
129222744|NCT04494256|465116177|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
129222745|NCT04494256|465116178|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
129222746|NCT04494256|465116172|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129222747|NCT04494256|465116173|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129222748|NCT04494256|465116174|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129222749|NCT04494256|465116175|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129222750|NCT04494256|465116176|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129222751|NCT04494256|465116177|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
129222752|NCT04494256|465116178|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
129222753|NCT02513303|465116188|FG000|Overall Study|Withdrawal by Subject|9|||
129222754|NCT02513303|465116189|FG001|Overall Study|Withdrawal by Subject|7|||
129222755|NCT02513303|465116190|FG002|Overall Study|Withdrawal by Subject|2|||
129222756|NCT02513303|465116188|FG000|Overall Study|Lost to Follow-up|2|||
129222757|NCT02513303|465116189|FG001|Overall Study|Lost to Follow-up|4|||
129222758|NCT02513303|465116190|FG002|Overall Study|Lost to Follow-up|0|||
128980586|NCT02181634|464216665|FG000|Overall Study|Symptomatic progression|1|||
128980587|NCT02181634|464216665|FG000|Overall Study|Patient opted to proceed to surgery|1|||
128980588|NCT02079077|464216669|FG000|Overall Study|Lost to Follow-up|5|||
128980589|NCT02079077|464216670|FG001|Overall Study|Lost to Follow-up|7|||
128980590|NCT02079077|464216669|FG000|Overall Study|Became STIs Positive|1|||
128980591|NCT02079077|464216670|FG001|Overall Study|Became STIs Positive|2|||
128980592|NCT00656136|464216671|FG000|Overall Study|Progressive disease|177|||
128980593|NCT00656136|464216672|FG001|Overall Study|Progressive disease|322|||
128980594|NCT00656136|464216671|FG000|Overall Study|Other Adverse Event|5|||
128980595|NCT00656136|464216672|FG001|Overall Study|Other Adverse Event|51|||
128980596|NCT00656136|464216671|FG000|Overall Study|Protocol Violation|2|||
128980597|NCT00656136|464216672|FG001|Overall Study|Protocol Violation|3|||
128980598|NCT00656136|464216671|FG000|Overall Study|Patient refused to take study medication|7|||
128980599|NCT00656136|464216672|FG001|Overall Study|Patient refused to take study medication|10|||
128980600|NCT00656136|464216671|FG000|Overall Study|Unknown and others|4|||
128980601|NCT00656136|464216672|FG001|Overall Study|Unknown and others|4|||
128980602|NCT02505945|464216673|FG000|Overall Study|Withdrawal by Subject|13|||
128980603|NCT02505945|464216674|FG001|Overall Study|Withdrawal by Subject|2|||
128980604|NCT02505945|464216673|FG000|Overall Study|Adverse Event|1|||
128980605|NCT02505945|464216674|FG001|Overall Study|Adverse Event|0|||
128980606|NCT02505945|464216673|FG000|Overall Study|Physician Decision|2|||
128980607|NCT02505945|464216674|FG001|Overall Study|Physician Decision|1|||
128980608|NCT02505945|464216673|FG000|Overall Study|Lost to Follow-up|6|||
128980609|NCT02505945|464216674|FG001|Overall Study|Lost to Follow-up|1|||
128980610|NCT01097057|464216675|FG000|Overall Study|Physician Decision|3|||
128980611|NCT02681094|464216676|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
128980612|NCT02681094|464216677|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
128980613|NCT02681094|464216678|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
128980614|NCT02681094|464216676|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
128980615|NCT02681094|464216677|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
128980616|NCT02681094|464216678|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
128980617|NCT02681094|464216676|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
128980618|NCT02681094|464216677|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
128980619|NCT02681094|464216678|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
128980620|NCT02681094|464216676|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
128980621|NCT02681094|464216677|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
128980622|NCT02681094|464216678|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
128980623|NCT02681094|464216676|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
128980624|NCT02681094|464216677|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
128980625|NCT02681094|464216678|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
128980626|NCT02681094|464216676|FG000|1 -Modified Enrolled Participants Set|Other|6|||
128980627|NCT02681094|464216677|FG001|1 -Modified Enrolled Participants Set|Other|6|||
128980628|NCT02681094|464216678|FG002|1 -Modified Enrolled Participants Set|Other|7|||
128980629|NCT02681094|464216676|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
128980630|NCT02681094|464216677|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
128980631|NCT02681094|464216678|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
128980632|NCT02681094|464216676|FG000|2 - Enrolled Participants Set|Participant decision|7|||
128980633|NCT02681094|464216677|FG001|2 - Enrolled Participants Set|Participant decision|10|||
128980634|NCT02681094|464216678|FG002|2 - Enrolled Participants Set|Participant decision|9|||
128980635|NCT02681094|464216676|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
128980636|NCT02681094|464216677|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
128980637|NCT02681094|464216678|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
128980638|NCT02681094|464216676|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
128980639|NCT02681094|464216677|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
129042131|NCT00484419|464445998|FG002|Overall Study|required restricted medication|1|||
129042132|NCT00484419|464445996|FG000|Overall Study|Physician Decision|1|||
129042133|NCT00484419|464445997|FG001|Overall Study|Physician Decision|1|||
129042134|NCT00484419|464445998|FG002|Overall Study|Physician Decision|1|||
129042135|NCT00484419|464445996|FG000|Overall Study|subject unable to receive medication|1|||
129042136|NCT00484419|464445997|FG001|Overall Study|subject unable to receive medication|0|||
129042137|NCT00484419|464445998|FG002|Overall Study|subject unable to receive medication|0|||
129042138|NCT00484419|464445996|FG000|Overall Study|subject relocated|0|||
129042139|NCT00484419|464445997|FG001|Overall Study|subject relocated|1|||
129042140|NCT00484419|464445998|FG002|Overall Study|subject relocated|0|||
129042141|NCT00484419|464445996|FG000|Overall Study|sponsor decision, randomized in error|0|||
129042142|NCT00484419|464445997|FG001|Overall Study|sponsor decision, randomized in error|0|||
129042143|NCT00484419|464445998|FG002|Overall Study|sponsor decision, randomized in error|2|||
129042144|NCT00102687|464446002|FG000|Initial Period|Withdrawal by Subject|6|||
129042145|NCT00102687|464446003|FG001|Initial Period|Withdrawal by Subject|3|||
129042146|NCT00102687|464446004|FG002|Initial Period|Withdrawal by Subject|5|||
129042147|NCT00102687|464446005|FG003|Initial Period|Withdrawal by Subject|0|||
129042148|NCT00102687|464446006|FG004|Initial Period|Withdrawal by Subject|0|||
129042149|NCT00102687|464446002|FG000|Initial Period|Adverse Event|4|||
129042150|NCT00102687|464446003|FG001|Initial Period|Adverse Event|7|||
129042151|NCT00102687|464446004|FG002|Initial Period|Adverse Event|9|||
129042152|NCT00102687|464446005|FG003|Initial Period|Adverse Event|0|||
129042153|NCT00102687|464446006|FG004|Initial Period|Adverse Event|0|||
129042154|NCT00102687|464446002|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
129222759|NCT02513303|465116188|FG000|Overall Study|Adverse Event|0|||
129222760|NCT02513303|465116189|FG001|Overall Study|Adverse Event|1|||
129222761|NCT02513303|465116190|FG002|Overall Study|Adverse Event|0|||
129042155|NCT00102687|464446003|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
129042156|NCT00102687|464446004|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
129042157|NCT00102687|464446005|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
129042158|NCT00102687|464446006|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
129042159|NCT00102687|464446002|FG000|Initial Period|Protocol Violation|0|||
129042160|NCT00102687|464446003|FG001|Initial Period|Protocol Violation|0|||
129222762|NCT02513303|465116188|FG000|Overall Study|Physician Decision|1|||
129222763|NCT02513303|465116189|FG001|Overall Study|Physician Decision|1|||
129042161|NCT00102687|464446004|FG002|Initial Period|Protocol Violation|2|||
129042162|NCT00102687|464446005|FG003|Initial Period|Protocol Violation|0|||
129042163|NCT00102687|464446006|FG004|Initial Period|Protocol Violation|0|||
129042164|NCT00102687|464446002|FG000|Initial Period|Physician Decision|2|||
129042165|NCT00102687|464446003|FG001|Initial Period|Physician Decision|9|||
129042166|NCT00102687|464446004|FG002|Initial Period|Physician Decision|6|||
129042167|NCT00102687|464446005|FG003|Initial Period|Physician Decision|0|||
129042168|NCT00102687|464446006|FG004|Initial Period|Physician Decision|0|||
129042169|NCT00102687|464446002|FG000|Initial Period|Sponsor's decision|0|||
129042170|NCT00102687|464446003|FG001|Initial Period|Sponsor's decision|1|||
129042171|NCT00102687|464446004|FG002|Initial Period|Sponsor's decision|1|||
129042172|NCT00102687|464446005|FG003|Initial Period|Sponsor's decision|0|||
129042173|NCT00102687|464446006|FG004|Initial Period|Sponsor's decision|0|||
129042174|NCT00102687|464446002|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
129042175|NCT00102687|464446003|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
129042176|NCT00102687|464446004|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
129042177|NCT00102687|464446005|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
129042178|NCT00102687|464446006|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
129222764|NCT02513303|465116190|FG002|Overall Study|Physician Decision|0|||
129222765|NCT02513303|465116188|FG000|Overall Study|Death|8|||
129222766|NCT02513303|465116189|FG001|Overall Study|Death|4|||
129222767|NCT02513303|465116190|FG002|Overall Study|Death|2|||
129222768|NCT06338462|465116199|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
129222769|NCT02720094|465116203|FG000|Overall Study|Ongoing|2210|||
129222770|NCT02720094|465116204|FG001|Overall Study|Ongoing|2203|||
129042179|NCT00102687|464446002|FG000|Initial Period|Death|1|||
129042180|NCT00102687|464446003|FG001|Initial Period|Death|1|||
129042181|NCT00102687|464446004|FG002|Initial Period|Death|1|||
129042182|NCT00102687|464446005|FG003|Initial Period|Death|0|||
129042183|NCT00102687|464446006|FG004|Initial Period|Death|0|||
129042184|NCT00102687|464446002|FG000|Maintenance Period|Withdrawal by Subject|4|||
129042185|NCT00102687|464446003|FG001|Maintenance Period|Withdrawal by Subject|0|||
129042186|NCT00102687|464446004|FG002|Maintenance Period|Withdrawal by Subject|2|||
129042187|NCT00102687|464446005|FG003|Maintenance Period|Withdrawal by Subject|3|||
129042188|NCT00102687|464446006|FG004|Maintenance Period|Withdrawal by Subject|1|||
129042189|NCT00102687|464446002|FG000|Maintenance Period|Adverse Event|1|||
129042190|NCT00102687|464446003|FG001|Maintenance Period|Adverse Event|0|||
129042191|NCT00102687|464446004|FG002|Maintenance Period|Adverse Event|0|||
129042192|NCT00102687|464446005|FG003|Maintenance Period|Adverse Event|1|||
129042193|NCT00102687|464446006|FG004|Maintenance Period|Adverse Event|3|||
129222771|NCT02720094|465116203|FG000|Overall Study|Scheduled exit visit/end of study|2|||
129042194|NCT00102687|464446002|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
129042195|NCT00102687|464446003|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
129042196|NCT00102687|464446004|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
129042197|NCT00102687|464446005|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
129042198|NCT00102687|464446006|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
129042199|NCT00102687|464446002|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
129042200|NCT00102687|464446003|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
129042201|NCT00102687|464446004|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
129042202|NCT00102687|464446005|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
129042203|NCT00102687|464446006|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
129042204|NCT00102687|464446002|FG000|Maintenance Period|Death|0|||
129042205|NCT00102687|464446003|FG001|Maintenance Period|Death|0|||
129042206|NCT00102687|464446004|FG002|Maintenance Period|Death|0|||
129042207|NCT00102687|464446005|FG003|Maintenance Period|Death|1|||
129042208|NCT00102687|464446006|FG004|Maintenance Period|Death|1|||
129042209|NCT00102687|464446002|FG000|Maintenance Period|Physician Decision|1|||
129042210|NCT00102687|464446003|FG001|Maintenance Period|Physician Decision|2|||
129042211|NCT00102687|464446004|FG002|Maintenance Period|Physician Decision|3|||
129042212|NCT00102687|464446005|FG003|Maintenance Period|Physician Decision|0|||
129042213|NCT00102687|464446006|FG004|Maintenance Period|Physician Decision|4|||
129042214|NCT00355472|464446007|FG000|Overall Study|Physician Decision|1|||
129042215|NCT03095118|464446008|FG000|Overall Study|Adverse Event|1|||
129042216|NCT03095118|464446008|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
129042217|NCT03847194|464446011|FG000|Overall Study|Lost to Follow-up|2|||
129042218|NCT03847194|464446012|FG001|Overall Study|Lost to Follow-up|5|||
129042219|NCT03847194|464446011|FG000|Overall Study|Withdrawal by Subject|1|||
129042220|NCT03847194|464446012|FG001|Overall Study|Withdrawal by Subject|2|||
129042221|NCT03847194|464446011|FG000|Overall Study|Death|0|||
129042222|NCT03847194|464446012|FG001|Overall Study|Death|1|||
129042223|NCT02408120|464446013|FG000|Overall Study|Withdrawal by Subject|0|||
129042224|NCT02408120|464446014|FG001|Overall Study|Withdrawal by Subject|1|||
129042225|NCT02408120|464446013|FG000|Overall Study|Treatment Refusal|1|||
129042226|NCT02408120|464446014|FG001|Overall Study|Treatment Refusal|0|||
129042227|NCT02408120|464446013|FG000|Overall Study|Received Steroids|1|||
129042228|NCT02408120|464446014|FG001|Overall Study|Received Steroids|1|||
129042229|NCT02408120|464446013|FG000|Overall Study|Discharged same day|1|||
129042230|NCT02408120|464446014|FG001|Overall Study|Discharged same day|1|||
129042231|NCT02408120|464446013|FG000|Overall Study|Did not receive insulin|1|||
129042232|NCT02408120|464446014|FG001|Overall Study|Did not receive insulin|2|||
129042233|NCT00351351|464446015|FG000|Overall Study|surgical access pbs; device issues|9|||
129042234|NCT00351351|464446016|FG001|Overall Study|surgical access pbs; device issues|4|||
129042235|NCT01341587|464446017|FG000|Overall Study|Lost to Follow-up|2|||
129042236|NCT01341587|464446018|FG001|Overall Study|Lost to Follow-up|0|||
129042237|NCT01341587|464446017|FG000|Overall Study|stopped using the meters|2|||
129042238|NCT01341587|464446018|FG001|Overall Study|stopped using the meters|10|||
129042239|NCT00680186|464446021|FG000|Overall Study|Adverse Event|47|||
129042240|NCT00680186|464446022|FG001|Overall Study|Adverse Event|44|||
129042241|NCT00680186|464446021|FG000|Overall Study|Protocol Violation|31|||
129042242|NCT00680186|464446022|FG001|Overall Study|Protocol Violation|26|||
129042243|NCT00680186|464446021|FG000|Overall Study|Lost to Follow-up|11|||
129042244|NCT00680186|464446022|FG001|Overall Study|Lost to Follow-up|6|||
129042245|NCT00680186|464446021|FG000|Overall Study|Withdrawal by Subject|32|||
129042246|NCT00680186|464446022|FG001|Overall Study|Withdrawal by Subject|39|||
129042247|NCT00680186|464446021|FG000|Overall Study|Other|4|||
128775296|NCT01474512|463468357|FG000|Long-Term Extension Period|Sponsor Decision|0|||
129042248|NCT00680186|464446022|FG001|Overall Study|Other|1|||
129042249|NCT04403763|464446023|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
129133709|NCT03166631|464782905|FG010|Overall Study|Adverse Event|1|||
129133710|NCT03166631|464782895|FG000|Overall Study|Withdrawal by Subject|0|||
129133711|NCT03166631|464782896|FG001|Overall Study|Withdrawal by Subject|0|||
129133712|NCT03166631|464782897|FG002|Overall Study|Withdrawal by Subject|0|||
129133713|NCT03166631|464782898|FG003|Overall Study|Withdrawal by Subject|0|||
129133714|NCT03166631|464782899|FG004|Overall Study|Withdrawal by Subject|0|||
129133715|NCT03166631|464782900|FG005|Overall Study|Withdrawal by Subject|0|||
129133716|NCT03166631|464782901|FG006|Overall Study|Withdrawal by Subject|0|||
129133717|NCT03166631|464782902|FG007|Overall Study|Withdrawal by Subject|0|||
129042250|NCT04403763|464446024|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
129042251|NCT04403763|464446025|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
129042252|NCT04403763|464446026|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
129042253|NCT04403763|464446027|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
129042254|NCT04403763|464446028|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
129042255|NCT04403763|464446029|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
129042256|NCT04403763|464446023|FG000|Stage 1|Early termination due to PK tube failure|0|||
129133718|NCT03166631|464782903|FG008|Overall Study|Withdrawal by Subject|1|||
128775297|NCT01474512|463468358|FG001|Long-Term Extension Period|Sponsor Decision|0|||
128980640|NCT02681094|464216678|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
128980641|NCT02681094|464216676|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
128980642|NCT02681094|464216677|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
128980643|NCT02681094|464216678|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
128980644|NCT02681094|464216676|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
128980645|NCT02681094|464216677|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
128980646|NCT02681094|464216678|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
128980647|NCT02681094|464216676|FG000|2 - Enrolled Participants Set|Other|6|||
128980648|NCT02681094|464216677|FG001|2 - Enrolled Participants Set|Other|6|||
128980649|NCT02681094|464216678|FG002|2 - Enrolled Participants Set|Other|7|||
128980650|NCT02681094|464216676|FG000|2 - Enrolled Participants Set|No treatment given|0|||
128980651|NCT02681094|464216677|FG001|2 - Enrolled Participants Set|No treatment given|1|||
128980652|NCT02681094|464216678|FG002|2 - Enrolled Participants Set|No treatment given|1|||
128980653|NCT01270139|464216679|FG000|Overall Study|Adverse Event|8|||
128980654|NCT01270139|464216680|FG001|Overall Study|Adverse Event|17|||
128980655|NCT01270139|464216681|FG002|Overall Study|Adverse Event|18|||
128980656|NCT01270139|464216679|FG000|Overall Study|Lost to Follow-up|10|||
128980657|NCT01270139|464216680|FG001|Overall Study|Lost to Follow-up|9|||
128980658|NCT01270139|464216681|FG002|Overall Study|Lost to Follow-up|2|||
128980659|NCT00134563|464216684|FG000|Overall Study|Not treated due to protocol violation|0|||
128980660|NCT00134563|464216685|FG001|Overall Study|Not treated due to protocol violation|1|||
128980661|NCT00134563|464216686|FG002|Overall Study|Not treated due to protocol violation|1|||
128980662|NCT00134563|464216684|FG000|Overall Study|Adverse Event|29|||
128980663|NCT00134563|464216685|FG001|Overall Study|Adverse Event|37|||
128980664|NCT00134563|464216686|FG002|Overall Study|Adverse Event|38|||
128980665|NCT00134563|464216684|FG000|Overall Study|Lack of Efficacy|24|||
128980666|NCT00134563|464216685|FG001|Overall Study|Lack of Efficacy|14|||
128980667|NCT00134563|464216686|FG002|Overall Study|Lack of Efficacy|17|||
128980668|NCT00134563|464216684|FG000|Overall Study|Protocol Violation|3|||
128980669|NCT00134563|464216685|FG001|Overall Study|Protocol Violation|2|||
128980670|NCT00134563|464216686|FG002|Overall Study|Protocol Violation|5|||
128980671|NCT00134563|464216684|FG000|Overall Study|Lost to Follow-up|4|||
128980672|NCT00134563|464216685|FG001|Overall Study|Lost to Follow-up|0|||
128980673|NCT00134563|464216686|FG002|Overall Study|Lost to Follow-up|2|||
128980674|NCT00134563|464216684|FG000|Overall Study|progressive disease|11|||
128980675|NCT00134563|464216685|FG001|Overall Study|progressive disease|4|||
128980676|NCT00134563|464216686|FG002|Overall Study|progressive disease|2|||
128980677|NCT00134563|464216684|FG000|Overall Study|did not wish to continue|33|||
128980678|NCT00134563|464216685|FG001|Overall Study|did not wish to continue|32|||
128980679|NCT00134563|464216686|FG002|Overall Study|did not wish to continue|26|||
128980680|NCT00134563|464216684|FG000|Overall Study|Reason other than above|0|||
128980681|NCT00134563|464216685|FG001|Overall Study|Reason other than above|2|||
128980682|NCT00134563|464216686|FG002|Overall Study|Reason other than above|5|||
128980683|NCT03382639|464216687|FG000|Overall Study|Adverse Event|2|||
128980684|NCT03382639|464216688|FG001|Overall Study|Adverse Event|0|||
128980685|NCT03382639|464216689|FG002|Overall Study|Adverse Event|1|||
128980686|NCT03382639|464216690|FG003|Overall Study|Adverse Event|1|||
128980687|NCT03382639|464216687|FG000|Overall Study|Lost to Follow-up|1|||
128980688|NCT03382639|464216688|FG001|Overall Study|Lost to Follow-up|0|||
128980689|NCT03382639|464216689|FG002|Overall Study|Lost to Follow-up|0|||
128980690|NCT03382639|464216690|FG003|Overall Study|Lost to Follow-up|0|||
128980691|NCT03382639|464216687|FG000|Overall Study|Withdrawal by Subject|4|||
128980692|NCT03382639|464216688|FG001|Overall Study|Withdrawal by Subject|3|||
128980693|NCT03382639|464216689|FG002|Overall Study|Withdrawal by Subject|2|||
128980694|NCT03382639|464216690|FG003|Overall Study|Withdrawal by Subject|3|||
128980695|NCT03382639|464216687|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
128980696|NCT03382639|464216688|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
128980697|NCT03382639|464216689|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
128980698|NCT03382639|464216690|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
128980699|NCT03382639|464216687|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
128980700|NCT03382639|464216688|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
128980701|NCT03382639|464216689|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
128980702|NCT03382639|464216690|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
128980703|NCT03382639|464216687|FG000|Overall Study|Other|2|||
128980704|NCT03382639|464216688|FG001|Overall Study|Other|0|||
128980705|NCT03382639|464216689|FG002|Overall Study|Other|0|||
129133719|NCT03166631|464782904|FG009|Overall Study|Withdrawal by Subject|1|||
129133720|NCT03166631|464782905|FG010|Overall Study|Withdrawal by Subject|0|||
129133721|NCT00284934|464782908|FG000|Overall Study|Adverse Event|1|||
129133722|NCT00284934|464782909|FG001|Overall Study|Adverse Event|2|||
129133723|NCT00284934|464782908|FG000|Overall Study|Other reasons|3|||
128980706|NCT03382639|464216690|FG003|Overall Study|Other|3|||
128980707|NCT02406586|464216691|FG000|Overall Study|Lost to Follow-up|0|||
128980708|NCT02406586|464216692|FG001|Overall Study|Lost to Follow-up|4|||
129042257|NCT04403763|464446024|FG001|Stage 1|Early termination due to PK tube failure|0|||
129042258|NCT04403763|464446025|FG002|Stage 1|Early termination due to PK tube failure|1|||
129042259|NCT04403763|464446026|FG003|Stage 1|Early termination due to PK tube failure|0|||
129042260|NCT04403763|464446027|FG004|Stage 1|Early termination due to PK tube failure|0|||
129042261|NCT04403763|464446028|FG005|Stage 1|Early termination due to PK tube failure|0|||
129042262|NCT04403763|464446029|FG006|Stage 1|Early termination due to PK tube failure|0|||
129042263|NCT04403763|464446023|FG000|Stage 2A|Adverse Event|0|||
129042264|NCT04403763|464446024|FG001|Stage 2A|Adverse Event|0|||
129042265|NCT04403763|464446025|FG002|Stage 2A|Adverse Event|0|||
129042266|NCT04403763|464446026|FG003|Stage 2A|Adverse Event|0|||
129042267|NCT04403763|464446027|FG004|Stage 2A|Adverse Event|0|||
129042268|NCT04403763|464446028|FG005|Stage 2A|Adverse Event|0|||
129042269|NCT04403763|464446029|FG006|Stage 2A|Adverse Event|1|||
129042270|NCT02470091|464446030|FG000|Overall Study|Withdrawal by Subject|1|||
129042271|NCT02470091|464446031|FG001|Overall Study|Withdrawal by Subject|0|||
129042272|NCT02470091|464446030|FG000|Overall Study|Ineligible|0|||
129042273|NCT02470091|464446031|FG001|Overall Study|Ineligible|2|||
129042274|NCT00606502|464446033|FG000|Randomization|Randomized but not treated|3|||
129042275|NCT00606502|464446034|FG001|Randomization|Randomized but not treated|0|||
129042276|NCT00606502|464446033|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
129042277|NCT00606502|464446034|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
129042278|NCT02083926|464446037|FG000|Overall Study|Withdrawal by Subject|1|||
129042279|NCT02083926|464446038|FG001|Overall Study|Withdrawal by Subject|0|||
129042280|NCT02697773|464446039|FG000|Overall Study|Adverse Event|2|||
129042281|NCT02697773|464446040|FG001|Overall Study|Adverse Event|1|||
129042282|NCT02697773|464446041|FG002|Overall Study|Adverse Event|2|||
129042283|NCT02697773|464446039|FG000|Overall Study|Death|0|||
129042284|NCT02697773|464446040|FG001|Overall Study|Death|0|||
129042285|NCT02697773|464446041|FG002|Overall Study|Death|2|||
129042286|NCT02697773|464446039|FG000|Overall Study|Lack of Efficacy|4|||
129042287|NCT02697773|464446040|FG001|Overall Study|Lack of Efficacy|6|||
129042288|NCT02697773|464446041|FG002|Overall Study|Lack of Efficacy|6|||
129042289|NCT02697773|464446039|FG000|Overall Study|Lost to Follow-up|5|||
129042290|NCT02697773|464446040|FG001|Overall Study|Lost to Follow-up|5|||
129042291|NCT02697773|464446041|FG002|Overall Study|Lost to Follow-up|7|||
129042292|NCT02697773|464446039|FG000|Overall Study|Other|15|||
129042293|NCT02697773|464446040|FG001|Overall Study|Other|11|||
129042294|NCT02697773|464446041|FG002|Overall Study|Other|10|||
129042295|NCT02697773|464446039|FG000|Overall Study|Protocol Violation|1|||
129042296|NCT02697773|464446040|FG001|Overall Study|Protocol Violation|1|||
129042297|NCT02697773|464446041|FG002|Overall Study|Protocol Violation|0|||
129042298|NCT02697773|464446039|FG000|Overall Study|Withdrawal by Subject|10|||
129042299|NCT02697773|464446040|FG001|Overall Study|Withdrawal by Subject|13|||
129042300|NCT02697773|464446041|FG002|Overall Study|Withdrawal by Subject|13|||
129042301|NCT02697773|464446039|FG000|Overall Study|Randomized but not treated|1|||
129042302|NCT02697773|464446040|FG001|Overall Study|Randomized but not treated|1|||
129042303|NCT02697773|464446041|FG002|Overall Study|Randomized but not treated|0|||
129042304|NCT00613834|464446042|FG000|Overall Study|Withdrawal by Subject|0|||
129042305|NCT00613834|464446043|FG001|Overall Study|Withdrawal by Subject|3|||
129042306|NCT01118117|464446046|FG000|Overall Study|Death|8|||
129133724|NCT00284934|464782909|FG001|Overall Study|Other reasons|1|||
129133725|NCT03309605|464782914|FG000|Overall Study|Adverse Event|0|||
129133726|NCT03309605|464782915|FG001|Overall Study|Adverse Event|0|||
129133727|NCT03309605|464782916|FG002|Overall Study|Adverse Event|0|||
129133728|NCT03309605|464782917|FG003|Overall Study|Adverse Event|1|||
129133729|NCT03309605|464782918|FG004|Overall Study|Adverse Event|0|||
129133730|NCT03309605|464782919|FG005|Overall Study|Adverse Event|0|||
129133731|NCT03309605|464782920|FG006|Overall Study|Adverse Event|2|||
129133732|NCT03309605|464782921|FG007|Overall Study|Adverse Event|1|||
129133733|NCT03309605|464782914|FG000|Overall Study|Withdrawal by Subject|0|||
129133734|NCT03309605|464782915|FG001|Overall Study|Withdrawal by Subject|0|||
129133735|NCT03309605|464782916|FG002|Overall Study|Withdrawal by Subject|0|||
128775298|NCT01474512|463468359|FG002|Long-Term Extension Period|Sponsor Decision|0|||
128775299|NCT01474512|463468360|FG003|Long-Term Extension Period|Sponsor Decision|0|||
128775300|NCT01474512|463468361|FG004|Long-Term Extension Period|Sponsor Decision|0|||
128775301|NCT01474512|463468362|FG005|Long-Term Extension Period|Sponsor Decision|0|||
129042307|NCT01118117|464446047|FG001|Overall Study|Death|0|||
129042308|NCT01118117|464446046|FG000|Overall Study|Lost to Follow-up|6|||
129042309|NCT01118117|464446047|FG001|Overall Study|Lost to Follow-up|0|||
129133736|NCT03309605|464782917|FG003|Overall Study|Withdrawal by Subject|0|||
129133737|NCT03309605|464782918|FG004|Overall Study|Withdrawal by Subject|1|||
129042310|NCT01118117|464446046|FG000|Overall Study|Missed 12 Month Visit|7|||
129042311|NCT01118117|464446047|FG001|Overall Study|Missed 12 Month Visit|0|||
129042312|NCT02985879|464446054|FG000|Overall Study|Adverse Event|7|||
129042313|NCT02985879|464446055|FG001|Overall Study|Adverse Event|9|||
129042314|NCT02985879|464446056|FG002|Overall Study|Adverse Event|7|||
129042315|NCT02985879|464446054|FG000|Overall Study|Withdrew consent|6|||
129042316|NCT02985879|464446055|FG001|Overall Study|Withdrew consent|8|||
129042317|NCT02985879|464446056|FG002|Overall Study|Withdrew consent|10|||
128718948|NCT03886220|463268911|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
128718949|NCT03886220|463268910|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
128718950|NCT03886220|463268911|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
128718951|NCT03886220|463268910|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
128718952|NCT03886220|463268911|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
128980709|NCT02406586|464216693|FG002|Overall Study|Lost to Follow-up|2|||
128980710|NCT02406586|464216691|FG000|Overall Study|Withdrawal by Subject|1|||
128980711|NCT02406586|464216692|FG001|Overall Study|Withdrawal by Subject|0|||
128980712|NCT02406586|464216693|FG002|Overall Study|Withdrawal by Subject|0|||
128980713|NCT00682539|464216696|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
128980714|NCT00682539|464216697|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
128980715|NCT00682539|464216698|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
128980716|NCT00682539|464216696|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
128980717|NCT00682539|464216697|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
128980718|NCT00682539|464216698|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
128980719|NCT02477215|464216701|FG000|Dose Escalation Phase|Physician Decision|1|||
128980720|NCT02477215|464216702|FG001|Dose Escalation Phase|Physician Decision|2|||
128980721|NCT02477215|464216703|FG002|Dose Escalation Phase|Physician Decision|0|||
128980722|NCT02477215|464216701|FG000|Fixed Dose Phase|Physician Decision|0|||
128980723|NCT02477215|464216702|FG001|Fixed Dose Phase|Physician Decision|7|||
128980724|NCT02477215|464216703|FG002|Fixed Dose Phase|Physician Decision|0|||
128980725|NCT01911546|464216706|FG000|Overall Study|Lost to Follow-up|1|||
128980726|NCT01911546|464216706|FG000|Overall Study|Everolimus was discontinued|5|||
128980727|NCT02210559|464216707|FG000|Overall Study|Progressive Disease|3|||
128980728|NCT02210559|464216708|FG001|Overall Study|Progressive Disease|2|||
128980729|NCT02210559|464216707|FG000|Overall Study|Adverse Event|2|||
128980730|NCT02210559|464216708|FG001|Overall Study|Adverse Event|2|||
128980731|NCT02210559|464216707|FG000|Overall Study|Physician Decision|1|||
128980732|NCT02210559|464216708|FG001|Overall Study|Physician Decision|0|||
128980733|NCT02210559|464216707|FG000|Overall Study|Withdrawal by Subject|0|||
128980734|NCT02210559|464216708|FG001|Overall Study|Withdrawal by Subject|1|||
128980735|NCT02210559|464216707|FG000|Overall Study|Other than specified|0|||
128980736|NCT02210559|464216708|FG001|Overall Study|Other than specified|1|||
128980737|NCT02546193|464216709|FG000|Overall Study|Withdrawal by Subject|2|||
128980738|NCT02546193|464216710|FG001|Overall Study|Withdrawal by Subject|0|||
128980739|NCT02546193|464216711|FG002|Overall Study|Withdrawal by Subject|1|||
128980740|NCT02546193|464216712|FG003|Overall Study|Withdrawal by Subject|0|||
128980741|NCT02546193|464216709|FG000|Overall Study|Not eligible at time of induction|4|||
128980742|NCT02546193|464216710|FG001|Overall Study|Not eligible at time of induction|6|||
128980743|NCT02546193|464216711|FG002|Overall Study|Not eligible at time of induction|1|||
128980744|NCT02546193|464216712|FG003|Overall Study|Not eligible at time of induction|0|||
128980745|NCT01474291|464216713|FG000|Overall Study|Not Evaluable for Efficacy|26|||
128980746|NCT01474291|464216713|FG000|Overall Study|Lack of Treatment Efficacy|88|||
128980747|NCT01474291|464216713|FG000|Overall Study|Adverse Event|53|||
128980748|NCT01474291|464216713|FG000|Overall Study|Lost to Follow-up|29|||
128980749|NCT01474291|464216713|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
128980750|NCT01474291|464216713|FG000|Overall Study|No Reason Reported|10|||
128980751|NCT01474291|464216713|FG000|Overall Study|Death|2|||
128980752|NCT00310440|464216714|FG000|Overall Study|Lost to Follow-up|17|||
128980753|NCT00310440|464216715|FG001|Overall Study|Lost to Follow-up|8|||
128980754|NCT00310440|464216714|FG000|Overall Study|Withdrawal by Subject|2|||
128980755|NCT00310440|464216715|FG001|Overall Study|Withdrawal by Subject|1|||
128980756|NCT00310440|464216714|FG000|Overall Study|Missed 12 Month Visit|7|||
128980757|NCT00310440|464216715|FG001|Overall Study|Missed 12 Month Visit|4|||
128980758|NCT01287403|464216716|FG000|1st Intervention (1 Day)|Adverse Event|1|||
128980759|NCT00148109|464216717|FG000|Overall Study|Lack of Efficacy|10|||
128980760|NCT00148109|464216718|FG001|Overall Study|Lack of Efficacy|18|||
128980761|NCT00148109|464216717|FG000|Overall Study|Adverse Event|0|||
128980762|NCT00148109|464216718|FG001|Overall Study|Adverse Event|2|||
128980763|NCT00148109|464216717|FG000|Overall Study|Withdrawal by Subject|2|||
128980764|NCT00148109|464216718|FG001|Overall Study|Withdrawal by Subject|0|||
129042318|NCT02985879|464446054|FG000|Overall Study|Lost to Follow-up|1|||
129042319|NCT02985879|464446055|FG001|Overall Study|Lost to Follow-up|0|||
128980765|NCT01098266|464216719|FG000|Overall Study|Physician Decision|1|||
128980766|NCT01098266|464216720|FG001|Overall Study|Physician Decision|0|||
129042320|NCT02985879|464446056|FG002|Overall Study|Lost to Follow-up|2|||
129042321|NCT02985879|464446054|FG000|Overall Study|Other, not specified|62|||
128980767|NCT01098266|464216719|FG000|Overall Study|Death|3|||
128980768|NCT01098266|464216720|FG001|Overall Study|Death|2|||
128980769|NCT01098266|464216719|FG000|Overall Study|Withdrawal by Subject|3|||
128980770|NCT01098266|464216720|FG001|Overall Study|Withdrawal by Subject|5|||
128980771|NCT00525499|464216724|FG000|Overall Study|Lost to Follow-up|2|||
129042322|NCT02985879|464446055|FG001|Overall Study|Other, not specified|58|||
128718953|NCT00768300|463268914|FG000|Overall Study|Randomized but not treated|1|||
128980772|NCT00525499|464216725|FG001|Overall Study|Lost to Follow-up|4|||
129042323|NCT02985879|464446056|FG002|Overall Study|Other, not specified|58|||
129042324|NCT01592721|464448500|FG000|Long-term Follow-up|Death|1|||
129042325|NCT02698865|464448508|FG000|Overall Study|Other|11|||
129042326|NCT02698865|464448509|FG001|Overall Study|Other|11|||
129042327|NCT02698865|464448508|FG000|Overall Study|Withdrawal by Subject|20|||
129042328|NCT02698865|464448509|FG001|Overall Study|Withdrawal by Subject|16|||
129042329|NCT02698865|464448508|FG000|Overall Study|Physician Decision|0|||
129042330|NCT02698865|464448509|FG001|Overall Study|Physician Decision|4|||
129042331|NCT02698865|464448508|FG000|Overall Study|Lost to Follow-up|4|||
129042332|NCT02698865|464448509|FG001|Overall Study|Lost to Follow-up|2|||
129042333|NCT03861481|464448510|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
129042334|NCT03861481|464448511|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
129042335|NCT03861481|464448510|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
129042336|NCT03861481|464448511|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
129042337|NCT03861481|464448510|FG000|Overall Study|Relapse|1|||
129042338|NCT03861481|464448511|FG001|Overall Study|Relapse|0|||
129042339|NCT03861481|464448510|FG000|Overall Study|Withdrawal by Subject|0|||
129042340|NCT03861481|464448511|FG001|Overall Study|Withdrawal by Subject|1|||
129042341|NCT03861481|464448510|FG000|Overall Study|Lack of Efficacy|4|||
129042342|NCT03861481|464448511|FG001|Overall Study|Lack of Efficacy|5|||
129042343|NCT00773734|464448512|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
129042344|NCT00773734|464448513|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
129042345|NCT00773734|464448514|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
129042346|NCT00773734|464448515|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
129042347|NCT00773734|464448516|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
129042348|NCT00773734|464448517|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
129042349|NCT00773734|464448512|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
129042350|NCT00773734|464448513|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
129042351|NCT00773734|464448514|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
129042352|NCT00773734|464448515|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
129042353|NCT00773734|464448516|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
129042354|NCT00773734|464448517|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
129042355|NCT00773734|464448512|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
129042356|NCT00773734|464448513|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
129042357|NCT00773734|464448514|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
129042358|NCT00773734|464448515|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
129042359|NCT00773734|464448516|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129042360|NCT00773734|464448517|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129042361|NCT00773734|464448512|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
129042362|NCT00773734|464448513|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129042363|NCT00773734|464448514|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129042364|NCT00773734|464448515|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129042365|NCT00773734|464448516|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129042366|NCT00773734|464448517|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129042367|NCT00773734|464448512|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
129042368|NCT00773734|464448513|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129042369|NCT00773734|464448514|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129042370|NCT00773734|464448515|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
129042371|NCT00773734|464448516|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129042372|NCT00773734|464448517|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129042373|NCT00773734|464448512|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
129042374|NCT00773734|464448513|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
129042375|NCT00773734|464448514|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
129042376|NCT00773734|464448515|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
129042377|NCT00773734|464448516|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
129042378|NCT00773734|464448517|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
129042379|NCT00773734|464448512|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129042380|NCT00773734|464448513|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129042381|NCT00773734|464448514|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129042382|NCT00773734|464448515|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129042383|NCT00773734|464448516|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
129042384|NCT00773734|464448517|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
129222772|NCT02720094|465116204|FG001|Overall Study|Scheduled exit visit/end of study|1|||
128718954|NCT00768300|463268915|FG001|Overall Study|Randomized but not treated|1|||
129222773|NCT02720094|465116203|FG000|Overall Study|Death|4|||
129222774|NCT02720094|465116204|FG001|Overall Study|Death|7|||
128718955|NCT00768300|463268914|FG000|Overall Study|Adverse Event|10|||
128718956|NCT00768300|463268915|FG001|Overall Study|Adverse Event|2|||
128718957|NCT00768300|463268914|FG000|Overall Study|Protocol Violation|6|||
129042385|NCT00773734|464448512|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
128980773|NCT00525499|464216726|FG002|Overall Study|Lost to Follow-up|1|||
128980774|NCT00525499|464216727|FG003|Overall Study|Lost to Follow-up|4|||
128980775|NCT00525499|464216724|FG000|Overall Study|Adverse Event|0|||
128980776|NCT00525499|464216725|FG001|Overall Study|Adverse Event|1|||
128980777|NCT00525499|464216726|FG002|Overall Study|Adverse Event|0|||
128980778|NCT00525499|464216727|FG003|Overall Study|Adverse Event|1|||
128980779|NCT00525499|464216724|FG000|Overall Study|Withdrawal by Subject|5|||
128980780|NCT00525499|464216725|FG001|Overall Study|Withdrawal by Subject|1|||
128980781|NCT00525499|464216726|FG002|Overall Study|Withdrawal by Subject|5|||
128980782|NCT00525499|464216727|FG003|Overall Study|Withdrawal by Subject|2|||
128980783|NCT00525499|464216724|FG000|Overall Study|Protocol Violation|0|||
128980784|NCT00525499|464216725|FG001|Overall Study|Protocol Violation|1|||
128980785|NCT00525499|464216726|FG002|Overall Study|Protocol Violation|1|||
128980786|NCT00525499|464216727|FG003|Overall Study|Protocol Violation|0|||
128980787|NCT00438815|464216728|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
128980788|NCT00438815|464216728|FG000|Overall Study|3-month follow-up no longer required|12|||
128980789|NCT00438815|464216728|FG000|Overall Study|Noncompliance with protocol requirements|9|||
128980790|NCT00438815|464216728|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
128980791|NCT00438815|464216728|FG000|Overall Study|Lost to Follow-up|6|||
128980792|NCT00438815|464216728|FG000|Overall Study|Withdrawal by Subject|6|||
128980793|NCT00438815|464216728|FG000|Overall Study|Death|1|||
128980794|NCT01733758|464216731|FG000|Overall Study|Adverse Event|5|||
128980795|NCT01733758|464216732|FG001|Overall Study|Adverse Event|7|||
128980796|NCT01733758|464216733|FG002|Overall Study|Adverse Event|8|||
128980797|NCT01733758|464216734|FG003|Overall Study|Adverse Event|1|||
128980798|NCT01733758|464216731|FG000|Overall Study|Withdrawal by Subject|1|||
128980799|NCT01733758|464216732|FG001|Overall Study|Withdrawal by Subject|1|||
128980800|NCT01733758|464216733|FG002|Overall Study|Withdrawal by Subject|5|||
128980801|NCT01733758|464216734|FG003|Overall Study|Withdrawal by Subject|3|||
128980802|NCT01733758|464216731|FG000|Overall Study|Persistent Hyperglycemia|3|||
128980803|NCT01733758|464216732|FG001|Overall Study|Persistent Hyperglycemia|2|||
128980804|NCT01733758|464216733|FG002|Overall Study|Persistent Hyperglycemia|0|||
128980805|NCT01733758|464216734|FG003|Overall Study|Persistent Hyperglycemia|0|||
128980806|NCT01733758|464216731|FG000|Overall Study|Protocol Violation|0|||
128980807|NCT01733758|464216732|FG001|Overall Study|Protocol Violation|1|||
128980808|NCT01733758|464216733|FG002|Overall Study|Protocol Violation|2|||
128980809|NCT01733758|464216734|FG003|Overall Study|Protocol Violation|2|||
128980810|NCT01733758|464216731|FG000|Overall Study|Non-compliance|1|||
128980811|NCT01733758|464216732|FG001|Overall Study|Non-compliance|0|||
128980812|NCT01733758|464216733|FG002|Overall Study|Non-compliance|0|||
128980813|NCT01733758|464216734|FG003|Overall Study|Non-compliance|0|||
128980814|NCT01733758|464216731|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
128980815|NCT01733758|464216732|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
128980816|NCT01733758|464216733|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
128980817|NCT01733758|464216734|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
128980818|NCT01733758|464216731|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
128980819|NCT01733758|464216732|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
128980820|NCT01733758|464216733|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
128980821|NCT01733758|464216734|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
128980822|NCT03380091|464216740|FG000|Overall Study|Withdrawal by Subject|2|||
128980823|NCT03380091|464216741|FG001|Overall Study|Withdrawal by Subject|1|||
128980824|NCT05602818|464216742|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
128980825|NCT05602818|464216743|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
128980826|NCT05602818|464216744|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
128980827|NCT05602818|464216745|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
128980828|NCT05602818|464216746|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
128980829|NCT05602818|464216747|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
128980830|NCT05602818|464216748|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
128980831|NCT05602818|464216749|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
128980832|NCT05602818|464216750|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
128980833|NCT05602818|464216751|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
128980834|NCT05602818|464216752|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
128980835|NCT05602818|464216753|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
128980836|NCT05602818|464216742|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
128980837|NCT05602818|464216743|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
128980838|NCT05602818|464216744|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980839|NCT05602818|464216745|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980840|NCT05602818|464216746|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980841|NCT05602818|464216747|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980842|NCT05602818|464216748|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129042386|NCT00773734|464448513|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
128980843|NCT05602818|464216749|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128718958|NCT00768300|463268915|FG001|Overall Study|Protocol Violation|1|||
128718959|NCT00768300|463268914|FG000|Overall Study|Withdrawal by Subject|13|||
128718960|NCT00768300|463268915|FG001|Overall Study|Withdrawal by Subject|7|||
128718961|NCT00768300|463268914|FG000|Overall Study|Physician Decision|2|||
128718962|NCT00768300|463268915|FG001|Overall Study|Physician Decision|3|||
128980844|NCT05602818|464216750|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980845|NCT05602818|464216751|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980846|NCT05602818|464216752|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980847|NCT05602818|464216753|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
128980848|NCT05602818|464216742|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
128980849|NCT05602818|464216743|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980850|NCT05602818|464216744|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980851|NCT05602818|464216745|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980852|NCT05602818|464216746|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980853|NCT05602818|464216747|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980854|NCT05602818|464216748|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980855|NCT05602818|464216749|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980856|NCT05602818|464216750|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980857|NCT05602818|464216751|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980858|NCT05602818|464216752|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980859|NCT05602818|464216753|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
128980860|NCT05602818|464216742|FG000|Qualification Phase (3 Days)|Other|1|||
128980861|NCT05602818|464216743|FG001|Qualification Phase (3 Days)|Other|0|||
128980862|NCT05602818|464216744|FG002|Qualification Phase (3 Days)|Other|0|||
128980863|NCT05602818|464216745|FG003|Qualification Phase (3 Days)|Other|0|||
128980864|NCT05602818|464216746|FG004|Qualification Phase (3 Days)|Other|0|||
128980865|NCT05602818|464216747|FG005|Qualification Phase (3 Days)|Other|0|||
128980866|NCT05602818|464216748|FG006|Qualification Phase (3 Days)|Other|0|||
128980867|NCT05602818|464216749|FG007|Qualification Phase (3 Days)|Other|0|||
128980868|NCT05602818|464216750|FG008|Qualification Phase (3 Days)|Other|0|||
128980869|NCT05602818|464216751|FG009|Qualification Phase (3 Days)|Other|0|||
128980870|NCT05602818|464216752|FG010|Qualification Phase (3 Days)|Other|0|||
128980871|NCT05602818|464216753|FG011|Qualification Phase (3 Days)|Other|0|||
128980872|NCT05602818|464216742|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980873|NCT05602818|464216743|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
128980874|NCT05602818|464216744|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980875|NCT05602818|464216745|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980876|NCT05602818|464216746|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980877|NCT05602818|464216747|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980878|NCT05602818|464216748|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980879|NCT05602818|464216749|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980880|NCT05602818|464216750|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980881|NCT05602818|464216751|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
128980882|NCT05602818|464216752|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129133738|NCT03309605|464782919|FG005|Overall Study|Withdrawal by Subject|0|||
129133739|NCT03309605|464782920|FG006|Overall Study|Withdrawal by Subject|1|||
129133740|NCT03309605|464782921|FG007|Overall Study|Withdrawal by Subject|1|||
129133741|NCT03197935|464782922|FG000|Overall Study|Death due to any cause|26|||
129133742|NCT03197935|464782923|FG001|Overall Study|Death due to any cause|15|||
129133743|NCT03197935|464782922|FG000|Overall Study|Lost to Follow-up|3|||
129133744|NCT03197935|464782923|FG001|Overall Study|Lost to Follow-up|5|||
129133745|NCT03197935|464782922|FG000|Overall Study|Physician Decision|2|||
129133746|NCT03197935|464782923|FG001|Overall Study|Physician Decision|1|||
129133747|NCT03197935|464782922|FG000|Overall Study|Withdrawal by Subject|16|||
129133748|NCT03197935|464782923|FG001|Overall Study|Withdrawal by Subject|8|||
129133749|NCT00864513|464782924|FG000|Overall Study|Withdrawal by Subject|3|||
129133750|NCT05938010|464782925|FG000|Overall Study|Lost to Follow-up|2|||
129133751|NCT03073109|464782926|FG000|Overall Study|Adverse Event|0|||
129133752|NCT03073109|464782927|FG001|Overall Study|Adverse Event|1|||
129133753|NCT03073109|464782926|FG000|Overall Study|Other|2|||
129133754|NCT03073109|464782927|FG001|Overall Study|Other|0|||
129133755|NCT03073109|464782926|FG000|Overall Study|Lost to Follow-up|8|||
129133756|NCT03073109|464782927|FG001|Overall Study|Lost to Follow-up|1|||
129133757|NCT00574951|464782938|FG000|Overall Study|Ineligible - improper prior treatment|1|||
128980883|NCT05602818|464216753|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129133758|NCT01160744|464782943|FG000|Overall Study|Withdrawal by Subject|11|||
129133759|NCT01160744|464782944|FG001|Overall Study|Withdrawal by Subject|5|||
128718963|NCT00768300|463268914|FG000|Overall Study|Study discontinued by Sponsor|271|||
128718964|NCT00768300|463268915|FG001|Overall Study|Study discontinued by Sponsor|140|||
129133760|NCT01160744|464782945|FG002|Overall Study|Withdrawal by Subject|6|||
129133761|NCT01160744|464782946|FG003|Overall Study|Withdrawal by Subject|4|||
129133762|NCT01160744|464782943|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
129133763|NCT01160744|464782944|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
129133764|NCT01160744|464782945|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
129133765|NCT01160744|464782946|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
129133766|NCT02301429|464782947|FG000|Overall Study|not acceptable vascular anatomy|3|||
129133767|NCT02217982|464782948|FG000|Overall Study|Trial discontinued|1|||
129133768|NCT02217982|464782949|FG001|Overall Study|Trial discontinued|0|||
129133769|NCT02217982|464782948|FG000|Overall Study|Adverse Event|0|||
129133770|NCT02217982|464782949|FG001|Overall Study|Adverse Event|1|||
129133771|NCT01755637|464782954|FG000|Period 1|Adverse Event|0|||
129133772|NCT01755637|464782955|FG001|Period 1|Adverse Event|1|||
129133773|NCT01814332|464782956|FG000|Overall Study|Adverse Event|8|||
129133774|NCT01814332|464782957|FG001|Overall Study|Adverse Event|3|||
129133775|NCT01814332|464782956|FG000|Overall Study|Withdrawal by Subject|3|||
129133776|NCT01814332|464782957|FG001|Overall Study|Withdrawal by Subject|8|||
129133777|NCT01814332|464782956|FG000|Overall Study|Protocol Violation|0|||
129133778|NCT01814332|464782957|FG001|Overall Study|Protocol Violation|4|||
129133779|NCT01814332|464782956|FG000|Overall Study|Lost to Follow-up|5|||
129133780|NCT01814332|464782957|FG001|Overall Study|Lost to Follow-up|1|||
129133781|NCT01096186|464782959|FG000|Overall Study|Adverse Event|16|||
129133782|NCT01096186|464782959|FG000|Overall Study|Death|4|||
129133783|NCT01096186|464782959|FG000|Overall Study|Lack of Efficacy|4|||
129133784|NCT01096186|464782959|FG000|Overall Study|Lost to Follow-up|2|||
129133785|NCT01096186|464782959|FG000|Overall Study|Withdrawal by Subject|22|||
129133786|NCT01096186|464782959|FG000|Overall Study|Physician Decision|1|||
129133787|NCT01096186|464782959|FG000|Overall Study|Noncompliance with study drug|1|||
129133788|NCT00122187|464782964|FG000|Overall Study|Withdrew because of resource limitations|2|||
129133789|NCT00122187|464782965|FG001|Overall Study|Withdrew because of resource limitations|2|||
129133790|NCT02061592|464782966|FG000|Period 1|Withdrawal by Subject|1|||
129133791|NCT02061592|464782967|FG001|Period 1|Withdrawal by Subject|0|||
129133792|NCT02061592|464782966|FG000|Period 1|Protocol Violation|1|||
129133793|NCT02061592|464782967|FG001|Period 1|Protocol Violation|0|||
129133794|NCT02061592|464782966|FG000|Period 2|Lost to Follow-up|0|||
129133795|NCT02061592|464782967|FG001|Period 2|Lost to Follow-up|1|||
129133796|NCT03338023|464782968|FG000|Overall Study|Withdrawal by Subject|3|||
129133797|NCT03338023|464782969|FG001|Overall Study|Withdrawal by Subject|4|||
129133798|NCT03338023|464782968|FG000|Overall Study|Protocol Violation|3|||
129133799|NCT03338023|464782969|FG001|Overall Study|Protocol Violation|3|||
129133800|NCT03338023|464782968|FG000|Overall Study|Lost to Follow-up|2|||
129133801|NCT03338023|464782969|FG001|Overall Study|Lost to Follow-up|1|||
129133802|NCT03338023|464782968|FG000|Overall Study|Physician Decision|1|||
129133803|NCT03338023|464782969|FG001|Overall Study|Physician Decision|2|||
129133804|NCT00685698|464782970|FG000|Overall Study|Withdrawal by Subject|1|||
129133805|NCT00685698|464782970|FG000|Overall Study|Protocol Violation|6|||
129133806|NCT00685698|464782970|FG000|Overall Study|Adverse Event|3|||
129133807|NCT00685698|464782970|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
129133808|NCT00685698|464782970|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
129133809|NCT00685698|464782970|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
129133810|NCT05061706|464782972|FG000|Overall Study|Adverse Event|29|||
129133811|NCT05061706|464782973|FG001|Overall Study|Adverse Event|1|||
129133812|NCT05061706|464782972|FG000|Overall Study|Lack of Efficacy|0|||
129133813|NCT05061706|464782973|FG001|Overall Study|Lack of Efficacy|1|||
129133814|NCT05061706|464782972|FG000|Overall Study|Lost to Follow-up|2|||
129133815|NCT05061706|464782973|FG001|Overall Study|Lost to Follow-up|2|||
129133816|NCT05061706|464782972|FG000|Overall Study|Protocol Violation|3|||
129133817|NCT05061706|464782973|FG001|Overall Study|Protocol Violation|1|||
129133818|NCT05061706|464782972|FG000|Overall Study|Withdrawal by Subject|3|||
129133819|NCT05061706|464782973|FG001|Overall Study|Withdrawal by Subject|9|||
128775302|NCT01474512|463468363|FG006|Long-Term Extension Period|Sponsor Decision|0|||
128775303|NCT01474512|463468364|FG007|Long-Term Extension Period|Sponsor Decision|0|||
128775304|NCT01474512|463468365|FG008|Long-Term Extension Period|Sponsor Decision|0|||
128775305|NCT01474512|463468366|FG009|Long-Term Extension Period|Sponsor Decision|0|||
129133820|NCT01873833|464782975|FG000|Overall Study|Withdrawal by Subject|1|||
129133821|NCT03983109|464782978|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
129133822|NCT03983109|464782979|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
129133823|NCT02068599|464782983|FG000|Overall Study|Adverse Event|4|||
129133824|NCT02068599|464782984|FG001|Overall Study|Adverse Event|1|||
129133825|NCT02068599|464782985|FG002|Overall Study|Adverse Event|1|||
129133826|NCT02068599|464782983|FG000|Overall Study|Withdrawal by Subject|2|||
129133827|NCT02068599|464782984|FG001|Overall Study|Withdrawal by Subject|7|||
129133828|NCT02068599|464782985|FG002|Overall Study|Withdrawal by Subject|5|||
129133829|NCT02068599|464782983|FG000|Overall Study|Protocol Violation|4|||
129133830|NCT02068599|464782984|FG001|Overall Study|Protocol Violation|2|||
129133831|NCT02068599|464782985|FG002|Overall Study|Protocol Violation|3|||
129133832|NCT02068599|464782983|FG000|Overall Study|Lost to Follow-up|1|||
129133833|NCT02068599|464782984|FG001|Overall Study|Lost to Follow-up|0|||
129042387|NCT00773734|464448514|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
129042388|NCT00773734|464448515|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
129042389|NCT00773734|464448516|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
129042390|NCT00773734|464448517|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
129042391|NCT00773734|464448512|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
129042392|NCT00773734|464448513|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
129042393|NCT00773734|464448514|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
129042394|NCT00773734|464448515|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
129042395|NCT00773734|464448516|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
129042396|NCT00773734|464448517|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
129042397|NCT00773734|464448512|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
129042398|NCT00773734|464448513|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
129042399|NCT00773734|464448514|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
129042400|NCT00773734|464448515|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
129042401|NCT00773734|464448516|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
129042402|NCT00773734|464448517|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
129042403|NCT00773734|464448512|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129042404|NCT00773734|464448513|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
129042405|NCT00773734|464448514|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
129042406|NCT00773734|464448515|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129042407|NCT00773734|464448516|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129042408|NCT00773734|464448517|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129042409|NCT00773734|464448512|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
129042410|NCT00773734|464448513|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129042411|NCT00773734|464448514|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129042412|NCT00773734|464448515|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129042413|NCT00773734|464448516|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
129042414|NCT00773734|464448517|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129042415|NCT00773734|464448512|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
129042416|NCT00773734|464448513|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
129042417|NCT00773734|464448514|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
129042418|NCT00773734|464448515|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
129042419|NCT00773734|464448516|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
129042420|NCT00773734|464448517|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
129042421|NCT00773734|464448512|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129042422|NCT00773734|464448513|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129042423|NCT00773734|464448514|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129042424|NCT00773734|464448515|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129042425|NCT00773734|464448516|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
129042426|NCT00773734|464448517|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
129042427|NCT00773734|464448512|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
129042428|NCT00773734|464448513|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
129042429|NCT00773734|464448514|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
129042430|NCT00773734|464448515|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
129042431|NCT00773734|464448516|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
129042432|NCT00773734|464448517|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
129042433|NCT00773734|464448512|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
129042434|NCT00773734|464448513|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
129042435|NCT00773734|464448514|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
129042436|NCT00773734|464448515|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
129042437|NCT00773734|464448516|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
129042438|NCT00773734|464448517|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
129042439|NCT00773734|464448512|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
129042440|NCT00773734|464448513|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
129042441|NCT00773734|464448514|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
129042442|NCT00773734|464448515|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
129042443|NCT00773734|464448516|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
129042444|NCT00773734|464448517|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
129042445|NCT00773734|464448512|FG000|Extension: Active Treatment Week 24-52|Other|0|||
129042446|NCT00773734|464448513|FG001|Extension: Active Treatment Week 24-52|Other|0|||
129042447|NCT00773734|464448514|FG002|Extension: Active Treatment Week 24-52|Other|1|||
129042448|NCT00773734|464448515|FG003|Extension: Active Treatment Week 24-52|Other|2|||
129042449|NCT00773734|464448516|FG004|Extension: Active Treatment Week 24-52|Other|0|||
129133834|NCT02068599|464782985|FG002|Overall Study|Lost to Follow-up|0|||
129133835|NCT02068599|464782983|FG000|Overall Study|Lack of Efficacy|0|||
129133836|NCT02068599|464782984|FG001|Overall Study|Lack of Efficacy|0|||
129042450|NCT00773734|464448517|FG005|Extension: Active Treatment Week 24-52|Other|1|||
129042451|NCT00773734|464448512|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129042452|NCT00773734|464448513|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129042453|NCT00773734|464448514|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129042454|NCT00773734|464448515|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
129042455|NCT00773734|464448516|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129042456|NCT00773734|464448517|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129042457|NCT00773734|464448512|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129042458|NCT00773734|464448513|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129042459|NCT00773734|464448514|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
129042460|NCT00773734|464448515|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
129042461|NCT00773734|464448516|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129042462|NCT00773734|464448517|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129042463|NCT00773734|464448512|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129042464|NCT00773734|464448513|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129042465|NCT00773734|464448514|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
129042466|NCT00773734|464448515|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
129042467|NCT00773734|464448516|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129042468|NCT00773734|464448517|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129042469|NCT00773734|464448512|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129042470|NCT00773734|464448513|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129042471|NCT00773734|464448514|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
129042472|NCT00773734|464448515|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
129042473|NCT00773734|464448516|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129042474|NCT00773734|464448517|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129042475|NCT01220297|464448520|FG000|Overall Study|Death|2|||
129042476|NCT01220297|464448520|FG000|Overall Study|Lost to Follow-up|1|||
129042477|NCT02581163|464448523|FG000|Overall Study|Failure to return|15|||
129042478|NCT02581163|464448523|FG000|Overall Study|Insufficient virological response|3|||
129042479|NCT02581163|464448523|FG000|Overall Study|Withdrew consent|1|||
129042480|NCT02581163|464448523|FG000|Overall Study|Death|1|||
129042481|NCT02581163|464448523|FG000|Overall Study|Other, not specified|9|||
129042482|NCT02791893|464448524|FG000|Blinded Phase|Lost to Follow-up|2|||
129042483|NCT02791893|464448525|FG001|Blinded Phase|Lost to Follow-up|2|||
129042484|NCT02791893|464448524|FG000|Blinded Phase|Withdrawal by Subject|1|||
129042485|NCT02791893|464448525|FG001|Blinded Phase|Withdrawal by Subject|2|||
129042486|NCT02791893|464448524|FG000|Open Label Phase|Lost to Follow-up|3|||
129042487|NCT02791893|464448525|FG001|Open Label Phase|Lost to Follow-up|0|||
129042488|NCT02791893|464448524|FG000|Open Label Phase|Withdrawal by Subject|0|||
129042489|NCT02791893|464448525|FG001|Open Label Phase|Withdrawal by Subject|2|||
129042490|NCT03438396|464448526|FG000|Overall Study|Reason Not Specified|9|||
129042491|NCT03438396|464448526|FG000|Overall Study|Withdrawal by Subject|5|||
129042492|NCT03438396|464448526|FG000|Overall Study|Lost to Follow-up|2|||
129042493|NCT03438396|464448526|FG000|Overall Study|Death|85|||
129042494|NCT03438396|464448526|FG000|Overall Study|Not treated|1|||
129042495|NCT00262041|464448527|FG000|Overall Study|Withdrawal by Subject|0|||
129042496|NCT00262041|464448528|FG001|Overall Study|Withdrawal by Subject|3|||
129042497|NCT00262041|464448529|FG002|Overall Study|Withdrawal by Subject|1|||
129042498|NCT00262041|464448527|FG000|Overall Study|Lost to Follow-up|1|||
129042499|NCT00262041|464448528|FG001|Overall Study|Lost to Follow-up|1|||
129042500|NCT00262041|464448529|FG002|Overall Study|Lost to Follow-up|5|||
129042501|NCT00262041|464448527|FG000|Overall Study|Unable to classify|1|||
129042502|NCT00262041|464448528|FG001|Overall Study|Unable to classify|0|||
129042503|NCT00262041|464448529|FG002|Overall Study|Unable to classify|0|||
129042504|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
129042505|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
129042506|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
129042507|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
129042508|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
129042509|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
128775306|NCT01474512|463468367|FG010|Long-Term Extension Period|Sponsor Decision|0|||
129042510|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
129042511|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
129042512|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
129042513|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
129042514|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
129042515|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
129042516|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
129042517|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
129042518|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
129042519|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
129042520|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
129042521|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
129222775|NCT02720094|465116203|FG000|Overall Study|Withdrawal by Subject|55|||
129222776|NCT02720094|465116204|FG001|Overall Study|Withdrawal by Subject|56|||
129222777|NCT02720094|465116203|FG000|Overall Study|Lost to Follow-up|2|||
129042522|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
129042523|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
129042524|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
129042525|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
129042526|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
129042527|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
129222778|NCT02720094|465116204|FG001|Overall Study|Lost to Follow-up|7|||
129222779|NCT02720094|465116203|FG000|Overall Study|Physician Decision|1|||
129222780|NCT02720094|465116204|FG001|Overall Study|Physician Decision|3|||
129222781|NCT02720094|465116203|FG000|Overall Study|Inappropriate enrollment|1|||
129222782|NCT02720094|465116204|FG001|Overall Study|Inappropriate enrollment|3|||
129222783|NCT02720094|465116203|FG000|Overall Study|Relocation|1|||
129222784|NCT02720094|465116204|FG001|Overall Study|Relocation|1|||
129222785|NCT01302834|465116205|FG000|Overall Study|Protocol Violation|17|||
129222786|NCT01302834|465116206|FG001|Overall Study|Protocol Violation|23|||
128980884|NCT05602818|464216742|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
129042528|NCT01421342|464448530|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
129042529|NCT01421342|464448531|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
129042530|NCT01421342|464448532|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
129042531|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
129042532|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
128980885|NCT05602818|464216743|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
128980886|NCT05602818|464216744|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
128980887|NCT05602818|464216745|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
128980888|NCT05602818|464216746|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
128980889|NCT05602818|464216747|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
128980890|NCT05602818|464216748|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
128980891|NCT05602818|464216749|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
128980892|NCT05602818|464216750|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
128980893|NCT05602818|464216751|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
128980894|NCT05602818|464216752|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
128980895|NCT05602818|464216753|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
128980896|NCT05602818|464216742|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980897|NCT05602818|464216743|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980898|NCT05602818|464216744|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980899|NCT05602818|464216745|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980900|NCT05602818|464216746|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980901|NCT05602818|464216747|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980902|NCT05602818|464216748|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980903|NCT05602818|464216749|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980904|NCT05602818|464216750|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980905|NCT05602818|464216751|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
128980906|NCT05602818|464216752|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
128980907|NCT05602818|464216753|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
128980908|NCT05602818|464216742|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
128980909|NCT05602818|464216743|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
128980910|NCT05602818|464216744|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
129042533|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
129042534|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
129042535|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
129042536|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
129042537|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
129042538|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
129042539|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
129042540|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
129042541|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
129042542|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
129042543|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
129042544|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
129042545|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
129222787|NCT01302834|465116205|FG000|Overall Study|HIV positive|1|||
129222788|NCT01302834|465116206|FG001|Overall Study|HIV positive|3|||
128718965|NCT00768300|463268914|FG000|Overall Study|Death|21|||
128718966|NCT00768300|463268915|FG001|Overall Study|Death|5|||
128718967|NCT00768300|463268914|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
128980911|NCT05602818|464216745|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
129222789|NCT03735238|465116207|FG000|Overall Study|Did not want to participate in research|3|||
129133837|NCT02068599|464782985|FG002|Overall Study|Lack of Efficacy|3|||
129133838|NCT02068599|464782983|FG000|Overall Study|Noncompliance|0|||
129133839|NCT02068599|464782984|FG001|Overall Study|Noncompliance|0|||
129133840|NCT02068599|464782985|FG002|Overall Study|Noncompliance|1|||
129133841|NCT01871727|464782986|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
129133842|NCT01871727|464782987|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
129133843|NCT01871727|464782988|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
129133844|NCT01871727|464782989|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
129133845|NCT01871727|464782990|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
129133846|NCT01871727|464782986|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
129133847|NCT01871727|464782987|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
129133848|NCT01871727|464782988|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
129133849|NCT01871727|464782989|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
129133850|NCT01871727|464782990|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
128980912|NCT05602818|464216746|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
128980913|NCT05602818|464216747|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
128980914|NCT05602818|464216748|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
128980915|NCT05602818|464216749|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
128980916|NCT05602818|464216750|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
128980917|NCT05602818|464216751|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
129133851|NCT01871727|464782986|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129133852|NCT01871727|464782987|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129133853|NCT01871727|464782988|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129133854|NCT01871727|464782989|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129133855|NCT01871727|464782990|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
129133856|NCT01871727|464782986|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129133857|NCT01871727|464782987|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129133858|NCT01871727|464782988|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129133859|NCT01871727|464782989|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129133860|NCT01871727|464782990|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
129133861|NCT01871727|464782986|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
128718968|NCT00768300|463268915|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
128718969|NCT00768300|463268914|FG000|Overall Study|Screen failure following randomization|1|||
128980918|NCT05602818|464216752|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
128980919|NCT05602818|464216753|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
128980920|NCT04594213|464216758|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
128980921|NCT04594213|464216759|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
128980922|NCT04594213|464216760|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
128980923|NCT04594213|464216761|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
128980924|NCT04594213|464216762|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
128980925|NCT04594213|464216763|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
128980926|NCT04594213|464216758|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
128980927|NCT04594213|464216759|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
128980928|NCT04594213|464216760|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
128980929|NCT04594213|464216761|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
128980930|NCT04594213|464216762|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
128980931|NCT04594213|464216763|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
128980932|NCT04594213|464216758|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
128980933|NCT04594213|464216759|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128980934|NCT04594213|464216760|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
128980935|NCT04594213|464216761|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128980936|NCT04594213|464216762|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128980937|NCT04594213|464216763|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128980938|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128980939|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128980940|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128980941|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128980942|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
128980943|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128980944|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
128980945|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
128980946|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
128980947|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
128980948|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
128980949|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
129133862|NCT01871727|464782987|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
129133863|NCT01871727|464782988|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
129133864|NCT01871727|464782989|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
129133865|NCT01871727|464782990|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
129042546|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
129042547|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
129042548|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
129042549|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
129042550|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
129042551|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
129042552|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
129042553|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
129042554|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
129042555|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
129042556|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
129042557|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
129042558|NCT01421342|464448530|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
129042559|NCT01421342|464448531|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
129042560|NCT01421342|464448532|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
129042561|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
129042562|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
129133866|NCT01871727|464782986|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129133867|NCT01871727|464782987|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129133868|NCT01871727|464782988|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129133869|NCT01871727|464782989|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129133870|NCT01871727|464782990|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
129133871|NCT01871727|464782986|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
129133872|NCT01871727|464782987|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
129133873|NCT01871727|464782988|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
129133874|NCT01871727|464782989|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
129133875|NCT01871727|464782990|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
129133876|NCT00356421|464782992|FG000|Overall Study|Lack of Efficacy|3|||
129133877|NCT00356421|464782993|FG001|Overall Study|Lack of Efficacy|0|||
129133878|NCT00356421|464782992|FG000|Overall Study|Withdrawal by Subject|9|||
129133879|NCT00356421|464782993|FG001|Overall Study|Withdrawal by Subject|2|||
129133880|NCT00356421|464782992|FG000|Overall Study|Related to study drug|15|||
129133881|NCT00356421|464782993|FG001|Overall Study|Related to study drug|12|||
129133882|NCT00356421|464782992|FG000|Overall Study|Not related to study drug|5|||
129133883|NCT00356421|464782993|FG001|Overall Study|Not related to study drug|3|||
129133884|NCT00501085|464782994|FG000|Overall Study|Lost to Follow-up|195|||
129133885|NCT00501085|464782994|FG000|Overall Study|Withdrawal by Subject|34|||
129133886|NCT00501085|464782994|FG000|Overall Study|Subject Decision|1|||
129133887|NCT00501085|464782994|FG000|Overall Study|Revision Surgery|7|||
129133888|NCT00501085|464782994|FG000|Overall Study|Explantation Surgery|26|||
129133889|NCT00501085|464782994|FG000|Overall Study|Adverse Event|4|||
129133890|NCT00501085|464782994|FG000|Overall Study|Non-Compliance|24|||
129133891|NCT00501085|464782994|FG000|Overall Study|Study closed by sponsor|109|||
129133892|NCT00501085|464782994|FG000|Overall Study|Other loss to follow-up|32|||
129133893|NCT02958527|464782995|FG000|Overall Study|Not collected CRFs|12|||
129133894|NCT02945046|464782996|FG000|Overall Study|Adverse Event|1|||
129133895|NCT02945046|464782997|FG001|Overall Study|Adverse Event|0|||
129133896|NCT02945046|464782998|FG002|Overall Study|Adverse Event|2|||
129133897|NCT02945046|464782996|FG000|Overall Study|Withdrawal by Subject|3|||
129133898|NCT02945046|464782997|FG001|Overall Study|Withdrawal by Subject|3|||
129133899|NCT02945046|464782998|FG002|Overall Study|Withdrawal by Subject|3|||
129133900|NCT02945046|464782996|FG000|Overall Study|Protocol Violation|2|||
129133901|NCT02945046|464782997|FG001|Overall Study|Protocol Violation|3|||
129133902|NCT02945046|464782998|FG002|Overall Study|Protocol Violation|2|||
129133903|NCT02945046|464782996|FG000|Overall Study|Lost to Follow-up|1|||
129222790|NCT03735238|465116207|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
129222791|NCT02427464|465116208|FG000|Overall Study|Adverse Event|6|||
129222792|NCT02427464|465116209|FG001|Overall Study|Adverse Event|1|||
128775307|NCT01474512|463468368|FG011|Long-Term Extension Period|Sponsor Decision|0|||
128775308|NCT01474512|463468369|FG012|Long-Term Extension Period|Sponsor Decision|6|||
128980950|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128980951|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128980952|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128980953|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128980954|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128980955|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
128980956|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128980957|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128980958|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129042563|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
129042564|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
129042565|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
129042566|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
129042567|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
129042568|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
129042569|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
129042570|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
129042571|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
129042572|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
129042573|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
129042574|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
129042575|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
129042576|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
129042577|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
129042578|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
129042579|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
129042580|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
129042581|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
129042582|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
129042583|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
129042584|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
129042585|NCT01421342|464448530|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
129042586|NCT01421342|464448531|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
129042587|NCT01421342|464448532|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
129042588|NCT02017860|464448536|FG000|Overall Study|Adverse Event|1|||
129042589|NCT02017860|464448536|FG000|Overall Study|Withdrawal by Subject|1|||
129042590|NCT02488330|464448537|FG000|Overall Study|Adverse Event|1|||
129042591|NCT02488330|464448537|FG000|Overall Study|Physician Decision|2|||
129042592|NCT02488330|464448537|FG000|Overall Study|Death|2|||
129042593|NCT02488330|464448537|FG000|Overall Study|Disease Progression|3|||
129042594|NCT02488330|464448537|FG000|Overall Study|Study Termination by Sponsor|4|||
129042595|NCT01206816|464448541|FG000|Overall Study|Protocol Violation|0|||
129042596|NCT01206816|464448542|FG001|Overall Study|Protocol Violation|0|||
129042597|NCT01206816|464448543|FG002|Overall Study|Protocol Violation|1|||
129042598|NCT01206816|464448544|FG003|Overall Study|Protocol Violation|0|||
129042599|NCT01206816|464448545|FG004|Overall Study|Protocol Violation|0|||
129042600|NCT01206816|464448546|FG005|Overall Study|Protocol Violation|0|||
129042601|NCT01206816|464448547|FG006|Overall Study|Protocol Violation|0|||
129042602|NCT01206816|464448541|FG000|Overall Study|Withdrawal by Subject|0|||
129042603|NCT01206816|464448542|FG001|Overall Study|Withdrawal by Subject|0|||
129042604|NCT01206816|464448543|FG002|Overall Study|Withdrawal by Subject|1|||
129042605|NCT01206816|464448544|FG003|Overall Study|Withdrawal by Subject|0|||
129042606|NCT01206816|464448545|FG004|Overall Study|Withdrawal by Subject|0|||
129042607|NCT01206816|464448546|FG005|Overall Study|Withdrawal by Subject|0|||
129042608|NCT01206816|464448547|FG006|Overall Study|Withdrawal by Subject|0|||
129042609|NCT01206816|464448541|FG000|Overall Study|Progressive disease|3|||
129042610|NCT01206816|464448542|FG001|Overall Study|Progressive disease|3|||
129042611|NCT01206816|464448543|FG002|Overall Study|Progressive disease|13|||
129042612|NCT01206816|464448544|FG003|Overall Study|Progressive disease|3|||
129133904|NCT02945046|464782997|FG001|Overall Study|Lost to Follow-up|1|||
129133905|NCT02945046|464782998|FG002|Overall Study|Lost to Follow-up|0|||
129133906|NCT02945046|464782996|FG000|Overall Study|Lack of Efficacy|1|||
129133907|NCT02945046|464782997|FG001|Overall Study|Lack of Efficacy|2|||
129133908|NCT02945046|464782998|FG002|Overall Study|Lack of Efficacy|1|||
129133909|NCT02945046|464782996|FG000|Overall Study|Other than specified|5|||
129133910|NCT02945046|464782997|FG001|Overall Study|Other than specified|4|||
129133911|NCT02945046|464782998|FG002|Overall Study|Other than specified|7|||
129133912|NCT03113136|464782999|FG000|Overall Study|Lost to Follow-up|22|||
129133913|NCT03113136|464783000|FG001|Overall Study|Lost to Follow-up|47|||
129133914|NCT03113136|464783001|FG002|Overall Study|Lost to Follow-up|54|||
129133915|NCT03113136|464782999|FG000|Overall Study|Withdrawal by Subject|4|||
129133916|NCT03113136|464783000|FG001|Overall Study|Withdrawal by Subject|13|||
129042613|NCT01206816|464448545|FG004|Overall Study|Progressive disease|3|||
129133917|NCT03113136|464783001|FG002|Overall Study|Withdrawal by Subject|14|||
129133918|NCT03113136|464782999|FG000|Overall Study|Ineligible|0|||
129133919|NCT03113136|464783000|FG001|Overall Study|Ineligible|2|||
129133920|NCT03113136|464783001|FG002|Overall Study|Ineligible|1|||
129133921|NCT03113136|464782999|FG000|Overall Study|Study Team Decision|1|||
129133922|NCT03113136|464783000|FG001|Overall Study|Study Team Decision|4|||
129133923|NCT03113136|464783001|FG002|Overall Study|Study Team Decision|0|||
129133924|NCT01666314|464783005|FG000|Overall Study|Adverse Event|3|||
129133925|NCT01666314|464783006|FG001|Overall Study|Adverse Event|13|||
129042614|NCT01206816|464448546|FG005|Overall Study|Progressive disease|16|||
129042615|NCT01206816|464448547|FG006|Overall Study|Progressive disease|3|||
129042616|NCT01206816|464448541|FG000|Overall Study|Other AE|0|||
129042617|NCT01206816|464448542|FG001|Overall Study|Other AE|0|||
129042618|NCT01206816|464448543|FG002|Overall Study|Other AE|4|||
129042619|NCT01206816|464448544|FG003|Overall Study|Other AE|0|||
129042620|NCT01206816|464448545|FG004|Overall Study|Other AE|0|||
129042621|NCT01206816|464448546|FG005|Overall Study|Other AE|3|||
129042622|NCT01206816|464448547|FG006|Overall Study|Other AE|2|||
129042623|NCT01206816|464448541|FG000|Overall Study|other than stated above|0|||
129042624|NCT01206816|464448542|FG001|Overall Study|other than stated above|0|||
129042625|NCT01206816|464448543|FG002|Overall Study|other than stated above|1|||
129042626|NCT01206816|464448544|FG003|Overall Study|other than stated above|0|||
129042627|NCT01206816|464448545|FG004|Overall Study|other than stated above|0|||
129042628|NCT01206816|464448546|FG005|Overall Study|other than stated above|0|||
129042629|NCT01206816|464448547|FG006|Overall Study|other than stated above|1|||
129042630|NCT02384941|464448550|FG000|Overall Study|Adverse Event|11|||
129042631|NCT02384941|464448551|FG001|Overall Study|Adverse Event|13|||
129042632|NCT02384941|464448552|FG002|Overall Study|Adverse Event|17|||
129042633|NCT02384941|464448550|FG000|Overall Study|Lost to Follow-up|3|||
129042634|NCT02384941|464448551|FG001|Overall Study|Lost to Follow-up|2|||
129042635|NCT02384941|464448552|FG002|Overall Study|Lost to Follow-up|1|||
129042636|NCT02384941|464448550|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129042637|NCT02384941|464448551|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129042638|NCT02384941|464448552|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129042639|NCT02384941|464448550|FG000|Overall Study|Physician Decision|1|||
129042640|NCT02384941|464448551|FG001|Overall Study|Physician Decision|1|||
129042641|NCT02384941|464448552|FG002|Overall Study|Physician Decision|0|||
129042642|NCT02384941|464448550|FG000|Overall Study|Protocol Violation|3|||
129042643|NCT02384941|464448551|FG001|Overall Study|Protocol Violation|0|||
129042644|NCT02384941|464448552|FG002|Overall Study|Protocol Violation|0|||
129042645|NCT02384941|464448550|FG000|Overall Study|Withdrawal by Subject|26|||
129042646|NCT02384941|464448551|FG001|Overall Study|Withdrawal by Subject|19|||
129042647|NCT02384941|464448552|FG002|Overall Study|Withdrawal by Subject|20|||
129042648|NCT02384941|464448550|FG000|Overall Study|Pregnancy|0|||
129042649|NCT02384941|464448551|FG001|Overall Study|Pregnancy|0|||
129042650|NCT02384941|464448552|FG002|Overall Study|Pregnancy|1|||
129042651|NCT02384941|464448550|FG000|Overall Study|Other than specified above|4|||
129042652|NCT02384941|464448551|FG001|Overall Study|Other than specified above|0|||
129042653|NCT02384941|464448552|FG002|Overall Study|Other than specified above|1|||
129042654|NCT02493777|464448553|FG000|Overall Study|Lost to Follow-up|0|||
129042655|NCT02493777|464448554|FG001|Overall Study|Lost to Follow-up|1|||
129042656|NCT01642914|464448555|FG000|Overall Study|Adverse Event|11|||
129042657|NCT01642914|464448556|FG001|Overall Study|Adverse Event|7|||
129042658|NCT01642914|464448557|FG002|Overall Study|Adverse Event|15|||
129042659|NCT01642914|464448555|FG000|Overall Study|Lack of Efficacy|9|||
129042660|NCT01642914|464448556|FG001|Overall Study|Lack of Efficacy|4|||
129042661|NCT01642914|464448557|FG002|Overall Study|Lack of Efficacy|2|||
129042662|NCT01642914|464448555|FG000|Overall Study|Protocol Violation|15|||
129042663|NCT01642914|464448556|FG001|Overall Study|Protocol Violation|13|||
129042664|NCT01642914|464448557|FG002|Overall Study|Protocol Violation|6|||
129042665|NCT01642914|464448555|FG000|Overall Study|Withdrawal by Subject|5|||
129042666|NCT01642914|464448556|FG001|Overall Study|Withdrawal by Subject|5|||
129042667|NCT01642914|464448557|FG002|Overall Study|Withdrawal by Subject|10|||
129042668|NCT01642914|464448555|FG000|Overall Study|Lost to Follow-up|5|||
128718970|NCT00768300|463268915|FG001|Overall Study|Screen failure following randomization|0|||
128718971|NCT00768300|463268914|FG000|Overall Study|Received lung transplant|1|||
129042669|NCT01642914|464448556|FG001|Overall Study|Lost to Follow-up|3|||
129042670|NCT01642914|464448557|FG002|Overall Study|Lost to Follow-up|7|||
129042671|NCT01642914|464448555|FG000|Overall Study|Other Reason|1|||
129042672|NCT01642914|464448556|FG001|Overall Study|Other Reason|0|||
129042673|NCT01642914|464448557|FG002|Overall Study|Other Reason|0|||
129042674|NCT02370914|464448558|FG000|Overall Study|Protocol Violation|2|||
129042675|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
129042676|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
129042677|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
129042678|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
129042679|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
129042680|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
129042681|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
129042682|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
129042683|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
129042684|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
129042685|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
129042686|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
129042687|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129042688|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129133926|NCT01666314|464783007|FG002|Overall Study|Adverse Event|7|||
128775309|NCT01474512|463468370|FG013|Long-Term Extension Period|Sponsor Decision|6|||
128980959|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
128980960|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128980961|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128980962|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
128980963|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
128980964|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
128980965|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
128980966|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
128980967|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
128980968|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
128980969|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
128980970|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
128980971|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
128980972|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
128980973|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
128980974|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
128980975|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
128980976|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
128980977|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
129133927|NCT01666314|464783008|FG003|Overall Study|Adverse Event|7|||
129133928|NCT01666314|464783005|FG000|Overall Study|Progressive Disease|11|||
129133929|NCT01666314|464783006|FG001|Overall Study|Progressive Disease|9|||
129133930|NCT01666314|464783007|FG002|Overall Study|Progressive Disease|19|||
129133931|NCT01666314|464783008|FG003|Overall Study|Progressive Disease|20|||
129133932|NCT01666314|464783005|FG000|Overall Study|Symptomatic Deterioration|1|||
129133933|NCT01666314|464783006|FG001|Overall Study|Symptomatic Deterioration|0|||
129133934|NCT01666314|464783007|FG002|Overall Study|Symptomatic Deterioration|2|||
129133935|NCT01666314|464783008|FG003|Overall Study|Symptomatic Deterioration|0|||
129133936|NCT01666314|464783005|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
128980978|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
128980979|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
128980980|NCT04594213|464216758|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
128980981|NCT04594213|464216759|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
128980982|NCT04594213|464216760|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
128980983|NCT04594213|464216761|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
128980984|NCT04594213|464216762|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
128980985|NCT04594213|464216763|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
128980986|NCT03814499|464216765|FG000|Overall Study|Lost to Follow-up|3|||
128980987|NCT01589185|464216766|FG000|Overall Study|Death|1|||
128980988|NCT01589185|464216767|FG001|Overall Study|Death|2|||
128980989|NCT01589185|464216768|FG002|Overall Study|Death|2|||
128980990|NCT01589185|464216769|FG003|Overall Study|Death|0|||
128980991|NCT01589185|464216770|FG004|Overall Study|Death|1|||
128980992|NCT01589185|464216766|FG000|Overall Study|Lost to Follow-up|1|||
128980993|NCT01589185|464216767|FG001|Overall Study|Lost to Follow-up|0|||
128980994|NCT01589185|464216768|FG002|Overall Study|Lost to Follow-up|2|||
129133937|NCT01666314|464783006|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
129133938|NCT01666314|464783007|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
129133939|NCT01666314|464783008|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
129133940|NCT01666314|464783005|FG000|Overall Study|Withdrawal by Subject|1|||
129133941|NCT01666314|464783006|FG001|Overall Study|Withdrawal by Subject|1|||
129133942|NCT01666314|464783007|FG002|Overall Study|Withdrawal by Subject|2|||
129133943|NCT01666314|464783008|FG003|Overall Study|Withdrawal by Subject|3|||
129133944|NCT01666314|464783005|FG000|Overall Study|Reason not Specified|10|||
129133945|NCT01666314|464783006|FG001|Overall Study|Reason not Specified|7|||
129133946|NCT01666314|464783007|FG002|Overall Study|Reason not Specified|5|||
129133947|NCT01666314|464783008|FG003|Overall Study|Reason not Specified|5|||
129133948|NCT02114684|464783011|FG000|Overall Study|Death|6|||
129133949|NCT02114684|464783012|FG001|Overall Study|Death|4|||
129133950|NCT02114684|464783011|FG000|Overall Study|Lost to Follow-up|1|||
129133951|NCT02114684|464783012|FG001|Overall Study|Lost to Follow-up|2|||
129133952|NCT02114684|464783011|FG000|Overall Study|Withdrawal by Subject|1|||
129133953|NCT02114684|464783012|FG001|Overall Study|Withdrawal by Subject|2|||
128980995|NCT01589185|464216769|FG003|Overall Study|Lost to Follow-up|3|||
128980996|NCT01589185|464216770|FG004|Overall Study|Lost to Follow-up|0|||
128980997|NCT02046993|464216771|FG000|Overall Study|Withdrawal by Subject|2|||
129133954|NCT02114684|464783011|FG000|Overall Study|Relocation|3|||
129133955|NCT02114684|464783012|FG001|Overall Study|Relocation|1|||
129133956|NCT02114684|464783011|FG000|Overall Study|Rifampicin resistant on culture|0|||
129133957|NCT02114684|464783012|FG001|Overall Study|Rifampicin resistant on culture|1|||
129133958|NCT02114684|464783011|FG000|Overall Study|Patient Incarcerated|1|||
129133959|NCT02114684|464783012|FG001|Overall Study|Patient Incarcerated|0|||
129133960|NCT04625972|464783015|FG000|Overall Study|Death|3|||
128775310|NCT01474512|463468371|FG014|Long-Term Extension Period|Sponsor Decision|0|||
129042689|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129042690|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129042691|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
129042692|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
129042693|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
129042694|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
129042695|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
129042696|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
129042697|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
129042698|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
129042699|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
129042700|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
129042701|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
129042702|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
129042703|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Death|0|||
129042704|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Death|1|||
129042705|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Death|0|||
129042706|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Death|0|||
129042707|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
129042708|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
129042709|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
129042710|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
129042711|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
129042712|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
129133961|NCT04625972|464783016|FG001|Overall Study|Death|2|||
129133962|NCT04625972|464783015|FG000|Overall Study|Lost to Follow-up|82|||
129133963|NCT04625972|464783016|FG001|Overall Study|Lost to Follow-up|38|||
129133964|NCT04625972|464783015|FG000|Overall Study|Physician Decision|2|||
129133965|NCT04625972|464783016|FG001|Overall Study|Physician Decision|0|||
129133966|NCT04625972|464783015|FG000|Overall Study|Protocol Violation|0|||
129133967|NCT04625972|464783016|FG001|Overall Study|Protocol Violation|1|||
129133968|NCT04625972|464783015|FG000|Overall Study|Withdrawal by Subject|37|||
129133969|NCT04625972|464783016|FG001|Overall Study|Withdrawal by Subject|24|||
129133970|NCT04625972|464783015|FG000|Overall Study|Not specified elsewhere|8|||
129133971|NCT04625972|464783016|FG001|Overall Study|Not specified elsewhere|6|||
129133972|NCT00694122|464783017|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
129133973|NCT00694122|464783018|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
129133974|NCT00694122|464783017|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
129133975|NCT00694122|464783018|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
129133976|NCT00694122|464783017|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
129133977|NCT00694122|464783018|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
129133978|NCT03020888|464783023|FG000|Overall Study|Physician Decision|4|||
129133979|NCT03020888|464783023|FG000|Overall Study|Withdrawal by Subject|6|||
129133980|NCT03020888|464783023|FG000|Overall Study|Insurance coverage|2|||
129133981|NCT03020888|464783023|FG000|Overall Study|Lost to Follow-up|1|||
129133982|NCT01198548|464783030|FG000|Overall Study|Disease Progression|9|||
129133983|NCT01198548|464783030|FG000|Overall Study|Administrative Decision|1|||
129133984|NCT01245062|464783032|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
129133985|NCT01245062|464783033|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
129133986|NCT01245062|464783034|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
129133987|NCT01245062|464783032|FG000|Randomization and Crossover Phase|Physician Decision|2|||
129133988|NCT01245062|464783033|FG001|Randomization and Crossover Phase|Physician Decision|4|||
129133989|NCT01245062|464783034|FG002|Randomization and Crossover Phase|Physician Decision|0|||
129133990|NCT01245062|464783032|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
129133991|NCT01245062|464783033|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
129133992|NCT01245062|464783034|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
129133993|NCT01245062|464783032|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
128775311|NCT01474512|463468372|FG015|Long-Term Extension Period|Sponsor Decision|0|||
128775312|NCT01474512|463468373|FG016|Long-Term Extension Period|Sponsor Decision|0|||
128775313|NCT01474512|463468374|FG017|Long-Term Extension Period|Sponsor Decision|0|||
128775314|NCT01474512|463468357|FG000|Long-Term Extension Period|Protocol Violation|0|||
129042713|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
129042714|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
129042715|NCT02990806|464448559|FG000|Stage 1 (22 Weeks)|Other|1|||
129222793|NCT02427464|465116208|FG000|Overall Study|Lost to Follow-up|16|||
129042716|NCT02990806|464448560|FG001|Stage 1 (22 Weeks)|Other|3|||
129042717|NCT02990806|464448561|FG002|Stage 1 (22 Weeks)|Other|0|||
129133994|NCT01245062|464783033|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
129133995|NCT01245062|464783034|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
129133996|NCT01245062|464783032|FG000|Cross-over Phase|Lost to Follow-up|0|||
129133997|NCT01245062|464783033|FG001|Cross-over Phase|Lost to Follow-up|0|||
128980998|NCT02046993|464216772|FG001|Overall Study|Withdrawal by Subject|10|||
128980999|NCT02046993|464216771|FG000|Overall Study|Lost to Follow-up|1|||
128981000|NCT02046993|464216772|FG001|Overall Study|Lost to Follow-up|1|||
128981001|NCT00598442|464216775|FG000|Overall Study|Adverse Event|3|||
128981002|NCT00598442|464216776|FG001|Overall Study|Adverse Event|0|||
128981003|NCT00598442|464216777|FG002|Overall Study|Adverse Event|0|||
128981004|NCT00598442|464216775|FG000|Overall Study|Death|19|||
128981005|NCT00598442|464216776|FG001|Overall Study|Death|11|||
128981006|NCT00598442|464216777|FG002|Overall Study|Death|11|||
128981007|NCT00598442|464216775|FG000|Overall Study|Lost to Follow-up|4|||
128981008|NCT00598442|464216776|FG001|Overall Study|Lost to Follow-up|3|||
128981009|NCT00598442|464216777|FG002|Overall Study|Lost to Follow-up|3|||
128981010|NCT00598442|464216775|FG000|Overall Study|Physician Decision|2|||
128981011|NCT00598442|464216776|FG001|Overall Study|Physician Decision|1|||
128981012|NCT00598442|464216777|FG002|Overall Study|Physician Decision|1|||
128981013|NCT00598442|464216775|FG000|Overall Study|Withdrawal by Subject|8|||
128981014|NCT00598442|464216776|FG001|Overall Study|Withdrawal by Subject|16|||
128981015|NCT00598442|464216777|FG002|Overall Study|Withdrawal by Subject|6|||
128981016|NCT00598442|464216775|FG000|Overall Study|Noncompliance|0|||
129042718|NCT02990806|464448562|FG003|Stage 1 (22 Weeks)|Other|0|||
129042719|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
129042720|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
129042721|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
129042722|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
129042723|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Death|1|||
129042724|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Death|0|||
129042725|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Death|0|||
129042726|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Death|0|||
129042727|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
129042728|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
129042729|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
129042730|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
129042731|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
129042732|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
129042733|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
129042734|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
129042735|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
129042736|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
129042737|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
129042738|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
129042739|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
129042740|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
129042741|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
129042742|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
129042743|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129042744|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129042745|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
129042746|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
129042747|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
129042748|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
129042749|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
129042750|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
129042751|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
129042752|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
129133998|NCT01245062|464783034|FG002|Cross-over Phase|Lost to Follow-up|1|||
129133999|NCT01245062|464783032|FG000|Cross-over Phase|Physician Decision|0|||
129134000|NCT01245062|464783033|FG001|Cross-over Phase|Physician Decision|0|||
128981017|NCT00598442|464216776|FG001|Overall Study|Noncompliance|2|||
128981018|NCT00598442|464216777|FG002|Overall Study|Noncompliance|1|||
128981019|NCT00598442|464216775|FG000|Overall Study|Relocation|1|||
128981020|NCT00598442|464216776|FG001|Overall Study|Relocation|4|||
129042753|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
129134001|NCT01245062|464783034|FG002|Cross-over Phase|Physician Decision|1|||
129134002|NCT01245062|464783032|FG000|Cross-over Phase|Withdrew Consent|0|||
129134003|NCT01245062|464783033|FG001|Cross-over Phase|Withdrew Consent|0|||
129134004|NCT01245062|464783034|FG002|Cross-over Phase|Withdrew Consent|4|||
129134005|NCT01245062|464783032|FG000|Cross-over Phase|Study closed/ terminated|0|||
129134006|NCT01245062|464783033|FG001|Cross-over Phase|Study closed/ terminated|0|||
129134007|NCT01245062|464783034|FG002|Cross-over Phase|Study closed/ terminated|11|||
129134008|NCT02015104|464783035|FG000|Overall Study|Withdrew consent after first dose drug|1|||
129134009|NCT02015104|464783036|FG001|Overall Study|Withdrew consent after first dose drug|0|||
129134010|NCT02015104|464783035|FG000|Overall Study|Withdrew consent prior to treatment|0|||
129134011|NCT02015104|464783036|FG001|Overall Study|Withdrew consent prior to treatment|1|||
128981021|NCT00598442|464216777|FG002|Overall Study|Relocation|0|||
129042754|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
129042755|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
129042756|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
129042757|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
129042758|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
129042759|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
129042760|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
129042761|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
129042762|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
129042763|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Other|3|||
129042764|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Other|0|||
129042765|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Other|4|||
129042766|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Other|1|||
129042767|NCT02990806|464448559|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
129042768|NCT02990806|464448560|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
129042769|NCT02990806|464448561|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
129042770|NCT02990806|464448562|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
129042771|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
129042772|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
129042773|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
129042774|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
129042775|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
129042776|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
129042777|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
129042778|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
129042779|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129042780|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129042781|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129042782|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129042783|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
129042784|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
129042785|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
129042786|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
129042787|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
129042788|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
129042789|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
129042790|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
129042791|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
129042792|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
129042793|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
129042794|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
129042795|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
129042796|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
129042797|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
129042798|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
129042799|NCT02990806|464448559|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
129042800|NCT02990806|464448560|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
129042801|NCT02990806|464448561|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
129042802|NCT02990806|464448562|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
129042803|NCT03739138|464448564|FG000|Overall Study|Death|0|||
129042804|NCT03739138|464448565|FG001|Overall Study|Death|7|||
129042805|NCT03739138|464448566|FG002|Overall Study|Death|4|||
129042806|NCT03739138|464448567|FG003|Overall Study|Death|13|||
128775315|NCT01474512|463468358|FG001|Long-Term Extension Period|Protocol Violation|0|||
128775316|NCT01474512|463468359|FG002|Long-Term Extension Period|Protocol Violation|0|||
128775317|NCT01474512|463468360|FG003|Long-Term Extension Period|Protocol Violation|0|||
128775318|NCT01474512|463468361|FG004|Long-Term Extension Period|Protocol Violation|0|||
128775319|NCT01474512|463468362|FG005|Long-Term Extension Period|Protocol Violation|0|||
128775320|NCT01474512|463468363|FG006|Long-Term Extension Period|Protocol Violation|0|||
128775321|NCT01474512|463468364|FG007|Long-Term Extension Period|Protocol Violation|0|||
128775322|NCT01474512|463468365|FG008|Long-Term Extension Period|Protocol Violation|0|||
128775323|NCT01474512|463468366|FG009|Long-Term Extension Period|Protocol Violation|0|||
128775324|NCT01474512|463468367|FG010|Long-Term Extension Period|Protocol Violation|0|||
128775325|NCT01474512|463468368|FG011|Long-Term Extension Period|Protocol Violation|0|||
128775326|NCT01474512|463468369|FG012|Long-Term Extension Period|Protocol Violation|5|||
128775327|NCT01474512|463468370|FG013|Long-Term Extension Period|Protocol Violation|5|||
128775328|NCT01474512|463468371|FG014|Long-Term Extension Period|Protocol Violation|0|||
129134012|NCT03554473|464784884|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
129134013|NCT03554473|464784885|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
129134014|NCT03554473|464784886|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
129134015|NCT03554473|464784884|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
129134016|NCT03554473|464784885|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
129134017|NCT03554473|464784886|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
129134018|NCT03554473|464784884|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
129042807|NCT03739138|464448568|FG004|Overall Study|Death|0|||
129042808|NCT03739138|464448564|FG000|Overall Study|Lost to Follow-up|0|||
129042809|NCT03739138|464448565|FG001|Overall Study|Lost to Follow-up|0|||
129042810|NCT03739138|464448566|FG002|Overall Study|Lost to Follow-up|1|||
129042811|NCT03739138|464448567|FG003|Overall Study|Lost to Follow-up|0|||
129042812|NCT03739138|464448568|FG004|Overall Study|Lost to Follow-up|0|||
129042813|NCT03739138|464448564|FG000|Overall Study|Study Terminated By Sponsor|0|||
129042814|NCT03739138|464448565|FG001|Overall Study|Study Terminated By Sponsor|0|||
129042815|NCT03739138|464448566|FG002|Overall Study|Study Terminated By Sponsor|0|||
129042816|NCT03739138|464448567|FG003|Overall Study|Study Terminated By Sponsor|4|||
129134019|NCT03554473|464784885|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
128775329|NCT01474512|463468372|FG015|Long-Term Extension Period|Protocol Violation|0|||
128775330|NCT01474512|463468373|FG016|Long-Term Extension Period|Protocol Violation|0|||
128775331|NCT01474512|463468374|FG017|Long-Term Extension Period|Protocol Violation|0|||
128775332|NCT01474512|463468357|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775333|NCT01474512|463468358|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775334|NCT01474512|463468359|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775335|NCT01474512|463468360|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775336|NCT01474512|463468361|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129042817|NCT03739138|464448568|FG004|Overall Study|Study Terminated By Sponsor|0|||
129042818|NCT03739138|464448564|FG000|Overall Study|Withdrawal by Subject|0|||
129042819|NCT03739138|464448565|FG001|Overall Study|Withdrawal by Subject|0|||
129042820|NCT03739138|464448566|FG002|Overall Study|Withdrawal by Subject|0|||
129042821|NCT03739138|464448567|FG003|Overall Study|Withdrawal by Subject|1|||
129042822|NCT03739138|464448568|FG004|Overall Study|Withdrawal by Subject|0|||
129042823|NCT02654587|464448569|FG000|Overall Study|patient alive at end of study|22|||
129042824|NCT02654587|464448570|FG001|Overall Study|patient alive at end of study|8|||
129042825|NCT02654587|464448569|FG000|Overall Study|Withdrawal by Subject|1|||
129042826|NCT02654587|464448570|FG001|Overall Study|Withdrawal by Subject|7|||
129042827|NCT01825837|464448571|FG000|PART I|Withdrawal by Subject|0|||
129042828|NCT01825837|464448572|FG001|PART I|Withdrawal by Subject|0|||
129042829|NCT01825837|464448573|FG002|PART I|Withdrawal by Subject|0|||
129042830|NCT01825837|464448574|FG003|PART I|Withdrawal by Subject|6|||
129042831|NCT01825837|464448571|FG000|PART I|Patient non-compliance|0|||
129042832|NCT01825837|464448572|FG001|PART I|Patient non-compliance|0|||
129042833|NCT01825837|464448573|FG002|PART I|Patient non-compliance|0|||
129042834|NCT01825837|464448574|FG003|PART I|Patient non-compliance|1|||
129042835|NCT01825837|464448571|FG000|PART I|Treatment failure|0|||
129042836|NCT01825837|464448572|FG001|PART I|Treatment failure|0|||
129042837|NCT01825837|464448573|FG002|PART I|Treatment failure|0|||
129042838|NCT01825837|464448574|FG003|PART I|Treatment failure|7|||
129042839|NCT01825837|464448571|FG000|PART I|reason unspecified|0|||
129042840|NCT01825837|464448572|FG001|PART I|reason unspecified|0|||
128775337|NCT01474512|463468362|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775338|NCT01474512|463468363|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129042841|NCT01825837|464448573|FG002|PART I|reason unspecified|0|||
129042842|NCT01825837|464448574|FG003|PART I|reason unspecified|3|||
129042843|NCT01825837|464448571|FG000|PART II|Withdrawal by Subject|3|||
129042844|NCT01825837|464448572|FG001|PART II|Withdrawal by Subject|3|||
129042845|NCT01825837|464448573|FG002|PART II|Withdrawal by Subject|7|||
129042846|NCT01825837|464448574|FG003|PART II|Withdrawal by Subject|0|||
129042847|NCT01825837|464448571|FG000|PART II|Patient non-compliance|5|||
129042848|NCT01825837|464448572|FG001|PART II|Patient non-compliance|2|||
129042849|NCT01825837|464448573|FG002|PART II|Patient non-compliance|4|||
129042850|NCT01825837|464448574|FG003|PART II|Patient non-compliance|0|||
129042851|NCT01825837|464448571|FG000|PART II|Adverse Event|3|||
129042852|NCT01825837|464448572|FG001|PART II|Adverse Event|3|||
129042853|NCT01825837|464448573|FG002|PART II|Adverse Event|1|||
129042854|NCT01825837|464448574|FG003|PART II|Adverse Event|0|||
129042855|NCT01825837|464448571|FG000|PART II|Treatment failure|6|||
129042856|NCT01825837|464448572|FG001|PART II|Treatment failure|4|||
129042857|NCT01825837|464448573|FG002|PART II|Treatment failure|5|||
129042858|NCT01825837|464448574|FG003|PART II|Treatment failure|0|||
129042859|NCT01825837|464448571|FG000|PART II|reason unspecified|2|||
129042860|NCT01825837|464448572|FG001|PART II|reason unspecified|2|||
129042861|NCT01825837|464448573|FG002|PART II|reason unspecified|2|||
128981022|NCT00598442|464216775|FG000|Overall Study|Renal transplant|0|||
128981023|NCT00598442|464216776|FG001|Overall Study|Renal transplant|0|||
128981024|NCT00598442|464216777|FG002|Overall Study|Renal transplant|1|||
128981025|NCT00598442|464216775|FG000|Overall Study|Site closed by sponsor|5|||
128981026|NCT00598442|464216776|FG001|Overall Study|Site closed by sponsor|2|||
128981027|NCT00598442|464216777|FG002|Overall Study|Site closed by sponsor|1|||
128981028|NCT00598442|464216775|FG000|Overall Study|Started dialysis|1|||
128981029|NCT00598442|464216776|FG001|Overall Study|Started dialysis|0|||
128981030|NCT00598442|464216777|FG002|Overall Study|Started dialysis|0|||
128981031|NCT00697255|464216778|FG000|Stage 1a|Insufficient ovarian response|1|||
128981032|NCT00697255|464216779|FG001|Stage 1a|Insufficient ovarian response|0|||
128981033|NCT00697255|464216778|FG000|Stage 1a|Multifollicular growth|1|||
128981034|NCT00697255|464216779|FG001|Stage 1a|Multifollicular growth|0|||
128981035|NCT00697255|464216778|FG000|Stage 1a|Not growing of dominant follicle|1|||
128981036|NCT00697255|464216779|FG001|Stage 1a|Not growing of dominant follicle|0|||
128981037|NCT00697255|464216778|FG000|Stage 1b|Not growing of dominant follicle|0|||
128981038|NCT00697255|464216779|FG001|Stage 1b|Not growing of dominant follicle|1|||
128981039|NCT00697255|464216778|FG000|Stage 1b|Insufficient ovarian response|0|||
128981040|NCT00697255|464216779|FG001|Stage 1b|Insufficient ovarian response|1|||
128981041|NCT01005875|464216789|FG000|Overall Study|Death|3|||
128981042|NCT03077646|464216792|FG000|Overall Study|Lost to Follow-up|29|||
128981043|NCT03077646|464216793|FG001|Overall Study|Lost to Follow-up|30|||
128981044|NCT03077646|464216794|FG002|Overall Study|Lost to Follow-up|31|||
128981045|NCT02058966|464216795|FG000|Open-Label Methamphetamine|Adverse Event|1|||
128981046|NCT02058966|464216795|FG000|First Intervention|Withdrawal by Subject|1|||
128981047|NCT00765726|464216796|FG000|Overall Study|Withdrawal by Subject|1|||
128981048|NCT00765726|464216796|FG000|Overall Study|Discontinuation of study by sponsor|8|||
128981049|NCT01265511|464216797|FG000|Overall Study|Lack of Efficacy|2|||
128981050|NCT01265511|464216798|FG001|Overall Study|Lack of Efficacy|1|||
128981051|NCT01265511|464216797|FG000|Overall Study|Met stopping rules|0|||
128981052|NCT01265511|464216798|FG001|Overall Study|Met stopping rules|2|||
128981053|NCT00323479|464216799|FG000|Overall Study|Adverse Event|2|||
128981054|NCT00323479|464216799|FG000|Overall Study|Withdrawal by Subject|2|||
128981055|NCT00323479|464216799|FG000|Overall Study|Protocol Violation|3|||
128981056|NCT00323479|464216799|FG000|Overall Study|house moving|1|||
128981057|NCT01362062|464216800|FG000|Overall Study|Adverse Event|1|||
128981058|NCT01362062|464216801|FG001|Overall Study|Adverse Event|0|||
128981059|NCT01362062|464216800|FG000|Overall Study|Lost to Follow-up|11|||
128981060|NCT01362062|464216801|FG001|Overall Study|Lost to Follow-up|0|||
128981061|NCT01362062|464216800|FG000|Overall Study|Withdrawal by Subject|2|||
128981062|NCT01362062|464216801|FG001|Overall Study|Withdrawal by Subject|0|||
128981063|NCT01362062|464216800|FG000|Overall Study|Non-compliant participant|2|||
128981064|NCT01362062|464216801|FG001|Overall Study|Non-compliant participant|0|||
128981065|NCT01362062|464216800|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
128981066|NCT01362062|464216801|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
128981067|NCT01362062|464216800|FG000|Overall Study|Had significant improvement|9|||
128981068|NCT01362062|464216801|FG001|Overall Study|Had significant improvement|0|||
128981069|NCT00967343|464216802|FG000|Overall Study|Study termination by sponsor|12|||
128981070|NCT00967343|464216802|FG000|Overall Study|Death|24|||
128981071|NCT00967343|464216802|FG000|Overall Study|Relapse|1|||
128981072|NCT00967343|464216802|FG000|Overall Study|Lost to Follow-up|1|||
128981073|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
128981074|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
128981075|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
128981076|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
128981077|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
128981078|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
128981079|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
128981080|NCT00950755|464216804|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
128981081|NCT00950755|464216804|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
128981082|NCT00950755|464216804|FG000|Long-Term Follow-Up|Death|8|||
128981083|NCT01336647|464218903|FG000|Overall Study|Lost to Follow-up|4|||
128981084|NCT01336647|464218904|FG001|Overall Study|Lost to Follow-up|1|||
128981085|NCT01336647|464218905|FG002|Overall Study|Lost to Follow-up|3|||
128981086|NCT01004822|464218906|FG000|Overall Study|Objective progression or relapse|3|||
128981087|NCT01004822|464218907|FG001|Overall Study|Objective progression or relapse|3|||
128981088|NCT01004822|464218908|FG002|Overall Study|Objective progression or relapse|0|||
128981089|NCT01004822|464218909|FG003|Overall Study|Objective progression or relapse|1|||
128981090|NCT01004822|464218910|FG004|Overall Study|Objective progression or relapse|2|||
128981091|NCT01004822|464218911|FG005|Overall Study|Objective progression or relapse|2|||
128981092|NCT01004822|464218912|FG006|Overall Study|Objective progression or relapse|1|||
128981093|NCT01004822|464218913|FG007|Overall Study|Objective progression or relapse|4|||
128981094|NCT01004822|464218906|FG000|Overall Study|Global deterioration of health status|0|||
128981095|NCT01004822|464218907|FG001|Overall Study|Global deterioration of health status|0|||
129042862|NCT01825837|464448574|FG003|PART II|reason unspecified|0|||
129042863|NCT00904748|464448575|FG000|Overall Study|Withdrawal by Subject|1|||
129042864|NCT00904748|464448576|FG001|Overall Study|Withdrawal by Subject|1|||
129042865|NCT00904748|464448577|FG002|Overall Study|Withdrawal by Subject|1|||
129042866|NCT00904748|464448578|FG003|Overall Study|Withdrawal by Subject|2|||
129042867|NCT00904748|464448579|FG004|Overall Study|Withdrawal by Subject|0|||
129042868|NCT00904748|464448580|FG005|Overall Study|Withdrawal by Subject|0|||
129042869|NCT00904748|464448575|FG000|Overall Study|Adverse Event|0|||
129042870|NCT00904748|464448576|FG001|Overall Study|Adverse Event|0|||
129042871|NCT00904748|464448577|FG002|Overall Study|Adverse Event|0|||
129042872|NCT00904748|464448578|FG003|Overall Study|Adverse Event|0|||
129134020|NCT03554473|464784886|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
129134021|NCT04971837|464784890|FG000|Overall Study|Long Term Illness|1|||
129134022|NCT04971837|464784890|FG000|Overall Study|BMI too low|9|||
129134023|NCT04971837|464784890|FG000|Overall Study|geographic location|1|||
129134024|NCT04971837|464784890|FG000|Overall Study|Discontinued scheduling conflict|1|||
129134025|NCT00567580|464784891|FG000|Overall Study|Protocol Violation|28|||
129134026|NCT00567580|464784892|FG001|Overall Study|Protocol Violation|24|||
129134027|NCT00567580|464784893|FG002|Overall Study|Protocol Violation|24|||
129134028|NCT00382070|464784894|FG000|Overall Study|No follow up data mapped to Other|17|||
129134029|NCT00382070|464784895|FG001|Overall Study|No follow up data mapped to Other|19|||
129134030|NCT00382070|464784894|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
129134031|NCT00382070|464784895|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
129134032|NCT00382070|464784894|FG000|Overall Study|No clinical assessment|9|||
129134033|NCT00382070|464784895|FG001|Overall Study|No clinical assessment|11|||
129134034|NCT02082483|464784901|FG000|Overall Study|Lost to Follow-up|1|||
129134035|NCT02082483|464784902|FG001|Overall Study|Lost to Follow-up|1|||
129134036|NCT02082483|464784901|FG000|Overall Study|Withdrawal by Subject|2|||
129134037|NCT02082483|464784902|FG001|Overall Study|Withdrawal by Subject|1|||
129134038|NCT02082483|464784901|FG000|Overall Study|Physician Decision|1|||
129134039|NCT02082483|464784902|FG001|Overall Study|Physician Decision|1|||
129134040|NCT02082483|464784901|FG000|Overall Study|Death|2|||
129134041|NCT02082483|464784902|FG001|Overall Study|Death|3|||
129134042|NCT01562444|464784905|FG000|Overall Study|Did not meet entry criteria|2|||
129134043|NCT01562444|464784906|FG001|Overall Study|Did not meet entry criteria|0|||
129134044|NCT01562444|464784907|FG002|Overall Study|Did not meet entry criteria|3|||
129134045|NCT01562444|464784905|FG000|Overall Study|Did not comply with blood draw schedule|1|||
129134046|NCT01562444|464784906|FG001|Overall Study|Did not comply with blood draw schedule|0|||
129134047|NCT01562444|464784907|FG002|Overall Study|Did not comply with blood draw schedule|1|||
129134048|NCT01562444|464784905|FG000|Overall Study|Unavailable serological results|0|||
129134049|NCT01562444|464784906|FG001|Overall Study|Unavailable serological results|2|||
129134050|NCT01562444|464784907|FG002|Overall Study|Unavailable serological results|2|||
129134051|NCT01562444|464784905|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
129134052|NCT01562444|464784906|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
129134053|NCT01562444|464784907|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
129134054|NCT01562444|464784905|FG000|Overall Study|Protocol forbidden medication|1|||
129134055|NCT01562444|464784906|FG001|Overall Study|Protocol forbidden medication|0|||
129134056|NCT01562444|464784907|FG002|Overall Study|Protocol forbidden medication|0|||
129134057|NCT03055195|464784908|FG000|Overall Study|Lack of Efficacy|1|||
129134058|NCT03055195|464784909|FG001|Overall Study|Lack of Efficacy|0|||
129134059|NCT03055195|464784908|FG000|Overall Study|Withdrawal by Subject|6|||
129134060|NCT03055195|464784909|FG001|Overall Study|Withdrawal by Subject|7|||
129134061|NCT03055195|464784908|FG000|Overall Study|Study Terminated by Sponsor|2|||
129134062|NCT03055195|464784909|FG001|Overall Study|Study Terminated by Sponsor|6|||
129134063|NCT03055195|464784908|FG000|Overall Study|Protocol Violation|2|||
129134064|NCT03055195|464784909|FG001|Overall Study|Protocol Violation|1|||
129134065|NCT03055195|464784908|FG000|Overall Study|Physician Decision|1|||
129134066|NCT03055195|464784909|FG001|Overall Study|Physician Decision|0|||
129134067|NCT01027416|464784910|FG000|Overall Study|Withdrawal by Subject|0|||
129042873|NCT00904748|464448579|FG004|Overall Study|Adverse Event|1|||
129042874|NCT00904748|464448580|FG005|Overall Study|Adverse Event|0|||
129042875|NCT02903238|464448587|FG000|Overall Study|Lost to Follow-up|4|||
129042876|NCT00700817|464448591|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
129134068|NCT01027416|464784911|FG001|Overall Study|Withdrawal by Subject|1|||
129134069|NCT01027416|464784910|FG000|Overall Study|Physician Decision|1|||
129042877|NCT00700817|464448592|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
129134070|NCT01027416|464784911|FG001|Overall Study|Physician Decision|4|||
129042878|NCT00700817|464448593|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
129042879|NCT00700817|464448594|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
129042880|NCT00700817|464448595|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
129134071|NCT02056288|464784918|FG000|In-Hospital Data|Surgery cancelled|1|||
129134072|NCT02056288|464784919|FG001|In-Hospital Data|Surgery cancelled|0|||
129134073|NCT02056288|464784918|FG000|In-Hospital Data|Protocol Violation|3|||
129134074|NCT02056288|464784919|FG001|In-Hospital Data|Protocol Violation|0|||
129134075|NCT02056288|464784918|FG000|In-Hospital Data|Physician Decision|1|||
129222794|NCT02427464|465116209|FG001|Overall Study|Lost to Follow-up|5|||
129222795|NCT02427464|465116208|FG000|Overall Study|Physician Decision|2|||
129222796|NCT02427464|465116209|FG001|Overall Study|Physician Decision|0|||
129042881|NCT00700817|464448591|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
129042882|NCT00700817|464448592|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
129042883|NCT00700817|464448593|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
129042884|NCT00700817|464448594|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
129042885|NCT00700817|464448595|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
129042886|NCT00700817|464448591|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
129042887|NCT00700817|464448592|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
129042888|NCT00700817|464448593|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
129042889|NCT00700817|464448594|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
129042890|NCT00700817|464448595|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
129042891|NCT00700817|464448591|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
129042892|NCT00700817|464448592|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
129042893|NCT00700817|464448593|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
129042894|NCT00700817|464448594|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
129042895|NCT00700817|464448595|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
129042896|NCT00700817|464448591|FG000|Week 0-26 (Main Period)|Unclassified|14|||
129042897|NCT00700817|464448592|FG001|Week 0-26 (Main Period)|Unclassified|4|||
129042898|NCT00700817|464448593|FG002|Week 0-26 (Main Period)|Unclassified|8|||
129042899|NCT00700817|464448594|FG003|Week 0-26 (Main Period)|Unclassified|0|||
129042900|NCT00700817|464448595|FG004|Week 0-26 (Main Period)|Unclassified|0|||
129042901|NCT00700817|464448591|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
129042902|NCT00700817|464448592|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
129042903|NCT00700817|464448593|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
129042904|NCT00700817|464448594|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
129042905|NCT00700817|464448595|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
129042906|NCT00700817|464448591|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
129042907|NCT00700817|464448592|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
129042908|NCT00700817|464448593|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
129042909|NCT00700817|464448594|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
129042910|NCT00700817|464448595|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
129042911|NCT00700817|464448591|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
129042912|NCT00700817|464448592|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
129042913|NCT00700817|464448593|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
129042914|NCT00700817|464448594|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
129042915|NCT00700817|464448595|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
129042916|NCT00700817|464448591|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
129042917|NCT00700817|464448592|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
129042918|NCT00700817|464448593|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
129042919|NCT00700817|464448594|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
129042920|NCT00700817|464448595|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
129042921|NCT00700817|464448591|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
129042922|NCT00700817|464448592|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
129042923|NCT00700817|464448593|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
129042924|NCT00700817|464448594|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
129042925|NCT00700817|464448595|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
129042926|NCT00700817|464448591|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
129042927|NCT00700817|464448592|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
129042928|NCT00700817|464448593|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
129042929|NCT00700817|464448594|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
129042930|NCT00700817|464448595|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
129042931|NCT00700817|464448591|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
129042932|NCT00700817|464448592|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
129042933|NCT00700817|464448593|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
129042934|NCT00700817|464448594|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
129042935|NCT00700817|464448595|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
129042936|NCT00700817|464448591|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
129042937|NCT00700817|464448592|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
129042938|NCT00700817|464448593|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
129042939|NCT00700817|464448594|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
129042940|NCT00700817|464448595|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
129042941|NCT00700817|464448591|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
129042942|NCT00700817|464448592|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
129042943|NCT00700817|464448593|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
129042944|NCT00700817|464448594|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
129042945|NCT00700817|464448595|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
129042946|NCT00700817|464448591|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
129222797|NCT02427464|465116208|FG000|Overall Study|Withdrawal by Subject|10|||
129042947|NCT00700817|464448592|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
129042948|NCT00700817|464448593|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
129042949|NCT00700817|464448594|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
129042950|NCT00700817|464448595|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
129042951|NCT00767520|464448596|FG000|Overall Study|Participants still on treatment|11|||
129042952|NCT00767520|464448597|FG001|Overall Study|Participants still on treatment|15|||
129042953|NCT00767520|464448596|FG000|Overall Study|Randomized in error and Never treated|0|||
129042954|NCT00767520|464448597|FG001|Overall Study|Randomized in error and Never treated|2|||
129042955|NCT00958126|464448600|FG000|Overall Study|Serious Adverse Event|0|||
129042956|NCT00958126|464448601|FG001|Overall Study|Serious Adverse Event|2|||
129042957|NCT00958126|464448602|FG002|Overall Study|Serious Adverse Event|0|||
129042958|NCT00958126|464448603|FG003|Overall Study|Serious Adverse Event|0|||
129042959|NCT00958126|464448604|FG004|Overall Study|Serious Adverse Event|0|||
129042960|NCT00958126|464448605|FG005|Overall Study|Serious Adverse Event|0|||
129042961|NCT00958126|464448606|FG006|Overall Study|Serious Adverse Event|1|||
129042962|NCT00958126|464448607|FG007|Overall Study|Serious Adverse Event|0|||
129042963|NCT00958126|464448600|FG000|Overall Study|Withdrawal by Subject|0|||
129042964|NCT00958126|464448601|FG001|Overall Study|Withdrawal by Subject|2|||
129042965|NCT00958126|464448602|FG002|Overall Study|Withdrawal by Subject|0|||
129042966|NCT00958126|464448603|FG003|Overall Study|Withdrawal by Subject|0|||
129042967|NCT00958126|464448604|FG004|Overall Study|Withdrawal by Subject|0|||
129042968|NCT00958126|464448605|FG005|Overall Study|Withdrawal by Subject|0|||
129042969|NCT00958126|464448606|FG006|Overall Study|Withdrawal by Subject|0|||
129042970|NCT00958126|464448607|FG007|Overall Study|Withdrawal by Subject|0|||
129042971|NCT00958126|464448600|FG000|Overall Study|Moved away from study area|0|||
129042972|NCT00958126|464448601|FG001|Overall Study|Moved away from study area|0|||
129042973|NCT00958126|464448602|FG002|Overall Study|Moved away from study area|1|||
129042974|NCT00958126|464448603|FG003|Overall Study|Moved away from study area|1|||
129042975|NCT00958126|464448604|FG004|Overall Study|Moved away from study area|0|||
129042976|NCT00958126|464448605|FG005|Overall Study|Moved away from study area|0|||
129042977|NCT00958126|464448606|FG006|Overall Study|Moved away from study area|0|||
129222798|NCT02427464|465116209|FG001|Overall Study|Withdrawal by Subject|8|||
129042978|NCT00958126|464448607|FG007|Overall Study|Moved away from study area|0|||
129042979|NCT00958126|464448600|FG000|Overall Study|Lost to Follow-up|1|||
129042980|NCT00958126|464448601|FG001|Overall Study|Lost to Follow-up|5|||
129042981|NCT00958126|464448602|FG002|Overall Study|Lost to Follow-up|9|||
129042982|NCT00958126|464448603|FG003|Overall Study|Lost to Follow-up|8|||
129042983|NCT00958126|464448604|FG004|Overall Study|Lost to Follow-up|0|||
129042984|NCT00958126|464448605|FG005|Overall Study|Lost to Follow-up|0|||
129042985|NCT00958126|464448606|FG006|Overall Study|Lost to Follow-up|0|||
129042986|NCT00958126|464448607|FG007|Overall Study|Lost to Follow-up|0|||
129042987|NCT00958126|464448600|FG000|Overall Study|Sponsor/Investigator decision|0|||
129042988|NCT00958126|464448601|FG001|Overall Study|Sponsor/Investigator decision|0|||
129042989|NCT00958126|464448602|FG002|Overall Study|Sponsor/Investigator decision|0|||
129042990|NCT00958126|464448603|FG003|Overall Study|Sponsor/Investigator decision|1|||
129042991|NCT00958126|464448604|FG004|Overall Study|Sponsor/Investigator decision|0|||
129042992|NCT00958126|464448605|FG005|Overall Study|Sponsor/Investigator decision|0|||
129042993|NCT00958126|464448606|FG006|Overall Study|Sponsor/Investigator decision|0|||
129042994|NCT00958126|464448607|FG007|Overall Study|Sponsor/Investigator decision|0|||
129042995|NCT00958126|464448600|FG000|Overall Study|Other Reason|0|||
129042996|NCT00958126|464448601|FG001|Overall Study|Other Reason|0|||
129042997|NCT00958126|464448602|FG002|Overall Study|Other Reason|0|||
129042998|NCT00958126|464448603|FG003|Overall Study|Other Reason|1|||
129042999|NCT00958126|464448604|FG004|Overall Study|Other Reason|0|||
129043000|NCT00958126|464448605|FG005|Overall Study|Other Reason|1|||
129043001|NCT00958126|464448606|FG006|Overall Study|Other Reason|0|||
129043002|NCT00958126|464448607|FG007|Overall Study|Other Reason|0|||
129043003|NCT00720226|464448608|FG000|Overall Study|Withdrawal by Subject|7|||
129043004|NCT00720226|464448609|FG001|Overall Study|Withdrawal by Subject|4|||
129043005|NCT03401073|464448612|FG000|Overall Study|Lost to Follow-up|1|||
129043006|NCT03401073|464448613|FG001|Overall Study|Lost to Follow-up|2|||
129043007|NCT00733369|464448614|FG000|Overall Study|Lost to Follow-up|2|||
129043008|NCT00733369|464448615|FG001|Overall Study|Lost to Follow-up|1|||
129043009|NCT00733369|464448614|FG000|Overall Study|Adverse Event|4|||
129043010|NCT00733369|464448615|FG001|Overall Study|Adverse Event|4|||
129043011|NCT00733369|464448614|FG000|Overall Study|Protocol Violation|4|||
129043012|NCT00733369|464448615|FG001|Overall Study|Protocol Violation|4|||
129043013|NCT01470612|464448619|FG000|Overall Study|Adverse Event|20|||
129043014|NCT01470612|464448620|FG001|Overall Study|Adverse Event|80|||
129043015|NCT01470612|464448619|FG000|Overall Study|Death|0|||
129043016|NCT01470612|464448620|FG001|Overall Study|Death|1|||
129043017|NCT01470612|464448619|FG000|Overall Study|Lack of Efficacy|20|||
129043018|NCT01470612|464448620|FG001|Overall Study|Lack of Efficacy|326|||
129043019|NCT01470612|464448619|FG000|Overall Study|Lost to Follow-up|2|||
129043020|NCT01470612|464448620|FG001|Overall Study|Lost to Follow-up|5|||
129043021|NCT01470612|464448619|FG000|Overall Study|Did not meet entrance criteria|0|||
129043022|NCT01470612|464448620|FG001|Overall Study|Did not meet entrance criteria|1|||
129043023|NCT01470612|464448619|FG000|Overall Study|Pregnancy|2|||
129043024|NCT01470612|464448620|FG001|Overall Study|Pregnancy|10|||
129043025|NCT01470612|464448619|FG000|Overall Study|Protocol Violation|2|||
129043026|NCT01470612|464448620|FG001|Overall Study|Protocol Violation|7|||
129043027|NCT01470612|464448619|FG000|Overall Study|Withdrawal by Subject|24|||
129043028|NCT01470612|464448620|FG001|Overall Study|Withdrawal by Subject|79|||
129043029|NCT01470612|464448619|FG000|Overall Study|Other|14|||
129043030|NCT01470612|464448620|FG001|Overall Study|Other|156|||
129043031|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
129043032|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
129043033|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
129043034|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
129043035|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
129043036|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
129043037|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
129043038|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
129043039|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
129043040|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
129043041|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
129043042|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
129043043|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
129043044|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
129043045|NCT02510014|464448624|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
129043046|NCT02510014|464448625|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
129043047|NCT02510014|464448624|FG000|Treatment Period|Adverse Event|11|||
129043048|NCT02510014|464448625|FG001|Treatment Period|Adverse Event|4|||
129043049|NCT02510014|464448624|FG000|Treatment Period|Withdrawal symptoms|3|||
129043050|NCT02510014|464448625|FG001|Treatment Period|Withdrawal symptoms|0|||
129043051|NCT02510014|464448624|FG000|Treatment Period|Lost to Follow-up|80|||
129043052|NCT02510014|464448625|FG001|Treatment Period|Lost to Follow-up|19|||
129043053|NCT02510014|464448624|FG000|Treatment Period|Physician Decision|5|||
129043054|NCT02510014|464448625|FG001|Treatment Period|Physician Decision|0|||
129043055|NCT02510014|464448624|FG000|Treatment Period|Withdrawal by Subject|67|||
129043056|NCT02510014|464448625|FG001|Treatment Period|Withdrawal by Subject|24|||
129043057|NCT02510014|464448624|FG000|Treatment Period|Withdrawn by the investigator|7|||
129043058|NCT02510014|464448625|FG001|Treatment Period|Withdrawn by the investigator|1|||
129043059|NCT02510014|464448624|FG000|Treatment Period|Protocol Violation|4|||
129043060|NCT02510014|464448625|FG001|Treatment Period|Protocol Violation|4|||
129043061|NCT02510014|464448624|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
129043062|NCT02510014|464448625|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
129043063|NCT02556307|464448629|FG000|Overall Study|Premature treatment interruption|11|||
129043064|NCT02556307|464448629|FG000|Overall Study|Lost to Follow-up|36|||
129043065|NCT02556307|464448629|FG000|Overall Study|Change to triple therapy|4|||
129043066|NCT02556307|464448629|FG000|Overall Study|Enrolled but not treated|2|||
129043067|NCT00384176|464448633|FG000|Overall Study|Death|239|||
129043068|NCT00384176|464448634|FG001|Overall Study|Death|247|||
129043069|NCT00384176|464448635|FG002|Overall Study|Death|105|||
129043070|NCT00384176|464448633|FG000|Overall Study|Withdrawal by Subject|52|||
129043071|NCT00384176|464448634|FG001|Overall Study|Withdrawal by Subject|48|||
129043072|NCT00384176|464448635|FG002|Overall Study|Withdrawal by Subject|22|||
129043073|NCT00384176|464448633|FG000|Overall Study|Lost to Follow-up|16|||
129134076|NCT02056288|464784919|FG001|In-Hospital Data|Physician Decision|0|||
129134077|NCT02056288|464784918|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
129134078|NCT02056288|464784919|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
129134079|NCT00500110|464784920|FG000|Overall Study|Withdrawal by Subject|3|||
129134080|NCT01502072|464784921|FG000|Overall Study|Withdrawal by Subject|1|||
129134081|NCT01502072|464784922|FG001|Overall Study|Withdrawal by Subject|0|||
129134082|NCT01502072|464784923|FG002|Overall Study|Withdrawal by Subject|0|||
129043074|NCT00384176|464448634|FG001|Overall Study|Lost to Follow-up|18|||
129043075|NCT00384176|464448635|FG002|Overall Study|Lost to Follow-up|4|||
129222799|NCT02427464|465116208|FG000|Overall Study|Noncompliance|16|||
129043076|NCT00384176|464448633|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
129043077|NCT00384176|464448634|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
129043078|NCT00384176|464448635|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
129043079|NCT00384176|464448633|FG000|Overall Study|Longer QTC as Visit 1|1|||
129043080|NCT00384176|464448634|FG001|Overall Study|Longer QTC as Visit 1|0|||
129043081|NCT00384176|464448635|FG002|Overall Study|Longer QTC as Visit 1|0|||
129043082|NCT00384176|464448633|FG000|Overall Study|Toxicity of treatment|1|||
129043083|NCT00384176|464448634|FG001|Overall Study|Toxicity of treatment|0|||
129043084|NCT00384176|464448635|FG002|Overall Study|Toxicity of treatment|0|||
129134083|NCT01502072|464784921|FG000|Overall Study|Death|0|||
129134084|NCT01502072|464784922|FG001|Overall Study|Death|1|||
129134085|NCT01502072|464784923|FG002|Overall Study|Death|0|||
129134086|NCT00617903|464784929|FG000|Overall Study|Withdrawal by Subject|2|||
129134087|NCT00617903|464784930|FG001|Overall Study|Withdrawal by Subject|3|||
129134088|NCT00617903|464784929|FG000|Overall Study|Lost to Follow-up|1|||
129134089|NCT00617903|464784930|FG001|Overall Study|Lost to Follow-up|1|||
129134090|NCT00617903|464784929|FG000|Overall Study|Lack of Efficacy|0|||
129134091|NCT00617903|464784930|FG001|Overall Study|Lack of Efficacy|1|||
129134092|NCT00617903|464784929|FG000|Overall Study|Adverse Event|0|||
129134093|NCT00617903|464784930|FG001|Overall Study|Adverse Event|1|||
129134094|NCT00617903|464784929|FG000|Overall Study|noncompliance|0|||
129134095|NCT00617903|464784930|FG001|Overall Study|noncompliance|1|||
129134096|NCT04676646|464784931|FG000|Open-label Run-in Phase|Adverse Event|3|||
129134097|NCT04676646|464784932|FG001|Open-label Run-in Phase|Adverse Event|0|||
129134098|NCT04676646|464784933|FG002|Open-label Run-in Phase|Adverse Event|0|||
129134099|NCT04676646|464784931|FG000|Open-label Run-in Phase|Death|3|||
129134100|NCT04676646|464784932|FG001|Open-label Run-in Phase|Death|0|||
129134101|NCT04676646|464784933|FG002|Open-label Run-in Phase|Death|0|||
129134102|NCT04676646|464784931|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
129134103|NCT04676646|464784932|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
129134104|NCT04676646|464784933|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
129222800|NCT02427464|465116209|FG001|Overall Study|Noncompliance|10|||
129222801|NCT06005597|465116210|FG000|Overall Study|Lost to Follow-up|1|||
128718972|NCT00768300|463268915|FG001|Overall Study|Received lung transplant|1|||
128718973|NCT00768300|463268914|FG000|Overall Study|Lost to Follow-up|0|||
128981096|NCT01004822|464218908|FG002|Overall Study|Global deterioration of health status|0|||
128981097|NCT01004822|464218909|FG003|Overall Study|Global deterioration of health status|1|||
128981098|NCT01004822|464218910|FG004|Overall Study|Global deterioration of health status|0|||
128981099|NCT01004822|464218911|FG005|Overall Study|Global deterioration of health status|0|||
128981100|NCT01004822|464218912|FG006|Overall Study|Global deterioration of health status|1|||
128981101|NCT01004822|464218913|FG007|Overall Study|Global deterioration of health status|0|||
128981102|NCT01004822|464218906|FG000|Overall Study|No longer willing to continue|0|||
128981103|NCT01004822|464218907|FG001|Overall Study|No longer willing to continue|0|||
128981104|NCT01004822|464218908|FG002|Overall Study|No longer willing to continue|0|||
128981105|NCT01004822|464218909|FG003|Overall Study|No longer willing to continue|1|||
128981106|NCT01004822|464218910|FG004|Overall Study|No longer willing to continue|2|||
128981107|NCT01004822|464218911|FG005|Overall Study|No longer willing to continue|1|||
128981108|NCT01004822|464218912|FG006|Overall Study|No longer willing to continue|1|||
128981109|NCT01004822|464218913|FG007|Overall Study|No longer willing to continue|0|||
128981110|NCT01004822|464218906|FG000|Overall Study|Adverse Event|0|||
128981111|NCT01004822|464218907|FG001|Overall Study|Adverse Event|0|||
128981112|NCT01004822|464218908|FG002|Overall Study|Adverse Event|0|||
128981113|NCT01004822|464218909|FG003|Overall Study|Adverse Event|0|||
128981114|NCT01004822|464218910|FG004|Overall Study|Adverse Event|0|||
128981115|NCT01004822|464218911|FG005|Overall Study|Adverse Event|0|||
128981116|NCT01004822|464218912|FG006|Overall Study|Adverse Event|1|||
128981117|NCT01004822|464218913|FG007|Overall Study|Adverse Event|1|||
128981118|NCT01004822|464218906|FG000|Overall Study|Other|0|||
128981119|NCT01004822|464218907|FG001|Overall Study|Other|0|||
128981120|NCT01004822|464218908|FG002|Overall Study|Other|4|||
128981121|NCT01004822|464218909|FG003|Overall Study|Other|1|||
128981122|NCT01004822|464218910|FG004|Overall Study|Other|0|||
128981123|NCT01004822|464218911|FG005|Overall Study|Other|1|||
128981124|NCT01004822|464218912|FG006|Overall Study|Other|0|||
128981125|NCT01004822|464218913|FG007|Overall Study|Other|0|||
128981126|NCT01858701|464218914|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
128981127|NCT01858701|464218915|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
128981128|NCT01858701|464218914|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
128981129|NCT01858701|464218915|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
128981130|NCT01858701|464218914|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
128981131|NCT01858701|464218915|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
128981132|NCT01858701|464218914|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
128981133|NCT01858701|464218915|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
128981134|NCT01789476|464218923|FG000|Overall Study|Lack of Efficacy|6|||
128981135|NCT01789476|464218924|FG001|Overall Study|Lack of Efficacy|2|||
128981136|NCT01789476|464218923|FG000|Overall Study|Adverse Event|1|||
128981137|NCT01789476|464218924|FG001|Overall Study|Adverse Event|0|||
129134105|NCT04676646|464784931|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
129134106|NCT04676646|464784932|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
129134107|NCT04676646|464784933|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
129134108|NCT04676646|464784931|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
129134109|NCT04676646|464784932|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
129134110|NCT04676646|464784933|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
129134111|NCT04676646|464784931|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
129134112|NCT04676646|464784932|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
129222802|NCT06005597|465116211|FG001|Overall Study|Lost to Follow-up|2|||
129134113|NCT04676646|464784933|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
129134114|NCT04676646|464784931|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
129134115|NCT04676646|464784932|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
129134116|NCT04676646|464784933|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
129134117|NCT04676646|464784931|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
129134118|NCT04676646|464784932|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
129134119|NCT04676646|464784933|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
129134120|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
129134121|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
129134122|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
129134123|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Death|0|||
129134124|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Death|1|||
129134125|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Death|2|||
129134126|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
129134127|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
128718974|NCT00768300|463268915|FG001|Overall Study|Lost to Follow-up|1|||
129134128|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
129134129|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
129134130|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
129134131|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
129134132|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
129134133|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
129134134|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
129134135|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
129134136|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
129134137|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
129134138|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
129134139|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
129134140|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
129134141|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
129134142|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
129134143|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
129134144|NCT04676646|464784931|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
129134145|NCT04676646|464784932|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
129134146|NCT04676646|464784933|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
129134147|NCT03123588|464784941|FG000|Overall Study|Study Terminated by Sponsor|2|||
129134148|NCT03123588|464784942|FG001|Overall Study|Study Terminated by Sponsor|5|||
129134149|NCT03123588|464784941|FG000|Overall Study|Withdrawal by Subject|1|||
129134150|NCT03123588|464784942|FG001|Overall Study|Withdrawal by Subject|0|||
129134151|NCT03123588|464784941|FG000|Overall Study|Adverse Event|1|||
129134152|NCT03123588|464784942|FG001|Overall Study|Adverse Event|0|||
129134153|NCT03123588|464784941|FG000|Overall Study|Physician Decision|2|||
129134154|NCT03123588|464784942|FG001|Overall Study|Physician Decision|1|||
129134155|NCT01058005|464784943|FG000|Overall Study|Adverse Event|0|||
129134156|NCT01058005|464784944|FG001|Overall Study|Adverse Event|2|||
129134157|NCT01058005|464784945|FG002|Overall Study|Adverse Event|1|||
129134158|NCT01058005|464784943|FG000|Overall Study|Physician Decision|2|||
129134159|NCT01058005|464784944|FG001|Overall Study|Physician Decision|2|||
129134160|NCT01058005|464784945|FG002|Overall Study|Physician Decision|0|||
129134161|NCT01058005|464784943|FG000|Overall Study|Withdrawal by Subject|4|||
129134162|NCT01058005|464784944|FG001|Overall Study|Withdrawal by Subject|5|||
129134163|NCT01058005|464784945|FG002|Overall Study|Withdrawal by Subject|11|||
129134164|NCT01058005|464784943|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
129134165|NCT01058005|464784944|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
129134166|NCT01058005|464784945|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
129134167|NCT01058005|464784943|FG000|Overall Study|Reason Missing|5|||
129134168|NCT01058005|464784944|FG001|Overall Study|Reason Missing|3|||
129134169|NCT01058005|464784945|FG002|Overall Study|Reason Missing|1|||
129134170|NCT02346370|464784948|FG000|Overall Study|Not treated|1|||
128718975|NCT00768300|463268914|FG000|Overall Study|Began prohibited concomitant medication|0|||
128718976|NCT00768300|463268915|FG001|Overall Study|Began prohibited concomitant medication|1|||
128718977|NCT00768300|463268914|FG000|Overall Study|Treated but never dosed with Study drug|1|||
129134171|NCT02346370|464784949|FG001|Overall Study|Not treated|0|||
129134172|NCT02346370|464784950|FG002|Overall Study|Not treated|0|||
129043085|NCT00384176|464448633|FG000|Overall Study|Did not receive study treatment|0|||
129043086|NCT00384176|464448634|FG001|Overall Study|Did not receive study treatment|1|||
129043087|NCT00384176|464448635|FG002|Overall Study|Did not receive study treatment|1|||
129043088|NCT00384176|464448633|FG000|Overall Study|Physician Decision|0|||
129043089|NCT00384176|464448634|FG001|Overall Study|Physician Decision|2|||
129043090|NCT00384176|464448635|FG002|Overall Study|Physician Decision|0|||
129043091|NCT00384176|464448633|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
129043092|NCT00384176|464448634|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
129043093|NCT00384176|464448635|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
129043094|NCT00049842|464448636|FG000|Treatment Phase|Adverse Event|47|||
129043095|NCT00049842|464448637|FG001|Treatment Phase|Adverse Event|12|||
129043096|NCT00049842|464448636|FG000|Treatment Phase|Withdrawal by Subject|35|||
129043097|NCT00049842|464448637|FG001|Treatment Phase|Withdrawal by Subject|46|||
129043098|NCT00049842|464448636|FG000|Treatment Phase|Non-compliance with protocol|7|||
129043099|NCT00049842|464448637|FG001|Treatment Phase|Non-compliance with protocol|8|||
129043100|NCT00049842|464448636|FG000|Treatment Phase|Lost to Follow-up|4|||
129043101|NCT00049842|464448637|FG001|Treatment Phase|Lost to Follow-up|8|||
129043102|NCT00049842|464448636|FG000|Treatment Phase|Administrative|0|||
129043103|NCT00049842|464448637|FG001|Treatment Phase|Administrative|3|||
129043104|NCT00049842|464448636|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
129043105|NCT00049842|464448637|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
129043106|NCT00049842|464448636|FG000|Follow-up Phase|Adverse Event|6|||
129043107|NCT00049842|464448637|FG001|Follow-up Phase|Adverse Event|1|||
129043108|NCT00049842|464448636|FG000|Follow-up Phase|Other|1|||
129043109|NCT00049842|464448637|FG001|Follow-up Phase|Other|4|||
129043110|NCT00307931|464448638|FG000|Overall Study|Adverse Event|1|||
129043111|NCT00854373|464448639|FG000|Overall Study|Withdrawal by Subject|1|||
129043112|NCT00854373|464448640|FG001|Overall Study|Withdrawal by Subject|3|||
129043113|NCT00854373|464448639|FG000|Overall Study|Forgot to take study drug|1|||
129043114|NCT00854373|464448640|FG001|Overall Study|Forgot to take study drug|1|||
129043115|NCT00293202|464448641|FG000|Overall Study|Withdrawal by Subject|1|||
129043116|NCT00293202|464448642|FG001|Overall Study|Withdrawal by Subject|2|||
129043117|NCT00293202|464448641|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
129043118|NCT00293202|464448642|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
129043119|NCT00293202|464448641|FG000|Overall Study|on-hold due to fistula maturation time|1|||
129043120|NCT00293202|464448642|FG001|Overall Study|on-hold due to fistula maturation time|0|||
129043121|NCT02442271|464448643|FG000|Overall Study|Adverse Event|1|||
129043122|NCT02442271|464448643|FG000|Overall Study|Withdrew Consent|1|||
129043123|NCT02442271|464448643|FG000|Overall Study|Lost to Follow-up|1|||
129043124|NCT02442271|464448643|FG000|Overall Study|Other|1|||
129043125|NCT02080832|464448644|FG000|Overall Study|Excluded from analysis by MRI|9|||
129043126|NCT02080832|464448645|FG001|Overall Study|Excluded from analysis by MRI|10|||
129043127|NCT02080832|464448646|FG002|Overall Study|Excluded from analysis by MRI|14|||
129043128|NCT02080832|464448644|FG000|Overall Study|Lost to Follow-up|0|||
129043129|NCT02080832|464448645|FG001|Overall Study|Lost to Follow-up|2|||
129043130|NCT02080832|464448646|FG002|Overall Study|Lost to Follow-up|2|||
129043131|NCT01560507|464448647|FG000|Overall Study|Lost to Follow-up|3|||
129043132|NCT01560507|464448648|FG001|Overall Study|Lost to Follow-up|1|||
129043133|NCT01560507|464448649|FG002|Overall Study|Lost to Follow-up|2|||
129043134|NCT01560507|464448647|FG000|Overall Study|Withdrawal by Subject|1|||
129043135|NCT01560507|464448648|FG001|Overall Study|Withdrawal by Subject|1|||
129043136|NCT01560507|464448649|FG002|Overall Study|Withdrawal by Subject|0|||
129043137|NCT01660022|464448650|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
129043138|NCT01660022|464448651|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
129043139|NCT01660022|464448652|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
129043140|NCT01660022|464448653|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
129043141|NCT01660022|464448654|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
129043142|NCT01660022|464448655|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
129043143|NCT01660022|464448650|FG000|First Sequence (7 Days)|Adverse Event|0|||
129043144|NCT01660022|464448651|FG001|First Sequence (7 Days)|Adverse Event|0|||
129043145|NCT01660022|464448652|FG002|First Sequence (7 Days)|Adverse Event|0|||
129043146|NCT01660022|464448653|FG003|First Sequence (7 Days)|Adverse Event|0|||
129043147|NCT01660022|464448654|FG004|First Sequence (7 Days)|Adverse Event|1|||
129043148|NCT01660022|464448655|FG005|First Sequence (7 Days)|Adverse Event|3|||
129043149|NCT01660022|464448650|FG000|First Sequence (7 Days)|Protocol Violation|0|||
129134173|NCT02346370|464784948|FG000|Overall Study|Withdrawal of consent|1|||
129134174|NCT02346370|464784949|FG001|Overall Study|Withdrawal of consent|0|||
129043150|NCT01660022|464448651|FG001|First Sequence (7 Days)|Protocol Violation|0|||
129134175|NCT02346370|464784950|FG002|Overall Study|Withdrawal of consent|0|||
129043151|NCT01660022|464448652|FG002|First Sequence (7 Days)|Protocol Violation|0|||
129043152|NCT01660022|464448653|FG003|First Sequence (7 Days)|Protocol Violation|0|||
129043153|NCT01660022|464448654|FG004|First Sequence (7 Days)|Protocol Violation|0|||
129043154|NCT01660022|464448655|FG005|First Sequence (7 Days)|Protocol Violation|1|||
129134176|NCT02346370|464784948|FG000|Overall Study|Death|1|||
129134177|NCT02346370|464784949|FG001|Overall Study|Death|3|||
129134178|NCT02346370|464784950|FG002|Overall Study|Death|1|||
129134179|NCT02346370|464784948|FG000|Overall Study|Sponsor discontinued study|5|||
129134180|NCT02346370|464784949|FG001|Overall Study|Sponsor discontinued study|0|||
129134181|NCT02346370|464784950|FG002|Overall Study|Sponsor discontinued study|2|||
129134182|NCT02346370|464784948|FG000|Overall Study|Radiologic progression|0|||
129134183|NCT02346370|464784949|FG001|Overall Study|Radiologic progression|0|||
129134184|NCT02346370|464784950|FG002|Overall Study|Radiologic progression|1|||
129134185|NCT02346370|464784948|FG000|Overall Study|Physician Decision|0|||
129134186|NCT02346370|464784949|FG001|Overall Study|Physician Decision|1|||
129134187|NCT02346370|464784950|FG002|Overall Study|Physician Decision|0|||
129134188|NCT03528577|464784951|FG000|Sequence 1|Failed Spirometry|1|||
129134189|NCT03528577|464784951|FG000|Sequence 1|Restricted medication|1|||
129134190|NCT03528577|464784951|FG000|Sequence 2|Adverse Event|1|||
129134191|NCT03528577|464784951|FG000|Sequence 2|Withdrawal by Subject|1|||
129134192|NCT03528577|464784951|FG000|Sequence 2|Failed Spirometry|1|||
129134193|NCT03528577|464784951|FG000|Sequence 3|Failed Spirometry|1|||
129134194|NCT03528577|464784951|FG000|Sequence 4|Failed Spirometry|2|||
129134195|NCT03528577|464784951|FG000|Sequence 4|Adverse Event|1|||
129134196|NCT04882215|464784952|FG000|Overall Study|Withdrawal by Subject|5|||
129134197|NCT04882215|464784953|FG001|Overall Study|Withdrawal by Subject|0|||
129134198|NCT04263532|464784954|FG000|Overall Study|Withdrawal by Subject|2|||
129134199|NCT04263532|464784955|FG001|Overall Study|Withdrawal by Subject|0|||
129134200|NCT04098302|464784958|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
129134201|NCT04098302|464784959|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
129134202|NCT04098302|464784960|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
129134203|NCT04098302|464784961|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
129134204|NCT04098302|464784958|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
129134205|NCT04098302|464784959|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
129134206|NCT04098302|464784960|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
129134207|NCT04098302|464784961|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
129134208|NCT04098302|464784958|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
129134209|NCT04098302|464784959|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
129134210|NCT04098302|464784960|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
129134211|NCT04098302|464784961|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
129134212|NCT04098302|464784958|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
129134213|NCT04098302|464784959|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
129134214|NCT04098302|464784960|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
129134215|NCT04098302|464784961|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
129134216|NCT04098302|464784958|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
129134217|NCT04098302|464784959|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
129134218|NCT04098302|464784960|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
129134219|NCT04098302|464784961|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
129134220|NCT04098302|464784958|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
128718978|NCT00768300|463268915|FG001|Overall Study|Treated but never dosed with Study drug|0|||
128981138|NCT01789476|464218923|FG000|Overall Study|Unable to get IV access|1|||
128981139|NCT01789476|464218924|FG001|Overall Study|Unable to get IV access|0|||
128981140|NCT00501969|464218925|FG000|Overall Study|Major Protocol Violation|4|||
128981141|NCT00501969|464218925|FG000|Overall Study|Lack of Efficacy|29|||
128981142|NCT00501969|464218925|FG000|Overall Study|Adverse Event|76|||
128981143|NCT00501969|464218925|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
128981144|NCT00501969|464218925|FG000|Overall Study|Subject withdrew consent|51|||
128981145|NCT00501969|464218925|FG000|Overall Study|Lost to Follow-up|4|||
128981146|NCT00501969|464218925|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
128981147|NCT00501969|464218925|FG000|Overall Study|Other: Sponsors Request|10|||
128981148|NCT00501969|464218925|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
128981149|NCT00501969|464218925|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
128981150|NCT00501969|464218925|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
128981151|NCT00501969|464218925|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
128981152|NCT00501969|464218925|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
128981153|NCT00501969|464218925|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
128981154|NCT00501969|464218925|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
128981155|NCT00501969|464218925|FG000|Overall Study|Other: As Required by Local EC|2|||
128981156|NCT00501969|464218925|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
128981157|NCT00501969|464218925|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
128981158|NCT00665366|464218926|FG000|Overall Study|Lack of Efficacy|11|||
128981159|NCT00665366|464218927|FG001|Overall Study|Lack of Efficacy|10|||
128981160|NCT00665366|464218926|FG000|Overall Study|Adverse Event|25|||
128981161|NCT00665366|464218927|FG001|Overall Study|Adverse Event|23|||
128981162|NCT00665366|464218926|FG000|Overall Study|Withdrawal by Subject|11|||
128981163|NCT00665366|464218927|FG001|Overall Study|Withdrawal by Subject|14|||
128981164|NCT00665366|464218926|FG000|Overall Study|Lost to Follow-up|3|||
129134221|NCT04098302|464784959|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
129134222|NCT04098302|464784960|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
129134223|NCT04098302|464784961|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
129134224|NCT04098302|464784958|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
129134225|NCT04098302|464784959|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
129134226|NCT04098302|464784960|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
129134227|NCT04098302|464784961|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
129134228|NCT04098302|464784958|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
129134229|NCT04098302|464784959|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
129134230|NCT04098302|464784960|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
129134231|NCT04098302|464784961|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
129134232|NCT01290731|464784964|FG000|Overall Study|Withdrawal by Subject|1|||
129134233|NCT01399099|464784965|FG000|Overall Study|Lost to Follow-up|14|||
129134234|NCT01399099|464784965|FG000|Overall Study|Physician Decision|1|||
129134235|NCT01399099|464784965|FG000|Overall Study|Protocol Violation|1|||
129134236|NCT01399099|464784965|FG000|Overall Study|Skin Irritation|13|||
129134237|NCT01399099|464784965|FG000|Overall Study|Infection|1|||
129134238|NCT01399099|464784965|FG000|Overall Study|Miscellaneous|4|||
129134239|NCT01668537|464784966|FG000|Overall Study|Request to Discontinue Prematurely|1|||
129134240|NCT01668537|464784967|FG001|Overall Study|Request to Discontinue Prematurely|1|||
129134241|NCT01668537|464784966|FG000|Overall Study|Subject unwilling/unable to comply|5|||
129134242|NCT01668537|464784967|FG001|Overall Study|Subject unwilling/unable to comply|0|||
129134243|NCT01668537|464784966|FG000|Overall Study|Reason Precludes Participation|1|||
129222803|NCT06005597|465116212|FG002|Overall Study|Lost to Follow-up|1|||
129134244|NCT01668537|464784967|FG001|Overall Study|Reason Precludes Participation|0|||
129134245|NCT01668537|464784966|FG000|Overall Study|Lost to Follow-up|13|||
129134246|NCT01668537|464784967|FG001|Overall Study|Lost to Follow-up|6|||
129134247|NCT01668537|464784966|FG000|Overall Study|Other|2|||
129134248|NCT01668537|464784967|FG001|Overall Study|Other|3|||
129134249|NCT05064800|464784968|FG000|Period 3|Withdrawal by Subject|0|||
129134250|NCT05064800|464784969|FG001|Period 3|Withdrawal by Subject|0|||
129134251|NCT05064800|464784970|FG002|Period 3|Withdrawal by Subject|0|||
129134252|NCT05064800|464784971|FG003|Period 3|Withdrawal by Subject|0|||
129134253|NCT05064800|464784972|FG004|Period 3|Withdrawal by Subject|1|||
129134254|NCT05064800|464784973|FG005|Period 3|Withdrawal by Subject|0|||
129134255|NCT04477486|464784974|FG000|Overall Study|Death|2|||
129134256|NCT04477486|464784974|FG000|Overall Study|Ongoing at Time of Analysis|11|||
129134257|NCT01078545|464784977|FG000|Overall Study|Lost to Follow-up|13|||
129134258|NCT01078545|464784977|FG000|Overall Study|Physician Decision|6|||
129222804|NCT06005597|465116213|FG003|Overall Study|Lost to Follow-up|2|||
129222805|NCT06005597|465116210|FG000|Overall Study|Death|1|||
129222806|NCT06005597|465116211|FG001|Overall Study|Death|1|||
129222807|NCT06005597|465116212|FG002|Overall Study|Death|1|||
129222808|NCT06005597|465116213|FG003|Overall Study|Death|0|||
129222809|NCT03375320|465116216|FG000|Overall Study|Adverse Event|34|||
129222810|NCT03375320|465116217|FG001|Overall Study|Adverse Event|9|||
129222811|NCT03375320|465116218|FG002|Overall Study|Adverse Event|10|||
129222812|NCT03375320|465116219|FG003|Overall Study|Adverse Event|0|||
129222813|NCT03375320|465116216|FG000|Overall Study|Death|6|||
129222814|NCT03375320|465116217|FG001|Overall Study|Death|3|||
129222815|NCT03375320|465116218|FG002|Overall Study|Death|0|||
129222816|NCT03375320|465116219|FG003|Overall Study|Death|0|||
129222817|NCT03375320|465116216|FG000|Overall Study|Withdrawal by Subject|7|||
129222818|NCT03375320|465116217|FG001|Overall Study|Withdrawal by Subject|4|||
129222819|NCT03375320|465116218|FG002|Overall Study|Withdrawal by Subject|5|||
129222820|NCT03375320|465116219|FG003|Overall Study|Withdrawal by Subject|4|||
129222821|NCT03375320|465116216|FG000|Overall Study|Progressive disease|55|||
129222822|NCT03375320|465116217|FG001|Overall Study|Progressive disease|41|||
129222823|NCT03375320|465116218|FG002|Overall Study|Progressive disease|29|||
129222824|NCT03375320|465116219|FG003|Overall Study|Progressive disease|24|||
129134259|NCT01078545|464784977|FG000|Overall Study|Withdrawal by Subject|3|||
129134260|NCT01078545|464784977|FG000|Overall Study|Death|3|||
129134261|NCT01078545|464784977|FG000|Overall Study|Participant moved to another physician|1|||
129134262|NCT02497755|464784978|FG000|Overall Study|Protocol Violation|1|||
129222825|NCT03375320|465116216|FG000|Overall Study|Alternative treatment|6|||
129222826|NCT03375320|465116217|FG001|Overall Study|Alternative treatment|1|||
129134263|NCT02497755|464784979|FG001|Overall Study|Protocol Violation|0|||
129134264|NCT01774370|464784982|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
129134265|NCT01774370|464784982|FG000|Overall Study|Administered prior to the contract date|4|||
129134266|NCT01774370|464784982|FG000|Overall Study|Subjects of contraindications|34|||
129134267|NCT01774370|464784982|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
129222827|NCT03375320|465116218|FG002|Overall Study|Alternative treatment|1|||
129222828|NCT03375320|465116219|FG003|Overall Study|Alternative treatment|0|||
129222829|NCT03375320|465116216|FG000|Overall Study|Other disease|1|||
129222830|NCT03375320|465116217|FG001|Overall Study|Other disease|1|||
129222831|NCT03375320|465116218|FG002|Overall Study|Other disease|3|||
129222832|NCT03375320|465116219|FG003|Overall Study|Other disease|0|||
129043155|NCT02181296|464448658|FG000|Overall Study|Lost to Follow-up|7|||
129043156|NCT02181296|464448659|FG001|Overall Study|Lost to Follow-up|6|||
129043157|NCT02149121|464448660|FG000|Main Study Period|Lack of Efficacy|2|||
129043158|NCT02149121|464448661|FG001|Main Study Period|Lack of Efficacy|2|||
129043159|NCT02149121|464448662|FG002|Main Study Period|Lack of Efficacy|1|||
129043160|NCT02149121|464448663|FG003|Main Study Period|Lack of Efficacy|0|||
129043161|NCT02149121|464448664|FG004|Main Study Period|Lack of Efficacy|0|||
129043162|NCT02149121|464448665|FG005|Main Study Period|Lack of Efficacy|0|||
129043163|NCT02149121|464448666|FG006|Main Study Period|Lack of Efficacy|0|||
129134268|NCT01774370|464784982|FG000|Overall Study|Follow-up failure|34|||
129134269|NCT05436288|464784983|FG000|Overall Study|Lost to Follow-up|1|||
129134270|NCT05436288|464784983|FG000|Overall Study|Adverse Event|1|||
129134271|NCT01436500|464784987|FG000|Overall Study|Death|1|||
129134272|NCT01436500|464784988|FG001|Overall Study|Death|0|||
129134273|NCT01436500|464784989|FG002|Overall Study|Death|0|||
129134274|NCT01436500|464784990|FG003|Overall Study|Death|0|||
129134275|NCT01436500|464784991|FG004|Overall Study|Death|0|||
129134276|NCT01436500|464784987|FG000|Overall Study|Adverse Event|0|||
129134277|NCT01436500|464784988|FG001|Overall Study|Adverse Event|2|||
129134278|NCT01436500|464784989|FG002|Overall Study|Adverse Event|2|||
129134279|NCT01436500|464784990|FG003|Overall Study|Adverse Event|0|||
129134280|NCT01436500|464784991|FG004|Overall Study|Adverse Event|1|||
129134281|NCT01436500|464784987|FG000|Overall Study|Withdrawal by Subject|0|||
129134282|NCT01436500|464784988|FG001|Overall Study|Withdrawal by Subject|0|||
129134283|NCT01436500|464784989|FG002|Overall Study|Withdrawal by Subject|2|||
129134284|NCT01436500|464784990|FG003|Overall Study|Withdrawal by Subject|0|||
129134285|NCT01436500|464784991|FG004|Overall Study|Withdrawal by Subject|2|||
129134286|NCT01436500|464784987|FG000|Overall Study|Physician Decision|0|||
129134287|NCT01436500|464784988|FG001|Overall Study|Physician Decision|0|||
129134288|NCT01436500|464784989|FG002|Overall Study|Physician Decision|1|||
129134289|NCT01436500|464784990|FG003|Overall Study|Physician Decision|0|||
129134290|NCT01436500|464784991|FG004|Overall Study|Physician Decision|0|||
129134291|NCT01436500|464784987|FG000|Overall Study|liver transplant|1|||
129134292|NCT01436500|464784988|FG001|Overall Study|liver transplant|0|||
129134293|NCT01436500|464784989|FG002|Overall Study|liver transplant|0|||
129134294|NCT01436500|464784990|FG003|Overall Study|liver transplant|0|||
129134295|NCT01436500|464784991|FG004|Overall Study|liver transplant|0|||
129134296|NCT01436500|464784987|FG000|Overall Study|initiation of dialysis|0|||
129134297|NCT01436500|464784988|FG001|Overall Study|initiation of dialysis|0|||
129134298|NCT01436500|464784989|FG002|Overall Study|initiation of dialysis|0|||
129134299|NCT01436500|464784990|FG003|Overall Study|initiation of dialysis|0|||
129134300|NCT01436500|464784991|FG004|Overall Study|initiation of dialysis|1|||
129134301|NCT01436500|464784987|FG000|Overall Study|discontinued study drug|1|||
129134302|NCT01436500|464784988|FG001|Overall Study|discontinued study drug|0|||
129134303|NCT01436500|464784989|FG002|Overall Study|discontinued study drug|0|||
129134304|NCT01436500|464784990|FG003|Overall Study|discontinued study drug|0|||
129134305|NCT01436500|464784991|FG004|Overall Study|discontinued study drug|0|||
129134306|NCT01436500|464784987|FG000|Overall Study|Other|0|||
129134307|NCT01436500|464784988|FG001|Overall Study|Other|1|||
129134308|NCT01436500|464784989|FG002|Overall Study|Other|0|||
129134309|NCT01436500|464784990|FG003|Overall Study|Other|1|||
129134310|NCT01436500|464784991|FG004|Overall Study|Other|0|||
129134311|NCT01487161|464784993|FG000|Overall Study|Adverse Event|1|||
129134312|NCT01487161|464784994|FG001|Overall Study|Adverse Event|0|||
129134313|NCT01487161|464784995|FG002|Overall Study|Adverse Event|0|||
129134314|NCT01487161|464784996|FG003|Overall Study|Adverse Event|0|||
129134315|NCT01487161|464784993|FG000|Overall Study|Withdrawal by Subject|1|||
129134316|NCT01487161|464784994|FG001|Overall Study|Withdrawal by Subject|1|||
129134317|NCT01487161|464784995|FG002|Overall Study|Withdrawal by Subject|1|||
129134318|NCT01487161|464784996|FG003|Overall Study|Withdrawal by Subject|2|||
129134319|NCT01487161|464784993|FG000|Overall Study|missing data|0|||
129134320|NCT01487161|464784994|FG001|Overall Study|missing data|1|||
129134321|NCT01487161|464784995|FG002|Overall Study|missing data|0|||
129134322|NCT01487161|464784996|FG003|Overall Study|missing data|0|||
129134323|NCT02675452|464784997|FG000|Overall Study|Sponsor decision|0|||
129134324|NCT02675452|464784998|FG001|Overall Study|Sponsor decision|0|||
129134325|NCT02675452|464784999|FG002|Overall Study|Sponsor decision|0|||
129134326|NCT02675452|464785000|FG003|Overall Study|Sponsor decision|0|||
129134327|NCT02675452|464785001|FG004|Overall Study|Sponsor decision|0|||
129134328|NCT02675452|464785002|FG005|Overall Study|Sponsor decision|0|||
129134329|NCT02675452|464785003|FG006|Overall Study|Sponsor decision|0|||
129134330|NCT02675452|464785004|FG007|Overall Study|Sponsor decision|0|||
129134331|NCT02675452|464785005|FG008|Overall Study|Sponsor decision|0|||
129134332|NCT02675452|464785006|FG009|Overall Study|Sponsor decision|1|||
129134333|NCT02675452|464785007|FG010|Overall Study|Sponsor decision|0|||
129134334|NCT02675452|464785008|FG011|Overall Study|Sponsor decision|0|||
129134335|NCT02675452|464785009|FG012|Overall Study|Sponsor decision|0|||
129134336|NCT02675452|464785010|FG013|Overall Study|Sponsor decision|2|||
129134337|NCT02675452|464785011|FG014|Overall Study|Sponsor decision|1|||
129134338|NCT02675452|464785012|FG015|Overall Study|Sponsor decision|0|||
129134339|NCT02675452|464785013|FG016|Overall Study|Sponsor decision|1|||
129134340|NCT02675452|464785014|FG017|Overall Study|Sponsor decision|0|||
129134341|NCT02675452|464785015|FG018|Overall Study|Sponsor decision|0|||
129134342|NCT02675452|464785016|FG019|Overall Study|Sponsor decision|0|||
129134343|NCT02675452|464785017|FG020|Overall Study|Sponsor decision|0|||
129134344|NCT02675452|464785018|FG021|Overall Study|Sponsor decision|0|||
129134345|NCT02675452|464785019|FG022|Overall Study|Sponsor decision|0|||
129134346|NCT02675452|464785020|FG023|Overall Study|Sponsor decision|0|||
129134347|NCT02675452|464785021|FG024|Overall Study|Sponsor decision|0|||
129134348|NCT02675452|464785022|FG025|Overall Study|Sponsor decision|0|||
129134349|NCT02675452|464785023|FG026|Overall Study|Sponsor decision|2|||
129134350|NCT02675452|464785024|FG027|Overall Study|Sponsor decision|0|||
129134351|NCT02675452|464785025|FG028|Overall Study|Sponsor decision|0|||
129134352|NCT02675452|464784997|FG000|Overall Study|Withdrawal by Subject|0|||
129134353|NCT02675452|464784998|FG001|Overall Study|Withdrawal by Subject|0|||
129134354|NCT02675452|464784999|FG002|Overall Study|Withdrawal by Subject|0|||
129134355|NCT02675452|464785000|FG003|Overall Study|Withdrawal by Subject|0|||
129134356|NCT02675452|464785001|FG004|Overall Study|Withdrawal by Subject|0|||
129134357|NCT02675452|464785002|FG005|Overall Study|Withdrawal by Subject|0|||
129134358|NCT02675452|464785003|FG006|Overall Study|Withdrawal by Subject|0|||
129134359|NCT02675452|464785004|FG007|Overall Study|Withdrawal by Subject|0|||
129134360|NCT02675452|464785005|FG008|Overall Study|Withdrawal by Subject|0|||
129134361|NCT02675452|464785006|FG009|Overall Study|Withdrawal by Subject|1|||
129134362|NCT02675452|464785007|FG010|Overall Study|Withdrawal by Subject|0|||
129134363|NCT02675452|464785008|FG011|Overall Study|Withdrawal by Subject|1|||
129134364|NCT02675452|464785009|FG012|Overall Study|Withdrawal by Subject|0|||
129134365|NCT02675452|464785010|FG013|Overall Study|Withdrawal by Subject|1|||
129134366|NCT02675452|464785011|FG014|Overall Study|Withdrawal by Subject|1|||
129134367|NCT02675452|464785012|FG015|Overall Study|Withdrawal by Subject|0|||
129134368|NCT02675452|464785013|FG016|Overall Study|Withdrawal by Subject|2|||
129134369|NCT02675452|464785014|FG017|Overall Study|Withdrawal by Subject|0|||
129134370|NCT02675452|464785015|FG018|Overall Study|Withdrawal by Subject|0|||
129134371|NCT02675452|464785016|FG019|Overall Study|Withdrawal by Subject|0|||
129134372|NCT02675452|464785017|FG020|Overall Study|Withdrawal by Subject|0|||
129134373|NCT02675452|464785018|FG021|Overall Study|Withdrawal by Subject|0|||
129134374|NCT02675452|464785019|FG022|Overall Study|Withdrawal by Subject|3|||
129134375|NCT02675452|464785020|FG023|Overall Study|Withdrawal by Subject|0|||
129134376|NCT02675452|464785021|FG024|Overall Study|Withdrawal by Subject|1|||
129134377|NCT02675452|464785022|FG025|Overall Study|Withdrawal by Subject|0|||
129134378|NCT02675452|464785023|FG026|Overall Study|Withdrawal by Subject|1|||
129134379|NCT02675452|464785024|FG027|Overall Study|Withdrawal by Subject|3|||
129134380|NCT02675452|464785025|FG028|Overall Study|Withdrawal by Subject|4|||
129134381|NCT02675452|464784997|FG000|Overall Study|Death|0|||
129134382|NCT02675452|464784998|FG001|Overall Study|Death|0|||
129134383|NCT02675452|464784999|FG002|Overall Study|Death|1|||
129134384|NCT02675452|464785000|FG003|Overall Study|Death|0|||
129134385|NCT02675452|464785001|FG004|Overall Study|Death|0|||
129134386|NCT02675452|464785002|FG005|Overall Study|Death|1|||
129134387|NCT02675452|464785003|FG006|Overall Study|Death|0|||
129134388|NCT02675452|464785004|FG007|Overall Study|Death|0|||
129134389|NCT02675452|464785005|FG008|Overall Study|Death|1|||
129134390|NCT02675452|464785006|FG009|Overall Study|Death|0|||
129134391|NCT02675452|464785007|FG010|Overall Study|Death|0|||
129134392|NCT02675452|464785008|FG011|Overall Study|Death|0|||
129134393|NCT02675452|464785009|FG012|Overall Study|Death|1|||
129134394|NCT02675452|464785010|FG013|Overall Study|Death|0|||
129134395|NCT02675452|464785011|FG014|Overall Study|Death|0|||
129134396|NCT02675452|464785012|FG015|Overall Study|Death|2|||
129134397|NCT02675452|464785013|FG016|Overall Study|Death|0|||
129134398|NCT02675452|464785014|FG017|Overall Study|Death|0|||
129134399|NCT02675452|464785015|FG018|Overall Study|Death|4|||
129134400|NCT02675452|464785016|FG019|Overall Study|Death|3|||
129134401|NCT02675452|464785017|FG020|Overall Study|Death|3|||
129134402|NCT02675452|464785018|FG021|Overall Study|Death|3|||
129134403|NCT02675452|464785019|FG022|Overall Study|Death|7|||
129134404|NCT02675452|464785020|FG023|Overall Study|Death|5|||
128775339|NCT01474512|463468364|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129134405|NCT02675452|464785021|FG024|Overall Study|Death|3|||
129134406|NCT02675452|464785022|FG025|Overall Study|Death|4|||
128775340|NCT01474512|463468365|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775341|NCT01474512|463468366|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775342|NCT01474512|463468367|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775343|NCT01474512|463468368|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775344|NCT01474512|463468369|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
128775345|NCT01474512|463468370|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
129134407|NCT02675452|464785023|FG026|Overall Study|Death|7|||
129134408|NCT02675452|464785024|FG027|Overall Study|Death|6|||
129134409|NCT02675452|464785025|FG028|Overall Study|Death|9|||
129134410|NCT02675452|464784997|FG000|Overall Study|Lost to Follow-up|0|||
129134411|NCT02675452|464784998|FG001|Overall Study|Lost to Follow-up|1|||
128718979|NCT00768300|463268914|FG000|Overall Study|Missing data|1|||
128718980|NCT00768300|463268915|FG001|Overall Study|Missing data|0|||
128718981|NCT01782664|463268921|FG000|Overall Study|Adverse Event|2|||
128718982|NCT01782664|463268922|FG001|Overall Study|Adverse Event|2|||
128718983|NCT01782664|463268923|FG002|Overall Study|Adverse Event|2|||
128718984|NCT01782664|463268924|FG003|Overall Study|Adverse Event|2|||
128718985|NCT01782664|463268925|FG004|Overall Study|Adverse Event|0|||
128981165|NCT00665366|464218927|FG001|Overall Study|Lost to Follow-up|5|||
128981166|NCT00665366|464218926|FG000|Overall Study|Poor compliance/noncompliance|3|||
128981167|NCT00665366|464218927|FG001|Overall Study|Poor compliance/noncompliance|5|||
128981168|NCT00665366|464218926|FG000|Overall Study|Pregnancy|1|||
128981169|NCT00665366|464218927|FG001|Overall Study|Pregnancy|0|||
128981170|NCT00665366|464218926|FG000|Overall Study|No longer meets study criteria|0|||
128981171|NCT00665366|464218927|FG001|Overall Study|No longer meets study criteria|1|||
128981172|NCT00665366|464218926|FG000|Overall Study|Other reasons|4|||
128981173|NCT00665366|464218927|FG001|Overall Study|Other reasons|1|||
128981174|NCT04177862|464218931|FG000|Overall Study|Protocol Violation|2|||
128981175|NCT04177862|464218932|FG001|Overall Study|Protocol Violation|7|||
128981176|NCT05111548|464218933|FG000|Overall Study|Withdrawal by Subject|2|||
128981177|NCT05111548|464218934|FG001|Overall Study|Withdrawal by Subject|1|||
128981178|NCT05111548|464218933|FG000|Overall Study|Adverse Event|1|||
128981179|NCT05111548|464218934|FG001|Overall Study|Adverse Event|0|||
128981180|NCT00379639|464218935|FG000|Overall Study|Disease Progression|3|||
128981181|NCT00379639|464218936|FG001|Overall Study|Disease Progression|3|||
128981182|NCT00379639|464218937|FG002|Overall Study|Disease Progression|3|||
128981183|NCT00379639|464218938|FG003|Overall Study|Disease Progression|4|||
128981184|NCT00379639|464218939|FG004|Overall Study|Disease Progression|4|||
128981185|NCT00379639|464218935|FG000|Overall Study|Physician Decision|0|||
128981186|NCT00379639|464218936|FG001|Overall Study|Physician Decision|2|||
128981187|NCT00379639|464218937|FG002|Overall Study|Physician Decision|1|||
128981188|NCT00379639|464218938|FG003|Overall Study|Physician Decision|1|||
128981189|NCT00379639|464218939|FG004|Overall Study|Physician Decision|0|||
128981190|NCT00379639|464218935|FG000|Overall Study|Symptomatic Deterioration|0|||
128981191|NCT00379639|464218936|FG001|Overall Study|Symptomatic Deterioration|0|||
128981192|NCT00379639|464218937|FG002|Overall Study|Symptomatic Deterioration|1|||
128981193|NCT00379639|464218938|FG003|Overall Study|Symptomatic Deterioration|0|||
128981194|NCT00379639|464218939|FG004|Overall Study|Symptomatic Deterioration|1|||
128981195|NCT00379639|464218935|FG000|Overall Study|Adverse Event|0|||
128981196|NCT00379639|464218936|FG001|Overall Study|Adverse Event|0|||
128981197|NCT00379639|464218937|FG002|Overall Study|Adverse Event|1|||
128981198|NCT00379639|464218938|FG003|Overall Study|Adverse Event|0|||
128981199|NCT00379639|464218939|FG004|Overall Study|Adverse Event|1|||
128981200|NCT00379639|464218935|FG000|Overall Study|Lost to Follow-up|0|||
128981201|NCT00379639|464218936|FG001|Overall Study|Lost to Follow-up|0|||
128981202|NCT00379639|464218937|FG002|Overall Study|Lost to Follow-up|0|||
128981203|NCT00379639|464218938|FG003|Overall Study|Lost to Follow-up|1|||
128981204|NCT00379639|464218939|FG004|Overall Study|Lost to Follow-up|0|||
128981205|NCT00379639|464218935|FG000|Overall Study|Other|0|||
128981206|NCT00379639|464218936|FG001|Overall Study|Other|0|||
128981207|NCT00379639|464218937|FG002|Overall Study|Other|3|||
128981208|NCT00379639|464218938|FG003|Overall Study|Other|0|||
128981209|NCT00379639|464218939|FG004|Overall Study|Other|0|||
128981210|NCT00594958|464218940|FG000|Overall Study|Withdrawal by Subject|1|||
128981211|NCT00594958|464218941|FG001|Overall Study|Withdrawal by Subject|0|||
128981212|NCT00594958|464218942|FG002|Overall Study|Withdrawal by Subject|1|||
128981213|NCT00594958|464218940|FG000|Overall Study|Adverse Event|4|||
128981214|NCT00594958|464218941|FG001|Overall Study|Adverse Event|1|||
128981215|NCT00594958|464218942|FG002|Overall Study|Adverse Event|2|||
128981216|NCT00594958|464218940|FG000|Overall Study|Pregnancy|0|||
128981217|NCT00594958|464218941|FG001|Overall Study|Pregnancy|2|||
128981218|NCT00594958|464218942|FG002|Overall Study|Pregnancy|0|||
128981219|NCT00594958|464218940|FG000|Overall Study|Protocol Violation|1|||
128981220|NCT00594958|464218941|FG001|Overall Study|Protocol Violation|0|||
128981221|NCT00594958|464218942|FG002|Overall Study|Protocol Violation|2|||
128981222|NCT00594958|464218940|FG000|Overall Study|Lost to Follow-up|5|||
128981223|NCT00594958|464218941|FG001|Overall Study|Lost to Follow-up|0|||
128981224|NCT00594958|464218942|FG002|Overall Study|Lost to Follow-up|3|||
128981225|NCT00594958|464218940|FG000|Overall Study|administrative|3|||
128981226|NCT00594958|464218941|FG001|Overall Study|administrative|0|||
128981227|NCT00594958|464218942|FG002|Overall Study|administrative|2|||
128981228|NCT03233009|464218955|FG000|Overall Study|Lost to Follow-up|1|||
128981229|NCT00151775|464218956|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
128981230|NCT00151775|464218957|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
128981231|NCT00151775|464218958|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981232|NCT00151775|464218959|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981233|NCT00151775|464218960|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981234|NCT00151775|464218961|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981235|NCT00151775|464218962|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128718986|NCT01782664|463268926|FG005|Overall Study|Adverse Event|0|||
129222833|NCT03375320|465116216|FG000|Overall Study|Withdrawal prior to initiation|2|||
129222834|NCT03375320|465116217|FG001|Overall Study|Withdrawal prior to initiation|2|||
129222835|NCT03375320|465116218|FG002|Overall Study|Withdrawal prior to initiation|1|||
128718987|NCT01782664|463268921|FG000|Overall Study|Lack of Efficacy|2|||
128718988|NCT01782664|463268922|FG001|Overall Study|Lack of Efficacy|0|||
128718989|NCT01782664|463268923|FG002|Overall Study|Lack of Efficacy|2|||
128718990|NCT01782664|463268924|FG003|Overall Study|Lack of Efficacy|2|||
129043164|NCT02149121|464448660|FG000|Main Study Period|Withdrawal by Subject|9|||
129043165|NCT02149121|464448661|FG001|Main Study Period|Withdrawal by Subject|5|||
129043166|NCT02149121|464448662|FG002|Main Study Period|Withdrawal by Subject|1|||
129043167|NCT02149121|464448663|FG003|Main Study Period|Withdrawal by Subject|0|||
129043168|NCT02149121|464448664|FG004|Main Study Period|Withdrawal by Subject|0|||
129043169|NCT02149121|464448665|FG005|Main Study Period|Withdrawal by Subject|0|||
129043170|NCT02149121|464448666|FG006|Main Study Period|Withdrawal by Subject|0|||
129043171|NCT02149121|464448660|FG000|Main Study Period|Adverse Event|2|||
129043172|NCT02149121|464448661|FG001|Main Study Period|Adverse Event|5|||
129043173|NCT02149121|464448662|FG002|Main Study Period|Adverse Event|1|||
129043174|NCT02149121|464448663|FG003|Main Study Period|Adverse Event|0|||
129043175|NCT02149121|464448664|FG004|Main Study Period|Adverse Event|0|||
129043176|NCT02149121|464448665|FG005|Main Study Period|Adverse Event|0|||
129043177|NCT02149121|464448666|FG006|Main Study Period|Adverse Event|0|||
129043178|NCT02149121|464448660|FG000|Main Study Period|Protocol Violation|2|||
129043179|NCT02149121|464448661|FG001|Main Study Period|Protocol Violation|0|||
129043180|NCT02149121|464448662|FG002|Main Study Period|Protocol Violation|0|||
129043181|NCT02149121|464448663|FG003|Main Study Period|Protocol Violation|0|||
129043182|NCT02149121|464448664|FG004|Main Study Period|Protocol Violation|0|||
129043183|NCT02149121|464448665|FG005|Main Study Period|Protocol Violation|0|||
129043184|NCT02149121|464448666|FG006|Main Study Period|Protocol Violation|0|||
129043185|NCT02149121|464448660|FG000|Main Study Period|Lost to Follow-up|2|||
129043186|NCT02149121|464448661|FG001|Main Study Period|Lost to Follow-up|1|||
129043187|NCT02149121|464448662|FG002|Main Study Period|Lost to Follow-up|0|||
129043188|NCT02149121|464448663|FG003|Main Study Period|Lost to Follow-up|0|||
129043189|NCT02149121|464448664|FG004|Main Study Period|Lost to Follow-up|0|||
129043190|NCT02149121|464448665|FG005|Main Study Period|Lost to Follow-up|0|||
129043191|NCT02149121|464448666|FG006|Main Study Period|Lost to Follow-up|0|||
129043192|NCT02149121|464448660|FG000|Main Study Period|Death|1|||
129043193|NCT02149121|464448661|FG001|Main Study Period|Death|0|||
129043194|NCT02149121|464448662|FG002|Main Study Period|Death|0|||
129043195|NCT02149121|464448663|FG003|Main Study Period|Death|0|||
129043196|NCT02149121|464448664|FG004|Main Study Period|Death|0|||
129043197|NCT02149121|464448665|FG005|Main Study Period|Death|0|||
129043198|NCT02149121|464448666|FG006|Main Study Period|Death|0|||
129043199|NCT02149121|464448660|FG000|Main Study Period|Physician Decision|1|||
129043200|NCT02149121|464448661|FG001|Main Study Period|Physician Decision|0|||
129043201|NCT02149121|464448662|FG002|Main Study Period|Physician Decision|0|||
129043202|NCT02149121|464448663|FG003|Main Study Period|Physician Decision|0|||
129043203|NCT02149121|464448664|FG004|Main Study Period|Physician Decision|0|||
129043204|NCT02149121|464448665|FG005|Main Study Period|Physician Decision|0|||
129043205|NCT02149121|464448666|FG006|Main Study Period|Physician Decision|0|||
129043206|NCT02149121|464448660|FG000|Main Study Period|Developed any malignancy|0|||
129043207|NCT02149121|464448661|FG001|Main Study Period|Developed any malignancy|1|||
129043208|NCT02149121|464448662|FG002|Main Study Period|Developed any malignancy|1|||
129043209|NCT02149121|464448663|FG003|Main Study Period|Developed any malignancy|0|||
129043210|NCT02149121|464448664|FG004|Main Study Period|Developed any malignancy|0|||
129043211|NCT02149121|464448665|FG005|Main Study Period|Developed any malignancy|0|||
129043212|NCT02149121|464448666|FG006|Main Study Period|Developed any malignancy|0|||
129043213|NCT02149121|464448660|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
129043214|NCT02149121|464448661|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
129134412|NCT02675452|464784999|FG002|Overall Study|Lost to Follow-up|0|||
129134413|NCT02675452|464785000|FG003|Overall Study|Lost to Follow-up|0|||
129134414|NCT02675452|464785001|FG004|Overall Study|Lost to Follow-up|0|||
129134415|NCT02675452|464785002|FG005|Overall Study|Lost to Follow-up|0|||
129134416|NCT02675452|464785003|FG006|Overall Study|Lost to Follow-up|0|||
129134417|NCT02675452|464785004|FG007|Overall Study|Lost to Follow-up|0|||
129134418|NCT02675452|464785005|FG008|Overall Study|Lost to Follow-up|0|||
129134419|NCT02675452|464785006|FG009|Overall Study|Lost to Follow-up|0|||
129134420|NCT02675452|464785007|FG010|Overall Study|Lost to Follow-up|0|||
129134421|NCT02675452|464785008|FG011|Overall Study|Lost to Follow-up|0|||
129134422|NCT02675452|464785009|FG012|Overall Study|Lost to Follow-up|1|||
129134423|NCT02675452|464785010|FG013|Overall Study|Lost to Follow-up|0|||
129134424|NCT02675452|464785011|FG014|Overall Study|Lost to Follow-up|0|||
129134425|NCT02675452|464785012|FG015|Overall Study|Lost to Follow-up|0|||
129134426|NCT02675452|464785013|FG016|Overall Study|Lost to Follow-up|0|||
129134427|NCT02675452|464785014|FG017|Overall Study|Lost to Follow-up|0|||
129134428|NCT02675452|464785015|FG018|Overall Study|Lost to Follow-up|0|||
129134429|NCT02675452|464785016|FG019|Overall Study|Lost to Follow-up|0|||
128718991|NCT01782664|463268925|FG004|Overall Study|Lack of Efficacy|0|||
129043215|NCT02149121|464448662|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
129043216|NCT02149121|464448663|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
129043217|NCT02149121|464448664|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
129043218|NCT02149121|464448665|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
129043219|NCT02149121|464448666|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
129043220|NCT02149121|464448660|FG000|Main Study Period|Disease progression|0|||
129043221|NCT02149121|464448661|FG001|Main Study Period|Disease progression|1|||
129043222|NCT02149121|464448662|FG002|Main Study Period|Disease progression|0|||
129043223|NCT02149121|464448663|FG003|Main Study Period|Disease progression|0|||
129043224|NCT02149121|464448664|FG004|Main Study Period|Disease progression|0|||
129043225|NCT02149121|464448665|FG005|Main Study Period|Disease progression|0|||
129043226|NCT02149121|464448666|FG006|Main Study Period|Disease progression|0|||
129043227|NCT02149121|464448660|FG000|Extension Study Period|Withdrawal by Subject|0|||
129043228|NCT02149121|464448661|FG001|Extension Study Period|Withdrawal by Subject|0|||
129043229|NCT02149121|464448662|FG002|Extension Study Period|Withdrawal by Subject|0|||
129043230|NCT02149121|464448663|FG003|Extension Study Period|Withdrawal by Subject|1|||
129043231|NCT02149121|464448664|FG004|Extension Study Period|Withdrawal by Subject|0|||
129043232|NCT02149121|464448665|FG005|Extension Study Period|Withdrawal by Subject|2|||
129043233|NCT02149121|464448666|FG006|Extension Study Period|Withdrawal by Subject|0|||
129043234|NCT00766831|464448667|FG000|Overall Study|Withdrawal by Subject|4|||
129043235|NCT00766831|464448667|FG000|Overall Study|Lost to Follow-up|3|||
129043236|NCT00766831|464448667|FG000|Overall Study|Adverse Event|20|||
129043237|NCT00766831|464448667|FG000|Overall Study|Protocol Violation|15|||
129043238|NCT00766831|464448667|FG000|Overall Study|Physician Decision|5|||
129043239|NCT00766831|464448667|FG000|Overall Study|Withdrawal of consent|26|||
129043240|NCT00766831|464448667|FG000|Overall Study|Non cooperation by participants|14|||
129043241|NCT00766831|464448667|FG000|Overall Study|Other|28|||
129043242|NCT03166124|464448668|FG000|Treatment Period 1|Adverse Event|0|||
129043243|NCT03166124|464448669|FG001|Treatment Period 1|Adverse Event|0|||
129043244|NCT03166124|464448670|FG002|Treatment Period 1|Adverse Event|1|||
129043245|NCT03166124|464448671|FG003|Treatment Period 1|Adverse Event|0|||
129043246|NCT03166124|464448668|FG000|Wash-out Period|Withdrawal by Subject|0|||
129043247|NCT03166124|464448669|FG001|Wash-out Period|Withdrawal by Subject|1|||
129043248|NCT03166124|464448670|FG002|Wash-out Period|Withdrawal by Subject|0|||
129043249|NCT03166124|464448671|FG003|Wash-out Period|Withdrawal by Subject|1|||
129043250|NCT03166124|464448668|FG000|Wash-out Period|Adverse Event|0|||
129043251|NCT03166124|464448669|FG001|Wash-out Period|Adverse Event|1|||
129043252|NCT03166124|464448670|FG002|Wash-out Period|Adverse Event|1|||
129043253|NCT03166124|464448671|FG003|Wash-out Period|Adverse Event|0|||
129043254|NCT05626803|464450536|FG000|Overall Study|Lost to Follow-up|0|||
129043255|NCT05626803|464450537|FG001|Overall Study|Lost to Follow-up|1|||
129043256|NCT05626803|464450538|FG002|Overall Study|Lost to Follow-up|0|||
129043257|NCT05626803|464450539|FG003|Overall Study|Lost to Follow-up|0|||
129043258|NCT01000610|464450547|FG000|Overall Study|Adverse Event|1|||
129043259|NCT01000610|464450547|FG000|Overall Study|Lost to Follow-up|4|||
129043260|NCT01000610|464450547|FG000|Overall Study|Treatment failure|1|||
129222836|NCT03375320|465116219|FG003|Overall Study|Withdrawal prior to initiation|0|||
129222837|NCT03375320|465116216|FG000|Overall Study|Physician Decision|1|||
129222838|NCT03375320|465116217|FG001|Overall Study|Physician Decision|1|||
129222839|NCT03375320|465116218|FG002|Overall Study|Physician Decision|1|||
129222840|NCT03375320|465116219|FG003|Overall Study|Physician Decision|1|||
129043261|NCT00493246|464450548|FG000|Overall Study|Withdrawal by Subject|0|||
129043262|NCT00493246|464450549|FG001|Overall Study|Withdrawal by Subject|0|||
129043263|NCT00493246|464450550|FG002|Overall Study|Withdrawal by Subject|0|||
129043264|NCT00493246|464450551|FG003|Overall Study|Withdrawal by Subject|0|||
129043265|NCT00493246|464450552|FG004|Overall Study|Withdrawal by Subject|1|||
129043266|NCT00493246|464450553|FG005|Overall Study|Withdrawal by Subject|0|||
129043267|NCT00493246|464450554|FG006|Overall Study|Withdrawal by Subject|0|||
129043268|NCT00493246|464450555|FG007|Overall Study|Withdrawal by Subject|0|||
129043269|NCT00493246|464450548|FG000|Overall Study|No access to draw blood|0|||
129043270|NCT00493246|464450549|FG001|Overall Study|No access to draw blood|0|||
129043271|NCT00493246|464450550|FG002|Overall Study|No access to draw blood|0|||
129043272|NCT00493246|464450551|FG003|Overall Study|No access to draw blood|0|||
129043273|NCT00493246|464450552|FG004|Overall Study|No access to draw blood|0|||
129043274|NCT00493246|464450553|FG005|Overall Study|No access to draw blood|1|||
129043275|NCT00493246|464450554|FG006|Overall Study|No access to draw blood|0|||
129043276|NCT00493246|464450555|FG007|Overall Study|No access to draw blood|0|||
129222841|NCT03375320|465116216|FG000|Overall Study|Non-compliance|1|||
129222842|NCT03375320|465116217|FG001|Overall Study|Non-compliance|0|||
129222843|NCT03375320|465116218|FG002|Overall Study|Non-compliance|0|||
129043277|NCT00493246|464450548|FG000|Overall Study|Lost to Follow-up|0|||
129043278|NCT00493246|464450549|FG001|Overall Study|Lost to Follow-up|0|||
129043279|NCT00493246|464450550|FG002|Overall Study|Lost to Follow-up|0|||
129043280|NCT00493246|464450551|FG003|Overall Study|Lost to Follow-up|0|||
129043281|NCT00493246|464450552|FG004|Overall Study|Lost to Follow-up|0|||
129043282|NCT00493246|464450553|FG005|Overall Study|Lost to Follow-up|0|||
129222844|NCT03375320|465116219|FG003|Overall Study|Non-compliance|0|||
129222845|NCT05214573|465118201|FG000|Overall Study|Physician Decision|5924|||
129222846|NCT05214573|465118202|FG001|Overall Study|Physician Decision|0|||
129222847|NCT02589522|465118205|FG000|Overall Study|Physician Decision|1|||
129222848|NCT02589522|465118206|FG001|Overall Study|Physician Decision|2|||
129222849|NCT02589522|465118207|FG002|Overall Study|Physician Decision|0|||
129222850|NCT02589522|465118205|FG000|Overall Study|Did not start treatment|1|||
129222851|NCT02589522|465118206|FG001|Overall Study|Did not start treatment|0|||
129222852|NCT02589522|465118207|FG002|Overall Study|Did not start treatment|0|||
129222853|NCT02486718|465118208|FG000|Enrollment Phase|Death|19|||
129222854|NCT02486718|465118209|FG001|Enrollment Phase|Death|0|||
129222855|NCT02486718|465118210|FG002|Enrollment Phase|Death|0|||
129222856|NCT02486718|465118208|FG000|Enrollment Phase|Symptomatic deterioration|1|||
129222857|NCT02486718|465118209|FG001|Enrollment Phase|Symptomatic deterioration|0|||
129222858|NCT02486718|465118210|FG002|Enrollment Phase|Symptomatic deterioration|0|||
129222859|NCT02486718|465118208|FG000|Enrollment Phase|Withdrawal by Subject|86|||
129222860|NCT02486718|465118209|FG001|Enrollment Phase|Withdrawal by Subject|0|||
129222861|NCT02486718|465118210|FG002|Enrollment Phase|Withdrawal by Subject|0|||
129222862|NCT02486718|465118208|FG000|Enrollment Phase|Protocol Violation|18|||
129222863|NCT02486718|465118209|FG001|Enrollment Phase|Protocol Violation|0|||
129222864|NCT02486718|465118210|FG002|Enrollment Phase|Protocol Violation|0|||
129222865|NCT02486718|465118208|FG000|Enrollment Phase|Physician Decision|18|||
129222866|NCT02486718|465118209|FG001|Enrollment Phase|Physician Decision|0|||
129222867|NCT02486718|465118210|FG002|Enrollment Phase|Physician Decision|0|||
129222868|NCT02486718|465118208|FG000|Enrollment Phase|Reason not provided|41|||
129222869|NCT02486718|465118209|FG001|Enrollment Phase|Reason not provided|0|||
129222870|NCT02486718|465118210|FG002|Enrollment Phase|Reason not provided|0|||
129222871|NCT02486718|465118208|FG000|Enrollment Phase|Disease relapse|54|||
129222872|NCT02486718|465118209|FG001|Enrollment Phase|Disease relapse|0|||
129222873|NCT02486718|465118210|FG002|Enrollment Phase|Disease relapse|0|||
129222874|NCT02486718|465118208|FG000|Enrollment Phase|Lost to Follow-up|4|||
129222875|NCT02486718|465118209|FG001|Enrollment Phase|Lost to Follow-up|0|||
128718992|NCT01782664|463268926|FG005|Overall Study|Lack of Efficacy|0|||
128718993|NCT01782664|463268921|FG000|Overall Study|Protocol Violation|0|||
128718994|NCT01782664|463268922|FG001|Overall Study|Protocol Violation|1|||
129222876|NCT02486718|465118210|FG002|Enrollment Phase|Lost to Follow-up|0|||
128718995|NCT01782664|463268923|FG002|Overall Study|Protocol Violation|0|||
129043283|NCT00493246|464450554|FG006|Overall Study|Lost to Follow-up|1|||
129043284|NCT00493246|464450555|FG007|Overall Study|Lost to Follow-up|0|||
129043285|NCT01287039|464450556|FG000|Overall Study|Noncompliance with study procedures|0|||
129043286|NCT01287039|464450557|FG001|Overall Study|Noncompliance with study procedures|1|||
129043287|NCT01287039|464450556|FG000|Overall Study|Change of location/residence|0|||
129043288|NCT01287039|464450557|FG001|Overall Study|Change of location/residence|3|||
129043289|NCT01287039|464450556|FG000|Overall Study|Elective surgery|0|||
129043290|NCT01287039|464450557|FG001|Overall Study|Elective surgery|1|||
129043291|NCT01287039|464450556|FG000|Overall Study|Protocol Violation|2|||
129043292|NCT01287039|464450557|FG001|Overall Study|Protocol Violation|3|||
129043293|NCT01287039|464450556|FG000|Overall Study|Excluded medication taken|1|||
129043294|NCT01287039|464450557|FG001|Overall Study|Excluded medication taken|0|||
129043295|NCT01287039|464450556|FG000|Overall Study|Noncompliance with study medication|0|||
129043296|NCT01287039|464450557|FG001|Overall Study|Noncompliance with study medication|1|||
129043297|NCT01287039|464450556|FG000|Overall Study|Problem with travel|0|||
129043298|NCT01287039|464450557|FG001|Overall Study|Problem with travel|1|||
129043299|NCT01287039|464450556|FG000|Overall Study|Death|1|||
129043300|NCT01287039|464450557|FG001|Overall Study|Death|0|||
129043301|NCT01287039|464450556|FG000|Overall Study|Change of residence|1|||
129043302|NCT01287039|464450557|FG001|Overall Study|Change of residence|0|||
129043303|NCT01287039|464450556|FG000|Overall Study|Adverse Event|7|||
129043304|NCT01287039|464450557|FG001|Overall Study|Adverse Event|4|||
129043305|NCT01287039|464450556|FG000|Overall Study|Withdrawal by Subject|14|||
129043306|NCT01287039|464450557|FG001|Overall Study|Withdrawal by Subject|11|||
129043307|NCT01287039|464450556|FG000|Overall Study|Lost to Follow-up|3|||
129043308|NCT01287039|464450557|FG001|Overall Study|Lost to Follow-up|2|||
129043309|NCT00099268|464450558|FG000|Overall Study|Withdrawal by Subject|46|||
129043310|NCT00099268|464450559|FG001|Overall Study|Withdrawal by Subject|28|||
129043311|NCT00099268|464450558|FG000|Overall Study|Adverse Event|19|||
129043312|NCT00099268|464450559|FG001|Overall Study|Adverse Event|19|||
129043313|NCT00099268|464450558|FG000|Overall Study|Protocol Violation|9|||
129043314|NCT00099268|464450559|FG001|Overall Study|Protocol Violation|8|||
129222877|NCT02486718|465118208|FG000|Enrollment Phase|Adverse Event|34|||
129222878|NCT02486718|465118209|FG001|Enrollment Phase|Adverse Event|0|||
129222879|NCT02486718|465118210|FG002|Enrollment Phase|Adverse Event|0|||
129222880|NCT02486718|465118208|FG000|Randomized Phase|Withdrawal by Subject|0|||
129222881|NCT02486718|465118209|FG001|Randomized Phase|Withdrawal by Subject|44|||
129222882|NCT02486718|465118210|FG002|Randomized Phase|Withdrawal by Subject|47|||
129222883|NCT02486718|465118208|FG000|Randomized Phase|Protocol Violation|0|||
128718996|NCT01782664|463268924|FG003|Overall Study|Protocol Violation|1|||
129043315|NCT00099268|464450558|FG000|Overall Study|Lost to Follow-up|6|||
128718997|NCT01782664|463268925|FG004|Overall Study|Protocol Violation|0|||
128718998|NCT01782664|463268926|FG005|Overall Study|Protocol Violation|0|||
128718999|NCT01782664|463268921|FG000|Overall Study|Withdrawal by Subject|2|||
128719000|NCT01782664|463268922|FG001|Overall Study|Withdrawal by Subject|2|||
128719001|NCT01782664|463268923|FG002|Overall Study|Withdrawal by Subject|0|||
128719002|NCT01782664|463268924|FG003|Overall Study|Withdrawal by Subject|0|||
128719003|NCT01782664|463268925|FG004|Overall Study|Withdrawal by Subject|0|||
128719004|NCT01782664|463268926|FG005|Overall Study|Withdrawal by Subject|0|||
128719005|NCT00651755|463268928|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
128719006|NCT00651755|463268929|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
128719007|NCT00651755|463268928|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
128719008|NCT00651755|463268929|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
129043316|NCT00099268|464450559|FG001|Overall Study|Lost to Follow-up|4|||
129043317|NCT00099268|464450558|FG000|Overall Study|Lack of Efficacy|5|||
129043318|NCT00099268|464450559|FG001|Overall Study|Lack of Efficacy|18|||
129043319|NCT00099268|464450558|FG000|Overall Study|Administrative problems|4|||
129043320|NCT00099268|464450559|FG001|Overall Study|Administrative problems|4|||
129043321|NCT00099268|464450558|FG000|Overall Study|Death|3|||
129043322|NCT00099268|464450559|FG001|Overall Study|Death|1|||
129043323|NCT05016622|464450560|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
129043324|NCT05016622|464450560|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
129043325|NCT02006628|464450562|FG000|Overall Study|Adverse Event|1|||
129043326|NCT02006628|464450563|FG001|Overall Study|Adverse Event|1|||
129043327|NCT02006628|464450562|FG000|Overall Study|Withdrawal by Subject|2|||
129043328|NCT02006628|464450563|FG001|Overall Study|Withdrawal by Subject|1|||
129043329|NCT01705236|464450567|FG000|Overall Study|Lost to Follow-up|1|||
129043330|NCT01705236|464450567|FG000|Overall Study|Administrative problems|2|||
129043331|NCT01705236|464450567|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129043332|NCT01705236|464450567|FG000|Overall Study|Protocol Violation|3|||
129043333|NCT01705236|464450567|FG000|Overall Study|Abnormal test procedure result(s)|4|||
129043334|NCT01705236|464450567|FG000|Overall Study|Abnormal laboratory value(s)|4|||
129043335|NCT01705236|464450567|FG000|Overall Study|Withdrawal by Subject|5|||
129043336|NCT01705236|464450567|FG000|Overall Study|Adverse Event|5|||
129043337|NCT00171301|464450568|FG000|Overall Study|Death|1|||
129043338|NCT00171301|464450569|FG001|Overall Study|Death|2|||
129043339|NCT00171301|464450568|FG000|Overall Study|Adverse Event|1|||
129043340|NCT00171301|464450569|FG001|Overall Study|Adverse Event|2|||
129043341|NCT00171301|464450568|FG000|Overall Study|Lost to Follow-up|6|||
129043342|NCT00171301|464450569|FG001|Overall Study|Lost to Follow-up|2|||
129043343|NCT00171301|464450568|FG000|Overall Study|Protocol Violation|0|||
129043344|NCT00171301|464450569|FG001|Overall Study|Protocol Violation|2|||
129043345|NCT00171301|464450568|FG000|Overall Study|Withdrawal by Subject|0|||
129134430|NCT02675452|464785017|FG020|Overall Study|Lost to Follow-up|0|||
129134431|NCT02675452|464785018|FG021|Overall Study|Lost to Follow-up|0|||
129134432|NCT02675452|464785019|FG022|Overall Study|Lost to Follow-up|0|||
129134433|NCT02675452|464785020|FG023|Overall Study|Lost to Follow-up|0|||
129134434|NCT02675452|464785021|FG024|Overall Study|Lost to Follow-up|0|||
129134435|NCT02675452|464785022|FG025|Overall Study|Lost to Follow-up|0|||
129134436|NCT02675452|464785023|FG026|Overall Study|Lost to Follow-up|1|||
129134437|NCT02675452|464785024|FG027|Overall Study|Lost to Follow-up|0|||
129134438|NCT02675452|464785025|FG028|Overall Study|Lost to Follow-up|0|||
129134439|NCT02675452|464784997|FG000|Overall Study|Other|0|||
129134440|NCT02675452|464784998|FG001|Overall Study|Other|0|||
129134441|NCT02675452|464784999|FG002|Overall Study|Other|0|||
129134442|NCT02675452|464785000|FG003|Overall Study|Other|0|||
129134443|NCT02675452|464785001|FG004|Overall Study|Other|0|||
129134444|NCT02675452|464785002|FG005|Overall Study|Other|0|||
129134445|NCT02675452|464785003|FG006|Overall Study|Other|0|||
129134446|NCT02675452|464785004|FG007|Overall Study|Other|0|||
129134447|NCT02675452|464785005|FG008|Overall Study|Other|0|||
129134448|NCT02675452|464785006|FG009|Overall Study|Other|0|||
129134449|NCT02675452|464785007|FG010|Overall Study|Other|0|||
128719009|NCT00624052|463268930|FG000|Overall Study|Adverse Event|7|||
128719010|NCT00624052|463268931|FG001|Overall Study|Adverse Event|6|||
128719011|NCT00624052|463268932|FG002|Overall Study|Adverse Event|0|||
129134450|NCT02675452|464785008|FG011|Overall Study|Other|0|||
129134451|NCT02675452|464785009|FG012|Overall Study|Other|0|||
128719012|NCT00624052|463268933|FG003|Overall Study|Adverse Event|3|||
128719013|NCT00624052|463268930|FG000|Overall Study|Lack of Efficacy|1|||
129043346|NCT00171301|464450569|FG001|Overall Study|Withdrawal by Subject|1|||
129134452|NCT02675452|464785010|FG013|Overall Study|Other|0|||
129134453|NCT02675452|464785011|FG014|Overall Study|Other|0|||
128719014|NCT00624052|463268931|FG001|Overall Study|Lack of Efficacy|1|||
128719015|NCT00624052|463268932|FG002|Overall Study|Lack of Efficacy|0|||
129043347|NCT04319159|464450570|FG000|Overall Study|Screening failure|13|||
129043348|NCT04319159|464450570|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
129134454|NCT02675452|464785012|FG015|Overall Study|Other|0|||
129134455|NCT02675452|464785013|FG016|Overall Study|Other|0|||
129134456|NCT02675452|464785014|FG017|Overall Study|Other|0|||
129134457|NCT02675452|464785015|FG018|Overall Study|Other|0|||
129222884|NCT02486718|465118209|FG001|Randomized Phase|Protocol Violation|2|||
129222885|NCT02486718|465118210|FG002|Randomized Phase|Protocol Violation|0|||
129222886|NCT02486718|465118208|FG000|Randomized Phase|Physician Decision|0|||
129222887|NCT02486718|465118209|FG001|Randomized Phase|Physician Decision|0|||
128981236|NCT00151775|464218963|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981237|NCT00151775|464218964|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981238|NCT00151775|464218965|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981239|NCT00151775|464218966|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981240|NCT00151775|464218967|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
128981241|NCT00151775|464218956|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
128981242|NCT00151775|464218957|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981243|NCT00151775|464218958|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981244|NCT00151775|464218959|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981245|NCT00151775|464218960|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981246|NCT00151775|464218961|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981247|NCT00151775|464218962|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
128981248|NCT00151775|464218963|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981249|NCT00151775|464218964|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981250|NCT00151775|464218965|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981251|NCT00151775|464218966|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
128981252|NCT00151775|464218967|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
128981253|NCT00151775|464218956|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981254|NCT00151775|464218957|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
128981255|NCT00151775|464218958|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981256|NCT00151775|464218959|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981257|NCT00151775|464218960|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981258|NCT00151775|464218961|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981259|NCT00151775|464218962|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981260|NCT00151775|464218963|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981261|NCT00151775|464218964|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981262|NCT00151775|464218965|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128719016|NCT00624052|463268933|FG003|Overall Study|Lack of Efficacy|0|||
128719017|NCT00624052|463268930|FG000|Overall Study|Lost to Follow-up|2|||
128719018|NCT00624052|463268931|FG001|Overall Study|Lost to Follow-up|3|||
128719019|NCT00624052|463268932|FG002|Overall Study|Lost to Follow-up|1|||
128719020|NCT00624052|463268933|FG003|Overall Study|Lost to Follow-up|0|||
128981263|NCT00151775|464218966|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981264|NCT00151775|464218967|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
128981265|NCT00151775|464218956|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
128981266|NCT00151775|464218957|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
128981267|NCT00151775|464218958|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
128981268|NCT00151775|464218959|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
128981269|NCT00151775|464218960|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
128981270|NCT00151775|464218961|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
129134458|NCT02675452|464785016|FG019|Overall Study|Other|0|||
129134459|NCT02675452|464785017|FG020|Overall Study|Other|0|||
129134460|NCT02675452|464785018|FG021|Overall Study|Other|0|||
129134461|NCT02675452|464785019|FG022|Overall Study|Other|0|||
129134462|NCT02675452|464785020|FG023|Overall Study|Other|0|||
129134463|NCT02675452|464785021|FG024|Overall Study|Other|0|||
129134464|NCT02675452|464785022|FG025|Overall Study|Other|0|||
129134465|NCT02675452|464785023|FG026|Overall Study|Other|1|||
129134466|NCT02675452|464785024|FG027|Overall Study|Other|0|||
129134467|NCT02675452|464785025|FG028|Overall Study|Other|0|||
129134468|NCT02939781|464785026|FG000|Overall Study|Protocol Violation|8|||
129134469|NCT02939781|464785026|FG000|Overall Study|Withdrawal by Subject|1|||
129134470|NCT02569242|464785028|FG000|Overall Study|Death|1|||
129134471|NCT02569242|464785029|FG001|Overall Study|Death|0|||
129134472|NCT02569242|464785028|FG000|Overall Study|Withdrawal by Subject|0|||
129134473|NCT02569242|464785029|FG001|Overall Study|Withdrawal by Subject|1|||
128719021|NCT00624052|463268930|FG000|Overall Study|Non compliant with the protocol|2|||
128981271|NCT00151775|464218962|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
129134474|NCT00689052|464785030|FG000|Overall Study|Adverse Event|4|||
129222888|NCT02486718|465118210|FG002|Randomized Phase|Physician Decision|3|||
129134475|NCT00689052|464785031|FG001|Overall Study|Adverse Event|6|||
129134476|NCT00689052|464785030|FG000|Overall Study|Protocol Violation|1|||
128719022|NCT00624052|463268931|FG001|Overall Study|Non compliant with the protocol|1|||
129134477|NCT00689052|464785031|FG001|Overall Study|Protocol Violation|0|||
129134478|NCT00689052|464785030|FG000|Overall Study|Lost to Follow-up|2|||
129134479|NCT00689052|464785031|FG001|Overall Study|Lost to Follow-up|0|||
129134480|NCT00689052|464785030|FG000|Overall Study|Withdrawal by Subject|2|||
129134481|NCT00689052|464785031|FG001|Overall Study|Withdrawal by Subject|0|||
128719023|NCT00624052|463268932|FG002|Overall Study|Non compliant with the protocol|1|||
129134482|NCT00689052|464785030|FG000|Overall Study|Early termination of the trial|22|||
129134483|NCT00689052|464785031|FG001|Overall Study|Early termination of the trial|24|||
129134484|NCT03003468|464785032|FG000|Overall Study|Withdrawal by Subject|0|||
129134485|NCT03003468|464785033|FG001|Overall Study|Withdrawal by Subject|0|||
129134486|NCT03003468|464785034|FG002|Overall Study|Withdrawal by Subject|1|||
129134487|NCT03003468|464785032|FG000|Overall Study|No measurable lesions|0|||
129134488|NCT03003468|464785033|FG001|Overall Study|No measurable lesions|0|||
129134489|NCT03003468|464785034|FG002|Overall Study|No measurable lesions|1|||
129134490|NCT03259308|464785042|FG000|Overall Study|Adverse Event|5|||
129134491|NCT03259308|464785043|FG001|Overall Study|Adverse Event|4|||
129134492|NCT03259308|464785044|FG002|Overall Study|Adverse Event|1|||
129134493|NCT03259308|464785042|FG000|Overall Study|Withdrawal by Subject|2|||
129134494|NCT03259308|464785043|FG001|Overall Study|Withdrawal by Subject|1|||
129134495|NCT03259308|464785044|FG002|Overall Study|Withdrawal by Subject|3|||
129134496|NCT03259308|464785042|FG000|Overall Study|Lost to Follow-up|0|||
129134497|NCT03259308|464785043|FG001|Overall Study|Lost to Follow-up|0|||
128719024|NCT00624052|463268933|FG003|Overall Study|Non compliant with the protocol|1|||
128719025|NCT00624052|463268930|FG000|Overall Study|Consent withdrawn|3|||
128981272|NCT00151775|464218963|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
129134498|NCT03259308|464785044|FG002|Overall Study|Lost to Follow-up|1|||
129134499|NCT03259308|464785042|FG000|Overall Study|Pregnancy|0|||
129134500|NCT03259308|464785043|FG001|Overall Study|Pregnancy|0|||
129134501|NCT03259308|464785044|FG002|Overall Study|Pregnancy|1|||
129134502|NCT03259308|464785042|FG000|Overall Study|Protocol Deviation|0|||
129134503|NCT03259308|464785043|FG001|Overall Study|Protocol Deviation|3|||
129134504|NCT03259308|464785044|FG002|Overall Study|Protocol Deviation|0|||
129134505|NCT03259308|464785042|FG000|Overall Study|Lack of Efficacy|0|||
129134506|NCT03259308|464785043|FG001|Overall Study|Lack of Efficacy|0|||
128981273|NCT00151775|464218964|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
128981274|NCT00151775|464218965|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
129134507|NCT03259308|464785044|FG002|Overall Study|Lack of Efficacy|1|||
129134508|NCT01727154|464785045|FG000|Overall Study|Death|17|||
129134509|NCT01727154|464785045|FG000|Overall Study|Withdrawal by Subject|14|||
129134510|NCT01727154|464785045|FG000|Overall Study|Subject Withdrew Consent|18|||
129134511|NCT01727154|464785045|FG000|Overall Study|Study Terminated|6|||
129134512|NCT01727154|464785045|FG000|Overall Study|No Discontinuation Documentation|4|||
129134513|NCT00003474|464785046|FG000|Overall Study|Not Evaluable|14|||
129134514|NCT06025695|464785047|FG000|Overall Study|Adverse Event|5|||
129134515|NCT06025695|464785048|FG001|Overall Study|Adverse Event|6|||
128981275|NCT00151775|464218966|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
128981276|NCT00151775|464218967|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
128981277|NCT00151775|464218956|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981278|NCT00151775|464218957|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981279|NCT00151775|464218958|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981280|NCT00151775|464218959|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981281|NCT00151775|464218960|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981282|NCT00151775|464218961|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
128981283|NCT00151775|464218962|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981284|NCT00151775|464218963|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981285|NCT00151775|464218964|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981286|NCT00151775|464218965|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981287|NCT00151775|464218966|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981288|NCT00151775|464218967|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
128981289|NCT00151775|464218956|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981290|NCT00151775|464218957|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981291|NCT00151775|464218958|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981292|NCT00151775|464218959|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981293|NCT00151775|464218960|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981294|NCT00151775|464218961|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
128981295|NCT00151775|464218962|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981296|NCT00151775|464218963|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981297|NCT00151775|464218964|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129134516|NCT06025695|464785047|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
129134517|NCT06025695|464785048|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
129134518|NCT06025695|464785047|FG000|Overall Study|Other|23|||
129134519|NCT06025695|464785048|FG001|Overall Study|Other|19|||
129134520|NCT06025695|464785047|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
129134521|NCT06025695|464785048|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
129134522|NCT03834883|464785049|FG000|Second Treatment|Withdrawal by Subject|1|||
129134523|NCT03834883|464785050|FG001|Second Treatment|Withdrawal by Subject|0|||
129134524|NCT03834883|464785051|FG002|Second Treatment|Withdrawal by Subject|0|||
129134525|NCT03834883|464785052|FG003|Second Treatment|Withdrawal by Subject|0|||
129134526|NCT03834883|464785049|FG000|Second Treatment|COVID-19 pandemic|1|||
129043349|NCT04319159|464450570|FG000|Overall Study|Withdrawal by Subject|1|||
129043350|NCT02100319|464450571|FG000|Overall Study|Case Report Forms Uncollected|11|||
129043351|NCT02100319|464450571|FG000|Overall Study|Protocol Deviation|5|||
129043352|NCT00754442|464450572|FG000|Overall Study|Withdrawal by Subject|5|||
129043353|NCT00754442|464450573|FG001|Overall Study|Withdrawal by Subject|3|||
129043354|NCT00296491|464450574|FG000|Overall Study|Low Pollen Counts|18|||
129043355|NCT00296491|464450575|FG001|Overall Study|Low Pollen Counts|26|||
129043356|NCT00296491|464450576|FG002|Overall Study|Low Pollen Counts|25|||
129043357|NCT00296491|464450577|FG003|Overall Study|Low Pollen Counts|16|||
129043358|NCT00296491|464450574|FG000|Overall Study|Protocol Violation|4|||
129043359|NCT00296491|464450575|FG001|Overall Study|Protocol Violation|6|||
129043360|NCT00296491|464450576|FG002|Overall Study|Protocol Violation|2|||
129043361|NCT00296491|464450577|FG003|Overall Study|Protocol Violation|3|||
129043362|NCT00296491|464450574|FG000|Overall Study|Adverse Event|1|||
129043363|NCT00296491|464450575|FG001|Overall Study|Adverse Event|3|||
129043364|NCT00296491|464450576|FG002|Overall Study|Adverse Event|1|||
129043365|NCT00296491|464450577|FG003|Overall Study|Adverse Event|4|||
129043366|NCT00296491|464450574|FG000|Overall Study|Withdrawn due to Asthma|0|||
129043367|NCT00296491|464450575|FG001|Overall Study|Withdrawn due to Asthma|0|||
129043368|NCT00296491|464450576|FG002|Overall Study|Withdrawn due to Asthma|0|||
129043369|NCT00296491|464450577|FG003|Overall Study|Withdrawn due to Asthma|4|||
128719026|NCT00624052|463268931|FG001|Overall Study|Consent withdrawn|1|||
128719027|NCT00624052|463268932|FG002|Overall Study|Consent withdrawn|1|||
128719028|NCT00624052|463268933|FG003|Overall Study|Consent withdrawn|0|||
128719029|NCT00624052|463268930|FG000|Overall Study|Changed job/ran out if meds|0|||
128719030|NCT00624052|463268931|FG001|Overall Study|Changed job/ran out if meds|2|||
128719031|NCT00624052|463268932|FG002|Overall Study|Changed job/ran out if meds|0|||
129043370|NCT00296491|464450574|FG000|Overall Study|Withdrawal by Subject|7|||
129043371|NCT00296491|464450575|FG001|Overall Study|Withdrawal by Subject|3|||
129043372|NCT00296491|464450576|FG002|Overall Study|Withdrawal by Subject|3|||
129043373|NCT00296491|464450577|FG003|Overall Study|Withdrawal by Subject|2|||
129043374|NCT00296491|464450574|FG000|Overall Study|Non-Compliance|12|||
129043375|NCT00296491|464450575|FG001|Overall Study|Non-Compliance|13|||
129043376|NCT00296491|464450576|FG002|Overall Study|Non-Compliance|10|||
129043377|NCT00296491|464450577|FG003|Overall Study|Non-Compliance|14|||
129043378|NCT00296491|464450574|FG000|Overall Study|Lost to Follow-up|0|||
129043379|NCT00296491|464450575|FG001|Overall Study|Lost to Follow-up|2|||
129043380|NCT00296491|464450576|FG002|Overall Study|Lost to Follow-up|2|||
129043381|NCT00296491|464450577|FG003|Overall Study|Lost to Follow-up|0|||
129043382|NCT01300052|464450578|FG000|Overall Study|Adverse Event|3|||
129043383|NCT01300052|464450579|FG001|Overall Study|Adverse Event|0|||
129043384|NCT01300052|464450578|FG000|Overall Study|Withdrawal by Subject|2|||
129043385|NCT01300052|464450579|FG001|Overall Study|Withdrawal by Subject|2|||
129043386|NCT01300052|464450578|FG000|Overall Study|Protocol Violation|1|||
129043387|NCT01300052|464450579|FG001|Overall Study|Protocol Violation|1|||
129043388|NCT01231373|464450580|FG000|Overall Study|Withdrew consent prior to randomization|2|||
129043389|NCT01231373|464450581|FG001|Overall Study|Withdrew consent prior to randomization|1|||
129043390|NCT01231373|464450582|FG002|Overall Study|Withdrew consent prior to randomization|0|||
129043391|NCT01231373|464450583|FG003|Overall Study|Withdrew consent prior to randomization|0|||
129043392|NCT01231373|464450580|FG000|Overall Study|Lost to Follow-up|0|||
129043393|NCT01231373|464450581|FG001|Overall Study|Lost to Follow-up|0|||
129043394|NCT01231373|464450582|FG002|Overall Study|Lost to Follow-up|0|||
129043395|NCT01231373|464450583|FG003|Overall Study|Lost to Follow-up|1|||
129043396|NCT01231373|464450580|FG000|Overall Study|Withdrew Consent|1|||
129043397|NCT01231373|464450581|FG001|Overall Study|Withdrew Consent|0|||
129043398|NCT01231373|464450582|FG002|Overall Study|Withdrew Consent|0|||
129043399|NCT01231373|464450583|FG003|Overall Study|Withdrew Consent|0|||
129043400|NCT03451006|464450584|FG000|Overall Study|Withdrawal by Subject|2|||
129043401|NCT03451006|464450585|FG001|Overall Study|Withdrawal by Subject|2|||
129043402|NCT02547766|464450586|FG000|Overall Study|Withdrawal by Subject|1|||
129043403|NCT01929395|464450587|FG000|Overall Study|Did not complete - non-related toxicity|1|||
129043404|NCT01929395|464450588|FG001|Overall Study|Did not complete - non-related toxicity|0|||
129043405|NCT01929395|464450589|FG002|Overall Study|Did not complete - non-related toxicity|0|||
129043406|NCT01929395|464450587|FG000|Overall Study|Withdrawal by Subject|0|||
128719032|NCT00624052|463268933|FG003|Overall Study|Changed job/ran out if meds|0|||
128719033|NCT00281684|463268936|FG000|Overall Study|Lost to Follow-up|0|||
128719034|NCT00281684|463268937|FG001|Overall Study|Lost to Follow-up|0|||
129043407|NCT01929395|464450588|FG001|Overall Study|Withdrawal by Subject|1|||
129043408|NCT01929395|464450589|FG002|Overall Study|Withdrawal by Subject|0|||
129043409|NCT01929395|464450587|FG000|Overall Study|Screen Fail|0|||
129043410|NCT01929395|464450588|FG001|Overall Study|Screen Fail|0|||
129043411|NCT01929395|464450589|FG002|Overall Study|Screen Fail|1|||
129043412|NCT03604341|464450590|FG000|Overall Study|Withdrawal by Subject|1|||
129043413|NCT03604341|464450591|FG001|Overall Study|Withdrawal by Subject|1|||
129043414|NCT03604341|464450590|FG000|Overall Study|Adverse Event|1|||
129043415|NCT03604341|464450591|FG001|Overall Study|Adverse Event|0|||
129043416|NCT03604341|464450590|FG000|Overall Study|Protocol Violation|0|||
129043417|NCT03604341|464450591|FG001|Overall Study|Protocol Violation|1|||
128719035|NCT00281684|463268938|FG002|Overall Study|Lost to Follow-up|1|||
128719036|NCT00281684|463268939|FG003|Overall Study|Lost to Follow-up|0|||
128719037|NCT00281684|463268936|FG000|Overall Study|Withdrawal by Subject|1|||
128719038|NCT00281684|463268937|FG001|Overall Study|Withdrawal by Subject|0|||
128981298|NCT00151775|464218965|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981299|NCT00151775|464218966|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981300|NCT00151775|464218967|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
128981301|NCT00151775|464218956|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981302|NCT00151775|464218957|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981303|NCT00151775|464218958|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981304|NCT00151775|464218959|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981305|NCT00151775|464218960|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981306|NCT00151775|464218961|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981307|NCT00151775|464218962|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
128981308|NCT00151775|464218963|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981309|NCT00151775|464218964|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981310|NCT00151775|464218965|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981311|NCT00151775|464218966|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981312|NCT00151775|464218967|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
128981313|NCT00151775|464218956|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981314|NCT00151775|464218957|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981315|NCT00151775|464218958|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981316|NCT00151775|464218959|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981317|NCT00151775|464218960|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981318|NCT00151775|464218961|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
128981319|NCT00151775|464218962|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981320|NCT00151775|464218963|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981321|NCT00151775|464218964|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981322|NCT00151775|464218965|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981323|NCT00151775|464218966|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981324|NCT00151775|464218967|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
128981325|NCT00151775|464218956|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
128981326|NCT00151775|464218957|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
128981327|NCT00151775|464218958|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
128981328|NCT00151775|464218959|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
128981329|NCT00151775|464218960|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
128981330|NCT00151775|464218961|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
128981331|NCT00151775|464218962|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
128981332|NCT00151775|464218963|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
128981333|NCT00151775|464218964|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
129043418|NCT01829113|464450595|FG000|Overall Study|Disease Progression|37|||
129043419|NCT01829113|464450596|FG001|Overall Study|Disease Progression|48|||
129043420|NCT01829113|464450595|FG000|Overall Study|Adverse Event|14|||
129043421|NCT01829113|464450596|FG001|Overall Study|Adverse Event|10|||
129043422|NCT01829113|464450595|FG000|Overall Study|Withdrawal by Subject|17|||
129043423|NCT01829113|464450596|FG001|Overall Study|Withdrawal by Subject|10|||
129043424|NCT01829113|464450595|FG000|Overall Study|Death|4|||
129043425|NCT01829113|464450596|FG001|Overall Study|Death|6|||
129043426|NCT01829113|464450595|FG000|Overall Study|Sponsor Decision|1|||
129043427|NCT01829113|464450596|FG001|Overall Study|Sponsor Decision|1|||
129134527|NCT03834883|464785050|FG001|Second Treatment|COVID-19 pandemic|0|||
129134528|NCT03834883|464785051|FG002|Second Treatment|COVID-19 pandemic|1|||
129134529|NCT03834883|464785052|FG003|Second Treatment|COVID-19 pandemic|1|||
129134530|NCT01629563|464786857|FG000|Overall Study|Adverse Event|16|||
129043428|NCT01829113|464450595|FG000|Overall Study|No Study Treatment Received|3|||
129043429|NCT01829113|464450596|FG001|Overall Study|No Study Treatment Received|2|||
129043430|NCT01829113|464450595|FG000|Overall Study|Physician Decision|1|||
129043431|NCT01829113|464450596|FG001|Overall Study|Physician Decision|1|||
129043432|NCT02010255|464450597|FG000|Overall Study|Death|0|||
129043433|NCT02010255|464450598|FG001|Overall Study|Death|1|||
129043434|NCT02010255|464450599|FG002|Overall Study|Death|4|||
129043435|NCT02010255|464450600|FG003|Overall Study|Death|4|||
129043436|NCT02010255|464450601|FG004|Overall Study|Death|2|||
129043437|NCT02010255|464450602|FG005|Overall Study|Death|0|||
129043438|NCT02010255|464450603|FG006|Overall Study|Death|1|||
129043439|NCT02010255|464450604|FG007|Overall Study|Death|1|||
129134531|NCT01629563|464786858|FG001|Overall Study|Adverse Event|16|||
128719039|NCT00281684|463268938|FG002|Overall Study|Withdrawal by Subject|0|||
129043440|NCT02010255|464450605|FG008|Overall Study|Death|1|||
129043441|NCT02010255|464450606|FG009|Overall Study|Death|0|||
129043442|NCT02010255|464450607|FG010|Overall Study|Death|1|||
129134532|NCT01629563|464786857|FG000|Overall Study|Death|2|||
128775346|NCT01474512|463468371|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775347|NCT01474512|463468372|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775348|NCT01474512|463468373|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128775349|NCT01474512|463468374|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
128981334|NCT00151775|464218965|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
128981335|NCT00151775|464218966|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
128981336|NCT00151775|464218967|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
128981337|NCT00151775|464218956|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981338|NCT00151775|464218957|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981339|NCT00151775|464218958|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981340|NCT00151775|464218959|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981341|NCT00151775|464218960|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981342|NCT00151775|464218961|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981343|NCT00151775|464218962|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
128981344|NCT00151775|464218963|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981345|NCT00151775|464218964|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981346|NCT00151775|464218965|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981347|NCT00151775|464218966|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981348|NCT00151775|464218967|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
128981349|NCT00151775|464218956|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981350|NCT00151775|464218957|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981351|NCT00151775|464218958|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
128981352|NCT00151775|464218959|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981353|NCT00151775|464218960|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981354|NCT00151775|464218961|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981355|NCT00151775|464218962|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981356|NCT00151775|464218963|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981357|NCT00151775|464218964|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981358|NCT00151775|464218965|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981359|NCT00151775|464218966|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981360|NCT00151775|464218967|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
128981361|NCT00151775|464218956|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981362|NCT00151775|464218957|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981363|NCT00151775|464218958|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
128981364|NCT00151775|464218959|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981365|NCT00151775|464218960|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981366|NCT00151775|464218961|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981367|NCT00151775|464218962|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981368|NCT00151775|464218963|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981369|NCT00151775|464218964|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981370|NCT00151775|464218965|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129043443|NCT02010255|464450608|FG011|Overall Study|Death|1|||
129043444|NCT02010255|464450609|FG012|Overall Study|Death|0|||
129043445|NCT02010255|464450610|FG013|Overall Study|Death|0|||
129043446|NCT02010255|464450597|FG000|Overall Study|Lack of Efficacy|4|||
129043447|NCT02010255|464450598|FG001|Overall Study|Lack of Efficacy|1|||
129043448|NCT02010255|464450599|FG002|Overall Study|Lack of Efficacy|2|||
129043449|NCT02010255|464450600|FG003|Overall Study|Lack of Efficacy|1|||
129043450|NCT02010255|464450601|FG004|Overall Study|Lack of Efficacy|1|||
129043451|NCT02010255|464450602|FG005|Overall Study|Lack of Efficacy|0|||
129043452|NCT02010255|464450603|FG006|Overall Study|Lack of Efficacy|0|||
129043453|NCT02010255|464450604|FG007|Overall Study|Lack of Efficacy|0|||
129043454|NCT02010255|464450605|FG008|Overall Study|Lack of Efficacy|0|||
129043455|NCT02010255|464450606|FG009|Overall Study|Lack of Efficacy|0|||
129043456|NCT02010255|464450607|FG010|Overall Study|Lack of Efficacy|1|||
129043457|NCT02010255|464450608|FG011|Overall Study|Lack of Efficacy|0|||
129043458|NCT02010255|464450609|FG012|Overall Study|Lack of Efficacy|0|||
129043459|NCT02010255|464450610|FG013|Overall Study|Lack of Efficacy|0|||
129043460|NCT02010255|464450597|FG000|Overall Study|Withdrew Consent|1|||
129043461|NCT02010255|464450598|FG001|Overall Study|Withdrew Consent|0|||
129043462|NCT02010255|464450599|FG002|Overall Study|Withdrew Consent|0|||
129043463|NCT02010255|464450600|FG003|Overall Study|Withdrew Consent|1|||
128775350|NCT01474512|463468357|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128981371|NCT00151775|464218966|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
128981372|NCT00151775|464218967|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129043464|NCT02010255|464450601|FG004|Overall Study|Withdrew Consent|0|||
129043465|NCT02010255|464450602|FG005|Overall Study|Withdrew Consent|0|||
129043466|NCT02010255|464450603|FG006|Overall Study|Withdrew Consent|0|||
129043467|NCT02010255|464450604|FG007|Overall Study|Withdrew Consent|0|||
129043468|NCT02010255|464450605|FG008|Overall Study|Withdrew Consent|0|||
129043469|NCT02010255|464450606|FG009|Overall Study|Withdrew Consent|0|||
129222889|NCT02486718|465118208|FG000|Randomized Phase|Lost to Follow-up|0|||
129222890|NCT02486718|465118209|FG001|Randomized Phase|Lost to Follow-up|5|||
129222891|NCT02486718|465118210|FG002|Randomized Phase|Lost to Follow-up|11|||
129222892|NCT02486718|465118208|FG000|Randomized Phase|Disease Relapse|0|||
129222893|NCT02486718|465118209|FG001|Randomized Phase|Disease Relapse|1|||
129222894|NCT02486718|465118210|FG002|Randomized Phase|Disease Relapse|0|||
129222895|NCT02486718|465118208|FG000|Randomized Phase|Death|0|||
129222896|NCT02486718|465118209|FG001|Randomized Phase|Death|154|||
129222897|NCT02486718|465118210|FG002|Randomized Phase|Death|155|||
129222898|NCT02486718|465118208|FG000|Randomized Phase|Ongoing|0|||
129222899|NCT02486718|465118209|FG001|Randomized Phase|Ongoing|301|||
129222900|NCT02486718|465118210|FG002|Randomized Phase|Ongoing|282|||
129222901|NCT05564052|465118211|FG000|Overall Study|Withdrawal by Subject|0|||
129222902|NCT05564052|465118212|FG001|Overall Study|Withdrawal by Subject|0|||
129222903|NCT05564052|465118213|FG002|Overall Study|Withdrawal by Subject|0|||
129222904|NCT05564052|465118214|FG003|Overall Study|Withdrawal by Subject|1|||
129222905|NCT03816332|465118215|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
129222906|NCT03816332|465118215|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
129222907|NCT04689828|465118218|FG000|Overall Study|Subject decision|5|||
129222908|NCT04689828|465118219|FG001|Overall Study|Subject decision|5|||
129222909|NCT04689828|465118218|FG000|Overall Study|Adverse Event|12|||
129222910|NCT04689828|465118219|FG001|Overall Study|Adverse Event|12|||
129222911|NCT04689828|465118218|FG000|Overall Study|Physician Decision|24|||
129222912|NCT04689828|465118219|FG001|Overall Study|Physician Decision|32|||
129222913|NCT04689828|465118218|FG000|Overall Study|Progressive disease|54|||
129222914|NCT04689828|465118219|FG001|Overall Study|Progressive disease|173|||
129222915|NCT04689828|465118218|FG000|Overall Study|Death|0|||
129222916|NCT04689828|465118219|FG001|Overall Study|Death|1|||
129222917|NCT04689828|465118218|FG000|Overall Study|Lost to Follow-up|1|||
129222918|NCT04689828|465118219|FG001|Overall Study|Lost to Follow-up|0|||
129222919|NCT04689828|465118218|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
129043470|NCT02010255|464450607|FG010|Overall Study|Withdrew Consent|0|||
129043471|NCT02010255|464450608|FG011|Overall Study|Withdrew Consent|0|||
129043472|NCT02010255|464450609|FG012|Overall Study|Withdrew Consent|0|||
129043473|NCT02010255|464450610|FG013|Overall Study|Withdrew Consent|0|||
129043474|NCT02010255|464450597|FG000|Overall Study|Adverse Event|1|||
129043475|NCT02010255|464450598|FG001|Overall Study|Adverse Event|0|||
129043476|NCT02010255|464450599|FG002|Overall Study|Adverse Event|0|||
129043477|NCT02010255|464450600|FG003|Overall Study|Adverse Event|0|||
129043478|NCT02010255|464450601|FG004|Overall Study|Adverse Event|0|||
129043479|NCT02010255|464450602|FG005|Overall Study|Adverse Event|0|||
129043480|NCT02010255|464450603|FG006|Overall Study|Adverse Event|0|||
129043481|NCT02010255|464450604|FG007|Overall Study|Adverse Event|0|||
129134533|NCT01629563|464786858|FG001|Overall Study|Death|0|||
129134534|NCT01629563|464786857|FG000|Overall Study|Lack of Efficacy|2|||
129134535|NCT01629563|464786858|FG001|Overall Study|Lack of Efficacy|3|||
129134536|NCT01629563|464786857|FG000|Overall Study|Lost to Follow-up|1|||
129134537|NCT01629563|464786858|FG001|Overall Study|Lost to Follow-up|0|||
129134538|NCT01629563|464786857|FG000|Overall Study|Pregnancy|1|||
129134539|NCT01629563|464786858|FG001|Overall Study|Pregnancy|2|||
129134540|NCT01629563|464786857|FG000|Overall Study|Protocol Violation|0|||
129134541|NCT01629563|464786858|FG001|Overall Study|Protocol Violation|1|||
129134542|NCT01629563|464786857|FG000|Overall Study|Withdrawal by Subject|27|||
129134543|NCT01629563|464786858|FG001|Overall Study|Withdrawal by Subject|20|||
129134544|NCT01629563|464786857|FG000|Overall Study|surgery|0|||
129134545|NCT01629563|464786858|FG001|Overall Study|surgery|3|||
129134546|NCT01629563|464786857|FG000|Overall Study|Lack of return of menses|12|||
129222920|NCT04689828|465118219|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
129222921|NCT04689828|465118218|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
129222922|NCT04689828|465118219|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
129222923|NCT04689828|465118218|FG000|Overall Study|Participants not treated|7|||
129222924|NCT04689828|465118219|FG001|Overall Study|Participants not treated|2|||
129222925|NCT03978624|465118220|FG000|Overall Study|Protocol Violation|1|||
129222926|NCT03978624|465118221|FG001|Overall Study|Protocol Violation|0|||
128719040|NCT00281684|463268939|FG003|Overall Study|Withdrawal by Subject|0|||
128719041|NCT00698581|463268942|FG000|Overall Study|Lack of Efficacy|23|||
128719042|NCT00698581|463268943|FG001|Overall Study|Lack of Efficacy|11|||
128719043|NCT00698581|463268942|FG000|Overall Study|Withdrawal by Subject|6|||
128719044|NCT00698581|463268943|FG001|Overall Study|Withdrawal by Subject|0|||
128719045|NCT00698581|463268942|FG000|Overall Study|Other reason|9|||
129043482|NCT02010255|464450605|FG008|Overall Study|Adverse Event|0|||
129043483|NCT02010255|464450606|FG009|Overall Study|Adverse Event|0|||
129043484|NCT02010255|464450607|FG010|Overall Study|Adverse Event|0|||
129043485|NCT02010255|464450608|FG011|Overall Study|Adverse Event|0|||
129134547|NCT01629563|464786858|FG001|Overall Study|Lack of return of menses|7|||
129134548|NCT01629563|464786857|FG000|Overall Study|Protocol Violation|0|||
129134549|NCT01629563|464786858|FG001|Overall Study|Protocol Violation|1|||
129222927|NCT05611996|465118222|FG000|Overall Study|Ineligible|1|||
129222928|NCT05611996|465118222|FG000|Overall Study|Withdrawal by Subject|9|||
129134550|NCT00454142|464786859|FG000|Overall Study|Withdrawal by Subject|1|||
129134551|NCT02545127|464786865|FG000|Overall Study|Lost to Follow-up|1|||
128719046|NCT00698581|463268943|FG001|Overall Study|Other reason|1|||
128719047|NCT00698581|463268942|FG000|Overall Study|SAE, non-fatal|1|||
129134552|NCT02545127|464786866|FG001|Overall Study|Lost to Follow-up|0|||
129134553|NCT05788328|464786867|FG000|Treatment Period 4 (5 Days)|Other|1|||
129134554|NCT05788328|464786867|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
129134555|NCT00145327|464786868|FG000|Overall Study|Withdrawal by Subject|77|||
129134556|NCT00145327|464786869|FG001|Overall Study|Withdrawal by Subject|72|||
129134557|NCT00145327|464786870|FG002|Overall Study|Withdrawal by Subject|164|||
128719048|NCT00698581|463268943|FG001|Overall Study|SAE, non-fatal|0|||
128719049|NCT00698581|463268942|FG000|Overall Study|AE, non-serious non-fatal|4|||
128719050|NCT00698581|463268943|FG001|Overall Study|AE, non-serious non-fatal|0|||
128719051|NCT00698581|463268942|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
128981373|NCT00151775|464218956|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981374|NCT00151775|464218957|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981375|NCT00151775|464218958|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981376|NCT00151775|464218959|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981377|NCT00151775|464218960|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981378|NCT00151775|464218961|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981379|NCT00151775|464218962|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981380|NCT00151775|464218963|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981381|NCT00151775|464218964|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981382|NCT00151775|464218965|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981383|NCT00151775|464218966|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
128981384|NCT00151775|464218967|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
128981385|NCT00151775|464218956|FG000|Period 4: Open Label|Increased blood pressure|0|||
128981386|NCT00151775|464218957|FG001|Period 4: Open Label|Increased blood pressure|0|||
128981387|NCT00151775|464218958|FG002|Period 4: Open Label|Increased blood pressure|0|||
128981388|NCT00151775|464218959|FG003|Period 4: Open Label|Increased blood pressure|0|||
128981389|NCT00151775|464218960|FG004|Period 4: Open Label|Increased blood pressure|1|||
128981390|NCT00151775|464218961|FG005|Period 4: Open Label|Increased blood pressure|0|||
128981391|NCT00151775|464218962|FG006|Period 4: Open Label|Increased blood pressure|0|||
128981392|NCT00151775|464218963|FG007|Period 4: Open Label|Increased blood pressure|0|||
128981393|NCT00151775|464218964|FG008|Period 4: Open Label|Increased blood pressure|0|||
128981394|NCT00151775|464218965|FG009|Period 4: Open Label|Increased blood pressure|1|||
128981395|NCT00151775|464218966|FG010|Period 4: Open Label|Increased blood pressure|0|||
128981396|NCT00151775|464218967|FG011|Period 4: Open Label|Increased blood pressure|0|||
128981397|NCT00151775|464218956|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
128981398|NCT00151775|464218957|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
128981399|NCT00151775|464218958|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
128981400|NCT00151775|464218959|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
128981401|NCT00151775|464218960|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
128981402|NCT00151775|464218961|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
128981403|NCT00151775|464218962|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
128981404|NCT00151775|464218963|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
128981405|NCT00151775|464218964|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
128981406|NCT00151775|464218965|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
128981407|NCT00151775|464218966|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
128981408|NCT00151775|464218967|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
128981409|NCT00151775|464218956|FG000|Period 4: Open Label|Adverse Event|0|||
128981410|NCT00151775|464218957|FG001|Period 4: Open Label|Adverse Event|0|||
128981411|NCT00151775|464218958|FG002|Period 4: Open Label|Adverse Event|0|||
128981412|NCT00151775|464218959|FG003|Period 4: Open Label|Adverse Event|0|||
128981413|NCT00151775|464218960|FG004|Period 4: Open Label|Adverse Event|1|||
128981414|NCT00151775|464218961|FG005|Period 4: Open Label|Adverse Event|0|||
128981415|NCT00151775|464218962|FG006|Period 4: Open Label|Adverse Event|0|||
128981416|NCT00151775|464218963|FG007|Period 4: Open Label|Adverse Event|0|||
128981417|NCT00151775|464218964|FG008|Period 4: Open Label|Adverse Event|0|||
128981418|NCT00151775|464218965|FG009|Period 4: Open Label|Adverse Event|2|||
128981419|NCT00151775|464218966|FG010|Period 4: Open Label|Adverse Event|0|||
129222929|NCT05182125|465118225|FG000|Overall Study|Withdrawal by Subject|0|||
128981420|NCT00151775|464218967|FG011|Period 4: Open Label|Adverse Event|0|||
128981421|NCT00151775|464218956|FG000|Period 4: Open Label|Lost to Follow-up|0|||
128981422|NCT00151775|464218957|FG001|Period 4: Open Label|Lost to Follow-up|0|||
128719052|NCT00698581|463268943|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129134558|NCT00145327|464786868|FG000|Overall Study|Death|26|||
128719053|NCT00698581|463268942|FG000|Overall Study|AE of unknown type|1|||
128775351|NCT01474512|463468358|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128981423|NCT00151775|464218958|FG002|Period 4: Open Label|Lost to Follow-up|0|||
129134559|NCT00145327|464786869|FG001|Overall Study|Death|18|||
129222930|NCT05182125|465118226|FG001|Overall Study|Withdrawal by Subject|0|||
129134560|NCT00145327|464786870|FG002|Overall Study|Death|30|||
129134561|NCT00145327|464786868|FG000|Overall Study|Adverse Event|14|||
129134562|NCT00145327|464786869|FG001|Overall Study|Adverse Event|11|||
129134563|NCT00145327|464786870|FG002|Overall Study|Adverse Event|22|||
129134564|NCT00145327|464786868|FG000|Overall Study|Lost to Follow-up|9|||
129134565|NCT00145327|464786869|FG001|Overall Study|Lost to Follow-up|14|||
129134566|NCT00145327|464786870|FG002|Overall Study|Lost to Follow-up|14|||
129134567|NCT00145327|464786868|FG000|Overall Study|Administrative problems|12|||
129134568|NCT00145327|464786869|FG001|Overall Study|Administrative problems|9|||
129134569|NCT00145327|464786870|FG002|Overall Study|Administrative problems|13|||
129134570|NCT00145327|464786868|FG000|Overall Study|Protocol Violation|2|||
129134571|NCT00145327|464786869|FG001|Overall Study|Protocol Violation|0|||
129134572|NCT00145327|464786870|FG002|Overall Study|Protocol Violation|2|||
129134573|NCT00145327|464786868|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129134574|NCT00145327|464786869|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129134575|NCT00145327|464786870|FG002|Overall Study|Abnormal laboratory value(s)|2|||
129134576|NCT00145327|464786868|FG000|Overall Study|Missing - not stated|1|||
129134577|NCT00145327|464786869|FG001|Overall Study|Missing - not stated|0|||
129134578|NCT00145327|464786870|FG002|Overall Study|Missing - not stated|1|||
129134579|NCT02802865|464786871|FG000|Overall Study|Pregnancy|1|||
129134580|NCT02802865|464786872|FG001|Overall Study|Pregnancy|1|||
129134581|NCT02802865|464786871|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
129134582|NCT02802865|464786872|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
129134583|NCT03315689|464786873|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
129134584|NCT03315689|464786874|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
129134585|NCT03315689|464786873|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
129134586|NCT03315689|464786874|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
129134587|NCT03315689|464786873|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
129134588|NCT03315689|464786874|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
129134589|NCT00762788|464786875|FG000|Overall Study|Lost to Follow-up|26|||
129134590|NCT00762788|464786876|FG001|Overall Study|Lost to Follow-up|37|||
129134591|NCT00762788|464786877|FG002|Overall Study|Lost to Follow-up|21|||
129134592|NCT00762788|464786878|FG003|Overall Study|Lost to Follow-up|26|||
129134593|NCT00762788|464786879|FG004|Overall Study|Lost to Follow-up|13|||
129134594|NCT00762788|464786880|FG005|Overall Study|Lost to Follow-up|21|||
129134595|NCT01783015|464786882|FG000|Blinded Treatment|Adverse Event|0|||
129134596|NCT01783015|464786883|FG001|Blinded Treatment|Adverse Event|1|||
129134597|NCT01783015|464786884|FG002|Blinded Treatment|Adverse Event|0|||
129134598|NCT01783015|464786882|FG000|Blinded Treatment|Protocol Violation|0|||
129134599|NCT01783015|464786883|FG001|Blinded Treatment|Protocol Violation|1|||
129134600|NCT01783015|464786884|FG002|Blinded Treatment|Protocol Violation|0|||
129134601|NCT01783015|464786882|FG000|Blinded Treatment|Withdrawal by Subject|0|||
129134602|NCT01783015|464786883|FG001|Blinded Treatment|Withdrawal by Subject|1|||
129134603|NCT01783015|464786884|FG002|Blinded Treatment|Withdrawal by Subject|0|||
129134604|NCT01783015|464786882|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
129134605|NCT01783015|464786883|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
129222931|NCT05182125|465118227|FG002|Overall Study|Withdrawal by Subject|0|||
129134606|NCT01783015|464786884|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
129134607|NCT01783015|464786882|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
129134608|NCT01783015|464786883|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
129134609|NCT01783015|464786884|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
129134610|NCT00669331|464786885|FG000|Randomisation to First Dose|Adverse Event|1|||
129134611|NCT00669331|464786886|FG001|Randomisation to First Dose|Adverse Event|0|||
129134612|NCT00669331|464786885|FG000|Randomisation to First Dose|Protocol Violation|1|||
129134613|NCT00669331|464786886|FG001|Randomisation to First Dose|Protocol Violation|0|||
129134614|NCT00669331|464786885|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
129134615|NCT00669331|464786886|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
129134616|NCT00669331|464786885|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
129134617|NCT00669331|464786886|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
129134618|NCT00669331|464786885|FG000|Randomisation to First Dose|Death|1|||
129134619|NCT00669331|464786886|FG001|Randomisation to First Dose|Death|0|||
129134620|NCT00669331|464786885|FG000|Randomisation to First Dose|Sponsor decision|0|||
129134621|NCT00669331|464786886|FG001|Randomisation to First Dose|Sponsor decision|1|||
129134622|NCT00669331|464786885|FG000|Randomisation to First Dose|Randomised in error|3|||
129134623|NCT00669331|464786886|FG001|Randomisation to First Dose|Randomised in error|10|||
129134624|NCT00669331|464786885|FG000|Blinded Treatment Period|Adverse Event|16|||
129134625|NCT00669331|464786886|FG001|Blinded Treatment Period|Adverse Event|10|||
129134626|NCT00669331|464786885|FG000|Blinded Treatment Period|Protocol Violation|1|||
129134627|NCT00669331|464786886|FG001|Blinded Treatment Period|Protocol Violation|1|||
129134628|NCT00669331|464786885|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
129134629|NCT00669331|464786886|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
129134630|NCT00669331|464786885|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
129134631|NCT00669331|464786886|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
129134632|NCT00669331|464786885|FG000|Blinded Treatment Period|Death|0|||
129043486|NCT02010255|464450609|FG012|Overall Study|Adverse Event|0|||
129043487|NCT02010255|464450610|FG013|Overall Study|Adverse Event|0|||
129043488|NCT02010255|464450597|FG000|Overall Study|Lost to Follow-up|0|||
129043489|NCT02010255|464450598|FG001|Overall Study|Lost to Follow-up|0|||
129043490|NCT02010255|464450599|FG002|Overall Study|Lost to Follow-up|1|||
129043491|NCT02010255|464450600|FG003|Overall Study|Lost to Follow-up|0|||
129043492|NCT02010255|464450601|FG004|Overall Study|Lost to Follow-up|1|||
129043493|NCT02010255|464450602|FG005|Overall Study|Lost to Follow-up|0|||
129043494|NCT02010255|464450603|FG006|Overall Study|Lost to Follow-up|0|||
129043495|NCT02010255|464450604|FG007|Overall Study|Lost to Follow-up|0|||
129043496|NCT02010255|464450605|FG008|Overall Study|Lost to Follow-up|0|||
129043497|NCT02010255|464450606|FG009|Overall Study|Lost to Follow-up|0|||
129043498|NCT02010255|464450607|FG010|Overall Study|Lost to Follow-up|0|||
129043499|NCT02010255|464450608|FG011|Overall Study|Lost to Follow-up|0|||
129043500|NCT02010255|464450609|FG012|Overall Study|Lost to Follow-up|0|||
129043501|NCT02010255|464450610|FG013|Overall Study|Lost to Follow-up|0|||
129043502|NCT02010255|464450597|FG000|Overall Study|Randomized but Not Treated|0|||
129043503|NCT02010255|464450598|FG001|Overall Study|Randomized but Not Treated|0|||
129043504|NCT02010255|464450599|FG002|Overall Study|Randomized but Not Treated|0|||
129043505|NCT02010255|464450600|FG003|Overall Study|Randomized but Not Treated|0|||
129043506|NCT02010255|464450601|FG004|Overall Study|Randomized but Not Treated|0|||
129043507|NCT02010255|464450602|FG005|Overall Study|Randomized but Not Treated|0|||
129043508|NCT02010255|464450603|FG006|Overall Study|Randomized but Not Treated|0|||
129043509|NCT02010255|464450604|FG007|Overall Study|Randomized but Not Treated|0|||
129043510|NCT02010255|464450605|FG008|Overall Study|Randomized but Not Treated|0|||
129043511|NCT02010255|464450606|FG009|Overall Study|Randomized but Not Treated|0|||
129043512|NCT02010255|464450607|FG010|Overall Study|Randomized but Not Treated|0|||
129043513|NCT02010255|464450608|FG011|Overall Study|Randomized but Not Treated|0|||
129043514|NCT02010255|464450609|FG012|Overall Study|Randomized but Not Treated|0|||
129043515|NCT02010255|464450610|FG013|Overall Study|Randomized but Not Treated|1|||
129043516|NCT00977431|464450616|FG000|Overall Study|Other than listed|1|||
129043517|NCT00977431|464450617|FG001|Overall Study|Other than listed|0|||
129043518|NCT00977431|464450618|FG002|Overall Study|Other than listed|0|||
129043519|NCT00977431|464450619|FG003|Overall Study|Other than listed|0|||
129043520|NCT00977431|464450620|FG004|Overall Study|Other than listed|2|||
129043521|NCT00977431|464450616|FG000|Overall Study|Protocol Violation|0|||
129043522|NCT00977431|464450617|FG001|Overall Study|Protocol Violation|0|||
129043523|NCT00977431|464450618|FG002|Overall Study|Protocol Violation|1|||
129043524|NCT00977431|464450619|FG003|Overall Study|Protocol Violation|0|||
129043525|NCT00977431|464450620|FG004|Overall Study|Protocol Violation|0|||
129043526|NCT00977431|464450616|FG000|Overall Study|Adverse Event|3|||
129043527|NCT00977431|464450617|FG001|Overall Study|Adverse Event|0|||
128719054|NCT00698581|463268943|FG001|Overall Study|AE of unknown type|0|||
128719055|NCT00449644|463268944|FG000|Overall Study|Adverse Event|0|||
128719056|NCT00449644|463268945|FG001|Overall Study|Adverse Event|0|||
129043528|NCT00977431|464450618|FG002|Overall Study|Adverse Event|4|||
129043529|NCT00977431|464450619|FG003|Overall Study|Adverse Event|0|||
129043530|NCT00977431|464450620|FG004|Overall Study|Adverse Event|6|||
129043531|NCT00977431|464450616|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
129043532|NCT00977431|464450617|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
129043533|NCT00977431|464450618|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
129043534|NCT00977431|464450619|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
129043535|NCT00977431|464450620|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
129043536|NCT00977431|464450616|FG000|Overall Study|Progressive disease|2|||
129043537|NCT00977431|464450617|FG001|Overall Study|Progressive disease|6|||
129043538|NCT00977431|464450618|FG002|Overall Study|Progressive disease|1|||
129043539|NCT00977431|464450619|FG003|Overall Study|Progressive disease|3|||
129043540|NCT00977431|464450620|FG004|Overall Study|Progressive disease|5|||
129043541|NCT01010750|464450621|FG000|Second Intervention|Adverse Event|0|||
129043542|NCT01010750|464450622|FG001|Second Intervention|Adverse Event|1|||
129043543|NCT01010750|464450623|FG002|Second Intervention|Adverse Event|0|||
129043544|NCT01010750|464450624|FG003|Second Intervention|Adverse Event|0|||
129043545|NCT01010750|464450625|FG004|Second Intervention|Adverse Event|0|||
129134633|NCT00669331|464786886|FG001|Blinded Treatment Period|Death|2|||
129134634|NCT00669331|464786885|FG000|Blinded Treatment Period|Physician Decision|3|||
129043546|NCT01010750|464450626|FG005|Second Intervention|Adverse Event|0|||
129043547|NCT02777918|464450628|FG000|Overall Study|Medical reasons|1|||
129043548|NCT02777918|464450629|FG001|Overall Study|Medical reasons|2|||
129043549|NCT02777918|464450628|FG000|Overall Study|Too busy / stressed|1|||
129043550|NCT02777918|464450629|FG001|Overall Study|Too busy / stressed|1|||
128719057|NCT00449644|463268946|FG002|Overall Study|Adverse Event|3|||
129043551|NCT02777918|464450628|FG000|Overall Study|Withdrawal by Subject|1|||
129043552|NCT02777918|464450629|FG001|Overall Study|Withdrawal by Subject|1|||
129043553|NCT01338987|464450630|FG000|Overall Study|enrolled on new protocol|0|||
129043554|NCT01338987|464450631|FG001|Overall Study|enrolled on new protocol|0|||
129043555|NCT01338987|464450632|FG002|Overall Study|enrolled on new protocol|1|||
129043556|NCT01338987|464450633|FG003|Overall Study|enrolled on new protocol|0|||
129043557|NCT01338987|464450634|FG004|Overall Study|enrolled on new protocol|0|||
129043558|NCT01338987|464450630|FG000|Overall Study|Disease progression on study|2|||
129043559|NCT01338987|464450631|FG001|Overall Study|Disease progression on study|1|||
129043560|NCT01338987|464450632|FG002|Overall Study|Disease progression on study|1|||
129043561|NCT01338987|464450633|FG003|Overall Study|Disease progression on study|0|||
129043562|NCT01338987|464450634|FG004|Overall Study|Disease progression on study|0|||
129043563|NCT00757848|464450635|FG000|Overall Study|Voluntary discontinuation|1|||
129043564|NCT00757848|464450636|FG001|Overall Study|Voluntary discontinuation|0|||
129043565|NCT00757848|464450635|FG000|Overall Study|Adverse Event|1|||
129043566|NCT00757848|464450636|FG001|Overall Study|Adverse Event|2|||
129043567|NCT00757848|464450635|FG000|Overall Study|Incorrect enrolment|1|||
129043568|NCT00757848|464450636|FG001|Overall Study|Incorrect enrolment|0|||
129043569|NCT00058214|464450639|FG000|Overall Study|Adverse Event|1|||
129043570|NCT03856593|464450649|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
129043571|NCT03856593|464450650|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
129043572|NCT01949116|464450651|FG000|Overall Study|Death|2|||
129043573|NCT01949116|464450652|FG001|Overall Study|Death|0|||
129043574|NCT01949116|464450651|FG000|Overall Study|Lost to Follow-up|1|||
129043575|NCT01949116|464450652|FG001|Overall Study|Lost to Follow-up|3|||
129043576|NCT01949116|464450651|FG000|Overall Study|Withdrawal by Subject|5|||
129043577|NCT01949116|464450652|FG001|Overall Study|Withdrawal by Subject|3|||
129043578|NCT02427984|464450654|FG000|Overall Study|Lost to Follow-up|13|||
129043579|NCT02427984|464450655|FG001|Overall Study|Lost to Follow-up|5|||
129043580|NCT02427984|464450656|FG002|Overall Study|Lost to Follow-up|18|||
129043581|NCT03545191|464450657|FG000|Overall Study|Death|1|||
129043582|NCT03545191|464450658|FG001|Overall Study|Death|0|||
129043583|NCT03545191|464450659|FG002|Overall Study|Death|0|||
129043584|NCT03545191|464450657|FG000|Overall Study|Adverse Event|4|||
129043585|NCT03545191|464450658|FG001|Overall Study|Adverse Event|2|||
129043586|NCT03545191|464450659|FG002|Overall Study|Adverse Event|7|||
129043587|NCT03545191|464450657|FG000|Overall Study|Other reasons|3|||
129043588|NCT03545191|464450658|FG001|Overall Study|Other reasons|11|||
129043589|NCT03545191|464450659|FG002|Overall Study|Other reasons|8|||
129043590|NCT03545191|464450657|FG000|Overall Study|Withdrawal by Subject|13|||
129043591|NCT03545191|464450658|FG001|Overall Study|Withdrawal by Subject|10|||
129043592|NCT03545191|464450659|FG002|Overall Study|Withdrawal by Subject|12|||
129043593|NCT03545191|464450657|FG000|Overall Study|Lost to Follow-up|1|||
129043594|NCT03545191|464450658|FG001|Overall Study|Lost to Follow-up|2|||
129043595|NCT03545191|464450659|FG002|Overall Study|Lost to Follow-up|3|||
129043596|NCT01524913|464450663|FG000|Overall Study|Lost to Follow-up|4|||
129043597|NCT01524913|464450664|FG001|Overall Study|Lost to Follow-up|0|||
129043598|NCT01524913|464450665|FG002|Overall Study|Lost to Follow-up|0|||
129043599|NCT00788593|464450666|FG000|Placebo Run-in Phase|Adverse Event|2|||
129043600|NCT00788593|464450667|FG001|Placebo Run-in Phase|Adverse Event|0|||
129043601|NCT00788593|464450668|FG002|Placebo Run-in Phase|Adverse Event|0|||
129043602|NCT00788593|464450666|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
129043603|NCT00788593|464450667|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
129043604|NCT00788593|464450668|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
129043605|NCT00788593|464450666|FG000|Placebo Run-in Phase|Protocol Violation|2|||
129043606|NCT00788593|464450667|FG001|Placebo Run-in Phase|Protocol Violation|0|||
129043607|NCT00788593|464450668|FG002|Placebo Run-in Phase|Protocol Violation|0|||
129043608|NCT00788593|464450666|FG000|First Intervention Period|Adverse Event|0|||
129134635|NCT00669331|464786886|FG001|Blinded Treatment Period|Physician Decision|3|||
129134636|NCT00669331|464786885|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
129134637|NCT00669331|464786886|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
129134638|NCT01454063|464786887|FG000|Randomized|Adverse Event|1|||
129134639|NCT01454063|464786888|FG001|Randomized|Adverse Event|1|||
129134640|NCT01454063|464786887|FG000|Randomized|Protocol Violation|0|||
129134641|NCT01454063|464786888|FG001|Randomized|Protocol Violation|1|||
128775352|NCT01474512|463468359|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129043609|NCT00788593|464450667|FG001|First Intervention Period|Adverse Event|1|||
129043610|NCT00788593|464450668|FG002|First Intervention Period|Adverse Event|0|||
129043611|NCT00788593|464450666|FG000|Second Intervention Period|Lost to Follow-up|0|||
129043612|NCT00788593|464450667|FG001|Second Intervention Period|Lost to Follow-up|1|||
129043613|NCT00788593|464450668|FG002|Second Intervention Period|Lost to Follow-up|0|||
129134642|NCT00509600|464786889|FG000|Overall Study|Adverse Event|1|||
129134643|NCT02568423|464786892|FG000|Overall Study|Lost to Follow-up|0|||
129134644|NCT02568423|464786893|FG001|Overall Study|Lost to Follow-up|2|||
129134645|NCT02568423|464786894|FG002|Overall Study|Lost to Follow-up|0|||
129134646|NCT02568423|464786895|FG003|Overall Study|Lost to Follow-up|0|||
129134647|NCT02568423|464786896|FG004|Overall Study|Lost to Follow-up|0|||
129043614|NCT00788593|464450666|FG000|Second Intervention Period|Other|0|||
129043615|NCT00788593|464450667|FG001|Second Intervention Period|Other|0|||
129043616|NCT00788593|464450668|FG002|Second Intervention Period|Other|1|||
129043617|NCT00515034|464450671|FG000|Overall Study|Adverse Event|2|||
129134648|NCT02568423|464786897|FG005|Overall Study|Lost to Follow-up|0|||
129134649|NCT02568423|464786898|FG006|Overall Study|Lost to Follow-up|0|||
128719058|NCT00449644|463268947|FG003|Overall Study|Adverse Event|5|||
128719059|NCT00449644|463268944|FG000|Overall Study|Death|1|||
128719060|NCT00449644|463268945|FG001|Overall Study|Death|0|||
129043618|NCT00515034|464450672|FG001|Overall Study|Adverse Event|0|||
129043619|NCT00515034|464450673|FG002|Overall Study|Adverse Event|1|||
129043620|NCT00515034|464450674|FG003|Overall Study|Adverse Event|0|||
129043621|NCT00515034|464450671|FG000|Overall Study|Death|4|||
129043622|NCT00515034|464450672|FG001|Overall Study|Death|2|||
129043623|NCT00515034|464450673|FG002|Overall Study|Death|1|||
129043624|NCT00515034|464450674|FG003|Overall Study|Death|3|||
129043625|NCT00515034|464450671|FG000|Overall Study|Withdrawal by Subject|1|||
129043626|NCT00515034|464450672|FG001|Overall Study|Withdrawal by Subject|0|||
129043627|NCT00515034|464450673|FG002|Overall Study|Withdrawal by Subject|3|||
129043628|NCT00515034|464450674|FG003|Overall Study|Withdrawal by Subject|0|||
129043629|NCT00515034|464450671|FG000|Overall Study|Physician Decision|0|||
129043630|NCT00515034|464450672|FG001|Overall Study|Physician Decision|0|||
129043631|NCT00515034|464450673|FG002|Overall Study|Physician Decision|1|||
129043632|NCT00515034|464450674|FG003|Overall Study|Physician Decision|1|||
129043633|NCT00515034|464450671|FG000|Overall Study|Other|1|||
129043634|NCT00515034|464450672|FG001|Overall Study|Other|0|||
129043635|NCT00515034|464450673|FG002|Overall Study|Other|2|||
129043636|NCT00515034|464450674|FG003|Overall Study|Other|1|||
129043637|NCT01392326|464450679|FG000|Overall Study|Death|2|||
129043638|NCT01392326|464450680|FG001|Overall Study|Death|0|||
129043639|NCT01392326|464450681|FG002|Overall Study|Death|0|||
129043640|NCT01392326|464450679|FG000|Overall Study|Withdrawal by Subject|12|||
129043641|NCT01392326|464450680|FG001|Overall Study|Withdrawal by Subject|11|||
129043642|NCT01392326|464450681|FG002|Overall Study|Withdrawal by Subject|15|||
129043643|NCT01392326|464450679|FG000|Overall Study|Protocol Violation|2|||
129043644|NCT01392326|464450680|FG001|Overall Study|Protocol Violation|0|||
129043645|NCT01392326|464450681|FG002|Overall Study|Protocol Violation|0|||
129043646|NCT01392326|464450679|FG000|Overall Study|Pregnancy|0|||
129043647|NCT01392326|464450680|FG001|Overall Study|Pregnancy|0|||
129043648|NCT01392326|464450681|FG002|Overall Study|Pregnancy|1|||
128719061|NCT00449644|463268946|FG002|Overall Study|Death|6|||
128719062|NCT00449644|463268947|FG003|Overall Study|Death|1|||
128719063|NCT00449644|463268944|FG000|Overall Study|Lost to Follow-up|1|||
128719064|NCT00449644|463268945|FG001|Overall Study|Lost to Follow-up|1|||
128775353|NCT01474512|463468360|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775354|NCT01474512|463468361|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775355|NCT01474512|463468362|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775356|NCT01474512|463468363|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775357|NCT01474512|463468364|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775358|NCT01474512|463468365|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775359|NCT01474512|463468366|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775360|NCT01474512|463468367|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775361|NCT01474512|463468368|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
128775362|NCT01474512|463468369|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775363|NCT01474512|463468370|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129043649|NCT01392326|464450679|FG000|Overall Study|Physician Decision|7|||
129043650|NCT01392326|464450680|FG001|Overall Study|Physician Decision|5|||
129043651|NCT01392326|464450681|FG002|Overall Study|Physician Decision|2|||
129043652|NCT01392326|464450679|FG000|Overall Study|Lost to Follow-up|1|||
128719065|NCT00449644|463268946|FG002|Overall Study|Lost to Follow-up|5|||
128719066|NCT00449644|463268947|FG003|Overall Study|Lost to Follow-up|3|||
128719067|NCT00449644|463268944|FG000|Overall Study|Pregnancy|0|||
128719068|NCT00449644|463268945|FG001|Overall Study|Pregnancy|0|||
128719069|NCT00449644|463268946|FG002|Overall Study|Pregnancy|3|||
128719070|NCT00449644|463268947|FG003|Overall Study|Pregnancy|2|||
128719071|NCT00449644|463268944|FG000|Overall Study|Protocol Violation|4|||
128719072|NCT00449644|463268945|FG001|Overall Study|Protocol Violation|4|||
128719073|NCT00449644|463268946|FG002|Overall Study|Protocol Violation|3|||
128719074|NCT00449644|463268947|FG003|Overall Study|Protocol Violation|7|||
128719075|NCT00449644|463268944|FG000|Overall Study|Withdrawal by Subject|3|||
128719076|NCT00449644|463268945|FG001|Overall Study|Withdrawal by Subject|4|||
128719077|NCT00449644|463268946|FG002|Overall Study|Withdrawal by Subject|6|||
128719078|NCT00449644|463268947|FG003|Overall Study|Withdrawal by Subject|7|||
128719079|NCT00449644|463268944|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
128719080|NCT00449644|463268945|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
128719081|NCT00449644|463268946|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
129043653|NCT01392326|464450680|FG001|Overall Study|Lost to Follow-up|3|||
129043654|NCT01392326|464450681|FG002|Overall Study|Lost to Follow-up|4|||
128719082|NCT00449644|463268947|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
129043655|NCT01392326|464450679|FG000|Overall Study|Lack of Efficacy|14|||
129043656|NCT01392326|464450680|FG001|Overall Study|Lack of Efficacy|10|||
129043657|NCT01392326|464450681|FG002|Overall Study|Lack of Efficacy|15|||
129043658|NCT01392326|464450679|FG000|Overall Study|Adverse Event|9|||
129043659|NCT01392326|464450680|FG001|Overall Study|Adverse Event|6|||
129043660|NCT01392326|464450681|FG002|Overall Study|Adverse Event|11|||
129043661|NCT00233987|464450686|FG000|Overall Study|Withdrawal by Subject|1|||
129043662|NCT00233987|464450686|FG000|Overall Study|Lack of Efficacy|2|||
129043663|NCT00233987|464450686|FG000|Overall Study|Reason Under Review|1|||
129043664|NCT00233987|464450686|FG000|Overall Study|Other - Not Protocol Specified|5|||
129043665|NCT00233987|464450686|FG000|Overall Study|Eligible but No Treatment Received|2|||
129043666|NCT00233987|464450686|FG000|Overall Study|Ineligible|4|||
129043667|NCT00518622|464450689|FG000|Overall Study|Lost to Follow-up|0|||
129043668|NCT00518622|464450690|FG001|Overall Study|Lost to Follow-up|0|||
129043669|NCT00518622|464450691|FG002|Overall Study|Lost to Follow-up|1|||
129043670|NCT00518622|464450692|FG003|Overall Study|Lost to Follow-up|0|||
129043671|NCT00518622|464450693|FG004|Overall Study|Lost to Follow-up|0|||
129043672|NCT00518622|464450694|FG005|Overall Study|Lost to Follow-up|0|||
129043673|NCT00518622|464450695|FG006|Overall Study|Lost to Follow-up|0|||
129043674|NCT00518622|464450696|FG007|Overall Study|Lost to Follow-up|0|||
129043675|NCT00518622|464450689|FG000|Overall Study|Study medication taken incorrectly|0|||
129043676|NCT00518622|464450690|FG001|Overall Study|Study medication taken incorrectly|1|||
129043677|NCT00518622|464450691|FG002|Overall Study|Study medication taken incorrectly|0|||
129043678|NCT00518622|464450692|FG003|Overall Study|Study medication taken incorrectly|0|||
129043679|NCT00518622|464450693|FG004|Overall Study|Study medication taken incorrectly|0|||
129043680|NCT00518622|464450694|FG005|Overall Study|Study medication taken incorrectly|0|||
129043681|NCT00518622|464450695|FG006|Overall Study|Study medication taken incorrectly|0|||
129043682|NCT00518622|464450696|FG007|Overall Study|Study medication taken incorrectly|0|||
129043683|NCT01688726|464450697|FG000|Overall Study|Adverse Event|1|||
129043684|NCT01688726|464450698|FG001|Overall Study|Adverse Event|0|||
129043685|NCT01688726|464450697|FG000|Overall Study|Relocated abroad|0|||
129043686|NCT01688726|464450698|FG001|Overall Study|Relocated abroad|1|||
129043687|NCT03499119|464450699|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
129043688|NCT03499119|464450700|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
129043689|NCT03499119|464450701|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
129043690|NCT03499119|464450702|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
129043691|NCT03499119|464450699|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
129043692|NCT03499119|464450700|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
129043693|NCT03499119|464450701|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
129043694|NCT03499119|464450702|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
129043695|NCT03499119|464450699|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
129043696|NCT03499119|464450700|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
129043697|NCT03499119|464450701|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
129043698|NCT03499119|464450702|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
129134650|NCT02568423|464786899|FG007|Overall Study|Lost to Follow-up|0|||
129134651|NCT02568423|464786892|FG000|Overall Study|Physician Decision|0|||
129134652|NCT02568423|464786893|FG001|Overall Study|Physician Decision|0|||
129134653|NCT02568423|464786894|FG002|Overall Study|Physician Decision|0|||
129134654|NCT02568423|464786895|FG003|Overall Study|Physician Decision|0|||
129134655|NCT02568423|464786896|FG004|Overall Study|Physician Decision|0|||
129134656|NCT02568423|464786897|FG005|Overall Study|Physician Decision|1|||
129134657|NCT02568423|464786898|FG006|Overall Study|Physician Decision|0|||
129134658|NCT02568423|464786899|FG007|Overall Study|Physician Decision|0|||
129134659|NCT02930941|464786903|FG000|Overall Study|Lost to Follow-up|1|||
129134660|NCT02930941|464786904|FG001|Overall Study|Lost to Follow-up|2|||
129134661|NCT00289978|464786907|FG000|Overall Study|Withdrawal by Subject|31|||
129134662|NCT00289978|464786908|FG001|Overall Study|Withdrawal by Subject|17|||
129134663|NCT00289978|464786909|FG002|Overall Study|Withdrawal by Subject|28|||
129134664|NCT00289978|464786907|FG000|Overall Study|Adverse Event|22|||
129134665|NCT00289978|464786908|FG001|Overall Study|Adverse Event|13|||
129134666|NCT00289978|464786909|FG002|Overall Study|Adverse Event|18|||
128775364|NCT01474512|463468371|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775365|NCT01474512|463468372|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128775366|NCT01474512|463468373|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129222932|NCT05182125|465118228|FG003|Overall Study|Withdrawal by Subject|0|||
129222933|NCT05182125|465118229|FG004|Overall Study|Withdrawal by Subject|2|||
129222934|NCT05182125|465118230|FG005|Overall Study|Withdrawal by Subject|0|||
129222935|NCT05182125|465118225|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
129043699|NCT03499119|464450699|FG000|Optional Extension Phase|Lost to Follow-up|0|||
129043700|NCT03499119|464450700|FG001|Optional Extension Phase|Lost to Follow-up|0|||
129043701|NCT03499119|464450701|FG002|Optional Extension Phase|Lost to Follow-up|0|||
129043702|NCT03499119|464450702|FG003|Optional Extension Phase|Lost to Follow-up|1|||
129043703|NCT03499119|464450699|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
129043704|NCT03499119|464450700|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
129043705|NCT03499119|464450701|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
129043706|NCT03499119|464450702|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
129134667|NCT00289978|464786907|FG000|Overall Study|Lack of Efficacy|13|||
129134668|NCT00289978|464786908|FG001|Overall Study|Lack of Efficacy|6|||
129134669|NCT00289978|464786909|FG002|Overall Study|Lack of Efficacy|25|||
129043707|NCT03499119|464450699|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
129043708|NCT03499119|464450700|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
129222936|NCT05182125|465118226|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
129222937|NCT05182125|465118227|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
129222938|NCT05182125|465118228|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
129222939|NCT05182125|465118229|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
129222940|NCT05182125|465118230|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
129222941|NCT05182125|465118225|FG000|Overall Study|Death|0|||
129222942|NCT05182125|465118226|FG001|Overall Study|Death|0|||
129222943|NCT05182125|465118227|FG002|Overall Study|Death|0|||
129222944|NCT05182125|465118228|FG003|Overall Study|Death|0|||
129222945|NCT05182125|465118229|FG004|Overall Study|Death|1|||
129222946|NCT05182125|465118230|FG005|Overall Study|Death|0|||
129222947|NCT04803214|465118231|FG000|Overall Study|Adverse Event|1|||
129222948|NCT04803214|465118232|FG001|Overall Study|Adverse Event|0|||
129222949|NCT04803214|465118231|FG000|Overall Study|Withdrawal by Subject|1|||
129222950|NCT04803214|465118232|FG001|Overall Study|Withdrawal by Subject|2|||
129222951|NCT04803214|465118231|FG000|Overall Study|Lost to Follow-up|2|||
129222952|NCT04803214|465118232|FG001|Overall Study|Lost to Follow-up|4|||
129222953|NCT04803214|465118231|FG000|Overall Study|Physician Decision|1|||
129222954|NCT04803214|465118232|FG001|Overall Study|Physician Decision|1|||
129222955|NCT04803214|465118231|FG000|Overall Study|Missed 12 month visit|0|||
129222956|NCT04803214|465118232|FG001|Overall Study|Missed 12 month visit|3|||
129222957|NCT04479475|465118233|FG000|Overall Study|Withdrawal by Subject|7|||
129222958|NCT03370276|465118234|FG000|Overall Study|Death|0|||
129222959|NCT03370276|465118235|FG001|Overall Study|Death|2|||
129222960|NCT03370276|465118236|FG002|Overall Study|Death|5|||
129222961|NCT05560763|465118237|FG000|Overall Study|Withdrawal by Subject|4|||
129222962|NCT03228537|465118238|FG000|Neoadjuvant|Adverse Event|2|||
129222963|NCT03228537|465118238|FG000|Neoadjuvant|Progression/Relapse|4|||
129222964|NCT03228537|465118238|FG000|Neoadjuvant|Death|1|||
128719083|NCT00449644|463268944|FG000|Overall Study|Other|1|||
128719084|NCT00449644|463268945|FG001|Overall Study|Other|4|||
128719085|NCT00449644|463268946|FG002|Overall Study|Other|1|||
129043709|NCT03499119|464450701|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
129043710|NCT03499119|464450702|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
129043711|NCT04553913|464450703|FG000|Overall Study|patient's block resolved prior to PACU|1|||
129043712|NCT04553913|464450703|FG000|Overall Study|did not use the device properly|5|||
129043713|NCT01481324|464450705|FG000|Overall Study|Missing Data|0|||
129043714|NCT01481324|464450706|FG001|Overall Study|Missing Data|2|||
129134670|NCT00289978|464786907|FG000|Overall Study|Abnormal laboratory value(s)|20|||
129134671|NCT00289978|464786908|FG001|Overall Study|Abnormal laboratory value(s)|9|||
129134672|NCT00289978|464786909|FG002|Overall Study|Abnormal laboratory value(s)|1|||
129134673|NCT00289978|464786907|FG000|Overall Study|Lost to Follow-up|3|||
129134674|NCT00289978|464786908|FG001|Overall Study|Lost to Follow-up|5|||
129134675|NCT00289978|464786909|FG002|Overall Study|Lost to Follow-up|7|||
129134676|NCT00289978|464786907|FG000|Overall Study|Protocol Violation|5|||
129134677|NCT00289978|464786908|FG001|Overall Study|Protocol Violation|5|||
129134678|NCT00289978|464786909|FG002|Overall Study|Protocol Violation|4|||
129134679|NCT00289978|464786907|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129134680|NCT00289978|464786908|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129134681|NCT00289978|464786909|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129134682|NCT00289978|464786907|FG000|Overall Study|Death|1|||
129134683|NCT00289978|464786908|FG001|Overall Study|Death|0|||
129134684|NCT00289978|464786909|FG002|Overall Study|Death|2|||
129222965|NCT03228537|465118238|FG000|Surgery|Death|1|||
129222966|NCT03228537|465118238|FG000|Surgery|Other - Not Protocol Specified|2|||
129222967|NCT03228537|465118238|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
129222968|NCT03228537|465118238|FG000|Maintenance|Progression/Relapse|10|||
128719086|NCT00449644|463268947|FG003|Overall Study|Other|0|||
129134685|NCT00720083|464786910|FG000|Overall Study|Ineligible|1|||
129134686|NCT00720083|464786911|FG001|Overall Study|Ineligible|2|||
129134687|NCT01967277|464786913|FG000|Overall Study|Lost to Follow-up|1|||
129134688|NCT01967277|464786914|FG001|Overall Study|Lost to Follow-up|2|||
129134689|NCT01967277|464786913|FG000|Overall Study|Unrelated illness|0|||
129134690|NCT01967277|464786914|FG001|Overall Study|Unrelated illness|1|||
129134691|NCT00585585|464786917|FG000|Overall Study|Adverse Event|1|||
129134692|NCT00103506|464786918|FG000|Overall Study|Study closed by sponsor|34|||
129134693|NCT00103506|464786919|FG001|Overall Study|Study closed by sponsor|37|||
129134694|NCT00103506|464786918|FG000|Overall Study|Death|257|||
129222969|NCT05064358|465118239|FG000|Overall Study|Death|23|||
129222970|NCT05064358|465118240|FG001|Overall Study|Death|23|||
128719087|NCT00449644|463268944|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
129222971|NCT05064358|465118241|FG002|Overall Study|Death|25|||
129222972|NCT05064358|465118242|FG003|Overall Study|Death|21|||
129222973|NCT05064358|465118243|FG004|Overall Study|Death|5|||
129222974|NCT05064358|465118239|FG000|Overall Study|Lost to Follow-up|1|||
129222975|NCT05064358|465118240|FG001|Overall Study|Lost to Follow-up|2|||
128719088|NCT00449644|463268945|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
128719089|NCT00449644|463268946|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
128719090|NCT00449644|463268947|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
128719091|NCT00853723|463268948|FG000|Overall Study|Adverse Event|3|||
128719092|NCT00853723|463268949|FG001|Overall Study|Adverse Event|4|||
128719093|NCT00853723|463268950|FG002|Overall Study|Adverse Event|1|||
128719094|NCT00853723|463268948|FG000|Overall Study|Withdrawal by Subject|2|||
128719095|NCT00853723|463268949|FG001|Overall Study|Withdrawal by Subject|1|||
128719096|NCT00853723|463268950|FG002|Overall Study|Withdrawal by Subject|0|||
128719097|NCT00853723|463268948|FG000|Overall Study|Protocol Violation|1|||
128719098|NCT00853723|463268949|FG001|Overall Study|Protocol Violation|2|||
128719099|NCT00853723|463268950|FG002|Overall Study|Protocol Violation|1|||
128719100|NCT01531387|463268951|FG000|Overall Study|Early termination of study|11|||
128719101|NCT01531387|463268952|FG001|Overall Study|Early termination of study|11|||
128719102|NCT03795298|463268955|FG000|Overall Study|Death|34|||
128719103|NCT03795298|463268956|FG001|Overall Study|Death|29|||
128719104|NCT03795298|463268955|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
128719105|NCT03795298|463268956|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
128719106|NCT03795298|463268955|FG000|Overall Study|Lost to Follow-up|28|||
128719107|NCT03795298|463268956|FG001|Overall Study|Lost to Follow-up|17|||
128719108|NCT03795298|463268955|FG000|Overall Study|Physician Decision|5|||
128719109|NCT03795298|463268956|FG001|Overall Study|Physician Decision|4|||
128719110|NCT03795298|463268955|FG000|Overall Study|Withdrawal by Subject|43|||
128719111|NCT03795298|463268956|FG001|Overall Study|Withdrawal by Subject|28|||
128719112|NCT03795298|463268955|FG000|Overall Study|Reason not reported|7|||
128719113|NCT03795298|463268956|FG001|Overall Study|Reason not reported|9|||
128719114|NCT04690751|463268959|FG000|Overall Study|Protocol Violation|0|||
128719115|NCT04690751|463268960|FG001|Overall Study|Protocol Violation|1|||
128719116|NCT04690751|463268961|FG002|Overall Study|Protocol Violation|0|||
128719117|NCT04690751|463268962|FG003|Overall Study|Protocol Violation|1|||
128719118|NCT04690751|463268963|FG004|Overall Study|Protocol Violation|2|||
128719119|NCT04690751|463268964|FG005|Overall Study|Protocol Violation|0|||
128719120|NCT04690751|463268959|FG000|Overall Study|Adverse Event|0|||
128719121|NCT04690751|463268960|FG001|Overall Study|Adverse Event|0|||
128719122|NCT04690751|463268961|FG002|Overall Study|Adverse Event|1|||
128719123|NCT04690751|463268962|FG003|Overall Study|Adverse Event|0|||
128719124|NCT04690751|463268963|FG004|Overall Study|Adverse Event|0|||
128719125|NCT04690751|463268964|FG005|Overall Study|Adverse Event|0|||
128719126|NCT04690751|463268959|FG000|Overall Study|Positive urine drug screen test|0|||
129134695|NCT00103506|464786919|FG001|Overall Study|Death|253|||
129134696|NCT00103506|464786918|FG000|Overall Study|Lost to Follow-up|13|||
129134697|NCT00103506|464786919|FG001|Overall Study|Lost to Follow-up|13|||
129134698|NCT00103506|464786918|FG000|Overall Study|Withdrawal by Subject|18|||
129134699|NCT00103506|464786919|FG001|Overall Study|Withdrawal by Subject|21|||
129134700|NCT00585169|464786920|FG000|Overall Study|Withdrawal by Subject|1|||
129134701|NCT00710970|464786921|FG000|Overall Study|Never took drug|3|||
129134702|NCT01028560|464786922|FG000|Overall Study|Lack of Efficacy|3|||
129134703|NCT01028560|464786923|FG001|Overall Study|Lack of Efficacy|6|||
129134704|NCT01028560|464786922|FG000|Overall Study|Withdrawal by Subject|7|||
129134705|NCT01028560|464786923|FG001|Overall Study|Withdrawal by Subject|12|||
129134706|NCT03055221|464786924|FG000|Overall Study|Adverse Event|2|||
129134707|NCT03055221|464786924|FG000|Overall Study|Withdrawal by Subject|4|||
129134708|NCT03055221|464786924|FG000|Overall Study|Death|6|||
128719127|NCT04690751|463268960|FG001|Overall Study|Positive urine drug screen test|0|||
128719128|NCT04690751|463268961|FG002|Overall Study|Positive urine drug screen test|0|||
128719129|NCT04690751|463268962|FG003|Overall Study|Positive urine drug screen test|0|||
128719130|NCT04690751|463268963|FG004|Overall Study|Positive urine drug screen test|1|||
128719131|NCT04690751|463268964|FG005|Overall Study|Positive urine drug screen test|0|||
128719132|NCT04364620|463268965|FG000|Overall Study|Disease Progression|20|||
128719133|NCT04364620|463268965|FG000|Overall Study|Adverse Event|5|||
128719134|NCT04364620|463268965|FG000|Overall Study|Physician Decision|4|||
128719135|NCT04364620|463268965|FG000|Overall Study|Death|3|||
128719136|NCT04364620|463268965|FG000|Overall Study|Other|2|||
128719137|NCT04364620|463268965|FG000|Overall Study|Withdrawal by Subject|1|||
128719138|NCT03759379|463270994|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
128719139|NCT03759379|463270995|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
128719140|NCT03759379|463270994|FG000|Treatment Period|Death|2|||
128719141|NCT03759379|463270995|FG001|Treatment Period|Death|3|||
129134709|NCT03055221|464786924|FG000|Overall Study|Physician Decision|1|||
129134710|NCT03055221|464786924|FG000|Overall Study|Study terminated by Sponsor|3|||
129134711|NCT03055221|464786924|FG000|Overall Study|Lost to Follow-up|4|||
129134712|NCT01243424|464786925|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
129134713|NCT01243424|464786926|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
129134714|NCT01243424|464786925|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
128719142|NCT03759379|463270994|FG000|Treatment Period|Lost to Follow-up|1|||
128719143|NCT03759379|463270995|FG001|Treatment Period|Lost to Follow-up|0|||
129134715|NCT01243424|464786926|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
129134716|NCT01243424|464786925|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
129134717|NCT01243424|464786926|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
129134718|NCT01243424|464786925|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
129134719|NCT01243424|464786926|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
129134720|NCT01243424|464786925|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
129134721|NCT01243424|464786926|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
129134722|NCT01243424|464786925|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
129134723|NCT01243424|464786926|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
129134724|NCT01243424|464786925|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
129134725|NCT01243424|464786926|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
129134726|NCT01243424|464786925|FG000|Discontinuation From Treatment|Not treated|5|||
129134727|NCT01243424|464786926|FG001|Discontinuation From Treatment|Not treated|4|||
129134728|NCT01243424|464786925|FG000|Discontinuation From Treatment|Adverse Event|457|||
129134729|NCT01243424|464786926|FG001|Discontinuation From Treatment|Adverse Event|523|||
129134730|NCT01243424|464786925|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
129134731|NCT01243424|464786926|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
129134732|NCT01243424|464786925|FG000|Discontinuation From Treatment|Protocol Violation|46|||
129134733|NCT01243424|464786926|FG001|Discontinuation From Treatment|Protocol Violation|47|||
129134734|NCT01243424|464786925|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
129134735|NCT01243424|464786926|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
129134736|NCT01243424|464786925|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
129134737|NCT01243424|464786926|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
129134738|NCT01243424|464786925|FG000|Discontinuation From Treatment|Other than listed above|230|||
129134739|NCT01243424|464786926|FG001|Discontinuation From Treatment|Other than listed above|211|||
129134740|NCT00397930|464786931|FG000|Overall Study|Personal reasons|14|||
129134741|NCT00397930|464786932|FG001|Overall Study|Personal reasons|8|||
129134742|NCT00397930|464786931|FG000|Overall Study|Other medical|9|||
129134743|NCT00397930|464786932|FG001|Overall Study|Other medical|4|||
129134744|NCT00397930|464786931|FG000|Overall Study|Unknown reasons|9|||
129134745|NCT00397930|464786932|FG001|Overall Study|Unknown reasons|14|||
129134746|NCT00397930|464786931|FG000|Overall Study|Noncompliant|3|||
129134747|NCT00397930|464786932|FG001|Overall Study|Noncompliant|2|||
129134748|NCT00397930|464786931|FG000|Overall Study|Too time-consuming|2|||
129222976|NCT05064358|465118241|FG002|Overall Study|Lost to Follow-up|0|||
129222977|NCT05064358|465118242|FG003|Overall Study|Lost to Follow-up|2|||
129222978|NCT05064358|465118243|FG004|Overall Study|Lost to Follow-up|0|||
128981424|NCT00151775|464218959|FG003|Period 4: Open Label|Lost to Follow-up|0|||
128981425|NCT00151775|464218960|FG004|Period 4: Open Label|Lost to Follow-up|17|||
128981426|NCT00151775|464218961|FG005|Period 4: Open Label|Lost to Follow-up|0|||
128981427|NCT00151775|464218962|FG006|Period 4: Open Label|Lost to Follow-up|0|||
128981428|NCT00151775|464218963|FG007|Period 4: Open Label|Lost to Follow-up|0|||
128981429|NCT00151775|464218964|FG008|Period 4: Open Label|Lost to Follow-up|0|||
128981430|NCT00151775|464218965|FG009|Period 4: Open Label|Lost to Follow-up|7|||
128981431|NCT00151775|464218966|FG010|Period 4: Open Label|Lost to Follow-up|0|||
128981432|NCT00151775|464218967|FG011|Period 4: Open Label|Lost to Follow-up|0|||
128981433|NCT00151775|464218956|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
128981434|NCT00151775|464218957|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
128981435|NCT00151775|464218958|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
128981436|NCT00151775|464218959|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
128981437|NCT00151775|464218960|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
128981438|NCT00151775|464218961|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
128981439|NCT00151775|464218962|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
128981440|NCT00151775|464218963|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
128981441|NCT00151775|464218964|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
128981442|NCT00151775|464218965|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
128981443|NCT00151775|464218966|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
128981444|NCT00151775|464218967|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
128981445|NCT00151775|464218956|FG000|Period 4: Open Label|Other|0|||
128981446|NCT00151775|464218957|FG001|Period 4: Open Label|Other|0|||
128981447|NCT00151775|464218958|FG002|Period 4: Open Label|Other|0|||
128981448|NCT00151775|464218959|FG003|Period 4: Open Label|Other|0|||
128981449|NCT00151775|464218960|FG004|Period 4: Open Label|Other|1|||
128981450|NCT00151775|464218961|FG005|Period 4: Open Label|Other|0|||
129222979|NCT05064358|465118239|FG000|Overall Study|Physician Decision|1|||
129134749|NCT00397930|464786932|FG001|Overall Study|Too time-consuming|9|||
128981451|NCT00151775|464218962|FG006|Period 4: Open Label|Other|0|||
129134750|NCT00397930|464786931|FG000|Overall Study|Started own yoga program|1|||
128981452|NCT00151775|464218963|FG007|Period 4: Open Label|Other|0|||
128981453|NCT00151775|464218964|FG008|Period 4: Open Label|Other|0|||
128981454|NCT00151775|464218965|FG009|Period 4: Open Label|Other|3|||
129134751|NCT00397930|464786932|FG001|Overall Study|Started own yoga program|1|||
129134752|NCT00397930|464786931|FG000|Overall Study|Did not want to be in control group|0|||
129134753|NCT00397930|464786932|FG001|Overall Study|Did not want to be in control group|1|||
129134754|NCT00397930|464786931|FG000|Overall Study|Withdrawal by Subject|0|||
129134755|NCT00397930|464786932|FG001|Overall Study|Withdrawal by Subject|8|||
129134756|NCT00397930|464786931|FG000|Overall Study|Missing data|0|||
129134757|NCT00397930|464786932|FG001|Overall Study|Missing data|4|||
129134758|NCT01960842|464786933|FG000|Overall Study|Adverse Event|1|||
129134759|NCT01960842|464786933|FG000|Overall Study|Withdrawal by Subject|2|||
129134760|NCT02391584|464786934|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
129134761|NCT02391584|464786935|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
129134762|NCT02391584|464786934|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
129134763|NCT02391584|464786935|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
129134764|NCT02391584|464786934|FG000|3 Month|Lost to Follow-up|1|||
129134765|NCT02391584|464786935|FG001|3 Month|Lost to Follow-up|0|||
129134766|NCT02391584|464786934|FG000|6 Month|Withdrawal by Subject|1|||
129134767|NCT02391584|464786935|FG001|6 Month|Withdrawal by Subject|0|||
129134768|NCT02391584|464786934|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
129134769|NCT02391584|464786935|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
129134770|NCT00710554|464786943|FG000|Overall Study|Adverse Event|24|||
129134771|NCT00710554|464786944|FG001|Overall Study|Adverse Event|7|||
129134772|NCT00710554|464786943|FG000|Overall Study|Withdrawal by Subject|7|||
129134773|NCT00710554|464786944|FG001|Overall Study|Withdrawal by Subject|3|||
129134774|NCT00710554|464786943|FG000|Overall Study|Lost to Follow-up|7|||
129134775|NCT00710554|464786944|FG001|Overall Study|Lost to Follow-up|1|||
129134776|NCT00710554|464786943|FG000|Overall Study|Lack of Efficacy|11|||
129134777|NCT00710554|464786944|FG001|Overall Study|Lack of Efficacy|12|||
129134778|NCT00710554|464786943|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
129134779|NCT00710554|464786944|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
129134780|NCT01301001|464786949|FG000|First Intervention|Lost to Follow-up|4|||
129134781|NCT01301001|464786950|FG001|First Intervention|Lost to Follow-up|4|||
129134782|NCT01301001|464786949|FG000|First Intervention|Withdrawal by Subject|1|||
129134783|NCT01301001|464786950|FG001|First Intervention|Withdrawal by Subject|4|||
129134784|NCT01301001|464786949|FG000|First Intervention|Adverse Event|5|||
129134785|NCT01301001|464786950|FG001|First Intervention|Adverse Event|0|||
129134786|NCT01301001|464786949|FG000|First Intervention|Protocol Violation|0|||
129134787|NCT01301001|464786950|FG001|First Intervention|Protocol Violation|1|||
129134788|NCT01301001|464786949|FG000|Second Intervention|Adverse Event|2|||
129134789|NCT01301001|464786950|FG001|Second Intervention|Adverse Event|0|||
129134790|NCT01301001|464786949|FG000|Second Intervention|Withdrawal by Subject|2|||
129134791|NCT01301001|464786950|FG001|Second Intervention|Withdrawal by Subject|0|||
129134792|NCT01433978|464786953|FG000|Core Study|Adverse Event, Non-Fatal|0|||
129134793|NCT01433978|464786954|FG001|Core Study|Adverse Event, Non-Fatal|1|||
129134794|NCT01433978|464786955|FG002|Core Study|Adverse Event, Non-Fatal|0|||
129134795|NCT01433978|464786953|FG000|Core Study|Lack of Efficacy|5|||
129134796|NCT01433978|464786954|FG001|Core Study|Lack of Efficacy|1|||
129134797|NCT01433978|464786955|FG002|Core Study|Lack of Efficacy|0|||
129134798|NCT01433978|464786953|FG000|Core Study|Study Terminated by Sponsor|6|||
129134799|NCT01433978|464786954|FG001|Core Study|Study Terminated by Sponsor|9|||
129134800|NCT01433978|464786955|FG002|Core Study|Study Terminated by Sponsor|0|||
129134801|NCT01433978|464786953|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
129134802|NCT01433978|464786954|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
129134803|NCT01433978|464786955|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
129134804|NCT01433978|464786953|FG000|Extension Phase|Lack of Efficacy|0|||
129134805|NCT01433978|464786954|FG001|Extension Phase|Lack of Efficacy|0|||
129134806|NCT01433978|464786955|FG002|Extension Phase|Lack of Efficacy|1|||
129134807|NCT01433978|464786953|FG000|Extension Phase|Study Terminated by Sponsor|0|||
129134808|NCT01433978|464786954|FG001|Extension Phase|Study Terminated by Sponsor|0|||
129134809|NCT01433978|464786955|FG002|Extension Phase|Study Terminated by Sponsor|4|||
129043715|NCT01481324|464450707|FG002|Overall Study|Missing Data|2|||
129043716|NCT01172821|464450710|FG000|Overall Study|Adverse Event|5|||
129043717|NCT01172821|464450711|FG001|Overall Study|Adverse Event|2|||
129043718|NCT01172821|464450712|FG002|Overall Study|Adverse Event|2|||
129043719|NCT01172821|464450713|FG003|Overall Study|Adverse Event|7|||
129043720|NCT01172821|464450710|FG000|Overall Study|Protocol Violation|0|||
129043721|NCT01172821|464450711|FG001|Overall Study|Protocol Violation|2|||
129043722|NCT01172821|464450712|FG002|Overall Study|Protocol Violation|1|||
129043723|NCT01172821|464450713|FG003|Overall Study|Protocol Violation|2|||
129043724|NCT01172821|464450710|FG000|Overall Study|Lost to Follow-up|4|||
129043725|NCT01172821|464450711|FG001|Overall Study|Lost to Follow-up|1|||
129043726|NCT01172821|464450712|FG002|Overall Study|Lost to Follow-up|2|||
129043727|NCT01172821|464450713|FG003|Overall Study|Lost to Follow-up|2|||
129043728|NCT01172821|464450710|FG000|Overall Study|Withdrawal by Subject|2|||
129134810|NCT01441414|464786956|FG000|Overall Study|Participant died|9|||
129134811|NCT01441414|464786956|FG000|Overall Study|Other reasons|3|||
129134812|NCT01441414|464786956|FG000|Overall Study|Study terminated by sponsor|2|||
129134813|NCT01441414|464786956|FG000|Overall Study|Subject refused further follow-up|1|||
129222980|NCT05064358|465118240|FG001|Overall Study|Physician Decision|1|||
129222981|NCT05064358|465118241|FG002|Overall Study|Physician Decision|2|||
129222982|NCT05064358|465118242|FG003|Overall Study|Physician Decision|0|||
129222983|NCT05064358|465118243|FG004|Overall Study|Physician Decision|0|||
129222984|NCT05064358|465118239|FG000|Overall Study|Withdrawal by Subject|4|||
129222985|NCT05064358|465118240|FG001|Overall Study|Withdrawal by Subject|5|||
129222986|NCT05064358|465118241|FG002|Overall Study|Withdrawal by Subject|3|||
129222987|NCT05064358|465118242|FG003|Overall Study|Withdrawal by Subject|6|||
129222988|NCT05064358|465118243|FG004|Overall Study|Withdrawal by Subject|3|||
129222989|NCT05064358|465118239|FG000|Overall Study|Ongoing at the time of analysis|1|||
129222990|NCT05064358|465118240|FG001|Overall Study|Ongoing at the time of analysis|2|||
129222991|NCT05064358|465118241|FG002|Overall Study|Ongoing at the time of analysis|2|||
129222992|NCT05064358|465118242|FG003|Overall Study|Ongoing at the time of analysis|2|||
129222993|NCT05064358|465118243|FG004|Overall Study|Ongoing at the time of analysis|2|||
129222994|NCT06972251|465118245|FG000|Overall Study|Withdrawal by Subject|1|||
129222995|NCT06972251|465118246|FG001|Overall Study|Withdrawal by Subject|0|||
129222996|NCT06972251|465118245|FG000|Overall Study|Lost to Follow-up|10|||
129222997|NCT06972251|465118246|FG001|Overall Study|Lost to Follow-up|2|||
129222998|NCT04572243|465118251|FG000|Core Study: 14 Weeks|Adverse Event|1|||
129222999|NCT04572243|465118252|FG001|Core Study: 14 Weeks|Adverse Event|2|||
129223000|NCT04572243|465118253|FG002|Core Study: 14 Weeks|Adverse Event|0|||
129223001|NCT04572243|465118254|FG003|Core Study: 14 Weeks|Adverse Event|0|||
129223002|NCT04572243|465118251|FG000|Core Study: 14 Weeks|Subject choice|0|||
129223003|NCT04572243|465118252|FG001|Core Study: 14 Weeks|Subject choice|2|||
129223004|NCT04572243|465118253|FG002|Core Study: 14 Weeks|Subject choice|0|||
129223005|NCT04572243|465118254|FG003|Core Study: 14 Weeks|Subject choice|0|||
129223006|NCT04572243|465118251|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
129223007|NCT04572243|465118252|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
129223008|NCT04572243|465118253|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
129223009|NCT04572243|465118254|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
129223010|NCT04572243|465118251|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
128719144|NCT03759379|463270994|FG000|Treatment Period|Physician Decision|0|||
128719145|NCT03759379|463270995|FG001|Treatment Period|Physician Decision|1|||
128719146|NCT04579380|463270997|FG000|Overall Study|Death|9|||
128981455|NCT00151775|464218966|FG010|Period 4: Open Label|Other|0|||
128981456|NCT00151775|464218967|FG011|Period 4: Open Label|Other|0|||
128981457|NCT00151775|464218956|FG000|Period 4: Open Label|Physician Decision|0|||
129134814|NCT01773889|464786963|FG000|Overall Study|lack of funding|2|||
129134815|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
129134816|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
129134817|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
129134818|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
129134819|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
129134820|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
129134821|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
129134822|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
129134823|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
129134824|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
129134825|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
129134826|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
129134827|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
129134828|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
129134829|NCT00976391|464786964|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
129134830|NCT00976391|464786965|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
129134831|NCT00976391|464786964|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
129134832|NCT00976391|464786965|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
129134833|NCT00976391|464786964|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
129134834|NCT00976391|464786965|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
129134835|NCT00976391|464786964|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
129134836|NCT00976391|464786965|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
129134837|NCT00976391|464786964|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
129134838|NCT00976391|464786965|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
129134839|NCT00976391|464786964|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
129223011|NCT04572243|465118252|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
129223012|NCT04572243|465118253|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
128981458|NCT00151775|464218957|FG001|Period 4: Open Label|Physician Decision|0|||
129134840|NCT00976391|464786965|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
128981459|NCT00151775|464218958|FG002|Period 4: Open Label|Physician Decision|0|||
129223013|NCT04572243|465118254|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
129223014|NCT03164564|465118255|FG000|Overall Study|Death|3|||
129223015|NCT03164564|465118256|FG001|Overall Study|Death|0|||
129223016|NCT03164564|465118255|FG000|Overall Study|Withdrawal by Subject|20|||
129223017|NCT03164564|465118256|FG001|Overall Study|Withdrawal by Subject|15|||
128719147|NCT04579380|463270998|FG001|Overall Study|Death|22|||
128981460|NCT00151775|464218959|FG003|Period 4: Open Label|Physician Decision|0|||
128981461|NCT00151775|464218960|FG004|Period 4: Open Label|Physician Decision|0|||
128981462|NCT00151775|464218961|FG005|Period 4: Open Label|Physician Decision|0|||
128981463|NCT00151775|464218962|FG006|Period 4: Open Label|Physician Decision|0|||
128981464|NCT00151775|464218963|FG007|Period 4: Open Label|Physician Decision|0|||
128981465|NCT00151775|464218964|FG008|Period 4: Open Label|Physician Decision|0|||
128981466|NCT00151775|464218965|FG009|Period 4: Open Label|Physician Decision|2|||
128981467|NCT00151775|464218966|FG010|Period 4: Open Label|Physician Decision|0|||
128981468|NCT00151775|464218967|FG011|Period 4: Open Label|Physician Decision|0|||
128981469|NCT00151775|464218956|FG000|Period 4: Open Label|Protocol Violation|0|||
128981470|NCT00151775|464218957|FG001|Period 4: Open Label|Protocol Violation|0|||
128981471|NCT00151775|464218958|FG002|Period 4: Open Label|Protocol Violation|0|||
128981472|NCT00151775|464218959|FG003|Period 4: Open Label|Protocol Violation|0|||
128981473|NCT00151775|464218960|FG004|Period 4: Open Label|Protocol Violation|1|||
128981474|NCT00151775|464218961|FG005|Period 4: Open Label|Protocol Violation|0|||
128981475|NCT00151775|464218962|FG006|Period 4: Open Label|Protocol Violation|0|||
128981476|NCT00151775|464218963|FG007|Period 4: Open Label|Protocol Violation|0|||
128981477|NCT00151775|464218964|FG008|Period 4: Open Label|Protocol Violation|0|||
128981478|NCT00151775|464218965|FG009|Period 4: Open Label|Protocol Violation|0|||
128981479|NCT00151775|464218966|FG010|Period 4: Open Label|Protocol Violation|0|||
129043729|NCT01172821|464450711|FG001|Overall Study|Withdrawal by Subject|3|||
129043730|NCT01172821|464450712|FG002|Overall Study|Withdrawal by Subject|3|||
129043731|NCT01172821|464450713|FG003|Overall Study|Withdrawal by Subject|3|||
129043732|NCT01172821|464450710|FG000|Overall Study|Other|3|||
129043733|NCT01172821|464450711|FG001|Overall Study|Other|4|||
129043734|NCT01172821|464450712|FG002|Overall Study|Other|5|||
129043735|NCT01172821|464450713|FG003|Overall Study|Other|3|||
129043736|NCT00094094|464450714|FG000|Overall Study|Death|2|||
129043737|NCT00094094|464450714|FG000|Overall Study|Lack of Efficacy|23|||
129043738|NCT00094094|464450714|FG000|Overall Study|Adverse Event|7|||
129043739|NCT00710749|464450715|FG000|First Intervention|Withdrawal by Subject|1|||
129043740|NCT00710749|464450716|FG001|First Intervention|Withdrawal by Subject|0|||
129043741|NCT04495283|464452836|FG000|Overall Study|Physician Decision|0|||
129043742|NCT04495283|464452837|FG001|Overall Study|Physician Decision|0|||
129043743|NCT04495283|464452838|FG002|Overall Study|Physician Decision|1|||
129043744|NCT04495283|464452836|FG000|Overall Study|Withdrawal by Subject|0|||
129043745|NCT04495283|464452837|FG001|Overall Study|Withdrawal by Subject|1|||
129043746|NCT04495283|464452838|FG002|Overall Study|Withdrawal by Subject|1|||
129043747|NCT04495283|464452836|FG000|Overall Study|Other|1|||
129043748|NCT04495283|464452837|FG001|Overall Study|Other|0|||
129043749|NCT04495283|464452838|FG002|Overall Study|Other|1|||
129043750|NCT02631876|464452843|FG000|Overall Study|Death|96|||
129043751|NCT02631876|464452844|FG001|Overall Study|Death|50|||
129043752|NCT02631876|464452843|FG000|Overall Study|Investigator's discretion|1|||
129043753|NCT02631876|464452844|FG001|Overall Study|Investigator's discretion|0|||
129043754|NCT02631876|464452843|FG000|Overall Study|Lost to Follow-up|2|||
129043755|NCT02631876|464452844|FG001|Overall Study|Lost to Follow-up|0|||
129043756|NCT02631876|464452843|FG000|Overall Study|Withdrawal by Subject|16|||
129043757|NCT02631876|464452844|FG001|Overall Study|Withdrawal by Subject|9|||
129043758|NCT02631876|464452843|FG000|Overall Study|Other than specified|4|||
129043759|NCT02631876|464452844|FG001|Overall Study|Other than specified|4|||
129043760|NCT01408563|464452849|FG000|Overall Study|Ineligible after consent/ registration|2|||
129043761|NCT00380692|464452850|FG000|Study Period II - Double Blind|Adverse Event|1|||
129043762|NCT00380692|464452851|FG001|Study Period II - Double Blind|Adverse Event|0|||
129043763|NCT00380692|464452850|FG000|Study Period II - Double Blind|Protocol Violation|2|||
129043764|NCT00380692|464452851|FG001|Study Period II - Double Blind|Protocol Violation|2|||
129043765|NCT00380692|464452850|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
129043766|NCT00380692|464452851|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
129043767|NCT00380692|464452850|FG000|Study Period II - Double Blind|Physician Decision|0|||
129043768|NCT00380692|464452851|FG001|Study Period II - Double Blind|Physician Decision|1|||
129043769|NCT00380692|464452850|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
129043770|NCT00380692|464452851|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
129043771|NCT00380692|464452850|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
129043772|NCT00380692|464452851|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
129043773|NCT00380692|464452850|FG000|Study Period III - Open Label|Adverse Event|5|||
129043774|NCT00380692|464452851|FG001|Study Period III - Open Label|Adverse Event|3|||
129043775|NCT00380692|464452850|FG000|Study Period III - Open Label|Protocol Violation|0|||
129043776|NCT00380692|464452851|FG001|Study Period III - Open Label|Protocol Violation|0|||
129043777|NCT00380692|464452850|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
129043778|NCT00380692|464452851|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
129043779|NCT00380692|464452850|FG000|Study Period III - Open Label|Physician Decision|0|||
129043780|NCT00380692|464452851|FG001|Study Period III - Open Label|Physician Decision|3|||
129043781|NCT00380692|464452850|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
129043782|NCT00380692|464452851|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
129043783|NCT00380692|464452850|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
129223018|NCT03164564|465118255|FG000|Overall Study|Lost to Follow-up|2|||
129223019|NCT03164564|465118256|FG001|Overall Study|Lost to Follow-up|0|||
129223020|NCT03164564|465118255|FG000|Overall Study|Physician Decision|0|||
129223021|NCT03164564|465118256|FG001|Overall Study|Physician Decision|1|||
129223022|NCT03164564|465118255|FG000|Overall Study|Adverse Event|0|||
129223023|NCT03164564|465118256|FG001|Overall Study|Adverse Event|1|||
129223024|NCT03164564|465118255|FG000|Overall Study|Ongoing|1586|||
129223025|NCT03164564|465118256|FG001|Overall Study|Ongoing|1586|||
129223026|NCT04976192|465118257|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223027|NCT04976192|465118258|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
129223028|NCT04976192|465118259|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223029|NCT04976192|465118260|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223030|NCT04976192|465118261|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223031|NCT04976192|465118262|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223032|NCT04976192|465118263|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223033|NCT04976192|465118264|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
128981480|NCT00151775|464218967|FG011|Period 4: Open Label|Protocol Violation|0|||
128981481|NCT00474994|464218969|FG000|Overall Study|Patient Not treated|1|||
128981482|NCT00474994|464218969|FG000|Overall Study|Patient evaluable for toxicity only|3|||
128981483|NCT00474994|464218969|FG000|Overall Study|Patient found to be ineligible|1|||
128981484|NCT00278473|464218970|FG000|Overall Study|drop out|4|||
128981485|NCT00278473|464218971|FG001|Overall Study|drop out|3|||
128981486|NCT04516291|464218972|FG000|Treatment Period (24 Weeks)|Other|1|||
128981487|NCT04516291|464218973|FG001|Treatment Period (24 Weeks)|Other|0|||
128981488|NCT04516291|464218974|FG002|Treatment Period (24 Weeks)|Other|0|||
128981489|NCT04516291|464218975|FG003|Treatment Period (24 Weeks)|Other|2|||
128981490|NCT04516291|464218976|FG004|Treatment Period (24 Weeks)|Other|2|||
128981491|NCT04516291|464218977|FG005|Treatment Period (24 Weeks)|Other|4|||
128981492|NCT04516291|464218978|FG006|Treatment Period (24 Weeks)|Other|2|||
128981493|NCT04516291|464218979|FG007|Treatment Period (24 Weeks)|Other|0|||
128981494|NCT04516291|464218972|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128981495|NCT04516291|464218973|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
128981496|NCT04516291|464218974|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
128981497|NCT04516291|464218975|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128981498|NCT04516291|464218976|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
128981499|NCT04516291|464218977|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128981500|NCT04516291|464218978|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128981501|NCT04516291|464218979|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128981502|NCT04516291|464218972|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
128981503|NCT04516291|464218973|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
128981504|NCT04516291|464218974|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
128981505|NCT04516291|464218975|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
128981506|NCT04516291|464218976|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
128981507|NCT04516291|464218977|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
128981508|NCT04516291|464218978|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
128981509|NCT04516291|464218979|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
128981510|NCT04516291|464218972|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128981511|NCT04516291|464218973|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
128981512|NCT04516291|464218974|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128981513|NCT04516291|464218975|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128981514|NCT04516291|464218976|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128981515|NCT04516291|464218977|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128981516|NCT04516291|464218978|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128981517|NCT04516291|464218979|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128981518|NCT04516291|464218972|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
128981519|NCT04516291|464218973|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
128981520|NCT04516291|464218974|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
129043784|NCT00380692|464452851|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
129223034|NCT04976192|465118265|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223035|NCT04976192|465118266|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129223036|NCT04976192|465118257|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
129223037|NCT04976192|465118258|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
128775367|NCT01474512|463468374|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
128981521|NCT04516291|464218975|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
128981522|NCT04516291|464218976|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
128981523|NCT04516291|464218977|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
128981524|NCT04516291|464218978|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
128981525|NCT04516291|464218979|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
128981526|NCT04516291|464218972|FG000|Follow-up Period (12 Weeks)|Other|0|||
128981527|NCT04516291|464218973|FG001|Follow-up Period (12 Weeks)|Other|1|||
129043785|NCT02177136|464452860|FG000|DB Phase|Withdrawal by Subject|2|||
128775368|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
128981528|NCT04516291|464218974|FG002|Follow-up Period (12 Weeks)|Other|0|||
128981529|NCT04516291|464218975|FG003|Follow-up Period (12 Weeks)|Other|2|||
129223038|NCT04976192|465118259|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
129223039|NCT04976192|465118260|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129223040|NCT04976192|465118261|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223041|NCT04976192|465118262|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223042|NCT04976192|465118263|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223043|NCT04976192|465118264|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223044|NCT04976192|465118265|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223045|NCT04976192|465118266|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223046|NCT04976192|465118257|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
129223047|NCT04976192|465118258|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223048|NCT04976192|465118259|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
129223049|NCT04976192|465118260|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223050|NCT04976192|465118261|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223051|NCT04976192|465118262|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223052|NCT04976192|465118263|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223053|NCT04976192|465118264|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223054|NCT04976192|465118265|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223055|NCT04976192|465118266|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129223056|NCT04976192|465118257|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223057|NCT04976192|465118258|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223058|NCT04976192|465118259|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223059|NCT04976192|465118260|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129223060|NCT04976192|465118261|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
129223061|NCT04976192|465118262|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
129223062|NCT04976192|465118263|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129223063|NCT04976192|465118264|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
129223064|NCT04976192|465118265|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
129223065|NCT04976192|465118266|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
129223066|NCT04976192|465118257|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223067|NCT04976192|465118258|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223068|NCT04976192|465118259|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223069|NCT04976192|465118260|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223070|NCT04976192|465118261|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
129223071|NCT04976192|465118262|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223072|NCT04976192|465118263|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223073|NCT04976192|465118264|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223074|NCT04976192|465118265|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223075|NCT04976192|465118266|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129223076|NCT04976192|465118257|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223077|NCT04976192|465118258|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223078|NCT04976192|465118259|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223079|NCT04976192|465118260|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223080|NCT04976192|465118261|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223081|NCT04976192|465118262|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129223082|NCT04976192|465118263|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223083|NCT04976192|465118264|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223084|NCT04976192|465118265|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223085|NCT04976192|465118266|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129223086|NCT02621151|465118267|FG000|Overall Study|Not eligible for trial|6|||
129223087|NCT04073225|465118268|FG000|Overall Study|Lost to Follow-up|4|||
129223088|NCT04073225|465118269|FG001|Overall Study|Lost to Follow-up|3|||
129223089|NCT03464097|465118270|FG000|Overall Study|Withdrawal by Subject|15|||
129223090|NCT03464097|465118271|FG001|Overall Study|Withdrawal by Subject|13|||
129223091|NCT03464097|465118272|FG002|Overall Study|Withdrawal by Subject|11|||
129223092|NCT03464097|465118270|FG000|Overall Study|Study terminated by sponsor|47|||
128981530|NCT04516291|464218976|FG004|Follow-up Period (12 Weeks)|Other|0|||
128981531|NCT04516291|464218977|FG005|Follow-up Period (12 Weeks)|Other|0|||
128981532|NCT04516291|464218978|FG006|Follow-up Period (12 Weeks)|Other|0|||
128981533|NCT04516291|464218979|FG007|Follow-up Period (12 Weeks)|Other|0|||
128981534|NCT04516291|464218972|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128981535|NCT04516291|464218973|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128981536|NCT04516291|464218974|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128719148|NCT04579380|463270999|FG002|Overall Study|Death|22|||
128719149|NCT04579380|463271000|FG003|Overall Study|Death|17|||
128981537|NCT04516291|464218975|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128981538|NCT04516291|464218976|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
129043786|NCT02177136|464452861|FG001|DB Phase|Withdrawal by Subject|0|||
128719150|NCT04579380|463271001|FG004|Overall Study|Death|6|||
128719151|NCT04579380|463271002|FG005|Overall Study|Death|21|||
128719152|NCT04579380|463271003|FG006|Overall Study|Death|10|||
128719153|NCT04579380|463271004|FG007|Overall Study|Death|11|||
128719154|NCT04579380|463271005|FG008|Overall Study|Death|25|||
128719155|NCT04579380|463270997|FG000|Overall Study|Withdrawal by Subject|0|||
128981539|NCT04516291|464218977|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128981540|NCT04516291|464218978|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128981541|NCT04516291|464218979|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128981542|NCT04516291|464218972|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
128981543|NCT04516291|464218973|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
128981544|NCT04516291|464218974|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
128981545|NCT04516291|464218975|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
129043787|NCT02177136|464452862|FG002|DB Phase|Withdrawal by Subject|0|||
129043788|NCT02177136|464452863|FG003|DB Phase|Withdrawal by Subject|0|||
129043789|NCT02177136|464452860|FG000|DB Phase|Discontinued Due to Pruritus|1|||
129043790|NCT02177136|464452861|FG001|DB Phase|Discontinued Due to Pruritus|3|||
129043791|NCT02177136|464452862|FG002|DB Phase|Discontinued Due to Pruritus|0|||
129043792|NCT02177136|464452863|FG003|DB Phase|Discontinued Due to Pruritus|0|||
129043793|NCT02177136|464452860|FG000|DB Phase|Adverse Event|3|||
129043794|NCT02177136|464452861|FG001|DB Phase|Adverse Event|2|||
129043795|NCT02177136|464452862|FG002|DB Phase|Adverse Event|3|||
129043796|NCT02177136|464452863|FG003|DB Phase|Adverse Event|0|||
129043797|NCT02177136|464452860|FG000|DB Phase|Protocol Violation|0|||
129043798|NCT02177136|464452861|FG001|DB Phase|Protocol Violation|0|||
129043799|NCT02177136|464452862|FG002|DB Phase|Protocol Violation|1|||
129043800|NCT02177136|464452863|FG003|DB Phase|Protocol Violation|0|||
129043801|NCT02177136|464452860|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
129043802|NCT02177136|464452861|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
129043803|NCT02177136|464452862|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
129043804|NCT02177136|464452863|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
129043805|NCT02177136|464452860|FG000|LTSE Phase|Withdrawal by Subject|0|||
129043806|NCT02177136|464452861|FG001|LTSE Phase|Withdrawal by Subject|0|||
129043807|NCT02177136|464452862|FG002|LTSE Phase|Withdrawal by Subject|0|||
129043808|NCT02177136|464452863|FG003|LTSE Phase|Withdrawal by Subject|6|||
129043809|NCT02177136|464452860|FG000|LTSE Phase|Adverse Event|0|||
129043810|NCT02177136|464452861|FG001|LTSE Phase|Adverse Event|0|||
129043811|NCT02177136|464452862|FG002|LTSE Phase|Adverse Event|0|||
129043812|NCT02177136|464452863|FG003|LTSE Phase|Adverse Event|10|||
129043813|NCT02177136|464452860|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
129043814|NCT02177136|464452861|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
129043815|NCT02177136|464452862|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
129043816|NCT02177136|464452863|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
129043817|NCT02177136|464452860|FG000|LTSE Phase|Physician Decision|0|||
129043818|NCT02177136|464452861|FG001|LTSE Phase|Physician Decision|0|||
129043819|NCT02177136|464452862|FG002|LTSE Phase|Physician Decision|0|||
129043820|NCT02177136|464452863|FG003|LTSE Phase|Physician Decision|2|||
129043821|NCT02177136|464452860|FG000|LTSE Phase|Lost to Follow-up|0|||
129043822|NCT02177136|464452861|FG001|LTSE Phase|Lost to Follow-up|0|||
129043823|NCT02177136|464452862|FG002|LTSE Phase|Lost to Follow-up|0|||
129043824|NCT02177136|464452863|FG003|LTSE Phase|Lost to Follow-up|1|||
129043825|NCT02177136|464452860|FG000|LTSE Phase|Participant Moved|0|||
129043826|NCT02177136|464452861|FG001|LTSE Phase|Participant Moved|0|||
129043827|NCT02177136|464452862|FG002|LTSE Phase|Participant Moved|0|||
129043828|NCT02177136|464452863|FG003|LTSE Phase|Participant Moved|1|||
129043829|NCT02054130|464452864|FG000|Overall Study|Withdrawal by Subject|4|||
129043830|NCT02054130|464452865|FG001|Overall Study|Withdrawal by Subject|4|||
129043831|NCT02054130|464452866|FG002|Overall Study|Withdrawal by Subject|7|||
129043832|NCT02054130|464452867|FG003|Overall Study|Withdrawal by Subject|10|||
129043833|NCT02054130|464452864|FG000|Overall Study|Death|0|||
129043834|NCT02054130|464452865|FG001|Overall Study|Death|1|||
129043835|NCT02054130|464452866|FG002|Overall Study|Death|0|||
129043836|NCT02054130|464452867|FG003|Overall Study|Death|0|||
129043837|NCT02054130|464452864|FG000|Overall Study|Lost to Follow-up|0|||
129043838|NCT02054130|464452865|FG001|Overall Study|Lost to Follow-up|0|||
129043839|NCT02054130|464452866|FG002|Overall Study|Lost to Follow-up|1|||
129043840|NCT02054130|464452867|FG003|Overall Study|Lost to Follow-up|2|||
129043841|NCT02054130|464452864|FG000|Overall Study|Missed dose|4|||
129043842|NCT02054130|464452865|FG001|Overall Study|Missed dose|6|||
129043843|NCT02054130|464452866|FG002|Overall Study|Missed dose|7|||
129043844|NCT02054130|464452867|FG003|Overall Study|Missed dose|10|||
129043845|NCT01386684|464452868|FG000|Overall Study|Lost to Follow-up|51|||
129043846|NCT01386684|464452868|FG000|Overall Study|Other|51|||
129043847|NCT01386684|464452868|FG000|Overall Study|Death|47|||
129043848|NCT01386684|464452868|FG000|Overall Study|Withdrawal of Consent|44|||
129043849|NCT01386684|464452868|FG000|Overall Study|Alternative Therapy Required|37|||
129043850|NCT01386684|464452868|FG000|Overall Study|Disease Progression|28|||
129043851|NCT01386684|464452868|FG000|Overall Study|Adverse Event|20|||
129043852|NCT01386684|464452868|FG000|Overall Study|Noncompliance|8|||
129043853|NCT01386684|464452868|FG000|Overall Study|Protocol Violation|4|||
129223093|NCT03464097|465118271|FG001|Overall Study|Study terminated by sponsor|44|||
129223094|NCT03464097|465118272|FG002|Overall Study|Study terminated by sponsor|40|||
129223095|NCT03464097|465118270|FG000|Overall Study|Pregnancy|0|||
128719156|NCT04579380|463270998|FG001|Overall Study|Withdrawal by Subject|3|||
128719157|NCT04579380|463270999|FG002|Overall Study|Withdrawal by Subject|4|||
128719158|NCT04579380|463271000|FG003|Overall Study|Withdrawal by Subject|0|||
128719159|NCT04579380|463271001|FG004|Overall Study|Withdrawal by Subject|1|||
128981546|NCT04516291|464218976|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
128981547|NCT04516291|464218977|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
128981548|NCT04516291|464218978|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
128981549|NCT04516291|464218979|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
128981550|NCT02452320|464218991|FG000|Overall Study|Adverse Event|0|||
128981551|NCT02452320|464218992|FG001|Overall Study|Adverse Event|1|||
128981552|NCT03198559|464218993|FG000|Overall Study|Adverse Event|2|||
128981553|NCT01072175|464218994|FG000|Part A (Drug-Drug Interaction)|Death|1|||
128981554|NCT01072175|464218995|FG001|Part A (Drug-Drug Interaction)|Death|0|||
128981555|NCT01072175|464218996|FG002|Part A (Drug-Drug Interaction)|Death|0|||
128981556|NCT01072175|464218997|FG003|Part A (Drug-Drug Interaction)|Death|0|||
128981557|NCT01072175|464218998|FG004|Part A (Drug-Drug Interaction)|Death|0|||
128981558|NCT01072175|464218999|FG005|Part A (Drug-Drug Interaction)|Death|0|||
128981559|NCT01072175|464219000|FG006|Part A (Drug-Drug Interaction)|Death|0|||
128981560|NCT01072175|464219001|FG007|Part A (Drug-Drug Interaction)|Death|0|||
128981561|NCT01072175|464219002|FG008|Part A (Drug-Drug Interaction)|Death|0|||
128981562|NCT01072175|464219003|FG009|Part A (Drug-Drug Interaction)|Death|0|||
128981563|NCT01072175|464219004|FG010|Part A (Drug-Drug Interaction)|Death|0|||
128981564|NCT01072175|464219005|FG011|Part A (Drug-Drug Interaction)|Death|0|||
128981565|NCT01072175|464219006|FG012|Part A (Drug-Drug Interaction)|Death|0|||
128981566|NCT01072175|464218994|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
128981567|NCT01072175|464218995|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981568|NCT01072175|464218996|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981569|NCT01072175|464218997|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981570|NCT01072175|464218998|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981571|NCT01072175|464218999|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981572|NCT01072175|464219000|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981573|NCT01072175|464219001|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981574|NCT01072175|464219002|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981575|NCT01072175|464219003|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981576|NCT01072175|464219004|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981577|NCT01072175|464219005|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981578|NCT01072175|464219006|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
128981579|NCT01072175|464218994|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
128981580|NCT01072175|464218995|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129043854|NCT01386684|464452868|FG000|Overall Study|Missing|3|||
129043855|NCT01032018|464452869|FG000|Overall Study|Lost to Follow-up|6|||
129043856|NCT01032018|464452870|FG001|Overall Study|Lost to Follow-up|5|||
129043857|NCT01032018|464452869|FG000|Overall Study|Death|0|||
129043858|NCT01032018|464452870|FG001|Overall Study|Death|1|||
129043859|NCT00094458|464452871|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
129043860|NCT00094458|464452872|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
129043861|NCT00094458|464452873|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
129043862|NCT00094458|464452874|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
129043863|NCT00094458|464452875|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
129043864|NCT00094458|464452876|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
129043865|NCT00094458|464452871|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
129043866|NCT00094458|464452872|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
129043867|NCT00094458|464452873|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
129043868|NCT00094458|464452874|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
129043869|NCT00094458|464452875|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
129043870|NCT00094458|464452876|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
128719160|NCT04579380|463271002|FG005|Overall Study|Withdrawal by Subject|2|||
128719161|NCT04579380|463271003|FG006|Overall Study|Withdrawal by Subject|0|||
128981581|NCT01072175|464218996|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981582|NCT01072175|464218997|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981583|NCT01072175|464218998|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981584|NCT01072175|464218999|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981585|NCT01072175|464219000|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129043871|NCT00094458|464452871|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
129043872|NCT00094458|464452872|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
129043873|NCT00094458|464452873|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
129043874|NCT00094458|464452874|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
129043875|NCT00094458|464452875|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
128981586|NCT01072175|464219001|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129223096|NCT03464097|465118271|FG001|Overall Study|Pregnancy|1|||
129223097|NCT03464097|465118272|FG002|Overall Study|Pregnancy|0|||
129223098|NCT03464097|465118270|FG000|Overall Study|Other reasons|5|||
129223099|NCT03464097|465118271|FG001|Overall Study|Other reasons|12|||
129223100|NCT03464097|465118272|FG002|Overall Study|Other reasons|14|||
129223101|NCT03464097|465118270|FG000|Overall Study|Lost to Follow-up|0|||
129223102|NCT03464097|465118271|FG001|Overall Study|Lost to Follow-up|1|||
129223103|NCT03464097|465118272|FG002|Overall Study|Lost to Follow-up|1|||
129223104|NCT03464097|465118270|FG000|Overall Study|Lack of Efficacy|11|||
129223105|NCT03464097|465118271|FG001|Overall Study|Lack of Efficacy|18|||
129223106|NCT03464097|465118272|FG002|Overall Study|Lack of Efficacy|30|||
129223107|NCT03464097|465118270|FG000|Overall Study|Death|1|||
128981587|NCT01072175|464219002|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981588|NCT01072175|464219003|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981589|NCT01072175|464219004|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981590|NCT01072175|464219005|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981591|NCT01072175|464219006|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
128981592|NCT01072175|464218994|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
128981593|NCT01072175|464218995|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
128981594|NCT01072175|464218996|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
128981595|NCT01072175|464218997|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
128981596|NCT01072175|464218998|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
128981597|NCT01072175|464218999|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
128981598|NCT01072175|464219000|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
128981599|NCT01072175|464219001|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
128981600|NCT01072175|464219002|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
128981601|NCT01072175|464219003|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
128981602|NCT01072175|464219004|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
128981603|NCT01072175|464219005|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
128981604|NCT01072175|464219006|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
128981605|NCT01072175|464218994|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981606|NCT01072175|464218995|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981607|NCT01072175|464218996|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
129043876|NCT00094458|464452876|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
129043877|NCT00094458|464452871|FG000|Main Study: Through Week 30|Adverse Event|38|||
129043878|NCT00094458|464452872|FG001|Main Study: Through Week 30|Adverse Event|20|||
129043879|NCT00094458|464452873|FG002|Main Study: Through Week 30|Adverse Event|28|||
129043880|NCT00094458|464452874|FG003|Main Study: Through Week 30|Adverse Event|0|||
129043881|NCT00094458|464452875|FG004|Main Study: Through Week 30|Adverse Event|0|||
129043882|NCT00094458|464452876|FG005|Main Study: Through Week 30|Adverse Event|0|||
129043883|NCT00094458|464452871|FG000|Main Study: Through Week 30|Death|1|||
129043884|NCT00094458|464452872|FG001|Main Study: Through Week 30|Death|0|||
129043885|NCT00094458|464452873|FG002|Main Study: Through Week 30|Death|0|||
129043886|NCT00094458|464452874|FG003|Main Study: Through Week 30|Death|0|||
129043887|NCT00094458|464452875|FG004|Main Study: Through Week 30|Death|0|||
129043888|NCT00094458|464452876|FG005|Main Study: Through Week 30|Death|0|||
129043889|NCT00094458|464452871|FG000|Main Study: Through Week 30|Other|19|||
129043890|NCT00094458|464452872|FG001|Main Study: Through Week 30|Other|16|||
129043891|NCT00094458|464452873|FG002|Main Study: Through Week 30|Other|9|||
129043892|NCT00094458|464452874|FG003|Main Study: Through Week 30|Other|0|||
129043893|NCT00094458|464452875|FG004|Main Study: Through Week 30|Other|0|||
129043894|NCT00094458|464452876|FG005|Main Study: Through Week 30|Other|0|||
129043895|NCT00094458|464452871|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
129043896|NCT00094458|464452872|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
129043897|NCT00094458|464452873|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
129043898|NCT00094458|464452874|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
129043899|NCT00094458|464452875|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
129043900|NCT00094458|464452876|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
129043901|NCT00094458|464452871|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
129043902|NCT00094458|464452872|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129043903|NCT00094458|464452873|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
129043904|NCT00094458|464452874|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129043905|NCT00094458|464452875|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129043906|NCT00094458|464452876|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129043907|NCT00094458|464452871|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
129043908|NCT00094458|464452872|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
129223108|NCT03464097|465118271|FG001|Overall Study|Death|0|||
129223109|NCT03464097|465118272|FG002|Overall Study|Death|0|||
129223110|NCT03464097|465118270|FG000|Overall Study|Adverse Event|13|||
129223111|NCT03464097|465118271|FG001|Overall Study|Adverse Event|6|||
128981608|NCT01072175|464218997|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129043909|NCT00094458|464452873|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
129134841|NCT00976391|464786964|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
129134842|NCT00976391|464786965|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
129134843|NCT05156125|464786966|FG000|Overall Study|Lack of Efficacy|1|||
129134844|NCT05156125|464786967|FG001|Overall Study|Lack of Efficacy|1|||
129134845|NCT05156125|464786968|FG002|Overall Study|Lack of Efficacy|1|||
129134846|NCT05156125|464786966|FG000|Overall Study|Physician Decision|0|||
129134847|NCT05156125|464786967|FG001|Overall Study|Physician Decision|0|||
129134848|NCT05156125|464786968|FG002|Overall Study|Physician Decision|1|||
129134849|NCT05156125|464786966|FG000|Overall Study|Non-compliance|0|||
129134850|NCT05156125|464786967|FG001|Overall Study|Non-compliance|1|||
129134851|NCT05156125|464786968|FG002|Overall Study|Non-compliance|1|||
129134852|NCT05156125|464786966|FG000|Overall Study|Withdrawal by Subject|0|||
129134853|NCT05156125|464786967|FG001|Overall Study|Withdrawal by Subject|0|||
129134854|NCT05156125|464786968|FG002|Overall Study|Withdrawal by Subject|1|||
129134855|NCT05156125|464786966|FG000|Overall Study|Adverse Event|2|||
129134856|NCT05156125|464786967|FG001|Overall Study|Adverse Event|1|||
129134857|NCT05156125|464786968|FG002|Overall Study|Adverse Event|0|||
129134858|NCT02852434|464786969|FG000|Overall Study|Withdrawal by Subject|0|||
128775369|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
128981609|NCT01072175|464218998|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
128981610|NCT01072175|464218999|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981611|NCT01072175|464219000|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981612|NCT01072175|464219001|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981613|NCT01072175|464219002|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981614|NCT01072175|464219003|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981615|NCT01072175|464219004|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981616|NCT01072175|464219005|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981617|NCT01072175|464219006|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
128981618|NCT01072175|464218994|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981619|NCT01072175|464218995|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
128981620|NCT01072175|464218996|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981621|NCT01072175|464218997|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
128981622|NCT01072175|464218998|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
128981623|NCT01072175|464218999|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981624|NCT01072175|464219000|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981625|NCT01072175|464219001|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981626|NCT01072175|464219002|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981627|NCT01072175|464219003|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981628|NCT01072175|464219004|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129043910|NCT00094458|464452874|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
129043911|NCT00094458|464452875|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
129043912|NCT00094458|464452876|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
129043913|NCT00094458|464452871|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
129043914|NCT00094458|464452872|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
129043915|NCT00094458|464452873|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
129043916|NCT00094458|464452874|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
129043917|NCT00094458|464452875|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
129043918|NCT00094458|464452876|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
129043919|NCT00094458|464452871|FG000|OLE: Open-Label Extension|Adverse Event|0|||
129043920|NCT00094458|464452872|FG001|OLE: Open-Label Extension|Adverse Event|0|||
129043921|NCT00094458|464452873|FG002|OLE: Open-Label Extension|Adverse Event|0|||
129043922|NCT00094458|464452874|FG003|OLE: Open-Label Extension|Adverse Event|0|||
129043923|NCT00094458|464452875|FG004|OLE: Open-Label Extension|Adverse Event|3|||
129043924|NCT00094458|464452876|FG005|OLE: Open-Label Extension|Adverse Event|4|||
129043925|NCT00094458|464452871|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129043926|NCT00094458|464452872|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129043927|NCT00094458|464452873|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129043928|NCT00094458|464452874|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
129043929|NCT00094458|464452875|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
129043930|NCT00094458|464452876|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129043931|NCT00094458|464452871|FG000|OLE: Open-Label Extension|Patient decision|0|||
129043932|NCT00094458|464452872|FG001|OLE: Open-Label Extension|Patient decision|0|||
129043933|NCT00094458|464452873|FG002|OLE: Open-Label Extension|Patient decision|0|||
129043934|NCT00094458|464452874|FG003|OLE: Open-Label Extension|Patient decision|0|||
129043935|NCT00094458|464452875|FG004|OLE: Open-Label Extension|Patient decision|1|||
129043936|NCT00094458|464452876|FG005|OLE: Open-Label Extension|Patient decision|0|||
129043937|NCT03265288|464452877|FG000|Overall Study|Adverse Event|0|||
129043938|NCT03265288|464452878|FG001|Overall Study|Adverse Event|1|||
129134859|NCT02852434|464786970|FG001|Overall Study|Withdrawal by Subject|1|||
129134860|NCT02852434|464786969|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
129223112|NCT03464097|465118272|FG002|Overall Study|Adverse Event|8|||
129134861|NCT02852434|464786970|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
129134862|NCT02018887|464786973|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
129134863|NCT02018887|464786974|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134864|NCT02018887|464786975|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134865|NCT02018887|464786976|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134866|NCT02018887|464786977|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134867|NCT02018887|464786978|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134868|NCT02018887|464786979|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134869|NCT02018887|464786980|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134870|NCT02018887|464786981|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134871|NCT02018887|464786982|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134872|NCT02018887|464786983|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129134873|NCT02018887|464786973|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134874|NCT02018887|464786974|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134875|NCT02018887|464786975|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134876|NCT02018887|464786976|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134877|NCT02018887|464786977|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
129134878|NCT02018887|464786978|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134879|NCT02018887|464786979|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
129134880|NCT02018887|464786980|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
129134881|NCT02018887|464786981|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134882|NCT02018887|464786982|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134883|NCT02018887|464786983|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129134884|NCT02018887|464786973|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
129134885|NCT02018887|464786974|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
129134886|NCT02018887|464786975|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
129134887|NCT02018887|464786976|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
129134888|NCT02018887|464786977|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
129134889|NCT02018887|464786978|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
129134890|NCT02018887|464786979|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
129134891|NCT02018887|464786980|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
129134892|NCT02018887|464786981|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
129134893|NCT02018887|464786982|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
129134894|NCT02018887|464786983|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
129134895|NCT02018887|464786973|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
129134896|NCT02018887|464786974|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
129134897|NCT02018887|464786975|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
129134898|NCT02018887|464786976|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
129134899|NCT02018887|464786977|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
129134900|NCT02018887|464786978|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
129134901|NCT02018887|464786979|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
129134902|NCT02018887|464786980|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
129134903|NCT02018887|464786981|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
129134904|NCT02018887|464786982|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
129134905|NCT02018887|464786983|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
129134906|NCT00927186|464786984|FG000|12 Months Primary Study|Adverse Event|5|||
129134907|NCT00927186|464786985|FG001|12 Months Primary Study|Adverse Event|2|||
129134908|NCT00927186|464786984|FG000|12 Months Primary Study|Lost to Follow-up|1|||
129134909|NCT00927186|464786985|FG001|12 Months Primary Study|Lost to Follow-up|0|||
129134910|NCT00927186|464786984|FG000|12 Months Primary Study|Protocol Violation|0|||
129134911|NCT00927186|464786985|FG001|12 Months Primary Study|Protocol Violation|1|||
129134912|NCT00927186|464786984|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
129134913|NCT00927186|464786985|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
129134914|NCT01698008|464786986|FG000|Overall Study|Withdrawal by Subject|1|||
129134915|NCT01698008|464786987|FG001|Overall Study|Withdrawal by Subject|2|||
129134916|NCT02287025|464786988|FG000|Overall Study|Not treated|2|||
129134917|NCT02287025|464786989|FG001|Overall Study|Not treated|0|||
129134918|NCT02287025|464786988|FG000|Overall Study|Progression of disease|3|||
129134919|NCT02287025|464786989|FG001|Overall Study|Progression of disease|2|||
129134920|NCT02287025|464786988|FG000|Overall Study|Adverse Event|2|||
129134921|NCT02287025|464786989|FG001|Overall Study|Adverse Event|4|||
129134922|NCT02287025|464786988|FG000|Overall Study|Withdrawal by Subject|2|||
129134923|NCT02287025|464786989|FG001|Overall Study|Withdrawal by Subject|2|||
129134924|NCT02287025|464786988|FG000|Overall Study|Screening failed|1|||
129134925|NCT02287025|464786989|FG001|Overall Study|Screening failed|1|||
129134926|NCT04053452|464786990|FG000|Overall Study|Withdrawal by Subject|1|||
129134927|NCT04053452|464786991|FG001|Overall Study|Withdrawal by Subject|0|||
129134928|NCT04053452|464786990|FG000|Overall Study|Time restraint due to inpatient needs|1|||
129134929|NCT04053452|464786991|FG001|Overall Study|Time restraint due to inpatient needs|2|||
128981629|NCT01072175|464219005|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129134930|NCT01421134|464786992|FG000|Overall Study|Adverse Event|3|||
129134931|NCT01421134|464786993|FG001|Overall Study|Adverse Event|5|||
129134932|NCT01421134|464786992|FG000|Overall Study|Lack of Efficacy|2|||
129134933|NCT01421134|464786993|FG001|Overall Study|Lack of Efficacy|4|||
129223113|NCT04675151|465118273|FG000|Overall Study|Protocol Violation|1|||
129223114|NCT04675151|465118274|FG001|Overall Study|Protocol Violation|0|||
128719162|NCT04579380|463271004|FG007|Overall Study|Withdrawal by Subject|1|||
128719163|NCT04579380|463271005|FG008|Overall Study|Withdrawal by Subject|2|||
128719164|NCT04579380|463270997|FG000|Overall Study|Ongoing|2|||
128719165|NCT04579380|463270998|FG001|Overall Study|Ongoing|6|||
128719166|NCT04579380|463270999|FG002|Overall Study|Ongoing|4|||
128719167|NCT04579380|463271000|FG003|Overall Study|Ongoing|8|||
128719168|NCT04579380|463271001|FG004|Overall Study|Ongoing|5|||
128981630|NCT01072175|464219006|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
128981631|NCT01072175|464218994|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981632|NCT01072175|464218995|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981633|NCT01072175|464218996|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
128981634|NCT01072175|464218997|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
128981635|NCT01072175|464218998|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
128981636|NCT01072175|464218999|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981637|NCT01072175|464219000|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981638|NCT01072175|464219001|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981639|NCT01072175|464219002|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981640|NCT01072175|464219003|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981641|NCT01072175|464219004|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981642|NCT01072175|464219005|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981643|NCT01072175|464219006|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
128981644|NCT01072175|464218994|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981645|NCT01072175|464218995|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
128981646|NCT01072175|464218996|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981647|NCT01072175|464218997|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
128981648|NCT01072175|464218998|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
128981649|NCT01072175|464218999|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981650|NCT01072175|464219000|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981651|NCT01072175|464219001|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981652|NCT01072175|464219002|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981653|NCT01072175|464219003|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981654|NCT01072175|464219004|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981655|NCT01072175|464219005|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981656|NCT01072175|464219006|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
128981657|NCT01072175|464218994|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
128981658|NCT01072175|464218995|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
128981659|NCT01072175|464218996|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
128981660|NCT01072175|464218997|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
128981661|NCT01072175|464218998|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
128981662|NCT01072175|464218999|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
128981663|NCT01072175|464219000|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
128981664|NCT01072175|464219001|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
128981665|NCT01072175|464219002|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
128981666|NCT01072175|464219003|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
128981667|NCT01072175|464219004|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
128981668|NCT01072175|464219005|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
128981669|NCT01072175|464219006|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
128981670|NCT01072175|464218994|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981671|NCT01072175|464218995|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981672|NCT01072175|464218996|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981673|NCT01072175|464218997|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129043939|NCT03265288|464452877|FG000|Overall Study|Withdrawal by Subject|13|||
129043940|NCT03265288|464452878|FG001|Overall Study|Withdrawal by Subject|5|||
129043941|NCT03265288|464452877|FG000|Overall Study|Drug Withdrawn|3|||
129043942|NCT03265288|464452878|FG001|Overall Study|Drug Withdrawn|3|||
129043943|NCT03265288|464452877|FG000|Overall Study|Any Other Reason|7|||
129043944|NCT03265288|464452878|FG001|Overall Study|Any Other Reason|3|||
129043945|NCT03197558|464452879|FG000|Overall Study|Tubes not placed|1|||
129043946|NCT03578237|464452880|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
129043947|NCT03578237|464452881|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
129223115|NCT04675151|465118275|FG002|Overall Study|Protocol Violation|0|||
128719169|NCT04579380|463271002|FG005|Overall Study|Ongoing|8|||
128981674|NCT01072175|464218998|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981675|NCT01072175|464218999|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
128719170|NCT04579380|463271003|FG006|Overall Study|Ongoing|3|||
128719171|NCT04579380|463271004|FG007|Overall Study|Ongoing|19|||
129134934|NCT01421134|464786992|FG000|Overall Study|Protocol Violation|0|||
129134935|NCT01421134|464786993|FG001|Overall Study|Protocol Violation|3|||
129223116|NCT04675151|465118276|FG003|Overall Study|Protocol Violation|1|||
129223117|NCT04035486|465118277|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
129223118|NCT04035486|465118278|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
129223119|NCT04035486|465118279|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
129223120|NCT04035486|465118280|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
129223121|NCT04035486|465118277|FG000|Overall Study|Death|6|||
129134936|NCT01421134|464786992|FG000|Overall Study|Withdrawal by Subject|1|||
129134937|NCT01421134|464786993|FG001|Overall Study|Withdrawal by Subject|1|||
129134938|NCT01421134|464786992|FG000|Overall Study|Administrative|0|||
129134939|NCT01421134|464786993|FG001|Overall Study|Administrative|1|||
129134940|NCT01421134|464786992|FG000|Overall Study|Lost to Follow-up|1|||
129134941|NCT01421134|464786993|FG001|Overall Study|Lost to Follow-up|1|||
129134942|NCT02959892|464786994|FG000|Overall Study|PET tracer synthesis failure|1|||
129134943|NCT02959892|464786995|FG001|Overall Study|PET tracer synthesis failure|0|||
129134944|NCT02959892|464786994|FG000|Overall Study|Study termination|0|||
129134945|NCT02959892|464786995|FG001|Overall Study|Study termination|1|||
129134946|NCT00799864|464786999|FG000|Overall Study|Participant reached a virologic endpoint|9|||
129134947|NCT00799864|464787000|FG001|Overall Study|Participant reached a virologic endpoint|2|||
129134948|NCT00799864|464787001|FG002|Overall Study|Participant reached a virologic endpoint|2|||
129134949|NCT00799864|464787002|FG003|Overall Study|Participant reached a virologic endpoint|0|||
129134950|NCT00799864|464787003|FG004|Overall Study|Participant reached a virologic endpoint|0|||
129134951|NCT00799864|464786999|FG000|Overall Study|Other|2|||
129134952|NCT00799864|464787000|FG001|Overall Study|Other|1|||
129134953|NCT00799864|464787001|FG002|Overall Study|Other|0|||
129134954|NCT00799864|464787002|FG003|Overall Study|Other|0|||
129134955|NCT00799864|464787003|FG004|Overall Study|Other|0|||
129134956|NCT03364686|464787004|FG000|Overall Study|Physician Decision|2|||
129134957|NCT01936974|464787007|FG000|Overall Study|Physician Decision|2|||
129134958|NCT01936974|464787008|FG001|Overall Study|Physician Decision|5|||
129134959|NCT04584554|464787011|FG000|Overall Study|Withdrawal by Subject|2|||
129134960|NCT04584554|464787012|FG001|Overall Study|Withdrawal by Subject|2|||
129134961|NCT02807181|464787013|FG000|Overall Study|Death|28|||
129134962|NCT02807181|464787014|FG001|Overall Study|Death|24|||
129134963|NCT02807181|464787013|FG000|Overall Study|Withdrawal by Subject|1|||
128981676|NCT01072175|464219000|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
128981677|NCT01072175|464219001|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
128981678|NCT01072175|464219002|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981679|NCT01072175|464219003|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981680|NCT01072175|464219004|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981681|NCT01072175|464219005|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981682|NCT01072175|464219006|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
128981683|NCT01072175|464218994|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981684|NCT01072175|464218995|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981685|NCT01072175|464218996|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981686|NCT01072175|464218997|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981687|NCT01072175|464218998|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981688|NCT01072175|464218999|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981689|NCT01072175|464219000|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
128981690|NCT01072175|464219001|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
128981691|NCT01072175|464219002|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981692|NCT01072175|464219003|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981693|NCT01072175|464219004|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981694|NCT01072175|464219005|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981695|NCT01072175|464219006|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
128981696|NCT01072175|464218994|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981697|NCT01072175|464218995|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981698|NCT01072175|464218996|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981699|NCT01072175|464218997|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129134964|NCT02807181|464787014|FG001|Overall Study|Withdrawal by Subject|1|||
129134965|NCT02807181|464787013|FG000|Overall Study|Lost to Follow-up|0|||
129134966|NCT02807181|464787014|FG001|Overall Study|Lost to Follow-up|2|||
129134967|NCT02807181|464787013|FG000|Overall Study|Subject decision|1|||
129134968|NCT02807181|464787014|FG001|Overall Study|Subject decision|0|||
129134969|NCT02807181|464787013|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
129134970|NCT02807181|464787014|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
129134971|NCT02807181|464787013|FG000|Overall Study|In Study|3|||
129134972|NCT02807181|464787014|FG001|Overall Study|In Study|3|||
129134973|NCT02807181|464787013|FG000|Overall Study|Post Progression|3|||
129134974|NCT02807181|464787014|FG001|Overall Study|Post Progression|2|||
129134975|NCT00063999|464787015|FG000|Overall Study|Withdrawal by Subject|1|||
129043948|NCT00973765|464452882|FG000|Overall Study|Lost to Follow-up|8|||
129043949|NCT00973765|464452883|FG001|Overall Study|Lost to Follow-up|14|||
129043950|NCT02011113|464452884|FG000|Overall Study|Adverse Event|4|||
129043951|NCT02011113|464452884|FG000|Overall Study|Disease Progression (DP)|16|||
129043952|NCT02011113|464452884|FG000|Overall Study|Death|1|||
129043953|NCT02011113|464452884|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
129134976|NCT00063999|464787016|FG001|Overall Study|Withdrawal by Subject|0|||
129134977|NCT00063999|464787015|FG000|Overall Study|Ineligible|44|||
129134978|NCT00063999|464787016|FG001|Overall Study|Ineligible|24|||
129134979|NCT03767894|464787017|FG000|Overall Study|Withdrawal by Subject|1|||
129134980|NCT04243837|464787021|FG000|Overall Study|Adverse Event|2|||
129134981|NCT04243837|464787022|FG001|Overall Study|Adverse Event|1|||
129134982|NCT04243837|464787021|FG000|Overall Study|Withdrawal by Subject|4|||
129134983|NCT04243837|464787022|FG001|Overall Study|Withdrawal by Subject|2|||
129134984|NCT04243837|464787021|FG000|Overall Study|Covid-19 lock down|1|||
129134985|NCT04243837|464787022|FG001|Overall Study|Covid-19 lock down|0|||
129134986|NCT04243837|464787021|FG000|Overall Study|Study Terminated by Sponsor|11|||
129134987|NCT04243837|464787022|FG001|Overall Study|Study Terminated by Sponsor|12|||
129134988|NCT02280499|464787026|FG000|Overall Study|Death|14|||
129134989|NCT02280499|464787026|FG000|Overall Study|Lost to Follow-up|42|||
129134990|NCT02280499|464787026|FG000|Overall Study|Adverse Event|5|||
129134991|NCT04689009|464787033|FG000|Overall Study|Adverse Event|1|||
129134992|NCT04689009|464787034|FG001|Overall Study|Adverse Event|0|||
129134993|NCT04689009|464787033|FG000|Overall Study|Lost to Follow-up|1|||
129134994|NCT04689009|464787034|FG001|Overall Study|Lost to Follow-up|2|||
129134995|NCT04689009|464787033|FG000|Overall Study|Withdrawal by Subject|4|||
129134996|NCT04689009|464787034|FG001|Overall Study|Withdrawal by Subject|3|||
129134997|NCT04689009|464787033|FG000|Overall Study|Protocol Violation|1|||
129134998|NCT04689009|464787034|FG001|Overall Study|Protocol Violation|0|||
129134999|NCT02187055|464787035|FG000|Overall Study|Lack of Efficacy|10|||
129135000|NCT02187055|464787036|FG001|Overall Study|Lack of Efficacy|3|||
129043954|NCT02011113|464452884|FG000|Overall Study|Investigator's judgement- DP|3|||
129043955|NCT02011113|464452884|FG000|Overall Study|Study terminated by sponsor|11|||
129043956|NCT01892657|464452887|FG000|Overall Study|Withdrawal by Subject|6|||
129043957|NCT01892657|464452887|FG000|Overall Study|Protocol Violation|12|||
129043958|NCT00468728|464452890|FG000|Treatment|criteria for mITT population|4|||
129043959|NCT00468728|464452891|FG001|Treatment|criteria for mITT population|11|||
129043960|NCT00468728|464452890|FG000|Follow-up|mITT failure|34|||
129043961|NCT00468728|464452891|FG001|Follow-up|mITT failure|31|||
129043962|NCT02712333|464452893|FG000|First Period|Withdrawal by Subject|3|||
129043963|NCT02712333|464452894|FG001|First Period|Withdrawal by Subject|2|||
129043964|NCT03463993|464452895|FG000|Overall Study|Lost to Follow-up|7|||
129043965|NCT03463993|464452896|FG001|Overall Study|Lost to Follow-up|8|||
129043966|NCT03463993|464452895|FG000|Overall Study|Withdrawal by Subject|2|||
129043967|NCT03463993|464452896|FG001|Overall Study|Withdrawal by Subject|0|||
129043968|NCT03463993|464452895|FG000|Overall Study|Protocol Violation|4|||
129043969|NCT03463993|464452896|FG001|Overall Study|Protocol Violation|1|||
129043970|NCT03463993|464452895|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
129043971|NCT03463993|464452896|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
129043972|NCT03463993|464452895|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
129043973|NCT03463993|464452896|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
129043974|NCT01478828|464452897|FG000|Overall Study|Adverse Event|1|||
129043975|NCT02278718|464452898|FG000|Overall Study|Adverse Event|1|||
129043976|NCT02278718|464452899|FG001|Overall Study|Adverse Event|0|||
129135001|NCT02187055|464787037|FG002|Overall Study|Lack of Efficacy|7|||
129135002|NCT02187055|464787035|FG000|Overall Study|Lost to Follow-up|2|||
129135003|NCT02187055|464787036|FG001|Overall Study|Lost to Follow-up|7|||
129135004|NCT02187055|464787037|FG002|Overall Study|Lost to Follow-up|3|||
129135005|NCT02187055|464787035|FG000|Overall Study|No longer meets eligibility criteria|0|||
129135006|NCT02187055|464787036|FG001|Overall Study|No longer meets eligibility criteria|2|||
129135007|NCT02187055|464787037|FG002|Overall Study|No longer meets eligibility criteria|0|||
129135008|NCT02187055|464787035|FG000|Overall Study|No longer willing to participate|6|||
129135009|NCT02187055|464787036|FG001|Overall Study|No longer willing to participate|8|||
129135010|NCT02187055|464787037|FG002|Overall Study|No longer willing to participate|10|||
129135011|NCT02187055|464787035|FG000|Overall Study|Other|5|||
129135012|NCT02187055|464787036|FG001|Overall Study|Other|6|||
129043977|NCT02278718|464452898|FG000|Overall Study|Lost to Follow-up|2|||
129043978|NCT02278718|464452899|FG001|Overall Study|Lost to Follow-up|4|||
129043979|NCT02278718|464452898|FG000|Overall Study|Withdrawal by Subject|1|||
129043980|NCT02278718|464452899|FG001|Overall Study|Withdrawal by Subject|4|||
129135013|NCT02187055|464787037|FG002|Overall Study|Other|3|||
129135014|NCT02187055|464787035|FG000|Overall Study|Protocol Violation|9|||
129135015|NCT02187055|464787036|FG001|Overall Study|Protocol Violation|9|||
129135016|NCT02187055|464787037|FG002|Overall Study|Protocol Violation|4|||
129135017|NCT02187055|464787035|FG000|Overall Study|Pregnancy|3|||
129135018|NCT02187055|464787036|FG001|Overall Study|Pregnancy|1|||
129135019|NCT02187055|464787037|FG002|Overall Study|Pregnancy|0|||
128981700|NCT01072175|464218998|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981701|NCT01072175|464218999|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
128981702|NCT01072175|464219000|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
128981703|NCT01072175|464219001|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
128981704|NCT01072175|464219002|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981705|NCT01072175|464219003|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981706|NCT01072175|464219004|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129043981|NCT02278718|464452898|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
129043982|NCT02278718|464452899|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
129043983|NCT02278718|464452898|FG000|Overall Study|Missing|0|||
129043984|NCT02278718|464452899|FG001|Overall Study|Missing|1|||
129043985|NCT04440449|464452900|FG000|Overall Study|Lost to Follow-up|2|||
129043986|NCT04440449|464452901|FG001|Overall Study|Lost to Follow-up|0|||
129043987|NCT01763918|464452902|FG000|Overall Study|Withdrawal by Subject|2|||
129043988|NCT01763918|464452903|FG001|Overall Study|Withdrawal by Subject|1|||
129043989|NCT01763918|464452904|FG002|Overall Study|Withdrawal by Subject|1|||
129043990|NCT01763918|464452905|FG003|Overall Study|Withdrawal by Subject|2|||
129043991|NCT01763918|464452902|FG000|Overall Study|Sponsor Decision|4|||
129043992|NCT01763918|464452903|FG001|Overall Study|Sponsor Decision|0|||
129043993|NCT01763918|464452904|FG002|Overall Study|Sponsor Decision|9|||
129043994|NCT01763918|464452905|FG003|Overall Study|Sponsor Decision|0|||
129043995|NCT00897949|464452906|FG000|Overall Study|Adverse Event|1|||
129043996|NCT00897949|464452907|FG001|Overall Study|Adverse Event|1|||
129043997|NCT00897949|464452908|FG002|Overall Study|Adverse Event|0|||
129043998|NCT00897949|464452906|FG000|Overall Study|Lost to Follow-up|0|||
129043999|NCT00897949|464452907|FG001|Overall Study|Lost to Follow-up|2|||
129044000|NCT00897949|464452908|FG002|Overall Study|Lost to Follow-up|1|||
129044001|NCT00897949|464452906|FG000|Overall Study|Protocol Violation|6|||
129135020|NCT02187055|464787035|FG000|Overall Study|Withdrawal by Subject|11|||
129135021|NCT02187055|464787036|FG001|Overall Study|Withdrawal by Subject|11|||
129135022|NCT02187055|464787037|FG002|Overall Study|Withdrawal by Subject|11|||
129135023|NCT02187055|464787035|FG000|Overall Study|Adverse Event|21|||
129135024|NCT02187055|464787036|FG001|Overall Study|Adverse Event|26|||
128981707|NCT01072175|464219005|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981708|NCT01072175|464219006|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
128981709|NCT01072175|464218994|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981710|NCT01072175|464218995|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981711|NCT01072175|464218996|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981712|NCT01072175|464218997|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981713|NCT01072175|464218998|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981714|NCT01072175|464218999|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
128981715|NCT01072175|464219000|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
128981716|NCT01072175|464219001|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981717|NCT01072175|464219002|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981718|NCT01072175|464219003|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981719|NCT01072175|464219004|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981720|NCT01072175|464219005|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981721|NCT01072175|464219006|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
128981722|NCT01072175|464218994|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981723|NCT01072175|464218995|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981724|NCT01072175|464218996|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981725|NCT01072175|464218997|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981726|NCT01072175|464218998|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981727|NCT01072175|464218999|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981728|NCT01072175|464219000|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981729|NCT01072175|464219001|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981730|NCT01072175|464219002|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
128981731|NCT01072175|464219003|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129044002|NCT00897949|464452907|FG001|Overall Study|Protocol Violation|3|||
129044003|NCT00897949|464452908|FG002|Overall Study|Protocol Violation|1|||
129044004|NCT00897949|464452906|FG000|Overall Study|Withdrawal by Subject|1|||
129135025|NCT02187055|464787037|FG002|Overall Study|Adverse Event|36|||
129135026|NCT02187055|464787035|FG000|Overall Study|Death|2|||
129135027|NCT02187055|464787036|FG001|Overall Study|Death|0|||
129135028|NCT02187055|464787037|FG002|Overall Study|Death|0|||
129044005|NCT00897949|464452907|FG001|Overall Study|Withdrawal by Subject|2|||
129044006|NCT00897949|464452908|FG002|Overall Study|Withdrawal by Subject|0|||
129044007|NCT00897949|464452906|FG000|Overall Study|Patient Uncoorperative|0|||
129044008|NCT00897949|464452907|FG001|Overall Study|Patient Uncoorperative|2|||
129135029|NCT00541775|464787038|FG000|Overall Study|Adverse Event|3|||
129135030|NCT00541775|464787039|FG001|Overall Study|Adverse Event|2|||
129135031|NCT00541775|464787040|FG002|Overall Study|Adverse Event|1|||
128719172|NCT04579380|463271005|FG008|Overall Study|Ongoing|6|||
128981732|NCT01072175|464219004|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981733|NCT01072175|464219005|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981734|NCT01072175|464219006|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
128981735|NCT01072175|464218994|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981736|NCT01072175|464218995|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981737|NCT01072175|464218996|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981738|NCT01072175|464218997|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981739|NCT01072175|464218998|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981740|NCT01072175|464218999|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128719182|NCT00939809|463271012|FG000|Overall Study|Adverse Event|2|||
128719183|NCT00939809|463271012|FG000|Overall Study|Death|1|||
128719184|NCT04447417|463271013|FG000|Overall Study|Withdrawal by Subject|1|||
128719185|NCT04447417|463271014|FG001|Overall Study|Withdrawal by Subject|0|||
128719186|NCT04447417|463271013|FG000|Overall Study|Failure to meet inclusion criteria|1|||
128719187|NCT04447417|463271014|FG001|Overall Study|Failure to meet inclusion criteria|0|||
128719188|NCT04447417|463271013|FG000|Overall Study|Lost to Follow-up|1|||
128719189|NCT04447417|463271014|FG001|Overall Study|Lost to Follow-up|0|||
128719190|NCT00156533|463271015|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
128719191|NCT00156533|463271016|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
128719192|NCT00156533|463271017|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
128719193|NCT00156533|463271018|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
128981741|NCT01072175|464219000|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981742|NCT01072175|464219001|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981743|NCT01072175|464219002|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
128981744|NCT01072175|464219003|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981745|NCT01072175|464219004|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981746|NCT01072175|464219005|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981747|NCT01072175|464219006|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
128981748|NCT01072175|464218994|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981749|NCT01072175|464218995|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981750|NCT01072175|464218996|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981751|NCT01072175|464218997|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981752|NCT01072175|464218998|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981753|NCT01072175|464218999|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981754|NCT01072175|464219000|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981755|NCT01072175|464219001|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981756|NCT01072175|464219002|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
128981757|NCT01072175|464219003|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981758|NCT01072175|464219004|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981759|NCT01072175|464219005|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981760|NCT01072175|464219006|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
128981761|NCT01072175|464218994|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981762|NCT01072175|464218995|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981763|NCT01072175|464218996|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981764|NCT01072175|464218997|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981765|NCT01072175|464218998|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981766|NCT01072175|464218999|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981767|NCT01072175|464219000|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981768|NCT01072175|464219001|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981769|NCT01072175|464219002|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
128981770|NCT01072175|464219003|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981771|NCT01072175|464219004|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981772|NCT01072175|464219005|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
128981773|NCT01072175|464219006|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129044009|NCT00897949|464452908|FG002|Overall Study|Patient Uncoorperative|1|||
129044010|NCT00897949|464452906|FG000|Overall Study|Lost to Follow-up|30|||
129044011|NCT00897949|464452907|FG001|Overall Study|Lost to Follow-up|23|||
129223122|NCT04035486|465118278|FG001|Overall Study|Death|3|||
128719194|NCT00156533|463271015|FG000|Overall Study|Withdrawal by Subject|1|||
128719195|NCT00156533|463271016|FG001|Overall Study|Withdrawal by Subject|0|||
128719196|NCT00156533|463271017|FG002|Overall Study|Withdrawal by Subject|0|||
128719197|NCT00156533|463271018|FG003|Overall Study|Withdrawal by Subject|1|||
128719198|NCT00156533|463271015|FG000|Overall Study|Failed Screening|1|||
128719199|NCT00156533|463271016|FG001|Overall Study|Failed Screening|0|||
128719200|NCT00156533|463271017|FG002|Overall Study|Failed Screening|1|||
128719201|NCT00156533|463271018|FG003|Overall Study|Failed Screening|1|||
129044012|NCT00897949|464452908|FG002|Overall Study|Lost to Follow-up|17|||
129044013|NCT00897949|464452906|FG000|Overall Study|Withdrawal by Subject|24|||
129044014|NCT00897949|464452907|FG001|Overall Study|Withdrawal by Subject|31|||
129044015|NCT00897949|464452908|FG002|Overall Study|Withdrawal by Subject|17|||
129044016|NCT00897949|464452906|FG000|Overall Study|Abnormal Prestudy Labs|2|||
129044017|NCT00897949|464452907|FG001|Overall Study|Abnormal Prestudy Labs|3|||
129044018|NCT00897949|464452908|FG002|Overall Study|Abnormal Prestudy Labs|4|||
129044019|NCT00897949|464452906|FG000|Overall Study|Abnormal Baseline ECG|2|||
129044020|NCT00897949|464452907|FG001|Overall Study|Abnormal Baseline ECG|2|||
129044021|NCT00897949|464452908|FG002|Overall Study|Abnormal Baseline ECG|4|||
129044022|NCT00897949|464452906|FG000|Overall Study|Need for Concom. Med.|0|||
129044023|NCT00897949|464452907|FG001|Overall Study|Need for Concom. Med.|1|||
129044024|NCT00897949|464452908|FG002|Overall Study|Need for Concom. Med.|1|||
129044025|NCT00897949|464452906|FG000|Overall Study|Lack of Migraine Attack|29|||
129044026|NCT00897949|464452907|FG001|Overall Study|Lack of Migraine Attack|30|||
129044027|NCT00897949|464452908|FG002|Overall Study|Lack of Migraine Attack|19|||
129044028|NCT00897949|464452906|FG000|Overall Study|Did not take study drug|9|||
129044029|NCT00897949|464452907|FG001|Overall Study|Did not take study drug|3|||
129044030|NCT00897949|464452908|FG002|Overall Study|Did not take study drug|4|||
129044031|NCT01553747|464452909|FG000|Overall Study|Protocol Violation|0|||
129044032|NCT01553747|464452910|FG001|Overall Study|Protocol Violation|2|||
129044033|NCT01553747|464452911|FG002|Overall Study|Protocol Violation|0|||
129044034|NCT01553747|464452909|FG000|Overall Study|Voluntarily withdrew|70|||
129044035|NCT01553747|464452910|FG001|Overall Study|Voluntarily withdrew|66|||
129044036|NCT01553747|464452911|FG002|Overall Study|Voluntarily withdrew|74|||
129044037|NCT01553747|464452909|FG000|Overall Study|Adverse event or SAE|32|||
128719202|NCT02608268|463271019|FG000|Overall Study|Adverse Event|0|||
128719203|NCT02608268|463271020|FG001|Overall Study|Adverse Event|0|||
128719204|NCT02608268|463271021|FG002|Overall Study|Adverse Event|1|||
129044038|NCT01553747|464452910|FG001|Overall Study|Adverse event or SAE|28|||
129044039|NCT01553747|464452911|FG002|Overall Study|Adverse event or SAE|19|||
129044040|NCT01553747|464452909|FG000|Overall Study|Physician decision: other|10|||
129044041|NCT01553747|464452910|FG001|Overall Study|Physician decision: other|8|||
129044042|NCT01553747|464452911|FG002|Overall Study|Physician decision: other|7|||
129044043|NCT01553747|464452909|FG000|Overall Study|Lost to Follow-up|11|||
129044044|NCT01553747|464452910|FG001|Overall Study|Lost to Follow-up|5|||
129044045|NCT01553747|464452911|FG002|Overall Study|Lost to Follow-up|6|||
129044046|NCT01553747|464452909|FG000|Overall Study|Sponsor decision, specify|7|||
129044047|NCT01553747|464452910|FG001|Overall Study|Sponsor decision, specify|5|||
129044048|NCT01553747|464452911|FG002|Overall Study|Sponsor decision, specify|0|||
129044049|NCT01553747|464452909|FG000|Overall Study|Physician decision: lack of efficacy|1|||
129044050|NCT01553747|464452910|FG001|Overall Study|Physician decision: lack of efficacy|5|||
129044051|NCT01553747|464452911|FG002|Overall Study|Physician decision: lack of efficacy|3|||
129044052|NCT01875471|464452925|FG000|Overall Study|Adverse Event|0|||
129044053|NCT01875471|464452926|FG001|Overall Study|Adverse Event|1|||
129044054|NCT01875471|464452925|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
129044055|NCT01875471|464452926|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
129044056|NCT03407118|464452928|FG000|Period 2|Withdrawal by Subject|1|||
129044057|NCT03407118|464452929|FG001|Period 2|Withdrawal by Subject|0|||
129044058|NCT02972502|464452932|FG000|Overall Study|Lost to Follow-up|3|||
129044059|NCT02972502|464452933|FG001|Overall Study|Lost to Follow-up|1|||
129044060|NCT02972502|464452932|FG000|Overall Study|Withdrawal by Subject|1|||
129044061|NCT02972502|464452933|FG001|Overall Study|Withdrawal by Subject|1|||
129044062|NCT01347866|464452936|FG000|Overall Study|Death|0|||
129044063|NCT01347866|464452937|FG001|Overall Study|Death|0|||
129044064|NCT01347866|464452938|FG002|Overall Study|Death|0|||
129044065|NCT01347866|464452939|FG003|Overall Study|Death|1|||
129044066|NCT01347866|464452940|FG004|Overall Study|Death|2|||
129044067|NCT01347866|464452941|FG005|Overall Study|Death|2|||
129044068|NCT01347866|464452942|FG006|Overall Study|Death|1|||
129044069|NCT01347866|464452943|FG007|Overall Study|Death|0|||
129044070|NCT01347866|464452944|FG008|Overall Study|Death|4|||
129044071|NCT01347866|464452945|FG009|Overall Study|Death|1|||
129044072|NCT01347866|464452946|FG010|Overall Study|Death|3|||
129044073|NCT01347866|464452947|FG011|Overall Study|Death|1|||
129044074|NCT01347866|464452948|FG012|Overall Study|Death|2|||
129044075|NCT01347866|464452949|FG013|Overall Study|Death|0|||
129044076|NCT01347866|464452950|FG014|Overall Study|Death|0|||
129044077|NCT01347866|464452951|FG015|Overall Study|Death|1|||
129044078|NCT01347866|464452952|FG016|Overall Study|Death|0|||
128719205|NCT02608268|463271022|FG003|Overall Study|Adverse Event|0|||
129044079|NCT01347866|464452936|FG000|Overall Study|Lost to Follow-up|0|||
129044080|NCT01347866|464452937|FG001|Overall Study|Lost to Follow-up|0|||
129044081|NCT01347866|464452938|FG002|Overall Study|Lost to Follow-up|0|||
128719206|NCT02608268|463271023|FG004|Overall Study|Adverse Event|0|||
129044082|NCT01347866|464452939|FG003|Overall Study|Lost to Follow-up|0|||
129044083|NCT01347866|464452940|FG004|Overall Study|Lost to Follow-up|0|||
129044084|NCT01347866|464452941|FG005|Overall Study|Lost to Follow-up|0|||
129044085|NCT01347866|464452942|FG006|Overall Study|Lost to Follow-up|0|||
129044086|NCT01347866|464452943|FG007|Overall Study|Lost to Follow-up|1|||
129044087|NCT01347866|464452944|FG008|Overall Study|Lost to Follow-up|1|||
129044088|NCT01347866|464452945|FG009|Overall Study|Lost to Follow-up|0|||
129044089|NCT01347866|464452946|FG010|Overall Study|Lost to Follow-up|0|||
129044090|NCT01347866|464452947|FG011|Overall Study|Lost to Follow-up|0|||
129044091|NCT01347866|464452948|FG012|Overall Study|Lost to Follow-up|0|||
129044092|NCT01347866|464452949|FG013|Overall Study|Lost to Follow-up|0|||
129044093|NCT01347866|464452950|FG014|Overall Study|Lost to Follow-up|0|||
129044094|NCT01347866|464452951|FG015|Overall Study|Lost to Follow-up|0|||
129044095|NCT01347866|464452952|FG016|Overall Study|Lost to Follow-up|0|||
129044096|NCT01347866|464452936|FG000|Overall Study|Other|3|||
129044097|NCT01347866|464452937|FG001|Overall Study|Other|1|||
129044098|NCT01347866|464452938|FG002|Overall Study|Other|1|||
129044099|NCT01347866|464452939|FG003|Overall Study|Other|4|||
129044100|NCT01347866|464452940|FG004|Overall Study|Other|5|||
129044101|NCT01347866|464452941|FG005|Overall Study|Other|0|||
129044102|NCT01347866|464452942|FG006|Overall Study|Other|5|||
129044103|NCT01347866|464452943|FG007|Overall Study|Other|3|||
129044104|NCT01347866|464452944|FG008|Overall Study|Other|22|||
129044105|NCT01347866|464452945|FG009|Overall Study|Other|5|||
129044106|NCT01347866|464452946|FG010|Overall Study|Other|0|||
129044107|NCT01347866|464452947|FG011|Overall Study|Other|3|||
129044108|NCT01347866|464452948|FG012|Overall Study|Other|4|||
129044109|NCT01347866|464452949|FG013|Overall Study|Other|4|||
129044110|NCT01347866|464452950|FG014|Overall Study|Other|2|||
129044111|NCT01347866|464452951|FG015|Overall Study|Other|3|||
129044112|NCT01347866|464452952|FG016|Overall Study|Other|0|||
129044113|NCT01347866|464452936|FG000|Overall Study|Subject refused further follow-up|2|||
129044114|NCT01347866|464452937|FG001|Overall Study|Subject refused further follow-up|0|||
129044115|NCT01347866|464452938|FG002|Overall Study|Subject refused further follow-up|0|||
129044116|NCT01347866|464452939|FG003|Overall Study|Subject refused further follow-up|2|||
129044117|NCT01347866|464452940|FG004|Overall Study|Subject refused further follow-up|0|||
129044118|NCT01347866|464452941|FG005|Overall Study|Subject refused further follow-up|1|||
129044119|NCT01347866|464452942|FG006|Overall Study|Subject refused further follow-up|0|||
129044120|NCT01347866|464452943|FG007|Overall Study|Subject refused further follow-up|0|||
129044121|NCT01347866|464452944|FG008|Overall Study|Subject refused further follow-up|4|||
129044122|NCT01347866|464452945|FG009|Overall Study|Subject refused further follow-up|1|||
129044123|NCT01347866|464452946|FG010|Overall Study|Subject refused further follow-up|0|||
129044124|NCT01347866|464452947|FG011|Overall Study|Subject refused further follow-up|0|||
129044125|NCT01347866|464452948|FG012|Overall Study|Subject refused further follow-up|1|||
129044126|NCT01347866|464452949|FG013|Overall Study|Subject refused further follow-up|3|||
129044127|NCT01347866|464452950|FG014|Overall Study|Subject refused further follow-up|1|||
129044128|NCT01347866|464452951|FG015|Overall Study|Subject refused further follow-up|0|||
129044129|NCT01347866|464452952|FG016|Overall Study|Subject refused further follow-up|2|||
129044130|NCT00430950|464452953|FG000|Overall Study|Adverse Event|7|||
129044131|NCT00430950|464452954|FG001|Overall Study|Adverse Event|6|||
129044132|NCT00430950|464452953|FG000|Overall Study|Withdrawal by Subject|1|||
129044133|NCT00430950|464452954|FG001|Overall Study|Withdrawal by Subject|0|||
129044134|NCT00430950|464452953|FG000|Overall Study|concomitant medication,etc.|5|||
129044135|NCT00430950|464452954|FG001|Overall Study|concomitant medication,etc.|7|||
129044136|NCT02429934|464452957|FG000|Overall Study|Withdrawal by Subject|0|||
129044137|NCT02429934|464452958|FG001|Overall Study|Withdrawal by Subject|2|||
129044138|NCT02429934|464452957|FG000|Overall Study|Adverse Event|2|||
129044139|NCT02429934|464452958|FG001|Overall Study|Adverse Event|0|||
129044140|NCT02429934|464452957|FG000|Overall Study|Lost to Follow-up|1|||
129044141|NCT02429934|464452958|FG001|Overall Study|Lost to Follow-up|1|||
129044142|NCT02429934|464452957|FG000|Overall Study|Physician Decision|1|||
129044143|NCT02429934|464452958|FG001|Overall Study|Physician Decision|0|||
129044144|NCT00706992|464452959|FG000|Overall Study|Study termination|5|||
129044145|NCT00706992|464452960|FG001|Overall Study|Study termination|5|||
129044146|NCT00706992|464452961|FG002|Overall Study|Study termination|6|||
129044147|NCT00706992|464452962|FG003|Overall Study|Study termination|2|||
129044148|NCT00706992|464452963|FG004|Overall Study|Study termination|3|||
129044149|NCT00706992|464452964|FG005|Overall Study|Study termination|2|||
129044150|NCT00706992|464452965|FG006|Overall Study|Study termination|3|||
129044151|NCT00706992|464452959|FG000|Overall Study|Disease progression before treatment|0|||
129044152|NCT00706992|464452960|FG001|Overall Study|Disease progression before treatment|0|||
129044153|NCT00706992|464452961|FG002|Overall Study|Disease progression before treatment|0|||
129044154|NCT00706992|464452962|FG003|Overall Study|Disease progression before treatment|0|||
129044155|NCT00706992|464452963|FG004|Overall Study|Disease progression before treatment|1|||
129044156|NCT00706992|464452964|FG005|Overall Study|Disease progression before treatment|0|||
129044157|NCT00706992|464452965|FG006|Overall Study|Disease progression before treatment|0|||
129044158|NCT01491035|464452966|FG000|Overall Study|Lost to Follow-up|0|||
129044159|NCT01491035|464452967|FG001|Overall Study|Lost to Follow-up|0|||
129044160|NCT01491035|464452968|FG002|Overall Study|Lost to Follow-up|0|||
129044161|NCT01491035|464452969|FG003|Overall Study|Lost to Follow-up|0|||
129044162|NCT01491035|464452970|FG004|Overall Study|Lost to Follow-up|1|||
129044163|NCT01491035|464452971|FG005|Overall Study|Lost to Follow-up|0|||
128719207|NCT02608268|463271024|FG005|Overall Study|Adverse Event|0|||
128719208|NCT02608268|463271025|FG006|Overall Study|Adverse Event|0|||
128719209|NCT02608268|463271026|FG007|Overall Study|Adverse Event|0|||
128719210|NCT02608268|463271027|FG008|Overall Study|Adverse Event|0|||
128719211|NCT02608268|463271028|FG009|Overall Study|Adverse Event|0|||
128719212|NCT02608268|463271029|FG010|Overall Study|Adverse Event|0|||
128981774|NCT01072175|464218994|FG000|Part D (HPMC Capsules)|Death|0|||
128981775|NCT01072175|464218995|FG001|Part D (HPMC Capsules)|Death|0|||
128981776|NCT01072175|464218996|FG002|Part D (HPMC Capsules)|Death|0|||
128981777|NCT01072175|464218997|FG003|Part D (HPMC Capsules)|Death|0|||
128981778|NCT01072175|464218998|FG004|Part D (HPMC Capsules)|Death|0|||
128981779|NCT01072175|464218999|FG005|Part D (HPMC Capsules)|Death|0|||
128981780|NCT01072175|464219000|FG006|Part D (HPMC Capsules)|Death|0|||
128981781|NCT01072175|464219001|FG007|Part D (HPMC Capsules)|Death|0|||
128981782|NCT01072175|464219002|FG008|Part D (HPMC Capsules)|Death|0|||
128981783|NCT01072175|464219003|FG009|Part D (HPMC Capsules)|Death|10|||
128981784|NCT01072175|464219004|FG010|Part D (HPMC Capsules)|Death|12|||
128981785|NCT01072175|464219005|FG011|Part D (HPMC Capsules)|Death|28|||
128981786|NCT01072175|464219006|FG012|Part D (HPMC Capsules)|Death|26|||
128981787|NCT01072175|464218994|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
128981788|NCT01072175|464218995|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
128981789|NCT01072175|464218996|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
128981790|NCT01072175|464218997|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
128981791|NCT01072175|464218998|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
128981792|NCT01072175|464218999|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
128981793|NCT01072175|464219000|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
128981794|NCT01072175|464219001|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
128981795|NCT01072175|464219002|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
128981796|NCT01072175|464219003|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
128981797|NCT01072175|464219004|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
128981798|NCT01072175|464219005|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
128981799|NCT01072175|464219006|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
128981800|NCT01072175|464218994|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981801|NCT01072175|464218995|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981802|NCT01072175|464218996|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981803|NCT01072175|464218997|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981804|NCT01072175|464218998|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981805|NCT01072175|464218999|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981806|NCT01072175|464219000|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981807|NCT01072175|464219001|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981808|NCT01072175|464219002|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981809|NCT01072175|464219003|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
128981810|NCT01072175|464219004|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
128981811|NCT01072175|464219005|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
128981812|NCT01072175|464219006|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
128981813|NCT01072175|464218994|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981814|NCT01072175|464218995|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981815|NCT01072175|464218996|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981816|NCT01072175|464218997|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981817|NCT01072175|464218998|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981818|NCT01072175|464218999|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981819|NCT01072175|464219000|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981820|NCT01072175|464219001|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981821|NCT01072175|464219002|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
128981822|NCT01072175|464219003|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
128981823|NCT01072175|464219004|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
128981824|NCT01072175|464219005|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
128981825|NCT01072175|464219006|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
128981826|NCT01072175|464218994|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981827|NCT01072175|464218995|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981828|NCT01072175|464218996|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128719213|NCT02608268|463271030|FG011|Overall Study|Adverse Event|0|||
128981829|NCT01072175|464218997|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981830|NCT01072175|464218998|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981831|NCT01072175|464218999|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981832|NCT01072175|464219000|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981833|NCT01072175|464219001|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981834|NCT01072175|464219002|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
128981835|NCT01072175|464219003|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129223123|NCT04035486|465118279|FG002|Overall Study|Death|70|||
128719214|NCT02608268|463271031|FG012|Overall Study|Adverse Event|2|||
128719215|NCT02608268|463271032|FG013|Overall Study|Adverse Event|0|||
128981836|NCT01072175|464219004|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
128981837|NCT01072175|464219005|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
128981838|NCT01072175|464219006|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129135032|NCT00541775|464787038|FG000|Overall Study|Lack of Efficacy|0|||
129135033|NCT00541775|464787039|FG001|Overall Study|Lack of Efficacy|0|||
129135034|NCT00541775|464787040|FG002|Overall Study|Lack of Efficacy|3|||
129135035|NCT00541775|464787038|FG000|Overall Study|Lost to Follow-up|0|||
129135036|NCT00541775|464787039|FG001|Overall Study|Lost to Follow-up|0|||
129135037|NCT00541775|464787040|FG002|Overall Study|Lost to Follow-up|2|||
129135038|NCT00541775|464787038|FG000|Overall Study|Protocol Violation|1|||
129135039|NCT00541775|464787039|FG001|Overall Study|Protocol Violation|0|||
129135040|NCT00541775|464787040|FG002|Overall Study|Protocol Violation|0|||
129135041|NCT00541775|464787038|FG000|Overall Study|Withdrawal by Subject and Other|5|||
129135042|NCT00541775|464787039|FG001|Overall Study|Withdrawal by Subject and Other|0|||
129135043|NCT00541775|464787040|FG002|Overall Study|Withdrawal by Subject and Other|2|||
129135044|NCT00032487|464787041|FG000|Overall Study|Withdrawal by Subject|67|||
129135045|NCT00032487|464787042|FG001|Overall Study|Withdrawal by Subject|43|||
129135046|NCT00032487|464787041|FG000|Overall Study|Adverse Event|3|||
129135047|NCT00032487|464787042|FG001|Overall Study|Adverse Event|7|||
129135048|NCT00032487|464787041|FG000|Overall Study|Lost to Follow-up|57|||
129135049|NCT00032487|464787042|FG001|Overall Study|Lost to Follow-up|58|||
129135050|NCT00032487|464787041|FG000|Overall Study|Had other reason|12|||
129135051|NCT00032487|464787042|FG001|Overall Study|Had other reason|12|||
128719216|NCT02608268|463271033|FG014|Overall Study|Adverse Event|0|||
128719217|NCT02608268|463271034|FG015|Overall Study|Adverse Event|0|||
128719218|NCT02608268|463271035|FG016|Overall Study|Adverse Event|0|||
128719219|NCT02608268|463271036|FG017|Overall Study|Adverse Event|0|||
128719220|NCT02608268|463271037|FG018|Overall Study|Adverse Event|0|||
128719221|NCT02608268|463271038|FG019|Overall Study|Adverse Event|0|||
128981839|NCT00649220|464219007|FG000|Overall Study|Adverse Event|2|||
128981840|NCT00649220|464219007|FG000|Overall Study|Withdrawal by Subject|1|||
128981841|NCT02557308|464219008|FG000|Overall Study|Withdrawal by Subject|11|||
128981842|NCT02557308|464219009|FG001|Overall Study|Withdrawal by Subject|3|||
128981843|NCT02557308|464219010|FG002|Overall Study|Withdrawal by Subject|2|||
128981844|NCT02557308|464219011|FG003|Overall Study|Withdrawal by Subject|0|||
128981845|NCT02557308|464219012|FG004|Overall Study|Withdrawal by Subject|1|||
128981846|NCT02557308|464219013|FG005|Overall Study|Withdrawal by Subject|0|||
128981847|NCT02557308|464219014|FG006|Overall Study|Withdrawal by Subject|10|||
128981848|NCT02557308|464219015|FG007|Overall Study|Withdrawal by Subject|1|||
128981849|NCT02557308|464219008|FG000|Overall Study|Disease Progression|0|||
128981850|NCT02557308|464219009|FG001|Overall Study|Disease Progression|1|||
128981851|NCT02557308|464219010|FG002|Overall Study|Disease Progression|0|||
128981852|NCT02557308|464219011|FG003|Overall Study|Disease Progression|0|||
128981853|NCT02557308|464219012|FG004|Overall Study|Disease Progression|0|||
128981854|NCT02557308|464219013|FG005|Overall Study|Disease Progression|0|||
128981855|NCT02557308|464219014|FG006|Overall Study|Disease Progression|0|||
128981856|NCT02557308|464219015|FG007|Overall Study|Disease Progression|0|||
128981857|NCT02557308|464219008|FG000|Overall Study|Lack of Efficacy|3|||
128981858|NCT02557308|464219009|FG001|Overall Study|Lack of Efficacy|0|||
128981859|NCT02557308|464219010|FG002|Overall Study|Lack of Efficacy|0|||
128981860|NCT02557308|464219011|FG003|Overall Study|Lack of Efficacy|0|||
128981861|NCT02557308|464219012|FG004|Overall Study|Lack of Efficacy|0|||
128981862|NCT02557308|464219013|FG005|Overall Study|Lack of Efficacy|0|||
128981863|NCT02557308|464219014|FG006|Overall Study|Lack of Efficacy|1|||
128981864|NCT02557308|464219015|FG007|Overall Study|Lack of Efficacy|0|||
128981865|NCT02557308|464219008|FG000|Overall Study|Adverse Event|4|||
128981866|NCT02557308|464219009|FG001|Overall Study|Adverse Event|1|||
128981867|NCT02557308|464219010|FG002|Overall Study|Adverse Event|2|||
128981868|NCT02557308|464219011|FG003|Overall Study|Adverse Event|0|||
128981869|NCT02557308|464219012|FG004|Overall Study|Adverse Event|0|||
128981870|NCT02557308|464219013|FG005|Overall Study|Adverse Event|0|||
128981871|NCT02557308|464219014|FG006|Overall Study|Adverse Event|4|||
128981872|NCT02557308|464219015|FG007|Overall Study|Adverse Event|1|||
128981873|NCT02557308|464219008|FG000|Overall Study|Lost to Follow-up|2|||
128981874|NCT02557308|464219009|FG001|Overall Study|Lost to Follow-up|0|||
128981875|NCT02557308|464219010|FG002|Overall Study|Lost to Follow-up|1|||
128981876|NCT02557308|464219011|FG003|Overall Study|Lost to Follow-up|0|||
128981877|NCT02557308|464219012|FG004|Overall Study|Lost to Follow-up|0|||
128981878|NCT02557308|464219013|FG005|Overall Study|Lost to Follow-up|0|||
128981879|NCT02557308|464219014|FG006|Overall Study|Lost to Follow-up|2|||
128981880|NCT02557308|464219015|FG007|Overall Study|Lost to Follow-up|0|||
128981881|NCT02557308|464219008|FG000|Overall Study|Death|1|||
128981882|NCT02557308|464219009|FG001|Overall Study|Death|0|||
128981883|NCT02557308|464219010|FG002|Overall Study|Death|0|||
128981884|NCT02557308|464219011|FG003|Overall Study|Death|0|||
128981885|NCT02557308|464219012|FG004|Overall Study|Death|0|||
128981886|NCT02557308|464219013|FG005|Overall Study|Death|0|||
128981887|NCT02557308|464219014|FG006|Overall Study|Death|0|||
128981888|NCT02557308|464219015|FG007|Overall Study|Death|0|||
128981889|NCT02557308|464219008|FG000|Overall Study|Study Close|98|||
129135052|NCT05737745|464787043|FG000|Overall Study|Withdrawal by Subject|0|||
129135053|NCT05737745|464787044|FG001|Overall Study|Withdrawal by Subject|6|||
129135054|NCT05737745|464787045|FG002|Overall Study|Withdrawal by Subject|1|||
129135055|NCT02547935|464787046|FG000|Overall Study|Other|0|||
129135056|NCT02547935|464787047|FG001|Overall Study|Other|1|||
129135057|NCT02547935|464787048|FG002|Overall Study|Other|0|||
129135058|NCT02547935|464787046|FG000|Overall Study|Withdrawal by Subject|2|||
129135059|NCT02547935|464787047|FG001|Overall Study|Withdrawal by Subject|3|||
129135060|NCT02547935|464787048|FG002|Overall Study|Withdrawal by Subject|4|||
129135061|NCT02547935|464787046|FG000|Overall Study|Screen Failure|2|||
129135062|NCT02547935|464787047|FG001|Overall Study|Screen Failure|0|||
129135063|NCT02547935|464787048|FG002|Overall Study|Screen Failure|0|||
128981890|NCT02557308|464219009|FG001|Overall Study|Study Close|18|||
128981891|NCT02557308|464219010|FG002|Overall Study|Study Close|5|||
128981892|NCT02557308|464219011|FG003|Overall Study|Study Close|3|||
128981893|NCT02557308|464219012|FG004|Overall Study|Study Close|1|||
128981894|NCT02557308|464219013|FG005|Overall Study|Study Close|0|||
128981895|NCT02557308|464219014|FG006|Overall Study|Study Close|123|||
128981896|NCT02557308|464219015|FG007|Overall Study|Study Close|5|||
128981897|NCT02557308|464219008|FG000|Overall Study|Except for study close|5|||
128981898|NCT02557308|464219009|FG001|Overall Study|Except for study close|0|||
128981899|NCT02557308|464219010|FG002|Overall Study|Except for study close|0|||
128981900|NCT02557308|464219011|FG003|Overall Study|Except for study close|0|||
128981901|NCT02557308|464219012|FG004|Overall Study|Except for study close|3|||
128981902|NCT02557308|464219013|FG005|Overall Study|Except for study close|0|||
128981903|NCT02557308|464219014|FG006|Overall Study|Except for study close|6|||
128981904|NCT02557308|464219015|FG007|Overall Study|Except for study close|10|||
128981905|NCT00368069|464219018|FG000|Overall Study|Adverse Event|5|||
128981906|NCT00368069|464219019|FG001|Overall Study|Adverse Event|2|||
128981907|NCT00368069|464219018|FG000|Overall Study|Lack of Efficacy|0|||
129044164|NCT01491035|464452972|FG006|Overall Study|Lost to Follow-up|0|||
129044165|NCT01491035|464452973|FG007|Overall Study|Lost to Follow-up|0|||
129044166|NCT02377063|464452974|FG000|Overall Study|Non-compliance|5|||
129044167|NCT01277718|464452978|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
129135064|NCT02547935|464787046|FG000|Overall Study|Physician Decision|0|||
129135065|NCT02547935|464787047|FG001|Overall Study|Physician Decision|1|||
129135066|NCT02547935|464787048|FG002|Overall Study|Physician Decision|0|||
129135067|NCT02547935|464787046|FG000|Overall Study|Lost to Follow-up|0|||
129135068|NCT02547935|464787047|FG001|Overall Study|Lost to Follow-up|2|||
129135069|NCT02547935|464787048|FG002|Overall Study|Lost to Follow-up|1|||
129135070|NCT02547935|464787046|FG000|Overall Study|Death|1|||
129135071|NCT02547935|464787047|FG001|Overall Study|Death|1|||
129135072|NCT02547935|464787048|FG002|Overall Study|Death|0|||
129135073|NCT02487199|464787051|FG000|Overall Study|Withdrew Consent|0|||
129135074|NCT02487199|464787052|FG001|Overall Study|Withdrew Consent|1|||
129135075|NCT03735498|464789090|FG000|Overall Study|Withdrawal by Subject|3|||
129135076|NCT03735498|464789090|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
129135077|NCT02014103|464789092|FG000|Overall Study|Protocol Violation|7|||
129135078|NCT02014103|464789093|FG001|Overall Study|Protocol Violation|7|||
129135079|NCT02014103|464789092|FG000|Overall Study|Adverse Event|1|||
129135080|NCT02014103|464789093|FG001|Overall Study|Adverse Event|0|||
129135081|NCT02014103|464789092|FG000|Overall Study|Lost venous access|1|||
129135082|NCT02014103|464789093|FG001|Overall Study|Lost venous access|0|||
129135083|NCT02014103|464789092|FG000|Overall Study|Withdrawal by Subject|0|||
129135084|NCT02014103|464789093|FG001|Overall Study|Withdrawal by Subject|2|||
129135085|NCT04289298|464789095|FG000|Overall Study|Lost to Follow-up|5|||
129135086|NCT04289298|464789096|FG001|Overall Study|Lost to Follow-up|0|||
129135087|NCT04289298|464789095|FG000|Overall Study|Withdrawal by Subject|2|||
129135088|NCT04289298|464789096|FG001|Overall Study|Withdrawal by Subject|0|||
129135089|NCT00620035|464789097|FG000|Overall Study|Adverse Event|106|||
129135090|NCT00620035|464789097|FG000|Overall Study|Withdrawal of Informed Consent|1|||
129135091|NCT00620035|464789097|FG000|Overall Study|Other Reason|38|||
129135092|NCT01108796|464789099|FG000|Overall Study|Adverse Event|0|||
129135093|NCT01108796|464789100|FG001|Overall Study|Adverse Event|1|||
129135094|NCT01108796|464789099|FG000|Overall Study|Lost to Follow-up|7|||
129135095|NCT01108796|464789100|FG001|Overall Study|Lost to Follow-up|6|||
129223124|NCT04035486|465118280|FG003|Overall Study|Death|77|||
129044168|NCT01277718|464452979|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
129044169|NCT01277718|464452978|FG000|Period 2 - Second Intervention|Physician Decision|0|||
129044170|NCT01277718|464452979|FG001|Period 2 - Second Intervention|Physician Decision|2|||
129044171|NCT00702208|464452983|FG000|Overall Study|Lost to Follow-up|28|||
129135096|NCT01245751|464789102|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
129135097|NCT01245751|464789103|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
128981908|NCT00368069|464219019|FG001|Overall Study|Lack of Efficacy|1|||
129135098|NCT01245751|464789104|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
129135099|NCT01245751|464789105|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
129135100|NCT01245751|464789102|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
129135101|NCT01245751|464789103|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
129135102|NCT01245751|464789104|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
129135103|NCT01245751|464789105|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
129135104|NCT01245751|464789102|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
129044172|NCT00702208|464452983|FG000|Overall Study|Did not self-lavage|1|||
129044173|NCT00702208|464452983|FG000|Overall Study|Unsatisfactory colposcopy|2|||
129044174|NCT02746627|464452987|FG000|Overall Study|Withdrawal by Subject|1|||
129044175|NCT02746627|464452988|FG001|Overall Study|Withdrawal by Subject|1|||
129044176|NCT02746627|464452989|FG002|Overall Study|Withdrawal by Subject|1|||
129044177|NCT03351231|464453003|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
129044178|NCT03351231|464453003|FG000|Combination Therapy Period|Disease progression|2|||
129044179|NCT03351231|464453003|FG000|Combination Therapy Period|Study drug toxicity|1|||
129044180|NCT03351231|464453003|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
129044181|NCT03351231|464453003|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
129044182|NCT03351231|464453003|FG000|Safety Follow-Up Period|Other reason|2|||
129044183|NCT02858726|464453004|FG000|Overall Study|Adverse Event|4|||
129044184|NCT02858726|464453005|FG001|Overall Study|Adverse Event|4|||
129044185|NCT02858726|464453006|FG002|Overall Study|Adverse Event|9|||
129044186|NCT02858726|464453007|FG003|Overall Study|Adverse Event|1|||
129044187|NCT02858726|464453004|FG000|Overall Study|Physician Decision|0|||
129044188|NCT02858726|464453005|FG001|Overall Study|Physician Decision|0|||
129044189|NCT02858726|464453006|FG002|Overall Study|Physician Decision|1|||
129044190|NCT02858726|464453007|FG003|Overall Study|Physician Decision|0|||
129044191|NCT02858726|464453004|FG000|Overall Study|Protocol Violation|0|||
129044192|NCT02858726|464453005|FG001|Overall Study|Protocol Violation|0|||
129044193|NCT02858726|464453006|FG002|Overall Study|Protocol Violation|0|||
129044194|NCT02858726|464453007|FG003|Overall Study|Protocol Violation|1|||
129044195|NCT02858726|464453004|FG000|Overall Study|Study Terminated by Sponsor|0|||
129044196|NCT02858726|464453005|FG001|Overall Study|Study Terminated by Sponsor|0|||
129044197|NCT02858726|464453006|FG002|Overall Study|Study Terminated by Sponsor|0|||
129044198|NCT02858726|464453007|FG003|Overall Study|Study Terminated by Sponsor|1|||
129044199|NCT02858726|464453004|FG000|Overall Study|Withdrawal by Subject|1|||
129044200|NCT02858726|464453005|FG001|Overall Study|Withdrawal by Subject|2|||
129044201|NCT02858726|464453006|FG002|Overall Study|Withdrawal by Subject|1|||
129044202|NCT02858726|464453007|FG003|Overall Study|Withdrawal by Subject|0|||
129044203|NCT02858726|464453004|FG000|Overall Study|Noncompliance|0|||
129044204|NCT02858726|464453005|FG001|Overall Study|Noncompliance|1|||
129044205|NCT02858726|464453006|FG002|Overall Study|Noncompliance|0|||
129044206|NCT02858726|464453007|FG003|Overall Study|Noncompliance|0|||
129044207|NCT02340221|464453008|FG000|Overall Study|Death|100|||
129044208|NCT02340221|464453009|FG001|Overall Study|Death|197|||
129044209|NCT02340221|464453008|FG000|Overall Study|Withdrawal by Participant|24|||
129044210|NCT02340221|464453009|FG001|Overall Study|Withdrawal by Participant|37|||
129044211|NCT02340221|464453008|FG000|Overall Study|Lost to Follow-up|4|||
129044212|NCT02340221|464453009|FG001|Overall Study|Lost to Follow-up|15|||
129044213|NCT02340221|464453008|FG000|Overall Study|Reason Not Specified|85|||
129044214|NCT02340221|464453009|FG001|Overall Study|Reason Not Specified|165|||
129044215|NCT02340221|464453008|FG000|Overall Study|Study Terminated by Sponsor|1|||
129044216|NCT02340221|464453009|FG001|Overall Study|Study Terminated by Sponsor|3|||
129044217|NCT00003138|464454698|FG000|Step 1|Reasons off treatment not documented|60|||
129044218|NCT00003138|464454699|FG001|Step 1|Reasons off treatment not documented|57|||
129044219|NCT00003138|464454698|FG000|Step 1|Never started treatment|1|||
129044220|NCT00003138|464454699|FG001|Step 1|Never started treatment|0|||
129044221|NCT00003138|464454698|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
129044222|NCT00003138|464454699|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
129044223|NCT00003138|464454698|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
129044224|NCT00003138|464454699|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
129044225|NCT00003138|464454698|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
129044226|NCT00003138|464454699|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
129044227|NCT00003138|464454698|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
129044228|NCT00003138|464454699|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
129044229|NCT05142566|464454701|FG000|Overall Study|Protocol Violation|1|||
129044230|NCT03247517|464454706|FG000|Overall Study|Adverse Event|0|||
129044231|NCT03247517|464454707|FG001|Overall Study|Adverse Event|4|||
129044232|NCT03247517|464454708|FG002|Overall Study|Adverse Event|2|||
128719222|NCT02608268|463271039|FG020|Overall Study|Adverse Event|1|||
128719223|NCT02608268|463271040|FG021|Overall Study|Adverse Event|1|||
129044233|NCT03247517|464454706|FG000|Overall Study|Lost to Follow-up|2|||
129044234|NCT03247517|464454707|FG001|Overall Study|Lost to Follow-up|6|||
129044235|NCT03247517|464454708|FG002|Overall Study|Lost to Follow-up|4|||
129044236|NCT03247517|464454706|FG000|Overall Study|Consent withdrawn by caregiver|1|||
129044237|NCT03247517|464454707|FG001|Overall Study|Consent withdrawn by caregiver|4|||
129044238|NCT03247517|464454708|FG002|Overall Study|Consent withdrawn by caregiver|7|||
129044239|NCT03247517|464454706|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
129044240|NCT03247517|464454707|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
129044241|NCT03247517|464454708|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
129044242|NCT03247517|464454706|FG000|Overall Study|Protocol Violation|0|||
128719224|NCT02608268|463271041|FG022|Overall Study|Adverse Event|0|||
129044243|NCT03247517|464454707|FG001|Overall Study|Protocol Violation|2|||
129044244|NCT03247517|464454708|FG002|Overall Study|Protocol Violation|0|||
129044245|NCT03247517|464454706|FG000|Overall Study|Multiple reasons|3|||
129044246|NCT03247517|464454707|FG001|Overall Study|Multiple reasons|1|||
129044247|NCT03247517|464454708|FG002|Overall Study|Multiple reasons|0|||
129044248|NCT02072148|464454719|FG000|Overall Study|withdrew prior to surgery|23|||
129044249|NCT02072148|464454720|FG001|Overall Study|withdrew prior to surgery|0|||
129044250|NCT02072148|464454721|FG002|Overall Study|withdrew prior to surgery|0|||
129044251|NCT02072148|464454719|FG000|Overall Study|Death|0|||
129044252|NCT02072148|464454720|FG001|Overall Study|Death|0|||
129044253|NCT02072148|464454721|FG002|Overall Study|Death|1|||
129044254|NCT02072148|464454719|FG000|Overall Study|Withdrawal by Subject|0|||
129044255|NCT02072148|464454720|FG001|Overall Study|Withdrawal by Subject|13|||
129044256|NCT02072148|464454721|FG002|Overall Study|Withdrawal by Subject|12|||
129044257|NCT01939496|464454723|FG000|Overall Study|Adverse Event|2|||
129044258|NCT01939496|464454724|FG001|Overall Study|Adverse Event|0|||
129044259|NCT01939496|464454725|FG002|Overall Study|Adverse Event|0|||
129044260|NCT01939496|464454723|FG000|Overall Study|Lost to Follow-up|1|||
129044261|NCT01939496|464454724|FG001|Overall Study|Lost to Follow-up|1|||
129044262|NCT01939496|464454725|FG002|Overall Study|Lost to Follow-up|0|||
129044263|NCT01939496|464454723|FG000|Overall Study|Physician Decision|1|||
129044264|NCT01939496|464454724|FG001|Overall Study|Physician Decision|0|||
129044265|NCT01939496|464454725|FG002|Overall Study|Physician Decision|0|||
129044266|NCT01939496|464454723|FG000|Overall Study|Protocol Violation|3|||
129044267|NCT01939496|464454724|FG001|Overall Study|Protocol Violation|0|||
129044268|NCT01939496|464454725|FG002|Overall Study|Protocol Violation|0|||
129044269|NCT01939496|464454723|FG000|Overall Study|Withdrawal by Subject|0|||
129044270|NCT01939496|464454724|FG001|Overall Study|Withdrawal by Subject|1|||
129044271|NCT01939496|464454725|FG002|Overall Study|Withdrawal by Subject|1|||
129044272|NCT01939496|464454723|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
129044273|NCT01939496|464454724|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
129044274|NCT01939496|464454725|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
129044275|NCT01939496|464454723|FG000|Overall Study|Other|2|||
129044276|NCT01939496|464454724|FG001|Overall Study|Other|0|||
129044277|NCT01939496|464454725|FG002|Overall Study|Other|1|||
129044278|NCT03052322|464454726|FG000|Overall Study|Other un-specified|1|||
128981909|NCT00368069|464219018|FG000|Overall Study|Lost to Follow-up|1|||
128981910|NCT00368069|464219019|FG001|Overall Study|Lost to Follow-up|0|||
128981911|NCT00368069|464219018|FG000|Overall Study|Protocol Violation|0|||
128981912|NCT00368069|464219019|FG001|Overall Study|Protocol Violation|2|||
128981913|NCT00368069|464219018|FG000|Overall Study|Withdrawal of Consent|2|||
128981914|NCT00368069|464219019|FG001|Overall Study|Withdrawal of Consent|1|||
129044279|NCT03052322|464454727|FG001|Overall Study|Other un-specified|2|||
129044280|NCT03052322|464454726|FG000|Overall Study|Withdrawal by Subject|10|||
129044281|NCT03052322|464454727|FG001|Overall Study|Withdrawal by Subject|9|||
129044282|NCT03052322|464454726|FG000|Overall Study|Death|0|||
129044283|NCT03052322|464454727|FG001|Overall Study|Death|2|||
129044284|NCT03052322|464454726|FG000|Overall Study|Lack of Efficacy|1|||
129044285|NCT03052322|464454727|FG001|Overall Study|Lack of Efficacy|2|||
129044286|NCT03052322|464454726|FG000|Overall Study|Protocol Violation|1|||
129044287|NCT03052322|464454727|FG001|Overall Study|Protocol Violation|0|||
129044288|NCT03052322|464454726|FG000|Overall Study|Lost to Follow-up|2|||
129044289|NCT03052322|464454727|FG001|Overall Study|Lost to Follow-up|4|||
129044290|NCT03052322|464454726|FG000|Overall Study|Adverse Event|6|||
129044291|NCT03052322|464454727|FG001|Overall Study|Adverse Event|13|||
129044292|NCT04920916|464454728|FG000|Phase IIa 60 Day Study|Death|2|||
129044293|NCT04920916|464454729|FG001|Phase IIa 60 Day Study|Death|5|||
129044294|NCT04920916|464454728|FG000|1 Year Follow up (Phone Call)|Death|1|||
129044295|NCT04920916|464454729|FG001|1 Year Follow up (Phone Call)|Death|3|||
129044296|NCT04920916|464454728|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
129044297|NCT04920916|464454729|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
129044298|NCT03251963|464454738|FG000|Overall Study|inappropriate Xa level timing|6|||
128719225|NCT02608268|463271042|FG023|Overall Study|Adverse Event|0|||
129044299|NCT03251963|464454739|FG001|Overall Study|inappropriate Xa level timing|3|||
129044300|NCT03251963|464454738|FG000|Overall Study|no peak Xa level drawn|2|||
129044301|NCT03251963|464454739|FG001|Overall Study|no peak Xa level drawn|0|||
129044302|NCT03251963|464454738|FG000|Overall Study|bled prior to Xa level|1|||
129044303|NCT03251963|464454739|FG001|Overall Study|bled prior to Xa level|2|||
129044304|NCT00136318|464454742|FG000|Overall Study|Adverse Event|5|||
128719226|NCT02608268|463271043|FG024|Overall Study|Adverse Event|1|||
128719227|NCT02608268|463271044|FG025|Overall Study|Adverse Event|0|||
128719228|NCT02608268|463271045|FG026|Overall Study|Adverse Event|0|||
128719229|NCT02608268|463271046|FG027|Overall Study|Adverse Event|0|||
128719230|NCT02608268|463271047|FG028|Overall Study|Adverse Event|1|||
129044305|NCT00136318|464454743|FG001|Overall Study|Adverse Event|5|||
128981915|NCT00368069|464219018|FG000|Overall Study|no blood sampling possible|0|||
128981916|NCT00368069|464219019|FG001|Overall Study|no blood sampling possible|1|||
128981917|NCT03907072|464219023|FG000|Overall Study|Study Terminated by Sponsor|2|||
129044306|NCT00136318|464454742|FG000|Overall Study|Withdrawal by Subject|2|||
129223125|NCT04035486|465118277|FG000|Overall Study|Screen Failure|0|||
129223126|NCT04035486|465118278|FG001|Overall Study|Screen Failure|0|||
129223127|NCT04035486|465118279|FG002|Overall Study|Screen Failure|1|||
129223128|NCT04035486|465118280|FG003|Overall Study|Screen Failure|1|||
129223129|NCT04035486|465118277|FG000|Overall Study|Withdrawal by Subject|1|||
129223130|NCT04035486|465118278|FG001|Overall Study|Withdrawal by Subject|1|||
129223131|NCT04035486|465118279|FG002|Overall Study|Withdrawal by Subject|11|||
129223132|NCT04035486|465118280|FG003|Overall Study|Withdrawal by Subject|9|||
129223133|NCT01730937|465118290|FG000|Overall Study|Protocol Violation|5|||
129223134|NCT01730937|465118291|FG001|Overall Study|Protocol Violation|11|||
129223135|NCT05445843|465118292|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
129223136|NCT05445843|465118293|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
129223137|NCT05445843|465118292|FG000|Overall Study|Progressive disease|17|||
128719231|NCT02608268|463271048|FG029|Overall Study|Adverse Event|0|||
128981918|NCT03907072|464219024|FG001|Overall Study|Study Terminated by Sponsor|2|||
128981919|NCT03907072|464219025|FG002|Overall Study|Study Terminated by Sponsor|2|||
128981920|NCT01430559|464219028|FG000|Overall Study|Adverse Event|7|||
128981921|NCT01430559|464219029|FG001|Overall Study|Adverse Event|3|||
128981922|NCT01430559|464219028|FG000|Overall Study|Entry criteria not met|1|||
128981923|NCT01430559|464219029|FG001|Overall Study|Entry criteria not met|1|||
128981924|NCT01430559|464219028|FG000|Overall Study|Lost to Follow-up|1|||
128981925|NCT01430559|464219029|FG001|Overall Study|Lost to Follow-up|0|||
128981926|NCT01430559|464219028|FG000|Overall Study|Medication error|1|||
128981927|NCT01430559|464219029|FG001|Overall Study|Medication error|0|||
128981928|NCT01430559|464219028|FG000|Overall Study|Withdrawal by Subject|3|||
128981929|NCT01430559|464219029|FG001|Overall Study|Withdrawal by Subject|2|||
128981930|NCT01430559|464219028|FG000|Overall Study|Protocol Violation|1|||
128981931|NCT01430559|464219029|FG001|Overall Study|Protocol Violation|0|||
128981932|NCT01430559|464219028|FG000|Overall Study|Other|3|||
129044307|NCT00136318|464454743|FG001|Overall Study|Withdrawal by Subject|2|||
129044308|NCT01546649|464454746|FG000|Overall Study|Adverse Event|4|||
129044309|NCT01546649|464454747|FG001|Overall Study|Adverse Event|5|||
129044310|NCT01546649|464454746|FG000|Overall Study|Protocol Violation|1|||
129044311|NCT01546649|464454747|FG001|Overall Study|Protocol Violation|0|||
129044312|NCT01546649|464454746|FG000|Overall Study|Lack of Efficacy|1|||
129044313|NCT01546649|464454747|FG001|Overall Study|Lack of Efficacy|0|||
129044314|NCT01546649|464454746|FG000|Overall Study|Recurrence|1|||
129044315|NCT01546649|464454747|FG001|Overall Study|Recurrence|1|||
129044316|NCT01546649|464454746|FG000|Overall Study|Discovery of secondary cancer|0|||
129044317|NCT01546649|464454747|FG001|Overall Study|Discovery of secondary cancer|1|||
129044318|NCT01546649|464454746|FG000|Overall Study|Withdrawal by Subject|1|||
129044319|NCT01546649|464454747|FG001|Overall Study|Withdrawal by Subject|2|||
129044320|NCT01134627|464454752|FG000|Overall Study|Adverse Event|47|||
129044321|NCT01134627|464454753|FG001|Overall Study|Adverse Event|31|||
129044322|NCT01134627|464454752|FG000|Overall Study|Lost to Follow-up|1|||
129044323|NCT01134627|464454753|FG001|Overall Study|Lost to Follow-up|2|||
129044324|NCT01134627|464454752|FG000|Overall Study|Protocol Violation|3|||
129044325|NCT01134627|464454753|FG001|Overall Study|Protocol Violation|5|||
129044326|NCT01134627|464454752|FG000|Overall Study|Lack of Efficacy|2|||
129044327|NCT01134627|464454753|FG001|Overall Study|Lack of Efficacy|12|||
129044328|NCT01134627|464454752|FG000|Overall Study|Withdrawal by Subject|4|||
129044329|NCT01134627|464454753|FG001|Overall Study|Withdrawal by Subject|3|||
129044330|NCT01134627|464454752|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
129044331|NCT01134627|464454753|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
129044332|NCT01134627|464454752|FG000|Overall Study|Other|11|||
129044333|NCT01134627|464454753|FG001|Overall Study|Other|14|||
129044334|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
129044335|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
129044336|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
129044337|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
129044338|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
128719232|NCT02608268|463271019|FG000|Overall Study|Death|1|||
129044339|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
129223138|NCT05445843|465118293|FG001|Overall Study|Progressive disease|9|||
129044340|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
129044341|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
129044342|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
129044343|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
129044344|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Subject decision|1|||
129223139|NCT05445843|465118292|FG000|Overall Study|Physician Decision|16|||
129044345|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Subject decision|1|||
129044346|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
129044347|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
129044348|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
129223140|NCT05445843|465118293|FG001|Overall Study|Physician Decision|4|||
128719233|NCT02608268|463271020|FG001|Overall Study|Death|0|||
129044349|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
129223141|NCT05445843|465118292|FG000|Overall Study|Death|6|||
129223142|NCT05445843|465118293|FG001|Overall Study|Death|3|||
129223143|NCT05445843|465118292|FG000|Overall Study|Subject decision|6|||
129223144|NCT05445843|465118293|FG001|Overall Study|Subject decision|2|||
129223145|NCT05445843|465118292|FG000|Overall Study|Adverse Event|2|||
129223146|NCT05445843|465118293|FG001|Overall Study|Adverse Event|0|||
129223147|NCT04469270|465118294|FG000|Overall Study|Adverse Event|2|||
129223148|NCT04469270|465118295|FG001|Overall Study|Adverse Event|0|||
129223149|NCT04469270|465118294|FG000|Overall Study|Lost to Follow-up|4|||
129223150|NCT04469270|465118295|FG001|Overall Study|Lost to Follow-up|3|||
129223151|NCT04469270|465118294|FG000|Overall Study|Withdrawal by Subject|7|||
129223152|NCT04469270|465118295|FG001|Overall Study|Withdrawal by Subject|3|||
129223153|NCT04469270|465118294|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
128719234|NCT02608268|463271021|FG002|Overall Study|Death|0|||
128719235|NCT02608268|463271022|FG003|Overall Study|Death|0|||
128719236|NCT02608268|463271023|FG004|Overall Study|Death|0|||
129044350|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
129044351|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
129044352|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
129044353|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
129044354|NCT00518882|464454759|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
129044355|NCT00518882|464454760|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
129044356|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
129044357|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
129044358|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
129044359|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
129044360|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
129044361|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
129044362|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
129044363|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
129044364|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
129044365|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
129044366|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
129044367|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
129044368|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
129044369|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
129044370|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
129044371|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
129044372|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
129044373|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
129044374|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
129044375|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
129044376|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
129044377|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
129044378|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
129044379|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
129044380|NCT00518882|464454759|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
129044381|NCT00518882|464454760|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
129044382|NCT03395639|464454761|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
129044383|NCT03395639|464454762|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
129044384|NCT03395639|464454763|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
129044385|NCT03395639|464454761|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
129044386|NCT03395639|464454762|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
129044387|NCT03395639|464454763|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
129044388|NCT03395639|464454761|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
129044389|NCT03395639|464454762|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
129044390|NCT03395639|464454763|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
129044391|NCT03395639|464454761|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
129044392|NCT03395639|464454762|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
129044393|NCT03395639|464454763|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
129044394|NCT03395639|464454761|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
129044395|NCT03395639|464454762|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
129044396|NCT03395639|464454763|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
129044397|NCT00942331|464454764|FG000|Overall Study|Did not start treatment|15|||
129044398|NCT00942331|464454765|FG001|Overall Study|Did not start treatment|22|||
129223154|NCT04469270|465118295|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
128719237|NCT02608268|463271024|FG005|Overall Study|Death|0|||
128719238|NCT02608268|463271025|FG006|Overall Study|Death|0|||
129044399|NCT00567476|464454770|FG000|Overall Study|Adverse Event|2|||
129044400|NCT00567476|464454771|FG001|Overall Study|Adverse Event|0|||
129044401|NCT00567476|464454770|FG000|Overall Study|Pregnancy|1|||
129044402|NCT00567476|464454771|FG001|Overall Study|Pregnancy|0|||
129044403|NCT00567476|464454770|FG000|Overall Study|Protocol Violation|4|||
129044404|NCT00567476|464454771|FG001|Overall Study|Protocol Violation|1|||
129044405|NCT00567476|464454770|FG000|Overall Study|Lost to Follow-up|0|||
129044406|NCT00567476|464454771|FG001|Overall Study|Lost to Follow-up|1|||
129044407|NCT00567476|464454770|FG000|Overall Study|Administrative issues|1|||
129135105|NCT01245751|464789103|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
129135106|NCT01245751|464789104|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
129135107|NCT01245751|464789105|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
129135108|NCT00985192|464789106|FG000|Overall Study|Withdrawal by Subject|1|||
129135109|NCT00985192|464789106|FG000|Overall Study|Disease Progression|1|||
129135110|NCT00985192|464789106|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
129135111|NCT00676052|464789109|FG000|Overall Study|Adverse Event|0|||
129135112|NCT00676052|464789110|FG001|Overall Study|Adverse Event|1|||
129135113|NCT00676052|464789111|FG002|Overall Study|Adverse Event|1|||
129135114|NCT00676052|464789112|FG003|Overall Study|Adverse Event|2|||
129135115|NCT00676052|464789113|FG004|Overall Study|Adverse Event|2|||
129135116|NCT00676052|464789114|FG005|Overall Study|Adverse Event|2|||
129135117|NCT00676052|464789109|FG000|Overall Study|Lack of Efficacy|2|||
129135118|NCT00676052|464789110|FG001|Overall Study|Lack of Efficacy|2|||
129135119|NCT00676052|464789111|FG002|Overall Study|Lack of Efficacy|1|||
129135120|NCT00676052|464789112|FG003|Overall Study|Lack of Efficacy|1|||
129135121|NCT00676052|464789113|FG004|Overall Study|Lack of Efficacy|2|||
129135122|NCT00676052|464789114|FG005|Overall Study|Lack of Efficacy|1|||
129135123|NCT00676052|464789109|FG000|Overall Study|Protocol Violation|5|||
129135124|NCT00676052|464789110|FG001|Overall Study|Protocol Violation|3|||
129135125|NCT00676052|464789111|FG002|Overall Study|Protocol Violation|2|||
129135126|NCT00676052|464789112|FG003|Overall Study|Protocol Violation|2|||
129135127|NCT00676052|464789113|FG004|Overall Study|Protocol Violation|1|||
129135128|NCT00676052|464789114|FG005|Overall Study|Protocol Violation|2|||
129135129|NCT00676052|464789109|FG000|Overall Study|Lost to Follow-up|0|||
129135130|NCT00676052|464789110|FG001|Overall Study|Lost to Follow-up|0|||
129135131|NCT00676052|464789111|FG002|Overall Study|Lost to Follow-up|0|||
129135132|NCT00676052|464789112|FG003|Overall Study|Lost to Follow-up|0|||
129135133|NCT00676052|464789113|FG004|Overall Study|Lost to Follow-up|1|||
129135134|NCT00676052|464789114|FG005|Overall Study|Lost to Follow-up|0|||
129135135|NCT00676052|464789109|FG000|Overall Study|Physician Decision|1|||
129135136|NCT00676052|464789110|FG001|Overall Study|Physician Decision|1|||
129135137|NCT00676052|464789111|FG002|Overall Study|Physician Decision|1|||
129135138|NCT00676052|464789112|FG003|Overall Study|Physician Decision|0|||
129135139|NCT00676052|464789113|FG004|Overall Study|Physician Decision|0|||
129135140|NCT00676052|464789114|FG005|Overall Study|Physician Decision|1|||
129135141|NCT00676052|464789109|FG000|Overall Study|Withdrawal by Subject|1|||
129135142|NCT00676052|464789110|FG001|Overall Study|Withdrawal by Subject|0|||
129135143|NCT00676052|464789111|FG002|Overall Study|Withdrawal by Subject|1|||
129135144|NCT00676052|464789112|FG003|Overall Study|Withdrawal by Subject|0|||
129135145|NCT00676052|464789113|FG004|Overall Study|Withdrawal by Subject|0|||
129135146|NCT00676052|464789114|FG005|Overall Study|Withdrawal by Subject|0|||
129135147|NCT01964560|464789128|FG000|Overall Study|Adverse Event|23|||
129135148|NCT01964560|464789128|FG000|Overall Study|Lack of Efficacy|46|||
129135149|NCT01964560|464789128|FG000|Overall Study|Protocol deviation|2|||
129135150|NCT01964560|464789128|FG000|Overall Study|Lost to Follow-up|4|||
129135151|NCT01964560|464789128|FG000|Overall Study|Withdrawal by Subject|64|||
129135152|NCT01964560|464789128|FG000|Overall Study|Surgery-hemispherotomy|1|||
129135153|NCT01964560|464789128|FG000|Overall Study|Surgery|1|||
129135154|NCT01964560|464789128|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
129135155|NCT01964560|464789128|FG000|Overall Study|Patient and Investigator choice|1|||
129135156|NCT01964560|464789128|FG000|Overall Study|Patient was prescribed CBD|1|||
129223155|NCT04469270|465118294|FG000|Overall Study|missing|1|||
128775370|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
128775371|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
128775372|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
128775373|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
129044408|NCT00567476|464454771|FG001|Overall Study|Administrative issues|0|||
129044409|NCT00567476|464454770|FG000|Overall Study|Medical Decision|0|||
129135157|NCT01964560|464789128|FG000|Overall Study|Participant moved to another country|1|||
129135158|NCT00378560|464789129|FG000|Overall Study|Adverse Event|1|||
129135159|NCT00378560|464789130|FG001|Overall Study|Adverse Event|0|||
129135160|NCT00378560|464789129|FG000|Overall Study|Lost to Follow-up|24|||
129135161|NCT00378560|464789130|FG001|Overall Study|Lost to Follow-up|29|||
129135162|NCT00378560|464789129|FG000|Overall Study|Protocol Violation|2|||
129135163|NCT00378560|464789130|FG001|Overall Study|Protocol Violation|0|||
129135164|NCT00378560|464789129|FG000|Overall Study|Withdrawal by Subject|17|||
129135165|NCT00378560|464789130|FG001|Overall Study|Withdrawal by Subject|21|||
129135166|NCT00378560|464789129|FG000|Overall Study|Moved|4|||
129223156|NCT04469270|465118295|FG001|Overall Study|missing|0|||
129044410|NCT00567476|464454771|FG001|Overall Study|Medical Decision|1|||
129044411|NCT00567476|464454770|FG000|Overall Study|Non-adherence to protocol|0|||
129044412|NCT00567476|464454771|FG001|Overall Study|Non-adherence to protocol|1|||
129044413|NCT02696031|464454773|FG000|Up to Week 24|Adverse Event|2|||
129044414|NCT02696031|464454774|FG001|Up to Week 24|Adverse Event|4|||
129044415|NCT02696031|464454775|FG002|Up to Week 24|Adverse Event|2|||
129044416|NCT02696031|464454776|FG003|Up to Week 24|Adverse Event|0|||
129044417|NCT02696031|464454777|FG004|Up to Week 24|Adverse Event|0|||
129044418|NCT02696031|464454778|FG005|Up to Week 24|Adverse Event|0|||
129044419|NCT02696031|464454773|FG000|Up to Week 24|Lack of Efficacy|2|||
129044420|NCT02696031|464454774|FG001|Up to Week 24|Lack of Efficacy|1|||
129044421|NCT02696031|464454775|FG002|Up to Week 24|Lack of Efficacy|2|||
129044422|NCT02696031|464454776|FG003|Up to Week 24|Lack of Efficacy|0|||
129044423|NCT02696031|464454777|FG004|Up to Week 24|Lack of Efficacy|0|||
129044424|NCT02696031|464454778|FG005|Up to Week 24|Lack of Efficacy|0|||
129044425|NCT02696031|464454773|FG000|Up to Week 24|Lost to Follow-up|0|||
129044426|NCT02696031|464454774|FG001|Up to Week 24|Lost to Follow-up|1|||
129044427|NCT02696031|464454775|FG002|Up to Week 24|Lost to Follow-up|1|||
129044428|NCT02696031|464454776|FG003|Up to Week 24|Lost to Follow-up|0|||
129044429|NCT02696031|464454777|FG004|Up to Week 24|Lost to Follow-up|0|||
129044430|NCT02696031|464454778|FG005|Up to Week 24|Lost to Follow-up|0|||
129044431|NCT02696031|464454773|FG000|Up to Week 24|Physician Decision|1|||
129044432|NCT02696031|464454774|FG001|Up to Week 24|Physician Decision|0|||
129044433|NCT02696031|464454775|FG002|Up to Week 24|Physician Decision|1|||
129044434|NCT02696031|464454776|FG003|Up to Week 24|Physician Decision|0|||
129044435|NCT02696031|464454777|FG004|Up to Week 24|Physician Decision|0|||
129044436|NCT02696031|464454778|FG005|Up to Week 24|Physician Decision|0|||
129044437|NCT02696031|464454773|FG000|Up to Week 24|Protocol Violation|1|||
129044438|NCT02696031|464454774|FG001|Up to Week 24|Protocol Violation|0|||
129044439|NCT02696031|464454775|FG002|Up to Week 24|Protocol Violation|0|||
129044440|NCT02696031|464454776|FG003|Up to Week 24|Protocol Violation|0|||
129044441|NCT02696031|464454777|FG004|Up to Week 24|Protocol Violation|0|||
129044442|NCT02696031|464454778|FG005|Up to Week 24|Protocol Violation|0|||
129044443|NCT02696031|464454773|FG000|Up to Week 24|Withdrawal by Subject|4|||
129044444|NCT02696031|464454774|FG001|Up to Week 24|Withdrawal by Subject|1|||
129044445|NCT02696031|464454775|FG002|Up to Week 24|Withdrawal by Subject|5|||
129044446|NCT02696031|464454776|FG003|Up to Week 24|Withdrawal by Subject|0|||
129044447|NCT02696031|464454777|FG004|Up to Week 24|Withdrawal by Subject|0|||
129044448|NCT02696031|464454778|FG005|Up to Week 24|Withdrawal by Subject|0|||
129044449|NCT02696031|464454773|FG000|Up to Week 52|Adverse Event|4|||
129044450|NCT02696031|464454774|FG001|Up to Week 52|Adverse Event|5|||
129044451|NCT02696031|464454775|FG002|Up to Week 52|Adverse Event|3|||
129044452|NCT02696031|464454776|FG003|Up to Week 52|Adverse Event|0|||
129044453|NCT02696031|464454777|FG004|Up to Week 52|Adverse Event|0|||
129044454|NCT02696031|464454778|FG005|Up to Week 52|Adverse Event|0|||
129044455|NCT02696031|464454773|FG000|Up to Week 52|Lack of Efficacy|10|||
129044456|NCT02696031|464454774|FG001|Up to Week 52|Lack of Efficacy|7|||
129044457|NCT02696031|464454775|FG002|Up to Week 52|Lack of Efficacy|11|||
129044458|NCT02696031|464454776|FG003|Up to Week 52|Lack of Efficacy|0|||
129044459|NCT02696031|464454777|FG004|Up to Week 52|Lack of Efficacy|0|||
129044460|NCT02696031|464454778|FG005|Up to Week 52|Lack of Efficacy|0|||
129044461|NCT02696031|464454773|FG000|Up to Week 52|Lost to Follow-up|1|||
129044462|NCT02696031|464454774|FG001|Up to Week 52|Lost to Follow-up|1|||
129044463|NCT02696031|464454775|FG002|Up to Week 52|Lost to Follow-up|1|||
129135167|NCT00378560|464789130|FG001|Overall Study|Moved|3|||
129135168|NCT00378560|464789129|FG000|Overall Study|Pregnancy|7|||
128719239|NCT02608268|463271026|FG007|Overall Study|Death|0|||
128719240|NCT02608268|463271027|FG008|Overall Study|Death|1|||
128719241|NCT02608268|463271028|FG009|Overall Study|Death|1|||
128719242|NCT02608268|463271029|FG010|Overall Study|Death|0|||
129044464|NCT02696031|464454776|FG003|Up to Week 52|Lost to Follow-up|0|||
129044465|NCT02696031|464454777|FG004|Up to Week 52|Lost to Follow-up|0|||
129135169|NCT00378560|464789130|FG001|Overall Study|Pregnancy|5|||
129135170|NCT00378560|464789129|FG000|Overall Study|Laboratory test values abnormal|1|||
129044466|NCT02696031|464454778|FG005|Up to Week 52|Lost to Follow-up|0|||
129044467|NCT02696031|464454773|FG000|Up to Week 52|Physician Decision|1|||
129135171|NCT00378560|464789130|FG001|Overall Study|Laboratory test values abnormal|0|||
129135172|NCT02565186|464789131|FG000|Overall Study|Adverse Event|113|||
128719243|NCT02608268|463271030|FG011|Overall Study|Death|0|||
128719244|NCT02608268|463271031|FG012|Overall Study|Death|0|||
129044468|NCT02696031|464454774|FG001|Up to Week 52|Physician Decision|1|||
129044469|NCT02696031|464454775|FG002|Up to Week 52|Physician Decision|2|||
129044470|NCT02696031|464454776|FG003|Up to Week 52|Physician Decision|0|||
129044471|NCT02696031|464454777|FG004|Up to Week 52|Physician Decision|0|||
129044472|NCT02696031|464454778|FG005|Up to Week 52|Physician Decision|0|||
129044473|NCT02696031|464454773|FG000|Up to Week 52|Pregnancy|0|||
129044474|NCT02696031|464454774|FG001|Up to Week 52|Pregnancy|2|||
129044475|NCT02696031|464454775|FG002|Up to Week 52|Pregnancy|0|||
129044476|NCT02696031|464454776|FG003|Up to Week 52|Pregnancy|0|||
129044477|NCT02696031|464454777|FG004|Up to Week 52|Pregnancy|0|||
129135173|NCT02565186|464789132|FG001|Overall Study|Adverse Event|148|||
129044478|NCT02696031|464454778|FG005|Up to Week 52|Pregnancy|0|||
129044479|NCT02696031|464454773|FG000|Up to Week 52|Protocol Violation|1|||
129044480|NCT02696031|464454774|FG001|Up to Week 52|Protocol Violation|0|||
129044481|NCT02696031|464454775|FG002|Up to Week 52|Protocol Violation|0|||
129044482|NCT02696031|464454776|FG003|Up to Week 52|Protocol Violation|0|||
129044483|NCT02696031|464454777|FG004|Up to Week 52|Protocol Violation|0|||
129044484|NCT02696031|464454778|FG005|Up to Week 52|Protocol Violation|0|||
129044485|NCT02696031|464454773|FG000|Up to Week 52|Withdrawal by Subject|12|||
129044486|NCT02696031|464454774|FG001|Up to Week 52|Withdrawal by Subject|3|||
129044487|NCT02696031|464454775|FG002|Up to Week 52|Withdrawal by Subject|9|||
129044488|NCT02696031|464454776|FG003|Up to Week 52|Withdrawal by Subject|0|||
129044489|NCT02696031|464454777|FG004|Up to Week 52|Withdrawal by Subject|0|||
129044490|NCT02696031|464454778|FG005|Up to Week 52|Withdrawal by Subject|0|||
129044491|NCT02696031|464454773|FG000|Up to Week 104|Pregnancy|0|||
129044492|NCT02696031|464454774|FG001|Up to Week 104|Pregnancy|2|||
129044493|NCT02696031|464454775|FG002|Up to Week 104|Pregnancy|1|||
129044494|NCT02696031|464454776|FG003|Up to Week 104|Pregnancy|0|||
129044495|NCT02696031|464454777|FG004|Up to Week 104|Pregnancy|0|||
129044496|NCT02696031|464454778|FG005|Up to Week 104|Pregnancy|0|||
129044497|NCT02696031|464454773|FG000|Up to Week 104|Withdrawal by Subject|15|||
129044498|NCT02696031|464454774|FG001|Up to Week 104|Withdrawal by Subject|10|||
129044499|NCT02696031|464454775|FG002|Up to Week 104|Withdrawal by Subject|16|||
129044500|NCT02696031|464454776|FG003|Up to Week 104|Withdrawal by Subject|0|||
129044501|NCT02696031|464454777|FG004|Up to Week 104|Withdrawal by Subject|0|||
129044502|NCT02696031|464454778|FG005|Up to Week 104|Withdrawal by Subject|0|||
129044503|NCT02696031|464454773|FG000|Up to Week 104|Protocol Violation|1|||
129044504|NCT02696031|464454774|FG001|Up to Week 104|Protocol Violation|0|||
129044505|NCT02696031|464454775|FG002|Up to Week 104|Protocol Violation|0|||
129044506|NCT02696031|464454776|FG003|Up to Week 104|Protocol Violation|0|||
129044507|NCT02696031|464454777|FG004|Up to Week 104|Protocol Violation|0|||
129044508|NCT02696031|464454778|FG005|Up to Week 104|Protocol Violation|0|||
129044509|NCT02696031|464454773|FG000|Up to Week 104|Physician Decision|1|||
129044510|NCT02696031|464454774|FG001|Up to Week 104|Physician Decision|2|||
129044511|NCT02696031|464454775|FG002|Up to Week 104|Physician Decision|3|||
129044512|NCT02696031|464454776|FG003|Up to Week 104|Physician Decision|0|||
129044513|NCT02696031|464454777|FG004|Up to Week 104|Physician Decision|0|||
129044514|NCT02696031|464454778|FG005|Up to Week 104|Physician Decision|0|||
129044515|NCT02696031|464454773|FG000|Up to Week 104|Lost to Follow-up|2|||
129044516|NCT02696031|464454774|FG001|Up to Week 104|Lost to Follow-up|3|||
129044517|NCT02696031|464454775|FG002|Up to Week 104|Lost to Follow-up|1|||
129044518|NCT02696031|464454776|FG003|Up to Week 104|Lost to Follow-up|0|||
129044519|NCT02696031|464454777|FG004|Up to Week 104|Lost to Follow-up|0|||
129044520|NCT02696031|464454778|FG005|Up to Week 104|Lost to Follow-up|0|||
129044521|NCT02696031|464454773|FG000|Up to Week 104|Lack of Efficacy|13|||
129044522|NCT02696031|464454774|FG001|Up to Week 104|Lack of Efficacy|12|||
129044523|NCT02696031|464454775|FG002|Up to Week 104|Lack of Efficacy|11|||
129044524|NCT02696031|464454776|FG003|Up to Week 104|Lack of Efficacy|0|||
129044525|NCT02696031|464454777|FG004|Up to Week 104|Lack of Efficacy|0|||
129044526|NCT02696031|464454778|FG005|Up to Week 104|Lack of Efficacy|0|||
129044527|NCT02696031|464454773|FG000|Up to Week 104|Adverse Event|7|||
129044528|NCT02696031|464454774|FG001|Up to Week 104|Adverse Event|11|||
129044529|NCT02696031|464454775|FG002|Up to Week 104|Adverse Event|5|||
129044530|NCT02696031|464454776|FG003|Up to Week 104|Adverse Event|0|||
129044531|NCT02696031|464454777|FG004|Up to Week 104|Adverse Event|0|||
129044532|NCT02696031|464454778|FG005|Up to Week 104|Adverse Event|0|||
129044533|NCT02696031|464454773|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129044534|NCT02696031|464454774|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
129135174|NCT02565186|464789131|FG000|Overall Study|Lost to Follow-up|102|||
129135175|NCT02565186|464789132|FG001|Overall Study|Lost to Follow-up|93|||
129044535|NCT02696031|464454775|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129044536|NCT02696031|464454776|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129044537|NCT02696031|464454777|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129044538|NCT02696031|464454778|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129044539|NCT02696031|464454773|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
129044540|NCT02696031|464454774|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
129044541|NCT02696031|464454775|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
129044542|NCT02696031|464454776|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
129135176|NCT02565186|464789131|FG000|Overall Study|Non-Compliance|57|||
129135177|NCT02565186|464789132|FG001|Overall Study|Non-Compliance|55|||
129044543|NCT02696031|464454777|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
129044544|NCT02696031|464454778|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
129044545|NCT02696031|464454773|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129044546|NCT02696031|464454774|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129044547|NCT02696031|464454775|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129135178|NCT02565186|464789131|FG000|Overall Study|Withdrawal by Subject|229|||
129135179|NCT02565186|464789132|FG001|Overall Study|Withdrawal by Subject|214|||
129135180|NCT02565186|464789131|FG000|Overall Study|Physician Decision|18|||
129135181|NCT02565186|464789132|FG001|Overall Study|Physician Decision|16|||
129135182|NCT02565186|464789131|FG000|Overall Study|Sponsor Request|5|||
129135183|NCT02565186|464789132|FG001|Overall Study|Sponsor Request|9|||
129135184|NCT02565186|464789131|FG000|Overall Study|Missing|1|||
129135185|NCT02565186|464789132|FG001|Overall Study|Missing|0|||
129135186|NCT02565186|464789131|FG000|Overall Study|Did Not Receive Study Drug|55|||
129135187|NCT02565186|464789132|FG001|Overall Study|Did Not Receive Study Drug|86|||
129135188|NCT01145222|464789133|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
129135189|NCT01145222|464789134|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
129135190|NCT01145222|464789135|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
129135191|NCT01145222|464789136|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
129135192|NCT01145222|464789133|FG000|Overall Study|Poor bowel preparation|0|||
129135193|NCT01145222|464789134|FG001|Overall Study|Poor bowel preparation|0|||
129135194|NCT01145222|464789135|FG002|Overall Study|Poor bowel preparation|0|||
129135195|NCT01145222|464789136|FG003|Overall Study|Poor bowel preparation|1|||
129135196|NCT01011283|464789138|FG000|Overall Study|Adverse Event|4|||
129044548|NCT02696031|464454776|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
129044549|NCT02696031|464454777|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
129044550|NCT02696031|464454778|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129044551|NCT02696031|464454773|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129044552|NCT02696031|464454774|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129044553|NCT02696031|464454775|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129044554|NCT02696031|464454776|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
129044555|NCT02696031|464454777|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129044556|NCT02696031|464454778|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129044557|NCT02696031|464454773|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129044558|NCT02696031|464454774|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129044559|NCT02696031|464454775|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129044560|NCT02696031|464454776|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129044561|NCT02696031|464454777|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
129044562|NCT02696031|464454778|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129044563|NCT02696031|464454773|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
129044564|NCT02696031|464454774|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
129044565|NCT02696031|464454775|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
129044566|NCT02696031|464454776|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
129044567|NCT02696031|464454777|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
129044568|NCT02696031|464454778|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
129044569|NCT02696031|464454773|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
129044570|NCT02696031|464454774|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
129044571|NCT02696031|464454775|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
129044572|NCT02696031|464454776|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
129044573|NCT02696031|464454777|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
129044574|NCT02696031|464454778|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
129044575|NCT00597116|464454779|FG000|Overall Study|Adverse Event|2|||
129044576|NCT00597116|464454780|FG001|Overall Study|Adverse Event|1|||
129044577|NCT00597116|464454779|FG000|Overall Study|Withdrawal by Subject|0|||
129135197|NCT01011283|464789139|FG001|Overall Study|Adverse Event|2|||
129135198|NCT01011283|464789138|FG000|Overall Study|Progressive Disease|0|||
129135199|NCT01011283|464789139|FG001|Overall Study|Progressive Disease|2|||
129135200|NCT01011283|464789138|FG000|Overall Study|Terminated by Sponsor|5|||
129135201|NCT01011283|464789139|FG001|Overall Study|Terminated by Sponsor|5|||
129135202|NCT01011283|464789138|FG000|Overall Study|Other|2|||
129135203|NCT01011283|464789139|FG001|Overall Study|Other|2|||
129135204|NCT04865978|464789143|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
129135205|NCT04865978|464789144|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
129135206|NCT03835117|464789145|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
129135207|NCT03835117|464789146|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
129135208|NCT01543503|464789150|FG000|Overall Study|Lost to Follow-up|32|||
128719245|NCT02608268|463271032|FG013|Overall Study|Death|0|||
128719246|NCT02608268|463271033|FG014|Overall Study|Death|0|||
128719247|NCT02608268|463271034|FG015|Overall Study|Death|1|||
129044578|NCT00597116|464454780|FG001|Overall Study|Withdrawal by Subject|2|||
128719248|NCT02608268|463271035|FG016|Overall Study|Death|0|||
128719249|NCT02608268|463271036|FG017|Overall Study|Death|1|||
128719250|NCT02608268|463271037|FG018|Overall Study|Death|0|||
129135209|NCT01543503|464789151|FG001|Overall Study|Lost to Follow-up|36|||
129135210|NCT01543503|464789150|FG000|Overall Study|Adverse Event|9|||
129135211|NCT01543503|464789151|FG001|Overall Study|Adverse Event|13|||
129135212|NCT01543503|464789150|FG000|Overall Study|Lack of Efficacy|4|||
129135213|NCT01543503|464789151|FG001|Overall Study|Lack of Efficacy|16|||
129044579|NCT00597116|464454779|FG000|Overall Study|Physician Decision|0|||
129044580|NCT00597116|464454780|FG001|Overall Study|Physician Decision|1|||
129044581|NCT00597116|464454779|FG000|Overall Study|Death|0|||
129044582|NCT00597116|464454780|FG001|Overall Study|Death|1|||
129044583|NCT00597116|464454779|FG000|Overall Study|Lost to Follow-up|1|||
129044584|NCT00597116|464454780|FG001|Overall Study|Lost to Follow-up|0|||
129044585|NCT00597116|464454779|FG000|Overall Study|Progressive disease|11|||
129044586|NCT00597116|464454780|FG001|Overall Study|Progressive disease|6|||
129044587|NCT01901874|464454783|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
129044588|NCT01901874|464454783|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
129044589|NCT01901874|464454783|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
129044590|NCT01901874|464454783|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
129044591|NCT01901874|464454783|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
129044592|NCT01901874|464454783|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
129044593|NCT03978091|464454784|FG000|Overall Study|Lost to Follow-up|0|||
129044594|NCT03978091|464454785|FG001|Overall Study|Lost to Follow-up|0|||
129044595|NCT03978091|464454786|FG002|Overall Study|Lost to Follow-up|1|||
129044596|NCT03978091|464454787|FG003|Overall Study|Lost to Follow-up|0|||
129044597|NCT03978091|464454788|FG004|Overall Study|Lost to Follow-up|0|||
129044598|NCT03978091|464454789|FG005|Overall Study|Lost to Follow-up|0|||
129044599|NCT03978091|464454784|FG000|Overall Study|Withdrawal by Subject|0|||
129044600|NCT03978091|464454785|FG001|Overall Study|Withdrawal by Subject|0|||
129044601|NCT03978091|464454786|FG002|Overall Study|Withdrawal by Subject|0|||
129044602|NCT03978091|464454787|FG003|Overall Study|Withdrawal by Subject|1|||
129044603|NCT03978091|464454788|FG004|Overall Study|Withdrawal by Subject|1|||
129044604|NCT03978091|464454789|FG005|Overall Study|Withdrawal by Subject|0|||
129044605|NCT02595008|464454794|FG000|Overall Study|Enrolled In Error|1|||
129044606|NCT02595008|464454795|FG001|Overall Study|Enrolled In Error|0|||
129223157|NCT05420012|465118296|FG000|Overall Study|Lost to Follow-up|0|||
129223158|NCT05420012|465118297|FG001|Overall Study|Lost to Follow-up|1|||
129223159|NCT03947684|465118301|FG000|Overall Study|Lost to Follow-up|13|||
129223160|NCT03947684|465118302|FG001|Overall Study|Lost to Follow-up|5|||
129223161|NCT03947684|465118303|FG002|Overall Study|Lost to Follow-up|1|||
129223162|NCT03947684|465118301|FG000|Overall Study|Withdrawal by Subject|11|||
129223163|NCT03947684|465118302|FG001|Overall Study|Withdrawal by Subject|4|||
129223164|NCT03947684|465118303|FG002|Overall Study|Withdrawal by Subject|0|||
129223165|NCT03947684|465118301|FG000|Overall Study|Physician Decision|1|||
129223166|NCT03947684|465118302|FG001|Overall Study|Physician Decision|0|||
129223167|NCT03947684|465118303|FG002|Overall Study|Physician Decision|0|||
129223168|NCT03947684|465118301|FG000|Overall Study|Lack of adherence to study protocol|2|||
129223169|NCT03947684|465118302|FG001|Overall Study|Lack of adherence to study protocol|0|||
129223170|NCT03947684|465118303|FG002|Overall Study|Lack of adherence to study protocol|0|||
129223171|NCT04576455|465118304|FG000|Overall Study|Ongoing in the Study|48|||
129223172|NCT04576455|465118305|FG001|Overall Study|Ongoing in the Study|58|||
129223173|NCT04576455|465118304|FG000|Overall Study|Death|83|||
129223174|NCT04576455|465118305|FG001|Overall Study|Death|77|||
129223175|NCT04576455|465118304|FG000|Overall Study|Lost to Follow-up|4|||
129223176|NCT04576455|465118305|FG001|Overall Study|Lost to Follow-up|5|||
129223177|NCT04576455|465118304|FG000|Overall Study|Withdrawal by Subject|16|||
129044607|NCT03078582|464454803|FG000|Overall Study|Adverse Event|0|||
129044608|NCT03078582|464454804|FG001|Overall Study|Adverse Event|8|||
129044609|NCT01843348|464454807|FG000|Overall Study|Withdrawal by Subject|4|||
129044610|NCT01843348|464454808|FG001|Overall Study|Withdrawal by Subject|16|||
129044611|NCT01843348|464454809|FG002|Overall Study|Withdrawal by Subject|18|||
129044612|NCT01843348|464454807|FG000|Overall Study|Lost to Follow-up|5|||
129044613|NCT01843348|464454808|FG001|Overall Study|Lost to Follow-up|4|||
129044614|NCT01843348|464454809|FG002|Overall Study|Lost to Follow-up|2|||
129044615|NCT01843348|464454807|FG000|Overall Study|Death|5|||
129044616|NCT01843348|464454808|FG001|Overall Study|Death|3|||
129044617|NCT01843348|464454809|FG002|Overall Study|Death|4|||
129044618|NCT01843348|464454807|FG000|Overall Study|Graft loss/retransplantation|5|||
129223178|NCT04576455|465118305|FG001|Overall Study|Withdrawal by Subject|12|||
129223179|NCT03253744|465118306|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
129223180|NCT03253744|465118307|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
129223181|NCT03253744|465118308|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
128719251|NCT02608268|463271038|FG019|Overall Study|Death|1|||
129223182|NCT03253744|465118309|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
129223183|NCT04134845|465118310|FG000|Overall Study|withdrawl by PI|5|||
128719252|NCT02608268|463271039|FG020|Overall Study|Death|1|||
129044619|NCT01843348|464454808|FG001|Overall Study|Graft loss/retransplantation|8|||
129044620|NCT01843348|464454809|FG002|Overall Study|Graft loss/retransplantation|11|||
129044621|NCT01843348|464454807|FG000|Overall Study|Various reasons|4|||
129044622|NCT01843348|464454808|FG001|Overall Study|Various reasons|9|||
129044623|NCT01843348|464454809|FG002|Overall Study|Various reasons|6|||
129044624|NCT02039414|464454818|FG000|Overall Study|Delivered|1|||
129044625|NCT02039414|464454819|FG001|Overall Study|Delivered|1|||
129044626|NCT02039414|464454818|FG000|Overall Study|Lost to Follow-up|2|||
129044627|NCT02039414|464454819|FG001|Overall Study|Lost to Follow-up|0|||
129044628|NCT02039414|464454818|FG000|Overall Study|Protocol Violation|3|||
129044629|NCT02039414|464454819|FG001|Overall Study|Protocol Violation|1|||
129044630|NCT03832738|464454820|FG000|Overall Study|Withdrawal by Subject|6|||
129044631|NCT03832738|464454821|FG001|Overall Study|Withdrawal by Subject|7|||
129044632|NCT03832738|464454822|FG002|Overall Study|Withdrawal by Subject|16|||
129044633|NCT03832738|464454820|FG000|Overall Study|Physician Decision|0|||
129044634|NCT03832738|464454821|FG001|Overall Study|Physician Decision|1|||
129044635|NCT03832738|464454822|FG002|Overall Study|Physician Decision|2|||
129044636|NCT03832738|464454820|FG000|Overall Study|Adverse Event|2|||
129044637|NCT03832738|464454821|FG001|Overall Study|Adverse Event|3|||
129044638|NCT03832738|464454822|FG002|Overall Study|Adverse Event|1|||
129044639|NCT03832738|464454820|FG000|Overall Study|Pregnancy|0|||
129044640|NCT03832738|464454821|FG001|Overall Study|Pregnancy|1|||
129044641|NCT03832738|464454822|FG002|Overall Study|Pregnancy|0|||
129044642|NCT03977701|464454823|FG000|Overall Study|COVID-19 pandemic|0|||
129044643|NCT03977701|464454824|FG001|Overall Study|COVID-19 pandemic|0|||
129044644|NCT03977701|464454825|FG002|Overall Study|COVID-19 pandemic|0|||
129044645|NCT03977701|464454826|FG003|Overall Study|COVID-19 pandemic|0|||
129044646|NCT03977701|464454827|FG004|Overall Study|COVID-19 pandemic|0|||
129044647|NCT03977701|464454828|FG005|Overall Study|COVID-19 pandemic|1|||
129044648|NCT03977701|464454829|FG006|Overall Study|COVID-19 pandemic|0|||
129044649|NCT03977701|464454830|FG007|Overall Study|COVID-19 pandemic|1|||
129044650|NCT03977701|464454831|FG008|Overall Study|COVID-19 pandemic|0|||
129044651|NCT03977701|464454832|FG009|Overall Study|COVID-19 pandemic|0|||
129044652|NCT00869024|464454833|FG000|Overall Study|Death|2|||
129044653|NCT00869024|464454834|FG001|Overall Study|Death|3|||
129044654|NCT00869024|464454833|FG000|Overall Study|Lost to Follow-up|0|||
129044655|NCT00869024|464454834|FG001|Overall Study|Lost to Follow-up|1|||
129044656|NCT00869024|464454833|FG000|Overall Study|Protocol Violation|0|||
129044657|NCT00869024|464454834|FG001|Overall Study|Protocol Violation|1|||
129044658|NCT00831623|464454838|FG000|Overall Study|Withdrawal by Subject|9|||
129044659|NCT00831623|464454838|FG000|Overall Study|Lost to Follow-up|1|||
129044660|NCT00831623|464454838|FG000|Overall Study|Not 2 years post-treatment|12|||
129044661|NCT01564459|464454842|FG000|Run-In|Adverse Event|7|||
129044662|NCT01564459|464454843|FG001|Run-In|Adverse Event|0|||
129044663|NCT01564459|464454844|FG002|Run-In|Adverse Event|0|||
129044664|NCT01564459|464454842|FG000|Run-In|Lost to Follow-up|1|||
129044665|NCT01564459|464454843|FG001|Run-In|Lost to Follow-up|0|||
129044666|NCT01564459|464454844|FG002|Run-In|Lost to Follow-up|0|||
129044667|NCT01564459|464454842|FG000|Run-In|Non-compliance with study drug|2|||
129044668|NCT01564459|464454843|FG001|Run-In|Non-compliance with study drug|0|||
129044669|NCT01564459|464454844|FG002|Run-In|Non-compliance with study drug|0|||
129044670|NCT01564459|464454842|FG000|Run-In|Protocol Violation|1|||
129044671|NCT01564459|464454843|FG001|Run-In|Protocol Violation|0|||
129044672|NCT01564459|464454844|FG002|Run-In|Protocol Violation|0|||
129223184|NCT04134845|465118311|FG001|Overall Study|withdrawl by PI|12|||
129044673|NCT01564459|464454842|FG000|Run-In|Withdrawal by Subject|1|||
129044674|NCT01564459|464454843|FG001|Run-In|Withdrawal by Subject|0|||
129044675|NCT01564459|464454844|FG002|Run-In|Withdrawal by Subject|0|||
129044676|NCT01564459|464454842|FG000|Double-blind Treatment|Adverse Event|0|||
129044677|NCT01564459|464454843|FG001|Double-blind Treatment|Adverse Event|0|||
129044678|NCT01564459|464454844|FG002|Double-blind Treatment|Adverse Event|1|||
129044679|NCT01138111|464454850|FG000|Overall Study|Withdrawal by Subject|5|||
129044680|NCT01138111|464454850|FG000|Overall Study|Adverse Event|1|||
129044681|NCT01138111|464454850|FG000|Overall Study|Death|1|||
129044682|NCT01138111|464454850|FG000|Overall Study|Lost to Follow-up|2|||
129044683|NCT00653991|464454851|FG000|3 Month Follow-up|Participant would not respond|150|||
129044684|NCT00653991|464454852|FG001|3 Month Follow-up|Participant would not respond|157|||
129044685|NCT00653991|464454851|FG000|6 Month Follow-up|Participant would not respond|133|||
129044686|NCT00653991|464454852|FG001|6 Month Follow-up|Participant would not respond|141|||
129044687|NCT02939014|464454855|FG000|Overall Study|Lost to Follow-up|1|||
129044688|NCT02939014|464454856|FG001|Overall Study|Lost to Follow-up|0|||
129044689|NCT02939014|464454855|FG000|Overall Study|Death|4|||
129044690|NCT02939014|464454856|FG001|Overall Study|Death|3|||
129044691|NCT00588640|464454859|FG000|Overall Study|Physician Decision|1|||
129044692|NCT00588640|464454859|FG000|Overall Study|Ineligible Patient|1|||
129044693|NCT03334721|464454860|FG000|Overall Study|Withdrawal by Subject|1|||
129044694|NCT03334721|464454861|FG001|Overall Study|Withdrawal by Subject|0|||
129044695|NCT03334721|464454860|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
129044696|NCT03334721|464454861|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
129044697|NCT04718194|464456742|FG000|Overall Study|Withdrawal by Subject|3|||
129044698|NCT04718194|464456743|FG001|Overall Study|Withdrawal by Subject|0|||
129044699|NCT04718194|464456742|FG000|Overall Study|Lost to Follow-up|3|||
129044700|NCT04718194|464456743|FG001|Overall Study|Lost to Follow-up|0|||
129044701|NCT02091141|464456745|FG000|Overall Study|Death|280|||
129044702|NCT02091141|464456746|FG001|Overall Study|Death|118|||
129044703|NCT02091141|464456747|FG002|Overall Study|Death|46|||
129044704|NCT02091141|464456748|FG003|Overall Study|Death|13|||
129044705|NCT02091141|464456749|FG004|Overall Study|Death|31|||
129044706|NCT02091141|464456750|FG005|Overall Study|Death|16|||
129223185|NCT02253316|465118312|FG000|Consolidation|Progression|4|||
129044707|NCT02091141|464456751|FG006|Overall Study|Death|12|||
129044708|NCT02091141|464456745|FG000|Overall Study|Withdrawal by Subject|21|||
129044709|NCT02091141|464456746|FG001|Overall Study|Withdrawal by Subject|13|||
129044710|NCT02091141|464456747|FG002|Overall Study|Withdrawal by Subject|3|||
129044711|NCT02091141|464456748|FG003|Overall Study|Withdrawal by Subject|2|||
129044712|NCT02091141|464456749|FG004|Overall Study|Withdrawal by Subject|2|||
129044713|NCT02091141|464456750|FG005|Overall Study|Withdrawal by Subject|3|||
129044714|NCT02091141|464456751|FG006|Overall Study|Withdrawal by Subject|0|||
129044715|NCT02091141|464456745|FG000|Overall Study|Lost to Follow-up|21|||
129044716|NCT02091141|464456746|FG001|Overall Study|Lost to Follow-up|5|||
129044717|NCT02091141|464456747|FG002|Overall Study|Lost to Follow-up|1|||
129044718|NCT02091141|464456748|FG003|Overall Study|Lost to Follow-up|0|||
129044719|NCT02091141|464456749|FG004|Overall Study|Lost to Follow-up|1|||
129044720|NCT02091141|464456750|FG005|Overall Study|Lost to Follow-up|2|||
129044721|NCT02091141|464456751|FG006|Overall Study|Lost to Follow-up|0|||
129044722|NCT02091141|464456745|FG000|Overall Study|Reason Not Specified|6|||
129044723|NCT02091141|464456746|FG001|Overall Study|Reason Not Specified|5|||
129044724|NCT02091141|464456747|FG002|Overall Study|Reason Not Specified|2|||
129044725|NCT02091141|464456748|FG003|Overall Study|Reason Not Specified|0|||
128719253|NCT02608268|463271040|FG021|Overall Study|Death|0|||
128719254|NCT02608268|463271041|FG022|Overall Study|Death|0|||
128719255|NCT02608268|463271042|FG023|Overall Study|Death|0|||
128719256|NCT02608268|463271043|FG024|Overall Study|Death|1|||
128719257|NCT02608268|463271044|FG025|Overall Study|Death|2|||
129044726|NCT02091141|464456749|FG004|Overall Study|Reason Not Specified|0|||
129044727|NCT02091141|464456750|FG005|Overall Study|Reason Not Specified|0|||
129044728|NCT02091141|464456751|FG006|Overall Study|Reason Not Specified|1|||
129044729|NCT02091141|464456745|FG000|Overall Study|Study Ended by Sponsor|1|||
129044730|NCT02091141|464456746|FG001|Overall Study|Study Ended by Sponsor|9|||
129044731|NCT02091141|464456747|FG002|Overall Study|Study Ended by Sponsor|0|||
129044732|NCT02091141|464456748|FG003|Overall Study|Study Ended by Sponsor|0|||
129044733|NCT02091141|464456749|FG004|Overall Study|Study Ended by Sponsor|0|||
129044734|NCT02091141|464456750|FG005|Overall Study|Study Ended by Sponsor|0|||
129044735|NCT02091141|464456751|FG006|Overall Study|Study Ended by Sponsor|0|||
129044736|NCT02091141|464456745|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
129044737|NCT02091141|464456746|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
129044738|NCT02091141|464456747|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
128719258|NCT02608268|463271045|FG026|Overall Study|Death|0|||
129044739|NCT02091141|464456748|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
129044740|NCT02091141|464456749|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
129044741|NCT02091141|464456750|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
129044742|NCT02091141|464456751|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
129044743|NCT02246439|464456752|FG000|Overall Study|Adverse Event|3|||
129044744|NCT02246439|464456753|FG001|Overall Study|Adverse Event|0|||
129044745|NCT02246439|464456752|FG000|Overall Study|Lost to Follow-up|7|||
129044746|NCT02246439|464456753|FG001|Overall Study|Lost to Follow-up|5|||
129044747|NCT02246439|464456752|FG000|Overall Study|Protocol Violation|0|||
129044748|NCT02246439|464456753|FG001|Overall Study|Protocol Violation|2|||
129044749|NCT02246439|464456752|FG000|Overall Study|Physician Decision|0|||
129044750|NCT02246439|464456753|FG001|Overall Study|Physician Decision|1|||
129044751|NCT02246439|464456752|FG000|Overall Study|Unkonwn|1|||
129044752|NCT02246439|464456753|FG001|Overall Study|Unkonwn|3|||
129044753|NCT02246439|464456752|FG000|Overall Study|Withdrawal by Subject|1|||
128719259|NCT02608268|463271046|FG027|Overall Study|Death|1|||
129044754|NCT02246439|464456753|FG001|Overall Study|Withdrawal by Subject|0|||
129044755|NCT03439852|464456754|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
128719260|NCT02608268|463271047|FG028|Overall Study|Death|4|||
128719261|NCT02608268|463271048|FG029|Overall Study|Death|0|||
128719262|NCT02608268|463271019|FG000|Overall Study|Physician Decision|0|||
128719263|NCT02608268|463271020|FG001|Overall Study|Physician Decision|0|||
128719264|NCT02608268|463271021|FG002|Overall Study|Physician Decision|0|||
128719265|NCT02608268|463271022|FG003|Overall Study|Physician Decision|0|||
129044756|NCT03439852|464456755|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
129044757|NCT03439852|464456754|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
129044758|NCT03439852|464456755|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
129044759|NCT03439852|464456754|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
129044760|NCT03439852|464456755|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
129044761|NCT01553279|464456756|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
129135214|NCT01543503|464789150|FG000|Overall Study|Participant withdrew informed consent|8|||
128719266|NCT02608268|463271023|FG004|Overall Study|Physician Decision|0|||
128719267|NCT02608268|463271024|FG005|Overall Study|Physician Decision|0|||
128775374|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
129044762|NCT01553279|464456757|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
128719268|NCT02608268|463271025|FG006|Overall Study|Physician Decision|0|||
128719269|NCT02608268|463271026|FG007|Overall Study|Physician Decision|0|||
129044763|NCT01553279|464456756|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
129044764|NCT01553279|464456757|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
129044765|NCT01553279|464456756|FG000|Interim Period|Withdrawal by Subject|2|||
129044766|NCT01553279|464456757|FG001|Interim Period|Withdrawal by Subject|2|||
129044767|NCT01553279|464456756|FG000|Interim Period|Lost to Follow-up|1|||
129044768|NCT01553279|464456757|FG001|Interim Period|Lost to Follow-up|0|||
129044769|NCT01553279|464456756|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
129044770|NCT01553279|464456757|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
129044771|NCT01553279|464456756|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
129044772|NCT01553279|464456757|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
129044773|NCT01215513|464456758|FG000|Overall Study|Not completed CS42|9|||
129044774|NCT01215513|464456758|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
129044775|NCT01215513|464456758|FG000|Overall Study|Adverse event (CS42A)|2|||
129044776|NCT01215513|464456758|FG000|Overall Study|Physician decision (CS42A)|6|||
129044777|NCT01215513|464456758|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
129044778|NCT01215513|464456758|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
129044779|NCT03955471|464456759|FG000|Overall Study|Death|22|||
129044780|NCT03955471|464456759|FG000|Overall Study|Lost to Follow-up|1|||
129044781|NCT03955471|464456759|FG000|Overall Study|Withdrawal by Subject|6|||
129044782|NCT03955471|464456759|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
129044783|NCT01996332|464456770|FG000|Overall Study|Adverse Event|117|||
129044784|NCT01996332|464456770|FG000|Overall Study|Lack of Efficacy|1245|||
129044785|NCT01996332|464456770|FG000|Overall Study|Death|264|||
129044786|NCT01996332|464456770|FG000|Overall Study|Protocol Violation|9|||
129044787|NCT01996332|464456770|FG000|Overall Study|Withdrawal by Subject|71|||
129044788|NCT01996332|464456770|FG000|Overall Study|Other|20|||
129044789|NCT01996332|464456770|FG000|Overall Study|Clinical Deterioration|28|||
129044790|NCT01996332|464456770|FG000|Overall Study|Physician Decision|17|||
129044791|NCT01996332|464456770|FG000|Overall Study|Lost to Follow-up|34|||
129044792|NCT02113189|464456771|FG000|Overall Study|Lost to follow up|2|||
129044793|NCT02113189|464456772|FG001|Overall Study|Lost to follow up|1|||
129044794|NCT02113189|464456773|FG002|Overall Study|Lost to follow up|3|||
129044795|NCT00430495|464456774|FG000|Overall Study|Adverse Event|2|||
129044796|NCT00430495|464456775|FG001|Overall Study|Adverse Event|3|||
129044797|NCT00430495|464456776|FG002|Overall Study|Adverse Event|2|||
129044798|NCT00430495|464456777|FG003|Overall Study|Adverse Event|0|||
129044799|NCT00430495|464456774|FG000|Overall Study|Death|0|||
129044800|NCT00430495|464456775|FG001|Overall Study|Death|0|||
129044801|NCT00430495|464456776|FG002|Overall Study|Death|1|||
129044802|NCT00430495|464456777|FG003|Overall Study|Death|0|||
129044803|NCT00430495|464456774|FG000|Overall Study|Lost to Follow-up|0|||
129044804|NCT00430495|464456775|FG001|Overall Study|Lost to Follow-up|1|||
129044805|NCT00430495|464456776|FG002|Overall Study|Lost to Follow-up|4|||
129044806|NCT00430495|464456777|FG003|Overall Study|Lost to Follow-up|0|||
129044807|NCT00430495|464456774|FG000|Overall Study|Protocol Violation|1|||
129044808|NCT00430495|464456775|FG001|Overall Study|Protocol Violation|0|||
129044809|NCT00430495|464456776|FG002|Overall Study|Protocol Violation|1|||
129044810|NCT00430495|464456777|FG003|Overall Study|Protocol Violation|0|||
129044811|NCT00430495|464456774|FG000|Overall Study|Disease Progression|1|||
129044812|NCT00430495|464456775|FG001|Overall Study|Disease Progression|1|||
129044813|NCT00430495|464456776|FG002|Overall Study|Disease Progression|0|||
129044814|NCT00430495|464456777|FG003|Overall Study|Disease Progression|0|||
129044815|NCT00430495|464456774|FG000|Overall Study|Other|8|||
129044816|NCT00430495|464456775|FG001|Overall Study|Other|2|||
129044817|NCT00430495|464456776|FG002|Overall Study|Other|5|||
129044818|NCT00430495|464456777|FG003|Overall Study|Other|4|||
129044819|NCT00430495|464456774|FG000|Overall Study|Randomized but not Treated|2|||
129044820|NCT00430495|464456775|FG001|Overall Study|Randomized but not Treated|0|||
129044821|NCT00430495|464456776|FG002|Overall Study|Randomized but not Treated|0|||
129044822|NCT00430495|464456777|FG003|Overall Study|Randomized but not Treated|0|||
129044823|NCT00158756|464456782|FG000|Overall Study|Withdrawal by Subject|5|||
129044824|NCT00158756|464456783|FG001|Overall Study|Withdrawal by Subject|0|||
129044825|NCT00158756|464456784|FG002|Overall Study|Withdrawal by Subject|6|||
129044826|NCT00158756|464456785|FG003|Overall Study|Withdrawal by Subject|1|||
129044827|NCT00158756|464456786|FG004|Overall Study|Withdrawal by Subject|3|||
129044828|NCT00158756|464456782|FG000|Overall Study|Adverse Event|0|||
129044829|NCT00158756|464456783|FG001|Overall Study|Adverse Event|0|||
129044830|NCT00158756|464456784|FG002|Overall Study|Adverse Event|1|||
129044831|NCT00158756|464456785|FG003|Overall Study|Adverse Event|0|||
129044832|NCT00158756|464456786|FG004|Overall Study|Adverse Event|0|||
129044833|NCT00158756|464456782|FG000|Overall Study|Serious adverse event|0|||
129044834|NCT00158756|464456783|FG001|Overall Study|Serious adverse event|0|||
129044835|NCT00158756|464456784|FG002|Overall Study|Serious adverse event|1|||
129044836|NCT00158756|464456785|FG003|Overall Study|Serious adverse event|0|||
129044837|NCT00158756|464456786|FG004|Overall Study|Serious adverse event|0|||
129044838|NCT02145026|464456787|FG000|Overall Study|Adverse Event|2|||
129044839|NCT02145026|464456787|FG000|Overall Study|Death|4|||
129044840|NCT02145026|464456787|FG000|Overall Study|Withdrawal by Subject|2|||
129044841|NCT02145026|464456787|FG000|Overall Study|Physician Decision|4|||
129044842|NCT01429051|464456788|FG000|Titration Phase|Death|1|||
129044843|NCT01429051|464456788|FG000|Titration Phase|Withdrawal by Subject|7|||
129044844|NCT01429051|464456788|FG000|Titration Phase|Physician Decision|1|||
129044845|NCT01429051|464456788|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
129044846|NCT01429051|464456788|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
129044847|NCT01429051|464456788|FG000|Efficacy Phase|Adverse Event|1|||
129044848|NCT01429051|464456788|FG000|Efficacy Phase|Death|1|||
129044849|NCT01429051|464456788|FG000|Tolerability Phase|Death|5|||
129044850|NCT01429051|464456788|FG000|Tolerability Phase|Adverse Event|2|||
129044851|NCT01429051|464456788|FG000|Tolerability Phase|Withdrawal by Subject|5|||
129044852|NCT01429051|464456788|FG000|Tolerability Phase|Physician Decision|1|||
129044853|NCT01429051|464456788|FG000|Tolerability Phase|Other|2|||
129044854|NCT04132336|464456789|FG000|Overall Study|Investigator Decision|0|||
129044855|NCT04132336|464456790|FG001|Overall Study|Investigator Decision|1|||
129044856|NCT04132336|464456791|FG002|Overall Study|Investigator Decision|0|||
129044857|NCT04132336|464456792|FG003|Overall Study|Investigator Decision|0|||
129044858|NCT04132336|464456793|FG004|Overall Study|Investigator Decision|0|||
129044859|NCT04132336|464456794|FG005|Overall Study|Investigator Decision|0|||
129044860|NCT04132336|464456795|FG006|Overall Study|Investigator Decision|0|||
129044861|NCT00857792|464456796|FG000|Overall Study|inadequate image quality for analysis|12|||
129044862|NCT01797835|464456797|FG000|Overall Study|Lost to Follow-up|31|||
129044863|NCT01797835|464456798|FG001|Overall Study|Lost to Follow-up|27|||
129044864|NCT02528123|464456800|FG000|Overall Study|Lost to Follow-up|1|||
129044865|NCT04421586|464456808|FG000|Overall Study|Death|0|||
129044866|NCT04421586|464456809|FG001|Overall Study|Death|1|||
129044867|NCT04421586|464456808|FG000|Overall Study|Lost to Follow-up|2|||
129044868|NCT04421586|464456809|FG001|Overall Study|Lost to Follow-up|2|||
129044869|NCT04421586|464456808|FG000|Overall Study|Withdrawn by PI|1|||
129044870|NCT04421586|464456809|FG001|Overall Study|Withdrawn by PI|0|||
129044871|NCT04421586|464456808|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
129044872|NCT04421586|464456809|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
129044873|NCT04505293|464456810|FG000|Overall Study|Lost to Follow-up|2|||
129044874|NCT04505293|464456810|FG000|Overall Study|Withdrawal by Subject|6|||
129044875|NCT04505293|464456810|FG000|Overall Study|CT scan unreadable|277|||
129044876|NCT04295135|464456811|FG000|Overall Study|Withdrawal by Subject|2|||
129044877|NCT04295135|464456812|FG001|Overall Study|Withdrawal by Subject|1|||
129044878|NCT04295135|464456811|FG000|Overall Study|Subject left organization|8|||
129044879|NCT04295135|464456812|FG001|Overall Study|Subject left organization|4|||
129044880|NCT03484117|464456814|FG000|Overall Study|Lost to Follow-up|1|||
129044881|NCT03484117|464456815|FG001|Overall Study|Lost to Follow-up|3|||
129044882|NCT03484117|464456814|FG000|Overall Study|Declined participation in exit assess|1|||
129044883|NCT03484117|464456815|FG001|Overall Study|Declined participation in exit assess|1|||
129044884|NCT00289874|464456816|FG000|Overall Study|Adverse Event|1|||
129044885|NCT00289874|464456817|FG001|Overall Study|Adverse Event|5|||
129044886|NCT00289874|464456816|FG000|Overall Study|Lost to Follow-up|1|||
129044887|NCT00289874|464456817|FG001|Overall Study|Lost to Follow-up|1|||
129044888|NCT00289874|464456816|FG000|Overall Study|Protocol Violation|3|||
129044889|NCT00289874|464456817|FG001|Overall Study|Protocol Violation|2|||
129044890|NCT00289874|464456816|FG000|Overall Study|Did not meet eligibility|1|||
129044891|NCT00289874|464456817|FG001|Overall Study|Did not meet eligibility|0|||
129135215|NCT01543503|464789151|FG001|Overall Study|Participant withdrew informed consent|10|||
129135216|NCT01543503|464789150|FG000|Overall Study|Change of jobs|0|||
129135217|NCT01543503|464789151|FG001|Overall Study|Change of jobs|1|||
129135218|NCT01543503|464789150|FG000|Overall Study|Intolerance to the biologic treatment|0|||
129135219|NCT01543503|464789151|FG001|Overall Study|Intolerance to the biologic treatment|1|||
129135220|NCT01543503|464789150|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
129135221|NCT01543503|464789151|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
129135222|NCT01543503|464789150|FG000|Overall Study|Participant did not complete last visit|0|||
129135223|NCT01543503|464789151|FG001|Overall Study|Participant did not complete last visit|2|||
129135224|NCT01543503|464789150|FG000|Overall Study|Refused to continue treatment|7|||
129135225|NCT01543503|464789151|FG001|Overall Study|Refused to continue treatment|0|||
128719270|NCT02608268|463271027|FG008|Overall Study|Physician Decision|0|||
129044892|NCT03835325|464456818|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
129044893|NCT03835325|464456818|FG000|Overall Study|Selection failure|1|||
129044894|NCT00775606|464456819|FG000|Overall Study|Study sponsor terminated funding|3|||
129044895|NCT00775606|464456820|FG001|Overall Study|Study sponsor terminated funding|0|||
129044896|NCT03212794|464456821|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
129044897|NCT03212794|464456822|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
129044898|NCT03212794|464456821|FG000|Overall Study|Lost to Follow-up|5|||
129044899|NCT03212794|464456822|FG001|Overall Study|Lost to Follow-up|6|||
129044900|NCT03212794|464456821|FG000|Overall Study|Incarcerated; unable to participate|2|||
129135226|NCT01543503|464789150|FG000|Overall Study|Incorrect medication received|1|||
128719271|NCT02608268|463271028|FG009|Overall Study|Physician Decision|0|||
129044901|NCT03212794|464456822|FG001|Overall Study|Incarcerated; unable to participate|0|||
129044902|NCT03212794|464456821|FG000|Overall Study|Withdrawal by Subject|1|||
129044903|NCT03212794|464456822|FG001|Overall Study|Withdrawal by Subject|0|||
129044904|NCT03212794|464456821|FG000|Overall Study|Death|0|||
129044905|NCT03212794|464456822|FG001|Overall Study|Death|1|||
129044906|NCT03212794|464456821|FG000|Overall Study|Found to be ineligible after allocation|0|||
129044907|NCT03212794|464456822|FG001|Overall Study|Found to be ineligible after allocation|1|||
129044908|NCT03212794|464456821|FG000|Overall Study|Relocated out of area|2|||
129044909|NCT03212794|464456822|FG001|Overall Study|Relocated out of area|0|||
129044910|NCT00257920|464456824|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
129044911|NCT00257920|464456825|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
129044912|NCT00257920|464456824|FG000|Period: Second Intervention|Other|2|||
129044913|NCT00257920|464456825|FG001|Period: Second Intervention|Other|1|||
129044914|NCT00770692|464456828|FG000|Overall Study|Withdrawal by Subject|7|||
129044915|NCT00770692|464456829|FG001|Overall Study|Withdrawal by Subject|9|||
129044916|NCT00770692|464456830|FG002|Overall Study|Withdrawal by Subject|9|||
129044917|NCT00770692|464456831|FG003|Overall Study|Withdrawal by Subject|6|||
129044918|NCT00770692|464456828|FG000|Overall Study|Adverse Event|3|||
129044919|NCT00770692|464456829|FG001|Overall Study|Adverse Event|0|||
129044920|NCT00770692|464456830|FG002|Overall Study|Adverse Event|4|||
129044921|NCT00770692|464456831|FG003|Overall Study|Adverse Event|4|||
129044922|NCT00770692|464456828|FG000|Overall Study|Investigator judgment|2|||
129044923|NCT00770692|464456829|FG001|Overall Study|Investigator judgment|0|||
129044924|NCT00770692|464456830|FG002|Overall Study|Investigator judgment|1|||
129044925|NCT00770692|464456831|FG003|Overall Study|Investigator judgment|1|||
129044926|NCT00560937|464456833|FG000|Overall Study|Withdrawal by Subject|0|||
129044927|NCT00560937|464456834|FG001|Overall Study|Withdrawal by Subject|1|||
129044928|NCT00560937|464456833|FG000|Overall Study|Physician Decision|1|||
129044929|NCT00560937|464456834|FG001|Overall Study|Physician Decision|1|||
129044930|NCT03629028|464456837|FG000|Overall Study|Lost to Follow-up|26|||
129044931|NCT03629028|464456838|FG001|Overall Study|Lost to Follow-up|23|||
129044932|NCT03629028|464456837|FG000|Overall Study|Pregnancy|4|||
129044933|NCT03629028|464456838|FG001|Overall Study|Pregnancy|2|||
129044934|NCT03629028|464456837|FG000|Overall Study|intolerance to examination|2|||
129044935|NCT03629028|464456838|FG001|Overall Study|intolerance to examination|0|||
129044936|NCT01846273|464456841|FG000|Overall Study|Adverse Event|9|||
129044937|NCT01846273|464456842|FG001|Overall Study|Adverse Event|7|||
129044938|NCT01846273|464456843|FG002|Overall Study|Adverse Event|0|||
129044939|NCT01846273|464456841|FG000|Overall Study|Subject withdrew consent|5|||
129044940|NCT01846273|464456842|FG001|Overall Study|Subject withdrew consent|8|||
129044941|NCT01846273|464456843|FG002|Overall Study|Subject withdrew consent|0|||
129044942|NCT01846273|464456841|FG000|Overall Study|Lost to Follow-up|2|||
129044943|NCT01846273|464456842|FG001|Overall Study|Lost to Follow-up|1|||
129044944|NCT01846273|464456843|FG002|Overall Study|Lost to Follow-up|0|||
129044945|NCT01846273|464456841|FG000|Overall Study|Administrative problems|1|||
129044946|NCT01846273|464456842|FG001|Overall Study|Administrative problems|0|||
129044947|NCT01846273|464456843|FG002|Overall Study|Administrative problems|0|||
129044948|NCT01846273|464456841|FG000|Overall Study|Death|2|||
129044949|NCT01846273|464456842|FG001|Overall Study|Death|1|||
129044950|NCT01846273|464456843|FG002|Overall Study|Death|0|||
129044951|NCT01846273|464456841|FG000|Overall Study|Disease Progression|0|||
129044952|NCT01846273|464456842|FG001|Overall Study|Disease Progression|4|||
129044953|NCT01846273|464456843|FG002|Overall Study|Disease Progression|0|||
129044954|NCT01846273|464456841|FG000|Overall Study|Protocol Deviation|2|||
129135227|NCT01543503|464789151|FG001|Overall Study|Incorrect medication received|0|||
129135228|NCT01543503|464789150|FG000|Overall Study|Participant moved to another city|2|||
129135229|NCT01543503|464789151|FG001|Overall Study|Participant moved to another city|0|||
129135230|NCT01543503|464789150|FG000|Overall Study|Participant will not return for visits|0|||
129135231|NCT01543503|464789151|FG001|Overall Study|Participant will not return for visits|2|||
129135232|NCT01543503|464789150|FG000|Overall Study|Participant transferred to another city|1|||
129135233|NCT01543503|464789151|FG001|Overall Study|Participant transferred to another city|0|||
129044955|NCT01846273|464456842|FG001|Overall Study|Protocol Deviation|3|||
129044956|NCT01846273|464456843|FG002|Overall Study|Protocol Deviation|0|||
129044957|NCT01846273|464456841|FG000|Overall Study|Physician Decision|1|||
129044958|NCT01846273|464456842|FG001|Overall Study|Physician Decision|2|||
129044959|NCT01846273|464456843|FG002|Overall Study|Physician Decision|0|||
129044960|NCT03864042|464456844|FG000|DDI Phase|Adverse Event|2|||
129044961|NCT03864042|464456845|FG001|DDI Phase|Adverse Event|0|||
129044962|NCT03864042|464456846|FG002|DDI Phase|Adverse Event|0|||
129044963|NCT03864042|464456844|FG000|DDI Phase|Physician Decision|1|||
129044964|NCT03864042|464456845|FG001|DDI Phase|Physician Decision|0|||
129044965|NCT03864042|464456846|FG002|DDI Phase|Physician Decision|0|||
129044966|NCT03864042|464456844|FG000|DDI Phase|Progressive Disease|1|||
129044967|NCT03864042|464456845|FG001|DDI Phase|Progressive Disease|0|||
129044968|NCT03864042|464456846|FG002|DDI Phase|Progressive Disease|0|||
129044969|NCT03864042|464456844|FG000|Post-DDI Phase|Adverse Event|5|||
129044970|NCT03864042|464456845|FG001|Post-DDI Phase|Adverse Event|3|||
129135234|NCT01543503|464789150|FG000|Overall Study|Participant moved to Scotland|1|||
129135235|NCT01543503|464789151|FG001|Overall Study|Participant moved to Scotland|0|||
129135236|NCT01543503|464789150|FG000|Overall Study|Participant decision to stop treatment|1|||
129044971|NCT03864042|464456846|FG002|Post-DDI Phase|Adverse Event|2|||
129044972|NCT03864042|464456844|FG000|Post-DDI Phase|Progressive Disease|11|||
129044973|NCT03864042|464456845|FG001|Post-DDI Phase|Progressive Disease|6|||
129044974|NCT03864042|464456846|FG002|Post-DDI Phase|Progressive Disease|13|||
129044975|NCT03864042|464456844|FG000|Post-DDI Phase|Discretion of investigator|1|||
129044976|NCT03864042|464456845|FG001|Post-DDI Phase|Discretion of investigator|1|||
129044977|NCT03864042|464456846|FG002|Post-DDI Phase|Discretion of investigator|0|||
129044978|NCT03864042|464456844|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
129044979|NCT03864042|464456845|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
129044980|NCT03864042|464456846|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
129044981|NCT03864042|464456844|FG000|Post-DDI Phase|Withdrawal of consent|1|||
129044982|NCT03864042|464456845|FG001|Post-DDI Phase|Withdrawal of consent|2|||
129044983|NCT03864042|464456846|FG002|Post-DDI Phase|Withdrawal of consent|0|||
129044984|NCT02220725|464456847|FG000|Overall Study|Lost to Follow-up|0|||
129044985|NCT02220725|464456848|FG001|Overall Study|Lost to Follow-up|0|||
129044986|NCT02220725|464456849|FG002|Overall Study|Lost to Follow-up|0|||
129044987|NCT02220725|464456850|FG003|Overall Study|Lost to Follow-up|1|||
129044988|NCT02220725|464456847|FG000|Overall Study|Withdrawal by Subject|0|||
129044989|NCT02220725|464456848|FG001|Overall Study|Withdrawal by Subject|0|||
129044990|NCT02220725|464456849|FG002|Overall Study|Withdrawal by Subject|0|||
129044991|NCT02220725|464456850|FG003|Overall Study|Withdrawal by Subject|1|||
129044992|NCT05069155|464456851|FG000|Overall Study|Withdrawal by Subject|1|||
129044993|NCT05069155|464456852|FG001|Overall Study|Withdrawal by Subject|3|||
129044994|NCT03487848|464456853|FG000|Overall Study|Lost to Follow-up|1|||
129044995|NCT00731549|464456854|FG000|Overall Study|Lost to Follow-up|19|||
129044996|NCT00731549|464456854|FG000|Overall Study|Met withdrawal criteria|24|||
129044997|NCT00731549|464456854|FG000|Overall Study|Physician Decision|16|||
129044998|NCT00731549|464456854|FG000|Overall Study|Withdrawal by Subject|89|||
129044999|NCT00731549|464456854|FG000|Overall Study|Protocol deviation|1|||
129045000|NCT00731549|464456854|FG000|Overall Study|Adverse Event|31|||
129045001|NCT00731549|464456854|FG000|Overall Study|Lack of efficacy with AE|37|||
129045002|NCT00731549|464456854|FG000|Overall Study|Lack of efficacy without AE|6|||
129045003|NCT00103402|464456855|FG000|Overall Study|Adverse Event|3|||
129045004|NCT00103402|464456856|FG001|Overall Study|Adverse Event|4|||
129045005|NCT00103402|464456855|FG000|Overall Study|Lost to Follow-up|8|||
129045006|NCT00103402|464456856|FG001|Overall Study|Lost to Follow-up|7|||
129045007|NCT00103402|464456855|FG000|Overall Study|Dissatisfied/No longer interested|6|||
129045008|NCT00103402|464456856|FG001|Overall Study|Dissatisfied/No longer interested|6|||
129045009|NCT00103402|464456855|FG000|Overall Study|Personal constraints/Other|5|||
129045010|NCT00103402|464456856|FG001|Overall Study|Personal constraints/Other|0|||
129045011|NCT01393730|464456857|FG000|Overall Study|Withdrawal by Subject|3|||
129045012|NCT01393730|464456857|FG000|Overall Study|Other|2|||
129045013|NCT01393730|464456857|FG000|Overall Study|Adverse Event|1|||
129045014|NCT02333487|464456858|FG000|Overall Study|Adverse Event|0|||
129045015|NCT02333487|464456859|FG001|Overall Study|Adverse Event|2|||
129045016|NCT02333487|464456860|FG002|Overall Study|Adverse Event|0|||
129045017|NCT01297322|464456861|FG000|Overall Study|Lost to Follow-up|1|||
129045018|NCT01297322|464456862|FG001|Overall Study|Lost to Follow-up|0|||
129135237|NCT01543503|464789151|FG001|Overall Study|Participant decision to stop treatment|0|||
129135238|NCT01543503|464789150|FG000|Overall Study|Investigator did not wish to participate|1|||
129045019|NCT01297322|464456861|FG000|Overall Study|Withdrawal by Subject|0|||
129045020|NCT01297322|464456862|FG001|Overall Study|Withdrawal by Subject|1|||
129045021|NCT01297322|464456861|FG000|Overall Study|Protocol Violation|0|||
129045022|NCT01297322|464456862|FG001|Overall Study|Protocol Violation|3|||
129045023|NCT01111019|464456863|FG000|Overall Study|Withdrew Prematurely|2|||
129045024|NCT01111019|464456863|FG000|Overall Study|Other|1|||
129045025|NCT01583218|464456867|FG000|Overall Study|Withdrawal by Subject|43|||
129045026|NCT01583218|464456868|FG001|Overall Study|Withdrawal by Subject|29|||
129135239|NCT01543503|464789151|FG001|Overall Study|Investigator did not wish to participate|1|||
129135240|NCT01543503|464789150|FG000|Overall Study|Participant recruited after closing date|0|||
129135241|NCT01543503|464789151|FG001|Overall Study|Participant recruited after closing date|1|||
129135242|NCT01543503|464789150|FG000|Overall Study|Site stopped participation|5|||
129045027|NCT01583218|464456867|FG000|Overall Study|Death|206|||
129045028|NCT01583218|464456868|FG001|Overall Study|Death|211|||
129045029|NCT01583218|464456867|FG000|Overall Study|Lost to Follow-up|11|||
129045030|NCT01583218|464456868|FG001|Overall Study|Lost to Follow-up|17|||
129045031|NCT01583218|464456867|FG000|Overall Study|Adverse event or serious adverse event|3|||
129045032|NCT01583218|464456868|FG001|Overall Study|Adverse event or serious adverse event|3|||
129045033|NCT01583218|464456867|FG000|Overall Study|Patient /Family decision|3|||
129045034|NCT01583218|464456868|FG001|Overall Study|Patient /Family decision|0|||
129045035|NCT01583218|464456867|FG000|Overall Study|Cannot contact patient directly|1|||
129045036|NCT01583218|464456868|FG001|Overall Study|Cannot contact patient directly|2|||
129045037|NCT01583218|464456867|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
129135243|NCT01543503|464789151|FG001|Overall Study|Site stopped participation|1|||
129045038|NCT01583218|464456868|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
129045039|NCT01583218|464456867|FG000|Overall Study|Patient did not wish to attend visits|0|||
129045040|NCT01583218|464456868|FG001|Overall Study|Patient did not wish to attend visits|1|||
129045041|NCT01583218|464456867|FG000|Overall Study|Patient randomized but not dosed|17|||
129045042|NCT01583218|464456868|FG001|Overall Study|Patient randomized but not dosed|16|||
129045043|NCT01583218|464456867|FG000|Overall Study|Patient was assessed via phone in person|1|||
129045044|NCT01583218|464456868|FG001|Overall Study|Patient was assessed via phone in person|0|||
129045045|NCT01583218|464456867|FG000|Overall Study|Patient deemed ineligible after random|2|||
129045046|NCT01583218|464456868|FG001|Overall Study|Patient deemed ineligible after random|0|||
129045047|NCT01583218|464456867|FG000|Overall Study|Patient was early terminated from study|0|||
129045048|NCT01583218|464456868|FG001|Overall Study|Patient was early terminated from study|1|||
129045049|NCT01583218|464456867|FG000|Overall Study|Patient was randomized due to mistake|1|||
129045050|NCT01583218|464456868|FG001|Overall Study|Patient was randomized due to mistake|0|||
129045051|NCT01583218|464456867|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
129045052|NCT01583218|464456868|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
129045053|NCT01583218|464456867|FG000|Overall Study|Withdraw of consent on day of random|1|||
129045054|NCT01583218|464456868|FG001|Overall Study|Withdraw of consent on day of random|0|||
129045055|NCT00712985|464456871|FG000|Overall Study|1 withdrew prior to start of drug|1|||
129045056|NCT00712985|464456871|FG000|Overall Study|1 patient moved out of state|1|||
129045057|NCT00712985|464456871|FG000|Overall Study|Lack of Efficacy|3|||
129045058|NCT02674061|464456872|FG000|Overall Study|Death|229|||
129045059|NCT02674061|464456873|FG001|Overall Study|Death|77|||
129045060|NCT02674061|464456872|FG000|Overall Study|Lost to Follow-up|3|||
129045061|NCT02674061|464456873|FG001|Overall Study|Lost to Follow-up|3|||
129045062|NCT02674061|464456872|FG000|Overall Study|Withdrawal by Subject|9|||
129045063|NCT02674061|464456873|FG001|Overall Study|Withdrawal by Subject|1|||
129045064|NCT02674061|464456872|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
129045065|NCT02674061|464456873|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
129045066|NCT01299805|464456876|FG000|Overall Study|Adverse Event|2|||
129045067|NCT01299805|464456877|FG001|Overall Study|Adverse Event|0|||
129045068|NCT00123955|464456881|FG000|Overall Study|Adverse Event|1|||
129045069|NCT00123955|464456882|FG001|Overall Study|Adverse Event|0|||
129045070|NCT00123955|464456881|FG000|Overall Study|Withdrawal by Subject|4|||
129045071|NCT00123955|464456882|FG001|Overall Study|Withdrawal by Subject|3|||
129045072|NCT00123955|464456881|FG000|Overall Study|Death|0|||
129045073|NCT00123955|464456882|FG001|Overall Study|Death|1|||
129045074|NCT04556552|464458332|FG000|Overall Study|Lost to Follow-up|1|||
129045075|NCT04556552|464458333|FG001|Overall Study|Lost to Follow-up|0|||
129045076|NCT04556552|464458332|FG000|Overall Study|Claustrophobia|0|||
129045077|NCT04556552|464458333|FG001|Overall Study|Claustrophobia|1|||
129045078|NCT04556552|464458332|FG000|Overall Study|Inability to continue|0|||
129045079|NCT04556552|464458333|FG001|Overall Study|Inability to continue|1|||
129045080|NCT00605865|464458334|FG000|Overall Study|Protocol Violation|115|||
129045081|NCT02858492|464458335|FG000|Overall Study|Withdrawal by Subject|0|||
129045082|NCT02858492|464458336|FG001|Overall Study|Withdrawal by Subject|1|||
129045083|NCT02858492|464458337|FG002|Overall Study|Withdrawal by Subject|0|||
129045084|NCT02858492|464458338|FG003|Overall Study|Withdrawal by Subject|1|||
129045085|NCT02858492|464458335|FG000|Overall Study|Adverse Event|0|||
129045086|NCT02858492|464458336|FG001|Overall Study|Adverse Event|0|||
129045087|NCT02858492|464458337|FG002|Overall Study|Adverse Event|0|||
129045088|NCT02858492|464458338|FG003|Overall Study|Adverse Event|3|||
129045089|NCT02858492|464458335|FG000|Overall Study|Lack of Efficacy|0|||
129045090|NCT02858492|464458336|FG001|Overall Study|Lack of Efficacy|0|||
129045091|NCT02858492|464458337|FG002|Overall Study|Lack of Efficacy|0|||
129045092|NCT02858492|464458338|FG003|Overall Study|Lack of Efficacy|1|||
129045093|NCT02858492|464458335|FG000|Overall Study|Protocol defined stopping criteria|0|||
129045094|NCT02858492|464458336|FG001|Overall Study|Protocol defined stopping criteria|0|||
129045095|NCT02858492|464458337|FG002|Overall Study|Protocol defined stopping criteria|0|||
129045096|NCT02858492|464458338|FG003|Overall Study|Protocol defined stopping criteria|1|||
129045097|NCT02119286|464458341|FG000|Overall Study|Adverse Event|9|||
129045098|NCT02119286|464458342|FG001|Overall Study|Adverse Event|7|||
129045099|NCT02119286|464458343|FG002|Overall Study|Adverse Event|2|||
129045100|NCT02119286|464458341|FG000|Overall Study|Lack of Efficacy|11|||
129045101|NCT02119286|464458342|FG001|Overall Study|Lack of Efficacy|3|||
129045102|NCT02119286|464458343|FG002|Overall Study|Lack of Efficacy|4|||
129045103|NCT02119286|464458341|FG000|Overall Study|Lost to Follow-up|2|||
129045104|NCT02119286|464458342|FG001|Overall Study|Lost to Follow-up|0|||
129045105|NCT02119286|464458343|FG002|Overall Study|Lost to Follow-up|1|||
129045106|NCT02119286|464458341|FG000|Overall Study|Withdrawal by Subject|4|||
129045107|NCT02119286|464458342|FG001|Overall Study|Withdrawal by Subject|1|||
129045108|NCT02119286|464458343|FG002|Overall Study|Withdrawal by Subject|0|||
129045109|NCT03310411|464458344|FG000|Period 1|Adverse Event|0|||
129045110|NCT03310411|464458345|FG001|Period 1|Adverse Event|0|||
129045111|NCT03310411|464458346|FG002|Period 1|Adverse Event|0|||
129045112|NCT03310411|464458347|FG003|Period 1|Adverse Event|1|||
129135244|NCT01543503|464789150|FG000|Overall Study|Participant did not attend a visit|1|||
129135245|NCT01543503|464789151|FG001|Overall Study|Participant did not attend a visit|0|||
129135246|NCT01543503|464789150|FG000|Overall Study|Moved to other rheumatologic site|0|||
129135247|NCT01543503|464789151|FG001|Overall Study|Moved to other rheumatologic site|1|||
129135248|NCT01543503|464789150|FG000|Overall Study|Participant consented to another study|0|||
129135249|NCT01543503|464789151|FG001|Overall Study|Participant consented to another study|2|||
129135250|NCT01543503|464789150|FG000|Overall Study|Participant went to United States|1|||
129135251|NCT01543503|464789151|FG001|Overall Study|Participant went to United States|0|||
129135252|NCT01543503|464789150|FG000|Overall Study|Screen failure|1|||
129135253|NCT01543503|464789151|FG001|Overall Study|Screen failure|0|||
129135254|NCT01210443|464789154|FG000|Overall Study|Study terminated by sponsor|2|||
129135255|NCT01309100|464789155|FG000|Overall Study|Protocol Violation|1|||
129135256|NCT01309100|464789155|FG000|Overall Study|Positive Slit lamp finding|1|||
129135257|NCT00977561|464789156|FG000|Overall Study|Death|3|||
129135258|NCT00977561|464789157|FG001|Overall Study|Death|2|||
129135259|NCT00977561|464789156|FG000|Overall Study|Study terminated|0|||
129135260|NCT00977561|464789157|FG001|Overall Study|Study terminated|2|||
129135261|NCT00977561|464789156|FG000|Overall Study|Other|2|||
129135262|NCT00977561|464789157|FG001|Overall Study|Other|0|||
129135263|NCT01968785|464789166|FG000|Overall Study|Withdrawal by Subject|1|||
129135264|NCT01968785|464789167|FG001|Overall Study|Withdrawal by Subject|0|||
129135265|NCT04560309|464789171|FG000|Overall Study|Meet drop out criteria|1|||
129135266|NCT04560309|464789172|FG001|Overall Study|Meet drop out criteria|1|||
129135267|NCT05085405|464789173|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129135268|NCT05085405|464789174|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129135269|NCT05085405|464789175|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
129135270|NCT05085405|464789176|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
129135271|NCT05085405|464789177|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129135272|NCT05085405|464789178|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129135273|NCT05085405|464789173|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129135274|NCT05085405|464789174|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129135275|NCT05085405|464789175|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129135276|NCT05085405|464789176|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
129135277|NCT05085405|464789177|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129135278|NCT05085405|464789178|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129135279|NCT04146909|464789179|FG000|Overall Study|Withdrawal by Subject|3|||
129135280|NCT04146909|464789179|FG000|Overall Study|Did not qualify after consented|1|||
129135281|NCT04000724|464789187|FG000|Overall Study|Withdrawal by Subject|5|||
129135282|NCT04000724|464789188|FG001|Overall Study|Withdrawal by Subject|3|||
129135283|NCT04000724|464789189|FG002|Overall Study|Withdrawal by Subject|4|||
129135284|NCT04000724|464789187|FG000|Overall Study|Lost to Follow-up|11|||
129135285|NCT04000724|464789188|FG001|Overall Study|Lost to Follow-up|7|||
129135286|NCT04000724|464789189|FG002|Overall Study|Lost to Follow-up|13|||
129135287|NCT00455455|464789190|FG000|Washout|Withdrawal by Subject|0|||
128719272|NCT02608268|463271029|FG010|Overall Study|Physician Decision|1|||
129045113|NCT00619112|464458348|FG000|Overall Study|Adverse Event|1|||
129045114|NCT00619112|464458349|FG001|Overall Study|Adverse Event|2|||
129045115|NCT03623386|464458350|FG000|Overall Study|Protocol Violation|3|||
129045116|NCT03623386|464458351|FG001|Overall Study|Protocol Violation|2|||
129045117|NCT03623386|464458352|FG002|Overall Study|Protocol Violation|0|||
129045118|NCT03623386|464458350|FG000|Overall Study|Physician Decision|1|||
129045119|NCT03623386|464458351|FG001|Overall Study|Physician Decision|1|||
129045120|NCT03623386|464458352|FG002|Overall Study|Physician Decision|0|||
129045121|NCT03623386|464458350|FG000|Overall Study|Lost to Follow-up|0|||
129045122|NCT03623386|464458351|FG001|Overall Study|Lost to Follow-up|2|||
129045123|NCT03623386|464458352|FG002|Overall Study|Lost to Follow-up|0|||
129045124|NCT03623386|464458350|FG000|Overall Study|COVID-19|0|||
129045125|NCT03623386|464458351|FG001|Overall Study|COVID-19|1|||
129045126|NCT03623386|464458352|FG002|Overall Study|COVID-19|0|||
129045127|NCT04271735|464458357|FG000|Overall Study|Physician Decision|2|||
129045128|NCT04271735|464458358|FG001|Overall Study|Physician Decision|0|||
129045129|NCT00515541|464458359|FG000|Overall Study|Physician Decision|0|||
129045130|NCT00515541|464458360|FG001|Overall Study|Physician Decision|2|||
128719273|NCT02608268|463271030|FG011|Overall Study|Physician Decision|0|||
128719274|NCT02608268|463271031|FG012|Overall Study|Physician Decision|0|||
128719275|NCT02608268|463271032|FG013|Overall Study|Physician Decision|1|||
129045131|NCT00515541|464458361|FG002|Overall Study|Physician Decision|0|||
129045132|NCT00515541|464458362|FG003|Overall Study|Physician Decision|1|||
129045133|NCT00515541|464458359|FG000|Overall Study|No show for appointments|0|||
129045134|NCT00515541|464458360|FG001|Overall Study|No show for appointments|1|||
129045135|NCT00515541|464458361|FG002|Overall Study|No show for appointments|0|||
129135288|NCT00455455|464789191|FG001|Washout|Withdrawal by Subject|1|||
129135289|NCT00455455|464789190|FG000|Washout|Withdrawal by Subject|1|||
129135290|NCT00455455|464789191|FG001|Washout|Withdrawal by Subject|0|||
129045136|NCT00515541|464458362|FG003|Overall Study|No show for appointments|2|||
129045137|NCT00515541|464458359|FG000|Overall Study|Withdrawal by Subject|0|||
129045138|NCT00515541|464458360|FG001|Overall Study|Withdrawal by Subject|2|||
129045139|NCT00515541|464458361|FG002|Overall Study|Withdrawal by Subject|0|||
129045140|NCT00515541|464458362|FG003|Overall Study|Withdrawal by Subject|2|||
129045141|NCT02040779|464458364|FG000|Overall Study|Adverse Event|1|||
129045142|NCT02040779|464458365|FG001|Overall Study|Adverse Event|0|||
129045143|NCT02040779|464458366|FG002|Overall Study|Adverse Event|0|||
129045144|NCT02040779|464458364|FG000|Overall Study|Withdrawal by Subject|4|||
129045145|NCT02040779|464458365|FG001|Overall Study|Withdrawal by Subject|1|||
129045146|NCT02040779|464458366|FG002|Overall Study|Withdrawal by Subject|3|||
128775375|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
128775376|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
128775377|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
128775378|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
128775379|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
129045147|NCT02040779|464458364|FG000|Overall Study|Non-compliance|0|||
129045148|NCT02040779|464458365|FG001|Overall Study|Non-compliance|1|||
129045149|NCT02040779|464458366|FG002|Overall Study|Non-compliance|0|||
129045150|NCT02040779|464458364|FG000|Overall Study|Protocol Violation|2|||
129045151|NCT02040779|464458365|FG001|Overall Study|Protocol Violation|1|||
129045152|NCT02040779|464458366|FG002|Overall Study|Protocol Violation|0|||
129045153|NCT02040779|464458364|FG000|Overall Study|Lost to Follow-up|1|||
129045154|NCT02040779|464458365|FG001|Overall Study|Lost to Follow-up|2|||
129045155|NCT02040779|464458366|FG002|Overall Study|Lost to Follow-up|1|||
129045156|NCT02040779|464458364|FG000|Overall Study|Lack of Efficacy|4|||
129045157|NCT02040779|464458365|FG001|Overall Study|Lack of Efficacy|2|||
129045158|NCT02040779|464458366|FG002|Overall Study|Lack of Efficacy|0|||
129045159|NCT02132637|464458367|FG000|Study Period 1|Withdrawal by Subject|0|||
129045160|NCT02132637|464458368|FG001|Study Period 1|Withdrawal by Subject|4|||
129045161|NCT02132637|464458367|FG000|Study Period 1|Physician Decision|1|||
129045162|NCT02132637|464458368|FG001|Study Period 1|Physician Decision|0|||
129045163|NCT02132637|464458367|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
129045164|NCT02132637|464458368|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
129045165|NCT02132637|464458367|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
129045166|NCT02132637|464458368|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
129045167|NCT00922272|464458371|FG000|Open-label Phase|Adverse Event|5|||
129045168|NCT00922272|464458372|FG001|Open-label Phase|Adverse Event|0|||
129045169|NCT00922272|464458371|FG000|Open-label Phase|Protocol Violation|1|||
129045170|NCT00922272|464458372|FG001|Open-label Phase|Protocol Violation|0|||
129045171|NCT00922272|464458371|FG000|Open-label Phase|Withdrawal by Subject|11|||
129045172|NCT00922272|464458372|FG001|Open-label Phase|Withdrawal by Subject|0|||
129045173|NCT00922272|464458371|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
129045174|NCT00922272|464458372|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
129045175|NCT00922272|464458371|FG000|Open-label Phase|Withdrawal criteria met|5|||
129045176|NCT00922272|464458372|FG001|Open-label Phase|Withdrawal criteria met|0|||
129045177|NCT00922272|464458371|FG000|Double-blind Phase|Adverse Event|1|||
129045178|NCT00922272|464458372|FG001|Double-blind Phase|Adverse Event|1|||
129045179|NCT00922272|464458371|FG000|Double-blind Phase|Withdrawal by Subject|1|||
128775380|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
128775381|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
128775382|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
128775383|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
128775384|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
128775385|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
128775386|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
128775387|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
128775388|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
128775389|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
128775390|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129045180|NCT00922272|464458372|FG001|Double-blind Phase|Withdrawal by Subject|1|||
129045181|NCT00922272|464458371|FG000|Double-blind Phase|Lost to Follow-up|2|||
129045182|NCT00922272|464458372|FG001|Double-blind Phase|Lost to Follow-up|1|||
129045183|NCT00922272|464458371|FG000|Double-blind Phase|Withdrawal criteria met|1|||
129045184|NCT00922272|464458372|FG001|Double-blind Phase|Withdrawal criteria met|1|||
128775391|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
128775392|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
128775393|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129045185|NCT00922272|464458371|FG000|Double-blind Phase|Noncompliance|1|||
129045186|NCT00922272|464458372|FG001|Double-blind Phase|Noncompliance|1|||
129045187|NCT00922272|464458371|FG000|Double-blind Phase|Positive urine drug screen|1|||
129045188|NCT00922272|464458372|FG001|Double-blind Phase|Positive urine drug screen|1|||
129045189|NCT02588950|464458373|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
129045190|NCT02588950|464458374|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
129045191|NCT02588950|464458375|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
129045192|NCT02588950|464458376|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
129045193|NCT02588950|464458373|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
129045194|NCT02588950|464458374|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
129045195|NCT02588950|464458375|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
129045196|NCT02588950|464458376|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
129045197|NCT00652028|464458379|FG000|Overall Study|Adverse Event|1|||
129045198|NCT00652028|464458380|FG001|Overall Study|Adverse Event|0|||
129135291|NCT03808909|464789192|FG000|Overall Study|Lost to Follow-up|3|||
129135292|NCT03808909|464789193|FG001|Overall Study|Lost to Follow-up|0|||
129135293|NCT01827943|464789194|FG000|Overall Study|Protocol Violation|8|||
129135294|NCT01827943|464789194|FG000|Overall Study|Never treated because of an rapid progression|1|||
129135295|NCT03335566|464789195|FG000|Overall Study|Adverse Event|0|||
129135296|NCT03335566|464789196|FG001|Overall Study|Adverse Event|1|||
129135297|NCT03335566|464789195|FG000|Overall Study|Lost to Follow-up|1|||
129045199|NCT00652028|464458381|FG002|Overall Study|Adverse Event|0|||
129045200|NCT00652028|464458382|FG003|Overall Study|Adverse Event|0|||
129045201|NCT00652028|464458379|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
129045202|NCT00652028|464458380|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
129135298|NCT03335566|464789196|FG001|Overall Study|Lost to Follow-up|0|||
129135299|NCT03335566|464789195|FG000|Overall Study|Technical Problems|1|||
129135300|NCT03335566|464789196|FG001|Overall Study|Technical Problems|0|||
128719276|NCT02608268|463271033|FG014|Overall Study|Physician Decision|0|||
128719277|NCT02608268|463271034|FG015|Overall Study|Physician Decision|0|||
129135301|NCT03335566|464789195|FG000|Overall Study|Protocol Violation|1|||
129135302|NCT03335566|464789196|FG001|Overall Study|Protocol Violation|0|||
129135303|NCT03335566|464789195|FG000|Overall Study|Other than specified above|1|||
129135304|NCT03335566|464789196|FG001|Overall Study|Other than specified above|2|||
129135305|NCT01084135|464789197|FG000|20 Week|Physician Decision|0|||
129135306|NCT01084135|464789198|FG001|20 Week|Physician Decision|1|||
129135307|NCT00663351|464789199|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
129135308|NCT00663351|464789200|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
129135309|NCT00663351|464789199|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
129135310|NCT00663351|464789200|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
129135311|NCT00663351|464789199|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
129135312|NCT00663351|464789200|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
128719278|NCT02608268|463271035|FG016|Overall Study|Physician Decision|0|||
128719279|NCT02608268|463271036|FG017|Overall Study|Physician Decision|0|||
128719280|NCT02608268|463271037|FG018|Overall Study|Physician Decision|0|||
128719281|NCT02608268|463271038|FG019|Overall Study|Physician Decision|0|||
128719282|NCT02608268|463271039|FG020|Overall Study|Physician Decision|0|||
129045203|NCT00652028|464458381|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
129045204|NCT00652028|464458382|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
129045205|NCT00652028|464458379|FG000|Overall Study|Physician Decision|0|||
129045206|NCT00652028|464458380|FG001|Overall Study|Physician Decision|0|||
129045207|NCT00652028|464458381|FG002|Overall Study|Physician Decision|1|||
129045208|NCT00652028|464458382|FG003|Overall Study|Physician Decision|0|||
129045209|NCT00931268|464458386|FG000|Overall Study|Lost to Follow-up|6|||
129045210|NCT01388166|464458387|FG000|Overall Study|Adverse Event|16|||
129045211|NCT01388166|464458387|FG000|Overall Study|Lost to Follow-up|30|||
129045212|NCT01388166|464458387|FG000|Overall Study|Others than specified above|13|||
129045213|NCT02751359|464458388|FG000|Overall Study|Lost to Follow-up|1|||
129045214|NCT02400671|464458389|FG000|Overall Study|Death|5|||
129045215|NCT02400671|464458390|FG001|Overall Study|Death|3|||
129045216|NCT02400671|464458391|FG002|Overall Study|Death|4|||
129045217|NCT02400671|464458389|FG000|Overall Study|Lost to Follow-up|20|||
129045218|NCT02400671|464458390|FG001|Overall Study|Lost to Follow-up|27|||
129045219|NCT02400671|464458391|FG002|Overall Study|Lost to Follow-up|24|||
129045220|NCT02400671|464458389|FG000|Overall Study|Withdrawal by Subject|2|||
129045221|NCT02400671|464458390|FG001|Overall Study|Withdrawal by Subject|2|||
129045222|NCT02400671|464458391|FG002|Overall Study|Withdrawal by Subject|0|||
129045223|NCT04397445|464458397|FG000|Overall Study|Withdrawal by Subject|1|||
129045224|NCT04397445|464458398|FG001|Overall Study|Withdrawal by Subject|0|||
129135313|NCT00663351|464789199|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
129135314|NCT00663351|464789200|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
129135315|NCT00663351|464789199|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
129135316|NCT00663351|464789200|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
129135317|NCT00663351|464789199|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
129135318|NCT00663351|464789200|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
129135319|NCT00545948|464789203|FG000|Overall Study|Not Treated|1|||
128719283|NCT02608268|463271040|FG021|Overall Study|Physician Decision|0|||
129045225|NCT04397445|464458399|FG002|Overall Study|Withdrawal by Subject|0|||
129045226|NCT04397445|464458400|FG003|Overall Study|Withdrawal by Subject|0|||
129045227|NCT03656874|464458402|FG000|Overall Study|Lost to Follow-up|3|||
129045228|NCT03656874|464458403|FG001|Overall Study|Lost to Follow-up|17|||
129045229|NCT00584844|464458404|FG000|Overall Study|Withdrawal by Subject|59|||
129135320|NCT00545948|464789204|FG001|Overall Study|Not Treated|1|||
129135321|NCT00545948|464789205|FG002|Overall Study|Not Treated|7|||
129045230|NCT00584844|464458404|FG000|Overall Study|Screen Failure|20|||
129045231|NCT03001219|464458409|FG000|Proof of Concept|Study Termination by Sponsor|0|||
129045232|NCT03001219|464458410|FG001|Proof of Concept|Study Termination by Sponsor|1|||
129045233|NCT03001219|464458409|FG000|Proof of Concept|Withdrawal by Subject|0|||
129045234|NCT03001219|464458410|FG001|Proof of Concept|Withdrawal by Subject|4|||
129045235|NCT03001219|464458409|FG000|Proof of Concept|Protocol Deviation|0|||
129045236|NCT03001219|464458410|FG001|Proof of Concept|Protocol Deviation|1|||
129045237|NCT03001219|464458409|FG000|Proof of Concept|Adverse Event|1|||
129045238|NCT03001219|464458410|FG001|Proof of Concept|Adverse Event|1|||
129045239|NCT03001219|464458409|FG000|Proof of Concept|Physician Decision|1|||
129045240|NCT03001219|464458410|FG001|Proof of Concept|Physician Decision|0|||
129045241|NCT03001219|464458409|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
129045242|NCT03001219|464458410|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
129045243|NCT03001219|464458409|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
129045244|NCT03001219|464458410|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
129045245|NCT03001219|464458409|FG000|Extension Period Analysis|Physician Decision|0|||
129045246|NCT03001219|464458410|FG001|Extension Period Analysis|Physician Decision|1|||
129045247|NCT03001219|464458409|FG000|Extension Period Analysis|Adverse Event|1|||
129045248|NCT03001219|464458410|FG001|Extension Period Analysis|Adverse Event|1|||
129045249|NCT03001219|464458409|FG000|Extension Period Analysis|Protocol Deviation|0|||
129045250|NCT03001219|464458410|FG001|Extension Period Analysis|Protocol Deviation|1|||
129045251|NCT03001219|464458409|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
129045252|NCT03001219|464458410|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
129045253|NCT01195103|464458411|FG000|Overall Study|Withdrawal by Subject|1|||
129045254|NCT01195103|464458412|FG001|Overall Study|Withdrawal by Subject|0|||
129045255|NCT01195103|464458413|FG002|Overall Study|Withdrawal by Subject|0|||
129045256|NCT03760250|464458414|FG000|Overall Study|Withdrawal by Subject|1|||
129045257|NCT03760250|464458414|FG000|Overall Study|Physician Decision|1|||
129045258|NCT03733210|464458415|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
129045259|NCT03733210|464458416|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
129045260|NCT02963441|464458417|FG000|Overall Study|Protocol violation or withdrawn|8|||
129045261|NCT02963441|464458417|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
129045262|NCT02963441|464458417|FG000|Overall Study|IDx-DR insufficient quality|33|||
129045263|NCT02669940|464458420|FG000|Overall Study|Failure to return|0|||
129045264|NCT02669940|464458421|FG001|Overall Study|Failure to return|3|||
129045265|NCT02669940|464458420|FG000|Overall Study|Insufficient follow-up data|1|||
129045266|NCT02669940|464458421|FG001|Overall Study|Insufficient follow-up data|0|||
129045267|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Adverse Event|9|||
129045268|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Adverse Event|4|||
129045269|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Adverse Event|5|||
129045270|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Adverse Event|9|||
129045271|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Adverse Event|8|||
129045272|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Adverse Event|0|||
129045273|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Adverse Event|0|||
129045274|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
129045275|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
129045276|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
129045277|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
129045278|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
129045279|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
129045280|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
129045281|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Death|1|||
129045282|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Death|1|||
129045283|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Death|1|||
129045284|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Death|1|||
129045285|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Death|0|||
129045286|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Death|0|||
129045287|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Death|0|||
129045288|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
129045289|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
129045290|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
129045291|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
129045292|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
129045293|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
129045294|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
129045295|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129045296|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129045297|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
129045298|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129045299|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129045300|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129045301|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
128719284|NCT02608268|463271041|FG022|Overall Study|Physician Decision|1|||
128719285|NCT02608268|463271042|FG023|Overall Study|Physician Decision|1|||
129045302|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
129045303|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
129045304|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
129045305|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
129045306|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
129045307|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
129045308|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
129045309|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Other|2|||
129045310|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Other|9|||
129045311|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Other|9|||
129045312|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Other|3|||
129045313|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Other|2|||
129045314|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Other|0|||
129045315|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Other|0|||
129045316|NCT00361335|464458423|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
129045317|NCT00361335|464458424|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
129045318|NCT00361335|464458425|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
129045319|NCT00361335|464458426|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
129045320|NCT00361335|464458427|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
129045321|NCT00361335|464458428|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
129045322|NCT00361335|464458429|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
129045323|NCT00361335|464458423|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
129045324|NCT00361335|464458424|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
129045325|NCT00361335|464458425|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
129045326|NCT00361335|464458426|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
129045327|NCT00361335|464458427|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
129045328|NCT00361335|464458428|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
129045329|NCT00361335|464458429|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
129045330|NCT00361335|464458423|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
129045331|NCT00361335|464458424|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129045332|NCT00361335|464458425|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
129045333|NCT00361335|464458426|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129045334|NCT00361335|464458427|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129045335|NCT00361335|464458428|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129045336|NCT00361335|464458429|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
129045337|NCT00361335|464458423|FG000|SC Period: Week E0 to Week E24|Death|0|||
129045338|NCT00361335|464458424|FG001|SC Period: Week E0 to Week E24|Death|0|||
129045339|NCT00361335|464458425|FG002|SC Period: Week E0 to Week E24|Death|0|||
129045340|NCT00361335|464458426|FG003|SC Period: Week E0 to Week E24|Death|0|||
129045341|NCT00361335|464458427|FG004|SC Period: Week E0 to Week E24|Death|0|||
129045342|NCT00361335|464458428|FG005|SC Period: Week E0 to Week E24|Death|0|||
129045343|NCT00361335|464458429|FG006|SC Period: Week E0 to Week E24|Death|1|||
129045344|NCT00361335|464458423|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129045345|NCT00361335|464458424|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
129045346|NCT00361335|464458425|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
129045347|NCT00361335|464458426|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
129135322|NCT03467945|464789206|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129135323|NCT03467945|464789207|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129135324|NCT03467945|464789208|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129135325|NCT03467945|464789209|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129135326|NCT03467945|464789206|FG000|Treatment Period 3|Withdrawal by Subject|1|||
129135327|NCT03467945|464789207|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129135328|NCT03467945|464789208|FG002|Treatment Period 3|Withdrawal by Subject|2|||
129135329|NCT03467945|464789209|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129135330|NCT03520387|464789214|FG000|Pre-Randomization|Withdrawal by Subject|1|||
129135331|NCT03520387|464789215|FG001|Pre-Randomization|Withdrawal by Subject|0|||
129135332|NCT03520387|464789216|FG002|Pre-Randomization|Withdrawal by Subject|0|||
129135333|NCT03520387|464789217|FG003|Pre-Randomization|Withdrawal by Subject|0|||
129135334|NCT03520387|464789218|FG004|Pre-Randomization|Withdrawal by Subject|0|||
129223186|NCT02253316|465118313|FG001|Consolidation|Progression|0|||
129045348|NCT00361335|464458427|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129045349|NCT00361335|464458428|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129135335|NCT03520387|464789214|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
129135336|NCT03520387|464789215|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129135337|NCT03520387|464789216|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129135338|NCT03520387|464789217|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129135339|NCT03520387|464789218|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129045350|NCT00361335|464458429|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129045351|NCT00361335|464458423|FG000|SC Period: Week E0 to Week E24|Other|1|||
129045352|NCT00361335|464458424|FG001|SC Period: Week E0 to Week E24|Other|0|||
129223187|NCT02253316|465118314|FG002|Consolidation|Progression|0|||
128775394|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129045353|NCT00361335|464458425|FG002|SC Period: Week E0 to Week E24|Other|0|||
129045354|NCT00361335|464458426|FG003|SC Period: Week E0 to Week E24|Other|1|||
129045355|NCT00361335|464458427|FG004|SC Period: Week E0 to Week E24|Other|0|||
129045356|NCT00361335|464458428|FG005|SC Period: Week E0 to Week E24|Other|1|||
129045357|NCT00361335|464458429|FG006|SC Period: Week E0 to Week E24|Other|2|||
129045358|NCT00361335|464458423|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129045359|NCT00361335|464458424|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129045360|NCT00361335|464458425|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
129045361|NCT00361335|464458426|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129045362|NCT00361335|464458427|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129045363|NCT00361335|464458428|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129045364|NCT00361335|464458429|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
129045365|NCT05065983|464458430|FG000|Overall Study|Lost to Follow-up|2|||
129045366|NCT01765582|464458431|FG000|Overall Study|Other|3|||
129045367|NCT01765582|464458432|FG001|Overall Study|Other|6|||
129045368|NCT01765582|464458433|FG002|Overall Study|Other|9|||
129045369|NCT01765582|464458431|FG000|Overall Study|Lost to Follow-up|2|||
129045370|NCT01765582|464458432|FG001|Overall Study|Lost to Follow-up|2|||
129045371|NCT01765582|464458433|FG002|Overall Study|Lost to Follow-up|1|||
129045372|NCT01765582|464458431|FG000|Overall Study|Death|31|||
129045373|NCT01765582|464458432|FG001|Overall Study|Death|36|||
129045374|NCT01765582|464458433|FG002|Overall Study|Death|33|||
129045375|NCT01765582|464458431|FG000|Overall Study|Sponsor Decision|46|||
129045376|NCT01765582|464458432|FG001|Overall Study|Sponsor Decision|42|||
129045377|NCT01765582|464458433|FG002|Overall Study|Sponsor Decision|42|||
129045378|NCT01765582|464458431|FG000|Overall Study|Withdrawal of Consent|11|||
129045379|NCT01765582|464458432|FG001|Overall Study|Withdrawal of Consent|6|||
129045380|NCT01765582|464458433|FG002|Overall Study|Withdrawal of Consent|10|||
129045381|NCT00986180|464458434|FG000|Overall Study|Adverse Event|21|||
129045382|NCT00986180|464458435|FG001|Overall Study|Adverse Event|23|||
129045383|NCT00986180|464458434|FG000|Overall Study|Lack of Efficacy|4|||
129045384|NCT00986180|464458435|FG001|Overall Study|Lack of Efficacy|3|||
129045385|NCT00986180|464458434|FG000|Overall Study|Lost to Follow-up|5|||
129045386|NCT00986180|464458435|FG001|Overall Study|Lost to Follow-up|7|||
129045387|NCT00986180|464458434|FG000|Overall Study|Physician Decision|1|||
129045388|NCT00986180|464458435|FG001|Overall Study|Physician Decision|3|||
129045389|NCT00986180|464458434|FG000|Overall Study|Protocol Violation|2|||
129045390|NCT00986180|464458435|FG001|Overall Study|Protocol Violation|0|||
129045391|NCT00986180|464458434|FG000|Overall Study|Withdrawal by Subject|1|||
129045392|NCT00986180|464458435|FG001|Overall Study|Withdrawal by Subject|9|||
129045393|NCT00986180|464458434|FG000|Overall Study|Miscellanies|10|||
129045394|NCT00986180|464458435|FG001|Overall Study|Miscellanies|11|||
129045395|NCT01691820|464458436|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
129045396|NCT01691820|464458437|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
129045397|NCT01691820|464458436|FG000|Overall Study|Migrated/moved from study area|7|||
129045398|NCT01691820|464458437|FG001|Overall Study|Migrated/moved from study area|4|||
129045399|NCT01691820|464458436|FG000|Overall Study|Lost to Follow-up|6|||
129045400|NCT01691820|464458437|FG001|Overall Study|Lost to Follow-up|17|||
129045401|NCT01691820|464458436|FG000|Overall Study|Other (unspecified)|4|||
129045402|NCT01691820|464458437|FG001|Overall Study|Other (unspecified)|1|||
129045403|NCT00076804|464458442|FG000|Overall Study|Death|9|||
129045404|NCT00076804|464458443|FG001|Overall Study|Death|20|||
129045405|NCT00076804|464458442|FG000|Overall Study|Lost to Follow-up|9|||
129045406|NCT00076804|464458443|FG001|Overall Study|Lost to Follow-up|9|||
129045407|NCT00076804|464458442|FG000|Overall Study|Withdrawal by Subject|10|||
129045408|NCT00076804|464458443|FG001|Overall Study|Withdrawal by Subject|8|||
129045409|NCT00076804|464458442|FG000|Overall Study|Early study Closure|32|||
129045410|NCT00076804|464458443|FG001|Overall Study|Early study Closure|32|||
129045411|NCT02458092|464458450|FG000|Overall Study|Withdrawal by Subject|1|||
129045412|NCT02458092|464458451|FG001|Overall Study|Withdrawal by Subject|0|||
129045413|NCT03852459|464458454|FG000|Overall Study|Adverse Event|2|||
129045414|NCT03852459|464458455|FG001|Overall Study|Adverse Event|2|||
129045415|NCT03852459|464458454|FG000|Overall Study|Withdrawal by Subject|1|||
129045416|NCT03852459|464458455|FG001|Overall Study|Withdrawal by Subject|1|||
129045417|NCT02025751|464458456|FG000|Overall Study|Lost to Follow-up|1|||
128775395|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
128775396|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129045418|NCT02025751|464458457|FG001|Overall Study|Lost to Follow-up|0|||
129045419|NCT02025751|464458456|FG000|Overall Study|Adverse Event|0|||
129045420|NCT02025751|464458457|FG001|Overall Study|Adverse Event|1|||
129045421|NCT02025751|464458456|FG000|Overall Study|Physician Decision|0|||
129045422|NCT02025751|464458457|FG001|Overall Study|Physician Decision|1|||
129045423|NCT02025751|464458456|FG000|Overall Study|Withdrawal by Subject|0|||
129045424|NCT02025751|464458457|FG001|Overall Study|Withdrawal by Subject|1|||
129045425|NCT00891839|464458458|FG000|Overall Study|Adverse Event|2|||
129045426|NCT00891839|464458458|FG000|Overall Study|Withdrawal by Subject|2|||
128775397|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129045427|NCT00891839|464458458|FG000|Overall Study|Disease progression|3|||
129045428|NCT00456495|464458459|FG000|Overall Study|Physician Decision|2|||
129045429|NCT01663727|464458462|FG000|Overall Study|Death|161|||
129045430|NCT01663727|464458463|FG001|Overall Study|Death|155|||
129045431|NCT01663727|464458462|FG000|Overall Study|Lost to Follow-up|10|||
129045432|NCT01663727|464458463|FG001|Overall Study|Lost to Follow-up|8|||
129045433|NCT01663727|464458462|FG000|Overall Study|Withdrawal by Subject|18|||
129045434|NCT01663727|464458463|FG001|Overall Study|Withdrawal by Subject|25|||
129045435|NCT01663727|464458462|FG000|Overall Study|Study Terminated|51|||
129045436|NCT01663727|464458463|FG001|Overall Study|Study Terminated|50|||
129045437|NCT01663727|464458462|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
129045438|NCT01663727|464458463|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
129045439|NCT01663727|464458462|FG000|Overall Study|Withdrawal prior to dosing.|1|||
129045440|NCT01663727|464458463|FG001|Overall Study|Withdrawal prior to dosing.|0|||
129045441|NCT04969861|464458465|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
129045442|NCT04969861|464458466|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
129045443|NCT02932228|464458471|FG000|Overall Study|Death|8|||
129045444|NCT02932228|464458472|FG001|Overall Study|Death|23|||
129045445|NCT02932228|464458471|FG000|Overall Study|not eligible upon chart review|2|||
129045446|NCT02932228|464458472|FG001|Overall Study|not eligible upon chart review|5|||
129045447|NCT03340064|464459992|FG000|First Period|Adverse Event, non-fatal|2|||
129045448|NCT03340064|464459993|FG001|First Period|Adverse Event, non-fatal|0|||
129045449|NCT03340064|464459992|FG000|First Period|Lack of Efficacy|3|||
129045450|NCT03340064|464459993|FG001|First Period|Lack of Efficacy|0|||
129045451|NCT03340064|464459992|FG000|Second Period|Adverse Event, non-fatal|1|||
129045452|NCT03340064|464459993|FG001|Second Period|Adverse Event, non-fatal|1|||
129045453|NCT03340064|464459992|FG000|Second Period|Lack of Efficacy|11|||
129045454|NCT03340064|464459993|FG001|Second Period|Lack of Efficacy|0|||
129045455|NCT03340064|464459992|FG000|Second Period|Physician Decision|3|||
129045456|NCT03340064|464459993|FG001|Second Period|Physician Decision|0|||
129045457|NCT03340064|464459992|FG000|Second Period|Withdrawal by Subject|2|||
129045458|NCT03340064|464459993|FG001|Second Period|Withdrawal by Subject|1|||
129045459|NCT03340064|464459992|FG000|Second Period|Approved Drug Available For Indication|1|||
129045460|NCT03340064|464459993|FG001|Second Period|Approved Drug Available For Indication|0|||
129045461|NCT03340064|464459992|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
129045462|NCT03340064|464459993|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
129045463|NCT02522403|464459994|FG000|Overall Study|Lost to Follow-up|2|||
129045464|NCT02522403|464459995|FG001|Overall Study|Lost to Follow-up|2|||
129045465|NCT02522403|464459994|FG000|Overall Study|Withdrawal by Subject|2|||
129045466|NCT02522403|464459995|FG001|Overall Study|Withdrawal by Subject|4|||
129045467|NCT00856973|464459998|FG000|Overall Study|Adverse Event|5|||
129045468|NCT00856973|464459999|FG001|Overall Study|Adverse Event|5|||
129045469|NCT00856973|464460000|FG002|Overall Study|Adverse Event|3|||
129045470|NCT00856973|464459998|FG000|Overall Study|Lost to Follow-up|6|||
129045471|NCT00856973|464459999|FG001|Overall Study|Lost to Follow-up|3|||
129045472|NCT00856973|464460000|FG002|Overall Study|Lost to Follow-up|5|||
129045473|NCT00856973|464459998|FG000|Overall Study|Physician Decision|0|||
129045474|NCT00856973|464459999|FG001|Overall Study|Physician Decision|3|||
129045475|NCT00856973|464460000|FG002|Overall Study|Physician Decision|1|||
129045476|NCT00856973|464459998|FG000|Overall Study|Protocol Violation|1|||
129045477|NCT00856973|464459999|FG001|Overall Study|Protocol Violation|2|||
129045478|NCT00856973|464460000|FG002|Overall Study|Protocol Violation|1|||
129045479|NCT00856973|464459998|FG000|Overall Study|Withdrawal by Subject|13|||
129045480|NCT00856973|464459999|FG001|Overall Study|Withdrawal by Subject|16|||
129045481|NCT00856973|464460000|FG002|Overall Study|Withdrawal by Subject|15|||
129045482|NCT00856973|464459998|FG000|Overall Study|Other|11|||
129045483|NCT00856973|464459999|FG001|Overall Study|Other|12|||
129045484|NCT00856973|464460000|FG002|Overall Study|Other|13|||
129045485|NCT00793780|464460006|FG000|Overall Study|Withdrawal by Subject|2|||
129045486|NCT00793780|464460007|FG001|Overall Study|Withdrawal by Subject|1|||
129045487|NCT00912093|464460012|FG000|The Controlled Phase|Death|0|||
129045488|NCT00912093|464460013|FG001|The Controlled Phase|Death|1|||
129045489|NCT00912093|464460014|FG002|The Controlled Phase|Death|0|||
129045490|NCT00912093|464460015|FG003|The Controlled Phase|Death|0|||
129045491|NCT00912093|464460016|FG004|The Controlled Phase|Death|0|||
129045492|NCT00912093|464460012|FG000|The Controlled Phase|Medical Condition|0|||
129045493|NCT00912093|464460013|FG001|The Controlled Phase|Medical Condition|1|||
129045494|NCT00912093|464460014|FG002|The Controlled Phase|Medical Condition|0|||
129045495|NCT00912093|464460015|FG003|The Controlled Phase|Medical Condition|0|||
129045496|NCT00912093|464460016|FG004|The Controlled Phase|Medical Condition|0|||
129045497|NCT00912093|464460012|FG000|The Controlled Phase|Lost to Follow-up|0|||
129045498|NCT00912093|464460013|FG001|The Controlled Phase|Lost to Follow-up|0|||
129045499|NCT00912093|464460014|FG002|The Controlled Phase|Lost to Follow-up|0|||
129045500|NCT00912093|464460015|FG003|The Controlled Phase|Lost to Follow-up|0|||
129045501|NCT00912093|464460016|FG004|The Controlled Phase|Lost to Follow-up|1|||
129045502|NCT02408068|464460019|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
129045503|NCT02408068|464460020|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
129045504|NCT02408068|464460021|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
129045505|NCT02408068|464460022|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
129045506|NCT02408068|464460023|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
129045507|NCT02408068|464460024|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
129045508|NCT02303041|464460025|FG000|Overall Study|Adverse Event|1|||
129045509|NCT02303041|464460026|FG001|Overall Study|Adverse Event|2|||
129045510|NCT01370213|464460027|FG000|Overall Study|Early Death|1|||
129045511|NCT01370213|464460028|FG001|Overall Study|Early Death|0|||
129045512|NCT01370213|464460029|FG002|Overall Study|Early Death|0|||
129045513|NCT01370213|464460027|FG000|Overall Study|Not evaluable|0|||
129045514|NCT01370213|464460028|FG001|Overall Study|Not evaluable|2|||
129045515|NCT01370213|464460029|FG002|Overall Study|Not evaluable|0|||
129045516|NCT01640873|464460030|FG000|Overall Study|Protocol Violation|2|||
129045517|NCT01640873|464460031|FG001|Overall Study|Protocol Violation|1|||
129045518|NCT01321008|464460032|FG000|Overall Study|Early Study Termination|1|||
129045519|NCT02749292|464460035|FG000|Overall Study|Physician Decision|1|||
129045520|NCT02749292|464460036|FG001|Overall Study|Physician Decision|0|||
129045521|NCT02749292|464460035|FG000|Overall Study|Withdrawal by Subject|5|||
129045522|NCT02749292|464460036|FG001|Overall Study|Withdrawal by Subject|7|||
129045523|NCT02749292|464460035|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
129045524|NCT02749292|464460036|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
129045525|NCT02749292|464460035|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
129045526|NCT02749292|464460036|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
129045527|NCT02749292|464460035|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
129045528|NCT02749292|464460036|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
129045529|NCT02749292|464460035|FG000|Overall Study|Adverse Event|4|||
129045530|NCT02749292|464460036|FG001|Overall Study|Adverse Event|1|||
129045531|NCT02749292|464460035|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
129045532|NCT02749292|464460036|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
129045533|NCT02749292|464460035|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
129045534|NCT02749292|464460036|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
129045535|NCT02749292|464460035|FG000|Overall Study|Requiring glucocorticoids|0|||
129045536|NCT02749292|464460036|FG001|Overall Study|Requiring glucocorticoids|3|||
129045537|NCT02749292|464460035|FG000|Overall Study|Cancer|1|||
129045538|NCT02749292|464460036|FG001|Overall Study|Cancer|0|||
129045539|NCT00251641|464460037|FG000|Overall Study|Adverse Event|80|||
129045540|NCT00251641|464460038|FG001|Overall Study|Adverse Event|8|||
129045541|NCT00251641|464460037|FG000|Overall Study|Lack of Efficacy|2|||
129045542|NCT00251641|464460038|FG001|Overall Study|Lack of Efficacy|1|||
129045543|NCT00251641|464460037|FG000|Overall Study|Progression of Disease|0|||
129045544|NCT00251641|464460038|FG001|Overall Study|Progression of Disease|2|||
129045545|NCT00251641|464460037|FG000|Overall Study|Lost to Follow-up|3|||
129045546|NCT00251641|464460038|FG001|Overall Study|Lost to Follow-up|3|||
129045547|NCT00251641|464460037|FG000|Overall Study|Withdrawal by Subject|6|||
129045548|NCT00251641|464460038|FG001|Overall Study|Withdrawal by Subject|8|||
129045549|NCT00251641|464460037|FG000|Overall Study|Protocol Violation|10|||
129045550|NCT00251641|464460038|FG001|Overall Study|Protocol Violation|2|||
129045551|NCT00251641|464460037|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
129045552|NCT00251641|464460038|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
129045553|NCT00251641|464460037|FG000|Overall Study|Switched Treatment|9|||
129045554|NCT00251641|464460038|FG001|Overall Study|Switched Treatment|63|||
129045555|NCT02093221|464460041|FG000|Overall Study|Adverse Event|1|||
129045556|NCT02093221|464460042|FG001|Overall Study|Adverse Event|0|||
129045557|NCT02093221|464460043|FG002|Overall Study|Adverse Event|0|||
129045558|NCT02093221|464460044|FG003|Overall Study|Adverse Event|0|||
129045559|NCT02093221|464460045|FG004|Overall Study|Adverse Event|0|||
129045560|NCT02093221|464460041|FG000|Overall Study|Withdrawal by Subject|1|||
129045561|NCT02093221|464460042|FG001|Overall Study|Withdrawal by Subject|1|||
129045562|NCT02093221|464460043|FG002|Overall Study|Withdrawal by Subject|4|||
129045563|NCT02093221|464460044|FG003|Overall Study|Withdrawal by Subject|1|||
129045564|NCT02093221|464460045|FG004|Overall Study|Withdrawal by Subject|1|||
129045565|NCT02093221|464460041|FG000|Overall Study|Lost to Follow-up|2|||
129045566|NCT02093221|464460042|FG001|Overall Study|Lost to Follow-up|0|||
129045567|NCT02093221|464460043|FG002|Overall Study|Lost to Follow-up|1|||
129045568|NCT02093221|464460044|FG003|Overall Study|Lost to Follow-up|1|||
129045569|NCT02093221|464460045|FG004|Overall Study|Lost to Follow-up|0|||
129045570|NCT02093221|464460041|FG000|Overall Study|Death|0|||
129045571|NCT02093221|464460042|FG001|Overall Study|Death|1|||
129045572|NCT02093221|464460043|FG002|Overall Study|Death|0|||
129045573|NCT02093221|464460044|FG003|Overall Study|Death|0|||
129045574|NCT02093221|464460045|FG004|Overall Study|Death|0|||
129045575|NCT02093221|464460041|FG000|Overall Study|Protocol Violation|0|||
129045576|NCT02093221|464460042|FG001|Overall Study|Protocol Violation|1|||
129045577|NCT02093221|464460043|FG002|Overall Study|Protocol Violation|0|||
129045578|NCT02093221|464460044|FG003|Overall Study|Protocol Violation|0|||
129045579|NCT02093221|464460045|FG004|Overall Study|Protocol Violation|0|||
129135340|NCT03336866|464789219|FG000|Overall Study|Lost to Follow-up|2|||
129135341|NCT03336866|464789220|FG001|Overall Study|Lost to Follow-up|0|||
129135342|NCT03336866|464789221|FG002|Overall Study|Lost to Follow-up|3|||
129135343|NCT03336866|464789219|FG000|Overall Study|Withdrawal by Subject|1|||
129135344|NCT03336866|464789220|FG001|Overall Study|Withdrawal by Subject|1|||
129135345|NCT03336866|464789221|FG002|Overall Study|Withdrawal by Subject|0|||
129135346|NCT03336866|464789219|FG000|Overall Study|Noncompliance with clinic house rules|0|||
129135347|NCT03336866|464789220|FG001|Overall Study|Noncompliance with clinic house rules|0|||
129135348|NCT03336866|464789221|FG002|Overall Study|Noncompliance with clinic house rules|1|||
129135349|NCT02975700|464789222|FG000|Overall Study|Adverse Event|1|||
129135350|NCT02975700|464789222|FG000|Overall Study|Progressive disease|3|||
129135351|NCT02975700|464789222|FG000|Overall Study|Failed screening criteria|2|||
129135352|NCT05660538|464789224|FG000|Overall Study|Adverse Event|0|||
129135353|NCT05660538|464789225|FG001|Overall Study|Adverse Event|0|||
129135354|NCT05660538|464789226|FG002|Overall Study|Adverse Event|1|||
129135355|NCT05660538|464789227|FG003|Overall Study|Adverse Event|0|||
129135356|NCT05660538|464789224|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129135357|NCT05660538|464789225|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
129135358|NCT05660538|464789226|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
129135359|NCT05660538|464789227|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
129045580|NCT02093221|464460041|FG000|Overall Study|Study termination|6|||
129045581|NCT02093221|464460042|FG001|Overall Study|Study termination|5|||
129045582|NCT02093221|464460043|FG002|Overall Study|Study termination|4|||
129045583|NCT02093221|464460044|FG003|Overall Study|Study termination|6|||
129045584|NCT02093221|464460045|FG004|Overall Study|Study termination|7|||
129045585|NCT03097588|464460062|FG000|Overall Study|Adverse Event|1|||
129045586|NCT02687360|464460063|FG000|Overall Study|Withdrawal by Subject|3|||
129045587|NCT02687360|464460064|FG001|Overall Study|Withdrawal by Subject|0|||
129045588|NCT03456960|464460065|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129045589|NCT03456960|464460066|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129045590|NCT03456960|464460067|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
129045591|NCT03456960|464460068|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
129045592|NCT03456960|464460069|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129045593|NCT03456960|464460070|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129045594|NCT03456960|464460065|FG000|Period 2 (1 Day)|Adverse Event|1|||
129045595|NCT03456960|464460066|FG001|Period 2 (1 Day)|Adverse Event|0|||
129045596|NCT03456960|464460067|FG002|Period 2 (1 Day)|Adverse Event|0|||
129045597|NCT03456960|464460068|FG003|Period 2 (1 Day)|Adverse Event|1|||
129045598|NCT03456960|464460069|FG004|Period 2 (1 Day)|Adverse Event|0|||
129045599|NCT03456960|464460070|FG005|Period 2 (1 Day)|Adverse Event|0|||
129045600|NCT02989168|464460071|FG000|Overall Study|Withdrawal by Subject|2|||
129045601|NCT02989168|464460072|FG001|Overall Study|Withdrawal by Subject|0|||
129045602|NCT02989168|464460071|FG000|Overall Study|Physician Decision|0|||
129045603|NCT02989168|464460072|FG001|Overall Study|Physician Decision|1|||
129045604|NCT02989168|464460071|FG000|Overall Study|Adverse Event|1|||
129045605|NCT02989168|464460072|FG001|Overall Study|Adverse Event|2|||
129045606|NCT02989168|464460071|FG000|Overall Study|Sponsor stopped study.|1|||
129045607|NCT02989168|464460072|FG001|Overall Study|Sponsor stopped study.|0|||
129045608|NCT03828448|464460073|FG000|Overall Study|Sponsor's Discretion|34|||
129045609|NCT02037165|464460074|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129045610|NCT02037165|464460075|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129045611|NCT02037165|464460076|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129045612|NCT02037165|464460077|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129045613|NCT02037165|464460078|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
129045614|NCT00532935|464460079|FG000|Overall Study|Adverse Event|11|||
129045615|NCT00532935|464460080|FG001|Overall Study|Adverse Event|12|||
129045616|NCT00532935|464460079|FG000|Overall Study|Lack of Efficacy|0|||
129045617|NCT00532935|464460080|FG001|Overall Study|Lack of Efficacy|3|||
129045618|NCT00532935|464460079|FG000|Overall Study|Lost to Follow-up|10|||
129045619|NCT00532935|464460080|FG001|Overall Study|Lost to Follow-up|6|||
129045620|NCT00532935|464460079|FG000|Overall Study|Physician Decision|4|||
129045621|NCT00532935|464460080|FG001|Overall Study|Physician Decision|5|||
129045622|NCT00532935|464460079|FG000|Overall Study|Pregnancy|1|||
129045623|NCT00532935|464460080|FG001|Overall Study|Pregnancy|0|||
129045624|NCT00532935|464460079|FG000|Overall Study|Protocol Violation|4|||
129045625|NCT00532935|464460080|FG001|Overall Study|Protocol Violation|2|||
129135360|NCT05660538|464789224|FG000|Overall Study|Lost to Follow-up|0|||
129135361|NCT05660538|464789225|FG001|Overall Study|Lost to Follow-up|0|||
129045626|NCT00532935|464460079|FG000|Overall Study|Withdrawal by Subject|10|||
129045627|NCT00532935|464460080|FG001|Overall Study|Withdrawal by Subject|9|||
129045628|NCT00532935|464460079|FG000|Overall Study|Protocol Specific Criteria|11|||
129045629|NCT00532935|464460080|FG001|Overall Study|Protocol Specific Criteria|15|||
129045630|NCT02192164|464460081|FG000|Overall Study|Other|8|||
129135362|NCT05660538|464789226|FG002|Overall Study|Lost to Follow-up|1|||
129135363|NCT05660538|464789227|FG003|Overall Study|Lost to Follow-up|1|||
129135364|NCT05660538|464789224|FG000|Overall Study|Death|0|||
129045631|NCT02192164|464460081|FG000|Overall Study|Withdrawal by Subject|1|||
129045632|NCT02192164|464460081|FG000|Overall Study|Physician Decision|4|||
129045633|NCT02192164|464460081|FG000|Overall Study|Did not meet the exclusion criteria|1|||
129045634|NCT01300923|464460082|FG000|Overall Study|Physician Decision|0|||
129045635|NCT01300923|464460083|FG001|Overall Study|Physician Decision|2|||
129045636|NCT01568866|464460084|FG000|Overall Study|Disease Progression|208|||
129045637|NCT01568866|464460085|FG001|Overall Study|Disease Progression|183|||
129045638|NCT01568866|464460084|FG000|Overall Study|Adverse Event|94|||
129045639|NCT01568866|464460085|FG001|Overall Study|Adverse Event|96|||
129045640|NCT01568866|464460084|FG000|Overall Study|Patient Request|55|||
129045641|NCT01568866|464460085|FG001|Overall Study|Patient Request|71|||
129045642|NCT01568866|464460084|FG000|Overall Study|Physician Decision|40|||
129045643|NCT01568866|464460085|FG001|Overall Study|Physician Decision|32|||
129045644|NCT01568866|464460084|FG000|Overall Study|Withdrawal by Subject|19|||
129045645|NCT01568866|464460085|FG001|Overall Study|Withdrawal by Subject|11|||
129045646|NCT01568866|464460084|FG000|Overall Study|Death|10|||
129045647|NCT01568866|464460085|FG001|Overall Study|Death|18|||
129045648|NCT01568866|464460084|FG000|Overall Study|Protocol Non-compliance|2|||
129045649|NCT01568866|464460085|FG001|Overall Study|Protocol Non-compliance|4|||
129045650|NCT01568866|464460084|FG000|Overall Study|Lost to Follow-up|1|||
129045651|NCT01568866|464460085|FG001|Overall Study|Lost to Follow-up|0|||
129045652|NCT01568866|464460084|FG000|Overall Study|Randomized but Not Dosed|9|||
129045653|NCT01568866|464460085|FG001|Overall Study|Randomized but Not Dosed|1|||
129045654|NCT01698775|464460088|FG000|Phase A|Adverse Event|2|||
129045655|NCT01698775|464460089|FG001|Phase A|Adverse Event|1|||
129045656|NCT01698775|464460088|FG000|Phase A|Death|1|||
129045657|NCT01698775|464460089|FG001|Phase A|Death|1|||
129045658|NCT01698775|464460088|FG000|Phase A|Lack of Efficacy|1|||
129045659|NCT01698775|464460089|FG001|Phase A|Lack of Efficacy|0|||
129045660|NCT01698775|464460088|FG000|Phase A|Lost to Follow-up|1|||
129045661|NCT01698775|464460089|FG001|Phase A|Lost to Follow-up|2|||
129045662|NCT01698775|464460088|FG000|Phase A|Protocol Violation|1|||
129045663|NCT01698775|464460089|FG001|Phase A|Protocol Violation|0|||
129045664|NCT01698775|464460088|FG000|Phase A|Withdrawal by Subject|3|||
129045665|NCT01698775|464460089|FG001|Phase A|Withdrawal by Subject|4|||
129045666|NCT01698775|464460088|FG000|Phase A|Kidney [transplant]|0|||
129045667|NCT01698775|464460089|FG001|Phase A|Kidney [transplant]|1|||
129045668|NCT01698775|464460088|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
129045669|NCT01698775|464460089|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
129045670|NCT01698775|464460088|FG000|Phase B|Adverse Event|6|||
129045671|NCT01698775|464460089|FG001|Phase B|Adverse Event|3|||
129045672|NCT01698775|464460088|FG000|Phase B|Death|0|||
129045673|NCT01698775|464460089|FG001|Phase B|Death|1|||
129045674|NCT01698775|464460088|FG000|Phase B|Lack of Efficacy|0|||
129045675|NCT01698775|464460089|FG001|Phase B|Lack of Efficacy|1|||
129045676|NCT01698775|464460088|FG000|Phase B|Lost to Follow-up|0|||
129045677|NCT01698775|464460089|FG001|Phase B|Lost to Follow-up|1|||
129045678|NCT01698775|464460088|FG000|Phase B|Physician Decision|1|||
129045679|NCT01698775|464460089|FG001|Phase B|Physician Decision|1|||
129045680|NCT01698775|464460088|FG000|Phase B|Protocol Violation|1|||
129045681|NCT01698775|464460089|FG001|Phase B|Protocol Violation|1|||
129045682|NCT01698775|464460088|FG000|Phase B|Withdrawal by Subject|6|||
129045683|NCT01698775|464460089|FG001|Phase B|Withdrawal by Subject|2|||
129045684|NCT00359788|464460090|FG000|Overall Study|Adverse Event|11|||
129045685|NCT00359788|464460091|FG001|Overall Study|Adverse Event|10|||
129045686|NCT00359788|464460090|FG000|Overall Study|Lack of Efficacy|1|||
129045687|NCT00359788|464460091|FG001|Overall Study|Lack of Efficacy|2|||
129045688|NCT00359788|464460090|FG000|Overall Study|Lost to Follow-up|3|||
129045689|NCT00359788|464460091|FG001|Overall Study|Lost to Follow-up|2|||
129045690|NCT00359788|464460090|FG000|Overall Study|Withdrawal by Subject|4|||
129045691|NCT00359788|464460091|FG001|Overall Study|Withdrawal by Subject|1|||
129045692|NCT00359788|464460090|FG000|Overall Study|Protocol Violation|4|||
129045693|NCT00359788|464460091|FG001|Overall Study|Protocol Violation|2|||
129045694|NCT02143583|464460092|FG000|Overall Study|Withdrawal by Subject|1|||
129045695|NCT02143583|464460093|FG001|Overall Study|Withdrawal by Subject|0|||
129045696|NCT02143583|464460094|FG002|Overall Study|Withdrawal by Subject|1|||
129045697|NCT02143583|464460092|FG000|Overall Study|husband illness|0|||
129045698|NCT02143583|464460093|FG001|Overall Study|husband illness|0|||
129045699|NCT02143583|464460094|FG002|Overall Study|husband illness|1|||
129135365|NCT05660538|464789225|FG001|Overall Study|Death|0|||
129135366|NCT05660538|464789226|FG002|Overall Study|Death|1|||
129045700|NCT01244061|464460095|FG000|Overall Study|Death|1|||
129045701|NCT01244061|464460096|FG001|Overall Study|Death|0|||
129045702|NCT01244061|464460095|FG000|Overall Study|Did not meet entrance criteria|1|||
129045703|NCT01244061|464460096|FG001|Overall Study|Did not meet entrance criteria|0|||
129045704|NCT01244061|464460095|FG000|Overall Study|Lack of Efficacy|1|||
129045705|NCT01244061|464460096|FG001|Overall Study|Lack of Efficacy|3|||
129045706|NCT01244061|464460095|FG000|Overall Study|Lost to Follow-up|34|||
129045707|NCT01244061|464460096|FG001|Overall Study|Lost to Follow-up|30|||
129045708|NCT01244061|464460095|FG000|Overall Study|Withdrawal by Subject|29|||
129045709|NCT01244061|464460096|FG001|Overall Study|Withdrawal by Subject|46|||
129045710|NCT01244061|464460095|FG000|Overall Study|Other|8|||
129045711|NCT01244061|464460096|FG001|Overall Study|Other|19|||
129045712|NCT01244061|464460095|FG000|Overall Study|Protocol Violation|1|||
129045713|NCT01244061|464460096|FG001|Overall Study|Protocol Violation|1|||
129045714|NCT01244061|464460095|FG000|Overall Study|Adverse Event|5|||
129045715|NCT01244061|464460096|FG001|Overall Study|Adverse Event|2|||
129045716|NCT01244061|464460095|FG000|Overall Study|Randomized but not treated|2|||
129045717|NCT01244061|464460096|FG001|Overall Study|Randomized but not treated|2|||
129045718|NCT00673933|464460097|FG000|Overall Study|Withdrawal by Subject|2|||
129045719|NCT00673933|464460097|FG000|Overall Study|Lost to Follow-up|1|||
129045720|NCT04932941|464460100|FG000|Overall Study|Lost to Follow-up|3|||
129045721|NCT04932941|464460101|FG001|Overall Study|Lost to Follow-up|1|||
129045722|NCT04932941|464460100|FG000|Overall Study|Withdrawal by Subject|7|||
129045723|NCT04932941|464460101|FG001|Overall Study|Withdrawal by Subject|4|||
129045724|NCT04932941|464460100|FG000|Overall Study|Other|4|||
129135367|NCT05660538|464789227|FG003|Overall Study|Death|0|||
129135368|NCT05660538|464789224|FG000|Overall Study|Physician Decision|0|||
129135369|NCT05660538|464789225|FG001|Overall Study|Physician Decision|0|||
129135370|NCT05660538|464789226|FG002|Overall Study|Physician Decision|0|||
129135371|NCT05660538|464789227|FG003|Overall Study|Physician Decision|1|||
129135372|NCT05660538|464789224|FG000|Overall Study|Sponsor Decision|1|||
129135373|NCT05660538|464789225|FG001|Overall Study|Sponsor Decision|0|||
129135374|NCT05660538|464789226|FG002|Overall Study|Sponsor Decision|0|||
129135375|NCT05660538|464789227|FG003|Overall Study|Sponsor Decision|0|||
129135376|NCT05660538|464789224|FG000|Overall Study|Other|1|||
129135377|NCT05660538|464789225|FG001|Overall Study|Other|0|||
129135378|NCT05660538|464789226|FG002|Overall Study|Other|0|||
129135379|NCT05660538|464789227|FG003|Overall Study|Other|1|||
129135380|NCT05660538|464789224|FG000|Overall Study|Randomized but did not receive study drug|1|||
129135381|NCT05660538|464789225|FG001|Overall Study|Randomized but did not receive study drug|0|||
129135382|NCT05660538|464789226|FG002|Overall Study|Randomized but did not receive study drug|0|||
129135383|NCT05660538|464789227|FG003|Overall Study|Randomized but did not receive study drug|1|||
129135384|NCT05660538|464789224|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
129135385|NCT05660538|464789225|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
129135386|NCT05660538|464789226|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
129135387|NCT05660538|464789227|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
129135388|NCT04518410|464789229|FG000|Overall Study|Lost to Follow-up|1|||
129135389|NCT04518410|464789230|FG001|Overall Study|Lost to Follow-up|1|||
129135390|NCT04518410|464789231|FG002|Overall Study|Lost to Follow-up|8|||
129135391|NCT04518410|464789232|FG003|Overall Study|Lost to Follow-up|5|||
129223188|NCT02253316|465118312|FG000|Consolidation|Non-Compliance|1|||
129223189|NCT02253316|465118313|FG001|Consolidation|Non-Compliance|0|||
129045725|NCT04932941|464460101|FG001|Overall Study|Other|2|||
129045726|NCT01929031|464460104|FG000|Overall Study|Adverse Event|3|||
129045727|NCT01929031|464460105|FG001|Overall Study|Adverse Event|1|||
129045728|NCT01929031|464460106|FG002|Overall Study|Adverse Event|1|||
129045729|NCT01929031|464460107|FG003|Overall Study|Adverse Event|0|||
129045730|NCT01929031|464460108|FG004|Overall Study|Adverse Event|0|||
129045731|NCT01929031|464460109|FG005|Overall Study|Adverse Event|0|||
129045732|NCT01929031|464460104|FG000|Overall Study|Protocol Violation|1|||
129045733|NCT01929031|464460105|FG001|Overall Study|Protocol Violation|0|||
129045734|NCT01929031|464460106|FG002|Overall Study|Protocol Violation|0|||
129045735|NCT01929031|464460107|FG003|Overall Study|Protocol Violation|0|||
129045736|NCT01929031|464460108|FG004|Overall Study|Protocol Violation|0|||
129045737|NCT01929031|464460109|FG005|Overall Study|Protocol Violation|1|||
129045738|NCT01929031|464460104|FG000|Overall Study|Reason other than specified above|0|||
129045739|NCT01929031|464460105|FG001|Overall Study|Reason other than specified above|1|||
129045740|NCT01929031|464460106|FG002|Overall Study|Reason other than specified above|0|||
129045741|NCT01929031|464460107|FG003|Overall Study|Reason other than specified above|0|||
129045742|NCT01929031|464460108|FG004|Overall Study|Reason other than specified above|1|||
129045743|NCT01929031|464460109|FG005|Overall Study|Reason other than specified above|0|||
129045744|NCT01366443|464460110|FG000|Overall Study|Lost to Follow-up|2|||
129045745|NCT01366443|464460110|FG000|Overall Study|Under 18 yo|1|||
129045746|NCT05816200|464460111|FG000|Overall Study|Lost to Follow-up|2|||
129135392|NCT04518410|464789233|FG004|Overall Study|Lost to Follow-up|92|||
129135393|NCT04518410|464789234|FG005|Overall Study|Lost to Follow-up|25|||
129135394|NCT04518410|464789235|FG006|Overall Study|Lost to Follow-up|25|||
129223190|NCT02253316|465118314|FG002|Consolidation|Non-Compliance|0|||
129045747|NCT05816200|464460112|FG001|Overall Study|Lost to Follow-up|1|||
129045748|NCT00369382|464460118|FG000|Overall Study|Death|0|||
128775398|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129045749|NCT00369382|464460119|FG001|Overall Study|Death|2|||
129045750|NCT00369382|464460118|FG000|Overall Study|Physician Decision|2|||
129045751|NCT00369382|464460119|FG001|Overall Study|Physician Decision|1|||
129045752|NCT00369382|464460118|FG000|Overall Study|Withdrawal by Subject|5|||
129045753|NCT00369382|464460119|FG001|Overall Study|Withdrawal by Subject|0|||
129135395|NCT04518410|464789236|FG007|Overall Study|Lost to Follow-up|3|||
129135396|NCT04518410|464789237|FG008|Overall Study|Lost to Follow-up|2|||
129135397|NCT04518410|464789238|FG009|Overall Study|Lost to Follow-up|13|||
129135398|NCT04518410|464789239|FG010|Overall Study|Lost to Follow-up|9|||
129135399|NCT04518410|464789240|FG011|Overall Study|Lost to Follow-up|13|||
129135400|NCT04518410|464789241|FG012|Overall Study|Lost to Follow-up|9|||
129135401|NCT04518410|464789242|FG013|Overall Study|Lost to Follow-up|13|||
129135402|NCT04518410|464789243|FG014|Overall Study|Lost to Follow-up|8|||
129135403|NCT04518410|464789244|FG015|Overall Study|Lost to Follow-up|10|||
129135404|NCT04518410|464789245|FG016|Overall Study|Lost to Follow-up|6|||
129135405|NCT04518410|464789246|FG017|Overall Study|Lost to Follow-up|13|||
128719286|NCT02608268|463271043|FG024|Overall Study|Physician Decision|1|||
128719287|NCT02608268|463271044|FG025|Overall Study|Physician Decision|0|||
128719288|NCT02608268|463271045|FG026|Overall Study|Physician Decision|0|||
129045754|NCT00369382|464460118|FG000|Overall Study|Randomized, not treated|2|||
129045755|NCT00369382|464460119|FG001|Overall Study|Randomized, not treated|0|||
129045756|NCT00369382|464460118|FG000|Overall Study|Other|1|||
129045757|NCT00369382|464460119|FG001|Overall Study|Other|0|||
129045758|NCT02394730|464460120|FG000|Overall Study|Lost to Follow-up|1|||
129045759|NCT02394730|464460121|FG001|Overall Study|Lost to Follow-up|0|||
129045760|NCT02394730|464460120|FG000|Overall Study|Withdrawal by Subject|0|||
129045761|NCT02394730|464460121|FG001|Overall Study|Withdrawal by Subject|1|||
129045762|NCT02384850|464460123|FG000|Overall Study|Withdrawal by Subject|2|||
129045763|NCT02384850|464460124|FG001|Overall Study|Withdrawal by Subject|2|||
129045764|NCT01673698|464460125|FG000|Overall Study|Lost to Follow-up|51|||
129045765|NCT01673698|464460126|FG001|Overall Study|Lost to Follow-up|13|||
129045766|NCT00507546|464460127|FG000|Overall Study|Withdrawal by Subject|1|||
129045767|NCT00507546|464460128|FG001|Overall Study|Withdrawal by Subject|0|||
129045768|NCT00507546|464460127|FG000|Overall Study|Protocol Violation|1|||
129045769|NCT00507546|464460128|FG001|Overall Study|Protocol Violation|0|||
129045770|NCT00507546|464460127|FG000|Overall Study|Physician Decision|0|||
129045771|NCT00507546|464460128|FG001|Overall Study|Physician Decision|1|||
129045772|NCT00448136|464460129|FG000|Overall Study|Death|3|||
129045773|NCT00448136|464460130|FG001|Overall Study|Death|8|||
129045774|NCT00448136|464460129|FG000|Overall Study|Investigator's decision (progression)|1|||
129045775|NCT00448136|464460130|FG001|Overall Study|Investigator's decision (progression)|0|||
129045776|NCT02013375|464460131|FG000|Overall Study|Did not engraft|1|||
129045777|NCT02013375|464460131|FG000|Overall Study|Did not engraft|1|||
129045778|NCT01334710|464460138|FG000|Overall Study|Trial was terminated|3|||
129045779|NCT01558297|464460139|FG000|Overall Study|Withdrawal by Subject|2|||
129045780|NCT01558297|464460140|FG001|Overall Study|Withdrawal by Subject|2|||
129045781|NCT01558297|464460141|FG002|Overall Study|Withdrawal by Subject|1|||
129045782|NCT00375492|464460142|FG000|Overall Study|Adverse Event|4|||
129045783|NCT00375492|464460143|FG001|Overall Study|Adverse Event|5|||
129045784|NCT00375492|464460142|FG000|Overall Study|Entry Criteria Not Met|0|||
129045785|NCT00375492|464460143|FG001|Overall Study|Entry Criteria Not Met|1|||
129045786|NCT00375492|464460142|FG000|Overall Study|Loss of Glucose Control|0|||
129045787|NCT00375492|464460143|FG001|Overall Study|Loss of Glucose Control|1|||
129045788|NCT00375492|464460142|FG000|Overall Study|Lost to Follow-up|10|||
129045789|NCT00375492|464460143|FG001|Overall Study|Lost to Follow-up|5|||
129045790|NCT00375492|464460142|FG000|Overall Study|Physician Decision|0|||
129045791|NCT00375492|464460143|FG001|Overall Study|Physician Decision|4|||
129045792|NCT00375492|464460142|FG000|Overall Study|Protocol Violation|6|||
129045793|NCT00375492|464460143|FG001|Overall Study|Protocol Violation|3|||
129045794|NCT00375492|464460142|FG000|Overall Study|Sponsor Decision|0|||
129045795|NCT00375492|464460143|FG001|Overall Study|Sponsor Decision|1|||
129045796|NCT00375492|464460142|FG000|Overall Study|Withdrawal by Subject|6|||
129045797|NCT00375492|464460143|FG001|Overall Study|Withdrawal by Subject|6|||
128719289|NCT02608268|463271046|FG027|Overall Study|Physician Decision|2|||
128719290|NCT02608268|463271047|FG028|Overall Study|Physician Decision|1|||
128719291|NCT02608268|463271048|FG029|Overall Study|Physician Decision|1|||
128719292|NCT02608268|463271019|FG000|Overall Study|Progressive disease|12|||
129045798|NCT01902628|464460144|FG000|Overall Study|Withdrawal of participant's consent|7|||
129135406|NCT04518410|464789247|FG018|Overall Study|Lost to Follow-up|21|||
129135407|NCT04518410|464789248|FG019|Overall Study|Lost to Follow-up|6|||
129135408|NCT04518410|464789249|FG020|Overall Study|Lost to Follow-up|7|||
128719293|NCT02608268|463271020|FG001|Overall Study|Progressive disease|8|||
128719294|NCT02608268|463271021|FG002|Overall Study|Progressive disease|13|||
128775399|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129045799|NCT01902628|464460144|FG000|Overall Study|Adverse Event|41|||
129045800|NCT01902628|464460144|FG000|Overall Study|Lost to Follow-up|35|||
129045801|NCT01232491|464460145|FG000|Overall Study|Adverse Event|13|||
129045802|NCT01232491|464460146|FG001|Overall Study|Adverse Event|8|||
129045803|NCT01232491|464460145|FG000|Overall Study|Lack of Efficacy|1|||
129045804|NCT01232491|464460146|FG001|Overall Study|Lack of Efficacy|5|||
129045805|NCT01232491|464460145|FG000|Overall Study|Protocol Violation|13|||
129045806|NCT01232491|464460146|FG001|Overall Study|Protocol Violation|11|||
129045807|NCT01232491|464460145|FG000|Overall Study|Withdrawal Criteria|12|||
129045808|NCT01232491|464460146|FG001|Overall Study|Withdrawal Criteria|21|||
129135409|NCT04518410|464789250|FG021|Overall Study|Lost to Follow-up|21|||
129045809|NCT01232491|464460145|FG000|Overall Study|Other|21|||
129045810|NCT01232491|464460146|FG001|Overall Study|Other|18|||
129045811|NCT04905290|464461581|FG000|Overall Study|Adverse Event|4|||
129045812|NCT04905290|464461581|FG000|Overall Study|Death|2|||
129135410|NCT04518410|464789251|FG022|Overall Study|Lost to Follow-up|1|||
129135411|NCT04518410|464789252|FG023|Overall Study|Lost to Follow-up|7|||
129135412|NCT04518410|464789253|FG024|Overall Study|Lost to Follow-up|6|||
129135413|NCT04518410|464789229|FG000|Overall Study|Withdrawal by Subject|1|||
129135414|NCT04518410|464789230|FG001|Overall Study|Withdrawal by Subject|2|||
129135415|NCT04518410|464789231|FG002|Overall Study|Withdrawal by Subject|2|||
129135416|NCT04518410|464789232|FG003|Overall Study|Withdrawal by Subject|3|||
129135417|NCT04518410|464789233|FG004|Overall Study|Withdrawal by Subject|20|||
129135418|NCT04518410|464789234|FG005|Overall Study|Withdrawal by Subject|20|||
129135419|NCT04518410|464789235|FG006|Overall Study|Withdrawal by Subject|25|||
129135420|NCT04518410|464789236|FG007|Overall Study|Withdrawal by Subject|6|||
129135421|NCT04518410|464789237|FG008|Overall Study|Withdrawal by Subject|1|||
129135422|NCT04518410|464789238|FG009|Overall Study|Withdrawal by Subject|12|||
129135423|NCT04518410|464789239|FG010|Overall Study|Withdrawal by Subject|5|||
129135424|NCT04518410|464789240|FG011|Overall Study|Withdrawal by Subject|7|||
129135425|NCT04518410|464789241|FG012|Overall Study|Withdrawal by Subject|2|||
129135426|NCT04518410|464789242|FG013|Overall Study|Withdrawal by Subject|13|||
129135427|NCT04518410|464789243|FG014|Overall Study|Withdrawal by Subject|4|||
129135428|NCT04518410|464789244|FG015|Overall Study|Withdrawal by Subject|9|||
129135429|NCT04518410|464789245|FG016|Overall Study|Withdrawal by Subject|0|||
129135430|NCT04518410|464789246|FG017|Overall Study|Withdrawal by Subject|15|||
129135431|NCT04518410|464789247|FG018|Overall Study|Withdrawal by Subject|12|||
129135432|NCT04518410|464789248|FG019|Overall Study|Withdrawal by Subject|9|||
129135433|NCT04518410|464789249|FG020|Overall Study|Withdrawal by Subject|14|||
129135434|NCT04518410|464789250|FG021|Overall Study|Withdrawal by Subject|3|||
129135435|NCT04518410|464789251|FG022|Overall Study|Withdrawal by Subject|2|||
129135436|NCT04518410|464789252|FG023|Overall Study|Withdrawal by Subject|9|||
129135437|NCT04518410|464789253|FG024|Overall Study|Withdrawal by Subject|8|||
129135438|NCT04518410|464789229|FG000|Overall Study|Other|1|||
129135439|NCT04518410|464789230|FG001|Overall Study|Other|0|||
129135440|NCT04518410|464789231|FG002|Overall Study|Other|0|||
129135441|NCT04518410|464789232|FG003|Overall Study|Other|1|||
129135442|NCT04518410|464789233|FG004|Overall Study|Other|6|||
129135443|NCT04518410|464789234|FG005|Overall Study|Other|6|||
129045813|NCT04905290|464461581|FG000|Overall Study|Withdrawal by Subject|4|||
129045814|NCT04905290|464461581|FG000|Overall Study|Physician Decision|2|||
129045815|NCT04905290|464461581|FG000|Overall Study|Lost to Follow-up|2|||
129045816|NCT04905290|464461581|FG000|Overall Study|Screen Failure|2|||
129045817|NCT04905290|464461581|FG000|Overall Study|Unsuccessful Procedure|2|||
129045818|NCT00821873|464461582|FG000|Overall Study|Lost to Follow-up|4|||
129045819|NCT01995266|464461584|FG000|Overall Study|Death|1|||
129045820|NCT01995266|464461584|FG000|Overall Study|Lack of Efficacy|6|||
129045821|NCT01995266|464461584|FG000|Overall Study|Adverse Event|2|||
129045822|NCT03596151|464461585|FG000|Overall Study|Withdrawal by Subject|1|||
129045823|NCT00729248|464461591|FG000|Overall Study|Physician Decision|2|||
129045824|NCT03222583|464461592|FG000|Overall Study|Withdrawal by Subject|3|||
129045825|NCT03222583|464461593|FG001|Overall Study|Withdrawal by Subject|3|||
129045826|NCT03222583|464461592|FG000|Overall Study|Lost to Follow-up|1|||
129045827|NCT03222583|464461593|FG001|Overall Study|Lost to Follow-up|0|||
129045828|NCT03222583|464461592|FG000|Overall Study|Other|1|||
129045829|NCT03222583|464461593|FG001|Overall Study|Other|3|||
129045830|NCT04280705|464461594|FG000|Overall Study|Enrolled but not treated|4|||
129135444|NCT04518410|464789235|FG006|Overall Study|Other|5|||
129135445|NCT04518410|464789236|FG007|Overall Study|Other|2|||
129135446|NCT04518410|464789237|FG008|Overall Study|Other|0|||
129135447|NCT04518410|464789238|FG009|Overall Study|Other|1|||
129135448|NCT04518410|464789239|FG010|Overall Study|Other|0|||
129135449|NCT04518410|464789240|FG011|Overall Study|Other|2|||
129135450|NCT04518410|464789241|FG012|Overall Study|Other|0|||
129135451|NCT04518410|464789242|FG013|Overall Study|Other|0|||
129135452|NCT04518410|464789243|FG014|Overall Study|Other|0|||
129135453|NCT04518410|464789244|FG015|Overall Study|Other|3|||
129135454|NCT04518410|464789245|FG016|Overall Study|Other|1|||
129135455|NCT04518410|464789246|FG017|Overall Study|Other|1|||
129135456|NCT04518410|464789247|FG018|Overall Study|Other|1|||
129135457|NCT04518410|464789248|FG019|Overall Study|Other|0|||
129135458|NCT04518410|464789249|FG020|Overall Study|Other|1|||
129135459|NCT04518410|464789250|FG021|Overall Study|Other|0|||
129045831|NCT04280705|464461595|FG001|Overall Study|Enrolled but not treated|10|||
129045832|NCT04280705|464461594|FG000|Overall Study|Physician Decision|1|||
129045833|NCT04280705|464461595|FG001|Overall Study|Physician Decision|0|||
129045834|NCT04280705|464461594|FG000|Overall Study|Withdrawal by Subject|7|||
129135460|NCT04518410|464789251|FG022|Overall Study|Other|1|||
129135461|NCT04518410|464789252|FG023|Overall Study|Other|2|||
129135462|NCT04518410|464789253|FG024|Overall Study|Other|2|||
129135463|NCT04518410|464789229|FG000|Overall Study|Protocol Violation|0|||
129045835|NCT04280705|464461595|FG001|Overall Study|Withdrawal by Subject|9|||
129045836|NCT04280705|464461594|FG000|Overall Study|Adverse Event|0|||
129045837|NCT04280705|464461595|FG001|Overall Study|Adverse Event|4|||
129045838|NCT04280705|464461594|FG000|Overall Study|Transferred to another hospital|1|||
129045839|NCT04280705|464461595|FG001|Overall Study|Transferred to another hospital|1|||
129045840|NCT03573505|464461596|FG000|Overall Study|Adverse Event|1|||
129045841|NCT03573505|464461597|FG001|Overall Study|Adverse Event|1|||
129045842|NCT03573505|464461596|FG000|Overall Study|Consent withdrawn|0|||
129045843|NCT03573505|464461597|FG001|Overall Study|Consent withdrawn|1|||
129045844|NCT03573505|464461596|FG000|Overall Study|Disease progression|0|||
129045845|NCT03573505|464461597|FG001|Overall Study|Disease progression|1|||
129045846|NCT03573505|464461596|FG000|Overall Study|Site Terminated by Sponsor|1|||
129045847|NCT03573505|464461597|FG001|Overall Study|Site Terminated by Sponsor|1|||
129045848|NCT03573505|464461596|FG000|Overall Study|Study terminated by sponsor|50|||
129045849|NCT03573505|464461597|FG001|Overall Study|Study terminated by sponsor|45|||
129045850|NCT03573505|464461596|FG000|Overall Study|Reason not specified|0|||
129045851|NCT03573505|464461597|FG001|Overall Study|Reason not specified|1|||
129045852|NCT03573505|464461596|FG000|Overall Study|Death|0|||
129045853|NCT03573505|464461597|FG001|Overall Study|Death|4|||
129045854|NCT04268316|464461600|FG000|Overall Study|Withdrawal by Subject|2|||
129045855|NCT04268316|464461601|FG001|Overall Study|Withdrawal by Subject|1|||
129045856|NCT04268316|464461602|FG002|Overall Study|Withdrawal by Subject|0|||
129045857|NCT03188718|464461603|FG000|Overall Study|Participant noncompliance|4|||
129045858|NCT03188718|464461603|FG000|Overall Study|Withdrawal by Subject|1|||
129045859|NCT03188718|464461603|FG000|Overall Study|Device failure|3|||
129045860|NCT04032158|464461604|FG000|Overall Study|Study Termination|2|||
129045861|NCT04032158|464461605|FG001|Overall Study|Study Termination|1|||
129045862|NCT02072824|464461606|FG000|Overall Study|Insufficient clinical response|1|||
129045863|NCT02072824|464461607|FG001|Overall Study|Insufficient clinical response|0|||
129045864|NCT02072824|464461608|FG002|Overall Study|Insufficient clinical response|1|||
129045865|NCT02072824|464461606|FG000|Overall Study|No longer willing to participate|1|||
129045866|NCT02072824|464461607|FG001|Overall Study|No longer willing to participate|0|||
129045867|NCT02072824|464461608|FG002|Overall Study|No longer willing to participate|1|||
129045868|NCT02072824|464461606|FG000|Overall Study|Medication error|0|||
129045869|NCT02072824|464461607|FG001|Overall Study|Medication error|1|||
129045870|NCT02072824|464461608|FG002|Overall Study|Medication error|0|||
129045871|NCT02072824|464461606|FG000|Overall Study|Adverse Event|0|||
129045872|NCT02072824|464461607|FG001|Overall Study|Adverse Event|0|||
129045873|NCT02072824|464461608|FG002|Overall Study|Adverse Event|1|||
129045874|NCT03084367|464461609|FG000|Overall Study|Lost to Follow-up|32|||
129045875|NCT03084367|464461609|FG000|Overall Study|Withdrawal by Subject|4|||
129045876|NCT03084367|464461609|FG000|Overall Study|Other|1|||
129045877|NCT00841906|464461610|FG000|Overall Study|Withdrawal by Subject|2|||
129045878|NCT00841906|464461611|FG001|Overall Study|Withdrawal by Subject|0|||
129045879|NCT01196078|464461614|FG000|Overall Study|Withdrawal by Subject|3|||
129045880|NCT01196078|464461615|FG001|Overall Study|Withdrawal by Subject|5|||
129045881|NCT01196078|464461614|FG000|Overall Study|Adverse Event|4|||
129045882|NCT01196078|464461615|FG001|Overall Study|Adverse Event|4|||
129045883|NCT01196078|464461614|FG000|Overall Study|Protocol Violation|2|||
129045884|NCT01196078|464461615|FG001|Overall Study|Protocol Violation|1|||
129045885|NCT01196078|464461614|FG000|Overall Study|Lack of Efficacy|17|||
129045886|NCT01196078|464461615|FG001|Overall Study|Lack of Efficacy|23|||
129045887|NCT01196078|464461614|FG000|Overall Study|Lost to Follow-up|1|||
129045888|NCT01196078|464461615|FG001|Overall Study|Lost to Follow-up|0|||
129045889|NCT01196078|464461614|FG000|Overall Study|Death|6|||
129045890|NCT01196078|464461615|FG001|Overall Study|Death|4|||
129045891|NCT02667288|464461616|FG000|Overall Study|Protocol Violation|5|||
129045892|NCT02667288|464461616|FG000|Overall Study|Lost to Follow-up|3|||
129045893|NCT02667288|464461616|FG000|Overall Study|Withdrawal by Subject|5|||
129045894|NCT00127036|464461617|FG000|Overall Study|Insufficient Data for Analysis|6|||
129045895|NCT00127036|464461618|FG001|Overall Study|Insufficient Data for Analysis|11|||
129045896|NCT00127036|464461617|FG000|Overall Study|Screen Failure|2|||
129045897|NCT00127036|464461618|FG001|Overall Study|Screen Failure|0|||
129045898|NCT03921151|464461619|FG000|Overall Study|Withdrawal by Subject|11|||
129045899|NCT03921151|464461620|FG001|Overall Study|Withdrawal by Subject|16|||
129045900|NCT00270257|464461623|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
129045901|NCT00270257|464461624|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
129045902|NCT01403064|464461625|FG000|Overall Study|Death|0|||
129045903|NCT01403064|464461626|FG001|Overall Study|Death|0|||
129045904|NCT01403064|464461627|FG002|Overall Study|Death|1|||
129045905|NCT01403064|464461628|FG003|Overall Study|Death|1|||
129045906|NCT01403064|464461625|FG000|Overall Study|Withdrawal by Subject|0|||
129045907|NCT01403064|464461626|FG001|Overall Study|Withdrawal by Subject|0|||
129045908|NCT01403064|464461627|FG002|Overall Study|Withdrawal by Subject|1|||
129045909|NCT01403064|464461628|FG003|Overall Study|Withdrawal by Subject|1|||
129045910|NCT01403064|464461625|FG000|Overall Study|Other|1|||
128719295|NCT02608268|463271022|FG003|Overall Study|Progressive disease|5|||
128719296|NCT02608268|463271023|FG004|Overall Study|Progressive disease|2|||
129135464|NCT04518410|464789230|FG001|Overall Study|Protocol Violation|0|||
129135465|NCT04518410|464789231|FG002|Overall Study|Protocol Violation|0|||
129135466|NCT04518410|464789232|FG003|Overall Study|Protocol Violation|2|||
129135467|NCT04518410|464789233|FG004|Overall Study|Protocol Violation|17|||
129135468|NCT04518410|464789234|FG005|Overall Study|Protocol Violation|1|||
129135469|NCT04518410|464789235|FG006|Overall Study|Protocol Violation|2|||
129135470|NCT04518410|464789236|FG007|Overall Study|Protocol Violation|1|||
129135471|NCT04518410|464789237|FG008|Overall Study|Protocol Violation|0|||
129135472|NCT04518410|464789238|FG009|Overall Study|Protocol Violation|0|||
129135473|NCT04518410|464789239|FG010|Overall Study|Protocol Violation|0|||
129135474|NCT04518410|464789240|FG011|Overall Study|Protocol Violation|0|||
129135475|NCT04518410|464789241|FG012|Overall Study|Protocol Violation|0|||
129135476|NCT04518410|464789242|FG013|Overall Study|Protocol Violation|0|||
129135477|NCT04518410|464789243|FG014|Overall Study|Protocol Violation|0|||
129135478|NCT04518410|464789244|FG015|Overall Study|Protocol Violation|0|||
129135479|NCT04518410|464789245|FG016|Overall Study|Protocol Violation|1|||
129135480|NCT04518410|464789246|FG017|Overall Study|Protocol Violation|1|||
129135481|NCT04518410|464789247|FG018|Overall Study|Protocol Violation|0|||
129135482|NCT04518410|464789248|FG019|Overall Study|Protocol Violation|0|||
129135483|NCT04518410|464789249|FG020|Overall Study|Protocol Violation|1|||
129135484|NCT04518410|464789250|FG021|Overall Study|Protocol Violation|2|||
129135485|NCT04518410|464789251|FG022|Overall Study|Protocol Violation|0|||
129135486|NCT04518410|464789252|FG023|Overall Study|Protocol Violation|3|||
129135487|NCT04518410|464789253|FG024|Overall Study|Protocol Violation|0|||
129135488|NCT04518410|464789229|FG000|Overall Study|Death|0|||
129135489|NCT04518410|464789230|FG001|Overall Study|Death|0|||
129135490|NCT04518410|464789231|FG002|Overall Study|Death|0|||
129135491|NCT04518410|464789232|FG003|Overall Study|Death|0|||
129135492|NCT04518410|464789233|FG004|Overall Study|Death|12|||
129135493|NCT04518410|464789234|FG005|Overall Study|Death|2|||
129135494|NCT04518410|464789235|FG006|Overall Study|Death|11|||
129135495|NCT04518410|464789236|FG007|Overall Study|Death|0|||
129045911|NCT01403064|464461626|FG001|Overall Study|Other|0|||
129045912|NCT01403064|464461627|FG002|Overall Study|Other|2|||
129045913|NCT01403064|464461628|FG003|Overall Study|Other|1|||
129045914|NCT02621034|464461629|FG000|Overall Study|Lost to Follow-up|3|||
129045915|NCT02621034|464461630|FG001|Overall Study|Lost to Follow-up|2|||
129045916|NCT02621034|464461631|FG002|Overall Study|Lost to Follow-up|5|||
129045917|NCT04688931|464461637|FG000|Overall Study|Adverse Event|4|||
129045918|NCT04688931|464461638|FG001|Overall Study|Adverse Event|1|||
129045919|NCT04688931|464461637|FG000|Overall Study|Withdrawal by Subject|5|||
129045920|NCT04688931|464461638|FG001|Overall Study|Withdrawal by Subject|16|||
129045921|NCT04688931|464461637|FG000|Overall Study|Physician Decision|3|||
129045922|NCT04688931|464461638|FG001|Overall Study|Physician Decision|5|||
129045923|NCT04688931|464461637|FG000|Overall Study|Noncompliance|0|||
129045924|NCT04688931|464461638|FG001|Overall Study|Noncompliance|1|||
129045925|NCT04688931|464461637|FG000|Overall Study|Lost to Follow-up|1|||
129045926|NCT04688931|464461638|FG001|Overall Study|Lost to Follow-up|3|||
129045927|NCT04688931|464461637|FG000|Overall Study|Randomization Error|3|||
129045928|NCT04688931|464461638|FG001|Overall Study|Randomization Error|0|||
129135496|NCT04518410|464789237|FG008|Overall Study|Death|1|||
129135497|NCT04518410|464789238|FG009|Overall Study|Death|0|||
129135498|NCT04518410|464789239|FG010|Overall Study|Death|0|||
129135499|NCT04518410|464789240|FG011|Overall Study|Death|0|||
129135500|NCT04518410|464789241|FG012|Overall Study|Death|0|||
129135501|NCT04518410|464789242|FG013|Overall Study|Death|1|||
129135502|NCT04518410|464789243|FG014|Overall Study|Death|1|||
129135503|NCT04518410|464789244|FG015|Overall Study|Death|0|||
129135504|NCT04518410|464789245|FG016|Overall Study|Death|0|||
129135505|NCT04518410|464789246|FG017|Overall Study|Death|1|||
129135506|NCT04518410|464789247|FG018|Overall Study|Death|4|||
129135507|NCT04518410|464789248|FG019|Overall Study|Death|4|||
129135508|NCT04518410|464789249|FG020|Overall Study|Death|1|||
129135509|NCT04518410|464789250|FG021|Overall Study|Death|0|||
129045929|NCT04688931|464461637|FG000|Overall Study|Not Eligible|1|||
129045930|NCT04688931|464461638|FG001|Overall Study|Not Eligible|3|||
129045931|NCT04688931|464461637|FG000|Overall Study|Disease Progression|0|||
129045932|NCT04688931|464461638|FG001|Overall Study|Disease Progression|2|||
129135510|NCT04518410|464789251|FG022|Overall Study|Death|0|||
129135511|NCT04518410|464789252|FG023|Overall Study|Death|0|||
129135512|NCT04518410|464789253|FG024|Overall Study|Death|0|||
129135513|NCT04518410|464789229|FG000|Overall Study|Requirement to start alternative therapy|0|||
129135514|NCT04518410|464789230|FG001|Overall Study|Requirement to start alternative therapy|0|||
129135515|NCT04518410|464789231|FG002|Overall Study|Requirement to start alternative therapy|1|||
129135516|NCT04518410|464789232|FG003|Overall Study|Requirement to start alternative therapy|0|||
129135517|NCT04518410|464789233|FG004|Overall Study|Requirement to start alternative therapy|0|||
129045933|NCT04688931|464461637|FG000|Overall Study|Sponsor Requirement|1|||
129045934|NCT04688931|464461638|FG001|Overall Study|Sponsor Requirement|1|||
129045935|NCT04688931|464461637|FG000|Overall Study|Other Reason|1|||
129135518|NCT04518410|464789234|FG005|Overall Study|Requirement to start alternative therapy|0|||
129135519|NCT04518410|464789235|FG006|Overall Study|Requirement to start alternative therapy|0|||
129223191|NCT02253316|465118312|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
129223192|NCT02253316|465118313|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
129223193|NCT02253316|465118314|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
129223194|NCT02253316|465118312|FG000|Consolidation|Secondary Malignancy|2|||
129223195|NCT02253316|465118313|FG001|Consolidation|Secondary Malignancy|0|||
129223196|NCT02253316|465118314|FG002|Consolidation|Secondary Malignancy|0|||
128719297|NCT02608268|463271024|FG005|Overall Study|Progressive disease|4|||
128719298|NCT02608268|463271025|FG006|Overall Study|Progressive disease|6|||
129045936|NCT04688931|464461638|FG001|Overall Study|Other Reason|2|||
129045937|NCT00450619|464461639|FG000|Overall Study|refused treatment after randomization|2|||
129045938|NCT00450619|464461640|FG001|Overall Study|refused treatment after randomization|0|||
129045939|NCT00450619|464461639|FG000|Overall Study|did not progress; refused further trmt|1|||
129045940|NCT00450619|464461640|FG001|Overall Study|did not progress; refused further trmt|1|||
129045941|NCT00450619|464461639|FG000|Overall Study|Adverse Event|1|||
129045942|NCT00450619|464461640|FG001|Overall Study|Adverse Event|0|||
129045943|NCT00616941|464461641|FG000|Overall Study|Progressive Disease|1|||
129045944|NCT00616941|464461642|FG001|Overall Study|Progressive Disease|2|||
129045945|NCT00616941|464461643|FG002|Overall Study|Progressive Disease|1|||
129045946|NCT00616941|464461641|FG000|Overall Study|Adverse Event|0|||
129045947|NCT00616941|464461642|FG001|Overall Study|Adverse Event|1|||
129045948|NCT00616941|464461643|FG002|Overall Study|Adverse Event|1|||
129045949|NCT00616941|464461641|FG000|Overall Study|Subject Non-compliance|0|||
129045950|NCT00616941|464461642|FG001|Overall Study|Subject Non-compliance|0|||
129045951|NCT00616941|464461643|FG002|Overall Study|Subject Non-compliance|1|||
129045952|NCT00616941|464461641|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
129045953|NCT00616941|464461642|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
129045954|NCT00616941|464461643|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
129045955|NCT00616941|464461641|FG000|Overall Study|Vaccination Suspended|0|||
129045956|NCT00616941|464461642|FG001|Overall Study|Vaccination Suspended|0|||
129045957|NCT00616941|464461643|FG002|Overall Study|Vaccination Suspended|3|||
129045958|NCT00714493|464461662|FG000|Overall Study|Adverse Event|11|||
129045959|NCT00714493|464461662|FG000|Overall Study|Death|3|||
129045960|NCT00714493|464461662|FG000|Overall Study|Lack of Efficacy|10|||
129045961|NCT00714493|464461662|FG000|Overall Study|Lost to Follow-up|3|||
129045962|NCT00714493|464461662|FG000|Overall Study|Protocol Violation|12|||
129045963|NCT00714493|464461662|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
129045964|NCT00714493|464461662|FG000|Overall Study|OTHER|2|||
129045965|NCT02372071|464461663|FG000|Overall Study|Protocol Violation|18|||
129045966|NCT00506129|464461664|FG000|Overall Study|Disease Progression/Relapse|15|||
129045967|NCT00506129|464461664|FG000|Overall Study|Death|7|||
129045968|NCT01968694|464461665|FG000|Washout (1 Month)|Lost to Follow-up|0|||
129045969|NCT01968694|464461666|FG001|Washout (1 Month)|Lost to Follow-up|1|||
129045970|NCT00354341|464461667|FG000|Overall Study|Adverse Event|1|||
129045971|NCT00354341|464461668|FG001|Overall Study|Adverse Event|0|||
129045972|NCT00354341|464461667|FG000|Overall Study|Death|0|||
129045973|NCT00354341|464461668|FG001|Overall Study|Death|2|||
129045974|NCT00354341|464461667|FG000|Overall Study|Refused treatment|1|||
129045975|NCT00354341|464461668|FG001|Overall Study|Refused treatment|2|||
129045976|NCT00354341|464461667|FG000|Overall Study|Failure to return|0|||
129045977|NCT00354341|464461668|FG001|Overall Study|Failure to return|1|||
129045978|NCT00354341|464461667|FG000|Overall Study|Other|1|||
129045979|NCT00354341|464461668|FG001|Overall Study|Other|2|||
129045980|NCT00251719|464461669|FG000|Overall Study|Adverse Event|14|||
129045981|NCT00251719|464461670|FG001|Overall Study|Adverse Event|8|||
129045982|NCT00251719|464461671|FG002|Overall Study|Adverse Event|7|||
129045983|NCT00251719|464461669|FG000|Overall Study|Protocol Violation|1|||
129045984|NCT00251719|464461670|FG001|Overall Study|Protocol Violation|1|||
129045985|NCT00251719|464461671|FG002|Overall Study|Protocol Violation|1|||
129045986|NCT00251719|464461669|FG000|Overall Study|Lost to Follow-up|5|||
129045987|NCT00251719|464461670|FG001|Overall Study|Lost to Follow-up|11|||
129045988|NCT00251719|464461671|FG002|Overall Study|Lost to Follow-up|8|||
129045989|NCT00251719|464461669|FG000|Overall Study|Withdrawal by Subject|14|||
129045990|NCT00251719|464461670|FG001|Overall Study|Withdrawal by Subject|12|||
128719299|NCT02608268|463271026|FG007|Overall Study|Progressive disease|2|||
128719300|NCT02608268|463271027|FG008|Overall Study|Progressive disease|5|||
128719301|NCT02608268|463271028|FG009|Overall Study|Progressive disease|6|||
129045991|NCT00251719|464461671|FG002|Overall Study|Withdrawal by Subject|11|||
129045992|NCT00251719|464461669|FG000|Overall Study|Lack of Efficacy|2|||
129045993|NCT00251719|464461670|FG001|Overall Study|Lack of Efficacy|1|||
129045994|NCT00251719|464461671|FG002|Overall Study|Lack of Efficacy|0|||
129045995|NCT00251719|464461669|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
129045996|NCT00251719|464461670|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
129045997|NCT00251719|464461671|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
129045998|NCT00251719|464461669|FG000|Overall Study|Investigator decision|1|||
129045999|NCT00251719|464461670|FG001|Overall Study|Investigator decision|1|||
129046000|NCT00251719|464461671|FG002|Overall Study|Investigator decision|0|||
129223197|NCT02253316|465118312|FG000|Consolidation|Adverse Event|7|||
129046001|NCT00251719|464461669|FG000|Overall Study|Noncompliance|2|||
129046002|NCT00251719|464461670|FG001|Overall Study|Noncompliance|3|||
129046003|NCT00251719|464461671|FG002|Overall Study|Noncompliance|1|||
129046004|NCT00251719|464461669|FG000|Overall Study|Barrett's esophagus|2|||
129046005|NCT00251719|464461670|FG001|Overall Study|Barrett's esophagus|2|||
129046006|NCT00251719|464461671|FG002|Overall Study|Barrett's esophagus|0|||
129046007|NCT01732874|464461674|FG000|Overall Study|Withdrawal by Subject|5|||
129046008|NCT01732874|464461675|FG001|Overall Study|Withdrawal by Subject|1|||
129046009|NCT01732874|464461674|FG000|Overall Study|Death of Infant|3|||
129046010|NCT01732874|464461675|FG001|Overall Study|Death of Infant|2|||
129046011|NCT00688376|464461678|FG000|Double-Blind Phase|Adverse Event|4|||
129046012|NCT00688376|464461679|FG001|Double-Blind Phase|Adverse Event|4|||
129046013|NCT00688376|464461678|FG000|Double-Blind Phase|Protocol Violation|1|||
129046014|NCT00688376|464461679|FG001|Double-Blind Phase|Protocol Violation|2|||
129046015|NCT00688376|464461678|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
129046016|NCT00688376|464461679|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
129046017|NCT00688376|464461678|FG000|Double-Blind Phase|Not treated|0|||
129046018|NCT00688376|464461679|FG001|Double-Blind Phase|Not treated|1|||
129046019|NCT00688376|464461678|FG000|Blinded Extension Phase|Adverse Event|3|||
129046020|NCT00688376|464461679|FG001|Blinded Extension Phase|Adverse Event|4|||
129046021|NCT00688376|464461678|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
129046022|NCT00688376|464461679|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
129046023|NCT00688376|464461678|FG000|Blinded Extension Phase|Physician Decision|1|||
129046024|NCT00688376|464461679|FG001|Blinded Extension Phase|Physician Decision|0|||
129046025|NCT00688376|464461678|FG000|Blinded Extension Phase|Other|1|||
129046026|NCT00688376|464461679|FG001|Blinded Extension Phase|Other|0|||
129046027|NCT00557076|464461680|FG000|Overall Study|Unblinding|0|||
129046028|NCT00557076|464461681|FG001|Overall Study|Unblinding|1|||
129046029|NCT04392583|464461682|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
129046030|NCT00857259|464461688|FG000|Overall Study|Protocol Violation|1|||
129046031|NCT00857259|464461689|FG001|Overall Study|Protocol Violation|0|||
129046032|NCT00857259|464461690|FG002|Overall Study|Protocol Violation|1|||
129046033|NCT02701413|464461691|FG000|Overall Study|Withdrawal by Subject|7|||
129046034|NCT02701413|464461692|FG001|Overall Study|Withdrawal by Subject|11|||
129046035|NCT01621191|464461695|FG000|Overall Study|Adverse Event|9|||
129046036|NCT01621191|464461695|FG000|Overall Study|Withdrawal by Subject|8|||
129046037|NCT01621191|464461695|FG000|Overall Study|Lack of Efficacy|6|||
129046038|NCT01621191|464461695|FG000|Overall Study|Lost to Follow-up|1|||
129046039|NCT01621191|464461695|FG000|Overall Study|Site Removed From Study|1|||
129046040|NCT00706381|464461696|FG000|Overall Study|Lost to Follow-up|0|||
129046041|NCT00706381|464461697|FG001|Overall Study|Lost to Follow-up|1|||
129046042|NCT00706381|464461698|FG002|Overall Study|Lost to Follow-up|1|||
129046043|NCT00706381|464461699|FG003|Overall Study|Lost to Follow-up|0|||
129046044|NCT00160641|464461703|FG000|Overall Study|Adverse Event|102|||
129046045|NCT00160641|464461703|FG000|Overall Study|Withdrawal by Subject|87|||
129046046|NCT00160641|464461703|FG000|Overall Study|Lost to Follow-up|8|||
129046047|NCT00160641|464461703|FG000|Overall Study|Lack of Efficacy|12|||
129046048|NCT00160641|464461703|FG000|Overall Study|Protocol Violation|3|||
129046049|NCT00160641|464461703|FG000|Overall Study|Other|9|||
129046050|NCT01782482|464461706|FG000|Overall Study|Adverse Event|2|||
129046051|NCT01782482|464461707|FG001|Overall Study|Adverse Event|1|||
129046052|NCT01782482|464461706|FG000|Overall Study|Lost to Follow-up|2|||
129046053|NCT01782482|464461707|FG001|Overall Study|Lost to Follow-up|3|||
129046054|NCT01782482|464461706|FG000|Overall Study|Physician Decision|1|||
129135520|NCT04518410|464789236|FG007|Overall Study|Requirement to start alternative therapy|0|||
129135521|NCT04518410|464789237|FG008|Overall Study|Requirement to start alternative therapy|0|||
129135522|NCT04518410|464789238|FG009|Overall Study|Requirement to start alternative therapy|0|||
129135523|NCT04518410|464789239|FG010|Overall Study|Requirement to start alternative therapy|0|||
129135524|NCT04518410|464789240|FG011|Overall Study|Requirement to start alternative therapy|0|||
129046055|NCT01782482|464461707|FG001|Overall Study|Physician Decision|0|||
129046056|NCT01782482|464461706|FG000|Overall Study|Protocol Violation|1|||
129046057|NCT01782482|464461707|FG001|Overall Study|Protocol Violation|0|||
129046058|NCT01782482|464461706|FG000|Overall Study|Withdrawal by Subject|2|||
129046059|NCT01782482|464461707|FG001|Overall Study|Withdrawal by Subject|3|||
129046060|NCT01782482|464461706|FG000|Overall Study|Randomized in Error|2|||
129046061|NCT01782482|464461707|FG001|Overall Study|Randomized in Error|2|||
129046062|NCT01782482|464461706|FG000|Overall Study|Habitually wearing toric lens OS|0|||
129046063|NCT01782482|464461707|FG001|Overall Study|Habitually wearing toric lens OS|1|||
129046064|NCT00038649|464461711|FG000|Overall Study|Adverse Event|9|||
129046065|NCT00995085|464461712|FG000|Overall Study|Withdrawal by Subject|5|||
129046066|NCT03096847|464461718|FG000|Overall Study|Other|2|||
129046067|NCT03096847|464461719|FG001|Overall Study|Other|1|||
129046068|NCT03096847|464461720|FG002|Overall Study|Other|2|||
129046069|NCT03096847|464461718|FG000|Overall Study|Lost to Follow-up|1|||
129046070|NCT03096847|464461719|FG001|Overall Study|Lost to Follow-up|0|||
129046071|NCT03096847|464461720|FG002|Overall Study|Lost to Follow-up|1|||
129046072|NCT03096847|464461718|FG000|Overall Study|Death|6|||
129046073|NCT03096847|464461719|FG001|Overall Study|Death|0|||
128719302|NCT02608268|463271029|FG010|Overall Study|Progressive disease|5|||
128719303|NCT02608268|463271030|FG011|Overall Study|Progressive disease|5|||
128719304|NCT02608268|463271031|FG012|Overall Study|Progressive disease|4|||
128719305|NCT02608268|463271032|FG013|Overall Study|Progressive disease|11|||
128719306|NCT02608268|463271033|FG014|Overall Study|Progressive disease|6|||
129135525|NCT04518410|464789241|FG012|Overall Study|Requirement to start alternative therapy|0|||
129135526|NCT04518410|464789242|FG013|Overall Study|Requirement to start alternative therapy|0|||
129135527|NCT04518410|464789243|FG014|Overall Study|Requirement to start alternative therapy|0|||
129135528|NCT04518410|464789244|FG015|Overall Study|Requirement to start alternative therapy|0|||
129135529|NCT04518410|464789245|FG016|Overall Study|Requirement to start alternative therapy|0|||
129135530|NCT04518410|464789246|FG017|Overall Study|Requirement to start alternative therapy|0|||
129135531|NCT04518410|464789247|FG018|Overall Study|Requirement to start alternative therapy|0|||
129135532|NCT04518410|464789248|FG019|Overall Study|Requirement to start alternative therapy|0|||
129135533|NCT04518410|464789249|FG020|Overall Study|Requirement to start alternative therapy|0|||
129135534|NCT04518410|464789250|FG021|Overall Study|Requirement to start alternative therapy|0|||
129135535|NCT04518410|464789251|FG022|Overall Study|Requirement to start alternative therapy|0|||
129135536|NCT04518410|464789252|FG023|Overall Study|Requirement to start alternative therapy|0|||
129135537|NCT04518410|464789253|FG024|Overall Study|Requirement to start alternative therapy|0|||
129135538|NCT04518410|464789229|FG000|Overall Study|Randomized but not treated|0|||
129135539|NCT04518410|464789230|FG001|Overall Study|Randomized but not treated|0|||
129135540|NCT04518410|464789231|FG002|Overall Study|Randomized but not treated|0|||
129135541|NCT04518410|464789232|FG003|Overall Study|Randomized but not treated|2|||
129135542|NCT04518410|464789233|FG004|Overall Study|Randomized but not treated|6|||
129135543|NCT04518410|464789234|FG005|Overall Study|Randomized but not treated|4|||
129135544|NCT04518410|464789235|FG006|Overall Study|Randomized but not treated|3|||
129135545|NCT04518410|464789236|FG007|Overall Study|Randomized but not treated|3|||
129135546|NCT04518410|464789237|FG008|Overall Study|Randomized but not treated|0|||
129135547|NCT04518410|464789238|FG009|Overall Study|Randomized but not treated|4|||
129135548|NCT04518410|464789239|FG010|Overall Study|Randomized but not treated|0|||
129135549|NCT04518410|464789240|FG011|Overall Study|Randomized but not treated|0|||
129135550|NCT04518410|464789241|FG012|Overall Study|Randomized but not treated|1|||
129223198|NCT02253316|465118313|FG001|Consolidation|Adverse Event|0|||
128719307|NCT02608268|463271034|FG015|Overall Study|Progressive disease|3|||
129046074|NCT03096847|464461720|FG002|Overall Study|Death|2|||
129046075|NCT03096847|464461718|FG000|Overall Study|Protocol Violation|3|||
128719308|NCT02608268|463271035|FG016|Overall Study|Progressive disease|5|||
128719309|NCT02608268|463271036|FG017|Overall Study|Progressive disease|5|||
128775400|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
128775401|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
129046076|NCT03096847|464461719|FG001|Overall Study|Protocol Violation|0|||
129046077|NCT03096847|464461720|FG002|Overall Study|Protocol Violation|6|||
129046078|NCT03096847|464461718|FG000|Overall Study|Physician Decision|12|||
129046079|NCT03096847|464461719|FG001|Overall Study|Physician Decision|2|||
129046080|NCT03096847|464461720|FG002|Overall Study|Physician Decision|8|||
129046081|NCT03096847|464461718|FG000|Overall Study|Withdrawal by Subject|24|||
129046082|NCT03096847|464461719|FG001|Overall Study|Withdrawal by Subject|1|||
129046083|NCT03096847|464461720|FG002|Overall Study|Withdrawal by Subject|12|||
129046084|NCT03096847|464461718|FG000|Overall Study|Adverse Event|72|||
129046085|NCT03096847|464461719|FG001|Overall Study|Adverse Event|6|||
129046086|NCT03096847|464461720|FG002|Overall Study|Adverse Event|28|||
129046087|NCT03096847|464461718|FG000|Overall Study|Progressive disease|97|||
129046088|NCT03096847|464461719|FG001|Overall Study|Progressive disease|10|||
129046089|NCT03096847|464461720|FG002|Overall Study|Progressive disease|78|||
129046090|NCT03096847|464461718|FG000|Overall Study|Non-compliance with study medication|1|||
129046091|NCT03096847|464461719|FG001|Overall Study|Non-compliance with study medication|0|||
129046092|NCT03096847|464461720|FG002|Overall Study|Non-compliance with study medication|0|||
129046093|NCT03096847|464461718|FG000|Overall Study|New therapy for study indication|1|||
129046094|NCT03096847|464461719|FG001|Overall Study|New therapy for study indication|0|||
129046095|NCT03096847|464461720|FG002|Overall Study|New therapy for study indication|1|||
129046096|NCT00609466|464461729|FG000|Overall Study|Withdrawal by Subject|0|||
129046097|NCT00609466|464461730|FG001|Overall Study|Withdrawal by Subject|1|||
129046098|NCT00609466|464461731|FG002|Overall Study|Withdrawal by Subject|1|||
129046099|NCT00609466|464461729|FG000|Overall Study|Adverse Event|2|||
129046100|NCT00609466|464461730|FG001|Overall Study|Adverse Event|3|||
128719310|NCT02608268|463271037|FG018|Overall Study|Progressive disease|5|||
129046101|NCT00609466|464461731|FG002|Overall Study|Adverse Event|1|||
129046102|NCT00609466|464461729|FG000|Overall Study|Lack of Efficacy|0|||
129046103|NCT00609466|464461730|FG001|Overall Study|Lack of Efficacy|2|||
129135551|NCT04518410|464789242|FG013|Overall Study|Randomized but not treated|3|||
129135552|NCT04518410|464789243|FG014|Overall Study|Randomized but not treated|3|||
128719311|NCT02608268|463271038|FG019|Overall Study|Progressive disease|2|||
129223199|NCT02253316|465118314|FG002|Consolidation|Adverse Event|0|||
128775402|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
129046104|NCT00609466|464461731|FG002|Overall Study|Lack of Efficacy|2|||
129046105|NCT03512262|464461732|FG000|Overall Study|Adverse Event|8|||
129046106|NCT03512262|464461733|FG001|Overall Study|Adverse Event|3|||
129046107|NCT03512262|464461732|FG000|Overall Study|Death (non-treatment emergent)|1|||
129046108|NCT03512262|464461733|FG001|Overall Study|Death (non-treatment emergent)|0|||
129046109|NCT03512262|464461732|FG000|Overall Study|Withdrawal by Subject|17|||
129046110|NCT03512262|464461733|FG001|Overall Study|Withdrawal by Subject|9|||
129046111|NCT03512262|464461732|FG000|Overall Study|Lost to Follow-up|7|||
129135553|NCT04518410|464789244|FG015|Overall Study|Randomized but not treated|3|||
129135554|NCT04518410|464789245|FG016|Overall Study|Randomized but not treated|4|||
129135555|NCT04518410|464789246|FG017|Overall Study|Randomized but not treated|5|||
129135556|NCT04518410|464789247|FG018|Overall Study|Randomized but not treated|4|||
129135557|NCT04518410|464789248|FG019|Overall Study|Randomized but not treated|0|||
129135558|NCT04518410|464789249|FG020|Overall Study|Randomized but not treated|0|||
129135559|NCT04518410|464789250|FG021|Overall Study|Randomized but not treated|5|||
129135560|NCT04518410|464789251|FG022|Overall Study|Randomized but not treated|0|||
129135561|NCT04518410|464789252|FG023|Overall Study|Randomized but not treated|3|||
129135562|NCT04518410|464789253|FG024|Overall Study|Randomized but not treated|1|||
129135563|NCT04518410|464789229|FG000|Overall Study|Screen Fail but Randomized|0|||
129135564|NCT04518410|464789230|FG001|Overall Study|Screen Fail but Randomized|0|||
129135565|NCT04518410|464789231|FG002|Overall Study|Screen Fail but Randomized|0|||
129135566|NCT04518410|464789232|FG003|Overall Study|Screen Fail but Randomized|0|||
129135567|NCT04518410|464789233|FG004|Overall Study|Screen Fail but Randomized|2|||
129135568|NCT04518410|464789234|FG005|Overall Study|Screen Fail but Randomized|0|||
129135569|NCT04518410|464789235|FG006|Overall Study|Screen Fail but Randomized|0|||
129135570|NCT04518410|464789236|FG007|Overall Study|Screen Fail but Randomized|0|||
129135571|NCT04518410|464789237|FG008|Overall Study|Screen Fail but Randomized|0|||
129135572|NCT04518410|464789238|FG009|Overall Study|Screen Fail but Randomized|0|||
129135573|NCT04518410|464789239|FG010|Overall Study|Screen Fail but Randomized|0|||
129135574|NCT04518410|464789240|FG011|Overall Study|Screen Fail but Randomized|0|||
129135575|NCT04518410|464789241|FG012|Overall Study|Screen Fail but Randomized|0|||
129135576|NCT04518410|464789242|FG013|Overall Study|Screen Fail but Randomized|0|||
129135577|NCT04518410|464789243|FG014|Overall Study|Screen Fail but Randomized|0|||
129135578|NCT04518410|464789244|FG015|Overall Study|Screen Fail but Randomized|0|||
129135579|NCT04518410|464789245|FG016|Overall Study|Screen Fail but Randomized|0|||
129135580|NCT04518410|464789246|FG017|Overall Study|Screen Fail but Randomized|0|||
129135581|NCT04518410|464789247|FG018|Overall Study|Screen Fail but Randomized|0|||
128719312|NCT02608268|463271039|FG020|Overall Study|Progressive disease|10|||
128719313|NCT02608268|463271040|FG021|Overall Study|Progressive disease|4|||
128719314|NCT02608268|463271041|FG022|Overall Study|Progressive disease|5|||
129046112|NCT03512262|464461733|FG001|Overall Study|Lost to Follow-up|1|||
129046113|NCT03512262|464461732|FG000|Overall Study|Other than Specified|2|||
129046114|NCT03512262|464461733|FG001|Overall Study|Other than Specified|2|||
129046115|NCT03407430|464461736|FG000|Washout|Protocol Violation|1|||
129046116|NCT03407430|464461737|FG001|Washout|Protocol Violation|0|||
129046117|NCT03510182|464461738|FG000|Overall Study|Withdrawal by Subject|2|||
129046118|NCT01195272|464461739|FG000|Overall Study|Adverse Event|1|||
129046119|NCT01195272|464461739|FG000|Overall Study|Lack of Efficacy|3|||
129046120|NCT03295318|464463148|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
129046121|NCT03295318|464463149|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
129046122|NCT03295318|464463150|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
129046123|NCT03295318|464463148|FG000|Overall Study|Death|1|||
129046124|NCT03295318|464463149|FG001|Overall Study|Death|1|||
129046125|NCT03295318|464463150|FG002|Overall Study|Death|1|||
129046126|NCT03295318|464463148|FG000|Overall Study|Protocol Violation|4|||
129046127|NCT03295318|464463149|FG001|Overall Study|Protocol Violation|3|||
129046128|NCT03295318|464463150|FG002|Overall Study|Protocol Violation|3|||
129046129|NCT03295318|464463148|FG000|Overall Study|Withdrawal by Subject|0|||
129046130|NCT03295318|464463149|FG001|Overall Study|Withdrawal by Subject|0|||
129046131|NCT03295318|464463150|FG002|Overall Study|Withdrawal by Subject|1|||
129046132|NCT03295318|464463148|FG000|Overall Study|Subject discontinued due to travel|0|||
129135582|NCT04518410|464789248|FG019|Overall Study|Screen Fail but Randomized|0|||
129135583|NCT04518410|464789249|FG020|Overall Study|Screen Fail but Randomized|0|||
129135584|NCT04518410|464789250|FG021|Overall Study|Screen Fail but Randomized|0|||
129135585|NCT04518410|464789251|FG022|Overall Study|Screen Fail but Randomized|0|||
129135586|NCT04518410|464789252|FG023|Overall Study|Screen Fail but Randomized|0|||
129135587|NCT04518410|464789253|FG024|Overall Study|Screen Fail but Randomized|0|||
128719315|NCT02608268|463271042|FG023|Overall Study|Progressive disease|5|||
129135588|NCT04518410|464789229|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129135589|NCT04518410|464789230|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129135590|NCT04518410|464789231|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129135591|NCT04518410|464789232|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129135592|NCT04518410|464789233|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
129135593|NCT04518410|464789234|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
129135594|NCT04518410|464789235|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
129135595|NCT04518410|464789236|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129135596|NCT04518410|464789237|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
129135597|NCT04518410|464789238|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
129135598|NCT04518410|464789239|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129135599|NCT04518410|464789240|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129135600|NCT04518410|464789241|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129135601|NCT04518410|464789242|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129135602|NCT04518410|464789243|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129135603|NCT04518410|464789244|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
129135604|NCT04518410|464789245|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
129135605|NCT04518410|464789246|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
129135606|NCT04518410|464789247|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
129135607|NCT04518410|464789248|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
129046133|NCT03295318|464463149|FG001|Overall Study|Subject discontinued due to travel|1|||
129046134|NCT03295318|464463150|FG002|Overall Study|Subject discontinued due to travel|0|||
129046135|NCT04319718|464463151|FG000|Overall Study|Adverse Event|0|||
129046136|NCT04319718|464463152|FG001|Overall Study|Adverse Event|2|||
129046137|NCT04319718|464463151|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
129046138|NCT04319718|464463152|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
129046139|NCT01288053|464463153|FG000|Overall Study|Death|1|||
129046140|NCT00144781|464463154|FG000|Overall Study|Adverse Event|0|||
129046141|NCT00144781|464463155|FG001|Overall Study|Adverse Event|1|||
129046142|NCT00144781|464463156|FG002|Overall Study|Adverse Event|0|||
129046143|NCT00144781|464463157|FG003|Overall Study|Adverse Event|0|||
129046144|NCT00144781|464463154|FG000|Overall Study|Non-compliant|0|||
129046145|NCT00144781|464463155|FG001|Overall Study|Non-compliant|1|||
129046146|NCT00144781|464463156|FG002|Overall Study|Non-compliant|0|||
129046147|NCT00144781|464463157|FG003|Overall Study|Non-compliant|0|||
129046148|NCT02068092|464463158|FG000|Overall Study|Physician Decision|2|||
129046149|NCT02068092|464463158|FG000|Overall Study|Adverse Event|2|||
129046150|NCT02068092|464463158|FG000|Overall Study|Lost to Follow-up|4|||
129046151|NCT02068092|464463158|FG000|Overall Study|Withdrawal by Subject|2|||
129046152|NCT01045421|464463159|FG000|Phase 1|Progressive Disease|0|||
129046153|NCT01045421|464463160|FG001|Phase 1|Progressive Disease|0|||
129046154|NCT01045421|464463161|FG002|Phase 1|Progressive Disease|0|||
129046155|NCT01045421|464463162|FG003|Phase 1|Progressive Disease|0|||
129046156|NCT01045421|464463163|FG004|Phase 1|Progressive Disease|1|||
129046157|NCT01045421|464463164|FG005|Phase 1|Progressive Disease|0|||
129046158|NCT01045421|464463165|FG006|Phase 1|Progressive Disease|0|||
129046159|NCT01045421|464463166|FG007|Phase 1|Progressive Disease|0|||
129046160|NCT01045421|464463167|FG008|Phase 1|Progressive Disease|0|||
129046161|NCT01045421|464463168|FG009|Phase 1|Progressive Disease|0|||
129046162|NCT01045421|464463169|FG010|Phase 1|Progressive Disease|0|||
129046163|NCT01045421|464463159|FG000|Phase 1|Withdrawal by Subject|0|||
129046164|NCT01045421|464463160|FG001|Phase 1|Withdrawal by Subject|0|||
129046165|NCT01045421|464463161|FG002|Phase 1|Withdrawal by Subject|0|||
129135608|NCT04518410|464789249|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
129135609|NCT04518410|464789250|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
129204716|NCT02079740|465046928|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
129046166|NCT01045421|464463162|FG003|Phase 1|Withdrawal by Subject|1|||
129046167|NCT01045421|464463163|FG004|Phase 1|Withdrawal by Subject|0|||
129046168|NCT01045421|464463164|FG005|Phase 1|Withdrawal by Subject|0|||
128719316|NCT02608268|463271043|FG024|Overall Study|Progressive disease|3|||
128719317|NCT02608268|463271044|FG025|Overall Study|Progressive disease|11|||
128719318|NCT02608268|463271045|FG026|Overall Study|Progressive disease|16|||
129046169|NCT01045421|464463165|FG006|Phase 1|Withdrawal by Subject|0|||
129046170|NCT01045421|464463166|FG007|Phase 1|Withdrawal by Subject|0|||
129046171|NCT01045421|464463167|FG008|Phase 1|Withdrawal by Subject|0|||
129046172|NCT01045421|464463168|FG009|Phase 1|Withdrawal by Subject|0|||
129046173|NCT01045421|464463169|FG010|Phase 1|Withdrawal by Subject|0|||
129046174|NCT01045421|464463159|FG000|Phase 2|Progressive Disease|0|||
129046175|NCT01045421|464463160|FG001|Phase 2|Progressive Disease|0|||
129046176|NCT01045421|464463161|FG002|Phase 2|Progressive Disease|0|||
129046177|NCT01045421|464463162|FG003|Phase 2|Progressive Disease|0|||
129046178|NCT01045421|464463163|FG004|Phase 2|Progressive Disease|0|||
128719319|NCT02608268|463271046|FG027|Overall Study|Progressive disease|11|||
128719320|NCT02608268|463271047|FG028|Overall Study|Progressive disease|10|||
128719321|NCT02608268|463271048|FG029|Overall Study|Progressive disease|15|||
128719322|NCT02608268|463271019|FG000|Overall Study|Subject/guardian decision|1|||
129046179|NCT01045421|464463164|FG005|Phase 2|Progressive Disease|0|||
129046180|NCT01045421|464463165|FG006|Phase 2|Progressive Disease|0|||
129046181|NCT01045421|464463166|FG007|Phase 2|Progressive Disease|1|||
129046182|NCT01045421|464463167|FG008|Phase 2|Progressive Disease|1|||
129046183|NCT01045421|464463168|FG009|Phase 2|Progressive Disease|1|||
129046184|NCT01045421|464463169|FG010|Phase 2|Progressive Disease|1|||
129046185|NCT01045421|464463159|FG000|Phase 2|Death|0|||
129046186|NCT01045421|464463160|FG001|Phase 2|Death|0|||
129046187|NCT01045421|464463161|FG002|Phase 2|Death|0|||
129046188|NCT01045421|464463162|FG003|Phase 2|Death|0|||
129046189|NCT01045421|464463163|FG004|Phase 2|Death|0|||
129046190|NCT01045421|464463164|FG005|Phase 2|Death|0|||
129046191|NCT01045421|464463165|FG006|Phase 2|Death|0|||
129046192|NCT01045421|464463166|FG007|Phase 2|Death|1|||
129046193|NCT01045421|464463167|FG008|Phase 2|Death|1|||
129046194|NCT01045421|464463168|FG009|Phase 2|Death|2|||
129046195|NCT01045421|464463169|FG010|Phase 2|Death|0|||
129046196|NCT01045421|464463159|FG000|Phase 2|Other|0|||
129046197|NCT01045421|464463160|FG001|Phase 2|Other|0|||
129046198|NCT01045421|464463161|FG002|Phase 2|Other|0|||
129046199|NCT01045421|464463162|FG003|Phase 2|Other|0|||
129046200|NCT01045421|464463163|FG004|Phase 2|Other|0|||
129046201|NCT01045421|464463164|FG005|Phase 2|Other|0|||
129046202|NCT01045421|464463165|FG006|Phase 2|Other|0|||
129046203|NCT01045421|464463166|FG007|Phase 2|Other|3|||
129046204|NCT01045421|464463167|FG008|Phase 2|Other|0|||
129046205|NCT01045421|464463168|FG009|Phase 2|Other|0|||
129046206|NCT01045421|464463169|FG010|Phase 2|Other|1|||
129046207|NCT04551911|464463170|FG000|Overall Study|Lost to Follow-up|2|||
129046208|NCT04551911|464463171|FG001|Overall Study|Lost to Follow-up|1|||
129046209|NCT04551911|464463170|FG000|Overall Study|Withdrawal by Subject|10|||
129046210|NCT04551911|464463171|FG001|Overall Study|Withdrawal by Subject|10|||
129046211|NCT04551911|464463170|FG000|Overall Study|Did not receive the study drug|3|||
129046212|NCT04551911|464463171|FG001|Overall Study|Did not receive the study drug|4|||
129046213|NCT01030341|464463172|FG000|Overall Study|Withdrawal by Subject|1|||
129046214|NCT01030341|464463172|FG000|Overall Study|Lost to Follow-up|2|||
129046215|NCT01400919|464463185|FG000|Overall Study|Withdrawal by Subject|4|||
129046216|NCT01400919|464463185|FG000|Overall Study|Lost to Follow-up|2|||
129046217|NCT01400919|464463185|FG000|Overall Study|Missed visit|2|||
129046218|NCT02923674|464463186|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
129046219|NCT02923674|464463187|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
129046220|NCT02923674|464463188|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
129046221|NCT02923674|464463186|FG000|Overall Study|Lost to Follow-up|7|||
129046222|NCT02923674|464463187|FG001|Overall Study|Lost to Follow-up|12|||
129046223|NCT02923674|464463188|FG002|Overall Study|Lost to Follow-up|7|||
129046224|NCT02923674|464463186|FG000|Overall Study|Problem with intervention|2|||
129046225|NCT02923674|464463187|FG001|Overall Study|Problem with intervention|2|||
129046226|NCT02923674|464463188|FG002|Overall Study|Problem with intervention|1|||
129046227|NCT02923674|464463186|FG000|Overall Study|Adverse Event|3|||
129046228|NCT02923674|464463187|FG001|Overall Study|Adverse Event|1|||
129046229|NCT02923674|464463188|FG002|Overall Study|Adverse Event|1|||
129046230|NCT02923674|464463186|FG000|Overall Study|Withdrawal by Subject|2|||
129046231|NCT02923674|464463187|FG001|Overall Study|Withdrawal by Subject|2|||
129046232|NCT02923674|464463188|FG002|Overall Study|Withdrawal by Subject|2|||
129046233|NCT00158600|464463191|FG000|Overall Study|unable to commit time to study|0|||
129046234|NCT00158600|464463192|FG001|Overall Study|unable to commit time to study|1|||
129046235|NCT00158600|464463191|FG000|Overall Study|Adverse Event|2|||
128719323|NCT02608268|463271020|FG001|Overall Study|Subject/guardian decision|1|||
129046236|NCT00158600|464463192|FG001|Overall Study|Adverse Event|1|||
129046237|NCT00158600|464463191|FG000|Overall Study|Death|1|||
129046238|NCT00158600|464463192|FG001|Overall Study|Death|0|||
129046239|NCT00158600|464463191|FG000|Overall Study|Withdrawal by Subject|2|||
129046240|NCT00158600|464463192|FG001|Overall Study|Withdrawal by Subject|2|||
129046241|NCT00846521|464463201|FG000|Overall Study|Withdrawal by Subject|5|||
129046242|NCT00846521|464463201|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
129046243|NCT00846521|464463201|FG000|Overall Study|Protocol Violation|1|||
129046244|NCT02618408|464463202|FG000|Overall Study|Withdrawal by Subject|1|||
129046245|NCT02618408|464463203|FG001|Overall Study|Withdrawal by Subject|0|||
129046246|NCT02618408|464463204|FG002|Overall Study|Withdrawal by Subject|4|||
129046247|NCT02618408|464463202|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
129046248|NCT02618408|464463203|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
129046249|NCT02618408|464463204|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
129046250|NCT02618408|464463202|FG000|Overall Study|Lost to Follow-up|4|||
129046251|NCT02618408|464463203|FG001|Overall Study|Lost to Follow-up|2|||
129046252|NCT02618408|464463204|FG002|Overall Study|Lost to Follow-up|6|||
129046253|NCT02618408|464463202|FG000|Overall Study|Adverse Event|4|||
129046254|NCT02618408|464463203|FG001|Overall Study|Adverse Event|0|||
129046255|NCT02618408|464463204|FG002|Overall Study|Adverse Event|10|||
129046256|NCT02618408|464463202|FG000|Overall Study|Physician Decision|1|||
129046257|NCT02618408|464463203|FG001|Overall Study|Physician Decision|1|||
129046258|NCT02618408|464463204|FG002|Overall Study|Physician Decision|2|||
129046259|NCT02618408|464463202|FG000|Overall Study|Protocol Violation|1|||
129046260|NCT02618408|464463203|FG001|Overall Study|Protocol Violation|1|||
129046261|NCT02618408|464463204|FG002|Overall Study|Protocol Violation|2|||
129046262|NCT02618408|464463202|FG000|Overall Study|Other, Multiple Categories|0|||
129046263|NCT02618408|464463203|FG001|Overall Study|Other, Multiple Categories|0|||
129046264|NCT02618408|464463204|FG002|Overall Study|Other, Multiple Categories|4|||
129046265|NCT01246011|464463206|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
129046266|NCT01246011|464463207|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
129046267|NCT01246011|464463208|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
129046268|NCT01246011|464463206|FG000|Overall Study|Withdrawal by Subject|0|||
129046269|NCT01246011|464463207|FG001|Overall Study|Withdrawal by Subject|0|||
129046270|NCT01246011|464463208|FG002|Overall Study|Withdrawal by Subject|1|||
129046271|NCT04492020|464463209|FG000|Overall Study|Adverse Event|1|||
129046272|NCT04492020|464463210|FG001|Overall Study|Adverse Event|3|||
129046273|NCT04492020|464463209|FG000|Overall Study|Withdrawal by Subject|4|||
129046274|NCT04492020|464463210|FG001|Overall Study|Withdrawal by Subject|3|||
129046275|NCT04492020|464463209|FG000|Overall Study|Lost to Follow-up|4|||
129046276|NCT04492020|464463210|FG001|Overall Study|Lost to Follow-up|3|||
129046277|NCT04492020|464463209|FG000|Overall Study|Protocol Violation|5|||
129046278|NCT04492020|464463210|FG001|Overall Study|Protocol Violation|2|||
129046279|NCT04492020|464463209|FG000|Overall Study|Lack of Qualifying Event|25|||
129046280|NCT04492020|464463210|FG001|Overall Study|Lack of Qualifying Event|27|||
129046281|NCT04492020|464463209|FG000|Overall Study|Non-compliance with Study Drug|2|||
129046282|NCT04492020|464463210|FG001|Overall Study|Non-compliance with Study Drug|1|||
129046283|NCT02792959|464463212|FG000|Overall Study|Protocol Violation|1|||
129046284|NCT00003875|464463224|FG000|Overall Study|Screen Failed|1|||
129046285|NCT01780987|464463225|FG000|Overall Study|Adverse Event|0|||
129046286|NCT01780987|464463226|FG001|Overall Study|Adverse Event|4|||
129046287|NCT01780987|464463225|FG000|Overall Study|Withdrawal by Subject|2|||
129046288|NCT01780987|464463226|FG001|Overall Study|Withdrawal by Subject|0|||
129046289|NCT01780987|464463225|FG000|Overall Study|Request of Changing Hospital|0|||
129046290|NCT01780987|464463226|FG001|Overall Study|Request of Changing Hospital|1|||
129046291|NCT01780987|464463225|FG000|Overall Study|Changing Residence|1|||
129046292|NCT01780987|464463226|FG001|Overall Study|Changing Residence|0|||
129046293|NCT01780987|464463225|FG000|Overall Study|Not Receiving any Study Medication|0|||
129046294|NCT01780987|464463226|FG001|Overall Study|Not Receiving any Study Medication|1|||
129046295|NCT04168190|464463227|FG000|Overall Study|Lost to Follow-up|0|||
129046296|NCT04168190|464463228|FG001|Overall Study|Lost to Follow-up|1|||
129046297|NCT04168190|464463229|FG002|Overall Study|Lost to Follow-up|0|||
129046298|NCT04168190|464463230|FG003|Overall Study|Lost to Follow-up|7|||
129046299|NCT04168190|464463231|FG004|Overall Study|Lost to Follow-up|5|||
129046300|NCT04168190|464463227|FG000|Overall Study|Withdrawal by Subject|1|||
129046301|NCT04168190|464463228|FG001|Overall Study|Withdrawal by Subject|0|||
129046302|NCT04168190|464463229|FG002|Overall Study|Withdrawal by Subject|0|||
129046303|NCT04168190|464463230|FG003|Overall Study|Withdrawal by Subject|2|||
129046304|NCT04168190|464463231|FG004|Overall Study|Withdrawal by Subject|4|||
129046305|NCT04168190|464463227|FG000|Overall Study|Death|0|||
129046306|NCT04168190|464463228|FG001|Overall Study|Death|0|||
129046307|NCT04168190|464463229|FG002|Overall Study|Death|0|||
129046308|NCT04168190|464463230|FG003|Overall Study|Death|1|||
129046309|NCT04168190|464463231|FG004|Overall Study|Death|0|||
129046310|NCT01070771|464463232|FG000|Overall Study|Adverse Event|2|||
129046311|NCT01070771|464463232|FG000|Overall Study|Protocol Violation|1|||
129046312|NCT00629265|464463233|FG000|Overall Study|Lost to Follow-up|4|||
129046313|NCT00629265|464463234|FG001|Overall Study|Lost to Follow-up|5|||
128719324|NCT02608268|463271021|FG002|Overall Study|Subject/guardian decision|2|||
128719325|NCT02608268|463271022|FG003|Overall Study|Subject/guardian decision|0|||
129046314|NCT00629265|464463233|FG000|Overall Study|Withdrawal by Subject|11|||
129046315|NCT00629265|464463234|FG001|Overall Study|Withdrawal by Subject|8|||
129046316|NCT00629265|464463233|FG000|Overall Study|Death|1|||
129046317|NCT00629265|464463234|FG001|Overall Study|Death|0|||
129046318|NCT00629265|464463233|FG000|Overall Study|Adverse Event|2|||
129046319|NCT00629265|464463234|FG001|Overall Study|Adverse Event|0|||
129046320|NCT00629265|464463233|FG000|Overall Study|HNC Recurrence|4|||
129046321|NCT00629265|464463234|FG001|Overall Study|HNC Recurrence|0|||
129046322|NCT00629265|464463233|FG000|Overall Study|Other CA Requiring Treatment|1|||
129046323|NCT00629265|464463234|FG001|Overall Study|Other CA Requiring Treatment|3|||
129046324|NCT00629265|464463233|FG000|Overall Study|Needed Esophageal Dilation|4|||
129046325|NCT00629265|464463234|FG001|Overall Study|Needed Esophageal Dilation|1|||
129046326|NCT00629265|464463233|FG000|Overall Study|Unrelated Medical Complications|3|||
129046327|NCT00629265|464463234|FG001|Overall Study|Unrelated Medical Complications|1|||
129046328|NCT00629265|464463233|FG000|Overall Study|Unknown Reason|2|||
129046329|NCT00629265|464463234|FG001|Overall Study|Unknown Reason|2|||
129046330|NCT04465630|464463235|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
129046331|NCT04465630|464463235|FG000|Overall Study|Screen failure|8|||
129046332|NCT04465630|464463235|FG000|Overall Study|Baseline failure|16|||
129046333|NCT02032706|464463238|FG000|Overall Study|Did not qualify|5|||
129046334|NCT02032706|464463238|FG000|Overall Study|Protocol Violation|1|||
129046335|NCT00895947|464463239|FG000|Overall Study|Adverse Event|3|||
129046336|NCT00895947|464463240|FG001|Overall Study|Adverse Event|4|||
129046337|NCT00895947|464463239|FG000|Overall Study|Lost to Follow-up|3|||
129046338|NCT00895947|464463240|FG001|Overall Study|Lost to Follow-up|4|||
129046339|NCT00895947|464463239|FG000|Overall Study|Protocol Violation|4|||
129046340|NCT00895947|464463240|FG001|Overall Study|Protocol Violation|2|||
129046341|NCT00895947|464463239|FG000|Overall Study|Withdrawal by Subject|2|||
129046342|NCT00895947|464463240|FG001|Overall Study|Withdrawal by Subject|0|||
129046343|NCT04620135|464463243|FG000|Study Completion|Adverse Event|2|||
129046344|NCT04620135|464463244|FG001|Study Completion|Adverse Event|3|||
129046345|NCT04620135|464463243|FG000|Study Completion|Withdrawal by Subject|2|||
129046346|NCT04620135|464463244|FG001|Study Completion|Withdrawal by Subject|0|||
129046347|NCT01615263|464463248|FG000|Overall Study|Post-randomization exclusion|0|||
129046348|NCT01615263|464463249|FG001|Overall Study|Post-randomization exclusion|2|||
129046349|NCT02138136|464463250|FG000|Overall Study|Protocol Violation|4|||
129046350|NCT02138136|464463250|FG000|Overall Study|Physician Decision|7|||
129046351|NCT02138136|464463250|FG000|Overall Study|Lack of Efficacy|35|||
129046352|NCT02138136|464463250|FG000|Overall Study|Pregnancy|2|||
129046353|NCT02138136|464463250|FG000|Overall Study|Adverse Event|18|||
129046354|NCT02138136|464463250|FG000|Overall Study|Withdrawal by Subject|36|||
129046355|NCT02138136|464463250|FG000|Overall Study|Lost to Follow-up|32|||
129046356|NCT02138136|464463250|FG000|Overall Study|Withdrawn by Sponsor|5|||
129046357|NCT03979820|464463253|FG000|Overall Study|Protocol Violation|1|||
129046358|NCT03979820|464463254|FG001|Overall Study|Protocol Violation|0|||
129046359|NCT03979820|464463255|FG002|Overall Study|Protocol Violation|0|||
129046360|NCT03979820|464463256|FG003|Overall Study|Protocol Violation|0|||
129046361|NCT03979820|464463253|FG000|Overall Study|Withdrawal by Subject|0|||
129046362|NCT03979820|464463254|FG001|Overall Study|Withdrawal by Subject|0|||
129046363|NCT03979820|464463255|FG002|Overall Study|Withdrawal by Subject|1|||
129046364|NCT03979820|464463256|FG003|Overall Study|Withdrawal by Subject|0|||
129046365|NCT03979820|464463253|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
129046366|NCT03979820|464463254|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
129046367|NCT03979820|464463255|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
129046368|NCT03979820|464463256|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
129046369|NCT04355663|464463257|FG000|Overall Study|Physician Decision|2|||
129046370|NCT04355663|464463258|FG001|Overall Study|Physician Decision|7|||
129046371|NCT04355663|464463259|FG002|Overall Study|Physician Decision|0|||
129046372|NCT04355663|464463257|FG000|Overall Study|Adverse Event|0|||
129046373|NCT04355663|464463258|FG001|Overall Study|Adverse Event|0|||
129046374|NCT04355663|464463259|FG002|Overall Study|Adverse Event|1|||
129046375|NCT04355663|464463257|FG000|Overall Study|Withdrawal by Subject|0|||
129046376|NCT04355663|464463258|FG001|Overall Study|Withdrawal by Subject|8|||
129046377|NCT04355663|464463259|FG002|Overall Study|Withdrawal by Subject|3|||
129046378|NCT00876018|464463262|FG000|Overall Study|Lost to Follow-up|0|||
129046379|NCT00876018|464463263|FG001|Overall Study|Lost to Follow-up|1|||
129046380|NCT00876018|464463264|FG002|Overall Study|Lost to Follow-up|1|||
129046381|NCT00876018|464463262|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
129046382|NCT00876018|464463263|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
129046383|NCT00876018|464463264|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
129046384|NCT01230892|464463265|FG000|Overall Study|Withdrawal by Subject|1|||
129046385|NCT01230892|464463266|FG001|Overall Study|Withdrawal by Subject|1|||
129046386|NCT01230892|464463265|FG000|Overall Study|Lost to Follow-up|2|||
129046387|NCT01230892|464463266|FG001|Overall Study|Lost to Follow-up|0|||
129046388|NCT00679913|464463267|FG000|Overall Study|Protocol Violation|18|||
129046389|NCT00679913|464463268|FG001|Overall Study|Protocol Violation|13|||
129046390|NCT00725621|464463269|FG000|Overall Study|Adverse Event|25|||
129046391|NCT00725621|464463269|FG000|Overall Study|Lack of Efficacy|46|||
129046392|NCT00725621|464463269|FG000|Overall Study|Withdrawal by Subject|57|||
129046393|NCT00725621|464463269|FG000|Overall Study|Physician Decision|19|||
129046394|NCT00725621|464463269|FG000|Overall Study|Lost to Follow-up|52|||
129046395|NCT00725621|464463269|FG000|Overall Study|Non-compliance|8|||
129046396|NCT00725621|464463269|FG000|Overall Study|Continued treatment by other physician|6|||
129046397|NCT00725621|464463269|FG000|Overall Study|Switched to other study|1|||
129046398|NCT00725621|464463269|FG000|Overall Study|Switched to other drug|1|||
129046399|NCT00725621|464463269|FG000|Overall Study|Prepared for elective surgery|1|||
129046400|NCT00725621|464463269|FG000|Overall Study|Reason not specified|55|||
129046401|NCT01189500|464463270|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
129046402|NCT01189500|464463270|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
129046403|NCT00062751|464463271|FG000|Overall Study|Disease progression|24|||
129046404|NCT00062751|464463272|FG001|Overall Study|Disease progression|17|||
129046405|NCT00062751|464463273|FG002|Overall Study|Disease progression|24|||
129223200|NCT02253316|465118312|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
129046406|NCT00062751|464463274|FG003|Overall Study|Disease progression|2|||
129046407|NCT00062751|464463275|FG004|Overall Study|Disease progression|2|||
129046408|NCT00062751|464463271|FG000|Overall Study|Adverse Event|4|||
129046409|NCT00062751|464463272|FG001|Overall Study|Adverse Event|7|||
129046410|NCT00062751|464463273|FG002|Overall Study|Adverse Event|2|||
129046411|NCT00062751|464463274|FG003|Overall Study|Adverse Event|2|||
129046412|NCT00062751|464463275|FG004|Overall Study|Adverse Event|2|||
129046413|NCT00062751|464463271|FG000|Overall Study|Other|2|||
129046414|NCT00062751|464463272|FG001|Overall Study|Other|3|||
129046415|NCT00062751|464463273|FG002|Overall Study|Other|1|||
129046416|NCT00062751|464463274|FG003|Overall Study|Other|0|||
129046417|NCT00062751|464463275|FG004|Overall Study|Other|1|||
129046418|NCT00062751|464463271|FG000|Overall Study|Withdrawal by Subject|1|||
129046419|NCT00062751|464463272|FG001|Overall Study|Withdrawal by Subject|2|||
129046420|NCT00062751|464463273|FG002|Overall Study|Withdrawal by Subject|2|||
129046421|NCT00062751|464463274|FG003|Overall Study|Withdrawal by Subject|1|||
129046422|NCT00062751|464463275|FG004|Overall Study|Withdrawal by Subject|0|||
129046423|NCT00062751|464463271|FG000|Overall Study|Symptomatic deterioration|1|||
129046424|NCT00062751|464463272|FG001|Overall Study|Symptomatic deterioration|1|||
129046425|NCT00062751|464463273|FG002|Overall Study|Symptomatic deterioration|0|||
129046426|NCT00062751|464463274|FG003|Overall Study|Symptomatic deterioration|0|||
129046427|NCT00062751|464463275|FG004|Overall Study|Symptomatic deterioration|1|||
129046428|NCT00062751|464463271|FG000|Overall Study|Death|1|||
129046429|NCT00062751|464463272|FG001|Overall Study|Death|0|||
129046430|NCT00062751|464463273|FG002|Overall Study|Death|1|||
129046431|NCT00062751|464463274|FG003|Overall Study|Death|0|||
129046432|NCT00062751|464463275|FG004|Overall Study|Death|0|||
129046433|NCT01144364|464463279|FG000|Induction Phase|Disease progression|14|||
129046434|NCT01144364|464463280|FG001|Induction Phase|Disease progression|0|||
129046435|NCT01144364|464463281|FG002|Induction Phase|Disease progression|0|||
129046436|NCT01144364|464463279|FG000|Induction Phase|Adverse Event|9|||
129046437|NCT01144364|464463280|FG001|Induction Phase|Adverse Event|0|||
129046438|NCT01144364|464463281|FG002|Induction Phase|Adverse Event|0|||
129046439|NCT01144364|464463279|FG000|Induction Phase|Death|1|||
129223201|NCT02253316|465118313|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
129223202|NCT02253316|465118314|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
129223203|NCT02253316|465118312|FG000|Maintenance|Physician Decision|0|||
129223204|NCT02253316|465118313|FG001|Maintenance|Physician Decision|7|||
129223205|NCT02253316|465118314|FG002|Maintenance|Physician Decision|16|||
129223206|NCT02253316|465118312|FG000|Maintenance|Non-Compliance|0|||
129223207|NCT02253316|465118313|FG001|Maintenance|Non-Compliance|1|||
129223208|NCT02253316|465118314|FG002|Maintenance|Non-Compliance|1|||
129223209|NCT02253316|465118312|FG000|Maintenance|Secondary Malignancy|0|||
129223210|NCT02253316|465118313|FG001|Maintenance|Secondary Malignancy|2|||
129223211|NCT02253316|465118314|FG002|Maintenance|Secondary Malignancy|6|||
129223212|NCT02253316|465118312|FG000|Maintenance|Adverse Event|0|||
129223213|NCT02253316|465118313|FG001|Maintenance|Adverse Event|8|||
129223214|NCT02253316|465118314|FG002|Maintenance|Adverse Event|12|||
129223215|NCT02253316|465118312|FG000|Maintenance|Still receiving active treatment|0|||
129223216|NCT02253316|465118313|FG001|Maintenance|Still receiving active treatment|4|||
129223217|NCT02253316|465118314|FG002|Maintenance|Still receiving active treatment|0|||
129223218|NCT02186847|465118315|FG000|Overall Study|Protocol Violation|3|||
129223219|NCT02186847|465118316|FG001|Overall Study|Protocol Violation|0|||
129223220|NCT00124306|465118320|FG000|Overall Study|Adverse Event|7|||
129223221|NCT00124306|465118321|FG001|Overall Study|Adverse Event|2|||
129223222|NCT00124306|465118320|FG000|Overall Study|Lost to Follow-up|10|||
129223223|NCT00124306|465118321|FG001|Overall Study|Lost to Follow-up|6|||
129046440|NCT01144364|464463280|FG001|Induction Phase|Death|0|||
129046441|NCT01144364|464463281|FG002|Induction Phase|Death|0|||
129046442|NCT01144364|464463279|FG000|Induction Phase|Withdrawal by Subject|1|||
129046443|NCT01144364|464463280|FG001|Induction Phase|Withdrawal by Subject|0|||
129046444|NCT01144364|464463281|FG002|Induction Phase|Withdrawal by Subject|0|||
129046445|NCT01144364|464463279|FG000|Induction Phase|Lost to Follow-up|2|||
129046446|NCT01144364|464463280|FG001|Induction Phase|Lost to Follow-up|0|||
129046447|NCT01144364|464463281|FG002|Induction Phase|Lost to Follow-up|0|||
129046448|NCT01144364|464463279|FG000|Induction Phase|Physician Decision|1|||
129046449|NCT01144364|464463280|FG001|Induction Phase|Physician Decision|0|||
129046450|NCT01144364|464463281|FG002|Induction Phase|Physician Decision|0|||
129046451|NCT01144364|464463279|FG000|Induction Phase|Stable disease|2|||
129046452|NCT01144364|464463280|FG001|Induction Phase|Stable disease|0|||
129046453|NCT01144364|464463281|FG002|Induction Phase|Stable disease|0|||
129046454|NCT01144364|464463279|FG000|Induction Phase|Secondary neoplasia|1|||
129046455|NCT01144364|464463280|FG001|Induction Phase|Secondary neoplasia|0|||
129046456|NCT01144364|464463281|FG002|Induction Phase|Secondary neoplasia|0|||
129046457|NCT01144364|464463279|FG000|Induction Phase|Protocol Violation|1|||
129046458|NCT01144364|464463280|FG001|Induction Phase|Protocol Violation|0|||
129046459|NCT01144364|464463281|FG002|Induction Phase|Protocol Violation|0|||
129046460|NCT01144364|464463279|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
128719326|NCT02608268|463271023|FG004|Overall Study|Subject/guardian decision|0|||
128719327|NCT02608268|463271024|FG005|Overall Study|Subject/guardian decision|0|||
128719328|NCT02608268|463271025|FG006|Overall Study|Subject/guardian decision|0|||
128719329|NCT02608268|463271026|FG007|Overall Study|Subject/guardian decision|0|||
128719330|NCT02608268|463271027|FG008|Overall Study|Subject/guardian decision|2|||
128719331|NCT02608268|463271028|FG009|Overall Study|Subject/guardian decision|2|||
128719332|NCT02608268|463271029|FG010|Overall Study|Subject/guardian decision|0|||
128719333|NCT02608268|463271030|FG011|Overall Study|Subject/guardian decision|1|||
129046461|NCT01144364|464463280|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
129046462|NCT01144364|464463281|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
129046463|NCT01144364|464463279|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
129046464|NCT01144364|464463280|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
129046465|NCT01144364|464463281|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
129046466|NCT01144364|464463279|FG000|Follow-Up/Maintenance Phase|Death|0|||
129046467|NCT01144364|464463280|FG001|Follow-Up/Maintenance Phase|Death|2|||
129046468|NCT01144364|464463281|FG002|Follow-Up/Maintenance Phase|Death|0|||
129046469|NCT01144364|464463279|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
129046470|NCT01144364|464463280|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
129046471|NCT01144364|464463281|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
129046472|NCT01144364|464463279|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
129046473|NCT01144364|464463280|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
129046474|NCT01144364|464463281|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
129046475|NCT01144364|464463279|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
129046476|NCT01144364|464463280|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
129046477|NCT01144364|464463281|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
129046478|NCT01144364|464463279|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
129046479|NCT01144364|464463280|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
129046480|NCT01144364|464463281|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
129046481|NCT01301508|464463284|FG000|Overall Study|Withdrawal by Subject|1|||
129046482|NCT01301508|464463285|FG001|Overall Study|Withdrawal by Subject|2|||
129046483|NCT01301508|464463284|FG000|Overall Study|Lost to Follow-up|0|||
129046484|NCT01301508|464463285|FG001|Overall Study|Lost to Follow-up|1|||
129046485|NCT00851643|464463286|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
129046486|NCT00851643|464463287|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129046487|NCT00851643|464463288|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129046488|NCT00851643|464463289|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129046489|NCT00851643|464463290|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129046490|NCT00851643|464463291|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129046491|NCT00851643|464463286|FG000|Base Study (Up to 12 Months)|Other|0|||
129046492|NCT00851643|464463287|FG001|Base Study (Up to 12 Months)|Other|0|||
129046493|NCT00851643|464463288|FG002|Base Study (Up to 12 Months)|Other|0|||
129046494|NCT00851643|464463289|FG003|Base Study (Up to 12 Months)|Other|0|||
129046495|NCT00851643|464463290|FG004|Base Study (Up to 12 Months)|Other|0|||
129046496|NCT00851643|464463291|FG005|Base Study (Up to 12 Months)|Other|1|||
129046497|NCT00851643|464463286|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
129046498|NCT00851643|464463287|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
129046499|NCT00851643|464463288|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
129046500|NCT00851643|464463289|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
129046501|NCT00851643|464463290|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
129046502|NCT00851643|464463291|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
129046503|NCT00851643|464463286|FG000|Extension Study (Up to 36 Months)|Moved|0|||
129046504|NCT00851643|464463287|FG001|Extension Study (Up to 36 Months)|Moved|2|||
129046505|NCT00851643|464463288|FG002|Extension Study (Up to 36 Months)|Moved|1|||
129046506|NCT00851643|464463289|FG003|Extension Study (Up to 36 Months)|Moved|1|||
129046507|NCT00851643|464463290|FG004|Extension Study (Up to 36 Months)|Moved|0|||
129046508|NCT00851643|464463291|FG005|Extension Study (Up to 36 Months)|Moved|1|||
129046509|NCT01940497|464463294|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
129046510|NCT01940497|464463295|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
129046511|NCT01940497|464463294|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
129046512|NCT01940497|464463295|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
129046513|NCT01940497|464463294|FG000|Overall Study|Violation of Entry Criteria|1|||
129046514|NCT01940497|464463295|FG001|Overall Study|Violation of Entry Criteria|1|||
129046515|NCT01940497|464463294|FG000|Overall Study|Refused Treatment|1|||
129046516|NCT01940497|464463295|FG001|Overall Study|Refused Treatment|3|||
129046517|NCT01940497|464463294|FG000|Overall Study|Withdrew Consent|6|||
129046518|NCT01940497|464463295|FG001|Overall Study|Withdrew Consent|2|||
129046519|NCT01940497|464463294|FG000|Overall Study|Administrative/Other|1|||
129046520|NCT01940497|464463295|FG001|Overall Study|Administrative/Other|1|||
129046521|NCT02707861|464463296|FG000|Overall Study|Went onto commercial drug|30|||
129046522|NCT02707861|464463297|FG001|Overall Study|Went onto commercial drug|23|||
129046523|NCT02707861|464463296|FG000|Overall Study|Adverse Event|2|||
129046524|NCT02707861|464463297|FG001|Overall Study|Adverse Event|3|||
129046525|NCT02707861|464463296|FG000|Overall Study|Death|5|||
129046526|NCT02707861|464463297|FG001|Overall Study|Death|2|||
129046527|NCT02707861|464463296|FG000|Overall Study|Lack of Efficacy|0|||
129046528|NCT02707861|464463297|FG001|Overall Study|Lack of Efficacy|2|||
129046529|NCT02707861|464463296|FG000|Overall Study|Physician Decision|1|||
129046530|NCT02707861|464463297|FG001|Overall Study|Physician Decision|4|||
129046531|NCT02707861|464463296|FG000|Overall Study|Withdrawal by Subject|2|||
129046532|NCT02707861|464463297|FG001|Overall Study|Withdrawal by Subject|1|||
129046533|NCT02707861|464463296|FG000|Overall Study|Lost to Follow-up|1|||
129046534|NCT02707861|464463297|FG001|Overall Study|Lost to Follow-up|3|||
129046535|NCT01641133|464463298|FG000|Overall Study|Protocol Violation|0|||
129046536|NCT01641133|464463299|FG001|Overall Study|Protocol Violation|1|||
129046537|NCT01641133|464463300|FG002|Overall Study|Protocol Violation|1|||
129046538|NCT01641133|464463298|FG000|Overall Study|Migrated/moved from study area|5|||
129046539|NCT01641133|464463299|FG001|Overall Study|Migrated/moved from study area|3|||
129046540|NCT01641133|464463300|FG002|Overall Study|Migrated/moved from study area|1|||
129046541|NCT01641133|464463298|FG000|Overall Study|Adverse Event|0|||
129046542|NCT01641133|464463299|FG001|Overall Study|Adverse Event|0|||
129046543|NCT01641133|464463300|FG002|Overall Study|Adverse Event|1|||
129046544|NCT01641133|464463298|FG000|Overall Study|Withdrawal by Subject|5|||
129046545|NCT01641133|464463299|FG001|Overall Study|Withdrawal by Subject|3|||
129046546|NCT01641133|464463300|FG002|Overall Study|Withdrawal by Subject|3|||
129046547|NCT01641133|464463298|FG000|Overall Study|Lost to Follow-up|0|||
129046548|NCT01641133|464463299|FG001|Overall Study|Lost to Follow-up|2|||
129046549|NCT01641133|464463300|FG002|Overall Study|Lost to Follow-up|2|||
129046550|NCT03123861|464463301|FG000|Overall Study|Protocol Violation|1|||
129046551|NCT03123861|464463302|FG001|Overall Study|Protocol Violation|1|||
129046552|NCT03123861|464463301|FG000|Overall Study|Withdrawal by Subject|2|||
129046553|NCT03123861|464463302|FG001|Overall Study|Withdrawal by Subject|2|||
129046554|NCT02206620|464463303|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129046555|NCT02206620|464463304|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129046556|NCT02206620|464463303|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
129046557|NCT02206620|464463304|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
129046558|NCT03188666|464464641|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
129046559|NCT03188666|464464642|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
129046560|NCT03188666|464464643|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
129046561|NCT03188666|464464644|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
129046562|NCT03188666|464464641|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
129046563|NCT03188666|464464642|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
129046564|NCT03188666|464464643|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
129046565|NCT03188666|464464644|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
129046566|NCT03188666|464464641|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
129046567|NCT03188666|464464642|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
129046568|NCT03188666|464464643|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
129046569|NCT03188666|464464644|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
129046570|NCT03188666|464464641|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
129046571|NCT03188666|464464642|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
129046572|NCT03188666|464464643|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
129046573|NCT03188666|464464644|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
129046574|NCT03696953|464464645|FG000|Overall Study|Withdrawal by Subject|6|||
129046575|NCT03696953|464464646|FG001|Overall Study|Withdrawal by Subject|1|||
129046576|NCT03696953|464464645|FG000|Overall Study|missed GBS swabs|2|||
129046577|NCT03696953|464464646|FG001|Overall Study|missed GBS swabs|2|||
129046578|NCT03696953|464464645|FG000|Overall Study|lost study bottle containing capsules|2|||
129046579|NCT03696953|464464646|FG001|Overall Study|lost study bottle containing capsules|0|||
129046580|NCT03696953|464464645|FG000|Overall Study|Premature birth|1|||
129046581|NCT03696953|464464646|FG001|Overall Study|Premature birth|4|||
129046582|NCT03696953|464464645|FG000|Overall Study|Gestational hypertension|1|||
129046583|NCT03696953|464464646|FG001|Overall Study|Gestational hypertension|1|||
129046584|NCT03696953|464464645|FG000|Overall Study|Gestational diabetes|2|||
129046585|NCT03696953|464464646|FG001|Overall Study|Gestational diabetes|1|||
129046586|NCT03696953|464464645|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
129046587|NCT03696953|464464646|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
129046588|NCT03696953|464464645|FG000|Overall Study|Changed prenatal provider|1|||
129046589|NCT03696953|464464646|FG001|Overall Study|Changed prenatal provider|1|||
129046590|NCT03502707|464464647|FG000|Overall Study|Adverse Event|0|||
129046591|NCT03502707|464464648|FG001|Overall Study|Adverse Event|0|||
129046592|NCT03502707|464464649|FG002|Overall Study|Adverse Event|0|||
129046593|NCT03502707|464464650|FG003|Overall Study|Adverse Event|0|||
129046594|NCT03502707|464464651|FG004|Overall Study|Adverse Event|0|||
129046595|NCT03502707|464464652|FG005|Overall Study|Adverse Event|0|||
129046596|NCT03502707|464464653|FG006|Overall Study|Adverse Event|0|||
129046597|NCT03502707|464464654|FG007|Overall Study|Adverse Event|0|||
129046598|NCT03502707|464464655|FG008|Overall Study|Adverse Event|0|||
129046599|NCT03502707|464464656|FG009|Overall Study|Adverse Event|0|||
129046600|NCT03502707|464464657|FG010|Overall Study|Adverse Event|0|||
129046601|NCT03502707|464464658|FG011|Overall Study|Adverse Event|0|||
129046602|NCT03502707|464464659|FG012|Overall Study|Adverse Event|0|||
129046603|NCT03502707|464464660|FG013|Overall Study|Adverse Event|0|||
129046604|NCT03502707|464464661|FG014|Overall Study|Adverse Event|0|||
129046605|NCT03502707|464464662|FG015|Overall Study|Adverse Event|1|||
129046606|NCT03502707|464464663|FG016|Overall Study|Adverse Event|5|||
129046607|NCT03502707|464464664|FG017|Overall Study|Adverse Event|0|||
129046608|NCT03502707|464464647|FG000|Overall Study|Death|0|||
129046609|NCT03502707|464464648|FG001|Overall Study|Death|0|||
129046610|NCT03502707|464464649|FG002|Overall Study|Death|0|||
129046611|NCT03502707|464464650|FG003|Overall Study|Death|1|||
129046612|NCT03502707|464464651|FG004|Overall Study|Death|0|||
129046613|NCT03502707|464464652|FG005|Overall Study|Death|0|||
129046614|NCT03502707|464464653|FG006|Overall Study|Death|0|||
129046615|NCT03502707|464464654|FG007|Overall Study|Death|0|||
129046616|NCT03502707|464464655|FG008|Overall Study|Death|1|||
129046617|NCT03502707|464464656|FG009|Overall Study|Death|1|||
129046618|NCT03502707|464464657|FG010|Overall Study|Death|0|||
129046619|NCT03502707|464464658|FG011|Overall Study|Death|0|||
129046620|NCT03502707|464464659|FG012|Overall Study|Death|1|||
129046621|NCT03502707|464464660|FG013|Overall Study|Death|0|||
129046622|NCT03502707|464464661|FG014|Overall Study|Death|0|||
129046623|NCT03502707|464464662|FG015|Overall Study|Death|1|||
129046624|NCT03502707|464464663|FG016|Overall Study|Death|0|||
129046625|NCT03502707|464464664|FG017|Overall Study|Death|0|||
129046626|NCT03502707|464464647|FG000|Overall Study|Lost to Follow-up|0|||
129046627|NCT03502707|464464648|FG001|Overall Study|Lost to Follow-up|0|||
129046628|NCT03502707|464464649|FG002|Overall Study|Lost to Follow-up|0|||
129046629|NCT03502707|464464650|FG003|Overall Study|Lost to Follow-up|0|||
129046630|NCT03502707|464464651|FG004|Overall Study|Lost to Follow-up|0|||
129046631|NCT03502707|464464652|FG005|Overall Study|Lost to Follow-up|0|||
129046632|NCT03502707|464464653|FG006|Overall Study|Lost to Follow-up|0|||
129046633|NCT03502707|464464654|FG007|Overall Study|Lost to Follow-up|5|||
129046634|NCT03502707|464464655|FG008|Overall Study|Lost to Follow-up|0|||
129046635|NCT03502707|464464656|FG009|Overall Study|Lost to Follow-up|2|||
129046636|NCT03502707|464464657|FG010|Overall Study|Lost to Follow-up|1|||
129046637|NCT03502707|464464658|FG011|Overall Study|Lost to Follow-up|2|||
129046638|NCT03502707|464464659|FG012|Overall Study|Lost to Follow-up|1|||
129046639|NCT03502707|464464660|FG013|Overall Study|Lost to Follow-up|1|||
129046640|NCT03502707|464464661|FG014|Overall Study|Lost to Follow-up|0|||
129046641|NCT03502707|464464662|FG015|Overall Study|Lost to Follow-up|4|||
129046642|NCT03502707|464464663|FG016|Overall Study|Lost to Follow-up|9|||
129046643|NCT03502707|464464664|FG017|Overall Study|Lost to Follow-up|2|||
129046644|NCT03502707|464464647|FG000|Overall Study|Physician Decision|0|||
129046645|NCT03502707|464464648|FG001|Overall Study|Physician Decision|0|||
129046646|NCT03502707|464464649|FG002|Overall Study|Physician Decision|0|||
129046647|NCT03502707|464464650|FG003|Overall Study|Physician Decision|0|||
129046648|NCT03502707|464464651|FG004|Overall Study|Physician Decision|0|||
129046649|NCT03502707|464464652|FG005|Overall Study|Physician Decision|0|||
129046650|NCT03502707|464464653|FG006|Overall Study|Physician Decision|0|||
129046651|NCT03502707|464464654|FG007|Overall Study|Physician Decision|0|||
129046652|NCT03502707|464464655|FG008|Overall Study|Physician Decision|2|||
129046653|NCT03502707|464464656|FG009|Overall Study|Physician Decision|1|||
129046654|NCT03502707|464464657|FG010|Overall Study|Physician Decision|0|||
129046655|NCT03502707|464464658|FG011|Overall Study|Physician Decision|0|||
129046656|NCT03502707|464464659|FG012|Overall Study|Physician Decision|0|||
129046657|NCT03502707|464464660|FG013|Overall Study|Physician Decision|0|||
129046658|NCT03502707|464464661|FG014|Overall Study|Physician Decision|1|||
129046659|NCT03502707|464464662|FG015|Overall Study|Physician Decision|3|||
129046660|NCT03502707|464464663|FG016|Overall Study|Physician Decision|0|||
129046661|NCT03502707|464464664|FG017|Overall Study|Physician Decision|0|||
129046662|NCT03502707|464464647|FG000|Overall Study|Protocol Violation|0|||
129046663|NCT03502707|464464648|FG001|Overall Study|Protocol Violation|0|||
129046664|NCT03502707|464464649|FG002|Overall Study|Protocol Violation|0|||
129046665|NCT03502707|464464650|FG003|Overall Study|Protocol Violation|0|||
129046666|NCT03502707|464464651|FG004|Overall Study|Protocol Violation|0|||
129046667|NCT03502707|464464652|FG005|Overall Study|Protocol Violation|0|||
129046668|NCT03502707|464464653|FG006|Overall Study|Protocol Violation|0|||
129046669|NCT03502707|464464654|FG007|Overall Study|Protocol Violation|0|||
129046670|NCT03502707|464464655|FG008|Overall Study|Protocol Violation|0|||
129046671|NCT03502707|464464656|FG009|Overall Study|Protocol Violation|0|||
129046672|NCT03502707|464464657|FG010|Overall Study|Protocol Violation|0|||
129046673|NCT03502707|464464658|FG011|Overall Study|Protocol Violation|0|||
129046674|NCT03502707|464464659|FG012|Overall Study|Protocol Violation|0|||
129046675|NCT03502707|464464660|FG013|Overall Study|Protocol Violation|0|||
128719334|NCT02608268|463271031|FG012|Overall Study|Subject/guardian decision|0|||
128719335|NCT02608268|463271032|FG013|Overall Study|Subject/guardian decision|1|||
128719336|NCT02608268|463271033|FG014|Overall Study|Subject/guardian decision|0|||
129046676|NCT03502707|464464661|FG014|Overall Study|Protocol Violation|0|||
129046677|NCT03502707|464464662|FG015|Overall Study|Protocol Violation|1|||
129046678|NCT03502707|464464663|FG016|Overall Study|Protocol Violation|0|||
129046679|NCT03502707|464464664|FG017|Overall Study|Protocol Violation|0|||
129046680|NCT03502707|464464647|FG000|Overall Study|Withdrawal by Subject|1|||
129046681|NCT03502707|464464648|FG001|Overall Study|Withdrawal by Subject|1|||
129046682|NCT03502707|464464649|FG002|Overall Study|Withdrawal by Subject|0|||
129046683|NCT03502707|464464650|FG003|Overall Study|Withdrawal by Subject|0|||
129046684|NCT03502707|464464651|FG004|Overall Study|Withdrawal by Subject|0|||
129046685|NCT03502707|464464652|FG005|Overall Study|Withdrawal by Subject|2|||
129046686|NCT03502707|464464653|FG006|Overall Study|Withdrawal by Subject|0|||
129046687|NCT03502707|464464654|FG007|Overall Study|Withdrawal by Subject|3|||
129046688|NCT03502707|464464655|FG008|Overall Study|Withdrawal by Subject|1|||
129046689|NCT03502707|464464656|FG009|Overall Study|Withdrawal by Subject|2|||
129046690|NCT03502707|464464657|FG010|Overall Study|Withdrawal by Subject|12|||
129046691|NCT03502707|464464658|FG011|Overall Study|Withdrawal by Subject|23|||
129046692|NCT03502707|464464659|FG012|Overall Study|Withdrawal by Subject|5|||
129046693|NCT03502707|464464660|FG013|Overall Study|Withdrawal by Subject|3|||
129046694|NCT03502707|464464661|FG014|Overall Study|Withdrawal by Subject|3|||
129046695|NCT03502707|464464662|FG015|Overall Study|Withdrawal by Subject|43|||
129046696|NCT03502707|464464663|FG016|Overall Study|Withdrawal by Subject|44|||
129046697|NCT03502707|464464664|FG017|Overall Study|Withdrawal by Subject|18|||
129046698|NCT03502707|464464647|FG000|Overall Study|Sponsor's Decision|1|||
129046699|NCT03502707|464464648|FG001|Overall Study|Sponsor's Decision|0|||
129046700|NCT03502707|464464649|FG002|Overall Study|Sponsor's Decision|0|||
129046701|NCT03502707|464464650|FG003|Overall Study|Sponsor's Decision|0|||
129046702|NCT03502707|464464651|FG004|Overall Study|Sponsor's Decision|0|||
129046703|NCT03502707|464464652|FG005|Overall Study|Sponsor's Decision|0|||
129046704|NCT03502707|464464653|FG006|Overall Study|Sponsor's Decision|0|||
129046705|NCT03502707|464464654|FG007|Overall Study|Sponsor's Decision|0|||
129046706|NCT03502707|464464655|FG008|Overall Study|Sponsor's Decision|0|||
129046707|NCT03502707|464464656|FG009|Overall Study|Sponsor's Decision|1|||
129046708|NCT03502707|464464657|FG010|Overall Study|Sponsor's Decision|0|||
129046709|NCT03502707|464464658|FG011|Overall Study|Sponsor's Decision|0|||
129046710|NCT03502707|464464659|FG012|Overall Study|Sponsor's Decision|0|||
129046711|NCT03502707|464464660|FG013|Overall Study|Sponsor's Decision|0|||
129046712|NCT03502707|464464661|FG014|Overall Study|Sponsor's Decision|0|||
129046713|NCT03502707|464464662|FG015|Overall Study|Sponsor's Decision|2|||
129046714|NCT03502707|464464663|FG016|Overall Study|Sponsor's Decision|1|||
129046715|NCT03502707|464464664|FG017|Overall Study|Sponsor's Decision|0|||
129046716|NCT03502707|464464647|FG000|Overall Study|Initiated Prohibited Medication|0|||
129046717|NCT03502707|464464648|FG001|Overall Study|Initiated Prohibited Medication|0|||
129046718|NCT03502707|464464649|FG002|Overall Study|Initiated Prohibited Medication|0|||
129046719|NCT03502707|464464650|FG003|Overall Study|Initiated Prohibited Medication|0|||
129046720|NCT03502707|464464651|FG004|Overall Study|Initiated Prohibited Medication|0|||
129046721|NCT03502707|464464652|FG005|Overall Study|Initiated Prohibited Medication|0|||
129046722|NCT03502707|464464653|FG006|Overall Study|Initiated Prohibited Medication|0|||
129046723|NCT03502707|464464654|FG007|Overall Study|Initiated Prohibited Medication|0|||
129046724|NCT03502707|464464655|FG008|Overall Study|Initiated Prohibited Medication|0|||
129046725|NCT03502707|464464656|FG009|Overall Study|Initiated Prohibited Medication|0|||
129046726|NCT03502707|464464657|FG010|Overall Study|Initiated Prohibited Medication|0|||
129046727|NCT03502707|464464658|FG011|Overall Study|Initiated Prohibited Medication|0|||
129046728|NCT03502707|464464659|FG012|Overall Study|Initiated Prohibited Medication|0|||
129046729|NCT03502707|464464660|FG013|Overall Study|Initiated Prohibited Medication|0|||
129046730|NCT03502707|464464661|FG014|Overall Study|Initiated Prohibited Medication|0|||
129046731|NCT03502707|464464662|FG015|Overall Study|Initiated Prohibited Medication|0|||
129046732|NCT03502707|464464663|FG016|Overall Study|Initiated Prohibited Medication|1|||
129046733|NCT03502707|464464664|FG017|Overall Study|Initiated Prohibited Medication|0|||
129046734|NCT03502707|464464647|FG000|Overall Study|Other|0|||
129135610|NCT04518410|464789251|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
129135611|NCT04518410|464789252|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129135612|NCT04518410|464789253|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
129135613|NCT04518410|464789229|FG000|Overall Study|Dual Enrolled Subject|0|||
128719337|NCT02608268|463271034|FG015|Overall Study|Subject/guardian decision|1|||
129046735|NCT03502707|464464648|FG001|Overall Study|Other|0|||
129046736|NCT03502707|464464649|FG002|Overall Study|Other|0|||
129046737|NCT03502707|464464650|FG003|Overall Study|Other|0|||
129046738|NCT03502707|464464651|FG004|Overall Study|Other|0|||
129046739|NCT03502707|464464652|FG005|Overall Study|Other|0|||
129046740|NCT03502707|464464653|FG006|Overall Study|Other|0|||
129046741|NCT03502707|464464654|FG007|Overall Study|Other|0|||
129046742|NCT03502707|464464655|FG008|Overall Study|Other|1|||
129046743|NCT03502707|464464656|FG009|Overall Study|Other|1|||
129046744|NCT03502707|464464657|FG010|Overall Study|Other|2|||
129046745|NCT03502707|464464658|FG011|Overall Study|Other|0|||
129046746|NCT03502707|464464659|FG012|Overall Study|Other|0|||
129046747|NCT03502707|464464660|FG013|Overall Study|Other|0|||
129046748|NCT03502707|464464661|FG014|Overall Study|Other|0|||
129046749|NCT03502707|464464662|FG015|Overall Study|Other|4|||
129046750|NCT03502707|464464663|FG016|Overall Study|Other|1|||
129046751|NCT03502707|464464664|FG017|Overall Study|Other|0|||
129046752|NCT03502707|464464647|FG000|Overall Study|Randomized but not vaccinated|0|||
129046753|NCT03502707|464464648|FG001|Overall Study|Randomized but not vaccinated|0|||
129046754|NCT03502707|464464649|FG002|Overall Study|Randomized but not vaccinated|0|||
129046755|NCT03502707|464464650|FG003|Overall Study|Randomized but not vaccinated|0|||
129046756|NCT03502707|464464651|FG004|Overall Study|Randomized but not vaccinated|0|||
129046757|NCT03502707|464464652|FG005|Overall Study|Randomized but not vaccinated|0|||
129135614|NCT04518410|464789230|FG001|Overall Study|Dual Enrolled Subject|0|||
129135615|NCT04518410|464789231|FG002|Overall Study|Dual Enrolled Subject|0|||
129046758|NCT03502707|464464653|FG006|Overall Study|Randomized but not vaccinated|0|||
129046759|NCT03502707|464464654|FG007|Overall Study|Randomized but not vaccinated|0|||
129046760|NCT03502707|464464655|FG008|Overall Study|Randomized but not vaccinated|0|||
129046761|NCT03502707|464464656|FG009|Overall Study|Randomized but not vaccinated|0|||
129046762|NCT03502707|464464657|FG010|Overall Study|Randomized but not vaccinated|0|||
129046763|NCT03502707|464464658|FG011|Overall Study|Randomized but not vaccinated|1|||
129046764|NCT03502707|464464659|FG012|Overall Study|Randomized but not vaccinated|0|||
129046765|NCT03502707|464464660|FG013|Overall Study|Randomized but not vaccinated|0|||
129046766|NCT03502707|464464661|FG014|Overall Study|Randomized but not vaccinated|0|||
129046767|NCT03502707|464464662|FG015|Overall Study|Randomized but not vaccinated|0|||
129046768|NCT03502707|464464663|FG016|Overall Study|Randomized but not vaccinated|0|||
129046769|NCT03502707|464464664|FG017|Overall Study|Randomized but not vaccinated|1|||
129046770|NCT04908683|464464665|FG000|Overall Study|Failure to meet continuation criteria|34|||
129046771|NCT04908683|464464666|FG001|Overall Study|Failure to meet continuation criteria|22|||
129046772|NCT04908683|464464665|FG000|Overall Study|Initiated prohibited medication|3|||
129046773|NCT04908683|464464666|FG001|Overall Study|Initiated prohibited medication|0|||
129046774|NCT04908683|464464665|FG000|Overall Study|Randomized by mistake|1|||
129046775|NCT04908683|464464666|FG001|Overall Study|Randomized by mistake|0|||
129046776|NCT04908683|464464665|FG000|Overall Study|Lost to Follow-up|679|||
129046777|NCT04908683|464464666|FG001|Overall Study|Lost to Follow-up|341|||
129046778|NCT04908683|464464665|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
129046779|NCT04908683|464464666|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
129046780|NCT04908683|464464665|FG000|Overall Study|Physician Decision|44|||
129046781|NCT04908683|464464666|FG001|Overall Study|Physician Decision|35|||
129046782|NCT04908683|464464665|FG000|Overall Study|Technical problems|12|||
129046783|NCT04908683|464464666|FG001|Overall Study|Technical problems|9|||
129046784|NCT04908683|464464665|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
129046785|NCT04908683|464464666|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
129046786|NCT04908683|464464665|FG000|Overall Study|Protocol Violation|2|||
129046787|NCT04908683|464464666|FG001|Overall Study|Protocol Violation|0|||
129046788|NCT04908683|464464665|FG000|Overall Study|Withdrawal by Subject|1188|||
129046789|NCT04908683|464464666|FG001|Overall Study|Withdrawal by Subject|570|||
129135616|NCT04518410|464789232|FG003|Overall Study|Dual Enrolled Subject|0|||
129135617|NCT04518410|464789233|FG004|Overall Study|Dual Enrolled Subject|0|||
129135618|NCT04518410|464789234|FG005|Overall Study|Dual Enrolled Subject|0|||
129046790|NCT04908683|464464665|FG000|Overall Study|Site Closure by Sponsor|6|||
129046791|NCT04908683|464464666|FG001|Overall Study|Site Closure by Sponsor|3|||
129046792|NCT04908683|464464665|FG000|Overall Study|Adverse Event|21|||
129046793|NCT04908683|464464666|FG001|Overall Study|Adverse Event|11|||
129046794|NCT04908683|464464665|FG000|Overall Study|Death|101|||
129046795|NCT04908683|464464666|FG001|Overall Study|Death|61|||
129046796|NCT04908683|464464665|FG000|Overall Study|Sponsor's decision|14398|||
129046797|NCT04908683|464464666|FG001|Overall Study|Sponsor's decision|7205|||
129046798|NCT04908683|464464665|FG000|Overall Study|Other|92|||
129046799|NCT04908683|464464666|FG001|Overall Study|Other|50|||
129046800|NCT04908683|464464665|FG000|Overall Study|Randomized not vaccinated|108|||
129046801|NCT04908683|464464666|FG001|Overall Study|Randomized not vaccinated|52|||
129046802|NCT06204887|464464668|FG000|Overall Study|Lost to Follow-up|3|||
129046803|NCT06204887|464464669|FG001|Overall Study|Lost to Follow-up|4|||
129046804|NCT06204887|464464670|FG002|Overall Study|Lost to Follow-up|1|||
129046805|NCT06204887|464464671|FG003|Overall Study|Lost to Follow-up|6|||
129135619|NCT04518410|464789235|FG006|Overall Study|Dual Enrolled Subject|0|||
129135620|NCT04518410|464789236|FG007|Overall Study|Dual Enrolled Subject|0|||
129135621|NCT04518410|464789237|FG008|Overall Study|Dual Enrolled Subject|0|||
129046806|NCT02221037|464464672|FG000|Overall Study|Physician Decision|0|||
129046807|NCT02221037|464464673|FG001|Overall Study|Physician Decision|0|||
129046808|NCT02221037|464464674|FG002|Overall Study|Physician Decision|1|||
129046809|NCT02221037|464464675|FG003|Overall Study|Physician Decision|0|||
129046810|NCT01884311|464464676|FG000|Overall Study|Withdrawal by Subject|3|||
129046811|NCT01884311|464464676|FG000|Overall Study|withdrew consent due to AEs|1|||
129046812|NCT01884311|464464676|FG000|Overall Study|Precautionary measure|1|||
129046813|NCT02307266|464464677|FG000|Overall Study|Adverse Event|3|||
129046814|NCT02307266|464464678|FG001|Overall Study|Adverse Event|1|||
129046815|NCT02307266|464464679|FG002|Overall Study|Adverse Event|5|||
129046816|NCT02307266|464464677|FG000|Overall Study|Withdrawal by Subject|2|||
129046817|NCT02307266|464464678|FG001|Overall Study|Withdrawal by Subject|0|||
129046818|NCT02307266|464464679|FG002|Overall Study|Withdrawal by Subject|1|||
129046819|NCT02307266|464464677|FG000|Overall Study|Lost to Follow-up|3|||
129046820|NCT02307266|464464678|FG001|Overall Study|Lost to Follow-up|0|||
129046821|NCT02307266|464464679|FG002|Overall Study|Lost to Follow-up|0|||
129046822|NCT02031458|464464691|FG000|May 8, 2015 to January 11, 2019|Death|89|||
129046823|NCT02031458|464464692|FG001|May 8, 2015 to January 11, 2019|Death|193|||
129046824|NCT02031458|464464693|FG002|May 8, 2015 to January 11, 2019|Death|198|||
129046825|NCT02031458|464464691|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
129046826|NCT02031458|464464692|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
129046827|NCT02031458|464464693|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
129046828|NCT02031458|464464691|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
129046829|NCT02031458|464464692|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
129046830|NCT02031458|464464693|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
129046831|NCT02031458|464464691|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
129046832|NCT02031458|464464692|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
129046833|NCT02031458|464464693|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
129046834|NCT02031458|464464691|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
129046835|NCT02031458|464464692|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
129046836|NCT02031458|464464693|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
129046837|NCT02031458|464464691|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
129135622|NCT04518410|464789238|FG009|Overall Study|Dual Enrolled Subject|0|||
129135623|NCT04518410|464789239|FG010|Overall Study|Dual Enrolled Subject|0|||
129135624|NCT04518410|464789240|FG011|Overall Study|Dual Enrolled Subject|0|||
129223224|NCT00124306|465118320|FG000|Overall Study|Lack of Efficacy|3|||
129223225|NCT00124306|465118321|FG001|Overall Study|Lack of Efficacy|6|||
129223226|NCT00124306|465118320|FG000|Overall Study|Personal constraints|0|||
129223227|NCT00124306|465118321|FG001|Overall Study|Personal constraints|2|||
129223228|NCT00124306|465118320|FG000|Overall Study|Use of unacceptable medication|1|||
129046838|NCT02031458|464464692|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
129046839|NCT02031458|464464693|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
129046840|NCT02031458|464464691|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
129046841|NCT02031458|464464692|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
129046842|NCT02031458|464464693|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
129046843|NCT02031458|464464691|FG000|Baseline to May 8, 2015|Death|36|||
129135625|NCT04518410|464789241|FG012|Overall Study|Dual Enrolled Subject|0|||
129135626|NCT04518410|464789242|FG013|Overall Study|Dual Enrolled Subject|0|||
129135627|NCT04518410|464789243|FG014|Overall Study|Dual Enrolled Subject|0|||
129135628|NCT04518410|464789244|FG015|Overall Study|Dual Enrolled Subject|0|||
129135629|NCT04518410|464789245|FG016|Overall Study|Dual Enrolled Subject|0|||
129223229|NCT00124306|465118321|FG001|Overall Study|Use of unacceptable medication|0|||
129223230|NCT00124306|465118320|FG000|Overall Study|Abnormal lab result|0|||
129223231|NCT00124306|465118321|FG001|Overall Study|Abnormal lab result|1|||
129223232|NCT00124306|465118320|FG000|Overall Study|Other|2|||
129223233|NCT00124306|465118321|FG001|Overall Study|Other|0|||
129223234|NCT03875235|465118322|FG000|Overall Study|Ongoing study treatment|63|||
129223235|NCT03875235|465118323|FG001|Overall Study|Ongoing study treatment|20|||
129223236|NCT03875235|465118322|FG000|Overall Study|Off treatment|77|||
129223237|NCT03875235|465118323|FG001|Overall Study|Off treatment|91|||
128775403|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
128775404|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775405|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775406|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775407|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775408|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775409|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775410|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775411|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775412|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775413|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775414|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775415|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775416|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775417|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
128775418|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
128775419|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
128775420|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
128775421|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
128775422|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128775423|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129046844|NCT02031458|464464692|FG001|Baseline to May 8, 2015|Death|87|||
129223238|NCT03875235|465118322|FG000|Overall Study|Withdrawal by Subject|3|||
129223239|NCT03875235|465118323|FG001|Overall Study|Withdrawal by Subject|10|||
129223240|NCT03875235|465118322|FG000|Overall Study|Death|198|||
129046845|NCT02031458|464464693|FG002|Baseline to May 8, 2015|Death|100|||
129046846|NCT02031458|464464691|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
129046847|NCT02031458|464464692|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
129046848|NCT02031458|464464693|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
129046849|NCT02031458|464464691|FG000|Baseline to May 8, 2015|Physician Decision|0|||
129046850|NCT02031458|464464692|FG001|Baseline to May 8, 2015|Physician Decision|1|||
129046851|NCT02031458|464464693|FG002|Baseline to May 8, 2015|Physician Decision|0|||
129046852|NCT02031458|464464691|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
129046853|NCT02031458|464464692|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
129046854|NCT02031458|464464693|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
129046855|NCT02031458|464464691|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
129046856|NCT02031458|464464692|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
129046857|NCT02031458|464464693|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
129046858|NCT02031458|464464691|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
129046859|NCT02031458|464464692|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
129046860|NCT02031458|464464693|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
129046861|NCT02031458|464464691|FG000|Baseline to May 8, 2015|On Treatment|43|||
129046862|NCT02031458|464464692|FG001|Baseline to May 8, 2015|On Treatment|81|||
129046863|NCT02031458|464464693|FG002|Baseline to May 8, 2015|On Treatment|73|||
129046864|NCT02031458|464464691|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
129046865|NCT02031458|464464692|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
129046866|NCT02031458|464464693|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
129046867|NCT05855616|464464694|FG000|Overall Study|Lost to Follow-up|1|||
129046868|NCT05855616|464464695|FG001|Overall Study|Lost to Follow-up|2|||
129046869|NCT00059787|464464696|FG000|Overall Study|Adverse Event|13|||
129046870|NCT00059787|464464696|FG000|Overall Study|disease progression|2|||
129046871|NCT00059787|464464696|FG000|Overall Study|ineligible|1|||
129046872|NCT00059787|464464696|FG000|Overall Study|Other|4|||
129046873|NCT00103311|464464705|FG000|Overall Study|Lost to Follow-up|1|||
129046874|NCT00103311|464464706|FG001|Overall Study|Lost to Follow-up|0|||
129046875|NCT00103311|464464705|FG000|Overall Study|Withdrawal by Subject|2|||
129046876|NCT00103311|464464706|FG001|Overall Study|Withdrawal by Subject|1|||
129046877|NCT00103311|464464705|FG000|Overall Study|Adverse Event|1|||
129046878|NCT00103311|464464706|FG001|Overall Study|Adverse Event|0|||
129046879|NCT00974974|464464714|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
129046880|NCT00974974|464464715|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
129046881|NCT00974974|464464714|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
129046882|NCT00974974|464464715|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
129046883|NCT00974974|464464714|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
129046884|NCT00974974|464464715|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
129046885|NCT00974974|464464714|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
129046886|NCT00974974|464464715|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
129046887|NCT00974974|464464714|FG000|IR CD-LD Dose Adjustment|Various|0|||
129046888|NCT00974974|464464715|FG001|IR CD-LD Dose Adjustment|Various|9|||
129046889|NCT00974974|464464714|FG000|IPX066 Dose Conversion|Adverse Event|23|||
129046890|NCT00974974|464464715|FG001|IPX066 Dose Conversion|Adverse Event|0|||
129046891|NCT00974974|464464714|FG000|IPX066 Dose Conversion|Death|2|||
129046892|NCT00974974|464464715|FG001|IPX066 Dose Conversion|Death|0|||
129046893|NCT00974974|464464714|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
129046894|NCT00974974|464464715|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
129046895|NCT00974974|464464714|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
129046896|NCT00974974|464464715|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
129046897|NCT00974974|464464714|FG000|IPX066 Dose Conversion|Various|3|||
129046898|NCT00974974|464464715|FG001|IPX066 Dose Conversion|Various|0|||
129046899|NCT00974974|464464714|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
129046900|NCT00974974|464464715|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
129046901|NCT00974974|464464714|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
129046902|NCT00974974|464464715|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
129046903|NCT00974974|464464714|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
129046904|NCT00974974|464464715|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
129046905|NCT00974974|464464714|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
129046906|NCT00974974|464464715|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
129046907|NCT00974974|464464714|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
129046908|NCT00974974|464464715|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
129046909|NCT00974974|464464714|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
129135630|NCT04518410|464789246|FG017|Overall Study|Dual Enrolled Subject|1|||
129135631|NCT04518410|464789247|FG018|Overall Study|Dual Enrolled Subject|0|||
129135632|NCT04518410|464789248|FG019|Overall Study|Dual Enrolled Subject|0|||
129135633|NCT04518410|464789249|FG020|Overall Study|Dual Enrolled Subject|0|||
129135634|NCT04518410|464789250|FG021|Overall Study|Dual Enrolled Subject|0|||
129135635|NCT04518410|464789251|FG022|Overall Study|Dual Enrolled Subject|0|||
129135636|NCT04518410|464789252|FG023|Overall Study|Dual Enrolled Subject|0|||
129135637|NCT04518410|464789253|FG024|Overall Study|Dual Enrolled Subject|0|||
129046910|NCT00974974|464464715|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
129046911|NCT00974974|464464714|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
129046912|NCT00974974|464464715|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
129046913|NCT00974974|464464714|FG000|Maintenance - Double Blind Treatment|Various|4|||
129046914|NCT00974974|464464715|FG001|Maintenance - Double Blind Treatment|Various|0|||
129046915|NCT01959035|464464716|FG000|Overall Study|Adverse Event|5|||
129046916|NCT01959035|464464716|FG000|Overall Study|Withdrawal by Subject|4|||
129046917|NCT01959035|464464716|FG000|Overall Study|Lost to Follow-up|1|||
129046918|NCT01959035|464464716|FG000|Overall Study|Other (no primary reason given)|1|||
129046919|NCT02034058|464464717|FG000|Overall Study|Death|3|||
129046920|NCT03254602|464464718|FG000|Overall Study|Lost to Follow-up|4|||
129046921|NCT02963311|464464723|FG000|Overall Study|Withdrawal by Subject|1|||
129046922|NCT02963311|464464723|FG000|Overall Study|Screen Failure|4|||
129046923|NCT02836496|464464726|FG000|Overall Study|Adverse Event|2|||
129046924|NCT02836496|464464727|FG001|Overall Study|Adverse Event|1|||
129046925|NCT02836496|464464726|FG000|Overall Study|Withdrawal by Subject|0|||
129046926|NCT02836496|464464727|FG001|Overall Study|Withdrawal by Subject|1|||
129046927|NCT03822832|464464728|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
129046928|NCT03822832|464464729|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
129046929|NCT03822832|464464728|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
129046930|NCT03822832|464464729|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
129046931|NCT03822832|464464728|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
129046932|NCT03822832|464464729|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
129046933|NCT03822832|464464728|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
129046934|NCT03822832|464464729|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
129046935|NCT03822832|464464728|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
129046936|NCT03822832|464464729|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
129046937|NCT03822832|464464728|FG000|Re-allocation|Not re-allocated to open label period|2|||
129046938|NCT03822832|464464729|FG001|Re-allocation|Not re-allocated to open label period|6|||
129046939|NCT03822832|464464728|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
129046940|NCT03822832|464464729|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
129046941|NCT03822832|464464728|FG000|Period 2 - Open Label Period|Adverse Event|0|||
129046942|NCT03822832|464464729|FG001|Period 2 - Open Label Period|Adverse Event|3|||
129046943|NCT02575911|464464731|FG000|Overall Study|Lost to Follow-up|1|||
129046944|NCT01249365|464464732|FG000|Overall Study|Lost to Follow-up|1|||
129046945|NCT01460901|464464733|FG000|Overall Study|Withdrawal by Subject|2|||
129046946|NCT02566993|464464734|FG000|Overall Study|Randomized but not treated|5|||
129046947|NCT02566993|464464735|FG001|Overall Study|Randomized but not treated|16|||
129046948|NCT02566993|464464734|FG000|Overall Study|Progressive disease|213|||
129046949|NCT02566993|464464735|FG001|Overall Study|Progressive disease|152|||
129046950|NCT02566993|464464734|FG000|Overall Study|Withdrawal by Subject|12|||
129046951|NCT02566993|464464735|FG001|Overall Study|Withdrawal by Subject|28|||
129046952|NCT02566993|464464734|FG000|Overall Study|Death|17|||
129046953|NCT02566993|464464735|FG001|Overall Study|Death|23|||
129046954|NCT02566993|464464734|FG000|Overall Study|Physician Decision|10|||
129046955|NCT02566993|464464735|FG001|Overall Study|Physician Decision|17|||
129046956|NCT02566993|464464734|FG000|Overall Study|Study drug-related adverse event|20|||
129046957|NCT02566993|464464735|FG001|Overall Study|Study drug-related adverse event|41|||
129046958|NCT02566993|464464734|FG000|Overall Study|Non study drug-related adverse event|9|||
129046959|NCT02566993|464464735|FG001|Overall Study|Non study drug-related adverse event|9|||
129046960|NCT02566993|464464734|FG000|Overall Study|Symptomatic deterioration|9|||
129046961|NCT02566993|464464735|FG001|Overall Study|Symptomatic deterioration|16|||
129046962|NCT02566993|464464734|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
129046963|NCT02566993|464464735|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
129046964|NCT02566993|464464734|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
129046965|NCT02566993|464464735|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
129046966|NCT02566993|464464734|FG000|Overall Study|Screening failure|2|||
129046967|NCT02566993|464464735|FG001|Overall Study|Screening failure|0|||
129046968|NCT02566993|464464734|FG000|Overall Study|Lost to Follow-up|0|||
129046969|NCT02566993|464464735|FG001|Overall Study|Lost to Follow-up|1|||
129046970|NCT02566993|464464734|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
129046971|NCT02566993|464464735|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
129046972|NCT01169532|464464740|FG000|Overall Study|Withdrawal by Subject|1|||
129046973|NCT03127644|464464748|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129046974|NCT03127644|464464749|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129046975|NCT03127644|464464750|FG002|Overall Study|Study-specific withdrawal criteria|2|||
129046976|NCT02005887|464464751|FG000|Overall Study|Protocol Violation|0|||
129046977|NCT02005887|464464752|FG001|Overall Study|Protocol Violation|2|||
129046978|NCT01550744|464464753|FG000|Open-Label|Lost to Follow-up|7|||
129046979|NCT01550744|464464754|FG001|Open-Label|Lost to Follow-up|0|||
129223241|NCT03875235|465118323|FG001|Overall Study|Death|223|||
129135638|NCT03462563|464789254|FG000|Overall Study|Death|1|||
129135639|NCT03462563|464789255|FG001|Overall Study|Death|1|||
129135640|NCT03462563|464789254|FG000|Overall Study|Termination of study|2|||
129135641|NCT03462563|464789255|FG001|Overall Study|Termination of study|1|||
129135642|NCT03462563|464789254|FG000|Overall Study|Adverse Event|1|||
129135643|NCT03462563|464789255|FG001|Overall Study|Adverse Event|3|||
129135644|NCT03462563|464789254|FG000|Overall Study|Unspecified reason|10|||
129135645|NCT03462563|464789255|FG001|Overall Study|Unspecified reason|12|||
129135646|NCT03462563|464789254|FG000|Overall Study|Physician Decision|1|||
129135647|NCT03462563|464789255|FG001|Overall Study|Physician Decision|0|||
129135648|NCT01740427|464789256|FG000|Overall Study|Objective Progression or Relapse|286|||
129135649|NCT01740427|464789257|FG001|Overall Study|Objective Progression or Relapse|172|||
129135650|NCT01740427|464789256|FG000|Overall Study|Adverse Event|32|||
129046980|NCT01550744|464464755|FG002|Open-Label|Lost to Follow-up|0|||
129135651|NCT01740427|464789257|FG001|Overall Study|Adverse Event|9|||
129135652|NCT01740427|464789256|FG000|Overall Study|Global Deterioration of Health Status|28|||
129135653|NCT01740427|464789257|FG001|Overall Study|Global Deterioration of Health Status|12|||
129135654|NCT01740427|464789256|FG000|Overall Study|Participant Refused Continued Treatment|27|||
129135655|NCT01740427|464789257|FG001|Overall Study|Participant Refused Continued Treatment|15|||
129135656|NCT01740427|464789256|FG000|Overall Study|Unspecified reasons|52|||
129135657|NCT01740427|464789257|FG001|Overall Study|Unspecified reasons|8|||
129135658|NCT01740427|464789256|FG000|Overall Study|Death|10|||
129135659|NCT01740427|464789257|FG001|Overall Study|Death|3|||
129135660|NCT01740427|464789256|FG000|Overall Study|Protocol Violation|5|||
129135661|NCT01740427|464789257|FG001|Overall Study|Protocol Violation|3|||
129135662|NCT01740427|464789256|FG000|Overall Study|Lost to Follow-up|3|||
129135663|NCT01740427|464789257|FG001|Overall Study|Lost to Follow-up|0|||
129135664|NCT01740427|464789256|FG000|Overall Study|Site Terminated by Sponsor|1|||
129135665|NCT01740427|464789257|FG001|Overall Study|Site Terminated by Sponsor|0|||
129135666|NCT04796207|464789258|FG000|Overall Study|Lost to Follow-up|7|||
129135667|NCT04796207|464789259|FG001|Overall Study|Lost to Follow-up|2|||
129135668|NCT02405962|464789262|FG000|Overall Study|Lost to Follow-up|1|||
129135669|NCT02405962|464789263|FG001|Overall Study|Lost to Follow-up|4|||
129135670|NCT02405962|464789262|FG000|Overall Study|A participant has moved to another place|0|||
129135671|NCT02405962|464789263|FG001|Overall Study|A participant has moved to another place|1|||
129223242|NCT02112916|465118324|FG000|Overall Study|Adverse Event|6|||
129223243|NCT02112916|465118325|FG001|Overall Study|Adverse Event|9|||
129223244|NCT02112916|465118326|FG002|Overall Study|Adverse Event|3|||
129223245|NCT02112916|465118327|FG003|Overall Study|Adverse Event|2|||
129223246|NCT02112916|465118324|FG000|Overall Study|Death|9|||
129223247|NCT02112916|465118325|FG001|Overall Study|Death|9|||
129223248|NCT02112916|465118326|FG002|Overall Study|Death|3|||
129223249|NCT02112916|465118327|FG003|Overall Study|Death|4|||
129223250|NCT02112916|465118324|FG000|Overall Study|Lost to Follow-up|1|||
129223251|NCT02112916|465118325|FG001|Overall Study|Lost to Follow-up|0|||
129046981|NCT01550744|464464753|FG000|Open-Label|Withdrawal by Subject|13|||
129046982|NCT01550744|464464754|FG001|Open-Label|Withdrawal by Subject|0|||
129046983|NCT01550744|464464755|FG002|Open-Label|Withdrawal by Subject|0|||
129046984|NCT01550744|464464753|FG000|Open-Label|Adverse Event|11|||
129046985|NCT01550744|464464754|FG001|Open-Label|Adverse Event|0|||
129046986|NCT01550744|464464755|FG002|Open-Label|Adverse Event|0|||
129046987|NCT01550744|464464753|FG000|Open-Label|Lack of Efficacy|4|||
129046988|NCT01550744|464464754|FG001|Open-Label|Lack of Efficacy|0|||
129046989|NCT01550744|464464755|FG002|Open-Label|Lack of Efficacy|0|||
129046990|NCT01550744|464464753|FG000|Open-Label|Protocol Violation|4|||
129046991|NCT01550744|464464754|FG001|Open-Label|Protocol Violation|0|||
129046992|NCT01550744|464464755|FG002|Open-Label|Protocol Violation|0|||
129046993|NCT01550744|464464753|FG000|Open-Label|Not all 3 study drug injections received|2|||
129046994|NCT01550744|464464754|FG001|Open-Label|Not all 3 study drug injections received|0|||
129046995|NCT01550744|464464755|FG002|Open-Label|Not all 3 study drug injections received|0|||
129046996|NCT01550744|464464753|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
129046997|NCT01550744|464464754|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
129046998|NCT01550744|464464755|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
129135672|NCT00165698|464789264|FG000|Overall Study|Adverse Event|2|||
129135673|NCT00165698|464789265|FG001|Overall Study|Adverse Event|10|||
129135674|NCT00165698|464789264|FG000|Overall Study|Lost to Follow-up|2|||
129135675|NCT00165698|464789265|FG001|Overall Study|Lost to Follow-up|2|||
129135676|NCT00165698|464789264|FG000|Overall Study|Withdrawal by Subject|2|||
129223252|NCT02112916|465118326|FG002|Overall Study|Lost to Follow-up|0|||
129223253|NCT02112916|465118327|FG003|Overall Study|Lost to Follow-up|0|||
129135677|NCT00165698|464789265|FG001|Overall Study|Withdrawal by Subject|1|||
129223254|NCT02112916|465118324|FG000|Overall Study|Physician Decision|94|||
129223255|NCT02112916|465118325|FG001|Overall Study|Physician Decision|72|||
129223256|NCT02112916|465118326|FG002|Overall Study|Physician Decision|24|||
129223257|NCT02112916|465118327|FG003|Overall Study|Physician Decision|15|||
129223258|NCT02112916|465118324|FG000|Overall Study|Withdrawal by Subject|5|||
129223259|NCT02112916|465118325|FG001|Overall Study|Withdrawal by Subject|3|||
129223260|NCT02112916|465118326|FG002|Overall Study|Withdrawal by Subject|1|||
128719338|NCT02608268|463271035|FG016|Overall Study|Subject/guardian decision|0|||
128719339|NCT02608268|463271036|FG017|Overall Study|Subject/guardian decision|0|||
128719340|NCT02608268|463271037|FG018|Overall Study|Subject/guardian decision|1|||
128719341|NCT02608268|463271038|FG019|Overall Study|Subject/guardian decision|0|||
129046999|NCT01550744|464464753|FG000|Open-Label|Other|1|||
129047000|NCT01550744|464464754|FG001|Open-Label|Other|0|||
129047001|NCT01550744|464464755|FG002|Open-Label|Other|0|||
129047002|NCT01550744|464464753|FG000|Double-Blind|Lost to Follow-up|0|||
129047003|NCT01550744|464464754|FG001|Double-Blind|Lost to Follow-up|6|||
129047004|NCT01550744|464464755|FG002|Double-Blind|Lost to Follow-up|12|||
129047005|NCT01550744|464464753|FG000|Double-Blind|Withdrawal by Subject|0|||
129047006|NCT01550744|464464754|FG001|Double-Blind|Withdrawal by Subject|2|||
129047007|NCT01550744|464464755|FG002|Double-Blind|Withdrawal by Subject|15|||
129047008|NCT01550744|464464753|FG000|Double-Blind|Adverse Event|0|||
129047009|NCT01550744|464464754|FG001|Double-Blind|Adverse Event|4|||
129047010|NCT01550744|464464755|FG002|Double-Blind|Adverse Event|15|||
129047011|NCT01550744|464464753|FG000|Double-Blind|Death|0|||
129047012|NCT01550744|464464754|FG001|Double-Blind|Death|1|||
129047013|NCT01550744|464464755|FG002|Double-Blind|Death|0|||
129047014|NCT01550744|464464753|FG000|Double-Blind|Lack of Efficacy|0|||
129047015|NCT01550744|464464754|FG001|Double-Blind|Lack of Efficacy|2|||
129047016|NCT01550744|464464755|FG002|Double-Blind|Lack of Efficacy|8|||
129047017|NCT01550744|464464753|FG000|Double-Blind|Protocol Violation|0|||
129047018|NCT01550744|464464754|FG001|Double-Blind|Protocol Violation|0|||
129047019|NCT01550744|464464755|FG002|Double-Blind|Protocol Violation|4|||
129047020|NCT01550744|464464753|FG000|Double-Blind|Pregnancy|0|||
129047021|NCT01550744|464464754|FG001|Double-Blind|Pregnancy|0|||
129047022|NCT01550744|464464755|FG002|Double-Blind|Pregnancy|3|||
129047023|NCT01550744|464464753|FG000|Double-Blind|Other|0|||
129047024|NCT01550744|464464754|FG001|Double-Blind|Other|2|||
129047025|NCT01550744|464464755|FG002|Double-Blind|Other|10|||
129047026|NCT01660334|464464756|FG000|Overall Study|Lost to Follow-up|1|||
129047027|NCT00311311|464464758|FG000|Overall Study|Adverse Event|3|||
129047028|NCT00311311|464464759|FG001|Overall Study|Adverse Event|2|||
129047029|NCT00311311|464464758|FG000|Overall Study|Withdrawal by Subject|1|||
129047030|NCT00311311|464464759|FG001|Overall Study|Withdrawal by Subject|1|||
129047031|NCT00311311|464464758|FG000|Overall Study|Noncompliance|0|||
129047032|NCT00311311|464464759|FG001|Overall Study|Noncompliance|1|||
129047033|NCT00311311|464464758|FG000|Overall Study|Study Termination by Sponsor|3|||
129047034|NCT00311311|464464759|FG001|Overall Study|Study Termination by Sponsor|4|||
129047035|NCT00311311|464464758|FG000|Overall Study|Death|1|||
129047036|NCT00311311|464464759|FG001|Overall Study|Death|0|||
129047037|NCT00311311|464464758|FG000|Overall Study|Lack of ancillary assistance|0|||
129047038|NCT00311311|464464759|FG001|Overall Study|Lack of ancillary assistance|1|||
129047039|NCT00988065|464464761|FG000|Overall Study|Adverse Event|4|||
129047040|NCT00988065|464464762|FG001|Overall Study|Adverse Event|10|||
129047041|NCT00988065|464464763|FG002|Overall Study|Adverse Event|2|||
129047042|NCT00988065|464464761|FG000|Overall Study|Lost to Follow-up|1|||
129047043|NCT00988065|464464762|FG001|Overall Study|Lost to Follow-up|2|||
129047044|NCT00988065|464464763|FG002|Overall Study|Lost to Follow-up|2|||
129047045|NCT00988065|464464761|FG000|Overall Study|Subject withdrew consent|3|||
129047046|NCT00988065|464464762|FG001|Overall Study|Subject withdrew consent|5|||
129047047|NCT00988065|464464763|FG002|Overall Study|Subject withdrew consent|2|||
129047048|NCT00988065|464464761|FG000|Overall Study|Noncompliance with protocol|5|||
129047049|NCT00988065|464464762|FG001|Overall Study|Noncompliance with protocol|6|||
129047050|NCT00988065|464464763|FG002|Overall Study|Noncompliance with protocol|9|||
129047051|NCT01229735|464464764|FG000|Overall Study|Lack of Efficacy|8|||
129047052|NCT01229735|464464765|FG001|Overall Study|Lack of Efficacy|8|||
129047053|NCT01229735|464464764|FG000|Overall Study|Protocol Violation|13|||
129047054|NCT01229735|464464765|FG001|Overall Study|Protocol Violation|8|||
129047055|NCT01229735|464464764|FG000|Overall Study|Lost to Follow-up|0|||
129047056|NCT01229735|464464765|FG001|Overall Study|Lost to Follow-up|2|||
129047057|NCT01229735|464464764|FG000|Overall Study|Withdrawal by Subject|18|||
129047058|NCT01229735|464464765|FG001|Overall Study|Withdrawal by Subject|17|||
129047059|NCT01229735|464464764|FG000|Overall Study|Other Reason|13|||
129047060|NCT01229735|464464765|FG001|Overall Study|Other Reason|10|||
129047061|NCT01229735|464464764|FG000|Overall Study|SAE, non-fatal|0|||
129047062|NCT01229735|464464765|FG001|Overall Study|SAE, non-fatal|4|||
129135678|NCT00165698|464789264|FG000|Overall Study|Protocol Violation|1|||
129047063|NCT01229735|464464764|FG000|Overall Study|AE, non-serious non-fatal|13|||
129047064|NCT01229735|464464765|FG001|Overall Study|AE, non-serious non-fatal|17|||
129047065|NCT01229735|464464764|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
128719342|NCT02608268|463271039|FG020|Overall Study|Subject/guardian decision|0|||
128719343|NCT02608268|463271040|FG021|Overall Study|Subject/guardian decision|0|||
129047066|NCT01229735|464464765|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129047067|NCT02685202|464464766|FG000|Overall Study|Lost to Follow-up|9|||
129047068|NCT02787408|464464767|FG000|Overall Study|Death|16|||
129047069|NCT02787408|464464767|FG000|Overall Study|Withdrawal by Subject|1|||
129135679|NCT00165698|464789265|FG001|Overall Study|Protocol Violation|0|||
129135680|NCT00165698|464789264|FG000|Overall Study|Not Taken/Lost the medicine|1|||
129047070|NCT02787408|464464767|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
129047071|NCT00985712|464464768|FG000|Overall Study|Adverse Event|0|||
129047072|NCT00985712|464464769|FG001|Overall Study|Adverse Event|1|||
129047073|NCT00985712|464464768|FG000|Overall Study|Lost to Follow-up|2|||
129047074|NCT00985712|464464769|FG001|Overall Study|Lost to Follow-up|2|||
129047075|NCT00985712|464464768|FG000|Overall Study|Protocol Violation|0|||
129047076|NCT00985712|464464769|FG001|Overall Study|Protocol Violation|1|||
129135681|NCT00165698|464789265|FG001|Overall Study|Not Taken/Lost the medicine|2|||
129135682|NCT03679884|464789266|FG000|Overall Study|Other|12|||
129135683|NCT03679884|464789267|FG001|Overall Study|Other|12|||
129135684|NCT03679884|464789268|FG002|Overall Study|Other|12|||
129135685|NCT03679884|464789269|FG003|Overall Study|Other|7|||
129135686|NCT03679884|464789270|FG004|Overall Study|Other|8|||
129135687|NCT03679884|464789266|FG000|Overall Study|Lack of Efficacy|15|||
129135688|NCT03679884|464789267|FG001|Overall Study|Lack of Efficacy|29|||
129135689|NCT03679884|464789268|FG002|Overall Study|Lack of Efficacy|13|||
129135690|NCT03679884|464789269|FG003|Overall Study|Lack of Efficacy|29|||
129135691|NCT03679884|464789270|FG004|Overall Study|Lack of Efficacy|10|||
129135692|NCT03679884|464789266|FG000|Overall Study|Death|1|||
129135693|NCT03679884|464789267|FG001|Overall Study|Death|0|||
129135694|NCT03679884|464789268|FG002|Overall Study|Death|0|||
129135695|NCT03679884|464789269|FG003|Overall Study|Death|0|||
129135696|NCT03679884|464789270|FG004|Overall Study|Death|0|||
129135697|NCT03679884|464789266|FG000|Overall Study|Adverse Event|2|||
129135698|NCT03679884|464789267|FG001|Overall Study|Adverse Event|10|||
129135699|NCT03679884|464789268|FG002|Overall Study|Adverse Event|9|||
129135700|NCT03679884|464789269|FG003|Overall Study|Adverse Event|6|||
129135701|NCT03679884|464789270|FG004|Overall Study|Adverse Event|6|||
129135702|NCT03679884|464789266|FG000|Overall Study|Withdrawal by Subject|12|||
129135703|NCT03679884|464789267|FG001|Overall Study|Withdrawal by Subject|23|||
129135704|NCT03679884|464789268|FG002|Overall Study|Withdrawal by Subject|8|||
129135705|NCT03679884|464789269|FG003|Overall Study|Withdrawal by Subject|8|||
129135706|NCT03679884|464789270|FG004|Overall Study|Withdrawal by Subject|9|||
129135707|NCT03679884|464789266|FG000|Overall Study|Lost to Follow-up|1|||
129135708|NCT03679884|464789267|FG001|Overall Study|Lost to Follow-up|4|||
129135709|NCT03679884|464789268|FG002|Overall Study|Lost to Follow-up|2|||
129135710|NCT03679884|464789269|FG003|Overall Study|Lost to Follow-up|0|||
129135711|NCT03679884|464789270|FG004|Overall Study|Lost to Follow-up|3|||
129135712|NCT01107457|464789271|FG000|Part A|Adverse Event|1|||
129135713|NCT01107457|464789272|FG001|Part A|Adverse Event|2|||
129135714|NCT01107457|464789273|FG002|Part A|Adverse Event|1|||
129135715|NCT01107457|464789274|FG003|Part A|Adverse Event|0|||
129223261|NCT02112916|465118327|FG003|Overall Study|Withdrawal by Subject|1|||
129047077|NCT00985712|464464768|FG000|Overall Study|Withdrawal by Subject|4|||
129047078|NCT00985712|464464769|FG001|Overall Study|Withdrawal by Subject|1|||
129047079|NCT00985712|464464768|FG000|Overall Study|Sponsor decision|0|||
129047080|NCT00985712|464464769|FG001|Overall Study|Sponsor decision|2|||
129047081|NCT01346774|464464770|FG000|Overall Study|Did not take a single dose|6|||
129047082|NCT01346774|464464771|FG001|Overall Study|Did not take a single dose|4|||
129047083|NCT01346774|464464770|FG000|Overall Study|Lost to Follow-up|3|||
129047084|NCT01346774|464464771|FG001|Overall Study|Lost to Follow-up|4|||
129047085|NCT01346774|464464770|FG000|Overall Study|Withdrawal by Subject|1|||
129047086|NCT01346774|464464771|FG001|Overall Study|Withdrawal by Subject|4|||
129047087|NCT01346774|464464770|FG000|Overall Study|Protocol Violation|2|||
129047088|NCT01346774|464464771|FG001|Overall Study|Protocol Violation|3|||
129047089|NCT01346774|464464770|FG000|Overall Study|Adverse Event|1|||
129047090|NCT01346774|464464771|FG001|Overall Study|Adverse Event|2|||
129047091|NCT00321737|464464774|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
129047092|NCT00321737|464464775|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
129047093|NCT00321737|464464776|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
129047094|NCT00321737|464464774|FG000|Overall Study|Adverse Event|11|||
129047095|NCT00321737|464464775|FG001|Overall Study|Adverse Event|3|||
129223262|NCT02112916|465118324|FG000|Overall Study|Ineligible|4|||
129223263|NCT02112916|465118325|FG001|Overall Study|Ineligible|8|||
129223264|NCT02112916|465118326|FG002|Overall Study|Ineligible|3|||
129223265|NCT02112916|465118327|FG003|Overall Study|Ineligible|8|||
129223266|NCT02112916|465118324|FG000|Overall Study|Inevaluable|6|||
129135716|NCT01107457|464789275|FG004|Part A|Adverse Event|0|||
129135717|NCT01107457|464789276|FG005|Part A|Adverse Event|0|||
129135718|NCT01107457|464789271|FG000|Part A|Withdrawal by Subject|3|||
129223267|NCT02112916|465118325|FG001|Overall Study|Inevaluable|4|||
129223268|NCT02112916|465118326|FG002|Overall Study|Inevaluable|5|||
129047096|NCT00321737|464464776|FG002|Overall Study|Adverse Event|6|||
129047097|NCT00321737|464464774|FG000|Overall Study|Lost to Follow-up|5|||
129047098|NCT00321737|464464775|FG001|Overall Study|Lost to Follow-up|5|||
129135719|NCT01107457|464789272|FG001|Part A|Withdrawal by Subject|3|||
129135720|NCT01107457|464789273|FG002|Part A|Withdrawal by Subject|0|||
129135721|NCT01107457|464789274|FG003|Part A|Withdrawal by Subject|3|||
129135722|NCT01107457|464789275|FG004|Part A|Withdrawal by Subject|1|||
129135723|NCT01107457|464789276|FG005|Part A|Withdrawal by Subject|0|||
129135724|NCT01107457|464789271|FG000|Part A|Lost to Follow-up|0|||
129047099|NCT00321737|464464776|FG002|Overall Study|Lost to Follow-up|6|||
129047100|NCT00321737|464464774|FG000|Overall Study|Withdrawal by Subject|19|||
129047101|NCT00321737|464464775|FG001|Overall Study|Withdrawal by Subject|12|||
129047102|NCT00321737|464464776|FG002|Overall Study|Withdrawal by Subject|17|||
129047103|NCT00321737|464464774|FG000|Overall Study|Protocol Violation|0|||
129047104|NCT00321737|464464775|FG001|Overall Study|Protocol Violation|0|||
129047105|NCT00321737|464464776|FG002|Overall Study|Protocol Violation|1|||
129047106|NCT00321737|464464774|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
129047107|NCT00321737|464464775|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129047108|NCT00321737|464464776|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129047109|NCT00321737|464464774|FG000|Overall Study|Possible Barrett's Esophagus|2|||
129047110|NCT00321737|464464775|FG001|Overall Study|Possible Barrett's Esophagus|1|||
129047111|NCT00321737|464464776|FG002|Overall Study|Possible Barrett's Esophagus|1|||
129047112|NCT00321737|464464774|FG000|Overall Study|Therapeutic Failure|6|||
129047113|NCT00321737|464464775|FG001|Overall Study|Therapeutic Failure|0|||
129047114|NCT00321737|464464776|FG002|Overall Study|Therapeutic Failure|2|||
129047115|NCT00321737|464464774|FG000|Overall Study|Pregnancy|0|||
129047116|NCT00321737|464464775|FG001|Overall Study|Pregnancy|2|||
129047117|NCT00321737|464464776|FG002|Overall Study|Pregnancy|0|||
129047118|NCT00321737|464464774|FG000|Overall Study|Noncompliance|2|||
129047119|NCT00321737|464464775|FG001|Overall Study|Noncompliance|0|||
129047120|NCT00321737|464464776|FG002|Overall Study|Noncompliance|0|||
129047121|NCT00321737|464464774|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
129047122|NCT00321737|464464775|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
129047123|NCT00321737|464464776|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
129047124|NCT01769339|464464777|FG000|Overall Study|Lost to Follow-up|42|||
129047125|NCT01769339|464464777|FG000|Overall Study|Adverse Event|1|||
129047126|NCT00290251|464464778|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129047127|NCT00290251|464464779|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129047128|NCT00290251|464464780|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129047129|NCT00290251|464464781|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129047130|NCT00290251|464464782|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129047131|NCT00290251|464464783|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
129047132|NCT00290251|464464778|FG000|Treatment 1 (Months 2-4)|headache|0|||
129047133|NCT00290251|464464779|FG001|Treatment 1 (Months 2-4)|headache|0|||
129047134|NCT00290251|464464780|FG002|Treatment 1 (Months 2-4)|headache|0|||
129047135|NCT00290251|464464781|FG003|Treatment 1 (Months 2-4)|headache|0|||
128719344|NCT02608268|463271041|FG022|Overall Study|Subject/guardian decision|1|||
128719345|NCT02608268|463271042|FG023|Overall Study|Subject/guardian decision|0|||
128719346|NCT02608268|463271043|FG024|Overall Study|Subject/guardian decision|0|||
128719347|NCT02608268|463271044|FG025|Overall Study|Subject/guardian decision|1|||
129047136|NCT00290251|464464782|FG004|Treatment 1 (Months 2-4)|headache|1|||
129047137|NCT00290251|464464783|FG005|Treatment 1 (Months 2-4)|headache|0|||
128719348|NCT02608268|463271045|FG026|Overall Study|Subject/guardian decision|1|||
128719349|NCT02608268|463271046|FG027|Overall Study|Subject/guardian decision|1|||
128719350|NCT02608268|463271047|FG028|Overall Study|Subject/guardian decision|1|||
128719351|NCT02608268|463271048|FG029|Overall Study|Subject/guardian decision|0|||
129047138|NCT00290251|464464778|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
129047139|NCT00290251|464464779|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
129047140|NCT00290251|464464780|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
129047141|NCT00290251|464464781|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
129047142|NCT00290251|464464782|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
128719352|NCT04014075|463271050|FG000|Overall Study|Progressive Disease|53|||
129047143|NCT00290251|464464783|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
129047144|NCT04062448|464466797|FG000|Overall Study|Lost to Follow-up|1|||
129047145|NCT04062448|464466797|FG000|Overall Study|Withdrawal by Subject|2|||
129047146|NCT00807248|464466798|FG000|Overall Study|Adverse Event|1|||
129047147|NCT00807248|464466799|FG001|Overall Study|Adverse Event|2|||
129047148|NCT00807248|464466800|FG002|Overall Study|Adverse Event|2|||
129047149|NCT00807248|464466801|FG003|Overall Study|Adverse Event|6|||
129047150|NCT00807248|464466798|FG000|Overall Study|Lack of Efficacy|14|||
129047151|NCT00807248|464466799|FG001|Overall Study|Lack of Efficacy|4|||
129047152|NCT00807248|464466800|FG002|Overall Study|Lack of Efficacy|8|||
129047153|NCT00807248|464466801|FG003|Overall Study|Lack of Efficacy|3|||
129047154|NCT00807248|464466798|FG000|Overall Study|Protocol Violation|0|||
129047155|NCT00807248|464466799|FG001|Overall Study|Protocol Violation|1|||
129047156|NCT00807248|464466800|FG002|Overall Study|Protocol Violation|1|||
129047157|NCT00807248|464466801|FG003|Overall Study|Protocol Violation|0|||
129047158|NCT00807248|464466798|FG000|Overall Study|Withdrawal of Consent|5|||
129047159|NCT00807248|464466799|FG001|Overall Study|Withdrawal of Consent|5|||
129047160|NCT00807248|464466800|FG002|Overall Study|Withdrawal of Consent|5|||
129047161|NCT00807248|464466801|FG003|Overall Study|Withdrawal of Consent|5|||
129047162|NCT00807248|464466798|FG000|Overall Study|Lost to Follow-up|1|||
129047163|NCT00807248|464466799|FG001|Overall Study|Lost to Follow-up|0|||
129047164|NCT00807248|464466800|FG002|Overall Study|Lost to Follow-up|0|||
129047165|NCT00807248|464466801|FG003|Overall Study|Lost to Follow-up|0|||
129135725|NCT01107457|464789272|FG001|Part A|Lost to Follow-up|1|||
129135726|NCT01107457|464789273|FG002|Part A|Lost to Follow-up|0|||
129135727|NCT01107457|464789274|FG003|Part A|Lost to Follow-up|0|||
129135728|NCT01107457|464789275|FG004|Part A|Lost to Follow-up|0|||
129135729|NCT01107457|464789276|FG005|Part A|Lost to Follow-up|0|||
129135730|NCT01107457|464789271|FG000|Part A|Lack of Efficacy|1|||
129135731|NCT01107457|464789272|FG001|Part A|Lack of Efficacy|0|||
129135732|NCT01107457|464789273|FG002|Part A|Lack of Efficacy|0|||
129135733|NCT01107457|464789274|FG003|Part A|Lack of Efficacy|0|||
129135734|NCT01107457|464789275|FG004|Part A|Lack of Efficacy|0|||
129135735|NCT01107457|464789276|FG005|Part A|Lack of Efficacy|0|||
129135736|NCT01107457|464789271|FG000|Part A|Protocol Violation|0|||
129223269|NCT02112916|465118327|FG003|Overall Study|Inevaluable|5|||
129223270|NCT02112916|465118324|FG000|Overall Study|Refusal of further protocol therapy|19|||
129047166|NCT00807248|464466798|FG000|Overall Study|Other Reason|0|||
129047167|NCT00807248|464466799|FG001|Overall Study|Other Reason|0|||
129047168|NCT00807248|464466800|FG002|Overall Study|Other Reason|2|||
129047169|NCT00807248|464466801|FG003|Overall Study|Other Reason|0|||
129047170|NCT00210249|464466802|FG000|Overall Study|Lost to Follow-up|5|||
129047171|NCT00210249|464466802|FG000|Overall Study|Protocol Violation|11|||
129047172|NCT02518919|464466803|FG000|Overall Study|Protocol Violation|1|||
129047173|NCT02518919|464466804|FG001|Overall Study|Protocol Violation|1|||
129047174|NCT02518919|464466805|FG002|Overall Study|Protocol Violation|2|||
129047175|NCT01293539|464466806|FG000|Overall Study|Physician Decision|1|||
129047176|NCT00866658|464466807|FG000|Overall Study|Adverse Event|5|||
129047177|NCT00866658|464466808|FG001|Overall Study|Adverse Event|14|||
129047178|NCT00866658|464466807|FG000|Overall Study|Lack of Efficacy|2|||
129047179|NCT00866658|464466808|FG001|Overall Study|Lack of Efficacy|1|||
129047180|NCT00866658|464466807|FG000|Overall Study|Withdrawal by Subject|1|||
129047181|NCT00866658|464466808|FG001|Overall Study|Withdrawal by Subject|0|||
129047182|NCT00866658|464466807|FG000|Overall Study|Protocol Violation|1|||
129047183|NCT00866658|464466808|FG001|Overall Study|Protocol Violation|1|||
129047184|NCT00866658|464466807|FG000|Overall Study|Familial and Personal Reasons|4|||
129047185|NCT00866658|464466808|FG001|Overall Study|Familial and Personal Reasons|5|||
129047186|NCT00609518|464466810|FG000|Overall Study|Death from Study Disease|32|||
129047187|NCT00609518|464466811|FG001|Overall Study|Death from Study Disease|32|||
129047188|NCT00609518|464466810|FG000|Overall Study|Withdrawal by Subject|5|||
129047189|NCT00609518|464466811|FG001|Overall Study|Withdrawal by Subject|3|||
129047190|NCT00609518|464466810|FG000|Overall Study|Lost to Follow-up|3|||
129047191|NCT00609518|464466811|FG001|Overall Study|Lost to Follow-up|0|||
129047192|NCT00609518|464466810|FG000|Overall Study|Physician Decision|1|||
129047193|NCT00609518|464466811|FG001|Overall Study|Physician Decision|3|||
129047194|NCT00609518|464466810|FG000|Overall Study|Death from Adverse Event|2|||
129047195|NCT00609518|464466811|FG001|Overall Study|Death from Adverse Event|2|||
129047196|NCT01687478|464466812|FG000|Overall Study|Adverse Event|3|||
129047197|NCT01687478|464466813|FG001|Overall Study|Adverse Event|10|||
129047198|NCT01687478|464466812|FG000|Overall Study|Lost to Follow-up|1|||
129047199|NCT01687478|464466813|FG001|Overall Study|Lost to Follow-up|3|||
129047200|NCT01687478|464466812|FG000|Overall Study|Protocol Violation|0|||
129047201|NCT01687478|464466813|FG001|Overall Study|Protocol Violation|2|||
129047202|NCT01687478|464466812|FG000|Overall Study|Withdrawal by Subject|21|||
129047203|NCT01687478|464466813|FG001|Overall Study|Withdrawal by Subject|19|||
129047204|NCT01687478|464466812|FG000|Overall Study|Physician Decision|1|||
129047205|NCT01687478|464466813|FG001|Overall Study|Physician Decision|3|||
129047206|NCT01687478|464466812|FG000|Overall Study|Entry Criteria Not Met|6|||
129047207|NCT01687478|464466813|FG001|Overall Study|Entry Criteria Not Met|2|||
129047208|NCT00292188|464466817|FG000|Single-Blind|Adverse Event|14|||
129047209|NCT00292188|464466818|FG001|Single-Blind|Adverse Event|0|||
129047210|NCT00292188|464466819|FG002|Single-Blind|Adverse Event|0|||
129047211|NCT00292188|464466817|FG000|Single-Blind|Lack of Efficacy|2|||
129047212|NCT00292188|464466818|FG001|Single-Blind|Lack of Efficacy|0|||
129047213|NCT00292188|464466819|FG002|Single-Blind|Lack of Efficacy|0|||
129047214|NCT00292188|464466817|FG000|Single-Blind|Laboratory Abnormality|5|||
129135737|NCT01107457|464789272|FG001|Part A|Protocol Violation|1|||
129135738|NCT01107457|464789273|FG002|Part A|Protocol Violation|0|||
129223271|NCT02112916|465118325|FG001|Overall Study|Refusal of further protocol therapy|16|||
129223272|NCT02112916|465118326|FG002|Overall Study|Refusal of further protocol therapy|1|||
129047215|NCT00292188|464466818|FG001|Single-Blind|Laboratory Abnormality|0|||
129047216|NCT00292188|464466819|FG002|Single-Blind|Laboratory Abnormality|0|||
129047217|NCT00292188|464466817|FG000|Single-Blind|Lost to Follow-up|3|||
129047218|NCT00292188|464466818|FG001|Single-Blind|Lost to Follow-up|0|||
129223273|NCT02112916|465118327|FG003|Overall Study|Refusal of further protocol therapy|7|||
129047219|NCT00292188|464466819|FG002|Single-Blind|Lost to Follow-up|0|||
129047220|NCT00292188|464466817|FG000|Single-Blind|Other|77|||
129135739|NCT01107457|464789274|FG003|Part A|Protocol Violation|0|||
129135740|NCT01107457|464789275|FG004|Part A|Protocol Violation|0|||
129223274|NCT02112916|465118324|FG000|Overall Study|Development of SMN|1|||
129047221|NCT00292188|464466818|FG001|Single-Blind|Other|0|||
129047222|NCT00292188|464466819|FG002|Single-Blind|Other|0|||
129047223|NCT00292188|464466817|FG000|Single-Blind|Withdrawal by Subject|12|||
129135741|NCT01107457|464789276|FG005|Part A|Protocol Violation|0|||
128719353|NCT04014075|463271050|FG000|Overall Study|Adverse Event|15|||
128719354|NCT04014075|463271050|FG000|Overall Study|Clinical Progression|4|||
128719355|NCT04014075|463271050|FG000|Overall Study|Death|2|||
128719356|NCT04014075|463271050|FG000|Overall Study|Withdrawal by Subject|2|||
128719357|NCT04014075|463271050|FG000|Overall Study|Miscellaneous|2|||
128719358|NCT04014075|463271050|FG000|Overall Study|Physician Decision|1|||
128719359|NCT05954052|463271051|FG000|Overall Study|Adverse Event|1|||
128719360|NCT01957462|463271052|FG000|Test Period 1|Withdrawal by Subject|1|||
128719361|NCT01957462|463271053|FG001|Test Period 1|Withdrawal by Subject|0|||
128719362|NCT01957462|463271052|FG000|Test Period 1|Adverse Event|1|||
128719363|NCT01957462|463271053|FG001|Test Period 1|Adverse Event|0|||
128719364|NCT02584504|463271054|FG000|Double-blind Treatment|Participant withdrew consent|0|||
128775424|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128719365|NCT02584504|463271055|FG001|Double-blind Treatment|Participant withdrew consent|0|||
128981933|NCT01430559|464219029|FG001|Overall Study|Other|3|||
128719366|NCT02584504|463271056|FG002|Double-blind Treatment|Participant withdrew consent|1|||
128719367|NCT02584504|463271054|FG000|Double-blind Treatment|Adverse Event|0|||
128719368|NCT02584504|463271055|FG001|Double-blind Treatment|Adverse Event|1|||
128981934|NCT01430559|464219028|FG000|Overall Study|Randomized, Not Treated|3|||
128981935|NCT01430559|464219029|FG001|Overall Study|Randomized, Not Treated|3|||
128981936|NCT01177943|464219031|FG000|First Intervention|Withdrawal by Subject|2|||
128981937|NCT01177943|464219032|FG001|First Intervention|Withdrawal by Subject|0|||
128981938|NCT00808665|464219033|FG000|Overall Study|Withdrawal by Subject|1|||
128981939|NCT00808665|464219034|FG001|Overall Study|Withdrawal by Subject|0|||
128981940|NCT00808665|464219033|FG000|Overall Study|only required minimally invasive surgery|1|||
128981941|NCT00808665|464219034|FG001|Overall Study|only required minimally invasive surgery|0|||
128981942|NCT00808665|464219033|FG000|Overall Study|surgery cancelled|1|||
128981943|NCT00808665|464219034|FG001|Overall Study|surgery cancelled|0|||
128981944|NCT00808665|464219033|FG000|Overall Study|required an additional procedure|0|||
128981945|NCT00808665|464219034|FG001|Overall Study|required an additional procedure|1|||
128981946|NCT00808665|464219033|FG000|Overall Study|Physician Decision|3|||
128981947|NCT00808665|464219034|FG001|Overall Study|Physician Decision|1|||
128981948|NCT00808665|464219033|FG000|Overall Study|Medication stopped by resident|0|||
128981949|NCT00808665|464219034|FG001|Overall Study|Medication stopped by resident|1|||
128981950|NCT03319160|464219035|FG000|Overall Study|Data not available.|7|||
128981951|NCT00665002|464219036|FG000|Overall Study|Progression/relapse during treatment|11|||
128981952|NCT00665002|464219036|FG000|Overall Study|Cytogenetic resistance|1|||
128981953|NCT01303159|464219044|FG000|Overall Study|Death|16|||
128981954|NCT01303159|464219044|FG000|Overall Study|Study Termination|7|||
128981955|NCT00496782|464219048|FG000|Overall Study|Protocol Violation|1|||
128981956|NCT00496782|464219049|FG001|Overall Study|Protocol Violation|2|||
128981957|NCT01288911|464219050|FG000|Double-blind Period|Death|11|||
128981958|NCT01288911|464219051|FG001|Double-blind Period|Death|7|||
128981959|NCT01288911|464219050|FG000|Double-blind Period|Lost to Follow-up|0|||
128981960|NCT01288911|464219051|FG001|Double-blind Period|Lost to Follow-up|2|||
128981961|NCT01288911|464219050|FG000|Double-blind Period|Progressive Disease|75|||
128981962|NCT01288911|464219051|FG001|Double-blind Period|Progressive Disease|103|||
128981963|NCT01288911|464219050|FG000|Double-blind Period|Protocol Violation|1|||
128981964|NCT01288911|464219051|FG001|Double-blind Period|Protocol Violation|0|||
128981965|NCT01288911|464219050|FG000|Double-blind Period|Withdrawal by Subject|25|||
128981966|NCT01288911|464219051|FG001|Double-blind Period|Withdrawal by Subject|26|||
128981967|NCT01288911|464219050|FG000|Double-blind Period|Miscellaneous Reason|29|||
128981968|NCT01288911|464219051|FG001|Double-blind Period|Miscellaneous Reason|42|||
128981969|NCT01288911|464219050|FG000|Double-blind Period|Randomized but never received study drug|1|||
128981970|NCT01288911|464219051|FG001|Double-blind Period|Randomized but never received study drug|2|||
128981971|NCT01288911|464219050|FG000|Open-label Period (All Enzalutamide)|Death|0|||
128981972|NCT01288911|464219051|FG001|Open-label Period (All Enzalutamide)|Death|1|||
128981973|NCT01288911|464219050|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
128981974|NCT01288911|464219051|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
128981975|NCT01288911|464219050|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
128981976|NCT01288911|464219051|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
128981977|NCT01288911|464219050|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
128981978|NCT01288911|464219051|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
128981979|NCT01288911|464219050|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
128981980|NCT01288911|464219051|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
128981981|NCT01288911|464219050|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
128981982|NCT01288911|464219051|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
128981983|NCT02431559|464219052|FG000|Overall Study|Adverse Event|0|||
128981984|NCT02431559|464219053|FG001|Overall Study|Adverse Event|1|||
128981985|NCT02431559|464219054|FG002|Overall Study|Adverse Event|0|||
128981986|NCT02431559|464219055|FG003|Overall Study|Adverse Event|4|||
129047224|NCT00292188|464466818|FG001|Single-Blind|Withdrawal by Subject|0|||
129047225|NCT00292188|464466819|FG002|Single-Blind|Withdrawal by Subject|0|||
129047226|NCT00292188|464466817|FG000|Single-Blind|Did not receive treatment|1|||
129047227|NCT00292188|464466818|FG001|Single-Blind|Did not receive treatment|0|||
129047228|NCT00292188|464466819|FG002|Single-Blind|Did not receive treatment|0|||
129047229|NCT00292188|464466817|FG000|Double-Blind|Adverse Event|0|||
129047230|NCT00292188|464466818|FG001|Double-Blind|Adverse Event|25|||
129047231|NCT00292188|464466819|FG002|Double-Blind|Adverse Event|9|||
129047232|NCT00292188|464466817|FG000|Double-Blind|Lack of Efficacy|0|||
129047233|NCT00292188|464466818|FG001|Double-Blind|Lack of Efficacy|2|||
129047234|NCT00292188|464466819|FG002|Double-Blind|Lack of Efficacy|12|||
129047235|NCT00292188|464466817|FG000|Double-Blind|Lost to Follow-up|0|||
129047236|NCT00292188|464466818|FG001|Double-Blind|Lost to Follow-up|1|||
129047237|NCT00292188|464466819|FG002|Double-Blind|Lost to Follow-up|0|||
129047238|NCT00292188|464466817|FG000|Double-Blind|Other|0|||
129047239|NCT00292188|464466818|FG001|Double-Blind|Other|3|||
129047240|NCT00292188|464466819|FG002|Double-Blind|Other|4|||
129047241|NCT00292188|464466817|FG000|Double-Blind|Withdrawal by Subject|0|||
129047242|NCT00292188|464466818|FG001|Double-Blind|Withdrawal by Subject|0|||
129047243|NCT00292188|464466819|FG002|Double-Blind|Withdrawal by Subject|3|||
129047244|NCT00292188|464466817|FG000|Double-Blind|Laboratory Abnormality|0|||
129047245|NCT00292188|464466818|FG001|Double-Blind|Laboratory Abnormality|0|||
129047246|NCT00292188|464466819|FG002|Double-Blind|Laboratory Abnormality|1|||
129047247|NCT00824616|464466820|FG000|Overall Study|Adverse Event|2|||
129047248|NCT00824616|464466821|FG001|Overall Study|Adverse Event|1|||
129047249|NCT00824616|464466820|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
129047250|NCT00824616|464466821|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
129047251|NCT00824616|464466820|FG000|Overall Study|Hyperglycemia|1|||
129047252|NCT00824616|464466821|FG001|Overall Study|Hyperglycemia|1|||
129047253|NCT00824616|464466820|FG000|Overall Study|Lack of Efficacy|2|||
129047254|NCT00824616|464466821|FG001|Overall Study|Lack of Efficacy|1|||
129047255|NCT00824616|464466820|FG000|Overall Study|Lost to Follow-up|0|||
129047256|NCT00824616|464466821|FG001|Overall Study|Lost to Follow-up|1|||
129047257|NCT00824616|464466820|FG000|Overall Study|Withdrawal by Subject|1|||
129047258|NCT00824616|464466821|FG001|Overall Study|Withdrawal by Subject|1|||
129047259|NCT04322149|464466822|FG000|Overall Study|Adverse Event|1|||
129047260|NCT04322149|464466823|FG001|Overall Study|Adverse Event|1|||
129047261|NCT04322149|464466824|FG002|Overall Study|Adverse Event|0|||
129047262|NCT04322149|464466825|FG003|Overall Study|Adverse Event|0|||
129047263|NCT04322149|464466822|FG000|Overall Study|Withdrawal by Subject|0|||
129047264|NCT04322149|464466823|FG001|Overall Study|Withdrawal by Subject|0|||
129047265|NCT04322149|464466824|FG002|Overall Study|Withdrawal by Subject|0|||
129047266|NCT04322149|464466825|FG003|Overall Study|Withdrawal by Subject|2|||
129047267|NCT04322149|464466822|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
129047268|NCT04322149|464466823|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
129047269|NCT04322149|464466824|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
129047270|NCT04322149|464466825|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
129047271|NCT01700049|464466828|FG000|Overall Study|Withdrawal by Subject|1|||
129047272|NCT01248013|464466829|FG000|Overall Study|Withdrawal by Subject|14|||
129047273|NCT01859130|464466830|FG000|Overall Study|Death|4|||
129047274|NCT01859130|464466830|FG000|Overall Study|Lost to Follow-up|16|||
129047275|NCT01859130|464466830|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
129047276|NCT01859130|464466830|FG000|Overall Study|Physician Decision|6|||
129047277|NCT01859130|464466830|FG000|Overall Study|Withdrawal by Subject|17|||
129047278|NCT01859130|464466830|FG000|Overall Study|Adverse Event|11|||
129047279|NCT00307034|464466831|FG000|Overall Study|Adverse Event|1|||
129047280|NCT00307034|464466832|FG001|Overall Study|Adverse Event|2|||
129047281|NCT00307034|464466831|FG000|Overall Study|Withdrawal by Subject|1|||
129047282|NCT00307034|464466832|FG001|Overall Study|Withdrawal by Subject|2|||
129047283|NCT00307034|464466831|FG000|Overall Study|Lost to Follow-up|0|||
129047284|NCT00307034|464466832|FG001|Overall Study|Lost to Follow-up|3|||
129047285|NCT04442490|464466837|FG000|Overall Study|Withdrawal by Subject|18|||
129047286|NCT04442490|464466838|FG001|Overall Study|Withdrawal by Subject|10|||
129047287|NCT04442490|464466837|FG000|Overall Study|Lost to Follow-up|7|||
128775425|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129047288|NCT04442490|464466838|FG001|Overall Study|Lost to Follow-up|7|||
129047289|NCT04442490|464466837|FG000|Overall Study|Adverse Event|2|||
129047290|NCT04442490|464466838|FG001|Overall Study|Adverse Event|6|||
129047291|NCT04442490|464466837|FG000|Overall Study|Noncompliance|3|||
129047292|NCT04442490|464466838|FG001|Overall Study|Noncompliance|1|||
129047293|NCT04442490|464466837|FG000|Overall Study|Physician Decision|2|||
129047294|NCT04442490|464466838|FG001|Overall Study|Physician Decision|1|||
129047295|NCT04442490|464466837|FG000|Overall Study|Reason not Specified|2|||
129047296|NCT04442490|464466838|FG001|Overall Study|Reason not Specified|1|||
129047297|NCT04442490|464466837|FG000|Overall Study|Randomized but not Treated|3|||
128775426|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128775427|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128981987|NCT02431559|464219052|FG000|Overall Study|Progressive disease|2|||
128981988|NCT02431559|464219053|FG001|Overall Study|Progressive disease|1|||
128981989|NCT02431559|464219054|FG002|Overall Study|Progressive disease|4|||
128981990|NCT02431559|464219055|FG003|Overall Study|Progressive disease|22|||
128981991|NCT02431559|464219052|FG000|Overall Study|Withdrawal by Subject|0|||
128981992|NCT02431559|464219053|FG001|Overall Study|Withdrawal by Subject|1|||
128981993|NCT02431559|464219054|FG002|Overall Study|Withdrawal by Subject|0|||
128981994|NCT02431559|464219055|FG003|Overall Study|Withdrawal by Subject|4|||
128981995|NCT02431559|464219052|FG000|Overall Study|Physician Decision|0|||
128981996|NCT02431559|464219053|FG001|Overall Study|Physician Decision|0|||
128981997|NCT02431559|464219054|FG002|Overall Study|Physician Decision|0|||
128981998|NCT02431559|464219055|FG003|Overall Study|Physician Decision|1|||
128981999|NCT02543918|464219056|FG000|Overall Study|Never treated|0|||
128982000|NCT02543918|464219057|FG001|Overall Study|Never treated|1|||
128982001|NCT02543918|464219056|FG000|Overall Study|Lost to Follow-up|1|||
128982002|NCT02543918|464219057|FG001|Overall Study|Lost to Follow-up|1|||
128982003|NCT02543918|464219056|FG000|Overall Study|Withdrawal by Subject|1|||
128982004|NCT02543918|464219057|FG001|Overall Study|Withdrawal by Subject|1|||
128982005|NCT02543918|464219056|FG000|Overall Study|Adverse Event|1|||
128982006|NCT02543918|464219057|FG001|Overall Study|Adverse Event|1|||
128982007|NCT00242658|464219058|FG000|Overall Study|Lost to Follow-up|22|||
128982008|NCT00242658|464219059|FG001|Overall Study|Lost to Follow-up|19|||
128982009|NCT01815099|464219060|FG000|Overall Study|Lack of Efficacy|1|||
128982010|NCT01815099|464219060|FG000|Overall Study|unable to attend study visits|1|||
128982011|NCT00643851|464219061|FG000|Overall Study|Death|0|||
128982012|NCT00643851|464219062|FG001|Overall Study|Death|1|||
128982013|NCT00643851|464219063|FG002|Overall Study|Death|0|||
128982014|NCT00643851|464219061|FG000|Overall Study|Lack of Efficacy|0|||
128982015|NCT00643851|464219062|FG001|Overall Study|Lack of Efficacy|1|||
128982016|NCT00643851|464219063|FG002|Overall Study|Lack of Efficacy|0|||
128982017|NCT00643851|464219061|FG000|Overall Study|Adverse Event|2|||
128982018|NCT00643851|464219062|FG001|Overall Study|Adverse Event|6|||
128982019|NCT00643851|464219063|FG002|Overall Study|Adverse Event|6|||
128982020|NCT00643851|464219061|FG000|Overall Study|Lost to Follow-up|4|||
128982021|NCT00643851|464219062|FG001|Overall Study|Lost to Follow-up|6|||
128982022|NCT00643851|464219063|FG002|Overall Study|Lost to Follow-up|9|||
128982023|NCT00643851|464219061|FG000|Overall Study|Withdrawal by Subject|8|||
128982024|NCT00643851|464219062|FG001|Overall Study|Withdrawal by Subject|15|||
128982025|NCT00643851|464219063|FG002|Overall Study|Withdrawal by Subject|9|||
128982026|NCT00643851|464219061|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
128982027|NCT00643851|464219062|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
128982028|NCT00643851|464219063|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
128982029|NCT04806334|464219066|FG000|Overall Study|Withdrawal by Subject|1|||
128982030|NCT04557189|464219067|FG000|Overall Study|Adverse Event|0|||
128982031|NCT04557189|464219068|FG001|Overall Study|Adverse Event|1|||
128982032|NCT04557189|464219067|FG000|Overall Study|Lost to Follow-up|1|||
128982033|NCT04557189|464219068|FG001|Overall Study|Lost to Follow-up|1|||
128982034|NCT04557189|464219067|FG000|Overall Study|Withdrawal by Subject|2|||
128982035|NCT04557189|464219068|FG001|Overall Study|Withdrawal by Subject|1|||
128982036|NCT04557189|464219067|FG000|Overall Study|Reason not Specified|3|||
128982037|NCT04557189|464219068|FG001|Overall Study|Reason not Specified|6|||
128982038|NCT01731600|464219071|FG000|Overall Study|Adverse Event|2|||
128982039|NCT01731600|464219072|FG001|Overall Study|Adverse Event|0|||
128982040|NCT01731600|464219071|FG000|Overall Study|Withdrawal criteria|1|||
128982041|NCT01731600|464219072|FG001|Overall Study|Withdrawal criteria|0|||
128982042|NCT01731600|464219071|FG000|Overall Study|Other reasons|3|||
128982043|NCT01731600|464219072|FG001|Overall Study|Other reasons|0|||
128982044|NCT00465894|464219073|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
128982045|NCT00465894|464219074|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
128982046|NCT00465894|464219073|FG000|Treatment For 12 Weeks|Family Issues|1|||
128982047|NCT00465894|464219074|FG001|Treatment For 12 Weeks|Family Issues|1|||
128982048|NCT00465894|464219073|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
128982049|NCT00465894|464219074|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
128982050|NCT01636076|464219075|FG000|Overall Study|Terminated by sponsor|1|||
128982051|NCT01636076|464219076|FG001|Overall Study|Terminated by sponsor|1|||
128982052|NCT01636076|464219075|FG000|Overall Study|Lack of Efficacy|0|||
128982053|NCT01636076|464219076|FG001|Overall Study|Lack of Efficacy|1|||
128982054|NCT01636076|464219075|FG000|Overall Study|Lost to Follow-up|1|||
128982055|NCT01636076|464219076|FG001|Overall Study|Lost to Follow-up|0|||
128982056|NCT01636076|464219075|FG000|Overall Study|Physician Decision|1|||
128982057|NCT01636076|464219076|FG001|Overall Study|Physician Decision|1|||
128982058|NCT01636076|464219075|FG000|Overall Study|Non-compliance with study treatment|1|||
128982059|NCT01636076|464219076|FG001|Overall Study|Non-compliance with study treatment|1|||
129047298|NCT04442490|464466838|FG001|Overall Study|Randomized but not Treated|3|||
129047299|NCT02227147|464466839|FG000|Controlled Treatment Period|Adverse Event|4|||
129047300|NCT02227147|464466840|FG001|Controlled Treatment Period|Adverse Event|3|||
129047301|NCT02227147|464466839|FG000|Controlled Treatment Period|Other|2|||
129047302|NCT02227147|464466840|FG001|Controlled Treatment Period|Other|0|||
129047303|NCT02227147|464466839|FG000|Follow-up Period|Other|3|||
129047304|NCT02227147|464466840|FG001|Follow-up Period|Other|5|||
129047305|NCT03514641|464466841|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
129047306|NCT03514641|464466842|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
129047307|NCT03514641|464466843|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
129047308|NCT03514641|464466844|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
129047309|NCT03514641|464466841|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
129047310|NCT03514641|464466842|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
129047311|NCT03514641|464466843|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
129047312|NCT03514641|464466844|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
129047313|NCT03514641|464466841|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
129047314|NCT03514641|464466842|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
129047315|NCT03514641|464466843|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
129047316|NCT03514641|464466844|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
129047317|NCT03514641|464466841|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
129047318|NCT03514641|464466842|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
129047319|NCT03514641|464466843|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
129047320|NCT03514641|464466844|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
129047321|NCT03514641|464466841|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
129047322|NCT03514641|464466842|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
129047323|NCT03514641|464466843|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
129047324|NCT03514641|464466844|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
129047325|NCT03514641|464466841|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
129047326|NCT03514641|464466842|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
129047327|NCT03514641|464466843|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
129047328|NCT03514641|464466844|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
129047329|NCT03514641|464466841|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
129047330|NCT03514641|464466842|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
129047331|NCT03514641|464466843|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
129047332|NCT03514641|464466844|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
129047333|NCT03514641|464466841|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
129047334|NCT03514641|464466842|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
129047335|NCT03514641|464466843|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
129047336|NCT03514641|464466844|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
129047337|NCT03514641|464466841|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
129047338|NCT03514641|464466842|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
129047339|NCT03514641|464466843|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
129047340|NCT03514641|464466844|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
129047341|NCT03514641|464466841|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
129047342|NCT03514641|464466842|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
129047343|NCT03514641|464466843|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
129047344|NCT03514641|464466844|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
129047345|NCT03514641|464466841|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
129047346|NCT03514641|464466842|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
129135742|NCT01107457|464789271|FG000|Part B and C|Adverse Event|0|||
129135743|NCT01107457|464789272|FG001|Part B and C|Adverse Event|0|||
129135744|NCT01107457|464789273|FG002|Part B and C|Adverse Event|0|||
129135745|NCT01107457|464789274|FG003|Part B and C|Adverse Event|0|||
129135746|NCT01107457|464789275|FG004|Part B and C|Adverse Event|0|||
129135747|NCT01107457|464789276|FG005|Part B and C|Adverse Event|12|||
129135748|NCT01107457|464789271|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129135749|NCT01107457|464789272|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129135750|NCT01107457|464789273|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129135751|NCT01107457|464789274|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129135752|NCT01107457|464789275|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129047347|NCT03514641|464466843|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
129047348|NCT03514641|464466844|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
129047349|NCT03514641|464466841|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
129047350|NCT03514641|464466842|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
129047351|NCT03514641|464466843|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
129047352|NCT03514641|464466844|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
129047353|NCT01449279|464466845|FG000|Overall Study|Lack of Efficacy|5|||
129047354|NCT01449279|464466845|FG000|Overall Study|Toxicity|2|||
129047355|NCT04234984|464466846|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
129135753|NCT01107457|464789276|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
129135754|NCT01107457|464789271|FG000|Part B and C|Physician Decision|0|||
128775428|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129047356|NCT04234984|464466846|FG000|Follow-up at the Second Time Point|Death|1|||
129047357|NCT04234984|464466846|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
129047358|NCT01055132|464466847|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
129047359|NCT01055132|464466848|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
129047360|NCT01055132|464466847|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
129047361|NCT01055132|464466848|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
129047362|NCT02038907|464466849|FG000|Overall Study|Protocol Violation|0|||
129047363|NCT02038907|464466850|FG001|Overall Study|Protocol Violation|0|||
129047364|NCT02038907|464466851|FG002|Overall Study|Protocol Violation|0|||
129047365|NCT02038907|464466852|FG003|Overall Study|Protocol Violation|0|||
129047366|NCT02038907|464466853|FG004|Overall Study|Protocol Violation|0|||
129047367|NCT02038907|464466854|FG005|Overall Study|Protocol Violation|0|||
129047368|NCT02038907|464466855|FG006|Overall Study|Protocol Violation|0|||
129047369|NCT02038907|464466856|FG007|Overall Study|Protocol Violation|0|||
129047370|NCT02038907|464466857|FG008|Overall Study|Protocol Violation|0|||
129047371|NCT02038907|464466858|FG009|Overall Study|Protocol Violation|0|||
129047372|NCT02038907|464466859|FG010|Overall Study|Protocol Violation|1|||
129047373|NCT02038907|464466860|FG011|Overall Study|Protocol Violation|0|||
129047374|NCT02038907|464466861|FG012|Overall Study|Protocol Violation|0|||
129047375|NCT02038907|464466862|FG013|Overall Study|Protocol Violation|0|||
129047376|NCT02038907|464466849|FG000|Overall Study|Withdrawal by Subject|0|||
129047377|NCT02038907|464466850|FG001|Overall Study|Withdrawal by Subject|0|||
129047378|NCT02038907|464466851|FG002|Overall Study|Withdrawal by Subject|0|||
129047379|NCT02038907|464466852|FG003|Overall Study|Withdrawal by Subject|0|||
129047380|NCT02038907|464466853|FG004|Overall Study|Withdrawal by Subject|0|||
129047381|NCT02038907|464466854|FG005|Overall Study|Withdrawal by Subject|0|||
129047382|NCT02038907|464466855|FG006|Overall Study|Withdrawal by Subject|0|||
129047383|NCT02038907|464466856|FG007|Overall Study|Withdrawal by Subject|0|||
129047384|NCT02038907|464466857|FG008|Overall Study|Withdrawal by Subject|0|||
129047385|NCT02038907|464466858|FG009|Overall Study|Withdrawal by Subject|0|||
129047386|NCT02038907|464466859|FG010|Overall Study|Withdrawal by Subject|1|||
129047387|NCT02038907|464466860|FG011|Overall Study|Withdrawal by Subject|0|||
129047388|NCT02038907|464466861|FG012|Overall Study|Withdrawal by Subject|0|||
129047389|NCT02038907|464466862|FG013|Overall Study|Withdrawal by Subject|0|||
129047390|NCT03914950|464466866|FG000|Overall Study|Physician Decision|54|||
129047391|NCT01156142|464466870|FG000|Overall Study|Withdrawal by Subject|8|||
129047392|NCT01156142|464466871|FG001|Overall Study|Withdrawal by Subject|6|||
129047393|NCT01156142|464466870|FG000|Overall Study|Ineligible|0|||
129047394|NCT01156142|464466871|FG001|Overall Study|Ineligible|1|||
129047395|NCT00893737|464466872|FG000|Overall Study|Adverse Event|4|||
129047396|NCT00893737|464466872|FG000|Overall Study|Withdrawal by Subject|2|||
129047397|NCT00893737|464466872|FG000|Overall Study|Lost to Follow-up|6|||
129047398|NCT02140411|464466873|FG000|Overall Study|Adverse Event|1|||
129047399|NCT03981419|464466876|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
129047400|NCT03981419|464466877|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
129047401|NCT01330459|464466878|FG000|Overall Study|Physician Decision|0|||
129047402|NCT01330459|464466879|FG001|Overall Study|Physician Decision|2|||
129047403|NCT01359644|464466893|FG000|Treatment Period|Lack of Efficacy|0|||
129047404|NCT01359644|464466894|FG001|Treatment Period|Lack of Efficacy|1|||
129047405|NCT01359644|464466895|FG002|Treatment Period|Lack of Efficacy|0|||
129047406|NCT01359644|464466896|FG003|Treatment Period|Lack of Efficacy|0|||
129047407|NCT01359644|464466897|FG004|Treatment Period|Lack of Efficacy|0|||
129047408|NCT01359644|464466898|FG005|Treatment Period|Lack of Efficacy|0|||
129047409|NCT01359644|464466899|FG006|Treatment Period|Lack of Efficacy|0|||
129047410|NCT01359644|464466900|FG007|Treatment Period|Lack of Efficacy|0|||
129047411|NCT01359644|464466901|FG008|Treatment Period|Lack of Efficacy|0|||
129047412|NCT01359644|464466902|FG009|Treatment Period|Lack of Efficacy|0|||
129047413|NCT01359644|464466893|FG000|Treatment Period|Adverse Event|0|||
129047414|NCT01359644|464466894|FG001|Treatment Period|Adverse Event|0|||
129047415|NCT01359644|464466895|FG002|Treatment Period|Adverse Event|1|||
129047416|NCT01359644|464466896|FG003|Treatment Period|Adverse Event|0|||
129047417|NCT01359644|464466897|FG004|Treatment Period|Adverse Event|0|||
129047418|NCT01359644|464466898|FG005|Treatment Period|Adverse Event|1|||
129047419|NCT01359644|464466899|FG006|Treatment Period|Adverse Event|0|||
129047420|NCT01359644|464466900|FG007|Treatment Period|Adverse Event|0|||
129047421|NCT01359644|464466901|FG008|Treatment Period|Adverse Event|0|||
129047422|NCT01359644|464466902|FG009|Treatment Period|Adverse Event|0|||
129047423|NCT01359644|464466893|FG000|Treatment Period|Lost to Follow-up|0|||
129047424|NCT01359644|464466894|FG001|Treatment Period|Lost to Follow-up|0|||
129047425|NCT01359644|464466895|FG002|Treatment Period|Lost to Follow-up|0|||
129047426|NCT01359644|464466896|FG003|Treatment Period|Lost to Follow-up|0|||
129047427|NCT01359644|464466897|FG004|Treatment Period|Lost to Follow-up|0|||
129047428|NCT01359644|464466898|FG005|Treatment Period|Lost to Follow-up|1|||
129047429|NCT01359644|464466899|FG006|Treatment Period|Lost to Follow-up|0|||
129047430|NCT01359644|464466900|FG007|Treatment Period|Lost to Follow-up|0|||
129047431|NCT01359644|464466901|FG008|Treatment Period|Lost to Follow-up|0|||
129135755|NCT01107457|464789272|FG001|Part B and C|Physician Decision|0|||
129135756|NCT01107457|464789273|FG002|Part B and C|Physician Decision|0|||
129135757|NCT01107457|464789274|FG003|Part B and C|Physician Decision|0|||
129135758|NCT01107457|464789275|FG004|Part B and C|Physician Decision|0|||
129135759|NCT01107457|464789276|FG005|Part B and C|Physician Decision|3|||
129135760|NCT01107457|464789271|FG000|Part B and C|Lack of Efficacy|0|||
129135761|NCT01107457|464789272|FG001|Part B and C|Lack of Efficacy|0|||
129135762|NCT01107457|464789273|FG002|Part B and C|Lack of Efficacy|0|||
129135763|NCT01107457|464789274|FG003|Part B and C|Lack of Efficacy|0|||
129135764|NCT01107457|464789275|FG004|Part B and C|Lack of Efficacy|0|||
129135765|NCT01107457|464789276|FG005|Part B and C|Lack of Efficacy|7|||
129135766|NCT01107457|464789271|FG000|Part B and C|Lost to Follow-up|0|||
129135767|NCT01107457|464789272|FG001|Part B and C|Lost to Follow-up|0|||
129135768|NCT01107457|464789273|FG002|Part B and C|Lost to Follow-up|0|||
129135769|NCT01107457|464789274|FG003|Part B and C|Lost to Follow-up|0|||
129135770|NCT01107457|464789275|FG004|Part B and C|Lost to Follow-up|0|||
129223275|NCT02112916|465118325|FG001|Overall Study|Development of SMN|0|||
129223276|NCT02112916|465118326|FG002|Overall Study|Development of SMN|0|||
129223277|NCT02112916|465118327|FG003|Overall Study|Development of SMN|1|||
129223278|NCT02112916|465118324|FG000|Overall Study|Relapse/Progression|10|||
129047432|NCT01359644|464466902|FG009|Treatment Period|Lost to Follow-up|0|||
129047433|NCT01359644|464466893|FG000|Follow-up Period|Withdrawal by Subject|0|||
129047434|NCT01359644|464466894|FG001|Follow-up Period|Withdrawal by Subject|0|||
129047435|NCT01359644|464466895|FG002|Follow-up Period|Withdrawal by Subject|0|||
129047436|NCT01359644|464466896|FG003|Follow-up Period|Withdrawal by Subject|0|||
129047437|NCT01359644|464466897|FG004|Follow-up Period|Withdrawal by Subject|0|||
129047438|NCT01359644|464466898|FG005|Follow-up Period|Withdrawal by Subject|1|||
129047439|NCT01359644|464466899|FG006|Follow-up Period|Withdrawal by Subject|0|||
129047440|NCT01359644|464466900|FG007|Follow-up Period|Withdrawal by Subject|0|||
129047441|NCT01359644|464466901|FG008|Follow-up Period|Withdrawal by Subject|0|||
129047442|NCT01359644|464466902|FG009|Follow-up Period|Withdrawal by Subject|0|||
129047443|NCT01359644|464466893|FG000|Follow-up Period|Lost to Follow-up|0|||
129047444|NCT01359644|464466894|FG001|Follow-up Period|Lost to Follow-up|0|||
129047445|NCT01359644|464466895|FG002|Follow-up Period|Lost to Follow-up|0|||
129047446|NCT01359644|464466896|FG003|Follow-up Period|Lost to Follow-up|0|||
129047447|NCT01359644|464466897|FG004|Follow-up Period|Lost to Follow-up|0|||
129047448|NCT01359644|464466898|FG005|Follow-up Period|Lost to Follow-up|0|||
129047449|NCT01359644|464466899|FG006|Follow-up Period|Lost to Follow-up|1|||
129047450|NCT01359644|464466900|FG007|Follow-up Period|Lost to Follow-up|2|||
129047451|NCT01359644|464466901|FG008|Follow-up Period|Lost to Follow-up|0|||
129047452|NCT01359644|464466902|FG009|Follow-up Period|Lost to Follow-up|0|||
129047453|NCT02130882|464466903|FG000|Overall Study|Withdrawal by Subject|0|||
129047454|NCT02130882|464466904|FG001|Overall Study|Withdrawal by Subject|1|||
129047455|NCT01355159|464466915|FG000|Overall Study|Withdrew consent|39|||
129047456|NCT01355159|464466916|FG001|Overall Study|Withdrew consent|47|||
129047457|NCT01355159|464466915|FG000|Overall Study|No primary outcome data|17|||
129047458|NCT01355159|464466916|FG001|Overall Study|No primary outcome data|11|||
129047459|NCT01355159|464466915|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
129047460|NCT01355159|464466916|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
129047461|NCT01355159|464466915|FG000|Overall Study|Early intrauterine fetal death|6|||
129047462|NCT01355159|464466916|FG001|Overall Study|Early intrauterine fetal death|6|||
129047463|NCT01194973|464466917|FG000|Screening Period|Screen Failure|3|||
129047464|NCT01194973|464466917|FG000|26 Week Treatment Period|Adverse Event|1|||
129047465|NCT01194973|464466917|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
129047466|NCT01194973|464466917|FG000|26 Week Treatment Period|Pregnancy|1|||
129047467|NCT00359632|464466920|FG000|Overall Study|Death|2|||
129047468|NCT00359632|464466921|FG001|Overall Study|Death|0|||
129047469|NCT00359632|464466920|FG000|Overall Study|Adverse Event|1|||
129047470|NCT00359632|464466921|FG001|Overall Study|Adverse Event|0|||
129047471|NCT00359632|464466920|FG000|Overall Study|Non-compliance with visit schedule|1|||
129047472|NCT00359632|464466921|FG001|Overall Study|Non-compliance with visit schedule|0|||
129047473|NCT04700280|464466922|FG000|Overall Study|Adverse Event|4|||
129047474|NCT04700280|464466923|FG001|Overall Study|Adverse Event|0|||
129047475|NCT04700280|464466922|FG000|Overall Study|Lack of Efficacy|1|||
129047476|NCT04700280|464466923|FG001|Overall Study|Lack of Efficacy|0|||
129047477|NCT04700280|464466922|FG000|Overall Study|Study terminated by sponsor|5|||
129047478|NCT04700280|464466923|FG001|Overall Study|Study terminated by sponsor|3|||
129047479|NCT04700280|464466922|FG000|Overall Study|Other than specified|1|||
129047480|NCT04700280|464466923|FG001|Overall Study|Other than specified|0|||
129047481|NCT02615171|464466924|FG000|Overall Study|Lost to Follow-up|2|||
129047482|NCT02615171|464466925|FG001|Overall Study|Lost to Follow-up|1|||
129135771|NCT01107457|464789276|FG005|Part B and C|Lost to Follow-up|10|||
129047483|NCT01000493|464466933|FG000|Overall Study|Adverse Event|3|||
129135772|NCT01107457|464789271|FG000|Part B and C|Protocol Violation|0|||
129223279|NCT02112916|465118325|FG001|Overall Study|Relapse/Progression|18|||
129047484|NCT01000493|464466934|FG001|Overall Study|Adverse Event|6|||
129135773|NCT01107457|464789272|FG001|Part B and C|Protocol Violation|0|||
129135774|NCT01107457|464789273|FG002|Part B and C|Protocol Violation|0|||
129135775|NCT01107457|464789274|FG003|Part B and C|Protocol Violation|0|||
129135776|NCT01107457|464789275|FG004|Part B and C|Protocol Violation|0|||
129135777|NCT01107457|464789276|FG005|Part B and C|Protocol Violation|1|||
129135778|NCT01107457|464789271|FG000|Part B and C|Sponsor Decision|0|||
129047485|NCT01000493|464466933|FG000|Overall Study|Lack of Efficacy|1|||
129047486|NCT01000493|464466934|FG001|Overall Study|Lack of Efficacy|1|||
129047487|NCT01000493|464466933|FG000|Overall Study|Protocol Violation|1|||
129047488|NCT01000493|464466934|FG001|Overall Study|Protocol Violation|8|||
129047489|NCT01000493|464466933|FG000|Overall Study|Study closed/terminated|25|||
129047490|NCT01000493|464466934|FG001|Overall Study|Study closed/terminated|23|||
129047491|NCT01000493|464466933|FG000|Overall Study|Lost to Follow-up|5|||
129047492|NCT01000493|464466934|FG001|Overall Study|Lost to Follow-up|9|||
129047493|NCT01000493|464466933|FG000|Overall Study|Physician Decision|1|||
129047494|NCT01000493|464466934|FG001|Overall Study|Physician Decision|1|||
129047495|NCT01000493|464466933|FG000|Overall Study|Withdrawal by Subject|3|||
129047496|NCT01000493|464466934|FG001|Overall Study|Withdrawal by Subject|7|||
129047497|NCT00502801|464466935|FG000|Treatment Period|Withdrawal by Subject|3|||
129047498|NCT00502801|464466935|FG000|Treatment Period|Adverse Event|7|||
129047499|NCT00502801|464466935|FG000|Treatment Period|Death|14|||
129047500|NCT00502801|464466935|FG000|Treatment Period|OTHER|30|||
129047501|NCT00502801|464466935|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
129047502|NCT00502801|464466935|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
129047503|NCT00502801|464466935|FG000|End of Therapy to Test of Cure|Death|3|||
129047504|NCT00502801|464466935|FG000|End of Therapy to Test of Cure|OTHER|2|||
129047505|NCT00444457|464466941|FG000|Infant Series|Other|0|||
129047506|NCT00444457|464466942|FG001|Infant Series|Other|1|||
129047507|NCT00444457|464466943|FG002|Infant Series|Other|0|||
129047508|NCT00444457|464466944|FG003|Infant Series|Other|0|||
129047509|NCT00444457|464466941|FG000|Infant Series|Parent or legal guardian request|18|||
129047510|NCT00444457|464466942|FG001|Infant Series|Parent or legal guardian request|29|||
129047511|NCT00444457|464466943|FG002|Infant Series|Parent or legal guardian request|34|||
129047512|NCT00444457|464466944|FG003|Infant Series|Parent or legal guardian request|14|||
129047513|NCT00444457|464466941|FG000|Infant Series|Lost to Follow-up|10|||
129047514|NCT00444457|464466942|FG001|Infant Series|Lost to Follow-up|11|||
129047515|NCT00444457|464466943|FG002|Infant Series|Lost to Follow-up|7|||
129047516|NCT00444457|464466944|FG003|Infant Series|Lost to Follow-up|6|||
129047517|NCT00444457|464466941|FG000|Infant Series|Protocol Violation|16|||
129047518|NCT00444457|464466942|FG001|Infant Series|Protocol Violation|8|||
129047519|NCT00444457|464466943|FG002|Infant Series|Protocol Violation|6|||
129047520|NCT00444457|464466944|FG003|Infant Series|Protocol Violation|3|||
129047521|NCT00444457|464466941|FG000|Infant Series|Failed to return|5|||
129047522|NCT00444457|464466942|FG001|Infant Series|Failed to return|4|||
129047523|NCT00444457|464466943|FG002|Infant Series|Failed to return|4|||
129047524|NCT00444457|464466944|FG003|Infant Series|Failed to return|2|||
129047525|NCT00444457|464466941|FG000|Infant Series|Investigator request|4|||
129047526|NCT00444457|464466942|FG001|Infant Series|Investigator request|3|||
129047527|NCT00444457|464466943|FG002|Infant Series|Investigator request|3|||
129047528|NCT00444457|464466944|FG003|Infant Series|Investigator request|2|||
129047529|NCT00444457|464466941|FG000|Infant Series|Other|0|||
129047530|NCT00444457|464466942|FG001|Infant Series|Other|2|||
129047531|NCT00444457|464466943|FG002|Infant Series|Other|4|||
129047532|NCT00444457|464466944|FG003|Infant Series|Other|0|||
129047533|NCT00444457|464466941|FG000|Infant Series|Adverse Event|1|||
129047534|NCT00444457|464466942|FG001|Infant Series|Adverse Event|2|||
129047535|NCT00444457|464466943|FG002|Infant Series|Adverse Event|2|||
129135779|NCT01107457|464789272|FG001|Part B and C|Sponsor Decision|0|||
129135780|NCT01107457|464789273|FG002|Part B and C|Sponsor Decision|0|||
129135781|NCT01107457|464789274|FG003|Part B and C|Sponsor Decision|0|||
129135782|NCT01107457|464789275|FG004|Part B and C|Sponsor Decision|0|||
129135783|NCT01107457|464789276|FG005|Part B and C|Sponsor Decision|66|||
129135784|NCT01107457|464789271|FG000|Part B and C|Withdrawal by Subject|0|||
129135785|NCT01107457|464789272|FG001|Part B and C|Withdrawal by Subject|0|||
129135786|NCT01107457|464789273|FG002|Part B and C|Withdrawal by Subject|0|||
128775429|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128775430|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129047536|NCT00444457|464466944|FG003|Infant Series|Adverse Event|0|||
129047537|NCT00444457|464466941|FG000|Infant Series|Death|0|||
129047538|NCT00444457|464466942|FG001|Infant Series|Death|1|||
129047539|NCT00444457|464466943|FG002|Infant Series|Death|1|||
129047540|NCT00444457|464466944|FG003|Infant Series|Death|1|||
129047541|NCT00444457|464466941|FG000|After Infant Series|Other|0|||
129047542|NCT00444457|464466942|FG001|After Infant Series|Other|1|||
129047543|NCT00444457|464466943|FG002|After Infant Series|Other|1|||
129047544|NCT00444457|464466944|FG003|After Infant Series|Other|1|||
129047545|NCT00444457|464466941|FG000|After Infant Series|Parent or legal guardian request|4|||
129047546|NCT00444457|464466942|FG001|After Infant Series|Parent or legal guardian request|11|||
129047547|NCT00444457|464466943|FG002|After Infant Series|Parent or legal guardian request|6|||
129047548|NCT00444457|464466944|FG003|After Infant Series|Parent or legal guardian request|3|||
129047549|NCT00444457|464466941|FG000|After Infant Series|Failed to return|7|||
129135787|NCT01107457|464789274|FG003|Part B and C|Withdrawal by Subject|0|||
129135788|NCT01107457|464789275|FG004|Part B and C|Withdrawal by Subject|0|||
129135789|NCT01107457|464789276|FG005|Part B and C|Withdrawal by Subject|16|||
129135790|NCT01107457|464789271|FG000|Part B and C|Clinical Relapse|0|||
129135791|NCT01107457|464789272|FG001|Part B and C|Clinical Relapse|0|||
129135792|NCT01107457|464789273|FG002|Part B and C|Clinical Relapse|0|||
129135793|NCT01107457|464789274|FG003|Part B and C|Clinical Relapse|0|||
129135794|NCT01107457|464789275|FG004|Part B and C|Clinical Relapse|0|||
129135795|NCT01107457|464789276|FG005|Part B and C|Clinical Relapse|4|||
129135796|NCT00362609|464789277|FG000|Overall Study|Withdrawal by Subject|0|||
129135797|NCT00362609|464789278|FG001|Overall Study|Withdrawal by Subject|1|||
129135798|NCT00362609|464789277|FG000|Overall Study|Protocol Violation|0|||
129135799|NCT00362609|464789278|FG001|Overall Study|Protocol Violation|1|||
129135800|NCT01800058|464789280|FG000|Overall Study|Lost to Follow-up|1|||
129135801|NCT05206604|464791095|FG000|Overall Study|Non-compliance with study drug|0|||
129135802|NCT05206604|464791096|FG001|Overall Study|Non-compliance with study drug|0|||
129135803|NCT05206604|464791097|FG002|Overall Study|Non-compliance with study drug|0|||
129135804|NCT05206604|464791098|FG003|Overall Study|Non-compliance with study drug|0|||
129135805|NCT05206604|464791099|FG004|Overall Study|Non-compliance with study drug|0|||
129135806|NCT05206604|464791100|FG005|Overall Study|Non-compliance with study drug|1|||
129135807|NCT05206604|464791101|FG006|Overall Study|Non-compliance with study drug|0|||
129135808|NCT05206604|464791102|FG007|Overall Study|Non-compliance with study drug|0|||
129135809|NCT03787212|464791103|FG000|Period 1|Study Termination|2|||
129135810|NCT03787212|464791104|FG001|Period 1|Study Termination|2|||
129135811|NCT04193176|464791105|FG000|Overall Study|Withdrawal by Subject|6|||
129135812|NCT04193176|464791106|FG001|Overall Study|Withdrawal by Subject|10|||
129135813|NCT02370394|464791108|FG000|Overall Study|Lost to Follow-up|2|||
129135814|NCT02370394|464791109|FG001|Overall Study|Lost to Follow-up|1|||
129135815|NCT02370394|464791108|FG000|Overall Study|Withdrawal by Subject|0|||
129135816|NCT02370394|464791109|FG001|Overall Study|Withdrawal by Subject|1|||
129135817|NCT00520572|464791111|FG000|Overall Study|Adverse Event|9|||
129135818|NCT00520572|464791112|FG001|Overall Study|Adverse Event|3|||
129135819|NCT00520572|464791113|FG002|Overall Study|Adverse Event|6|||
129135820|NCT00520572|464791114|FG003|Overall Study|Adverse Event|9|||
129135821|NCT00520572|464791115|FG004|Overall Study|Adverse Event|7|||
129135822|NCT00520572|464791116|FG005|Overall Study|Adverse Event|2|||
129135823|NCT00520572|464791111|FG000|Overall Study|Withdrawal by Subject|0|||
129135824|NCT00520572|464791112|FG001|Overall Study|Withdrawal by Subject|9|||
129135825|NCT00520572|464791113|FG002|Overall Study|Withdrawal by Subject|5|||
129135826|NCT00520572|464791114|FG003|Overall Study|Withdrawal by Subject|2|||
129135827|NCT00520572|464791115|FG004|Overall Study|Withdrawal by Subject|2|||
129135828|NCT00520572|464791116|FG005|Overall Study|Withdrawal by Subject|0|||
129135829|NCT00520572|464791111|FG000|Overall Study|Protocol Violation|0|||
129135830|NCT00520572|464791112|FG001|Overall Study|Protocol Violation|0|||
128775431|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128775432|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128775433|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129047550|NCT00444457|464466942|FG001|After Infant Series|Failed to return|6|||
129047551|NCT00444457|464466943|FG002|After Infant Series|Failed to return|5|||
129047552|NCT00444457|464466944|FG003|After Infant Series|Failed to return|1|||
129047553|NCT00444457|464466941|FG000|After Infant Series|Lost to Follow-up|5|||
129047554|NCT00444457|464466942|FG001|After Infant Series|Lost to Follow-up|5|||
129047555|NCT00444457|464466943|FG002|After Infant Series|Lost to Follow-up|5|||
129047556|NCT00444457|464466944|FG003|After Infant Series|Lost to Follow-up|2|||
129047557|NCT00444457|464466941|FG000|After Infant Series|Protocol Violation|2|||
129047558|NCT00444457|464466942|FG001|After Infant Series|Protocol Violation|4|||
129047559|NCT00444457|464466943|FG002|After Infant Series|Protocol Violation|2|||
129047560|NCT00444457|464466944|FG003|After Infant Series|Protocol Violation|2|||
129047561|NCT00444457|464466941|FG000|After Infant Series|Adverse Event|2|||
129047562|NCT00444457|464466942|FG001|After Infant Series|Adverse Event|2|||
129047563|NCT00444457|464466943|FG002|After Infant Series|Adverse Event|0|||
129047564|NCT00444457|464466944|FG003|After Infant Series|Adverse Event|0|||
129047565|NCT00444457|464466941|FG000|After Infant Series|Investigator request|0|||
129047566|NCT00444457|464466942|FG001|After Infant Series|Investigator request|0|||
129047567|NCT00444457|464466943|FG002|After Infant Series|Investigator request|0|||
129047568|NCT00444457|464466944|FG003|After Infant Series|Investigator request|1|||
129047569|NCT00444457|464466941|FG000|After Infant Series|Other|0|||
129135831|NCT00520572|464791113|FG002|Overall Study|Protocol Violation|1|||
129135832|NCT00520572|464791114|FG003|Overall Study|Protocol Violation|0|||
129135833|NCT00520572|464791115|FG004|Overall Study|Protocol Violation|0|||
129047570|NCT00444457|464466942|FG001|After Infant Series|Other|1|||
129047571|NCT00444457|464466943|FG002|After Infant Series|Other|0|||
129135834|NCT00520572|464791116|FG005|Overall Study|Protocol Violation|0|||
129135835|NCT00520572|464791111|FG000|Overall Study|Lack of Efficacy|1|||
129047572|NCT00444457|464466944|FG003|After Infant Series|Other|0|||
129047573|NCT00444457|464466941|FG000|Toddler Dose|Lost to Follow-up|4|||
129135836|NCT00520572|464791112|FG001|Overall Study|Lack of Efficacy|1|||
129047574|NCT00444457|464466942|FG001|Toddler Dose|Lost to Follow-up|1|||
129047575|NCT00444457|464466943|FG002|Toddler Dose|Lost to Follow-up|1|||
129047576|NCT00444457|464466944|FG003|Toddler Dose|Lost to Follow-up|3|||
129047577|NCT00444457|464466941|FG000|Toddler Dose|Failed to return|2|||
129047578|NCT00444457|464466942|FG001|Toddler Dose|Failed to return|2|||
129047579|NCT00444457|464466943|FG002|Toddler Dose|Failed to return|1|||
129047580|NCT00444457|464466944|FG003|Toddler Dose|Failed to return|3|||
129047581|NCT00444457|464466941|FG000|Toddler Dose|Parent or legal guardian request|0|||
129047582|NCT00444457|464466942|FG001|Toddler Dose|Parent or legal guardian request|3|||
129047583|NCT00444457|464466943|FG002|Toddler Dose|Parent or legal guardian request|2|||
129047584|NCT00444457|464466944|FG003|Toddler Dose|Parent or legal guardian request|1|||
129047585|NCT00444457|464466941|FG000|Toddler Dose|Protocol Violation|1|||
129047586|NCT00444457|464466942|FG001|Toddler Dose|Protocol Violation|0|||
129047587|NCT00444457|464466943|FG002|Toddler Dose|Protocol Violation|0|||
129047588|NCT00444457|464466944|FG003|Toddler Dose|Protocol Violation|1|||
129047589|NCT01121666|464466947|FG000|Overall Study|Protocol Violation|29|||
129047590|NCT01121666|464466948|FG001|Overall Study|Protocol Violation|10|||
129047591|NCT03176459|464466951|FG000|Overall Study|Lost to Follow-up|5|||
129047592|NCT03176459|464466952|FG001|Overall Study|Lost to Follow-up|7|||
129047593|NCT01602965|464466953|FG000|Overall Study|Lost to Follow-up|4|||
129047594|NCT01602965|464466954|FG001|Overall Study|Lost to Follow-up|2|||
129047595|NCT02283294|464466955|FG000|Overall Study|Lost to Follow-up|1|||
129047596|NCT02283294|464466956|FG001|Overall Study|Lost to Follow-up|1|||
129047597|NCT02283294|464466955|FG000|Overall Study|Withdrawal by Subject|1|||
129047598|NCT02283294|464466956|FG001|Overall Study|Withdrawal by Subject|6|||
129047599|NCT02283294|464466955|FG000|Overall Study|Protocol Violation|1|||
129047600|NCT02283294|464466956|FG001|Overall Study|Protocol Violation|0|||
129047601|NCT02283294|464466955|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
129047602|NCT02283294|464466956|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
129047603|NCT05101486|464469901|FG000|Overall Study|Death|1|||
129047604|NCT05101486|464469902|FG001|Overall Study|Death|0|||
129047605|NCT05101486|464469903|FG002|Overall Study|Death|1|||
129047606|NCT05101486|464469901|FG000|Overall Study|Lost to Follow-up|12|||
129047607|NCT05101486|464469902|FG001|Overall Study|Lost to Follow-up|8|||
129047608|NCT05101486|464469903|FG002|Overall Study|Lost to Follow-up|17|||
129047609|NCT05101486|464469901|FG000|Overall Study|Physician Decision|1|||
129047610|NCT05101486|464469902|FG001|Overall Study|Physician Decision|0|||
129047611|NCT05101486|464469903|FG002|Overall Study|Physician Decision|0|||
129047612|NCT05101486|464469901|FG000|Overall Study|Protocol Violation|0|||
129047613|NCT05101486|464469902|FG001|Overall Study|Protocol Violation|0|||
129047614|NCT05101486|464469903|FG002|Overall Study|Protocol Violation|1|||
129047615|NCT05101486|464469901|FG000|Overall Study|Withdrawal by Subject|5|||
129047616|NCT05101486|464469902|FG001|Overall Study|Withdrawal by Subject|2|||
129047617|NCT05101486|464469903|FG002|Overall Study|Withdrawal by Subject|4|||
129047618|NCT05101486|464469901|FG000|Overall Study|Randomized but not vaccinated|1|||
129047619|NCT05101486|464469902|FG001|Overall Study|Randomized but not vaccinated|1|||
129047620|NCT05101486|464469903|FG002|Overall Study|Randomized but not vaccinated|1|||
129047621|NCT02788045|464469904|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
129047622|NCT02788045|464469905|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
129047623|NCT02788045|464469906|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
129047624|NCT02788045|464469904|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
129047625|NCT02788045|464469905|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
129047626|NCT02788045|464469906|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
129047627|NCT02788045|464469904|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
129047628|NCT02788045|464469905|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
129047629|NCT02788045|464469906|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
129047630|NCT02788045|464469904|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
129047631|NCT02788045|464469905|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
129047632|NCT02788045|464469906|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
129047633|NCT02788045|464469904|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
129047634|NCT02788045|464469905|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
129047635|NCT02788045|464469906|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
129047636|NCT02788045|464469904|FG000|Main Study (Up to Week 72)|Other|3|||
129047637|NCT02788045|464469905|FG001|Main Study (Up to Week 72)|Other|0|||
129047638|NCT02788045|464469906|FG002|Main Study (Up to Week 72)|Other|0|||
129047639|NCT02788045|464469904|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
129047640|NCT02788045|464469905|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
129047641|NCT02788045|464469906|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
129047642|NCT02788045|464469904|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
129047643|NCT02788045|464469905|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
129047644|NCT02788045|464469906|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
129047645|NCT02788045|464469904|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
129047646|NCT02788045|464469905|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
129047647|NCT02788045|464469906|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
129047648|NCT03047473|464469907|FG000|Overall Study|Lost to Follow-up|2|||
129223280|NCT02112916|465118326|FG002|Overall Study|Relapse/Progression|15|||
129223281|NCT02112916|465118327|FG003|Overall Study|Relapse/Progression|2|||
129223282|NCT02112916|465118324|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
129223283|NCT02112916|465118325|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
129047649|NCT02935686|464469908|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
129047650|NCT02935686|464469909|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129047651|NCT02935686|464469910|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129047652|NCT02935686|464469911|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129047653|NCT02935686|464469912|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129047654|NCT02935686|464469908|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
129047655|NCT02935686|464469909|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
129047656|NCT02935686|464469910|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
129047657|NCT02935686|464469911|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
129047658|NCT02935686|464469912|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
129047659|NCT02935686|464469908|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129047660|NCT02935686|464469909|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
129047661|NCT02935686|464469910|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129047662|NCT02935686|464469911|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129047663|NCT02935686|464469912|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129047664|NCT02935686|464469908|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
129047665|NCT02935686|464469909|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
129047666|NCT02935686|464469910|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
129047667|NCT02935686|464469911|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
129047668|NCT02935686|464469912|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
129047669|NCT02935686|464469908|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
129047670|NCT02935686|464469909|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
129047671|NCT02935686|464469910|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
129047672|NCT02935686|464469911|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
129047673|NCT02935686|464469912|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
129047674|NCT02935686|464469908|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129047675|NCT02935686|464469909|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
129047676|NCT02935686|464469910|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129047677|NCT02935686|464469911|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129047678|NCT02935686|464469912|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129047679|NCT02935686|464469908|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
129047680|NCT02935686|464469909|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
129047681|NCT02935686|464469910|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
129047682|NCT02935686|464469911|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
129047683|NCT02935686|464469912|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
129047684|NCT02935686|464469908|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129047685|NCT02935686|464469909|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
129047686|NCT02935686|464469910|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129047687|NCT02935686|464469911|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129047688|NCT02935686|464469912|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129047689|NCT02935686|464469908|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129047690|NCT02935686|464469909|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
129047691|NCT02935686|464469910|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129047692|NCT02935686|464469911|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129047693|NCT02935686|464469912|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129047694|NCT02935686|464469908|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129047695|NCT02935686|464469909|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129047696|NCT02935686|464469910|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129047697|NCT02935686|464469911|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129047698|NCT02935686|464469912|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
129047699|NCT02935686|464469908|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
129047700|NCT02935686|464469909|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
129047701|NCT02935686|464469910|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
129047702|NCT02935686|464469911|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
129047703|NCT02935686|464469912|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
129047704|NCT00541970|464469918|FG000|Month 7|Protocol Violation|9|||
129047705|NCT00541970|464469919|FG001|Month 7|Protocol Violation|13|||
129047706|NCT00541970|464469920|FG002|Month 7|Protocol Violation|11|||
129047707|NCT00541970|464469921|FG003|Month 7|Protocol Violation|5|||
129047708|NCT00541970|464469918|FG000|Month 12|Adverse Event|0|||
129047709|NCT00541970|464469919|FG001|Month 12|Adverse Event|1|||
129047710|NCT00541970|464469920|FG002|Month 12|Adverse Event|1|||
129047711|NCT00541970|464469921|FG003|Month 12|Adverse Event|1|||
129047712|NCT00541970|464469918|FG000|Month 12|Protocol Violation|12|||
128719369|NCT02584504|463271056|FG002|Double-blind Treatment|Adverse Event|0|||
128719370|NCT02584504|463271054|FG000|Double-blind Treatment|Family Matter|0|||
128719371|NCT02584504|463271055|FG001|Double-blind Treatment|Family Matter|1|||
128719372|NCT02584504|463271056|FG002|Double-blind Treatment|Family Matter|0|||
129047713|NCT00541970|464469919|FG001|Month 12|Protocol Violation|21|||
129047714|NCT00541970|464469920|FG002|Month 12|Protocol Violation|20|||
129047715|NCT00541970|464469921|FG003|Month 12|Protocol Violation|15|||
129047716|NCT00541970|464469918|FG000|Month 18|Adverse Event|0|||
129047717|NCT00541970|464469919|FG001|Month 18|Adverse Event|1|||
129047718|NCT00541970|464469920|FG002|Month 18|Adverse Event|1|||
129047719|NCT00541970|464469921|FG003|Month 18|Adverse Event|1|||
129047720|NCT00541970|464469918|FG000|Month 18|Protocol Violation|14|||
129047721|NCT00541970|464469919|FG001|Month 18|Protocol Violation|23|||
129047722|NCT00541970|464469920|FG002|Month 18|Protocol Violation|24|||
129047723|NCT00541970|464469921|FG003|Month 18|Protocol Violation|16|||
129135837|NCT00520572|464791113|FG002|Overall Study|Lack of Efficacy|1|||
129047724|NCT00541970|464469918|FG000|Month 24|Adverse Event|0|||
129047725|NCT00541970|464469919|FG001|Month 24|Adverse Event|1|||
129047726|NCT00541970|464469920|FG002|Month 24|Adverse Event|1|||
129047727|NCT00541970|464469921|FG003|Month 24|Adverse Event|1|||
129047728|NCT00541970|464469918|FG000|Month 24|Protocol Violation|29|||
129047729|NCT00541970|464469919|FG001|Month 24|Protocol Violation|31|||
129047730|NCT00541970|464469920|FG002|Month 24|Protocol Violation|31|||
129047731|NCT00541970|464469921|FG003|Month 24|Protocol Violation|21|||
129047732|NCT00541970|464469918|FG000|Month 36|Protocol Violation|61|||
129047733|NCT00541970|464469919|FG001|Month 36|Protocol Violation|66|||
129047734|NCT00541970|464469920|FG002|Month 36|Protocol Violation|66|||
129047735|NCT00541970|464469921|FG003|Month 36|Protocol Violation|60|||
129047736|NCT00541970|464469918|FG000|Month 48|Withdrawal by Subject|2|||
129047737|NCT00541970|464469919|FG001|Month 48|Withdrawal by Subject|4|||
129047738|NCT00541970|464469920|FG002|Month 48|Withdrawal by Subject|4|||
129047739|NCT00541970|464469921|FG003|Month 48|Withdrawal by Subject|2|||
129047740|NCT00541970|464469918|FG000|Month 48|Other|3|||
129047741|NCT00541970|464469919|FG001|Month 48|Other|1|||
129047742|NCT00541970|464469920|FG002|Month 48|Other|1|||
129047743|NCT00541970|464469921|FG003|Month 48|Other|0|||
129047744|NCT00541970|464469918|FG000|Month 48|Lost to Follow-up|66|||
129047745|NCT00541970|464469919|FG001|Month 48|Lost to Follow-up|68|||
129047746|NCT00541970|464469920|FG002|Month 48|Lost to Follow-up|68|||
129047747|NCT00541970|464469921|FG003|Month 48|Lost to Follow-up|73|||
129047748|NCT00541970|464469918|FG000|Month 60|Protocol Violation|78|||
129047749|NCT00541970|464469919|FG001|Month 60|Protocol Violation|77|||
129047750|NCT00541970|464469920|FG002|Month 60|Protocol Violation|82|||
129047751|NCT00541970|464469921|FG003|Month 60|Protocol Violation|72|||
129047752|NCT00321828|464469922|FG000|Overall Study|Ineligible|3|||
129047753|NCT00321828|464469922|FG000|Overall Study|No follow up data|1|||
129047754|NCT00062010|464469925|FG000|Overall Study|Ineligible|3|||
129047755|NCT02856880|464469926|FG000|Overall Study|Withdrawal of consent|1|||
129047756|NCT00573157|464469927|FG000|Overall Study|Adverse Event|3|||
129047757|NCT00573157|464469928|FG001|Overall Study|Adverse Event|1|||
129047758|NCT00573157|464469927|FG000|Overall Study|Other|1|||
129047759|NCT00573157|464469928|FG001|Overall Study|Other|1|||
129047760|NCT02944383|464469929|FG000|Overall Study|Lost to Follow-up|0|||
129047761|NCT02944383|464469930|FG001|Overall Study|Lost to Follow-up|0|||
129047762|NCT02944383|464469931|FG002|Overall Study|Lost to Follow-up|1|||
129047763|NCT02944383|464469929|FG000|Overall Study|Withdrawal by Subject|1|||
128719373|NCT02584504|463271054|FG000|Open-label Treatment|Participant withdrew consent|0|||
129047764|NCT02944383|464469930|FG001|Overall Study|Withdrawal by Subject|0|||
129047765|NCT02944383|464469931|FG002|Overall Study|Withdrawal by Subject|0|||
129047766|NCT01183221|464469934|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
128719374|NCT02584504|463271055|FG001|Open-label Treatment|Participant withdrew consent|0|||
128719375|NCT02584504|463271056|FG002|Open-label Treatment|Participant withdrew consent|4|||
128719376|NCT02584504|463271054|FG000|Open-label Treatment|Adverse Event|2|||
128719377|NCT02584504|463271055|FG001|Open-label Treatment|Adverse Event|2|||
128719378|NCT02584504|463271056|FG002|Open-label Treatment|Adverse Event|3|||
129047767|NCT01183221|464469935|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
129047768|NCT00858143|464469941|FG000|Overall Study|Adverse Event|16|||
129047769|NCT00858143|464469941|FG000|Overall Study|Lack of Efficacy|4|||
129047770|NCT00858143|464469941|FG000|Overall Study|Death|7|||
129047771|NCT00858143|464469941|FG000|Overall Study|Other|23|||
129047772|NCT00852969|464469942|FG000|Overall Study|Adverse Event|0|||
129047773|NCT00852969|464469943|FG001|Overall Study|Adverse Event|1|||
129047774|NCT00852969|464469942|FG000|Overall Study|Lost to Follow-up|0|||
129047775|NCT00852969|464469943|FG001|Overall Study|Lost to Follow-up|1|||
129047776|NCT03853148|464469944|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
129047777|NCT03853148|464469945|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
129047778|NCT03853148|464469946|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
129135838|NCT00520572|464791114|FG003|Overall Study|Lack of Efficacy|2|||
129135839|NCT00520572|464791115|FG004|Overall Study|Lack of Efficacy|1|||
128719379|NCT02584504|463271054|FG000|Open-label Treatment|Physician Decision|0|||
129047779|NCT03853148|464469947|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
129047780|NCT00658658|464469950|FG000|Overall Study|Withdrawal by Subject|0|||
129047781|NCT00658658|464469951|FG001|Overall Study|Withdrawal by Subject|1|||
129047782|NCT00658658|464469952|FG002|Overall Study|Withdrawal by Subject|0|||
129047783|NCT00658658|464469953|FG003|Overall Study|Withdrawal by Subject|0|||
129047784|NCT00658658|464469954|FG004|Overall Study|Withdrawal by Subject|0|||
129047785|NCT00658658|464469950|FG000|Overall Study|Death|4|||
129047786|NCT00658658|464469951|FG001|Overall Study|Death|0|||
129047787|NCT00658658|464469952|FG002|Overall Study|Death|0|||
129047788|NCT00658658|464469953|FG003|Overall Study|Death|1|||
129047789|NCT00658658|464469954|FG004|Overall Study|Death|1|||
129047790|NCT00658658|464469950|FG000|Overall Study|Disease Progression|0|||
129047791|NCT00658658|464469951|FG001|Overall Study|Disease Progression|1|||
129047792|NCT00658658|464469952|FG002|Overall Study|Disease Progression|0|||
129047793|NCT00658658|464469953|FG003|Overall Study|Disease Progression|1|||
129047794|NCT00658658|464469954|FG004|Overall Study|Disease Progression|3|||
129047795|NCT00658658|464469950|FG000|Overall Study|Protocol-specified Criteria|1|||
129047796|NCT00658658|464469951|FG001|Overall Study|Protocol-specified Criteria|0|||
129047797|NCT00658658|464469952|FG002|Overall Study|Protocol-specified Criteria|0|||
129047798|NCT00658658|464469953|FG003|Overall Study|Protocol-specified Criteria|0|||
129047799|NCT00658658|464469954|FG004|Overall Study|Protocol-specified Criteria|0|||
129047800|NCT00658658|464469950|FG000|Overall Study|Other|0|||
129047801|NCT00658658|464469951|FG001|Overall Study|Other|0|||
129047802|NCT00658658|464469952|FG002|Overall Study|Other|0|||
129047803|NCT00658658|464469953|FG003|Overall Study|Other|0|||
129047804|NCT00658658|464469954|FG004|Overall Study|Other|1|||
129047805|NCT00678041|464469955|FG000|Overall Study|Physician Decision|5|||
129047806|NCT00678041|464469956|FG001|Overall Study|Physician Decision|5|||
129047807|NCT02358343|464469957|FG000|Screening Intervention|Death|0|||
129047808|NCT02358343|464469958|FG001|Screening Intervention|Death|2|||
129047809|NCT02358343|464469959|FG002|Screening Intervention|Death|0|||
129047810|NCT02358343|464469960|FG003|Screening Intervention|Death|0|||
129047811|NCT02358343|464469961|FG004|Screening Intervention|Death|0|||
129047812|NCT02358343|464469957|FG000|Screening Intervention|Withdrawal by Subject|1|||
129047813|NCT02358343|464469958|FG001|Screening Intervention|Withdrawal by Subject|0|||
129047814|NCT02358343|464469959|FG002|Screening Intervention|Withdrawal by Subject|0|||
129047815|NCT02358343|464469960|FG003|Screening Intervention|Withdrawal by Subject|0|||
129047816|NCT02358343|464469961|FG004|Screening Intervention|Withdrawal by Subject|0|||
129047817|NCT02358343|464469957|FG000|Screening Intervention|Determined Ineligible|5|||
129047818|NCT02358343|464469958|FG001|Screening Intervention|Determined Ineligible|6|||
129047819|NCT02358343|464469959|FG002|Screening Intervention|Determined Ineligible|0|||
129047820|NCT02358343|464469960|FG003|Screening Intervention|Determined Ineligible|0|||
129047821|NCT02358343|464469961|FG004|Screening Intervention|Determined Ineligible|0|||
129047822|NCT02358343|464469957|FG000|Comparative Efficacy Trial / Observation|Death|0|||
129047823|NCT02358343|464469958|FG001|Comparative Efficacy Trial / Observation|Death|0|||
129047824|NCT02358343|464469959|FG002|Comparative Efficacy Trial / Observation|Death|2|||
129047825|NCT02358343|464469960|FG003|Comparative Efficacy Trial / Observation|Death|0|||
129047826|NCT02358343|464469961|FG004|Comparative Efficacy Trial / Observation|Death|0|||
129047827|NCT02358343|464469957|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
129047828|NCT02358343|464469958|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
129047829|NCT02358343|464469959|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
129047830|NCT02358343|464469960|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
129047831|NCT02358343|464469961|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
129047832|NCT02358343|464469957|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129047833|NCT02358343|464469958|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129047834|NCT02358343|464469959|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
129047835|NCT02358343|464469960|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129047836|NCT02358343|464469961|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129047837|NCT00090610|464469964|FG000|Overall Study|Withdrawal by Subject|1|||
129047838|NCT00090610|464469965|FG001|Overall Study|Withdrawal by Subject|1|||
129047839|NCT02444793|464469966|FG000|Overall Study|Lost to Follow-up|2|||
129047840|NCT02444793|464469967|FG001|Overall Study|Lost to Follow-up|2|||
129047841|NCT02444793|464469968|FG002|Overall Study|Lost to Follow-up|0|||
129047842|NCT02444793|464469969|FG003|Overall Study|Lost to Follow-up|0|||
129047843|NCT02444793|464469966|FG000|Overall Study|Death|0|||
129047844|NCT02444793|464469967|FG001|Overall Study|Death|3|||
129047845|NCT02444793|464469968|FG002|Overall Study|Death|0|||
129047846|NCT02444793|464469969|FG003|Overall Study|Death|0|||
129047847|NCT02444793|464469966|FG000|Overall Study|Other|0|||
129047848|NCT02444793|464469967|FG001|Overall Study|Other|0|||
129047849|NCT02444793|464469968|FG002|Overall Study|Other|2|||
129047850|NCT02444793|464469969|FG003|Overall Study|Other|0|||
129047851|NCT02444793|464469966|FG000|Overall Study|Objective progression or relapse|9|||
129047852|NCT02444793|464469967|FG001|Overall Study|Objective progression or relapse|1|||
129047853|NCT02444793|464469968|FG002|Overall Study|Objective progression or relapse|2|||
129047854|NCT02444793|464469969|FG003|Overall Study|Objective progression or relapse|3|||
129047855|NCT02504671|464469971|FG000|Overall Study|Withdrawal by Subject|1|||
129047856|NCT02504671|464469972|FG001|Overall Study|Withdrawal by Subject|5|||
129047857|NCT02504671|464469973|FG002|Overall Study|Withdrawal by Subject|4|||
129047858|NCT02504671|464469974|FG003|Overall Study|Withdrawal by Subject|4|||
129047859|NCT02504671|464469975|FG004|Overall Study|Withdrawal by Subject|5|||
129047860|NCT02504671|464469976|FG005|Overall Study|Withdrawal by Subject|3|||
129047861|NCT02504671|464469971|FG000|Overall Study|Lack of Efficacy|1|||
129047862|NCT02504671|464469972|FG001|Overall Study|Lack of Efficacy|3|||
129047863|NCT02504671|464469973|FG002|Overall Study|Lack of Efficacy|1|||
129047864|NCT02504671|464469974|FG003|Overall Study|Lack of Efficacy|0|||
129047865|NCT02504671|464469975|FG004|Overall Study|Lack of Efficacy|4|||
129047866|NCT02504671|464469976|FG005|Overall Study|Lack of Efficacy|4|||
129047867|NCT02504671|464469971|FG000|Overall Study|Adverse Event|1|||
129047868|NCT02504671|464469972|FG001|Overall Study|Adverse Event|1|||
129047869|NCT02504671|464469973|FG002|Overall Study|Adverse Event|0|||
129047870|NCT02504671|464469974|FG003|Overall Study|Adverse Event|1|||
129047871|NCT02504671|464469975|FG004|Overall Study|Adverse Event|0|||
129047872|NCT02504671|464469976|FG005|Overall Study|Adverse Event|2|||
129047873|NCT02504671|464469971|FG000|Overall Study|Protocol Violation|2|||
129047874|NCT02504671|464469972|FG001|Overall Study|Protocol Violation|1|||
129047875|NCT02504671|464469973|FG002|Overall Study|Protocol Violation|0|||
129047876|NCT02504671|464469974|FG003|Overall Study|Protocol Violation|0|||
129047877|NCT02504671|464469975|FG004|Overall Study|Protocol Violation|0|||
129047878|NCT02504671|464469976|FG005|Overall Study|Protocol Violation|1|||
129047879|NCT02504671|464469971|FG000|Overall Study|Lost to Follow-up|0|||
129047880|NCT02504671|464469972|FG001|Overall Study|Lost to Follow-up|0|||
129047881|NCT02504671|464469973|FG002|Overall Study|Lost to Follow-up|2|||
129047882|NCT02504671|464469974|FG003|Overall Study|Lost to Follow-up|0|||
129047883|NCT02504671|464469975|FG004|Overall Study|Lost to Follow-up|0|||
129047884|NCT02504671|464469976|FG005|Overall Study|Lost to Follow-up|1|||
129047885|NCT02504671|464469971|FG000|Overall Study|Protocol defined stopping criteria|7|||
129047886|NCT02504671|464469972|FG001|Overall Study|Protocol defined stopping criteria|4|||
129047887|NCT02504671|464469973|FG002|Overall Study|Protocol defined stopping criteria|3|||
129047888|NCT02504671|464469974|FG003|Overall Study|Protocol defined stopping criteria|5|||
129047889|NCT02504671|464469975|FG004|Overall Study|Protocol defined stopping criteria|3|||
129047890|NCT02504671|464469976|FG005|Overall Study|Protocol defined stopping criteria|3|||
129047891|NCT00599521|464469977|FG000|Overall Study|Lack of Efficacy|4|||
129047892|NCT00599521|464469978|FG001|Overall Study|Lack of Efficacy|8|||
129047893|NCT00599521|464469977|FG000|Overall Study|Adverse Event|4|||
129047894|NCT00599521|464469978|FG001|Overall Study|Adverse Event|1|||
129047895|NCT00599521|464469977|FG000|Overall Study|Withdrawal by Subject|28|||
129047896|NCT00599521|464469978|FG001|Overall Study|Withdrawal by Subject|34|||
129047897|NCT00599521|464469977|FG000|Overall Study|Protocol Violation|1|||
129047898|NCT00599521|464469978|FG001|Overall Study|Protocol Violation|1|||
129047899|NCT00599521|464469977|FG000|Overall Study|Lost to Follow-up|23|||
129047900|NCT00599521|464469978|FG001|Overall Study|Lost to Follow-up|23|||
129047901|NCT00599521|464469977|FG000|Overall Study|Pregnancy|0|||
129047902|NCT00599521|464469978|FG001|Overall Study|Pregnancy|2|||
129047903|NCT04498403|464469979|FG000|Overall Study|Adverse Event|1|||
129047904|NCT04498403|464469980|FG001|Overall Study|Adverse Event|0|||
129047905|NCT04498403|464469979|FG000|Overall Study|Study Terminated By Sponsor|29|||
129047906|NCT04498403|464469980|FG001|Overall Study|Study Terminated By Sponsor|10|||
129047907|NCT01951885|464469982|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
129047908|NCT01951885|464469983|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
129047909|NCT01951885|464469982|FG000|Overall Study|Adverse Event|1|||
129047910|NCT01951885|464469983|FG001|Overall Study|Adverse Event|0|||
129047911|NCT01951885|464469982|FG000|Overall Study|Withdrawal by Subject|0|||
129047912|NCT01951885|464469983|FG001|Overall Study|Withdrawal by Subject|1|||
129047913|NCT01951885|464469982|FG000|Overall Study|ineligible due to a change in donor|0|||
129047914|NCT01951885|464469983|FG001|Overall Study|ineligible due to a change in donor|1|||
129047915|NCT01951885|464469982|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
129047916|NCT01951885|464469983|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
129047917|NCT01206101|464469984|FG000|Overall Study|Adverse Event|1|||
129047918|NCT01206101|464469985|FG001|Overall Study|Adverse Event|0|||
129047919|NCT01206101|464469984|FG000|Overall Study|Physician Decision|0|||
129047920|NCT01206101|464469985|FG001|Overall Study|Physician Decision|1|||
129047921|NCT01206101|464469984|FG000|Overall Study|Unclassified|1|||
129047922|NCT01206101|464469985|FG001|Overall Study|Unclassified|0|||
129047923|NCT02746471|464469989|FG000|Overall Study|Death|43|||
129047924|NCT02746471|464469989|FG000|Overall Study|Exited before 36 months|1119|||
129047925|NCT04594707|464469993|FG000|Overall Study|Adverse Event|0|||
129047926|NCT04594707|464469994|FG001|Overall Study|Adverse Event|0|||
129047927|NCT04594707|464469995|FG002|Overall Study|Adverse Event|1|||
129047928|NCT04594707|464469993|FG000|Overall Study|Death|0|||
129047929|NCT04594707|464469994|FG001|Overall Study|Death|2|||
129047930|NCT04594707|464469995|FG002|Overall Study|Death|2|||
129047931|NCT04594707|464469993|FG000|Overall Study|Lung Transplant|0|||
129047932|NCT04594707|464469994|FG001|Overall Study|Lung Transplant|0|||
129047933|NCT04594707|464469995|FG002|Overall Study|Lung Transplant|1|||
129047934|NCT04594707|464469993|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
129047935|NCT04594707|464469994|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
129047936|NCT04594707|464469995|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
129047937|NCT04594707|464469993|FG000|Overall Study|Study Terminated By Sponsor|19|||
129047938|NCT04594707|464469994|FG001|Overall Study|Study Terminated By Sponsor|47|||
129047939|NCT04594707|464469995|FG002|Overall Study|Study Terminated By Sponsor|41|||
129047940|NCT04594707|464469993|FG000|Overall Study|Withdrawal by Subject|1|||
129047941|NCT04594707|464469994|FG001|Overall Study|Withdrawal by Subject|0|||
129047942|NCT04594707|464469995|FG002|Overall Study|Withdrawal by Subject|2|||
129047943|NCT01593696|464469996|FG000|Dose Escalation|Progressive Disease|2|||
129047944|NCT01593696|464469997|FG001|Dose Escalation|Progressive Disease|0|||
129047945|NCT01593696|464469998|FG002|Dose Escalation|Progressive Disease|0|||
129047946|NCT01593696|464469999|FG003|Dose Escalation|Progressive Disease|0|||
129047947|NCT01593696|464469996|FG000|Dose Expansion|Fungal infection|0|||
129047948|NCT01593696|464469997|FG001|Dose Expansion|Fungal infection|0|||
129047949|NCT01593696|464469998|FG002|Dose Expansion|Fungal infection|1|||
129047950|NCT01593696|464469999|FG003|Dose Expansion|Fungal infection|0|||
129047951|NCT01936623|464470000|FG000|Overall Study|Lost to Follow-up|0|||
129047952|NCT01936623|464470001|FG001|Overall Study|Lost to Follow-up|5|||
129047953|NCT01340768|464470002|FG000|Overall Study|Lost to Follow-up|10|||
129047954|NCT01340768|464470003|FG001|Overall Study|Lost to Follow-up|4|||
129135840|NCT00520572|464791116|FG005|Overall Study|Lack of Efficacy|0|||
129135841|NCT00520572|464791111|FG000|Overall Study|Lost to Follow-up|0|||
129135842|NCT00520572|464791112|FG001|Overall Study|Lost to Follow-up|0|||
129135843|NCT00520572|464791113|FG002|Overall Study|Lost to Follow-up|0|||
129135844|NCT00520572|464791114|FG003|Overall Study|Lost to Follow-up|0|||
129135845|NCT00520572|464791115|FG004|Overall Study|Lost to Follow-up|1|||
129135846|NCT00520572|464791116|FG005|Overall Study|Lost to Follow-up|0|||
129135847|NCT00520572|464791111|FG000|Overall Study|Incorrect enrollment|1|||
129135848|NCT00520572|464791112|FG001|Overall Study|Incorrect enrollment|0|||
129135849|NCT00520572|464791113|FG002|Overall Study|Incorrect enrollment|1|||
129135850|NCT00520572|464791114|FG003|Overall Study|Incorrect enrollment|0|||
129135851|NCT00520572|464791115|FG004|Overall Study|Incorrect enrollment|1|||
129135852|NCT00520572|464791116|FG005|Overall Study|Incorrect enrollment|0|||
129135853|NCT00520572|464791111|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
129135854|NCT00520572|464791112|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
129135855|NCT00520572|464791113|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
129135856|NCT00520572|464791114|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
129135857|NCT00520572|464791115|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
129223284|NCT02112916|465118326|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
129223285|NCT02112916|465118327|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
129047955|NCT01340768|464470002|FG000|Overall Study|Withdrawal by Subject|5|||
129047956|NCT01340768|464470003|FG001|Overall Study|Withdrawal by Subject|1|||
129047957|NCT01340768|464470002|FG000|Overall Study|Other|2|||
129047958|NCT01340768|464470003|FG001|Overall Study|Other|0|||
129047959|NCT03052959|464470008|FG000|Overall Study|Lost to Follow-up|4|||
129047960|NCT03052959|464470009|FG001|Overall Study|Lost to Follow-up|5|||
129047961|NCT00950963|464470010|FG000|Overall Study|Lost to Follow-up|29|||
129047962|NCT00950963|464470011|FG001|Overall Study|Lost to Follow-up|24|||
129047963|NCT00655876|464470012|FG000|Overall Study|Protocol Violation|9|||
129047964|NCT00655876|464470013|FG001|Overall Study|Protocol Violation|7|||
129047965|NCT01831765|464470014|FG000|Overall Study|Lack of Efficacy|1|||
129047966|NCT01831765|464470015|FG001|Overall Study|Lack of Efficacy|0|||
129047967|NCT01831765|464470016|FG002|Overall Study|Lack of Efficacy|0|||
129047968|NCT01831765|464470014|FG000|Overall Study|Other, sponsor withdrew subject|0|||
129223286|NCT02112916|465118324|FG000|Overall Study|Still on Therapy|44|||
129223287|NCT02112916|465118325|FG001|Overall Study|Still on Therapy|47|||
129223288|NCT02112916|465118326|FG002|Overall Study|Still on Therapy|3|||
129047969|NCT01831765|464470015|FG001|Overall Study|Other, sponsor withdrew subject|1|||
129047970|NCT01831765|464470016|FG002|Overall Study|Other, sponsor withdrew subject|0|||
129047971|NCT01831765|464470014|FG000|Overall Study|Pregnancy|1|||
129047972|NCT01831765|464470015|FG001|Overall Study|Pregnancy|1|||
129047973|NCT01831765|464470016|FG002|Overall Study|Pregnancy|2|||
129047974|NCT01831765|464470014|FG000|Overall Study|Death|0|||
129047975|NCT01831765|464470015|FG001|Overall Study|Death|1|||
129047976|NCT01831765|464470016|FG002|Overall Study|Death|1|||
129047977|NCT01831765|464470014|FG000|Overall Study|Other, site closed|1|||
129047978|NCT01831765|464470015|FG001|Overall Study|Other, site closed|1|||
129047979|NCT01831765|464470016|FG002|Overall Study|Other, site closed|0|||
129135858|NCT00520572|464791116|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
129135859|NCT00520572|464791111|FG000|Overall Study|Long break in taking Medication|0|||
129135860|NCT00520572|464791112|FG001|Overall Study|Long break in taking Medication|0|||
129135861|NCT00520572|464791113|FG002|Overall Study|Long break in taking Medication|0|||
129135862|NCT00520572|464791114|FG003|Overall Study|Long break in taking Medication|1|||
129135863|NCT00520572|464791115|FG004|Overall Study|Long break in taking Medication|0|||
129135864|NCT00520572|464791116|FG005|Overall Study|Long break in taking Medication|0|||
129135865|NCT00520572|464791111|FG000|Overall Study|Did not receive Treatment|1|||
129135866|NCT00520572|464791112|FG001|Overall Study|Did not receive Treatment|0|||
129135867|NCT00520572|464791113|FG002|Overall Study|Did not receive Treatment|1|||
129135868|NCT00520572|464791114|FG003|Overall Study|Did not receive Treatment|0|||
129135869|NCT00520572|464791115|FG004|Overall Study|Did not receive Treatment|0|||
129135870|NCT00520572|464791116|FG005|Overall Study|Did not receive Treatment|0|||
129135871|NCT02181621|464791117|FG000|Overall Study|Adverse Event|1|||
129135872|NCT02181621|464791118|FG001|Overall Study|Adverse Event|0|||
129135873|NCT02181621|464791117|FG000|Overall Study|Previously Enrolled|0|||
129135874|NCT02181621|464791118|FG001|Overall Study|Previously Enrolled|1|||
129135875|NCT02181621|464791117|FG000|Overall Study|Enrollment Hold|1|||
129135876|NCT02181621|464791118|FG001|Overall Study|Enrollment Hold|1|||
129135877|NCT00960856|464791119|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129135878|NCT00960856|464791120|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
129135879|NCT00960856|464791121|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
129135880|NCT00960856|464791122|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
129135881|NCT00960856|464791119|FG000|Washout Period of 7 Days|Adverse Event|0|||
129135882|NCT00960856|464791120|FG001|Washout Period of 7 Days|Adverse Event|0|||
129135883|NCT00960856|464791121|FG002|Washout Period of 7 Days|Adverse Event|1|||
129135884|NCT00960856|464791122|FG003|Washout Period of 7 Days|Adverse Event|0|||
129135885|NCT03387046|464791124|FG000|Overall Study|Adverse Event|1|||
129135886|NCT03387046|464791125|FG001|Overall Study|Adverse Event|1|||
129135887|NCT03794544|464791127|FG000|Overall Study|Withdrawal by Subject|1|||
129135888|NCT03794544|464791128|FG001|Overall Study|Withdrawal by Subject|1|||
129135889|NCT03794544|464791129|FG002|Overall Study|Withdrawal by Subject|0|||
129135890|NCT03794544|464791130|FG003|Overall Study|Withdrawal by Subject|0|||
129135891|NCT03794544|464791127|FG000|Overall Study|Death|0|||
129135892|NCT03794544|464791128|FG001|Overall Study|Death|0|||
129135893|NCT03794544|464791129|FG002|Overall Study|Death|0|||
129135894|NCT03794544|464791130|FG003|Overall Study|Death|1|||
129135895|NCT03794544|464791127|FG000|Overall Study|Lost to Follow-up|0|||
129047980|NCT01831765|464470014|FG000|Overall Study|Adverse Event|5|||
129047981|NCT01831765|464470015|FG001|Overall Study|Adverse Event|3|||
129047982|NCT01831765|464470016|FG002|Overall Study|Adverse Event|3|||
129047983|NCT01831765|464470014|FG000|Overall Study|Withdrawal by Subject|22|||
129047984|NCT01831765|464470015|FG001|Overall Study|Withdrawal by Subject|7|||
129047985|NCT01831765|464470016|FG002|Overall Study|Withdrawal by Subject|17|||
129047986|NCT01831765|464470014|FG000|Overall Study|Withdrawal criteria|12|||
129047987|NCT01831765|464470015|FG001|Overall Study|Withdrawal criteria|10|||
129047988|NCT01831765|464470016|FG002|Overall Study|Withdrawal criteria|16|||
129047989|NCT01831765|464470014|FG000|Overall Study|Lost to Follow-up|2|||
129047990|NCT01831765|464470015|FG001|Overall Study|Lost to Follow-up|3|||
129047991|NCT01831765|464470016|FG002|Overall Study|Lost to Follow-up|3|||
129047992|NCT00928707|464470018|FG000|Overall Study|Protocol Violation|1|||
129047993|NCT00928707|464470019|FG001|Overall Study|Protocol Violation|0|||
129047994|NCT00132028|464470020|FG000|Overall Study|Adverse Event|7|||
129047995|NCT00132028|464470020|FG000|Overall Study|Death|2|||
129047996|NCT00132028|464470020|FG000|Overall Study|Lack of Efficacy|11|||
129047997|NCT00132028|464470020|FG000|Overall Study|Withdrawal by Subject|2|||
129047998|NCT00132028|464470020|FG000|Overall Study|not eligible|2|||
129047999|NCT00132028|464470020|FG000|Overall Study|Physician Decision|3|||
129048000|NCT04647721|464470021|FG000|Overall Study|Withdrawal by Subject|0|||
129048001|NCT04647721|464470022|FG001|Overall Study|Withdrawal by Subject|2|||
129048002|NCT04647721|464470021|FG000|Overall Study|Lost to Follow-up|2|||
129048003|NCT04647721|464470022|FG001|Overall Study|Lost to Follow-up|0|||
129048004|NCT05070546|464470023|FG000|Overall Study|Death|0|||
129048005|NCT05070546|464470024|FG001|Overall Study|Death|0|||
129048006|NCT05070546|464470025|FG002|Overall Study|Death|0|||
129048007|NCT05070546|464470026|FG003|Overall Study|Death|0|||
129135896|NCT03794544|464791128|FG001|Overall Study|Lost to Follow-up|1|||
129135897|NCT03794544|464791129|FG002|Overall Study|Lost to Follow-up|1|||
129135898|NCT03794544|464791130|FG003|Overall Study|Lost to Follow-up|0|||
129135899|NCT03794544|464791127|FG000|Overall Study|Other|0|||
129135900|NCT03794544|464791128|FG001|Overall Study|Other|1|||
129135901|NCT03794544|464791129|FG002|Overall Study|Other|0|||
129048008|NCT05070546|464470027|FG004|Overall Study|Death|0|||
129048009|NCT05070546|464470028|FG005|Overall Study|Death|1|||
129135902|NCT03794544|464791130|FG003|Overall Study|Other|0|||
129135903|NCT00120250|464791133|FG000|Overall Study|Lost to Follow-up|1|||
129135904|NCT00120250|464791134|FG001|Overall Study|Lost to Follow-up|1|||
129135905|NCT00120250|464791133|FG000|Overall Study|Protocol Violation|0|||
129135906|NCT00120250|464791134|FG001|Overall Study|Protocol Violation|1|||
129048010|NCT05070546|464470023|FG000|Overall Study|Lost to Follow-up|8|||
129048011|NCT05070546|464470024|FG001|Overall Study|Lost to Follow-up|2|||
129048012|NCT05070546|464470025|FG002|Overall Study|Lost to Follow-up|7|||
129048013|NCT05070546|464470026|FG003|Overall Study|Lost to Follow-up|1|||
129135907|NCT00337194|464791137|FG000|Overall Study|Adverse Event|5|||
128775434|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128775435|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129048014|NCT05070546|464470027|FG004|Overall Study|Lost to Follow-up|2|||
129048015|NCT05070546|464470028|FG005|Overall Study|Lost to Follow-up|0|||
129048016|NCT05070546|464470023|FG000|Overall Study|Withdrawal by Subject|1|||
129048017|NCT05070546|464470024|FG001|Overall Study|Withdrawal by Subject|1|||
129048018|NCT05070546|464470025|FG002|Overall Study|Withdrawal by Subject|3|||
129048019|NCT05070546|464470026|FG003|Overall Study|Withdrawal by Subject|0|||
129048020|NCT05070546|464470027|FG004|Overall Study|Withdrawal by Subject|0|||
129048021|NCT05070546|464470028|FG005|Overall Study|Withdrawal by Subject|0|||
129048022|NCT05070546|464470023|FG000|Overall Study|Other|0|||
129048023|NCT05070546|464470024|FG001|Overall Study|Other|0|||
129048024|NCT05070546|464470025|FG002|Overall Study|Other|0|||
129048025|NCT05070546|464470026|FG003|Overall Study|Other|0|||
129048026|NCT05070546|464470027|FG004|Overall Study|Other|3|||
129048027|NCT05070546|464470028|FG005|Overall Study|Other|0|||
129048028|NCT05070546|464470023|FG000|Overall Study|Randomized but not vaccinated|1|||
129048029|NCT05070546|464470024|FG001|Overall Study|Randomized but not vaccinated|0|||
129048030|NCT05070546|464470025|FG002|Overall Study|Randomized but not vaccinated|1|||
129048031|NCT05070546|464470026|FG003|Overall Study|Randomized but not vaccinated|1|||
129048032|NCT05070546|464470027|FG004|Overall Study|Randomized but not vaccinated|3|||
129048033|NCT05070546|464470028|FG005|Overall Study|Randomized but not vaccinated|0|||
129048034|NCT00816361|464470033|FG000|Overall Study|Withdrawal by Subject|0|||
129048035|NCT00816361|464470034|FG001|Overall Study|Withdrawal by Subject|0|||
129048036|NCT00816361|464470035|FG002|Overall Study|Withdrawal by Subject|0|||
129048037|NCT00816361|464470036|FG003|Overall Study|Withdrawal by Subject|0|||
129048038|NCT00816361|464470037|FG004|Overall Study|Withdrawal by Subject|1|||
129048039|NCT00816361|464470038|FG005|Overall Study|Withdrawal by Subject|2|||
129048040|NCT00816361|464470039|FG006|Overall Study|Withdrawal by Subject|0|||
129048041|NCT00816361|464470040|FG007|Overall Study|Withdrawal by Subject|2|||
129048042|NCT00816361|464470041|FG008|Overall Study|Withdrawal by Subject|1|||
129048043|NCT00816361|464470033|FG000|Overall Study|Death|4|||
129048044|NCT00816361|464470034|FG001|Overall Study|Death|3|||
129048045|NCT00816361|464470035|FG002|Overall Study|Death|3|||
129048046|NCT00816361|464470036|FG003|Overall Study|Death|3|||
129048047|NCT00816361|464470037|FG004|Overall Study|Death|1|||
129048048|NCT00816361|464470038|FG005|Overall Study|Death|1|||
129048049|NCT00816361|464470039|FG006|Overall Study|Death|3|||
129048050|NCT00816361|464470040|FG007|Overall Study|Death|7|||
129048051|NCT00816361|464470041|FG008|Overall Study|Death|8|||
129048052|NCT00816361|464470033|FG000|Overall Study|Other|0|||
129048053|NCT00816361|464470034|FG001|Overall Study|Other|0|||
129048054|NCT00816361|464470035|FG002|Overall Study|Other|0|||
129048055|NCT00816361|464470036|FG003|Overall Study|Other|0|||
129048056|NCT00816361|464470037|FG004|Overall Study|Other|0|||
129048057|NCT00816361|464470038|FG005|Overall Study|Other|0|||
129048058|NCT00816361|464470039|FG006|Overall Study|Other|0|||
129048059|NCT00816361|464470040|FG007|Overall Study|Other|0|||
129048060|NCT00816361|464470041|FG008|Overall Study|Other|1|||
129048061|NCT00546572|464470042|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
129048062|NCT00546572|464470043|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
129048063|NCT00546572|464470042|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
129048064|NCT00546572|464470043|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
129048065|NCT00546572|464470042|FG000|Vax 1 / Year 0|Protocol Violation|3|||
129048066|NCT00546572|464470043|FG001|Vax 1 / Year 0|Protocol Violation|4|||
129048067|NCT00546572|464470042|FG000|Vax 1 / Year 0|Death|2|||
129048068|NCT00546572|464470043|FG001|Vax 1 / Year 0|Death|2|||
129048069|NCT00546572|464470042|FG000|Vax 1 / Year 0|Adverse Event|0|||
129048070|NCT00546572|464470043|FG001|Vax 1 / Year 0|Adverse Event|1|||
129048071|NCT00546572|464470042|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
129048072|NCT00546572|464470043|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
129048073|NCT00546572|464470042|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
128775436|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129048074|NCT00546572|464470043|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
129048075|NCT00546572|464470042|FG000|Vax 2 / Year 1|Other|1|||
129048076|NCT00546572|464470043|FG001|Vax 2 / Year 1|Other|1|||
129048077|NCT00546572|464470042|FG000|Vax 2 / Year 1|Adverse Event|1|||
129048078|NCT00546572|464470043|FG001|Vax 2 / Year 1|Adverse Event|0|||
129048079|NCT00546572|464470042|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
129048080|NCT00546572|464470043|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
129048081|NCT00741936|464470049|FG000|Overall Study|Lost to Follow-up|1|||
129048082|NCT00741936|464470050|FG001|Overall Study|Lost to Follow-up|1|||
129048083|NCT00741936|464470049|FG000|Overall Study|Adverse Event|3|||
129048084|NCT00741936|464470050|FG001|Overall Study|Adverse Event|4|||
129048085|NCT00741936|464470049|FG000|Overall Study|Pregnancy|0|||
129048086|NCT00741936|464470050|FG001|Overall Study|Pregnancy|1|||
129048087|NCT00741936|464470049|FG000|Overall Study|Protocol Violation|2|||
129048088|NCT00741936|464470050|FG001|Overall Study|Protocol Violation|0|||
129048089|NCT00741936|464470049|FG000|Overall Study|Lack of Efficacy|0|||
129048090|NCT00741936|464470050|FG001|Overall Study|Lack of Efficacy|2|||
129048091|NCT00741936|464470049|FG000|Overall Study|Low compliance|3|||
129048092|NCT00741936|464470050|FG001|Overall Study|Low compliance|0|||
129048093|NCT01408628|464470051|FG000|Consented|Withdrawal by Subject|12|||
129048094|NCT01408628|464470051|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
129048095|NCT01408628|464470051|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
129048096|NCT01408628|464470051|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
129048097|NCT01941940|464470052|FG000|Overall Study|Adverse Event|11|||
129048098|NCT01941940|464470052|FG000|Overall Study|Lost to Follow-up|2|||
129048099|NCT01941940|464470052|FG000|Overall Study|Physician Decision|2|||
129048100|NCT01941940|464470052|FG000|Overall Study|Withdrawal by Subject|15|||
129048101|NCT01941940|464470052|FG000|Overall Study|Death|1|||
129048102|NCT01941940|464470052|FG000|Overall Study|Other|1|||
129048103|NCT01941940|464470052|FG000|Overall Study|Other|1|||
129048104|NCT00750308|464470053|FG000|First Treatment|Adverse Event|0|||
129048105|NCT00750308|464470054|FG001|First Treatment|Adverse Event|1|||
129048106|NCT00750308|464470055|FG002|First Treatment|Adverse Event|0|||
129048107|NCT00750308|464470056|FG003|First Treatment|Adverse Event|0|||
129048108|NCT00750308|464470057|FG004|First Treatment|Adverse Event|0|||
129048109|NCT00750308|464470058|FG005|First Treatment|Adverse Event|0|||
129048110|NCT00750308|464470059|FG006|First Treatment|Adverse Event|0|||
129048111|NCT00750308|464470060|FG007|First Treatment|Adverse Event|0|||
129048112|NCT00750308|464470061|FG008|First Treatment|Adverse Event|0|||
129048113|NCT00750308|464470062|FG009|First Treatment|Adverse Event|0|||
129048114|NCT00750308|464470063|FG010|First Treatment|Adverse Event|1|||
129048115|NCT00750308|464470064|FG011|First Treatment|Adverse Event|1|||
129048116|NCT00750308|464470053|FG000|First Treatment|Withdrawal by Subject|0|||
129048117|NCT00750308|464470054|FG001|First Treatment|Withdrawal by Subject|0|||
129048118|NCT00750308|464470055|FG002|First Treatment|Withdrawal by Subject|0|||
129048119|NCT00750308|464470056|FG003|First Treatment|Withdrawal by Subject|1|||
129048120|NCT00750308|464470057|FG004|First Treatment|Withdrawal by Subject|0|||
129048121|NCT00750308|464470058|FG005|First Treatment|Withdrawal by Subject|0|||
129048122|NCT00750308|464470059|FG006|First Treatment|Withdrawal by Subject|0|||
129048123|NCT00750308|464470060|FG007|First Treatment|Withdrawal by Subject|1|||
129048124|NCT00750308|464470061|FG008|First Treatment|Withdrawal by Subject|0|||
129048125|NCT00750308|464470062|FG009|First Treatment|Withdrawal by Subject|0|||
129048126|NCT00750308|464470063|FG010|First Treatment|Withdrawal by Subject|0|||
129048127|NCT00750308|464470064|FG011|First Treatment|Withdrawal by Subject|0|||
129048128|NCT00750308|464470053|FG000|Second Treatment|Adverse Event|0|||
129048129|NCT00750308|464470054|FG001|Second Treatment|Adverse Event|0|||
129048130|NCT00750308|464470055|FG002|Second Treatment|Adverse Event|0|||
129048131|NCT00750308|464470056|FG003|Second Treatment|Adverse Event|0|||
129048132|NCT00750308|464470057|FG004|Second Treatment|Adverse Event|0|||
129135908|NCT00337194|464791138|FG001|Overall Study|Adverse Event|1|||
129135909|NCT00337194|464791137|FG000|Overall Study|Death|2|||
129135910|NCT00337194|464791138|FG001|Overall Study|Death|0|||
129135911|NCT00337194|464791137|FG000|Overall Study|Withdrawal by Subject|1|||
129135912|NCT00337194|464791138|FG001|Overall Study|Withdrawal by Subject|0|||
129135913|NCT00337194|464791137|FG000|Overall Study|Disease progression|1|||
129135914|NCT00337194|464791138|FG001|Overall Study|Disease progression|2|||
129135915|NCT00337194|464791137|FG000|Overall Study|Subsequent non-protocol therapy|3|||
129135916|NCT00337194|464791138|FG001|Overall Study|Subsequent non-protocol therapy|1|||
129135917|NCT03188705|464791139|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
129135918|NCT03188705|464791139|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
129135919|NCT04389671|464791140|FG000|Overall Study|Death|7|||
129135920|NCT03994120|464791141|FG000|Overall Study|Lost to Follow-up|3|||
129135921|NCT03994120|464791142|FG001|Overall Study|Lost to Follow-up|1|||
129135922|NCT00609973|464791147|FG000|Overall Study|Adverse Event|2|||
129135923|NCT00609973|464791148|FG001|Overall Study|Adverse Event|1|||
129135924|NCT00609973|464791147|FG000|Overall Study|Protocol Violation|4|||
129135925|NCT00609973|464791148|FG001|Overall Study|Protocol Violation|3|||
129135926|NCT00609973|464791147|FG000|Overall Study|Lost to Follow-up|2|||
129135927|NCT00609973|464791148|FG001|Overall Study|Lost to Follow-up|1|||
129135928|NCT00609973|464791147|FG000|Overall Study|Withdrawal by Subject|0|||
129135929|NCT00609973|464791148|FG001|Overall Study|Withdrawal by Subject|1|||
129048133|NCT00750308|464470058|FG005|Second Treatment|Adverse Event|1|||
129048134|NCT00750308|464470059|FG006|Second Treatment|Adverse Event|0|||
129048135|NCT00750308|464470060|FG007|Second Treatment|Adverse Event|0|||
129048136|NCT00750308|464470061|FG008|Second Treatment|Adverse Event|1|||
129048137|NCT00750308|464470062|FG009|Second Treatment|Adverse Event|0|||
129048138|NCT00750308|464470063|FG010|Second Treatment|Adverse Event|0|||
129048139|NCT00750308|464470064|FG011|Second Treatment|Adverse Event|0|||
129135930|NCT00191152|464791149|FG000|Initial Treatment|Adverse Event|43|||
129135931|NCT00191152|464791150|FG001|Initial Treatment|Adverse Event|67|||
129135932|NCT00191152|464791149|FG000|Initial Treatment|Physician Decision|40|||
129048140|NCT00750308|464470053|FG000|Second Treatment|Withdrawal by Subject|0|||
129135933|NCT00191152|464791150|FG001|Initial Treatment|Physician Decision|31|||
129135934|NCT00191152|464791149|FG000|Initial Treatment|Withdrawal by Subject|40|||
129135935|NCT00191152|464791150|FG001|Initial Treatment|Withdrawal by Subject|28|||
129135936|NCT00191152|464791149|FG000|Initial Treatment|Lost to Follow-up|0|||
129048141|NCT00750308|464470054|FG001|Second Treatment|Withdrawal by Subject|0|||
129048142|NCT00750308|464470055|FG002|Second Treatment|Withdrawal by Subject|0|||
129048143|NCT00750308|464470056|FG003|Second Treatment|Withdrawal by Subject|0|||
129048144|NCT00750308|464470057|FG004|Second Treatment|Withdrawal by Subject|1|||
129048145|NCT00750308|464470058|FG005|Second Treatment|Withdrawal by Subject|0|||
129048146|NCT00750308|464470059|FG006|Second Treatment|Withdrawal by Subject|0|||
129048147|NCT00750308|464470060|FG007|Second Treatment|Withdrawal by Subject|0|||
129048148|NCT00750308|464470061|FG008|Second Treatment|Withdrawal by Subject|0|||
129048149|NCT00750308|464470062|FG009|Second Treatment|Withdrawal by Subject|0|||
129048150|NCT00750308|464470063|FG010|Second Treatment|Withdrawal by Subject|0|||
129048151|NCT00750308|464470064|FG011|Second Treatment|Withdrawal by Subject|0|||
129048152|NCT00750308|464470053|FG000|Third Treatment|Withdrawal by Subject|0|||
129048153|NCT00750308|464470054|FG001|Third Treatment|Withdrawal by Subject|1|||
129048154|NCT00750308|464470055|FG002|Third Treatment|Withdrawal by Subject|0|||
129048155|NCT00750308|464470056|FG003|Third Treatment|Withdrawal by Subject|0|||
129048156|NCT00750308|464470057|FG004|Third Treatment|Withdrawal by Subject|0|||
129048157|NCT00750308|464470058|FG005|Third Treatment|Withdrawal by Subject|0|||
129048158|NCT00750308|464470059|FG006|Third Treatment|Withdrawal by Subject|0|||
129048159|NCT00750308|464470060|FG007|Third Treatment|Withdrawal by Subject|0|||
129048160|NCT00750308|464470061|FG008|Third Treatment|Withdrawal by Subject|0|||
129048161|NCT00750308|464470062|FG009|Third Treatment|Withdrawal by Subject|0|||
129048162|NCT00750308|464470063|FG010|Third Treatment|Withdrawal by Subject|0|||
129048163|NCT00750308|464470064|FG011|Third Treatment|Withdrawal by Subject|0|||
129048164|NCT00513682|464470065|FG000|Washout Phase|Adverse Event|2|||
129048165|NCT02450526|464470066|FG000|DB Period (Cycle 1)|Adverse Event|0|||
129048166|NCT02450526|464470067|FG001|DB Period (Cycle 1)|Adverse Event|0|||
129048167|NCT02450526|464470068|FG002|DB Period (Cycle 1)|Adverse Event|2|||
129048168|NCT02450526|464470069|FG003|DB Period (Cycle 1)|Adverse Event|0|||
129048169|NCT02450526|464470070|FG004|DB Period (Cycle 1)|Adverse Event|0|||
129048170|NCT02450526|464470066|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
129048171|NCT02450526|464470067|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
129048172|NCT02450526|464470068|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
129048173|NCT02450526|464470069|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
129048174|NCT02450526|464470070|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
129048175|NCT02450526|464470066|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
129048176|NCT02450526|464470067|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
129048177|NCT02450526|464470068|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
129048178|NCT02450526|464470069|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
129048179|NCT02450526|464470070|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
129048180|NCT02450526|464470066|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
129048181|NCT02450526|464470067|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
129048182|NCT02450526|464470068|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
129048183|NCT02450526|464470069|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
129048184|NCT02450526|464470070|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
129048185|NCT02450526|464470066|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
129048186|NCT02450526|464470067|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
129048187|NCT02450526|464470068|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
129048188|NCT02450526|464470069|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
129048189|NCT02450526|464470070|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
129048190|NCT02450526|464470066|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129048191|NCT02450526|464470067|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129048192|NCT02450526|464470068|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129048193|NCT02450526|464470069|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129048194|NCT02450526|464470070|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
129048195|NCT02450526|464470066|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129048196|NCT02450526|464470067|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129048197|NCT02450526|464470068|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129048198|NCT02450526|464470069|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129048199|NCT02450526|464470070|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
129048200|NCT02450526|464470066|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
129048201|NCT02450526|464470067|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
129048202|NCT02450526|464470068|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
129048203|NCT02450526|464470069|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
129048204|NCT02450526|464470070|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
129048205|NCT03212521|464470071|FG000|Overall Study|Adverse Event|1|||
129048206|NCT03212521|464470071|FG000|Overall Study|Lost to Follow-up|4|||
129048207|NCT03212521|464470071|FG000|Overall Study|Withdrawal by Subject|1|||
129048208|NCT03212521|464470071|FG000|Overall Study|Other|1|||
129048209|NCT02435836|464470072|FG000|Overall Study|Lost to Follow-up|21|||
129048210|NCT02435836|464470072|FG000|Overall Study|Lack of Efficacy|1|||
129048211|NCT02435836|464470072|FG000|Overall Study|Withdrawal by Subject|236|||
129048212|NCT02435836|464470072|FG000|Overall Study|Insufficient Clinical Response|26|||
129048213|NCT02435836|464470072|FG000|Overall Study|Adverse Event|44|||
129048214|NCT02435836|464470072|FG000|Overall Study|Sponsor discontinued trial|167|||
129048215|NCT02435836|464470072|FG000|Overall Study|Noncompliance|27|||
129048216|NCT02435836|464470072|FG000|Overall Study|Protocol Violation|6|||
128719380|NCT02584504|463271055|FG001|Open-label Treatment|Physician Decision|1|||
129048217|NCT02435836|464470072|FG000|Overall Study|Met Withdrawal Criteria|7|||
129048218|NCT02435836|464470072|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
129048219|NCT01970865|464470073|FG000|Overall Study|Death|3|||
129048220|NCT01970865|464470074|FG001|Overall Study|Death|2|||
129048221|NCT01970865|464470075|FG002|Overall Study|Death|3|||
129048222|NCT01970865|464470076|FG003|Overall Study|Death|6|||
129048223|NCT01970865|464470077|FG004|Overall Study|Death|9|||
129048224|NCT01970865|464470078|FG005|Overall Study|Death|3|||
129048225|NCT01970865|464470079|FG006|Overall Study|Death|2|||
129048226|NCT01970865|464470080|FG007|Overall Study|Death|3|||
129048227|NCT01970865|464470081|FG008|Overall Study|Death|2|||
129048228|NCT01970865|464470082|FG009|Overall Study|Death|2|||
129048229|NCT01970865|464470083|FG010|Overall Study|Death|8|||
129048230|NCT01970865|464470084|FG011|Overall Study|Death|13|||
129048231|NCT01970865|464470085|FG012|Overall Study|Death|25|||
129048232|NCT01970865|464470086|FG013|Overall Study|Death|46|||
129048233|NCT01970865|464470087|FG014|Overall Study|Death|37|||
129048234|NCT01970865|464470088|FG015|Overall Study|Death|22|||
129048235|NCT01970865|464470089|FG016|Overall Study|Death|1|||
129048236|NCT01970865|464470090|FG017|Overall Study|Death|17|||
129048237|NCT01970865|464470073|FG000|Overall Study|Lost to Follow-up|0|||
129048238|NCT01970865|464470074|FG001|Overall Study|Lost to Follow-up|0|||
129048239|NCT01970865|464470075|FG002|Overall Study|Lost to Follow-up|0|||
129048240|NCT01970865|464470076|FG003|Overall Study|Lost to Follow-up|1|||
129048241|NCT01970865|464470077|FG004|Overall Study|Lost to Follow-up|1|||
129048242|NCT01970865|464470078|FG005|Overall Study|Lost to Follow-up|0|||
129048243|NCT01970865|464470079|FG006|Overall Study|Lost to Follow-up|0|||
128719381|NCT02584504|463271056|FG002|Open-label Treatment|Physician Decision|0|||
129048244|NCT01970865|464470080|FG007|Overall Study|Lost to Follow-up|0|||
129048245|NCT01970865|464470081|FG008|Overall Study|Lost to Follow-up|0|||
129048246|NCT01970865|464470082|FG009|Overall Study|Lost to Follow-up|0|||
129223289|NCT02112916|465118327|FG003|Overall Study|Still on Therapy|2|||
129048247|NCT01970865|464470083|FG010|Overall Study|Lost to Follow-up|1|||
129048248|NCT01970865|464470084|FG011|Overall Study|Lost to Follow-up|0|||
129048249|NCT01970865|464470085|FG012|Overall Study|Lost to Follow-up|2|||
129048250|NCT01970865|464470086|FG013|Overall Study|Lost to Follow-up|0|||
129048251|NCT01970865|464470087|FG014|Overall Study|Lost to Follow-up|1|||
129048252|NCT01970865|464470088|FG015|Overall Study|Lost to Follow-up|4|||
129048253|NCT01970865|464470089|FG016|Overall Study|Lost to Follow-up|0|||
129048254|NCT01970865|464470090|FG017|Overall Study|Lost to Follow-up|1|||
129048255|NCT01970865|464470073|FG000|Overall Study|Other|0|||
129048256|NCT01970865|464470074|FG001|Overall Study|Other|1|||
129048257|NCT01970865|464470075|FG002|Overall Study|Other|0|||
129048258|NCT01970865|464470076|FG003|Overall Study|Other|1|||
129048259|NCT01970865|464470077|FG004|Overall Study|Other|1|||
129048260|NCT01970865|464470078|FG005|Overall Study|Other|0|||
129048261|NCT01970865|464470079|FG006|Overall Study|Other|1|||
129048262|NCT01970865|464470080|FG007|Overall Study|Other|0|||
129048263|NCT01970865|464470081|FG008|Overall Study|Other|0|||
129048264|NCT01970865|464470082|FG009|Overall Study|Other|0|||
129048265|NCT01970865|464470083|FG010|Overall Study|Other|2|||
129048266|NCT01970865|464470084|FG011|Overall Study|Other|3|||
129048267|NCT01970865|464470085|FG012|Overall Study|Other|8|||
129048268|NCT01970865|464470086|FG013|Overall Study|Other|3|||
129048269|NCT01970865|464470087|FG014|Overall Study|Other|2|||
129048270|NCT01970865|464470088|FG015|Overall Study|Other|3|||
129048271|NCT01970865|464470089|FG016|Overall Study|Other|0|||
129048272|NCT01970865|464470090|FG017|Overall Study|Other|2|||
129048273|NCT01970865|464470073|FG000|Overall Study|Participant refused further follow-up|0|||
129048274|NCT01970865|464470074|FG001|Overall Study|Participant refused further follow-up|0|||
129048275|NCT01970865|464470075|FG002|Overall Study|Participant refused further follow-up|0|||
129048276|NCT01970865|464470076|FG003|Overall Study|Participant refused further follow-up|2|||
129048277|NCT01970865|464470077|FG004|Overall Study|Participant refused further follow-up|3|||
129048278|NCT01970865|464470078|FG005|Overall Study|Participant refused further follow-up|0|||
128719382|NCT02584504|463271054|FG000|Open-label Treatment|Entered but not treated|0|||
129048279|NCT01970865|464470079|FG006|Overall Study|Participant refused further follow-up|0|||
129048280|NCT01970865|464470080|FG007|Overall Study|Participant refused further follow-up|0|||
129048281|NCT01970865|464470081|FG008|Overall Study|Participant refused further follow-up|0|||
129223290|NCT02112916|465118324|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
129048282|NCT01970865|464470082|FG009|Overall Study|Participant refused further follow-up|0|||
129223291|NCT02112916|465118325|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
129048283|NCT01970865|464470083|FG010|Overall Study|Participant refused further follow-up|1|||
129048284|NCT01970865|464470084|FG011|Overall Study|Participant refused further follow-up|4|||
129048285|NCT01970865|464470085|FG012|Overall Study|Participant refused further follow-up|7|||
129048286|NCT01970865|464470086|FG013|Overall Study|Participant refused further follow-up|8|||
129048287|NCT01970865|464470087|FG014|Overall Study|Participant refused further follow-up|3|||
129048288|NCT01970865|464470088|FG015|Overall Study|Participant refused further follow-up|11|||
129048289|NCT01970865|464470089|FG016|Overall Study|Participant refused further follow-up|0|||
129048290|NCT01970865|464470090|FG017|Overall Study|Participant refused further follow-up|6|||
129135937|NCT00191152|464791150|FG001|Initial Treatment|Lost to Follow-up|6|||
129135938|NCT00191152|464791149|FG000|Initial Treatment|Other|18|||
129135939|NCT00191152|464791150|FG001|Initial Treatment|Other|21|||
128719383|NCT02584504|463271055|FG001|Open-label Treatment|Entered but not treated|1|||
128719384|NCT02584504|463271056|FG002|Open-label Treatment|Entered but not treated|1|||
129048291|NCT02041091|464470093|FG000|Treatment|Adverse Event|3|||
129048292|NCT02041091|464470094|FG001|Treatment|Adverse Event|3|||
129048293|NCT02041091|464470093|FG000|Treatment|Withdrawal by Subject|2|||
129048294|NCT02041091|464470094|FG001|Treatment|Withdrawal by Subject|4|||
129048295|NCT02041091|464470093|FG000|Treatment|Physician Decision|1|||
129048296|NCT02041091|464470094|FG001|Treatment|Physician Decision|0|||
129048297|NCT02041091|464470093|FG000|Treatment|Sponsor Decision|15|||
129048298|NCT02041091|464470094|FG001|Treatment|Sponsor Decision|16|||
129048299|NCT02041091|464470093|FG000|Treatment|Lost to Follow-up|1|||
129048300|NCT02041091|464470094|FG001|Treatment|Lost to Follow-up|0|||
129048301|NCT02041091|464470093|FG000|Optional Safety Extension Period|Adverse Event|4|||
129048302|NCT02041091|464470094|FG001|Optional Safety Extension Period|Adverse Event|2|||
129048303|NCT02041091|464470093|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
129048304|NCT02041091|464470094|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
129048305|NCT02041091|464470093|FG000|Optional Safety Extension Period|Protocol Violation|2|||
129048306|NCT02041091|464470094|FG001|Optional Safety Extension Period|Protocol Violation|0|||
129048307|NCT02041091|464470093|FG000|Optional Safety Extension Period|Physician Decision|2|||
129048308|NCT02041091|464470094|FG001|Optional Safety Extension Period|Physician Decision|1|||
129048309|NCT02041091|464470093|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
129048310|NCT02041091|464470094|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
129048311|NCT02041091|464470093|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
129048312|NCT02041091|464470094|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
129048313|NCT01855074|464470095|FG000|Overall Study|Adverse Event|1|||
129048314|NCT01855074|464470095|FG000|Overall Study|Lost to Follow-up|4|||
129048315|NCT01855074|464470095|FG000|Overall Study|Withdrawal by Subject|8|||
129048316|NCT01855074|464470095|FG000|Overall Study|Started but not treated|1|||
129048317|NCT01150890|464470096|FG000|Overall Study|Other|0|||
129048318|NCT01150890|464470097|FG001|Overall Study|Other|1|||
129048319|NCT01150890|464470098|FG002|Overall Study|Other|0|||
129048320|NCT01150890|464470099|FG003|Overall Study|Other|2|||
129048321|NCT01150890|464470096|FG000|Overall Study|Pregnancy|0|||
129048322|NCT01150890|464470097|FG001|Overall Study|Pregnancy|0|||
129048323|NCT01150890|464470098|FG002|Overall Study|Pregnancy|0|||
129048324|NCT01150890|464470099|FG003|Overall Study|Pregnancy|1|||
129048325|NCT01150890|464470096|FG000|Overall Study|Administrative Decision|4|||
129048326|NCT01150890|464470097|FG001|Overall Study|Administrative Decision|4|||
129048327|NCT01150890|464470098|FG002|Overall Study|Administrative Decision|5|||
129048328|NCT01150890|464470099|FG003|Overall Study|Administrative Decision|6|||
129048329|NCT01150890|464470096|FG000|Overall Study|Ineligibility determined|0|||
129048330|NCT01150890|464470097|FG001|Overall Study|Ineligibility determined|1|||
129048331|NCT01150890|464470098|FG002|Overall Study|Ineligibility determined|0|||
129048332|NCT01150890|464470099|FG003|Overall Study|Ineligibility determined|0|||
129048333|NCT01150890|464470096|FG000|Overall Study|Adverse Event|0|||
129048334|NCT01150890|464470097|FG001|Overall Study|Adverse Event|0|||
129048335|NCT01150890|464470098|FG002|Overall Study|Adverse Event|2|||
129048336|NCT01150890|464470099|FG003|Overall Study|Adverse Event|0|||
129048337|NCT01150890|464470096|FG000|Overall Study|Withdrawal by Subject|0|||
129048338|NCT01150890|464470097|FG001|Overall Study|Withdrawal by Subject|0|||
129048339|NCT01150890|464470098|FG002|Overall Study|Withdrawal by Subject|2|||
129048340|NCT01150890|464470099|FG003|Overall Study|Withdrawal by Subject|1|||
129048341|NCT01150890|464470096|FG000|Overall Study|Disease progression|0|||
129048342|NCT01150890|464470097|FG001|Overall Study|Disease progression|7|||
129048343|NCT01150890|464470098|FG002|Overall Study|Disease progression|3|||
129048344|NCT01150890|464470099|FG003|Overall Study|Disease progression|7|||
129048345|NCT00922987|464470100|FG000|Overall Study|Insufficient clinical response|1|||
129135940|NCT00191152|464791149|FG000|Crossover Treatment|Adverse Event|8|||
129135941|NCT00191152|464791150|FG001|Crossover Treatment|Adverse Event|8|||
129048346|NCT00922987|464470100|FG000|Overall Study|Protocol Violation|2|||
129048347|NCT00922987|464470100|FG000|Overall Study|Adverse Event|1|||
129135942|NCT00191152|464791149|FG000|Crossover Treatment|Physician Decision|7|||
129048348|NCT00446199|464470101|FG000|Overall Study|Adverse Event|7|||
129048349|NCT00446199|464470102|FG001|Overall Study|Adverse Event|4|||
129048350|NCT00446199|464470103|FG002|Overall Study|Adverse Event|6|||
129048351|NCT00446199|464470104|FG003|Overall Study|Adverse Event|4|||
129048352|NCT00446199|464470101|FG000|Overall Study|Lost to Follow-up|4|||
129048353|NCT00446199|464470102|FG001|Overall Study|Lost to Follow-up|5|||
129048354|NCT00446199|464470103|FG002|Overall Study|Lost to Follow-up|2|||
129135943|NCT00191152|464791150|FG001|Crossover Treatment|Physician Decision|7|||
129048355|NCT00446199|464470104|FG003|Overall Study|Lost to Follow-up|6|||
129048356|NCT00446199|464470101|FG000|Overall Study|Protocol Violation|1|||
129048357|NCT00446199|464470102|FG001|Overall Study|Protocol Violation|2|||
129135944|NCT00191152|464791149|FG000|Crossover Treatment|Withdrawal by Subject|6|||
129135945|NCT00191152|464791150|FG001|Crossover Treatment|Withdrawal by Subject|9|||
129135946|NCT00191152|464791149|FG000|Crossover Treatment|Lost to Follow-up|2|||
129135947|NCT00191152|464791150|FG001|Crossover Treatment|Lost to Follow-up|1|||
129135948|NCT00191152|464791149|FG000|Crossover Treatment|Other|4|||
129135949|NCT00191152|464791150|FG001|Crossover Treatment|Other|3|||
129135950|NCT00114777|464791154|FG000|Randomization to Month 36|Death|10|||
129135951|NCT00114777|464791155|FG001|Randomization to Month 36|Death|4|||
129135952|NCT00114777|464791156|FG002|Randomization to Month 36|Death|3|||
129135953|NCT00114777|464791154|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
129135954|NCT00114777|464791155|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
129135955|NCT00114777|464791156|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
129135956|NCT00114777|464791154|FG000|Randomization to Month 36|Lack of Efficacy|19|||
129135957|NCT00114777|464791155|FG001|Randomization to Month 36|Lack of Efficacy|15|||
129135958|NCT00114777|464791156|FG002|Randomization to Month 36|Lack of Efficacy|17|||
129135959|NCT00114777|464791154|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
129135960|NCT00114777|464791155|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
129135961|NCT00114777|464791156|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
129135962|NCT00114777|464791154|FG000|Randomization to Month 36|Adverse Event|34|||
129135963|NCT00114777|464791155|FG001|Randomization to Month 36|Adverse Event|35|||
129135964|NCT00114777|464791156|FG002|Randomization to Month 36|Adverse Event|44|||
129135965|NCT00114777|464791154|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
129135966|NCT00114777|464791155|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
129135967|NCT00114777|464791156|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
129135968|NCT00114777|464791154|FG000|Randomization to Month 36|Other|9|||
129135969|NCT00114777|464791155|FG001|Randomization to Month 36|Other|3|||
129135970|NCT00114777|464791156|FG002|Randomization to Month 36|Other|12|||
129135971|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Death|8|||
129135972|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Death|13|||
129135973|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Death|7|||
129135974|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
129135975|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
129135976|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
129135977|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
129135978|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
129135979|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
129135980|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
129135981|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
129135982|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
129223292|NCT02112916|465118326|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
129048358|NCT00446199|464470103|FG002|Overall Study|Protocol Violation|1|||
129048359|NCT00446199|464470104|FG003|Overall Study|Protocol Violation|3|||
129048360|NCT00446199|464470101|FG000|Overall Study|Withdrawal by Subject|2|||
129048361|NCT00446199|464470102|FG001|Overall Study|Withdrawal by Subject|5|||
129048362|NCT00446199|464470103|FG002|Overall Study|Withdrawal by Subject|9|||
129048363|NCT00446199|464470104|FG003|Overall Study|Withdrawal by Subject|10|||
129048364|NCT00446199|464470101|FG000|Overall Study|Site termination|2|||
129048365|NCT00446199|464470102|FG001|Overall Study|Site termination|0|||
129048366|NCT00446199|464470103|FG002|Overall Study|Site termination|0|||
129048367|NCT00446199|464470104|FG003|Overall Study|Site termination|1|||
129048368|NCT00446199|464470101|FG000|Overall Study|Randomization in Error|2|||
129048369|NCT00446199|464470102|FG001|Overall Study|Randomization in Error|0|||
129048370|NCT00446199|464470103|FG002|Overall Study|Randomization in Error|1|||
129048371|NCT00446199|464470104|FG003|Overall Study|Randomization in Error|1|||
129048372|NCT00446199|464470101|FG000|Overall Study|Lack of Efficacy|1|||
129048373|NCT00446199|464470102|FG001|Overall Study|Lack of Efficacy|0|||
129048374|NCT00446199|464470103|FG002|Overall Study|Lack of Efficacy|0|||
129048375|NCT00446199|464470104|FG003|Overall Study|Lack of Efficacy|1|||
129048376|NCT00446199|464470101|FG000|Overall Study|Non-compliant with study drug|1|||
129048377|NCT00446199|464470102|FG001|Overall Study|Non-compliant with study drug|0|||
129048378|NCT00446199|464470103|FG002|Overall Study|Non-compliant with study drug|5|||
129048379|NCT00446199|464470104|FG003|Overall Study|Non-compliant with study drug|0|||
129048380|NCT00446199|464470101|FG000|Overall Study|Non-compliant with visit schedule|1|||
129048381|NCT00446199|464470102|FG001|Overall Study|Non-compliant with visit schedule|1|||
129048382|NCT00446199|464470103|FG002|Overall Study|Non-compliant with visit schedule|1|||
129048383|NCT00446199|464470104|FG003|Overall Study|Non-compliant with visit schedule|2|||
129048384|NCT00446199|464470101|FG000|Overall Study|Hormone fear|0|||
129048385|NCT00446199|464470102|FG001|Overall Study|Hormone fear|0|||
129135983|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
129135984|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
129135985|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
129135986|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
129048386|NCT00446199|464470103|FG002|Overall Study|Hormone fear|0|||
128719385|NCT03102918|463271057|FG000|Overall Study|Protocol Violation|1|||
129048387|NCT00446199|464470104|FG003|Overall Study|Hormone fear|1|||
129048388|NCT00446199|464470101|FG000|Overall Study|Lost interest in study participation|0|||
129048389|NCT00446199|464470102|FG001|Overall Study|Lost interest in study participation|1|||
129048390|NCT00446199|464470103|FG002|Overall Study|Lost interest in study participation|0|||
129048391|NCT00446199|464470104|FG003|Overall Study|Lost interest in study participation|0|||
129048392|NCT00446199|464470101|FG000|Overall Study|In-/Exclusion criterion violated|2|||
129048393|NCT00446199|464470102|FG001|Overall Study|In-/Exclusion criterion violated|1|||
129048394|NCT00446199|464470103|FG002|Overall Study|In-/Exclusion criterion violated|2|||
129048395|NCT00446199|464470104|FG003|Overall Study|In-/Exclusion criterion violated|1|||
129048396|NCT00446199|464470101|FG000|Overall Study|Move|0|||
129048397|NCT00446199|464470102|FG001|Overall Study|Move|1|||
129048398|NCT00446199|464470103|FG002|Overall Study|Move|0|||
129048399|NCT00446199|464470104|FG003|Overall Study|Move|0|||
129048400|NCT03071094|464470108|FG000|Overall Study|Death|1|||
129048401|NCT03071094|464470109|FG001|Overall Study|Death|1|||
129048402|NCT03071094|464470108|FG000|Overall Study|Adverse Event|1|||
129048403|NCT03071094|464470109|FG001|Overall Study|Adverse Event|0|||
129048404|NCT02312063|464470110|FG000|Overall Study|Withdrawal by Subject|0|||
129048405|NCT02312063|464470111|FG001|Overall Study|Withdrawal by Subject|1|||
129048406|NCT01079832|464470112|FG000|Overall Study|Withdrawal by Subject|1|||
129048407|NCT00577395|464471999|FG000|Overall Study|Study was terminated early by Sponsor|7|||
129048408|NCT00577395|464472000|FG001|Overall Study|Study was terminated early by Sponsor|6|||
129048409|NCT04709835|464472005|FG000|Overall Study|Withdrawal by Subject|0|||
128719386|NCT03102918|463271058|FG001|Overall Study|Protocol Violation|0|||
128719387|NCT02066467|463271063|FG000|Overall Study|Did not undergo implant procedure|24|||
128982060|NCT01636076|464219075|FG000|Overall Study|Adverse Event|6|||
128982061|NCT01636076|464219076|FG001|Overall Study|Adverse Event|11|||
128982062|NCT01636076|464219075|FG000|Overall Study|Withdrawal by Subject|7|||
128982063|NCT01636076|464219076|FG001|Overall Study|Withdrawal by Subject|10|||
128982064|NCT02173158|464219078|FG000|Efficacy Phase|Adverse Event|1|||
128982065|NCT01728454|464219090|FG000|Stage 1 and 2|Pregnancy|1|||
128982066|NCT01728454|464219091|FG001|Stage 1 and 2|Pregnancy|0|||
128982067|NCT01728454|464219092|FG002|Stage 1 and 2|Pregnancy|0|||
128982068|NCT01728454|464219090|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
128982069|NCT01728454|464219091|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
128982070|NCT01728454|464219092|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
128982071|NCT01728454|464219090|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
128982072|NCT01728454|464219091|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
128982073|NCT01728454|464219092|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
128982074|NCT01728454|464219090|FG000|Stage 1 and 2|Lost to Follow-up|1|||
128982075|NCT01728454|464219091|FG001|Stage 1 and 2|Lost to Follow-up|1|||
128982076|NCT01728454|464219092|FG002|Stage 1 and 2|Lost to Follow-up|0|||
128982077|NCT01728454|464219090|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
128982078|NCT01728454|464219091|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
128982079|NCT01728454|464219092|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
128982080|NCT01728454|464219090|FG000|Stage 3|Reason Missing|0|||
128982081|NCT01728454|464219091|FG001|Stage 3|Reason Missing|0|||
128982082|NCT01728454|464219092|FG002|Stage 3|Reason Missing|1|||
128982083|NCT01728454|464219090|FG000|Stage 3|Subject Required Other Treatment|0|||
128982084|NCT01728454|464219091|FG001|Stage 3|Subject Required Other Treatment|1|||
128982085|NCT01728454|464219092|FG002|Stage 3|Subject Required Other Treatment|0|||
128982086|NCT01728454|464219090|FG000|Stage 3|Pregnancy|1|||
128982087|NCT01728454|464219091|FG001|Stage 3|Pregnancy|0|||
128982088|NCT01728454|464219092|FG002|Stage 3|Pregnancy|0|||
128982089|NCT01728454|464219090|FG000|Stage 3|Withdrew Consent|1|||
128982090|NCT01728454|464219091|FG001|Stage 3|Withdrew Consent|0|||
128982091|NCT01728454|464219092|FG002|Stage 3|Withdrew Consent|1|||
128982092|NCT01728454|464219090|FG000|Stage 3|Non-compliance with Protocol|0|||
128982093|NCT01728454|464219091|FG001|Stage 3|Non-compliance with Protocol|0|||
128982094|NCT01728454|464219092|FG002|Stage 3|Non-compliance with Protocol|1|||
128982095|NCT01728454|464219090|FG000|Stage 3|Lost to Follow-up|0|||
128982096|NCT01728454|464219091|FG001|Stage 3|Lost to Follow-up|3|||
128982097|NCT01728454|464219092|FG002|Stage 3|Lost to Follow-up|1|||
128982098|NCT01728454|464219090|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
128982099|NCT01728454|464219091|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
128982100|NCT01728454|464219092|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
128982101|NCT01190839|464219093|FG000|Overall Study|Adverse Event|32|||
128982102|NCT01190839|464219094|FG001|Overall Study|Adverse Event|41|||
128982103|NCT01190839|464219093|FG000|Overall Study|Protocol Violation|2|||
128982104|NCT01190839|464219094|FG001|Overall Study|Protocol Violation|2|||
128982105|NCT01190839|464219093|FG000|Overall Study|Lost to Follow-up|7|||
128982106|NCT01190839|464219094|FG001|Overall Study|Lost to Follow-up|1|||
128982107|NCT01190839|464219093|FG000|Overall Study|Death|1|||
128982108|NCT01190839|464219094|FG001|Overall Study|Death|0|||
128982109|NCT01190839|464219093|FG000|Overall Study|Trial stopped by Sponsor|71|||
129135987|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
129135988|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
129135989|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
129135990|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
129135991|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
129135992|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
129135993|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
129135994|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
129135995|NCT00114777|464791154|FG000|Long-Term Extension to Month 84|Other|2|||
129135996|NCT00114777|464791155|FG001|Long-Term Extension to Month 84|Other|0|||
129135997|NCT00114777|464791156|FG002|Long-Term Extension to Month 84|Other|2|||
129135998|NCT00629239|464791157|FG000|Overall Study|Adverse Event|7|||
129135999|NCT00629239|464791158|FG001|Overall Study|Adverse Event|4|||
129136000|NCT00629239|464791157|FG000|Overall Study|Physician Decision|1|||
129136001|NCT00629239|464791158|FG001|Overall Study|Physician Decision|0|||
129136002|NCT01851369|464791159|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136003|NCT01851369|464791160|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136004|NCT01851369|464791161|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136005|NCT01851369|464791162|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136006|NCT01851369|464791163|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129048410|NCT04709835|464472006|FG001|Overall Study|Withdrawal by Subject|1|||
129048411|NCT04709835|464472007|FG002|Overall Study|Withdrawal by Subject|0|||
129048412|NCT04325204|464472008|FG000|Overall Study|Death|0|||
129048413|NCT04325204|464472009|FG001|Overall Study|Death|1|||
129048414|NCT04325204|464472008|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
129048415|NCT04325204|464472009|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
129048416|NCT04325204|464472008|FG000|Overall Study|Lost to Follow-up|8|||
129048417|NCT04325204|464472009|FG001|Overall Study|Lost to Follow-up|8|||
129048418|NCT04325204|464472008|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
129048419|NCT04325204|464472009|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
129048420|NCT04711902|464472011|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
129048421|NCT04711902|464472012|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
129048422|NCT04711902|464472013|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
129048423|NCT04711902|464472014|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
129048424|NCT04711902|464472015|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
129048425|NCT04711902|464472016|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
129048426|NCT04710979|464472017|FG000|Overall Study|Lost to Follow-up|2|||
129048427|NCT04710979|464472018|FG001|Overall Study|Lost to Follow-up|4|||
129048428|NCT04710979|464472017|FG000|Overall Study|Withdrawal by Subject|1|||
129048429|NCT04710979|464472018|FG001|Overall Study|Withdrawal by Subject|0|||
129048430|NCT01462318|464472021|FG000|Main Study / TP-DI Study|Other|2|||
129048431|NCT01462318|464472022|FG001|Main Study / TP-DI Study|Other|0|||
129048432|NCT01462318|464472023|FG002|Main Study / TP-DI Study|Other|0|||
129048433|NCT01462318|464472021|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
129048434|NCT01462318|464472022|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
129048435|NCT01462318|464472023|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
129048436|NCT01462318|464472021|FG000|Main Study / TP-DI Study|Adverse Event|4|||
129048437|NCT01462318|464472022|FG001|Main Study / TP-DI Study|Adverse Event|0|||
129048438|NCT01462318|464472023|FG002|Main Study / TP-DI Study|Adverse Event|0|||
129048439|NCT01462318|464472021|FG000|Extension Phase|Lost to Follow-up|0|||
129048440|NCT01462318|464472022|FG001|Extension Phase|Lost to Follow-up|0|||
129048441|NCT01462318|464472023|FG002|Extension Phase|Lost to Follow-up|1|||
129136007|NCT01851369|464791164|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
129136008|NCT01851369|464791165|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136009|NCT01851369|464791166|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136010|NCT01851369|464791167|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136011|NCT01851369|464791168|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136012|NCT01851369|464791169|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129048442|NCT01462318|464472021|FG000|Extension Phase|Other|0|||
129048443|NCT01462318|464472022|FG001|Extension Phase|Other|0|||
129048444|NCT01462318|464472023|FG002|Extension Phase|Other|1|||
129048445|NCT01462318|464472021|FG000|Extension Phase|Disease Progression|0|||
129048446|NCT01462318|464472022|FG001|Extension Phase|Disease Progression|0|||
129136013|NCT01851369|464791170|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129223293|NCT02112916|465118327|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
129048447|NCT01462318|464472023|FG002|Extension Phase|Disease Progression|1|||
129048448|NCT01462318|464472021|FG000|Extension Phase|Withdrawal by Subject|0|||
129048449|NCT01462318|464472022|FG001|Extension Phase|Withdrawal by Subject|0|||
129048450|NCT01462318|464472023|FG002|Extension Phase|Withdrawal by Subject|15|||
129048451|NCT01462318|464472021|FG000|Extension Phase|Investigator Decision|0|||
129048452|NCT01462318|464472022|FG001|Extension Phase|Investigator Decision|0|||
129048453|NCT01462318|464472023|FG002|Extension Phase|Investigator Decision|5|||
129048454|NCT01462318|464472021|FG000|Extension Phase|Adverse Event|0|||
129048455|NCT01462318|464472022|FG001|Extension Phase|Adverse Event|0|||
129048456|NCT01462318|464472023|FG002|Extension Phase|Adverse Event|22|||
129048457|NCT03827564|464472024|FG000|Overall Study|Discontinued due to Study Termination|1|||
129048458|NCT03827564|464472025|FG001|Overall Study|Discontinued due to Study Termination|0|||
129048459|NCT00891371|464472026|FG000|Pre-assignment|Inclusion/exclusion|5|||
129048460|NCT00891371|464472026|FG000|Pre-assignment|Consent withdrawal|1|||
129048461|NCT00891371|464472026|FG000|Treatment|Lack of Efficacy|5|||
129048462|NCT00891371|464472026|FG000|Treatment|Adverse Event|2|||
129048463|NCT00891371|464472026|FG000|Treatment|Death|1|||
129048464|NCT00891371|464472026|FG000|Treatment|Lost to Follow-up|1|||
129048465|NCT02238626|464472027|FG000|Overall Study|Adverse Event|3|||
129048466|NCT02238626|464472028|FG001|Overall Study|Adverse Event|5|||
129048467|NCT02238626|464472029|FG002|Overall Study|Adverse Event|0|||
129048468|NCT02238626|464472030|FG003|Overall Study|Adverse Event|3|||
129048469|NCT02238626|464472027|FG000|Overall Study|Lost to Follow-up|2|||
129048470|NCT02238626|464472028|FG001|Overall Study|Lost to Follow-up|4|||
129048471|NCT02238626|464472029|FG002|Overall Study|Lost to Follow-up|2|||
129048472|NCT02238626|464472030|FG003|Overall Study|Lost to Follow-up|2|||
129048473|NCT02238626|464472027|FG000|Overall Study|Withdrawal by Subject|0|||
129048474|NCT02238626|464472028|FG001|Overall Study|Withdrawal by Subject|3|||
129048475|NCT02238626|464472029|FG002|Overall Study|Withdrawal by Subject|0|||
129048476|NCT02238626|464472030|FG003|Overall Study|Withdrawal by Subject|1|||
129048477|NCT02238626|464472027|FG000|Overall Study|Death|0|||
129048478|NCT02238626|464472028|FG001|Overall Study|Death|0|||
129048479|NCT02238626|464472029|FG002|Overall Study|Death|1|||
129048480|NCT02238626|464472030|FG003|Overall Study|Death|1|||
129048481|NCT02238626|464472027|FG000|Overall Study|Other|0|||
129048482|NCT02238626|464472028|FG001|Overall Study|Other|2|||
129048483|NCT02238626|464472029|FG002|Overall Study|Other|0|||
129048484|NCT02238626|464472030|FG003|Overall Study|Other|0|||
129048485|NCT02622113|464472033|FG000|Overall Study|Adverse Event|4|||
129048486|NCT02622113|464472034|FG001|Overall Study|Adverse Event|4|||
129048487|NCT02622113|464472033|FG000|Overall Study|Physician Decision|0|||
129048488|NCT02622113|464472034|FG001|Overall Study|Physician Decision|1|||
129048489|NCT02622113|464472033|FG000|Overall Study|Withdrawal by Subject|0|||
129048490|NCT02622113|464472034|FG001|Overall Study|Withdrawal by Subject|2|||
129048491|NCT02622113|464472033|FG000|Overall Study|Stopping Criteria|1|||
129048492|NCT02622113|464472034|FG001|Overall Study|Stopping Criteria|3|||
129048493|NCT00667810|464472035|FG000|Overall Study|Adverse Event|13|||
128719388|NCT02066467|463271063|FG000|Overall Study|Attempted to implant withoput success|43|||
128719389|NCT02066467|463271063|FG000|Overall Study|Consent ineligible|1|||
128719390|NCT02066467|463271063|FG000|Overall Study|Death|54|||
128719391|NCT02066467|463271063|FG000|Overall Study|Lost to Follow-up|51|||
128719392|NCT02066467|463271063|FG000|Overall Study|Adverse Event|20|||
129048494|NCT00667810|464472036|FG001|Overall Study|Adverse Event|14|||
129048495|NCT00667810|464472037|FG002|Overall Study|Adverse Event|19|||
129048496|NCT00667810|464472038|FG003|Overall Study|Adverse Event|1|||
129048497|NCT00667810|464472035|FG000|Overall Study|Death|1|||
129048498|NCT00667810|464472036|FG001|Overall Study|Death|1|||
129048499|NCT00667810|464472037|FG002|Overall Study|Death|3|||
129048500|NCT00667810|464472038|FG003|Overall Study|Death|0|||
129048501|NCT00667810|464472035|FG000|Overall Study|Lack of Efficacy|1|||
129136014|NCT01851369|464791171|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129136015|NCT02453191|464791172|FG000|Overall Study|Withdrawal by Subject|1|||
128719393|NCT02066467|463271063|FG000|Overall Study|Withdrawal by Subject|16|||
129136016|NCT00183391|464791173|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
128719394|NCT02066467|463271063|FG000|Overall Study|Physician Decision|2|||
128719395|NCT02066467|463271063|FG000|Overall Study|Not defined|4|||
129048502|NCT00667810|464472036|FG001|Overall Study|Lack of Efficacy|0|||
129048503|NCT00667810|464472037|FG002|Overall Study|Lack of Efficacy|2|||
129048504|NCT00667810|464472038|FG003|Overall Study|Lack of Efficacy|0|||
129048505|NCT00667810|464472035|FG000|Overall Study|Lost to Follow-up|1|||
129048506|NCT00667810|464472036|FG001|Overall Study|Lost to Follow-up|4|||
129048507|NCT00667810|464472037|FG002|Overall Study|Lost to Follow-up|2|||
129048508|NCT00667810|464472038|FG003|Overall Study|Lost to Follow-up|0|||
129048509|NCT00667810|464472035|FG000|Overall Study|Physician Decision|1|||
129048510|NCT00667810|464472036|FG001|Overall Study|Physician Decision|1|||
129136017|NCT00183391|464791174|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
129136018|NCT00183391|464791173|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
129048511|NCT00667810|464472037|FG002|Overall Study|Physician Decision|2|||
129048512|NCT00667810|464472038|FG003|Overall Study|Physician Decision|0|||
129048513|NCT00667810|464472035|FG000|Overall Study|Protocol Violation|0|||
129048514|NCT00667810|464472036|FG001|Overall Study|Protocol Violation|2|||
129048515|NCT00667810|464472037|FG002|Overall Study|Protocol Violation|0|||
129048516|NCT00667810|464472038|FG003|Overall Study|Protocol Violation|0|||
129048517|NCT00667810|464472035|FG000|Overall Study|Withdrawal by Subject|14|||
129048518|NCT00667810|464472036|FG001|Overall Study|Withdrawal by Subject|20|||
129048519|NCT00667810|464472037|FG002|Overall Study|Withdrawal by Subject|29|||
129048520|NCT00667810|464472038|FG003|Overall Study|Withdrawal by Subject|1|||
129048521|NCT00667810|464472035|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
129048522|NCT00667810|464472036|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
129048523|NCT00667810|464472037|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
129048524|NCT00667810|464472038|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129048525|NCT00667810|464472035|FG000|Overall Study|Failed to Return|0|||
129048526|NCT00667810|464472036|FG001|Overall Study|Failed to Return|0|||
129048527|NCT00667810|464472037|FG002|Overall Study|Failed to Return|2|||
129048528|NCT00667810|464472038|FG003|Overall Study|Failed to Return|0|||
129048529|NCT00667810|464472035|FG000|Overall Study|Loss of Caregiver|0|||
129048530|NCT00667810|464472036|FG001|Overall Study|Loss of Caregiver|1|||
129048531|NCT00667810|464472037|FG002|Overall Study|Loss of Caregiver|3|||
129048532|NCT00667810|464472038|FG003|Overall Study|Loss of Caregiver|0|||
129048533|NCT00667810|464472035|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
129048534|NCT00667810|464472036|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
129048535|NCT00667810|464472037|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
129048536|NCT00667810|464472038|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
129048537|NCT00667810|464472035|FG000|Overall Study|Other|6|||
129048538|NCT00667810|464472036|FG001|Overall Study|Other|6|||
129048539|NCT00667810|464472037|FG002|Overall Study|Other|5|||
129048540|NCT00667810|464472038|FG003|Overall Study|Other|0|||
129048541|NCT00505375|464472041|FG000|Overall Study|Death|1|||
129048542|NCT00505375|464472042|FG001|Overall Study|Death|0|||
129048543|NCT00505375|464472041|FG000|Overall Study|Withdrawal by Subject|2|||
129048544|NCT00505375|464472042|FG001|Overall Study|Withdrawal by Subject|2|||
129048545|NCT00505375|464472041|FG000|Overall Study|Lost to Follow-up|0|||
129048546|NCT00505375|464472042|FG001|Overall Study|Lost to Follow-up|2|||
129048547|NCT00505375|464472041|FG000|Overall Study|Pregnancy|1|||
129048548|NCT00505375|464472042|FG001|Overall Study|Pregnancy|0|||
129048549|NCT00505375|464472041|FG000|Overall Study|Travel issues|0|||
129048550|NCT00505375|464472042|FG001|Overall Study|Travel issues|1|||
129048551|NCT03709823|464472043|FG000|Overall Study|Adverse Event|0|||
129048552|NCT03709823|464472044|FG001|Overall Study|Adverse Event|0|||
129048553|NCT03709823|464472045|FG002|Overall Study|Adverse Event|1|||
129048554|NCT03709823|464472046|FG003|Overall Study|Adverse Event|0|||
129048555|NCT03709823|464472047|FG004|Overall Study|Adverse Event|0|||
129048556|NCT03709823|464472048|FG005|Overall Study|Adverse Event|0|||
129048557|NCT03709823|464472043|FG000|Overall Study|Lost to Follow-up|2|||
129048558|NCT03709823|464472044|FG001|Overall Study|Lost to Follow-up|2|||
129048559|NCT03709823|464472045|FG002|Overall Study|Lost to Follow-up|2|||
129048560|NCT03709823|464472046|FG003|Overall Study|Lost to Follow-up|1|||
129048561|NCT03709823|464472047|FG004|Overall Study|Lost to Follow-up|1|||
129048562|NCT03709823|464472048|FG005|Overall Study|Lost to Follow-up|0|||
129048563|NCT03709823|464472043|FG000|Overall Study|Withdrawal by Subject|1|||
129048564|NCT03709823|464472044|FG001|Overall Study|Withdrawal by Subject|3|||
129048565|NCT03709823|464472045|FG002|Overall Study|Withdrawal by Subject|0|||
129048566|NCT03709823|464472046|FG003|Overall Study|Withdrawal by Subject|0|||
129048567|NCT03709823|464472047|FG004|Overall Study|Withdrawal by Subject|0|||
129048568|NCT03709823|464472048|FG005|Overall Study|Withdrawal by Subject|0|||
129048569|NCT03709823|464472043|FG000|Overall Study|Other, Not Specified|0|||
129048570|NCT03709823|464472044|FG001|Overall Study|Other, Not Specified|0|||
129048571|NCT03709823|464472045|FG002|Overall Study|Other, Not Specified|0|||
129048572|NCT03709823|464472046|FG003|Overall Study|Other, Not Specified|1|||
129048573|NCT03709823|464472047|FG004|Overall Study|Other, Not Specified|0|||
129048574|NCT03709823|464472048|FG005|Overall Study|Other, Not Specified|0|||
129048575|NCT03201250|464472049|FG000|Overall Study|screen failures|3|||
129048576|NCT03201250|464472050|FG001|Overall Study|screen failures|0|||
129048577|NCT03201250|464472051|FG002|Overall Study|screen failures|0|||
129048578|NCT03167723|464472052|FG000|Overall Study|Protocol Violation|4|||
129048579|NCT03167723|464472053|FG001|Overall Study|Protocol Violation|6|||
129048580|NCT01175811|464472054|FG000|Overall Study|Adverse Event|1|||
129048581|NCT01175811|464472055|FG001|Overall Study|Adverse Event|1|||
129048582|NCT01175811|464472054|FG000|Overall Study|Entry criteria not met|3|||
129048583|NCT01175811|464472055|FG001|Overall Study|Entry criteria not met|1|||
129048584|NCT01175811|464472054|FG000|Overall Study|Lack of Efficacy|1|||
129048585|NCT01175811|464472055|FG001|Overall Study|Lack of Efficacy|0|||
129048586|NCT01175811|464472054|FG000|Overall Study|Lost to Follow-up|3|||
129048587|NCT01175811|464472055|FG001|Overall Study|Lost to Follow-up|2|||
129048588|NCT01175811|464472054|FG000|Overall Study|Physician Decision|1|||
129048589|NCT01175811|464472055|FG001|Overall Study|Physician Decision|1|||
129048590|NCT01175811|464472054|FG000|Overall Study|Protocol Violation|1|||
129048591|NCT01175811|464472055|FG001|Overall Study|Protocol Violation|2|||
129048592|NCT01175811|464472054|FG000|Overall Study|Withdrawal by Subject|6|||
129048593|NCT01175811|464472055|FG001|Overall Study|Withdrawal by Subject|7|||
129048594|NCT03579966|464472056|FG000|Overall Study|Adverse Event|6|||
129048595|NCT03579966|464472056|FG000|Overall Study|Lost to Follow-up|4|||
129048596|NCT03579966|464472056|FG000|Overall Study|Physician Decision|10|||
129136019|NCT00183391|464791174|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
129136020|NCT02336503|464791176|FG000|Overall Study|Lost to Follow-up|0|||
129136021|NCT02336503|464791177|FG001|Overall Study|Lost to Follow-up|3|||
129136022|NCT02336503|464791178|FG002|Overall Study|Lost to Follow-up|0|||
129136023|NCT02336503|464791179|FG003|Overall Study|Lost to Follow-up|2|||
129136024|NCT02336503|464791176|FG000|Overall Study|Withdrawal by Subject|2|||
129136025|NCT02336503|464791177|FG001|Overall Study|Withdrawal by Subject|0|||
129136026|NCT02336503|464791178|FG002|Overall Study|Withdrawal by Subject|0|||
129136027|NCT02336503|464791179|FG003|Overall Study|Withdrawal by Subject|4|||
129048597|NCT03579966|464472056|FG000|Overall Study|Pregnancy|1|||
129048598|NCT03579966|464472056|FG000|Overall Study|Withdrawal by Subject|16|||
129136028|NCT02336503|464791176|FG000|Overall Study|Adverse Event|0|||
129136029|NCT02336503|464791177|FG001|Overall Study|Adverse Event|0|||
129136030|NCT02336503|464791178|FG002|Overall Study|Adverse Event|1|||
129136031|NCT02336503|464791179|FG003|Overall Study|Adverse Event|0|||
129136032|NCT02460380|464791180|FG000|Overall Study|Withdrawal by Subject|10|||
129136033|NCT02460380|464791181|FG001|Overall Study|Withdrawal by Subject|5|||
129136034|NCT00395512|464791182|FG000|Overall Study|Adverse Event|3|||
129136035|NCT00395512|464791183|FG001|Overall Study|Adverse Event|8|||
129136036|NCT00395512|464791184|FG002|Overall Study|Adverse Event|6|||
129136037|NCT00395512|464791185|FG003|Overall Study|Adverse Event|6|||
129136038|NCT00395512|464791182|FG000|Overall Study|Protocol Violation|2|||
129136039|NCT00395512|464791183|FG001|Overall Study|Protocol Violation|3|||
129136040|NCT00395512|464791184|FG002|Overall Study|Protocol Violation|6|||
129136041|NCT00395512|464791185|FG003|Overall Study|Protocol Violation|7|||
129136042|NCT00395512|464791182|FG000|Overall Study|Lost to Follow-up|2|||
129136043|NCT00395512|464791183|FG001|Overall Study|Lost to Follow-up|6|||
129136044|NCT00395512|464791184|FG002|Overall Study|Lost to Follow-up|5|||
129136045|NCT00395512|464791185|FG003|Overall Study|Lost to Follow-up|5|||
129136046|NCT00395512|464791182|FG000|Overall Study|Withdrawal by Subject|6|||
129136047|NCT00395512|464791183|FG001|Overall Study|Withdrawal by Subject|5|||
129136048|NCT00395512|464791184|FG002|Overall Study|Withdrawal by Subject|5|||
128719396|NCT01316276|463271064|FG000|Overall Study|Death|1|||
128719397|NCT01316276|463271064|FG000|Overall Study|Adverse Event|19|||
128719398|NCT01316276|463271064|FG000|Overall Study|Withdrawal of consent|24|||
128719399|NCT01316276|463271064|FG000|Overall Study|Lost to Follow-up|1|||
129048599|NCT03579966|464472056|FG000|Overall Study|Study terminated by Sponsor|22|||
129048600|NCT03579966|464472056|FG000|Overall Study|Protocol Violation|1|||
129048601|NCT00140426|464472057|FG000|Overall Study|Withdrawal by Subject|0|||
129048602|NCT00140426|464472058|FG001|Overall Study|Withdrawal by Subject|3|||
129048603|NCT02149108|464472059|FG000|Overall Study|Not treated|1|||
129048604|NCT02149108|464472060|FG001|Overall Study|Not treated|2|||
129048605|NCT02149108|464472059|FG000|Overall Study|Progressive Disease (PD)|324|||
129048606|NCT02149108|464472060|FG001|Overall Study|Progressive Disease (PD)|318|||
129048607|NCT02149108|464472059|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
129048608|NCT02149108|464472060|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
129048609|NCT02149108|464472059|FG000|Overall Study|Other Adverse Event (AE)|8|||
129048610|NCT02149108|464472060|FG001|Overall Study|Other Adverse Event (AE)|18|||
129048611|NCT02149108|464472059|FG000|Overall Study|Other not defined above|0|||
129048612|NCT02149108|464472060|FG001|Overall Study|Other not defined above|2|||
129048613|NCT02149108|464472059|FG000|Overall Study|Refusal to continue trial medication|15|||
129136049|NCT00395512|464791185|FG003|Overall Study|Withdrawal by Subject|12|||
128719400|NCT01316276|463271064|FG000|Overall Study|Other|22|||
128719401|NCT02596854|463271065|FG000|Overall Study|Withdrawn|8|||
129048614|NCT02149108|464472060|FG001|Overall Study|Refusal to continue trial medication|11|||
129136050|NCT00395512|464791182|FG000|Overall Study|Physician Decision|6|||
129048615|NCT02149108|464472059|FG000|Overall Study|Lost to Follow-up|1|||
129136051|NCT00395512|464791183|FG001|Overall Study|Physician Decision|4|||
129136052|NCT00395512|464791184|FG002|Overall Study|Physician Decision|2|||
129136053|NCT00395512|464791185|FG003|Overall Study|Physician Decision|2|||
129136054|NCT00395512|464791182|FG000|Overall Study|Other|1|||
129136055|NCT00395512|464791183|FG001|Overall Study|Other|1|||
129136056|NCT00395512|464791184|FG002|Overall Study|Other|0|||
129136057|NCT00395512|464791185|FG003|Overall Study|Other|0|||
129136058|NCT00395512|464791182|FG000|Overall Study|Hyperglycemic Rescue|18|||
129136059|NCT00395512|464791183|FG001|Overall Study|Hyperglycemic Rescue|10|||
129136060|NCT00395512|464791184|FG002|Overall Study|Hyperglycemic Rescue|4|||
129136061|NCT00395512|464791185|FG003|Overall Study|Hyperglycemic Rescue|6|||
129136062|NCT01986751|464791190|FG000|Overall Study|improperly consented|10|||
129136063|NCT01986751|464791191|FG001|Overall Study|improperly consented|2|||
129136064|NCT01478087|464791192|FG000|Overall Study|due to sponsor closing study|1|||
129136065|NCT03566550|464791193|FG000|Overall Study|Withdrawal by Subject|0|||
129136066|NCT03566550|464791194|FG001|Overall Study|Withdrawal by Subject|1|||
128719402|NCT00405587|463271072|FG000|Overall Study|Death|0|||
128719403|NCT00405587|463271073|FG001|Overall Study|Death|0|||
129136067|NCT04576949|464791200|FG000|Overall Study|Adverse Event|1|||
129136068|NCT04576949|464791201|FG001|Overall Study|Adverse Event|3|||
129048616|NCT02149108|464472060|FG001|Overall Study|Lost to Follow-up|0|||
129048617|NCT04765384|464472061|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
129048618|NCT04765384|464472062|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
129048619|NCT04765384|464472063|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
129048620|NCT04765384|464472064|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
129048621|NCT04765384|464472065|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
129048622|NCT04765384|464472066|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
129048623|NCT04765384|464472061|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
129048624|NCT04765384|464472062|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
129048625|NCT04765384|464472063|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
129048626|NCT04765384|464472064|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
129048627|NCT04765384|464472065|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
129048628|NCT04765384|464472066|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
129048629|NCT04765384|464472061|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129048630|NCT04765384|464472062|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129048631|NCT04765384|464472063|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129048632|NCT04765384|464472064|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129048633|NCT04765384|464472065|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129048634|NCT04765384|464472066|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
129048635|NCT04765384|464472061|FG000|Post-natal: Neonates and Infants|Death|0|||
129048636|NCT04765384|464472062|FG001|Post-natal: Neonates and Infants|Death|0|||
129048637|NCT04765384|464472063|FG002|Post-natal: Neonates and Infants|Death|0|||
129048638|NCT04765384|464472064|FG003|Post-natal: Neonates and Infants|Death|1|||
129048639|NCT04765384|464472065|FG004|Post-natal: Neonates and Infants|Death|0|||
129048640|NCT04765384|464472066|FG005|Post-natal: Neonates and Infants|Death|0|||
129048641|NCT04765384|464472061|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129048642|NCT04765384|464472062|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129048643|NCT04765384|464472063|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129048644|NCT04765384|464472064|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129048645|NCT04765384|464472065|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129048646|NCT04765384|464472066|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
129048647|NCT01971970|464472067|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
129048648|NCT01971970|464472068|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
129048649|NCT01971970|464472067|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
129048650|NCT01971970|464472068|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
129048651|NCT01971970|464472067|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
129048652|NCT01971970|464472068|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
129048653|NCT01971970|464472067|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
129048654|NCT01971970|464472068|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
129048655|NCT01971970|464472067|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
129048656|NCT01971970|464472068|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
129048657|NCT01971970|464472067|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
129048658|NCT01971970|464472068|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
129048659|NCT01971970|464472067|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
129048660|NCT01971970|464472068|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
129048661|NCT00848107|464472069|FG000|Overall Study|Lost to Follow-up|2|||
129048662|NCT00848107|464472069|FG000|Overall Study|Withdrawal by Subject|8|||
129048663|NCT00848107|464472069|FG000|Overall Study|Adverse Event|9|||
129048664|NCT00848107|464472069|FG000|Overall Study|Death|1|||
129048665|NCT00848107|464472069|FG000|Overall Study|Pregnancy|1|||
129048666|NCT02335983|464472070|FG000|Overall Study|Sponsor Decision|0|||
129048667|NCT02335983|464472071|FG001|Overall Study|Sponsor Decision|0|||
129048668|NCT02335983|464472072|FG002|Overall Study|Sponsor Decision|1|||
129048669|NCT02335983|464472073|FG003|Overall Study|Sponsor Decision|1|||
129048670|NCT02335983|464472074|FG004|Overall Study|Sponsor Decision|0|||
129048671|NCT02335983|464472075|FG005|Overall Study|Sponsor Decision|1|||
129048672|NCT02335983|464472070|FG000|Overall Study|Withdrawal by Subject|3|||
129048673|NCT02335983|464472071|FG001|Overall Study|Withdrawal by Subject|2|||
129048674|NCT02335983|464472072|FG002|Overall Study|Withdrawal by Subject|2|||
129048675|NCT02335983|464472073|FG003|Overall Study|Withdrawal by Subject|1|||
129048676|NCT02335983|464472074|FG004|Overall Study|Withdrawal by Subject|3|||
129048677|NCT02335983|464472075|FG005|Overall Study|Withdrawal by Subject|9|||
129048678|NCT02335983|464472070|FG000|Overall Study|Death|0|||
129048679|NCT02335983|464472071|FG001|Overall Study|Death|0|||
129048680|NCT02335983|464472072|FG002|Overall Study|Death|2|||
129048681|NCT02335983|464472073|FG003|Overall Study|Death|0|||
129048682|NCT02335983|464472074|FG004|Overall Study|Death|0|||
129048683|NCT02335983|464472075|FG005|Overall Study|Death|0|||
129048684|NCT02335983|464472070|FG000|Overall Study|Lost to Follow-up|0|||
129048685|NCT02335983|464472071|FG001|Overall Study|Lost to Follow-up|0|||
129048686|NCT02335983|464472072|FG002|Overall Study|Lost to Follow-up|0|||
128719404|NCT00405587|463271074|FG002|Overall Study|Death|0|||
129048687|NCT02335983|464472073|FG003|Overall Study|Lost to Follow-up|0|||
129048688|NCT02335983|464472074|FG004|Overall Study|Lost to Follow-up|0|||
129048689|NCT02335983|464472075|FG005|Overall Study|Lost to Follow-up|1|||
129048690|NCT02335983|464472070|FG000|Overall Study|Protocol Specified Criteria|5|||
129048691|NCT02335983|464472071|FG001|Overall Study|Protocol Specified Criteria|7|||
129048692|NCT02335983|464472072|FG002|Overall Study|Protocol Specified Criteria|27|||
129048693|NCT02335983|464472073|FG003|Overall Study|Protocol Specified Criteria|7|||
129048694|NCT02335983|464472074|FG004|Overall Study|Protocol Specified Criteria|5|||
129048695|NCT02335983|464472075|FG005|Overall Study|Protocol Specified Criteria|21|||
129048696|NCT00987389|464472076|FG000|Overall Study|Ineligible|0|||
129048697|NCT00987389|464472077|FG001|Overall Study|Ineligible|3|||
129048698|NCT00987389|464472078|FG002|Overall Study|Ineligible|0|||
129048699|NCT00987389|464472079|FG003|Overall Study|Ineligible|0|||
129048700|NCT00987389|464472076|FG000|Overall Study|Lost to Follow-up|4|||
129048701|NCT00987389|464472077|FG001|Overall Study|Lost to Follow-up|1|||
129048702|NCT00987389|464472078|FG002|Overall Study|Lost to Follow-up|3|||
129048703|NCT00987389|464472079|FG003|Overall Study|Lost to Follow-up|1|||
129048704|NCT00987389|464472076|FG000|Overall Study|Withdrawal by Subject|4|||
129048705|NCT00987389|464472077|FG001|Overall Study|Withdrawal by Subject|3|||
129048706|NCT00987389|464472078|FG002|Overall Study|Withdrawal by Subject|2|||
129048707|NCT00987389|464472079|FG003|Overall Study|Withdrawal by Subject|1|||
129048708|NCT00987389|464472076|FG000|Overall Study|Withdrawn from Treatment|0|||
129048709|NCT00987389|464472077|FG001|Overall Study|Withdrawn from Treatment|1|||
129048710|NCT00987389|464472078|FG002|Overall Study|Withdrawn from Treatment|0|||
129048711|NCT00987389|464472079|FG003|Overall Study|Withdrawn from Treatment|0|||
129048712|NCT00987389|464472076|FG000|Overall Study|Multiple different reasons|1|||
129048713|NCT00987389|464472077|FG001|Overall Study|Multiple different reasons|0|||
129048714|NCT00987389|464472078|FG002|Overall Study|Multiple different reasons|3|||
129048715|NCT00987389|464472079|FG003|Overall Study|Multiple different reasons|1|||
129048716|NCT00326963|464472080|FG000|Overall Study|Adverse Event|2|||
129048717|NCT00326963|464472080|FG000|Overall Study|Injection site reaction|1|||
129048718|NCT00326963|464472080|FG000|Overall Study|Death|1|||
129048719|NCT00326963|464472080|FG000|Overall Study|Failure to return|10|||
129048720|NCT00326963|464472080|FG000|Overall Study|Withdrawal by Subject|10|||
129048721|NCT00326963|464472080|FG000|Overall Study|Refused treatment / did not cooperate|5|||
129048722|NCT00326963|464472080|FG000|Overall Study|Violation of selection criteria at entry|2|||
129048723|NCT00326963|464472080|FG000|Overall Study|Other protocol violation|1|||
129048724|NCT00326963|464472080|FG000|Overall Study|Administrative / other|1|||
129048725|NCT00507130|464472081|FG000|Overall Study|Lost to Follow-up|0|||
129048726|NCT00507130|464472082|FG001|Overall Study|Lost to Follow-up|0|||
129048727|NCT00507130|464472083|FG002|Overall Study|Lost to Follow-up|1|||
129048728|NCT00507130|464472084|FG003|Overall Study|Lost to Follow-up|1|||
129048729|NCT00507130|464472081|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
129048730|NCT00507130|464472082|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
129048731|NCT00507130|464472083|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
129048732|NCT00507130|464472084|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
129048733|NCT02524730|464472085|FG000|Overall Study|Lost to Follow-up|5|||
129048734|NCT02524730|464472085|FG000|Overall Study|Withdrawal by Subject|18|||
129048735|NCT02524730|464472085|FG000|Overall Study|Death|10|||
129048736|NCT02524730|464472085|FG000|Overall Study|Adverse Event|8|||
129048737|NCT02524730|464472085|FG000|Overall Study|Protocol Violation|1|||
129048738|NCT02524730|464472085|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
129048739|NCT00859586|464472086|FG000|Overall Study|Donors|4|||
129048740|NCT00977379|464472091|FG000|Overall Study|Withdrawal by Subject|1|||
129048741|NCT00977379|464472092|FG001|Overall Study|Withdrawal by Subject|1|||
129048742|NCT00977379|464472091|FG000|Overall Study|Death|7|||
129048743|NCT00977379|464472092|FG001|Overall Study|Death|9|||
129048744|NCT00977379|464472091|FG000|Overall Study|Premature Study Termination|4|||
129048745|NCT00977379|464472092|FG001|Overall Study|Premature Study Termination|0|||
129048746|NCT00977379|464472091|FG000|Overall Study|Participant Moving House|0|||
129048747|NCT00977379|464472092|FG001|Overall Study|Participant Moving House|1|||
129048748|NCT00977379|464472091|FG000|Overall Study|Randomization Error|0|||
129048749|NCT00977379|464472092|FG001|Overall Study|Randomization Error|1|||
129048750|NCT00080938|464472093|FG000|Overall Study|Adverse Event|3|||
129048751|NCT00080938|464472093|FG000|Overall Study|Withdrawal by Subject|6|||
129048752|NCT00080938|464472093|FG000|Overall Study|Death|2|||
129048753|NCT00080938|464472093|FG000|Overall Study|Lack of Efficacy|7|||
129048754|NCT00080938|464472093|FG000|Overall Study|other disease|1|||
129048755|NCT00080938|464472093|FG000|Overall Study|Not started protocol therapy|1|||
129048756|NCT00080938|464472093|FG000|Overall Study|Ineligible|4|||
129048757|NCT00706511|464472098|FG000|Overall Study|Withdrawal by Subject|1|||
129048758|NCT00706511|464472099|FG001|Overall Study|Withdrawal by Subject|0|||
129048759|NCT00706511|464472100|FG002|Overall Study|Withdrawal by Subject|0|||
129048760|NCT00706511|464472101|FG003|Overall Study|Withdrawal by Subject|0|||
129048761|NCT02992418|464472106|FG000|Overall Study|Withdrawal by Subject|11|||
129048762|NCT02992418|464472107|FG001|Overall Study|Withdrawal by Subject|12|||
129048763|NCT02992418|464472106|FG000|Overall Study|Non-compliance with the protocol|308|||
129048764|NCT02992418|464472107|FG001|Overall Study|Non-compliance with the protocol|308|||
129048765|NCT02992418|464472106|FG000|Overall Study|Lost to Follow-up|27|||
129048766|NCT02992418|464472107|FG001|Overall Study|Lost to Follow-up|22|||
129048767|NCT03246126|464472112|FG000|Overall Study|Withdrawal by Subject|0|||
129048768|NCT03246126|464472113|FG001|Overall Study|Withdrawal by Subject|1|||
129048769|NCT01006135|464472122|FG000|Overall Study|Adverse Event|22|||
129048770|NCT01006135|464472122|FG000|Overall Study|Protocol Violation|14|||
129048771|NCT01006135|464472122|FG000|Overall Study|Lost to Follow-up|32|||
129048772|NCT01006135|464472122|FG000|Overall Study|Other|72|||
129048773|NCT05297578|464472124|FG000|Overall Study|Lost to Follow-up|1|||
129048774|NCT05297578|464472125|FG001|Overall Study|Lost to Follow-up|1|||
129048775|NCT05297578|464472126|FG002|Overall Study|Lost to Follow-up|2|||
129048776|NCT05297578|464472127|FG003|Overall Study|Lost to Follow-up|1|||
129048777|NCT05297578|464472124|FG000|Overall Study|Death|0|||
129048778|NCT05297578|464472125|FG001|Overall Study|Death|1|||
129048779|NCT05297578|464472126|FG002|Overall Study|Death|0|||
129048780|NCT05297578|464472127|FG003|Overall Study|Death|0|||
129048781|NCT05297578|464472124|FG000|Overall Study|Withdrawal by Subject|0|||
129048782|NCT05297578|464472125|FG001|Overall Study|Withdrawal by Subject|0|||
129048783|NCT05297578|464472126|FG002|Overall Study|Withdrawal by Subject|1|||
129048784|NCT05297578|464472127|FG003|Overall Study|Withdrawal by Subject|0|||
129048785|NCT01732484|464472128|FG000|Overall Study|Death|7|||
129048786|NCT01732484|464472128|FG000|Overall Study|Lost to Follow-up|14|||
129048787|NCT01732484|464472128|FG000|Overall Study|chronical illness|5|||
129048788|NCT01087489|464472129|FG000|Overall Study|enrolled in another VA study|0|||
129048789|NCT01087489|464472130|FG001|Overall Study|enrolled in another VA study|1|||
129048790|NCT01087489|464472129|FG000|Overall Study|Death|0|||
129048791|NCT01087489|464472130|FG001|Overall Study|Death|1|||
129048792|NCT01087489|464472129|FG000|Overall Study|unable to survey by telephone|0|||
129048793|NCT01087489|464472130|FG001|Overall Study|unable to survey by telephone|1|||
129048794|NCT02266134|464472131|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
129048795|NCT02266134|464472132|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
129048796|NCT02266134|464472133|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
129048797|NCT02266134|464472134|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
129048798|NCT02266134|464472131|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
129048799|NCT02266134|464472132|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
129048800|NCT02266134|464472133|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
129048801|NCT02266134|464472134|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
129048802|NCT02266134|464472131|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
129048803|NCT02266134|464472132|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
129048804|NCT02266134|464472133|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
129048805|NCT02266134|464472134|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
129048806|NCT02266134|464472131|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
129048807|NCT02266134|464472132|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
129048808|NCT02266134|464472133|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
129048809|NCT02266134|464472134|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
129048810|NCT02266134|464472131|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
129048811|NCT02266134|464472132|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
129048812|NCT02266134|464472133|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
129048813|NCT02266134|464472134|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
129048814|NCT02266134|464472131|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
129048815|NCT02266134|464472132|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
129048816|NCT02266134|464472133|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
129048817|NCT02266134|464472134|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
129136069|NCT04576949|464791202|FG002|Overall Study|Adverse Event|2|||
129136070|NCT04576949|464791200|FG000|Overall Study|Withdrawal by Subject|41|||
129136071|NCT04576949|464791201|FG001|Overall Study|Withdrawal by Subject|26|||
129136072|NCT04576949|464791202|FG002|Overall Study|Withdrawal by Subject|18|||
129136073|NCT04576949|464791200|FG000|Overall Study|Physician Decision|3|||
129136074|NCT04576949|464791201|FG001|Overall Study|Physician Decision|0|||
129048818|NCT02731326|464472137|FG000|Overall Study|Withdrawal by Subject|4|||
129048819|NCT02731326|464472138|FG001|Overall Study|Withdrawal by Subject|1|||
129136075|NCT04576949|464791202|FG002|Overall Study|Physician Decision|0|||
129048820|NCT02731326|464472137|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
129048821|NCT02731326|464472138|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
129048822|NCT02731326|464472137|FG000|Overall Study|Discharged without AliveCor|10|||
129136076|NCT04576949|464791200|FG000|Overall Study|Death|0|||
129136077|NCT04576949|464791201|FG001|Overall Study|Death|1|||
129136078|NCT04576949|464791202|FG002|Overall Study|Death|0|||
128719405|NCT00405587|463271075|FG003|Overall Study|Death|1|||
128719406|NCT00405587|463271072|FG000|Overall Study|Disease Progression|22|||
129048823|NCT02731326|464472138|FG001|Overall Study|Discharged without AliveCor|0|||
129136079|NCT04576949|464791200|FG000|Overall Study|Lost to Follow-up|29|||
129136080|NCT04576949|464791201|FG001|Overall Study|Lost to Follow-up|37|||
129048824|NCT02731326|464472137|FG000|Overall Study|Duplicate Participant|1|||
129048825|NCT02731326|464472138|FG001|Overall Study|Duplicate Participant|1|||
129048826|NCT02272634|464472141|FG000|Overall Study|Adverse Event|1|||
129048827|NCT02272634|464472142|FG001|Overall Study|Adverse Event|0|||
129048828|NCT02272634|464472143|FG002|Overall Study|Adverse Event|0|||
129048829|NCT02272634|464472141|FG000|Overall Study|Protocol Violation|0|||
129048830|NCT02272634|464472142|FG001|Overall Study|Protocol Violation|0|||
129048831|NCT02272634|464472143|FG002|Overall Study|Protocol Violation|1|||
129048832|NCT02272634|464472141|FG000|Overall Study|Withdrawal by Subject|0|||
129048833|NCT02272634|464472142|FG001|Overall Study|Withdrawal by Subject|1|||
129048834|NCT02272634|464472143|FG002|Overall Study|Withdrawal by Subject|0|||
129048835|NCT01437943|464472145|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
129048836|NCT01437943|464472146|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
129048837|NCT01437943|464472145|FG000|Overall Study|Subject expressed pregnancy plans|1|||
129048838|NCT01437943|464472146|FG001|Overall Study|Subject expressed pregnancy plans|0|||
129048839|NCT01437943|464472145|FG000|Overall Study|Adverse Event|2|||
129048840|NCT01437943|464472146|FG001|Overall Study|Adverse Event|0|||
129048841|NCT00302081|464472147|FG000|Overall Study|Adverse Event|6|||
129048842|NCT00302081|464472148|FG001|Overall Study|Adverse Event|5|||
129048843|NCT00302081|464472149|FG002|Overall Study|Adverse Event|4|||
129048844|NCT00302081|464472147|FG000|Overall Study|Lost to Follow-up|21|||
129048845|NCT00302081|464472148|FG001|Overall Study|Lost to Follow-up|18|||
129048846|NCT00302081|464472149|FG002|Overall Study|Lost to Follow-up|28|||
129048847|NCT00302081|464472147|FG000|Overall Study|Withdrawal by Subject|8|||
129048848|NCT00302081|464472148|FG001|Overall Study|Withdrawal by Subject|12|||
129048849|NCT00302081|464472149|FG002|Overall Study|Withdrawal by Subject|8|||
129048850|NCT00302081|464472147|FG000|Overall Study|Protocol Violation|5|||
129048851|NCT00302081|464472148|FG001|Overall Study|Protocol Violation|1|||
129048852|NCT00302081|464472149|FG002|Overall Study|Protocol Violation|2|||
129048853|NCT00302081|464472147|FG000|Overall Study|Lack of Efficacy|1|||
129048854|NCT00302081|464472148|FG001|Overall Study|Lack of Efficacy|0|||
129048855|NCT00302081|464472149|FG002|Overall Study|Lack of Efficacy|5|||
129048856|NCT00302081|464472147|FG000|Overall Study|Death|2|||
129223294|NCT02112916|465118324|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
129223295|NCT02112916|465118325|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
129223296|NCT02112916|465118326|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
129223297|NCT02112916|465118327|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
129223298|NCT02254278|465118328|FG000|Overall Study|Protocol Violation|1|||
129223299|NCT02254278|465118329|FG001|Overall Study|Protocol Violation|1|||
129223300|NCT04238819|465118330|FG000|Overall Study|Ongoing Treatment|0|||
129223301|NCT04238819|465118331|FG001|Overall Study|Ongoing Treatment|0|||
129223302|NCT04238819|465118332|FG002|Overall Study|Ongoing Treatment|0|||
129223303|NCT04238819|465118333|FG003|Overall Study|Ongoing Treatment|0|||
129223304|NCT04238819|465118334|FG004|Overall Study|Ongoing Treatment|1|||
129223305|NCT04238819|465118335|FG005|Overall Study|Ongoing Treatment|4|||
129223306|NCT04238819|465118336|FG006|Overall Study|Ongoing Treatment|0|||
129223307|NCT04238819|465118330|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
129223308|NCT04238819|465118331|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
129223309|NCT04238819|465118332|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
129223310|NCT04238819|465118333|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
129223311|NCT04238819|465118334|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
129223312|NCT04238819|465118335|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
129223313|NCT04238819|465118336|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
129223314|NCT05774197|465118337|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
129223315|NCT04526665|465118339|FG000|Overall Study|Withdrawal by Subject|6|||
129223316|NCT04526665|465118340|FG001|Overall Study|Withdrawal by Subject|3|||
129223317|NCT04526665|465118339|FG000|Overall Study|Adverse Event|4|||
129223318|NCT04526665|465118340|FG001|Overall Study|Adverse Event|1|||
129223319|NCT04526665|465118339|FG000|Overall Study|Physician Decision|2|||
129223320|NCT04526665|465118340|FG001|Overall Study|Physician Decision|2|||
129048857|NCT00302081|464472148|FG001|Overall Study|Death|1|||
129048858|NCT00302081|464472149|FG002|Overall Study|Death|0|||
129048859|NCT00302081|464472147|FG000|Overall Study|Other|13|||
129048860|NCT00302081|464472148|FG001|Overall Study|Other|6|||
129048861|NCT00302081|464472149|FG002|Overall Study|Other|5|||
129223321|NCT04526665|465118339|FG000|Overall Study|Death|2|||
129223322|NCT04526665|465118340|FG001|Overall Study|Death|0|||
128775437|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
128775438|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
129048862|NCT04771403|464472150|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
129048863|NCT04771403|464472151|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
129048864|NCT04771403|464472150|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
129223323|NCT04526665|465118339|FG000|Overall Study|Other|0|||
129223324|NCT04526665|465118340|FG001|Overall Study|Other|1|||
129048865|NCT04771403|464472151|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
129048866|NCT04771403|464472150|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
129048867|NCT04771403|464472151|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
129048868|NCT04771403|464472150|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
129048869|NCT04771403|464472151|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
129048870|NCT04771403|464472150|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
129048871|NCT04771403|464472151|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
129048872|NCT04771403|464472150|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
129048873|NCT04771403|464472151|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
129048874|NCT04771403|464472150|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
129048875|NCT04771403|464472151|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
129048876|NCT04771403|464472150|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
129048877|NCT04771403|464472151|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
129048878|NCT05442866|464472152|FG000|Overall Study|Death|1|||
129048879|NCT05442866|464472152|FG000|Overall Study|Lost to Follow-up|9|||
129048880|NCT05442866|464472152|FG000|Overall Study|Protocol Violation|1|||
129048881|NCT03819049|464472153|FG000|Overall Study|Lost to Follow-up|1|||
129048882|NCT03819049|464472154|FG001|Overall Study|Lost to Follow-up|2|||
129048883|NCT03819049|464472155|FG002|Overall Study|Lost to Follow-up|9|||
129048884|NCT03819049|464472156|FG003|Overall Study|Lost to Follow-up|0|||
128719407|NCT00405587|463271073|FG001|Overall Study|Disease Progression|23|||
128719408|NCT00405587|463271074|FG002|Overall Study|Disease Progression|21|||
129048885|NCT03819049|464472157|FG004|Overall Study|Lost to Follow-up|3|||
129048886|NCT03819049|464472158|FG005|Overall Study|Lost to Follow-up|1|||
129048887|NCT03819049|464472159|FG006|Overall Study|Lost to Follow-up|0|||
129048888|NCT03819049|464472153|FG000|Overall Study|Withdrawal by Subject|0|||
129048889|NCT03819049|464472154|FG001|Overall Study|Withdrawal by Subject|0|||
129048890|NCT03819049|464472155|FG002|Overall Study|Withdrawal by Subject|18|||
129048891|NCT03819049|464472156|FG003|Overall Study|Withdrawal by Subject|0|||
129048892|NCT03819049|464472157|FG004|Overall Study|Withdrawal by Subject|10|||
129048893|NCT03819049|464472158|FG005|Overall Study|Withdrawal by Subject|9|||
129048894|NCT03819049|464472159|FG006|Overall Study|Withdrawal by Subject|1|||
129048895|NCT03819049|464472153|FG000|Overall Study|Ongoing|0|||
129048896|NCT03819049|464472154|FG001|Overall Study|Ongoing|0|||
129048897|NCT03819049|464472155|FG002|Overall Study|Ongoing|75|||
129048898|NCT03819049|464472156|FG003|Overall Study|Ongoing|0|||
129048899|NCT03819049|464472157|FG004|Overall Study|Ongoing|41|||
129048900|NCT03819049|464472158|FG005|Overall Study|Ongoing|0|||
129048901|NCT03819049|464472159|FG006|Overall Study|Ongoing|0|||
129048902|NCT03819049|464472153|FG000|Overall Study|Other|0|||
129048903|NCT03819049|464472154|FG001|Overall Study|Other|0|||
129048904|NCT03819049|464472155|FG002|Overall Study|Other|2|||
129048905|NCT03819049|464472156|FG003|Overall Study|Other|0|||
129048906|NCT03819049|464472157|FG004|Overall Study|Other|0|||
129048907|NCT03819049|464472158|FG005|Overall Study|Other|0|||
129048908|NCT03819049|464472159|FG006|Overall Study|Other|0|||
129048909|NCT03819049|464472153|FG000|Overall Study|Randomized but not vaccinated|0|||
129048910|NCT03819049|464472154|FG001|Overall Study|Randomized but not vaccinated|0|||
129048911|NCT03819049|464472155|FG002|Overall Study|Randomized but not vaccinated|0|||
129136081|NCT04576949|464791202|FG002|Overall Study|Lost to Follow-up|24|||
129136082|NCT04576949|464791200|FG000|Overall Study|Other, Not Specified|2|||
129136083|NCT04576949|464791201|FG001|Overall Study|Other, Not Specified|3|||
129136084|NCT04576949|464791202|FG002|Overall Study|Other, Not Specified|1|||
129136085|NCT04576949|464791200|FG000|Overall Study|Other|1|||
128719409|NCT00405587|463271075|FG003|Overall Study|Disease Progression|17|||
129048912|NCT03819049|464472156|FG003|Overall Study|Randomized but not vaccinated|1|||
129136086|NCT04576949|464791201|FG001|Overall Study|Other|0|||
128719410|NCT00405587|463271072|FG000|Overall Study|Physician Decision|3|||
128719411|NCT00405587|463271073|FG001|Overall Study|Physician Decision|2|||
129048913|NCT03819049|464472157|FG004|Overall Study|Randomized but not vaccinated|0|||
129048914|NCT03819049|464472158|FG005|Overall Study|Randomized but not vaccinated|2|||
129136087|NCT04576949|464791202|FG002|Overall Study|Other|0|||
129136088|NCT00052715|464791203|FG000|Overall Study|wrong histology|1|||
129136089|NCT01063881|464791204|FG000|Overall Study|Adverse Event|12|||
129136090|NCT01063881|464791205|FG001|Overall Study|Adverse Event|2|||
129136091|NCT01063881|464791206|FG002|Overall Study|Adverse Event|0|||
128719412|NCT00405587|463271074|FG002|Overall Study|Physician Decision|0|||
128719413|NCT00405587|463271075|FG003|Overall Study|Physician Decision|0|||
128719414|NCT00405587|463271072|FG000|Overall Study|Adverse Event|1|||
128719415|NCT00405587|463271073|FG001|Overall Study|Adverse Event|0|||
129048915|NCT03819049|464472159|FG006|Overall Study|Randomized but not vaccinated|1|||
129048916|NCT03819049|464472153|FG000|Overall Study|Physician Decision|0|||
129048917|NCT03819049|464472154|FG001|Overall Study|Physician Decision|0|||
129048918|NCT03819049|464472155|FG002|Overall Study|Physician Decision|0|||
129048919|NCT03819049|464472156|FG003|Overall Study|Physician Decision|0|||
129048920|NCT03819049|464472157|FG004|Overall Study|Physician Decision|0|||
129048921|NCT03819049|464472158|FG005|Overall Study|Physician Decision|0|||
129048922|NCT03819049|464472159|FG006|Overall Study|Physician Decision|1|||
129048923|NCT01986010|464472160|FG000|Overall Study|Adverse Event|0|||
129048924|NCT01986010|464472161|FG001|Overall Study|Adverse Event|1|||
129048925|NCT01986010|464472162|FG002|Overall Study|Adverse Event|0|||
129048926|NCT01986010|464472163|FG003|Overall Study|Adverse Event|0|||
129048927|NCT01986010|464472164|FG004|Overall Study|Adverse Event|0|||
129048928|NCT01986010|464472165|FG005|Overall Study|Adverse Event|0|||
129048929|NCT01986010|464472166|FG006|Overall Study|Adverse Event|0|||
129048930|NCT01986010|464472167|FG007|Overall Study|Adverse Event|0|||
129048931|NCT01986010|464472168|FG008|Overall Study|Adverse Event|0|||
129048932|NCT01986010|464472169|FG009|Overall Study|Adverse Event|0|||
129048933|NCT01986010|464472170|FG010|Overall Study|Adverse Event|0|||
129048934|NCT01986010|464472171|FG011|Overall Study|Adverse Event|0|||
129048935|NCT01986010|464472172|FG012|Overall Study|Adverse Event|0|||
129048936|NCT01986010|464472173|FG013|Overall Study|Adverse Event|0|||
129048937|NCT01986010|464472174|FG014|Overall Study|Adverse Event|0|||
129048938|NCT01986010|464472175|FG015|Overall Study|Adverse Event|1|||
129048939|NCT01986010|464472176|FG016|Overall Study|Adverse Event|0|||
129048940|NCT01986010|464472160|FG000|Overall Study|Lost to Follow-up|2|||
129048941|NCT01986010|464472161|FG001|Overall Study|Lost to Follow-up|1|||
129048942|NCT01986010|464472162|FG002|Overall Study|Lost to Follow-up|2|||
129048943|NCT01986010|464472163|FG003|Overall Study|Lost to Follow-up|2|||
129048944|NCT01986010|464472164|FG004|Overall Study|Lost to Follow-up|2|||
129048945|NCT01986010|464472165|FG005|Overall Study|Lost to Follow-up|2|||
129048946|NCT01986010|464472166|FG006|Overall Study|Lost to Follow-up|0|||
129048947|NCT01986010|464472167|FG007|Overall Study|Lost to Follow-up|0|||
129048948|NCT01986010|464472168|FG008|Overall Study|Lost to Follow-up|4|||
129048949|NCT01986010|464472169|FG009|Overall Study|Lost to Follow-up|2|||
129048950|NCT01986010|464472170|FG010|Overall Study|Lost to Follow-up|0|||
129048951|NCT01986010|464472171|FG011|Overall Study|Lost to Follow-up|1|||
129048952|NCT01986010|464472172|FG012|Overall Study|Lost to Follow-up|1|||
129048953|NCT01986010|464472173|FG013|Overall Study|Lost to Follow-up|1|||
129048954|NCT01986010|464472174|FG014|Overall Study|Lost to Follow-up|2|||
129048955|NCT01986010|464472175|FG015|Overall Study|Lost to Follow-up|0|||
129048956|NCT01986010|464472176|FG016|Overall Study|Lost to Follow-up|0|||
129048957|NCT01986010|464472160|FG000|Overall Study|Physician Decision|0|||
129048958|NCT01986010|464472161|FG001|Overall Study|Physician Decision|0|||
129048959|NCT01986010|464472162|FG002|Overall Study|Physician Decision|0|||
129048960|NCT01986010|464472163|FG003|Overall Study|Physician Decision|0|||
129048961|NCT01986010|464472164|FG004|Overall Study|Physician Decision|0|||
129048962|NCT01986010|464472165|FG005|Overall Study|Physician Decision|0|||
129048963|NCT01986010|464472166|FG006|Overall Study|Physician Decision|0|||
129048964|NCT01986010|464472167|FG007|Overall Study|Physician Decision|0|||
129048965|NCT01986010|464472168|FG008|Overall Study|Physician Decision|0|||
129048966|NCT01986010|464472169|FG009|Overall Study|Physician Decision|0|||
129048967|NCT01986010|464472170|FG010|Overall Study|Physician Decision|0|||
129048968|NCT01986010|464472171|FG011|Overall Study|Physician Decision|0|||
129048969|NCT01986010|464472172|FG012|Overall Study|Physician Decision|0|||
129048970|NCT01986010|464472173|FG013|Overall Study|Physician Decision|0|||
129048971|NCT01986010|464472174|FG014|Overall Study|Physician Decision|1|||
129048972|NCT01986010|464472175|FG015|Overall Study|Physician Decision|0|||
129048973|NCT01986010|464472176|FG016|Overall Study|Physician Decision|0|||
129048974|NCT01986010|464472160|FG000|Overall Study|Withdrawal by Subject|2|||
129048975|NCT01986010|464472161|FG001|Overall Study|Withdrawal by Subject|2|||
129048976|NCT01986010|464472162|FG002|Overall Study|Withdrawal by Subject|3|||
129048977|NCT01986010|464472163|FG003|Overall Study|Withdrawal by Subject|0|||
129136092|NCT01063881|464791204|FG000|Overall Study|Lost to Follow-up|13|||
129048978|NCT01986010|464472164|FG004|Overall Study|Withdrawal by Subject|2|||
129048979|NCT01986010|464472165|FG005|Overall Study|Withdrawal by Subject|4|||
129048980|NCT01986010|464472166|FG006|Overall Study|Withdrawal by Subject|0|||
129048981|NCT01986010|464472167|FG007|Overall Study|Withdrawal by Subject|0|||
129136093|NCT01063881|464791205|FG001|Overall Study|Lost to Follow-up|7|||
129136094|NCT01063881|464791206|FG002|Overall Study|Lost to Follow-up|1|||
129136095|NCT01063881|464791204|FG000|Overall Study|Withdrawal by Subject|25|||
129048982|NCT01986010|464472168|FG008|Overall Study|Withdrawal by Subject|0|||
129048983|NCT01986010|464472169|FG009|Overall Study|Withdrawal by Subject|0|||
129048984|NCT01986010|464472170|FG010|Overall Study|Withdrawal by Subject|0|||
129048985|NCT01986010|464472171|FG011|Overall Study|Withdrawal by Subject|2|||
129048986|NCT01986010|464472172|FG012|Overall Study|Withdrawal by Subject|0|||
129048987|NCT01986010|464472173|FG013|Overall Study|Withdrawal by Subject|1|||
129048988|NCT01986010|464472174|FG014|Overall Study|Withdrawal by Subject|2|||
129048989|NCT01986010|464472175|FG015|Overall Study|Withdrawal by Subject|0|||
129048990|NCT01986010|464472176|FG016|Overall Study|Withdrawal by Subject|0|||
129136096|NCT01063881|464791205|FG001|Overall Study|Withdrawal by Subject|1|||
129136097|NCT01063881|464791206|FG002|Overall Study|Withdrawal by Subject|0|||
129048991|NCT01986010|464472160|FG000|Overall Study|Status Not Recorded|2|||
129048992|NCT01986010|464472161|FG001|Overall Study|Status Not Recorded|4|||
129048993|NCT01986010|464472162|FG002|Overall Study|Status Not Recorded|2|||
129048994|NCT01986010|464472163|FG003|Overall Study|Status Not Recorded|0|||
129048995|NCT01986010|464472164|FG004|Overall Study|Status Not Recorded|1|||
129048996|NCT01986010|464472165|FG005|Overall Study|Status Not Recorded|2|||
129048997|NCT01986010|464472166|FG006|Overall Study|Status Not Recorded|0|||
129048998|NCT01986010|464472167|FG007|Overall Study|Status Not Recorded|0|||
129048999|NCT01986010|464472168|FG008|Overall Study|Status Not Recorded|2|||
129049000|NCT01986010|464472169|FG009|Overall Study|Status Not Recorded|1|||
129049001|NCT01986010|464472170|FG010|Overall Study|Status Not Recorded|7|||
129049002|NCT01986010|464472171|FG011|Overall Study|Status Not Recorded|7|||
129049003|NCT01986010|464472172|FG012|Overall Study|Status Not Recorded|9|||
129049004|NCT01986010|464472173|FG013|Overall Study|Status Not Recorded|9|||
129049005|NCT01986010|464472174|FG014|Overall Study|Status Not Recorded|5|||
129049006|NCT01986010|464472175|FG015|Overall Study|Status Not Recorded|10|||
129049007|NCT01986010|464472176|FG016|Overall Study|Status Not Recorded|4|||
129049008|NCT01335997|464472177|FG000|Period I and II|Adverse Event|63|||
129049009|NCT01335997|464472178|FG001|Period I and II|Adverse Event|43|||
129049010|NCT01335997|464472177|FG000|Period I and II|Noncompliance with Study Drug|1|||
129049011|NCT01335997|464472178|FG001|Period I and II|Noncompliance with Study Drug|1|||
129049012|NCT01335997|464472177|FG000|Period I and II|Lost to Follow-up|3|||
129049013|NCT01335997|464472178|FG001|Period I and II|Lost to Follow-up|5|||
129049014|NCT01335997|464472177|FG000|Period I and II|Withdrawal by Subject|9|||
129049015|NCT01335997|464472178|FG001|Period I and II|Withdrawal by Subject|4|||
129049016|NCT01335997|464472177|FG000|Period I and II|Study Terminated by Sponsor|406|||
129049017|NCT01335997|464472178|FG001|Period I and II|Study Terminated by Sponsor|415|||
129049018|NCT01335997|464472177|FG000|Period I and II|Protocol Violation|9|||
129049019|NCT01335997|464472178|FG001|Period I and II|Protocol Violation|10|||
129049020|NCT01335997|464472177|FG000|Period I and II|Physician Decision|2|||
129049021|NCT01335997|464472178|FG001|Period I and II|Physician Decision|1|||
129049022|NCT01335997|464472177|FG000|Period III|Adverse Event|0|||
129049023|NCT01335997|464472178|FG001|Period III|Adverse Event|2|||
129049024|NCT01335997|464472177|FG000|Period III|Study Terminated by Sponsor|77|||
129049025|NCT01335997|464472178|FG001|Period III|Study Terminated by Sponsor|76|||
129049026|NCT01335997|464472177|FG000|Period III|Protocol Violation|0|||
129049027|NCT01335997|464472178|FG001|Period III|Protocol Violation|1|||
129049028|NCT01335997|464472177|FG000|Period III|Lost to Follow-up|1|||
129049029|NCT01335997|464472178|FG001|Period III|Lost to Follow-up|0|||
129049030|NCT04740814|464472179|FG000|Overall Study|Adverse Event|3|||
129049031|NCT04740814|464472179|FG000|Overall Study|Protocol Violation|2|||
129049032|NCT04740814|464472179|FG000|Overall Study|Lost to Follow-up|2|||
129049033|NCT04740814|464472179|FG000|Overall Study|Withdrawal by Subject|3|||
129049034|NCT02500641|464472182|FG000|Overall Study|Adverse Event|0|||
129049035|NCT02500641|464472183|FG001|Overall Study|Adverse Event|2|||
129049036|NCT02500641|464472182|FG000|Overall Study|Withdrawal by Subject|4|||
129049037|NCT02500641|464472183|FG001|Overall Study|Withdrawal by Subject|5|||
129049038|NCT02500641|464472182|FG000|Overall Study|Unable to follow study procedures|3|||
129049039|NCT02500641|464472183|FG001|Overall Study|Unable to follow study procedures|2|||
129049040|NCT02500641|464472182|FG000|Overall Study|Protocol Violation|1|||
129049041|NCT02500641|464472183|FG001|Overall Study|Protocol Violation|2|||
129049042|NCT02500641|464472182|FG000|Overall Study|Lost to Follow-up|1|||
129049043|NCT02500641|464472183|FG001|Overall Study|Lost to Follow-up|0|||
129049044|NCT02500641|464472182|FG000|Overall Study|Sponsor decision|1|||
129049045|NCT02500641|464472183|FG001|Overall Study|Sponsor decision|0|||
129049046|NCT02500641|464472182|FG000|Overall Study|Non compliance to study drug|0|||
129049047|NCT02500641|464472183|FG001|Overall Study|Non compliance to study drug|1|||
129049048|NCT01763684|464472185|FG000|Overall Study|Study terminated early due to low enrollment|126|||
129049049|NCT01763684|464472186|FG001|Overall Study|Study terminated early due to low enrollment|127|||
129049050|NCT01763684|464472185|FG000|Overall Study|Study surgery not performed|7|||
129049051|NCT01763684|464472186|FG001|Overall Study|Study surgery not performed|6|||
129049052|NCT00643565|464472187|FG000|Overall Study|Death|12|||
129049053|NCT00643565|464472188|FG001|Overall Study|Death|11|||
129049054|NCT00643565|464472187|FG000|Overall Study|Withdrawal by Subject|4|||
129049055|NCT00643565|464472188|FG001|Overall Study|Withdrawal by Subject|1|||
129049056|NCT00643565|464472187|FG000|Overall Study|Lost to Follow-up|0|||
129049057|NCT00643565|464472188|FG001|Overall Study|Lost to Follow-up|6|||
129049058|NCT00643565|464472187|FG000|Overall Study|Other|7|||
129049059|NCT00643565|464472188|FG001|Overall Study|Other|8|||
129049060|NCT00643565|464472187|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
129049061|NCT00643565|464472188|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
129049062|NCT00643565|464472187|FG000|Overall Study|Recurrence of Disease|2|||
129049063|NCT00643565|464472188|FG001|Overall Study|Recurrence of Disease|1|||
129049064|NCT00643565|464472187|FG000|Overall Study|Progression of Disease|18|||
129049065|NCT00643565|464472188|FG001|Overall Study|Progression of Disease|14|||
129049066|NCT00643565|464472187|FG000|Overall Study|Protocol Violation|3|||
129049067|NCT00643565|464472188|FG001|Overall Study|Protocol Violation|0|||
129049068|NCT00643565|464472187|FG000|Overall Study|Did Not Cooperate|0|||
129049069|NCT00643565|464472188|FG001|Overall Study|Did Not Cooperate|1|||
129049070|NCT00643565|464472187|FG000|Overall Study|Administrative|22|||
129049071|NCT00643565|464472188|FG001|Overall Study|Administrative|16|||
129049072|NCT00643565|464472187|FG000|Overall Study|Adverse Event|5|||
129049073|NCT00643565|464472188|FG001|Overall Study|Adverse Event|8|||
129049074|NCT02317614|464472189|FG000|Overall Study|Lost to Follow-up|1|||
129049075|NCT02317614|464472190|FG001|Overall Study|Lost to Follow-up|1|||
129049076|NCT02317614|464472189|FG000|Overall Study|Withdrawal by Subject|1|||
129049077|NCT02317614|464472190|FG001|Overall Study|Withdrawal by Subject|0|||
129049078|NCT02317614|464472189|FG000|Overall Study|Death|1|||
129049079|NCT02317614|464472190|FG001|Overall Study|Death|1|||
129049080|NCT00669071|464472195|FG000|Overall Study|Lost to Follow-up|3|||
129049081|NCT00669071|464472195|FG000|Overall Study|Final visit 40 days out of window|1|||
129049082|NCT02980874|464472196|FG000|Overall Study|Adverse Event|2|||
129049083|NCT02980874|464472197|FG001|Overall Study|Adverse Event|7|||
129049084|NCT02980874|464472196|FG000|Overall Study|Withdrawal by Subject|7|||
129049085|NCT02980874|464472197|FG001|Overall Study|Withdrawal by Subject|2|||
129049086|NCT02980874|464472196|FG000|Overall Study|Lost to Follow-up|5|||
129049087|NCT02980874|464472197|FG001|Overall Study|Lost to Follow-up|5|||
129049088|NCT02980874|464472196|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
129049089|NCT02980874|464472197|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
129049090|NCT02980874|464472196|FG000|Overall Study|Unknown study completion status|1|||
129049091|NCT02980874|464472197|FG001|Overall Study|Unknown study completion status|0|||
129049092|NCT06077487|464474258|FG000|Overall Study|Withdrawal by Subject|0|||
129049093|NCT06077487|464474259|FG001|Overall Study|Withdrawal by Subject|1|||
129049094|NCT00759902|464474261|FG000|Overall Study|Adverse Event|0|||
129049095|NCT00759902|464474262|FG001|Overall Study|Adverse Event|1|||
129049096|NCT02128217|464474265|FG000|Overall Study|Lost to Follow-up|0|||
129049097|NCT02128217|464474266|FG001|Overall Study|Lost to Follow-up|1|||
129049098|NCT05071313|464474267|FG000|Overall Study|Lost to Follow-up|17|||
129049099|NCT05071313|464474268|FG001|Overall Study|Lost to Follow-up|10|||
129049100|NCT05071313|464474267|FG000|Overall Study|Physician Decision|1|||
129049101|NCT05071313|464474268|FG001|Overall Study|Physician Decision|6|||
129049102|NCT05071313|464474267|FG000|Overall Study|Death|1|||
129049103|NCT05071313|464474268|FG001|Overall Study|Death|0|||
129049104|NCT05071313|464474267|FG000|Overall Study|Withdrawal by Subject|10|||
129049105|NCT05071313|464474268|FG001|Overall Study|Withdrawal by Subject|15|||
129049106|NCT05071313|464474267|FG000|Overall Study|Other|1|||
129049107|NCT05071313|464474268|FG001|Overall Study|Other|0|||
129049108|NCT05071313|464474267|FG000|Overall Study|Randomized but not vaccinated|4|||
129049109|NCT05071313|464474268|FG001|Overall Study|Randomized but not vaccinated|2|||
129049110|NCT03107026|464474269|FG000|Overall Study|Adverse Event|2|||
129049111|NCT03107026|464474270|FG001|Overall Study|Adverse Event|14|||
129049112|NCT03107026|464474271|FG002|Overall Study|Adverse Event|23|||
129049113|NCT03107026|464474269|FG000|Overall Study|Lost to Follow-up|12|||
129049114|NCT03107026|464474270|FG001|Overall Study|Lost to Follow-up|12|||
129049115|NCT03107026|464474271|FG002|Overall Study|Lost to Follow-up|13|||
129049116|NCT03107026|464474269|FG000|Overall Study|Protocol Violation|1|||
129049117|NCT03107026|464474270|FG001|Overall Study|Protocol Violation|2|||
129049118|NCT03107026|464474271|FG002|Overall Study|Protocol Violation|0|||
129049119|NCT03107026|464474269|FG000|Overall Study|Pregnancy|1|||
129049120|NCT03107026|464474270|FG001|Overall Study|Pregnancy|0|||
129049121|NCT03107026|464474271|FG002|Overall Study|Pregnancy|0|||
129049122|NCT03107026|464474269|FG000|Overall Study|Withdrawal by Subject|13|||
129049123|NCT03107026|464474270|FG001|Overall Study|Withdrawal by Subject|5|||
129049124|NCT03107026|464474271|FG002|Overall Study|Withdrawal by Subject|17|||
129049125|NCT03107026|464474269|FG000|Overall Study|non compliance with study visits|1|||
129049126|NCT03107026|464474270|FG001|Overall Study|non compliance with study visits|2|||
129049127|NCT03107026|464474271|FG002|Overall Study|non compliance with study visits|0|||
129049128|NCT03107026|464474269|FG000|Overall Study|non-compliance with study drug|2|||
129049129|NCT03107026|464474270|FG001|Overall Study|non-compliance with study drug|2|||
129049130|NCT03107026|464474271|FG002|Overall Study|non-compliance with study drug|3|||
129049131|NCT03107026|464474269|FG000|Overall Study|Physician Decision|0|||
129049132|NCT03107026|464474270|FG001|Overall Study|Physician Decision|1|||
129049133|NCT03107026|464474271|FG002|Overall Study|Physician Decision|0|||
129049134|NCT02049450|464474272|FG000|Overall Study|Adverse Event|2|||
129049135|NCT02049450|464474272|FG000|Overall Study|Withdrawal by Subject|1|||
129049136|NCT02049450|464474272|FG000|Overall Study|Patients/guardian decision|1|||
129049137|NCT01561430|464474278|FG000|Overall Study|Adverse Event|0|||
129049138|NCT01561430|464474279|FG001|Overall Study|Adverse Event|0|||
129049139|NCT01561430|464474280|FG002|Overall Study|Adverse Event|3|||
129049140|NCT01561430|464474281|FG003|Overall Study|Adverse Event|1|||
129049141|NCT01561430|464474278|FG000|Overall Study|Withdrawal by Subject|0|||
129049142|NCT01561430|464474279|FG001|Overall Study|Withdrawal by Subject|0|||
129049143|NCT01561430|464474280|FG002|Overall Study|Withdrawal by Subject|1|||
128719416|NCT00405587|463271074|FG002|Overall Study|Adverse Event|0|||
128719417|NCT00405587|463271075|FG003|Overall Study|Adverse Event|0|||
128719418|NCT00405587|463271072|FG000|Overall Study|Lost to Follow-up|0|||
128719419|NCT00405587|463271073|FG001|Overall Study|Lost to Follow-up|1|||
129049144|NCT01561430|464474281|FG003|Overall Study|Withdrawal by Subject|0|||
129049145|NCT01561430|464474278|FG000|Overall Study|Physician Decision|0|||
129049146|NCT01561430|464474279|FG001|Overall Study|Physician Decision|1|||
129049147|NCT01561430|464474280|FG002|Overall Study|Physician Decision|0|||
129049148|NCT01561430|464474281|FG003|Overall Study|Physician Decision|0|||
129049149|NCT01561430|464474278|FG000|Overall Study|Sponsor Decision|1|||
129049150|NCT01561430|464474279|FG001|Overall Study|Sponsor Decision|14|||
129049151|NCT01561430|464474280|FG002|Overall Study|Sponsor Decision|13|||
129049152|NCT01561430|464474281|FG003|Overall Study|Sponsor Decision|12|||
129049153|NCT03347422|464474282|FG000|Part A (26 Weeks)|Adverse Event|3|||
129049154|NCT03347422|464474283|FG001|Part A (26 Weeks)|Adverse Event|0|||
129049155|NCT03347422|464474282|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
129049156|NCT03347422|464474283|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
129049157|NCT03347422|464474282|FG000|Part B (149 Weeks)|Adverse Event|0|||
129049158|NCT03347422|464474283|FG001|Part B (149 Weeks)|Adverse Event|1|||
129049159|NCT03347422|464474282|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
129049160|NCT03347422|464474283|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
129049161|NCT03347422|464474282|FG000|Part B (149 Weeks)|Other|1|||
129049162|NCT03347422|464474283|FG001|Part B (149 Weeks)|Other|0|||
129049163|NCT00415194|464474287|FG000|Overall Study|Adverse Event|37|||
129049164|NCT00415194|464474288|FG001|Overall Study|Adverse Event|32|||
129049165|NCT00415194|464474287|FG000|Overall Study|Entry Criteria Not Met|4|||
129049166|NCT00415194|464474288|FG001|Overall Study|Entry Criteria Not Met|8|||
129049167|NCT00415194|464474287|FG000|Overall Study|Lost to Follow-up|1|||
129049168|NCT00415194|464474288|FG001|Overall Study|Lost to Follow-up|0|||
129049169|NCT00415194|464474287|FG000|Overall Study|Physician Decision|10|||
129049170|NCT00415194|464474288|FG001|Overall Study|Physician Decision|16|||
129049171|NCT00415194|464474287|FG000|Overall Study|Progressive Disease|180|||
129049172|NCT00415194|464474288|FG001|Overall Study|Progressive Disease|217|||
129049173|NCT00415194|464474287|FG000|Overall Study|Protocol Violation|4|||
129049174|NCT00415194|464474288|FG001|Overall Study|Protocol Violation|2|||
129049175|NCT00415194|464474287|FG000|Overall Study|Withdrawal by Subject|28|||
129049176|NCT00415194|464474288|FG001|Overall Study|Withdrawal by Subject|21|||
129049177|NCT00415194|464474287|FG000|Overall Study|Death Due to Study Disease|26|||
129049178|NCT00415194|464474288|FG001|Overall Study|Death Due to Study Disease|29|||
129049179|NCT00415194|464474287|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
129049180|NCT00415194|464474288|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
129049181|NCT00415194|464474287|FG000|Overall Study|Death Due to Procedural Related AE|0|||
129049182|NCT00415194|464474288|FG001|Overall Study|Death Due to Procedural Related AE|1|||
129049183|NCT00415194|464474287|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
129049184|NCT00415194|464474288|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
129049185|NCT01297465|464474289|FG000|Overall Study|Lack of Ovarian Response|1|||
129049186|NCT01297465|464474290|FG001|Overall Study|Lack of Ovarian Response|1|||
129049187|NCT01297465|464474289|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129049188|NCT01297465|464474290|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129049189|NCT01297465|464474289|FG000|Overall Study|No Oocytes Retrieved|1|||
129049190|NCT01297465|464474290|FG001|Overall Study|No Oocytes Retrieved|1|||
129049191|NCT01297465|464474289|FG000|Overall Study|Poor oocyte quality|0|||
129049192|NCT01297465|464474290|FG001|Overall Study|Poor oocyte quality|1|||
129049193|NCT01297465|464474289|FG000|Overall Study|No Fertilization|6|||
129049194|NCT01297465|464474290|FG001|Overall Study|No Fertilization|4|||
129049195|NCT01297465|464474289|FG000|Overall Study|All Embryos Discarded|0|||
129049196|NCT01297465|464474290|FG001|Overall Study|All Embryos Discarded|1|||
129049197|NCT01297465|464474289|FG000|Overall Study|Intention to Freeze all Embryos|0|||
129049198|NCT01297465|464474290|FG001|Overall Study|Intention to Freeze all Embryos|1|||
128719420|NCT00405587|463271074|FG002|Overall Study|Lost to Follow-up|1|||
128719421|NCT00405587|463271075|FG003|Overall Study|Lost to Follow-up|0|||
129049199|NCT00969540|464474291|FG000|Overall Study|Lost to Follow-up|1|||
129049200|NCT00969540|464474292|FG001|Overall Study|Lost to Follow-up|1|||
128719422|NCT00405587|463271072|FG000|Overall Study|Radiation induced necrosis|0|||
128719423|NCT00405587|463271073|FG001|Overall Study|Radiation induced necrosis|1|||
129049201|NCT00369655|464474293|FG000|Overall Study|Refusal of further treatment|2|||
129049202|NCT02397408|464474294|FG000|Overall Study|Physician Decision|4|||
129049203|NCT02397408|464474294|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
129049204|NCT01646138|464474295|FG000|Overall Study|Lost to Follow-up|0|||
128719424|NCT00405587|463271074|FG002|Overall Study|Radiation induced necrosis|0|||
128719425|NCT00405587|463271075|FG003|Overall Study|Radiation induced necrosis|0|||
129049205|NCT01646138|464474296|FG001|Overall Study|Lost to Follow-up|0|||
129049206|NCT01646138|464474297|FG002|Overall Study|Lost to Follow-up|0|||
129049207|NCT01646138|464474298|FG003|Overall Study|Lost to Follow-up|0|||
129049208|NCT01646138|464474299|FG004|Overall Study|Lost to Follow-up|2|||
129049209|NCT01683838|464474300|FG000|Overall Study|Adverse Event|12|||
129049210|NCT01683838|464474301|FG001|Overall Study|Adverse Event|2|||
129136098|NCT01063881|464791204|FG000|Overall Study|Reason for not completed not specified|5|||
129136099|NCT01063881|464791205|FG001|Overall Study|Reason for not completed not specified|1|||
129136100|NCT01063881|464791206|FG002|Overall Study|Reason for not completed not specified|0|||
129136101|NCT01489358|464791207|FG000|Overall Study|Lost to Follow-up|0|||
129136102|NCT01489358|464791208|FG001|Overall Study|Lost to Follow-up|0|||
129136103|NCT01489358|464791209|FG002|Overall Study|Lost to Follow-up|2|||
129136104|NCT00736476|464791210|FG000|Overall Study|Adverse Event|1|||
129136105|NCT00736476|464791211|FG001|Overall Study|Adverse Event|0|||
129049211|NCT01683838|464474300|FG000|Overall Study|Protocol Violation|3|||
129049212|NCT01683838|464474301|FG001|Overall Study|Protocol Violation|1|||
129049213|NCT01683838|464474300|FG000|Overall Study|Withdrawal by Subject|6|||
129049214|NCT01683838|464474301|FG001|Overall Study|Withdrawal by Subject|5|||
129049215|NCT01683838|464474300|FG000|Overall Study|Lost to Follow-up|1|||
129049216|NCT01683838|464474301|FG001|Overall Study|Lost to Follow-up|1|||
129049217|NCT01683838|464474300|FG000|Overall Study|Other|4|||
129049218|NCT01683838|464474301|FG001|Overall Study|Other|3|||
129049219|NCT04049617|464474302|FG000|Overall Study|Adverse Event|0|||
129049220|NCT04049617|464474303|FG001|Overall Study|Adverse Event|0|||
129049221|NCT04049617|464474304|FG002|Overall Study|Adverse Event|0|||
129049222|NCT04049617|464474305|FG003|Overall Study|Adverse Event|1|||
129049223|NCT04049617|464474306|FG004|Overall Study|Adverse Event|0|||
129049224|NCT04049617|464474307|FG005|Overall Study|Adverse Event|0|||
129049225|NCT04049617|464474302|FG000|Overall Study|Death|0|||
129049226|NCT04049617|464474303|FG001|Overall Study|Death|0|||
129049227|NCT04049617|464474304|FG002|Overall Study|Death|0|||
129049228|NCT04049617|464474305|FG003|Overall Study|Death|0|||
129049229|NCT04049617|464474306|FG004|Overall Study|Death|0|||
129049230|NCT04049617|464474307|FG005|Overall Study|Death|1|||
129049231|NCT04049617|464474302|FG000|Overall Study|Lost to Follow-up|0|||
129049232|NCT04049617|464474303|FG001|Overall Study|Lost to Follow-up|0|||
129049233|NCT04049617|464474304|FG002|Overall Study|Lost to Follow-up|0|||
129049234|NCT04049617|464474305|FG003|Overall Study|Lost to Follow-up|1|||
129049235|NCT04049617|464474306|FG004|Overall Study|Lost to Follow-up|0|||
129049236|NCT04049617|464474307|FG005|Overall Study|Lost to Follow-up|0|||
129049237|NCT04049617|464474302|FG000|Overall Study|Withdrew consent|0|||
129049238|NCT04049617|464474303|FG001|Overall Study|Withdrew consent|0|||
129049239|NCT04049617|464474304|FG002|Overall Study|Withdrew consent|1|||
129049240|NCT04049617|464474305|FG003|Overall Study|Withdrew consent|0|||
129049241|NCT04049617|464474306|FG004|Overall Study|Withdrew consent|0|||
129049242|NCT04049617|464474307|FG005|Overall Study|Withdrew consent|0|||
129049243|NCT03551496|464474308|FG000|Overall Study|Death|11|||
129136106|NCT03518203|464791216|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
129136107|NCT03518203|464791216|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
129136108|NCT03511066|464791219|FG000|Overall Study|Withdrawal by Subject|1|||
129136109|NCT03511066|464791220|FG001|Overall Study|Withdrawal by Subject|2|||
129136110|NCT03511066|464791221|FG002|Overall Study|Withdrawal by Subject|3|||
129136111|NCT03511066|464791219|FG000|Overall Study|Lost to Follow-up|2|||
129136112|NCT03511066|464791220|FG001|Overall Study|Lost to Follow-up|3|||
129049244|NCT03551496|464474309|FG001|Overall Study|Death|7|||
129049245|NCT03551496|464474308|FG000|Overall Study|Withdrawal by Subject|4|||
129049246|NCT03551496|464474309|FG001|Overall Study|Withdrawal by Subject|3|||
129049247|NCT03551496|464474308|FG000|Overall Study|Other Reasons|1|||
129049248|NCT03551496|464474309|FG001|Overall Study|Other Reasons|0|||
129049249|NCT01524679|464474310|FG000|Overall Study|Lost to Follow-up|1|||
129049250|NCT01524679|464474311|FG001|Overall Study|Lost to Follow-up|4|||
129049251|NCT01524679|464474310|FG000|Overall Study|Withdrawal by Subject|4|||
129049252|NCT01524679|464474311|FG001|Overall Study|Withdrawal by Subject|4|||
129049253|NCT01524679|464474310|FG000|Overall Study|Adverse Event|9|||
129136113|NCT03511066|464791221|FG002|Overall Study|Lost to Follow-up|0|||
129136114|NCT00567112|464791222|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
129136115|NCT00567112|464791223|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
129223325|NCT03892967|465118341|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
129049254|NCT01524679|464474311|FG001|Overall Study|Adverse Event|0|||
129049255|NCT01524679|464474310|FG000|Overall Study|Protocol Violation|1|||
129049256|NCT01524679|464474311|FG001|Overall Study|Protocol Violation|0|||
129136116|NCT00567112|464791224|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
129136117|NCT00567112|464791222|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
129049257|NCT01524679|464474310|FG000|Overall Study|Lack of Efficacy|2|||
129049258|NCT01524679|464474311|FG001|Overall Study|Lack of Efficacy|0|||
129049259|NCT01524679|464474310|FG000|Overall Study|e.g.wish for children, relocation|6|||
129049260|NCT01524679|464474311|FG001|Overall Study|e.g.wish for children, relocation|1|||
129049261|NCT00801099|464474312|FG000|Overall Study|Lost to Follow-up|101|||
129049262|NCT03321630|464474315|FG000|Overall Study|Adverse Event|1|||
129049263|NCT03321630|464474315|FG000|Overall Study|Investigator Discretion|2|||
129049264|NCT03321630|464474315|FG000|Overall Study|Withdrawal by Subject|1|||
129049265|NCT02455050|464474316|FG000|Treatment Period 1|Lost to Follow-up|1|||
129049266|NCT02455050|464474317|FG001|Treatment Period 1|Lost to Follow-up|1|||
128719426|NCT00405587|463271072|FG000|Overall Study|Withdrawal by Subject|0|||
128719427|NCT00405587|463271073|FG001|Overall Study|Withdrawal by Subject|0|||
128719428|NCT00405587|463271074|FG002|Overall Study|Withdrawal by Subject|0|||
128719429|NCT00405587|463271075|FG003|Overall Study|Withdrawal by Subject|2|||
128719430|NCT00405587|463271072|FG000|Overall Study|Participant not dosed|0|||
128719431|NCT00405587|463271073|FG001|Overall Study|Participant not dosed|1|||
128719432|NCT00405587|463271074|FG002|Overall Study|Participant not dosed|0|||
128719433|NCT00405587|463271075|FG003|Overall Study|Participant not dosed|0|||
128719434|NCT06027866|463271076|FG000|Overall Study|Withdrawal by Subject|2|||
128719435|NCT00507442|463271077|FG000|Overall Study|Adverse Event|8|||
128719436|NCT00507442|463271078|FG001|Overall Study|Adverse Event|11|||
128719437|NCT00507442|463271079|FG002|Overall Study|Adverse Event|4|||
128719438|NCT00507442|463271080|FG003|Overall Study|Adverse Event|1|||
128719439|NCT00507442|463271077|FG000|Overall Study|Protocol Violation|0|||
128719440|NCT00507442|463271078|FG001|Overall Study|Protocol Violation|1|||
128719441|NCT00507442|463271079|FG002|Overall Study|Protocol Violation|0|||
128719442|NCT00507442|463271080|FG003|Overall Study|Protocol Violation|0|||
128719443|NCT00507442|463271077|FG000|Overall Study|Lost to Follow-up|0|||
128719444|NCT00507442|463271078|FG001|Overall Study|Lost to Follow-up|0|||
128719445|NCT00507442|463271079|FG002|Overall Study|Lost to Follow-up|1|||
128719446|NCT00507442|463271080|FG003|Overall Study|Lost to Follow-up|0|||
128719447|NCT00507442|463271077|FG000|Overall Study|Physician Decision|0|||
128719448|NCT00507442|463271078|FG001|Overall Study|Physician Decision|2|||
128719449|NCT00507442|463271079|FG002|Overall Study|Physician Decision|4|||
129049267|NCT02455050|464474318|FG002|Treatment Period 1|Lost to Follow-up|1|||
129049268|NCT02455050|464474319|FG003|Treatment Period 1|Lost to Follow-up|2|||
129049269|NCT02455050|464474316|FG000|Treatment Period 2|Lost to Follow-up|1|||
129049270|NCT02455050|464474317|FG001|Treatment Period 2|Lost to Follow-up|0|||
129049271|NCT02455050|464474318|FG002|Treatment Period 2|Lost to Follow-up|2|||
129049272|NCT02455050|464474319|FG003|Treatment Period 2|Lost to Follow-up|1|||
129049273|NCT02981303|464474320|FG000|Overall Study|Progressive Disease|17|||
129049274|NCT02981303|464474321|FG001|Overall Study|Progressive Disease|37|||
129049275|NCT02981303|464474320|FG000|Overall Study|Adverse Event|1|||
129049276|NCT02981303|464474321|FG001|Overall Study|Adverse Event|4|||
129049277|NCT02981303|464474320|FG000|Overall Study|Withdrawal by Subject|0|||
129049278|NCT02981303|464474321|FG001|Overall Study|Withdrawal by Subject|1|||
129049279|NCT02325518|464474322|FG000|Overall Study|Adverse Event|4|||
129049280|NCT02325518|464474323|FG001|Overall Study|Adverse Event|1|||
129049281|NCT02325518|464474322|FG000|Overall Study|Physician Decision|0|||
129049282|NCT02325518|464474323|FG001|Overall Study|Physician Decision|1|||
129049283|NCT02325518|464474322|FG000|Overall Study|Withdrawal by Subject|0|||
129049284|NCT02325518|464474323|FG001|Overall Study|Withdrawal by Subject|1|||
129049285|NCT03393806|464474326|FG000|Overall Study|Physician Decision|1|||
129049286|NCT03393806|464474327|FG001|Overall Study|Physician Decision|0|||
129049287|NCT00886288|464474328|FG000|Overall Study|no respect of the 12 weeks period|657|||
129049288|NCT00886288|464474329|FG001|Overall Study|no respect of the 12 weeks period|227|||
129049289|NCT00886288|464474328|FG000|Overall Study|Lost to Follow-up|86|||
129049290|NCT00886288|464474329|FG001|Overall Study|Lost to Follow-up|0|||
129049291|NCT01259115|464474330|FG000|Period 1|Adverse Event|1|||
129049292|NCT01259115|464474331|FG001|Period 1|Adverse Event|0|||
129049293|NCT01259115|464474330|FG000|Period 1|Protocol Violation|2|||
129049294|NCT01259115|464474331|FG001|Period 1|Protocol Violation|0|||
129049295|NCT01259115|464474330|FG000|Period 1|Lost to Follow-up|0|||
129049296|NCT01259115|464474331|FG001|Period 1|Lost to Follow-up|1|||
129049297|NCT01259115|464474330|FG000|Period 2|Adverse Event|1|||
129049298|NCT01259115|464474331|FG001|Period 2|Adverse Event|0|||
129049299|NCT01675661|464474332|FG000|Overall Study|Lost to Follow-up|22|||
129049300|NCT01675661|464474333|FG001|Overall Study|Lost to Follow-up|23|||
129049301|NCT01675661|464474332|FG000|Overall Study|Practical problems|9|||
129049302|NCT01675661|464474333|FG001|Overall Study|Practical problems|5|||
129049303|NCT01675661|464474332|FG000|Overall Study|Moved away|5|||
129049304|NCT01675661|464474333|FG001|Overall Study|Moved away|6|||
129049305|NCT01675661|464474332|FG000|Overall Study|Withdrawal by Subject|3|||
128719450|NCT00507442|463271080|FG003|Overall Study|Physician Decision|1|||
128719451|NCT00507442|463271077|FG000|Overall Study|Progressive Disease|2|||
128719452|NCT00507442|463271078|FG001|Overall Study|Progressive Disease|4|||
128719453|NCT00507442|463271079|FG002|Overall Study|Progressive Disease|2|||
128719454|NCT00507442|463271080|FG003|Overall Study|Progressive Disease|0|||
128775439|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
128719455|NCT00507442|463271077|FG000|Overall Study|Withdrawal by Subject|4|||
128719456|NCT00507442|463271078|FG001|Overall Study|Withdrawal by Subject|4|||
129049306|NCT01675661|464474333|FG001|Overall Study|Withdrawal by Subject|7|||
129049307|NCT01675661|464474332|FG000|Overall Study|Physician Decision|0|||
129049308|NCT01675661|464474333|FG001|Overall Study|Physician Decision|2|||
129049309|NCT01675661|464474332|FG000|Overall Study|Death|0|||
129049310|NCT01675661|464474333|FG001|Overall Study|Death|1|||
129049311|NCT01675661|464474332|FG000|Overall Study|Other reason|1|||
129049312|NCT01675661|464474333|FG001|Overall Study|Other reason|2|||
129049313|NCT02393248|464474334|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049314|NCT02393248|464474335|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
129049315|NCT02393248|464474336|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049316|NCT02393248|464474337|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049317|NCT02393248|464474338|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049318|NCT02393248|464474339|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
129049319|NCT02393248|464474340|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
129049320|NCT02393248|464474341|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049321|NCT02393248|464474342|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049322|NCT02393248|464474343|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049323|NCT02393248|464474344|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049324|NCT02393248|464474345|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049325|NCT02393248|464474346|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049326|NCT02393248|464474347|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049327|NCT02393248|464474348|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049328|NCT02393248|464474349|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049329|NCT02393248|464474350|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049330|NCT02393248|464474351|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049331|NCT02393248|464474352|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049332|NCT02393248|464474353|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049333|NCT02393248|464474354|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049334|NCT02393248|464474355|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049335|NCT02393248|464474356|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049336|NCT02393248|464474357|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049337|NCT02393248|464474358|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129049338|NCT02393248|464474334|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049339|NCT02393248|464474335|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
129049340|NCT02393248|464474336|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049341|NCT02393248|464474337|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049342|NCT02393248|464474338|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049343|NCT02393248|464474339|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049344|NCT02393248|464474340|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049345|NCT02393248|464474341|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049346|NCT02393248|464474342|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049347|NCT02393248|464474343|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049348|NCT02393248|464474344|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049349|NCT02393248|464474345|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049350|NCT02393248|464474346|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049351|NCT02393248|464474347|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049352|NCT02393248|464474348|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049353|NCT02393248|464474349|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049354|NCT02393248|464474350|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049355|NCT02393248|464474351|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049356|NCT02393248|464474352|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049357|NCT02393248|464474353|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049358|NCT02393248|464474354|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049359|NCT02393248|464474355|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049360|NCT02393248|464474356|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049361|NCT02393248|464474357|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049362|NCT02393248|464474358|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129049363|NCT02393248|464474334|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
129049364|NCT02393248|464474335|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
129049365|NCT02393248|464474336|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
129049366|NCT02393248|464474337|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
129049367|NCT02393248|464474338|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
129049368|NCT02393248|464474339|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
129049369|NCT02393248|464474340|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
129049370|NCT02393248|464474341|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
129049371|NCT02393248|464474342|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
129049372|NCT02393248|464474343|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
129136118|NCT00567112|464791223|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
128775440|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
129049373|NCT02393248|464474344|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
129136119|NCT00567112|464791224|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
129136120|NCT00567112|464791222|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
129049374|NCT02393248|464474345|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
129049375|NCT02393248|464474346|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
129049376|NCT02393248|464474347|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
128775441|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
128775442|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
128775443|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
128775444|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
128775445|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
128775446|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
128775447|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
128775448|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
128775449|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
128775450|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
128775451|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
128775452|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
128775453|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
128775454|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
128775455|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
128775456|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
128775457|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
128775458|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775459|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
129049377|NCT02393248|464474348|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
129049378|NCT02393248|464474349|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
129049379|NCT02393248|464474350|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
129049380|NCT02393248|464474351|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
129049381|NCT02393248|464474352|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
129049382|NCT02393248|464474353|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
129049383|NCT02393248|464474354|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
129049384|NCT02393248|464474355|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
129049385|NCT02393248|464474356|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
129049386|NCT02393248|464474357|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
129049387|NCT02393248|464474358|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
129049388|NCT02393248|464474334|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
129049389|NCT02393248|464474335|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049390|NCT02393248|464474336|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049391|NCT02393248|464474337|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049392|NCT02393248|464474338|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049393|NCT02393248|464474339|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049394|NCT02393248|464474340|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049395|NCT02393248|464474341|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049396|NCT02393248|464474342|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049397|NCT02393248|464474343|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049398|NCT02393248|464474344|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049399|NCT02393248|464474345|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049400|NCT02393248|464474346|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049401|NCT02393248|464474347|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049402|NCT02393248|464474348|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049403|NCT02393248|464474349|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049404|NCT02393248|464474350|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049405|NCT02393248|464474351|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049406|NCT02393248|464474352|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049407|NCT02393248|464474353|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049408|NCT02393248|464474354|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049409|NCT02393248|464474355|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049410|NCT02393248|464474356|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049411|NCT02393248|464474357|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129136121|NCT00567112|464791223|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
129136122|NCT00567112|464791224|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
129136123|NCT02362412|464791225|FG000|Treatment Period III|Lost to Follow-up|0|||
129136124|NCT02362412|464791226|FG001|Treatment Period III|Lost to Follow-up|1|||
129136125|NCT04913675|464791237|FG000|Main Study (Up to Week 36)|Death|0|||
129136126|NCT04913675|464791238|FG001|Main Study (Up to Week 36)|Death|2|||
129136127|NCT04913675|464791239|FG002|Main Study (Up to Week 36)|Death|2|||
129136128|NCT04913675|464791240|FG003|Main Study (Up to Week 36)|Death|0|||
129136129|NCT04913675|464791237|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
129049412|NCT02393248|464474358|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129049413|NCT02393248|464474334|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049414|NCT02393248|464474335|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049415|NCT02393248|464474336|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129136130|NCT04913675|464791238|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
128775460|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
129049416|NCT02393248|464474337|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049417|NCT02393248|464474338|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049418|NCT02393248|464474339|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
129049419|NCT02393248|464474340|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
129049420|NCT02393248|464474341|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049421|NCT02393248|464474342|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049422|NCT02393248|464474343|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
129049423|NCT02393248|464474344|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049424|NCT02393248|464474345|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049425|NCT02393248|464474346|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049426|NCT02393248|464474347|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049427|NCT02393248|464474348|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049428|NCT02393248|464474349|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049429|NCT02393248|464474350|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049430|NCT02393248|464474351|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049431|NCT02393248|464474352|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049432|NCT02393248|464474353|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049433|NCT02393248|464474354|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049434|NCT02393248|464474355|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049435|NCT02393248|464474356|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049436|NCT02393248|464474357|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049437|NCT02393248|464474358|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129049438|NCT02393248|464474334|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049439|NCT02393248|464474335|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049440|NCT02393248|464474336|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049441|NCT02393248|464474337|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049442|NCT02393248|464474338|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049443|NCT02393248|464474339|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049444|NCT02393248|464474340|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
129049445|NCT02393248|464474341|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049446|NCT02393248|464474342|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049447|NCT02393248|464474343|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049448|NCT02393248|464474344|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049449|NCT02393248|464474345|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049450|NCT02393248|464474346|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049451|NCT02393248|464474347|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049452|NCT02393248|464474348|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049453|NCT02393248|464474349|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049454|NCT02393248|464474350|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049455|NCT02393248|464474351|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049456|NCT02393248|464474352|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049457|NCT02393248|464474353|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049458|NCT02393248|464474354|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049459|NCT02393248|464474355|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049460|NCT02393248|464474356|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
128719457|NCT00507442|463271079|FG002|Overall Study|Withdrawal by Subject|2|||
128719458|NCT00507442|463271080|FG003|Overall Study|Withdrawal by Subject|1|||
128719459|NCT00507442|463271077|FG000|Overall Study|Other|2|||
128719460|NCT00507442|463271078|FG001|Overall Study|Other|5|||
128719461|NCT00507442|463271079|FG002|Overall Study|Other|2|||
128719462|NCT00507442|463271080|FG003|Overall Study|Other|2|||
128719463|NCT02410954|463271082|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
128719464|NCT02410954|463271083|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
128719465|NCT02410954|463271082|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
128719466|NCT02410954|463271083|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
128719467|NCT03803774|463271084|FG000|Dose Escalation|Withdrawal by Subject|0|||
128719468|NCT03803774|463271085|FG001|Dose Escalation|Withdrawal by Subject|0|||
128719469|NCT03803774|463271086|FG002|Dose Escalation|Withdrawal by Subject|0|||
129049461|NCT02393248|464474357|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049462|NCT02393248|464474358|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129049463|NCT02393248|464474334|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049464|NCT02393248|464474335|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049465|NCT02393248|464474336|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049466|NCT02393248|464474337|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049467|NCT02393248|464474338|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049468|NCT02393248|464474339|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049469|NCT02393248|464474340|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049470|NCT02393248|464474341|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049471|NCT02393248|464474342|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049472|NCT02393248|464474343|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049473|NCT02393248|464474344|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049474|NCT02393248|464474345|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
129049475|NCT02393248|464474346|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
129049476|NCT02393248|464474347|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
129049477|NCT02393248|464474348|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
129049478|NCT02393248|464474349|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049479|NCT02393248|464474350|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049480|NCT02393248|464474351|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049481|NCT02393248|464474352|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049482|NCT02393248|464474353|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049483|NCT02393248|464474354|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049484|NCT02393248|464474355|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049485|NCT02393248|464474356|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049486|NCT02393248|464474357|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049487|NCT02393248|464474358|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129049488|NCT02393248|464474334|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049489|NCT02393248|464474335|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049490|NCT02393248|464474336|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049491|NCT02393248|464474337|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049492|NCT02393248|464474338|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049493|NCT02393248|464474339|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049494|NCT02393248|464474340|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049495|NCT02393248|464474341|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049496|NCT02393248|464474342|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049497|NCT02393248|464474343|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049498|NCT02393248|464474344|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
129049499|NCT02393248|464474345|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
129049500|NCT02393248|464474346|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049501|NCT02393248|464474347|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049502|NCT02393248|464474348|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049503|NCT02393248|464474349|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049504|NCT02393248|464474350|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049505|NCT02393248|464474351|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049506|NCT02393248|464474352|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049507|NCT02393248|464474353|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049508|NCT02393248|464474354|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049509|NCT02393248|464474355|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129049510|NCT02393248|464474356|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129136131|NCT04913675|464791239|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
129136132|NCT04913675|464791240|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
129136133|NCT04913675|464791237|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
129136134|NCT04913675|464791238|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
129136135|NCT04913675|464791239|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
129136136|NCT04913675|464791240|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
129136137|NCT04913675|464791237|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
129136138|NCT04913675|464791238|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
129136139|NCT04913675|464791239|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
129136140|NCT04913675|464791240|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
129136141|NCT04913675|464791237|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
128775461|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
129049511|NCT02393248|464474357|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129136142|NCT04913675|464791238|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
129049512|NCT02393248|464474358|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
128775462|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
129049513|NCT02393248|464474334|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
128775463|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
129136143|NCT04913675|464791239|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
129136144|NCT04913675|464791240|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
129136145|NCT01541254|464791241|FG000|Overall Study|Withdrawal by Subject|1|||
129136146|NCT01541254|464791241|FG000|Overall Study|excluded - metal allergy|1|||
129136147|NCT01541254|464791241|FG000|Overall Study|enrolled after study closed|1|||
129136148|NCT01541254|464791241|FG000|Overall Study|GI bleed prior to procedure|1|||
128775464|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775465|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775466|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775467|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775468|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775469|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775470|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775471|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775472|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775473|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
128775474|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
129049514|NCT02393248|464474335|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
129049515|NCT02393248|464474336|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
129049516|NCT02393248|464474337|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
129049517|NCT02393248|464474338|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
129049518|NCT02393248|464474339|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
129049519|NCT02393248|464474340|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
129049520|NCT02393248|464474341|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
129049521|NCT02393248|464474342|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
129049522|NCT02393248|464474343|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
129049523|NCT02393248|464474344|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
129049524|NCT02393248|464474345|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
129049525|NCT02393248|464474346|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
129049526|NCT02393248|464474347|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
129049527|NCT02393248|464474348|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
129049528|NCT02393248|464474349|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
129049529|NCT02393248|464474350|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
129049530|NCT02393248|464474351|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
129049531|NCT02393248|464474352|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
129049532|NCT02393248|464474353|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
129049533|NCT02393248|464474354|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
129049534|NCT02393248|464474355|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
129049535|NCT02393248|464474356|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
129049536|NCT02393248|464474357|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
129049537|NCT02393248|464474358|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
129049538|NCT02393248|464474334|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049539|NCT02393248|464474335|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049540|NCT02393248|464474336|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049541|NCT02393248|464474337|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049542|NCT02393248|464474338|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049543|NCT02393248|464474339|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
128719470|NCT03803774|463271087|FG003|Dose Escalation|Withdrawal by Subject|1|||
128719471|NCT03803774|463271088|FG004|Dose Escalation|Withdrawal by Subject|0|||
128719472|NCT01408030|463271094|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
128719473|NCT01408030|463271095|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
128719474|NCT01408030|463271096|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
128719475|NCT01408030|463271097|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
128719476|NCT01408030|463271094|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
128719477|NCT01408030|463271095|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
128719478|NCT01408030|463271096|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
128719479|NCT01408030|463271097|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
129049544|NCT02393248|464474340|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129136149|NCT01541254|464791241|FG000|Overall Study|stent not required|1|||
129136150|NCT01541254|464791241|FG000|Overall Study|alternate stent used|1|||
129136151|NCT05103332|464791244|FG000|Overall Study|Lost to Follow-up|0|||
129136152|NCT05103332|464791245|FG001|Overall Study|Lost to Follow-up|2|||
129136153|NCT05103332|464791246|FG002|Overall Study|Lost to Follow-up|1|||
129136154|NCT05103332|464791247|FG003|Overall Study|Lost to Follow-up|0|||
129136155|NCT05103332|464791248|FG004|Overall Study|Lost to Follow-up|0|||
129136156|NCT05103332|464791249|FG005|Overall Study|Lost to Follow-up|2|||
128719480|NCT01408030|463271094|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
128719481|NCT01408030|463271095|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
128775475|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
128719482|NCT01408030|463271096|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
128775476|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
128775477|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
128775478|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
129049545|NCT02393248|464474341|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049546|NCT02393248|464474342|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049547|NCT02393248|464474343|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049548|NCT02393248|464474344|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049549|NCT02393248|464474345|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
129049550|NCT02393248|464474346|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049551|NCT02393248|464474347|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
129049552|NCT02393248|464474348|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049553|NCT02393248|464474349|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049554|NCT02393248|464474350|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049555|NCT02393248|464474351|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049556|NCT02393248|464474352|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049557|NCT02393248|464474353|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049558|NCT02393248|464474354|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049559|NCT02393248|464474355|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049560|NCT02393248|464474356|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049561|NCT02393248|464474357|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049562|NCT02393248|464474358|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129049563|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049564|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049565|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049566|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049567|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049568|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049569|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049570|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049571|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049572|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049573|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049574|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049575|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049576|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049577|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049578|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049579|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049580|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049581|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
129049582|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049583|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
129049584|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
129049585|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049586|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
129049587|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129049588|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Death|0|||
129049589|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Death|0|||
129049590|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Death|0|||
129049591|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Death|0|||
129049592|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Death|0|||
129049593|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Death|0|||
129136157|NCT05103332|464791244|FG000|Overall Study|Physician Decision|0|||
129136158|NCT05103332|464791245|FG001|Overall Study|Physician Decision|1|||
129136159|NCT05103332|464791246|FG002|Overall Study|Physician Decision|0|||
128719483|NCT01408030|463271097|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
128719484|NCT01408030|463271094|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
128719485|NCT01408030|463271095|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
128719486|NCT01408030|463271096|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
129049594|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Death|0|||
129136160|NCT05103332|464791247|FG003|Overall Study|Physician Decision|1|||
129136161|NCT05103332|464791248|FG004|Overall Study|Physician Decision|0|||
129136162|NCT05103332|464791249|FG005|Overall Study|Physician Decision|0|||
129136163|NCT05103332|464791244|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
129136164|NCT05103332|464791245|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
129136165|NCT05103332|464791246|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
129136166|NCT05103332|464791247|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
129049595|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Death|0|||
129049596|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Death|0|||
129136167|NCT05103332|464791248|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
128719487|NCT01408030|463271097|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
129223326|NCT03892967|465118342|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
129223327|NCT03892967|465118343|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
129223328|NCT03892967|465118344|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
128719488|NCT01408030|463271094|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
128719489|NCT01408030|463271095|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
128719490|NCT01408030|463271096|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
128719491|NCT01408030|463271097|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
128719492|NCT01408030|463271094|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
129136168|NCT05103332|464791249|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
129136169|NCT05103332|464791244|FG000|Overall Study|Unspeccified|0|||
129136170|NCT05103332|464791245|FG001|Overall Study|Unspeccified|0|||
129136171|NCT05103332|464791246|FG002|Overall Study|Unspeccified|0|||
129136172|NCT05103332|464791247|FG003|Overall Study|Unspeccified|1|||
129136173|NCT05103332|464791248|FG004|Overall Study|Unspeccified|0|||
129136174|NCT05103332|464791249|FG005|Overall Study|Unspeccified|0|||
129136175|NCT02218268|464791250|FG000|24 Hour Washout|Physician Decision|11|||
129136176|NCT02218268|464791251|FG001|24 Hour Washout|Physician Decision|9|||
129136177|NCT03651336|464791252|FG000|Overall Study|Withdrawal by Subject|4|||
129136178|NCT01125748|464791255|FG000|Overall Study|Adverse Event|0|||
129136179|NCT01125748|464791256|FG001|Overall Study|Adverse Event|2|||
129136180|NCT01125748|464791255|FG000|Overall Study|Lost to Follow-up|0|||
129136181|NCT01125748|464791256|FG001|Overall Study|Lost to Follow-up|1|||
129136182|NCT01125748|464791255|FG000|Overall Study|Physician Decision|8|||
129136183|NCT01125748|464791256|FG001|Overall Study|Physician Decision|7|||
129136184|NCT01125748|464791255|FG000|Overall Study|Patient Decision to Withdraw|2|||
129136185|NCT01125748|464791256|FG001|Overall Study|Patient Decision to Withdraw|4|||
129136186|NCT01028391|464791257|FG000|Overall Study|Adverse Event|4|||
129136187|NCT01028391|464791258|FG001|Overall Study|Adverse Event|0|||
129136188|NCT01028391|464791257|FG000|Overall Study|Lack of Efficacy|0|||
129136189|NCT01028391|464791258|FG001|Overall Study|Lack of Efficacy|2|||
129136190|NCT01028391|464791257|FG000|Overall Study|Lost to Follow-up|3|||
129136191|NCT01028391|464791258|FG001|Overall Study|Lost to Follow-up|4|||
129136192|NCT01028391|464791257|FG000|Overall Study|Physician Decision|0|||
129136193|NCT01028391|464791258|FG001|Overall Study|Physician Decision|1|||
129136194|NCT01028391|464791257|FG000|Overall Study|Withdrawal by Subject|6|||
129136195|NCT01028391|464791258|FG001|Overall Study|Withdrawal by Subject|3|||
129136196|NCT01028391|464791257|FG000|Overall Study|Needed excluded medication|1|||
129136197|NCT01028391|464791258|FG001|Overall Study|Needed excluded medication|1|||
129136198|NCT01227395|464791259|FG000|Overall Study|Protocol Violation|0|||
129136199|NCT01227395|464791260|FG001|Overall Study|Protocol Violation|1|||
129136200|NCT00086307|464791265|FG000|Overall Study|Lack of Efficacy|1|||
129136201|NCT00086307|464791266|FG001|Overall Study|Lack of Efficacy|1|||
129136202|NCT00086307|464791267|FG002|Overall Study|Lack of Efficacy|2|||
129136203|NCT00086307|464791265|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
129136204|NCT00086307|464791266|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
129136205|NCT00086307|464791267|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
129136206|NCT00086307|464791265|FG000|Overall Study|Nausea and headaches|0|||
129136207|NCT00086307|464791266|FG001|Overall Study|Nausea and headaches|0|||
128719493|NCT01408030|463271095|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
128719494|NCT01408030|463271096|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
129049597|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Death|0|||
129049598|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Death|0|||
129049599|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Death|0|||
129049600|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Death|0|||
129049601|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Death|0|||
129049602|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Death|0|||
129049603|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Death|1|||
129049604|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Death|7|||
129049605|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Death|5|||
129049606|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Death|5|||
129049607|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Death|3|||
129049608|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Death|7|||
129049609|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Death|5|||
129049610|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Death|6|||
129049611|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Death|3|||
129049612|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Death|0|||
129049613|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049614|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049615|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129136208|NCT00086307|464791267|FG002|Overall Study|Nausea and headaches|1|||
129049616|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129136209|NCT00086307|464791265|FG000|Overall Study|Constipation and sleepiness|0|||
129136210|NCT00086307|464791266|FG001|Overall Study|Constipation and sleepiness|0|||
129049617|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049618|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049619|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049620|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049621|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049622|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049623|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049624|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049625|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049626|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049627|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049628|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049629|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049630|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129049631|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129049632|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129049633|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129049634|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129049635|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129049636|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
129049637|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129049638|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Disease Progression|0|||
129049639|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Disease Progression|0|||
129049640|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Disease Progression|0|||
129049641|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Disease Progression|0|||
129049642|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Disease Progression|0|||
129049643|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Disease Progression|0|||
129049644|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Disease Progression|0|||
129049645|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Disease Progression|0|||
129049646|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Disease Progression|0|||
129136211|NCT00086307|464791267|FG002|Overall Study|Constipation and sleepiness|1|||
129136212|NCT00086307|464791265|FG000|Overall Study|Suicidal ideation|0|||
129136213|NCT00086307|464791266|FG001|Overall Study|Suicidal ideation|0|||
129136214|NCT00086307|464791267|FG002|Overall Study|Suicidal ideation|1|||
129136215|NCT00086307|464791265|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
129136216|NCT00086307|464791266|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
129136217|NCT00086307|464791267|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
129136218|NCT00086307|464791265|FG000|Overall Study|Withdrawal by Subject|0|||
129136219|NCT00086307|464791266|FG001|Overall Study|Withdrawal by Subject|0|||
129136220|NCT00086307|464791267|FG002|Overall Study|Withdrawal by Subject|2|||
129136221|NCT00105508|464791268|FG000|Overall Study|Prephase Dropout|1|||
129136222|NCT00105508|464791269|FG001|Overall Study|Prephase Dropout|0|||
129136223|NCT00105508|464791268|FG000|Overall Study|Adverse Event|16|||
129136224|NCT00105508|464791269|FG001|Overall Study|Adverse Event|19|||
129136225|NCT00105508|464791268|FG000|Overall Study|Insufficient Efficacy|1|||
129136226|NCT00105508|464791269|FG001|Overall Study|Insufficient Efficacy|0|||
129136227|NCT00105508|464791268|FG000|Overall Study|Withdrawal by Subject|10|||
129136228|NCT00105508|464791269|FG001|Overall Study|Withdrawal by Subject|6|||
129136229|NCT00105508|464791268|FG000|Overall Study|Lost to Follow-up|3|||
129136230|NCT00105508|464791269|FG001|Overall Study|Lost to Follow-up|0|||
129136231|NCT00105508|464791268|FG000|Overall Study|Protocol Violation|1|||
129136232|NCT00105508|464791269|FG001|Overall Study|Protocol Violation|2|||
129136233|NCT00105508|464791268|FG000|Overall Study|Other|8|||
129136234|NCT00105508|464791269|FG001|Overall Study|Other|9|||
129136235|NCT00683384|464791270|FG000|Overall Study|Death|1|||
129136236|NCT00683384|464791270|FG000|Overall Study|Adverse Event|1|||
129136237|NCT00120874|464791272|FG000|Overall Study|Death|0|||
129136238|NCT00120874|464791273|FG001|Overall Study|Death|1|||
129136239|NCT03548415|464792919|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
129136240|NCT03548415|464792920|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
129136241|NCT03548415|464792921|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
129136242|NCT03548415|464792922|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
129136243|NCT03548415|464792923|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
129136244|NCT01803737|464792924|FG000|Overall Study|Lack of Time|1|||
129136245|NCT01803737|464792925|FG001|Overall Study|Lack of Time|0|||
129136246|NCT01803737|464792924|FG000|Overall Study|Medical Reason|0|||
129136247|NCT01803737|464792925|FG001|Overall Study|Medical Reason|1|||
129136248|NCT01803737|464792924|FG000|Overall Study|Lost to Follow-up|0|||
129136249|NCT01803737|464792925|FG001|Overall Study|Lost to Follow-up|2|||
129136250|NCT01174459|464792928|FG000|Overall Study|case report form (CRF) not collected|5|||
129136251|NCT01717859|464792930|FG000|Overall Study|Adverse Event|5|||
129136252|NCT01717859|464792930|FG000|Overall Study|Moved out of state|1|||
129049647|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Disease Progression|0|||
129049648|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Disease Progression|0|||
129049649|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Disease Progression|0|||
129049650|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Disease Progression|0|||
129049651|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Disease Progression|0|||
129049652|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Disease Progression|0|||
129049653|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Disease Progression|0|||
129049654|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Disease Progression|0|||
129049655|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Disease Progression|0|||
129049656|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Disease Progression|0|||
129049657|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Disease Progression|0|||
129049658|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Disease Progression|2|||
129049659|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Disease Progression|1|||
129049660|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Disease Progression|0|||
129049661|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Disease Progression|0|||
129049662|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Disease Progression|0|||
129049663|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049664|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049665|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049666|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049667|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049668|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049669|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049670|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049671|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049672|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049673|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049674|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049675|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049676|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049677|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049678|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049679|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049680|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049681|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
129136253|NCT01717859|464792930|FG000|Overall Study|Patient concerned about mental health|1|||
129136254|NCT01717859|464792930|FG000|Overall Study|Lost to Follow-up|1|||
129136255|NCT01717859|464792930|FG000|Overall Study|Withdrawal by Subject|2|||
129136256|NCT01623752|464792931|FG000|Phase 1 (78 Weeks)|No Data|249|||
129136257|NCT01623752|464792932|FG001|Phase 1 (78 Weeks)|No Data|66|||
129136258|NCT01623752|464792933|FG002|Phase 1 (78 Weeks)|No Data|2|||
129136259|NCT01623752|464792931|FG000|Phase 1 (78 Weeks)|Other|33|||
129136260|NCT01623752|464792932|FG001|Phase 1 (78 Weeks)|Other|20|||
129136261|NCT01623752|464792933|FG002|Phase 1 (78 Weeks)|Other|0|||
129136262|NCT01623752|464792931|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
129136263|NCT01623752|464792932|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
129136264|NCT01623752|464792933|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
129136265|NCT01623752|464792931|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
129136266|NCT01623752|464792932|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
129136267|NCT01623752|464792933|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
129136268|NCT01623752|464792931|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
129136269|NCT01623752|464792932|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
129136270|NCT01623752|464792933|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
129136271|NCT01623752|464792931|FG000|Phase 2 (78 Weeks)|Other|5|||
129136272|NCT01623752|464792932|FG001|Phase 2 (78 Weeks)|Other|1|||
129136273|NCT01623752|464792933|FG002|Phase 2 (78 Weeks)|Other|0|||
129136274|NCT01623752|464792931|FG000|Phase 2 (78 Weeks)|No Data|43|||
129136275|NCT01623752|464792932|FG001|Phase 2 (78 Weeks)|No Data|11|||
129136276|NCT01623752|464792933|FG002|Phase 2 (78 Weeks)|No Data|0|||
129136277|NCT01623752|464792931|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
129136278|NCT01623752|464792932|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
129136279|NCT01623752|464792933|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
129049682|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049683|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
129049684|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
129136280|NCT01111292|464792934|FG000|Treatment|Physician Decision|1|||
129136281|NCT01111292|464792935|FG001|Treatment|Physician Decision|1|||
129136282|NCT01217047|464792938|FG000|Overall Study|Lost to Follow-up|0|||
129136283|NCT01217047|464792939|FG001|Overall Study|Lost to Follow-up|1|||
129136284|NCT01217047|464792940|FG002|Overall Study|Lost to Follow-up|0|||
129136285|NCT05529173|464792941|FG000|Overall Study|Physician Decision|3|||
129136286|NCT05529173|464792942|FG001|Overall Study|Physician Decision|6|||
129136287|NCT05529173|464792941|FG000|Overall Study|Sample shipment delay more than one day|4|||
129136288|NCT05529173|464792942|FG001|Overall Study|Sample shipment delay more than one day|0|||
129049685|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049686|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049687|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
129049688|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049689|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049690|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049691|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049692|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049693|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049694|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049695|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049696|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049697|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049698|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049699|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049700|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049701|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049702|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049703|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049704|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049705|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049706|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049707|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049708|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
129049709|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049710|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049711|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049712|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129049713|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Adverse Event|0|||
129049714|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Adverse Event|0|||
129049715|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Adverse Event|0|||
129049716|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Adverse Event|0|||
129049717|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Adverse Event|0|||
129049718|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Adverse Event|0|||
129049719|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Adverse Event|0|||
129049720|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Adverse Event|0|||
129049721|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Adverse Event|0|||
129049722|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Adverse Event|0|||
129049723|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Adverse Event|0|||
129049724|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Adverse Event|0|||
129049725|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Adverse Event|0|||
129049726|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Adverse Event|0|||
129049727|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Adverse Event|0|||
129049728|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Adverse Event|0|||
129049729|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Adverse Event|0|||
129049730|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Adverse Event|0|||
129136289|NCT01530997|464792951|FG000|Overall Study|Physician Decision|1|||
129136290|NCT01530997|464792951|FG000|Overall Study|Withdrawal by Subject|1|||
129136291|NCT03892915|464792952|FG000|Overall Study|Lost to Follow-up|6|||
129136292|NCT03892915|464792953|FG001|Overall Study|Lost to Follow-up|12|||
129136293|NCT03892915|464792952|FG000|Overall Study|Death|0|||
129136294|NCT03892915|464792953|FG001|Overall Study|Death|2|||
129136295|NCT03892915|464792952|FG000|Overall Study|Withdrawal by Subject|1|||
129136296|NCT03892915|464792953|FG001|Overall Study|Withdrawal by Subject|1|||
129136297|NCT03892915|464792952|FG000|Overall Study|unsuccessful delivery|13|||
129136298|NCT03892915|464792953|FG001|Overall Study|unsuccessful delivery|18|||
129136299|NCT02181738|464792956|FG000|Overall Study|Participant Withdrew Consent|2|||
129136300|NCT02181738|464792957|FG001|Overall Study|Participant Withdrew Consent|1|||
129136301|NCT02181738|464792958|FG002|Overall Study|Participant Withdrew Consent|1|||
129136302|NCT02181738|464792959|FG003|Overall Study|Participant Withdrew Consent|1|||
129136303|NCT02181738|464792956|FG000|Overall Study|Lost to Follow-up|1|||
128775479|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
129049731|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Adverse Event|0|||
129049732|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Adverse Event|0|||
129049733|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Adverse Event|0|||
129049734|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Adverse Event|0|||
129049735|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Adverse Event|0|||
129049736|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Adverse Event|1|||
129049737|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Adverse Event|0|||
129049738|NCT02393248|464474334|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049739|NCT02393248|464474335|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049740|NCT02393248|464474336|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049741|NCT02393248|464474337|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049742|NCT02393248|464474338|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049743|NCT02393248|464474339|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049744|NCT02393248|464474340|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049745|NCT02393248|464474341|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049746|NCT02393248|464474342|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049747|NCT02393248|464474343|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049748|NCT02393248|464474344|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049749|NCT02393248|464474345|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049750|NCT02393248|464474346|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049751|NCT02393248|464474347|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049752|NCT02393248|464474348|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049753|NCT02393248|464474349|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049754|NCT02393248|464474350|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049755|NCT02393248|464474351|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049756|NCT02393248|464474352|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049757|NCT02393248|464474353|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049758|NCT02393248|464474354|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049759|NCT02393248|464474355|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049760|NCT02393248|464474356|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049761|NCT02393248|464474357|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
129049762|NCT02393248|464474358|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129049763|NCT00117325|464474359|FG000|Overall Study|Adverse Event|3|||
129049764|NCT00117325|464474360|FG001|Overall Study|Adverse Event|3|||
129049765|NCT00117325|464474359|FG000|Overall Study|Lost to Follow-up|1|||
129049766|NCT00117325|464474360|FG001|Overall Study|Lost to Follow-up|1|||
129049767|NCT00117325|464474359|FG000|Overall Study|Protocol Violation|2|||
129049768|NCT00117325|464474360|FG001|Overall Study|Protocol Violation|3|||
129049769|NCT00117325|464474359|FG000|Overall Study|Withdrawal by Subject|3|||
129049770|NCT00117325|464474360|FG001|Overall Study|Withdrawal by Subject|2|||
129049771|NCT00117325|464474359|FG000|Overall Study|Lack of Efficacy|1|||
129049772|NCT00117325|464474360|FG001|Overall Study|Lack of Efficacy|0|||
129049773|NCT00117325|464474359|FG000|Overall Study|Use of prohibited medicine|1|||
129049774|NCT00117325|464474360|FG001|Overall Study|Use of prohibited medicine|2|||
129049775|NCT00117325|464474359|FG000|Overall Study|Early termination|1|||
129049776|NCT00117325|464474360|FG001|Overall Study|Early termination|1|||
129049777|NCT00117325|464474359|FG000|Overall Study|Admisnitrative|1|||
129049778|NCT00117325|464474360|FG001|Overall Study|Admisnitrative|0|||
129049779|NCT00338455|464474368|FG000|Overall Study|Death|2|||
129049780|NCT00338455|464474369|FG001|Overall Study|Death|1|||
129049781|NCT00338455|464474368|FG000|Overall Study|Physician Decision|1|||
129049782|NCT00338455|464474369|FG001|Overall Study|Physician Decision|0|||
129049783|NCT05084963|464474370|FG000|Overall Study|Withdrawal by Subject|0|||
129049784|NCT05084963|464474371|FG001|Overall Study|Withdrawal by Subject|0|||
129049785|NCT05084963|464474372|FG002|Overall Study|Withdrawal by Subject|1|||
129049786|NCT01568320|464474373|FG000|Overall Study|Death|20|||
129049787|NCT01568320|464474373|FG000|Overall Study|Lost to Follow-up|9|||
129049788|NCT01568320|464474373|FG000|Overall Study|Withdrawal by Subject|10|||
129049789|NCT01568320|464474373|FG000|Overall Study|Conversion to open repair|1|||
129049790|NCT01568320|464474373|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
129049791|NCT01616953|464474374|FG000|Overall Study|Lost to Follow-up|1|||
129049792|NCT01616953|464474375|FG001|Overall Study|Lost to Follow-up|0|||
129136304|NCT02181738|464792957|FG001|Overall Study|Lost to Follow-up|2|||
129136305|NCT02181738|464792958|FG002|Overall Study|Lost to Follow-up|1|||
129136306|NCT02181738|464792959|FG003|Overall Study|Lost to Follow-up|1|||
129136307|NCT02181738|464792956|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
129136308|NCT02181738|464792957|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
128719495|NCT01408030|463271097|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
129223329|NCT03892967|465118345|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
129223330|NCT03892967|465118341|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
129223331|NCT03892967|465118342|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
129223332|NCT03892967|465118343|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
129223333|NCT03892967|465118344|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
129223334|NCT03892967|465118345|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
129223335|NCT03892967|465118341|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
129223336|NCT03892967|465118342|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
129223337|NCT03892967|465118343|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
129223338|NCT03892967|465118344|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
129223339|NCT03892967|465118345|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
129223340|NCT03892967|465118341|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
129223341|NCT03892967|465118342|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
129223342|NCT03892967|465118343|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
129223343|NCT03892967|465118344|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
129223344|NCT03892967|465118345|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
129223345|NCT03892967|465118341|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
129223346|NCT03892967|465118342|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
129223347|NCT03892967|465118343|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
129223348|NCT03892967|465118344|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
129223349|NCT03892967|465118345|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
129223350|NCT03892967|465118341|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
129223351|NCT03892967|465118342|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
129223352|NCT03892967|465118343|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
129223353|NCT03892967|465118344|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
129223354|NCT03892967|465118345|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
129223355|NCT02999477|465118348|FG000|Overall Study|found ineligible after first dose|0|||
129223356|NCT02999477|465118349|FG001|Overall Study|found ineligible after first dose|1|||
129223357|NCT02999477|465118348|FG000|Overall Study|Withdrawal by Subject|1|||
129223358|NCT02999477|465118349|FG001|Overall Study|Withdrawal by Subject|1|||
129223359|NCT04266795|465118351|FG000|Overall Study|Adverse Event|10|||
129223360|NCT04266795|465118352|FG001|Overall Study|Adverse Event|19|||
129223361|NCT04266795|465118351|FG000|Overall Study|Death|7|||
129223362|NCT04266795|465118352|FG001|Overall Study|Death|8|||
129223363|NCT04266795|465118351|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
129223364|NCT04266795|465118352|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
129223365|NCT04266795|465118351|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129223366|NCT04266795|465118352|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129223367|NCT04266795|465118351|FG000|Overall Study|Progressive Disease|12|||
129223368|NCT04266795|465118352|FG001|Overall Study|Progressive Disease|9|||
129223369|NCT04266795|465118351|FG000|Overall Study|Withdrawal by Patient|5|||
129223370|NCT04266795|465118352|FG001|Overall Study|Withdrawal by Patient|6|||
129223371|NCT04266795|465118351|FG000|Overall Study|Disease Relapse|3|||
129223372|NCT04266795|465118352|FG001|Overall Study|Disease Relapse|6|||
129223373|NCT04266795|465118351|FG000|Overall Study|Reason not Specified|12|||
129223374|NCT04266795|465118352|FG001|Overall Study|Reason not Specified|10|||
129223375|NCT04266795|465118351|FG000|Overall Study|Participants Ongoing on Treatment|25|||
129223376|NCT04266795|465118352|FG001|Overall Study|Participants Ongoing on Treatment|23|||
129223377|NCT03587727|465118353|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
129223378|NCT03587727|465118353|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
129223379|NCT04647253|465118354|FG000|Overall Study|Death ≤ 365 Days|16|||
129223380|NCT04647253|465118355|FG001|Overall Study|Death ≤ 365 Days|7|||
129223381|NCT04647253|465118354|FG000|Overall Study|Physician Decision|0|||
129223382|NCT04647253|465118355|FG001|Overall Study|Physician Decision|1|||
129223383|NCT04647253|465118354|FG000|Overall Study|Withdrawal by Subject|7|||
128719496|NCT01408030|463271094|FG000|Observation Phase (Off Drug)|Other|1|||
128719497|NCT01408030|463271095|FG001|Observation Phase (Off Drug)|Other|1|||
128719498|NCT01408030|463271096|FG002|Observation Phase (Off Drug)|Other|1|||
128719499|NCT01408030|463271097|FG003|Observation Phase (Off Drug)|Other|1|||
128719500|NCT00003641|463271100|FG000|Overall Study|Withdrawal by Subject|0|||
128719501|NCT00003641|463271101|FG001|Overall Study|Withdrawal by Subject|100|||
128719502|NCT00003641|463271100|FG000|Overall Study|Adverse Event|0|||
129049793|NCT01616953|464474374|FG000|Overall Study|lack of bone and soft tissue|1|||
129049794|NCT01616953|464474375|FG001|Overall Study|lack of bone and soft tissue|0|||
129049795|NCT01394952|464474376|FG000|Overall Study|Lost to Follow-up|0|||
129049796|NCT01394952|464474377|FG001|Overall Study|Lost to Follow-up|5|||
129049797|NCT01394952|464474376|FG000|Overall Study|Withdrawal by Subject|10|||
129049798|NCT01394952|464474377|FG001|Overall Study|Withdrawal by Subject|5|||
129049799|NCT01394952|464474376|FG000|Overall Study|Physician Decision|2|||
129049800|NCT01394952|464474377|FG001|Overall Study|Physician Decision|0|||
129049801|NCT01394952|464474376|FG000|Overall Study|Sponsor Decision|5|||
129049802|NCT01394952|464474377|FG001|Overall Study|Sponsor Decision|7|||
129049803|NCT01103466|464474380|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
129049804|NCT01103466|464474381|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
129049805|NCT01103466|464474382|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
129049806|NCT01103466|464474380|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
129049807|NCT01103466|464474381|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
129049808|NCT01103466|464474382|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
129049809|NCT01103466|464474380|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
129049810|NCT01103466|464474381|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
129049811|NCT01103466|464474382|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
129049812|NCT01103466|464474380|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
129049813|NCT01103466|464474381|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
129049814|NCT01103466|464474382|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
129049815|NCT01103466|464474380|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
129049816|NCT01103466|464474381|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
129049817|NCT01103466|464474382|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
129049818|NCT01103466|464474380|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
129049819|NCT01103466|464474381|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
129049820|NCT01103466|464474382|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
129049821|NCT02283983|464474390|FG000|Overall Study|Inclusion criteria not met|0|||
129049822|NCT02283983|464474391|FG001|Overall Study|Inclusion criteria not met|1|||
129049823|NCT02283983|464474390|FG000|Overall Study|Withdrawal by Subject|4|||
129049824|NCT02283983|464474391|FG001|Overall Study|Withdrawal by Subject|2|||
129049825|NCT02283983|464474390|FG000|Overall Study|Protocol Violation|0|||
129049826|NCT02283983|464474391|FG001|Overall Study|Protocol Violation|4|||
129049827|NCT02283983|464474390|FG000|Overall Study|Physician Decision|2|||
129049828|NCT02283983|464474391|FG001|Overall Study|Physician Decision|4|||
129049829|NCT02283983|464474390|FG000|Overall Study|Death|1|||
129049830|NCT02283983|464474391|FG001|Overall Study|Death|0|||
129049831|NCT02283983|464474390|FG000|Overall Study|Adverse Event|1|||
129049832|NCT02283983|464474391|FG001|Overall Study|Adverse Event|0|||
129049833|NCT02283983|464474390|FG000|Overall Study|Lost to Follow-up|9|||
129049834|NCT02283983|464474391|FG001|Overall Study|Lost to Follow-up|8|||
129049835|NCT02283983|464474390|FG000|Overall Study|Relapse|1|||
129049836|NCT02283983|464474391|FG001|Overall Study|Relapse|0|||
129049837|NCT04453202|464474396|FG000|Overall Study|Adverse Event|0|||
129049838|NCT04453202|464474397|FG001|Overall Study|Adverse Event|0|||
129049839|NCT04453202|464474398|FG002|Overall Study|Adverse Event|0|||
129049840|NCT04453202|464474399|FG003|Overall Study|Adverse Event|0|||
129049841|NCT04453202|464474400|FG004|Overall Study|Adverse Event|0|||
129049842|NCT04453202|464474401|FG005|Overall Study|Adverse Event|0|||
129049843|NCT04453202|464474402|FG006|Overall Study|Adverse Event|1|||
129049844|NCT04453202|464474403|FG007|Overall Study|Adverse Event|0|||
129049845|NCT04453202|464474404|FG008|Overall Study|Adverse Event|0|||
129049846|NCT04453202|464474405|FG009|Overall Study|Adverse Event|0|||
129049847|NCT04453202|464474406|FG010|Overall Study|Adverse Event|0|||
129049848|NCT04453202|464474396|FG000|Overall Study|Death|0|||
129049849|NCT04453202|464474397|FG001|Overall Study|Death|0|||
129049850|NCT04453202|464474398|FG002|Overall Study|Death|0|||
128719503|NCT00003641|463271101|FG001|Overall Study|Adverse Event|38|||
129049851|NCT04453202|464474399|FG003|Overall Study|Death|0|||
129049852|NCT04453202|464474400|FG004|Overall Study|Death|0|||
129049853|NCT04453202|464474401|FG005|Overall Study|Death|0|||
129049854|NCT04453202|464474402|FG006|Overall Study|Death|0|||
129049855|NCT04453202|464474403|FG007|Overall Study|Death|0|||
129049856|NCT04453202|464474404|FG008|Overall Study|Death|0|||
129049857|NCT04453202|464474405|FG009|Overall Study|Death|1|||
129049858|NCT04453202|464474406|FG010|Overall Study|Death|0|||
129049859|NCT04453202|464474396|FG000|Overall Study|Lost to Follow-up|0|||
129049860|NCT04453202|464474397|FG001|Overall Study|Lost to Follow-up|1|||
129049861|NCT04453202|464474398|FG002|Overall Study|Lost to Follow-up|0|||
128719504|NCT00003641|463271100|FG000|Overall Study|Disease progression|0|||
129223384|NCT04647253|465118355|FG001|Overall Study|Withdrawal by Subject|2|||
129223385|NCT04647253|465118354|FG000|Overall Study|Missed 12-Month Visit|9|||
128719505|NCT00003641|463271101|FG001|Overall Study|Disease progression|2|||
128719506|NCT00003641|463271100|FG000|Overall Study|Unknown/missing|0|||
128719507|NCT00003641|463271101|FG001|Overall Study|Unknown/missing|22|||
128719508|NCT00003641|463271100|FG000|Overall Study|Should not receive interferon therapy|2|||
128719509|NCT00003641|463271101|FG001|Overall Study|Should not receive interferon therapy|0|||
128719510|NCT00003641|463271100|FG000|Overall Study|Never started interferon|567|||
128719511|NCT00003641|463271101|FG001|Overall Study|Never started interferon|12|||
128719512|NCT02154581|463271102|FG000|Overall Study|Lost to Follow-up|7|||
128719513|NCT02154581|463271103|FG001|Overall Study|Lost to Follow-up|8|||
129049862|NCT04453202|464474399|FG003|Overall Study|Lost to Follow-up|1|||
129049863|NCT04453202|464474400|FG004|Overall Study|Lost to Follow-up|0|||
129049864|NCT04453202|464474401|FG005|Overall Study|Lost to Follow-up|0|||
129049865|NCT04453202|464474402|FG006|Overall Study|Lost to Follow-up|0|||
129049866|NCT04453202|464474403|FG007|Overall Study|Lost to Follow-up|0|||
129049867|NCT04453202|464474404|FG008|Overall Study|Lost to Follow-up|0|||
129049868|NCT04453202|464474405|FG009|Overall Study|Lost to Follow-up|1|||
129049869|NCT04453202|464474406|FG010|Overall Study|Lost to Follow-up|1|||
129049870|NCT04453202|464474396|FG000|Overall Study|Withdrawal by Subject|1|||
129049871|NCT04453202|464474397|FG001|Overall Study|Withdrawal by Subject|2|||
129049872|NCT04453202|464474398|FG002|Overall Study|Withdrawal by Subject|1|||
129049873|NCT04453202|464474399|FG003|Overall Study|Withdrawal by Subject|2|||
129049874|NCT04453202|464474400|FG004|Overall Study|Withdrawal by Subject|1|||
129049875|NCT04453202|464474401|FG005|Overall Study|Withdrawal by Subject|1|||
129049876|NCT04453202|464474402|FG006|Overall Study|Withdrawal by Subject|0|||
129049877|NCT04453202|464474403|FG007|Overall Study|Withdrawal by Subject|0|||
129049878|NCT04453202|464474404|FG008|Overall Study|Withdrawal by Subject|0|||
129049879|NCT04453202|464474405|FG009|Overall Study|Withdrawal by Subject|1|||
129049880|NCT04453202|464474406|FG010|Overall Study|Withdrawal by Subject|0|||
129049881|NCT04453202|464474396|FG000|Overall Study|Adverse Event|0|||
129049882|NCT04453202|464474397|FG001|Overall Study|Adverse Event|0|||
129049883|NCT04453202|464474398|FG002|Overall Study|Adverse Event|0|||
129049884|NCT04453202|464474399|FG003|Overall Study|Adverse Event|0|||
129049885|NCT04453202|464474400|FG004|Overall Study|Adverse Event|0|||
129049886|NCT04453202|464474401|FG005|Overall Study|Adverse Event|1|||
129049887|NCT04453202|464474402|FG006|Overall Study|Adverse Event|0|||
129049888|NCT04453202|464474403|FG007|Overall Study|Adverse Event|0|||
129049889|NCT04453202|464474404|FG008|Overall Study|Adverse Event|0|||
129049890|NCT04453202|464474405|FG009|Overall Study|Adverse Event|0|||
129049891|NCT04453202|464474406|FG010|Overall Study|Adverse Event|0|||
129049892|NCT01157897|464474407|FG000|Overall Study|Lost to Follow-up|2|||
129049893|NCT01157897|464474408|FG001|Overall Study|Lost to Follow-up|0|||
129049894|NCT01157897|464474409|FG002|Overall Study|Lost to Follow-up|0|||
129049895|NCT01157897|464474410|FG003|Overall Study|Lost to Follow-up|1|||
129049896|NCT01157897|464474407|FG000|Overall Study|Relocated|0|||
129049897|NCT01157897|464474408|FG001|Overall Study|Relocated|2|||
129049898|NCT01157897|464474409|FG002|Overall Study|Relocated|0|||
129049899|NCT01157897|464474410|FG003|Overall Study|Relocated|0|||
129049900|NCT03276221|464474411|FG000|Overall Study|Lost to Follow-up|6|||
129049901|NCT03276221|464474412|FG001|Overall Study|Lost to Follow-up|2|||
129049902|NCT03276221|464474413|FG002|Overall Study|Lost to Follow-up|0|||
129049903|NCT03276221|464474411|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
129049904|NCT03276221|464474412|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
129049905|NCT03276221|464474413|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
129049906|NCT00424775|464474414|FG000|Overall Study|Adverse Event|2|||
129049907|NCT00424775|464474415|FG001|Overall Study|Adverse Event|0|||
129049908|NCT00424775|464474414|FG000|Overall Study|Lack of Efficacy|1|||
129049909|NCT00424775|464474415|FG001|Overall Study|Lack of Efficacy|0|||
129049910|NCT02912650|464474416|FG000|Overall Study|Withdrawal by Subject|1|||
129049911|NCT02912650|464474417|FG001|Overall Study|Withdrawal by Subject|0|||
129049912|NCT02912650|464474418|FG002|Overall Study|Withdrawal by Subject|1|||
129049913|NCT02912650|464474419|FG003|Overall Study|Withdrawal by Subject|5|||
129049914|NCT02912650|464474416|FG000|Overall Study|Adverse Event|0|||
129049915|NCT02912650|464474417|FG001|Overall Study|Adverse Event|0|||
129049916|NCT02912650|464474418|FG002|Overall Study|Adverse Event|1|||
129049917|NCT02912650|464474419|FG003|Overall Study|Adverse Event|0|||
129049918|NCT02562482|464474421|FG000|Overall Study|Enrolled, but did not receive product|4|||
129049919|NCT02562482|464474422|FG001|Overall Study|Enrolled, but did not receive product|0|||
129049920|NCT02562482|464474421|FG000|Overall Study|Lost to Follow-up|9|||
129049921|NCT02562482|464474422|FG001|Overall Study|Lost to Follow-up|6|||
128719514|NCT01712854|463271104|FG000|Overall Study|Physician Decision|1|||
129049922|NCT02562482|464474421|FG000|Overall Study|Moved from area|2|||
129049923|NCT02562482|464474422|FG001|Overall Study|Moved from area|3|||
129049924|NCT02562482|464474421|FG000|Overall Study|Withdrawal by Subject|5|||
129049925|NCT02562482|464474422|FG001|Overall Study|Withdrawal by Subject|3|||
129049926|NCT02562482|464474421|FG000|Overall Study|Physician Decision|1|||
129049927|NCT02562482|464474422|FG001|Overall Study|Physician Decision|3|||
129049928|NCT02562482|464474421|FG000|Overall Study|Illness/Injury unrelated to product|0|||
129049929|NCT02562482|464474422|FG001|Overall Study|Illness/Injury unrelated to product|1|||
129136309|NCT02181738|464792958|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
129136310|NCT02181738|464792959|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
129136311|NCT02181738|464792956|FG000|Overall Study|Poor/Non-Compliance|1|||
129136312|NCT02181738|464792957|FG001|Overall Study|Poor/Non-Compliance|0|||
129136313|NCT02181738|464792958|FG002|Overall Study|Poor/Non-Compliance|2|||
129136314|NCT02181738|464792959|FG003|Overall Study|Poor/Non-Compliance|1|||
129136315|NCT02181738|464792956|FG000|Overall Study|Disease Progression|28|||
129136316|NCT02181738|464792957|FG001|Overall Study|Disease Progression|35|||
129136317|NCT02181738|464792958|FG002|Overall Study|Disease Progression|40|||
129136318|NCT02181738|464792959|FG003|Overall Study|Disease Progression|0|||
129136319|NCT02181738|464792956|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
129136320|NCT02181738|464792957|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
129136321|NCT02181738|464792958|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
129136322|NCT02181738|464792959|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
129136323|NCT02181738|464792956|FG000|Overall Study|Study Drug Toxicity|6|||
129136324|NCT02181738|464792957|FG001|Overall Study|Study Drug Toxicity|11|||
129136325|NCT02181738|464792958|FG002|Overall Study|Study Drug Toxicity|8|||
129136326|NCT02181738|464792959|FG003|Overall Study|Study Drug Toxicity|1|||
129136327|NCT02181738|464792956|FG000|Overall Study|Other Reasons|14|||
129136328|NCT02181738|464792957|FG001|Overall Study|Other Reasons|16|||
129136329|NCT02181738|464792958|FG002|Overall Study|Other Reasons|28|||
129136330|NCT02181738|464792959|FG003|Overall Study|Other Reasons|0|||
129136331|NCT02181738|464792956|FG000|Overall Study|Maximum Clinical Benefit|3|||
129136332|NCT02181738|464792957|FG001|Overall Study|Maximum Clinical Benefit|0|||
129136333|NCT02181738|464792958|FG002|Overall Study|Maximum Clinical Benefit|1|||
129049930|NCT00975286|464474430|FG000|Overall Study|Adverse Event|9|||
129049931|NCT00975286|464474431|FG001|Overall Study|Adverse Event|19|||
129049932|NCT00975286|464474430|FG000|Overall Study|Protocol Violation|1|||
129049933|NCT00975286|464474431|FG001|Overall Study|Protocol Violation|2|||
129049934|NCT00975286|464474430|FG000|Overall Study|Withdrawal by Subject|0|||
129049935|NCT00975286|464474431|FG001|Overall Study|Withdrawal by Subject|2|||
129049936|NCT00975286|464474430|FG000|Overall Study|Familial and Personal Reasons|2|||
129049937|NCT00975286|464474431|FG001|Overall Study|Familial and Personal Reasons|2|||
129049938|NCT00975286|464474430|FG000|Overall Study|Poor Compliance to Protocol|0|||
129049939|NCT00975286|464474431|FG001|Overall Study|Poor Compliance to Protocol|2|||
129049940|NCT00975286|464474430|FG000|Overall Study|Sponsor Decision|0|||
129049941|NCT00975286|464474431|FG001|Overall Study|Sponsor Decision|2|||
129049942|NCT01674647|464474432|FG000|Treatment Period|Death|4|||
129049943|NCT01674647|464474433|FG001|Treatment Period|Death|1|||
129049944|NCT01674647|464474432|FG000|Treatment Period|Efficacy outcome reached|0|||
129049945|NCT01674647|464474433|FG001|Treatment Period|Efficacy outcome reached|1|||
129049946|NCT01674647|464474432|FG000|Treatment Period|Physician Decision|3|||
129049947|NCT01674647|464474433|FG001|Treatment Period|Physician Decision|1|||
129049948|NCT01674647|464474432|FG000|Treatment Period|Adverse Event|60|||
129049949|NCT01674647|464474433|FG001|Treatment Period|Adverse Event|22|||
129049950|NCT01674647|464474432|FG000|Treatment Period|Non-compliance with study drug|3|||
129049951|NCT01674647|464474433|FG001|Treatment Period|Non-compliance with study drug|0|||
129049952|NCT01674647|464474432|FG000|Treatment Period|Lost to Follow-up|1|||
129049953|NCT01674647|464474433|FG001|Treatment Period|Lost to Follow-up|1|||
129049954|NCT01674647|464474432|FG000|Treatment Period|Withdrawal by Subject|19|||
129049955|NCT01674647|464474433|FG001|Treatment Period|Withdrawal by Subject|16|||
129049956|NCT01674647|464474432|FG000|Treatment Period|Switching to other therapy|5|||
129049957|NCT01674647|464474433|FG001|Treatment Period|Switching to other therapy|2|||
129049958|NCT01674647|464474432|FG000|Treatment Period|Logistical difficulties|5|||
129049959|NCT01674647|464474433|FG001|Treatment Period|Logistical difficulties|8|||
129049960|NCT01674647|464474432|FG000|Treatment Period|Treatment failure|0|||
129049961|NCT01674647|464474433|FG001|Treatment Period|Treatment failure|14|||
129136334|NCT02181738|464792959|FG003|Overall Study|Maximum Clinical Benefit|0|||
129136335|NCT02181738|464792956|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
128775480|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
129049962|NCT01674647|464474432|FG000|Treatment Period|Protocol Violation|56|||
129049963|NCT01674647|464474433|FG001|Treatment Period|Protocol Violation|36|||
129049964|NCT01674647|464474432|FG000|30-day Safety Follow-up Period|Death|3|||
129136336|NCT02181738|464792957|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129136337|NCT02181738|464792958|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
129136338|NCT02181738|464792959|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129136339|NCT02318277|464792963|FG000|Overall Study|Physician Decision|0|||
128775481|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
129049965|NCT01674647|464474433|FG001|30-day Safety Follow-up Period|Death|2|||
129049966|NCT01674647|464474432|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
129049967|NCT01674647|464474433|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
129049968|NCT01674647|464474432|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
129136340|NCT02318277|464792964|FG001|Overall Study|Physician Decision|0|||
129136341|NCT02318277|464792965|FG002|Overall Study|Physician Decision|0|||
129136342|NCT02318277|464792966|FG003|Overall Study|Physician Decision|0|||
129136343|NCT02318277|464792967|FG004|Overall Study|Physician Decision|0|||
129136344|NCT02318277|464792968|FG005|Overall Study|Physician Decision|0|||
129049969|NCT01674647|464474433|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
129049970|NCT01674647|464474432|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
129049971|NCT01674647|464474433|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
129049972|NCT01674647|464474432|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
129049973|NCT01674647|464474433|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
129049974|NCT01674647|464474432|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
129049975|NCT01674647|464474433|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
129049976|NCT01490866|464474434|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
129049977|NCT01490866|464474434|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
129049978|NCT01490866|464474434|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
129049979|NCT01490866|464474434|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
129049980|NCT01490866|464474434|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
129049981|NCT01490866|464474434|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
129049982|NCT01490866|464474434|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
129049983|NCT01490866|464474434|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
129049984|NCT01490866|464474434|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
129049985|NCT01490866|464474434|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
129049986|NCT01490866|464474434|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
129049987|NCT02722148|464474435|FG000|Overall Study|Lost to Follow-up|2|||
129049988|NCT02722148|464474435|FG000|Overall Study|Non compliant with treatment regimen|3|||
129049989|NCT00914459|464474437|FG000|Overall Study|Protocol Violation|0|||
129049990|NCT00914459|464474438|FG001|Overall Study|Protocol Violation|1|||
129049991|NCT00914459|464474437|FG000|Overall Study|Parent/Legal guardian request|1|||
129049992|NCT00914459|464474438|FG001|Overall Study|Parent/Legal guardian request|0|||
129049993|NCT01661179|464474442|FG000|Overall Study|Death|1|||
129049994|NCT01661179|464474442|FG000|Overall Study|Withdrawal by Subject|1|||
129049995|NCT01661179|464474442|FG000|Overall Study|Other Eligibility criteria|4|||
129049996|NCT01946191|464474443|FG000|Allocation|Did not complete orientation|1|||
129049997|NCT01946191|464474444|FG001|Allocation|Did not complete orientation|1|||
129049998|NCT01946191|464474443|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
129049999|NCT01946191|464474444|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
129050000|NCT01946191|464474443|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
129050001|NCT01946191|464474444|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
129050002|NCT01946191|464474443|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
129050003|NCT01946191|464474444|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
129050004|NCT04188301|464474447|FG000|Month 3|Lost to Follow-up|0|||
129050005|NCT04188301|464474448|FG001|Month 3|Lost to Follow-up|0|||
129050006|NCT04188301|464474449|FG002|Month 3|Lost to Follow-up|1|||
129050007|NCT04188301|464474447|FG000|Month 12|Lost to Follow-up|0|||
129050008|NCT04188301|464474448|FG001|Month 12|Lost to Follow-up|0|||
129050009|NCT04188301|464474449|FG002|Month 12|Lost to Follow-up|2|||
129050010|NCT04188301|464474447|FG000|Month 12|Death|1|||
129050011|NCT04188301|464474448|FG001|Month 12|Death|1|||
129050012|NCT04188301|464474449|FG002|Month 12|Death|0|||
129050013|NCT04188301|464474447|FG000|Month 18|Lost to Follow-up|6|||
129050014|NCT04188301|464474448|FG001|Month 18|Lost to Follow-up|0|||
129050015|NCT04188301|464474449|FG002|Month 18|Lost to Follow-up|0|||
129050016|NCT01104779|464474452|FG000|Overall Study|Protocol Violation|1|||
129050017|NCT01104779|464474453|FG001|Overall Study|Protocol Violation|2|||
129050018|NCT01104779|464474454|FG002|Overall Study|Protocol Violation|2|||
129050019|NCT01104779|464474452|FG000|Overall Study|Lack of Efficacy|26|||
129050020|NCT01104779|464474453|FG001|Overall Study|Lack of Efficacy|12|||
129050021|NCT01104779|464474454|FG002|Overall Study|Lack of Efficacy|13|||
129050022|NCT01104779|464474452|FG000|Overall Study|Adverse Event|13|||
129050023|NCT01104779|464474453|FG001|Overall Study|Adverse Event|14|||
129050024|NCT01104779|464474454|FG002|Overall Study|Adverse Event|13|||
129050025|NCT01104779|464474452|FG000|Overall Study|Did not meet inc/exc criteria|1|||
129050026|NCT01104779|464474453|FG001|Overall Study|Did not meet inc/exc criteria|1|||
129050027|NCT01104779|464474454|FG002|Overall Study|Did not meet inc/exc criteria|1|||
129050028|NCT01104779|464474452|FG000|Overall Study|Other reasons|0|||
129050029|NCT01104779|464474453|FG001|Overall Study|Other reasons|1|||
129050030|NCT01104779|464474454|FG002|Overall Study|Other reasons|0|||
129050031|NCT01104779|464474452|FG000|Overall Study|Lost to Follow-up|2|||
129050032|NCT01104779|464474453|FG001|Overall Study|Lost to Follow-up|0|||
129050033|NCT01104779|464474454|FG002|Overall Study|Lost to Follow-up|1|||
129050034|NCT01104779|464474452|FG000|Overall Study|Withdrawal by Subject|16|||
129136345|NCT02318277|464792969|FG006|Overall Study|Physician Decision|0|||
129136346|NCT02318277|464792970|FG007|Overall Study|Physician Decision|1|||
129050035|NCT01104779|464474453|FG001|Overall Study|Withdrawal by Subject|25|||
129050036|NCT01104779|464474454|FG002|Overall Study|Withdrawal by Subject|32|||
129050037|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
129050038|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
129050039|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050040|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050041|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050042|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050043|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050044|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050045|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050046|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050047|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050048|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050049|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050050|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129050051|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
129050052|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
129050053|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050054|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050055|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050056|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050057|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050058|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050059|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050060|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050061|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050062|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050063|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129136347|NCT02318277|464792963|FG000|Overall Study|Other|0|||
129136348|NCT02318277|464792964|FG001|Overall Study|Other|0|||
129136349|NCT02318277|464792965|FG002|Overall Study|Other|0|||
129136350|NCT02318277|464792966|FG003|Overall Study|Other|0|||
129136351|NCT02318277|464792967|FG004|Overall Study|Other|0|||
129136352|NCT02318277|464792968|FG005|Overall Study|Other|0|||
129223386|NCT04647253|465118355|FG001|Overall Study|Missed 12-Month Visit|7|||
129223387|NCT04647253|465118354|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
129223388|NCT04647253|465118355|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
129223389|NCT06729606|465118360|FG000|Overall Study|Adverse Event|0|||
129223390|NCT06729606|465118361|FG001|Overall Study|Adverse Event|2|||
129223391|NCT06729606|465118360|FG000|Overall Study|Death|1|||
129223392|NCT06729606|465118361|FG001|Overall Study|Death|0|||
129223393|NCT06729606|465118360|FG000|Overall Study|Physician Decision|0|||
129223394|NCT06729606|465118361|FG001|Overall Study|Physician Decision|1|||
129223395|NCT06729606|465118360|FG000|Overall Study|Withdrawal by Subject|2|||
129223396|NCT06729606|465118361|FG001|Overall Study|Withdrawal by Subject|4|||
129223397|NCT04102189|465118362|FG000|Overall Study|Withdrawal by Subject|1|||
129223398|NCT04102189|465118363|FG001|Overall Study|Withdrawal by Subject|2|||
129223399|NCT04102189|465118362|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129223400|NCT04102189|465118363|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129223401|NCT04102189|465118362|FG000|Overall Study|Lost to Follow-up|1|||
129223402|NCT04102189|465118363|FG001|Overall Study|Lost to Follow-up|0|||
129223403|NCT03568461|465118364|FG000|Overall Study|Death|7|||
129223404|NCT03568461|465118364|FG000|Overall Study|Physician Decision|5|||
129223405|NCT03568461|465118364|FG000|Overall Study|Subject decision|5|||
129223406|NCT03568461|465118364|FG000|Overall Study|Lost to Follow-up|1|||
129223407|NCT04873232|465118367|FG000|Overall Study|Lost to Follow-up|1|||
129050064|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129050065|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
129136353|NCT02318277|464792969|FG006|Overall Study|Other|1|||
129136354|NCT02318277|464792970|FG007|Overall Study|Other|0|||
129136355|NCT02318277|464792963|FG000|Overall Study|Withdrawal by Subject|0|||
129223408|NCT04873232|465118368|FG001|Overall Study|Lost to Follow-up|4|||
129050066|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
129050067|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050068|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129136356|NCT02318277|464792964|FG001|Overall Study|Withdrawal by Subject|0|||
129223409|NCT04873232|465118367|FG000|Overall Study|Withdrawal by Subject|1|||
129223410|NCT04873232|465118368|FG001|Overall Study|Withdrawal by Subject|0|||
129223411|NCT05109234|465118369|FG000|Overall Study|Adverse Event|2|||
129050069|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050070|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129136357|NCT02318277|464792965|FG002|Overall Study|Withdrawal by Subject|1|||
129223412|NCT05109234|465118370|FG001|Overall Study|Adverse Event|2|||
129223413|NCT05109234|465118369|FG000|Overall Study|Lack of Efficacy|5|||
129136358|NCT02318277|464792966|FG003|Overall Study|Withdrawal by Subject|0|||
129136359|NCT02318277|464792967|FG004|Overall Study|Withdrawal by Subject|1|||
129136360|NCT02318277|464792968|FG005|Overall Study|Withdrawal by Subject|1|||
129136361|NCT02318277|464792969|FG006|Overall Study|Withdrawal by Subject|6|||
129136362|NCT02318277|464792970|FG007|Overall Study|Withdrawal by Subject|14|||
129136363|NCT02318277|464792963|FG000|Overall Study|Participant trial terminated by sponsor|0|||
129136364|NCT02318277|464792964|FG001|Overall Study|Participant trial terminated by sponsor|0|||
129136365|NCT02318277|464792965|FG002|Overall Study|Participant trial terminated by sponsor|1|||
129136366|NCT02318277|464792966|FG003|Overall Study|Participant trial terminated by sponsor|0|||
129136367|NCT02318277|464792967|FG004|Overall Study|Participant trial terminated by sponsor|1|||
129136368|NCT02318277|464792968|FG005|Overall Study|Participant trial terminated by sponsor|2|||
129136369|NCT02318277|464792969|FG006|Overall Study|Participant trial terminated by sponsor|5|||
129136370|NCT02318277|464792970|FG007|Overall Study|Participant trial terminated by sponsor|16|||
129136371|NCT02318277|464792963|FG000|Overall Study|Lost to Follow-up|1|||
129136372|NCT02318277|464792964|FG001|Overall Study|Lost to Follow-up|0|||
129136373|NCT02318277|464792965|FG002|Overall Study|Lost to Follow-up|1|||
128719515|NCT00322842|463271105|FG000|Overall Study|Withdrawal by Subject|0|||
128719516|NCT00322842|463271106|FG001|Overall Study|Withdrawal by Subject|1|||
128719517|NCT00322842|463271105|FG000|Overall Study|Lost to Follow-up|0|||
128719518|NCT00322842|463271106|FG001|Overall Study|Lost to Follow-up|1|||
128719519|NCT00322842|463271105|FG000|Overall Study|Refused transplant|1|||
128719520|NCT00322842|463271106|FG001|Overall Study|Refused transplant|0|||
128719521|NCT00322842|463271105|FG000|Overall Study|Death|1|||
128719522|NCT00322842|463271106|FG001|Overall Study|Death|0|||
129050071|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050072|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050073|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050074|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050075|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050076|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050077|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050078|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129050079|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
129050080|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
129050081|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050082|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050083|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050084|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050085|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050086|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050087|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050088|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050089|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050090|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050091|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050092|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129050093|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
129050094|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
129050095|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050096|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050097|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050098|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050099|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050100|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050101|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050102|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050103|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050104|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050105|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050106|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129050107|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
129050108|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
129050109|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050110|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050111|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129136374|NCT02318277|464792966|FG003|Overall Study|Lost to Follow-up|0|||
129136375|NCT02318277|464792967|FG004|Overall Study|Lost to Follow-up|0|||
129136376|NCT02318277|464792968|FG005|Overall Study|Lost to Follow-up|0|||
129136377|NCT02318277|464792969|FG006|Overall Study|Lost to Follow-up|3|||
128719523|NCT02068222|463271107|FG000|Overall Study|Lost to Follow-up|1|||
128719524|NCT00302458|463271110|FG000|Overall Study|Lost to Follow-up|1|||
129136378|NCT02318277|464792970|FG007|Overall Study|Lost to Follow-up|4|||
128719525|NCT00302458|463271110|FG000|Overall Study|Ineligible after screening|1|||
128719526|NCT00302458|463271110|FG000|Overall Study|Withdrawal by Subject|1|||
128719527|NCT02642432|463271111|FG000|Overall Study|Adverse Event|2|||
128719528|NCT02642432|463271111|FG000|Overall Study|Withdrew Consent|1|||
128719529|NCT02642432|463271111|FG000|Overall Study|Lost to Follow-up|2|||
128719530|NCT02642432|463271111|FG000|Overall Study|Other|3|||
128719531|NCT03245008|463271112|FG000|Overall Study|Adverse Event|15|||
128719532|NCT03245008|463271113|FG001|Overall Study|Adverse Event|18|||
128719533|NCT03245008|463271114|FG002|Overall Study|Adverse Event|15|||
128719534|NCT03245008|463271115|FG003|Overall Study|Adverse Event|0|||
128719535|NCT03245008|463271116|FG004|Overall Study|Adverse Event|1|||
128719536|NCT03245008|463271112|FG000|Overall Study|Lack of Efficacy|0|||
128719537|NCT03245008|463271113|FG001|Overall Study|Lack of Efficacy|1|||
128719538|NCT03245008|463271114|FG002|Overall Study|Lack of Efficacy|0|||
128719539|NCT03245008|463271115|FG003|Overall Study|Lack of Efficacy|0|||
128719540|NCT03245008|463271116|FG004|Overall Study|Lack of Efficacy|0|||
128719541|NCT03245008|463271112|FG000|Overall Study|Lost to Follow-up|4|||
128719542|NCT03245008|463271113|FG001|Overall Study|Lost to Follow-up|1|||
128719543|NCT03245008|463271114|FG002|Overall Study|Lost to Follow-up|0|||
129050112|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050113|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050114|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050115|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050116|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050117|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050118|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050119|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050120|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129050121|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
129050122|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
129050123|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050124|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050125|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050126|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050127|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050128|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050129|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050130|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050131|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050132|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050133|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050134|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129050135|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
129050136|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
129050137|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050138|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050139|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050140|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050141|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050142|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050143|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050144|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050145|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050146|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050147|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050148|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129050149|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
129050150|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
129050151|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050152|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050153|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050154|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050155|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129136379|NCT02318277|464792963|FG000|Overall Study|Death|5|||
129136380|NCT02318277|464792964|FG001|Overall Study|Death|3|||
128719544|NCT03245008|463271115|FG003|Overall Study|Lost to Follow-up|0|||
128719545|NCT03245008|463271116|FG004|Overall Study|Lost to Follow-up|1|||
128775482|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
128719546|NCT03245008|463271112|FG000|Overall Study|Physician Decision|1|||
128719547|NCT03245008|463271113|FG001|Overall Study|Physician Decision|3|||
129050156|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050157|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050158|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050159|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050160|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050161|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050162|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129050163|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
129050164|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
129050165|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050166|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050167|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050168|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050169|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050170|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050171|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050172|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050173|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050174|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050175|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050176|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129050177|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
129050178|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
129050179|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050180|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050181|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050182|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050183|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050184|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050185|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050186|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050187|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050188|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050189|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050190|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129050191|NCT03982199|464474455|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
129050192|NCT03982199|464474456|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
129050193|NCT03982199|464474457|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050194|NCT03982199|464474458|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050195|NCT03982199|464474459|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050196|NCT03982199|464474460|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050197|NCT03982199|464474461|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050198|NCT03982199|464474462|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129136381|NCT02318277|464792965|FG002|Overall Study|Death|1|||
129136382|NCT02318277|464792966|FG003|Overall Study|Death|4|||
129136383|NCT02318277|464792967|FG004|Overall Study|Death|6|||
129136384|NCT02318277|464792968|FG005|Overall Study|Death|5|||
129136385|NCT02318277|464792969|FG006|Overall Study|Death|34|||
129136386|NCT02318277|464792970|FG007|Overall Study|Death|58|||
129136387|NCT02318277|464792963|FG000|Overall Study|Transitioned to Hospice|0|||
129136388|NCT02318277|464792964|FG001|Overall Study|Transitioned to Hospice|0|||
129136389|NCT02318277|464792965|FG002|Overall Study|Transitioned to Hospice|0|||
129136390|NCT02318277|464792966|FG003|Overall Study|Transitioned to Hospice|0|||
129136391|NCT02318277|464792967|FG004|Overall Study|Transitioned to Hospice|0|||
128719548|NCT03245008|463271114|FG002|Overall Study|Physician Decision|4|||
128719549|NCT03245008|463271115|FG003|Overall Study|Physician Decision|0|||
128719550|NCT03245008|463271116|FG004|Overall Study|Physician Decision|0|||
128719551|NCT03245008|463271112|FG000|Overall Study|Protocol Violation|0|||
128719552|NCT03245008|463271113|FG001|Overall Study|Protocol Violation|1|||
128719553|NCT03245008|463271114|FG002|Overall Study|Protocol Violation|0|||
128719554|NCT03245008|463271115|FG003|Overall Study|Protocol Violation|0|||
128719555|NCT03245008|463271116|FG004|Overall Study|Protocol Violation|0|||
128719556|NCT03245008|463271112|FG000|Overall Study|Withdrawal by Subject|20|||
128719557|NCT03245008|463271113|FG001|Overall Study|Withdrawal by Subject|19|||
129136392|NCT02318277|464792968|FG005|Overall Study|Transitioned to Hospice|1|||
129136393|NCT02318277|464792969|FG006|Overall Study|Transitioned to Hospice|0|||
129136394|NCT02318277|464792970|FG007|Overall Study|Transitioned to Hospice|0|||
128719558|NCT03245008|463271114|FG002|Overall Study|Withdrawal by Subject|11|||
128719559|NCT03245008|463271115|FG003|Overall Study|Withdrawal by Subject|0|||
129050199|NCT03982199|464474463|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050200|NCT03982199|464474464|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050201|NCT03982199|464474465|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050202|NCT03982199|464474466|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050203|NCT03982199|464474467|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050204|NCT03982199|464474468|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129050205|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050206|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050207|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050208|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
129050209|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050210|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050211|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050212|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050213|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050214|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050215|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050216|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050217|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050218|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129050219|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050220|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050221|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
129050222|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050223|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050224|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050225|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050226|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050227|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050228|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050229|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050230|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050231|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050232|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129050233|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050234|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050235|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
129050236|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050237|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050238|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050239|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050240|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050241|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050242|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050243|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050244|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050245|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050246|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129050247|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050248|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050249|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
129050250|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
129050251|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050252|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050253|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050254|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
128719560|NCT03245008|463271116|FG004|Overall Study|Withdrawal by Subject|0|||
128719561|NCT03245008|463271112|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
128719562|NCT03245008|463271113|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
129050255|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050256|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050257|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050258|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050259|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
128719563|NCT03245008|463271114|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
128719564|NCT03245008|463271115|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
128719565|NCT03245008|463271116|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
128719566|NCT03245008|463271112|FG000|Overall Study|Failure to meet randomization criteria|0|||
128719567|NCT03245008|463271113|FG001|Overall Study|Failure to meet randomization criteria|1|||
128719568|NCT03245008|463271114|FG002|Overall Study|Failure to meet randomization criteria|0|||
128719569|NCT03245008|463271115|FG003|Overall Study|Failure to meet randomization criteria|1|||
128719570|NCT03245008|463271116|FG004|Overall Study|Failure to meet randomization criteria|0|||
128719571|NCT01286012|463271117|FG000|Overall Study|Adverse Event|3|||
128719572|NCT01286012|463271118|FG001|Overall Study|Adverse Event|3|||
128719573|NCT01286012|463271117|FG000|Overall Study|Death|2|||
128719574|NCT01286012|463271118|FG001|Overall Study|Death|3|||
128719575|NCT01286012|463271117|FG000|Overall Study|Protocol Violation|1|||
128719576|NCT01286012|463271118|FG001|Overall Study|Protocol Violation|1|||
128719577|NCT01286012|463271117|FG000|Overall Study|Withdrawal by Subject|4|||
128719578|NCT01286012|463271118|FG001|Overall Study|Withdrawal by Subject|4|||
128719579|NCT01286012|463271117|FG000|Overall Study|Physician Decision|2|||
128719580|NCT01286012|463271118|FG001|Overall Study|Physician Decision|0|||
128719581|NCT01286012|463271117|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
128719582|NCT01286012|463271118|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
128719583|NCT03615105|463271128|FG000|Overall Study|Protocol Violation|1|||
128719584|NCT03615105|463271129|FG001|Overall Study|Protocol Violation|0|||
128719585|NCT03615105|463271130|FG002|Overall Study|Protocol Violation|0|||
128719586|NCT03615105|463271128|FG000|Overall Study|Death|0|||
128719587|NCT03615105|463271129|FG001|Overall Study|Death|2|||
128719588|NCT03615105|463271130|FG002|Overall Study|Death|0|||
128719589|NCT05214768|463271131|FG000|Induction Period|Withdrawal by Subject|1|||
128719590|NCT05214768|463271132|FG001|Induction Period|Withdrawal by Subject|0|||
128719591|NCT05214768|463271133|FG002|Induction Period|Withdrawal by Subject|0|||
128719592|NCT05214768|463271134|FG003|Induction Period|Withdrawal by Subject|0|||
129050260|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129050261|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050262|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050263|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050264|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
129050265|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050266|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050267|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050268|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050269|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050270|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050271|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050272|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050273|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050274|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129050275|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050276|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050277|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
129050278|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
129050279|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050280|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050281|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050282|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050283|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050284|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050285|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050286|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050287|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050288|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129050289|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050290|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050291|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050292|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050293|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050294|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050295|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
128719593|NCT05214768|463271135|FG004|Induction Period|Withdrawal by Subject|0|||
128719594|NCT05214768|463271136|FG005|Induction Period|Withdrawal by Subject|0|||
128719595|NCT05214768|463271131|FG000|Induction Period|Physician Decision|1|||
129050296|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050297|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
129050298|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050299|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050300|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050301|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050302|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129050303|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050304|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050305|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050306|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050307|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050308|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050309|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050310|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050311|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
129050312|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050313|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050314|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050315|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050316|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129050317|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050318|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050319|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050320|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050321|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050322|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050323|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050324|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050325|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
129050326|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050327|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050328|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
128719596|NCT05214768|463271132|FG001|Induction Period|Physician Decision|0|||
128719597|NCT05214768|463271133|FG002|Induction Period|Physician Decision|0|||
128719598|NCT05214768|463271134|FG003|Induction Period|Physician Decision|0|||
128719599|NCT05214768|463271135|FG004|Induction Period|Physician Decision|0|||
128719600|NCT05214768|463271136|FG005|Induction Period|Physician Decision|0|||
128719601|NCT05214768|463271131|FG000|Maintenance Period|Other Reasons|0|||
128719602|NCT05214768|463271132|FG001|Maintenance Period|Other Reasons|0|||
128719603|NCT05214768|463271133|FG002|Maintenance Period|Other Reasons|1|||
128719604|NCT05214768|463271134|FG003|Maintenance Period|Other Reasons|1|||
128719605|NCT05214768|463271135|FG004|Maintenance Period|Other Reasons|0|||
128719606|NCT05214768|463271136|FG005|Maintenance Period|Other Reasons|0|||
128719607|NCT05214768|463271131|FG000|Maintenance Period|Withdrawal by Subject|0|||
128719608|NCT05214768|463271132|FG001|Maintenance Period|Withdrawal by Subject|0|||
128719609|NCT05214768|463271133|FG002|Maintenance Period|Withdrawal by Subject|0|||
128719610|NCT05214768|463271134|FG003|Maintenance Period|Withdrawal by Subject|1|||
128719611|NCT05214768|463271135|FG004|Maintenance Period|Withdrawal by Subject|0|||
128719612|NCT05214768|463271136|FG005|Maintenance Period|Withdrawal by Subject|0|||
128719613|NCT05214768|463271131|FG000|Maintenance Period|Lack of Efficacy|0|||
128719614|NCT05214768|463271132|FG001|Maintenance Period|Lack of Efficacy|0|||
128719615|NCT05214768|463271133|FG002|Maintenance Period|Lack of Efficacy|1|||
128719616|NCT05214768|463271134|FG003|Maintenance Period|Lack of Efficacy|0|||
128719617|NCT05214768|463271135|FG004|Maintenance Period|Lack of Efficacy|1|||
128719618|NCT05214768|463271136|FG005|Maintenance Period|Lack of Efficacy|0|||
128719619|NCT05214768|463271131|FG000|Open Label Extension Period|Physician Decision|0|||
128719620|NCT05214768|463271132|FG001|Open Label Extension Period|Physician Decision|0|||
128775483|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
129050329|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129050330|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
128719621|NCT05214768|463271133|FG002|Open Label Extension Period|Physician Decision|0|||
128719622|NCT05214768|463271134|FG003|Open Label Extension Period|Physician Decision|0|||
128719623|NCT05214768|463271135|FG004|Open Label Extension Period|Physician Decision|0|||
128719624|NCT05214768|463271136|FG005|Open Label Extension Period|Physician Decision|1|||
128719625|NCT05214768|463271131|FG000|Open Label Extension Period|Lack of Efficacy|0|||
129050331|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050332|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050333|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050334|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050335|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050336|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050337|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050338|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050339|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
129050340|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050341|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050342|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050343|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050344|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129050345|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050346|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050347|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050348|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050349|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050350|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050351|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050352|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050353|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
129050354|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050355|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050356|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050357|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050358|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129050359|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050360|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050361|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050362|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050363|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050364|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
129050365|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050366|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
129050367|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
129050368|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050369|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050370|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050371|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050372|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129050373|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050374|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050375|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050376|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050377|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050378|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050379|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050380|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050381|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
129050382|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050383|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050384|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050385|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050386|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129050387|NCT03982199|464474455|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050388|NCT03982199|464474456|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050389|NCT03982199|464474457|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050390|NCT03982199|464474458|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050391|NCT03982199|464474459|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129136395|NCT01520714|464792973|FG000|Overall Study|Protocol Violation|0|||
129136396|NCT01520714|464792974|FG001|Overall Study|Protocol Violation|3|||
129136397|NCT01520714|464792973|FG000|Overall Study|Adverse Event|0|||
129136398|NCT01520714|464792974|FG001|Overall Study|Adverse Event|2|||
129223414|NCT05109234|465118370|FG001|Overall Study|Lack of Efficacy|0|||
129223415|NCT05109234|465118369|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
129223416|NCT05109234|465118370|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
129223417|NCT05109234|465118369|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
129223418|NCT05109234|465118370|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
129223419|NCT05109234|465118369|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
129223420|NCT05109234|465118370|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
129223421|NCT05109234|465118369|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
129223422|NCT05109234|465118370|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
129223423|NCT05437510|465118371|FG000|Overall Study|Adverse Event|2|||
129223424|NCT05437510|465118372|FG001|Overall Study|Adverse Event|1|||
129223425|NCT05437510|465118371|FG000|Overall Study|Protocol Deviation|1|||
129223426|NCT05437510|465118372|FG001|Overall Study|Protocol Deviation|6|||
129223427|NCT05437510|465118371|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
129223428|NCT05437510|465118372|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
129223429|NCT05437510|465118371|FG000|Overall Study|Lost to Follow-up|265|||
129223430|NCT05437510|465118372|FG001|Overall Study|Lost to Follow-up|358|||
129223431|NCT02355184|465118373|FG000|Overall Study|Lost to Follow-up|2|||
129223432|NCT02355184|465118373|FG000|Overall Study|Study Terminated|10|||
129223433|NCT02655016|465118874|FG000|Overall Study|Disease progression|6|||
129223434|NCT02655016|465118875|FG001|Overall Study|Disease progression|4|||
129223435|NCT02655016|465118874|FG000|Overall Study|Site closed|0|||
129223436|NCT02655016|465118875|FG001|Overall Study|Site closed|1|||
129223437|NCT02655016|465118874|FG000|Overall Study|Death|30|||
129223438|NCT02655016|465118875|FG001|Overall Study|Death|48|||
129223439|NCT02655016|465118874|FG000|Overall Study|Lost to Follow-up|1|||
129223440|NCT02655016|465118875|FG001|Overall Study|Lost to Follow-up|1|||
129223441|NCT02655016|465118874|FG000|Overall Study|Withdrawal by Subject|18|||
129223442|NCT02655016|465118875|FG001|Overall Study|Withdrawal by Subject|36|||
129223443|NCT05959629|465118879|FG000|Overall Study|partially necrotic/technical issues|2|||
129223444|NCT05959629|465118880|FG001|Overall Study|partially necrotic/technical issues|2|||
129223445|NCT03573401|465118881|FG000|Overall Study|Withdrawal by Subject|2|||
129050392|NCT03982199|464474460|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
129050393|NCT03982199|464474461|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050394|NCT03982199|464474462|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
129050395|NCT03982199|464474463|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
129050396|NCT03982199|464474464|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050397|NCT03982199|464474465|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050398|NCT03982199|464474466|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050399|NCT03982199|464474467|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050400|NCT03982199|464474468|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129050401|NCT03982199|464474455|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050402|NCT03982199|464474456|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050403|NCT03982199|464474457|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050404|NCT03982199|464474458|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050405|NCT03982199|464474459|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050406|NCT03982199|464474460|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050407|NCT03982199|464474461|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050408|NCT03982199|464474462|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050409|NCT03982199|464474463|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129050410|NCT03982199|464474464|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
129050411|NCT03982199|464474465|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
129050412|NCT03982199|464474466|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
129050413|NCT03982199|464474467|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
129050414|NCT03982199|464474468|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
129050415|NCT03982199|464474455|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050416|NCT03982199|464474456|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050417|NCT03982199|464474457|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050418|NCT03982199|464474458|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050419|NCT03982199|464474459|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050420|NCT03982199|464474460|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129223446|NCT03573401|465118882|FG001|Overall Study|Withdrawal by Subject|0|||
129223447|NCT03573401|465118881|FG000|Overall Study|Subject non-compliance with study schedule|1|||
128719626|NCT05214768|463271132|FG001|Open Label Extension Period|Lack of Efficacy|0|||
129223448|NCT03573401|465118882|FG001|Overall Study|Subject non-compliance with study schedule|0|||
129223449|NCT03573401|465118881|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
129136399|NCT01520714|464792973|FG000|Overall Study|Lack of Efficacy|0|||
129136400|NCT01520714|464792974|FG001|Overall Study|Lack of Efficacy|1|||
129136401|NCT01691482|464792975|FG000|Treatment Period 2|Adverse Event|0|||
129136402|NCT01691482|464792976|FG001|Treatment Period 2|Adverse Event|1|||
129136403|NCT01691482|464792975|FG000|Treatment Period 2|Protocol Violation|1|||
129136404|NCT01691482|464792976|FG001|Treatment Period 2|Protocol Violation|1|||
129136405|NCT00407030|464792977|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
129223450|NCT03573401|465118882|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
129223451|NCT03573401|465118881|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
129223452|NCT03573401|465118882|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
129223453|NCT03576274|465118884|FG000|Overall Study|Lost to Follow-up|3|||
129223454|NCT03576274|465118885|FG001|Overall Study|Lost to Follow-up|2|||
129223455|NCT03576274|465118886|FG002|Overall Study|Lost to Follow-up|3|||
129223456|NCT03576274|465118887|FG003|Overall Study|Lost to Follow-up|1|||
129223457|NCT03576274|465118888|FG004|Overall Study|Lost to Follow-up|3|||
129223458|NCT03576274|465118884|FG000|Overall Study|Withdrawal by Subject|5|||
129223459|NCT03576274|465118885|FG001|Overall Study|Withdrawal by Subject|3|||
129223460|NCT03576274|465118886|FG002|Overall Study|Withdrawal by Subject|2|||
129223461|NCT03576274|465118887|FG003|Overall Study|Withdrawal by Subject|8|||
129223462|NCT03576274|465118888|FG004|Overall Study|Withdrawal by Subject|6|||
129223463|NCT04459715|465118889|FG000|Overall Study|Adverse Event|3|||
129223464|NCT04459715|465118890|FG001|Overall Study|Adverse Event|3|||
129223465|NCT04459715|465118889|FG000|Overall Study|Death|111|||
128719627|NCT05214768|463271133|FG002|Open Label Extension Period|Lack of Efficacy|0|||
128719628|NCT05214768|463271134|FG003|Open Label Extension Period|Lack of Efficacy|0|||
128719629|NCT05214768|463271135|FG004|Open Label Extension Period|Lack of Efficacy|0|||
128719630|NCT05214768|463271136|FG005|Open Label Extension Period|Lack of Efficacy|1|||
128719631|NCT05214768|463271131|FG000|Open Label Extension Period|Ongoing Study|0|||
128719632|NCT05214768|463271132|FG001|Open Label Extension Period|Ongoing Study|0|||
128719633|NCT05214768|463271133|FG002|Open Label Extension Period|Ongoing Study|0|||
128719634|NCT05214768|463271134|FG003|Open Label Extension Period|Ongoing Study|0|||
128719635|NCT05214768|463271135|FG004|Open Label Extension Period|Ongoing Study|0|||
128719636|NCT05214768|463271136|FG005|Open Label Extension Period|Ongoing Study|42|||
128719637|NCT04303780|463271137|FG000|Overall Study|Death|104|||
128719638|NCT04303780|463271138|FG001|Overall Study|Death|85|||
128719639|NCT04303780|463271137|FG000|Overall Study|Lost to Follow-up|5|||
128719640|NCT04303780|463271138|FG001|Overall Study|Lost to Follow-up|2|||
128719641|NCT04303780|463271137|FG000|Overall Study|Withdrawal by Subject|12|||
128719642|NCT04303780|463271138|FG001|Overall Study|Withdrawal by Subject|39|||
128719643|NCT04303780|463271137|FG000|Overall Study|Ongoing in study|50|||
128719644|NCT04303780|463271138|FG001|Overall Study|Ongoing in study|45|||
129050421|NCT03982199|464474461|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050422|NCT03982199|464474462|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050423|NCT03982199|464474463|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050424|NCT03982199|464474464|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
129050425|NCT03982199|464474465|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050426|NCT03982199|464474466|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050427|NCT03982199|464474467|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050428|NCT03982199|464474468|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129050429|NCT03982199|464474455|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050430|NCT03982199|464474456|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050431|NCT03982199|464474457|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050432|NCT03982199|464474458|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050433|NCT03982199|464474459|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050434|NCT03982199|464474460|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050435|NCT03982199|464474461|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050436|NCT03982199|464474462|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050437|NCT03982199|464474463|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050438|NCT03982199|464474464|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050439|NCT03982199|464474465|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050440|NCT03982199|464474466|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129050441|NCT03982199|464474467|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129136406|NCT00407030|464792978|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
129136407|NCT00407030|464792979|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
129136408|NCT00407030|464792977|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
129223466|NCT04459715|465118890|FG001|Overall Study|Death|93|||
129223467|NCT04459715|465118889|FG000|Overall Study|Lost to Follow-up|10|||
128719645|NCT03482791|463271139|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
128719646|NCT03482791|463271140|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
128719647|NCT01344161|463271142|FG000|Overall Study|Lost to Follow-up|4|||
128719648|NCT01344161|463271143|FG001|Overall Study|Lost to Follow-up|1|||
129050442|NCT03982199|464474468|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
129050443|NCT03982199|464474455|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050444|NCT03982199|464474456|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050445|NCT03982199|464474457|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050446|NCT03982199|464474458|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050447|NCT03982199|464474459|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050448|NCT03982199|464474460|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050449|NCT03982199|464474461|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050450|NCT03982199|464474462|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050451|NCT03982199|464474463|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050452|NCT03982199|464474464|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050453|NCT03982199|464474465|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
129050454|NCT03982199|464474466|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
129050455|NCT03982199|464474467|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
129050456|NCT03982199|464474468|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129050457|NCT03982199|464474455|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050458|NCT03982199|464474456|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050459|NCT03982199|464474457|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050460|NCT03982199|464474458|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050461|NCT03982199|464474459|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050462|NCT03982199|464474460|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050463|NCT03982199|464474461|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050464|NCT03982199|464474462|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050465|NCT03982199|464474463|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050466|NCT03982199|464474464|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050467|NCT03982199|464474465|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050468|NCT03982199|464474466|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050469|NCT03982199|464474467|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129050470|NCT03982199|464474468|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
129050471|NCT03982199|464474455|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050472|NCT03982199|464474456|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050473|NCT03982199|464474457|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050474|NCT03982199|464474458|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050475|NCT03982199|464474459|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050476|NCT03982199|464474460|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050477|NCT03982199|464474461|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050478|NCT03982199|464474462|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050479|NCT03982199|464474463|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050480|NCT03982199|464474464|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050481|NCT03982199|464474465|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050482|NCT03982199|464474466|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129050483|NCT03982199|464474467|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
129050484|NCT03982199|464474468|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
129050485|NCT03982199|464474455|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050486|NCT03982199|464474456|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050487|NCT03982199|464474457|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050488|NCT03982199|464474458|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050489|NCT03982199|464474459|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050490|NCT03982199|464474460|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050491|NCT03982199|464474461|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050492|NCT03982199|464474462|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050493|NCT03982199|464474463|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050494|NCT03982199|464474464|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050495|NCT03982199|464474465|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050496|NCT03982199|464474466|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050497|NCT03982199|464474467|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
129050498|NCT03982199|464474468|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129050499|NCT00594646|464474469|FG000|Overall Study|Withdrawal by Subject|1|||
129050500|NCT00594646|464474469|FG000|Overall Study|Lost to Follow-up|15|||
129050501|NCT03907462|464474472|FG000|Overall Study|Physician Decision|1|||
129050502|NCT03907462|464474473|FG001|Overall Study|Physician Decision|3|||
129050503|NCT03907462|464474474|FG002|Overall Study|Physician Decision|1|||
129050504|NCT03907462|464474472|FG000|Overall Study|Withdrawal by Subject|6|||
129050505|NCT03907462|464474473|FG001|Overall Study|Withdrawal by Subject|3|||
129136409|NCT00407030|464792978|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
129136410|NCT00407030|464792979|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
129136411|NCT00407030|464792977|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
129136412|NCT00407030|464792978|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
129136413|NCT00407030|464792979|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
129136414|NCT00407030|464792977|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
129136415|NCT00407030|464792978|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
129136416|NCT00407030|464792979|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
129136417|NCT00407030|464792977|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
129136418|NCT00407030|464792978|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
129136419|NCT00407030|464792979|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
129136420|NCT00407030|464792977|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
129136421|NCT00407030|464792978|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
129136422|NCT00407030|464792979|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
129136423|NCT00407030|464792977|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
129136424|NCT00407030|464792978|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
129136425|NCT00407030|464792979|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
129136426|NCT00407030|464792977|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
129136427|NCT00407030|464792978|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
129136428|NCT00407030|464792979|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
129136429|NCT00407030|464792977|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
129136430|NCT00407030|464792978|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
129050506|NCT03907462|464474474|FG002|Overall Study|Withdrawal by Subject|3|||
129050507|NCT03907462|464474472|FG000|Overall Study|Pregnancy|4|||
129050508|NCT03907462|464474473|FG001|Overall Study|Pregnancy|2|||
129050509|NCT03907462|464474474|FG002|Overall Study|Pregnancy|6|||
129050510|NCT03907462|464474472|FG000|Overall Study|Lost to Follow-up|16|||
129050511|NCT03907462|464474473|FG001|Overall Study|Lost to Follow-up|18|||
129050512|NCT03907462|464474474|FG002|Overall Study|Lost to Follow-up|22|||
129050513|NCT03548064|464476527|FG000|Overall Study|Withdrawal by Subject|0|||
129050514|NCT03548064|464476528|FG001|Overall Study|Withdrawal by Subject|0|||
129050515|NCT03548064|464476529|FG002|Overall Study|Withdrawal by Subject|0|||
129050516|NCT03548064|464476530|FG003|Overall Study|Withdrawal by Subject|1|||
129050517|NCT03548064|464476531|FG004|Overall Study|Withdrawal by Subject|0|||
129050518|NCT03548064|464476532|FG005|Overall Study|Withdrawal by Subject|0|||
129050519|NCT03548064|464476533|FG006|Overall Study|Withdrawal by Subject|0|||
129050520|NCT03548064|464476534|FG007|Overall Study|Withdrawal by Subject|0|||
129050521|NCT03548064|464476527|FG000|Overall Study|Lost to Follow-up|0|||
129050522|NCT03548064|464476528|FG001|Overall Study|Lost to Follow-up|0|||
129050523|NCT03548064|464476529|FG002|Overall Study|Lost to Follow-up|0|||
129050524|NCT03548064|464476530|FG003|Overall Study|Lost to Follow-up|0|||
129050525|NCT03548064|464476531|FG004|Overall Study|Lost to Follow-up|2|||
129050526|NCT03548064|464476532|FG005|Overall Study|Lost to Follow-up|0|||
129050527|NCT03548064|464476533|FG006|Overall Study|Lost to Follow-up|0|||
129050528|NCT03548064|464476534|FG007|Overall Study|Lost to Follow-up|0|||
129050529|NCT03548064|464476527|FG000|Overall Study|Covid-19 Pandemic|0|||
129050530|NCT03548064|464476528|FG001|Overall Study|Covid-19 Pandemic|0|||
129050531|NCT03548064|464476529|FG002|Overall Study|Covid-19 Pandemic|0|||
129050532|NCT03548064|464476530|FG003|Overall Study|Covid-19 Pandemic|0|||
129050533|NCT03548064|464476531|FG004|Overall Study|Covid-19 Pandemic|10|||
129050534|NCT03548064|464476532|FG005|Overall Study|Covid-19 Pandemic|3|||
129050535|NCT03548064|464476533|FG006|Overall Study|Covid-19 Pandemic|0|||
129050536|NCT03548064|464476534|FG007|Overall Study|Covid-19 Pandemic|0|||
129050537|NCT05011123|464476535|FG000|Overall Study|Withdrawal by Subject|4|||
129050538|NCT05011123|464476536|FG001|Overall Study|Withdrawal by Subject|2|||
129050539|NCT05011123|464476535|FG000|Overall Study|Lost to Follow-up|7|||
129050540|NCT05011123|464476536|FG001|Overall Study|Lost to Follow-up|6|||
129050541|NCT05011123|464476535|FG000|Overall Study|Ongoing at the time of DBL date|36|||
129050542|NCT05011123|464476536|FG001|Overall Study|Ongoing at the time of DBL date|10|||
129050543|NCT05011123|464476535|FG000|Overall Study|Randomized but did not receive vaccination|1|||
129050544|NCT05011123|464476536|FG001|Overall Study|Randomized but did not receive vaccination|0|||
129050545|NCT04221789|464476537|FG000|Overall Study|deviation from protoco|22|||
129136431|NCT00407030|464792979|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
129136432|NCT00407030|464792977|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
129136433|NCT00407030|464792978|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
129050546|NCT04221789|464476538|FG001|Overall Study|deviation from protoco|8|||
129050547|NCT04732221|464476539|FG000|Base Period|Death|2|||
129050548|NCT04732221|464476540|FG001|Base Period|Death|0|||
129050549|NCT04732221|464476541|FG002|Base Period|Death|0|||
129050550|NCT04732221|464476542|FG003|Base Period|Death|0|||
129050551|NCT04732221|464476543|FG004|Base Period|Death|0|||
129050552|NCT04732221|464476544|FG005|Base Period|Death|0|||
129050553|NCT04732221|464476545|FG006|Base Period|Death|0|||
129050554|NCT04732221|464476539|FG000|Base Period|Withdrawal by Subject|0|||
129050555|NCT04732221|464476540|FG001|Base Period|Withdrawal by Subject|1|||
129223468|NCT04459715|465118890|FG001|Overall Study|Lost to Follow-up|9|||
129050556|NCT04732221|464476541|FG002|Base Period|Withdrawal by Subject|1|||
129050557|NCT04732221|464476542|FG003|Base Period|Withdrawal by Subject|0|||
129050558|NCT04732221|464476543|FG004|Base Period|Withdrawal by Subject|0|||
129050559|NCT04732221|464476544|FG005|Base Period|Withdrawal by Subject|0|||
129050560|NCT04732221|464476545|FG006|Base Period|Withdrawal by Subject|0|||
129050561|NCT04732221|464476539|FG000|Extension Period|Adverse Event|0|||
129050562|NCT04732221|464476540|FG001|Extension Period|Adverse Event|0|||
129050563|NCT04732221|464476541|FG002|Extension Period|Adverse Event|0|||
129050564|NCT04732221|464476542|FG003|Extension Period|Adverse Event|0|||
129050565|NCT04732221|464476543|FG004|Extension Period|Adverse Event|0|||
129050566|NCT04732221|464476544|FG005|Extension Period|Adverse Event|1|||
129050567|NCT04732221|464476545|FG006|Extension Period|Adverse Event|0|||
129050568|NCT04732221|464476539|FG000|Extension Period|Death|0|||
129050569|NCT04732221|464476540|FG001|Extension Period|Death|0|||
129050570|NCT04732221|464476541|FG002|Extension Period|Death|0|||
129050571|NCT04732221|464476542|FG003|Extension Period|Death|0|||
129050572|NCT04732221|464476543|FG004|Extension Period|Death|1|||
129050573|NCT04732221|464476544|FG005|Extension Period|Death|0|||
129050574|NCT04732221|464476545|FG006|Extension Period|Death|2|||
129050575|NCT04732221|464476539|FG000|Extension Period|Pregnancy|0|||
129050576|NCT04732221|464476540|FG001|Extension Period|Pregnancy|0|||
129050577|NCT04732221|464476541|FG002|Extension Period|Pregnancy|0|||
129050578|NCT04732221|464476542|FG003|Extension Period|Pregnancy|0|||
129050579|NCT04732221|464476543|FG004|Extension Period|Pregnancy|1|||
129050580|NCT04732221|464476544|FG005|Extension Period|Pregnancy|0|||
129050581|NCT04732221|464476545|FG006|Extension Period|Pregnancy|0|||
129050582|NCT04732221|464476539|FG000|Extension Period|Sponsors Decision|0|||
129050583|NCT04732221|464476540|FG001|Extension Period|Sponsors Decision|0|||
129050584|NCT04732221|464476541|FG002|Extension Period|Sponsors Decision|0|||
129050585|NCT04732221|464476542|FG003|Extension Period|Sponsors Decision|0|||
129050586|NCT04732221|464476543|FG004|Extension Period|Sponsors Decision|41|||
129050587|NCT04732221|464476544|FG005|Extension Period|Sponsors Decision|40|||
129050588|NCT04732221|464476545|FG006|Extension Period|Sponsors Decision|40|||
129050589|NCT04732221|464476539|FG000|Extension Period|Withdrawal by Subject|0|||
129050590|NCT04732221|464476540|FG001|Extension Period|Withdrawal by Subject|0|||
129050591|NCT04732221|464476541|FG002|Extension Period|Withdrawal by Subject|0|||
129050592|NCT04732221|464476542|FG003|Extension Period|Withdrawal by Subject|0|||
129050593|NCT04732221|464476543|FG004|Extension Period|Withdrawal by Subject|1|||
129050594|NCT04732221|464476544|FG005|Extension Period|Withdrawal by Subject|5|||
129050595|NCT04732221|464476545|FG006|Extension Period|Withdrawal by Subject|2|||
129050596|NCT03303625|464476546|FG000|Overall Study|Withdrawal by Subject|2|||
129050597|NCT03303625|464476547|FG001|Overall Study|Withdrawal by Subject|0|||
129050598|NCT03303625|464476548|FG002|Overall Study|Withdrawal by Subject|0|||
129136434|NCT00407030|464792979|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
129136435|NCT00407030|464792977|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
129136436|NCT00407030|464792978|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
129136437|NCT00407030|464792979|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
129136438|NCT00407030|464792977|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
129136439|NCT00407030|464792978|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
129136440|NCT00407030|464792979|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
129136441|NCT00407030|464792977|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
129136442|NCT00407030|464792978|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
129136443|NCT00407030|464792979|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
129136444|NCT02829957|464792981|FG000|Overall Study|Lost to Follow-up|2|||
129136445|NCT02829957|464792982|FG001|Overall Study|Lost to Follow-up|1|||
129136446|NCT00754559|464792983|FG000|Overall Study|Adverse Event|15|||
129136447|NCT00754559|464792983|FG000|Overall Study|Protocol Violation|11|||
129136448|NCT00754559|464792983|FG000|Overall Study|Lack of Efficacy|10|||
129136449|NCT00754559|464792983|FG000|Overall Study|Lost to Follow-up|2|||
129136450|NCT00754559|464792983|FG000|Overall Study|Administrative reason|1|||
129136451|NCT00754559|464792983|FG000|Overall Study|Other|5|||
129136452|NCT00754559|464792983|FG000|Overall Study|Withdrawal by Subject|3|||
129136453|NCT01663987|464792984|FG000|Overall Study|Adverse Event|7|||
129136454|NCT01663987|464792985|FG001|Overall Study|Adverse Event|2|||
129136455|NCT01663987|464792984|FG000|Overall Study|Lost to Follow-up|1|||
129136456|NCT01663987|464792985|FG001|Overall Study|Lost to Follow-up|1|||
129136457|NCT01663987|464792984|FG000|Overall Study|Withdrawal by Subject|2|||
129136458|NCT01663987|464792985|FG001|Overall Study|Withdrawal by Subject|3|||
129136459|NCT01663987|464792984|FG000|Overall Study|Other reason not defined above|3|||
128719649|NCT01344161|463271142|FG000|Overall Study|Pregnancy|0|||
129050599|NCT03303625|464476549|FG003|Overall Study|Withdrawal by Subject|0|||
129050600|NCT05327816|464476550|FG000|Overall Study|Lost to Follow-up|1|||
129050601|NCT05327816|464476551|FG001|Overall Study|Lost to Follow-up|0|||
129050602|NCT05327816|464476552|FG002|Overall Study|Lost to Follow-up|0|||
129050603|NCT05327816|464476553|FG003|Overall Study|Lost to Follow-up|0|||
129050604|NCT05327816|464476554|FG004|Overall Study|Lost to Follow-up|0|||
129050605|NCT05327816|464476555|FG005|Overall Study|Lost to Follow-up|0|||
128719650|NCT01344161|463271143|FG001|Overall Study|Pregnancy|1|||
129050606|NCT05327816|464476556|FG006|Overall Study|Lost to Follow-up|0|||
129050607|NCT05327816|464476557|FG007|Overall Study|Lost to Follow-up|0|||
129050608|NCT05327816|464476558|FG008|Overall Study|Lost to Follow-up|0|||
129050609|NCT05327816|464476559|FG009|Overall Study|Lost to Follow-up|1|||
129050610|NCT05327816|464476560|FG010|Overall Study|Lost to Follow-up|0|||
129050611|NCT05327816|464476550|FG000|Overall Study|Withdrawal by Subject|0|||
129050612|NCT05327816|464476551|FG001|Overall Study|Withdrawal by Subject|0|||
129050613|NCT05327816|464476552|FG002|Overall Study|Withdrawal by Subject|0|||
129050614|NCT05327816|464476553|FG003|Overall Study|Withdrawal by Subject|0|||
129050615|NCT05327816|464476554|FG004|Overall Study|Withdrawal by Subject|1|||
129050616|NCT05327816|464476555|FG005|Overall Study|Withdrawal by Subject|1|||
129050617|NCT05327816|464476556|FG006|Overall Study|Withdrawal by Subject|0|||
129050618|NCT05327816|464476557|FG007|Overall Study|Withdrawal by Subject|0|||
129050619|NCT05327816|464476558|FG008|Overall Study|Withdrawal by Subject|0|||
129050620|NCT05327816|464476559|FG009|Overall Study|Withdrawal by Subject|0|||
129223469|NCT04459715|465118889|FG000|Overall Study|Other Reasons|4|||
129050621|NCT05327816|464476560|FG010|Overall Study|Withdrawal by Subject|0|||
129050622|NCT05327816|464476550|FG000|Overall Study|Study Terminated by Sponsor|11|||
129050623|NCT05327816|464476551|FG001|Overall Study|Study Terminated by Sponsor|12|||
129050624|NCT05327816|464476552|FG002|Overall Study|Study Terminated by Sponsor|12|||
129050625|NCT05327816|464476553|FG003|Overall Study|Study Terminated by Sponsor|12|||
129050626|NCT05327816|464476554|FG004|Overall Study|Study Terminated by Sponsor|11|||
129050627|NCT05327816|464476555|FG005|Overall Study|Study Terminated by Sponsor|11|||
129050628|NCT05327816|464476556|FG006|Overall Study|Study Terminated by Sponsor|11|||
129050629|NCT05327816|464476557|FG007|Overall Study|Study Terminated by Sponsor|11|||
129050630|NCT05327816|464476558|FG008|Overall Study|Study Terminated by Sponsor|11|||
129050631|NCT05327816|464476559|FG009|Overall Study|Study Terminated by Sponsor|11|||
129050632|NCT05327816|464476560|FG010|Overall Study|Study Terminated by Sponsor|12|||
129050633|NCT05327816|464476550|FG000|Overall Study|Randomized but not treated|0|||
129050634|NCT05327816|464476551|FG001|Overall Study|Randomized but not treated|0|||
129050635|NCT05327816|464476552|FG002|Overall Study|Randomized but not treated|0|||
129050636|NCT05327816|464476553|FG003|Overall Study|Randomized but not treated|0|||
129050637|NCT05327816|464476554|FG004|Overall Study|Randomized but not treated|0|||
129050638|NCT05327816|464476555|FG005|Overall Study|Randomized but not treated|0|||
129050639|NCT05327816|464476556|FG006|Overall Study|Randomized but not treated|1|||
129050640|NCT05327816|464476557|FG007|Overall Study|Randomized but not treated|1|||
129050641|NCT05327816|464476558|FG008|Overall Study|Randomized but not treated|1|||
129050642|NCT05327816|464476559|FG009|Overall Study|Randomized but not treated|0|||
129050643|NCT05327816|464476560|FG010|Overall Study|Randomized but not treated|0|||
129050644|NCT04305587|464476561|FG000|Overall Study|Withdrawal by Subject|0|||
129050645|NCT04305587|464476562|FG001|Overall Study|Withdrawal by Subject|0|||
129050646|NCT04305587|464476563|FG002|Overall Study|Withdrawal by Subject|0|||
129050647|NCT04305587|464476564|FG003|Overall Study|Withdrawal by Subject|1|||
129050648|NCT04305587|464476565|FG004|Overall Study|Withdrawal by Subject|0|||
129050649|NCT04305587|464476566|FG005|Overall Study|Withdrawal by Subject|0|||
129050650|NCT04305587|464476567|FG006|Overall Study|Withdrawal by Subject|0|||
129050651|NCT04305587|464476568|FG007|Overall Study|Withdrawal by Subject|0|||
129050652|NCT04305587|464476569|FG008|Overall Study|Withdrawal by Subject|0|||
129050653|NCT01367665|464476570|FG000|Overall Study|Death|102|||
129050654|NCT01367665|464476571|FG001|Overall Study|Death|19|||
129050655|NCT01367665|464476570|FG000|Overall Study|Lost to Follow-up|222|||
129050656|NCT01367665|464476571|FG001|Overall Study|Lost to Follow-up|22|||
129050657|NCT01367665|464476570|FG000|Overall Study|Not Done|118|||
129050658|NCT01367665|464476571|FG001|Overall Study|Not Done|14|||
129050659|NCT02752906|464476572|FG000|Overall Study|Protocol Violation|2|||
129050660|NCT02752906|464476573|FG001|Overall Study|Protocol Violation|1|||
129050661|NCT02752906|464476572|FG000|Overall Study|Withdrawal by Subject|2|||
129050662|NCT02752906|464476573|FG001|Overall Study|Withdrawal by Subject|2|||
129050663|NCT02752906|464476572|FG000|Overall Study|Lost to Follow-up|3|||
129050664|NCT02752906|464476573|FG001|Overall Study|Lost to Follow-up|2|||
129050665|NCT02771795|464476575|FG000|Overall Study|Withdrawal by Subject|47|||
129050666|NCT02771795|464476576|FG001|Overall Study|Withdrawal by Subject|37|||
129050667|NCT02771795|464476575|FG000|Overall Study|Termination by premature discontinuation of study|168|||
129050668|NCT02771795|464476576|FG001|Overall Study|Termination by premature discontinuation of study|185|||
129050669|NCT04112173|464476577|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
129050670|NCT02906930|464476578|FG000|Overall Study|Withdrawal by Subject|0|||
129050671|NCT02906930|464476579|FG001|Overall Study|Withdrawal by Subject|5|||
129050672|NCT02906930|464476580|FG002|Overall Study|Withdrawal by Subject|5|||
129050673|NCT02906930|464476581|FG003|Overall Study|Withdrawal by Subject|4|||
129050674|NCT02906930|464476578|FG000|Overall Study|Lost to Follow-up|5|||
129050675|NCT02906930|464476579|FG001|Overall Study|Lost to Follow-up|7|||
129050676|NCT02906930|464476580|FG002|Overall Study|Lost to Follow-up|5|||
129223470|NCT04459715|465118890|FG001|Overall Study|Other Reasons|5|||
129050677|NCT02906930|464476581|FG003|Overall Study|Lost to Follow-up|2|||
129050678|NCT02906930|464476578|FG000|Overall Study|Death|0|||
128719651|NCT01344161|463271142|FG000|Overall Study|Protocol Violation|1|||
129050679|NCT02906930|464476579|FG001|Overall Study|Death|0|||
129050680|NCT02906930|464476580|FG002|Overall Study|Death|1|||
129050681|NCT02906930|464476581|FG003|Overall Study|Death|0|||
129050682|NCT02906930|464476578|FG000|Overall Study|Other|1|||
129050683|NCT02906930|464476579|FG001|Overall Study|Other|2|||
129050684|NCT02906930|464476580|FG002|Overall Study|Other|1|||
129050685|NCT02906930|464476581|FG003|Overall Study|Other|2|||
129050686|NCT02570113|464476584|FG000|Overall Study|Withdrawal by Subject|3|||
129050687|NCT02564211|464476585|FG000|Overall Study|Adverse Event|4|||
129050688|NCT00910091|464476586|FG000|Pre-assignment|Withdrawal by Subject|0|||
129050689|NCT00910091|464476587|FG001|Pre-assignment|Withdrawal by Subject|2|||
129050690|NCT00910091|464476586|FG000|Treatment and Survival|Withdrawal by Subject|3|||
129050691|NCT00910091|464476587|FG001|Treatment and Survival|Withdrawal by Subject|4|||
129050692|NCT00910091|464476586|FG000|Treatment and Survival|Adverse Event|1|||
129050693|NCT00910091|464476587|FG001|Treatment and Survival|Adverse Event|0|||
129050694|NCT00622466|464476588|FG000|Overall Study|Death|1|||
129050695|NCT00622466|464476588|FG000|Overall Study|Adverse Event|1|||
129050696|NCT00622466|464476588|FG000|Overall Study|Withdrawal by Subject|2|||
129050697|NCT01908816|464476589|FG000|Overall Study|Subject's no longer requires study drug|0|||
129050698|NCT01908816|464476590|FG001|Overall Study|Subject's no longer requires study drug|0|||
129050699|NCT01908816|464476591|FG002|Overall Study|Subject's no longer requires study drug|0|||
129050700|NCT01908816|464476592|FG003|Overall Study|Subject's no longer requires study drug|1|||
129050701|NCT01908816|464476589|FG000|Overall Study|Protocol deviation|1|||
129050702|NCT01908816|464476590|FG001|Overall Study|Protocol deviation|2|||
129050703|NCT01908816|464476591|FG002|Overall Study|Protocol deviation|1|||
129050704|NCT01908816|464476592|FG003|Overall Study|Protocol deviation|1|||
129050705|NCT01908816|464476589|FG000|Overall Study|Withdrawal by Subject|0|||
129050706|NCT01908816|464476590|FG001|Overall Study|Withdrawal by Subject|4|||
129050707|NCT01908816|464476591|FG002|Overall Study|Withdrawal by Subject|2|||
129050708|NCT01908816|464476592|FG003|Overall Study|Withdrawal by Subject|2|||
129050709|NCT01908816|464476589|FG000|Overall Study|Lost to Follow-up|3|||
129050710|NCT01908816|464476590|FG001|Overall Study|Lost to Follow-up|5|||
129050711|NCT01908816|464476591|FG002|Overall Study|Lost to Follow-up|4|||
129050712|NCT01908816|464476592|FG003|Overall Study|Lost to Follow-up|2|||
129050713|NCT01908816|464476589|FG000|Overall Study|Death|1|||
129050714|NCT01908816|464476590|FG001|Overall Study|Death|0|||
129050715|NCT01908816|464476591|FG002|Overall Study|Death|7|||
129050716|NCT01908816|464476592|FG003|Overall Study|Death|1|||
129050717|NCT01908816|464476589|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129050718|NCT01908816|464476590|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
129050719|NCT01908816|464476591|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
129050720|NCT01908816|464476592|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129050721|NCT01908816|464476589|FG000|Overall Study|Early termination|87|||
129050722|NCT01908816|464476590|FG001|Overall Study|Early termination|60|||
129050723|NCT01908816|464476591|FG002|Overall Study|Early termination|43|||
129050724|NCT01908816|464476592|FG003|Overall Study|Early termination|28|||
129050725|NCT05183217|464476593|FG000|Overall Study|Withdrawal by Subject|1|||
129050726|NCT05183217|464476594|FG001|Overall Study|Withdrawal by Subject|1|||
129050727|NCT01155024|464476596|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
129050728|NCT01155024|464476597|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
129050729|NCT01155024|464476596|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
129050730|NCT01155024|464476597|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
129050731|NCT01155024|464476596|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
129050732|NCT01155024|464476597|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
129050733|NCT04585789|464476598|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
129050734|NCT04585789|464476599|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
129050735|NCT04585789|464476600|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
128719652|NCT01344161|463271143|FG001|Overall Study|Protocol Violation|1|||
129050736|NCT04585789|464476598|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
128719653|NCT02967692|463273192|FG000|Overall Study|Progressive disease|3|||
128719654|NCT02967692|463273193|FG001|Overall Study|Progressive disease|15|||
129050737|NCT04585789|464476599|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
129050738|NCT04585789|464476600|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
129050739|NCT01154816|464476603|FG000|Overall Study|Withdrawal by Subject|1|||
128719655|NCT02967692|463273194|FG002|Overall Study|Progressive disease|114|||
128719656|NCT02967692|463273195|FG003|Overall Study|Progressive disease|151|||
129050740|NCT01154816|464476604|FG001|Overall Study|Withdrawal by Subject|0|||
129050741|NCT01154816|464476605|FG002|Overall Study|Withdrawal by Subject|0|||
129050742|NCT01154816|464476606|FG003|Overall Study|Withdrawal by Subject|1|||
129050743|NCT01154816|464476607|FG004|Overall Study|Withdrawal by Subject|0|||
129050744|NCT01154816|464476608|FG005|Overall Study|Withdrawal by Subject|0|||
129050745|NCT01154816|464476609|FG006|Overall Study|Withdrawal by Subject|0|||
129050746|NCT01154816|464476610|FG007|Overall Study|Withdrawal by Subject|0|||
129050747|NCT01154816|464476611|FG008|Overall Study|Withdrawal by Subject|1|||
129050748|NCT01154816|464476612|FG009|Overall Study|Withdrawal by Subject|3|||
129050749|NCT01154816|464476613|FG010|Overall Study|Withdrawal by Subject|0|||
128719657|NCT02967692|463273192|FG000|Overall Study|Subject/guardian decision|1|||
129050750|NCT01154816|464476614|FG011|Overall Study|Withdrawal by Subject|0|||
129050751|NCT01154816|464476603|FG000|Overall Study|Progressive Disease|13|||
129050752|NCT01154816|464476604|FG001|Overall Study|Progressive Disease|8|||
129050753|NCT01154816|464476605|FG002|Overall Study|Progressive Disease|9|||
129050754|NCT01154816|464476606|FG003|Overall Study|Progressive Disease|9|||
129050755|NCT01154816|464476607|FG004|Overall Study|Progressive Disease|8|||
129050756|NCT01154816|464476608|FG005|Overall Study|Progressive Disease|8|||
129050757|NCT01154816|464476609|FG006|Overall Study|Progressive Disease|5|||
129050758|NCT01154816|464476610|FG007|Overall Study|Progressive Disease|6|||
129050759|NCT01154816|464476611|FG008|Overall Study|Progressive Disease|8|||
129050760|NCT01154816|464476612|FG009|Overall Study|Progressive Disease|6|||
129050761|NCT01154816|464476613|FG010|Overall Study|Progressive Disease|10|||
129050762|NCT01154816|464476614|FG011|Overall Study|Progressive Disease|3|||
129050763|NCT01154816|464476603|FG000|Overall Study|Physician Decision|1|||
129050764|NCT01154816|464476604|FG001|Overall Study|Physician Decision|0|||
129050765|NCT01154816|464476605|FG002|Overall Study|Physician Decision|1|||
129050766|NCT01154816|464476606|FG003|Overall Study|Physician Decision|0|||
129050767|NCT01154816|464476607|FG004|Overall Study|Physician Decision|2|||
129050768|NCT01154816|464476608|FG005|Overall Study|Physician Decision|0|||
129050769|NCT01154816|464476609|FG006|Overall Study|Physician Decision|0|||
129050770|NCT01154816|464476610|FG007|Overall Study|Physician Decision|0|||
129050771|NCT01154816|464476611|FG008|Overall Study|Physician Decision|0|||
129050772|NCT01154816|464476612|FG009|Overall Study|Physician Decision|1|||
129223471|NCT04459715|465118889|FG000|Overall Study|PROTOCOL DEVIATION|0|||
129223472|NCT04459715|465118890|FG001|Overall Study|PROTOCOL DEVIATION|1|||
129050773|NCT01154816|464476613|FG010|Overall Study|Physician Decision|1|||
129050774|NCT01154816|464476614|FG011|Overall Study|Physician Decision|1|||
129050775|NCT01154816|464476603|FG000|Overall Study|Adverse Event|5|||
129050776|NCT01154816|464476604|FG001|Overall Study|Adverse Event|2|||
129050777|NCT01154816|464476605|FG002|Overall Study|Adverse Event|0|||
129050778|NCT01154816|464476606|FG003|Overall Study|Adverse Event|0|||
129050779|NCT01154816|464476607|FG004|Overall Study|Adverse Event|0|||
129050780|NCT01154816|464476608|FG005|Overall Study|Adverse Event|0|||
129050781|NCT01154816|464476609|FG006|Overall Study|Adverse Event|1|||
129050782|NCT01154816|464476610|FG007|Overall Study|Adverse Event|1|||
129050783|NCT01154816|464476611|FG008|Overall Study|Adverse Event|0|||
129050784|NCT01154816|464476612|FG009|Overall Study|Adverse Event|0|||
129050785|NCT01154816|464476613|FG010|Overall Study|Adverse Event|0|||
129050786|NCT01154816|464476614|FG011|Overall Study|Adverse Event|0|||
129050787|NCT03397771|464476615|FG000|Overall Study|2 erroneously randomized, never treated|3|||
129050788|NCT03397771|464476616|FG001|Overall Study|2 erroneously randomized, never treated|1|||
129050789|NCT03397771|464476615|FG000|Overall Study|Withdrawal by Subject|1|||
129050790|NCT03397771|464476616|FG001|Overall Study|Withdrawal by Subject|3|||
129050791|NCT03397771|464476615|FG000|Overall Study|Protocol Violation|2|||
129050792|NCT03397771|464476616|FG001|Overall Study|Protocol Violation|2|||
129050793|NCT03397771|464476615|FG000|Overall Study|Adverse Event|2|||
129050794|NCT03397771|464476616|FG001|Overall Study|Adverse Event|1|||
129050795|NCT04078126|464476622|FG000|Washout|Study put on hold due to COVID-19|0|||
129050796|NCT04078126|464476623|FG001|Washout|Study put on hold due to COVID-19|2|||
129050797|NCT04078126|464476622|FG000|Period 2|Study put on hold due to COVID-19|1|||
129050798|NCT04078126|464476623|FG001|Period 2|Study put on hold due to COVID-19|1|||
129050799|NCT02669758|464476626|FG000|Overall Study|Withdrawal by Subject|43|||
129050800|NCT02669758|464476626|FG000|Overall Study|Lost to Follow-up|19|||
129050801|NCT02669758|464476626|FG000|Overall Study|Adverse Event|16|||
129050802|NCT02669758|464476626|FG000|Overall Study|Non-Compliance with Study Drug|8|||
129050803|NCT02669758|464476626|FG000|Overall Study|Lack of Efficacy|5|||
129136460|NCT01663987|464792985|FG001|Overall Study|Other reason not defined above|0|||
129136461|NCT01370538|464792987|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
129136462|NCT01370538|464792988|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
129136463|NCT01370538|464792987|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129136464|NCT01370538|464792988|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129136465|NCT01370538|464792987|FG000|Overall Study|Adverse Event|1|||
129136466|NCT01370538|464792988|FG001|Overall Study|Adverse Event|0|||
129050804|NCT02669758|464476626|FG000|Overall Study|Pregnancy|1|||
129050805|NCT02669758|464476626|FG000|Overall Study|Study noncompliance|1|||
129050806|NCT02669758|464476626|FG000|Overall Study|Protocol Violation|1|||
129050807|NCT02605993|464476629|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
129136467|NCT01370538|464792987|FG000|Overall Study|Protocol Violation|8|||
129050808|NCT02605993|464476630|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
129050809|NCT02605993|464476631|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
129050810|NCT02605993|464476632|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
129050811|NCT02603393|464476633|FG000|Overall Study|Patient/guardian decision|32|||
129136468|NCT01370538|464792988|FG001|Overall Study|Protocol Violation|5|||
129223473|NCT04459715|465118889|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
129223474|NCT04459715|465118890|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
128719658|NCT02967692|463273193|FG001|Overall Study|Subject/guardian decision|1|||
129136469|NCT01370538|464792987|FG000|Overall Study|Development of study specific withdrawal|1|||
129136470|NCT01370538|464792988|FG001|Overall Study|Development of study specific withdrawal|1|||
129050812|NCT02603393|464476634|FG001|Overall Study|Patient/guardian decision|18|||
129050813|NCT02603393|464476633|FG000|Overall Study|Adverse Event|17|||
129050814|NCT02603393|464476634|FG001|Overall Study|Adverse Event|15|||
129050815|NCT02603393|464476633|FG000|Overall Study|Technical problems|4|||
129050816|NCT02603393|464476634|FG001|Overall Study|Technical problems|7|||
129050817|NCT02603393|464476633|FG000|Overall Study|Lack of Efficacy|7|||
129050818|NCT02603393|464476634|FG001|Overall Study|Lack of Efficacy|2|||
129050819|NCT02603393|464476633|FG000|Overall Study|Death|3|||
129050820|NCT02603393|464476634|FG001|Overall Study|Death|4|||
129050821|NCT02603393|464476633|FG000|Overall Study|Physician Decision|3|||
129050822|NCT02603393|464476634|FG001|Overall Study|Physician Decision|3|||
129050823|NCT02603393|464476633|FG000|Overall Study|Protocol deviation|2|||
129050824|NCT02603393|464476634|FG001|Overall Study|Protocol deviation|3|||
129050825|NCT02603393|464476633|FG000|Overall Study|Lost to Follow-up|1|||
129050826|NCT02603393|464476634|FG001|Overall Study|Lost to Follow-up|2|||
129050827|NCT02603393|464476633|FG000|Overall Study|Non-compliance with study treatment|1|||
129050828|NCT02603393|464476634|FG001|Overall Study|Non-compliance with study treatment|0|||
129050829|NCT02603393|464476633|FG000|Overall Study|Sponsor decision|1|||
129050830|NCT02603393|464476634|FG001|Overall Study|Sponsor decision|0|||
129050831|NCT01868893|464476637|FG000|Overall Study|Adverse Event|2|||
129050832|NCT01868893|464476637|FG000|Overall Study|Commercial availability of study drug|17|||
129050833|NCT01868893|464476637|FG000|Overall Study|Neutropenia|1|||
129050834|NCT01783548|464476638|FG000|Overall Study|Adverse Event|8|||
129050835|NCT01783548|464476639|FG001|Overall Study|Adverse Event|4|||
129050836|NCT01783548|464476638|FG000|Overall Study|Withdrawal by Subject|11|||
129050837|NCT01783548|464476639|FG001|Overall Study|Withdrawal by Subject|8|||
129050838|NCT01783548|464476638|FG000|Overall Study|Non-compliance|4|||
129050839|NCT01783548|464476639|FG001|Overall Study|Non-compliance|0|||
129050840|NCT01783548|464476638|FG000|Overall Study|Protocol Violation|2|||
129050841|NCT01783548|464476639|FG001|Overall Study|Protocol Violation|2|||
129050842|NCT01783548|464476638|FG000|Overall Study|Lost to Follow-up|8|||
129050843|NCT01783548|464476639|FG001|Overall Study|Lost to Follow-up|3|||
129050844|NCT01783548|464476638|FG000|Overall Study|Lack of Efficacy|1|||
129050845|NCT01783548|464476639|FG001|Overall Study|Lack of Efficacy|1|||
129050846|NCT00988442|464476640|FG000|Overall Study|Death|1|||
129050847|NCT00988442|464476641|FG001|Overall Study|Death|2|||
129050848|NCT00988442|464476640|FG000|Overall Study|Lost to Follow-up|0|||
129050849|NCT00988442|464476641|FG001|Overall Study|Lost to Follow-up|1|||
129050850|NCT00988442|464476640|FG000|Overall Study|Early Study Closure|29|||
129050851|NCT00988442|464476641|FG001|Overall Study|Early Study Closure|25|||
129050852|NCT01212588|464476645|FG000|Overall Study|Physician Decision|0|||
129050853|NCT01212588|464476646|FG001|Overall Study|Physician Decision|1|||
129050854|NCT01212588|464476645|FG000|Overall Study|Protocol Violation|1|||
129050855|NCT01212588|464476646|FG001|Overall Study|Protocol Violation|1|||
129050856|NCT03317834|464476649|FG000|Overall Study|Death|2|||
129050857|NCT03317834|464476649|FG000|Overall Study|Device Revision|5|||
129050858|NCT03317834|464476649|FG000|Overall Study|Withdrawal by Subject|13|||
129050859|NCT03317834|464476649|FG000|Overall Study|Lost to Follow-up|13|||
129050860|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
129050861|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
129050862|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
129050863|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
129050864|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
129050865|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
129050866|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
129050867|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
129136471|NCT01370538|464792987|FG000|Overall Study|Lost to follow up|6|||
129050868|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
129050869|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129050870|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
129050871|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129050872|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129050873|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129136472|NCT01370538|464792988|FG001|Overall Study|Lost to follow up|10|||
129136473|NCT04193527|464792989|FG000|Overall Study|Other|1|||
129050874|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129050875|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129050876|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129050877|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129050878|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050879|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
129050880|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129136474|NCT04193527|464792990|FG001|Overall Study|Other|1|||
129050881|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
129050882|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050883|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050884|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050885|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050886|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050887|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129050888|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
129050889|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129050890|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
129050891|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129050892|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129050893|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129050894|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129050895|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129050896|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
129050897|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
129050898|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
129050899|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050900|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
129050901|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050902|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050903|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050904|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050905|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050906|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
129050907|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050908|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050909|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050910|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050911|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050912|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050913|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129050914|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050915|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050916|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050917|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
129050918|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050919|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050920|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050921|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050922|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050923|NCT03893565|464476659|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129050924|NCT03893565|464476660|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
129050925|NCT03893565|464476661|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
129050926|NCT03893565|464476662|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
129050927|NCT03893565|464476663|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129050928|NCT03893565|464476664|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129050929|NCT03893565|464476665|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129050930|NCT03893565|464476666|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129050931|NCT03893565|464476667|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129050932|NCT03893565|464476659|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
129050933|NCT03893565|464476660|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
129050934|NCT03893565|464476661|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
129050935|NCT03893565|464476662|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
129050936|NCT03893565|464476663|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
129050937|NCT03893565|464476664|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
129050938|NCT03893565|464476665|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
129050939|NCT03893565|464476666|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
129136475|NCT04193527|464792991|FG002|Overall Study|Other|0|||
129136476|NCT00676689|464792992|FG000|Overall Study|Screen Failure|2|||
128775484|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
129136477|NCT00676689|464792992|FG000|Overall Study|Death|2|||
129050940|NCT03893565|464476667|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
129050941|NCT03893565|464476659|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050942|NCT03893565|464476660|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050943|NCT03893565|464476661|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050944|NCT03893565|464476662|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050945|NCT03893565|464476663|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050946|NCT03893565|464476664|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050947|NCT03893565|464476665|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
129050948|NCT03893565|464476666|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050949|NCT03893565|464476667|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129050950|NCT03893565|464476659|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129050951|NCT03893565|464476660|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129050952|NCT03893565|464476661|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129050953|NCT03893565|464476662|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129050954|NCT03893565|464476663|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129050955|NCT03893565|464476664|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
129050956|NCT03893565|464476665|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
129050957|NCT03893565|464476666|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129050958|NCT03893565|464476667|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129050959|NCT03893565|464476659|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
129050960|NCT03893565|464476660|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
129050961|NCT03893565|464476661|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
129050962|NCT03893565|464476662|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
129050963|NCT03893565|464476663|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
129050964|NCT03893565|464476664|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
129050965|NCT03893565|464476665|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
129050966|NCT03893565|464476666|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
129050967|NCT03893565|464476667|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
129050968|NCT03893565|464476659|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050969|NCT03893565|464476660|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050970|NCT03893565|464476661|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050971|NCT03893565|464476662|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050972|NCT03893565|464476663|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050973|NCT03893565|464476664|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050974|NCT03893565|464476665|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050975|NCT03893565|464476666|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
129050976|NCT03893565|464476667|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129050977|NCT03893565|464476659|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050978|NCT03893565|464476660|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050979|NCT03893565|464476661|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050980|NCT03893565|464476662|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050981|NCT03893565|464476663|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050982|NCT03893565|464476664|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050983|NCT03893565|464476665|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050984|NCT03893565|464476666|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
129050985|NCT03893565|464476667|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129050986|NCT03893565|464476659|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050987|NCT03893565|464476660|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050988|NCT03893565|464476661|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050989|NCT03893565|464476662|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050990|NCT03893565|464476663|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050991|NCT03893565|464476664|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050992|NCT03893565|464476665|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050993|NCT03893565|464476666|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
129050994|NCT03893565|464476667|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129050995|NCT03893565|464476659|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129050996|NCT03893565|464476660|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129050997|NCT03893565|464476661|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129050998|NCT03893565|464476662|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129050999|NCT03893565|464476663|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129051000|NCT03893565|464476664|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129136478|NCT00676689|464792992|FG000|Overall Study|Lost to Follow-up|4|||
129136479|NCT00676689|464792992|FG000|Overall Study|Physician Decision|1|||
129051001|NCT03893565|464476665|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129051002|NCT03893565|464476666|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129051003|NCT03893565|464476667|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
129051004|NCT02387983|464476671|FG000|Overall Study|Adverse Event|4|||
129051005|NCT02387983|464476671|FG000|Overall Study|Protocol Violation|1|||
129051006|NCT02387983|464476671|FG000|Overall Study|Withdrawal by Subject|2|||
129051007|NCT02331368|464476674|FG000|Overall Study|Withdrawal by Subject|3|||
129051008|NCT02302859|464476680|FG000|Overall Study|Lost Phone|1|||
129051009|NCT02302859|464476681|FG001|Overall Study|Lost Phone|1|||
129051010|NCT02302859|464476680|FG000|Overall Study|Withdrawal by Subject|0|||
129051011|NCT02302859|464476681|FG001|Overall Study|Withdrawal by Subject|1|||
129051012|NCT03285308|464476686|FG000|Overall Study|Adverse Event|3|||
129051013|NCT03285308|464476687|FG001|Overall Study|Adverse Event|7|||
129051014|NCT03285308|464476686|FG000|Overall Study|Withdrawal by Subject|8|||
129051015|NCT03285308|464476687|FG001|Overall Study|Withdrawal by Subject|9|||
129051016|NCT03285308|464476686|FG000|Overall Study|Lost to Follow-up|3|||
129051017|NCT03285308|464476687|FG001|Overall Study|Lost to Follow-up|1|||
129051018|NCT03285308|464476686|FG000|Overall Study|Protocol Deviation|6|||
129051019|NCT03285308|464476687|FG001|Overall Study|Protocol Deviation|5|||
129051020|NCT03285308|464476686|FG000|Overall Study|Reason not Specified|0|||
129051021|NCT03285308|464476687|FG001|Overall Study|Reason not Specified|1|||
129051022|NCT03734666|464476690|FG000|Overall Study|Other|7|||
129051023|NCT03734666|464476691|FG001|Overall Study|Other|4|||
129051024|NCT03734666|464476690|FG000|Overall Study|Lost to Follow-up|12|||
129051025|NCT03734666|464476691|FG001|Overall Study|Lost to Follow-up|12|||
129051026|NCT00681590|464476692|FG000|Overall Study|Withdrawal by Subject|2|||
129051027|NCT00681590|464476693|FG001|Overall Study|Withdrawal by Subject|12|||
129051028|NCT01791153|464476694|FG000|Part 1: Blinded Period|Adverse Event|7|||
129051029|NCT01791153|464476695|FG001|Part 1: Blinded Period|Adverse Event|3|||
129051030|NCT01791153|464476696|FG002|Part 1: Blinded Period|Adverse Event|2|||
129051031|NCT01791153|464476697|FG003|Part 1: Blinded Period|Adverse Event|0|||
129051032|NCT01791153|464476698|FG004|Part 1: Blinded Period|Adverse Event|0|||
129051033|NCT01791153|464476699|FG005|Part 1: Blinded Period|Adverse Event|0|||
129051034|NCT01791153|464476700|FG006|Part 1: Blinded Period|Adverse Event|0|||
129051035|NCT01791153|464476701|FG007|Part 1: Blinded Period|Adverse Event|0|||
129051036|NCT01791153|464476694|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
129051037|NCT01791153|464476695|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
129051038|NCT01791153|464476696|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
129051039|NCT01791153|464476697|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
129051040|NCT01791153|464476698|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
129051041|NCT01791153|464476699|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
129051042|NCT01791153|464476700|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
129051043|NCT01791153|464476701|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
129051044|NCT01791153|464476694|FG000|Part 1: Blinded Period|Non-Compliance|1|||
129051045|NCT01791153|464476695|FG001|Part 1: Blinded Period|Non-Compliance|0|||
129051046|NCT01791153|464476696|FG002|Part 1: Blinded Period|Non-Compliance|0|||
129051047|NCT01791153|464476697|FG003|Part 1: Blinded Period|Non-Compliance|0|||
129051048|NCT01791153|464476698|FG004|Part 1: Blinded Period|Non-Compliance|0|||
129051049|NCT01791153|464476699|FG005|Part 1: Blinded Period|Non-Compliance|0|||
129051050|NCT01791153|464476700|FG006|Part 1: Blinded Period|Non-Compliance|0|||
129051051|NCT01791153|464476701|FG007|Part 1: Blinded Period|Non-Compliance|0|||
129051052|NCT01791153|464476694|FG000|Part 1: Blinded Period|Physician Decision|0|||
129051053|NCT01791153|464476695|FG001|Part 1: Blinded Period|Physician Decision|0|||
129051054|NCT01791153|464476696|FG002|Part 1: Blinded Period|Physician Decision|0|||
129051055|NCT01791153|464476697|FG003|Part 1: Blinded Period|Physician Decision|1|||
129051056|NCT01791153|464476698|FG004|Part 1: Blinded Period|Physician Decision|0|||
129051057|NCT01791153|464476699|FG005|Part 1: Blinded Period|Physician Decision|0|||
129051058|NCT01791153|464476700|FG006|Part 1: Blinded Period|Physician Decision|0|||
129051059|NCT01791153|464476701|FG007|Part 1: Blinded Period|Physician Decision|0|||
129136480|NCT00676689|464792992|FG000|Overall Study|Withdrawal by Subject|3|||
129136481|NCT00676689|464792992|FG000|Overall Study|Continuing FU|49|||
129136482|NCT02366130|464792993|FG000|Overall Study|Withdrawal by Subject|3|||
129136483|NCT02366130|464792993|FG000|Overall Study|Ineligible|6|||
129051060|NCT01791153|464476694|FG000|Part 1: Blinded Period|Protocol Violation|0|||
129051061|NCT01791153|464476695|FG001|Part 1: Blinded Period|Protocol Violation|0|||
129051062|NCT01791153|464476696|FG002|Part 1: Blinded Period|Protocol Violation|0|||
129051063|NCT01791153|464476697|FG003|Part 1: Blinded Period|Protocol Violation|1|||
129051064|NCT01791153|464476698|FG004|Part 1: Blinded Period|Protocol Violation|0|||
129136484|NCT01945242|464792994|FG000|Overall Study|Physician Decision|3|||
129136485|NCT01945242|464792995|FG001|Overall Study|Physician Decision|3|||
129051065|NCT01791153|464476699|FG005|Part 1: Blinded Period|Protocol Violation|0|||
129051066|NCT01791153|464476700|FG006|Part 1: Blinded Period|Protocol Violation|0|||
129051067|NCT01791153|464476701|FG007|Part 1: Blinded Period|Protocol Violation|0|||
129051068|NCT01791153|464476694|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
129051069|NCT01791153|464476695|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
129136486|NCT05661734|464792996|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
129051070|NCT01791153|464476696|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
129051071|NCT01791153|464476697|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
129051072|NCT01791153|464476698|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
129051073|NCT01791153|464476699|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
129051074|NCT01791153|464476700|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
129051075|NCT01791153|464476701|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
129051076|NCT01791153|464476694|FG000|Part 2: Open-label Period|Adverse Event|0|||
129051077|NCT01791153|464476695|FG001|Part 2: Open-label Period|Adverse Event|0|||
129051078|NCT01791153|464476696|FG002|Part 2: Open-label Period|Adverse Event|0|||
129051079|NCT01791153|464476697|FG003|Part 2: Open-label Period|Adverse Event|0|||
129051080|NCT01791153|464476698|FG004|Part 2: Open-label Period|Adverse Event|0|||
129051081|NCT01791153|464476699|FG005|Part 2: Open-label Period|Adverse Event|1|||
129051082|NCT01791153|464476700|FG006|Part 2: Open-label Period|Adverse Event|1|||
129051083|NCT01791153|464476701|FG007|Part 2: Open-label Period|Adverse Event|2|||
129051084|NCT01791153|464476694|FG000|Part 2: Open-label Period|Death|0|||
129051085|NCT01791153|464476695|FG001|Part 2: Open-label Period|Death|0|||
129051086|NCT01791153|464476696|FG002|Part 2: Open-label Period|Death|0|||
129051087|NCT01791153|464476697|FG003|Part 2: Open-label Period|Death|0|||
129051088|NCT01791153|464476698|FG004|Part 2: Open-label Period|Death|0|||
129051089|NCT01791153|464476699|FG005|Part 2: Open-label Period|Death|1|||
129051090|NCT01791153|464476700|FG006|Part 2: Open-label Period|Death|1|||
129051091|NCT01791153|464476701|FG007|Part 2: Open-label Period|Death|1|||
129051092|NCT01791153|464476694|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
129051093|NCT01791153|464476695|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
129051094|NCT01791153|464476696|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
129051095|NCT01791153|464476697|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
129051096|NCT01791153|464476698|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
129051097|NCT01791153|464476699|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
129051098|NCT01791153|464476700|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
129051099|NCT01791153|464476701|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
129051100|NCT01791153|464476694|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
129051101|NCT01791153|464476695|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
129051102|NCT01791153|464476696|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
129051103|NCT01791153|464476697|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
129051104|NCT01791153|464476698|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
129051105|NCT01791153|464476699|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
129051106|NCT01791153|464476700|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
129051107|NCT01791153|464476701|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
129051108|NCT01791153|464476694|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
129051109|NCT01791153|464476695|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
129051110|NCT01791153|464476696|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
129051111|NCT01791153|464476697|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
129051112|NCT01791153|464476698|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
129051113|NCT01791153|464476699|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
129051114|NCT01791153|464476700|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
129051115|NCT01791153|464476701|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
129051116|NCT01791153|464476694|FG000|Part 2: Open-label Period|Physician Decision|0|||
129051117|NCT01791153|464476695|FG001|Part 2: Open-label Period|Physician Decision|0|||
129051118|NCT01791153|464476696|FG002|Part 2: Open-label Period|Physician Decision|0|||
129051119|NCT01791153|464476697|FG003|Part 2: Open-label Period|Physician Decision|0|||
129051120|NCT01791153|464476698|FG004|Part 2: Open-label Period|Physician Decision|1|||
129051121|NCT01791153|464476699|FG005|Part 2: Open-label Period|Physician Decision|1|||
129051122|NCT01791153|464476700|FG006|Part 2: Open-label Period|Physician Decision|0|||
129051123|NCT01791153|464476701|FG007|Part 2: Open-label Period|Physician Decision|0|||
129051124|NCT02357342|464476702|FG000|First 6 Months|Death|2|||
129051125|NCT02357342|464476703|FG001|First 6 Months|Death|0|||
129051126|NCT04156620|464476705|FG000|Overall Study|Adverse event - TP 1|5|||
129051127|NCT04156620|464476706|FG001|Overall Study|Adverse event - TP 1|2|||
129051128|NCT04156620|464476705|FG000|Overall Study|Lost to follow-up TP 1|1|||
129051129|NCT04156620|464476706|FG001|Overall Study|Lost to follow-up TP 1|1|||
129051130|NCT04156620|464476705|FG000|Overall Study|Progressive disease - TP 1|0|||
129051131|NCT04156620|464476706|FG001|Overall Study|Progressive disease - TP 1|1|||
129051132|NCT04156620|464476705|FG000|Overall Study|Subject decision - TP 1|3|||
129051133|NCT04156620|464476706|FG001|Overall Study|Subject decision - TP 1|5|||
129051134|NCT04156620|464476705|FG000|Overall Study|Adverse event - TP 2|5|||
129051135|NCT04156620|464476706|FG001|Overall Study|Adverse event - TP 2|6|||
129051136|NCT04156620|464476705|FG000|Overall Study|Death - TP 2|1|||
129051137|NCT04156620|464476706|FG001|Overall Study|Death - TP 2|0|||
129051138|NCT04156620|464476705|FG000|Overall Study|Lost to follow-up - TP 2|5|||
129051139|NCT04156620|464476706|FG001|Overall Study|Lost to follow-up - TP 2|2|||
129051140|NCT04156620|464476705|FG000|Overall Study|Physician decision - TP 2|4|||
129051141|NCT04156620|464476706|FG001|Overall Study|Physician decision - TP 2|2|||
129051142|NCT04156620|464476705|FG000|Overall Study|Pregnancy - TP 2|1|||
129051143|NCT04156620|464476706|FG001|Overall Study|Pregnancy - TP 2|1|||
129051144|NCT04156620|464476705|FG000|Overall Study|Subject decision - TP 2|11|||
129051145|NCT04156620|464476706|FG001|Overall Study|Subject decision - TP 2|9|||
129051146|NCT04156620|464476705|FG000|Overall Study|New therapy for study indication - TP 2|1|||
129051147|NCT04156620|464476706|FG001|Overall Study|New therapy for study indication - TP 2|0|||
129051148|NCT01753336|464476707|FG000|Overall Study|Patient decision|12|||
129051149|NCT01753336|464476707|FG000|Overall Study|Lost to Follow-up|3|||
129051150|NCT01753336|464476707|FG000|Overall Study|Physician Decision|2|||
129051151|NCT01753336|464476707|FG000|Overall Study|Sponsor's decision|2|||
129051152|NCT01753336|464476707|FG000|Overall Study|Withdrawal by Subject|1|||
129051153|NCT01629966|464476708|FG000|Overall Study|Pregnancy|0|||
129051154|NCT01629966|464476709|FG001|Overall Study|Pregnancy|1|||
129051155|NCT01629966|464476710|FG002|Overall Study|Pregnancy|0|||
129051156|NCT01629966|464476708|FG000|Overall Study|Lost to Follow-up|10|||
129051157|NCT01629966|464476709|FG001|Overall Study|Lost to Follow-up|13|||
129051158|NCT01629966|464476710|FG002|Overall Study|Lost to Follow-up|9|||
129051159|NCT01629966|464476708|FG000|Overall Study|Withdrawal by Subject|8|||
129051160|NCT01629966|464476709|FG001|Overall Study|Withdrawal by Subject|9|||
129051161|NCT01629966|464476710|FG002|Overall Study|Withdrawal by Subject|16|||
129051162|NCT01629966|464476708|FG000|Overall Study|Protocol Violation|7|||
129051163|NCT01629966|464476709|FG001|Overall Study|Protocol Violation|9|||
129051164|NCT01629966|464476710|FG002|Overall Study|Protocol Violation|7|||
129051165|NCT01629966|464476708|FG000|Overall Study|Lack of Efficacy|5|||
129051166|NCT01629966|464476709|FG001|Overall Study|Lack of Efficacy|2|||
129051167|NCT01629966|464476710|FG002|Overall Study|Lack of Efficacy|4|||
129051168|NCT01629966|464476708|FG000|Overall Study|Adverse Event|11|||
129051169|NCT01629966|464476709|FG001|Overall Study|Adverse Event|18|||
129051170|NCT01629966|464476710|FG002|Overall Study|Adverse Event|30|||
129051171|NCT04568031|464476711|FG000|Overall Study|Lost to Follow-up|1|||
129051172|NCT04568031|464476712|FG001|Overall Study|Lost to Follow-up|0|||
129051173|NCT04568031|464476713|FG002|Overall Study|Lost to Follow-up|0|||
129051174|NCT04568031|464476714|FG003|Overall Study|Lost to Follow-up|0|||
129051175|NCT04568031|464476711|FG000|Overall Study|Physician Decision|1|||
129051176|NCT04568031|464476712|FG001|Overall Study|Physician Decision|0|||
129051177|NCT04568031|464476713|FG002|Overall Study|Physician Decision|1|||
129051178|NCT04568031|464476714|FG003|Overall Study|Physician Decision|0|||
129051179|NCT04568031|464476711|FG000|Overall Study|Withdrawal by Subject|1|||
129051180|NCT04568031|464476712|FG001|Overall Study|Withdrawal by Subject|0|||
129051181|NCT04568031|464476713|FG002|Overall Study|Withdrawal by Subject|4|||
129051182|NCT04568031|464476714|FG003|Overall Study|Withdrawal by Subject|1|||
129051183|NCT00006721|464478896|FG000|Overall Study|Adverse Event|0|||
129051184|NCT00006721|464478897|FG001|Overall Study|Adverse Event|4|||
129051185|NCT00006721|464478898|FG002|Overall Study|Adverse Event|4|||
129051186|NCT00006721|464478896|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129051187|NCT00006721|464478897|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
129051188|NCT00006721|464478898|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
129051189|NCT00006721|464478896|FG000|Overall Study|Progression/Relapse|0|||
129051190|NCT00006721|464478897|FG001|Overall Study|Progression/Relapse|1|||
129051191|NCT00006721|464478898|FG002|Overall Study|Progression/Relapse|2|||
129051192|NCT00006721|464478896|FG000|Overall Study|Death|0|||
129051193|NCT00006721|464478897|FG001|Overall Study|Death|1|||
129051194|NCT00006721|464478898|FG002|Overall Study|Death|2|||
129051195|NCT00006721|464478896|FG000|Overall Study|Other - Not Protocol Specified|0|||
129051196|NCT00006721|464478897|FG001|Overall Study|Other - Not Protocol Specified|7|||
129051197|NCT00006721|464478898|FG002|Overall Study|Other - Not Protocol Specified|7|||
129051198|NCT00006721|464478896|FG000|Overall Study|Ineligible|2|||
129051199|NCT00006721|464478897|FG001|Overall Study|Ineligible|12|||
129051200|NCT00006721|464478898|FG002|Overall Study|Ineligible|10|||
129051201|NCT00006721|464478896|FG000|Overall Study|Eligible but no Treatment Received|1|||
129051202|NCT00006721|464478897|FG001|Overall Study|Eligible but no Treatment Received|0|||
129051203|NCT00006721|464478898|FG002|Overall Study|Eligible but no Treatment Received|0|||
129051204|NCT05091307|464478899|FG000|Overall Study|Death|0|||
129051205|NCT05091307|464478900|FG001|Overall Study|Death|0|||
129051206|NCT05091307|464478901|FG002|Overall Study|Death|1|||
129051207|NCT05091307|464478902|FG003|Overall Study|Death|0|||
129051208|NCT05091307|464478899|FG000|Overall Study|Lost to Follow-up|33|||
129051209|NCT05091307|464478900|FG001|Overall Study|Lost to Follow-up|33|||
129051210|NCT05091307|464478901|FG002|Overall Study|Lost to Follow-up|2|||
129051211|NCT05091307|464478902|FG003|Overall Study|Lost to Follow-up|0|||
129051212|NCT05091307|464478899|FG000|Overall Study|Physician Decision|1|||
129051213|NCT05091307|464478900|FG001|Overall Study|Physician Decision|0|||
129051214|NCT05091307|464478901|FG002|Overall Study|Physician Decision|0|||
129051215|NCT05091307|464478902|FG003|Overall Study|Physician Decision|0|||
129051216|NCT05091307|464478899|FG000|Overall Study|Protocol Violation|1|||
129051217|NCT05091307|464478900|FG001|Overall Study|Protocol Violation|0|||
129051218|NCT05091307|464478901|FG002|Overall Study|Protocol Violation|0|||
129051219|NCT05091307|464478902|FG003|Overall Study|Protocol Violation|0|||
129051220|NCT05091307|464478899|FG000|Overall Study|Withdrawal by Subject|16|||
129051221|NCT05091307|464478900|FG001|Overall Study|Withdrawal by Subject|16|||
129051222|NCT05091307|464478901|FG002|Overall Study|Withdrawal by Subject|0|||
129136487|NCT05661734|464792996|FG000|Overall Study|Lost to Follow-up|13|||
129136488|NCT05661734|464792996|FG000|Overall Study|Enrolled but not dosed|2|||
129136489|NCT01026038|464792997|FG000|Overall Study|Lost to Follow-up|1|||
129136490|NCT01026038|464792998|FG001|Overall Study|Lost to Follow-up|1|||
129051223|NCT05091307|464478902|FG003|Overall Study|Withdrawal by Subject|1|||
129051224|NCT05091307|464478899|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
129051225|NCT05091307|464478900|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
129051226|NCT05091307|464478901|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
129051227|NCT05091307|464478902|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
129051228|NCT05091307|464478899|FG000|Overall Study|Initiated Prohibited Medication|1|||
129051229|NCT05091307|464478900|FG001|Overall Study|Initiated Prohibited Medication|0|||
129051230|NCT05091307|464478901|FG002|Overall Study|Initiated Prohibited Medication|0|||
129051231|NCT05091307|464478902|FG003|Overall Study|Initiated Prohibited Medication|0|||
129051232|NCT05091307|464478899|FG000|Overall Study|Other|4|||
129051233|NCT05091307|464478900|FG001|Overall Study|Other|4|||
129051234|NCT05091307|464478901|FG002|Overall Study|Other|0|||
129051235|NCT05091307|464478902|FG003|Overall Study|Other|0|||
129051236|NCT05091307|464478899|FG000|Overall Study|Randomized but not vaccinated|0|||
129051237|NCT05091307|464478900|FG001|Overall Study|Randomized but not vaccinated|2|||
129051238|NCT05091307|464478901|FG002|Overall Study|Randomized but not vaccinated|0|||
129051239|NCT05091307|464478902|FG003|Overall Study|Randomized but not vaccinated|0|||
129051240|NCT03747601|464478903|FG000|Overall Study|COVID halt to visits|4|||
129051241|NCT04347122|464478904|FG000|Overall Study|Physician Decision|0|||
129051242|NCT04347122|464478905|FG001|Overall Study|Physician Decision|3|||
129051243|NCT04347122|464478906|FG002|Overall Study|Physician Decision|3|||
129051244|NCT04347122|464478907|FG003|Overall Study|Physician Decision|6|||
129051245|NCT00112866|464478908|FG000|Overall Study|Protocol Violation|1|||
129051246|NCT00112866|464478909|FG001|Overall Study|Protocol Violation|0|||
129051247|NCT00112866|464478908|FG000|Overall Study|did not start treatment post-op|1|||
129051248|NCT00112866|464478909|FG001|Overall Study|did not start treatment post-op|2|||
129051249|NCT01167257|464478911|FG000|Overall Study|Lost to Follow-up|2|||
129051250|NCT01167257|464478912|FG001|Overall Study|Lost to Follow-up|2|||
129051251|NCT01167257|464478911|FG000|Overall Study|Withdrew consent|1|||
129051252|NCT01167257|464478912|FG001|Overall Study|Withdrew consent|1|||
129051253|NCT02492880|464478913|FG000|Overall Study|Lost to Follow-up|1|||
129051254|NCT02492880|464478913|FG000|Overall Study|Protocol Violation|1|||
129051255|NCT00554190|464478914|FG000|Overall Study|Termination forms not completed|10|||
129051256|NCT04241315|464478921|FG000|Overall Study|Withdrawal by Subject|0|||
129051257|NCT04241315|464478922|FG001|Overall Study|Withdrawal by Subject|1|||
129051258|NCT00699283|464478923|FG000|Overall Study|Lack of Efficacy|15|||
129051259|NCT00699283|464478924|FG001|Overall Study|Lack of Efficacy|5|||
129051260|NCT00699283|464478923|FG000|Overall Study|Lost to Follow-up|2|||
129051261|NCT00699283|464478924|FG001|Overall Study|Lost to Follow-up|0|||
129051262|NCT00699283|464478923|FG000|Overall Study|Withdrawal by Subject|1|||
129051263|NCT00699283|464478924|FG001|Overall Study|Withdrawal by Subject|0|||
129051264|NCT00699283|464478923|FG000|Overall Study|Other Reason|5|||
129051265|NCT00699283|464478924|FG001|Overall Study|Other Reason|1|||
129051266|NCT00699283|464478923|FG000|Overall Study|SAE, non-fatal|1|||
129051267|NCT00699283|464478924|FG001|Overall Study|SAE, non-fatal|1|||
129051268|NCT00699283|464478923|FG000|Overall Study|AE, non-serious non-fatal|8|||
129051269|NCT00699283|464478924|FG001|Overall Study|AE, non-serious non-fatal|1|||
129051270|NCT00699283|464478923|FG000|Overall Study|AE of unknown type|1|||
129051271|NCT00699283|464478924|FG001|Overall Study|AE of unknown type|0|||
129051272|NCT00394524|464478925|FG000|Overall Study|Protocol Violation|2|||
129051273|NCT00394524|464478926|FG001|Overall Study|Protocol Violation|3|||
129051274|NCT00394524|464478925|FG000|Overall Study|Death|1|||
129051275|NCT00394524|464478926|FG001|Overall Study|Death|0|||
129051276|NCT00394524|464478925|FG000|Overall Study|Withdrawal by Subject|0|||
129051277|NCT00394524|464478926|FG001|Overall Study|Withdrawal by Subject|1|||
129051278|NCT01398514|464478927|FG000|Overall Study|Adverse Event|1|||
129051279|NCT01398514|464478928|FG001|Overall Study|Adverse Event|0|||
129051280|NCT01398514|464478927|FG000|Overall Study|Non-compliance with study procedures|2|||
129051281|NCT01398514|464478928|FG001|Overall Study|Non-compliance with study procedures|0|||
129051282|NCT01398514|464478927|FG000|Overall Study|Physiologic non-responsiveness|1|||
129136491|NCT01026038|464792999|FG002|Overall Study|Lost to Follow-up|0|||
129136492|NCT03601052|464793000|FG000|Overall Study|Lost to Follow-up|2|||
129051283|NCT01398514|464478928|FG001|Overall Study|Physiologic non-responsiveness|3|||
129051284|NCT01398514|464478927|FG000|Overall Study|Failure to show a conditioned response|4|||
129051285|NCT01398514|464478928|FG001|Overall Study|Failure to show a conditioned response|3|||
129136493|NCT01348490|464793001|FG000|Overall Study|Death|1|||
129136494|NCT01348490|464793001|FG000|Overall Study|Adverse Event|3|||
129136495|NCT01348490|464793001|FG000|Overall Study|Consent withdrawn|7|||
129051286|NCT01345175|464478930|FG000|Overall Study|Physician Decision|0|||
129051287|NCT01345175|464478931|FG001|Overall Study|Physician Decision|1|||
129051288|NCT01345175|464478930|FG000|Overall Study|Withdrawal by Subject|1|||
129051289|NCT01345175|464478931|FG001|Overall Study|Withdrawal by Subject|1|||
129051290|NCT01345175|464478930|FG000|Overall Study|Failed to complete BFI|3|||
129051291|NCT01345175|464478931|FG001|Overall Study|Failed to complete BFI|2|||
129051292|NCT01345175|464478930|FG000|Overall Study|Stopped taking medication|2|||
129051293|NCT01345175|464478931|FG001|Overall Study|Stopped taking medication|2|||
129051294|NCT03537599|464478942|FG000|Overall Study|Disease Progression|2|||
129051295|NCT03537599|464478943|FG001|Overall Study|Disease Progression|1|||
129051296|NCT03537599|464478942|FG000|Overall Study|Death|0|||
129051297|NCT03537599|464478943|FG001|Overall Study|Death|1|||
129051298|NCT00114166|464478946|FG000|Overall Study|Wrong primary|0|||
129051299|NCT00114166|464478947|FG001|Overall Study|Wrong primary|1|||
129051300|NCT03560986|464478948|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
129051301|NCT03560986|464478949|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
129051302|NCT03560986|464478948|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
129051303|NCT03560986|464478949|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
129051304|NCT03560986|464478948|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
129051305|NCT03560986|464478949|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
129051306|NCT03560986|464478948|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
129051307|NCT03560986|464478949|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
129051308|NCT03560986|464478948|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
129051309|NCT03560986|464478949|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
129051310|NCT03560986|464478948|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
129051311|NCT03560986|464478949|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
129051312|NCT03560986|464478948|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
129051313|NCT03560986|464478949|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
129051314|NCT00593736|464478961|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
129051315|NCT00593736|464478962|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
129051316|NCT00593736|464478963|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
129051317|NCT00593736|464478964|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
129051318|NCT00593736|464478961|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
129051319|NCT00593736|464478962|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
129051320|NCT00593736|464478963|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
129051321|NCT00593736|464478964|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
129051322|NCT00593736|464478961|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
129051323|NCT00593736|464478962|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
129051324|NCT00593736|464478963|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
129051325|NCT00593736|464478964|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
129051326|NCT00593736|464478961|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
129051327|NCT00593736|464478962|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
129051328|NCT00593736|464478963|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
129051329|NCT00593736|464478964|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
129051330|NCT00593736|464478961|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
129051331|NCT00593736|464478962|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
129051332|NCT00593736|464478963|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
129051333|NCT00593736|464478964|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
129051334|NCT00593736|464478961|FG000|Screening Period and Placebo Run-in|Various|0|||
129051335|NCT00593736|464478962|FG001|Screening Period and Placebo Run-in|Various|0|||
129051336|NCT00593736|464478963|FG002|Screening Period and Placebo Run-in|Various|0|||
129051337|NCT00593736|464478964|FG003|Screening Period and Placebo Run-in|Various|25|||
129051338|NCT00593736|464478961|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
129051339|NCT00593736|464478962|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
129051340|NCT00593736|464478963|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
129051341|NCT00593736|464478964|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
129051342|NCT00593736|464478961|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
129051343|NCT00593736|464478962|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
129051344|NCT00593736|464478963|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
129051345|NCT00593736|464478964|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
129051346|NCT00593736|464478961|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
129051347|NCT00593736|464478962|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
129051348|NCT00593736|464478963|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
129051349|NCT00593736|464478964|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
129051350|NCT00593736|464478961|FG000|Treatment Period and Placebo Run-out|Various|1|||
129051351|NCT00593736|464478962|FG001|Treatment Period and Placebo Run-out|Various|1|||
129051352|NCT00593736|464478963|FG002|Treatment Period and Placebo Run-out|Various|1|||
129051353|NCT00593736|464478964|FG003|Treatment Period and Placebo Run-out|Various|0|||
129051354|NCT01857271|464478965|FG000|Overall Study|Lost to Follow-up|1|||
129051355|NCT03493386|464478966|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129051356|NCT03493386|464478967|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
129051357|NCT03493386|464478968|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129051358|NCT03493386|464478969|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129051359|NCT02116608|464478971|FG000|Overall Study|Lost to Follow-up|0|||
129051360|NCT02116608|464478972|FG001|Overall Study|Lost to Follow-up|0|||
129051361|NCT02116608|464478973|FG002|Overall Study|Lost to Follow-up|1|||
129051362|NCT02116608|464478971|FG000|Overall Study|Physician Decision|0|||
129136496|NCT01348490|464793001|FG000|Overall Study|Disease progression|3|||
129136497|NCT01348490|464793001|FG000|Overall Study|Lost to Follow-up|1|||
129136498|NCT01348490|464793001|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
129136499|NCT01348490|464793001|FG000|Overall Study|Other Unspecified|8|||
129136500|NCT00300495|464793002|FG000|Overall Study|Protocol Violation|4|||
129136501|NCT00300495|464793003|FG001|Overall Study|Protocol Violation|1|||
129136502|NCT01184118|464793004|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
129136503|NCT01184118|464793004|FG000|Overall Study|No physiologic confirmation of asthma|8|||
129136504|NCT01184118|464793004|FG000|Overall Study|FEV1 <60% predicted|2|||
129136505|NCT01184118|464793004|FG000|Overall Study|Exclusionary medical condition|2|||
129136506|NCT01184118|464793004|FG000|Overall Study|Withdrawal by Subject|5|||
129136507|NCT03632720|464793005|FG000|Overall Study|Adverse Event|2|||
129136508|NCT03632720|464793006|FG001|Overall Study|Adverse Event|0|||
129136509|NCT03632720|464793007|FG002|Overall Study|Adverse Event|0|||
129136510|NCT03632720|464793005|FG000|Overall Study|Lost to Follow-up|0|||
129136511|NCT03632720|464793006|FG001|Overall Study|Lost to Follow-up|1|||
129051363|NCT02116608|464478972|FG001|Overall Study|Physician Decision|1|||
129051364|NCT02116608|464478973|FG002|Overall Study|Physician Decision|0|||
129051365|NCT02116608|464478971|FG000|Overall Study|Death|0|||
129051366|NCT02116608|464478972|FG001|Overall Study|Death|1|||
129051367|NCT02116608|464478973|FG002|Overall Study|Death|0|||
129051368|NCT01468818|464478975|FG000|Overall Study|Death during treatment|2|||
129051369|NCT02338193|464478977|FG000|Overall Study|Withdrawal by Subject|0|||
129051370|NCT02338193|464478978|FG001|Overall Study|Withdrawal by Subject|0|||
129051371|NCT02338193|464478979|FG002|Overall Study|Withdrawal by Subject|2|||
129051372|NCT02338193|464478977|FG000|Overall Study|Pregnancy|0|||
129051373|NCT02338193|464478978|FG001|Overall Study|Pregnancy|1|||
129051374|NCT02338193|464478979|FG002|Overall Study|Pregnancy|1|||
129051375|NCT02338193|464478977|FG000|Overall Study|Noncompliant with visits|2|||
129051376|NCT02338193|464478978|FG001|Overall Study|Noncompliant with visits|2|||
129051377|NCT02338193|464478979|FG002|Overall Study|Noncompliant with visits|7|||
129051378|NCT02338193|464478977|FG000|Overall Study|moved out of state|0|||
129051379|NCT02338193|464478978|FG001|Overall Study|moved out of state|1|||
129051380|NCT02338193|464478979|FG002|Overall Study|moved out of state|0|||
129051381|NCT02338193|464478977|FG000|Overall Study|intolerant of side effects|1|||
129051382|NCT02338193|464478978|FG001|Overall Study|intolerant of side effects|0|||
129051383|NCT02338193|464478979|FG002|Overall Study|intolerant of side effects|0|||
129051384|NCT01735955|464478980|FG000|Overall Study|Administrative problems|1|||
129051385|NCT01735955|464478980|FG000|Overall Study|Patient/guardian decision|1|||
129051386|NCT01735955|464478980|FG000|Overall Study|Patient withdrew consent|2|||
129051387|NCT01735955|464478980|FG000|Overall Study|Physician Decision|4|||
129051388|NCT01735955|464478980|FG000|Overall Study|Disease progression|24|||
129051389|NCT01735955|464478980|FG000|Overall Study|Adverse Event|5|||
129051390|NCT00123474|464478981|FG000|Randomized to Treatment|Randomized, never treated|1|||
129051391|NCT00123474|464478982|FG001|Randomized to Treatment|Randomized, never treated|4|||
129051392|NCT00123474|464478983|FG002|Randomized to Treatment|Randomized, never treated|2|||
129051393|NCT00123474|464478984|FG003|Randomized to Treatment|Randomized, never treated|1|||
129051394|NCT00123474|464478981|FG000|As Treated at Study Closure|not reported when site closed|1|||
129051395|NCT00123474|464478982|FG001|As Treated at Study Closure|not reported when site closed|0|||
129051396|NCT00123474|464478983|FG002|As Treated at Study Closure|not reported when site closed|1|||
129051397|NCT00123474|464478984|FG003|As Treated at Study Closure|not reported when site closed|0|||
129051398|NCT00123474|464478981|FG000|As Treated at Study Closure|Adverse Event|10|||
129051399|NCT00123474|464478982|FG001|As Treated at Study Closure|Adverse Event|4|||
129051400|NCT00123474|464478983|FG002|As Treated at Study Closure|Adverse Event|10|||
129051401|NCT00123474|464478984|FG003|As Treated at Study Closure|Adverse Event|8|||
129051402|NCT00123474|464478981|FG000|As Treated at Study Closure|Disease Progression|35|||
129136512|NCT03632720|464793007|FG002|Overall Study|Lost to Follow-up|0|||
129136513|NCT03632720|464793005|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
129136514|NCT03632720|464793006|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
129136515|NCT03632720|464793007|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
129051403|NCT00123474|464478982|FG001|As Treated at Study Closure|Disease Progression|42|||
129051404|NCT00123474|464478983|FG002|As Treated at Study Closure|Disease Progression|29|||
129051405|NCT00123474|464478984|FG003|As Treated at Study Closure|Disease Progression|27|||
129051406|NCT00123474|464478981|FG000|As Treated at Study Closure|Investigator Request|12|||
129136516|NCT03632720|464793005|FG000|Overall Study|Screen failure|0|||
129136517|NCT03632720|464793006|FG001|Overall Study|Screen failure|1|||
129051407|NCT00123474|464478982|FG001|As Treated at Study Closure|Investigator Request|6|||
129051408|NCT00123474|464478983|FG002|As Treated at Study Closure|Investigator Request|7|||
129051409|NCT00123474|464478984|FG003|As Treated at Study Closure|Investigator Request|5|||
129051410|NCT00123474|464478981|FG000|As Treated at Study Closure|non-specified|54|||
129051411|NCT00123474|464478982|FG001|As Treated at Study Closure|non-specified|47|||
129051412|NCT00123474|464478983|FG002|As Treated at Study Closure|non-specified|57|||
129051413|NCT00123474|464478984|FG003|As Treated at Study Closure|non-specified|60|||
129051414|NCT00123474|464478981|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
129051415|NCT00123474|464478982|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
129051416|NCT00123474|464478983|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
129051417|NCT00123474|464478984|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
129051418|NCT00123474|464478981|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
129051419|NCT00123474|464478982|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
129051420|NCT00123474|464478983|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
129051421|NCT00123474|464478984|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
129051422|NCT01059344|464478985|FG000|Overall Study|Adverse Event|12|||
129051423|NCT01059344|464478986|FG001|Overall Study|Adverse Event|30|||
129051424|NCT01059344|464478985|FG000|Overall Study|Withdrawal by Subject|6|||
129051425|NCT01059344|464478986|FG001|Overall Study|Withdrawal by Subject|9|||
129051426|NCT01059344|464478985|FG000|Overall Study|Lost to Follow-up|1|||
129051427|NCT01059344|464478986|FG001|Overall Study|Lost to Follow-up|1|||
129051428|NCT01059344|464478985|FG000|Overall Study|Other|3|||
129051429|NCT01059344|464478986|FG001|Overall Study|Other|6|||
129051430|NCT01739348|464478987|FG000|Part I (Base Study)|Adverse Event|41|||
129051431|NCT01739348|464478988|FG001|Part I (Base Study)|Adverse Event|52|||
129051432|NCT01739348|464478989|FG002|Part I (Base Study)|Adverse Event|8|||
129051433|NCT01739348|464478990|FG003|Part I (Base Study)|Adverse Event|33|||
129051434|NCT01739348|464478987|FG000|Part I (Base Study)|Death|10|||
129051435|NCT01739348|464478988|FG001|Part I (Base Study)|Death|7|||
129051436|NCT01739348|464478989|FG002|Part I (Base Study)|Death|2|||
129051437|NCT01739348|464478990|FG003|Part I (Base Study)|Death|8|||
129051438|NCT01739348|464478987|FG000|Part I (Base Study)|Lack of Efficacy|3|||
129051439|NCT01739348|464478988|FG001|Part I (Base Study)|Lack of Efficacy|8|||
129051440|NCT01739348|464478989|FG002|Part I (Base Study)|Lack of Efficacy|0|||
129051441|NCT01739348|464478990|FG003|Part I (Base Study)|Lack of Efficacy|7|||
129051442|NCT01739348|464478987|FG000|Part I (Base Study)|Lost to Follow-up|4|||
129051443|NCT01739348|464478988|FG001|Part I (Base Study)|Lost to Follow-up|2|||
129051444|NCT01739348|464478989|FG002|Part I (Base Study)|Lost to Follow-up|4|||
129051445|NCT01739348|464478990|FG003|Part I (Base Study)|Lost to Follow-up|4|||
129051446|NCT01739348|464478987|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
129051447|NCT01739348|464478988|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
129051448|NCT01739348|464478989|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
129051449|NCT01739348|464478990|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
129051450|NCT01739348|464478987|FG000|Part I (Base Study)|Physician Decision|10|||
129051451|NCT01739348|464478988|FG001|Part I (Base Study)|Physician Decision|7|||
129051452|NCT01739348|464478989|FG002|Part I (Base Study)|Physician Decision|1|||
129051453|NCT01739348|464478990|FG003|Part I (Base Study)|Physician Decision|4|||
129051454|NCT01739348|464478987|FG000|Part I (Base Study)|Protocol Violation|2|||
129051455|NCT01739348|464478988|FG001|Part I (Base Study)|Protocol Violation|0|||
129051456|NCT01739348|464478989|FG002|Part I (Base Study)|Protocol Violation|1|||
129051457|NCT01739348|464478990|FG003|Part I (Base Study)|Protocol Violation|2|||
129051458|NCT01739348|464478987|FG000|Part I (Base Study)|Screen Failure|2|||
129051459|NCT01739348|464478988|FG001|Part I (Base Study)|Screen Failure|0|||
129051460|NCT01739348|464478989|FG002|Part I (Base Study)|Screen Failure|0|||
129051461|NCT01739348|464478990|FG003|Part I (Base Study)|Screen Failure|0|||
129051462|NCT01739348|464478987|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
129051463|NCT01739348|464478988|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
128719659|NCT02967692|463273194|FG002|Overall Study|Subject/guardian decision|14|||
129051464|NCT01739348|464478989|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
129051465|NCT01739348|464478990|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
129051466|NCT01739348|464478987|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
129051467|NCT01739348|464478988|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
129051468|NCT01739348|464478989|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
129051469|NCT01739348|464478990|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
129051470|NCT01739348|464478987|FG000|Part I (Base Study)|Participant Moved|4|||
129051471|NCT01739348|464478988|FG001|Part I (Base Study)|Participant Moved|3|||
129051472|NCT01739348|464478989|FG002|Part I (Base Study)|Participant Moved|1|||
129051473|NCT01739348|464478990|FG003|Part I (Base Study)|Participant Moved|7|||
129051474|NCT01739348|464478987|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
129051475|NCT01739348|464478988|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
129051476|NCT01739348|464478989|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
129051477|NCT01739348|464478990|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
129051478|NCT01739348|464478987|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
129051479|NCT01739348|464478988|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
129051480|NCT01739348|464478989|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
129051481|NCT01739348|464478990|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
129051482|NCT01739348|464478987|FG000|Part II (Extension Study)|Adverse Event|10|||
128719660|NCT02967692|463273195|FG003|Overall Study|Subject/guardian decision|22|||
129051483|NCT01739348|464478988|FG001|Part II (Extension Study)|Adverse Event|11|||
129051484|NCT01739348|464478989|FG002|Part II (Extension Study)|Adverse Event|7|||
129051485|NCT01739348|464478990|FG003|Part II (Extension Study)|Adverse Event|26|||
129051486|NCT01739348|464478987|FG000|Part II (Extension Study)|Death|3|||
129051487|NCT01739348|464478988|FG001|Part II (Extension Study)|Death|3|||
129051488|NCT01739348|464478989|FG002|Part II (Extension Study)|Death|2|||
129051489|NCT01739348|464478990|FG003|Part II (Extension Study)|Death|6|||
129051490|NCT01739348|464478987|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
129051491|NCT01739348|464478988|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
129051492|NCT01739348|464478989|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
129051493|NCT01739348|464478990|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
129051494|NCT01739348|464478987|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
129051495|NCT01739348|464478988|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
129051496|NCT01739348|464478989|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
129051497|NCT01739348|464478990|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
129051498|NCT01739348|464478987|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
129051499|NCT01739348|464478988|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
129051500|NCT01739348|464478989|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
129051501|NCT01739348|464478990|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
129051502|NCT01739348|464478987|FG000|Part II (Extension Study)|Physician Decision|7|||
129051503|NCT01739348|464478988|FG001|Part II (Extension Study)|Physician Decision|11|||
129051504|NCT01739348|464478989|FG002|Part II (Extension Study)|Physician Decision|6|||
129051505|NCT01739348|464478990|FG003|Part II (Extension Study)|Physician Decision|12|||
129051506|NCT01739348|464478987|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
129051507|NCT01739348|464478988|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
129051508|NCT01739348|464478989|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
129051509|NCT01739348|464478990|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
129051510|NCT01739348|464478987|FG000|Part II (Extension Study)|Participant Moved|3|||
129051511|NCT01739348|464478988|FG001|Part II (Extension Study)|Participant Moved|3|||
129051512|NCT01739348|464478989|FG002|Part II (Extension Study)|Participant Moved|0|||
129051513|NCT01739348|464478990|FG003|Part II (Extension Study)|Participant Moved|3|||
129051514|NCT01739348|464478987|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
129051515|NCT01739348|464478988|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
129051516|NCT01739348|464478989|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
129051517|NCT01739348|464478990|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
129051518|NCT01739348|464478987|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
129051519|NCT01739348|464478988|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
129051520|NCT01739348|464478989|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
129051521|NCT01739348|464478990|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
129051522|NCT01447420|464478994|FG000|Overall Study|Adverse Event|2|||
129051523|NCT01447420|464478995|FG001|Overall Study|Adverse Event|4|||
129051524|NCT01447420|464478996|FG002|Overall Study|Adverse Event|2|||
129051525|NCT01447420|464478994|FG000|Overall Study|Protocol Violation|3|||
129051526|NCT01447420|464478995|FG001|Overall Study|Protocol Violation|3|||
129051527|NCT01447420|464478996|FG002|Overall Study|Protocol Violation|0|||
129051528|NCT01447420|464478994|FG000|Overall Study|Withdrawal by Subject|4|||
129051529|NCT01447420|464478995|FG001|Overall Study|Withdrawal by Subject|1|||
129051530|NCT01447420|464478996|FG002|Overall Study|Withdrawal by Subject|0|||
129051531|NCT01447420|464478994|FG000|Overall Study|Lack of Efficacy|1|||
129051532|NCT01447420|464478995|FG001|Overall Study|Lack of Efficacy|19|||
129051533|NCT01447420|464478996|FG002|Overall Study|Lack of Efficacy|8|||
129051534|NCT05788289|464479003|FG000|Overall Study|Death|3|||
129051535|NCT01974440|464479004|FG000|Overall Study|Lost to Follow-up|7|||
129051536|NCT01974440|464479005|FG001|Overall Study|Lost to Follow-up|7|||
129051537|NCT01974440|464479004|FG000|Overall Study|Withdrawal by Subject|24|||
129051538|NCT01974440|464479005|FG001|Overall Study|Withdrawal by Subject|20|||
129051539|NCT01974440|464479004|FG000|Overall Study|Sponsor decision|109|||
129051540|NCT01974440|464479005|FG001|Overall Study|Sponsor decision|110|||
129051541|NCT00762437|464479006|FG000|Overall Study|Lost to Follow-up|7|||
129051542|NCT00762437|464479006|FG000|Overall Study|Missed final study visit|11|||
129051543|NCT00762437|464479006|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
129051544|NCT03569228|464479007|FG000|Overall Study|Withdrawal by PI|0|||
129051545|NCT03569228|464479008|FG001|Overall Study|Withdrawal by PI|0|||
129051546|NCT03569228|464479009|FG002|Overall Study|Withdrawal by PI|2|||
129051547|NCT03569228|464479010|FG003|Overall Study|Withdrawal by PI|2|||
129136518|NCT03632720|464793007|FG002|Overall Study|Screen failure|0|||
129136519|NCT00682435|464793008|FG000|Overall Study|Insufficient data|5|||
129136520|NCT00682435|464793008|FG000|Overall Study|Erroneously enrolled twice|2|||
129051548|NCT03569228|464479011|FG004|Overall Study|Withdrawal by PI|1|||
129051549|NCT03569228|464479012|FG005|Overall Study|Withdrawal by PI|0|||
129051550|NCT03569228|464479013|FG006|Overall Study|Withdrawal by PI|0|||
129051551|NCT03569228|464479014|FG007|Overall Study|Withdrawal by PI|0|||
129051552|NCT03569228|464479015|FG008|Overall Study|Withdrawal by PI|0|||
129051553|NCT03569228|464479007|FG000|Overall Study|Lost to Follow-up|0|||
129051554|NCT03569228|464479008|FG001|Overall Study|Lost to Follow-up|0|||
129051555|NCT03569228|464479009|FG002|Overall Study|Lost to Follow-up|0|||
129051556|NCT03569228|464479010|FG003|Overall Study|Lost to Follow-up|0|||
129051557|NCT03569228|464479011|FG004|Overall Study|Lost to Follow-up|0|||
129051558|NCT03569228|464479012|FG005|Overall Study|Lost to Follow-up|0|||
129051559|NCT03569228|464479013|FG006|Overall Study|Lost to Follow-up|0|||
129051560|NCT03569228|464479014|FG007|Overall Study|Lost to Follow-up|0|||
129051561|NCT03569228|464479015|FG008|Overall Study|Lost to Follow-up|1|||
129051562|NCT03569228|464479007|FG000|Overall Study|Screen Fail|2|||
129051563|NCT03569228|464479008|FG001|Overall Study|Screen Fail|2|||
129051564|NCT03569228|464479009|FG002|Overall Study|Screen Fail|1|||
129051565|NCT03569228|464479010|FG003|Overall Study|Screen Fail|1|||
129051566|NCT03569228|464479011|FG004|Overall Study|Screen Fail|1|||
129051567|NCT03569228|464479012|FG005|Overall Study|Screen Fail|3|||
129051568|NCT03569228|464479013|FG006|Overall Study|Screen Fail|1|||
129051569|NCT03569228|464479014|FG007|Overall Study|Screen Fail|5|||
129051570|NCT03569228|464479015|FG008|Overall Study|Screen Fail|2|||
129051571|NCT06354998|464479016|FG000|Overall Study|Withdrawal by Subject|3|||
129051572|NCT06354998|464479017|FG001|Overall Study|Withdrawal by Subject|0|||
129051573|NCT00085423|464479022|FG000|Overall Study|Withdrawal by Subject|1|||
129051574|NCT00085423|464479022|FG000|Overall Study|screen failure|1|||
129051575|NCT02440568|464479025|FG000|Overall Study|Death|1|||
129051576|NCT02440568|464479026|FG001|Overall Study|Death|3|||
129051577|NCT02440568|464479027|FG002|Overall Study|Death|4|||
129051578|NCT02440568|464479028|FG003|Overall Study|Death|2|||
129051579|NCT02440568|464479025|FG000|Overall Study|Lack of Efficacy|2|||
129051580|NCT02440568|464479026|FG001|Overall Study|Lack of Efficacy|0|||
129051581|NCT02440568|464479027|FG002|Overall Study|Lack of Efficacy|1|||
129051582|NCT02440568|464479028|FG003|Overall Study|Lack of Efficacy|0|||
129051583|NCT02440568|464479025|FG000|Overall Study|Lost to Follow-up|1|||
129051584|NCT02440568|464479026|FG001|Overall Study|Lost to Follow-up|0|||
129051585|NCT02440568|464479027|FG002|Overall Study|Lost to Follow-up|0|||
129051586|NCT02440568|464479028|FG003|Overall Study|Lost to Follow-up|0|||
129051587|NCT00536263|464479034|FG000|Overall Study|Adverse Event|5|||
129051588|NCT00536263|464479035|FG001|Overall Study|Adverse Event|5|||
129051589|NCT00536263|464479036|FG002|Overall Study|Adverse Event|7|||
129051590|NCT00536263|464479034|FG000|Overall Study|Lost to Follow-up|3|||
129051591|NCT00536263|464479035|FG001|Overall Study|Lost to Follow-up|4|||
129051592|NCT00536263|464479036|FG002|Overall Study|Lost to Follow-up|4|||
129051593|NCT00536263|464479034|FG000|Overall Study|Subject withdrew - not treatment related|2|||
129051594|NCT00536263|464479035|FG001|Overall Study|Subject withdrew - not treatment related|0|||
129051595|NCT00536263|464479036|FG002|Overall Study|Subject withdrew - not treatment related|5|||
129051596|NCT00536263|464479034|FG000|Overall Study|Subject withdrew - treatment related|0|||
129051597|NCT00536263|464479035|FG001|Overall Study|Subject withdrew - treatment related|3|||
129051598|NCT00536263|464479036|FG002|Overall Study|Subject withdrew - treatment related|2|||
129051599|NCT00536263|464479034|FG000|Overall Study|Noncompliance with protocol|0|||
129051600|NCT00536263|464479035|FG001|Overall Study|Noncompliance with protocol|0|||
129051601|NCT00536263|464479036|FG002|Overall Study|Noncompliance with protocol|1|||
129051602|NCT00536263|464479034|FG000|Overall Study|Did not meet protocol eligibility|1|||
129051603|NCT00536263|464479035|FG001|Overall Study|Did not meet protocol eligibility|2|||
129051604|NCT00536263|464479036|FG002|Overall Study|Did not meet protocol eligibility|2|||
129051605|NCT01181271|464479043|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
129051606|NCT01181271|464479043|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
129051607|NCT01181271|464479043|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
129051608|NCT01181271|464479043|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
129051609|NCT03201211|464479044|FG000|Overall Study|Adverse Event|1|||
129051610|NCT03201211|464479045|FG001|Overall Study|Adverse Event|0|||
129051611|NCT03201211|464479046|FG002|Overall Study|Adverse Event|0|||
129051612|NCT03201211|464479044|FG000|Overall Study|Protocol Violation|1|||
129051613|NCT03201211|464479045|FG001|Overall Study|Protocol Violation|0|||
128775485|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
129051614|NCT03201211|464479046|FG002|Overall Study|Protocol Violation|0|||
129051615|NCT03201211|464479044|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129051616|NCT03201211|464479045|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129051617|NCT03201211|464479046|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
129051618|NCT03201211|464479044|FG000|Overall Study|OTHER unknown reasons|0|||
129051619|NCT03201211|464479045|FG001|Overall Study|OTHER unknown reasons|1|||
129051620|NCT03201211|464479046|FG002|Overall Study|OTHER unknown reasons|0|||
129051621|NCT01083810|464479047|FG000|Overall Study|Lost to Follow-up|23|||
129051622|NCT01083810|464479048|FG001|Overall Study|Lost to Follow-up|11|||
129051623|NCT01083810|464479049|FG002|Overall Study|Lost to Follow-up|4|||
129051624|NCT01083810|464479047|FG000|Overall Study|Adverse Event|15|||
129051625|NCT01083810|464479048|FG001|Overall Study|Adverse Event|11|||
129051626|NCT01083810|464479049|FG002|Overall Study|Adverse Event|4|||
129051627|NCT01083810|464479047|FG000|Overall Study|Withdrawal by Subject|7|||
129051628|NCT01083810|464479048|FG001|Overall Study|Withdrawal by Subject|2|||
129051629|NCT01083810|464479049|FG002|Overall Study|Withdrawal by Subject|4|||
129051630|NCT01083810|464479047|FG000|Overall Study|Reason not reported|6|||
129051631|NCT01083810|464479048|FG001|Overall Study|Reason not reported|1|||
129051632|NCT01083810|464479049|FG002|Overall Study|Reason not reported|1|||
129051633|NCT01083810|464479047|FG000|Overall Study|Non-compliance|4|||
129051634|NCT01083810|464479048|FG001|Overall Study|Non-compliance|7|||
129051635|NCT01083810|464479049|FG002|Overall Study|Non-compliance|2|||
129051636|NCT01083810|464479047|FG000|Overall Study|Simplification|4|||
129051637|NCT01083810|464479048|FG001|Overall Study|Simplification|1|||
129051638|NCT01083810|464479049|FG002|Overall Study|Simplification|0|||
129051639|NCT01083810|464479047|FG000|Overall Study|Death|2|||
129051640|NCT01083810|464479048|FG001|Overall Study|Death|2|||
129051641|NCT01083810|464479049|FG002|Overall Study|Death|3|||
129051642|NCT01083810|464479047|FG000|Overall Study|Co-morbidities|1|||
129051643|NCT01083810|464479048|FG001|Overall Study|Co-morbidities|0|||
129051644|NCT01083810|464479049|FG002|Overall Study|Co-morbidities|0|||
129051645|NCT01083810|464479047|FG000|Overall Study|Participation in study|1|||
129051646|NCT01083810|464479048|FG001|Overall Study|Participation in study|0|||
129051647|NCT01083810|464479049|FG002|Overall Study|Participation in study|0|||
129051648|NCT01083810|464479047|FG000|Overall Study|Therapy break|1|||
129051649|NCT01083810|464479048|FG001|Overall Study|Therapy break|2|||
129051650|NCT01083810|464479049|FG002|Overall Study|Therapy break|2|||
129051651|NCT01083810|464479047|FG000|Overall Study|Virologic failure|1|||
129051652|NCT01083810|464479048|FG001|Overall Study|Virologic failure|8|||
129051653|NCT01083810|464479049|FG002|Overall Study|Virologic failure|0|||
129051654|NCT03118570|464479052|FG000|Overall Study|Adverse Event|2|||
129051655|NCT03118570|464479053|FG001|Overall Study|Adverse Event|0|||
129051656|NCT03118570|464479054|FG002|Overall Study|Adverse Event|0|||
129051657|NCT03118570|464479055|FG003|Overall Study|Adverse Event|0|||
129051658|NCT03118570|464479056|FG004|Overall Study|Adverse Event|3|||
129051659|NCT03118570|464479052|FG000|Overall Study|Withdrawal by Subject|0|||
129051660|NCT03118570|464479053|FG001|Overall Study|Withdrawal by Subject|1|||
129051661|NCT03118570|464479054|FG002|Overall Study|Withdrawal by Subject|4|||
129051662|NCT03118570|464479055|FG003|Overall Study|Withdrawal by Subject|0|||
129051663|NCT03118570|464479056|FG004|Overall Study|Withdrawal by Subject|1|||
129051664|NCT03118570|464479052|FG000|Overall Study|Lost to Follow-up|2|||
129051665|NCT03118570|464479053|FG001|Overall Study|Lost to Follow-up|3|||
129051666|NCT03118570|464479054|FG002|Overall Study|Lost to Follow-up|1|||
129051667|NCT03118570|464479055|FG003|Overall Study|Lost to Follow-up|0|||
129051668|NCT03118570|464479056|FG004|Overall Study|Lost to Follow-up|1|||
129051669|NCT03118570|464479052|FG000|Overall Study|Other, Not Specified|1|||
129051670|NCT03118570|464479053|FG001|Overall Study|Other, Not Specified|3|||
129051671|NCT03118570|464479054|FG002|Overall Study|Other, Not Specified|0|||
129051672|NCT03118570|464479055|FG003|Overall Study|Other, Not Specified|0|||
129051673|NCT03118570|464479056|FG004|Overall Study|Other, Not Specified|0|||
129051674|NCT00477295|464479059|FG000|Overall Study|Adverse Event|31|||
129051675|NCT00477295|464479060|FG001|Overall Study|Adverse Event|35|||
129051676|NCT00477295|464479059|FG000|Overall Study|Withdrawal by Subject|35|||
129051677|NCT00477295|464479060|FG001|Overall Study|Withdrawal by Subject|24|||
129051678|NCT00477295|464479059|FG000|Overall Study|Lack of Efficacy|23|||
129051679|NCT00477295|464479060|FG001|Overall Study|Lack of Efficacy|23|||
129051680|NCT00477295|464479059|FG000|Overall Study|Protocol Violation|3|||
129051681|NCT00477295|464479060|FG001|Overall Study|Protocol Violation|8|||
129051682|NCT00477295|464479059|FG000|Overall Study|Physician Decision|4|||
129051683|NCT00477295|464479060|FG001|Overall Study|Physician Decision|5|||
129051684|NCT00477295|464479059|FG000|Overall Study|Lost to Follow-up|21|||
129051685|NCT00477295|464479060|FG001|Overall Study|Lost to Follow-up|11|||
129051686|NCT00477295|464479059|FG000|Overall Study|Other|4|||
129051687|NCT00477295|464479060|FG001|Overall Study|Other|3|||
129051688|NCT00228423|464479063|FG000|Overall Study|Adverse Event|2|||
129136521|NCT01049828|464793010|FG000|Overall Study|Claustrophibia and Frustration|2|||
129136522|NCT00290238|464793011|FG000|Overall Study|Study terminated|27|||
129136523|NCT00290238|464793012|FG001|Overall Study|Study terminated|27|||
128775486|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
129051689|NCT00228423|464479064|FG001|Overall Study|Adverse Event|5|||
129051690|NCT00228423|464479063|FG000|Overall Study|Withdrawal by Subject|7|||
129051691|NCT00228423|464479064|FG001|Overall Study|Withdrawal by Subject|3|||
129051692|NCT00228423|464479063|FG000|Overall Study|Protocol Violation|1|||
129051693|NCT00228423|464479064|FG001|Overall Study|Protocol Violation|3|||
129136524|NCT00290238|464793011|FG000|Overall Study|Lost to Follow-up|0|||
129051694|NCT00228423|464479063|FG000|Overall Study|Physician Decision|0|||
129051695|NCT00228423|464479064|FG001|Overall Study|Physician Decision|1|||
129051696|NCT01709838|464479078|FG000|Overall Study|Withdrawal by Subject|21|||
129051697|NCT01709838|464479078|FG000|Overall Study|Lost to Follow-up|16|||
129051698|NCT01709838|464479078|FG000|Overall Study|Pregnancy|10|||
129051699|NCT01709838|464479078|FG000|Overall Study|Subject/guardian decision|8|||
129051700|NCT01709838|464479078|FG000|Overall Study|Adverse Event|4|||
129051701|NCT01709838|464479078|FG000|Overall Study|Physician Decision|4|||
129051702|NCT01709838|464479078|FG000|Overall Study|Death|3|||
129136525|NCT00290238|464793012|FG001|Overall Study|Lost to Follow-up|1|||
129136526|NCT00290238|464793011|FG000|Overall Study|Withdrawal by Subject|15|||
129136527|NCT00290238|464793012|FG001|Overall Study|Withdrawal by Subject|13|||
129136528|NCT02186171|464793013|FG000|Overall Study|Withdrawal by Subject|1|||
129136529|NCT02186171|464793014|FG001|Overall Study|Withdrawal by Subject|9|||
129136530|NCT02186171|464793013|FG000|Overall Study|Lost to Follow-up|2|||
129136531|NCT02186171|464793014|FG001|Overall Study|Lost to Follow-up|2|||
129136532|NCT02186171|464793013|FG000|Overall Study|Death|1|||
129136533|NCT02186171|464793014|FG001|Overall Study|Death|2|||
129136534|NCT02186171|464793013|FG000|Overall Study|Protocol-specified Criteria|0|||
129136535|NCT02186171|464793014|FG001|Overall Study|Protocol-specified Criteria|2|||
129136536|NCT06868667|464793015|FG000|Overall Study|Death|0|||
129136537|NCT06868667|464793016|FG001|Overall Study|Death|4|||
129136538|NCT06868667|464793015|FG000|Overall Study|Lost to Follow-up|0|||
129136539|NCT06868667|464793016|FG001|Overall Study|Lost to Follow-up|1|||
129136540|NCT06868667|464793015|FG000|Overall Study|Withdrawal by Subject|1|||
129136541|NCT06868667|464793016|FG001|Overall Study|Withdrawal by Subject|0|||
129136542|NCT06868667|464793015|FG000|Overall Study|Ongoing|9|||
129136543|NCT06868667|464793016|FG001|Overall Study|Ongoing|9|||
129136544|NCT05330429|464793019|FG000|Overall Study|Study Terminated by Sponsor|4|||
129136545|NCT05330429|464793020|FG001|Overall Study|Study Terminated by Sponsor|33|||
129136546|NCT05330429|464793021|FG002|Overall Study|Study Terminated by Sponsor|12|||
129136547|NCT05330429|464793019|FG000|Overall Study|Death|5|||
129136548|NCT05330429|464793020|FG001|Overall Study|Death|2|||
129136549|NCT05330429|464793021|FG002|Overall Study|Death|4|||
129136550|NCT05330429|464793019|FG000|Overall Study|Withdrew Consent|0|||
129136551|NCT05330429|464793020|FG001|Overall Study|Withdrew Consent|5|||
129136552|NCT05330429|464793021|FG002|Overall Study|Withdrew Consent|4|||
129136553|NCT05330429|464793019|FG000|Overall Study|Investigator's Discretion|0|||
129136554|NCT05330429|464793020|FG001|Overall Study|Investigator's Discretion|1|||
129136555|NCT05330429|464793021|FG002|Overall Study|Investigator's Discretion|3|||
129136556|NCT05330429|464793019|FG000|Overall Study|Subject Decision|1|||
129136557|NCT05330429|464793020|FG001|Overall Study|Subject Decision|2|||
129136558|NCT05330429|464793021|FG002|Overall Study|Subject Decision|0|||
129136559|NCT05330429|464793019|FG000|Overall Study|Lost to Follow-up|0|||
129136560|NCT05330429|464793020|FG001|Overall Study|Lost to Follow-up|1|||
129136561|NCT05330429|464793021|FG002|Overall Study|Lost to Follow-up|0|||
129223475|NCT04459715|465118889|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
129223476|NCT04459715|465118890|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
129051703|NCT01709838|464479078|FG000|Overall Study|Protocol Violation|1|||
129051704|NCT03753763|464479086|FG000|Overall Study|Adverse Event|2|||
129051705|NCT03753763|464479087|FG001|Overall Study|Adverse Event|0|||
129051706|NCT03753763|464479086|FG000|Overall Study|Withdrawal by Subject|3|||
129051707|NCT03753763|464479087|FG001|Overall Study|Withdrawal by Subject|1|||
129051708|NCT03753763|464479086|FG000|Overall Study|clinical deterioration|1|||
129051709|NCT03753763|464479087|FG001|Overall Study|clinical deterioration|0|||
129051710|NCT00389831|464479088|FG000|Overall Study|Lack of Efficacy|0|||
129051711|NCT00389831|464479089|FG001|Overall Study|Lack of Efficacy|2|||
129051712|NCT00389831|464479088|FG000|Overall Study|Did not receive treatment.|0|||
129051713|NCT00389831|464479089|FG001|Overall Study|Did not receive treatment.|2|||
129051714|NCT00389831|464479088|FG000|Overall Study|Other reasons|0|||
129051715|NCT00389831|464479089|FG001|Overall Study|Other reasons|2|||
129051716|NCT00389831|464479088|FG000|Overall Study|Lost to Follow-up|0|||
129051717|NCT00389831|464479089|FG001|Overall Study|Lost to Follow-up|1|||
129051718|NCT03433755|464479090|FG000|Overall Study|Lost to Follow-up|1|||
129051719|NCT03433755|464479091|FG001|Overall Study|Lost to Follow-up|0|||
129051720|NCT03433755|464479092|FG002|Overall Study|Lost to Follow-up|0|||
129051721|NCT03433755|464479093|FG003|Overall Study|Lost to Follow-up|0|||
129051722|NCT03433755|464479090|FG000|Overall Study|Decision by Sponsor|1|||
129051723|NCT03433755|464479091|FG001|Overall Study|Decision by Sponsor|0|||
129051724|NCT03433755|464479092|FG002|Overall Study|Decision by Sponsor|0|||
129051725|NCT03433755|464479093|FG003|Overall Study|Decision by Sponsor|0|||
129051726|NCT03190330|464481611|FG000|Overall Study|Adverse Event|2|||
129051727|NCT03190330|464481611|FG000|Overall Study|Death|10|||
129051728|NCT03190330|464481611|FG000|Overall Study|Lost to Follow-up|1|||
129136562|NCT03572218|464793022|FG000|Overall Study|Lost to Follow-up|3|||
129136563|NCT03572218|464793023|FG001|Overall Study|Lost to Follow-up|2|||
129136564|NCT03572218|464793022|FG000|Overall Study|No longer available for study visits|2|||
129223477|NCT04459715|465118889|FG000|Overall Study|Withdrawal by Subject|22|||
129051729|NCT03190330|464481611|FG000|Overall Study|Withdrawal by Subject|6|||
129051730|NCT03190330|464481611|FG000|Overall Study|Progressive Disease|1|||
129051731|NCT02081209|464481614|FG000|Overall Study|Withdrawal by Subject|1|||
129051732|NCT04994483|464481625|FG000|Overall Study|Adverse Event|26|||
129051733|NCT04994483|464481626|FG001|Overall Study|Adverse Event|17|||
129051734|NCT04994483|464481625|FG000|Overall Study|Lost to Follow-up|6|||
129136565|NCT03572218|464793023|FG001|Overall Study|No longer available for study visits|1|||
129136566|NCT03572218|464793022|FG000|Overall Study|No longer interested|1|||
129136567|NCT03572218|464793023|FG001|Overall Study|No longer interested|2|||
129136568|NCT00286455|464793024|FG000|Overall Study|Hyperglycemia rescue|19|||
129223478|NCT04459715|465118890|FG001|Overall Study|Withdrawal by Subject|22|||
129223479|NCT03976323|465118892|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
129223480|NCT03976323|465118893|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
129223481|NCT03976323|465118894|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
129223482|NCT03976323|465118892|FG000|Induction Phase|Death|80|||
129223483|NCT03976323|465118893|FG001|Induction Phase|Death|0|||
129223484|NCT03976323|465118894|FG002|Induction Phase|Death|0|||
128719661|NCT02967692|463273192|FG000|Overall Study|Death|0|||
128719662|NCT02967692|463273193|FG001|Overall Study|Death|1|||
128719663|NCT02967692|463273194|FG002|Overall Study|Death|13|||
129223485|NCT03976323|465118892|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
129223486|NCT03976323|465118893|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
129223487|NCT03976323|465118894|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
129223488|NCT03976323|465118892|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129223489|NCT03976323|465118893|FG001|Maintenance Phase|Withdrawal by Subject|9|||
129223490|NCT03976323|465118894|FG002|Maintenance Phase|Withdrawal by Subject|3|||
129223491|NCT03976323|465118892|FG000|Maintenance Phase|Physician Decision|0|||
129223492|NCT03976323|465118893|FG001|Maintenance Phase|Physician Decision|0|||
129223493|NCT03976323|465118894|FG002|Maintenance Phase|Physician Decision|1|||
129223494|NCT03976323|465118892|FG000|Maintenance Phase|Death|0|||
129223495|NCT03976323|465118893|FG001|Maintenance Phase|Death|228|||
129223496|NCT03976323|465118894|FG002|Maintenance Phase|Death|234|||
129051735|NCT04994483|464481626|FG001|Overall Study|Lost to Follow-up|10|||
129051736|NCT04994483|464481625|FG000|Overall Study|Noncompliance with study drug|8|||
129051737|NCT04994483|464481626|FG001|Overall Study|Noncompliance with study drug|5|||
129051738|NCT04994483|464481625|FG000|Overall Study|Physician Decision|5|||
129051739|NCT04994483|464481626|FG001|Overall Study|Physician Decision|0|||
129051740|NCT04994483|464481625|FG000|Overall Study|Withdrawal by Subject|41|||
129051741|NCT04994483|464481626|FG001|Overall Study|Withdrawal by Subject|38|||
129051742|NCT04994483|464481625|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
129051743|NCT04994483|464481626|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
129051744|NCT04994483|464481625|FG000|Overall Study|Met stopping criteria|1|||
129051745|NCT04994483|464481626|FG001|Overall Study|Met stopping criteria|0|||
129051746|NCT04994483|464481625|FG000|Overall Study|Randomized in error, not treated|4|||
129051747|NCT04994483|464481626|FG001|Overall Study|Randomized in error, not treated|3|||
129051748|NCT04994483|464481625|FG000|Overall Study|Lack of a reliable study partner|0|||
129051749|NCT04994483|464481626|FG001|Overall Study|Lack of a reliable study partner|1|||
129051750|NCT04994483|464481625|FG000|Overall Study|Met MRI exclusion criteria|0|||
129051751|NCT04994483|464481626|FG001|Overall Study|Met MRI exclusion criteria|1|||
129051752|NCT03589768|464481631|FG000|Overall Study|Death|1|||
129051753|NCT03589768|464481632|FG001|Overall Study|Death|0|||
128719664|NCT02967692|463273195|FG003|Overall Study|Death|13|||
129051754|NCT03589768|464481633|FG002|Overall Study|Death|8|||
129051755|NCT03589768|464481634|FG003|Overall Study|Death|3|||
129051756|NCT03589768|464481631|FG000|Overall Study|Withdrawal by Subject|2|||
129051757|NCT03589768|464481632|FG001|Overall Study|Withdrawal by Subject|0|||
129051758|NCT03589768|464481633|FG002|Overall Study|Withdrawal by Subject|0|||
129051759|NCT03589768|464481634|FG003|Overall Study|Withdrawal by Subject|0|||
129051760|NCT03589768|464481631|FG000|Overall Study|Protocol Violation|1|||
129051761|NCT03589768|464481632|FG001|Overall Study|Protocol Violation|0|||
129051762|NCT03589768|464481633|FG002|Overall Study|Protocol Violation|0|||
129051763|NCT03589768|464481634|FG003|Overall Study|Protocol Violation|0|||
129051764|NCT01200992|464481637|FG000|Overall Study|Study terminated early|35|||
129051765|NCT01200992|464481638|FG001|Overall Study|Study terminated early|41|||
129051766|NCT01200992|464481637|FG000|Overall Study|Randomized but not treated|2|||
129051767|NCT01200992|464481638|FG001|Overall Study|Randomized but not treated|0|||
129051768|NCT02213510|464481647|FG000|Overall Study|Death|0|||
129051769|NCT02213510|464481648|FG001|Overall Study|Death|1|||
129051770|NCT02213510|464481647|FG000|Overall Study|Lost to Follow-up|1|||
129051771|NCT02213510|464481648|FG001|Overall Study|Lost to Follow-up|0|||
129051772|NCT01502410|464481652|FG000|Overall Study|Adverse Event|1|||
129051773|NCT01502410|464481653|FG001|Overall Study|Adverse Event|2|||
129051774|NCT01502410|464481654|FG002|Overall Study|Adverse Event|0|||
129051775|NCT01502410|464481655|FG003|Overall Study|Adverse Event|0|||
129051776|NCT01502410|464481652|FG000|Overall Study|Lack of Efficacy|7|||
129051777|NCT01502410|464481653|FG001|Overall Study|Lack of Efficacy|7|||
129051778|NCT01502410|464481654|FG002|Overall Study|Lack of Efficacy|0|||
129051779|NCT01502410|464481655|FG003|Overall Study|Lack of Efficacy|0|||
129051780|NCT01502410|464481652|FG000|Overall Study|Physician Decision|0|||
129051781|NCT01502410|464481653|FG001|Overall Study|Physician Decision|1|||
129051782|NCT01502410|464481654|FG002|Overall Study|Physician Decision|0|||
129051783|NCT01502410|464481655|FG003|Overall Study|Physician Decision|0|||
129051784|NCT01502410|464481652|FG000|Overall Study|Withdrawal by Subject|2|||
129051785|NCT01502410|464481653|FG001|Overall Study|Withdrawal by Subject|0|||
129051786|NCT01502410|464481654|FG002|Overall Study|Withdrawal by Subject|0|||
129051787|NCT01502410|464481655|FG003|Overall Study|Withdrawal by Subject|0|||
129051788|NCT02903030|464481656|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129051789|NCT02903030|464481657|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129051790|NCT03786718|464481661|FG000|Overall Study|Lost to Follow-up|3|||
129051791|NCT03786718|464481661|FG000|Overall Study|Withdrawal by Subject|1|||
129051792|NCT03786718|464481661|FG000|Overall Study|Did not use the intervention|2|||
129051793|NCT03786718|464481661|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
129051794|NCT00754650|464481675|FG000|Overall Study|Disease Progression|2|||
129051795|NCT00805675|464481676|FG000|Overall Study|Adverse Event|0|||
129051796|NCT00805675|464481677|FG001|Overall Study|Adverse Event|0|||
129051797|NCT00805675|464481678|FG002|Overall Study|Adverse Event|1|||
129051798|NCT01007942|464481682|FG000|Overall Study|Adverse Event|29|||
129051799|NCT01007942|464481683|FG001|Overall Study|Adverse Event|14|||
129051800|NCT01007942|464481682|FG000|Overall Study|Abnormal test procedure|0|||
129051801|NCT01007942|464481683|FG001|Overall Study|Abnormal test procedure|1|||
129051802|NCT01007942|464481682|FG000|Overall Study|Disease progression|217|||
129051803|NCT01007942|464481683|FG001|Overall Study|Disease progression|242|||
129051804|NCT01007942|464481682|FG000|Overall Study|New cancer therapy|5|||
129051805|NCT01007942|464481683|FG001|Overall Study|New cancer therapy|1|||
129051806|NCT01007942|464481682|FG000|Overall Study|Protocol Violation|1|||
129051807|NCT01007942|464481683|FG001|Overall Study|Protocol Violation|1|||
129051808|NCT01007942|464481682|FG000|Overall Study|Withdrawal by Subject|19|||
129051809|NCT01007942|464481683|FG001|Overall Study|Withdrawal by Subject|14|||
129051810|NCT01007942|464481682|FG000|Overall Study|Lost to Follow-up|1|||
129051811|NCT01007942|464481683|FG001|Overall Study|Lost to Follow-up|0|||
129051812|NCT01007942|464481682|FG000|Overall Study|Administrative problems|2|||
129051813|NCT01007942|464481683|FG001|Overall Study|Administrative problems|0|||
129051814|NCT01007942|464481682|FG000|Overall Study|Death|3|||
129051815|NCT01007942|464481683|FG001|Overall Study|Death|2|||
129051816|NCT01007942|464481682|FG000|Overall Study|Patients untreated|4|||
129051817|NCT01007942|464481683|FG001|Overall Study|Patients untreated|3|||
129051818|NCT05083585|464481688|FG000|Overall Study|Death|1|||
129051819|NCT05083585|464481689|FG001|Overall Study|Death|1|||
129051820|NCT05083585|464481688|FG000|Overall Study|Lost to Follow-up|1|||
129051821|NCT05083585|464481689|FG001|Overall Study|Lost to Follow-up|1|||
129051822|NCT05083585|464481688|FG000|Overall Study|Withdrawal by Subject|2|||
129051823|NCT05083585|464481689|FG001|Overall Study|Withdrawal by Subject|0|||
129051824|NCT05083585|464481688|FG000|Overall Study|Randomized but not vaccinated|2|||
129051825|NCT05083585|464481689|FG001|Overall Study|Randomized but not vaccinated|0|||
129051826|NCT01383135|464481690|FG000|Overall Study|Not Scanned / Imaged|1|||
129051827|NCT01383135|464481691|FG001|Overall Study|Not Scanned / Imaged|0|||
129051828|NCT01383135|464481692|FG002|Overall Study|Not Scanned / Imaged|1|||
129051829|NCT01383135|464481693|FG003|Overall Study|Not Scanned / Imaged|0|||
129051830|NCT03929757|464481694|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
129051831|NCT03929757|464481695|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
129051832|NCT03929757|464481696|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
129051833|NCT03929757|464481694|FG000|Main Study: Up to Day 365|Other|1|||
129051834|NCT03929757|464481695|FG001|Main Study: Up to Day 365|Other|0|||
129051835|NCT03929757|464481696|FG002|Main Study: Up to Day 365|Other|0|||
129051836|NCT03929757|464481694|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
129051837|NCT03929757|464481695|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
129051838|NCT03929757|464481696|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
129051839|NCT00806286|464481698|FG000|Overall Study|Adverse Event|5|||
129051840|NCT00806286|464481699|FG001|Overall Study|Adverse Event|2|||
129051841|NCT00806286|464481700|FG002|Overall Study|Adverse Event|0|||
129051842|NCT00806286|464481698|FG000|Overall Study|Disease progression|31|||
129051843|NCT00806286|464481699|FG001|Overall Study|Disease progression|38|||
129051844|NCT00806286|464481700|FG002|Overall Study|Disease progression|1|||
129136569|NCT00286455|464793025|FG001|Overall Study|Hyperglycemia rescue|13|||
129136570|NCT00286455|464793026|FG002|Overall Study|Hyperglycemia rescue|10|||
129136571|NCT00286455|464793024|FG000|Overall Study|Adverse Event|1|||
129136572|NCT00286455|464793025|FG001|Overall Study|Adverse Event|3|||
129136573|NCT00286455|464793026|FG002|Overall Study|Adverse Event|2|||
129136574|NCT00286455|464793024|FG000|Overall Study|Lost to Follow-up|0|||
129136575|NCT00286455|464793025|FG001|Overall Study|Lost to Follow-up|3|||
129051845|NCT00806286|464481698|FG000|Overall Study|Death|1|||
129051846|NCT00806286|464481699|FG001|Overall Study|Death|6|||
129051847|NCT00806286|464481700|FG002|Overall Study|Death|0|||
129051848|NCT00806286|464481698|FG000|Overall Study|Lost to Follow-up|0|||
129051849|NCT00806286|464481699|FG001|Overall Study|Lost to Follow-up|1|||
129051850|NCT00806286|464481700|FG002|Overall Study|Lost to Follow-up|0|||
129051851|NCT00806286|464481698|FG000|Overall Study|Withdrawal by Subject|8|||
129051852|NCT00806286|464481699|FG001|Overall Study|Withdrawal by Subject|3|||
129051853|NCT00806286|464481700|FG002|Overall Study|Withdrawal by Subject|1|||
129051854|NCT00806286|464481698|FG000|Overall Study|Physician Decision|2|||
129051855|NCT00806286|464481699|FG001|Overall Study|Physician Decision|2|||
129051856|NCT00806286|464481700|FG002|Overall Study|Physician Decision|0|||
129051857|NCT00806286|464481698|FG000|Overall Study|Due to a variety of reasons|7|||
129051858|NCT00806286|464481699|FG001|Overall Study|Due to a variety of reasons|2|||
129051859|NCT00806286|464481700|FG002|Overall Study|Due to a variety of reasons|1|||
129051860|NCT03402750|464481701|FG000|Overall Study|Lost to Follow-up|2|||
129051861|NCT03402750|464481702|FG001|Overall Study|Lost to Follow-up|1|||
129051862|NCT03469336|464481703|FG000|Overall Study|Adverse Event|1|||
129051863|NCT02628743|464481705|FG000|Overall Study|Other|3|||
129051864|NCT02628743|464481705|FG000|Overall Study|Withdrawal by Subject|50|||
129051865|NCT02628743|464481705|FG000|Overall Study|Study Terminated by Sponsor|76|||
129051866|NCT02628743|464481705|FG000|Overall Study|Physician Decision|2|||
129051867|NCT02534844|464481706|FG000|Part B|Withdrawal by Subject|0|||
129051868|NCT02534844|464481707|FG001|Part B|Withdrawal by Subject|0|||
129051869|NCT02534844|464481708|FG002|Part B|Withdrawal by Subject|0|||
129051870|NCT02534844|464481709|FG003|Part B|Withdrawal by Subject|0|||
129051871|NCT02534844|464481710|FG004|Part B|Withdrawal by Subject|2|||
129051872|NCT02534844|464481711|FG005|Part B|Withdrawal by Subject|1|||
129051873|NCT04645966|464481712|FG000|Vaccination Phase|Adverse Event|1|||
129051874|NCT04645966|464481713|FG001|Vaccination Phase|Adverse Event|0|||
129051875|NCT04645966|464481714|FG002|Vaccination Phase|Adverse Event|0|||
129051876|NCT04645966|464481715|FG003|Vaccination Phase|Adverse Event|0|||
129051877|NCT04645966|464481716|FG004|Vaccination Phase|Adverse Event|0|||
129051878|NCT04645966|464481717|FG005|Vaccination Phase|Adverse Event|0|||
129051879|NCT04645966|464481718|FG006|Vaccination Phase|Adverse Event|1|||
129051880|NCT04645966|464481719|FG007|Vaccination Phase|Adverse Event|0|||
129051881|NCT04645966|464481720|FG008|Vaccination Phase|Adverse Event|0|||
129051882|NCT04645966|464481712|FG000|Vaccination Phase|Death|0|||
129051883|NCT04645966|464481713|FG001|Vaccination Phase|Death|0|||
129051884|NCT04645966|464481714|FG002|Vaccination Phase|Death|0|||
129051885|NCT04645966|464481715|FG003|Vaccination Phase|Death|0|||
129051886|NCT04645966|464481716|FG004|Vaccination Phase|Death|0|||
129051887|NCT04645966|464481717|FG005|Vaccination Phase|Death|1|||
129051888|NCT04645966|464481718|FG006|Vaccination Phase|Death|0|||
129051889|NCT04645966|464481719|FG007|Vaccination Phase|Death|0|||
129051890|NCT04645966|464481720|FG008|Vaccination Phase|Death|0|||
129051891|NCT04645966|464481712|FG000|Vaccination Phase|Protocol Violation|0|||
129051892|NCT04645966|464481713|FG001|Vaccination Phase|Protocol Violation|0|||
129051893|NCT04645966|464481714|FG002|Vaccination Phase|Protocol Violation|0|||
129051894|NCT04645966|464481715|FG003|Vaccination Phase|Protocol Violation|0|||
129051895|NCT04645966|464481716|FG004|Vaccination Phase|Protocol Violation|1|||
129051896|NCT04645966|464481717|FG005|Vaccination Phase|Protocol Violation|0|||
129051897|NCT04645966|464481718|FG006|Vaccination Phase|Protocol Violation|0|||
129051898|NCT04645966|464481719|FG007|Vaccination Phase|Protocol Violation|0|||
129051899|NCT04645966|464481720|FG008|Vaccination Phase|Protocol Violation|0|||
129051900|NCT04645966|464481712|FG000|Vaccination Phase|Study terminated by sponsor|0|||
129051901|NCT04645966|464481713|FG001|Vaccination Phase|Study terminated by sponsor|0|||
129051902|NCT04645966|464481714|FG002|Vaccination Phase|Study terminated by sponsor|14|||
129051903|NCT04645966|464481715|FG003|Vaccination Phase|Study terminated by sponsor|15|||
129051904|NCT04645966|464481716|FG004|Vaccination Phase|Study terminated by sponsor|47|||
129051905|NCT04645966|464481717|FG005|Vaccination Phase|Study terminated by sponsor|43|||
129051906|NCT04645966|464481718|FG006|Vaccination Phase|Study terminated by sponsor|29|||
129051907|NCT04645966|464481719|FG007|Vaccination Phase|Study terminated by sponsor|29|||
129051908|NCT04645966|464481720|FG008|Vaccination Phase|Study terminated by sponsor|12|||
129051909|NCT04645966|464481712|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
129051910|NCT04645966|464481713|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
129051911|NCT04645966|464481714|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
129051912|NCT04645966|464481715|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
129051913|NCT04645966|464481716|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
129051914|NCT04645966|464481717|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
129051915|NCT04645966|464481718|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
129051916|NCT04645966|464481719|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
129051917|NCT04645966|464481720|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
129051918|NCT04645966|464481712|FG000|Vaccination Phase|Other|0|||
129051919|NCT04645966|464481713|FG001|Vaccination Phase|Other|0|||
129051920|NCT04645966|464481714|FG002|Vaccination Phase|Other|0|||
129051921|NCT04645966|464481715|FG003|Vaccination Phase|Other|0|||
129051922|NCT04645966|464481716|FG004|Vaccination Phase|Other|0|||
129051923|NCT04645966|464481717|FG005|Vaccination Phase|Other|2|||
129051924|NCT04645966|464481718|FG006|Vaccination Phase|Other|0|||
129051925|NCT04645966|464481719|FG007|Vaccination Phase|Other|0|||
129051926|NCT04645966|464481720|FG008|Vaccination Phase|Other|0|||
129051927|NCT04645966|464481712|FG000|Vaccination Phase|Lost to Follow-up|0|||
129051928|NCT04645966|464481713|FG001|Vaccination Phase|Lost to Follow-up|0|||
129051929|NCT04645966|464481714|FG002|Vaccination Phase|Lost to Follow-up|0|||
129051930|NCT04645966|464481715|FG003|Vaccination Phase|Lost to Follow-up|0|||
129051931|NCT04645966|464481716|FG004|Vaccination Phase|Lost to Follow-up|0|||
129051932|NCT04645966|464481717|FG005|Vaccination Phase|Lost to Follow-up|0|||
129051933|NCT04645966|464481718|FG006|Vaccination Phase|Lost to Follow-up|0|||
129051934|NCT04645966|464481719|FG007|Vaccination Phase|Lost to Follow-up|1|||
129051935|NCT04645966|464481720|FG008|Vaccination Phase|Lost to Follow-up|0|||
129051936|NCT04645966|464481712|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
129051937|NCT04645966|464481713|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
129051938|NCT04645966|464481714|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
129051939|NCT04645966|464481715|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
129051940|NCT04645966|464481716|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
129051941|NCT04645966|464481717|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
129051942|NCT04645966|464481718|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
129051943|NCT04645966|464481719|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
129051944|NCT04645966|464481720|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
129051945|NCT04645966|464481712|FG000|Follow-up Phase|Lost to Follow-up|0|||
129051946|NCT04645966|464481713|FG001|Follow-up Phase|Lost to Follow-up|0|||
129051947|NCT04645966|464481714|FG002|Follow-up Phase|Lost to Follow-up|0|||
129051948|NCT04645966|464481715|FG003|Follow-up Phase|Lost to Follow-up|0|||
129051949|NCT04645966|464481716|FG004|Follow-up Phase|Lost to Follow-up|0|||
129051950|NCT04645966|464481717|FG005|Follow-up Phase|Lost to Follow-up|0|||
129051951|NCT04645966|464481718|FG006|Follow-up Phase|Lost to Follow-up|0|||
129051952|NCT04645966|464481719|FG007|Follow-up Phase|Lost to Follow-up|1|||
129051953|NCT04645966|464481720|FG008|Follow-up Phase|Lost to Follow-up|0|||
129051954|NCT03825341|464481721|FG000|Overall Study|Withdrawal by Subject|0|||
129051955|NCT03825341|464481722|FG001|Overall Study|Withdrawal by Subject|1|||
129136576|NCT00286455|464793026|FG002|Overall Study|Lost to Follow-up|3|||
129051956|NCT00289536|464481724|FG000|Period 3|Lost to Follow-up|0|||
129051957|NCT00289536|464481725|FG001|Period 3|Lost to Follow-up|0|||
129051958|NCT00289536|464481726|FG002|Period 3|Lost to Follow-up|1|||
129136577|NCT00286455|464793024|FG000|Overall Study|Physician Decision|3|||
129136578|NCT00286455|464793025|FG001|Overall Study|Physician Decision|0|||
129136579|NCT00286455|464793026|FG002|Overall Study|Physician Decision|2|||
129051959|NCT04283500|464481727|FG000|Overall Study|Lost to Follow-up|8|||
129051960|NCT04283500|464481727|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
129051961|NCT02006693|464481730|FG000|Overall Study|No Reason Specified|6|||
129051962|NCT02006693|464481731|FG001|Overall Study|No Reason Specified|8|||
129136580|NCT00286455|464793024|FG000|Overall Study|Protocol Violation|1|||
128719665|NCT02967692|463273192|FG000|Overall Study|Protocol deviation|1|||
129051963|NCT02006693|464481730|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
129051964|NCT02006693|464481731|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
129051965|NCT02006693|464481730|FG000|Overall Study|XEN Implant Explantation|0|||
129051966|NCT02006693|464481731|FG001|Overall Study|XEN Implant Explantation|1|||
129051967|NCT02006693|464481730|FG000|Overall Study|Death|2|||
129051968|NCT02006693|464481731|FG001|Overall Study|Death|2|||
129051969|NCT02006693|464481730|FG000|Overall Study|Lost to Follow-up|4|||
129051970|NCT02006693|464481731|FG001|Overall Study|Lost to Follow-up|1|||
129051971|NCT02006693|464481730|FG000|Overall Study|Patient Decision|4|||
129051972|NCT02006693|464481731|FG001|Overall Study|Patient Decision|0|||
129136581|NCT00286455|464793025|FG001|Overall Study|Protocol Violation|1|||
129051973|NCT01119508|464481734|FG000|Overall Study|Adverse Event|56|||
129051974|NCT01119508|464481734|FG000|Overall Study|Withdrawal by Subject|2|||
129051975|NCT01119508|464481734|FG000|Overall Study|Died before tumor response evaluation|1|||
129051976|NCT00265395|464481735|FG000|Overall Study|Adverse Event|3|||
129051977|NCT00265395|464481736|FG001|Overall Study|Adverse Event|6|||
129051978|NCT00265395|464481735|FG000|Overall Study|Lost to Follow-up|2|||
129051979|NCT00265395|464481736|FG001|Overall Study|Lost to Follow-up|1|||
129051980|NCT00265395|464481735|FG000|Overall Study|Withdrawal by Subject|1|||
129051981|NCT00265395|464481736|FG001|Overall Study|Withdrawal by Subject|6|||
129051982|NCT00265395|464481735|FG000|Overall Study|Protocol Violation|2|||
129051983|NCT00265395|464481736|FG001|Overall Study|Protocol Violation|2|||
129051984|NCT00265395|464481735|FG000|Overall Study|Lack of Efficacy|0|||
129051985|NCT00265395|464481736|FG001|Overall Study|Lack of Efficacy|1|||
129051986|NCT00265395|464481735|FG000|Overall Study|Administrative|0|||
129051987|NCT00265395|464481736|FG001|Overall Study|Administrative|1|||
129051988|NCT04053465|464481742|FG000|Overall Study|Withdrawal by Subject|4|||
129051989|NCT04053465|464481743|FG001|Overall Study|Withdrawal by Subject|4|||
129051990|NCT00742924|464481744|FG000|Overall Study|Adverse Event|0|||
129051991|NCT00742924|464481745|FG001|Overall Study|Adverse Event|0|||
129051992|NCT00742924|464481746|FG002|Overall Study|Adverse Event|1|||
129051993|NCT00742924|464481747|FG003|Overall Study|Adverse Event|1|||
129051994|NCT00742924|464481744|FG000|Overall Study|Lack of Efficacy|5|||
129051995|NCT00742924|464481745|FG001|Overall Study|Lack of Efficacy|1|||
129051996|NCT00742924|464481746|FG002|Overall Study|Lack of Efficacy|2|||
129136582|NCT00286455|464793026|FG002|Overall Study|Protocol Violation|0|||
129136583|NCT00286455|464793024|FG000|Overall Study|Participant Non-compliance|1|||
129136584|NCT00286455|464793025|FG001|Overall Study|Participant Non-compliance|0|||
129136585|NCT00286455|464793026|FG002|Overall Study|Participant Non-compliance|0|||
129136586|NCT00286455|464793024|FG000|Overall Study|Withdrawal by Subject|0|||
129136587|NCT00286455|464793025|FG001|Overall Study|Withdrawal by Subject|8|||
129051997|NCT00742924|464481747|FG003|Overall Study|Lack of Efficacy|4|||
129051998|NCT00742924|464481744|FG000|Overall Study|Physician Decision|0|||
129051999|NCT00742924|464481745|FG001|Overall Study|Physician Decision|0|||
129052000|NCT00742924|464481746|FG002|Overall Study|Physician Decision|0|||
129052001|NCT00742924|464481747|FG003|Overall Study|Physician Decision|1|||
129052002|NCT00742924|464481744|FG000|Overall Study|Withdrawal by Subject|0|||
129052003|NCT00742924|464481745|FG001|Overall Study|Withdrawal by Subject|1|||
129052004|NCT00742924|464481746|FG002|Overall Study|Withdrawal by Subject|1|||
129052005|NCT00742924|464481747|FG003|Overall Study|Withdrawal by Subject|0|||
129052006|NCT00660400|464481748|FG000|Overall Study|Lack of insurance approval|1|||
129052007|NCT00660400|464481748|FG000|Overall Study|Suboptimal organ function|1|||
129052008|NCT00660400|464481748|FG000|Overall Study|Intracranial hemorrhage|1|||
129052009|NCT00660400|464481748|FG000|Overall Study|Withdrawal by Subject|1|||
129052010|NCT02643355|464481749|FG000|Overall Study|Withdrawal by Subject|1|||
129052011|NCT02643355|464481750|FG001|Overall Study|Withdrawal by Subject|3|||
129052012|NCT02643355|464481749|FG000|Overall Study|Protocol Violation|0|||
129052013|NCT02643355|464481750|FG001|Overall Study|Protocol Violation|2|||
129052014|NCT04524364|464481751|FG000|Overall Study|Physician Decision|3|||
129052015|NCT04524364|464481752|FG001|Overall Study|Physician Decision|6|||
129052016|NCT04524364|464481751|FG000|Overall Study|Adverse Event|0|||
129052017|NCT04524364|464481752|FG001|Overall Study|Adverse Event|1|||
129052018|NCT04524364|464481751|FG000|Overall Study|Investigational device deficiency|0|||
129052019|NCT04524364|464481752|FG001|Overall Study|Investigational device deficiency|1|||
129052020|NCT04524364|464481751|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
129052021|NCT04524364|464481752|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
129052022|NCT04524364|464481751|FG000|Overall Study|Device unavailability|0|||
129052023|NCT04524364|464481752|FG001|Overall Study|Device unavailability|2|||
129052024|NCT04524364|464481751|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
129052025|NCT04524364|464481752|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
129136588|NCT00286455|464793026|FG002|Overall Study|Withdrawal by Subject|7|||
129136589|NCT06097273|464793027|FG000|Overall Study|Death|2|||
129136590|NCT06097273|464793028|FG001|Overall Study|Death|1|||
129136591|NCT06097273|464793029|FG002|Overall Study|Death|2|||
129136592|NCT06097273|464793030|FG003|Overall Study|Death|2|||
129136593|NCT06097273|464793027|FG000|Overall Study|Lost to Follow-up|27|||
129136594|NCT06097273|464793028|FG001|Overall Study|Lost to Follow-up|18|||
129052026|NCT04524364|464481751|FG000|Overall Study|Low International normalized ratio (INR)|1|||
129052027|NCT04524364|464481752|FG001|Overall Study|Low International normalized ratio (INR)|0|||
129052028|NCT00826449|464481753|FG000|Overall Study|Disease Progression|4|||
129052029|NCT00826449|464481753|FG000|Overall Study|Withdrawal by Subject|1|||
129052030|NCT03233230|464481754|FG000|Overall Study|Adverse Event|6|||
129052031|NCT03233230|464481755|FG001|Overall Study|Adverse Event|3|||
129052032|NCT03233230|464481756|FG002|Overall Study|Adverse Event|6|||
129052033|NCT03233230|464481757|FG003|Overall Study|Adverse Event|3|||
129052034|NCT03233230|464481754|FG000|Overall Study|Protocol Violation|1|||
129052035|NCT03233230|464481755|FG001|Overall Study|Protocol Violation|2|||
129136595|NCT06097273|464793029|FG002|Overall Study|Lost to Follow-up|36|||
129052036|NCT03233230|464481756|FG002|Overall Study|Protocol Violation|1|||
129052037|NCT03233230|464481757|FG003|Overall Study|Protocol Violation|1|||
129052038|NCT03233230|464481754|FG000|Overall Study|Lack of Efficacy|1|||
129052039|NCT03233230|464481755|FG001|Overall Study|Lack of Efficacy|0|||
129052040|NCT03233230|464481756|FG002|Overall Study|Lack of Efficacy|0|||
129052041|NCT03233230|464481757|FG003|Overall Study|Lack of Efficacy|0|||
129052042|NCT03233230|464481754|FG000|Overall Study|Other|5|||
129052043|NCT03233230|464481755|FG001|Overall Study|Other|5|||
129052044|NCT03233230|464481756|FG002|Overall Study|Other|5|||
129052045|NCT03233230|464481757|FG003|Overall Study|Other|3|||
129052046|NCT03233230|464481754|FG000|Overall Study|Withdrawal by Subject|2|||
129052047|NCT03233230|464481755|FG001|Overall Study|Withdrawal by Subject|2|||
129052048|NCT03233230|464481756|FG002|Overall Study|Withdrawal by Subject|0|||
129052049|NCT03233230|464481757|FG003|Overall Study|Withdrawal by Subject|1|||
129052050|NCT03233230|464481754|FG000|Overall Study|Lost to Follow-up|0|||
129052051|NCT03233230|464481755|FG001|Overall Study|Lost to Follow-up|3|||
129052052|NCT03233230|464481756|FG002|Overall Study|Lost to Follow-up|0|||
129052053|NCT03233230|464481757|FG003|Overall Study|Lost to Follow-up|0|||
129052054|NCT02994940|464481758|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
129052055|NCT02994940|464481759|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
129052056|NCT02994940|464481758|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
129052057|NCT02994940|464481759|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
129052058|NCT02994940|464481758|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
129052059|NCT02994940|464481759|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
129052060|NCT02987959|464481760|FG000|Overall Study|Grantor stopped supply of drugs|6|||
129052061|NCT02853370|464481761|FG000|Overall Study|Physician Decision|1|||
129052062|NCT02853370|464481761|FG000|Overall Study|Lack of Efficacy|2|||
129052063|NCT02853370|464481761|FG000|Overall Study|Death|1|||
129052064|NCT02853370|464481761|FG000|Overall Study|Adverse Event|4|||
129052065|NCT02853370|464481761|FG000|Overall Study|Withdrawal by Subject|3|||
129052066|NCT01898650|464481767|FG000|Overall Study|the subject would not lie still for imaging|1|||
129052067|NCT04135196|464481768|FG000|Overall Study|Lost to Follow-up|8|||
129052068|NCT04135196|464481769|FG001|Overall Study|Lost to Follow-up|7|||
129052069|NCT04135196|464481770|FG002|Overall Study|Lost to Follow-up|8|||
129052070|NCT04135196|464481771|FG003|Overall Study|Lost to Follow-up|9|||
129052071|NCT04135196|464481772|FG004|Overall Study|Lost to Follow-up|1|||
129052072|NCT04135196|464481768|FG000|Overall Study|Pregnancy|0|||
129052073|NCT04135196|464481769|FG001|Overall Study|Pregnancy|0|||
129052074|NCT04135196|464481770|FG002|Overall Study|Pregnancy|1|||
129052075|NCT04135196|464481771|FG003|Overall Study|Pregnancy|0|||
129052076|NCT04135196|464481772|FG004|Overall Study|Pregnancy|0|||
129052077|NCT04135196|464481768|FG000|Overall Study|Withdrawal by Subject|0|||
129052078|NCT04135196|464481769|FG001|Overall Study|Withdrawal by Subject|0|||
129052079|NCT04135196|464481770|FG002|Overall Study|Withdrawal by Subject|0|||
129052080|NCT04135196|464481771|FG003|Overall Study|Withdrawal by Subject|0|||
129052081|NCT04135196|464481772|FG004|Overall Study|Withdrawal by Subject|1|||
129052082|NCT00911807|464481773|FG000|Overall Study|Adverse Event|2|||
129052083|NCT00911807|464481774|FG001|Overall Study|Adverse Event|1|||
129052084|NCT00911807|464481775|FG002|Overall Study|Adverse Event|5|||
129052085|NCT00911807|464481773|FG000|Overall Study|Death|0|||
129052086|NCT00911807|464481774|FG001|Overall Study|Death|0|||
129052087|NCT00911807|464481775|FG002|Overall Study|Death|1|||
129052088|NCT00911807|464481773|FG000|Overall Study|Protocol Violation|6|||
129052089|NCT00911807|464481774|FG001|Overall Study|Protocol Violation|4|||
129052090|NCT00911807|464481775|FG002|Overall Study|Protocol Violation|9|||
129052091|NCT00911807|464481773|FG000|Overall Study|Withdrawal by Subject|8|||
129052092|NCT00911807|464481774|FG001|Overall Study|Withdrawal by Subject|10|||
129052093|NCT00911807|464481775|FG002|Overall Study|Withdrawal by Subject|7|||
129052094|NCT00911807|464481773|FG000|Overall Study|Organizational reasons|1|||
129052095|NCT00911807|464481774|FG001|Overall Study|Organizational reasons|3|||
129052096|NCT00911807|464481775|FG002|Overall Study|Organizational reasons|1|||
129052097|NCT00809159|464481776|FG000|Part 1|Adverse Event|1|||
129052098|NCT00809159|464481777|FG001|Part 1|Adverse Event|1|||
129052099|NCT00809159|464481778|FG002|Part 1|Adverse Event|0|||
129052100|NCT00809159|464481779|FG003|Part 1|Adverse Event|0|||
129052101|NCT00809159|464481780|FG004|Part 1|Adverse Event|0|||
129052102|NCT00809159|464481781|FG005|Part 1|Adverse Event|0|||
129052103|NCT00809159|464481776|FG000|Part 1|Lost to Follow-up|1|||
129052104|NCT00809159|464481777|FG001|Part 1|Lost to Follow-up|0|||
129052105|NCT00809159|464481778|FG002|Part 1|Lost to Follow-up|0|||
129052106|NCT00809159|464481779|FG003|Part 1|Lost to Follow-up|0|||
129052107|NCT00809159|464481780|FG004|Part 1|Lost to Follow-up|0|||
129052108|NCT00809159|464481781|FG005|Part 1|Lost to Follow-up|0|||
129052109|NCT00809159|464481776|FG000|Part 1|Withdrawal by Subject|3|||
129052110|NCT00809159|464481777|FG001|Part 1|Withdrawal by Subject|1|||
129052111|NCT00809159|464481778|FG002|Part 1|Withdrawal by Subject|0|||
129052112|NCT00809159|464481779|FG003|Part 1|Withdrawal by Subject|0|||
129052113|NCT00809159|464481780|FG004|Part 1|Withdrawal by Subject|0|||
129052114|NCT00809159|464481781|FG005|Part 1|Withdrawal by Subject|0|||
129052115|NCT00809159|464481776|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
129052116|NCT00809159|464481777|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
129052117|NCT00809159|464481778|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
129052118|NCT00809159|464481779|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
129052119|NCT00809159|464481780|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
129052120|NCT00809159|464481781|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
129052121|NCT00809159|464481776|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
129052122|NCT00809159|464481777|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
129052123|NCT00809159|464481778|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
129052124|NCT00809159|464481779|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
129052125|NCT00809159|464481780|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
129052126|NCT00809159|464481781|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
129052127|NCT00809159|464481776|FG000|Part 1 and 2|Administrative problems|0|||
129052128|NCT00809159|464481777|FG001|Part 1 and 2|Administrative problems|0|||
129052129|NCT00809159|464481778|FG002|Part 1 and 2|Administrative problems|0|||
129052130|NCT00809159|464481779|FG003|Part 1 and 2|Administrative problems|1|||
129052131|NCT00809159|464481780|FG004|Part 1 and 2|Administrative problems|0|||
129052132|NCT00809159|464481781|FG005|Part 1 and 2|Administrative problems|0|||
129052133|NCT00809159|464481776|FG000|Part 1 and 2|Adverse Event|0|||
129052134|NCT00809159|464481777|FG001|Part 1 and 2|Adverse Event|0|||
129052135|NCT00809159|464481778|FG002|Part 1 and 2|Adverse Event|1|||
129052136|NCT00809159|464481779|FG003|Part 1 and 2|Adverse Event|0|||
129052137|NCT00809159|464481780|FG004|Part 1 and 2|Adverse Event|1|||
129052138|NCT00809159|464481781|FG005|Part 1 and 2|Adverse Event|1|||
129052139|NCT00809159|464481776|FG000|Part 1 and 2|Lost to Follow-up|0|||
129052140|NCT00809159|464481777|FG001|Part 1 and 2|Lost to Follow-up|0|||
129052141|NCT00809159|464481778|FG002|Part 1 and 2|Lost to Follow-up|1|||
129052142|NCT00809159|464481779|FG003|Part 1 and 2|Lost to Follow-up|1|||
129052143|NCT00809159|464481780|FG004|Part 1 and 2|Lost to Follow-up|0|||
129052144|NCT00809159|464481781|FG005|Part 1 and 2|Lost to Follow-up|0|||
129052145|NCT00809159|464481776|FG000|Part 1 and 2|Withdrawal by Subject|0|||
129052146|NCT00809159|464481777|FG001|Part 1 and 2|Withdrawal by Subject|0|||
129052147|NCT00809159|464481778|FG002|Part 1 and 2|Withdrawal by Subject|4|||
129052148|NCT00809159|464481779|FG003|Part 1 and 2|Withdrawal by Subject|0|||
129052149|NCT00809159|464481780|FG004|Part 1 and 2|Withdrawal by Subject|0|||
129052150|NCT00809159|464481781|FG005|Part 1 and 2|Withdrawal by Subject|1|||
129052151|NCT02991430|464481782|FG000|Treatment Period 1|Adverse Event|1|||
129052152|NCT02991430|464481783|FG001|Treatment Period 1|Adverse Event|0|||
129052153|NCT02991430|464481784|FG002|Treatment Period 1|Adverse Event|2|||
129052154|NCT02991430|464481782|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129052155|NCT02991430|464481783|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129052156|NCT02991430|464481784|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129052157|NCT02991430|464481782|FG000|Treatment Period 2|Study Termination|6|||
129052158|NCT02991430|464481783|FG001|Treatment Period 2|Study Termination|3|||
129052159|NCT02991430|464481784|FG002|Treatment Period 2|Study Termination|3|||
129052160|NCT02991430|464481782|FG000|Treatment Period 2|Lost to Follow-up|0|||
129052161|NCT02991430|464481783|FG001|Treatment Period 2|Lost to Follow-up|0|||
129052162|NCT02991430|464481784|FG002|Treatment Period 2|Lost to Follow-up|1|||
129052163|NCT02991430|464481782|FG000|Post-treatment Observation Period|Study Termination|3|||
129052164|NCT02991430|464481783|FG001|Post-treatment Observation Period|Study Termination|6|||
129052165|NCT02991430|464481784|FG002|Post-treatment Observation Period|Study Termination|5|||
129052166|NCT03970837|464481785|FG000|Overall Study|Adverse Event|23|||
129052167|NCT03970837|464481786|FG001|Overall Study|Adverse Event|20|||
129052168|NCT03970837|464481787|FG002|Overall Study|Adverse Event|16|||
129052169|NCT03970837|464481788|FG003|Overall Study|Adverse Event|6|||
129052170|NCT03970837|464481789|FG004|Overall Study|Adverse Event|4|||
129052171|NCT03970837|464481790|FG005|Overall Study|Adverse Event|5|||
129052172|NCT03970837|464481791|FG006|Overall Study|Adverse Event|1|||
129052173|NCT03970837|464481792|FG007|Overall Study|Adverse Event|5|||
129052174|NCT03970837|464481793|FG008|Overall Study|Adverse Event|0|||
129052175|NCT03970837|464481794|FG009|Overall Study|Adverse Event|0|||
129052176|NCT03970837|464481795|FG010|Overall Study|Adverse Event|1|||
129052177|NCT03970837|464481796|FG011|Overall Study|Adverse Event|1|||
128719666|NCT02967692|463273193|FG001|Overall Study|Protocol deviation|0|||
129052178|NCT03970837|464481785|FG000|Overall Study|Lack of Efficacy|14|||
129052179|NCT03970837|464481786|FG001|Overall Study|Lack of Efficacy|12|||
129052180|NCT03970837|464481787|FG002|Overall Study|Lack of Efficacy|1|||
129052181|NCT03970837|464481788|FG003|Overall Study|Lack of Efficacy|2|||
129052182|NCT03970837|464481789|FG004|Overall Study|Lack of Efficacy|3|||
129052183|NCT03970837|464481790|FG005|Overall Study|Lack of Efficacy|4|||
129052184|NCT03970837|464481791|FG006|Overall Study|Lack of Efficacy|6|||
129052185|NCT03970837|464481792|FG007|Overall Study|Lack of Efficacy|1|||
129052186|NCT03970837|464481793|FG008|Overall Study|Lack of Efficacy|1|||
129052187|NCT03970837|464481794|FG009|Overall Study|Lack of Efficacy|0|||
129052188|NCT03970837|464481795|FG010|Overall Study|Lack of Efficacy|0|||
129052189|NCT03970837|464481796|FG011|Overall Study|Lack of Efficacy|0|||
129052190|NCT03970837|464481785|FG000|Overall Study|Lost to Follow-up|6|||
129052191|NCT03970837|464481786|FG001|Overall Study|Lost to Follow-up|5|||
129052192|NCT03970837|464481787|FG002|Overall Study|Lost to Follow-up|5|||
129052193|NCT03970837|464481788|FG003|Overall Study|Lost to Follow-up|1|||
129052194|NCT03970837|464481789|FG004|Overall Study|Lost to Follow-up|0|||
129052195|NCT03970837|464481790|FG005|Overall Study|Lost to Follow-up|2|||
129052196|NCT03970837|464481791|FG006|Overall Study|Lost to Follow-up|0|||
129052197|NCT03970837|464481792|FG007|Overall Study|Lost to Follow-up|0|||
129052198|NCT03970837|464481793|FG008|Overall Study|Lost to Follow-up|0|||
129052199|NCT03970837|464481794|FG009|Overall Study|Lost to Follow-up|0|||
129052200|NCT03970837|464481795|FG010|Overall Study|Lost to Follow-up|0|||
129052201|NCT03970837|464481796|FG011|Overall Study|Lost to Follow-up|0|||
129052202|NCT03970837|464481785|FG000|Overall Study|Protocol Violation|1|||
129052203|NCT03970837|464481786|FG001|Overall Study|Protocol Violation|0|||
129052204|NCT03970837|464481787|FG002|Overall Study|Protocol Violation|0|||
129052205|NCT03970837|464481788|FG003|Overall Study|Protocol Violation|0|||
129052206|NCT03970837|464481789|FG004|Overall Study|Protocol Violation|0|||
129052207|NCT03970837|464481790|FG005|Overall Study|Protocol Violation|0|||
129052208|NCT03970837|464481791|FG006|Overall Study|Protocol Violation|0|||
129052209|NCT03970837|464481792|FG007|Overall Study|Protocol Violation|0|||
129052210|NCT03970837|464481793|FG008|Overall Study|Protocol Violation|0|||
129052211|NCT03970837|464481794|FG009|Overall Study|Protocol Violation|0|||
129052212|NCT03970837|464481795|FG010|Overall Study|Protocol Violation|0|||
129052213|NCT03970837|464481796|FG011|Overall Study|Protocol Violation|0|||
129052214|NCT03970837|464481785|FG000|Overall Study|Physician Decision|5|||
129052215|NCT03970837|464481786|FG001|Overall Study|Physician Decision|8|||
129052216|NCT03970837|464481787|FG002|Overall Study|Physician Decision|4|||
129052217|NCT03970837|464481788|FG003|Overall Study|Physician Decision|1|||
129052218|NCT03970837|464481789|FG004|Overall Study|Physician Decision|5|||
129052219|NCT03970837|464481790|FG005|Overall Study|Physician Decision|2|||
129052220|NCT03970837|464481791|FG006|Overall Study|Physician Decision|4|||
129052221|NCT03970837|464481792|FG007|Overall Study|Physician Decision|5|||
129052222|NCT03970837|464481793|FG008|Overall Study|Physician Decision|0|||
129052223|NCT03970837|464481794|FG009|Overall Study|Physician Decision|1|||
129052224|NCT03970837|464481795|FG010|Overall Study|Physician Decision|0|||
129052225|NCT03970837|464481796|FG011|Overall Study|Physician Decision|0|||
129052226|NCT03970837|464481785|FG000|Overall Study|Withdrawal by Subject|32|||
129052227|NCT03970837|464481786|FG001|Overall Study|Withdrawal by Subject|35|||
129052228|NCT03970837|464481787|FG002|Overall Study|Withdrawal by Subject|12|||
129052229|NCT03970837|464481788|FG003|Overall Study|Withdrawal by Subject|8|||
129052230|NCT03970837|464481789|FG004|Overall Study|Withdrawal by Subject|6|||
129052231|NCT03970837|464481790|FG005|Overall Study|Withdrawal by Subject|8|||
129052232|NCT03970837|464481791|FG006|Overall Study|Withdrawal by Subject|2|||
129052233|NCT03970837|464481792|FG007|Overall Study|Withdrawal by Subject|3|||
129052234|NCT03970837|464481793|FG008|Overall Study|Withdrawal by Subject|0|||
129052235|NCT03970837|464481794|FG009|Overall Study|Withdrawal by Subject|0|||
129052236|NCT03970837|464481795|FG010|Overall Study|Withdrawal by Subject|0|||
129052237|NCT03970837|464481796|FG011|Overall Study|Withdrawal by Subject|1|||
129052238|NCT03970837|464481785|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
129052239|NCT03970837|464481786|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
129052240|NCT03970837|464481787|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
129052241|NCT03970837|464481788|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129052242|NCT03970837|464481789|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
129052243|NCT03970837|464481790|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129052244|NCT03970837|464481791|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129052245|NCT03970837|464481792|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129052246|NCT03970837|464481793|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129052247|NCT03970837|464481794|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129052248|NCT03970837|464481795|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129052249|NCT03970837|464481796|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129052250|NCT03970837|464481785|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129052251|NCT03970837|464481786|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129052252|NCT03970837|464481787|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129136596|NCT06097273|464793030|FG003|Overall Study|Lost to Follow-up|31|||
129136597|NCT06097273|464793027|FG000|Overall Study|Physician Decision|0|||
129052253|NCT03970837|464481788|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129052254|NCT03970837|464481789|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129052255|NCT03970837|464481790|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129052256|NCT03970837|464481791|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
129052257|NCT03970837|464481792|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
129136598|NCT06097273|464793028|FG001|Overall Study|Physician Decision|1|||
129136599|NCT06097273|464793029|FG002|Overall Study|Physician Decision|0|||
129136600|NCT06097273|464793030|FG003|Overall Study|Physician Decision|3|||
129052258|NCT03970837|464481793|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
129052259|NCT03970837|464481794|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
129052260|NCT03970837|464481795|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
129052261|NCT03970837|464481796|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
129052262|NCT04430855|464481801|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
129052263|NCT04430855|464481802|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
129052264|NCT04430855|464481801|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
129052265|NCT04430855|464481802|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
129052266|NCT04430855|464481801|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
129052267|NCT04430855|464481802|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
129052268|NCT04430855|464481801|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
129052269|NCT04430855|464481802|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
129052270|NCT04430855|464481801|FG000|Period 1 (Weeks 1-12)|Other|0|||
129052271|NCT04430855|464481802|FG001|Period 1 (Weeks 1-12)|Other|1|||
129052272|NCT04430855|464481801|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
129052273|NCT04430855|464481802|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
129052274|NCT04430855|464481801|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
129052275|NCT04430855|464481802|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
129052276|NCT04430855|464481801|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
129052277|NCT04430855|464481802|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
129052278|NCT01425723|464481803|FG000|Overall Study|Lack of Efficacy|0|||
129052279|NCT01425723|464481804|FG001|Overall Study|Lack of Efficacy|1|||
129052280|NCT01425723|464481803|FG000|Overall Study|Withdrawal by Subject|1|||
129052281|NCT01425723|464481804|FG001|Overall Study|Withdrawal by Subject|4|||
129052282|NCT01425723|464481803|FG000|Overall Study|Lost to Follow-up|0|||
129052283|NCT01425723|464481804|FG001|Overall Study|Lost to Follow-up|3|||
129052284|NCT01425723|464481803|FG000|Overall Study|Physician Decision|2|||
129052285|NCT01425723|464481804|FG001|Overall Study|Physician Decision|0|||
129052286|NCT01425723|464481803|FG000|Overall Study|Other|1|||
129052287|NCT01425723|464481804|FG001|Overall Study|Other|10|||
129052288|NCT00186043|464481805|FG000|Overall Study|Lack of Efficacy|1|||
129052289|NCT00186043|464481806|FG001|Overall Study|Lack of Efficacy|3|||
129052290|NCT00186043|464481805|FG000|Overall Study|Lost to Follow-up|4|||
129052291|NCT00186043|464481806|FG001|Overall Study|Lost to Follow-up|6|||
129052292|NCT00186043|464481805|FG000|Overall Study|Withdrawal by Subject|1|||
129052293|NCT00186043|464481806|FG001|Overall Study|Withdrawal by Subject|0|||
129052294|NCT00186043|464481805|FG000|Overall Study|Adverse Event|7|||
129052295|NCT00186043|464481806|FG001|Overall Study|Adverse Event|3|||
129052296|NCT00186043|464481805|FG000|Overall Study|Protocol Violation|2|||
129052297|NCT00186043|464481806|FG001|Overall Study|Protocol Violation|1|||
129052298|NCT04874636|464481807|FG000|Overall Study|Adverse Event|17|||
129052299|NCT04874636|464481808|FG001|Overall Study|Adverse Event|7|||
129052300|NCT04874636|464481807|FG000|Overall Study|Lost to Follow-up|1|||
129052301|NCT04874636|464481808|FG001|Overall Study|Lost to Follow-up|0|||
129052302|NCT04874636|464481807|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129052303|NCT04874636|464481808|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129052304|NCT04874636|464481807|FG000|Overall Study|Physician Decision|1|||
129052305|NCT04874636|464481808|FG001|Overall Study|Physician Decision|0|||
129052306|NCT04874636|464481807|FG000|Overall Study|Withdrawal by Subject|6|||
129052307|NCT04874636|464481808|FG001|Overall Study|Withdrawal by Subject|5|||
129052308|NCT01770392|464481809|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
129052309|NCT04639713|464481810|FG000|Overall Study|Protocol Noncompliance|2|||
129052310|NCT04639713|464481810|FG000|Overall Study|Withdrawal by Subject|1|||
129052311|NCT00390221|464481813|FG000|Overall Study|Lost to Follow-up|0|||
129052312|NCT00390221|464481814|FG001|Overall Study|Lost to Follow-up|3|||
129052313|NCT00390221|464481815|FG002|Overall Study|Lost to Follow-up|0|||
129052314|NCT00390221|464481813|FG000|Overall Study|Adverse Event|1|||
129052315|NCT00390221|464481814|FG001|Overall Study|Adverse Event|4|||
129052316|NCT00390221|464481815|FG002|Overall Study|Adverse Event|3|||
129052317|NCT00390221|464481813|FG000|Overall Study|Investigator Decision|0|||
129052318|NCT00390221|464481814|FG001|Overall Study|Investigator Decision|0|||
129052319|NCT00390221|464481815|FG002|Overall Study|Investigator Decision|1|||
129052320|NCT00390221|464481813|FG000|Overall Study|Withdrawal by Subject|13|||
129052321|NCT00390221|464481814|FG001|Overall Study|Withdrawal by Subject|9|||
129052322|NCT00390221|464481815|FG002|Overall Study|Withdrawal by Subject|7|||
129052323|NCT00390221|464481813|FG000|Overall Study|Subject Non-compliance|1|||
129052324|NCT00390221|464481814|FG001|Overall Study|Subject Non-compliance|0|||
129052325|NCT00390221|464481815|FG002|Overall Study|Subject Non-compliance|2|||
129052326|NCT00390221|464481813|FG000|Overall Study|Other|3|||
128719667|NCT02967692|463273194|FG002|Overall Study|Protocol deviation|1|||
129052327|NCT00390221|464481814|FG001|Overall Study|Other|4|||
129052328|NCT00390221|464481815|FG002|Overall Study|Other|2|||
129052329|NCT02533375|464481816|FG000|Overall Study|Lack of Efficacy|3|||
129052330|NCT02533375|464481816|FG000|Overall Study|Adverse Event|2|||
129052331|NCT03870477|464481825|FG000|Overall Study|Early Study Termination|1|||
129052332|NCT03258853|464481826|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
129052333|NCT03258853|464481827|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
129052334|NCT04941729|464484353|FG000|Overall Study|Death|0|||
129052335|NCT04941729|464484354|FG001|Overall Study|Death|1|||
129052336|NCT04941729|464484353|FG000|Overall Study|Study terminated by sponsor|11|||
129052337|NCT04941729|464484354|FG001|Overall Study|Study terminated by sponsor|10|||
129052338|NCT03845296|464484364|FG000|Overall Study|On Treatment|2|||
129136601|NCT06097273|464793027|FG000|Overall Study|Protocol Violation|1|||
129136602|NCT06097273|464793028|FG001|Overall Study|Protocol Violation|1|||
129136603|NCT06097273|464793029|FG002|Overall Study|Protocol Violation|2|||
129136604|NCT06097273|464793030|FG003|Overall Study|Protocol Violation|1|||
129136605|NCT06097273|464793027|FG000|Overall Study|Withdrawal by Subject|14|||
129136606|NCT06097273|464793028|FG001|Overall Study|Withdrawal by Subject|11|||
129136607|NCT06097273|464793029|FG002|Overall Study|Withdrawal by Subject|14|||
129052339|NCT03845296|464484365|FG001|Overall Study|On Treatment|1|||
129052340|NCT03845296|464484364|FG000|Overall Study|Adverse Event|4|||
129052341|NCT03845296|464484365|FG001|Overall Study|Adverse Event|11|||
129052342|NCT03845296|464484364|FG000|Overall Study|Refusal unrelated to adverse event|0|||
129052343|NCT03845296|464484365|FG001|Overall Study|Refusal unrelated to adverse event|1|||
129052344|NCT03845296|464484364|FG000|Overall Study|Progression/relapse|14|||
129052345|NCT03845296|464484365|FG001|Overall Study|Progression/relapse|18|||
129052346|NCT03845296|464484364|FG000|Overall Study|Death|4|||
129052347|NCT03845296|464484365|FG001|Overall Study|Death|0|||
129052348|NCT03845296|464484364|FG000|Overall Study|Other - not protocol specified|1|||
129052349|NCT03845296|464484365|FG001|Overall Study|Other - not protocol specified|3|||
129052350|NCT03611543|464484366|FG000|Overall Study|Withdrawal by Subject|4|||
129052351|NCT03611543|464484367|FG001|Overall Study|Withdrawal by Subject|4|||
129052352|NCT03611543|464484366|FG000|Overall Study|Physician Decision|1|||
129052353|NCT03611543|464484367|FG001|Overall Study|Physician Decision|1|||
129052354|NCT03611543|464484366|FG000|Overall Study|Protocol Violation|2|||
129052355|NCT03611543|464484367|FG001|Overall Study|Protocol Violation|2|||
129052356|NCT03611543|464484366|FG000|Overall Study|Device failure|2|||
129052357|NCT03611543|464484367|FG001|Overall Study|Device failure|2|||
129052358|NCT03611543|464484366|FG000|Overall Study|Missing information|5|||
129052359|NCT03611543|464484367|FG001|Overall Study|Missing information|5|||
129052360|NCT02799095|464484368|FG000|Part A|Adverse Event|1|||
129052361|NCT02799095|464484369|FG001|Part A|Adverse Event|0|||
129052362|NCT02799095|464484370|FG002|Part A|Adverse Event|1|||
129052363|NCT02799095|464484371|FG003|Part A|Adverse Event|4|||
129052364|NCT02799095|464484372|FG004|Part A|Adverse Event|1|||
129052365|NCT02799095|464484373|FG005|Part A|Adverse Event|0|||
129052366|NCT02799095|464484374|FG006|Part A|Adverse Event|0|||
129052367|NCT02799095|464484375|FG007|Part A|Adverse Event|0|||
129052368|NCT02799095|464484376|FG008|Part A|Adverse Event|0|||
129052369|NCT02799095|464484377|FG009|Part A|Adverse Event|0|||
129052370|NCT02799095|464484378|FG010|Part A|Adverse Event|0|||
129052371|NCT02799095|464484379|FG011|Part A|Adverse Event|0|||
129052372|NCT02799095|464484380|FG012|Part A|Adverse Event|0|||
129052373|NCT02799095|464484381|FG013|Part A|Adverse Event|0|||
129052374|NCT02799095|464484382|FG014|Part A|Adverse Event|0|||
129052375|NCT02799095|464484383|FG015|Part A|Adverse Event|0|||
129052376|NCT02799095|464484384|FG016|Part A|Adverse Event|0|||
129052377|NCT02799095|464484368|FG000|Part A|Death|0|||
129052378|NCT02799095|464484369|FG001|Part A|Death|0|||
129052379|NCT02799095|464484370|FG002|Part A|Death|0|||
129052380|NCT02799095|464484371|FG003|Part A|Death|0|||
129052381|NCT02799095|464484372|FG004|Part A|Death|0|||
129052382|NCT02799095|464484373|FG005|Part A|Death|0|||
129052383|NCT02799095|464484374|FG006|Part A|Death|3|||
129052384|NCT02799095|464484375|FG007|Part A|Death|0|||
129052385|NCT02799095|464484376|FG008|Part A|Death|0|||
129052386|NCT02799095|464484377|FG009|Part A|Death|0|||
129052387|NCT02799095|464484378|FG010|Part A|Death|0|||
129052388|NCT02799095|464484379|FG011|Part A|Death|0|||
129052389|NCT02799095|464484380|FG012|Part A|Death|0|||
129052390|NCT02799095|464484381|FG013|Part A|Death|0|||
129052391|NCT02799095|464484382|FG014|Part A|Death|0|||
129052392|NCT02799095|464484383|FG015|Part A|Death|0|||
129052393|NCT02799095|464484384|FG016|Part A|Death|0|||
129052394|NCT02799095|464484368|FG000|Part A|Lost to Follow-up|0|||
129052395|NCT02799095|464484369|FG001|Part A|Lost to Follow-up|1|||
129052396|NCT02799095|464484370|FG002|Part A|Lost to Follow-up|0|||
129052397|NCT02799095|464484371|FG003|Part A|Lost to Follow-up|0|||
129052398|NCT02799095|464484372|FG004|Part A|Lost to Follow-up|0|||
128719668|NCT02967692|463273195|FG003|Overall Study|Protocol deviation|1|||
129052399|NCT02799095|464484373|FG005|Part A|Lost to Follow-up|0|||
129136608|NCT06097273|464793030|FG003|Overall Study|Withdrawal by Subject|15|||
129052400|NCT02799095|464484374|FG006|Part A|Lost to Follow-up|1|||
129052401|NCT02799095|464484375|FG007|Part A|Lost to Follow-up|0|||
129052402|NCT02799095|464484376|FG008|Part A|Lost to Follow-up|0|||
129052403|NCT02799095|464484377|FG009|Part A|Lost to Follow-up|0|||
129052404|NCT02799095|464484378|FG010|Part A|Lost to Follow-up|0|||
129052405|NCT02799095|464484379|FG011|Part A|Lost to Follow-up|0|||
129052406|NCT02799095|464484380|FG012|Part A|Lost to Follow-up|0|||
129052407|NCT02799095|464484381|FG013|Part A|Lost to Follow-up|0|||
129052408|NCT02799095|464484382|FG014|Part A|Lost to Follow-up|0|||
129052409|NCT02799095|464484383|FG015|Part A|Lost to Follow-up|0|||
129052410|NCT02799095|464484384|FG016|Part A|Lost to Follow-up|0|||
129052411|NCT02799095|464484368|FG000|Part A|Progressive Disease|3|||
129052412|NCT02799095|464484369|FG001|Part A|Progressive Disease|3|||
129052413|NCT02799095|464484370|FG002|Part A|Progressive Disease|3|||
129052414|NCT02799095|464484371|FG003|Part A|Progressive Disease|2|||
129052415|NCT02799095|464484372|FG004|Part A|Progressive Disease|2|||
129052416|NCT02799095|464484373|FG005|Part A|Progressive Disease|0|||
129052417|NCT02799095|464484374|FG006|Part A|Progressive Disease|0|||
129052418|NCT02799095|464484375|FG007|Part A|Progressive Disease|0|||
129052419|NCT02799095|464484376|FG008|Part A|Progressive Disease|0|||
129052420|NCT02799095|464484377|FG009|Part A|Progressive Disease|0|||
129052421|NCT02799095|464484378|FG010|Part A|Progressive Disease|0|||
129052422|NCT02799095|464484379|FG011|Part A|Progressive Disease|0|||
129052423|NCT02799095|464484380|FG012|Part A|Progressive Disease|0|||
129052424|NCT02799095|464484381|FG013|Part A|Progressive Disease|0|||
129052425|NCT02799095|464484382|FG014|Part A|Progressive Disease|0|||
129052426|NCT02799095|464484383|FG015|Part A|Progressive Disease|0|||
129052427|NCT02799095|464484384|FG016|Part A|Progressive Disease|0|||
129052428|NCT02799095|464484368|FG000|Part A|Clinical Progression|1|||
129052429|NCT02799095|464484369|FG001|Part A|Clinical Progression|0|||
129052430|NCT02799095|464484370|FG002|Part A|Clinical Progression|2|||
129052431|NCT02799095|464484371|FG003|Part A|Clinical Progression|1|||
129052432|NCT02799095|464484372|FG004|Part A|Clinical Progression|5|||
129052433|NCT02799095|464484373|FG005|Part A|Clinical Progression|0|||
129052434|NCT02799095|464484374|FG006|Part A|Clinical Progression|0|||
129052435|NCT02799095|464484375|FG007|Part A|Clinical Progression|0|||
129052436|NCT02799095|464484376|FG008|Part A|Clinical Progression|0|||
129052437|NCT02799095|464484377|FG009|Part A|Clinical Progression|0|||
129052438|NCT02799095|464484378|FG010|Part A|Clinical Progression|0|||
129052439|NCT02799095|464484379|FG011|Part A|Clinical Progression|0|||
129052440|NCT02799095|464484380|FG012|Part A|Clinical Progression|0|||
129052441|NCT02799095|464484381|FG013|Part A|Clinical Progression|0|||
129052442|NCT02799095|464484382|FG014|Part A|Clinical Progression|0|||
129052443|NCT02799095|464484383|FG015|Part A|Clinical Progression|0|||
129052444|NCT02799095|464484384|FG016|Part A|Clinical Progression|0|||
129052445|NCT02799095|464484368|FG000|Part A|Protocol Deviation|0|||
129052446|NCT02799095|464484369|FG001|Part A|Protocol Deviation|0|||
129052447|NCT02799095|464484370|FG002|Part A|Protocol Deviation|1|||
129052448|NCT02799095|464484371|FG003|Part A|Protocol Deviation|0|||
129052449|NCT02799095|464484372|FG004|Part A|Protocol Deviation|0|||
129052450|NCT02799095|464484373|FG005|Part A|Protocol Deviation|0|||
128775487|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
128775488|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
128775489|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
129052451|NCT02799095|464484374|FG006|Part A|Protocol Deviation|0|||
129052452|NCT02799095|464484375|FG007|Part A|Protocol Deviation|0|||
129052453|NCT02799095|464484376|FG008|Part A|Protocol Deviation|0|||
129052454|NCT02799095|464484377|FG009|Part A|Protocol Deviation|0|||
129052455|NCT02799095|464484378|FG010|Part A|Protocol Deviation|0|||
129052456|NCT02799095|464484379|FG011|Part A|Protocol Deviation|0|||
129052457|NCT02799095|464484380|FG012|Part A|Protocol Deviation|0|||
129052458|NCT02799095|464484381|FG013|Part A|Protocol Deviation|0|||
129052459|NCT02799095|464484382|FG014|Part A|Protocol Deviation|0|||
129052460|NCT02799095|464484383|FG015|Part A|Protocol Deviation|0|||
129052461|NCT02799095|464484384|FG016|Part A|Protocol Deviation|0|||
129052462|NCT02799095|464484368|FG000|Part A|Withdrawal by Subject|0|||
129052463|NCT02799095|464484369|FG001|Part A|Withdrawal by Subject|0|||
129052464|NCT02799095|464484370|FG002|Part A|Withdrawal by Subject|0|||
129052465|NCT02799095|464484371|FG003|Part A|Withdrawal by Subject|1|||
129052466|NCT02799095|464484372|FG004|Part A|Withdrawal by Subject|3|||
129052467|NCT02799095|464484373|FG005|Part A|Withdrawal by Subject|1|||
129052468|NCT02799095|464484374|FG006|Part A|Withdrawal by Subject|1|||
129052469|NCT02799095|464484375|FG007|Part A|Withdrawal by Subject|0|||
129052470|NCT02799095|464484376|FG008|Part A|Withdrawal by Subject|0|||
129052471|NCT02799095|464484377|FG009|Part A|Withdrawal by Subject|0|||
129052472|NCT02799095|464484378|FG010|Part A|Withdrawal by Subject|0|||
129052473|NCT02799095|464484379|FG011|Part A|Withdrawal by Subject|0|||
129052474|NCT02799095|464484380|FG012|Part A|Withdrawal by Subject|0|||
129052475|NCT02799095|464484381|FG013|Part A|Withdrawal by Subject|0|||
129052476|NCT02799095|464484382|FG014|Part A|Withdrawal by Subject|0|||
129052477|NCT02799095|464484383|FG015|Part A|Withdrawal by Subject|0|||
129052478|NCT02799095|464484384|FG016|Part A|Withdrawal by Subject|0|||
129052479|NCT02799095|464484368|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
129052480|NCT02799095|464484369|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
129052481|NCT02799095|464484370|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
129052482|NCT02799095|464484371|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
129052483|NCT02799095|464484372|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
129052484|NCT02799095|464484373|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
129052485|NCT02799095|464484374|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
129052486|NCT02799095|464484375|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
129052487|NCT02799095|464484376|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
129052488|NCT02799095|464484377|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
129052489|NCT02799095|464484378|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
129052490|NCT02799095|464484379|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
129052491|NCT02799095|464484380|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
129052492|NCT02799095|464484381|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
129052493|NCT02799095|464484382|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
129052494|NCT02799095|464484383|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
129052495|NCT02799095|464484384|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
129052496|NCT02799095|464484368|FG000|Part B|Death|0|||
129052497|NCT02799095|464484369|FG001|Part B|Death|0|||
129052498|NCT02799095|464484370|FG002|Part B|Death|0|||
129052499|NCT02799095|464484371|FG003|Part B|Death|0|||
129052500|NCT02799095|464484372|FG004|Part B|Death|0|||
129052501|NCT02799095|464484373|FG005|Part B|Death|0|||
129052502|NCT02799095|464484374|FG006|Part B|Death|0|||
129052503|NCT02799095|464484375|FG007|Part B|Death|7|||
129052504|NCT02799095|464484376|FG008|Part B|Death|7|||
129052505|NCT02799095|464484377|FG009|Part B|Death|0|||
129052506|NCT02799095|464484378|FG010|Part B|Death|0|||
129052507|NCT02799095|464484379|FG011|Part B|Death|0|||
129052508|NCT02799095|464484380|FG012|Part B|Death|0|||
129052509|NCT02799095|464484381|FG013|Part B|Death|0|||
129052510|NCT02799095|464484382|FG014|Part B|Death|0|||
129052511|NCT02799095|464484383|FG015|Part B|Death|0|||
129052512|NCT02799095|464484384|FG016|Part B|Death|0|||
129052513|NCT02799095|464484368|FG000|Part B|Progressive Disease|0|||
129052514|NCT02799095|464484369|FG001|Part B|Progressive Disease|0|||
129052515|NCT02799095|464484370|FG002|Part B|Progressive Disease|0|||
129052516|NCT02799095|464484371|FG003|Part B|Progressive Disease|0|||
129052517|NCT02799095|464484372|FG004|Part B|Progressive Disease|0|||
129052518|NCT02799095|464484373|FG005|Part B|Progressive Disease|0|||
129052519|NCT02799095|464484374|FG006|Part B|Progressive Disease|0|||
129052520|NCT02799095|464484375|FG007|Part B|Progressive Disease|1|||
129136609|NCT06097273|464793027|FG000|Overall Study|Other Than Specified|7|||
129136610|NCT06097273|464793028|FG001|Overall Study|Other Than Specified|3|||
129136611|NCT06097273|464793029|FG002|Overall Study|Other Than Specified|11|||
129136612|NCT06097273|464793030|FG003|Overall Study|Other Than Specified|6|||
129136613|NCT03882801|464794440|FG000|Period 1|Adverse Event|0|||
129136614|NCT03882801|464794441|FG001|Period 1|Adverse Event|1|||
129136615|NCT03882801|464794440|FG000|Period 1|Non-compliance with study drug|1|||
129136616|NCT03882801|464794441|FG001|Period 1|Non-compliance with study drug|1|||
129136617|NCT03882801|464794440|FG000|Period 1|Never treated with study drug|1|||
129136618|NCT03882801|464794441|FG001|Period 1|Never treated with study drug|0|||
129136619|NCT03882801|464794440|FG000|Washout Period|Physician Decision|0|||
129136620|NCT03882801|464794441|FG001|Washout Period|Physician Decision|1|||
129136621|NCT03882801|464794440|FG000|Period 2|Non-compliance with study drug|0|||
129136622|NCT03882801|464794441|FG001|Period 2|Non-compliance with study drug|1|||
129136623|NCT00394472|464794446|FG000|Overall Study|Protocol Violation|1|||
129136624|NCT00394472|464794447|FG001|Overall Study|Protocol Violation|3|||
129136625|NCT00394472|464794446|FG000|Overall Study|incorrect enrolment|4|||
129136626|NCT00394472|464794447|FG001|Overall Study|incorrect enrolment|2|||
129136627|NCT00394472|464794446|FG000|Overall Study|Adverse Event|4|||
129136628|NCT00394472|464794447|FG001|Overall Study|Adverse Event|2|||
129136629|NCT00394472|464794446|FG000|Overall Study|Withdrawal by Subject|0|||
129136630|NCT00394472|464794447|FG001|Overall Study|Withdrawal by Subject|2|||
129136631|NCT00394472|464794446|FG000|Overall Study|Physician Decision|0|||
129136632|NCT00394472|464794447|FG001|Overall Study|Physician Decision|1|||
129136633|NCT00394472|464794446|FG000|Overall Study|Lost to Follow-up|0|||
129136634|NCT00394472|464794447|FG001|Overall Study|Lost to Follow-up|1|||
129136635|NCT03931785|464794449|FG000|Overall Study|Lost to Follow-up|4|||
129136636|NCT03931785|464794450|FG001|Overall Study|Lost to Follow-up|1|||
129136637|NCT03931785|464794451|FG002|Overall Study|Lost to Follow-up|4|||
129136638|NCT03931785|464794452|FG003|Overall Study|Lost to Follow-up|3|||
129136639|NCT03931785|464794449|FG000|Overall Study|Adverse Event|1|||
129136640|NCT03931785|464794450|FG001|Overall Study|Adverse Event|0|||
129136641|NCT03931785|464794451|FG002|Overall Study|Adverse Event|3|||
129136642|NCT03931785|464794452|FG003|Overall Study|Adverse Event|4|||
129136643|NCT03931785|464794449|FG000|Overall Study|Protocol Violation|0|||
129136644|NCT03931785|464794450|FG001|Overall Study|Protocol Violation|1|||
129136645|NCT03931785|464794451|FG002|Overall Study|Protocol Violation|0|||
129136646|NCT03931785|464794452|FG003|Overall Study|Protocol Violation|0|||
129136647|NCT03931785|464794449|FG000|Overall Study|Noncompliance With Study drug|0|||
129136648|NCT03931785|464794450|FG001|Overall Study|Noncompliance With Study drug|1|||
129136649|NCT03931785|464794451|FG002|Overall Study|Noncompliance With Study drug|0|||
129136650|NCT03931785|464794452|FG003|Overall Study|Noncompliance With Study drug|0|||
129136651|NCT03931785|464794449|FG000|Overall Study|Other Not specified|0|||
129136652|NCT03931785|464794450|FG001|Overall Study|Other Not specified|2|||
129136653|NCT03931785|464794451|FG002|Overall Study|Other Not specified|2|||
129136654|NCT03931785|464794452|FG003|Overall Study|Other Not specified|2|||
129136655|NCT03931785|464794449|FG000|Overall Study|Withdrawal by Subject|0|||
129136656|NCT03931785|464794450|FG001|Overall Study|Withdrawal by Subject|2|||
129136657|NCT03931785|464794451|FG002|Overall Study|Withdrawal by Subject|4|||
129136658|NCT03931785|464794452|FG003|Overall Study|Withdrawal by Subject|1|||
129052521|NCT02799095|464484376|FG008|Part B|Progressive Disease|0|||
129052522|NCT02799095|464484377|FG009|Part B|Progressive Disease|0|||
129052523|NCT02799095|464484378|FG010|Part B|Progressive Disease|0|||
129052524|NCT02799095|464484379|FG011|Part B|Progressive Disease|0|||
129052525|NCT02799095|464484380|FG012|Part B|Progressive Disease|0|||
129052526|NCT02799095|464484381|FG013|Part B|Progressive Disease|0|||
129052527|NCT02799095|464484382|FG014|Part B|Progressive Disease|0|||
129052528|NCT02799095|464484383|FG015|Part B|Progressive Disease|0|||
129052529|NCT02799095|464484384|FG016|Part B|Progressive Disease|0|||
129052530|NCT02799095|464484368|FG000|Part B|Withdrawal by Subject|0|||
129052531|NCT02799095|464484369|FG001|Part B|Withdrawal by Subject|0|||
129052532|NCT02799095|464484370|FG002|Part B|Withdrawal by Subject|0|||
129052533|NCT02799095|464484371|FG003|Part B|Withdrawal by Subject|0|||
129052534|NCT02799095|464484372|FG004|Part B|Withdrawal by Subject|0|||
129052535|NCT02799095|464484373|FG005|Part B|Withdrawal by Subject|0|||
129052536|NCT02799095|464484374|FG006|Part B|Withdrawal by Subject|0|||
129052537|NCT02799095|464484375|FG007|Part B|Withdrawal by Subject|10|||
129052538|NCT02799095|464484376|FG008|Part B|Withdrawal by Subject|7|||
129052539|NCT02799095|464484377|FG009|Part B|Withdrawal by Subject|0|||
129052540|NCT02799095|464484378|FG010|Part B|Withdrawal by Subject|0|||
129052541|NCT02799095|464484379|FG011|Part B|Withdrawal by Subject|0|||
129052542|NCT02799095|464484380|FG012|Part B|Withdrawal by Subject|0|||
129052543|NCT02799095|464484381|FG013|Part B|Withdrawal by Subject|0|||
129052544|NCT02799095|464484382|FG014|Part B|Withdrawal by Subject|0|||
129052545|NCT02799095|464484383|FG015|Part B|Withdrawal by Subject|0|||
129052546|NCT02799095|464484384|FG016|Part B|Withdrawal by Subject|0|||
129052547|NCT02799095|464484368|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
129052548|NCT02799095|464484369|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
129052549|NCT02799095|464484370|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
129052550|NCT02799095|464484371|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
129052551|NCT02799095|464484372|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
129052552|NCT02799095|464484373|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
129052553|NCT02799095|464484374|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
129052554|NCT02799095|464484375|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
129052555|NCT02799095|464484376|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
129052556|NCT02799095|464484377|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
129052557|NCT02799095|464484378|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
129052558|NCT02799095|464484379|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
129052559|NCT02799095|464484380|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
129052560|NCT02799095|464484381|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
129052561|NCT02799095|464484382|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
129052562|NCT02799095|464484383|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
129052563|NCT02799095|464484384|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
129052564|NCT02799095|464484368|FG000|Part C|Adverse Event|0|||
129052565|NCT02799095|464484369|FG001|Part C|Adverse Event|0|||
129052566|NCT02799095|464484370|FG002|Part C|Adverse Event|0|||
129052567|NCT02799095|464484371|FG003|Part C|Adverse Event|0|||
129136659|NCT03931785|464794449|FG000|Overall Study|Pregnancy|0|||
129136660|NCT03931785|464794450|FG001|Overall Study|Pregnancy|0|||
129136661|NCT03931785|464794451|FG002|Overall Study|Pregnancy|0|||
129136662|NCT03931785|464794452|FG003|Overall Study|Pregnancy|1|||
129136663|NCT04605588|464794455|FG000|Overall Study|Withdrawal by Subject|1|||
129136664|NCT04605588|464794456|FG001|Overall Study|Withdrawal by Subject|0|||
129136665|NCT01230814|464794457|FG000|Overall Study|Lost to Follow-up|11|||
129136666|NCT01230814|464794458|FG001|Overall Study|Lost to Follow-up|3|||
129136667|NCT01230814|464794457|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
129136668|NCT01230814|464794458|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
129136669|NCT01748552|464794463|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
129136670|NCT01748552|464794464|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
129136671|NCT01748552|464794465|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
129136672|NCT01748552|464794466|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
129136673|NCT01748552|464794467|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
129136674|NCT01748552|464794468|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
129136675|NCT01748552|464794469|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
129136676|NCT01748552|464794470|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
129136677|NCT01748552|464794471|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
129136678|NCT01748552|464794472|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
129136679|NCT01748552|464794473|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
129136680|NCT01748552|464794474|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
129052568|NCT02799095|464484372|FG004|Part C|Adverse Event|0|||
129052569|NCT02799095|464484373|FG005|Part C|Adverse Event|0|||
129052570|NCT02799095|464484374|FG006|Part C|Adverse Event|0|||
129052571|NCT02799095|464484375|FG007|Part C|Adverse Event|0|||
129052572|NCT02799095|464484376|FG008|Part C|Adverse Event|0|||
129052573|NCT02799095|464484377|FG009|Part C|Adverse Event|0|||
129052574|NCT02799095|464484378|FG010|Part C|Adverse Event|3|||
129052575|NCT02799095|464484379|FG011|Part C|Adverse Event|1|||
129052576|NCT02799095|464484380|FG012|Part C|Adverse Event|0|||
129052577|NCT02799095|464484381|FG013|Part C|Adverse Event|1|||
129052578|NCT02799095|464484382|FG014|Part C|Adverse Event|0|||
129052579|NCT02799095|464484383|FG015|Part C|Adverse Event|0|||
129052580|NCT02799095|464484384|FG016|Part C|Adverse Event|0|||
129052581|NCT02799095|464484368|FG000|Part C|Death|0|||
128719669|NCT02967692|463273192|FG000|Overall Study|Lost to Follow-up|0|||
129052582|NCT02799095|464484369|FG001|Part C|Death|0|||
129052583|NCT02799095|464484370|FG002|Part C|Death|0|||
129052584|NCT02799095|464484371|FG003|Part C|Death|0|||
129052585|NCT02799095|464484372|FG004|Part C|Death|0|||
129052586|NCT02799095|464484373|FG005|Part C|Death|0|||
129052587|NCT02799095|464484374|FG006|Part C|Death|0|||
129052588|NCT02799095|464484375|FG007|Part C|Death|0|||
129052589|NCT02799095|464484376|FG008|Part C|Death|0|||
129052590|NCT02799095|464484377|FG009|Part C|Death|0|||
129052591|NCT02799095|464484378|FG010|Part C|Death|7|||
129052592|NCT02799095|464484379|FG011|Part C|Death|5|||
129052593|NCT02799095|464484380|FG012|Part C|Death|6|||
129052594|NCT02799095|464484381|FG013|Part C|Death|8|||
129052595|NCT02799095|464484382|FG014|Part C|Death|1|||
129052596|NCT02799095|464484383|FG015|Part C|Death|8|||
129052597|NCT02799095|464484384|FG016|Part C|Death|1|||
129052598|NCT02799095|464484368|FG000|Part C|Lost to Follow-up|0|||
129052599|NCT02799095|464484369|FG001|Part C|Lost to Follow-up|0|||
129052600|NCT02799095|464484370|FG002|Part C|Lost to Follow-up|0|||
129052601|NCT02799095|464484371|FG003|Part C|Lost to Follow-up|0|||
129052602|NCT02799095|464484372|FG004|Part C|Lost to Follow-up|0|||
129052603|NCT02799095|464484373|FG005|Part C|Lost to Follow-up|0|||
129052604|NCT02799095|464484374|FG006|Part C|Lost to Follow-up|0|||
129052605|NCT02799095|464484375|FG007|Part C|Lost to Follow-up|0|||
129052606|NCT02799095|464484376|FG008|Part C|Lost to Follow-up|0|||
129052607|NCT02799095|464484377|FG009|Part C|Lost to Follow-up|0|||
129052608|NCT02799095|464484378|FG010|Part C|Lost to Follow-up|1|||
129052609|NCT02799095|464484379|FG011|Part C|Lost to Follow-up|1|||
129052610|NCT02799095|464484380|FG012|Part C|Lost to Follow-up|1|||
129052611|NCT02799095|464484381|FG013|Part C|Lost to Follow-up|3|||
129052612|NCT02799095|464484382|FG014|Part C|Lost to Follow-up|0|||
129052613|NCT02799095|464484383|FG015|Part C|Lost to Follow-up|0|||
129052614|NCT02799095|464484384|FG016|Part C|Lost to Follow-up|0|||
129052615|NCT02799095|464484368|FG000|Part C|Progressive Disease|0|||
129052616|NCT02799095|464484369|FG001|Part C|Progressive Disease|0|||
129052617|NCT02799095|464484370|FG002|Part C|Progressive Disease|0|||
129052618|NCT02799095|464484371|FG003|Part C|Progressive Disease|0|||
129052619|NCT02799095|464484372|FG004|Part C|Progressive Disease|0|||
129052620|NCT02799095|464484373|FG005|Part C|Progressive Disease|0|||
129052621|NCT02799095|464484374|FG006|Part C|Progressive Disease|0|||
129052622|NCT02799095|464484375|FG007|Part C|Progressive Disease|0|||
129052623|NCT02799095|464484376|FG008|Part C|Progressive Disease|0|||
129052624|NCT02799095|464484377|FG009|Part C|Progressive Disease|2|||
129052625|NCT02799095|464484378|FG010|Part C|Progressive Disease|13|||
129052626|NCT02799095|464484379|FG011|Part C|Progressive Disease|2|||
129052627|NCT02799095|464484380|FG012|Part C|Progressive Disease|0|||
129052628|NCT02799095|464484381|FG013|Part C|Progressive Disease|1|||
129052629|NCT02799095|464484382|FG014|Part C|Progressive Disease|0|||
129052630|NCT02799095|464484383|FG015|Part C|Progressive Disease|0|||
129052631|NCT02799095|464484384|FG016|Part C|Progressive Disease|0|||
129052632|NCT02799095|464484368|FG000|Part C|Clinical Progression|0|||
129052633|NCT02799095|464484369|FG001|Part C|Clinical Progression|0|||
129052634|NCT02799095|464484370|FG002|Part C|Clinical Progression|0|||
129052635|NCT02799095|464484371|FG003|Part C|Clinical Progression|0|||
129052636|NCT02799095|464484372|FG004|Part C|Clinical Progression|0|||
129052637|NCT02799095|464484373|FG005|Part C|Clinical Progression|0|||
129052638|NCT02799095|464484374|FG006|Part C|Clinical Progression|0|||
129052639|NCT02799095|464484375|FG007|Part C|Clinical Progression|0|||
129052640|NCT02799095|464484376|FG008|Part C|Clinical Progression|0|||
129052641|NCT02799095|464484377|FG009|Part C|Clinical Progression|1|||
129136681|NCT01748552|464794463|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129052642|NCT02799095|464484378|FG010|Part C|Clinical Progression|3|||
129052643|NCT02799095|464484379|FG011|Part C|Clinical Progression|0|||
129052644|NCT02799095|464484380|FG012|Part C|Clinical Progression|0|||
129052645|NCT02799095|464484381|FG013|Part C|Clinical Progression|1|||
129052646|NCT02799095|464484382|FG014|Part C|Clinical Progression|0|||
129052647|NCT02799095|464484383|FG015|Part C|Clinical Progression|0|||
129052648|NCT02799095|464484384|FG016|Part C|Clinical Progression|0|||
129052649|NCT02799095|464484368|FG000|Part C|Withdrawal by Subject|0|||
129052650|NCT02799095|464484369|FG001|Part C|Withdrawal by Subject|0|||
129052651|NCT02799095|464484370|FG002|Part C|Withdrawal by Subject|0|||
129052652|NCT02799095|464484371|FG003|Part C|Withdrawal by Subject|0|||
129052653|NCT02799095|464484372|FG004|Part C|Withdrawal by Subject|0|||
129052654|NCT02799095|464484373|FG005|Part C|Withdrawal by Subject|0|||
129052655|NCT02799095|464484374|FG006|Part C|Withdrawal by Subject|0|||
129052656|NCT02799095|464484375|FG007|Part C|Withdrawal by Subject|0|||
129052657|NCT02799095|464484376|FG008|Part C|Withdrawal by Subject|0|||
129052658|NCT02799095|464484377|FG009|Part C|Withdrawal by Subject|0|||
129052659|NCT02799095|464484378|FG010|Part C|Withdrawal by Subject|13|||
129052660|NCT02799095|464484379|FG011|Part C|Withdrawal by Subject|15|||
129052661|NCT02799095|464484380|FG012|Part C|Withdrawal by Subject|13|||
129052662|NCT02799095|464484381|FG013|Part C|Withdrawal by Subject|21|||
129052663|NCT02799095|464484382|FG014|Part C|Withdrawal by Subject|0|||
128719670|NCT02967692|463273193|FG001|Overall Study|Lost to Follow-up|0|||
128719671|NCT02967692|463273194|FG002|Overall Study|Lost to Follow-up|1|||
128719672|NCT02967692|463273195|FG003|Overall Study|Lost to Follow-up|0|||
128719673|NCT02967692|463273192|FG000|Overall Study|Physician Decision|0|||
128719674|NCT02967692|463273193|FG001|Overall Study|Physician Decision|0|||
128719675|NCT02967692|463273194|FG002|Overall Study|Physician Decision|22|||
128719676|NCT02967692|463273195|FG003|Overall Study|Physician Decision|13|||
128719677|NCT02967692|463273192|FG000|Overall Study|Adverse Event|2|||
128719678|NCT02967692|463273193|FG001|Overall Study|Adverse Event|9|||
128775490|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
128775491|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
128775492|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
128775493|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
129052664|NCT02799095|464484383|FG015|Part C|Withdrawal by Subject|12|||
129052665|NCT02799095|464484384|FG016|Part C|Withdrawal by Subject|1|||
129052666|NCT02799095|464484368|FG000|Part C|Physician Decision|0|||
129052667|NCT02799095|464484369|FG001|Part C|Physician Decision|0|||
129052668|NCT02799095|464484370|FG002|Part C|Physician Decision|0|||
129052669|NCT02799095|464484371|FG003|Part C|Physician Decision|0|||
129052670|NCT02799095|464484372|FG004|Part C|Physician Decision|0|||
129052671|NCT02799095|464484373|FG005|Part C|Physician Decision|0|||
129052672|NCT02799095|464484374|FG006|Part C|Physician Decision|0|||
129052673|NCT02799095|464484375|FG007|Part C|Physician Decision|0|||
129052674|NCT02799095|464484376|FG008|Part C|Physician Decision|0|||
129052675|NCT02799095|464484377|FG009|Part C|Physician Decision|0|||
129052676|NCT02799095|464484378|FG010|Part C|Physician Decision|1|||
129052677|NCT02799095|464484379|FG011|Part C|Physician Decision|0|||
128775494|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
129052678|NCT02799095|464484380|FG012|Part C|Physician Decision|0|||
129052679|NCT02799095|464484381|FG013|Part C|Physician Decision|0|||
129052680|NCT02799095|464484382|FG014|Part C|Physician Decision|0|||
129052681|NCT02799095|464484383|FG015|Part C|Physician Decision|0|||
129052682|NCT02799095|464484384|FG016|Part C|Physician Decision|0|||
129052683|NCT02799095|464484368|FG000|Part C|Other|0|||
129052684|NCT02799095|464484369|FG001|Part C|Other|0|||
129052685|NCT02799095|464484370|FG002|Part C|Other|0|||
129052686|NCT02799095|464484371|FG003|Part C|Other|0|||
129052687|NCT02799095|464484372|FG004|Part C|Other|0|||
129052688|NCT02799095|464484373|FG005|Part C|Other|0|||
129052689|NCT02799095|464484374|FG006|Part C|Other|0|||
129052690|NCT02799095|464484375|FG007|Part C|Other|0|||
129052691|NCT02799095|464484376|FG008|Part C|Other|0|||
129052692|NCT02799095|464484377|FG009|Part C|Other|0|||
129052693|NCT02799095|464484378|FG010|Part C|Other|0|||
129052694|NCT02799095|464484379|FG011|Part C|Other|2|||
129052695|NCT02799095|464484380|FG012|Part C|Other|2|||
129052696|NCT02799095|464484381|FG013|Part C|Other|0|||
129052697|NCT02799095|464484382|FG014|Part C|Other|0|||
129052698|NCT02799095|464484383|FG015|Part C|Other|0|||
129052699|NCT02799095|464484384|FG016|Part C|Other|0|||
129052700|NCT00191113|464484385|FG000|Core Study|Withdrawal by Subject|25|||
129052701|NCT00191113|464484386|FG001|Core Study|Withdrawal by Subject|9|||
129052702|NCT00191113|464484385|FG000|Core Study|Protocol Violation|6|||
129052703|NCT00191113|464484386|FG001|Core Study|Protocol Violation|2|||
129052704|NCT00191113|464484385|FG000|Core Study|Lost to Follow-up|3|||
129052705|NCT00191113|464484386|FG001|Core Study|Lost to Follow-up|0|||
129052706|NCT00191113|464484385|FG000|Core Study|Adverse Event|0|||
129052707|NCT00191113|464484386|FG001|Core Study|Adverse Event|2|||
129052708|NCT00191113|464484385|FG000|Core Study|Lack of Efficacy|0|||
129052709|NCT00191113|464484386|FG001|Core Study|Lack of Efficacy|2|||
129052710|NCT00191113|464484385|FG000|Core Study|Death|1|||
129052711|NCT00191113|464484386|FG001|Core Study|Death|0|||
129052712|NCT00368979|464484391|FG000|Overall Study|Adverse Event|9|||
129052713|NCT00368979|464484392|FG001|Overall Study|Adverse Event|16|||
129052714|NCT00368979|464484391|FG000|Overall Study|Lack of Efficacy|5|||
129052715|NCT00368979|464484392|FG001|Overall Study|Lack of Efficacy|3|||
129052716|NCT00368979|464484391|FG000|Overall Study|Other|3|||
129052717|NCT00368979|464484392|FG001|Overall Study|Other|1|||
129052718|NCT00368979|464484391|FG000|Overall Study|Lost to Follow-up|1|||
129052719|NCT00368979|464484392|FG001|Overall Study|Lost to Follow-up|0|||
129052720|NCT00368979|464484391|FG000|Overall Study|Protocol Violation|2|||
128719679|NCT02967692|463273194|FG002|Overall Study|Adverse Event|60|||
128719680|NCT02967692|463273195|FG003|Overall Study|Adverse Event|28|||
128719681|NCT02967692|463273192|FG000|Overall Study|Study terminated by sponsor|2|||
129052721|NCT00368979|464484392|FG001|Overall Study|Protocol Violation|1|||
129052722|NCT00368979|464484391|FG000|Overall Study|Withdrawal by Subject|5|||
129052723|NCT00368979|464484392|FG001|Overall Study|Withdrawal by Subject|9|||
129052724|NCT00631657|464484395|FG000|6-Month Treatment Period|Adverse Event|47|||
129052725|NCT00631657|464484396|FG001|6-Month Treatment Period|Adverse Event|0|||
129052726|NCT00631657|464484397|FG002|6-Month Treatment Period|Adverse Event|7|||
129052727|NCT00631657|464484395|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
129052728|NCT00631657|464484396|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
129052729|NCT00631657|464484397|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
129052730|NCT00631657|464484395|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
129052731|NCT00631657|464484396|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
129052732|NCT00631657|464484397|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
129052733|NCT00631657|464484395|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
129052734|NCT00631657|464484396|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
129052735|NCT00631657|464484397|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
129052736|NCT00631657|464484395|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
129052737|NCT00631657|464484396|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
129052738|NCT00631657|464484397|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
129052739|NCT00631657|464484395|FG000|6-Month Treatment Period|Other|16|||
129052740|NCT00631657|464484396|FG001|6-Month Treatment Period|Other|0|||
129052741|NCT00631657|464484397|FG002|6-Month Treatment Period|Other|4|||
129052742|NCT00631657|464484395|FG000|6-Month Treatment Period|Not Treated|2|||
129052743|NCT00631657|464484396|FG001|6-Month Treatment Period|Not Treated|0|||
129052744|NCT00631657|464484397|FG002|6-Month Treatment Period|Not Treated|1|||
129052745|NCT00631657|464484395|FG000|7-Day Discontinuation Period|Not Treated|1|||
129052746|NCT00631657|464484396|FG001|7-Day Discontinuation Period|Not Treated|1|||
129052747|NCT00631657|464484397|FG002|7-Day Discontinuation Period|Not Treated|1|||
129052748|NCT00631657|464484395|FG000|7-Day Discontinuation Period|Other|1|||
129052749|NCT00631657|464484396|FG001|7-Day Discontinuation Period|Other|0|||
129052750|NCT00631657|464484397|FG002|7-Day Discontinuation Period|Other|0|||
129052751|NCT00325195|464484398|FG000|Randomized|Not dosed|5|||
129052752|NCT00325195|464484399|FG001|Randomized|Not dosed|5|||
129052753|NCT00325195|464484400|FG002|Randomized|Not dosed|3|||
129052754|NCT00325195|464484398|FG000|Received Intervention: ITT Population|Adverse Event|15|||
129052755|NCT00325195|464484399|FG001|Received Intervention: ITT Population|Adverse Event|17|||
129052756|NCT00325195|464484400|FG002|Received Intervention: ITT Population|Adverse Event|1|||
129052757|NCT00325195|464484398|FG000|Received Intervention: ITT Population|Death|3|||
129052758|NCT00325195|464484399|FG001|Received Intervention: ITT Population|Death|1|||
129052759|NCT00325195|464484400|FG002|Received Intervention: ITT Population|Death|0|||
129052760|NCT00325195|464484398|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
129052761|NCT00325195|464484399|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
129136682|NCT01748552|464794464|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136683|NCT01748552|464794465|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136684|NCT01748552|464794466|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136685|NCT01748552|464794467|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136686|NCT01748552|464794468|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136687|NCT01748552|464794469|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
129136688|NCT01748552|464794470|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
129136689|NCT01748552|464794471|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
129136690|NCT01748552|464794472|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136691|NCT01748552|464794473|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136692|NCT01748552|464794474|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129136693|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
129136694|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
129136695|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
129136696|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
128719682|NCT02967692|463273193|FG001|Overall Study|Study terminated by sponsor|1|||
128719683|NCT02967692|463273194|FG002|Overall Study|Study terminated by sponsor|42|||
128719684|NCT02967692|463273195|FG003|Overall Study|Study terminated by sponsor|37|||
129052762|NCT00325195|464484400|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
129052763|NCT00325195|464484398|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
129052764|NCT00325195|464484399|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
129052765|NCT00325195|464484400|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
129052766|NCT00325195|464484398|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
129052767|NCT00325195|464484399|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
129052768|NCT00325195|464484400|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
129052769|NCT00552578|464484406|FG000|Overall Study|Lost to Follow-up|1|||
129136697|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
129136698|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
128719685|NCT01536379|463273196|FG000|Overall Study|Adverse Event|1|||
129052770|NCT00552578|464484407|FG001|Overall Study|Lost to Follow-up|1|||
129052771|NCT01716715|464484408|FG000|Overall Study|Never Treated|2|||
129052772|NCT01716715|464484409|FG001|Overall Study|Never Treated|4|||
129052773|NCT00626392|464484410|FG000|Run-in Period|Adverse Event|0|||
129052774|NCT00626392|464484411|FG001|Run-in Period|Adverse Event|0|||
129052775|NCT00626392|464484412|FG002|Run-in Period|Adverse Event|1|||
128719686|NCT01536379|463273197|FG001|Overall Study|Adverse Event|2|||
128719687|NCT01536379|463273196|FG000|Overall Study|Withdrawal by Subject|1|||
129052776|NCT00626392|464484413|FG003|Run-in Period|Adverse Event|0|||
129052777|NCT00626392|464484414|FG004|Run-in Period|Adverse Event|1|||
129052778|NCT00626392|464484415|FG005|Run-in Period|Adverse Event|0|||
129052779|NCT00626392|464484410|FG000|Run-in Period|Withdrawal by Subject|0|||
129052780|NCT00626392|464484411|FG001|Run-in Period|Withdrawal by Subject|1|||
129052781|NCT00626392|464484412|FG002|Run-in Period|Withdrawal by Subject|1|||
129052782|NCT00626392|464484413|FG003|Run-in Period|Withdrawal by Subject|1|||
129052783|NCT00626392|464484414|FG004|Run-in Period|Withdrawal by Subject|3|||
129052784|NCT00626392|464484415|FG005|Run-in Period|Withdrawal by Subject|1|||
129052785|NCT00626392|464484410|FG000|Run-in Period|Noncompliance|1|||
129052786|NCT00626392|464484411|FG001|Run-in Period|Noncompliance|0|||
129052787|NCT00626392|464484412|FG002|Run-in Period|Noncompliance|1|||
129052788|NCT00626392|464484413|FG003|Run-in Period|Noncompliance|0|||
129052789|NCT00626392|464484414|FG004|Run-in Period|Noncompliance|0|||
129052790|NCT00626392|464484415|FG005|Run-in Period|Noncompliance|0|||
129052791|NCT00626392|464484410|FG000|Coadministration Period|Adverse Event|3|||
129052792|NCT00626392|464484411|FG001|Coadministration Period|Adverse Event|1|||
129052793|NCT00626392|464484412|FG002|Coadministration Period|Adverse Event|7|||
129052794|NCT00626392|464484413|FG003|Coadministration Period|Adverse Event|4|||
129052795|NCT00626392|464484414|FG004|Coadministration Period|Adverse Event|3|||
129052796|NCT00626392|464484415|FG005|Coadministration Period|Adverse Event|4|||
129052797|NCT00626392|464484410|FG000|Coadministration Period|Withdrawal by Subject|1|||
129052798|NCT00626392|464484411|FG001|Coadministration Period|Withdrawal by Subject|1|||
129052799|NCT00626392|464484412|FG002|Coadministration Period|Withdrawal by Subject|0|||
129052800|NCT00626392|464484413|FG003|Coadministration Period|Withdrawal by Subject|1|||
129052801|NCT00626392|464484414|FG004|Coadministration Period|Withdrawal by Subject|0|||
129052802|NCT00626392|464484415|FG005|Coadministration Period|Withdrawal by Subject|1|||
129052803|NCT00626392|464484410|FG000|Coadministration Period|Protocol Violation|0|||
129052804|NCT00626392|464484411|FG001|Coadministration Period|Protocol Violation|1|||
129052805|NCT00626392|464484412|FG002|Coadministration Period|Protocol Violation|0|||
129052806|NCT00626392|464484413|FG003|Coadministration Period|Protocol Violation|1|||
129052807|NCT00626392|464484414|FG004|Coadministration Period|Protocol Violation|1|||
129052808|NCT00626392|464484415|FG005|Coadministration Period|Protocol Violation|0|||
129052809|NCT00626392|464484410|FG000|Coadministration Period|Other|0|||
129052810|NCT00626392|464484411|FG001|Coadministration Period|Other|2|||
129052811|NCT00626392|464484412|FG002|Coadministration Period|Other|3|||
129052812|NCT00626392|464484413|FG003|Coadministration Period|Other|1|||
129052813|NCT00626392|464484414|FG004|Coadministration Period|Other|1|||
129052814|NCT00626392|464484415|FG005|Coadministration Period|Other|1|||
129052815|NCT03327792|464484416|FG000|Overall Study|Adverse Event|4|||
129052816|NCT03327792|464484417|FG001|Overall Study|Adverse Event|0|||
129052817|NCT03327792|464484416|FG000|Overall Study|Family/Personal issues|3|||
129052818|NCT03327792|464484417|FG001|Overall Study|Family/Personal issues|2|||
129052819|NCT03327792|464484416|FG000|Overall Study|Lost to Follow-up|0|||
129052820|NCT03327792|464484417|FG001|Overall Study|Lost to Follow-up|1|||
129052821|NCT01085734|464484422|FG000|Overall Study|Adverse Event|0|||
129052822|NCT01085734|464484423|FG001|Overall Study|Adverse Event|2|||
129052823|NCT01085734|464484422|FG000|Overall Study|Death|1|||
128719688|NCT01536379|463273197|FG001|Overall Study|Withdrawal by Subject|1|||
129052824|NCT01085734|464484423|FG001|Overall Study|Death|0|||
129052825|NCT01085734|464484422|FG000|Overall Study|Lost to Follow-up|0|||
129052826|NCT01085734|464484423|FG001|Overall Study|Lost to Follow-up|1|||
129052827|NCT01085734|464484422|FG000|Overall Study|Withdrawal by Subject|0|||
129052828|NCT01085734|464484423|FG001|Overall Study|Withdrawal by Subject|1|||
129052829|NCT01715571|464484424|FG000|Overall Study|Lost to Follow-up|8|||
129052830|NCT04480710|464484425|FG000|Overall Study|Adverse Event|0|||
129052831|NCT04480710|464484426|FG001|Overall Study|Adverse Event|2|||
129052832|NCT04480710|464484427|FG002|Overall Study|Adverse Event|0|||
129052833|NCT04480710|464484428|FG003|Overall Study|Adverse Event|0|||
129052834|NCT04480710|464484425|FG000|Overall Study|Withdrawal by Subject|0|||
129052835|NCT04480710|464484426|FG001|Overall Study|Withdrawal by Subject|1|||
129052836|NCT04480710|464484427|FG002|Overall Study|Withdrawal by Subject|0|||
129052837|NCT04480710|464484428|FG003|Overall Study|Withdrawal by Subject|0|||
129052838|NCT04480710|464484425|FG000|Overall Study|Physician Decision|0|||
129052839|NCT04480710|464484426|FG001|Overall Study|Physician Decision|0|||
129052840|NCT04480710|464484427|FG002|Overall Study|Physician Decision|1|||
129052841|NCT04480710|464484428|FG003|Overall Study|Physician Decision|0|||
129052842|NCT02196701|464484431|FG000|Overall Study|Adverse Event|1|||
129052843|NCT02196701|464484431|FG000|Overall Study|Lost to Follow-up|1|||
129052844|NCT02196701|464484431|FG000|Overall Study|Non-adherence to Protocol|1|||
129052845|NCT03275064|464484432|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129052846|NCT03275064|464484433|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129052847|NCT03275064|464484434|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129052848|NCT03275064|464484435|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
129052849|NCT03275064|464484436|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129052850|NCT03275064|464484432|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
129052851|NCT03275064|464484433|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129052852|NCT03275064|464484434|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129052853|NCT03275064|464484435|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129052854|NCT03275064|464484436|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129052855|NCT03275064|464484432|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
129052856|NCT03275064|464484433|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
129052857|NCT03275064|464484434|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
129052858|NCT03275064|464484435|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
129052859|NCT03275064|464484436|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
129052860|NCT03275064|464484432|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129052861|NCT03275064|464484433|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129052862|NCT03275064|464484434|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129052863|NCT03275064|464484435|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
129052864|NCT03275064|464484436|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129052865|NCT03275064|464484432|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
129052866|NCT03275064|464484433|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
129052867|NCT03275064|464484434|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
129052868|NCT03275064|464484435|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
129052869|NCT03275064|464484436|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
129052870|NCT04159935|464484437|FG000|Overall Study|Study terminated due to COVID-19|1|||
129052871|NCT04159935|464484438|FG001|Overall Study|Study terminated due to COVID-19|3|||
129052872|NCT01341782|464484439|FG000|Overall Study|Adverse Event|1|||
129052873|NCT01341782|464484440|FG001|Overall Study|Adverse Event|1|||
129052874|NCT01341782|464484439|FG000|Overall Study|Withdrawal by Subject|6|||
129052875|NCT01341782|464484440|FG001|Overall Study|Withdrawal by Subject|5|||
129052876|NCT01341782|464484439|FG000|Overall Study|Missed 3 consecutive doses|0|||
129052877|NCT01341782|464484440|FG001|Overall Study|Missed 3 consecutive doses|4|||
129052878|NCT01341782|464484439|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
129052879|NCT01341782|464484440|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
129052880|NCT01341782|464484439|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
129052881|NCT01341782|464484440|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
129052882|NCT01341782|464484439|FG000|Overall Study|Other|5|||
129052883|NCT01341782|464484440|FG001|Overall Study|Other|0|||
129052884|NCT00620555|464484441|FG000|Overall Study|Adverse Event|4|||
129052885|NCT00620555|464484441|FG000|Overall Study|Protocol Violation|2|||
129052886|NCT00620555|464484441|FG000|Overall Study|Lack of Efficacy|12|||
129052887|NCT00620555|464484441|FG000|Overall Study|Withdrawal by Subject|1|||
129052888|NCT00620555|464484441|FG000|Overall Study|Choice of other treatment|1|||
129052889|NCT00620555|464484441|FG000|Overall Study|Visit failure against planned|1|||
129052890|NCT01140503|464484442|FG000|Overall Study|Withdrawal by Subject|1|||
129052891|NCT00724048|464484443|FG000|Overall Study|Adverse Event|1|||
129052892|NCT00724048|464484444|FG001|Overall Study|Adverse Event|1|||
129052893|NCT00724048|464484445|FG002|Overall Study|Adverse Event|1|||
129052894|NCT00724048|464484446|FG003|Overall Study|Adverse Event|0|||
129052895|NCT00724048|464484443|FG000|Overall Study|Lost to Follow-up|0|||
129052896|NCT00724048|464484444|FG001|Overall Study|Lost to Follow-up|1|||
129052897|NCT00724048|464484445|FG002|Overall Study|Lost to Follow-up|0|||
129052898|NCT00724048|464484446|FG003|Overall Study|Lost to Follow-up|0|||
129052899|NCT00724048|464484443|FG000|Overall Study|Withdrawal by Subject|1|||
129052900|NCT00724048|464484444|FG001|Overall Study|Withdrawal by Subject|2|||
129136699|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
129136700|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
129136701|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
129136702|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
129052901|NCT00724048|464484445|FG002|Overall Study|Withdrawal by Subject|1|||
129052902|NCT00724048|464484446|FG003|Overall Study|Withdrawal by Subject|2|||
129052903|NCT00724048|464484443|FG000|Overall Study|Investigator decision|0|||
129052904|NCT00724048|464484444|FG001|Overall Study|Investigator decision|0|||
129052905|NCT00724048|464484445|FG002|Overall Study|Investigator decision|1|||
129052906|NCT00724048|464484446|FG003|Overall Study|Investigator decision|0|||
129136703|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
129136704|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
129136705|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
129136706|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
129052907|NCT00724048|464484443|FG000|Overall Study|Did not tolerate study drug|0|||
129052908|NCT00724048|464484444|FG001|Overall Study|Did not tolerate study drug|0|||
129052909|NCT00724048|464484445|FG002|Overall Study|Did not tolerate study drug|0|||
129052910|NCT00724048|464484446|FG003|Overall Study|Did not tolerate study drug|1|||
129052911|NCT00724048|464484443|FG000|Overall Study|Other than specified|1|||
129052912|NCT00724048|464484444|FG001|Overall Study|Other than specified|1|||
129052913|NCT00724048|464484445|FG002|Overall Study|Other than specified|0|||
129052914|NCT00724048|464484446|FG003|Overall Study|Other than specified|0|||
129052915|NCT03923530|464484447|FG000|Overall Study|Withdrawal by Subject|1|||
129052916|NCT03923530|464484447|FG000|Overall Study|screen failure|3|||
129052917|NCT00407758|464484448|FG000|Overall Study|ineligible -improper prior treatment|1|||
129052918|NCT01822275|464484456|FG000|Overall Study|Withdrawal by Subject|3|||
129052919|NCT01822275|464484456|FG000|Overall Study|Adverse Event|3|||
129052920|NCT01822275|464484456|FG000|Overall Study|Progression|14|||
129052921|NCT01822275|464484456|FG000|Overall Study|Physician Decision|2|||
129052922|NCT00073021|464484458|FG000|Overall Study|Protocol Violation|2|||
129052923|NCT00073021|464484459|FG001|Overall Study|Protocol Violation|1|||
129052924|NCT00073021|464484458|FG000|Overall Study|Adverse Event|4|||
129052925|NCT00073021|464484459|FG001|Overall Study|Adverse Event|4|||
129052926|NCT00073021|464484458|FG000|Overall Study|Withdrawal by Subject|6|||
129052927|NCT00073021|464484459|FG001|Overall Study|Withdrawal by Subject|5|||
129052928|NCT00073021|464484458|FG000|Overall Study|Physician Decision|3|||
129052929|NCT00073021|464484459|FG001|Overall Study|Physician Decision|1|||
129052930|NCT00073021|464484458|FG000|Overall Study|Lack of Efficacy|11|||
129052931|NCT00073021|464484459|FG001|Overall Study|Lack of Efficacy|5|||
129052932|NCT01458106|464484460|FG000|Overall Study|Withdrawal by Subject|2|||
129052933|NCT01458106|464484461|FG001|Overall Study|Withdrawal by Subject|0|||
129052934|NCT01458106|464484460|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
129052935|NCT01458106|464484461|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
129052936|NCT01458106|464484460|FG000|Overall Study|Withdrawn Per Protocol|0|||
129052937|NCT01458106|464484461|FG001|Overall Study|Withdrawn Per Protocol|1|||
129052938|NCT00855803|464484462|FG000|Overall Study|Death|2|||
129052939|NCT00855803|464484462|FG000|Overall Study|Lost to Follow-up|2|||
129052940|NCT00855803|464484462|FG000|Overall Study|Technical inability to undergo procedure|2|||
129052941|NCT00855803|464484462|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
129052942|NCT00855803|464484462|FG000|Overall Study|Withdrawal by Subject|3|||
129052943|NCT00855803|464484462|FG000|Overall Study|Physician Decision|3|||
129052944|NCT01672970|464484466|FG000|Overall Study|Lack of Efficacy|12|||
129052945|NCT01672970|464484466|FG000|Overall Study|Adverse Event|18|||
129052946|NCT01672970|464484466|FG000|Overall Study|Withdrawal by Subject|2|||
129052947|NCT01672970|464484466|FG000|Overall Study|Lost to Follow-up|5|||
129052948|NCT01672970|464484466|FG000|Overall Study|Other|9|||
129052949|NCT01672970|464484466|FG000|Overall Study|Enrolled but not treated|1|||
129052950|NCT02132754|464484467|FG000|Overall Study|Adverse Event|0|||
129052951|NCT02132754|464484468|FG001|Overall Study|Adverse Event|0|||
129052952|NCT02132754|464484469|FG002|Overall Study|Adverse Event|0|||
129052953|NCT02132754|464484470|FG003|Overall Study|Adverse Event|0|||
129052954|NCT02132754|464484471|FG004|Overall Study|Adverse Event|0|||
129052955|NCT02132754|464484472|FG005|Overall Study|Adverse Event|0|||
129052956|NCT02132754|464484473|FG006|Overall Study|Adverse Event|0|||
129052957|NCT02132754|464484474|FG007|Overall Study|Adverse Event|0|||
129136707|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
129136708|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
129136709|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
129136710|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
129136711|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
129136712|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
129052958|NCT02132754|464484475|FG008|Overall Study|Adverse Event|0|||
129052959|NCT02132754|464484476|FG009|Overall Study|Adverse Event|0|||
129136713|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
128719689|NCT00066066|463273200|FG000|Overall Study|Lost to Follow-up|6|||
129052960|NCT02132754|464484477|FG010|Overall Study|Adverse Event|0|||
129052961|NCT02132754|464484478|FG011|Overall Study|Adverse Event|0|||
129052962|NCT02132754|464484479|FG012|Overall Study|Adverse Event|0|||
129052963|NCT02132754|464484480|FG013|Overall Study|Adverse Event|0|||
129052964|NCT02132754|464484481|FG014|Overall Study|Adverse Event|0|||
129052965|NCT02132754|464484482|FG015|Overall Study|Adverse Event|0|||
129052966|NCT02132754|464484483|FG016|Overall Study|Adverse Event|0|||
129052967|NCT02132754|464484484|FG017|Overall Study|Adverse Event|1|||
129052968|NCT02132754|464484485|FG018|Overall Study|Adverse Event|0|||
129052969|NCT02132754|464484486|FG019|Overall Study|Adverse Event|0|||
129052970|NCT02132754|464484487|FG020|Overall Study|Adverse Event|0|||
129052971|NCT02132754|464484488|FG021|Overall Study|Adverse Event|0|||
129052972|NCT02132754|464484489|FG022|Overall Study|Adverse Event|0|||
129052973|NCT02132754|464484490|FG023|Overall Study|Adverse Event|0|||
129052974|NCT02132754|464484491|FG024|Overall Study|Adverse Event|0|||
129052975|NCT02132754|464484492|FG025|Overall Study|Adverse Event|1|||
129052976|NCT02132754|464484493|FG026|Overall Study|Adverse Event|1|||
129052977|NCT02132754|464484494|FG027|Overall Study|Adverse Event|0|||
129052978|NCT02132754|464484495|FG028|Overall Study|Adverse Event|0|||
129052979|NCT02132754|464484496|FG029|Overall Study|Adverse Event|0|||
129052980|NCT02132754|464484497|FG030|Overall Study|Adverse Event|1|||
129052981|NCT02132754|464484498|FG031|Overall Study|Adverse Event|0|||
129052982|NCT02132754|464484499|FG032|Overall Study|Adverse Event|1|||
129052983|NCT02132754|464484500|FG033|Overall Study|Adverse Event|1|||
129052984|NCT02132754|464484467|FG000|Overall Study|Clinical Progression|0|||
129052985|NCT02132754|464484468|FG001|Overall Study|Clinical Progression|0|||
129052986|NCT02132754|464484469|FG002|Overall Study|Clinical Progression|0|||
129052987|NCT02132754|464484470|FG003|Overall Study|Clinical Progression|0|||
129052988|NCT02132754|464484471|FG004|Overall Study|Clinical Progression|0|||
129052989|NCT02132754|464484472|FG005|Overall Study|Clinical Progression|0|||
129052990|NCT02132754|464484473|FG006|Overall Study|Clinical Progression|0|||
129052991|NCT02132754|464484474|FG007|Overall Study|Clinical Progression|0|||
129052992|NCT02132754|464484475|FG008|Overall Study|Clinical Progression|0|||
129052993|NCT02132754|464484476|FG009|Overall Study|Clinical Progression|1|||
129052994|NCT02132754|464484477|FG010|Overall Study|Clinical Progression|0|||
129052995|NCT02132754|464484478|FG011|Overall Study|Clinical Progression|0|||
129052996|NCT02132754|464484479|FG012|Overall Study|Clinical Progression|0|||
129052997|NCT02132754|464484480|FG013|Overall Study|Clinical Progression|0|||
129052998|NCT02132754|464484481|FG014|Overall Study|Clinical Progression|0|||
129052999|NCT02132754|464484482|FG015|Overall Study|Clinical Progression|0|||
129053000|NCT02132754|464484483|FG016|Overall Study|Clinical Progression|1|||
129053001|NCT02132754|464484484|FG017|Overall Study|Clinical Progression|1|||
129053002|NCT02132754|464484485|FG018|Overall Study|Clinical Progression|0|||
129053003|NCT02132754|464484486|FG019|Overall Study|Clinical Progression|1|||
129053004|NCT02132754|464484487|FG020|Overall Study|Clinical Progression|0|||
129053005|NCT02132754|464484488|FG021|Overall Study|Clinical Progression|0|||
129053006|NCT02132754|464484489|FG022|Overall Study|Clinical Progression|1|||
129053007|NCT02132754|464484490|FG023|Overall Study|Clinical Progression|0|||
129053008|NCT02132754|464484491|FG024|Overall Study|Clinical Progression|1|||
129053009|NCT02132754|464484492|FG025|Overall Study|Clinical Progression|1|||
129053010|NCT02132754|464484493|FG026|Overall Study|Clinical Progression|0|||
129053011|NCT02132754|464484494|FG027|Overall Study|Clinical Progression|1|||
129053012|NCT02132754|464484495|FG028|Overall Study|Clinical Progression|1|||
129053013|NCT02132754|464484496|FG029|Overall Study|Clinical Progression|0|||
129053014|NCT02132754|464484497|FG030|Overall Study|Clinical Progression|1|||
129053015|NCT02132754|464484498|FG031|Overall Study|Clinical Progression|0|||
129053016|NCT02132754|464484499|FG032|Overall Study|Clinical Progression|0|||
129053017|NCT02132754|464484500|FG033|Overall Study|Clinical Progression|2|||
129053018|NCT02132754|464484467|FG000|Overall Study|Death|0|||
129053019|NCT02132754|464484468|FG001|Overall Study|Death|0|||
129053020|NCT02132754|464484469|FG002|Overall Study|Death|0|||
129053021|NCT02132754|464484470|FG003|Overall Study|Death|0|||
129053022|NCT02132754|464484471|FG004|Overall Study|Death|0|||
129053023|NCT02132754|464484472|FG005|Overall Study|Death|0|||
129053024|NCT02132754|464484473|FG006|Overall Study|Death|0|||
129053025|NCT02132754|464484474|FG007|Overall Study|Death|0|||
129053026|NCT02132754|464484475|FG008|Overall Study|Death|0|||
129053027|NCT02132754|464484476|FG009|Overall Study|Death|0|||
129053028|NCT02132754|464484477|FG010|Overall Study|Death|0|||
129053029|NCT02132754|464484478|FG011|Overall Study|Death|0|||
129053030|NCT02132754|464484479|FG012|Overall Study|Death|0|||
129053031|NCT02132754|464484480|FG013|Overall Study|Death|0|||
129053032|NCT02132754|464484481|FG014|Overall Study|Death|0|||
129053033|NCT02132754|464484482|FG015|Overall Study|Death|1|||
129053034|NCT02132754|464484483|FG016|Overall Study|Death|0|||
129053035|NCT02132754|464484484|FG017|Overall Study|Death|0|||
129053036|NCT02132754|464484485|FG018|Overall Study|Death|0|||
129053037|NCT02132754|464484486|FG019|Overall Study|Death|1|||
129053038|NCT02132754|464484487|FG020|Overall Study|Death|0|||
129053039|NCT02132754|464484488|FG021|Overall Study|Death|1|||
129136714|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
129136715|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
129053040|NCT02132754|464484489|FG022|Overall Study|Death|0|||
129053041|NCT02132754|464484490|FG023|Overall Study|Death|0|||
129053042|NCT02132754|464484491|FG024|Overall Study|Death|0|||
129053043|NCT02132754|464484492|FG025|Overall Study|Death|0|||
129053044|NCT02132754|464484493|FG026|Overall Study|Death|1|||
129053045|NCT02132754|464484494|FG027|Overall Study|Death|0|||
129053046|NCT02132754|464484495|FG028|Overall Study|Death|0|||
129053047|NCT02132754|464484496|FG029|Overall Study|Death|0|||
129053048|NCT02132754|464484497|FG030|Overall Study|Death|0|||
129053049|NCT02132754|464484498|FG031|Overall Study|Death|0|||
129053050|NCT02132754|464484499|FG032|Overall Study|Death|0|||
129053051|NCT02132754|464484500|FG033|Overall Study|Death|2|||
129053052|NCT02132754|464484467|FG000|Overall Study|Excluded Medication|0|||
129053053|NCT02132754|464484468|FG001|Overall Study|Excluded Medication|0|||
129053054|NCT02132754|464484469|FG002|Overall Study|Excluded Medication|0|||
129053055|NCT02132754|464484470|FG003|Overall Study|Excluded Medication|0|||
129053056|NCT02132754|464484471|FG004|Overall Study|Excluded Medication|0|||
129053057|NCT02132754|464484472|FG005|Overall Study|Excluded Medication|0|||
129053058|NCT02132754|464484473|FG006|Overall Study|Excluded Medication|0|||
129053059|NCT02132754|464484474|FG007|Overall Study|Excluded Medication|0|||
129053060|NCT02132754|464484475|FG008|Overall Study|Excluded Medication|0|||
129053061|NCT02132754|464484476|FG009|Overall Study|Excluded Medication|0|||
129053062|NCT02132754|464484477|FG010|Overall Study|Excluded Medication|0|||
129053063|NCT02132754|464484478|FG011|Overall Study|Excluded Medication|0|||
129053064|NCT02132754|464484479|FG012|Overall Study|Excluded Medication|0|||
129053065|NCT02132754|464484480|FG013|Overall Study|Excluded Medication|0|||
129053066|NCT02132754|464484481|FG014|Overall Study|Excluded Medication|0|||
129053067|NCT02132754|464484482|FG015|Overall Study|Excluded Medication|0|||
129053068|NCT02132754|464484483|FG016|Overall Study|Excluded Medication|0|||
129053069|NCT02132754|464484484|FG017|Overall Study|Excluded Medication|0|||
129053070|NCT02132754|464484485|FG018|Overall Study|Excluded Medication|0|||
129053071|NCT02132754|464484486|FG019|Overall Study|Excluded Medication|0|||
129053072|NCT02132754|464484487|FG020|Overall Study|Excluded Medication|1|||
129053073|NCT02132754|464484488|FG021|Overall Study|Excluded Medication|0|||
129053074|NCT02132754|464484489|FG022|Overall Study|Excluded Medication|0|||
129053075|NCT02132754|464484490|FG023|Overall Study|Excluded Medication|0|||
129053076|NCT02132754|464484491|FG024|Overall Study|Excluded Medication|0|||
129053077|NCT02132754|464484492|FG025|Overall Study|Excluded Medication|0|||
129053078|NCT02132754|464484493|FG026|Overall Study|Excluded Medication|0|||
129053079|NCT02132754|464484494|FG027|Overall Study|Excluded Medication|0|||
129053080|NCT02132754|464484495|FG028|Overall Study|Excluded Medication|0|||
129053081|NCT02132754|464484496|FG029|Overall Study|Excluded Medication|0|||
129053082|NCT02132754|464484497|FG030|Overall Study|Excluded Medication|0|||
129053083|NCT02132754|464484498|FG031|Overall Study|Excluded Medication|0|||
129053084|NCT02132754|464484499|FG032|Overall Study|Excluded Medication|0|||
129053085|NCT02132754|464484500|FG033|Overall Study|Excluded Medication|1|||
129053086|NCT02132754|464484467|FG000|Overall Study|Physician Decision|0|||
129053087|NCT02132754|464484468|FG001|Overall Study|Physician Decision|0|||
129053088|NCT02132754|464484469|FG002|Overall Study|Physician Decision|0|||
129053089|NCT02132754|464484470|FG003|Overall Study|Physician Decision|0|||
129053090|NCT02132754|464484471|FG004|Overall Study|Physician Decision|0|||
129136716|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
129136717|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
129136718|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
129136719|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
129136720|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
129136721|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
129136722|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
129136723|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
129136724|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
129136725|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
129136726|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
129136727|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
129136728|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
129136729|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
129136730|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
129136731|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
129136732|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
129136733|NCT02596893|464794477|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
129136734|NCT02596893|464794478|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
129136735|NCT02596893|464794479|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
129136736|NCT02596893|464794480|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
129136737|NCT01529112|464794483|FG000|Overall Study|Adverse Event|2|||
129053091|NCT02132754|464484472|FG005|Overall Study|Physician Decision|0|||
129053092|NCT02132754|464484473|FG006|Overall Study|Physician Decision|0|||
129053093|NCT02132754|464484474|FG007|Overall Study|Physician Decision|0|||
129053094|NCT02132754|464484475|FG008|Overall Study|Physician Decision|0|||
129136738|NCT01529112|464794484|FG001|Overall Study|Adverse Event|0|||
129053095|NCT02132754|464484476|FG009|Overall Study|Physician Decision|1|||
129053096|NCT02132754|464484477|FG010|Overall Study|Physician Decision|0|||
129053097|NCT02132754|464484478|FG011|Overall Study|Physician Decision|1|||
129053098|NCT02132754|464484479|FG012|Overall Study|Physician Decision|1|||
129053099|NCT02132754|464484480|FG013|Overall Study|Physician Decision|0|||
129053100|NCT02132754|464484481|FG014|Overall Study|Physician Decision|0|||
129053101|NCT02132754|464484482|FG015|Overall Study|Physician Decision|1|||
129053102|NCT02132754|464484483|FG016|Overall Study|Physician Decision|0|||
129053103|NCT02132754|464484484|FG017|Overall Study|Physician Decision|0|||
129053104|NCT02132754|464484485|FG018|Overall Study|Physician Decision|0|||
129053105|NCT02132754|464484486|FG019|Overall Study|Physician Decision|0|||
129053106|NCT02132754|464484487|FG020|Overall Study|Physician Decision|0|||
129053107|NCT02132754|464484488|FG021|Overall Study|Physician Decision|0|||
129053108|NCT02132754|464484489|FG022|Overall Study|Physician Decision|0|||
129053109|NCT02132754|464484490|FG023|Overall Study|Physician Decision|0|||
129053110|NCT02132754|464484491|FG024|Overall Study|Physician Decision|1|||
129053111|NCT02132754|464484492|FG025|Overall Study|Physician Decision|0|||
129053112|NCT02132754|464484493|FG026|Overall Study|Physician Decision|0|||
129053113|NCT02132754|464484494|FG027|Overall Study|Physician Decision|0|||
129053114|NCT02132754|464484495|FG028|Overall Study|Physician Decision|0|||
129053115|NCT02132754|464484496|FG029|Overall Study|Physician Decision|0|||
129053116|NCT02132754|464484497|FG030|Overall Study|Physician Decision|0|||
129053117|NCT02132754|464484498|FG031|Overall Study|Physician Decision|1|||
129053118|NCT02132754|464484499|FG032|Overall Study|Physician Decision|0|||
129053119|NCT02132754|464484500|FG033|Overall Study|Physician Decision|3|||
129053120|NCT02132754|464484467|FG000|Overall Study|Progressive Disease|1|||
129053121|NCT02132754|464484468|FG001|Overall Study|Progressive Disease|1|||
129053122|NCT02132754|464484469|FG002|Overall Study|Progressive Disease|1|||
129053123|NCT02132754|464484470|FG003|Overall Study|Progressive Disease|1|||
129053124|NCT02132754|464484471|FG004|Overall Study|Progressive Disease|1|||
129053125|NCT02132754|464484472|FG005|Overall Study|Progressive Disease|1|||
129053126|NCT02132754|464484473|FG006|Overall Study|Progressive Disease|1|||
129053127|NCT02132754|464484474|FG007|Overall Study|Progressive Disease|1|||
129053128|NCT02132754|464484475|FG008|Overall Study|Progressive Disease|1|||
129053129|NCT02132754|464484476|FG009|Overall Study|Progressive Disease|3|||
129053130|NCT02132754|464484477|FG010|Overall Study|Progressive Disease|3|||
129053131|NCT02132754|464484478|FG011|Overall Study|Progressive Disease|2|||
129053132|NCT02132754|464484479|FG012|Overall Study|Progressive Disease|2|||
129053133|NCT02132754|464484480|FG013|Overall Study|Progressive Disease|3|||
129053134|NCT02132754|464484481|FG014|Overall Study|Progressive Disease|2|||
129053135|NCT02132754|464484482|FG015|Overall Study|Progressive Disease|1|||
129053136|NCT02132754|464484483|FG016|Overall Study|Progressive Disease|2|||
129053137|NCT02132754|464484484|FG017|Overall Study|Progressive Disease|1|||
129053138|NCT02132754|464484485|FG018|Overall Study|Progressive Disease|3|||
129053139|NCT02132754|464484486|FG019|Overall Study|Progressive Disease|1|||
129053140|NCT02132754|464484487|FG020|Overall Study|Progressive Disease|1|||
129053141|NCT02132754|464484488|FG021|Overall Study|Progressive Disease|3|||
129053142|NCT02132754|464484489|FG022|Overall Study|Progressive Disease|2|||
129053143|NCT02132754|464484490|FG023|Overall Study|Progressive Disease|3|||
129053144|NCT02132754|464484491|FG024|Overall Study|Progressive Disease|0|||
129053145|NCT02132754|464484492|FG025|Overall Study|Progressive Disease|1|||
129053146|NCT02132754|464484493|FG026|Overall Study|Progressive Disease|2|||
129053147|NCT02132754|464484494|FG027|Overall Study|Progressive Disease|1|||
129053148|NCT02132754|464484495|FG028|Overall Study|Progressive Disease|2|||
129053149|NCT02132754|464484496|FG029|Overall Study|Progressive Disease|3|||
129053150|NCT02132754|464484497|FG030|Overall Study|Progressive Disease|1|||
129053151|NCT02132754|464484498|FG031|Overall Study|Progressive Disease|1|||
129053152|NCT02132754|464484499|FG032|Overall Study|Progressive Disease|3|||
129053153|NCT02132754|464484500|FG033|Overall Study|Progressive Disease|6|||
129053154|NCT02132754|464484467|FG000|Overall Study|Screen Failure|0|||
129053155|NCT02132754|464484468|FG001|Overall Study|Screen Failure|0|||
129053156|NCT02132754|464484469|FG002|Overall Study|Screen Failure|0|||
129053157|NCT02132754|464484470|FG003|Overall Study|Screen Failure|0|||
129053158|NCT02132754|464484471|FG004|Overall Study|Screen Failure|0|||
128719690|NCT00066066|463273201|FG001|Overall Study|Lost to Follow-up|4|||
129053159|NCT02132754|464484472|FG005|Overall Study|Screen Failure|0|||
129053160|NCT02132754|464484473|FG006|Overall Study|Screen Failure|0|||
129053161|NCT02132754|464484474|FG007|Overall Study|Screen Failure|0|||
129053162|NCT02132754|464484475|FG008|Overall Study|Screen Failure|0|||
129053163|NCT02132754|464484476|FG009|Overall Study|Screen Failure|0|||
129053164|NCT02132754|464484477|FG010|Overall Study|Screen Failure|0|||
129053165|NCT02132754|464484478|FG011|Overall Study|Screen Failure|0|||
129053166|NCT02132754|464484479|FG012|Overall Study|Screen Failure|0|||
129053167|NCT02132754|464484480|FG013|Overall Study|Screen Failure|0|||
129053168|NCT02132754|464484481|FG014|Overall Study|Screen Failure|0|||
129053169|NCT02132754|464484482|FG015|Overall Study|Screen Failure|0|||
129053170|NCT02132754|464484483|FG016|Overall Study|Screen Failure|0|||
129053171|NCT02132754|464484484|FG017|Overall Study|Screen Failure|0|||
129053172|NCT02132754|464484485|FG018|Overall Study|Screen Failure|0|||
129053173|NCT02132754|464484486|FG019|Overall Study|Screen Failure|1|||
129053174|NCT02132754|464484487|FG020|Overall Study|Screen Failure|0|||
129053175|NCT02132754|464484488|FG021|Overall Study|Screen Failure|1|||
129053176|NCT02132754|464484489|FG022|Overall Study|Screen Failure|0|||
129053177|NCT02132754|464484490|FG023|Overall Study|Screen Failure|0|||
129053178|NCT02132754|464484491|FG024|Overall Study|Screen Failure|0|||
129053179|NCT02132754|464484492|FG025|Overall Study|Screen Failure|0|||
129053180|NCT02132754|464484493|FG026|Overall Study|Screen Failure|0|||
129053181|NCT02132754|464484494|FG027|Overall Study|Screen Failure|0|||
129053182|NCT02132754|464484495|FG028|Overall Study|Screen Failure|0|||
129053183|NCT02132754|464484496|FG029|Overall Study|Screen Failure|0|||
129136739|NCT01529112|464794483|FG000|Overall Study|Death|59|||
129053184|NCT02132754|464484497|FG030|Overall Study|Screen Failure|0|||
129053185|NCT02132754|464484498|FG031|Overall Study|Screen Failure|0|||
129053186|NCT02132754|464484499|FG032|Overall Study|Screen Failure|0|||
129053187|NCT02132754|464484500|FG033|Overall Study|Screen Failure|0|||
129053188|NCT02132754|464484467|FG000|Overall Study|Transferred to Extension Study|0|||
129053189|NCT02132754|464484468|FG001|Overall Study|Transferred to Extension Study|0|||
129053190|NCT02132754|464484469|FG002|Overall Study|Transferred to Extension Study|0|||
129053191|NCT02132754|464484470|FG003|Overall Study|Transferred to Extension Study|0|||
129053192|NCT02132754|464484471|FG004|Overall Study|Transferred to Extension Study|0|||
129053193|NCT02132754|464484472|FG005|Overall Study|Transferred to Extension Study|0|||
129053194|NCT02132754|464484473|FG006|Overall Study|Transferred to Extension Study|0|||
129053195|NCT02132754|464484474|FG007|Overall Study|Transferred to Extension Study|0|||
129053196|NCT02132754|464484475|FG008|Overall Study|Transferred to Extension Study|0|||
129053197|NCT02132754|464484476|FG009|Overall Study|Transferred to Extension Study|0|||
129053198|NCT02132754|464484477|FG010|Overall Study|Transferred to Extension Study|0|||
129053199|NCT02132754|464484478|FG011|Overall Study|Transferred to Extension Study|0|||
129053200|NCT02132754|464484479|FG012|Overall Study|Transferred to Extension Study|0|||
129053201|NCT02132754|464484480|FG013|Overall Study|Transferred to Extension Study|0|||
129053202|NCT02132754|464484481|FG014|Overall Study|Transferred to Extension Study|0|||
129053203|NCT02132754|464484482|FG015|Overall Study|Transferred to Extension Study|0|||
129053204|NCT02132754|464484483|FG016|Overall Study|Transferred to Extension Study|0|||
129053205|NCT02132754|464484484|FG017|Overall Study|Transferred to Extension Study|0|||
129053206|NCT02132754|464484485|FG018|Overall Study|Transferred to Extension Study|0|||
128719691|NCT00066066|463273202|FG002|Overall Study|Lost to Follow-up|7|||
128719692|NCT00066066|463273203|FG003|Overall Study|Lost to Follow-up|4|||
128719693|NCT00066066|463273204|FG004|Overall Study|Lost to Follow-up|3|||
128719694|NCT00066066|463273205|FG005|Overall Study|Lost to Follow-up|5|||
128719695|NCT02268409|463273206|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
129053207|NCT02132754|464484486|FG019|Overall Study|Transferred to Extension Study|0|||
129053208|NCT02132754|464484487|FG020|Overall Study|Transferred to Extension Study|0|||
129053209|NCT02132754|464484488|FG021|Overall Study|Transferred to Extension Study|0|||
129053210|NCT02132754|464484489|FG022|Overall Study|Transferred to Extension Study|0|||
129053211|NCT02132754|464484490|FG023|Overall Study|Transferred to Extension Study|0|||
129053212|NCT02132754|464484491|FG024|Overall Study|Transferred to Extension Study|0|||
129053213|NCT02132754|464484492|FG025|Overall Study|Transferred to Extension Study|0|||
129053214|NCT02132754|464484493|FG026|Overall Study|Transferred to Extension Study|0|||
129053215|NCT02132754|464484494|FG027|Overall Study|Transferred to Extension Study|0|||
129053216|NCT02132754|464484495|FG028|Overall Study|Transferred to Extension Study|0|||
129053217|NCT02132754|464484496|FG029|Overall Study|Transferred to Extension Study|0|||
129053218|NCT02132754|464484497|FG030|Overall Study|Transferred to Extension Study|0|||
129053219|NCT02132754|464484498|FG031|Overall Study|Transferred to Extension Study|0|||
129053220|NCT02132754|464484499|FG032|Overall Study|Transferred to Extension Study|0|||
129053221|NCT02132754|464484500|FG033|Overall Study|Transferred to Extension Study|6|||
129053222|NCT02132754|464484467|FG000|Overall Study|Withdrawal by Subject|0|||
129053223|NCT02132754|464484468|FG001|Overall Study|Withdrawal by Subject|0|||
129053224|NCT02132754|464484469|FG002|Overall Study|Withdrawal by Subject|0|||
129053225|NCT02132754|464484470|FG003|Overall Study|Withdrawal by Subject|0|||
129053226|NCT02132754|464484471|FG004|Overall Study|Withdrawal by Subject|0|||
129053227|NCT02132754|464484472|FG005|Overall Study|Withdrawal by Subject|0|||
129053228|NCT02132754|464484473|FG006|Overall Study|Withdrawal by Subject|0|||
129053229|NCT02132754|464484474|FG007|Overall Study|Withdrawal by Subject|0|||
129053230|NCT02132754|464484475|FG008|Overall Study|Withdrawal by Subject|0|||
129053231|NCT02132754|464484476|FG009|Overall Study|Withdrawal by Subject|1|||
129053232|NCT02132754|464484477|FG010|Overall Study|Withdrawal by Subject|0|||
129053233|NCT02132754|464484478|FG011|Overall Study|Withdrawal by Subject|0|||
129053234|NCT02132754|464484479|FG012|Overall Study|Withdrawal by Subject|1|||
129053235|NCT02132754|464484480|FG013|Overall Study|Withdrawal by Subject|0|||
129053236|NCT02132754|464484481|FG014|Overall Study|Withdrawal by Subject|1|||
129053237|NCT02132754|464484482|FG015|Overall Study|Withdrawal by Subject|2|||
129053238|NCT02132754|464484483|FG016|Overall Study|Withdrawal by Subject|1|||
129053239|NCT02132754|464484484|FG017|Overall Study|Withdrawal by Subject|0|||
129053240|NCT02132754|464484485|FG018|Overall Study|Withdrawal by Subject|0|||
129053241|NCT02132754|464484486|FG019|Overall Study|Withdrawal by Subject|0|||
129053242|NCT02132754|464484487|FG020|Overall Study|Withdrawal by Subject|1|||
129053243|NCT02132754|464484488|FG021|Overall Study|Withdrawal by Subject|0|||
129053244|NCT02132754|464484489|FG022|Overall Study|Withdrawal by Subject|0|||
129053245|NCT02132754|464484490|FG023|Overall Study|Withdrawal by Subject|0|||
129053246|NCT02132754|464484491|FG024|Overall Study|Withdrawal by Subject|1|||
129053247|NCT02132754|464484492|FG025|Overall Study|Withdrawal by Subject|0|||
129053248|NCT02132754|464484493|FG026|Overall Study|Withdrawal by Subject|0|||
129053249|NCT02132754|464484494|FG027|Overall Study|Withdrawal by Subject|1|||
129053250|NCT02132754|464484495|FG028|Overall Study|Withdrawal by Subject|0|||
129053251|NCT02132754|464484496|FG029|Overall Study|Withdrawal by Subject|0|||
129053252|NCT02132754|464484497|FG030|Overall Study|Withdrawal by Subject|0|||
129053253|NCT02132754|464484498|FG031|Overall Study|Withdrawal by Subject|1|||
129053254|NCT02132754|464484499|FG032|Overall Study|Withdrawal by Subject|0|||
129053255|NCT02132754|464484500|FG033|Overall Study|Withdrawal by Subject|2|||
129053256|NCT03050060|464484503|FG000|Overall Study|Adverse Event|7|||
129053257|NCT03050060|464484503|FG000|Overall Study|Withdrawal by Subject|1|||
129053258|NCT03050060|464484503|FG000|Overall Study|Progression|7|||
129053259|NCT03276780|464484504|FG000|Overall Study|Withdrawal by Subject|5|||
129053260|NCT03276780|464484505|FG001|Overall Study|Withdrawal by Subject|3|||
129053261|NCT03276780|464484504|FG000|Overall Study|Lost to Follow-up|3|||
129053262|NCT03276780|464484505|FG001|Overall Study|Lost to Follow-up|5|||
129053263|NCT03276780|464484504|FG000|Overall Study|Moved out of state|1|||
129053264|NCT03276780|464484505|FG001|Overall Study|Moved out of state|1|||
129053265|NCT03276780|464484504|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
129053266|NCT03276780|464484505|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
129053267|NCT03276780|464484504|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
129053268|NCT03276780|464484505|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
129053269|NCT03835221|464484506|FG000|Methafilcon A|Withdrawal by Subject|1|||
129053270|NCT02582866|464484509|FG000|Overall Study|Death|1|||
129053271|NCT02582866|464484509|FG000|Overall Study|Lack of Efficacy|2|||
129053272|NCT02582866|464484509|FG000|Overall Study|Lost to Follow-up|2|||
129053273|NCT02582866|464484509|FG000|Overall Study|Withdrawal by Subject|7|||
129053274|NCT02582866|464484509|FG000|Overall Study|Investigator decision|5|||
129053275|NCT02582866|464484509|FG000|Overall Study|Participant wants to get pregnant|1|||
129053276|NCT02582866|464484509|FG000|Overall Study|Pregnancy|2|||
129053277|NCT02582866|464484509|FG000|Overall Study|Sponsor decision|1|||
129053278|NCT02582866|464484509|FG000|Overall Study|Withdrawal due to personal reasons|1|||
129053279|NCT01193127|464484518|FG000|Randomized|Surgery Cancelled|0|||
129053280|NCT01193127|464484519|FG001|Randomized|Surgery Cancelled|0|||
129053281|NCT01193127|464484520|FG002|Randomized|Surgery Cancelled|0|||
129053282|NCT01193127|464484521|FG003|Randomized|Surgery Cancelled|1|||
129053283|NCT01193127|464484518|FG000|Treated|Withdrawal by Subject|0|||
129053284|NCT01193127|464484519|FG001|Treated|Withdrawal by Subject|0|||
129053285|NCT01193127|464484520|FG002|Treated|Withdrawal by Subject|0|||
129053286|NCT01193127|464484521|FG003|Treated|Withdrawal by Subject|1|||
129053287|NCT03246646|464484522|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
129053288|NCT03246646|464484523|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
129053289|NCT03246646|464484522|FG000|Overall Study|Withdrawal by Subject|3|||
129053290|NCT03246646|464484523|FG001|Overall Study|Withdrawal by Subject|0|||
129053291|NCT03246646|464484522|FG000|Overall Study|Lost to Follow-up|7|||
129053292|NCT03246646|464484523|FG001|Overall Study|Lost to Follow-up|0|||
129053293|NCT02352779|464484524|FG000|Overall Study|Personal Issues|1|||
129053294|NCT02352779|464484525|FG001|Overall Study|Personal Issues|1|||
129053295|NCT02352779|464484526|FG002|Overall Study|Personal Issues|0|||
129053296|NCT02352779|464484524|FG000|Overall Study|Too Many Forms|2|||
129053297|NCT02352779|464484525|FG001|Overall Study|Too Many Forms|0|||
129053298|NCT02352779|464484526|FG002|Overall Study|Too Many Forms|0|||
129053299|NCT02352779|464484524|FG000|Overall Study|Feeling Overwhelmed|1|||
129053300|NCT02352779|464484525|FG001|Overall Study|Feeling Overwhelmed|0|||
129053301|NCT02352779|464484526|FG002|Overall Study|Feeling Overwhelmed|0|||
129053302|NCT02352779|464484524|FG000|Overall Study|Disliked Intervention|1|||
129053303|NCT02352779|464484525|FG001|Overall Study|Disliked Intervention|0|||
129053304|NCT02352779|464484526|FG002|Overall Study|Disliked Intervention|0|||
129053305|NCT02352779|464484524|FG000|Overall Study|Changed Mind|1|||
129053306|NCT02352779|464484525|FG001|Overall Study|Changed Mind|0|||
129053307|NCT02352779|464484526|FG002|Overall Study|Changed Mind|0|||
129053308|NCT02352779|464484524|FG000|Overall Study|Study Related Symptoms|1|||
129053309|NCT02352779|464484525|FG001|Overall Study|Study Related Symptoms|0|||
129053310|NCT02352779|464484526|FG002|Overall Study|Study Related Symptoms|0|||
129053311|NCT02352779|464484524|FG000|Overall Study|Absence of Symptoms|1|||
129053312|NCT02352779|464484525|FG001|Overall Study|Absence of Symptoms|0|||
129053313|NCT02352779|464484526|FG002|Overall Study|Absence of Symptoms|0|||
129053314|NCT02352779|464484524|FG000|Overall Study|Other Medical Reason|0|||
129053315|NCT02352779|464484525|FG001|Overall Study|Other Medical Reason|0|||
129053316|NCT02352779|464484526|FG002|Overall Study|Other Medical Reason|1|||
129053317|NCT02352779|464484524|FG000|Overall Study|No Reason|0|||
129053318|NCT02352779|464484525|FG001|Overall Study|No Reason|0|||
129053319|NCT02352779|464484526|FG002|Overall Study|No Reason|1|||
129053320|NCT00871741|464484529|FG000|Overall Study|Premature study termination|9|||
129053321|NCT00871741|464484530|FG001|Overall Study|Premature study termination|7|||
129053322|NCT01565850|464484535|FG000|Overall Study|Adverse Event|0|||
129053323|NCT01565850|464484536|FG001|Overall Study|Adverse Event|1|||
129053324|NCT01565850|464484535|FG000|Overall Study|Lost to Follow-up|12|||
129053325|NCT01565850|464484536|FG001|Overall Study|Lost to Follow-up|4|||
129053326|NCT01565850|464484535|FG000|Overall Study|Investigator's Discretion|2|||
129053327|NCT01565850|464484536|FG001|Overall Study|Investigator's Discretion|1|||
129053328|NCT01565850|464484535|FG000|Overall Study|Participant noncompliance|2|||
129053329|NCT01565850|464484536|FG001|Overall Study|Participant noncompliance|0|||
129053330|NCT01565850|464484535|FG000|Overall Study|Withdrew Consent|4|||
129053331|NCT01565850|464484536|FG001|Overall Study|Withdrew Consent|2|||
129053332|NCT03283319|464487387|FG000|Overall Study|Lost to Follow-up|5|||
129053333|NCT03283319|464487388|FG001|Overall Study|Lost to Follow-up|4|||
129053334|NCT03283319|464487389|FG002|Overall Study|Lost to Follow-up|5|||
129053335|NCT03283319|464487390|FG003|Overall Study|Lost to Follow-up|5|||
129053336|NCT03283319|464487391|FG004|Overall Study|Lost to Follow-up|4|||
129053337|NCT03283319|464487392|FG005|Overall Study|Lost to Follow-up|3|||
129053338|NCT03283319|464487387|FG000|Overall Study|Withdrawal by Subject|2|||
129053339|NCT03283319|464487388|FG001|Overall Study|Withdrawal by Subject|2|||
129136740|NCT01529112|464794484|FG001|Overall Study|Death|38|||
129136741|NCT01529112|464794483|FG000|Overall Study|Protocol Violation|1|||
129136742|NCT01529112|464794484|FG001|Overall Study|Protocol Violation|0|||
129136743|NCT01529112|464794483|FG000|Overall Study|Withdrawal by Subject|7|||
129136744|NCT01529112|464794484|FG001|Overall Study|Withdrawal by Subject|3|||
129136745|NCT00004228|464794485|FG000|Overall Study|Adverse Event|0|||
129136746|NCT00004228|464794486|FG001|Overall Study|Adverse Event|1|||
129136747|NCT00004228|464794487|FG002|Overall Study|Adverse Event|0|||
129136748|NCT00004228|464794488|FG003|Overall Study|Adverse Event|0|||
129136749|NCT00004228|464794489|FG004|Overall Study|Adverse Event|1|||
129136750|NCT00004228|464794490|FG005|Overall Study|Adverse Event|0|||
129136751|NCT00004228|464794491|FG006|Overall Study|Adverse Event|0|||
129136752|NCT00004228|464794485|FG000|Overall Study|Death|0|||
129136753|NCT00004228|464794486|FG001|Overall Study|Death|1|||
129136754|NCT00004228|464794487|FG002|Overall Study|Death|2|||
129136755|NCT00004228|464794488|FG003|Overall Study|Death|0|||
129136756|NCT00004228|464794489|FG004|Overall Study|Death|1|||
129136757|NCT00004228|464794490|FG005|Overall Study|Death|0|||
129136758|NCT00004228|464794491|FG006|Overall Study|Death|0|||
129136759|NCT00004228|464794485|FG000|Overall Study|Lack of Efficacy|1|||
129136760|NCT00004228|464794486|FG001|Overall Study|Lack of Efficacy|6|||
129136761|NCT00004228|464794487|FG002|Overall Study|Lack of Efficacy|5|||
129136762|NCT00004228|464794488|FG003|Overall Study|Lack of Efficacy|3|||
129136763|NCT00004228|464794489|FG004|Overall Study|Lack of Efficacy|9|||
129136764|NCT00004228|464794490|FG005|Overall Study|Lack of Efficacy|8|||
129136765|NCT00004228|464794491|FG006|Overall Study|Lack of Efficacy|4|||
129136766|NCT00004228|464794485|FG000|Overall Study|Lost to Follow-up|0|||
129136767|NCT00004228|464794486|FG001|Overall Study|Lost to Follow-up|0|||
129136768|NCT00004228|464794487|FG002|Overall Study|Lost to Follow-up|1|||
129136769|NCT00004228|464794488|FG003|Overall Study|Lost to Follow-up|0|||
129136770|NCT00004228|464794489|FG004|Overall Study|Lost to Follow-up|0|||
129136771|NCT00004228|464794490|FG005|Overall Study|Lost to Follow-up|0|||
129136772|NCT00004228|464794491|FG006|Overall Study|Lost to Follow-up|0|||
129136773|NCT00004228|464794485|FG000|Overall Study|Physician Decision|1|||
129136774|NCT00004228|464794486|FG001|Overall Study|Physician Decision|0|||
129136775|NCT00004228|464794487|FG002|Overall Study|Physician Decision|3|||
129136776|NCT00004228|464794488|FG003|Overall Study|Physician Decision|2|||
129136777|NCT00004228|464794489|FG004|Overall Study|Physician Decision|1|||
129136778|NCT00004228|464794490|FG005|Overall Study|Physician Decision|1|||
129136779|NCT00004228|464794491|FG006|Overall Study|Physician Decision|1|||
129136780|NCT00004228|464794485|FG000|Overall Study|Protocol Violation|0|||
129136781|NCT00004228|464794486|FG001|Overall Study|Protocol Violation|5|||
129136782|NCT00004228|464794487|FG002|Overall Study|Protocol Violation|2|||
129136783|NCT00004228|464794488|FG003|Overall Study|Protocol Violation|1|||
129136784|NCT00004228|464794489|FG004|Overall Study|Protocol Violation|1|||
129136785|NCT00004228|464794490|FG005|Overall Study|Protocol Violation|2|||
129136786|NCT00004228|464794491|FG006|Overall Study|Protocol Violation|0|||
129053340|NCT03283319|464487389|FG002|Overall Study|Withdrawal by Subject|2|||
129053341|NCT03283319|464487390|FG003|Overall Study|Withdrawal by Subject|1|||
129136787|NCT00004228|464794485|FG000|Overall Study|Withdrawal by Subject|3|||
129136788|NCT00004228|464794486|FG001|Overall Study|Withdrawal by Subject|0|||
129136789|NCT00004228|464794487|FG002|Overall Study|Withdrawal by Subject|1|||
129053342|NCT03283319|464487391|FG004|Overall Study|Withdrawal by Subject|0|||
129053343|NCT03283319|464487392|FG005|Overall Study|Withdrawal by Subject|1|||
129136790|NCT00004228|464794488|FG003|Overall Study|Withdrawal by Subject|0|||
129136791|NCT00004228|464794489|FG004|Overall Study|Withdrawal by Subject|2|||
129136792|NCT00004228|464794490|FG005|Overall Study|Withdrawal by Subject|1|||
129136793|NCT00004228|464794491|FG006|Overall Study|Withdrawal by Subject|2|||
129136794|NCT00004228|464794485|FG000|Overall Study|Other|0|||
129136795|NCT00004228|464794486|FG001|Overall Study|Other|0|||
129136796|NCT00004228|464794487|FG002|Overall Study|Other|1|||
129136797|NCT00004228|464794488|FG003|Overall Study|Other|0|||
129136798|NCT00004228|464794489|FG004|Overall Study|Other|0|||
129136799|NCT00004228|464794490|FG005|Overall Study|Other|0|||
129136800|NCT00004228|464794491|FG006|Overall Study|Other|0|||
129136801|NCT00004228|464794485|FG000|Overall Study|ineligible|4|||
129136802|NCT00004228|464794486|FG001|Overall Study|ineligible|2|||
129136803|NCT00004228|464794487|FG002|Overall Study|ineligible|4|||
129136804|NCT00004228|464794488|FG003|Overall Study|ineligible|1|||
129136805|NCT00004228|464794489|FG004|Overall Study|ineligible|1|||
129136806|NCT00004228|464794490|FG005|Overall Study|ineligible|2|||
129136807|NCT00004228|464794491|FG006|Overall Study|ineligible|5|||
129136808|NCT02255279|464794492|FG000|Overall Study|Lost to Follow-up|2|||
129136809|NCT02255279|464794493|FG001|Overall Study|Lost to Follow-up|2|||
129136810|NCT02255279|464794492|FG000|Overall Study|Protocol Violation|0|||
129136811|NCT02255279|464794493|FG001|Overall Study|Protocol Violation|1|||
129136812|NCT02255279|464794492|FG000|Overall Study|Withdrawal by Subject|3|||
129136813|NCT02255279|464794493|FG001|Overall Study|Withdrawal by Subject|6|||
129136814|NCT03607695|464794494|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
129136815|NCT03607695|464794494|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
129053344|NCT03283319|464487387|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
129053345|NCT03283319|464487388|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
129053346|NCT03283319|464487389|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
129053347|NCT03283319|464487390|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
129053348|NCT03283319|464487391|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
129053349|NCT03283319|464487392|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
129053350|NCT00721630|464487393|FG000|Overall Study|Participant found to be ineligible|1|||
129053351|NCT03186781|464487394|FG000|Overall Study|Lost to Follow-up|0|||
129053352|NCT03186781|464487395|FG001|Overall Study|Lost to Follow-up|0|||
129053353|NCT03186781|464487396|FG002|Overall Study|Lost to Follow-up|1|||
129053354|NCT03186781|464487397|FG003|Overall Study|Lost to Follow-up|0|||
129053355|NCT03186781|464487398|FG004|Overall Study|Lost to Follow-up|1|||
129053356|NCT03186781|464487399|FG005|Overall Study|Lost to Follow-up|0|||
129053357|NCT03186781|464487394|FG000|Overall Study|Moved from Area|0|||
129053358|NCT03186781|464487395|FG001|Overall Study|Moved from Area|0|||
129053359|NCT03186781|464487396|FG002|Overall Study|Moved from Area|0|||
129053360|NCT03186781|464487397|FG003|Overall Study|Moved from Area|0|||
129053361|NCT03186781|464487398|FG004|Overall Study|Moved from Area|1|||
129053362|NCT03186781|464487399|FG005|Overall Study|Moved from Area|0|||
129053363|NCT03186781|464487394|FG000|Overall Study|Withdrawal by Subject|0|||
129053364|NCT03186781|464487395|FG001|Overall Study|Withdrawal by Subject|0|||
129053365|NCT03186781|464487396|FG002|Overall Study|Withdrawal by Subject|0|||
129053366|NCT03186781|464487397|FG003|Overall Study|Withdrawal by Subject|0|||
129053367|NCT03186781|464487398|FG004|Overall Study|Withdrawal by Subject|1|||
129053368|NCT03186781|464487399|FG005|Overall Study|Withdrawal by Subject|0|||
129053369|NCT00792935|464487400|FG000|Overall Study|Adverse Event|2|||
129053370|NCT00792935|464487401|FG001|Overall Study|Adverse Event|1|||
129053371|NCT00792935|464487400|FG000|Overall Study|Lost to Follow-up|0|||
129053372|NCT00792935|464487401|FG001|Overall Study|Lost to Follow-up|1|||
129053373|NCT00792935|464487400|FG000|Overall Study|Protocol Violation|2|||
129053374|NCT00792935|464487401|FG001|Overall Study|Protocol Violation|0|||
129053375|NCT00792935|464487400|FG000|Overall Study|Withdrawal by Subject|0|||
129053376|NCT00792935|464487401|FG001|Overall Study|Withdrawal by Subject|1|||
129053377|NCT04663295|464487402|FG000|Run-in Period|Withdrawal by Subject|3|||
129053378|NCT04663295|464487402|FG000|Overall Study Period|Pregnancy|1|||
129053379|NCT04663295|464487402|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
129053380|NCT03954834|464487403|FG000|Overall Study|Adverse Event|1|||
129053381|NCT03954834|464487404|FG001|Overall Study|Adverse Event|3|||
129053382|NCT03954834|464487405|FG002|Overall Study|Adverse Event|1|||
129053383|NCT03954834|464487406|FG003|Overall Study|Adverse Event|1|||
129053384|NCT03954834|464487403|FG000|Overall Study|Death|0|||
129053385|NCT03954834|464487404|FG001|Overall Study|Death|0|||
129053386|NCT03954834|464487405|FG002|Overall Study|Death|0|||
129053387|NCT03954834|464487406|FG003|Overall Study|Death|1|||
129053388|NCT03954834|464487403|FG000|Overall Study|Physician Decision|0|||
129053389|NCT03954834|464487404|FG001|Overall Study|Physician Decision|1|||
129053390|NCT03954834|464487405|FG002|Overall Study|Physician Decision|0|||
129053391|NCT03954834|464487406|FG003|Overall Study|Physician Decision|2|||
129053392|NCT03954834|464487403|FG000|Overall Study|Protocol Violation|1|||
129053393|NCT03954834|464487404|FG001|Overall Study|Protocol Violation|0|||
129136816|NCT02741193|464794495|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
129136817|NCT02741193|464794495|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
129136818|NCT02502383|464794496|FG000|Overall Study|Lost to Follow-up|130|||
129053394|NCT03954834|464487405|FG002|Overall Study|Protocol Violation|0|||
129053395|NCT03954834|464487406|FG003|Overall Study|Protocol Violation|1|||
129053396|NCT03954834|464487403|FG000|Overall Study|Withdrawal by Subject|2|||
129053397|NCT03954834|464487404|FG001|Overall Study|Withdrawal by Subject|3|||
129053398|NCT03954834|464487405|FG002|Overall Study|Withdrawal by Subject|13|||
129053399|NCT03954834|464487406|FG003|Overall Study|Withdrawal by Subject|6|||
129053400|NCT03954834|464487403|FG000|Overall Study|Participant left the country|0|||
129053401|NCT03954834|464487404|FG001|Overall Study|Participant left the country|0|||
129053402|NCT03954834|464487405|FG002|Overall Study|Participant left the country|1|||
129053403|NCT03954834|464487406|FG003|Overall Study|Participant left the country|0|||
129136819|NCT02502383|464794497|FG001|Overall Study|Lost to Follow-up|131|||
129053404|NCT03954834|464487403|FG000|Overall Study|Lost to Follow-up|3|||
129053405|NCT03954834|464487404|FG001|Overall Study|Lost to Follow-up|2|||
129053406|NCT03954834|464487405|FG002|Overall Study|Lost to Follow-up|3|||
129053407|NCT03954834|464487406|FG003|Overall Study|Lost to Follow-up|5|||
129053408|NCT00663026|464487407|FG000|Overall Study|Lost to Follow-up|1|||
129053409|NCT00663026|464487408|FG001|Overall Study|Lost to Follow-up|0|||
129053410|NCT00663026|464487409|FG002|Overall Study|Lost to Follow-up|0|||
129053411|NCT00663026|464487407|FG000|Overall Study|Other|1|||
129053412|NCT00663026|464487408|FG001|Overall Study|Other|2|||
129053413|NCT00663026|464487409|FG002|Overall Study|Other|0|||
129053414|NCT00663026|464487407|FG000|Overall Study|Adverse Event|0|||
129053415|NCT00663026|464487408|FG001|Overall Study|Adverse Event|2|||
129053416|NCT00663026|464487409|FG002|Overall Study|Adverse Event|3|||
129053417|NCT00663026|464487407|FG000|Overall Study|Caregiver Request|0|||
129053418|NCT00663026|464487408|FG001|Overall Study|Caregiver Request|2|||
129053419|NCT00663026|464487409|FG002|Overall Study|Caregiver Request|0|||
129053420|NCT00663026|464487407|FG000|Overall Study|Withdrawal by Subject|0|||
129053421|NCT00663026|464487408|FG001|Overall Study|Withdrawal by Subject|0|||
129053422|NCT00663026|464487409|FG002|Overall Study|Withdrawal by Subject|1|||
129053423|NCT01570686|464487410|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129053424|NCT01570686|464487411|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129053425|NCT01570686|464487410|FG000|Overall Study|Administrative problems|0|||
129053426|NCT01570686|464487411|FG001|Overall Study|Administrative problems|1|||
128719696|NCT02268409|463273206|FG000|Overall Study|Death|1|||
129053427|NCT01570686|464487410|FG000|Overall Study|Adverse Event|8|||
129053428|NCT01570686|464487411|FG001|Overall Study|Adverse Event|6|||
129053429|NCT01570686|464487410|FG000|Overall Study|Lost to Follow-up|4|||
129053430|NCT01570686|464487411|FG001|Overall Study|Lost to Follow-up|3|||
129053431|NCT01570686|464487410|FG000|Overall Study|Protocol Deviation|3|||
129053432|NCT01570686|464487411|FG001|Overall Study|Protocol Deviation|0|||
129053433|NCT01570686|464487410|FG000|Overall Study|Withdrawal by Subject|4|||
129053434|NCT01570686|464487411|FG001|Overall Study|Withdrawal by Subject|4|||
129053435|NCT01570686|464487410|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129053436|NCT01570686|464487411|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129053437|NCT00686075|464487413|FG000|Overall Study|Withdrawal by Subject|4|||
129053438|NCT00686075|464487414|FG001|Overall Study|Withdrawal by Subject|3|||
129053439|NCT00686075|464487415|FG002|Overall Study|Withdrawal by Subject|3|||
129053440|NCT00686075|464487416|FG003|Overall Study|Withdrawal by Subject|7|||
129053441|NCT00686075|464487417|FG004|Overall Study|Withdrawal by Subject|1|||
129053442|NCT00686075|464487418|FG005|Overall Study|Withdrawal by Subject|0|||
129053443|NCT00686075|464487419|FG006|Overall Study|Withdrawal by Subject|0|||
129053444|NCT00686075|464487420|FG007|Overall Study|Withdrawal by Subject|2|||
129053445|NCT00686075|464487421|FG008|Overall Study|Withdrawal by Subject|4|||
129053446|NCT00686075|464487422|FG009|Overall Study|Withdrawal by Subject|6|||
129053447|NCT00686075|464487413|FG000|Overall Study|Lost to Follow-up|3|||
129053448|NCT00686075|464487414|FG001|Overall Study|Lost to Follow-up|6|||
129053449|NCT00686075|464487415|FG002|Overall Study|Lost to Follow-up|3|||
129053450|NCT00686075|464487416|FG003|Overall Study|Lost to Follow-up|2|||
129053451|NCT00686075|464487417|FG004|Overall Study|Lost to Follow-up|3|||
129053452|NCT00686075|464487418|FG005|Overall Study|Lost to Follow-up|3|||
129053453|NCT00686075|464487419|FG006|Overall Study|Lost to Follow-up|0|||
129053454|NCT00686075|464487420|FG007|Overall Study|Lost to Follow-up|0|||
129053455|NCT00686075|464487421|FG008|Overall Study|Lost to Follow-up|2|||
129053456|NCT00686075|464487422|FG009|Overall Study|Lost to Follow-up|3|||
129053457|NCT00686075|464487413|FG000|Overall Study|Other|1|||
129053458|NCT00686075|464487414|FG001|Overall Study|Other|1|||
129053459|NCT00686075|464487415|FG002|Overall Study|Other|0|||
129053460|NCT00686075|464487416|FG003|Overall Study|Other|0|||
129053461|NCT00686075|464487417|FG004|Overall Study|Other|0|||
129053462|NCT00686075|464487418|FG005|Overall Study|Other|0|||
129053463|NCT00686075|464487419|FG006|Overall Study|Other|0|||
129053464|NCT00686075|464487420|FG007|Overall Study|Other|0|||
129053465|NCT00686075|464487421|FG008|Overall Study|Other|0|||
129053466|NCT00686075|464487422|FG009|Overall Study|Other|1|||
129053467|NCT04715932|464487423|FG000|Overall Study|Lost to Follow-up|1|||
128719697|NCT02268409|463273206|FG000|Overall Study|Lost to Follow-up|1|||
129053468|NCT04715932|464487424|FG001|Overall Study|Lost to Follow-up|0|||
129053469|NCT02740699|464487436|FG000|Overall Study|Lost to Follow-up|5|||
129053470|NCT02740699|464487436|FG000|Overall Study|Withdrawal by Subject|14|||
129053471|NCT02740699|464487436|FG000|Overall Study|Physician Decision|5|||
129053472|NCT03783039|464487438|FG000|Overall Study|Death|2|||
129053473|NCT03783039|464487439|FG001|Overall Study|Death|1|||
129053474|NCT01682863|464487440|FG000|Overall Study|Subject/guardian decision|19|||
129053475|NCT01682863|464487441|FG001|Overall Study|Subject/guardian decision|12|||
129053476|NCT01682863|464487442|FG002|Overall Study|Subject/guardian decision|10|||
129053477|NCT01682863|464487440|FG000|Overall Study|Lost to Follow-up|5|||
128719698|NCT02268409|463273206|FG000|Overall Study|Protocol Violation|3|||
129053478|NCT01682863|464487441|FG001|Overall Study|Lost to Follow-up|1|||
129053479|NCT01682863|464487442|FG002|Overall Study|Lost to Follow-up|6|||
129053480|NCT01682863|464487440|FG000|Overall Study|Death|1|||
128719699|NCT02268409|463273206|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
129053481|NCT01682863|464487441|FG001|Overall Study|Death|3|||
129053482|NCT01682863|464487442|FG002|Overall Study|Death|4|||
129053483|NCT01682863|464487440|FG000|Overall Study|Protocol deviation|1|||
129053484|NCT01682863|464487441|FG001|Overall Study|Protocol deviation|0|||
129053485|NCT01682863|464487442|FG002|Overall Study|Protocol deviation|1|||
129053486|NCT01682863|464487440|FG000|Overall Study|Technical problems|1|||
128719700|NCT02268409|463273206|FG000|Overall Study|Withdrawal by Subject|5|||
128719701|NCT01254227|463273214|FG000|Overall Study|Withdrawal by Subject|6|||
128719702|NCT01254227|463273214|FG000|Overall Study|Lost to Follow-up|6|||
128719703|NCT01254227|463273214|FG000|Overall Study|Adverse Event|5|||
128719704|NCT01254227|463273214|FG000|Overall Study|Abnormal test procedure result|5|||
128719705|NCT01254227|463273214|FG000|Overall Study|Administrative problems|2|||
128719706|NCT01254227|463273214|FG000|Overall Study|Death|1|||
128719707|NCT01254227|463273214|FG000|Overall Study|Protocol deviation|1|||
128719708|NCT03265249|463273217|FG000|Overall Study|Withdrawal by Subject|0|||
128719709|NCT03265249|463273218|FG001|Overall Study|Withdrawal by Subject|1|||
128719710|NCT01614990|463273219|FG000|Overall Study|Protocol Violation|1|||
128719711|NCT01614990|463273220|FG001|Overall Study|Protocol Violation|1|||
128719712|NCT05129488|463273223|FG000|Overall Study|Protocol Violation|3|||
128719713|NCT01012622|463273225|FG000|Overall Study|Withdrawal by Subject|6|||
128719714|NCT01012622|463273225|FG000|Overall Study|Lost to Follow-up|5|||
128719715|NCT01012622|463273225|FG000|Overall Study|Adverse Event|7|||
128719716|NCT01012622|463273225|FG000|Overall Study|non-compliance with the drug|9|||
128719717|NCT01012622|463273225|FG000|Overall Study|Other|1|||
128719718|NCT01012622|463273225|FG000|Overall Study|screening failure|1|||
128719719|NCT01012622|463273225|FG000|Overall Study|withdrawal of consent by a parent|2|||
128719720|NCT03873987|463273228|FG000|Overall Study|Adverse Event|1|||
128719721|NCT03873987|463273229|FG001|Overall Study|Adverse Event|0|||
128719722|NCT03873987|463273228|FG000|Overall Study|staff was unable to start a new IV line|1|||
128719723|NCT03873987|463273229|FG001|Overall Study|staff was unable to start a new IV line|0|||
128719724|NCT03873987|463273228|FG000|Overall Study|Lost to Follow-up|0|||
128719725|NCT03873987|463273229|FG001|Overall Study|Lost to Follow-up|1|||
128719726|NCT02535741|463273230|FG000|Overall Study|Adverse Event|3|||
128719727|NCT02535741|463273230|FG000|Overall Study|Withdrawal by Subject|9|||
128719728|NCT02535741|463273230|FG000|Overall Study|Lost to Follow-up|10|||
128719729|NCT02535741|463273230|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
128719730|NCT02535741|463273230|FG000|Overall Study|Missing data|6|||
128719731|NCT00798369|463273231|FG000|Overall Study|Subject withdrew consent|0|||
128719732|NCT00798369|463273232|FG001|Overall Study|Subject withdrew consent|0|||
128719733|NCT00798369|463273233|FG002|Overall Study|Subject withdrew consent|1|||
128719734|NCT00798369|463273234|FG003|Overall Study|Subject withdrew consent|1|||
128719735|NCT00798369|463273235|FG004|Overall Study|Subject withdrew consent|0|||
128719736|NCT00798369|463273236|FG005|Overall Study|Subject withdrew consent|2|||
128719737|NCT00798369|463273231|FG000|Overall Study|Lost to Follow-up|1|||
128719738|NCT00798369|463273232|FG001|Overall Study|Lost to Follow-up|1|||
128719739|NCT00798369|463273233|FG002|Overall Study|Lost to Follow-up|1|||
128719740|NCT00798369|463273234|FG003|Overall Study|Lost to Follow-up|0|||
128719741|NCT00798369|463273235|FG004|Overall Study|Lost to Follow-up|1|||
128719742|NCT00798369|463273236|FG005|Overall Study|Lost to Follow-up|0|||
128719743|NCT00798369|463273231|FG000|Overall Study|Adminstrative problems|0|||
128719744|NCT00798369|463273232|FG001|Overall Study|Adminstrative problems|0|||
128719745|NCT00798369|463273233|FG002|Overall Study|Adminstrative problems|0|||
128719746|NCT00798369|463273234|FG003|Overall Study|Adminstrative problems|0|||
128719747|NCT00798369|463273235|FG004|Overall Study|Adminstrative problems|0|||
128719748|NCT00798369|463273236|FG005|Overall Study|Adminstrative problems|1|||
128719749|NCT04475588|463273237|FG000|Overall Study|Adverse Event|2|||
128719750|NCT04475588|463273238|FG001|Overall Study|Adverse Event|0|||
128719751|NCT02082210|463273239|FG000|Overall Study|Death|0|||
128719752|NCT02082210|463273240|FG001|Overall Study|Death|0|||
128719753|NCT02082210|463273241|FG002|Overall Study|Death|1|||
128719754|NCT02082210|463273242|FG003|Overall Study|Death|1|||
128719755|NCT02082210|463273243|FG004|Overall Study|Death|1|||
128719756|NCT02082210|463273244|FG005|Overall Study|Death|0|||
128719757|NCT02082210|463273239|FG000|Overall Study|Withdrawal by Subject|0|||
128719758|NCT02082210|463273240|FG001|Overall Study|Withdrawal by Subject|0|||
128719759|NCT02082210|463273241|FG002|Overall Study|Withdrawal by Subject|0|||
128719760|NCT02082210|463273242|FG003|Overall Study|Withdrawal by Subject|1|||
128719761|NCT02082210|463273243|FG004|Overall Study|Withdrawal by Subject|2|||
128719762|NCT02082210|463273244|FG005|Overall Study|Withdrawal by Subject|2|||
128719763|NCT02082210|463273239|FG000|Overall Study|Clinical Progression|0|||
128719764|NCT02082210|463273240|FG001|Overall Study|Clinical Progression|0|||
128719765|NCT02082210|463273241|FG002|Overall Study|Clinical Progression|0|||
129053487|NCT01682863|464487441|FG001|Overall Study|Technical problems|0|||
129053488|NCT01682863|464487442|FG002|Overall Study|Technical problems|0|||
128719766|NCT02082210|463273242|FG003|Overall Study|Clinical Progression|1|||
128719767|NCT02082210|463273243|FG004|Overall Study|Clinical Progression|0|||
129053489|NCT01682863|464487440|FG000|Overall Study|Adverse Event|0|||
128719768|NCT02082210|463273244|FG005|Overall Study|Clinical Progression|0|||
128719769|NCT02082210|463273239|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
128719770|NCT02082210|463273240|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
128719771|NCT02082210|463273241|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
128719772|NCT02082210|463273242|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
128719773|NCT02082210|463273243|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
128719774|NCT02082210|463273244|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
128719775|NCT02082210|463273239|FG000|Overall Study|Physician Decision|0|||
128719776|NCT02082210|463273240|FG001|Overall Study|Physician Decision|0|||
128719777|NCT02082210|463273241|FG002|Overall Study|Physician Decision|1|||
128719778|NCT02082210|463273242|FG003|Overall Study|Physician Decision|1|||
128719779|NCT02082210|463273243|FG004|Overall Study|Physician Decision|0|||
128719780|NCT02082210|463273244|FG005|Overall Study|Physician Decision|0|||
128719781|NCT01063764|463273245|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
128719782|NCT01063764|463273245|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
128719783|NCT01063764|463273245|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
128719784|NCT01063764|463273245|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
128719785|NCT01063764|463273245|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
128719786|NCT01063764|463273245|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
128719787|NCT01063764|463273245|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
128719788|NCT00697515|463273246|FG000|Dose Optimization Period|Adverse Event|4|||
128719789|NCT00697515|463273247|FG001|Dose Optimization Period|Adverse Event|0|||
129053490|NCT01682863|464487441|FG001|Overall Study|Adverse Event|1|||
129053491|NCT01682863|464487442|FG002|Overall Study|Adverse Event|2|||
129053492|NCT01682863|464487440|FG000|Overall Study|Physician Decision|0|||
129053493|NCT01682863|464487441|FG001|Overall Study|Physician Decision|0|||
129053494|NCT01682863|464487442|FG002|Overall Study|Physician Decision|1|||
129053495|NCT00918138|464487444|FG000|Overall Study|Subject withdrew consent|1|||
129053496|NCT00918138|464487445|FG001|Overall Study|Subject withdrew consent|1|||
129053497|NCT00918138|464487444|FG000|Overall Study|Death|1|||
129053498|NCT00918138|464487445|FG001|Overall Study|Death|0|||
129053499|NCT00699374|464487446|FG000|Overall Study|Death|93|||
129053500|NCT00699374|464487447|FG001|Overall Study|Death|83|||
129053501|NCT00699374|464487446|FG000|Overall Study|Adverse Event|70|||
129053502|NCT00699374|464487447|FG001|Overall Study|Adverse Event|67|||
129053503|NCT00699374|464487446|FG000|Overall Study|Global deterioration of health status|7|||
129053504|NCT00699374|464487447|FG001|Overall Study|Global deterioration of health status|8|||
129053505|NCT00699374|464487446|FG000|Overall Study|Lost to Follow-up|3|||
129053506|NCT00699374|464487447|FG001|Overall Study|Lost to Follow-up|5|||
129053507|NCT00699374|464487446|FG000|Overall Study|Withdrawal by Subject|34|||
129053508|NCT00699374|464487447|FG001|Overall Study|Withdrawal by Subject|44|||
129053509|NCT00699374|464487446|FG000|Overall Study|Objective progression or relapse|281|||
129053510|NCT00699374|464487447|FG001|Overall Study|Objective progression or relapse|277|||
129053511|NCT00699374|464487446|FG000|Overall Study|Other|18|||
129053512|NCT00699374|464487447|FG001|Overall Study|Other|15|||
129053513|NCT00699374|464487446|FG000|Overall Study|Protocol Violation|2|||
129053514|NCT00699374|464487447|FG001|Overall Study|Protocol Violation|6|||
129053515|NCT00699374|464487446|FG000|Overall Study|Study terminated by sponsor|13|||
129053516|NCT00699374|464487447|FG001|Overall Study|Study terminated by sponsor|28|||
129053517|NCT00699374|464487446|FG000|Overall Study|Randomized but not treated|4|||
129053518|NCT00699374|464487447|FG001|Overall Study|Randomized but not treated|2|||
129053519|NCT00699374|464487446|FG000|Overall Study|Died 28 days after last dose|5|||
129053520|NCT00699374|464487447|FG001|Overall Study|Died 28 days after last dose|9|||
129053521|NCT01136967|464487451|FG000|Overall Study|Adverse Event|9|||
129053522|NCT01136967|464487452|FG001|Overall Study|Adverse Event|12|||
129053523|NCT01136967|464487451|FG000|Overall Study|Participant Choice|8|||
129053524|NCT01136967|464487452|FG001|Overall Study|Participant Choice|3|||
129053525|NCT01136967|464487451|FG000|Overall Study|Lost to Follow-up|0|||
129136820|NCT02502383|464794496|FG000|Overall Study|Withdrawal by Subject|31|||
129136821|NCT02502383|464794497|FG001|Overall Study|Withdrawal by Subject|24|||
128719790|NCT00697515|463273246|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
128719791|NCT00697515|463273247|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
128719792|NCT00697515|463273246|FG000|Dose Optimization Period|Lost to Follow-up|2|||
128719793|NCT00697515|463273247|FG001|Dose Optimization Period|Lost to Follow-up|0|||
128719794|NCT00697515|463273246|FG000|Dose Optimization Period|sponsor request|2|||
128719795|NCT00697515|463273247|FG001|Dose Optimization Period|sponsor request|0|||
128719796|NCT00697515|463273246|FG000|Dose Optimization Period|called to active duty|1|||
129053526|NCT01136967|464487452|FG001|Overall Study|Lost to Follow-up|1|||
129053527|NCT01136967|464487451|FG000|Overall Study|Withdrawal by Subject|1|||
129053528|NCT01136967|464487452|FG001|Overall Study|Withdrawal by Subject|2|||
129053529|NCT01136967|464487451|FG000|Overall Study|Clinical Progression|3|||
129053530|NCT01136967|464487452|FG001|Overall Study|Clinical Progression|5|||
129053531|NCT01136967|464487451|FG000|Overall Study|Radiation|1|||
129053532|NCT01136967|464487452|FG001|Overall Study|Radiation|0|||
129053533|NCT01136967|464487451|FG000|Overall Study|Non-compliance|1|||
129053534|NCT01136967|464487452|FG001|Overall Study|Non-compliance|0|||
129053535|NCT01136967|464487451|FG000|Overall Study|Investigator's Choice|1|||
129053536|NCT01136967|464487452|FG001|Overall Study|Investigator's Choice|1|||
129053537|NCT01136967|464487451|FG000|Overall Study|Increase in Lesion Size|0|||
129053538|NCT01136967|464487452|FG001|Overall Study|Increase in Lesion Size|2|||
129053539|NCT01136967|464487451|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
129053540|NCT01136967|464487452|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
129053541|NCT02885181|464487453|FG000|Overall Study|Investigator's Discretion|0|||
129053542|NCT02885181|464487454|FG001|Overall Study|Investigator's Discretion|1|||
129053543|NCT02885181|464487455|FG002|Overall Study|Investigator's Discretion|0|||
129053544|NCT02885181|464487456|FG003|Overall Study|Investigator's Discretion|1|||
129053545|NCT02885181|464487453|FG000|Overall Study|Adverse Event|0|||
129053546|NCT02885181|464487454|FG001|Overall Study|Adverse Event|0|||
129053547|NCT02885181|464487455|FG002|Overall Study|Adverse Event|0|||
129053548|NCT02885181|464487456|FG003|Overall Study|Adverse Event|1|||
129053549|NCT02885181|464487453|FG000|Overall Study|Withdrawal by Subject|0|||
129053550|NCT02885181|464487454|FG001|Overall Study|Withdrawal by Subject|0|||
129053551|NCT02885181|464487455|FG002|Overall Study|Withdrawal by Subject|0|||
129053552|NCT02885181|464487456|FG003|Overall Study|Withdrawal by Subject|1|||
129053553|NCT03839823|464487457|FG000|Overall Study|Adverse Event|8|||
129053554|NCT03839823|464487458|FG001|Overall Study|Adverse Event|4|||
129053555|NCT03839823|464487457|FG000|Overall Study|Death|1|||
129053556|NCT03839823|464487458|FG001|Overall Study|Death|0|||
129053557|NCT03839823|464487457|FG000|Overall Study|Physician Decision|1|||
129053558|NCT03839823|464487458|FG001|Overall Study|Physician Decision|5|||
129053559|NCT03839823|464487457|FG000|Overall Study|Progressive Disease (PD)|65|||
129053560|NCT03839823|464487458|FG001|Overall Study|Progressive Disease (PD)|65|||
129053561|NCT03839823|464487457|FG000|Overall Study|Subject Decision|2|||
129053562|NCT03839823|464487458|FG001|Overall Study|Subject Decision|9|||
129053563|NCT03839823|464487457|FG000|Overall Study|Not Treated|0|||
129053564|NCT03839823|464487458|FG001|Overall Study|Not Treated|10|||
129053565|NCT04228783|464487459|FG000|Overall Study|Adverse Event|1|||
129053566|NCT04228783|464487460|FG001|Overall Study|Adverse Event|0|||
129053567|NCT04228783|464487461|FG002|Overall Study|Adverse Event|2|||
129053568|NCT04228783|464487462|FG003|Overall Study|Adverse Event|0|||
129053569|NCT04228783|464487463|FG004|Overall Study|Adverse Event|0|||
129053570|NCT04228783|464487464|FG005|Overall Study|Adverse Event|1|||
129053571|NCT04228783|464487459|FG000|Overall Study|Death|0|||
129053572|NCT04228783|464487460|FG001|Overall Study|Death|0|||
129053573|NCT04228783|464487461|FG002|Overall Study|Death|0|||
129053574|NCT04228783|464487462|FG003|Overall Study|Death|0|||
128719797|NCT00697515|463273247|FG001|Dose Optimization Period|called to active duty|0|||
128719798|NCT00697515|463273246|FG000|Dose Optimization Period|elevated QTc|1|||
128719799|NCT00697515|463273247|FG001|Dose Optimization Period|elevated QTc|0|||
128719800|NCT00697515|463273246|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
128719801|NCT00697515|463273247|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
128719802|NCT00697515|463273246|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
128719803|NCT00697515|463273247|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
128719804|NCT00697515|463273246|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
128719805|NCT00697515|463273247|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
128719806|NCT00697515|463273246|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
128719807|NCT00697515|463273247|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
128719808|NCT01727141|463273249|FG000|Overall Study|Physician Decision|0|||
128719809|NCT01727141|463273250|FG001|Overall Study|Physician Decision|1|||
128719810|NCT01727141|463273251|FG002|Overall Study|Physician Decision|0|||
128719811|NCT01727141|463273252|FG003|Overall Study|Physician Decision|2|||
128719812|NCT01727141|463273249|FG000|Overall Study|Lost to Follow-up|0|||
128719813|NCT01727141|463273250|FG001|Overall Study|Lost to Follow-up|2|||
128719814|NCT01727141|463273251|FG002|Overall Study|Lost to Follow-up|0|||
128719815|NCT01727141|463273252|FG003|Overall Study|Lost to Follow-up|0|||
128719816|NCT01727141|463273249|FG000|Overall Study|Death|0|||
128719817|NCT01727141|463273250|FG001|Overall Study|Death|1|||
128719818|NCT01727141|463273251|FG002|Overall Study|Death|1|||
128719819|NCT01727141|463273252|FG003|Overall Study|Death|1|||
128719820|NCT01727141|463273249|FG000|Overall Study|Protocol deviation|1|||
128719821|NCT01727141|463273250|FG001|Overall Study|Protocol deviation|1|||
128719822|NCT01727141|463273251|FG002|Overall Study|Protocol deviation|0|||
128719823|NCT01727141|463273252|FG003|Overall Study|Protocol deviation|1|||
128719824|NCT01727141|463273249|FG000|Overall Study|Withdrawal by Subject|4|||
128719825|NCT01727141|463273250|FG001|Overall Study|Withdrawal by Subject|4|||
129053575|NCT04228783|464487463|FG004|Overall Study|Death|1|||
129053576|NCT04228783|464487464|FG005|Overall Study|Death|0|||
129053577|NCT04228783|464487459|FG000|Overall Study|Lost to Follow-up|36|||
129053578|NCT04228783|464487460|FG001|Overall Study|Lost to Follow-up|36|||
129053579|NCT04228783|464487461|FG002|Overall Study|Lost to Follow-up|28|||
129053580|NCT04228783|464487462|FG003|Overall Study|Lost to Follow-up|6|||
129053581|NCT04228783|464487463|FG004|Overall Study|Lost to Follow-up|14|||
129053582|NCT04228783|464487464|FG005|Overall Study|Lost to Follow-up|3|||
129053583|NCT04228783|464487459|FG000|Overall Study|Physician Decision|1|||
129053584|NCT04228783|464487460|FG001|Overall Study|Physician Decision|2|||
129053585|NCT04228783|464487461|FG002|Overall Study|Physician Decision|0|||
129053586|NCT04228783|464487462|FG003|Overall Study|Physician Decision|0|||
129053587|NCT04228783|464487463|FG004|Overall Study|Physician Decision|0|||
129053588|NCT04228783|464487464|FG005|Overall Study|Physician Decision|0|||
129053589|NCT04228783|464487459|FG000|Overall Study|Protocol Violation|0|||
129053590|NCT04228783|464487460|FG001|Overall Study|Protocol Violation|0|||
129053591|NCT04228783|464487461|FG002|Overall Study|Protocol Violation|0|||
129053592|NCT04228783|464487462|FG003|Overall Study|Protocol Violation|1|||
129053593|NCT04228783|464487463|FG004|Overall Study|Protocol Violation|0|||
129053594|NCT04228783|464487464|FG005|Overall Study|Protocol Violation|0|||
129053595|NCT04228783|464487459|FG000|Overall Study|Withdrawal by Subject|6|||
129053596|NCT04228783|464487460|FG001|Overall Study|Withdrawal by Subject|10|||
129053597|NCT04228783|464487461|FG002|Overall Study|Withdrawal by Subject|19|||
129053598|NCT04228783|464487462|FG003|Overall Study|Withdrawal by Subject|1|||
129053599|NCT04228783|464487463|FG004|Overall Study|Withdrawal by Subject|2|||
129053600|NCT04228783|464487464|FG005|Overall Study|Withdrawal by Subject|0|||
129053601|NCT04228783|464487459|FG000|Overall Study|Other|4|||
129053602|NCT04228783|464487460|FG001|Overall Study|Other|3|||
129053603|NCT04228783|464487461|FG002|Overall Study|Other|2|||
129053604|NCT04228783|464487462|FG003|Overall Study|Other|1|||
129053605|NCT04228783|464487463|FG004|Overall Study|Other|0|||
129053606|NCT04228783|464487464|FG005|Overall Study|Other|0|||
129053607|NCT03151811|464487469|FG000|Overall Study|Randomized But Not Treated|18|||
129053608|NCT03151811|464487470|FG001|Overall Study|Randomized But Not Treated|3|||
129053609|NCT03151811|464487469|FG000|Overall Study|Progressive Disease|130|||
129053610|NCT03151811|464487470|FG001|Overall Study|Progressive Disease|170|||
129053611|NCT03151811|464487469|FG000|Overall Study|Adverse Event|49|||
129053612|NCT03151811|464487470|FG001|Overall Study|Adverse Event|40|||
129053613|NCT03151811|464487469|FG000|Overall Study|Lack of Efficacy|6|||
129053614|NCT03151811|464487470|FG001|Overall Study|Lack of Efficacy|8|||
129053615|NCT03151811|464487469|FG000|Overall Study|Physician Decision|21|||
129053616|NCT03151811|464487470|FG001|Overall Study|Physician Decision|9|||
129053617|NCT03151811|464487469|FG000|Overall Study|Withdrawal by Subject|17|||
129053618|NCT03151811|464487470|FG001|Overall Study|Withdrawal by Subject|7|||
129053619|NCT03151811|464487469|FG000|Overall Study|Lost to Follow-up|0|||
129053620|NCT03151811|464487470|FG001|Overall Study|Lost to Follow-up|1|||
129053621|NCT03151811|464487469|FG000|Overall Study|Study Terminated by Sponsor|5|||
129053622|NCT03151811|464487470|FG001|Overall Study|Study Terminated by Sponsor|11|||
129053623|NCT01517373|464487471|FG000|Run-in Period|Death|1|||
129053624|NCT01517373|464487472|FG001|Run-in Period|Death|0|||
129053625|NCT01517373|464487473|FG002|Run-in Period|Death|0|||
129053626|NCT01517373|464487474|FG003|Run-in Period|Death|0|||
129053627|NCT01517373|464487475|FG004|Run-in Period|Death|0|||
129053628|NCT01517373|464487476|FG005|Run-in Period|Death|0|||
129053629|NCT01517373|464487471|FG000|Run-in Period|Adverse Event|5|||
129053630|NCT01517373|464487472|FG001|Run-in Period|Adverse Event|0|||
129053631|NCT01517373|464487473|FG002|Run-in Period|Adverse Event|0|||
129053632|NCT01517373|464487474|FG003|Run-in Period|Adverse Event|0|||
129053633|NCT01517373|464487475|FG004|Run-in Period|Adverse Event|0|||
129053634|NCT01517373|464487476|FG005|Run-in Period|Adverse Event|0|||
129053635|NCT01517373|464487471|FG000|Run-in Period|Did not meet eligibility criteria|34|||
129053636|NCT01517373|464487472|FG001|Run-in Period|Did not meet eligibility criteria|0|||
129053637|NCT01517373|464487473|FG002|Run-in Period|Did not meet eligibility criteria|0|||
129053638|NCT01517373|464487474|FG003|Run-in Period|Did not meet eligibility criteria|0|||
129053639|NCT01517373|464487475|FG004|Run-in Period|Did not meet eligibility criteria|0|||
129053640|NCT01517373|464487476|FG005|Run-in Period|Did not meet eligibility criteria|0|||
129053641|NCT01517373|464487471|FG000|Run-in Period|Lost to Follow-up|1|||
129053642|NCT01517373|464487472|FG001|Run-in Period|Lost to Follow-up|0|||
129053643|NCT01517373|464487473|FG002|Run-in Period|Lost to Follow-up|0|||
129053644|NCT01517373|464487474|FG003|Run-in Period|Lost to Follow-up|0|||
129053645|NCT01517373|464487475|FG004|Run-in Period|Lost to Follow-up|0|||
129053646|NCT01517373|464487476|FG005|Run-in Period|Lost to Follow-up|0|||
129053647|NCT01517373|464487471|FG000|Run-in Period|Withdrawal by Subject|12|||
129053648|NCT01517373|464487472|FG001|Run-in Period|Withdrawal by Subject|0|||
129053649|NCT01517373|464487473|FG002|Run-in Period|Withdrawal by Subject|0|||
129053650|NCT01517373|464487474|FG003|Run-in Period|Withdrawal by Subject|0|||
128775495|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
129053651|NCT01517373|464487475|FG004|Run-in Period|Withdrawal by Subject|0|||
129053652|NCT01517373|464487476|FG005|Run-in Period|Withdrawal by Subject|0|||
129053653|NCT01517373|464487471|FG000|Run-in Period|Sponsor Decision|3|||
129053654|NCT01517373|464487472|FG001|Run-in Period|Sponsor Decision|0|||
129053655|NCT01517373|464487473|FG002|Run-in Period|Sponsor Decision|0|||
129053656|NCT01517373|464487474|FG003|Run-in Period|Sponsor Decision|0|||
129053657|NCT01517373|464487475|FG004|Run-in Period|Sponsor Decision|0|||
128775496|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
129053658|NCT01517373|464487476|FG005|Run-in Period|Sponsor Decision|0|||
129053659|NCT01517373|464487471|FG000|Run-in Period|Other|1|||
129053660|NCT01517373|464487472|FG001|Run-in Period|Other|0|||
129053661|NCT01517373|464487473|FG002|Run-in Period|Other|0|||
129053662|NCT01517373|464487474|FG003|Run-in Period|Other|0|||
129053663|NCT01517373|464487475|FG004|Run-in Period|Other|0|||
129053664|NCT01517373|464487476|FG005|Run-in Period|Other|0|||
129053665|NCT01517373|464487471|FG000|Treatment Period|Adverse Event|0|||
129053666|NCT01517373|464487472|FG001|Treatment Period|Adverse Event|0|||
129053667|NCT01517373|464487473|FG002|Treatment Period|Adverse Event|0|||
129053668|NCT01517373|464487474|FG003|Treatment Period|Adverse Event|0|||
129053669|NCT01517373|464487475|FG004|Treatment Period|Adverse Event|0|||
129053670|NCT01517373|464487476|FG005|Treatment Period|Adverse Event|2|||
129053671|NCT01517373|464487471|FG000|Treatment Period|Lost to Follow-up|0|||
129053672|NCT01517373|464487472|FG001|Treatment Period|Lost to Follow-up|0|||
129053673|NCT01517373|464487473|FG002|Treatment Period|Lost to Follow-up|1|||
129053674|NCT01517373|464487474|FG003|Treatment Period|Lost to Follow-up|1|||
129053675|NCT01517373|464487475|FG004|Treatment Period|Lost to Follow-up|0|||
129053676|NCT01517373|464487476|FG005|Treatment Period|Lost to Follow-up|0|||
129053677|NCT01517373|464487471|FG000|Treatment Period|Withdrawal by Subject|0|||
129053678|NCT01517373|464487472|FG001|Treatment Period|Withdrawal by Subject|3|||
129053679|NCT01517373|464487473|FG002|Treatment Period|Withdrawal by Subject|2|||
129053680|NCT01517373|464487474|FG003|Treatment Period|Withdrawal by Subject|2|||
129053681|NCT01517373|464487475|FG004|Treatment Period|Withdrawal by Subject|2|||
129053682|NCT01517373|464487476|FG005|Treatment Period|Withdrawal by Subject|3|||
129053683|NCT01517373|464487471|FG000|Treatment Period|Other|0|||
129053684|NCT01517373|464487472|FG001|Treatment Period|Other|0|||
129053685|NCT01517373|464487473|FG002|Treatment Period|Other|0|||
129053686|NCT01517373|464487474|FG003|Treatment Period|Other|0|||
129053687|NCT01517373|464487475|FG004|Treatment Period|Other|1|||
129053688|NCT01517373|464487476|FG005|Treatment Period|Other|0|||
129053689|NCT01517373|464487471|FG000|Treatment Period|Protocol Violation|0|||
129053690|NCT01517373|464487472|FG001|Treatment Period|Protocol Violation|0|||
129053691|NCT01517373|464487473|FG002|Treatment Period|Protocol Violation|0|||
129053692|NCT01517373|464487474|FG003|Treatment Period|Protocol Violation|0|||
129053693|NCT01517373|464487475|FG004|Treatment Period|Protocol Violation|1|||
129053694|NCT01517373|464487476|FG005|Treatment Period|Protocol Violation|0|||
129053695|NCT01517373|464487471|FG000|Treatment Period|Lack of Efficacy|0|||
129053696|NCT01517373|464487472|FG001|Treatment Period|Lack of Efficacy|1|||
129053697|NCT01517373|464487473|FG002|Treatment Period|Lack of Efficacy|1|||
129053698|NCT01517373|464487474|FG003|Treatment Period|Lack of Efficacy|3|||
129053699|NCT01517373|464487475|FG004|Treatment Period|Lack of Efficacy|2|||
129053700|NCT01517373|464487476|FG005|Treatment Period|Lack of Efficacy|0|||
129053701|NCT01517373|464487471|FG000|Treatment Period|Medication error without AEs|0|||
129053702|NCT01517373|464487472|FG001|Treatment Period|Medication error without AEs|0|||
129053703|NCT01517373|464487473|FG002|Treatment Period|Medication error without AEs|2|||
129053704|NCT01517373|464487474|FG003|Treatment Period|Medication error without AEs|1|||
129053705|NCT01517373|464487475|FG004|Treatment Period|Medication error without AEs|0|||
129053706|NCT01517373|464487476|FG005|Treatment Period|Medication error without AEs|2|||
129053707|NCT04562155|464487480|FG000|Overall Study|COVID-19 pandemic|0|||
129136822|NCT00363467|464794498|FG000|Overall Study|Physician Decision|1|||
129136823|NCT00903344|464794499|FG000|Overall Study|Pregnancy|2|||
129136824|NCT00903344|464794500|FG001|Overall Study|Pregnancy|3|||
129136825|NCT00903344|464794499|FG000|Overall Study|Lost to Follow-up|3|||
129136826|NCT00903344|464794500|FG001|Overall Study|Lost to Follow-up|0|||
129136827|NCT01524705|464794501|FG000|Overall Study|Adverse Event|2|||
129136828|NCT01524705|464794502|FG001|Overall Study|Adverse Event|0|||
129136829|NCT01524705|464794501|FG000|Overall Study|Death|1|||
129136830|NCT01524705|464794502|FG001|Overall Study|Death|0|||
129136831|NCT01524705|464794501|FG000|Overall Study|Lost to Follow-up|0|||
129136832|NCT01524705|464794502|FG001|Overall Study|Lost to Follow-up|1|||
129136833|NCT01524705|464794501|FG000|Overall Study|Withdrawal by Subject|0|||
129136834|NCT01524705|464794502|FG001|Overall Study|Withdrawal by Subject|1|||
129136835|NCT01524705|464794501|FG000|Overall Study|Pancreatic Cancer|0|||
129136836|NCT01524705|464794502|FG001|Overall Study|Pancreatic Cancer|1|||
129136837|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
129136838|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
129136839|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
129136840|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
129136841|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
129053708|NCT04562155|464487481|FG001|Overall Study|COVID-19 pandemic|0|||
129053709|NCT04562155|464487482|FG002|Overall Study|COVID-19 pandemic|0|||
129053710|NCT04562155|464487483|FG003|Overall Study|COVID-19 pandemic|1|||
129053711|NCT04562155|464487480|FG000|Overall Study|Adverse Event|7|||
129053712|NCT04562155|464487481|FG001|Overall Study|Adverse Event|3|||
129053713|NCT04562155|464487482|FG002|Overall Study|Adverse Event|8|||
129053714|NCT04562155|464487483|FG003|Overall Study|Adverse Event|1|||
129053715|NCT04562155|464487480|FG000|Overall Study|Withdrawal by Subject|3|||
129053716|NCT04562155|464487481|FG001|Overall Study|Withdrawal by Subject|6|||
129136842|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
129136843|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
129136844|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
128719826|NCT01727141|463273251|FG002|Overall Study|Withdrawal by Subject|2|||
128719827|NCT01727141|463273252|FG003|Overall Study|Withdrawal by Subject|11|||
128719828|NCT02603432|463273255|FG000|Overall Study|Adverse Event|1|||
128719829|NCT02603432|463273256|FG001|Overall Study|Adverse Event|0|||
128719830|NCT02603432|463273255|FG000|Overall Study|Death|221|||
128719831|NCT02603432|463273256|FG001|Overall Study|Death|242|||
128719832|NCT02603432|463273255|FG000|Overall Study|Lost to Follow-up|3|||
128719833|NCT02603432|463273256|FG001|Overall Study|Lost to Follow-up|9|||
128719834|NCT02603432|463273255|FG000|Overall Study|Progressive Disease|7|||
128719835|NCT02603432|463273256|FG001|Overall Study|Progressive Disease|5|||
129053717|NCT04562155|464487482|FG002|Overall Study|Withdrawal by Subject|3|||
129053718|NCT04562155|464487483|FG003|Overall Study|Withdrawal by Subject|3|||
129053719|NCT04562155|464487480|FG000|Overall Study|Participant personal reason|1|||
129053720|NCT04562155|464487481|FG001|Overall Study|Participant personal reason|0|||
129053721|NCT04562155|464487482|FG002|Overall Study|Participant personal reason|2|||
129053722|NCT04562155|464487483|FG003|Overall Study|Participant personal reason|1|||
129053723|NCT01085201|464487486|FG000|Overall Study|Scheduling conflict|1|||
129053724|NCT01085201|464487487|FG001|Overall Study|Scheduling conflict|0|||
129053725|NCT01085201|464487488|FG002|Overall Study|Scheduling conflict|1|||
129053726|NCT01085201|464487489|FG003|Overall Study|Scheduling conflict|0|||
129053727|NCT01085201|464487490|FG004|Overall Study|Scheduling conflict|0|||
129053728|NCT01085201|464487486|FG000|Overall Study|Unknown- no study drug|2|||
129053729|NCT01085201|464487487|FG001|Overall Study|Unknown- no study drug|0|||
129053730|NCT01085201|464487488|FG002|Overall Study|Unknown- no study drug|0|||
129053731|NCT01085201|464487489|FG003|Overall Study|Unknown- no study drug|0|||
129053732|NCT01085201|464487490|FG004|Overall Study|Unknown- no study drug|0|||
129053733|NCT01085201|464487486|FG000|Overall Study|Fond ineligible after consent|0|||
129053734|NCT01085201|464487487|FG001|Overall Study|Fond ineligible after consent|1|||
129053735|NCT01085201|464487488|FG002|Overall Study|Fond ineligible after consent|1|||
129053736|NCT01085201|464487489|FG003|Overall Study|Fond ineligible after consent|0|||
129053737|NCT01085201|464487490|FG004|Overall Study|Fond ineligible after consent|0|||
129053738|NCT04516759|464487493|FG000|Overall Study|Withdrawal by Subject|1|||
129053739|NCT04516759|464487494|FG001|Overall Study|Withdrawal by Subject|1|||
129053740|NCT04516759|464487493|FG000|Overall Study|Other|0|||
129053741|NCT04516759|464487494|FG001|Overall Study|Other|1|||
129053742|NCT00528411|464487495|FG000|Overall Study|Adverse Event|4|||
129053743|NCT00528411|464487496|FG001|Overall Study|Adverse Event|0|||
129053744|NCT00528411|464487497|FG002|Overall Study|Adverse Event|1|||
129053745|NCT00528411|464487495|FG000|Overall Study|Incorrect Enrolment|1|||
129053746|NCT00528411|464487496|FG001|Overall Study|Incorrect Enrolment|1|||
129053747|NCT00528411|464487497|FG002|Overall Study|Incorrect Enrolment|0|||
129053748|NCT00528411|464487495|FG000|Overall Study|Severe non-compliance to protocol|0|||
129053749|NCT00528411|464487496|FG001|Overall Study|Severe non-compliance to protocol|1|||
129053750|NCT00528411|464487497|FG002|Overall Study|Severe non-compliance to protocol|0|||
129053751|NCT00528411|464487495|FG000|Overall Study|Prior commitment medication|0|||
129053752|NCT00528411|464487496|FG001|Overall Study|Prior commitment medication|1|||
129053753|NCT00528411|464487497|FG002|Overall Study|Prior commitment medication|0|||
129053754|NCT01221363|464487501|FG000|Overall Study|Pregnancy|1|||
129053755|NCT01221363|464487502|FG001|Overall Study|Pregnancy|0|||
129053756|NCT01221363|464487501|FG000|Overall Study|Withdrawal by Subject|11|||
129053757|NCT01221363|464487502|FG001|Overall Study|Withdrawal by Subject|5|||
129053758|NCT02695537|464487507|FG000|Overall Study|Adverse Event|3|||
129053759|NCT02695537|464487507|FG000|Overall Study|Lack of Efficacy|28|||
129053760|NCT02695537|464487507|FG000|Overall Study|Withdrawal by Subject|4|||
129053761|NCT02695537|464487507|FG000|Overall Study|Protocol Violation|3|||
129053762|NCT03597529|464487508|FG000|Overall Study|Lost to Follow-up|10|||
129053763|NCT03597529|464487509|FG001|Overall Study|Lost to Follow-up|12|||
129053764|NCT03597529|464487508|FG000|Overall Study|Physician Decision|3|||
129053765|NCT03597529|464487509|FG001|Overall Study|Physician Decision|1|||
129053766|NCT03597529|464487508|FG000|Overall Study|Withdrawal by Subject|6|||
129053767|NCT03597529|464487509|FG001|Overall Study|Withdrawal by Subject|3|||
129053768|NCT03597529|464487508|FG000|Overall Study|Non-compliant with study activities|1|||
129053769|NCT03597529|464487509|FG001|Overall Study|Non-compliant with study activities|2|||
129053770|NCT00998309|464487516|FG000|Overall Study|Protocol Violation|4|||
129136845|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
128719836|NCT02603432|463273255|FG000|Overall Study|Withdrawal by Subject|12|||
128719837|NCT02603432|463273256|FG001|Overall Study|Withdrawal by Subject|18|||
129053771|NCT02865460|464487517|FG000|Overall Study|Adverse Event|1|||
129053772|NCT02865460|464487518|FG001|Overall Study|Adverse Event|0|||
129053773|NCT02865460|464487517|FG000|Overall Study|Withdrawal by Subject|1|||
129053774|NCT02865460|464487518|FG001|Overall Study|Withdrawal by Subject|1|||
128719838|NCT02603432|463273255|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
129053775|NCT02865460|464487517|FG000|Overall Study|Lost to Follow-up|7|||
129053776|NCT02865460|464487518|FG001|Overall Study|Lost to Follow-up|4|||
129053777|NCT02865460|464487517|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
129053778|NCT02865460|464487518|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
129053779|NCT02238795|464487531|FG000|Overall Study|Patient without purpura fulminans|1|||
129053780|NCT01292226|464487536|FG000|Overall Study|Adverse Event|5|||
129053781|NCT01292226|464487536|FG000|Overall Study|Death|1|||
129053782|NCT01292226|464487536|FG000|Overall Study|Graft loss|1|||
129053783|NCT01292226|464487536|FG000|Overall Study|Protocol Violation|3|||
129053784|NCT01292226|464487536|FG000|Overall Study|Withdrawal by Subject|1|||
129053785|NCT01292226|464487536|FG000|Overall Study|Other|2|||
129053786|NCT04126213|464487537|FG000|Overall Study|Lost to Follow-up|9|||
129053787|NCT04126213|464487538|FG001|Overall Study|Lost to Follow-up|1|||
129053788|NCT04126213|464487539|FG002|Overall Study|Lost to Follow-up|5|||
129053789|NCT04126213|464487540|FG003|Overall Study|Lost to Follow-up|10|||
129053790|NCT04126213|464487541|FG004|Overall Study|Lost to Follow-up|4|||
129053791|NCT04126213|464487542|FG005|Overall Study|Lost to Follow-up|7|||
129053792|NCT04126213|464487537|FG000|Overall Study|Withdrawal by Subject|3|||
129053793|NCT04126213|464487538|FG001|Overall Study|Withdrawal by Subject|2|||
129053794|NCT04126213|464487539|FG002|Overall Study|Withdrawal by Subject|1|||
129053795|NCT04126213|464487540|FG003|Overall Study|Withdrawal by Subject|1|||
129053796|NCT04126213|464487541|FG004|Overall Study|Withdrawal by Subject|1|||
129053797|NCT04126213|464487542|FG005|Overall Study|Withdrawal by Subject|1|||
129053798|NCT04126213|464487537|FG000|Overall Study|Other|0|||
129053799|NCT04126213|464487538|FG001|Overall Study|Other|0|||
129053800|NCT04126213|464487539|FG002|Overall Study|Other|2|||
129053801|NCT04126213|464487540|FG003|Overall Study|Other|2|||
129053802|NCT04126213|464487541|FG004|Overall Study|Other|0|||
129053803|NCT04126213|464487542|FG005|Overall Study|Other|1|||
129053804|NCT04126213|464487537|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129053805|NCT04126213|464487538|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129053806|NCT04126213|464487539|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129053807|NCT04126213|464487540|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129053808|NCT04126213|464487541|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129053809|NCT04126213|464487542|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129053810|NCT02823652|464487543|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
129053811|NCT02823652|464487544|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
129053812|NCT02823652|464487545|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
129053813|NCT02823652|464487543|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
129053814|NCT02823652|464487544|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
129053815|NCT02823652|464487545|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
129053816|NCT02823652|464487543|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
129053817|NCT02823652|464487544|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
129053818|NCT02823652|464487545|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
129053819|NCT02823652|464487543|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
129053820|NCT02823652|464487544|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
129053821|NCT02823652|464487545|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
129053822|NCT03567382|464487546|FG000|Overall Study|Lost to Follow-up|1|||
129053823|NCT03567382|464487547|FG001|Overall Study|Lost to Follow-up|21|||
129053824|NCT03567382|464487548|FG002|Overall Study|Lost to Follow-up|1|||
129053825|NCT03567382|464487549|FG003|Overall Study|Lost to Follow-up|21|||
129053826|NCT03567382|464487546|FG000|Overall Study|Withdrawal by Subject|2|||
129053827|NCT03567382|464487547|FG001|Overall Study|Withdrawal by Subject|14|||
129053828|NCT03567382|464487548|FG002|Overall Study|Withdrawal by Subject|1|||
129053829|NCT03567382|464487549|FG003|Overall Study|Withdrawal by Subject|12|||
129053830|NCT00620659|464487552|FG000|Treatment Period 1|Adverse Event|1|||
129053831|NCT00620659|464487553|FG001|Treatment Period 1|Adverse Event|0|||
128719839|NCT02603432|463273256|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
128719840|NCT02603432|463273255|FG000|Overall Study|Study terminated by sponsor|74|||
128719841|NCT02603432|463273256|FG001|Overall Study|Study terminated by sponsor|75|||
128719842|NCT02603432|463273255|FG000|Overall Study|Other|13|||
128719843|NCT02603432|463273256|FG001|Overall Study|Other|0|||
129053832|NCT00620659|464487554|FG002|Treatment Period 1|Adverse Event|0|||
129053833|NCT00620659|464487555|FG003|Treatment Period 1|Adverse Event|3|||
129053834|NCT00620659|464487556|FG004|Treatment Period 1|Adverse Event|0|||
128719844|NCT04765358|463273260|FG000|Overall Study|Withdrawal by Subject|1|||
128719845|NCT02731729|463273261|FG000|Overall Study|Death|2|||
128719846|NCT02731729|463273262|FG001|Overall Study|Death|2|||
128719847|NCT02731729|463273261|FG000|Overall Study|Study terminated by Sponsor|6|||
128719848|NCT02731729|463273262|FG001|Overall Study|Study terminated by Sponsor|6|||
128719849|NCT02731729|463273261|FG000|Overall Study|Withdrawal by Subject|1|||
128719850|NCT02731729|463273262|FG001|Overall Study|Withdrawal by Subject|0|||
129053835|NCT00620659|464487557|FG005|Treatment Period 1|Adverse Event|0|||
129053836|NCT00620659|464487552|FG000|Treatment Period 1|Protocol Violation|1|||
129053837|NCT00620659|464487553|FG001|Treatment Period 1|Protocol Violation|0|||
129053838|NCT00620659|464487554|FG002|Treatment Period 1|Protocol Violation|0|||
129053839|NCT00620659|464487555|FG003|Treatment Period 1|Protocol Violation|0|||
129053840|NCT00620659|464487556|FG004|Treatment Period 1|Protocol Violation|0|||
129053841|NCT00620659|464487557|FG005|Treatment Period 1|Protocol Violation|0|||
129053842|NCT00620659|464487552|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129053843|NCT00620659|464487553|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129053844|NCT00620659|464487554|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129053845|NCT00620659|464487555|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129053846|NCT00620659|464487556|FG004|Treatment Period 1|Withdrawal by Subject|1|||
129053847|NCT00620659|464487557|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129053848|NCT00620659|464487552|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
129053849|NCT00620659|464487553|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
129053850|NCT00620659|464487554|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
129053851|NCT00620659|464487555|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
129053852|NCT00620659|464487556|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
129053853|NCT00620659|464487557|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
129053854|NCT00620659|464487552|FG000|Treatment Period 2|Adverse Event|0|||
129053855|NCT00620659|464487553|FG001|Treatment Period 2|Adverse Event|3|||
129053856|NCT00620659|464487554|FG002|Treatment Period 2|Adverse Event|0|||
129053857|NCT00620659|464487555|FG003|Treatment Period 2|Adverse Event|0|||
129053858|NCT00620659|464487556|FG004|Treatment Period 2|Adverse Event|2|||
129053859|NCT00620659|464487557|FG005|Treatment Period 2|Adverse Event|0|||
129053860|NCT00620659|464487552|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129053861|NCT00620659|464487553|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129053862|NCT00620659|464487554|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129053863|NCT00620659|464487555|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129053864|NCT00620659|464487556|FG004|Treatment Period 2|Withdrawal by Subject|3|||
129053865|NCT00620659|464487557|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129053866|NCT00620659|464487552|FG000|Placebo Washout Period 2|Adverse Event|2|||
129053867|NCT00620659|464487553|FG001|Placebo Washout Period 2|Adverse Event|0|||
129053868|NCT00620659|464487554|FG002|Placebo Washout Period 2|Adverse Event|0|||
129053869|NCT00620659|464487555|FG003|Placebo Washout Period 2|Adverse Event|0|||
129053870|NCT00620659|464487556|FG004|Placebo Washout Period 2|Adverse Event|0|||
129053871|NCT00620659|464487557|FG005|Placebo Washout Period 2|Adverse Event|0|||
129053872|NCT00620659|464487552|FG000|Treatment Period 3|Adverse Event|0|||
129053873|NCT00620659|464487553|FG001|Treatment Period 3|Adverse Event|2|||
129053874|NCT00620659|464487554|FG002|Treatment Period 3|Adverse Event|0|||
129053875|NCT00620659|464487555|FG003|Treatment Period 3|Adverse Event|0|||
129053876|NCT00620659|464487556|FG004|Treatment Period 3|Adverse Event|0|||
129053877|NCT00620659|464487557|FG005|Treatment Period 3|Adverse Event|0|||
129053878|NCT00620659|464487552|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129053879|NCT00620659|464487553|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129053880|NCT00620659|464487554|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129053881|NCT00620659|464487555|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129053882|NCT00620659|464487556|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129053883|NCT00620659|464487557|FG005|Treatment Period 3|Withdrawal by Subject|0|||
129053884|NCT01214915|464487559|FG000|Overall Study|Adverse Event|8|||
129053885|NCT01214915|464487559|FG000|Overall Study|Lack of Efficacy|3|||
129053886|NCT02056392|464487560|FG000|Overall Study|Lost to Follow-up|0|||
129053887|NCT02056392|464487561|FG001|Overall Study|Lost to Follow-up|1|||
129053888|NCT02056392|464487562|FG002|Overall Study|Lost to Follow-up|2|||
129053889|NCT02056392|464487563|FG003|Overall Study|Lost to Follow-up|0|||
129053890|NCT02056392|464487564|FG004|Overall Study|Lost to Follow-up|0|||
129053891|NCT02056392|464487565|FG005|Overall Study|Lost to Follow-up|0|||
129053892|NCT02056392|464487560|FG000|Overall Study|Protocol Violation|1|||
129053893|NCT02056392|464487561|FG001|Overall Study|Protocol Violation|0|||
129053894|NCT02056392|464487562|FG002|Overall Study|Protocol Violation|1|||
129053895|NCT02056392|464487563|FG003|Overall Study|Protocol Violation|0|||
129053896|NCT02056392|464487564|FG004|Overall Study|Protocol Violation|0|||
129053897|NCT02056392|464487565|FG005|Overall Study|Protocol Violation|0|||
129053898|NCT02056392|464487560|FG000|Overall Study|Withdrawal by Subject|1|||
129053899|NCT02056392|464487561|FG001|Overall Study|Withdrawal by Subject|0|||
129053900|NCT02056392|464487562|FG002|Overall Study|Withdrawal by Subject|0|||
129053901|NCT02056392|464487563|FG003|Overall Study|Withdrawal by Subject|0|||
129053902|NCT02056392|464487564|FG004|Overall Study|Withdrawal by Subject|1|||
129053903|NCT02056392|464487565|FG005|Overall Study|Withdrawal by Subject|0|||
129053904|NCT04555720|464487568|FG000|Overall Study|Lost to Follow-up|2|||
129053905|NCT04555720|464487569|FG001|Overall Study|Lost to Follow-up|0|||
129053906|NCT04555720|464487570|FG002|Overall Study|Lost to Follow-up|0|||
129053907|NCT04555720|464487571|FG003|Overall Study|Lost to Follow-up|0|||
129053908|NCT04555720|464487568|FG000|Overall Study|Withdrawal by Subject|4|||
129053909|NCT04555720|464487569|FG001|Overall Study|Withdrawal by Subject|6|||
129053910|NCT04555720|464487570|FG002|Overall Study|Withdrawal by Subject|0|||
129053911|NCT04555720|464487571|FG003|Overall Study|Withdrawal by Subject|0|||
129053912|NCT00968799|464487572|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
129053913|NCT00719849|464487573|FG000|Overall Study|Death|0|||
129053914|NCT00719849|464487574|FG001|Overall Study|Death|1|||
129053915|NCT01372774|464487577|FG000|Overall Study|Withdrawal prior to treatment|4|||
129053916|NCT01372774|464487578|FG001|Overall Study|Withdrawal prior to treatment|5|||
129053917|NCT02201290|464487579|FG000|Overall Study|Withdrawal by Subject|2|||
129053918|NCT02201290|464487579|FG000|Overall Study|Lack of Efficacy|2|||
129053919|NCT02201290|464487579|FG000|Overall Study|Adverse Event|1|||
129053920|NCT00633243|464489560|FG000|Overall Study|Withdrawal by Subject|0|||
129053921|NCT00633243|464489561|FG001|Overall Study|Withdrawal by Subject|1|||
129053922|NCT00633243|464489560|FG000|Overall Study|incarceration|0|||
129053923|NCT00633243|464489561|FG001|Overall Study|incarceration|2|||
129053924|NCT00633243|464489560|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
129053925|NCT00633243|464489561|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
129053926|NCT00633243|464489560|FG000|Overall Study|Not comfortable with self-injecting|0|||
129053927|NCT00633243|464489561|FG001|Overall Study|Not comfortable with self-injecting|1|||
129053928|NCT00633243|464489560|FG000|Overall Study|Mental Health--Depression|0|||
129053929|NCT00633243|464489561|FG001|Overall Study|Mental Health--Depression|1|||
129053930|NCT00633243|464489560|FG000|Overall Study|Couldn't tolerate side-effects|1|||
129053931|NCT00633243|464489561|FG001|Overall Study|Couldn't tolerate side-effects|1|||
129053932|NCT02022748|464489562|FG000|Overall Study|Adverse Event|1|||
129053933|NCT02022748|464489563|FG001|Overall Study|Adverse Event|1|||
129053934|NCT02022748|464489564|FG002|Overall Study|Adverse Event|0|||
129053935|NCT02022748|464489562|FG000|Overall Study|Withdrawal by Subject|0|||
129053936|NCT02022748|464489563|FG001|Overall Study|Withdrawal by Subject|1|||
129053937|NCT02022748|464489564|FG002|Overall Study|Withdrawal by Subject|0|||
129053938|NCT00461253|464489565|FG000|Overall Study|Death|985|||
129053939|NCT00461253|464489566|FG001|Overall Study|Death|0|||
129053940|NCT00461253|464489565|FG000|Overall Study|Protocol Violation|613|||
129053941|NCT00461253|464489566|FG001|Overall Study|Protocol Violation|236|||
129053942|NCT00461253|464489565|FG000|Overall Study|no response|2609|||
129053943|NCT00461253|464489566|FG001|Overall Study|no response|11789|||
129053944|NCT00461253|464489565|FG000|Overall Study|administrative|773|||
129053945|NCT00461253|464489566|FG001|Overall Study|administrative|7773|||
129053946|NCT04240392|464489567|FG000|Overall Study|Withdrawal by Subject|13|||
129053947|NCT04240392|464489568|FG001|Overall Study|Withdrawal by Subject|4|||
129053948|NCT04240392|464489567|FG000|Overall Study|Lost to Follow-up|11|||
129053949|NCT04240392|464489568|FG001|Overall Study|Lost to Follow-up|12|||
129053950|NCT01523457|464489569|FG000|Overall Study|Withdrawal by Subject|7|||
129053951|NCT01523457|464489570|FG001|Overall Study|Withdrawal by Subject|2|||
129053952|NCT03665441|464489571|FG000|Overall Study|survival follow up ongoing|23|||
129053953|NCT03665441|464489572|FG001|Overall Study|survival follow up ongoing|0|||
129053954|NCT03665441|464489571|FG000|Overall Study|Patients ongoing on treatment|9|||
129053955|NCT03665441|464489572|FG001|Overall Study|Patients ongoing on treatment|6|||
129053956|NCT03665441|464489571|FG000|Overall Study|Randomized but not treated|7|||
129053957|NCT03665441|464489572|FG001|Overall Study|Randomized but not treated|11|||
129053958|NCT03700385|464489575|FG000|Overall Study|Lost to Follow-up|1|||
129053959|NCT01555671|464489579|FG000|Overall Study|Physician Decision|20|||
129053960|NCT01555671|464489580|FG001|Overall Study|Physician Decision|25|||
129053961|NCT00372411|464489581|FG000|Overall Study|Withdrawal by Subject|3|||
129053962|NCT00372411|464489582|FG001|Overall Study|Withdrawal by Subject|4|||
129053963|NCT00372411|464489583|FG002|Overall Study|Withdrawal by Subject|1|||
129053964|NCT00372411|464489581|FG000|Overall Study|Death|0|||
129053965|NCT00372411|464489582|FG001|Overall Study|Death|2|||
129053966|NCT00372411|464489583|FG002|Overall Study|Death|1|||
129053967|NCT00372411|464489581|FG000|Overall Study|Lost to Follow-up|1|||
129053968|NCT00372411|464489582|FG001|Overall Study|Lost to Follow-up|1|||
129053969|NCT00372411|464489583|FG002|Overall Study|Lost to Follow-up|1|||
129053970|NCT00372411|464489581|FG000|Overall Study|Adverse Event|1|||
129053971|NCT00372411|464489582|FG001|Overall Study|Adverse Event|1|||
129053972|NCT00372411|464489583|FG002|Overall Study|Adverse Event|0|||
129053973|NCT04590040|464489584|FG000|Treatment Period|Lost to Follow-up|2|||
129053974|NCT04590040|464489585|FG001|Treatment Period|Lost to Follow-up|5|||
129053975|NCT04590040|464489586|FG002|Treatment Period|Lost to Follow-up|0|||
129053976|NCT04590040|464489584|FG000|Treatment Period|Physician Decision|0|||
129053977|NCT04590040|464489585|FG001|Treatment Period|Physician Decision|0|||
129053978|NCT04590040|464489586|FG002|Treatment Period|Physician Decision|2|||
129053979|NCT03047330|464489587|FG000|Sleep Block 1|Withdrawal by Subject|3|||
129053980|NCT01284361|464489593|FG000|Overall Study|Withdrawal by Subject|1|||
129053981|NCT01284361|464489593|FG000|Overall Study|Protocol Violation|5|||
129053982|NCT01284361|464489593|FG000|Overall Study|Adverse Event|1|||
129136846|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
129136847|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
129136848|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
129053983|NCT01284361|464489593|FG000|Overall Study|Lost to Follow-up|2|||
129053984|NCT04003896|464489594|FG000|Overall Study|Withdrawal by Subject|3|||
128719851|NCT03446040|463273265|FG000|Overall Study|Disease progression|3|||
129053985|NCT04003896|464489594|FG000|Overall Study|Physician Decision|1|||
129053986|NCT01957397|464489595|FG000|Test Period 1|sudden leakage/small bag|1|||
129053987|NCT01957397|464489596|FG001|Test Period 1|sudden leakage/small bag|1|||
129053988|NCT01957397|464489595|FG000|Test Period 1|Withdrawal by Subject|1|||
129053989|NCT01957397|464489596|FG001|Test Period 1|Withdrawal by Subject|0|||
129053990|NCT01957397|464489595|FG000|Test Period 2|Adverse Event|0|||
129053991|NCT01957397|464489596|FG001|Test Period 2|Adverse Event|1|||
129053992|NCT01957397|464489595|FG000|Test Period 3|Adverse Event|1|||
129136849|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
129053993|NCT01957397|464489596|FG001|Test Period 3|Adverse Event|2|||
129053994|NCT01957397|464489595|FG000|Test Period 3|the adhesive did not work|1|||
129053995|NCT01957397|464489596|FG001|Test Period 3|the adhesive did not work|0|||
129053996|NCT00324649|464489597|FG000|Overall Study|Adverse Event|1|||
129053997|NCT00324649|464489598|FG001|Overall Study|Adverse Event|4|||
129053998|NCT00324649|464489597|FG000|Overall Study|Withdrawal by Subject|0|||
129053999|NCT00324649|464489598|FG001|Overall Study|Withdrawal by Subject|1|||
129054000|NCT00324649|464489597|FG000|Overall Study|Noncompliance|1|||
129054001|NCT00324649|464489598|FG001|Overall Study|Noncompliance|0|||
129054002|NCT04713553|464489601|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
129054003|NCT04713553|464489602|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
129054004|NCT04713553|464489603|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
129054005|NCT04713553|464489604|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
129054006|NCT04713553|464489605|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
129054007|NCT04713553|464489606|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
129054008|NCT04713553|464489607|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
129054009|NCT04713553|464489601|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129054010|NCT04713553|464489602|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129054011|NCT04713553|464489603|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129054012|NCT04713553|464489604|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
129054013|NCT04713553|464489605|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129054014|NCT04713553|464489606|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129054015|NCT04713553|464489607|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129054016|NCT04713553|464489601|FG000|Primary Study (2 Months)|Other|1|||
129054017|NCT04713553|464489602|FG001|Primary Study (2 Months)|Other|2|||
129054018|NCT04713553|464489603|FG002|Primary Study (2 Months)|Other|0|||
129054019|NCT04713553|464489604|FG003|Primary Study (2 Months)|Other|0|||
129054020|NCT04713553|464489605|FG004|Primary Study (2 Months)|Other|1|||
129054021|NCT04713553|464489606|FG005|Primary Study (2 Months)|Other|0|||
129054022|NCT04713553|464489607|FG006|Primary Study (2 Months)|Other|0|||
129054023|NCT04713553|464489601|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
129054024|NCT04713553|464489602|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
129054025|NCT04713553|464489603|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
129054026|NCT04713553|464489604|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
129054027|NCT04713553|464489605|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
129054028|NCT04713553|464489606|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
129054029|NCT04713553|464489607|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
129054030|NCT04713553|464489601|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
129054031|NCT04713553|464489602|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
129054032|NCT04713553|464489603|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
129054033|NCT04713553|464489604|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
129054034|NCT04713553|464489605|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
129054035|NCT04713553|464489606|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
129054036|NCT04713553|464489607|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
129054037|NCT02315196|464489614|FG000|Overall Study|Withdrew consent|9|||
129054038|NCT02085135|464489615|FG000|Overall Study|Adverse Event|4|||
129054039|NCT02085135|464489616|FG001|Overall Study|Adverse Event|7|||
129054040|NCT02085135|464489615|FG000|Overall Study|Lost to Follow-up|2|||
129054041|NCT02085135|464489616|FG001|Overall Study|Lost to Follow-up|2|||
129054042|NCT02085135|464489615|FG000|Overall Study|Withdrawal by Subject|3|||
129054043|NCT02085135|464489616|FG001|Overall Study|Withdrawal by Subject|0|||
129054044|NCT02085135|464489615|FG000|Overall Study|Lack of Efficacy|2|||
129054045|NCT02085135|464489616|FG001|Overall Study|Lack of Efficacy|0|||
129054046|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
129054047|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
129054048|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
129054049|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
129054050|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
129054051|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
129054052|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
129054053|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
129136850|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
129136851|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
129054054|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
129054055|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
129054056|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Death|1|||
129054057|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Death|0|||
129054058|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Death|0|||
129054059|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Death|0|||
129054060|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Death|0|||
129054061|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
129054062|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
129054063|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
129054064|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
129054065|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
129054066|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
129054067|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
129054068|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
129054069|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
129054070|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
129054071|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
129054072|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
129054073|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
129054074|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
129054075|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
129054076|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
129054077|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
129054078|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
129054079|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
129054080|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129054081|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
129054082|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129054083|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129054084|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129054085|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129054086|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Other|4|||
129054087|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Other|4|||
129054088|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Other|3|||
129054089|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Other|1|||
129054090|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Other|0|||
129054091|NCT01081834|464489621|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
129054092|NCT01081834|464489622|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
129054093|NCT01081834|464489623|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129054094|NCT01081834|464489624|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129054095|NCT01081834|464489625|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129054096|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129054097|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
128719852|NCT03446040|463273266|FG001|Overall Study|Disease progression|3|||
128719853|NCT03446040|463273267|FG002|Overall Study|Disease progression|3|||
128719854|NCT03446040|463273268|FG003|Overall Study|Disease progression|4|||
128719855|NCT03446040|463273269|FG004|Overall Study|Disease progression|4|||
128719856|NCT03446040|463273270|FG005|Overall Study|Disease progression|6|||
128719857|NCT03446040|463273271|FG006|Overall Study|Disease progression|3|||
128719858|NCT03446040|463273272|FG007|Overall Study|Disease progression|4|||
128719859|NCT03446040|463273273|FG008|Overall Study|Disease progression|2|||
128719860|NCT03446040|463273274|FG009|Overall Study|Disease progression|4|||
128719861|NCT03446040|463273275|FG010|Overall Study|Disease progression|9|||
128719862|NCT03446040|463273276|FG011|Overall Study|Disease progression|3|||
128719863|NCT03446040|463273277|FG012|Overall Study|Disease progression|7|||
128719864|NCT03446040|463273278|FG013|Overall Study|Disease progression|7|||
128719865|NCT03446040|463273265|FG000|Overall Study|Study drug toxicity|0|||
128719866|NCT03446040|463273266|FG001|Overall Study|Study drug toxicity|0|||
128719867|NCT03446040|463273267|FG002|Overall Study|Study drug toxicity|0|||
128719868|NCT03446040|463273268|FG003|Overall Study|Study drug toxicity|0|||
128719869|NCT03446040|463273269|FG004|Overall Study|Study drug toxicity|0|||
128719870|NCT03446040|463273270|FG005|Overall Study|Study drug toxicity|0|||
128719871|NCT03446040|463273271|FG006|Overall Study|Study drug toxicity|0|||
128719872|NCT03446040|463273272|FG007|Overall Study|Study drug toxicity|0|||
128719873|NCT03446040|463273273|FG008|Overall Study|Study drug toxicity|1|||
128719874|NCT03446040|463273274|FG009|Overall Study|Study drug toxicity|0|||
129054098|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129054099|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129054100|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129054101|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Death|1|||
129054102|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Death|0|||
129136852|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
128719875|NCT03446040|463273275|FG010|Overall Study|Study drug toxicity|0|||
128719876|NCT03446040|463273276|FG011|Overall Study|Study drug toxicity|0|||
128719877|NCT03446040|463273277|FG012|Overall Study|Study drug toxicity|0|||
128719878|NCT03446040|463273278|FG013|Overall Study|Study drug toxicity|0|||
128775497|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
128719879|NCT03446040|463273265|FG000|Overall Study|Adverse Event|0|||
129054103|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Death|0|||
129054104|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Death|0|||
129054105|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Death|0|||
129054106|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
129054107|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
129054108|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129054109|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129054110|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129054111|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129054112|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129054113|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129054114|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129054115|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129054116|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129054117|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
129054118|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129054119|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129054120|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129054121|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129054122|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129054123|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129054124|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129054125|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129054126|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
129054127|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
129054128|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
129054129|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
129054130|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
129054131|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Other|4|||
129054132|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Other|5|||
129054133|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Other|4|||
129054134|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Other|0|||
129054135|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Other|0|||
129054136|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
129054137|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
129054138|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
129054139|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
129054140|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
129054141|NCT01081834|464489621|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129054142|NCT01081834|464489622|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
129054143|NCT01081834|464489623|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129054144|NCT01081834|464489624|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129054145|NCT01081834|464489625|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129054146|NCT01475097|464489632|FG000|Overall Study|Protocol Violation|1|||
129054147|NCT01475097|464489633|FG001|Overall Study|Protocol Violation|1|||
129054148|NCT00851318|464489644|FG000|Overall Study|Withdrawal by Subject|7|||
129054149|NCT00851318|464489645|FG001|Overall Study|Withdrawal by Subject|1|||
129054150|NCT00851318|464489646|FG002|Overall Study|Withdrawal by Subject|5|||
129054151|NCT00851318|464489647|FG003|Overall Study|Withdrawal by Subject|3|||
129054152|NCT00851318|464489644|FG000|Overall Study|Adverse Event|13|||
129054153|NCT00851318|464489645|FG001|Overall Study|Adverse Event|2|||
128719880|NCT03446040|463273266|FG001|Overall Study|Adverse Event|0|||
128719881|NCT03446040|463273267|FG002|Overall Study|Adverse Event|0|||
128719882|NCT03446040|463273268|FG003|Overall Study|Adverse Event|0|||
129054154|NCT00851318|464489646|FG002|Overall Study|Adverse Event|9|||
129054155|NCT00851318|464489647|FG003|Overall Study|Adverse Event|12|||
128719883|NCT03446040|463273269|FG004|Overall Study|Adverse Event|0|||
128719884|NCT03446040|463273270|FG005|Overall Study|Adverse Event|2|||
128719885|NCT03446040|463273271|FG006|Overall Study|Adverse Event|0|||
128719886|NCT03446040|463273272|FG007|Overall Study|Adverse Event|0|||
128719887|NCT03446040|463273273|FG008|Overall Study|Adverse Event|1|||
128719888|NCT03446040|463273274|FG009|Overall Study|Adverse Event|0|||
129054156|NCT00851318|464489644|FG000|Overall Study|Pregnancy|0|||
129054157|NCT00851318|464489645|FG001|Overall Study|Pregnancy|0|||
129054158|NCT00851318|464489646|FG002|Overall Study|Pregnancy|1|||
128719889|NCT03446040|463273275|FG010|Overall Study|Adverse Event|0|||
128719890|NCT03446040|463273276|FG011|Overall Study|Adverse Event|0|||
128719891|NCT03446040|463273277|FG012|Overall Study|Adverse Event|0|||
129054159|NCT00851318|464489647|FG003|Overall Study|Pregnancy|1|||
129054160|NCT00851318|464489644|FG000|Overall Study|Lack of Efficacy|8|||
129054161|NCT00851318|464489645|FG001|Overall Study|Lack of Efficacy|2|||
129054162|NCT00851318|464489646|FG002|Overall Study|Lack of Efficacy|4|||
129054163|NCT00851318|464489647|FG003|Overall Study|Lack of Efficacy|2|||
129054164|NCT00851318|464489644|FG000|Overall Study|Non-compliance with Study Procedures|2|||
129054165|NCT00851318|464489645|FG001|Overall Study|Non-compliance with Study Procedures|0|||
129054166|NCT00851318|464489646|FG002|Overall Study|Non-compliance with Study Procedures|1|||
129054167|NCT00851318|464489647|FG003|Overall Study|Non-compliance with Study Procedures|0|||
129054168|NCT00851318|464489644|FG000|Overall Study|Physician Decision|0|||
129054169|NCT00851318|464489645|FG001|Overall Study|Physician Decision|0|||
129054170|NCT00851318|464489646|FG002|Overall Study|Physician Decision|1|||
129054171|NCT00851318|464489647|FG003|Overall Study|Physician Decision|1|||
129054172|NCT01844856|464489654|FG000|Overall Study|Lost to Follow-up|15|||
129054173|NCT01844856|464489655|FG001|Overall Study|Lost to Follow-up|3|||
129054174|NCT01844856|464489654|FG000|Overall Study|Adverse Event|3|||
129054175|NCT01844856|464489655|FG001|Overall Study|Adverse Event|6|||
129054176|NCT01844856|464489654|FG000|Overall Study|Withdrawal by Subject|3|||
129054177|NCT01844856|464489655|FG001|Overall Study|Withdrawal by Subject|2|||
129054178|NCT01844856|464489654|FG000|Overall Study|Noncompliance|2|||
129054179|NCT01844856|464489655|FG001|Overall Study|Noncompliance|3|||
129054180|NCT01844856|464489654|FG000|Overall Study|Enterococcus Resistant|0|||
129054181|NCT01844856|464489655|FG001|Overall Study|Enterococcus Resistant|1|||
129054182|NCT01844856|464489654|FG000|Overall Study|Inadvertently Not Scheduled|1|||
129054183|NCT01844856|464489655|FG001|Overall Study|Inadvertently Not Scheduled|0|||
129054184|NCT01844856|464489654|FG000|Overall Study|Randomized but was a Screen Failure|0|||
129054185|NCT01844856|464489655|FG001|Overall Study|Randomized but was a Screen Failure|1|||
129054186|NCT01001988|464489656|FG000|Overall Study|Protocol Violation|84|||
129054187|NCT01001988|464489656|FG000|Overall Study|Withdrawal by Subject|18|||
129054188|NCT01001988|464489656|FG000|Overall Study|Lost to Follow-up|15|||
129054189|NCT01442688|464489657|FG000|First Intervention|Withdrawal by Subject|1|||
129054190|NCT01442688|464489658|FG001|First Intervention|Withdrawal by Subject|0|||
129054191|NCT01442688|464489657|FG000|First Intervention|subject incarcerated|1|||
129054192|NCT01442688|464489658|FG001|First Intervention|subject incarcerated|0|||
129054193|NCT01442688|464489657|FG000|Second Intervention|Adverse Event|1|||
129054194|NCT01442688|464489658|FG001|Second Intervention|Adverse Event|0|||
129054195|NCT00927394|464489661|FG000|Overall Study|Adverse Event|14|||
129054196|NCT00927394|464489662|FG001|Overall Study|Adverse Event|9|||
128719892|NCT03446040|463273278|FG013|Overall Study|Adverse Event|0|||
128719893|NCT03446040|463273265|FG000|Overall Study|Death|0|||
128719894|NCT03446040|463273266|FG001|Overall Study|Death|0|||
128719895|NCT03446040|463273267|FG002|Overall Study|Death|0|||
128719896|NCT03446040|463273268|FG003|Overall Study|Death|0|||
128719897|NCT03446040|463273269|FG004|Overall Study|Death|0|||
128719898|NCT03446040|463273270|FG005|Overall Study|Death|0|||
128719899|NCT03446040|463273271|FG006|Overall Study|Death|0|||
128719900|NCT03446040|463273272|FG007|Overall Study|Death|0|||
128719901|NCT03446040|463273273|FG008|Overall Study|Death|0|||
128719902|NCT03446040|463273274|FG009|Overall Study|Death|0|||
128719903|NCT03446040|463273275|FG010|Overall Study|Death|1|||
128719904|NCT03446040|463273276|FG011|Overall Study|Death|0|||
128719905|NCT03446040|463273277|FG012|Overall Study|Death|0|||
128719906|NCT03446040|463273278|FG013|Overall Study|Death|2|||
128719907|NCT03446040|463273265|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
128719908|NCT03446040|463273266|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
128719909|NCT03446040|463273267|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
128719910|NCT03446040|463273268|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
128719911|NCT03446040|463273269|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
128719912|NCT03446040|463273270|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
128719913|NCT03446040|463273271|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
128719914|NCT03446040|463273272|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
128719915|NCT03446040|463273273|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
129054197|NCT00927394|464489661|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
129054198|NCT00927394|464489662|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
129054199|NCT00927394|464489661|FG000|Overall Study|Withdrawal by Subject|20|||
129054200|NCT00927394|464489662|FG001|Overall Study|Withdrawal by Subject|24|||
129054201|NCT00927394|464489661|FG000|Overall Study|Lost to Follow-up|8|||
129054202|NCT00927394|464489662|FG001|Overall Study|Lost to Follow-up|14|||
129054203|NCT00927394|464489661|FG000|Overall Study|Administrative Problem|1|||
129054204|NCT00927394|464489662|FG001|Overall Study|Administrative Problem|0|||
128719916|NCT03446040|463273274|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
128719917|NCT03446040|463273275|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
129054205|NCT00927394|464489661|FG000|Overall Study|Death|1|||
129054206|NCT00927394|464489662|FG001|Overall Study|Death|1|||
129054207|NCT00927394|464489661|FG000|Overall Study|Protocol deviation|16|||
129054208|NCT00927394|464489662|FG001|Overall Study|Protocol deviation|13|||
129054209|NCT00927394|464489661|FG000|Overall Study|Randomized in error|0|||
129054210|NCT00927394|464489662|FG001|Overall Study|Randomized in error|1|||
129054211|NCT01329549|464489665|FG000|Overall Study|Withdrawal by Subject|1|||
129054212|NCT01329549|464489665|FG000|Overall Study|Adverse Event|1|||
129054213|NCT02792699|464489675|FG000|Overall Study|Adverse Event|1|||
129054214|NCT02792699|464489676|FG001|Overall Study|Adverse Event|2|||
129054215|NCT02792699|464489677|FG002|Overall Study|Adverse Event|4|||
129054216|NCT02792699|464489675|FG000|Overall Study|Withdrawal by Subject|4|||
129054217|NCT02792699|464489676|FG001|Overall Study|Withdrawal by Subject|4|||
129054218|NCT02792699|464489677|FG002|Overall Study|Withdrawal by Subject|3|||
129054219|NCT02792699|464489675|FG000|Overall Study|Lost to Follow-up|0|||
129054220|NCT02792699|464489676|FG001|Overall Study|Lost to Follow-up|1|||
129054221|NCT02792699|464489677|FG002|Overall Study|Lost to Follow-up|2|||
129054222|NCT02792699|464489675|FG000|Overall Study|Physician Decision|2|||
129054223|NCT02792699|464489676|FG001|Overall Study|Physician Decision|0|||
129054224|NCT02792699|464489677|FG002|Overall Study|Physician Decision|0|||
129054225|NCT02792699|464489675|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
129054226|NCT02792699|464489676|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
129054227|NCT02792699|464489677|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
129054228|NCT02792699|464489675|FG000|Overall Study|Other|1|||
129054229|NCT02792699|464489676|FG001|Overall Study|Other|0|||
129054230|NCT02792699|464489677|FG002|Overall Study|Other|0|||
129054231|NCT01755767|464489678|FG000|Overall Study|Progressive Disease|8|||
129054232|NCT01755767|464489679|FG001|Overall Study|Progressive Disease|7|||
129054233|NCT01755767|464489680|FG002|Overall Study|Progressive Disease|91|||
129054234|NCT01755767|464489681|FG003|Overall Study|Progressive Disease|43|||
129054235|NCT01755767|464489678|FG000|Overall Study|Clinical Disease Progression|4|||
129054236|NCT01755767|464489679|FG001|Overall Study|Clinical Disease Progression|2|||
129054237|NCT01755767|464489680|FG002|Overall Study|Clinical Disease Progression|29|||
129054238|NCT01755767|464489681|FG003|Overall Study|Clinical Disease Progression|20|||
129054239|NCT01755767|464489678|FG000|Overall Study|Radiographic Disease Progression|9|||
129054240|NCT01755767|464489679|FG001|Overall Study|Radiographic Disease Progression|4|||
129054241|NCT01755767|464489680|FG002|Overall Study|Radiographic Disease Progression|44|||
129054242|NCT01755767|464489681|FG003|Overall Study|Radiographic Disease Progression|27|||
129054243|NCT01755767|464489678|FG000|Overall Study|Adverse Event|6|||
129054244|NCT01755767|464489679|FG001|Overall Study|Adverse Event|0|||
129054245|NCT01755767|464489680|FG002|Overall Study|Adverse Event|28|||
129054246|NCT01755767|464489681|FG003|Overall Study|Adverse Event|11|||
129054247|NCT01755767|464489678|FG000|Overall Study|Death|1|||
129054248|NCT01755767|464489679|FG001|Overall Study|Death|2|||
129054249|NCT01755767|464489680|FG002|Overall Study|Death|15|||
129054250|NCT01755767|464489681|FG003|Overall Study|Death|4|||
129054251|NCT01755767|464489678|FG000|Overall Study|Subject Decision|0|||
129054252|NCT01755767|464489679|FG001|Overall Study|Subject Decision|0|||
129054253|NCT01755767|464489680|FG002|Overall Study|Subject Decision|10|||
129054254|NCT01755767|464489681|FG003|Overall Study|Subject Decision|3|||
129054255|NCT01755767|464489678|FG000|Overall Study|Withdrawal by Subject|0|||
129054256|NCT01755767|464489679|FG001|Overall Study|Withdrawal by Subject|0|||
129054257|NCT01755767|464489680|FG002|Overall Study|Withdrawal by Subject|2|||
129054258|NCT01755767|464489681|FG003|Overall Study|Withdrawal by Subject|1|||
129054259|NCT01755767|464489678|FG000|Overall Study|Other|0|||
129054260|NCT01755767|464489679|FG001|Overall Study|Other|0|||
129054261|NCT01755767|464489680|FG002|Overall Study|Other|2|||
129054262|NCT01755767|464489681|FG003|Overall Study|Other|3|||
129054263|NCT01755767|464489678|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
129054264|NCT01755767|464489679|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
129054265|NCT01755767|464489680|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
129054266|NCT01755767|464489681|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
128719918|NCT03446040|463273276|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
128719919|NCT03446040|463273277|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
129054267|NCT03464630|464489682|FG000|Overall Study|Lost to Follow-up|62|||
129054268|NCT03464630|464489683|FG001|Overall Study|Lost to Follow-up|52|||
129054269|NCT03464630|464489682|FG000|Overall Study|Withdrawal by Subject|16|||
129054270|NCT03464630|464489683|FG001|Overall Study|Withdrawal by Subject|10|||
129054271|NCT03464630|464489682|FG000|Overall Study|Passive Disengagement|8|||
128719920|NCT03446040|463273278|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
129054272|NCT03464630|464489683|FG001|Overall Study|Passive Disengagement|4|||
129054273|NCT00191165|464489684|FG000|Overall Study|Adverse Event|2|||
129054274|NCT00191165|464489685|FG001|Overall Study|Adverse Event|0|||
129054275|NCT00191165|464489684|FG000|Overall Study|Protocol Violation|0|||
129054276|NCT00191165|464489685|FG001|Overall Study|Protocol Violation|1|||
129054277|NCT00191165|464489684|FG000|Overall Study|Participant Moved Away|0|||
129054278|NCT00191165|464489685|FG001|Overall Study|Participant Moved Away|1|||
129054279|NCT03196635|464489686|FG000|Overall Study|Withdrawal by Subject|1|||
129054280|NCT00380744|464489691|FG000|Overall Study|Death|0|||
129054281|NCT00380744|464489692|FG001|Overall Study|Death|0|||
129054282|NCT00380744|464489693|FG002|Overall Study|Death|0|||
129054283|NCT00380744|464489694|FG003|Overall Study|Death|0|||
129054284|NCT00380744|464489695|FG004|Overall Study|Death|0|||
129054285|NCT00380744|464489696|FG005|Overall Study|Death|0|||
129054286|NCT00380744|464489697|FG006|Overall Study|Death|1|||
129054287|NCT00380744|464489691|FG000|Overall Study|Withdrawal by Subject|1|||
129054288|NCT00380744|464489692|FG001|Overall Study|Withdrawal by Subject|0|||
129054289|NCT00380744|464489693|FG002|Overall Study|Withdrawal by Subject|0|||
129054290|NCT00380744|464489694|FG003|Overall Study|Withdrawal by Subject|0|||
129054291|NCT00380744|464489695|FG004|Overall Study|Withdrawal by Subject|0|||
129054292|NCT00380744|464489696|FG005|Overall Study|Withdrawal by Subject|0|||
129054293|NCT00380744|464489697|FG006|Overall Study|Withdrawal by Subject|0|||
129054294|NCT01338870|464489698|FG000|Overall Study|Lost to Follow-up|0|||
129054295|NCT01338870|464489699|FG001|Overall Study|Lost to Follow-up|0|||
129054296|NCT01338870|464489700|FG002|Overall Study|Lost to Follow-up|1|||
129054297|NCT01338870|464489701|FG003|Overall Study|Lost to Follow-up|0|||
129054298|NCT01338870|464489702|FG004|Overall Study|Lost to Follow-up|1|||
129054299|NCT01338870|464489703|FG005|Overall Study|Lost to Follow-up|0|||
129054300|NCT01338870|464489698|FG000|Overall Study|Withdrawal by Subject|2|||
129054301|NCT01338870|464489699|FG001|Overall Study|Withdrawal by Subject|3|||
129054302|NCT01338870|464489700|FG002|Overall Study|Withdrawal by Subject|4|||
129054303|NCT01338870|464489701|FG003|Overall Study|Withdrawal by Subject|0|||
129054304|NCT01338870|464489702|FG004|Overall Study|Withdrawal by Subject|0|||
129054305|NCT01338870|464489703|FG005|Overall Study|Withdrawal by Subject|2|||
129054306|NCT01338870|464489698|FG000|Overall Study|Other|3|||
129054307|NCT01338870|464489699|FG001|Overall Study|Other|3|||
129054308|NCT01338870|464489700|FG002|Overall Study|Other|3|||
129054309|NCT01338870|464489701|FG003|Overall Study|Other|2|||
129054310|NCT01338870|464489702|FG004|Overall Study|Other|0|||
129054311|NCT01338870|464489703|FG005|Overall Study|Other|2|||
129054312|NCT01338870|464489698|FG000|Overall Study|Protocol Violation|0|||
129054313|NCT01338870|464489699|FG001|Overall Study|Protocol Violation|2|||
129054314|NCT01338870|464489700|FG002|Overall Study|Protocol Violation|2|||
129054315|NCT01338870|464489701|FG003|Overall Study|Protocol Violation|2|||
129054316|NCT01338870|464489702|FG004|Overall Study|Protocol Violation|1|||
129054317|NCT01338870|464489703|FG005|Overall Study|Protocol Violation|1|||
129054318|NCT01338870|464489698|FG000|Overall Study|Adverse Event|4|||
129054319|NCT01338870|464489699|FG001|Overall Study|Adverse Event|4|||
129054320|NCT01338870|464489700|FG002|Overall Study|Adverse Event|1|||
129054321|NCT01338870|464489701|FG003|Overall Study|Adverse Event|5|||
129054322|NCT01338870|464489702|FG004|Overall Study|Adverse Event|4|||
129054323|NCT01338870|464489703|FG005|Overall Study|Adverse Event|1|||
129054324|NCT04480021|464489708|FG000|Overall Study|Lost to Follow-up|3|||
129054325|NCT04480021|464489709|FG001|Overall Study|Lost to Follow-up|4|||
129054326|NCT01844505|464489712|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
129054327|NCT01844505|464489713|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
129054328|NCT01844505|464489714|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
129054329|NCT01844505|464489712|FG000|Treatment Period|Other Reasons|120|||
129054330|NCT01844505|464489713|FG001|Treatment Period|Other Reasons|136|||
129054331|NCT01844505|464489714|FG002|Treatment Period|Other Reasons|58|||
129054332|NCT01844505|464489712|FG000|Treatment Period|Lost to Follow-up|9|||
129054333|NCT01844505|464489713|FG001|Treatment Period|Lost to Follow-up|11|||
129054334|NCT01844505|464489714|FG002|Treatment Period|Lost to Follow-up|6|||
129054335|NCT01844505|464489712|FG000|Treatment Period|Death|175|||
129054336|NCT01844505|464489713|FG001|Treatment Period|Death|154|||
129054337|NCT01844505|464489714|FG002|Treatment Period|Death|228|||
129054338|NCT03384654|464489715|FG000|Overall Study|Withdrawal by Subject|0|||
129054339|NCT03384654|464489716|FG001|Overall Study|Withdrawal by Subject|0|||
129054340|NCT03384654|464489717|FG002|Overall Study|Withdrawal by Subject|1|||
128719921|NCT03446040|463273265|FG000|Overall Study|Participant withdrew consent|0|||
129054341|NCT03384654|464489718|FG003|Overall Study|Withdrawal by Subject|0|||
129054342|NCT00423319|464489719|FG000|Overall Study|Death|2|||
129054343|NCT00423319|464489720|FG001|Overall Study|Death|0|||
129054344|NCT00423319|464489719|FG000|Overall Study|Adverse Event|93|||
129054345|NCT00423319|464489720|FG001|Overall Study|Adverse Event|112|||
129054346|NCT00423319|464489719|FG000|Overall Study|Withdrawal by Subject|86|||
129054347|NCT00423319|464489720|FG001|Overall Study|Withdrawal by Subject|99|||
129054348|NCT00423319|464489719|FG000|Overall Study|Lost to Follow-up|4|||
129054349|NCT00423319|464489720|FG001|Overall Study|Lost to Follow-up|3|||
129054350|NCT00423319|464489719|FG000|Overall Study|Poor compliance or noncompliance|1|||
129054351|NCT00423319|464489720|FG001|Overall Study|Poor compliance or noncompliance|1|||
129054352|NCT00423319|464489719|FG000|Overall Study|No longer meets study criteria|15|||
129054353|NCT00423319|464489720|FG001|Overall Study|No longer meets study criteria|15|||
129054354|NCT00423319|464489719|FG000|Overall Study|Other|23|||
129054355|NCT00423319|464489720|FG001|Overall Study|Other|22|||
129054356|NCT01584843|464489721|FG000|First Treatment Period|Adverse Event|0|||
129054357|NCT01584843|464489722|FG001|First Treatment Period|Adverse Event|0|||
129054358|NCT01584843|464489723|FG002|First Treatment Period|Adverse Event|1|||
129054359|NCT01584843|464489724|FG003|First Treatment Period|Adverse Event|0|||
129054360|NCT01584843|464489725|FG004|First Treatment Period|Adverse Event|0|||
129054361|NCT01584843|464489726|FG005|First Treatment Period|Adverse Event|0|||
129054362|NCT01584843|464489721|FG000|First Treatment Period|Protocol Violation|0|||
129054363|NCT01584843|464489722|FG001|First Treatment Period|Protocol Violation|0|||
129054364|NCT01584843|464489723|FG002|First Treatment Period|Protocol Violation|0|||
129054365|NCT01584843|464489724|FG003|First Treatment Period|Protocol Violation|0|||
129054366|NCT01584843|464489725|FG004|First Treatment Period|Protocol Violation|0|||
129054367|NCT01584843|464489726|FG005|First Treatment Period|Protocol Violation|1|||
129054368|NCT01584843|464489721|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129054369|NCT01584843|464489722|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129054370|NCT01584843|464489723|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129054371|NCT01584843|464489724|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129054372|NCT01584843|464489725|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129054373|NCT01584843|464489726|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
129054374|NCT01584843|464489721|FG000|Second Treatment Period|Withdrawal by Subject|0|||
129054375|NCT01584843|464489722|FG001|Second Treatment Period|Withdrawal by Subject|0|||
129054376|NCT01584843|464489723|FG002|Second Treatment Period|Withdrawal by Subject|0|||
129054377|NCT01584843|464489724|FG003|Second Treatment Period|Withdrawal by Subject|0|||
129054378|NCT01584843|464489725|FG004|Second Treatment Period|Withdrawal by Subject|0|||
129054379|NCT01584843|464489726|FG005|Second Treatment Period|Withdrawal by Subject|1|||
129054380|NCT00311402|464489727|FG000|Overall Study|Adverse Event|118|||
129054381|NCT00311402|464489728|FG001|Overall Study|Adverse Event|105|||
129054382|NCT00311402|464489727|FG000|Overall Study|Lost to Follow-up|0|||
129054383|NCT00311402|464489728|FG001|Overall Study|Lost to Follow-up|3|||
129054384|NCT00311402|464489727|FG000|Overall Study|Withdrawal by Subject|17|||
129054385|NCT00311402|464489728|FG001|Overall Study|Withdrawal by Subject|18|||
129054386|NCT00311402|464489727|FG000|Overall Study|Lack of Efficacy|58|||
129054387|NCT00311402|464489728|FG001|Overall Study|Lack of Efficacy|42|||
129054388|NCT00311402|464489727|FG000|Overall Study|Protocol Violation|7|||
129054389|NCT00311402|464489728|FG001|Overall Study|Protocol Violation|6|||
129054390|NCT00311402|464489727|FG000|Overall Study|IRB's rejection etc.|10|||
129054391|NCT00311402|464489728|FG001|Overall Study|IRB's rejection etc.|3|||
129054392|NCT02640053|464489729|FG000|Overall Study|Withdrawal by Subject|2|||
129054393|NCT02640053|464489730|FG001|Overall Study|Withdrawal by Subject|1|||
129054394|NCT02640053|464489729|FG000|Overall Study|Adverse Event|1|||
129054395|NCT02640053|464489730|FG001|Overall Study|Adverse Event|1|||
128719922|NCT03446040|463273266|FG001|Overall Study|Participant withdrew consent|0|||
128719923|NCT03446040|463273267|FG002|Overall Study|Participant withdrew consent|0|||
128719924|NCT03446040|463273268|FG003|Overall Study|Participant withdrew consent|0|||
128719925|NCT03446040|463273269|FG004|Overall Study|Participant withdrew consent|0|||
128719926|NCT03446040|463273270|FG005|Overall Study|Participant withdrew consent|1|||
128719927|NCT03446040|463273271|FG006|Overall Study|Participant withdrew consent|0|||
128719928|NCT03446040|463273272|FG007|Overall Study|Participant withdrew consent|1|||
128719929|NCT03446040|463273273|FG008|Overall Study|Participant withdrew consent|0|||
128719930|NCT03446040|463273274|FG009|Overall Study|Participant withdrew consent|0|||
128719931|NCT03446040|463273275|FG010|Overall Study|Participant withdrew consent|0|||
128719932|NCT03446040|463273276|FG011|Overall Study|Participant withdrew consent|0|||
128719933|NCT03446040|463273277|FG012|Overall Study|Participant withdrew consent|0|||
128719934|NCT03446040|463273278|FG013|Overall Study|Participant withdrew consent|0|||
129054396|NCT02640053|464489729|FG000|Overall Study|Alternative Therapy|1|||
129054397|NCT02640053|464489730|FG001|Overall Study|Alternative Therapy|1|||
129136853|NCT01755156|464794503|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
129054398|NCT02640053|464489729|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
129054399|NCT02640053|464489730|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
129136854|NCT01755156|464794504|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
128719935|NCT03446040|463273265|FG000|Overall Study|Not reported|0|||
129054400|NCT03283761|464489731|FG000|Study Treatment|Patient Non-Compliance|1|||
129054401|NCT03283761|464489731|FG000|Study Treatment|Alternative Cancer Therapy|7|||
129054402|NCT03283761|464489731|FG000|Study Treatment|Disease progression|21|||
129054403|NCT03283761|464489731|FG000|Study Treatment|Adverse Event|3|||
129054404|NCT03283761|464489731|FG000|Study Treatment|Withdrawal by Subject|4|||
129054405|NCT03283761|464489731|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
129054406|NCT03283761|464489731|FG000|Study Treatment|Symptomatic Deterioration|1|||
129054407|NCT03283761|464489731|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
129054408|NCT03283761|464489731|FG000|Follow up|Lost to Follow-up|1|||
129054409|NCT03283761|464489731|FG000|Follow up|Symptomatic Deterioration|1|||
129054410|NCT03283761|464489731|FG000|Follow up|Death|29|||
129054411|NCT03283761|464489731|FG000|Follow up|study terminated|4|||
129054412|NCT03283761|464489731|FG000|Follow up|Primary Investigator Withdrawal|1|||
129054413|NCT03283761|464489731|FG000|Follow up|Switched to alternative therapy|1|||
129054414|NCT03283761|464489731|FG000|Follow up|Subject is now in Hospice|1|||
129054415|NCT02036775|464489732|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129054416|NCT02036775|464489733|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129054417|NCT02036775|464489734|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129054418|NCT02036775|464489735|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129054419|NCT02036775|464489736|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129054420|NCT02036775|464489737|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
129054421|NCT01268501|464489738|FG000|Overall Study|Lost to Follow-up|1|||
129054422|NCT01268501|464489738|FG000|Overall Study|Withdrawal by Subject|3|||
129054423|NCT01268501|464489738|FG000|Overall Study|Unacceptable Subjective Vision|3|||
129054424|NCT01268501|464489738|FG000|Overall Study|Handling Difficulties|2|||
129054425|NCT00678886|464489739|FG000|Overall Study|Withdrawal by Subject|0|||
129054426|NCT00678886|464489740|FG001|Overall Study|Withdrawal by Subject|0|||
129054427|NCT00678886|464489741|FG002|Overall Study|Withdrawal by Subject|4|||
129054428|NCT00678886|464489742|FG003|Overall Study|Withdrawal by Subject|6|||
129054429|NCT00678886|464489739|FG000|Overall Study|Physician Decision|0|||
129054430|NCT00678886|464489740|FG001|Overall Study|Physician Decision|0|||
129054431|NCT00678886|464489741|FG002|Overall Study|Physician Decision|1|||
129054432|NCT00678886|464489742|FG003|Overall Study|Physician Decision|1|||
129054433|NCT00678886|464489739|FG000|Overall Study|Lost to Follow-up|0|||
129054434|NCT00678886|464489740|FG001|Overall Study|Lost to Follow-up|0|||
129054435|NCT00678886|464489741|FG002|Overall Study|Lost to Follow-up|3|||
129054436|NCT00678886|464489742|FG003|Overall Study|Lost to Follow-up|2|||
129136855|NCT01755156|464794503|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
129136856|NCT01755156|464794504|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
129136857|NCT01755156|464794503|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
129136858|NCT01755156|464794504|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
129136859|NCT00527748|464794507|FG000|Overall Study|Other|3|||
129136860|NCT01093885|464794509|FG000|Overall Study|Adverse Event|4|||
129136861|NCT01093885|464794509|FG000|Overall Study|Lost to Follow-up|1|||
129136862|NCT02533674|464794510|FG000|Dose Level I|Progressive disease|1|||
129136863|NCT02533674|464794511|FG001|Dose Level I|Progressive disease|0|||
129136864|NCT02533674|464794512|FG002|Dose Level I|Progressive disease|0|||
129136865|NCT02533674|464794513|FG003|Dose Level I|Progressive disease|0|||
129136866|NCT02533674|464794514|FG004|Dose Level I|Progressive disease|0|||
129136867|NCT02533674|464794515|FG005|Dose Level I|Progressive disease|0|||
129136868|NCT02533674|464794516|FG006|Dose Level I|Progressive disease|0|||
129136869|NCT02533674|464794517|FG007|Dose Level I|Progressive disease|0|||
129136870|NCT02533674|464794510|FG000|Dose Level I|Withdrawal by Subject|1|||
129136871|NCT02533674|464794511|FG001|Dose Level I|Withdrawal by Subject|0|||
129136872|NCT02533674|464794512|FG002|Dose Level I|Withdrawal by Subject|0|||
129136873|NCT02533674|464794513|FG003|Dose Level I|Withdrawal by Subject|0|||
129136874|NCT02533674|464794514|FG004|Dose Level I|Withdrawal by Subject|0|||
129136875|NCT02533674|464794515|FG005|Dose Level I|Withdrawal by Subject|0|||
129136876|NCT02533674|464794516|FG006|Dose Level I|Withdrawal by Subject|0|||
129136877|NCT02533674|464794517|FG007|Dose Level I|Withdrawal by Subject|0|||
129136878|NCT02533674|464794510|FG000|Dose Level I|Physician Decision|1|||
129136879|NCT02533674|464794511|FG001|Dose Level I|Physician Decision|0|||
129136880|NCT02533674|464794512|FG002|Dose Level I|Physician Decision|0|||
129136881|NCT02533674|464794513|FG003|Dose Level I|Physician Decision|0|||
129136882|NCT02533674|464794514|FG004|Dose Level I|Physician Decision|0|||
129136883|NCT02533674|464794515|FG005|Dose Level I|Physician Decision|0|||
128775498|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
128775499|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
128775500|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
128775501|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
129054437|NCT00678886|464489739|FG000|Overall Study|Other|0|||
129136884|NCT02533674|464794516|FG006|Dose Level I|Physician Decision|0|||
129136885|NCT02533674|464794517|FG007|Dose Level I|Physician Decision|0|||
129136886|NCT02533674|464794510|FG000|Dose Level I|Death|1|||
129054438|NCT00678886|464489740|FG001|Overall Study|Other|0|||
129054439|NCT00678886|464489741|FG002|Overall Study|Other|1|||
129054440|NCT00678886|464489742|FG003|Overall Study|Other|0|||
129054441|NCT00206323|464489743|FG000|Overall Study|Lack of Efficacy|4|||
129054442|NCT00206323|464489744|FG001|Overall Study|Lack of Efficacy|1|||
129136887|NCT02533674|464794511|FG001|Dose Level I|Death|0|||
129054443|NCT00206323|464489743|FG000|Overall Study|Adverse Event|1|||
129136888|NCT02533674|464794512|FG002|Dose Level I|Death|0|||
129136889|NCT02533674|464794513|FG003|Dose Level I|Death|0|||
129136890|NCT02533674|464794514|FG004|Dose Level I|Death|0|||
129136891|NCT02533674|464794515|FG005|Dose Level I|Death|0|||
129136892|NCT02533674|464794516|FG006|Dose Level I|Death|0|||
129136893|NCT02533674|464794517|FG007|Dose Level I|Death|0|||
129136894|NCT02533674|464794510|FG000|Dose Level I|Never Treated|1|||
129136895|NCT02533674|464794511|FG001|Dose Level I|Never Treated|0|||
129136896|NCT02533674|464794512|FG002|Dose Level I|Never Treated|0|||
129136897|NCT02533674|464794513|FG003|Dose Level I|Never Treated|0|||
129136898|NCT02533674|464794514|FG004|Dose Level I|Never Treated|0|||
129136899|NCT02533674|464794515|FG005|Dose Level I|Never Treated|0|||
129136900|NCT02533674|464794516|FG006|Dose Level I|Never Treated|0|||
129136901|NCT02533674|464794517|FG007|Dose Level I|Never Treated|0|||
129136902|NCT02533674|464794510|FG000|Dose Level II|Progressive disease|0|||
129136903|NCT02533674|464794511|FG001|Dose Level II|Progressive disease|3|||
129136904|NCT02533674|464794512|FG002|Dose Level II|Progressive disease|0|||
129136905|NCT02533674|464794513|FG003|Dose Level II|Progressive disease|0|||
129136906|NCT02533674|464794514|FG004|Dose Level II|Progressive disease|0|||
129136907|NCT02533674|464794515|FG005|Dose Level II|Progressive disease|0|||
129136908|NCT02533674|464794516|FG006|Dose Level II|Progressive disease|0|||
129136909|NCT02533674|464794517|FG007|Dose Level II|Progressive disease|0|||
129136910|NCT02533674|464794510|FG000|Dose Level II|Withdrawal by Subject|0|||
129136911|NCT02533674|464794511|FG001|Dose Level II|Withdrawal by Subject|1|||
129136912|NCT02533674|464794512|FG002|Dose Level II|Withdrawal by Subject|0|||
129136913|NCT02533674|464794513|FG003|Dose Level II|Withdrawal by Subject|0|||
129136914|NCT02533674|464794514|FG004|Dose Level II|Withdrawal by Subject|0|||
129054444|NCT00206323|464489744|FG001|Overall Study|Adverse Event|1|||
129054445|NCT00206323|464489743|FG000|Overall Study|Lost to Follow-up|1|||
129054446|NCT00206323|464489744|FG001|Overall Study|Lost to Follow-up|1|||
129054447|NCT00827632|464489748|FG000|Overall Study|Lost to Follow-up|8|||
129054448|NCT00827632|464489749|FG001|Overall Study|Lost to Follow-up|12|||
129054449|NCT00827632|464489748|FG000|Overall Study|Early withdrawal|14|||
129054450|NCT00827632|464489749|FG001|Overall Study|Early withdrawal|11|||
129054451|NCT01910389|464489751|FG000|Overall Study|Withdrawal by Subject|2|||
129054452|NCT01910389|464489752|FG001|Overall Study|Withdrawal by Subject|0|||
129054453|NCT01910389|464489751|FG000|Overall Study|Study Closed|13|||
129054454|NCT01910389|464489752|FG001|Overall Study|Study Closed|8|||
129054455|NCT04669691|464489756|FG000|Overall Study|Death|0|||
129054456|NCT04669691|464489757|FG001|Overall Study|Death|1|||
129054457|NCT04669691|464489758|FG002|Overall Study|Death|0|||
129054458|NCT04669691|464489759|FG003|Overall Study|Death|0|||
129054459|NCT04669691|464489760|FG004|Overall Study|Death|0|||
129054460|NCT04669691|464489761|FG005|Overall Study|Death|0|||
129054461|NCT02304458|464489762|FG000|Overall Study|Adverse Event|0|||
129054462|NCT02304458|464489763|FG001|Overall Study|Adverse Event|0|||
129054463|NCT02304458|464489764|FG002|Overall Study|Adverse Event|7|||
129054464|NCT02304458|464489765|FG003|Overall Study|Adverse Event|0|||
129054465|NCT02304458|464489766|FG004|Overall Study|Adverse Event|0|||
129054466|NCT02304458|464489767|FG005|Overall Study|Adverse Event|0|||
129054467|NCT02304458|464489768|FG006|Overall Study|Adverse Event|3|||
129054468|NCT02304458|464489769|FG007|Overall Study|Adverse Event|4|||
129054469|NCT02304458|464489762|FG000|Overall Study|Death|0|||
129054470|NCT02304458|464489763|FG001|Overall Study|Death|0|||
129054471|NCT02304458|464489764|FG002|Overall Study|Death|2|||
129054472|NCT02304458|464489765|FG003|Overall Study|Death|0|||
129054473|NCT02304458|464489766|FG004|Overall Study|Death|0|||
129054474|NCT02304458|464489767|FG005|Overall Study|Death|0|||
129054475|NCT02304458|464489768|FG006|Overall Study|Death|1|||
129054476|NCT02304458|464489769|FG007|Overall Study|Death|0|||
129054477|NCT02304458|464489762|FG000|Overall Study|Lack of Efficacy|4|||
129054478|NCT02304458|464489763|FG001|Overall Study|Lack of Efficacy|6|||
129054479|NCT02304458|464489764|FG002|Overall Study|Lack of Efficacy|38|||
129136915|NCT02533674|464794515|FG005|Dose Level II|Withdrawal by Subject|0|||
129136916|NCT02533674|464794516|FG006|Dose Level II|Withdrawal by Subject|0|||
129136917|NCT02533674|464794517|FG007|Dose Level II|Withdrawal by Subject|0|||
129136918|NCT02533674|464794510|FG000|Dose Level II|Treatment-related AE|0|||
129136919|NCT02533674|464794511|FG001|Dose Level II|Treatment-related AE|1|||
129136920|NCT02533674|464794512|FG002|Dose Level II|Treatment-related AE|0|||
129136921|NCT02533674|464794513|FG003|Dose Level II|Treatment-related AE|0|||
128719936|NCT03446040|463273266|FG001|Overall Study|Not reported|0|||
129054480|NCT02304458|464489765|FG003|Overall Study|Lack of Efficacy|5|||
129054481|NCT02304458|464489766|FG004|Overall Study|Lack of Efficacy|6|||
129054482|NCT02304458|464489767|FG005|Overall Study|Lack of Efficacy|6|||
129054483|NCT02304458|464489768|FG006|Overall Study|Lack of Efficacy|21|||
129054484|NCT02304458|464489769|FG007|Overall Study|Lack of Efficacy|4|||
129054485|NCT02304458|464489762|FG000|Overall Study|Physician Decision|2|||
129054486|NCT02304458|464489763|FG001|Overall Study|Physician Decision|0|||
129054487|NCT02304458|464489764|FG002|Overall Study|Physician Decision|16|||
129054488|NCT02304458|464489765|FG003|Overall Study|Physician Decision|1|||
129054489|NCT02304458|464489766|FG004|Overall Study|Physician Decision|0|||
129054490|NCT02304458|464489767|FG005|Overall Study|Physician Decision|0|||
129054491|NCT02304458|464489768|FG006|Overall Study|Physician Decision|3|||
129054492|NCT02304458|464489769|FG007|Overall Study|Physician Decision|0|||
129054493|NCT02304458|464489762|FG000|Overall Study|Protocol Violation|0|||
129054494|NCT02304458|464489763|FG001|Overall Study|Protocol Violation|0|||
129054495|NCT02304458|464489764|FG002|Overall Study|Protocol Violation|1|||
129054496|NCT02304458|464489765|FG003|Overall Study|Protocol Violation|0|||
129054497|NCT02304458|464489766|FG004|Overall Study|Protocol Violation|0|||
129054498|NCT02304458|464489767|FG005|Overall Study|Protocol Violation|0|||
129054499|NCT02304458|464489768|FG006|Overall Study|Protocol Violation|0|||
129054500|NCT02304458|464489769|FG007|Overall Study|Protocol Violation|0|||
129054501|NCT02304458|464489762|FG000|Overall Study|Withdrawal by Subject|1|||
129054502|NCT02304458|464489763|FG001|Overall Study|Withdrawal by Subject|0|||
129054503|NCT02304458|464489764|FG002|Overall Study|Withdrawal by Subject|7|||
129054504|NCT02304458|464489765|FG003|Overall Study|Withdrawal by Subject|0|||
129054505|NCT02304458|464489766|FG004|Overall Study|Withdrawal by Subject|0|||
129054506|NCT02304458|464489767|FG005|Overall Study|Withdrawal by Subject|0|||
129054507|NCT02304458|464489768|FG006|Overall Study|Withdrawal by Subject|1|||
129054508|NCT02304458|464489769|FG007|Overall Study|Withdrawal by Subject|0|||
129054509|NCT03401450|464489770|FG000|Overall Study|Lost to Follow-up|4|||
129054510|NCT03401450|464489771|FG001|Overall Study|Lost to Follow-up|6|||
129054511|NCT03401450|464489770|FG000|Overall Study|Anesthesia plan changed|2|||
129054512|NCT03401450|464489771|FG001|Overall Study|Anesthesia plan changed|2|||
129054513|NCT03401450|464489770|FG000|Overall Study|Did not complete medication diary|4|||
129054514|NCT03401450|464489771|FG001|Overall Study|Did not complete medication diary|2|||
129054515|NCT03401450|464489770|FG000|Overall Study|post surgery medication change|2|||
129054516|NCT03401450|464489771|FG001|Overall Study|post surgery medication change|1|||
129136922|NCT02533674|464794514|FG004|Dose Level II|Treatment-related AE|0|||
129136923|NCT02533674|464794515|FG005|Dose Level II|Treatment-related AE|0|||
129136924|NCT02533674|464794516|FG006|Dose Level II|Treatment-related AE|0|||
129136925|NCT02533674|464794517|FG007|Dose Level II|Treatment-related AE|0|||
129136926|NCT02533674|464794510|FG000|Dose Level II|Physician Decision|0|||
129136927|NCT02533674|464794511|FG001|Dose Level II|Physician Decision|1|||
129136928|NCT02533674|464794512|FG002|Dose Level II|Physician Decision|0|||
129136929|NCT02533674|464794513|FG003|Dose Level II|Physician Decision|0|||
129136930|NCT02533674|464794514|FG004|Dose Level II|Physician Decision|0|||
129136931|NCT02533674|464794515|FG005|Dose Level II|Physician Decision|0|||
129136932|NCT02533674|464794516|FG006|Dose Level II|Physician Decision|0|||
129136933|NCT02533674|464794517|FG007|Dose Level II|Physician Decision|0|||
129136934|NCT02533674|464794510|FG000|Dose Level II|Non-treatment-related AE|0|||
129136935|NCT02533674|464794511|FG001|Dose Level II|Non-treatment-related AE|1|||
128719937|NCT03446040|463273267|FG002|Overall Study|Not reported|1|||
129054517|NCT03401450|464489770|FG000|Overall Study|Cancelled surgery|0|||
129054518|NCT03401450|464489771|FG001|Overall Study|Cancelled surgery|2|||
129054519|NCT02288182|464489772|FG000|Overall Study|Adverse Event|0|||
129054520|NCT02288182|464489773|FG001|Overall Study|Adverse Event|1|||
129054521|NCT02288182|464489772|FG000|Overall Study|Lost to Follow-up|0|||
129054522|NCT02288182|464489773|FG001|Overall Study|Lost to Follow-up|1|||
129054523|NCT03395405|464491261|FG000|Overall Study|Death|0|||
129054524|NCT03395405|464491262|FG001|Overall Study|Death|2|||
129054525|NCT03395405|464491261|FG000|Overall Study|Lost to Follow-up|0|||
129054526|NCT03395405|464491262|FG001|Overall Study|Lost to Follow-up|1|||
129054527|NCT03395405|464491261|FG000|Overall Study|Protocol Violation|0|||
129054528|NCT03395405|464491262|FG001|Overall Study|Protocol Violation|1|||
129054529|NCT03395405|464491261|FG000|Overall Study|Withdrawal by Subject|3|||
129054530|NCT03395405|464491262|FG001|Overall Study|Withdrawal by Subject|1|||
129054531|NCT03395405|464491261|FG000|Overall Study|COVID-19 Pandemic|1|||
129136936|NCT02533674|464794512|FG002|Dose Level II|Non-treatment-related AE|0|||
128719938|NCT03446040|463273268|FG003|Overall Study|Not reported|0|||
129136937|NCT02533674|464794513|FG003|Dose Level II|Non-treatment-related AE|0|||
128719939|NCT03446040|463273269|FG004|Overall Study|Not reported|0|||
128719940|NCT03446040|463273270|FG005|Overall Study|Not reported|0|||
128719941|NCT03446040|463273271|FG006|Overall Study|Not reported|0|||
129054532|NCT03395405|464491262|FG001|Overall Study|COVID-19 Pandemic|0|||
129054533|NCT04345601|464491263|FG000|Overall Study|Death|0|||
129054534|NCT04345601|464491264|FG001|Overall Study|Death|3|||
129054535|NCT04345601|464491265|FG002|Overall Study|Death|2|||
129054536|NCT04345601|464491263|FG000|Overall Study|Lost to Follow-up|0|||
129054537|NCT04345601|464491264|FG001|Overall Study|Lost to Follow-up|0|||
129054538|NCT04345601|464491265|FG002|Overall Study|Lost to Follow-up|2|||
129136938|NCT02533674|464794514|FG004|Dose Level II|Non-treatment-related AE|0|||
129136939|NCT02533674|464794515|FG005|Dose Level II|Non-treatment-related AE|0|||
129054539|NCT00000378|464491266|FG000|Overall Study|Lack of Efficacy|16|||
129054540|NCT00000378|464491267|FG001|Overall Study|Lack of Efficacy|14|||
129054541|NCT00540293|464491272|FG000|Overall Study|Adverse event related to study drug|10|||
129054542|NCT00540293|464491272|FG000|Overall Study|Adverse event not related to study drug|7|||
129054543|NCT00540293|464491272|FG000|Overall Study|Withdrawal by Subject|6|||
129054544|NCT00540293|464491272|FG000|Overall Study|Protocol violation, & subject schedule|12|||
129054545|NCT02585934|464491275|FG000|Overall Study|Lost to Follow-up|2|||
129054546|NCT02585934|464491276|FG001|Overall Study|Lost to Follow-up|2|||
129054547|NCT02585934|464491275|FG000|Overall Study|Protocol Violation|14|||
129054548|NCT02585934|464491276|FG001|Overall Study|Protocol Violation|11|||
129054549|NCT02585934|464491275|FG000|Overall Study|Adverse Event|21|||
129054550|NCT02585934|464491276|FG001|Overall Study|Adverse Event|22|||
129054551|NCT02585934|464491275|FG000|Overall Study|Physician Decision|3|||
129054552|NCT02585934|464491276|FG001|Overall Study|Physician Decision|2|||
129054553|NCT02585934|464491275|FG000|Overall Study|Withdrawal by Subject|7|||
129054554|NCT02585934|464491276|FG001|Overall Study|Withdrawal by Subject|21|||
129054555|NCT02585934|464491275|FG000|Overall Study|Lack of Efficacy|2|||
129054556|NCT02585934|464491276|FG001|Overall Study|Lack of Efficacy|1|||
129054557|NCT02585934|464491275|FG000|Overall Study|Death|2|||
129054558|NCT02585934|464491276|FG001|Overall Study|Death|0|||
129054559|NCT02585934|464491275|FG000|Overall Study|Caregiver Withdrew Consent|7|||
129054560|NCT02585934|464491276|FG001|Overall Study|Caregiver Withdrew Consent|7|||
129054561|NCT02585934|464491275|FG000|Overall Study|Sponsor Termination|1|||
129054562|NCT02585934|464491276|FG001|Overall Study|Sponsor Termination|2|||
129054563|NCT02585934|464491275|FG000|Overall Study|Another Reason|10|||
129054564|NCT02585934|464491276|FG001|Overall Study|Another Reason|5|||
129054565|NCT02448706|464491277|FG000|Overall Study|Withdrawal by Subject|4|||
129054566|NCT02448706|464491278|FG001|Overall Study|Withdrawal by Subject|3|||
129054567|NCT02448706|464491277|FG000|Overall Study|Protocol Violation|1|||
129054568|NCT02448706|464491278|FG001|Overall Study|Protocol Violation|1|||
129054569|NCT01359969|464491279|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
129054570|NCT00470067|464491287|FG000|Overall Study|Death|1|||
129054571|NCT00470067|464491287|FG000|Overall Study|Disease Progression|6|||
129054572|NCT03400943|464491288|FG000|Treatment Period 1|Adverse Event|0|||
129054573|NCT03400943|464491289|FG001|Treatment Period 1|Adverse Event|0|||
129054574|NCT03400943|464491290|FG002|Treatment Period 1|Adverse Event|0|||
129054575|NCT03400943|464491291|FG003|Treatment Period 1|Adverse Event|1|||
129054576|NCT03400943|464491288|FG000|Treatment Period 1|Lost to Follow-up|1|||
129054577|NCT03400943|464491289|FG001|Treatment Period 1|Lost to Follow-up|0|||
129054578|NCT03400943|464491290|FG002|Treatment Period 1|Lost to Follow-up|0|||
129054579|NCT03400943|464491291|FG003|Treatment Period 1|Lost to Follow-up|0|||
129054580|NCT03400943|464491288|FG000|Treatment Period 1|Protocol Violation|0|||
129054581|NCT03400943|464491289|FG001|Treatment Period 1|Protocol Violation|1|||
129054582|NCT03400943|464491290|FG002|Treatment Period 1|Protocol Violation|1|||
129054583|NCT03400943|464491291|FG003|Treatment Period 1|Protocol Violation|0|||
129054584|NCT03400943|464491288|FG000|Treatment Period 1|Study terminated by sponsor|2|||
129054585|NCT03400943|464491289|FG001|Treatment Period 1|Study terminated by sponsor|0|||
129054586|NCT03400943|464491290|FG002|Treatment Period 1|Study terminated by sponsor|0|||
129054587|NCT03400943|464491291|FG003|Treatment Period 1|Study terminated by sponsor|1|||
129054588|NCT03400943|464491288|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129054589|NCT03400943|464491289|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129054590|NCT03400943|464491290|FG002|Treatment Period 1|Withdrawal by Subject|3|||
129054591|NCT03400943|464491291|FG003|Treatment Period 1|Withdrawal by Subject|1|||
129054592|NCT03400943|464491288|FG000|Treatment Period 1|Other|2|||
129054593|NCT03400943|464491289|FG001|Treatment Period 1|Other|1|||
129054594|NCT03400943|464491290|FG002|Treatment Period 1|Other|2|||
128775502|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
128775503|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
129054595|NCT03400943|464491291|FG003|Treatment Period 1|Other|2|||
129054596|NCT03400943|464491288|FG000|Post-treatment Period 1|Adverse Event|2|||
129054597|NCT03400943|464491289|FG001|Post-treatment Period 1|Adverse Event|0|||
129054598|NCT03400943|464491290|FG002|Post-treatment Period 1|Adverse Event|0|||
129054599|NCT03400943|464491291|FG003|Post-treatment Period 1|Adverse Event|0|||
129054600|NCT03400943|464491288|FG000|Post-treatment Period 1|Protocol Violation|1|||
129054601|NCT03400943|464491289|FG001|Post-treatment Period 1|Protocol Violation|0|||
128775504|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
129054602|NCT03400943|464491290|FG002|Post-treatment Period 1|Protocol Violation|0|||
129054603|NCT03400943|464491291|FG003|Post-treatment Period 1|Protocol Violation|0|||
129054604|NCT03400943|464491288|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
129054605|NCT03400943|464491289|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
129054606|NCT03400943|464491290|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
129054607|NCT03400943|464491291|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
129054608|NCT03400943|464491288|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
129054609|NCT03400943|464491289|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
129054610|NCT03400943|464491290|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
128775505|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
128775506|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
129136940|NCT02533674|464794516|FG006|Dose Level II|Non-treatment-related AE|0|||
129136941|NCT02533674|464794517|FG007|Dose Level II|Non-treatment-related AE|0|||
129136942|NCT02533674|464794510|FG000|Dose Level III|Progressive disease|0|||
129136943|NCT02533674|464794511|FG001|Dose Level III|Progressive disease|0|||
129136944|NCT02533674|464794512|FG002|Dose Level III|Progressive disease|2|||
129136945|NCT02533674|464794513|FG003|Dose Level III|Progressive disease|0|||
129136946|NCT02533674|464794514|FG004|Dose Level III|Progressive disease|0|||
129136947|NCT02533674|464794515|FG005|Dose Level III|Progressive disease|0|||
129136948|NCT02533674|464794516|FG006|Dose Level III|Progressive disease|0|||
129136949|NCT02533674|464794517|FG007|Dose Level III|Progressive disease|0|||
129136950|NCT02533674|464794510|FG000|Dose Level III|Withdrawal by Subject|0|||
129136951|NCT02533674|464794511|FG001|Dose Level III|Withdrawal by Subject|0|||
129136952|NCT02533674|464794512|FG002|Dose Level III|Withdrawal by Subject|1|||
129136953|NCT02533674|464794513|FG003|Dose Level III|Withdrawal by Subject|0|||
129136954|NCT02533674|464794514|FG004|Dose Level III|Withdrawal by Subject|0|||
129136955|NCT02533674|464794515|FG005|Dose Level III|Withdrawal by Subject|0|||
129136956|NCT02533674|464794516|FG006|Dose Level III|Withdrawal by Subject|0|||
129136957|NCT02533674|464794517|FG007|Dose Level III|Withdrawal by Subject|0|||
129136958|NCT02533674|464794510|FG000|Dose Level III|Treatment-related AE|0|||
129136959|NCT02533674|464794511|FG001|Dose Level III|Treatment-related AE|0|||
129136960|NCT02533674|464794512|FG002|Dose Level III|Treatment-related AE|1|||
129136961|NCT02533674|464794513|FG003|Dose Level III|Treatment-related AE|0|||
129136962|NCT02533674|464794514|FG004|Dose Level III|Treatment-related AE|0|||
129136963|NCT02533674|464794515|FG005|Dose Level III|Treatment-related AE|0|||
129136964|NCT02533674|464794516|FG006|Dose Level III|Treatment-related AE|0|||
129136965|NCT02533674|464794517|FG007|Dose Level III|Treatment-related AE|0|||
129136966|NCT02533674|464794510|FG000|Dose Level IV|Progressive disease|0|||
129136967|NCT02533674|464794511|FG001|Dose Level IV|Progressive disease|0|||
129136968|NCT02533674|464794512|FG002|Dose Level IV|Progressive disease|0|||
129136969|NCT02533674|464794513|FG003|Dose Level IV|Progressive disease|3|||
129136970|NCT02533674|464794514|FG004|Dose Level IV|Progressive disease|0|||
129136971|NCT02533674|464794515|FG005|Dose Level IV|Progressive disease|0|||
129136972|NCT02533674|464794516|FG006|Dose Level IV|Progressive disease|0|||
129136973|NCT02533674|464794517|FG007|Dose Level IV|Progressive disease|0|||
129136974|NCT02533674|464794510|FG000|Dose Level IV|Withdrawal by Subject|0|||
129136975|NCT02533674|464794511|FG001|Dose Level IV|Withdrawal by Subject|0|||
129136976|NCT02533674|464794512|FG002|Dose Level IV|Withdrawal by Subject|0|||
129136977|NCT02533674|464794513|FG003|Dose Level IV|Withdrawal by Subject|1|||
129136978|NCT02533674|464794514|FG004|Dose Level IV|Withdrawal by Subject|0|||
129136979|NCT02533674|464794515|FG005|Dose Level IV|Withdrawal by Subject|0|||
129136980|NCT02533674|464794516|FG006|Dose Level IV|Withdrawal by Subject|0|||
129136981|NCT02533674|464794517|FG007|Dose Level IV|Withdrawal by Subject|0|||
129136982|NCT02533674|464794510|FG000|Dose Level IV|Physician Decision|0|||
129136983|NCT02533674|464794511|FG001|Dose Level IV|Physician Decision|0|||
129136984|NCT02533674|464794512|FG002|Dose Level IV|Physician Decision|0|||
129136985|NCT02533674|464794513|FG003|Dose Level IV|Physician Decision|1|||
129136986|NCT02533674|464794514|FG004|Dose Level IV|Physician Decision|0|||
129136987|NCT02533674|464794515|FG005|Dose Level IV|Physician Decision|0|||
129136988|NCT02533674|464794516|FG006|Dose Level IV|Physician Decision|0|||
129136989|NCT02533674|464794517|FG007|Dose Level IV|Physician Decision|0|||
129136990|NCT02533674|464794510|FG000|Dose Level V|Progressive disease|0|||
129136991|NCT02533674|464794511|FG001|Dose Level V|Progressive disease|0|||
129136992|NCT02533674|464794512|FG002|Dose Level V|Progressive disease|0|||
129136993|NCT02533674|464794513|FG003|Dose Level V|Progressive disease|0|||
129136994|NCT02533674|464794514|FG004|Dose Level V|Progressive disease|3|||
129136995|NCT02533674|464794515|FG005|Dose Level V|Progressive disease|0|||
129136996|NCT02533674|464794516|FG006|Dose Level V|Progressive disease|0|||
129136997|NCT02533674|464794517|FG007|Dose Level V|Progressive disease|0|||
129136998|NCT02533674|464794510|FG000|Dose Level V|Withdrawal by Subject|0|||
129136999|NCT02533674|464794511|FG001|Dose Level V|Withdrawal by Subject|0|||
129137000|NCT02533674|464794512|FG002|Dose Level V|Withdrawal by Subject|0|||
129137001|NCT02533674|464794513|FG003|Dose Level V|Withdrawal by Subject|0|||
129137002|NCT02533674|464794514|FG004|Dose Level V|Withdrawal by Subject|1|||
129137003|NCT02533674|464794515|FG005|Dose Level V|Withdrawal by Subject|0|||
129137004|NCT02533674|464794516|FG006|Dose Level V|Withdrawal by Subject|0|||
129137005|NCT02533674|464794517|FG007|Dose Level V|Withdrawal by Subject|0|||
129137006|NCT02533674|464794510|FG000|Dose Level V|Physician Decision|0|||
129137007|NCT02533674|464794511|FG001|Dose Level V|Physician Decision|0|||
129137008|NCT02533674|464794512|FG002|Dose Level V|Physician Decision|0|||
129137009|NCT02533674|464794513|FG003|Dose Level V|Physician Decision|0|||
129137010|NCT02533674|464794514|FG004|Dose Level V|Physician Decision|1|||
129137011|NCT02533674|464794515|FG005|Dose Level V|Physician Decision|0|||
129137012|NCT02533674|464794516|FG006|Dose Level V|Physician Decision|0|||
129137013|NCT02533674|464794517|FG007|Dose Level V|Physician Decision|0|||
129137014|NCT02533674|464794510|FG000|Dose Level VI|Progressive disease|0|||
129137015|NCT02533674|464794511|FG001|Dose Level VI|Progressive disease|0|||
129054611|NCT03400943|464491291|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
129054612|NCT03400943|464491288|FG000|Post-treatment Period 1|Other|2|||
129054613|NCT03400943|464491289|FG001|Post-treatment Period 1|Other|0|||
129054614|NCT03400943|464491290|FG002|Post-treatment Period 1|Other|4|||
129054615|NCT03400943|464491291|FG003|Post-treatment Period 1|Other|5|||
129054616|NCT03400943|464491288|FG000|Treatment Period 2|Study terminated by sponsor|0|||
129054617|NCT03400943|464491289|FG001|Treatment Period 2|Study terminated by sponsor|1|||
129054618|NCT03400943|464491290|FG002|Treatment Period 2|Study terminated by sponsor|0|||
129054619|NCT03400943|464491291|FG003|Treatment Period 2|Study terminated by sponsor|0|||
129054620|NCT03400943|464491288|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129054621|NCT03400943|464491289|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129054622|NCT03400943|464491290|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129054623|NCT03400943|464491291|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129054624|NCT03400943|464491288|FG000|Treatment Period 2|Other|1|||
129054625|NCT03400943|464491289|FG001|Treatment Period 2|Other|6|||
129054626|NCT03400943|464491290|FG002|Treatment Period 2|Other|0|||
129054627|NCT03400943|464491291|FG003|Treatment Period 2|Other|0|||
129054628|NCT03400943|464491288|FG000|Follow-up Period|Withdrawal by Subject|1|||
129054629|NCT03400943|464491289|FG001|Follow-up Period|Withdrawal by Subject|0|||
129054630|NCT03400943|464491290|FG002|Follow-up Period|Withdrawal by Subject|0|||
129054631|NCT03400943|464491291|FG003|Follow-up Period|Withdrawal by Subject|0|||
129054632|NCT02563106|464491292|FG000|Overall Study|Withdrawal by Subject|7|||
129054633|NCT02563106|464491293|FG001|Overall Study|Withdrawal by Subject|8|||
129054634|NCT02563106|464491292|FG000|Overall Study|Adverse Event|17|||
129054635|NCT02563106|464491293|FG001|Overall Study|Adverse Event|15|||
129054636|NCT02563106|464491292|FG000|Overall Study|Protocol Violation|1|||
129054637|NCT02563106|464491293|FG001|Overall Study|Protocol Violation|0|||
129054638|NCT02563106|464491292|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
129054639|NCT02563106|464491293|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
129054640|NCT02563106|464491292|FG000|Overall Study|Lost to Follow-up|3|||
129054641|NCT02563106|464491293|FG001|Overall Study|Lost to Follow-up|2|||
129054642|NCT02563106|464491292|FG000|Overall Study|Physician Decision|3|||
129054643|NCT02563106|464491293|FG001|Overall Study|Physician Decision|1|||
129054644|NCT02563106|464491292|FG000|Overall Study|Other reason - not specified|2|||
129054645|NCT02563106|464491293|FG001|Overall Study|Other reason - not specified|1|||
129054646|NCT04729309|464491294|FG000|Period 1|Subject unable to return for Period 2|3|||
129054647|NCT04729309|464491295|FG001|Period 1|Subject unable to return for Period 2|0|||
129054648|NCT04729309|464491294|FG000|Period 1|Lost to Follow-up|1|||
129054649|NCT04729309|464491295|FG001|Period 1|Lost to Follow-up|0|||
129054650|NCT01059539|464491296|FG000|Overall Study|Adverse Event|66|||
129054651|NCT01059539|464491296|FG000|Overall Study|Insufficient Therapeutic Response|26|||
129054652|NCT01059539|464491296|FG000|Overall Study|Protocol Violation|55|||
129054653|NCT01059539|464491296|FG000|Overall Study|Withdrawal of Consent|80|||
129054654|NCT01059539|464491296|FG000|Overall Study|Lost to Follow-up|42|||
129054655|NCT01059539|464491296|FG000|Overall Study|Reason Not Specified|2|||
129054656|NCT00537303|464491297|FG000|Overall Study|Adverse Event|1|||
129054657|NCT00537303|464491298|FG001|Overall Study|Adverse Event|4|||
129054658|NCT00537303|464491297|FG000|Overall Study|Lack of Efficacy|6|||
129054659|NCT00537303|464491298|FG001|Overall Study|Lack of Efficacy|7|||
129054660|NCT00537303|464491297|FG000|Overall Study|Protocol Violation|8|||
129054661|NCT00537303|464491298|FG001|Overall Study|Protocol Violation|4|||
129054662|NCT00537303|464491297|FG000|Overall Study|Withdrawal criteria|3|||
129054663|NCT00537303|464491298|FG001|Overall Study|Withdrawal criteria|3|||
129054664|NCT00537303|464491297|FG000|Overall Study|Unclassified|8|||
129054665|NCT00537303|464491298|FG001|Overall Study|Unclassified|7|||
129054666|NCT04091659|464491301|FG000|Overall Study|Protocol Violation|3|||
129054667|NCT04091659|464491302|FG001|Overall Study|Protocol Violation|0|||
129054668|NCT04091659|464491301|FG000|Overall Study|Lost to Follow-up|0|||
129054669|NCT04091659|464491302|FG001|Overall Study|Lost to Follow-up|1|||
129054670|NCT03678285|464491307|FG000|Overall Study|Adverse Event|2|||
129054671|NCT03678285|464491307|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
129054672|NCT03678285|464491307|FG000|Overall Study|Dehydrated prior to start of workout|1|||
129054673|NCT00616629|464491308|FG000|Overall Study|Protocol Violation|1|||
129054674|NCT00616629|464491309|FG001|Overall Study|Protocol Violation|2|||
129054675|NCT00616629|464491310|FG002|Overall Study|Protocol Violation|1|||
129054676|NCT00616629|464491311|FG003|Overall Study|Protocol Violation|0|||
128719942|NCT03446040|463273272|FG007|Overall Study|Not reported|0|||
128719943|NCT03446040|463273273|FG008|Overall Study|Not reported|0|||
128719944|NCT03446040|463273274|FG009|Overall Study|Not reported|0|||
129054677|NCT00616629|464491312|FG004|Overall Study|Protocol Violation|0|||
129054678|NCT00616629|464491308|FG000|Overall Study|AV-block|1|||
129054679|NCT00616629|464491309|FG001|Overall Study|AV-block|0|||
129054680|NCT00616629|464491310|FG002|Overall Study|AV-block|0|||
129054681|NCT00616629|464491311|FG003|Overall Study|AV-block|0|||
129054682|NCT00616629|464491312|FG004|Overall Study|AV-block|0|||
129054683|NCT01777620|464491313|FG000|Overall Study|Subject Withdrawal|1|||
129054684|NCT01777620|464491314|FG001|Overall Study|Subject Withdrawal|0|||
128719945|NCT03446040|463273275|FG010|Overall Study|Not reported|0|||
128719946|NCT03446040|463273276|FG011|Overall Study|Not reported|0|||
128719947|NCT03446040|463273277|FG012|Overall Study|Not reported|0|||
128719948|NCT03446040|463273278|FG013|Overall Study|Not reported|0|||
128719949|NCT00456521|463273279|FG000|Overall Study|Adverse Event|150|||
129054685|NCT04005352|464491316|FG000|Overall Study|Adverse Event|4|||
129054686|NCT04005352|464491317|FG001|Overall Study|Adverse Event|5|||
129054687|NCT04005352|464491316|FG000|Overall Study|Death|4|||
129054688|NCT04005352|464491317|FG001|Overall Study|Death|2|||
129054689|NCT04005352|464491316|FG000|Overall Study|Lost to Follow-up|6|||
129054690|NCT04005352|464491317|FG001|Overall Study|Lost to Follow-up|2|||
129054691|NCT04005352|464491316|FG000|Overall Study|Physician Decision|7|||
129054692|NCT04005352|464491317|FG001|Overall Study|Physician Decision|13|||
129054693|NCT04005352|464491316|FG000|Overall Study|Protocol Violation|0|||
129054694|NCT04005352|464491317|FG001|Overall Study|Protocol Violation|1|||
129054695|NCT04005352|464491316|FG000|Overall Study|Withdrawal by Subject|28|||
129054696|NCT04005352|464491317|FG001|Overall Study|Withdrawal by Subject|38|||
129054697|NCT00936897|464491320|FG000|Overall Study|Withdrawal by Subject|9|||
129054698|NCT00936897|464491321|FG001|Overall Study|Withdrawal by Subject|19|||
129054699|NCT00936897|464491320|FG000|Overall Study|Adverse Event|4|||
129054700|NCT00936897|464491321|FG001|Overall Study|Adverse Event|13|||
129054701|NCT00936897|464491320|FG000|Overall Study|Other|3|||
129054702|NCT00936897|464491321|FG001|Overall Study|Other|9|||
129054703|NCT00936897|464491320|FG000|Overall Study|Lost to Follow-up|1|||
129054704|NCT00936897|464491321|FG001|Overall Study|Lost to Follow-up|10|||
129054705|NCT00936897|464491320|FG000|Overall Study|Administrative Decision|1|||
129054706|NCT00936897|464491321|FG001|Overall Study|Administrative Decision|2|||
129054707|NCT00936897|464491320|FG000|Overall Study|Protocol Violation|1|||
128719950|NCT00456521|463273280|FG001|Overall Study|Adverse Event|25|||
129054708|NCT00936897|464491321|FG001|Overall Study|Protocol Violation|1|||
129054709|NCT00936897|464491320|FG000|Overall Study|Ineligibility Determined|0|||
129054710|NCT00936897|464491321|FG001|Overall Study|Ineligibility Determined|3|||
129054711|NCT00936897|464491320|FG000|Overall Study|Noncompliance|0|||
129054712|NCT00936897|464491321|FG001|Overall Study|Noncompliance|2|||
128719951|NCT00456521|463273279|FG000|Overall Study|Withdrawal by Subject|43|||
129054713|NCT00936897|464491320|FG000|Overall Study|Death|0|||
129054714|NCT00936897|464491321|FG001|Overall Study|Death|1|||
129054715|NCT04058067|464491322|FG000|Overall Study|Adverse Event|2|||
129054716|NCT04058067|464491323|FG001|Overall Study|Adverse Event|0|||
128719952|NCT00456521|463273280|FG001|Overall Study|Withdrawal by Subject|24|||
129054717|NCT04058067|464491322|FG000|Overall Study|Death|0|||
128719953|NCT00456521|463273279|FG000|Overall Study|Lost to Follow-up|22|||
128719954|NCT00456521|463273280|FG001|Overall Study|Lost to Follow-up|17|||
128719955|NCT00456521|463273279|FG000|Overall Study|Lack of Efficacy|3|||
129054718|NCT04058067|464491323|FG001|Overall Study|Death|1|||
129054719|NCT04058067|464491322|FG000|Overall Study|Physician Decision|3|||
129054720|NCT04058067|464491323|FG001|Overall Study|Physician Decision|1|||
129054721|NCT04058067|464491322|FG000|Overall Study|Protocol Violation|0|||
129054722|NCT04058067|464491323|FG001|Overall Study|Protocol Violation|1|||
129054723|NCT04058067|464491322|FG000|Overall Study|Withdrawal by Subject|7|||
129054724|NCT04058067|464491323|FG001|Overall Study|Withdrawal by Subject|8|||
129054725|NCT00417170|464491324|FG000|Overall Study|Adverse Event|1|||
129054726|NCT00417170|464491325|FG001|Overall Study|Adverse Event|1|||
129054727|NCT00417170|464491324|FG000|Overall Study|Withdrawal by Subject|1|||
129054728|NCT00417170|464491325|FG001|Overall Study|Withdrawal by Subject|1|||
129054729|NCT00417170|464491324|FG000|Overall Study|Lost to Follow-up|0|||
129054730|NCT00417170|464491325|FG001|Overall Study|Lost to Follow-up|1|||
129054731|NCT05005312|464491326|FG000|Overall Study|Enrolled, but not treated|0|||
129054732|NCT05005312|464491327|FG001|Overall Study|Enrolled, but not treated|1|||
129054733|NCT01283035|464491329|FG000|Overall Study|Subject later found ineligible|1|||
129054734|NCT00867503|464491330|FG000|Overall Study|Withdrawal by Subject|1|||
129054735|NCT02704403|464491331|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
129054736|NCT02704403|464491332|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
129054737|NCT02704403|464491331|FG000|Overall Study|Administrative reasons by sponsor|1251|||
129054738|NCT02704403|464491332|FG001|Overall Study|Administrative reasons by sponsor|616|||
129054739|NCT02704403|464491331|FG000|Overall Study|Death|4|||
129054740|NCT02704403|464491332|FG001|Overall Study|Death|3|||
129054741|NCT02704403|464491331|FG000|Overall Study|Endpoint event|52|||
129054742|NCT02704403|464491332|FG001|Overall Study|Endpoint event|24|||
129054743|NCT02704403|464491331|FG000|Overall Study|Lost to Follow-up|22|||
129054744|NCT02704403|464491332|FG001|Overall Study|Lost to Follow-up|11|||
129054745|NCT02704403|464491331|FG000|Overall Study|Protocol Violation|15|||
129054746|NCT02704403|464491332|FG001|Overall Study|Protocol Violation|15|||
129054747|NCT02704403|464491331|FG000|Overall Study|Adverse Event|2|||
129054748|NCT02704403|464491332|FG001|Overall Study|Adverse Event|0|||
129054749|NCT02704403|464491331|FG000|Overall Study|Withdrawal by Subject|85|||
129054750|NCT02704403|464491332|FG001|Overall Study|Withdrawal by Subject|45|||
129054751|NCT02704403|464491331|FG000|Overall Study|Investigator decision|1|||
129054752|NCT02704403|464491332|FG001|Overall Study|Investigator decision|1|||
129054753|NCT02704403|464491331|FG000|Overall Study|Follow-up not possible|1|||
129054754|NCT02704403|464491332|FG001|Overall Study|Follow-up not possible|2|||
129054755|NCT02348723|464491333|FG000|Overall Study|No ablation|21|||
129054756|NCT02348723|464491334|FG001|Overall Study|No ablation|20|||
129054757|NCT02348723|464491333|FG000|Overall Study|Non-compliant with Protocol|1|||
129054758|NCT02348723|464491334|FG001|Overall Study|Non-compliant with Protocol|0|||
129054759|NCT02348723|464491333|FG000|Overall Study|Lost to Follow-up|1|||
129054760|NCT02348723|464491334|FG001|Overall Study|Lost to Follow-up|1|||
129054761|NCT02348723|464491333|FG000|Overall Study|Consent withdrawn|1|||
129054762|NCT02348723|464491334|FG001|Overall Study|Consent withdrawn|3|||
129054763|NCT02348723|464491333|FG000|Overall Study|Reason other than specified|1|||
129054764|NCT02348723|464491334|FG001|Overall Study|Reason other than specified|1|||
129054765|NCT02348723|464491333|FG000|Overall Study|Adverse Event|3|||
129054766|NCT02348723|464491334|FG001|Overall Study|Adverse Event|1|||
129054767|NCT04874155|464491335|FG000|Overall Study|Lost to Follow-up|1|||
129054768|NCT04874155|464491336|FG001|Overall Study|Lost to Follow-up|1|||
129054769|NCT04874155|464491335|FG000|Overall Study|Withdrawal by Subject|2|||
129054770|NCT04874155|464491336|FG001|Overall Study|Withdrawal by Subject|2|||
129054771|NCT02329847|464491337|FG000|Overall Study|Death|4|||
129054772|NCT02329847|464491338|FG001|Overall Study|Death|4|||
129054773|NCT02329847|464491339|FG002|Overall Study|Death|22|||
129054774|NCT02329847|464491340|FG003|Overall Study|Death|12|||
129054775|NCT02329847|464491341|FG004|Overall Study|Death|20|||
129054776|NCT02329847|464491342|FG005|Overall Study|Death|13|||
129054777|NCT02329847|464491337|FG000|Overall Study|Lost to Follow-up|0|||
129054778|NCT02329847|464491338|FG001|Overall Study|Lost to Follow-up|0|||
129054779|NCT02329847|464491339|FG002|Overall Study|Lost to Follow-up|2|||
129054780|NCT02329847|464491340|FG003|Overall Study|Lost to Follow-up|3|||
129054781|NCT02329847|464491341|FG004|Overall Study|Lost to Follow-up|0|||
129054782|NCT02329847|464491342|FG005|Overall Study|Lost to Follow-up|1|||
129054783|NCT02329847|464491337|FG000|Overall Study|Physician Decision|0|||
129054784|NCT02329847|464491338|FG001|Overall Study|Physician Decision|0|||
129054785|NCT02329847|464491339|FG002|Overall Study|Physician Decision|0|||
129054786|NCT02329847|464491340|FG003|Overall Study|Physician Decision|0|||
129054787|NCT02329847|464491341|FG004|Overall Study|Physician Decision|1|||
129054788|NCT02329847|464491342|FG005|Overall Study|Physician Decision|0|||
129137016|NCT02533674|464794512|FG002|Dose Level VI|Progressive disease|0|||
128719956|NCT00456521|463273280|FG001|Overall Study|Lack of Efficacy|6|||
129054789|NCT02329847|464491337|FG000|Overall Study|Withdrawal by Subject|2|||
129054790|NCT02329847|464491338|FG001|Overall Study|Withdrawal by Subject|1|||
129054791|NCT02329847|464491339|FG002|Overall Study|Withdrawal by Subject|5|||
129054792|NCT02329847|464491340|FG003|Overall Study|Withdrawal by Subject|7|||
129054793|NCT02329847|464491341|FG004|Overall Study|Withdrawal by Subject|8|||
129054794|NCT02329847|464491342|FG005|Overall Study|Withdrawal by Subject|3|||
129054795|NCT02329847|464491337|FG000|Overall Study|Other|1|||
129054796|NCT02329847|464491338|FG001|Overall Study|Other|2|||
129054797|NCT02329847|464491339|FG002|Overall Study|Other|6|||
129054798|NCT02329847|464491340|FG003|Overall Study|Other|13|||
129054799|NCT02329847|464491341|FG004|Overall Study|Other|10|||
129054800|NCT02329847|464491342|FG005|Overall Study|Other|3|||
129054801|NCT05293639|464491343|FG000|Overall Study|Withdrawal by Subject|1|||
129054802|NCT05293639|464491344|FG001|Overall Study|Withdrawal by Subject|1|||
129054803|NCT05293639|464491345|FG002|Overall Study|Withdrawal by Subject|2|||
129054804|NCT05293639|464491343|FG000|Overall Study|Death|0|||
129054805|NCT05293639|464491344|FG001|Overall Study|Death|1|||
129054806|NCT05293639|464491345|FG002|Overall Study|Death|0|||
129054807|NCT05293639|464491343|FG000|Overall Study|Lost to Follow-up|0|||
129054808|NCT05293639|464491344|FG001|Overall Study|Lost to Follow-up|0|||
129054809|NCT05293639|464491345|FG002|Overall Study|Lost to Follow-up|5|||
129054810|NCT05293639|464491343|FG000|Overall Study|Other|0|||
129054811|NCT05293639|464491344|FG001|Overall Study|Other|0|||
129054812|NCT05293639|464491345|FG002|Overall Study|Other|1|||
129054813|NCT03918109|464491356|FG000|Overall Study|Withdrawal by Subject|0|||
129054814|NCT03918109|464491357|FG001|Overall Study|Withdrawal by Subject|0|||
129054815|NCT03918109|464491358|FG002|Overall Study|Withdrawal by Subject|2|||
129054816|NCT03918109|464491359|FG003|Overall Study|Withdrawal by Subject|1|||
129054817|NCT03918109|464491356|FG000|Overall Study|Lost to Follow-up|0|||
129054818|NCT03918109|464491357|FG001|Overall Study|Lost to Follow-up|0|||
129054819|NCT03918109|464491358|FG002|Overall Study|Lost to Follow-up|0|||
129054820|NCT03918109|464491359|FG003|Overall Study|Lost to Follow-up|1|||
129054821|NCT00758680|464491360|FG000|Overall Study|Adverse Event|0|||
129054822|NCT00758680|464491361|FG001|Overall Study|Adverse Event|0|||
129054823|NCT00758680|464491362|FG002|Overall Study|Adverse Event|0|||
129054824|NCT00758680|464491363|FG003|Overall Study|Adverse Event|0|||
129054825|NCT00758680|464491364|FG004|Overall Study|Adverse Event|0|||
129054826|NCT00758680|464491365|FG005|Overall Study|Adverse Event|0|||
129054827|NCT00758680|464491366|FG006|Overall Study|Adverse Event|0|||
129054828|NCT00758680|464491367|FG007|Overall Study|Adverse Event|1|||
129054829|NCT00758680|464491368|FG008|Overall Study|Adverse Event|0|||
129054830|NCT00758680|464491369|FG009|Overall Study|Adverse Event|1|||
129054831|NCT00758680|464491360|FG000|Overall Study|Laboratory Adverse Event|0|||
129054832|NCT00758680|464491361|FG001|Overall Study|Laboratory Adverse Event|0|||
129054833|NCT00758680|464491362|FG002|Overall Study|Laboratory Adverse Event|0|||
129054834|NCT00758680|464491363|FG003|Overall Study|Laboratory Adverse Event|0|||
129054835|NCT00758680|464491364|FG004|Overall Study|Laboratory Adverse Event|0|||
129054836|NCT00758680|464491365|FG005|Overall Study|Laboratory Adverse Event|0|||
129054837|NCT00758680|464491366|FG006|Overall Study|Laboratory Adverse Event|0|||
129054838|NCT00758680|464491367|FG007|Overall Study|Laboratory Adverse Event|0|||
129054839|NCT00758680|464491368|FG008|Overall Study|Laboratory Adverse Event|1|||
129054840|NCT00758680|464491369|FG009|Overall Study|Laboratory Adverse Event|0|||
129054841|NCT00758680|464491360|FG000|Overall Study|Withdrawal by Subject|0|||
129054842|NCT00758680|464491361|FG001|Overall Study|Withdrawal by Subject|0|||
129054843|NCT00758680|464491362|FG002|Overall Study|Withdrawal by Subject|0|||
129054844|NCT00758680|464491363|FG003|Overall Study|Withdrawal by Subject|0|||
129054845|NCT00758680|464491364|FG004|Overall Study|Withdrawal by Subject|0|||
129054846|NCT00758680|464491365|FG005|Overall Study|Withdrawal by Subject|0|||
129054847|NCT00758680|464491366|FG006|Overall Study|Withdrawal by Subject|1|||
129054848|NCT00758680|464491367|FG007|Overall Study|Withdrawal by Subject|0|||
129054849|NCT00758680|464491368|FG008|Overall Study|Withdrawal by Subject|1|||
129054850|NCT00758680|464491369|FG009|Overall Study|Withdrawal by Subject|0|||
129054851|NCT00761865|464491370|FG000|Overall Study|Lost to Follow-up|8|||
129054852|NCT00761865|464491371|FG001|Overall Study|Lost to Follow-up|7|||
129054853|NCT01094886|464491374|FG000|Overall Study|Adverse Event|2|||
129054854|NCT01094886|464491374|FG000|Overall Study|Withdrawal by Subject|5|||
129054855|NCT03866902|464491376|FG000|Overall Study|Lost to Follow-up|98|||
129054856|NCT03866902|464491377|FG001|Overall Study|Lost to Follow-up|82|||
129054857|NCT03866902|464491376|FG000|Overall Study|Pregnancy|18|||
129054858|NCT03866902|464491377|FG001|Overall Study|Pregnancy|24|||
129054859|NCT04730349|464491380|FG000|Overall Study|Participant withdrew consent|1|||
129054860|NCT04730349|464491381|FG001|Overall Study|Participant withdrew consent|0|||
129054861|NCT04730349|464491380|FG000|Overall Study|Disease progression|6|||
129054862|NCT04730349|464491381|FG001|Overall Study|Disease progression|4|||
129054863|NCT04730349|464491380|FG000|Overall Study|Study drug toxicity|0|||
129054864|NCT04730349|464491381|FG001|Overall Study|Study drug toxicity|1|||
129054865|NCT00638027|464491382|FG000|Overall Study|Adverse Event|0|||
129054866|NCT00638027|464491383|FG001|Overall Study|Adverse Event|2|||
129054867|NCT03014180|464491385|FG000|Overall Study|Protocol Violation|2|||
129054868|NCT01284621|464491386|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129054869|NCT01284621|464491387|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129054870|NCT01284621|464491388|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129054871|NCT01284621|464491389|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129054872|NCT01284621|464491390|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
129054873|NCT01284621|464491391|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129054874|NCT02802631|464491394|FG000|Overall Study|Withdrawal by Subject|1|||
129054875|NCT02802631|464491395|FG001|Overall Study|Withdrawal by Subject|0|||
129054876|NCT02802631|464491396|FG002|Overall Study|Withdrawal by Subject|0|||
129054877|NCT02802631|464491397|FG003|Overall Study|Withdrawal by Subject|0|||
129054878|NCT02802631|464491398|FG004|Overall Study|Withdrawal by Subject|0|||
129054879|NCT02802631|464491399|FG005|Overall Study|Withdrawal by Subject|0|||
129054880|NCT02802631|464491400|FG006|Overall Study|Withdrawal by Subject|0|||
129054881|NCT02802631|464491401|FG007|Overall Study|Withdrawal by Subject|0|||
129054882|NCT02802631|464491394|FG000|Overall Study|Physician Decision|1|||
129054883|NCT02802631|464491395|FG001|Overall Study|Physician Decision|0|||
129054884|NCT02802631|464491396|FG002|Overall Study|Physician Decision|0|||
129054885|NCT02802631|464491397|FG003|Overall Study|Physician Decision|0|||
129054886|NCT02802631|464491398|FG004|Overall Study|Physician Decision|0|||
129054887|NCT02802631|464491399|FG005|Overall Study|Physician Decision|0|||
129054888|NCT02802631|464491400|FG006|Overall Study|Physician Decision|1|||
129054889|NCT02802631|464491401|FG007|Overall Study|Physician Decision|0|||
129054890|NCT02802631|464491394|FG000|Overall Study|Adverse Event|0|||
129054891|NCT02802631|464491395|FG001|Overall Study|Adverse Event|2|||
129054892|NCT02802631|464491396|FG002|Overall Study|Adverse Event|0|||
129054893|NCT02802631|464491397|FG003|Overall Study|Adverse Event|1|||
129054894|NCT02802631|464491398|FG004|Overall Study|Adverse Event|6|||
129054895|NCT02802631|464491399|FG005|Overall Study|Adverse Event|1|||
129054896|NCT02802631|464491400|FG006|Overall Study|Adverse Event|4|||
129054897|NCT02802631|464491401|FG007|Overall Study|Adverse Event|0|||
129054898|NCT02802631|464491394|FG000|Overall Study|Sponsor Decision|0|||
129054899|NCT02802631|464491395|FG001|Overall Study|Sponsor Decision|0|||
129054900|NCT02802631|464491396|FG002|Overall Study|Sponsor Decision|6|||
129054901|NCT02802631|464491397|FG003|Overall Study|Sponsor Decision|0|||
129054902|NCT02802631|464491398|FG004|Overall Study|Sponsor Decision|2|||
129054903|NCT02802631|464491399|FG005|Overall Study|Sponsor Decision|0|||
129054904|NCT02802631|464491400|FG006|Overall Study|Sponsor Decision|0|||
129054905|NCT02802631|464491401|FG007|Overall Study|Sponsor Decision|4|||
129054906|NCT02342639|464491402|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
129054907|NCT02342639|464491403|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
129054908|NCT02342639|464491402|FG000|Overall Study|Protocol Violation|0|||
129054909|NCT02342639|464491403|FG001|Overall Study|Protocol Violation|2|||
129054910|NCT03155945|464491404|FG000|Overall Study|Lost to Follow-up|0|||
129054911|NCT03155945|464491405|FG001|Overall Study|Lost to Follow-up|1|||
129054912|NCT03155945|464491404|FG000|Overall Study|Withdrawal by Subject|0|||
129054913|NCT03155945|464491405|FG001|Overall Study|Withdrawal by Subject|1|||
129054914|NCT03155945|464491404|FG000|Overall Study|Other Reason|0|||
129054915|NCT03155945|464491405|FG001|Overall Study|Other Reason|1|||
129054916|NCT01177059|464491407|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
129054917|NCT01177059|464491407|FG000|Overall Study|Withdrew consent|2|||
129054918|NCT01177059|464491407|FG000|Overall Study|Lost to Follow-up|18|||
129054919|NCT02886624|464492853|FG000|12-week Post Treatment Follow-up|Death|1|||
129054920|NCT02886624|464492853|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
129054921|NCT03972163|464492854|FG000|Overall Study|Death|0|||
129054922|NCT03972163|464492855|FG001|Overall Study|Death|1|||
129054923|NCT00492024|464492866|FG000|Treatment|Adverse Event|3|||
129054924|NCT00492024|464492867|FG001|Treatment|Adverse Event|1|||
129054925|NCT00492024|464492866|FG000|Treatment|Lack of Efficacy|21|||
129054926|NCT00492024|464492867|FG001|Treatment|Lack of Efficacy|20|||
129054927|NCT00492024|464492866|FG000|Treatment|Lost to Follow-up|3|||
129054928|NCT00492024|464492867|FG001|Treatment|Lost to Follow-up|1|||
129054929|NCT00492024|464492866|FG000|Treatment|Withdrawal by Subject|2|||
129054930|NCT00492024|464492867|FG001|Treatment|Withdrawal by Subject|0|||
129054931|NCT00492024|464492866|FG000|Follow up|Lack of Efficacy|0|||
129054932|NCT00492024|464492867|FG001|Follow up|Lack of Efficacy|1|||
129054933|NCT00492024|464492866|FG000|Follow up|Lost to Follow-up|1|||
129054934|NCT00492024|464492867|FG001|Follow up|Lost to Follow-up|1|||
129054935|NCT03247816|464492870|FG000|Overall Study|Adverse Event|12|||
129054936|NCT03247816|464492870|FG000|Overall Study|Physician Decision|3|||
129054937|NCT03247816|464492870|FG000|Overall Study|Lack of Efficacy|1|||
129054938|NCT03247816|464492870|FG000|Overall Study|Lost to Follow-up|10|||
129054939|NCT03247816|464492870|FG000|Overall Study|Missing Feraccru stop date|3|||
129054940|NCT03257865|464492871|FG000|Overall Study|Adverse Event|4|||
129054941|NCT03257865|464492872|FG001|Overall Study|Adverse Event|8|||
129054942|NCT03257865|464492871|FG000|Overall Study|Lack of Efficacy|1|||
129054943|NCT03257865|464492872|FG001|Overall Study|Lack of Efficacy|2|||
129137017|NCT02533674|464794513|FG003|Dose Level VI|Progressive disease|0|||
129054944|NCT03257865|464492871|FG000|Overall Study|Non-compliance with Study Drug|0|||
129054945|NCT03257865|464492872|FG001|Overall Study|Non-compliance with Study Drug|2|||
129054946|NCT03257865|464492871|FG000|Overall Study|Withdrawal by Subject|23|||
129054947|NCT03257865|464492872|FG001|Overall Study|Withdrawal by Subject|17|||
129054948|NCT03257865|464492871|FG000|Overall Study|Physician Decision|3|||
129054949|NCT03257865|464492872|FG001|Overall Study|Physician Decision|1|||
129054950|NCT03257865|464492871|FG000|Overall Study|Other|0|||
129054951|NCT03257865|464492872|FG001|Overall Study|Other|1|||
129054952|NCT03257865|464492871|FG000|Overall Study|Lost to Follow-up|4|||
129054953|NCT03257865|464492872|FG001|Overall Study|Lost to Follow-up|4|||
129054954|NCT04015908|464492873|FG000|Overall Study|Lost to Follow-up|0|||
129054955|NCT04015908|464492874|FG001|Overall Study|Lost to Follow-up|1|||
129054956|NCT04623086|464492875|FG000|Overall Study|Withdrawal by Subject|0|||
129054957|NCT04623086|464492876|FG001|Overall Study|Withdrawal by Subject|0|||
129054958|NCT04623086|464492877|FG002|Overall Study|Withdrawal by Subject|10|||
129054959|NCT02538965|464492878|FG000|Treatment Period|Other = Death due to disease progression|1|||
129054960|NCT02538965|464492878|FG000|Treatment Period|Adverse Event|2|||
129054961|NCT02538965|464492878|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
129054962|NCT02538965|464492878|FG000|Treatment Period|Treatment Failure|9|||
129054963|NCT02538965|464492878|FG000|Treatment Period|Disease Progression|1|||
129054964|NCT02538965|464492878|FG000|Treatment Period|Physician Decision|2|||
129054965|NCT02538965|464492878|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
129054966|NCT02538965|464492878|FG000|Follow-Up Period|Withdrawal by Parent|4|||
129054967|NCT04546724|464492879|FG000|Overall Study|Withdrawal by Subject|145|||
129054968|NCT04546724|464492880|FG001|Overall Study|Withdrawal by Subject|41|||
129054969|NCT04546724|464492879|FG000|Overall Study|Adverse Event|1|||
129054970|NCT04546724|464492880|FG001|Overall Study|Adverse Event|1|||
129054971|NCT04546724|464492879|FG000|Overall Study|Lost to Follow-up|186|||
129054972|NCT04546724|464492880|FG001|Overall Study|Lost to Follow-up|63|||
129054973|NCT04546724|464492879|FG000|Overall Study|Physician Decision|8|||
129054974|NCT04546724|464492880|FG001|Overall Study|Physician Decision|2|||
129054975|NCT04546724|464492879|FG000|Overall Study|Death|2|||
129054976|NCT04546724|464492880|FG001|Overall Study|Death|1|||
129054977|NCT04546724|464492879|FG000|Overall Study|subject has been out of town|1|||
129054978|NCT04546724|464492880|FG001|Overall Study|subject has been out of town|0|||
129054979|NCT04546724|464492879|FG000|Overall Study|subject is incarcerated|2|||
129054980|NCT04546724|464492880|FG001|Overall Study|subject is incarcerated|0|||
129054981|NCT04546724|464492879|FG000|Overall Study|subject is relocating|12|||
129054982|NCT04546724|464492880|FG001|Overall Study|subject is relocating|4|||
129054983|NCT04546724|464492879|FG000|Overall Study|Subject in another study|1|||
129054984|NCT04546724|464492880|FG001|Overall Study|Subject in another study|1|||
129054985|NCT00077857|464492882|FG000|Overall Study|Adverse Event|30|||
129054986|NCT00077857|464492883|FG001|Overall Study|Adverse Event|32|||
129054987|NCT00077857|464492882|FG000|Overall Study|Death|7|||
129054988|NCT00077857|464492883|FG001|Overall Study|Death|3|||
129054989|NCT00077857|464492882|FG000|Overall Study|Insufficient therapeutic response|112|||
129054990|NCT00077857|464492883|FG001|Overall Study|Insufficient therapeutic response|128|||
129054991|NCT00077857|464492882|FG000|Overall Study|Violation of selection criteria at entry|3|||
129054992|NCT00077857|464492883|FG001|Overall Study|Violation of selection criteria at entry|1|||
129054993|NCT00077857|464492882|FG000|Overall Study|Other protocol violation|0|||
129054994|NCT00077857|464492883|FG001|Overall Study|Other protocol violation|1|||
129054995|NCT00077857|464492882|FG000|Overall Study|Refused treatment|29|||
129054996|NCT00077857|464492883|FG001|Overall Study|Refused treatment|21|||
129054997|NCT00077857|464492882|FG000|Overall Study|Failure to return|5|||
129054998|NCT00077857|464492883|FG001|Overall Study|Failure to return|5|||
129054999|NCT00077857|464492882|FG000|Overall Study|Other|15|||
129055000|NCT00077857|464492883|FG001|Overall Study|Other|13|||
129055001|NCT02365558|464492890|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
129055002|NCT02365558|464492891|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
129055003|NCT02365558|464492890|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
129055004|NCT02365558|464492891|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
129055005|NCT00369317|464492892|FG000|Overall Study|Adverse Event|3|||
129055006|NCT00369317|464492892|FG000|Overall Study|Death|1|||
129055007|NCT00369317|464492892|FG000|Overall Study|Lack of Efficacy|5|||
129055008|NCT00369317|464492892|FG000|Overall Study|Physician Decision|2|||
129055009|NCT00369317|464492892|FG000|Overall Study|Withdrawal by Subject|8|||
129055010|NCT00369317|464492892|FG000|Overall Study|Ineligible|1|||
129055011|NCT03185013|464492903|FG000|Overall Study|Withdrawal by Subject|5|||
129055012|NCT03185013|464492904|FG001|Overall Study|Withdrawal by Subject|3|||
129055013|NCT03185013|464492903|FG000|Overall Study|Adverse Event|1|||
129055014|NCT03185013|464492904|FG001|Overall Study|Adverse Event|0|||
129055015|NCT03185013|464492903|FG000|Overall Study|Progressive Disease|1|||
129055016|NCT03185013|464492904|FG001|Overall Study|Progressive Disease|0|||
129055017|NCT03185013|464492903|FG000|Overall Study|Lost to Follow-up|8|||
129055018|NCT03185013|464492904|FG001|Overall Study|Lost to Follow-up|2|||
129055019|NCT03185013|464492903|FG000|Overall Study|Physician Decision|1|||
129055020|NCT03185013|464492904|FG001|Overall Study|Physician Decision|0|||
129055021|NCT03185013|464492903|FG000|Overall Study|Protocol Deviation|2|||
129137018|NCT02533674|464794514|FG004|Dose Level VI|Progressive disease|0|||
128719957|NCT00456521|463273279|FG000|Overall Study|Protocol Violation|4|||
129055022|NCT03185013|464492904|FG001|Overall Study|Protocol Deviation|0|||
129055023|NCT03185013|464492903|FG000|Overall Study|Reason not Specified|3|||
129055024|NCT03185013|464492904|FG001|Overall Study|Reason not Specified|2|||
129055025|NCT03185013|464492903|FG000|Overall Study|Death|1|||
129055026|NCT03185013|464492904|FG001|Overall Study|Death|0|||
129055027|NCT00510289|464492908|FG000|Overall Study|Withdrawal by Subject|7|||
129055028|NCT00510289|464492908|FG000|Overall Study|Refused bone marrow biopsy|2|||
129055029|NCT00510289|464492908|FG000|Overall Study|Lost to Follow-up|1|||
129055030|NCT00510289|464492908|FG000|Overall Study|Progressed prior to starting drug|2|||
129055031|NCT00673387|464492911|FG000|Overall Study|Withdrawal by Subject|15|||
129055032|NCT00673387|464492912|FG001|Overall Study|Withdrawal by Subject|16|||
129055033|NCT00673387|464492913|FG002|Overall Study|Withdrawal by Subject|20|||
129055034|NCT00673387|464492914|FG003|Overall Study|Withdrawal by Subject|16|||
129055035|NCT00673387|464492915|FG004|Overall Study|Withdrawal by Subject|18|||
129055036|NCT00673387|464492916|FG005|Overall Study|Withdrawal by Subject|21|||
129055037|NCT00673387|464492917|FG006|Overall Study|Withdrawal by Subject|15|||
129055038|NCT00673387|464492918|FG007|Overall Study|Withdrawal by Subject|21|||
129055039|NCT00673387|464492911|FG000|Overall Study|Adverse Event|3|||
129055040|NCT00673387|464492912|FG001|Overall Study|Adverse Event|1|||
129055041|NCT00673387|464492913|FG002|Overall Study|Adverse Event|5|||
129055042|NCT00673387|464492914|FG003|Overall Study|Adverse Event|2|||
129055043|NCT00673387|464492915|FG004|Overall Study|Adverse Event|6|||
129055044|NCT00673387|464492916|FG005|Overall Study|Adverse Event|2|||
129055045|NCT00673387|464492917|FG006|Overall Study|Adverse Event|5|||
129055046|NCT00673387|464492918|FG007|Overall Study|Adverse Event|5|||
129055047|NCT00673387|464492911|FG000|Overall Study|Physician Decision|0|||
129055048|NCT00673387|464492912|FG001|Overall Study|Physician Decision|0|||
129055049|NCT00673387|464492913|FG002|Overall Study|Physician Decision|0|||
129055050|NCT00673387|464492914|FG003|Overall Study|Physician Decision|0|||
129055051|NCT00673387|464492915|FG004|Overall Study|Physician Decision|0|||
129055052|NCT00673387|464492916|FG005|Overall Study|Physician Decision|5|||
129055053|NCT00673387|464492917|FG006|Overall Study|Physician Decision|1|||
129055054|NCT00673387|464492918|FG007|Overall Study|Physician Decision|1|||
129055055|NCT00673387|464492911|FG000|Overall Study|Protocol Violation|3|||
129055056|NCT00673387|464492912|FG001|Overall Study|Protocol Violation|0|||
129055057|NCT00673387|464492913|FG002|Overall Study|Protocol Violation|1|||
129055058|NCT00673387|464492914|FG003|Overall Study|Protocol Violation|2|||
129055059|NCT00673387|464492915|FG004|Overall Study|Protocol Violation|0|||
129055060|NCT00673387|464492916|FG005|Overall Study|Protocol Violation|1|||
129055061|NCT00673387|464492917|FG006|Overall Study|Protocol Violation|1|||
129055062|NCT00673387|464492918|FG007|Overall Study|Protocol Violation|3|||
129055063|NCT00673387|464492911|FG000|Overall Study|Lost to Follow-up|8|||
129055064|NCT00673387|464492912|FG001|Overall Study|Lost to Follow-up|6|||
129055065|NCT00673387|464492913|FG002|Overall Study|Lost to Follow-up|5|||
129055066|NCT00673387|464492914|FG003|Overall Study|Lost to Follow-up|6|||
129055067|NCT00673387|464492915|FG004|Overall Study|Lost to Follow-up|6|||
129055068|NCT00673387|464492916|FG005|Overall Study|Lost to Follow-up|5|||
129055069|NCT00673387|464492917|FG006|Overall Study|Lost to Follow-up|8|||
129055070|NCT00673387|464492918|FG007|Overall Study|Lost to Follow-up|5|||
129055071|NCT00960115|464492921|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
129055072|NCT00960115|464492922|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
129055073|NCT00861198|464492923|FG000|Overall Study|SpyGlass Failed|5|||
129055074|NCT02011386|464492924|FG000|Overall Study|Non-compliance|2|||
129055075|NCT02011386|464492924|FG000|Overall Study|Lack of Efficacy|3|||
129055076|NCT01197755|464492925|FG000|Overall Study|Adverse Event|8|||
129055077|NCT01197755|464492926|FG001|Overall Study|Adverse Event|10|||
129055078|NCT01197755|464492927|FG002|Overall Study|Adverse Event|10|||
129055079|NCT01197755|464492925|FG000|Overall Study|Study-specific discontinuation criteria|2|||
129055080|NCT01197755|464492926|FG001|Overall Study|Study-specific discontinuation criteria|1|||
129055081|NCT01197755|464492927|FG002|Overall Study|Study-specific discontinuation criteria|0|||
129055082|NCT01197755|464492925|FG000|Overall Study|Entered the long-term extension study|18|||
129055083|NCT01197755|464492926|FG001|Overall Study|Entered the long-term extension study|21|||
129055084|NCT01197755|464492927|FG002|Overall Study|Entered the long-term extension study|35|||
129055085|NCT01197755|464492925|FG000|Overall Study|Lack of therapeutic response|0|||
129055086|NCT01197755|464492926|FG001|Overall Study|Lack of therapeutic response|7|||
129055087|NCT01197755|464492927|FG002|Overall Study|Lack of therapeutic response|4|||
129055088|NCT01197755|464492925|FG000|Overall Study|Severe non-compliance to the protocol|2|||
129055089|NCT01197755|464492926|FG001|Overall Study|Severe non-compliance to the protocol|1|||
129055090|NCT01197755|464492927|FG002|Overall Study|Severe non-compliance to the protocol|2|||
129055091|NCT01197755|464492925|FG000|Overall Study|Withdrawal by Subject|1|||
128719958|NCT00456521|463273280|FG001|Overall Study|Protocol Violation|0|||
129055092|NCT01197755|464492926|FG001|Overall Study|Withdrawal by Subject|0|||
129055093|NCT01197755|464492927|FG002|Overall Study|Withdrawal by Subject|0|||
129055094|NCT01197755|464492925|FG000|Overall Study|Lost to Follow-up|0|||
129055095|NCT01197755|464492926|FG001|Overall Study|Lost to Follow-up|0|||
129055096|NCT01197755|464492927|FG002|Overall Study|Lost to Follow-up|1|||
129055097|NCT01197755|464492925|FG000|Overall Study|eg, change in circumstances|7|||
129055098|NCT01197755|464492926|FG001|Overall Study|eg, change in circumstances|3|||
128719959|NCT00456521|463273279|FG000|Overall Study|Pregnancy|1|||
129137019|NCT02533674|464794515|FG005|Dose Level VI|Progressive disease|7|||
129137020|NCT02533674|464794516|FG006|Dose Level VI|Progressive disease|0|||
129137021|NCT02533674|464794517|FG007|Dose Level VI|Progressive disease|0|||
129137022|NCT02533674|464794510|FG000|Dose Level VI|Withdrawal by Subject|0|||
129137023|NCT02533674|464794511|FG001|Dose Level VI|Withdrawal by Subject|0|||
128719960|NCT00456521|463273280|FG001|Overall Study|Pregnancy|1|||
128719961|NCT00456521|463273279|FG000|Overall Study|Drug non-compliance, moved, other|26|||
129055099|NCT01197755|464492927|FG002|Overall Study|eg, change in circumstances|2|||
129055100|NCT03255655|464492928|FG000|Overall Study|Lost to Follow-up|7|||
129055101|NCT03255655|464492929|FG001|Overall Study|Lost to Follow-up|4|||
129055102|NCT04428333|464492932|FG000|Overall Study|Physician Decision|5|||
129055103|NCT04428333|464492933|FG001|Overall Study|Physician Decision|6|||
129055104|NCT04428333|464492932|FG000|Overall Study|Withdrawal by Subject|1|||
129055105|NCT04428333|464492933|FG001|Overall Study|Withdrawal by Subject|3|||
129055106|NCT04428333|464492932|FG000|Overall Study|Study Terminated By Sponsor|14|||
129055107|NCT04428333|464492933|FG001|Overall Study|Study Terminated By Sponsor|16|||
129055108|NCT03582826|464492934|FG000|Overall Study|Lost to Follow-up|39|||
129055109|NCT03582826|464492935|FG001|Overall Study|Lost to Follow-up|0|||
129055110|NCT03582826|464492934|FG000|Overall Study|Withdrawal by Subject|2|||
129055111|NCT03582826|464492935|FG001|Overall Study|Withdrawal by Subject|0|||
129055112|NCT00499174|464492936|FG000|Overall Study|Physician Decision|78|||
129055113|NCT00499174|464492937|FG001|Overall Study|Physician Decision|9|||
129055114|NCT02269163|464492938|FG000|Overall Study|Lost to Follow-up|1|||
129055115|NCT02269163|464492939|FG001|Overall Study|Lost to Follow-up|0|||
129055116|NCT02269163|464492938|FG000|Overall Study|Major protocol violation|0|||
129055117|NCT02269163|464492939|FG001|Overall Study|Major protocol violation|1|||
129055118|NCT02269163|464492938|FG000|Overall Study|Other|2|||
129055119|NCT02269163|464492939|FG001|Overall Study|Other|2|||
129055120|NCT02269163|464492938|FG000|Overall Study|Withdrawal by Subject|0|||
129055121|NCT02269163|464492939|FG001|Overall Study|Withdrawal by Subject|3|||
129055122|NCT02269163|464492938|FG000|Overall Study|Physician Decision|0|||
129055123|NCT02269163|464492939|FG001|Overall Study|Physician Decision|1|||
129055124|NCT02351960|464492942|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
129055125|NCT02351960|464492943|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
129055126|NCT02351960|464492942|FG000|Overall Study|Voluntary Withdrawal|5|||
129055127|NCT02351960|464492943|FG001|Overall Study|Voluntary Withdrawal|4|||
129055128|NCT02351960|464492942|FG000|Overall Study|Significant Protocol Deviation|0|||
129055129|NCT02351960|464492943|FG001|Overall Study|Significant Protocol Deviation|5|||
129055130|NCT00319982|464492944|FG000|Overall Study|Withdrawal by Subject|1|||
129055131|NCT00319982|464492945|FG001|Overall Study|Withdrawal by Subject|0|||
129055132|NCT00371397|464492948|FG000|Session 1|Withdrawal by Subject|1|||
129055133|NCT00371397|464492949|FG001|Session 1|Withdrawal by Subject|0|||
129055134|NCT00371397|464492950|FG002|Session 1|Withdrawal by Subject|0|||
129055135|NCT00371397|464492951|FG003|Session 1|Withdrawal by Subject|0|||
129055136|NCT00371397|464492952|FG004|Session 1|Withdrawal by Subject|0|||
129055137|NCT00371397|464492953|FG005|Session 1|Withdrawal by Subject|0|||
129055138|NCT00371397|464492954|FG006|Session 1|Withdrawal by Subject|0|||
129055139|NCT00371397|464492955|FG007|Session 1|Withdrawal by Subject|1|||
129055140|NCT00371397|464492956|FG008|Session 1|Withdrawal by Subject|0|||
129055141|NCT00371397|464492957|FG009|Session 1|Withdrawal by Subject|0|||
129055142|NCT00371397|464492958|FG010|Session 1|Withdrawal by Subject|0|||
129055143|NCT00371397|464492959|FG011|Session 1|Withdrawal by Subject|0|||
129055144|NCT02377427|464492960|FG000|Part A (Up to Week 20)|Physician Decision|1|||
129055145|NCT02377427|464492961|FG001|Part A (Up to Week 20)|Physician Decision|0|||
129055146|NCT02377427|464492962|FG002|Part A (Up to Week 20)|Physician Decision|0|||
129055147|NCT02377427|464492963|FG003|Part A (Up to Week 20)|Physician Decision|0|||
129055148|NCT02377427|464492964|FG004|Part A (Up to Week 20)|Physician Decision|0|||
129055149|NCT02377427|464492960|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
129055150|NCT02377427|464492961|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129055151|NCT02377427|464492962|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129055152|NCT02377427|464492963|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129055153|NCT02377427|464492964|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129055154|NCT02377427|464492960|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
129137024|NCT02533674|464794512|FG002|Dose Level VI|Withdrawal by Subject|0|||
128719962|NCT00456521|463273280|FG001|Overall Study|Drug non-compliance, moved, other|11|||
129055155|NCT02377427|464492961|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129055156|NCT02377427|464492962|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129055157|NCT02377427|464492963|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129055158|NCT02377427|464492964|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129055159|NCT02377427|464492960|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129055160|NCT02377427|464492961|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129055161|NCT02377427|464492962|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
129055162|NCT02377427|464492963|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129055163|NCT02377427|464492964|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129137025|NCT02533674|464794513|FG003|Dose Level VI|Withdrawal by Subject|0|||
129055164|NCT02212379|464492965|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
129055165|NCT02212379|464492965|FG000|From Baseline to Week 48|Adverse Event|7|||
129055166|NCT02212379|464492965|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
129055167|NCT02212379|464492965|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
129055168|NCT02212379|464492965|FG000|From Week 48 to Week 96|Adverse Event|1|||
129055169|NCT02212379|464492965|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
129055170|NCT02105974|464492966|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
129055171|NCT02105974|464492967|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
129055172|NCT02105974|464492968|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
129055173|NCT02105974|464492966|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
129055174|NCT02105974|464492967|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
129055175|NCT02105974|464492968|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
129055176|NCT02105974|464492966|FG000|2 Week Run-in Period|Adverse Event|6|||
129055177|NCT02105974|464492967|FG001|2 Week Run-in Period|Adverse Event|0|||
129055178|NCT02105974|464492968|FG002|2 Week Run-in Period|Adverse Event|0|||
129055179|NCT02105974|464492966|FG000|2 Week Run-in Period|Study closed/terminated|1|||
129055180|NCT02105974|464492967|FG001|2 Week Run-in Period|Study closed/terminated|0|||
129055181|NCT02105974|464492968|FG002|2 Week Run-in Period|Study closed/terminated|0|||
129055182|NCT02105974|464492966|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
129055183|NCT02105974|464492967|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
129055184|NCT02105974|464492968|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
129055185|NCT02105974|464492966|FG000|2 Week Run-in Period|Withdrew consent|23|||
129055186|NCT02105974|464492967|FG001|2 Week Run-in Period|Withdrew consent|0|||
129055187|NCT02105974|464492968|FG002|2 Week Run-in Period|Withdrew consent|0|||
129055188|NCT02105974|464492966|FG000|2 Week Run-in Period|Investigator discretion|8|||
129055189|NCT02105974|464492967|FG001|2 Week Run-in Period|Investigator discretion|0|||
129055190|NCT02105974|464492968|FG002|2 Week Run-in Period|Investigator discretion|0|||
129055191|NCT02105974|464492966|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
129055192|NCT02105974|464492967|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
129055193|NCT02105974|464492968|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
129055194|NCT02105974|464492966|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
129055195|NCT02105974|464492967|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
129055196|NCT02105974|464492968|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
129055197|NCT02105974|464492966|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
129055198|NCT02105974|464492967|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
129055199|NCT02105974|464492968|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
129055200|NCT02105974|464492966|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
129055201|NCT02105974|464492967|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
129055202|NCT02105974|464492968|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
129055203|NCT02105974|464492966|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
129055204|NCT02105974|464492967|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
129055205|NCT02105974|464492968|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
129055206|NCT02105974|464492966|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
129055207|NCT02105974|464492967|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
129055208|NCT02105974|464492968|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
129055209|NCT02105974|464492966|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
129055210|NCT02105974|464492967|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
129055211|NCT02105974|464492968|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
129055212|NCT02968849|464492969|FG000|Overall Study|Death|8|||
129055213|NCT02968849|464492970|FG001|Overall Study|Death|10|||
129055214|NCT02968849|464492969|FG000|Overall Study|Lost to Follow-up|31|||
129055215|NCT02968849|464492970|FG001|Overall Study|Lost to Follow-up|29|||
129055216|NCT02968849|464492969|FG000|Overall Study|Withdrawal by Subject|73|||
129055217|NCT02968849|464492970|FG001|Overall Study|Withdrawal by Subject|64|||
129055218|NCT02968849|464492969|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
129055219|NCT02968849|464492970|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
129055220|NCT02968849|464492969|FG000|Overall Study|Physician Decision|6|||
129055221|NCT02968849|464492970|FG001|Overall Study|Physician Decision|9|||
129055222|NCT02968849|464492969|FG000|Overall Study|Other|16|||
129055223|NCT02968849|464492970|FG001|Overall Study|Other|10|||
129055224|NCT02013674|464492973|FG000|Overall Study|Death|0|||
129055225|NCT02013674|464492974|FG001|Overall Study|Death|1|||
129055226|NCT02013674|464492973|FG000|Overall Study|Lost to Follow-up|1|||
129055227|NCT02013674|464492974|FG001|Overall Study|Lost to Follow-up|0|||
129055228|NCT00416884|464492976|FG000|Overall Study|Study terminated due to low accrual|1|||
129055229|NCT02203331|464492977|FG000|Overall Study|Pregnancy|1|||
129055230|NCT02203331|464492978|FG001|Overall Study|Pregnancy|0|||
129055231|NCT02203331|464492979|FG002|Overall Study|Pregnancy|0|||
129055232|NCT02203331|464492980|FG003|Overall Study|Pregnancy|0|||
129055233|NCT02203331|464492981|FG004|Overall Study|Pregnancy|2|||
129055234|NCT02203331|464492982|FG005|Overall Study|Pregnancy|0|||
129055235|NCT02203331|464492977|FG000|Overall Study|Withdrawal by Subject|1|||
129055236|NCT02203331|464492978|FG001|Overall Study|Withdrawal by Subject|0|||
129055237|NCT02203331|464492979|FG002|Overall Study|Withdrawal by Subject|1|||
129055238|NCT02203331|464492980|FG003|Overall Study|Withdrawal by Subject|0|||
129055239|NCT02203331|464492981|FG004|Overall Study|Withdrawal by Subject|0|||
129055240|NCT02203331|464492982|FG005|Overall Study|Withdrawal by Subject|3|||
129055241|NCT02203331|464492977|FG000|Overall Study|Adverse Event|4|||
129055242|NCT02203331|464492978|FG001|Overall Study|Adverse Event|8|||
129055243|NCT02203331|464492979|FG002|Overall Study|Adverse Event|3|||
129055244|NCT02203331|464492980|FG003|Overall Study|Adverse Event|4|||
129055245|NCT02203331|464492981|FG004|Overall Study|Adverse Event|3|||
129055246|NCT02203331|464492982|FG005|Overall Study|Adverse Event|3|||
129055247|NCT02203331|464492977|FG000|Overall Study|Other Reasons|1|||
129055248|NCT02203331|464492978|FG001|Overall Study|Other Reasons|2|||
129055249|NCT02203331|464492979|FG002|Overall Study|Other Reasons|0|||
129055250|NCT02203331|464492980|FG003|Overall Study|Other Reasons|2|||
129055251|NCT02203331|464492981|FG004|Overall Study|Other Reasons|0|||
129055252|NCT02203331|464492982|FG005|Overall Study|Other Reasons|0|||
129055253|NCT02203331|464492977|FG000|Overall Study|Lack of Efficacy|0|||
129055254|NCT02203331|464492978|FG001|Overall Study|Lack of Efficacy|2|||
129055255|NCT02203331|464492979|FG002|Overall Study|Lack of Efficacy|1|||
129055256|NCT02203331|464492980|FG003|Overall Study|Lack of Efficacy|0|||
129055257|NCT02203331|464492981|FG004|Overall Study|Lack of Efficacy|0|||
129055258|NCT02203331|464492982|FG005|Overall Study|Lack of Efficacy|1|||
129055259|NCT02203331|464492977|FG000|Overall Study|Protocol Violation|0|||
129055260|NCT02203331|464492978|FG001|Overall Study|Protocol Violation|2|||
129055261|NCT02203331|464492979|FG002|Overall Study|Protocol Violation|0|||
129055262|NCT02203331|464492980|FG003|Overall Study|Protocol Violation|1|||
129055263|NCT02203331|464492981|FG004|Overall Study|Protocol Violation|1|||
129055264|NCT02203331|464492982|FG005|Overall Study|Protocol Violation|0|||
129055265|NCT02203331|464492977|FG000|Overall Study|Lost to Follow-up|0|||
129055266|NCT02203331|464492978|FG001|Overall Study|Lost to Follow-up|0|||
129055267|NCT02203331|464492979|FG002|Overall Study|Lost to Follow-up|0|||
129055268|NCT02203331|464492980|FG003|Overall Study|Lost to Follow-up|0|||
129055269|NCT02203331|464492981|FG004|Overall Study|Lost to Follow-up|1|||
129055270|NCT02203331|464492982|FG005|Overall Study|Lost to Follow-up|0|||
129055271|NCT00704730|464492989|FG000|Overall Study|Adverse Event|35|||
129055272|NCT00704730|464492990|FG001|Overall Study|Adverse Event|9|||
129055273|NCT00704730|464492989|FG000|Overall Study|Death|11|||
129055274|NCT00704730|464492990|FG001|Overall Study|Death|5|||
129055275|NCT00704730|464492989|FG000|Overall Study|Physician Decision|2|||
129055276|NCT00704730|464492990|FG001|Overall Study|Physician Decision|0|||
129055277|NCT00704730|464492989|FG000|Overall Study|Did not receive drug|5|||
129055278|NCT00704730|464492990|FG001|Overall Study|Did not receive drug|2|||
129055279|NCT00704730|464492989|FG000|Overall Study|Disease progression per PI|58|||
129055280|NCT00704730|464492990|FG001|Overall Study|Disease progression per PI|67|||
129055281|NCT00704730|464492989|FG000|Overall Study|data unavailable|1|||
129055282|NCT00704730|464492990|FG001|Overall Study|data unavailable|0|||
129055283|NCT00704730|464492989|FG000|Overall Study|Withdrawal by Subject|9|||
129055284|NCT00704730|464492990|FG001|Overall Study|Withdrawal by Subject|13|||
129055285|NCT05065567|464492992|FG000|Overall Study|Lost to Follow-up|10|||
129055286|NCT05065567|464492993|FG001|Overall Study|Lost to Follow-up|9|||
129055287|NCT05065567|464492994|FG002|Overall Study|Lost to Follow-up|6|||
129055288|NCT02551666|464492995|FG000|Overall Study|Withdrawal by Subject|1|||
129055289|NCT02551666|464492996|FG001|Overall Study|Withdrawal by Subject|3|||
129055290|NCT04051619|464492997|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
129055291|NCT04051619|464492998|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
129055292|NCT04051619|464492997|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
129055293|NCT04051619|464492998|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
129055294|NCT03510598|464494319|FG000|Overall Study|Withdrawal by Subject|1|||
128719963|NCT00605475|463273281|FG000|Overall Study|Abnormal Laboratory Values|0|||
128719964|NCT00605475|463273282|FG001|Overall Study|Abnormal Laboratory Values|0|||
129055295|NCT05307510|464494323|FG000|Overall Study|Lost to Follow-up|3|||
129055296|NCT05307510|464494324|FG001|Overall Study|Lost to Follow-up|6|||
129055297|NCT05307510|464494323|FG000|Overall Study|Withdrawal by Subject|0|||
128719965|NCT00605475|463273283|FG002|Overall Study|Abnormal Laboratory Values|0|||
129055298|NCT05307510|464494324|FG001|Overall Study|Withdrawal by Subject|1|||
128719966|NCT00605475|463273284|FG003|Overall Study|Abnormal Laboratory Values|0|||
129055299|NCT03610516|464494327|FG000|Treatment Epoch|Adverse Event|3|||
129055300|NCT03610516|464494328|FG001|Treatment Epoch|Adverse Event|1|||
129055301|NCT03610516|464494327|FG000|Treatment Epoch|Death|1|||
129055302|NCT03610516|464494328|FG001|Treatment Epoch|Death|0|||
129055303|NCT03610516|464494327|FG000|Treatment Epoch|Lack of Efficacy|0|||
129055304|NCT03610516|464494328|FG001|Treatment Epoch|Lack of Efficacy|1|||
129055305|NCT03610516|464494327|FG000|Treatment Epoch|No longer requires treatment|1|||
129055306|NCT03610516|464494328|FG001|Treatment Epoch|No longer requires treatment|0|||
129055307|NCT03610516|464494327|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
129055308|NCT03610516|464494328|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
129055309|NCT03610516|464494327|FG000|Treatment Epoch|Physician Decision|8|||
129055310|NCT03610516|464494328|FG001|Treatment Epoch|Physician Decision|5|||
129055311|NCT03610516|464494327|FG000|Treatment Epoch|Protocol Deviation|1|||
129055312|NCT03610516|464494328|FG001|Treatment Epoch|Protocol Deviation|0|||
129055313|NCT03610516|464494327|FG000|Treatment Epoch|Withdrawal by Subject|3|||
129055314|NCT03610516|464494328|FG001|Treatment Epoch|Withdrawal by Subject|1|||
129055315|NCT03610516|464494327|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
129055316|NCT03610516|464494328|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
129055317|NCT03610516|464494327|FG000|Post-Treatment Follow-up|Death|1|||
129055318|NCT03610516|464494328|FG001|Post-Treatment Follow-up|Death|0|||
129055319|NCT01664130|464494333|FG000|Overall Study|competing secondary disease|2|||
129055320|NCT00554606|464494334|FG000|Overall Study|Adverse Event|3|||
129055321|NCT00554606|464494334|FG000|Overall Study|Abnormal laboratory values|1|||
129055322|NCT00554606|464494334|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
129055323|NCT00554606|464494334|FG000|Overall Study|Subject withdrew consent|2|||
129055324|NCT00554606|464494334|FG000|Overall Study|Lost to Follow-up|2|||
129055325|NCT00554606|464494334|FG000|Overall Study|Administrative problems|60|||
129055326|NCT00554606|464494334|FG000|Overall Study|Death|1|||
129055327|NCT00554606|464494334|FG000|Overall Study|Protocol deviation|2|||
129055328|NCT01161407|464494335|FG000|Overall Study|Protocol Violation|3|||
129055329|NCT01161407|464494336|FG001|Overall Study|Protocol Violation|1|||
129055330|NCT00849186|464494339|FG000|Overall Study|Adverse Event|2|||
129055331|NCT00849186|464494339|FG000|Overall Study|Withdrawal by Subject|1|||
129055332|NCT00849186|464494339|FG000|Overall Study|not treated|6|||
129055333|NCT00849186|464494339|FG000|Overall Study|Other|1|||
129055334|NCT02677714|464494344|FG000|Overall Study|Withdrawal by Subject|2|||
129055335|NCT02677714|464494345|FG001|Overall Study|Withdrawal by Subject|0|||
129055336|NCT01422187|464494347|FG000|Overall Study|Personal reason|1|||
129055337|NCT01422187|464494348|FG001|Overall Study|Personal reason|0|||
129055338|NCT01422187|464494349|FG002|Overall Study|Personal reason|0|||
129055339|NCT01422187|464494347|FG000|Overall Study|Lost to Follow-up|0|||
129055340|NCT01422187|464494348|FG001|Overall Study|Lost to Follow-up|1|||
129055341|NCT01422187|464494349|FG002|Overall Study|Lost to Follow-up|0|||
129055342|NCT02227446|464494350|FG000|Overall Study|not eligible post randomization|18|||
129055343|NCT02227446|464494351|FG001|Overall Study|not eligible post randomization|29|||
129055344|NCT02227446|464494350|FG000|Overall Study|Withdrawal by Subject|4|||
129137026|NCT02533674|464794514|FG004|Dose Level VI|Withdrawal by Subject|0|||
129137027|NCT02533674|464794515|FG005|Dose Level VI|Withdrawal by Subject|1|||
129137028|NCT02533674|464794516|FG006|Dose Level VI|Withdrawal by Subject|0|||
129137029|NCT02533674|464794517|FG007|Dose Level VI|Withdrawal by Subject|0|||
129137030|NCT02533674|464794510|FG000|Dose Level VI|Treatment-related AE|0|||
129137031|NCT02533674|464794511|FG001|Dose Level VI|Treatment-related AE|0|||
129137032|NCT02533674|464794512|FG002|Dose Level VI|Treatment-related AE|0|||
129137033|NCT02533674|464794513|FG003|Dose Level VI|Treatment-related AE|0|||
129137034|NCT02533674|464794514|FG004|Dose Level VI|Treatment-related AE|0|||
129137035|NCT02533674|464794515|FG005|Dose Level VI|Treatment-related AE|1|||
129137036|NCT02533674|464794516|FG006|Dose Level VI|Treatment-related AE|0|||
129137037|NCT02533674|464794517|FG007|Dose Level VI|Treatment-related AE|0|||
129137038|NCT02533674|464794510|FG000|Dose Level VII|Progressive disease|0|||
129137039|NCT02533674|464794511|FG001|Dose Level VII|Progressive disease|0|||
129137040|NCT02533674|464794512|FG002|Dose Level VII|Progressive disease|0|||
129137041|NCT02533674|464794513|FG003|Dose Level VII|Progressive disease|0|||
129137042|NCT02533674|464794514|FG004|Dose Level VII|Progressive disease|0|||
129137043|NCT02533674|464794515|FG005|Dose Level VII|Progressive disease|0|||
129137044|NCT02533674|464794516|FG006|Dose Level VII|Progressive disease|10|||
129137045|NCT02533674|464794517|FG007|Dose Level VII|Progressive disease|0|||
129137046|NCT02533674|464794510|FG000|Dose Level VII|Withdrawal by Subject|0|||
129137047|NCT02533674|464794511|FG001|Dose Level VII|Withdrawal by Subject|0|||
129137048|NCT02533674|464794512|FG002|Dose Level VII|Withdrawal by Subject|0|||
129055345|NCT02227446|464494351|FG001|Overall Study|Withdrawal by Subject|5|||
129055346|NCT00875797|464494352|FG000|Overall Study|Protocol Violation|6|||
129055347|NCT00875797|464494353|FG001|Overall Study|Protocol Violation|3|||
129055348|NCT00715624|464494354|FG000|Overall Study|Adverse Event|12|||
129137049|NCT02533674|464794513|FG003|Dose Level VII|Withdrawal by Subject|0|||
129137050|NCT02533674|464794514|FG004|Dose Level VII|Withdrawal by Subject|0|||
128775507|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
129055349|NCT00715624|464494355|FG001|Overall Study|Adverse Event|37|||
129055350|NCT00715624|464494354|FG000|Overall Study|Lack of Efficacy|11|||
129055351|NCT00715624|464494355|FG001|Overall Study|Lack of Efficacy|11|||
129055352|NCT00715624|464494354|FG000|Overall Study|Lost to Follow-up|1|||
129055353|NCT00715624|464494355|FG001|Overall Study|Lost to Follow-up|2|||
129055354|NCT00715624|464494354|FG000|Overall Study|Protocol Violation|1|||
129137051|NCT02533674|464794515|FG005|Dose Level VII|Withdrawal by Subject|0|||
129137052|NCT02533674|464794516|FG006|Dose Level VII|Withdrawal by Subject|3|||
129055355|NCT00715624|464494355|FG001|Overall Study|Protocol Violation|0|||
129055356|NCT00715624|464494354|FG000|Overall Study|Withdrawal by Subject|11|||
129055357|NCT00715624|464494355|FG001|Overall Study|Withdrawal by Subject|25|||
129055358|NCT00715624|464494354|FG000|Overall Study|Familial and personal reasons|10|||
129055359|NCT00715624|464494355|FG001|Overall Study|Familial and personal reasons|22|||
129055360|NCT00715624|464494354|FG000|Overall Study|Poor compliance|6|||
129055361|NCT00715624|464494355|FG001|Overall Study|Poor compliance|13|||
129055362|NCT00715624|464494354|FG000|Overall Study|Sponsor decision|0|||
129055363|NCT00715624|464494355|FG001|Overall Study|Sponsor decision|4|||
129055364|NCT00715624|464494354|FG000|Overall Study|Incorrect randomization (not treated)|0|||
129055365|NCT00715624|464494355|FG001|Overall Study|Incorrect randomization (not treated)|1|||
129055366|NCT00715624|464494354|FG000|Overall Study|Other|0|||
129055367|NCT00715624|464494355|FG001|Overall Study|Other|1|||
129055368|NCT03200912|464494356|FG000|Overall Study|Adverse Event|3|||
129055369|NCT03200912|464494357|FG001|Overall Study|Adverse Event|0|||
129055370|NCT03200912|464494358|FG002|Overall Study|Adverse Event|0|||
129055371|NCT03200912|464494356|FG000|Overall Study|Withdrawal by Subject|1|||
129055372|NCT03200912|464494357|FG001|Overall Study|Withdrawal by Subject|2|||
129055373|NCT03200912|464494358|FG002|Overall Study|Withdrawal by Subject|4|||
129055374|NCT03200912|464494356|FG000|Overall Study|Non-compliance with study drug|0|||
129055375|NCT03200912|464494357|FG001|Overall Study|Non-compliance with study drug|1|||
129055376|NCT03200912|464494358|FG002|Overall Study|Non-compliance with study drug|0|||
129055377|NCT02309138|464494359|FG000|Overall Study|Withdrawal by Subject|44|||
129055378|NCT02309138|464494360|FG001|Overall Study|Withdrawal by Subject|15|||
129055379|NCT02309138|464494359|FG000|Overall Study|Protocol Violation|4|||
129055380|NCT02309138|464494360|FG001|Overall Study|Protocol Violation|2|||
129055381|NCT02309138|464494359|FG000|Overall Study|delivered before visit 2|0|||
129055382|NCT02309138|464494360|FG001|Overall Study|delivered before visit 2|1|||
129055383|NCT03421730|464494369|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055384|NCT03421730|464494370|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
129055385|NCT03421730|464494371|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055386|NCT03421730|464494372|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055387|NCT03421730|464494373|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055388|NCT03421730|464494374|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055389|NCT03421730|464494375|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055390|NCT03421730|464494376|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055391|NCT03421730|464494377|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055392|NCT03421730|464494378|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055393|NCT03421730|464494379|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055394|NCT03421730|464494380|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129055395|NCT03421730|464494369|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055396|NCT03421730|464494370|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055397|NCT03421730|464494371|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055398|NCT03421730|464494372|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055399|NCT03421730|464494373|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
129055400|NCT03421730|464494374|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055401|NCT03421730|464494375|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055402|NCT03421730|464494376|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055403|NCT03421730|464494377|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055404|NCT03421730|464494378|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055405|NCT03421730|464494379|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055406|NCT03421730|464494380|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129055407|NCT02901548|464494385|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
129055408|NCT01955083|464494386|FG000|Overall Study|Lost to Follow-up|1|||
129055409|NCT01955083|464494387|FG001|Overall Study|Lost to Follow-up|1|||
129055410|NCT02871492|464494396|FG000|Overall Study|Lost to Follow-up|6|||
129055411|NCT02871492|464494397|FG001|Overall Study|Lost to Follow-up|3|||
129055412|NCT02871492|464494398|FG002|Overall Study|Lost to Follow-up|5|||
129055413|NCT02871492|464494396|FG000|Overall Study|Withdrawal by Subject|0|||
129055414|NCT02871492|464494397|FG001|Overall Study|Withdrawal by Subject|0|||
129055415|NCT02871492|464494398|FG002|Overall Study|Withdrawal by Subject|1|||
129055416|NCT02256436|464494399|FG000|Overall Study|Adverse Event|9|||
129055417|NCT02256436|464494400|FG001|Overall Study|Adverse Event|14|||
129055418|NCT02256436|464494399|FG000|Overall Study|Death|216|||
129055419|NCT02256436|464494400|FG001|Overall Study|Death|208|||
129055420|NCT02256436|464494399|FG000|Overall Study|Lost to Follow-up|1|||
128719967|NCT00605475|463273285|FG004|Overall Study|Abnormal Laboratory Values|0|||
128719968|NCT00605475|463273286|FG005|Overall Study|Abnormal Laboratory Values|0|||
128719969|NCT00605475|463273287|FG006|Overall Study|Abnormal Laboratory Values|0|||
128719970|NCT00605475|463273288|FG007|Overall Study|Abnormal Laboratory Values|0|||
128719971|NCT00605475|463273289|FG008|Overall Study|Abnormal Laboratory Values|1|||
129055421|NCT02256436|464494400|FG001|Overall Study|Lost to Follow-up|2|||
129055422|NCT02256436|464494399|FG000|Overall Study|Physician Decision|1|||
129055423|NCT02256436|464494400|FG001|Overall Study|Physician Decision|0|||
129055424|NCT02256436|464494399|FG000|Overall Study|Protocol Violation|0|||
129055425|NCT02256436|464494400|FG001|Overall Study|Protocol Violation|1|||
129055426|NCT02256436|464494399|FG000|Overall Study|Withdrawal by Subject|26|||
129055427|NCT02256436|464494400|FG001|Overall Study|Withdrawal by Subject|10|||
129055428|NCT02256436|464494399|FG000|Overall Study|Transferred to Extension Study|11|||
129055429|NCT02256436|464494400|FG001|Overall Study|Transferred to Extension Study|23|||
129055430|NCT02256436|464494399|FG000|Overall Study|Did Not Continue on Extension Study|8|||
129055431|NCT02256436|464494400|FG001|Overall Study|Did Not Continue on Extension Study|12|||
129055432|NCT03583086|464494401|FG000|Overall Study|Death|2|||
129055433|NCT03583086|464494402|FG001|Overall Study|Death|6|||
129055434|NCT03583086|464494403|FG002|Overall Study|Death|12|||
129055435|NCT03583086|464494404|FG003|Overall Study|Death|10|||
129055436|NCT03583086|464494405|FG004|Overall Study|Death|14|||
129055437|NCT03583086|464494406|FG005|Overall Study|Death|14|||
129055438|NCT03583086|464494407|FG006|Overall Study|Death|4|||
129055439|NCT03583086|464494401|FG000|Overall Study|Withdrawal by Subject|0|||
129055440|NCT03583086|464494402|FG001|Overall Study|Withdrawal by Subject|0|||
129055441|NCT03583086|464494403|FG002|Overall Study|Withdrawal by Subject|1|||
129055442|NCT03583086|464494404|FG003|Overall Study|Withdrawal by Subject|0|||
129055443|NCT03583086|464494405|FG004|Overall Study|Withdrawal by Subject|0|||
129055444|NCT03583086|464494406|FG005|Overall Study|Withdrawal by Subject|0|||
129055445|NCT03583086|464494407|FG006|Overall Study|Withdrawal by Subject|1|||
129055446|NCT03583086|464494401|FG000|Overall Study|Refused follow-up|0|||
129055447|NCT03583086|464494402|FG001|Overall Study|Refused follow-up|0|||
129055448|NCT03583086|464494403|FG002|Overall Study|Refused follow-up|1|||
129055449|NCT03583086|464494404|FG003|Overall Study|Refused follow-up|0|||
129055450|NCT03583086|464494405|FG004|Overall Study|Refused follow-up|1|||
129055451|NCT03583086|464494406|FG005|Overall Study|Refused follow-up|0|||
129055452|NCT03583086|464494407|FG006|Overall Study|Refused follow-up|0|||
129055453|NCT03583086|464494401|FG000|Overall Study|Declining Performance Status|0|||
129055454|NCT03583086|464494402|FG001|Overall Study|Declining Performance Status|0|||
129055455|NCT03583086|464494403|FG002|Overall Study|Declining Performance Status|1|||
129055456|NCT03583086|464494404|FG003|Overall Study|Declining Performance Status|0|||
129055457|NCT03583086|464494405|FG004|Overall Study|Declining Performance Status|0|||
129055458|NCT03583086|464494406|FG005|Overall Study|Declining Performance Status|0|||
129055459|NCT03583086|464494407|FG006|Overall Study|Declining Performance Status|0|||
129055460|NCT03583086|464494401|FG000|Overall Study|Still on study|0|||
129055461|NCT03583086|464494402|FG001|Overall Study|Still on study|0|||
129055462|NCT03583086|464494403|FG002|Overall Study|Still on study|0|||
129055463|NCT03583086|464494404|FG003|Overall Study|Still on study|1|||
129055464|NCT03583086|464494405|FG004|Overall Study|Still on study|0|||
129055465|NCT03583086|464494406|FG005|Overall Study|Still on study|0|||
129055466|NCT03583086|464494407|FG006|Overall Study|Still on study|1|||
129055467|NCT03583086|464494401|FG000|Overall Study|Disease progression|0|||
129055468|NCT03583086|464494402|FG001|Overall Study|Disease progression|0|||
129055469|NCT03583086|464494403|FG002|Overall Study|Disease progression|0|||
129055470|NCT03583086|464494404|FG003|Overall Study|Disease progression|0|||
129055471|NCT03583086|464494405|FG004|Overall Study|Disease progression|0|||
129055472|NCT03583086|464494406|FG005|Overall Study|Disease progression|0|||
129055473|NCT03583086|464494407|FG006|Overall Study|Disease progression|1|||
129055474|NCT03583086|464494401|FG000|Overall Study|Undergoing radiation therapy|0|||
129055475|NCT03583086|464494402|FG001|Overall Study|Undergoing radiation therapy|0|||
129055476|NCT03583086|464494403|FG002|Overall Study|Undergoing radiation therapy|0|||
129055477|NCT03583086|464494404|FG003|Overall Study|Undergoing radiation therapy|0|||
129137053|NCT02533674|464794517|FG007|Dose Level VII|Withdrawal by Subject|0|||
129137054|NCT02533674|464794510|FG000|Dose Level VII|Treatment-related AE|0|||
129137055|NCT02533674|464794511|FG001|Dose Level VII|Treatment-related AE|0|||
129137056|NCT02533674|464794512|FG002|Dose Level VII|Treatment-related AE|0|||
129055478|NCT03583086|464494405|FG004|Overall Study|Undergoing radiation therapy|0|||
129055479|NCT03583086|464494406|FG005|Overall Study|Undergoing radiation therapy|0|||
129055480|NCT03583086|464494407|FG006|Overall Study|Undergoing radiation therapy|1|||
129055481|NCT03583086|464494401|FG000|Overall Study|Lost to Follow-up|0|||
129055482|NCT03583086|464494402|FG001|Overall Study|Lost to Follow-up|0|||
129055483|NCT03583086|464494403|FG002|Overall Study|Lost to Follow-up|0|||
129055484|NCT03583086|464494404|FG003|Overall Study|Lost to Follow-up|0|||
129055485|NCT03583086|464494405|FG004|Overall Study|Lost to Follow-up|0|||
129055486|NCT03583086|464494406|FG005|Overall Study|Lost to Follow-up|1|||
129055487|NCT03583086|464494407|FG006|Overall Study|Lost to Follow-up|0|||
129055488|NCT03583086|464494401|FG000|Overall Study|Adverse Event|0|||
129055489|NCT03583086|464494402|FG001|Overall Study|Adverse Event|0|||
129137057|NCT02533674|464794513|FG003|Dose Level VII|Treatment-related AE|0|||
129055490|NCT03583086|464494403|FG002|Overall Study|Adverse Event|0|||
129055491|NCT03583086|464494404|FG003|Overall Study|Adverse Event|0|||
129055492|NCT03583086|464494405|FG004|Overall Study|Adverse Event|0|||
129055493|NCT03583086|464494406|FG005|Overall Study|Adverse Event|1|||
129055494|NCT03583086|464494407|FG006|Overall Study|Adverse Event|0|||
129055495|NCT01696279|464494408|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
129055496|NCT01696279|464494409|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
129055497|NCT01696279|464494410|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
129055498|NCT01696279|464494411|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
129055499|NCT01696279|464494408|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
129055500|NCT01696279|464494409|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
129055501|NCT01696279|464494410|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
129055502|NCT01696279|464494411|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
129055503|NCT01696279|464494408|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
129055504|NCT01696279|464494409|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
129055505|NCT01696279|464494410|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
129055506|NCT01696279|464494411|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
129055507|NCT01696279|464494408|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
129055508|NCT01696279|464494409|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
129055509|NCT01696279|464494410|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
129055510|NCT01696279|464494411|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
129055511|NCT01696279|464494408|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
129055512|NCT01696279|464494409|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
129055513|NCT01696279|464494410|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
129055514|NCT01696279|464494411|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
129055515|NCT01696279|464494408|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
129055516|NCT01696279|464494409|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
129055517|NCT01696279|464494410|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
129055518|NCT01696279|464494411|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
129055519|NCT01696279|464494408|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
129055520|NCT01696279|464494409|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
129055521|NCT01696279|464494410|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
129055522|NCT01696279|464494411|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
129055523|NCT01696279|464494408|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
129055524|NCT01696279|464494409|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
129055525|NCT01696279|464494410|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
129055526|NCT01696279|464494411|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
129055527|NCT01696279|464494408|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
129055528|NCT01696279|464494409|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
129055529|NCT01696279|464494410|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
129055530|NCT01696279|464494411|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
129055531|NCT01696279|464494408|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
129055532|NCT01696279|464494409|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
129055533|NCT01696279|464494410|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
129055534|NCT01696279|464494411|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
129055535|NCT01696279|464494408|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
129055536|NCT01696279|464494409|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
129055537|NCT01696279|464494410|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
129055538|NCT01696279|464494411|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
129055539|NCT01441947|464494414|FG000|Overall Study|Withdrawal by Subject|3|||
129055540|NCT01441947|464494415|FG001|Overall Study|Withdrawal by Subject|0|||
129055541|NCT04106661|464494419|FG000|Overall Study|Protocol Violation|3|||
129055542|NCT04106661|464494420|FG001|Overall Study|Protocol Violation|0|||
129137058|NCT02533674|464794514|FG004|Dose Level VII|Treatment-related AE|0|||
129137059|NCT02533674|464794515|FG005|Dose Level VII|Treatment-related AE|0|||
129137060|NCT02533674|464794516|FG006|Dose Level VII|Treatment-related AE|1|||
129137061|NCT02533674|464794517|FG007|Dose Level VII|Treatment-related AE|0|||
129137062|NCT02533674|464794510|FG000|Dose Level VII|Death|0|||
129137063|NCT02533674|464794511|FG001|Dose Level VII|Death|0|||
129137064|NCT02533674|464794512|FG002|Dose Level VII|Death|0|||
128719972|NCT00605475|463273290|FG009|Overall Study|Abnormal Laboratory Values|0|||
128719973|NCT00605475|463273281|FG000|Overall Study|Administrative problems|0|||
128719974|NCT00605475|463273282|FG001|Overall Study|Administrative problems|0|||
128719975|NCT00605475|463273283|FG002|Overall Study|Administrative problems|0|||
129055543|NCT04106661|464494419|FG000|Overall Study|Scheduling difficulties|1|||
129055544|NCT04106661|464494420|FG001|Overall Study|Scheduling difficulties|1|||
129137065|NCT02533674|464794513|FG003|Dose Level VII|Death|0|||
129137066|NCT02533674|464794514|FG004|Dose Level VII|Death|0|||
129137067|NCT02533674|464794515|FG005|Dose Level VII|Death|0|||
128719976|NCT00605475|463273284|FG003|Overall Study|Administrative problems|0|||
128719977|NCT00605475|463273285|FG004|Overall Study|Administrative problems|0|||
129055545|NCT00468650|464494422|FG000|Overall Study|Lost to Follow-up|4|||
129055546|NCT00468650|464494422|FG000|Overall Study|Withdrawal by Subject|2|||
129055547|NCT00468650|464494422|FG000|Overall Study|Protocol Violation|1|||
129055548|NCT02639052|464494423|FG000|Overall Study|Lost to Follow-up|1|||
129055549|NCT00128830|464494425|FG000|Overall Study|Adverse Event|10|||
129055550|NCT00128830|464494425|FG000|Overall Study|Withdrawal by Subject|14|||
129055551|NCT00128830|464494425|FG000|Overall Study|Lost to Follow-up|4|||
129055552|NCT00128830|464494425|FG000|Overall Study|Reached a virologic endpoint|29|||
129055553|NCT00128830|464494425|FG000|Overall Study|Non-compliant|4|||
129055554|NCT00128830|464494425|FG000|Overall Study|Discontinued or ineligible for study|2|||
129055555|NCT00128830|464494425|FG000|Overall Study|Other|9|||
129055556|NCT02730351|464494426|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
129055557|NCT02730351|464494427|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
129055558|NCT02730351|464494426|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
129055559|NCT02730351|464494427|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
129055560|NCT02730351|464494426|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
129055561|NCT02730351|464494427|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
129055562|NCT02730351|464494426|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
129055563|NCT02730351|464494427|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
129055564|NCT02730351|464494426|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
129055565|NCT02730351|464494427|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
129055566|NCT00838435|464494428|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
129055567|NCT00838435|464494428|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
129055568|NCT00838435|464494428|FG000|Part 2 (7 Years)|Adverse Event|2|||
129055569|NCT00838435|464494428|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
129055570|NCT00838435|464494428|FG000|Part 2 (7 Years)|Physician Decision|1|||
129055571|NCT00838435|464494428|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
129055572|NCT00838435|464494428|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
129055573|NCT03796039|464494430|FG000|Overall Study|Death|2|||
129055574|NCT03796039|464494431|FG001|Overall Study|Death|1|||
129055575|NCT03796039|464494430|FG000|Overall Study|Withdrawal by Subject|7|||
129055576|NCT03796039|464494431|FG001|Overall Study|Withdrawal by Subject|4|||
129055577|NCT02927366|464494432|FG000|Overall Study|Adverse Event|1|||
129055578|NCT02927366|464494433|FG001|Overall Study|Adverse Event|0|||
129055579|NCT02927366|464494432|FG000|Overall Study|Patient schedule|1|||
129055580|NCT02927366|464494433|FG001|Overall Study|Patient schedule|0|||
129055581|NCT00587990|464494438|FG000|Overall Study|Death|0|||
129055582|NCT00587990|464494439|FG001|Overall Study|Death|0|||
129055583|NCT00587990|464494440|FG002|Overall Study|Death|1|||
129055584|NCT02754856|464494441|FG000|Overall Study|Withdrawal by Subject|1|||
129055585|NCT00530218|464494442|FG000|Overall Study|CMV Not Detected|13|||
129055586|NCT00530218|464494442|FG000|Overall Study|Death|12|||
129055587|NCT03477903|464494447|FG000|Overall Study|Study Terminated by Sponsor|1|||
129055588|NCT01147107|464494448|FG000|Overall Study|Lack of Efficacy|5|||
129055589|NCT01147107|464494449|FG001|Overall Study|Lack of Efficacy|0|||
129055590|NCT01147107|464494448|FG000|Overall Study|Withdrawal by Subject|1|||
129055591|NCT01147107|464494449|FG001|Overall Study|Withdrawal by Subject|1|||
129055592|NCT03201965|464494450|FG000|Overall Study|Death|5|||
129055593|NCT03201965|464494451|FG001|Overall Study|Death|27|||
129055594|NCT03201965|464494452|FG002|Overall Study|Death|27|||
129055595|NCT03201965|464494450|FG000|Overall Study|Lost to Follow-up|0|||
129055596|NCT03201965|464494451|FG001|Overall Study|Lost to Follow-up|1|||
129055597|NCT03201965|464494452|FG002|Overall Study|Lost to Follow-up|0|||
129055598|NCT03201965|464494450|FG000|Overall Study|Withdrawal by Subject|3|||
129055599|NCT03201965|464494451|FG001|Overall Study|Withdrawal by Subject|13|||
129055600|NCT03201965|464494452|FG002|Overall Study|Withdrawal by Subject|4|||
129055601|NCT03201965|464494450|FG000|Overall Study|Ongoing|20|||
129055602|NCT03201965|464494451|FG001|Overall Study|Ongoing|152|||
129055603|NCT03201965|464494452|FG002|Overall Study|Ongoing|164|||
129137068|NCT02533674|464794516|FG006|Dose Level VII|Death|2|||
129055604|NCT00426361|464494456|FG000|Overall Study|Lost to Follow-up|3|||
129055605|NCT00426361|464494457|FG001|Overall Study|Lost to Follow-up|2|||
129055606|NCT00426361|464494458|FG002|Overall Study|Lost to Follow-up|5|||
129055607|NCT00426361|464494456|FG000|Overall Study|Withdrawal by Subject|1|||
129055608|NCT00426361|464494457|FG001|Overall Study|Withdrawal by Subject|3|||
129137069|NCT02533674|464794517|FG007|Dose Level VII|Death|0|||
129137070|NCT02533674|464794510|FG000|Dose Level VIII|Progressive disease|0|||
129137071|NCT02533674|464794511|FG001|Dose Level VIII|Progressive disease|0|||
129055609|NCT00426361|464494458|FG002|Overall Study|Withdrawal by Subject|0|||
129055610|NCT02828241|464494459|FG000|Overall Study|Adverse Event|7|||
129055611|NCT02828241|464494460|FG001|Overall Study|Adverse Event|2|||
129137072|NCT02533674|464794512|FG002|Dose Level VIII|Progressive disease|0|||
129137073|NCT02533674|464794513|FG003|Dose Level VIII|Progressive disease|0|||
129055612|NCT02828241|464494459|FG000|Overall Study|Protocol Violation|1|||
129055613|NCT02828241|464494460|FG001|Overall Study|Protocol Violation|0|||
129055614|NCT02478320|464494463|FG000|Overall Study|Adverse Event|2|||
129055615|NCT02478320|464494464|FG001|Overall Study|Adverse Event|0|||
129055616|NCT02478320|464494463|FG000|Overall Study|Death|1|||
129055617|NCT02478320|464494464|FG001|Overall Study|Death|0|||
129055618|NCT02478320|464494463|FG000|Overall Study|Lack of Efficacy|4|||
129055619|NCT02478320|464494464|FG001|Overall Study|Lack of Efficacy|0|||
129055620|NCT02478320|464494463|FG000|Overall Study|Withdrawal by Subject|2|||
129055621|NCT02478320|464494464|FG001|Overall Study|Withdrawal by Subject|0|||
129055622|NCT02478320|464494463|FG000|Overall Study|Screen Failure|3|||
129055623|NCT02478320|464494464|FG001|Overall Study|Screen Failure|0|||
129055624|NCT03365011|464494465|FG000|Overall Study|Withdrawal by Subject|1|||
129055625|NCT03365011|464494466|FG001|Overall Study|Withdrawal by Subject|2|||
129055626|NCT04853992|464494467|FG000|Treatment Period A|Adverse Event|0|||
129055627|NCT04853992|464494468|FG001|Treatment Period A|Adverse Event|1|||
129055628|NCT04853992|464494467|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
129055629|NCT04853992|464494468|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
129055630|NCT03480386|464494469|FG000|Overall Study|Did not complete measures at 3-months|17|||
129055631|NCT03480386|464494470|FG001|Overall Study|Did not complete measures at 3-months|14|||
129055632|NCT03480386|464494469|FG000|Overall Study|No baseline measures|11|||
129055633|NCT03480386|464494470|FG001|Overall Study|No baseline measures|14|||
129055634|NCT03480386|464494469|FG000|Overall Study|Death|0|||
129055635|NCT03480386|464494470|FG001|Overall Study|Death|5|||
129055636|NCT03480386|464494469|FG000|Overall Study|Withdrawal by Subject|12|||
129055637|NCT03480386|464494470|FG001|Overall Study|Withdrawal by Subject|8|||
129055638|NCT03480386|464494469|FG000|Overall Study|Lost to Follow-up|2|||
129055639|NCT03480386|464494470|FG001|Overall Study|Lost to Follow-up|1|||
129055640|NCT03480386|464494469|FG000|Overall Study|Complicating disease|0|||
129055641|NCT03480386|464494470|FG001|Overall Study|Complicating disease|1|||
129055642|NCT03480386|464494469|FG000|Overall Study|Disease progression|3|||
129055643|NCT03480386|464494470|FG001|Overall Study|Disease progression|0|||
129055644|NCT03480386|464494469|FG000|Overall Study|Became ineligible|0|||
129055645|NCT03480386|464494470|FG001|Overall Study|Became ineligible|2|||
129055646|NCT00574912|464494471|FG000|Overall Study|Could not place IV lines.|3|||
129055647|NCT00574912|464494471|FG000|Overall Study|scheduling conflicts|3|||
129055648|NCT00574912|464494471|FG000|Overall Study|Physician Decision|2|||
129055649|NCT02099682|464494477|FG000|Overall Study|Data Not Available|51|||
129055650|NCT02099682|464494477|FG000|Overall Study|Lost to Follow-up|31|||
129055651|NCT02099682|464494477|FG000|Overall Study|Other|29|||
129055652|NCT00660907|464496694|FG000|Overall Study|Incorrect Enrollment|1|||
129055653|NCT00660907|464496695|FG001|Overall Study|Incorrect Enrollment|1|||
129055654|NCT00660907|464496694|FG000|Overall Study|Adverse Event|33|||
129055655|NCT00660907|464496695|FG001|Overall Study|Adverse Event|19|||
129055656|NCT00660907|464496694|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
129055657|NCT00660907|464496695|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
129055658|NCT00660907|464496694|FG000|Overall Study|Withdrawal by Subject|23|||
129055659|NCT00660907|464496695|FG001|Overall Study|Withdrawal by Subject|32|||
129055660|NCT00660907|464496694|FG000|Overall Study|Lost to Follow-up|3|||
129055661|NCT00660907|464496695|FG001|Overall Study|Lost to Follow-up|3|||
129055662|NCT00660907|464496694|FG000|Overall Study|Poor/Non-Compliance|5|||
129055663|NCT00660907|464496695|FG001|Overall Study|Poor/Non-Compliance|1|||
129055664|NCT00660907|464496694|FG000|Overall Study|Safety|1|||
129055665|NCT00660907|464496695|FG001|Overall Study|Safety|0|||
129055666|NCT00660907|464496694|FG000|Overall Study|Death|1|||
129055667|NCT00660907|464496695|FG001|Overall Study|Death|3|||
129055668|NCT00660907|464496694|FG000|Overall Study|Various|11|||
129055669|NCT00660907|464496695|FG001|Overall Study|Various|8|||
129055670|NCT04975191|464496698|FG000|Overall Study|Protocol Violation|1|||
129055671|NCT04975191|464496699|FG001|Overall Study|Protocol Violation|2|||
129055672|NCT04975191|464496700|FG002|Overall Study|Protocol Violation|2|||
129055673|NCT04975191|464496701|FG003|Overall Study|Protocol Violation|2|||
129055674|NCT04975191|464496698|FG000|Overall Study|Lost to Follow-up|13|||
129055675|NCT04975191|464496699|FG001|Overall Study|Lost to Follow-up|3|||
129055676|NCT04975191|464496700|FG002|Overall Study|Lost to Follow-up|8|||
129055677|NCT04975191|464496701|FG003|Overall Study|Lost to Follow-up|8|||
129055678|NCT05776862|464496714|FG000|Overall Study|Adverse Event|0|||
129055679|NCT05776862|464496715|FG001|Overall Study|Adverse Event|1|||
129055680|NCT05776862|464496714|FG000|Overall Study|non-compliance|1|||
128775508|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
129055681|NCT05776862|464496715|FG001|Overall Study|non-compliance|0|||
129055682|NCT01199471|464496716|FG000|Overall Study|Protocol Violation|4|||
129055683|NCT01199471|464496716|FG000|Overall Study|Withdrawal by Subject|1|||
129055684|NCT01199471|464496716|FG000|Overall Study|Physician Decision|1|||
129055685|NCT02065700|464496717|FG000|Overall Study|Adverse Event|165|||
129055686|NCT02065700|464496718|FG001|Overall Study|Adverse Event|101|||
129055687|NCT02065700|464496717|FG000|Overall Study|Withdrawal by Subject|90|||
129055688|NCT02065700|464496718|FG001|Overall Study|Withdrawal by Subject|29|||
129055689|NCT02065700|464496717|FG000|Overall Study|Lost to Follow-up|12|||
129055690|NCT02065700|464496718|FG001|Overall Study|Lost to Follow-up|9|||
129055691|NCT02065700|464496717|FG000|Overall Study|Physician Decision|2|||
129055692|NCT02065700|464496718|FG001|Overall Study|Physician Decision|0|||
129055693|NCT02065700|464496717|FG000|Overall Study|Sponsor Request|38|||
129055694|NCT02065700|464496718|FG001|Overall Study|Sponsor Request|15|||
129055695|NCT02065700|464496717|FG000|Overall Study|Treatment Failure|3|||
129055696|NCT02065700|464496718|FG001|Overall Study|Treatment Failure|2|||
129055697|NCT02065700|464496717|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
129055698|NCT02065700|464496718|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
129055699|NCT02065700|464496717|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
129055700|NCT02065700|464496718|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
129055701|NCT02065700|464496717|FG000|Overall Study|Non-compliance with Study Procedures|2|||
129055702|NCT02065700|464496718|FG001|Overall Study|Non-compliance with Study Procedures|0|||
129055703|NCT02065700|464496717|FG000|Overall Study|Not Defined|21|||
129055704|NCT02065700|464496718|FG001|Overall Study|Not Defined|3|||
129055705|NCT03323437|464496720|FG000|Overall Study|Withdrawal by Subject|0|||
129055706|NCT03323437|464496721|FG001|Overall Study|Withdrawal by Subject|4|||
129055707|NCT03511326|464496729|FG000|Overall Study|Withdrawal by Subject|1|||
129055708|NCT01305044|464496730|FG000|Overall Study|Withdrawal by Subject|3|||
129055709|NCT01305044|464496731|FG001|Overall Study|Withdrawal by Subject|6|||
129055710|NCT04628793|464496732|FG000|Overall Study|Study terminated by sponsor|0|||
129055711|NCT04628793|464496733|FG001|Overall Study|Study terminated by sponsor|0|||
129055712|NCT04628793|464496734|FG002|Overall Study|Study terminated by sponsor|8|||
129055713|NCT04628793|464496732|FG000|Overall Study|Withdrawal by Subject|2|||
129055714|NCT04628793|464496733|FG001|Overall Study|Withdrawal by Subject|3|||
129055715|NCT04628793|464496734|FG002|Overall Study|Withdrawal by Subject|0|||
129055716|NCT04628793|464496732|FG000|Overall Study|Lost to Follow-up|0|||
129055717|NCT04628793|464496733|FG001|Overall Study|Lost to Follow-up|1|||
129055718|NCT04628793|464496734|FG002|Overall Study|Lost to Follow-up|0|||
129055719|NCT04746794|464496736|FG000|Overall Study|Did not complete any study assessment|50303|||
129055720|NCT04746794|464496737|FG001|Overall Study|Did not complete any study assessment|44997|||
129055721|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
129055722|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
129055723|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
129055724|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
129055725|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
129055726|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
129055727|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
129055728|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
129055729|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
129055730|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
129055731|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
129055732|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
129055733|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
129055734|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
129055735|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
129055736|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
129055737|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
129055738|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
129055739|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
129055740|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
129055741|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
129055742|NCT04040192|464496738|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
129055743|NCT04040192|464496739|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
129055744|NCT04040192|464496740|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
129055745|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
129055746|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
129055747|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
129055748|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
129055749|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
129055750|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
129055751|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
129055752|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
129055753|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
129055754|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
129055755|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
129055756|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
129055757|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129055758|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
129055759|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
129055760|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
129055761|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
129055762|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
129055763|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
129055764|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
129055765|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
129055766|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
129055767|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
129055768|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
129055769|NCT04040192|464496738|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
129055770|NCT04040192|464496739|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
129055771|NCT04040192|464496740|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
129055772|NCT03207243|464496741|FG000|Overall Study|Adverse Event|2|||
129055773|NCT03207243|464496742|FG001|Overall Study|Adverse Event|2|||
129055774|NCT03207243|464496741|FG000|Overall Study|Loss of Asthma Control|47|||
129055775|NCT03207243|464496742|FG001|Overall Study|Loss of Asthma Control|31|||
129055776|NCT03207243|464496741|FG000|Overall Study|Withdrawal by Subject|2|||
129055777|NCT03207243|464496742|FG001|Overall Study|Withdrawal by Subject|4|||
129055778|NCT03207243|464496741|FG000|Overall Study|Physician Decision|1|||
129055779|NCT03207243|464496742|FG001|Overall Study|Physician Decision|1|||
129055780|NCT03207243|464496741|FG000|Overall Study|Lost to Follow-up|0|||
129055781|NCT03207243|464496742|FG001|Overall Study|Lost to Follow-up|1|||
129055782|NCT03207243|464496741|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
129055783|NCT03207243|464496742|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
129055784|NCT03207243|464496741|FG000|Overall Study|Protocol Violation|0|||
129055785|NCT03207243|464496742|FG001|Overall Study|Protocol Violation|3|||
129055786|NCT00229723|464496743|FG000|Concomitant Phase|Adverse Event|4|||
129055787|NCT00229723|464496744|FG001|Concomitant Phase|Adverse Event|2|||
129055788|NCT00229723|464496745|FG002|Concomitant Phase|Adverse Event|5|||
129055789|NCT00229723|464496746|FG003|Concomitant Phase|Adverse Event|2|||
129055790|NCT00229723|464496747|FG004|Concomitant Phase|Adverse Event|0|||
129055791|NCT00229723|464496748|FG005|Concomitant Phase|Adverse Event|1|||
129055792|NCT00229723|464496749|FG006|Concomitant Phase|Adverse Event|2|||
129055793|NCT00229723|464496743|FG000|Concomitant Phase|Objective disease progression|0|||
129055794|NCT00229723|464496744|FG001|Concomitant Phase|Objective disease progression|0|||
129055795|NCT00229723|464496745|FG002|Concomitant Phase|Objective disease progression|0|||
129055796|NCT00229723|464496746|FG003|Concomitant Phase|Objective disease progression|0|||
129055797|NCT00229723|464496747|FG004|Concomitant Phase|Objective disease progression|0|||
129055798|NCT00229723|464496748|FG005|Concomitant Phase|Objective disease progression|0|||
129055799|NCT00229723|464496749|FG006|Concomitant Phase|Objective disease progression|0|||
129055800|NCT00229723|464496743|FG000|Concomitant Phase|Clinical progression|0|||
129055801|NCT00229723|464496744|FG001|Concomitant Phase|Clinical progression|0|||
129055802|NCT00229723|464496745|FG002|Concomitant Phase|Clinical progression|0|||
129055803|NCT00229723|464496746|FG003|Concomitant Phase|Clinical progression|0|||
129055804|NCT00229723|464496747|FG004|Concomitant Phase|Clinical progression|0|||
129055805|NCT00229723|464496748|FG005|Concomitant Phase|Clinical progression|0|||
129055806|NCT00229723|464496749|FG006|Concomitant Phase|Clinical progression|1|||
129055807|NCT00229723|464496743|FG000|Concomitant Phase|Lost to Follow-up|0|||
129055808|NCT00229723|464496744|FG001|Concomitant Phase|Lost to Follow-up|0|||
129055809|NCT00229723|464496745|FG002|Concomitant Phase|Lost to Follow-up|0|||
129055810|NCT00229723|464496746|FG003|Concomitant Phase|Lost to Follow-up|0|||
129055811|NCT00229723|464496747|FG004|Concomitant Phase|Lost to Follow-up|1|||
129055812|NCT00229723|464496748|FG005|Concomitant Phase|Lost to Follow-up|0|||
129055813|NCT00229723|464496749|FG006|Concomitant Phase|Lost to Follow-up|0|||
129055814|NCT00229723|464496743|FG000|Concomitant Phase|Informed consent withdrawn|3|||
129055815|NCT00229723|464496744|FG001|Concomitant Phase|Informed consent withdrawn|2|||
129055816|NCT00229723|464496745|FG002|Concomitant Phase|Informed consent withdrawn|0|||
129055817|NCT00229723|464496746|FG003|Concomitant Phase|Informed consent withdrawn|2|||
129055818|NCT00229723|464496747|FG004|Concomitant Phase|Informed consent withdrawn|0|||
129137074|NCT02533674|464794514|FG004|Dose Level VIII|Progressive disease|0|||
129137075|NCT02533674|464794515|FG005|Dose Level VIII|Progressive disease|0|||
129137076|NCT02533674|464794516|FG006|Dose Level VIII|Progressive disease|0|||
129137077|NCT02533674|464794517|FG007|Dose Level VIII|Progressive disease|3|||
129137078|NCT02533674|464794510|FG000|Dose Level VIII|Withdrawal by Subject|0|||
129137079|NCT02533674|464794511|FG001|Dose Level VIII|Withdrawal by Subject|0|||
129137080|NCT02533674|464794512|FG002|Dose Level VIII|Withdrawal by Subject|0|||
129137081|NCT02533674|464794513|FG003|Dose Level VIII|Withdrawal by Subject|0|||
129055819|NCT00229723|464496748|FG005|Concomitant Phase|Informed consent withdrawn|0|||
129137082|NCT02533674|464794514|FG004|Dose Level VIII|Withdrawal by Subject|0|||
129055820|NCT00229723|464496749|FG006|Concomitant Phase|Informed consent withdrawn|0|||
129055821|NCT00229723|464496743|FG000|Concomitant Phase|Severe non-compliance|0|||
129055822|NCT00229723|464496744|FG001|Concomitant Phase|Severe non-compliance|1|||
129055823|NCT00229723|464496745|FG002|Concomitant Phase|Severe non-compliance|0|||
129055824|NCT00229723|464496746|FG003|Concomitant Phase|Severe non-compliance|0|||
129055825|NCT00229723|464496747|FG004|Concomitant Phase|Severe non-compliance|1|||
129055826|NCT00229723|464496748|FG005|Concomitant Phase|Severe non-compliance|0|||
129055827|NCT00229723|464496749|FG006|Concomitant Phase|Severe non-compliance|0|||
129055828|NCT00229723|464496743|FG000|Concomitant Phase|Other|3|||
129055829|NCT00229723|464496744|FG001|Concomitant Phase|Other|0|||
129055830|NCT00229723|464496745|FG002|Concomitant Phase|Other|1|||
129055831|NCT00229723|464496746|FG003|Concomitant Phase|Other|1|||
129055832|NCT00229723|464496747|FG004|Concomitant Phase|Other|0|||
129055833|NCT00229723|464496748|FG005|Concomitant Phase|Other|2|||
129055834|NCT00229723|464496749|FG006|Concomitant Phase|Other|0|||
129055835|NCT00229723|464496743|FG000|Maintenance Phase|Adverse Event|7|||
129055836|NCT00229723|464496744|FG001|Maintenance Phase|Adverse Event|2|||
129055837|NCT00229723|464496745|FG002|Maintenance Phase|Adverse Event|1|||
129055838|NCT00229723|464496746|FG003|Maintenance Phase|Adverse Event|4|||
129055839|NCT00229723|464496747|FG004|Maintenance Phase|Adverse Event|7|||
129055840|NCT00229723|464496748|FG005|Maintenance Phase|Adverse Event|5|||
129055841|NCT00229723|464496749|FG006|Maintenance Phase|Adverse Event|2|||
129055842|NCT00229723|464496743|FG000|Maintenance Phase|Objective disease progression|5|||
129055843|NCT00229723|464496744|FG001|Maintenance Phase|Objective disease progression|5|||
129055844|NCT00229723|464496745|FG002|Maintenance Phase|Objective disease progression|3|||
129055845|NCT00229723|464496746|FG003|Maintenance Phase|Objective disease progression|6|||
129055846|NCT00229723|464496747|FG004|Maintenance Phase|Objective disease progression|2|||
129055847|NCT00229723|464496748|FG005|Maintenance Phase|Objective disease progression|9|||
129055848|NCT00229723|464496749|FG006|Maintenance Phase|Objective disease progression|5|||
129055849|NCT00229723|464496743|FG000|Maintenance Phase|Clinical progression|4|||
129055850|NCT00229723|464496744|FG001|Maintenance Phase|Clinical progression|1|||
129055851|NCT00229723|464496745|FG002|Maintenance Phase|Clinical progression|2|||
129055852|NCT00229723|464496746|FG003|Maintenance Phase|Clinical progression|2|||
129055853|NCT00229723|464496747|FG004|Maintenance Phase|Clinical progression|1|||
129055854|NCT00229723|464496748|FG005|Maintenance Phase|Clinical progression|1|||
129055855|NCT00229723|464496749|FG006|Maintenance Phase|Clinical progression|1|||
129055856|NCT00229723|464496743|FG000|Maintenance Phase|Lost to Follow-up|0|||
129055857|NCT00229723|464496744|FG001|Maintenance Phase|Lost to Follow-up|1|||
129055858|NCT00229723|464496745|FG002|Maintenance Phase|Lost to Follow-up|2|||
129055859|NCT00229723|464496746|FG003|Maintenance Phase|Lost to Follow-up|2|||
129055860|NCT00229723|464496747|FG004|Maintenance Phase|Lost to Follow-up|0|||
129055861|NCT00229723|464496748|FG005|Maintenance Phase|Lost to Follow-up|0|||
129055862|NCT00229723|464496749|FG006|Maintenance Phase|Lost to Follow-up|1|||
129055863|NCT00229723|464496743|FG000|Maintenance Phase|Informed consent withdrawn|1|||
129055864|NCT00229723|464496744|FG001|Maintenance Phase|Informed consent withdrawn|0|||
129055865|NCT00229723|464496745|FG002|Maintenance Phase|Informed consent withdrawn|0|||
129055866|NCT00229723|464496746|FG003|Maintenance Phase|Informed consent withdrawn|1|||
128719978|NCT00605475|463273286|FG005|Overall Study|Administrative problems|0|||
128719979|NCT00605475|463273287|FG006|Overall Study|Administrative problems|1|||
128719980|NCT00605475|463273288|FG007|Overall Study|Administrative problems|0|||
128719981|NCT00605475|463273289|FG008|Overall Study|Administrative problems|0|||
128719982|NCT00605475|463273290|FG009|Overall Study|Administrative problems|0|||
128719983|NCT00605475|463273281|FG000|Overall Study|Lost to Follow-up|0|||
128719984|NCT00605475|463273282|FG001|Overall Study|Lost to Follow-up|0|||
128719985|NCT00605475|463273283|FG002|Overall Study|Lost to Follow-up|0|||
128719986|NCT00605475|463273284|FG003|Overall Study|Lost to Follow-up|0|||
128775509|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
128775510|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
128775511|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
129055867|NCT00229723|464496747|FG004|Maintenance Phase|Informed consent withdrawn|1|||
129055868|NCT00229723|464496748|FG005|Maintenance Phase|Informed consent withdrawn|1|||
129055869|NCT00229723|464496749|FG006|Maintenance Phase|Informed consent withdrawn|0|||
129055870|NCT00229723|464496743|FG000|Maintenance Phase|Severe non-compliance|3|||
129055871|NCT00229723|464496744|FG001|Maintenance Phase|Severe non-compliance|1|||
129055872|NCT00229723|464496745|FG002|Maintenance Phase|Severe non-compliance|0|||
129055873|NCT00229723|464496746|FG003|Maintenance Phase|Severe non-compliance|0|||
129055874|NCT00229723|464496747|FG004|Maintenance Phase|Severe non-compliance|1|||
129055875|NCT00229723|464496748|FG005|Maintenance Phase|Severe non-compliance|0|||
129055876|NCT00229723|464496749|FG006|Maintenance Phase|Severe non-compliance|0|||
129055877|NCT00229723|464496743|FG000|Maintenance Phase|Other|5|||
129055878|NCT00229723|464496744|FG001|Maintenance Phase|Other|4|||
129055879|NCT00229723|464496745|FG002|Maintenance Phase|Other|1|||
129055880|NCT00229723|464496746|FG003|Maintenance Phase|Other|2|||
129055881|NCT00229723|464496747|FG004|Maintenance Phase|Other|3|||
128719987|NCT00605475|463273285|FG004|Overall Study|Lost to Follow-up|0|||
128719988|NCT00605475|463273286|FG005|Overall Study|Lost to Follow-up|0|||
129055882|NCT00229723|464496748|FG005|Maintenance Phase|Other|3|||
129055883|NCT00229723|464496749|FG006|Maintenance Phase|Other|1|||
129055884|NCT00735397|464496752|FG000|Overall Study|Adverse Event|194|||
129055885|NCT00735397|464496752|FG000|Overall Study|Lost to Follow-up|33|||
129055886|NCT00735397|464496752|FG000|Overall Study|Participant choice|252|||
129055887|NCT00735397|464496752|FG000|Overall Study|Inadequate therapeutic effect|202|||
129055888|NCT00735397|464496752|FG000|Overall Study|Administrative/Other|502|||
129055889|NCT03016975|464496757|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
129055890|NCT03016975|464496758|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
129055891|NCT03016975|464496759|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
129055892|NCT03016975|464496757|FG000|At 6 Months Follow-up|Death|2|||
129055893|NCT03016975|464496758|FG001|At 6 Months Follow-up|Death|0|||
129055894|NCT03016975|464496759|FG002|At 6 Months Follow-up|Death|0|||
129055895|NCT03016975|464496757|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
129055896|NCT03016975|464496758|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
129055897|NCT03016975|464496759|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
129055898|NCT03016975|464496757|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
129055899|NCT03016975|464496758|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
129055900|NCT03016975|464496759|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
129055901|NCT03016975|464496757|FG000|At 6 Months Follow-up|Aborted implant|1|||
129055902|NCT03016975|464496758|FG001|At 6 Months Follow-up|Aborted implant|0|||
129055903|NCT03016975|464496759|FG002|At 6 Months Follow-up|Aborted implant|0|||
129055904|NCT03016975|464496757|FG000|At 2 Year Follow-up|Death|1|||
129055905|NCT03016975|464496758|FG001|At 2 Year Follow-up|Death|0|||
129055906|NCT03016975|464496759|FG002|At 2 Year Follow-up|Death|0|||
129055907|NCT03016975|464496757|FG000|At 3 Year Follow-up|Death|1|||
129055908|NCT03016975|464496758|FG001|At 3 Year Follow-up|Death|0|||
129055909|NCT03016975|464496759|FG002|At 3 Year Follow-up|Death|0|||
129055910|NCT03016975|464496757|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
129055911|NCT03016975|464496758|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
129055912|NCT03016975|464496759|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
129055913|NCT03016975|464496757|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
129055914|NCT03016975|464496758|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
129055915|NCT03016975|464496759|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
129055916|NCT01590797|464496762|FG000|Overall Study|Adverse Event|4|||
129055917|NCT01590797|464496763|FG001|Overall Study|Adverse Event|3|||
129055918|NCT01590797|464496762|FG000|Overall Study|Lack of Efficacy|0|||
129055919|NCT01590797|464496763|FG001|Overall Study|Lack of Efficacy|2|||
129055920|NCT01590797|464496762|FG000|Overall Study|Lost to Follow-up|0|||
129055921|NCT01590797|464496763|FG001|Overall Study|Lost to Follow-up|1|||
129055922|NCT01590797|464496762|FG000|Overall Study|Protocol Violation|4|||
129055923|NCT01590797|464496763|FG001|Overall Study|Protocol Violation|1|||
129055924|NCT01590797|464496762|FG000|Overall Study|Withdrawal by Subject|7|||
129055925|NCT01590797|464496763|FG001|Overall Study|Withdrawal by Subject|5|||
129055926|NCT01590797|464496762|FG000|Overall Study|Other Protocol Specified Criteria|2|||
129055927|NCT01590797|464496763|FG001|Overall Study|Other Protocol Specified Criteria|4|||
129055928|NCT01559389|464496769|FG000|Overall Study|Withdrawal by Subject|20|||
129055929|NCT01559389|464496770|FG001|Overall Study|Withdrawal by Subject|20|||
129055930|NCT01228019|464496771|FG000|Overall Study|Dose Violation|70|||
129055931|NCT01228019|464496771|FG000|Overall Study|Duplicate enrollment|1|||
129055932|NCT01228019|464496771|FG000|Overall Study|Missing pre-treatment data|72|||
129055933|NCT01228019|464496771|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
129055934|NCT01228019|464496771|FG000|Overall Study|Violation of Entry Criterion|9|||
129055935|NCT01346293|464496772|FG000|Overall Study|Protocol Violation|30|||
129055936|NCT01346293|464496773|FG001|Overall Study|Protocol Violation|9|||
129055937|NCT01346293|464496772|FG000|Overall Study|Lost to Follow-up|21|||
129055938|NCT01346293|464496773|FG001|Overall Study|Lost to Follow-up|8|||
129055939|NCT01346293|464496772|FG000|Overall Study|Withdrawal by Subject|15|||
129055940|NCT01346293|464496773|FG001|Overall Study|Withdrawal by Subject|4|||
129055941|NCT01346293|464496772|FG000|Overall Study|Other|1|||
129055942|NCT01346293|464496773|FG001|Overall Study|Other|0|||
129055943|NCT03503864|464496774|FG000|Overall Study|Protocol Violation|6|||
129055944|NCT03503864|464496774|FG000|Overall Study|Withdrawal by Subject|7|||
129055945|NCT02910063|464496775|FG000|Phase 2|Withdrawal by Subject|3|||
129055946|NCT02910063|464496776|FG001|Phase 2|Withdrawal by Subject|0|||
129055947|NCT02910063|464496777|FG002|Phase 2|Withdrawal by Subject|0|||
129055948|NCT02910063|464496775|FG000|Phase 2|Lost to Follow-up|1|||
129055949|NCT02910063|464496776|FG001|Phase 2|Lost to Follow-up|0|||
129055950|NCT02910063|464496777|FG002|Phase 2|Lost to Follow-up|0|||
129055951|NCT02910063|464496775|FG000|Phase 2|Death|24|||
129055952|NCT02910063|464496776|FG001|Phase 2|Death|0|||
129055953|NCT02910063|464496777|FG002|Phase 2|Death|0|||
129055954|NCT04693416|464496778|FG000|Overall Study|Lost to Follow-up|13|||
129055955|NCT04693416|464496779|FG001|Overall Study|Lost to Follow-up|0|||
129055956|NCT00474266|464496780|FG000|Overall Study|Withdrawal by Subject|7|||
129055957|NCT00474266|464496781|FG001|Overall Study|Withdrawal by Subject|20|||
129055958|NCT00474266|464496782|FG002|Overall Study|Withdrawal by Subject|4|||
129055959|NCT00474266|464496783|FG003|Overall Study|Withdrawal by Subject|7|||
129055960|NCT02774642|464496784|FG000|Overall Study|Lost to Follow-up|9|||
129055961|NCT02774642|464496785|FG001|Overall Study|Lost to Follow-up|7|||
129055962|NCT04642365|464496795|FG000|Overall Study|Death|3|||
129055963|NCT04642365|464496796|FG001|Overall Study|Death|2|||
129055964|NCT04642365|464496797|FG002|Overall Study|Death|4|||
129055965|NCT04642365|464496798|FG003|Overall Study|Death|5|||
129055966|NCT04642365|464496799|FG004|Overall Study|Death|5|||
129055967|NCT04642365|464496800|FG005|Overall Study|Death|3|||
129055968|NCT04642365|464496801|FG006|Overall Study|Death|2|||
129055969|NCT04642365|464496802|FG007|Overall Study|Death|1|||
129055970|NCT04642365|464496795|FG000|Overall Study|Physician Decision|1|||
129055971|NCT04642365|464496796|FG001|Overall Study|Physician Decision|0|||
129055972|NCT04642365|464496797|FG002|Overall Study|Physician Decision|0|||
129055973|NCT04642365|464496798|FG003|Overall Study|Physician Decision|0|||
129055974|NCT04642365|464496799|FG004|Overall Study|Physician Decision|0|||
129055975|NCT04642365|464496800|FG005|Overall Study|Physician Decision|0|||
129055976|NCT04642365|464496801|FG006|Overall Study|Physician Decision|0|||
129055977|NCT04642365|464496802|FG007|Overall Study|Physician Decision|0|||
129055978|NCT04642365|464496795|FG000|Overall Study|Progressive Disease|1|||
129055979|NCT04642365|464496796|FG001|Overall Study|Progressive Disease|1|||
129055980|NCT04642365|464496797|FG002|Overall Study|Progressive Disease|1|||
129055981|NCT04642365|464496798|FG003|Overall Study|Progressive Disease|0|||
129055982|NCT04642365|464496799|FG004|Overall Study|Progressive Disease|0|||
129055983|NCT04642365|464496800|FG005|Overall Study|Progressive Disease|0|||
129055984|NCT04642365|464496801|FG006|Overall Study|Progressive Disease|1|||
129055985|NCT04642365|464496802|FG007|Overall Study|Progressive Disease|0|||
129055986|NCT04642365|464496795|FG000|Overall Study|Study Terminated By Sponsor|0|||
129055987|NCT04642365|464496796|FG001|Overall Study|Study Terminated By Sponsor|2|||
129055988|NCT04642365|464496797|FG002|Overall Study|Study Terminated By Sponsor|1|||
129055989|NCT04642365|464496798|FG003|Overall Study|Study Terminated By Sponsor|1|||
129055990|NCT04642365|464496799|FG004|Overall Study|Study Terminated By Sponsor|1|||
129055991|NCT04642365|464496800|FG005|Overall Study|Study Terminated By Sponsor|2|||
129055992|NCT04642365|464496801|FG006|Overall Study|Study Terminated By Sponsor|2|||
129055993|NCT04642365|464496802|FG007|Overall Study|Study Terminated By Sponsor|1|||
129055994|NCT04642365|464496795|FG000|Overall Study|Symptomatic Deterioration|1|||
129055995|NCT04642365|464496796|FG001|Overall Study|Symptomatic Deterioration|1|||
129055996|NCT04642365|464496797|FG002|Overall Study|Symptomatic Deterioration|0|||
129055997|NCT04642365|464496798|FG003|Overall Study|Symptomatic Deterioration|0|||
129055998|NCT04642365|464496799|FG004|Overall Study|Symptomatic Deterioration|0|||
129055999|NCT04642365|464496800|FG005|Overall Study|Symptomatic Deterioration|1|||
129056000|NCT04642365|464496801|FG006|Overall Study|Symptomatic Deterioration|0|||
129056001|NCT04642365|464496802|FG007|Overall Study|Symptomatic Deterioration|0|||
129056002|NCT04642365|464496795|FG000|Overall Study|Withdrawal by Subject|0|||
129056003|NCT04642365|464496796|FG001|Overall Study|Withdrawal by Subject|0|||
129056004|NCT04642365|464496797|FG002|Overall Study|Withdrawal by Subject|1|||
129056005|NCT04642365|464496798|FG003|Overall Study|Withdrawal by Subject|1|||
129056006|NCT04642365|464496799|FG004|Overall Study|Withdrawal by Subject|0|||
129056007|NCT04642365|464496800|FG005|Overall Study|Withdrawal by Subject|0|||
129056008|NCT04642365|464496801|FG006|Overall Study|Withdrawal by Subject|2|||
129056009|NCT04642365|464496802|FG007|Overall Study|Withdrawal by Subject|0|||
129056010|NCT04642365|464496795|FG000|Overall Study|Adverse Event|0|||
129056011|NCT04642365|464496796|FG001|Overall Study|Adverse Event|0|||
129056012|NCT04642365|464496797|FG002|Overall Study|Adverse Event|0|||
129056013|NCT04642365|464496798|FG003|Overall Study|Adverse Event|0|||
129056014|NCT04642365|464496799|FG004|Overall Study|Adverse Event|0|||
129056015|NCT04642365|464496800|FG005|Overall Study|Adverse Event|0|||
129056016|NCT04642365|464496801|FG006|Overall Study|Adverse Event|0|||
129137083|NCT02533674|464794515|FG005|Dose Level VIII|Withdrawal by Subject|0|||
129137084|NCT02533674|464794516|FG006|Dose Level VIII|Withdrawal by Subject|0|||
129137085|NCT02533674|464794517|FG007|Dose Level VIII|Withdrawal by Subject|1|||
129137086|NCT02533674|464794510|FG000|Dose Level VIII|Treatment-related AE|0|||
129056017|NCT04642365|464496802|FG007|Overall Study|Adverse Event|1|||
129056018|NCT01144715|464496803|FG000|Overall Study|Lost to Follow-up|2|||
129056019|NCT01144715|464496804|FG001|Overall Study|Lost to Follow-up|1|||
129056020|NCT01144715|464496803|FG000|Overall Study|Withdrawal by Subject|2|||
129056021|NCT01144715|464496804|FG001|Overall Study|Withdrawal by Subject|1|||
129056022|NCT01144715|464496803|FG000|Overall Study|Adverse Event|0|||
129137087|NCT02533674|464794511|FG001|Dose Level VIII|Treatment-related AE|0|||
129137088|NCT02533674|464794512|FG002|Dose Level VIII|Treatment-related AE|0|||
129137089|NCT02533674|464794513|FG003|Dose Level VIII|Treatment-related AE|0|||
129137090|NCT02533674|464794514|FG004|Dose Level VIII|Treatment-related AE|0|||
128719989|NCT00605475|463273287|FG006|Overall Study|Lost to Follow-up|0|||
129056023|NCT01144715|464496804|FG001|Overall Study|Adverse Event|1|||
129056024|NCT06281171|464496805|FG000|Timepoint 2|Lost to Follow-up|6|||
129056025|NCT06281171|464496806|FG001|Timepoint 2|Lost to Follow-up|4|||
129056026|NCT06281171|464496805|FG000|Timepoint 3|Lost to Follow-up|0|||
129056027|NCT06281171|464496806|FG001|Timepoint 3|Lost to Follow-up|5|||
129056028|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
129137091|NCT02533674|464794515|FG005|Dose Level VIII|Treatment-related AE|0|||
129056029|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
129056030|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
129056031|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
129056032|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
129056033|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
129056034|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
129056035|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
129056036|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
129056037|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
129056038|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
129056039|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
129056040|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
128719990|NCT00605475|463273288|FG007|Overall Study|Lost to Follow-up|0|||
128719991|NCT00605475|463273289|FG008|Overall Study|Lost to Follow-up|1|||
128719992|NCT00605475|463273290|FG009|Overall Study|Lost to Follow-up|1|||
129056041|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
129056042|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
129056043|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
129056044|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
129056045|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
129056046|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
129056047|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
129056048|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
129056049|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
129056050|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
129056051|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
129056052|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
129056053|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
129056054|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
129056055|NCT02552212|464496807|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
129056056|NCT02552212|464496808|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
129056057|NCT02552212|464496809|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
129056058|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
129056059|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
129056060|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
129056061|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
129056062|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
129056063|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
129056064|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
129056065|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
129056066|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
129056067|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
129056068|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
129056069|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
129056070|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
129056071|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
129056072|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
129056073|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
129056074|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
129056075|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
129056076|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
129056077|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
129056078|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
129056079|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
129056080|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
129056081|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
129056082|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
129056083|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
129056084|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
129056085|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
129056086|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
129056087|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
129056088|NCT02552212|464496807|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
129056089|NCT02552212|464496808|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
129056090|NCT02552212|464496809|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
129056091|NCT00205803|464496816|FG000|Infant Series|Lost to Follow-up|10|||
129056092|NCT00205803|464496817|FG001|Infant Series|Lost to Follow-up|4|||
129056093|NCT00205803|464496816|FG000|Infant Series|Withdrawal by Subject|2|||
129056094|NCT00205803|464496817|FG001|Infant Series|Withdrawal by Subject|5|||
129056095|NCT00205803|464496816|FG000|Infant Series|Physician Decision|3|||
129056096|NCT00205803|464496817|FG001|Infant Series|Physician Decision|1|||
129056097|NCT00205803|464496816|FG000|Infant Series|Protocol Violation|1|||
129056098|NCT00205803|464496817|FG001|Infant Series|Protocol Violation|0|||
129056099|NCT00205803|464496816|FG000|Infant Series|Lost Kaiser coverage|0|||
129056100|NCT00205803|464496817|FG001|Infant Series|Lost Kaiser coverage|1|||
129056101|NCT00205803|464496816|FG000|Infant Series|Non-compliant|1|||
129056102|NCT00205803|464496817|FG001|Infant Series|Non-compliant|0|||
129056103|NCT00205803|464496816|FG000|Infant Series|Sponsor request|1|||
129056104|NCT00205803|464496817|FG001|Infant Series|Sponsor request|0|||
129056105|NCT00205803|464496816|FG000|After Infant Series|Adverse Event|1|||
129056106|NCT00205803|464496817|FG001|After Infant Series|Adverse Event|1|||
129056107|NCT00205803|464496816|FG000|After Infant Series|Protocol Violation|1|||
129056108|NCT00205803|464496817|FG001|After Infant Series|Protocol Violation|1|||
129056109|NCT00205803|464496816|FG000|After Infant Series|Lost to Follow-up|2|||
129056110|NCT00205803|464496817|FG001|After Infant Series|Lost to Follow-up|1|||
129056111|NCT00205803|464496816|FG000|After Infant Series|Physician Decision|3|||
129056112|NCT00205803|464496817|FG001|After Infant Series|Physician Decision|2|||
129056113|NCT00205803|464496816|FG000|After Infant Series|Withdrawal by Subject|1|||
129056114|NCT00205803|464496817|FG001|After Infant Series|Withdrawal by Subject|4|||
129056115|NCT00205803|464496816|FG000|After Infant Series|Other|10|||
129056116|NCT00205803|464496817|FG001|After Infant Series|Other|4|||
129056117|NCT00205803|464496816|FG000|Toddler Dose|Lost to Follow-up|2|||
129056118|NCT00205803|464496817|FG001|Toddler Dose|Lost to Follow-up|3|||
129056119|NCT02369458|464496819|FG000|Overall Study|Determined to be not eligible|1|||
129056120|NCT02369458|464496820|FG001|Overall Study|Determined to be not eligible|0|||
129056121|NCT04572893|464496821|FG000|Part A|Adverse Event|1|||
129056122|NCT04572893|464496822|FG001|Part A|Adverse Event|0|||
129056123|NCT04572893|464496823|FG002|Part A|Adverse Event|0|||
129056124|NCT04572893|464496824|FG003|Part A|Adverse Event|0|||
129056125|NCT04572893|464496825|FG004|Part A|Adverse Event|0|||
129056126|NCT04572893|464496826|FG005|Part A|Adverse Event|0|||
129056127|NCT04572893|464496827|FG006|Part A|Adverse Event|0|||
129056128|NCT04572893|464496821|FG000|Part B|Withdrawal by Subject|0|||
129056129|NCT04572893|464496822|FG001|Part B|Withdrawal by Subject|0|||
129056130|NCT04572893|464496823|FG002|Part B|Withdrawal by Subject|0|||
129056131|NCT04572893|464496824|FG003|Part B|Withdrawal by Subject|0|||
129056132|NCT04572893|464496825|FG004|Part B|Withdrawal by Subject|0|||
129056133|NCT04572893|464496826|FG005|Part B|Withdrawal by Subject|1|||
129056134|NCT04572893|464496827|FG006|Part B|Withdrawal by Subject|0|||
129056135|NCT04572893|464496821|FG000|Part B|Study terminated by sponsor|0|||
129056136|NCT04572893|464496822|FG001|Part B|Study terminated by sponsor|0|||
129056137|NCT04572893|464496823|FG002|Part B|Study terminated by sponsor|0|||
129056138|NCT04572893|464496824|FG003|Part B|Study terminated by sponsor|0|||
129056139|NCT04572893|464496825|FG004|Part B|Study terminated by sponsor|7|||
129056140|NCT04572893|464496826|FG005|Part B|Study terminated by sponsor|5|||
129056141|NCT04572893|464496827|FG006|Part B|Study terminated by sponsor|3|||
129056142|NCT04572893|464496821|FG000|Part B|Lost to Follow-up|0|||
129056143|NCT04572893|464496822|FG001|Part B|Lost to Follow-up|0|||
129056144|NCT04572893|464496823|FG002|Part B|Lost to Follow-up|0|||
129056145|NCT04572893|464496824|FG003|Part B|Lost to Follow-up|0|||
129056146|NCT04572893|464496825|FG004|Part B|Lost to Follow-up|0|||
129056147|NCT04572893|464496826|FG005|Part B|Lost to Follow-up|0|||
129056148|NCT04572893|464496827|FG006|Part B|Lost to Follow-up|1|||
129056149|NCT04572893|464496821|FG000|Part B|Adverse Event|0|||
129056150|NCT04572893|464496822|FG001|Part B|Adverse Event|0|||
129056151|NCT04572893|464496823|FG002|Part B|Adverse Event|0|||
129056152|NCT04572893|464496824|FG003|Part B|Adverse Event|0|||
129056153|NCT04572893|464496825|FG004|Part B|Adverse Event|1|||
129056154|NCT04572893|464496826|FG005|Part B|Adverse Event|1|||
129056155|NCT04572893|464496827|FG006|Part B|Adverse Event|0|||
129056156|NCT00121134|464496828|FG000|Overall Study|Progression of Disease|5|||
129056157|NCT00121134|464496829|FG001|Overall Study|Progression of Disease|3|||
129056158|NCT00121134|464496830|FG002|Overall Study|Progression of Disease|4|||
129056159|NCT00121134|464496831|FG003|Overall Study|Progression of Disease|2|||
129056160|NCT00121134|464496828|FG000|Overall Study|Toxicity|4|||
129056161|NCT00121134|464496829|FG001|Overall Study|Toxicity|7|||
129056162|NCT00121134|464496830|FG002|Overall Study|Toxicity|13|||
129056163|NCT00121134|464496831|FG003|Overall Study|Toxicity|5|||
129056164|NCT00121134|464496828|FG000|Overall Study|Physician Decision|6|||
129056165|NCT00121134|464496829|FG001|Overall Study|Physician Decision|4|||
129056166|NCT00121134|464496830|FG002|Overall Study|Physician Decision|4|||
129056167|NCT00121134|464496831|FG003|Overall Study|Physician Decision|1|||
129056168|NCT00121134|464496828|FG000|Overall Study|Treatment Delay|1|||
129056169|NCT00121134|464496829|FG001|Overall Study|Treatment Delay|0|||
129056170|NCT00121134|464496830|FG002|Overall Study|Treatment Delay|0|||
129056171|NCT00121134|464496831|FG003|Overall Study|Treatment Delay|0|||
129056172|NCT00121134|464496828|FG000|Overall Study|Intercurrent Illness|0|||
129056173|NCT00121134|464496829|FG001|Overall Study|Intercurrent Illness|0|||
129056174|NCT00121134|464496830|FG002|Overall Study|Intercurrent Illness|0|||
129056175|NCT00121134|464496831|FG003|Overall Study|Intercurrent Illness|1|||
129056176|NCT00121134|464496828|FG000|Overall Study|Patient Personal Reasons|0|||
129056177|NCT00121134|464496829|FG001|Overall Study|Patient Personal Reasons|1|||
129056178|NCT00121134|464496830|FG002|Overall Study|Patient Personal Reasons|0|||
129056179|NCT00121134|464496831|FG003|Overall Study|Patient Personal Reasons|0|||
129056180|NCT01102374|464496845|FG000|Overall Study|Death|9|||
129056181|NCT01102374|464496846|FG001|Overall Study|Death|13|||
129056182|NCT01102374|464496845|FG000|Overall Study|Lost to Follow-up|7|||
129056183|NCT01102374|464496846|FG001|Overall Study|Lost to Follow-up|6|||
129056184|NCT00418821|464496847|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
129056185|NCT02071849|464496848|FG000|6-month Primary Endpoint|Did not receive device|4|||
129056186|NCT02071849|464496848|FG000|6-month Primary Endpoint|Adverse Event|1|||
129056187|NCT02071849|464496848|FG000|2-year Extended Follow-up|Adverse Event|1|||
129056188|NCT04619992|464496849|FG000|Overall Study|Withdrawal by Subject|1|||
129056189|NCT04619992|464496850|FG001|Overall Study|Withdrawal by Subject|0|||
129056190|NCT00805467|464498461|FG000|Overall Study|Lack of Efficacy|0|||
129056191|NCT00805467|464498462|FG001|Overall Study|Lack of Efficacy|8|||
129056192|NCT00805467|464498463|FG002|Overall Study|Lack of Efficacy|13|||
129056193|NCT00805467|464498464|FG003|Overall Study|Lack of Efficacy|86|||
129056194|NCT00805467|464498461|FG000|Overall Study|Lost to Follow-up|0|||
129056195|NCT00805467|464498462|FG001|Overall Study|Lost to Follow-up|1|||
129056196|NCT00805467|464498463|FG002|Overall Study|Lost to Follow-up|7|||
129056197|NCT00805467|464498464|FG003|Overall Study|Lost to Follow-up|21|||
129056198|NCT00805467|464498461|FG000|Overall Study|Withdrawal by Subject|0|||
129056199|NCT00805467|464498462|FG001|Overall Study|Withdrawal by Subject|6|||
129056200|NCT00805467|464498463|FG002|Overall Study|Withdrawal by Subject|45|||
129056201|NCT00805467|464498464|FG003|Overall Study|Withdrawal by Subject|50|||
129056202|NCT00805467|464498461|FG000|Overall Study|Protocol Violation|0|||
129056203|NCT00805467|464498462|FG001|Overall Study|Protocol Violation|3|||
129056204|NCT00805467|464498463|FG002|Overall Study|Protocol Violation|0|||
129056205|NCT00805467|464498464|FG003|Overall Study|Protocol Violation|5|||
129056206|NCT00805467|464498461|FG000|Overall Study|Adverse Event|0|||
129056207|NCT00805467|464498462|FG001|Overall Study|Adverse Event|13|||
129056208|NCT00805467|464498463|FG002|Overall Study|Adverse Event|26|||
129056209|NCT00805467|464498464|FG003|Overall Study|Adverse Event|57|||
129056210|NCT00805467|464498461|FG000|Overall Study|Death|0|||
129056211|NCT00805467|464498462|FG001|Overall Study|Death|2|||
129056212|NCT00805467|464498463|FG002|Overall Study|Death|7|||
129056213|NCT00805467|464498464|FG003|Overall Study|Death|5|||
129056214|NCT00805467|464498461|FG000|Overall Study|Physician Decision|0|||
129056215|NCT00805467|464498462|FG001|Overall Study|Physician Decision|1|||
129056216|NCT00805467|464498463|FG002|Overall Study|Physician Decision|2|||
129056217|NCT00805467|464498464|FG003|Overall Study|Physician Decision|6|||
129056218|NCT00805467|464498461|FG000|Overall Study|Not reported|0|||
129056219|NCT00805467|464498462|FG001|Overall Study|Not reported|0|||
129056220|NCT00805467|464498463|FG002|Overall Study|Not reported|3|||
129056221|NCT00805467|464498464|FG003|Overall Study|Not reported|7|||
129056222|NCT00213135|464498465|FG000|Overall Study|Adverse Event|9|||
129056223|NCT00213135|464498466|FG001|Overall Study|Adverse Event|5|||
129056224|NCT00213135|464498467|FG002|Overall Study|Adverse Event|5|||
129056225|NCT00213135|464498465|FG000|Overall Study|Lost to Follow-up|11|||
129056226|NCT00213135|464498466|FG001|Overall Study|Lost to Follow-up|8|||
129056227|NCT00213135|464498467|FG002|Overall Study|Lost to Follow-up|4|||
129056228|NCT00213135|464498465|FG000|Overall Study|Protocol Violation|4|||
129056229|NCT00213135|464498466|FG001|Overall Study|Protocol Violation|4|||
129056230|NCT00213135|464498467|FG002|Overall Study|Protocol Violation|10|||
129056231|NCT00213135|464498465|FG000|Overall Study|Death|1|||
129056232|NCT00213135|464498466|FG001|Overall Study|Death|1|||
129056233|NCT00213135|464498467|FG002|Overall Study|Death|2|||
129056234|NCT00213135|464498465|FG000|Overall Study|Disease progression|4|||
129056235|NCT00213135|464498466|FG001|Overall Study|Disease progression|5|||
129056236|NCT00213135|464498467|FG002|Overall Study|Disease progression|21|||
129056237|NCT00213135|464498465|FG000|Overall Study|Other|21|||
129056238|NCT00213135|464498466|FG001|Overall Study|Other|12|||
128775512|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129056239|NCT00213135|464498467|FG002|Overall Study|Other|15|||
129056240|NCT01056289|464498476|FG000|Open-label Phase|Adverse Event|29|||
129056241|NCT01056289|464498477|FG001|Open-label Phase|Adverse Event|0|||
129056242|NCT01056289|464498478|FG002|Open-label Phase|Adverse Event|0|||
129056243|NCT01056289|464498479|FG003|Open-label Phase|Adverse Event|0|||
128775513|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129056244|NCT01056289|464498476|FG000|Open-label Phase|Lost to Follow-up|30|||
129056245|NCT01056289|464498477|FG001|Open-label Phase|Lost to Follow-up|0|||
129056246|NCT01056289|464498478|FG002|Open-label Phase|Lost to Follow-up|0|||
129137092|NCT02533674|464794516|FG006|Dose Level VIII|Treatment-related AE|0|||
129056247|NCT01056289|464498479|FG003|Open-label Phase|Lost to Follow-up|0|||
129056248|NCT01056289|464498476|FG000|Open-label Phase|Other|9|||
129056249|NCT01056289|464498477|FG001|Open-label Phase|Other|0|||
129056250|NCT01056289|464498478|FG002|Open-label Phase|Other|0|||
129056251|NCT01056289|464498479|FG003|Open-label Phase|Other|0|||
129056252|NCT01056289|464498476|FG000|Open-label Phase|Protocol Violation|6|||
129056253|NCT01056289|464498477|FG001|Open-label Phase|Protocol Violation|0|||
129056254|NCT01056289|464498478|FG002|Open-label Phase|Protocol Violation|0|||
129056255|NCT01056289|464498479|FG003|Open-label Phase|Protocol Violation|0|||
129056256|NCT01056289|464498476|FG000|Open-label Phase|Withdrawal by Subject|26|||
129056257|NCT01056289|464498477|FG001|Open-label Phase|Withdrawal by Subject|0|||
129056258|NCT01056289|464498478|FG002|Open-label Phase|Withdrawal by Subject|0|||
129056259|NCT01056289|464498479|FG003|Open-label Phase|Withdrawal by Subject|0|||
129056260|NCT01056289|464498476|FG000|Open-label Phase|Lack of Efficacy|18|||
129056261|NCT01056289|464498477|FG001|Open-label Phase|Lack of Efficacy|0|||
129056262|NCT01056289|464498478|FG002|Open-label Phase|Lack of Efficacy|0|||
129056263|NCT01056289|464498479|FG003|Open-label Phase|Lack of Efficacy|0|||
129056264|NCT01056289|464498476|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
129056265|NCT01056289|464498477|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
129056266|NCT01056289|464498478|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
129056267|NCT01056289|464498479|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
129056268|NCT01056289|464498476|FG000|Double-blind Phase|Adverse Event|0|||
129056269|NCT01056289|464498477|FG001|Double-blind Phase|Adverse Event|1|||
129056270|NCT01056289|464498478|FG002|Double-blind Phase|Adverse Event|2|||
129056271|NCT01056289|464498479|FG003|Double-blind Phase|Adverse Event|1|||
129056272|NCT01056289|464498476|FG000|Double-blind Phase|Lost to Follow-up|0|||
129056273|NCT01056289|464498477|FG001|Double-blind Phase|Lost to Follow-up|2|||
129056274|NCT01056289|464498478|FG002|Double-blind Phase|Lost to Follow-up|2|||
129056275|NCT01056289|464498479|FG003|Double-blind Phase|Lost to Follow-up|2|||
129056276|NCT01056289|464498476|FG000|Double-blind Phase|Other|0|||
129056277|NCT01056289|464498477|FG001|Double-blind Phase|Other|0|||
129056278|NCT01056289|464498478|FG002|Double-blind Phase|Other|1|||
129056279|NCT01056289|464498479|FG003|Double-blind Phase|Other|2|||
129056280|NCT01056289|464498476|FG000|Double-blind Phase|Protocol Violation|0|||
129056281|NCT01056289|464498477|FG001|Double-blind Phase|Protocol Violation|0|||
129056282|NCT01056289|464498478|FG002|Double-blind Phase|Protocol Violation|1|||
129056283|NCT01056289|464498479|FG003|Double-blind Phase|Protocol Violation|1|||
129056284|NCT01056289|464498476|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129056285|NCT01056289|464498477|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129056286|NCT01056289|464498478|FG002|Double-blind Phase|Withdrawal by Subject|4|||
129056287|NCT01056289|464498479|FG003|Double-blind Phase|Withdrawal by Subject|2|||
129056288|NCT01056289|464498476|FG000|Double-blind Phase|Discontinuation symptom|0|||
129056289|NCT01056289|464498477|FG001|Double-blind Phase|Discontinuation symptom|1|||
129056290|NCT01056289|464498478|FG002|Double-blind Phase|Discontinuation symptom|2|||
129056291|NCT01056289|464498479|FG003|Double-blind Phase|Discontinuation symptom|2|||
129056292|NCT01056289|464498476|FG000|Double-blind Phase|Physician Decision|0|||
129056293|NCT01056289|464498477|FG001|Double-blind Phase|Physician Decision|0|||
129056294|NCT01056289|464498478|FG002|Double-blind Phase|Physician Decision|1|||
129056295|NCT01056289|464498479|FG003|Double-blind Phase|Physician Decision|0|||
129056296|NCT02618759|464498490|FG000|Overall Study|Lost to Follow-up|0|||
129056297|NCT02618759|464498491|FG001|Overall Study|Lost to Follow-up|1|||
129056298|NCT02618759|464498490|FG000|Overall Study|Withdrawal by Subject|1|||
129056299|NCT02618759|464498491|FG001|Overall Study|Withdrawal by Subject|0|||
129056300|NCT02618759|464498490|FG000|Overall Study|Other Reasons|1|||
129056301|NCT02618759|464498491|FG001|Overall Study|Other Reasons|4|||
129056302|NCT02856555|464498494|FG000|Overall Study|Adverse Event|1|||
129056303|NCT02856555|464498495|FG001|Overall Study|Adverse Event|0|||
129056304|NCT02856555|464498496|FG002|Overall Study|Adverse Event|0|||
129056305|NCT02856555|464498494|FG000|Overall Study|Lost to Follow-up|1|||
129056306|NCT02856555|464498495|FG001|Overall Study|Lost to Follow-up|3|||
129137093|NCT02533674|464794517|FG007|Dose Level VIII|Treatment-related AE|1|||
129137094|NCT02533674|464794510|FG000|Dose Level VIII|Never treated|0|||
128775514|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775515|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775516|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775517|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775518|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775519|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129056307|NCT02856555|464498496|FG002|Overall Study|Lost to Follow-up|0|||
129056308|NCT02856555|464498494|FG000|Overall Study|Withdrawal by Subject|3|||
129056309|NCT02856555|464498495|FG001|Overall Study|Withdrawal by Subject|0|||
129056310|NCT02856555|464498496|FG002|Overall Study|Withdrawal by Subject|0|||
129056311|NCT02856555|464498494|FG000|Overall Study|Randomized but Never Treated|0|||
129056312|NCT02856555|464498495|FG001|Overall Study|Randomized but Never Treated|1|||
129056313|NCT02856555|464498496|FG002|Overall Study|Randomized but Never Treated|0|||
129056314|NCT03333941|464498497|FG000|Overall Study|Lost to Follow-up|10|||
129056315|NCT03333941|464498497|FG000|Overall Study|Death|2|||
129056316|NCT03333941|464498497|FG000|Overall Study|Adverse Event|1|||
129056317|NCT02932306|464498498|FG000|Overall Study|Withdrawal by Subject|16|||
129056318|NCT02932306|464498499|FG001|Overall Study|Withdrawal by Subject|25|||
129137095|NCT02533674|464794511|FG001|Dose Level VIII|Never treated|0|||
129137096|NCT02533674|464794512|FG002|Dose Level VIII|Never treated|0|||
129137097|NCT02533674|464794513|FG003|Dose Level VIII|Never treated|0|||
129137098|NCT02533674|464794514|FG004|Dose Level VIII|Never treated|0|||
129137099|NCT02533674|464794515|FG005|Dose Level VIII|Never treated|0|||
129137100|NCT02533674|464794516|FG006|Dose Level VIII|Never treated|0|||
129137101|NCT02533674|464794517|FG007|Dose Level VIII|Never treated|1|||
129137102|NCT01560988|464794518|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
129137103|NCT01560988|464794519|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
129137104|NCT01560988|464794518|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
129137105|NCT01560988|464794519|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
129137106|NCT01560988|464794518|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
129137107|NCT01560988|464794519|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
129137108|NCT01346709|464794520|FG000|Overall Study|Protocol Violation|35|||
129137109|NCT01346709|464794520|FG000|Overall Study|Lost to Follow-up|31|||
129137110|NCT01346709|464794520|FG000|Overall Study|Missing data in candidate risk factor|285|||
129137111|NCT01292473|464794524|FG000|Overall Study|Adverse Event|1|||
129137112|NCT01292473|464794525|FG001|Overall Study|Adverse Event|0|||
129137113|NCT01292473|464794526|FG002|Overall Study|Adverse Event|1|||
129137114|NCT01292473|464794527|FG003|Overall Study|Adverse Event|1|||
129137115|NCT01292473|464794524|FG000|Overall Study|Lost to Follow-up|1|||
129137116|NCT01292473|464794525|FG001|Overall Study|Lost to Follow-up|1|||
129137117|NCT01292473|464794526|FG002|Overall Study|Lost to Follow-up|2|||
129137118|NCT01292473|464794527|FG003|Overall Study|Lost to Follow-up|2|||
129137119|NCT01292473|464794524|FG000|Overall Study|Withdrawal by Subject|3|||
129137120|NCT01292473|464794525|FG001|Overall Study|Withdrawal by Subject|4|||
129137121|NCT01292473|464794526|FG002|Overall Study|Withdrawal by Subject|3|||
129137122|NCT01292473|464794527|FG003|Overall Study|Withdrawal by Subject|3|||
128775520|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129056319|NCT02932306|464498498|FG000|Overall Study|Adverse Event|3|||
129056320|NCT02932306|464498499|FG001|Overall Study|Adverse Event|0|||
129056321|NCT02932306|464498498|FG000|Overall Study|Pregnancy|2|||
129056322|NCT02932306|464498499|FG001|Overall Study|Pregnancy|0|||
129056323|NCT02932306|464498498|FG000|Overall Study|Protocol Violation|1|||
129056324|NCT02932306|464498499|FG001|Overall Study|Protocol Violation|1|||
129056325|NCT02932306|464498498|FG000|Overall Study|Noncompliance with Study Drug|1|||
129056326|NCT02932306|464498499|FG001|Overall Study|Noncompliance with Study Drug|1|||
129056327|NCT02932306|464498498|FG000|Overall Study|Lost to Follow-up|36|||
129056328|NCT02932306|464498499|FG001|Overall Study|Lost to Follow-up|40|||
129056329|NCT02932306|464498498|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
129056330|NCT02932306|464498499|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
129056331|NCT02932306|464498498|FG000|Overall Study|Lack of Efficacy|0|||
129056332|NCT02932306|464498499|FG001|Overall Study|Lack of Efficacy|2|||
129056333|NCT02932306|464498498|FG000|Overall Study|Worsening condition|2|||
129056334|NCT02932306|464498499|FG001|Overall Study|Worsening condition|0|||
129056335|NCT02932306|464498498|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
129056336|NCT02932306|464498499|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
129056337|NCT00605540|464498504|FG000|Overall Study|Death|15|||
129056338|NCT00605540|464498504|FG000|Overall Study|Lost to Follow-up|23|||
129056339|NCT01544179|464498507|FG000|Overall Study|Death|50|||
128775521|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775522|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775523|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775524|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775525|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
128775526|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
128775527|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129056340|NCT01544179|464498508|FG001|Overall Study|Death|37|||
129056341|NCT01544179|464498507|FG000|Overall Study|Lost to Follow-up|0|||
129056342|NCT01544179|464498508|FG001|Overall Study|Lost to Follow-up|1|||
129056343|NCT01544179|464498507|FG000|Overall Study|Adverse Event|0|||
129056344|NCT01544179|464498508|FG001|Overall Study|Adverse Event|1|||
129056345|NCT01544179|464498507|FG000|Overall Study|Withdrawal by Subject|12|||
129056346|NCT01544179|464498508|FG001|Overall Study|Withdrawal by Subject|7|||
129056347|NCT01544179|464498507|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
129056348|NCT01544179|464498508|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129056349|NCT00049530|464498509|FG000|Overall Study|Lack of Efficacy|25|||
129056350|NCT00049530|464498509|FG000|Overall Study|Adverse Event|2|||
129056351|NCT00049530|464498509|FG000|Overall Study|Death|1|||
129056352|NCT00049530|464498509|FG000|Overall Study|symptomatic deterioration|1|||
129056353|NCT00049530|464498509|FG000|Overall Study|ineligible|3|||
129056354|NCT01635283|464498510|FG000|Overall Study|Tumor Progression|3|||
129056355|NCT01635283|464498510|FG000|Overall Study|Lost to Follow-up|1|||
129137123|NCT01292473|464794524|FG000|Overall Study|Physician Decision|0|||
129137124|NCT01292473|464794525|FG001|Overall Study|Physician Decision|1|||
129137125|NCT01292473|464794526|FG002|Overall Study|Physician Decision|0|||
129137126|NCT01292473|464794527|FG003|Overall Study|Physician Decision|0|||
129137127|NCT01292473|464794524|FG000|Overall Study|Disease Progression|0|||
129056356|NCT01438996|464498511|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
129056357|NCT01438996|464498512|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
129056358|NCT01438996|464498513|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
129056359|NCT01433549|464498514|FG000|Phase 2: Second Study Product|Adverse Event|0|||
129056360|NCT01433549|464498515|FG001|Phase 2: Second Study Product|Adverse Event|1|||
129056361|NCT01696058|464498519|FG000|Overall Study|Adverse Event|21|||
129056362|NCT01696058|464498520|FG001|Overall Study|Adverse Event|11|||
129056363|NCT01696058|464498519|FG000|Overall Study|Lack of Efficacy|2|||
129056364|NCT01696058|464498520|FG001|Overall Study|Lack of Efficacy|3|||
129056365|NCT01696058|464498519|FG000|Overall Study|Protocol Violation|9|||
129056366|NCT01696058|464498520|FG001|Overall Study|Protocol Violation|3|||
129056367|NCT01696058|464498519|FG000|Overall Study|Lost to Follow-up|2|||
129056368|NCT01696058|464498520|FG001|Overall Study|Lost to Follow-up|5|||
129056369|NCT01696058|464498519|FG000|Overall Study|Withdrawal by Subject|4|||
129056370|NCT01696058|464498520|FG001|Overall Study|Withdrawal by Subject|6|||
129056371|NCT01696058|464498519|FG000|Overall Study|Other reason prematurely discontinued|5|||
129056372|NCT01696058|464498520|FG001|Overall Study|Other reason prematurely discontinued|3|||
129056373|NCT02278055|464498521|FG000|Overall Study|Adverse Event|1|||
129056374|NCT02278055|464498521|FG000|Overall Study|Lost to Follow-up|1|||
129056375|NCT02278055|464498521|FG000|Overall Study|Withdrawal by Subject|2|||
129056376|NCT02278055|464498521|FG000|Overall Study|Progressive Disease|4|||
129056377|NCT01934335|464498522|FG000|Overall Study|Withdrawal by Subject|1|||
129056378|NCT01934335|464498523|FG001|Overall Study|Withdrawal by Subject|1|||
129056379|NCT05384171|464498524|FG000|Overall Study|Lost to Follow-up|9|||
129056380|NCT05384171|464498525|FG001|Overall Study|Lost to Follow-up|9|||
129056381|NCT05384171|464498524|FG000|Overall Study|Withdrawal by Subject|3|||
129056382|NCT05384171|464498525|FG001|Overall Study|Withdrawal by Subject|0|||
129056383|NCT00106964|464498528|FG000|Overall Study|Lost to Follow-up|8|||
129056384|NCT00106964|464498529|FG001|Overall Study|Lost to Follow-up|6|||
129056385|NCT00106964|464498530|FG002|Overall Study|Lost to Follow-up|2|||
129056386|NCT00106964|464498528|FG000|Overall Study|Pregnancy|2|||
129056387|NCT00106964|464498529|FG001|Overall Study|Pregnancy|3|||
129056388|NCT00106964|464498530|FG002|Overall Study|Pregnancy|2|||
129056389|NCT00106964|464498528|FG000|Overall Study|Death|1|||
129056390|NCT00106964|464498529|FG001|Overall Study|Death|1|||
129056391|NCT00106964|464498530|FG002|Overall Study|Death|0|||
129056392|NCT00106964|464498528|FG000|Overall Study|Incarceration|0|||
129056393|NCT00106964|464498529|FG001|Overall Study|Incarceration|1|||
129056394|NCT00106964|464498530|FG002|Overall Study|Incarceration|0|||
129056395|NCT00106964|464498528|FG000|Overall Study|Site Funding Terminated|0|||
129056396|NCT00106964|464498529|FG001|Overall Study|Site Funding Terminated|1|||
129056397|NCT00106964|464498530|FG002|Overall Study|Site Funding Terminated|1|||
129056398|NCT00106964|464498528|FG000|Overall Study|Failure to adhere|2|||
129056399|NCT00106964|464498529|FG001|Overall Study|Failure to adhere|0|||
129056400|NCT00106964|464498530|FG002|Overall Study|Failure to adhere|0|||
129056401|NCT00106964|464498528|FG000|Overall Study|Did not meet eligibility criteria|0|||
129056402|NCT00106964|464498529|FG001|Overall Study|Did not meet eligibility criteria|2|||
129056403|NCT00106964|464498530|FG002|Overall Study|Did not meet eligibility criteria|2|||
129056404|NCT00106964|464498528|FG000|Overall Study|Required disallowed medication|0|||
129056405|NCT00106964|464498529|FG001|Overall Study|Required disallowed medication|1|||
129056406|NCT00106964|464498530|FG002|Overall Study|Required disallowed medication|0|||
129056407|NCT01756079|464498531|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
129056408|NCT01756079|464498531|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
129056409|NCT01756079|464498531|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
129056410|NCT01756079|464498531|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
129056411|NCT01756079|464498531|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
129056412|NCT00168818|464498536|FG000|Overall Study|Adverse Event|23|||
129056413|NCT00168818|464498537|FG001|Overall Study|Adverse Event|29|||
129056414|NCT00168818|464498538|FG002|Overall Study|Adverse Event|31|||
129056415|NCT00168818|464498536|FG000|Overall Study|Protocol Violation|16|||
129056416|NCT00168818|464498537|FG001|Overall Study|Protocol Violation|11|||
129056417|NCT00168818|464498538|FG002|Overall Study|Protocol Violation|11|||
129056418|NCT00168818|464498536|FG000|Overall Study|Lost to Follow-up|13|||
129056419|NCT00168818|464498537|FG001|Overall Study|Lost to Follow-up|4|||
129137128|NCT01292473|464794525|FG001|Overall Study|Disease Progression|1|||
128775528|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129056420|NCT00168818|464498538|FG002|Overall Study|Lost to Follow-up|15|||
129056421|NCT00168818|464498536|FG000|Overall Study|Withdrawal by Subject|43|||
129056422|NCT00168818|464498537|FG001|Overall Study|Withdrawal by Subject|41|||
129056423|NCT00168818|464498538|FG002|Overall Study|Withdrawal by Subject|37|||
129056424|NCT00168818|464498536|FG000|Overall Study|Other|22|||
129056425|NCT00168818|464498537|FG001|Overall Study|Other|24|||
129056426|NCT00168818|464498538|FG002|Overall Study|Other|30|||
129056427|NCT00168818|464498536|FG000|Treatment|Adverse Event|77|||
129056428|NCT00168818|464498537|FG001|Treatment|Adverse Event|89|||
129056429|NCT00168818|464498538|FG002|Treatment|Adverse Event|68|||
128719993|NCT00605475|463273281|FG000|Overall Study|Protocol Violation|0|||
128719994|NCT00605475|463273282|FG001|Overall Study|Protocol Violation|0|||
128719995|NCT00605475|463273283|FG002|Overall Study|Protocol Violation|0|||
128719996|NCT00605475|463273284|FG003|Overall Study|Protocol Violation|0|||
128719997|NCT00605475|463273285|FG004|Overall Study|Protocol Violation|1|||
128719998|NCT00605475|463273286|FG005|Overall Study|Protocol Violation|0|||
128719999|NCT00605475|463273287|FG006|Overall Study|Protocol Violation|0|||
128720000|NCT00605475|463273288|FG007|Overall Study|Protocol Violation|0|||
128720001|NCT00605475|463273289|FG008|Overall Study|Protocol Violation|0|||
128720002|NCT00605475|463273290|FG009|Overall Study|Protocol Violation|0|||
128720003|NCT00605475|463273281|FG000|Overall Study|Withdrawal by Subject|0|||
128720004|NCT00605475|463273282|FG001|Overall Study|Withdrawal by Subject|0|||
128720005|NCT00605475|463273283|FG002|Overall Study|Withdrawal by Subject|0|||
128720006|NCT00605475|463273284|FG003|Overall Study|Withdrawal by Subject|0|||
128720007|NCT00605475|463273285|FG004|Overall Study|Withdrawal by Subject|0|||
128720008|NCT00605475|463273286|FG005|Overall Study|Withdrawal by Subject|2|||
128720009|NCT00605475|463273287|FG006|Overall Study|Withdrawal by Subject|0|||
128720010|NCT00605475|463273288|FG007|Overall Study|Withdrawal by Subject|0|||
128720011|NCT00605475|463273289|FG008|Overall Study|Withdrawal by Subject|0|||
128720012|NCT00605475|463273290|FG009|Overall Study|Withdrawal by Subject|1|||
128720013|NCT00297037|463273293|FG000|Overall Study|Withdrawal by Subject|2|||
128720014|NCT00297037|463273294|FG001|Overall Study|Withdrawal by Subject|0|||
128720015|NCT00076011|463273295|FG000|Overall Study|Death|1|||
128720016|NCT00076011|463273295|FG000|Overall Study|Adverse Event|10|||
128720017|NCT00076011|463273295|FG000|Overall Study|Lack of Efficacy|25|||
128720018|NCT00076011|463273295|FG000|Overall Study|Withdrawal by Subject|1|||
128720019|NCT00076011|463273295|FG000|Overall Study|Study terminated by sponsor|3|||
128720020|NCT00076011|463273295|FG000|Overall Study|Other|11|||
128720021|NCT00076011|463273295|FG000|Overall Study|Ongoing|1|||
128720022|NCT00581776|463273296|FG000|Overall Study|Disease progression or no response|3|||
128720023|NCT04461015|463273307|FG000|Overall Study|IV access lost during the study|0|||
128720024|NCT04461015|463273308|FG001|Overall Study|IV access lost during the study|1|||
128720025|NCT04461015|463273307|FG000|Overall Study|Withdrawal by Subject|0|||
128775529|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
129056430|NCT00168818|464498536|FG000|Treatment|Protocol Violation|8|||
129056431|NCT00168818|464498537|FG001|Treatment|Protocol Violation|11|||
129056432|NCT00168818|464498538|FG002|Treatment|Protocol Violation|11|||
129056433|NCT00168818|464498536|FG000|Treatment|Lost to Follow-up|0|||
129056434|NCT00168818|464498537|FG001|Treatment|Lost to Follow-up|2|||
129056435|NCT00168818|464498538|FG002|Treatment|Lost to Follow-up|1|||
129056436|NCT00168818|464498536|FG000|Treatment|Withdrawal by Subject|25|||
129056437|NCT00168818|464498537|FG001|Treatment|Withdrawal by Subject|20|||
129056438|NCT00168818|464498538|FG002|Treatment|Withdrawal by Subject|22|||
129056439|NCT00168818|464498536|FG000|Treatment|Other|23|||
129056440|NCT00168818|464498537|FG001|Treatment|Other|29|||
129056441|NCT00168818|464498538|FG002|Treatment|Other|31|||
129056442|NCT00469144|464498539|FG000|Overall Study|Death|0|||
129056443|NCT00469144|464498540|FG001|Overall Study|Death|1|||
129056444|NCT00469144|464498539|FG000|Overall Study|No Response|5|||
129056445|NCT00469144|464498540|FG001|Overall Study|No Response|5|||
129056446|NCT00469144|464498539|FG000|Overall Study|Progressive Disease|1|||
129056447|NCT00469144|464498540|FG001|Overall Study|Progressive Disease|0|||
129056448|NCT04602546|464498541|FG000|Overall Study|Training|2|||
129056449|NCT04602546|464498542|FG001|Overall Study|Training|2|||
129056450|NCT04602546|464498543|FG002|Overall Study|Training|1|||
128720026|NCT04461015|463273308|FG001|Overall Study|Withdrawal by Subject|1|||
128720027|NCT00464568|463273310|FG000|Overall Study|Adverse Event|2|||
128775530|NCT01474512|463468357|FG000|Post-Treatment Follow-Up|Death|0|||
129056451|NCT04602546|464498544|FG003|Overall Study|Training|2|||
129056452|NCT04602546|464498545|FG004|Overall Study|Training|0|||
129056453|NCT04602546|464498541|FG000|Overall Study|Randomized with disqualified data|2|||
129056454|NCT04602546|464498542|FG001|Overall Study|Randomized with disqualified data|0|||
128720028|NCT03615326|463273311|FG000|Overall Study|Death|266|||
128720029|NCT03615326|463273312|FG001|Overall Study|Death|286|||
128720030|NCT03615326|463273313|FG002|Overall Study|Death|14|||
128720031|NCT03615326|463273314|FG003|Overall Study|Death|17|||
128720032|NCT03615326|463273311|FG000|Overall Study|Lost to Follow-up|0|||
128720033|NCT03615326|463273312|FG001|Overall Study|Lost to Follow-up|1|||
128720034|NCT03615326|463273313|FG002|Overall Study|Lost to Follow-up|0|||
129056455|NCT04602546|464498543|FG002|Overall Study|Randomized with disqualified data|2|||
129056456|NCT04602546|464498544|FG003|Overall Study|Randomized with disqualified data|5|||
129056457|NCT04602546|464498545|FG004|Overall Study|Randomized with disqualified data|3|||
129056458|NCT02794246|464498546|FG000|Overall Study|Withdrawal by Subject|2|||
129056459|NCT02794246|464498546|FG000|Overall Study|Physician Decision|4|||
129056460|NCT01994291|464498547|FG000|Overall Study|Adverse Event|4|||
129056461|NCT01994291|464498548|FG001|Overall Study|Adverse Event|1|||
129056462|NCT01994291|464498549|FG002|Overall Study|Adverse Event|3|||
129056463|NCT01994291|464498547|FG000|Overall Study|Lost to Follow-up|1|||
129056464|NCT01994291|464498548|FG001|Overall Study|Lost to Follow-up|1|||
129056465|NCT01994291|464498549|FG002|Overall Study|Lost to Follow-up|0|||
129056466|NCT01994291|464498547|FG000|Overall Study|Does not meet entrance criteria|1|||
129056467|NCT01994291|464498548|FG001|Overall Study|Does not meet entrance criteria|0|||
129056468|NCT01994291|464498549|FG002|Overall Study|Does not meet entrance criteria|0|||
129056469|NCT01994291|464498547|FG000|Overall Study|Medication error without associated AE|1|||
129056470|NCT01994291|464498548|FG001|Overall Study|Medication error without associated AE|0|||
129056471|NCT01994291|464498549|FG002|Overall Study|Medication error without associated AE|1|||
129056472|NCT01994291|464498547|FG000|Overall Study|Protocol Violation|1|||
129056473|NCT01994291|464498548|FG001|Overall Study|Protocol Violation|0|||
129056474|NCT01994291|464498549|FG002|Overall Study|Protocol Violation|0|||
129056475|NCT01994291|464498547|FG000|Overall Study|Withdrawal by Subject|6|||
129056476|NCT01994291|464498548|FG001|Overall Study|Withdrawal by Subject|3|||
128720035|NCT03615326|463273314|FG003|Overall Study|Lost to Follow-up|0|||
128720036|NCT03615326|463273311|FG000|Overall Study|Withdrawal by Subject|1|||
129056477|NCT01994291|464498549|FG002|Overall Study|Withdrawal by Subject|5|||
129056478|NCT01994291|464498547|FG000|Overall Study|Other|1|||
129056479|NCT01994291|464498548|FG001|Overall Study|Other|2|||
129056480|NCT01994291|464498549|FG002|Overall Study|Other|0|||
129056481|NCT01775189|464498550|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129056482|NCT01775189|464498551|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
129056483|NCT01775189|464498552|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129056484|NCT01775189|464498553|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129056485|NCT01775189|464498554|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129056486|NCT01775189|464498555|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129056487|NCT01775189|464498556|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129056488|NCT01775189|464498550|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129056489|NCT01775189|464498551|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
129056490|NCT01775189|464498552|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129056491|NCT01775189|464498553|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129056492|NCT01775189|464498554|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129056493|NCT01775189|464498555|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129056494|NCT01775189|464498556|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129056495|NCT01775189|464498550|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129056496|NCT01775189|464498551|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
129056497|NCT01775189|464498552|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
129056498|NCT01775189|464498553|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129056499|NCT01775189|464498554|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129056500|NCT01775189|464498555|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129056501|NCT01775189|464498556|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129056502|NCT01775189|464498550|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129056503|NCT01775189|464498551|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129056504|NCT01775189|464498552|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129056505|NCT01775189|464498553|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129056506|NCT01775189|464498554|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129056507|NCT01775189|464498555|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
129056508|NCT01775189|464498556|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129056509|NCT01775189|464498550|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129056510|NCT01775189|464498551|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129056511|NCT01775189|464498552|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129056512|NCT01775189|464498553|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
129056513|NCT01775189|464498554|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129056514|NCT01775189|464498555|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129056515|NCT01775189|464498556|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129056516|NCT01775189|464498550|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129056517|NCT01775189|464498551|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129056518|NCT01775189|464498552|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129056519|NCT01775189|464498553|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
129056520|NCT01775189|464498554|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129056521|NCT01775189|464498555|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129056522|NCT01775189|464498556|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
129056523|NCT00856375|464498557|FG000|Overall Study|Other|0|||
129056524|NCT00856375|464498558|FG001|Overall Study|Other|1|||
129056525|NCT00856375|464498557|FG000|Overall Study|Death|32|||
128720037|NCT03615326|463273312|FG001|Overall Study|Withdrawal by Subject|3|||
128720038|NCT03615326|463273313|FG002|Overall Study|Withdrawal by Subject|0|||
128720039|NCT03615326|463273314|FG003|Overall Study|Withdrawal by Subject|0|||
128720040|NCT03615326|463273311|FG000|Overall Study|Participants Ongoing|83|||
128720041|NCT03615326|463273312|FG001|Overall Study|Participants Ongoing|58|||
128720042|NCT03615326|463273313|FG002|Overall Study|Participants Ongoing|6|||
128720043|NCT03615326|463273314|FG003|Overall Study|Participants Ongoing|3|||
129056526|NCT00856375|464498558|FG001|Overall Study|Death|30|||
129056527|NCT00856375|464498557|FG000|Overall Study|Sponsor Terminated Study|7|||
129056528|NCT00856375|464498558|FG001|Overall Study|Sponsor Terminated Study|7|||
129056529|NCT00856375|464498557|FG000|Overall Study|Withdrawal by Subject|2|||
129056530|NCT00856375|464498558|FG001|Overall Study|Withdrawal by Subject|1|||
129056531|NCT00856375|464498557|FG000|Overall Study|Lost to Follow-up|1|||
129056532|NCT00856375|464498558|FG001|Overall Study|Lost to Follow-up|2|||
129056533|NCT02121392|464498561|FG000|Prior to Intervention|Protocol Violation|40|||
129056534|NCT02121392|464498562|FG001|Prior to Intervention|Protocol Violation|35|||
129056535|NCT02121392|464498561|FG000|Prior to Intervention|Withdrawal by Subject|8|||
129056536|NCT02121392|464498562|FG001|Prior to Intervention|Withdrawal by Subject|6|||
129056537|NCT02121392|464498561|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
129056538|NCT02121392|464498562|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
129056539|NCT02121392|464498561|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
129056540|NCT02121392|464498562|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
129056541|NCT00901576|464498571|FG000|Second Intervention|Withdrawal by Subject|0|||
129056542|NCT00901576|464498572|FG001|Second Intervention|Withdrawal by Subject|0|||
129056543|NCT00901576|464498573|FG002|Second Intervention|Withdrawal by Subject|0|||
129056544|NCT00901576|464498574|FG003|Second Intervention|Withdrawal by Subject|1|||
129056545|NCT00901576|464498575|FG004|Second Intervention|Withdrawal by Subject|0|||
129056546|NCT00901576|464498576|FG005|Second Intervention|Withdrawal by Subject|1|||
129056547|NCT00901576|464498571|FG000|Second Intervention|Physician Decision|1|||
129056548|NCT00901576|464498572|FG001|Second Intervention|Physician Decision|0|||
129056549|NCT00901576|464498573|FG002|Second Intervention|Physician Decision|0|||
129056550|NCT00901576|464498574|FG003|Second Intervention|Physician Decision|0|||
129056551|NCT00901576|464498575|FG004|Second Intervention|Physician Decision|0|||
129056552|NCT00901576|464498576|FG005|Second Intervention|Physician Decision|0|||
129056553|NCT03201445|464498577|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
129056554|NCT03201445|464498578|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
129056555|NCT03201445|464498577|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
129056556|NCT03201445|464498578|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
129056557|NCT03201445|464498577|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
129056558|NCT03201445|464498578|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
129056559|NCT03201445|464498577|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
129056560|NCT03201445|464498578|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
129056561|NCT03201445|464498577|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
129056562|NCT03201445|464498578|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
129056563|NCT03201445|464498577|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
129056564|NCT03201445|464498578|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
129056565|NCT03201445|464498577|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
129056566|NCT03201445|464498578|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
129056567|NCT03201445|464498577|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
129056568|NCT03201445|464498578|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
129056569|NCT03201445|464498577|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
129056570|NCT03201445|464498578|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
129056571|NCT03201445|464498577|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
129056572|NCT03201445|464498578|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
129056573|NCT03201445|464498577|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
129056574|NCT03201445|464498578|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
129056575|NCT03201445|464498577|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
129056576|NCT03201445|464498578|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
129056577|NCT03201445|464498577|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
129056578|NCT03201445|464498578|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
129056579|NCT03201445|464498577|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
129056580|NCT03201445|464498578|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
129056581|NCT03201445|464498577|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
129056582|NCT03201445|464498578|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
129056583|NCT03201445|464498577|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
129056584|NCT03201445|464498578|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
129056585|NCT03201445|464498577|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
129056586|NCT03201445|464498578|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
129056587|NCT03201445|464498577|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
129056588|NCT03201445|464498578|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
129056589|NCT03201445|464498577|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
129056590|NCT03201445|464498578|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
129056591|NCT03201445|464498577|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
129056592|NCT03201445|464498578|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
129056593|NCT03201445|464498577|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
129056594|NCT03201445|464498578|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
129056595|NCT00843635|464498585|FG000|Overall Study|Adverse Event|2|||
129056596|NCT00843635|464498586|FG001|Overall Study|Adverse Event|2|||
129056597|NCT00843635|464498587|FG002|Overall Study|Adverse Event|0|||
129056598|NCT03496610|464498588|FG000|Overall Study|Lost to Follow-up|3|||
129056599|NCT03496610|464498589|FG001|Overall Study|Lost to Follow-up|2|||
129056600|NCT03496610|464498588|FG000|Overall Study|Physician Decision|1|||
129056601|NCT03496610|464498589|FG001|Overall Study|Physician Decision|0|||
129056602|NCT03496610|464498588|FG000|Overall Study|Withdrawal by Subject|1|||
129056603|NCT03496610|464498589|FG001|Overall Study|Withdrawal by Subject|0|||
129056604|NCT04435184|464498590|FG000|Overall Study|follow-up blood draws missing|3|||
129056605|NCT04435184|464498591|FG001|Overall Study|follow-up blood draws missing|5|||
129056606|NCT02714426|464498595|FG000|Overall Study|Withdrawal by Subject|2|||
129056607|NCT02714426|464498596|FG001|Overall Study|Withdrawal by Subject|2|||
129056608|NCT00813800|464498600|FG000|Overall Study|Screen Failure after Consent|2|||
129056609|NCT00813800|464498600|FG000|Overall Study|Adverse Event|1|||
129056610|NCT00813800|464498600|FG000|Overall Study|Worsening of depression|2|||
129056611|NCT00813800|464498600|FG000|Overall Study|Physician Decision|1|||
129056612|NCT03456453|464498601|FG000|Overall Study|Withdrawal by Subject|2|||
129056613|NCT03456453|464498602|FG001|Overall Study|Withdrawal by Subject|0|||
129056614|NCT03456453|464498601|FG000|Overall Study|Not released to community|1|||
129056615|NCT03456453|464498602|FG001|Overall Study|Not released to community|5|||
129056616|NCT03456453|464498601|FG000|Overall Study|Lost to Follow-up|0|||
129056617|NCT03456453|464498602|FG001|Overall Study|Lost to Follow-up|2|||
129056618|NCT01860677|464498603|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
129056619|NCT01860677|464498604|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
129056620|NCT04762277|464498605|FG000|Overall Study|Withdrawal by Subject|0|||
129056621|NCT04762277|464498606|FG001|Overall Study|Withdrawal by Subject|2|||
129056622|NCT04762277|464498605|FG000|Overall Study|Protocol Violation|0|||
129056623|NCT04762277|464498606|FG001|Overall Study|Protocol Violation|1|||
129056624|NCT04762277|464498605|FG000|Overall Study|Adverse Event|1|||
129056625|NCT04762277|464498606|FG001|Overall Study|Adverse Event|0|||
129056626|NCT00896480|464498607|FG000|Overall Study|Disease progression/recurrence|21|||
129056627|NCT00642278|464498608|FG000|Overall Study|Adverse Event|2|||
129056628|NCT00642278|464498609|FG001|Overall Study|Adverse Event|1|||
129056629|NCT00642278|464498610|FG002|Overall Study|Adverse Event|3|||
129056630|NCT00642278|464498611|FG003|Overall Study|Adverse Event|1|||
129056631|NCT00642278|464498612|FG004|Overall Study|Adverse Event|2|||
129056632|NCT00642278|464498613|FG005|Overall Study|Adverse Event|2|||
129056633|NCT00642278|464498614|FG006|Overall Study|Adverse Event|0|||
129056634|NCT00642278|464498608|FG000|Overall Study|Lack of Efficacy|0|||
129056635|NCT00642278|464498609|FG001|Overall Study|Lack of Efficacy|1|||
129056636|NCT00642278|464498610|FG002|Overall Study|Lack of Efficacy|0|||
129056637|NCT00642278|464498611|FG003|Overall Study|Lack of Efficacy|0|||
129056638|NCT00642278|464498612|FG004|Overall Study|Lack of Efficacy|0|||
129056639|NCT00642278|464498613|FG005|Overall Study|Lack of Efficacy|0|||
129056640|NCT00642278|464498614|FG006|Overall Study|Lack of Efficacy|0|||
129056641|NCT00642278|464498608|FG000|Overall Study|Lost to Follow-up|5|||
129056642|NCT00642278|464498609|FG001|Overall Study|Lost to Follow-up|1|||
129056643|NCT00642278|464498610|FG002|Overall Study|Lost to Follow-up|0|||
129056644|NCT00642278|464498611|FG003|Overall Study|Lost to Follow-up|1|||
129056645|NCT00642278|464498612|FG004|Overall Study|Lost to Follow-up|0|||
129056646|NCT00642278|464498613|FG005|Overall Study|Lost to Follow-up|1|||
129056647|NCT00642278|464498614|FG006|Overall Study|Lost to Follow-up|1|||
129056648|NCT00642278|464498608|FG000|Overall Study|Physician Decision|0|||
129056649|NCT00642278|464498609|FG001|Overall Study|Physician Decision|0|||
129056650|NCT00642278|464498610|FG002|Overall Study|Physician Decision|0|||
129056651|NCT00642278|464498611|FG003|Overall Study|Physician Decision|1|||
129056652|NCT00642278|464498612|FG004|Overall Study|Physician Decision|0|||
129056653|NCT00642278|464498613|FG005|Overall Study|Physician Decision|0|||
129056654|NCT00642278|464498614|FG006|Overall Study|Physician Decision|0|||
129056655|NCT00642278|464498608|FG000|Overall Study|Protocol Violation|0|||
129056656|NCT00642278|464498609|FG001|Overall Study|Protocol Violation|0|||
129056657|NCT00642278|464498610|FG002|Overall Study|Protocol Violation|1|||
129056658|NCT00642278|464498611|FG003|Overall Study|Protocol Violation|1|||
129056659|NCT00642278|464498612|FG004|Overall Study|Protocol Violation|0|||
129056660|NCT00642278|464498613|FG005|Overall Study|Protocol Violation|1|||
129056661|NCT00642278|464498614|FG006|Overall Study|Protocol Violation|2|||
129056662|NCT00642278|464498608|FG000|Overall Study|Withdrawal by Subject|1|||
129056663|NCT00642278|464498609|FG001|Overall Study|Withdrawal by Subject|1|||
129056664|NCT00642278|464498610|FG002|Overall Study|Withdrawal by Subject|1|||
129056665|NCT00642278|464498611|FG003|Overall Study|Withdrawal by Subject|3|||
129056666|NCT00642278|464498612|FG004|Overall Study|Withdrawal by Subject|6|||
129056667|NCT00642278|464498613|FG005|Overall Study|Withdrawal by Subject|2|||
129056668|NCT00642278|464498614|FG006|Overall Study|Withdrawal by Subject|2|||
129056669|NCT00642278|464498608|FG000|Overall Study|Noncompliance with study drug regimen|0|||
129056670|NCT00642278|464498609|FG001|Overall Study|Noncompliance with study drug regimen|0|||
129056671|NCT00642278|464498610|FG002|Overall Study|Noncompliance with study drug regimen|0|||
129056672|NCT00642278|464498611|FG003|Overall Study|Noncompliance with study drug regimen|1|||
129056673|NCT00642278|464498612|FG004|Overall Study|Noncompliance with study drug regimen|0|||
129056674|NCT00642278|464498613|FG005|Overall Study|Noncompliance with study drug regimen|0|||
129056675|NCT00642278|464498614|FG006|Overall Study|Noncompliance with study drug regimen|0|||
129056676|NCT00642278|464498608|FG000|Overall Study|Other|2|||
129056677|NCT00642278|464498609|FG001|Overall Study|Other|1|||
129056678|NCT00642278|464498610|FG002|Overall Study|Other|0|||
129056679|NCT00642278|464498611|FG003|Overall Study|Other|1|||
129056680|NCT00642278|464498612|FG004|Overall Study|Other|0|||
129056681|NCT00642278|464498613|FG005|Overall Study|Other|1|||
129056682|NCT00642278|464498614|FG006|Overall Study|Other|0|||
129056683|NCT00090363|464498615|FG000|Overall Study|Lost to Follow-up|1|||
129056684|NCT00090363|464498616|FG001|Overall Study|Lost to Follow-up|2|||
129056685|NCT00090363|464498617|FG002|Overall Study|Lost to Follow-up|1|||
129056686|NCT00090363|464498615|FG000|Overall Study|Withdrawal by Subject|7|||
129056687|NCT00090363|464498616|FG001|Overall Study|Withdrawal by Subject|7|||
129056688|NCT00090363|464498617|FG002|Overall Study|Withdrawal by Subject|6|||
129056689|NCT00090363|464498615|FG000|Overall Study|Study-specific discontinuation criteria|75|||
129056690|NCT00090363|464498616|FG001|Overall Study|Study-specific discontinuation criteria|74|||
129056691|NCT00090363|464498617|FG002|Overall Study|Study-specific discontinuation criteria|62|||
129056692|NCT00090363|464498615|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129056693|NCT00090363|464498616|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129056694|NCT00090363|464498617|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129056695|NCT00090363|464498615|FG000|Overall Study|Consent expired|7|||
129056696|NCT00090363|464498616|FG001|Overall Study|Consent expired|10|||
129056697|NCT00090363|464498617|FG002|Overall Study|Consent expired|9|||
129056698|NCT00090363|464498615|FG000|Overall Study|Reasons not specified|2|||
129056699|NCT00090363|464498616|FG001|Overall Study|Reasons not specified|1|||
129056700|NCT00090363|464498617|FG002|Overall Study|Reasons not specified|1|||
129056701|NCT00090363|464498615|FG000|Overall Study|Continuing on study off treatment|14|||
129056702|NCT00090363|464498616|FG001|Overall Study|Continuing on study off treatment|13|||
129056703|NCT00090363|464498617|FG002|Overall Study|Continuing on study off treatment|16|||
129056704|NCT03713619|464498618|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
129056705|NCT03713619|464498619|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129056706|NCT03713619|464498620|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
129056707|NCT03713619|464498621|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129056708|NCT03713619|464498622|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129056709|NCT03713619|464498618|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
129056710|NCT03713619|464498619|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129056711|NCT03713619|464498620|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129056712|NCT03713619|464498621|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129056713|NCT03713619|464498622|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129056714|NCT03713619|464498618|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
129056715|NCT03713619|464498619|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
129056716|NCT03713619|464498620|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
129056717|NCT03713619|464498621|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
129056718|NCT03713619|464498622|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
129056719|NCT03713619|464498618|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
129056720|NCT03713619|464498619|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129056721|NCT03713619|464498620|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129056722|NCT03713619|464498621|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129056723|NCT03713619|464498622|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129056724|NCT03713619|464498618|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
129056725|NCT03713619|464498619|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
129056726|NCT03713619|464498620|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
129056727|NCT03713619|464498621|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129056728|NCT03713619|464498622|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129056729|NCT03713619|464498618|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129056730|NCT03713619|464498619|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129056731|NCT03713619|464498620|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
129056732|NCT03713619|464498621|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129056733|NCT03713619|464498622|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129056734|NCT03713619|464498618|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
129056735|NCT03713619|464498619|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
129056736|NCT03713619|464498620|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
129056737|NCT03713619|464498621|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
129056738|NCT03713619|464498622|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
129056739|NCT03713619|464498618|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
129056740|NCT03713619|464498619|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
129056741|NCT03713619|464498620|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
129056742|NCT03713619|464498621|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
129056743|NCT03713619|464498622|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
129056744|NCT03713619|464498618|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
129056745|NCT03713619|464498619|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129056746|NCT03713619|464498620|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129056747|NCT03713619|464498621|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
129056748|NCT03713619|464498622|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129056749|NCT03713619|464498618|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
129056750|NCT03713619|464498619|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
129056751|NCT03713619|464498620|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
129056752|NCT03713619|464498621|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
129056753|NCT03713619|464498622|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
129056754|NCT03713619|464498618|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
129056755|NCT03713619|464498619|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
129056756|NCT03713619|464498620|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
129056757|NCT03713619|464498621|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
129056758|NCT03713619|464498622|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
129056759|NCT03713619|464498618|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
129056760|NCT03713619|464498619|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
129056761|NCT03713619|464498620|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
129056762|NCT03713619|464498621|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
129056763|NCT03713619|464498622|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
129056764|NCT03713619|464498618|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129056765|NCT03713619|464498619|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
129056766|NCT03713619|464498620|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129056767|NCT03713619|464498621|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
129056768|NCT03713619|464498622|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
129056769|NCT00197496|464498628|FG000|Baseline to Discharge|not interested|1|||
129056770|NCT00197496|464498629|FG001|Baseline to Discharge|not interested|0|||
129056771|NCT00197496|464498628|FG000|Baseline to Discharge|MRSA|1|||
129056772|NCT00197496|464498629|FG001|Baseline to Discharge|MRSA|0|||
129056773|NCT00197496|464498628|FG000|Baseline to Discharge|Physician Decision|0|||
129056774|NCT00197496|464498629|FG001|Baseline to Discharge|Physician Decision|1|||
129056775|NCT00197496|464498628|FG000|Baseline to Discharge|Protocol Violation|0|||
129056776|NCT00197496|464498629|FG001|Baseline to Discharge|Protocol Violation|1|||
129056777|NCT00197496|464498628|FG000|Follow-up|Lost to Follow-up|2|||
129056778|NCT00197496|464498629|FG001|Follow-up|Lost to Follow-up|1|||
129056779|NCT00857584|464498630|FG000|Overall Study|Lack of Efficacy|1|||
129056780|NCT00857584|464498631|FG001|Overall Study|Lack of Efficacy|2|||
129056781|NCT00857584|464498630|FG000|Overall Study|Adverse Event|2|||
129056782|NCT00857584|464498631|FG001|Overall Study|Adverse Event|2|||
129056783|NCT00857584|464498630|FG000|Overall Study|Physician Decision|1|||
129056784|NCT00857584|464498631|FG001|Overall Study|Physician Decision|1|||
129056785|NCT00259272|464498632|FG000|Overall Study|Adverse Event|2|||
129056786|NCT00259272|464498633|FG001|Overall Study|Adverse Event|1|||
129056787|NCT00259272|464498634|FG002|Overall Study|Adverse Event|0|||
129056788|NCT00259272|464498635|FG003|Overall Study|Adverse Event|3|||
129056789|NCT00259272|464498632|FG000|Overall Study|Lack of Efficacy|5|||
129056790|NCT00259272|464498633|FG001|Overall Study|Lack of Efficacy|1|||
129056791|NCT00259272|464498634|FG002|Overall Study|Lack of Efficacy|2|||
129056792|NCT00259272|464498635|FG003|Overall Study|Lack of Efficacy|6|||
129056793|NCT00259272|464498632|FG000|Overall Study|Physician Decision|1|||
128720044|NCT03506373|463273321|FG000|Overall Study|Adverse Event|6|||
128720045|NCT03506373|463273321|FG000|Overall Study|Withdrawal by Subject|2|||
128720046|NCT03506373|463273321|FG000|Overall Study|Disease progression|5|||
128720047|NCT03506373|463273321|FG000|Overall Study|Other|3|||
128720048|NCT00885755|463273322|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
128720049|NCT00885755|463273323|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
128720050|NCT00885755|463273324|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
128720051|NCT00885755|463273322|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
128720052|NCT00885755|463273323|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
128720053|NCT00885755|463273324|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
129056794|NCT00259272|464498633|FG001|Overall Study|Physician Decision|2|||
129056795|NCT00259272|464498634|FG002|Overall Study|Physician Decision|1|||
129056796|NCT00259272|464498635|FG003|Overall Study|Physician Decision|3|||
129056797|NCT00259272|464498632|FG000|Overall Study|Protocol Violation|2|||
129056798|NCT00259272|464498633|FG001|Overall Study|Protocol Violation|0|||
129056799|NCT00259272|464498634|FG002|Overall Study|Protocol Violation|0|||
129056800|NCT00259272|464498635|FG003|Overall Study|Protocol Violation|1|||
129056801|NCT00259272|464498632|FG000|Overall Study|Sponsor Decision|0|||
129056802|NCT00259272|464498633|FG001|Overall Study|Sponsor Decision|1|||
129056803|NCT00259272|464498634|FG002|Overall Study|Sponsor Decision|0|||
129056804|NCT00259272|464498635|FG003|Overall Study|Sponsor Decision|0|||
129056805|NCT00259272|464498632|FG000|Overall Study|Withdrawal by Subject|4|||
129056806|NCT00259272|464498633|FG001|Overall Study|Withdrawal by Subject|2|||
129056807|NCT00259272|464498634|FG002|Overall Study|Withdrawal by Subject|2|||
129056808|NCT00259272|464498635|FG003|Overall Study|Withdrawal by Subject|7|||
129056809|NCT00259272|464498632|FG000|Overall Study|Lost to Follow-up|1|||
129056810|NCT00259272|464498633|FG001|Overall Study|Lost to Follow-up|0|||
129056811|NCT00259272|464498634|FG002|Overall Study|Lost to Follow-up|0|||
129056812|NCT00259272|464498635|FG003|Overall Study|Lost to Follow-up|1|||
129056813|NCT01908907|464500033|FG000|Overall Study|Physician Decision|1|||
129056814|NCT01908907|464500034|FG001|Overall Study|Physician Decision|0|||
129056815|NCT01908907|464500033|FG000|Overall Study|Protocol Violation|1|||
129056816|NCT01908907|464500034|FG001|Overall Study|Protocol Violation|0|||
129056817|NCT00761657|464500035|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
129056818|NCT00761657|464500036|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
129056819|NCT00761657|464500037|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
129056820|NCT00761657|464500038|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
129056821|NCT00761657|464500039|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
129056822|NCT00761657|464500040|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
129056823|NCT00761657|464500041|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
129056824|NCT00761657|464500042|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
129056825|NCT00761657|464500043|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
129056826|NCT00761657|464500035|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129056827|NCT00761657|464500036|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129056828|NCT00761657|464500037|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
129056829|NCT00761657|464500038|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
129056830|NCT00761657|464500039|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129056831|NCT00761657|464500040|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129056832|NCT00761657|464500041|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129056833|NCT00761657|464500042|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129056834|NCT00761657|464500043|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129056835|NCT00761657|464500035|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
129056836|NCT00761657|464500036|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
129056837|NCT00761657|464500037|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
129056838|NCT00761657|464500038|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
129056839|NCT00761657|464500039|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
129056840|NCT00761657|464500040|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
129056841|NCT00761657|464500041|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
129056842|NCT00761657|464500042|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
129056843|NCT00761657|464500043|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
129056844|NCT00761657|464500035|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
129056845|NCT00761657|464500036|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
129056846|NCT00761657|464500037|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
129056847|NCT00761657|464500038|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
129056848|NCT00761657|464500039|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
128720054|NCT00885755|463273322|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
129056849|NCT00761657|464500040|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
129056850|NCT00761657|464500041|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
129056851|NCT00761657|464500042|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
129056852|NCT00761657|464500043|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
129056853|NCT00359801|464500044|FG000|Overall Study|Lost to Follow-up|72|||
128720055|NCT00885755|463273323|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
128720056|NCT00885755|463273324|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
128720057|NCT00885755|463273322|FG000|Part I: Trastuzumab+Taxane|Death|0|||
128720058|NCT00885755|463273323|FG001|Part I: Trastuzumab+Taxane|Death|0|||
129056854|NCT00359801|464500045|FG001|Overall Study|Lost to Follow-up|58|||
129056855|NCT00359801|464500044|FG000|Overall Study|Withdrawal by Subject|143|||
129056856|NCT00359801|464500045|FG001|Overall Study|Withdrawal by Subject|96|||
128720059|NCT00885755|463273324|FG002|Part I: Trastuzumab+Taxane|Death|1|||
128720060|NCT00885755|463273322|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
128720061|NCT00885755|463273323|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
129056857|NCT00359801|464500044|FG000|Overall Study|Other|66|||
129056858|NCT00359801|464500045|FG001|Overall Study|Other|46|||
129056859|NCT00359801|464500044|FG000|Overall Study|Final Status Unknown: missing data|7|||
129056860|NCT00359801|464500045|FG001|Overall Study|Final Status Unknown: missing data|4|||
129056861|NCT00359801|464500044|FG000|Overall Study|Sponsor Decision|17|||
129056862|NCT00359801|464500045|FG001|Overall Study|Sponsor Decision|16|||
129056863|NCT02500043|464500050|FG000|Overall Study|Randomized, but not Treated|2|||
129056864|NCT02500043|464500051|FG001|Overall Study|Randomized, but not Treated|2|||
128720062|NCT00885755|463273324|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
129056865|NCT02500043|464500050|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
129056866|NCT02500043|464500051|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
129056867|NCT02500043|464500050|FG000|Overall Study|Adverse Event|33|||
129056868|NCT02500043|464500051|FG001|Overall Study|Adverse Event|11|||
129056869|NCT02500043|464500050|FG000|Overall Study|Clinical Progression|54|||
129056870|NCT02500043|464500051|FG001|Overall Study|Clinical Progression|35|||
129056871|NCT02500043|464500050|FG000|Overall Study|Radiological Progression|192|||
129056872|NCT02500043|464500051|FG001|Overall Study|Radiological Progression|110|||
129056873|NCT02500043|464500050|FG000|Overall Study|Physician's Decision|11|||
129056874|NCT02500043|464500051|FG001|Overall Study|Physician's Decision|3|||
129056875|NCT02500043|464500050|FG000|Overall Study|Withdrawal by Subject|14|||
129056876|NCT02500043|464500051|FG001|Overall Study|Withdrawal by Subject|4|||
129056877|NCT02500043|464500050|FG000|Overall Study|Death|11|||
129056878|NCT02500043|464500051|FG001|Overall Study|Death|2|||
129056879|NCT02500043|464500050|FG000|Overall Study|Protocol Deviation|1|||
129056880|NCT02500043|464500051|FG001|Overall Study|Protocol Deviation|0|||
129056881|NCT03151408|464500052|FG000|Overall Study|Adverse Event|24|||
129056882|NCT03151408|464500053|FG001|Overall Study|Adverse Event|23|||
129056883|NCT03151408|464500052|FG000|Overall Study|Death|46|||
129056884|NCT03151408|464500053|FG001|Overall Study|Death|26|||
128720063|NCT05442554|463273325|FG000|Overall Study|Adverse Event|1|||
128720064|NCT01852812|463273326|FG000|Overall Study|Adverse Event|0|||
128720065|NCT01852812|463273327|FG001|Overall Study|Adverse Event|0|||
128720066|NCT01852812|463273328|FG002|Overall Study|Adverse Event|1|||
128720067|NCT01852812|463273326|FG000|Overall Study|Non-compliance With Study Drug|0|||
128720068|NCT01852812|463273327|FG001|Overall Study|Non-compliance With Study Drug|1|||
128720069|NCT01852812|463273328|FG002|Overall Study|Non-compliance With Study Drug|0|||
128720070|NCT02250443|463273329|FG000|Overall Study|Administrative problems|7|||
128720071|NCT02250443|463273329|FG000|Overall Study|Adverse Event|3|||
128720072|NCT01549964|463273330|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
128720073|NCT01549964|463273331|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
128720074|NCT01549964|463273332|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
128720075|NCT01549964|463273333|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
128720076|NCT01549964|463273330|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
128720077|NCT01549964|463273331|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
128720078|NCT01549964|463273332|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
128720079|NCT01549964|463273333|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
128720080|NCT01549964|463273330|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
128720081|NCT01549964|463273331|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
128720082|NCT01549964|463273332|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
128720083|NCT01549964|463273333|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
128720084|NCT01549964|463273330|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
128720085|NCT01549964|463273331|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
128720086|NCT01549964|463273332|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
128720087|NCT01549964|463273333|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
128720088|NCT01549964|463273330|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
128720089|NCT01549964|463273331|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
129056885|NCT03151408|464500052|FG000|Overall Study|Physician Decision|13|||
129056886|NCT03151408|464500053|FG001|Overall Study|Physician Decision|19|||
129056887|NCT03151408|464500052|FG000|Overall Study|Withdrawal by Subject|16|||
129056888|NCT03151408|464500053|FG001|Overall Study|Withdrawal by Subject|20|||
129056889|NCT03151408|464500052|FG000|Overall Study|Progressive disease|45|||
129056890|NCT03151408|464500053|FG001|Overall Study|Progressive disease|61|||
129056891|NCT03151408|464500052|FG000|Overall Study|non-compliance by patient|1|||
129056892|NCT03151408|464500053|FG001|Overall Study|non-compliance by patient|0|||
129056893|NCT03151408|464500052|FG000|Overall Study|other reasons|56|||
129056894|NCT03151408|464500053|FG001|Overall Study|other reasons|52|||
128720090|NCT01549964|463273332|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
128775531|NCT01474512|463468358|FG001|Post-Treatment Follow-Up|Death|0|||
128775532|NCT01474512|463468359|FG002|Post-Treatment Follow-Up|Death|0|||
129056895|NCT03151408|464500052|FG000|Overall Study|randomized and not treated|2|||
129056896|NCT03151408|464500053|FG001|Overall Study|randomized and not treated|2|||
129056897|NCT01473524|464500056|FG000|DB Phase|Adverse Event|4|||
129056898|NCT01473524|464500057|FG001|DB Phase|Adverse Event|8|||
129056899|NCT01473524|464500058|FG002|DB Phase|Adverse Event|2|||
129056900|NCT01473524|464500059|FG003|DB Phase|Adverse Event|0|||
129056901|NCT01473524|464500060|FG004|DB Phase|Adverse Event|0|||
129056902|NCT01473524|464500061|FG005|DB Phase|Adverse Event|0|||
129056903|NCT01473524|464500056|FG000|DB Phase|Death|1|||
128720091|NCT01549964|463273333|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
128720092|NCT01549964|463273330|FG000|24-Week Treatment Period|Other|1|||
129056904|NCT01473524|464500057|FG001|DB Phase|Death|0|||
129056905|NCT01473524|464500058|FG002|DB Phase|Death|0|||
129056906|NCT01473524|464500059|FG003|DB Phase|Death|0|||
129056907|NCT01473524|464500060|FG004|DB Phase|Death|0|||
128720093|NCT01549964|463273331|FG001|24-Week Treatment Period|Other|0|||
128775533|NCT01474512|463468360|FG003|Post-Treatment Follow-Up|Death|0|||
129056908|NCT01473524|464500061|FG005|DB Phase|Death|0|||
129056909|NCT01473524|464500056|FG000|DB Phase|Withdrawal by Subject|2|||
129056910|NCT01473524|464500057|FG001|DB Phase|Withdrawal by Subject|1|||
129056911|NCT01473524|464500058|FG002|DB Phase|Withdrawal by Subject|1|||
129056912|NCT01473524|464500059|FG003|DB Phase|Withdrawal by Subject|0|||
129056913|NCT01473524|464500060|FG004|DB Phase|Withdrawal by Subject|0|||
129056914|NCT01473524|464500061|FG005|DB Phase|Withdrawal by Subject|0|||
129056915|NCT01473524|464500056|FG000|LTSE Phase|Withdrawal by Subject|0|||
129056916|NCT01473524|464500057|FG001|LTSE Phase|Withdrawal by Subject|0|||
129056917|NCT01473524|464500058|FG002|LTSE Phase|Withdrawal by Subject|0|||
129056918|NCT01473524|464500059|FG003|LTSE Phase|Withdrawal by Subject|3|||
129056919|NCT01473524|464500060|FG004|LTSE Phase|Withdrawal by Subject|3|||
129056920|NCT01473524|464500061|FG005|LTSE Phase|Withdrawal by Subject|6|||
129056921|NCT01473524|464500056|FG000|LTSE Phase|Death|0|||
129056922|NCT01473524|464500057|FG001|LTSE Phase|Death|0|||
129056923|NCT01473524|464500058|FG002|LTSE Phase|Death|0|||
129056924|NCT01473524|464500059|FG003|LTSE Phase|Death|0|||
129056925|NCT01473524|464500060|FG004|LTSE Phase|Death|1|||
129056926|NCT01473524|464500061|FG005|LTSE Phase|Death|0|||
129056927|NCT01473524|464500056|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
129056928|NCT01473524|464500057|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
129056929|NCT01473524|464500058|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
129056930|NCT01473524|464500059|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
129056931|NCT01473524|464500060|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
129056932|NCT01473524|464500061|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
129056933|NCT01473524|464500056|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
129056934|NCT01473524|464500057|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
129056935|NCT01473524|464500058|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
129056936|NCT01473524|464500059|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
129056937|NCT01473524|464500060|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
129056938|NCT01473524|464500061|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
129056939|NCT01473524|464500056|FG000|LTSE Phase|Lost to Follow-up|0|||
129056940|NCT01473524|464500057|FG001|LTSE Phase|Lost to Follow-up|0|||
129056941|NCT01473524|464500058|FG002|LTSE Phase|Lost to Follow-up|0|||
129056942|NCT01473524|464500059|FG003|LTSE Phase|Lost to Follow-up|1|||
129056943|NCT01473524|464500060|FG004|LTSE Phase|Lost to Follow-up|3|||
129056944|NCT01473524|464500061|FG005|LTSE Phase|Lost to Follow-up|2|||
129056945|NCT01473524|464500056|FG000|LTSE Phase|Principal Investigator Decision|0|||
129056946|NCT01473524|464500057|FG001|LTSE Phase|Principal Investigator Decision|0|||
129056947|NCT01473524|464500058|FG002|LTSE Phase|Principal Investigator Decision|0|||
129056948|NCT01473524|464500059|FG003|LTSE Phase|Principal Investigator Decision|1|||
129056949|NCT01473524|464500060|FG004|LTSE Phase|Principal Investigator Decision|1|||
129056950|NCT01473524|464500061|FG005|LTSE Phase|Principal Investigator Decision|3|||
129056951|NCT01473524|464500056|FG000|LTSE Phase|Liver Transplantation|0|||
129056952|NCT01473524|464500057|FG001|LTSE Phase|Liver Transplantation|0|||
129056953|NCT01473524|464500058|FG002|LTSE Phase|Liver Transplantation|0|||
129056954|NCT01473524|464500059|FG003|LTSE Phase|Liver Transplantation|0|||
129056955|NCT01473524|464500060|FG004|LTSE Phase|Liver Transplantation|0|||
129056956|NCT01473524|464500061|FG005|LTSE Phase|Liver Transplantation|1|||
129056957|NCT01473524|464500056|FG000|LTSE Phase|Pregnancy|0|||
129056958|NCT01473524|464500057|FG001|LTSE Phase|Pregnancy|0|||
129056959|NCT01473524|464500058|FG002|LTSE Phase|Pregnancy|0|||
129056960|NCT01473524|464500059|FG003|LTSE Phase|Pregnancy|1|||
129056961|NCT01473524|464500060|FG004|LTSE Phase|Pregnancy|0|||
129056962|NCT01473524|464500061|FG005|LTSE Phase|Pregnancy|0|||
129056963|NCT01473524|464500056|FG000|LTSE Phase|Protocol Violation|0|||
129056964|NCT01473524|464500057|FG001|LTSE Phase|Protocol Violation|0|||
129056965|NCT01473524|464500058|FG002|LTSE Phase|Protocol Violation|0|||
129056966|NCT01473524|464500059|FG003|LTSE Phase|Protocol Violation|0|||
129056967|NCT01473524|464500060|FG004|LTSE Phase|Protocol Violation|0|||
129056968|NCT01473524|464500061|FG005|LTSE Phase|Protocol Violation|1|||
129056969|NCT02383810|464500062|FG000|Overall Study|Physician Decision|1|||
129056970|NCT02383810|464500063|FG001|Overall Study|Physician Decision|1|||
129056971|NCT02383810|464500064|FG002|Overall Study|Physician Decision|0|||
129056972|NCT02383810|464500065|FG003|Overall Study|Physician Decision|0|||
129056973|NCT02383810|464500066|FG004|Overall Study|Physician Decision|0|||
129056974|NCT02383810|464500067|FG005|Overall Study|Physician Decision|0|||
129056975|NCT02383810|464500068|FG006|Overall Study|Physician Decision|0|||
129056976|NCT02383810|464500069|FG007|Overall Study|Physician Decision|0|||
129056977|NCT02383810|464500062|FG000|Overall Study|Withdrawal by Subject|2|||
129056978|NCT02383810|464500063|FG001|Overall Study|Withdrawal by Subject|3|||
129056979|NCT02383810|464500064|FG002|Overall Study|Withdrawal by Subject|3|||
129056980|NCT02383810|464500065|FG003|Overall Study|Withdrawal by Subject|3|||
129056981|NCT02383810|464500066|FG004|Overall Study|Withdrawal by Subject|0|||
129056982|NCT02383810|464500067|FG005|Overall Study|Withdrawal by Subject|0|||
129056983|NCT02383810|464500068|FG006|Overall Study|Withdrawal by Subject|0|||
129056984|NCT02383810|464500069|FG007|Overall Study|Withdrawal by Subject|0|||
129056985|NCT02383810|464500062|FG000|Overall Study|Adverse Event|0|||
129056986|NCT02383810|464500063|FG001|Overall Study|Adverse Event|2|||
129056987|NCT02383810|464500064|FG002|Overall Study|Adverse Event|4|||
129056988|NCT02383810|464500065|FG003|Overall Study|Adverse Event|5|||
129056989|NCT02383810|464500066|FG004|Overall Study|Adverse Event|0|||
129056990|NCT02383810|464500067|FG005|Overall Study|Adverse Event|1|||
129056991|NCT02383810|464500068|FG006|Overall Study|Adverse Event|1|||
129056992|NCT02383810|464500069|FG007|Overall Study|Adverse Event|0|||
129056993|NCT02383810|464500062|FG000|Overall Study|Lost to Follow-up|0|||
129056994|NCT02383810|464500063|FG001|Overall Study|Lost to Follow-up|1|||
129056995|NCT02383810|464500064|FG002|Overall Study|Lost to Follow-up|0|||
129056996|NCT02383810|464500065|FG003|Overall Study|Lost to Follow-up|1|||
129056997|NCT02383810|464500066|FG004|Overall Study|Lost to Follow-up|0|||
129056998|NCT02383810|464500067|FG005|Overall Study|Lost to Follow-up|0|||
129056999|NCT02383810|464500068|FG006|Overall Study|Lost to Follow-up|0|||
129057000|NCT02383810|464500069|FG007|Overall Study|Lost to Follow-up|0|||
129057001|NCT02383810|464500062|FG000|Overall Study|other|0|||
129057002|NCT02383810|464500063|FG001|Overall Study|other|0|||
129057003|NCT02383810|464500064|FG002|Overall Study|other|0|||
129057004|NCT02383810|464500065|FG003|Overall Study|other|2|||
129057005|NCT02383810|464500066|FG004|Overall Study|other|0|||
129057006|NCT02383810|464500067|FG005|Overall Study|other|0|||
129057007|NCT02383810|464500068|FG006|Overall Study|other|0|||
129057008|NCT02383810|464500069|FG007|Overall Study|other|0|||
129057009|NCT02383810|464500062|FG000|Overall Study|subject did not receive study treatment|0|||
129057010|NCT02383810|464500063|FG001|Overall Study|subject did not receive study treatment|1|||
129057011|NCT02383810|464500064|FG002|Overall Study|subject did not receive study treatment|0|||
129057012|NCT02383810|464500065|FG003|Overall Study|subject did not receive study treatment|0|||
129057013|NCT02383810|464500066|FG004|Overall Study|subject did not receive study treatment|0|||
129057014|NCT02383810|464500067|FG005|Overall Study|subject did not receive study treatment|0|||
129057015|NCT02383810|464500068|FG006|Overall Study|subject did not receive study treatment|0|||
129057016|NCT02383810|464500069|FG007|Overall Study|subject did not receive study treatment|0|||
129057017|NCT00282919|464500070|FG000|Overall Study|Lack of Efficacy|4|||
129057018|NCT00282919|464500070|FG000|Overall Study|Withdrawal by Subject|1|||
129057019|NCT00282919|464500070|FG000|Overall Study|Asymptomatic Parasitemia|2|||
129057020|NCT02540850|464500073|FG000|Overall Study|Lost to Follow-up|69|||
129057021|NCT02540850|464500074|FG001|Overall Study|Lost to Follow-up|66|||
129057022|NCT02540850|464500075|FG002|Overall Study|Lost to Follow-up|34|||
129057023|NCT02861014|464500076|FG000|Primary Analysis|Adverse Event|7|||
129057024|NCT02861014|464500076|FG000|Primary Analysis|Death|1|||
129057025|NCT02861014|464500076|FG000|Primary Analysis|Lack of Efficacy|3|||
129057026|NCT02861014|464500076|FG000|Primary Analysis|Physician Decision|2|||
129057027|NCT02861014|464500076|FG000|Primary Analysis|Pregnancy|4|||
129057028|NCT02861014|464500076|FG000|Primary Analysis|Protocol Violation|2|||
129057029|NCT02861014|464500076|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
129057030|NCT02861014|464500076|FG000|Primary Analysis|Withdrawal by Subject|14|||
129057031|NCT02861014|464500076|FG000|Primary Analysis|Commercial ocrelizumab|3|||
129057032|NCT02861014|464500076|FG000|Safety Follow-up|Adverse Event|1|||
129057033|NCT02861014|464500076|FG000|Safety Follow-up|Pregnancy|1|||
129057034|NCT02861014|464500076|FG000|Safety Follow-up|Withdrawal by Subject|9|||
129057035|NCT02861014|464500076|FG000|Safety Follow-up|Study terminated by sponsor|1|||
129057036|NCT02861014|464500076|FG000|Safety Follow-up|Physician Decision|1|||
129057037|NCT02861014|464500076|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
129057038|NCT02861014|464500076|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
129057039|NCT00926783|464500077|FG000|Overall Study|Incomplete CFAE Procedures|3|||
129057040|NCT00926783|464500078|FG001|Overall Study|Incomplete CFAE Procedures|3|||
128720094|NCT01549964|463273332|FG002|24-Week Treatment Period|Other|1|||
128720095|NCT01549964|463273333|FG003|24-Week Treatment Period|Other|0|||
129057041|NCT02549027|464500080|FG000|Washout After Period 4|Withdrawal by Subject|0|||
129057042|NCT02549027|464500081|FG001|Washout After Period 4|Withdrawal by Subject|1|||
129057043|NCT02549027|464500082|FG002|Washout After Period 4|Withdrawal by Subject|1|||
129057044|NCT02549027|464500083|FG003|Washout After Period 4|Withdrawal by Subject|1|||
129057045|NCT02549027|464500084|FG004|Washout After Period 4|Withdrawal by Subject|0|||
129057046|NCT02549027|464500085|FG005|Washout After Period 4|Withdrawal by Subject|0|||
129057047|NCT02549027|464500080|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129057048|NCT02549027|464500081|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129057049|NCT02549027|464500082|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129057050|NCT02549027|464500083|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129137129|NCT01292473|464794526|FG002|Overall Study|Disease Progression|3|||
129137130|NCT01292473|464794527|FG003|Overall Study|Disease Progression|6|||
129137131|NCT02123511|464794532|FG000|Overall Study|Cancelled treatment|1|||
129137132|NCT02123511|464794533|FG001|Overall Study|Cancelled treatment|0|||
129137133|NCT02123511|464794532|FG000|Overall Study|Incomplete data|1|||
129137134|NCT02123511|464794533|FG001|Overall Study|Incomplete data|3|||
129137135|NCT02123511|464794532|FG000|Overall Study|Ineligible|0|||
129137136|NCT02123511|464794533|FG001|Overall Study|Ineligible|1|||
129137137|NCT04821245|464794534|FG000|Overall Study|Withdrawal by Subject|3|||
129137138|NCT04821245|464794534|FG000|Overall Study|Physician Decision|1|||
129137139|NCT04821245|464794534|FG000|Overall Study|Protocol Violation|5|||
129137140|NCT00458705|464794535|FG000|Overall Study|Adverse Event|4|||
129057051|NCT02549027|464500084|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
129057052|NCT02549027|464500085|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129057053|NCT02186834|464500086|FG000|Dose Escalation|Death|0|||
129057054|NCT02186834|464500087|FG001|Dose Escalation|Death|0|||
129057055|NCT02186834|464500088|FG002|Dose Escalation|Death|0|||
129057056|NCT02186834|464500089|FG003|Dose Escalation|Death|1|||
129057057|NCT02186834|464500090|FG004|Dose Escalation|Death|0|||
129057058|NCT02186834|464500091|FG005|Dose Escalation|Death|0|||
129057059|NCT02186834|464500086|FG000|Treatment at RP2D|Died prior to treatment|0|||
129057060|NCT02186834|464500087|FG001|Treatment at RP2D|Died prior to treatment|0|||
129057061|NCT02186834|464500088|FG002|Treatment at RP2D|Died prior to treatment|0|||
129057062|NCT02186834|464500089|FG003|Treatment at RP2D|Died prior to treatment|0|||
129057063|NCT02186834|464500090|FG004|Treatment at RP2D|Died prior to treatment|0|||
129057064|NCT02186834|464500091|FG005|Treatment at RP2D|Died prior to treatment|1|||
129057065|NCT01421511|464500097|FG000|Overall Study|Lost to Follow-up|11|||
129057066|NCT01421511|464500098|FG001|Overall Study|Lost to Follow-up|14|||
129057067|NCT01421511|464500097|FG000|Overall Study|Randomized but didn't receive study drug|1|||
129057068|NCT01421511|464500098|FG001|Overall Study|Randomized but didn't receive study drug|7|||
129057069|NCT01421511|464500097|FG000|Overall Study|Physician Decision|0|||
129057070|NCT01421511|464500098|FG001|Overall Study|Physician Decision|1|||
129057071|NCT01421511|464500097|FG000|Overall Study|Withdrawal by Subject|6|||
129057072|NCT01421511|464500098|FG001|Overall Study|Withdrawal by Subject|5|||
129057073|NCT01421511|464500097|FG000|Overall Study|Death|1|||
129057074|NCT01421511|464500098|FG001|Overall Study|Death|1|||
129057075|NCT00749892|464500099|FG000|Overall Study|Withdrawal by Subject|3|||
129057076|NCT04581369|464500100|FG000|Overall Study|Death|7|||
129057077|NCT04581369|464500101|FG001|Overall Study|Death|6|||
129057078|NCT04581369|464500102|FG002|Overall Study|Death|0|||
129057079|NCT04581369|464500100|FG000|Overall Study|Lost to Follow-up|7|||
129057080|NCT04581369|464500101|FG001|Overall Study|Lost to Follow-up|3|||
129057081|NCT04581369|464500102|FG002|Overall Study|Lost to Follow-up|0|||
129057082|NCT04581369|464500100|FG000|Overall Study|liver transplant|2|||
129057083|NCT04581369|464500101|FG001|Overall Study|liver transplant|2|||
129057084|NCT04581369|464500102|FG002|Overall Study|liver transplant|0|||
129057085|NCT04581369|464500100|FG000|Overall Study|transitioned to hospice care|0|||
129057086|NCT04581369|464500101|FG001|Overall Study|transitioned to hospice care|5|||
129057087|NCT04581369|464500102|FG002|Overall Study|transitioned to hospice care|0|||
129057088|NCT00780910|464500103|FG000|Overall Study|Adverse Event|2|||
129057089|NCT01111825|464500104|FG000|Overall Study|Withdrawal by Subject|0|||
129057090|NCT01111825|464500105|FG001|Overall Study|Withdrawal by Subject|0|||
129057091|NCT01111825|464500106|FG002|Overall Study|Withdrawal by Subject|1|||
129057092|NCT01111825|464500107|FG003|Overall Study|Withdrawal by Subject|0|||
129057093|NCT01111825|464500104|FG000|Overall Study|Lost to Follow-up|0|||
129057094|NCT01111825|464500105|FG001|Overall Study|Lost to Follow-up|0|||
129057095|NCT01111825|464500106|FG002|Overall Study|Lost to Follow-up|3|||
129057096|NCT01111825|464500107|FG003|Overall Study|Lost to Follow-up|1|||
129057097|NCT01111825|464500104|FG000|Overall Study|Adverse Event|2|||
129057098|NCT01111825|464500105|FG001|Overall Study|Adverse Event|1|||
129057099|NCT01111825|464500106|FG002|Overall Study|Adverse Event|4|||
129057100|NCT01111825|464500107|FG003|Overall Study|Adverse Event|0|||
129057101|NCT01111825|464500104|FG000|Overall Study|Disease Progression|1|||
129057102|NCT01111825|464500105|FG001|Overall Study|Disease Progression|0|||
129057103|NCT01111825|464500106|FG002|Overall Study|Disease Progression|0|||
129057104|NCT01111825|464500107|FG003|Overall Study|Disease Progression|0|||
129057105|NCT01111825|464500104|FG000|Overall Study|Discontinuation by Sponsor|0|||
129057106|NCT01111825|464500105|FG001|Overall Study|Discontinuation by Sponsor|0|||
129057107|NCT01111825|464500106|FG002|Overall Study|Discontinuation by Sponsor|0|||
129057108|NCT01111825|464500107|FG003|Overall Study|Discontinuation by Sponsor|20|||
129057109|NCT01352416|464500116|FG000|Overall Study|Physician Decision|1|||
129057110|NCT01352416|464500117|FG001|Overall Study|Physician Decision|2|||
129057111|NCT01352416|464500118|FG002|Overall Study|Physician Decision|2|||
128775534|NCT01474512|463468361|FG004|Post-Treatment Follow-Up|Death|0|||
129057112|NCT01352416|464500119|FG003|Overall Study|Physician Decision|1|||
129057113|NCT00811928|464500124|FG000|Overall Study|AEs and SAEs Including Death|7|||
129057114|NCT00811928|464500125|FG001|Overall Study|AEs and SAEs Including Death|11|||
129057115|NCT00811928|464500124|FG000|Overall Study|Withdrawal by Subject|18|||
129057116|NCT00811928|464500125|FG001|Overall Study|Withdrawal by Subject|12|||
129057117|NCT00811928|464500124|FG000|Overall Study|Did Not Take Study Drug|3|||
129057118|NCT00811928|464500125|FG001|Overall Study|Did Not Take Study Drug|0|||
129057119|NCT00811928|464500124|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
129057120|NCT00811928|464500125|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
129057121|NCT00811928|464500124|FG000|Overall Study|Investigator Decision|2|||
129057122|NCT00811928|464500125|FG001|Overall Study|Investigator Decision|1|||
129057123|NCT00811928|464500124|FG000|Overall Study|Poor Compliance|2|||
129057124|NCT00811928|464500125|FG001|Overall Study|Poor Compliance|5|||
129057125|NCT00171951|464500126|FG000|Overall Study|Adverse Event|1|||
129057126|NCT00171951|464500126|FG000|Overall Study|Abnormal Laboratory Values|2|||
129057127|NCT00171951|464500126|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129057128|NCT00171951|464500126|FG000|Overall Study|Participants Withdrew Consent|3|||
128775535|NCT01474512|463468362|FG005|Post-Treatment Follow-Up|Death|0|||
128775536|NCT01474512|463468363|FG006|Post-Treatment Follow-Up|Death|0|||
128775537|NCT01474512|463468364|FG007|Post-Treatment Follow-Up|Death|0|||
128775538|NCT01474512|463468365|FG008|Post-Treatment Follow-Up|Death|0|||
128775539|NCT01474512|463468366|FG009|Post-Treatment Follow-Up|Death|0|||
129057129|NCT00171951|464500126|FG000|Overall Study|New Cancer Therapy|5|||
129057130|NCT00171951|464500126|FG000|Overall Study|Reason not Specified|2|||
129057131|NCT00396812|464500127|FG000|Overall Study|Physician Decision|1|||
129057132|NCT00233402|464500128|FG000|Overall Study|No pathology data|12|||
129057133|NCT00233402|464500129|FG001|Overall Study|No pathology data|9|||
129057134|NCT00233402|464500128|FG000|Overall Study|No Ta/T1|89|||
129057135|NCT00233402|464500129|FG001|Overall Study|No Ta/T1|94|||
129057136|NCT00233402|464500128|FG000|Overall Study|Lost to follow up etc|3|||
129057137|NCT00233402|464500129|FG001|Overall Study|Lost to follow up etc|21|||
129057138|NCT02087189|464500132|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
129057139|NCT01189487|464500137|FG000|Overall Study|Lack of Efficacy|2|||
129057140|NCT01189487|464500137|FG000|Overall Study|Adverse Event|1|||
129057141|NCT04630158|464500138|FG000|Overall Study|Adverse Event|1|||
129057142|NCT04630158|464500139|FG001|Overall Study|Adverse Event|1|||
129057143|NCT04630158|464500140|FG002|Overall Study|Adverse Event|1|||
129057144|NCT04630158|464500138|FG000|Overall Study|Physician Decision|0|||
129057145|NCT04630158|464500139|FG001|Overall Study|Physician Decision|2|||
129057146|NCT04630158|464500140|FG002|Overall Study|Physician Decision|0|||
129057147|NCT04630158|464500138|FG000|Overall Study|Protocol Violation|1|||
129057148|NCT04630158|464500139|FG001|Overall Study|Protocol Violation|0|||
129057149|NCT04630158|464500140|FG002|Overall Study|Protocol Violation|1|||
129057150|NCT04630158|464500138|FG000|Overall Study|Withdrawal by Subject|2|||
129057151|NCT04630158|464500139|FG001|Overall Study|Withdrawal by Subject|1|||
129057152|NCT04630158|464500140|FG002|Overall Study|Withdrawal by Subject|2|||
129057153|NCT03136965|464500146|FG000|Overall Study|Lost to Follow-up|0|||
129057154|NCT03136965|464500147|FG001|Overall Study|Lost to Follow-up|1|||
129057155|NCT03136965|464500148|FG002|Overall Study|Lost to Follow-up|0|||
129057156|NCT04868968|464500149|FG000|Overall Study|Lost to Follow-up|1|||
129057157|NCT03553576|464500152|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
129057158|NCT03553576|464500153|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
129057159|NCT03553576|464500152|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
129057160|NCT03553576|464500153|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
129057161|NCT03553576|464500152|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
129057162|NCT03553576|464500153|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
129057163|NCT03553576|464500152|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
129057164|NCT03553576|464500153|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
129057165|NCT03553576|464500152|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
129057166|NCT03553576|464500153|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
129057167|NCT03553576|464500152|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
129057168|NCT03553576|464500153|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
129057169|NCT03553576|464500152|FG000|Overall Study|Physician Decision|2|||
129057170|NCT03553576|464500153|FG001|Overall Study|Physician Decision|5|||
129057171|NCT05038800|464500155|FG000|Overall Study|Death|1|||
129057172|NCT05038800|464500156|FG001|Overall Study|Death|1|||
129057173|NCT05038800|464500157|FG002|Overall Study|Death|5|||
129057174|NCT05038800|464500158|FG003|Overall Study|Death|3|||
129057175|NCT05038800|464500159|FG004|Overall Study|Death|1|||
129057176|NCT05038800|464500155|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129137141|NCT00458705|464794535|FG000|Overall Study|Not Treated|1|||
129137142|NCT00604383|464794540|FG000|Overall Study|Withdrawal by Subject|33|||
129137143|NCT00604383|464794541|FG001|Overall Study|Withdrawal by Subject|31|||
129137144|NCT00604383|464794540|FG000|Overall Study|Lost to Follow-up|24|||
129137145|NCT00604383|464794541|FG001|Overall Study|Lost to Follow-up|19|||
129137146|NCT00604383|464794540|FG000|Overall Study|Death|14|||
129137147|NCT00604383|464794541|FG001|Overall Study|Death|22|||
128775540|NCT01474512|463468367|FG010|Post-Treatment Follow-Up|Death|0|||
128775541|NCT01474512|463468368|FG011|Post-Treatment Follow-Up|Death|0|||
129057177|NCT05038800|464500156|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129057178|NCT05038800|464500157|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129057179|NCT05038800|464500158|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129057180|NCT05038800|464500159|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129057181|NCT05038800|464500155|FG000|Overall Study|Lack of Efficacy|0|||
129057182|NCT05038800|464500156|FG001|Overall Study|Lack of Efficacy|0|||
129057183|NCT05038800|464500157|FG002|Overall Study|Lack of Efficacy|0|||
129057184|NCT05038800|464500158|FG003|Overall Study|Lack of Efficacy|0|||
129137148|NCT00604383|464794540|FG000|Overall Study|Adverse Event|16|||
129057185|NCT05038800|464500159|FG004|Overall Study|Lack of Efficacy|1|||
129057186|NCT01104792|464500160|FG000|Overall Study|Adverse Event|77|||
129057187|NCT01104792|464500160|FG000|Overall Study|Insufficient Therapeutic Response|22|||
129057188|NCT01104792|464500160|FG000|Overall Study|Protocol Violation|45|||
129057189|NCT01104792|464500160|FG000|Overall Study|Withdrawal of Consent|179|||
129057190|NCT01104792|464500160|FG000|Overall Study|Lost to Follow-up|43|||
129057191|NCT01104792|464500160|FG000|Overall Study|Reasons Not Specified|27|||
129057192|NCT01104792|464500160|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
129057193|NCT00658021|464500162|FG000|28-Week Treatment Period|Adverse Event|3|||
129057194|NCT00658021|464500163|FG001|28-Week Treatment Period|Adverse Event|1|||
129057195|NCT00658021|464500164|FG002|28-Week Treatment Period|Adverse Event|0|||
129057196|NCT00658021|464500162|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
129057197|NCT00658021|464500163|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
129057198|NCT00658021|464500164|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
129057199|NCT00658021|464500162|FG000|28-Week Treatment Period|Protocol Violation|0|||
129057200|NCT00658021|464500163|FG001|28-Week Treatment Period|Protocol Violation|2|||
129057201|NCT00658021|464500164|FG002|28-Week Treatment Period|Protocol Violation|1|||
129057202|NCT00658021|464500162|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
129057203|NCT00658021|464500163|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
129057204|NCT00658021|464500164|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
129057205|NCT00658021|464500162|FG000|28-Week Treatment Period|Physician Decision|1|||
129057206|NCT00658021|464500163|FG001|28-Week Treatment Period|Physician Decision|2|||
129057207|NCT00658021|464500164|FG002|28-Week Treatment Period|Physician Decision|1|||
129057208|NCT00658021|464500162|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
129057209|NCT00658021|464500163|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
129057210|NCT00658021|464500164|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
129057211|NCT00658021|464500162|FG000|28-Week Treatment Period|Loss of glucose control|1|||
129057212|NCT00658021|464500163|FG001|28-Week Treatment Period|Loss of glucose control|1|||
129057213|NCT00658021|464500164|FG002|28-Week Treatment Period|Loss of glucose control|10|||
129057214|NCT00658021|464500162|FG000|28-Week Treatment Period|Other|2|||
129057215|NCT00658021|464500163|FG001|28-Week Treatment Period|Other|3|||
129057216|NCT00658021|464500164|FG002|28-Week Treatment Period|Other|1|||
129057217|NCT00658021|464500162|FG000|28-Week Treatment Period|Did not receive treatment|2|||
129057218|NCT00658021|464500163|FG001|28-Week Treatment Period|Did not receive treatment|0|||
129057219|NCT00658021|464500164|FG002|28-Week Treatment Period|Did not receive treatment|0|||
129057220|NCT00658021|464500162|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
129057221|NCT00658021|464500163|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
129057222|NCT00658021|464500164|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
129057223|NCT00658021|464500162|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
129057224|NCT00658021|464500163|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
129057225|NCT00658021|464500164|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
129057226|NCT04123561|464500173|FG000|Overall Study|Lost to Follow-up|20|||
129057227|NCT04123561|464500174|FG001|Overall Study|Lost to Follow-up|12|||
129057228|NCT04123561|464500175|FG002|Overall Study|Lost to Follow-up|5|||
129057229|NCT04123561|464500173|FG000|Overall Study|Withdrawal by Subject|9|||
129057230|NCT04123561|464500174|FG001|Overall Study|Withdrawal by Subject|7|||
129057231|NCT04123561|464500175|FG002|Overall Study|Withdrawal by Subject|9|||
129057232|NCT04123561|464500173|FG000|Overall Study|Lack of Efficacy|7|||
129057233|NCT04123561|464500174|FG001|Overall Study|Lack of Efficacy|8|||
129057234|NCT04123561|464500175|FG002|Overall Study|Lack of Efficacy|6|||
129057235|NCT04123561|464500173|FG000|Overall Study|Adverse Event|5|||
129057236|NCT04123561|464500174|FG001|Overall Study|Adverse Event|2|||
129057237|NCT04123561|464500175|FG002|Overall Study|Adverse Event|3|||
129057238|NCT04123561|464500173|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
129057239|NCT04123561|464500174|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
129057240|NCT04123561|464500175|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
129057241|NCT04123561|464500173|FG000|Overall Study|Death|0|||
129057242|NCT04123561|464500174|FG001|Overall Study|Death|0|||
129057243|NCT04123561|464500175|FG002|Overall Study|Death|1|||
129057244|NCT04123561|464500173|FG000|Overall Study|Protocol Violation|0|||
129057245|NCT04123561|464500174|FG001|Overall Study|Protocol Violation|1|||
129057246|NCT04123561|464500175|FG002|Overall Study|Protocol Violation|0|||
129137149|NCT00604383|464794541|FG001|Overall Study|Adverse Event|9|||
129057247|NCT00278889|464500186|FG000|Overall Study|Withdrawal by Subject|0|||
129057248|NCT00278889|464500187|FG001|Overall Study|Withdrawal by Subject|5|||
129057249|NCT00278889|464500188|FG002|Overall Study|Withdrawal by Subject|3|||
129057250|NCT00278889|464500186|FG000|Overall Study|Lost to Follow-up|1|||
129057251|NCT00278889|464500187|FG001|Overall Study|Lost to Follow-up|1|||
129057252|NCT00278889|464500188|FG002|Overall Study|Lost to Follow-up|0|||
129057253|NCT00278889|464500186|FG000|Overall Study|Death|24|||
129057254|NCT00278889|464500187|FG001|Overall Study|Death|21|||
129057255|NCT00278889|464500188|FG002|Overall Study|Death|17|||
129057256|NCT03462459|464500189|FG000|Overall Study|Death|1|||
129057257|NCT03462459|464500190|FG001|Overall Study|Death|0|||
129057258|NCT03462459|464500189|FG000|Overall Study|Lack of Efficacy|2|||
129057259|NCT03462459|464500190|FG001|Overall Study|Lack of Efficacy|4|||
129057260|NCT03462459|464500189|FG000|Overall Study|Lost to Follow-up|1|||
129057261|NCT03462459|464500190|FG001|Overall Study|Lost to Follow-up|3|||
129057262|NCT03462459|464500189|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
129057263|NCT03462459|464500190|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
129057264|NCT03462459|464500189|FG000|Overall Study|Withdrawal by Subject|3|||
129057265|NCT03462459|464500190|FG001|Overall Study|Withdrawal by Subject|2|||
129057266|NCT03462459|464500189|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
129057267|NCT03462459|464500190|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
129057268|NCT04042376|464500192|FG000|Overall Study|Withdrawal by Subject|1|||
129057269|NCT04042376|464500192|FG000|Overall Study|Death|3|||
129057270|NCT00270855|464501688|FG000|Overall Study|Withdrawal by Subject|8|||
129057271|NCT00270855|464501689|FG001|Overall Study|Withdrawal by Subject|8|||
129057272|NCT01396512|464501692|FG000|Overall Study|Withdrawal by Subject|0|||
129057273|NCT01396512|464501693|FG001|Overall Study|Withdrawal by Subject|1|||
129057274|NCT02755649|464501694|FG000|Overall Study|Transitioned into OLE study|99|||
129057275|NCT02755649|464501695|FG001|Overall Study|Transitioned into OLE study|98|||
129057276|NCT02755649|464501696|FG002|Overall Study|Transitioned into OLE study|100|||
129057277|NCT02755649|464501694|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
129057278|NCT02755649|464501695|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
129057279|NCT02755649|464501696|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
129057280|NCT02755649|464501694|FG000|Overall Study|Physician Decision|0|||
129057281|NCT02755649|464501695|FG001|Overall Study|Physician Decision|0|||
129057282|NCT02755649|464501696|FG002|Overall Study|Physician Decision|2|||
129057283|NCT02755649|464501694|FG000|Overall Study|Withdrawal by Subject|0|||
129057284|NCT02755649|464501695|FG001|Overall Study|Withdrawal by Subject|1|||
128720096|NCT01549964|463273330|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129057285|NCT02755649|464501696|FG002|Overall Study|Withdrawal by Subject|0|||
129057286|NCT02755649|464501694|FG000|Overall Study|Undecided|1|||
128720097|NCT01549964|463273331|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
128775542|NCT01474512|463468369|FG012|Post-Treatment Follow-Up|Death|0|||
129057287|NCT02755649|464501695|FG001|Overall Study|Undecided|0|||
129057288|NCT02755649|464501696|FG002|Overall Study|Undecided|0|||
129057289|NCT02152605|464501697|FG000|Overall Study|Adverse Event|6|||
129057290|NCT02152605|464501698|FG001|Overall Study|Adverse Event|8|||
129057291|NCT02152605|464501697|FG000|Overall Study|Lack of Efficacy|7|||
129057292|NCT02152605|464501698|FG001|Overall Study|Lack of Efficacy|4|||
129057293|NCT02152605|464501697|FG000|Overall Study|Protocol deviation|1|||
129057294|NCT02152605|464501698|FG001|Overall Study|Protocol deviation|4|||
129057295|NCT02152605|464501697|FG000|Overall Study|Lost to Follow-up|1|||
129057296|NCT02152605|464501698|FG001|Overall Study|Lost to Follow-up|0|||
129057297|NCT02152605|464501697|FG000|Overall Study|Withdrew consent|4|||
129057298|NCT02152605|464501698|FG001|Overall Study|Withdrew consent|2|||
129057299|NCT03301649|464501699|FG000|Overall Study|Need alternate therapy due to live lice|17|||
129057300|NCT03301649|464501700|FG001|Overall Study|Need alternate therapy due to live lice|25|||
129057301|NCT03301649|464501701|FG002|Overall Study|Need alternate therapy due to live lice|81|||
129057302|NCT03301649|464501699|FG000|Overall Study|Lost to Follow-up|11|||
129057303|NCT03301649|464501700|FG001|Overall Study|Lost to Follow-up|11|||
129057304|NCT03301649|464501701|FG002|Overall Study|Lost to Follow-up|3|||
129057305|NCT03301649|464501699|FG000|Overall Study|Protocol Violation|0|||
129057306|NCT03301649|464501700|FG001|Overall Study|Protocol Violation|1|||
129057307|NCT03301649|464501701|FG002|Overall Study|Protocol Violation|1|||
129057308|NCT03301649|464501699|FG000|Overall Study|Withdrawal by Subject|10|||
129057309|NCT03301649|464501700|FG001|Overall Study|Withdrawal by Subject|4|||
129057310|NCT03301649|464501701|FG002|Overall Study|Withdrawal by Subject|0|||
129057311|NCT03301649|464501699|FG000|Overall Study|Other than specified|5|||
129057312|NCT03301649|464501700|FG001|Overall Study|Other than specified|3|||
129057313|NCT03301649|464501701|FG002|Overall Study|Other than specified|0|||
129057314|NCT01564537|464501702|FG000|Overall Study|Site Terminated by Sponsor|1|||
129057315|NCT01564537|464501703|FG001|Overall Study|Site Terminated by Sponsor|0|||
129057316|NCT01564537|464501702|FG000|Overall Study|Withdrawal by Subject|12|||
129057317|NCT01564537|464501703|FG001|Overall Study|Withdrawal by Subject|14|||
129137150|NCT00604383|464794540|FG000|Overall Study|Physician Decision|0|||
129137151|NCT00604383|464794541|FG001|Overall Study|Physician Decision|3|||
129057318|NCT01564537|464501702|FG000|Overall Study|Lost to Follow-up|7|||
129057319|NCT01564537|464501703|FG001|Overall Study|Lost to Follow-up|3|||
129057320|NCT01564537|464501702|FG000|Overall Study|Reason not specified|81|||
129137152|NCT01122680|464794544|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
129057321|NCT01564537|464501703|FG001|Overall Study|Reason not specified|82|||
129057322|NCT00837473|464501704|FG000|Overall Study|Lost to Follow-up|1|||
129057323|NCT00837473|464501704|FG000|Overall Study|Withdrawal by Subject|2|||
129057324|NCT01635218|464501705|FG000|Overall Study|Lost to Follow-up|3|||
129057325|NCT01635218|464501706|FG001|Overall Study|Lost to Follow-up|7|||
129057326|NCT01635218|464501707|FG002|Overall Study|Lost to Follow-up|6|||
129057327|NCT03559400|464501708|FG000|Overall Study|Lost to Follow-up|9|||
129057328|NCT03559400|464501709|FG001|Overall Study|Lost to Follow-up|7|||
129057329|NCT03559400|464501708|FG000|Overall Study|Death|0|||
129057330|NCT03559400|464501709|FG001|Overall Study|Death|2|||
129057331|NCT03262038|464501710|FG000|Overall Study|Withdrawal by Subject|0|||
129057332|NCT03262038|464501711|FG001|Overall Study|Withdrawal by Subject|1|||
129057333|NCT04933968|464501712|FG000|Overall Study|Adverse Event|0|||
129057334|NCT04933968|464501713|FG001|Overall Study|Adverse Event|0|||
129057335|NCT04933968|464501714|FG002|Overall Study|Adverse Event|1|||
129057336|NCT04933968|464501715|FG003|Overall Study|Adverse Event|1|||
129057337|NCT04933968|464501716|FG004|Overall Study|Adverse Event|0|||
129057338|NCT04933968|464501717|FG005|Overall Study|Adverse Event|0|||
129057339|NCT04933968|464501712|FG000|Overall Study|Lost to Follow-up|1|||
129057340|NCT04933968|464501713|FG001|Overall Study|Lost to Follow-up|0|||
129057341|NCT04933968|464501714|FG002|Overall Study|Lost to Follow-up|1|||
129057342|NCT04933968|464501715|FG003|Overall Study|Lost to Follow-up|0|||
129057343|NCT04933968|464501716|FG004|Overall Study|Lost to Follow-up|0|||
129057344|NCT04933968|464501717|FG005|Overall Study|Lost to Follow-up|0|||
129057345|NCT04933968|464501712|FG000|Overall Study|Randomized not treated|1|||
129057346|NCT04933968|464501713|FG001|Overall Study|Randomized not treated|0|||
129057347|NCT04933968|464501714|FG002|Overall Study|Randomized not treated|0|||
129057348|NCT04933968|464501715|FG003|Overall Study|Randomized not treated|0|||
129057349|NCT04933968|464501716|FG004|Overall Study|Randomized not treated|0|||
129057350|NCT04933968|464501717|FG005|Overall Study|Randomized not treated|0|||
129057351|NCT04933968|464501712|FG000|Overall Study|Sponsor terminated study|0|||
129057352|NCT04933968|464501713|FG001|Overall Study|Sponsor terminated study|0|||
129057353|NCT04933968|464501714|FG002|Overall Study|Sponsor terminated study|0|||
129057354|NCT04933968|464501715|FG003|Overall Study|Sponsor terminated study|1|||
129057355|NCT04933968|464501716|FG004|Overall Study|Sponsor terminated study|2|||
129057356|NCT04933968|464501717|FG005|Overall Study|Sponsor terminated study|0|||
129057357|NCT04933968|464501712|FG000|Overall Study|Other|0|||
129057358|NCT04933968|464501713|FG001|Overall Study|Other|0|||
129057359|NCT04933968|464501714|FG002|Overall Study|Other|0|||
129057360|NCT04933968|464501715|FG003|Overall Study|Other|1|||
129057361|NCT04933968|464501716|FG004|Overall Study|Other|0|||
129057362|NCT04933968|464501717|FG005|Overall Study|Other|0|||
129057363|NCT04933968|464501712|FG000|Overall Study|Missing|1|||
129057364|NCT04933968|464501713|FG001|Overall Study|Missing|3|||
129057365|NCT04933968|464501714|FG002|Overall Study|Missing|2|||
129057366|NCT04933968|464501715|FG003|Overall Study|Missing|1|||
129057367|NCT04933968|464501716|FG004|Overall Study|Missing|1|||
129057368|NCT04933968|464501717|FG005|Overall Study|Missing|0|||
129057369|NCT01724489|464501718|FG000|Overall Study|Adverse Event|8|||
129057370|NCT01724489|464501719|FG001|Overall Study|Adverse Event|3|||
129057371|NCT01724489|464501718|FG000|Overall Study|Surgery, medication|1|||
129057372|NCT01724489|464501719|FG001|Overall Study|Surgery, medication|1|||
129057373|NCT01724489|464501718|FG000|Overall Study|Lost to Follow-up|1|||
129057374|NCT01724489|464501719|FG001|Overall Study|Lost to Follow-up|2|||
129057375|NCT01724489|464501718|FG000|Overall Study|Withdrawal by Subject|6|||
129057376|NCT01724489|464501719|FG001|Overall Study|Withdrawal by Subject|6|||
129057377|NCT04576923|464501720|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
129057378|NCT02679235|464501723|FG000|Overall Study|Withdrawal by Subject|3|||
129057379|NCT02679235|464501723|FG000|Overall Study|Adverse Event|1|||
129057380|NCT00923273|464501724|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129057381|NCT00923273|464501725|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129057382|NCT00923273|464501726|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129057383|NCT00923273|464501727|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
129057384|NCT00923273|464501728|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129057385|NCT00923273|464501724|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129057386|NCT00923273|464501725|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129057387|NCT00923273|464501726|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129057388|NCT00923273|464501727|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
129057389|NCT00923273|464501728|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129057390|NCT00094861|464501729|FG000|Overall Study|Adverse Event|5|||
129057391|NCT00094861|464501730|FG001|Overall Study|Adverse Event|2|||
129057392|NCT00094861|464501729|FG000|Overall Study|Withdrawal by Subject|5|||
129057393|NCT00094861|464501730|FG001|Overall Study|Withdrawal by Subject|3|||
129057394|NCT00094861|464501729|FG000|Overall Study|Physician Decision|1|||
129057395|NCT00094861|464501730|FG001|Overall Study|Physician Decision|1|||
129057396|NCT00094861|464501729|FG000|Overall Study|Lost to Follow-up|0|||
129057397|NCT00094861|464501730|FG001|Overall Study|Lost to Follow-up|1|||
129057398|NCT00094861|464501729|FG000|Overall Study|Death|4|||
129057399|NCT00094861|464501730|FG001|Overall Study|Death|2|||
129057400|NCT00094861|464501729|FG000|Overall Study|Other|3|||
129057401|NCT00094861|464501730|FG001|Overall Study|Other|0|||
129057402|NCT00509366|464501731|FG000|Overall Study|Not Treated (Screen Failure)|1|||
129057403|NCT00509366|464501732|FG001|Overall Study|Not Treated (Screen Failure)|1|||
129057404|NCT00509366|464501733|FG002|Overall Study|Not Treated (Screen Failure)|1|||
129057405|NCT00509366|464501734|FG003|Overall Study|Not Treated (Screen Failure)|0|||
129057406|NCT00509366|464501735|FG004|Overall Study|Not Treated (Screen Failure)|0|||
129057407|NCT01377987|464501742|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
129057408|NCT01377987|464501743|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
129057409|NCT02552303|464501746|FG000|Allocation|Withdrawal by Subject|2|||
129057410|NCT02552303|464501747|FG001|Allocation|Withdrawal by Subject|1|||
129057411|NCT02552303|464501748|FG002|Allocation|Withdrawal by Subject|1|||
129057412|NCT02552303|464501749|FG003|Allocation|Withdrawal by Subject|1|||
129057413|NCT02552303|464501746|FG000|Allocation|ineligible|1|||
129057414|NCT02552303|464501747|FG001|Allocation|ineligible|1|||
129057415|NCT02552303|464501748|FG002|Allocation|ineligible|0|||
129057416|NCT02552303|464501749|FG003|Allocation|ineligible|0|||
129057417|NCT02552303|464501746|FG000|Follow-Up|Lost to Follow-up|0|||
129057418|NCT02552303|464501747|FG001|Follow-Up|Lost to Follow-up|0|||
129057419|NCT02552303|464501748|FG002|Follow-Up|Lost to Follow-up|1|||
129057420|NCT02552303|464501749|FG003|Follow-Up|Lost to Follow-up|0|||
129057421|NCT02552303|464501746|FG000|Follow-Up|ineligible|0|||
129057422|NCT02552303|464501747|FG001|Follow-Up|ineligible|2|||
129057423|NCT02552303|464501748|FG002|Follow-Up|ineligible|0|||
129057424|NCT02552303|464501749|FG003|Follow-Up|ineligible|0|||
129057425|NCT00741286|464501756|FG000|Overall Study|Lost to Follow-up|15|||
129057426|NCT00741286|464501757|FG001|Overall Study|Lost to Follow-up|10|||
129057427|NCT00741286|464501756|FG000|Overall Study|Adverse Event|1|||
129057428|NCT00741286|464501757|FG001|Overall Study|Adverse Event|6|||
129057429|NCT00741286|464501756|FG000|Overall Study|Protocol Violation|3|||
129057430|NCT00741286|464501757|FG001|Overall Study|Protocol Violation|2|||
129057431|NCT00741286|464501756|FG000|Overall Study|Primary Outcome|1|||
129057432|NCT00741286|464501757|FG001|Overall Study|Primary Outcome|1|||
129057433|NCT01831258|464501758|FG000|Overall Study|Withdrawal by Subject|2|||
129057434|NCT01831258|464501759|FG001|Overall Study|Withdrawal by Subject|1|||
129057435|NCT01831258|464501758|FG000|Overall Study|Lost to Follow-up|3|||
129057436|NCT01831258|464501759|FG001|Overall Study|Lost to Follow-up|2|||
129057437|NCT00253448|464501762|FG000|Overall Study|Withdrawal by Subject|1|||
129057438|NCT02564887|464501763|FG000|Overall Study|Lost to Follow-up|6|||
129057439|NCT02564887|464501764|FG001|Overall Study|Lost to Follow-up|0|||
129057440|NCT01851330|464501765|FG000|Overall Study|Lack of Efficacy|10|||
129057441|NCT01851330|464501766|FG001|Overall Study|Lack of Efficacy|9|||
129057442|NCT01851330|464501767|FG002|Overall Study|Lack of Efficacy|2|||
129057443|NCT01851330|464501765|FG000|Overall Study|Lost to Follow-up|1|||
129057444|NCT01851330|464501766|FG001|Overall Study|Lost to Follow-up|6|||
129057445|NCT01851330|464501767|FG002|Overall Study|Lost to Follow-up|9|||
129057446|NCT01851330|464501765|FG000|Overall Study|Withdrew Consent|2|||
129057447|NCT01851330|464501766|FG001|Overall Study|Withdrew Consent|1|||
129057448|NCT01851330|464501767|FG002|Overall Study|Withdrew Consent|0|||
129057449|NCT01851330|464501765|FG000|Overall Study|Investigator's Discretion|0|||
129057450|NCT01851330|464501766|FG001|Overall Study|Investigator's Discretion|0|||
129057451|NCT01851330|464501767|FG002|Overall Study|Investigator's Discretion|1|||
129057452|NCT01199016|464501768|FG000|Overall Study|No longer meets eligibility criteria|4|||
129057453|NCT01199016|464501768|FG000|Overall Study|Entrance criteria|5|||
129057454|NCT01199016|464501768|FG000|Overall Study|Protocol Violation|9|||
129057455|NCT01199016|464501768|FG000|Overall Study|Other|13|||
129057456|NCT01199016|464501768|FG000|Overall Study|Withdrawal by Subject|21|||
129057457|NCT01199016|464501768|FG000|Overall Study|Lost to Follow-up|25|||
129057458|NCT02368314|464501779|FG000|Overall Study|Withdrawal by Subject|2|||
129057459|NCT02368314|464501780|FG001|Overall Study|Withdrawal by Subject|1|||
129057460|NCT02368314|464501779|FG000|Overall Study|Adverse Event|1|||
129057461|NCT02368314|464501780|FG001|Overall Study|Adverse Event|2|||
129057462|NCT02842073|464501785|FG000|Overall Study|Withdrawal by Subject|1|||
129057463|NCT00195338|464501786|FG000|Overall Study|Lost to Follow-up|2|||
129057464|NCT00195338|464501786|FG000|Overall Study|Adverse Event|5|||
129057465|NCT00195338|464501786|FG000|Overall Study|Lack of Efficacy|1|||
129057466|NCT00195338|464501786|FG000|Overall Study|Early closure of the site|4|||
129057467|NCT00314951|464501787|FG000|Treatment|Didn't meet criteria for mITT population|16|||
129057468|NCT00314951|464501788|FG001|Treatment|Didn't meet criteria for mITT population|11|||
128720098|NCT01549964|463273332|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
128720099|NCT01549964|463273333|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129057469|NCT00314951|464501787|FG000|Follow-up|mITT failure|44|||
129057470|NCT00314951|464501788|FG001|Follow-up|mITT failure|34|||
129057471|NCT05320887|464501791|FG000|Overall Study|Lost to Follow-up|0|||
129057472|NCT05320887|464501792|FG001|Overall Study|Lost to Follow-up|3|||
129057473|NCT05320887|464501793|FG002|Overall Study|Lost to Follow-up|0|||
129057474|NCT05320887|464501794|FG003|Overall Study|Lost to Follow-up|0|||
129057475|NCT02289456|464501795|FG000|Induction Period|Death|2|||
129057476|NCT02289456|464501795|FG000|Induction Period|Adverse Event|11|||
129057477|NCT02289456|464501795|FG000|Induction Period|Progressive Disease (PD)|4|||
129057478|NCT02289456|464501795|FG000|Induction Period|Symptomatic Deterioration|4|||
129137153|NCT01122680|464794545|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
129137154|NCT01122680|464794546|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
128720100|NCT01549964|463273330|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
128720101|NCT01549964|463273331|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
129057479|NCT02289456|464501795|FG000|Induction Period|Withdrawal by Subject|2|||
128720102|NCT01549964|463273332|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
128720103|NCT01549964|463273333|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
129057480|NCT02289456|464501795|FG000|Induction Period|Miscellaneous|1|||
129057481|NCT02289456|464501795|FG000|Monotherapy Period|Death|1|||
129057482|NCT02289456|464501795|FG000|Monotherapy Period|Adverse Event|1|||
129057483|NCT02289456|464501795|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
129057484|NCT02289456|464501795|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
128720104|NCT01549964|463273330|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
128720105|NCT01549964|463273331|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
128720106|NCT01549964|463273332|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
129057485|NCT02289456|464501795|FG000|Monotherapy Period|Withdrawal by Subject|2|||
129057486|NCT02289456|464501795|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
129057487|NCT02289456|464501795|FG000|Monotherapy Period|Miscellaneous|1|||
128720107|NCT01549964|463273333|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
128720108|NCT01549964|463273330|FG000|80-Week Extension Period|Pregnancy|0|||
128720109|NCT01549964|463273331|FG001|80-Week Extension Period|Pregnancy|0|||
128720110|NCT01549964|463273332|FG002|80-Week Extension Period|Pregnancy|1|||
128720111|NCT01549964|463273333|FG003|80-Week Extension Period|Pregnancy|0|||
129057488|NCT02015065|464501798|FG000|Overall Study|Death on study|1|||
129057489|NCT02015065|464501799|FG001|Overall Study|Death on study|2|||
129057490|NCT02015065|464501800|FG002|Overall Study|Death on study|1|||
129057491|NCT03485365|464501833|FG000|Overall Study|Protocol Violation|0|||
129057492|NCT03485365|464501834|FG001|Overall Study|Protocol Violation|0|||
129057493|NCT03485365|464501835|FG002|Overall Study|Protocol Violation|0|||
129057494|NCT03485365|464501836|FG003|Overall Study|Protocol Violation|1|||
129057495|NCT03485365|464501837|FG004|Overall Study|Protocol Violation|0|||
129057496|NCT03485365|464501838|FG005|Overall Study|Protocol Violation|0|||
129057497|NCT03485365|464501839|FG006|Overall Study|Protocol Violation|1|||
129057498|NCT03485365|464501840|FG007|Overall Study|Protocol Violation|0|||
129057499|NCT03485365|464501841|FG008|Overall Study|Protocol Violation|0|||
129057500|NCT01547130|464501844|FG000|Overall Study|Lost to Follow-up|9|||
129057501|NCT01547130|464501845|FG001|Overall Study|Lost to Follow-up|5|||
129057502|NCT00103610|464501849|FG000|Overall Study|Entered Rescue Procedure|10|||
129057503|NCT00103610|464501850|FG001|Overall Study|Entered Rescue Procedure|52|||
129057504|NCT00103610|464501849|FG000|Overall Study|Death|16|||
129057505|NCT00103610|464501850|FG001|Overall Study|Death|12|||
129137155|NCT01122680|464794547|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
129137156|NCT01122680|464794544|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
129137157|NCT01122680|464794545|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
129137158|NCT01122680|464794546|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
129137159|NCT01122680|464794547|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
129137160|NCT01122680|464794544|FG000|Period 1 (4 Weeks)|Other|1|||
129137161|NCT01122680|464794545|FG001|Period 1 (4 Weeks)|Other|1|||
129137162|NCT01122680|464794546|FG002|Period 1 (4 Weeks)|Other|0|||
129137163|NCT01122680|464794547|FG003|Period 1 (4 Weeks)|Other|0|||
129137164|NCT01122680|464794544|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
129137165|NCT01122680|464794545|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
129137166|NCT01122680|464794546|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
129137167|NCT01122680|464794547|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
129137168|NCT01122680|464794544|FG000|Period 2 (4 Weeks)|Other|1|||
129137169|NCT01122680|464794545|FG001|Period 2 (4 Weeks)|Other|0|||
129137170|NCT01122680|464794546|FG002|Period 2 (4 Weeks)|Other|0|||
129137171|NCT01122680|464794547|FG003|Period 2 (4 Weeks)|Other|0|||
129137172|NCT01122680|464794544|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
129137173|NCT01122680|464794545|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
129137174|NCT01122680|464794546|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
129137175|NCT01122680|464794547|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
129137176|NCT01122680|464794544|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129137177|NCT01122680|464794545|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
129137178|NCT01122680|464794546|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129137179|NCT01122680|464794547|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129137180|NCT00576407|464794548|FG000|Overall Study|Death|7|||
129137181|NCT00576407|464794548|FG000|Overall Study|Physician Decision|1|||
129137182|NCT00225758|464794549|FG000|Overall Study|Adverse Event|4|||
129137183|NCT00756444|464794550|FG000|Overall Study|Adverse Event|1|||
129137184|NCT00756444|464794551|FG001|Overall Study|Adverse Event|1|||
129137185|NCT00756444|464794550|FG000|Overall Study|Withdrawal by Subject|6|||
129137186|NCT00756444|464794551|FG001|Overall Study|Withdrawal by Subject|8|||
129137187|NCT00756444|464794550|FG000|Overall Study|Lost to Follow-up|0|||
129137188|NCT00756444|464794551|FG001|Overall Study|Lost to Follow-up|1|||
129137189|NCT00756444|464794550|FG000|Overall Study|Death|5|||
129137190|NCT00756444|464794551|FG001|Overall Study|Death|4|||
129137191|NCT00756444|464794550|FG000|Overall Study|Disease Progression|2|||
129137192|NCT00756444|464794551|FG001|Overall Study|Disease Progression|7|||
129137193|NCT00756444|464794550|FG000|Overall Study|Ineligibility Determined|1|||
129137194|NCT00756444|464794551|FG001|Overall Study|Ineligibility Determined|0|||
129137195|NCT00564070|464794552|FG000|Overall Study|Lost to Follow-up|9|||
129137196|NCT00564070|464794553|FG001|Overall Study|Lost to Follow-up|7|||
129137197|NCT00564070|464794552|FG000|Overall Study|Worsening depression, referred to care|3|||
129137198|NCT00564070|464794553|FG001|Overall Study|Worsening depression, referred to care|0|||
129137199|NCT03142334|464794557|FG000|Overall Study|Death|18|||
129137200|NCT03142334|464794558|FG001|Overall Study|Death|33|||
129137201|NCT03142334|464794557|FG000|Overall Study|Withdrawal by Subject|15|||
129137202|NCT03142334|464794558|FG001|Overall Study|Withdrawal by Subject|11|||
129137203|NCT03142334|464794557|FG000|Overall Study|Ongoing on trial follow up|463|||
129137204|NCT03142334|464794558|FG001|Overall Study|Ongoing on trial follow up|454|||
129137205|NCT03071965|464794559|FG000|Overall Study|Adverse Event|0|||
129057506|NCT00103610|464501849|FG000|Overall Study|Elective Withdrawal|4|||
129057507|NCT00103610|464501850|FG001|Overall Study|Elective Withdrawal|0|||
129057508|NCT00103610|464501849|FG000|Overall Study|Lost to Follow-up|3|||
129057509|NCT00103610|464501850|FG001|Overall Study|Lost to Follow-up|1|||
129137206|NCT03071965|464794560|FG001|Overall Study|Adverse Event|0|||
129137207|NCT03071965|464794561|FG002|Overall Study|Adverse Event|1|||
129137208|NCT03071965|464794562|FG003|Overall Study|Adverse Event|0|||
129137209|NCT03071965|464794559|FG000|Overall Study|Death|0|||
129057510|NCT00103610|464501849|FG000|Overall Study|Adverse Event|2|||
129057511|NCT00103610|464501850|FG001|Overall Study|Adverse Event|2|||
129057512|NCT00103610|464501849|FG000|Overall Study|Other|2|||
129057513|NCT00103610|464501850|FG001|Overall Study|Other|7|||
129057514|NCT00103610|464501849|FG000|Overall Study|Failed mobilization|1|||
129057515|NCT00103610|464501850|FG001|Overall Study|Failed mobilization|5|||
129057516|NCT00103610|464501849|FG000|Overall Study|Noncompliance|0|||
129057517|NCT00103610|464501850|FG001|Overall Study|Noncompliance|1|||
129057518|NCT03301623|464501851|FG000|Overall Study|Death|3|||
129057519|NCT03301623|464501852|FG001|Overall Study|Death|1|||
129057520|NCT03301623|464501851|FG000|Overall Study|Withdrawal by Subject|11|||
129057521|NCT03301623|464501852|FG001|Overall Study|Withdrawal by Subject|13|||
129057522|NCT03301623|464501851|FG000|Overall Study|Lost to Follow-up|3|||
129057523|NCT03301623|464501852|FG001|Overall Study|Lost to Follow-up|1|||
129057524|NCT02092467|464501855|FG000|Overall Study|Death|49|||
129057525|NCT02092467|464501856|FG001|Overall Study|Death|66|||
129057526|NCT02092467|464501857|FG002|Overall Study|Death|38|||
129057527|NCT02092467|464501855|FG000|Overall Study|Lost to Follow-up|38|||
129057528|NCT02092467|464501856|FG001|Overall Study|Lost to Follow-up|35|||
129057529|NCT02092467|464501857|FG002|Overall Study|Lost to Follow-up|40|||
129057530|NCT02092467|464501855|FG000|Overall Study|Global Deterioration of Health Status|1|||
129057531|NCT02092467|464501856|FG001|Overall Study|Global Deterioration of Health Status|0|||
129057532|NCT02092467|464501857|FG002|Overall Study|Global Deterioration of Health Status|0|||
129057533|NCT02092467|464501855|FG000|Overall Study|Other|32|||
129057534|NCT02092467|464501856|FG001|Overall Study|Other|30|||
129057535|NCT02092467|464501857|FG002|Overall Study|Other|24|||
129057536|NCT02092467|464501855|FG000|Overall Study|Withdrawal by Subject|282|||
129057537|NCT02092467|464501856|FG001|Overall Study|Withdrawal by Subject|327|||
129057538|NCT02092467|464501857|FG002|Overall Study|Withdrawal by Subject|289|||
129057539|NCT02092467|464501855|FG000|Overall Study|Randomized but not treated|2|||
129057540|NCT02092467|464501856|FG001|Overall Study|Randomized but not treated|1|||
129057541|NCT02092467|464501857|FG002|Overall Study|Randomized but not treated|7|||
129057542|NCT02952898|464501863|FG000|Overall Study|Withdrawal by Subject|10|||
129057543|NCT02952898|464501864|FG001|Overall Study|Withdrawal by Subject|8|||
129057544|NCT02952898|464501865|FG002|Overall Study|Withdrawal by Subject|8|||
129057545|NCT02952898|464501863|FG000|Overall Study|Adverse Event|8|||
129057546|NCT02952898|464501864|FG001|Overall Study|Adverse Event|8|||
129057547|NCT02952898|464501865|FG002|Overall Study|Adverse Event|3|||
129057548|NCT02952898|464501863|FG000|Overall Study|Lost to Follow-up|3|||
129057549|NCT02952898|464501864|FG001|Overall Study|Lost to Follow-up|2|||
129057550|NCT02952898|464501865|FG002|Overall Study|Lost to Follow-up|2|||
129057551|NCT02952898|464501863|FG000|Overall Study|Non-compliance with study drug|1|||
129057552|NCT02952898|464501864|FG001|Overall Study|Non-compliance with study drug|1|||
129057553|NCT02952898|464501865|FG002|Overall Study|Non-compliance with study drug|2|||
129057554|NCT04844762|464501870|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057555|NCT04844762|464501871|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057556|NCT04844762|464501872|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
129057557|NCT04844762|464501873|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057558|NCT04844762|464501874|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057559|NCT04844762|464501875|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057560|NCT04844762|464501870|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
129057561|NCT04844762|464501871|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
129057562|NCT04844762|464501872|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
129057563|NCT04844762|464501873|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
129057564|NCT04844762|464501874|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
129057565|NCT04844762|464501875|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
129057566|NCT04844762|464501870|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057567|NCT04844762|464501871|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057568|NCT04844762|464501872|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129057569|NCT04844762|464501873|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
129057570|NCT04844762|464501874|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057571|NCT04844762|464501875|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
128775543|NCT01474512|463468370|FG013|Post-Treatment Follow-Up|Death|0|||
129137210|NCT03071965|464794560|FG001|Overall Study|Death|0|||
129057572|NCT04844762|464501870|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057573|NCT04844762|464501871|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057574|NCT04844762|464501872|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
129057575|NCT04844762|464501873|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
129057576|NCT04844762|464501874|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
129057577|NCT04844762|464501875|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057578|NCT04844762|464501870|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
129057579|NCT04844762|464501871|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
129137211|NCT03071965|464794561|FG002|Overall Study|Death|1|||
129137212|NCT03071965|464794562|FG003|Overall Study|Death|1|||
129057580|NCT04844762|464501872|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057581|NCT04844762|464501873|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057582|NCT04844762|464501874|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057583|NCT04844762|464501875|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057584|NCT04844762|464501870|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129057585|NCT04844762|464501871|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057586|NCT04844762|464501872|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057587|NCT04844762|464501873|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057588|NCT04844762|464501874|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057589|NCT04844762|464501875|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057590|NCT04844762|464501870|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057591|NCT04844762|464501871|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057592|NCT04844762|464501872|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057593|NCT04844762|464501873|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057594|NCT04844762|464501874|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
129057595|NCT04844762|464501875|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129057596|NCT04844762|464501870|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
129057597|NCT04844762|464501871|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
128720112|NCT01549964|463273330|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
129057598|NCT04844762|464501872|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057599|NCT04844762|464501873|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057600|NCT04844762|464501874|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057601|NCT04844762|464501875|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129057602|NCT04844762|464501870|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129057603|NCT04844762|464501871|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057604|NCT04844762|464501872|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057605|NCT04844762|464501873|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057606|NCT04844762|464501874|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129057607|NCT04844762|464501875|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129057608|NCT04844762|464501870|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129057609|NCT04844762|464501871|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
129057610|NCT04844762|464501872|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129057611|NCT04844762|464501873|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129057612|NCT04844762|464501874|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129057613|NCT04844762|464501875|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129057614|NCT04844762|464501870|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129057615|NCT04844762|464501871|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129057616|NCT04844762|464501872|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129057617|NCT04844762|464501873|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
129057618|NCT04844762|464501874|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129057619|NCT04844762|464501875|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129057620|NCT04400682|464501876|FG000|Period 1|Withdrawal by Subject|1|||
129057621|NCT04400682|464501877|FG001|Period 1|Withdrawal by Subject|4|||
129057622|NCT02293863|464501878|FG000|Overall Study|Death|4|||
129057623|NCT02293863|464501879|FG001|Overall Study|Death|6|||
129057624|NCT02293863|464501880|FG002|Overall Study|Death|4|||
129057625|NCT02293863|464501878|FG000|Overall Study|Lost to Follow-up|2|||
129057626|NCT02293863|464501879|FG001|Overall Study|Lost to Follow-up|2|||
129057627|NCT02293863|464501880|FG002|Overall Study|Lost to Follow-up|2|||
129057628|NCT02293863|464501878|FG000|Overall Study|Withdrawal by Subject|3|||
129057629|NCT02293863|464501879|FG001|Overall Study|Withdrawal by Subject|3|||
129057630|NCT02293863|464501880|FG002|Overall Study|Withdrawal by Subject|1|||
129057631|NCT02293863|464501878|FG000|Overall Study|Reason Not Specified|0|||
129057632|NCT02293863|464501879|FG001|Overall Study|Reason Not Specified|2|||
129057633|NCT02293863|464501880|FG002|Overall Study|Reason Not Specified|2|||
129057634|NCT00477633|464501881|FG000|Overall Study|Did not receive treatment|23|||
129057635|NCT00477633|464501881|FG000|Overall Study|Adverse Event|143|||
129057636|NCT00477633|464501881|FG000|Overall Study|Pregnancy|23|||
129057637|NCT00477633|464501881|FG000|Overall Study|Lost to Follow-up|271|||
128720113|NCT01549964|463273331|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
128720114|NCT01549964|463273332|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
129057638|NCT00477633|464501881|FG000|Overall Study|Withdrawal by Subject|149|||
129057639|NCT00477633|464501881|FG000|Overall Study|Protocol Violation|25|||
128720115|NCT01549964|463273333|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
128720116|NCT01549964|463273330|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
128720117|NCT01549964|463273331|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
129057640|NCT00477633|464501881|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
129057641|NCT01374269|464501887|FG000|Overall Study|Withdrawal by Subject|4|||
129057642|NCT01374269|464501888|FG001|Overall Study|Withdrawal by Subject|0|||
129057643|NCT01374269|464501887|FG000|Overall Study|Lost to Follow-up|1|||
129057644|NCT01374269|464501888|FG001|Overall Study|Lost to Follow-up|3|||
129057645|NCT01374269|464501887|FG000|Overall Study|closed research|1|||
129057646|NCT01374269|464501888|FG001|Overall Study|closed research|2|||
129057647|NCT00478244|464504165|FG000|Overall Study|Did not receive transplant|1|||
129057648|NCT02929056|464504166|FG000|Overall Study|Lost to Follow-up|0|||
129057649|NCT02929056|464504167|FG001|Overall Study|Lost to Follow-up|1|||
129057650|NCT03132155|464504168|FG000|Overall Study|Lack of Efficacy|6|||
129057651|NCT03132155|464504168|FG000|Overall Study|Lost to Follow-up|1|||
129057652|NCT03132155|464504168|FG000|Overall Study|Withdrawal by Subject|1|||
129057653|NCT02925403|464504175|FG000|Overall Study|Lost to Follow-up|0|||
129057654|NCT02925403|464504176|FG001|Overall Study|Lost to Follow-up|1|||
129057655|NCT00459043|464504177|FG000|Overall Study|Withdrawal by Subject|1|||
128720118|NCT01549964|463273332|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
128720119|NCT01549964|463273333|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
128720120|NCT01549964|463273330|FG000|80-Week Extension Period|Lost to Follow-up|1|||
129057656|NCT00459043|464504178|FG001|Overall Study|Withdrawal by Subject|0|||
129057657|NCT02899195|464504181|FG000|Concurrent Durvalumab|Adverse Event|4|||
129057658|NCT02899195|464504181|FG000|Concurrent Durvalumab|Physician Decision|1|||
129057659|NCT02899195|464504181|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
129057660|NCT02899195|464504181|FG000|Concurrent Durvalumab|Progressive Disease|5|||
129057661|NCT02899195|464504181|FG000|Maintenance Durvalumab|Adverse Event|1|||
128720121|NCT01549964|463273331|FG001|80-Week Extension Period|Lost to Follow-up|0|||
129057662|NCT02899195|464504181|FG000|Maintenance Durvalumab|Physician Decision|1|||
129057663|NCT02899195|464504181|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
129057664|NCT02899195|464504181|FG000|Maintenance Durvalumab|Progressive Disease|31|||
129057665|NCT03156504|464504183|FG000|Overall Study|Withdrawal by Subject|1|||
129057666|NCT00450801|464504184|FG000|Overall Study|Death|1|||
129057667|NCT03452137|464504185|FG000|Overall Study|Death|67|||
129057668|NCT03452137|464504186|FG001|Overall Study|Death|70|||
129057669|NCT03452137|464504185|FG000|Overall Study|Lost to Follow-up|4|||
129057670|NCT03452137|464504186|FG001|Overall Study|Lost to Follow-up|2|||
129057671|NCT03452137|464504185|FG000|Overall Study|Physician Decision|0|||
129057672|NCT03452137|464504186|FG001|Overall Study|Physician Decision|1|||
129057673|NCT03452137|464504185|FG000|Overall Study|Study Terminated by Sponsor|120|||
129057674|NCT03452137|464504186|FG001|Overall Study|Study Terminated by Sponsor|121|||
129057675|NCT03452137|464504185|FG000|Overall Study|Withdrawal by Subject|12|||
129057676|NCT03452137|464504186|FG001|Overall Study|Withdrawal by Subject|9|||
129057677|NCT00587860|464504187|FG000|Overall Study|Lost to Follow-up|2|||
129057678|NCT00587860|464504188|FG001|Overall Study|Lost to Follow-up|2|||
129057679|NCT00587860|464504187|FG000|Overall Study|Withdrawal by Subject|3|||
129057680|NCT00587860|464504188|FG001|Overall Study|Withdrawal by Subject|3|||
129057681|NCT00261443|464504189|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
129057682|NCT00261443|464504190|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
129057683|NCT00261443|464504191|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
129057684|NCT00261443|464504189|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
129057685|NCT00261443|464504190|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
129057686|NCT00261443|464504191|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
129057687|NCT00261443|464504189|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
129057688|NCT00261443|464504190|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
129057689|NCT00261443|464504191|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
129057690|NCT00261443|464504189|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
129057691|NCT00261443|464504190|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
129057692|NCT00261443|464504191|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
129057693|NCT00261443|464504189|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
129057694|NCT00261443|464504190|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
129057695|NCT00261443|464504191|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
129057696|NCT00261443|464504189|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
129057697|NCT00261443|464504190|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
129057698|NCT00261443|464504191|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
129057699|NCT00261443|464504189|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
129057700|NCT00261443|464504190|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
129057701|NCT00261443|464504191|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
129057702|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
129057703|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
129057704|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
129057705|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
129057706|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
129057707|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
129057708|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
129057709|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
129057710|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
129057711|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
129057712|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
129057713|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
129057714|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
129057715|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
129057716|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
129057717|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
129057718|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
129057719|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
129057720|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
129057721|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
129057722|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
129057723|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
129057724|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
129057725|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
129057726|NCT00261443|464504189|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
129057727|NCT00261443|464504190|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
129057728|NCT00261443|464504191|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
129057729|NCT00261443|464504189|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
129057730|NCT00261443|464504190|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
129057731|NCT00261443|464504191|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
128720122|NCT01549964|463273332|FG002|80-Week Extension Period|Lost to Follow-up|2|||
128720123|NCT01549964|463273333|FG003|80-Week Extension Period|Lost to Follow-up|1|||
128720124|NCT01549964|463273330|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
128720125|NCT01549964|463273331|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
128720126|NCT01549964|463273332|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
128720127|NCT01549964|463273333|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
129057732|NCT00261443|464504189|FG000|3: Assessment of Relapse|Adverse Event|0|||
129057733|NCT00261443|464504190|FG001|3: Assessment of Relapse|Adverse Event|15|||
129057734|NCT00261443|464504191|FG002|3: Assessment of Relapse|Adverse Event|19|||
129057735|NCT00261443|464504189|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
129057736|NCT00261443|464504190|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
129057737|NCT00261443|464504191|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
129057738|NCT00261443|464504189|FG000|3: Assessment of Relapse|Death|0|||
129057739|NCT00261443|464504190|FG001|3: Assessment of Relapse|Death|0|||
129057740|NCT00261443|464504191|FG002|3: Assessment of Relapse|Death|1|||
129057741|NCT00261443|464504189|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
129057742|NCT00261443|464504190|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
129057743|NCT00261443|464504191|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
129057744|NCT00261443|464504189|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
129057745|NCT00261443|464504190|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
129057746|NCT00261443|464504191|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
129057747|NCT00261443|464504189|FG000|3: Assessment of Relapse|Pregnancy|0|||
129057748|NCT00261443|464504190|FG001|3: Assessment of Relapse|Pregnancy|2|||
129057749|NCT00261443|464504191|FG002|3: Assessment of Relapse|Pregnancy|1|||
129057750|NCT00261443|464504189|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
129057751|NCT00261443|464504190|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
129057752|NCT00261443|464504191|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
129057753|NCT00261443|464504189|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
129057754|NCT00261443|464504190|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
129057755|NCT00261443|464504191|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
129057756|NCT00261443|464504189|FG000|3: Assessment of Relapse|Other Reasons|0|||
129057757|NCT00261443|464504190|FG001|3: Assessment of Relapse|Other Reasons|4|||
129057758|NCT00261443|464504191|FG002|3: Assessment of Relapse|Other Reasons|3|||
129057759|NCT00261443|464504189|FG000|4: Extension Phase|Adverse Event|0|||
129057760|NCT00261443|464504190|FG001|4: Extension Phase|Adverse Event|1|||
129057761|NCT00261443|464504191|FG002|4: Extension Phase|Adverse Event|0|||
129057762|NCT00261443|464504189|FG000|4: Extension Phase|Withdrawal by Subject|0|||
129057763|NCT00261443|464504190|FG001|4: Extension Phase|Withdrawal by Subject|1|||
129057764|NCT00261443|464504191|FG002|4: Extension Phase|Withdrawal by Subject|2|||
129057765|NCT00261443|464504189|FG000|4: Extension Phase|Lost to Follow-up|0|||
129057766|NCT00261443|464504190|FG001|4: Extension Phase|Lost to Follow-up|1|||
129057767|NCT00261443|464504191|FG002|4: Extension Phase|Lost to Follow-up|0|||
129057768|NCT01286753|464504194|FG000|Overall Study|Adverse Event|7|||
129057769|NCT01286753|464504195|FG001|Overall Study|Adverse Event|6|||
129057770|NCT01286753|464504194|FG000|Overall Study|Progression|11|||
129057771|NCT01286753|464504195|FG001|Overall Study|Progression|13|||
129057772|NCT01286753|464504194|FG000|Overall Study|Refused Treatment|1|||
129057773|NCT01286753|464504195|FG001|Overall Study|Refused Treatment|0|||
129057774|NCT01286753|464504194|FG000|Overall Study|Withdrawal of Consent|0|||
129057775|NCT01286753|464504195|FG001|Overall Study|Withdrawal of Consent|2|||
129057776|NCT01286753|464504194|FG000|Overall Study|Discontinued to Join Extension Study|6|||
129057777|NCT01286753|464504195|FG001|Overall Study|Discontinued to Join Extension Study|4|||
129057778|NCT01286753|464504194|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
129057779|NCT01286753|464504195|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
129057780|NCT02094417|464504203|FG000|Overall Study|Adverse Event|0|||
129057781|NCT02094417|464504204|FG001|Overall Study|Adverse Event|0|||
129057782|NCT02094417|464504205|FG002|Overall Study|Adverse Event|0|||
129057783|NCT02094417|464504206|FG003|Overall Study|Adverse Event|1|||
129057784|NCT02094417|464504203|FG000|Overall Study|Eligibility criteria|0|||
129057785|NCT02094417|464504204|FG001|Overall Study|Eligibility criteria|1|||
129057786|NCT02094417|464504205|FG002|Overall Study|Eligibility criteria|0|||
129057787|NCT02094417|464504206|FG003|Overall Study|Eligibility criteria|0|||
129057788|NCT02094417|464504203|FG000|Overall Study|No responder|4|||
129057789|NCT02094417|464504204|FG001|Overall Study|No responder|4|||
129057790|NCT02094417|464504205|FG002|Overall Study|No responder|4|||
129057791|NCT02094417|464504206|FG003|Overall Study|No responder|3|||
129057792|NCT02094417|464504203|FG000|Overall Study|Unable to conduct observations or assess|0|||
129057793|NCT02094417|464504204|FG001|Overall Study|Unable to conduct observations or assess|1|||
129057794|NCT02094417|464504205|FG002|Overall Study|Unable to conduct observations or assess|0|||
129057795|NCT02094417|464504206|FG003|Overall Study|Unable to conduct observations or assess|0|||
129057796|NCT02094417|464504203|FG000|Overall Study|Withdrawal by Subject|1|||
129057797|NCT02094417|464504204|FG001|Overall Study|Withdrawal by Subject|2|||
129057798|NCT02094417|464504205|FG002|Overall Study|Withdrawal by Subject|1|||
128720128|NCT02290821|463273334|FG000|Overall Study|Withdrawal by Subject|1|||
129057799|NCT02094417|464504206|FG003|Overall Study|Withdrawal by Subject|3|||
129057800|NCT02119819|464504209|FG000|Overall Study|Adverse Event|3|||
129057801|NCT02119819|464504210|FG001|Overall Study|Adverse Event|1|||
129057802|NCT02119819|464504211|FG002|Overall Study|Adverse Event|2|||
129057803|NCT02119819|464504212|FG003|Overall Study|Adverse Event|3|||
129057804|NCT02119819|464504213|FG004|Overall Study|Adverse Event|0|||
129057805|NCT02119819|464504214|FG005|Overall Study|Adverse Event|1|||
129057806|NCT02119819|464504209|FG000|Overall Study|Lack of Efficacy|0|||
129057807|NCT02119819|464504210|FG001|Overall Study|Lack of Efficacy|0|||
129057808|NCT02119819|464504211|FG002|Overall Study|Lack of Efficacy|0|||
129057809|NCT02119819|464504212|FG003|Overall Study|Lack of Efficacy|0|||
129057810|NCT02119819|464504213|FG004|Overall Study|Lack of Efficacy|0|||
129057811|NCT02119819|464504214|FG005|Overall Study|Lack of Efficacy|1|||
129057812|NCT02119819|464504209|FG000|Overall Study|Lost to Follow-up|0|||
129057813|NCT02119819|464504210|FG001|Overall Study|Lost to Follow-up|0|||
129057814|NCT02119819|464504211|FG002|Overall Study|Lost to Follow-up|1|||
129057815|NCT02119819|464504212|FG003|Overall Study|Lost to Follow-up|2|||
129057816|NCT02119819|464504213|FG004|Overall Study|Lost to Follow-up|1|||
129057817|NCT02119819|464504214|FG005|Overall Study|Lost to Follow-up|2|||
129057818|NCT02119819|464504209|FG000|Overall Study|Physician Decision|1|||
129057819|NCT02119819|464504210|FG001|Overall Study|Physician Decision|1|||
129057820|NCT02119819|464504211|FG002|Overall Study|Physician Decision|0|||
129057821|NCT02119819|464504212|FG003|Overall Study|Physician Decision|0|||
129057822|NCT02119819|464504213|FG004|Overall Study|Physician Decision|0|||
129057823|NCT02119819|464504214|FG005|Overall Study|Physician Decision|1|||
129057824|NCT02119819|464504209|FG000|Overall Study|Withdrawal by Subject|5|||
129057825|NCT02119819|464504210|FG001|Overall Study|Withdrawal by Subject|3|||
129057826|NCT02119819|464504211|FG002|Overall Study|Withdrawal by Subject|0|||
129057827|NCT02119819|464504212|FG003|Overall Study|Withdrawal by Subject|0|||
128720129|NCT02290821|463273335|FG001|Overall Study|Withdrawal by Subject|1|||
128720130|NCT02290821|463273334|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
129057828|NCT02119819|464504213|FG004|Overall Study|Withdrawal by Subject|6|||
129057829|NCT02119819|464504214|FG005|Overall Study|Withdrawal by Subject|10|||
129057830|NCT02119819|464504209|FG000|Overall Study|Jury Duty|0|||
129057831|NCT02119819|464504210|FG001|Overall Study|Jury Duty|0|||
129057832|NCT02119819|464504211|FG002|Overall Study|Jury Duty|1|||
129057833|NCT02119819|464504212|FG003|Overall Study|Jury Duty|0|||
129057834|NCT02119819|464504213|FG004|Overall Study|Jury Duty|0|||
129057835|NCT02119819|464504214|FG005|Overall Study|Jury Duty|0|||
129057836|NCT02119819|464504209|FG000|Overall Study|Protocol Violation|0|||
129057837|NCT02119819|464504210|FG001|Overall Study|Protocol Violation|0|||
129057838|NCT02119819|464504211|FG002|Overall Study|Protocol Violation|0|||
129057839|NCT02119819|464504212|FG003|Overall Study|Protocol Violation|1|||
129057840|NCT02119819|464504213|FG004|Overall Study|Protocol Violation|0|||
129057841|NCT02119819|464504214|FG005|Overall Study|Protocol Violation|0|||
129057842|NCT02119819|464504209|FG000|Overall Study|Left the city to get a job|0|||
129057843|NCT02119819|464504210|FG001|Overall Study|Left the city to get a job|0|||
129057844|NCT02119819|464504211|FG002|Overall Study|Left the city to get a job|0|||
129057845|NCT02119819|464504212|FG003|Overall Study|Left the city to get a job|1|||
129057846|NCT02119819|464504213|FG004|Overall Study|Left the city to get a job|0|||
128720131|NCT02290821|463273335|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
129057847|NCT02119819|464504214|FG005|Overall Study|Left the city to get a job|0|||
129057848|NCT02699684|464504215|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
129057849|NCT02699684|464504216|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
129057850|NCT01439009|464504217|FG000|Overall Study|Physician Decision|5|||
129057851|NCT01439009|464504218|FG001|Overall Study|Physician Decision|3|||
129057852|NCT01439009|464504217|FG000|Overall Study|Protocol Violation|2|||
129057853|NCT01439009|464504218|FG001|Overall Study|Protocol Violation|0|||
129057854|NCT01439009|464504217|FG000|Overall Study|Deviation of exclusion criteria|1|||
129057855|NCT01439009|464504218|FG001|Overall Study|Deviation of exclusion criteria|0|||
129057856|NCT01191944|464504223|FG000|Overall Study|Adverse Event|11|||
129057857|NCT01191944|464504224|FG001|Overall Study|Adverse Event|12|||
129057858|NCT01191944|464504223|FG000|Overall Study|Protocol Violation|1|||
129057859|NCT01191944|464504224|FG001|Overall Study|Protocol Violation|2|||
129057860|NCT01191944|464504223|FG000|Overall Study|Withdrawal by Subject|4|||
129057861|NCT01191944|464504224|FG001|Overall Study|Withdrawal by Subject|2|||
129057862|NCT01191944|464504223|FG000|Overall Study|Other|1|||
129057863|NCT01191944|464504224|FG001|Overall Study|Other|3|||
129057864|NCT00603837|464504225|FG000|Overall Study|Physician Decision|3|||
129057865|NCT00603837|464504226|FG001|Overall Study|Physician Decision|0|||
129057866|NCT04611529|464504227|FG000|2-day Follow up|Lost to Follow-up|5|||
129057867|NCT04611529|464504228|FG001|2-day Follow up|Lost to Follow-up|6|||
129057868|NCT04611529|464504229|FG002|2-day Follow up|Lost to Follow-up|3|||
129057869|NCT02052011|464504230|FG000|Overall Study|Lost to Follow-up|3|||
129057870|NCT02052011|464504231|FG001|Overall Study|Lost to Follow-up|0|||
129057871|NCT02052011|464504230|FG000|Overall Study|Withdrawal by Subject|1|||
129057872|NCT02052011|464504231|FG001|Overall Study|Withdrawal by Subject|2|||
129057873|NCT00000620|464504232|FG000|Overall Study|Death|86|||
129057874|NCT00000620|464504233|FG001|Overall Study|Death|67|||
129057875|NCT00000620|464504234|FG002|Overall Study|Death|112|||
129057876|NCT00000620|464504235|FG003|Overall Study|Death|126|||
129057877|NCT00000620|464504236|FG004|Overall Study|Death|64|||
129057878|NCT00000620|464504237|FG005|Overall Study|Death|77|||
129057879|NCT00000620|464504238|FG006|Overall Study|Death|91|||
129057880|NCT00000620|464504239|FG007|Overall Study|Death|95|||
129057881|NCT00000620|464504232|FG000|Overall Study|Lost to Follow-up|14|||
129057882|NCT00000620|464504233|FG001|Overall Study|Lost to Follow-up|14|||
129057883|NCT00000620|464504234|FG002|Overall Study|Lost to Follow-up|14|||
129057884|NCT00000620|464504235|FG003|Overall Study|Lost to Follow-up|14|||
129057885|NCT00000620|464504236|FG004|Overall Study|Lost to Follow-up|15|||
129057886|NCT00000620|464504237|FG005|Overall Study|Lost to Follow-up|15|||
129057887|NCT00000620|464504238|FG006|Overall Study|Lost to Follow-up|13|||
129057888|NCT00000620|464504239|FG007|Overall Study|Lost to Follow-up|14|||
129057889|NCT00000620|464504232|FG000|Overall Study|Withdrawal by Subject|40|||
129057890|NCT00000620|464504233|FG001|Overall Study|Withdrawal by Subject|27|||
129057891|NCT00000620|464504234|FG002|Overall Study|Withdrawal by Subject|28|||
129057892|NCT00000620|464504235|FG003|Overall Study|Withdrawal by Subject|27|||
129057893|NCT00000620|464504236|FG004|Overall Study|Withdrawal by Subject|30|||
129057894|NCT00000620|464504237|FG005|Overall Study|Withdrawal by Subject|32|||
129057895|NCT00000620|464504238|FG006|Overall Study|Withdrawal by Subject|32|||
129057896|NCT00000620|464504239|FG007|Overall Study|Withdrawal by Subject|21|||
129057897|NCT00000620|464504232|FG000|Overall Study|missed closeout visit|22|||
129057898|NCT00000620|464504233|FG001|Overall Study|missed closeout visit|28|||
129057899|NCT00000620|464504234|FG002|Overall Study|missed closeout visit|16|||
129057900|NCT00000620|464504235|FG003|Overall Study|missed closeout visit|11|||
129057901|NCT00000620|464504236|FG004|Overall Study|missed closeout visit|26|||
129057902|NCT00000620|464504237|FG005|Overall Study|missed closeout visit|28|||
129057903|NCT00000620|464504238|FG006|Overall Study|missed closeout visit|13|||
129057904|NCT00000620|464504239|FG007|Overall Study|missed closeout visit|16|||
129057905|NCT02648932|464504240|FG000|Overall Study|No transplant|3|||
129057906|NCT02648932|464504241|FG001|Overall Study|No transplant|1|||
129057907|NCT02960490|464504242|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
129057908|NCT02960490|464504243|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
129057909|NCT02960490|464504244|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057910|NCT02960490|464504245|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057911|NCT02960490|464504246|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057912|NCT02960490|464504247|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057913|NCT02960490|464504248|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057914|NCT02960490|464504249|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057915|NCT02960490|464504250|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057916|NCT02960490|464504251|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129057917|NCT02960490|464504242|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057918|NCT02960490|464504243|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
129057919|NCT02960490|464504244|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057920|NCT02960490|464504245|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
128720132|NCT02290821|463273334|FG000|Overall Study|Lost to Follow-up|3|||
129057921|NCT02960490|464504246|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057922|NCT02960490|464504247|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057923|NCT02960490|464504248|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057924|NCT02960490|464504249|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057925|NCT02960490|464504250|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057926|NCT02960490|464504251|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129057927|NCT02960490|464504242|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
129057928|NCT02960490|464504243|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
129057929|NCT02960490|464504244|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057930|NCT02960490|464504245|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057931|NCT02960490|464504246|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057932|NCT02960490|464504247|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057933|NCT02960490|464504248|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057934|NCT02960490|464504249|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057935|NCT02960490|464504250|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057936|NCT02960490|464504251|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129057937|NCT02960490|464504242|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
129057938|NCT02960490|464504243|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
129057939|NCT02960490|464504244|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057940|NCT02960490|464504245|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057941|NCT02960490|464504246|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057942|NCT02960490|464504247|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057943|NCT02960490|464504248|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057944|NCT02960490|464504249|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057945|NCT02960490|464504250|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057946|NCT02960490|464504251|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129057947|NCT02960490|464504242|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129057948|NCT02960490|464504243|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129057949|NCT02960490|464504244|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
129057950|NCT02960490|464504245|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
129057951|NCT02960490|464504246|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129057952|NCT02960490|464504247|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
129057953|NCT02960490|464504248|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129057954|NCT02960490|464504249|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129057955|NCT02960490|464504250|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129057956|NCT02960490|464504251|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129057957|NCT02960490|464504242|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057958|NCT02960490|464504243|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057959|NCT02960490|464504244|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
129057960|NCT02960490|464504245|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057961|NCT02960490|464504246|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
129057962|NCT02960490|464504247|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057963|NCT02960490|464504248|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057964|NCT02960490|464504249|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057965|NCT02960490|464504250|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057966|NCT02960490|464504251|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129057967|NCT02960490|464504242|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
129057968|NCT02960490|464504243|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
129057969|NCT02960490|464504244|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
129057970|NCT02960490|464504245|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
129057971|NCT02960490|464504246|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
129057972|NCT02960490|464504247|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
129057973|NCT02960490|464504248|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
129057974|NCT02960490|464504249|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
128720133|NCT02290821|463273335|FG001|Overall Study|Lost to Follow-up|2|||
128720134|NCT00751348|463273336|FG000|Overall Study|Withdrawal by Subject|5|||
128720135|NCT00751348|463273337|FG001|Overall Study|Withdrawal by Subject|2|||
128720136|NCT00751348|463273336|FG000|Overall Study|Migration from study area|1|||
128720137|NCT00751348|463273337|FG001|Overall Study|Migration from study area|0|||
128720138|NCT05172544|463273342|FG000|Overall Study|Withdrawal by Subject|1|||
129057975|NCT02960490|464504250|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
129057976|NCT02960490|464504251|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
129057977|NCT02960490|464504242|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129057978|NCT02960490|464504243|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129057979|NCT02960490|464504244|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
128775544|NCT01474512|463468371|FG014|Post-Treatment Follow-Up|Death|0|||
129057980|NCT02960490|464504245|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129057981|NCT02960490|464504246|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129057982|NCT02960490|464504247|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129057983|NCT02960490|464504248|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
129057984|NCT02960490|464504249|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
129057985|NCT02960490|464504250|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
129057986|NCT02960490|464504251|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129057987|NCT02960490|464504242|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057988|NCT02960490|464504243|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057989|NCT02960490|464504244|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057990|NCT02960490|464504245|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057991|NCT02960490|464504246|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057992|NCT02960490|464504247|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057993|NCT02960490|464504248|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057994|NCT02960490|464504249|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
129057995|NCT02960490|464504250|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057996|NCT02960490|464504251|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129057997|NCT02960490|464504242|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129057998|NCT02960490|464504243|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129057999|NCT02960490|464504244|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129058000|NCT02960490|464504245|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129058001|NCT02960490|464504246|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129058002|NCT02960490|464504247|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129058003|NCT02960490|464504248|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
129058004|NCT02960490|464504249|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
129058005|NCT02960490|464504250|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
129058006|NCT02960490|464504251|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
129058007|NCT02960490|464504242|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058008|NCT02960490|464504243|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058009|NCT02960490|464504244|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058010|NCT02960490|464504245|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058011|NCT02960490|464504246|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058012|NCT02960490|464504247|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058013|NCT02960490|464504248|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
129058014|NCT02960490|464504249|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058015|NCT02960490|464504250|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058016|NCT02960490|464504251|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129058017|NCT02960490|464504242|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058018|NCT02960490|464504243|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058019|NCT02960490|464504244|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058020|NCT02960490|464504245|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058021|NCT02960490|464504246|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058022|NCT02960490|464504247|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058023|NCT02960490|464504248|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058024|NCT02960490|464504249|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
129058025|NCT02960490|464504250|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058026|NCT02960490|464504251|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
129058027|NCT01307111|464504254|FG000|IUD Insertion|Lost to Follow-up|2|||
129058028|NCT01307111|464504255|FG001|IUD Insertion|Lost to Follow-up|0|||
129058029|NCT01307111|464504254|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
129058030|NCT01307111|464504255|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
129058031|NCT01333397|464504256|FG000|Overall Study|Lost to Follow-up|1|||
129058032|NCT01333397|464504257|FG001|Overall Study|Lost to Follow-up|0|||
129058033|NCT01333397|464504258|FG002|Overall Study|Lost to Follow-up|0|||
129058034|NCT01333397|464504259|FG003|Overall Study|Lost to Follow-up|1|||
129058035|NCT01333397|464504260|FG004|Overall Study|Lost to Follow-up|0|||
129058036|NCT01085357|464504261|FG000|Overall Study|Adverse Event|1|||
129058037|NCT01085357|464504262|FG001|Overall Study|Adverse Event|1|||
129058038|NCT01085357|464504261|FG000|Overall Study|Subject Decision|4|||
128720139|NCT05172544|463273343|FG001|Overall Study|Withdrawal by Subject|0|||
128720140|NCT05172544|463273344|FG002|Overall Study|Withdrawal by Subject|0|||
128720141|NCT05172544|463273342|FG000|Overall Study|Physician Decision|0|||
129058039|NCT01085357|464504262|FG001|Overall Study|Subject Decision|3|||
129137213|NCT03071965|464794559|FG000|Overall Study|COVID-19|0|||
129137214|NCT03071965|464794560|FG001|Overall Study|COVID-19|1|||
129137215|NCT03071965|464794561|FG002|Overall Study|COVID-19|0|||
129137216|NCT03071965|464794562|FG003|Overall Study|COVID-19|1|||
129058040|NCT01085357|464504261|FG000|Overall Study|Investigator Decision|1|||
129137217|NCT03071965|464794559|FG000|Overall Study|Other Health Reason|0|||
129137218|NCT03071965|464794560|FG001|Overall Study|Other Health Reason|0|||
129058041|NCT01085357|464504262|FG001|Overall Study|Investigator Decision|1|||
129058042|NCT01085357|464504261|FG000|Overall Study|Death|11|||
129058043|NCT01085357|464504262|FG001|Overall Study|Death|1|||
129058044|NCT01085357|464504261|FG000|Overall Study|Lost to Follow-up|2|||
129058045|NCT01085357|464504262|FG001|Overall Study|Lost to Follow-up|0|||
129058046|NCT00920790|464504271|FG000|Overall Study|aggravation of general condition|14|||
129058047|NCT01661062|464504274|FG000|Overall Study|Completed Treatment Off Study|3|||
129058048|NCT01661062|464504274|FG000|Overall Study|Withdrawal by Subject|2|||
129058049|NCT00895414|464504277|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
129058050|NCT00895414|464504278|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
129058051|NCT00895414|464504277|FG000|First Intervention (14 Days)|Physician Decision|0|||
129058052|NCT00895414|464504278|FG001|First Intervention (14 Days)|Physician Decision|1|||
129058053|NCT00252239|464504279|FG000|Overall Study|Withdrawal by Subject|1|||
129058054|NCT00252239|464504280|FG001|Overall Study|Withdrawal by Subject|0|||
129058055|NCT00252239|464504281|FG002|Overall Study|Withdrawal by Subject|0|||
129058056|NCT00252239|464504282|FG003|Overall Study|Withdrawal by Subject|1|||
129058057|NCT00252239|464504279|FG000|Overall Study|Lost to Follow-up|0|||
129058058|NCT00252239|464504280|FG001|Overall Study|Lost to Follow-up|0|||
129058059|NCT00252239|464504281|FG002|Overall Study|Lost to Follow-up|2|||
129058060|NCT00252239|464504282|FG003|Overall Study|Lost to Follow-up|0|||
129058061|NCT00478426|464504283|FG000|Overall Study|Withdrawal by Subject|1|||
129058062|NCT02752087|464504288|FG000|Washout|Physician Decision|1|||
129058063|NCT02752087|464504289|FG001|Washout|Physician Decision|0|||
129058064|NCT02785952|464504290|FG000|Overall Study|Adverse Event|31|||
129058065|NCT02785952|464504291|FG001|Overall Study|Adverse Event|19|||
129058066|NCT02785952|464504290|FG000|Overall Study|Refusal unrelated to adverse events|10|||
129058067|NCT02785952|464504291|FG001|Overall Study|Refusal unrelated to adverse events|5|||
129058068|NCT02785952|464504290|FG000|Overall Study|Disease progression/relapse|61|||
129058069|NCT02785952|464504291|FG001|Overall Study|Disease progression/relapse|89|||
129058070|NCT02785952|464504290|FG000|Overall Study|Death|11|||
129058071|NCT02785952|464504291|FG001|Overall Study|Death|7|||
129058072|NCT02785952|464504290|FG000|Overall Study|Other- not protocol specified|6|||
129058073|NCT02785952|464504291|FG001|Overall Study|Other- not protocol specified|4|||
129058074|NCT02785952|464504290|FG000|Overall Study|On protocol treatment|6|||
129058075|NCT02785952|464504291|FG001|Overall Study|On protocol treatment|3|||
129058076|NCT02728843|464504292|FG000|Overall Study|Adverse Event|0|||
129058077|NCT02728843|464504293|FG001|Overall Study|Adverse Event|2|||
128720142|NCT05172544|463273343|FG001|Overall Study|Physician Decision|0|||
128720143|NCT05172544|463273344|FG002|Overall Study|Physician Decision|1|||
129058078|NCT02728843|464504294|FG002|Overall Study|Adverse Event|3|||
129058079|NCT02728843|464504295|FG003|Overall Study|Adverse Event|1|||
129058080|NCT02728843|464504296|FG004|Overall Study|Adverse Event|2|||
129058081|NCT02728843|464504292|FG000|Overall Study|Lack of Efficacy|0|||
129058082|NCT02728843|464504293|FG001|Overall Study|Lack of Efficacy|1|||
129058083|NCT02728843|464504294|FG002|Overall Study|Lack of Efficacy|1|||
129058084|NCT02728843|464504295|FG003|Overall Study|Lack of Efficacy|0|||
129058085|NCT02728843|464504296|FG004|Overall Study|Lack of Efficacy|0|||
129058086|NCT02728843|464504292|FG000|Overall Study|Protocol Violation|2|||
129058087|NCT02728843|464504293|FG001|Overall Study|Protocol Violation|0|||
129058088|NCT02728843|464504294|FG002|Overall Study|Protocol Violation|4|||
129058089|NCT02728843|464504295|FG003|Overall Study|Protocol Violation|2|||
129058090|NCT02728843|464504296|FG004|Overall Study|Protocol Violation|2|||
129058091|NCT02728843|464504292|FG000|Overall Study|Withdrawal by Subject|1|||
129058092|NCT02728843|464504293|FG001|Overall Study|Withdrawal by Subject|0|||
128720144|NCT00362115|463273345|FG000|Overall Study|Adverse Event|0|||
128720145|NCT00362115|463273346|FG001|Overall Study|Adverse Event|1|||
129058093|NCT02728843|464504294|FG002|Overall Study|Withdrawal by Subject|0|||
129058094|NCT02728843|464504295|FG003|Overall Study|Withdrawal by Subject|1|||
129058095|NCT02728843|464504296|FG004|Overall Study|Withdrawal by Subject|0|||
129058096|NCT02728843|464504292|FG000|Overall Study|Use of rescue medication|0|||
129137219|NCT03071965|464794561|FG002|Overall Study|Other Health Reason|0|||
129137220|NCT03071965|464794562|FG003|Overall Study|Other Health Reason|1|||
129137221|NCT05587998|464794563|FG000|Overall Study|Withdrawal by Subject|1|||
129137222|NCT05587998|464794564|FG001|Overall Study|Withdrawal by Subject|1|||
129137223|NCT05587998|464794563|FG000|Overall Study|Not treated|3|||
129137224|NCT05587998|464794564|FG001|Overall Study|Not treated|1|||
129137225|NCT05587998|464794563|FG000|Overall Study|Non-compliance with study procedures|0|||
128720146|NCT00362115|463273347|FG002|Overall Study|Adverse Event|1|||
129058097|NCT02728843|464504293|FG001|Overall Study|Use of rescue medication|2|||
129058098|NCT02728843|464504294|FG002|Overall Study|Use of rescue medication|0|||
129058099|NCT02728843|464504295|FG003|Overall Study|Use of rescue medication|2|||
129058100|NCT02728843|464504296|FG004|Overall Study|Use of rescue medication|1|||
129137226|NCT05587998|464794564|FG001|Overall Study|Non-compliance with study procedures|1|||
129137227|NCT01181128|464794565|FG000|Overall Study|Withdrawal by Subject|2|||
129058101|NCT01671332|464504297|FG000|Overall Study|Withdrawal by Subject|1|||
128720147|NCT00362115|463273348|FG003|Overall Study|Adverse Event|1|||
128720148|NCT00362115|463273349|FG004|Overall Study|Adverse Event|2|||
129058102|NCT01671332|464504298|FG001|Overall Study|Withdrawal by Subject|1|||
129058103|NCT00351533|464504299|FG000|Overall Study|Extubated before first BAL|1|||
129058104|NCT00351533|464504300|FG001|Overall Study|Extubated before first BAL|0|||
129058105|NCT00351533|464504299|FG000|Overall Study|Lost to Follow-up|1|||
129058106|NCT00351533|464504300|FG001|Overall Study|Lost to Follow-up|3|||
129058107|NCT00351533|464504299|FG000|Overall Study|Physician Decision|0|||
129058108|NCT00351533|464504300|FG001|Overall Study|Physician Decision|1|||
129058109|NCT00351533|464504299|FG000|Overall Study|Withdrawal by Subject|0|||
129058110|NCT00351533|464504300|FG001|Overall Study|Withdrawal by Subject|1|||
129058111|NCT01806506|464504301|FG000|Overall Study|Lost to Follow-up|2|||
129058112|NCT01806506|464504302|FG001|Overall Study|Lost to Follow-up|1|||
129058113|NCT00996892|464504308|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
129058114|NCT00996892|464504309|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
129058115|NCT00996892|464504310|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
129058116|NCT00996892|464504311|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
129058117|NCT00996892|464504312|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
129058118|NCT00996892|464504313|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
129058119|NCT00996892|464504314|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
129058120|NCT00996892|464504315|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
129058121|NCT00996892|464504316|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
129058122|NCT00996892|464504317|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
129058123|NCT00996892|464504318|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
129058124|NCT00996892|464504319|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
129058125|NCT00996892|464504320|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
129058126|NCT00996892|464504321|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
129058127|NCT00996892|464504322|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
129058128|NCT00996892|464504323|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
129058129|NCT00996892|464504324|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
129058130|NCT00996892|464504325|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
129058131|NCT00996892|464504326|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
129058132|NCT00996892|464504327|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
129058133|NCT00996892|464504308|FG000|Dose-Escalation Stage 1|Death|1|||
129058134|NCT00996892|464504309|FG001|Dose-Escalation Stage 1|Death|0|||
129058135|NCT00996892|464504310|FG002|Dose-Escalation Stage 1|Death|0|||
129058136|NCT00996892|464504311|FG003|Dose-Escalation Stage 1|Death|0|||
129058137|NCT00996892|464504312|FG004|Dose-Escalation Stage 1|Death|0|||
129058138|NCT00996892|464504313|FG005|Dose-Escalation Stage 1|Death|1|||
129058139|NCT00996892|464504314|FG006|Dose-Escalation Stage 1|Death|0|||
129058140|NCT00996892|464504315|FG007|Dose-Escalation Stage 1|Death|0|||
129058141|NCT00996892|464504316|FG008|Dose-Escalation Stage 1|Death|0|||
129058142|NCT00996892|464504317|FG009|Dose-Escalation Stage 1|Death|0|||
129058143|NCT00996892|464504318|FG010|Dose-Escalation Stage 1|Death|0|||
129058144|NCT00996892|464504319|FG011|Dose-Escalation Stage 1|Death|0|||
129058145|NCT00996892|464504320|FG012|Dose-Escalation Stage 1|Death|0|||
129058146|NCT00996892|464504321|FG013|Dose-Escalation Stage 1|Death|0|||
129058147|NCT00996892|464504322|FG014|Dose-Escalation Stage 1|Death|0|||
129058148|NCT00996892|464504323|FG015|Dose-Escalation Stage 1|Death|0|||
129058149|NCT00996892|464504324|FG016|Dose-Escalation Stage 1|Death|0|||
129058150|NCT00996892|464504325|FG017|Dose-Escalation Stage 1|Death|0|||
129058151|NCT00996892|464504326|FG018|Dose-Escalation Stage 1|Death|0|||
129058152|NCT00996892|464504327|FG019|Dose-Escalation Stage 1|Death|0|||
129058153|NCT00996892|464504308|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
129058154|NCT00996892|464504309|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
129058155|NCT00996892|464504310|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
129058156|NCT00996892|464504311|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
129058157|NCT00996892|464504312|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
129058158|NCT00996892|464504313|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
128720149|NCT00362115|463273350|FG005|Overall Study|Adverse Event|2|||
128720150|NCT00362115|463273351|FG006|Overall Study|Adverse Event|1|||
128720151|NCT00362115|463273345|FG000|Overall Study|Protocol Violation|0|||
128720152|NCT00362115|463273346|FG001|Overall Study|Protocol Violation|0|||
128720153|NCT00362115|463273347|FG002|Overall Study|Protocol Violation|0|||
129058159|NCT00996892|464504314|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
128720154|NCT00362115|463273348|FG003|Overall Study|Protocol Violation|0|||
129058160|NCT00996892|464504315|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
129058161|NCT00996892|464504316|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
129058162|NCT00996892|464504317|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
129058163|NCT00996892|464504318|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
129058164|NCT00996892|464504319|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
129058165|NCT00996892|464504320|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
129058166|NCT00996892|464504321|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
129058167|NCT00996892|464504322|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
129058168|NCT00996892|464504323|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
129058169|NCT00996892|464504324|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
129058170|NCT00996892|464504325|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
128720155|NCT00362115|463273349|FG004|Overall Study|Protocol Violation|0|||
129058171|NCT00996892|464504326|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
129058172|NCT00996892|464504327|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
129058173|NCT00996892|464504308|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058174|NCT00996892|464504309|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129058175|NCT00996892|464504310|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058176|NCT00996892|464504311|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
129058177|NCT00996892|464504312|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129058178|NCT00996892|464504313|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129058179|NCT00996892|464504314|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129058180|NCT00996892|464504315|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058181|NCT00996892|464504316|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058182|NCT00996892|464504317|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058183|NCT00996892|464504318|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058184|NCT00996892|464504319|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058185|NCT00996892|464504320|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058186|NCT00996892|464504321|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058187|NCT00996892|464504322|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058188|NCT00996892|464504323|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058189|NCT00996892|464504324|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058190|NCT00996892|464504325|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058191|NCT00996892|464504326|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058192|NCT00996892|464504327|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129058193|NCT00996892|464504308|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
129058194|NCT00996892|464504309|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
129058195|NCT00996892|464504310|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
129058196|NCT00996892|464504311|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
129058197|NCT00996892|464504312|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
129058198|NCT00996892|464504313|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
129058199|NCT00996892|464504314|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
129058200|NCT00996892|464504315|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
129058201|NCT00996892|464504316|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
129058202|NCT00996892|464504317|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
129058203|NCT00996892|464504318|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
129058204|NCT00996892|464504319|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
129058205|NCT00996892|464504320|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
129058206|NCT00996892|464504321|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
129058207|NCT00996892|464504322|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
129058208|NCT00996892|464504323|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
129058209|NCT00996892|464504324|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
129058210|NCT00996892|464504325|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
129058211|NCT00996892|464504326|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
129058212|NCT00996892|464504327|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
129058213|NCT00996892|464504308|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
129058214|NCT00996892|464504309|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
129058215|NCT00996892|464504310|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
129058216|NCT00996892|464504311|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
129058217|NCT00996892|464504312|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
129058218|NCT00996892|464504313|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
129058219|NCT00996892|464504314|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
129058220|NCT00996892|464504315|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
129058221|NCT00996892|464504316|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
129058222|NCT00996892|464504317|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
129058223|NCT00996892|464504318|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
129058224|NCT00996892|464504319|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
129058225|NCT00996892|464504320|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
129058226|NCT00996892|464504321|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
129058227|NCT00996892|464504322|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
129058228|NCT00996892|464504323|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
129058229|NCT00996892|464504324|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
129058230|NCT00996892|464504325|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
129058231|NCT00996892|464504326|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
129058232|NCT00996892|464504327|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
129058233|NCT00996892|464504308|FG000|Dose-Escalation Stage 1A|Death|0|||
129058234|NCT00996892|464504309|FG001|Dose-Escalation Stage 1A|Death|0|||
129058235|NCT00996892|464504310|FG002|Dose-Escalation Stage 1A|Death|0|||
129058236|NCT00996892|464504311|FG003|Dose-Escalation Stage 1A|Death|0|||
129058237|NCT00996892|464504312|FG004|Dose-Escalation Stage 1A|Death|0|||
129058238|NCT00996892|464504313|FG005|Dose-Escalation Stage 1A|Death|0|||
129058239|NCT00996892|464504314|FG006|Dose-Escalation Stage 1A|Death|0|||
129058240|NCT00996892|464504315|FG007|Dose-Escalation Stage 1A|Death|0|||
129058241|NCT00996892|464504316|FG008|Dose-Escalation Stage 1A|Death|0|||
129058242|NCT00996892|464504317|FG009|Dose-Escalation Stage 1A|Death|2|||
129058243|NCT00996892|464504318|FG010|Dose-Escalation Stage 1A|Death|0|||
129058244|NCT00996892|464504319|FG011|Dose-Escalation Stage 1A|Death|1|||
129058245|NCT00996892|464504320|FG012|Dose-Escalation Stage 1A|Death|1|||
129058246|NCT00996892|464504321|FG013|Dose-Escalation Stage 1A|Death|0|||
129058247|NCT00996892|464504322|FG014|Dose-Escalation Stage 1A|Death|0|||
129058248|NCT00996892|464504323|FG015|Dose-Escalation Stage 1A|Death|0|||
129058249|NCT00996892|464504324|FG016|Dose-Escalation Stage 1A|Death|0|||
129058250|NCT00996892|464504325|FG017|Dose-Escalation Stage 1A|Death|0|||
129058251|NCT00996892|464504326|FG018|Dose-Escalation Stage 1A|Death|0|||
129058252|NCT00996892|464504327|FG019|Dose-Escalation Stage 1A|Death|0|||
129058253|NCT00996892|464504308|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
129058254|NCT00996892|464504309|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
129058255|NCT00996892|464504310|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
129058256|NCT00996892|464504311|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
129058257|NCT00996892|464504312|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
129058258|NCT00996892|464504313|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
129058259|NCT00996892|464504314|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
129058260|NCT00996892|464504315|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
129058261|NCT00996892|464504316|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
129058262|NCT00996892|464504317|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
129058263|NCT00996892|464504318|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
129058264|NCT00996892|464504319|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
129058265|NCT00996892|464504320|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
129058266|NCT00996892|464504321|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
129058267|NCT00996892|464504322|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
129058268|NCT00996892|464504323|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
129058269|NCT00996892|464504324|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
129058270|NCT00996892|464504325|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
129058271|NCT00996892|464504326|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
129058272|NCT00996892|464504327|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
129058273|NCT00996892|464504308|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058274|NCT00996892|464504309|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058275|NCT00996892|464504310|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058276|NCT00996892|464504311|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058277|NCT00996892|464504312|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058278|NCT00996892|464504313|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058279|NCT00996892|464504314|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058280|NCT00996892|464504315|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058281|NCT00996892|464504316|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058282|NCT00996892|464504317|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129058283|NCT00996892|464504318|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129058284|NCT00996892|464504319|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129058285|NCT00996892|464504320|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129058286|NCT00996892|464504321|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058287|NCT00996892|464504322|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058288|NCT00996892|464504323|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058289|NCT00996892|464504324|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058290|NCT00996892|464504325|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058291|NCT00996892|464504326|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058292|NCT00996892|464504327|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129058293|NCT00996892|464504308|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
129058294|NCT00996892|464504309|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
129058295|NCT00996892|464504310|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
129058296|NCT00996892|464504311|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
129058297|NCT00996892|464504312|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
129058298|NCT00996892|464504313|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
129058299|NCT00996892|464504314|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
129058300|NCT00996892|464504315|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
129058301|NCT00996892|464504316|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
129058302|NCT00996892|464504317|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
129058303|NCT00996892|464504318|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
129058304|NCT00996892|464504319|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
129058305|NCT00996892|464504320|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
129058306|NCT00996892|464504321|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
129058307|NCT00996892|464504322|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
129058308|NCT00996892|464504323|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
129058309|NCT00996892|464504324|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
129058310|NCT00996892|464504325|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
129058311|NCT00996892|464504326|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
129058312|NCT00996892|464504327|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
129058313|NCT00996892|464504308|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
129058314|NCT00996892|464504309|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
129058315|NCT00996892|464504310|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
129058316|NCT00996892|464504311|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
129058317|NCT00996892|464504312|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
129058318|NCT00996892|464504313|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
129058319|NCT00996892|464504314|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
129058320|NCT00996892|464504315|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
129058321|NCT00996892|464504316|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
129058322|NCT00996892|464504317|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
129058323|NCT00996892|464504318|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
129058324|NCT00996892|464504319|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
129058325|NCT00996892|464504320|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
129058326|NCT00996892|464504321|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
129058327|NCT00996892|464504322|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
129058328|NCT00996892|464504323|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
129058329|NCT00996892|464504324|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
129058330|NCT00996892|464504325|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
129058331|NCT00996892|464504326|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
129058332|NCT00996892|464504327|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
129058333|NCT00996892|464504308|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
129058334|NCT00996892|464504309|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
129058335|NCT00996892|464504310|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
129058336|NCT00996892|464504311|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
129058337|NCT00996892|464504312|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
129058338|NCT00996892|464504313|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
129058339|NCT00996892|464504314|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
129058340|NCT00996892|464504315|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
129058341|NCT00996892|464504316|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
129058342|NCT00996892|464504317|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
129058343|NCT00996892|464504318|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
129058344|NCT00996892|464504319|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
129058345|NCT00996892|464504320|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
129058346|NCT00996892|464504321|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
129058347|NCT00996892|464504322|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
129058348|NCT00996892|464504323|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
129058349|NCT00996892|464504324|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
129058350|NCT00996892|464504325|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
129058351|NCT00996892|464504326|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
129058352|NCT00996892|464504327|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
129058353|NCT00996892|464504308|FG000|Expansion Stage 2|Adverse Event|0|||
129058354|NCT00996892|464504309|FG001|Expansion Stage 2|Adverse Event|0|||
129058355|NCT00996892|464504310|FG002|Expansion Stage 2|Adverse Event|0|||
129058356|NCT00996892|464504311|FG003|Expansion Stage 2|Adverse Event|0|||
129058357|NCT00996892|464504312|FG004|Expansion Stage 2|Adverse Event|0|||
129058358|NCT00996892|464504313|FG005|Expansion Stage 2|Adverse Event|0|||
129058359|NCT00996892|464504314|FG006|Expansion Stage 2|Adverse Event|0|||
129058360|NCT00996892|464504315|FG007|Expansion Stage 2|Adverse Event|0|||
129058361|NCT00996892|464504316|FG008|Expansion Stage 2|Adverse Event|0|||
129058362|NCT00996892|464504317|FG009|Expansion Stage 2|Adverse Event|0|||
129058363|NCT00996892|464504318|FG010|Expansion Stage 2|Adverse Event|0|||
129058364|NCT00996892|464504319|FG011|Expansion Stage 2|Adverse Event|0|||
129058365|NCT00996892|464504320|FG012|Expansion Stage 2|Adverse Event|0|||
129058366|NCT00996892|464504321|FG013|Expansion Stage 2|Adverse Event|0|||
129058367|NCT00996892|464504322|FG014|Expansion Stage 2|Adverse Event|0|||
129058368|NCT00996892|464504323|FG015|Expansion Stage 2|Adverse Event|0|||
129058369|NCT00996892|464504324|FG016|Expansion Stage 2|Adverse Event|0|||
129058370|NCT00996892|464504325|FG017|Expansion Stage 2|Adverse Event|0|||
129058371|NCT00996892|464504326|FG018|Expansion Stage 2|Adverse Event|3|||
129058372|NCT00996892|464504327|FG019|Expansion Stage 2|Adverse Event|0|||
129058373|NCT00996892|464504308|FG000|Expansion Stage 2|Death|0|||
129058374|NCT00996892|464504309|FG001|Expansion Stage 2|Death|0|||
129058375|NCT00996892|464504310|FG002|Expansion Stage 2|Death|0|||
129058376|NCT00996892|464504311|FG003|Expansion Stage 2|Death|0|||
129058377|NCT00996892|464504312|FG004|Expansion Stage 2|Death|0|||
129058378|NCT00996892|464504313|FG005|Expansion Stage 2|Death|0|||
129058379|NCT00996892|464504314|FG006|Expansion Stage 2|Death|0|||
129058380|NCT00996892|464504315|FG007|Expansion Stage 2|Death|0|||
129058381|NCT00996892|464504316|FG008|Expansion Stage 2|Death|0|||
129058382|NCT00996892|464504317|FG009|Expansion Stage 2|Death|0|||
129058383|NCT00996892|464504318|FG010|Expansion Stage 2|Death|0|||
129058384|NCT00996892|464504319|FG011|Expansion Stage 2|Death|0|||
129058385|NCT00996892|464504320|FG012|Expansion Stage 2|Death|0|||
129058386|NCT00996892|464504321|FG013|Expansion Stage 2|Death|0|||
129058387|NCT00996892|464504322|FG014|Expansion Stage 2|Death|0|||
129058388|NCT00996892|464504323|FG015|Expansion Stage 2|Death|0|||
129058389|NCT00996892|464504324|FG016|Expansion Stage 2|Death|0|||
129058390|NCT00996892|464504325|FG017|Expansion Stage 2|Death|0|||
129058391|NCT00996892|464504326|FG018|Expansion Stage 2|Death|2|||
129058392|NCT00996892|464504327|FG019|Expansion Stage 2|Death|0|||
129058393|NCT00996892|464504308|FG000|Expansion Stage 2|Physician Decision|0|||
129058394|NCT00996892|464504309|FG001|Expansion Stage 2|Physician Decision|0|||
129058395|NCT00996892|464504310|FG002|Expansion Stage 2|Physician Decision|0|||
129058396|NCT00996892|464504311|FG003|Expansion Stage 2|Physician Decision|0|||
129058397|NCT00996892|464504312|FG004|Expansion Stage 2|Physician Decision|0|||
129058398|NCT00996892|464504313|FG005|Expansion Stage 2|Physician Decision|0|||
129058399|NCT00996892|464504314|FG006|Expansion Stage 2|Physician Decision|0|||
129058400|NCT00996892|464504315|FG007|Expansion Stage 2|Physician Decision|0|||
129058401|NCT00996892|464504316|FG008|Expansion Stage 2|Physician Decision|0|||
129058402|NCT00996892|464504317|FG009|Expansion Stage 2|Physician Decision|0|||
129058403|NCT00996892|464504318|FG010|Expansion Stage 2|Physician Decision|0|||
129058404|NCT00996892|464504319|FG011|Expansion Stage 2|Physician Decision|0|||
129058405|NCT00996892|464504320|FG012|Expansion Stage 2|Physician Decision|0|||
129058406|NCT00996892|464504321|FG013|Expansion Stage 2|Physician Decision|0|||
129058407|NCT00996892|464504322|FG014|Expansion Stage 2|Physician Decision|0|||
129058408|NCT00996892|464504323|FG015|Expansion Stage 2|Physician Decision|0|||
129058409|NCT00996892|464504324|FG016|Expansion Stage 2|Physician Decision|0|||
129058410|NCT00996892|464504325|FG017|Expansion Stage 2|Physician Decision|0|||
129058411|NCT00996892|464504326|FG018|Expansion Stage 2|Physician Decision|1|||
129058412|NCT00996892|464504327|FG019|Expansion Stage 2|Physician Decision|0|||
129058413|NCT00996892|464504308|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
129058414|NCT00996892|464504309|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
129058415|NCT00996892|464504310|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
129058416|NCT00996892|464504311|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
129058417|NCT00996892|464504312|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
129058418|NCT00996892|464504313|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
129058419|NCT00996892|464504314|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
129058420|NCT00996892|464504315|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
129058421|NCT00996892|464504316|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
129058422|NCT00996892|464504317|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
129058423|NCT00996892|464504318|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
129058424|NCT00996892|464504319|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
129058425|NCT00996892|464504320|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
129058426|NCT00996892|464504321|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
129058427|NCT00996892|464504322|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
129058428|NCT00996892|464504323|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
129058429|NCT00996892|464504324|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
129058430|NCT00996892|464504325|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
129058431|NCT00996892|464504326|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
129058432|NCT00996892|464504327|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
129058433|NCT00996892|464504308|FG000|Expansion Stage 2|Disease Progression|0|||
128720156|NCT00362115|463273350|FG005|Overall Study|Protocol Violation|1|||
129058434|NCT00996892|464504309|FG001|Expansion Stage 2|Disease Progression|0|||
129058435|NCT00996892|464504310|FG002|Expansion Stage 2|Disease Progression|0|||
129058436|NCT00996892|464504311|FG003|Expansion Stage 2|Disease Progression|0|||
129058437|NCT00996892|464504312|FG004|Expansion Stage 2|Disease Progression|0|||
129058438|NCT00996892|464504313|FG005|Expansion Stage 2|Disease Progression|0|||
129058439|NCT00996892|464504314|FG006|Expansion Stage 2|Disease Progression|0|||
128720157|NCT00362115|463273351|FG006|Overall Study|Protocol Violation|0|||
128720158|NCT00362115|463273345|FG000|Overall Study|Lost to Follow-up|0|||
128720159|NCT00362115|463273346|FG001|Overall Study|Lost to Follow-up|1|||
128720160|NCT00362115|463273347|FG002|Overall Study|Lost to Follow-up|0|||
128720161|NCT00362115|463273348|FG003|Overall Study|Lost to Follow-up|0|||
128720162|NCT00362115|463273349|FG004|Overall Study|Lost to Follow-up|2|||
128720163|NCT00362115|463273350|FG005|Overall Study|Lost to Follow-up|0|||
129058440|NCT00996892|464504315|FG007|Expansion Stage 2|Disease Progression|0|||
129058441|NCT00996892|464504316|FG008|Expansion Stage 2|Disease Progression|0|||
129058442|NCT00996892|464504317|FG009|Expansion Stage 2|Disease Progression|0|||
129058443|NCT00996892|464504318|FG010|Expansion Stage 2|Disease Progression|0|||
129058444|NCT00996892|464504319|FG011|Expansion Stage 2|Disease Progression|0|||
129058445|NCT00996892|464504320|FG012|Expansion Stage 2|Disease Progression|0|||
129058446|NCT00996892|464504321|FG013|Expansion Stage 2|Disease Progression|0|||
129058447|NCT00996892|464504322|FG014|Expansion Stage 2|Disease Progression|0|||
129058448|NCT00996892|464504323|FG015|Expansion Stage 2|Disease Progression|0|||
129058449|NCT00996892|464504324|FG016|Expansion Stage 2|Disease Progression|0|||
129058450|NCT00996892|464504325|FG017|Expansion Stage 2|Disease Progression|0|||
129058451|NCT00996892|464504326|FG018|Expansion Stage 2|Disease Progression|28|||
129058452|NCT00996892|464504327|FG019|Expansion Stage 2|Disease Progression|0|||
129058453|NCT00996892|464504308|FG000|Expansion Stage 2A|Adverse Event|0|||
129058454|NCT00996892|464504309|FG001|Expansion Stage 2A|Adverse Event|0|||
129058455|NCT00996892|464504310|FG002|Expansion Stage 2A|Adverse Event|0|||
129058456|NCT00996892|464504311|FG003|Expansion Stage 2A|Adverse Event|0|||
129058457|NCT00996892|464504312|FG004|Expansion Stage 2A|Adverse Event|0|||
129058458|NCT00996892|464504313|FG005|Expansion Stage 2A|Adverse Event|0|||
129058459|NCT00996892|464504314|FG006|Expansion Stage 2A|Adverse Event|0|||
129058460|NCT00996892|464504315|FG007|Expansion Stage 2A|Adverse Event|0|||
129058461|NCT00996892|464504316|FG008|Expansion Stage 2A|Adverse Event|0|||
129058462|NCT00996892|464504317|FG009|Expansion Stage 2A|Adverse Event|0|||
129058463|NCT00996892|464504318|FG010|Expansion Stage 2A|Adverse Event|0|||
129058464|NCT00996892|464504319|FG011|Expansion Stage 2A|Adverse Event|0|||
129058465|NCT00996892|464504320|FG012|Expansion Stage 2A|Adverse Event|0|||
129058466|NCT00996892|464504321|FG013|Expansion Stage 2A|Adverse Event|0|||
129058467|NCT00996892|464504322|FG014|Expansion Stage 2A|Adverse Event|0|||
129058468|NCT00996892|464504323|FG015|Expansion Stage 2A|Adverse Event|0|||
129058469|NCT00996892|464504324|FG016|Expansion Stage 2A|Adverse Event|0|||
129058470|NCT00996892|464504325|FG017|Expansion Stage 2A|Adverse Event|0|||
129058471|NCT00996892|464504326|FG018|Expansion Stage 2A|Adverse Event|0|||
129058472|NCT00996892|464504327|FG019|Expansion Stage 2A|Adverse Event|8|||
129058473|NCT00996892|464504308|FG000|Expansion Stage 2A|Physician Decision|0|||
129058474|NCT00996892|464504309|FG001|Expansion Stage 2A|Physician Decision|0|||
129058475|NCT00996892|464504310|FG002|Expansion Stage 2A|Physician Decision|0|||
129058476|NCT00996892|464504311|FG003|Expansion Stage 2A|Physician Decision|0|||
129058477|NCT00996892|464504312|FG004|Expansion Stage 2A|Physician Decision|0|||
129058478|NCT00996892|464504313|FG005|Expansion Stage 2A|Physician Decision|0|||
129058479|NCT00996892|464504314|FG006|Expansion Stage 2A|Physician Decision|0|||
129058480|NCT00996892|464504315|FG007|Expansion Stage 2A|Physician Decision|0|||
129058481|NCT00996892|464504316|FG008|Expansion Stage 2A|Physician Decision|0|||
129058482|NCT00996892|464504317|FG009|Expansion Stage 2A|Physician Decision|0|||
129058483|NCT00996892|464504318|FG010|Expansion Stage 2A|Physician Decision|0|||
129058484|NCT00996892|464504319|FG011|Expansion Stage 2A|Physician Decision|0|||
129058485|NCT00996892|464504320|FG012|Expansion Stage 2A|Physician Decision|0|||
129058486|NCT00996892|464504321|FG013|Expansion Stage 2A|Physician Decision|0|||
129058487|NCT00996892|464504322|FG014|Expansion Stage 2A|Physician Decision|0|||
129058488|NCT00996892|464504323|FG015|Expansion Stage 2A|Physician Decision|0|||
129058489|NCT00996892|464504324|FG016|Expansion Stage 2A|Physician Decision|0|||
129058490|NCT00996892|464504325|FG017|Expansion Stage 2A|Physician Decision|0|||
129058491|NCT00996892|464504326|FG018|Expansion Stage 2A|Physician Decision|0|||
129058492|NCT00996892|464504327|FG019|Expansion Stage 2A|Physician Decision|2|||
129058493|NCT00996892|464504308|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
129058494|NCT00996892|464504309|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
129058495|NCT00996892|464504310|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
129058496|NCT00996892|464504311|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
129058497|NCT00996892|464504312|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
129058498|NCT00996892|464504313|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
129058499|NCT00996892|464504314|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
129058500|NCT00996892|464504315|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
128720164|NCT00362115|463273351|FG006|Overall Study|Lost to Follow-up|1|||
129058501|NCT00996892|464504316|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
129058502|NCT00996892|464504317|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
129058503|NCT00996892|464504318|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
129058504|NCT00996892|464504319|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
129058505|NCT00996892|464504320|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
129058506|NCT00996892|464504321|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
129058507|NCT00996892|464504322|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
129058508|NCT00996892|464504323|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
129058509|NCT00996892|464504324|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
129058510|NCT00996892|464504325|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
129058511|NCT00996892|464504326|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
129058512|NCT00996892|464504327|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
129058513|NCT00996892|464504308|FG000|Expansion Stage 2A|Disease Progression|0|||
129058514|NCT00996892|464504309|FG001|Expansion Stage 2A|Disease Progression|0|||
129058515|NCT00996892|464504310|FG002|Expansion Stage 2A|Disease Progression|0|||
129058516|NCT00996892|464504311|FG003|Expansion Stage 2A|Disease Progression|0|||
129058517|NCT00996892|464504312|FG004|Expansion Stage 2A|Disease Progression|0|||
129058518|NCT00996892|464504313|FG005|Expansion Stage 2A|Disease Progression|0|||
129058519|NCT00996892|464504314|FG006|Expansion Stage 2A|Disease Progression|0|||
129058520|NCT00996892|464504315|FG007|Expansion Stage 2A|Disease Progression|0|||
129058521|NCT00996892|464504316|FG008|Expansion Stage 2A|Disease Progression|0|||
129058522|NCT00996892|464504317|FG009|Expansion Stage 2A|Disease Progression|0|||
129058523|NCT00996892|464504318|FG010|Expansion Stage 2A|Disease Progression|0|||
129058524|NCT00996892|464504319|FG011|Expansion Stage 2A|Disease Progression|0|||
129058525|NCT00996892|464504320|FG012|Expansion Stage 2A|Disease Progression|0|||
129058526|NCT00996892|464504321|FG013|Expansion Stage 2A|Disease Progression|0|||
129058527|NCT00996892|464504322|FG014|Expansion Stage 2A|Disease Progression|0|||
129058528|NCT00996892|464504323|FG015|Expansion Stage 2A|Disease Progression|0|||
129058529|NCT00996892|464504324|FG016|Expansion Stage 2A|Disease Progression|0|||
129058530|NCT00996892|464504325|FG017|Expansion Stage 2A|Disease Progression|0|||
129058531|NCT00996892|464504326|FG018|Expansion Stage 2A|Disease Progression|0|||
129058532|NCT00996892|464504327|FG019|Expansion Stage 2A|Disease Progression|31|||
129058533|NCT01653912|464504328|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129058534|NCT01653912|464504329|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
129058535|NCT01653912|464504330|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129058536|NCT01653912|464504331|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129058537|NCT01653912|464504332|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129058538|NCT01653912|464504333|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129058539|NCT01653912|464504328|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129058540|NCT01653912|464504329|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129058541|NCT01653912|464504330|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
129058542|NCT01653912|464504331|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129058543|NCT01653912|464504332|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129058544|NCT01653912|464504333|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129058545|NCT01653912|464504328|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129058546|NCT01653912|464504329|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129058547|NCT01653912|464504330|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129058548|NCT01653912|464504331|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
129058549|NCT01653912|464504332|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129058550|NCT01653912|464504333|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129058551|NCT01653912|464504328|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058552|NCT01653912|464504329|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058553|NCT01653912|464504330|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058554|NCT01653912|464504331|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
129058555|NCT01653912|464504332|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058556|NCT01653912|464504333|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058557|NCT01653912|464504328|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129058558|NCT01653912|464504329|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129058559|NCT01653912|464504330|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129058560|NCT01653912|464504331|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129058561|NCT01653912|464504332|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129058562|NCT01653912|464504333|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
129058563|NCT01653912|464504328|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129058564|NCT01653912|464504329|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129058565|NCT01653912|464504330|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129058566|NCT01653912|464504331|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129058567|NCT01653912|464504332|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129058568|NCT01653912|464504333|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
129058569|NCT01653912|464504328|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058570|NCT01653912|464504329|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058571|NCT01653912|464504330|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058572|NCT01653912|464504331|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
128775545|NCT01474512|463468372|FG015|Post-Treatment Follow-Up|Death|0|||
128775546|NCT01474512|463468373|FG016|Post-Treatment Follow-Up|Death|1|||
129058573|NCT01653912|464504332|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129058574|NCT01653912|464504333|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
129058575|NCT01987479|464504334|FG000|Overall Study|Protocol Violation|1|||
129058576|NCT01987479|464504334|FG000|Overall Study|Physician Decision|2|||
129058577|NCT01987479|464504334|FG000|Overall Study|Participant/legal guardian decision|1|||
129058578|NCT01987479|464504334|FG000|Overall Study|Other|5|||
129058579|NCT01987479|464504334|FG000|Overall Study|Lost to Follow-up|1|||
129058580|NCT01987479|464504334|FG000|Overall Study|Adverse Event|7|||
129058581|NCT00602641|464506095|FG000|Overall Study|Never started protocol therapy|6|||
129058582|NCT00602641|464506096|FG001|Overall Study|Never started protocol therapy|2|||
128775547|NCT01474512|463468374|FG017|Post-Treatment Follow-Up|Death|0|||
129058583|NCT00602641|464506095|FG000|Overall Study|Still on treatment at time of analysis|8|||
129058584|NCT00602641|464506096|FG001|Overall Study|Still on treatment at time of analysis|15|||
129058585|NCT00602641|464506095|FG000|Overall Study|Adverse Event|62|||
129058586|NCT00602641|464506096|FG001|Overall Study|Adverse Event|53|||
129058587|NCT00602641|464506095|FG000|Overall Study|Disease progression|38|||
129058588|NCT00602641|464506096|FG001|Overall Study|Disease progression|55|||
129058589|NCT00602641|464506095|FG000|Overall Study|Death|6|||
129058590|NCT00602641|464506096|FG001|Overall Study|Death|5|||
129058591|NCT00602641|464506095|FG000|Overall Study|Withdrawal by Subject|15|||
129058592|NCT00602641|464506096|FG001|Overall Study|Withdrawal by Subject|12|||
129058593|NCT00602641|464506095|FG000|Overall Study|Alternative therapy|5|||
129058594|NCT00602641|464506096|FG001|Overall Study|Alternative therapy|2|||
129058595|NCT00602641|464506095|FG000|Overall Study|Other Complicating Disease|5|||
129058596|NCT00602641|464506096|FG001|Overall Study|Other Complicating Disease|2|||
129058597|NCT00602641|464506095|FG000|Overall Study|Physician Decision|5|||
129058598|NCT00602641|464506096|FG001|Overall Study|Physician Decision|4|||
129058599|NCT00602641|464506095|FG000|Overall Study|Administrative Closure|1|||
129058600|NCT00602641|464506096|FG001|Overall Study|Administrative Closure|1|||
129058601|NCT00602641|464506095|FG000|Overall Study|Other|3|||
129058602|NCT00602641|464506096|FG001|Overall Study|Other|1|||
129058603|NCT02245412|464506106|FG000|Treatment Period|Death|1|||
129058604|NCT02245412|464506107|FG001|Treatment Period|Death|1|||
129058605|NCT02245412|464506108|FG002|Treatment Period|Death|0|||
129058606|NCT02245412|464506106|FG000|Treatment Period|Physician Decision|1|||
129058607|NCT02245412|464506107|FG001|Treatment Period|Physician Decision|1|||
129058608|NCT02245412|464506108|FG002|Treatment Period|Physician Decision|0|||
129058609|NCT02245412|464506106|FG000|Treatment Period|Withdrawal by Subject|2|||
129058610|NCT02245412|464506107|FG001|Treatment Period|Withdrawal by Subject|1|||
129058611|NCT02245412|464506108|FG002|Treatment Period|Withdrawal by Subject|0|||
129058612|NCT02245412|464506106|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
129058613|NCT02245412|464506107|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
129058614|NCT02245412|464506108|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
129058615|NCT02245412|464506106|FG000|Follow-Up Period|Death|4|||
129058616|NCT02245412|464506107|FG001|Follow-Up Period|Death|2|||
129058617|NCT02245412|464506108|FG002|Follow-Up Period|Death|1|||
129058618|NCT02245412|464506106|FG000|Follow-Up Period|Physician Decision|1|||
129058619|NCT02245412|464506107|FG001|Follow-Up Period|Physician Decision|0|||
129058620|NCT02245412|464506108|FG002|Follow-Up Period|Physician Decision|0|||
129058621|NCT02245412|464506106|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
129058622|NCT02245412|464506107|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
129058623|NCT02245412|464506108|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
129058624|NCT01371747|464506109|FG000|Overall Study|Adverse Event|4|||
129058625|NCT01371747|464506110|FG001|Overall Study|Adverse Event|2|||
129058626|NCT01371747|464506111|FG002|Overall Study|Adverse Event|7|||
129058627|NCT01371747|464506112|FG003|Overall Study|Adverse Event|2|||
129058628|NCT01371747|464506113|FG004|Overall Study|Adverse Event|2|||
129058629|NCT01371747|464506114|FG005|Overall Study|Adverse Event|2|||
129058630|NCT01371747|464506109|FG000|Overall Study|Death|1|||
129058631|NCT01371747|464506110|FG001|Overall Study|Death|0|||
129058632|NCT01371747|464506111|FG002|Overall Study|Death|4|||
129058633|NCT01371747|464506112|FG003|Overall Study|Death|1|||
129058634|NCT01371747|464506113|FG004|Overall Study|Death|2|||
129058635|NCT01371747|464506114|FG005|Overall Study|Death|0|||
129058636|NCT01371747|464506109|FG000|Overall Study|Abnormal Renal Function|0|||
129058637|NCT01371747|464506110|FG001|Overall Study|Abnormal Renal Function|2|||
129058638|NCT01371747|464506111|FG002|Overall Study|Abnormal Renal Function|0|||
129058639|NCT01371747|464506112|FG003|Overall Study|Abnormal Renal Function|1|||
129058640|NCT01371747|464506113|FG004|Overall Study|Abnormal Renal Function|0|||
129058641|NCT01371747|464506114|FG005|Overall Study|Abnormal Renal Function|1|||
129058642|NCT01371747|464506109|FG000|Overall Study|High Serum Potassium Results|1|||
129058643|NCT01371747|464506110|FG001|Overall Study|High Serum Potassium Results|1|||
129058644|NCT01371747|464506111|FG002|Overall Study|High Serum Potassium Results|1|||
129058645|NCT01371747|464506112|FG003|Overall Study|High Serum Potassium Results|2|||
129058646|NCT01371747|464506113|FG004|Overall Study|High Serum Potassium Results|0|||
129058647|NCT01371747|464506114|FG005|Overall Study|High Serum Potassium Results|2|||
129058648|NCT01371747|464506109|FG000|Overall Study|Low Serum Potassium Results|1|||
129058649|NCT01371747|464506110|FG001|Overall Study|Low Serum Potassium Results|1|||
129058650|NCT01371747|464506111|FG002|Overall Study|Low Serum Potassium Results|1|||
129058651|NCT01371747|464506112|FG003|Overall Study|Low Serum Potassium Results|1|||
129058652|NCT01371747|464506113|FG004|Overall Study|Low Serum Potassium Results|0|||
129058653|NCT01371747|464506114|FG005|Overall Study|Low Serum Potassium Results|3|||
129058654|NCT01371747|464506109|FG000|Overall Study|Protocol Violation|0|||
129058655|NCT01371747|464506110|FG001|Overall Study|Protocol Violation|0|||
129058656|NCT01371747|464506111|FG002|Overall Study|Protocol Violation|1|||
129058657|NCT01371747|464506112|FG003|Overall Study|Protocol Violation|0|||
129058658|NCT01371747|464506113|FG004|Overall Study|Protocol Violation|0|||
129058659|NCT01371747|464506114|FG005|Overall Study|Protocol Violation|0|||
129058660|NCT01371747|464506109|FG000|Overall Study|Non-Compliance|3|||
129058661|NCT01371747|464506110|FG001|Overall Study|Non-Compliance|4|||
129058662|NCT01371747|464506111|FG002|Overall Study|Non-Compliance|3|||
129058663|NCT01371747|464506112|FG003|Overall Study|Non-Compliance|0|||
129058664|NCT01371747|464506113|FG004|Overall Study|Non-Compliance|0|||
129058665|NCT01371747|464506114|FG005|Overall Study|Non-Compliance|1|||
129058666|NCT01371747|464506109|FG000|Overall Study|Physician Decision|0|||
129058667|NCT01371747|464506110|FG001|Overall Study|Physician Decision|0|||
129058668|NCT01371747|464506111|FG002|Overall Study|Physician Decision|0|||
129058669|NCT01371747|464506112|FG003|Overall Study|Physician Decision|0|||
129058670|NCT01371747|464506113|FG004|Overall Study|Physician Decision|1|||
129058671|NCT01371747|464506114|FG005|Overall Study|Physician Decision|0|||
129058672|NCT01371747|464506109|FG000|Overall Study|Withdrawal by Subject|6|||
129058673|NCT01371747|464506110|FG001|Overall Study|Withdrawal by Subject|12|||
129058674|NCT01371747|464506111|FG002|Overall Study|Withdrawal by Subject|5|||
129058675|NCT01371747|464506112|FG003|Overall Study|Withdrawal by Subject|2|||
129058676|NCT01371747|464506113|FG004|Overall Study|Withdrawal by Subject|2|||
129058677|NCT01371747|464506114|FG005|Overall Study|Withdrawal by Subject|4|||
129058678|NCT01371747|464506109|FG000|Overall Study|Other Reasons|2|||
129058679|NCT01371747|464506110|FG001|Overall Study|Other Reasons|1|||
129058680|NCT01371747|464506111|FG002|Overall Study|Other Reasons|2|||
129058681|NCT01371747|464506112|FG003|Overall Study|Other Reasons|0|||
129058682|NCT01371747|464506113|FG004|Overall Study|Other Reasons|0|||
129058683|NCT01371747|464506114|FG005|Overall Study|Other Reasons|1|||
129058684|NCT00580788|464506115|FG000|Overall Study|Adverse Event|0|||
129058685|NCT00580788|464506116|FG001|Overall Study|Adverse Event|0|||
129058686|NCT00580788|464506117|FG002|Overall Study|Adverse Event|0|||
129058687|NCT00580788|464506118|FG003|Overall Study|Adverse Event|1|||
129058688|NCT01443728|464506119|FG000|Overall Study|Lost to Follow-up|2|||
129058689|NCT01443728|464506120|FG001|Overall Study|Lost to Follow-up|0|||
129058690|NCT01443728|464506119|FG000|Overall Study|Withdrawal by Subject|1|||
129058691|NCT01443728|464506120|FG001|Overall Study|Withdrawal by Subject|1|||
129058692|NCT01443728|464506119|FG000|Overall Study|Adverse Event|0|||
129058693|NCT01443728|464506120|FG001|Overall Study|Adverse Event|2|||
129058694|NCT04971187|464506121|FG000|Overall Study|Screen failures|2|||
129058695|NCT02906358|464506122|FG000|Overall Study|Withdrawal by Subject|10|||
129058696|NCT02906358|464506123|FG001|Overall Study|Withdrawal by Subject|7|||
129058697|NCT02906358|464506122|FG000|Overall Study|Lost to Follow-up|12|||
129058698|NCT02906358|464506123|FG001|Overall Study|Lost to Follow-up|15|||
129058699|NCT01145508|464506125|FG000|Overall Study|Adverse Event|1|||
129058700|NCT01145508|464506126|FG001|Overall Study|Adverse Event|0|||
129058701|NCT01145508|464506125|FG000|Overall Study|Death|1|||
129058702|NCT01145508|464506126|FG001|Overall Study|Death|0|||
129058703|NCT01145508|464506125|FG000|Overall Study|Physician Decision|2|||
129058704|NCT01145508|464506126|FG001|Overall Study|Physician Decision|1|||
129058705|NCT01145508|464506125|FG000|Overall Study|Never started treatment|1|||
129058706|NCT01145508|464506126|FG001|Overall Study|Never started treatment|1|||
129058707|NCT02045147|464506127|FG000|Overall Study|Withdrawal by Subject|2|||
129058708|NCT02045147|464506128|FG001|Overall Study|Withdrawal by Subject|0|||
129058709|NCT02045147|464506129|FG002|Overall Study|Withdrawal by Subject|0|||
129058710|NCT02045147|464506130|FG003|Overall Study|Withdrawal by Subject|0|||
129058711|NCT02045147|464506131|FG004|Overall Study|Withdrawal by Subject|0|||
129058712|NCT02045147|464506132|FG005|Overall Study|Withdrawal by Subject|0|||
129058713|NCT02045147|464506133|FG006|Overall Study|Withdrawal by Subject|0|||
129058714|NCT02045147|464506134|FG007|Overall Study|Withdrawal by Subject|1|||
129058715|NCT02045147|464506127|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
129058716|NCT02045147|464506128|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
129058717|NCT02045147|464506129|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
129058718|NCT02045147|464506130|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
129058719|NCT02045147|464506131|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
129058720|NCT02045147|464506132|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
129058721|NCT02045147|464506133|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
129058722|NCT02045147|464506134|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
129058723|NCT04839692|464506135|FG000|Overall Study|Withdrawal by Subject|0|||
129058724|NCT04839692|464506136|FG001|Overall Study|Withdrawal by Subject|3|||
129058725|NCT04839692|464506135|FG000|Overall Study|Physician Decision|1|||
129058726|NCT04839692|464506136|FG001|Overall Study|Physician Decision|0|||
129058727|NCT03146962|464506137|FG000|Overall Study|Lost to Follow-up|1|||
129058728|NCT03146962|464506138|FG001|Overall Study|Lost to Follow-up|1|||
129058729|NCT03146962|464506139|FG002|Overall Study|Lost to Follow-up|0|||
129058730|NCT03146962|464506140|FG003|Overall Study|Lost to Follow-up|0|||
129058731|NCT03146962|464506141|FG004|Overall Study|Lost to Follow-up|0|||
129058732|NCT03146962|464506142|FG005|Overall Study|Lost to Follow-up|0|||
129058733|NCT03146962|464506143|FG006|Overall Study|Lost to Follow-up|0|||
129058734|NCT03146962|464506144|FG007|Overall Study|Lost to Follow-up|0|||
129058735|NCT03146962|464506145|FG008|Overall Study|Lost to Follow-up|0|||
129058736|NCT03146962|464506146|FG009|Overall Study|Lost to Follow-up|0|||
129058737|NCT03146962|464506137|FG000|Overall Study|Adverse Event|0|||
129058738|NCT03146962|464506138|FG001|Overall Study|Adverse Event|3|||
129058739|NCT03146962|464506139|FG002|Overall Study|Adverse Event|0|||
129058740|NCT03146962|464506140|FG003|Overall Study|Adverse Event|0|||
129058741|NCT03146962|464506141|FG004|Overall Study|Adverse Event|0|||
129058742|NCT03146962|464506142|FG005|Overall Study|Adverse Event|0|||
129058743|NCT03146962|464506143|FG006|Overall Study|Adverse Event|0|||
129058744|NCT03146962|464506144|FG007|Overall Study|Adverse Event|1|||
129058745|NCT03146962|464506145|FG008|Overall Study|Adverse Event|0|||
129058746|NCT03146962|464506146|FG009|Overall Study|Adverse Event|0|||
129058747|NCT03146962|464506137|FG000|Overall Study|Withdrawal by Subject|0|||
129058748|NCT03146962|464506138|FG001|Overall Study|Withdrawal by Subject|0|||
129058749|NCT03146962|464506139|FG002|Overall Study|Withdrawal by Subject|0|||
129058750|NCT03146962|464506140|FG003|Overall Study|Withdrawal by Subject|0|||
129058751|NCT03146962|464506141|FG004|Overall Study|Withdrawal by Subject|1|||
129058752|NCT03146962|464506142|FG005|Overall Study|Withdrawal by Subject|0|||
129058753|NCT03146962|464506143|FG006|Overall Study|Withdrawal by Subject|0|||
129058754|NCT03146962|464506144|FG007|Overall Study|Withdrawal by Subject|0|||
129058755|NCT03146962|464506145|FG008|Overall Study|Withdrawal by Subject|0|||
129058756|NCT03146962|464506146|FG009|Overall Study|Withdrawal by Subject|0|||
129058757|NCT03146962|464506137|FG000|Overall Study|Death|0|||
129058758|NCT03146962|464506138|FG001|Overall Study|Death|1|||
129058759|NCT03146962|464506139|FG002|Overall Study|Death|0|||
129058760|NCT03146962|464506140|FG003|Overall Study|Death|0|||
129058761|NCT03146962|464506141|FG004|Overall Study|Death|0|||
129058762|NCT03146962|464506142|FG005|Overall Study|Death|0|||
129058763|NCT03146962|464506143|FG006|Overall Study|Death|0|||
129058764|NCT03146962|464506144|FG007|Overall Study|Death|0|||
129058765|NCT03146962|464506145|FG008|Overall Study|Death|0|||
129058766|NCT03146962|464506146|FG009|Overall Study|Death|0|||
129058767|NCT03146962|464506137|FG000|Overall Study|COVID Precautions|1|||
129058768|NCT03146962|464506138|FG001|Overall Study|COVID Precautions|0|||
129058769|NCT03146962|464506139|FG002|Overall Study|COVID Precautions|0|||
129058770|NCT03146962|464506140|FG003|Overall Study|COVID Precautions|0|||
129058771|NCT03146962|464506141|FG004|Overall Study|COVID Precautions|0|||
129058772|NCT03146962|464506142|FG005|Overall Study|COVID Precautions|0|||
129058773|NCT03146962|464506143|FG006|Overall Study|COVID Precautions|0|||
129058774|NCT03146962|464506144|FG007|Overall Study|COVID Precautions|0|||
129058775|NCT03146962|464506145|FG008|Overall Study|COVID Precautions|0|||
129058776|NCT03146962|464506146|FG009|Overall Study|COVID Precautions|0|||
129058777|NCT03146962|464506137|FG000|Overall Study|Physician Decision|0|||
129058778|NCT03146962|464506138|FG001|Overall Study|Physician Decision|0|||
129058779|NCT03146962|464506139|FG002|Overall Study|Physician Decision|0|||
129058780|NCT03146962|464506140|FG003|Overall Study|Physician Decision|0|||
129058781|NCT03146962|464506141|FG004|Overall Study|Physician Decision|0|||
129058782|NCT03146962|464506142|FG005|Overall Study|Physician Decision|0|||
129058783|NCT03146962|464506143|FG006|Overall Study|Physician Decision|0|||
129058784|NCT03146962|464506144|FG007|Overall Study|Physician Decision|0|||
129058785|NCT03146962|464506145|FG008|Overall Study|Physician Decision|0|||
129058786|NCT03146962|464506146|FG009|Overall Study|Physician Decision|1|||
129058787|NCT03146962|464506137|FG000|Overall Study|Started New Treatment|0|||
129058788|NCT03146962|464506138|FG001|Overall Study|Started New Treatment|1|||
129058789|NCT03146962|464506139|FG002|Overall Study|Started New Treatment|0|||
129058790|NCT03146962|464506140|FG003|Overall Study|Started New Treatment|0|||
129058791|NCT03146962|464506141|FG004|Overall Study|Started New Treatment|0|||
129058792|NCT03146962|464506142|FG005|Overall Study|Started New Treatment|0|||
129058793|NCT03146962|464506143|FG006|Overall Study|Started New Treatment|0|||
129058794|NCT03146962|464506144|FG007|Overall Study|Started New Treatment|0|||
129058795|NCT03146962|464506145|FG008|Overall Study|Started New Treatment|0|||
129058796|NCT03146962|464506146|FG009|Overall Study|Started New Treatment|0|||
129058797|NCT00264550|464506149|FG000|Overall Study|Death|0|||
128720165|NCT00362115|463273345|FG000|Overall Study|Withdrawal by Subject|1|||
128720166|NCT00362115|463273346|FG001|Overall Study|Withdrawal by Subject|3|||
129058798|NCT00264550|464506150|FG001|Overall Study|Death|3|||
128720167|NCT00362115|463273347|FG002|Overall Study|Withdrawal by Subject|1|||
129058799|NCT00264550|464506151|FG002|Overall Study|Death|0|||
129058800|NCT00264550|464506152|FG003|Overall Study|Death|0|||
128720168|NCT00362115|463273348|FG003|Overall Study|Withdrawal by Subject|0|||
129058801|NCT00264550|464506149|FG000|Overall Study|Lost to Follow-up|3|||
129058802|NCT00264550|464506150|FG001|Overall Study|Lost to Follow-up|1|||
129058803|NCT00264550|464506151|FG002|Overall Study|Lost to Follow-up|1|||
129058804|NCT00264550|464506152|FG003|Overall Study|Lost to Follow-up|1|||
128720169|NCT00362115|463273349|FG004|Overall Study|Withdrawal by Subject|1|||
129058805|NCT00264550|464506149|FG000|Overall Study|Adverse Event|23|||
129058806|NCT00264550|464506150|FG001|Overall Study|Adverse Event|18|||
129058807|NCT00264550|464506151|FG002|Overall Study|Adverse Event|9|||
129058808|NCT00264550|464506152|FG003|Overall Study|Adverse Event|14|||
129058809|NCT00264550|464506149|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129058810|NCT00264550|464506150|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
129058811|NCT00264550|464506151|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
128720170|NCT00362115|463273350|FG005|Overall Study|Withdrawal by Subject|3|||
128720171|NCT00362115|463273351|FG006|Overall Study|Withdrawal by Subject|4|||
128720172|NCT00362115|463273345|FG000|Overall Study|Lack of Efficacy|1|||
128720173|NCT00362115|463273346|FG001|Overall Study|Lack of Efficacy|0|||
128720174|NCT00362115|463273347|FG002|Overall Study|Lack of Efficacy|5|||
128720175|NCT00362115|463273348|FG003|Overall Study|Lack of Efficacy|2|||
128720176|NCT00362115|463273349|FG004|Overall Study|Lack of Efficacy|2|||
128720177|NCT00362115|463273350|FG005|Overall Study|Lack of Efficacy|0|||
128720178|NCT00362115|463273351|FG006|Overall Study|Lack of Efficacy|3|||
129058812|NCT00264550|464506152|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
128720179|NCT00362115|463273345|FG000|Overall Study|Physician Decision|0|||
129058813|NCT00264550|464506149|FG000|Overall Study|Discontinued oral study agent|0|||
129058814|NCT00264550|464506150|FG001|Overall Study|Discontinued oral study agent|1|||
129058815|NCT00264550|464506151|FG002|Overall Study|Discontinued oral study agent|0|||
129058816|NCT00264550|464506152|FG003|Overall Study|Discontinued oral study agent|0|||
129058817|NCT00264550|464506149|FG000|Overall Study|Other|13|||
129058818|NCT00264550|464506150|FG001|Overall Study|Other|7|||
129058819|NCT00264550|464506151|FG002|Overall Study|Other|3|||
129058820|NCT00264550|464506152|FG003|Overall Study|Other|9|||
129058821|NCT04497948|464506153|FG000|Overall Study|Death|2|||
129058822|NCT02246114|464506154|FG000|Overall Study|miscarriage|1|||
129058823|NCT02246114|464506155|FG001|Overall Study|miscarriage|0|||
129058824|NCT00696787|464506162|FG000|Overall Study|Adverse Event|1|||
129058825|NCT00696787|464506163|FG001|Overall Study|Adverse Event|0|||
129058826|NCT00696787|464506164|FG002|Overall Study|Adverse Event|6|||
129058827|NCT00696787|464506162|FG000|Overall Study|Discontinuation by Sponsor|9|||
129058828|NCT00696787|464506163|FG001|Overall Study|Discontinuation by Sponsor|13|||
129058829|NCT00696787|464506164|FG002|Overall Study|Discontinuation by Sponsor|14|||
129058830|NCT00696787|464506162|FG000|Overall Study|Lack of Efficacy|0|||
129058831|NCT00696787|464506163|FG001|Overall Study|Lack of Efficacy|1|||
129058832|NCT00696787|464506164|FG002|Overall Study|Lack of Efficacy|0|||
129058833|NCT00696787|464506162|FG000|Overall Study|Lost to Follow-up|4|||
129058834|NCT00696787|464506163|FG001|Overall Study|Lost to Follow-up|0|||
129058835|NCT00696787|464506164|FG002|Overall Study|Lost to Follow-up|3|||
128720180|NCT00362115|463273346|FG001|Overall Study|Physician Decision|0|||
128720181|NCT00362115|463273347|FG002|Overall Study|Physician Decision|0|||
128720182|NCT00362115|463273348|FG003|Overall Study|Physician Decision|0|||
128720183|NCT00362115|463273349|FG004|Overall Study|Physician Decision|0|||
128775548|NCT01023308|463468379|FG000|Overall Study|Abnormal test proceedure results|3|||
128775549|NCT01023308|463468380|FG001|Overall Study|Abnormal test proceedure results|8|||
128775550|NCT01023308|463468379|FG000|Overall Study|Administrative problems|2|||
128775551|NCT01023308|463468380|FG001|Overall Study|Administrative problems|1|||
128775552|NCT01023308|463468379|FG000|Overall Study|Adverse Event|130|||
129058836|NCT00696787|464506162|FG000|Overall Study|Withdrawal by Subject|0|||
129058837|NCT00696787|464506163|FG001|Overall Study|Withdrawal by Subject|3|||
129058838|NCT00696787|464506164|FG002|Overall Study|Withdrawal by Subject|2|||
129058839|NCT00696787|464506162|FG000|Overall Study|Failed to return|1|||
129058840|NCT00696787|464506163|FG001|Overall Study|Failed to return|3|||
129058841|NCT00696787|464506164|FG002|Overall Study|Failed to return|1|||
129058842|NCT00129389|464506165|FG000|Overall Study|Adverse Event|19|||
129058843|NCT00129389|464506166|FG001|Overall Study|Adverse Event|87|||
129058844|NCT00129389|464506165|FG000|Overall Study|Death|0|||
129058845|NCT00129389|464506166|FG001|Overall Study|Death|1|||
129058846|NCT00129389|464506165|FG000|Overall Study|Lost to Follow-up|2|||
129058847|NCT00129389|464506166|FG001|Overall Study|Lost to Follow-up|1|||
129058848|NCT00129389|464506165|FG000|Overall Study|Physician Decision|0|||
129058849|NCT00129389|464506166|FG001|Overall Study|Physician Decision|4|||
129058850|NCT00129389|464506165|FG000|Overall Study|Protocol Violation|0|||
129058851|NCT00129389|464506166|FG001|Overall Study|Protocol Violation|6|||
129058852|NCT00129389|464506165|FG000|Overall Study|Withdrawal by Subject|9|||
129058853|NCT00129389|464506166|FG001|Overall Study|Withdrawal by Subject|23|||
129058854|NCT00129389|464506165|FG000|Overall Study|Relapse|1|||
129058855|NCT00129389|464506166|FG001|Overall Study|Relapse|0|||
129058856|NCT00129389|464506165|FG000|Overall Study|Not eligible|1|||
129058857|NCT00129389|464506166|FG001|Overall Study|Not eligible|2|||
129058858|NCT00129389|464506165|FG000|Overall Study|Crossed to the other arm|1|||
129058859|NCT00129389|464506166|FG001|Overall Study|Crossed to the other arm|16|||
129058860|NCT03760185|464506167|FG000|Overall Study|Lost to Follow-up|1|||
129058861|NCT03760185|464506168|FG001|Overall Study|Lost to Follow-up|1|||
129058862|NCT00425373|464506234|FG000|Overall Study|Adverse Event|2|||
129058863|NCT00425373|464506235|FG001|Overall Study|Adverse Event|2|||
129058864|NCT00425373|464506236|FG002|Overall Study|Adverse Event|0|||
129058865|NCT00425373|464506237|FG003|Overall Study|Adverse Event|1|||
128775553|NCT01023308|463468380|FG001|Overall Study|Adverse Event|66|||
129058866|NCT00425373|464506238|FG004|Overall Study|Adverse Event|4|||
129058867|NCT00425373|464506239|FG005|Overall Study|Adverse Event|6|||
129058868|NCT00425373|464506240|FG006|Overall Study|Adverse Event|2|||
128720184|NCT00362115|463273350|FG005|Overall Study|Physician Decision|0|||
128720185|NCT00362115|463273351|FG006|Overall Study|Physician Decision|3|||
128720186|NCT00362115|463273345|FG000|Overall Study|Other|0|||
129058869|NCT00425373|464506241|FG007|Overall Study|Adverse Event|3|||
129058870|NCT00425373|464506242|FG008|Overall Study|Adverse Event|8|||
129058871|NCT00425373|464506234|FG000|Overall Study|Lost to Follow-up|0|||
129058872|NCT00425373|464506235|FG001|Overall Study|Lost to Follow-up|1|||
129058873|NCT00425373|464506236|FG002|Overall Study|Lost to Follow-up|0|||
129058874|NCT00425373|464506237|FG003|Overall Study|Lost to Follow-up|0|||
129058875|NCT00425373|464506238|FG004|Overall Study|Lost to Follow-up|1|||
129058876|NCT00425373|464506239|FG005|Overall Study|Lost to Follow-up|0|||
129058877|NCT00425373|464506240|FG006|Overall Study|Lost to Follow-up|0|||
129058878|NCT00425373|464506241|FG007|Overall Study|Lost to Follow-up|0|||
129058879|NCT00425373|464506242|FG008|Overall Study|Lost to Follow-up|0|||
129058880|NCT00425373|464506234|FG000|Overall Study|Protocol Violation|1|||
129058881|NCT00425373|464506235|FG001|Overall Study|Protocol Violation|0|||
129058882|NCT00425373|464506236|FG002|Overall Study|Protocol Violation|1|||
129058883|NCT00425373|464506237|FG003|Overall Study|Protocol Violation|0|||
129058884|NCT00425373|464506238|FG004|Overall Study|Protocol Violation|0|||
129058885|NCT00425373|464506239|FG005|Overall Study|Protocol Violation|0|||
129058886|NCT00425373|464506240|FG006|Overall Study|Protocol Violation|0|||
129058887|NCT00425373|464506241|FG007|Overall Study|Protocol Violation|5|||
129058888|NCT00425373|464506242|FG008|Overall Study|Protocol Violation|3|||
129058889|NCT00425373|464506234|FG000|Overall Study|Withdrawal by Subject|2|||
129058890|NCT00425373|464506235|FG001|Overall Study|Withdrawal by Subject|0|||
129058891|NCT00425373|464506236|FG002|Overall Study|Withdrawal by Subject|2|||
129058892|NCT00425373|464506237|FG003|Overall Study|Withdrawal by Subject|1|||
129058893|NCT00425373|464506238|FG004|Overall Study|Withdrawal by Subject|4|||
129058894|NCT00425373|464506239|FG005|Overall Study|Withdrawal by Subject|0|||
129058895|NCT00425373|464506240|FG006|Overall Study|Withdrawal by Subject|2|||
129058896|NCT00425373|464506241|FG007|Overall Study|Withdrawal by Subject|2|||
129058897|NCT00425373|464506242|FG008|Overall Study|Withdrawal by Subject|2|||
129058898|NCT00425373|464506234|FG000|Overall Study|Lack of Efficacy|0|||
129058899|NCT00425373|464506235|FG001|Overall Study|Lack of Efficacy|0|||
129058900|NCT00425373|464506236|FG002|Overall Study|Lack of Efficacy|0|||
129058901|NCT00425373|464506237|FG003|Overall Study|Lack of Efficacy|0|||
129058902|NCT00425373|464506238|FG004|Overall Study|Lack of Efficacy|1|||
129058903|NCT00425373|464506239|FG005|Overall Study|Lack of Efficacy|3|||
129058904|NCT00425373|464506240|FG006|Overall Study|Lack of Efficacy|3|||
129058905|NCT00425373|464506241|FG007|Overall Study|Lack of Efficacy|0|||
129058906|NCT00425373|464506242|FG008|Overall Study|Lack of Efficacy|5|||
129058907|NCT02952586|464506255|FG000|Lead-In Phase (7 Days)|Death|0|||
129058908|NCT02952586|464506256|FG001|Lead-In Phase (7 Days)|Death|1|||
129058909|NCT02952586|464506255|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
129058910|NCT02952586|464506256|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
128720187|NCT00362115|463273346|FG001|Overall Study|Other|1|||
128720188|NCT00362115|463273347|FG002|Overall Study|Other|0|||
128720189|NCT00362115|463273348|FG003|Overall Study|Other|1|||
128720190|NCT00362115|463273349|FG004|Overall Study|Other|0|||
129058911|NCT02952586|464506255|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
129058912|NCT02952586|464506256|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
129058913|NCT02952586|464506255|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
129058914|NCT02952586|464506256|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
129058915|NCT02952586|464506255|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
129058916|NCT02952586|464506256|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
129058917|NCT02952586|464506255|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
129058918|NCT02952586|464506256|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
129058919|NCT02952586|464506255|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
128720191|NCT00362115|463273350|FG005|Overall Study|Other|1|||
128720192|NCT00362115|463273351|FG006|Overall Study|Other|0|||
128720193|NCT01826487|463273352|FG000|Overall Study|Adverse Event|1|||
129058920|NCT02952586|464506256|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
129058921|NCT02952586|464506255|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
129058922|NCT02952586|464506256|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
129058923|NCT02952586|464506255|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
129058924|NCT02952586|464506256|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
129058925|NCT02952586|464506255|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
129058926|NCT02952586|464506256|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
129058927|NCT02952586|464506255|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
129058928|NCT02952586|464506256|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
128720194|NCT01826487|463273353|FG001|Overall Study|Adverse Event|1|||
128720195|NCT01826487|463273352|FG000|Overall Study|Lost to Follow-up|1|||
128720196|NCT01826487|463273353|FG001|Overall Study|Lost to Follow-up|0|||
129058929|NCT02952586|464506255|FG000|CRT for Cisplatin (63 Days)|Death|3|||
129058930|NCT02952586|464506256|FG001|CRT for Cisplatin (63 Days)|Death|8|||
129058931|NCT02952586|464506255|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
129058932|NCT02952586|464506256|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
129058933|NCT02952586|464506255|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
129058934|NCT02952586|464506256|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
129058935|NCT02952586|464506255|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
129058936|NCT02952586|464506256|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
129058937|NCT02952586|464506255|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
129058938|NCT02952586|464506256|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
129058939|NCT02952586|464506255|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
129058940|NCT02952586|464506256|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
129058941|NCT02952586|464506255|FG000|CRT for Cisplatin (63 Days)|Other|1|||
129058942|NCT02952586|464506256|FG001|CRT for Cisplatin (63 Days)|Other|1|||
129058943|NCT02952586|464506255|FG000|CRT for IMRT (63 Days)|Death|5|||
129058944|NCT02952586|464506256|FG001|CRT for IMRT (63 Days)|Death|8|||
129058945|NCT02952586|464506255|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
129058946|NCT02952586|464506256|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
129058947|NCT02952586|464506255|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
129058948|NCT02952586|464506256|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
129058949|NCT02952586|464506255|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
129058950|NCT02952586|464506256|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
129058951|NCT02952586|464506255|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
129058952|NCT02952586|464506256|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
129058953|NCT02952586|464506255|FG000|CRT for IMRT (63 Days)|Other|1|||
129058954|NCT02952586|464506256|FG001|CRT for IMRT (63 Days)|Other|0|||
129058955|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Death|17|||
129058956|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Death|11|||
129058957|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
129058958|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
129058959|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
129058960|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
129058961|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
129058962|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
129058963|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
129058964|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
129058965|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
129058966|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
129058967|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
129058968|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
129058969|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
129058970|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
129058971|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Other|2|||
129058972|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Other|1|||
129058973|NCT02952586|464506255|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
129058974|NCT02952586|464506256|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
129058975|NCT02952586|464506255|FG000|Follow-Up Phase (90 Days)|Death|12|||
129058976|NCT02952586|464506256|FG001|Follow-Up Phase (90 Days)|Death|10|||
129058977|NCT02952586|464506255|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
129058978|NCT02952586|464506256|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
128720197|NCT01826487|463273352|FG000|Overall Study|Withdrawal by Subject|1|||
128720198|NCT01826487|463273353|FG001|Overall Study|Withdrawal by Subject|3|||
128720199|NCT01826487|463273352|FG000|Overall Study|Protocol Violation|1|||
128720200|NCT01826487|463273353|FG001|Overall Study|Protocol Violation|1|||
128720201|NCT02081079|463273354|FG000|Overall Study|Lack of Efficacy|3|||
128720202|NCT02081079|463273355|FG001|Overall Study|Lack of Efficacy|2|||
128720203|NCT02081079|463273354|FG000|Overall Study|Lost to Follow-up|1|||
128720204|NCT02081079|463273355|FG001|Overall Study|Lost to Follow-up|0|||
128720205|NCT02225743|463273356|FG000|Overall Study|Withdrawal by Subject|18|||
129058979|NCT02952586|464506255|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
129058980|NCT02952586|464506256|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
129058981|NCT02952586|464506255|FG000|Follow-Up Phase (90 Days)|Other|7|||
129058982|NCT02952586|464506256|FG001|Follow-Up Phase (90 Days)|Other|5|||
129058983|NCT02952586|464506255|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
129058984|NCT02952586|464506256|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
128720206|NCT02867709|463273361|FG000|Treatment Period|Adverse Event|1|||
128720207|NCT02867709|463273362|FG001|Treatment Period|Adverse Event|1|||
128720208|NCT02867709|463273363|FG002|Treatment Period|Adverse Event|2|||
129058985|NCT02952586|464506255|FG000|LT Follow-up (up to 45 Months)|Death|51|||
128720209|NCT02867709|463273361|FG000|Treatment Period|Withdrawal of Consent|7|||
128720210|NCT02867709|463273362|FG001|Treatment Period|Withdrawal of Consent|9|||
128720211|NCT02867709|463273363|FG002|Treatment Period|Withdrawal of Consent|8|||
128720212|NCT02867709|463273361|FG000|Treatment Period|Lost to Follow-up|17|||
128720213|NCT02867709|463273362|FG001|Treatment Period|Lost to Follow-up|20|||
128720214|NCT02867709|463273363|FG002|Treatment Period|Lost to Follow-up|20|||
128720215|NCT02867709|463273361|FG000|Treatment Period|Lack of Qualifying Event|42|||
128720216|NCT02867709|463273362|FG001|Treatment Period|Lack of Qualifying Event|55|||
128720217|NCT02867709|463273363|FG002|Treatment Period|Lack of Qualifying Event|42|||
128720218|NCT02867709|463273361|FG000|Treatment Period|Protocol Violation|3|||
129058986|NCT02952586|464506256|FG001|LT Follow-up (up to 45 Months)|Death|31|||
129058987|NCT02952586|464506255|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
129058988|NCT02952586|464506256|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
129058989|NCT02952586|464506255|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
129058990|NCT02952586|464506256|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
129058991|NCT02952586|464506255|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
129058992|NCT02952586|464506256|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
129058993|NCT03717012|464506257|FG000|Overall Study|Due to trial termination|1|||
129058994|NCT03717012|464506258|FG001|Overall Study|Due to trial termination|2|||
129058995|NCT03717012|464506257|FG000|Overall Study|Protocol Violation|0|||
129058996|NCT03717012|464506258|FG001|Overall Study|Protocol Violation|2|||
129058997|NCT03717012|464506257|FG000|Overall Study|Adverse Event|0|||
129058998|NCT03717012|464506258|FG001|Overall Study|Adverse Event|1|||
129058999|NCT03717012|464506257|FG000|Overall Study|Lung transplant|0|||
129059000|NCT03717012|464506258|FG001|Overall Study|Lung transplant|1|||
129059001|NCT00789035|464506259|FG000|Overall Study|Adverse Event|0|||
129059002|NCT00789035|464506260|FG001|Overall Study|Adverse Event|2|||
129059003|NCT00789035|464506261|FG002|Overall Study|Adverse Event|0|||
129059004|NCT00789035|464506262|FG003|Overall Study|Adverse Event|1|||
129059005|NCT00789035|464506263|FG004|Overall Study|Adverse Event|3|||
129059006|NCT00789035|464506259|FG000|Overall Study|Lack of Efficacy|3|||
129059007|NCT00789035|464506260|FG001|Overall Study|Lack of Efficacy|0|||
129059008|NCT00789035|464506261|FG002|Overall Study|Lack of Efficacy|0|||
129059009|NCT00789035|464506262|FG003|Overall Study|Lack of Efficacy|0|||
129059010|NCT00789035|464506263|FG004|Overall Study|Lack of Efficacy|2|||
129059011|NCT00789035|464506259|FG000|Overall Study|Protocol Violation|1|||
129059012|NCT00789035|464506260|FG001|Overall Study|Protocol Violation|0|||
129059013|NCT00789035|464506261|FG002|Overall Study|Protocol Violation|0|||
129059014|NCT00789035|464506262|FG003|Overall Study|Protocol Violation|0|||
129059015|NCT00789035|464506263|FG004|Overall Study|Protocol Violation|0|||
129059016|NCT00789035|464506259|FG000|Overall Study|Withdrawal by Subject|0|||
129059017|NCT00789035|464506260|FG001|Overall Study|Withdrawal by Subject|2|||
129059018|NCT00789035|464506261|FG002|Overall Study|Withdrawal by Subject|0|||
129059019|NCT00789035|464506262|FG003|Overall Study|Withdrawal by Subject|0|||
129059020|NCT00789035|464506263|FG004|Overall Study|Withdrawal by Subject|0|||
129059021|NCT00789035|464506259|FG000|Overall Study|Other reason not defined above|2|||
129059022|NCT00789035|464506260|FG001|Overall Study|Other reason not defined above|3|||
129059023|NCT00789035|464506261|FG002|Overall Study|Other reason not defined above|1|||
129059024|NCT00789035|464506262|FG003|Overall Study|Other reason not defined above|0|||
129059025|NCT00789035|464506263|FG004|Overall Study|Other reason not defined above|1|||
129059026|NCT02640690|464506264|FG000|Overall Study|Lost to Follow-up|7|||
129059027|NCT02640690|464506265|FG001|Overall Study|Lost to Follow-up|7|||
129059028|NCT02640690|464506264|FG000|Overall Study|Withdrawal by Subject|16|||
129059029|NCT02640690|464506265|FG001|Overall Study|Withdrawal by Subject|20|||
129059030|NCT02640690|464506264|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
129059031|NCT02640690|464506265|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
129059032|NCT01118975|464506266|FG000|Overall Study|Adverse Event|0|||
129059033|NCT01118975|464506267|FG001|Overall Study|Adverse Event|1|||
128720219|NCT02867709|463273362|FG001|Treatment Period|Protocol Violation|2|||
128720220|NCT02867709|463273363|FG002|Treatment Period|Protocol Violation|3|||
128720221|NCT02867709|463273361|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
128720222|NCT02867709|463273362|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
128720223|NCT02867709|463273363|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
129059034|NCT01520870|464506268|FG000|Overall Study|Withdrawal by Subject|2|||
129059035|NCT02463357|464506269|FG000|Overall Study|Withdrawal by Subject|1|||
129059036|NCT02463357|464506270|FG001|Overall Study|Withdrawal by Subject|0|||
129059037|NCT02463357|464506271|FG002|Overall Study|Withdrawal by Subject|0|||
128720224|NCT02867709|463273361|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
128720225|NCT02867709|463273362|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
128720226|NCT02867709|463273363|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
128720227|NCT02867709|463273361|FG000|Safety Follow-up Period|Pregnancy|0|||
128720228|NCT02867709|463273362|FG001|Safety Follow-up Period|Pregnancy|1|||
129059038|NCT02463357|464506272|FG003|Overall Study|Withdrawal by Subject|0|||
129059039|NCT02463357|464506273|FG004|Overall Study|Withdrawal by Subject|0|||
129059040|NCT02463357|464506269|FG000|Overall Study|Withdrawal by Subject|0|||
129059041|NCT02463357|464506270|FG001|Overall Study|Withdrawal by Subject|0|||
129059042|NCT02463357|464506271|FG002|Overall Study|Withdrawal by Subject|0|||
129059043|NCT02463357|464506272|FG003|Overall Study|Withdrawal by Subject|0|||
129059044|NCT02463357|464506273|FG004|Overall Study|Withdrawal by Subject|1|||
129059045|NCT01399658|464506274|FG000|Overall Study|Ineligible|1|||
128720229|NCT02867709|463273363|FG002|Safety Follow-up Period|Pregnancy|0|||
129059046|NCT01399658|464506274|FG000|Overall Study|Machine Technical Issue|3|||
129059047|NCT01399658|464506274|FG000|Overall Study|Alternative therapy|1|||
129059048|NCT01399658|464506274|FG000|Overall Study|No reason given|1|||
129059049|NCT02460679|464506275|FG000|Overall Study|Investigator Decision|1|||
129059050|NCT02460679|464506275|FG000|Overall Study|Withdrawal by Subject|4|||
129059051|NCT02620579|464506276|FG000|Overall Study|Physician Decision|0|||
129059052|NCT02620579|464506277|FG001|Overall Study|Physician Decision|0|||
129059053|NCT02620579|464506278|FG002|Overall Study|Physician Decision|0|||
129059054|NCT02620579|464506279|FG003|Overall Study|Physician Decision|1|||
129059055|NCT02620579|464506276|FG000|Overall Study|Withdrawal by Subject|0|||
129059056|NCT02620579|464506277|FG001|Overall Study|Withdrawal by Subject|1|||
129059057|NCT02620579|464506278|FG002|Overall Study|Withdrawal by Subject|1|||
129059058|NCT02620579|464506279|FG003|Overall Study|Withdrawal by Subject|0|||
129059059|NCT00796107|464506280|FG000|Overall Study|Lack of Efficacy|1|||
129059060|NCT00796107|464506280|FG000|Overall Study|Progressive Disease|5|||
129059061|NCT04411914|464506281|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
129059062|NCT04411914|464506282|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
129059063|NCT01721317|464506284|FG000|Overall Study|Study Closed / Terminated|2|||
129059064|NCT01721317|464506285|FG001|Overall Study|Study Closed / Terminated|2|||
129059065|NCT01721317|464506284|FG000|Overall Study|Physician Decision|0|||
129059066|NCT01721317|464506285|FG001|Overall Study|Physician Decision|1|||
129059067|NCT01721317|464506284|FG000|Overall Study|Withdrawal by Subject|0|||
129059068|NCT01721317|464506285|FG001|Overall Study|Withdrawal by Subject|1|||
129059069|NCT02806024|464506302|FG000|Overall Study|Night Delivery|1|||
129059070|NCT02806024|464506303|FG001|Overall Study|Night Delivery|1|||
129059071|NCT02806024|464506302|FG000|Overall Study|DVT during antepartum admission|0|||
129059072|NCT02806024|464506303|FG001|Overall Study|DVT during antepartum admission|1|||
129059073|NCT02892149|464506304|FG000|Overall Study|Death|262|||
129059074|NCT02892149|464506305|FG001|Overall Study|Death|278|||
129059075|NCT02892149|464506304|FG000|Overall Study|Withdrawal by Subject|53|||
129059076|NCT02892149|464506305|FG001|Overall Study|Withdrawal by Subject|47|||
129059077|NCT02892149|464506304|FG000|Overall Study|Lost to Follow-up|37|||
129059078|NCT02892149|464506305|FG001|Overall Study|Lost to Follow-up|31|||
129059079|NCT01994850|464506310|FG000|Overall Study|Physician Decision|1|||
129059080|NCT01994850|464506310|FG000|Overall Study|Withdrawal by Subject|1|||
129059081|NCT00789737|464506313|FG000|Overall Study|Withdrawal by Subject|13|||
129059082|NCT00789737|464506314|FG001|Overall Study|Withdrawal by Subject|22|||
129059083|NCT00789737|464506313|FG000|Overall Study|Lost to Follow-up|10|||
129059084|NCT00789737|464506314|FG001|Overall Study|Lost to Follow-up|14|||
129059085|NCT00789737|464506313|FG000|Overall Study|Adverse Event|8|||
129059086|NCT00789737|464506314|FG001|Overall Study|Adverse Event|8|||
129059087|NCT00789737|464506313|FG000|Overall Study|Protocol Violation|3|||
129059088|NCT00789737|464506314|FG001|Overall Study|Protocol Violation|0|||
129059089|NCT00789737|464506313|FG000|Overall Study|Lack of Efficacy|3|||
129059090|NCT00789737|464506314|FG001|Overall Study|Lack of Efficacy|0|||
129059091|NCT00789737|464506313|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
129059092|NCT00789737|464506314|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
129059093|NCT00789737|464506313|FG000|Overall Study|Other|11|||
129059094|NCT00789737|464506314|FG001|Overall Study|Other|7|||
129059095|NCT03489109|464506317|FG000|Overall Study|Lost to Follow-up|1|||
129059096|NCT03489109|464506318|FG001|Overall Study|Lost to Follow-up|2|||
129059097|NCT00384930|464506319|FG000|Overall Study|Adverse Event|5|||
129059098|NCT00384930|464506320|FG001|Overall Study|Adverse Event|4|||
129059099|NCT00384930|464506321|FG002|Overall Study|Adverse Event|12|||
129059100|NCT00384930|464506322|FG003|Overall Study|Adverse Event|11|||
129059101|NCT00384930|464506323|FG004|Overall Study|Adverse Event|14|||
129059102|NCT00384930|464506319|FG000|Overall Study|Entry Criteria Not Met|2|||
129059103|NCT00384930|464506320|FG001|Overall Study|Entry Criteria Not Met|6|||
129059104|NCT00384930|464506321|FG002|Overall Study|Entry Criteria Not Met|7|||
128720230|NCT02867709|463273361|FG000|Safety Follow-up Period|Protocol Violation|0|||
128720231|NCT02867709|463273362|FG001|Safety Follow-up Period|Protocol Violation|1|||
129059105|NCT00384930|464506322|FG003|Overall Study|Entry Criteria Not Met|8|||
129059106|NCT00384930|464506323|FG004|Overall Study|Entry Criteria Not Met|4|||
129059107|NCT00384930|464506319|FG000|Overall Study|Lack of Efficacy|1|||
129059108|NCT00384930|464506320|FG001|Overall Study|Lack of Efficacy|1|||
129059109|NCT00384930|464506321|FG002|Overall Study|Lack of Efficacy|2|||
129059110|NCT00384930|464506322|FG003|Overall Study|Lack of Efficacy|1|||
129059111|NCT00384930|464506323|FG004|Overall Study|Lack of Efficacy|2|||
129059112|NCT00384930|464506319|FG000|Overall Study|Lost to Follow-up|5|||
129059113|NCT00384930|464506320|FG001|Overall Study|Lost to Follow-up|3|||
129059114|NCT00384930|464506321|FG002|Overall Study|Lost to Follow-up|0|||
129059115|NCT00384930|464506322|FG003|Overall Study|Lost to Follow-up|4|||
129059116|NCT00384930|464506323|FG004|Overall Study|Lost to Follow-up|6|||
129059117|NCT00384930|464506319|FG000|Overall Study|Physician Decision|0|||
129059118|NCT00384930|464506320|FG001|Overall Study|Physician Decision|1|||
129059119|NCT00384930|464506321|FG002|Overall Study|Physician Decision|1|||
129059120|NCT00384930|464506322|FG003|Overall Study|Physician Decision|0|||
129059121|NCT00384930|464506323|FG004|Overall Study|Physician Decision|1|||
129059122|NCT00384930|464506319|FG000|Overall Study|Protocol Violation|1|||
129059123|NCT00384930|464506320|FG001|Overall Study|Protocol Violation|0|||
129059124|NCT00384930|464506321|FG002|Overall Study|Protocol Violation|1|||
129059125|NCT00384930|464506322|FG003|Overall Study|Protocol Violation|6|||
129059126|NCT00384930|464506323|FG004|Overall Study|Protocol Violation|4|||
129059127|NCT00384930|464506319|FG000|Overall Study|Sponsor Decision|3|||
129059128|NCT00384930|464506320|FG001|Overall Study|Sponsor Decision|4|||
129059129|NCT00384930|464506321|FG002|Overall Study|Sponsor Decision|0|||
129059130|NCT00384930|464506322|FG003|Overall Study|Sponsor Decision|5|||
129059131|NCT00384930|464506323|FG004|Overall Study|Sponsor Decision|0|||
129059132|NCT00384930|464506319|FG000|Overall Study|Withdrawal by Subject|9|||
129059133|NCT00384930|464506320|FG001|Overall Study|Withdrawal by Subject|7|||
129059134|NCT00384930|464506321|FG002|Overall Study|Withdrawal by Subject|7|||
129059135|NCT00384930|464506322|FG003|Overall Study|Withdrawal by Subject|6|||
129059136|NCT00384930|464506323|FG004|Overall Study|Withdrawal by Subject|16|||
129059137|NCT00384930|464506319|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
129059138|NCT00384930|464506320|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
128720232|NCT02867709|463273363|FG002|Safety Follow-up Period|Protocol Violation|1|||
128720233|NCT03878446|463273364|FG000|Overall Study|Withdrawn by parent or guardian|1|||
128720234|NCT03878446|463273365|FG001|Overall Study|Withdrawn by parent or guardian|0|||
128720235|NCT03878446|463273366|FG002|Overall Study|Withdrawn by parent or guardian|0|||
128720236|NCT03878446|463273367|FG003|Overall Study|Withdrawn by parent or guardian|0|||
129059139|NCT00384930|464506321|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
129059140|NCT00384930|464506322|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
129059141|NCT00384930|464506323|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
129059142|NCT02181790|464506324|FG000|Overall Study|study terminated|2|||
129059143|NCT02181790|464506325|FG001|Overall Study|study terminated|0|||
129059144|NCT02613182|464506326|FG000|Overall Study|Death|6|||
129059145|NCT02613182|464506326|FG000|Overall Study|Physician Decision|1|||
129059146|NCT02613182|464506326|FG000|Overall Study|Study Terminated by Sponsor|21|||
129059147|NCT02613182|464506326|FG000|Overall Study|Withdrawal by Subject|6|||
129059148|NCT03968978|464506327|FG000|Overall Study|Adverse Event|1|||
129059149|NCT03968978|464506328|FG001|Overall Study|Adverse Event|0|||
129059150|NCT00863772|464506329|FG000|Overall Study|Adverse Event|1|||
129059151|NCT00863772|464506330|FG001|Overall Study|Adverse Event|4|||
129059152|NCT00863772|464506331|FG002|Overall Study|Adverse Event|0|||
129059153|NCT00863772|464506329|FG000|Overall Study|Lack of Efficacy|4|||
129059154|NCT00863772|464506330|FG001|Overall Study|Lack of Efficacy|2|||
129059155|NCT00863772|464506331|FG002|Overall Study|Lack of Efficacy|4|||
129059156|NCT00863772|464506329|FG000|Overall Study|Lost to Follow-up|5|||
129059157|NCT00863772|464506330|FG001|Overall Study|Lost to Follow-up|1|||
129059158|NCT00863772|464506331|FG002|Overall Study|Lost to Follow-up|1|||
129059159|NCT00863772|464506329|FG000|Overall Study|Protocol Violation|2|||
129059160|NCT00863772|464506330|FG001|Overall Study|Protocol Violation|0|||
129059161|NCT00863772|464506331|FG002|Overall Study|Protocol Violation|2|||
129059162|NCT00863772|464506329|FG000|Overall Study|Withdrawal by Subject|4|||
129059163|NCT00863772|464506330|FG001|Overall Study|Withdrawal by Subject|7|||
129059164|NCT00863772|464506331|FG002|Overall Study|Withdrawal by Subject|5|||
129059165|NCT00863772|464506329|FG000|Overall Study|Study terminated by sponsor|44|||
129059166|NCT00863772|464506330|FG001|Overall Study|Study terminated by sponsor|45|||
129059167|NCT00863772|464506331|FG002|Overall Study|Study terminated by sponsor|36|||
129059168|NCT00863772|464506329|FG000|Overall Study|Entered extension study|6|||
129059169|NCT00863772|464506330|FG001|Overall Study|Entered extension study|4|||
129059170|NCT00863772|464506331|FG002|Overall Study|Entered extension study|9|||
129059171|NCT00863772|464506329|FG000|Overall Study|Other|1|||
129059172|NCT00863772|464506330|FG001|Overall Study|Other|2|||
129059173|NCT00863772|464506331|FG002|Overall Study|Other|4|||
129059174|NCT00863772|464506329|FG000|Overall Study|Randomized but not Treated|1|||
129059175|NCT00863772|464506330|FG001|Overall Study|Randomized but not Treated|0|||
129059176|NCT00863772|464506331|FG002|Overall Study|Randomized but not Treated|0|||
129059177|NCT00908310|464506334|FG000|Overall Study|Death|37|||
129059178|NCT00908310|464506334|FG000|Overall Study|Withdrawal by Subject|7|||
128775554|NCT01023308|463468379|FG000|Overall Study|Death|21|||
129059179|NCT00908310|464506334|FG000|Overall Study|Lost to Follow-up|7|||
129059180|NCT00908310|464506334|FG000|Overall Study|Screening failure|5|||
129059181|NCT00908310|464506334|FG000|Overall Study|Other reasons|4|||
129059182|NCT04614246|464506337|FG000|Overall Study|Adverse Event|0|||
129059183|NCT04614246|464506338|FG001|Overall Study|Adverse Event|1|||
129059184|NCT04614246|464506339|FG002|Overall Study|Adverse Event|1|||
129059185|NCT04614246|464506340|FG003|Overall Study|Adverse Event|2|||
129059186|NCT04614246|464506341|FG004|Overall Study|Adverse Event|1|||
129059187|NCT04614246|464506337|FG000|Overall Study|Lost to Follow-up|0|||
129059188|NCT04614246|464506338|FG001|Overall Study|Lost to Follow-up|1|||
129059189|NCT04614246|464506339|FG002|Overall Study|Lost to Follow-up|0|||
129059190|NCT04614246|464506340|FG003|Overall Study|Lost to Follow-up|1|||
129059191|NCT04614246|464506341|FG004|Overall Study|Lost to Follow-up|3|||
129059192|NCT04614246|464506337|FG000|Overall Study|Other reason|0|||
129059193|NCT04614246|464506338|FG001|Overall Study|Other reason|1|||
129059194|NCT04614246|464506339|FG002|Overall Study|Other reason|2|||
129059195|NCT04614246|464506340|FG003|Overall Study|Other reason|0|||
129059196|NCT04614246|464506341|FG004|Overall Study|Other reason|0|||
129059197|NCT04614246|464506337|FG000|Overall Study|Withdrawal by Subject|4|||
129059198|NCT04614246|464506338|FG001|Overall Study|Withdrawal by Subject|2|||
129059199|NCT04614246|464506339|FG002|Overall Study|Withdrawal by Subject|4|||
129059200|NCT04614246|464506340|FG003|Overall Study|Withdrawal by Subject|3|||
129059201|NCT04614246|464506341|FG004|Overall Study|Withdrawal by Subject|4|||
129059202|NCT04614246|464506337|FG000|Overall Study|Physician Decision|0|||
129059203|NCT04614246|464506338|FG001|Overall Study|Physician Decision|2|||
129059204|NCT04614246|464506339|FG002|Overall Study|Physician Decision|1|||
129059205|NCT04614246|464506340|FG003|Overall Study|Physician Decision|0|||
129059206|NCT04614246|464506341|FG004|Overall Study|Physician Decision|0|||
129059207|NCT04614246|464506337|FG000|Overall Study|Study terminated by sponsor|10|||
129059208|NCT04614246|464506338|FG001|Overall Study|Study terminated by sponsor|15|||
129059209|NCT04614246|464506339|FG002|Overall Study|Study terminated by sponsor|12|||
129059210|NCT04614246|464506340|FG003|Overall Study|Study terminated by sponsor|13|||
129059211|NCT04614246|464506341|FG004|Overall Study|Study terminated by sponsor|9|||
129059212|NCT04614246|464506337|FG000|Overall Study|Pregnancy|2|||
129059213|NCT04614246|464506338|FG001|Overall Study|Pregnancy|0|||
129059214|NCT04614246|464506339|FG002|Overall Study|Pregnancy|1|||
129059215|NCT04614246|464506340|FG003|Overall Study|Pregnancy|0|||
129059216|NCT04614246|464506341|FG004|Overall Study|Pregnancy|0|||
129059217|NCT01680497|464506342|FG000|Overall Study|Lost to Follow-up|2|||
129059218|NCT00725205|464506343|FG000|Overall Study|Adverse Event|22|||
129059219|NCT00725205|464506343|FG000|Overall Study|Investigator Discontinued|1|||
129059220|NCT00725205|464506343|FG000|Overall Study|Non-compliance With Protocol|14|||
129059221|NCT00725205|464506343|FG000|Overall Study|Other|8|||
129059222|NCT00725205|464506343|FG000|Overall Study|Protocol Defined Clinical Event|1|||
129059223|NCT00725205|464506343|FG000|Overall Study|Treatment Failure|41|||
129059224|NCT01200069|464508445|FG000|Overall Study|Withdrawal by Subject|0|||
129059225|NCT01200069|464508446|FG001|Overall Study|Withdrawal by Subject|1|||
129059226|NCT03408639|464508447|FG000|Overall Study|Death|5|||
129059227|NCT03408639|464508448|FG001|Overall Study|Death|5|||
129059228|NCT03408639|464508447|FG000|Overall Study|Lost to Follow-up|1|||
129059229|NCT03408639|464508448|FG001|Overall Study|Lost to Follow-up|4|||
129059230|NCT03408639|464508447|FG000|Overall Study|Withdrawal by Subject|2|||
129059231|NCT03408639|464508448|FG001|Overall Study|Withdrawal by Subject|7|||
129059232|NCT03408639|464508447|FG000|Overall Study|Physician Decision|3|||
129059233|NCT03408639|464508448|FG001|Overall Study|Physician Decision|6|||
129059234|NCT04998851|464508449|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
129059235|NCT04998851|464508450|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
129059236|NCT04998851|464508449|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
129059237|NCT04998851|464508450|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
129059238|NCT00070499|464508451|FG000|Overall Study|Adverse Event|6|||
129059239|NCT00070499|464508452|FG001|Overall Study|Adverse Event|6|||
129059240|NCT00070499|464508453|FG002|Overall Study|Adverse Event|19|||
129059241|NCT00070499|464508454|FG003|Overall Study|Adverse Event|15|||
129059242|NCT00070499|464508451|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
129059243|NCT00070499|464508452|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
129059244|NCT00070499|464508453|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
129059245|NCT00070499|464508454|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
129059246|NCT00070499|464508451|FG000|Overall Study|Progression/relapse|4|||
129059247|NCT00070499|464508452|FG001|Overall Study|Progression/relapse|2|||
129059248|NCT00070499|464508453|FG002|Overall Study|Progression/relapse|1|||
129059249|NCT00070499|464508454|FG003|Overall Study|Progression/relapse|4|||
129059250|NCT00070499|464508451|FG000|Overall Study|Death|1|||
129059251|NCT00070499|464508452|FG001|Overall Study|Death|1|||
129059252|NCT00070499|464508453|FG002|Overall Study|Death|1|||
129059253|NCT00070499|464508454|FG003|Overall Study|Death|2|||
129059254|NCT00070499|464508451|FG000|Overall Study|Other - not protocol specified|7|||
129059255|NCT00070499|464508452|FG001|Overall Study|Other - not protocol specified|3|||
129059256|NCT00070499|464508453|FG002|Overall Study|Other - not protocol specified|12|||
129059257|NCT00070499|464508454|FG003|Overall Study|Other - not protocol specified|20|||
129059258|NCT00070499|464508451|FG000|Overall Study|Still on protocol treatment|10|||
129059259|NCT00070499|464508452|FG001|Overall Study|Still on protocol treatment|4|||
129059260|NCT00070499|464508453|FG002|Overall Study|Still on protocol treatment|79|||
129059261|NCT00070499|464508454|FG003|Overall Study|Still on protocol treatment|57|||
129059262|NCT00070499|464508451|FG000|Overall Study|Did not start treatment|1|||
129059263|NCT00070499|464508452|FG001|Overall Study|Did not start treatment|0|||
129059264|NCT00070499|464508453|FG002|Overall Study|Did not start treatment|0|||
129059265|NCT00070499|464508454|FG003|Overall Study|Did not start treatment|2|||
129059266|NCT00070499|464508451|FG000|Overall Study|Not eligible|2|||
129059267|NCT00070499|464508452|FG001|Overall Study|Not eligible|5|||
129059268|NCT00070499|464508453|FG002|Overall Study|Not eligible|3|||
129059269|NCT00070499|464508454|FG003|Overall Study|Not eligible|2|||
129059270|NCT02883049|464508455|FG000|Induction|Adverse Event|52|||
129059271|NCT02883049|464508456|FG001|Induction|Adverse Event|2|||
129059272|NCT02883049|464508457|FG002|Induction|Adverse Event|0|||
129059273|NCT02883049|464508458|FG003|Induction|Adverse Event|0|||
129059274|NCT02883049|464508459|FG004|Induction|Adverse Event|0|||
129059275|NCT02883049|464508460|FG005|Induction|Adverse Event|0|||
129059276|NCT02883049|464508461|FG006|Induction|Adverse Event|0|||
129059277|NCT02883049|464508462|FG007|Induction|Adverse Event|0|||
129059278|NCT02883049|464508463|FG008|Induction|Adverse Event|0|||
129059279|NCT02883049|464508464|FG009|Induction|Adverse Event|0|||
129059280|NCT02883049|464508465|FG010|Induction|Adverse Event|0|||
129059281|NCT02883049|464508466|FG011|Induction|Adverse Event|0|||
129059282|NCT02883049|464508467|FG012|Induction|Adverse Event|0|||
129059283|NCT02883049|464508468|FG013|Induction|Adverse Event|0|||
129059284|NCT02883049|464508469|FG014|Induction|Adverse Event|0|||
129059285|NCT02883049|464508470|FG015|Induction|Adverse Event|0|||
129059286|NCT02883049|464508455|FG000|Induction|Death|76|||
129059287|NCT02883049|464508456|FG001|Induction|Death|8|||
129059288|NCT02883049|464508457|FG002|Induction|Death|0|||
129059289|NCT02883049|464508458|FG003|Induction|Death|0|||
129059290|NCT02883049|464508459|FG004|Induction|Death|0|||
129059291|NCT02883049|464508460|FG005|Induction|Death|0|||
129059292|NCT02883049|464508461|FG006|Induction|Death|0|||
129059293|NCT02883049|464508462|FG007|Induction|Death|0|||
129059294|NCT02883049|464508463|FG008|Induction|Death|0|||
129059295|NCT02883049|464508464|FG009|Induction|Death|0|||
129059296|NCT02883049|464508465|FG010|Induction|Death|0|||
129059297|NCT02883049|464508466|FG011|Induction|Death|0|||
129059298|NCT02883049|464508467|FG012|Induction|Death|0|||
129059299|NCT02883049|464508468|FG013|Induction|Death|0|||
129059300|NCT02883049|464508469|FG014|Induction|Death|0|||
129059301|NCT02883049|464508470|FG015|Induction|Death|0|||
129059302|NCT02883049|464508455|FG000|Induction|Lost to Follow-up|2|||
129059303|NCT02883049|464508456|FG001|Induction|Lost to Follow-up|0|||
129059304|NCT02883049|464508457|FG002|Induction|Lost to Follow-up|0|||
129059305|NCT02883049|464508458|FG003|Induction|Lost to Follow-up|0|||
129059306|NCT02883049|464508459|FG004|Induction|Lost to Follow-up|0|||
129059307|NCT02883049|464508460|FG005|Induction|Lost to Follow-up|0|||
129059308|NCT02883049|464508461|FG006|Induction|Lost to Follow-up|0|||
129059309|NCT02883049|464508462|FG007|Induction|Lost to Follow-up|0|||
129059310|NCT02883049|464508463|FG008|Induction|Lost to Follow-up|0|||
129059311|NCT02883049|464508464|FG009|Induction|Lost to Follow-up|0|||
129059312|NCT02883049|464508465|FG010|Induction|Lost to Follow-up|0|||
129059313|NCT02883049|464508466|FG011|Induction|Lost to Follow-up|0|||
129059314|NCT02883049|464508467|FG012|Induction|Lost to Follow-up|0|||
129059315|NCT02883049|464508468|FG013|Induction|Lost to Follow-up|0|||
129059316|NCT02883049|464508469|FG014|Induction|Lost to Follow-up|0|||
129059317|NCT02883049|464508470|FG015|Induction|Lost to Follow-up|0|||
129059318|NCT02883049|464508455|FG000|Induction|Physician Decision|1407|||
129059319|NCT02883049|464508456|FG001|Induction|Physician Decision|8|||
129059320|NCT02883049|464508457|FG002|Induction|Physician Decision|0|||
129059321|NCT02883049|464508458|FG003|Induction|Physician Decision|0|||
128720237|NCT03878446|463273368|FG004|Overall Study|Withdrawn by parent or guardian|0|||
129059322|NCT02883049|464508459|FG004|Induction|Physician Decision|0|||
129059323|NCT02883049|464508460|FG005|Induction|Physician Decision|0|||
129059324|NCT02883049|464508461|FG006|Induction|Physician Decision|0|||
129059325|NCT02883049|464508462|FG007|Induction|Physician Decision|0|||
129059326|NCT02883049|464508463|FG008|Induction|Physician Decision|0|||
129059327|NCT02883049|464508464|FG009|Induction|Physician Decision|0|||
129059328|NCT02883049|464508465|FG010|Induction|Physician Decision|0|||
129059329|NCT02883049|464508466|FG011|Induction|Physician Decision|0|||
129059330|NCT02883049|464508467|FG012|Induction|Physician Decision|0|||
129059331|NCT02883049|464508468|FG013|Induction|Physician Decision|0|||
129059332|NCT02883049|464508469|FG014|Induction|Physician Decision|0|||
129059333|NCT02883049|464508470|FG015|Induction|Physician Decision|0|||
129059334|NCT02883049|464508455|FG000|Induction|Protocol Violation|6|||
129059335|NCT02883049|464508456|FG001|Induction|Protocol Violation|0|||
129059336|NCT02883049|464508457|FG002|Induction|Protocol Violation|0|||
129059337|NCT02883049|464508458|FG003|Induction|Protocol Violation|0|||
129059338|NCT02883049|464508459|FG004|Induction|Protocol Violation|0|||
129059339|NCT02883049|464508460|FG005|Induction|Protocol Violation|0|||
129059340|NCT02883049|464508461|FG006|Induction|Protocol Violation|0|||
129059341|NCT02883049|464508462|FG007|Induction|Protocol Violation|0|||
129059342|NCT02883049|464508463|FG008|Induction|Protocol Violation|0|||
129059343|NCT02883049|464508464|FG009|Induction|Protocol Violation|0|||
128720238|NCT05041322|463273369|FG000|Baseline|Withdrawal by Subject|1|||
129059344|NCT02883049|464508465|FG010|Induction|Protocol Violation|0|||
129059345|NCT02883049|464508466|FG011|Induction|Protocol Violation|0|||
129059346|NCT02883049|464508467|FG012|Induction|Protocol Violation|0|||
129059347|NCT02883049|464508468|FG013|Induction|Protocol Violation|0|||
129059348|NCT02883049|464508469|FG014|Induction|Protocol Violation|0|||
129059349|NCT02883049|464508470|FG015|Induction|Protocol Violation|0|||
129059350|NCT02883049|464508455|FG000|Induction|Withdrawal by Subject|6|||
129059351|NCT02883049|464508456|FG001|Induction|Withdrawal by Subject|0|||
129059352|NCT02883049|464508457|FG002|Induction|Withdrawal by Subject|0|||
129059353|NCT02883049|464508458|FG003|Induction|Withdrawal by Subject|0|||
129059354|NCT02883049|464508459|FG004|Induction|Withdrawal by Subject|0|||
129059355|NCT02883049|464508460|FG005|Induction|Withdrawal by Subject|0|||
129059356|NCT02883049|464508461|FG006|Induction|Withdrawal by Subject|0|||
129059357|NCT02883049|464508462|FG007|Induction|Withdrawal by Subject|0|||
129059358|NCT02883049|464508463|FG008|Induction|Withdrawal by Subject|0|||
129059359|NCT02883049|464508464|FG009|Induction|Withdrawal by Subject|0|||
129059360|NCT02883049|464508465|FG010|Induction|Withdrawal by Subject|0|||
129059361|NCT02883049|464508466|FG011|Induction|Withdrawal by Subject|0|||
129059362|NCT02883049|464508467|FG012|Induction|Withdrawal by Subject|0|||
129059363|NCT02883049|464508468|FG013|Induction|Withdrawal by Subject|0|||
129059364|NCT02883049|464508469|FG014|Induction|Withdrawal by Subject|0|||
129059365|NCT02883049|464508470|FG015|Induction|Withdrawal by Subject|0|||
129059366|NCT02883049|464508455|FG000|Induction|Ineligible|35|||
129059367|NCT02883049|464508456|FG001|Induction|Ineligible|1|||
129059368|NCT02883049|464508457|FG002|Induction|Ineligible|0|||
129059369|NCT02883049|464508458|FG003|Induction|Ineligible|0|||
129059370|NCT02883049|464508459|FG004|Induction|Ineligible|0|||
129059371|NCT02883049|464508460|FG005|Induction|Ineligible|0|||
129059372|NCT02883049|464508461|FG006|Induction|Ineligible|0|||
129059373|NCT02883049|464508462|FG007|Induction|Ineligible|0|||
129059374|NCT02883049|464508463|FG008|Induction|Ineligible|0|||
129059375|NCT02883049|464508464|FG009|Induction|Ineligible|0|||
129059376|NCT02883049|464508465|FG010|Induction|Ineligible|0|||
128720239|NCT05041322|463273370|FG001|Baseline|Withdrawal by Subject|0|||
129059377|NCT02883049|464508466|FG011|Induction|Ineligible|0|||
129059378|NCT02883049|464508467|FG012|Induction|Ineligible|0|||
128720240|NCT05041322|463273369|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
128720241|NCT05041322|463273370|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
129059379|NCT02883049|464508468|FG013|Induction|Ineligible|0|||
129059380|NCT02883049|464508469|FG014|Induction|Ineligible|0|||
129059381|NCT02883049|464508470|FG015|Induction|Ineligible|0|||
129059382|NCT02883049|464508455|FG000|Induction|Refusal of further protocol therapy|466|||
129059383|NCT02883049|464508456|FG001|Induction|Refusal of further protocol therapy|2|||
128720242|NCT05041322|463273369|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
129059384|NCT02883049|464508457|FG002|Induction|Refusal of further protocol therapy|0|||
128720243|NCT05041322|463273370|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
129059385|NCT02883049|464508458|FG003|Induction|Refusal of further protocol therapy|0|||
128720244|NCT04837131|463273371|FG000|Overall Study|Death|1|||
129059386|NCT02883049|464508459|FG004|Induction|Refusal of further protocol therapy|0|||
129059387|NCT02883049|464508460|FG005|Induction|Refusal of further protocol therapy|0|||
129059388|NCT02883049|464508461|FG006|Induction|Refusal of further protocol therapy|0|||
129059389|NCT02883049|464508462|FG007|Induction|Refusal of further protocol therapy|0|||
129059390|NCT02883049|464508463|FG008|Induction|Refusal of further protocol therapy|0|||
129059391|NCT02883049|464508464|FG009|Induction|Refusal of further protocol therapy|0|||
129059392|NCT02883049|464508465|FG010|Induction|Refusal of further protocol therapy|0|||
129059393|NCT02883049|464508466|FG011|Induction|Refusal of further protocol therapy|0|||
129059394|NCT02883049|464508467|FG012|Induction|Refusal of further protocol therapy|0|||
129059395|NCT02883049|464508468|FG013|Induction|Refusal of further protocol therapy|0|||
129059396|NCT02883049|464508469|FG014|Induction|Refusal of further protocol therapy|0|||
129059397|NCT02883049|464508470|FG015|Induction|Refusal of further protocol therapy|0|||
129059398|NCT02883049|464508455|FG000|Induction|Identified as Ph+ patients|279|||
129059399|NCT02883049|464508456|FG001|Induction|Identified as Ph+ patients|1|||
129059400|NCT02883049|464508457|FG002|Induction|Identified as Ph+ patients|0|||
129059401|NCT02883049|464508458|FG003|Induction|Identified as Ph+ patients|0|||
129059402|NCT02883049|464508459|FG004|Induction|Identified as Ph+ patients|0|||
129059403|NCT02883049|464508460|FG005|Induction|Identified as Ph+ patients|0|||
129059404|NCT02883049|464508461|FG006|Induction|Identified as Ph+ patients|0|||
129059405|NCT02883049|464508462|FG007|Induction|Identified as Ph+ patients|0|||
129059406|NCT02883049|464508463|FG008|Induction|Identified as Ph+ patients|0|||
129059407|NCT02883049|464508464|FG009|Induction|Identified as Ph+ patients|0|||
129059408|NCT02883049|464508465|FG010|Induction|Identified as Ph+ patients|0|||
129059409|NCT02883049|464508466|FG011|Induction|Identified as Ph+ patients|0|||
129059410|NCT02883049|464508467|FG012|Induction|Identified as Ph+ patients|0|||
129059411|NCT02883049|464508468|FG013|Induction|Identified as Ph+ patients|0|||
129059412|NCT02883049|464508469|FG014|Induction|Identified as Ph+ patients|0|||
129059413|NCT02883049|464508470|FG015|Induction|Identified as Ph+ patients|0|||
129059414|NCT02883049|464508455|FG000|Induction|M3 Marrow at Day29|8|||
129059415|NCT02883049|464508456|FG001|Induction|M3 Marrow at Day29|1|||
129059416|NCT02883049|464508457|FG002|Induction|M3 Marrow at Day29|0|||
129059417|NCT02883049|464508458|FG003|Induction|M3 Marrow at Day29|0|||
129059418|NCT02883049|464508459|FG004|Induction|M3 Marrow at Day29|0|||
129059419|NCT02883049|464508460|FG005|Induction|M3 Marrow at Day29|0|||
129059420|NCT02883049|464508461|FG006|Induction|M3 Marrow at Day29|0|||
129059421|NCT02883049|464508462|FG007|Induction|M3 Marrow at Day29|0|||
129059422|NCT02883049|464508463|FG008|Induction|M3 Marrow at Day29|0|||
129059423|NCT02883049|464508464|FG009|Induction|M3 Marrow at Day29|0|||
129059424|NCT02883049|464508465|FG010|Induction|M3 Marrow at Day29|0|||
129059425|NCT02883049|464508466|FG011|Induction|M3 Marrow at Day29|0|||
129059426|NCT02883049|464508467|FG012|Induction|M3 Marrow at Day29|0|||
129059427|NCT02883049|464508468|FG013|Induction|M3 Marrow at Day29|0|||
129059428|NCT02883049|464508469|FG014|Induction|M3 Marrow at Day29|0|||
129059429|NCT02883049|464508470|FG015|Induction|M3 Marrow at Day29|0|||
129059430|NCT02883049|464508455|FG000|Induction|Inevaluable|33|||
129059431|NCT02883049|464508456|FG001|Induction|Inevaluable|1|||
129059432|NCT02883049|464508457|FG002|Induction|Inevaluable|0|||
129059433|NCT02883049|464508458|FG003|Induction|Inevaluable|0|||
129059434|NCT02883049|464508459|FG004|Induction|Inevaluable|0|||
129059435|NCT02883049|464508460|FG005|Induction|Inevaluable|0|||
129059436|NCT02883049|464508461|FG006|Induction|Inevaluable|0|||
129059437|NCT02883049|464508462|FG007|Induction|Inevaluable|0|||
129059438|NCT02883049|464508463|FG008|Induction|Inevaluable|0|||
129059439|NCT02883049|464508464|FG009|Induction|Inevaluable|0|||
129059440|NCT02883049|464508465|FG010|Induction|Inevaluable|0|||
129059441|NCT02883049|464508466|FG011|Induction|Inevaluable|0|||
129059442|NCT02883049|464508467|FG012|Induction|Inevaluable|0|||
129059443|NCT02883049|464508468|FG013|Induction|Inevaluable|0|||
129059444|NCT02883049|464508469|FG014|Induction|Inevaluable|0|||
129059445|NCT02883049|464508470|FG015|Induction|Inevaluable|0|||
129059446|NCT02883049|464508455|FG000|Induction|Identified as VHR at end of Induction|244|||
129059447|NCT02883049|464508456|FG001|Induction|Identified as VHR at end of Induction|0|||
129059448|NCT02883049|464508457|FG002|Induction|Identified as VHR at end of Induction|0|||
129059449|NCT02883049|464508458|FG003|Induction|Identified as VHR at end of Induction|0|||
129059450|NCT02883049|464508459|FG004|Induction|Identified as VHR at end of Induction|0|||
129059451|NCT02883049|464508460|FG005|Induction|Identified as VHR at end of Induction|0|||
129059452|NCT02883049|464508461|FG006|Induction|Identified as VHR at end of Induction|0|||
129059453|NCT02883049|464508462|FG007|Induction|Identified as VHR at end of Induction|0|||
128775555|NCT01023308|463468380|FG001|Overall Study|Death|17|||
129059454|NCT02883049|464508463|FG008|Induction|Identified as VHR at end of Induction|0|||
129059455|NCT02883049|464508464|FG009|Induction|Identified as VHR at end of Induction|0|||
129059456|NCT02883049|464508465|FG010|Induction|Identified as VHR at end of Induction|0|||
129059457|NCT02883049|464508466|FG011|Induction|Identified as VHR at end of Induction|0|||
129059458|NCT02883049|464508467|FG012|Induction|Identified as VHR at end of Induction|0|||
129059459|NCT02883049|464508468|FG013|Induction|Identified as VHR at end of Induction|0|||
129059460|NCT02883049|464508469|FG014|Induction|Identified as VHR at end of Induction|0|||
129059461|NCT02883049|464508470|FG015|Induction|Identified as VHR at end of Induction|0|||
128720245|NCT04837131|463273371|FG000|Overall Study|Withdrawal by Subject|1|||
128720246|NCT04837131|463273371|FG000|Overall Study|Adverse Event|1|||
128720247|NCT04837131|463273371|FG000|Overall Study|Protocol Violation|1|||
129059462|NCT02883049|464508455|FG000|Induction|Moved to another non-COG institution|3|||
129059463|NCT02883049|464508456|FG001|Induction|Moved to another non-COG institution|0|||
129059464|NCT02883049|464508457|FG002|Induction|Moved to another non-COG institution|0|||
129059465|NCT02883049|464508458|FG003|Induction|Moved to another non-COG institution|0|||
129059466|NCT02883049|464508459|FG004|Induction|Moved to another non-COG institution|0|||
129059467|NCT02883049|464508460|FG005|Induction|Moved to another non-COG institution|0|||
129059468|NCT02883049|464508461|FG006|Induction|Moved to another non-COG institution|0|||
129059469|NCT02883049|464508462|FG007|Induction|Moved to another non-COG institution|0|||
129059470|NCT02883049|464508463|FG008|Induction|Moved to another non-COG institution|0|||
129059471|NCT02883049|464508464|FG009|Induction|Moved to another non-COG institution|0|||
129059472|NCT02883049|464508465|FG010|Induction|Moved to another non-COG institution|0|||
129059473|NCT02883049|464508466|FG011|Induction|Moved to another non-COG institution|0|||
129059474|NCT02883049|464508467|FG012|Induction|Moved to another non-COG institution|0|||
129059475|NCT02883049|464508468|FG013|Induction|Moved to another non-COG institution|0|||
129059476|NCT02883049|464508469|FG014|Induction|Moved to another non-COG institution|0|||
129059477|NCT02883049|464508470|FG015|Induction|Moved to another non-COG institution|0|||
129059478|NCT02883049|464508455|FG000|Induction|Randomization closed|41|||
129059479|NCT02883049|464508456|FG001|Induction|Randomization closed|0|||
129059480|NCT02883049|464508457|FG002|Induction|Randomization closed|0|||
129059481|NCT02883049|464508458|FG003|Induction|Randomization closed|0|||
129059482|NCT02883049|464508459|FG004|Induction|Randomization closed|0|||
129059483|NCT02883049|464508460|FG005|Induction|Randomization closed|0|||
129059484|NCT02883049|464508461|FG006|Induction|Randomization closed|0|||
129059485|NCT02883049|464508462|FG007|Induction|Randomization closed|0|||
129059486|NCT02883049|464508463|FG008|Induction|Randomization closed|0|||
129059487|NCT02883049|464508464|FG009|Induction|Randomization closed|0|||
129059488|NCT02883049|464508465|FG010|Induction|Randomization closed|0|||
129059489|NCT02883049|464508466|FG011|Induction|Randomization closed|0|||
129059490|NCT02883049|464508467|FG012|Induction|Randomization closed|0|||
129059491|NCT02883049|464508468|FG013|Induction|Randomization closed|0|||
129059492|NCT02883049|464508469|FG014|Induction|Randomization closed|0|||
129059493|NCT02883049|464508470|FG015|Induction|Randomization closed|0|||
129059494|NCT02883049|464508455|FG000|Induction|MRD negative|36|||
129059495|NCT02883049|464508456|FG001|Induction|MRD negative|0|||
129059496|NCT02883049|464508457|FG002|Induction|MRD negative|0|||
129059497|NCT02883049|464508458|FG003|Induction|MRD negative|0|||
129059498|NCT02883049|464508459|FG004|Induction|MRD negative|0|||
129059499|NCT02883049|464508460|FG005|Induction|MRD negative|0|||
129059500|NCT02883049|464508461|FG006|Induction|MRD negative|0|||
129059501|NCT02883049|464508462|FG007|Induction|MRD negative|0|||
129059502|NCT02883049|464508463|FG008|Induction|MRD negative|0|||
129059503|NCT02883049|464508464|FG009|Induction|MRD negative|0|||
129059504|NCT02883049|464508465|FG010|Induction|MRD negative|0|||
129059505|NCT02883049|464508466|FG011|Induction|MRD negative|0|||
129059506|NCT02883049|464508467|FG012|Induction|MRD negative|0|||
129059507|NCT02883049|464508468|FG013|Induction|MRD negative|0|||
129059508|NCT02883049|464508469|FG014|Induction|MRD negative|0|||
129059509|NCT02883049|464508470|FG015|Induction|MRD negative|0|||
129059510|NCT02883049|464508455|FG000|Induction|Identified as HR patients|165|||
129059511|NCT02883049|464508456|FG001|Induction|Identified as HR patients|0|||
129059512|NCT02883049|464508457|FG002|Induction|Identified as HR patients|0|||
129059513|NCT02883049|464508458|FG003|Induction|Identified as HR patients|0|||
129059514|NCT02883049|464508459|FG004|Induction|Identified as HR patients|0|||
129059515|NCT02883049|464508460|FG005|Induction|Identified as HR patients|0|||
129059516|NCT02883049|464508461|FG006|Induction|Identified as HR patients|0|||
129059517|NCT02883049|464508462|FG007|Induction|Identified as HR patients|0|||
129059518|NCT02883049|464508463|FG008|Induction|Identified as HR patients|0|||
129059519|NCT02883049|464508464|FG009|Induction|Identified as HR patients|0|||
128720248|NCT01239368|463274904|FG000|Overall Study|Principal investigator discretion|1|||
128720249|NCT01239368|463274905|FG001|Overall Study|Principal investigator discretion|0|||
128720250|NCT01239368|463274906|FG002|Overall Study|Principal investigator discretion|0|||
128720251|NCT01239368|463274907|FG003|Overall Study|Principal investigator discretion|0|||
129059520|NCT02883049|464508465|FG010|Induction|Identified as HR patients|0|||
129059521|NCT02883049|464508466|FG011|Induction|Identified as HR patients|0|||
129059522|NCT02883049|464508467|FG012|Induction|Identified as HR patients|0|||
129059523|NCT02883049|464508468|FG013|Induction|Identified as HR patients|0|||
129059524|NCT02883049|464508469|FG014|Induction|Identified as HR patients|0|||
128720252|NCT01239368|463274908|FG004|Overall Study|Principal investigator discretion|1|||
128720253|NCT01239368|463274909|FG005|Overall Study|Principal investigator discretion|2|||
129059525|NCT02883049|464508470|FG015|Induction|Identified as HR patients|0|||
129059526|NCT02883049|464508455|FG000|Induction|Developed SMN|0|||
129059527|NCT02883049|464508456|FG001|Induction|Developed SMN|1|||
129059528|NCT02883049|464508457|FG002|Induction|Developed SMN|0|||
129059529|NCT02883049|464508458|FG003|Induction|Developed SMN|0|||
129059530|NCT02883049|464508459|FG004|Induction|Developed SMN|0|||
129059531|NCT02883049|464508460|FG005|Induction|Developed SMN|0|||
129059532|NCT02883049|464508461|FG006|Induction|Developed SMN|0|||
129059533|NCT02883049|464508462|FG007|Induction|Developed SMN|0|||
129059534|NCT02883049|464508463|FG008|Induction|Developed SMN|0|||
129059535|NCT02883049|464508464|FG009|Induction|Developed SMN|0|||
129059536|NCT02883049|464508465|FG010|Induction|Developed SMN|0|||
129059537|NCT02883049|464508466|FG011|Induction|Developed SMN|0|||
129059538|NCT02883049|464508467|FG012|Induction|Developed SMN|0|||
129059539|NCT02883049|464508468|FG013|Induction|Developed SMN|0|||
129059540|NCT02883049|464508469|FG014|Induction|Developed SMN|0|||
129059541|NCT02883049|464508470|FG015|Induction|Developed SMN|0|||
129059542|NCT02883049|464508455|FG000|Induction|Enrolled onto another COG study|72|||
129059543|NCT02883049|464508456|FG001|Induction|Enrolled onto another COG study|0|||
129059544|NCT02883049|464508457|FG002|Induction|Enrolled onto another COG study|0|||
129059545|NCT02883049|464508458|FG003|Induction|Enrolled onto another COG study|0|||
129059546|NCT02883049|464508459|FG004|Induction|Enrolled onto another COG study|0|||
129059547|NCT02883049|464508460|FG005|Induction|Enrolled onto another COG study|0|||
129059548|NCT02883049|464508461|FG006|Induction|Enrolled onto another COG study|0|||
129059549|NCT02883049|464508462|FG007|Induction|Enrolled onto another COG study|0|||
129059550|NCT02883049|464508463|FG008|Induction|Enrolled onto another COG study|0|||
129059551|NCT02883049|464508464|FG009|Induction|Enrolled onto another COG study|0|||
129059552|NCT02883049|464508465|FG010|Induction|Enrolled onto another COG study|0|||
129059553|NCT02883049|464508466|FG011|Induction|Enrolled onto another COG study|0|||
129059554|NCT02883049|464508467|FG012|Induction|Enrolled onto another COG study|0|||
129059555|NCT02883049|464508468|FG013|Induction|Enrolled onto another COG study|0|||
129059556|NCT02883049|464508469|FG014|Induction|Enrolled onto another COG study|0|||
129059557|NCT02883049|464508470|FG015|Induction|Enrolled onto another COG study|0|||
129059558|NCT02883049|464508455|FG000|Induction|Incomplete induction data|17|||
129059559|NCT02883049|464508456|FG001|Induction|Incomplete induction data|0|||
129059560|NCT02883049|464508457|FG002|Induction|Incomplete induction data|0|||
129059561|NCT02883049|464508458|FG003|Induction|Incomplete induction data|0|||
129059562|NCT02883049|464508459|FG004|Induction|Incomplete induction data|0|||
129059563|NCT02883049|464508460|FG005|Induction|Incomplete induction data|0|||
129059564|NCT02883049|464508461|FG006|Induction|Incomplete induction data|0|||
129059565|NCT02883049|464508462|FG007|Induction|Incomplete induction data|0|||
129059566|NCT02883049|464508463|FG008|Induction|Incomplete induction data|0|||
129059567|NCT02883049|464508464|FG009|Induction|Incomplete induction data|0|||
129059568|NCT02883049|464508465|FG010|Induction|Incomplete induction data|0|||
129059569|NCT02883049|464508466|FG011|Induction|Incomplete induction data|0|||
129059570|NCT02883049|464508467|FG012|Induction|Incomplete induction data|0|||
129059571|NCT02883049|464508468|FG013|Induction|Incomplete induction data|0|||
129059572|NCT02883049|464508469|FG014|Induction|Incomplete induction data|0|||
129059573|NCT02883049|464508470|FG015|Induction|Incomplete induction data|0|||
129059574|NCT02883049|464508455|FG000|Post Induction|Adverse Event|0|||
129059575|NCT02883049|464508456|FG001|Post Induction|Adverse Event|0|||
129059576|NCT02883049|464508457|FG002|Post Induction|Adverse Event|0|||
129059577|NCT02883049|464508458|FG003|Post Induction|Adverse Event|7|||
128720254|NCT01239368|463274910|FG006|Overall Study|Principal investigator discretion|0|||
128720255|NCT01239368|463274911|FG007|Overall Study|Principal investigator discretion|0|||
129059578|NCT02883049|464508459|FG004|Post Induction|Adverse Event|8|||
129059579|NCT02883049|464508460|FG005|Post Induction|Adverse Event|3|||
129059580|NCT02883049|464508461|FG006|Post Induction|Adverse Event|4|||
129059581|NCT02883049|464508462|FG007|Post Induction|Adverse Event|5|||
129059582|NCT02883049|464508463|FG008|Post Induction|Adverse Event|6|||
129059583|NCT02883049|464508464|FG009|Post Induction|Adverse Event|7|||
129059584|NCT02883049|464508465|FG010|Post Induction|Adverse Event|2|||
129059585|NCT02883049|464508466|FG011|Post Induction|Adverse Event|2|||
129059586|NCT02883049|464508467|FG012|Post Induction|Adverse Event|0|||
129059587|NCT02883049|464508468|FG013|Post Induction|Adverse Event|0|||
129059588|NCT02883049|464508469|FG014|Post Induction|Adverse Event|5|||
129059589|NCT02883049|464508470|FG015|Post Induction|Adverse Event|2|||
129059590|NCT02883049|464508455|FG000|Post Induction|Death|0|||
129059591|NCT02883049|464508456|FG001|Post Induction|Death|0|||
129059592|NCT02883049|464508457|FG002|Post Induction|Death|0|||
129059593|NCT02883049|464508458|FG003|Post Induction|Death|9|||
129059594|NCT02883049|464508459|FG004|Post Induction|Death|9|||
129059595|NCT02883049|464508460|FG005|Post Induction|Death|0|||
129059596|NCT02883049|464508461|FG006|Post Induction|Death|1|||
129059597|NCT02883049|464508462|FG007|Post Induction|Death|6|||
129059598|NCT02883049|464508463|FG008|Post Induction|Death|5|||
128720256|NCT01239368|463274912|FG008|Overall Study|Principal investigator discretion|0|||
128720257|NCT01239368|463274913|FG009|Overall Study|Principal investigator discretion|1|||
128720258|NCT01239368|463274904|FG000|Overall Study|Disease progression on study|1|||
128720259|NCT01239368|463274905|FG001|Overall Study|Disease progression on study|1|||
128720260|NCT01239368|463274906|FG002|Overall Study|Disease progression on study|1|||
128720261|NCT01239368|463274907|FG003|Overall Study|Disease progression on study|1|||
128720262|NCT01239368|463274908|FG004|Overall Study|Disease progression on study|4|||
128720263|NCT01239368|463274909|FG005|Overall Study|Disease progression on study|2|||
128720264|NCT01239368|463274910|FG006|Overall Study|Disease progression on study|5|||
128720265|NCT01239368|463274911|FG007|Overall Study|Disease progression on study|0|||
128775556|NCT01023308|463468379|FG000|Overall Study|Disease progression|82|||
129059599|NCT02883049|464508464|FG009|Post Induction|Death|3|||
129059600|NCT02883049|464508465|FG010|Post Induction|Death|1|||
129059601|NCT02883049|464508466|FG011|Post Induction|Death|0|||
129059602|NCT02883049|464508467|FG012|Post Induction|Death|1|||
129059603|NCT02883049|464508468|FG013|Post Induction|Death|1|||
129059604|NCT02883049|464508469|FG014|Post Induction|Death|10|||
129059605|NCT02883049|464508470|FG015|Post Induction|Death|2|||
129059606|NCT02883049|464508455|FG000|Post Induction|Lost to Follow-up|0|||
129059607|NCT02883049|464508456|FG001|Post Induction|Lost to Follow-up|0|||
129059608|NCT02883049|464508457|FG002|Post Induction|Lost to Follow-up|0|||
129059609|NCT02883049|464508458|FG003|Post Induction|Lost to Follow-up|0|||
129059610|NCT02883049|464508459|FG004|Post Induction|Lost to Follow-up|1|||
129059611|NCT02883049|464508460|FG005|Post Induction|Lost to Follow-up|1|||
128720266|NCT01239368|463274912|FG008|Overall Study|Disease progression on study|0|||
129059612|NCT02883049|464508461|FG006|Post Induction|Lost to Follow-up|0|||
129059613|NCT02883049|464508462|FG007|Post Induction|Lost to Follow-up|0|||
129059614|NCT02883049|464508463|FG008|Post Induction|Lost to Follow-up|3|||
129059615|NCT02883049|464508464|FG009|Post Induction|Lost to Follow-up|0|||
129059616|NCT02883049|464508465|FG010|Post Induction|Lost to Follow-up|1|||
129059617|NCT02883049|464508466|FG011|Post Induction|Lost to Follow-up|0|||
129059618|NCT02883049|464508467|FG012|Post Induction|Lost to Follow-up|0|||
129059619|NCT02883049|464508468|FG013|Post Induction|Lost to Follow-up|0|||
129059620|NCT02883049|464508469|FG014|Post Induction|Lost to Follow-up|0|||
129059621|NCT02883049|464508470|FG015|Post Induction|Lost to Follow-up|0|||
129059622|NCT02883049|464508455|FG000|Post Induction|Physician Decision|0|||
129059623|NCT02883049|464508456|FG001|Post Induction|Physician Decision|0|||
129059624|NCT02883049|464508457|FG002|Post Induction|Physician Decision|0|||
129059625|NCT02883049|464508458|FG003|Post Induction|Physician Decision|27|||
129059626|NCT02883049|464508459|FG004|Post Induction|Physician Decision|27|||
129059627|NCT02883049|464508460|FG005|Post Induction|Physician Decision|23|||
129059628|NCT02883049|464508461|FG006|Post Induction|Physician Decision|30|||
129059629|NCT02883049|464508462|FG007|Post Induction|Physician Decision|56|||
129059630|NCT02883049|464508463|FG008|Post Induction|Physician Decision|85|||
128720267|NCT01239368|463274913|FG009|Overall Study|Disease progression on study|2|||
128720268|NCT01239368|463274904|FG000|Overall Study|Refused further treatment|0|||
128775557|NCT01023308|463468380|FG001|Overall Study|Disease progression|153|||
128775558|NCT01023308|463468379|FG000|Overall Study|New Cancer therapy|4|||
129059631|NCT02883049|464508464|FG009|Post Induction|Physician Decision|12|||
129059632|NCT02883049|464508465|FG010|Post Induction|Physician Decision|5|||
129059633|NCT02883049|464508466|FG011|Post Induction|Physician Decision|14|||
128775559|NCT01023308|463468380|FG001|Overall Study|New Cancer therapy|7|||
129059634|NCT02883049|464508467|FG012|Post Induction|Physician Decision|1|||
129059635|NCT02883049|464508468|FG013|Post Induction|Physician Decision|11|||
129059636|NCT02883049|464508469|FG014|Post Induction|Physician Decision|19|||
129059637|NCT02883049|464508470|FG015|Post Induction|Physician Decision|5|||
129059638|NCT02883049|464508455|FG000|Post Induction|Protocol Violation|0|||
128775560|NCT01023308|463468379|FG000|Overall Study|Protocol Violation|3|||
129059639|NCT02883049|464508456|FG001|Post Induction|Protocol Violation|0|||
129059640|NCT02883049|464508457|FG002|Post Induction|Protocol Violation|0|||
129059641|NCT02883049|464508458|FG003|Post Induction|Protocol Violation|0|||
129059642|NCT02883049|464508459|FG004|Post Induction|Protocol Violation|0|||
129059643|NCT02883049|464508460|FG005|Post Induction|Protocol Violation|0|||
129059644|NCT02883049|464508461|FG006|Post Induction|Protocol Violation|0|||
129059645|NCT02883049|464508462|FG007|Post Induction|Protocol Violation|1|||
129059646|NCT02883049|464508463|FG008|Post Induction|Protocol Violation|0|||
129059647|NCT02883049|464508464|FG009|Post Induction|Protocol Violation|0|||
129059648|NCT02883049|464508465|FG010|Post Induction|Protocol Violation|0|||
129059649|NCT02883049|464508466|FG011|Post Induction|Protocol Violation|0|||
129059650|NCT02883049|464508467|FG012|Post Induction|Protocol Violation|0|||
129059651|NCT02883049|464508468|FG013|Post Induction|Protocol Violation|0|||
129059652|NCT02883049|464508469|FG014|Post Induction|Protocol Violation|0|||
129059653|NCT02883049|464508470|FG015|Post Induction|Protocol Violation|0|||
129059654|NCT02883049|464508455|FG000|Post Induction|Withdrawal by Subject|0|||
129059655|NCT02883049|464508456|FG001|Post Induction|Withdrawal by Subject|0|||
129059656|NCT02883049|464508457|FG002|Post Induction|Withdrawal by Subject|0|||
129059657|NCT02883049|464508458|FG003|Post Induction|Withdrawal by Subject|5|||
129059658|NCT02883049|464508459|FG004|Post Induction|Withdrawal by Subject|2|||
129059659|NCT02883049|464508460|FG005|Post Induction|Withdrawal by Subject|1|||
129059660|NCT02883049|464508461|FG006|Post Induction|Withdrawal by Subject|0|||
128775561|NCT01023308|463468380|FG001|Overall Study|Protocol Violation|4|||
128775562|NCT01023308|463468379|FG000|Overall Study|Untreated|5|||
129059661|NCT02883049|464508462|FG007|Post Induction|Withdrawal by Subject|0|||
129059662|NCT02883049|464508463|FG008|Post Induction|Withdrawal by Subject|2|||
129059663|NCT02883049|464508464|FG009|Post Induction|Withdrawal by Subject|0|||
129059664|NCT02883049|464508465|FG010|Post Induction|Withdrawal by Subject|1|||
129059665|NCT02883049|464508466|FG011|Post Induction|Withdrawal by Subject|1|||
129059666|NCT02883049|464508467|FG012|Post Induction|Withdrawal by Subject|0|||
129059667|NCT02883049|464508468|FG013|Post Induction|Withdrawal by Subject|0|||
129059668|NCT02883049|464508469|FG014|Post Induction|Withdrawal by Subject|1|||
129059669|NCT02883049|464508470|FG015|Post Induction|Withdrawal by Subject|0|||
129059670|NCT02883049|464508455|FG000|Post Induction|Ineligible|0|||
129059671|NCT02883049|464508456|FG001|Post Induction|Ineligible|0|||
129059672|NCT02883049|464508457|FG002|Post Induction|Ineligible|2|||
129059673|NCT02883049|464508458|FG003|Post Induction|Ineligible|0|||
129059674|NCT02883049|464508459|FG004|Post Induction|Ineligible|0|||
129059675|NCT02883049|464508460|FG005|Post Induction|Ineligible|0|||
129059676|NCT02883049|464508461|FG006|Post Induction|Ineligible|1|||
129059677|NCT02883049|464508462|FG007|Post Induction|Ineligible|0|||
129059678|NCT02883049|464508463|FG008|Post Induction|Ineligible|0|||
129059679|NCT02883049|464508464|FG009|Post Induction|Ineligible|0|||
129059680|NCT02883049|464508465|FG010|Post Induction|Ineligible|1|||
129059681|NCT02883049|464508466|FG011|Post Induction|Ineligible|0|||
129059682|NCT02883049|464508467|FG012|Post Induction|Ineligible|0|||
129059683|NCT02883049|464508468|FG013|Post Induction|Ineligible|0|||
129059684|NCT02883049|464508469|FG014|Post Induction|Ineligible|0|||
129059685|NCT02883049|464508470|FG015|Post Induction|Ineligible|1|||
129059686|NCT02883049|464508455|FG000|Post Induction|Refusal of further protocol therapy|0|||
129059687|NCT02883049|464508456|FG001|Post Induction|Refusal of further protocol therapy|0|||
129059688|NCT02883049|464508457|FG002|Post Induction|Refusal of further protocol therapy|0|||
129059689|NCT02883049|464508458|FG003|Post Induction|Refusal of further protocol therapy|11|||
129059690|NCT02883049|464508459|FG004|Post Induction|Refusal of further protocol therapy|15|||
129059691|NCT02883049|464508460|FG005|Post Induction|Refusal of further protocol therapy|9|||
129059692|NCT02883049|464508461|FG006|Post Induction|Refusal of further protocol therapy|13|||
129059693|NCT02883049|464508462|FG007|Post Induction|Refusal of further protocol therapy|5|||
129059694|NCT02883049|464508463|FG008|Post Induction|Refusal of further protocol therapy|21|||
129059695|NCT02883049|464508464|FG009|Post Induction|Refusal of further protocol therapy|7|||
129059696|NCT02883049|464508465|FG010|Post Induction|Refusal of further protocol therapy|0|||
129059697|NCT02883049|464508466|FG011|Post Induction|Refusal of further protocol therapy|7|||
129059698|NCT02883049|464508467|FG012|Post Induction|Refusal of further protocol therapy|3|||
129059699|NCT02883049|464508468|FG013|Post Induction|Refusal of further protocol therapy|0|||
129059700|NCT02883049|464508469|FG014|Post Induction|Refusal of further protocol therapy|4|||
129059701|NCT02883049|464508470|FG015|Post Induction|Refusal of further protocol therapy|1|||
129059702|NCT02883049|464508455|FG000|Post Induction|Inevaluable|0|||
129059703|NCT02883049|464508456|FG001|Post Induction|Inevaluable|0|||
129059704|NCT02883049|464508457|FG002|Post Induction|Inevaluable|0|||
129059705|NCT02883049|464508458|FG003|Post Induction|Inevaluable|1|||
129059706|NCT02883049|464508459|FG004|Post Induction|Inevaluable|1|||
129059707|NCT02883049|464508460|FG005|Post Induction|Inevaluable|2|||
129059708|NCT02883049|464508461|FG006|Post Induction|Inevaluable|7|||
129059709|NCT02883049|464508462|FG007|Post Induction|Inevaluable|6|||
129059710|NCT02883049|464508463|FG008|Post Induction|Inevaluable|4|||
129059711|NCT02883049|464508464|FG009|Post Induction|Inevaluable|4|||
129059712|NCT02883049|464508465|FG010|Post Induction|Inevaluable|1|||
129059713|NCT02883049|464508466|FG011|Post Induction|Inevaluable|1|||
129059714|NCT02883049|464508467|FG012|Post Induction|Inevaluable|2|||
129059715|NCT02883049|464508468|FG013|Post Induction|Inevaluable|0|||
129059716|NCT02883049|464508469|FG014|Post Induction|Inevaluable|0|||
129059717|NCT02883049|464508470|FG015|Post Induction|Inevaluable|1|||
129059718|NCT02883049|464508455|FG000|Post Induction|Moved to another non-COG institution|0|||
129059719|NCT02883049|464508456|FG001|Post Induction|Moved to another non-COG institution|0|||
129059720|NCT02883049|464508457|FG002|Post Induction|Moved to another non-COG institution|0|||
129059721|NCT02883049|464508458|FG003|Post Induction|Moved to another non-COG institution|0|||
129059722|NCT02883049|464508459|FG004|Post Induction|Moved to another non-COG institution|0|||
129059723|NCT02883049|464508460|FG005|Post Induction|Moved to another non-COG institution|0|||
129059724|NCT02883049|464508461|FG006|Post Induction|Moved to another non-COG institution|0|||
129059725|NCT02883049|464508462|FG007|Post Induction|Moved to another non-COG institution|2|||
129059726|NCT02883049|464508463|FG008|Post Induction|Moved to another non-COG institution|2|||
129059727|NCT02883049|464508464|FG009|Post Induction|Moved to another non-COG institution|0|||
129059728|NCT02883049|464508465|FG010|Post Induction|Moved to another non-COG institution|0|||
129059729|NCT02883049|464508466|FG011|Post Induction|Moved to another non-COG institution|1|||
129059730|NCT02883049|464508467|FG012|Post Induction|Moved to another non-COG institution|0|||
129059731|NCT02883049|464508468|FG013|Post Induction|Moved to another non-COG institution|0|||
129059732|NCT02883049|464508469|FG014|Post Induction|Moved to another non-COG institution|0|||
129059733|NCT02883049|464508470|FG015|Post Induction|Moved to another non-COG institution|0|||
129059734|NCT02883049|464508455|FG000|Post Induction|Randomization closed|0|||
129059735|NCT02883049|464508456|FG001|Post Induction|Randomization closed|0|||
129059736|NCT02883049|464508457|FG002|Post Induction|Randomization closed|0|||
129059737|NCT02883049|464508458|FG003|Post Induction|Randomization closed|0|||
129059738|NCT02883049|464508459|FG004|Post Induction|Randomization closed|0|||
129059739|NCT02883049|464508460|FG005|Post Induction|Randomization closed|0|||
129059740|NCT02883049|464508461|FG006|Post Induction|Randomization closed|0|||
129059741|NCT02883049|464508462|FG007|Post Induction|Randomization closed|20|||
129059742|NCT02883049|464508463|FG008|Post Induction|Randomization closed|0|||
129059743|NCT02883049|464508464|FG009|Post Induction|Randomization closed|0|||
129059744|NCT02883049|464508465|FG010|Post Induction|Randomization closed|0|||
129059745|NCT02883049|464508466|FG011|Post Induction|Randomization closed|0|||
129059746|NCT02883049|464508467|FG012|Post Induction|Randomization closed|0|||
129059747|NCT02883049|464508468|FG013|Post Induction|Randomization closed|0|||
129059748|NCT02883049|464508469|FG014|Post Induction|Randomization closed|0|||
129059749|NCT02883049|464508470|FG015|Post Induction|Randomization closed|0|||
129059750|NCT02883049|464508455|FG000|Post Induction|MRD negative|0|||
129059751|NCT02883049|464508456|FG001|Post Induction|MRD negative|0|||
129059752|NCT02883049|464508457|FG002|Post Induction|MRD negative|0|||
129059753|NCT02883049|464508458|FG003|Post Induction|MRD negative|0|||
129059754|NCT02883049|464508459|FG004|Post Induction|MRD negative|0|||
129059755|NCT02883049|464508460|FG005|Post Induction|MRD negative|0|||
129059756|NCT02883049|464508461|FG006|Post Induction|MRD negative|0|||
129059757|NCT02883049|464508462|FG007|Post Induction|MRD negative|11|||
129059758|NCT02883049|464508463|FG008|Post Induction|MRD negative|0|||
129059759|NCT02883049|464508464|FG009|Post Induction|MRD negative|0|||
129059760|NCT02883049|464508465|FG010|Post Induction|MRD negative|0|||
129059761|NCT02883049|464508466|FG011|Post Induction|MRD negative|0|||
129059762|NCT02883049|464508467|FG012|Post Induction|MRD negative|0|||
129059763|NCT02883049|464508468|FG013|Post Induction|MRD negative|0|||
129059764|NCT02883049|464508469|FG014|Post Induction|MRD negative|0|||
129059765|NCT02883049|464508470|FG015|Post Induction|MRD negative|0|||
129059766|NCT02883049|464508455|FG000|Post Induction|Developed SMN|0|||
129059767|NCT02883049|464508456|FG001|Post Induction|Developed SMN|0|||
129059768|NCT02883049|464508457|FG002|Post Induction|Developed SMN|0|||
129059769|NCT02883049|464508458|FG003|Post Induction|Developed SMN|0|||
129059770|NCT02883049|464508459|FG004|Post Induction|Developed SMN|1|||
129059771|NCT02883049|464508460|FG005|Post Induction|Developed SMN|0|||
129059772|NCT02883049|464508461|FG006|Post Induction|Developed SMN|1|||
129059773|NCT02883049|464508462|FG007|Post Induction|Developed SMN|0|||
129059774|NCT02883049|464508463|FG008|Post Induction|Developed SMN|0|||
129059775|NCT02883049|464508464|FG009|Post Induction|Developed SMN|0|||
129059776|NCT02883049|464508465|FG010|Post Induction|Developed SMN|1|||
129059777|NCT02883049|464508466|FG011|Post Induction|Developed SMN|1|||
129059778|NCT02883049|464508467|FG012|Post Induction|Developed SMN|0|||
129059779|NCT02883049|464508468|FG013|Post Induction|Developed SMN|0|||
129059780|NCT02883049|464508469|FG014|Post Induction|Developed SMN|1|||
129059781|NCT02883049|464508470|FG015|Post Induction|Developed SMN|0|||
129059782|NCT02883049|464508455|FG000|Post Induction|Enrolled onto another COG study|0|||
129059783|NCT02883049|464508456|FG001|Post Induction|Enrolled onto another COG study|0|||
129059784|NCT02883049|464508457|FG002|Post Induction|Enrolled onto another COG study|0|||
129059785|NCT02883049|464508458|FG003|Post Induction|Enrolled onto another COG study|1|||
129059786|NCT02883049|464508459|FG004|Post Induction|Enrolled onto another COG study|1|||
129059787|NCT02883049|464508460|FG005|Post Induction|Enrolled onto another COG study|0|||
129059788|NCT02883049|464508461|FG006|Post Induction|Enrolled onto another COG study|0|||
129059789|NCT02883049|464508462|FG007|Post Induction|Enrolled onto another COG study|4|||
129059790|NCT02883049|464508463|FG008|Post Induction|Enrolled onto another COG study|0|||
129059791|NCT02883049|464508464|FG009|Post Induction|Enrolled onto another COG study|0|||
129059792|NCT02883049|464508465|FG010|Post Induction|Enrolled onto another COG study|0|||
129059793|NCT02883049|464508466|FG011|Post Induction|Enrolled onto another COG study|2|||
129059794|NCT02883049|464508467|FG012|Post Induction|Enrolled onto another COG study|0|||
129059795|NCT02883049|464508468|FG013|Post Induction|Enrolled onto another COG study|1|||
129059796|NCT02883049|464508469|FG014|Post Induction|Enrolled onto another COG study|0|||
129059797|NCT02883049|464508470|FG015|Post Induction|Enrolled onto another COG study|0|||
129059798|NCT02883049|464508455|FG000|Post Induction|Recurrent leukemia|0|||
129059799|NCT02883049|464508456|FG001|Post Induction|Recurrent leukemia|0|||
129059800|NCT02883049|464508457|FG002|Post Induction|Recurrent leukemia|0|||
129059801|NCT02883049|464508458|FG003|Post Induction|Recurrent leukemia|17|||
129059802|NCT02883049|464508459|FG004|Post Induction|Recurrent leukemia|12|||
129059803|NCT02883049|464508460|FG005|Post Induction|Recurrent leukemia|4|||
129059804|NCT02883049|464508461|FG006|Post Induction|Recurrent leukemia|1|||
129059805|NCT02883049|464508462|FG007|Post Induction|Recurrent leukemia|13|||
129059806|NCT02883049|464508463|FG008|Post Induction|Recurrent leukemia|27|||
129059807|NCT02883049|464508464|FG009|Post Induction|Recurrent leukemia|5|||
129059808|NCT02883049|464508465|FG010|Post Induction|Recurrent leukemia|3|||
129059809|NCT02883049|464508466|FG011|Post Induction|Recurrent leukemia|12|||
129059810|NCT02883049|464508467|FG012|Post Induction|Recurrent leukemia|1|||
129059811|NCT02883049|464508468|FG013|Post Induction|Recurrent leukemia|1|||
129059812|NCT02883049|464508469|FG014|Post Induction|Recurrent leukemia|9|||
129059813|NCT02883049|464508470|FG015|Post Induction|Recurrent leukemia|3|||
129059814|NCT02883049|464508455|FG000|Post Induction|Induction Failure|0|||
129059815|NCT02883049|464508456|FG001|Post Induction|Induction Failure|0|||
129059816|NCT02883049|464508457|FG002|Post Induction|Induction Failure|0|||
129059817|NCT02883049|464508458|FG003|Post Induction|Induction Failure|0|||
129059818|NCT02883049|464508459|FG004|Post Induction|Induction Failure|0|||
129059819|NCT02883049|464508460|FG005|Post Induction|Induction Failure|0|||
129059820|NCT02883049|464508461|FG006|Post Induction|Induction Failure|0|||
129059821|NCT02883049|464508462|FG007|Post Induction|Induction Failure|2|||
129059822|NCT02883049|464508463|FG008|Post Induction|Induction Failure|2|||
129059823|NCT02883049|464508464|FG009|Post Induction|Induction Failure|0|||
129059824|NCT02883049|464508465|FG010|Post Induction|Induction Failure|0|||
129059825|NCT02883049|464508466|FG011|Post Induction|Induction Failure|0|||
129059826|NCT02883049|464508467|FG012|Post Induction|Induction Failure|0|||
129059827|NCT02883049|464508468|FG013|Post Induction|Induction Failure|2|||
129059828|NCT02883049|464508469|FG014|Post Induction|Induction Failure|0|||
129059829|NCT02883049|464508470|FG015|Post Induction|Induction Failure|0|||
129059830|NCT01924754|464508474|FG000|Overall Study|Lost to Follow-up|1|||
129059831|NCT01924754|464508475|FG001|Overall Study|Lost to Follow-up|2|||
129059832|NCT01924754|464508476|FG002|Overall Study|Lost to Follow-up|1|||
129059833|NCT01924754|464508474|FG000|Overall Study|Pregnancy|0|||
129059834|NCT01924754|464508475|FG001|Overall Study|Pregnancy|1|||
129059835|NCT01924754|464508476|FG002|Overall Study|Pregnancy|2|||
129059836|NCT00369486|464508477|FG000|4-Week Visit|Missed visit|2|||
129059837|NCT00369486|464508478|FG001|4-Week Visit|Missed visit|2|||
129059838|NCT00369486|464508479|FG002|4-Week Visit|Missed visit|0|||
129059839|NCT00369486|464508480|FG003|4-Week Visit|Missed visit|2|||
129059840|NCT00369486|464508481|FG004|4-Week Visit|Missed visit|1|||
129059841|NCT00369486|464508477|FG000|4-Week Visit|Dropped|0|||
129059842|NCT00369486|464508478|FG001|4-Week Visit|Dropped|0|||
129059843|NCT00369486|464508479|FG002|4-Week Visit|Dropped|1|||
129059844|NCT00369486|464508480|FG003|4-Week Visit|Dropped|0|||
129059845|NCT00369486|464508481|FG004|4-Week Visit|Dropped|0|||
129059846|NCT00369486|464508477|FG000|8-Week Visit|Missed visit|0|||
129059847|NCT00369486|464508478|FG001|8-Week Visit|Missed visit|1|||
129059848|NCT00369486|464508479|FG002|8-Week Visit|Missed visit|0|||
129059849|NCT00369486|464508480|FG003|8-Week Visit|Missed visit|0|||
129059850|NCT00369486|464508481|FG004|8-Week Visit|Missed visit|1|||
129059851|NCT00369486|464508477|FG000|8-Week Visit|Dropped|0|||
129059852|NCT00369486|464508478|FG001|8-Week Visit|Dropped|0|||
129059853|NCT00369486|464508479|FG002|8-Week Visit|Dropped|0|||
129059854|NCT00369486|464508480|FG003|8-Week Visit|Dropped|1|||
129059855|NCT00369486|464508481|FG004|8-Week Visit|Dropped|0|||
129059856|NCT00369486|464508477|FG000|17-Week Visit|Missed visit|0|||
129059857|NCT00369486|464508478|FG001|17-Week Visit|Missed visit|0|||
129059858|NCT00369486|464508479|FG002|17-Week Visit|Missed visit|1|||
129059859|NCT00369486|464508480|FG003|17-Week Visit|Missed visit|1|||
129059860|NCT00369486|464508481|FG004|17-Week Visit|Missed visit|1|||
129059861|NCT00369486|464508477|FG000|34-Week Visit|Dropped|0|||
129059862|NCT00369486|464508478|FG001|34-Week Visit|Dropped|1|||
129059863|NCT00369486|464508479|FG002|34-Week Visit|Dropped|1|||
129059864|NCT00369486|464508480|FG003|34-Week Visit|Dropped|3|||
129059865|NCT00369486|464508481|FG004|34-Week Visit|Dropped|3|||
129059866|NCT01392963|464508482|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
129059867|NCT01392963|464508483|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
129059868|NCT01392963|464508482|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
129059869|NCT01392963|464508483|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
129059870|NCT01392963|464508482|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
129059871|NCT01392963|464508483|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
129059872|NCT00402116|464508484|FG000|Overall Study|Jaw infection after surgery-other|1|||
129059873|NCT00402116|464508485|FG001|Overall Study|Jaw infection after surgery-other|0|||
129059874|NCT00402116|464508486|FG002|Overall Study|Jaw infection after surgery-other|0|||
129059875|NCT00402116|464508484|FG000|Overall Study|Withdrawal by Subject|1|||
129059876|NCT00402116|464508485|FG001|Overall Study|Withdrawal by Subject|0|||
129059877|NCT00402116|464508486|FG002|Overall Study|Withdrawal by Subject|5|||
128720269|NCT01239368|463274905|FG001|Overall Study|Refused further treatment|0|||
128720270|NCT01239368|463274906|FG002|Overall Study|Refused further treatment|0|||
128720271|NCT01239368|463274907|FG003|Overall Study|Refused further treatment|0|||
128720272|NCT01239368|463274908|FG004|Overall Study|Refused further treatment|0|||
128720273|NCT01239368|463274909|FG005|Overall Study|Refused further treatment|0|||
128720274|NCT01239368|463274910|FG006|Overall Study|Refused further treatment|0|||
129059878|NCT00402116|464508484|FG000|Overall Study|Treatment completed per protocol|1|||
129059879|NCT00402116|464508485|FG001|Overall Study|Treatment completed per protocol|1|||
129059880|NCT00402116|464508486|FG002|Overall Study|Treatment completed per protocol|2|||
129059881|NCT00402116|464508484|FG000|Overall Study|other complicating disease|0|||
129059882|NCT00402116|464508485|FG001|Overall Study|other complicating disease|0|||
129059883|NCT00402116|464508486|FG002|Overall Study|other complicating disease|2|||
129059884|NCT00402116|464508484|FG000|Overall Study|Disease Progression|0|||
129059885|NCT00402116|464508485|FG001|Overall Study|Disease Progression|4|||
129059886|NCT00402116|464508486|FG002|Overall Study|Disease Progression|38|||
129059887|NCT00402116|464508484|FG000|Overall Study|mistaken thrombocytopenia|0|||
129059888|NCT00402116|464508485|FG001|Overall Study|mistaken thrombocytopenia|0|||
129059889|NCT00402116|464508486|FG002|Overall Study|mistaken thrombocytopenia|1|||
129059890|NCT00402116|464508484|FG000|Overall Study|decline related hyponatremia/tumor|0|||
129059891|NCT00402116|464508485|FG001|Overall Study|decline related hyponatremia/tumor|0|||
129059892|NCT00402116|464508486|FG002|Overall Study|decline related hyponatremia/tumor|1|||
129059893|NCT00402116|464508484|FG000|Overall Study|Adverse Event|0|||
129059894|NCT00402116|464508485|FG001|Overall Study|Adverse Event|1|||
129059895|NCT00402116|464508486|FG002|Overall Study|Adverse Event|6|||
129059896|NCT04778904|464508487|FG000|Overall Study|Protocol Violation|1|||
129059897|NCT04778904|464508488|FG001|Overall Study|Protocol Violation|0|||
129059898|NCT04778904|464508489|FG002|Overall Study|Protocol Violation|0|||
129059899|NCT04778904|464508490|FG003|Overall Study|Protocol Violation|0|||
129059900|NCT04778904|464508487|FG000|Overall Study|Withdrawal by Subject|0|||
129059901|NCT04778904|464508488|FG001|Overall Study|Withdrawal by Subject|0|||
129059902|NCT04778904|464508489|FG002|Overall Study|Withdrawal by Subject|1|||
129059903|NCT04778904|464508490|FG003|Overall Study|Withdrawal by Subject|0|||
129059904|NCT05048329|464508497|FG000|Overall Study|Withdrawal by Subject|1|||
129059905|NCT05048329|464508497|FG000|Overall Study|Screenfail|1|||
129059906|NCT03772717|464508498|FG000|Overall Study|Withdrawal by Subject|2|||
129059907|NCT04138043|464508499|FG000|Overall Study|Withdrawal by Subject|0|||
129059908|NCT04138043|464508500|FG001|Overall Study|Withdrawal by Subject|1|||
129059909|NCT02856802|464508501|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
129059910|NCT02856802|464508502|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
129059911|NCT02856802|464508501|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
129059912|NCT02856802|464508502|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
129059913|NCT02856802|464508501|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
129059914|NCT02856802|464508502|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
129059915|NCT02856802|464508501|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
129059916|NCT02856802|464508502|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
129059917|NCT02856802|464508501|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
129059918|NCT02856802|464508502|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
129059919|NCT02856802|464508501|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
129059920|NCT02856802|464508502|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
129059921|NCT03092219|464508503|FG000|Overall Study|Protocol Violation|7|||
129059922|NCT03092219|464508504|FG001|Overall Study|Protocol Violation|4|||
129059923|NCT01403051|464508510|FG000|Overall Study|Protocol Violation|2|||
129059924|NCT01403051|464508511|FG001|Overall Study|Protocol Violation|0|||
129059925|NCT01403051|464508510|FG000|Overall Study|Death|1|||
129059926|NCT01403051|464508511|FG001|Overall Study|Death|0|||
129059927|NCT01403051|464508510|FG000|Overall Study|Withdrawal by Subject|2|||
129059928|NCT01403051|464508511|FG001|Overall Study|Withdrawal by Subject|1|||
129059929|NCT01403051|464508510|FG000|Overall Study|Lost to Follow-up|5|||
129059930|NCT01403051|464508511|FG001|Overall Study|Lost to Follow-up|5|||
129059931|NCT00459355|464508523|FG000|Overall Study|Subject no longer met inc criteria|20|||
129059932|NCT00459355|464508524|FG001|Overall Study|Subject no longer met inc criteria|18|||
129059933|NCT00287586|464508525|FG000|Overall Study|Withdrew Consent|19|||
129059934|NCT00287586|464508526|FG001|Overall Study|Withdrew Consent|30|||
129059935|NCT00287586|464508525|FG000|Overall Study|Lost to Follow-up|5|||
128720275|NCT01239368|463274911|FG007|Overall Study|Refused further treatment|0|||
128720276|NCT01239368|463274912|FG008|Overall Study|Refused further treatment|0|||
129059936|NCT00287586|464508526|FG001|Overall Study|Lost to Follow-up|4|||
129059937|NCT00287586|464508525|FG000|Overall Study|Death|2|||
129059938|NCT00287586|464508526|FG001|Overall Study|Death|3|||
129059939|NCT00287586|464508525|FG000|Overall Study|Elevated Hematocrit|3|||
129059940|NCT00287586|464508526|FG001|Overall Study|Elevated Hematocrit|0|||
129059941|NCT00287586|464508525|FG000|Overall Study|Rash|3|||
129059942|NCT00287586|464508526|FG001|Overall Study|Rash|0|||
129059943|NCT00287586|464508525|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
129059944|NCT00287586|464508526|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
128720277|NCT01239368|463274913|FG009|Overall Study|Refused further treatment|1|||
129059945|NCT00287586|464508525|FG000|Overall Study|Stroke|2|||
129059946|NCT00287586|464508526|FG001|Overall Study|Stroke|0|||
129059947|NCT00287586|464508525|FG000|Overall Study|Myocardial Infarction|1|||
129059948|NCT00287586|464508526|FG001|Overall Study|Myocardial Infarction|0|||
129059949|NCT00287586|464508525|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
129059950|NCT00287586|464508526|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
129059951|NCT00287586|464508525|FG000|Overall Study|Cognitive Impairment|1|||
129059952|NCT00287586|464508526|FG001|Overall Study|Cognitive Impairment|0|||
129059953|NCT00287586|464508525|FG000|Overall Study|Pancreatic Cancer|1|||
129059954|NCT00287586|464508526|FG001|Overall Study|Pancreatic Cancer|3|||
129059955|NCT00287586|464508525|FG000|Overall Study|Sleep Apnea|1|||
129059956|NCT00287586|464508526|FG001|Overall Study|Sleep Apnea|0|||
129059957|NCT00287586|464508525|FG000|Overall Study|Shoulder Pain|1|||
129059958|NCT00287586|464508526|FG001|Overall Study|Shoulder Pain|0|||
129059959|NCT00287586|464508525|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
129059960|NCT00287586|464508526|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
129059961|NCT00287586|464508525|FG000|Overall Study|Nonadherence|1|||
129059962|NCT00287586|464508526|FG001|Overall Study|Nonadherence|1|||
129059963|NCT00287586|464508525|FG000|Overall Study|Enrolled in Another Study|1|||
129059964|NCT00287586|464508526|FG001|Overall Study|Enrolled in Another Study|0|||
129059965|NCT00287586|464508525|FG000|Overall Study|Major Depression|0|||
129059966|NCT00287586|464508526|FG001|Overall Study|Major Depression|2|||
129059967|NCT00287586|464508525|FG000|Overall Study|Lung Cancer|0|||
129059968|NCT00287586|464508526|FG001|Overall Study|Lung Cancer|2|||
129059969|NCT00287586|464508525|FG000|Overall Study|Elevated IPSS Score|0|||
129059970|NCT00287586|464508526|FG001|Overall Study|Elevated IPSS Score|1|||
129059971|NCT00287586|464508525|FG000|Overall Study|Retroperitoneal Cancer|0|||
129059972|NCT00287586|464508526|FG001|Overall Study|Retroperitoneal Cancer|1|||
129059973|NCT00287586|464508525|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
129059974|NCT00287586|464508526|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
129059975|NCT00287586|464508525|FG000|Overall Study|Mood Swings and Irritability|0|||
129059976|NCT00287586|464508526|FG001|Overall Study|Mood Swings and Irritability|1|||
129059977|NCT00287586|464508525|FG000|Overall Study|Bradycardia|0|||
129059978|NCT00287586|464508526|FG001|Overall Study|Bradycardia|1|||
129059979|NCT00287586|464508525|FG000|Overall Study|Itchy Swollen Eyes|0|||
129059980|NCT00287586|464508526|FG001|Overall Study|Itchy Swollen Eyes|1|||
129059981|NCT00287586|464508525|FG000|Overall Study|Recurrent Melanoma|0|||
129059982|NCT00287586|464508526|FG001|Overall Study|Recurrent Melanoma|1|||
129059983|NCT02135614|464508527|FG000|Overall Study|Randomized but Not Treated|2|||
129059984|NCT02135614|464508528|FG001|Overall Study|Randomized but Not Treated|1|||
129059985|NCT02135614|464508527|FG000|Overall Study|Adverse Event|0|||
129059986|NCT02135614|464508528|FG001|Overall Study|Adverse Event|1|||
129059987|NCT02135614|464508527|FG000|Overall Study|Death|1|||
129059988|NCT02135614|464508528|FG001|Overall Study|Death|0|||
129059989|NCT02135614|464508527|FG000|Overall Study|Investigator's Discretion|0|||
129059990|NCT02135614|464508528|FG001|Overall Study|Investigator's Discretion|1|||
129059991|NCT02135614|464508527|FG000|Overall Study|Withdrew Consent|2|||
129059992|NCT02135614|464508528|FG001|Overall Study|Withdrew Consent|2|||
129059993|NCT02135614|464508527|FG000|Overall Study|Lost to Follow-up|3|||
129059994|NCT02135614|464508528|FG001|Overall Study|Lost to Follow-up|0|||
129059995|NCT03743415|464508530|FG000|Overall Study|Death|5|||
129059996|NCT03743415|464508531|FG001|Overall Study|Death|3|||
129059997|NCT03743415|464508532|FG002|Overall Study|Death|1|||
129059998|NCT03743415|464508533|FG003|Overall Study|Death|4|||
129059999|NCT03743415|464508534|FG004|Overall Study|Death|0|||
129060000|NCT03743415|464508535|FG005|Overall Study|Death|0|||
129060001|NCT03743415|464508536|FG006|Overall Study|Death|0|||
129060002|NCT03743415|464508537|FG007|Overall Study|Death|0|||
129060003|NCT03743415|464508538|FG008|Overall Study|Death|1|||
129060004|NCT03743415|464508539|FG009|Overall Study|Death|0|||
129060005|NCT03743415|464508530|FG000|Overall Study|Withdrawal by Subject|1|||
129060006|NCT03743415|464508531|FG001|Overall Study|Withdrawal by Subject|0|||
129060007|NCT03743415|464508532|FG002|Overall Study|Withdrawal by Subject|4|||
129060008|NCT03743415|464508533|FG003|Overall Study|Withdrawal by Subject|5|||
128775563|NCT01023308|463468380|FG001|Overall Study|Untreated|5|||
129060009|NCT03743415|464508534|FG004|Overall Study|Withdrawal by Subject|5|||
129060010|NCT03743415|464508535|FG005|Overall Study|Withdrawal by Subject|2|||
129060011|NCT03743415|464508536|FG006|Overall Study|Withdrawal by Subject|2|||
129060012|NCT03743415|464508537|FG007|Overall Study|Withdrawal by Subject|5|||
129060013|NCT03743415|464508538|FG008|Overall Study|Withdrawal by Subject|9|||
129060014|NCT03743415|464508539|FG009|Overall Study|Withdrawal by Subject|10|||
129060015|NCT03743415|464508530|FG000|Overall Study|Lost to Follow-up|2|||
129060016|NCT03743415|464508531|FG001|Overall Study|Lost to Follow-up|0|||
129060017|NCT03743415|464508532|FG002|Overall Study|Lost to Follow-up|2|||
129060018|NCT03743415|464508533|FG003|Overall Study|Lost to Follow-up|1|||
129060019|NCT03743415|464508534|FG004|Overall Study|Lost to Follow-up|1|||
129060020|NCT03743415|464508535|FG005|Overall Study|Lost to Follow-up|0|||
129060021|NCT03743415|464508536|FG006|Overall Study|Lost to Follow-up|1|||
129060022|NCT03743415|464508537|FG007|Overall Study|Lost to Follow-up|4|||
129060023|NCT03743415|464508538|FG008|Overall Study|Lost to Follow-up|13|||
129060024|NCT03743415|464508539|FG009|Overall Study|Lost to Follow-up|13|||
129060025|NCT02242045|464508543|FG000|Overall Study|Investigator's Discretion|1|||
129060026|NCT02242045|464508543|FG000|Overall Study|Progressive Disease|2|||
129060027|NCT02242045|464508543|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
129060028|NCT02242045|464508543|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
129060029|NCT02473523|464508544|FG000|Overall Study|Death|1|||
129060030|NCT02473523|464508544|FG000|Overall Study|Lost to Follow-up|1|||
129060031|NCT00976911|464508550|FG000|Overall Study|Withdrawal by Subject|4|||
129060032|NCT00976911|464508551|FG001|Overall Study|Withdrawal by Subject|6|||
129060033|NCT00976911|464508550|FG000|Overall Study|Death|138|||
129060034|NCT00976911|464508551|FG001|Overall Study|Death|126|||
129060035|NCT00976911|464508550|FG000|Overall Study|Adverse Event|0|||
129060036|NCT00976911|464508551|FG001|Overall Study|Adverse Event|1|||
129060037|NCT00976911|464508550|FG000|Overall Study|Protocol Violation|2|||
129060038|NCT00976911|464508551|FG001|Overall Study|Protocol Violation|0|||
129060039|NCT00976911|464508550|FG000|Overall Study|Other|8|||
129060040|NCT00976911|464508551|FG001|Overall Study|Other|9|||
129060041|NCT00976911|464508550|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
129060042|NCT00976911|464508551|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
129060043|NCT02954991|464508552|FG000|Overall Study|Death|92|||
129060044|NCT02954991|464508553|FG001|Overall Study|Death|11|||
129060045|NCT02954991|464508554|FG002|Overall Study|Death|2|||
129060046|NCT02954991|464508552|FG000|Overall Study|Lost to Follow-up|3|||
129060047|NCT02954991|464508553|FG001|Overall Study|Lost to Follow-up|2|||
129060048|NCT02954991|464508554|FG002|Overall Study|Lost to Follow-up|0|||
129060049|NCT02954991|464508552|FG000|Overall Study|Withdrawal by Subject|9|||
129060050|NCT02954991|464508553|FG001|Overall Study|Withdrawal by Subject|8|||
129060051|NCT02954991|464508554|FG002|Overall Study|Withdrawal by Subject|1|||
129060052|NCT02954991|464508552|FG000|Overall Study|Study Terminated by Sponsor|18|||
129060053|NCT02954991|464508553|FG001|Overall Study|Study Terminated by Sponsor|10|||
129060054|NCT02954991|464508554|FG002|Overall Study|Study Terminated by Sponsor|1|||
129060055|NCT02954991|464508552|FG000|Overall Study|Miscellaneous|2|||
129060056|NCT02954991|464508553|FG001|Overall Study|Miscellaneous|1|||
129060057|NCT02954991|464508554|FG002|Overall Study|Miscellaneous|1|||
129060058|NCT00576316|464508555|FG000|Overall Study|Adverse Event|9|||
129060059|NCT00576316|464508555|FG000|Overall Study|Withdrawal by Subject|2|||
129060060|NCT00576316|464508555|FG000|Overall Study|Protocol Violation|9|||
129060061|NCT01266031|464508557|FG000|Overall Study|Not treated|0|||
129060062|NCT01266031|464508558|FG001|Overall Study|Not treated|3|||
129060063|NCT01266031|464508559|FG002|Overall Study|Not treated|2|||
129060064|NCT01434810|464508560|FG000|Overall Study|Did not receive treatment|11|||
129060065|NCT01434810|464508561|FG001|Overall Study|Did not receive treatment|3|||
129060066|NCT01434810|464508560|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
129060067|NCT01434810|464508561|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
129060068|NCT04893018|464508563|FG000|Overall Study|Lost to Follow-up|1|||
129060069|NCT04893018|464508564|FG001|Overall Study|Lost to Follow-up|0|||
129060070|NCT04893018|464508563|FG000|Overall Study|Withdrawal by Subject|2|||
129060071|NCT04893018|464508564|FG001|Overall Study|Withdrawal by Subject|0|||
129060072|NCT04893018|464508563|FG000|Overall Study|Study Terminated|1|||
129060073|NCT04893018|464508564|FG001|Overall Study|Study Terminated|2|||
129060074|NCT01275729|464508569|FG000|Overall Study|Death|3|||
129060075|NCT01275729|464508569|FG000|Overall Study|Withdrawal by Subject|1|||
129060076|NCT02252406|464508570|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
129060077|NCT02252406|464508571|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
129060078|NCT02252406|464508570|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
129060079|NCT02252406|464508571|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
129060080|NCT02252406|464508570|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
129060081|NCT02252406|464508571|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
129060082|NCT02252406|464508570|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
129060083|NCT02252406|464508571|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
129060084|NCT02252406|464508570|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
129060085|NCT02252406|464508571|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
129060086|NCT02533180|464508572|FG000|Overall Study|Death|0|||
129060087|NCT02533180|464508573|FG001|Overall Study|Death|2|||
128775564|NCT01023308|463468379|FG000|Overall Study|Lost to Follow-up|1|||
129060088|NCT02533180|464508572|FG000|Overall Study|Lost to Follow-up|0|||
129060089|NCT02533180|464508573|FG001|Overall Study|Lost to Follow-up|1|||
129060090|NCT02533180|464508572|FG000|Overall Study|Physician Decision|0|||
129060091|NCT02533180|464508573|FG001|Overall Study|Physician Decision|1|||
129060092|NCT02533180|464508572|FG000|Overall Study|Withdrawal by Subject|2|||
129060093|NCT02533180|464508573|FG001|Overall Study|Withdrawal by Subject|5|||
129060094|NCT02533180|464508572|FG000|Overall Study|Screen Failure|37|||
129060095|NCT02533180|464508573|FG001|Overall Study|Screen Failure|0|||
129060096|NCT02533180|464508572|FG000|Overall Study|Protocol Deviation|0|||
129060097|NCT02533180|464508573|FG001|Overall Study|Protocol Deviation|1|||
129060098|NCT02533180|464508572|FG000|Overall Study|Non-compliance|0|||
129060099|NCT02533180|464508573|FG001|Overall Study|Non-compliance|1|||
129060100|NCT00447876|464508574|FG000|Overall Study|Withdrawal by Subject|1|||
129060101|NCT00447876|464508575|FG001|Overall Study|Withdrawal by Subject|4|||
129060102|NCT00447876|464508574|FG000|Overall Study|Lost to Follow-up|1|||
129060103|NCT00447876|464508575|FG001|Overall Study|Lost to Follow-up|0|||
129060104|NCT00447876|464508574|FG000|Overall Study|Deterioration of symptomology|1|||
129060105|NCT00447876|464508575|FG001|Overall Study|Deterioration of symptomology|0|||
129060106|NCT00005957|464508578|FG000|Overall Study|No treated|3|||
129060107|NCT00005957|464508579|FG001|Overall Study|No treated|9|||
129060108|NCT00005957|464508578|FG000|Overall Study|Crossover to the other arm|5|||
129060109|NCT00005957|464508579|FG001|Overall Study|Crossover to the other arm|19|||
129060110|NCT01609023|464508580|FG000|Overall Study|Lack of Efficacy|3|||
129060111|NCT01609023|464508580|FG000|Overall Study|Withdrawal by Subject|4|||
129060112|NCT01609023|464508580|FG000|Overall Study|Lost to Follow-up|8|||
129060113|NCT01609023|464508580|FG000|Overall Study|Toxicity|3|||
129060114|NCT01609023|464508580|FG000|Overall Study|Disease progression|10|||
129060115|NCT01609023|464508580|FG000|Overall Study|Physician Decision|2|||
129060116|NCT01609023|464508580|FG000|Overall Study|Death|2|||
129060117|NCT01609023|464508580|FG000|Overall Study|Personal reasons|1|||
129060118|NCT02047734|464508582|FG000|Overall Study|Adverse Event|18|||
129060119|NCT02047734|464508583|FG001|Overall Study|Adverse Event|13|||
129060120|NCT02047734|464508584|FG002|Overall Study|Adverse Event|13|||
129060121|NCT02047734|464508582|FG000|Overall Study|Lack of Efficacy|4|||
129060122|NCT02047734|464508583|FG001|Overall Study|Lack of Efficacy|5|||
129060123|NCT02047734|464508584|FG002|Overall Study|Lack of Efficacy|1|||
129060124|NCT02047734|464508582|FG000|Overall Study|Protocol Violation|3|||
129060125|NCT02047734|464508583|FG001|Overall Study|Protocol Violation|1|||
129060126|NCT02047734|464508584|FG002|Overall Study|Protocol Violation|1|||
129060127|NCT02047734|464508582|FG000|Overall Study|Lost to Follow-up|1|||
129060128|NCT02047734|464508583|FG001|Overall Study|Lost to Follow-up|4|||
129060129|NCT02047734|464508584|FG002|Overall Study|Lost to Follow-up|0|||
129060130|NCT02047734|464508582|FG000|Overall Study|Death|0|||
129060131|NCT02047734|464508583|FG001|Overall Study|Death|1|||
129060132|NCT02047734|464508584|FG002|Overall Study|Death|0|||
129060133|NCT02047734|464508582|FG000|Overall Study|Withdrawal by Subject|30|||
129060134|NCT02047734|464508583|FG001|Overall Study|Withdrawal by Subject|31|||
129060135|NCT02047734|464508584|FG002|Overall Study|Withdrawal by Subject|19|||
129060136|NCT02047734|464508582|FG000|Overall Study|Physician Decision|7|||
129060137|NCT02047734|464508583|FG001|Overall Study|Physician Decision|6|||
129060138|NCT02047734|464508584|FG002|Overall Study|Physician Decision|5|||
129060139|NCT02047734|464508582|FG000|Overall Study|Miscellaneous|2|||
129060140|NCT02047734|464508583|FG001|Overall Study|Miscellaneous|4|||
129060141|NCT02047734|464508584|FG002|Overall Study|Miscellaneous|6|||
129060142|NCT02047734|464508582|FG000|Overall Study|Did Not Receive Study Drug|2|||
129060143|NCT02047734|464508583|FG001|Overall Study|Did Not Receive Study Drug|4|||
129060144|NCT02047734|464508584|FG002|Overall Study|Did Not Receive Study Drug|1|||
129060145|NCT00799825|464508587|FG000|Overall Study|Adverse Event|1|||
129060146|NCT00799825|464508587|FG000|Overall Study|Withdrawal by Subject|6|||
129060147|NCT00799825|464508587|FG000|Overall Study|Lost to Follow-up|38|||
128720278|NCT01239368|463274904|FG000|Overall Study|Death|0|||
128720279|NCT01239368|463274905|FG001|Overall Study|Death|0|||
128720280|NCT01239368|463274906|FG002|Overall Study|Death|0|||
128720281|NCT01239368|463274907|FG003|Overall Study|Death|0|||
128720282|NCT01239368|463274908|FG004|Overall Study|Death|0|||
128720283|NCT01239368|463274909|FG005|Overall Study|Death|0|||
129060148|NCT00799825|464508587|FG000|Overall Study|Pregnancy|3|||
129060149|NCT02439970|464508588|FG000|Overall Study|Study Terminated|2|||
129060150|NCT02439970|464508589|FG001|Overall Study|Study Terminated|3|||
129060151|NCT00492778|464508590|FG000|Overall Study|Ineligible by Pathology Review|8|||
129060152|NCT00492778|464508591|FG001|Overall Study|Ineligible by Pathology Review|1|||
129060153|NCT02910011|464508594|FG000|Overall Study|Physician Decision|2|||
129060154|NCT02458287|464508602|FG000|Overall Study|Adverse Event|0|||
129060155|NCT02458287|464508603|FG001|Overall Study|Adverse Event|0|||
129060156|NCT02458287|464508604|FG002|Overall Study|Adverse Event|0|||
129060157|NCT02458287|464508605|FG003|Overall Study|Adverse Event|1|||
129060158|NCT02458287|464508602|FG000|Overall Study|Lost to Follow-up|0|||
128720284|NCT01239368|463274910|FG006|Overall Study|Death|1|||
128720285|NCT01239368|463274911|FG007|Overall Study|Death|0|||
128720286|NCT01239368|463274912|FG008|Overall Study|Death|0|||
129060159|NCT02458287|464508603|FG001|Overall Study|Lost to Follow-up|1|||
129060160|NCT02458287|464508604|FG002|Overall Study|Lost to Follow-up|1|||
129060161|NCT02458287|464508605|FG003|Overall Study|Lost to Follow-up|0|||
129060162|NCT02458287|464508602|FG000|Overall Study|Protocol Violation|0|||
129060163|NCT02458287|464508603|FG001|Overall Study|Protocol Violation|1|||
129060164|NCT02458287|464508604|FG002|Overall Study|Protocol Violation|0|||
129060165|NCT02458287|464508605|FG003|Overall Study|Protocol Violation|0|||
129060166|NCT02458287|464508602|FG000|Overall Study|Withdrawal by Subject|0|||
129060167|NCT02458287|464508603|FG001|Overall Study|Withdrawal by Subject|2|||
128720287|NCT01239368|463274913|FG009|Overall Study|Death|0|||
128720288|NCT01541969|463274916|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
129060168|NCT02458287|464508604|FG002|Overall Study|Withdrawal by Subject|2|||
129060169|NCT02458287|464508605|FG003|Overall Study|Withdrawal by Subject|1|||
129060170|NCT02458287|464508602|FG000|Overall Study|Relocated Out of State|0|||
129060171|NCT02458287|464508603|FG001|Overall Study|Relocated Out of State|0|||
129060172|NCT02458287|464508604|FG002|Overall Study|Relocated Out of State|0|||
129060173|NCT02458287|464508605|FG003|Overall Study|Relocated Out of State|1|||
129060174|NCT00025259|464508607|FG000|Overall Study|Death|1|||
129060175|NCT00025259|464508608|FG001|Overall Study|Death|3|||
129060176|NCT00025259|464508609|FG002|Overall Study|Death|0|||
129060177|NCT00025259|464508610|FG003|Overall Study|Death|3|||
129060178|NCT00025259|464508611|FG004|Overall Study|Death|0|||
129060179|NCT00025259|464508612|FG005|Overall Study|Death|1|||
129060180|NCT00025259|464508613|FG006|Overall Study|Death|2|||
129060181|NCT00025259|464508607|FG000|Overall Study|Lack of Efficacy|2|||
129060182|NCT00025259|464508608|FG001|Overall Study|Lack of Efficacy|46|||
129060183|NCT00025259|464508609|FG002|Overall Study|Lack of Efficacy|60|||
129060184|NCT00025259|464508610|FG003|Overall Study|Lack of Efficacy|78|||
129060185|NCT00025259|464508611|FG004|Overall Study|Lack of Efficacy|11|||
129060186|NCT00025259|464508612|FG005|Overall Study|Lack of Efficacy|30|||
129060187|NCT00025259|464508613|FG006|Overall Study|Lack of Efficacy|38|||
129060188|NCT00025259|464508607|FG000|Overall Study|Lost to Follow-up|2|||
129060189|NCT00025259|464508608|FG001|Overall Study|Lost to Follow-up|9|||
129060190|NCT00025259|464508609|FG002|Overall Study|Lost to Follow-up|13|||
129060191|NCT00025259|464508610|FG003|Overall Study|Lost to Follow-up|13|||
129060192|NCT00025259|464508611|FG004|Overall Study|Lost to Follow-up|1|||
129060193|NCT00025259|464508612|FG005|Overall Study|Lost to Follow-up|3|||
129060194|NCT00025259|464508613|FG006|Overall Study|Lost to Follow-up|1|||
129060195|NCT00025259|464508607|FG000|Overall Study|Physician Decision|12|||
129060196|NCT00025259|464508608|FG001|Overall Study|Physician Decision|1|||
129060197|NCT00025259|464508609|FG002|Overall Study|Physician Decision|0|||
129060198|NCT00025259|464508610|FG003|Overall Study|Physician Decision|5|||
129060199|NCT00025259|464508611|FG004|Overall Study|Physician Decision|4|||
129060200|NCT00025259|464508612|FG005|Overall Study|Physician Decision|2|||
129060201|NCT00025259|464508613|FG006|Overall Study|Physician Decision|1|||
129060202|NCT00025259|464508607|FG000|Overall Study|Protocol Violation|3|||
129060203|NCT00025259|464508608|FG001|Overall Study|Protocol Violation|2|||
129060204|NCT00025259|464508609|FG002|Overall Study|Protocol Violation|2|||
129060205|NCT00025259|464508610|FG003|Overall Study|Protocol Violation|1|||
129060206|NCT00025259|464508611|FG004|Overall Study|Protocol Violation|2|||
129060207|NCT00025259|464508612|FG005|Overall Study|Protocol Violation|1|||
129060208|NCT00025259|464508613|FG006|Overall Study|Protocol Violation|3|||
129060209|NCT00025259|464508607|FG000|Overall Study|Withdrawal by Subject|9|||
129060210|NCT00025259|464508608|FG001|Overall Study|Withdrawal by Subject|27|||
129060211|NCT00025259|464508609|FG002|Overall Study|Withdrawal by Subject|6|||
129060212|NCT00025259|464508610|FG003|Overall Study|Withdrawal by Subject|14|||
129060213|NCT00025259|464508611|FG004|Overall Study|Withdrawal by Subject|11|||
129060214|NCT00025259|464508612|FG005|Overall Study|Withdrawal by Subject|8|||
129060215|NCT00025259|464508613|FG006|Overall Study|Withdrawal by Subject|3|||
129060216|NCT00025259|464508607|FG000|Overall Study|Ineligible|14|||
129060217|NCT00025259|464508608|FG001|Overall Study|Ineligible|1|||
129060218|NCT00025259|464508609|FG002|Overall Study|Ineligible|0|||
129060219|NCT00025259|464508610|FG003|Overall Study|Ineligible|0|||
129060220|NCT00025259|464508611|FG004|Overall Study|Ineligible|6|||
129060221|NCT00025259|464508612|FG005|Overall Study|Ineligible|0|||
129060222|NCT00025259|464508613|FG006|Overall Study|Ineligible|1|||
129060223|NCT00025259|464508607|FG000|Overall Study|Randomization error|1|||
129060224|NCT00025259|464508608|FG001|Overall Study|Randomization error|0|||
129060225|NCT00025259|464508609|FG002|Overall Study|Randomization error|0|||
129060226|NCT00025259|464508610|FG003|Overall Study|Randomization error|0|||
129060227|NCT00025259|464508611|FG004|Overall Study|Randomization error|1|||
129060228|NCT00025259|464508612|FG005|Overall Study|Randomization error|7|||
129060229|NCT00025259|464508613|FG006|Overall Study|Randomization error|2|||
129060230|NCT00025259|464508607|FG000|Overall Study|Adverse Event|1|||
129060231|NCT00025259|464508608|FG001|Overall Study|Adverse Event|0|||
129060232|NCT00025259|464508609|FG002|Overall Study|Adverse Event|0|||
129060233|NCT00025259|464508610|FG003|Overall Study|Adverse Event|0|||
129060234|NCT00025259|464508611|FG004|Overall Study|Adverse Event|0|||
129060235|NCT00025259|464508612|FG005|Overall Study|Adverse Event|0|||
129060236|NCT00025259|464508613|FG006|Overall Study|Adverse Event|0|||
129060237|NCT01449370|464508614|FG000|Overall Study|Disease Progression|5|||
129060238|NCT01449370|464508615|FG001|Overall Study|Disease Progression|4|||
129060239|NCT01449370|464508616|FG002|Overall Study|Disease Progression|8|||
129060240|NCT01449370|464508617|FG003|Overall Study|Disease Progression|3|||
129060241|NCT01449370|464508618|FG004|Overall Study|Disease Progression|3|||
129060242|NCT01449370|464508619|FG005|Overall Study|Disease Progression|3|||
129060243|NCT01449370|464508620|FG006|Overall Study|Disease Progression|3|||
129060244|NCT01449370|464508621|FG007|Overall Study|Disease Progression|2|||
129060245|NCT01449370|464508622|FG008|Overall Study|Disease Progression|9|||
129060246|NCT01449370|464508623|FG009|Overall Study|Disease Progression|1|||
129060247|NCT01449370|464508624|FG010|Overall Study|Disease Progression|3|||
129060248|NCT01449370|464508625|FG011|Overall Study|Disease Progression|3|||
129060249|NCT01449370|464508626|FG012|Overall Study|Disease Progression|2|||
129060250|NCT01449370|464508627|FG013|Overall Study|Disease Progression|8|||
129060251|NCT01449370|464508628|FG014|Overall Study|Disease Progression|3|||
129060252|NCT01449370|464508629|FG015|Overall Study|Disease Progression|1|||
129060253|NCT01449370|464508630|FG016|Overall Study|Disease Progression|4|||
129060254|NCT01449370|464508631|FG017|Overall Study|Disease Progression|3|||
129060255|NCT01449370|464508632|FG018|Overall Study|Disease Progression|1|||
129060256|NCT01449370|464508633|FG019|Overall Study|Disease Progression|2|||
129060257|NCT01449370|464508634|FG020|Overall Study|Disease Progression|5|||
129060258|NCT01449370|464508635|FG021|Overall Study|Disease Progression|2|||
129060259|NCT01449370|464508636|FG022|Overall Study|Disease Progression|3|||
129060260|NCT01449370|464508637|FG023|Overall Study|Disease Progression|7|||
129060261|NCT01449370|464508638|FG024|Overall Study|Disease Progression|3|||
129060262|NCT01449370|464508614|FG000|Overall Study|Adverse Event|1|||
129060263|NCT01449370|464508615|FG001|Overall Study|Adverse Event|2|||
129060264|NCT01449370|464508616|FG002|Overall Study|Adverse Event|0|||
129060265|NCT01449370|464508617|FG003|Overall Study|Adverse Event|1|||
129060266|NCT01449370|464508618|FG004|Overall Study|Adverse Event|0|||
129060267|NCT01449370|464508619|FG005|Overall Study|Adverse Event|0|||
129060268|NCT01449370|464508620|FG006|Overall Study|Adverse Event|0|||
129060269|NCT01449370|464508621|FG007|Overall Study|Adverse Event|0|||
129060270|NCT01449370|464508622|FG008|Overall Study|Adverse Event|1|||
129060271|NCT01449370|464508623|FG009|Overall Study|Adverse Event|1|||
129060272|NCT01449370|464508624|FG010|Overall Study|Adverse Event|0|||
129060273|NCT01449370|464508625|FG011|Overall Study|Adverse Event|0|||
129060274|NCT01449370|464508626|FG012|Overall Study|Adverse Event|0|||
129060275|NCT01449370|464508627|FG013|Overall Study|Adverse Event|2|||
129060276|NCT01449370|464508628|FG014|Overall Study|Adverse Event|0|||
129060277|NCT01449370|464508629|FG015|Overall Study|Adverse Event|1|||
129060278|NCT01449370|464508630|FG016|Overall Study|Adverse Event|0|||
129060279|NCT01449370|464508631|FG017|Overall Study|Adverse Event|0|||
129060280|NCT01449370|464508632|FG018|Overall Study|Adverse Event|1|||
129060281|NCT01449370|464508633|FG019|Overall Study|Adverse Event|1|||
129060282|NCT01449370|464508634|FG020|Overall Study|Adverse Event|0|||
129060283|NCT01449370|464508635|FG021|Overall Study|Adverse Event|1|||
129060284|NCT01449370|464508636|FG022|Overall Study|Adverse Event|0|||
129060285|NCT01449370|464508637|FG023|Overall Study|Adverse Event|1|||
129060286|NCT01449370|464508638|FG024|Overall Study|Adverse Event|3|||
129060287|NCT01449370|464508614|FG000|Overall Study|Participant Decision|0|||
129060288|NCT01449370|464508615|FG001|Overall Study|Participant Decision|0|||
129060289|NCT01449370|464508616|FG002|Overall Study|Participant Decision|0|||
129060290|NCT01449370|464508617|FG003|Overall Study|Participant Decision|0|||
129060291|NCT01449370|464508618|FG004|Overall Study|Participant Decision|0|||
129060292|NCT01449370|464508619|FG005|Overall Study|Participant Decision|0|||
129060293|NCT01449370|464508620|FG006|Overall Study|Participant Decision|0|||
129060294|NCT01449370|464508621|FG007|Overall Study|Participant Decision|1|||
129060295|NCT01449370|464508622|FG008|Overall Study|Participant Decision|1|||
129060296|NCT01449370|464508623|FG009|Overall Study|Participant Decision|0|||
129060297|NCT01449370|464508624|FG010|Overall Study|Participant Decision|0|||
129060298|NCT01449370|464508625|FG011|Overall Study|Participant Decision|0|||
129060299|NCT01449370|464508626|FG012|Overall Study|Participant Decision|1|||
129060300|NCT01449370|464508627|FG013|Overall Study|Participant Decision|1|||
129060301|NCT01449370|464508628|FG014|Overall Study|Participant Decision|0|||
129060302|NCT01449370|464508629|FG015|Overall Study|Participant Decision|1|||
129060303|NCT01449370|464508630|FG016|Overall Study|Participant Decision|3|||
129060304|NCT01449370|464508631|FG017|Overall Study|Participant Decision|0|||
129060305|NCT01449370|464508632|FG018|Overall Study|Participant Decision|1|||
129060306|NCT01449370|464508633|FG019|Overall Study|Participant Decision|0|||
129060307|NCT01449370|464508634|FG020|Overall Study|Participant Decision|0|||
129060308|NCT01449370|464508635|FG021|Overall Study|Participant Decision|1|||
129060309|NCT01449370|464508636|FG022|Overall Study|Participant Decision|0|||
129060310|NCT01449370|464508637|FG023|Overall Study|Participant Decision|0|||
129060311|NCT01449370|464508638|FG024|Overall Study|Participant Decision|1|||
129060312|NCT01449370|464508614|FG000|Overall Study|Lost to Follow-up|0|||
129060313|NCT01449370|464508615|FG001|Overall Study|Lost to Follow-up|0|||
129060314|NCT01449370|464508616|FG002|Overall Study|Lost to Follow-up|0|||
128720289|NCT01541969|463274917|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
128720290|NCT01541969|463274916|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
128720291|NCT01541969|463274917|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
128720292|NCT01541969|463274916|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
128720293|NCT01541969|463274917|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
128720294|NCT01541969|463274916|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
128720295|NCT01541969|463274917|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
128775565|NCT01023308|463468380|FG001|Overall Study|Lost to Follow-up|0|||
129060315|NCT01449370|464508617|FG003|Overall Study|Lost to Follow-up|0|||
129060316|NCT01449370|464508618|FG004|Overall Study|Lost to Follow-up|0|||
129060317|NCT01449370|464508619|FG005|Overall Study|Lost to Follow-up|0|||
129060318|NCT01449370|464508620|FG006|Overall Study|Lost to Follow-up|0|||
129060319|NCT01449370|464508621|FG007|Overall Study|Lost to Follow-up|0|||
129060320|NCT01449370|464508622|FG008|Overall Study|Lost to Follow-up|0|||
129060321|NCT01449370|464508623|FG009|Overall Study|Lost to Follow-up|0|||
129060322|NCT01449370|464508624|FG010|Overall Study|Lost to Follow-up|0|||
129060323|NCT01449370|464508625|FG011|Overall Study|Lost to Follow-up|0|||
129060324|NCT01449370|464508626|FG012|Overall Study|Lost to Follow-up|0|||
129060325|NCT01449370|464508627|FG013|Overall Study|Lost to Follow-up|0|||
129060326|NCT01449370|464508628|FG014|Overall Study|Lost to Follow-up|0|||
129060327|NCT01449370|464508629|FG015|Overall Study|Lost to Follow-up|0|||
129060328|NCT01449370|464508630|FG016|Overall Study|Lost to Follow-up|0|||
129060329|NCT01449370|464508631|FG017|Overall Study|Lost to Follow-up|0|||
129060330|NCT01449370|464508632|FG018|Overall Study|Lost to Follow-up|0|||
129060331|NCT01449370|464508633|FG019|Overall Study|Lost to Follow-up|0|||
129060332|NCT01449370|464508634|FG020|Overall Study|Lost to Follow-up|1|||
129060333|NCT01449370|464508635|FG021|Overall Study|Lost to Follow-up|0|||
129060334|NCT01449370|464508636|FG022|Overall Study|Lost to Follow-up|0|||
129060335|NCT01449370|464508637|FG023|Overall Study|Lost to Follow-up|0|||
129060336|NCT01449370|464508638|FG024|Overall Study|Lost to Follow-up|0|||
129060337|NCT01449370|464508614|FG000|Overall Study|Other|0|||
129060338|NCT01449370|464508615|FG001|Overall Study|Other|0|||
129060339|NCT01449370|464508616|FG002|Overall Study|Other|0|||
129060340|NCT01449370|464508617|FG003|Overall Study|Other|0|||
129060341|NCT01449370|464508618|FG004|Overall Study|Other|0|||
129060342|NCT01449370|464508619|FG005|Overall Study|Other|0|||
129060343|NCT01449370|464508620|FG006|Overall Study|Other|0|||
129060344|NCT01449370|464508621|FG007|Overall Study|Other|0|||
129060345|NCT01449370|464508622|FG008|Overall Study|Other|1|||
129060346|NCT01449370|464508623|FG009|Overall Study|Other|1|||
129060347|NCT01449370|464508624|FG010|Overall Study|Other|0|||
129060348|NCT01449370|464508625|FG011|Overall Study|Other|0|||
129060349|NCT01449370|464508626|FG012|Overall Study|Other|0|||
129060350|NCT01449370|464508627|FG013|Overall Study|Other|0|||
129060351|NCT01449370|464508628|FG014|Overall Study|Other|0|||
129060352|NCT01449370|464508629|FG015|Overall Study|Other|0|||
129060353|NCT01449370|464508630|FG016|Overall Study|Other|0|||
129060354|NCT01449370|464508631|FG017|Overall Study|Other|0|||
129060355|NCT01449370|464508632|FG018|Overall Study|Other|0|||
129060356|NCT01449370|464508633|FG019|Overall Study|Other|0|||
129060357|NCT01449370|464508634|FG020|Overall Study|Other|0|||
129060358|NCT01449370|464508635|FG021|Overall Study|Other|0|||
129060359|NCT01449370|464508636|FG022|Overall Study|Other|1|||
129060360|NCT01449370|464508637|FG023|Overall Study|Other|1|||
129060361|NCT01449370|464508638|FG024|Overall Study|Other|0|||
129060362|NCT01449370|464508614|FG000|Overall Study|Medication Prohibited by Protocol|0|||
129060363|NCT01449370|464508615|FG001|Overall Study|Medication Prohibited by Protocol|0|||
129060364|NCT01449370|464508616|FG002|Overall Study|Medication Prohibited by Protocol|0|||
129060365|NCT01449370|464508617|FG003|Overall Study|Medication Prohibited by Protocol|0|||
129060366|NCT01449370|464508618|FG004|Overall Study|Medication Prohibited by Protocol|0|||
129060367|NCT01449370|464508619|FG005|Overall Study|Medication Prohibited by Protocol|0|||
129060368|NCT01449370|464508620|FG006|Overall Study|Medication Prohibited by Protocol|0|||
129060369|NCT01449370|464508621|FG007|Overall Study|Medication Prohibited by Protocol|0|||
129060370|NCT01449370|464508622|FG008|Overall Study|Medication Prohibited by Protocol|0|||
129060371|NCT01449370|464508623|FG009|Overall Study|Medication Prohibited by Protocol|0|||
129060372|NCT01449370|464508624|FG010|Overall Study|Medication Prohibited by Protocol|0|||
129060373|NCT01449370|464508625|FG011|Overall Study|Medication Prohibited by Protocol|0|||
129060374|NCT01449370|464508626|FG012|Overall Study|Medication Prohibited by Protocol|0|||
129060375|NCT01449370|464508627|FG013|Overall Study|Medication Prohibited by Protocol|0|||
129060376|NCT01449370|464508628|FG014|Overall Study|Medication Prohibited by Protocol|0|||
129060377|NCT01449370|464508629|FG015|Overall Study|Medication Prohibited by Protocol|0|||
129060378|NCT01449370|464508630|FG016|Overall Study|Medication Prohibited by Protocol|0|||
129060379|NCT01449370|464508631|FG017|Overall Study|Medication Prohibited by Protocol|0|||
129060380|NCT01449370|464508632|FG018|Overall Study|Medication Prohibited by Protocol|0|||
129060381|NCT01449370|464508633|FG019|Overall Study|Medication Prohibited by Protocol|0|||
129060382|NCT01449370|464508634|FG020|Overall Study|Medication Prohibited by Protocol|0|||
129060383|NCT01449370|464508635|FG021|Overall Study|Medication Prohibited by Protocol|0|||
129060384|NCT01449370|464508636|FG022|Overall Study|Medication Prohibited by Protocol|0|||
129060385|NCT01449370|464508637|FG023|Overall Study|Medication Prohibited by Protocol|1|||
129060386|NCT01449370|464508638|FG024|Overall Study|Medication Prohibited by Protocol|0|||
129060387|NCT01449370|464508614|FG000|Overall Study|Death|0|||
129060388|NCT01449370|464508615|FG001|Overall Study|Death|0|||
129060389|NCT01449370|464508616|FG002|Overall Study|Death|0|||
129060390|NCT01449370|464508617|FG003|Overall Study|Death|0|||
129060391|NCT01449370|464508618|FG004|Overall Study|Death|0|||
129060392|NCT01449370|464508619|FG005|Overall Study|Death|0|||
129060393|NCT01449370|464508620|FG006|Overall Study|Death|0|||
129060394|NCT01449370|464508621|FG007|Overall Study|Death|0|||
129060395|NCT01449370|464508622|FG008|Overall Study|Death|0|||
129060396|NCT01449370|464508623|FG009|Overall Study|Death|0|||
128720296|NCT01541969|463274916|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
128720297|NCT01541969|463274917|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
128720298|NCT01541969|463274916|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
128720299|NCT01541969|463274917|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
128720300|NCT01541969|463274916|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
128720301|NCT01541969|463274917|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
128720302|NCT01541969|463274916|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
128720303|NCT01541969|463274917|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
128720304|NCT01541969|463274916|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
128720305|NCT01541969|463274917|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
128720306|NCT01541969|463274916|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
128720307|NCT01541969|463274917|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
128720308|NCT05123222|463274918|FG000|Overall Study|Lost to Follow-up|2|||
128720309|NCT05123222|463274919|FG001|Overall Study|Lost to Follow-up|0|||
128720310|NCT05123222|463274920|FG002|Overall Study|Lost to Follow-up|0|||
128720311|NCT05123222|463274921|FG003|Overall Study|Lost to Follow-up|0|||
128720312|NCT05123222|463274918|FG000|Overall Study|Protocol Violation|0|||
128720313|NCT05123222|463274919|FG001|Overall Study|Protocol Violation|0|||
128720314|NCT05123222|463274920|FG002|Overall Study|Protocol Violation|1|||
128720315|NCT05123222|463274921|FG003|Overall Study|Protocol Violation|0|||
128720316|NCT02255500|463274926|FG000|Overall Study|Withdrawal by Subject|1|||
128720317|NCT02255500|463274927|FG001|Overall Study|Withdrawal by Subject|0|||
128720318|NCT00265343|463274928|FG000|Overall Study|Adverse Event|10|||
128720319|NCT00265343|463274929|FG001|Overall Study|Adverse Event|7|||
128720320|NCT00265343|463274928|FG000|Overall Study|Withdrawal by Subject|3|||
128720321|NCT00265343|463274929|FG001|Overall Study|Withdrawal by Subject|9|||
128720322|NCT00265343|463274928|FG000|Overall Study|Other|8|||
128720323|NCT00265343|463274929|FG001|Overall Study|Other|3|||
129060397|NCT01449370|464508624|FG010|Overall Study|Death|0|||
129060398|NCT01449370|464508625|FG011|Overall Study|Death|0|||
129060399|NCT01449370|464508626|FG012|Overall Study|Death|0|||
129060400|NCT01449370|464508627|FG013|Overall Study|Death|0|||
129060401|NCT01449370|464508628|FG014|Overall Study|Death|0|||
129060402|NCT01449370|464508629|FG015|Overall Study|Death|0|||
129060403|NCT01449370|464508630|FG016|Overall Study|Death|0|||
129060404|NCT01449370|464508631|FG017|Overall Study|Death|0|||
129060405|NCT01449370|464508632|FG018|Overall Study|Death|0|||
129060406|NCT01449370|464508633|FG019|Overall Study|Death|0|||
129060407|NCT01449370|464508634|FG020|Overall Study|Death|0|||
129060408|NCT01449370|464508635|FG021|Overall Study|Death|0|||
129060409|NCT01449370|464508636|FG022|Overall Study|Death|0|||
129060410|NCT01449370|464508637|FG023|Overall Study|Death|0|||
129060411|NCT01449370|464508638|FG024|Overall Study|Death|1|||
129060412|NCT00534404|464508639|FG000|Overall Study|Death|0|||
129060413|NCT00534404|464508640|FG001|Overall Study|Death|0|||
129060414|NCT00534404|464508641|FG002|Overall Study|Death|2|||
129060415|NCT00534404|464508639|FG000|Overall Study|Withdrawal by Subject|8|||
129060416|NCT00534404|464508640|FG001|Overall Study|Withdrawal by Subject|2|||
129060417|NCT00534404|464508641|FG002|Overall Study|Withdrawal by Subject|38|||
129060418|NCT00534404|464508639|FG000|Overall Study|Removed by study staff|2|||
129060419|NCT00534404|464508640|FG001|Overall Study|Removed by study staff|3|||
129060420|NCT00534404|464508641|FG002|Overall Study|Removed by study staff|1|||
129060421|NCT00534404|464508639|FG000|Overall Study|Lost to Follow-up|170|||
129060422|NCT00534404|464508640|FG001|Overall Study|Lost to Follow-up|138|||
129060423|NCT00534404|464508641|FG002|Overall Study|Lost to Follow-up|201|||
129060424|NCT00315731|464508646|FG000|Overall Study|Lost to Follow-up|1|||
129060425|NCT00315731|464508646|FG000|Overall Study|Death|5|||
129060426|NCT03597464|464508647|FG000|Overall Study|Withdrawal by Subject|4|||
129060427|NCT03597464|464508648|FG001|Overall Study|Withdrawal by Subject|5|||
129060428|NCT03597464|464508647|FG000|Overall Study|Lost to Follow-up|3|||
129060429|NCT03597464|464508648|FG001|Overall Study|Lost to Follow-up|1|||
129060430|NCT03597464|464508647|FG000|Overall Study|Pregnancy|3|||
129060431|NCT03597464|464508648|FG001|Overall Study|Pregnancy|1|||
129060432|NCT03597464|464508647|FG000|Overall Study|Lack of Efficacy|2|||
128720324|NCT04865354|463274930|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
128720325|NCT04865354|463274931|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
128720326|NCT04865354|463274930|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
129060433|NCT03597464|464508648|FG001|Overall Study|Lack of Efficacy|0|||
129060434|NCT03597464|464508647|FG000|Overall Study|Physician Decision|2|||
129060435|NCT03597464|464508648|FG001|Overall Study|Physician Decision|2|||
129060436|NCT03597464|464508647|FG000|Overall Study|Protocol Violation|1|||
129060437|NCT03597464|464508648|FG001|Overall Study|Protocol Violation|1|||
129060438|NCT03597464|464508647|FG000|Overall Study|Adverse Event|0|||
129060439|NCT03597464|464508648|FG001|Overall Study|Adverse Event|2|||
129060440|NCT03597464|464508647|FG000|Overall Study|Death|0|||
129060441|NCT03597464|464508648|FG001|Overall Study|Death|3|||
129060442|NCT02542605|464508651|FG000|Part B: Challenge Phase|Sponsor decision|1|||
129060443|NCT02542605|464508652|FG001|Part B: Challenge Phase|Sponsor decision|0|||
129060444|NCT02542605|464508653|FG002|Part B: Challenge Phase|Sponsor decision|0|||
129060445|NCT02542605|464508651|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
129060446|NCT02542605|464508652|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
129060447|NCT02542605|464508653|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
129060448|NCT02682927|464508654|FG000|Overall Study|Adverse Event|0|||
129060449|NCT02682927|464508655|FG001|Overall Study|Adverse Event|0|||
129060450|NCT02682927|464508656|FG002|Overall Study|Adverse Event|5|||
129060451|NCT02682927|464508657|FG003|Overall Study|Adverse Event|1|||
129060452|NCT02682927|464508658|FG004|Overall Study|Adverse Event|0|||
129060453|NCT02682927|464508659|FG005|Overall Study|Adverse Event|2|||
129060454|NCT02682927|464508654|FG000|Overall Study|Death|0|||
129060455|NCT02682927|464508655|FG001|Overall Study|Death|0|||
129060456|NCT02682927|464508656|FG002|Overall Study|Death|0|||
129060457|NCT02682927|464508657|FG003|Overall Study|Death|1|||
129060458|NCT02682927|464508658|FG004|Overall Study|Death|0|||
129060459|NCT02682927|464508659|FG005|Overall Study|Death|0|||
129060460|NCT02682927|464508654|FG000|Overall Study|Lack of Efficacy|1|||
129060461|NCT02682927|464508655|FG001|Overall Study|Lack of Efficacy|0|||
129060462|NCT02682927|464508656|FG002|Overall Study|Lack of Efficacy|0|||
129060463|NCT02682927|464508657|FG003|Overall Study|Lack of Efficacy|1|||
129060464|NCT02682927|464508658|FG004|Overall Study|Lack of Efficacy|0|||
129060465|NCT02682927|464508659|FG005|Overall Study|Lack of Efficacy|0|||
129060466|NCT02682927|464508654|FG000|Overall Study|Other|0|||
129060467|NCT02682927|464508655|FG001|Overall Study|Other|0|||
129060468|NCT02682927|464508656|FG002|Overall Study|Other|0|||
129060469|NCT02682927|464508657|FG003|Overall Study|Other|2|||
129060470|NCT02682927|464508658|FG004|Overall Study|Other|0|||
129060471|NCT02682927|464508659|FG005|Overall Study|Other|0|||
129060472|NCT02682927|464508654|FG000|Overall Study|Withdrawal by Subject|2|||
129060473|NCT02682927|464508655|FG001|Overall Study|Withdrawal by Subject|0|||
129060474|NCT02682927|464508656|FG002|Overall Study|Withdrawal by Subject|1|||
129060475|NCT02682927|464508657|FG003|Overall Study|Withdrawal by Subject|0|||
129060476|NCT02682927|464508658|FG004|Overall Study|Withdrawal by Subject|1|||
129060477|NCT02682927|464508659|FG005|Overall Study|Withdrawal by Subject|1|||
129060478|NCT05314816|464508661|FG000|Overall Study|Lost to Follow-up|5|||
129060479|NCT05314816|464508662|FG001|Overall Study|Lost to Follow-up|0|||
129060480|NCT05314816|464508663|FG002|Overall Study|Lost to Follow-up|1|||
129060481|NCT05314816|464508661|FG000|Overall Study|Protocol Violation|13|||
129060482|NCT05314816|464508662|FG001|Overall Study|Protocol Violation|8|||
129060483|NCT05314816|464508663|FG002|Overall Study|Protocol Violation|0|||
129060484|NCT01810302|464510547|FG000|Overall Study|Death|1|||
129060485|NCT01810302|464510548|FG001|Overall Study|Death|0|||
129060486|NCT01810302|464510547|FG000|Overall Study|Physician Decision|0|||
129060487|NCT01810302|464510548|FG001|Overall Study|Physician Decision|1|||
129060488|NCT04981717|464510552|FG000|Overall Study|Protocol Violation|0|||
129060489|NCT04981717|464510553|FG001|Overall Study|Protocol Violation|3|||
129060490|NCT04981717|464510552|FG000|Overall Study|Adverse Event|1|||
129060491|NCT04981717|464510553|FG001|Overall Study|Adverse Event|3|||
129060492|NCT04981717|464510552|FG000|Overall Study|Pregnancy|1|||
129060493|NCT04981717|464510553|FG001|Overall Study|Pregnancy|0|||
129060494|NCT04981717|464510552|FG000|Overall Study|Physician Decision|1|||
129060495|NCT04981717|464510553|FG001|Overall Study|Physician Decision|0|||
129060496|NCT04981717|464510552|FG000|Overall Study|Sponsor Request|157|||
129060497|NCT04981717|464510553|FG001|Overall Study|Sponsor Request|172|||
129060498|NCT04981717|464510552|FG000|Overall Study|Lost to Follow-up|4|||
129060499|NCT04981717|464510553|FG001|Overall Study|Lost to Follow-up|5|||
129060500|NCT04981717|464510552|FG000|Overall Study|Withdrawal by Subject|50|||
128720327|NCT04865354|463274931|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
129060501|NCT04981717|464510553|FG001|Overall Study|Withdrawal by Subject|37|||
129060502|NCT02207634|464510554|FG000|Overall Study|Withdrawal by Subject|21|||
129060503|NCT02207634|464510555|FG001|Overall Study|Withdrawal by Subject|31|||
128720328|NCT04865354|463274930|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
129060504|NCT02207634|464510554|FG000|Overall Study|Lost to Follow-up|1|||
129060505|NCT02207634|464510555|FG001|Overall Study|Lost to Follow-up|0|||
129060506|NCT00887289|464510556|FG000|Overall Study|Lack of Efficacy|14|||
129060507|NCT00887289|464510556|FG000|Overall Study|Adverse Event|27|||
129060508|NCT00887289|464510556|FG000|Overall Study|Withdrawal by Subject|26|||
129060509|NCT00887289|464510556|FG000|Overall Study|Lost to Follow-up|8|||
129060510|NCT00887289|464510556|FG000|Overall Study|Other|20|||
129060511|NCT00591773|464510557|FG000|Overall Study|Adverse Event|9|||
129060512|NCT00591773|464510558|FG001|Overall Study|Adverse Event|9|||
128775566|NCT01023308|463468379|FG000|Overall Study|Withdrawal by Subject|34|||
129060513|NCT00591773|464510559|FG002|Overall Study|Adverse Event|6|||
129060514|NCT00591773|464510557|FG000|Overall Study|Protocol Violation|2|||
129060515|NCT00591773|464510558|FG001|Overall Study|Protocol Violation|3|||
129060516|NCT00591773|464510559|FG002|Overall Study|Protocol Violation|0|||
129060517|NCT00591773|464510557|FG000|Overall Study|Lost to Follow-up|1|||
129060518|NCT00591773|464510558|FG001|Overall Study|Lost to Follow-up|4|||
129060519|NCT00591773|464510559|FG002|Overall Study|Lost to Follow-up|1|||
129060520|NCT00591773|464510557|FG000|Overall Study|Withdrawal by Subject|2|||
129060521|NCT00591773|464510558|FG001|Overall Study|Withdrawal by Subject|5|||
129060522|NCT00591773|464510559|FG002|Overall Study|Withdrawal by Subject|3|||
129060523|NCT00591773|464510557|FG000|Overall Study|Lack of Efficacy|1|||
129060524|NCT00591773|464510558|FG001|Overall Study|Lack of Efficacy|2|||
129060525|NCT00591773|464510559|FG002|Overall Study|Lack of Efficacy|2|||
129060526|NCT00591773|464510557|FG000|Overall Study|Other|1|||
129060527|NCT00591773|464510558|FG001|Overall Study|Other|1|||
129060528|NCT00591773|464510559|FG002|Overall Study|Other|4|||
129060529|NCT01371539|464510560|FG000|Period One: One Week|Lost to Follow-up|0|||
129060530|NCT01371539|464510561|FG001|Period One: One Week|Lost to Follow-up|1|||
129060531|NCT01371539|464510560|FG000|Period Two: One Week|Lost to Follow-up|0|||
129060532|NCT01371539|464510561|FG001|Period Two: One Week|Lost to Follow-up|1|||
129060533|NCT01371539|464510560|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
129060534|NCT01371539|464510561|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
129060535|NCT01371539|464510560|FG000|Period Two: One Week|Time/job conflict|0|||
129060536|NCT01371539|464510561|FG001|Period Two: One Week|Time/job conflict|1|||
129060537|NCT03713632|464510562|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
129060538|NCT03713632|464510563|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
129060539|NCT03713632|464510564|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
129060540|NCT03713632|464510565|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129060541|NCT03713632|464510566|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129060542|NCT03713632|464510562|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
129060543|NCT03713632|464510563|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
129060544|NCT03713632|464510564|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
129060545|NCT03713632|464510565|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129060546|NCT03713632|464510566|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129060547|NCT03713632|464510562|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129060548|NCT03713632|464510563|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129060549|NCT03713632|464510564|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129060550|NCT03713632|464510565|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129060551|NCT03713632|464510566|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129060552|NCT03713632|464510562|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
129060553|NCT03713632|464510563|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
129060554|NCT03713632|464510564|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
129060555|NCT03713632|464510565|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
129060556|NCT03713632|464510566|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
129060557|NCT03713632|464510562|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
129060558|NCT03713632|464510563|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129060559|NCT03713632|464510564|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
129060560|NCT03713632|464510565|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129060561|NCT03713632|464510566|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129060562|NCT03713632|464510562|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129060563|NCT03713632|464510563|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129060564|NCT03713632|464510564|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
129060565|NCT03713632|464510565|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129060566|NCT03713632|464510566|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129060567|NCT03713632|464510562|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
129060568|NCT03713632|464510563|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129060569|NCT03713632|464510564|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129060570|NCT03713632|464510565|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129060571|NCT03713632|464510566|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129060572|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
129060573|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
129060574|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
129060575|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
129060576|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
129060577|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
129060578|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
129060579|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
128775567|NCT01023308|463468380|FG001|Overall Study|Withdrawal by Subject|18|||
129060580|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
129060581|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
129060582|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
129060583|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
129060584|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
129060585|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
129060586|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
129060587|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
129060588|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
129060589|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
129060590|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
129060591|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
129060592|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
129060593|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
129060594|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129060595|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129060596|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
129060597|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
129060598|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129060599|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129060600|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129060601|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129060602|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Death|0|||
129060603|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Death|1|||
129060604|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Death|0|||
129060605|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Death|0|||
129060606|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Death|0|||
129060607|NCT03713632|464510562|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129060608|NCT03713632|464510563|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
129060609|NCT03713632|464510564|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129060610|NCT03713632|464510565|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129060611|NCT03713632|464510566|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129060612|NCT01098474|464510567|FG000|Active Phase|Other|0|||
129060613|NCT01098474|464510568|FG001|Active Phase|Other|0|||
129060614|NCT01098474|464510569|FG002|Active Phase|Other|3|||
129060615|NCT01098474|464510570|FG003|Active Phase|Other|0|||
129060616|NCT01098474|464510571|FG004|Active Phase|Other|0|||
129060617|NCT01098474|464510572|FG005|Active Phase|Other|0|||
129060618|NCT01098474|464510567|FG000|Active Phase|Withdrawal by Subject|1|||
129060619|NCT01098474|464510568|FG001|Active Phase|Withdrawal by Subject|1|||
129060620|NCT01098474|464510569|FG002|Active Phase|Withdrawal by Subject|2|||
129060621|NCT01098474|464510570|FG003|Active Phase|Withdrawal by Subject|0|||
129060622|NCT01098474|464510571|FG004|Active Phase|Withdrawal by Subject|0|||
129060623|NCT01098474|464510572|FG005|Active Phase|Withdrawal by Subject|0|||
129060624|NCT01098474|464510567|FG000|Active Phase|Lost to Follow-up|1|||
129060625|NCT01098474|464510568|FG001|Active Phase|Lost to Follow-up|0|||
129060626|NCT01098474|464510569|FG002|Active Phase|Lost to Follow-up|0|||
129060627|NCT01098474|464510570|FG003|Active Phase|Lost to Follow-up|0|||
129060628|NCT01098474|464510571|FG004|Active Phase|Lost to Follow-up|0|||
129060629|NCT01098474|464510572|FG005|Active Phase|Lost to Follow-up|0|||
129060630|NCT01098474|464510567|FG000|Follow Up Phase|Travelled out of study area|0|||
129060631|NCT01098474|464510568|FG001|Follow Up Phase|Travelled out of study area|0|||
129060632|NCT01098474|464510569|FG002|Follow Up Phase|Travelled out of study area|0|||
129060633|NCT01098474|464510570|FG003|Follow Up Phase|Travelled out of study area|0|||
129060634|NCT01098474|464510571|FG004|Follow Up Phase|Travelled out of study area|1|||
129060635|NCT01098474|464510572|FG005|Follow Up Phase|Travelled out of study area|0|||
129060636|NCT01098474|464510567|FG000|Follow Up Phase|Other|0|||
129060637|NCT01098474|464510568|FG001|Follow Up Phase|Other|0|||
129060638|NCT01098474|464510569|FG002|Follow Up Phase|Other|0|||
129060639|NCT01098474|464510570|FG003|Follow Up Phase|Other|0|||
129060640|NCT01098474|464510571|FG004|Follow Up Phase|Other|0|||
129060641|NCT01098474|464510572|FG005|Follow Up Phase|Other|4|||
129060642|NCT01098474|464510567|FG000|Follow Up Phase|Withdrawal by Subject|0|||
129060643|NCT01098474|464510568|FG001|Follow Up Phase|Withdrawal by Subject|0|||
129060644|NCT01098474|464510569|FG002|Follow Up Phase|Withdrawal by Subject|0|||
129060645|NCT01098474|464510570|FG003|Follow Up Phase|Withdrawal by Subject|2|||
129060646|NCT01098474|464510571|FG004|Follow Up Phase|Withdrawal by Subject|0|||
129060647|NCT01098474|464510572|FG005|Follow Up Phase|Withdrawal by Subject|1|||
129060648|NCT01098474|464510567|FG000|Follow Up Phase|Lost to Follow-up|0|||
129060649|NCT01098474|464510568|FG001|Follow Up Phase|Lost to Follow-up|0|||
129060650|NCT01098474|464510569|FG002|Follow Up Phase|Lost to Follow-up|0|||
129060651|NCT01098474|464510570|FG003|Follow Up Phase|Lost to Follow-up|0|||
129060652|NCT01098474|464510571|FG004|Follow Up Phase|Lost to Follow-up|1|||
129060653|NCT01098474|464510572|FG005|Follow Up Phase|Lost to Follow-up|0|||
129060654|NCT00595309|464510575|FG000|Overall Study|Lost to Follow-up|1|||
129060655|NCT00595309|464510575|FG000|Overall Study|planned vaccination against yellow fever|1|||
129060656|NCT00595309|464510575|FG000|Overall Study|acute infection after V0|1|||
129060657|NCT00595309|464510575|FG000|Overall Study|personal reason|1|||
129060658|NCT00626561|464510578|FG000|Overall Study|Withdrawal by Subject|2|||
129060659|NCT00626561|464510578|FG000|Overall Study|Disease Progression|2|||
129060660|NCT00101283|464510579|FG000|Overall Study|Withdrawal by Subject|0|||
129060661|NCT00101283|464510580|FG001|Overall Study|Withdrawal by Subject|1|||
129060662|NCT00101283|464510579|FG000|Overall Study|Insurance Refusal|0|||
129060663|NCT00101283|464510580|FG001|Overall Study|Insurance Refusal|1|||
129060664|NCT00101283|464510579|FG000|Overall Study|Prostate Cancer Recurrence|0|||
129060665|NCT00101283|464510580|FG001|Overall Study|Prostate Cancer Recurrence|1|||
129060666|NCT00398866|464510587|FG000|Overall Study|Adverse Event|1|||
129060667|NCT00398866|464510588|FG001|Overall Study|Adverse Event|0|||
129060668|NCT00398866|464510589|FG002|Overall Study|Adverse Event|0|||
129060669|NCT00398866|464510587|FG000|Overall Study|Lack of Efficacy|0|||
129060670|NCT00398866|464510588|FG001|Overall Study|Lack of Efficacy|0|||
129060671|NCT00398866|464510589|FG002|Overall Study|Lack of Efficacy|1|||
129060672|NCT00398866|464510587|FG000|Overall Study|Lost to Follow-up|7|||
129060673|NCT00398866|464510588|FG001|Overall Study|Lost to Follow-up|6|||
129060674|NCT00398866|464510589|FG002|Overall Study|Lost to Follow-up|4|||
129060675|NCT00398866|464510587|FG000|Overall Study|Withdrawal by Subject|5|||
129060676|NCT00398866|464510588|FG001|Overall Study|Withdrawal by Subject|1|||
129060677|NCT00398866|464510589|FG002|Overall Study|Withdrawal by Subject|2|||
129060678|NCT00398866|464510587|FG000|Overall Study|Unable to complete requirements of study|1|||
129060679|NCT00398866|464510588|FG001|Overall Study|Unable to complete requirements of study|1|||
129060680|NCT00398866|464510589|FG002|Overall Study|Unable to complete requirements of study|1|||
129060681|NCT00442962|464510593|FG000|Overall Study|Pregnancy|1|||
129060682|NCT00442962|464510593|FG000|Overall Study|Lost to Follow-up|7|||
129060683|NCT03633825|464510594|FG000|Enrollment|Did not post on network|5066|||
129060684|NCT03633825|464510595|FG001|Enrollment|Did not post on network|5080|||
129060685|NCT03633825|464510594|FG000|Enrollment|Post not classified as crisis|13967|||
129060686|NCT03633825|464510595|FG001|Enrollment|Post not classified as crisis|13757|||
129060687|NCT03633825|464510594|FG000|Follow up|Lost to Follow-up|478|||
129060688|NCT03633825|464510595|FG001|Follow up|Lost to Follow-up|450|||
129060689|NCT04841577|464510597|FG000|Overall Study|Adverse Event|5|||
129060690|NCT04841577|464510598|FG001|Overall Study|Adverse Event|10|||
129060691|NCT04841577|464510597|FG000|Overall Study|Lost to Follow-up|8|||
129060692|NCT04841577|464510598|FG001|Overall Study|Lost to Follow-up|7|||
129060693|NCT04841577|464510597|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
129060694|NCT04841577|464510598|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
129060695|NCT04841577|464510597|FG000|Overall Study|Other|0|||
129060696|NCT04841577|464510598|FG001|Overall Study|Other|1|||
129060697|NCT00182325|464510599|FG000|Overall Study|Lost to Follow-up|7|||
129060698|NCT00182325|464510600|FG001|Overall Study|Lost to Follow-up|7|||
128720329|NCT04865354|463274931|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
129060699|NCT00182325|464510599|FG000|Overall Study|Miscarriage|5|||
129060700|NCT00182325|464510600|FG001|Overall Study|Miscarriage|3|||
129060701|NCT00182325|464510599|FG000|Overall Study|Did not complete survey|22|||
129060702|NCT00182325|464510600|FG001|Overall Study|Did not complete survey|43|||
129060703|NCT01420965|464510605|FG000|Overall Study|Withdrawal by Subject|1|||
129060704|NCT01420965|464510606|FG001|Overall Study|Withdrawal by Subject|0|||
129060705|NCT01420965|464510607|FG002|Overall Study|Withdrawal by Subject|0|||
129060706|NCT01420965|464510605|FG000|Overall Study|Adverse Event|0|||
129060707|NCT01420965|464510606|FG001|Overall Study|Adverse Event|1|||
129060708|NCT01420965|464510607|FG002|Overall Study|Adverse Event|0|||
129060709|NCT00339144|464510612|FG000|Overall Study|Disease progression|5|||
129060710|NCT00339144|464510613|FG001|Overall Study|Disease progression|2|||
129060711|NCT00339144|464510614|FG002|Overall Study|Disease progression|2|||
129060712|NCT00339144|464510612|FG000|Overall Study|Study drug toxicity|3|||
129060713|NCT00339144|464510613|FG001|Overall Study|Study drug toxicity|1|||
129060714|NCT00339144|464510614|FG002|Overall Study|Study drug toxicity|1|||
129060715|NCT00339144|464510612|FG000|Overall Study|Participant's request to discontinuation|1|||
129060716|NCT00339144|464510613|FG001|Overall Study|Participant's request to discontinuation|0|||
129060717|NCT00339144|464510614|FG002|Overall Study|Participant's request to discontinuation|1|||
129060718|NCT01890434|464510615|FG000|Overall Study|Adverse Event|8|||
129060719|NCT01890434|464510615|FG000|Overall Study|PCI at external hospital|1|||
129060720|NCT01890434|464510615|FG000|Overall Study|Assessment discrepancy|1|||
129060721|NCT01890434|464510615|FG000|Overall Study|CRC didn't contact participant for FU|1|||
129060722|NCT01890434|464510615|FG000|Overall Study|Could not get whole set of images|1|||
129060723|NCT01890434|464510615|FG000|Overall Study|Decline to return for GSPECT|1|||
129060724|NCT01890434|464510615|FG000|Overall Study|GSPECT at rest was not done|1|||
129060725|NCT01890434|464510615|FG000|Overall Study|Participant didn't complete MRI|1|||
129060726|NCT01890434|464510615|FG000|Overall Study|Uncontactable by phone|1|||
129060727|NCT01890434|464510615|FG000|Overall Study|Moved out of position|1|||
129060728|NCT01890434|464510615|FG000|Overall Study|Unable to contact|1|||
129060729|NCT01890434|464510615|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
129060730|NCT03280381|464510616|FG000|Overall Study|Physician Decision|0|||
129060731|NCT03280381|464510617|FG001|Overall Study|Physician Decision|2|||
129060732|NCT01141205|464510618|FG000|Overall Study|Physician Decision|1|||
129060733|NCT01141205|464510619|FG001|Overall Study|Physician Decision|1|||
129060734|NCT01141205|464510618|FG000|Overall Study|Lost to Follow-up|1|||
129060735|NCT01141205|464510619|FG001|Overall Study|Lost to Follow-up|0|||
129060736|NCT01141205|464510618|FG000|Overall Study|Withdrawal by Subject|1|||
129060737|NCT01141205|464510619|FG001|Overall Study|Withdrawal by Subject|1|||
129060738|NCT02257385|464510621|FG000|Overall Study|Adverse Event|12|||
129060739|NCT02257385|464510622|FG001|Overall Study|Adverse Event|8|||
129060740|NCT02257385|464510621|FG000|Overall Study|Lack of Efficacy|1|||
129060741|NCT02257385|464510622|FG001|Overall Study|Lack of Efficacy|2|||
129060742|NCT02257385|464510621|FG000|Overall Study|Protocol Violation|5|||
129060743|NCT02257385|464510622|FG001|Overall Study|Protocol Violation|7|||
129060744|NCT02257385|464510621|FG000|Overall Study|Lost to Follow-up|0|||
129060745|NCT02257385|464510622|FG001|Overall Study|Lost to Follow-up|1|||
129060746|NCT02257385|464510621|FG000|Overall Study|Withdrawal by Subject|4|||
129060747|NCT02257385|464510622|FG001|Overall Study|Withdrawal by Subject|4|||
129060748|NCT01822366|464510623|FG000|Overall Study|Lost to Follow-up|5|||
129060749|NCT01822366|464510624|FG001|Overall Study|Lost to Follow-up|1|||
129060750|NCT01822366|464510625|FG002|Overall Study|Lost to Follow-up|5|||
129060751|NCT01822366|464510626|FG003|Overall Study|Lost to Follow-up|1|||
129060752|NCT01822366|464510623|FG000|Overall Study|Withdrawal by Subject|0|||
129060753|NCT01822366|464510624|FG001|Overall Study|Withdrawal by Subject|6|||
129060754|NCT01822366|464510625|FG002|Overall Study|Withdrawal by Subject|0|||
129060755|NCT01822366|464510626|FG003|Overall Study|Withdrawal by Subject|6|||
128720330|NCT00706641|463274936|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
128720331|NCT00706641|463274936|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
128720332|NCT00706641|463274936|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
128720333|NCT00588822|463274937|FG000|Overall Study|progression of disease|8|||
129060756|NCT01822366|464510623|FG000|Overall Study|Partial Intervention Completion|0|||
129060757|NCT01822366|464510624|FG001|Overall Study|Partial Intervention Completion|15|||
129060758|NCT01822366|464510625|FG002|Overall Study|Partial Intervention Completion|0|||
129060759|NCT01822366|464510626|FG003|Overall Study|Partial Intervention Completion|15|||
129060760|NCT05199090|464510627|FG000|Overall Study|Adverse Event|1|||
129060761|NCT05199090|464510628|FG001|Overall Study|Adverse Event|4|||
129060762|NCT05199090|464510629|FG002|Overall Study|Adverse Event|0|||
129060763|NCT05199090|464510630|FG003|Overall Study|Adverse Event|0|||
129060764|NCT05199090|464510631|FG004|Overall Study|Adverse Event|0|||
129060765|NCT05199090|464510632|FG005|Overall Study|Adverse Event|0|||
129060766|NCT05199090|464510627|FG000|Overall Study|Lost to Follow-up|1|||
129060767|NCT05199090|464510628|FG001|Overall Study|Lost to Follow-up|0|||
129060768|NCT05199090|464510629|FG002|Overall Study|Lost to Follow-up|1|||
129060769|NCT05199090|464510630|FG003|Overall Study|Lost to Follow-up|4|||
128720334|NCT04762680|463274939|FG000|Phase 2|Adverse Event|0|||
128720335|NCT04762680|463274940|FG001|Phase 2|Adverse Event|1|||
128720336|NCT04762680|463274941|FG002|Phase 2|Adverse Event|0|||
128720337|NCT04762680|463274942|FG003|Phase 2|Adverse Event|0|||
128720338|NCT04762680|463274943|FG004|Phase 2|Adverse Event|0|||
128720339|NCT04762680|463274944|FG005|Phase 2|Adverse Event|0|||
128720340|NCT04762680|463274945|FG006|Phase 2|Adverse Event|0|||
128720341|NCT04762680|463274946|FG007|Phase 2|Adverse Event|0|||
128720342|NCT04762680|463274947|FG008|Phase 2|Adverse Event|0|||
128720343|NCT04762680|463274948|FG009|Phase 2|Adverse Event|0|||
128720344|NCT04762680|463274949|FG010|Phase 2|Adverse Event|0|||
128720345|NCT04762680|463274950|FG011|Phase 2|Adverse Event|0|||
128720346|NCT04762680|463274951|FG012|Phase 2|Adverse Event|0|||
128720347|NCT04762680|463274952|FG013|Phase 2|Adverse Event|0|||
128720348|NCT04762680|463274953|FG014|Phase 2|Adverse Event|0|||
128720349|NCT04762680|463274954|FG015|Phase 2|Adverse Event|0|||
128720350|NCT04762680|463274955|FG016|Phase 2|Adverse Event|0|||
128720351|NCT04762680|463274956|FG017|Phase 2|Adverse Event|0|||
128720352|NCT04762680|463274957|FG018|Phase 2|Adverse Event|0|||
128720353|NCT04762680|463274958|FG019|Phase 2|Adverse Event|0|||
128720354|NCT04762680|463274959|FG020|Phase 2|Adverse Event|0|||
128720355|NCT04762680|463274960|FG021|Phase 2|Adverse Event|0|||
128720356|NCT04762680|463274939|FG000|Phase 2|Protocol Violation|5|||
128720357|NCT04762680|463274940|FG001|Phase 2|Protocol Violation|5|||
128720358|NCT04762680|463274941|FG002|Phase 2|Protocol Violation|1|||
128720359|NCT04762680|463274942|FG003|Phase 2|Protocol Violation|0|||
128720360|NCT04762680|463274943|FG004|Phase 2|Protocol Violation|0|||
128720361|NCT04762680|463274944|FG005|Phase 2|Protocol Violation|0|||
129060770|NCT05199090|464510631|FG004|Overall Study|Lost to Follow-up|0|||
129060771|NCT05199090|464510632|FG005|Overall Study|Lost to Follow-up|5|||
129060772|NCT05199090|464510627|FG000|Overall Study|Physician Decision|0|||
129060773|NCT05199090|464510628|FG001|Overall Study|Physician Decision|0|||
129060774|NCT05199090|464510629|FG002|Overall Study|Physician Decision|0|||
129060775|NCT05199090|464510630|FG003|Overall Study|Physician Decision|0|||
129060776|NCT05199090|464510631|FG004|Overall Study|Physician Decision|0|||
129060777|NCT05199090|464510632|FG005|Overall Study|Physician Decision|1|||
129060778|NCT05199090|464510627|FG000|Overall Study|Study terminated by sponsor|0|||
129060779|NCT05199090|464510628|FG001|Overall Study|Study terminated by sponsor|6|||
129060780|NCT05199090|464510629|FG002|Overall Study|Study terminated by sponsor|0|||
129060781|NCT05199090|464510630|FG003|Overall Study|Study terminated by sponsor|0|||
129060782|NCT05199090|464510631|FG004|Overall Study|Study terminated by sponsor|0|||
129060783|NCT05199090|464510632|FG005|Overall Study|Study terminated by sponsor|5|||
129060784|NCT05199090|464510627|FG000|Overall Study|Subject decision|0|||
129060785|NCT05199090|464510628|FG001|Overall Study|Subject decision|4|||
129060786|NCT05199090|464510629|FG002|Overall Study|Subject decision|0|||
129060787|NCT05199090|464510630|FG003|Overall Study|Subject decision|2|||
129060788|NCT05199090|464510631|FG004|Overall Study|Subject decision|5|||
129060789|NCT05199090|464510632|FG005|Overall Study|Subject decision|2|||
129060790|NCT03276078|464510634|FG000|Overall Study|Adverse Event|1|||
128720362|NCT04762680|463274945|FG006|Phase 2|Protocol Violation|0|||
128720363|NCT04762680|463274946|FG007|Phase 2|Protocol Violation|0|||
128720364|NCT04762680|463274947|FG008|Phase 2|Protocol Violation|0|||
128720365|NCT04762680|463274948|FG009|Phase 2|Protocol Violation|0|||
128720366|NCT04762680|463274949|FG010|Phase 2|Protocol Violation|0|||
128720367|NCT04762680|463274950|FG011|Phase 2|Protocol Violation|0|||
128720368|NCT04762680|463274951|FG012|Phase 2|Protocol Violation|0|||
128720369|NCT04762680|463274952|FG013|Phase 2|Protocol Violation|0|||
128720370|NCT04762680|463274953|FG014|Phase 2|Protocol Violation|0|||
128720371|NCT04762680|463274954|FG015|Phase 2|Protocol Violation|0|||
128720372|NCT04762680|463274955|FG016|Phase 2|Protocol Violation|0|||
128720373|NCT04762680|463274956|FG017|Phase 2|Protocol Violation|0|||
128720374|NCT04762680|463274957|FG018|Phase 2|Protocol Violation|0|||
129060791|NCT02552732|464510635|FG000|Overall Study|Lost to Follow-up|2|||
129060792|NCT02552732|464510635|FG000|Overall Study|Physician Decision|1|||
129060793|NCT02552732|464510635|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
129060794|NCT02552732|464510635|FG000|Overall Study|Withdrawal by Subject|6|||
129060795|NCT04988087|464510638|FG000|Overall Study|Adverse Event|4|||
129060796|NCT04988087|464510639|FG001|Overall Study|Adverse Event|0|||
129060797|NCT04988087|464510640|FG002|Overall Study|Adverse Event|0|||
129060798|NCT04988087|464510641|FG003|Overall Study|Adverse Event|0|||
128720375|NCT04762680|463274958|FG019|Phase 2|Protocol Violation|0|||
128720376|NCT04762680|463274959|FG020|Phase 2|Protocol Violation|0|||
128720377|NCT04762680|463274960|FG021|Phase 2|Protocol Violation|0|||
128720378|NCT04762680|463274939|FG000|Phase 2|Withdrawal by Subject|23|||
128720379|NCT04762680|463274940|FG001|Phase 2|Withdrawal by Subject|21|||
128720380|NCT04762680|463274941|FG002|Phase 2|Withdrawal by Subject|28|||
128720381|NCT04762680|463274942|FG003|Phase 2|Withdrawal by Subject|0|||
128720382|NCT04762680|463274943|FG004|Phase 2|Withdrawal by Subject|0|||
128720383|NCT04762680|463274944|FG005|Phase 2|Withdrawal by Subject|0|||
128720384|NCT04762680|463274945|FG006|Phase 2|Withdrawal by Subject|0|||
128720385|NCT04762680|463274946|FG007|Phase 2|Withdrawal by Subject|0|||
129060799|NCT04988087|464510638|FG000|Overall Study|Withdrawal by Subject|1|||
129060800|NCT04988087|464510639|FG001|Overall Study|Withdrawal by Subject|1|||
129060801|NCT04988087|464510640|FG002|Overall Study|Withdrawal by Subject|0|||
129060802|NCT04988087|464510641|FG003|Overall Study|Withdrawal by Subject|0|||
129060803|NCT04988087|464510638|FG000|Overall Study|Technical problems|7|||
129060804|NCT04988087|464510639|FG001|Overall Study|Technical problems|9|||
129060805|NCT04988087|464510640|FG002|Overall Study|Technical problems|1|||
129060806|NCT04988087|464510641|FG003|Overall Study|Technical problems|2|||
129060807|NCT02290223|464510642|FG000|6 Months|Lost to Follow-up|9|||
129060808|NCT02290223|464510643|FG001|6 Months|Lost to Follow-up|6|||
129060809|NCT02290223|464510642|FG000|6 Months|Withdrawal by Subject|5|||
129060810|NCT02290223|464510643|FG001|6 Months|Withdrawal by Subject|0|||
129060811|NCT02290223|464510642|FG000|6 Months|deceased (not related to study)|2|||
129060812|NCT02290223|464510643|FG001|6 Months|deceased (not related to study)|0|||
129060813|NCT02290223|464510642|FG000|12 Months|Lost to Follow-up|16|||
129060814|NCT02290223|464510643|FG001|12 Months|Lost to Follow-up|10|||
129060815|NCT02290223|464510642|FG000|12 Months|Refusal|0|||
129060816|NCT02290223|464510643|FG001|12 Months|Refusal|1|||
129060817|NCT02800642|464510647|FG000|Overall Study|Death|3|||
129060818|NCT02800642|464510647|FG000|Overall Study|Other|10|||
129060819|NCT02800642|464510647|FG000|Overall Study|Physician Decision|2|||
129060820|NCT02800642|464510647|FG000|Overall Study|Adverse Event|6|||
129060821|NCT02800642|464510647|FG000|Overall Study|Withdrawal by Subject|3|||
129060822|NCT02800642|464510647|FG000|Overall Study|Lost to Follow-up|1|||
129060823|NCT01004003|464510648|FG000|Overall Study|Progressive disease|2|||
129060824|NCT01004003|464510649|FG001|Overall Study|Progressive disease|1|||
129060825|NCT01004003|464510650|FG002|Overall Study|Progressive disease|1|||
129060826|NCT01004003|464510651|FG003|Overall Study|Progressive disease|0|||
129060827|NCT01004003|464510652|FG004|Overall Study|Progressive disease|2|||
129060828|NCT01004003|464510653|FG005|Overall Study|Progressive disease|1|||
129060829|NCT01004003|464510654|FG006|Overall Study|Progressive disease|1|||
129060830|NCT01004003|464510655|FG007|Overall Study|Progressive disease|39|||
129060831|NCT01004003|464510656|FG008|Overall Study|Progressive disease|22|||
129060832|NCT01004003|464510648|FG000|Overall Study|Adverse Event|4|||
129060833|NCT01004003|464510649|FG001|Overall Study|Adverse Event|2|||
129060834|NCT01004003|464510650|FG002|Overall Study|Adverse Event|3|||
129060835|NCT01004003|464510651|FG003|Overall Study|Adverse Event|3|||
129060836|NCT01004003|464510652|FG004|Overall Study|Adverse Event|2|||
129060837|NCT01004003|464510653|FG005|Overall Study|Adverse Event|2|||
129060838|NCT01004003|464510654|FG006|Overall Study|Adverse Event|7|||
129060839|NCT01004003|464510655|FG007|Overall Study|Adverse Event|21|||
129060840|NCT01004003|464510656|FG008|Overall Study|Adverse Event|6|||
129060841|NCT01004003|464510648|FG000|Overall Study|Refused to continue taking trial med.|0|||
129060842|NCT01004003|464510649|FG001|Overall Study|Refused to continue taking trial med.|0|||
129060843|NCT01004003|464510650|FG002|Overall Study|Refused to continue taking trial med.|0|||
129060844|NCT01004003|464510651|FG003|Overall Study|Refused to continue taking trial med.|0|||
129060845|NCT01004003|464510652|FG004|Overall Study|Refused to continue taking trial med.|0|||
129060846|NCT01004003|464510653|FG005|Overall Study|Refused to continue taking trial med.|0|||
129060847|NCT01004003|464510654|FG006|Overall Study|Refused to continue taking trial med.|0|||
129060848|NCT01004003|464510655|FG007|Overall Study|Refused to continue taking trial med.|0|||
129060849|NCT01004003|464510656|FG008|Overall Study|Refused to continue taking trial med.|2|||
129060850|NCT01004003|464510648|FG000|Overall Study|Other|0|||
129060851|NCT01004003|464510649|FG001|Overall Study|Other|0|||
129060852|NCT01004003|464510650|FG002|Overall Study|Other|0|||
129060853|NCT01004003|464510651|FG003|Overall Study|Other|0|||
129060854|NCT01004003|464510652|FG004|Overall Study|Other|0|||
129060855|NCT01004003|464510653|FG005|Overall Study|Other|1|||
129060856|NCT01004003|464510654|FG006|Overall Study|Other|0|||
129060857|NCT01004003|464510655|FG007|Overall Study|Other|0|||
129060858|NCT01004003|464510656|FG008|Overall Study|Other|0|||
129060859|NCT01130597|464510663|FG000|Overall Study|Protocol-specified (High K+)|1|||
129060860|NCT01130597|464510663|FG000|Overall Study|Adverse Event|4|||
129060861|NCT01130597|464510663|FG000|Overall Study|Death|1|||
128720386|NCT04762680|463274947|FG008|Phase 2|Withdrawal by Subject|0|||
128720387|NCT04762680|463274948|FG009|Phase 2|Withdrawal by Subject|0|||
128720388|NCT04762680|463274949|FG010|Phase 2|Withdrawal by Subject|0|||
129060862|NCT01130597|464510663|FG000|Overall Study|Protocol Violation|1|||
129060863|NCT03371459|464510664|FG000|Washout|Lost to Follow-up|0|||
129060864|NCT03371459|464510665|FG001|Washout|Lost to Follow-up|1|||
129060865|NCT05794503|464510666|FG000|Overall Study|Operation Cancelled|2|||
129060866|NCT05794503|464510667|FG001|Overall Study|Operation Cancelled|0|||
129060867|NCT05794503|464510666|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
129060868|NCT05794503|464510667|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
129060869|NCT05794503|464510666|FG000|Overall Study|Protocol Violation|1|||
129060870|NCT05794503|464510667|FG001|Overall Study|Protocol Violation|0|||
129060871|NCT01589497|464510668|FG000|Overall Study|Withdrawal by Subject|0|||
128720389|NCT04762680|463274950|FG011|Phase 2|Withdrawal by Subject|0|||
129060872|NCT01589497|464510669|FG001|Overall Study|Withdrawal by Subject|1|||
129060873|NCT01589497|464510670|FG002|Overall Study|Withdrawal by Subject|0|||
129060874|NCT01589497|464510671|FG003|Overall Study|Withdrawal by Subject|1|||
129060875|NCT01589497|464510668|FG000|Overall Study|Death|1|||
129060876|NCT01589497|464510669|FG001|Overall Study|Death|0|||
129060877|NCT01589497|464510670|FG002|Overall Study|Death|0|||
129060878|NCT01589497|464510671|FG003|Overall Study|Death|0|||
129060879|NCT01589497|464510668|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
129060880|NCT01589497|464510669|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
129060881|NCT01589497|464510670|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
129060882|NCT01589497|464510671|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
129060883|NCT05819203|464510679|FG000|Overall Study|Protocol Violation|1|||
129060884|NCT05819203|464510680|FG001|Overall Study|Protocol Violation|2|||
129060885|NCT05819203|464510679|FG000|Overall Study|Withdrawal by Subject|1|||
129060886|NCT05819203|464510680|FG001|Overall Study|Withdrawal by Subject|0|||
129060887|NCT02185053|464510681|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
129060888|NCT02185053|464510682|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
129060889|NCT02185053|464510683|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
129060890|NCT02185053|464510681|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
129060891|NCT02185053|464510682|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129060892|NCT02185053|464510683|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129060893|NCT02185053|464510681|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
129060894|NCT02185053|464510682|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
129060895|NCT02185053|464510683|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
129060896|NCT02185053|464510681|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
129060897|NCT02185053|464510682|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
129060898|NCT02185053|464510683|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
129060899|NCT02185053|464510681|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129060900|NCT02185053|464510682|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
129060901|NCT02185053|464510683|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129060902|NCT02185053|464510681|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
129060903|NCT02185053|464510682|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
129060904|NCT02185053|464510683|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
129060905|NCT02185053|464510681|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
129060906|NCT02185053|464510682|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
129060907|NCT02185053|464510683|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
129060908|NCT02185053|464510681|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
129060909|NCT02185053|464510682|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
129060910|NCT02185053|464510683|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
129060911|NCT02521376|464510686|FG000|Overall Study|Enrolled, But Not Treated|1|||
129060912|NCT02521376|464510687|FG001|Overall Study|Enrolled, But Not Treated|0|||
129060913|NCT02521376|464510688|FG002|Overall Study|Enrolled, But Not Treated|0|||
129060914|NCT02521376|464510689|FG003|Overall Study|Enrolled, But Not Treated|0|||
129060915|NCT00708227|464510697|FG000|Overall Study|Physician Decision|0|||
129060916|NCT00708227|464510698|FG001|Overall Study|Physician Decision|3|||
129060917|NCT00708227|464510699|FG002|Overall Study|Physician Decision|1|||
129060918|NCT00708227|464510700|FG003|Overall Study|Physician Decision|2|||
129060919|NCT00708227|464510697|FG000|Overall Study|Withdrawal by Subject|1|||
129060920|NCT00708227|464510698|FG001|Overall Study|Withdrawal by Subject|2|||
129060921|NCT00708227|464510699|FG002|Overall Study|Withdrawal by Subject|0|||
129060922|NCT00708227|464510700|FG003|Overall Study|Withdrawal by Subject|1|||
129060923|NCT04007991|464510701|FG000|Overall Study|Withdrawal by Subject|1|||
129060924|NCT04007991|464510702|FG001|Overall Study|Withdrawal by Subject|1|||
129060925|NCT04007991|464510701|FG000|Overall Study|Physician Decision|1|||
129060926|NCT04007991|464510702|FG001|Overall Study|Physician Decision|1|||
129060927|NCT04007991|464510701|FG000|Overall Study|Non-compliance with Study Drug|0|||
129060928|NCT04007991|464510702|FG001|Overall Study|Non-compliance with Study Drug|1|||
128720390|NCT04762680|463274951|FG012|Phase 2|Withdrawal by Subject|0|||
128720391|NCT04762680|463274952|FG013|Phase 2|Withdrawal by Subject|0|||
128720392|NCT04762680|463274953|FG014|Phase 2|Withdrawal by Subject|0|||
128720393|NCT04762680|463274954|FG015|Phase 2|Withdrawal by Subject|0|||
128720394|NCT04762680|463274955|FG016|Phase 2|Withdrawal by Subject|0|||
128720395|NCT04762680|463274956|FG017|Phase 2|Withdrawal by Subject|0|||
128720396|NCT04762680|463274957|FG018|Phase 2|Withdrawal by Subject|0|||
129060929|NCT04007991|464510701|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
129060930|NCT04007991|464510702|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
129060931|NCT04007991|464510701|FG000|Overall Study|Adverse event, non-fatal|5|||
129060932|NCT04007991|464510702|FG001|Overall Study|Adverse event, non-fatal|0|||
129060933|NCT04007991|464510701|FG000|Overall Study|Lost to Follow-up|2|||
129060934|NCT04007991|464510702|FG001|Overall Study|Lost to Follow-up|1|||
129060935|NCT02126826|464511787|FG000|Overall Study|Withdrawal by Subject|0|||
129060936|NCT02126826|464511788|FG001|Overall Study|Withdrawal by Subject|0|||
129060937|NCT02126826|464511789|FG002|Overall Study|Withdrawal by Subject|0|||
129060938|NCT02126826|464511790|FG003|Overall Study|Withdrawal by Subject|1|||
128720397|NCT04762680|463274958|FG019|Phase 2|Withdrawal by Subject|0|||
128720398|NCT04762680|463274959|FG020|Phase 2|Withdrawal by Subject|0|||
129060939|NCT02126826|464511791|FG004|Overall Study|Withdrawal by Subject|0|||
129060940|NCT02126826|464511792|FG005|Overall Study|Withdrawal by Subject|0|||
129060941|NCT02126826|464511793|FG006|Overall Study|Withdrawal by Subject|0|||
129060942|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #1|24|||
129060943|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #1|0|||
129060944|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
129060945|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
129060946|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129060947|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060948|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
129060949|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
129060950|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
129060951|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
129060952|NCT03888066|464511794|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129060953|NCT03888066|464511795|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060954|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129060955|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060956|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
129060957|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
129060958|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129060959|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060960|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
129060961|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060962|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #2|5|||
129060963|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #2|0|||
129060964|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
129060965|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
129060966|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
129060967|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
129060968|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
129060969|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
129060970|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #3|11|||
129060971|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #3|0|||
129060972|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
129060973|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
129060974|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
129060975|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129060976|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129060977|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060978|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #4|3|||
129060979|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #4|0|||
129060980|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
129060981|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
129060982|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
129060983|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
129060984|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
129060985|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129060986|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
129060987|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
129060988|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
129060989|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060990|NCT03888066|464511794|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
129060991|NCT03888066|464511795|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129060992|NCT03888066|464511794|FG000|Run-in Phase|AE (Adverse Event)|17|||
129060993|NCT03888066|464511795|FG001|Run-in Phase|AE (Adverse Event)|0|||
129060994|NCT03888066|464511794|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
129060995|NCT03888066|464511795|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
129060996|NCT03888066|464511794|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129060997|NCT03888066|464511795|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129060998|NCT03888066|464511794|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129060999|NCT03888066|464511795|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129061000|NCT03888066|464511794|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
129061001|NCT03888066|464511795|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129061002|NCT03888066|464511794|FG000|Run-in Phase|Withdrawal by Subject|43|||
129061003|NCT03888066|464511795|FG001|Run-in Phase|Withdrawal by Subject|0|||
129061004|NCT03888066|464511794|FG000|Run-in Phase|AE; Physician Decision|1|||
129061005|NCT03888066|464511795|FG001|Run-in Phase|AE; Physician Decision|0|||
129061006|NCT03888066|464511794|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
129061007|NCT03888066|464511795|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129061008|NCT03888066|464511794|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
129061009|NCT03888066|464511795|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
129061010|NCT03888066|464511794|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
129061011|NCT03888066|464511795|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129061012|NCT03888066|464511794|FG000|Run-in Phase|Death|1|||
129061013|NCT03888066|464511795|FG001|Run-in Phase|Death|0|||
129061014|NCT03888066|464511794|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
129061015|NCT03888066|464511795|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
129061016|NCT03888066|464511794|FG000|Run-in Phase|Physician Decision|1|||
129061017|NCT03888066|464511795|FG001|Run-in Phase|Physician Decision|0|||
129061018|NCT03888066|464511794|FG000|Run-in Phase|Protocol Violation|13|||
129061019|NCT03888066|464511795|FG001|Run-in Phase|Protocol Violation|0|||
129061020|NCT03888066|464511794|FG000|Run-in Phase|Sponsor Request|34|||
129061021|NCT03888066|464511795|FG001|Run-in Phase|Sponsor Request|0|||
129061022|NCT03888066|464511794|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
129061023|NCT03888066|464511795|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
129061024|NCT03888066|464511794|FG000|Run-in Phase|Withdrawal Of Consent|1|||
129061025|NCT03888066|464511795|FG001|Run-in Phase|Withdrawal Of Consent|0|||
129061026|NCT03888066|464511794|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
129061027|NCT03888066|464511795|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
129061028|NCT03888066|464511794|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
129061029|NCT03888066|464511795|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
129061030|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
129061031|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
129061032|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
129061033|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
129061034|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
129061035|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
129061036|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
129061037|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
129061038|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
129061039|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
129061040|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
129061041|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
129061042|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
129061043|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
129061044|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
129061045|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
129061046|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
129061047|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
129061048|NCT03888066|464511794|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
129061049|NCT03888066|464511795|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
129061050|NCT03278626|464511796|FG000|Overall Study|Death|2|||
129061051|NCT03278626|464511796|FG000|Overall Study|Toxicity|1|||
129061052|NCT03278626|464511796|FG000|Overall Study|Disease Progression|2|||
129061053|NCT05013008|464511798|FG000|Overall Study|Exclusion from mBFAS|5|||
129061054|NCT05013008|464511799|FG001|Overall Study|Exclusion from mBFAS|25|||
129061055|NCT02111603|464511809|FG000|Overall Study|Withdrawal by Subject|1|||
129061056|NCT03106987|464511810|FG000|Overall Study|Death|37|||
129061057|NCT03106987|464511811|FG001|Overall Study|Death|22|||
129061058|NCT03106987|464511812|FG002|Overall Study|Death|12|||
129061059|NCT03106987|464511813|FG003|Overall Study|Death|8|||
129061060|NCT03106987|464511810|FG000|Overall Study|Lost to Follow-up|2|||
129061061|NCT03106987|464511811|FG001|Overall Study|Lost to Follow-up|0|||
129061062|NCT03106987|464511812|FG002|Overall Study|Lost to Follow-up|2|||
129061063|NCT03106987|464511813|FG003|Overall Study|Lost to Follow-up|2|||
129061064|NCT03106987|464511810|FG000|Overall Study|Withdrawal by Subject|5|||
129061065|NCT03106987|464511811|FG001|Overall Study|Withdrawal by Subject|1|||
129061066|NCT03106987|464511812|FG002|Overall Study|Withdrawal by Subject|4|||
129061067|NCT03106987|464511813|FG003|Overall Study|Withdrawal by Subject|1|||
129061068|NCT02114385|464511815|FG000|Overall Study|Withdrawal by Subject|3|||
129061069|NCT02114385|464511816|FG001|Overall Study|Withdrawal by Subject|2|||
129061070|NCT02114385|464511815|FG000|Overall Study|Lost to Follow-up|0|||
129061071|NCT02114385|464511816|FG001|Overall Study|Lost to Follow-up|6|||
129061072|NCT01174043|464511820|FG000|Overall Study|Disease progression|5|||
129061073|NCT01174043|464511820|FG000|Overall Study|Adverse Event|3|||
129061074|NCT01174043|464511820|FG000|Overall Study|Death|1|||
129061075|NCT01174043|464511820|FG000|Overall Study|Withdrawal by Subject|2|||
129061076|NCT00582010|464511825|FG000|Overall Study|Death|0|||
129061077|NCT00582010|464511826|FG001|Overall Study|Death|1|||
129061078|NCT02681510|464511834|FG000|Overall Study|Withdrawal by Subject|1|||
129061079|NCT02681510|464511834|FG000|Overall Study|Lost to Follow-up|9|||
129061080|NCT00741338|464511838|FG000|Overall Study|Adverse Event|0|||
129061081|NCT00741338|464511839|FG001|Overall Study|Adverse Event|1|||
129061082|NCT02165735|464511842|FG000|Overall Study|Lost to Follow-up|12|||
129061083|NCT02165735|464511843|FG001|Overall Study|Lost to Follow-up|10|||
129061084|NCT02165735|464511842|FG000|Overall Study|Withdrawal by Subject|3|||
129061085|NCT02165735|464511843|FG001|Overall Study|Withdrawal by Subject|0|||
129061086|NCT02165735|464511842|FG000|Overall Study|Participant indicated lack of time|1|||
129061087|NCT02165735|464511843|FG001|Overall Study|Participant indicated lack of time|3|||
129061088|NCT02165735|464511842|FG000|Overall Study|Protocol Violation|0|||
129061089|NCT02165735|464511843|FG001|Overall Study|Protocol Violation|1|||
129061090|NCT03066258|464511844|FG000|Overall Study|Death|1|||
129061091|NCT03066258|464511845|FG001|Overall Study|Death|0|||
129061092|NCT03066258|464511846|FG002|Overall Study|Death|0|||
129061093|NCT03066258|464511847|FG003|Overall Study|Death|0|||
129061094|NCT03066258|464511848|FG004|Overall Study|Death|1|||
129061095|NCT02784795|464511849|FG000|Overall Study|Progressive Disease|2|||
129061096|NCT02784795|464511850|FG001|Overall Study|Progressive Disease|1|||
129061097|NCT02784795|464511851|FG002|Overall Study|Progressive Disease|1|||
129061098|NCT02784795|464511852|FG003|Overall Study|Progressive Disease|0|||
129061099|NCT02784795|464511853|FG004|Overall Study|Progressive Disease|2|||
129061100|NCT02784795|464511854|FG005|Overall Study|Progressive Disease|0|||
129061101|NCT02784795|464511855|FG006|Overall Study|Progressive Disease|2|||
129061102|NCT02784795|464511856|FG007|Overall Study|Progressive Disease|0|||
129061103|NCT02784795|464511857|FG008|Overall Study|Progressive Disease|0|||
129061104|NCT02784795|464511858|FG009|Overall Study|Progressive Disease|0|||
129061105|NCT02784795|464511859|FG010|Overall Study|Progressive Disease|1|||
129061106|NCT02784795|464511860|FG011|Overall Study|Progressive Disease|0|||
129061107|NCT02784795|464511849|FG000|Overall Study|Adverse Event|1|||
129061108|NCT02784795|464511850|FG001|Overall Study|Adverse Event|0|||
129061109|NCT02784795|464511851|FG002|Overall Study|Adverse Event|0|||
129061110|NCT02784795|464511852|FG003|Overall Study|Adverse Event|1|||
129061111|NCT02784795|464511853|FG004|Overall Study|Adverse Event|0|||
129061112|NCT02784795|464511854|FG005|Overall Study|Adverse Event|0|||
129061113|NCT02784795|464511855|FG006|Overall Study|Adverse Event|1|||
129061114|NCT02784795|464511856|FG007|Overall Study|Adverse Event|0|||
129061115|NCT02784795|464511857|FG008|Overall Study|Adverse Event|0|||
129061116|NCT02784795|464511858|FG009|Overall Study|Adverse Event|0|||
129061117|NCT02784795|464511859|FG010|Overall Study|Adverse Event|0|||
129061118|NCT02784795|464511860|FG011|Overall Study|Adverse Event|2|||
129061119|NCT02784795|464511849|FG000|Overall Study|Withdrawal by Subject|1|||
129061120|NCT02784795|464511850|FG001|Overall Study|Withdrawal by Subject|0|||
129061121|NCT02784795|464511851|FG002|Overall Study|Withdrawal by Subject|2|||
129061122|NCT02784795|464511852|FG003|Overall Study|Withdrawal by Subject|1|||
129061123|NCT02784795|464511853|FG004|Overall Study|Withdrawal by Subject|3|||
129061124|NCT02784795|464511854|FG005|Overall Study|Withdrawal by Subject|0|||
129061125|NCT02784795|464511855|FG006|Overall Study|Withdrawal by Subject|0|||
129061126|NCT02784795|464511856|FG007|Overall Study|Withdrawal by Subject|1|||
129061127|NCT02784795|464511857|FG008|Overall Study|Withdrawal by Subject|0|||
129061128|NCT02784795|464511858|FG009|Overall Study|Withdrawal by Subject|0|||
129061129|NCT02784795|464511859|FG010|Overall Study|Withdrawal by Subject|0|||
128720399|NCT04762680|463274960|FG021|Phase 2|Withdrawal by Subject|0|||
129061130|NCT02784795|464511860|FG011|Overall Study|Withdrawal by Subject|2|||
128720400|NCT04762680|463274939|FG000|Phase 2|Lost to Follow-up|14|||
129061131|NCT02784795|464511849|FG000|Overall Study|Death|0|||
129061132|NCT02784795|464511850|FG001|Overall Study|Death|0|||
129061133|NCT02784795|464511851|FG002|Overall Study|Death|0|||
129061134|NCT02784795|464511852|FG003|Overall Study|Death|0|||
129061135|NCT02784795|464511853|FG004|Overall Study|Death|1|||
129061136|NCT02784795|464511854|FG005|Overall Study|Death|0|||
129061137|NCT02784795|464511855|FG006|Overall Study|Death|0|||
129061138|NCT02784795|464511856|FG007|Overall Study|Death|0|||
129061139|NCT02784795|464511857|FG008|Overall Study|Death|0|||
129061140|NCT02784795|464511858|FG009|Overall Study|Death|0|||
129061141|NCT02784795|464511859|FG010|Overall Study|Death|0|||
129061142|NCT02784795|464511860|FG011|Overall Study|Death|0|||
129061143|NCT02784795|464511849|FG000|Overall Study|Physician Decision|0|||
129061144|NCT02784795|464511850|FG001|Overall Study|Physician Decision|0|||
129061145|NCT02784795|464511851|FG002|Overall Study|Physician Decision|0|||
129061146|NCT02784795|464511852|FG003|Overall Study|Physician Decision|0|||
129061147|NCT02784795|464511853|FG004|Overall Study|Physician Decision|0|||
128720401|NCT04762680|463274940|FG001|Phase 2|Lost to Follow-up|8|||
128720402|NCT04762680|463274941|FG002|Phase 2|Lost to Follow-up|9|||
128720403|NCT04762680|463274942|FG003|Phase 2|Lost to Follow-up|0|||
129061148|NCT02784795|464511854|FG005|Overall Study|Physician Decision|0|||
129061149|NCT02784795|464511855|FG006|Overall Study|Physician Decision|1|||
129061150|NCT02784795|464511856|FG007|Overall Study|Physician Decision|0|||
129061151|NCT02784795|464511857|FG008|Overall Study|Physician Decision|0|||
129061152|NCT02784795|464511858|FG009|Overall Study|Physician Decision|0|||
129061153|NCT02784795|464511859|FG010|Overall Study|Physician Decision|0|||
129061154|NCT02784795|464511860|FG011|Overall Study|Physician Decision|0|||
129061155|NCT00704132|464511865|FG000|Overall Study|Clinical Adverse Experience|1|||
129061156|NCT00704132|464511866|FG001|Overall Study|Clinical Adverse Experience|0|||
129061157|NCT00704132|464511865|FG000|Overall Study|Lack of Efficacy|0|||
129061158|NCT00704132|464511866|FG001|Overall Study|Lack of Efficacy|1|||
129061159|NCT00704132|464511865|FG000|Overall Study|Withdrawal by Subject|0|||
129061160|NCT00704132|464511866|FG001|Overall Study|Withdrawal by Subject|1|||
129061161|NCT01267994|464511869|FG000|Overall Study|Adverse Event|2|||
129061162|NCT02655666|464511870|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
129061163|NCT03837743|464511871|FG000|Overall Study|Adverse Event|1|||
129061164|NCT03837743|464511871|FG000|Overall Study|Withdrawal by Subject|2|||
129061165|NCT00086281|464511877|FG000|Phase 1|Adverse Event|0|||
129061166|NCT00086281|464511878|FG001|Phase 1|Adverse Event|0|||
129061167|NCT00086281|464511879|FG002|Phase 1|Adverse Event|0|||
129061168|NCT00086281|464511880|FG003|Phase 1|Adverse Event|0|||
129061169|NCT00086281|464511881|FG004|Phase 1|Adverse Event|0|||
129061170|NCT00086281|464511882|FG005|Phase 1|Adverse Event|0|||
129061171|NCT00086281|464511883|FG006|Phase 1|Adverse Event|0|||
129061172|NCT00086281|464511884|FG007|Phase 1|Adverse Event|0|||
129061173|NCT00086281|464511885|FG008|Phase 1|Adverse Event|0|||
129061174|NCT00086281|464511886|FG009|Phase 1|Adverse Event|1|||
129061175|NCT00086281|464511887|FG010|Phase 1|Adverse Event|2|||
129061176|NCT00086281|464511888|FG011|Phase 1|Adverse Event|1|||
129061177|NCT00086281|464511889|FG012|Phase 1|Adverse Event|1|||
129061178|NCT00086281|464511890|FG013|Phase 1|Adverse Event|1|||
129061179|NCT00086281|464511891|FG014|Phase 1|Adverse Event|2|||
129061180|NCT00086281|464511877|FG000|Phase 1|Protocol Violation|0|||
129061181|NCT00086281|464511878|FG001|Phase 1|Protocol Violation|0|||
129061182|NCT00086281|464511879|FG002|Phase 1|Protocol Violation|0|||
129061183|NCT00086281|464511880|FG003|Phase 1|Protocol Violation|0|||
129061184|NCT00086281|464511881|FG004|Phase 1|Protocol Violation|0|||
129061185|NCT00086281|464511882|FG005|Phase 1|Protocol Violation|0|||
129061186|NCT00086281|464511883|FG006|Phase 1|Protocol Violation|0|||
129061187|NCT00086281|464511884|FG007|Phase 1|Protocol Violation|0|||
129061188|NCT00086281|464511885|FG008|Phase 1|Protocol Violation|0|||
129061189|NCT00086281|464511886|FG009|Phase 1|Protocol Violation|0|||
129061190|NCT00086281|464511887|FG010|Phase 1|Protocol Violation|1|||
129061191|NCT00086281|464511888|FG011|Phase 1|Protocol Violation|0|||
129061192|NCT00086281|464511889|FG012|Phase 1|Protocol Violation|0|||
129061193|NCT00086281|464511890|FG013|Phase 1|Protocol Violation|0|||
129061194|NCT00086281|464511891|FG014|Phase 1|Protocol Violation|0|||
129061195|NCT00086281|464511877|FG000|Phase 1|Serious Adverse Event|0|||
129061196|NCT00086281|464511878|FG001|Phase 1|Serious Adverse Event|0|||
129061197|NCT00086281|464511879|FG002|Phase 1|Serious Adverse Event|0|||
129061198|NCT00086281|464511880|FG003|Phase 1|Serious Adverse Event|0|||
129061199|NCT00086281|464511881|FG004|Phase 1|Serious Adverse Event|0|||
129061200|NCT00086281|464511882|FG005|Phase 1|Serious Adverse Event|0|||
129061201|NCT00086281|464511883|FG006|Phase 1|Serious Adverse Event|0|||
129061202|NCT00086281|464511884|FG007|Phase 1|Serious Adverse Event|0|||
129061203|NCT00086281|464511885|FG008|Phase 1|Serious Adverse Event|0|||
129061204|NCT00086281|464511886|FG009|Phase 1|Serious Adverse Event|0|||
129061205|NCT00086281|464511887|FG010|Phase 1|Serious Adverse Event|0|||
129061206|NCT00086281|464511888|FG011|Phase 1|Serious Adverse Event|0|||
129061207|NCT00086281|464511889|FG012|Phase 1|Serious Adverse Event|0|||
129061208|NCT00086281|464511890|FG013|Phase 1|Serious Adverse Event|0|||
129061209|NCT00086281|464511891|FG014|Phase 1|Serious Adverse Event|1|||
129061210|NCT00086281|464511877|FG000|Phase 2|Adverse Event|0|||
129061211|NCT00086281|464511878|FG001|Phase 2|Adverse Event|0|||
129061212|NCT00086281|464511879|FG002|Phase 2|Adverse Event|0|||
129061213|NCT00086281|464511880|FG003|Phase 2|Adverse Event|0|||
129061214|NCT00086281|464511881|FG004|Phase 2|Adverse Event|0|||
129061215|NCT00086281|464511882|FG005|Phase 2|Adverse Event|0|||
129061216|NCT00086281|464511883|FG006|Phase 2|Adverse Event|0|||
129061217|NCT00086281|464511884|FG007|Phase 2|Adverse Event|0|||
129061218|NCT00086281|464511885|FG008|Phase 2|Adverse Event|0|||
129061219|NCT00086281|464511886|FG009|Phase 2|Adverse Event|0|||
129061220|NCT00086281|464511887|FG010|Phase 2|Adverse Event|0|||
129061221|NCT00086281|464511888|FG011|Phase 2|Adverse Event|0|||
128720404|NCT04762680|463274943|FG004|Phase 2|Lost to Follow-up|0|||
129061222|NCT00086281|464511889|FG012|Phase 2|Adverse Event|1|||
129061223|NCT00086281|464511890|FG013|Phase 2|Adverse Event|1|||
129061224|NCT00086281|464511891|FG014|Phase 2|Adverse Event|0|||
129061225|NCT04759768|464511892|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
129061226|NCT04759768|464511893|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
129061227|NCT04759768|464511892|FG000|Washout (7 Days)|Physician Decision|0|||
129061228|NCT04759768|464511893|FG001|Washout (7 Days)|Physician Decision|1|||
129061229|NCT02996487|464511894|FG000|Overall Study|Lost to Follow-up|1|||
129061230|NCT02996487|464511895|FG001|Overall Study|Lost to Follow-up|1|||
129061231|NCT02996487|464511896|FG002|Overall Study|Lost to Follow-up|0|||
129061232|NCT02996487|464511894|FG000|Overall Study|Death|0|||
129061233|NCT02996487|464511895|FG001|Overall Study|Death|1|||
129061234|NCT02996487|464511896|FG002|Overall Study|Death|0|||
129061235|NCT02996487|464511894|FG000|Overall Study|Withdrawal by Subject|2|||
129061236|NCT02996487|464511895|FG001|Overall Study|Withdrawal by Subject|3|||
129061237|NCT02996487|464511896|FG002|Overall Study|Withdrawal by Subject|0|||
129061238|NCT02027428|464511897|FG000|Induction|Never treated|7|||
129061239|NCT02027428|464511898|FG001|Induction|Never treated|0|||
129061240|NCT02027428|464511899|FG002|Induction|Never treated|0|||
129061241|NCT02027428|464511897|FG000|Induction|Progressive disease|77|||
129061242|NCT02027428|464511898|FG001|Induction|Progressive disease|0|||
129061243|NCT02027428|464511899|FG002|Induction|Progressive disease|0|||
129061244|NCT02027428|464511897|FG000|Induction|Adverse Event|51|||
129061245|NCT02027428|464511898|FG001|Induction|Adverse Event|0|||
129061246|NCT02027428|464511899|FG002|Induction|Adverse Event|0|||
129061247|NCT02027428|464511897|FG000|Induction|Withdrawal by Subject|22|||
129061248|NCT02027428|464511898|FG001|Induction|Withdrawal by Subject|0|||
129061249|NCT02027428|464511899|FG002|Induction|Withdrawal by Subject|0|||
129061250|NCT02027428|464511897|FG000|Induction|Death|21|||
129061251|NCT02027428|464511898|FG001|Induction|Death|0|||
129061252|NCT02027428|464511899|FG002|Induction|Death|0|||
129061253|NCT02027428|464511897|FG000|Induction|Symptomatic deterioration|16|||
129061254|NCT02027428|464511898|FG001|Induction|Symptomatic deterioration|0|||
129061255|NCT02027428|464511899|FG002|Induction|Symptomatic deterioration|0|||
129061256|NCT02027428|464511897|FG000|Induction|Study terminated by sponsor|12|||
129061257|NCT02027428|464511898|FG001|Induction|Study terminated by sponsor|0|||
129061258|NCT02027428|464511899|FG002|Induction|Study terminated by sponsor|0|||
129061259|NCT02027428|464511897|FG000|Induction|Protocol Violation|1|||
129061260|NCT02027428|464511898|FG001|Induction|Protocol Violation|0|||
129061261|NCT02027428|464511899|FG002|Induction|Protocol Violation|0|||
129061262|NCT02027428|464511897|FG000|Induction|Miscellaneous|14|||
129061263|NCT02027428|464511898|FG001|Induction|Miscellaneous|0|||
129061264|NCT02027428|464511899|FG002|Induction|Miscellaneous|0|||
129061265|NCT02027428|464511897|FG000|Induction|Induction Treatment Ongoing|4|||
129061266|NCT02027428|464511898|FG001|Induction|Induction Treatment Ongoing|0|||
129061267|NCT02027428|464511899|FG002|Induction|Induction Treatment Ongoing|0|||
129061268|NCT02027428|464511897|FG000|Maintenance|Death|0|||
129061269|NCT02027428|464511898|FG001|Maintenance|Death|3|||
129061270|NCT02027428|464511899|FG002|Maintenance|Death|2|||
129061271|NCT02027428|464511897|FG000|Maintenance|Adverse Event|0|||
129061272|NCT02027428|464511898|FG001|Maintenance|Adverse Event|21|||
129061273|NCT02027428|464511899|FG002|Maintenance|Adverse Event|1|||
129061274|NCT02027428|464511897|FG000|Maintenance|Progressive disease|0|||
129061275|NCT02027428|464511898|FG001|Maintenance|Progressive disease|84|||
129061276|NCT02027428|464511899|FG002|Maintenance|Progressive disease|47|||
129061277|NCT02027428|464511897|FG000|Maintenance|Symptomatic deterioration|0|||
129061278|NCT02027428|464511898|FG001|Maintenance|Symptomatic deterioration|4|||
129061279|NCT02027428|464511899|FG002|Maintenance|Symptomatic deterioration|1|||
129061280|NCT02027428|464511897|FG000|Maintenance|Withdrawal by Subject|0|||
129061281|NCT02027428|464511898|FG001|Maintenance|Withdrawal by Subject|6|||
129061282|NCT02027428|464511899|FG002|Maintenance|Withdrawal by Subject|5|||
129061283|NCT02027428|464511897|FG000|Maintenance|Protocol Violation|0|||
129061284|NCT02027428|464511898|FG001|Maintenance|Protocol Violation|0|||
129061285|NCT02027428|464511899|FG002|Maintenance|Protocol Violation|1|||
129061286|NCT02027428|464511897|FG000|Maintenance|Other|0|||
129061287|NCT02027428|464511898|FG001|Maintenance|Other|6|||
129061288|NCT02027428|464511899|FG002|Maintenance|Other|3|||
129061289|NCT02027428|464511897|FG000|Survival Follow-up|Death|0|||
129061290|NCT02027428|464511898|FG001|Survival Follow-up|Death|78|||
129061291|NCT02027428|464511899|FG002|Survival Follow-up|Death|45|||
129061292|NCT02027428|464511897|FG000|Survival Follow-up|Lost to Follow-up|0|||
129061293|NCT02027428|464511898|FG001|Survival Follow-up|Lost to Follow-up|1|||
129061294|NCT02027428|464511899|FG002|Survival Follow-up|Lost to Follow-up|1|||
129061295|NCT04873934|464511900|FG000|Overall Study|Adverse Event|0|||
129061296|NCT04873934|464511901|FG001|Overall Study|Adverse Event|1|||
129061297|NCT04873934|464511900|FG000|Overall Study|Death|0|||
129061298|NCT04873934|464511901|FG001|Overall Study|Death|2|||
129061299|NCT04873934|464511900|FG000|Overall Study|Lost to Follow-up|13|||
129061300|NCT04873934|464511901|FG001|Overall Study|Lost to Follow-up|9|||
129061301|NCT04873934|464511900|FG000|Overall Study|Physician Decision|1|||
129061302|NCT04873934|464511901|FG001|Overall Study|Physician Decision|1|||
129061303|NCT04873934|464511900|FG000|Overall Study|Protocol deviation|2|||
129061304|NCT04873934|464511901|FG001|Overall Study|Protocol deviation|1|||
129061305|NCT04873934|464511900|FG000|Overall Study|Subject decision|1|||
129061306|NCT04873934|464511901|FG001|Overall Study|Subject decision|8|||
129061307|NCT04873934|464511900|FG000|Overall Study|Withdrew consent|0|||
129061308|NCT04873934|464511901|FG001|Overall Study|Withdrew consent|4|||
129061309|NCT04873934|464511900|FG000|Overall Study|Missing|1|||
129061310|NCT04873934|464511901|FG001|Overall Study|Missing|0|||
129061311|NCT04784533|464511904|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
129061312|NCT04784533|464511905|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
129061313|NCT04784533|464511906|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129061314|NCT04784533|464511907|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129061315|NCT04784533|464511908|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129061316|NCT04784533|464511909|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
128720405|NCT04762680|463274944|FG005|Phase 2|Lost to Follow-up|0|||
128720406|NCT04762680|463274945|FG006|Phase 2|Lost to Follow-up|0|||
128720407|NCT04762680|463274946|FG007|Phase 2|Lost to Follow-up|0|||
128720408|NCT04762680|463274947|FG008|Phase 2|Lost to Follow-up|0|||
128720409|NCT04762680|463274948|FG009|Phase 2|Lost to Follow-up|0|||
128720410|NCT04762680|463274949|FG010|Phase 2|Lost to Follow-up|0|||
128720411|NCT04762680|463274950|FG011|Phase 2|Lost to Follow-up|0|||
128720412|NCT04762680|463274951|FG012|Phase 2|Lost to Follow-up|0|||
128720413|NCT04762680|463274952|FG013|Phase 2|Lost to Follow-up|0|||
129061317|NCT04784533|464511910|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129061318|NCT04784533|464511911|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129061319|NCT04784533|464511912|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129061320|NCT04784533|464511913|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129061321|NCT04784533|464511904|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
129061322|NCT04784533|464511905|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
129061323|NCT04784533|464511906|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061324|NCT04784533|464511907|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061325|NCT04784533|464511908|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061326|NCT04784533|464511909|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061327|NCT04784533|464511910|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061328|NCT04784533|464511911|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061329|NCT04784533|464511912|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061330|NCT04784533|464511913|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129061331|NCT04784533|464511904|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061332|NCT04784533|464511905|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
129061333|NCT04784533|464511906|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061334|NCT04784533|464511907|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061335|NCT04784533|464511908|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061336|NCT04784533|464511909|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061337|NCT04784533|464511910|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061338|NCT04784533|464511911|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061339|NCT04784533|464511912|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061340|NCT04784533|464511913|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129061341|NCT04784533|464511904|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
129061342|NCT04784533|464511905|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061343|NCT04784533|464511906|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061344|NCT04784533|464511907|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061345|NCT04784533|464511908|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061346|NCT04784533|464511909|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061347|NCT04784533|464511910|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061348|NCT04784533|464511911|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061349|NCT04784533|464511912|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061350|NCT04784533|464511913|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129061351|NCT04784533|464511904|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
129061352|NCT04784533|464511905|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
129061353|NCT04784533|464511906|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129061354|NCT04784533|464511907|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129061355|NCT04784533|464511908|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129061356|NCT04784533|464511909|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129061357|NCT04784533|464511910|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129061358|NCT04784533|464511911|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129061359|NCT04784533|464511912|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
128720414|NCT04762680|463274953|FG014|Phase 2|Lost to Follow-up|0|||
128720415|NCT04762680|463274954|FG015|Phase 2|Lost to Follow-up|0|||
129061360|NCT04784533|464511913|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129061361|NCT04784533|464511904|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
129061362|NCT04784533|464511905|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
129061363|NCT04784533|464511906|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061364|NCT04784533|464511907|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061365|NCT04784533|464511908|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061366|NCT04784533|464511909|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061367|NCT04784533|464511910|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061368|NCT04784533|464511911|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061369|NCT04784533|464511912|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061370|NCT04784533|464511913|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129061371|NCT04784533|464511904|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061372|NCT04784533|464511905|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061373|NCT04784533|464511906|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
129061374|NCT04784533|464511907|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061375|NCT04784533|464511908|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
128720416|NCT04762680|463274955|FG016|Phase 2|Lost to Follow-up|0|||
128720417|NCT04762680|463274956|FG017|Phase 2|Lost to Follow-up|0|||
128720418|NCT04762680|463274957|FG018|Phase 2|Lost to Follow-up|0|||
129061376|NCT04784533|464511909|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061377|NCT04784533|464511910|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061378|NCT04784533|464511911|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061379|NCT04784533|464511912|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061380|NCT04784533|464511913|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129061381|NCT04784533|464511904|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061382|NCT04784533|464511905|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061383|NCT04784533|464511906|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061384|NCT04784533|464511907|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061385|NCT04784533|464511908|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061386|NCT04784533|464511909|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061387|NCT04784533|464511910|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061388|NCT04784533|464511911|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061389|NCT04784533|464511912|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
129061390|NCT04784533|464511913|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129061391|NCT04784533|464511904|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061392|NCT04784533|464511905|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061393|NCT04784533|464511906|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061394|NCT04784533|464511907|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061395|NCT04784533|464511908|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061396|NCT04784533|464511909|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061397|NCT04784533|464511910|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061398|NCT04784533|464511911|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129061399|NCT04784533|464511912|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
129061400|NCT04784533|464511913|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
129061401|NCT00307437|464511914|FG000|Controlled Period|Adverse Event|7|||
129061402|NCT00307437|464511915|FG001|Controlled Period|Adverse Event|2|||
129061403|NCT00307437|464511916|FG002|Controlled Period|Adverse Event|5|||
129061404|NCT00307437|464511917|FG003|Controlled Period|Adverse Event|0|||
129061405|NCT00307437|464511918|FG004|Controlled Period|Adverse Event|0|||
129061406|NCT00307437|464511919|FG005|Controlled Period|Adverse Event|0|||
129061407|NCT00307437|464511920|FG006|Controlled Period|Adverse Event|0|||
129061408|NCT00307437|464511914|FG000|Controlled Period|Death|0|||
129061409|NCT00307437|464511915|FG001|Controlled Period|Death|0|||
129061410|NCT00307437|464511916|FG002|Controlled Period|Death|1|||
129061411|NCT00307437|464511917|FG003|Controlled Period|Death|0|||
129061412|NCT00307437|464511918|FG004|Controlled Period|Death|0|||
129061413|NCT00307437|464511919|FG005|Controlled Period|Death|0|||
129061414|NCT00307437|464511920|FG006|Controlled Period|Death|0|||
129061415|NCT00307437|464511914|FG000|Controlled Period|Lack of Efficacy|2|||
129061416|NCT00307437|464511915|FG001|Controlled Period|Lack of Efficacy|0|||
129061417|NCT00307437|464511916|FG002|Controlled Period|Lack of Efficacy|0|||
129061418|NCT00307437|464511917|FG003|Controlled Period|Lack of Efficacy|0|||
129061419|NCT00307437|464511918|FG004|Controlled Period|Lack of Efficacy|0|||
129061420|NCT00307437|464511919|FG005|Controlled Period|Lack of Efficacy|0|||
129061421|NCT00307437|464511920|FG006|Controlled Period|Lack of Efficacy|0|||
129061422|NCT00307437|464511914|FG000|Controlled Period|Lost to Follow-up|2|||
129061423|NCT00307437|464511915|FG001|Controlled Period|Lost to Follow-up|3|||
129061424|NCT00307437|464511916|FG002|Controlled Period|Lost to Follow-up|0|||
129061425|NCT00307437|464511917|FG003|Controlled Period|Lost to Follow-up|0|||
129061426|NCT00307437|464511918|FG004|Controlled Period|Lost to Follow-up|0|||
129061427|NCT00307437|464511919|FG005|Controlled Period|Lost to Follow-up|0|||
129061428|NCT00307437|464511920|FG006|Controlled Period|Lost to Follow-up|0|||
129061429|NCT00307437|464511914|FG000|Controlled Period|Other|5|||
129061430|NCT00307437|464511915|FG001|Controlled Period|Other|1|||
129061431|NCT00307437|464511916|FG002|Controlled Period|Other|3|||
129061432|NCT00307437|464511917|FG003|Controlled Period|Other|0|||
129061433|NCT00307437|464511918|FG004|Controlled Period|Other|0|||
129061434|NCT00307437|464511919|FG005|Controlled Period|Other|0|||
129061435|NCT00307437|464511920|FG006|Controlled Period|Other|0|||
129061436|NCT00307437|464511914|FG000|After Controlled Period|Adverse Event|0|||
129061437|NCT00307437|464511915|FG001|After Controlled Period|Adverse Event|0|||
129061438|NCT00307437|464511916|FG002|After Controlled Period|Adverse Event|0|||
129061439|NCT00307437|464511917|FG003|After Controlled Period|Adverse Event|18|||
129061440|NCT00307437|464511918|FG004|After Controlled Period|Adverse Event|16|||
129061441|NCT00307437|464511919|FG005|After Controlled Period|Adverse Event|31|||
129061442|NCT00307437|464511920|FG006|After Controlled Period|Adverse Event|40|||
129061443|NCT00307437|464511914|FG000|After Controlled Period|Death|0|||
129061444|NCT00307437|464511915|FG001|After Controlled Period|Death|0|||
129061445|NCT00307437|464511916|FG002|After Controlled Period|Death|0|||
129061446|NCT00307437|464511917|FG003|After Controlled Period|Death|3|||
129061447|NCT00307437|464511918|FG004|After Controlled Period|Death|1|||
129061448|NCT00307437|464511919|FG005|After Controlled Period|Death|1|||
129061449|NCT00307437|464511920|FG006|After Controlled Period|Death|3|||
129061450|NCT00307437|464511914|FG000|After Controlled Period|Lack of Efficacy|0|||
129061451|NCT00307437|464511915|FG001|After Controlled Period|Lack of Efficacy|0|||
129061452|NCT00307437|464511916|FG002|After Controlled Period|Lack of Efficacy|0|||
129061453|NCT00307437|464511917|FG003|After Controlled Period|Lack of Efficacy|15|||
129061454|NCT00307437|464511918|FG004|After Controlled Period|Lack of Efficacy|17|||
129061455|NCT00307437|464511919|FG005|After Controlled Period|Lack of Efficacy|37|||
129061456|NCT00307437|464511920|FG006|After Controlled Period|Lack of Efficacy|24|||
129061457|NCT00307437|464511914|FG000|After Controlled Period|Lost to Follow-up|0|||
129061458|NCT00307437|464511915|FG001|After Controlled Period|Lost to Follow-up|0|||
129061459|NCT00307437|464511916|FG002|After Controlled Period|Lost to Follow-up|0|||
129061460|NCT00307437|464511917|FG003|After Controlled Period|Lost to Follow-up|7|||
129061461|NCT00307437|464511918|FG004|After Controlled Period|Lost to Follow-up|12|||
129061462|NCT00307437|464511919|FG005|After Controlled Period|Lost to Follow-up|13|||
129061463|NCT00307437|464511920|FG006|After Controlled Period|Lost to Follow-up|18|||
129061464|NCT00307437|464511914|FG000|After Controlled Period|Other|0|||
129061465|NCT00307437|464511915|FG001|After Controlled Period|Other|0|||
129061466|NCT00307437|464511916|FG002|After Controlled Period|Other|0|||
129061467|NCT00307437|464511917|FG003|After Controlled Period|Other|15|||
129061468|NCT00307437|464511918|FG004|After Controlled Period|Other|9|||
129061469|NCT00307437|464511919|FG005|After Controlled Period|Other|40|||
129061470|NCT00307437|464511920|FG006|After Controlled Period|Other|28|||
129061471|NCT00338728|464511927|FG000|Overall Study|Screen Failure|14|||
129061472|NCT00143247|464511931|FG000|Overall Study|Death|8|||
129061473|NCT00143247|464511931|FG000|Overall Study|Adverse Event|19|||
129061474|NCT00143247|464511931|FG000|Overall Study|Lack of Efficacy|3|||
129061475|NCT00143247|464511931|FG000|Overall Study|Withdrawal by Subject|55|||
129061476|NCT00143247|464511931|FG000|Overall Study|Study terminated by sponsor|31|||
129061477|NCT00143247|464511931|FG000|Overall Study|Protocol Violation|15|||
129061478|NCT00143247|464511931|FG000|Overall Study|Lost to Follow-up|12|||
129061479|NCT00143247|464511931|FG000|Overall Study|following inaccurate lab adverse event|1|||
129061480|NCT00143247|464511931|FG000|Overall Study|Other|12|||
129061481|NCT02766283|464511936|FG000|Overall Study|Lost to Follow-up|27|||
129061482|NCT00340678|464511937|FG000|Overall Study|Lost to Follow-up|1|||
129061483|NCT00340678|464511938|FG001|Overall Study|Lost to Follow-up|0|||
128720419|NCT04762680|463274958|FG019|Phase 2|Lost to Follow-up|0|||
128720420|NCT04762680|463274959|FG020|Phase 2|Lost to Follow-up|0|||
128720421|NCT04762680|463274960|FG021|Phase 2|Lost to Follow-up|0|||
128720422|NCT04762680|463274939|FG000|Phase 3|Adverse Event|0|||
128720423|NCT04762680|463274940|FG001|Phase 3|Adverse Event|0|||
128720424|NCT04762680|463274941|FG002|Phase 3|Adverse Event|0|||
128720425|NCT04762680|463274942|FG003|Phase 3|Adverse Event|1|||
128720426|NCT04762680|463274943|FG004|Phase 3|Adverse Event|0|||
128720427|NCT04762680|463274944|FG005|Phase 3|Adverse Event|0|||
128720428|NCT04762680|463274945|FG006|Phase 3|Adverse Event|0|||
129061484|NCT00340678|464511939|FG002|Overall Study|Lost to Follow-up|0|||
129061485|NCT00340678|464511940|FG003|Overall Study|Lost to Follow-up|0|||
129061486|NCT04803305|464511941|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
129061487|NCT04803305|464511942|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
129061488|NCT04803305|464511941|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
129061489|NCT04803305|464511942|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
129061490|NCT04803305|464511941|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
129061491|NCT04803305|464511942|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
129061492|NCT04803305|464511941|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
129061493|NCT04803305|464511942|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
129061494|NCT04803305|464511941|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
129061495|NCT04803305|464511942|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
129061496|NCT04803305|464511941|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
129061497|NCT04803305|464511942|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
129061498|NCT04803305|464511941|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
129061499|NCT04803305|464511942|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
129061500|NCT04803305|464511941|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
128775568|NCT00551213|463468381|FG000|Overall Study|Adverse Event|6|||
129061501|NCT04803305|464511942|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
129061502|NCT03316547|464511944|FG000|Overall Study|Death|3|||
129061503|NCT03316547|464511945|FG001|Overall Study|Death|1|||
128720429|NCT04762680|463274946|FG007|Phase 3|Adverse Event|0|||
128720430|NCT04762680|463274947|FG008|Phase 3|Adverse Event|0|||
128720431|NCT04762680|463274948|FG009|Phase 3|Adverse Event|0|||
128720432|NCT04762680|463274949|FG010|Phase 3|Adverse Event|0|||
128775569|NCT00551213|463468382|FG001|Overall Study|Adverse Event|3|||
129061504|NCT03316547|464511944|FG000|Overall Study|Lost to Follow-up|6|||
129061505|NCT03316547|464511945|FG001|Overall Study|Lost to Follow-up|6|||
129061506|NCT03316547|464511944|FG000|Overall Study|Withdrawal by Subject|3|||
129061507|NCT03316547|464511945|FG001|Overall Study|Withdrawal by Subject|2|||
129061508|NCT03316547|464511944|FG000|Overall Study|Transfer to another hospital|6|||
129061509|NCT03316547|464511945|FG001|Overall Study|Transfer to another hospital|4|||
129061510|NCT00721227|464511946|FG000|Overall Study|Lost to Follow-up|3|||
129061511|NCT00721227|464511947|FG001|Overall Study|Lost to Follow-up|0|||
129061512|NCT00721227|464511946|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
129061513|NCT00721227|464511947|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
129061514|NCT03654599|464511953|FG000|Overall Study|Lost to Follow-up|14|||
129061515|NCT03654599|464511954|FG001|Overall Study|Lost to Follow-up|12|||
129061516|NCT03654599|464511953|FG000|Overall Study|Death|8|||
129061517|NCT03654599|464511954|FG001|Overall Study|Death|6|||
129061518|NCT03654599|464511953|FG000|Overall Study|Withdrawal by Subject|6|||
129061519|NCT03654599|464511954|FG001|Overall Study|Withdrawal by Subject|4|||
129061520|NCT01243775|464511955|FG000|Overall Study|Withdrawal by Subject|2|||
129061521|NCT01659125|464513789|FG000|Overall Study|Withdrawal by Subject|2|||
129061522|NCT01659125|464513789|FG000|Overall Study|Lost to Follow-up|7|||
129061523|NCT01659125|464513789|FG000|Overall Study|Technical Problem|1|||
129061524|NCT01659125|464513789|FG000|Overall Study|Time Constraints|2|||
129061525|NCT01659125|464513789|FG000|Overall Study|Failed to Start Treatment|2|||
129061526|NCT01762800|464513792|FG000|Overall Study|Adverse Event|8|||
129061527|NCT01762800|464513793|FG001|Overall Study|Adverse Event|13|||
129061528|NCT01762800|464513792|FG000|Overall Study|Lack of Efficacy|3|||
129061529|NCT01762800|464513793|FG001|Overall Study|Lack of Efficacy|2|||
129061530|NCT01762800|464513792|FG000|Overall Study|Study Closed/Terminated|0|||
129061531|NCT01762800|464513793|FG001|Overall Study|Study Closed/Terminated|1|||
129061532|NCT01762800|464513792|FG000|Overall Study|Physician Decision|1|||
129061533|NCT01762800|464513793|FG001|Overall Study|Physician Decision|1|||
129061534|NCT01762800|464513792|FG000|Overall Study|Withdrawal by Subject|7|||
129061535|NCT01762800|464513793|FG001|Overall Study|Withdrawal by Subject|4|||
129061536|NCT02640482|464513794|FG000|Overall Study|Lost to Follow-up|3|||
129061537|NCT02640482|464513795|FG001|Overall Study|Lost to Follow-up|0|||
129061538|NCT00113763|464513797|FG000|Overall Study|Adverse Event|5|||
129061539|NCT00113763|464513798|FG001|Overall Study|Adverse Event|2|||
129061540|NCT00113763|464513797|FG000|Overall Study|Disease Progression|28|||
129061541|NCT00113763|464513798|FG001|Overall Study|Disease Progression|14|||
129061542|NCT00113763|464513797|FG000|Overall Study|Lost to Follow-up|10|||
129061543|NCT00113763|464513798|FG001|Overall Study|Lost to Follow-up|0|||
129061544|NCT00113763|464513797|FG000|Overall Study|Withdrawal by Subject|1|||
129061545|NCT00113763|464513798|FG001|Overall Study|Withdrawal by Subject|4|||
129061546|NCT00113763|464513797|FG000|Overall Study|Other|27|||
129061547|NCT00113763|464513798|FG001|Overall Study|Other|6|||
129061548|NCT00113763|464513797|FG000|Overall Study|Non-compliance|1|||
129061549|NCT00113763|464513798|FG001|Overall Study|Non-compliance|0|||
129061550|NCT00113763|464513797|FG000|Overall Study|Ongoing|1|||
129061551|NCT00113763|464513798|FG001|Overall Study|Ongoing|0|||
129061552|NCT00517881|464513799|FG000|Overall Study|Protocol Violation|2|||
129061553|NCT00517881|464513799|FG000|Overall Study|Adverse Event|1|||
129061554|NCT00517881|464513799|FG000|Overall Study|Renal transplantation|2|||
129061555|NCT01383707|464513802|FG000|Overall Study|Consent withdrawal|6|||
129061556|NCT01383707|464513802|FG000|Overall Study|Death|19|||
129061557|NCT01383707|464513802|FG000|Overall Study|Other|8|||
129061558|NCT01383707|464513802|FG000|Overall Study|Sponsor's decision|2|||
129061559|NCT01383707|464513802|FG000|Overall Study|Adverse Event|14|||
129061560|NCT01383707|464513802|FG000|Overall Study|Progressive disease|23|||
129061561|NCT02013817|464513807|FG000|Overall Study|Adverse Event|12|||
129061562|NCT02013817|464513807|FG000|Overall Study|Withdrawal by Subject|4|||
129061563|NCT02013817|464513807|FG000|Overall Study|Death|2|||
129061564|NCT02013817|464513807|FG000|Overall Study|Other|9|||
129061565|NCT03336528|464513816|FG000|Overall Study|Protocol Violation|1|||
129061566|NCT03336528|464513817|FG001|Overall Study|Protocol Violation|1|||
129061567|NCT03336528|464513816|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
129061568|NCT03336528|464513817|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
129061569|NCT03336528|464513816|FG000|Overall Study|Did not receive study medication|1|||
129061570|NCT03336528|464513817|FG001|Overall Study|Did not receive study medication|2|||
129061571|NCT00230178|464513822|FG000|Overall Study|Adverse Event|1|||
129061572|NCT00230178|464513823|FG001|Overall Study|Adverse Event|5|||
129061573|NCT00230178|464513824|FG002|Overall Study|Adverse Event|2|||
129061574|NCT00230178|464513822|FG000|Overall Study|Withdrawal by Subject|0|||
129061575|NCT00230178|464513823|FG001|Overall Study|Withdrawal by Subject|0|||
129061576|NCT00230178|464513824|FG002|Overall Study|Withdrawal by Subject|1|||
129061577|NCT00230178|464513822|FG000|Overall Study|Various other reasons|3|||
128775570|NCT00551213|463468381|FG000|Overall Study|Progressive Disease|41|||
129061578|NCT00230178|464513823|FG001|Overall Study|Various other reasons|2|||
129061579|NCT00230178|464513824|FG002|Overall Study|Various other reasons|4|||
129061580|NCT01753297|464513825|FG000|Overall Study|Lost to Follow-up|7|||
129061581|NCT01753297|464513826|FG001|Overall Study|Lost to Follow-up|2|||
129061582|NCT01753297|464513825|FG000|Overall Study|Withdrawal by Subject|26|||
129061583|NCT01753297|464513826|FG001|Overall Study|Withdrawal by Subject|23|||
129061584|NCT01753297|464513825|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
129061585|NCT01753297|464513826|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
129061586|NCT01753297|464513825|FG000|Overall Study|Death|0|||
129061587|NCT01753297|464513826|FG001|Overall Study|Death|2|||
129061588|NCT01753297|464513825|FG000|Overall Study|Did not attend end of study visit|7|||
129061589|NCT01753297|464513826|FG001|Overall Study|Did not attend end of study visit|8|||
129061590|NCT04974749|464513833|FG000|Overall Study|Withdrawal by Subject|2|||
129061591|NCT04974749|464513833|FG000|Overall Study|Gestation|1|||
129061592|NCT01645787|464513834|FG000|Washout (2 Weeks)|Adverse Event|1|||
129061593|NCT01645787|464513835|FG001|Washout (2 Weeks)|Adverse Event|0|||
129061594|NCT04315506|464513837|FG000|Overall Study|Lost to Follow-up|74|||
129061595|NCT04315506|464513838|FG001|Overall Study|Lost to Follow-up|82|||
129061596|NCT04315506|464513837|FG000|Overall Study|Withdrawal by Subject|8|||
129061597|NCT04315506|464513838|FG001|Overall Study|Withdrawal by Subject|8|||
129061598|NCT04315506|464513837|FG000|Overall Study|Physician Decision|0|||
129061599|NCT04315506|464513838|FG001|Overall Study|Physician Decision|1|||
129061600|NCT00958893|464513845|FG000|Overall Study|Study prematurely terminated|4|||
129061601|NCT03593395|464513852|FG000|Overall Study|Lost to Follow-up|48|||
129061602|NCT03593395|464513853|FG001|Overall Study|Lost to Follow-up|3|||
129061603|NCT03593395|464513852|FG000|Overall Study|Withdrawal by Subject|5|||
129061604|NCT03593395|464513853|FG001|Overall Study|Withdrawal by Subject|24|||
129061605|NCT03593395|464513852|FG000|Overall Study|Death|2|||
129061606|NCT03593395|464513853|FG001|Overall Study|Death|3|||
129061607|NCT03593395|464513852|FG000|Overall Study|Physician Decision|0|||
129061608|NCT03593395|464513853|FG001|Overall Study|Physician Decision|6|||
129061609|NCT03593395|464513852|FG000|Overall Study|Participant Relocated|19|||
129061610|NCT03593395|464513853|FG001|Overall Study|Participant Relocated|3|||
129061611|NCT03593395|464513852|FG000|Overall Study|No Information|1|||
129061612|NCT03593395|464513853|FG001|Overall Study|No Information|7|||
129061613|NCT01524978|464513854|FG000|Overall Study|Other|16|||
129061614|NCT01524978|464513855|FG001|Overall Study|Other|2|||
129061615|NCT01524978|464513856|FG002|Overall Study|Other|1|||
129061616|NCT01524978|464513857|FG003|Overall Study|Other|2|||
129061617|NCT01524978|464513858|FG004|Overall Study|Other|1|||
129061618|NCT01524978|464513859|FG005|Overall Study|Other|3|||
129061619|NCT01524978|464513860|FG006|Overall Study|Other|17|||
129061620|NCT01524978|464513861|FG007|Overall Study|Other|1|||
129061621|NCT01524978|464513862|FG008|Overall Study|Other|2|||
129061622|NCT01524978|464513863|FG009|Overall Study|Other|2|||
129061623|NCT01524978|464513864|FG010|Overall Study|Other|5|||
129061624|NCT01524978|464513854|FG000|Overall Study|Withdrawal by Subject|12|||
129061625|NCT01524978|464513855|FG001|Overall Study|Withdrawal by Subject|0|||
129061626|NCT01524978|464513856|FG002|Overall Study|Withdrawal by Subject|1|||
129061627|NCT01524978|464513857|FG003|Overall Study|Withdrawal by Subject|1|||
129061628|NCT01524978|464513858|FG004|Overall Study|Withdrawal by Subject|3|||
129061629|NCT01524978|464513859|FG005|Overall Study|Withdrawal by Subject|1|||
129061630|NCT01524978|464513860|FG006|Overall Study|Withdrawal by Subject|6|||
129061631|NCT01524978|464513861|FG007|Overall Study|Withdrawal by Subject|2|||
129061632|NCT01524978|464513862|FG008|Overall Study|Withdrawal by Subject|4|||
129061633|NCT01524978|464513863|FG009|Overall Study|Withdrawal by Subject|0|||
129061634|NCT01524978|464513864|FG010|Overall Study|Withdrawal by Subject|5|||
129061635|NCT01524978|464513854|FG000|Overall Study|Lost to Follow-up|0|||
129061636|NCT01524978|464513855|FG001|Overall Study|Lost to Follow-up|0|||
129061637|NCT01524978|464513856|FG002|Overall Study|Lost to Follow-up|3|||
129061638|NCT01524978|464513857|FG003|Overall Study|Lost to Follow-up|0|||
129061639|NCT01524978|464513858|FG004|Overall Study|Lost to Follow-up|1|||
129061640|NCT01524978|464513859|FG005|Overall Study|Lost to Follow-up|1|||
129061641|NCT01524978|464513860|FG006|Overall Study|Lost to Follow-up|2|||
129061642|NCT01524978|464513861|FG007|Overall Study|Lost to Follow-up|0|||
129061643|NCT01524978|464513862|FG008|Overall Study|Lost to Follow-up|1|||
129061644|NCT01524978|464513863|FG009|Overall Study|Lost to Follow-up|1|||
129061645|NCT01524978|464513864|FG010|Overall Study|Lost to Follow-up|1|||
129061646|NCT01524978|464513854|FG000|Overall Study|Death|34|||
129061647|NCT01524978|464513855|FG001|Overall Study|Death|2|||
129061648|NCT01524978|464513856|FG002|Overall Study|Death|5|||
129061649|NCT01524978|464513857|FG003|Overall Study|Death|24|||
129061650|NCT01524978|464513858|FG004|Overall Study|Death|4|||
129061651|NCT01524978|464513859|FG005|Overall Study|Death|4|||
129061652|NCT01524978|464513860|FG006|Overall Study|Death|1|||
129061653|NCT01524978|464513861|FG007|Overall Study|Death|9|||
129061654|NCT01524978|464513862|FG008|Overall Study|Death|5|||
129061655|NCT01524978|464513863|FG009|Overall Study|Death|6|||
129061656|NCT01524978|464513864|FG010|Overall Study|Death|17|||
129061657|NCT00606632|464513867|FG000|Overall Study|Withdrawal by Subject|13|||
129061658|NCT00606632|464513867|FG000|Overall Study|Miscellaneous reasons|9|||
129061659|NCT02481869|464513868|FG000|Overall Study|Lost to Follow-up|3|||
129061660|NCT02481869|464513869|FG001|Overall Study|Lost to Follow-up|4|||
129061661|NCT02481869|464513868|FG000|Overall Study|Withdrawal by Subject|2|||
128720433|NCT04762680|463274950|FG011|Phase 3|Adverse Event|0|||
128720434|NCT04762680|463274951|FG012|Phase 3|Adverse Event|0|||
128720435|NCT04762680|463274952|FG013|Phase 3|Adverse Event|0|||
128720436|NCT04762680|463274953|FG014|Phase 3|Adverse Event|0|||
129061662|NCT02481869|464513869|FG001|Overall Study|Withdrawal by Subject|0|||
129061663|NCT00711880|464513870|FG000|Overall Study|Adverse Event|11|||
129061664|NCT00711880|464513871|FG001|Overall Study|Adverse Event|2|||
129061665|NCT00711880|464513870|FG000|Overall Study|Patient non-compliance|1|||
129061666|NCT00711880|464513871|FG001|Overall Study|Patient non-compliance|0|||
129061667|NCT00711880|464513870|FG000|Overall Study|Lack of Efficacy|1|||
129061668|NCT00711880|464513871|FG001|Overall Study|Lack of Efficacy|5|||
129061669|NCT04238650|464513874|FG000|Overall Study|Withdrawal by Subject|0|||
129061670|NCT04238650|464513875|FG001|Overall Study|Withdrawal by Subject|1|||
129061671|NCT02756208|464513879|FG000|Overall Study|Withdrawal by Subject|1|||
129061672|NCT02756208|464513880|FG001|Overall Study|Withdrawal by Subject|0|||
129061673|NCT02756208|464513881|FG002|Overall Study|Withdrawal by Subject|1|||
129061674|NCT02756208|464513882|FG003|Overall Study|Withdrawal by Subject|3|||
129061675|NCT02756208|464513879|FG000|Overall Study|Lost to Follow-up|3|||
129061676|NCT02756208|464513880|FG001|Overall Study|Lost to Follow-up|1|||
129061677|NCT02756208|464513881|FG002|Overall Study|Lost to Follow-up|1|||
129061678|NCT02756208|464513882|FG003|Overall Study|Lost to Follow-up|1|||
129061679|NCT02756208|464513879|FG000|Overall Study|Physician Decision|1|||
129061680|NCT02756208|464513880|FG001|Overall Study|Physician Decision|0|||
129061681|NCT02756208|464513881|FG002|Overall Study|Physician Decision|0|||
129061682|NCT02756208|464513882|FG003|Overall Study|Physician Decision|0|||
129061683|NCT02756208|464513879|FG000|Overall Study|Protocol Violation|0|||
129061684|NCT02756208|464513880|FG001|Overall Study|Protocol Violation|1|||
129061685|NCT02756208|464513881|FG002|Overall Study|Protocol Violation|0|||
129061686|NCT02756208|464513882|FG003|Overall Study|Protocol Violation|0|||
129061687|NCT02370238|464513883|FG000|Overall Study|Death|42|||
129061688|NCT02370238|464513884|FG001|Overall Study|Death|35|||
129061689|NCT02370238|464513883|FG000|Overall Study|Lost to Follow-up|1|||
129061690|NCT02370238|464513884|FG001|Overall Study|Lost to Follow-up|3|||
129061691|NCT02370238|464513883|FG000|Overall Study|Withdrawal by Subject|2|||
129061692|NCT02370238|464513884|FG001|Overall Study|Withdrawal by Subject|6|||
129061693|NCT02370238|464513883|FG000|Overall Study|Other|2|||
129061694|NCT02370238|464513884|FG001|Overall Study|Other|1|||
129061695|NCT01295320|464513889|FG000|Overall Study|Adverse Event|2|||
129061696|NCT01295320|464513889|FG000|Overall Study|Lost to Follow-up|4|||
129061697|NCT01295320|464513889|FG000|Overall Study|Withdrawal by Subject|2|||
129061698|NCT01295320|464513889|FG000|Overall Study|Subject was bedridden|1|||
129061699|NCT01295320|464513889|FG000|Overall Study|Unable to travel|1|||
129061700|NCT00652340|464513890|FG000|Overall Study|Had not progressed.|4|||
129061701|NCT00652340|464513891|FG001|Overall Study|Had not progressed.|3|||
128720437|NCT04762680|463274954|FG015|Phase 3|Adverse Event|0|||
129061702|NCT03682107|464513892|FG000|Overall Study|Withdrawal by Subject|0|||
129061703|NCT03682107|464513893|FG001|Overall Study|Withdrawal by Subject|1|||
129061704|NCT03682107|464513894|FG002|Overall Study|Withdrawal by Subject|0|||
129061705|NCT03682107|464513895|FG003|Overall Study|Withdrawal by Subject|0|||
129061706|NCT03682107|464513896|FG004|Overall Study|Withdrawal by Subject|0|||
129061707|NCT04342819|464513897|FG000|Overall Study|Declined|4|||
128720438|NCT04762680|463274955|FG016|Phase 3|Adverse Event|0|||
128720439|NCT04762680|463274956|FG017|Phase 3|Adverse Event|3|||
129061708|NCT04342819|464513897|FG000|Overall Study|Not meeeting selection criteria|1|||
129061709|NCT00214383|464513898|FG000|Overall Study|Lost to Follow-up|16|||
129061710|NCT00214383|464513899|FG001|Overall Study|Lost to Follow-up|26|||
129061711|NCT01569295|464513900|FG000|Overall Study|Progressive Disease|75|||
129061712|NCT01569295|464513901|FG001|Overall Study|Progressive Disease|139|||
129061713|NCT01569295|464513900|FG000|Overall Study|Adverse Event|39|||
129061714|NCT01569295|464513901|FG001|Overall Study|Adverse Event|14|||
129061715|NCT01569295|464513900|FG000|Overall Study|Withdrawal by Subject|25|||
129061716|NCT01569295|464513901|FG001|Overall Study|Withdrawal by Subject|12|||
129061717|NCT01569295|464513900|FG000|Overall Study|Death|19|||
129061718|NCT01569295|464513901|FG001|Overall Study|Death|15|||
129061719|NCT01569295|464513900|FG000|Overall Study|Physician Decision|13|||
129061720|NCT01569295|464513901|FG001|Overall Study|Physician Decision|18|||
129061721|NCT01569295|464513900|FG000|Overall Study|Study Terminated by Sponsor|24|||
129061722|NCT01569295|464513901|FG001|Overall Study|Study Terminated by Sponsor|2|||
129061723|NCT01569295|464513900|FG000|Overall Study|Other Reason not Specified|3|||
129061724|NCT01569295|464513901|FG001|Overall Study|Other Reason not Specified|5|||
129061725|NCT01569295|464513900|FG000|Overall Study|Non-Compliance with Study Drug|6|||
129061726|NCT01569295|464513901|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129061727|NCT01569295|464513900|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
129061728|NCT01569295|464513901|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
129061729|NCT01569295|464513900|FG000|Overall Study|Lost to Follow-up|1|||
129061730|NCT01569295|464513901|FG001|Overall Study|Lost to Follow-up|1|||
129061731|NCT00879411|464513902|FG000|Overall Study|lost to follow-up (non-AE)|162|||
129061732|NCT03607487|464513903|FG000|Overall Study|Withdrawal by Subject|2|||
129061733|NCT03607487|464513904|FG001|Overall Study|Withdrawal by Subject|0|||
129061734|NCT03607487|464513905|FG002|Overall Study|Withdrawal by Subject|0|||
129061735|NCT03607487|464513906|FG003|Overall Study|Withdrawal by Subject|1|||
129061736|NCT01884337|464513907|FG000|Treatment|Adverse Event|2|||
129061737|NCT01884337|464513908|FG001|Treatment|Adverse Event|2|||
129061738|NCT01884337|464513907|FG000|Treatment|Subj. request to discont. treatment|2|||
129061739|NCT01884337|464513908|FG001|Treatment|Subj. request to discont. treatment|0|||
129061740|NCT01884337|464513907|FG000|Follow-up Period|Lost to Follow-up|1|||
129061741|NCT01884337|464513908|FG001|Follow-up Period|Lost to Follow-up|1|||
129061742|NCT02455518|464513909|FG000|Overall Study|Protocol Violation|0|||
129061743|NCT02455518|464513910|FG001|Overall Study|Protocol Violation|1|||
129061744|NCT02455518|464513911|FG002|Overall Study|Protocol Violation|1|||
129061745|NCT02455518|464513912|FG003|Overall Study|Protocol Violation|3|||
129061746|NCT01038297|464513915|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
129061747|NCT01038297|464513916|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
129061748|NCT01038297|464513917|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
129061749|NCT02508935|464513919|FG000|Overall Study|Withdrawal by Subject|1|||
129061750|NCT02508935|464513919|FG000|Overall Study|Withdrawal by Caregiver|8|||
129061751|NCT02508935|464513919|FG000|Overall Study|Pain Score <4|1|||
129061752|NCT02508935|464513919|FG000|Overall Study|Emesis|3|||
129061753|NCT02508935|464513919|FG000|Overall Study|Adverse Event|3|||
129061754|NCT02508935|464513919|FG000|Overall Study|Protocol Violation|1|||
129061755|NCT02508935|464513919|FG000|Overall Study|Physician Decision|1|||
129061756|NCT02508935|464513919|FG000|Overall Study|Trial terminated by sponsor|5|||
129061757|NCT01973595|464513920|FG000|Washout|Withdrawal by Subject|1|||
129061758|NCT01973595|464513921|FG001|Washout|Withdrawal by Subject|0|||
129061759|NCT01973595|464513922|FG002|Washout|Withdrawal by Subject|1|||
129061760|NCT01973595|464513923|FG003|Washout|Withdrawal by Subject|0|||
129061761|NCT01210612|464513928|FG000|Overall Study|Withdrawal by Subject|0|||
129061762|NCT01210612|464513929|FG001|Overall Study|Withdrawal by Subject|2|||
129061763|NCT01275430|464513930|FG000|Overall Study|Adverse Event|1|||
129061764|NCT01275430|464513930|FG000|Overall Study|No Contrast Injection|6|||
129061765|NCT01275430|464513930|FG000|Overall Study|Device Malfunction|1|||
129061766|NCT01275430|464513930|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
129061767|NCT04036110|464513931|FG000|Overall Study|Lost to Follow-up|3|||
129061768|NCT04036110|464513932|FG001|Overall Study|Lost to Follow-up|2|||
129061769|NCT04036110|464513933|FG002|Overall Study|Lost to Follow-up|1|||
129061770|NCT04036110|464513931|FG000|Overall Study|Study Suspended|4|||
129061771|NCT04036110|464513932|FG001|Overall Study|Study Suspended|5|||
129061772|NCT04036110|464513933|FG002|Overall Study|Study Suspended|1|||
129061773|NCT02516553|464513939|FG000|Overall Study|Progressive disease|2|||
129061774|NCT02516553|464513940|FG001|Overall Study|Progressive disease|2|||
129061775|NCT02516553|464513941|FG002|Overall Study|Progressive disease|3|||
129061776|NCT02516553|464513942|FG003|Overall Study|Progressive disease|5|||
129061777|NCT02516553|464513943|FG004|Overall Study|Progressive disease|3|||
129061778|NCT02516553|464513944|FG005|Overall Study|Progressive disease|0|||
129061779|NCT02516553|464513945|FG006|Overall Study|Progressive disease|5|||
129061780|NCT02516553|464513946|FG007|Overall Study|Progressive disease|5|||
129061781|NCT02516553|464513947|FG008|Overall Study|Progressive disease|11|||
128775571|NCT00551213|463468382|FG001|Overall Study|Progressive Disease|12|||
128775572|NCT00551213|463468381|FG000|Overall Study|Withdrawal by Subject|2|||
128775573|NCT00551213|463468382|FG001|Overall Study|Withdrawal by Subject|0|||
129061782|NCT02516553|464513948|FG009|Overall Study|Progressive disease|3|||
129061783|NCT02516553|464513949|FG010|Overall Study|Progressive disease|10|||
129061784|NCT02516553|464513950|FG011|Overall Study|Progressive disease|8|||
129061785|NCT02516553|464513951|FG012|Overall Study|Progressive disease|8|||
129061786|NCT02516553|464513952|FG013|Overall Study|Progressive disease|2|||
129061787|NCT02516553|464513953|FG014|Overall Study|Progressive disease|2|||
129061788|NCT02516553|464513954|FG015|Overall Study|Progressive disease|2|||
129061789|NCT02516553|464513955|FG016|Overall Study|Progressive disease|1|||
129061790|NCT02516553|464513956|FG017|Overall Study|Progressive disease|9|||
129061791|NCT02516553|464513957|FG018|Overall Study|Progressive disease|12|||
129061792|NCT02516553|464513958|FG019|Overall Study|Progressive disease|7|||
129061793|NCT02516553|464513959|FG020|Overall Study|Progressive disease|16|||
129061794|NCT02516553|464513960|FG021|Overall Study|Progressive disease|18|||
129061795|NCT02516553|464513939|FG000|Overall Study|Dose limiting toxicity|0|||
129061796|NCT02516553|464513940|FG001|Overall Study|Dose limiting toxicity|0|||
129061797|NCT02516553|464513941|FG002|Overall Study|Dose limiting toxicity|0|||
129061798|NCT02516553|464513942|FG003|Overall Study|Dose limiting toxicity|0|||
129061799|NCT02516553|464513943|FG004|Overall Study|Dose limiting toxicity|3|||
129061800|NCT02516553|464513944|FG005|Overall Study|Dose limiting toxicity|1|||
129061801|NCT02516553|464513945|FG006|Overall Study|Dose limiting toxicity|1|||
129061802|NCT02516553|464513946|FG007|Overall Study|Dose limiting toxicity|0|||
129061803|NCT02516553|464513947|FG008|Overall Study|Dose limiting toxicity|1|||
129061804|NCT02516553|464513948|FG009|Overall Study|Dose limiting toxicity|0|||
129061805|NCT02516553|464513949|FG010|Overall Study|Dose limiting toxicity|0|||
129061806|NCT02516553|464513950|FG011|Overall Study|Dose limiting toxicity|1|||
129061807|NCT02516553|464513951|FG012|Overall Study|Dose limiting toxicity|0|||
129061808|NCT02516553|464513952|FG013|Overall Study|Dose limiting toxicity|1|||
129061809|NCT02516553|464513953|FG014|Overall Study|Dose limiting toxicity|0|||
129061810|NCT02516553|464513954|FG015|Overall Study|Dose limiting toxicity|0|||
129061811|NCT02516553|464513955|FG016|Overall Study|Dose limiting toxicity|1|||
129061812|NCT02516553|464513956|FG017|Overall Study|Dose limiting toxicity|1|||
129061813|NCT02516553|464513957|FG018|Overall Study|Dose limiting toxicity|0|||
129061814|NCT02516553|464513958|FG019|Overall Study|Dose limiting toxicity|2|||
129061815|NCT02516553|464513959|FG020|Overall Study|Dose limiting toxicity|0|||
129061816|NCT02516553|464513960|FG021|Overall Study|Dose limiting toxicity|0|||
129061817|NCT02516553|464513939|FG000|Overall Study|Other Adverse Events|0|||
129061818|NCT02516553|464513940|FG001|Overall Study|Other Adverse Events|0|||
129061819|NCT02516553|464513941|FG002|Overall Study|Other Adverse Events|0|||
129061820|NCT02516553|464513942|FG003|Overall Study|Other Adverse Events|1|||
129061821|NCT02516553|464513943|FG004|Overall Study|Other Adverse Events|0|||
129061822|NCT02516553|464513944|FG005|Overall Study|Other Adverse Events|1|||
129061823|NCT02516553|464513945|FG006|Overall Study|Other Adverse Events|0|||
129061824|NCT02516553|464513946|FG007|Overall Study|Other Adverse Events|0|||
129061825|NCT02516553|464513947|FG008|Overall Study|Other Adverse Events|0|||
129061826|NCT02516553|464513948|FG009|Overall Study|Other Adverse Events|1|||
129061827|NCT02516553|464513949|FG010|Overall Study|Other Adverse Events|3|||
129061828|NCT02516553|464513950|FG011|Overall Study|Other Adverse Events|2|||
129061829|NCT02516553|464513951|FG012|Overall Study|Other Adverse Events|0|||
129061830|NCT02516553|464513952|FG013|Overall Study|Other Adverse Events|1|||
129061831|NCT02516553|464513953|FG014|Overall Study|Other Adverse Events|0|||
129061832|NCT02516553|464513954|FG015|Overall Study|Other Adverse Events|0|||
129061833|NCT02516553|464513955|FG016|Overall Study|Other Adverse Events|0|||
129061834|NCT02516553|464513956|FG017|Overall Study|Other Adverse Events|2|||
129061835|NCT02516553|464513957|FG018|Overall Study|Other Adverse Events|1|||
129061836|NCT02516553|464513958|FG019|Overall Study|Other Adverse Events|2|||
129061837|NCT02516553|464513959|FG020|Overall Study|Other Adverse Events|2|||
129061838|NCT02516553|464513960|FG021|Overall Study|Other Adverse Events|1|||
129061839|NCT02516553|464513939|FG000|Overall Study|Refused to continue trial medication|0|||
129061840|NCT02516553|464513940|FG001|Overall Study|Refused to continue trial medication|0|||
129061841|NCT02516553|464513941|FG002|Overall Study|Refused to continue trial medication|0|||
129061842|NCT02516553|464513942|FG003|Overall Study|Refused to continue trial medication|0|||
129061843|NCT02516553|464513943|FG004|Overall Study|Refused to continue trial medication|0|||
129061844|NCT02516553|464513944|FG005|Overall Study|Refused to continue trial medication|0|||
129061845|NCT02516553|464513945|FG006|Overall Study|Refused to continue trial medication|0|||
129061846|NCT02516553|464513946|FG007|Overall Study|Refused to continue trial medication|0|||
129061847|NCT02516553|464513947|FG008|Overall Study|Refused to continue trial medication|0|||
129061848|NCT02516553|464513948|FG009|Overall Study|Refused to continue trial medication|0|||
129061849|NCT02516553|464513949|FG010|Overall Study|Refused to continue trial medication|1|||
129061850|NCT02516553|464513950|FG011|Overall Study|Refused to continue trial medication|0|||
129061851|NCT02516553|464513951|FG012|Overall Study|Refused to continue trial medication|0|||
129061852|NCT02516553|464513952|FG013|Overall Study|Refused to continue trial medication|0|||
128775574|NCT00551213|463468381|FG000|Overall Study|Not Treated|1|||
128775575|NCT00551213|463468382|FG001|Overall Study|Not Treated|2|||
128775576|NCT01890967|463468383|FG000|Overall Study|Adverse Event|3|||
128775577|NCT01890967|463468384|FG001|Overall Study|Adverse Event|3|||
128775578|NCT01890967|463468385|FG002|Overall Study|Adverse Event|3|||
128775579|NCT01890967|463468386|FG003|Overall Study|Adverse Event|2|||
128775580|NCT01890967|463468387|FG004|Overall Study|Adverse Event|1|||
128775581|NCT01890967|463468388|FG005|Overall Study|Adverse Event|7|||
129061853|NCT02516553|464513953|FG014|Overall Study|Refused to continue trial medication|0|||
129061854|NCT02516553|464513954|FG015|Overall Study|Refused to continue trial medication|0|||
129061855|NCT02516553|464513955|FG016|Overall Study|Refused to continue trial medication|0|||
129061856|NCT02516553|464513956|FG017|Overall Study|Refused to continue trial medication|0|||
129061857|NCT02516553|464513957|FG018|Overall Study|Refused to continue trial medication|1|||
129061858|NCT02516553|464513958|FG019|Overall Study|Refused to continue trial medication|0|||
129061859|NCT02516553|464513959|FG020|Overall Study|Refused to continue trial medication|0|||
129061860|NCT02516553|464513960|FG021|Overall Study|Refused to continue trial medication|1|||
129061861|NCT02516553|464513939|FG000|Overall Study|other reasons than listed|0|||
129061862|NCT02516553|464513940|FG001|Overall Study|other reasons than listed|0|||
129061863|NCT02516553|464513941|FG002|Overall Study|other reasons than listed|0|||
129061864|NCT02516553|464513942|FG003|Overall Study|other reasons than listed|0|||
129061865|NCT02516553|464513943|FG004|Overall Study|other reasons than listed|0|||
129061866|NCT02516553|464513944|FG005|Overall Study|other reasons than listed|0|||
129061867|NCT02516553|464513945|FG006|Overall Study|other reasons than listed|0|||
129061868|NCT02516553|464513946|FG007|Overall Study|other reasons than listed|1|||
129061869|NCT02516553|464513947|FG008|Overall Study|other reasons than listed|1|||
129061870|NCT02516553|464513948|FG009|Overall Study|other reasons than listed|0|||
129061871|NCT02516553|464513949|FG010|Overall Study|other reasons than listed|1|||
129061872|NCT02516553|464513950|FG011|Overall Study|other reasons than listed|1|||
129061873|NCT02516553|464513951|FG012|Overall Study|other reasons than listed|0|||
129061874|NCT02516553|464513952|FG013|Overall Study|other reasons than listed|0|||
129061875|NCT02516553|464513953|FG014|Overall Study|other reasons than listed|0|||
129061876|NCT02516553|464513954|FG015|Overall Study|other reasons than listed|0|||
129061877|NCT02516553|464513955|FG016|Overall Study|other reasons than listed|0|||
129061878|NCT02516553|464513956|FG017|Overall Study|other reasons than listed|0|||
129061879|NCT02516553|464513957|FG018|Overall Study|other reasons than listed|0|||
129061880|NCT02516553|464513958|FG019|Overall Study|other reasons than listed|0|||
129061881|NCT02516553|464513959|FG020|Overall Study|other reasons than listed|2|||
129061882|NCT02516553|464513960|FG021|Overall Study|other reasons than listed|2|||
129061883|NCT03052127|464513961|FG000|Overall Study|Withdrawal by Subject|0|||
129061884|NCT03052127|464513962|FG001|Overall Study|Withdrawal by Subject|0|||
129061885|NCT03052127|464513963|FG002|Overall Study|Withdrawal by Subject|0|||
129061886|NCT03052127|464513964|FG003|Overall Study|Withdrawal by Subject|0|||
129061887|NCT03052127|464513965|FG004|Overall Study|Withdrawal by Subject|0|||
129061888|NCT03052127|464513966|FG005|Overall Study|Withdrawal by Subject|0|||
129061889|NCT03052127|464513967|FG006|Overall Study|Withdrawal by Subject|0|||
129061890|NCT03052127|464513968|FG007|Overall Study|Withdrawal by Subject|1|||
129061891|NCT03052127|464513969|FG008|Overall Study|Withdrawal by Subject|1|||
129061892|NCT03052127|464513970|FG009|Overall Study|Withdrawal by Subject|1|||
129061893|NCT03052127|464513971|FG010|Overall Study|Withdrawal by Subject|0|||
129061894|NCT03052127|464513972|FG011|Overall Study|Withdrawal by Subject|0|||
129061895|NCT03052127|464513961|FG000|Overall Study|Discontinuation by Sponsor|0|||
129061896|NCT03052127|464513962|FG001|Overall Study|Discontinuation by Sponsor|0|||
129061897|NCT03052127|464513963|FG002|Overall Study|Discontinuation by Sponsor|0|||
129061898|NCT03052127|464513964|FG003|Overall Study|Discontinuation by Sponsor|0|||
129061899|NCT03052127|464513965|FG004|Overall Study|Discontinuation by Sponsor|0|||
129061900|NCT03052127|464513966|FG005|Overall Study|Discontinuation by Sponsor|0|||
129061901|NCT03052127|464513967|FG006|Overall Study|Discontinuation by Sponsor|0|||
129061902|NCT03052127|464513968|FG007|Overall Study|Discontinuation by Sponsor|0|||
129061903|NCT03052127|464513969|FG008|Overall Study|Discontinuation by Sponsor|4|||
129061904|NCT03052127|464513970|FG009|Overall Study|Discontinuation by Sponsor|2|||
129061905|NCT03052127|464513971|FG010|Overall Study|Discontinuation by Sponsor|5|||
129061906|NCT03052127|464513972|FG011|Overall Study|Discontinuation by Sponsor|13|||
129061907|NCT03052127|464513961|FG000|Overall Study|Inability to comply with trial requirements|0|||
129061908|NCT03052127|464513962|FG001|Overall Study|Inability to comply with trial requirements|0|||
129061909|NCT03052127|464513963|FG002|Overall Study|Inability to comply with trial requirements|1|||
129061910|NCT03052127|464513964|FG003|Overall Study|Inability to comply with trial requirements|0|||
129061911|NCT03052127|464513965|FG004|Overall Study|Inability to comply with trial requirements|0|||
129061912|NCT03052127|464513966|FG005|Overall Study|Inability to comply with trial requirements|0|||
129061913|NCT03052127|464513967|FG006|Overall Study|Inability to comply with trial requirements|0|||
129061914|NCT03052127|464513968|FG007|Overall Study|Inability to comply with trial requirements|0|||
128775582|NCT01890967|463468383|FG000|Overall Study|Death|1|||
128775583|NCT01890967|463468384|FG001|Overall Study|Death|0|||
128775584|NCT01890967|463468385|FG002|Overall Study|Death|0|||
128775585|NCT01890967|463468386|FG003|Overall Study|Death|0|||
129061915|NCT03052127|464513969|FG008|Overall Study|Inability to comply with trial requirements|0|||
129061916|NCT03052127|464513970|FG009|Overall Study|Inability to comply with trial requirements|0|||
129061917|NCT03052127|464513971|FG010|Overall Study|Inability to comply with trial requirements|0|||
129061918|NCT03052127|464513972|FG011|Overall Study|Inability to comply with trial requirements|0|||
129061919|NCT03052127|464513961|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129061920|NCT03052127|464513962|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061921|NCT03052127|464513963|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061922|NCT03052127|464513964|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061923|NCT03052127|464513965|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129061924|NCT03052127|464513966|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129061925|NCT03052127|464513967|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129061926|NCT03052127|464513968|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061927|NCT03052127|464513969|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061928|NCT03052127|464513970|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061929|NCT03052127|464513971|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061930|NCT03052127|464513972|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129061931|NCT03694327|464513973|FG000|Overall Study|Lost to Follow-up|13|||
129061932|NCT03694327|464513974|FG001|Overall Study|Lost to Follow-up|23|||
129061933|NCT01464931|464513977|FG000|Overall Study|Withdrawal by Subject|1|||
129061934|NCT01464931|464513978|FG001|Overall Study|Withdrawal by Subject|0|||
129061935|NCT01982812|464513979|FG000|Overall Study|Death|1|||
129061936|NCT01982812|464513980|FG001|Overall Study|Death|5|||
129061937|NCT01982812|464513979|FG000|Overall Study|Adverse Event|0|||
129061938|NCT01982812|464513980|FG001|Overall Study|Adverse Event|5|||
129061939|NCT02933255|464513983|FG000|Overall Study|Discontinued due to study closure.|1|||
129061940|NCT02933255|464513984|FG001|Overall Study|Discontinued due to study closure.|0|||
129061941|NCT05833139|464516537|FG000|Study Period 2|Adverse Event|1|||
129061942|NCT03922529|464516538|FG000|Overall Study|Withdrawal by Subject|13|||
129061943|NCT03922529|464516539|FG001|Overall Study|Withdrawal by Subject|12|||
129061944|NCT03922529|464516538|FG000|Overall Study|Death|7|||
129061945|NCT03922529|464516539|FG001|Overall Study|Death|12|||
129061946|NCT03922529|464516538|FG000|Overall Study|Lost to Follow-up|12|||
129061947|NCT03922529|464516539|FG001|Overall Study|Lost to Follow-up|19|||
129061948|NCT03922529|464516538|FG000|Overall Study|Adverse Event|1|||
129061949|NCT03922529|464516539|FG001|Overall Study|Adverse Event|0|||
129061950|NCT03922529|464516538|FG000|Overall Study|Death after withdrawal|1|||
129061951|NCT03922529|464516539|FG001|Overall Study|Death after withdrawal|0|||
129061952|NCT03922529|464516538|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
129061953|NCT03922529|464516539|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
129061954|NCT03922529|464516538|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
129061955|NCT03922529|464516539|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
129061956|NCT02017015|464516540|FG000|Overall Study|Adverse Event|9|||
129061957|NCT02017015|464516540|FG000|Overall Study|Withdrawal by Subject|21|||
129061958|NCT02017015|464516540|FG000|Overall Study|Death|4|||
129061959|NCT02017015|464516540|FG000|Overall Study|Progressive Disease|31|||
129061960|NCT02017015|464516540|FG000|Overall Study|Non-compliance with study drug|2|||
129061961|NCT02017015|464516540|FG000|Overall Study|Physician Decision|2|||
129061962|NCT04158245|464516541|FG000|Overall Study|Lost to Follow-up|1|||
129061963|NCT02567435|464516544|FG000|Overall Study|Death|1|||
129061964|NCT02567435|464516545|FG001|Overall Study|Death|1|||
129061965|NCT02567435|464516546|FG002|Overall Study|Death|0|||
129061966|NCT02567435|464516547|FG003|Overall Study|Death|0|||
129061967|NCT02567435|464516544|FG000|Overall Study|Ineligible|1|||
129061968|NCT02567435|464516545|FG001|Overall Study|Ineligible|3|||
129061969|NCT02567435|464516546|FG002|Overall Study|Ineligible|0|||
129061970|NCT02567435|464516547|FG003|Overall Study|Ineligible|0|||
129061971|NCT02567435|464516544|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
129061972|NCT02567435|464516545|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
129061973|NCT02567435|464516546|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
129061974|NCT02567435|464516547|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
129061975|NCT06390826|464516548|FG000|Overall Study|Never Start Protocol Therapy|1|||
129061976|NCT06390826|464516548|FG000|Overall Study|Adverse Event|1|||
129061977|NCT06390826|464516548|FG000|Overall Study|Disease Progression|8|||
129061978|NCT03765788|464516549|FG000|Overall Study|Subject decision|2|||
129061979|NCT03765788|464516550|FG001|Overall Study|Subject decision|3|||
128720440|NCT04762680|463274957|FG018|Phase 3|Adverse Event|0|||
129061980|NCT03765788|464516549|FG000|Overall Study|Physician Decision|2|||
129061981|NCT03765788|464516550|FG001|Overall Study|Physician Decision|4|||
129061982|NCT03765788|464516549|FG000|Overall Study|Death|0|||
129061983|NCT03765788|464516550|FG001|Overall Study|Death|1|||
129061984|NCT03765788|464516549|FG000|Overall Study|Lost to Follow-up|1|||
129061985|NCT03765788|464516550|FG001|Overall Study|Lost to Follow-up|0|||
129061986|NCT03055624|464516551|FG000|Overall Study|Study closed|9|||
129061987|NCT02794870|464516555|FG000|Overall Study|Withdrawal by Subject|2|||
129061988|NCT02794870|464516556|FG001|Overall Study|Withdrawal by Subject|0|||
129061989|NCT02437903|464516557|FG000|Overall Study|Adverse Event|1|||
129061990|NCT02437903|464516557|FG000|Overall Study|Withdrawal by Subject|1|||
129061991|NCT02437903|464516557|FG000|Overall Study|Lost to Follow-up|3|||
129061992|NCT04414618|464516561|FG000|Overall Study|Death|3|||
129061993|NCT04414618|464516562|FG001|Overall Study|Death|3|||
129061994|NCT04414618|464516561|FG000|Overall Study|Withdrawal by Subject|2|||
129061995|NCT04414618|464516562|FG001|Overall Study|Withdrawal by Subject|1|||
129061996|NCT04414618|464516561|FG000|Overall Study|Lost to Follow-up|2|||
129061997|NCT04414618|464516562|FG001|Overall Study|Lost to Follow-up|3|||
129061998|NCT04414618|464516561|FG000|Overall Study|Physician Decision|1|||
129061999|NCT04414618|464516562|FG001|Overall Study|Physician Decision|0|||
129062000|NCT00658879|464516563|FG000|Overall Study|Protocol Violation|1|||
129062001|NCT00616421|464516564|FG000|Overall Study|Withdrawal by Subject|9|||
129062002|NCT00616421|464516565|FG001|Overall Study|Withdrawal by Subject|11|||
129062003|NCT00616421|464516566|FG002|Overall Study|Withdrawal by Subject|8|||
129062004|NCT00616421|464516564|FG000|Overall Study|Lost to Follow-up|12|||
129062005|NCT00616421|464516565|FG001|Overall Study|Lost to Follow-up|26|||
129062006|NCT00616421|464516566|FG002|Overall Study|Lost to Follow-up|30|||
129062007|NCT00616421|464516564|FG000|Overall Study|Inappropriate enrollment|3|||
129062008|NCT00616421|464516565|FG001|Overall Study|Inappropriate enrollment|0|||
129062009|NCT00616421|464516566|FG002|Overall Study|Inappropriate enrollment|1|||
129062010|NCT00616421|464516564|FG000|Overall Study|Administrative reason|1|||
129062011|NCT00616421|464516565|FG001|Overall Study|Administrative reason|0|||
129062012|NCT00616421|464516566|FG002|Overall Study|Administrative reason|0|||
129062013|NCT00616421|464516564|FG000|Overall Study|Protocol Violation|0|||
129062014|NCT00616421|464516565|FG001|Overall Study|Protocol Violation|1|||
129062015|NCT00616421|464516566|FG002|Overall Study|Protocol Violation|2|||
129062016|NCT00616421|464516564|FG000|Overall Study|Unable to classify|1|||
129062017|NCT00616421|464516565|FG001|Overall Study|Unable to classify|0|||
129062018|NCT00616421|464516566|FG002|Overall Study|Unable to classify|0|||
129062019|NCT02661217|464516567|FG000|Overall Study|Physician Decision|12|||
129062020|NCT02661217|464516568|FG001|Overall Study|Physician Decision|15|||
129062021|NCT02661217|464516567|FG000|Overall Study|Lost to Follow-up|1|||
129062022|NCT02661217|464516568|FG001|Overall Study|Lost to Follow-up|4|||
129062023|NCT02661217|464516567|FG000|Overall Study|Protocol Deviation|0|||
129062024|NCT02661217|464516568|FG001|Overall Study|Protocol Deviation|4|||
129062025|NCT02661217|464516567|FG000|Overall Study|Non-compliance with study treatment|5|||
129062026|NCT02661217|464516568|FG001|Overall Study|Non-compliance with study treatment|5|||
129062027|NCT02661217|464516567|FG000|Overall Study|Death|21|||
129062028|NCT02661217|464516568|FG001|Overall Study|Death|15|||
129062029|NCT02661217|464516567|FG000|Overall Study|Adverse Event|10|||
129062030|NCT02661217|464516568|FG001|Overall Study|Adverse Event|8|||
129062031|NCT02661217|464516567|FG000|Overall Study|Withdrawal by Subject|15|||
129062032|NCT02661217|464516568|FG001|Overall Study|Withdrawal by Subject|19|||
129062033|NCT02661217|464516567|FG000|Overall Study|Did not enter follow-up epoch|7|||
129062034|NCT02661217|464516568|FG001|Overall Study|Did not enter follow-up epoch|10|||
129062035|NCT02661217|464516567|FG000|Overall Study|Death - no study drug received|1|||
129062036|NCT02661217|464516568|FG001|Overall Study|Death - no study drug received|2|||
129062037|NCT02661217|464516567|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
129062038|NCT02661217|464516568|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
129062039|NCT02604407|464516571|FG000|Overall Study|Adverse Event|0|||
129062040|NCT02604407|464516572|FG001|Overall Study|Adverse Event|7|||
129062041|NCT02604407|464516573|FG002|Overall Study|Adverse Event|5|||
129062042|NCT02604407|464516571|FG000|Overall Study|Protocol Violation|2|||
129062043|NCT02604407|464516572|FG001|Overall Study|Protocol Violation|0|||
129062044|NCT02604407|464516573|FG002|Overall Study|Protocol Violation|0|||
129062045|NCT02604407|464516571|FG000|Overall Study|Withdrawal by Subject|3|||
129062046|NCT02604407|464516572|FG001|Overall Study|Withdrawal by Subject|3|||
129062047|NCT02604407|464516573|FG002|Overall Study|Withdrawal by Subject|5|||
129062048|NCT02604407|464516571|FG000|Overall Study|Lost to Follow-up|2|||
129062049|NCT02604407|464516572|FG001|Overall Study|Lost to Follow-up|1|||
129062050|NCT02604407|464516573|FG002|Overall Study|Lost to Follow-up|2|||
129062051|NCT02604407|464516571|FG000|Overall Study|Lack of Efficacy|1|||
129062052|NCT02604407|464516572|FG001|Overall Study|Lack of Efficacy|0|||
129062053|NCT02604407|464516573|FG002|Overall Study|Lack of Efficacy|0|||
129062054|NCT02604407|464516571|FG000|Overall Study|Other|3|||
129062055|NCT02604407|464516572|FG001|Overall Study|Other|1|||
129062056|NCT02604407|464516573|FG002|Overall Study|Other|4|||
128720441|NCT04762680|463274958|FG019|Phase 3|Adverse Event|0|||
129062057|NCT00185588|464516574|FG000|Overall Study|Adverse Event|3|||
129062058|NCT00185588|464516575|FG001|Overall Study|Adverse Event|1|||
129062059|NCT00185588|464516576|FG002|Overall Study|Adverse Event|4|||
129062060|NCT00185588|464516577|FG003|Overall Study|Adverse Event|2|||
129062061|NCT00185588|464516574|FG000|Overall Study|Lost to Follow-up|0|||
129062062|NCT00185588|464516575|FG001|Overall Study|Lost to Follow-up|0|||
129062063|NCT00185588|464516576|FG002|Overall Study|Lost to Follow-up|1|||
129062064|NCT00185588|464516577|FG003|Overall Study|Lost to Follow-up|2|||
129062065|NCT00185588|464516574|FG000|Overall Study|Withdrawal by Subject|0|||
129062066|NCT00185588|464516575|FG001|Overall Study|Withdrawal by Subject|1|||
129062067|NCT00185588|464516576|FG002|Overall Study|Withdrawal by Subject|0|||
129062068|NCT00185588|464516577|FG003|Overall Study|Withdrawal by Subject|0|||
129062069|NCT00185588|464516574|FG000|Overall Study|Physician Decision|0|||
129062070|NCT00185588|464516575|FG001|Overall Study|Physician Decision|0|||
129062071|NCT00185588|464516576|FG002|Overall Study|Physician Decision|1|||
129062072|NCT00185588|464516577|FG003|Overall Study|Physician Decision|0|||
129062073|NCT03908437|464516578|FG000|Overall Study|Death|0|||
129062074|NCT03908437|464516579|FG001|Overall Study|Death|1|||
129062075|NCT03908437|464516578|FG000|Overall Study|Lost to Follow-up|31|||
129062076|NCT03908437|464516579|FG001|Overall Study|Lost to Follow-up|24|||
129062077|NCT05445492|464516580|FG000|Overall Study|Physician Decision|1|||
129062078|NCT00191191|464516581|FG000|Overall Study|Entry Criteria Exclusion|2|||
129062079|NCT00191191|464516582|FG001|Overall Study|Entry Criteria Exclusion|0|||
129062080|NCT00191191|464516581|FG000|Overall Study|Treated with Another Systemic Agent|1|||
129062081|NCT00191191|464516582|FG001|Overall Study|Treated with Another Systemic Agent|1|||
129062082|NCT00191191|464516581|FG000|Overall Study|Adverse Event|11|||
129062083|NCT00191191|464516582|FG001|Overall Study|Adverse Event|21|||
129062084|NCT00191191|464516581|FG000|Overall Study|Progressive Disease|84|||
129062085|NCT00191191|464516582|FG001|Overall Study|Progressive Disease|72|||
129062086|NCT00191191|464516581|FG000|Overall Study|Toxicity After Dose Reduction|7|||
129062087|NCT00191191|464516582|FG001|Overall Study|Toxicity After Dose Reduction|8|||
129062088|NCT00191191|464516581|FG000|Overall Study|Family/Caregiver Decision|5|||
129062089|NCT00191191|464516582|FG001|Overall Study|Family/Caregiver Decision|7|||
129062090|NCT00191191|464516581|FG000|Overall Study|Lost to Follow-up|1|||
129062091|NCT00191191|464516582|FG001|Overall Study|Lost to Follow-up|0|||
129062092|NCT00191191|464516581|FG000|Overall Study|Physician Decision|3|||
129062093|NCT00191191|464516582|FG001|Overall Study|Physician Decision|2|||
129062094|NCT00191191|464516581|FG000|Overall Study|Good Clinical Practice Violation|0|||
129062095|NCT00191191|464516582|FG001|Overall Study|Good Clinical Practice Violation|1|||
129062096|NCT04289363|464516583|FG000|Overall Study|Lost to Follow-up|14|||
129062097|NCT04289363|464516584|FG001|Overall Study|Lost to Follow-up|0|||
129062098|NCT03348163|464516585|FG000|Overall Study|Withdrawal by Subject|2|||
129062099|NCT03348163|464516586|FG001|Overall Study|Withdrawal by Subject|0|||
129062100|NCT02585778|464516587|FG000|Overall Study|Adverse Event|17|||
129062101|NCT02585778|464516588|FG001|Overall Study|Adverse Event|4|||
129062102|NCT02585778|464516587|FG000|Overall Study|Participant did not wish to continue|9|||
129062103|NCT02585778|464516588|FG001|Overall Study|Participant did not wish to continue|4|||
129062104|NCT02585778|464516587|FG000|Overall Study|Poor compliance to study protocol|0|||
129062105|NCT02585778|464516588|FG001|Overall Study|Poor compliance to study protocol|2|||
129062106|NCT02585778|464516587|FG000|Overall Study|Death|0|||
129062107|NCT02585778|464516588|FG001|Overall Study|Death|1|||
129062108|NCT02585778|464516587|FG000|Overall Study|Randomized but not treated|1|||
129062109|NCT02585778|464516588|FG001|Overall Study|Randomized but not treated|2|||
129062110|NCT02585778|464516587|FG000|Overall Study|Other than specified above|6|||
129062111|NCT02585778|464516588|FG001|Overall Study|Other than specified above|2|||
129062112|NCT02789137|464516590|FG000|Overall Study|Dropped out/Died|58|||
129062113|NCT01482312|464516593|FG000|Period 1, 90 Minutes of Wear|Other|1|||
129062114|NCT01482312|464516594|FG001|Period 1, 90 Minutes of Wear|Other|0|||
129062115|NCT01482312|464516595|FG002|Period 1, 90 Minutes of Wear|Other|0|||
129062116|NCT01482312|464516593|FG000|Period 2, 90 Minutes of Wear|Other|1|||
129062117|NCT01482312|464516594|FG001|Period 2, 90 Minutes of Wear|Other|0|||
129062118|NCT01482312|464516595|FG002|Period 2, 90 Minutes of Wear|Other|0|||
129062119|NCT03597295|464516597|FG000|Overall Study|Death|70|||
129062120|NCT03597295|464516597|FG000|Overall Study|Lost to Follow-up|7|||
129062121|NCT00428116|464516598|FG000|Overall Study|Death|1|||
129062122|NCT00428116|464516599|FG001|Overall Study|Death|0|||
129062123|NCT00428116|464516598|FG000|Overall Study|Withdrawal by Subject|1|||
129062124|NCT00428116|464516599|FG001|Overall Study|Withdrawal by Subject|0|||
129062125|NCT00428116|464516598|FG000|Overall Study|Lost to Follow-up|1|||
129062126|NCT00428116|464516599|FG001|Overall Study|Lost to Follow-up|0|||
129062127|NCT02125877|464516600|FG000|Overall Study|Physician Decision|1|||
129062128|NCT02125877|464516601|FG001|Overall Study|Physician Decision|0|||
129062129|NCT02125877|464516600|FG000|Overall Study|Death|0|||
129062130|NCT02125877|464516601|FG001|Overall Study|Death|1|||
129062131|NCT02125877|464516600|FG000|Overall Study|Administrative problems|0|||
129062132|NCT02125877|464516601|FG001|Overall Study|Administrative problems|1|||
129062133|NCT02125877|464516600|FG000|Overall Study|Participant/guardian decision|0|||
129062134|NCT02125877|464516601|FG001|Overall Study|Participant/guardian decision|2|||
129062135|NCT02125877|464516600|FG000|Overall Study|Withdrawal by Subject|2|||
129062136|NCT02125877|464516601|FG001|Overall Study|Withdrawal by Subject|1|||
129062137|NCT02125877|464516600|FG000|Overall Study|Protocol deviation|4|||
129062138|NCT02125877|464516601|FG001|Overall Study|Protocol deviation|1|||
129062139|NCT02125877|464516600|FG000|Overall Study|Adverse Event|6|||
129062140|NCT02125877|464516601|FG001|Overall Study|Adverse Event|4|||
129062141|NCT00710866|464516602|FG000|Overall Study|Protocol Violation|5|||
128720442|NCT04762680|463274959|FG020|Phase 3|Adverse Event|0|||
128720443|NCT04762680|463274960|FG021|Phase 3|Adverse Event|0|||
129062142|NCT00710866|464516603|FG001|Overall Study|Protocol Violation|4|||
129062143|NCT00710866|464516602|FG000|Overall Study|Withdrawal by Subject|2|||
129062144|NCT00710866|464516603|FG001|Overall Study|Withdrawal by Subject|1|||
128720444|NCT04762680|463274939|FG000|Phase 3|Protocol Violation|0|||
128720445|NCT04762680|463274940|FG001|Phase 3|Protocol Violation|0|||
128720446|NCT04762680|463274941|FG002|Phase 3|Protocol Violation|0|||
128720447|NCT04762680|463274942|FG003|Phase 3|Protocol Violation|4|||
128720448|NCT04762680|463274943|FG004|Phase 3|Protocol Violation|1|||
128720449|NCT04762680|463274944|FG005|Phase 3|Protocol Violation|5|||
128720450|NCT04762680|463274945|FG006|Phase 3|Protocol Violation|1|||
128720451|NCT04762680|463274946|FG007|Phase 3|Protocol Violation|0|||
128720452|NCT04762680|463274947|FG008|Phase 3|Protocol Violation|0|||
128720453|NCT04762680|463274948|FG009|Phase 3|Protocol Violation|0|||
128720454|NCT04762680|463274949|FG010|Phase 3|Protocol Violation|0|||
128720455|NCT04762680|463274950|FG011|Phase 3|Protocol Violation|2|||
128720456|NCT04762680|463274951|FG012|Phase 3|Protocol Violation|3|||
128720457|NCT04762680|463274952|FG013|Phase 3|Protocol Violation|0|||
128720458|NCT04762680|463274953|FG014|Phase 3|Protocol Violation|0|||
128720459|NCT04762680|463274954|FG015|Phase 3|Protocol Violation|1|||
128720460|NCT04762680|463274955|FG016|Phase 3|Protocol Violation|0|||
128720461|NCT04762680|463274956|FG017|Phase 3|Protocol Violation|10|||
128720462|NCT04762680|463274957|FG018|Phase 3|Protocol Violation|0|||
128720463|NCT04762680|463274958|FG019|Phase 3|Protocol Violation|0|||
128720464|NCT04762680|463274959|FG020|Phase 3|Protocol Violation|0|||
128720465|NCT04762680|463274960|FG021|Phase 3|Protocol Violation|0|||
128720466|NCT04762680|463274939|FG000|Phase 3|Withdrawal by Subject|0|||
128720467|NCT04762680|463274940|FG001|Phase 3|Withdrawal by Subject|0|||
128720468|NCT04762680|463274941|FG002|Phase 3|Withdrawal by Subject|0|||
128720469|NCT04762680|463274942|FG003|Phase 3|Withdrawal by Subject|13|||
128720470|NCT04762680|463274943|FG004|Phase 3|Withdrawal by Subject|17|||
128720471|NCT04762680|463274944|FG005|Phase 3|Withdrawal by Subject|12|||
128720472|NCT04762680|463274945|FG006|Phase 3|Withdrawal by Subject|8|||
128720473|NCT04762680|463274946|FG007|Phase 3|Withdrawal by Subject|3|||
128720474|NCT04762680|463274947|FG008|Phase 3|Withdrawal by Subject|2|||
128720475|NCT04762680|463274948|FG009|Phase 3|Withdrawal by Subject|4|||
128720476|NCT04762680|463274949|FG010|Phase 3|Withdrawal by Subject|3|||
129062145|NCT00710866|464516602|FG000|Overall Study|Lost to Follow-up|1|||
129062146|NCT00710866|464516603|FG001|Overall Study|Lost to Follow-up|0|||
129062147|NCT00710866|464516602|FG000|Overall Study|Failed to meet eligibility|1|||
129062148|NCT00710866|464516603|FG001|Overall Study|Failed to meet eligibility|1|||
129062149|NCT00396565|464516604|FG000|Overall Study|Physician Decision|3|||
129062150|NCT00396565|464516605|FG001|Overall Study|Physician Decision|1|||
129062151|NCT00396565|464516606|FG002|Overall Study|Physician Decision|2|||
129062152|NCT00396565|464516604|FG000|Overall Study|Adverse Event|5|||
129062153|NCT00396565|464516605|FG001|Overall Study|Adverse Event|13|||
129062154|NCT00396565|464516606|FG002|Overall Study|Adverse Event|3|||
129062155|NCT00396565|464516604|FG000|Overall Study|Withdrawal by Subject|8|||
129137228|NCT01181128|464794566|FG001|Overall Study|Withdrawal by Subject|2|||
129137229|NCT01181128|464794567|FG002|Overall Study|Withdrawal by Subject|0|||
129137230|NCT01181128|464794565|FG000|Overall Study|Death|1|||
129137231|NCT01181128|464794566|FG001|Overall Study|Death|0|||
129137232|NCT01181128|464794567|FG002|Overall Study|Death|0|||
129137233|NCT01181128|464794565|FG000|Overall Study|Physician Decision|2|||
129137234|NCT01181128|464794566|FG001|Overall Study|Physician Decision|0|||
129137235|NCT01181128|464794567|FG002|Overall Study|Physician Decision|0|||
129137236|NCT01181128|464794565|FG000|Overall Study|Adverse Event|0|||
129137237|NCT01181128|464794566|FG001|Overall Study|Adverse Event|2|||
129137238|NCT01181128|464794567|FG002|Overall Study|Adverse Event|0|||
129137239|NCT01181128|464794565|FG000|Overall Study|Other|1|||
129137240|NCT01181128|464794566|FG001|Overall Study|Other|1|||
129137241|NCT01181128|464794567|FG002|Overall Study|Other|1|||
129137242|NCT01362270|464794568|FG000|Overall Study|Withdrawal by Subject|1|||
129137243|NCT01362270|464794569|FG001|Overall Study|Withdrawal by Subject|0|||
128720477|NCT04762680|463274950|FG011|Phase 3|Withdrawal by Subject|1|||
128720478|NCT04762680|463274951|FG012|Phase 3|Withdrawal by Subject|3|||
128720479|NCT04762680|463274952|FG013|Phase 3|Withdrawal by Subject|2|||
128720480|NCT04762680|463274953|FG014|Phase 3|Withdrawal by Subject|1|||
128720481|NCT04762680|463274954|FG015|Phase 3|Withdrawal by Subject|4|||
128720482|NCT04762680|463274955|FG016|Phase 3|Withdrawal by Subject|6|||
128720483|NCT04762680|463274956|FG017|Phase 3|Withdrawal by Subject|32|||
129062156|NCT00396565|464516605|FG001|Overall Study|Withdrawal by Subject|13|||
129137244|NCT01362270|464794568|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
128720484|NCT04762680|463274957|FG018|Phase 3|Withdrawal by Subject|0|||
128720485|NCT04762680|463274958|FG019|Phase 3|Withdrawal by Subject|0|||
128720486|NCT04762680|463274959|FG020|Phase 3|Withdrawal by Subject|0|||
128720487|NCT04762680|463274960|FG021|Phase 3|Withdrawal by Subject|0|||
128720488|NCT04762680|463274939|FG000|Phase 3|Lost to Follow-up|0|||
128720489|NCT04762680|463274940|FG001|Phase 3|Lost to Follow-up|0|||
128720490|NCT04762680|463274941|FG002|Phase 3|Lost to Follow-up|0|||
128720491|NCT04762680|463274942|FG003|Phase 3|Lost to Follow-up|9|||
128720492|NCT04762680|463274943|FG004|Phase 3|Lost to Follow-up|22|||
128720493|NCT04762680|463274944|FG005|Phase 3|Lost to Follow-up|24|||
128720494|NCT04762680|463274945|FG006|Phase 3|Lost to Follow-up|2|||
128720495|NCT04762680|463274946|FG007|Phase 3|Lost to Follow-up|4|||
128720496|NCT04762680|463274947|FG008|Phase 3|Lost to Follow-up|6|||
128720497|NCT04762680|463274948|FG009|Phase 3|Lost to Follow-up|4|||
128720498|NCT04762680|463274949|FG010|Phase 3|Lost to Follow-up|3|||
129062157|NCT00396565|464516606|FG002|Overall Study|Withdrawal by Subject|1|||
129062158|NCT00396565|464516604|FG000|Overall Study|Lack of Efficacy|32|||
128720499|NCT04762680|463274950|FG011|Phase 3|Lost to Follow-up|0|||
128720500|NCT04762680|463274951|FG012|Phase 3|Lost to Follow-up|5|||
128775586|NCT01890967|463468387|FG004|Overall Study|Death|0|||
129062159|NCT00396565|464516605|FG001|Overall Study|Lack of Efficacy|64|||
129062160|NCT00396565|464516606|FG002|Overall Study|Lack of Efficacy|11|||
129062161|NCT04324021|464516608|FG000|Overall Study|Adverse Event|1|||
129062162|NCT04324021|464516609|FG001|Overall Study|Adverse Event|0|||
129062163|NCT04324021|464516610|FG002|Overall Study|Adverse Event|0|||
129062164|NCT04324021|464516608|FG000|Overall Study|Lack of Efficacy|0|||
129062165|NCT04324021|464516609|FG001|Overall Study|Lack of Efficacy|0|||
129062166|NCT04324021|464516610|FG002|Overall Study|Lack of Efficacy|1|||
129062167|NCT04324021|464516608|FG000|Overall Study|Death|1|||
129062168|NCT04324021|464516609|FG001|Overall Study|Death|1|||
129062169|NCT04324021|464516610|FG002|Overall Study|Death|0|||
128720501|NCT04762680|463274952|FG013|Phase 3|Lost to Follow-up|4|||
128720502|NCT04762680|463274953|FG014|Phase 3|Lost to Follow-up|6|||
128720503|NCT04762680|463274954|FG015|Phase 3|Lost to Follow-up|1|||
128720504|NCT04762680|463274955|FG016|Phase 3|Lost to Follow-up|1|||
129062170|NCT03097991|464516611|FG000|Overall Study|Didn't meet study criteria|8|||
129062171|NCT03097991|464516612|FG001|Overall Study|Didn't meet study criteria|0|||
129062172|NCT03097991|464516611|FG000|Overall Study|Withdrawal by Subject|12|||
129062173|NCT03097991|464516612|FG001|Overall Study|Withdrawal by Subject|6|||
129062174|NCT03097991|464516611|FG000|Overall Study|Death of Baby|3|||
129062175|NCT03097991|464516612|FG001|Overall Study|Death of Baby|1|||
129062176|NCT03097991|464516611|FG000|Overall Study|Lost to Follow-up|24|||
129062177|NCT03097991|464516612|FG001|Overall Study|Lost to Follow-up|38|||
129062178|NCT03097991|464516611|FG000|Overall Study|Adverse Event|3|||
129062179|NCT03097991|464516612|FG001|Overall Study|Adverse Event|5|||
129062180|NCT00246324|464516613|FG000|Overall Study|Withdrawal by Subject|1|||
129062181|NCT02006732|464516614|FG000|Overall Study|Adverse Event|10|||
129062182|NCT02006732|464516615|FG001|Overall Study|Adverse Event|7|||
129062183|NCT02006732|464516616|FG002|Overall Study|Adverse Event|4|||
129062184|NCT02006732|464516617|FG003|Overall Study|Adverse Event|2|||
129062185|NCT02006732|464516614|FG000|Overall Study|Lack of Efficacy|6|||
129062186|NCT02006732|464516615|FG001|Overall Study|Lack of Efficacy|3|||
129062187|NCT02006732|464516616|FG002|Overall Study|Lack of Efficacy|1|||
129062188|NCT02006732|464516617|FG003|Overall Study|Lack of Efficacy|1|||
129062189|NCT02006732|464516614|FG000|Overall Study|Protocol Violation|1|||
129062190|NCT02006732|464516615|FG001|Overall Study|Protocol Violation|1|||
129062191|NCT02006732|464516616|FG002|Overall Study|Protocol Violation|0|||
129062192|NCT02006732|464516617|FG003|Overall Study|Protocol Violation|0|||
129062193|NCT02006732|464516614|FG000|Overall Study|Lost to Follow-up|0|||
129062194|NCT02006732|464516615|FG001|Overall Study|Lost to Follow-up|1|||
129062195|NCT02006732|464516616|FG002|Overall Study|Lost to Follow-up|0|||
129062196|NCT02006732|464516617|FG003|Overall Study|Lost to Follow-up|0|||
129062197|NCT02006732|464516614|FG000|Overall Study|Withdrawal by Subject|3|||
129062198|NCT02006732|464516615|FG001|Overall Study|Withdrawal by Subject|0|||
129062199|NCT02006732|464516616|FG002|Overall Study|Withdrawal by Subject|4|||
129062200|NCT02006732|464516617|FG003|Overall Study|Withdrawal by Subject|1|||
129062201|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
129062202|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
129062203|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
129062204|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Death|1|||
129062205|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Death|3|||
129062206|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Death|1|||
129062207|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
128775587|NCT01890967|463468388|FG005|Overall Study|Death|0|||
128775588|NCT01890967|463468383|FG000|Overall Study|Lost to Follow-up|1|||
128775589|NCT01890967|463468384|FG001|Overall Study|Lost to Follow-up|1|||
128775590|NCT01890967|463468385|FG002|Overall Study|Lost to Follow-up|1|||
128775591|NCT01890967|463468386|FG003|Overall Study|Lost to Follow-up|1|||
129062208|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
129062209|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
129062210|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
129062211|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
129062212|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
129062213|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
129062214|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
129062215|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
129062216|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
129062217|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
129062218|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
129062219|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
129062220|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
129062221|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
129062222|NCT00299130|464516618|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
129062223|NCT00299130|464516619|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
129062224|NCT00299130|464516620|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
129062225|NCT00299130|464516618|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
129062226|NCT00299130|464516619|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
129062227|NCT00299130|464516620|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
129062228|NCT00299130|464516618|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
129062229|NCT00299130|464516619|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
129062230|NCT00299130|464516620|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
129062231|NCT00299130|464516618|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
129062232|NCT00299130|464516619|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
129062233|NCT00299130|464516620|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
129062234|NCT00299130|464516618|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
129062235|NCT00299130|464516619|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
129062236|NCT00299130|464516620|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
128775592|NCT01890967|463468387|FG004|Overall Study|Lost to Follow-up|0|||
129062237|NCT00299130|464516618|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
129062238|NCT00299130|464516619|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
129062239|NCT00299130|464516620|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
129062240|NCT00299130|464516618|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
129062241|NCT00299130|464516619|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
129062242|NCT00299130|464516620|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
129062243|NCT00299130|464516618|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
129062244|NCT00299130|464516619|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
129062245|NCT00299130|464516620|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
129062246|NCT00299130|464516618|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
129062247|NCT00299130|464516619|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
129062248|NCT00299130|464516620|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
129062249|NCT00299130|464516618|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
129062250|NCT00299130|464516619|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
129062251|NCT00299130|464516620|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
129062252|NCT01198132|464516621|FG000|Overall Study|Withdrawal by Subject|4|||
129062253|NCT01198132|464516622|FG001|Overall Study|Withdrawal by Subject|5|||
129062254|NCT01198132|464516621|FG000|Overall Study|Physician Decision|5|||
129062255|NCT01198132|464516622|FG001|Overall Study|Physician Decision|4|||
129062256|NCT01198132|464516621|FG000|Overall Study|Other Unspecified|3|||
129062257|NCT01198132|464516622|FG001|Overall Study|Other Unspecified|6|||
129062258|NCT01198132|464516621|FG000|Overall Study|Lack of Efficacy|2|||
129062259|NCT01198132|464516622|FG001|Overall Study|Lack of Efficacy|3|||
129062260|NCT01198132|464516621|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
129062261|NCT01198132|464516622|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
129062262|NCT01198132|464516621|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
129062263|NCT01198132|464516622|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
129062264|NCT01198132|464516621|FG000|Overall Study|Adverse Event|0|||
129062265|NCT01198132|464516622|FG001|Overall Study|Adverse Event|1|||
129062266|NCT01198132|464516621|FG000|Overall Study|Protocol Violation|1|||
129062267|NCT01198132|464516622|FG001|Overall Study|Protocol Violation|0|||
129062268|NCT03516513|464516623|FG000|Overall Study|Withdrawal by Subject|2|||
129062269|NCT03516513|464516624|FG001|Overall Study|Withdrawal by Subject|2|||
129062270|NCT03516513|464516625|FG002|Overall Study|Withdrawal by Subject|0|||
129062271|NCT03516513|464516626|FG003|Overall Study|Withdrawal by Subject|0|||
129062272|NCT01098487|464516628|FG000|Overall Study|Adverse Event|22|||
129062273|NCT01098487|464516628|FG000|Overall Study|Lack of Efficacy|11|||
129062274|NCT01098487|464516628|FG000|Overall Study|Withdrawal by Subject|7|||
129062275|NCT01098487|464516628|FG000|Overall Study|Lost to Follow-up|3|||
129062276|NCT01098487|464516628|FG000|Overall Study|Physician Decision|1|||
129062277|NCT00345631|464516629|FG000|Overall Study|Withdrawal by Subject|1|||
129062278|NCT00345631|464516630|FG001|Overall Study|Withdrawal by Subject|0|||
129062279|NCT00345631|464516631|FG002|Overall Study|Withdrawal by Subject|1|||
129062280|NCT00345631|464516629|FG000|Overall Study|Adverse Event|0|||
129062281|NCT00345631|464516630|FG001|Overall Study|Adverse Event|1|||
129062282|NCT00345631|464516631|FG002|Overall Study|Adverse Event|0|||
129062283|NCT00345631|464516629|FG000|Overall Study|Lost to Follow-up|3|||
129062284|NCT00345631|464516630|FG001|Overall Study|Lost to Follow-up|7|||
129062285|NCT00345631|464516631|FG002|Overall Study|Lost to Follow-up|4|||
129062286|NCT00345631|464516629|FG000|Overall Study|Other reasons|0|||
129062287|NCT00345631|464516630|FG001|Overall Study|Other reasons|0|||
129062288|NCT00345631|464516631|FG002|Overall Study|Other reasons|1|||
129062289|NCT01301729|464516632|FG000|Overall Study|Withdrawal by Subject|2|||
129062290|NCT01301729|464516632|FG000|Overall Study|Participant did not Return for Treatment|1|||
129062291|NCT01301729|464516632|FG000|Overall Study|Violated Selection Criteria|1|||
129062292|NCT03071276|464516633|FG000|Overall Study|Adverse Event|1|||
129062293|NCT03071276|464516633|FG000|Overall Study|Lack of Efficacy|14|||
129062294|NCT01885195|464516634|FG000|Overall Study|Adverse Event|29|||
129062295|NCT01885195|464516634|FG000|Overall Study|Death|1|||
129062296|NCT01885195|464516634|FG000|Overall Study|Disease Progression|67|||
129062297|NCT01885195|464516634|FG000|Overall Study|Protocol Deviation|2|||
129062298|NCT01885195|464516634|FG000|Overall Study|Physician Decision|3|||
129062299|NCT01885195|464516634|FG000|Overall Study|Patient/guardian decision|8|||
129062300|NCT03390426|464516635|FG000|Overall Study|Protocol Violation|0|||
129062301|NCT03390426|464516636|FG001|Overall Study|Protocol Violation|1|||
129062302|NCT00548093|464516641|FG000|Overall Study|Death|33|||
129062303|NCT00548093|464516642|FG001|Overall Study|Death|13|||
129062304|NCT00548093|464516641|FG000|Overall Study|Lost to Follow-up|3|||
129062305|NCT00548093|464516642|FG001|Overall Study|Lost to Follow-up|1|||
129062306|NCT00548093|464516641|FG000|Overall Study|Objective progression or relapse|1|||
129062307|NCT00548093|464516642|FG001|Overall Study|Objective progression or relapse|1|||
129062308|NCT00548093|464516641|FG000|Overall Study|Other|11|||
129062309|NCT00548093|464516642|FG001|Overall Study|Other|1|||
129062310|NCT00548093|464516641|FG000|Overall Study|Withdrawal by Subject|1|||
129062311|NCT00548093|464516642|FG001|Overall Study|Withdrawal by Subject|0|||
129062312|NCT00548093|464516641|FG000|Overall Study|Completed post-treatment follow-up|1|||
129062313|NCT00548093|464516642|FG001|Overall Study|Completed post-treatment follow-up|0|||
129062314|NCT02924727|464516643|FG000|Overall Study|Withdrawal by Subject|2|||
129062315|NCT02924727|464516644|FG001|Overall Study|Withdrawal by Subject|4|||
129062316|NCT02924727|464516643|FG000|Overall Study|Lost to Follow-up|2|||
129062317|NCT02924727|464516644|FG001|Overall Study|Lost to Follow-up|5|||
129062318|NCT02924727|464516643|FG000|Overall Study|Death|221|||
129062319|NCT02924727|464516644|FG001|Overall Study|Death|247|||
129062320|NCT02924727|464516643|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
129062321|NCT02924727|464516644|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
129062322|NCT00509795|464516651|FG000|Overall Study|Adverse Event|4|||
129062323|NCT00509795|464516652|FG001|Overall Study|Adverse Event|3|||
129062324|NCT00509795|464516653|FG002|Overall Study|Adverse Event|5|||
129062325|NCT00509795|464516654|FG003|Overall Study|Adverse Event|4|||
129062326|NCT00509795|464516651|FG000|Overall Study|Death|3|||
129062327|NCT00509795|464516652|FG001|Overall Study|Death|1|||
129062328|NCT00509795|464516653|FG002|Overall Study|Death|2|||
129062329|NCT00509795|464516654|FG003|Overall Study|Death|7|||
129062330|NCT00509795|464516651|FG000|Overall Study|Lack of Efficacy|0|||
129062331|NCT00509795|464516652|FG001|Overall Study|Lack of Efficacy|0|||
129062332|NCT00509795|464516653|FG002|Overall Study|Lack of Efficacy|2|||
129062333|NCT00509795|464516654|FG003|Overall Study|Lack of Efficacy|2|||
129062334|NCT00509795|464516651|FG000|Overall Study|Lost to Follow-up|1|||
129062335|NCT00509795|464516652|FG001|Overall Study|Lost to Follow-up|2|||
129062336|NCT00509795|464516653|FG002|Overall Study|Lost to Follow-up|4|||
129062337|NCT00509795|464516654|FG003|Overall Study|Lost to Follow-up|4|||
129062338|NCT00509795|464516651|FG000|Overall Study|OTHER|1|||
129062339|NCT00509795|464516652|FG001|Overall Study|OTHER|0|||
129062340|NCT00509795|464516653|FG002|Overall Study|OTHER|4|||
129062341|NCT00509795|464516654|FG003|Overall Study|OTHER|1|||
129062342|NCT00509795|464516651|FG000|Overall Study|Protocol Violation|3|||
129062343|NCT00509795|464516652|FG001|Overall Study|Protocol Violation|0|||
129062344|NCT00509795|464516653|FG002|Overall Study|Protocol Violation|3|||
129062345|NCT00509795|464516654|FG003|Overall Study|Protocol Violation|1|||
129062346|NCT00509795|464516651|FG000|Overall Study|Withdrawal by Subject|10|||
129062347|NCT00509795|464516652|FG001|Overall Study|Withdrawal by Subject|5|||
129062348|NCT00509795|464516653|FG002|Overall Study|Withdrawal by Subject|7|||
129062349|NCT00509795|464516654|FG003|Overall Study|Withdrawal by Subject|8|||
129062350|NCT04386616|464516660|FG000|Overall Study|Death|22|||
129062351|NCT04386616|464516661|FG001|Overall Study|Death|22|||
129062352|NCT04386616|464516662|FG002|Overall Study|Death|21|||
129062353|NCT04386616|464516660|FG000|Overall Study|Lost to Follow-up|5|||
129062354|NCT04386616|464516661|FG001|Overall Study|Lost to Follow-up|8|||
129062355|NCT04386616|464516662|FG002|Overall Study|Lost to Follow-up|6|||
129062356|NCT04386616|464516660|FG000|Overall Study|Withdrawal by Subject|2|||
129062357|NCT04386616|464516661|FG001|Overall Study|Withdrawal by Subject|4|||
129062358|NCT04386616|464516662|FG002|Overall Study|Withdrawal by Subject|1|||
129062359|NCT04386616|464516660|FG000|Overall Study|Adverse Event|1|||
129062360|NCT04386616|464516661|FG001|Overall Study|Adverse Event|1|||
129062361|NCT04386616|464516662|FG002|Overall Study|Adverse Event|0|||
129062362|NCT02759692|464516663|FG000|Period 1|Test article no longer available|1|||
129062363|NCT02759692|464516664|FG001|Period 1|Test article no longer available|1|||
129062364|NCT02759692|464516663|FG000|Period 1|No longer meets eligibility criteria.|1|||
129062365|NCT02759692|464516664|FG001|Period 1|No longer meets eligibility criteria.|0|||
129062366|NCT02759692|464516663|FG000|Period 1|Miss-Randomized|1|||
129062367|NCT02759692|464516664|FG001|Period 1|Miss-Randomized|1|||
129062368|NCT02759692|464516663|FG000|Period 2|Lost to Follow-up|1|||
129062369|NCT02759692|464516664|FG001|Period 2|Lost to Follow-up|0|||
129062370|NCT02759692|464516663|FG000|Period 2|Test article no longer available|0|||
129062371|NCT02759692|464516664|FG001|Period 2|Test article no longer available|1|||
129062372|NCT00451178|464516665|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
129062373|NCT00451178|464516666|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
129062374|NCT00451178|464516665|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
129062375|NCT00451178|464516666|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
129062376|NCT00451178|464516665|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
129062377|NCT00451178|464516666|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
128720505|NCT04762680|463274956|FG017|Phase 3|Lost to Follow-up|66|||
129062378|NCT00451178|464516665|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
129062379|NCT00451178|464516666|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
129062380|NCT00451178|464516665|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
129062381|NCT00451178|464516666|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
129062382|NCT00451178|464516665|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
129062383|NCT00451178|464516666|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
129062384|NCT00451178|464516665|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
129062385|NCT00451178|464516666|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
129062386|NCT00451178|464516665|FG000|Prior to Maintenance Therapy|PD|2|||
129062387|NCT00451178|464516666|FG001|Prior to Maintenance Therapy|PD|0|||
128720506|NCT04762680|463274957|FG018|Phase 3|Lost to Follow-up|0|||
128720507|NCT04762680|463274958|FG019|Phase 3|Lost to Follow-up|0|||
128720508|NCT04762680|463274959|FG020|Phase 3|Lost to Follow-up|0|||
128720509|NCT04762680|463274960|FG021|Phase 3|Lost to Follow-up|0|||
128775593|NCT01890967|463468388|FG005|Overall Study|Lost to Follow-up|1|||
128720510|NCT04762680|463274939|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720511|NCT04762680|463274940|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720512|NCT04762680|463274941|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720513|NCT04762680|463274942|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720514|NCT04762680|463274943|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720515|NCT04762680|463274944|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720516|NCT04762680|463274945|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720517|NCT04762680|463274946|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720518|NCT04762680|463274947|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720519|NCT04762680|463274948|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720520|NCT04762680|463274949|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720521|NCT04762680|463274950|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720522|NCT04762680|463274951|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720523|NCT04762680|463274952|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720524|NCT04762680|463274953|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720525|NCT04762680|463274954|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720526|NCT04762680|463274955|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720527|NCT04762680|463274956|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720528|NCT04762680|463274957|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720529|NCT04762680|463274958|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720530|NCT04762680|463274959|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
128720531|NCT04762680|463274960|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
128720532|NCT04762680|463274939|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720533|NCT04762680|463274940|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720534|NCT04762680|463274941|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720535|NCT04762680|463274942|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720536|NCT04762680|463274943|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720537|NCT04762680|463274944|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720538|NCT04762680|463274945|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720539|NCT04762680|463274946|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720540|NCT04762680|463274947|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720541|NCT04762680|463274948|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720542|NCT04762680|463274949|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
129062388|NCT00451178|464516665|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
129062389|NCT00451178|464516666|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
129062390|NCT00451178|464516665|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
129062391|NCT00451178|464516666|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
129062392|NCT00451178|464516665|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
129062393|NCT00451178|464516666|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
129062394|NCT00451178|464516665|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
128720543|NCT04762680|463274950|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
128775594|NCT01890967|463468383|FG000|Overall Study|Protocol Violation|0|||
129062395|NCT00451178|464516666|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
129062396|NCT00451178|464516665|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
129062397|NCT00451178|464516666|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
129062398|NCT00451178|464516665|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
129062399|NCT00451178|464516666|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
129062400|NCT00451178|464516665|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
129062401|NCT00451178|464516666|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
129062402|NCT02447744|464516669|FG000|Overall Study|Withdrawal by Subject|3|||
128775595|NCT01890967|463468384|FG001|Overall Study|Protocol Violation|3|||
128720544|NCT04762680|463274951|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720545|NCT04762680|463274952|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720546|NCT04762680|463274953|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720547|NCT04762680|463274954|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
129062403|NCT02447744|464516670|FG001|Overall Study|Withdrawal by Subject|1|||
129062404|NCT02447744|464516669|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
129062405|NCT02447744|464516670|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
129062406|NCT03207867|464516671|FG000|Overall Study|Adverse Event|1|||
129062407|NCT03207867|464516672|FG001|Overall Study|Adverse Event|0|||
129062408|NCT03207867|464516673|FG002|Overall Study|Adverse Event|1|||
129062409|NCT03207867|464516674|FG003|Overall Study|Adverse Event|0|||
129062410|NCT03207867|464516675|FG004|Overall Study|Adverse Event|0|||
129062411|NCT03207867|464516676|FG005|Overall Study|Adverse Event|2|||
129062412|NCT03207867|464516677|FG006|Overall Study|Adverse Event|1|||
129062413|NCT03207867|464516678|FG007|Overall Study|Adverse Event|1|||
129062414|NCT03207867|464516679|FG008|Overall Study|Adverse Event|2|||
129062415|NCT03207867|464516680|FG009|Overall Study|Adverse Event|2|||
129062416|NCT03207867|464516681|FG010|Overall Study|Adverse Event|0|||
129062417|NCT03207867|464516682|FG011|Overall Study|Adverse Event|0|||
129062418|NCT03207867|464516683|FG012|Overall Study|Adverse Event|0|||
129062419|NCT03207867|464516684|FG013|Overall Study|Adverse Event|0|||
129062420|NCT03207867|464516685|FG014|Overall Study|Adverse Event|0|||
129062421|NCT03207867|464516686|FG015|Overall Study|Adverse Event|0|||
129062422|NCT03207867|464516687|FG016|Overall Study|Adverse Event|3|||
129062423|NCT03207867|464516688|FG017|Overall Study|Adverse Event|1|||
129062424|NCT03207867|464516689|FG018|Overall Study|Adverse Event|2|||
129062425|NCT03207867|464516690|FG019|Overall Study|Adverse Event|1|||
129062426|NCT03207867|464516691|FG020|Overall Study|Adverse Event|0|||
129062427|NCT03207867|464516692|FG021|Overall Study|Adverse Event|0|||
129062428|NCT03207867|464516693|FG022|Overall Study|Adverse Event|0|||
129062429|NCT03207867|464516694|FG023|Overall Study|Adverse Event|0|||
129062430|NCT03207867|464516671|FG000|Overall Study|Death|0|||
129062431|NCT03207867|464516672|FG001|Overall Study|Death|0|||
129062432|NCT03207867|464516673|FG002|Overall Study|Death|0|||
129062433|NCT03207867|464516674|FG003|Overall Study|Death|0|||
129062434|NCT03207867|464516675|FG004|Overall Study|Death|0|||
129062435|NCT03207867|464516676|FG005|Overall Study|Death|1|||
129062436|NCT03207867|464516677|FG006|Overall Study|Death|0|||
129062437|NCT03207867|464516678|FG007|Overall Study|Death|3|||
129062438|NCT03207867|464516679|FG008|Overall Study|Death|1|||
129062439|NCT03207867|464516680|FG009|Overall Study|Death|2|||
129062440|NCT03207867|464516681|FG010|Overall Study|Death|0|||
129062441|NCT03207867|464516682|FG011|Overall Study|Death|1|||
129062442|NCT03207867|464516683|FG012|Overall Study|Death|0|||
129062443|NCT03207867|464516684|FG013|Overall Study|Death|1|||
129062444|NCT03207867|464516685|FG014|Overall Study|Death|0|||
129062445|NCT03207867|464516686|FG015|Overall Study|Death|0|||
129062446|NCT03207867|464516687|FG016|Overall Study|Death|0|||
129062447|NCT03207867|464516688|FG017|Overall Study|Death|2|||
129062448|NCT03207867|464516689|FG018|Overall Study|Death|0|||
129062449|NCT03207867|464516690|FG019|Overall Study|Death|1|||
129062450|NCT03207867|464516691|FG020|Overall Study|Death|0|||
129062451|NCT03207867|464516692|FG021|Overall Study|Death|0|||
129062452|NCT03207867|464516693|FG022|Overall Study|Death|0|||
129062453|NCT03207867|464516694|FG023|Overall Study|Death|0|||
129062454|NCT03207867|464516671|FG000|Overall Study|Physician Decision|3|||
129062455|NCT03207867|464516672|FG001|Overall Study|Physician Decision|5|||
129062456|NCT03207867|464516673|FG002|Overall Study|Physician Decision|0|||
129062457|NCT03207867|464516674|FG003|Overall Study|Physician Decision|3|||
129062458|NCT03207867|464516675|FG004|Overall Study|Physician Decision|2|||
129062459|NCT03207867|464516676|FG005|Overall Study|Physician Decision|0|||
129062460|NCT03207867|464516677|FG006|Overall Study|Physician Decision|0|||
129062461|NCT03207867|464516678|FG007|Overall Study|Physician Decision|0|||
129062462|NCT03207867|464516679|FG008|Overall Study|Physician Decision|4|||
129062463|NCT03207867|464516680|FG009|Overall Study|Physician Decision|2|||
129062464|NCT03207867|464516681|FG010|Overall Study|Physician Decision|0|||
129062465|NCT03207867|464516682|FG011|Overall Study|Physician Decision|4|||
129062466|NCT03207867|464516683|FG012|Overall Study|Physician Decision|0|||
129062467|NCT03207867|464516684|FG013|Overall Study|Physician Decision|0|||
129062468|NCT03207867|464516685|FG014|Overall Study|Physician Decision|2|||
129062469|NCT03207867|464516686|FG015|Overall Study|Physician Decision|1|||
129062470|NCT03207867|464516687|FG016|Overall Study|Physician Decision|1|||
129062471|NCT03207867|464516688|FG017|Overall Study|Physician Decision|2|||
129062472|NCT03207867|464516689|FG018|Overall Study|Physician Decision|1|||
129062473|NCT03207867|464516690|FG019|Overall Study|Physician Decision|3|||
129062474|NCT03207867|464516691|FG020|Overall Study|Physician Decision|0|||
129062475|NCT03207867|464516692|FG021|Overall Study|Physician Decision|0|||
129062476|NCT03207867|464516693|FG022|Overall Study|Physician Decision|0|||
129062477|NCT03207867|464516694|FG023|Overall Study|Physician Decision|0|||
129062478|NCT03207867|464516671|FG000|Overall Study|Progressive Disease|7|||
129062479|NCT03207867|464516672|FG001|Overall Study|Progressive Disease|7|||
129062480|NCT03207867|464516673|FG002|Overall Study|Progressive Disease|9|||
129062481|NCT03207867|464516674|FG003|Overall Study|Progressive Disease|10|||
129062482|NCT03207867|464516675|FG004|Overall Study|Progressive Disease|11|||
129062483|NCT03207867|464516676|FG005|Overall Study|Progressive Disease|10|||
129062484|NCT03207867|464516677|FG006|Overall Study|Progressive Disease|9|||
129062485|NCT03207867|464516678|FG007|Overall Study|Progressive Disease|8|||
129062486|NCT03207867|464516679|FG008|Overall Study|Progressive Disease|19|||
129062487|NCT03207867|464516680|FG009|Overall Study|Progressive Disease|23|||
129062488|NCT03207867|464516681|FG010|Overall Study|Progressive Disease|2|||
129062489|NCT03207867|464516682|FG011|Overall Study|Progressive Disease|24|||
129062490|NCT03207867|464516683|FG012|Overall Study|Progressive Disease|3|||
129062491|NCT03207867|464516684|FG013|Overall Study|Progressive Disease|11|||
129062492|NCT03207867|464516685|FG014|Overall Study|Progressive Disease|9|||
129062493|NCT03207867|464516686|FG015|Overall Study|Progressive Disease|5|||
129062494|NCT03207867|464516687|FG016|Overall Study|Progressive Disease|10|||
129062495|NCT03207867|464516688|FG017|Overall Study|Progressive Disease|14|||
129062496|NCT03207867|464516689|FG018|Overall Study|Progressive Disease|13|||
129062497|NCT03207867|464516690|FG019|Overall Study|Progressive Disease|14|||
129062498|NCT03207867|464516691|FG020|Overall Study|Progressive Disease|6|||
129062499|NCT03207867|464516692|FG021|Overall Study|Progressive Disease|3|||
129062500|NCT03207867|464516693|FG022|Overall Study|Progressive Disease|3|||
129062501|NCT03207867|464516694|FG023|Overall Study|Progressive Disease|3|||
129062502|NCT03207867|464516671|FG000|Overall Study|Patient/guardian Decision|0|||
129062503|NCT03207867|464516672|FG001|Overall Study|Patient/guardian Decision|0|||
129062504|NCT03207867|464516673|FG002|Overall Study|Patient/guardian Decision|1|||
129062505|NCT03207867|464516674|FG003|Overall Study|Patient/guardian Decision|1|||
129062506|NCT03207867|464516675|FG004|Overall Study|Patient/guardian Decision|1|||
129062507|NCT03207867|464516676|FG005|Overall Study|Patient/guardian Decision|2|||
129062508|NCT03207867|464516677|FG006|Overall Study|Patient/guardian Decision|1|||
129062509|NCT03207867|464516678|FG007|Overall Study|Patient/guardian Decision|0|||
129062510|NCT03207867|464516679|FG008|Overall Study|Patient/guardian Decision|1|||
129062511|NCT03207867|464516680|FG009|Overall Study|Patient/guardian Decision|0|||
129062512|NCT03207867|464516681|FG010|Overall Study|Patient/guardian Decision|0|||
129062513|NCT03207867|464516682|FG011|Overall Study|Patient/guardian Decision|1|||
129062514|NCT03207867|464516683|FG012|Overall Study|Patient/guardian Decision|0|||
129062515|NCT03207867|464516684|FG013|Overall Study|Patient/guardian Decision|1|||
129062516|NCT03207867|464516685|FG014|Overall Study|Patient/guardian Decision|2|||
129062517|NCT03207867|464516686|FG015|Overall Study|Patient/guardian Decision|0|||
129062518|NCT03207867|464516687|FG016|Overall Study|Patient/guardian Decision|1|||
129062519|NCT03207867|464516688|FG017|Overall Study|Patient/guardian Decision|3|||
129062520|NCT03207867|464516689|FG018|Overall Study|Patient/guardian Decision|4|||
129062521|NCT03207867|464516690|FG019|Overall Study|Patient/guardian Decision|1|||
129062522|NCT03207867|464516691|FG020|Overall Study|Patient/guardian Decision|0|||
129062523|NCT03207867|464516692|FG021|Overall Study|Patient/guardian Decision|0|||
129062524|NCT03207867|464516693|FG022|Overall Study|Patient/guardian Decision|0|||
129062525|NCT03207867|464516694|FG023|Overall Study|Patient/guardian Decision|0|||
129062526|NCT00912912|464516695|FG000|Overall Study|Withdrawal by Subject|1|||
129062527|NCT00912912|464516695|FG000|Overall Study|Disease Progression|3|||
129062528|NCT00306995|464516696|FG000|Study Part I|Withdrawal by Subject|0|||
129062529|NCT00306995|464516697|FG001|Study Part I|Withdrawal by Subject|0|||
129062530|NCT00306995|464516698|FG002|Study Part I|Withdrawal by Subject|0|||
129062531|NCT00306995|464516699|FG003|Study Part I|Withdrawal by Subject|0|||
129062532|NCT00306995|464516700|FG004|Study Part I|Withdrawal by Subject|0|||
129062533|NCT00306995|464516701|FG005|Study Part I|Withdrawal by Subject|0|||
129062534|NCT00306995|464516702|FG006|Study Part I|Withdrawal by Subject|1|||
129062535|NCT00306995|464516696|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
129062536|NCT00306995|464516697|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
129062537|NCT00306995|464516698|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
129062538|NCT00306995|464516699|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
129062539|NCT00306995|464516700|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
129062540|NCT00306995|464516701|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
129062541|NCT00306995|464516702|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
129062542|NCT05422625|464516703|FG000|Overall Study|Withdrawal by Subject|1|||
129062543|NCT05422625|464516704|FG001|Overall Study|Withdrawal by Subject|0|||
129062544|NCT04324073|464518566|FG000|Overall Study|withdrew consent|0|||
129062545|NCT04324073|464518567|FG001|Overall Study|withdrew consent|4|||
129062546|NCT04324073|464518568|FG002|Overall Study|withdrew consent|2|||
129062547|NCT04324073|464518569|FG003|Overall Study|withdrew consent|8|||
129062548|NCT02506153|464518570|FG000|Overall Study|Adverse Event|359|||
129062549|NCT02506153|464518571|FG001|Overall Study|Adverse Event|114|||
129062550|NCT02506153|464518570|FG000|Overall Study|Refused unrelated to adverse event|127|||
129062551|NCT02506153|464518571|FG001|Overall Study|Refused unrelated to adverse event|18|||
129062552|NCT02506153|464518570|FG000|Overall Study|Progression/relapse|91|||
129062553|NCT02506153|464518571|FG001|Overall Study|Progression/relapse|136|||
129062554|NCT02506153|464518570|FG000|Overall Study|Death|2|||
129062555|NCT02506153|464518571|FG001|Overall Study|Death|1|||
129062556|NCT02506153|464518570|FG000|Overall Study|Other - not protocol specified|23|||
129062557|NCT02506153|464518571|FG001|Overall Study|Other - not protocol specified|12|||
129062558|NCT01277601|464518574|FG000|Overall Study|Adverse Event|5|||
129062559|NCT01277601|464518575|FG001|Overall Study|Adverse Event|3|||
129062560|NCT01277601|464518576|FG002|Overall Study|Adverse Event|0|||
129062561|NCT01277601|464518577|FG003|Overall Study|Adverse Event|7|||
129062562|NCT01277601|464518574|FG000|Overall Study|Withdrawal by Subject|18|||
128720548|NCT04762680|463274955|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
129062563|NCT01277601|464518575|FG001|Overall Study|Withdrawal by Subject|21|||
129062564|NCT01277601|464518576|FG002|Overall Study|Withdrawal by Subject|8|||
129062565|NCT01277601|464518577|FG003|Overall Study|Withdrawal by Subject|17|||
129062566|NCT01277601|464518574|FG000|Overall Study|Lost to Follow-up|7|||
129062567|NCT01277601|464518575|FG001|Overall Study|Lost to Follow-up|9|||
129062568|NCT01277601|464518576|FG002|Overall Study|Lost to Follow-up|4|||
129062569|NCT01277601|464518577|FG003|Overall Study|Lost to Follow-up|2|||
129062570|NCT01277601|464518574|FG000|Overall Study|Physician Decision|3|||
129062571|NCT01277601|464518575|FG001|Overall Study|Physician Decision|5|||
129062572|NCT01277601|464518576|FG002|Overall Study|Physician Decision|1|||
129062573|NCT01277601|464518577|FG003|Overall Study|Physician Decision|6|||
129062574|NCT01277601|464518574|FG000|Overall Study|Pregnancy|2|||
129062575|NCT01277601|464518575|FG001|Overall Study|Pregnancy|2|||
129062576|NCT01277601|464518576|FG002|Overall Study|Pregnancy|4|||
129062577|NCT01277601|464518577|FG003|Overall Study|Pregnancy|1|||
129062578|NCT01277601|464518574|FG000|Overall Study|Noncompliance with Study Drug|1|||
129062579|NCT01277601|464518575|FG001|Overall Study|Noncompliance with Study Drug|3|||
129062580|NCT01277601|464518576|FG002|Overall Study|Noncompliance with Study Drug|2|||
129062581|NCT01277601|464518577|FG003|Overall Study|Noncompliance with Study Drug|0|||
129062582|NCT01277601|464518574|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
129062583|NCT01277601|464518575|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
129062584|NCT01277601|464518576|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
129062585|NCT01277601|464518577|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
129062586|NCT01277601|464518574|FG000|Overall Study|Protocol Violation|0|||
129062587|NCT01277601|464518575|FG001|Overall Study|Protocol Violation|2|||
129062588|NCT01277601|464518576|FG002|Overall Study|Protocol Violation|5|||
129062589|NCT01277601|464518577|FG003|Overall Study|Protocol Violation|0|||
129062590|NCT01277601|464518574|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
129062591|NCT01277601|464518575|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
129062592|NCT01277601|464518576|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
129062593|NCT01277601|464518577|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
129062594|NCT03842228|464518578|FG000|Overall Study|Adverse Event|1|||
129062595|NCT03842228|464518579|FG001|Overall Study|Adverse Event|1|||
129062596|NCT03842228|464518580|FG002|Overall Study|Adverse Event|1|||
129062597|NCT03842228|464518581|FG003|Overall Study|Adverse Event|0|||
129062598|NCT03842228|464518582|FG004|Overall Study|Adverse Event|0|||
129062599|NCT03842228|464518583|FG005|Overall Study|Adverse Event|0|||
129062600|NCT03842228|464518584|FG006|Overall Study|Adverse Event|0|||
129062601|NCT03842228|464518578|FG000|Overall Study|Death|0|||
129062602|NCT03842228|464518579|FG001|Overall Study|Death|1|||
129062603|NCT03842228|464518580|FG002|Overall Study|Death|0|||
129062604|NCT03842228|464518581|FG003|Overall Study|Death|0|||
129062605|NCT03842228|464518582|FG004|Overall Study|Death|0|||
129062606|NCT03842228|464518583|FG005|Overall Study|Death|0|||
129062607|NCT03842228|464518584|FG006|Overall Study|Death|0|||
129062608|NCT03842228|464518578|FG000|Overall Study|Withdrawal by Subject|0|||
129062609|NCT03842228|464518579|FG001|Overall Study|Withdrawal by Subject|0|||
129062610|NCT03842228|464518580|FG002|Overall Study|Withdrawal by Subject|2|||
129062611|NCT03842228|464518581|FG003|Overall Study|Withdrawal by Subject|1|||
129062612|NCT03842228|464518582|FG004|Overall Study|Withdrawal by Subject|0|||
129062613|NCT03842228|464518583|FG005|Overall Study|Withdrawal by Subject|0|||
129062614|NCT03842228|464518584|FG006|Overall Study|Withdrawal by Subject|2|||
129062615|NCT03842228|464518578|FG000|Overall Study|Progression|8|||
129062616|NCT03842228|464518579|FG001|Overall Study|Progression|1|||
129062617|NCT03842228|464518580|FG002|Overall Study|Progression|7|||
129062618|NCT03842228|464518581|FG003|Overall Study|Progression|5|||
129062619|NCT03842228|464518582|FG004|Overall Study|Progression|4|||
129062620|NCT03842228|464518583|FG005|Overall Study|Progression|2|||
129062621|NCT03842228|464518584|FG006|Overall Study|Progression|3|||
129062622|NCT02291510|464518585|FG000|Overall Study|Adverse Event|0|||
129062623|NCT02291510|464518586|FG001|Overall Study|Adverse Event|0|||
129062624|NCT02291510|464518587|FG002|Overall Study|Adverse Event|0|||
129062625|NCT02291510|464518588|FG003|Overall Study|Adverse Event|1|||
129062626|NCT06390839|464518589|FG000|Overall Study|Ineligible|2|||
129062627|NCT06390839|464518589|FG000|Overall Study|Never start protocol therapy|3|||
129062628|NCT06390839|464518589|FG000|Overall Study|Adverse Event|1|||
128720549|NCT04762680|463274956|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
129062629|NCT06390839|464518589|FG000|Overall Study|Alternative therapy|2|||
129062630|NCT06390839|464518589|FG000|Overall Study|Death|3|||
129062631|NCT06390839|464518589|FG000|Overall Study|Disease progression|28|||
129062632|NCT06390839|464518589|FG000|Overall Study|Withdrawal by Subject|2|||
129062633|NCT06390839|464518589|FG000|Overall Study|Complicating disease|1|||
129062634|NCT06390839|464518589|FG000|Overall Study|Noncompliance|1|||
129062635|NCT04458922|464518590|FG000|Overall Study|Withdrawal by Subject|1|||
129062636|NCT04458922|464518591|FG001|Overall Study|Withdrawal by Subject|0|||
129062637|NCT04458922|464518592|FG002|Overall Study|Withdrawal by Subject|2|||
129062638|NCT04458922|464518590|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
129062639|NCT04458922|464518591|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
129062640|NCT04458922|464518592|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
129062641|NCT04458922|464518590|FG000|Overall Study|Adverse Event|1|||
129062642|NCT04458922|464518591|FG001|Overall Study|Adverse Event|0|||
129062643|NCT04458922|464518592|FG002|Overall Study|Adverse Event|0|||
129062644|NCT04458922|464518590|FG000|Overall Study|Started new study|0|||
129062645|NCT04458922|464518591|FG001|Overall Study|Started new study|0|||
129062646|NCT04458922|464518592|FG002|Overall Study|Started new study|1|||
129062647|NCT04458922|464518590|FG000|Overall Study|Progressive disease|6|||
129062648|NCT04458922|464518591|FG001|Overall Study|Progressive disease|8|||
129062649|NCT04458922|464518592|FG002|Overall Study|Progressive disease|2|||
129062650|NCT04458922|464518590|FG000|Overall Study|Death|1|||
129062651|NCT04458922|464518591|FG001|Overall Study|Death|0|||
129062652|NCT04458922|464518592|FG002|Overall Study|Death|2|||
129062653|NCT04458922|464518590|FG000|Overall Study|Participant started chemotherapy|0|||
129062654|NCT04458922|464518591|FG001|Overall Study|Participant started chemotherapy|1|||
129062655|NCT04458922|464518592|FG002|Overall Study|Participant started chemotherapy|0|||
129062656|NCT03203850|464518593|FG000|Overall Study|Subject/guardian decision|4|||
129062657|NCT03203850|464518594|FG001|Overall Study|Subject/guardian decision|3|||
129062658|NCT03203850|464518593|FG000|Overall Study|Adverse Event|3|||
129062659|NCT03203850|464518594|FG001|Overall Study|Adverse Event|0|||
129062660|NCT03203850|464518593|FG000|Overall Study|Death|1|||
129062661|NCT03203850|464518594|FG001|Overall Study|Death|0|||
129062662|NCT01272037|464518595|FG000|Overall Study|Death|25|||
129062663|NCT01272037|464518596|FG001|Overall Study|Death|28|||
128720550|NCT04762680|463274957|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720551|NCT04762680|463274958|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
129062664|NCT01272037|464518595|FG000|Overall Study|Adverse Event|12|||
129062665|NCT01272037|464518596|FG001|Overall Study|Adverse Event|7|||
129062666|NCT01272037|464518595|FG000|Overall Study|Withdrawal by Subject|175|||
129062667|NCT01272037|464518596|FG001|Overall Study|Withdrawal by Subject|93|||
129062668|NCT01272037|464518595|FG000|Overall Study|Disease progression|70|||
129062669|NCT01272037|464518596|FG001|Overall Study|Disease progression|111|||
129062670|NCT01272037|464518595|FG000|Overall Study|Other reason|42|||
129062671|NCT01272037|464518596|FG001|Overall Study|Other reason|41|||
129062672|NCT01272037|464518595|FG000|Overall Study|Delinquent data|24|||
129062673|NCT01272037|464518596|FG001|Overall Study|Delinquent data|19|||
128720552|NCT04762680|463274959|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
129062674|NCT01272037|464518595|FG000|Overall Study|Reason under review|33|||
129062675|NCT01272037|464518596|FG001|Overall Study|Reason under review|29|||
129062676|NCT01272037|464518595|FG000|Overall Study|On treatment|626|||
129062677|NCT01272037|464518596|FG001|Overall Study|On treatment|632|||
129062678|NCT04856930|464518597|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
128720553|NCT04762680|463274960|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
128720554|NCT02520011|463274964|FG000|Overall Study|Adverse Event|0|||
128720555|NCT02520011|463274965|FG001|Overall Study|Adverse Event|1|||
128720556|NCT02520011|463274966|FG002|Overall Study|Adverse Event|2|||
128720557|NCT02520011|463274964|FG000|Overall Study|Death|0|||
128720558|NCT02520011|463274965|FG001|Overall Study|Death|8|||
128720559|NCT02520011|463274966|FG002|Overall Study|Death|1|||
128720560|NCT02520011|463274964|FG000|Overall Study|Lack of Efficacy|4|||
128720561|NCT02520011|463274965|FG001|Overall Study|Lack of Efficacy|26|||
128720562|NCT02520011|463274966|FG002|Overall Study|Lack of Efficacy|4|||
128720563|NCT02520011|463274964|FG000|Overall Study|Physician Decision|0|||
128720564|NCT02520011|463274965|FG001|Overall Study|Physician Decision|2|||
128720565|NCT02520011|463274966|FG002|Overall Study|Physician Decision|0|||
129062679|NCT04856930|464518598|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
129062680|NCT04856930|464518599|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
129062681|NCT04856930|464518597|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
129062682|NCT04856930|464518598|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
129062683|NCT04856930|464518599|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
129062684|NCT04856930|464518597|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
129062685|NCT04856930|464518598|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
129062686|NCT04856930|464518599|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
129062687|NCT04856930|464518597|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
129062688|NCT04856930|464518598|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
129062689|NCT04856930|464518599|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
129062690|NCT04856930|464518597|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
129062691|NCT04856930|464518598|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
129062692|NCT04856930|464518599|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
129062693|NCT04856930|464518597|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129062694|NCT04856930|464518598|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
129062695|NCT04856930|464518599|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129062696|NCT04856930|464518597|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
129062697|NCT04856930|464518598|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
129062698|NCT04856930|464518599|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
129062699|NCT04856930|464518597|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
129062700|NCT04856930|464518598|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
129062701|NCT04856930|464518599|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
129062702|NCT04856930|464518597|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
129062703|NCT04856930|464518598|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
129062704|NCT04856930|464518599|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
129062705|NCT04856930|464518597|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
129062706|NCT04856930|464518598|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
129062707|NCT04856930|464518599|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
129062708|NCT04856930|464518597|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
129062709|NCT04856930|464518598|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129062710|NCT04856930|464518599|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129062711|NCT04856930|464518597|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
129062712|NCT04856930|464518598|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
129062713|NCT04856930|464518599|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
129062714|NCT04856930|464518597|FG000|Extension Period (16 Weeks)|Other than specified|0|||
129062715|NCT04856930|464518598|FG001|Extension Period (16 Weeks)|Other than specified|0|||
129062716|NCT04856930|464518599|FG002|Extension Period (16 Weeks)|Other than specified|1|||
129062717|NCT04856930|464518597|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
129062718|NCT04856930|464518598|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
129062719|NCT04856930|464518599|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
129062720|NCT04856930|464518597|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
129062721|NCT04856930|464518598|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
129062722|NCT04856930|464518599|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
129062723|NCT04856930|464518597|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
129062724|NCT04856930|464518598|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
128720566|NCT02520011|463274964|FG000|Overall Study|Withdrawal by Subject|1|||
128720567|NCT02520011|463274965|FG001|Overall Study|Withdrawal by Subject|3|||
128720568|NCT02520011|463274966|FG002|Overall Study|Withdrawal by Subject|0|||
128720569|NCT02520011|463274964|FG000|Overall Study|Protocol Deviation|0|||
129062725|NCT04856930|464518599|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
129062726|NCT04856930|464518597|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
128720570|NCT02520011|463274965|FG001|Overall Study|Protocol Deviation|1|||
128720571|NCT02520011|463274966|FG002|Overall Study|Protocol Deviation|0|||
128720572|NCT02520011|463274964|FG000|Overall Study|Patient went to hospice|0|||
128720573|NCT02520011|463274965|FG001|Overall Study|Patient went to hospice|1|||
128720574|NCT02520011|463274966|FG002|Overall Study|Patient went to hospice|0|||
129062727|NCT04856930|464518598|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
129062728|NCT04856930|464518599|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
129062729|NCT00678210|464518601|FG000|Overall Study|Adverse Event|1|||
129062730|NCT00678210|464518602|FG001|Overall Study|Adverse Event|2|||
129062731|NCT00678210|464518603|FG002|Overall Study|Adverse Event|3|||
129062732|NCT00678210|464518604|FG003|Overall Study|Adverse Event|3|||
129062733|NCT00678210|464518601|FG000|Overall Study|Lack of Efficacy|2|||
129062734|NCT00678210|464518602|FG001|Overall Study|Lack of Efficacy|3|||
129062735|NCT00678210|464518603|FG002|Overall Study|Lack of Efficacy|1|||
129062736|NCT00678210|464518604|FG003|Overall Study|Lack of Efficacy|9|||
129062737|NCT00678210|464518601|FG000|Overall Study|Lost to Follow-up|4|||
129062738|NCT00678210|464518602|FG001|Overall Study|Lost to Follow-up|2|||
129062739|NCT00678210|464518603|FG002|Overall Study|Lost to Follow-up|0|||
129062740|NCT00678210|464518604|FG003|Overall Study|Lost to Follow-up|1|||
129062741|NCT00678210|464518601|FG000|Overall Study|Withdrawal by Subject|3|||
129062742|NCT00678210|464518602|FG001|Overall Study|Withdrawal by Subject|4|||
129062743|NCT00678210|464518603|FG002|Overall Study|Withdrawal by Subject|1|||
129062744|NCT00678210|464518604|FG003|Overall Study|Withdrawal by Subject|7|||
129062745|NCT00678210|464518601|FG000|Overall Study|Other|1|||
129062746|NCT00678210|464518602|FG001|Overall Study|Other|0|||
129062747|NCT00678210|464518603|FG002|Overall Study|Other|1|||
129062748|NCT00678210|464518604|FG003|Overall Study|Other|0|||
129062749|NCT04825912|464518605|FG000|Overall Study|Death|3|||
129062750|NCT04825912|464518605|FG000|Overall Study|Withdrawal by Subject|1|||
129062751|NCT02077140|464518606|FG000|Overall Study|Lost to Follow-up|4|||
129062752|NCT02077140|464518607|FG001|Overall Study|Lost to Follow-up|1|||
129062753|NCT02077140|464518608|FG002|Overall Study|Lost to Follow-up|2|||
129062754|NCT02077140|464518609|FG003|Overall Study|Lost to Follow-up|2|||
129062755|NCT02077140|464518610|FG004|Overall Study|Lost to Follow-up|3|||
129062756|NCT02077140|464518606|FG000|Overall Study|Withdrawal by Subject|0|||
129062757|NCT02077140|464518607|FG001|Overall Study|Withdrawal by Subject|1|||
129062758|NCT02077140|464518608|FG002|Overall Study|Withdrawal by Subject|0|||
129062759|NCT02077140|464518609|FG003|Overall Study|Withdrawal by Subject|2|||
129062760|NCT02077140|464518610|FG004|Overall Study|Withdrawal by Subject|2|||
129062761|NCT00974922|464518611|FG000|Overall Study|study terminated|24|||
129062762|NCT03965689|464518612|FG000|Overall Study|Too sick to get study intervention|2|||
129062763|NCT03022084|464518613|FG000|Overall Study|Lost to Follow-up|2|||
129062764|NCT03022084|464518614|FG001|Overall Study|Lost to Follow-up|3|||
129062765|NCT01173120|464518615|FG000|Overall Study|Lack of Efficacy|2|||
129062766|NCT01173120|464518615|FG000|Overall Study|Lost to Follow-up|1|||
129062767|NCT01173120|464518615|FG000|Overall Study|Participant Decision|2|||
129062768|NCT01173120|464518615|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
129062769|NCT01173120|464518615|FG000|Overall Study|Switch-Participant Decision|12|||
129062770|NCT01173120|464518615|FG000|Overall Study|Switch-Difficulty With Device|12|||
129062771|NCT01207583|464518616|FG000|Overall Study|Withdrawal by Subject|0|||
129062772|NCT01207583|464518617|FG001|Overall Study|Withdrawal by Subject|3|||
129062773|NCT01207583|464518618|FG002|Overall Study|Withdrawal by Subject|1|||
129062774|NCT01207583|464518616|FG000|Overall Study|Participant failed to return|1|||
129062775|NCT01207583|464518617|FG001|Overall Study|Participant failed to return|0|||
129062776|NCT01207583|464518618|FG002|Overall Study|Participant failed to return|0|||
129062777|NCT01207583|464518616|FG000|Overall Study|Lost to Follow-up|0|||
129062778|NCT01207583|464518617|FG001|Overall Study|Lost to Follow-up|2|||
129062779|NCT01207583|464518618|FG002|Overall Study|Lost to Follow-up|0|||
129062780|NCT03104400|464518619|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
129062781|NCT03104400|464518620|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
129062782|NCT03104400|464518621|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
129062783|NCT03104400|464518622|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
129062784|NCT03104400|464518623|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
129062785|NCT03104400|464518624|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
129062786|NCT03104400|464518625|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
129062787|NCT03104400|464518626|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
129062788|NCT03104400|464518627|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
129062789|NCT03104400|464518628|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
129062790|NCT03104400|464518619|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
129062791|NCT03104400|464518620|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
128775596|NCT01890967|463468385|FG002|Overall Study|Protocol Violation|3|||
129062792|NCT03104400|464518621|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
129062793|NCT03104400|464518622|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
129062794|NCT03104400|464518623|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
129062795|NCT03104400|464518624|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129062796|NCT03104400|464518625|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129062797|NCT03104400|464518626|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129062798|NCT03104400|464518627|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129062799|NCT03104400|464518628|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129062800|NCT03104400|464518619|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
129062801|NCT03104400|464518620|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
129062802|NCT03104400|464518621|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
129062803|NCT03104400|464518622|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
129062804|NCT03104400|464518623|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
129062805|NCT03104400|464518624|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129062806|NCT03104400|464518625|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129062807|NCT03104400|464518626|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129062808|NCT03104400|464518627|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129062809|NCT03104400|464518628|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129062810|NCT03104400|464518619|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
129062811|NCT03104400|464518620|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
129062812|NCT03104400|464518621|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
129062813|NCT03104400|464518622|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
129062814|NCT03104400|464518623|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
129062815|NCT03104400|464518624|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129062816|NCT03104400|464518625|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129062817|NCT03104400|464518626|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129062818|NCT03104400|464518627|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129062819|NCT03104400|464518628|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129062820|NCT03104400|464518619|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062821|NCT03104400|464518620|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062822|NCT03104400|464518621|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062823|NCT03104400|464518622|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
129062824|NCT03104400|464518623|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062825|NCT03104400|464518624|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062826|NCT03104400|464518625|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062827|NCT03104400|464518626|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062828|NCT03104400|464518627|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062829|NCT03104400|464518628|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129062830|NCT03104400|464518619|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
129062831|NCT03104400|464518620|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
129062832|NCT03104400|464518621|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
129062833|NCT03104400|464518622|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
129062834|NCT03104400|464518623|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
129062835|NCT03104400|464518624|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
129062836|NCT03104400|464518625|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
129062837|NCT03104400|464518626|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
129062838|NCT03104400|464518627|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
129062839|NCT03104400|464518628|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
129062840|NCT03104400|464518619|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062841|NCT03104400|464518620|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062842|NCT03104400|464518621|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062843|NCT03104400|464518622|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
129062844|NCT03104400|464518623|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062845|NCT03104400|464518624|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062846|NCT03104400|464518625|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062847|NCT03104400|464518626|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062848|NCT03104400|464518627|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062849|NCT03104400|464518628|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129062850|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
129062851|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
128775597|NCT01890967|463468386|FG003|Overall Study|Protocol Violation|2|||
128775598|NCT01890967|463468387|FG004|Overall Study|Protocol Violation|4|||
128775599|NCT01890967|463468388|FG005|Overall Study|Protocol Violation|1|||
128775600|NCT01890967|463468383|FG000|Overall Study|Sponsor Decision|2|||
128775601|NCT01890967|463468384|FG001|Overall Study|Sponsor Decision|0|||
128775602|NCT01890967|463468385|FG002|Overall Study|Sponsor Decision|1|||
128775603|NCT01890967|463468386|FG003|Overall Study|Sponsor Decision|3|||
128775604|NCT01890967|463468387|FG004|Overall Study|Sponsor Decision|2|||
128775605|NCT01890967|463468388|FG005|Overall Study|Sponsor Decision|3|||
128775606|NCT01890967|463468383|FG000|Overall Study|Withdrawal by Subject|3|||
128775607|NCT01890967|463468384|FG001|Overall Study|Withdrawal by Subject|4|||
129062852|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
129062853|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
129062854|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
129062855|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
129062856|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
128775608|NCT01890967|463468385|FG002|Overall Study|Withdrawal by Subject|2|||
128775609|NCT01890967|463468386|FG003|Overall Study|Withdrawal by Subject|3|||
128775610|NCT01890967|463468387|FG004|Overall Study|Withdrawal by Subject|3|||
129062857|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
129062858|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
129062859|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
129062860|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129062861|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129062862|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129062863|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129062864|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129062865|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
129062866|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
129062867|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
129062868|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
129062869|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
129062870|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129062871|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129062872|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129062873|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129062874|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129062875|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
129062876|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
129062877|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
129062878|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
129062879|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
129062880|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129062881|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129062882|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129062883|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129062884|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129062885|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
129062886|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
129062887|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
129137245|NCT01362270|464794569|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
129137246|NCT01362270|464794568|FG000|Overall Study|Met excl. criteria before 1st session|1|||
129137247|NCT01362270|464794569|FG001|Overall Study|Met excl. criteria before 1st session|1|||
129137248|NCT04595370|464794572|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
129137249|NCT04595370|464794573|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129137250|NCT04595370|464794574|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129137251|NCT04595370|464794575|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129137252|NCT04595370|464794576|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129137253|NCT04595370|464794577|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129137254|NCT04595370|464794572|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129137255|NCT04595370|464794573|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129137256|NCT04595370|464794574|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
129137257|NCT04595370|464794575|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129137258|NCT04595370|464794576|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129137259|NCT04595370|464794577|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129137260|NCT04595370|464794572|FG000|Overall Study|Adverse Event|0|||
129137261|NCT04595370|464794573|FG001|Overall Study|Adverse Event|4|||
129137262|NCT04595370|464794574|FG002|Overall Study|Adverse Event|3|||
129137263|NCT04595370|464794575|FG003|Overall Study|Adverse Event|1|||
129137264|NCT04595370|464794576|FG004|Overall Study|Adverse Event|1|||
129137265|NCT04595370|464794577|FG005|Overall Study|Adverse Event|1|||
129137266|NCT04595370|464794572|FG000|Overall Study|Withdrawal of Consent|1|||
129137267|NCT04595370|464794573|FG001|Overall Study|Withdrawal of Consent|1|||
129137268|NCT04595370|464794574|FG002|Overall Study|Withdrawal of Consent|1|||
129137269|NCT04595370|464794575|FG003|Overall Study|Withdrawal of Consent|0|||
129137270|NCT04595370|464794576|FG004|Overall Study|Withdrawal of Consent|0|||
129137271|NCT04595370|464794577|FG005|Overall Study|Withdrawal of Consent|0|||
129137272|NCT04595370|464794572|FG000|Overall Study|Death|0|||
129137273|NCT04595370|464794573|FG001|Overall Study|Death|1|||
129137274|NCT04595370|464794574|FG002|Overall Study|Death|0|||
129137275|NCT04595370|464794575|FG003|Overall Study|Death|0|||
129137276|NCT04595370|464794576|FG004|Overall Study|Death|1|||
129137277|NCT04595370|464794577|FG005|Overall Study|Death|0|||
129137278|NCT04595370|464794572|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129137279|NCT04595370|464794573|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129137280|NCT04595370|464794574|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129137281|NCT04595370|464794575|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129137282|NCT04595370|464794576|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129137283|NCT04595370|464794577|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129137284|NCT04595370|464794572|FG000|Overall Study|Withdrawal by Subject|0|||
129062888|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
129062889|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
129062890|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129062891|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129062892|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129062893|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129062894|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129062895|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129062896|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
129062897|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129062898|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
129062899|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
129062900|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062901|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062902|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062903|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062904|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062905|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062906|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062907|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
129062908|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
129062909|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129062910|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
129062911|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
129062912|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
129062913|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
129062914|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
129062915|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
129062916|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
129062917|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
129062918|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
129062919|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
129062920|NCT03104400|464518619|FG000|Period 2 Week 56 - 260)|Other|0|||
129062921|NCT03104400|464518620|FG001|Period 2 Week 56 - 260)|Other|0|||
129062922|NCT03104400|464518621|FG002|Period 2 Week 56 - 260)|Other|0|||
129062923|NCT03104400|464518622|FG003|Period 2 Week 56 - 260)|Other|0|||
129062924|NCT03104400|464518623|FG004|Period 2 Week 56 - 260)|Other|0|||
129062925|NCT03104400|464518624|FG005|Period 2 Week 56 - 260)|Other|0|||
129062926|NCT03104400|464518625|FG006|Period 2 Week 56 - 260)|Other|0|||
129062927|NCT03104400|464518626|FG007|Period 2 Week 56 - 260)|Other|0|||
129062928|NCT03104400|464518627|FG008|Period 2 Week 56 - 260)|Other|1|||
129062929|NCT03104400|464518628|FG009|Period 2 Week 56 - 260)|Other|1|||
129062930|NCT04948333|464518629|FG000|Overall Study|Adverse Event|6|||
129062931|NCT04948333|464518630|FG001|Overall Study|Adverse Event|4|||
129062932|NCT04948333|464518631|FG002|Overall Study|Adverse Event|0|||
129062933|NCT04948333|464518632|FG003|Overall Study|Adverse Event|2|||
129062934|NCT04948333|464518629|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
129062935|NCT04948333|464518630|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129062936|NCT04948333|464518631|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129062937|NCT04948333|464518632|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129062938|NCT04948333|464518629|FG000|Overall Study|Progressive Disease|1|||
129062939|NCT04948333|464518630|FG001|Overall Study|Progressive Disease|5|||
129062940|NCT04948333|464518631|FG002|Overall Study|Progressive Disease|0|||
129062941|NCT04948333|464518632|FG003|Overall Study|Progressive Disease|0|||
129062942|NCT04948333|464518629|FG000|Overall Study|Physician Decision|2|||
129062943|NCT04948333|464518630|FG001|Overall Study|Physician Decision|2|||
129062944|NCT04948333|464518631|FG002|Overall Study|Physician Decision|0|||
129062945|NCT04948333|464518632|FG003|Overall Study|Physician Decision|0|||
129062946|NCT04948333|464518629|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
129062947|NCT04948333|464518630|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
129062948|NCT04948333|464518631|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
129062949|NCT04948333|464518632|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
129062950|NCT04948333|464518629|FG000|Overall Study|Withdrawal by Subject|2|||
129062951|NCT04948333|464518630|FG001|Overall Study|Withdrawal by Subject|0|||
129062952|NCT04948333|464518631|FG002|Overall Study|Withdrawal by Subject|0|||
129062953|NCT04948333|464518632|FG003|Overall Study|Withdrawal by Subject|1|||
129062954|NCT04948333|464518629|FG000|Overall Study|Protocol Violation|0|||
129062955|NCT04948333|464518630|FG001|Overall Study|Protocol Violation|1|||
129062956|NCT04948333|464518631|FG002|Overall Study|Protocol Violation|0|||
129062957|NCT04948333|464518632|FG003|Overall Study|Protocol Violation|0|||
129062958|NCT04948333|464518629|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
129062959|NCT04948333|464518630|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
129062960|NCT04948333|464518631|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
129062961|NCT04948333|464518632|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
129062962|NCT02129608|464518633|FG000|Overall Study|Lost to Follow-up|0|||
129062963|NCT02129608|464518634|FG001|Overall Study|Lost to Follow-up|1|||
129062964|NCT02129608|464518635|FG002|Overall Study|Lost to Follow-up|1|||
129062965|NCT02129608|464518633|FG000|Overall Study|Withdrawal by Subject|0|||
129062966|NCT02129608|464518634|FG001|Overall Study|Withdrawal by Subject|0|||
129062967|NCT02129608|464518635|FG002|Overall Study|Withdrawal by Subject|2|||
129062968|NCT00451204|464518636|FG000|Overall Study|Adverse Event|4|||
129062969|NCT00451204|464518637|FG001|Overall Study|Adverse Event|6|||
129062970|NCT00451204|464518636|FG000|Overall Study|Lack of Efficacy|4|||
129062971|NCT00451204|464518637|FG001|Overall Study|Lack of Efficacy|4|||
129062972|NCT00451204|464518636|FG000|Overall Study|Lost to Follow-up|4|||
129062973|NCT00451204|464518637|FG001|Overall Study|Lost to Follow-up|4|||
129062974|NCT00451204|464518636|FG000|Overall Study|Protocol Violation|1|||
129062975|NCT00451204|464518637|FG001|Overall Study|Protocol Violation|0|||
129062976|NCT00451204|464518636|FG000|Overall Study|Patient refusal|8|||
129062977|NCT00451204|464518637|FG001|Overall Study|Patient refusal|4|||
129062978|NCT00451204|464518636|FG000|Overall Study|Other|1|||
129062979|NCT00451204|464518637|FG001|Overall Study|Other|2|||
129062980|NCT01582152|464518638|FG000|Overall Study|Disease Progression|4|||
129062981|NCT01582152|464518639|FG001|Overall Study|Disease Progression|5|||
129062982|NCT01582152|464518638|FG000|Overall Study|Adverse Event|2|||
129062983|NCT01582152|464518639|FG001|Overall Study|Adverse Event|1|||
129062984|NCT04172597|464518642|FG000|Overall Study|Disease Progression|0|||
129062985|NCT04172597|464518643|FG001|Overall Study|Disease Progression|0|||
129062986|NCT04172597|464518644|FG002|Overall Study|Disease Progression|0|||
129062987|NCT04172597|464518645|FG003|Overall Study|Disease Progression|0|||
129062988|NCT04172597|464518646|FG004|Overall Study|Disease Progression|1|||
129062989|NCT00794339|464518647|FG000|Overall Study|Withdrawal by Subject|3|||
129062990|NCT00794339|464518647|FG000|Overall Study|Ineligible|4|||
129062991|NCT00794339|464518647|FG000|Overall Study|Tx prior to ATSM|3|||
129062992|NCT00794339|464518647|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
129062993|NCT00794339|464518647|FG000|Overall Study|Tx not per protocol|1|||
129062994|NCT01611857|464518648|FG000|Overall Study|Withdrawal by Subject|0|||
129062995|NCT01611857|464518649|FG001|Overall Study|Withdrawal by Subject|2|||
129062996|NCT00362336|464518666|FG000|Overall Study|Serious Adverse Event|1|||
129062997|NCT00362336|464518667|FG001|Overall Study|Serious Adverse Event|0|||
129062998|NCT00362336|464518668|FG002|Overall Study|Serious Adverse Event|1|||
129062999|NCT00362336|464518666|FG000|Overall Study|Protocol Violation|0|||
129063000|NCT00362336|464518667|FG001|Overall Study|Protocol Violation|0|||
129063001|NCT00362336|464518668|FG002|Overall Study|Protocol Violation|1|||
129063002|NCT00362336|464518666|FG000|Overall Study|Lost to Follow-up|6|||
129063003|NCT00362336|464518667|FG001|Overall Study|Lost to Follow-up|4|||
129063004|NCT00362336|464518668|FG002|Overall Study|Lost to Follow-up|0|||
129063005|NCT00362336|464518666|FG000|Overall Study|Withdrawal by Subject|3|||
129063006|NCT00362336|464518667|FG001|Overall Study|Withdrawal by Subject|3|||
129063007|NCT00362336|464518668|FG002|Overall Study|Withdrawal by Subject|1|||
129063008|NCT01121562|464518671|FG000|Overall Study|Objective progression or relapse|8|||
129063009|NCT01121562|464518671|FG000|Overall Study|Withdrawal by Subject|1|||
129063010|NCT01121562|464518671|FG000|Overall Study|Adverse Event|1|||
129063011|NCT01121562|464518671|FG000|Overall Study|Sponsor Decision|1|||
129063012|NCT01121562|464518671|FG000|Overall Study|Met study discontinuation criteria|1|||
129063013|NCT01495702|464518672|FG000|Randomized Phase|Randomized But Not Treated|1|||
129063014|NCT01495702|464518673|FG001|Randomized Phase|Randomized But Not Treated|4|||
129063015|NCT01495702|464518672|FG000|Randomized Phase|Adverse Event|2|||
129063016|NCT01495702|464518673|FG001|Randomized Phase|Adverse Event|2|||
129063017|NCT01495702|464518672|FG000|Randomized Phase|Death|1|||
129063018|NCT01495702|464518673|FG001|Randomized Phase|Death|0|||
129063019|NCT01495702|464518672|FG000|Randomized Phase|Lack of Efficacy|2|||
129063020|NCT01495702|464518673|FG001|Randomized Phase|Lack of Efficacy|0|||
129063021|NCT01495702|464518672|FG000|Randomized Phase|Investigators Discretion|2|||
129063022|NCT01495702|464518673|FG001|Randomized Phase|Investigators Discretion|0|||
129063023|NCT01495702|464518672|FG000|Randomized Phase|Withdrew Consent|10|||
129063024|NCT01495702|464518673|FG001|Randomized Phase|Withdrew Consent|18|||
129063025|NCT01495702|464518672|FG000|Randomized Phase|Lost to Follow-up|4|||
129063026|NCT01495702|464518673|FG001|Randomized Phase|Lost to Follow-up|3|||
129063027|NCT01495702|464518672|FG000|Randomized Phase|Participant Noncompliance|1|||
129063028|NCT01495702|464518673|FG001|Randomized Phase|Participant Noncompliance|0|||
129063029|NCT01495702|464518672|FG000|Randomized Phase|Protocol Violation|3|||
129063030|NCT01495702|464518673|FG001|Randomized Phase|Protocol Violation|1|||
129063031|NCT04152863|464518674|FG000|Overall Study|Death|13|||
129063032|NCT04152863|464518675|FG001|Overall Study|Death|12|||
129063033|NCT04152863|464518676|FG002|Overall Study|Death|7|||
129063034|NCT04152863|464518674|FG000|Overall Study|Physician Decision|1|||
129063035|NCT04152863|464518675|FG001|Overall Study|Physician Decision|1|||
129063036|NCT04152863|464518676|FG002|Overall Study|Physician Decision|1|||
128720575|NCT02520011|463274964|FG000|Overall Study|Progressive disease following response|0|||
128720576|NCT02520011|463274965|FG001|Overall Study|Progressive disease following response|4|||
128720577|NCT02520011|463274966|FG002|Overall Study|Progressive disease following response|2|||
128720578|NCT03425331|463274974|FG000|Overall Study|Withdrawal by Subject|1|||
128720579|NCT03425331|463274974|FG000|Overall Study|Death|1|||
128720580|NCT03425331|463274974|FG000|Overall Study|Adverse Event|1|||
128720581|NCT03425331|463274974|FG000|Overall Study|Disease Progression|2|||
128720582|NCT02864251|463274977|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
128720583|NCT02864251|463274978|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
128720584|NCT02864251|463274979|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
128720585|NCT02864251|463274977|FG000|Pre-Treatment|Withdrawal by Participant|0|||
128720586|NCT02864251|463274978|FG001|Pre-Treatment|Withdrawal by Participant|0|||
128720587|NCT02864251|463274979|FG002|Pre-Treatment|Withdrawal by Participant|4|||
128720588|NCT02864251|463274977|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
128720589|NCT02864251|463274978|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
128720590|NCT02864251|463274979|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
128720591|NCT02864251|463274977|FG000|Pre-Treatment|Other Reasons|0|||
128720592|NCT02864251|463274978|FG001|Pre-Treatment|Other Reasons|1|||
128720593|NCT02864251|463274979|FG002|Pre-Treatment|Other Reasons|1|||
128720594|NCT02864251|463274977|FG000|Treatment|Disease Progression|109|||
128720595|NCT02864251|463274978|FG001|Treatment|Disease Progression|52|||
128720596|NCT02864251|463274979|FG002|Treatment|Disease Progression|101|||
128720597|NCT02864251|463274977|FG000|Treatment|Study Drug Toxicity|9|||
128720598|NCT02864251|463274978|FG001|Treatment|Study Drug Toxicity|4|||
128720599|NCT02864251|463274979|FG002|Treatment|Study Drug Toxicity|10|||
128720600|NCT02864251|463274977|FG000|Treatment|Death|0|||
129063037|NCT04152863|464518674|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
129063038|NCT04152863|464518675|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
129063039|NCT04152863|464518676|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
129063040|NCT04152863|464518674|FG000|Overall Study|Withdrawal by Subject|2|||
129063041|NCT04152863|464518675|FG001|Overall Study|Withdrawal by Subject|1|||
128720601|NCT02864251|463274978|FG001|Treatment|Death|2|||
128720602|NCT02864251|463274979|FG002|Treatment|Death|3|||
128720603|NCT02864251|463274977|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
128720604|NCT02864251|463274978|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
128720605|NCT02864251|463274979|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
128720606|NCT02864251|463274977|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
128720607|NCT02864251|463274978|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
128720608|NCT02864251|463274979|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
128720609|NCT02864251|463274977|FG000|Treatment|Withdrawal by Participant|8|||
128720610|NCT02864251|463274978|FG001|Treatment|Withdrawal by Participant|5|||
128720611|NCT02864251|463274979|FG002|Treatment|Withdrawal by Participant|13|||
128720612|NCT02864251|463274977|FG000|Treatment|Maximum Clinical Benefit|1|||
128720613|NCT02864251|463274978|FG001|Treatment|Maximum Clinical Benefit|0|||
128720614|NCT02864251|463274979|FG002|Treatment|Maximum Clinical Benefit|1|||
128720615|NCT02864251|463274977|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
128720616|NCT02864251|463274978|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
128720617|NCT02864251|463274979|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
129063042|NCT04152863|464518676|FG002|Overall Study|Withdrawal by Subject|3|||
128720618|NCT02864251|463274977|FG000|Treatment|Other Reasons|1|||
128720619|NCT02864251|463274978|FG001|Treatment|Other Reasons|1|||
128720620|NCT02864251|463274979|FG002|Treatment|Other Reasons|4|||
128720621|NCT02864251|463274977|FG000|Treatment|Administrative Reason by Sponsor|1|||
128720622|NCT02864251|463274978|FG001|Treatment|Administrative Reason by Sponsor|0|||
128720623|NCT02864251|463274979|FG002|Treatment|Administrative Reason by Sponsor|0|||
128720624|NCT04343521|463274980|FG000|Overall Study|Adverse Event|0|||
128720625|NCT04343521|463274981|FG001|Overall Study|Adverse Event|2|||
128720626|NCT04343521|463274980|FG000|Overall Study|Death|1|||
128720627|NCT04343521|463274981|FG001|Overall Study|Death|2|||
128720628|NCT04343521|463274980|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
128775611|NCT01890967|463468388|FG005|Overall Study|Withdrawal by Subject|1|||
128775612|NCT01383993|463468390|FG000|Overall Study|Adverse Event|1|||
128775613|NCT01383993|463468391|FG001|Overall Study|Adverse Event|1|||
128775614|NCT01383993|463468392|FG002|Overall Study|Adverse Event|0|||
129063043|NCT02075515|464518677|FG000|Overall Study|Serious Adverse Event|1|||
129063044|NCT02075515|464518678|FG001|Overall Study|Serious Adverse Event|1|||
129063045|NCT02075515|464518679|FG002|Overall Study|Serious Adverse Event|1|||
129063046|NCT02075515|464518677|FG000|Overall Study|Non-Serious Adverse Event|0|||
128720629|NCT04343521|463274981|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
128720630|NCT04343521|463274980|FG000|Overall Study|Withdrawal by Subject|70|||
128720631|NCT04343521|463274981|FG001|Overall Study|Withdrawal by Subject|95|||
128775615|NCT01383993|463468390|FG000|Overall Study|Withdrawal by Subject|0|||
129063047|NCT02075515|464518678|FG001|Overall Study|Non-Serious Adverse Event|1|||
129063048|NCT02075515|464518679|FG002|Overall Study|Non-Serious Adverse Event|0|||
129063049|NCT02075515|464518677|FG000|Overall Study|Withdrawal by Subject|2|||
129063050|NCT02075515|464518678|FG001|Overall Study|Withdrawal by Subject|0|||
129063051|NCT02075515|464518679|FG002|Overall Study|Withdrawal by Subject|1|||
129063052|NCT02075515|464518677|FG000|Overall Study|Lost to Follow-up|1|||
129063053|NCT02075515|464518678|FG001|Overall Study|Lost to Follow-up|3|||
129063054|NCT02075515|464518679|FG002|Overall Study|Lost to Follow-up|6|||
129063055|NCT00378573|464518682|FG000|Treatment Period|Adverse Event|9|||
129063056|NCT00378573|464518682|FG000|Treatment Period|Physician Decision|1|||
129063057|NCT00378573|464518682|FG000|Treatment Period|Withdrawal by Subject|2|||
129063058|NCT00378573|464518682|FG000|Treatment Period|Disease Progression|4|||
129063059|NCT00378573|464518682|FG000|Treatment Period|Sponsor decision to close study|1|||
129063060|NCT00378573|464518682|FG000|Follow-up|Death|12|||
129063061|NCT00378573|464518682|FG000|Follow-up|Lost to Follow-up|1|||
129063062|NCT00378573|464518682|FG000|Follow-up|Withdrawal by Subject|1|||
129063063|NCT00196326|464518683|FG000|Overall Study|Did not meet protocol requirements|64|||
129063064|NCT00196326|464518683|FG000|Overall Study|Non-compliance with the protocol|81|||
129063065|NCT00196326|464518683|FG000|Overall Study|Physician Decision|3|||
129063066|NCT00196326|464518683|FG000|Overall Study|Withdrawal by Subject|225|||
129063067|NCT00196326|464518683|FG000|Overall Study|Adverse Event|253|||
129063068|NCT00196326|464518683|FG000|Overall Study|Pregnancy|34|||
129063069|NCT00196326|464518683|FG000|Overall Study|Lost to Follow-up|304|||
129063070|NCT00196326|464518683|FG000|Overall Study|Other|22|||
129063071|NCT02797171|464518684|FG000|Overall Study|Lost to Follow-up|2|||
129063072|NCT02797171|464518685|FG001|Overall Study|Lost to Follow-up|0|||
129063073|NCT02797171|464518686|FG002|Overall Study|Lost to Follow-up|2|||
129063074|NCT02797171|464518687|FG003|Overall Study|Lost to Follow-up|1|||
129063075|NCT02797171|464518688|FG004|Overall Study|Lost to Follow-up|2|||
129063076|NCT02797171|464518689|FG005|Overall Study|Lost to Follow-up|0|||
129063077|NCT02797171|464518684|FG000|Overall Study|Withdrawal by Subject|1|||
129063078|NCT02797171|464518685|FG001|Overall Study|Withdrawal by Subject|1|||
129063079|NCT02797171|464518686|FG002|Overall Study|Withdrawal by Subject|0|||
129063080|NCT02797171|464518687|FG003|Overall Study|Withdrawal by Subject|0|||
129063081|NCT02797171|464518688|FG004|Overall Study|Withdrawal by Subject|0|||
129063082|NCT02797171|464518689|FG005|Overall Study|Withdrawal by Subject|0|||
129063083|NCT02797171|464518684|FG000|Overall Study|Protocol Violation|1|||
129063084|NCT02797171|464518685|FG001|Overall Study|Protocol Violation|0|||
129063085|NCT02797171|464518686|FG002|Overall Study|Protocol Violation|0|||
129063086|NCT02797171|464518687|FG003|Overall Study|Protocol Violation|0|||
129063087|NCT02797171|464518688|FG004|Overall Study|Protocol Violation|0|||
129063088|NCT02797171|464518689|FG005|Overall Study|Protocol Violation|0|||
129063089|NCT02797171|464518684|FG000|Overall Study|Participant unable to adhere|0|||
129063090|NCT02797171|464518685|FG001|Overall Study|Participant unable to adhere|1|||
129063091|NCT02797171|464518686|FG002|Overall Study|Participant unable to adhere|0|||
129063092|NCT02797171|464518687|FG003|Overall Study|Participant unable to adhere|0|||
129063093|NCT02797171|464518688|FG004|Overall Study|Participant unable to adhere|0|||
129063094|NCT02797171|464518689|FG005|Overall Study|Participant unable to adhere|0|||
129063095|NCT02797171|464518684|FG000|Overall Study|Not Randomized|0|||
129063096|NCT02797171|464518685|FG001|Overall Study|Not Randomized|0|||
129063097|NCT02797171|464518686|FG002|Overall Study|Not Randomized|0|||
129063098|NCT02797171|464518687|FG003|Overall Study|Not Randomized|0|||
129063099|NCT02797171|464518688|FG004|Overall Study|Not Randomized|0|||
129063100|NCT02797171|464518689|FG005|Overall Study|Not Randomized|1|||
129063101|NCT02540083|464518690|FG000|Overall Study|Withdrawal by Subject|16|||
129063102|NCT01372748|464518691|FG000|Overall Study|Lost to Follow-up|16|||
129063103|NCT01372748|464518692|FG001|Overall Study|Lost to Follow-up|34|||
128720632|NCT04343521|463274980|FG000|Overall Study|Withdrawal by study team|6|||
128720633|NCT04343521|463274981|FG001|Overall Study|Withdrawal by study team|12|||
128720634|NCT00107198|463274982|FG000|Overall Study|Lack of Efficacy|28|||
129063104|NCT01372748|464518691|FG000|Overall Study|Withdrawal by Subject|7|||
129063105|NCT01372748|464518692|FG001|Overall Study|Withdrawal by Subject|5|||
129063106|NCT00134901|464518693|FG000|Overall Study|Lost to Follow-up|5|||
129063107|NCT00134901|464518694|FG001|Overall Study|Lost to Follow-up|5|||
129063108|NCT00134901|464518693|FG000|Overall Study|discontinued intervention|12|||
129063109|NCT00134901|464518694|FG001|Overall Study|discontinued intervention|10|||
129063110|NCT00445432|464518697|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
129063111|NCT00445432|464518698|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
129063112|NCT00445432|464518699|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
129063113|NCT00445432|464518700|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
129063114|NCT00445432|464518697|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
129063115|NCT00445432|464518698|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
129063116|NCT00445432|464518699|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
129063117|NCT00445432|464518700|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
129063118|NCT00445432|464518697|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
129063119|NCT00445432|464518698|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
129063120|NCT00445432|464518699|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
129063121|NCT00445432|464518700|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
129063122|NCT00445432|464518697|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
129063123|NCT00445432|464518698|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
129063124|NCT00445432|464518699|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
129063125|NCT00445432|464518700|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
129063126|NCT00445432|464518697|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
129063127|NCT00445432|464518698|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
129063128|NCT00445432|464518699|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
129063129|NCT00445432|464518700|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
129063130|NCT00445432|464518697|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
129063131|NCT00445432|464518698|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
129063132|NCT00445432|464518699|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
129063133|NCT00445432|464518700|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
129063134|NCT00445432|464518697|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
129063135|NCT00445432|464518698|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
129063136|NCT00445432|464518699|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
129063137|NCT00445432|464518700|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
129063138|NCT01699815|464518701|FG000|Overall Study|Protocol Violation|4|||
129063139|NCT01699815|464518702|FG001|Overall Study|Protocol Violation|7|||
129063140|NCT01699815|464518701|FG000|Overall Study|record could not be located|1|||
129063141|NCT01699815|464518702|FG001|Overall Study|record could not be located|0|||
129063142|NCT01699815|464518701|FG000|Overall Study|Adverse Event|0|||
129063143|NCT01699815|464518702|FG001|Overall Study|Adverse Event|1|||
129063144|NCT00356525|464518703|FG000|Overall Study|Progressive Disease|8|||
129063145|NCT00356525|464518704|FG001|Overall Study|Progressive Disease|5|||
129063146|NCT00356525|464518705|FG002|Overall Study|Progressive Disease|4|||
129063147|NCT00356525|464518706|FG003|Overall Study|Progressive Disease|2|||
129063148|NCT00356525|464518703|FG000|Overall Study|Adverse Event|1|||
129063149|NCT00356525|464518704|FG001|Overall Study|Adverse Event|3|||
129063150|NCT00356525|464518705|FG002|Overall Study|Adverse Event|1|||
129063151|NCT00356525|464518706|FG003|Overall Study|Adverse Event|1|||
129063152|NCT00356525|464518703|FG000|Overall Study|Lost to Follow-up|1|||
129063153|NCT00356525|464518704|FG001|Overall Study|Lost to Follow-up|0|||
129063154|NCT00356525|464518705|FG002|Overall Study|Lost to Follow-up|0|||
129063155|NCT00356525|464518706|FG003|Overall Study|Lost to Follow-up|0|||
129063156|NCT00356525|464518703|FG000|Overall Study|Physician Decision|2|||
129063157|NCT00356525|464518704|FG001|Overall Study|Physician Decision|2|||
129063158|NCT00356525|464518705|FG002|Overall Study|Physician Decision|2|||
129063159|NCT00356525|464518706|FG003|Overall Study|Physician Decision|1|||
129063160|NCT00356525|464518703|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
129063161|NCT00356525|464518704|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
129063162|NCT00356525|464518705|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
129063163|NCT00356525|464518706|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
128720635|NCT00107198|463274982|FG000|Overall Study|Lost to Follow-up|12|||
129063164|NCT00356525|464518703|FG000|Overall Study|Withdrawal by Subject|1|||
129063165|NCT00356525|464518704|FG001|Overall Study|Withdrawal by Subject|1|||
129063166|NCT00356525|464518705|FG002|Overall Study|Withdrawal by Subject|0|||
129063167|NCT00356525|464518706|FG003|Overall Study|Withdrawal by Subject|3|||
129063168|NCT00356525|464518703|FG000|Overall Study|Death|0|||
129063169|NCT00356525|464518704|FG001|Overall Study|Death|0|||
129063170|NCT00356525|464518705|FG002|Overall Study|Death|0|||
128720636|NCT00107198|463274982|FG000|Overall Study|Protocol Violation|1|||
129063171|NCT00356525|464518706|FG003|Overall Study|Death|1|||
129063172|NCT00356525|464518703|FG000|Overall Study|Sponsor Decision|0|||
129063173|NCT00356525|464518704|FG001|Overall Study|Sponsor Decision|0|||
129063174|NCT00356525|464518705|FG002|Overall Study|Sponsor Decision|0|||
129063175|NCT00356525|464518706|FG003|Overall Study|Sponsor Decision|1|||
129063176|NCT01685840|464518722|FG000|Overall Study|Death|77|||
129063177|NCT01685840|464518723|FG001|Overall Study|Death|66|||
129063178|NCT01685840|464518722|FG000|Overall Study|Lost to Follow-up|27|||
129063179|NCT01685840|464518723|FG001|Overall Study|Lost to Follow-up|25|||
129063180|NCT01685840|464518722|FG000|Overall Study|Physician Decision|3|||
129063181|NCT01685840|464518723|FG001|Overall Study|Physician Decision|7|||
129063182|NCT01685840|464518722|FG000|Overall Study|Withdrawal by Subject|14|||
129063183|NCT01685840|464518723|FG001|Overall Study|Withdrawal by Subject|17|||
129063184|NCT01685840|464518722|FG000|Overall Study|Futility|197|||
129063185|NCT01685840|464518723|FG001|Overall Study|Futility|200|||
129063186|NCT01685840|464518722|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
129063187|NCT01685840|464518723|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
129063188|NCT01128543|464518731|FG000|Overall Study|Withdrawal by Subject|3|||
129063189|NCT01128543|464518731|FG000|Overall Study|Protocol Violation|1|||
129063190|NCT04487067|464518735|FG000|Overall Study|Adverse Event|3|||
129063191|NCT04487067|464518735|FG000|Overall Study|Death Other Than Progressive Disease|60|||
129063192|NCT04487067|464518735|FG000|Overall Study|Death Due To Progressive Disease|40|||
129063193|NCT04487067|464518735|FG000|Overall Study|Lost to Follow-up|3|||
129063194|NCT04487067|464518735|FG000|Overall Study|Progressive Disease|1|||
129063195|NCT04487067|464518735|FG000|Overall Study|Protocol Violation|3|||
129063196|NCT04487067|464518735|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
129063197|NCT04487067|464518735|FG000|Overall Study|Withdrawal by Subject|15|||
129063198|NCT02211417|464518736|FG000|Overall Study|Withdrawal by Subject|11|||
129063199|NCT02211417|464518737|FG001|Overall Study|Withdrawal by Subject|8|||
129063200|NCT02211417|464518736|FG000|Overall Study|Protocol Violation|1|||
129063201|NCT02211417|464518737|FG001|Overall Study|Protocol Violation|0|||
129063202|NCT02211417|464518736|FG000|Overall Study|Pregnancy|0|||
129063203|NCT02211417|464518737|FG001|Overall Study|Pregnancy|1|||
129063204|NCT02211417|464518736|FG000|Overall Study|Lost to Follow-up|2|||
129063205|NCT02211417|464518737|FG001|Overall Study|Lost to Follow-up|3|||
129063206|NCT02211417|464518736|FG000|Overall Study|Adverse Event|1|||
129063207|NCT02211417|464518737|FG001|Overall Study|Adverse Event|4|||
129063208|NCT01755091|464518738|FG000|Overall Study|Withdrawal by Subject|6|||
129063209|NCT01755091|464518739|FG001|Overall Study|Withdrawal by Subject|1|||
129063210|NCT01755091|464518740|FG002|Overall Study|Withdrawal by Subject|3|||
129063211|NCT01755091|464518738|FG000|Overall Study|Adverse Event|1|||
129063212|NCT01755091|464518739|FG001|Overall Study|Adverse Event|1|||
129063213|NCT01755091|464518740|FG002|Overall Study|Adverse Event|1|||
129063214|NCT01755091|464518738|FG000|Overall Study|Lost to Follow-up|1|||
129063215|NCT01755091|464518739|FG001|Overall Study|Lost to Follow-up|0|||
129063216|NCT01755091|464518740|FG002|Overall Study|Lost to Follow-up|1|||
129063217|NCT01755091|464518738|FG000|Overall Study|Physician Decision|1|||
129063218|NCT01755091|464518739|FG001|Overall Study|Physician Decision|1|||
129063219|NCT01755091|464518740|FG002|Overall Study|Physician Decision|2|||
129063220|NCT00490841|464518741|FG000|Overall Study|Death|5|||
129063221|NCT00490841|464518741|FG000|Overall Study|Withdrawal by Subject|4|||
129063222|NCT00490841|464518741|FG000|Overall Study|Lost to Follow-up|1|||
129063223|NCT00490841|464518741|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
129063224|NCT06385483|464518744|FG000|Overall Study|Withdrawal by Subject|2|||
129063225|NCT06385483|464518744|FG000|Overall Study|Never start protocol therapy|2|||
129063226|NCT06385483|464518744|FG000|Overall Study|Disease progression|15|||
129063227|NCT04700137|464518749|FG000|Overall Study|Lost to Follow-up|1|||
129063228|NCT04700137|464518750|FG001|Overall Study|Lost to Follow-up|6|||
129063229|NCT04700137|464518751|FG002|Overall Study|Lost to Follow-up|1|||
129063230|NCT04700137|464518752|FG003|Overall Study|Lost to Follow-up|1|||
129063231|NCT04700137|464518749|FG000|Overall Study|Withdrawal by Subject|0|||
129063232|NCT04700137|464518750|FG001|Overall Study|Withdrawal by Subject|0|||
129063233|NCT04700137|464518751|FG002|Overall Study|Withdrawal by Subject|1|||
129063234|NCT04700137|464518752|FG003|Overall Study|Withdrawal by Subject|0|||
129063235|NCT04700137|464518749|FG000|Overall Study|Death|0|||
129063236|NCT04700137|464518750|FG001|Overall Study|Death|0|||
129063237|NCT04700137|464518751|FG002|Overall Study|Death|1|||
129063238|NCT04700137|464518752|FG003|Overall Study|Death|0|||
129063239|NCT01320150|464518754|FG000|Overall Study|Protocol Violation|15|||
129063240|NCT01320150|464518754|FG000|Overall Study|Withdrawal by Subject|5|||
129063241|NCT01320150|464518754|FG000|Overall Study|Death|2|||
129063242|NCT01320150|464518754|FG000|Overall Study|Lost to Follow-up|44|||
129063243|NCT00919854|464518757|FG000|Overall Study|Adverse Event|1|||
129063244|NCT01862484|464518760|FG000|Overall Study|Lack of Efficacy|1|||
129063245|NCT01862484|464518761|FG001|Overall Study|Lack of Efficacy|1|||
129063246|NCT01862484|464518760|FG000|Overall Study|Lost to Follow-up|1|||
129063247|NCT01862484|464518761|FG001|Overall Study|Lost to Follow-up|2|||
129063248|NCT01862484|464518760|FG000|Overall Study|Protocol Violation|0|||
129063249|NCT01862484|464518761|FG001|Overall Study|Protocol Violation|2|||
129063250|NCT01862484|464518760|FG000|Overall Study|Withdrawal by Subject|0|||
129063251|NCT01862484|464518761|FG001|Overall Study|Withdrawal by Subject|3|||
129063252|NCT01632280|464518762|FG000|Overall Study|Withdrawal by Subject|1|||
129063253|NCT01632280|464518763|FG001|Overall Study|Withdrawal by Subject|0|||
129063254|NCT00993421|464518764|FG000|Overall Study|Adverse Event|2|||
129063255|NCT00993421|464518765|FG001|Overall Study|Adverse Event|7|||
129063256|NCT00993421|464518766|FG002|Overall Study|Adverse Event|6|||
129063257|NCT00993421|464518767|FG003|Overall Study|Adverse Event|9|||
129063258|NCT00993421|464518768|FG004|Overall Study|Adverse Event|5|||
129063259|NCT00993421|464518769|FG005|Overall Study|Adverse Event|7|||
129063260|NCT00993421|464518770|FG006|Overall Study|Adverse Event|1|||
128720637|NCT00107198|463274982|FG000|Overall Study|Withdrawal by Subject|6|||
128720638|NCT00107198|463274982|FG000|Overall Study|Ineligible|5|||
129063261|NCT00993421|464518764|FG000|Overall Study|Sponsor Decision|36|||
129063262|NCT00993421|464518765|FG001|Overall Study|Sponsor Decision|31|||
129063263|NCT00993421|464518766|FG002|Overall Study|Sponsor Decision|28|||
129063264|NCT00993421|464518767|FG003|Overall Study|Sponsor Decision|30|||
129063265|NCT00993421|464518768|FG004|Overall Study|Sponsor Decision|38|||
129063266|NCT00993421|464518769|FG005|Overall Study|Sponsor Decision|30|||
129063267|NCT00993421|464518770|FG006|Overall Study|Sponsor Decision|29|||
129063268|NCT00993421|464518764|FG000|Overall Study|Lost to Follow-up|3|||
129063269|NCT00993421|464518765|FG001|Overall Study|Lost to Follow-up|5|||
129063270|NCT00993421|464518766|FG002|Overall Study|Lost to Follow-up|5|||
129063271|NCT00993421|464518767|FG003|Overall Study|Lost to Follow-up|0|||
129063272|NCT00993421|464518768|FG004|Overall Study|Lost to Follow-up|0|||
129063273|NCT00993421|464518769|FG005|Overall Study|Lost to Follow-up|0|||
129063274|NCT00993421|464518770|FG006|Overall Study|Lost to Follow-up|6|||
129063275|NCT00993421|464518764|FG000|Overall Study|Withdrawal by Subject|3|||
129063276|NCT00993421|464518765|FG001|Overall Study|Withdrawal by Subject|2|||
129063277|NCT00993421|464518766|FG002|Overall Study|Withdrawal by Subject|3|||
129063278|NCT00993421|464518767|FG003|Overall Study|Withdrawal by Subject|3|||
129063279|NCT00993421|464518768|FG004|Overall Study|Withdrawal by Subject|3|||
129063280|NCT00993421|464518769|FG005|Overall Study|Withdrawal by Subject|5|||
129063281|NCT00993421|464518770|FG006|Overall Study|Withdrawal by Subject|3|||
129063282|NCT00993421|464518764|FG000|Overall Study|Death|0|||
129063283|NCT00993421|464518765|FG001|Overall Study|Death|0|||
129063284|NCT00993421|464518766|FG002|Overall Study|Death|0|||
129063285|NCT00993421|464518767|FG003|Overall Study|Death|0|||
129063286|NCT00993421|464518768|FG004|Overall Study|Death|0|||
129063287|NCT00993421|464518769|FG005|Overall Study|Death|0|||
129063288|NCT00993421|464518770|FG006|Overall Study|Death|1|||
129063289|NCT00993421|464518764|FG000|Overall Study|Entry Criteria Exclusion|0|||
129063290|NCT00993421|464518765|FG001|Overall Study|Entry Criteria Exclusion|0|||
129063291|NCT00993421|464518766|FG002|Overall Study|Entry Criteria Exclusion|1|||
129063292|NCT00993421|464518767|FG003|Overall Study|Entry Criteria Exclusion|3|||
129063293|NCT00993421|464518768|FG004|Overall Study|Entry Criteria Exclusion|0|||
129063294|NCT00993421|464518769|FG005|Overall Study|Entry Criteria Exclusion|1|||
129063295|NCT00993421|464518770|FG006|Overall Study|Entry Criteria Exclusion|0|||
129063296|NCT00993421|464518764|FG000|Overall Study|Physician Decision|0|||
129063297|NCT00993421|464518765|FG001|Overall Study|Physician Decision|0|||
129063298|NCT00993421|464518766|FG002|Overall Study|Physician Decision|0|||
129063299|NCT00993421|464518767|FG003|Overall Study|Physician Decision|0|||
129063300|NCT00993421|464518768|FG004|Overall Study|Physician Decision|0|||
129063301|NCT00993421|464518769|FG005|Overall Study|Physician Decision|1|||
129063302|NCT00993421|464518770|FG006|Overall Study|Physician Decision|1|||
129063303|NCT00993421|464518764|FG000|Overall Study|Protocol Violation|0|||
129063304|NCT00993421|464518765|FG001|Overall Study|Protocol Violation|0|||
129063305|NCT00993421|464518766|FG002|Overall Study|Protocol Violation|0|||
129063306|NCT00993421|464518767|FG003|Overall Study|Protocol Violation|0|||
129063307|NCT00993421|464518768|FG004|Overall Study|Protocol Violation|0|||
129063308|NCT00993421|464518769|FG005|Overall Study|Protocol Violation|2|||
129063309|NCT00993421|464518770|FG006|Overall Study|Protocol Violation|1|||
129063310|NCT02215967|464518771|FG000|Overall Study|Patient became ineligible for treatment|0|||
129063311|NCT02215967|464518772|FG001|Overall Study|Patient became ineligible for treatment|0|||
129063312|NCT02215967|464518773|FG002|Overall Study|Patient became ineligible for treatment|0|||
129063313|NCT02215967|464518774|FG003|Overall Study|Patient became ineligible for treatment|3|||
129063314|NCT02215967|464518771|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
129063315|NCT02215967|464518772|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
129063316|NCT02215967|464518773|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
129063317|NCT02215967|464518774|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
129063318|NCT00352417|464518775|FG000|Overall Study|Adverse Event|1|||
129063319|NCT00352417|464518776|FG001|Overall Study|Adverse Event|0|||
129063320|NCT00352417|464518775|FG000|Overall Study|Protocol Violation|0|||
129063321|NCT00352417|464518776|FG001|Overall Study|Protocol Violation|2|||
129063322|NCT00352417|464518775|FG000|Overall Study|Withdrawal by Subject|1|||
129063323|NCT00352417|464518776|FG001|Overall Study|Withdrawal by Subject|2|||
129063324|NCT00352417|464518775|FG000|Overall Study|Lost to Follow-up|1|||
129063325|NCT00352417|464518776|FG001|Overall Study|Lost to Follow-up|0|||
129063326|NCT00352417|464518775|FG000|Overall Study|Schedule Change|2|||
129063327|NCT00352417|464518776|FG001|Overall Study|Schedule Change|1|||
129063328|NCT01496976|464520397|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
129063329|NCT05292183|464520398|FG000|Overall Study|Adverse Event|1|||
129063330|NCT00371033|464520399|FG000|Overall Study|Lost to Follow-up|3|||
129063331|NCT00371033|464520400|FG001|Overall Study|Lost to Follow-up|2|||
129063332|NCT00371033|464520399|FG000|Overall Study|No longer interested|2|||
129063333|NCT00371033|464520400|FG001|Overall Study|No longer interested|0|||
129063334|NCT00371033|464520399|FG000|Overall Study|Uknown|3|||
129063335|NCT00371033|464520400|FG001|Overall Study|Uknown|1|||
129063336|NCT06400238|464520405|FG000|Overall Study|Started Protocol Therapy|2|||
129063337|NCT06400238|464520405|FG000|Overall Study|Adverse Event|1|||
129063338|NCT06400238|464520405|FG000|Overall Study|Death|1|||
129063339|NCT06400238|464520405|FG000|Overall Study|Disease Progression|27|||
129063340|NCT06400238|464520405|FG000|Overall Study|Withdrawal by Subject|2|||
129063341|NCT06400238|464520405|FG000|Overall Study|Physician Decision|2|||
129063342|NCT04034927|464520406|FG000|Overall Study|Adverse Event|4|||
129063343|NCT04034927|464520407|FG001|Overall Study|Adverse Event|9|||
129063344|NCT04034927|464520406|FG000|Overall Study|Death|0|||
129063345|NCT04034927|464520407|FG001|Overall Study|Death|1|||
129137285|NCT04595370|464794573|FG001|Overall Study|Withdrawal by Subject|0|||
129137286|NCT04595370|464794574|FG002|Overall Study|Withdrawal by Subject|1|||
129137287|NCT04595370|464794575|FG003|Overall Study|Withdrawal by Subject|0|||
129137288|NCT04595370|464794576|FG004|Overall Study|Withdrawal by Subject|2|||
129137289|NCT04595370|464794577|FG005|Overall Study|Withdrawal by Subject|0|||
129137290|NCT04595370|464794572|FG000|Overall Study|Lost to Follow-up|0|||
129137291|NCT04595370|464794573|FG001|Overall Study|Lost to Follow-up|0|||
129137292|NCT04595370|464794574|FG002|Overall Study|Lost to Follow-up|0|||
129137293|NCT04595370|464794575|FG003|Overall Study|Lost to Follow-up|0|||
129137294|NCT04595370|464794576|FG004|Overall Study|Lost to Follow-up|1|||
129137295|NCT04595370|464794577|FG005|Overall Study|Lost to Follow-up|0|||
129137296|NCT04595370|464794572|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
129137297|NCT04595370|464794573|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
129137298|NCT04595370|464794574|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
129137299|NCT04595370|464794575|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
129137300|NCT04595370|464794576|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
129137301|NCT04595370|464794577|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
129137302|NCT01341990|464794578|FG000|Overall Study|Adverse Event|0|||
129137303|NCT01341990|464794579|FG001|Overall Study|Adverse Event|1|||
129137304|NCT01341990|464794578|FG000|Overall Study|Torn Study Lens|1|||
129137305|NCT01341990|464794579|FG001|Overall Study|Torn Study Lens|0|||
129137306|NCT01341990|464794578|FG000|Overall Study|Withdrawal by Subject|2|||
129137307|NCT01341990|464794579|FG001|Overall Study|Withdrawal by Subject|0|||
129137308|NCT01751685|464794581|FG000|6-mo Followup|Missed study visit|1|||
129137309|NCT01751685|464794582|FG001|6-mo Followup|Missed study visit|0|||
129137310|NCT01751685|464794581|FG000|6-mo Followup|Withdrawal by Subject|2|||
129063346|NCT04034927|464520406|FG000|Overall Study|Withdrawal by Subject|0|||
129063347|NCT04034927|464520407|FG001|Overall Study|Withdrawal by Subject|3|||
129063348|NCT04034927|464520406|FG000|Overall Study|Still on Treatment|2|||
129063349|NCT04034927|464520407|FG001|Overall Study|Still on Treatment|1|||
129063350|NCT04034927|464520406|FG000|Overall Study|Other|1|||
129063351|NCT04034927|464520407|FG001|Overall Study|Other|1|||
129063352|NCT03996447|464520408|FG000|First MRI Examination|Adverse Event|2|||
129063353|NCT03996447|464520409|FG001|First MRI Examination|Adverse Event|0|||
129063354|NCT03996447|464520408|FG000|First MRI Examination|Withdrawal by Subject|1|||
129063355|NCT03996447|464520409|FG001|First MRI Examination|Withdrawal by Subject|2|||
129063356|NCT03996447|464520408|FG000|First MRI Examination|Protocol Violation|0|||
129063357|NCT03996447|464520409|FG001|First MRI Examination|Protocol Violation|1|||
129063358|NCT03996447|464520408|FG000|Washout|Adverse Event|2|||
129063359|NCT03996447|464520409|FG001|Washout|Adverse Event|0|||
129063360|NCT03996447|464520408|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
129063361|NCT03996447|464520409|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
129063362|NCT03996447|464520408|FG000|Washout|Withdrawal by Subject|0|||
129063363|NCT03996447|464520409|FG001|Washout|Withdrawal by Subject|1|||
129063364|NCT03996447|464520408|FG000|Washout|Other reason|1|||
129063365|NCT03996447|464520409|FG001|Washout|Other reason|1|||
129063366|NCT06351371|464520412|FG000|Overall Study|Mutation Status Not Confirmed|9|||
129063367|NCT06351371|464520412|FG000|Overall Study|Ineligible|1|||
129063368|NCT06351371|464520412|FG000|Overall Study|Adverse Event|4|||
129063369|NCT06351371|464520412|FG000|Overall Study|Death|1|||
129063370|NCT06351371|464520412|FG000|Overall Study|Disease progression|14|||
129063371|NCT06351371|464520412|FG000|Overall Study|Withdrawal by Subject|3|||
129063372|NCT06351371|464520412|FG000|Overall Study|Physician Decision|3|||
129063373|NCT01009814|464520414|FG000|Overall Study|No longer met study criteria|1|||
129063374|NCT01009814|464520415|FG001|Overall Study|No longer met study criteria|1|||
129063375|NCT01009814|464520416|FG002|Overall Study|No longer met study criteria|0|||
129063376|NCT01009814|464520417|FG003|Overall Study|No longer met study criteria|0|||
129063377|NCT01009814|464520418|FG004|Overall Study|No longer met study criteria|0|||
129063378|NCT00618371|464520419|FG000|Overall Study|Withdrawal by Subject|2|||
129063379|NCT03698019|464520422|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
129063380|NCT03698019|464520423|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
129063381|NCT03698019|464520422|FG000|Step 1: Registration|Withdrawal by Subject|7|||
129063382|NCT03698019|464520423|FG001|Step 1: Registration|Withdrawal by Subject|2|||
129063383|NCT03698019|464520422|FG000|Step 1: Registration|Toxicity|0|||
129063384|NCT03698019|464520423|FG001|Step 1: Registration|Toxicity|1|||
129063385|NCT03698019|464520422|FG000|Step 1: Registration|Disease Progression|0|||
129063386|NCT03698019|464520423|FG001|Step 1: Registration|Disease Progression|12|||
129063387|NCT03698019|464520422|FG000|Step 1: Registration|Co-morbidities|0|||
129063388|NCT03698019|464520423|FG001|Step 1: Registration|Co-morbidities|1|||
129063389|NCT03698019|464520422|FG000|Step 1: Registration|Scheduling Issues|1|||
129063390|NCT03698019|464520423|FG001|Step 1: Registration|Scheduling Issues|0|||
129063391|NCT03698019|464520422|FG000|Step 1: Registration|Participant Refusal|0|||
129063392|NCT03698019|464520423|FG001|Step 1: Registration|Participant Refusal|1|||
129063393|NCT03698019|464520422|FG000|Step 2: Surgery|Participant Refusal|2|||
129063394|NCT03698019|464520423|FG001|Step 2: Surgery|Participant Refusal|1|||
129063395|NCT03698019|464520422|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
129063396|NCT03698019|464520423|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
129063397|NCT03698019|464520422|FG000|Step 2: Surgery|Metastatic Disease|16|||
129063398|NCT03698019|464520423|FG001|Step 2: Surgery|Metastatic Disease|9|||
129137311|NCT01751685|464794582|FG001|6-mo Followup|Withdrawal by Subject|2|||
129137312|NCT01751685|464794581|FG000|6-mo Followup|Lost to Follow-up|0|||
129137313|NCT01751685|464794582|FG001|6-mo Followup|Lost to Follow-up|1|||
129137314|NCT01751685|464794581|FG000|12-mo Followup|Lost to Follow-up|5|||
129137315|NCT01751685|464794582|FG001|12-mo Followup|Lost to Follow-up|0|||
129063399|NCT03698019|464520422|FG000|Step 2: Surgery|Residual Disease|2|||
129063400|NCT03698019|464520423|FG001|Step 2: Surgery|Residual Disease|1|||
129063401|NCT03698019|464520422|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
129063402|NCT03698019|464520423|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
129063403|NCT03698019|464520422|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
129063404|NCT03698019|464520423|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
129137316|NCT04401293|464794583|FG000|Overall Study|Withdrawal by Subject|1|||
129063405|NCT03698019|464520422|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
129063406|NCT03698019|464520423|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
129063407|NCT03698019|464520422|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
129063408|NCT03698019|464520423|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
129063409|NCT03698019|464520422|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
129063410|NCT03698019|464520423|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
129137317|NCT04401293|464794584|FG001|Overall Study|Withdrawal by Subject|3|||
129063411|NCT03698019|464520422|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
129137318|NCT00694161|464794585|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
128775616|NCT01383993|463468391|FG001|Overall Study|Withdrawal by Subject|0|||
129063412|NCT03698019|464520423|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
129063413|NCT03698019|464520422|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
129063414|NCT03698019|464520423|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
128775617|NCT01383993|463468392|FG002|Overall Study|Withdrawal by Subject|1|||
128775618|NCT01383993|463468390|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
128775619|NCT01383993|463468391|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
128775620|NCT01383993|463468392|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
128775621|NCT02561455|463468395|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
128775622|NCT02561455|463468396|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
128775623|NCT02561455|463468397|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
128775624|NCT02561455|463468398|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
128775625|NCT02561455|463468395|FG000|Overall Study|Withdrawal by Subject|1|||
128775626|NCT02561455|463468396|FG001|Overall Study|Withdrawal by Subject|0|||
128775627|NCT02561455|463468397|FG002|Overall Study|Withdrawal by Subject|1|||
128775628|NCT02561455|463468398|FG003|Overall Study|Withdrawal by Subject|0|||
128775629|NCT02561455|463468395|FG000|Overall Study|Disease Progression|0|||
129063415|NCT03698019|464520422|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
129063416|NCT03698019|464520423|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
129063417|NCT00588770|464520424|FG000|Overall Study|Disease progression|85|||
129063418|NCT00588770|464520425|FG001|Overall Study|Disease progression|68|||
129063419|NCT00588770|464520424|FG000|Overall Study|Adverse Event|29|||
129063420|NCT00588770|464520425|FG001|Overall Study|Adverse Event|58|||
129063421|NCT00588770|464520424|FG000|Overall Study|Death|13|||
129063422|NCT00588770|464520425|FG001|Overall Study|Death|22|||
129063423|NCT00588770|464520424|FG000|Overall Study|Withdrawal by Subject|15|||
129063424|NCT00588770|464520425|FG001|Overall Study|Withdrawal by Subject|25|||
129063425|NCT00588770|464520424|FG000|Overall Study|Alternative therapy|2|||
129063426|NCT00588770|464520425|FG001|Overall Study|Alternative therapy|4|||
129063427|NCT00588770|464520424|FG000|Overall Study|Other complicating disease|3|||
129063428|NCT00588770|464520425|FG001|Overall Study|Other complicating disease|2|||
129063429|NCT00588770|464520424|FG000|Overall Study|Not start protocol therapy|0|||
129063430|NCT00588770|464520425|FG001|Overall Study|Not start protocol therapy|9|||
129063431|NCT00588770|464520424|FG000|Overall Study|Lack of Efficacy|8|||
129063432|NCT00588770|464520425|FG001|Overall Study|Lack of Efficacy|10|||
129063433|NCT00588770|464520424|FG000|Overall Study|Physician discretion|2|||
129063434|NCT00588770|464520425|FG001|Overall Study|Physician discretion|0|||
129137319|NCT00694161|464794585|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
129137320|NCT00694161|464794585|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
129137321|NCT00837330|464794586|FG000|Overall Study|Lost to Follow-up|1|||
129137322|NCT00837330|464794587|FG001|Overall Study|Lost to Follow-up|3|||
129137323|NCT01117350|464794595|FG000|Comparative Period|Not Treated|5|||
129137324|NCT01117350|464794596|FG001|Comparative Period|Not Treated|8|||
129137325|NCT01117350|464794595|FG000|Comparative Period|Adverse Event|6|||
129137326|NCT01117350|464794596|FG001|Comparative Period|Adverse Event|33|||
129137327|NCT01117350|464794595|FG000|Comparative Period|Lost to Follow-up|11|||
129137328|NCT01117350|464794596|FG001|Comparative Period|Lost to Follow-up|7|||
129137329|NCT01117350|464794595|FG000|Comparative Period|Withdrawal by Subject|9|||
129137330|NCT01117350|464794596|FG001|Comparative Period|Withdrawal by Subject|13|||
129137331|NCT01117350|464794595|FG000|Comparative Period|Protocol Violation|8|||
129137332|NCT01117350|464794596|FG001|Comparative Period|Protocol Violation|12|||
129137333|NCT01117350|464794595|FG000|Comparative Period|Lack of Efficacy|1|||
128720639|NCT02438722|463274983|FG000|Overall Study|Adverse Event|12|||
128720640|NCT02438722|463274984|FG001|Overall Study|Adverse Event|9|||
128720641|NCT02438722|463274983|FG000|Overall Study|Refusal unrelated to AE|2|||
128720642|NCT02438722|463274984|FG001|Overall Study|Refusal unrelated to AE|5|||
128720643|NCT02438722|463274983|FG000|Overall Study|Disease progression/relapse|46|||
128720644|NCT02438722|463274984|FG001|Overall Study|Disease progression/relapse|51|||
128720645|NCT02438722|463274983|FG000|Overall Study|Death|0|||
128720646|NCT02438722|463274984|FG001|Overall Study|Death|3|||
128720647|NCT02438722|463274983|FG000|Overall Study|Physician Decision|2|||
128720648|NCT02438722|463274984|FG001|Overall Study|Physician Decision|2|||
128720649|NCT02438722|463274983|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
128775630|NCT02561455|463468396|FG001|Overall Study|Disease Progression|1|||
128775631|NCT02561455|463468397|FG002|Overall Study|Disease Progression|0|||
128775632|NCT02561455|463468398|FG003|Overall Study|Disease Progression|0|||
128775633|NCT03249376|463468401|FG000|Overall Study|Adverse Event|11|||
128775634|NCT03249376|463468402|FG001|Overall Study|Adverse Event|5|||
129063435|NCT00588770|464520424|FG000|Overall Study|Patient non-compliance|2|||
129063436|NCT00588770|464520425|FG001|Overall Study|Patient non-compliance|2|||
128720650|NCT02438722|463274984|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
128720651|NCT02438722|463274983|FG000|Overall Study|Withdrawal by Subject|0|||
128720652|NCT02438722|463274984|FG001|Overall Study|Withdrawal by Subject|1|||
128720653|NCT02438722|463274983|FG000|Overall Study|On protocol treatment|15|||
128720654|NCT02438722|463274984|FG001|Overall Study|On protocol treatment|14|||
128720655|NCT02438722|463274983|FG000|Overall Study|Did not receive protocol treatment|5|||
128720656|NCT02438722|463274984|FG001|Overall Study|Did not receive protocol treatment|0|||
128720657|NCT00909779|463274985|FG000|Overall Study|Adverse Event|53|||
128720658|NCT00909779|463274986|FG001|Overall Study|Adverse Event|55|||
128720659|NCT00909779|463274985|FG000|Overall Study|Lack of Efficacy|7|||
128720660|NCT00909779|463274986|FG001|Overall Study|Lack of Efficacy|4|||
128720661|NCT00909779|463274985|FG000|Overall Study|Lost to Follow-up|19|||
128720662|NCT00909779|463274986|FG001|Overall Study|Lost to Follow-up|15|||
128720663|NCT00909779|463274985|FG000|Overall Study|Physician Decision|8|||
128720664|NCT00909779|463274986|FG001|Overall Study|Physician Decision|2|||
128720665|NCT00909779|463274985|FG000|Overall Study|Protocol Violation|2|||
128720666|NCT00909779|463274986|FG001|Overall Study|Protocol Violation|5|||
128720667|NCT00909779|463274985|FG000|Overall Study|Withdrawal by Subject|116|||
128720668|NCT00909779|463274986|FG001|Overall Study|Withdrawal by Subject|80|||
128720669|NCT00909779|463274985|FG000|Overall Study|Site Ceasing Operation|2|||
128720670|NCT00909779|463274986|FG001|Overall Study|Site Ceasing Operation|2|||
129063437|NCT02642042|464520426|FG000|Overall Study|Adverse Event|22|||
129063438|NCT02642042|464520426|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129063439|NCT02642042|464520426|FG000|Overall Study|Progression/Relapse|28|||
129063440|NCT02642042|464520426|FG000|Overall Study|Death|1|||
129063441|NCT02642042|464520426|FG000|Overall Study|Not Protocol Specified|2|||
129063442|NCT04976621|464520427|FG000|Overall Study|Lost to Follow-up|2|||
129063443|NCT04976621|464520428|FG001|Overall Study|Lost to Follow-up|1|||
129063444|NCT04976621|464520427|FG000|Overall Study|Withdrawal by Subject|1|||
128720671|NCT00909779|463274985|FG000|Overall Study|Medical Monitor Decision|1|||
128720672|NCT00909779|463274986|FG001|Overall Study|Medical Monitor Decision|0|||
128720673|NCT00909779|463274985|FG000|Overall Study|Noncompliance|1|||
128720674|NCT00909779|463274986|FG001|Overall Study|Noncompliance|1|||
128720675|NCT00909779|463274985|FG000|Overall Study|Randomized in error|1|||
128720676|NCT00909779|463274986|FG001|Overall Study|Randomized in error|1|||
128720677|NCT00949325|463274989|FG000|Overall Study|Adverse Event|0|||
128720678|NCT00949325|463274990|FG001|Overall Study|Adverse Event|2|||
128720679|NCT00949325|463274991|FG002|Overall Study|Adverse Event|0|||
128720680|NCT00791518|463274992|FG000|Overall Study|Protocol Violation|93|||
128720681|NCT01520363|463274993|FG000|Overall Study|Withdrawal by Subject|2|||
128720682|NCT01520363|463274994|FG001|Overall Study|Withdrawal by Subject|0|||
128720683|NCT01498952|463274998|FG000|Overall Study|Death|2|||
128720684|NCT01498952|463274999|FG001|Overall Study|Death|2|||
128720685|NCT01498952|463275000|FG002|Overall Study|Death|0|||
128720686|NCT01498952|463275001|FG003|Overall Study|Death|0|||
128720687|NCT01498952|463275002|FG004|Overall Study|Death|0|||
128720688|NCT04191382|463275003|FG000|Overall Study|Withdrawal by Subject|1|||
128720689|NCT04191382|463275004|FG001|Overall Study|Withdrawal by Subject|0|||
128720690|NCT04191382|463275005|FG002|Overall Study|Withdrawal by Subject|0|||
128720691|NCT05237206|463275006|FG000|Overall Study|screen failure-did not receive treatment|8|||
129063445|NCT04976621|464520428|FG001|Overall Study|Withdrawal by Subject|0|||
129137334|NCT01117350|464794596|FG001|Comparative Period|Lack of Efficacy|0|||
129137335|NCT01117350|464794595|FG000|Comparative Period|Physician Decision|0|||
129137336|NCT01117350|464794596|FG001|Comparative Period|Physician Decision|1|||
129137337|NCT01117350|464794595|FG000|Comparative Period|Move to another city/country|2|||
129137338|NCT01117350|464794596|FG001|Comparative Period|Move to another city/country|1|||
129137339|NCT01117350|464794595|FG000|Extension Period|Not included in extension, not treated|0|||
129137340|NCT01117350|464794596|FG001|Extension Period|Not included in extension, not treated|50|||
129137341|NCT01117350|464794595|FG000|Extension Period|Adverse Event|0|||
129137342|NCT01117350|464794596|FG001|Extension Period|Adverse Event|2|||
129137343|NCT01117350|464794595|FG000|Extension Period|Protocol Violation|0|||
129137344|NCT01117350|464794596|FG001|Extension Period|Protocol Violation|2|||
129137345|NCT01117350|464794595|FG000|Extension Period|Lost to Follow-up|0|||
129137346|NCT01117350|464794596|FG001|Extension Period|Lost to Follow-up|2|||
129137347|NCT01117350|464794595|FG000|Extension Period|Withdrawal by Subject|0|||
129137348|NCT01117350|464794596|FG001|Extension Period|Withdrawal by Subject|3|||
129137349|NCT01117350|464794595|FG000|Extension Period|Lack of Efficacy|0|||
129137350|NCT01117350|464794596|FG001|Extension Period|Lack of Efficacy|2|||
129137351|NCT01117350|464794595|FG000|Extension Period|Inclusion criteria not respected|0|||
128720692|NCT05237206|463275006|FG000|Overall Study|did not receive treatment|3|||
128720693|NCT00454987|463275010|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
128720694|NCT00454987|463275011|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
128720695|NCT00454987|463275012|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
129137352|NCT01117350|464794596|FG001|Extension Period|Inclusion criteria not respected|1|||
129137353|NCT01117350|464794595|FG000|Extension Period|Prohibited medication|0|||
129063446|NCT03348631|464520431|FG000|Overall Study|Not Eligible, No treatment|0|||
129063447|NCT03348631|464520432|FG001|Overall Study|Not Eligible, No treatment|1|||
129063448|NCT03348631|464520431|FG000|Overall Study|Not Eligible, Treated|2|||
129063449|NCT03348631|464520432|FG001|Overall Study|Not Eligible, Treated|0|||
129063450|NCT03348631|464520431|FG000|Overall Study|Eligible, No Treatment|1|||
129063451|NCT03348631|464520432|FG001|Overall Study|Eligible, No Treatment|0|||
129063452|NCT01625988|464520434|FG000|Overall Study|Lost to Follow-up|5|||
129063453|NCT01625988|464520435|FG001|Overall Study|Lost to Follow-up|6|||
129063454|NCT01625988|464520434|FG000|Overall Study|Withdrawal by Subject|8|||
129063455|NCT01625988|464520435|FG001|Overall Study|Withdrawal by Subject|3|||
129063456|NCT01625988|464520434|FG000|Overall Study|Adverse Event|0|||
129063457|NCT01625988|464520435|FG001|Overall Study|Adverse Event|1|||
129063458|NCT01625988|464520434|FG000|Overall Study|Lack of Efficacy|0|||
129063459|NCT01625988|464520435|FG001|Overall Study|Lack of Efficacy|1|||
129063460|NCT01625988|464520434|FG000|Overall Study|Randomized Inappropriately|1|||
129063461|NCT01625988|464520435|FG001|Overall Study|Randomized Inappropriately|0|||
129063462|NCT01625988|464520434|FG000|Overall Study|Protocol Violation|0|||
129063463|NCT01625988|464520435|FG001|Overall Study|Protocol Violation|2|||
129063464|NCT01644617|464520436|FG000|Overall Study|Withdrawal by Subject|3|||
129063465|NCT01644617|464520437|FG001|Overall Study|Withdrawal by Subject|4|||
129063466|NCT01644617|464520438|FG002|Overall Study|Withdrawal by Subject|1|||
129063467|NCT01644617|464520436|FG000|Overall Study|Lost to Follow-up|0|||
129063468|NCT01644617|464520437|FG001|Overall Study|Lost to Follow-up|1|||
129063469|NCT01644617|464520438|FG002|Overall Study|Lost to Follow-up|0|||
129063470|NCT01644617|464520436|FG000|Overall Study|Adverse Event|3|||
129063471|NCT01644617|464520437|FG001|Overall Study|Adverse Event|0|||
129063472|NCT01644617|464520438|FG002|Overall Study|Adverse Event|6|||
129063473|NCT01427608|464520442|FG000|Overall Study|Death|1|||
129063474|NCT01427608|464520443|FG001|Overall Study|Death|0|||
129063475|NCT01427608|464520442|FG000|Overall Study|Withdrawal by Subject|7|||
129063476|NCT01427608|464520443|FG001|Overall Study|Withdrawal by Subject|3|||
129063477|NCT01427608|464520442|FG000|Overall Study|Relapsed-all cause|13|||
129063478|NCT01427608|464520443|FG001|Overall Study|Relapsed-all cause|34|||
129063479|NCT01427608|464520442|FG000|Overall Study|Events not attributed to study meds|0|||
129063480|NCT01427608|464520443|FG001|Overall Study|Events not attributed to study meds|1|||
128720696|NCT00454987|463275010|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
128720697|NCT00454987|463275011|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
128720698|NCT00454987|463275012|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
128720699|NCT00454987|463275010|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
128720700|NCT00454987|463275011|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
128720701|NCT00454987|463275012|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
128720702|NCT01476696|463275013|FG000|Overall Study|Sponsor decision|2|||
128720703|NCT01476696|463275014|FG001|Overall Study|Sponsor decision|1|||
128720704|NCT01476696|463275015|FG002|Overall Study|Sponsor decision|0|||
128720705|NCT01476696|463275013|FG000|Overall Study|Withdrawal by Subject|1|||
128720706|NCT01476696|463275014|FG001|Overall Study|Withdrawal by Subject|0|||
128720707|NCT01476696|463275015|FG002|Overall Study|Withdrawal by Subject|0|||
128720708|NCT00728130|463275016|FG000|Overall Study|Withdrawal by Subject|1|||
128720709|NCT00728130|463275016|FG000|Overall Study|Paperwork not completed in time|1|||
128720710|NCT00728130|463275016|FG000|Overall Study|Physician Decision|1|||
128720711|NCT02073279|463275021|FG000|Double-blind Period|Adverse Event|1|||
128720712|NCT02073279|463275022|FG001|Double-blind Period|Adverse Event|1|||
128720713|NCT02073279|463275021|FG000|Double-blind Period|Switched to another treatment|1|||
128720714|NCT02073279|463275022|FG001|Double-blind Period|Switched to another treatment|2|||
128720715|NCT02073279|463275021|FG000|Double-blind Period|Protocol Violation|0|||
128720716|NCT02073279|463275022|FG001|Double-blind Period|Protocol Violation|1|||
128720717|NCT02073279|463275021|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
128720718|NCT02073279|463275022|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
128720719|NCT02073279|463275021|FG000|Double-blind Period|Withdrawal by Subject|2|||
128720720|NCT02073279|463275022|FG001|Double-blind Period|Withdrawal by Subject|2|||
128720721|NCT02073279|463275021|FG000|Open-label Extension Period|Adverse Event|1|||
128720722|NCT02073279|463275022|FG001|Open-label Extension Period|Adverse Event|0|||
128720723|NCT02073279|463275021|FG000|Open-label Extension Period|Lack of Efficacy|1|||
128720724|NCT02073279|463275022|FG001|Open-label Extension Period|Lack of Efficacy|0|||
128720725|NCT02073279|463275021|FG000|Open-label Extension Period|Lost to Follow-up|0|||
128720726|NCT02073279|463275022|FG001|Open-label Extension Period|Lost to Follow-up|4|||
128720727|NCT02073279|463275021|FG000|Open-label Extension Period|Switched to another treatment|1|||
128720728|NCT02073279|463275022|FG001|Open-label Extension Period|Switched to another treatment|4|||
128720729|NCT02073279|463275021|FG000|Open-label Extension Period|Protocol Violation|0|||
129063481|NCT03993379|464520444|FG000|Overall Study|The study was terminated early due to business decision.|0|||
129063482|NCT03993379|464520445|FG001|Overall Study|The study was terminated early due to business decision.|2|||
129063483|NCT03993379|464520446|FG002|Overall Study|The study was terminated early due to business decision.|0|||
129063484|NCT03993379|464520447|FG003|Overall Study|The study was terminated early due to business decision.|0|||
129063485|NCT03993379|464520444|FG000|Overall Study|Withdrawal by Subject|0|||
129063486|NCT03993379|464520445|FG001|Overall Study|Withdrawal by Subject|1|||
129063487|NCT03993379|464520446|FG002|Overall Study|Withdrawal by Subject|0|||
129063488|NCT03993379|464520447|FG003|Overall Study|Withdrawal by Subject|0|||
129063489|NCT05223920|464520448|FG000|Overall Study|Adverse Event|6|||
128720730|NCT02073279|463275022|FG001|Open-label Extension Period|Protocol Violation|1|||
128720731|NCT02073279|463275021|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
128720732|NCT02073279|463275022|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
128720733|NCT02073279|463275021|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
128720734|NCT02073279|463275022|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
128720735|NCT00973479|463275023|FG000|Overall Study|Lost to Follow-up|0|||
128720736|NCT00973479|463275024|FG001|Overall Study|Lost to Follow-up|3|||
128720737|NCT00973479|463275023|FG000|Overall Study|Death|2|||
128720738|NCT00973479|463275024|FG001|Overall Study|Death|2|||
128720739|NCT00973479|463275023|FG000|Overall Study|Withdrawal by Subject|15|||
128720740|NCT00973479|463275024|FG001|Overall Study|Withdrawal by Subject|16|||
128720741|NCT00973479|463275023|FG000|Overall Study|Lack of Efficacy|5|||
128720742|NCT00973479|463275024|FG001|Overall Study|Lack of Efficacy|7|||
128720743|NCT00973479|463275023|FG000|Overall Study|Adverse Event|12|||
128720744|NCT00973479|463275024|FG001|Overall Study|Adverse Event|32|||
128720745|NCT00973479|463275023|FG000|Overall Study|Protocol Violation|2|||
128720746|NCT00973479|463275024|FG001|Overall Study|Protocol Violation|2|||
128720747|NCT00973479|463275023|FG000|Overall Study|Other|1|||
128720748|NCT00973479|463275024|FG001|Overall Study|Other|7|||
128720749|NCT01737047|463275025|FG000|Overall Study|Death|10|||
128720750|NCT01737047|463275026|FG001|Overall Study|Death|0|||
128720751|NCT01737047|463275027|FG002|Overall Study|Death|1|||
128720752|NCT01737047|463275025|FG000|Overall Study|Withdrawal by Subject|17|||
128720753|NCT01737047|463275026|FG001|Overall Study|Withdrawal by Subject|11|||
128720754|NCT01737047|463275027|FG002|Overall Study|Withdrawal by Subject|4|||
128720755|NCT00335972|463275028|FG000|Overall Study|not given treatments|0|||
128720756|NCT00335972|463275029|FG001|Overall Study|not given treatments|3|||
128720757|NCT03965962|463275030|FG000|Overall Study|Adverse Event|1|||
128720758|NCT03965962|463275031|FG001|Overall Study|Adverse Event|0|||
128720759|NCT03965962|463275032|FG002|Overall Study|Adverse Event|0|||
128720760|NCT03965962|463275033|FG003|Overall Study|Adverse Event|0|||
128720761|NCT03965962|463275030|FG000|Overall Study|Protocol Violation|21|||
128720762|NCT03965962|463275031|FG001|Overall Study|Protocol Violation|4|||
128720763|NCT03965962|463275032|FG002|Overall Study|Protocol Violation|10|||
128720764|NCT03965962|463275033|FG003|Overall Study|Protocol Violation|5|||
128720765|NCT03965962|463275030|FG000|Overall Study|Lost to Follow-up|0|||
128720766|NCT03965962|463275031|FG001|Overall Study|Lost to Follow-up|1|||
128720767|NCT03965962|463275032|FG002|Overall Study|Lost to Follow-up|0|||
128720768|NCT03965962|463275033|FG003|Overall Study|Lost to Follow-up|0|||
128720769|NCT03965962|463275030|FG000|Overall Study|Withdrawal by Subject|3|||
128720770|NCT03965962|463275031|FG001|Overall Study|Withdrawal by Subject|0|||
128720771|NCT03965962|463275032|FG002|Overall Study|Withdrawal by Subject|0|||
128720772|NCT03965962|463275033|FG003|Overall Study|Withdrawal by Subject|1|||
128720773|NCT02039674|463275034|FG000|Overall Study|Adverse Event|0|||
128720774|NCT02039674|463275035|FG001|Overall Study|Adverse Event|0|||
128720775|NCT02039674|463275036|FG002|Overall Study|Adverse Event|0|||
128720776|NCT02039674|463275037|FG003|Overall Study|Adverse Event|1|||
128720777|NCT02039674|463275038|FG004|Overall Study|Adverse Event|0|||
128720778|NCT02039674|463275039|FG005|Overall Study|Adverse Event|0|||
128720779|NCT02039674|463275040|FG006|Overall Study|Adverse Event|0|||
128720780|NCT02039674|463275041|FG007|Overall Study|Adverse Event|0|||
128720781|NCT02039674|463275042|FG008|Overall Study|Adverse Event|2|||
128720782|NCT02039674|463275043|FG009|Overall Study|Adverse Event|1|||
128720783|NCT02039674|463275044|FG010|Overall Study|Adverse Event|0|||
128720784|NCT02039674|463275045|FG011|Overall Study|Adverse Event|2|||
128720785|NCT02039674|463275046|FG012|Overall Study|Adverse Event|3|||
128720786|NCT02039674|463275047|FG013|Overall Study|Adverse Event|1|||
128720787|NCT02039674|463275034|FG000|Overall Study|Death|2|||
128720788|NCT02039674|463275035|FG001|Overall Study|Death|0|||
128720789|NCT02039674|463275036|FG002|Overall Study|Death|2|||
128720790|NCT02039674|463275037|FG003|Overall Study|Death|3|||
128720791|NCT02039674|463275038|FG004|Overall Study|Death|0|||
128720792|NCT02039674|463275039|FG005|Overall Study|Death|0|||
128720793|NCT02039674|463275040|FG006|Overall Study|Death|1|||
128720794|NCT02039674|463275041|FG007|Overall Study|Death|0|||
128720795|NCT02039674|463275042|FG008|Overall Study|Death|2|||
128720796|NCT02039674|463275043|FG009|Overall Study|Death|0|||
128720797|NCT02039674|463275044|FG010|Overall Study|Death|1|||
128720798|NCT02039674|463275045|FG011|Overall Study|Death|3|||
128720799|NCT02039674|463275046|FG012|Overall Study|Death|2|||
128720800|NCT02039674|463275047|FG013|Overall Study|Death|8|||
128720801|NCT02039674|463275034|FG000|Overall Study|Excluded Medication|1|||
128720802|NCT02039674|463275035|FG001|Overall Study|Excluded Medication|1|||
128720803|NCT02039674|463275036|FG002|Overall Study|Excluded Medication|0|||
128720804|NCT02039674|463275037|FG003|Overall Study|Excluded Medication|1|||
128720805|NCT02039674|463275038|FG004|Overall Study|Excluded Medication|0|||
128720806|NCT02039674|463275039|FG005|Overall Study|Excluded Medication|1|||
129063490|NCT05223920|464520449|FG001|Overall Study|Adverse Event|3|||
128720807|NCT02039674|463275040|FG006|Overall Study|Excluded Medication|0|||
128720808|NCT02039674|463275041|FG007|Overall Study|Excluded Medication|0|||
128720809|NCT02039674|463275042|FG008|Overall Study|Excluded Medication|2|||
128720810|NCT02039674|463275043|FG009|Overall Study|Excluded Medication|3|||
128720811|NCT02039674|463275044|FG010|Overall Study|Excluded Medication|5|||
128720812|NCT02039674|463275045|FG011|Overall Study|Excluded Medication|6|||
128720813|NCT02039674|463275046|FG012|Overall Study|Excluded Medication|8|||
128720814|NCT02039674|463275047|FG013|Overall Study|Excluded Medication|3|||
128720815|NCT02039674|463275034|FG000|Overall Study|Lost to Follow-up|0|||
128720816|NCT02039674|463275035|FG001|Overall Study|Lost to Follow-up|0|||
128720817|NCT02039674|463275036|FG002|Overall Study|Lost to Follow-up|0|||
128720818|NCT02039674|463275037|FG003|Overall Study|Lost to Follow-up|0|||
128720819|NCT02039674|463275038|FG004|Overall Study|Lost to Follow-up|1|||
128720820|NCT02039674|463275039|FG005|Overall Study|Lost to Follow-up|1|||
128720821|NCT02039674|463275040|FG006|Overall Study|Lost to Follow-up|0|||
128720822|NCT02039674|463275041|FG007|Overall Study|Lost to Follow-up|0|||
128720823|NCT02039674|463275042|FG008|Overall Study|Lost to Follow-up|0|||
128720824|NCT02039674|463275043|FG009|Overall Study|Lost to Follow-up|0|||
128720825|NCT02039674|463275044|FG010|Overall Study|Lost to Follow-up|0|||
128720826|NCT02039674|463275045|FG011|Overall Study|Lost to Follow-up|2|||
128720827|NCT02039674|463275046|FG012|Overall Study|Lost to Follow-up|2|||
128720828|NCT02039674|463275047|FG013|Overall Study|Lost to Follow-up|1|||
128720829|NCT02039674|463275034|FG000|Overall Study|Physician Decision|0|||
128720830|NCT02039674|463275035|FG001|Overall Study|Physician Decision|0|||
128720831|NCT02039674|463275036|FG002|Overall Study|Physician Decision|0|||
128720832|NCT02039674|463275037|FG003|Overall Study|Physician Decision|0|||
128720833|NCT02039674|463275038|FG004|Overall Study|Physician Decision|0|||
128720834|NCT02039674|463275039|FG005|Overall Study|Physician Decision|0|||
128720835|NCT02039674|463275040|FG006|Overall Study|Physician Decision|0|||
128720836|NCT02039674|463275041|FG007|Overall Study|Physician Decision|0|||
128720837|NCT02039674|463275042|FG008|Overall Study|Physician Decision|0|||
128720838|NCT02039674|463275043|FG009|Overall Study|Physician Decision|0|||
128720839|NCT02039674|463275044|FG010|Overall Study|Physician Decision|0|||
128720840|NCT02039674|463275045|FG011|Overall Study|Physician Decision|1|||
128720841|NCT02039674|463275046|FG012|Overall Study|Physician Decision|1|||
128720842|NCT02039674|463275047|FG013|Overall Study|Physician Decision|0|||
128720843|NCT02039674|463275034|FG000|Overall Study|Progressive Disease|8|||
128720844|NCT02039674|463275035|FG001|Overall Study|Progressive Disease|8|||
128720845|NCT02039674|463275036|FG002|Overall Study|Progressive Disease|6|||
128720846|NCT02039674|463275037|FG003|Overall Study|Progressive Disease|7|||
128720847|NCT02039674|463275038|FG004|Overall Study|Progressive Disease|9|||
128720848|NCT02039674|463275039|FG005|Overall Study|Progressive Disease|10|||
128720849|NCT02039674|463275040|FG006|Overall Study|Progressive Disease|1|||
128720850|NCT02039674|463275041|FG007|Overall Study|Progressive Disease|3|||
128720851|NCT02039674|463275042|FG008|Overall Study|Progressive Disease|6|||
128720852|NCT02039674|463275043|FG009|Overall Study|Progressive Disease|4|||
128720853|NCT02039674|463275044|FG010|Overall Study|Progressive Disease|0|||
128720854|NCT02039674|463275045|FG011|Overall Study|Progressive Disease|34|||
128720855|NCT02039674|463275046|FG012|Overall Study|Progressive Disease|34|||
128720856|NCT02039674|463275047|FG013|Overall Study|Progressive Disease|18|||
128720857|NCT02039674|463275034|FG000|Overall Study|Withdrawal by Subject|1|||
128720858|NCT02039674|463275035|FG001|Overall Study|Withdrawal by Subject|2|||
128720859|NCT02039674|463275036|FG002|Overall Study|Withdrawal by Subject|3|||
128720860|NCT02039674|463275037|FG003|Overall Study|Withdrawal by Subject|0|||
128720861|NCT02039674|463275038|FG004|Overall Study|Withdrawal by Subject|1|||
128720862|NCT02039674|463275039|FG005|Overall Study|Withdrawal by Subject|0|||
128720863|NCT02039674|463275040|FG006|Overall Study|Withdrawal by Subject|0|||
128720864|NCT02039674|463275041|FG007|Overall Study|Withdrawal by Subject|0|||
128720865|NCT02039674|463275042|FG008|Overall Study|Withdrawal by Subject|0|||
128720866|NCT02039674|463275043|FG009|Overall Study|Withdrawal by Subject|1|||
128720867|NCT02039674|463275044|FG010|Overall Study|Withdrawal by Subject|1|||
128720868|NCT02039674|463275045|FG011|Overall Study|Withdrawal by Subject|4|||
128720869|NCT02039674|463275046|FG012|Overall Study|Withdrawal by Subject|6|||
128720870|NCT02039674|463275047|FG013|Overall Study|Withdrawal by Subject|2|||
128720871|NCT02039674|463275034|FG000|Overall Study|Clinical Progression|0|||
128720872|NCT02039674|463275035|FG001|Overall Study|Clinical Progression|0|||
128720873|NCT02039674|463275036|FG002|Overall Study|Clinical Progression|0|||
128720874|NCT02039674|463275037|FG003|Overall Study|Clinical Progression|0|||
128720875|NCT02039674|463275038|FG004|Overall Study|Clinical Progression|0|||
128720876|NCT02039674|463275039|FG005|Overall Study|Clinical Progression|0|||
128720877|NCT02039674|463275040|FG006|Overall Study|Clinical Progression|1|||
128720878|NCT02039674|463275041|FG007|Overall Study|Clinical Progression|0|||
128720879|NCT02039674|463275042|FG008|Overall Study|Clinical Progression|0|||
128720880|NCT02039674|463275043|FG009|Overall Study|Clinical Progression|0|||
128720881|NCT02039674|463275044|FG010|Overall Study|Clinical Progression|0|||
128720882|NCT02039674|463275045|FG011|Overall Study|Clinical Progression|0|||
128720883|NCT02039674|463275046|FG012|Overall Study|Clinical Progression|1|||
128720884|NCT02039674|463275047|FG013|Overall Study|Clinical Progression|0|||
128720885|NCT02039674|463275034|FG000|Overall Study|Sponsor Decision|1|||
128720886|NCT02039674|463275035|FG001|Overall Study|Sponsor Decision|1|||
128720887|NCT02039674|463275036|FG002|Overall Study|Sponsor Decision|1|||
128720888|NCT02039674|463275037|FG003|Overall Study|Sponsor Decision|1|||
128720889|NCT02039674|463275038|FG004|Overall Study|Sponsor Decision|1|||
128720890|NCT02039674|463275039|FG005|Overall Study|Sponsor Decision|0|||
128720891|NCT02039674|463275040|FG006|Overall Study|Sponsor Decision|0|||
128720892|NCT02039674|463275041|FG007|Overall Study|Sponsor Decision|0|||
128720893|NCT02039674|463275042|FG008|Overall Study|Sponsor Decision|0|||
128720894|NCT02039674|463275043|FG009|Overall Study|Sponsor Decision|3|||
128720895|NCT02039674|463275044|FG010|Overall Study|Sponsor Decision|0|||
128720896|NCT02039674|463275045|FG011|Overall Study|Sponsor Decision|8|||
128720897|NCT02039674|463275046|FG012|Overall Study|Sponsor Decision|5|||
128720898|NCT02039674|463275047|FG013|Overall Study|Sponsor Decision|0|||
128720899|NCT02039674|463275034|FG000|Overall Study|Other|0|||
128720900|NCT02039674|463275035|FG001|Overall Study|Other|0|||
128720901|NCT02039674|463275036|FG002|Overall Study|Other|0|||
128720902|NCT02039674|463275037|FG003|Overall Study|Other|0|||
128720903|NCT02039674|463275038|FG004|Overall Study|Other|0|||
128720904|NCT02039674|463275039|FG005|Overall Study|Other|0|||
128720905|NCT02039674|463275040|FG006|Overall Study|Other|0|||
128720906|NCT02039674|463275041|FG007|Overall Study|Other|0|||
128720907|NCT02039674|463275042|FG008|Overall Study|Other|0|||
128720908|NCT02039674|463275043|FG009|Overall Study|Other|0|||
128720909|NCT02039674|463275044|FG010|Overall Study|Other|0|||
128720910|NCT02039674|463275045|FG011|Overall Study|Other|0|||
128720911|NCT02039674|463275046|FG012|Overall Study|Other|1|||
128720912|NCT02039674|463275047|FG013|Overall Study|Other|0|||
128720913|NCT00729183|463275048|FG000|Overall Study|Adverse Event|11|||
128720914|NCT00729183|463275049|FG001|Overall Study|Adverse Event|5|||
128720915|NCT00729183|463275048|FG000|Overall Study|Lack of Efficacy|0|||
128720916|NCT00729183|463275049|FG001|Overall Study|Lack of Efficacy|1|||
128720917|NCT00729183|463275048|FG000|Overall Study|Lost to Follow-up|3|||
128720918|NCT00729183|463275049|FG001|Overall Study|Lost to Follow-up|1|||
128720919|NCT00729183|463275048|FG000|Overall Study|Physician Decision|1|||
128720920|NCT00729183|463275049|FG001|Overall Study|Physician Decision|1|||
128720921|NCT00729183|463275048|FG000|Overall Study|Protocol Violation|1|||
128720922|NCT00729183|463275049|FG001|Overall Study|Protocol Violation|0|||
128720923|NCT00729183|463275048|FG000|Overall Study|Withdrawal by Subject|9|||
128720924|NCT00729183|463275049|FG001|Overall Study|Withdrawal by Subject|7|||
128720925|NCT05497284|463275052|FG000|Overall Study|Adverse Event|1|||
128720926|NCT05497284|463275053|FG001|Overall Study|Adverse Event|0|||
128720927|NCT05497284|463275052|FG000|Overall Study|Physician Decision|0|||
128720928|NCT05497284|463275053|FG001|Overall Study|Physician Decision|1|||
128720929|NCT05497284|463275052|FG000|Overall Study|Study terminated by sponsor|7|||
128720930|NCT05497284|463275053|FG001|Overall Study|Study terminated by sponsor|4|||
128720931|NCT05497284|463275052|FG000|Overall Study|Subject Decision|0|||
128720932|NCT05497284|463275053|FG001|Overall Study|Subject Decision|1|||
128720933|NCT01502423|463275054|FG000|Overall Study|Withdrawal by Subject|0|||
128720934|NCT01502423|463275055|FG001|Overall Study|Withdrawal by Subject|1|||
128720935|NCT00567892|463275056|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
128720936|NCT00567892|463275057|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
128775635|NCT03249376|463468401|FG000|Overall Study|Lack of Efficacy|2|||
128775636|NCT03249376|463468402|FG001|Overall Study|Lack of Efficacy|4|||
128775637|NCT03249376|463468401|FG000|Overall Study|Protocol Violation|3|||
128775638|NCT03249376|463468402|FG001|Overall Study|Protocol Violation|2|||
128775639|NCT03249376|463468401|FG000|Overall Study|Physician Decision|0|||
128775640|NCT03249376|463468402|FG001|Overall Study|Physician Decision|2|||
128775641|NCT03249376|463468401|FG000|Overall Study|Withdrawal by Subject|3|||
128775642|NCT03249376|463468402|FG001|Overall Study|Withdrawal by Subject|9|||
128775643|NCT03249376|463468401|FG000|Overall Study|LTFU|2|||
128775644|NCT03249376|463468402|FG001|Overall Study|LTFU|1|||
128775645|NCT01686932|463468410|FG000|Period 1|Adverse Event|1|||
128775646|NCT01686932|463468411|FG001|Period 1|Adverse Event|1|||
128775647|NCT04716881|463468416|FG000|Overall Study|Adverse Event|1|||
128775648|NCT04716881|463468416|FG000|Overall Study|Lost to Follow-up|1|||
128775649|NCT01558674|463468419|FG000|Part 1|Study Terminated by Sponsor|10|||
128775650|NCT01558674|463468420|FG001|Part 1|Study Terminated by Sponsor|0|||
128775651|NCT01558674|463468419|FG000|Part 1|Withdrawal by Subject|1|||
128775652|NCT01558674|463468420|FG001|Part 1|Withdrawal by Subject|0|||
128775653|NCT04147260|463468421|FG000|Overall Study|Adverse Event|1|||
128775654|NCT04147260|463468422|FG001|Overall Study|Adverse Event|0|||
128775655|NCT04147260|463468423|FG002|Overall Study|Adverse Event|1|||
128775656|NCT04147260|463468424|FG003|Overall Study|Adverse Event|2|||
128775657|NCT04147260|463468425|FG004|Overall Study|Adverse Event|0|||
129137354|NCT01117350|464794596|FG001|Extension Period|Prohibited medication|1|||
129137355|NCT02946996|464794603|FG000|Overall Study|non-evaluable|3|||
129137356|NCT02946996|464794604|FG001|Overall Study|non-evaluable|6|||
129137357|NCT02946996|464794605|FG002|Overall Study|non-evaluable|5|||
129137358|NCT02562040|464796227|FG000|Overall Study|Lost to Follow-up|20|||
129137359|NCT02562040|464796228|FG001|Overall Study|Lost to Follow-up|28|||
129137360|NCT02562040|464796227|FG000|Overall Study|Withdrawal by Subject|8|||
129137361|NCT02562040|464796228|FG001|Overall Study|Withdrawal by Subject|7|||
129137362|NCT02562040|464796227|FG000|Overall Study|Adverse Event|1|||
129137363|NCT02562040|464796228|FG001|Overall Study|Adverse Event|0|||
128775658|NCT04147260|463468421|FG000|Overall Study|Withdrawal by Subject|0|||
129063491|NCT05223920|464520448|FG000|Overall Study|Death|2|||
129063492|NCT05223920|464520449|FG001|Overall Study|Death|0|||
129063493|NCT05223920|464520448|FG000|Overall Study|Disease Progression|1|||
129137364|NCT01902303|464796229|FG000|Overall Study|Adverse Event|0|||
129137365|NCT01902303|464796230|FG001|Overall Study|Adverse Event|1|||
129137366|NCT01902303|464796229|FG000|Overall Study|Lost to Follow-up|0|||
129137367|NCT01902303|464796230|FG001|Overall Study|Lost to Follow-up|1|||
129137368|NCT01902303|464796229|FG000|Overall Study|Protocol Violation|2|||
128775659|NCT04147260|463468422|FG001|Overall Study|Withdrawal by Subject|0|||
128775660|NCT04147260|463468423|FG002|Overall Study|Withdrawal by Subject|1|||
128775661|NCT04147260|463468424|FG003|Overall Study|Withdrawal by Subject|1|||
128775662|NCT04147260|463468425|FG004|Overall Study|Withdrawal by Subject|0|||
128775663|NCT01555021|463468426|FG000|Overall Study|Lost to Follow-up|1|||
128775664|NCT01555021|463468427|FG001|Overall Study|Lost to Follow-up|2|||
129063494|NCT05223920|464520449|FG001|Overall Study|Disease Progression|2|||
129063495|NCT05223920|464520448|FG000|Overall Study|Physician Decision|1|||
129063496|NCT05223920|464520449|FG001|Overall Study|Physician Decision|2|||
129063497|NCT05223920|464520448|FG000|Overall Study|Sponsor decision|11|||
129063498|NCT05223920|464520449|FG001|Overall Study|Sponsor decision|9|||
129063499|NCT05223920|464520448|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
129063500|NCT05223920|464520449|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
129063501|NCT05223920|464520448|FG000|Overall Study|Subject decision|1|||
129063502|NCT05223920|464520449|FG001|Overall Study|Subject decision|0|||
129063503|NCT05223920|464520448|FG000|Overall Study|Withdrawal by Subject|1|||
129063504|NCT05223920|464520449|FG001|Overall Study|Withdrawal by Subject|6|||
129063505|NCT03790657|464520450|FG000|Overall Study|Adverse Event|1|||
129063506|NCT03790657|464520451|FG001|Overall Study|Adverse Event|1|||
129063507|NCT03790657|464520450|FG000|Overall Study|Withdrawal by Subject|1|||
129063508|NCT03790657|464520451|FG001|Overall Study|Withdrawal by Subject|1|||
129063509|NCT01807065|464520452|FG000|Overall Study|Receive no sip-T due to IV access|1|||
129063510|NCT01807065|464520453|FG001|Overall Study|Receive no sip-T due to IV access|1|||
129063511|NCT05246670|464520458|FG000|Overall Study|Withdrawal by Subject|2|||
129063512|NCT05246670|464520459|FG001|Overall Study|Withdrawal by Subject|3|||
129063513|NCT05246670|464520460|FG002|Overall Study|Withdrawal by Subject|0|||
129063514|NCT05246670|464520461|FG003|Overall Study|Withdrawal by Subject|1|||
129063515|NCT05246670|464520458|FG000|Overall Study|Adverse Event|0|||
129063516|NCT05246670|464520459|FG001|Overall Study|Adverse Event|0|||
129137369|NCT01902303|464796230|FG001|Overall Study|Protocol Violation|2|||
128775665|NCT01734850|463468430|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
128775666|NCT01734850|463468431|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
129063517|NCT05246670|464520460|FG002|Overall Study|Adverse Event|1|||
129063518|NCT05246670|464520461|FG003|Overall Study|Adverse Event|0|||
128775667|NCT01734850|463468432|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
128775668|NCT01734850|463468430|FG000|Overall Study|Not infused due to manufacturing failure|0|||
128775669|NCT01734850|463468431|FG001|Overall Study|Not infused due to manufacturing failure|0|||
128775670|NCT01734850|463468432|FG002|Overall Study|Not infused due to manufacturing failure|1|||
129063519|NCT05246670|464520458|FG000|Overall Study|Physician Decision|1|||
129063520|NCT05246670|464520459|FG001|Overall Study|Physician Decision|0|||
129063521|NCT05246670|464520460|FG002|Overall Study|Physician Decision|0|||
129063522|NCT05246670|464520461|FG003|Overall Study|Physician Decision|0|||
129137370|NCT01902303|464796229|FG000|Overall Study|subject lost investigational product|0|||
129137371|NCT01902303|464796230|FG001|Overall Study|subject lost investigational product|1|||
129137372|NCT01902303|464796229|FG000|Overall Study|Did not develop a cold sore|21|||
129137373|NCT01902303|464796230|FG001|Overall Study|Did not develop a cold sore|19|||
129137374|NCT02821000|464796231|FG000|Overall Study|Death|89|||
129137375|NCT02821000|464796231|FG000|Overall Study|Sponsor Decision|12|||
129137376|NCT02821000|464796231|FG000|Overall Study|Withdrawal by Subject|2|||
129137377|NCT04359680|464796232|FG000|Overall Study|Withdrawal by Subject|29|||
128720937|NCT00567892|463275058|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
128720938|NCT00567892|463275059|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
128720939|NCT00567892|463275056|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
128720940|NCT00567892|463275057|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
128720941|NCT00567892|463275058|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
128720942|NCT00567892|463275059|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
128720943|NCT04383743|463275060|FG000|Overall Study|Withdrawal by Subject|1|||
128720944|NCT04383743|463275060|FG000|Overall Study|Adverse Event|1|||
128720945|NCT00489853|463277202|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
128720946|NCT00489853|463277203|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
128720947|NCT00489853|463277204|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
128720948|NCT00489853|463277202|FG000|Wash-out Period 1|Adverse Event|0|||
128720949|NCT00489853|463277203|FG001|Wash-out Period 1|Adverse Event|1|||
128720950|NCT00489853|463277204|FG002|Wash-out Period 1|Adverse Event|1|||
128720951|NCT00489853|463277202|FG000|Wash-out Period 1|Protocol Violation|0|||
128720952|NCT00489853|463277203|FG001|Wash-out Period 1|Protocol Violation|1|||
128720953|NCT00489853|463277204|FG002|Wash-out Period 1|Protocol Violation|1|||
128720954|NCT00489853|463277202|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
128720955|NCT00489853|463277203|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
128720956|NCT00489853|463277204|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
128720957|NCT00489853|463277202|FG000|Wash-out Period 2|Adverse Event|1|||
128720958|NCT00489853|463277203|FG001|Wash-out Period 2|Adverse Event|1|||
128720959|NCT00489853|463277204|FG002|Wash-out Period 2|Adverse Event|0|||
128720960|NCT00489853|463277202|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
128720961|NCT00489853|463277203|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
128720962|NCT00489853|463277204|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
128720963|NCT00489853|463277202|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
128720964|NCT00489853|463277203|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
128720965|NCT00489853|463277204|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
128720966|NCT02436759|463277205|FG000|Overall Study|Adverse Event|3|||
129063523|NCT05246670|464520458|FG000|Overall Study|Protocol Violation|1|||
129063524|NCT05246670|464520459|FG001|Overall Study|Protocol Violation|0|||
129063525|NCT05246670|464520460|FG002|Overall Study|Protocol Violation|0|||
129063526|NCT05246670|464520461|FG003|Overall Study|Protocol Violation|0|||
129063527|NCT03154125|464520467|FG000|Overall Study|Lost to Follow-up|11|||
129063528|NCT03154125|464520468|FG001|Overall Study|Lost to Follow-up|11|||
129063529|NCT03154125|464520469|FG002|Overall Study|Lost to Follow-up|0|||
129063530|NCT03154125|464520467|FG000|Overall Study|Withdrawal by Subject|49|||
129063531|NCT03154125|464520468|FG001|Overall Study|Withdrawal by Subject|55|||
129063532|NCT03154125|464520469|FG002|Overall Study|Withdrawal by Subject|8|||
129063533|NCT03154125|464520467|FG000|Overall Study|Physician Decision|13|||
129063534|NCT03154125|464520468|FG001|Overall Study|Physician Decision|6|||
129063535|NCT03154125|464520469|FG002|Overall Study|Physician Decision|0|||
129063536|NCT03154125|464520467|FG000|Overall Study|Protocol Violation|3|||
129063537|NCT03154125|464520468|FG001|Overall Study|Protocol Violation|5|||
129063538|NCT03154125|464520469|FG002|Overall Study|Protocol Violation|0|||
129063539|NCT00799058|464520470|FG000|Overall Study|Withdrawal by Subject|2|||
129063540|NCT00799058|464520471|FG001|Overall Study|Withdrawal by Subject|2|||
129063541|NCT00799058|464520472|FG002|Overall Study|Withdrawal by Subject|2|||
129063542|NCT00799058|464520470|FG000|Overall Study|Lost to Follow-up|1|||
129063543|NCT00799058|464520471|FG001|Overall Study|Lost to Follow-up|2|||
129063544|NCT00799058|464520472|FG002|Overall Study|Lost to Follow-up|1|||
129063545|NCT00799058|464520470|FG000|Overall Study|Adverse Event|0|||
128720967|NCT02436759|463277206|FG001|Overall Study|Adverse Event|0|||
128720968|NCT02436759|463277205|FG000|Overall Study|Protocol Violation|1|||
128720969|NCT02436759|463277206|FG001|Overall Study|Protocol Violation|0|||
128720970|NCT02436759|463277205|FG000|Overall Study|Withdrawal by Subject|0|||
129063546|NCT00799058|464520471|FG001|Overall Study|Adverse Event|2|||
129063547|NCT00799058|464520472|FG002|Overall Study|Adverse Event|0|||
129063548|NCT00799058|464520470|FG000|Overall Study|Pregnancy|1|||
129063549|NCT00799058|464520471|FG001|Overall Study|Pregnancy|0|||
129063550|NCT00799058|464520472|FG002|Overall Study|Pregnancy|0|||
129063551|NCT00799058|464520470|FG000|Overall Study|Not adherent|3|||
129063552|NCT00799058|464520471|FG001|Overall Study|Not adherent|2|||
129063553|NCT00799058|464520472|FG002|Overall Study|Not adherent|1|||
129063554|NCT00799058|464520470|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
129063555|NCT00799058|464520471|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
129063556|NCT00799058|464520472|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
129063557|NCT00799058|464520470|FG000|Overall Study|IP dispensing error|1|||
129063558|NCT00799058|464520471|FG001|Overall Study|IP dispensing error|0|||
129063559|NCT00799058|464520472|FG002|Overall Study|IP dispensing error|0|||
129063560|NCT00799058|464520470|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
129063561|NCT00799058|464520471|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
129063562|NCT00799058|464520472|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
129063563|NCT00799058|464520470|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
129063564|NCT00799058|464520471|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
129063565|NCT00799058|464520472|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
129063566|NCT00799058|464520470|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
129063567|NCT00799058|464520471|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
129063568|NCT00799058|464520472|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
129063569|NCT00799058|464520470|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
129063570|NCT00799058|464520471|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
129063571|NCT00799058|464520472|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
129063572|NCT03639779|464520473|FG000|Overall Study|Lost to Follow-up|1|||
129063573|NCT02088697|464520474|FG000|Period I|Physician Decision|1|||
129063574|NCT02088697|464520475|FG001|Period I|Physician Decision|4|||
129063575|NCT02088697|464520474|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
129063576|NCT02088697|464520475|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
129063577|NCT00810511|464520476|FG000|Overall Study|Protocol Violation|0|||
129063578|NCT00810511|464520477|FG001|Overall Study|Protocol Violation|1|||
129063579|NCT00810511|464520476|FG000|Overall Study|Lack of Efficacy|9|||
129063580|NCT00810511|464520477|FG001|Overall Study|Lack of Efficacy|1|||
129063581|NCT00810511|464520476|FG000|Overall Study|death in the family|0|||
129063582|NCT00810511|464520477|FG001|Overall Study|death in the family|1|||
129063583|NCT00810511|464520476|FG000|Overall Study|Lost to Follow-up|1|||
129063584|NCT00810511|464520477|FG001|Overall Study|Lost to Follow-up|0|||
129063585|NCT00810511|464520476|FG000|Overall Study|deposits on contact lens|0|||
129063586|NCT00810511|464520477|FG001|Overall Study|deposits on contact lens|1|||
129063587|NCT00462904|464520478|FG000|Overall Study|Lost to Follow-up|1|||
129063588|NCT05219448|464520479|FG000|Overall Study|Lost to Follow-up|9|||
129063589|NCT05219448|464520480|FG001|Overall Study|Lost to Follow-up|0|||
129063590|NCT00911300|464520484|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
129063591|NCT00911300|464520485|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
129063592|NCT00911300|464520484|FG000|Overall Study|Death|1|||
129063593|NCT00911300|464520485|FG001|Overall Study|Death|0|||
129137378|NCT04359680|464796233|FG001|Overall Study|Withdrawal by Subject|24|||
129137379|NCT04359680|464796232|FG000|Overall Study|Adverse Event|6|||
129137380|NCT04359680|464796233|FG001|Overall Study|Adverse Event|2|||
129137381|NCT04359680|464796232|FG000|Overall Study|Lost to Follow-up|56|||
129137382|NCT04359680|464796233|FG001|Overall Study|Lost to Follow-up|59|||
129137383|NCT04359680|464796232|FG000|Overall Study|Protocol Violation|3|||
129137384|NCT04359680|464796233|FG001|Overall Study|Protocol Violation|5|||
129137385|NCT04359680|464796232|FG000|Overall Study|Physician Decision|1|||
129137386|NCT04359680|464796233|FG001|Overall Study|Physician Decision|1|||
129137387|NCT04359680|464796232|FG000|Overall Study|Sponsor Decision|0|||
129137388|NCT04359680|464796233|FG001|Overall Study|Sponsor Decision|1|||
129137389|NCT01530256|464796234|FG000|Overall Study|Death|2|||
128720971|NCT02436759|463277206|FG001|Overall Study|Withdrawal by Subject|1|||
128720972|NCT00902564|463277207|FG000|Overall Study|Withdrawal by Subject|2|||
128720973|NCT00922766|463277208|FG000|Overall Study|Death|3|||
128720974|NCT00922766|463277208|FG000|Overall Study|Withdrawal by Subject|2|||
128720975|NCT00922766|463277208|FG000|Overall Study|Other|1|||
128720976|NCT00922766|463277208|FG000|Overall Study|Adverse Event|1|||
128720977|NCT03616912|463277211|FG000|Overall Study|Adverse Event|17|||
128720978|NCT03616912|463277212|FG001|Overall Study|Adverse Event|21|||
128720979|NCT03616912|463277213|FG002|Overall Study|Adverse Event|9|||
128720980|NCT03616912|463277214|FG003|Overall Study|Adverse Event|0|||
128720981|NCT03616912|463277215|FG004|Overall Study|Adverse Event|0|||
128720982|NCT03616912|463277216|FG005|Overall Study|Adverse Event|0|||
128720983|NCT03616912|463277211|FG000|Overall Study|Death|1|||
128720984|NCT03616912|463277212|FG001|Overall Study|Death|1|||
128720985|NCT03616912|463277213|FG002|Overall Study|Death|0|||
128720986|NCT03616912|463277214|FG003|Overall Study|Death|0|||
128720987|NCT03616912|463277215|FG004|Overall Study|Death|0|||
128720988|NCT03616912|463277216|FG005|Overall Study|Death|0|||
128720989|NCT03616912|463277211|FG000|Overall Study|Lack of Efficacy|13|||
128720990|NCT03616912|463277212|FG001|Overall Study|Lack of Efficacy|6|||
128720991|NCT03616912|463277213|FG002|Overall Study|Lack of Efficacy|8|||
128720992|NCT03616912|463277214|FG003|Overall Study|Lack of Efficacy|4|||
128720993|NCT03616912|463277215|FG004|Overall Study|Lack of Efficacy|5|||
128720994|NCT03616912|463277216|FG005|Overall Study|Lack of Efficacy|1|||
128720995|NCT03616912|463277211|FG000|Overall Study|Lost to Follow-up|1|||
128720996|NCT03616912|463277212|FG001|Overall Study|Lost to Follow-up|2|||
128720997|NCT03616912|463277213|FG002|Overall Study|Lost to Follow-up|3|||
128720998|NCT03616912|463277214|FG003|Overall Study|Lost to Follow-up|0|||
128720999|NCT03616912|463277215|FG004|Overall Study|Lost to Follow-up|0|||
128721000|NCT03616912|463277216|FG005|Overall Study|Lost to Follow-up|0|||
128721001|NCT03616912|463277211|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
128721002|NCT03616912|463277212|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
128721003|NCT03616912|463277213|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
128721004|NCT03616912|463277214|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
128721005|NCT03616912|463277215|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
128721006|NCT03616912|463277216|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
128721007|NCT03616912|463277211|FG000|Overall Study|Withdrawal by Subject|12|||
128721008|NCT03616912|463277212|FG001|Overall Study|Withdrawal by Subject|12|||
128721009|NCT03616912|463277213|FG002|Overall Study|Withdrawal by Subject|15|||
128721010|NCT03616912|463277214|FG003|Overall Study|Withdrawal by Subject|2|||
128721011|NCT03616912|463277215|FG004|Overall Study|Withdrawal by Subject|0|||
128721012|NCT03616912|463277216|FG005|Overall Study|Withdrawal by Subject|2|||
128721013|NCT03616912|463277211|FG000|Overall Study|Study Terminated by Sponsor|0|||
128721014|NCT03616912|463277212|FG001|Overall Study|Study Terminated by Sponsor|0|||
128721015|NCT03616912|463277213|FG002|Overall Study|Study Terminated by Sponsor|0|||
128721016|NCT03616912|463277214|FG003|Overall Study|Study Terminated by Sponsor|10|||
128721017|NCT03616912|463277215|FG004|Overall Study|Study Terminated by Sponsor|9|||
129137390|NCT02004275|464796235|FG000|Phase 1|Ineligible|0|||
129137391|NCT02004275|464796236|FG001|Phase 1|Ineligible|0|||
129137392|NCT02004275|464796237|FG002|Phase 1|Ineligible|0|||
128721018|NCT03616912|463277216|FG005|Overall Study|Study Terminated by Sponsor|11|||
128721019|NCT03616912|463277211|FG000|Overall Study|Protocol Deviation|1|||
128721020|NCT03616912|463277212|FG001|Overall Study|Protocol Deviation|1|||
128721021|NCT03616912|463277213|FG002|Overall Study|Protocol Deviation|0|||
128721022|NCT03616912|463277214|FG003|Overall Study|Protocol Deviation|0|||
128721023|NCT03616912|463277215|FG004|Overall Study|Protocol Deviation|0|||
128721024|NCT03616912|463277216|FG005|Overall Study|Protocol Deviation|0|||
128721025|NCT03616912|463277211|FG000|Overall Study|Pregnancy|1|||
128721026|NCT03616912|463277212|FG001|Overall Study|Pregnancy|0|||
128721027|NCT03616912|463277213|FG002|Overall Study|Pregnancy|4|||
128721028|NCT03616912|463277214|FG003|Overall Study|Pregnancy|0|||
128721029|NCT03616912|463277215|FG004|Overall Study|Pregnancy|0|||
128721030|NCT03616912|463277216|FG005|Overall Study|Pregnancy|0|||
128721031|NCT03616912|463277211|FG000|Overall Study|Protocol Violation|1|||
129137393|NCT02004275|464796238|FG003|Phase 1|Ineligible|1|||
129137394|NCT02004275|464796239|FG004|Phase 1|Ineligible|1|||
129063594|NCT00911300|464520484|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
129063595|NCT00911300|464520485|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
129063596|NCT00911300|464520484|FG000|Overall Study|Adverse Event|14|||
129063597|NCT00911300|464520485|FG001|Overall Study|Adverse Event|6|||
129063598|NCT00911300|464520484|FG000|Overall Study|Protocol Violation|3|||
129063599|NCT00911300|464520485|FG001|Overall Study|Protocol Violation|2|||
129063600|NCT00911300|464520484|FG000|Overall Study|Consent Withdrawn|4|||
129063601|NCT00911300|464520485|FG001|Overall Study|Consent Withdrawn|12|||
129063602|NCT00911300|464520484|FG000|Overall Study|Coronary Angiography Performed|1|||
129063603|NCT00911300|464520485|FG001|Overall Study|Coronary Angiography Performed|0|||
128721032|NCT03616912|463277212|FG001|Overall Study|Protocol Violation|0|||
128721033|NCT03616912|463277213|FG002|Overall Study|Protocol Violation|2|||
128721034|NCT03616912|463277214|FG003|Overall Study|Protocol Violation|0|||
128721035|NCT03616912|463277215|FG004|Overall Study|Protocol Violation|0|||
128721036|NCT03616912|463277216|FG005|Overall Study|Protocol Violation|0|||
128721037|NCT03616912|463277211|FG000|Overall Study|Physician Decision|2|||
128721038|NCT03616912|463277212|FG001|Overall Study|Physician Decision|0|||
128721039|NCT03616912|463277213|FG002|Overall Study|Physician Decision|0|||
128721040|NCT03616912|463277214|FG003|Overall Study|Physician Decision|0|||
128721041|NCT03616912|463277215|FG004|Overall Study|Physician Decision|1|||
128721042|NCT03616912|463277216|FG005|Overall Study|Physician Decision|0|||
128721043|NCT03616912|463277211|FG000|Overall Study|Randomized But Never Treated|0|||
128721044|NCT03616912|463277212|FG001|Overall Study|Randomized But Never Treated|2|||
128721045|NCT03616912|463277213|FG002|Overall Study|Randomized But Never Treated|0|||
128721046|NCT03616912|463277214|FG003|Overall Study|Randomized But Never Treated|0|||
128721047|NCT03616912|463277215|FG004|Overall Study|Randomized But Never Treated|0|||
128721048|NCT03616912|463277216|FG005|Overall Study|Randomized But Never Treated|0|||
128721049|NCT02510794|463277217|FG000|Overall Study|Adverse Event|0|||
128721050|NCT02510794|463277218|FG001|Overall Study|Adverse Event|1|||
128721051|NCT02510794|463277219|FG002|Overall Study|Adverse Event|0|||
128721052|NCT02510794|463277220|FG003|Overall Study|Adverse Event|0|||
128721053|NCT02510794|463277217|FG000|Overall Study|Death|1|||
128721054|NCT02510794|463277218|FG001|Overall Study|Death|2|||
128721055|NCT02510794|463277219|FG002|Overall Study|Death|1|||
128721056|NCT02510794|463277220|FG003|Overall Study|Death|1|||
128721057|NCT02510794|463277217|FG000|Overall Study|Lack of Efficacy|3|||
128721058|NCT02510794|463277218|FG001|Overall Study|Lack of Efficacy|1|||
128721059|NCT02510794|463277219|FG002|Overall Study|Lack of Efficacy|1|||
128721060|NCT02510794|463277220|FG003|Overall Study|Lack of Efficacy|0|||
128721061|NCT02510794|463277217|FG000|Overall Study|Participant moved out of the area|0|||
128721062|NCT02510794|463277218|FG001|Overall Study|Participant moved out of the area|0|||
128721063|NCT02510794|463277219|FG002|Overall Study|Participant moved out of the area|0|||
128721064|NCT02510794|463277220|FG003|Overall Study|Participant moved out of the area|1|||
128721065|NCT02510794|463277217|FG000|Overall Study|Physician Decision|3|||
128721066|NCT02510794|463277218|FG001|Overall Study|Physician Decision|0|||
128721067|NCT02510794|463277219|FG002|Overall Study|Physician Decision|0|||
128721068|NCT02510794|463277220|FG003|Overall Study|Physician Decision|0|||
128721069|NCT02510794|463277217|FG000|Overall Study|Protocol Violation|0|||
128721070|NCT02510794|463277218|FG001|Overall Study|Protocol Violation|0|||
128721071|NCT02510794|463277219|FG002|Overall Study|Protocol Violation|1|||
128721072|NCT02510794|463277220|FG003|Overall Study|Protocol Violation|0|||
128721073|NCT02510794|463277217|FG000|Overall Study|Withdrawal by Subject|1|||
128721074|NCT02510794|463277218|FG001|Overall Study|Withdrawal by Subject|2|||
128721075|NCT02510794|463277219|FG002|Overall Study|Withdrawal by Subject|4|||
128721076|NCT02510794|463277220|FG003|Overall Study|Withdrawal by Subject|3|||
128721077|NCT01649375|463277221|FG000|Up to Week 16|Adverse Event|2|||
128721078|NCT01649375|463277222|FG001|Up to Week 16|Adverse Event|5|||
128721079|NCT01649375|463277223|FG002|Up to Week 16|Adverse Event|4|||
128721080|NCT01649375|463277224|FG003|Up to Week 16|Adverse Event|0|||
128721081|NCT01649375|463277225|FG004|Up to Week 16|Adverse Event|0|||
128721082|NCT01649375|463277221|FG000|Up to Week 16|Lack of Efficacy|0|||
128721083|NCT01649375|463277222|FG001|Up to Week 16|Lack of Efficacy|0|||
129063604|NCT00911300|464520484|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
128721084|NCT01649375|463277223|FG002|Up to Week 16|Lack of Efficacy|1|||
128721085|NCT01649375|463277224|FG003|Up to Week 16|Lack of Efficacy|0|||
128721086|NCT01649375|463277225|FG004|Up to Week 16|Lack of Efficacy|0|||
128721087|NCT01649375|463277221|FG000|Up to Week 16|Physician Decision|0|||
128721088|NCT01649375|463277222|FG001|Up to Week 16|Physician Decision|0|||
128721089|NCT01649375|463277223|FG002|Up to Week 16|Physician Decision|1|||
128775671|NCT02204293|463468433|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
128721090|NCT01649375|463277224|FG003|Up to Week 16|Physician Decision|0|||
129063605|NCT00911300|464520485|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
129063606|NCT00911300|464520484|FG000|Overall Study|Received Commercial Treatment|1|||
129063607|NCT00911300|464520485|FG001|Overall Study|Received Commercial Treatment|0|||
129063608|NCT00911300|464520484|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
128721091|NCT01649375|463277225|FG004|Up to Week 16|Physician Decision|0|||
128721092|NCT01649375|463277221|FG000|Up to Week 16|Withdrawal by Subject|2|||
128721093|NCT01649375|463277222|FG001|Up to Week 16|Withdrawal by Subject|1|||
128775672|NCT02204293|463468434|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
128775673|NCT02204293|463468435|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
128775674|NCT02204293|463468436|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
128775675|NCT02204293|463468437|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
128775676|NCT02204293|463468438|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
128775677|NCT02204293|463468433|FG000|Core Study Part I|Adverse Event|1|||
128775678|NCT02204293|463468434|FG001|Core Study Part I|Adverse Event|0|||
128775679|NCT02204293|463468435|FG002|Core Study Part I|Adverse Event|0|||
128775680|NCT02204293|463468436|FG003|Core Study Part I|Adverse Event|0|||
128775681|NCT02204293|463468437|FG004|Core Study Part I|Adverse Event|0|||
128775682|NCT02204293|463468438|FG005|Core Study Part I|Adverse Event|0|||
128775683|NCT02204293|463468433|FG000|Core Study Part I|Physician Decision|0|||
128775684|NCT02204293|463468434|FG001|Core Study Part I|Physician Decision|3|||
128775685|NCT02204293|463468435|FG002|Core Study Part I|Physician Decision|0|||
128775686|NCT02204293|463468436|FG003|Core Study Part I|Physician Decision|0|||
128775687|NCT02204293|463468437|FG004|Core Study Part I|Physician Decision|0|||
128775688|NCT02204293|463468438|FG005|Core Study Part I|Physician Decision|0|||
128775689|NCT02204293|463468433|FG000|LTE Phase|Study Suspended|0|||
128775690|NCT02204293|463468434|FG001|LTE Phase|Study Suspended|0|||
128775691|NCT02204293|463468435|FG002|LTE Phase|Study Suspended|0|||
128775692|NCT02204293|463468436|FG003|LTE Phase|Study Suspended|0|||
128775693|NCT02204293|463468437|FG004|LTE Phase|Study Suspended|0|||
128775694|NCT02204293|463468438|FG005|LTE Phase|Study Suspended|7|||
128775695|NCT02019602|463468439|FG000|Screening Period|Ineligibility|4|||
128775696|NCT02019602|463468440|FG001|Screening Period|Ineligibility|0|||
128775697|NCT02019602|463468439|FG000|Screening Period|Adverse Event|1|||
128775698|NCT02019602|463468440|FG001|Screening Period|Adverse Event|0|||
128775699|NCT00322374|463468441|FG000|Starting Dose|Physician Decision|2|||
128775700|NCT00322374|463468442|FG001|Starting Dose|Physician Decision|0|||
128775701|NCT00322374|463468443|FG002|Starting Dose|Physician Decision|0|||
128775702|NCT00322374|463468444|FG003|Starting Dose|Physician Decision|0|||
128775703|NCT00322374|463468441|FG000|Starting Dose|Study Drug Toxicity|4|||
128775704|NCT00322374|463468442|FG001|Starting Dose|Study Drug Toxicity|0|||
128775705|NCT00322374|463468443|FG002|Starting Dose|Study Drug Toxicity|0|||
128775706|NCT00322374|463468444|FG003|Starting Dose|Study Drug Toxicity|0|||
128775707|NCT00322374|463468441|FG000|First Escalation|Documented Disease Progression|0|||
128775708|NCT00322374|463468442|FG001|First Escalation|Documented Disease Progression|6|||
128775709|NCT00322374|463468443|FG002|First Escalation|Documented Disease Progression|0|||
128775710|NCT00322374|463468444|FG003|First Escalation|Documented Disease Progression|0|||
128775711|NCT00322374|463468441|FG000|First Escalation|Physician Decision|0|||
128775712|NCT00322374|463468442|FG001|First Escalation|Physician Decision|12|||
128775713|NCT00322374|463468443|FG002|First Escalation|Physician Decision|0|||
128775714|NCT00322374|463468444|FG003|First Escalation|Physician Decision|0|||
128775715|NCT00322374|463468441|FG000|First Escalation|Study Drug Toxicity|0|||
128775716|NCT00322374|463468442|FG001|First Escalation|Study Drug Toxicity|11|||
128775717|NCT00322374|463468443|FG002|First Escalation|Study Drug Toxicity|0|||
128775718|NCT00322374|463468444|FG003|First Escalation|Study Drug Toxicity|0|||
128775719|NCT00322374|463468441|FG000|First Escalation|Participant Request|0|||
128775720|NCT00322374|463468442|FG001|First Escalation|Participant Request|1|||
128775721|NCT00322374|463468443|FG002|First Escalation|Participant Request|0|||
129063609|NCT00911300|464520485|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
129063610|NCT00911300|464520484|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
129063611|NCT00911300|464520485|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
129063612|NCT00911300|464520484|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
129063613|NCT00911300|464520485|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
129063614|NCT00911300|464520484|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
129063615|NCT00911300|464520485|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
129063616|NCT00911300|464520484|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
129063617|NCT00911300|464520485|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
129063618|NCT00911300|464520484|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
129063619|NCT00911300|464520485|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
129063620|NCT00911300|464520484|FG000|Overall Study|International Normalized Ratio Too High|0|||
129063621|NCT00911300|464520485|FG001|Overall Study|International Normalized Ratio Too High|1|||
129063622|NCT00911300|464520484|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
129063623|NCT00911300|464520485|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
129137395|NCT02004275|464796240|FG005|Phase 1|Ineligible|0|||
129137396|NCT02004275|464796235|FG000|Phase 1|Protocol Violation|0|||
129137397|NCT02004275|464796236|FG001|Phase 1|Protocol Violation|0|||
128775722|NCT00322374|463468444|FG003|First Escalation|Participant Request|0|||
128775723|NCT00322374|463468441|FG000|Second Escalation|Physician Decision|0|||
129063624|NCT00911300|464520484|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
129137398|NCT02004275|464796237|FG002|Phase 1|Protocol Violation|0|||
128775724|NCT00322374|463468442|FG001|Second Escalation|Physician Decision|0|||
128775725|NCT00322374|463468443|FG002|Second Escalation|Physician Decision|5|||
128775726|NCT00322374|463468444|FG003|Second Escalation|Physician Decision|0|||
128775727|NCT00322374|463468441|FG000|Second Escalation|Study Drug Toxicity|0|||
128775728|NCT00322374|463468442|FG001|Second Escalation|Study Drug Toxicity|0|||
128775729|NCT00322374|463468443|FG002|Second Escalation|Study Drug Toxicity|1|||
128775730|NCT00322374|463468444|FG003|Second Escalation|Study Drug Toxicity|0|||
128775731|NCT01058863|463468445|FG000|Overall Study|Lost to Follow-up|1|||
128775732|NCT01058863|463468445|FG000|Overall Study|Withdrawal by Subject|1|||
128775733|NCT01058863|463468445|FG000|Overall Study|Sponsor requested withdrawal|1|||
128775734|NCT01058863|463468445|FG000|Overall Study|Randomized in error|1|||
128775735|NCT00681187|463468446|FG000|Overall Study|Withdrawal by Subject|1|||
128775736|NCT00681187|463468447|FG001|Overall Study|Withdrawal by Subject|0|||
129137399|NCT02004275|464796238|FG003|Phase 1|Protocol Violation|1|||
128721094|NCT01649375|463277223|FG002|Up to Week 16|Withdrawal by Subject|2|||
128721095|NCT01649375|463277224|FG003|Up to Week 16|Withdrawal by Subject|0|||
128721096|NCT01649375|463277225|FG004|Up to Week 16|Withdrawal by Subject|0|||
128721097|NCT01649375|463277221|FG000|Up to Week 16|Death|1|||
128721098|NCT01649375|463277222|FG001|Up to Week 16|Death|0|||
128721099|NCT01649375|463277223|FG002|Up to Week 16|Death|0|||
128721100|NCT01649375|463277224|FG003|Up to Week 16|Death|0|||
128721101|NCT01649375|463277225|FG004|Up to Week 16|Death|0|||
128721102|NCT01649375|463277221|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
128721103|NCT01649375|463277222|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
128721104|NCT01649375|463277223|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
128721105|NCT01649375|463277224|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
128721106|NCT01649375|463277225|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
128721107|NCT01649375|463277221|FG000|Week 16 up to Week 260|Non-compliance|0|||
128721108|NCT01649375|463277222|FG001|Week 16 up to Week 260|Non-compliance|1|||
128721109|NCT01649375|463277223|FG002|Week 16 up to Week 260|Non-compliance|0|||
128721110|NCT01649375|463277224|FG003|Week 16 up to Week 260|Non-compliance|1|||
128721111|NCT01649375|463277225|FG004|Week 16 up to Week 260|Non-compliance|0|||
128721112|NCT01649375|463277221|FG000|Week 16 up to Week 260|Physician Decision|0|||
128721113|NCT01649375|463277222|FG001|Week 16 up to Week 260|Physician Decision|2|||
128721114|NCT01649375|463277223|FG002|Week 16 up to Week 260|Physician Decision|0|||
128721115|NCT01649375|463277224|FG003|Week 16 up to Week 260|Physician Decision|0|||
128721116|NCT01649375|463277225|FG004|Week 16 up to Week 260|Physician Decision|0|||
128721117|NCT01649375|463277221|FG000|Week 16 up to Week 260|Technical issues|0|||
128721118|NCT01649375|463277222|FG001|Week 16 up to Week 260|Technical issues|1|||
128721119|NCT01649375|463277223|FG002|Week 16 up to Week 260|Technical issues|0|||
128721120|NCT01649375|463277224|FG003|Week 16 up to Week 260|Technical issues|1|||
128721121|NCT01649375|463277225|FG004|Week 16 up to Week 260|Technical issues|0|||
128721122|NCT01649375|463277221|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
128721123|NCT01649375|463277222|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
128721124|NCT01649375|463277223|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
128721125|NCT01649375|463277224|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
128721126|NCT01649375|463277225|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
128721127|NCT01649375|463277221|FG000|Week 16 up to Week 260|Death|1|||
128721128|NCT01649375|463277222|FG001|Week 16 up to Week 260|Death|1|||
128721129|NCT01649375|463277223|FG002|Week 16 up to Week 260|Death|0|||
128721130|NCT01649375|463277224|FG003|Week 16 up to Week 260|Death|0|||
128721131|NCT01649375|463277225|FG004|Week 16 up to Week 260|Death|0|||
128721132|NCT01649375|463277221|FG000|Week 16 up to Week 260|Adverse Event|5|||
128721133|NCT01649375|463277222|FG001|Week 16 up to Week 260|Adverse Event|2|||
128721134|NCT01649375|463277223|FG002|Week 16 up to Week 260|Adverse Event|0|||
128721135|NCT01649375|463277224|FG003|Week 16 up to Week 260|Adverse Event|3|||
128721136|NCT01649375|463277225|FG004|Week 16 up to Week 260|Adverse Event|2|||
129137400|NCT02004275|464796239|FG004|Phase 1|Protocol Violation|0|||
129137401|NCT02004275|464796240|FG005|Phase 1|Protocol Violation|5|||
129137402|NCT02004275|464796235|FG000|Phase 2 Part 1|Ineligible|6|||
129137403|NCT02004275|464796236|FG001|Phase 2 Part 1|Ineligible|9|||
129137404|NCT02004275|464796237|FG002|Phase 2 Part 1|Ineligible|0|||
129137405|NCT02004275|464796238|FG003|Phase 2 Part 1|Ineligible|0|||
129137406|NCT02004275|464796239|FG004|Phase 2 Part 1|Ineligible|0|||
129137407|NCT02004275|464796240|FG005|Phase 2 Part 1|Ineligible|0|||
128721137|NCT01124604|463277226|FG000|Overall Study|Adverse Event|10|||
128721138|NCT01124604|463277227|FG001|Overall Study|Adverse Event|1|||
128721139|NCT01124604|463277226|FG000|Overall Study|Lack of Efficacy|1|||
128721140|NCT01124604|463277227|FG001|Overall Study|Lack of Efficacy|0|||
129137408|NCT02004275|464796235|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
128721141|NCT01124604|463277226|FG000|Overall Study|Withdrawal by Subject|4|||
128721142|NCT01124604|463277227|FG001|Overall Study|Withdrawal by Subject|0|||
128721143|NCT01124604|463277226|FG000|Overall Study|Disease Progression|0|||
128721144|NCT01124604|463277227|FG001|Overall Study|Disease Progression|1|||
128775737|NCT00681187|463468446|FG000|Overall Study|Death|0|||
128775738|NCT00681187|463468447|FG001|Overall Study|Death|1|||
129137409|NCT02004275|464796236|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
129137410|NCT02004275|464796237|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
128775739|NCT00681187|463468446|FG000|Overall Study|Adverse Event|0|||
129137411|NCT02004275|464796238|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
129137412|NCT02004275|464796239|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
128721145|NCT01856790|463277228|FG000|Closed Loop Control|Withdrawal by Subject|2|||
129063625|NCT00911300|464520485|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
129063626|NCT00911300|464520484|FG000|Overall Study|Physician Decision|0|||
129063627|NCT00911300|464520485|FG001|Overall Study|Physician Decision|1|||
129063628|NCT00911300|464520484|FG000|Overall Study|Treatment Stopped by Mistake|0|||
129063629|NCT00911300|464520485|FG001|Overall Study|Treatment Stopped by Mistake|1|||
129063630|NCT00911300|464520484|FG000|Overall Study|Randomized; No Study Medication Received|0|||
129063631|NCT00911300|464520485|FG001|Overall Study|Randomized; No Study Medication Received|2|||
129063632|NCT02287922|464520486|FG000|Overall Study|Adverse Event|1|||
129063633|NCT02287922|464520487|FG001|Overall Study|Adverse Event|1|||
129063634|NCT02287922|464520488|FG002|Overall Study|Adverse Event|3|||
129063635|NCT02287922|464520489|FG003|Overall Study|Adverse Event|4|||
129063636|NCT02287922|464520486|FG000|Overall Study|Withdrawal by Subject|1|||
129063637|NCT02287922|464520487|FG001|Overall Study|Withdrawal by Subject|1|||
129063638|NCT02287922|464520488|FG002|Overall Study|Withdrawal by Subject|1|||
129063639|NCT02287922|464520489|FG003|Overall Study|Withdrawal by Subject|2|||
129063640|NCT02287922|464520486|FG000|Overall Study|Lost to Follow-up|0|||
129063641|NCT02287922|464520487|FG001|Overall Study|Lost to Follow-up|0|||
129063642|NCT02287922|464520488|FG002|Overall Study|Lost to Follow-up|1|||
129063643|NCT02287922|464520489|FG003|Overall Study|Lost to Follow-up|0|||
129063644|NCT02287922|464520486|FG000|Overall Study|Sponsor's decision|0|||
129063645|NCT02287922|464520487|FG001|Overall Study|Sponsor's decision|0|||
129063646|NCT02287922|464520488|FG002|Overall Study|Sponsor's decision|0|||
129063647|NCT02287922|464520489|FG003|Overall Study|Sponsor's decision|1|||
129063648|NCT02287922|464520486|FG000|Overall Study|Other|1|||
129063649|NCT02287922|464520487|FG001|Overall Study|Other|0|||
129063650|NCT02287922|464520488|FG002|Overall Study|Other|2|||
129063651|NCT02287922|464520489|FG003|Overall Study|Other|0|||
129063652|NCT04152291|464520490|FG000|Overall Study|Covid-19 restrictions|27|||
129063653|NCT04152291|464520490|FG000|Overall Study|Withdrawal by Subject|3|||
129063654|NCT05124691|464520491|FG000|Phase II|Eligibility criteria|0|||
129063655|NCT05124691|464520492|FG001|Phase II|Eligibility criteria|1|||
129063656|NCT05124691|464520493|FG002|Phase II|Eligibility criteria|0|||
129063657|NCT05124691|464520491|FG000|Phase II|Withdrawal by Subject|6|||
129063658|NCT05124691|464520492|FG001|Phase II|Withdrawal by Subject|2|||
129063659|NCT05124691|464520493|FG002|Phase II|Withdrawal by Subject|3|||
129063660|NCT05124691|464520491|FG000|Phase III|Withdrawal by Subject|6|||
129063661|NCT05124691|464520492|FG001|Phase III|Withdrawal by Subject|4|||
129063662|NCT05124691|464520493|FG002|Phase III|Withdrawal by Subject|4|||
129063663|NCT05124691|464520491|FG000|Phase III|Lost to Follow-up|1|||
129063664|NCT05124691|464520492|FG001|Phase III|Lost to Follow-up|0|||
129063665|NCT05124691|464520493|FG002|Phase III|Lost to Follow-up|0|||
129063666|NCT04223752|464520496|FG000|Overall Study|Participant enrolled in error|0|||
129063667|NCT04223752|464520497|FG001|Overall Study|Participant enrolled in error|0|||
129063668|NCT04223752|464520498|FG002|Overall Study|Participant enrolled in error|0|||
129063669|NCT04223752|464520499|FG003|Overall Study|Participant enrolled in error|0|||
129063670|NCT04223752|464520500|FG004|Overall Study|Participant enrolled in error|1|||
129063671|NCT04223752|464520496|FG000|Overall Study|Death|0|||
129063672|NCT04223752|464520497|FG001|Overall Study|Death|0|||
129063673|NCT04223752|464520498|FG002|Overall Study|Death|0|||
129063674|NCT04223752|464520499|FG003|Overall Study|Death|2|||
129063675|NCT04223752|464520500|FG004|Overall Study|Death|1|||
129063676|NCT00447993|464520503|FG000|Overall Study|Lost to Follow-up|0|||
129063677|NCT00447993|464520504|FG001|Overall Study|Lost to Follow-up|0|||
129063678|NCT00447993|464520505|FG002|Overall Study|Lost to Follow-up|2|||
129063679|NCT00447993|464520506|FG003|Overall Study|Lost to Follow-up|2|||
129063680|NCT00447993|464520503|FG000|Overall Study|Withdrawal by Subject|0|||
129063681|NCT00447993|464520504|FG001|Overall Study|Withdrawal by Subject|0|||
129063682|NCT00447993|464520505|FG002|Overall Study|Withdrawal by Subject|2|||
129063683|NCT00447993|464520506|FG003|Overall Study|Withdrawal by Subject|2|||
129063684|NCT02503787|464520507|FG000|Enrollment|Withdrawal by Subject|6|||
129063685|NCT02503787|464520507|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
129063686|NCT02503787|464520507|FG000|Enrollment|Physician Decision|2|||
129063687|NCT02503787|464520507|FG000|Enrollment|Insurance issue|2|||
129063688|NCT02503787|464520507|FG000|Enrollment|Lost to Follow-up|1|||
129063689|NCT02503787|464520507|FG000|Enrollment|Study closure|1|||
129063690|NCT02503787|464520507|FG000|Enrollment|Adverse Event|1|||
129063691|NCT02503787|464520507|FG000|Enrollment|Protocol Violation|1|||
129063692|NCT02503787|464520507|FG000|Enrollment|Inability to implant system|1|||
129063693|NCT02503787|464520507|FG000|Enrollment|Unable to be programmed|1|||
129063694|NCT02503787|464520507|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
129063695|NCT02503787|464520507|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
129137413|NCT02004275|464796240|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
129063696|NCT02503787|464520507|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
129063697|NCT02503787|464520507|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
129063698|NCT02503787|464520507|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
129063699|NCT02503787|464520507|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
129063700|NCT04787627|464520508|FG000|Overall Study|Withdrawal by Subject|3|||
129063701|NCT04787627|464520509|FG001|Overall Study|Withdrawal by Subject|0|||
129063702|NCT04787627|464520508|FG000|Overall Study|Physician Decision|2|||
129063703|NCT04787627|464520509|FG001|Overall Study|Physician Decision|0|||
129063704|NCT04787627|464520508|FG000|Overall Study|Excluded|0|||
129063705|NCT04787627|464520509|FG001|Overall Study|Excluded|1|||
129063706|NCT00174954|464520511|FG000|Overall Study|Adverse Event|2|||
129063707|NCT00174954|464520511|FG000|Overall Study|No tophi found in MRI|1|||
129063708|NCT00174954|464520511|FG000|Overall Study|Physician Decision|1|||
129063709|NCT00839254|464520512|FG000|Overall Study|Protocol Violation|0|||
129063710|NCT00839254|464520513|FG001|Overall Study|Protocol Violation|1|||
129063711|NCT00839254|464520514|FG002|Overall Study|Protocol Violation|1|||
129063712|NCT00839254|464520515|FG003|Overall Study|Protocol Violation|1|||
129063713|NCT00839254|464520516|FG004|Overall Study|Protocol Violation|0|||
129063714|NCT00839254|464520517|FG005|Overall Study|Protocol Violation|0|||
129063715|NCT00839254|464520518|FG006|Overall Study|Protocol Violation|1|||
129063716|NCT00839254|464520519|FG007|Overall Study|Protocol Violation|2|||
129063717|NCT00839254|464520512|FG000|Overall Study|Physician Decision|0|||
129063718|NCT00839254|464520513|FG001|Overall Study|Physician Decision|1|||
129063719|NCT00839254|464520514|FG002|Overall Study|Physician Decision|0|||
129063720|NCT00839254|464520515|FG003|Overall Study|Physician Decision|0|||
129063721|NCT00839254|464520516|FG004|Overall Study|Physician Decision|0|||
129063722|NCT00839254|464520517|FG005|Overall Study|Physician Decision|0|||
129063723|NCT00839254|464520518|FG006|Overall Study|Physician Decision|0|||
129063724|NCT00839254|464520519|FG007|Overall Study|Physician Decision|1|||
129063725|NCT00839254|464520512|FG000|Overall Study|Wrong treatment number allocation|0|||
129137414|NCT00292370|464796241|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
129137415|NCT00292370|464796242|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
129137416|NCT00292370|464796243|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
129137417|NCT00292370|464796241|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
129137418|NCT00292370|464796242|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
129137419|NCT00292370|464796243|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
129137420|NCT00292370|464796241|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
129137421|NCT00292370|464796242|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
129063726|NCT00839254|464520513|FG001|Overall Study|Wrong treatment number allocation|1|||
129063727|NCT00839254|464520514|FG002|Overall Study|Wrong treatment number allocation|0|||
129063728|NCT00839254|464520515|FG003|Overall Study|Wrong treatment number allocation|0|||
129063729|NCT00839254|464520516|FG004|Overall Study|Wrong treatment number allocation|0|||
129063730|NCT00839254|464520517|FG005|Overall Study|Wrong treatment number allocation|1|||
129063731|NCT00839254|464520518|FG006|Overall Study|Wrong treatment number allocation|0|||
129063732|NCT00839254|464520519|FG007|Overall Study|Wrong treatment number allocation|0|||
129063733|NCT00839254|464520512|FG000|Overall Study|Adverse Event|12|||
129063734|NCT00839254|464520513|FG001|Overall Study|Adverse Event|6|||
129063735|NCT00839254|464520514|FG002|Overall Study|Adverse Event|3|||
129063736|NCT00839254|464520515|FG003|Overall Study|Adverse Event|5|||
129063737|NCT00839254|464520516|FG004|Overall Study|Adverse Event|2|||
129063738|NCT00839254|464520517|FG005|Overall Study|Adverse Event|1|||
129063739|NCT00839254|464520518|FG006|Overall Study|Adverse Event|0|||
129063740|NCT00839254|464520519|FG007|Overall Study|Adverse Event|1|||
129063741|NCT00839254|464520512|FG000|Overall Study|Withdrawal by Subject|87|||
129063742|NCT00839254|464520513|FG001|Overall Study|Withdrawal by Subject|53|||
129063743|NCT00839254|464520514|FG002|Overall Study|Withdrawal by Subject|54|||
129063744|NCT00839254|464520515|FG003|Overall Study|Withdrawal by Subject|32|||
129063745|NCT00839254|464520516|FG004|Overall Study|Withdrawal by Subject|27|||
129063746|NCT00839254|464520517|FG005|Overall Study|Withdrawal by Subject|15|||
129063747|NCT00839254|464520518|FG006|Overall Study|Withdrawal by Subject|22|||
129063748|NCT00839254|464520519|FG007|Overall Study|Withdrawal by Subject|9|||
129063749|NCT00839254|464520512|FG000|Overall Study|Wrong group allocation|0|||
129063750|NCT00839254|464520513|FG001|Overall Study|Wrong group allocation|0|||
129063751|NCT00839254|464520514|FG002|Overall Study|Wrong group allocation|0|||
129063752|NCT00839254|464520515|FG003|Overall Study|Wrong group allocation|0|||
129063753|NCT00839254|464520516|FG004|Overall Study|Wrong group allocation|0|||
129063754|NCT00839254|464520517|FG005|Overall Study|Wrong group allocation|0|||
129063755|NCT00839254|464520518|FG006|Overall Study|Wrong group allocation|1|||
129063756|NCT00839254|464520519|FG007|Overall Study|Wrong group allocation|0|||
129063757|NCT00839254|464520512|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
129063758|NCT00839254|464520513|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
129063759|NCT00839254|464520514|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
129063760|NCT00839254|464520515|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
129137422|NCT00292370|464796243|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
129137423|NCT00292370|464796241|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
128721146|NCT01856790|463277228|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
129063761|NCT00839254|464520516|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
129063762|NCT00839254|464520517|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
129063763|NCT00839254|464520518|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
129063764|NCT00839254|464520519|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
129063765|NCT00839254|464520512|FG000|Overall Study|Withdrawn due to non-compliance|2|||
129063766|NCT00839254|464520513|FG001|Overall Study|Withdrawn due to non-compliance|0|||
129063767|NCT00839254|464520514|FG002|Overall Study|Withdrawn due to non-compliance|0|||
129063768|NCT00839254|464520515|FG003|Overall Study|Withdrawn due to non-compliance|0|||
129063769|NCT00839254|464520516|FG004|Overall Study|Withdrawn due to non-compliance|0|||
129063770|NCT00839254|464520517|FG005|Overall Study|Withdrawn due to non-compliance|0|||
129063771|NCT00839254|464520518|FG006|Overall Study|Withdrawn due to non-compliance|0|||
129063772|NCT00839254|464520519|FG007|Overall Study|Withdrawn due to non-compliance|0|||
129063773|NCT00839254|464520512|FG000|Overall Study|Lost to Follow-up|51|||
128721147|NCT04091646|463277231|FG000|Overall Study|Adverse Event|2|||
128721148|NCT04091646|463277232|FG001|Overall Study|Adverse Event|1|||
128721149|NCT04091646|463277231|FG000|Overall Study|Lost to Follow-up|6|||
128721150|NCT04091646|463277232|FG001|Overall Study|Lost to Follow-up|2|||
128721151|NCT04091646|463277231|FG000|Overall Study|Protocol Violation|0|||
128721152|NCT04091646|463277232|FG001|Overall Study|Protocol Violation|1|||
128721153|NCT04091646|463277231|FG000|Overall Study|Withdrawal by Subject|4|||
129137424|NCT00292370|464796242|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
129137425|NCT00292370|464796243|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
129137426|NCT00292370|464796241|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
129137427|NCT00292370|464796242|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
128721154|NCT04091646|463277232|FG001|Overall Study|Withdrawal by Subject|1|||
128721155|NCT04091646|463277231|FG000|Overall Study|Participant Incarcerated|1|||
128721156|NCT04091646|463277232|FG001|Overall Study|Participant Incarcerated|0|||
128721157|NCT01762943|463277233|FG000|Overall Study|Physician Decision|1|||
128721158|NCT01762943|463277234|FG001|Overall Study|Physician Decision|1|||
128721159|NCT01762943|463277233|FG000|Overall Study|Protocol Violation|1|||
128721160|NCT01762943|463277234|FG001|Overall Study|Protocol Violation|0|||
128721161|NCT01762943|463277233|FG000|Overall Study|Withdrawal by Subject|2|||
128721162|NCT01762943|463277234|FG001|Overall Study|Withdrawal by Subject|1|||
128721163|NCT02658890|463277238|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721164|NCT02658890|463277239|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721165|NCT02658890|463277240|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721166|NCT02658890|463277241|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721167|NCT02658890|463277242|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721168|NCT02658890|463277243|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721169|NCT02658890|463277244|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721170|NCT02658890|463277245|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721171|NCT02658890|463277246|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
128721172|NCT02658890|463277247|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129063774|NCT00839254|464520513|FG001|Overall Study|Lost to Follow-up|30|||
128721173|NCT02658890|463277248|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721174|NCT02658890|463277249|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721175|NCT02658890|463277250|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721176|NCT02658890|463277251|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721177|NCT02658890|463277252|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721178|NCT02658890|463277253|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721179|NCT02658890|463277254|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721180|NCT02658890|463277255|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721181|NCT02658890|463277256|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721182|NCT02658890|463277257|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721183|NCT02658890|463277258|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721184|NCT02658890|463277259|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129063775|NCT00839254|464520514|FG002|Overall Study|Lost to Follow-up|32|||
129063776|NCT00839254|464520515|FG003|Overall Study|Lost to Follow-up|24|||
129063777|NCT00839254|464520516|FG004|Overall Study|Lost to Follow-up|8|||
129063778|NCT00839254|464520517|FG005|Overall Study|Lost to Follow-up|8|||
129063779|NCT00839254|464520518|FG006|Overall Study|Lost to Follow-up|4|||
129063780|NCT00839254|464520519|FG007|Overall Study|Lost to Follow-up|2|||
129063781|NCT00985491|464520520|FG000|Overall Study|Adverse Event|8|||
129063782|NCT00985491|464520520|FG000|Overall Study|device migration|7|||
129063783|NCT00985491|464520520|FG000|Overall Study|Withdrawal by Subject|1|||
129137428|NCT00292370|464796243|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
129137429|NCT00292370|464796241|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
129137430|NCT00292370|464796242|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
129137431|NCT00292370|464796243|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
129063784|NCT00985491|464520520|FG000|Overall Study|implant failure|3|||
129063785|NCT00489827|464520525|FG000|Overall Study|Intraoperative exclusion criteria|1|||
129063786|NCT00489827|464520526|FG001|Overall Study|Intraoperative exclusion criteria|1|||
129063787|NCT00489827|464520525|FG000|Overall Study|Intraoperative exclusion criteria|1|||
129063788|NCT00489827|464520526|FG001|Overall Study|Intraoperative exclusion criteria|1|||
129063789|NCT02296931|464520527|FG000|Overall Study|Protocol Violation|0|||
129063790|NCT02296931|464520528|FG001|Overall Study|Protocol Violation|2|||
129063791|NCT01590277|464520529|FG000|Overall Study|Withdrawal by Subject|3|||
129063792|NCT01590277|464520529|FG000|Overall Study|Withdrawal by Subject|2|||
129063793|NCT01590277|464520529|FG000|Overall Study|Withdrawal by Subject|1|||
129063794|NCT01590277|464520529|FG000|Overall Study|Withdrawal by Subject|1|||
129063795|NCT01377012|464520530|FG000|Core Study|Study terminated by Sponsor|47|||
129063796|NCT01377012|464520531|FG001|Core Study|Study terminated by Sponsor|54|||
129063797|NCT01377012|464520532|FG002|Core Study|Study terminated by Sponsor|46|||
129063798|NCT01377012|464520530|FG000|Core Study|Technical problems|1|||
129063799|NCT01377012|464520531|FG001|Core Study|Technical problems|0|||
129063800|NCT01377012|464520532|FG002|Core Study|Technical problems|0|||
129063801|NCT01377012|464520530|FG000|Core Study|Withdrawal by Subject|15|||
129063802|NCT01377012|464520531|FG001|Core Study|Withdrawal by Subject|23|||
129063803|NCT01377012|464520532|FG002|Core Study|Withdrawal by Subject|18|||
129063804|NCT01377012|464520530|FG000|Core Study|Protocol Violation|7|||
129063805|NCT01377012|464520531|FG001|Core Study|Protocol Violation|3|||
129063806|NCT01377012|464520532|FG002|Core Study|Protocol Violation|2|||
129063807|NCT01377012|464520530|FG000|Core Study|Pregnancy|0|||
129063808|NCT01377012|464520531|FG001|Core Study|Pregnancy|0|||
129063809|NCT01377012|464520532|FG002|Core Study|Pregnancy|1|||
129063810|NCT01377012|464520530|FG000|Core Study|Physician Decision|5|||
129063811|NCT01377012|464520531|FG001|Core Study|Physician Decision|4|||
129063812|NCT01377012|464520532|FG002|Core Study|Physician Decision|10|||
129063813|NCT01377012|464520530|FG000|Core Study|Non-Compliant with study treatment|0|||
129063814|NCT01377012|464520531|FG001|Core Study|Non-Compliant with study treatment|0|||
129063815|NCT01377012|464520532|FG002|Core Study|Non-Compliant with study treatment|1|||
129063816|NCT01377012|464520530|FG000|Core Study|No Longer require treatment|0|||
129063817|NCT01377012|464520531|FG001|Core Study|No Longer require treatment|0|||
129063818|NCT01377012|464520532|FG002|Core Study|No Longer require treatment|1|||
129063819|NCT01377012|464520530|FG000|Core Study|Lost to Follow-up|7|||
129063820|NCT01377012|464520531|FG001|Core Study|Lost to Follow-up|5|||
129063821|NCT01377012|464520532|FG002|Core Study|Lost to Follow-up|4|||
129063822|NCT01377012|464520530|FG000|Core Study|Lack of Efficacy|41|||
129063823|NCT01377012|464520531|FG001|Core Study|Lack of Efficacy|28|||
129063824|NCT01377012|464520532|FG002|Core Study|Lack of Efficacy|37|||
129063825|NCT01377012|464520530|FG000|Core Study|Death|1|||
129063826|NCT01377012|464520531|FG001|Core Study|Death|1|||
129063827|NCT01377012|464520532|FG002|Core Study|Death|1|||
129063828|NCT01377012|464520530|FG000|Core Study|Adverse Event|10|||
129063829|NCT01377012|464520531|FG001|Core Study|Adverse Event|14|||
129063830|NCT01377012|464520532|FG002|Core Study|Adverse Event|13|||
129063831|NCT01377012|464520530|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
129063832|NCT01377012|464520531|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
129063833|NCT01377012|464520532|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
129063834|NCT01377012|464520530|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
129063835|NCT01377012|464520531|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
129063836|NCT01377012|464520532|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
129063837|NCT01377012|464520530|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
129063838|NCT01377012|464520531|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
129063839|NCT01377012|464520532|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
129063840|NCT01377012|464520530|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
129063841|NCT01377012|464520531|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
129063842|NCT01377012|464520532|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
129063843|NCT01377012|464520530|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
129063844|NCT01377012|464520531|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
129063845|NCT01377012|464520532|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
129063846|NCT01377012|464520530|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
129063847|NCT01377012|464520531|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
129063848|NCT01377012|464520532|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
129137432|NCT02595437|464796245|FG000|Triferic Via IV|Withdrawal by Subject|1|||
129137433|NCT01975285|464796261|FG000|Overall Study|Failed Block and follow up|2|||
129137434|NCT01975285|464796262|FG001|Overall Study|Failed Block and follow up|2|||
129063849|NCT04380961|464520535|FG000|Overall Study|Lost to Follow-up|17|||
129063850|NCT04380961|464520536|FG001|Overall Study|Lost to Follow-up|11|||
129063851|NCT04380961|464520535|FG000|Overall Study|Withdrawal by Subject|3|||
129063852|NCT04380961|464520536|FG001|Overall Study|Withdrawal by Subject|0|||
129063853|NCT04380961|464520535|FG000|Overall Study|Death|22|||
129063854|NCT04380961|464520536|FG001|Overall Study|Death|16|||
129063855|NCT04380961|464520535|FG000|Overall Study|Other|1|||
129063856|NCT04380961|464520536|FG001|Overall Study|Other|0|||
129063857|NCT04380961|464520535|FG000|Overall Study|Randomized but Not Treated|1|||
129063858|NCT04380961|464520536|FG001|Overall Study|Randomized but Not Treated|2|||
129063859|NCT00805961|464520537|FG000|Modality Therapy|Withdrawal by Subject|1|||
129063860|NCT00805961|464520537|FG000|Modality Therapy|Adverse Event|1|||
128775740|NCT00681187|463468447|FG001|Overall Study|Adverse Event|1|||
128775741|NCT03653416|463468448|FG000|Overall Study|Protocol Violation|6|||
128775742|NCT03653416|463468449|FG001|Overall Study|Protocol Violation|1|||
128775743|NCT04230980|463468450|FG000|Overall Study|Lost to Follow-up|1|||
128775744|NCT04230980|463468451|FG001|Overall Study|Lost to Follow-up|2|||
128775745|NCT04230980|463468450|FG000|Overall Study|Adverse Event|0|||
128775746|NCT04230980|463468451|FG001|Overall Study|Adverse Event|1|||
128775747|NCT02788006|463468453|FG000|Overall Study|Patient not treated|1|||
128775748|NCT03050398|463468456|FG000|Overall Study|Study terminated by sponsor|8|||
128775749|NCT00598481|463468457|FG000|Treatment|Physician Decision|1|||
128775750|NCT03523871|463468458|FG000|Overall Study|Death|1|||
128775751|NCT01994720|463468459|FG000|Overall Study|Withdrawal by Subject|46|||
128775752|NCT01994720|463468460|FG001|Overall Study|Withdrawal by Subject|56|||
128775753|NCT01991197|463468461|FG000|Overall Study|Lost to Follow-up|1|||
128775754|NCT01991197|463468462|FG001|Overall Study|Lost to Follow-up|1|||
128775755|NCT01991197|463468461|FG000|Overall Study|Physician Decision|0|||
128775756|NCT01991197|463468462|FG001|Overall Study|Physician Decision|2|||
128775757|NCT01991197|463468461|FG000|Overall Study|Withdrawal by Subject|2|||
128775758|NCT01991197|463468462|FG001|Overall Study|Withdrawal by Subject|0|||
128775759|NCT02397460|463468466|FG000|Treatment Period 2|Adverse Event|0|||
128775760|NCT02397460|463468467|FG001|Treatment Period 2|Adverse Event|0|||
128775761|NCT02397460|463468468|FG002|Treatment Period 2|Adverse Event|0|||
128775762|NCT02397460|463468469|FG003|Treatment Period 2|Adverse Event|0|||
128775763|NCT02397460|463468470|FG004|Treatment Period 2|Adverse Event|0|||
128775764|NCT02397460|463468471|FG005|Treatment Period 2|Adverse Event|0|||
128775765|NCT02397460|463468472|FG006|Treatment Period 2|Adverse Event|0|||
128775766|NCT02397460|463468473|FG007|Treatment Period 2|Adverse Event|1|||
128775767|NCT02397460|463468466|FG000|Treatment Period 4|Adverse Event|0|||
128775768|NCT02397460|463468467|FG001|Treatment Period 4|Adverse Event|1|||
128775769|NCT02397460|463468468|FG002|Treatment Period 4|Adverse Event|0|||
128775770|NCT02397460|463468469|FG003|Treatment Period 4|Adverse Event|0|||
128775771|NCT02397460|463468470|FG004|Treatment Period 4|Adverse Event|0|||
128775772|NCT02397460|463468471|FG005|Treatment Period 4|Adverse Event|0|||
128775773|NCT02397460|463468472|FG006|Treatment Period 4|Adverse Event|0|||
128775774|NCT02397460|463468473|FG007|Treatment Period 4|Adverse Event|0|||
128775775|NCT02397460|463468466|FG000|Treatment Period 4|Physician Decision|0|||
128775776|NCT02397460|463468467|FG001|Treatment Period 4|Physician Decision|0|||
128775777|NCT02397460|463468468|FG002|Treatment Period 4|Physician Decision|0|||
128775778|NCT02397460|463468469|FG003|Treatment Period 4|Physician Decision|0|||
128775779|NCT02397460|463468470|FG004|Treatment Period 4|Physician Decision|1|||
128775780|NCT02397460|463468471|FG005|Treatment Period 4|Physician Decision|0|||
128775781|NCT02397460|463468472|FG006|Treatment Period 4|Physician Decision|0|||
128775782|NCT02397460|463468473|FG007|Treatment Period 4|Physician Decision|0|||
128775783|NCT01406717|463468474|FG000|Overall Study|Subject non-compliance|4|||
128775784|NCT01406717|463468475|FG001|Overall Study|Subject non-compliance|3|||
128775785|NCT01406717|463468474|FG000|Overall Study|Protocol Violation|5|||
128775786|NCT01406717|463468475|FG001|Overall Study|Protocol Violation|1|||
128775787|NCT01406717|463468474|FG000|Overall Study|Lost to Follow-up|14|||
128775788|NCT01406717|463468475|FG001|Overall Study|Lost to Follow-up|8|||
128775789|NCT01406717|463468474|FG000|Overall Study|Withdrawal by Subject|19|||
128775790|NCT01406717|463468475|FG001|Overall Study|Withdrawal by Subject|15|||
128775791|NCT01406717|463468474|FG000|Overall Study|Adverse Event|1|||
128775792|NCT01406717|463468475|FG001|Overall Study|Adverse Event|2|||
128775793|NCT01406717|463468474|FG000|Overall Study|Lack of Efficacy|0|||
128775794|NCT01406717|463468475|FG001|Overall Study|Lack of Efficacy|1|||
128775795|NCT01406717|463468474|FG000|Overall Study|Non-completion of visit activity|0|||
128775796|NCT01406717|463468475|FG001|Overall Study|Non-completion of visit activity|1|||
128775797|NCT03257995|463468476|FG000|Overall Study|Adverse Event|0|||
128775798|NCT03257995|463468477|FG001|Overall Study|Adverse Event|1|||
128775799|NCT03257995|463468478|FG002|Overall Study|Adverse Event|0|||
129063861|NCT00805961|464520537|FG000|Modality Therapy|Disease Progression|2|||
129063862|NCT00805961|464520537|FG000|Treatment-Free Interval|Adverse Event|3|||
129063863|NCT00805961|464520537|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
129063864|NCT00805961|464520537|FG000|Treatment-Free Interval|Physician Decision|1|||
129063865|NCT00805961|464520537|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
129063866|NCT00805961|464520537|FG000|Maintenance Treatment|Lack of Efficacy|13|||
129063867|NCT00805961|464520537|FG000|Maintenance Treatment|Intercurrent Illness|7|||
129063868|NCT00805961|464520537|FG000|Maintenance Treatment|Adverse Event|6|||
129063869|NCT00805961|464520537|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
128775800|NCT03257995|463468479|FG003|Overall Study|Adverse Event|0|||
128775801|NCT03257995|463468480|FG004|Overall Study|Adverse Event|0|||
128775802|NCT03257995|463468481|FG005|Overall Study|Adverse Event|0|||
128775803|NCT03257995|463468476|FG000|Overall Study|Protocol deviation|0|||
128775804|NCT03257995|463468477|FG001|Overall Study|Protocol deviation|0|||
128775805|NCT03257995|463468478|FG002|Overall Study|Protocol deviation|0|||
128775806|NCT03257995|463468479|FG003|Overall Study|Protocol deviation|0|||
129063870|NCT00805961|464520537|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
129063871|NCT00805961|464520537|FG000|Maintenance Treatment|Withdrawn Consent|1|||
128721185|NCT02658890|463277260|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721186|NCT02658890|463277261|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721187|NCT02658890|463277262|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721188|NCT02658890|463277263|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721189|NCT02658890|463277264|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721190|NCT02658890|463277238|FG000|Treatment Phase|Adverse Event|0|||
128721191|NCT02658890|463277239|FG001|Treatment Phase|Adverse Event|1|||
128721192|NCT02658890|463277240|FG002|Treatment Phase|Adverse Event|2|||
128721193|NCT02658890|463277241|FG003|Treatment Phase|Adverse Event|2|||
128721194|NCT02658890|463277242|FG004|Treatment Phase|Adverse Event|1|||
128721195|NCT02658890|463277243|FG005|Treatment Phase|Adverse Event|0|||
128721196|NCT02658890|463277244|FG006|Treatment Phase|Adverse Event|0|||
128721197|NCT02658890|463277245|FG007|Treatment Phase|Adverse Event|2|||
128721198|NCT02658890|463277246|FG008|Treatment Phase|Adverse Event|1|||
128721199|NCT02658890|463277247|FG009|Treatment Phase|Adverse Event|2|||
128721200|NCT02658890|463277248|FG010|Treatment Phase|Adverse Event|3|||
128721201|NCT02658890|463277249|FG011|Treatment Phase|Adverse Event|0|||
128721202|NCT02658890|463277250|FG012|Treatment Phase|Adverse Event|1|||
128721203|NCT02658890|463277251|FG013|Treatment Phase|Adverse Event|4|||
128721204|NCT02658890|463277252|FG014|Treatment Phase|Adverse Event|0|||
128721205|NCT02658890|463277253|FG015|Treatment Phase|Adverse Event|0|||
128721206|NCT02658890|463277254|FG016|Treatment Phase|Adverse Event|0|||
128721207|NCT02658890|463277255|FG017|Treatment Phase|Adverse Event|0|||
128721208|NCT02658890|463277256|FG018|Treatment Phase|Adverse Event|5|||
128721209|NCT02658890|463277257|FG019|Treatment Phase|Adverse Event|1|||
128721210|NCT02658890|463277258|FG020|Treatment Phase|Adverse Event|3|||
128721211|NCT02658890|463277259|FG021|Treatment Phase|Adverse Event|0|||
128721212|NCT02658890|463277260|FG022|Treatment Phase|Adverse Event|5|||
128721213|NCT02658890|463277261|FG023|Treatment Phase|Adverse Event|0|||
128721214|NCT02658890|463277262|FG024|Treatment Phase|Adverse Event|0|||
128721215|NCT02658890|463277263|FG025|Treatment Phase|Adverse Event|2|||
128721216|NCT02658890|463277264|FG026|Treatment Phase|Adverse Event|1|||
128721217|NCT02658890|463277238|FG000|Treatment Phase|Death|0|||
128721218|NCT02658890|463277239|FG001|Treatment Phase|Death|0|||
128721219|NCT02658890|463277240|FG002|Treatment Phase|Death|0|||
128721220|NCT02658890|463277241|FG003|Treatment Phase|Death|0|||
129063872|NCT03736031|464520539|FG000|Overall Study|Death|2|||
129063873|NCT03736031|464520540|FG001|Overall Study|Death|4|||
129063874|NCT03736031|464520539|FG000|Overall Study|Lost to Follow-up|21|||
129063875|NCT03736031|464520540|FG001|Overall Study|Lost to Follow-up|2|||
129063876|NCT03736031|464520539|FG000|Overall Study|Withdrawal by Subject|9|||
129063877|NCT03736031|464520540|FG001|Overall Study|Withdrawal by Subject|0|||
129063878|NCT01954745|464520544|FG000|Overall Study|Radiological Progression|11|||
129063879|NCT01954745|464520544|FG000|Overall Study|Clinical Progression|5|||
129063880|NCT01954745|464520544|FG000|Overall Study|Adverse Event|2|||
129063881|NCT01954745|464520544|FG000|Overall Study|Death|1|||
129063882|NCT03514017|464520545|FG000|Overall Study|Death|1|||
129063883|NCT03514017|464520545|FG000|Overall Study|Adverse Event|1|||
129063884|NCT05938621|464521741|FG000|Overall Study|Lost to Follow-up|1|||
129063885|NCT05938621|464521742|FG001|Overall Study|Lost to Follow-up|5|||
129063886|NCT05938621|464521743|FG002|Overall Study|Lost to Follow-up|2|||
129063887|NCT05938621|464521744|FG003|Overall Study|Lost to Follow-up|2|||
129063888|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
129063889|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
129063890|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
129063891|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
129063892|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
129063893|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
129063894|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
129063895|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
128721221|NCT02658890|463277242|FG004|Treatment Phase|Death|0|||
128721222|NCT02658890|463277243|FG005|Treatment Phase|Death|0|||
128721223|NCT02658890|463277244|FG006|Treatment Phase|Death|0|||
128721224|NCT02658890|463277245|FG007|Treatment Phase|Death|0|||
129063896|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
128721225|NCT02658890|463277246|FG008|Treatment Phase|Death|0|||
128721226|NCT02658890|463277247|FG009|Treatment Phase|Death|0|||
128721227|NCT02658890|463277248|FG010|Treatment Phase|Death|0|||
128721228|NCT02658890|463277249|FG011|Treatment Phase|Death|0|||
128721229|NCT02658890|463277250|FG012|Treatment Phase|Death|0|||
128721230|NCT02658890|463277251|FG013|Treatment Phase|Death|0|||
128721231|NCT02658890|463277252|FG014|Treatment Phase|Death|0|||
128721232|NCT02658890|463277253|FG015|Treatment Phase|Death|0|||
128721233|NCT02658890|463277254|FG016|Treatment Phase|Death|0|||
128721234|NCT02658890|463277255|FG017|Treatment Phase|Death|0|||
129063897|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
129063898|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
129063899|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
129063900|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
128721235|NCT02658890|463277256|FG018|Treatment Phase|Death|1|||
128721236|NCT02658890|463277257|FG019|Treatment Phase|Death|0|||
128721237|NCT02658890|463277258|FG020|Treatment Phase|Death|0|||
128721238|NCT02658890|463277259|FG021|Treatment Phase|Death|0|||
128721239|NCT02658890|463277260|FG022|Treatment Phase|Death|0|||
128721240|NCT02658890|463277261|FG023|Treatment Phase|Death|0|||
128721241|NCT02658890|463277262|FG024|Treatment Phase|Death|0|||
128721242|NCT02658890|463277263|FG025|Treatment Phase|Death|0|||
128721243|NCT02658890|463277264|FG026|Treatment Phase|Death|0|||
128721244|NCT02658890|463277238|FG000|Treatment Phase|Lost to Follow-up|0|||
128721245|NCT02658890|463277239|FG001|Treatment Phase|Lost to Follow-up|0|||
128721246|NCT02658890|463277240|FG002|Treatment Phase|Lost to Follow-up|0|||
128721247|NCT02658890|463277241|FG003|Treatment Phase|Lost to Follow-up|0|||
129063901|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129063902|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129063903|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
129063904|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129063905|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129063906|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
129063907|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
129063908|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
129063909|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129063910|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129063911|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
128721248|NCT02658890|463277242|FG004|Treatment Phase|Lost to Follow-up|0|||
128721249|NCT02658890|463277243|FG005|Treatment Phase|Lost to Follow-up|0|||
128721250|NCT02658890|463277244|FG006|Treatment Phase|Lost to Follow-up|1|||
128721251|NCT02658890|463277245|FG007|Treatment Phase|Lost to Follow-up|0|||
128721252|NCT02658890|463277246|FG008|Treatment Phase|Lost to Follow-up|0|||
128721253|NCT02658890|463277247|FG009|Treatment Phase|Lost to Follow-up|0|||
129063912|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129063913|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129063914|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129063915|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
129063916|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
129063917|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
129063918|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129063919|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129063920|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129063921|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129063922|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129063923|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129063924|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
129063925|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
129063926|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
129063927|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129063928|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129063929|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
128721254|NCT02658890|463277248|FG010|Treatment Phase|Lost to Follow-up|0|||
129063930|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
129063931|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129063932|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129063933|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
129063934|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063935|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063936|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063937|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063938|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063939|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063940|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063941|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129063942|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063943|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
129063944|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129137435|NCT01061710|464796264|FG000|Overall Study|Protocol Violation|14|||
129137436|NCT03757715|464796266|FG000|Overall Study|Lost to Follow-up|4|||
129137437|NCT03757715|464796267|FG001|Overall Study|Lost to Follow-up|9|||
129137438|NCT03757715|464796266|FG000|Overall Study|Withdrawal by Subject|1|||
129137439|NCT03757715|464796267|FG001|Overall Study|Withdrawal by Subject|1|||
129137440|NCT00281580|464796268|FG000|Overall Study|Adverse Event|2|||
129137441|NCT00281580|464796269|FG001|Overall Study|Adverse Event|0|||
129063945|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063946|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063947|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063948|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063949|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063950|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063951|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129063952|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129063953|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
129063954|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129063955|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
128721255|NCT02658890|463277249|FG011|Treatment Phase|Lost to Follow-up|0|||
128721256|NCT02658890|463277250|FG012|Treatment Phase|Lost to Follow-up|0|||
128721257|NCT02658890|463277251|FG013|Treatment Phase|Lost to Follow-up|0|||
128721258|NCT02658890|463277252|FG014|Treatment Phase|Lost to Follow-up|0|||
128721259|NCT02658890|463277253|FG015|Treatment Phase|Lost to Follow-up|0|||
128721260|NCT02658890|463277254|FG016|Treatment Phase|Lost to Follow-up|0|||
128721261|NCT02658890|463277255|FG017|Treatment Phase|Lost to Follow-up|0|||
128721262|NCT02658890|463277256|FG018|Treatment Phase|Lost to Follow-up|0|||
128721263|NCT02658890|463277257|FG019|Treatment Phase|Lost to Follow-up|0|||
128721264|NCT02658890|463277258|FG020|Treatment Phase|Lost to Follow-up|0|||
128721265|NCT02658890|463277259|FG021|Treatment Phase|Lost to Follow-up|0|||
128721266|NCT02658890|463277260|FG022|Treatment Phase|Lost to Follow-up|0|||
128721267|NCT02658890|463277261|FG023|Treatment Phase|Lost to Follow-up|0|||
128721268|NCT02658890|463277262|FG024|Treatment Phase|Lost to Follow-up|0|||
128721269|NCT02658890|463277263|FG025|Treatment Phase|Lost to Follow-up|0|||
128721270|NCT02658890|463277264|FG026|Treatment Phase|Lost to Follow-up|0|||
128721271|NCT02658890|463277238|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
128721272|NCT02658890|463277239|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
128721273|NCT02658890|463277240|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
128721274|NCT02658890|463277241|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
128721275|NCT02658890|463277242|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
128721276|NCT02658890|463277243|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
128721277|NCT02658890|463277244|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
128721278|NCT02658890|463277245|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
128721279|NCT02658890|463277246|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
128721280|NCT02658890|463277247|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
128721281|NCT02658890|463277248|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
128721282|NCT02658890|463277249|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
128721283|NCT02658890|463277250|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
128721284|NCT02658890|463277251|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
128721285|NCT02658890|463277252|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
128721286|NCT02658890|463277253|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
128721287|NCT02658890|463277254|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
128721288|NCT02658890|463277255|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
128721289|NCT02658890|463277256|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
128721290|NCT02658890|463277257|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
128721291|NCT02658890|463277258|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
128721292|NCT02658890|463277259|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
128721293|NCT02658890|463277260|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
128721294|NCT02658890|463277261|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
128721295|NCT02658890|463277262|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
128721296|NCT02658890|463277263|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
128721297|NCT02658890|463277264|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
128721298|NCT02658890|463277238|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
128721299|NCT02658890|463277239|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
128721300|NCT02658890|463277240|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
128721301|NCT02658890|463277241|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
128721302|NCT02658890|463277242|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
128721303|NCT02658890|463277243|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
128721304|NCT02658890|463277244|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
128721305|NCT02658890|463277245|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
128721306|NCT02658890|463277246|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
128721307|NCT02658890|463277247|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
128721308|NCT02658890|463277248|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
128721309|NCT02658890|463277249|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
128721310|NCT02658890|463277250|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
128721311|NCT02658890|463277251|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
128721312|NCT02658890|463277252|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
128721313|NCT02658890|463277253|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
128721314|NCT02658890|463277254|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
128721315|NCT02658890|463277255|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
128721316|NCT02658890|463277256|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
129063956|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
128721317|NCT02658890|463277257|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
128721318|NCT02658890|463277258|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
128721319|NCT02658890|463277259|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
128721320|NCT02658890|463277260|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
128721321|NCT02658890|463277261|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
128721322|NCT02658890|463277262|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
128721323|NCT02658890|463277263|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
128721324|NCT02658890|463277264|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
128721325|NCT02658890|463277238|FG000|Treatment Phase|Other Reasons|0|||
128721326|NCT02658890|463277239|FG001|Treatment Phase|Other Reasons|0|||
128721327|NCT02658890|463277240|FG002|Treatment Phase|Other Reasons|0|||
128721328|NCT02658890|463277241|FG003|Treatment Phase|Other Reasons|0|||
128721329|NCT02658890|463277242|FG004|Treatment Phase|Other Reasons|0|||
128721330|NCT02658890|463277243|FG005|Treatment Phase|Other Reasons|0|||
128721331|NCT02658890|463277244|FG006|Treatment Phase|Other Reasons|1|||
128721332|NCT02658890|463277245|FG007|Treatment Phase|Other Reasons|0|||
128721333|NCT02658890|463277246|FG008|Treatment Phase|Other Reasons|1|||
128721334|NCT02658890|463277247|FG009|Treatment Phase|Other Reasons|0|||
128721335|NCT02658890|463277248|FG010|Treatment Phase|Other Reasons|0|||
128721336|NCT02658890|463277249|FG011|Treatment Phase|Other Reasons|0|||
128721337|NCT02658890|463277250|FG012|Treatment Phase|Other Reasons|0|||
128721338|NCT02658890|463277251|FG013|Treatment Phase|Other Reasons|2|||
128721339|NCT02658890|463277252|FG014|Treatment Phase|Other Reasons|0|||
128721340|NCT02658890|463277253|FG015|Treatment Phase|Other Reasons|0|||
128721341|NCT02658890|463277254|FG016|Treatment Phase|Other Reasons|0|||
128721342|NCT02658890|463277255|FG017|Treatment Phase|Other Reasons|0|||
128721343|NCT02658890|463277256|FG018|Treatment Phase|Other Reasons|1|||
128721344|NCT02658890|463277257|FG019|Treatment Phase|Other Reasons|0|||
128721345|NCT02658890|463277258|FG020|Treatment Phase|Other Reasons|0|||
128721346|NCT02658890|463277259|FG021|Treatment Phase|Other Reasons|0|||
128721347|NCT02658890|463277260|FG022|Treatment Phase|Other Reasons|0|||
128721348|NCT02658890|463277261|FG023|Treatment Phase|Other Reasons|0|||
128721349|NCT02658890|463277262|FG024|Treatment Phase|Other Reasons|1|||
128721350|NCT02658890|463277263|FG025|Treatment Phase|Other Reasons|0|||
128721351|NCT02658890|463277264|FG026|Treatment Phase|Other Reasons|1|||
128721352|NCT02658890|463277238|FG000|Treatment Phase|Progressive Disease|6|||
128721353|NCT02658890|463277239|FG001|Treatment Phase|Progressive Disease|7|||
128721354|NCT02658890|463277240|FG002|Treatment Phase|Progressive Disease|6|||
128721355|NCT02658890|463277241|FG003|Treatment Phase|Progressive Disease|12|||
128721356|NCT02658890|463277242|FG004|Treatment Phase|Progressive Disease|6|||
128721357|NCT02658890|463277243|FG005|Treatment Phase|Progressive Disease|18|||
128721358|NCT02658890|463277244|FG006|Treatment Phase|Progressive Disease|12|||
128721359|NCT02658890|463277245|FG007|Treatment Phase|Progressive Disease|19|||
128721360|NCT02658890|463277246|FG008|Treatment Phase|Progressive Disease|26|||
128721361|NCT02658890|463277247|FG009|Treatment Phase|Progressive Disease|8|||
128721362|NCT02658890|463277248|FG010|Treatment Phase|Progressive Disease|7|||
128721363|NCT02658890|463277249|FG011|Treatment Phase|Progressive Disease|9|||
128721364|NCT02658890|463277250|FG012|Treatment Phase|Progressive Disease|8|||
128721365|NCT02658890|463277251|FG013|Treatment Phase|Progressive Disease|29|||
128721366|NCT02658890|463277252|FG014|Treatment Phase|Progressive Disease|6|||
128721367|NCT02658890|463277253|FG015|Treatment Phase|Progressive Disease|2|||
128721368|NCT02658890|463277254|FG016|Treatment Phase|Progressive Disease|32|||
128721369|NCT02658890|463277255|FG017|Treatment Phase|Progressive Disease|14|||
128721370|NCT02658890|463277256|FG018|Treatment Phase|Progressive Disease|40|||
128721371|NCT02658890|463277257|FG019|Treatment Phase|Progressive Disease|32|||
128721372|NCT02658890|463277258|FG020|Treatment Phase|Progressive Disease|19|||
128721373|NCT02658890|463277259|FG021|Treatment Phase|Progressive Disease|30|||
128721374|NCT02658890|463277260|FG022|Treatment Phase|Progressive Disease|15|||
128721375|NCT02658890|463277261|FG023|Treatment Phase|Progressive Disease|0|||
128721376|NCT02658890|463277262|FG024|Treatment Phase|Progressive Disease|0|||
128721377|NCT02658890|463277263|FG025|Treatment Phase|Progressive Disease|14|||
128721378|NCT02658890|463277264|FG026|Treatment Phase|Progressive Disease|11|||
128721379|NCT02658890|463277238|FG000|Treatment Phase|Study Drug Toxicity|0|||
128721380|NCT02658890|463277239|FG001|Treatment Phase|Study Drug Toxicity|0|||
128721381|NCT02658890|463277240|FG002|Treatment Phase|Study Drug Toxicity|2|||
128721382|NCT02658890|463277241|FG003|Treatment Phase|Study Drug Toxicity|0|||
128721383|NCT02658890|463277242|FG004|Treatment Phase|Study Drug Toxicity|0|||
128721384|NCT02658890|463277243|FG005|Treatment Phase|Study Drug Toxicity|0|||
128721385|NCT02658890|463277244|FG006|Treatment Phase|Study Drug Toxicity|0|||
128721386|NCT02658890|463277245|FG007|Treatment Phase|Study Drug Toxicity|0|||
128721387|NCT02658890|463277246|FG008|Treatment Phase|Study Drug Toxicity|3|||
128721388|NCT02658890|463277247|FG009|Treatment Phase|Study Drug Toxicity|0|||
128721389|NCT02658890|463277248|FG010|Treatment Phase|Study Drug Toxicity|1|||
128721390|NCT02658890|463277249|FG011|Treatment Phase|Study Drug Toxicity|1|||
128721391|NCT02658890|463277250|FG012|Treatment Phase|Study Drug Toxicity|2|||
128721392|NCT02658890|463277251|FG013|Treatment Phase|Study Drug Toxicity|9|||
128721393|NCT02658890|463277252|FG014|Treatment Phase|Study Drug Toxicity|0|||
129137442|NCT00281580|464796270|FG002|Overall Study|Adverse Event|2|||
129137443|NCT00281580|464796271|FG003|Overall Study|Adverse Event|4|||
129137444|NCT00281580|464796272|FG004|Overall Study|Adverse Event|1|||
129137445|NCT00281580|464796273|FG005|Overall Study|Adverse Event|0|||
129137446|NCT00281580|464796274|FG006|Overall Study|Adverse Event|1|||
129137447|NCT00281580|464796275|FG007|Overall Study|Adverse Event|0|||
129137448|NCT00281580|464796276|FG008|Overall Study|Adverse Event|1|||
129137449|NCT00281580|464796277|FG009|Overall Study|Adverse Event|6|||
129137450|NCT00281580|464796278|FG010|Overall Study|Adverse Event|0|||
128721394|NCT02658890|463277253|FG015|Treatment Phase|Study Drug Toxicity|1|||
128721395|NCT02658890|463277254|FG016|Treatment Phase|Study Drug Toxicity|1|||
128721396|NCT02658890|463277255|FG017|Treatment Phase|Study Drug Toxicity|0|||
128721397|NCT02658890|463277256|FG018|Treatment Phase|Study Drug Toxicity|8|||
128721398|NCT02658890|463277257|FG019|Treatment Phase|Study Drug Toxicity|3|||
128721399|NCT02658890|463277258|FG020|Treatment Phase|Study Drug Toxicity|2|||
128721400|NCT02658890|463277259|FG021|Treatment Phase|Study Drug Toxicity|0|||
128721401|NCT02658890|463277260|FG022|Treatment Phase|Study Drug Toxicity|8|||
128721402|NCT02658890|463277261|FG023|Treatment Phase|Study Drug Toxicity|0|||
128721403|NCT02658890|463277262|FG024|Treatment Phase|Study Drug Toxicity|0|||
128721404|NCT02658890|463277263|FG025|Treatment Phase|Study Drug Toxicity|2|||
128721405|NCT02658890|463277264|FG026|Treatment Phase|Study Drug Toxicity|0|||
128721406|NCT02658890|463277238|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721407|NCT02658890|463277239|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721408|NCT02658890|463277240|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721409|NCT02658890|463277241|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
128721410|NCT02658890|463277242|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721411|NCT02658890|463277243|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721412|NCT02658890|463277244|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721413|NCT02658890|463277245|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721414|NCT02658890|463277246|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721415|NCT02658890|463277247|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
128721416|NCT02658890|463277248|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721417|NCT02658890|463277249|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721418|NCT02658890|463277250|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721419|NCT02658890|463277251|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721420|NCT02658890|463277252|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721421|NCT02658890|463277253|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721422|NCT02658890|463277254|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721423|NCT02658890|463277255|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721424|NCT02658890|463277256|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
128721425|NCT02658890|463277257|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721426|NCT02658890|463277258|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721427|NCT02658890|463277259|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129063957|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129063958|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129063959|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129063960|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
129063961|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063962|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063963|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063964|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063965|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063966|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063967|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063968|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129063969|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
129063970|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129063971|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129063972|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129063973|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129137451|NCT00281580|464796279|FG011|Overall Study|Adverse Event|5|||
129137452|NCT00281580|464796280|FG012|Overall Study|Adverse Event|8|||
129137453|NCT00281580|464796281|FG013|Overall Study|Adverse Event|2|||
129137454|NCT00281580|464796282|FG014|Overall Study|Adverse Event|3|||
129137455|NCT00281580|464796283|FG015|Overall Study|Adverse Event|3|||
129137456|NCT00281580|464796268|FG000|Overall Study|Protocol Violation|0|||
129137457|NCT00281580|464796269|FG001|Overall Study|Protocol Violation|0|||
129137458|NCT00281580|464796270|FG002|Overall Study|Protocol Violation|1|||
129137459|NCT00281580|464796271|FG003|Overall Study|Protocol Violation|1|||
129137460|NCT00281580|464796272|FG004|Overall Study|Protocol Violation|0|||
129137461|NCT00281580|464796273|FG005|Overall Study|Protocol Violation|0|||
129137462|NCT00281580|464796274|FG006|Overall Study|Protocol Violation|1|||
129137463|NCT00281580|464796275|FG007|Overall Study|Protocol Violation|0|||
128721428|NCT02658890|463277260|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
128721429|NCT02658890|463277261|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721430|NCT02658890|463277262|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721431|NCT02658890|463277263|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721432|NCT02658890|463277264|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
128721433|NCT02658890|463277238|FG000|Treatment Phase|Withdrawal by Subject|0|||
128721434|NCT02658890|463277239|FG001|Treatment Phase|Withdrawal by Subject|1|||
128721435|NCT02658890|463277240|FG002|Treatment Phase|Withdrawal by Subject|0|||
128721436|NCT02658890|463277241|FG003|Treatment Phase|Withdrawal by Subject|0|||
128721437|NCT02658890|463277242|FG004|Treatment Phase|Withdrawal by Subject|0|||
128721438|NCT02658890|463277243|FG005|Treatment Phase|Withdrawal by Subject|0|||
128721439|NCT02658890|463277244|FG006|Treatment Phase|Withdrawal by Subject|1|||
128721440|NCT02658890|463277245|FG007|Treatment Phase|Withdrawal by Subject|0|||
128721441|NCT02658890|463277246|FG008|Treatment Phase|Withdrawal by Subject|0|||
128721442|NCT02658890|463277247|FG009|Treatment Phase|Withdrawal by Subject|1|||
128721443|NCT02658890|463277248|FG010|Treatment Phase|Withdrawal by Subject|0|||
128721444|NCT02658890|463277249|FG011|Treatment Phase|Withdrawal by Subject|0|||
128775807|NCT03257995|463468480|FG004|Overall Study|Protocol deviation|0|||
129063974|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129063975|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129063976|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129063977|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129063978|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
129063979|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063980|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063981|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063982|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063983|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063984|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063985|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063986|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129063987|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063988|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
129063989|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
129063990|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063991|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063992|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063993|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063994|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063995|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129063996|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
129063997|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
129063998|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129063999|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129064000|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129064001|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129064002|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129064003|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129064004|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129064005|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129064006|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
129064007|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129064008|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129064009|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129064010|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129137464|NCT00281580|464796276|FG008|Overall Study|Protocol Violation|2|||
129137465|NCT00281580|464796277|FG009|Overall Study|Protocol Violation|0|||
129137466|NCT00281580|464796278|FG010|Overall Study|Protocol Violation|1|||
129064011|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129064012|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129064013|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129064014|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064015|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
129064016|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064017|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064018|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064019|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064020|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064021|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064022|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129064023|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064024|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064025|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
129064026|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064027|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064028|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064029|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064030|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064031|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129064032|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064033|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064034|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
129064035|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064036|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064037|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064038|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064039|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064040|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129064041|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129064042|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129064043|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
129064044|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129064045|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129064046|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129064047|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
128721445|NCT02658890|463277250|FG012|Treatment Phase|Withdrawal by Subject|1|||
128721446|NCT02658890|463277251|FG013|Treatment Phase|Withdrawal by Subject|3|||
128721447|NCT02658890|463277252|FG014|Treatment Phase|Withdrawal by Subject|0|||
128721448|NCT02658890|463277253|FG015|Treatment Phase|Withdrawal by Subject|0|||
128721449|NCT02658890|463277254|FG016|Treatment Phase|Withdrawal by Subject|1|||
128721450|NCT02658890|463277255|FG017|Treatment Phase|Withdrawal by Subject|0|||
128721451|NCT02658890|463277256|FG018|Treatment Phase|Withdrawal by Subject|4|||
128721452|NCT02658890|463277257|FG019|Treatment Phase|Withdrawal by Subject|3|||
128721453|NCT02658890|463277258|FG020|Treatment Phase|Withdrawal by Subject|0|||
128721454|NCT02658890|463277259|FG021|Treatment Phase|Withdrawal by Subject|4|||
128721455|NCT02658890|463277260|FG022|Treatment Phase|Withdrawal by Subject|1|||
128721456|NCT02658890|463277261|FG023|Treatment Phase|Withdrawal by Subject|1|||
128721457|NCT02658890|463277262|FG024|Treatment Phase|Withdrawal by Subject|0|||
128721458|NCT02658890|463277263|FG025|Treatment Phase|Withdrawal by Subject|0|||
128721459|NCT02658890|463277264|FG026|Treatment Phase|Withdrawal by Subject|0|||
128721460|NCT02474199|463277265|FG000|Overall Study|Lost to Follow-up|1|||
128721461|NCT02474199|463277266|FG001|Overall Study|Lost to Follow-up|0|||
128721462|NCT02474199|463277267|FG002|Overall Study|Lost to Follow-up|0|||
128721463|NCT02474199|463277268|FG003|Overall Study|Lost to Follow-up|0|||
128721464|NCT02474199|463277265|FG000|Overall Study|Withdrawal by Subject|1|||
128721465|NCT02474199|463277266|FG001|Overall Study|Withdrawal by Subject|2|||
128721466|NCT02474199|463277267|FG002|Overall Study|Withdrawal by Subject|0|||
128721467|NCT02474199|463277268|FG003|Overall Study|Withdrawal by Subject|1|||
128721468|NCT02474199|463277265|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
128721469|NCT02474199|463277266|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
128721470|NCT02474199|463277267|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
128775808|NCT03257995|463468481|FG005|Overall Study|Protocol deviation|2|||
128775809|NCT02584855|463468487|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
128775810|NCT02584855|463468488|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
128775811|NCT02584855|463468489|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129064048|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129064049|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129064050|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064051|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064052|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064053|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064054|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064055|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064056|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
129064057|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064058|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129064059|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
129064060|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
129064061|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129064062|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129064063|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129064064|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129064065|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129064066|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129064067|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129064068|NCT03598790|464521745|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064069|NCT03598790|464521746|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064070|NCT03598790|464521747|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
129064071|NCT03598790|464521748|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064072|NCT03598790|464521749|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064073|NCT03598790|464521750|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064074|NCT03598790|464521751|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064075|NCT03598790|464521752|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064076|NCT03598790|464521753|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129064077|NCT03598790|464521745|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129064078|NCT03598790|464521746|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129064079|NCT03598790|464521747|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129064080|NCT03598790|464521748|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
129064081|NCT03598790|464521749|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
129064082|NCT03598790|464521750|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
129064083|NCT03598790|464521751|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129064084|NCT03598790|464521752|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129064085|NCT03598790|464521753|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129064086|NCT03598790|464521745|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064087|NCT03598790|464521746|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064088|NCT03598790|464521747|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064089|NCT03598790|464521748|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
129064090|NCT03598790|464521749|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064091|NCT03598790|464521750|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064092|NCT03598790|464521751|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064093|NCT03598790|464521752|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064094|NCT03598790|464521753|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129064095|NCT03598790|464521745|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129064096|NCT03598790|464521746|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129064097|NCT03598790|464521747|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128775812|NCT02584855|463468490|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
128721471|NCT02474199|463277268|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
128721472|NCT02474199|463277265|FG000|Overall Study|Did not meet eligibility criteria|0|||
128721473|NCT02474199|463277266|FG001|Overall Study|Did not meet eligibility criteria|0|||
128721474|NCT02474199|463277267|FG002|Overall Study|Did not meet eligibility criteria|2|||
128721475|NCT02474199|463277268|FG003|Overall Study|Did not meet eligibility criteria|2|||
128721476|NCT00159588|463277269|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
128721477|NCT00159588|463277270|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
128721478|NCT00159588|463277271|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
128721479|NCT03253848|463277273|FG000|Overall Study|Adverse Event|7|||
128721480|NCT03253848|463277273|FG000|Overall Study|Death|5|||
128721481|NCT03253848|463277273|FG000|Overall Study|initiation of other treatments|3|||
128721482|NCT03253848|463277273|FG000|Overall Study|Other complicating disease|1|||
128721483|NCT03253848|463277273|FG000|Overall Study|Withdrawal by Subject|1|||
128721484|NCT03253848|463277273|FG000|Overall Study|Declining health|1|||
128721485|NCT05352815|463277274|FG000|Overall Study|Withdrawal by Subject|28|||
128721486|NCT05352815|463277275|FG001|Overall Study|Withdrawal by Subject|24|||
128721487|NCT05352815|463277274|FG000|Overall Study|Lost to Follow-up|4|||
128721488|NCT05352815|463277275|FG001|Overall Study|Lost to Follow-up|7|||
128721489|NCT05352815|463277274|FG000|Overall Study|Death|2|||
128721490|NCT05352815|463277275|FG001|Overall Study|Death|3|||
128721491|NCT05352815|463277274|FG000|Overall Study|Site closure|1|||
128721492|NCT05352815|463277275|FG001|Overall Study|Site closure|0|||
128721493|NCT02759120|463277276|FG000|Overall Study|Death|34|||
128721494|NCT02759120|463277277|FG001|Overall Study|Death|36|||
128721495|NCT02759120|463277276|FG000|Overall Study|Lost to Follow-up|4|||
128721496|NCT02759120|463277277|FG001|Overall Study|Lost to Follow-up|7|||
128721497|NCT02759120|463277276|FG000|Overall Study|Physician Decision|3|||
128721498|NCT02759120|463277277|FG001|Overall Study|Physician Decision|0|||
128721499|NCT02759120|463277276|FG000|Overall Study|Withdrawal by Subject|28|||
129064098|NCT03598790|464521748|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
129064099|NCT03598790|464521749|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129064100|NCT03598790|464521750|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129064101|NCT03598790|464521751|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129064102|NCT03598790|464521752|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129064103|NCT03598790|464521753|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129064104|NCT03598790|464521745|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129064105|NCT03598790|464521746|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129064106|NCT03598790|464521747|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129064107|NCT03598790|464521748|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
129064108|NCT03598790|464521749|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
129064109|NCT03598790|464521750|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129064110|NCT03598790|464521751|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129064111|NCT03598790|464521752|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129064112|NCT03598790|464521753|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129064113|NCT03598790|464521745|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064114|NCT03598790|464521746|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064115|NCT03598790|464521747|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064116|NCT03598790|464521748|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
129064117|NCT03598790|464521749|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064118|NCT03598790|464521750|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064119|NCT03598790|464521751|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064120|NCT03598790|464521752|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064121|NCT03598790|464521753|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129064122|NCT05929651|464521768|FG000|Overall Study|Protocol Deviation|1|||
129064123|NCT05929651|464521768|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
129064124|NCT02260570|464521769|FG000|Overall Study|Withdrawal by Subject|2|||
129064125|NCT02260570|464521770|FG001|Overall Study|Withdrawal by Subject|1|||
129064126|NCT02260570|464521769|FG000|Overall Study|Physician Decision|1|||
129064127|NCT02260570|464521770|FG001|Overall Study|Physician Decision|1|||
129064128|NCT05026177|464521771|FG000|Overall Study|Adverse Event|33|||
129064129|NCT05026177|464521772|FG001|Overall Study|Adverse Event|33|||
129064130|NCT05026177|464521773|FG002|Overall Study|Adverse Event|17|||
129064131|NCT05026177|464521771|FG000|Overall Study|Lost to Follow-up|7|||
129064132|NCT05026177|464521772|FG001|Overall Study|Lost to Follow-up|6|||
129064133|NCT05026177|464521773|FG002|Overall Study|Lost to Follow-up|8|||
129064134|NCT05026177|464521771|FG000|Overall Study|Noncompliance with study drug|6|||
129064135|NCT05026177|464521772|FG001|Overall Study|Noncompliance with study drug|2|||
128721500|NCT02759120|463277277|FG001|Overall Study|Withdrawal by Subject|15|||
128721501|NCT02759120|463277276|FG000|Overall Study|Moved out of area|3|||
128775813|NCT02584855|463468491|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
128721502|NCT02759120|463277277|FG001|Overall Study|Moved out of area|4|||
129064136|NCT05026177|464521773|FG002|Overall Study|Noncompliance with study drug|1|||
129064137|NCT05026177|464521771|FG000|Overall Study|Physician Decision|4|||
129064138|NCT05026177|464521772|FG001|Overall Study|Physician Decision|1|||
129064139|NCT05026177|464521773|FG002|Overall Study|Physician Decision|0|||
128721503|NCT02759120|463277276|FG000|Overall Study|Lung transplant|3|||
128721504|NCT02759120|463277277|FG001|Overall Study|Lung transplant|5|||
128721505|NCT02759120|463277276|FG000|Overall Study|Other reason not completed|10|||
128721506|NCT02759120|463277277|FG001|Overall Study|Other reason not completed|12|||
128721507|NCT03056755|463277279|FG000|Treatment- Core Phase|Progressive disease|89|||
128721508|NCT03056755|463277280|FG001|Treatment- Core Phase|Progressive disease|88|||
128721509|NCT03056755|463277281|FG002|Treatment- Core Phase|Progressive disease|90|||
129137467|NCT00281580|464796279|FG011|Overall Study|Protocol Violation|2|||
129137468|NCT00281580|464796280|FG012|Overall Study|Protocol Violation|0|||
129064140|NCT05026177|464521771|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
129064141|NCT05026177|464521772|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
129064142|NCT05026177|464521773|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
129137469|NCT00281580|464796281|FG013|Overall Study|Protocol Violation|1|||
129137470|NCT00281580|464796282|FG014|Overall Study|Protocol Violation|1|||
129137471|NCT00281580|464796283|FG015|Overall Study|Protocol Violation|3|||
129137472|NCT00281580|464796268|FG000|Overall Study|Withdrawal by Subject|3|||
129137473|NCT00281580|464796269|FG001|Overall Study|Withdrawal by Subject|0|||
129137474|NCT00281580|464796270|FG002|Overall Study|Withdrawal by Subject|1|||
129137475|NCT00281580|464796271|FG003|Overall Study|Withdrawal by Subject|1|||
129137476|NCT00281580|464796272|FG004|Overall Study|Withdrawal by Subject|1|||
129137477|NCT00281580|464796273|FG005|Overall Study|Withdrawal by Subject|2|||
129137478|NCT00281580|464796274|FG006|Overall Study|Withdrawal by Subject|2|||
129137479|NCT00281580|464796275|FG007|Overall Study|Withdrawal by Subject|0|||
129137480|NCT00281580|464796276|FG008|Overall Study|Withdrawal by Subject|1|||
129137481|NCT00281580|464796277|FG009|Overall Study|Withdrawal by Subject|4|||
129137482|NCT00281580|464796278|FG010|Overall Study|Withdrawal by Subject|1|||
129137483|NCT00281580|464796279|FG011|Overall Study|Withdrawal by Subject|1|||
129137484|NCT00281580|464796280|FG012|Overall Study|Withdrawal by Subject|2|||
129137485|NCT00281580|464796281|FG013|Overall Study|Withdrawal by Subject|2|||
129137486|NCT00281580|464796282|FG014|Overall Study|Withdrawal by Subject|1|||
129137487|NCT00281580|464796283|FG015|Overall Study|Withdrawal by Subject|5|||
129137488|NCT00281580|464796268|FG000|Overall Study|Lack of Efficacy|2|||
129137489|NCT00281580|464796269|FG001|Overall Study|Lack of Efficacy|1|||
129137490|NCT00281580|464796270|FG002|Overall Study|Lack of Efficacy|1|||
129137491|NCT00281580|464796271|FG003|Overall Study|Lack of Efficacy|6|||
129137492|NCT00281580|464796272|FG004|Overall Study|Lack of Efficacy|2|||
129137493|NCT00281580|464796273|FG005|Overall Study|Lack of Efficacy|0|||
129137494|NCT00281580|464796274|FG006|Overall Study|Lack of Efficacy|0|||
128721510|NCT03056755|463277279|FG000|Treatment- Core Phase|Adverse Event|20|||
129064143|NCT05026177|464521771|FG000|Overall Study|Withdrawal by Subject|53|||
129064144|NCT05026177|464521772|FG001|Overall Study|Withdrawal by Subject|51|||
129064145|NCT05026177|464521773|FG002|Overall Study|Withdrawal by Subject|55|||
129064146|NCT05026177|464521771|FG000|Overall Study|Protocol Violation|0|||
129064147|NCT05026177|464521772|FG001|Overall Study|Protocol Violation|1|||
129064148|NCT05026177|464521773|FG002|Overall Study|Protocol Violation|0|||
129064149|NCT05026177|464521771|FG000|Overall Study|Study terminated by sponsor|70|||
129064150|NCT05026177|464521772|FG001|Overall Study|Study terminated by sponsor|74|||
129064151|NCT05026177|464521773|FG002|Overall Study|Study terminated by sponsor|67|||
129064152|NCT05026177|464521771|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
129064153|NCT05026177|464521772|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
129064154|NCT05026177|464521773|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
129064155|NCT05026177|464521771|FG000|Overall Study|Starting alternative treatment|0|||
129064156|NCT05026177|464521772|FG001|Overall Study|Starting alternative treatment|1|||
129064157|NCT05026177|464521773|FG002|Overall Study|Starting alternative treatment|1|||
129064158|NCT05026177|464521771|FG000|Overall Study|Noncompliance with study procedures|0|||
129064159|NCT05026177|464521772|FG001|Overall Study|Noncompliance with study procedures|1|||
129064160|NCT05026177|464521773|FG002|Overall Study|Noncompliance with study procedures|1|||
129064161|NCT05026177|464521771|FG000|Overall Study|Met stopping criteria|0|||
129064162|NCT05026177|464521772|FG001|Overall Study|Met stopping criteria|0|||
129064163|NCT05026177|464521773|FG002|Overall Study|Met stopping criteria|1|||
129064164|NCT05026177|464521771|FG000|Overall Study|Health issues preventing continuation|0|||
129064165|NCT05026177|464521772|FG001|Overall Study|Health issues preventing continuation|0|||
129064166|NCT05026177|464521773|FG002|Overall Study|Health issues preventing continuation|1|||
129064167|NCT05026177|464521771|FG000|Overall Study|Randomized in error, not treated|0|||
129064168|NCT05026177|464521772|FG001|Overall Study|Randomized in error, not treated|0|||
129137495|NCT00281580|464796275|FG007|Overall Study|Lack of Efficacy|0|||
128775814|NCT02584855|463468492|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
129137496|NCT00281580|464796276|FG008|Overall Study|Lack of Efficacy|0|||
129137497|NCT00281580|464796277|FG009|Overall Study|Lack of Efficacy|0|||
129137498|NCT00281580|464796278|FG010|Overall Study|Lack of Efficacy|0|||
129137499|NCT00281580|464796279|FG011|Overall Study|Lack of Efficacy|1|||
129137500|NCT00281580|464796280|FG012|Overall Study|Lack of Efficacy|0|||
128721511|NCT03056755|463277280|FG001|Treatment- Core Phase|Adverse Event|14|||
129064169|NCT05026177|464521773|FG002|Overall Study|Randomized in error, not treated|2|||
129137501|NCT00281580|464796281|FG013|Overall Study|Lack of Efficacy|2|||
129064170|NCT04856917|464521774|FG000|Overall Study|Withdrawal by Subject|4|||
129064171|NCT04856917|464521775|FG001|Overall Study|Withdrawal by Subject|3|||
129064172|NCT04856917|464521776|FG002|Overall Study|Withdrawal by Subject|1|||
129064173|NCT04856917|464521774|FG000|Overall Study|Lost to Follow-up|3|||
129064174|NCT04856917|464521775|FG001|Overall Study|Lost to Follow-up|1|||
129064175|NCT04856917|464521776|FG002|Overall Study|Lost to Follow-up|1|||
129064176|NCT04856917|464521774|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
129064177|NCT04856917|464521775|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
129064178|NCT04856917|464521776|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
129064179|NCT04856917|464521774|FG000|Overall Study|Other|1|||
129064180|NCT04856917|464521775|FG001|Overall Study|Other|1|||
129064181|NCT04856917|464521776|FG002|Overall Study|Other|0|||
129064182|NCT01169337|464521777|FG000|Overall Study|Lack of Efficacy|5|||
129064183|NCT01169337|464521778|FG001|Overall Study|Lack of Efficacy|7|||
129137502|NCT00281580|464796282|FG014|Overall Study|Lack of Efficacy|1|||
129137503|NCT00281580|464796283|FG015|Overall Study|Lack of Efficacy|0|||
129137504|NCT00281580|464796268|FG000|Overall Study|Lost to Follow-up|0|||
129137505|NCT00281580|464796269|FG001|Overall Study|Lost to Follow-up|0|||
129137506|NCT00281580|464796270|FG002|Overall Study|Lost to Follow-up|0|||
129137507|NCT00281580|464796271|FG003|Overall Study|Lost to Follow-up|3|||
129137508|NCT00281580|464796272|FG004|Overall Study|Lost to Follow-up|0|||
129137509|NCT00281580|464796273|FG005|Overall Study|Lost to Follow-up|1|||
129137510|NCT00281580|464796274|FG006|Overall Study|Lost to Follow-up|0|||
129137511|NCT00281580|464796275|FG007|Overall Study|Lost to Follow-up|1|||
129064184|NCT01169337|464521779|FG002|Overall Study|Lack of Efficacy|0|||
129064185|NCT01169337|464521777|FG000|Overall Study|Adverse Event|12|||
129064186|NCT01169337|464521778|FG001|Overall Study|Adverse Event|18|||
129064187|NCT01169337|464521779|FG002|Overall Study|Adverse Event|0|||
129064188|NCT01169337|464521777|FG000|Overall Study|Death|2|||
129064189|NCT01169337|464521778|FG001|Overall Study|Death|0|||
129064190|NCT01169337|464521779|FG002|Overall Study|Death|0|||
129064191|NCT01169337|464521777|FG000|Overall Study|Withdrawal by Subject|11|||
129064192|NCT01169337|464521778|FG001|Overall Study|Withdrawal by Subject|11|||
129064193|NCT01169337|464521779|FG002|Overall Study|Withdrawal by Subject|6|||
129064194|NCT01169337|464521777|FG000|Overall Study|Noncompliance|2|||
129064195|NCT01169337|464521778|FG001|Overall Study|Noncompliance|0|||
129064196|NCT01169337|464521779|FG002|Overall Study|Noncompliance|0|||
129064197|NCT01169337|464521777|FG000|Overall Study|Other complicating disease|1|||
129064198|NCT01169337|464521778|FG001|Overall Study|Other complicating disease|1|||
129064199|NCT01169337|464521779|FG002|Overall Study|Other complicating disease|0|||
129064200|NCT01169337|464521777|FG000|Overall Study|Physician Decision|1|||
129064201|NCT01169337|464521778|FG001|Overall Study|Physician Decision|5|||
129064202|NCT01169337|464521779|FG002|Overall Study|Physician Decision|0|||
129064203|NCT01169337|464521777|FG000|Overall Study|Alternative therapy|0|||
129064204|NCT01169337|464521778|FG001|Overall Study|Alternative therapy|2|||
129064205|NCT01169337|464521779|FG002|Overall Study|Alternative therapy|0|||
129064206|NCT01169337|464521777|FG000|Overall Study|Changed hospital|0|||
129064207|NCT01169337|464521778|FG001|Overall Study|Changed hospital|1|||
129064208|NCT01169337|464521779|FG002|Overall Study|Changed hospital|0|||
129064209|NCT01169337|464521777|FG000|Overall Study|Never started treatment|0|||
129064210|NCT01169337|464521778|FG001|Overall Study|Never started treatment|2|||
129064211|NCT01169337|464521779|FG002|Overall Study|Never started treatment|0|||
129064212|NCT01169337|464521777|FG000|Overall Study|Reason not reported|1|||
129064213|NCT01169337|464521778|FG001|Overall Study|Reason not reported|0|||
129064214|NCT01169337|464521779|FG002|Overall Study|Reason not reported|0|||
129064215|NCT01169337|464521777|FG000|Overall Study|Continuing lenalidomide|9|||
129064216|NCT01169337|464521778|FG001|Overall Study|Continuing lenalidomide|43|||
129064217|NCT01169337|464521779|FG002|Overall Study|Continuing lenalidomide|0|||
129064218|NCT03560037|464521780|FG000|Overall Study|Protocol Violation|1|||
129064219|NCT03560037|464521781|FG001|Overall Study|Protocol Violation|0|||
129064220|NCT03560037|464521780|FG000|Overall Study|Physician Decision|0|||
129137512|NCT00281580|464796276|FG008|Overall Study|Lost to Follow-up|2|||
129137513|NCT00281580|464796277|FG009|Overall Study|Lost to Follow-up|1|||
129137514|NCT00281580|464796278|FG010|Overall Study|Lost to Follow-up|1|||
129064221|NCT03560037|464521781|FG001|Overall Study|Physician Decision|1|||
129064222|NCT03816878|464521784|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
129064223|NCT03816878|464521785|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
129064224|NCT03816878|464521784|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
129064225|NCT03816878|464521785|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
129064226|NCT03355469|464521786|FG000|Overall Study|COVID-19|3|||
129064227|NCT03355469|464521787|FG001|Overall Study|COVID-19|2|||
129064228|NCT03355469|464521788|FG002|Overall Study|COVID-19|3|||
129064229|NCT03355469|464521789|FG003|Overall Study|COVID-19|3|||
129064230|NCT03355469|464521786|FG000|Overall Study|Lost to Follow-up|1|||
129064231|NCT03355469|464521787|FG001|Overall Study|Lost to Follow-up|0|||
129137515|NCT00281580|464796279|FG011|Overall Study|Lost to Follow-up|0|||
129137516|NCT00281580|464796280|FG012|Overall Study|Lost to Follow-up|1|||
129137517|NCT00281580|464796281|FG013|Overall Study|Lost to Follow-up|0|||
129064232|NCT03355469|464521788|FG002|Overall Study|Lost to Follow-up|1|||
129064233|NCT03355469|464521789|FG003|Overall Study|Lost to Follow-up|0|||
129064234|NCT03355469|464521786|FG000|Overall Study|Withdrawal by Subject|2|||
129064235|NCT03355469|464521787|FG001|Overall Study|Withdrawal by Subject|1|||
129064236|NCT03355469|464521788|FG002|Overall Study|Withdrawal by Subject|0|||
129064237|NCT03355469|464521789|FG003|Overall Study|Withdrawal by Subject|3|||
129064238|NCT01708941|464521790|FG000|Overall Study|Adverse Event|4|||
129064239|NCT01708941|464521791|FG001|Overall Study|Adverse Event|6|||
129064240|NCT01708941|464521792|FG002|Overall Study|Adverse Event|1|||
129064241|NCT01708941|464521793|FG003|Overall Study|Adverse Event|0|||
129064242|NCT01708941|464521790|FG000|Overall Study|Death|1|||
129064243|NCT01708941|464521791|FG001|Overall Study|Death|1|||
129064244|NCT01708941|464521792|FG002|Overall Study|Death|2|||
129064245|NCT01708941|464521793|FG003|Overall Study|Death|14|||
129064246|NCT01708941|464521790|FG000|Overall Study|Withdrawal by Subject|1|||
129064247|NCT01708941|464521791|FG001|Overall Study|Withdrawal by Subject|0|||
129064248|NCT01708941|464521792|FG002|Overall Study|Withdrawal by Subject|3|||
129064249|NCT01708941|464521793|FG003|Overall Study|Withdrawal by Subject|4|||
129064250|NCT01708941|464521790|FG000|Overall Study|Disease progression|9|||
129064251|NCT01708941|464521791|FG001|Overall Study|Disease progression|10|||
129064252|NCT01708941|464521792|FG002|Overall Study|Disease progression|8|||
129064253|NCT01708941|464521793|FG003|Overall Study|Disease progression|0|||
129064254|NCT01708941|464521790|FG000|Overall Study|Alternative therapy|0|||
129064255|NCT01708941|464521791|FG001|Overall Study|Alternative therapy|0|||
129064256|NCT01708941|464521792|FG002|Overall Study|Alternative therapy|2|||
129064257|NCT01708941|464521793|FG003|Overall Study|Alternative therapy|0|||
129064258|NCT01708941|464521790|FG000|Overall Study|Ineligible and never started treatment|1|||
129064259|NCT01708941|464521791|FG001|Overall Study|Ineligible and never started treatment|0|||
129064260|NCT01708941|464521792|FG002|Overall Study|Ineligible and never started treatment|1|||
129064261|NCT01708941|464521793|FG003|Overall Study|Ineligible and never started treatment|0|||
129064262|NCT01708941|464521790|FG000|Overall Study|Never started treatment|2|||
129064263|NCT01708941|464521791|FG001|Overall Study|Never started treatment|1|||
129064264|NCT01708941|464521792|FG002|Overall Study|Never started treatment|0|||
129064265|NCT01708941|464521793|FG003|Overall Study|Never started treatment|0|||
129064266|NCT01708941|464521790|FG000|Overall Study|Ineligible|0|||
129064267|NCT01708941|464521791|FG001|Overall Study|Ineligible|0|||
129064268|NCT01708941|464521792|FG002|Overall Study|Ineligible|2|||
129064269|NCT01708941|464521793|FG003|Overall Study|Ineligible|0|||
129064270|NCT01575548|464521794|FG000|Overall Study|Adverse Event|15|||
129064271|NCT01575548|464521795|FG001|Overall Study|Adverse Event|2|||
129064272|NCT01575548|464521794|FG000|Overall Study|Disease progression|12|||
129064273|NCT01575548|464521795|FG001|Overall Study|Disease progression|25|||
129064274|NCT01575548|464521794|FG000|Overall Study|Death|1|||
129064275|NCT01575548|464521795|FG001|Overall Study|Death|0|||
129064276|NCT01575548|464521794|FG000|Overall Study|Other complicating disease|1|||
129064277|NCT01575548|464521795|FG001|Overall Study|Other complicating disease|0|||
129064278|NCT01575548|464521794|FG000|Overall Study|Withdrawal by Subject|7|||
129064279|NCT01575548|464521795|FG001|Overall Study|Withdrawal by Subject|3|||
129064280|NCT01575548|464521794|FG000|Overall Study|Noncompliance|1|||
129064281|NCT01575548|464521795|FG001|Overall Study|Noncompliance|0|||
129064282|NCT01575548|464521794|FG000|Overall Study|Anticipated surgery|0|||
129064283|NCT01575548|464521795|FG001|Overall Study|Anticipated surgery|1|||
129064284|NCT01575548|464521794|FG000|Overall Study|Never started protocol therapy|3|||
129064285|NCT01575548|464521795|FG001|Overall Study|Never started protocol therapy|2|||
129064286|NCT04175912|464521796|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
129064287|NCT04175912|464521797|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
129064288|NCT04175912|464521796|FG000|Overall Study|Adverse Event|0|||
129064289|NCT04175912|464521797|FG001|Overall Study|Adverse Event|3|||
129064290|NCT04175912|464521796|FG000|Overall Study|Never started treatment|3|||
129064291|NCT04175912|464521797|FG001|Overall Study|Never started treatment|3|||
129064292|NCT04175912|464521796|FG000|Overall Study|Death|0|||
129064293|NCT04175912|464521797|FG001|Overall Study|Death|1|||
129064294|NCT02048813|464521798|FG000|Overall Study|Still on treatment|279|||
129064295|NCT02048813|464521799|FG001|Overall Study|Still on treatment|0|||
129064296|NCT02048813|464521798|FG000|Overall Study|Adverse Event|40|||
129064297|NCT02048813|464521799|FG001|Overall Study|Adverse Event|38|||
129064298|NCT02048813|464521798|FG000|Overall Study|Disease progression|13|||
129064299|NCT02048813|464521799|FG001|Overall Study|Disease progression|3|||
129064300|NCT02048813|464521798|FG000|Overall Study|Withdrawal by Subject|7|||
129064301|NCT02048813|464521799|FG001|Overall Study|Withdrawal by Subject|8|||
129064302|NCT02048813|464521798|FG000|Overall Study|Death|2|||
129064303|NCT02048813|464521799|FG001|Overall Study|Death|1|||
129064304|NCT02048813|464521798|FG000|Overall Study|Complication|2|||
129064305|NCT02048813|464521799|FG001|Overall Study|Complication|2|||
129064306|NCT02048813|464521798|FG000|Overall Study|Non-protocol therapy|0|||
129064307|NCT02048813|464521799|FG001|Overall Study|Non-protocol therapy|1|||
129064308|NCT02048813|464521798|FG000|Overall Study|Second primary cancer|2|||
129064309|NCT02048813|464521799|FG001|Overall Study|Second primary cancer|0|||
129064310|NCT02048813|464521798|FG000|Overall Study|Insurance|2|||
129064311|NCT02048813|464521799|FG001|Overall Study|Insurance|0|||
129064312|NCT02048813|464521798|FG000|Overall Study|Wound infection/healing|2|||
129064313|NCT02048813|464521799|FG001|Overall Study|Wound infection/healing|0|||
129064314|NCT02048813|464521798|FG000|Overall Study|Missed appointment|3|||
129064315|NCT02048813|464521799|FG001|Overall Study|Missed appointment|0|||
129064316|NCT02048813|464521798|FG000|Overall Study|Never started treatment|2|||
129064317|NCT02048813|464521799|FG001|Overall Study|Never started treatment|17|||
129064318|NCT01708954|464521800|FG000|Step 1|Disease progression|26|||
129064319|NCT01708954|464521801|FG001|Step 1|Disease progression|17|||
129064320|NCT01708954|464521802|FG002|Step 1|Disease progression|14|||
129064321|NCT01708954|464521800|FG000|Step 1|Adverse Event|3|||
129064322|NCT01708954|464521801|FG001|Step 1|Adverse Event|11|||
129064323|NCT01708954|464521802|FG002|Step 1|Adverse Event|13|||
129064324|NCT01708954|464521800|FG000|Step 1|Death|3|||
129064325|NCT01708954|464521801|FG001|Step 1|Death|2|||
129064326|NCT01708954|464521802|FG002|Step 1|Death|3|||
129064327|NCT01708954|464521800|FG000|Step 1|Withdrawal by Subject|2|||
129064328|NCT01708954|464521801|FG001|Step 1|Withdrawal by Subject|5|||
129064329|NCT01708954|464521802|FG002|Step 1|Withdrawal by Subject|3|||
129064330|NCT01708954|464521800|FG000|Step 1|Other complicating disease|0|||
129064331|NCT01708954|464521801|FG001|Step 1|Other complicating disease|2|||
129064332|NCT01708954|464521802|FG002|Step 1|Other complicating disease|0|||
129064333|NCT01708954|464521800|FG000|Step 1|Crossed over to Step 2|2|||
129064334|NCT01708954|464521801|FG001|Step 1|Crossed over to Step 2|0|||
129064335|NCT01708954|464521802|FG002|Step 1|Crossed over to Step 2|0|||
129064336|NCT01708954|464521800|FG000|Step 1|Symptomatic deterioration|1|||
129064337|NCT01708954|464521801|FG001|Step 1|Symptomatic deterioration|0|||
129064338|NCT01708954|464521802|FG002|Step 1|Symptomatic deterioration|1|||
129064339|NCT01708954|464521800|FG000|Step 1|Off-treatment reason not submitted|1|||
129064340|NCT01708954|464521801|FG001|Step 1|Off-treatment reason not submitted|1|||
129064341|NCT01708954|464521802|FG002|Step 1|Off-treatment reason not submitted|1|||
129064342|NCT01708954|464521800|FG000|Step 1|Ineligible or never received treatment|4|||
129064343|NCT01708954|464521801|FG001|Step 1|Ineligible or never received treatment|2|||
129064344|NCT01708954|464521802|FG002|Step 1|Ineligible or never received treatment|8|||
129064345|NCT01708954|464521800|FG000|Step 2|Disease progression|9|||
129064346|NCT01708954|464521801|FG001|Step 2|Disease progression|4|||
129064347|NCT01708954|464521802|FG002|Step 2|Disease progression|0|||
129064348|NCT01708954|464521800|FG000|Step 2|Adverse Event|3|||
129064349|NCT01708954|464521801|FG001|Step 2|Adverse Event|2|||
129064350|NCT01708954|464521802|FG002|Step 2|Adverse Event|0|||
129064351|NCT01708954|464521800|FG000|Step 2|Withdrawal by Subject|1|||
129064352|NCT01708954|464521801|FG001|Step 2|Withdrawal by Subject|1|||
129064353|NCT01708954|464521802|FG002|Step 2|Withdrawal by Subject|0|||
129064354|NCT06400251|464521803|FG000|Overall Study|Never Start Protocol Therapy|1|||
129064355|NCT06400251|464521803|FG000|Overall Study|Ineligible|2|||
129064356|NCT06400251|464521803|FG000|Overall Study|Mutation Status Not Confirmed|3|||
129064357|NCT06400251|464521803|FG000|Overall Study|Disease Progression|25|||
129064358|NCT06400251|464521803|FG000|Overall Study|Adverse Event|1|||
129064359|NCT06400251|464521803|FG000|Overall Study|Complicating Disease|1|||
129064360|NCT06400251|464521803|FG000|Overall Study|Physician Decision|2|||
129064361|NCT03631199|464521804|FG000|Overall Study|Progressive disease|9|||
129064362|NCT03631199|464521805|FG001|Overall Study|Progressive disease|5|||
129064363|NCT03631199|464521806|FG002|Overall Study|Progressive disease|5|||
129137518|NCT00281580|464796282|FG014|Overall Study|Lost to Follow-up|0|||
129137519|NCT00281580|464796283|FG015|Overall Study|Lost to Follow-up|0|||
129137520|NCT00281580|464796268|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
128721512|NCT03056755|463277281|FG002|Treatment- Core Phase|Adverse Event|13|||
129064364|NCT03631199|464521807|FG003|Overall Study|Progressive disease|149|||
129064365|NCT03631199|464521808|FG004|Overall Study|Progressive disease|148|||
129064366|NCT03631199|464521804|FG000|Overall Study|Physician Decision|0|||
129137521|NCT00281580|464796269|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
129137522|NCT00281580|464796270|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
129137523|NCT00281580|464796271|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
128721513|NCT03056755|463277279|FG000|Treatment- Core Phase|Physician Decision|7|||
128721514|NCT03056755|463277280|FG001|Treatment- Core Phase|Physician Decision|13|||
128721515|NCT03056755|463277281|FG002|Treatment- Core Phase|Physician Decision|5|||
129064367|NCT03631199|464521805|FG001|Overall Study|Physician Decision|2|||
129064368|NCT03631199|464521806|FG002|Overall Study|Physician Decision|3|||
129064369|NCT03631199|464521807|FG003|Overall Study|Physician Decision|19|||
129064370|NCT03631199|464521808|FG004|Overall Study|Physician Decision|13|||
129064371|NCT03631199|464521804|FG000|Overall Study|Adverse Event|1|||
129064372|NCT03631199|464521805|FG001|Overall Study|Adverse Event|1|||
129064373|NCT03631199|464521806|FG002|Overall Study|Adverse Event|0|||
129064374|NCT03631199|464521807|FG003|Overall Study|Adverse Event|28|||
129064375|NCT03631199|464521808|FG004|Overall Study|Adverse Event|29|||
129064376|NCT03631199|464521804|FG000|Overall Study|Death|0|||
129064377|NCT03631199|464521805|FG001|Overall Study|Death|1|||
129064378|NCT03631199|464521806|FG002|Overall Study|Death|0|||
129064379|NCT03631199|464521807|FG003|Overall Study|Death|35|||
129064380|NCT03631199|464521808|FG004|Overall Study|Death|48|||
129064381|NCT03631199|464521804|FG000|Overall Study|Subject decision|0|||
129064382|NCT03631199|464521805|FG001|Overall Study|Subject decision|1|||
129064383|NCT03631199|464521806|FG002|Overall Study|Subject decision|0|||
129064384|NCT03631199|464521807|FG003|Overall Study|Subject decision|12|||
129064385|NCT03631199|464521808|FG004|Overall Study|Subject decision|12|||
129064386|NCT03631199|464521804|FG000|Overall Study|No treated|0|||
129064387|NCT03631199|464521805|FG001|Overall Study|No treated|0|||
129064388|NCT03631199|464521806|FG002|Overall Study|No treated|0|||
129064389|NCT03631199|464521807|FG003|Overall Study|No treated|0|||
129064390|NCT03631199|464521808|FG004|Overall Study|No treated|1|||
129064391|NCT03631199|464521804|FG000|Overall Study|Treatment ongoing|0|||
129064392|NCT03631199|464521805|FG001|Overall Study|Treatment ongoing|1|||
129064393|NCT03631199|464521806|FG002|Overall Study|Treatment ongoing|1|||
129064394|NCT03631199|464521807|FG003|Overall Study|Treatment ongoing|76|||
129064395|NCT03631199|464521808|FG004|Overall Study|Treatment ongoing|71|||
129064396|NCT03631199|464521804|FG000|Overall Study|Guardian decision|0|||
129064397|NCT03631199|464521805|FG001|Overall Study|Guardian decision|0|||
129064398|NCT03631199|464521806|FG002|Overall Study|Guardian decision|0|||
129064399|NCT03631199|464521807|FG003|Overall Study|Guardian decision|1|||
129064400|NCT03631199|464521808|FG004|Overall Study|Guardian decision|1|||
129064401|NCT03651700|464521809|FG000|Overall Study|Withdrawal by Subject|1|||
129064402|NCT03651700|464521810|FG001|Overall Study|Withdrawal by Subject|0|||
129064403|NCT02847260|464521811|FG000|Overall Study|Adverse Event|3|||
129064404|NCT02847260|464521811|FG000|Overall Study|Withdrawal by Subject|2|||
129064405|NCT02847260|464521811|FG000|Overall Study|Clinical Deterioration|1|||
129064406|NCT02847260|464521811|FG000|Overall Study|Physician Decision|1|||
129064407|NCT01856192|464521812|FG000|Overall Study|Adverse Event|12|||
129064408|NCT01856192|464521813|FG001|Overall Study|Adverse Event|4|||
129064409|NCT01856192|464521812|FG000|Overall Study|Alternative therapy|0|||
129064410|NCT01856192|464521813|FG001|Overall Study|Alternative therapy|3|||
129064411|NCT01856192|464521812|FG000|Overall Study|Death|3|||
129064412|NCT01856192|464521813|FG001|Overall Study|Death|5|||
129064413|NCT01856192|464521812|FG000|Overall Study|Lack of Efficacy|0|||
129064414|NCT01856192|464521813|FG001|Overall Study|Lack of Efficacy|5|||
129064415|NCT01856192|464521812|FG000|Overall Study|Withdrawal by Subject|1|||
129064416|NCT01856192|464521813|FG001|Overall Study|Withdrawal by Subject|1|||
129064417|NCT01856192|464521812|FG000|Overall Study|Other diseases|1|||
129064418|NCT01856192|464521813|FG001|Overall Study|Other diseases|0|||
129064419|NCT01856192|464521812|FG000|Overall Study|Never started treatment|7|||
129064420|NCT01856192|464521813|FG001|Overall Study|Never started treatment|5|||
129064421|NCT01856192|464521812|FG000|Overall Study|Path ineligible|20|||
129137524|NCT00281580|464796272|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
129137525|NCT00281580|464796273|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
129137526|NCT00281580|464796274|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
129137527|NCT00281580|464796275|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
129137528|NCT00281580|464796276|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
129137529|NCT00281580|464796277|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
129137530|NCT00281580|464796278|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
129137531|NCT00281580|464796279|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
129137532|NCT00281580|464796280|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
129137533|NCT00281580|464796281|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
129137534|NCT00281580|464796282|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
129137535|NCT00281580|464796283|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
129137536|NCT03302936|464796284|FG000|Overall Study|Protocol Violation|3|||
129137537|NCT03302936|464796285|FG001|Overall Study|Protocol Violation|4|||
129137538|NCT01550965|464796286|FG000|Overall Study|Adverse Event|26|||
129137539|NCT01550965|464796286|FG000|Overall Study|Withdrawal by Subject|10|||
129137540|NCT01550965|464796286|FG000|Overall Study|Lost to Follow-up|2|||
129137541|NCT01550965|464796286|FG000|Overall Study|Lack of Efficacy|59|||
129137542|NCT01550965|464796286|FG000|Overall Study|Other|13|||
129137543|NCT03016403|464796289|FG000|Baseline|Death|5|||
129137544|NCT03016403|464796290|FG001|Baseline|Death|8|||
129064422|NCT01856192|464521813|FG001|Overall Study|Path ineligible|34|||
129064423|NCT01856192|464521812|FG000|Overall Study|Non-path ineligible|2|||
129064424|NCT01856192|464521813|FG001|Overall Study|Non-path ineligible|2|||
129064425|NCT01856192|464521812|FG000|Overall Study|Physician Decision|1|||
129137545|NCT03016403|464796291|FG002|Baseline|Death|1|||
129137546|NCT03016403|464796292|FG003|Baseline|Death|0|||
129064426|NCT01856192|464521813|FG001|Overall Study|Physician Decision|1|||
129064427|NCT01856192|464521812|FG000|Overall Study|Suspicion of progressive disease|1|||
129064428|NCT01856192|464521813|FG001|Overall Study|Suspicion of progressive disease|0|||
129064429|NCT01856192|464521812|FG000|Overall Study|Non-compliance|1|||
129137547|NCT03016403|464796289|FG000|Baseline|Withdrawal by Subject|2|||
129137548|NCT03016403|464796290|FG001|Baseline|Withdrawal by Subject|8|||
129137549|NCT03016403|464796291|FG002|Baseline|Withdrawal by Subject|4|||
129064430|NCT01856192|464521813|FG001|Overall Study|Non-compliance|0|||
129064431|NCT04759703|464521822|FG000|Overall Study|Withdrawal by Subject|4|||
129064432|NCT04759703|464521823|FG001|Overall Study|Withdrawal by Subject|9|||
129064433|NCT04759703|464521822|FG000|Overall Study|Adverse Event|1|||
129064434|NCT04759703|464521823|FG001|Overall Study|Adverse Event|0|||
129064435|NCT04759703|464521822|FG000|Overall Study|Lost to Follow-up|2|||
129064436|NCT04759703|464521823|FG001|Overall Study|Lost to Follow-up|0|||
129064437|NCT04186845|464521824|FG000|Overall Study|Death|2|||
129064438|NCT04186845|464521824|FG000|Overall Study|Lost to Follow-up|1|||
129064439|NCT04186845|464521824|FG000|Overall Study|Physician Decision|1|||
129064440|NCT04186845|464521824|FG000|Overall Study|Protocol Violation|1|||
129064441|NCT04186845|464521824|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
129064442|NCT04186845|464521824|FG000|Overall Study|Biopsy ordered but not done|1|||
129064443|NCT04186845|464521824|FG000|Overall Study|It was previously confirmed|1|||
129064444|NCT04186845|464521824|FG000|Overall Study|Patient cancelled scheduled scans|2|||
129064445|NCT04186845|464521824|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
129064446|NCT04186845|464521824|FG000|Overall Study|Subject refused confirmatory imaging|1|||
129064447|NCT04186845|464521824|FG000|Overall Study|Too small to biopsy|1|||
129064448|NCT01814553|464521827|FG000|Overall Study|PD per clinical progression|6|||
129064449|NCT01814553|464521828|FG001|Overall Study|PD per clinical progression|8|||
129064450|NCT01814553|464521827|FG000|Overall Study|Other Adverse Event|4|||
129064451|NCT01814553|464521828|FG001|Overall Study|Other Adverse Event|5|||
129064452|NCT01814553|464521827|FG000|Overall Study|Withdrawal by Subject|1|||
129064453|NCT01814553|464521828|FG001|Overall Study|Withdrawal by Subject|1|||
129064454|NCT01814553|464521827|FG000|Overall Study|Other than stated|7|||
129064455|NCT01814553|464521828|FG001|Overall Study|Other than stated|8|||
129064456|NCT02859142|464521829|FG000|Overall Study|Adverse Event|1|||
129064457|NCT02859142|464521830|FG001|Overall Study|Adverse Event|2|||
129064458|NCT02859142|464521829|FG000|Overall Study|Lost to Follow-up|1|||
129064459|NCT02859142|464521830|FG001|Overall Study|Lost to Follow-up|4|||
129064460|NCT02859142|464521829|FG000|Overall Study|Withdrawal by Subject|2|||
129064461|NCT02859142|464521830|FG001|Overall Study|Withdrawal by Subject|0|||
129064462|NCT02859142|464521829|FG000|Overall Study|Scheduling difficulties|0|||
129064463|NCT02859142|464521830|FG001|Overall Study|Scheduling difficulties|3|||
129064464|NCT03290079|464521831|FG000|Overall Study|Death|2|||
129064465|NCT01941498|464521832|FG000|Overall Study|Relocated out of state|1|||
129064466|NCT04697069|464521834|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
129064467|NCT04697069|464521835|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
129064468|NCT04697069|464521834|FG000|Overall Study|Study termination|2|||
129064469|NCT04697069|464521835|FG001|Overall Study|Study termination|1|||
129064470|NCT04739800|464521836|FG000|Overall Study|Adverse Event|2|||
129064471|NCT04739800|464521837|FG001|Overall Study|Adverse Event|1|||
129064472|NCT04739800|464521838|FG002|Overall Study|Adverse Event|4|||
129064473|NCT04739800|464521839|FG003|Overall Study|Adverse Event|5|||
129064474|NCT04739800|464521836|FG000|Overall Study|Never Treated|2|||
129064475|NCT04739800|464521837|FG001|Overall Study|Never Treated|0|||
129064476|NCT04739800|464521838|FG002|Overall Study|Never Treated|1|||
129064477|NCT04739800|464521839|FG003|Overall Study|Never Treated|1|||
129064478|NCT04739800|464521836|FG000|Overall Study|On Treatment|5|||
129064479|NCT04739800|464521837|FG001|Overall Study|On Treatment|9|||
129064480|NCT04739800|464521838|FG002|Overall Study|On Treatment|9|||
129064481|NCT04739800|464521839|FG003|Overall Study|On Treatment|9|||
129064482|NCT04739800|464521836|FG000|Overall Study|Symptomatic Deterioration|1|||
129064483|NCT04739800|464521837|FG001|Overall Study|Symptomatic Deterioration|1|||
129064484|NCT04739800|464521838|FG002|Overall Study|Symptomatic Deterioration|3|||
129064485|NCT04739800|464521839|FG003|Overall Study|Symptomatic Deterioration|0|||
129064486|NCT04739800|464521836|FG000|Overall Study|Withdrawal by Subject|1|||
129064487|NCT04739800|464521837|FG001|Overall Study|Withdrawal by Subject|2|||
129064488|NCT04739800|464521838|FG002|Overall Study|Withdrawal by Subject|1|||
129064489|NCT04739800|464521839|FG003|Overall Study|Withdrawal by Subject|3|||
129064490|NCT04739800|464521836|FG000|Overall Study|Other Reason|1|||
129064491|NCT04739800|464521837|FG001|Overall Study|Other Reason|3|||
129064492|NCT04739800|464521838|FG002|Overall Study|Other Reason|5|||
129064493|NCT04739800|464521839|FG003|Overall Study|Other Reason|4|||
129064494|NCT02779855|464521840|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
129064495|NCT02779855|464521841|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
129064496|NCT02779855|464521842|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
129064497|NCT04597632|464521843|FG000|Overall Study|Withdrawal by Subject|10|||
129064498|NCT04597632|464521843|FG000|Overall Study|Lost to Follow-up|1|||
129064499|NCT04597632|464521843|FG000|Overall Study|Death|1|||
129064500|NCT04597632|464521843|FG000|Overall Study|Adverse Event|5|||
129137550|NCT03016403|464796292|FG003|Baseline|Withdrawal by Subject|10|||
129137551|NCT03016403|464796289|FG000|Baseline|Lost to Follow-up|9|||
129137552|NCT03016403|464796290|FG001|Baseline|Lost to Follow-up|11|||
129137553|NCT03016403|464796291|FG002|Baseline|Lost to Follow-up|6|||
129137554|NCT03016403|464796292|FG003|Baseline|Lost to Follow-up|24|||
129137555|NCT03016403|464796289|FG000|6-week Follow-up|Death|1|||
129137556|NCT03016403|464796290|FG001|6-week Follow-up|Death|4|||
129137557|NCT03016403|464796291|FG002|6-week Follow-up|Death|0|||
129137558|NCT03016403|464796292|FG003|6-week Follow-up|Death|0|||
129137559|NCT03016403|464796289|FG000|6-week Follow-up|Lost to Follow-up|2|||
129137560|NCT03016403|464796290|FG001|6-week Follow-up|Lost to Follow-up|7|||
129137561|NCT03016403|464796291|FG002|6-week Follow-up|Lost to Follow-up|4|||
129137562|NCT03016403|464796292|FG003|6-week Follow-up|Lost to Follow-up|8|||
129137563|NCT03016403|464796289|FG000|6-week Follow-up|Withdrawal by Subject|0|||
129137564|NCT03016403|464796290|FG001|6-week Follow-up|Withdrawal by Subject|2|||
129137565|NCT03016403|464796291|FG002|6-week Follow-up|Withdrawal by Subject|0|||
128721516|NCT03056755|463277279|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
128721517|NCT03056755|463277280|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
128721518|NCT03056755|463277281|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
128721519|NCT03056755|463277279|FG000|Treatment- Core Phase|Death|3|||
128721520|NCT03056755|463277280|FG001|Treatment- Core Phase|Death|2|||
128721521|NCT03056755|463277281|FG002|Treatment- Core Phase|Death|4|||
128721522|NCT03056755|463277279|FG000|Treatment- Core Phase|Protocol deviation|1|||
128721523|NCT03056755|463277280|FG001|Treatment- Core Phase|Protocol deviation|1|||
128721524|NCT03056755|463277281|FG002|Treatment- Core Phase|Protocol deviation|0|||
128721525|NCT03056755|463277279|FG000|Treatment- Core Phase|Technical problems|1|||
128775815|NCT02584855|463468487|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
128775816|NCT02584855|463468488|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
129137566|NCT03016403|464796292|FG003|6-week Follow-up|Withdrawal by Subject|1|||
129137567|NCT03016403|464796289|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
129137568|NCT03016403|464796290|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
129137569|NCT03016403|464796291|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
129137570|NCT03016403|464796292|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
129137571|NCT03016403|464796289|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
129137572|NCT03016403|464796290|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
129137573|NCT03016403|464796291|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
129137574|NCT03016403|464796292|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
129137575|NCT03016403|464796289|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
129137576|NCT03016403|464796290|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
129137577|NCT03016403|464796291|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
129137578|NCT03016403|464796292|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
128775817|NCT02584855|463468489|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
128775818|NCT02584855|463468490|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
128775819|NCT02584855|463468491|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
128775820|NCT02584855|463468492|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
128775821|NCT02584855|463468487|FG000|Open-Label Treatment Period|Adverse Event|14|||
128775822|NCT02584855|463468488|FG001|Open-Label Treatment Period|Adverse Event|0|||
128775823|NCT02584855|463468489|FG002|Open-Label Treatment Period|Adverse Event|0|||
128775824|NCT02584855|463468490|FG003|Open-Label Treatment Period|Adverse Event|0|||
128775825|NCT02584855|463468491|FG004|Open-Label Treatment Period|Adverse Event|0|||
128775826|NCT02584855|463468492|FG005|Open-Label Treatment Period|Adverse Event|0|||
128775827|NCT02584855|463468487|FG000|Open-Label Treatment Period|Death|2|||
128775828|NCT02584855|463468488|FG001|Open-Label Treatment Period|Death|0|||
128775829|NCT02584855|463468489|FG002|Open-Label Treatment Period|Death|0|||
128775830|NCT02584855|463468490|FG003|Open-Label Treatment Period|Death|0|||
128775831|NCT02584855|463468491|FG004|Open-Label Treatment Period|Death|0|||
128775832|NCT02584855|463468492|FG005|Open-Label Treatment Period|Death|0|||
128775833|NCT02584855|463468487|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
128775834|NCT02584855|463468488|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
128775835|NCT02584855|463468489|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
128775836|NCT02584855|463468490|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
128775837|NCT02584855|463468491|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
129137579|NCT05463705|464796293|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
129137580|NCT05463705|464796294|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
129137581|NCT05463705|464796295|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
129137582|NCT05463705|464796296|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
128721526|NCT03056755|463277280|FG001|Treatment- Core Phase|Technical problems|0|||
128721527|NCT03056755|463277281|FG002|Treatment- Core Phase|Technical problems|0|||
128775838|NCT02584855|463468492|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
129137583|NCT05463705|464796297|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
129137584|NCT05463705|464796298|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
128775839|NCT02584855|463468487|FG000|Open-Label Treatment Period|Protocol Violation|1|||
129064501|NCT01893346|464521846|FG000|Overall Study|Lost to Follow-up|0|||
129064502|NCT01893346|464521847|FG001|Overall Study|Lost to Follow-up|1|||
129064503|NCT01893346|464521848|FG002|Overall Study|Lost to Follow-up|0|||
129064504|NCT01893346|464521849|FG003|Overall Study|Lost to Follow-up|0|||
129064505|NCT01893346|464521846|FG000|Overall Study|Protocol Violation|1|||
129064506|NCT01893346|464521847|FG001|Overall Study|Protocol Violation|0|||
129064507|NCT01893346|464521848|FG002|Overall Study|Protocol Violation|0|||
129064508|NCT01893346|464521849|FG003|Overall Study|Protocol Violation|0|||
129064509|NCT01893346|464521846|FG000|Overall Study|Withdrawal by Subject|2|||
129064510|NCT01893346|464521847|FG001|Overall Study|Withdrawal by Subject|0|||
129064511|NCT01893346|464521848|FG002|Overall Study|Withdrawal by Subject|0|||
129064512|NCT01893346|464521849|FG003|Overall Study|Withdrawal by Subject|0|||
129064513|NCT01449812|464521850|FG000|Overall Study|Migrated/moved from study area|1|||
129064514|NCT01449812|464521851|FG001|Overall Study|Migrated/moved from study area|0|||
129064515|NCT01449812|464521852|FG002|Overall Study|Migrated/moved from study area|0|||
129064516|NCT01449812|464521850|FG000|Overall Study|Withdrawal by Subject|0|||
129064517|NCT01449812|464521851|FG001|Overall Study|Withdrawal by Subject|0|||
129064518|NCT01449812|464521852|FG002|Overall Study|Withdrawal by Subject|1|||
129064519|NCT01449812|464521850|FG000|Overall Study|Lost to Follow-up|1|||
129064520|NCT01449812|464521851|FG001|Overall Study|Lost to Follow-up|0|||
129064521|NCT01449812|464521852|FG002|Overall Study|Lost to Follow-up|0|||
129064522|NCT04239027|464521853|FG000|Overall Study|Adverse Event|4|||
129064523|NCT04239027|464521853|FG000|Overall Study|Withdrawal by Subject|9|||
129064524|NCT04239027|464521853|FG000|Overall Study|Death|1|||
129064525|NCT04239027|464521853|FG000|Overall Study|Physician Decision|9|||
129064526|NCT04239027|464521853|FG000|Overall Study|Lost to Follow-up|2|||
129064527|NCT04239027|464521853|FG000|Overall Study|Lack of Efficacy|1|||
129064528|NCT02839707|464521856|FG000|Phase I|Not eligible for analysis|9|||
129064529|NCT02839707|464521857|FG001|Phase I|Not eligible for analysis|0|||
129064530|NCT02839707|464521858|FG002|Phase I|Not eligible for analysis|0|||
129064531|NCT02839707|464521856|FG000|Phase II|Not treated according to protocol|4|||
129064532|NCT02839707|464521857|FG001|Phase II|Not treated according to protocol|0|||
129064533|NCT02839707|464521858|FG002|Phase II|Not treated according to protocol|2|||
129064534|NCT02839707|464521856|FG000|Phase III|Not treated according to protocol|0|||
129064535|NCT02839707|464521857|FG001|Phase III|Not treated according to protocol|0|||
129064536|NCT02839707|464521858|FG002|Phase III|Not treated according to protocol|4|||
129064537|NCT01290302|464523660|FG000|Overall Study|Adverse Event|2|||
129064538|NCT01290302|464523661|FG001|Overall Study|Adverse Event|0|||
129064539|NCT01290302|464523660|FG000|Overall Study|Withdrawal by Subject|1|||
129064540|NCT01290302|464523661|FG001|Overall Study|Withdrawal by Subject|0|||
129064541|NCT01290302|464523660|FG000|Overall Study|Physician Decision|0|||
129064542|NCT01290302|464523661|FG001|Overall Study|Physician Decision|2|||
129064543|NCT01290302|464523660|FG000|Overall Study|Expiration of time for screening window|1|||
129064544|NCT01290302|464523661|FG001|Overall Study|Expiration of time for screening window|0|||
129064545|NCT06419907|464523664|FG000|Overall Study|Protocol Violation|0|||
129064546|NCT06419907|464523665|FG001|Overall Study|Protocol Violation|3|||
129064547|NCT06419907|464523666|FG002|Overall Study|Protocol Violation|0|||
129064548|NCT06419907|464523667|FG003|Overall Study|Protocol Violation|1|||
129064549|NCT06419907|464523664|FG000|Overall Study|Lost to Follow-up|0|||
129064550|NCT06419907|464523665|FG001|Overall Study|Lost to Follow-up|0|||
129064551|NCT06419907|464523666|FG002|Overall Study|Lost to Follow-up|2|||
129064552|NCT06419907|464523667|FG003|Overall Study|Lost to Follow-up|1|||
129064553|NCT02454608|464523670|FG000|Double-Blind Period|Lack of Efficacy|0|||
129064554|NCT02454608|464523671|FG001|Double-Blind Period|Lack of Efficacy|2|||
129137585|NCT00621322|464796299|FG000|Overall Study|Lost to Follow-up|0|||
129137586|NCT00621322|464796300|FG001|Overall Study|Lost to Follow-up|0|||
129137587|NCT00621322|464796301|FG002|Overall Study|Lost to Follow-up|0|||
129137588|NCT00621322|464796302|FG003|Overall Study|Lost to Follow-up|0|||
129137589|NCT00621322|464796303|FG004|Overall Study|Lost to Follow-up|1|||
129137590|NCT00621322|464796304|FG005|Overall Study|Lost to Follow-up|0|||
129137591|NCT00621322|464796299|FG000|Overall Study|Physician Decision|0|||
129137592|NCT00621322|464796300|FG001|Overall Study|Physician Decision|0|||
129137593|NCT00621322|464796301|FG002|Overall Study|Physician Decision|1|||
129137594|NCT00621322|464796302|FG003|Overall Study|Physician Decision|1|||
129137595|NCT00621322|464796303|FG004|Overall Study|Physician Decision|0|||
129137596|NCT00621322|464796304|FG005|Overall Study|Physician Decision|0|||
129064555|NCT02454608|464523672|FG002|Double-Blind Period|Lack of Efficacy|0|||
129064556|NCT02454608|464523670|FG000|Open Label Period|Lost to Follow-up|0|||
129064557|NCT02454608|464523671|FG001|Open Label Period|Lost to Follow-up|0|||
129064558|NCT02454608|464523672|FG002|Open Label Period|Lost to Follow-up|11|||
129064559|NCT02454608|464523670|FG000|Open Label Period|Withdrawal by Subject|0|||
129064560|NCT02454608|464523671|FG001|Open Label Period|Withdrawal by Subject|0|||
129064561|NCT02454608|464523672|FG002|Open Label Period|Withdrawal by Subject|8|||
129064562|NCT03573830|464523673|FG000|Overall Study|Dropped without completing treatment|0|||
129064563|NCT03573830|464523674|FG001|Overall Study|Dropped without completing treatment|7|||
129064564|NCT03573830|464523673|FG000|Overall Study|Lost to Follow-up|4|||
129064565|NCT03573830|464523674|FG001|Overall Study|Lost to Follow-up|0|||
129064566|NCT01769456|464523675|FG000|Overall Study|Lost to Follow-up|19|||
129064567|NCT01769456|464523675|FG000|Overall Study|Withdrawal by Subject|3|||
129064568|NCT01769456|464523675|FG000|Overall Study|Did not receive PCC intervention|6|||
129064569|NCT01769456|464523675|FG000|Overall Study|Moved out of the area|3|||
129064570|NCT01769456|464523675|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
129064571|NCT01769456|464523675|FG000|Overall Study|Parental request to youth to withdraw|1|||
129064572|NCT05244122|464523686|FG000|Overall Study|Withdrawal by Subject|318|||
129064573|NCT02969382|464523691|FG000|Overall Study|Adverse Event|8|||
129064574|NCT02969382|464523692|FG001|Overall Study|Adverse Event|10|||
129064575|NCT02969382|464523691|FG000|Overall Study|Lack of Efficacy|4|||
129064576|NCT02969382|464523692|FG001|Overall Study|Lack of Efficacy|5|||
129064577|NCT02969382|464523691|FG000|Overall Study|Death|0|||
129064578|NCT02969382|464523692|FG001|Overall Study|Death|1|||
129064579|NCT02969382|464523691|FG000|Overall Study|PROTOCOL DEVIATION|0|||
129064580|NCT02969382|464523692|FG001|Overall Study|PROTOCOL DEVIATION|1|||
129064581|NCT02969382|464523691|FG000|Overall Study|Withdrawal by Subject|14|||
129064582|NCT02969382|464523692|FG001|Overall Study|Withdrawal by Subject|9|||
129064583|NCT01692626|464523694|FG000|Overall Study|Death|0|||
129064584|NCT01692626|464523695|FG001|Overall Study|Death|1|||
129064585|NCT01692626|464523694|FG000|Overall Study|Adverse Event|2|||
129064586|NCT01692626|464523695|FG001|Overall Study|Adverse Event|3|||
129064587|NCT01692626|464523694|FG000|Overall Study|Protocol Violation|1|||
129064588|NCT01692626|464523695|FG001|Overall Study|Protocol Violation|2|||
129064589|NCT01692626|464523694|FG000|Overall Study|Withdrawal by Subject|1|||
129064590|NCT01692626|464523695|FG001|Overall Study|Withdrawal by Subject|0|||
129064591|NCT02422797|464523696|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
129064592|NCT02422797|464523697|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
129064593|NCT02422797|464523696|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
129064594|NCT02422797|464523697|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
129064595|NCT02422797|464523696|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
129064596|NCT02422797|464523697|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
129064597|NCT02422797|464523696|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
129064598|NCT02422797|464523697|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
129064599|NCT02422797|464523696|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
129064600|NCT02422797|464523697|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
129064601|NCT02422797|464523696|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
129064602|NCT02422797|464523697|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
129064603|NCT02422797|464523696|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
129064604|NCT02422797|464523697|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
129064605|NCT02422797|464523696|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
129064606|NCT02422797|464523697|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
129064607|NCT02422797|464523696|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
129064608|NCT02422797|464523697|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
129064609|NCT02422797|464523696|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
129064610|NCT02422797|464523697|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
129064611|NCT02422797|464523696|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
129064612|NCT02422797|464523697|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
129137597|NCT00621322|464796299|FG000|Overall Study|Withdrawal by Subject|0|||
129137598|NCT00621322|464796300|FG001|Overall Study|Withdrawal by Subject|0|||
129137599|NCT00621322|464796301|FG002|Overall Study|Withdrawal by Subject|0|||
129137600|NCT00621322|464796302|FG003|Overall Study|Withdrawal by Subject|1|||
129137601|NCT00621322|464796303|FG004|Overall Study|Withdrawal by Subject|0|||
129137602|NCT00621322|464796304|FG005|Overall Study|Withdrawal by Subject|2|||
129137603|NCT00621322|464796299|FG000|Overall Study|Migrated/moved from study area|1|||
129137604|NCT00621322|464796300|FG001|Overall Study|Migrated/moved from study area|0|||
129137605|NCT00621322|464796301|FG002|Overall Study|Migrated/moved from study area|1|||
128775840|NCT02584855|463468488|FG001|Open-Label Treatment Period|Protocol Violation|0|||
129064613|NCT02422797|464523696|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
129064614|NCT02422797|464523697|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
129064615|NCT02422797|464523696|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
129064616|NCT02422797|464523697|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
129064617|NCT02422797|464523696|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
129064618|NCT02422797|464523697|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
129064619|NCT02422797|464523696|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
129064620|NCT02422797|464523697|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
129064621|NCT02422797|464523696|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
129064622|NCT02422797|464523697|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
129064623|NCT02422797|464523696|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
129137606|NCT00621322|464796302|FG003|Overall Study|Migrated/moved from study area|1|||
129137607|NCT00621322|464796303|FG004|Overall Study|Migrated/moved from study area|0|||
129064624|NCT02422797|464523697|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
129064625|NCT02422797|464523696|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
129064626|NCT02422797|464523697|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
129064627|NCT02422797|464523696|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
129064628|NCT02422797|464523697|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
129064629|NCT02422797|464523696|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
129064630|NCT02422797|464523697|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
129064631|NCT02422797|464523696|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
129064632|NCT02422797|464523697|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
129064633|NCT00369941|464523698|FG000|Overall Study|Never Treated|1|||
129064634|NCT00369941|464523699|FG001|Overall Study|Never Treated|2|||
129064635|NCT00369941|464523698|FG000|Overall Study|Adverse Event|14|||
129064636|NCT00369941|464523699|FG001|Overall Study|Adverse Event|28|||
129064637|NCT00369941|464523698|FG000|Overall Study|Lack of Efficacy|6|||
129064638|NCT00369941|464523699|FG001|Overall Study|Lack of Efficacy|10|||
129064639|NCT00369941|464523698|FG000|Overall Study|Lost to Follow-up|12|||
129064640|NCT00369941|464523699|FG001|Overall Study|Lost to Follow-up|22|||
129064641|NCT00369941|464523698|FG000|Overall Study|Protocol Violation|5|||
129064642|NCT00369941|464523699|FG001|Overall Study|Protocol Violation|3|||
129064643|NCT00369941|464523698|FG000|Overall Study|Withdrawal by Subject|5|||
129064644|NCT00369941|464523699|FG001|Overall Study|Withdrawal by Subject|18|||
129064645|NCT00369941|464523698|FG000|Overall Study|Pregnancy|4|||
129064646|NCT00369941|464523699|FG001|Overall Study|Pregnancy|2|||
129064647|NCT00369941|464523698|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
129064648|NCT00369941|464523699|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
129064649|NCT00369941|464523698|FG000|Overall Study|Moved|11|||
129064650|NCT00369941|464523699|FG001|Overall Study|Moved|5|||
129064651|NCT00369941|464523698|FG000|Overall Study|Treatment with Prohibited Medication|3|||
129064652|NCT00369941|464523699|FG001|Overall Study|Treatment with Prohibited Medication|1|||
129064653|NCT00369941|464523698|FG000|Overall Study|Employment Interfered with Study Visits|1|||
129064654|NCT00369941|464523699|FG001|Overall Study|Employment Interfered with Study Visits|0|||
129064655|NCT00369941|464523698|FG000|Overall Study|Study Site Terminated|2|||
129064656|NCT00369941|464523699|FG001|Overall Study|Study Site Terminated|0|||
129064657|NCT00369941|464523698|FG000|Overall Study|Miscellaneous|3|||
129064658|NCT00369941|464523699|FG001|Overall Study|Miscellaneous|3|||
129064659|NCT02276807|464523700|FG000|Overall Study|Withdrawal by Subject|8|||
129064660|NCT02276807|464523701|FG001|Overall Study|Withdrawal by Subject|7|||
129064661|NCT02276807|464523700|FG000|Overall Study|Lost to Follow-up|10|||
129064662|NCT02276807|464523701|FG001|Overall Study|Lost to Follow-up|10|||
129064663|NCT03971474|464523702|FG000|Overall Study|Adverse Event|11|||
129064664|NCT03971474|464523703|FG001|Overall Study|Adverse Event|7|||
129064665|NCT03971474|464523702|FG000|Overall Study|Refusal unrelated to adverse event|5|||
129064666|NCT03971474|464523703|FG001|Overall Study|Refusal unrelated to adverse event|1|||
129064667|NCT03971474|464523702|FG000|Overall Study|Progression/relapse|40|||
129064668|NCT03971474|464523703|FG001|Overall Study|Progression/relapse|47|||
129064669|NCT03971474|464523702|FG000|Overall Study|Death|6|||
129064670|NCT03971474|464523703|FG001|Overall Study|Death|3|||
129064671|NCT03971474|464523702|FG000|Overall Study|Other - not protocol specified|5|||
129064672|NCT03971474|464523703|FG001|Overall Study|Other - not protocol specified|4|||
129064673|NCT03971474|464523702|FG000|Overall Study|On treatment|0|||
129064674|NCT03971474|464523703|FG001|Overall Study|On treatment|7|||
129064675|NCT00261950|464523704|FG000|Overall Study|Lost to Follow-up|2|||
129064676|NCT00261950|464523704|FG000|Overall Study|Death|6|||
129064677|NCT00261950|464523704|FG000|Overall Study|Withdrawal by Subject|5|||
129064678|NCT00261950|464523704|FG000|Overall Study|Other|1|||
129064679|NCT00261950|464523704|FG000|Overall Study|Physician Decision|1|||
129064680|NCT00261950|464523704|FG000|Overall Study|Protocol specified Criteria|11|||
129064681|NCT01937871|464523711|FG000|Overall Study|Adverse Event|6|||
129064682|NCT01937871|464523712|FG001|Overall Study|Adverse Event|6|||
129064683|NCT01937871|464523713|FG002|Overall Study|Adverse Event|2|||
129064684|NCT01937871|464523711|FG000|Overall Study|Lost to Follow-up|8|||
129064685|NCT01937871|464523712|FG001|Overall Study|Lost to Follow-up|2|||
129064686|NCT01937871|464523713|FG002|Overall Study|Lost to Follow-up|4|||
129064687|NCT01937871|464523711|FG000|Overall Study|Withdrawal by Subject|9|||
129064688|NCT01937871|464523712|FG001|Overall Study|Withdrawal by Subject|6|||
129064689|NCT01937871|464523713|FG002|Overall Study|Withdrawal by Subject|4|||
129064690|NCT01937871|464523711|FG000|Overall Study|Physician Decision|0|||
129064691|NCT01937871|464523712|FG001|Overall Study|Physician Decision|1|||
129064692|NCT01937871|464523713|FG002|Overall Study|Physician Decision|0|||
129064693|NCT01937871|464523711|FG000|Overall Study|Entry Criteria Not Met|1|||
129064694|NCT01937871|464523712|FG001|Overall Study|Entry Criteria Not Met|2|||
129064695|NCT01937871|464523713|FG002|Overall Study|Entry Criteria Not Met|1|||
129064696|NCT00577863|464523720|FG000|Overall Study|Adverse Event|4|||
129064697|NCT00577863|464523721|FG001|Overall Study|Adverse Event|2|||
129064698|NCT00577863|464523720|FG000|Overall Study|Death|1|||
129064699|NCT00577863|464523721|FG001|Overall Study|Death|0|||
129137608|NCT00621322|464796304|FG005|Overall Study|Migrated/moved from study area|2|||
129137609|NCT01655069|464796310|FG000|Overall Study|Physician Decision|0|||
129137610|NCT01655069|464796311|FG001|Overall Study|Physician Decision|0|||
128721528|NCT03056755|463277279|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
128721529|NCT03056755|463277280|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
128721530|NCT03056755|463277281|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
128721531|NCT03056755|463277279|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
128721532|NCT03056755|463277280|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
128721533|NCT03056755|463277281|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
129064700|NCT00577863|464523720|FG000|Overall Study|Lost to Follow-up|2|||
129064701|NCT00577863|464523721|FG001|Overall Study|Lost to Follow-up|2|||
129064702|NCT00577863|464523720|FG000|Overall Study|Entry Criteria Exclusion|1|||
129064703|NCT00577863|464523721|FG001|Overall Study|Entry Criteria Exclusion|0|||
129064704|NCT00577863|464523720|FG000|Overall Study|Withdrawal by Subject|0|||
129064705|NCT00577863|464523721|FG001|Overall Study|Withdrawal by Subject|2|||
129064706|NCT00577863|464523720|FG000|Overall Study|Sponsor Decision|2|||
129064707|NCT00577863|464523721|FG001|Overall Study|Sponsor Decision|7|||
129064708|NCT00577863|464523720|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
129064709|NCT00577863|464523721|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
129064710|NCT00668317|464523722|FG000|Overall Study|Adverse Event|2|||
129064711|NCT03509467|464523726|FG000|Overall Study|Withdrawal by Subject|5|||
129064712|NCT03509467|464523727|FG001|Overall Study|Withdrawal by Subject|1|||
129064713|NCT03509467|464523728|FG002|Overall Study|Withdrawal by Subject|6|||
129064714|NCT03509467|464523729|FG003|Overall Study|Withdrawal by Subject|7|||
129064715|NCT03509467|464523730|FG004|Overall Study|Withdrawal by Subject|10|||
129064716|NCT03509467|464523731|FG005|Overall Study|Withdrawal by Subject|10|||
129064717|NCT03509467|464523732|FG006|Overall Study|Withdrawal by Subject|10|||
129064718|NCT03509467|464523733|FG007|Overall Study|Withdrawal by Subject|10|||
129064719|NCT03509467|464523726|FG000|Overall Study|Death|0|||
129064720|NCT03509467|464523727|FG001|Overall Study|Death|0|||
129064721|NCT03509467|464523728|FG002|Overall Study|Death|2|||
129064722|NCT03509467|464523729|FG003|Overall Study|Death|2|||
129064723|NCT03509467|464523730|FG004|Overall Study|Death|1|||
129064724|NCT03509467|464523731|FG005|Overall Study|Death|0|||
129064725|NCT03509467|464523732|FG006|Overall Study|Death|1|||
129064726|NCT03509467|464523733|FG007|Overall Study|Death|0|||
129064727|NCT03509467|464523726|FG000|Overall Study|Proxy Withdrawal|0|||
129064728|NCT03509467|464523727|FG001|Overall Study|Proxy Withdrawal|0|||
129064729|NCT03509467|464523728|FG002|Overall Study|Proxy Withdrawal|0|||
129064730|NCT03509467|464523729|FG003|Overall Study|Proxy Withdrawal|0|||
129064731|NCT03509467|464523730|FG004|Overall Study|Proxy Withdrawal|0|||
129064732|NCT03509467|464523731|FG005|Overall Study|Proxy Withdrawal|0|||
129064733|NCT03509467|464523732|FG006|Overall Study|Proxy Withdrawal|0|||
129064734|NCT03509467|464523733|FG007|Overall Study|Proxy Withdrawal|1|||
129064735|NCT02829918|464523739|FG000|Overall Study|Death|2|||
129064736|NCT02829918|464523739|FG000|Overall Study|Withdrawal by Subject|4|||
129064737|NCT02829918|464523739|FG000|Overall Study|Adverse Event|1|||
129064738|NCT02829918|464523739|FG000|Overall Study|Progression|1|||
129064739|NCT04138823|464523746|FG000|Overall Study|Clinical disease progression|0|||
129064740|NCT04138823|464523747|FG001|Overall Study|Clinical disease progression|0|||
129064741|NCT04138823|464523748|FG002|Overall Study|Clinical disease progression|1|||
129064742|NCT04138823|464523746|FG000|Overall Study|Objective disease progression|3|||
129064743|NCT04138823|464523747|FG001|Overall Study|Objective disease progression|2|||
129064744|NCT04138823|464523748|FG002|Overall Study|Objective disease progression|5|||
129064745|NCT02676765|464523749|FG000|Overall Study|Lost to Follow-up|0|||
129064746|NCT02676765|464523750|FG001|Overall Study|Lost to Follow-up|1|||
129064747|NCT03340974|464523751|FG000|Completion of Study -Long Term Follow up|Death|8|||
129064748|NCT03340974|464523752|FG001|Completion of Study -Long Term Follow up|Death|5|||
129064749|NCT03340974|464523753|FG002|Completion of Study -Long Term Follow up|Death|5|||
129064750|NCT03340974|464523754|FG003|Completion of Study -Long Term Follow up|Death|7|||
129064751|NCT03340974|464523751|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
129064752|NCT03340974|464523752|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
129064753|NCT03340974|464523753|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
129064754|NCT03340974|464523754|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
129064755|NCT03340974|464523751|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
129064756|NCT03340974|464523752|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
129064757|NCT03340974|464523753|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
129064758|NCT03340974|464523754|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
128721534|NCT03056755|463277279|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
129064759|NCT03340974|464523751|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
129064760|NCT03340974|464523752|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
129137611|NCT01655069|464796312|FG002|Overall Study|Physician Decision|0|||
129137612|NCT01655069|464796313|FG003|Overall Study|Physician Decision|1|||
129064761|NCT03340974|464523753|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
129064762|NCT03340974|464523754|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
129064763|NCT02466685|464523755|FG000|Overall Study|Adverse Event|5|||
129064764|NCT02466685|464523756|FG001|Overall Study|Adverse Event|2|||
129064765|NCT02466685|464523755|FG000|Overall Study|Lost to Follow-up|1|||
129064766|NCT02466685|464523756|FG001|Overall Study|Lost to Follow-up|1|||
129064767|NCT02466685|464523755|FG000|Overall Study|Withdrawal by Subject|1|||
129064768|NCT02466685|464523756|FG001|Overall Study|Withdrawal by Subject|0|||
129064769|NCT02466685|464523755|FG000|Overall Study|Physician Decision|1|||
129064770|NCT02466685|464523756|FG001|Overall Study|Physician Decision|1|||
129064771|NCT05299528|464523761|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129064772|NCT05299528|464523762|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
129064773|NCT05299528|464523763|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129064774|NCT05299528|464523764|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129064775|NCT05299528|464523765|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129064776|NCT05299528|464523766|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129064777|NCT05299528|464523767|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129064778|NCT05299528|464523761|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129064779|NCT05299528|464523762|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129064780|NCT05299528|464523763|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129064781|NCT05299528|464523764|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129064782|NCT05299528|464523765|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129137613|NCT01655069|464796310|FG000|Overall Study|Adverse Event|6|||
129137614|NCT01655069|464796311|FG001|Overall Study|Adverse Event|7|||
129137615|NCT01655069|464796312|FG002|Overall Study|Adverse Event|2|||
129137616|NCT01655069|464796313|FG003|Overall Study|Adverse Event|3|||
129137617|NCT01655069|464796310|FG000|Overall Study|Lack of Efficacy|0|||
129137618|NCT01655069|464796311|FG001|Overall Study|Lack of Efficacy|1|||
129137619|NCT01655069|464796312|FG002|Overall Study|Lack of Efficacy|0|||
129137620|NCT01655069|464796313|FG003|Overall Study|Lack of Efficacy|0|||
129137621|NCT01655069|464796310|FG000|Overall Study|No Treatment Needed|0|||
129137622|NCT01655069|464796311|FG001|Overall Study|No Treatment Needed|1|||
129137623|NCT01655069|464796312|FG002|Overall Study|No Treatment Needed|0|||
129137624|NCT01655069|464796313|FG003|Overall Study|No Treatment Needed|0|||
129137625|NCT01655069|464796310|FG000|Overall Study|Withdrawal by Subject|2|||
129137626|NCT01655069|464796311|FG001|Overall Study|Withdrawal by Subject|3|||
128721535|NCT03056755|463277280|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
128721536|NCT03056755|463277281|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
128721537|NCT03056755|463277279|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
128721538|NCT03056755|463277280|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
128721539|NCT03056755|463277281|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
128721540|NCT02419742|463277282|FG000|Overall Study|Adverse Event|2|||
128721541|NCT02419742|463277283|FG001|Overall Study|Adverse Event|0|||
128721542|NCT02419742|463277282|FG000|Overall Study|Disease Progression|0|||
128721543|NCT02419742|463277283|FG001|Overall Study|Disease Progression|1|||
128721544|NCT02419742|463277282|FG000|Overall Study|Withdrew Consent|2|||
129137627|NCT01655069|464796312|FG002|Overall Study|Withdrawal by Subject|0|||
129137628|NCT01655069|464796313|FG003|Overall Study|Withdrawal by Subject|0|||
129137629|NCT06399471|464796314|FG000|Overall Study|Withdrawal by Subject|1|||
129137630|NCT00986102|464796315|FG000|Overall Study|Lost to Follow-up|0|||
129137631|NCT00986102|464796316|FG001|Overall Study|Lost to Follow-up|1|||
129137632|NCT00986102|464796317|FG002|Overall Study|Lost to Follow-up|0|||
129137633|NCT00986102|464796318|FG003|Overall Study|Lost to Follow-up|1|||
129137634|NCT00986102|464796315|FG000|Overall Study|Withdrawal by Subject|1|||
129137635|NCT00986102|464796316|FG001|Overall Study|Withdrawal by Subject|1|||
129137636|NCT00986102|464796317|FG002|Overall Study|Withdrawal by Subject|0|||
128721545|NCT02419742|463277283|FG001|Overall Study|Withdrew Consent|1|||
129064783|NCT05299528|464523766|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
129064784|NCT05299528|464523767|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129137637|NCT00986102|464796318|FG003|Overall Study|Withdrawal by Subject|0|||
129137638|NCT06083493|464796319|FG000|Overall Study|Technical issues with the interventional device|2|||
129137639|NCT06083493|464796320|FG001|Overall Study|Technical issues with the interventional device|2|||
128721546|NCT02419742|463277282|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
129064785|NCT05299528|464523761|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
129137640|NCT06083493|464796319|FG000|Overall Study|Performed incorrect visual task|1|||
129137641|NCT06083493|464796320|FG001|Overall Study|Performed incorrect visual task|0|||
128721547|NCT02419742|463277283|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
128721548|NCT05071183|463277292|FG000|Overall Study|Death|1|||
129064786|NCT05299528|464523762|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
129064787|NCT05299528|464523763|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
129064788|NCT05299528|464523764|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
129064789|NCT05299528|464523765|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
129064790|NCT05299528|464523766|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
129064791|NCT05299528|464523767|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
129064792|NCT04877457|464523768|FG000|Overall Study|Early termination of study due to low enrollment|2|||
129064793|NCT04877457|464523769|FG001|Overall Study|Early termination of study due to low enrollment|1|||
129064794|NCT05180227|464523773|FG000|Overall Study|Hypertension at screening|1|||
129064795|NCT05180227|464523773|FG000|Overall Study|Lost to Follow-up|1|||
129064796|NCT03548337|464523774|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
129064797|NCT03548337|464523775|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
129064798|NCT03548337|464523774|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
129064799|NCT03548337|464523775|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
129064800|NCT03548337|464523774|FG000|Infant Series|Lost to Follow-up|2|||
129064801|NCT03548337|464523775|FG001|Infant Series|Lost to Follow-up|1|||
129064802|NCT03548337|464523774|FG000|Infant Series|Adverse Event|0|||
129064803|NCT03548337|464523775|FG001|Infant Series|Adverse Event|2|||
129064804|NCT03548337|464523774|FG000|Infant Series|Randomized but Not Vaccinated|1|||
129064805|NCT03548337|464523775|FG001|Infant Series|Randomized but Not Vaccinated|0|||
129064806|NCT03548337|464523774|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
129064807|NCT03548337|464523775|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
129064808|NCT01911273|464523778|FG000|Overall Study|Progression of Disease|1|||
129064809|NCT01911273|464523779|FG001|Overall Study|Progression of Disease|0|||
129064810|NCT01911273|464523778|FG000|Overall Study|Withdrawal by Subject|0|||
129064811|NCT01911273|464523779|FG001|Overall Study|Withdrawal by Subject|2|||
129064812|NCT01070953|464523780|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
129064813|NCT01070953|464523780|FG000|Participants for Safety Evaluation|Off-label use|283|||
129064814|NCT01070953|464523780|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
129064815|NCT01070953|464523780|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
129064816|NCT01070953|464523780|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
129064817|NCT01070953|464523780|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
129064818|NCT01070953|464523780|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
129064819|NCT01070953|464523780|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
129064820|NCT01070953|464523780|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
129064821|NCT01070953|464523780|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
129064822|NCT02445963|464523781|FG000|Overall Study|Lost to Follow-up|1|||
129064823|NCT02445963|464523782|FG001|Overall Study|Lost to Follow-up|0|||
129064824|NCT02445963|464523783|FG002|Overall Study|Lost to Follow-up|0|||
129064825|NCT02445963|464523784|FG003|Overall Study|Lost to Follow-up|0|||
129064826|NCT02445963|464523781|FG000|Overall Study|Change in employment|1|||
129064827|NCT02445963|464523782|FG001|Overall Study|Change in employment|0|||
129064828|NCT02445963|464523783|FG002|Overall Study|Change in employment|0|||
129064829|NCT02445963|464523784|FG003|Overall Study|Change in employment|0|||
129064830|NCT02445963|464523781|FG000|Overall Study|Symptoms post-vaccination|0|||
129064831|NCT02445963|464523782|FG001|Overall Study|Symptoms post-vaccination|0|||
129064832|NCT02445963|464523783|FG002|Overall Study|Symptoms post-vaccination|1|||
129064833|NCT02445963|464523784|FG003|Overall Study|Symptoms post-vaccination|0|||
129064834|NCT01957176|464523788|FG000|Overall Study|Adverse Event|2|||
129064835|NCT01957176|464523789|FG001|Overall Study|Adverse Event|0|||
129064836|NCT01957176|464523788|FG000|Overall Study|Physician Decision|2|||
129064837|NCT01957176|464523789|FG001|Overall Study|Physician Decision|1|||
129064838|NCT01957176|464523788|FG000|Overall Study|Withdrawal by Subject|1|||
129064839|NCT01957176|464523789|FG001|Overall Study|Withdrawal by Subject|0|||
129064840|NCT02359994|464523790|FG000|Overall Population Study|Adverse Event|1|||
129064841|NCT02359994|464523791|FG001|Overall Population Study|Adverse Event|1|||
129064842|NCT02359994|464523790|FG000|Overall Population Study|Death|1|||
129064843|NCT02359994|464523791|FG001|Overall Population Study|Death|5|||
129064844|NCT02359994|464523790|FG000|Overall Population Study|Lost to Follow-up|1|||
129064845|NCT02359994|464523791|FG001|Overall Population Study|Lost to Follow-up|1|||
129064846|NCT02359994|464523790|FG000|Overall Population Study|Withdrawal by Subject|1|||
129064847|NCT02359994|464523791|FG001|Overall Population Study|Withdrawal by Subject|0|||
129064848|NCT02359994|464523790|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
129064849|NCT02359994|464523791|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
129137642|NCT06083493|464796319|FG000|Overall Study|Insufficient baseline performance|0|||
129137643|NCT06083493|464796320|FG001|Overall Study|Insufficient baseline performance|1|||
129064850|NCT02359994|464523790|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
129064851|NCT02359994|464523791|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
129064852|NCT02359994|464523790|FG000|Extended Oncology 24-Month Survival|Death|19|||
129064853|NCT02359994|464523791|FG001|Extended Oncology 24-Month Survival|Death|21|||
129064854|NCT02359994|464523790|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
129064855|NCT02359994|464523791|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
129064856|NCT01823835|464523794|FG000|Overall Study|Adverse Event|0|||
129064857|NCT01823835|464523795|FG001|Overall Study|Adverse Event|0|||
129064858|NCT01823835|464523796|FG002|Overall Study|Adverse Event|0|||
129064859|NCT01823835|464523797|FG003|Overall Study|Adverse Event|0|||
129064860|NCT01823835|464523798|FG004|Overall Study|Adverse Event|1|||
129064861|NCT01823835|464523799|FG005|Overall Study|Adverse Event|0|||
129064862|NCT01823835|464523800|FG006|Overall Study|Adverse Event|1|||
129064863|NCT01823835|464523801|FG007|Overall Study|Adverse Event|0|||
129064864|NCT01823835|464523802|FG008|Overall Study|Adverse Event|0|||
129064865|NCT01823835|464523803|FG009|Overall Study|Adverse Event|0|||
129064866|NCT01823835|464523804|FG010|Overall Study|Adverse Event|1|||
129064867|NCT01823835|464523805|FG011|Overall Study|Adverse Event|2|||
129064868|NCT01823835|464523806|FG012|Overall Study|Adverse Event|0|||
129064869|NCT01823835|464523807|FG013|Overall Study|Adverse Event|0|||
129064870|NCT01823835|464523808|FG014|Overall Study|Adverse Event|0|||
129064871|NCT01823835|464523794|FG000|Overall Study|Physician Decision|0|||
129064872|NCT01823835|464523795|FG001|Overall Study|Physician Decision|0|||
129064873|NCT01823835|464523796|FG002|Overall Study|Physician Decision|0|||
129064874|NCT01823835|464523797|FG003|Overall Study|Physician Decision|0|||
129064875|NCT01823835|464523798|FG004|Overall Study|Physician Decision|0|||
129064876|NCT01823835|464523799|FG005|Overall Study|Physician Decision|0|||
129064877|NCT01823835|464523800|FG006|Overall Study|Physician Decision|0|||
129064878|NCT01823835|464523801|FG007|Overall Study|Physician Decision|0|||
129064879|NCT01823835|464523802|FG008|Overall Study|Physician Decision|0|||
129064880|NCT01823835|464523803|FG009|Overall Study|Physician Decision|0|||
129064881|NCT01823835|464523804|FG010|Overall Study|Physician Decision|0|||
129064882|NCT01823835|464523805|FG011|Overall Study|Physician Decision|2|||
129064883|NCT01823835|464523806|FG012|Overall Study|Physician Decision|0|||
129064884|NCT01823835|464523807|FG013|Overall Study|Physician Decision|0|||
129064885|NCT01823835|464523808|FG014|Overall Study|Physician Decision|0|||
129064886|NCT01823835|464523794|FG000|Overall Study|Progressive Disease|3|||
129064887|NCT01823835|464523795|FG001|Overall Study|Progressive Disease|4|||
129064888|NCT01823835|464523796|FG002|Overall Study|Progressive Disease|3|||
129064889|NCT01823835|464523797|FG003|Overall Study|Progressive Disease|6|||
129064890|NCT01823835|464523798|FG004|Overall Study|Progressive Disease|4|||
129064891|NCT01823835|464523799|FG005|Overall Study|Progressive Disease|6|||
129064892|NCT01823835|464523800|FG006|Overall Study|Progressive Disease|5|||
129064893|NCT01823835|464523801|FG007|Overall Study|Progressive Disease|3|||
129064894|NCT01823835|464523802|FG008|Overall Study|Progressive Disease|3|||
129064895|NCT01823835|464523803|FG009|Overall Study|Progressive Disease|18|||
129064896|NCT01823835|464523804|FG010|Overall Study|Progressive Disease|8|||
129064897|NCT01823835|464523805|FG011|Overall Study|Progressive Disease|46|||
129064898|NCT01823835|464523806|FG012|Overall Study|Progressive Disease|18|||
129064899|NCT01823835|464523807|FG013|Overall Study|Progressive Disease|4|||
129064900|NCT01823835|464523808|FG014|Overall Study|Progressive Disease|6|||
129064901|NCT01823835|464523794|FG000|Overall Study|Study Termination|0|||
129064902|NCT01823835|464523795|FG001|Overall Study|Study Termination|0|||
129064903|NCT01823835|464523796|FG002|Overall Study|Study Termination|0|||
129064904|NCT01823835|464523797|FG003|Overall Study|Study Termination|0|||
129064905|NCT01823835|464523798|FG004|Overall Study|Study Termination|1|||
129064906|NCT01823835|464523799|FG005|Overall Study|Study Termination|0|||
129064907|NCT01823835|464523800|FG006|Overall Study|Study Termination|0|||
129064908|NCT01823835|464523801|FG007|Overall Study|Study Termination|0|||
129064909|NCT01823835|464523802|FG008|Overall Study|Study Termination|0|||
129064910|NCT01823835|464523803|FG009|Overall Study|Study Termination|0|||
129064911|NCT01823835|464523804|FG010|Overall Study|Study Termination|0|||
129064912|NCT01823835|464523805|FG011|Overall Study|Study Termination|1|||
129064913|NCT01823835|464523806|FG012|Overall Study|Study Termination|0|||
129064914|NCT01823835|464523807|FG013|Overall Study|Study Termination|0|||
129064915|NCT01823835|464523808|FG014|Overall Study|Study Termination|0|||
129064916|NCT01823835|464523794|FG000|Overall Study|Withdrawal by Subject|0|||
129064917|NCT01823835|464523795|FG001|Overall Study|Withdrawal by Subject|0|||
129064918|NCT01823835|464523796|FG002|Overall Study|Withdrawal by Subject|1|||
129064919|NCT01823835|464523797|FG003|Overall Study|Withdrawal by Subject|0|||
129064920|NCT01823835|464523798|FG004|Overall Study|Withdrawal by Subject|0|||
129064921|NCT01823835|464523799|FG005|Overall Study|Withdrawal by Subject|0|||
128775841|NCT02584855|463468489|FG002|Open-Label Treatment Period|Protocol Violation|0|||
129064922|NCT01823835|464523800|FG006|Overall Study|Withdrawal by Subject|0|||
129064923|NCT01823835|464523801|FG007|Overall Study|Withdrawal by Subject|0|||
129064924|NCT01823835|464523802|FG008|Overall Study|Withdrawal by Subject|0|||
129064925|NCT01823835|464523803|FG009|Overall Study|Withdrawal by Subject|1|||
129064926|NCT01823835|464523804|FG010|Overall Study|Withdrawal by Subject|1|||
129064927|NCT01823835|464523805|FG011|Overall Study|Withdrawal by Subject|2|||
129064928|NCT01823835|464523806|FG012|Overall Study|Withdrawal by Subject|1|||
129064929|NCT01823835|464523807|FG013|Overall Study|Withdrawal by Subject|0|||
129064930|NCT01823835|464523808|FG014|Overall Study|Withdrawal by Subject|0|||
129064931|NCT03017612|464523809|FG000|Overall Study|Adverse Event|2|||
129064932|NCT04895982|464523810|FG000|Overall Study|Withdrawal by Subject|0|||
129064933|NCT04895982|464523811|FG001|Overall Study|Withdrawal by Subject|0|||
129064934|NCT04895982|464523812|FG002|Overall Study|Withdrawal by Subject|0|||
129064935|NCT04895982|464523813|FG003|Overall Study|Withdrawal by Subject|0|||
129064936|NCT04895982|464523814|FG004|Overall Study|Withdrawal by Subject|0|||
129064937|NCT04895982|464523815|FG005|Overall Study|Withdrawal by Subject|1|||
129064938|NCT04895982|464523816|FG006|Overall Study|Withdrawal by Subject|1|||
129064939|NCT04895982|464523817|FG007|Overall Study|Withdrawal by Subject|0|||
129064940|NCT04895982|464523818|FG008|Overall Study|Withdrawal by Subject|0|||
129064941|NCT04895982|464523819|FG009|Overall Study|Withdrawal by Subject|1|||
129064942|NCT04895982|464523820|FG010|Overall Study|Withdrawal by Subject|0|||
129064943|NCT04895982|464523821|FG011|Overall Study|Withdrawal by Subject|1|||
129064944|NCT04895982|464523810|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129064945|NCT04895982|464523811|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129064946|NCT04895982|464523812|FG002|Overall Study|Withdrawal by parent/guardian|3|||
129064947|NCT04895982|464523813|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129064948|NCT04895982|464523814|FG004|Overall Study|Withdrawal by parent/guardian|3|||
129064949|NCT04895982|464523815|FG005|Overall Study|Withdrawal by parent/guardian|2|||
129064950|NCT04895982|464523816|FG006|Overall Study|Withdrawal by parent/guardian|1|||
129064951|NCT04895982|464523817|FG007|Overall Study|Withdrawal by parent/guardian|0|||
129064952|NCT04895982|464523818|FG008|Overall Study|Withdrawal by parent/guardian|3|||
129064953|NCT04895982|464523819|FG009|Overall Study|Withdrawal by parent/guardian|0|||
129064954|NCT04895982|464523820|FG010|Overall Study|Withdrawal by parent/guardian|0|||
129064955|NCT04895982|464523821|FG011|Overall Study|Withdrawal by parent/guardian|0|||
129064956|NCT04895982|464523810|FG000|Overall Study|Other|0|||
129064957|NCT04895982|464523811|FG001|Overall Study|Other|0|||
129064958|NCT04895982|464523812|FG002|Overall Study|Other|1|||
129064959|NCT04895982|464523813|FG003|Overall Study|Other|1|||
129064960|NCT04895982|464523814|FG004|Overall Study|Other|0|||
129064961|NCT04895982|464523815|FG005|Overall Study|Other|0|||
129064962|NCT04895982|464523816|FG006|Overall Study|Other|0|||
129064963|NCT04895982|464523817|FG007|Overall Study|Other|0|||
129064964|NCT04895982|464523818|FG008|Overall Study|Other|0|||
129064965|NCT04895982|464523819|FG009|Overall Study|Other|1|||
129064966|NCT04895982|464523820|FG010|Overall Study|Other|0|||
129137644|NCT03225989|464796321|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
129137645|NCT03225989|464796322|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
129137646|NCT03225989|464796323|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
129137647|NCT03225989|464796321|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
129137648|NCT03225989|464796322|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
128721549|NCT05071183|463277293|FG001|Overall Study|Death|2|||
128721550|NCT05071183|463277294|FG002|Overall Study|Death|0|||
128721551|NCT05071183|463277292|FG000|Overall Study|Other Reasons|1|||
128721552|NCT05071183|463277293|FG001|Overall Study|Other Reasons|3|||
128721553|NCT05071183|463277294|FG002|Overall Study|Other Reasons|2|||
128721554|NCT02211131|463277306|FG000|Overall Study|Death|26|||
128721555|NCT02211131|463277307|FG001|Overall Study|Death|16|||
128775842|NCT02584855|463468490|FG003|Open-Label Treatment Period|Protocol Violation|0|||
129064967|NCT04895982|464523821|FG011|Overall Study|Other|0|||
129064968|NCT04895982|464523810|FG000|Overall Study|Protocol Violation|0|||
129137649|NCT03225989|464796323|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
129137650|NCT03225989|464796321|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
129137651|NCT03225989|464796322|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
129137652|NCT03225989|464796323|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
129137653|NCT03225989|464796321|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
129137654|NCT03225989|464796322|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
129137655|NCT03225989|464796323|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
129137656|NCT03225989|464796321|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
129137657|NCT03225989|464796322|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
129137658|NCT03225989|464796323|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
129137659|NCT03225989|464796321|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
129064969|NCT04895982|464523811|FG001|Overall Study|Protocol Violation|0|||
129064970|NCT04895982|464523812|FG002|Overall Study|Protocol Violation|1|||
129064971|NCT04895982|464523813|FG003|Overall Study|Protocol Violation|1|||
129064972|NCT04895982|464523814|FG004|Overall Study|Protocol Violation|1|||
129064973|NCT04895982|464523815|FG005|Overall Study|Protocol Violation|0|||
129064974|NCT04895982|464523816|FG006|Overall Study|Protocol Violation|0|||
129064975|NCT04895982|464523817|FG007|Overall Study|Protocol Violation|1|||
129064976|NCT04895982|464523818|FG008|Overall Study|Protocol Violation|0|||
128721556|NCT02211131|463277306|FG000|Overall Study|Lost to Follow-up|4|||
128721557|NCT02211131|463277307|FG001|Overall Study|Lost to Follow-up|3|||
128721558|NCT02211131|463277306|FG000|Overall Study|Decision by Sponsor|1|||
128721559|NCT02211131|463277307|FG001|Overall Study|Decision by Sponsor|1|||
128721560|NCT02211131|463277306|FG000|Overall Study|Withdrawal by Subject|3|||
128721561|NCT02211131|463277307|FG001|Overall Study|Withdrawal by Subject|8|||
129064977|NCT04895982|464523819|FG009|Overall Study|Protocol Violation|0|||
129064978|NCT04895982|464523820|FG010|Overall Study|Protocol Violation|0|||
129064979|NCT04895982|464523821|FG011|Overall Study|Protocol Violation|0|||
129064980|NCT04895982|464523810|FG000|Overall Study|Lost to Follow-up|0|||
129064981|NCT04895982|464523811|FG001|Overall Study|Lost to Follow-up|0|||
129064982|NCT04895982|464523812|FG002|Overall Study|Lost to Follow-up|1|||
129064983|NCT04895982|464523813|FG003|Overall Study|Lost to Follow-up|0|||
129064984|NCT04895982|464523814|FG004|Overall Study|Lost to Follow-up|0|||
129064985|NCT04895982|464523815|FG005|Overall Study|Lost to Follow-up|1|||
129064986|NCT04895982|464523816|FG006|Overall Study|Lost to Follow-up|0|||
129064987|NCT04895982|464523817|FG007|Overall Study|Lost to Follow-up|0|||
129064988|NCT04895982|464523818|FG008|Overall Study|Lost to Follow-up|1|||
129064989|NCT04895982|464523819|FG009|Overall Study|Lost to Follow-up|0|||
129064990|NCT04895982|464523820|FG010|Overall Study|Lost to Follow-up|0|||
129064991|NCT04895982|464523821|FG011|Overall Study|Lost to Follow-up|0|||
129064992|NCT04895982|464523810|FG000|Overall Study|Refused further study procedures|0|||
129064993|NCT04895982|464523811|FG001|Overall Study|Refused further study procedures|0|||
129064994|NCT04895982|464523812|FG002|Overall Study|Refused further study procedures|1|||
129064995|NCT04895982|464523813|FG003|Overall Study|Refused further study procedures|0|||
129064996|NCT04895982|464523814|FG004|Overall Study|Refused further study procedures|0|||
129064997|NCT04895982|464523815|FG005|Overall Study|Refused further study procedures|0|||
129064998|NCT04895982|464523816|FG006|Overall Study|Refused further study procedures|0|||
129064999|NCT04895982|464523817|FG007|Overall Study|Refused further study procedures|0|||
129065000|NCT04895982|464523818|FG008|Overall Study|Refused further study procedures|0|||
129065001|NCT04895982|464523819|FG009|Overall Study|Refused further study procedures|0|||
129065002|NCT04895982|464523820|FG010|Overall Study|Refused further study procedures|0|||
129065003|NCT04895982|464523821|FG011|Overall Study|Refused further study procedures|0|||
129065004|NCT01059786|464525586|FG000|Overall Study|Did not receive 6 cycles.|0|||
129065005|NCT01059786|464525587|FG001|Overall Study|Did not receive 6 cycles.|0|||
129065006|NCT01059786|464525588|FG002|Overall Study|Did not receive 6 cycles.|4|||
129065007|NCT01059786|464525589|FG003|Overall Study|Did not receive 6 cycles.|1|||
129065008|NCT01059786|464525590|FG004|Overall Study|Did not receive 6 cycles.|0|||
129065009|NCT04460885|464525591|FG000|Overall Study|Withdrawal by Subject|6|||
129065010|NCT04460885|464525592|FG001|Overall Study|Withdrawal by Subject|8|||
129065011|NCT04460885|464525591|FG000|Overall Study|Site closure|1|||
129065012|NCT04460885|464525592|FG001|Overall Study|Site closure|0|||
129065013|NCT04460885|464525591|FG000|Overall Study|Death|5|||
129065014|NCT04460885|464525592|FG001|Overall Study|Death|4|||
129065015|NCT04460885|464525591|FG000|Overall Study|Physician Decision|2|||
129065016|NCT04460885|464525592|FG001|Overall Study|Physician Decision|1|||
129065017|NCT04460885|464525591|FG000|Overall Study|Lost to Follow-up|4|||
129065018|NCT04460885|464525592|FG001|Overall Study|Lost to Follow-up|4|||
129065019|NCT04559347|464525593|FG000|Overall Study|Death|1|||
129065020|NCT04559347|464525594|FG001|Overall Study|Death|0|||
129065021|NCT04559347|464525593|FG000|Overall Study|Thoracotomy conversion|1|||
129065022|NCT04559347|464525594|FG001|Overall Study|Thoracotomy conversion|1|||
129065023|NCT04559347|464525593|FG000|Overall Study|Provider unavailable|2|||
129065024|NCT04559347|464525594|FG001|Overall Study|Provider unavailable|1|||
129065025|NCT04559347|464525593|FG000|Overall Study|Other|2|||
129065026|NCT04559347|464525594|FG001|Overall Study|Other|1|||
129065027|NCT02586688|464525596|FG000|Overall Study|Lost to Follow-up|2|||
129065028|NCT02586688|464525597|FG001|Overall Study|Lost to Follow-up|1|||
129065029|NCT02586688|464525596|FG000|Overall Study|Withdrawal by Subject|1|||
129065030|NCT02586688|464525597|FG001|Overall Study|Withdrawal by Subject|1|||
129065031|NCT02586688|464525596|FG000|Overall Study|Adverse Event|3|||
129065032|NCT02586688|464525597|FG001|Overall Study|Adverse Event|1|||
129065033|NCT01433055|464525598|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
129065034|NCT01433055|464525599|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
129065035|NCT01433055|464525598|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
129065036|NCT01433055|464525599|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
129065037|NCT02465398|464525603|FG000|Overall Study|Death|7|||
129065038|NCT02465398|464525603|FG000|Overall Study|Revision|7|||
128721562|NCT02939560|463277309|FG000|Overall Study|Withdrawal by Subject|2|||
128721563|NCT02939560|463277309|FG000|Overall Study|Protocol Violation|1|||
129065039|NCT02465398|464525603|FG000|Overall Study|did not receive study device|1|||
129065040|NCT02465398|464525603|FG000|Overall Study|Withdrawal by Subject|1|||
129065041|NCT02465398|464525603|FG000|Overall Study|Lost to Follow-up|14|||
129065042|NCT00064987|464525604|FG000|Overall Study|Physician Decision|3|||
129065043|NCT00064987|464525605|FG001|Overall Study|Physician Decision|0|||
129065044|NCT00764881|464525606|FG000|Overall Study|Adverse Event|5|||
128721564|NCT03340025|463277310|FG000|Overall Study|Lost to Follow-up|2|||
129065045|NCT00764881|464525607|FG001|Overall Study|Adverse Event|1|||
129065046|NCT00764881|464525606|FG000|Overall Study|Withdrawal by Subject|1|||
129065047|NCT00764881|464525607|FG001|Overall Study|Withdrawal by Subject|3|||
128775843|NCT02584855|463468491|FG004|Open-Label Treatment Period|Protocol Violation|0|||
129065048|NCT00764881|464525606|FG000|Overall Study|Protocol Violation|2|||
129137660|NCT03225989|464796322|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
129137661|NCT03225989|464796323|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
129137662|NCT03225989|464796321|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
129137663|NCT03225989|464796322|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
129137664|NCT03225989|464796323|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
129137665|NCT03225989|464796321|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
129137666|NCT03225989|464796322|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
129137667|NCT03225989|464796323|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
129137668|NCT03225989|464796321|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
129137669|NCT03225989|464796322|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
129137670|NCT03225989|464796323|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
129137671|NCT03225989|464796321|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
129137672|NCT03225989|464796322|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
129137673|NCT03225989|464796323|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
129137674|NCT03225989|464796321|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
129137675|NCT03225989|464796322|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
129137676|NCT03225989|464796323|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
129137677|NCT03225989|464796321|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
129137678|NCT03225989|464796322|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
129137679|NCT03225989|464796323|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
129137680|NCT00601107|464796324|FG000|Overall Study|Adverse Event|0|||
129137681|NCT00601107|464796325|FG001|Overall Study|Adverse Event|1|||
129137682|NCT00601107|464796326|FG002|Overall Study|Adverse Event|3|||
129137683|NCT00601107|464796327|FG003|Overall Study|Adverse Event|0|||
129137684|NCT00601107|464796324|FG000|Overall Study|Withdrawal by Subject|5|||
129137685|NCT00601107|464796325|FG001|Overall Study|Withdrawal by Subject|4|||
129137686|NCT00601107|464796326|FG002|Overall Study|Withdrawal by Subject|7|||
129137687|NCT00601107|464796327|FG003|Overall Study|Withdrawal by Subject|4|||
128775844|NCT02584855|463468492|FG005|Open-Label Treatment Period|Protocol Violation|0|||
129065049|NCT00764881|464525607|FG001|Overall Study|Protocol Violation|2|||
129065050|NCT00764881|464525606|FG000|Overall Study|Lost to Follow-up|2|||
129065051|NCT00764881|464525607|FG001|Overall Study|Lost to Follow-up|0|||
129065052|NCT00764881|464525606|FG000|Overall Study|Noncompliant|1|||
129065053|NCT00764881|464525607|FG001|Overall Study|Noncompliant|0|||
129065054|NCT00764881|464525606|FG000|Overall Study|Accidentally discontinued study drug|1|||
129065055|NCT00764881|464525607|FG001|Overall Study|Accidentally discontinued study drug|0|||
129065056|NCT00764881|464525606|FG000|Overall Study|Wished to become pregnant|1|||
129065057|NCT00764881|464525607|FG001|Overall Study|Wished to become pregnant|0|||
129065058|NCT00764881|464525606|FG000|Overall Study|Carcinoma detected|1|||
129065059|NCT00764881|464525607|FG001|Overall Study|Carcinoma detected|0|||
129065060|NCT00764881|464525606|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
129065061|NCT00764881|464525607|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
129065062|NCT00764881|464525606|FG000|Overall Study|no treatment or no observation|2|||
129065063|NCT00764881|464525607|FG001|Overall Study|no treatment or no observation|2|||
129065064|NCT01214655|464525608|FG000|Part A|Progressive Disease|7|||
129065065|NCT01214655|464525609|FG001|Part A|Progressive Disease|0|||
129065066|NCT01214655|464525610|FG002|Part A|Progressive Disease|0|||
129065067|NCT01214655|464525608|FG000|Part A|Physician Decision|1|||
129065068|NCT01214655|464525609|FG001|Part A|Physician Decision|0|||
129065069|NCT01214655|464525610|FG002|Part A|Physician Decision|0|||
129065070|NCT01214655|464525608|FG000|Part B|Progressive disease|0|||
129065071|NCT01214655|464525609|FG001|Part B|Progressive disease|10|||
129065072|NCT01214655|464525610|FG002|Part B|Progressive disease|0|||
129065073|NCT01214655|464525608|FG000|Part B|Death|0|||
129065074|NCT01214655|464525609|FG001|Part B|Death|1|||
129065075|NCT01214655|464525610|FG002|Part B|Death|0|||
129065076|NCT01214655|464525608|FG000|Part B|Withdrawal by Subject|0|||
129065077|NCT01214655|464525609|FG001|Part B|Withdrawal by Subject|2|||
129065078|NCT01214655|464525610|FG002|Part B|Withdrawal by Subject|0|||
129065079|NCT01214655|464525608|FG000|Part C|Progressive Disease|0|||
129065080|NCT01214655|464525609|FG001|Part C|Progressive Disease|0|||
129065081|NCT01214655|464525610|FG002|Part C|Progressive Disease|5|||
129065082|NCT01214655|464525608|FG000|Part C|Death|0|||
129137688|NCT00601107|464796324|FG000|Overall Study|Lost to Follow-up|3|||
129137689|NCT00601107|464796325|FG001|Overall Study|Lost to Follow-up|3|||
128775845|NCT02584855|463468487|FG000|Open-Label Treatment Period|No PI Available|2|||
129065083|NCT01214655|464525609|FG001|Part C|Death|0|||
129065084|NCT01214655|464525610|FG002|Part C|Death|1|||
129065085|NCT01214655|464525608|FG000|Part C|Physician Decision|0|||
129065086|NCT01214655|464525609|FG001|Part C|Physician Decision|0|||
129065087|NCT01214655|464525610|FG002|Part C|Physician Decision|1|||
129137690|NCT00601107|464796326|FG002|Overall Study|Lost to Follow-up|0|||
129137691|NCT00601107|464796327|FG003|Overall Study|Lost to Follow-up|3|||
129065088|NCT05256134|464525614|FG000|Overall Study|Study Terminated by Sponsor|11|||
129065089|NCT05256134|464525615|FG001|Overall Study|Study Terminated by Sponsor|10|||
129065090|NCT05256134|464525614|FG000|Overall Study|Withdrawal by Subject|1|||
129065091|NCT05256134|464525615|FG001|Overall Study|Withdrawal by Subject|3|||
129065092|NCT01567462|464525616|FG000|Overall Study|Withdrawal by Subject|4|||
129065093|NCT01567462|464525617|FG001|Overall Study|Withdrawal by Subject|7|||
129065094|NCT00886015|464525626|FG000|Overall Study|Death|0|||
129065095|NCT00886015|464525627|FG001|Overall Study|Death|2|||
129065096|NCT01977417|464525628|FG000|Overall Study|Adverse Event|1|||
129065097|NCT01977417|464525629|FG001|Overall Study|Adverse Event|0|||
129065098|NCT01977417|464525628|FG000|Overall Study|Withdrawal by Subject|2|||
129065099|NCT01977417|464525629|FG001|Overall Study|Withdrawal by Subject|4|||
129065100|NCT01977417|464525628|FG000|Overall Study|Female enrollment goal met|0|||
129065101|NCT01977417|464525629|FG001|Overall Study|Female enrollment goal met|2|||
129065102|NCT00855894|464525634|FG000|Overall Study|Death|31|||
129065103|NCT00855894|464525634|FG000|Overall Study|Patient's decision|1|||
129065104|NCT00855894|464525634|FG000|Overall Study|Disease progression|1|||
129065105|NCT05490771|464525638|FG000|Overall Study|Disease progression|18|||
129065106|NCT05490771|464525638|FG000|Overall Study|Adverse Event|3|||
129065107|NCT05490771|464525638|FG000|Overall Study|Other complicating disease|1|||
129065108|NCT05490771|464525638|FG000|Overall Study|Withdrawal by Subject|3|||
129065109|NCT05490771|464525638|FG000|Overall Study|Physician Decision|1|||
129065110|NCT05490771|464525638|FG000|Overall Study|Still on treatment|2|||
129065111|NCT05490771|464525638|FG000|Overall Study|Never start protocol therapy|5|||
129065112|NCT05490771|464525638|FG000|Overall Study|Ineligible|2|||
129065113|NCT01720225|464525639|FG000|Overall Study|Withdrawal by Subject|0|||
129065114|NCT01720225|464525640|FG001|Overall Study|Withdrawal by Subject|1|||
129065115|NCT01720225|464525639|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
129065116|NCT01720225|464525640|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
129065117|NCT04071405|464525641|FG000|Overall Study|Protocol Violation|3|||
129065118|NCT00403585|464525645|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
129065119|NCT00403585|464525645|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
129065120|NCT00403585|464525645|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
129065121|NCT00661193|464525646|FG000|Overall Study|Adverse Event|2|||
129065122|NCT00661193|464525647|FG001|Overall Study|Adverse Event|1|||
129065123|NCT00661193|464525646|FG000|Overall Study|Withdrawal by Subject|3|||
129065124|NCT00661193|464525647|FG001|Overall Study|Withdrawal by Subject|1|||
129065125|NCT00661193|464525646|FG000|Overall Study|Progression|27|||
129065126|NCT00661193|464525647|FG001|Overall Study|Progression|24|||
129065127|NCT00661193|464525646|FG000|Overall Study|Not protocol specified|1|||
129065128|NCT00661193|464525647|FG001|Overall Study|Not protocol specified|0|||
129065129|NCT02964312|464525654|FG000|Overall Study|Lost to Follow-up|28|||
129065130|NCT02964312|464525654|FG000|Overall Study|Withdrawal by Subject|11|||
129065131|NCT02964312|464525654|FG000|Overall Study|Lack of Efficacy|10|||
129065132|NCT02964312|464525654|FG000|Overall Study|Did not consent to long-term FU|14|||
129065133|NCT02964312|464525654|FG000|Overall Study|Death|1|||
129065134|NCT02862730|464525657|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129065135|NCT02862730|464525658|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129065136|NCT02862730|464525659|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
129065137|NCT02862730|464525660|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129065138|NCT02862730|464525661|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129065139|NCT02862730|464525662|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129065140|NCT02862730|464525663|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129065141|NCT02862730|464525657|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
129065142|NCT02862730|464525658|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129065143|NCT02862730|464525659|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129065144|NCT02862730|464525660|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129065145|NCT02862730|464525661|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129065146|NCT02862730|464525662|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129065147|NCT02862730|464525663|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129065148|NCT02862730|464525657|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129065149|NCT02862730|464525658|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129065150|NCT02862730|464525659|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
129065151|NCT02862730|464525660|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129065152|NCT02862730|464525661|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
129065153|NCT02862730|464525662|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129137692|NCT00601107|464796324|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
129137693|NCT00601107|464796325|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
128721565|NCT03340025|463277311|FG001|Overall Study|Lost to Follow-up|2|||
129065154|NCT02862730|464525663|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129065155|NCT02862730|464525657|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129065156|NCT02862730|464525658|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129065157|NCT02862730|464525659|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
128721566|NCT01480076|463277314|FG000|Overall Study|Run-in Failure|52|||
128721567|NCT01480076|463277314|FG000|Overall Study|Adverse Event|39|||
128721568|NCT01480076|463277314|FG000|Overall Study|Death|2|||
128721569|NCT01480076|463277314|FG000|Overall Study|Disease Progression|5|||
128721570|NCT01480076|463277314|FG000|Overall Study|Non-compliance With Study Protocol|15|||
128721571|NCT01480076|463277314|FG000|Overall Study|Withdrawal by Subject|105|||
129065158|NCT02862730|464525660|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
129065159|NCT02862730|464525661|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129065160|NCT02862730|464525662|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129065161|NCT02862730|464525663|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129065162|NCT03685344|464525664|FG000|Overall Study|Withdrawal by Subject|1|||
129065163|NCT03685344|464525665|FG001|Overall Study|Withdrawal by Subject|1|||
129065164|NCT03685344|464525666|FG002|Overall Study|Withdrawal by Subject|2|||
129065165|NCT03685344|464525667|FG003|Overall Study|Withdrawal by Subject|0|||
129065166|NCT03685344|464525664|FG000|Overall Study|Physician Decision|1|||
129065167|NCT03685344|464525665|FG001|Overall Study|Physician Decision|1|||
129065168|NCT03685344|464525666|FG002|Overall Study|Physician Decision|5|||
129065169|NCT03685344|464525667|FG003|Overall Study|Physician Decision|0|||
129065170|NCT03685344|464525664|FG000|Overall Study|Death|1|||
129065171|NCT03685344|464525665|FG001|Overall Study|Death|1|||
129065172|NCT03685344|464525666|FG002|Overall Study|Death|0|||
129065173|NCT03685344|464525667|FG003|Overall Study|Death|0|||
129065174|NCT03126435|464525669|FG000|Overall Study|Death|90|||
129065175|NCT03126435|464525670|FG001|Overall Study|Death|84|||
129065176|NCT03126435|464525669|FG000|Overall Study|Lost to Follow-up|4|||
129065177|NCT03126435|464525670|FG001|Overall Study|Lost to Follow-up|3|||
129065178|NCT03126435|464525669|FG000|Overall Study|Physician Decision|0|||
129065179|NCT03126435|464525670|FG001|Overall Study|Physician Decision|1|||
129065180|NCT03126435|464525669|FG000|Overall Study|Withdrawal by Subject|6|||
129065181|NCT03126435|464525670|FG001|Overall Study|Withdrawal by Subject|12|||
129065182|NCT03126435|464525669|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
129065183|NCT03126435|464525670|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
129065184|NCT01023035|464525672|FG000|Treatment Period|Adverse Event|27|||
129065185|NCT01023035|464525673|FG001|Treatment Period|Adverse Event|32|||
129065186|NCT01023035|464525674|FG002|Treatment Period|Adverse Event|50|||
129065187|NCT01023035|464525672|FG000|Treatment Period|Non-Medical Reasons|19|||
129065188|NCT01023035|464525673|FG001|Treatment Period|Non-Medical Reasons|22|||
129065189|NCT01023035|464525674|FG002|Treatment Period|Non-Medical Reasons|44|||
129065190|NCT01023035|464525672|FG000|Treatment Period|Treatment Failure|26|||
129065191|NCT01023035|464525673|FG001|Treatment Period|Treatment Failure|31|||
129065192|NCT01023035|464525674|FG002|Treatment Period|Treatment Failure|24|||
129065193|NCT01023035|464525672|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
129065194|NCT01023035|464525673|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
129065195|NCT01023035|464525674|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
129065196|NCT01023035|464525672|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
129065197|NCT01023035|464525673|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
129065198|NCT01023035|464525674|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
129065199|NCT00524420|464525675|FG000|Overall Study|Lack of Efficacy|1|||
129065200|NCT00524420|464525676|FG001|Overall Study|Lack of Efficacy|0|||
129065201|NCT01090414|464525677|FG000|Study 101-99|Progressive Disease|28|||
129065202|NCT01090414|464525678|FG001|Study 101-99|Progressive Disease|48|||
129065203|NCT01090414|464525679|FG002|Study 101-99|Progressive Disease|10|||
129065204|NCT01090414|464525680|FG003|Study 101-99|Progressive Disease|4|||
129065205|NCT01090414|464525677|FG000|Study 101-99|Adverse Event|10|||
129065206|NCT01090414|464525678|FG001|Study 101-99|Adverse Event|28|||
129065207|NCT01090414|464525679|FG002|Study 101-99|Adverse Event|18|||
129065208|NCT01090414|464525680|FG003|Study 101-99|Adverse Event|0|||
129065209|NCT01090414|464525677|FG000|Study 101-99|Investigator Request|1|||
129065210|NCT01090414|464525678|FG001|Study 101-99|Investigator Request|11|||
129065211|NCT01090414|464525679|FG002|Study 101-99|Investigator Request|4|||
129065212|NCT01090414|464525680|FG003|Study 101-99|Investigator Request|0|||
129065213|NCT01090414|464525677|FG000|Study 101-99|Death|3|||
129065214|NCT01090414|464525678|FG001|Study 101-99|Death|8|||
129065215|NCT01090414|464525679|FG002|Study 101-99|Death|1|||
129065216|NCT01090414|464525680|FG003|Study 101-99|Death|0|||
128721572|NCT01480076|463277314|FG000|Overall Study|Lost to Follow-up|7|||
128721573|NCT01480076|463277314|FG000|Overall Study|Investigator Decision|13|||
129065217|NCT01090414|464525677|FG000|Study 101-99|Sponsor Discontinued Study|0|||
129065218|NCT01090414|464525678|FG001|Study 101-99|Sponsor Discontinued Study|7|||
129065219|NCT01090414|464525679|FG002|Study 101-99|Sponsor Discontinued Study|5|||
129065220|NCT01090414|464525680|FG003|Study 101-99|Sponsor Discontinued Study|0|||
129065221|NCT01090414|464525677|FG000|Study 101-99|Other (Unknown Reasons)|3|||
129065222|NCT01090414|464525678|FG001|Study 101-99|Other (Unknown Reasons)|3|||
129065223|NCT01090414|464525679|FG002|Study 101-99|Other (Unknown Reasons)|0|||
129065224|NCT01090414|464525680|FG003|Study 101-99|Other (Unknown Reasons)|0|||
129065225|NCT01090414|464525677|FG000|Study 101-99|Withdrew Consent|0|||
129065226|NCT01090414|464525678|FG001|Study 101-99|Withdrew Consent|2|||
129065227|NCT01090414|464525679|FG002|Study 101-99|Withdrew Consent|3|||
129065228|NCT01090414|464525680|FG003|Study 101-99|Withdrew Consent|1|||
129065229|NCT01090414|464525677|FG000|Study 101-99|Participant Request|3|||
129065230|NCT01090414|464525678|FG001|Study 101-99|Participant Request|1|||
129065231|NCT01090414|464525679|FG002|Study 101-99|Participant Request|0|||
129065232|NCT01090414|464525680|FG003|Study 101-99|Participant Request|0|||
129065233|NCT02413229|464525689|FG000|Overall Study|Adverse Event|0|||
129065234|NCT02413229|464525690|FG001|Overall Study|Adverse Event|0|||
129065235|NCT02413229|464525691|FG002|Overall Study|Adverse Event|0|||
129065236|NCT02413229|464525692|FG003|Overall Study|Adverse Event|1|||
129065237|NCT02413229|464525693|FG004|Overall Study|Adverse Event|0|||
129065238|NCT02413229|464525694|FG005|Overall Study|Adverse Event|0|||
129065239|NCT02413229|464525695|FG006|Overall Study|Adverse Event|0|||
129065240|NCT02413229|464525696|FG007|Overall Study|Adverse Event|1|||
129065241|NCT02413229|464525689|FG000|Overall Study|Lost to Follow-up|0|||
129065242|NCT02413229|464525690|FG001|Overall Study|Lost to Follow-up|0|||
129065243|NCT02413229|464525691|FG002|Overall Study|Lost to Follow-up|1|||
129065244|NCT02413229|464525692|FG003|Overall Study|Lost to Follow-up|0|||
129065245|NCT02413229|464525693|FG004|Overall Study|Lost to Follow-up|2|||
129065246|NCT02413229|464525694|FG005|Overall Study|Lost to Follow-up|0|||
129065247|NCT02413229|464525695|FG006|Overall Study|Lost to Follow-up|0|||
129065248|NCT02413229|464525696|FG007|Overall Study|Lost to Follow-up|0|||
129065249|NCT02413229|464525689|FG000|Overall Study|Withdrawal by Subject|1|||
129065250|NCT02413229|464525690|FG001|Overall Study|Withdrawal by Subject|1|||
129065251|NCT02413229|464525691|FG002|Overall Study|Withdrawal by Subject|0|||
129065252|NCT02413229|464525692|FG003|Overall Study|Withdrawal by Subject|0|||
129065253|NCT02413229|464525693|FG004|Overall Study|Withdrawal by Subject|1|||
129065254|NCT02413229|464525694|FG005|Overall Study|Withdrawal by Subject|0|||
129065255|NCT02413229|464525695|FG006|Overall Study|Withdrawal by Subject|0|||
129065256|NCT02413229|464525696|FG007|Overall Study|Withdrawal by Subject|2|||
129065257|NCT02413229|464525689|FG000|Overall Study|Progressive Disease|0|||
129065258|NCT02413229|464525690|FG001|Overall Study|Progressive Disease|0|||
129065259|NCT02413229|464525691|FG002|Overall Study|Progressive Disease|0|||
129065260|NCT02413229|464525692|FG003|Overall Study|Progressive Disease|0|||
129065261|NCT02413229|464525693|FG004|Overall Study|Progressive Disease|0|||
129065262|NCT02413229|464525694|FG005|Overall Study|Progressive Disease|0|||
129065263|NCT02413229|464525695|FG006|Overall Study|Progressive Disease|0|||
129065264|NCT02413229|464525696|FG007|Overall Study|Progressive Disease|1|||
129065265|NCT00699816|464525699|FG000|Overall Study|Protocol Violation|1|||
129065266|NCT00699816|464525700|FG001|Overall Study|Protocol Violation|3|||
129065267|NCT02454933|464525701|FG000|Overall Study|Progressive disease|10|||
129065268|NCT02454933|464525702|FG001|Overall Study|Progressive disease|7|||
129065269|NCT02454933|464525701|FG000|Overall Study|Adverse Event|1|||
129065270|NCT02454933|464525702|FG001|Overall Study|Adverse Event|1|||
129065271|NCT02454933|464525701|FG000|Overall Study|Withdrawal by Subject|0|||
129065272|NCT02454933|464525702|FG001|Overall Study|Withdrawal by Subject|3|||
129065273|NCT02454933|464525701|FG000|Overall Study|Lost to Follow-up|1|||
129065274|NCT02454933|464525702|FG001|Overall Study|Lost to Follow-up|0|||
129065275|NCT01526655|464525703|FG000|Overall Study|Withdrawal by Subject|0|||
129065276|NCT01526655|464525704|FG001|Overall Study|Withdrawal by Subject|1|||
129065277|NCT05211726|464525716|FG000|Overall Study|Withdrawal by Subject|2|||
129065278|NCT05211726|464525717|FG001|Overall Study|Withdrawal by Subject|3|||
129065279|NCT05211726|464525716|FG000|Overall Study|Protocol Violation|0|||
129065280|NCT05211726|464525717|FG001|Overall Study|Protocol Violation|1|||
129065281|NCT05061420|464525726|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
129065282|NCT05061420|464525727|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129065283|NCT05061420|464525728|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129065284|NCT05061420|464525726|FG000|Overall Study|Progressive disease|11|||
129065285|NCT05061420|464525727|FG001|Overall Study|Progressive disease|15|||
129065286|NCT05061420|464525728|FG002|Overall Study|Progressive disease|14|||
129065287|NCT05061420|464525726|FG000|Overall Study|Withdrawal by Subject|2|||
129137694|NCT00601107|464796326|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
129137695|NCT00601107|464796327|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
128721574|NCT01480076|463277314|FG000|Overall Study|Other|52|||
129065288|NCT05061420|464525727|FG001|Overall Study|Withdrawal by Subject|0|||
129065289|NCT05061420|464525728|FG002|Overall Study|Withdrawal by Subject|1|||
129065290|NCT05061420|464525726|FG000|Overall Study|Not related to COVID-19|2|||
129065291|NCT05061420|464525727|FG001|Overall Study|Not related to COVID-19|0|||
129137696|NCT00601107|464796324|FG000|Overall Study|Worsening of Psoriasis|4|||
129065292|NCT05061420|464525728|FG002|Overall Study|Not related to COVID-19|0|||
129065293|NCT04868500|464525729|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
129065294|NCT04868500|464525730|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
129065295|NCT04868500|464525729|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
129065296|NCT04868500|464525730|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
129065297|NCT02374346|464525732|FG000|Overall Study|operated or discharged during weekend|48|||
129065298|NCT04807400|464525733|FG000|Overall Study|Adverse Event|2|||
129065299|NCT04807400|464525734|FG001|Overall Study|Adverse Event|3|||
129065300|NCT04807400|464525735|FG002|Overall Study|Adverse Event|3|||
129065301|NCT04807400|464525733|FG000|Overall Study|Death|2|||
129065302|NCT04807400|464525734|FG001|Overall Study|Death|0|||
129065303|NCT04807400|464525735|FG002|Overall Study|Death|0|||
129065304|NCT04807400|464525733|FG000|Overall Study|Lost to Follow-up|8|||
129065305|NCT04807400|464525734|FG001|Overall Study|Lost to Follow-up|6|||
129065306|NCT04807400|464525735|FG002|Overall Study|Lost to Follow-up|6|||
129065307|NCT04807400|464525733|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129065308|NCT04807400|464525734|FG001|Overall Study|Non-Compliance With Study Drug|4|||
129065309|NCT04807400|464525735|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129065310|NCT04807400|464525733|FG000|Overall Study|Participant Decision|20|||
129065311|NCT04807400|464525734|FG001|Overall Study|Participant Decision|19|||
129065312|NCT04807400|464525735|FG002|Overall Study|Participant Decision|26|||
129065313|NCT04807400|464525733|FG000|Overall Study|Physician Decision|0|||
129065314|NCT04807400|464525734|FG001|Overall Study|Physician Decision|1|||
129065315|NCT04807400|464525735|FG002|Overall Study|Physician Decision|0|||
129065316|NCT04807400|464525733|FG000|Overall Study|Protocol Violation|4|||
129065317|NCT04807400|464525734|FG001|Overall Study|Protocol Violation|3|||
129065318|NCT04807400|464525735|FG002|Overall Study|Protocol Violation|7|||
129065319|NCT04807400|464525733|FG000|Overall Study|Withdrawal by Subject|13|||
129065320|NCT04807400|464525734|FG001|Overall Study|Withdrawal by Subject|9|||
129065321|NCT04807400|464525735|FG002|Overall Study|Withdrawal by Subject|20|||
129065322|NCT04807400|464525733|FG000|Overall Study|Mis-randomized|1|||
129065323|NCT04807400|464525734|FG001|Overall Study|Mis-randomized|0|||
129065324|NCT04807400|464525735|FG002|Overall Study|Mis-randomized|0|||
129065325|NCT01332292|464525740|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
129065326|NCT01332292|464525741|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129065327|NCT01332292|464525740|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
129065328|NCT01332292|464525741|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
129065329|NCT01332292|464525740|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
129065330|NCT01332292|464525741|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
129065331|NCT04650204|464525742|FG000|Overall Study|Study was Terminated|2|||
129065332|NCT04650204|464525743|FG001|Overall Study|Study was Terminated|1|||
129065333|NCT01330303|464525744|FG000|Period 1|Adverse Event|1|||
129065334|NCT01330303|464525745|FG001|Period 1|Adverse Event|0|||
129065335|NCT01330303|464525744|FG000|Period 1|Protocol Violation|0|||
129065336|NCT01330303|464525745|FG001|Period 1|Protocol Violation|1|||
129065337|NCT01330303|464525744|FG000|Period 1|Withdrawal by Subject|0|||
129065338|NCT01330303|464525745|FG001|Period 1|Withdrawal by Subject|1|||
129065339|NCT01107197|464525746|FG000|Overall Study|Death|12|||
129065340|NCT01107197|464525747|FG001|Overall Study|Death|10|||
129065341|NCT01107197|464525746|FG000|Overall Study|Lost to Follow-up|5|||
129065342|NCT01107197|464525747|FG001|Overall Study|Lost to Follow-up|8|||
129065343|NCT01107197|464525746|FG000|Overall Study|Withdrawal by Subject|3|||
129065344|NCT01107197|464525747|FG001|Overall Study|Withdrawal by Subject|5|||
129065345|NCT03999996|464527525|FG000|Prior to Booster|Adverse Event|2|||
129065346|NCT03999996|464527526|FG001|Prior to Booster|Adverse Event|0|||
129065347|NCT03999996|464527527|FG002|Prior to Booster|Adverse Event|0|||
129065348|NCT03999996|464527528|FG003|Prior to Booster|Adverse Event|0|||
129065349|NCT03999996|464527525|FG000|Prior to Booster|Lost to Follow-up|17|||
128721575|NCT02120950|463277316|FG000|Overall Study|Adverse Event|5|||
128721576|NCT02120950|463277317|FG001|Overall Study|Adverse Event|4|||
129065350|NCT03999996|464527526|FG001|Prior to Booster|Lost to Follow-up|22|||
129065351|NCT03999996|464527527|FG002|Prior to Booster|Lost to Follow-up|0|||
129065352|NCT03999996|464527528|FG003|Prior to Booster|Lost to Follow-up|0|||
129065353|NCT03999996|464527525|FG000|Prior to Booster|Withdrawal of Consent|51|||
129065354|NCT03999996|464527526|FG001|Prior to Booster|Withdrawal of Consent|8|||
129065355|NCT03999996|464527527|FG002|Prior to Booster|Withdrawal of Consent|0|||
129065356|NCT03999996|464527528|FG003|Prior to Booster|Withdrawal of Consent|0|||
129065357|NCT03999996|464527525|FG000|Prior to Booster|Death|0|||
128721577|NCT02120950|463277318|FG002|Overall Study|Adverse Event|3|||
129065358|NCT03999996|464527526|FG001|Prior to Booster|Death|1|||
129065359|NCT03999996|464527527|FG002|Prior to Booster|Death|0|||
129065360|NCT03999996|464527528|FG003|Prior to Booster|Death|0|||
129065361|NCT03999996|464527525|FG000|Prior to Booster|Reason Not Specified|27|||
129065362|NCT03999996|464527526|FG001|Prior to Booster|Reason Not Specified|4|||
129065363|NCT03999996|464527527|FG002|Prior to Booster|Reason Not Specified|0|||
129065364|NCT03999996|464527528|FG003|Prior to Booster|Reason Not Specified|0|||
129137697|NCT00601107|464796325|FG001|Overall Study|Worsening of Psoriasis|1|||
129137698|NCT00601107|464796326|FG002|Overall Study|Worsening of Psoriasis|1|||
128721578|NCT02120950|463277316|FG000|Overall Study|Death|3|||
129065365|NCT03999996|464527525|FG000|Booster Phase|Lost to Follow-up|0|||
129065366|NCT03999996|464527526|FG001|Booster Phase|Lost to Follow-up|0|||
129065367|NCT03999996|464527527|FG002|Booster Phase|Lost to Follow-up|3|||
129065368|NCT03999996|464527528|FG003|Booster Phase|Lost to Follow-up|3|||
129065369|NCT03999996|464527525|FG000|Booster Phase|Withdrawal of Consent|0|||
129065370|NCT03999996|464527526|FG001|Booster Phase|Withdrawal of Consent|0|||
129137699|NCT00601107|464796327|FG003|Overall Study|Worsening of Psoriasis|4|||
129065371|NCT03999996|464527527|FG002|Booster Phase|Withdrawal of Consent|0|||
129065372|NCT03999996|464527528|FG003|Booster Phase|Withdrawal of Consent|1|||
129065373|NCT03999996|464527525|FG000|Booster Phase|Reason Not Specified|0|||
129065374|NCT03999996|464527526|FG001|Booster Phase|Reason Not Specified|0|||
129065375|NCT03999996|464527527|FG002|Booster Phase|Reason Not Specified|0|||
129065376|NCT03999996|464527528|FG003|Booster Phase|Reason Not Specified|1|||
129065377|NCT02717455|464527529|FG000|Overall Study|Adverse Event|1|||
129065378|NCT02717455|464527530|FG001|Overall Study|Adverse Event|0|||
129065379|NCT02717455|464527531|FG002|Overall Study|Adverse Event|0|||
129065380|NCT02717455|464527532|FG003|Overall Study|Adverse Event|2|||
129065381|NCT02717455|464527533|FG004|Overall Study|Adverse Event|2|||
129065382|NCT02717455|464527534|FG005|Overall Study|Adverse Event|2|||
129065383|NCT02717455|464527529|FG000|Overall Study|Withdrawal by Subject|1|||
129065384|NCT02717455|464527530|FG001|Overall Study|Withdrawal by Subject|1|||
129065385|NCT02717455|464527531|FG002|Overall Study|Withdrawal by Subject|0|||
129065386|NCT02717455|464527532|FG003|Overall Study|Withdrawal by Subject|2|||
129065387|NCT02717455|464527533|FG004|Overall Study|Withdrawal by Subject|2|||
129065388|NCT02717455|464527534|FG005|Overall Study|Withdrawal by Subject|1|||
129065389|NCT02717455|464527529|FG000|Overall Study|Death|1|||
129065390|NCT02717455|464527530|FG001|Overall Study|Death|0|||
129065391|NCT02717455|464527531|FG002|Overall Study|Death|0|||
129065392|NCT02717455|464527532|FG003|Overall Study|Death|0|||
129065393|NCT02717455|464527533|FG004|Overall Study|Death|1|||
129065394|NCT02717455|464527534|FG005|Overall Study|Death|0|||
129065395|NCT02717455|464527529|FG000|Overall Study|Did not receive study drug|0|||
129065396|NCT02717455|464527530|FG001|Overall Study|Did not receive study drug|0|||
129065397|NCT02717455|464527531|FG002|Overall Study|Did not receive study drug|0|||
129065398|NCT02717455|464527532|FG003|Overall Study|Did not receive study drug|1|||
129065399|NCT02717455|464527533|FG004|Overall Study|Did not receive study drug|0|||
129065400|NCT02717455|464527534|FG005|Overall Study|Did not receive study drug|1|||
129065401|NCT02717455|464527529|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129065402|NCT02717455|464527530|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129065403|NCT02717455|464527531|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129065404|NCT02717455|464527532|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129065405|NCT02717455|464527533|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129065406|NCT02717455|464527534|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
129065407|NCT02717455|464527529|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
129065408|NCT02717455|464527530|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
129065409|NCT02717455|464527531|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
129065410|NCT02717455|464527532|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
129065411|NCT02717455|464527533|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
129065412|NCT02717455|464527534|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
129065413|NCT00233948|464527541|FG000|Overall Study|Adverse Event|1|||
129065414|NCT00233948|464527542|FG001|Overall Study|Adverse Event|0|||
129065415|NCT00233948|464527543|FG002|Overall Study|Adverse Event|0|||
129065416|NCT00233948|464527544|FG003|Overall Study|Adverse Event|0|||
129065417|NCT00233948|464527545|FG004|Overall Study|Adverse Event|0|||
129065418|NCT00233948|464527546|FG005|Overall Study|Adverse Event|0|||
129065419|NCT00733005|464527547|FG000|Overall Study|Adverse Event|0|||
129065420|NCT00733005|464527548|FG001|Overall Study|Adverse Event|1|||
129065421|NCT00733005|464527547|FG000|Overall Study|Treatment Failure|0|||
129065422|NCT00733005|464527548|FG001|Overall Study|Treatment Failure|1|||
129065423|NCT00733005|464527547|FG000|Overall Study|Withdrawal by Subject|0|||
129065424|NCT00733005|464527548|FG001|Overall Study|Withdrawal by Subject|1|||
129065425|NCT00733005|464527547|FG000|Overall Study|Protocol Violation|2|||
129065426|NCT00733005|464527548|FG001|Overall Study|Protocol Violation|0|||
129065427|NCT03410056|464527549|FG000|Overall Study|Decision by Sponsor|0|||
129065428|NCT03410056|464527550|FG001|Overall Study|Decision by Sponsor|0|||
129065429|NCT03410056|464527551|FG002|Overall Study|Decision by Sponsor|3|||
129065430|NCT03410056|464527552|FG003|Overall Study|Decision by Sponsor|0|||
129065431|NCT03410056|464527553|FG004|Overall Study|Decision by Sponsor|0|||
129065432|NCT03410056|464527554|FG005|Overall Study|Decision by Sponsor|0|||
129065433|NCT03410056|464527555|FG006|Overall Study|Decision by Sponsor|0|||
129065434|NCT03410056|464527549|FG000|Overall Study|Withdrawal by Subject|0|||
129065435|NCT03410056|464527550|FG001|Overall Study|Withdrawal by Subject|2|||
129065436|NCT03410056|464527551|FG002|Overall Study|Withdrawal by Subject|5|||
129065437|NCT03410056|464527552|FG003|Overall Study|Withdrawal by Subject|5|||
129065438|NCT03410056|464527553|FG004|Overall Study|Withdrawal by Subject|0|||
129065439|NCT03410056|464527554|FG005|Overall Study|Withdrawal by Subject|0|||
129065440|NCT03410056|464527555|FG006|Overall Study|Withdrawal by Subject|0|||
129065441|NCT00266630|464527556|FG000|Overall Study|Adverse Event|8|||
129065442|NCT00266630|464527557|FG001|Overall Study|Adverse Event|6|||
129065443|NCT00266630|464527556|FG000|Overall Study|Lack of Efficacy|1|||
129065444|NCT00266630|464527557|FG001|Overall Study|Lack of Efficacy|4|||
129065445|NCT00266630|464527556|FG000|Overall Study|Entry Criteria not met|1|||
129065446|NCT00266630|464527557|FG001|Overall Study|Entry Criteria not met|0|||
129065447|NCT00266630|464527556|FG000|Overall Study|Protocol Violation|1|||
129065448|NCT00266630|464527557|FG001|Overall Study|Protocol Violation|3|||
129065449|NCT00266630|464527556|FG000|Overall Study|Physician Decision|1|||
129065450|NCT00266630|464527557|FG001|Overall Study|Physician Decision|2|||
129065451|NCT00266630|464527556|FG000|Overall Study|Withdrawal by Subject|10|||
129065452|NCT00266630|464527557|FG001|Overall Study|Withdrawal by Subject|2|||
129065453|NCT00266630|464527556|FG000|Overall Study|Lost to Follow-up|1|||
129065454|NCT00266630|464527557|FG001|Overall Study|Lost to Follow-up|0|||
129065455|NCT00266630|464527556|FG000|Overall Study|Other|19|||
129065456|NCT00266630|464527557|FG001|Overall Study|Other|11|||
129065457|NCT02548156|464527563|FG000|Washout Period 1|Lost to Follow-up|0|||
129065458|NCT02548156|464527564|FG001|Washout Period 1|Lost to Follow-up|0|||
129065459|NCT02548156|464527565|FG002|Washout Period 1|Lost to Follow-up|0|||
129065460|NCT02548156|464527566|FG003|Washout Period 1|Lost to Follow-up|0|||
129065461|NCT02548156|464527567|FG004|Washout Period 1|Lost to Follow-up|1|||
129065462|NCT02548156|464527568|FG005|Washout Period 1|Lost to Follow-up|0|||
129065463|NCT01068262|464527573|FG000|Overall Study|Adverse Event|2|||
129065464|NCT01068262|464527574|FG001|Overall Study|Adverse Event|0|||
129065465|NCT01068262|464527575|FG002|Overall Study|Adverse Event|1|||
129065466|NCT01068262|464527576|FG003|Overall Study|Adverse Event|0|||
129065467|NCT01068262|464527573|FG000|Overall Study|Protocol Violation|1|||
129065468|NCT01068262|464527574|FG001|Overall Study|Protocol Violation|0|||
129065469|NCT01068262|464527575|FG002|Overall Study|Protocol Violation|0|||
129065470|NCT01068262|464527576|FG003|Overall Study|Protocol Violation|0|||
129065471|NCT01068262|464527573|FG000|Overall Study|Withdrawal by Subject|0|||
129065472|NCT01068262|464527574|FG001|Overall Study|Withdrawal by Subject|1|||
129065473|NCT01068262|464527575|FG002|Overall Study|Withdrawal by Subject|0|||
129065474|NCT01068262|464527576|FG003|Overall Study|Withdrawal by Subject|0|||
129065475|NCT00444587|464527579|FG000|Overall Study|Death|2|||
129065476|NCT00444587|464527580|FG001|Overall Study|Death|1|||
129065477|NCT00444587|464527579|FG000|Overall Study|Progression of the disease|73|||
128721579|NCT02120950|463277317|FG001|Overall Study|Death|0|||
128721580|NCT02120950|463277318|FG002|Overall Study|Death|1|||
129065478|NCT00444587|464527580|FG001|Overall Study|Progression of the disease|8|||
129065479|NCT00444587|464527579|FG000|Overall Study|Refused treatment/did not cooperate|4|||
128721581|NCT02120950|463277316|FG000|Overall Study|Withdrawal by Subject|6|||
128721582|NCT02120950|463277317|FG001|Overall Study|Withdrawal by Subject|3|||
129065480|NCT00444587|464527580|FG001|Overall Study|Refused treatment/did not cooperate|1|||
129065481|NCT00444587|464527579|FG000|Overall Study|Investigator decision|3|||
129065482|NCT00444587|464527580|FG001|Overall Study|Investigator decision|0|||
129065483|NCT00444587|464527579|FG000|Overall Study|Protocol Violation|1|||
129065484|NCT00444587|464527580|FG001|Overall Study|Protocol Violation|0|||
129065485|NCT00444587|464527579|FG000|Overall Study|Missing|0|||
129137700|NCT00601107|464796324|FG000|Overall Study|Undefined|1|||
129137701|NCT00601107|464796325|FG001|Overall Study|Undefined|0|||
129137702|NCT00601107|464796326|FG002|Overall Study|Undefined|1|||
129137703|NCT00601107|464796327|FG003|Overall Study|Undefined|0|||
129137704|NCT00147537|464796328|FG000|Phase 1b|Death|0|||
129137705|NCT00147537|464796329|FG001|Phase 1b|Death|1|||
129137706|NCT00147537|464796330|FG002|Phase 1b|Death|2|||
129137707|NCT00147537|464796331|FG003|Phase 1b|Death|1|||
129137708|NCT00147537|464796332|FG004|Phase 1b|Death|2|||
129137709|NCT00147537|464796333|FG005|Phase 1b|Death|2|||
129137710|NCT00147537|464796334|FG006|Phase 1b|Death|1|||
129137711|NCT00147537|464796335|FG007|Phase 1b|Death|3|||
129137712|NCT00147537|464796336|FG008|Phase 1b|Death|9|||
129065486|NCT00444587|464527580|FG001|Overall Study|Missing|5|||
129065487|NCT01473407|464527589|FG000|Overall Study|Physician Decision|1|||
129065488|NCT01473407|464527590|FG001|Overall Study|Physician Decision|4|||
129065489|NCT01473407|464527589|FG000|Overall Study|Lost to Follow-up|10|||
129065490|NCT01473407|464527590|FG001|Overall Study|Lost to Follow-up|4|||
129065491|NCT01473407|464527589|FG000|Overall Study|Adverse Event|8|||
129065492|NCT01473407|464527590|FG001|Overall Study|Adverse Event|8|||
129065493|NCT01473407|464527589|FG000|Overall Study|Randomization Error|3|||
129065494|NCT01473407|464527590|FG001|Overall Study|Randomization Error|1|||
129065495|NCT01473407|464527589|FG000|Overall Study|Withdrawal by Subject|4|||
129065496|NCT01473407|464527590|FG001|Overall Study|Withdrawal by Subject|7|||
129065497|NCT01473407|464527589|FG000|Overall Study|Kidney Transplant|7|||
129065498|NCT01473407|464527590|FG001|Overall Study|Kidney Transplant|6|||
129065499|NCT01473407|464527589|FG000|Overall Study|Vacation/Travel|1|||
129065500|NCT01473407|464527590|FG001|Overall Study|Vacation/Travel|1|||
129065501|NCT01473407|464527589|FG000|Overall Study|Elevated Hemoglobin|1|||
129065502|NCT01473407|464527590|FG001|Overall Study|Elevated Hemoglobin|0|||
129065503|NCT01473407|464527589|FG000|Overall Study|Patient Received Aranesp|1|||
129065504|NCT01473407|464527590|FG001|Overall Study|Patient Received Aranesp|0|||
129065505|NCT01473407|464527589|FG000|Overall Study|Patient Lost Green Card Status|1|||
129065506|NCT01473407|464527590|FG001|Overall Study|Patient Lost Green Card Status|0|||
129065507|NCT01473407|464527589|FG000|Overall Study|Temperature Excursion|2|||
129065508|NCT01473407|464527590|FG001|Overall Study|Temperature Excursion|3|||
129065509|NCT01473407|464527589|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
129065510|NCT01473407|464527590|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
129065511|NCT01473407|464527589|FG000|Overall Study|Sponsor's Decision|10|||
129065512|NCT01473407|464527590|FG001|Overall Study|Sponsor's Decision|10|||
129065513|NCT01473407|464527589|FG000|Overall Study|Site Closure|1|||
129065514|NCT01473407|464527590|FG001|Overall Study|Site Closure|0|||
129065515|NCT01027702|464527591|FG000|Overall Study|Received subsequent therapy|1|||
129065516|NCT01027702|464527592|FG001|Overall Study|Received subsequent therapy|2|||
129065517|NCT01027702|464527593|FG002|Overall Study|Received subsequent therapy|0|||
129065518|NCT01027702|464527594|FG003|Overall Study|Received subsequent therapy|4|||
129065519|NCT01027702|464527595|FG004|Overall Study|Received subsequent therapy|1|||
129065520|NCT01027702|464527596|FG005|Overall Study|Received subsequent therapy|0|||
129065521|NCT01027702|464527597|FG006|Overall Study|Received subsequent therapy|1|||
129065522|NCT01027702|464527591|FG000|Overall Study|Death|0|||
129065523|NCT01027702|464527592|FG001|Overall Study|Death|0|||
129065524|NCT01027702|464527593|FG002|Overall Study|Death|1|||
129065525|NCT01027702|464527594|FG003|Overall Study|Death|0|||
129137713|NCT00147537|464796337|FG009|Phase 1b|Death|0|||
129137714|NCT00147537|464796338|FG010|Phase 1b|Death|0|||
129137715|NCT00147537|464796328|FG000|Phase 1b|Lost to Follow-up|2|||
129137716|NCT00147537|464796329|FG001|Phase 1b|Lost to Follow-up|1|||
129137717|NCT00147537|464796330|FG002|Phase 1b|Lost to Follow-up|0|||
129137718|NCT00147537|464796331|FG003|Phase 1b|Lost to Follow-up|0|||
129065526|NCT01027702|464527595|FG004|Overall Study|Death|0|||
129065527|NCT01027702|464527596|FG005|Overall Study|Death|0|||
129065528|NCT01027702|464527597|FG006|Overall Study|Death|0|||
129065529|NCT02301390|464527598|FG000|Overall Study|Withdrawal by Subject|3|||
129065530|NCT02301390|464527599|FG001|Overall Study|Withdrawal by Subject|5|||
128775846|NCT02584855|463468488|FG001|Open-Label Treatment Period|No PI Available|0|||
129065531|NCT02301390|464527598|FG000|Overall Study|Protocol Violation|1|||
129065532|NCT02301390|464527599|FG001|Overall Study|Protocol Violation|0|||
129137719|NCT00147537|464796332|FG004|Phase 1b|Lost to Follow-up|0|||
129137720|NCT00147537|464796333|FG005|Phase 1b|Lost to Follow-up|0|||
129137721|NCT00147537|464796334|FG006|Phase 1b|Lost to Follow-up|2|||
129137722|NCT00147537|464796335|FG007|Phase 1b|Lost to Follow-up|0|||
129065533|NCT02301390|464527598|FG000|Overall Study|Physician Decision|1|||
129065534|NCT02301390|464527599|FG001|Overall Study|Physician Decision|0|||
129065535|NCT02301390|464527598|FG000|Overall Study|Lost to Follow-up|0|||
129065536|NCT02301390|464527599|FG001|Overall Study|Lost to Follow-up|1|||
129065537|NCT02301390|464527598|FG000|Overall Study|Death|2|||
129065538|NCT02301390|464527599|FG001|Overall Study|Death|2|||
129065539|NCT02301390|464527598|FG000|Overall Study|Procedure not completed|0|||
129065540|NCT02301390|464527599|FG001|Overall Study|Procedure not completed|4|||
129137723|NCT00147537|464796336|FG008|Phase 1b|Lost to Follow-up|1|||
129137724|NCT00147537|464796337|FG009|Phase 1b|Lost to Follow-up|0|||
129137725|NCT00147537|464796338|FG010|Phase 1b|Lost to Follow-up|0|||
129065541|NCT02301390|464527598|FG000|Overall Study|Missed multiple visits|1|||
129065542|NCT02301390|464527599|FG001|Overall Study|Missed multiple visits|1|||
129065543|NCT02301390|464527598|FG000|Overall Study|study terminated|2|||
129065544|NCT02301390|464527599|FG001|Overall Study|study terminated|0|||
129065545|NCT01153425|464527603|FG000|Overall Study|Withdrawal by Subject|3|||
129065546|NCT01153425|464527604|FG001|Overall Study|Withdrawal by Subject|3|||
129065547|NCT02932462|464527608|FG000|Overall Study|Adverse Event|1|||
129065548|NCT02932462|464527609|FG001|Overall Study|Adverse Event|2|||
129065549|NCT02932462|464527608|FG000|Overall Study|Lost to Follow-up|4|||
129065550|NCT02932462|464527609|FG001|Overall Study|Lost to Follow-up|1|||
129065551|NCT02932462|464527608|FG000|Overall Study|Protocol Violation|0|||
129065552|NCT02932462|464527609|FG001|Overall Study|Protocol Violation|5|||
129065553|NCT02932462|464527608|FG000|Overall Study|Withdrawal by Subject|1|||
129065554|NCT02932462|464527609|FG001|Overall Study|Withdrawal by Subject|4|||
129065555|NCT02932462|464527608|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129065556|NCT02932462|464527609|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129065557|NCT02932462|464527608|FG000|Overall Study|Progressive Disease|1|||
129065558|NCT02932462|464527609|FG001|Overall Study|Progressive Disease|0|||
129065559|NCT02652949|464527610|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
129065560|NCT02652949|464527610|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
128721583|NCT02120950|463277318|FG002|Overall Study|Withdrawal by Subject|2|||
128721584|NCT02120950|463277316|FG000|Overall Study|Protocol Violation|1|||
128721585|NCT02120950|463277317|FG001|Overall Study|Protocol Violation|1|||
129065561|NCT02652949|464527610|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
129065562|NCT02652949|464527610|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
129065563|NCT02652949|464527610|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
129065564|NCT02652949|464527610|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
129065565|NCT02652949|464527610|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
129065566|NCT02652949|464527610|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
129065567|NCT02652949|464527610|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
129065568|NCT02652949|464527610|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
129065569|NCT02652949|464527610|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
129065570|NCT02652949|464527610|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
129065571|NCT02652949|464527610|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
129065572|NCT02652949|464527610|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
129065573|NCT02652949|464527610|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
129065574|NCT02652949|464527610|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
129065575|NCT02652949|464527610|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
129137726|NCT00147537|464796328|FG000|Phase 1b|Other|0|||
129137727|NCT00147537|464796329|FG001|Phase 1b|Other|0|||
129137728|NCT00147537|464796330|FG002|Phase 1b|Other|2|||
129137729|NCT00147537|464796331|FG003|Phase 1b|Other|1|||
129137730|NCT00147537|464796332|FG004|Phase 1b|Other|1|||
129137731|NCT00147537|464796333|FG005|Phase 1b|Other|1|||
129137732|NCT00147537|464796334|FG006|Phase 1b|Other|14|||
129137733|NCT00147537|464796335|FG007|Phase 1b|Other|4|||
129137734|NCT00147537|464796336|FG008|Phase 1b|Other|4|||
129137735|NCT00147537|464796337|FG009|Phase 1b|Other|0|||
129137736|NCT00147537|464796338|FG010|Phase 1b|Other|0|||
129137737|NCT00147537|464796328|FG000|Phase 1b|Withdrawal by Subject|0|||
129137738|NCT00147537|464796329|FG001|Phase 1b|Withdrawal by Subject|0|||
129137739|NCT00147537|464796330|FG002|Phase 1b|Withdrawal by Subject|0|||
129137740|NCT00147537|464796331|FG003|Phase 1b|Withdrawal by Subject|0|||
129137741|NCT00147537|464796332|FG004|Phase 1b|Withdrawal by Subject|0|||
129137742|NCT00147537|464796333|FG005|Phase 1b|Withdrawal by Subject|0|||
129137743|NCT00147537|464796334|FG006|Phase 1b|Withdrawal by Subject|0|||
129137744|NCT00147537|464796335|FG007|Phase 1b|Withdrawal by Subject|0|||
129137745|NCT00147537|464796336|FG008|Phase 1b|Withdrawal by Subject|2|||
129137746|NCT00147537|464796337|FG009|Phase 1b|Withdrawal by Subject|0|||
129137747|NCT00147537|464796338|FG010|Phase 1b|Withdrawal by Subject|0|||
129137748|NCT00147537|464796328|FG000|Phase 1b|Randomized but not treated|0|||
129137749|NCT00147537|464796329|FG001|Phase 1b|Randomized but not treated|0|||
129137750|NCT00147537|464796330|FG002|Phase 1b|Randomized but not treated|0|||
129137751|NCT00147537|464796331|FG003|Phase 1b|Randomized but not treated|0|||
129137752|NCT00147537|464796332|FG004|Phase 1b|Randomized but not treated|0|||
129137753|NCT00147537|464796333|FG005|Phase 1b|Randomized but not treated|0|||
129137754|NCT00147537|464796334|FG006|Phase 1b|Randomized but not treated|1|||
129065576|NCT03594071|464527611|FG000|Overall Study|Re-operation|3|||
129137755|NCT00147537|464796335|FG007|Phase 1b|Randomized but not treated|0|||
129137756|NCT00147537|464796336|FG008|Phase 1b|Randomized but not treated|1|||
129137757|NCT00147537|464796337|FG009|Phase 1b|Randomized but not treated|0|||
129137758|NCT00147537|464796338|FG010|Phase 1b|Randomized but not treated|0|||
129137759|NCT00147537|464796328|FG000|Phase 2|Death|0|||
129137760|NCT00147537|464796329|FG001|Phase 2|Death|0|||
129137761|NCT00147537|464796330|FG002|Phase 2|Death|0|||
129137762|NCT00147537|464796331|FG003|Phase 2|Death|0|||
129137763|NCT00147537|464796332|FG004|Phase 2|Death|0|||
129137764|NCT00147537|464796333|FG005|Phase 2|Death|0|||
129065577|NCT03594071|464527611|FG000|Overall Study|Missed visit|2|||
129065578|NCT03022370|464527612|FG000|Overall Study|Death|6|||
129065579|NCT03022370|464527613|FG001|Overall Study|Death|12|||
129065580|NCT03022370|464527612|FG000|Overall Study|Lost to Follow-up|174|||
129065581|NCT03022370|464527613|FG001|Overall Study|Lost to Follow-up|109|||
129065582|NCT03668808|464527616|FG000|First Intervention|Withdrawal by Subject|2|||
129065583|NCT03668808|464527617|FG001|First Intervention|Withdrawal by Subject|2|||
129065584|NCT00280735|464527627|FG000|Overall Study|Adverse Event|5|||
129065585|NCT00280735|464527627|FG000|Overall Study|Lack of Efficacy|3|||
129065586|NCT00280735|464527627|FG000|Overall Study|Withdrawal by Subject|8|||
129065587|NCT00280735|464527627|FG000|Overall Study|Intercurrent Illness|2|||
129065588|NCT04753216|464527628|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
129065589|NCT04753216|464527628|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
129065590|NCT04753216|464527628|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
129065591|NCT02001987|464527630|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
129065592|NCT02001987|464527630|FG000|Core Study Period (24 Weeks)|Death|1|||
129065593|NCT02001987|464527630|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
129065594|NCT02001987|464527630|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
129065595|NCT02001987|464527630|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
129065596|NCT02001987|464527630|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
129065597|NCT02001987|464527630|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
129065598|NCT02001987|464527630|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
129065599|NCT02001987|464527630|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
129065600|NCT02001987|464527630|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
129065601|NCT02001987|464527630|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
129065602|NCT02001987|464527630|FG000|LTE Period (52 Weeks)|Other|3|||
129065603|NCT01965860|464527631|FG000|Overall Study|Pregnancy|1|||
129065604|NCT01965860|464527632|FG001|Overall Study|Pregnancy|0|||
129065605|NCT01965860|464527633|FG002|Overall Study|Pregnancy|1|||
129065606|NCT01965860|464527631|FG000|Overall Study|Logistics|1|||
129065607|NCT01965860|464527632|FG001|Overall Study|Logistics|0|||
129065608|NCT01965860|464527633|FG002|Overall Study|Logistics|0|||
129065609|NCT01895777|464527634|FG000|Overall Study|Adverse Event|1|||
129065610|NCT01895777|464527635|FG001|Overall Study|Adverse Event|2|||
129065611|NCT01895777|464527634|FG000|Overall Study|Lost to Follow-up|2|||
129065612|NCT01895777|464527635|FG001|Overall Study|Lost to Follow-up|0|||
129065613|NCT01895777|464527634|FG000|Overall Study|Not treated|1|||
129065614|NCT01895777|464527635|FG001|Overall Study|Not treated|0|||
129065615|NCT01895777|464527634|FG000|Overall Study|Other reasons|3|||
129065616|NCT01895777|464527635|FG001|Overall Study|Other reasons|2|||
129065617|NCT01895777|464527634|FG000|Overall Study|Non-compliance with the CTP|2|||
129065618|NCT01895777|464527635|FG001|Overall Study|Non-compliance with the CTP|1|||
129065619|NCT02288325|464527639|FG000|Run-in Period|Adverse Event|48|||
129065620|NCT02288325|464527640|FG001|Run-in Period|Adverse Event|0|||
129065621|NCT02288325|464527641|FG002|Run-in Period|Adverse Event|0|||
129065622|NCT02288325|464527639|FG000|Run-in Period|Lack of Efficacy|16|||
129065623|NCT02288325|464527640|FG001|Run-in Period|Lack of Efficacy|0|||
129065624|NCT02288325|464527641|FG002|Run-in Period|Lack of Efficacy|0|||
129065625|NCT02288325|464527639|FG000|Run-in Period|Withdrawal of Consent|28|||
129065626|NCT02288325|464527640|FG001|Run-in Period|Withdrawal of Consent|0|||
129065627|NCT02288325|464527641|FG002|Run-in Period|Withdrawal of Consent|0|||
129065628|NCT02288325|464527639|FG000|Run-in Period|Lost to Follow-up|25|||
129065629|NCT02288325|464527640|FG001|Run-in Period|Lost to Follow-up|0|||
129065630|NCT02288325|464527641|FG002|Run-in Period|Lost to Follow-up|0|||
129065631|NCT02288325|464527639|FG000|Run-in Period|Protocol Violation|17|||
129065632|NCT02288325|464527640|FG001|Run-in Period|Protocol Violation|0|||
129065633|NCT02288325|464527641|FG002|Run-in Period|Protocol Violation|0|||
129065634|NCT02288325|464527639|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
129065635|NCT02288325|464527640|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
129065636|NCT02288325|464527641|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
129065637|NCT02288325|464527639|FG000|Run-in Period|Reason not Specified|8|||
129065638|NCT02288325|464527640|FG001|Run-in Period|Reason not Specified|0|||
129065639|NCT02288325|464527641|FG002|Run-in Period|Reason not Specified|0|||
129065640|NCT02288325|464527639|FG000|Stabilization Period|Adverse Event|13|||
129065641|NCT02288325|464527640|FG001|Stabilization Period|Adverse Event|0|||
129065642|NCT02288325|464527641|FG002|Stabilization Period|Adverse Event|0|||
129065643|NCT02288325|464527639|FG000|Stabilization Period|Lack of Efficacy|22|||
129065644|NCT02288325|464527640|FG001|Stabilization Period|Lack of Efficacy|0|||
129065645|NCT02288325|464527641|FG002|Stabilization Period|Lack of Efficacy|0|||
129065646|NCT02288325|464527639|FG000|Stabilization Period|Withdrawal of Consent|23|||
129065647|NCT02288325|464527640|FG001|Stabilization Period|Withdrawal of Consent|0|||
129065648|NCT02288325|464527641|FG002|Stabilization Period|Withdrawal of Consent|0|||
129065649|NCT02288325|464527639|FG000|Stabilization Period|Lost to Follow-up|12|||
129065650|NCT02288325|464527640|FG001|Stabilization Period|Lost to Follow-up|0|||
129065651|NCT02288325|464527641|FG002|Stabilization Period|Lost to Follow-up|0|||
129065652|NCT02288325|464527639|FG000|Stabilization Period|Protocol Violation|8|||
129065653|NCT02288325|464527640|FG001|Stabilization Period|Protocol Violation|0|||
129065654|NCT02288325|464527641|FG002|Stabilization Period|Protocol Violation|0|||
129065655|NCT02288325|464527639|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
129065656|NCT02288325|464527640|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
129065657|NCT02288325|464527641|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
129065658|NCT02288325|464527639|FG000|Stabilization Period|Reason not Specified|15|||
129065659|NCT02288325|464527640|FG001|Stabilization Period|Reason not Specified|0|||
129065660|NCT02288325|464527641|FG002|Stabilization Period|Reason not Specified|0|||
129065661|NCT02288325|464527639|FG000|Double-blind Treatment Period|Adverse Event|0|||
129065662|NCT02288325|464527640|FG001|Double-blind Treatment Period|Adverse Event|2|||
129065663|NCT02288325|464527641|FG002|Double-blind Treatment Period|Adverse Event|5|||
129065664|NCT02288325|464527639|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
129065665|NCT02288325|464527640|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
129065666|NCT02288325|464527641|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
129065667|NCT02288325|464527639|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129065668|NCT02288325|464527640|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
129065669|NCT02288325|464527641|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
129065670|NCT02288325|464527639|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129065671|NCT02288325|464527640|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129065672|NCT02288325|464527641|FG002|Double-blind Treatment Period|Protocol Violation|2|||
129065673|NCT02288325|464527639|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
129065674|NCT02288325|464527640|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
129065675|NCT02288325|464527641|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
129065676|NCT02288325|464527639|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
129065677|NCT02288325|464527640|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
129065678|NCT02288325|464527641|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
129065679|NCT03735121|464527644|FG000|Overall Study|Death|3|||
129065680|NCT03735121|464527645|FG001|Overall Study|Death|6|||
129065681|NCT03735121|464527646|FG002|Overall Study|Death|8|||
129065682|NCT03735121|464527647|FG003|Overall Study|Death|37|||
129065683|NCT03735121|464527648|FG004|Overall Study|Death|86|||
129065684|NCT03735121|464527644|FG000|Overall Study|Withdrawal by Subject|1|||
129065685|NCT03735121|464527645|FG001|Overall Study|Withdrawal by Subject|1|||
129065686|NCT03735121|464527646|FG002|Overall Study|Withdrawal by Subject|3|||
129065687|NCT03735121|464527647|FG003|Overall Study|Withdrawal by Subject|4|||
129065688|NCT03735121|464527648|FG004|Overall Study|Withdrawal by Subject|2|||
129065689|NCT03735121|464527644|FG000|Overall Study|Progressive Disease|0|||
129065690|NCT03735121|464527645|FG001|Overall Study|Progressive Disease|0|||
129065691|NCT03735121|464527646|FG002|Overall Study|Progressive Disease|1|||
129065692|NCT03735121|464527647|FG003|Overall Study|Progressive Disease|0|||
129065693|NCT03735121|464527648|FG004|Overall Study|Progressive Disease|0|||
129065694|NCT03735121|464527644|FG000|Overall Study|Lost to Follow-up|0|||
129065695|NCT03735121|464527645|FG001|Overall Study|Lost to Follow-up|0|||
129065696|NCT03735121|464527646|FG002|Overall Study|Lost to Follow-up|0|||
129065697|NCT03735121|464527647|FG003|Overall Study|Lost to Follow-up|0|||
129065698|NCT03735121|464527648|FG004|Overall Study|Lost to Follow-up|1|||
129137765|NCT00147537|464796334|FG006|Phase 2|Death|0|||
129137766|NCT00147537|464796335|FG007|Phase 2|Death|0|||
129137767|NCT00147537|464796336|FG008|Phase 2|Death|0|||
129137768|NCT00147537|464796337|FG009|Phase 2|Death|85|||
129137769|NCT00147537|464796338|FG010|Phase 2|Death|31|||
129137770|NCT00147537|464796328|FG000|Phase 2|Lost to Follow-up|0|||
129137771|NCT00147537|464796329|FG001|Phase 2|Lost to Follow-up|0|||
129137772|NCT00147537|464796330|FG002|Phase 2|Lost to Follow-up|0|||
129137773|NCT00147537|464796331|FG003|Phase 2|Lost to Follow-up|0|||
129137774|NCT00147537|464796332|FG004|Phase 2|Lost to Follow-up|0|||
129137775|NCT00147537|464796333|FG005|Phase 2|Lost to Follow-up|0|||
129065699|NCT03735121|464527644|FG000|Overall Study|Ongoing|3|||
129137776|NCT00147537|464796334|FG006|Phase 2|Lost to Follow-up|0|||
129137777|NCT00147537|464796335|FG007|Phase 2|Lost to Follow-up|0|||
129137778|NCT00147537|464796336|FG008|Phase 2|Lost to Follow-up|0|||
129137779|NCT00147537|464796337|FG009|Phase 2|Lost to Follow-up|12|||
129137780|NCT00147537|464796338|FG010|Phase 2|Lost to Follow-up|4|||
129137781|NCT00147537|464796328|FG000|Phase 2|Other|0|||
129137782|NCT00147537|464796329|FG001|Phase 2|Other|0|||
129137783|NCT00147537|464796330|FG002|Phase 2|Other|0|||
129137784|NCT00147537|464796331|FG003|Phase 2|Other|0|||
129137785|NCT00147537|464796332|FG004|Phase 2|Other|0|||
129137786|NCT00147537|464796333|FG005|Phase 2|Other|0|||
129137787|NCT00147537|464796334|FG006|Phase 2|Other|0|||
129137788|NCT00147537|464796335|FG007|Phase 2|Other|0|||
129137789|NCT00147537|464796336|FG008|Phase 2|Other|0|||
129137790|NCT00147537|464796337|FG009|Phase 2|Other|47|||
129137791|NCT00147537|464796338|FG010|Phase 2|Other|12|||
129137792|NCT00147537|464796328|FG000|Phase 2|Withdrawal by Subject|0|||
129137793|NCT00147537|464796329|FG001|Phase 2|Withdrawal by Subject|0|||
129137794|NCT00147537|464796330|FG002|Phase 2|Withdrawal by Subject|0|||
129137795|NCT00147537|464796331|FG003|Phase 2|Withdrawal by Subject|0|||
129065700|NCT03735121|464527645|FG001|Overall Study|Ongoing|3|||
129065701|NCT03735121|464527646|FG002|Overall Study|Ongoing|26|||
129065702|NCT03735121|464527647|FG003|Overall Study|Ongoing|83|||
129065703|NCT03735121|464527648|FG004|Overall Study|Ongoing|158|||
129065704|NCT00344448|464527649|FG000|Screening|Withdrawal by Subject|0|||
129065705|NCT00344448|464527650|FG001|Screening|Withdrawal by Subject|1|||
129065706|NCT00344448|464527649|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
129065707|NCT00344448|464527650|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
129065708|NCT00344448|464527649|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
129065709|NCT00344448|464527650|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
129065710|NCT00344448|464527649|FG000|Open Label|Withdrawal by Subject|1|||
129065711|NCT00344448|464527650|FG001|Open Label|Withdrawal by Subject|1|||
129065712|NCT00344448|464527649|FG000|Open Label|Study terminated|1|||
129065713|NCT00344448|464527650|FG001|Open Label|Study terminated|0|||
129065714|NCT03138655|464527652|FG000|Overall Study|Adverse Event|2|||
129065715|NCT03138655|464527653|FG001|Overall Study|Adverse Event|1|||
129065716|NCT03138655|464527654|FG002|Overall Study|Adverse Event|2|||
129065717|NCT03138655|464527655|FG003|Overall Study|Adverse Event|1|||
129065718|NCT03138655|464527656|FG004|Overall Study|Adverse Event|1|||
129065719|NCT03138655|464527657|FG005|Overall Study|Adverse Event|4|||
129065720|NCT03138655|464527658|FG006|Overall Study|Adverse Event|2|||
129065721|NCT03138655|464527659|FG007|Overall Study|Adverse Event|2|||
129065722|NCT03138655|464527652|FG000|Overall Study|Withdrawal by Subject|0|||
129065723|NCT03138655|464527653|FG001|Overall Study|Withdrawal by Subject|1|||
129065724|NCT03138655|464527654|FG002|Overall Study|Withdrawal by Subject|0|||
129065725|NCT03138655|464527655|FG003|Overall Study|Withdrawal by Subject|0|||
129065726|NCT03138655|464527656|FG004|Overall Study|Withdrawal by Subject|0|||
129065727|NCT03138655|464527657|FG005|Overall Study|Withdrawal by Subject|0|||
129065728|NCT03138655|464527658|FG006|Overall Study|Withdrawal by Subject|1|||
129065729|NCT03138655|464527659|FG007|Overall Study|Withdrawal by Subject|0|||
129065730|NCT03138655|464527652|FG000|Overall Study|Reason not Specified|1|||
129065731|NCT03138655|464527653|FG001|Overall Study|Reason not Specified|0|||
129065732|NCT03138655|464527654|FG002|Overall Study|Reason not Specified|0|||
129065733|NCT03138655|464527655|FG003|Overall Study|Reason not Specified|2|||
129065734|NCT03138655|464527656|FG004|Overall Study|Reason not Specified|1|||
129065735|NCT03138655|464527657|FG005|Overall Study|Reason not Specified|1|||
129065736|NCT03138655|464527658|FG006|Overall Study|Reason not Specified|0|||
129065737|NCT03138655|464527659|FG007|Overall Study|Reason not Specified|0|||
129065738|NCT02565511|464527660|FG000|Overall Study|Study terminated by Sponsor|35|||
129065739|NCT02565511|464527661|FG001|Overall Study|Study terminated by Sponsor|22|||
129065740|NCT02565511|464527662|FG002|Overall Study|Study terminated by Sponsor|235|||
129065741|NCT02565511|464527663|FG003|Overall Study|Study terminated by Sponsor|156|||
129065742|NCT02565511|464527660|FG000|Overall Study|Withdrawal by Subject|3|||
129065743|NCT02565511|464527661|FG001|Overall Study|Withdrawal by Subject|0|||
129065744|NCT02565511|464527662|FG002|Overall Study|Withdrawal by Subject|12|||
129065745|NCT02565511|464527663|FG003|Overall Study|Withdrawal by Subject|5|||
129065746|NCT02565511|464527660|FG000|Overall Study|Adverse Event|0|||
129065747|NCT02565511|464527661|FG001|Overall Study|Adverse Event|0|||
129065748|NCT02565511|464527662|FG002|Overall Study|Adverse Event|1|||
129065749|NCT02565511|464527663|FG003|Overall Study|Adverse Event|1|||
129065750|NCT02565511|464527660|FG000|Overall Study|Lost to Follow-up|4|||
129065751|NCT02565511|464527661|FG001|Overall Study|Lost to Follow-up|1|||
129065752|NCT02565511|464527662|FG002|Overall Study|Lost to Follow-up|0|||
129065753|NCT02565511|464527663|FG003|Overall Study|Lost to Follow-up|1|||
129065754|NCT02565511|464527660|FG000|Overall Study|Physician Decision|0|||
129065755|NCT02565511|464527661|FG001|Overall Study|Physician Decision|0|||
129065756|NCT02565511|464527662|FG002|Overall Study|Physician Decision|0|||
129065757|NCT02565511|464527663|FG003|Overall Study|Physician Decision|1|||
129065758|NCT02565511|464527660|FG000|Overall Study|Protocol deviation|0|||
129065759|NCT02565511|464527661|FG001|Overall Study|Protocol deviation|0|||
129065760|NCT02565511|464527662|FG002|Overall Study|Protocol deviation|3|||
129065761|NCT02565511|464527663|FG003|Overall Study|Protocol deviation|0|||
129065762|NCT03656744|464527664|FG000|Overall Study|Adverse Event|1|||
129065763|NCT03656744|464527665|FG001|Overall Study|Adverse Event|4|||
129065764|NCT03656744|464527666|FG002|Overall Study|Adverse Event|1|||
128721586|NCT02120950|463277318|FG002|Overall Study|Protocol Violation|7|||
129065765|NCT03656744|464527664|FG000|Overall Study|Protocol Violation|1|||
129065766|NCT03656744|464527665|FG001|Overall Study|Protocol Violation|0|||
128721587|NCT02120950|463277316|FG000|Overall Study|Other reasons|5|||
129065767|NCT03656744|464527666|FG002|Overall Study|Protocol Violation|0|||
129065768|NCT03656744|464527664|FG000|Overall Study|Lost to Follow-up|2|||
129065769|NCT03656744|464527665|FG001|Overall Study|Lost to Follow-up|2|||
129065770|NCT03656744|464527666|FG002|Overall Study|Lost to Follow-up|0|||
129137796|NCT00147537|464796332|FG004|Phase 2|Withdrawal by Subject|0|||
129065771|NCT03656744|464527664|FG000|Overall Study|Withdrawal by Subject|0|||
129065772|NCT03656744|464527665|FG001|Overall Study|Withdrawal by Subject|1|||
129065773|NCT03656744|464527666|FG002|Overall Study|Withdrawal by Subject|0|||
129065774|NCT03656744|464527664|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
129065775|NCT03656744|464527665|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
129065776|NCT03656744|464527666|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
129065777|NCT03910673|464527672|FG000|Overall Study|Adverse Event|0|||
129065778|NCT03910673|464527673|FG001|Overall Study|Adverse Event|0|||
129065779|NCT03910673|464527674|FG002|Overall Study|Adverse Event|0|||
129065780|NCT03910673|464527675|FG003|Overall Study|Adverse Event|2|||
129065781|NCT03910673|464527676|FG004|Overall Study|Adverse Event|0|||
129065782|NCT00098774|464527677|FG000|Overall Study|Adverse Event|2|||
129065783|NCT00098774|464527677|FG000|Overall Study|Disease Progression|9|||
129065784|NCT00098774|464527677|FG000|Overall Study|Withdrawal by Subject|1|||
129065785|NCT00098774|464527677|FG000|Overall Study|Failed (to respond) during induction|4|||
129065786|NCT00098774|464527677|FG000|Overall Study|Physician Decision|2|||
129065787|NCT00796757|464527678|FG000|Overall Study|Withdrawal by Subject|14|||
129065788|NCT00796757|464527678|FG000|Overall Study|Death|61|||
129065789|NCT00796757|464527678|FG000|Overall Study|Protocol Violation|1|||
129065790|NCT00796757|464527678|FG000|Overall Study|Participant noncompliance|1|||
129065791|NCT00796757|464527678|FG000|Overall Study|Investigator's decision|2|||
129065792|NCT00796757|464527678|FG000|Overall Study|Other|7|||
129065793|NCT01277211|464527679|FG000|Overall Study|Adverse Event|60|||
129065794|NCT01277211|464527680|FG001|Overall Study|Adverse Event|22|||
129065795|NCT01277211|464527679|FG000|Overall Study|Pregnancy|9|||
129065796|NCT01277211|464527680|FG001|Overall Study|Pregnancy|4|||
129065797|NCT01277211|464527679|FG000|Overall Study|Lost to Follow-up|14|||
129065798|NCT01277211|464527680|FG001|Overall Study|Lost to Follow-up|9|||
129065799|NCT01277211|464527679|FG000|Overall Study|Did not wish to continue|17|||
129065800|NCT01277211|464527680|FG001|Overall Study|Did not wish to continue|0|||
129065801|NCT01277211|464527679|FG000|Overall Study|Withdrew Consent|9|||
129065802|NCT01277211|464527680|FG001|Overall Study|Withdrew Consent|9|||
129065803|NCT01277211|464527679|FG000|Overall Study|Non-compliance with protocol|13|||
129065804|NCT01277211|464527680|FG001|Overall Study|Non-compliance with protocol|4|||
129065805|NCT01277211|464527679|FG000|Overall Study|Did not meet protocol eligibility|1|||
129065806|NCT01277211|464527680|FG001|Overall Study|Did not meet protocol eligibility|0|||
129065807|NCT01277211|464527679|FG000|Overall Study|Administrative|3|||
129137797|NCT00147537|464796333|FG005|Phase 2|Withdrawal by Subject|0|||
129137798|NCT00147537|464796334|FG006|Phase 2|Withdrawal by Subject|0|||
129137799|NCT00147537|464796335|FG007|Phase 2|Withdrawal by Subject|0|||
129137800|NCT00147537|464796336|FG008|Phase 2|Withdrawal by Subject|0|||
129137801|NCT00147537|464796337|FG009|Phase 2|Withdrawal by Subject|16|||
129137802|NCT00147537|464796338|FG010|Phase 2|Withdrawal by Subject|4|||
129137803|NCT00147537|464796328|FG000|Phase 2|Randomized but not treated|0|||
129137804|NCT00147537|464796329|FG001|Phase 2|Randomized but not treated|0|||
129137805|NCT00147537|464796330|FG002|Phase 2|Randomized but not treated|0|||
129137806|NCT00147537|464796331|FG003|Phase 2|Randomized but not treated|0|||
129137807|NCT00147537|464796332|FG004|Phase 2|Randomized but not treated|0|||
129137808|NCT00147537|464796333|FG005|Phase 2|Randomized but not treated|0|||
129137809|NCT00147537|464796334|FG006|Phase 2|Randomized but not treated|0|||
129137810|NCT00147537|464796335|FG007|Phase 2|Randomized but not treated|0|||
129137811|NCT00147537|464796336|FG008|Phase 2|Randomized but not treated|0|||
129137812|NCT00147537|464796337|FG009|Phase 2|Randomized but not treated|1|||
129137813|NCT00147537|464796338|FG010|Phase 2|Randomized but not treated|1|||
129137814|NCT00345592|464796339|FG000|Overall Study|Death|14|||
129137815|NCT00345592|464796340|FG001|Overall Study|Death|16|||
129137816|NCT00345592|464796339|FG000|Overall Study|Withdrawal by Subject|11|||
129137817|NCT00345592|464796340|FG001|Overall Study|Withdrawal by Subject|8|||
129137818|NCT02006654|464796342|FG000|Overall Study|Withdrawal before treatment|4|||
129065808|NCT01277211|464527680|FG001|Overall Study|Administrative|0|||
129065809|NCT01277211|464527679|FG000|Overall Study|Pregnancy wish|0|||
129137819|NCT02006654|464796343|FG001|Overall Study|Withdrawal before treatment|2|||
129137820|NCT02006654|464796342|FG000|Overall Study|Adverse Event|16|||
129137821|NCT02006654|464796343|FG001|Overall Study|Adverse Event|17|||
129137822|NCT02006654|464796342|FG000|Overall Study|Death|1|||
129137823|NCT02006654|464796343|FG001|Overall Study|Death|0|||
129137824|NCT02006654|464796342|FG000|Overall Study|Withdrawal by Subject|14|||
129137825|NCT02006654|464796343|FG001|Overall Study|Withdrawal by Subject|12|||
129137826|NCT02006654|464796342|FG000|Overall Study|Protocol Violation|5|||
129137827|NCT02006654|464796343|FG001|Overall Study|Protocol Violation|8|||
128721588|NCT02120950|463277317|FG001|Overall Study|Other reasons|4|||
129065810|NCT01277211|464527680|FG001|Overall Study|Pregnancy wish|2|||
129065811|NCT01277211|464527679|FG000|Overall Study|Discontinued prior to treatment|24|||
129065812|NCT01277211|464527680|FG001|Overall Study|Discontinued prior to treatment|13|||
129065813|NCT00879086|464527681|FG000|Overall Study|Adverse Event|3|||
129065814|NCT00879086|464527682|FG001|Overall Study|Adverse Event|15|||
129137828|NCT02006654|464796342|FG000|Overall Study|Lost to Follow-up|1|||
129137829|NCT02006654|464796343|FG001|Overall Study|Lost to Follow-up|0|||
129137830|NCT02006654|464796342|FG000|Overall Study|patient's will|2|||
129137831|NCT02006654|464796343|FG001|Overall Study|patient's will|1|||
129137832|NCT02006654|464796342|FG000|Overall Study|insufficient compliance|1|||
129065815|NCT00879086|464527681|FG000|Overall Study|Participant choice|2|||
129065816|NCT00879086|464527682|FG001|Overall Study|Participant choice|2|||
129065817|NCT00879086|464527681|FG000|Overall Study|Progression of disease|40|||
129065818|NCT00879086|464527682|FG001|Overall Study|Progression of disease|26|||
129065819|NCT00879086|464527681|FG000|Overall Study|Withdrawal of consent|2|||
129065820|NCT00879086|464527682|FG001|Overall Study|Withdrawal of consent|1|||
129065821|NCT00879086|464527681|FG000|Overall Study|Other|4|||
129065822|NCT00879086|464527682|FG001|Overall Study|Other|6|||
129065823|NCT00879086|464527681|FG000|Overall Study|Death|1|||
129065824|NCT00879086|464527682|FG001|Overall Study|Death|2|||
129065825|NCT01487525|464527683|FG000|Overall Study|Withdrawal by Subject|0|||
129065826|NCT01487525|464527684|FG001|Overall Study|Withdrawal by Subject|1|||
129065827|NCT03449446|464527685|FG000|Overall Study|Randomized but Never Treated|0|||
129065828|NCT03449446|464527686|FG001|Overall Study|Randomized but Never Treated|0|||
129065829|NCT03449446|464527687|FG002|Overall Study|Randomized but Never Treated|1|||
129065830|NCT03449446|464527688|FG003|Overall Study|Randomized but Never Treated|1|||
129065831|NCT03449446|464527689|FG004|Overall Study|Randomized but Never Treated|1|||
129065832|NCT03449446|464527690|FG005|Overall Study|Randomized but Never Treated|0|||
129065833|NCT03449446|464527691|FG006|Overall Study|Randomized but Never Treated|0|||
129065834|NCT03449446|464527685|FG000|Overall Study|Unknown Reason|33|||
129065835|NCT03449446|464527686|FG001|Overall Study|Unknown Reason|1|||
129065836|NCT03449446|464527687|FG002|Overall Study|Unknown Reason|1|||
129065837|NCT03449446|464527688|FG003|Overall Study|Unknown Reason|1|||
129065838|NCT03449446|464527689|FG004|Overall Study|Unknown Reason|2|||
129065839|NCT03449446|464527690|FG005|Overall Study|Unknown Reason|2|||
129065840|NCT03449446|464527691|FG006|Overall Study|Unknown Reason|0|||
129065841|NCT03449446|464527685|FG000|Overall Study|Withdrew Consent|1|||
129065842|NCT03449446|464527686|FG001|Overall Study|Withdrew Consent|3|||
129065843|NCT03449446|464527687|FG002|Overall Study|Withdrew Consent|1|||
129065844|NCT03449446|464527688|FG003|Overall Study|Withdrew Consent|4|||
129065845|NCT03449446|464527689|FG004|Overall Study|Withdrew Consent|4|||
129065846|NCT03449446|464527690|FG005|Overall Study|Withdrew Consent|4|||
129065847|NCT03449446|464527691|FG006|Overall Study|Withdrew Consent|1|||
129065848|NCT03449446|464527685|FG000|Overall Study|Adverse Event|1|||
129065849|NCT03449446|464527686|FG001|Overall Study|Adverse Event|2|||
129137833|NCT02006654|464796343|FG001|Overall Study|insufficient compliance|0|||
129137834|NCT02006654|464796342|FG000|Overall Study|worsening cognitive condition|0|||
129137835|NCT02006654|464796343|FG001|Overall Study|worsening cognitive condition|1|||
129137836|NCT02006654|464796342|FG000|Overall Study|faecal incontinence|0|||
129137837|NCT02006654|464796343|FG001|Overall Study|faecal incontinence|1|||
129137838|NCT02006654|464796342|FG000|Overall Study|mood disorder|0|||
129137839|NCT02006654|464796343|FG001|Overall Study|mood disorder|1|||
129137840|NCT02006654|464796342|FG000|Overall Study|disallowed medication|1|||
129137841|NCT02006654|464796343|FG001|Overall Study|disallowed medication|0|||
129137842|NCT02006654|464796342|FG000|Overall Study|moving out of state|0|||
129137843|NCT02006654|464796343|FG001|Overall Study|moving out of state|1|||
129137844|NCT03438656|464796344|FG000|Overall Study|Lost to Follow-up|2|||
129137845|NCT03721965|464796345|FG000|Overall Study|Death|1|||
129137846|NCT03721965|464796345|FG000|Overall Study|Study Terminated by Sponsor|1|||
129137847|NCT00563316|464796346|FG000|Overall Study|Adverse Event|2|||
129137848|NCT00563316|464796346|FG000|Overall Study|Physician Decision|1|||
129137849|NCT00563316|464796346|FG000|Overall Study|Lost to Follow-up|2|||
129137850|NCT00563316|464796346|FG000|Overall Study|Death|1|||
129137851|NCT00563316|464796346|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
129137852|NCT00563316|464796346|FG000|Overall Study|Other|1|||
129137853|NCT01108055|464796353|FG000|Overall Study|Ineligible|11|||
129137854|NCT01108055|464796353|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
129137855|NCT03339453|464796355|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
129137856|NCT03339453|464796356|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
129137857|NCT00800384|464796359|FG000|Overall Study|Withdrawal by Subject|24|||
129137858|NCT00800384|464796360|FG001|Overall Study|Withdrawal by Subject|17|||
129137859|NCT00800384|464796359|FG000|Overall Study|Lost to Follow-up|17|||
128721589|NCT02120950|463277318|FG002|Overall Study|Other reasons|1|||
129065850|NCT03449446|464527687|FG002|Overall Study|Adverse Event|1|||
129065851|NCT03449446|464527688|FG003|Overall Study|Adverse Event|0|||
129065852|NCT03449446|464527689|FG004|Overall Study|Adverse Event|0|||
129065853|NCT03449446|464527690|FG005|Overall Study|Adverse Event|2|||
129065854|NCT03449446|464527691|FG006|Overall Study|Adverse Event|0|||
129065855|NCT03449446|464527685|FG000|Overall Study|Lost to Follow-up|0|||
129065856|NCT03449446|464527686|FG001|Overall Study|Lost to Follow-up|0|||
129065857|NCT03449446|464527687|FG002|Overall Study|Lost to Follow-up|2|||
129137860|NCT00800384|464796360|FG001|Overall Study|Lost to Follow-up|26|||
129137861|NCT00450749|464796363|FG000|Overall Study|Withdrawal by Subject|0|||
129137862|NCT00450749|464796364|FG001|Overall Study|Withdrawal by Subject|0|||
129137863|NCT00450749|464796365|FG002|Overall Study|Withdrawal by Subject|2|||
129137864|NCT00450749|464796363|FG000|Overall Study|Noncompliant|0|||
129137865|NCT00450749|464796364|FG001|Overall Study|Noncompliant|1|||
129137866|NCT00450749|464796365|FG002|Overall Study|Noncompliant|0|||
129065858|NCT03449446|464527688|FG003|Overall Study|Lost to Follow-up|1|||
129065859|NCT03449446|464527689|FG004|Overall Study|Lost to Follow-up|3|||
129065860|NCT03449446|464527690|FG005|Overall Study|Lost to Follow-up|0|||
129065861|NCT03449446|464527691|FG006|Overall Study|Lost to Follow-up|0|||
129065862|NCT03449446|464527685|FG000|Overall Study|Investigator's Discretion|0|||
129065863|NCT03449446|464527686|FG001|Overall Study|Investigator's Discretion|1|||
129065864|NCT03449446|464527687|FG002|Overall Study|Investigator's Discretion|1|||
129065865|NCT03449446|464527688|FG003|Overall Study|Investigator's Discretion|2|||
129065866|NCT03449446|464527689|FG004|Overall Study|Investigator's Discretion|0|||
129065867|NCT03449446|464527690|FG005|Overall Study|Investigator's Discretion|0|||
129065868|NCT03449446|464527691|FG006|Overall Study|Investigator's Discretion|0|||
129065869|NCT03449446|464527685|FG000|Overall Study|Non Compliance with Study Drug|1|||
129065870|NCT03449446|464527686|FG001|Overall Study|Non Compliance with Study Drug|0|||
129065871|NCT03449446|464527687|FG002|Overall Study|Non Compliance with Study Drug|0|||
128721590|NCT02120950|463277316|FG000|Overall Study|Lost to Follow-up|0|||
129065872|NCT03449446|464527688|FG003|Overall Study|Non Compliance with Study Drug|0|||
129065873|NCT03449446|464527689|FG004|Overall Study|Non Compliance with Study Drug|0|||
129065874|NCT03449446|464527690|FG005|Overall Study|Non Compliance with Study Drug|0|||
129065875|NCT03449446|464527691|FG006|Overall Study|Non Compliance with Study Drug|0|||
129065876|NCT03449446|464527685|FG000|Overall Study|Protocol Violation|0|||
129065877|NCT03449446|464527686|FG001|Overall Study|Protocol Violation|0|||
129065878|NCT03449446|464527687|FG002|Overall Study|Protocol Violation|0|||
129065879|NCT03449446|464527688|FG003|Overall Study|Protocol Violation|0|||
129065880|NCT03449446|464527689|FG004|Overall Study|Protocol Violation|1|||
129065881|NCT03449446|464527690|FG005|Overall Study|Protocol Violation|1|||
129065882|NCT03449446|464527691|FG006|Overall Study|Protocol Violation|0|||
129065883|NCT03449446|464527685|FG000|Overall Study|Death|0|||
129065884|NCT03449446|464527686|FG001|Overall Study|Death|0|||
129065885|NCT03449446|464527687|FG002|Overall Study|Death|0|||
129065886|NCT03449446|464527688|FG003|Overall Study|Death|0|||
129065887|NCT03449446|464527689|FG004|Overall Study|Death|1|||
129065888|NCT03449446|464527690|FG005|Overall Study|Death|0|||
129065889|NCT03449446|464527691|FG006|Overall Study|Death|0|||
129065890|NCT01450683|464527712|FG000|Overall Study|Adverse Event|2|||
129065891|NCT02108912|464527714|FG000|Overall Study|Lost to Follow-up|1|||
129065892|NCT02108912|464527715|FG001|Overall Study|Lost to Follow-up|1|||
129065893|NCT02108912|464527714|FG000|Overall Study|lack of transportation|1|||
129065894|NCT02108912|464527715|FG001|Overall Study|lack of transportation|0|||
129065895|NCT02108912|464527714|FG000|Overall Study|high blood pressure|1|||
129065896|NCT02108912|464527715|FG001|Overall Study|high blood pressure|0|||
129137867|NCT01245049|464796368|FG000|Overall Study|Migrated/moved from study area|0|||
129137868|NCT01245049|464796369|FG001|Overall Study|Migrated/moved from study area|1|||
129137869|NCT01245049|464796368|FG000|Overall Study|Withdrawal by Subject|0|||
129137870|NCT01245049|464796369|FG001|Overall Study|Withdrawal by Subject|1|||
129137871|NCT01245049|464796368|FG000|Overall Study|Lost to Follow-up|1|||
129137872|NCT01245049|464796369|FG001|Overall Study|Lost to Follow-up|2|||
129137873|NCT01027754|464798344|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
129137874|NCT01027754|464798345|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
129137875|NCT01027754|464798344|FG000|Overall Study|Withdrawal by Subject|0|||
129137876|NCT01027754|464798345|FG001|Overall Study|Withdrawal by Subject|5|||
129137877|NCT01213251|464798346|FG000|Overall Study|Death|2|||
129137878|NCT01213251|464798347|FG001|Overall Study|Death|1|||
129137879|NCT01213251|464798348|FG002|Overall Study|Death|2|||
129137880|NCT01213251|464798346|FG000|Overall Study|Exit|3|||
129137881|NCT01213251|464798347|FG001|Overall Study|Exit|2|||
129137882|NCT01213251|464798348|FG002|Overall Study|Exit|8|||
129137883|NCT01213251|464798346|FG000|Overall Study|Protocol Violation|1|||
129137884|NCT01213251|464798347|FG001|Overall Study|Protocol Violation|1|||
129137885|NCT01213251|464798348|FG002|Overall Study|Protocol Violation|0|||
129137886|NCT01213251|464798346|FG000|Overall Study|Missed 18-Month Follow-up|0|||
129137887|NCT01213251|464798347|FG001|Overall Study|Missed 18-Month Follow-up|0|||
129137888|NCT01213251|464798348|FG002|Overall Study|Missed 18-Month Follow-up|1|||
129137889|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
128721591|NCT02120950|463277317|FG001|Overall Study|Lost to Follow-up|2|||
128721592|NCT02120950|463277318|FG002|Overall Study|Lost to Follow-up|1|||
128721593|NCT02738333|463277322|FG000|Overall Study|Death|1|||
128721594|NCT02738333|463277323|FG001|Overall Study|Death|0|||
129065897|NCT01950390|464527716|FG000|Overall Study|Never started treatment|3|||
129065898|NCT01950390|464527717|FG001|Overall Study|Never started treatment|2|||
129065899|NCT01950390|464527716|FG000|Overall Study|Disease progression|45|||
129065900|NCT01950390|464527717|FG001|Overall Study|Disease progression|52|||
129065901|NCT01950390|464527716|FG000|Overall Study|Adverse Event|22|||
128721595|NCT02738333|463277324|FG002|Overall Study|Death|0|||
129065902|NCT01950390|464527717|FG001|Overall Study|Adverse Event|16|||
129137890|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129137891|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129137892|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129137893|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129065903|NCT01950390|464527716|FG000|Overall Study|Death|5|||
129065904|NCT01950390|464527717|FG001|Overall Study|Death|3|||
129065905|NCT01950390|464527716|FG000|Overall Study|Withdrawal by Subject|5|||
129065906|NCT01950390|464527717|FG001|Overall Study|Withdrawal by Subject|1|||
129065907|NCT01950390|464527716|FG000|Overall Study|Alternative therapy|0|||
129065908|NCT01950390|464527717|FG001|Overall Study|Alternative therapy|3|||
129065909|NCT01950390|464527716|FG000|Overall Study|Complicating disease|1|||
129065910|NCT01950390|464527717|FG001|Overall Study|Complicating disease|0|||
129065911|NCT01950390|464527716|FG000|Overall Study|On treatment|1|||
129065912|NCT01950390|464527717|FG001|Overall Study|On treatment|0|||
129065913|NCT01950390|464527716|FG000|Overall Study|Symptomatic deterioration|2|||
129065914|NCT01950390|464527717|FG001|Overall Study|Symptomatic deterioration|1|||
129065915|NCT01950390|464527716|FG000|Overall Study|Physician Decision|0|||
129065916|NCT01950390|464527717|FG001|Overall Study|Physician Decision|4|||
129065917|NCT01950390|464527716|FG000|Overall Study|Lack of clinical benefit|0|||
129065918|NCT01950390|464527717|FG001|Overall Study|Lack of clinical benefit|1|||
129065919|NCT01950390|464527716|FG000|Overall Study|Maintained PR and moved to observation only|0|||
129065920|NCT01950390|464527717|FG001|Overall Study|Maintained PR and moved to observation only|1|||
129065921|NCT01128179|464527718|FG000|Overall Study|Death|1|||
129065922|NCT01128179|464527719|FG001|Overall Study|Death|0|||
129065923|NCT01128179|464527718|FG000|Overall Study|Protocol Violation|1|||
129065924|NCT01128179|464527719|FG001|Overall Study|Protocol Violation|0|||
129065925|NCT01682811|464527720|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129065926|NCT01682811|464527721|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129065927|NCT01682811|464527722|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129065928|NCT01682811|464527723|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129065929|NCT01682811|464527724|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
129065930|NCT01682811|464527725|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129065931|NCT01682811|464527726|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129065932|NCT01682811|464527720|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
129065933|NCT01682811|464527721|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
129065934|NCT01682811|464527722|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
129065935|NCT01682811|464527723|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
129065936|NCT01682811|464527724|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
129065937|NCT01682811|464527725|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
129065938|NCT01682811|464527726|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
129065939|NCT01682811|464527720|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
129065940|NCT01682811|464527721|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
128721596|NCT02738333|463277322|FG000|Overall Study|Lost to Follow-up|1|||
128721597|NCT02738333|463277323|FG001|Overall Study|Lost to Follow-up|0|||
128721598|NCT02738333|463277324|FG002|Overall Study|Lost to Follow-up|0|||
128721599|NCT00579826|463277325|FG000|Overall Study|Withdrawal by Subject|5|||
128721600|NCT00579826|463277326|FG001|Overall Study|Withdrawal by Subject|3|||
128721601|NCT02205333|463277329|FG000|Overall Study|Death|5|||
128721602|NCT02205333|463277330|FG001|Overall Study|Death|6|||
128721603|NCT02205333|463277331|FG002|Overall Study|Death|2|||
128721604|NCT02205333|463277332|FG003|Overall Study|Death|6|||
128721605|NCT02205333|463277333|FG004|Overall Study|Death|5|||
128721606|NCT02205333|463277334|FG005|Overall Study|Death|3|||
128721607|NCT02205333|463277335|FG006|Overall Study|Death|3|||
128721608|NCT02205333|463277336|FG007|Overall Study|Death|2|||
128721609|NCT02205333|463277337|FG008|Overall Study|Death|0|||
128721610|NCT02205333|463277329|FG000|Overall Study|Withdrawal by Subject|1|||
128721611|NCT02205333|463277330|FG001|Overall Study|Withdrawal by Subject|0|||
128721612|NCT02205333|463277331|FG002|Overall Study|Withdrawal by Subject|0|||
128721613|NCT02205333|463277332|FG003|Overall Study|Withdrawal by Subject|1|||
128721614|NCT02205333|463277333|FG004|Overall Study|Withdrawal by Subject|0|||
129065941|NCT01682811|464527722|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
129065942|NCT01682811|464527723|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
129065943|NCT01682811|464527724|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
129065944|NCT01682811|464527725|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
129065945|NCT01682811|464527726|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
129065946|NCT01682811|464527720|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
129065947|NCT01682811|464527721|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
129065948|NCT01682811|464527722|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
129065949|NCT01682811|464527723|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
129065950|NCT01682811|464527724|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
129065951|NCT01682811|464527725|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
128721615|NCT02205333|463277334|FG005|Overall Study|Withdrawal by Subject|0|||
128721616|NCT02205333|463277335|FG006|Overall Study|Withdrawal by Subject|2|||
129065952|NCT01682811|464527726|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
128721617|NCT02205333|463277336|FG007|Overall Study|Withdrawal by Subject|0|||
128721618|NCT02205333|463277337|FG008|Overall Study|Withdrawal by Subject|0|||
128721619|NCT02009046|463277338|FG000|Overall Study|Lost to Follow-up|256|||
129065953|NCT05192889|464527727|FG000|Block 1: All Eligible Patients|Death|2|||
129065954|NCT05192889|464527728|FG001|Block 1: All Eligible Patients|Death|0|||
129065955|NCT05192889|464527729|FG002|Block 1: All Eligible Patients|Death|0|||
128721620|NCT02009046|463277339|FG001|Overall Study|Lost to Follow-up|206|||
128721621|NCT00304356|463277345|FG000|Nitazoxanide|Physician Decision|5|||
128721622|NCT00304356|463277345|FG000|Nitazoxanide|Physician Decision|1|||
128721623|NCT00304356|463277345|FG000|Nitazoxanide|number is 0|1|||
128721624|NCT00304356|463277345|FG000|Nitazoxanide|Physician Decision|1|||
128721625|NCT00304356|463277345|FG000|Nitazoxanide|Physician Decision|1|||
128721626|NCT00304356|463277345|FG000|Nitazoxanide|Physician Decision|1|||
128721627|NCT01154218|463277346|FG000|Third Intervention Period|Adverse Event|0|||
128721628|NCT01154218|463277347|FG001|Third Intervention Period|Adverse Event|1|||
128721629|NCT01154218|463277348|FG002|Third Intervention Period|Adverse Event|0|||
128721630|NCT01154218|463277349|FG003|Third Intervention Period|Adverse Event|0|||
128721631|NCT01154218|463277346|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
128721632|NCT01154218|463277347|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
128721633|NCT01154218|463277348|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
128721634|NCT01154218|463277349|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
128721635|NCT01154218|463277346|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
128721636|NCT01154218|463277347|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
128721637|NCT01154218|463277348|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
128721638|NCT01154218|463277349|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
128721639|NCT02140567|463277352|FG000|Overall Study|Problems with recording equipment|6|||
128721640|NCT02882854|463277353|FG000|Overall Study|Lost to Follow-up|1|||
128721641|NCT02882854|463277354|FG001|Overall Study|Lost to Follow-up|2|||
128721642|NCT02882854|463277353|FG000|Overall Study|Physician Decision|0|||
128721643|NCT02882854|463277354|FG001|Overall Study|Physician Decision|1|||
128721644|NCT01358357|463277358|FG000|Open Label Phase|Adverse Event|0|||
128721645|NCT01358357|463277359|FG001|Open Label Phase|Adverse Event|0|||
128721646|NCT01358357|463277360|FG002|Open Label Phase|Adverse Event|59|||
128721647|NCT01358357|463277358|FG000|Open Label Phase|Lack of Efficacy|0|||
128721648|NCT01358357|463277359|FG001|Open Label Phase|Lack of Efficacy|0|||
128721649|NCT01358357|463277360|FG002|Open Label Phase|Lack of Efficacy|107|||
128721650|NCT01358357|463277358|FG000|Open Label Phase|Lost to Follow-up|0|||
128721651|NCT01358357|463277359|FG001|Open Label Phase|Lost to Follow-up|0|||
128721652|NCT01358357|463277360|FG002|Open Label Phase|Lost to Follow-up|76|||
128721653|NCT01358357|463277358|FG000|Open Label Phase|Protocol Violation|0|||
128721654|NCT01358357|463277359|FG001|Open Label Phase|Protocol Violation|0|||
128721655|NCT01358357|463277360|FG002|Open Label Phase|Protocol Violation|45|||
128721656|NCT01358357|463277358|FG000|Open Label Phase|Withdrawal by Subject|0|||
128721657|NCT01358357|463277359|FG001|Open Label Phase|Withdrawal by Subject|0|||
128721658|NCT01358357|463277360|FG002|Open Label Phase|Withdrawal by Subject|112|||
128721659|NCT01358357|463277358|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
128721660|NCT01358357|463277359|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
128721661|NCT01358357|463277360|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
129065956|NCT05192889|464527727|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
129065957|NCT05192889|464527728|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
129065958|NCT05192889|464527729|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
129065959|NCT05192889|464527727|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
129065960|NCT05192889|464527728|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
129065961|NCT05192889|464527729|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
129065962|NCT02731638|464529710|FG000|Overall Study|Lost to Follow-up|6|||
129065963|NCT02731638|464529711|FG001|Overall Study|Lost to Follow-up|9|||
129065964|NCT03284723|464529712|FG000|Overall Study|Death|0|||
129065965|NCT03284723|464529713|FG001|Overall Study|Death|0|||
129065966|NCT03284723|464529714|FG002|Overall Study|Death|0|||
129065967|NCT03284723|464529715|FG003|Overall Study|Death|1|||
129065968|NCT03284723|464529716|FG004|Overall Study|Death|0|||
129065969|NCT03284723|464529717|FG005|Overall Study|Death|0|||
129065970|NCT03284723|464529718|FG006|Overall Study|Death|1|||
129065971|NCT03284723|464529719|FG007|Overall Study|Death|0|||
128721662|NCT01358357|463277358|FG000|Open Label Phase|Terminated at study completion|0|||
128721663|NCT01358357|463277359|FG001|Open Label Phase|Terminated at study completion|0|||
128721664|NCT01358357|463277360|FG002|Open Label Phase|Terminated at study completion|5|||
128721665|NCT01358357|463277358|FG000|Open Label Phase|Mood episode|0|||
128775847|NCT02584855|463468489|FG002|Open-Label Treatment Period|No PI Available|0|||
128775848|NCT02584855|463468490|FG003|Open-Label Treatment Period|No PI Available|0|||
129065972|NCT03284723|464529720|FG008|Overall Study|Death|0|||
129065973|NCT03284723|464529721|FG009|Overall Study|Death|2|||
128721666|NCT01358357|463277359|FG001|Open Label Phase|Mood episode|0|||
128721667|NCT01358357|463277360|FG002|Open Label Phase|Mood episode|42|||
128721668|NCT01358357|463277358|FG000|Double-Blind Phase|Adverse Event|8|||
128721669|NCT01358357|463277359|FG001|Double-Blind Phase|Adverse Event|5|||
128721670|NCT01358357|463277360|FG002|Double-Blind Phase|Adverse Event|0|||
128721671|NCT01358357|463277358|FG000|Double-Blind Phase|Lost to Follow-up|5|||
128721672|NCT01358357|463277359|FG001|Double-Blind Phase|Lost to Follow-up|7|||
128721673|NCT01358357|463277360|FG002|Double-Blind Phase|Lost to Follow-up|0|||
128721674|NCT01358357|463277358|FG000|Double-Blind Phase|Protocol Violation|1|||
129065974|NCT03284723|464529722|FG010|Overall Study|Death|1|||
129065975|NCT03284723|464529723|FG011|Overall Study|Death|0|||
129065976|NCT03284723|464529712|FG000|Overall Study|Lost to Follow-up|0|||
129065977|NCT03284723|464529713|FG001|Overall Study|Lost to Follow-up|0|||
129065978|NCT03284723|464529714|FG002|Overall Study|Lost to Follow-up|0|||
128721675|NCT01358357|463277359|FG001|Double-Blind Phase|Protocol Violation|11|||
128721676|NCT01358357|463277360|FG002|Double-Blind Phase|Protocol Violation|0|||
128721677|NCT01358357|463277358|FG000|Double-Blind Phase|Protocol Violation|16|||
129065979|NCT03284723|464529715|FG003|Overall Study|Lost to Follow-up|0|||
129065980|NCT03284723|464529716|FG004|Overall Study|Lost to Follow-up|0|||
129065981|NCT03284723|464529717|FG005|Overall Study|Lost to Follow-up|2|||
129065982|NCT03284723|464529718|FG006|Overall Study|Lost to Follow-up|1|||
129065983|NCT03284723|464529719|FG007|Overall Study|Lost to Follow-up|0|||
129065984|NCT03284723|464529720|FG008|Overall Study|Lost to Follow-up|0|||
129065985|NCT03284723|464529721|FG009|Overall Study|Lost to Follow-up|2|||
129065986|NCT03284723|464529722|FG010|Overall Study|Lost to Follow-up|0|||
129065987|NCT03284723|464529723|FG011|Overall Study|Lost to Follow-up|0|||
129065988|NCT03284723|464529712|FG000|Overall Study|Study Terminated By Sponsor|0|||
129065989|NCT03284723|464529713|FG001|Overall Study|Study Terminated By Sponsor|0|||
129065990|NCT03284723|464529714|FG002|Overall Study|Study Terminated By Sponsor|0|||
129065991|NCT03284723|464529715|FG003|Overall Study|Study Terminated By Sponsor|0|||
129065992|NCT03284723|464529716|FG004|Overall Study|Study Terminated By Sponsor|1|||
129065993|NCT03284723|464529717|FG005|Overall Study|Study Terminated By Sponsor|0|||
129065994|NCT03284723|464529718|FG006|Overall Study|Study Terminated By Sponsor|0|||
129065995|NCT03284723|464529719|FG007|Overall Study|Study Terminated By Sponsor|0|||
129065996|NCT03284723|464529720|FG008|Overall Study|Study Terminated By Sponsor|1|||
129065997|NCT03284723|464529721|FG009|Overall Study|Study Terminated By Sponsor|1|||
129065998|NCT03284723|464529722|FG010|Overall Study|Study Terminated By Sponsor|1|||
129065999|NCT03284723|464529723|FG011|Overall Study|Study Terminated By Sponsor|1|||
129066000|NCT03284723|464529712|FG000|Overall Study|Withdrawal by Subject|0|||
129066001|NCT03284723|464529713|FG001|Overall Study|Withdrawal by Subject|0|||
129066002|NCT03284723|464529714|FG002|Overall Study|Withdrawal by Subject|0|||
128721678|NCT01358357|463277359|FG001|Double-Blind Phase|Protocol Violation|12|||
128721679|NCT01358357|463277360|FG002|Double-Blind Phase|Protocol Violation|0|||
128721680|NCT01358357|463277358|FG000|Double-Blind Phase|Terminated at study completion|2|||
128721681|NCT01358357|463277359|FG001|Double-Blind Phase|Terminated at study completion|0|||
128721682|NCT01358357|463277360|FG002|Double-Blind Phase|Terminated at study completion|0|||
129066003|NCT03284723|464529715|FG003|Overall Study|Withdrawal by Subject|0|||
129066004|NCT03284723|464529716|FG004|Overall Study|Withdrawal by Subject|5|||
129066005|NCT03284723|464529717|FG005|Overall Study|Withdrawal by Subject|3|||
129066006|NCT03284723|464529718|FG006|Overall Study|Withdrawal by Subject|1|||
129066007|NCT03284723|464529719|FG007|Overall Study|Withdrawal by Subject|0|||
129066008|NCT03284723|464529720|FG008|Overall Study|Withdrawal by Subject|6|||
129066009|NCT03284723|464529721|FG009|Overall Study|Withdrawal by Subject|0|||
129066010|NCT03284723|464529722|FG010|Overall Study|Withdrawal by Subject|3|||
129066011|NCT03284723|464529723|FG011|Overall Study|Withdrawal by Subject|1|||
129066012|NCT03284723|464529712|FG000|Overall Study|Other|1|||
129066013|NCT03284723|464529713|FG001|Overall Study|Other|0|||
129066014|NCT03284723|464529714|FG002|Overall Study|Other|1|||
129066015|NCT03284723|464529715|FG003|Overall Study|Other|0|||
129066016|NCT03284723|464529716|FG004|Overall Study|Other|1|||
129066017|NCT03284723|464529717|FG005|Overall Study|Other|0|||
129066018|NCT03284723|464529718|FG006|Overall Study|Other|0|||
129066019|NCT03284723|464529719|FG007|Overall Study|Other|0|||
129066020|NCT03284723|464529720|FG008|Overall Study|Other|0|||
129066021|NCT03284723|464529721|FG009|Overall Study|Other|0|||
129066022|NCT03284723|464529722|FG010|Overall Study|Other|1|||
128721683|NCT01358357|463277358|FG000|Double-Blind Phase|Recurrence of mood event|48|||
129066023|NCT03284723|464529723|FG011|Overall Study|Other|0|||
129066024|NCT03284723|464529712|FG000|Overall Study|Adverse Event|0|||
129066025|NCT03284723|464529713|FG001|Overall Study|Adverse Event|0|||
129066026|NCT03284723|464529714|FG002|Overall Study|Adverse Event|0|||
129066027|NCT03284723|464529715|FG003|Overall Study|Adverse Event|0|||
129066028|NCT03284723|464529716|FG004|Overall Study|Adverse Event|0|||
129066029|NCT03284723|464529717|FG005|Overall Study|Adverse Event|0|||
129066030|NCT03284723|464529718|FG006|Overall Study|Adverse Event|0|||
129066031|NCT03284723|464529719|FG007|Overall Study|Adverse Event|0|||
129066032|NCT03284723|464529720|FG008|Overall Study|Adverse Event|1|||
129066033|NCT03284723|464529721|FG009|Overall Study|Adverse Event|0|||
129066034|NCT03284723|464529722|FG010|Overall Study|Adverse Event|0|||
129066035|NCT03284723|464529723|FG011|Overall Study|Adverse Event|0|||
128721684|NCT01358357|463277359|FG001|Double-Blind Phase|Recurrence of mood event|64|||
128721685|NCT01358357|463277360|FG002|Double-Blind Phase|Recurrence of mood event|0|||
129066036|NCT00615199|464529724|FG000|Overall Study|Adverse Event|3|||
129066037|NCT00615199|464529725|FG001|Overall Study|Adverse Event|1|||
129066038|NCT00615199|464529726|FG002|Overall Study|Adverse Event|1|||
129066039|NCT00615199|464529727|FG003|Overall Study|Adverse Event|0|||
129066040|NCT00615199|464529724|FG000|Overall Study|Lack of Efficacy|2|||
129066041|NCT00615199|464529725|FG001|Overall Study|Lack of Efficacy|0|||
129066042|NCT00615199|464529726|FG002|Overall Study|Lack of Efficacy|0|||
129066043|NCT00615199|464529727|FG003|Overall Study|Lack of Efficacy|1|||
129066044|NCT00615199|464529724|FG000|Overall Study|Lost to Follow-up|1|||
128721686|NCT01358357|463277358|FG000|Double-Blind Phase|Administrative|0|||
128721687|NCT01358357|463277359|FG001|Double-Blind Phase|Administrative|1|||
128721688|NCT01358357|463277360|FG002|Double-Blind Phase|Administrative|0|||
128721689|NCT02136576|463277361|FG000|Overall Study|Lost to Follow-up|2|||
129066045|NCT00615199|464529725|FG001|Overall Study|Lost to Follow-up|0|||
129066046|NCT00615199|464529726|FG002|Overall Study|Lost to Follow-up|0|||
129066047|NCT00615199|464529727|FG003|Overall Study|Lost to Follow-up|0|||
129066048|NCT00615199|464529724|FG000|Overall Study|Other|0|||
129066049|NCT00615199|464529725|FG001|Overall Study|Other|0|||
129066050|NCT00615199|464529726|FG002|Overall Study|Other|0|||
129066051|NCT00615199|464529727|FG003|Overall Study|Other|1|||
129066052|NCT00615199|464529724|FG000|Overall Study|Withdrawal by Subject|2|||
129066053|NCT00615199|464529725|FG001|Overall Study|Withdrawal by Subject|1|||
129066054|NCT00615199|464529726|FG002|Overall Study|Withdrawal by Subject|0|||
129066055|NCT00615199|464529727|FG003|Overall Study|Withdrawal by Subject|0|||
129066056|NCT02121652|464529730|FG000|Overall Study|Lost to Follow-up|2|||
129066057|NCT02121652|464529731|FG001|Overall Study|Lost to Follow-up|1|||
129066058|NCT02121652|464529730|FG000|Overall Study|Death|1|||
129066059|NCT02121652|464529731|FG001|Overall Study|Death|0|||
129066060|NCT02121652|464529730|FG000|Overall Study|Withdrawal by Subject|3|||
129066061|NCT02121652|464529731|FG001|Overall Study|Withdrawal by Subject|3|||
129066062|NCT01232452|464529732|FG000|Overall Study|Adverse Event|17|||
129066063|NCT01232452|464529733|FG001|Overall Study|Adverse Event|15|||
129066064|NCT01232452|464529732|FG000|Overall Study|Withdrawal by Subject|11|||
129066065|NCT01232452|464529733|FG001|Overall Study|Withdrawal by Subject|8|||
129066066|NCT01232452|464529732|FG000|Overall Study|Physician Decision|8|||
129066067|NCT01232452|464529733|FG001|Overall Study|Physician Decision|12|||
129066068|NCT01232452|464529732|FG000|Overall Study|Protocol entry criterion not met|0|||
129066069|NCT01232452|464529733|FG001|Overall Study|Protocol entry criterion not met|2|||
129066070|NCT01232452|464529732|FG000|Overall Study|Sponsor Decision|3|||
129066071|NCT01232452|464529733|FG001|Overall Study|Sponsor Decision|1|||
129066072|NCT01232452|464529732|FG000|Overall Study|Protocol Violation|0|||
129066073|NCT01232452|464529733|FG001|Overall Study|Protocol Violation|1|||
129066074|NCT05024747|464529734|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
129066075|NCT05024747|464529735|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
129066076|NCT05024747|464529734|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
129066077|NCT05024747|464529735|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
129066078|NCT05024747|464529734|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
129066079|NCT05024747|464529735|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
129066080|NCT00662649|464529736|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
129066081|NCT00662649|464529737|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
129066082|NCT00662649|464529738|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
129066083|NCT00662649|464529739|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
129066084|NCT00662649|464529740|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
129066085|NCT00662649|464529736|FG000|Core Study (24 Months)|Adverse Event|22|||
129066086|NCT00662649|464529737|FG001|Core Study (24 Months)|Adverse Event|13|||
129066087|NCT00662649|464529738|FG002|Core Study (24 Months)|Adverse Event|18|||
129066088|NCT00662649|464529739|FG003|Core Study (24 Months)|Adverse Event|0|||
129066089|NCT00662649|464529740|FG004|Core Study (24 Months)|Adverse Event|0|||
129066090|NCT00662649|464529736|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
129066091|NCT00662649|464529737|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
129066092|NCT00662649|464529738|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
129066093|NCT00662649|464529739|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
129066094|NCT00662649|464529740|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
129066095|NCT00662649|464529736|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
129066096|NCT00662649|464529737|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
129066097|NCT00662649|464529738|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
129066098|NCT00662649|464529739|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
129066099|NCT00662649|464529740|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
129066100|NCT00662649|464529736|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
129066101|NCT00662649|464529737|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
129137894|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
129137895|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
128721690|NCT02136576|463277362|FG001|Overall Study|Lost to Follow-up|0|||
128721691|NCT02136576|463277363|FG002|Overall Study|Lost to Follow-up|0|||
128721692|NCT00537381|463277364|FG000|Overall Study|Adverse Event|13|||
129066102|NCT00662649|464529738|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
129066103|NCT00662649|464529739|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
129066104|NCT00662649|464529740|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
129066105|NCT00662649|464529736|FG000|Core Study (24 Months)|Protocol Violation|5|||
129066106|NCT00662649|464529737|FG001|Core Study (24 Months)|Protocol Violation|5|||
129066107|NCT00662649|464529738|FG002|Core Study (24 Months)|Protocol Violation|4|||
129066108|NCT00662649|464529739|FG003|Core Study (24 Months)|Protocol Violation|0|||
128721693|NCT00537381|463277365|FG001|Overall Study|Adverse Event|9|||
129066109|NCT00662649|464529740|FG004|Core Study (24 Months)|Protocol Violation|0|||
129066110|NCT00662649|464529736|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
129066111|NCT00662649|464529737|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
129066112|NCT00662649|464529738|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
129066113|NCT00662649|464529739|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
129066114|NCT00662649|464529740|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
129066115|NCT00662649|464529736|FG000|Core Study (24 Months)|Death|1|||
129066116|NCT00662649|464529737|FG001|Core Study (24 Months)|Death|0|||
129066117|NCT00662649|464529738|FG002|Core Study (24 Months)|Death|2|||
129066118|NCT00662649|464529739|FG003|Core Study (24 Months)|Death|0|||
129066119|NCT00662649|464529740|FG004|Core Study (24 Months)|Death|0|||
129066120|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
129066121|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
129066122|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
129066123|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
129066124|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
129066125|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
129066126|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
129066127|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
129066128|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
129066129|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
129066130|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
129066131|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
129066132|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
129066133|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
129066134|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
129066135|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
129066136|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
129066137|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
129066138|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
129066139|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
129066140|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
129066141|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
129066142|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
129066143|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
129066144|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
129066145|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
129066146|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
129066147|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
129066148|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
129066149|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
129066150|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
129066151|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
129066152|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
129066153|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
129066154|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
129066155|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129066156|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
129066157|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129066158|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129137896|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
129137897|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129137898|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
129137899|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129137900|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129137901|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129137902|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129137903|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
129137904|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129137905|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129137906|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128721694|NCT00537381|463277364|FG000|Overall Study|Death|3|||
129066159|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129066160|NCT00662649|464529736|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
129137907|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129066161|NCT00662649|464529737|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
129066162|NCT00662649|464529738|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
129066163|NCT00662649|464529739|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
129066164|NCT00662649|464529740|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
129066165|NCT02009722|464529747|FG000|Overall Study|Protocol Violation|1|||
129066166|NCT02009722|464529748|FG001|Overall Study|Protocol Violation|2|||
129066167|NCT02009722|464529747|FG000|Overall Study|Did not receive intervention|0|||
129066168|NCT02009722|464529748|FG001|Overall Study|Did not receive intervention|1|||
129066169|NCT02955212|464529749|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
129066170|NCT02955212|464529750|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
129066171|NCT02955212|464529749|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
129066172|NCT02955212|464529750|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
129066173|NCT02955212|464529749|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
129066174|NCT02955212|464529750|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
129066175|NCT02955212|464529749|FG000|Period 1: Double-blind Treatment Period|Other|3|||
129066176|NCT02955212|464529750|FG001|Period 1: Double-blind Treatment Period|Other|2|||
129066177|NCT02955212|464529749|FG000|Period 2: Open-label Extension|Adverse Event|11|||
129066178|NCT02955212|464529750|FG001|Period 2: Open-label Extension|Adverse Event|7|||
129066179|NCT02955212|464529749|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
129066180|NCT02955212|464529750|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
129066181|NCT02955212|464529749|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
129066182|NCT02955212|464529750|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
129066183|NCT02955212|464529749|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
129066184|NCT02955212|464529750|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
129066185|NCT02955212|464529749|FG000|Period 2: Open-label Extension|Other|2|||
129066186|NCT02955212|464529750|FG001|Period 2: Open-label Extension|Other|4|||
129066187|NCT00545714|464529753|FG000|Induction Phase (6 Months)|Physician Decision|3|||
129066188|NCT00545714|464529753|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
129066189|NCT00545714|464529753|FG000|Induction Phase (6 Months)|Disease Progression|1|||
129066190|NCT00545714|464529753|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
129066191|NCT00545714|464529753|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
129066192|NCT00545714|464529753|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
129066193|NCT00545714|464529753|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
129066194|NCT00545714|464529753|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
129066195|NCT00545714|464529753|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
129066196|NCT00545714|464529753|FG000|Maintenance Phase (36 Months)|Death|2|||
129066197|NCT04428034|464529758|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
129066198|NCT00560391|464529761|FG000|Overall Study|Still on treatment|0|||
129066199|NCT00560391|464529762|FG001|Overall Study|Still on treatment|0|||
129066200|NCT00560391|464529763|FG002|Overall Study|Still on treatment|0|||
129066201|NCT00560391|464529764|FG003|Overall Study|Still on treatment|1|||
129066202|NCT00560391|464529765|FG004|Overall Study|Still on treatment|2|||
129066203|NCT02556801|464529766|FG000|Overall Study|Lost to Follow-up|1|||
129066204|NCT02556801|464529767|FG001|Overall Study|Lost to Follow-up|0|||
129066205|NCT02556801|464529768|FG002|Overall Study|Lost to Follow-up|2|||
129066206|NCT02556801|464529769|FG003|Overall Study|Lost to Follow-up|0|||
129066207|NCT02556801|464529766|FG000|Overall Study|Withdrawal by Subject|1|||
129066208|NCT02556801|464529767|FG001|Overall Study|Withdrawal by Subject|1|||
129066209|NCT02556801|464529768|FG002|Overall Study|Withdrawal by Subject|1|||
129066210|NCT02556801|464529769|FG003|Overall Study|Withdrawal by Subject|0|||
129066211|NCT02556801|464529766|FG000|Overall Study|Protocol Violation|0|||
129066212|NCT02556801|464529767|FG001|Overall Study|Protocol Violation|3|||
129066213|NCT02556801|464529768|FG002|Overall Study|Protocol Violation|1|||
129066214|NCT02556801|464529769|FG003|Overall Study|Protocol Violation|1|||
129066215|NCT02556801|464529766|FG000|Overall Study|Adverse Event|0|||
129066216|NCT02556801|464529767|FG001|Overall Study|Adverse Event|2|||
129066217|NCT02556801|464529768|FG002|Overall Study|Adverse Event|0|||
129066218|NCT02556801|464529769|FG003|Overall Study|Adverse Event|3|||
129066219|NCT02556801|464529766|FG000|Overall Study|Pregnancy|0|||
129066220|NCT02556801|464529767|FG001|Overall Study|Pregnancy|1|||
129066221|NCT02556801|464529768|FG002|Overall Study|Pregnancy|0|||
129066222|NCT02556801|464529769|FG003|Overall Study|Pregnancy|0|||
129066223|NCT02556801|464529766|FG000|Overall Study|Personal reasons patient|0|||
128721695|NCT00537381|463277365|FG001|Overall Study|Death|3|||
128721696|NCT00537381|463277364|FG000|Overall Study|Withdrawal by Subject|5|||
129066224|NCT02556801|464529767|FG001|Overall Study|Personal reasons patient|0|||
129066225|NCT02556801|464529768|FG002|Overall Study|Personal reasons patient|0|||
129066226|NCT02556801|464529769|FG003|Overall Study|Personal reasons patient|1|||
129066227|NCT03519087|464529773|FG000|Clinic Evaluation|Physician Decision|15|||
129066228|NCT03519087|464529774|FG001|Clinic Evaluation|Physician Decision|18|||
128721697|NCT00537381|463277365|FG001|Overall Study|Withdrawal by Subject|14|||
128721698|NCT00537381|463277364|FG000|Overall Study|Physician Decision|7|||
128721699|NCT00537381|463277365|FG001|Overall Study|Physician Decision|6|||
129066229|NCT03519087|464529775|FG002|Clinic Evaluation|Physician Decision|0|||
129066230|NCT03519087|464529776|FG003|Clinic Evaluation|Physician Decision|0|||
129066231|NCT03519087|464529777|FG004|Clinic Evaluation|Physician Decision|0|||
129066232|NCT03519087|464529773|FG000|Clinic Evaluation|Protocol Violation|1|||
129066233|NCT03519087|464529774|FG001|Clinic Evaluation|Protocol Violation|0|||
129066234|NCT03519087|464529775|FG002|Clinic Evaluation|Protocol Violation|0|||
129066235|NCT03519087|464529776|FG003|Clinic Evaluation|Protocol Violation|0|||
129066236|NCT03519087|464529777|FG004|Clinic Evaluation|Protocol Violation|0|||
129066237|NCT03519087|464529773|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
129066238|NCT03519087|464529774|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
129066239|NCT03519087|464529775|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
129066240|NCT03519087|464529776|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
129066241|NCT03519087|464529777|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
129066242|NCT03519087|464529773|FG000|Re-randomization for Treatment|Not appropriate|2|||
129066243|NCT03519087|464529774|FG001|Re-randomization for Treatment|Not appropriate|3|||
129066244|NCT03519087|464529775|FG002|Re-randomization for Treatment|Not appropriate|0|||
129066245|NCT03519087|464529776|FG003|Re-randomization for Treatment|Not appropriate|0|||
129066246|NCT03519087|464529777|FG004|Re-randomization for Treatment|Not appropriate|0|||
129066247|NCT03519087|464529773|FG000|Laboratory Testing|Lost to Follow-up|0|||
129066248|NCT03519087|464529774|FG001|Laboratory Testing|Lost to Follow-up|0|||
129066249|NCT03519087|464529775|FG002|Laboratory Testing|Lost to Follow-up|2|||
129066250|NCT03519087|464529776|FG003|Laboratory Testing|Lost to Follow-up|3|||
129066251|NCT03519087|464529777|FG004|Laboratory Testing|Lost to Follow-up|6|||
129066252|NCT03519087|464529773|FG000|Laboratory Testing|Protocol Violation|0|||
129066253|NCT03519087|464529774|FG001|Laboratory Testing|Protocol Violation|0|||
129066254|NCT03519087|464529775|FG002|Laboratory Testing|Protocol Violation|0|||
129066255|NCT03519087|464529776|FG003|Laboratory Testing|Protocol Violation|1|||
129066256|NCT03519087|464529777|FG004|Laboratory Testing|Protocol Violation|0|||
129066257|NCT01137071|464529778|FG000|Overall Study|Disease Progression|11|||
129066258|NCT01137071|464529778|FG000|Overall Study|Withdrawal by Subject|2|||
129066259|NCT01137071|464529778|FG000|Overall Study|Wrongly Included|1|||
129066260|NCT02324582|464529779|FG000|Overall Study|Screen Failures|0|||
129066261|NCT02324582|464529780|FG001|Overall Study|Screen Failures|5|||
129066262|NCT04388553|464529783|FG000|Overall Study|Protocol Violation|1|||
129066263|NCT04388553|464529784|FG001|Overall Study|Protocol Violation|0|||
129066264|NCT02123446|464529785|FG000|Washout Period (1 Day)|Physician Decision|1|||
129066265|NCT02123446|464529786|FG001|Washout Period (1 Day)|Physician Decision|0|||
129066266|NCT04604795|464529787|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
129066267|NCT04604795|464529788|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
129066268|NCT04604795|464529789|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066269|NCT04604795|464529790|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066270|NCT04604795|464529791|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066271|NCT04604795|464529792|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066272|NCT04604795|464529793|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066273|NCT04604795|464529794|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066274|NCT04604795|464529795|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066275|NCT04604795|464529796|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129066276|NCT04604795|464529787|FG000|Part B: Up to Day 14|Adverse Event|0|||
129066277|NCT04604795|464529788|FG001|Part B: Up to Day 14|Adverse Event|0|||
129066278|NCT04604795|464529789|FG002|Part B: Up to Day 14|Adverse Event|0|||
129066279|NCT04604795|464529790|FG003|Part B: Up to Day 14|Adverse Event|0|||
129066280|NCT04604795|464529791|FG004|Part B: Up to Day 14|Adverse Event|2|||
129066281|NCT04604795|464529792|FG005|Part B: Up to Day 14|Adverse Event|1|||
129066282|NCT04604795|464529793|FG006|Part B: Up to Day 14|Adverse Event|0|||
129066283|NCT04604795|464529794|FG007|Part B: Up to Day 14|Adverse Event|0|||
129066284|NCT04604795|464529795|FG008|Part B: Up to Day 14|Adverse Event|0|||
129066285|NCT04604795|464529796|FG009|Part B: Up to Day 14|Adverse Event|0|||
129066286|NCT04604795|464529787|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066287|NCT04604795|464529788|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066288|NCT04604795|464529789|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066289|NCT04604795|464529790|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066290|NCT04604795|464529791|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066291|NCT04604795|464529792|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066292|NCT04604795|464529793|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066293|NCT04604795|464529794|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066294|NCT04604795|464529795|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129066295|NCT04604795|464529796|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
129066296|NCT04604795|464529787|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066297|NCT04604795|464529788|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066298|NCT04604795|464529789|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066299|NCT04604795|464529790|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066300|NCT04604795|464529791|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066301|NCT04604795|464529792|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066302|NCT04604795|464529793|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066303|NCT04604795|464529794|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066304|NCT04604795|464529795|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
129066305|NCT04604795|464529796|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129066306|NCT04604795|464529787|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066307|NCT04604795|464529788|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066308|NCT04604795|464529789|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066309|NCT04604795|464529790|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066310|NCT04604795|464529791|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066311|NCT04604795|464529792|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066312|NCT04604795|464529793|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066313|NCT04604795|464529794|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066314|NCT04604795|464529795|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
129066315|NCT04604795|464529796|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129066316|NCT04604795|464529787|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066317|NCT04604795|464529788|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066318|NCT04604795|464529789|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066319|NCT04604795|464529790|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066320|NCT04604795|464529791|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066321|NCT04604795|464529792|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066322|NCT04604795|464529793|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066323|NCT04604795|464529794|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066324|NCT04604795|464529795|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
129066325|NCT04604795|464529796|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
129066326|NCT04502212|464529802|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
129066327|NCT04502212|464529802|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
129066328|NCT00111241|464529807|FG000|Overall Study|Lost to Follow-up|1|||
129066329|NCT00111241|464529808|FG001|Overall Study|Lost to Follow-up|0|||
129066330|NCT00111241|464529807|FG000|Overall Study|Withdrawal by Subject|4|||
129066331|NCT00111241|464529808|FG001|Overall Study|Withdrawal by Subject|0|||
129066332|NCT00111241|464529807|FG000|Overall Study|Protocol Violation|9|||
129066333|NCT00111241|464529808|FG001|Overall Study|Protocol Violation|8|||
129066334|NCT00111241|464529807|FG000|Overall Study|Adverse Event|1|||
129066335|NCT00111241|464529808|FG001|Overall Study|Adverse Event|0|||
129066336|NCT02096744|464529809|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
129066337|NCT02096744|464529810|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
129066338|NCT02096744|464529809|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
129066339|NCT02096744|464529810|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
129066340|NCT02096744|464529809|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
129066341|NCT02096744|464529810|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
129066342|NCT00952731|464529816|FG000|Overall Study|Drug supply expired|1|||
129066343|NCT00952731|464529817|FG001|Overall Study|Drug supply expired|0|||
129066344|NCT01855828|464529818|FG000|Overall Study|Adverse Event|1|||
129066345|NCT01855828|464529818|FG000|Overall Study|Withdrawal by Subject|1|||
129066346|NCT01866098|464529823|FG000|Overall Study|Lost to Follow-up|11|||
129066347|NCT01866098|464529824|FG001|Overall Study|Lost to Follow-up|18|||
129066348|NCT01866098|464529825|FG002|Overall Study|Lost to Follow-up|13|||
129066349|NCT01866098|464529823|FG000|Overall Study|Physician Decision|0|||
129066350|NCT01866098|464529824|FG001|Overall Study|Physician Decision|1|||
129066351|NCT01866098|464529825|FG002|Overall Study|Physician Decision|2|||
129066352|NCT01866098|464529823|FG000|Overall Study|Adverse Event|1|||
129066353|NCT01866098|464529824|FG001|Overall Study|Adverse Event|5|||
129066354|NCT01866098|464529825|FG002|Overall Study|Adverse Event|4|||
129066355|NCT01866098|464529823|FG000|Overall Study|Protocol Violation|1|||
129066356|NCT01866098|464529824|FG001|Overall Study|Protocol Violation|0|||
129137908|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128721700|NCT00537381|463277364|FG000|Overall Study|Disease Progression|9|||
128721701|NCT00537381|463277365|FG001|Overall Study|Disease Progression|18|||
129137909|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
128721702|NCT00537381|463277364|FG000|Overall Study|Sponsor decision|14|||
128721703|NCT00537381|463277365|FG001|Overall Study|Sponsor decision|9|||
129137910|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
128721704|NCT00537381|463277364|FG000|Overall Study|Other|5|||
128721705|NCT00537381|463277365|FG001|Overall Study|Other|3|||
129066357|NCT01866098|464529825|FG002|Overall Study|Protocol Violation|0|||
129066358|NCT01866098|464529823|FG000|Overall Study|Withdrawal by Subject|1|||
129066359|NCT01866098|464529824|FG001|Overall Study|Withdrawal by Subject|2|||
129066360|NCT01866098|464529825|FG002|Overall Study|Withdrawal by Subject|0|||
129066361|NCT01866098|464529823|FG000|Overall Study|Unrelated Hospitalization|2|||
129066362|NCT01866098|464529824|FG001|Overall Study|Unrelated Hospitalization|0|||
129066363|NCT01866098|464529825|FG002|Overall Study|Unrelated Hospitalization|1|||
129066364|NCT01866098|464529823|FG000|Overall Study|Non-compliance|1|||
129066365|NCT01866098|464529824|FG001|Overall Study|Non-compliance|0|||
129066366|NCT01866098|464529825|FG002|Overall Study|Non-compliance|1|||
129066367|NCT01866098|464529823|FG000|Overall Study|Pregnancy|2|||
129066368|NCT01866098|464529824|FG001|Overall Study|Pregnancy|0|||
129066369|NCT01866098|464529825|FG002|Overall Study|Pregnancy|0|||
129066370|NCT01866098|464529823|FG000|Overall Study|Death|0|||
129066371|NCT01866098|464529824|FG001|Overall Study|Death|1|||
129066372|NCT01866098|464529825|FG002|Overall Study|Death|0|||
129066373|NCT02517463|464529833|FG000|Overall Study|Lost to Follow-up|5|||
129066374|NCT02517463|464529834|FG001|Overall Study|Lost to Follow-up|2|||
129066375|NCT03172494|464529839|FG000|Overall Study|Adverse Event|5|||
129066376|NCT03172494|464529840|FG001|Overall Study|Adverse Event|1|||
129066377|NCT03172494|464529841|FG002|Overall Study|Adverse Event|15|||
129066378|NCT03172494|464529839|FG000|Overall Study|Protocol Violation|3|||
129066379|NCT03172494|464529840|FG001|Overall Study|Protocol Violation|2|||
129066380|NCT03172494|464529841|FG002|Overall Study|Protocol Violation|1|||
129066381|NCT03172494|464529839|FG000|Overall Study|Lack of Efficacy|0|||
129066382|NCT03172494|464529840|FG001|Overall Study|Lack of Efficacy|0|||
129066383|NCT03172494|464529841|FG002|Overall Study|Lack of Efficacy|4|||
129066384|NCT03172494|464529839|FG000|Overall Study|Pregnancy|0|||
129066385|NCT03172494|464529840|FG001|Overall Study|Pregnancy|1|||
129066386|NCT03172494|464529841|FG002|Overall Study|Pregnancy|0|||
129066387|NCT03172494|464529839|FG000|Overall Study|Withdrawal by Subject|10|||
129066388|NCT03172494|464529840|FG001|Overall Study|Withdrawal by Subject|8|||
129066389|NCT03172494|464529841|FG002|Overall Study|Withdrawal by Subject|8|||
129066390|NCT03172494|464529839|FG000|Overall Study|Severe hypoglycaemic episode|0|||
129066391|NCT03172494|464529840|FG001|Overall Study|Severe hypoglycaemic episode|0|||
129066392|NCT03172494|464529841|FG002|Overall Study|Severe hypoglycaemic episode|1|||
129066393|NCT03172494|464529839|FG000|Overall Study|Non-compliance towards treatment|2|||
129066394|NCT03172494|464529840|FG001|Overall Study|Non-compliance towards treatment|0|||
129066395|NCT03172494|464529841|FG002|Overall Study|Non-compliance towards treatment|0|||
129066396|NCT02764151|464529842|FG000|Overall Study|Subject refused further follow-up|0|||
129066397|NCT02764151|464529843|FG001|Overall Study|Subject refused further follow-up|0|||
129066398|NCT02764151|464529844|FG002|Overall Study|Subject refused further follow-up|0|||
129066399|NCT02764151|464529845|FG003|Overall Study|Subject refused further follow-up|1|||
129066400|NCT02764151|464529842|FG000|Overall Study|Other|0|||
129066401|NCT02764151|464529843|FG001|Overall Study|Other|0|||
129066402|NCT02764151|464529844|FG002|Overall Study|Other|0|||
129066403|NCT02764151|464529845|FG003|Overall Study|Other|2|||
128721706|NCT02590939|463277366|FG000|Overall Study|Withdrawal by Subject|3|||
128721707|NCT02590939|463277367|FG001|Overall Study|Withdrawal by Subject|1|||
128721708|NCT02590939|463277366|FG000|Overall Study|Failed the nociceptive test|2|||
129066404|NCT00852202|464529853|FG000|Overall Study|Adverse Event|2|||
129066405|NCT00852202|464529854|FG001|Overall Study|Adverse Event|3|||
129066406|NCT00852202|464529855|FG002|Overall Study|Adverse Event|7|||
129066407|NCT00852202|464529853|FG000|Overall Study|Lack of Efficacy|4|||
129066408|NCT00852202|464529854|FG001|Overall Study|Lack of Efficacy|1|||
129066409|NCT00852202|464529855|FG002|Overall Study|Lack of Efficacy|2|||
129066410|NCT00852202|464529853|FG000|Overall Study|Protocol Violation|2|||
129066411|NCT00852202|464529854|FG001|Overall Study|Protocol Violation|2|||
129066412|NCT00852202|464529855|FG002|Overall Study|Protocol Violation|7|||
129066413|NCT00852202|464529853|FG000|Overall Study|Withdrawal by Subject|3|||
129066414|NCT00852202|464529854|FG001|Overall Study|Withdrawal by Subject|1|||
129066415|NCT00852202|464529855|FG002|Overall Study|Withdrawal by Subject|2|||
129066416|NCT00852202|464529853|FG000|Overall Study|Lost to Follow-up|5|||
129066417|NCT00852202|464529854|FG001|Overall Study|Lost to Follow-up|5|||
129066418|NCT00852202|464529855|FG002|Overall Study|Lost to Follow-up|6|||
129066419|NCT00852202|464529853|FG000|Overall Study|pregnancy,moving away and surgery|1|||
129066420|NCT00852202|464529854|FG001|Overall Study|pregnancy,moving away and surgery|0|||
129066421|NCT00852202|464529855|FG002|Overall Study|pregnancy,moving away and surgery|2|||
129066422|NCT05022212|464529858|FG000|Overall Study|Lost to Follow-up|0|||
129066423|NCT05022212|464529859|FG001|Overall Study|Lost to Follow-up|2|||
129066424|NCT02890355|464529860|FG000|Overall Study|Adverse Event|5|||
129066425|NCT02890355|464529861|FG001|Overall Study|Adverse Event|5|||
129066426|NCT02890355|464529860|FG000|Overall Study|Refusal unrelated to adverse event|5|||
129066427|NCT02890355|464529861|FG001|Overall Study|Refusal unrelated to adverse event|10|||
128721709|NCT02590939|463277367|FG001|Overall Study|Failed the nociceptive test|1|||
129066428|NCT02890355|464529860|FG000|Overall Study|Progression/relapse|46|||
129066429|NCT02890355|464529861|FG001|Overall Study|Progression/relapse|39|||
129066430|NCT02890355|464529860|FG000|Overall Study|Not protocol specified|3|||
129066431|NCT02890355|464529861|FG001|Overall Study|Not protocol specified|4|||
129066432|NCT02694328|464529862|FG000|Overall Study|Adverse Event|27|||
129066433|NCT02694328|464529863|FG001|Overall Study|Adverse Event|33|||
129066434|NCT02694328|464529862|FG000|Overall Study|Withdrawal by Subject|27|||
129066435|NCT02694328|464529863|FG001|Overall Study|Withdrawal by Subject|23|||
129066436|NCT02694328|464529862|FG000|Overall Study|Lost to Follow-up|26|||
129066437|NCT02694328|464529863|FG001|Overall Study|Lost to Follow-up|22|||
129066438|NCT02694328|464529862|FG000|Overall Study|Noncompliant with study drug|11|||
129066439|NCT02694328|464529863|FG001|Overall Study|Noncompliant with study drug|8|||
129066440|NCT02694328|464529862|FG000|Overall Study|Incarceration|1|||
129066441|NCT02694328|464529863|FG001|Overall Study|Incarceration|1|||
129066442|NCT02694328|464529862|FG000|Overall Study|Lack of Efficacy|1|||
129066443|NCT02694328|464529863|FG001|Overall Study|Lack of Efficacy|2|||
129066444|NCT02694328|464529862|FG000|Overall Study|Pregnancy|1|||
129066445|NCT02694328|464529863|FG001|Overall Study|Pregnancy|1|||
129066446|NCT02694328|464529862|FG000|Overall Study|Protocol Violation|6|||
129066447|NCT02694328|464529863|FG001|Overall Study|Protocol Violation|5|||
129066448|NCT02694328|464529862|FG000|Overall Study|Abnormal Laboratory Value|0|||
129066449|NCT02694328|464529863|FG001|Overall Study|Abnormal Laboratory Value|3|||
129066450|NCT01260701|464529865|FG000|Overall Study|Adverse Event|9|||
129066451|NCT01260701|464529865|FG000|Overall Study|Withdrawal by Subject|2|||
129066452|NCT01260701|464529865|FG000|Overall Study|Progression|53|||
129066453|NCT01260701|464529865|FG000|Overall Study|Death|2|||
129066454|NCT01260701|464529865|FG000|Overall Study|Not protocol specified|3|||
129066455|NCT01260701|464529865|FG000|Overall Study|Under review|1|||
129066456|NCT01260701|464529865|FG000|Overall Study|Ineligible|4|||
129066457|NCT01260701|464529865|FG000|Overall Study|Did not begin protocol therapy|1|||
129066458|NCT00720382|464529866|FG000|Overall Study|Adverse Event|54|||
129066459|NCT00720382|464529867|FG001|Overall Study|Adverse Event|17|||
129066460|NCT00720382|464529866|FG000|Overall Study|Lack of Efficacy|18|||
129066461|NCT00720382|464529867|FG001|Overall Study|Lack of Efficacy|7|||
129066462|NCT00720382|464529866|FG000|Overall Study|Non-Compliance|15|||
129066463|NCT00720382|464529867|FG001|Overall Study|Non-Compliance|5|||
129066464|NCT00720382|464529866|FG000|Overall Study|Withdrawal by Subject|47|||
129066465|NCT00720382|464529867|FG001|Overall Study|Withdrawal by Subject|11|||
129066466|NCT00720382|464529866|FG000|Overall Study|Lost to Follow-up|28|||
129066467|NCT00720382|464529867|FG001|Overall Study|Lost to Follow-up|14|||
129066468|NCT00720382|464529866|FG000|Overall Study|administrative|14|||
129066469|NCT00720382|464529867|FG001|Overall Study|administrative|5|||
129066470|NCT04205812|464531755|FG000|Randomized Treatment Period|Ongoing|28|||
129066471|NCT04205812|464531756|FG001|Randomized Treatment Period|Ongoing|138|||
129066472|NCT04205812|464531755|FG000|Randomized Treatment Period|Death|94|||
129066473|NCT04205812|464531756|FG001|Randomized Treatment Period|Death|226|||
129066474|NCT04205812|464531755|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
129066475|NCT04205812|464531756|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
129066476|NCT04205812|464531755|FG000|Randomized Treatment Period|Physician Decision|1|||
129066477|NCT04205812|464531756|FG001|Randomized Treatment Period|Physician Decision|4|||
129137911|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129137912|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129137913|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129066478|NCT04205812|464531755|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
129066479|NCT04205812|464531756|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
129066480|NCT04205812|464531755|FG000|Randomized Treatment Period|Progressive Disease|0|||
129066481|NCT04205812|464531756|FG001|Randomized Treatment Period|Progressive Disease|1|||
129066482|NCT04205812|464531755|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
129066483|NCT04205812|464531756|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
129066484|NCT04205812|464531755|FG000|Monotherapy Treatment Period|Ongoing|17|||
129066485|NCT04205812|464531756|FG001|Monotherapy Treatment Period|Ongoing|0|||
129066486|NCT04205812|464531755|FG000|Monotherapy Treatment Period|Death|39|||
129066487|NCT04205812|464531756|FG001|Monotherapy Treatment Period|Death|0|||
129066488|NCT04205812|464531755|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
129066489|NCT04205812|464531756|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
129066490|NCT04205812|464531755|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
129066491|NCT04205812|464531756|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
129066492|NCT05221320|464531757|FG000|Overall Study|Lack of Efficacy|3|||
129066493|NCT05221320|464531758|FG001|Overall Study|Lack of Efficacy|7|||
129066494|NCT05221320|464531759|FG002|Overall Study|Lack of Efficacy|10|||
129066495|NCT05221320|464531760|FG003|Overall Study|Lack of Efficacy|1|||
129066496|NCT05221320|464531761|FG004|Overall Study|Lack of Efficacy|0|||
129066497|NCT05221320|464531762|FG005|Overall Study|Lack of Efficacy|0|||
129066498|NCT05221320|464531757|FG000|Overall Study|Physician Decision|1|||
129066499|NCT05221320|464531758|FG001|Overall Study|Physician Decision|0|||
129066500|NCT05221320|464531759|FG002|Overall Study|Physician Decision|3|||
129137914|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129066501|NCT05221320|464531760|FG003|Overall Study|Physician Decision|1|||
129066502|NCT05221320|464531761|FG004|Overall Study|Physician Decision|0|||
129066503|NCT05221320|464531762|FG005|Overall Study|Physician Decision|0|||
129066504|NCT05221320|464531757|FG000|Overall Study|Withdrawal by Subject|0|||
129066505|NCT05221320|464531758|FG001|Overall Study|Withdrawal by Subject|3|||
129066506|NCT05221320|464531759|FG002|Overall Study|Withdrawal by Subject|1|||
129066507|NCT05221320|464531760|FG003|Overall Study|Withdrawal by Subject|0|||
129066508|NCT05221320|464531761|FG004|Overall Study|Withdrawal by Subject|0|||
129066509|NCT05221320|464531762|FG005|Overall Study|Withdrawal by Subject|0|||
129066510|NCT05221320|464531757|FG000|Overall Study|Death|0|||
129066511|NCT05221320|464531758|FG001|Overall Study|Death|5|||
129066512|NCT05221320|464531759|FG002|Overall Study|Death|6|||
129066513|NCT05221320|464531760|FG003|Overall Study|Death|0|||
129066514|NCT05221320|464531761|FG004|Overall Study|Death|1|||
129066515|NCT05221320|464531762|FG005|Overall Study|Death|0|||
129066516|NCT06473519|464531763|FG000|Overall Study|Lost to Follow-up|2|||
129066517|NCT06473519|464531764|FG001|Overall Study|Lost to Follow-up|5|||
129066518|NCT06473519|464531763|FG000|Overall Study|Withdrawal by Subject|1|||
129066519|NCT06473519|464531764|FG001|Overall Study|Withdrawal by Subject|4|||
129066520|NCT06473519|464531763|FG000|Overall Study|Randomized but not vaccinated|1|||
129066521|NCT06473519|464531764|FG001|Overall Study|Randomized but not vaccinated|2|||
129066522|NCT02514447|464531766|FG000|Overall Study|Withdrawal by Subject|3|||
129066523|NCT02514447|464531767|FG001|Overall Study|Withdrawal by Subject|1|||
129066524|NCT02514447|464531768|FG002|Overall Study|Withdrawal by Subject|1|||
129066525|NCT02514447|464531769|FG003|Overall Study|Withdrawal by Subject|0|||
129066526|NCT02514447|464531770|FG004|Overall Study|Withdrawal by Subject|0|||
129066527|NCT02514447|464531771|FG005|Overall Study|Withdrawal by Subject|0|||
129066528|NCT02514447|464531772|FG006|Overall Study|Withdrawal by Subject|0|||
129066529|NCT02514447|464531773|FG007|Overall Study|Withdrawal by Subject|1|||
129066530|NCT02514447|464531774|FG008|Overall Study|Withdrawal by Subject|1|||
129066531|NCT02514447|464531766|FG000|Overall Study|Death|24|||
129066532|NCT02514447|464531767|FG001|Overall Study|Death|28|||
129066533|NCT02514447|464531768|FG002|Overall Study|Death|29|||
128721710|NCT03774433|463277372|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
128721711|NCT00108160|463277373|FG000|Overall Study|Lost to Follow-up|25|||
128721712|NCT00108160|463277374|FG001|Overall Study|Lost to Follow-up|12|||
128721713|NCT00108160|463277373|FG000|Overall Study|Death|1|||
128721714|NCT00108160|463277374|FG001|Overall Study|Death|2|||
129066534|NCT02514447|464531769|FG003|Overall Study|Death|0|||
129066535|NCT02514447|464531770|FG004|Overall Study|Death|3|||
129066536|NCT02514447|464531771|FG005|Overall Study|Death|4|||
129066537|NCT02514447|464531772|FG006|Overall Study|Death|8|||
129066538|NCT02514447|464531773|FG007|Overall Study|Death|6|||
129066539|NCT02514447|464531774|FG008|Overall Study|Death|5|||
129066540|NCT02514447|464531766|FG000|Overall Study|Lost to Follow-up|1|||
129066541|NCT02514447|464531767|FG001|Overall Study|Lost to Follow-up|0|||
129066542|NCT02514447|464531768|FG002|Overall Study|Lost to Follow-up|0|||
129066543|NCT02514447|464531769|FG003|Overall Study|Lost to Follow-up|0|||
129066544|NCT02514447|464531770|FG004|Overall Study|Lost to Follow-up|0|||
129066545|NCT02514447|464531771|FG005|Overall Study|Lost to Follow-up|0|||
129066546|NCT02514447|464531772|FG006|Overall Study|Lost to Follow-up|0|||
129066547|NCT02514447|464531773|FG007|Overall Study|Lost to Follow-up|0|||
129066548|NCT02514447|464531774|FG008|Overall Study|Lost to Follow-up|1|||
129066549|NCT02514447|464531766|FG000|Overall Study|Sponsor Termination of Study|0|||
129066550|NCT02514447|464531767|FG001|Overall Study|Sponsor Termination of Study|1|||
129066551|NCT02514447|464531768|FG002|Overall Study|Sponsor Termination of Study|1|||
129066552|NCT02514447|464531769|FG003|Overall Study|Sponsor Termination of Study|0|||
129066553|NCT02514447|464531770|FG004|Overall Study|Sponsor Termination of Study|0|||
129066554|NCT02514447|464531771|FG005|Overall Study|Sponsor Termination of Study|0|||
129066555|NCT02514447|464531772|FG006|Overall Study|Sponsor Termination of Study|0|||
129066556|NCT02514447|464531773|FG007|Overall Study|Sponsor Termination of Study|0|||
129066557|NCT02514447|464531774|FG008|Overall Study|Sponsor Termination of Study|0|||
129066558|NCT02514447|464531766|FG000|Overall Study|Study completion per Investigator|1|||
129066559|NCT02514447|464531767|FG001|Overall Study|Study completion per Investigator|0|||
129066560|NCT02514447|464531768|FG002|Overall Study|Study completion per Investigator|1|||
129066561|NCT02514447|464531769|FG003|Overall Study|Study completion per Investigator|2|||
129066562|NCT02514447|464531770|FG004|Overall Study|Study completion per Investigator|0|||
129066563|NCT02514447|464531771|FG005|Overall Study|Study completion per Investigator|0|||
129066564|NCT02514447|464531772|FG006|Overall Study|Study completion per Investigator|0|||
129066565|NCT02514447|464531773|FG007|Overall Study|Study completion per Investigator|0|||
129066566|NCT02514447|464531774|FG008|Overall Study|Study completion per Investigator|1|||
129066567|NCT05626231|464531775|FG000|Provider Enrollment|Worked part-time|4|||
129066568|NCT05626231|464531775|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
129066569|NCT05626231|464531775|FG000|Provider Enrollment|Non-clinical employee|1|||
129066570|NCT05626231|464531775|FG000|Provider Enrollment|Provider does not see clients|3|||
129066571|NCT05626231|464531775|FG000|Provider Enrollment|Other|5|||
129066572|NCT02653625|464531778|FG000|Overall Study|Adverse Event|1|||
129066573|NCT02653625|464531778|FG000|Overall Study|Non-compliance with Study Drug|1|||
129066574|NCT02653625|464531778|FG000|Overall Study|Protocol Violation|1|||
129066575|NCT02653625|464531778|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
129066576|NCT05377749|464531779|FG000|3 Weeks|Lost to Follow-up|2|||
129066577|NCT05377749|464531780|FG001|3 Weeks|Lost to Follow-up|4|||
129137915|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
128721715|NCT00108160|463277373|FG000|Overall Study|Withdrawal by Subject|4|||
128721716|NCT00108160|463277374|FG001|Overall Study|Withdrawal by Subject|2|||
128721717|NCT00108160|463277373|FG000|Overall Study|Protocol Violation|9|||
128721718|NCT00108160|463277374|FG001|Overall Study|Protocol Violation|5|||
128721719|NCT03082599|463277378|FG000|Overall Study|Lost to Follow-up|1|||
128721720|NCT03082599|463277379|FG001|Overall Study|Lost to Follow-up|0|||
128721721|NCT04709575|463279238|FG000|Overall Study|Withdrawal by Subject|6|||
128721722|NCT04709575|463279239|FG001|Overall Study|Withdrawal by Subject|2|||
128721723|NCT04709575|463279238|FG000|Overall Study|Lost to Follow-up|2|||
129066578|NCT05377749|464531779|FG000|3 Weeks|Withdrawal by Subject|1|||
129066579|NCT05377749|464531780|FG001|3 Weeks|Withdrawal by Subject|1|||
129066580|NCT01499095|464531781|FG000|Overall Study|Randomized But Not Treated|1|||
129066581|NCT01499095|464531782|FG001|Overall Study|Randomized But Not Treated|1|||
129066582|NCT01499095|464531781|FG000|Overall Study|Adverse Event|12|||
129066583|NCT01499095|464531782|FG001|Overall Study|Adverse Event|7|||
129066584|NCT01499095|464531781|FG000|Overall Study|Lack of Efficacy|2|||
129066585|NCT01499095|464531782|FG001|Overall Study|Lack of Efficacy|1|||
129066586|NCT01499095|464531781|FG000|Overall Study|Protocol Violation|6|||
129066587|NCT01499095|464531782|FG001|Overall Study|Protocol Violation|7|||
129066588|NCT01499095|464531781|FG000|Overall Study|Received Rescue Therapy|32|||
129066589|NCT01499095|464531782|FG001|Overall Study|Received Rescue Therapy|40|||
129066590|NCT01499095|464531781|FG000|Overall Study|Diverse Reasons|22|||
129066591|NCT01499095|464531782|FG001|Overall Study|Diverse Reasons|25|||
129066592|NCT01499095|464531781|FG000|Overall Study|Lost to Follow-up|6|||
129066593|NCT01499095|464531782|FG001|Overall Study|Lost to Follow-up|4|||
129066594|NCT01499095|464531781|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
129066595|NCT01499095|464531782|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
129066596|NCT01499095|464531781|FG000|Overall Study|Hypoglycemia|3|||
129066597|NCT01499095|464531782|FG001|Overall Study|Hypoglycemia|1|||
129066598|NCT01499095|464531781|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
129066599|NCT01499095|464531782|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
129066600|NCT01499095|464531781|FG000|Overall Study|Change in Injection Schedule|2|||
129066601|NCT01499095|464531782|FG001|Overall Study|Change in Injection Schedule|0|||
129066602|NCT01499095|464531781|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129066603|NCT01499095|464531782|FG001|Overall Study|Perceived Lack of Efficacy|1|||
129066604|NCT02762929|464531783|FG000|Overall Study|Adverse Event|0|||
129066605|NCT02762929|464531784|FG001|Overall Study|Adverse Event|0|||
129066606|NCT02762929|464531785|FG002|Overall Study|Adverse Event|0|||
129066607|NCT02762929|464531786|FG003|Overall Study|Adverse Event|1|||
129066608|NCT02762929|464531787|FG004|Overall Study|Adverse Event|0|||
129066609|NCT02762929|464531788|FG005|Overall Study|Adverse Event|0|||
129066610|NCT02762929|464531783|FG000|Overall Study|Lost to Follow-up|1|||
129066611|NCT02762929|464531784|FG001|Overall Study|Lost to Follow-up|2|||
129066612|NCT02762929|464531785|FG002|Overall Study|Lost to Follow-up|0|||
129066613|NCT02762929|464531786|FG003|Overall Study|Lost to Follow-up|1|||
129066614|NCT02762929|464531787|FG004|Overall Study|Lost to Follow-up|0|||
129066615|NCT02762929|464531788|FG005|Overall Study|Lost to Follow-up|0|||
129066616|NCT02762929|464531783|FG000|Overall Study|Withdrawal by Subject|0|||
129066617|NCT02762929|464531784|FG001|Overall Study|Withdrawal by Subject|1|||
129066618|NCT02762929|464531785|FG002|Overall Study|Withdrawal by Subject|0|||
129066619|NCT02762929|464531786|FG003|Overall Study|Withdrawal by Subject|0|||
129066620|NCT02762929|464531787|FG004|Overall Study|Withdrawal by Subject|0|||
129066621|NCT02762929|464531788|FG005|Overall Study|Withdrawal by Subject|0|||
129066622|NCT02762929|464531783|FG000|Overall Study|exclusionary medication disclosed late|0|||
129066623|NCT02762929|464531784|FG001|Overall Study|exclusionary medication disclosed late|0|||
129066624|NCT02762929|464531785|FG002|Overall Study|exclusionary medication disclosed late|0|||
129066625|NCT02762929|464531786|FG003|Overall Study|exclusionary medication disclosed late|1|||
129066626|NCT02762929|464531787|FG004|Overall Study|exclusionary medication disclosed late|0|||
128721724|NCT04709575|463279239|FG001|Overall Study|Lost to Follow-up|2|||
128721725|NCT04709575|463279238|FG000|Overall Study|Adverse Event|1|||
129066627|NCT02762929|464531788|FG005|Overall Study|exclusionary medication disclosed late|0|||
129066628|NCT01811472|464531791|FG000|Overall Study|Adverse Event|1|||
129066629|NCT01811472|464531792|FG001|Overall Study|Adverse Event|0|||
129066630|NCT01811472|464531793|FG002|Overall Study|Adverse Event|4|||
129066631|NCT01811472|464531791|FG000|Overall Study|Lost to Follow-up|0|||
129066632|NCT01811472|464531792|FG001|Overall Study|Lost to Follow-up|0|||
129066633|NCT01811472|464531793|FG002|Overall Study|Lost to Follow-up|1|||
129066634|NCT01811472|464531791|FG000|Overall Study|Subject/guardian decision|1|||
129066635|NCT01811472|464531792|FG001|Overall Study|Subject/guardian decision|0|||
129137916|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
128721726|NCT04709575|463279239|FG001|Overall Study|Adverse Event|0|||
128721727|NCT04709575|463279238|FG000|Overall Study|Protocol Violation|1|||
128721728|NCT04709575|463279239|FG001|Overall Study|Protocol Violation|1|||
129137917|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
128721729|NCT03181399|463279240|FG000|6 Months on Treatment|Protocol non-compliance|7|||
128721730|NCT03181399|463279240|FG000|6 Months on Treatment|Adverse Event|4|||
128721731|NCT03181399|463279240|FG000|6 Months on Treatment|Tried alternative treatment|2|||
128721732|NCT03181399|463279240|FG000|6 Months on Treatment|Lost to Follow-up|2|||
128721733|NCT03181399|463279240|FG000|6 Months on Treatment|Personal reasons|1|||
128721734|NCT03181399|463279240|FG000|3 Months Off-treatment|Parent unable to travel|1|||
128721735|NCT00004888|463279250|FG000|Overall Study|Adverse Event|5|||
128721736|NCT00004888|463279251|FG001|Overall Study|Adverse Event|10|||
128721737|NCT00004888|463279250|FG000|Overall Study|Withdrawal by Subject|0|||
128721738|NCT00004888|463279251|FG001|Overall Study|Withdrawal by Subject|3|||
128721739|NCT00004888|463279250|FG000|Overall Study|Physician Decision|1|||
128721740|NCT00004888|463279251|FG001|Overall Study|Physician Decision|1|||
128721741|NCT00004888|463279250|FG000|Overall Study|Progressive Disease|4|||
128721742|NCT00004888|463279251|FG001|Overall Study|Progressive Disease|9|||
128721743|NCT00004888|463279250|FG000|Overall Study|Death without progressive disease|0|||
128721744|NCT00004888|463279251|FG001|Overall Study|Death without progressive disease|1|||
128721745|NCT00004888|463279250|FG000|Overall Study|Toxic death|1|||
128721746|NCT00004888|463279251|FG001|Overall Study|Toxic death|0|||
128721747|NCT02579265|463279252|FG000|Overall Study|Weaned off earlier than 28 days|44|||
128721748|NCT02579265|463279253|FG001|Overall Study|Weaned off earlier than 28 days|43|||
128721749|NCT02579265|463279252|FG000|Overall Study|Adverse Event|2|||
128721750|NCT02579265|463279253|FG001|Overall Study|Adverse Event|0|||
128721751|NCT02579265|463279252|FG000|Overall Study|Any other reason not specified|0|||
128721752|NCT02579265|463279253|FG001|Overall Study|Any other reason not specified|2|||
128721753|NCT02579265|463279252|FG000|Overall Study|Withdrawal by Subject|2|||
128721754|NCT02579265|463279253|FG001|Overall Study|Withdrawal by Subject|0|||
128721755|NCT02579265|463279252|FG000|Overall Study|Physician Decision|1|||
128721756|NCT02579265|463279253|FG001|Overall Study|Physician Decision|0|||
128721757|NCT02579265|463279252|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
128721758|NCT02579265|463279253|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
128721759|NCT02174848|463279254|FG000|Overall Study|Adverse Event|2|||
128721760|NCT02174848|463279255|FG001|Overall Study|Adverse Event|1|||
128721761|NCT02174848|463279254|FG000|Overall Study|Withdrawal by Subject|3|||
128721762|NCT02174848|463279255|FG001|Overall Study|Withdrawal by Subject|3|||
128721763|NCT02174848|463279254|FG000|Overall Study|Lost to Follow-up|0|||
128721764|NCT02174848|463279255|FG001|Overall Study|Lost to Follow-up|1|||
128721765|NCT02174848|463279254|FG000|Overall Study|Worsening of disease|1|||
128721766|NCT02174848|463279255|FG001|Overall Study|Worsening of disease|1|||
128721767|NCT02174848|463279254|FG000|Overall Study|Unable to comply with study requirements|1|||
128721768|NCT02174848|463279255|FG001|Overall Study|Unable to comply with study requirements|0|||
128721769|NCT04254978|463279259|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
128721770|NCT04254978|463279259|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
128721771|NCT04254978|463279259|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
128721772|NCT04254978|463279259|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
128721773|NCT04254978|463279259|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
128721774|NCT04254978|463279259|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
128721775|NCT00644969|463279260|FG000|Treatment Phase|Randomized, not treated|1|||
128721776|NCT00644969|463279261|FG001|Treatment Phase|Randomized, not treated|0|||
128721777|NCT00644969|463279260|FG000|Treatment Phase|Adverse Event|3|||
128721778|NCT00644969|463279261|FG001|Treatment Phase|Adverse Event|0|||
128721779|NCT00644969|463279260|FG000|Treatment Phase|Withdrawal by Subject|4|||
128721780|NCT00644969|463279261|FG001|Treatment Phase|Withdrawal by Subject|0|||
128721781|NCT00644969|463279260|FG000|Treatment Phase|Lost to Follow-up|2|||
128721782|NCT00644969|463279261|FG001|Treatment Phase|Lost to Follow-up|2|||
128721783|NCT00644969|463279260|FG000|Treatment Phase|Other|4|||
128721784|NCT00644969|463279261|FG001|Treatment Phase|Other|1|||
128721785|NCT00644969|463279260|FG000|Post Treatment Phase|Death|1|||
128721786|NCT00644969|463279261|FG001|Post Treatment Phase|Death|0|||
128721787|NCT00644969|463279260|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
128721788|NCT00644969|463279261|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
128721789|NCT00644969|463279260|FG000|Post Treatment Phase|Lost to Follow-up|4|||
128721790|NCT00644969|463279261|FG001|Post Treatment Phase|Lost to Follow-up|1|||
128721791|NCT00644969|463279260|FG000|Post Treatment Phase|Other|1|||
128721792|NCT00644969|463279261|FG001|Post Treatment Phase|Other|0|||
128721793|NCT02515942|463279262|FG000|Overall Study|Adverse Event|5|||
128721794|NCT02515942|463279263|FG001|Overall Study|Adverse Event|0|||
128721795|NCT02515942|463279264|FG002|Overall Study|Adverse Event|0|||
128721796|NCT02515942|463279262|FG000|Overall Study|Death|0|||
128721797|NCT02515942|463279263|FG001|Overall Study|Death|0|||
128721798|NCT02515942|463279264|FG002|Overall Study|Death|1|||
128721799|NCT02515942|463279262|FG000|Overall Study|Lack of Efficacy|0|||
128721800|NCT02515942|463279263|FG001|Overall Study|Lack of Efficacy|0|||
128721801|NCT02515942|463279264|FG002|Overall Study|Lack of Efficacy|1|||
128775849|NCT02584855|463468491|FG004|Open-Label Treatment Period|No PI Available|0|||
128721802|NCT02515942|463279262|FG000|Overall Study|Lost to Follow-up|2|||
128721803|NCT02515942|463279263|FG001|Overall Study|Lost to Follow-up|0|||
129066636|NCT01811472|464531793|FG002|Overall Study|Subject/guardian decision|0|||
129066637|NCT03280264|464531794|FG000|Overall Study|Adverse Event|1|||
129066638|NCT03280264|464531794|FG000|Overall Study|Physician Decision|1|||
129066639|NCT03280264|464531794|FG000|Overall Study|Withdrawal by Subject|1|||
129066640|NCT02738138|464531796|FG000|Overall Study|Adverse Event|0|||
129066641|NCT02738138|464531797|FG001|Overall Study|Adverse Event|1|||
129066642|NCT02738138|464531796|FG000|Overall Study|Lost to Follow-up|2|||
129066643|NCT02738138|464531797|FG001|Overall Study|Lost to Follow-up|0|||
129066644|NCT02738138|464531796|FG000|Overall Study|Other - not further specified|1|||
129066645|NCT02738138|464531797|FG001|Overall Study|Other - not further specified|0|||
129066646|NCT01995513|464531803|FG000|Period 1: First Open Label Treatment|Other|34|||
129066647|NCT01995513|464531804|FG001|Period 1: First Open Label Treatment|Other|0|||
129066648|NCT01995513|464531805|FG002|Period 1: First Open Label Treatment|Other|0|||
129066649|NCT01995513|464531806|FG003|Period 1: First Open Label Treatment|Other|0|||
129066650|NCT01995513|464531803|FG000|Period 1: First Open Label Treatment|Death|14|||
129066651|NCT01995513|464531804|FG001|Period 1: First Open Label Treatment|Death|0|||
129066652|NCT01995513|464531805|FG002|Period 1: First Open Label Treatment|Death|0|||
129066653|NCT01995513|464531806|FG003|Period 1: First Open Label Treatment|Death|0|||
129066654|NCT01995513|464531803|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
129066655|NCT01995513|464531804|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
129066656|NCT01995513|464531805|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
129066657|NCT01995513|464531806|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
129066658|NCT01995513|464531803|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
129066659|NCT01995513|464531804|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
129066660|NCT01995513|464531805|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
129066661|NCT01995513|464531806|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
129066662|NCT01995513|464531803|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
129066663|NCT01995513|464531804|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
129066664|NCT01995513|464531805|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
129066665|NCT01995513|464531806|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
129066666|NCT01995513|464531803|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
129066667|NCT01995513|464531804|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
129066668|NCT01995513|464531805|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
129066669|NCT01995513|464531806|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
129066670|NCT01995513|464531803|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
129066671|NCT01995513|464531804|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
129066672|NCT01995513|464531805|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
129066673|NCT01995513|464531806|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
129066674|NCT01995513|464531803|FG000|Period 1: Second Open Label Treatment|Other|0|||
129066675|NCT01995513|464531804|FG001|Period 1: Second Open Label Treatment|Other|2|||
129137918|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
129137919|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129137920|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129137921|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129137922|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129137923|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129137924|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129137925|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129137926|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129137927|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129137928|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129137929|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
129137930|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
129137931|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129137932|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
129137933|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
129137934|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129137935|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129137936|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
129137937|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129137938|NCT01557244|464798349|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
129137939|NCT01557244|464798350|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129137940|NCT01557244|464798351|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
129137941|NCT01557244|464798352|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129137942|NCT01557244|464798353|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129137943|NCT01557244|464798354|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129137944|NCT01557244|464798355|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129137945|NCT01557244|464798349|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
129137946|NCT01557244|464798350|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
129066676|NCT01995513|464531805|FG002|Period 1: Second Open Label Treatment|Other|0|||
129066677|NCT01995513|464531806|FG003|Period 1: Second Open Label Treatment|Other|0|||
129066678|NCT01995513|464531803|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
129066679|NCT01995513|464531804|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
129137947|NCT01557244|464798351|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129137948|NCT01557244|464798352|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129066680|NCT01995513|464531805|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
129066681|NCT01995513|464531806|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
129066682|NCT01995513|464531803|FG000|Period 2: Double Blind Treatment|Death|0|||
129066683|NCT01995513|464531804|FG001|Period 2: Double Blind Treatment|Death|0|||
129066684|NCT01995513|464531805|FG002|Period 2: Double Blind Treatment|Death|0|||
129066685|NCT01995513|464531806|FG003|Period 2: Double Blind Treatment|Death|1|||
129066686|NCT01995513|464531803|FG000|Period 2: Double Blind Treatment|Other|0|||
129066687|NCT01995513|464531804|FG001|Period 2: Double Blind Treatment|Other|0|||
129066688|NCT01995513|464531805|FG002|Period 2: Double Blind Treatment|Other|3|||
129066689|NCT01995513|464531806|FG003|Period 2: Double Blind Treatment|Other|3|||
129066690|NCT01995513|464531803|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
129066691|NCT01995513|464531804|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
129066692|NCT01995513|464531805|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
129066693|NCT01995513|464531806|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
129066694|NCT01995513|464531803|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
129066695|NCT01995513|464531804|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
129066696|NCT01995513|464531805|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
129066697|NCT01995513|464531806|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
129066698|NCT01995513|464531803|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
129066699|NCT01995513|464531804|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
129066700|NCT01995513|464531805|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
129066701|NCT01995513|464531806|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
129066702|NCT01995513|464531803|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
129066703|NCT01995513|464531804|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
129066704|NCT01995513|464531805|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
129066705|NCT01995513|464531806|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
129066706|NCT04108299|464531812|FG000|Overall Study|Not interested in participating|2|||
129066707|NCT04108299|464531813|FG001|Overall Study|Not interested in participating|1|||
128721804|NCT02515942|463279264|FG002|Overall Study|Lost to Follow-up|0|||
129066708|NCT04108299|464531814|FG002|Overall Study|Not interested in participating|2|||
129066709|NCT04108299|464531815|FG003|Overall Study|Not interested in participating|1|||
129066710|NCT04123405|464531816|FG000|Overall Study|Adverse Event|1|||
129066711|NCT04123405|464531817|FG001|Overall Study|Adverse Event|2|||
128721805|NCT02515942|463279262|FG000|Overall Study|Withdrawal by Subject|0|||
128721806|NCT02515942|463279263|FG001|Overall Study|Withdrawal by Subject|3|||
128721807|NCT02515942|463279264|FG002|Overall Study|Withdrawal by Subject|2|||
128721808|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
128721809|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
128721810|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
128721811|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
128721812|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
128721813|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
128721814|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
128721815|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
128721816|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
128721817|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
128721818|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
128721819|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
128721820|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
128721821|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
128721822|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
128721823|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
128721824|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
128721825|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
128721826|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
128721827|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
128721828|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
128721829|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
128721830|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
128721831|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
128721832|NCT00277212|463279265|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
128721833|NCT00277212|463279266|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
128721834|NCT00277212|463279267|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
128721835|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
128721836|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
128721837|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
129066712|NCT04123405|464531818|FG002|Overall Study|Adverse Event|3|||
129066713|NCT04123405|464531819|FG003|Overall Study|Adverse Event|3|||
129066714|NCT04123405|464531816|FG000|Overall Study|Exclusion criteria met|1|||
128721838|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
129066715|NCT04123405|464531817|FG001|Overall Study|Exclusion criteria met|2|||
129066716|NCT04123405|464531818|FG002|Overall Study|Exclusion criteria met|0|||
129066717|NCT04123405|464531819|FG003|Overall Study|Exclusion criteria met|2|||
129066718|NCT04123405|464531816|FG000|Overall Study|Withdrawal by Subject|1|||
129066719|NCT04123405|464531817|FG001|Overall Study|Withdrawal by Subject|3|||
129066720|NCT04123405|464531818|FG002|Overall Study|Withdrawal by Subject|0|||
129066721|NCT04123405|464531819|FG003|Overall Study|Withdrawal by Subject|2|||
129066722|NCT04123405|464531816|FG000|Overall Study|Contact to subject lost|0|||
129066723|NCT04123405|464531817|FG001|Overall Study|Contact to subject lost|0|||
129066724|NCT04123405|464531818|FG002|Overall Study|Contact to subject lost|0|||
129066725|NCT04123405|464531819|FG003|Overall Study|Contact to subject lost|1|||
129066726|NCT04123405|464531816|FG000|Overall Study|screening failure|1|||
129066727|NCT04123405|464531817|FG001|Overall Study|screening failure|0|||
129066728|NCT04123405|464531818|FG002|Overall Study|screening failure|0|||
129066729|NCT04123405|464531819|FG003|Overall Study|screening failure|0|||
129066730|NCT00247676|464531820|FG000|Overall Study|Death|5|||
129066731|NCT00247676|464531820|FG000|Overall Study|Adverse Event|11|||
129066732|NCT00247676|464531820|FG000|Overall Study|Lack of Efficacy|15|||
129066733|NCT00247676|464531820|FG000|Overall Study|Other|3|||
129066734|NCT00247676|464531820|FG000|Overall Study|Withdrawal by Subject|2|||
129066735|NCT01026194|464531821|FG000|Period 1：Double Blind Period|Adverse Event|2|||
129066736|NCT01026194|464531822|FG001|Period 1：Double Blind Period|Adverse Event|1|||
129066737|NCT01026194|464531821|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
129066738|NCT01026194|464531822|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
129066739|NCT01026194|464531821|FG000|Period 1：Double Blind Period|Physician Decision|0|||
129066740|NCT01026194|464531822|FG001|Period 1：Double Blind Period|Physician Decision|4|||
129066741|NCT01026194|464531821|FG000|Period 2：Open-label Period|Adverse Event|4|||
129066742|NCT01026194|464531822|FG001|Period 2：Open-label Period|Adverse Event|5|||
129066743|NCT01026194|464531821|FG000|Period 2：Open-label Period|Physician Decision|3|||
129066744|NCT01026194|464531822|FG001|Period 2：Open-label Period|Physician Decision|1|||
129066745|NCT01026194|464531821|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
129066746|NCT01026194|464531822|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
129066747|NCT01750190|464531823|FG000|Overall Study|Adverse Event|47|||
129066748|NCT01750190|464531824|FG001|Overall Study|Adverse Event|19|||
129066749|NCT01750190|464531823|FG000|Overall Study|Death|38|||
129066750|NCT01750190|464531824|FG001|Overall Study|Death|11|||
129066751|NCT01750190|464531823|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
129066752|NCT01750190|464531824|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
129066753|NCT01750190|464531823|FG000|Overall Study|Lost to Follow-up|28|||
129066754|NCT01750190|464531824|FG001|Overall Study|Lost to Follow-up|7|||
129066755|NCT01750190|464531823|FG000|Overall Study|Physician Decision|16|||
129066756|NCT01750190|464531824|FG001|Overall Study|Physician Decision|17|||
129066757|NCT01750190|464531823|FG000|Overall Study|Protocol Violation|6|||
129066758|NCT01750190|464531824|FG001|Overall Study|Protocol Violation|5|||
129066759|NCT01750190|464531823|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
129066760|NCT01750190|464531824|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
129066761|NCT01750190|464531823|FG000|Overall Study|Withdrawal by Subject|83|||
129066762|NCT01750190|464531824|FG001|Overall Study|Withdrawal by Subject|89|||
129066763|NCT01750190|464531823|FG000|Overall Study|Kidney Transplant|8|||
129066764|NCT01750190|464531824|FG001|Overall Study|Kidney Transplant|4|||
129066765|NCT01750190|464531823|FG000|Overall Study|Dialysis|22|||
129066766|NCT01750190|464531824|FG001|Overall Study|Dialysis|8|||
129066767|NCT01750190|464531823|FG000|Overall Study|Other than Specified|13|||
129066768|NCT01750190|464531824|FG001|Overall Study|Other than Specified|4|||
129066769|NCT02071225|464531827|FG000|Overall Study|Withdrawal of Consent|2|||
129066770|NCT02071225|464531827|FG000|Overall Study|Protocol Deviation|1|||
129066771|NCT02071225|464531827|FG000|Overall Study|Lost to Follow-up|2|||
129066772|NCT02071225|464531827|FG000|Overall Study|Death|25|||
129066773|NCT02064296|464531830|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
129066774|NCT02064296|464531831|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
129066775|NCT02064296|464531832|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
129066776|NCT02064296|464531830|FG000|Intervention|Withdrawal by Subject|0|||
129137949|NCT01557244|464798353|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129137950|NCT01557244|464798354|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
129137951|NCT01557244|464798355|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129137952|NCT01557244|464798349|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
129137953|NCT01557244|464798350|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
129137954|NCT01557244|464798351|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129137955|NCT01557244|464798352|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129066777|NCT02064296|464531831|FG001|Intervention|Withdrawal by Subject|1|||
129066778|NCT02064296|464531832|FG002|Intervention|Withdrawal by Subject|2|||
129066779|NCT03934541|464531841|FG000|Overall Study|Study Terminated by Sponsor|0|||
129066780|NCT03934541|464531842|FG001|Overall Study|Study Terminated by Sponsor|1|||
129066781|NCT03934541|464531843|FG002|Overall Study|Study Terminated by Sponsor|0|||
129066782|NCT03934541|464531844|FG003|Overall Study|Study Terminated by Sponsor|0|||
129066783|NCT02673775|464531845|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
129066784|NCT02673775|464531846|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
129066785|NCT02673775|464531845|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
129066786|NCT02673775|464531846|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
129066787|NCT02673775|464531845|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
129066788|NCT02673775|464531846|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
129066789|NCT02673775|464531845|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
129066790|NCT02673775|464531846|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
129066791|NCT02441686|464531847|FG000|Induction|Adverse Event|4|||
129066792|NCT02441686|464531847|FG000|Induction|Complicating disease|1|||
129066793|NCT02441686|464531847|FG000|Induction|Physician Decision|1|||
129066794|NCT02441686|464531847|FG000|Induction|Withdrawal by Subject|1|||
129066795|NCT02441686|464531847|FG000|Induction|Did not receive treatment|1|||
129066796|NCT02441686|464531847|FG000|Maintenance|Remaining on Treatment|23|||
129066797|NCT02441686|464531847|FG000|Maintenance|Physician Decision|1|||
129066798|NCT02441686|464531847|FG000|Maintenance|Adverse Event|3|||
129066799|NCT02441686|464531847|FG000|Maintenance|Progressive Disease|10|||
129066800|NCT02441686|464531847|FG000|Maintenance|Withdrawal by Subject|1|||
129066801|NCT03151304|464531848|FG000|Overall Study|Termination of study by Sponsor|23|||
129066802|NCT03151304|464531848|FG000|Overall Study|missing|3|||
129066803|NCT03151304|464531848|FG000|Overall Study|Withdrawal by Subject|8|||
129066804|NCT03151304|464531848|FG000|Overall Study|multiple reasons|30|||
129066805|NCT04194645|464531851|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066806|NCT04194645|464531852|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066807|NCT04194645|464531853|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066808|NCT04194645|464531854|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066809|NCT04194645|464531855|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066810|NCT04194645|464531856|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066811|NCT04194645|464531857|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066812|NCT04194645|464531858|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066813|NCT04194645|464531859|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
128721839|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
128721840|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
128721841|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
129066814|NCT04194645|464531860|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
129066815|NCT04194645|464531861|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066816|NCT04194645|464531862|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066817|NCT04194645|464531863|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066818|NCT04194645|464531864|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066819|NCT04194645|464531865|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129066820|NCT03076775|464531866|FG000|Overall Study|Lost to Follow-up|1|||
129066821|NCT03076775|464531867|FG001|Overall Study|Lost to Follow-up|0|||
129066822|NCT01783886|464531868|FG000|Overall Study|Lost to Follow-up|0|||
129066823|NCT01783886|464531869|FG001|Overall Study|Lost to Follow-up|3|||
129066824|NCT01783886|464531870|FG002|Overall Study|Lost to Follow-up|0|||
129066825|NCT01783886|464531868|FG000|Overall Study|Protocol deviation|0|||
129066826|NCT01783886|464531869|FG001|Overall Study|Protocol deviation|0|||
129066827|NCT01783886|464531870|FG002|Overall Study|Protocol deviation|2|||
129066828|NCT01783886|464531868|FG000|Overall Study|Withdrawal of consent by participant|1|||
129066829|NCT01783886|464531869|FG001|Overall Study|Withdrawal of consent by participant|3|||
129066830|NCT01783886|464531870|FG002|Overall Study|Withdrawal of consent by participant|4|||
129066831|NCT01783886|464531868|FG000|Overall Study|Adverse Event|4|||
129066832|NCT01783886|464531869|FG001|Overall Study|Adverse Event|5|||
129066833|NCT01783886|464531870|FG002|Overall Study|Adverse Event|4|||
129066834|NCT04542057|464531871|FG000|Overall Study|Death|3|||
129066835|NCT04542057|464531872|FG001|Overall Study|Death|1|||
129066836|NCT04542057|464531871|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
129066837|NCT04542057|464531872|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
129066838|NCT04542057|464531871|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
129066839|NCT04542057|464531872|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
129066840|NCT04542057|464531871|FG000|Overall Study|Adverse Event|15|||
129066841|NCT04542057|464531872|FG001|Overall Study|Adverse Event|6|||
129066842|NCT04542057|464531871|FG000|Overall Study|COVID-19 adverse event|6|||
129066843|NCT04542057|464531872|FG001|Overall Study|COVID-19 adverse event|4|||
129066844|NCT04542057|464531871|FG000|Overall Study|Lack of Efficacy|2|||
129066845|NCT04542057|464531872|FG001|Overall Study|Lack of Efficacy|5|||
129066846|NCT04542057|464531871|FG000|Overall Study|Study terminated by sponsor|1|||
129066847|NCT04542057|464531872|FG001|Overall Study|Study terminated by sponsor|0|||
129066848|NCT04542057|464531871|FG000|Overall Study|Investigator discretion|2|||
129066849|NCT04542057|464531872|FG001|Overall Study|Investigator discretion|1|||
129066850|NCT04542057|464531871|FG000|Overall Study|Withdrawal by Subject|52|||
129066851|NCT04542057|464531872|FG001|Overall Study|Withdrawal by Subject|30|||
129066852|NCT04542057|464531871|FG000|Overall Study|Lost to Follow-up|8|||
129066853|NCT04542057|464531872|FG001|Overall Study|Lost to Follow-up|11|||
129066854|NCT04542057|464531871|FG000|Overall Study|Other|2|||
129066855|NCT04542057|464531872|FG001|Overall Study|Other|2|||
129066856|NCT00104572|464531873|FG000|Overall Study|Withdrawal by Subject|3|||
129066857|NCT00104572|464531874|FG001|Overall Study|Withdrawal by Subject|3|||
129066858|NCT00104572|464531875|FG002|Overall Study|Withdrawal by Subject|0|||
129066859|NCT00940316|464531878|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
129066860|NCT00940316|464531879|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
129066861|NCT00940316|464531880|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
129066862|NCT00940316|464531878|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
129066863|NCT00940316|464531879|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
129066864|NCT00940316|464531880|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
129066865|NCT00940316|464531878|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
129066866|NCT00940316|464531879|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
129066867|NCT00940316|464531880|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
129066868|NCT00940316|464531878|FG000|Treated After Cycle 5|Adverse Event|0|||
129066869|NCT00940316|464531879|FG001|Treated After Cycle 5|Adverse Event|0|||
129066870|NCT00940316|464531880|FG002|Treated After Cycle 5|Adverse Event|1|||
129137956|NCT01557244|464798353|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129137957|NCT01557244|464798354|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129137958|NCT01557244|464798355|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129137959|NCT01557244|464798349|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129066871|NCT00940316|464531878|FG000|Treated After Cycle 5|Progressive disease|0|||
129066872|NCT00940316|464531879|FG001|Treated After Cycle 5|Progressive disease|1|||
129066873|NCT00940316|464531880|FG002|Treated After Cycle 5|Progressive disease|0|||
129066874|NCT02290405|464531884|FG000|Overall Study|Withdrawal by Subject|1|||
129066875|NCT02290405|464531885|FG001|Overall Study|Withdrawal by Subject|0|||
129066876|NCT02016183|464531886|FG000|Overall Study|Case Report Forms Uncollected|13|||
129066877|NCT02016183|464531886|FG000|Overall Study|Protocol Violation|52|||
129137960|NCT01557244|464798350|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129137961|NCT01557244|464798351|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129137962|NCT01557244|464798352|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
129066878|NCT00996489|464531887|FG000|Overall Study|Device failure|45|||
129066879|NCT00996489|464531887|FG000|Overall Study|Discontinued|116|||
129066880|NCT03142191|464531888|FG000|Placebo Controlled Period|Death|0|||
129066881|NCT03142191|464531889|FG001|Placebo Controlled Period|Death|1|||
129066882|NCT03142191|464531890|FG002|Placebo Controlled Period|Death|1|||
129066883|NCT03142191|464531891|FG003|Placebo Controlled Period|Death|0|||
129066884|NCT03142191|464531892|FG004|Placebo Controlled Period|Death|0|||
129066885|NCT03142191|464531888|FG000|Placebo Controlled Period|Adverse Event|4|||
129066886|NCT03142191|464531889|FG001|Placebo Controlled Period|Adverse Event|5|||
129066887|NCT03142191|464531890|FG002|Placebo Controlled Period|Adverse Event|1|||
129066888|NCT03142191|464531891|FG003|Placebo Controlled Period|Adverse Event|0|||
129066889|NCT03142191|464531892|FG004|Placebo Controlled Period|Adverse Event|0|||
129066890|NCT03142191|464531888|FG000|Placebo Controlled Period|Progressive Disease|1|||
129066891|NCT03142191|464531889|FG001|Placebo Controlled Period|Progressive Disease|0|||
129066892|NCT03142191|464531890|FG002|Placebo Controlled Period|Progressive Disease|1|||
129066893|NCT03142191|464531891|FG003|Placebo Controlled Period|Progressive Disease|0|||
129066894|NCT03142191|464531892|FG004|Placebo Controlled Period|Progressive Disease|0|||
129066895|NCT03142191|464531888|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
129066896|NCT03142191|464531889|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
129066897|NCT03142191|464531890|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
129066898|NCT03142191|464531891|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
129066899|NCT03142191|464531892|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
129066900|NCT03142191|464531888|FG000|Placebo Controlled Period|Other Reasons|1|||
129066901|NCT03142191|464531889|FG001|Placebo Controlled Period|Other Reasons|0|||
129066902|NCT03142191|464531890|FG002|Placebo Controlled Period|Other Reasons|0|||
129066903|NCT03142191|464531891|FG003|Placebo Controlled Period|Other Reasons|0|||
129066904|NCT03142191|464531892|FG004|Placebo Controlled Period|Other Reasons|0|||
129066905|NCT03142191|464531888|FG000|Active Treatment Extension Period|Death|2|||
129066906|NCT03142191|464531889|FG001|Active Treatment Extension Period|Death|1|||
129066907|NCT03142191|464531890|FG002|Active Treatment Extension Period|Death|1|||
129066908|NCT03142191|464531891|FG003|Active Treatment Extension Period|Death|1|||
129066909|NCT03142191|464531892|FG004|Active Treatment Extension Period|Death|0|||
129066910|NCT03142191|464531888|FG000|Active Treatment Extension Period|Adverse Event|6|||
129066911|NCT03142191|464531889|FG001|Active Treatment Extension Period|Adverse Event|5|||
129066912|NCT03142191|464531890|FG002|Active Treatment Extension Period|Adverse Event|4|||
129066913|NCT03142191|464531891|FG003|Active Treatment Extension Period|Adverse Event|1|||
129066914|NCT03142191|464531892|FG004|Active Treatment Extension Period|Adverse Event|0|||
129066915|NCT03142191|464531888|FG000|Active Treatment Extension Period|Progressive Disease|10|||
129066916|NCT03142191|464531889|FG001|Active Treatment Extension Period|Progressive Disease|5|||
129066917|NCT03142191|464531890|FG002|Active Treatment Extension Period|Progressive Disease|4|||
129066918|NCT03142191|464531891|FG003|Active Treatment Extension Period|Progressive Disease|1|||
129066919|NCT03142191|464531892|FG004|Active Treatment Extension Period|Progressive Disease|2|||
129066920|NCT03142191|464531888|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
129066921|NCT03142191|464531889|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
129066922|NCT03142191|464531890|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
129066923|NCT03142191|464531891|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
129066924|NCT03142191|464531892|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
129066925|NCT03142191|464531888|FG000|Active Treatment Extension Period|Physician Decision|2|||
129066926|NCT03142191|464531889|FG001|Active Treatment Extension Period|Physician Decision|0|||
129066927|NCT03142191|464531890|FG002|Active Treatment Extension Period|Physician Decision|0|||
129066928|NCT03142191|464531891|FG003|Active Treatment Extension Period|Physician Decision|0|||
129066929|NCT03142191|464531892|FG004|Active Treatment Extension Period|Physician Decision|0|||
129066930|NCT03142191|464531888|FG000|Active Treatment Extension Period|Other Reasons|3|||
129066931|NCT03142191|464531889|FG001|Active Treatment Extension Period|Other Reasons|3|||
129066932|NCT03142191|464531890|FG002|Active Treatment Extension Period|Other Reasons|3|||
129066933|NCT03142191|464531891|FG003|Active Treatment Extension Period|Other Reasons|8|||
129066934|NCT03142191|464531892|FG004|Active Treatment Extension Period|Other Reasons|3|||
129066935|NCT03142191|464531888|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
129066936|NCT03142191|464531889|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
129066937|NCT03142191|464531890|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
129066938|NCT03142191|464531891|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
129066939|NCT03142191|464531892|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
129066940|NCT00770328|464531895|FG000|Overall Study|Adverse Event|11|||
129066941|NCT00770328|464531896|FG001|Overall Study|Adverse Event|2|||
129066942|NCT00770328|464531895|FG000|Overall Study|Lost to Follow-up|2|||
129066943|NCT00770328|464531896|FG001|Overall Study|Lost to Follow-up|2|||
129066944|NCT01130493|464531897|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
129066945|NCT01130493|464531898|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
129066946|NCT01130493|464531899|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
129066947|NCT01130493|464531897|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
129066948|NCT01130493|464531898|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
129066949|NCT01130493|464531899|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
129066950|NCT01130493|464531897|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
129066951|NCT01130493|464531898|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
129066952|NCT01130493|464531899|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
129066953|NCT01130493|464531897|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
129066954|NCT01130493|464531898|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
129066955|NCT01130493|464531899|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
129066956|NCT01130493|464531897|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
129066957|NCT01130493|464531898|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
129066958|NCT01130493|464531899|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
129066959|NCT01130493|464531897|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
129066960|NCT01130493|464531898|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
129066961|NCT01130493|464531899|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
129066962|NCT01130493|464531897|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
129066963|NCT01130493|464531898|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
129066964|NCT01130493|464531899|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
129066965|NCT01130493|464531897|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
129066966|NCT01130493|464531898|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
129066967|NCT01130493|464531899|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
129066968|NCT01130493|464531897|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
129066969|NCT01130493|464531898|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
129066970|NCT01130493|464531899|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
129066971|NCT01130493|464531897|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
129066972|NCT01130493|464531898|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
129066973|NCT01130493|464531899|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
129066974|NCT01130493|464531897|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
129066975|NCT01130493|464531898|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
129066976|NCT01130493|464531899|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
129066977|NCT01130493|464531897|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
129066978|NCT01130493|464531898|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
129066979|NCT01130493|464531899|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
129066980|NCT01130493|464531897|FG000|Part 2: OLE|Adverse Event|0|||
129066981|NCT01130493|464531898|FG001|Part 2: OLE|Adverse Event|2|||
129066982|NCT01130493|464531899|FG002|Part 2: OLE|Adverse Event|1|||
129066983|NCT01130493|464531897|FG000|Part 2: OLE|Withdrawal by Subject|0|||
129066984|NCT01130493|464531898|FG001|Part 2: OLE|Withdrawal by Subject|1|||
129066985|NCT01130493|464531899|FG002|Part 2: OLE|Withdrawal by Subject|4|||
129066986|NCT03452943|464531900|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
129066987|NCT03452943|464531901|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
129066988|NCT03452943|464531900|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
129066989|NCT03452943|464531901|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
128721842|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
129066990|NCT03452943|464531900|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
129066991|NCT03452943|464531901|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
129066992|NCT03452943|464531900|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
129066993|NCT03452943|464531901|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
129066994|NCT03452943|464531900|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
129066995|NCT03452943|464531901|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
129066996|NCT03452943|464531900|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
129066997|NCT03452943|464531901|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
129066998|NCT03541317|464531902|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
129066999|NCT03541317|464531903|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129067000|NCT03541317|464531904|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129067001|NCT03541317|464531905|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129067002|NCT03541317|464531906|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129067003|NCT03541317|464531907|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129067004|NCT02286843|464531908|FG000|Overall Study|Not Treated|4|||
129067005|NCT02286843|464531908|FG000|Overall Study|Protocol Violation|1|||
129067006|NCT02286843|464531908|FG000|Overall Study|Withdrawal by Subject|1|||
129067007|NCT02536846|464531909|FG000|Overall Study|Withdrawal by Subject|1|||
129137963|NCT01557244|464798353|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129137964|NCT01557244|464798354|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129137965|NCT01557244|464798355|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129067008|NCT02593110|464531910|FG000|Overall Study|Withdrawal by Subject|0|||
129067009|NCT02593110|464531911|FG001|Overall Study|Withdrawal by Subject|3|||
129067010|NCT02593110|464531912|FG002|Overall Study|Withdrawal by Subject|3|||
129067011|NCT02593110|464531913|FG003|Overall Study|Withdrawal by Subject|2|||
129067012|NCT02593110|464531910|FG000|Overall Study|Death|0|||
129067013|NCT02593110|464531911|FG001|Overall Study|Death|0|||
129067014|NCT02593110|464531912|FG002|Overall Study|Death|1|||
129137966|NCT01557244|464798349|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
129067015|NCT02593110|464531913|FG003|Overall Study|Death|0|||
129067016|NCT03086551|464531914|FG000|First Intervention|Failure to meet inclusion criterion|1|||
129067017|NCT03086551|464531915|FG001|First Intervention|Failure to meet inclusion criterion|0|||
129067018|NCT03086551|464531914|FG000|First Intervention|Lost to Follow-up|0|||
129067019|NCT03086551|464531915|FG001|First Intervention|Lost to Follow-up|1|||
129067020|NCT03086551|464531914|FG000|Washout|Lost to Follow-up|1|||
129067021|NCT03086551|464531915|FG001|Washout|Lost to Follow-up|2|||
129067022|NCT03086551|464531914|FG000|Washout|Withdrawal by Subject|2|||
129067023|NCT03086551|464531915|FG001|Washout|Withdrawal by Subject|1|||
129067024|NCT00625872|464531918|FG000|Overall Study|Withdrawal by Subject|1|||
129067025|NCT00625872|464531919|FG001|Overall Study|Withdrawal by Subject|0|||
129067026|NCT00625872|464531918|FG000|Overall Study|Does not meet inclusion criteria|1|||
129137967|NCT01557244|464798350|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
129137968|NCT01557244|464798351|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129137969|NCT01557244|464798352|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129137970|NCT01557244|464798353|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129137971|NCT01557244|464798354|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129137972|NCT01557244|464798355|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129137973|NCT01313676|464798356|FG000|Overall Study|Adverse Event|395|||
129137974|NCT01313676|464798357|FG001|Overall Study|Adverse Event|365|||
129137975|NCT01313676|464798358|FG002|Overall Study|Adverse Event|372|||
129137976|NCT01313676|464798359|FG003|Overall Study|Adverse Event|333|||
129137977|NCT01313676|464798356|FG000|Overall Study|Lack of Efficacy|98|||
129137978|NCT01313676|464798357|FG001|Overall Study|Lack of Efficacy|90|||
129137979|NCT01313676|464798358|FG002|Overall Study|Lack of Efficacy|65|||
129137980|NCT01313676|464798359|FG003|Overall Study|Lack of Efficacy|46|||
129137981|NCT01313676|464798356|FG000|Overall Study|Protocol Violation|37|||
129137982|NCT01313676|464798357|FG001|Overall Study|Protocol Violation|44|||
129137983|NCT01313676|464798358|FG002|Overall Study|Protocol Violation|46|||
129137984|NCT01313676|464798359|FG003|Overall Study|Protocol Violation|44|||
129137985|NCT01313676|464798356|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
129137986|NCT01313676|464798357|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
129137987|NCT01313676|464798358|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
129137988|NCT01313676|464798359|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
129137989|NCT01313676|464798356|FG000|Overall Study|Study Closed/terminated|7|||
129137990|NCT01313676|464798357|FG001|Overall Study|Study Closed/terminated|6|||
129137991|NCT01313676|464798358|FG002|Overall Study|Study Closed/terminated|9|||
129137992|NCT01313676|464798359|FG003|Overall Study|Study Closed/terminated|9|||
129137993|NCT01313676|464798356|FG000|Overall Study|Lost to Follow-up|0|||
129137994|NCT01313676|464798357|FG001|Overall Study|Lost to Follow-up|0|||
129137995|NCT01313676|464798358|FG002|Overall Study|Lost to Follow-up|1|||
129137996|NCT01313676|464798359|FG003|Overall Study|Lost to Follow-up|0|||
129137997|NCT01313676|464798356|FG000|Overall Study|Physician Decision|53|||
129137998|NCT01313676|464798357|FG001|Overall Study|Physician Decision|64|||
129137999|NCT01313676|464798358|FG002|Overall Study|Physician Decision|62|||
129138000|NCT01313676|464798359|FG003|Overall Study|Physician Decision|48|||
129138001|NCT01313676|464798356|FG000|Overall Study|Decision by Participant or Proxy|643|||
129138002|NCT01313676|464798357|FG001|Overall Study|Decision by Participant or Proxy|527|||
129138003|NCT01313676|464798358|FG002|Overall Study|Decision by Participant or Proxy|515|||
129138004|NCT01313676|464798359|FG003|Overall Study|Decision by Participant or Proxy|492|||
129138005|NCT01313676|464798356|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
129138006|NCT01313676|464798357|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
129138007|NCT01313676|464798358|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
129138008|NCT01313676|464798359|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
129138009|NCT01313676|464798356|FG000|Overall Study|Investigator Site Closed|12|||
129138010|NCT01313676|464798357|FG001|Overall Study|Investigator Site Closed|11|||
129138011|NCT01313676|464798358|FG002|Overall Study|Investigator Site Closed|15|||
129138012|NCT01313676|464798359|FG003|Overall Study|Investigator Site Closed|10|||
129138013|NCT01313676|464798356|FG000|Overall Study|Missing|1|||
129138014|NCT01313676|464798357|FG001|Overall Study|Missing|1|||
129138015|NCT01313676|464798358|FG002|Overall Study|Missing|1|||
129138016|NCT01313676|464798359|FG003|Overall Study|Missing|0|||
129067027|NCT00625872|464531919|FG001|Overall Study|Does not meet inclusion criteria|0|||
129067028|NCT00625872|464531918|FG000|Overall Study|Terminated by sponsor|2|||
129138017|NCT03312114|464798360|FG000|Overall Study|All the five enrolled dropped out of the|5|||
129138018|NCT00944645|464798361|FG000|Period 2|Adverse Event|1|||
129138019|NCT00944645|464798362|FG001|Period 2|Adverse Event|0|||
128775850|NCT02584855|463468492|FG005|Open-Label Treatment Period|No PI Available|0|||
128775851|NCT02584855|463468487|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
129067029|NCT00625872|464531919|FG001|Overall Study|Terminated by sponsor|5|||
129067030|NCT00625872|464531918|FG000|Overall Study|Randomized but not treated|0|||
129067031|NCT00625872|464531919|FG001|Overall Study|Randomized but not treated|1|||
129067032|NCT04208750|464531920|FG000|Overall Study|Lost to Follow-up|16|||
129067033|NCT04208750|464531921|FG001|Overall Study|Lost to Follow-up|15|||
129067034|NCT02201277|464531922|FG000|Overall Study|Death|3|||
129067035|NCT02201277|464531923|FG001|Overall Study|Death|4|||
129067036|NCT02201277|464531922|FG000|Overall Study|Lost to Follow-up|2|||
129067037|NCT02201277|464531923|FG001|Overall Study|Lost to Follow-up|1|||
129067038|NCT02201277|464531922|FG000|Overall Study|Failed retrieval|1|||
129067039|NCT02201277|464531923|FG001|Overall Study|Failed retrieval|0|||
129067040|NCT02201277|464531922|FG000|Overall Study|Physician Decision|1|||
129067041|NCT02201277|464531923|FG001|Overall Study|Physician Decision|0|||
129067042|NCT03485352|464531924|FG000|Overall Study|Lost to Follow-up|9|||
129067043|NCT01512160|464531925|FG000|Overall Study|Lost to Follow-up|1|||
129067044|NCT01512160|464531926|FG001|Overall Study|Lost to Follow-up|0|||
129067045|NCT01512160|464531927|FG002|Overall Study|Lost to Follow-up|0|||
129067046|NCT01512160|464531928|FG003|Overall Study|Lost to Follow-up|0|||
129067047|NCT01512160|464531925|FG000|Overall Study|Withdrawal by Subject|1|||
129067048|NCT01512160|464531926|FG001|Overall Study|Withdrawal by Subject|0|||
129067049|NCT01512160|464531927|FG002|Overall Study|Withdrawal by Subject|0|||
129067050|NCT01512160|464531928|FG003|Overall Study|Withdrawal by Subject|1|||
129138020|NCT00944645|464798361|FG000|Period 2|Lost to Follow-up|0|||
129138021|NCT00944645|464798362|FG001|Period 2|Lost to Follow-up|3|||
129138022|NCT00944645|464798361|FG000|Period 2|Withdrawal by Subject|7|||
129138023|NCT00944645|464798362|FG001|Period 2|Withdrawal by Subject|6|||
129138024|NCT03537729|464798363|FG000|Overall Study|Death|2|||
129138025|NCT03537729|464798364|FG001|Overall Study|Death|2|||
129138026|NCT03537729|464798365|FG002|Overall Study|Death|7|||
129138027|NCT03537729|464798363|FG000|Overall Study|Withdrawal by Subject|3|||
129138028|NCT03537729|464798364|FG001|Overall Study|Withdrawal by Subject|3|||
129138029|NCT03537729|464798365|FG002|Overall Study|Withdrawal by Subject|0|||
129138030|NCT03537729|464798363|FG000|Overall Study|Subject Moved|8|||
129138031|NCT03537729|464798364|FG001|Overall Study|Subject Moved|5|||
129138032|NCT03537729|464798365|FG002|Overall Study|Subject Moved|4|||
129138033|NCT03537729|464798363|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
129138034|NCT03537729|464798364|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
129138035|NCT03537729|464798365|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
129138036|NCT03537729|464798363|FG000|Overall Study|COVID-19 Site Restrictions|11|||
129138037|NCT03537729|464798364|FG001|Overall Study|COVID-19 Site Restrictions|15|||
129138038|NCT03537729|464798365|FG002|Overall Study|COVID-19 Site Restrictions|18|||
129138039|NCT03537729|464798363|FG000|Overall Study|Decline in Health|5|||
129138040|NCT03537729|464798364|FG001|Overall Study|Decline in Health|9|||
129138041|NCT03537729|464798365|FG002|Overall Study|Decline in Health|4|||
129138042|NCT03537729|464798363|FG000|Overall Study|Determined Ineligible|0|||
129138043|NCT03537729|464798364|FG001|Overall Study|Determined Ineligible|0|||
129138044|NCT03537729|464798365|FG002|Overall Study|Determined Ineligible|1|||
129138045|NCT00326495|464798367|FG000|Overall Study|Switched to alternative treatment|1|||
129138046|NCT00326495|464798367|FG000|Overall Study|Disease progression before treatment|1|||
129138047|NCT00326495|464798367|FG000|Overall Study|Refused further treatment|2|||
129138048|NCT00326495|464798367|FG000|Overall Study|Subject off study before assessment|1|||
129138049|NCT01654250|464798368|FG000|Overall Study|Lost to Follow-up|1|||
129138050|NCT01654250|464798369|FG001|Overall Study|Lost to Follow-up|0|||
129138051|NCT01862029|464798370|FG000|Overall Study|Physician Decision|1|||
129138052|NCT00504556|464798372|FG000|Overall Study|Adverse Event|11|||
129138053|NCT00504556|464798373|FG001|Overall Study|Adverse Event|11|||
129138054|NCT00504556|464798374|FG002|Overall Study|Adverse Event|14|||
129138055|NCT00504556|464798375|FG003|Overall Study|Adverse Event|13|||
129138056|NCT00504556|464798376|FG004|Overall Study|Adverse Event|5|||
129138057|NCT00504556|464798372|FG000|Overall Study|Death|3|||
129138058|NCT00504556|464798373|FG001|Overall Study|Death|3|||
129138059|NCT00504556|464798374|FG002|Overall Study|Death|1|||
129138060|NCT00504556|464798375|FG003|Overall Study|Death|0|||
129138061|NCT00504556|464798376|FG004|Overall Study|Death|2|||
129138062|NCT00504556|464798372|FG000|Overall Study|Protocol Violation|1|||
129138063|NCT00504556|464798373|FG001|Overall Study|Protocol Violation|3|||
129138064|NCT00504556|464798374|FG002|Overall Study|Protocol Violation|2|||
129138065|NCT00504556|464798375|FG003|Overall Study|Protocol Violation|1|||
129138066|NCT00504556|464798376|FG004|Overall Study|Protocol Violation|2|||
129138067|NCT00504556|464798372|FG000|Overall Study|Lost to Follow-up|0|||
129138068|NCT00504556|464798373|FG001|Overall Study|Lost to Follow-up|0|||
129138069|NCT00504556|464798374|FG002|Overall Study|Lost to Follow-up|1|||
129138070|NCT00504556|464798375|FG003|Overall Study|Lost to Follow-up|1|||
129138071|NCT00504556|464798376|FG004|Overall Study|Lost to Follow-up|1|||
129138072|NCT00504556|464798372|FG000|Overall Study|Withdrawal by Subject|16|||
128721843|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
129067051|NCT04903288|464533124|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
129067052|NCT04903288|464533124|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
129067053|NCT04903288|464533124|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
129067054|NCT04903288|464533124|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
129067055|NCT05878093|464533128|FG000|Overall Study|Withdrawal by Subject|3|||
129067056|NCT05878093|464533129|FG001|Overall Study|Withdrawal by Subject|1|||
129067057|NCT03690388|464533132|FG000|Overall Study|Adverse Event|8|||
129067058|NCT03690388|464533133|FG001|Overall Study|Adverse Event|1|||
129067059|NCT03690388|464533132|FG000|Overall Study|Radiographic Progression|14|||
129067060|NCT03690388|464533133|FG001|Overall Study|Radiographic Progression|29|||
129067061|NCT03690388|464533132|FG000|Overall Study|Clinical deterioration|10|||
129067062|NCT03690388|464533133|FG001|Overall Study|Clinical deterioration|6|||
129067063|NCT03690388|464533132|FG000|Overall Study|Withdrawal by Subject|2|||
129067064|NCT03690388|464533133|FG001|Overall Study|Withdrawal by Subject|0|||
129067065|NCT03690388|464533132|FG000|Overall Study|Lack of Efficacy|1|||
129067066|NCT03690388|464533133|FG001|Overall Study|Lack of Efficacy|0|||
129067067|NCT03690388|464533132|FG000|Overall Study|Lost to Follow-up|1|||
129067068|NCT03690388|464533133|FG001|Overall Study|Lost to Follow-up|0|||
129067069|NCT04100018|464533135|FG000|Pre-Treatment Period|Not Reported|0|||
129067070|NCT04100018|464533136|FG001|Pre-Treatment Period|Not Reported|4|||
129067071|NCT04100018|464533135|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
129067072|NCT04100018|464533136|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
129067073|NCT04100018|464533135|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
129067074|NCT04100018|464533136|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
129067075|NCT04100018|464533135|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
129067076|NCT04100018|464533136|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129067077|NCT04100018|464533135|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129067078|NCT04100018|464533136|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
129067079|NCT04100018|464533135|FG000|Treatment Period|Ongoing Treatment|1|||
129067080|NCT04100018|464533136|FG001|Treatment Period|Ongoing Treatment|0|||
129067081|NCT04100018|464533135|FG000|Treatment Period|Other Reason|26|||
129067082|NCT04100018|464533136|FG001|Treatment Period|Other Reason|37|||
129067083|NCT04100018|464533135|FG000|Treatment Period|Completed treatment as per protocol|1|||
129067084|NCT04100018|464533136|FG001|Treatment Period|Completed treatment as per protocol|2|||
129067085|NCT04100018|464533135|FG000|Treatment Period|Maximum clinical benefit|3|||
129067086|NCT04100018|464533136|FG001|Treatment Period|Maximum clinical benefit|0|||
129067087|NCT04100018|464533135|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
129067088|NCT04100018|464533136|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
129067089|NCT04100018|464533135|FG000|Treatment Period|Study drug toxicity|67|||
129067090|NCT04100018|464533136|FG001|Treatment Period|Study drug toxicity|28|||
129067091|NCT04100018|464533135|FG000|Treatment Period|Disease Progression|284|||
129067092|NCT04100018|464533136|FG001|Treatment Period|Disease Progression|327|||
129067093|NCT04100018|464533135|FG000|Treatment Period|Administrative reasons by sponsor|16|||
129067094|NCT04100018|464533136|FG001|Treatment Period|Administrative reasons by sponsor|30|||
129067095|NCT04100018|464533135|FG000|Treatment Period|Poor/Non-Compliance|1|||
129067096|NCT04100018|464533136|FG001|Treatment Period|Poor/Non-Compliance|0|||
129067097|NCT04100018|464533135|FG000|Treatment Period|Lost to Follow-up|2|||
129067098|NCT04100018|464533136|FG001|Treatment Period|Lost to Follow-up|2|||
129067099|NCT04100018|464533135|FG000|Treatment Period|Death|16|||
129067100|NCT04100018|464533136|FG001|Treatment Period|Death|11|||
129067101|NCT04100018|464533135|FG000|Treatment Period|Participant withdrew consent|10|||
129067102|NCT04100018|464533136|FG001|Treatment Period|Participant withdrew consent|10|||
129067103|NCT04100018|464533135|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
129067104|NCT04100018|464533136|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
129067105|NCT04100018|464533135|FG000|Treatment Period|Adverse Event|14|||
129067106|NCT04100018|464533136|FG001|Treatment Period|Adverse Event|6|||
129067107|NCT04100018|464533135|FG000|Treatment Period|Lack of Efficacy|4|||
129067108|NCT04100018|464533136|FG001|Treatment Period|Lack of Efficacy|2|||
129067109|NCT02090725|464533141|FG000|Overall Study|Withdrawal by Subject|1|||
129067110|NCT02090725|464533141|FG000|Overall Study|participants moved from area|3|||
129067111|NCT04358081|464533145|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
129067112|NCT04358081|464533146|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
129067113|NCT04358081|464533147|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
129067114|NCT04358081|464533145|FG000|Treatment Phase of Study|Adverse Event|1|||
129067115|NCT04358081|464533146|FG001|Treatment Phase of Study|Adverse Event|0|||
129067116|NCT04358081|464533147|FG002|Treatment Phase of Study|Adverse Event|1|||
129067117|NCT04358081|464533145|FG000|Treatment Phase of Study|Physician Decision|2|||
129067118|NCT04358081|464533146|FG001|Treatment Phase of Study|Physician Decision|0|||
129067119|NCT04358081|464533147|FG002|Treatment Phase of Study|Physician Decision|1|||
129067120|NCT04358081|464533145|FG000|Treatment Phase of Study|Protocol Violation|1|||
129067121|NCT04358081|464533146|FG001|Treatment Phase of Study|Protocol Violation|0|||
129138073|NCT00504556|464798373|FG001|Overall Study|Withdrawal by Subject|16|||
129138074|NCT00504556|464798374|FG002|Overall Study|Withdrawal by Subject|7|||
129138075|NCT00504556|464798375|FG003|Overall Study|Withdrawal by Subject|8|||
129138076|NCT00504556|464798376|FG004|Overall Study|Withdrawal by Subject|12|||
129138077|NCT00504556|464798372|FG000|Overall Study|administrative reasons|0|||
129138078|NCT00504556|464798373|FG001|Overall Study|administrative reasons|2|||
129138079|NCT00504556|464798374|FG002|Overall Study|administrative reasons|2|||
129138080|NCT00504556|464798375|FG003|Overall Study|administrative reasons|1|||
129138081|NCT00504556|464798376|FG004|Overall Study|administrative reasons|2|||
129138082|NCT00504556|464798372|FG000|Overall Study|did not meet entry criteria|2|||
129138083|NCT00504556|464798373|FG001|Overall Study|did not meet entry criteria|0|||
129138084|NCT00504556|464798374|FG002|Overall Study|did not meet entry criteria|1|||
129138085|NCT00504556|464798375|FG003|Overall Study|did not meet entry criteria|1|||
129067122|NCT04358081|464533147|FG002|Treatment Phase of Study|Protocol Violation|0|||
129067123|NCT04358081|464533145|FG000|Study Completion Phase|Death|0|||
129067124|NCT04358081|464533146|FG001|Study Completion Phase|Death|0|||
129067125|NCT04358081|464533147|FG002|Study Completion Phase|Death|1|||
129067126|NCT04358081|464533145|FG000|Study Completion Phase|Lost to Follow-up|1|||
129067127|NCT04358081|464533146|FG001|Study Completion Phase|Lost to Follow-up|0|||
129067128|NCT04358081|464533147|FG002|Study Completion Phase|Lost to Follow-up|1|||
129067129|NCT01130532|464533148|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
129067130|NCT01130532|464533149|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
128721844|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
128721845|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
128721846|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
128721847|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
128721848|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
128721849|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
129067131|NCT01130532|464533150|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
129067132|NCT01130532|464533151|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
129067133|NCT01130532|464533148|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
129138086|NCT00504556|464798376|FG004|Overall Study|did not meet entry criteria|0|||
129138087|NCT00504556|464798372|FG000|Overall Study|data monitor committee decision|0|||
129138088|NCT00504556|464798373|FG001|Overall Study|data monitor committee decision|0|||
128721850|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
128721851|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
129067134|NCT01130532|464533149|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
129138089|NCT00504556|464798374|FG002|Overall Study|data monitor committee decision|0|||
129067135|NCT01130532|464533150|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
129138090|NCT00504556|464798375|FG003|Overall Study|data monitor committee decision|100|||
129138091|NCT00504556|464798376|FG004|Overall Study|data monitor committee decision|0|||
129138092|NCT00504556|464798372|FG000|Overall Study|Other|2|||
129138093|NCT00504556|464798373|FG001|Overall Study|Other|2|||
128721852|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
128721853|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
129067136|NCT01130532|464533151|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
129067137|NCT01130532|464533148|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
129067138|NCT01130532|464533149|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
129067139|NCT01130532|464533150|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
129067140|NCT01130532|464533151|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
129067141|NCT01130532|464533148|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
129067142|NCT01130532|464533149|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
129067143|NCT01130532|464533150|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
129067144|NCT01130532|464533151|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
129067145|NCT01130532|464533148|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
129067146|NCT01130532|464533149|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
129067147|NCT01130532|464533150|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
129067148|NCT01130532|464533151|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
129067149|NCT01130532|464533148|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
129067150|NCT01130532|464533149|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
129067151|NCT01130532|464533150|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
129067152|NCT01130532|464533151|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
129067153|NCT01130532|464533148|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
129067154|NCT01130532|464533149|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
129067155|NCT01130532|464533150|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
129067156|NCT01130532|464533151|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
129067157|NCT01130532|464533148|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
129067158|NCT01130532|464533149|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
129067159|NCT01130532|464533150|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
129067160|NCT01130532|464533151|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
129067161|NCT01130532|464533148|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
129067162|NCT01130532|464533149|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
129067163|NCT01130532|464533150|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
129067164|NCT01130532|464533151|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
129067165|NCT01130532|464533148|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
129067166|NCT01130532|464533149|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
129067167|NCT01130532|464533150|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
129067168|NCT01130532|464533151|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
129067169|NCT01130532|464533148|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
129067170|NCT01130532|464533149|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
129067171|NCT01130532|464533150|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
129067172|NCT01130532|464533151|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
129067173|NCT02656303|464533152|FG000|Overall Study|Adverse Event|3|||
129067174|NCT02656303|464533153|FG001|Overall Study|Adverse Event|2|||
129067175|NCT02656303|464533154|FG002|Overall Study|Adverse Event|0|||
129067176|NCT02656303|464533152|FG000|Overall Study|Death|12|||
129067177|NCT02656303|464533153|FG001|Overall Study|Death|4|||
129067178|NCT02656303|464533154|FG002|Overall Study|Death|1|||
129067179|NCT02656303|464533152|FG000|Overall Study|Lack of Efficacy|1|||
129067180|NCT02656303|464533153|FG001|Overall Study|Lack of Efficacy|0|||
129067181|NCT02656303|464533154|FG002|Overall Study|Lack of Efficacy|0|||
129067182|NCT02656303|464533152|FG000|Overall Study|Non-Compliance with Study|1|||
129067183|NCT02656303|464533153|FG001|Overall Study|Non-Compliance with Study|1|||
129067184|NCT02656303|464533154|FG002|Overall Study|Non-Compliance with Study|0|||
129067185|NCT02656303|464533152|FG000|Overall Study|Investigator Decision|2|||
129067186|NCT02656303|464533153|FG001|Overall Study|Investigator Decision|1|||
129067187|NCT02656303|464533154|FG002|Overall Study|Investigator Decision|0|||
129067188|NCT02656303|464533152|FG000|Overall Study|Progressive Disease|25|||
129067189|NCT02656303|464533153|FG001|Overall Study|Progressive Disease|14|||
129067190|NCT02656303|464533154|FG002|Overall Study|Progressive Disease|10|||
129067191|NCT02656303|464533152|FG000|Overall Study|Study Terminated by Sponsor|20|||
129067192|NCT02656303|464533153|FG001|Overall Study|Study Terminated by Sponsor|7|||
129067193|NCT02656303|464533154|FG002|Overall Study|Study Terminated by Sponsor|5|||
129067194|NCT02656303|464533152|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
129067195|NCT02656303|464533153|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
129067196|NCT02656303|464533154|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
129067197|NCT02656303|464533152|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
129067198|NCT02656303|464533153|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
129067199|NCT02656303|464533154|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
128721854|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
128721855|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
129067200|NCT02656303|464533152|FG000|Overall Study|Reason not Specified|1|||
129067201|NCT02656303|464533153|FG001|Overall Study|Reason not Specified|1|||
129067202|NCT02656303|464533154|FG002|Overall Study|Reason not Specified|2|||
128721856|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
129067203|NCT03041311|464533155|FG000|Overall Study|Death|39|||
129067204|NCT03041311|464533156|FG001|Overall Study|Death|42|||
129067205|NCT03041311|464533155|FG000|Overall Study|Lost to Follow-up|0|||
129067206|NCT03041311|464533156|FG001|Overall Study|Lost to Follow-up|1|||
129067207|NCT03041311|464533155|FG000|Overall Study|Withdrawal by Subject|8|||
129067208|NCT03041311|464533156|FG001|Overall Study|Withdrawal by Subject|5|||
129067209|NCT03041311|464533155|FG000|Overall Study|Sponsor Terminated Study|2|||
129067210|NCT03041311|464533156|FG001|Overall Study|Sponsor Terminated Study|4|||
129067211|NCT03041311|464533155|FG000|Overall Study|Disease Progression|3|||
129067212|NCT03041311|464533156|FG001|Overall Study|Disease Progression|1|||
129067213|NCT03041311|464533155|FG000|Overall Study|Randomized in error, did not receive drug|2|||
129067214|NCT03041311|464533156|FG001|Overall Study|Randomized in error, did not receive drug|0|||
129067215|NCT01842438|464533157|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
129067216|NCT01842438|464533158|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
129067217|NCT01842438|464533157|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
129067218|NCT01842438|464533158|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
129067219|NCT01842438|464533157|FG000|T2: 6month Follow-up|Death|0|||
129067220|NCT01842438|464533158|FG001|T2: 6month Follow-up|Death|1|||
129067221|NCT00782626|464533162|FG000|Overall Study|Adverse Event|1|||
129067222|NCT00782626|464533162|FG000|Overall Study|Progressive Disease|5|||
129067223|NCT00782626|464533162|FG000|Overall Study|Other Complicating Disease|1|||
129067224|NCT04909853|464533163|FG000|Part 1|Assigned but not treated|0|||
129067225|NCT04909853|464533164|FG001|Part 1|Assigned but not treated|0|||
129067226|NCT04909853|464533165|FG002|Part 1|Assigned but not treated|1|||
129067227|NCT04909853|464533166|FG003|Part 1|Assigned but not treated|0|||
129067228|NCT04909853|464533163|FG000|Part 2|Adverse Event|0|||
129067229|NCT04909853|464533164|FG001|Part 2|Adverse Event|0|||
129067230|NCT04909853|464533165|FG002|Part 2|Adverse Event|0|||
129067231|NCT04909853|464533166|FG003|Part 2|Adverse Event|1|||
129067232|NCT04054765|464533167|FG000|Baseline|Withdrawal by Subject|5|||
129067233|NCT04054765|464533168|FG001|Baseline|Withdrawal by Subject|3|||
129067234|NCT04054765|464533167|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
129067235|NCT04054765|464533168|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
129067236|NCT04054765|464533167|FG000|3-month Follow up|Withdrawal by Subject|0|||
129067237|NCT04054765|464533168|FG001|3-month Follow up|Withdrawal by Subject|3|||
129067238|NCT04054765|464533167|FG000|6-month Follow up|Lost to Follow-up|32|||
129067239|NCT04054765|464533168|FG001|6-month Follow up|Lost to Follow-up|32|||
129067240|NCT04182490|464533170|FG000|Overall Study|Withdrawal by Subject|3|||
129067241|NCT04182490|464533171|FG001|Overall Study|Withdrawal by Subject|3|||
129067242|NCT04182490|464533170|FG000|Overall Study|Lost to Follow-up|0|||
129067243|NCT04182490|464533171|FG001|Overall Study|Lost to Follow-up|1|||
129067244|NCT04182490|464533170|FG000|Overall Study|Physician Decision|0|||
129067245|NCT04182490|464533171|FG001|Overall Study|Physician Decision|1|||
129138094|NCT00504556|464798374|FG002|Overall Study|Other|2|||
129138095|NCT00504556|464798375|FG003|Overall Study|Other|3|||
129138096|NCT00504556|464798376|FG004|Overall Study|Other|0|||
129138097|NCT00504556|464798372|FG000|Overall Study|not in safety analysis set|0|||
129138098|NCT00504556|464798373|FG001|Overall Study|not in safety analysis set|1|||
129138099|NCT00504556|464798374|FG002|Overall Study|not in safety analysis set|1|||
129138100|NCT00504556|464798375|FG003|Overall Study|not in safety analysis set|0|||
129138101|NCT00504556|464798376|FG004|Overall Study|not in safety analysis set|1|||
129138102|NCT03280615|464798377|FG000|Overall Study|Lost to Follow-up|1|||
129138103|NCT03280615|464798378|FG001|Overall Study|Lost to Follow-up|2|||
129138104|NCT03280615|464798377|FG000|Overall Study|Adverse Event|1|||
129138105|NCT03280615|464798378|FG001|Overall Study|Adverse Event|1|||
129138106|NCT03280615|464798377|FG000|Overall Study|Withdrawal by Subject|2|||
129138107|NCT03280615|464798378|FG001|Overall Study|Withdrawal by Subject|2|||
129138108|NCT01013870|464798381|FG000|Overall Study|Lost to Follow-up|1|||
129138109|NCT01013870|464798382|FG001|Overall Study|Lost to Follow-up|3|||
129138110|NCT01386645|464798383|FG000|Overall Study|Physician Decision|0|||
129138111|NCT01386645|464798384|FG001|Overall Study|Physician Decision|0|||
129138112|NCT01386645|464798385|FG002|Overall Study|Physician Decision|1|||
129138113|NCT01386645|464798383|FG000|Overall Study|Withdrawal by Subject|0|||
129138114|NCT01386645|464798384|FG001|Overall Study|Withdrawal by Subject|1|||
129138115|NCT01386645|464798385|FG002|Overall Study|Withdrawal by Subject|1|||
129138116|NCT00432991|464798386|FG000|Overall Study|Protocol Violation|7|||
128775852|NCT02584855|463468488|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
128775853|NCT02584855|463468489|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
128775854|NCT02584855|463468490|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
128775855|NCT02584855|463468491|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
129067246|NCT00853099|464533172|FG000|Double-blind Period|Adverse Event|7|||
128775856|NCT02584855|463468492|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
129138117|NCT00432991|464798387|FG001|Overall Study|Protocol Violation|12|||
129138118|NCT03142451|464798397|FG000|Overall Study|Adverse Event|5|||
129138119|NCT03142451|464798398|FG001|Overall Study|Adverse Event|2|||
129138120|NCT03142451|464798397|FG000|Overall Study|Lost to Follow-up|25|||
129138121|NCT03142451|464798398|FG001|Overall Study|Lost to Follow-up|8|||
129138122|NCT03142451|464798397|FG000|Overall Study|Participant request|24|||
129138123|NCT03142451|464798398|FG001|Overall Study|Participant request|12|||
129138124|NCT03142451|464798397|FG000|Overall Study|Protocol Violation|3|||
128721857|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
128721858|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
128721859|NCT00277212|463279265|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
128721860|NCT00277212|463279266|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
129067247|NCT00853099|464533173|FG001|Double-blind Period|Adverse Event|9|||
129067248|NCT00853099|464533174|FG002|Double-blind Period|Adverse Event|13|||
129067249|NCT00853099|464533175|FG003|Double-blind Period|Adverse Event|0|||
129067250|NCT00853099|464533172|FG000|Double-blind Period|Withdrawal by Subject|2|||
129067251|NCT00853099|464533173|FG001|Double-blind Period|Withdrawal by Subject|3|||
129067252|NCT00853099|464533174|FG002|Double-blind Period|Withdrawal by Subject|0|||
129067253|NCT00853099|464533175|FG003|Double-blind Period|Withdrawal by Subject|0|||
129067254|NCT00853099|464533172|FG000|Double-blind Period|Lack of Efficacy|14|||
129067255|NCT00853099|464533173|FG001|Double-blind Period|Lack of Efficacy|17|||
129067256|NCT00853099|464533174|FG002|Double-blind Period|Lack of Efficacy|16|||
129067257|NCT00853099|464533175|FG003|Double-blind Period|Lack of Efficacy|0|||
129067258|NCT00853099|464533172|FG000|Double-blind Period|Other|0|||
129067259|NCT00853099|464533173|FG001|Double-blind Period|Other|0|||
129067260|NCT00853099|464533174|FG002|Double-blind Period|Other|1|||
129067261|NCT00853099|464533175|FG003|Double-blind Period|Other|0|||
129067262|NCT00853099|464533172|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
129067263|NCT00853099|464533173|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
129067264|NCT00853099|464533174|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
129067265|NCT00853099|464533175|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
129067266|NCT00853099|464533172|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
129067267|NCT00853099|464533173|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
129067268|NCT00853099|464533174|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
129067269|NCT00853099|464533175|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
129067270|NCT00853099|464533172|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
129067271|NCT00853099|464533173|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
129067272|NCT00853099|464533174|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
129067273|NCT00853099|464533175|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
129067274|NCT00853099|464533172|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
129067275|NCT00853099|464533173|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
129067276|NCT00853099|464533174|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
129067277|NCT00853099|464533175|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
129067278|NCT00853099|464533172|FG000|Double-blind + Open-label Periods|Other|0|||
129067279|NCT00853099|464533173|FG001|Double-blind + Open-label Periods|Other|0|||
129067280|NCT00853099|464533174|FG002|Double-blind + Open-label Periods|Other|0|||
129067281|NCT00853099|464533175|FG003|Double-blind + Open-label Periods|Other|6|||
129067282|NCT01342081|464533184|FG000|Overall Study|Did not receive allocated intervention|0|||
129067283|NCT01342081|464533185|FG001|Overall Study|Did not receive allocated intervention|0|||
129067284|NCT01342081|464533186|FG002|Overall Study|Did not receive allocated intervention|1|||
129067285|NCT01342081|464533184|FG000|Overall Study|Adverse Event|1|||
129067286|NCT01342081|464533185|FG001|Overall Study|Adverse Event|0|||
129067287|NCT01342081|464533186|FG002|Overall Study|Adverse Event|0|||
129067288|NCT01342081|464533184|FG000|Overall Study|Physician Decision|0|||
129067289|NCT01342081|464533185|FG001|Overall Study|Physician Decision|1|||
129138125|NCT03142451|464798398|FG001|Overall Study|Protocol Violation|1|||
129138126|NCT03142451|464798397|FG000|Overall Study|Other|1|||
129067290|NCT01342081|464533186|FG002|Overall Study|Physician Decision|0|||
129067291|NCT01342081|464533184|FG000|Overall Study|Withdrawal by Subject|1|||
129067292|NCT01342081|464533185|FG001|Overall Study|Withdrawal by Subject|1|||
129067293|NCT01342081|464533186|FG002|Overall Study|Withdrawal by Subject|0|||
128721861|NCT00277212|463279267|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
129067294|NCT02790437|464533187|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
129138127|NCT03142451|464798398|FG001|Overall Study|Other|1|||
128721862|NCT03336216|463279268|FG000|Randomization|Not reported|2|||
128721863|NCT03336216|463279269|FG001|Randomization|Not reported|0|||
128721864|NCT03336216|463279270|FG002|Randomization|Not reported|1|||
129067295|NCT02790437|464533188|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
129067296|NCT02790437|464533187|FG000|Overall Study|Adverse Event|1|||
129067297|NCT02790437|464533188|FG001|Overall Study|Adverse Event|0|||
129067298|NCT02790437|464533187|FG000|Overall Study|Withdrawal by Subject|1|||
129067299|NCT02790437|464533188|FG001|Overall Study|Withdrawal by Subject|0|||
129138128|NCT00090402|464798399|FG000|Overall Study|Death|1|||
129138129|NCT00090402|464798400|FG001|Overall Study|Death|1|||
129138130|NCT00090402|464798401|FG002|Overall Study|Death|0|||
129067300|NCT03908125|464533193|FG000|Overall Study|Withdrawal by Subject|92|||
129067301|NCT03908125|464533193|FG000|Overall Study|Lost to Follow-up|8|||
129067302|NCT00114140|464533194|FG000|Overall Study|Protocol Violation|7|||
129067303|NCT00666328|464533198|FG000|Overall Study|Death|2|||
129067304|NCT00666328|464533198|FG000|Overall Study|Lost to Follow-up|2|||
129067305|NCT00666328|464533198|FG000|Overall Study|No longer met eligibility criteria|1|||
129067306|NCT03885661|464533201|FG000|Overall Study|Withdrawal by Subject|0|||
129067307|NCT03885661|464533202|FG001|Overall Study|Withdrawal by Subject|1|||
129067308|NCT03885661|464533201|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
129067309|NCT03885661|464533202|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
129067310|NCT05064397|464533203|FG000|Overall Study|Adverse Event|4|||
129067311|NCT05064397|464533203|FG000|Overall Study|Lack of Efficacy|12|||
129067312|NCT05064397|464533203|FG000|Overall Study|Withdrawal by Subject|3|||
129067313|NCT05064397|464533203|FG000|Overall Study|Lost to Follow-up|1|||
129067314|NCT05064397|464533203|FG000|Overall Study|Other reasons|3|||
129067315|NCT02232984|464533204|FG000|Overall Study|Withdrawal by Subject|5|||
129067316|NCT02232984|464533204|FG000|Overall Study|Death|1|||
129067317|NCT02232984|464533204|FG000|Overall Study|Investigator withdrawal|10|||
129067318|NCT02232984|464533204|FG000|Overall Study|Device implant unsuccessful|53|||
129067319|NCT02232984|464533204|FG000|Overall Study|not disclosed by site|7|||
129067320|NCT02232984|464533204|FG000|Overall Study|Protocol Violation|1|||
129067321|NCT00535405|464533209|FG000|Overall Study|Adverse Event|6|||
129067322|NCT00535405|464533210|FG001|Overall Study|Adverse Event|8|||
129067323|NCT00535405|464533211|FG002|Overall Study|Adverse Event|3|||
129067324|NCT00535405|464533212|FG003|Overall Study|Adverse Event|8|||
129067325|NCT00535405|464533213|FG004|Overall Study|Adverse Event|6|||
129067326|NCT00535405|464533209|FG000|Overall Study|Lost to Follow-up|1|||
129067327|NCT00535405|464533210|FG001|Overall Study|Lost to Follow-up|3|||
129067328|NCT00535405|464533211|FG002|Overall Study|Lost to Follow-up|3|||
129067329|NCT00535405|464533212|FG003|Overall Study|Lost to Follow-up|2|||
129067330|NCT00535405|464533213|FG004|Overall Study|Lost to Follow-up|1|||
129067331|NCT00535405|464533209|FG000|Overall Study|Physician Decision|3|||
129067332|NCT00535405|464533210|FG001|Overall Study|Physician Decision|2|||
129067333|NCT00535405|464533211|FG002|Overall Study|Physician Decision|0|||
129067334|NCT00535405|464533212|FG003|Overall Study|Physician Decision|1|||
129067335|NCT00535405|464533213|FG004|Overall Study|Physician Decision|1|||
129067336|NCT00535405|464533209|FG000|Overall Study|Protocol Violation|2|||
129067337|NCT00535405|464533210|FG001|Overall Study|Protocol Violation|2|||
129067338|NCT00535405|464533211|FG002|Overall Study|Protocol Violation|2|||
129067339|NCT00535405|464533212|FG003|Overall Study|Protocol Violation|1|||
129067340|NCT00535405|464533213|FG004|Overall Study|Protocol Violation|0|||
129067341|NCT00535405|464533209|FG000|Overall Study|Withdrawal by Subject|5|||
129067342|NCT00535405|464533210|FG001|Overall Study|Withdrawal by Subject|11|||
129067343|NCT00535405|464533211|FG002|Overall Study|Withdrawal by Subject|10|||
129067344|NCT00535405|464533212|FG003|Overall Study|Withdrawal by Subject|10|||
129067345|NCT00535405|464533213|FG004|Overall Study|Withdrawal by Subject|8|||
129067346|NCT00489255|464533220|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
129067347|NCT00489255|464533221|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
129067348|NCT00489255|464533220|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
129067349|NCT00489255|464533221|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
129067350|NCT00489255|464533220|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
129067351|NCT00489255|464533221|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
129067352|NCT00489255|464533220|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
129067353|NCT00489255|464533221|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
129067354|NCT00489255|464533220|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
129067355|NCT00489255|464533221|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
129067356|NCT00489255|464533220|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
129067357|NCT00489255|464533221|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
129067358|NCT00489255|464533220|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
129067359|NCT00489255|464533221|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
129067360|NCT00489255|464533220|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
129067361|NCT00489255|464533221|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
129067362|NCT00489255|464533220|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
129067363|NCT00489255|464533221|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
129067364|NCT00489255|464533220|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
129067365|NCT00489255|464533221|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
129067366|NCT02163057|464533223|FG000|Overall Study|Participant Refusal to Continue|2|||
129067367|NCT02163057|464533224|FG001|Overall Study|Participant Refusal to Continue|2|||
129067368|NCT02163057|464533223|FG000|Overall Study|Participant Significant Noncompliance|0|||
129067369|NCT02163057|464533224|FG001|Overall Study|Participant Significant Noncompliance|1|||
129138131|NCT00090402|464798399|FG000|Overall Study|subject moved|0|||
129067370|NCT02163057|464533223|FG000|Overall Study|Progression of Disease|1|||
129067371|NCT02163057|464533224|FG001|Overall Study|Progression of Disease|2|||
129067372|NCT01625091|464533225|FG000|Intervention|Death|1|||
129067373|NCT01625091|464533226|FG001|Intervention|Death|1|||
129067374|NCT01625091|464533225|FG000|Intervention|Withdrawal by Subject|4|||
128721865|NCT03336216|463279271|FG003|Randomization|Not reported|0|||
128721866|NCT03336216|463279268|FG000|Randomization|Other reasons|1|||
128721867|NCT03336216|463279269|FG001|Randomization|Other reasons|1|||
128721868|NCT03336216|463279270|FG002|Randomization|Other reasons|1|||
128721869|NCT03336216|463279271|FG003|Randomization|Other reasons|0|||
128721870|NCT03336216|463279268|FG000|Randomization|Participant no longer meets study criteria|0|||
128721871|NCT03336216|463279269|FG001|Randomization|Participant no longer meets study criteria|2|||
128721872|NCT03336216|463279270|FG002|Randomization|Participant no longer meets study criteria|4|||
128721873|NCT03336216|463279271|FG003|Randomization|Participant no longer meets study criteria|1|||
128721874|NCT03336216|463279268|FG000|Randomization|Lost to Follow-up|1|||
128721875|NCT03336216|463279269|FG001|Randomization|Lost to Follow-up|0|||
129067375|NCT01625091|464533226|FG001|Intervention|Withdrawal by Subject|1|||
129067376|NCT01625091|464533225|FG000|Intervention|Adverse Event|0|||
129067377|NCT01625091|464533226|FG001|Intervention|Adverse Event|2|||
129067378|NCT01625091|464533225|FG000|Intervention|Lost to Follow-up|4|||
129067379|NCT01625091|464533226|FG001|Intervention|Lost to Follow-up|4|||
129067380|NCT01625091|464533225|FG000|Intervention|Study termination|2|||
129067381|NCT01625091|464533226|FG001|Intervention|Study termination|3|||
129067382|NCT01625091|464533225|FG000|Post-intervention|Death|0|||
129067383|NCT01625091|464533226|FG001|Post-intervention|Death|1|||
129067384|NCT01625091|464533225|FG000|Post-intervention|Lost to Follow-up|2|||
129067385|NCT01625091|464533226|FG001|Post-intervention|Lost to Follow-up|0|||
129067386|NCT01625091|464533225|FG000|Post-intervention|Study termination|2|||
129067387|NCT01625091|464533226|FG001|Post-intervention|Study termination|1|||
129067388|NCT01959295|464533230|FG000|Overall Study|Adverse Event|2|||
129067389|NCT01959295|464533231|FG001|Overall Study|Adverse Event|0|||
129067390|NCT01959295|464533230|FG000|Overall Study|Lost to Follow-up|0|||
129067391|NCT01959295|464533231|FG001|Overall Study|Lost to Follow-up|2|||
129067392|NCT01959295|464533230|FG000|Overall Study|Physician Decision|2|||
129067393|NCT01959295|464533231|FG001|Overall Study|Physician Decision|3|||
129067394|NCT01959295|464533230|FG000|Overall Study|Protocol Violation|16|||
129067395|NCT01959295|464533231|FG001|Overall Study|Protocol Violation|5|||
129067396|NCT01959295|464533230|FG000|Overall Study|Withdrawal by Subject|3|||
129067397|NCT01959295|464533231|FG001|Overall Study|Withdrawal by Subject|1|||
129067398|NCT01959295|464533230|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
129067399|NCT01959295|464533231|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
129067400|NCT03130777|464534661|FG000|Overall Study|Death|0|||
129067401|NCT03130777|464534662|FG001|Overall Study|Death|1|||
129067402|NCT03130777|464534661|FG000|Overall Study|Did not meet eligibility criteria|1|||
129067403|NCT03130777|464534662|FG001|Overall Study|Did not meet eligibility criteria|0|||
129067404|NCT02498613|464534664|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
129067405|NCT02498613|464534665|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
129067406|NCT02498613|464534666|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
129067407|NCT02498613|464534667|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
129067408|NCT02498613|464534664|FG000|Overall Study|Withdrawal by Subject|3|||
129067409|NCT02498613|464534665|FG001|Overall Study|Withdrawal by Subject|1|||
129067410|NCT02498613|464534666|FG002|Overall Study|Withdrawal by Subject|0|||
129067411|NCT02498613|464534667|FG003|Overall Study|Withdrawal by Subject|0|||
129067412|NCT05168202|464534668|FG000|Overall Study|Progressive Disease|4|||
129067413|NCT05168202|464534669|FG001|Overall Study|Progressive Disease|4|||
129067414|NCT05168202|464534670|FG002|Overall Study|Progressive Disease|2|||
129067415|NCT05168202|464534671|FG003|Overall Study|Progressive Disease|3|||
129067416|NCT05168202|464534672|FG004|Overall Study|Progressive Disease|2|||
129067417|NCT05168202|464534673|FG005|Overall Study|Progressive Disease|3|||
129138132|NCT00090402|464798400|FG001|Overall Study|subject moved|1|||
128721876|NCT03336216|463279270|FG002|Randomization|Lost to Follow-up|0|||
128721877|NCT03336216|463279271|FG003|Randomization|Lost to Follow-up|0|||
129067418|NCT05168202|464534674|FG006|Overall Study|Progressive Disease|2|||
129067419|NCT05168202|464534668|FG000|Overall Study|Adverse Event|2|||
129067420|NCT05168202|464534669|FG001|Overall Study|Adverse Event|1|||
129067421|NCT05168202|464534670|FG002|Overall Study|Adverse Event|4|||
129067422|NCT05168202|464534671|FG003|Overall Study|Adverse Event|4|||
129067423|NCT05168202|464534672|FG004|Overall Study|Adverse Event|3|||
129067424|NCT05168202|464534673|FG005|Overall Study|Adverse Event|2|||
129067425|NCT05168202|464534674|FG006|Overall Study|Adverse Event|0|||
129138133|NCT00090402|464798401|FG002|Overall Study|subject moved|0|||
129138134|NCT00090402|464798399|FG000|Overall Study|stopped taking study medication|1|||
129138135|NCT00090402|464798400|FG001|Overall Study|stopped taking study medication|0|||
129138136|NCT00090402|464798401|FG002|Overall Study|stopped taking study medication|1|||
129138137|NCT04621786|464798412|FG000|Overall Study|Lost to Follow-up|9|||
129138138|NCT04621786|464798412|FG000|Overall Study|Protocol Violation|3|||
129138139|NCT02365064|464798415|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
129138140|NCT02365064|464798416|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
129138141|NCT02365064|464798415|FG000|Overall Study|Withdrawal by Subject|6|||
129138142|NCT02365064|464798416|FG001|Overall Study|Withdrawal by Subject|9|||
129138143|NCT02365064|464798415|FG000|Overall Study|Treatment intolerance|2|||
129067426|NCT05168202|464534668|FG000|Overall Study|Lack of Efficacy|0|||
129067427|NCT05168202|464534669|FG001|Overall Study|Lack of Efficacy|1|||
129067428|NCT05168202|464534670|FG002|Overall Study|Lack of Efficacy|1|||
129067429|NCT05168202|464534671|FG003|Overall Study|Lack of Efficacy|0|||
129067430|NCT05168202|464534672|FG004|Overall Study|Lack of Efficacy|1|||
129067431|NCT05168202|464534673|FG005|Overall Study|Lack of Efficacy|2|||
129067432|NCT05168202|464534674|FG006|Overall Study|Lack of Efficacy|2|||
129067433|NCT05168202|464534668|FG000|Overall Study|Withdrawal by Subject|0|||
129067434|NCT05168202|464534669|FG001|Overall Study|Withdrawal by Subject|0|||
129067435|NCT05168202|464534670|FG002|Overall Study|Withdrawal by Subject|1|||
129067436|NCT05168202|464534671|FG003|Overall Study|Withdrawal by Subject|1|||
129067437|NCT05168202|464534672|FG004|Overall Study|Withdrawal by Subject|1|||
129067438|NCT05168202|464534673|FG005|Overall Study|Withdrawal by Subject|1|||
129067439|NCT05168202|464534674|FG006|Overall Study|Withdrawal by Subject|0|||
129067440|NCT05168202|464534668|FG000|Overall Study|Disease Relapse|0|||
129067441|NCT05168202|464534669|FG001|Overall Study|Disease Relapse|1|||
129067442|NCT05168202|464534670|FG002|Overall Study|Disease Relapse|0|||
129067443|NCT05168202|464534671|FG003|Overall Study|Disease Relapse|1|||
129067444|NCT05168202|464534672|FG004|Overall Study|Disease Relapse|1|||
129067445|NCT05168202|464534673|FG005|Overall Study|Disease Relapse|0|||
129067446|NCT05168202|464534674|FG006|Overall Study|Disease Relapse|0|||
129067447|NCT05168202|464534668|FG000|Overall Study|Other Reasons|0|||
129067448|NCT05168202|464534669|FG001|Overall Study|Other Reasons|0|||
129067449|NCT05168202|464534670|FG002|Overall Study|Other Reasons|0|||
129067450|NCT05168202|464534671|FG003|Overall Study|Other Reasons|0|||
129067451|NCT05168202|464534672|FG004|Overall Study|Other Reasons|0|||
129067452|NCT05168202|464534673|FG005|Overall Study|Other Reasons|2|||
129067453|NCT05168202|464534674|FG006|Overall Study|Other Reasons|1|||
129067454|NCT05168202|464534668|FG000|Overall Study|Physician Decision|0|||
129067455|NCT05168202|464534669|FG001|Overall Study|Physician Decision|1|||
129067456|NCT05168202|464534670|FG002|Overall Study|Physician Decision|1|||
129067457|NCT05168202|464534671|FG003|Overall Study|Physician Decision|0|||
129067458|NCT05168202|464534672|FG004|Overall Study|Physician Decision|0|||
129067459|NCT05168202|464534673|FG005|Overall Study|Physician Decision|0|||
129067460|NCT05168202|464534674|FG006|Overall Study|Physician Decision|0|||
129067461|NCT05168202|464534668|FG000|Overall Study|Study Terminated by Sponsor|0|||
129067462|NCT05168202|464534669|FG001|Overall Study|Study Terminated by Sponsor|0|||
129067463|NCT05168202|464534670|FG002|Overall Study|Study Terminated by Sponsor|0|||
129067464|NCT05168202|464534671|FG003|Overall Study|Study Terminated by Sponsor|1|||
129067465|NCT05168202|464534672|FG004|Overall Study|Study Terminated by Sponsor|0|||
129067466|NCT05168202|464534673|FG005|Overall Study|Study Terminated by Sponsor|0|||
129067467|NCT05168202|464534674|FG006|Overall Study|Study Terminated by Sponsor|0|||
129067468|NCT05109611|464534675|FG000|Overall Study|Adverse Event|13|||
129067469|NCT05109611|464534676|FG001|Overall Study|Adverse Event|10|||
129067470|NCT05109611|464534675|FG000|Overall Study|Withdrawal by Subject|1|||
129067471|NCT05109611|464534676|FG001|Overall Study|Withdrawal by Subject|0|||
129067472|NCT05109611|464534675|FG000|Overall Study|Lost to Follow-up|1|||
129067473|NCT05109611|464534676|FG001|Overall Study|Lost to Follow-up|2|||
129067474|NCT05109611|464534675|FG000|Overall Study|Protocol Violation|0|||
129067475|NCT05109611|464534676|FG001|Overall Study|Protocol Violation|4|||
129067476|NCT05109611|464534675|FG000|Overall Study|Information unavailable|1|||
129067477|NCT05109611|464534676|FG001|Overall Study|Information unavailable|1|||
129067478|NCT06195930|464534679|FG000|Overall Study|Adverse Event|4|||
129067479|NCT04995029|464534680|FG000|Induction Phase|Did not meet eligibility criteria|5|||
129067480|NCT04995029|464534681|FG001|Induction Phase|Did not meet eligibility criteria|2|||
129067481|NCT04995029|464534682|FG002|Induction Phase|Did not meet eligibility criteria|0|||
129067482|NCT04995029|464534683|FG003|Induction Phase|Did not meet eligibility criteria|0|||
129067483|NCT04995029|464534680|FG000|Induction Phase|Withdrawal by Subject|85|||
129067484|NCT04995029|464534681|FG001|Induction Phase|Withdrawal by Subject|42|||
129067485|NCT04995029|464534682|FG002|Induction Phase|Withdrawal by Subject|0|||
129067486|NCT04995029|464534683|FG003|Induction Phase|Withdrawal by Subject|0|||
129067487|NCT04995029|464534680|FG000|Induction Phase|Lost to Follow-up|103|||
129067488|NCT04995029|464534681|FG001|Induction Phase|Lost to Follow-up|67|||
129067489|NCT04995029|464534682|FG002|Induction Phase|Lost to Follow-up|0|||
129067490|NCT04995029|464534683|FG003|Induction Phase|Lost to Follow-up|0|||
129067491|NCT04995029|464534680|FG000|Induction Phase|Adverse Event|5|||
129067492|NCT04995029|464534681|FG001|Induction Phase|Adverse Event|3|||
129067493|NCT04995029|464534682|FG002|Induction Phase|Adverse Event|0|||
129067494|NCT04995029|464534683|FG003|Induction Phase|Adverse Event|0|||
129067495|NCT04995029|464534680|FG000|Induction Phase|Physician Decision|11|||
128721878|NCT03336216|463279268|FG000|Randomization|Participant withdrew consent|9|||
128721879|NCT03336216|463279269|FG001|Randomization|Participant withdrew consent|1|||
128721880|NCT03336216|463279270|FG002|Randomization|Participant withdrew consent|0|||
128721881|NCT03336216|463279271|FG003|Randomization|Participant withdrew consent|0|||
128721882|NCT03336216|463279268|FG000|Randomization|Adverse Event|1|||
128721883|NCT03336216|463279269|FG001|Randomization|Adverse Event|1|||
128721884|NCT03336216|463279270|FG002|Randomization|Adverse Event|0|||
128721885|NCT03336216|463279271|FG003|Randomization|Adverse Event|0|||
128721886|NCT03336216|463279268|FG000|Treatment|Adverse Event|2|||
128721887|NCT03336216|463279269|FG001|Treatment|Adverse Event|3|||
128721888|NCT03336216|463279270|FG002|Treatment|Adverse Event|4|||
128721889|NCT03336216|463279271|FG003|Treatment|Adverse Event|4|||
128721890|NCT03336216|463279268|FG000|Treatment|Participant request to discontinue treatment|2|||
128721891|NCT03336216|463279269|FG001|Treatment|Participant request to discontinue treatment|1|||
128721892|NCT03336216|463279270|FG002|Treatment|Participant request to discontinue treatment|2|||
128721893|NCT03336216|463279271|FG003|Treatment|Participant request to discontinue treatment|2|||
128721894|NCT03336216|463279268|FG000|Treatment|Participant withdrew consent|7|||
128721895|NCT03336216|463279269|FG001|Treatment|Participant withdrew consent|2|||
128721896|NCT03336216|463279270|FG002|Treatment|Participant withdrew consent|3|||
128721897|NCT03336216|463279271|FG003|Treatment|Participant withdrew consent|2|||
128721898|NCT03336216|463279268|FG000|Treatment|Death|2|||
128721899|NCT03336216|463279269|FG001|Treatment|Death|3|||
128721900|NCT03336216|463279270|FG002|Treatment|Death|3|||
128721901|NCT03336216|463279271|FG003|Treatment|Death|4|||
128721902|NCT03336216|463279268|FG000|Treatment|Participant no longer meets study criteria|0|||
128721903|NCT03336216|463279269|FG001|Treatment|Participant no longer meets study criteria|1|||
128721904|NCT03336216|463279270|FG002|Treatment|Participant no longer meets study criteria|0|||
128721905|NCT03336216|463279271|FG003|Treatment|Participant no longer meets study criteria|0|||
128721906|NCT03336216|463279268|FG000|Treatment|Other reasons|2|||
128721907|NCT03336216|463279269|FG001|Treatment|Other reasons|0|||
128721908|NCT03336216|463279270|FG002|Treatment|Other reasons|0|||
128721909|NCT03336216|463279271|FG003|Treatment|Other reasons|3|||
128721910|NCT03336216|463279268|FG000|Treatment|Disease progression|23|||
128721911|NCT03336216|463279269|FG001|Treatment|Disease progression|34|||
128721912|NCT03336216|463279270|FG002|Treatment|Disease progression|33|||
128721913|NCT03336216|463279271|FG003|Treatment|Disease progression|26|||
128721914|NCT03336216|463279268|FG000|Treatment|Study drug toxicity|0|||
128721915|NCT03336216|463279269|FG001|Treatment|Study drug toxicity|3|||
128721916|NCT03336216|463279270|FG002|Treatment|Study drug toxicity|2|||
128721917|NCT03336216|463279271|FG003|Treatment|Study drug toxicity|0|||
128721918|NCT03336216|463279268|FG000|Treatment|Adverse Event unrelated to study drug|1|||
128721919|NCT03336216|463279269|FG001|Treatment|Adverse Event unrelated to study drug|1|||
128721920|NCT03336216|463279270|FG002|Treatment|Adverse Event unrelated to study drug|1|||
128721921|NCT03336216|463279271|FG003|Treatment|Adverse Event unrelated to study drug|0|||
128721922|NCT03336216|463279268|FG000|Treatment|Disease Recurrence|1|||
128721923|NCT03336216|463279269|FG001|Treatment|Disease Recurrence|0|||
128721924|NCT03336216|463279270|FG002|Treatment|Disease Recurrence|0|||
128721925|NCT03336216|463279271|FG003|Treatment|Disease Recurrence|0|||
128721926|NCT03239470|463279277|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
128721927|NCT03239470|463279278|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
128721928|NCT00666757|463279281|FG000|Overall Study|Lost to Follow-up|39|||
128721929|NCT00666757|463279282|FG001|Overall Study|Lost to Follow-up|35|||
128721930|NCT00666757|463279281|FG000|Overall Study|Protocol Violation|23|||
128721931|NCT00666757|463279282|FG001|Overall Study|Protocol Violation|24|||
128721932|NCT00666757|463279281|FG000|Overall Study|Adverse Event|22|||
128721933|NCT00666757|463279282|FG001|Overall Study|Adverse Event|12|||
128721934|NCT00666757|463279281|FG000|Overall Study|Withdrawal by Subject|13|||
128721935|NCT00666757|463279282|FG001|Overall Study|Withdrawal by Subject|17|||
128721936|NCT00666757|463279281|FG000|Overall Study|Lack of Efficacy|3|||
128721937|NCT00666757|463279282|FG001|Overall Study|Lack of Efficacy|6|||
128721938|NCT00666757|463279281|FG000|Overall Study|Physician Decision|0|||
128721939|NCT00666757|463279282|FG001|Overall Study|Physician Decision|2|||
128721940|NCT00666757|463279281|FG000|Overall Study|Sponsor decision|0|||
128721941|NCT00666757|463279282|FG001|Overall Study|Sponsor decision|1|||
128721942|NCT01231581|463279283|FG000|Overall Study|Lost to Follow-up|2|||
128721943|NCT01231581|463279284|FG001|Overall Study|Lost to Follow-up|2|||
128721944|NCT01231581|463279283|FG000|Overall Study|Withdrawal by Subject|6|||
128721945|NCT01231581|463279284|FG001|Overall Study|Withdrawal by Subject|9|||
128721946|NCT01231581|463279283|FG000|Overall Study|Study Closed/Terminated|6|||
128721947|NCT01231581|463279284|FG001|Overall Study|Study Closed/Terminated|5|||
128721948|NCT01231581|463279283|FG000|Overall Study|Death|65|||
128721949|NCT01231581|463279284|FG001|Overall Study|Death|64|||
128721950|NCT01231581|463279283|FG000|Overall Study|Ongoing|1|||
128721951|NCT01231581|463279284|FG001|Overall Study|Ongoing|0|||
128721952|NCT00539838|463279285|FG000|Overall Study|Fail to return|2|||
128721953|NCT00539838|463279286|FG001|Overall Study|Fail to return|0|||
128721954|NCT00539838|463279287|FG002|Overall Study|Fail to return|0|||
129067496|NCT04995029|464534681|FG001|Induction Phase|Physician Decision|8|||
129067497|NCT04995029|464534682|FG002|Induction Phase|Physician Decision|0|||
129067498|NCT04995029|464534683|FG003|Induction Phase|Physician Decision|0|||
129067499|NCT04995029|464534680|FG000|Induction Phase|Incarceration|6|||
129067500|NCT04995029|464534681|FG001|Induction Phase|Incarceration|3|||
129067501|NCT04995029|464534682|FG002|Induction Phase|Incarceration|0|||
129067502|NCT04995029|464534683|FG003|Induction Phase|Incarceration|0|||
129067503|NCT04995029|464534680|FG000|Induction Phase|Not otherwise described|5|||
129067504|NCT04995029|464534681|FG001|Induction Phase|Not otherwise described|5|||
129067505|NCT04995029|464534682|FG002|Induction Phase|Not otherwise described|0|||
129067506|NCT04995029|464534683|FG003|Induction Phase|Not otherwise described|0|||
129067507|NCT04995029|464534680|FG000|Maintenance Phase|Lost to Follow-up|0|||
129067508|NCT04995029|464534681|FG001|Maintenance Phase|Lost to Follow-up|0|||
129067509|NCT04995029|464534682|FG002|Maintenance Phase|Lost to Follow-up|51|||
129067510|NCT04995029|464534683|FG003|Maintenance Phase|Lost to Follow-up|44|||
129067511|NCT04995029|464534680|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
129067512|NCT04995029|464534681|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
129067513|NCT04995029|464534682|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
129067514|NCT04995029|464534683|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
129067515|NCT04995029|464534680|FG000|Maintenance Phase|Adverse Event|0|||
129067516|NCT04995029|464534681|FG001|Maintenance Phase|Adverse Event|0|||
129067517|NCT04995029|464534682|FG002|Maintenance Phase|Adverse Event|0|||
129067518|NCT04995029|464534683|FG003|Maintenance Phase|Adverse Event|1|||
129067519|NCT04995029|464534680|FG000|Maintenance Phase|Physician Decision|0|||
129067520|NCT04995029|464534681|FG001|Maintenance Phase|Physician Decision|0|||
129067521|NCT04995029|464534682|FG002|Maintenance Phase|Physician Decision|8|||
129067522|NCT04995029|464534683|FG003|Maintenance Phase|Physician Decision|4|||
129067523|NCT04995029|464534680|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129067524|NCT04995029|464534681|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129067525|NCT04995029|464534682|FG002|Maintenance Phase|Withdrawal by Subject|17|||
129067526|NCT04995029|464534683|FG003|Maintenance Phase|Withdrawal by Subject|31|||
129067527|NCT04995029|464534680|FG000|Maintenance Phase|Incarceration|0|||
129067528|NCT04995029|464534681|FG001|Maintenance Phase|Incarceration|0|||
129067529|NCT04995029|464534682|FG002|Maintenance Phase|Incarceration|4|||
129067530|NCT04995029|464534683|FG003|Maintenance Phase|Incarceration|3|||
129067531|NCT04995029|464534680|FG000|Maintenance Phase|Not otherwise described|0|||
129067532|NCT04995029|464534681|FG001|Maintenance Phase|Not otherwise described|0|||
129067533|NCT04995029|464534682|FG002|Maintenance Phase|Not otherwise described|2|||
129067534|NCT04995029|464534683|FG003|Maintenance Phase|Not otherwise described|3|||
129067535|NCT04995029|464534680|FG000|Maintenance Phase|Pregnancy|0|||
129067536|NCT04995029|464534681|FG001|Maintenance Phase|Pregnancy|0|||
129067537|NCT04995029|464534682|FG002|Maintenance Phase|Pregnancy|2|||
129067538|NCT04995029|464534683|FG003|Maintenance Phase|Pregnancy|2|||
129067539|NCT00077207|464534686|FG000|Overall Study|Adverse Event|5|||
128775857|NCT02584855|463468487|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
128775858|NCT02584855|463468488|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
128775859|NCT02584855|463468489|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
128775860|NCT02584855|463468490|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
128775861|NCT02584855|463468491|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
128775862|NCT02584855|463468492|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
128775863|NCT02584855|463468487|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
128775864|NCT02584855|463468488|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
128775865|NCT02584855|463468489|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
128775866|NCT02584855|463468490|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
128775867|NCT02584855|463468491|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
128775868|NCT02584855|463468492|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
128775869|NCT02584855|463468487|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
128775870|NCT02584855|463468488|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
128775871|NCT02584855|463468489|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129067540|NCT00077207|464534686|FG000|Overall Study|Lack of Efficacy|12|||
129067541|NCT00077207|464534686|FG000|Overall Study|Physician Decision|6|||
129067542|NCT00077207|464534686|FG000|Overall Study|Withdrawal by Subject|6|||
129067543|NCT00077207|464534686|FG000|Overall Study|Ineligible|1|||
129138144|NCT02365064|464798416|FG001|Overall Study|Treatment intolerance|4|||
129138145|NCT01716559|464798417|FG000|Overall Study|Adverse Event|11|||
129138146|NCT01716559|464798417|FG000|Overall Study|Death|21|||
128775872|NCT02584855|463468490|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
128775873|NCT02584855|463468491|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
128775874|NCT02584855|463468492|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129138147|NCT01716559|464798417|FG000|Overall Study|Withdrawal by Subject|4|||
129067544|NCT00970593|464534691|FG000|Overall Study|Adverse Event|1|||
129067545|NCT00970593|464534692|FG001|Overall Study|Adverse Event|1|||
129067546|NCT00970593|464534693|FG002|Overall Study|Adverse Event|0|||
129067547|NCT00970593|464534694|FG003|Overall Study|Adverse Event|0|||
129067548|NCT00970593|464534695|FG004|Overall Study|Adverse Event|0|||
129138148|NCT01716559|464798417|FG000|Overall Study|Other withdrawal reason|75|||
129138149|NCT01133977|464798420|FG000|Overall Study|Adverse Event|0|||
129138150|NCT01133977|464798421|FG001|Overall Study|Adverse Event|0|||
129138151|NCT01133977|464798422|FG002|Overall Study|Adverse Event|1|||
129138152|NCT01133977|464798423|FG003|Overall Study|Adverse Event|0|||
129138153|NCT01133977|464798424|FG004|Overall Study|Adverse Event|0|||
129138154|NCT01133977|464798420|FG000|Overall Study|Death|1|||
129138155|NCT01133977|464798421|FG001|Overall Study|Death|1|||
129138156|NCT01133977|464798422|FG002|Overall Study|Death|1|||
129138157|NCT01133977|464798423|FG003|Overall Study|Death|7|||
129138158|NCT01133977|464798424|FG004|Overall Study|Death|3|||
129138159|NCT01133977|464798420|FG000|Overall Study|Started a New Line of Therapy|2|||
129138160|NCT01133977|464798421|FG001|Overall Study|Started a New Line of Therapy|6|||
129138161|NCT01133977|464798422|FG002|Overall Study|Started a New Line of Therapy|4|||
129138162|NCT01133977|464798423|FG003|Overall Study|Started a New Line of Therapy|25|||
129138163|NCT01133977|464798424|FG004|Overall Study|Started a New Line of Therapy|33|||
129138164|NCT01133977|464798420|FG000|Overall Study|Lost to Follow-up|0|||
129138165|NCT01133977|464798421|FG001|Overall Study|Lost to Follow-up|0|||
129138166|NCT01133977|464798422|FG002|Overall Study|Lost to Follow-up|0|||
129138167|NCT01133977|464798423|FG003|Overall Study|Lost to Follow-up|2|||
129138168|NCT01133977|464798424|FG004|Overall Study|Lost to Follow-up|1|||
129138169|NCT01133977|464798420|FG000|Overall Study|Withdrawal by Subject|0|||
129138170|NCT01133977|464798421|FG001|Overall Study|Withdrawal by Subject|0|||
129138171|NCT01133977|464798422|FG002|Overall Study|Withdrawal by Subject|0|||
129138172|NCT01133977|464798423|FG003|Overall Study|Withdrawal by Subject|5|||
129138173|NCT01133977|464798424|FG004|Overall Study|Withdrawal by Subject|1|||
129138174|NCT02773537|464798425|FG000|Overall Study|Lost to Follow-up|0|||
129138175|NCT02773537|464798426|FG001|Overall Study|Lost to Follow-up|1|||
129138176|NCT02773537|464798427|FG002|Overall Study|Lost to Follow-up|4|||
129138177|NCT01840163|464798428|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
129138178|NCT01840163|464798429|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
129138179|NCT01840163|464798428|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
129138180|NCT01840163|464798429|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
129138181|NCT01840163|464798428|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
129138182|NCT01840163|464798429|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
129138183|NCT00662038|464798430|FG000|Overall Study|Reason not specified|3|||
129138184|NCT00662038|464798430|FG000|Overall Study|Withdrawn consent|22|||
129138185|NCT00662038|464798430|FG000|Overall Study|Withdrawal by Subject|83|||
129138186|NCT00662038|464798430|FG000|Overall Study|Sponsor decision|1|||
129138187|NCT00662038|464798430|FG000|Overall Study|Physician Decision|19|||
129138188|NCT00662038|464798430|FG000|Overall Study|Lung transplantation|44|||
129138189|NCT00662038|464798430|FG000|Overall Study|Lost to Follow-up|1|||
129138190|NCT00662038|464798430|FG000|Overall Study|Death|95|||
129138191|NCT00662038|464798430|FG000|Overall Study|Adverse Event|358|||
129138192|NCT00662038|464798430|FG000|Overall Study|Continued treatment|5|||
129138193|NCT00397046|464798431|FG000|Overall Study|Disease Progression|3|||
129138194|NCT00397046|464798432|FG001|Overall Study|Disease Progression|3|||
129138195|NCT00397046|464798433|FG002|Overall Study|Disease Progression|10|||
129138196|NCT00397046|464798434|FG003|Overall Study|Disease Progression|5|||
129138197|NCT03636269|464798436|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
129138198|NCT03636269|464798437|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
129138199|NCT03636269|464798438|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
129138200|NCT03636269|464798436|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
129138201|NCT03636269|464798437|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
128721955|NCT00539838|463279285|FG000|Overall Study|Withdrawal by Subject|0|||
128721956|NCT00539838|463279286|FG001|Overall Study|Withdrawal by Subject|4|||
128721957|NCT00539838|463279287|FG002|Overall Study|Withdrawal by Subject|0|||
128721958|NCT00539838|463279285|FG000|Overall Study|Death|0|||
129138202|NCT03636269|464798438|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
129138203|NCT03636269|464798436|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
129138204|NCT03636269|464798437|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
129138205|NCT03636269|464798438|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
128721959|NCT00539838|463279286|FG001|Overall Study|Death|2|||
129138206|NCT03636269|464798436|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
129138207|NCT03636269|464798437|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
128721960|NCT00539838|463279287|FG002|Overall Study|Death|0|||
129138208|NCT03636269|464798438|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
128721961|NCT00539838|463279285|FG000|Overall Study|Did not cooperate|1|||
128721962|NCT00539838|463279286|FG001|Overall Study|Did not cooperate|0|||
129138209|NCT03636269|464798436|FG000|Period 1: Double-blind Phase|Other|6|||
129138210|NCT03636269|464798437|FG001|Period 1: Double-blind Phase|Other|3|||
129138211|NCT03636269|464798438|FG002|Period 1: Double-blind Phase|Other|0|||
129138212|NCT03636269|464798436|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
129138213|NCT03636269|464798437|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129138214|NCT03636269|464798438|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
128721963|NCT00539838|463279287|FG002|Overall Study|Did not cooperate|1|||
128721964|NCT00539838|463279285|FG000|Overall Study|Administrative|4|||
128721965|NCT00539838|463279286|FG001|Overall Study|Administrative|0|||
128721966|NCT00539838|463279287|FG002|Overall Study|Administrative|8|||
128721967|NCT03090100|463279288|FG000|Overall Study|Adverse Event|9|||
128721968|NCT03090100|463279289|FG001|Overall Study|Adverse Event|11|||
128721969|NCT03090100|463279288|FG000|Overall Study|Pregnancy|1|||
128721970|NCT03090100|463279289|FG001|Overall Study|Pregnancy|1|||
128721971|NCT03090100|463279288|FG000|Overall Study|Lack of Efficacy|2|||
128721972|NCT03090100|463279289|FG001|Overall Study|Lack of Efficacy|7|||
128721973|NCT03090100|463279288|FG000|Overall Study|Lost to Follow-up|2|||
128721974|NCT03090100|463279289|FG001|Overall Study|Lost to Follow-up|2|||
128721975|NCT03090100|463279288|FG000|Overall Study|Withdrawal by Subject|7|||
128721976|NCT03090100|463279289|FG001|Overall Study|Withdrawal by Subject|19|||
128721977|NCT03090100|463279288|FG000|Overall Study|Protocol Violation|2|||
128721978|NCT03090100|463279289|FG001|Overall Study|Protocol Violation|6|||
128721979|NCT03090100|463279288|FG000|Overall Study|Non-compliance|2|||
128721980|NCT03090100|463279289|FG001|Overall Study|Non-compliance|0|||
128721981|NCT03090100|463279288|FG000|Overall Study|Other|2|||
128721982|NCT03090100|463279289|FG001|Overall Study|Other|2|||
128721983|NCT01660711|463279290|FG000|Overall Study|Adverse Event|7|||
128721984|NCT01660711|463279290|FG000|Overall Study|Withdrawal by Subject|1|||
128721985|NCT03406858|463279291|FG000|Overall Study|Failure to receive treatment drug.|1|||
128721986|NCT03406858|463279291|FG000|Overall Study|ineligible|1|||
128721987|NCT02420691|463279296|FG000|Overall Study|Adverse Event|3|||
128721988|NCT02420691|463279296|FG000|Overall Study|Withdrawal by Subject|3|||
128721989|NCT03897179|463279302|FG000|Overall Study|Withdrawal by Subject|1|||
128721990|NCT00704535|463279303|FG000|Overall Study|Adverse Event|2|||
128721991|NCT00704535|463279303|FG000|Overall Study|Death|2|||
128721992|NCT00704535|463279303|FG000|Overall Study|Lost to Follow-up|8|||
128721993|NCT00704535|463279303|FG000|Overall Study|Protocol Violation|10|||
128721994|NCT00704535|463279303|FG000|Overall Study|Completed status not on Case Report Form|124|||
128721995|NCT02503332|463279304|FG000|Overall Study|Adverse Event|17|||
128721996|NCT02503332|463279305|FG001|Overall Study|Adverse Event|5|||
128721997|NCT02503332|463279306|FG002|Overall Study|Adverse Event|3|||
128721998|NCT02503332|463279307|FG003|Overall Study|Adverse Event|1|||
128721999|NCT02503332|463279304|FG000|Overall Study|Investigator's Decision|5|||
128722000|NCT02503332|463279305|FG001|Overall Study|Investigator's Decision|1|||
128722001|NCT02503332|463279306|FG002|Overall Study|Investigator's Decision|0|||
128722002|NCT02503332|463279307|FG003|Overall Study|Investigator's Decision|0|||
128722003|NCT02503332|463279304|FG000|Overall Study|Sponsor's Decision|1|||
128722004|NCT02503332|463279305|FG001|Overall Study|Sponsor's Decision|0|||
128722005|NCT02503332|463279306|FG002|Overall Study|Sponsor's Decision|0|||
128722006|NCT02503332|463279307|FG003|Overall Study|Sponsor's Decision|1|||
128722007|NCT02503332|463279304|FG000|Overall Study|Subject Request|6|||
128722008|NCT02503332|463279305|FG001|Overall Study|Subject Request|5|||
128722009|NCT02503332|463279306|FG002|Overall Study|Subject Request|2|||
128722010|NCT02503332|463279307|FG003|Overall Study|Subject Request|1|||
128722011|NCT02503332|463279304|FG000|Overall Study|Death|0|||
128722012|NCT02503332|463279305|FG001|Overall Study|Death|2|||
128722013|NCT02503332|463279306|FG002|Overall Study|Death|2|||
128722014|NCT02503332|463279307|FG003|Overall Study|Death|0|||
128722015|NCT02503332|463279304|FG000|Overall Study|Other|5|||
128722016|NCT02503332|463279305|FG001|Overall Study|Other|6|||
128722017|NCT02503332|463279306|FG002|Overall Study|Other|1|||
128722018|NCT02503332|463279307|FG003|Overall Study|Other|1|||
128722019|NCT01413360|463279308|FG000|Overall Study|Lost to Follow-up|2|||
128722020|NCT01413360|463279308|FG000|Overall Study|Adverse Event|1|||
128722021|NCT02424383|463279311|FG000|Overall Study|Withdrawal by Subject|32|||
128722022|NCT02424383|463279311|FG000|Overall Study|Death|170|||
128722023|NCT02424383|463279311|FG000|Overall Study|Sponsor's decision|3|||
128722024|NCT02424383|463279311|FG000|Overall Study|Investigator's decision|44|||
128722025|NCT02424383|463279311|FG000|Overall Study|Lost to Follow-up|81|||
128722026|NCT02424383|463279311|FG000|Overall Study|Other|7|||
128722027|NCT02424383|463279311|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
128722028|NCT01817725|463279312|FG000|Overall Study|Withdrawal by Subject|1|||
129067549|NCT00970593|464534696|FG005|Overall Study|Adverse Event|0|||
129067550|NCT00970593|464534697|FG006|Overall Study|Adverse Event|0|||
129067551|NCT00970593|464534691|FG000|Overall Study|Discontinuation of study by sponsor|0|||
129067552|NCT00970593|464534692|FG001|Overall Study|Discontinuation of study by sponsor|0|||
129067553|NCT00970593|464534693|FG002|Overall Study|Discontinuation of study by sponsor|5|||
129067554|NCT00970593|464534694|FG003|Overall Study|Discontinuation of study by sponsor|0|||
129067555|NCT00970593|464534695|FG004|Overall Study|Discontinuation of study by sponsor|0|||
129067556|NCT00970593|464534696|FG005|Overall Study|Discontinuation of study by sponsor|0|||
129067557|NCT00970593|464534697|FG006|Overall Study|Discontinuation of study by sponsor|2|||
129067558|NCT00970593|464534691|FG000|Overall Study|Withdrawal by Subject|0|||
129067559|NCT00970593|464534692|FG001|Overall Study|Withdrawal by Subject|0|||
129067560|NCT00970593|464534693|FG002|Overall Study|Withdrawal by Subject|1|||
129067561|NCT00970593|464534694|FG003|Overall Study|Withdrawal by Subject|0|||
129067562|NCT00970593|464534695|FG004|Overall Study|Withdrawal by Subject|0|||
129067563|NCT00970593|464534696|FG005|Overall Study|Withdrawal by Subject|0|||
129067564|NCT00970593|464534697|FG006|Overall Study|Withdrawal by Subject|0|||
129067565|NCT01202175|464534705|FG000|Overall Study|Lost to Follow-up|2|||
129067566|NCT01202175|464534705|FG000|Overall Study|Withdrawal by Subject|1|||
129067567|NCT01202175|464534705|FG000|Overall Study|Adverse Event|2|||
129067568|NCT01942993|464534710|FG000|Overall Study|Lost to Follow-up|1|||
129067569|NCT01942993|464534710|FG000|Overall Study|Physician Decision|1|||
129067570|NCT01350271|464534711|FG000|Overall Study|Lost to Follow-up|21|||
129067571|NCT01350271|464534712|FG001|Overall Study|Lost to Follow-up|17|||
129067572|NCT01350271|464534713|FG002|Overall Study|Lost to Follow-up|26|||
129067573|NCT01349192|464534714|FG000|Overall Study|Protocol Violation|0|||
129067574|NCT01349192|464534715|FG001|Overall Study|Protocol Violation|1|||
129067575|NCT01349192|464534714|FG000|Overall Study|Withdrawal by Subject|0|||
128722029|NCT02972632|463279320|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
128722030|NCT02972632|463279320|FG000|Overall Study|Lost to Follow-up|4|||
128722031|NCT02972632|463279320|FG000|Overall Study|Voluntary Withdrawal|10|||
128722032|NCT01488097|463279329|FG000|Overall Study|Lost to Follow-up|1|||
128722033|NCT02016482|463279333|FG000|Period A|Adverse Event|3|||
128722034|NCT02016482|463279334|FG001|Period A|Adverse Event|5|||
128722035|NCT02016482|463279333|FG000|Period A|Withdrawal by Subject|3|||
128722036|NCT02016482|463279334|FG001|Period A|Withdrawal by Subject|4|||
128722037|NCT02016482|463279333|FG000|Period A|Lost to Follow-up|3|||
128722038|NCT02016482|463279334|FG001|Period A|Lost to Follow-up|3|||
128722039|NCT02016482|463279333|FG000|Period A|Lack of Efficacy|2|||
128722040|NCT02016482|463279334|FG001|Period A|Lack of Efficacy|1|||
128722041|NCT02016482|463279333|FG000|Period A|Other|3|||
128722042|NCT02016482|463279334|FG001|Period A|Other|0|||
128722043|NCT02016482|463279333|FG000|Period A|Protocol Violation|0|||
128722044|NCT02016482|463279334|FG001|Period A|Protocol Violation|1|||
128722045|NCT02016482|463279333|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
128722046|NCT02016482|463279334|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
128722047|NCT02016482|463279333|FG000|Period B|Withdrawal by Subject|1|||
128722048|NCT02016482|463279334|FG001|Period B|Withdrawal by Subject|1|||
128722049|NCT02016482|463279333|FG000|Period B|Lost to Follow-up|2|||
128722050|NCT02016482|463279334|FG001|Period B|Lost to Follow-up|0|||
128722051|NCT02016482|463279333|FG000|Period B|Lack of Efficacy|6|||
128722052|NCT02016482|463279334|FG001|Period B|Lack of Efficacy|4|||
128722053|NCT02016482|463279333|FG000|Period B|Other|4|||
128722054|NCT02016482|463279334|FG001|Period B|Other|0|||
128722055|NCT02016482|463279333|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
128722056|NCT02016482|463279334|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
128722057|NCT01251380|463279346|FG000|Overall Study|Other (Not otherwise specified)|12|||
128722058|NCT01251380|463279346|FG000|Overall Study|Withdrawal by Subject|6|||
128722059|NCT01251380|463279346|FG000|Overall Study|Lack of Efficacy|1|||
128722060|NCT01251380|463279346|FG000|Overall Study|Adverse Event|1|||
128722061|NCT01251380|463279346|FG000|Overall Study|Lost to Follow-up|2|||
128722062|NCT03054870|463279353|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
128722063|NCT03054870|463279353|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
128722064|NCT00129129|463279354|FG000|Primary Phase|Adverse Event|2|||
128722065|NCT00129129|463279355|FG001|Primary Phase|Adverse Event|1|||
128722066|NCT00129129|463279356|FG002|Primary Phase|Adverse Event|0|||
128722067|NCT00129129|463279357|FG003|Primary Phase|Adverse Event|0|||
128722068|NCT00129129|463279358|FG004|Primary Phase|Adverse Event|0|||
128722069|NCT00129129|463279354|FG000|Primary Phase|Withdrawal by Subject|12|||
128722070|NCT00129129|463279355|FG001|Primary Phase|Withdrawal by Subject|10|||
128722071|NCT00129129|463279356|FG002|Primary Phase|Withdrawal by Subject|0|||
128722072|NCT00129129|463279357|FG003|Primary Phase|Withdrawal by Subject|0|||
128722073|NCT00129129|463279358|FG004|Primary Phase|Withdrawal by Subject|0|||
128722074|NCT00129129|463279354|FG000|Primary Phase|Migration from study area|1|||
128722075|NCT00129129|463279355|FG001|Primary Phase|Migration from study area|3|||
128722076|NCT00129129|463279356|FG002|Primary Phase|Migration from study area|0|||
128722077|NCT00129129|463279357|FG003|Primary Phase|Migration from study area|0|||
128722078|NCT00129129|463279358|FG004|Primary Phase|Migration from study area|0|||
128722079|NCT00129129|463279354|FG000|Primary Phase|Lost to Follow-up|8|||
128722080|NCT00129129|463279355|FG001|Primary Phase|Lost to Follow-up|6|||
128722081|NCT00129129|463279356|FG002|Primary Phase|Lost to Follow-up|0|||
129067576|NCT01349192|464534715|FG001|Overall Study|Withdrawal by Subject|2|||
129067577|NCT01349192|464534714|FG000|Overall Study|Lost to Follow-up|1|||
129067578|NCT01349192|464534715|FG001|Overall Study|Lost to Follow-up|3|||
129067579|NCT01349192|464534714|FG000|Overall Study|Failure to adhere to Protocol|2|||
128722082|NCT00129129|463279357|FG003|Primary Phase|Lost to Follow-up|0|||
128722083|NCT00129129|463279358|FG004|Primary Phase|Lost to Follow-up|0|||
128722084|NCT00129129|463279354|FG000|Primary Phase|Other|2|||
129067580|NCT01349192|464534715|FG001|Overall Study|Failure to adhere to Protocol|0|||
129067581|NCT02262325|464534717|FG000|Overall Study|Death|16|||
129067582|NCT02262325|464534717|FG000|Overall Study|Lost to Follow-up|1|||
129067583|NCT01071915|464534718|FG000|Overall Study|Adverse Event|3|||
129067584|NCT01071915|464534718|FG000|Overall Study|Physician Decision|2|||
129067585|NCT01071915|464534718|FG000|Overall Study|Withdrawal by Subject|2|||
129067586|NCT01071915|464534718|FG000|Overall Study|Miscellaneous Reasons|2|||
129067587|NCT03404674|464534721|FG000|Overall Study|Inability to Attend Future Visits|0|||
129067588|NCT03404674|464534722|FG001|Overall Study|Inability to Attend Future Visits|1|||
129067589|NCT03404674|464534723|FG002|Overall Study|Inability to Attend Future Visits|1|||
129067590|NCT03404674|464534724|FG003|Overall Study|Inability to Attend Future Visits|0|||
129067591|NCT03404674|464534725|FG004|Overall Study|Inability to Attend Future Visits|0|||
129067592|NCT03404674|464534726|FG005|Overall Study|Inability to Attend Future Visits|0|||
129067593|NCT03404674|464534721|FG000|Overall Study|Behavioral Problems|0|||
129067594|NCT03404674|464534722|FG001|Overall Study|Behavioral Problems|0|||
129067595|NCT03404674|464534723|FG002|Overall Study|Behavioral Problems|1|||
129067596|NCT03404674|464534724|FG003|Overall Study|Behavioral Problems|0|||
129138215|NCT03636269|464798436|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
129138216|NCT03636269|464798437|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
129138217|NCT03636269|464798438|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
129138218|NCT03636269|464798436|FG000|Period 2: Open-label Phase|Adverse Event|0|||
129138219|NCT03636269|464798437|FG001|Period 2: Open-label Phase|Adverse Event|0|||
129138220|NCT03636269|464798438|FG002|Period 2: Open-label Phase|Adverse Event|21|||
129138221|NCT03636269|464798436|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
129138222|NCT03636269|464798437|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
129138223|NCT03636269|464798438|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
129138224|NCT03636269|464798436|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
129138225|NCT03636269|464798437|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
129138226|NCT03636269|464798438|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
129138227|NCT03636269|464798436|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
129138228|NCT03636269|464798437|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
129138229|NCT03636269|464798438|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
129138230|NCT03636269|464798436|FG000|Period 2: Open-label Phase|Administrative|0|||
129138231|NCT03636269|464798437|FG001|Period 2: Open-label Phase|Administrative|0|||
129138232|NCT03636269|464798438|FG002|Period 2: Open-label Phase|Administrative|36|||
129138233|NCT03636269|464798436|FG000|Period 2: Open-label Phase|Other|0|||
129138234|NCT03636269|464798437|FG001|Period 2: Open-label Phase|Other|0|||
129138235|NCT03636269|464798438|FG002|Period 2: Open-label Phase|Other|9|||
129138236|NCT03636269|464798436|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
129138237|NCT03636269|464798437|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
129138238|NCT03636269|464798438|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
129138239|NCT00493285|464798448|FG000|Overall Study|Lost to Follow-up|0|||
129138240|NCT00493285|464798449|FG001|Overall Study|Lost to Follow-up|0|||
129138241|NCT00493285|464798450|FG002|Overall Study|Lost to Follow-up|0|||
129138242|NCT00493285|464798451|FG003|Overall Study|Lost to Follow-up|0|||
129138243|NCT00493285|464798452|FG004|Overall Study|Lost to Follow-up|1|||
129138244|NCT00493285|464798453|FG005|Overall Study|Lost to Follow-up|0|||
129138245|NCT04535362|464798454|FG000|Overall Study|Lost to Follow-up|3|||
129138246|NCT04535362|464798455|FG001|Overall Study|Lost to Follow-up|1|||
129138247|NCT03791060|464798456|FG000|Overall Study|Withdrawal by Subject|1|||
129138248|NCT03774810|464798457|FG000|Phase 1|Lack of Efficacy|21|||
129138249|NCT03774810|464798458|FG001|Phase 1|Lack of Efficacy|0|||
129138250|NCT03774810|464798459|FG002|Phase 1|Lack of Efficacy|0|||
128722085|NCT00129129|463279355|FG001|Primary Phase|Other|5|||
128722086|NCT00129129|463279356|FG002|Primary Phase|Other|0|||
128722087|NCT00129129|463279357|FG003|Primary Phase|Other|0|||
128722088|NCT00129129|463279358|FG004|Primary Phase|Other|0|||
129067597|NCT03404674|464534725|FG004|Overall Study|Behavioral Problems|0|||
129067598|NCT03404674|464534726|FG005|Overall Study|Behavioral Problems|0|||
129067599|NCT03404674|464534721|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
129067600|NCT03404674|464534722|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
129138251|NCT03774810|464798460|FG003|Phase 1|Lack of Efficacy|0|||
129138252|NCT03774810|464798461|FG004|Phase 1|Lack of Efficacy|0|||
129138253|NCT03774810|464798457|FG000|Phase 1|Withdrawal by Subject|9|||
129138254|NCT03774810|464798458|FG001|Phase 1|Withdrawal by Subject|0|||
129138255|NCT03774810|464798459|FG002|Phase 1|Withdrawal by Subject|0|||
129138256|NCT03774810|464798460|FG003|Phase 1|Withdrawal by Subject|0|||
129138257|NCT03774810|464798461|FG004|Phase 1|Withdrawal by Subject|0|||
129138258|NCT03774810|464798457|FG000|Phase 1|Lost to Follow-up|2|||
129138259|NCT03774810|464798458|FG001|Phase 1|Lost to Follow-up|0|||
128722089|NCT00129129|463279354|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
128722090|NCT00129129|463279355|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
128722091|NCT00129129|463279356|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
128722092|NCT00129129|463279357|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
129067601|NCT03404674|464534723|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
129067602|NCT03404674|464534724|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
129067603|NCT03404674|464534725|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
129067604|NCT03404674|464534726|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
129067605|NCT02969044|464534731|FG000|Overall Study|Withdrawal by Subject|2|||
129067606|NCT02969044|464534732|FG001|Overall Study|Withdrawal by Subject|6|||
129067607|NCT02969044|464534731|FG000|Overall Study|Adverse Event|3|||
129067608|NCT02969044|464534732|FG001|Overall Study|Adverse Event|0|||
129067609|NCT04728802|464534733|FG000|Overall Study|Withdrawal by Subject|4|||
129067610|NCT04728802|464534734|FG001|Overall Study|Withdrawal by Subject|20|||
129067611|NCT04728802|464534733|FG000|Overall Study|Physician Decision|7|||
129067612|NCT04728802|464534734|FG001|Overall Study|Physician Decision|7|||
129067613|NCT04728802|464534733|FG000|Overall Study|Protocol Violation|10|||
129067614|NCT04728802|464534734|FG001|Overall Study|Protocol Violation|4|||
129067615|NCT04728802|464534733|FG000|Overall Study|Transfer|1|||
129067616|NCT04728802|464534734|FG001|Overall Study|Transfer|0|||
129067617|NCT04728802|464534733|FG000|Overall Study|Death|4|||
129067618|NCT04728802|464534734|FG001|Overall Study|Death|5|||
129067619|NCT04728802|464534733|FG000|Overall Study|Other|3|||
129067620|NCT04728802|464534734|FG001|Overall Study|Other|0|||
129067621|NCT01176513|464534735|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
129067622|NCT03164616|464534736|FG000|Overall Study|Death|250|||
129067623|NCT03164616|464534737|FG001|Overall Study|Death|264|||
129067624|NCT03164616|464534738|FG002|Overall Study|Death|279|||
129067625|NCT03164616|464534736|FG000|Overall Study|Lost to Follow-up|2|||
129067626|NCT03164616|464534737|FG001|Overall Study|Lost to Follow-up|2|||
129067627|NCT03164616|464534738|FG002|Overall Study|Lost to Follow-up|2|||
129067628|NCT03164616|464534736|FG000|Overall Study|Withdrawal by Subject|6|||
129067629|NCT03164616|464534737|FG001|Overall Study|Withdrawal by Subject|7|||
129067630|NCT03164616|464534738|FG002|Overall Study|Withdrawal by Subject|16|||
129067631|NCT00143390|464534753|FG000|Overall Study|Death|2|||
129067632|NCT00143390|464534754|FG001|Overall Study|Death|0|||
129067633|NCT00143390|464534753|FG000|Overall Study|Not meeting entry criteria|2|||
129067634|NCT00143390|464534754|FG001|Overall Study|Not meeting entry criteria|5|||
129067635|NCT00143390|464534753|FG000|Overall Study|Withdrawal by Subject|4|||
129067636|NCT00143390|464534754|FG001|Overall Study|Withdrawal by Subject|4|||
129067637|NCT00143390|464534753|FG000|Overall Study|Progressive disease|119|||
129067638|NCT00143390|464534754|FG001|Overall Study|Progressive disease|115|||
129067639|NCT00143390|464534753|FG000|Overall Study|Protocol Violation|2|||
129067640|NCT00143390|464534754|FG001|Overall Study|Protocol Violation|0|||
129067641|NCT00143390|464534753|FG000|Overall Study|Study termination|10|||
129067642|NCT00143390|464534754|FG001|Overall Study|Study termination|15|||
129067643|NCT00143390|464534753|FG000|Overall Study|Adverse Event|9|||
129067644|NCT00143390|464534754|FG001|Overall Study|Adverse Event|8|||
129067645|NCT00143390|464534753|FG000|Overall Study|Other|1|||
129138260|NCT03774810|464798459|FG002|Phase 1|Lost to Follow-up|0|||
129138261|NCT03774810|464798460|FG003|Phase 1|Lost to Follow-up|0|||
129138262|NCT03774810|464798461|FG004|Phase 1|Lost to Follow-up|0|||
129138263|NCT03774810|464798457|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
129138264|NCT03774810|464798458|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
129138265|NCT03774810|464798459|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
129138266|NCT03774810|464798460|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
129138267|NCT03774810|464798461|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
129138268|NCT03774810|464798457|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
129138269|NCT03774810|464798458|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
129138270|NCT03774810|464798459|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
129138271|NCT03774810|464798460|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
129138272|NCT03774810|464798461|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
129138273|NCT03774810|464798457|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
129138274|NCT03774810|464798458|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
128722093|NCT00129129|463279358|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
128722094|NCT00129129|463279354|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
128722095|NCT00129129|463279355|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
129067646|NCT00143390|464534754|FG001|Overall Study|Other|2|||
129067647|NCT00041132|464534757|FG000|Overall Study|Adverse Event|19|||
129067648|NCT00041132|464534757|FG000|Overall Study|Death|1|||
129067649|NCT00041132|464534757|FG000|Overall Study|Not Eligible|7|||
129067650|NCT00041132|464534757|FG000|Overall Study|Withdrawal by Subject|1|||
129067651|NCT00041132|464534757|FG000|Overall Study|Physician Decision|2|||
129067652|NCT03180645|464534758|FG000|Overall Study|Adverse Event|0|||
129067653|NCT03180645|464534759|FG001|Overall Study|Adverse Event|1|||
129067654|NCT03180645|464534760|FG002|Overall Study|Adverse Event|2|||
129138275|NCT03774810|464798459|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
129138276|NCT03774810|464798460|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
129067655|NCT02729909|464534762|FG000|Overall Study|Lost to Follow-up|0|||
129067656|NCT02729909|464534763|FG001|Overall Study|Lost to Follow-up|1|||
129067657|NCT02729909|464534762|FG000|Overall Study|Lack of Efficacy|0|||
129067658|NCT02729909|464534763|FG001|Overall Study|Lack of Efficacy|2|||
129067659|NCT02729909|464534762|FG000|Overall Study|Significant Protocol Deviation|0|||
129067660|NCT02729909|464534763|FG001|Overall Study|Significant Protocol Deviation|2|||
129067661|NCT02729909|464534762|FG000|Overall Study|Voluntary Withdrawal|1|||
129067662|NCT02729909|464534763|FG001|Overall Study|Voluntary Withdrawal|0|||
129067663|NCT00866359|464534764|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
129067664|NCT00866359|464534765|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
129067665|NCT00866359|464534766|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
129067666|NCT00866359|464534767|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
129067667|NCT00866359|464534764|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
129067668|NCT00866359|464534765|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
129067669|NCT00866359|464534766|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
129067670|NCT00866359|464534767|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
129067671|NCT00866359|464534764|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
129067672|NCT00866359|464534765|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
129067673|NCT00866359|464534766|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
129067674|NCT00866359|464534767|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
129067675|NCT00866359|464534764|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
129067676|NCT00866359|464534765|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
129067677|NCT00866359|464534766|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
129067678|NCT00866359|464534767|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
129067679|NCT00866359|464534764|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
129067680|NCT00866359|464534765|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
129067681|NCT00866359|464534766|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
129067682|NCT00866359|464534767|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
129067683|NCT00866359|464534764|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
129067684|NCT00866359|464534765|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
129067685|NCT00866359|464534766|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
129067686|NCT00866359|464534767|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
129067687|NCT00768248|464534769|FG000|Overall Study|Research coordinator didn't collect data|1|||
129067688|NCT00768248|464534770|FG001|Overall Study|Research coordinator didn't collect data|1|||
129067689|NCT01547390|464534771|FG000|Overall Study|Withdrawal by Subject|10|||
129067690|NCT01547390|464534772|FG001|Overall Study|Withdrawal by Subject|7|||
129067691|NCT01547390|464534771|FG000|Overall Study|termination of pregnancy|0|||
129067692|NCT01547390|464534772|FG001|Overall Study|termination of pregnancy|1|||
129067693|NCT01547390|464534771|FG000|Overall Study|Lost to Follow-up|0|||
129067694|NCT01547390|464534772|FG001|Overall Study|Lost to Follow-up|2|||
129067695|NCT01547390|464534771|FG000|Overall Study|Adverse Event|3|||
129067696|NCT01547390|464534772|FG001|Overall Study|Adverse Event|0|||
129067697|NCT01459783|464534773|FG000|Baseline to 6 Months|Death|1|||
129067698|NCT01459783|464534774|FG001|Baseline to 6 Months|Death|0|||
129067699|NCT01459783|464534773|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
129067700|NCT01459783|464534774|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
129067701|NCT01459783|464534773|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
129067702|NCT01459783|464534774|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
129067703|NCT01459783|464534773|FG000|6 Months to 12 Months|Death|0|||
129067704|NCT01459783|464534774|FG001|6 Months to 12 Months|Death|1|||
129067705|NCT01459783|464534773|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
129067706|NCT01459783|464534774|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
129067707|NCT01459783|464534773|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
129067708|NCT01459783|464534774|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
129067709|NCT01459783|464534773|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
129067710|NCT01459783|464534774|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
129067711|NCT06018129|464534776|FG000|Overall Study|Death|1|||
129067712|NCT06018129|464534777|FG001|Overall Study|Death|1|||
129067713|NCT06018129|464534778|FG002|Overall Study|Death|2|||
129067714|NCT06018129|464534776|FG000|Overall Study|Sponsor Decision|2|||
129067715|NCT06018129|464534777|FG001|Overall Study|Sponsor Decision|2|||
129067716|NCT06018129|464534778|FG002|Overall Study|Sponsor Decision|1|||
129067717|NCT04917861|464534779|FG000|Main Study (196 Days)|Adverse Event|0|||
129067718|NCT04917861|464534780|FG001|Main Study (196 Days)|Adverse Event|1|||
128722096|NCT00129129|463279356|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
128722097|NCT00129129|463279357|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
128722098|NCT00129129|463279358|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
128722099|NCT00129129|463279354|FG000|Fourth Dose Phase|Migration from study area|0|||
128722100|NCT00129129|463279355|FG001|Fourth Dose Phase|Migration from study area|0|||
128722101|NCT00129129|463279356|FG002|Fourth Dose Phase|Migration from study area|0|||
128722102|NCT00129129|463279357|FG003|Fourth Dose Phase|Migration from study area|0|||
128722103|NCT00129129|463279358|FG004|Fourth Dose Phase|Migration from study area|2|||
128722104|NCT00129129|463279354|FG000|Fourth Dose Phase|Other|0|||
128722105|NCT00129129|463279355|FG001|Fourth Dose Phase|Other|0|||
129067719|NCT04917861|464534781|FG002|Main Study (196 Days)|Adverse Event|0|||
128722106|NCT00129129|463279356|FG002|Fourth Dose Phase|Other|0|||
128722107|NCT00129129|463279357|FG003|Fourth Dose Phase|Other|1|||
128722108|NCT00129129|463279358|FG004|Fourth Dose Phase|Other|1|||
128722109|NCT00129129|463279354|FG000|Fourth Dose Phase|Protocol Violation|0|||
128722110|NCT00129129|463279355|FG001|Fourth Dose Phase|Protocol Violation|0|||
128722111|NCT00129129|463279356|FG002|Fourth Dose Phase|Protocol Violation|0|||
128722112|NCT00129129|463279357|FG003|Fourth Dose Phase|Protocol Violation|1|||
128722113|NCT00129129|463279358|FG004|Fourth Dose Phase|Protocol Violation|0|||
128722114|NCT03089606|463279359|FG000|Overall Study|Progression after Cycle 1|1|||
128722115|NCT01709695|463279363|FG000|Overall Study|Withdrawal by Subject|1|||
128722116|NCT01709695|463279364|FG001|Overall Study|Withdrawal by Subject|1|||
128722117|NCT02802592|463279365|FG000|Overall Study|Study terminated due to loss of funding|4|||
128722118|NCT01150123|463279367|FG000|Overall Study|Withdrawal by Subject|1|||
128722119|NCT01150123|463279368|FG001|Overall Study|Withdrawal by Subject|1|||
128722120|NCT01150123|463279369|FG002|Overall Study|Withdrawal by Subject|2|||
128722121|NCT01150123|463279370|FG003|Overall Study|Withdrawal by Subject|1|||
128722122|NCT01150123|463279371|FG004|Overall Study|Withdrawal by Subject|1|||
128722123|NCT01150123|463279372|FG005|Overall Study|Withdrawal by Subject|1|||
128722124|NCT01150123|463279373|FG006|Overall Study|Withdrawal by Subject|0|||
128722125|NCT01150123|463279374|FG007|Overall Study|Withdrawal by Subject|3|||
128722126|NCT01150123|463279375|FG008|Overall Study|Withdrawal by Subject|2|||
128722127|NCT01150123|463279376|FG009|Overall Study|Withdrawal by Subject|0|||
128722128|NCT01150123|463279377|FG010|Overall Study|Withdrawal by Subject|1|||
128722129|NCT01150123|463279378|FG011|Overall Study|Withdrawal by Subject|0|||
128722130|NCT01150123|463279379|FG012|Overall Study|Withdrawal by Subject|1|||
128722131|NCT01150123|463279380|FG013|Overall Study|Withdrawal by Subject|0|||
128722132|NCT01150123|463279381|FG014|Overall Study|Withdrawal by Subject|0|||
128722133|NCT01150123|463279382|FG015|Overall Study|Withdrawal by Subject|1|||
128722134|NCT01150123|463279383|FG016|Overall Study|Withdrawal by Subject|0|||
128722135|NCT01150123|463279384|FG017|Overall Study|Withdrawal by Subject|1|||
128722136|NCT01150123|463279367|FG000|Overall Study|Lost to Follow-up|2|||
128722137|NCT01150123|463279368|FG001|Overall Study|Lost to Follow-up|1|||
128722138|NCT01150123|463279369|FG002|Overall Study|Lost to Follow-up|2|||
128722139|NCT01150123|463279370|FG003|Overall Study|Lost to Follow-up|2|||
128722140|NCT01150123|463279371|FG004|Overall Study|Lost to Follow-up|2|||
128722141|NCT01150123|463279372|FG005|Overall Study|Lost to Follow-up|5|||
128722142|NCT01150123|463279373|FG006|Overall Study|Lost to Follow-up|0|||
129067720|NCT04917861|464534782|FG003|Main Study (196 Days)|Adverse Event|0|||
129067721|NCT04917861|464534779|FG000|Main Study (196 Days)|Death|0|||
129067722|NCT04917861|464534780|FG001|Main Study (196 Days)|Death|0|||
129067723|NCT04917861|464534781|FG002|Main Study (196 Days)|Death|0|||
129067724|NCT04917861|464534782|FG003|Main Study (196 Days)|Death|1|||
129067725|NCT04917861|464534779|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
129067726|NCT04917861|464534780|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
129067727|NCT04917861|464534781|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
129067728|NCT04917861|464534782|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
129067729|NCT04917861|464534779|FG000|Main Study (196 Days)|Physician Decision|0|||
128722143|NCT01150123|463279374|FG007|Overall Study|Lost to Follow-up|0|||
129067730|NCT04917861|464534780|FG001|Main Study (196 Days)|Physician Decision|0|||
128722144|NCT01150123|463279375|FG008|Overall Study|Lost to Follow-up|3|||
128722145|NCT01150123|463279376|FG009|Overall Study|Lost to Follow-up|1|||
128722146|NCT01150123|463279377|FG010|Overall Study|Lost to Follow-up|1|||
129067731|NCT04917861|464534781|FG002|Main Study (196 Days)|Physician Decision|0|||
129067732|NCT04917861|464534782|FG003|Main Study (196 Days)|Physician Decision|1|||
128722147|NCT01150123|463279378|FG011|Overall Study|Lost to Follow-up|1|||
128722148|NCT01150123|463279379|FG012|Overall Study|Lost to Follow-up|2|||
128722149|NCT01150123|463279380|FG013|Overall Study|Lost to Follow-up|0|||
128722150|NCT01150123|463279381|FG014|Overall Study|Lost to Follow-up|0|||
129067733|NCT04917861|464534779|FG000|Main Study (196 Days)|Pregnancy|1|||
129067734|NCT04917861|464534780|FG001|Main Study (196 Days)|Pregnancy|1|||
129067735|NCT04917861|464534781|FG002|Main Study (196 Days)|Pregnancy|0|||
129067736|NCT04917861|464534782|FG003|Main Study (196 Days)|Pregnancy|0|||
129067737|NCT04917861|464534779|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
129067738|NCT04917861|464534780|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
129067739|NCT04917861|464534781|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
129067740|NCT04917861|464534782|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
129067741|NCT04917861|464534779|FG000|Main Study (196 Days)|Other Than Specified|1|||
129067742|NCT04917861|464534780|FG001|Main Study (196 Days)|Other Than Specified|0|||
129067743|NCT04917861|464534781|FG002|Main Study (196 Days)|Other Than Specified|1|||
129067744|NCT04917861|464534782|FG003|Main Study (196 Days)|Other Than Specified|2|||
129067745|NCT04917861|464534779|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
129067746|NCT04917861|464534780|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
129067747|NCT04917861|464534781|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
129067748|NCT04917861|464534782|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
129067749|NCT04917861|464534779|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
129138277|NCT03774810|464798461|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
129138278|NCT03774810|464798457|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
129138279|NCT03774810|464798458|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
129138280|NCT03774810|464798459|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
129138281|NCT03774810|464798460|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
129138282|NCT03774810|464798461|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
129138283|NCT03774810|464798457|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
129138284|NCT03774810|464798458|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
129138285|NCT03774810|464798459|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
129138286|NCT03774810|464798460|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
129138287|NCT03774810|464798461|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
128722151|NCT01150123|463279382|FG015|Overall Study|Lost to Follow-up|0|||
128722152|NCT01150123|463279383|FG016|Overall Study|Lost to Follow-up|0|||
128722153|NCT01150123|463279384|FG017|Overall Study|Lost to Follow-up|0|||
128722154|NCT02347189|463279391|FG000|Overall Study|No implant attempted of study device|9|||
128722155|NCT02347189|463279391|FG000|Overall Study|No primary outcome data available|2|||
128722156|NCT00735878|463279392|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
128722157|NCT00735878|463279393|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
128722158|NCT00735878|463279394|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
128722159|NCT00994240|463279395|FG000|Overall Study|Lost to Follow-up|3|||
128722160|NCT00994240|463279396|FG001|Overall Study|Lost to Follow-up|2|||
128722161|NCT00994240|463279395|FG000|Overall Study|Withdrawal by Subject|1|||
128722162|NCT00994240|463279396|FG001|Overall Study|Withdrawal by Subject|0|||
128722163|NCT00994240|463279395|FG000|Overall Study|study termination|2|||
128722164|NCT00994240|463279396|FG001|Overall Study|study termination|3|||
128722165|NCT00352846|463279397|FG000|Overall Study|Disease progression|0|||
128722166|NCT00352846|463279398|FG001|Overall Study|Disease progression|2|||
128722167|NCT00352846|463279397|FG000|Overall Study|Withdrawal by Subject|3|||
128722168|NCT00352846|463279398|FG001|Overall Study|Withdrawal by Subject|8|||
128722169|NCT00352846|463279397|FG000|Overall Study|Ineligible|3|||
128722170|NCT00352846|463279398|FG001|Overall Study|Ineligible|2|||
128722171|NCT00352846|463279397|FG000|Overall Study|Non-compliance|2|||
128722172|NCT00352846|463279398|FG001|Overall Study|Non-compliance|0|||
128722173|NCT00352846|463279397|FG000|Overall Study|Death|0|||
128722174|NCT00352846|463279398|FG001|Overall Study|Death|1|||
128722175|NCT01527682|463279399|FG000|Overall Study|Protocol Violation|8|||
128722176|NCT00549562|463279401|FG000|Overall Study|Adverse Event|1|||
128722177|NCT00549562|463279401|FG000|Overall Study|Lack of Efficacy|1|||
128722178|NCT00323115|463279404|FG000|Vaccine Administration|Adverse Event|1|||
128722179|NCT00323115|463279404|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
128722180|NCT00952341|463280356|FG000|Cycle 1|Adverse Event|4|||
128722181|NCT00952341|463280357|FG001|Cycle 1|Adverse Event|1|||
128722182|NCT00952341|463280356|FG000|Cycle 1|Withdrawal by Subject|3|||
128722183|NCT00952341|463280357|FG001|Cycle 1|Withdrawal by Subject|8|||
128722184|NCT00952341|463280356|FG000|Cycle 1|Protocol Violation|2|||
128722185|NCT00952341|463280357|FG001|Cycle 1|Protocol Violation|1|||
128722186|NCT00952341|463280356|FG000|Cycle 1|Lost to Follow-up|11|||
128722187|NCT00952341|463280357|FG001|Cycle 1|Lost to Follow-up|2|||
128722188|NCT00952341|463280356|FG000|Cycle 1|Physician Decision|0|||
129067750|NCT04917861|464534780|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
129067751|NCT04917861|464534781|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
128722189|NCT00952341|463280357|FG001|Cycle 1|Physician Decision|1|||
128722190|NCT00952341|463280356|FG000|Cycle 2|Withdrawal by Subject|1|||
128722191|NCT00952341|463280357|FG001|Cycle 2|Withdrawal by Subject|1|||
128722192|NCT00952341|463280356|FG000|Cycle 2|Protocol Violation|1|||
128722193|NCT00952341|463280357|FG001|Cycle 2|Protocol Violation|0|||
128722194|NCT00952341|463280356|FG000|Cycle 2|Lost to Follow-up|6|||
128722195|NCT00952341|463280357|FG001|Cycle 2|Lost to Follow-up|9|||
128722196|NCT00952341|463280356|FG000|Cycle 2|Physician Decision|1|||
128722197|NCT00952341|463280357|FG001|Cycle 2|Physician Decision|1|||
128722198|NCT00952341|463280356|FG000|Cycle 2|Progressive Disease|0|||
128722199|NCT00952341|463280357|FG001|Cycle 2|Progressive Disease|1|||
128722200|NCT04920123|463280358|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
128722201|NCT04920123|463280359|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
128722202|NCT04920123|463280360|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
128722203|NCT00278954|463280363|FG000|Overall Study|Adverse Event|3|||
128722204|NCT00278954|463280363|FG000|Overall Study|Lost to Follow-up|1|||
128722205|NCT00278954|463280363|FG000|Overall Study|Withdrawal by Subject|1|||
128722206|NCT02532647|463280370|FG000|Overall Study|Did not receive trial medication|1|||
128722207|NCT02532647|463280371|FG001|Overall Study|Did not receive trial medication|0|||
128722208|NCT02532647|463280372|FG002|Overall Study|Did not receive trial medication|1|||
128722209|NCT05664490|463280378|FG000|Overall Study|Withdrawal by Subject|0|||
128722210|NCT05664490|463280379|FG001|Overall Study|Withdrawal by Subject|1|||
128722211|NCT05664490|463280378|FG000|Overall Study|Lost to Follow-up|14|||
128722212|NCT05664490|463280379|FG001|Overall Study|Lost to Follow-up|22|||
128722213|NCT05694546|463280380|FG000|Overall Study|Lost to Follow-up|11|||
128722214|NCT01589445|463280384|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
128722215|NCT01589445|463280384|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
128722216|NCT01589445|463280384|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
129067752|NCT04917861|464534782|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
129067753|NCT04917861|464534779|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
129067754|NCT04917861|464534780|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
129067755|NCT04917861|464534781|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
129067756|NCT04917861|464534782|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
129067757|NCT04917861|464534779|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
129067758|NCT04917861|464534780|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
129067759|NCT04917861|464534781|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
129067760|NCT04917861|464534782|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
129067761|NCT04917861|464534779|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
129067762|NCT04917861|464534780|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
129067763|NCT04917861|464534781|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
129067764|NCT04917861|464534782|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
129067765|NCT04917861|464534779|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
129067766|NCT04917861|464534780|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
129067767|NCT04917861|464534781|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
129067768|NCT04917861|464534782|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
129067769|NCT06389487|464534783|FG000|Overall Study|Lost to Follow-up|9|||
129067770|NCT06389487|464534784|FG001|Overall Study|Lost to Follow-up|5|||
129067771|NCT06389487|464534785|FG002|Overall Study|Lost to Follow-up|13|||
129067772|NCT06389487|464534783|FG000|Overall Study|Protocol Violation|0|||
128722217|NCT01589445|463280384|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
128722218|NCT01589445|463280384|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
128722219|NCT01589445|463280384|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
129067773|NCT06389487|464534784|FG001|Overall Study|Protocol Violation|0|||
129067774|NCT06389487|464534785|FG002|Overall Study|Protocol Violation|2|||
129067775|NCT06389487|464534783|FG000|Overall Study|Withdrawal by Subject|2|||
129067776|NCT06389487|464534784|FG001|Overall Study|Withdrawal by Subject|2|||
129067777|NCT06389487|464534785|FG002|Overall Study|Withdrawal by Subject|1|||
129067778|NCT06389487|464534783|FG000|Overall Study|Other|1|||
129067779|NCT06389487|464534784|FG001|Overall Study|Other|0|||
129067780|NCT06389487|464534785|FG002|Overall Study|Other|1|||
129067781|NCT03493685|464536645|FG000|Overall Study|Death|4|||
129067782|NCT03493685|464536646|FG001|Overall Study|Death|3|||
129067783|NCT03493685|464536645|FG000|Overall Study|Lost to Follow-up|3|||
129067784|NCT03493685|464536646|FG001|Overall Study|Lost to Follow-up|2|||
129138288|NCT03774810|464798457|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
129138289|NCT03774810|464798458|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
129138290|NCT03774810|464798459|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
129138291|NCT03774810|464798460|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
129138292|NCT03774810|464798461|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
129138293|NCT00290758|464798471|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
129138294|NCT00290758|464798472|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
129138295|NCT00290758|464798471|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
129138296|NCT00290758|464798472|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
129138297|NCT00290758|464798471|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
129138298|NCT00290758|464798472|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
129138299|NCT00290758|464798471|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
129138300|NCT00290758|464798472|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
129138301|NCT00290758|464798471|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
129138302|NCT00290758|464798472|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
129138303|NCT00290758|464798471|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
129138304|NCT00290758|464798472|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
129138305|NCT00290758|464798471|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
129138306|NCT00290758|464798472|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
129138307|NCT00290758|464798471|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
129138308|NCT00290758|464798472|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
129138309|NCT00474968|464798473|FG000|Overall Study|Withdrawal by Subject|8|||
129138310|NCT00474968|464798474|FG001|Overall Study|Withdrawal by Subject|7|||
129138311|NCT00474968|464798473|FG000|Overall Study|Protocol Violation|9|||
129138312|NCT00474968|464798474|FG001|Overall Study|Protocol Violation|8|||
129138313|NCT00474968|464798473|FG000|Overall Study|Sample not collected|1|||
129138314|NCT00474968|464798474|FG001|Overall Study|Sample not collected|1|||
129138315|NCT04914000|464798475|FG000|Overall Study|Lost to Follow-up|8|||
129138316|NCT04914000|464798475|FG000|Overall Study|Withdrawal by Subject|1|||
129138317|NCT01429623|464798476|FG000|Overall Study|Death|1|||
128722220|NCT01589445|463280384|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
128722221|NCT01589445|463280384|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
128722222|NCT01589445|463280384|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
128722223|NCT01589445|463280384|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
128722224|NCT00325754|463280385|FG000|Overall Study|Adverse Event|4|||
129067785|NCT03493685|464536645|FG000|Overall Study|Physician Decision|2|||
129067786|NCT03493685|464536646|FG001|Overall Study|Physician Decision|0|||
129067787|NCT03493685|464536645|FG000|Overall Study|Withdrawal by Subject|7|||
129067788|NCT03493685|464536646|FG001|Overall Study|Withdrawal by Subject|11|||
129067789|NCT04452669|464536647|FG000|Overall Study|Death|1|||
129067790|NCT04452669|464536648|FG001|Overall Study|Death|4|||
128722225|NCT00325754|463280386|FG001|Overall Study|Adverse Event|1|||
128722226|NCT02625090|463280391|FG000|Overall Study|Participant wants to be pregnant|2|||
129067791|NCT03300817|464536649|FG000|Overall Study|Withdrawal by Subject|1|||
129067792|NCT03300817|464536649|FG000|Overall Study|Adverse Event|1|||
129067793|NCT03300817|464536649|FG000|Overall Study|Subject Found to be Ineligible|2|||
129067794|NCT03729596|464536652|FG000|Overall Study|Death|3|||
129067795|NCT03729596|464536653|FG001|Overall Study|Death|5|||
129067796|NCT03729596|464536654|FG002|Overall Study|Death|4|||
129138318|NCT01429623|464798477|FG001|Overall Study|Death|0|||
129138319|NCT01429623|464798476|FG000|Overall Study|Adverse Event|7|||
129138320|NCT01429623|464798477|FG001|Overall Study|Adverse Event|14|||
129138321|NCT01429623|464798476|FG000|Overall Study|Withdrawal by Subject|19|||
129138322|NCT01429623|464798477|FG001|Overall Study|Withdrawal by Subject|13|||
129138323|NCT01429623|464798476|FG000|Overall Study|Physician Decision|2|||
129138324|NCT01429623|464798477|FG001|Overall Study|Physician Decision|3|||
128722227|NCT02625090|463280391|FG000|Overall Study|For the Promoter|1|||
129067797|NCT03729596|464536655|FG003|Overall Study|Death|1|||
129067798|NCT03729596|464536656|FG004|Overall Study|Death|0|||
129067799|NCT03729596|464536657|FG005|Overall Study|Death|34|||
129067800|NCT03729596|464536658|FG006|Overall Study|Death|18|||
129067801|NCT03729596|464536659|FG007|Overall Study|Death|14|||
128722228|NCT02625090|463280391|FG000|Overall Study|Sponsor's Decision|9|||
128722229|NCT02625090|463280391|FG000|Overall Study|Somnolence|1|||
128722230|NCT02625090|463280391|FG000|Overall Study|Study terminated by Sponsor|7|||
128722231|NCT02625090|463280391|FG000|Overall Study|Negative Benefit/Risk|1|||
128722232|NCT02625090|463280391|FG000|Overall Study|Protocol Deviation|2|||
128722233|NCT02625090|463280391|FG000|Overall Study|Lack of Efficacy|16|||
128722234|NCT02625090|463280391|FG000|Overall Study|Adverse Event|3|||
128722235|NCT02439320|463280398|FG000|Overall Study|Adverse Event|0|||
128722236|NCT02439320|463280399|FG001|Overall Study|Adverse Event|2|||
128722237|NCT02439320|463280400|FG002|Overall Study|Adverse Event|0|||
128722238|NCT02439320|463280398|FG000|Overall Study|Lost to Follow-up|37|||
128722239|NCT02439320|463280399|FG001|Overall Study|Lost to Follow-up|34|||
128722240|NCT02439320|463280400|FG002|Overall Study|Lost to Follow-up|42|||
128722241|NCT02439320|463280398|FG000|Overall Study|Death|0|||
128722242|NCT02439320|463280399|FG001|Overall Study|Death|1|||
128722243|NCT02439320|463280400|FG002|Overall Study|Death|0|||
128722244|NCT02439320|463280398|FG000|Overall Study|Noncompliance with Protocol|10|||
128722245|NCT02439320|463280399|FG001|Overall Study|Noncompliance with Protocol|11|||
128722246|NCT02439320|463280400|FG002|Overall Study|Noncompliance with Protocol|7|||
128722247|NCT02439320|463280398|FG000|Overall Study|Pregnancy|0|||
128722248|NCT02439320|463280399|FG001|Overall Study|Pregnancy|1|||
128722249|NCT02439320|463280400|FG002|Overall Study|Pregnancy|1|||
128722250|NCT02439320|463280398|FG000|Overall Study|Withdrawal by Subject|12|||
128722251|NCT02439320|463280399|FG001|Overall Study|Withdrawal by Subject|16|||
128722252|NCT02439320|463280400|FG002|Overall Study|Withdrawal by Subject|14|||
128722253|NCT02439320|463280398|FG000|Overall Study|Physician Decision|2|||
128722254|NCT02439320|463280399|FG001|Overall Study|Physician Decision|1|||
128722255|NCT02439320|463280400|FG002|Overall Study|Physician Decision|0|||
128722256|NCT02439320|463280398|FG000|Overall Study|Sponsor Request|0|||
128722257|NCT02439320|463280399|FG001|Overall Study|Sponsor Request|2|||
128722258|NCT02439320|463280400|FG002|Overall Study|Sponsor Request|1|||
128722259|NCT02439320|463280398|FG000|Overall Study|Randomization Failure|35|||
128722260|NCT02439320|463280399|FG001|Overall Study|Randomization Failure|46|||
128722261|NCT02439320|463280400|FG002|Overall Study|Randomization Failure|34|||
128722262|NCT04404855|463280406|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
128722263|NCT04404855|463280407|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
128722264|NCT03320564|463280408|FG000|Overall Study|Protocol Violation|1|||
128722265|NCT00788827|463280409|FG000|Overall Study|Lack of Efficacy|2|||
128722266|NCT01586819|463280416|FG000|Overall Study|Withdrawal by Subject|1|||
128722267|NCT01586819|463280417|FG001|Overall Study|Withdrawal by Subject|0|||
128722268|NCT01359254|463280418|FG000|Overall Study|Death|1|||
128722269|NCT01359254|463280419|FG001|Overall Study|Death|0|||
128722270|NCT03979638|463280421|FG000|Period 1|Physician Decision|1|||
128722271|NCT03979638|463280422|FG001|Period 1|Physician Decision|1|||
128722272|NCT03979638|463280421|FG000|Period 1|Withdrawal by Subject|4|||
128722273|NCT03979638|463280422|FG001|Period 1|Withdrawal by Subject|3|||
128722274|NCT03979638|463280421|FG000|Period 1|Study terminated by Sponsor|1|||
128722275|NCT03979638|463280422|FG001|Period 1|Study terminated by Sponsor|3|||
128722276|NCT03979638|463280421|FG000|Period 1|Protocol Violation|1|||
128722277|NCT03979638|463280422|FG001|Period 1|Protocol Violation|0|||
128722278|NCT03979638|463280421|FG000|Period 2|Study terminated by Sponsor|1|||
128722279|NCT03979638|463280422|FG001|Period 2|Study terminated by Sponsor|1|||
128722280|NCT04248933|463280425|FG000|Overall Study|Lost to Follow-up|9|||
128722281|NCT04248933|463280425|FG000|Overall Study|Withdrawal by Subject|2|||
128722282|NCT00600938|463280426|FG000|Core Study|Abnormal test procedure result(s)|3|||
128722283|NCT00600938|463280427|FG001|Core Study|Abnormal test procedure result(s)|2|||
129067802|NCT03729596|464536660|FG008|Overall Study|Death|19|||
129067803|NCT03729596|464536661|FG009|Overall Study|Death|9|||
128722284|NCT00600938|463280428|FG002|Core Study|Abnormal test procedure result(s)|0|||
128722285|NCT00600938|463280429|FG003|Core Study|Abnormal test procedure result(s)|0|||
128722286|NCT00600938|463280426|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
128722287|NCT00600938|463280427|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
128722288|NCT00600938|463280428|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
128722289|NCT00600938|463280429|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
129067804|NCT03729596|464536652|FG000|Overall Study|Lost to Follow-up|0|||
129067805|NCT03729596|464536653|FG001|Overall Study|Lost to Follow-up|0|||
128722290|NCT00600938|463280426|FG000|Core Study|Patient withdrew consent|7|||
128722291|NCT00600938|463280427|FG001|Core Study|Patient withdrew consent|12|||
128722292|NCT00600938|463280428|FG002|Core Study|Patient withdrew consent|0|||
128722293|NCT00600938|463280429|FG003|Core Study|Patient withdrew consent|0|||
128722294|NCT00600938|463280426|FG000|Core Study|Lost to Follow-up|3|||
128722295|NCT00600938|463280427|FG001|Core Study|Lost to Follow-up|2|||
128722296|NCT00600938|463280428|FG002|Core Study|Lost to Follow-up|0|||
128722297|NCT00600938|463280429|FG003|Core Study|Lost to Follow-up|0|||
128722298|NCT00600938|463280426|FG000|Core Study|Death|1|||
128722299|NCT00600938|463280427|FG001|Core Study|Death|1|||
128722300|NCT00600938|463280428|FG002|Core Study|Death|0|||
128722301|NCT00600938|463280429|FG003|Core Study|Death|0|||
129138325|NCT01429623|464798476|FG000|Overall Study|Protocol Violation|3|||
129138326|NCT01429623|464798477|FG001|Overall Study|Protocol Violation|2|||
129138327|NCT01429623|464798476|FG000|Overall Study|Assorted|1|||
129138328|NCT01429623|464798477|FG001|Overall Study|Assorted|2|||
129138329|NCT01429623|464798476|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
129138330|NCT01429623|464798477|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
129138331|NCT01429623|464798476|FG000|Overall Study|No post baseline data|4|||
129138332|NCT01429623|464798477|FG001|Overall Study|No post baseline data|4|||
129138333|NCT01750281|464798478|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
129138334|NCT01750281|464798479|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
129138335|NCT01750281|464798480|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
129138336|NCT01750281|464798478|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
129138337|NCT01750281|464798479|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
129138338|NCT01750281|464798480|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
129138339|NCT01750281|464798478|FG000|Overall Study|Did not receive treatment|0|||
129138340|NCT01750281|464798479|FG001|Overall Study|Did not receive treatment|1|||
129138341|NCT01750281|464798480|FG002|Overall Study|Did not receive treatment|0|||
129138342|NCT01896986|464798481|FG000|Overall Study|samples lost|14|||
129138343|NCT01896986|464798482|FG001|Overall Study|samples lost|23|||
129138344|NCT04189588|464798485|FG000|Overall Study|Death|0|||
129138345|NCT04189588|464798486|FG001|Overall Study|Death|1|||
129138346|NCT04189588|464798485|FG000|Overall Study|Lost to Follow-up|0|||
129138347|NCT04189588|464798486|FG001|Overall Study|Lost to Follow-up|1|||
129138348|NCT01658735|464798489|FG000|Overall Study|Lack of Efficacy|1|||
129138349|NCT01658735|464798490|FG001|Overall Study|Lack of Efficacy|0|||
129138350|NCT01658735|464798491|FG002|Overall Study|Lack of Efficacy|1|||
129138351|NCT01658735|464798489|FG000|Overall Study|Lost to Follow-up|1|||
129138352|NCT01658735|464798490|FG001|Overall Study|Lost to Follow-up|1|||
129138353|NCT01658735|464798491|FG002|Overall Study|Lost to Follow-up|0|||
129138354|NCT01658735|464798489|FG000|Overall Study|Protocol Violation|0|||
129138355|NCT01658735|464798490|FG001|Overall Study|Protocol Violation|1|||
129138356|NCT01658735|464798491|FG002|Overall Study|Protocol Violation|0|||
129138357|NCT01658735|464798489|FG000|Overall Study|Withdrawal by Subject|3|||
129067806|NCT03729596|464536654|FG002|Overall Study|Lost to Follow-up|0|||
129138358|NCT01658735|464798490|FG001|Overall Study|Withdrawal by Subject|5|||
129138359|NCT01658735|464798491|FG002|Overall Study|Withdrawal by Subject|3|||
129138360|NCT03156621|464798492|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
129138361|NCT03156621|464798493|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
129067807|NCT03729596|464536655|FG003|Overall Study|Lost to Follow-up|0|||
129067808|NCT03729596|464536656|FG004|Overall Study|Lost to Follow-up|0|||
129067809|NCT03729596|464536657|FG005|Overall Study|Lost to Follow-up|0|||
129067810|NCT03729596|464536658|FG006|Overall Study|Lost to Follow-up|1|||
129067811|NCT03729596|464536659|FG007|Overall Study|Lost to Follow-up|0|||
129067812|NCT03729596|464536660|FG008|Overall Study|Lost to Follow-up|0|||
129067813|NCT03729596|464536661|FG009|Overall Study|Lost to Follow-up|1|||
129067814|NCT03729596|464536652|FG000|Overall Study|protocol amendment|0|||
129067815|NCT03729596|464536653|FG001|Overall Study|protocol amendment|1|||
129067816|NCT03729596|464536654|FG002|Overall Study|protocol amendment|3|||
129067817|NCT03729596|464536655|FG003|Overall Study|protocol amendment|6|||
129067818|NCT03729596|464536656|FG004|Overall Study|protocol amendment|5|||
129067819|NCT03729596|464536657|FG005|Overall Study|protocol amendment|0|||
129067820|NCT03729596|464536658|FG006|Overall Study|protocol amendment|0|||
129138362|NCT03156621|464798492|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129138363|NCT03156621|464798493|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
129138364|NCT01379937|464798494|FG000|Overall Study|Protocol Violation|0|||
129067821|NCT03729596|464536659|FG007|Overall Study|protocol amendment|0|||
129067822|NCT03729596|464536660|FG008|Overall Study|protocol amendment|0|||
129067823|NCT03729596|464536661|FG009|Overall Study|protocol amendment|0|||
129138365|NCT01379937|464798495|FG001|Overall Study|Protocol Violation|0|||
129138366|NCT01379937|464798496|FG002|Overall Study|Protocol Violation|0|||
129138367|NCT01379937|464798497|FG003|Overall Study|Protocol Violation|1|||
128722302|NCT00600938|463280426|FG000|Core Study|Protocol Violation|1|||
128722303|NCT00600938|463280427|FG001|Core Study|Protocol Violation|2|||
128722304|NCT00600938|463280428|FG002|Core Study|Protocol Violation|0|||
128722305|NCT00600938|463280429|FG003|Core Study|Protocol Violation|0|||
128722306|NCT00600938|463280426|FG000|Extension Study|Adverse Event|1|||
128722307|NCT00600938|463280427|FG001|Extension Study|Adverse Event|0|||
128722308|NCT00600938|463280428|FG002|Extension Study|Adverse Event|2|||
128722309|NCT00600938|463280429|FG003|Extension Study|Adverse Event|0|||
128722310|NCT00600938|463280426|FG000|Extension Study|Abnormal test procedure results|0|||
128722311|NCT00600938|463280427|FG001|Extension Study|Abnormal test procedure results|1|||
128722312|NCT00600938|463280428|FG002|Extension Study|Abnormal test procedure results|1|||
128722313|NCT00600938|463280429|FG003|Extension Study|Abnormal test procedure results|1|||
128722314|NCT00600938|463280426|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
128722315|NCT00600938|463280427|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
128722316|NCT00600938|463280428|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
128722317|NCT00600938|463280429|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
128722318|NCT00600938|463280426|FG000|Extension Study|Withdrawal by Subject|2|||
128722319|NCT00600938|463280427|FG001|Extension Study|Withdrawal by Subject|2|||
128722320|NCT00600938|463280428|FG002|Extension Study|Withdrawal by Subject|3|||
128722321|NCT00600938|463280429|FG003|Extension Study|Withdrawal by Subject|0|||
128722322|NCT00600938|463280426|FG000|Extension Study|Lost to Follow-up|1|||
128722323|NCT00600938|463280427|FG001|Extension Study|Lost to Follow-up|1|||
128722324|NCT00600938|463280428|FG002|Extension Study|Lost to Follow-up|2|||
128722325|NCT00600938|463280429|FG003|Extension Study|Lost to Follow-up|0|||
128722326|NCT00600938|463280426|FG000|Extension Study|Death|1|||
128722327|NCT00600938|463280427|FG001|Extension Study|Death|0|||
128722328|NCT00600938|463280428|FG002|Extension Study|Death|0|||
128722329|NCT00600938|463280429|FG003|Extension Study|Death|0|||
128722330|NCT01124643|463280430|FG000|Overall Study|Death|1|||
128722331|NCT02680639|463280433|FG000|Screening Period|Screen Failure|7|||
128722332|NCT02680639|463280434|FG001|Screening Period|Screen Failure|0|||
128722333|NCT02680639|463280435|FG002|Screening Period|Screen Failure|0|||
128722334|NCT01063595|463280436|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
128722335|NCT01063595|463280437|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
128722336|NCT01063595|463280436|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
128722337|NCT01063595|463280437|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
128722338|NCT01063595|463280436|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
128722339|NCT01063595|463280437|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
128722340|NCT01063595|463280436|FG000|First Intervention|Adverse Event|1|||
128722341|NCT01063595|463280437|FG001|First Intervention|Adverse Event|4|||
128722342|NCT01063595|463280436|FG000|First Intervention|Withdrawal by Subject|1|||
128775875|NCT02584855|463468487|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
128775876|NCT02584855|463468488|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
128775877|NCT02584855|463468489|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129067824|NCT03729596|464536652|FG000|Overall Study|Withdrawal by Subject|0|||
129067825|NCT03729596|464536653|FG001|Overall Study|Withdrawal by Subject|0|||
129067826|NCT03729596|464536654|FG002|Overall Study|Withdrawal by Subject|0|||
129067827|NCT03729596|464536655|FG003|Overall Study|Withdrawal by Subject|0|||
129067828|NCT03729596|464536656|FG004|Overall Study|Withdrawal by Subject|0|||
129067829|NCT03729596|464536657|FG005|Overall Study|Withdrawal by Subject|4|||
129067830|NCT03729596|464536658|FG006|Overall Study|Withdrawal by Subject|2|||
129067831|NCT03729596|464536659|FG007|Overall Study|Withdrawal by Subject|3|||
129067832|NCT03729596|464536660|FG008|Overall Study|Withdrawal by Subject|2|||
129067833|NCT03729596|464536661|FG009|Overall Study|Withdrawal by Subject|3|||
129067834|NCT03729596|464536652|FG000|Overall Study|study terminated by sponsor|0|||
129067835|NCT03729596|464536653|FG001|Overall Study|study terminated by sponsor|0|||
129067836|NCT03729596|464536654|FG002|Overall Study|study terminated by sponsor|0|||
129067837|NCT03729596|464536655|FG003|Overall Study|study terminated by sponsor|0|||
129138368|NCT01379937|464798494|FG000|Overall Study|Consent withdrawal|0|||
129138369|NCT01379937|464798495|FG001|Overall Study|Consent withdrawal|1|||
129138370|NCT01379937|464798496|FG002|Overall Study|Consent withdrawal|0|||
128722343|NCT01063595|463280437|FG001|First Intervention|Withdrawal by Subject|0|||
128722344|NCT01063595|463280436|FG000|First Intervention|Reason not Specified|0|||
129067838|NCT03729596|464536656|FG004|Overall Study|study terminated by sponsor|1|||
129067839|NCT03729596|464536657|FG005|Overall Study|study terminated by sponsor|3|||
129067840|NCT03729596|464536658|FG006|Overall Study|study terminated by sponsor|0|||
129067841|NCT03729596|464536659|FG007|Overall Study|study terminated by sponsor|1|||
129067842|NCT03729596|464536660|FG008|Overall Study|study terminated by sponsor|0|||
128722345|NCT01063595|463280437|FG001|First Intervention|Reason not Specified|1|||
128722346|NCT02678676|463280438|FG000|Overall Study|Death|619|||
128722347|NCT02678676|463280439|FG001|Overall Study|Death|649|||
128722348|NCT02678676|463280438|FG000|Overall Study|Withdrawal by Subject|13|||
128722349|NCT02678676|463280439|FG001|Overall Study|Withdrawal by Subject|5|||
128722350|NCT02678676|463280438|FG000|Overall Study|Lost to Follow-up|171|||
128722351|NCT02678676|463280439|FG001|Overall Study|Lost to Follow-up|151|||
128722352|NCT02678676|463280438|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
128722353|NCT02678676|463280439|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
128722354|NCT00747435|463280440|FG000|Overall Study|Lost to Follow-up|2|||
128722355|NCT00747435|463280440|FG000|Overall Study|Withdrawal by Subject|3|||
128722356|NCT00747435|463280440|FG000|Overall Study|Still undergoing follow up|1|||
128722357|NCT04056195|463280441|FG000|Overall Study|Adverse Event|1|||
128722358|NCT04056195|463280442|FG001|Overall Study|Adverse Event|0|||
128722359|NCT04056195|463280443|FG002|Overall Study|Adverse Event|0|||
128722360|NCT04056195|463280441|FG000|Overall Study|Withdrawal by Subject|0|||
128722361|NCT04056195|463280442|FG001|Overall Study|Withdrawal by Subject|1|||
128722362|NCT04056195|463280443|FG002|Overall Study|Withdrawal by Subject|1|||
128722363|NCT04056195|463280441|FG000|Overall Study|Physician Decision|1|||
128722364|NCT04056195|463280442|FG001|Overall Study|Physician Decision|1|||
128722365|NCT04056195|463280443|FG002|Overall Study|Physician Decision|1|||
128722366|NCT01380184|463280454|FG000|Part 1 (19 Days)|Adverse Event|1|||
128722367|NCT01380184|463280454|FG000|Part 2|Adverse Event|5|||
128722368|NCT01380184|463280454|FG000|Part 2|Disease Progression|8|||
128775878|NCT02584855|463468490|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129067843|NCT03729596|464536661|FG009|Overall Study|study terminated by sponsor|0|||
129067844|NCT03713593|464536662|FG000|Overall Study|Sponsor Decision|73|||
129067845|NCT03713593|464536663|FG001|Overall Study|Sponsor Decision|41|||
129067846|NCT03713593|464536662|FG000|Overall Study|Lost to Follow-up|2|||
129067847|NCT03713593|464536663|FG001|Overall Study|Lost to Follow-up|1|||
129067848|NCT03713593|464536662|FG000|Overall Study|Death|314|||
129067849|NCT03713593|464536663|FG001|Overall Study|Death|349|||
129067850|NCT03713593|464536662|FG000|Overall Study|Withdrawal by Subject|6|||
129067851|NCT03713593|464536663|FG001|Overall Study|Withdrawal by Subject|8|||
129067852|NCT04653454|464536664|FG000|Overall Study|Withdrawal by Subject|1|||
129067853|NCT04653454|464536664|FG000|Overall Study|Physician Decision|40|||
129067854|NCT03620708|464536665|FG000|Overall Study|Lost to Follow-up|1|||
129067855|NCT03620708|464536666|FG001|Overall Study|Lost to Follow-up|1|||
129067856|NCT03620708|464536667|FG002|Overall Study|Lost to Follow-up|2|||
129067857|NCT03620708|464536665|FG000|Overall Study|Withdrawal by Subject|0|||
129067858|NCT03620708|464536666|FG001|Overall Study|Withdrawal by Subject|0|||
129067859|NCT03620708|464536667|FG002|Overall Study|Withdrawal by Subject|1|||
129067860|NCT05126693|464536668|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
129067861|NCT05126693|464536669|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
129067862|NCT05126693|464536668|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
129067863|NCT05126693|464536669|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
129067864|NCT05126693|464536668|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
129067865|NCT05126693|464536669|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
129067866|NCT04011722|464536673|FG000|30 Days|Death|5|||
129067867|NCT04011722|464536674|FG001|30 Days|Death|1|||
129067868|NCT04011722|464536673|FG000|1 Year|Death|13|||
129067869|NCT04011722|464536674|FG001|1 Year|Death|5|||
129067870|NCT04011722|464536673|FG000|1 Year|Withdrawal by Subject|8|||
129067871|NCT04011722|464536674|FG001|1 Year|Withdrawal by Subject|2|||
129067872|NCT04011722|464536673|FG000|1 Year|Missed Visit|6|||
129067873|NCT04011722|464536674|FG001|1 Year|Missed Visit|1|||
129067874|NCT04011722|464536673|FG000|1 Year|Pending Visit|0|||
129067875|NCT04011722|464536674|FG001|1 Year|Pending Visit|11|||
129067876|NCT04011722|464536673|FG000|1 Year|Not Yet Due|0|||
129067877|NCT04011722|464536674|FG001|1 Year|Not Yet Due|9|||
129067878|NCT04011722|464536673|FG000|2 Year|Death|16|||
129067879|NCT04011722|464536674|FG001|2 Year|Death|1|||
129067880|NCT04011722|464536673|FG000|2 Year|Withdrawal by Subject|10|||
129067881|NCT04011722|464536674|FG001|2 Year|Withdrawal by Subject|1|||
129067882|NCT04011722|464536673|FG000|2 Year|Missed Visit|9|||
129067883|NCT04011722|464536674|FG001|2 Year|Missed Visit|0|||
129138371|NCT01379937|464798497|FG003|Overall Study|Consent withdrawal|0|||
129138372|NCT01379937|464798494|FG000|Overall Study|Lost to Follow-up|1|||
129138373|NCT01379937|464798495|FG001|Overall Study|Lost to Follow-up|2|||
129138374|NCT01379937|464798496|FG002|Overall Study|Lost to Follow-up|2|||
129067884|NCT04011722|464536673|FG000|2 Year|Visit Pending|1|||
129067885|NCT04011722|464536674|FG001|2 Year|Visit Pending|3|||
129138375|NCT01379937|464798497|FG003|Overall Study|Lost to Follow-up|0|||
128722369|NCT01380184|463280454|FG000|Part 2|Lost to Follow-up|1|||
129067886|NCT04011722|464536673|FG000|2 Year|Not Yet Due|43|||
129067887|NCT04011722|464536674|FG001|2 Year|Not Yet Due|54|||
129067888|NCT04011722|464536673|FG000|3 Year|Death|10|||
129067889|NCT04011722|464536674|FG001|3 Year|Death|0|||
129067890|NCT04011722|464536673|FG000|3 Year|Withdrawal by Subject|2|||
129138376|NCT01260311|464798504|FG000|Overall Study|Adverse Event|11|||
128722370|NCT03532295|463280455|FG000|Overall Study|Did not start treatment|0|||
128722371|NCT03532295|463280456|FG001|Overall Study|Did not start treatment|2|||
129067891|NCT04011722|464536674|FG001|3 Year|Withdrawal by Subject|0|||
129067892|NCT04011722|464536673|FG000|3 Year|Missed Visit|2|||
129067893|NCT04011722|464536674|FG001|3 Year|Missed Visit|0|||
129067894|NCT04011722|464536673|FG000|3 Year|Pending Visit|34|||
129067895|NCT04011722|464536674|FG001|3 Year|Pending Visit|0|||
129067896|NCT04011722|464536673|FG000|3 Year|Not Yet Due|99|||
129138377|NCT01260311|464798504|FG000|Overall Study|Lack of Efficacy|4|||
129138378|NCT01260311|464798504|FG000|Overall Study|Lost to Follow-up|25|||
129138379|NCT01260311|464798504|FG000|Overall Study|Withdrawal by Subject|6|||
129138380|NCT01260311|464798504|FG000|Overall Study|Financial Constraints|77|||
129138381|NCT01260311|464798504|FG000|Overall Study|Gone to Province|2|||
129138382|NCT01260311|464798504|FG000|Overall Study|Medication Stopped|1|||
129138383|NCT01260311|464798504|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
129138384|NCT00478140|464798512|FG000|Overall Study|Clinical Disease Progression|1|||
129138385|NCT02489045|464798521|FG000|Overall Study|unable to collect usable data|53|||
129138386|NCT02489045|464798521|FG000|Follow-up|Lost to Follow-up|10|||
129138387|NCT03111732|464798524|FG000|Overall Study|Enrolled in different study|1|||
129138388|NCT03111732|464798524|FG000|Overall Study|Progressive disease|3|||
129138389|NCT03111732|464798524|FG000|Overall Study|Withdrawal by Subject|1|||
129138390|NCT02151604|464798526|FG000|Overall Study|Lost to Follow-up|3|||
129138391|NCT02151604|464798526|FG000|Overall Study|Withdrawal by Subject|2|||
129138392|NCT02151604|464798526|FG000|Overall Study|Physician Decision|3|||
129138393|NCT02151604|464798526|FG000|Overall Study|Death|1|||
129138394|NCT04495478|464798527|FG000|Overall Study|Withdrawal by Subject|0|||
129138395|NCT04495478|464798528|FG001|Overall Study|Withdrawal by Subject|0|||
129138396|NCT04495478|464798529|FG002|Overall Study|Withdrawal by Subject|0|||
129138397|NCT04495478|464798530|FG003|Overall Study|Withdrawal by Subject|1|||
129138398|NCT04495478|464798531|FG004|Overall Study|Withdrawal by Subject|0|||
129138399|NCT04495478|464798532|FG005|Overall Study|Withdrawal by Subject|0|||
129138400|NCT04495478|464798533|FG006|Overall Study|Withdrawal by Subject|0|||
129138401|NCT04495478|464798527|FG000|Overall Study|Physician Decision|0|||
129138402|NCT04495478|464798528|FG001|Overall Study|Physician Decision|1|||
129138403|NCT04495478|464798529|FG002|Overall Study|Physician Decision|0|||
129138404|NCT04495478|464798530|FG003|Overall Study|Physician Decision|0|||
128775879|NCT02584855|463468491|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
128775880|NCT02584855|463468492|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
128775881|NCT02584855|463468487|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
128775882|NCT02584855|463468488|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
128775883|NCT02584855|463468489|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
128775884|NCT02584855|463468490|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
128775885|NCT02584855|463468491|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
128775886|NCT02584855|463468492|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
128775887|NCT02584855|463468487|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
128775888|NCT02584855|463468488|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
128775889|NCT02584855|463468489|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
128775890|NCT02584855|463468490|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
128775891|NCT02584855|463468491|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
128775892|NCT02584855|463468492|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
128775893|NCT02258464|463468493|FG000|Overall Study|Progressive disease (PD)|9|||
128775894|NCT02258464|463468494|FG001|Overall Study|Progressive disease (PD)|17|||
128775895|NCT02258464|463468493|FG000|Overall Study|Study drug never administered|1|||
128775896|NCT02258464|463468494|FG001|Overall Study|Study drug never administered|1|||
128775897|NCT02258464|463468493|FG000|Overall Study|AE not related to clinical PD|1|||
129138405|NCT04495478|464798531|FG004|Overall Study|Physician Decision|1|||
129138406|NCT04495478|464798532|FG005|Overall Study|Physician Decision|0|||
129138407|NCT04495478|464798533|FG006|Overall Study|Physician Decision|0|||
129138408|NCT03004183|464800460|FG000|Overall Study|Adverse Event|7|||
129138409|NCT03004183|464800460|FG000|Overall Study|Lost to Follow-up|1|||
129138410|NCT03004183|464800460|FG000|Overall Study|Physician Decision|40|||
129138411|NCT03004183|464800460|FG000|Overall Study|Withdrawal by Subject|1|||
129067897|NCT04011722|464536674|FG001|3 Year|Not Yet Due|0|||
129067898|NCT05061134|464536675|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
129067899|NCT05061134|464536676|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
129067900|NCT05061134|464536677|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
129067901|NCT05061134|464536675|FG000|Overall Study|Subject not treated|0|||
129067902|NCT05061134|464536676|FG001|Overall Study|Subject not treated|0|||
129067903|NCT05061134|464536677|FG002|Overall Study|Subject not treated|2|||
129067904|NCT05061134|464536675|FG000|Overall Study|Other|0|||
129067905|NCT05061134|464536676|FG001|Overall Study|Other|0|||
129067906|NCT05061134|464536677|FG002|Overall Study|Other|9|||
129067907|NCT05061134|464536675|FG000|Overall Study|Withdrawal by Subject|9|||
129138412|NCT03004183|464800460|FG000|Overall Study|COVID-19|1|||
129067908|NCT05061134|464536676|FG001|Overall Study|Withdrawal by Subject|8|||
129067909|NCT05061134|464536677|FG002|Overall Study|Withdrawal by Subject|5|||
129067910|NCT05061134|464536675|FG000|Overall Study|Study Terminated by Sponsor|22|||
129138413|NCT02529488|464800461|FG000|Overall Study|Adverse Event|1|||
129138414|NCT02529488|464800461|FG000|Overall Study|Death|3|||
129138415|NCT02698787|464800462|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
129138416|NCT02698787|464800463|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
129138417|NCT02933151|464800472|FG000|Overall Study|Lost to Follow-up|19|||
129138418|NCT02933151|464800473|FG001|Overall Study|Lost to Follow-up|18|||
129138419|NCT02933151|464800472|FG000|Overall Study|Death|1732|||
129138420|NCT02933151|464800473|FG001|Overall Study|Death|1827|||
129138421|NCT02933151|464800472|FG000|Overall Study|Transplant|210|||
129138422|NCT02933151|464800473|FG001|Overall Study|Transplant|278|||
129138423|NCT02933151|464800472|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
129138424|NCT02933151|464800473|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
129138425|NCT02933151|464800472|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
129138426|NCT02933151|464800473|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
129138427|NCT02933151|464800472|FG000|Overall Study|Recovered Kidney Function|47|||
129138428|NCT02933151|464800473|FG001|Overall Study|Recovered Kidney Function|29|||
129138429|NCT03048019|464800474|FG000|Overall Study|Adverse Event|1|||
129138430|NCT03048019|464800475|FG001|Overall Study|Adverse Event|0|||
129138431|NCT03400787|464800476|FG000|Overall Study|Lost to Follow-up|1|||
129138432|NCT03400787|464800477|FG001|Overall Study|Lost to Follow-up|0|||
129138433|NCT03400787|464800476|FG000|Overall Study|Death|1|||
129138434|NCT03400787|464800477|FG001|Overall Study|Death|0|||
129138435|NCT03400787|464800476|FG000|Overall Study|Protocol Violation|0|||
129138436|NCT03400787|464800477|FG001|Overall Study|Protocol Violation|2|||
129138437|NCT03400787|464800476|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
129138438|NCT03400787|464800477|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
129138439|NCT00348374|464800485|FG000|Overall Study|Adverse Event|1|||
129138440|NCT00348374|464800486|FG001|Overall Study|Adverse Event|4|||
129138441|NCT00348374|464800485|FG000|Overall Study|Lost to Follow-up|1|||
129138442|NCT00348374|464800486|FG001|Overall Study|Lost to Follow-up|3|||
129138443|NCT00348374|464800485|FG000|Overall Study|Withdrawal by Subject|5|||
129138444|NCT00348374|464800486|FG001|Overall Study|Withdrawal by Subject|5|||
129138445|NCT00348374|464800485|FG000|Overall Study|Other|11|||
129138446|NCT00348374|464800486|FG001|Overall Study|Other|12|||
129138447|NCT00348374|464800485|FG000|Overall Study|ongoing at date of cutoff|1|||
129138448|NCT00348374|464800486|FG001|Overall Study|ongoing at date of cutoff|1|||
129138449|NCT00348374|464800485|FG000|Overall Study|randomized but did not receive treatment|0|||
129138450|NCT00348374|464800486|FG001|Overall Study|randomized but did not receive treatment|7|||
129138451|NCT02070380|464800495|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
129138452|NCT02070380|464800496|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
129138453|NCT02070380|464800497|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
129138454|NCT02070380|464800498|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
129138455|NCT02070380|464800495|FG000|Second Injection|Image sets missing or technically inadeq|0|||
129138456|NCT02070380|464800496|FG001|Second Injection|Image sets missing or technically inadeq|1|||
129138457|NCT02070380|464800497|FG002|Second Injection|Image sets missing or technically inadeq|0|||
129138458|NCT02070380|464800498|FG003|Second Injection|Image sets missing or technically inadeq|0|||
129138459|NCT02070380|464800495|FG000|Second Injection|Protocol Violation|0|||
129138460|NCT02070380|464800496|FG001|Second Injection|Protocol Violation|1|||
129138461|NCT02070380|464800497|FG002|Second Injection|Protocol Violation|1|||
129138462|NCT02070380|464800498|FG003|Second Injection|Protocol Violation|5|||
129138463|NCT02105012|464800511|FG000|Overall Study|Withdrawal by Subject|11|||
129138464|NCT02105012|464800511|FG000|Overall Study|Protocol Specified Criteria|9|||
129138465|NCT02105012|464800511|FG000|Overall Study|Lost to Follow-up|4|||
129138466|NCT02105012|464800511|FG000|Overall Study|Protocol Violation|4|||
129138467|NCT02105012|464800511|FG000|Overall Study|Physician Decision|3|||
129138468|NCT02105012|464800511|FG000|Overall Study|Adverse Event|1|||
129138469|NCT02105012|464800511|FG000|Overall Study|Lack of Efficacy|1|||
129138470|NCT03436420|464800512|FG000|Overall Study|Lack of Efficacy|3|||
129138471|NCT00981175|464800513|FG000|Primary Dose Vaccination|Adverse Event|1|||
129138472|NCT00981175|464800514|FG001|Primary Dose Vaccination|Adverse Event|0|||
129138473|NCT00981175|464800513|FG000|Primary Dose Vaccination|Protocol Violation|0|||
129138474|NCT00981175|464800514|FG001|Primary Dose Vaccination|Protocol Violation|1|||
129138475|NCT00981175|464800513|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
129138476|NCT00981175|464800514|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
129138477|NCT00981175|464800513|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
129138478|NCT00981175|464800514|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
129138479|NCT02619812|464800515|FG000|Overall Study|Withdrawal by Subject|0|||
129138480|NCT02619812|464800516|FG001|Overall Study|Withdrawal by Subject|0|||
129138481|NCT02619812|464800517|FG002|Overall Study|Withdrawal by Subject|1|||
129138482|NCT02619812|464800518|FG003|Overall Study|Withdrawal by Subject|2|||
129138483|NCT01104870|464800522|FG000|Overall Study|Adverse Event|1|||
129138484|NCT01104870|464800523|FG001|Overall Study|Adverse Event|1|||
129138485|NCT01104870|464800524|FG002|Overall Study|Adverse Event|0|||
129138486|NCT01104870|464800522|FG000|Overall Study|Death|0|||
129138487|NCT01104870|464800523|FG001|Overall Study|Death|0|||
129138488|NCT01104870|464800524|FG002|Overall Study|Death|1|||
129138489|NCT01104870|464800522|FG000|Overall Study|Withdrawal by Subject|0|||
129138490|NCT01104870|464800523|FG001|Overall Study|Withdrawal by Subject|0|||
129067911|NCT05061134|464536676|FG001|Overall Study|Study Terminated by Sponsor|14|||
129067912|NCT05061134|464536677|FG002|Overall Study|Study Terminated by Sponsor|7|||
129067913|NCT05061134|464536675|FG000|Overall Study|Progressive Disease|1|||
129067914|NCT05061134|464536676|FG001|Overall Study|Progressive Disease|2|||
129067915|NCT05061134|464536677|FG002|Overall Study|Progressive Disease|0|||
129067916|NCT05061134|464536675|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
129067917|NCT05061134|464536676|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
129067918|NCT05061134|464536677|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
129067919|NCT05061134|464536675|FG000|Overall Study|Lost to Follow-up|1|||
129067920|NCT05061134|464536676|FG001|Overall Study|Lost to Follow-up|0|||
129067921|NCT05061134|464536677|FG002|Overall Study|Lost to Follow-up|0|||
129067922|NCT05061134|464536675|FG000|Overall Study|Physician Decision|1|||
129067923|NCT05061134|464536676|FG001|Overall Study|Physician Decision|1|||
129067924|NCT05061134|464536677|FG002|Overall Study|Physician Decision|0|||
129067925|NCT05061134|464536675|FG000|Overall Study|Disease progression|1|||
129067926|NCT05061134|464536676|FG001|Overall Study|Disease progression|0|||
129067927|NCT05061134|464536677|FG002|Overall Study|Disease progression|0|||
129067928|NCT05061134|464536675|FG000|Overall Study|Death|43|||
129067929|NCT05061134|464536676|FG001|Overall Study|Death|23|||
129067930|NCT05061134|464536677|FG002|Overall Study|Death|14|||
129067931|NCT05061134|464536675|FG000|Overall Study|Database lock|2|||
129067932|NCT05061134|464536676|FG001|Overall Study|Database lock|0|||
129067933|NCT05061134|464536677|FG002|Overall Study|Database lock|0|||
129067934|NCT00001521|464536683|FG000|Overall Study|Withdrawal by Subject|3|||
129067935|NCT00001521|464536684|FG001|Overall Study|Withdrawal by Subject|3|||
129067936|NCT00001521|464536683|FG000|Overall Study|Physician Decision|1|||
128722372|NCT02776917|463280457|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
128722373|NCT04365556|463280458|FG000|Overall Study|No longer eligible due to treatment plan|1|||
129067937|NCT00001521|464536684|FG001|Overall Study|Physician Decision|1|||
129067938|NCT00001521|464536683|FG000|Overall Study|Noncompliant|6|||
129067939|NCT00001521|464536684|FG001|Overall Study|Noncompliant|3|||
129067940|NCT02366689|464536689|FG000|Overall Study|Withdrawal by Subject|1|||
129067941|NCT02366689|464536690|FG001|Overall Study|Withdrawal by Subject|0|||
129067942|NCT02366689|464536691|FG002|Overall Study|Withdrawal by Subject|1|||
129067943|NCT02366689|464536689|FG000|Overall Study|Lost to Follow-up|3|||
129067944|NCT02366689|464536690|FG001|Overall Study|Lost to Follow-up|2|||
129067945|NCT02366689|464536691|FG002|Overall Study|Lost to Follow-up|0|||
129067946|NCT02366689|464536689|FG000|Overall Study|Pregnancy|0|||
129067947|NCT02366689|464536690|FG001|Overall Study|Pregnancy|1|||
129067948|NCT02366689|464536691|FG002|Overall Study|Pregnancy|1|||
129067949|NCT03283566|464536692|FG000|Overall Study|Lost to Follow-up|1|||
129067950|NCT03283566|464536693|FG001|Overall Study|Lost to Follow-up|2|||
129067951|NCT04882241|464536697|FG000|Overall Study|Ongoing in study|46|||
129067952|NCT04882241|464536698|FG001|Overall Study|Ongoing in study|48|||
129067953|NCT04882241|464536699|FG002|Overall Study|Ongoing in study|0|||
129067954|NCT04882241|464536700|FG003|Overall Study|Ongoing in study|0|||
129067955|NCT04882241|464536697|FG000|Overall Study|Death|13|||
129067956|NCT04882241|464536698|FG001|Overall Study|Death|13|||
129067957|NCT04882241|464536699|FG002|Overall Study|Death|0|||
129067958|NCT04882241|464536700|FG003|Overall Study|Death|0|||
129067959|NCT00470535|464536713|FG000|Overall Study|Disease Progression|13|||
129067960|NCT00470535|464536713|FG000|Overall Study|Withdrawal by Subject|1|||
129067961|NCT00470535|464536713|FG000|Overall Study|Adverse Event|1|||
129067962|NCT00470535|464536713|FG000|Overall Study|Death|1|||
129067963|NCT00470535|464536713|FG000|Overall Study|Other|2|||
129067964|NCT02070965|464536718|FG000|Overall Study|Lost to Follow-up|0|||
129067965|NCT02070965|464536719|FG001|Overall Study|Lost to Follow-up|1|||
129067966|NCT02070965|464536720|FG002|Overall Study|Lost to Follow-up|0|||
129067967|NCT02070965|464536718|FG000|Overall Study|Withdrawal by Subject|1|||
129067968|NCT02070965|464536719|FG001|Overall Study|Withdrawal by Subject|1|||
129067969|NCT02070965|464536720|FG002|Overall Study|Withdrawal by Subject|1|||
129067970|NCT02070965|464536718|FG000|Overall Study|Subject moved|1|||
129067971|NCT02070965|464536719|FG001|Overall Study|Subject moved|0|||
129067972|NCT02070965|464536720|FG002|Overall Study|Subject moved|0|||
129067973|NCT02515331|464536721|FG000|Overall Study|Withdrawal by Subject|0|||
129067974|NCT02515331|464536722|FG001|Overall Study|Withdrawal by Subject|0|||
129067975|NCT02515331|464536723|FG002|Overall Study|Withdrawal by Subject|1|||
129067976|NCT02515331|464536721|FG000|Overall Study|Protocol deviation|0|||
129067977|NCT02515331|464536722|FG001|Overall Study|Protocol deviation|0|||
129067978|NCT02515331|464536723|FG002|Overall Study|Protocol deviation|3|||
129067979|NCT02515331|464536721|FG000|Overall Study|Adverse Event|2|||
129067980|NCT02515331|464536722|FG001|Overall Study|Adverse Event|0|||
129067981|NCT02515331|464536723|FG002|Overall Study|Adverse Event|0|||
129067982|NCT00124748|464536724|FG000|Overall Study|Adverse Event|8|||
129067983|NCT00124748|464536725|FG001|Overall Study|Adverse Event|39|||
129067984|NCT00124748|464536724|FG000|Overall Study|Abnormal laboratory Value|2|||
129067985|NCT00124748|464536725|FG001|Overall Study|Abnormal laboratory Value|2|||
129067986|NCT00124748|464536724|FG000|Overall Study|Abnormal Procedure|0|||
129067987|NCT00124748|464536725|FG001|Overall Study|Abnormal Procedure|1|||
129067988|NCT00124748|464536724|FG000|Overall Study|Lack of Efficacy|20|||
129067989|NCT00124748|464536725|FG001|Overall Study|Lack of Efficacy|41|||
129067990|NCT00124748|464536724|FG000|Overall Study|No longer requires study drug|1|||
129067991|NCT00124748|464536725|FG001|Overall Study|No longer requires study drug|1|||
129067992|NCT00124748|464536724|FG000|Overall Study|Protocol Violation|3|||
129067993|NCT00124748|464536725|FG001|Overall Study|Protocol Violation|1|||
129067994|NCT00124748|464536724|FG000|Overall Study|Withdrawal by Subject|5|||
129067995|NCT00124748|464536725|FG001|Overall Study|Withdrawal by Subject|15|||
129067996|NCT00124748|464536724|FG000|Overall Study|Lost to Follow-up|2|||
129067997|NCT00124748|464536725|FG001|Overall Study|Lost to Follow-up|7|||
129067998|NCT00124748|464536724|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
129067999|NCT00124748|464536725|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
129068000|NCT00124748|464536724|FG000|Overall Study|Death|1|||
129068001|NCT00124748|464536725|FG001|Overall Study|Death|3|||
129068002|NCT00322712|464536726|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
129068003|NCT03889886|464536727|FG000|Overall Study|Other|0|||
129068004|NCT03889886|464536728|FG001|Overall Study|Other|1|||
129068005|NCT03889886|464536729|FG002|Overall Study|Other|0|||
129068006|NCT03889886|464536730|FG003|Overall Study|Other|1|||
129068007|NCT03889886|464536727|FG000|Overall Study|Withdrawal by Subject|0|||
129068008|NCT03889886|464536728|FG001|Overall Study|Withdrawal by Subject|0|||
129068009|NCT03889886|464536729|FG002|Overall Study|Withdrawal by Subject|1|||
129068010|NCT03889886|464536730|FG003|Overall Study|Withdrawal by Subject|0|||
129068011|NCT03889886|464536727|FG000|Overall Study|Adverse Event|0|||
129068012|NCT03889886|464536728|FG001|Overall Study|Adverse Event|0|||
129068013|NCT03889886|464536729|FG002|Overall Study|Adverse Event|0|||
129068014|NCT03889886|464536730|FG003|Overall Study|Adverse Event|6|||
129068015|NCT04176250|464536731|FG000|Overall Study|Adverse Event|0|||
129068016|NCT04176250|464536732|FG001|Overall Study|Adverse Event|1|||
129068017|NCT04176250|464536733|FG002|Overall Study|Adverse Event|0|||
129068018|NCT04176250|464536734|FG003|Overall Study|Adverse Event|1|||
129068019|NCT04176250|464536735|FG004|Overall Study|Adverse Event|0|||
129068020|NCT04176250|464536736|FG005|Overall Study|Adverse Event|1|||
129068021|NCT04176250|464536731|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129068022|NCT04176250|464536732|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129068023|NCT04176250|464536733|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
129068024|NCT04176250|464536734|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
129068025|NCT04176250|464536735|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129138491|NCT01104870|464800524|FG002|Overall Study|Withdrawal by Subject|1|||
129138492|NCT04985682|464800525|FG000|Overall Study|Withdrawal by Subject|1|||
129138493|NCT00079781|464800537|FG000|Pre-implant Period|Withdrawal by Subject|2|||
129138494|NCT00079781|464800538|FG001|Pre-implant Period|Withdrawal by Subject|0|||
129138495|NCT00079781|464800539|FG002|Pre-implant Period|Withdrawal by Subject|0|||
129138496|NCT00079781|464800537|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
129138497|NCT00079781|464800538|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
129138498|NCT00079781|464800539|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
129138499|NCT00079781|464800537|FG000|Follow-up Period|Withdrawal by Subject|3|||
129138500|NCT00079781|464800538|FG001|Follow-up Period|Withdrawal by Subject|0|||
129138501|NCT00079781|464800539|FG002|Follow-up Period|Withdrawal by Subject|1|||
129138502|NCT00079781|464800537|FG000|Follow-up Period|Lost to Follow-up|1|||
129138503|NCT00079781|464800538|FG001|Follow-up Period|Lost to Follow-up|0|||
129138504|NCT00079781|464800539|FG002|Follow-up Period|Lost to Follow-up|0|||
129068026|NCT04176250|464536736|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129068027|NCT04176250|464536731|FG000|Overall Study|Withdrawal by Subject|0|||
129138505|NCT00079781|464800537|FG000|Follow-up Period|Death|0|||
128775898|NCT02258464|463468494|FG001|Overall Study|AE not related to clinical PD|3|||
129138506|NCT00079781|464800538|FG001|Follow-up Period|Death|0|||
129138507|NCT00079781|464800539|FG002|Follow-up Period|Death|1|||
129138508|NCT04641975|464800540|FG000|Overall Study|Protocol Violation|1|||
129068028|NCT04176250|464536732|FG001|Overall Study|Withdrawal by Subject|0|||
128775899|NCT02258464|463468493|FG000|Overall Study|Withdrawal by Subject|5|||
128775900|NCT02258464|463468494|FG001|Overall Study|Withdrawal by Subject|4|||
128775901|NCT02258464|463468493|FG000|Overall Study|AE related to clinical PD|1|||
128775902|NCT02258464|463468494|FG001|Overall Study|AE related to clinical PD|0|||
128775903|NCT02337478|463468495|FG000|Overall Study|Lack of Efficacy|5|||
128775904|NCT00932646|463468496|FG000|Overall Study|Adverse Event|2|||
128775905|NCT00932646|463468497|FG001|Overall Study|Adverse Event|1|||
128775906|NCT00932646|463468498|FG002|Overall Study|Adverse Event|1|||
128775907|NCT00932646|463468499|FG003|Overall Study|Adverse Event|1|||
128775908|NCT00932646|463468496|FG000|Overall Study|Lost to Follow-up|2|||
128775909|NCT00932646|463468497|FG001|Overall Study|Lost to Follow-up|1|||
128775910|NCT00932646|463468498|FG002|Overall Study|Lost to Follow-up|0|||
128775911|NCT00932646|463468499|FG003|Overall Study|Lost to Follow-up|0|||
128775912|NCT00932646|463468496|FG000|Overall Study|Withdrawal by Subject|1|||
128775913|NCT00932646|463468497|FG001|Overall Study|Withdrawal by Subject|1|||
128775914|NCT00932646|463468498|FG002|Overall Study|Withdrawal by Subject|3|||
128775915|NCT00932646|463468499|FG003|Overall Study|Withdrawal by Subject|0|||
128775916|NCT00653263|463468500|FG000|Overall Study|Withdrawal by Subject|1|||
128775917|NCT00653263|463468500|FG000|Overall Study|Physician Decision|1|||
128775918|NCT00776100|463468511|FG000|Overall Study|Disease Progression|1|||
128775919|NCT00776100|463468512|FG001|Overall Study|Disease Progression|0|||
128775920|NCT04793464|463468513|FG000|Overall Study|Lost to Follow-up|458|||
128775921|NCT04793464|463468514|FG001|Overall Study|Lost to Follow-up|168|||
128775922|NCT04793464|463468515|FG002|Overall Study|Lost to Follow-up|5|||
128775923|NCT04793464|463468513|FG000|Overall Study|Withdrawal by Subject|43|||
128775924|NCT04793464|463468514|FG001|Overall Study|Withdrawal by Subject|15|||
128775925|NCT04793464|463468515|FG002|Overall Study|Withdrawal by Subject|0|||
128775926|NCT00641186|463468516|FG000|Overall Study|Adverse Event|3|||
128775927|NCT01671748|463468517|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
128775928|NCT01671748|463468518|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
128775929|NCT01671748|463468517|FG000|4 Week run-in Phase|Adverse Event|1|||
128775930|NCT01671748|463468518|FG001|4 Week run-in Phase|Adverse Event|0|||
128775931|NCT01671748|463468517|FG000|4 Week run-in Phase|Not eligible|9|||
128775932|NCT01671748|463468518|FG001|4 Week run-in Phase|Not eligible|0|||
128775933|NCT02169830|463470307|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
128775934|NCT02169830|463470308|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
128775935|NCT02169830|463470309|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
128775936|NCT02169830|463470307|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
128775937|NCT02169830|463470308|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
128775938|NCT02169830|463470309|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129068029|NCT04176250|464536733|FG002|Overall Study|Withdrawal by Subject|0|||
129068030|NCT04176250|464536734|FG003|Overall Study|Withdrawal by Subject|0|||
129068031|NCT04176250|464536735|FG004|Overall Study|Withdrawal by Subject|0|||
129068032|NCT04176250|464536736|FG005|Overall Study|Withdrawal by Subject|1|||
129068033|NCT04176250|464536731|FG000|Overall Study|Randomized in error|0|||
129068034|NCT04176250|464536732|FG001|Overall Study|Randomized in error|0|||
129068035|NCT04176250|464536733|FG002|Overall Study|Randomized in error|0|||
129068036|NCT04176250|464536734|FG003|Overall Study|Randomized in error|0|||
129068037|NCT04176250|464536735|FG004|Overall Study|Randomized in error|1|||
129068038|NCT04176250|464536736|FG005|Overall Study|Randomized in error|0|||
129068039|NCT04747470|464536748|FG000|Overall Study|Death|0|||
129068040|NCT04747470|464536749|FG001|Overall Study|Death|3|||
128775939|NCT02169830|463470307|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
128775940|NCT02169830|463470308|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
128775941|NCT02169830|463470309|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
128775942|NCT02169830|463470307|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
128775943|NCT02169830|463470308|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
129068041|NCT04747470|464536750|FG002|Overall Study|Death|2|||
129068042|NCT04747470|464536751|FG003|Overall Study|Death|2|||
129068043|NCT04747470|464536752|FG004|Overall Study|Death|2|||
129068044|NCT04747470|464536753|FG005|Overall Study|Death|0|||
128775944|NCT02169830|463470309|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
128775945|NCT02169830|463470307|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
128775946|NCT02169830|463470308|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
128775947|NCT02169830|463470309|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
128775948|NCT03204695|463470310|FG000|Overall Study|Death|1|||
128775949|NCT03204695|463470310|FG000|Overall Study|Participant was treated with another device|1|||
128775950|NCT03204695|463470310|FG000|Overall Study|Physician Decision|2|||
128775951|NCT00742885|463470311|FG000|Overall Study|Lost to Follow-up|1|||
128775952|NCT00742885|463470312|FG001|Overall Study|Lost to Follow-up|0|||
128775953|NCT03615482|463470313|FG000|Overall Study|Death|1|||
128775954|NCT03615482|463470314|FG001|Overall Study|Death|0|||
129068045|NCT04747470|464536754|FG006|Overall Study|Death|0|||
129068046|NCT04747470|464536755|FG007|Overall Study|Death|0|||
129068047|NCT04747470|464536756|FG008|Overall Study|Death|0|||
129068048|NCT04747470|464536757|FG009|Overall Study|Death|0|||
128722374|NCT04365556|463280459|FG001|Overall Study|No longer eligible due to treatment plan|0|||
128722375|NCT04365556|463280458|FG000|Overall Study|Lost to Follow-up|3|||
128722376|NCT04365556|463280459|FG001|Overall Study|Lost to Follow-up|2|||
128722377|NCT04439318|463280462|FG000|Overall Study|Ineligible|1|||
128722378|NCT04439318|463280462|FG000|Overall Study|Never Started Treatment|3|||
128722379|NCT04439318|463280462|FG000|Overall Study|Adverse Event|10|||
128722380|NCT04439318|463280462|FG000|Overall Study|Death|2|||
128722381|NCT04439318|463280462|FG000|Overall Study|Disease Progression|25|||
128722382|NCT04439318|463280462|FG000|Overall Study|Other Complicating Disease|2|||
128722383|NCT04439318|463280462|FG000|Overall Study|Withdrawal by Subject|4|||
128722384|NCT04439318|463280462|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
128722385|NCT04439318|463280462|FG000|Overall Study|Non-Compliance|1|||
128722386|NCT04439318|463280462|FG000|Overall Study|Still on Treatment|1|||
128722387|NCT00699972|463282202|FG000|Overall Study|Adverse Event|7|||
128722388|NCT00699972|463282203|FG001|Overall Study|Adverse Event|9|||
128722389|NCT00699972|463282204|FG002|Overall Study|Adverse Event|24|||
128722390|NCT00699972|463282202|FG000|Overall Study|Lost to Follow-up|0|||
128722391|NCT00699972|463282203|FG001|Overall Study|Lost to Follow-up|2|||
128722392|NCT00699972|463282204|FG002|Overall Study|Lost to Follow-up|0|||
128722393|NCT00699972|463282202|FG000|Overall Study|Withdrawal by Subject|3|||
128722394|NCT00699972|463282203|FG001|Overall Study|Withdrawal by Subject|7|||
128722395|NCT00699972|463282204|FG002|Overall Study|Withdrawal by Subject|4|||
128722396|NCT00699972|463282202|FG000|Overall Study|Lack of Efficacy|2|||
128722397|NCT00699972|463282203|FG001|Overall Study|Lack of Efficacy|0|||
128722398|NCT00699972|463282204|FG002|Overall Study|Lack of Efficacy|2|||
128722399|NCT00699972|463282202|FG000|Overall Study|Administrative/Other|3|||
128722400|NCT00699972|463282203|FG001|Overall Study|Administrative/Other|1|||
128722401|NCT00699972|463282204|FG002|Overall Study|Administrative/Other|4|||
128722402|NCT00699972|463282202|FG000|Overall Study|Randomized, Not Treated|1|||
128722403|NCT00699972|463282203|FG001|Overall Study|Randomized, Not Treated|0|||
128722404|NCT00699972|463282204|FG002|Overall Study|Randomized, Not Treated|1|||
128722405|NCT03509675|463282206|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
128722406|NCT03509675|463282207|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
128722407|NCT03509675|463282206|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
128722408|NCT03509675|463282207|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
128722409|NCT03509675|463282206|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
128722410|NCT03509675|463282207|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
128722411|NCT03509675|463282206|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
128722412|NCT03509675|463282207|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
128722413|NCT01023581|463282208|FG000|Overall Study|Adverse Event|4|||
128722414|NCT01023581|463282209|FG001|Overall Study|Adverse Event|4|||
128722415|NCT01023581|463282210|FG002|Overall Study|Adverse Event|7|||
129138509|NCT04641975|464800541|FG001|Overall Study|Protocol Violation|2|||
129138510|NCT04641975|464800542|FG002|Overall Study|Protocol Violation|0|||
129138511|NCT04641975|464800543|FG003|Overall Study|Protocol Violation|0|||
129138512|NCT04641975|464800540|FG000|Overall Study|Adverse Event|0|||
129138513|NCT04641975|464800541|FG001|Overall Study|Adverse Event|0|||
129138514|NCT04641975|464800542|FG002|Overall Study|Adverse Event|1|||
129138515|NCT04641975|464800543|FG003|Overall Study|Adverse Event|1|||
128722416|NCT01023581|463282211|FG003|Overall Study|Adverse Event|3|||
128722417|NCT01023581|463282212|FG004|Overall Study|Adverse Event|2|||
128722418|NCT01023581|463282213|FG005|Overall Study|Adverse Event|5|||
128722419|NCT01023581|463282214|FG006|Overall Study|Adverse Event|11|||
128722420|NCT01023581|463282208|FG000|Overall Study|Major protocol deviation|2|||
128722421|NCT01023581|463282209|FG001|Overall Study|Major protocol deviation|0|||
128722422|NCT01023581|463282210|FG002|Overall Study|Major protocol deviation|3|||
128722423|NCT01023581|463282211|FG003|Overall Study|Major protocol deviation|0|||
128722424|NCT01023581|463282212|FG004|Overall Study|Major protocol deviation|0|||
128722425|NCT01023581|463282213|FG005|Overall Study|Major protocol deviation|0|||
128722426|NCT01023581|463282214|FG006|Overall Study|Major protocol deviation|0|||
128722427|NCT01023581|463282208|FG000|Overall Study|Lost to Follow-up|4|||
128722428|NCT01023581|463282209|FG001|Overall Study|Lost to Follow-up|8|||
128722429|NCT01023581|463282210|FG002|Overall Study|Lost to Follow-up|7|||
128722430|NCT01023581|463282211|FG003|Overall Study|Lost to Follow-up|2|||
128722431|NCT01023581|463282212|FG004|Overall Study|Lost to Follow-up|5|||
128722432|NCT01023581|463282213|FG005|Overall Study|Lost to Follow-up|2|||
128722433|NCT01023581|463282214|FG006|Overall Study|Lost to Follow-up|2|||
128722434|NCT01023581|463282208|FG000|Overall Study|Withdrawal by Subject|13|||
128722435|NCT01023581|463282209|FG001|Overall Study|Withdrawal by Subject|8|||
128722436|NCT01023581|463282210|FG002|Overall Study|Withdrawal by Subject|16|||
128722437|NCT01023581|463282211|FG003|Overall Study|Withdrawal by Subject|10|||
128722438|NCT01023581|463282212|FG004|Overall Study|Withdrawal by Subject|6|||
128722439|NCT01023581|463282213|FG005|Overall Study|Withdrawal by Subject|8|||
128722440|NCT01023581|463282214|FG006|Overall Study|Withdrawal by Subject|5|||
128722441|NCT01023581|463282208|FG000|Overall Study|Pregnancy|0|||
128722442|NCT01023581|463282209|FG001|Overall Study|Pregnancy|0|||
129138516|NCT04641975|464800540|FG000|Overall Study|Withdrawal by Subject|1|||
129068049|NCT04747470|464536758|FG010|Overall Study|Death|0|||
129068050|NCT04747470|464536748|FG000|Overall Study|Withdrew Consent|0|||
129068051|NCT04747470|464536749|FG001|Overall Study|Withdrew Consent|0|||
129068052|NCT04747470|464536750|FG002|Overall Study|Withdrew Consent|0|||
129068053|NCT04747470|464536751|FG003|Overall Study|Withdrew Consent|1|||
129068054|NCT04747470|464536752|FG004|Overall Study|Withdrew Consent|0|||
129068055|NCT04747470|464536753|FG005|Overall Study|Withdrew Consent|0|||
129068056|NCT04747470|464536754|FG006|Overall Study|Withdrew Consent|0|||
129068057|NCT04747470|464536755|FG007|Overall Study|Withdrew Consent|0|||
129068058|NCT04747470|464536756|FG008|Overall Study|Withdrew Consent|0|||
129068059|NCT04747470|464536757|FG009|Overall Study|Withdrew Consent|0|||
129068060|NCT04747470|464536758|FG010|Overall Study|Withdrew Consent|0|||
129068061|NCT04747470|464536748|FG000|Overall Study|Study Terminated by Sponsor|0|||
129138517|NCT04641975|464800541|FG001|Overall Study|Withdrawal by Subject|0|||
129138518|NCT04641975|464800542|FG002|Overall Study|Withdrawal by Subject|0|||
129138519|NCT04641975|464800543|FG003|Overall Study|Withdrawal by Subject|0|||
129138520|NCT01259024|464800545|FG000|Overall Study|Physician Decision|1|||
129138521|NCT01657500|464800546|FG000|Overall Study|set impropperly matched|3|||
129138522|NCT01657500|464800547|FG001|Overall Study|set impropperly matched|3|||
129138523|NCT01657500|464800546|FG000|Overall Study|Lost to Follow-up|2|||
129138524|NCT01657500|464800547|FG001|Overall Study|Lost to Follow-up|2|||
129138525|NCT02067156|464800550|FG000|Overall Study|Lost to Follow-up|4|||
129138526|NCT04034056|464800551|FG000|Overall Study|Withdrawal by Subject|2|||
129138527|NCT04034056|464800551|FG000|Overall Study|Reason Not Specified|13|||
129138528|NCT04034056|464800551|FG000|Overall Study|Adverse Event|56|||
129138529|NCT04008069|464800552|FG000|Open-Label Period|Adverse Event|1|||
129138530|NCT04008069|464800553|FG001|Open-Label Period|Adverse Event|0|||
129138531|NCT04008069|464800554|FG002|Open-Label Period|Adverse Event|0|||
129138532|NCT04008069|464800552|FG000|Open-Label Period|Lack of Efficacy|4|||
129138533|NCT04008069|464800553|FG001|Open-Label Period|Lack of Efficacy|0|||
129138534|NCT04008069|464800554|FG002|Open-Label Period|Lack of Efficacy|0|||
129138535|NCT04008069|464800552|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
129138536|NCT04008069|464800553|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
129138537|NCT04008069|464800554|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
129138538|NCT04008069|464800552|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
129138539|NCT04008069|464800553|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
129138540|NCT04008069|464800554|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
129138541|NCT02134028|464800556|FG000|Overall Study|Lack of Efficacy|1|||
129138542|NCT02134028|464800557|FG001|Overall Study|Lack of Efficacy|0|||
129138543|NCT02134028|464800558|FG002|Overall Study|Lack of Efficacy|3|||
129138544|NCT02134028|464800559|FG003|Overall Study|Lack of Efficacy|2|||
129138545|NCT02134028|464800560|FG004|Overall Study|Lack of Efficacy|1|||
129138546|NCT02134028|464800561|FG005|Overall Study|Lack of Efficacy|2|||
129138547|NCT02134028|464800562|FG006|Overall Study|Lack of Efficacy|1|||
129138548|NCT02134028|464800563|FG007|Overall Study|Lack of Efficacy|0|||
129138549|NCT02134028|464800556|FG000|Overall Study|Poor compliance to protocol|1|||
129138550|NCT02134028|464800557|FG001|Overall Study|Poor compliance to protocol|1|||
129138551|NCT02134028|464800558|FG002|Overall Study|Poor compliance to protocol|3|||
129138552|NCT02134028|464800559|FG003|Overall Study|Poor compliance to protocol|7|||
129138553|NCT02134028|464800560|FG004|Overall Study|Poor compliance to protocol|1|||
129138554|NCT02134028|464800561|FG005|Overall Study|Poor compliance to protocol|1|||
129138555|NCT02134028|464800562|FG006|Overall Study|Poor compliance to protocol|0|||
129138556|NCT02134028|464800563|FG007|Overall Study|Poor compliance to protocol|0|||
129138557|NCT02134028|464800556|FG000|Overall Study|Other unspecified|4|||
129138558|NCT02134028|464800557|FG001|Overall Study|Other unspecified|22|||
129138559|NCT02134028|464800558|FG002|Overall Study|Other unspecified|33|||
129138560|NCT02134028|464800559|FG003|Overall Study|Other unspecified|64|||
128722443|NCT01023581|463282210|FG002|Overall Study|Pregnancy|0|||
128722444|NCT01023581|463282211|FG003|Overall Study|Pregnancy|2|||
128722445|NCT01023581|463282212|FG004|Overall Study|Pregnancy|0|||
128722446|NCT01023581|463282213|FG005|Overall Study|Pregnancy|1|||
128722447|NCT01023581|463282214|FG006|Overall Study|Pregnancy|0|||
129068062|NCT04747470|464536749|FG001|Overall Study|Study Terminated by Sponsor|0|||
129068063|NCT04747470|464536750|FG002|Overall Study|Study Terminated by Sponsor|1|||
129068064|NCT04747470|464536751|FG003|Overall Study|Study Terminated by Sponsor|0|||
129138561|NCT02134028|464800560|FG004|Overall Study|Other unspecified|8|||
129138562|NCT02134028|464800561|FG005|Overall Study|Other unspecified|6|||
129138563|NCT02134028|464800562|FG006|Overall Study|Other unspecified|2|||
129138564|NCT02134028|464800563|FG007|Overall Study|Other unspecified|1|||
129138565|NCT02134028|464800556|FG000|Overall Study|Adverse Event|3|||
128722448|NCT01023581|463282208|FG000|Overall Study|Lack of Efficacy|9|||
128722449|NCT01023581|463282209|FG001|Overall Study|Lack of Efficacy|3|||
129068065|NCT04747470|464536752|FG004|Overall Study|Study Terminated by Sponsor|2|||
129138566|NCT02134028|464800557|FG001|Overall Study|Adverse Event|19|||
129138567|NCT02134028|464800558|FG002|Overall Study|Adverse Event|13|||
129138568|NCT02134028|464800559|FG003|Overall Study|Adverse Event|32|||
129138569|NCT02134028|464800560|FG004|Overall Study|Adverse Event|4|||
129138570|NCT02134028|464800561|FG005|Overall Study|Adverse Event|5|||
129138571|NCT02134028|464800562|FG006|Overall Study|Adverse Event|1|||
128722450|NCT01023581|463282210|FG002|Overall Study|Lack of Efficacy|6|||
128722451|NCT01023581|463282211|FG003|Overall Study|Lack of Efficacy|2|||
128722452|NCT01023581|463282212|FG004|Overall Study|Lack of Efficacy|1|||
128722453|NCT01023581|463282213|FG005|Overall Study|Lack of Efficacy|2|||
128722454|NCT01023581|463282214|FG006|Overall Study|Lack of Efficacy|1|||
128722455|NCT01023581|463282208|FG000|Overall Study|Physician Decision|2|||
128722456|NCT01023581|463282209|FG001|Overall Study|Physician Decision|0|||
128722457|NCT01023581|463282210|FG002|Overall Study|Physician Decision|2|||
128722458|NCT01023581|463282211|FG003|Overall Study|Physician Decision|1|||
128722459|NCT01023581|463282212|FG004|Overall Study|Physician Decision|1|||
128722460|NCT01023581|463282213|FG005|Overall Study|Physician Decision|1|||
128722461|NCT01023581|463282214|FG006|Overall Study|Physician Decision|1|||
128722462|NCT01023581|463282208|FG000|Overall Study|Other|1|||
128722463|NCT01023581|463282209|FG001|Overall Study|Other|0|||
128722464|NCT01023581|463282210|FG002|Overall Study|Other|1|||
128722465|NCT01023581|463282211|FG003|Overall Study|Other|0|||
128722466|NCT01023581|463282212|FG004|Overall Study|Other|1|||
128722467|NCT01023581|463282213|FG005|Overall Study|Other|0|||
128722468|NCT01023581|463282214|FG006|Overall Study|Other|0|||
128722469|NCT03412084|463282217|FG000|Overall Study|Withdrawal by Subject|2|||
128722470|NCT03412084|463282218|FG001|Overall Study|Withdrawal by Subject|0|||
128722471|NCT03412084|463282217|FG000|Overall Study|Participant moved|1|||
128722472|NCT03412084|463282218|FG001|Overall Study|Participant moved|0|||
128722473|NCT03412084|463282217|FG000|Overall Study|Lost to Follow-up|1|||
128722474|NCT03412084|463282218|FG001|Overall Study|Lost to Follow-up|1|||
128722475|NCT02023151|463282223|FG000|Overall Study|Lost to Follow-up|4|||
129068066|NCT04747470|464536753|FG005|Overall Study|Study Terminated by Sponsor|0|||
129068067|NCT04747470|464536754|FG006|Overall Study|Study Terminated by Sponsor|0|||
129068068|NCT04747470|464536755|FG007|Overall Study|Study Terminated by Sponsor|0|||
129068069|NCT04747470|464536756|FG008|Overall Study|Study Terminated by Sponsor|0|||
129068070|NCT04747470|464536757|FG009|Overall Study|Study Terminated by Sponsor|0|||
129068071|NCT04747470|464536758|FG010|Overall Study|Study Terminated by Sponsor|0|||
129068072|NCT04720053|464536759|FG000|Overall Study|Lost to Follow-up|12|||
129068073|NCT02906670|464536763|FG000|Cohort 1, QW|Radiological Progression|1|||
129068074|NCT02906670|464536764|FG001|Cohort 1, QW|Radiological Progression|0|||
129068075|NCT02906670|464536765|FG002|Cohort 1, QW|Radiological Progression|0|||
129068076|NCT02906670|464536766|FG003|Cohort 1, QW|Radiological Progression|0|||
129068077|NCT02906670|464536767|FG004|Cohort 1, QW|Radiological Progression|0|||
129068078|NCT02906670|464536768|FG005|Cohort 1, QW|Radiological Progression|0|||
129068079|NCT02906670|464536769|FG006|Cohort 1, QW|Radiological Progression|0|||
129068080|NCT02906670|464536770|FG007|Cohort 1, QW|Radiological Progression|0|||
129068081|NCT02906670|464536771|FG008|Cohort 1, QW|Radiological Progression|0|||
129068082|NCT02906670|464536772|FG009|Cohort 1, QW|Radiological Progression|0|||
129068083|NCT02906670|464536763|FG000|Cohort 2, QW|Radiological Progression|0|||
129068084|NCT02906670|464536764|FG001|Cohort 2, QW|Radiological Progression|1|||
129068085|NCT02906670|464536765|FG002|Cohort 2, QW|Radiological Progression|0|||
129068086|NCT02906670|464536766|FG003|Cohort 2, QW|Radiological Progression|0|||
129068087|NCT02906670|464536767|FG004|Cohort 2, QW|Radiological Progression|0|||
129068088|NCT02906670|464536768|FG005|Cohort 2, QW|Radiological Progression|0|||
128722476|NCT04064294|463282224|FG000|Overall Study|Adverse Event|1|||
128722477|NCT04064294|463282225|FG001|Overall Study|Adverse Event|0|||
128722478|NCT04064294|463282226|FG002|Overall Study|Adverse Event|0|||
128722479|NCT03450707|463282227|FG000|Overall Study|Outside enrollment window|4|||
128722480|NCT03450707|463282228|FG001|Overall Study|Outside enrollment window|1|||
128722481|NCT03450707|463282227|FG000|Overall Study|Death|1|||
128722482|NCT03450707|463282228|FG001|Overall Study|Death|0|||
128722483|NCT03450707|463282227|FG000|Overall Study|Indication for thiamine|1|||
128722484|NCT03450707|463282228|FG001|Overall Study|Indication for thiamine|1|||
128722485|NCT03450707|463282227|FG000|Overall Study|Evidence of traumatic brain injury|1|||
129068089|NCT02906670|464536769|FG006|Cohort 2, QW|Radiological Progression|0|||
129068090|NCT02906670|464536770|FG007|Cohort 2, QW|Radiological Progression|0|||
129068091|NCT02906670|464536771|FG008|Cohort 2, QW|Radiological Progression|0|||
128722486|NCT03450707|463282228|FG001|Overall Study|Evidence of traumatic brain injury|0|||
128722487|NCT03450707|463282227|FG000|Overall Study|Following commands|0|||
128722488|NCT03450707|463282228|FG001|Overall Study|Following commands|3|||
129138572|NCT02134028|464800563|FG007|Overall Study|Adverse Event|2|||
129068092|NCT02906670|464536772|FG009|Cohort 2, QW|Radiological Progression|0|||
129068093|NCT02906670|464536763|FG000|Cohort 3, QW|Radiological Progression|0|||
129068094|NCT02906670|464536764|FG001|Cohort 3, QW|Radiological Progression|0|||
129068095|NCT02906670|464536765|FG002|Cohort 3, QW|Radiological Progression|2|||
129068096|NCT02906670|464536766|FG003|Cohort 3, QW|Radiological Progression|0|||
129068097|NCT02906670|464536767|FG004|Cohort 3, QW|Radiological Progression|0|||
129068098|NCT02906670|464536768|FG005|Cohort 3, QW|Radiological Progression|0|||
129068099|NCT02906670|464536769|FG006|Cohort 3, QW|Radiological Progression|0|||
129068100|NCT02906670|464536770|FG007|Cohort 3, QW|Radiological Progression|0|||
129068101|NCT02906670|464536771|FG008|Cohort 3, QW|Radiological Progression|0|||
129068102|NCT02906670|464536772|FG009|Cohort 3, QW|Radiological Progression|0|||
129068103|NCT02906670|464536763|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068104|NCT02906670|464536764|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068105|NCT02906670|464536765|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
129068106|NCT02906670|464536766|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068107|NCT02906670|464536767|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068108|NCT02906670|464536768|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068109|NCT02906670|464536769|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068110|NCT02906670|464536770|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068111|NCT02906670|464536771|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068112|NCT02906670|464536772|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
129068113|NCT02906670|464536763|FG000|Cohort 4, Q2W|Radiological Progression|0|||
129068114|NCT02906670|464536764|FG001|Cohort 4, Q2W|Radiological Progression|0|||
129068115|NCT02906670|464536765|FG002|Cohort 4, Q2W|Radiological Progression|0|||
129068116|NCT02906670|464536766|FG003|Cohort 4, Q2W|Radiological Progression|0|||
129068117|NCT02906670|464536767|FG004|Cohort 4, Q2W|Radiological Progression|0|||
129068118|NCT02906670|464536768|FG005|Cohort 4, Q2W|Radiological Progression|1|||
129068119|NCT02906670|464536769|FG006|Cohort 4, Q2W|Radiological Progression|0|||
129068120|NCT02906670|464536770|FG007|Cohort 4, Q2W|Radiological Progression|0|||
129068121|NCT02906670|464536771|FG008|Cohort 4, Q2W|Radiological Progression|0|||
129068122|NCT02906670|464536772|FG009|Cohort 4, Q2W|Radiological Progression|0|||
129068123|NCT02906670|464536763|FG000|Cohort 4, Q2W|Clinical Progression|0|||
129068124|NCT02906670|464536764|FG001|Cohort 4, Q2W|Clinical Progression|0|||
129068125|NCT02906670|464536765|FG002|Cohort 4, Q2W|Clinical Progression|0|||
129068126|NCT02906670|464536766|FG003|Cohort 4, Q2W|Clinical Progression|0|||
129068127|NCT02906670|464536767|FG004|Cohort 4, Q2W|Clinical Progression|0|||
129068128|NCT02906670|464536768|FG005|Cohort 4, Q2W|Clinical Progression|2|||
129068129|NCT02906670|464536769|FG006|Cohort 4, Q2W|Clinical Progression|0|||
129068130|NCT02906670|464536770|FG007|Cohort 4, Q2W|Clinical Progression|0|||
129068131|NCT02906670|464536771|FG008|Cohort 4, Q2W|Clinical Progression|0|||
129068132|NCT02906670|464536772|FG009|Cohort 4, Q2W|Clinical Progression|0|||
129068133|NCT02906670|464536763|FG000|Cohort 5, Q2W|Radiological Progression|0|||
129068134|NCT02906670|464536764|FG001|Cohort 5, Q2W|Radiological Progression|0|||
129068135|NCT02906670|464536765|FG002|Cohort 5, Q2W|Radiological Progression|0|||
129068136|NCT02906670|464536766|FG003|Cohort 5, Q2W|Radiological Progression|0|||
129138573|NCT00819832|464800566|FG000|Overall Study|Sponsor Termination of Study|3|||
129138574|NCT00819832|464800567|FG001|Overall Study|Sponsor Termination of Study|0|||
129138575|NCT00819832|464800568|FG002|Overall Study|Sponsor Termination of Study|0|||
129138576|NCT00819832|464800569|FG003|Overall Study|Sponsor Termination of Study|0|||
129138577|NCT00819832|464800570|FG004|Overall Study|Sponsor Termination of Study|0|||
129138578|NCT00819832|464800571|FG005|Overall Study|Sponsor Termination of Study|0|||
129138579|NCT01452789|464800580|FG000|Overall Study|Withdrawal by Subject|3|||
129138580|NCT01452789|464800581|FG001|Overall Study|Withdrawal by Subject|2|||
129138581|NCT01340170|464800582|FG000|Overall Study|Lost to Follow-up|2|||
129138582|NCT01340170|464800583|FG001|Overall Study|Lost to Follow-up|4|||
129138583|NCT01340170|464800584|FG002|Overall Study|Lost to Follow-up|0|||
128722489|NCT03450707|463282227|FG000|Overall Study|Lactate < 3.5|0|||
128722490|NCT03450707|463282228|FG001|Overall Study|Lactate < 3.5|2|||
128722491|NCT03450707|463282227|FG000|Overall Study|Rearrest with ECMO|0|||
129068137|NCT02906670|464536767|FG004|Cohort 5, Q2W|Radiological Progression|0|||
129068138|NCT02906670|464536768|FG005|Cohort 5, Q2W|Radiological Progression|0|||
129068139|NCT02906670|464536769|FG006|Cohort 5, Q2W|Radiological Progression|4|||
129068140|NCT02906670|464536770|FG007|Cohort 5, Q2W|Radiological Progression|0|||
129138584|NCT01340170|464800582|FG000|Overall Study|Implant failure|1|||
129138585|NCT01340170|464800583|FG001|Overall Study|Implant failure|3|||
129068141|NCT02906670|464536771|FG008|Cohort 5, Q2W|Radiological Progression|0|||
129068142|NCT02906670|464536772|FG009|Cohort 5, Q2W|Radiological Progression|0|||
129068143|NCT02906670|464536763|FG000|Cohort 5, Q2W|Clinical Progression|0|||
129068144|NCT02906670|464536764|FG001|Cohort 5, Q2W|Clinical Progression|0|||
129068145|NCT02906670|464536765|FG002|Cohort 5, Q2W|Clinical Progression|0|||
129068146|NCT02906670|464536766|FG003|Cohort 5, Q2W|Clinical Progression|0|||
129068147|NCT02906670|464536767|FG004|Cohort 5, Q2W|Clinical Progression|0|||
129068148|NCT02906670|464536768|FG005|Cohort 5, Q2W|Clinical Progression|0|||
129138586|NCT01340170|464800584|FG002|Overall Study|Implant failure|0|||
129138587|NCT03878602|464800585|FG000|Overall Study|cord blood donation|7|||
128722492|NCT03450707|463282228|FG001|Overall Study|Rearrest with ECMO|1|||
129068149|NCT02906670|464536769|FG006|Cohort 5, Q2W|Clinical Progression|1|||
129068150|NCT02906670|464536770|FG007|Cohort 5, Q2W|Clinical Progression|0|||
129068151|NCT02906670|464536771|FG008|Cohort 5, Q2W|Clinical Progression|0|||
129068152|NCT02906670|464536772|FG009|Cohort 5, Q2W|Clinical Progression|0|||
129068153|NCT02906670|464536763|FG000|Cohort 5, Q2W|Adverse Event|0|||
129068154|NCT02906670|464536764|FG001|Cohort 5, Q2W|Adverse Event|0|||
129068155|NCT02906670|464536765|FG002|Cohort 5, Q2W|Adverse Event|0|||
129068156|NCT02906670|464536766|FG003|Cohort 5, Q2W|Adverse Event|0|||
129068157|NCT02906670|464536767|FG004|Cohort 5, Q2W|Adverse Event|0|||
129068158|NCT02906670|464536768|FG005|Cohort 5, Q2W|Adverse Event|0|||
129068159|NCT02906670|464536769|FG006|Cohort 5, Q2W|Adverse Event|1|||
129068160|NCT02906670|464536770|FG007|Cohort 5, Q2W|Adverse Event|0|||
129068161|NCT02906670|464536771|FG008|Cohort 5, Q2W|Adverse Event|0|||
129068162|NCT02906670|464536772|FG009|Cohort 5, Q2W|Adverse Event|0|||
129068163|NCT02906670|464536763|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068164|NCT02906670|464536764|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068165|NCT02906670|464536765|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068166|NCT02906670|464536766|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068167|NCT02906670|464536767|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068168|NCT02906670|464536768|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068169|NCT02906670|464536769|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
129068170|NCT02906670|464536770|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068171|NCT02906670|464536771|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068172|NCT02906670|464536772|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129068173|NCT02906670|464536763|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
129068174|NCT02906670|464536764|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
129068175|NCT02906670|464536765|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
129068176|NCT02906670|464536766|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
129068177|NCT02906670|464536767|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
129068178|NCT02906670|464536768|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
129068179|NCT02906670|464536769|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
129068180|NCT02906670|464536770|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
129068181|NCT02906670|464536771|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
129068182|NCT02906670|464536772|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
129068183|NCT02906670|464536763|FG000|Cohort 5P, Q2W|Adverse Event|0|||
129068184|NCT02906670|464536764|FG001|Cohort 5P, Q2W|Adverse Event|0|||
129068185|NCT02906670|464536765|FG002|Cohort 5P, Q2W|Adverse Event|0|||
129068186|NCT02906670|464536766|FG003|Cohort 5P, Q2W|Adverse Event|0|||
129068187|NCT02906670|464536767|FG004|Cohort 5P, Q2W|Adverse Event|0|||
129068188|NCT02906670|464536768|FG005|Cohort 5P, Q2W|Adverse Event|0|||
129068189|NCT02906670|464536769|FG006|Cohort 5P, Q2W|Adverse Event|0|||
129068190|NCT02906670|464536770|FG007|Cohort 5P, Q2W|Adverse Event|1|||
129068191|NCT02906670|464536771|FG008|Cohort 5P, Q2W|Adverse Event|0|||
129068192|NCT02906670|464536772|FG009|Cohort 5P, Q2W|Adverse Event|0|||
129068193|NCT02906670|464536763|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
129068194|NCT02906670|464536764|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
129068195|NCT02906670|464536765|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
129068196|NCT02906670|464536766|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
129068197|NCT02906670|464536767|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
129068198|NCT02906670|464536768|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
129068199|NCT02906670|464536769|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
129068200|NCT02906670|464536770|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
129068201|NCT02906670|464536771|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
129068202|NCT02906670|464536772|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
129068203|NCT02906670|464536763|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
129068204|NCT02906670|464536764|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
129068205|NCT02906670|464536765|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
129068206|NCT02906670|464536766|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
129068207|NCT02906670|464536767|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
129068208|NCT02906670|464536768|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
129068209|NCT02906670|464536769|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
129068210|NCT02906670|464536770|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
129068211|NCT02906670|464536771|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
129068212|NCT02906670|464536772|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
129068213|NCT02906670|464536763|FG000|Cohort 4P, QW|Radiological Progression|0|||
129068214|NCT02906670|464536764|FG001|Cohort 4P, QW|Radiological Progression|0|||
129068215|NCT02906670|464536765|FG002|Cohort 4P, QW|Radiological Progression|0|||
129068216|NCT02906670|464536766|FG003|Cohort 4P, QW|Radiological Progression|3|||
129068217|NCT02906670|464536767|FG004|Cohort 4P, QW|Radiological Progression|0|||
129068218|NCT02906670|464536768|FG005|Cohort 4P, QW|Radiological Progression|0|||
129068219|NCT02906670|464536769|FG006|Cohort 4P, QW|Radiological Progression|0|||
128722493|NCT03450707|463282227|FG000|Overall Study|Indication for thiamine + head CT results|0|||
129068220|NCT02906670|464536770|FG007|Cohort 4P, QW|Radiological Progression|0|||
129068221|NCT02906670|464536771|FG008|Cohort 4P, QW|Radiological Progression|0|||
129068222|NCT02906670|464536772|FG009|Cohort 4P, QW|Radiological Progression|0|||
129068223|NCT02906670|464536763|FG000|Cohort 7P, Q2W|Adverse Event|0|||
129068224|NCT02906670|464536764|FG001|Cohort 7P, Q2W|Adverse Event|0|||
129068225|NCT02906670|464536765|FG002|Cohort 7P, Q2W|Adverse Event|0|||
129068226|NCT02906670|464536766|FG003|Cohort 7P, Q2W|Adverse Event|0|||
129068227|NCT02906670|464536767|FG004|Cohort 7P, Q2W|Adverse Event|0|||
129068228|NCT02906670|464536768|FG005|Cohort 7P, Q2W|Adverse Event|0|||
129068229|NCT02906670|464536769|FG006|Cohort 7P, Q2W|Adverse Event|0|||
129068230|NCT02906670|464536770|FG007|Cohort 7P, Q2W|Adverse Event|0|||
129068231|NCT02906670|464536771|FG008|Cohort 7P, Q2W|Adverse Event|0|||
129068232|NCT02906670|464536772|FG009|Cohort 7P, Q2W|Adverse Event|1|||
129068233|NCT02906670|464536763|FG000|Cohort 7P, Q2W|Physician Decision|0|||
129068234|NCT02906670|464536764|FG001|Cohort 7P, Q2W|Physician Decision|0|||
129068235|NCT02906670|464536765|FG002|Cohort 7P, Q2W|Physician Decision|0|||
129068236|NCT02906670|464536766|FG003|Cohort 7P, Q2W|Physician Decision|0|||
129068237|NCT02906670|464536767|FG004|Cohort 7P, Q2W|Physician Decision|0|||
129068238|NCT02906670|464536768|FG005|Cohort 7P, Q2W|Physician Decision|0|||
129068239|NCT02906670|464536769|FG006|Cohort 7P, Q2W|Physician Decision|0|||
129068240|NCT02906670|464536770|FG007|Cohort 7P, Q2W|Physician Decision|0|||
129068241|NCT02906670|464536771|FG008|Cohort 7P, Q2W|Physician Decision|0|||
129068242|NCT02906670|464536772|FG009|Cohort 7P, Q2W|Physician Decision|1|||
129068243|NCT02906670|464536763|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068244|NCT02906670|464536764|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068245|NCT02906670|464536765|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068246|NCT02906670|464536766|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068247|NCT02906670|464536767|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068248|NCT02906670|464536768|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068249|NCT02906670|464536769|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068250|NCT02906670|464536770|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068251|NCT02906670|464536771|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129068252|NCT02906670|464536772|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
129068253|NCT02906670|464536763|FG000|Cohort 5P, QW|Radiological Progression|0|||
129068254|NCT02906670|464536764|FG001|Cohort 5P, QW|Radiological Progression|0|||
129068255|NCT02906670|464536765|FG002|Cohort 5P, QW|Radiological Progression|0|||
129068256|NCT02906670|464536766|FG003|Cohort 5P, QW|Radiological Progression|0|||
129068257|NCT02906670|464536767|FG004|Cohort 5P, QW|Radiological Progression|3|||
129068258|NCT02906670|464536768|FG005|Cohort 5P, QW|Radiological Progression|0|||
129068259|NCT02906670|464536769|FG006|Cohort 5P, QW|Radiological Progression|0|||
129138588|NCT03878602|464800586|FG001|Overall Study|cord blood donation|1|||
129138589|NCT03878602|464800585|FG000|Overall Study|incomplete data collection|2|||
129138590|NCT03878602|464800586|FG001|Overall Study|incomplete data collection|0|||
129138591|NCT00066170|464800587|FG000|Overall Study|Adverse Event|2|||
129138592|NCT00066170|464800588|FG001|Overall Study|Adverse Event|4|||
129138593|NCT00066170|464800589|FG002|Overall Study|Adverse Event|1|||
129138594|NCT00066170|464800590|FG003|Overall Study|Adverse Event|7|||
129138595|NCT00066170|464800587|FG000|Overall Study|Serious Adverse Event|0|||
129138596|NCT00066170|464800588|FG001|Overall Study|Serious Adverse Event|0|||
129138597|NCT00066170|464800589|FG002|Overall Study|Serious Adverse Event|1|||
129138598|NCT00066170|464800590|FG003|Overall Study|Serious Adverse Event|1|||
129138599|NCT00066170|464800587|FG000|Overall Study|Lost to Follow-up|0|||
128722494|NCT03450707|463282228|FG001|Overall Study|Indication for thiamine + head CT results|1|||
128722495|NCT03450707|463282227|FG000|Overall Study|Family/patient goals of care|0|||
128722496|NCT03450707|463282228|FG001|Overall Study|Family/patient goals of care|1|||
128722497|NCT00481195|463282229|FG000|Overall Study|Adverse Event|16|||
128722498|NCT00481195|463282230|FG001|Overall Study|Adverse Event|11|||
128722499|NCT00481195|463282229|FG000|Overall Study|Lack of Efficacy|1|||
128722500|NCT00481195|463282230|FG001|Overall Study|Lack of Efficacy|3|||
128722501|NCT00481195|463282229|FG000|Overall Study|Lost to Follow-up|4|||
128722502|NCT00481195|463282230|FG001|Overall Study|Lost to Follow-up|6|||
128722503|NCT00481195|463282229|FG000|Overall Study|Physician Decision|3|||
128722504|NCT00481195|463282230|FG001|Overall Study|Physician Decision|1|||
128722505|NCT00481195|463282229|FG000|Overall Study|Protocol Violation|10|||
128722506|NCT00481195|463282230|FG001|Overall Study|Protocol Violation|7|||
128722507|NCT00481195|463282229|FG000|Overall Study|Withdrawal by Subject|3|||
129068260|NCT02906670|464536770|FG007|Cohort 5P, QW|Radiological Progression|0|||
128722508|NCT00481195|463282230|FG001|Overall Study|Withdrawal by Subject|9|||
129068261|NCT02906670|464536771|FG008|Cohort 5P, QW|Radiological Progression|0|||
129068262|NCT02906670|464536772|FG009|Cohort 5P, QW|Radiological Progression|0|||
129068263|NCT03749330|464536773|FG000|Overall Study|Clinicians left work in the CICU|0|||
129068264|NCT03749330|464536774|FG001|Overall Study|Clinicians left work in the CICU|2|||
129068265|NCT03749330|464536775|FG002|Overall Study|Clinicians left work in the CICU|0|||
129068266|NCT03749330|464536776|FG003|Overall Study|Clinicians left work in the CICU|0|||
129068267|NCT03749330|464536777|FG004|Overall Study|Clinicians left work in the CICU|0|||
129138600|NCT00066170|464800588|FG001|Overall Study|Lost to Follow-up|1|||
128722509|NCT00481195|463282229|FG000|Overall Study|Miscellaneous|2|||
128722510|NCT00481195|463282230|FG001|Overall Study|Miscellaneous|2|||
128722511|NCT03343483|463282231|FG000|Overall Study|Death|0|||
129138601|NCT00066170|464800589|FG002|Overall Study|Lost to Follow-up|0|||
129068268|NCT03749330|464536778|FG005|Overall Study|Clinicians left work in the CICU|0|||
129068269|NCT01973439|464536779|FG000|Overall Study|Lost samples from one PK Day|2|||
129068270|NCT01973439|464536779|FG000|Overall Study|Vomiting after commencing once daily|1|||
129068271|NCT01973439|464536779|FG000|Overall Study|PK curve incomplete|2|||
129068272|NCT02815995|464536780|FG000|Overall Study|Disease Progression|3|||
128722512|NCT03343483|463282232|FG001|Overall Study|Death|3|||
128722513|NCT03343483|463282231|FG000|Overall Study|Lost to Follow-up|9|||
128722514|NCT03343483|463282232|FG001|Overall Study|Lost to Follow-up|13|||
128722515|NCT03343483|463282231|FG000|Overall Study|Withdrawal by Subject|8|||
128722516|NCT03343483|463282232|FG001|Overall Study|Withdrawal by Subject|17|||
128722517|NCT01505608|463282233|FG000|Phase I|Lack of Efficacy|0|||
128722518|NCT01505608|463282234|FG001|Phase I|Lack of Efficacy|4|||
128722519|NCT01505608|463282233|FG000|Phase I|Adverse Event|0|||
128722520|NCT01505608|463282234|FG001|Phase I|Adverse Event|1|||
128722521|NCT01505608|463282233|FG000|Phase I|Withdrawal by Subject|0|||
128722522|NCT01505608|463282234|FG001|Phase I|Withdrawal by Subject|1|||
128722523|NCT01505608|463282233|FG000|Phase II|Lack of Efficacy|2|||
128722524|NCT01505608|463282234|FG001|Phase II|Lack of Efficacy|1|||
128722525|NCT01505608|463282233|FG000|Phase II|Protocol Violation|0|||
128722526|NCT01505608|463282234|FG001|Phase II|Protocol Violation|1|||
128722527|NCT01289847|463282235|FG000|Overall Study|Patient could not comply with visits|1|||
128722528|NCT03975647|463282238|FG000|Overall Study|Death|71|||
128722529|NCT03975647|463282239|FG001|Overall Study|Death|63|||
128722530|NCT03975647|463282238|FG000|Overall Study|Lost to Follow-up|2|||
128722531|NCT03975647|463282239|FG001|Overall Study|Lost to Follow-up|2|||
128722532|NCT03975647|463282238|FG000|Overall Study|Subject withdrawal of consent|7|||
128722533|NCT03975647|463282239|FG001|Overall Study|Subject withdrawal of consent|11|||
128722534|NCT02872116|463282240|FG000|Pre-Treatment|Disease Progression|0|||
128722535|NCT02872116|463282241|FG001|Pre-Treatment|Disease Progression|1|||
128722536|NCT02872116|463282242|FG002|Pre-Treatment|Disease Progression|0|||
128775955|NCT03615482|463470313|FG000|Overall Study|Lost to Follow-up|7|||
129068273|NCT02815995|464536781|FG001|Overall Study|Disease Progression|7|||
128722537|NCT02872116|463282240|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
128722538|NCT02872116|463282241|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
128722539|NCT02872116|463282242|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
128722540|NCT02872116|463282240|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
128722541|NCT02872116|463282241|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
128722542|NCT02872116|463282242|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
128722543|NCT02872116|463282240|FG000|Pre-Treatment|Participant withdrew consent|2|||
128722544|NCT02872116|463282241|FG001|Pre-Treatment|Participant withdrew consent|20|||
128722545|NCT02872116|463282242|FG002|Pre-Treatment|Participant withdrew consent|3|||
128722546|NCT02872116|463282240|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
128722547|NCT02872116|463282241|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
128722548|NCT02872116|463282242|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
128722549|NCT02872116|463282240|FG000|Pre-Treatment|Other reasons|1|||
128722550|NCT02872116|463282241|FG001|Pre-Treatment|Other reasons|2|||
128722551|NCT02872116|463282242|FG002|Pre-Treatment|Other reasons|2|||
128722552|NCT02872116|463282240|FG000|Treatment|Death|121|||
128722553|NCT02872116|463282241|FG001|Treatment|Death|94|||
128722554|NCT02872116|463282242|FG002|Treatment|Death|68|||
128722555|NCT02872116|463282240|FG000|Treatment|Lost to Follow-up|5|||
128722556|NCT02872116|463282241|FG001|Treatment|Lost to Follow-up|7|||
128722557|NCT02872116|463282242|FG002|Treatment|Lost to Follow-up|3|||
128722558|NCT02872116|463282240|FG000|Treatment|Participant withdrew consent|20|||
128722559|NCT02872116|463282241|FG001|Treatment|Participant withdrew consent|40|||
128722560|NCT02872116|463282242|FG002|Treatment|Participant withdrew consent|8|||
128722561|NCT02872116|463282240|FG000|Treatment|Other reasons|13|||
128722562|NCT02872116|463282241|FG001|Treatment|Other reasons|12|||
128722563|NCT02872116|463282242|FG002|Treatment|Other reasons|5|||
128722564|NCT02404350|463282247|FG000|Overall Study|Adverse Event|2|||
128722565|NCT02404350|463282248|FG001|Overall Study|Adverse Event|2|||
128722566|NCT02404350|463282249|FG002|Overall Study|Adverse Event|3|||
128722567|NCT02404350|463282250|FG003|Overall Study|Adverse Event|9|||
128722568|NCT02404350|463282247|FG000|Overall Study|Lack of Efficacy|3|||
128722569|NCT02404350|463282248|FG001|Overall Study|Lack of Efficacy|1|||
128722570|NCT02404350|463282249|FG002|Overall Study|Lack of Efficacy|0|||
128722571|NCT02404350|463282250|FG003|Overall Study|Lack of Efficacy|3|||
128722572|NCT02404350|463282247|FG000|Overall Study|Lost to Follow-up|2|||
128722573|NCT02404350|463282248|FG001|Overall Study|Lost to Follow-up|0|||
128722574|NCT02404350|463282249|FG002|Overall Study|Lost to Follow-up|0|||
128722575|NCT02404350|463282250|FG003|Overall Study|Lost to Follow-up|1|||
128722576|NCT02404350|463282247|FG000|Overall Study|Physician Decision|1|||
128722577|NCT02404350|463282248|FG001|Overall Study|Physician Decision|0|||
128722578|NCT02404350|463282249|FG002|Overall Study|Physician Decision|0|||
128722579|NCT02404350|463282250|FG003|Overall Study|Physician Decision|2|||
128722580|NCT02404350|463282247|FG000|Overall Study|Pregnancy|0|||
128722581|NCT02404350|463282248|FG001|Overall Study|Pregnancy|0|||
128722582|NCT02404350|463282249|FG002|Overall Study|Pregnancy|0|||
128722583|NCT02404350|463282250|FG003|Overall Study|Pregnancy|1|||
128722584|NCT02404350|463282247|FG000|Overall Study|Withdrawal by Subject|7|||
129138602|NCT00066170|464800590|FG003|Overall Study|Lost to Follow-up|0|||
129138603|NCT00066170|464800587|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
129138604|NCT00066170|464800588|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
129138605|NCT00066170|464800589|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
129138606|NCT00066170|464800590|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
129138607|NCT00066170|464800587|FG000|Overall Study|Protocol Violation|3|||
129138608|NCT00066170|464800588|FG001|Overall Study|Protocol Violation|0|||
129138609|NCT00066170|464800589|FG002|Overall Study|Protocol Violation|0|||
129138610|NCT00066170|464800590|FG003|Overall Study|Protocol Violation|0|||
129138611|NCT00066170|464800587|FG000|Overall Study|Other|1|||
129138612|NCT00066170|464800588|FG001|Overall Study|Other|5|||
129138613|NCT00066170|464800589|FG002|Overall Study|Other|2|||
129138614|NCT00066170|464800590|FG003|Overall Study|Other|0|||
129138615|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Adverse Event|14|||
129138616|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Adverse Event|27|||
129138617|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Adverse Event|60|||
129138618|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Adverse Event|0|||
129138619|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Adverse Event|0|||
129138620|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Pregnancy|0|||
129138621|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Pregnancy|7|||
129138622|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Pregnancy|9|||
129138623|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Pregnancy|0|||
129138624|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Pregnancy|0|||
129138625|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
129138626|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
129138627|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
129138628|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
129138629|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
129138630|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
129138631|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
129138632|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
129138633|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
129138634|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
129138635|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Death|1|||
129138636|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Death|2|||
129138637|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Death|2|||
129138638|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Death|0|||
129138639|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Death|0|||
129138640|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
129138641|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
129138642|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
129138643|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
128722585|NCT02404350|463282248|FG001|Overall Study|Withdrawal by Subject|3|||
128722586|NCT02404350|463282249|FG002|Overall Study|Withdrawal by Subject|3|||
128722587|NCT02404350|463282250|FG003|Overall Study|Withdrawal by Subject|19|||
128722588|NCT02404350|463282247|FG000|Overall Study|Due to Non-compliance with treatment|0|||
128722589|NCT02404350|463282248|FG001|Overall Study|Due to Non-compliance with treatment|0|||
128722590|NCT02404350|463282249|FG002|Overall Study|Due to Non-compliance with treatment|0|||
128722591|NCT02404350|463282250|FG003|Overall Study|Due to Non-compliance with treatment|1|||
128722592|NCT02404350|463282247|FG000|Overall Study|Due to Technical problems|0|||
128722593|NCT02404350|463282248|FG001|Overall Study|Due to Technical problems|0|||
128722594|NCT02404350|463282249|FG002|Overall Study|Due to Technical problems|0|||
128722595|NCT02404350|463282250|FG003|Overall Study|Due to Technical problems|1|||
128722596|NCT01324388|463282251|FG000|Part 1 of Study|Adverse Event|2|||
128722597|NCT01324388|463282252|FG001|Part 1 of Study|Adverse Event|0|||
128722598|NCT01324388|463282253|FG002|Part 1 of Study|Adverse Event|0|||
128722599|NCT01324388|463282254|FG003|Part 1 of Study|Adverse Event|0|||
128722600|NCT01324388|463282251|FG000|Part 1 of Study|Protocol Violation|1|||
128722601|NCT01324388|463282252|FG001|Part 1 of Study|Protocol Violation|2|||
128722602|NCT01324388|463282253|FG002|Part 1 of Study|Protocol Violation|0|||
128722603|NCT01324388|463282254|FG003|Part 1 of Study|Protocol Violation|0|||
128722604|NCT01324388|463282251|FG000|Part 1 of Study|Physician Decision|1|||
128722605|NCT01324388|463282252|FG001|Part 1 of Study|Physician Decision|0|||
128722606|NCT01324388|463282253|FG002|Part 1 of Study|Physician Decision|0|||
128722607|NCT01324388|463282254|FG003|Part 1 of Study|Physician Decision|0|||
128722608|NCT01324388|463282251|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
128722609|NCT01324388|463282252|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
128722610|NCT01324388|463282253|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
128775956|NCT03615482|463470314|FG001|Overall Study|Lost to Follow-up|7|||
129138644|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
129138645|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
129138646|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
129138647|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
129138648|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
129138649|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
128775957|NCT03615482|463470313|FG000|Overall Study|Physician Decision|2|||
128775958|NCT03615482|463470314|FG001|Overall Study|Physician Decision|3|||
128775959|NCT03615482|463470313|FG000|Overall Study|Withdrawal by Subject|7|||
128775960|NCT03615482|463470314|FG001|Overall Study|Withdrawal by Subject|7|||
128775961|NCT01500226|463470317|FG000|Overall Study|Adverse Event|31|||
128775962|NCT01500226|463470318|FG001|Overall Study|Adverse Event|38|||
128775963|NCT01500226|463470317|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
128775964|NCT01500226|463470318|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
128775965|NCT01500226|463470317|FG000|Overall Study|Withdrawal by Subject|93|||
128775966|NCT01500226|463470318|FG001|Overall Study|Withdrawal by Subject|96|||
128775967|NCT01500226|463470317|FG000|Overall Study|Death|12|||
128775968|NCT01500226|463470318|FG001|Overall Study|Death|4|||
128775969|NCT01500226|463470317|FG000|Overall Study|Disease Progression|16|||
128775970|NCT01500226|463470318|FG001|Overall Study|Disease Progression|14|||
128775971|NCT01500226|463470317|FG000|Overall Study|Protocol Violation|53|||
128775972|NCT01500226|463470318|FG001|Overall Study|Protocol Violation|39|||
128775973|NCT01500226|463470317|FG000|Overall Study|Physician Decision|17|||
128775974|NCT01500226|463470318|FG001|Overall Study|Physician Decision|15|||
128775975|NCT01500226|463470317|FG000|Overall Study|Lack of Efficacy|14|||
128775976|NCT01500226|463470318|FG001|Overall Study|Lack of Efficacy|30|||
128775977|NCT01500226|463470317|FG000|Overall Study|Lost to Follow-up|9|||
128775978|NCT01500226|463470318|FG001|Overall Study|Lost to Follow-up|5|||
128775979|NCT01500226|463470317|FG000|Overall Study|Other Reasons|19|||
128775980|NCT01500226|463470318|FG001|Overall Study|Other Reasons|16|||
129138650|NCT00098293|464800591|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
129138651|NCT00098293|464800592|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
129138652|NCT00098293|464800593|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
129138653|NCT00098293|464800594|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
129138654|NCT00098293|464800595|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
128775981|NCT04212169|463470319|FG000|Overall Study|Adverse Event|0|||
128775982|NCT04212169|463470320|FG001|Overall Study|Adverse Event|0|||
128775983|NCT04212169|463470321|FG002|Overall Study|Adverse Event|0|||
128775984|NCT04212169|463470322|FG003|Overall Study|Adverse Event|2|||
128775985|NCT04212169|463470319|FG000|Overall Study|Lost to Follow-up|1|||
128775986|NCT04212169|463470320|FG001|Overall Study|Lost to Follow-up|0|||
128775987|NCT04212169|463470321|FG002|Overall Study|Lost to Follow-up|0|||
128775988|NCT04212169|463470322|FG003|Overall Study|Lost to Follow-up|2|||
128775989|NCT04212169|463470319|FG000|Overall Study|Withdrawal by Subject|10|||
128775990|NCT04212169|463470320|FG001|Overall Study|Withdrawal by Subject|2|||
128775991|NCT04212169|463470321|FG002|Overall Study|Withdrawal by Subject|5|||
128775992|NCT04212169|463470322|FG003|Overall Study|Withdrawal by Subject|7|||
128775993|NCT04212169|463470319|FG000|Overall Study|Other reason, unspecified|3|||
128775994|NCT04212169|463470320|FG001|Overall Study|Other reason, unspecified|1|||
128775995|NCT04212169|463470321|FG002|Overall Study|Other reason, unspecified|0|||
128775996|NCT04212169|463470322|FG003|Overall Study|Other reason, unspecified|2|||
128775997|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
128775998|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
128775999|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
128776000|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
128776001|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
128776002|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
128776003|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
128776004|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
128776005|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
128776006|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
128776007|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129068274|NCT02815995|464536782|FG002|Overall Study|Disease Progression|2|||
129068275|NCT02815995|464536783|FG003|Overall Study|Disease Progression|4|||
129068276|NCT02815995|464536784|FG004|Overall Study|Disease Progression|3|||
129068277|NCT02815995|464536785|FG005|Overall Study|Disease Progression|9|||
129068278|NCT02815995|464536786|FG006|Overall Study|Disease Progression|3|||
129068279|NCT02815995|464536787|FG007|Overall Study|Disease Progression|1|||
129068280|NCT02815995|464536780|FG000|Overall Study|Adverse Event|1|||
129068281|NCT02815995|464536781|FG001|Overall Study|Adverse Event|2|||
129138655|NCT00098293|464800591|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129138656|NCT00098293|464800592|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129138657|NCT00098293|464800593|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
128776008|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
128776009|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
128776010|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
128776011|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
129068282|NCT02815995|464536782|FG002|Overall Study|Adverse Event|2|||
129068283|NCT02815995|464536783|FG003|Overall Study|Adverse Event|0|||
129138658|NCT00098293|464800594|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129068284|NCT02815995|464536784|FG004|Overall Study|Adverse Event|0|||
129068285|NCT02815995|464536785|FG005|Overall Study|Adverse Event|1|||
129068286|NCT02815995|464536786|FG006|Overall Study|Adverse Event|0|||
129068287|NCT02815995|464536787|FG007|Overall Study|Adverse Event|0|||
129068288|NCT02815995|464536780|FG000|Overall Study|Pregnancy|0|||
129068289|NCT02815995|464536781|FG001|Overall Study|Pregnancy|0|||
129068290|NCT02815995|464536782|FG002|Overall Study|Pregnancy|0|||
129068291|NCT02815995|464536783|FG003|Overall Study|Pregnancy|0|||
129068292|NCT02815995|464536784|FG004|Overall Study|Pregnancy|0|||
129068293|NCT02815995|464536785|FG005|Overall Study|Pregnancy|0|||
129068294|NCT02815995|464536786|FG006|Overall Study|Pregnancy|1|||
129068295|NCT02815995|464536787|FG007|Overall Study|Pregnancy|0|||
129068296|NCT01269918|464536790|FG000|Overall Study|Did not receive study drug|0|||
129068297|NCT01269918|464536791|FG001|Overall Study|Did not receive study drug|3|||
129068298|NCT03571828|464536792|FG000|Overall Study|Withdrawal by Subject|1|||
129068299|NCT03571828|464536793|FG001|Overall Study|Withdrawal by Subject|0|||
129068300|NCT03571828|464536792|FG000|Overall Study|Decision by sponsor|5|||
129068301|NCT03571828|464536793|FG001|Overall Study|Decision by sponsor|1|||
128776012|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
128776013|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129068302|NCT03571828|464536792|FG000|Overall Study|Death|2|||
129068303|NCT03571828|464536793|FG001|Overall Study|Death|0|||
129068304|NCT00769379|464536794|FG000|Overall Study|No follow up data mapped to Other.|3|||
129068305|NCT00769379|464536795|FG001|Overall Study|No follow up data mapped to Other.|13|||
129068306|NCT01928472|464536796|FG000|Overall Study|Death|0|||
129068307|NCT01928472|464536797|FG001|Overall Study|Death|0|||
129068308|NCT01928472|464536798|FG002|Overall Study|Death|1|||
129068309|NCT01928472|464536799|FG003|Overall Study|Death|0|||
129068310|NCT01928472|464536796|FG000|Overall Study|Withdrawal by Subject|4|||
129068311|NCT01928472|464536797|FG001|Overall Study|Withdrawal by Subject|4|||
129068312|NCT01928472|464536798|FG002|Overall Study|Withdrawal by Subject|1|||
129068313|NCT01928472|464536799|FG003|Overall Study|Withdrawal by Subject|2|||
129068314|NCT01928472|464536796|FG000|Overall Study|Lost to Follow-up|2|||
129068315|NCT01928472|464536797|FG001|Overall Study|Lost to Follow-up|3|||
129068316|NCT01928472|464536798|FG002|Overall Study|Lost to Follow-up|4|||
129068317|NCT01928472|464536799|FG003|Overall Study|Lost to Follow-up|0|||
129068318|NCT01928472|464536796|FG000|Overall Study|Administrative Reason|2|||
129068319|NCT01928472|464536797|FG001|Overall Study|Administrative Reason|1|||
129068320|NCT01928472|464536798|FG002|Overall Study|Administrative Reason|0|||
129068321|NCT01928472|464536799|FG003|Overall Study|Administrative Reason|0|||
129068322|NCT01928472|464536796|FG000|Overall Study|Unclassified|0|||
129068323|NCT01928472|464536797|FG001|Overall Study|Unclassified|0|||
129068324|NCT01928472|464536798|FG002|Overall Study|Unclassified|1|||
129068325|NCT01928472|464536799|FG003|Overall Study|Unclassified|0|||
129068326|NCT01308424|464536800|FG000|Baseline Eligibility|Screen Failures|71|||
129068327|NCT01308424|464536801|FG001|Baseline Eligibility|Screen Failures|0|||
129068328|NCT01308424|464536802|FG002|Baseline Eligibility|Screen Failures|0|||
129068329|NCT01308424|464536800|FG000|Randomization|Adverse Event|0|||
129068330|NCT01308424|464536801|FG001|Randomization|Adverse Event|1|||
129068331|NCT01308424|464536802|FG002|Randomization|Adverse Event|1|||
129068332|NCT01308424|464536800|FG000|Randomization|Lost to Follow-up|0|||
129068333|NCT01308424|464536801|FG001|Randomization|Lost to Follow-up|1|||
129068334|NCT01308424|464536802|FG002|Randomization|Lost to Follow-up|0|||
129068335|NCT01308424|464536800|FG000|Randomization|Physician Decision|0|||
129068336|NCT01308424|464536801|FG001|Randomization|Physician Decision|1|||
129068337|NCT01308424|464536802|FG002|Randomization|Physician Decision|1|||
129068338|NCT04471428|464536806|FG000|Overall Study|Withdrawal by Subject|29|||
129068339|NCT04471428|464536807|FG001|Overall Study|Withdrawal by Subject|1|||
129138659|NCT00098293|464800595|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129138660|NCT00098293|464800591|FG000|Open-label (OL) Phase|Adverse Event|0|||
129138661|NCT00098293|464800592|FG001|Open-label (OL) Phase|Adverse Event|3|||
129138662|NCT00098293|464800593|FG002|Open-label (OL) Phase|Adverse Event|7|||
129138663|NCT00098293|464800594|FG003|Open-label (OL) Phase|Adverse Event|6|||
129138664|NCT00098293|464800595|FG004|Open-label (OL) Phase|Adverse Event|0|||
129138665|NCT00098293|464800591|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
129138666|NCT00098293|464800592|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
129138667|NCT00098293|464800593|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
129138668|NCT00098293|464800594|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
129068340|NCT04471428|464536806|FG000|Overall Study|Physician Decision|0|||
129068341|NCT04471428|464536807|FG001|Overall Study|Physician Decision|1|||
129068342|NCT04471428|464536806|FG000|Overall Study|Reason Not Specified|0|||
129068343|NCT04471428|464536807|FG001|Overall Study|Reason Not Specified|2|||
129068344|NCT04471428|464536806|FG000|Overall Study|Death|106|||
129068345|NCT04471428|464536807|FG001|Overall Study|Death|114|||
129068346|NCT04471428|464536806|FG000|Overall Study|Ongoing in the study|45|||
129068347|NCT04471428|464536807|FG001|Overall Study|Ongoing in the study|68|||
129068348|NCT00129545|464536810|FG000|Overall Study|Death|5|||
129068349|NCT00129545|464536811|FG001|Overall Study|Death|60|||
129138669|NCT00098293|464800595|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
128776014|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
128776015|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
128776016|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
128776017|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
128776018|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
128776019|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
128776020|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
128776021|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
128776022|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
128776023|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
128776024|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
128776025|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
128776026|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
128776027|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
128776028|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
128776029|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
128776030|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
128776031|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
128776032|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
128776033|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
128776034|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
128776035|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
128776036|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
128776037|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776038|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776039|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
128776040|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
128776041|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776042|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776043|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776044|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776045|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776046|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
128776047|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776048|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129138670|NCT00098293|464800591|FG000|Open-label (OL) Phase|Pregnancy|0|||
129138671|NCT00098293|464800592|FG001|Open-label (OL) Phase|Pregnancy|1|||
129138672|NCT00098293|464800593|FG002|Open-label (OL) Phase|Pregnancy|0|||
129138673|NCT00098293|464800594|FG003|Open-label (OL) Phase|Pregnancy|3|||
129138674|NCT00098293|464800595|FG004|Open-label (OL) Phase|Pregnancy|0|||
129138675|NCT00098293|464800591|FG000|Open-label (OL) Phase|Protocol Violation|0|||
129138676|NCT00098293|464800592|FG001|Open-label (OL) Phase|Protocol Violation|6|||
129138677|NCT00098293|464800593|FG002|Open-label (OL) Phase|Protocol Violation|13|||
128776049|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776050|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776051|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
128776052|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776053|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776054|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776055|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776056|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
128776057|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
128776058|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
128776059|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
128776060|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
128776061|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
128776062|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
128776063|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
128776064|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
128776065|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
128776066|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129138678|NCT00098293|464800594|FG003|Open-label (OL) Phase|Protocol Violation|16|||
129138679|NCT00098293|464800595|FG004|Open-label (OL) Phase|Protocol Violation|0|||
129138680|NCT00098293|464800591|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
129138681|NCT00098293|464800592|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
129068350|NCT00129545|464536812|FG002|Overall Study|Death|44|||
129068351|NCT00129545|464536810|FG000|Overall Study|Withdrawal by Subject|3|||
129068352|NCT00129545|464536811|FG001|Overall Study|Withdrawal by Subject|18|||
129068353|NCT00129545|464536812|FG002|Overall Study|Withdrawal by Subject|44|||
129068354|NCT00129545|464536810|FG000|Overall Study|Lost to Follow-up|2|||
129068355|NCT00129545|464536811|FG001|Overall Study|Lost to Follow-up|22|||
129068356|NCT00129545|464536812|FG002|Overall Study|Lost to Follow-up|13|||
129068357|NCT00129545|464536810|FG000|Overall Study|Physician Decision|0|||
129068358|NCT00129545|464536811|FG001|Overall Study|Physician Decision|3|||
129068359|NCT00129545|464536812|FG002|Overall Study|Physician Decision|10|||
129068360|NCT00129545|464536810|FG000|Overall Study|Device not implanted|16|||
129068361|NCT00129545|464536811|FG001|Overall Study|Device not implanted|61|||
129068362|NCT00129545|464536812|FG002|Overall Study|Device not implanted|0|||
129068363|NCT01841593|464536813|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
129068364|NCT01841593|464536814|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
129068365|NCT01841593|464536813|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
129068366|NCT01841593|464536814|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
129068367|NCT00307086|464536815|FG000|Overall Study|ineligible|5|||
129068368|NCT01870778|464536819|FG000|Overall Study|Withdrawal by Subject|8|||
129068369|NCT01870778|464536820|FG001|Overall Study|Withdrawal by Subject|7|||
129068370|NCT01870778|464536819|FG000|Overall Study|Lost to Follow-up|0|||
129068371|NCT01870778|464536820|FG001|Overall Study|Lost to Follow-up|2|||
128722611|NCT01324388|463282254|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
129068372|NCT00312338|464536821|FG000|Overall Study|Adverse Event|7|||
129068373|NCT00312338|464536822|FG001|Overall Study|Adverse Event|2|||
129068374|NCT00312338|464536821|FG000|Overall Study|Lost to Follow-up|9|||
129068375|NCT00312338|464536822|FG001|Overall Study|Lost to Follow-up|1|||
129068376|NCT00312338|464536821|FG000|Overall Study|Withdrawal by Subject|4|||
129068377|NCT00312338|464536822|FG001|Overall Study|Withdrawal by Subject|0|||
129068378|NCT00312338|464536821|FG000|Overall Study|Subsequent infection|2|||
129068379|NCT00312338|464536822|FG001|Overall Study|Subsequent infection|0|||
128722612|NCT01324388|463282251|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
129068380|NCT00262028|464536823|FG000|Overall Study|Withdrawal by Subject|6|||
129068381|NCT00262028|464536824|FG001|Overall Study|Withdrawal by Subject|3|||
129068382|NCT00262028|464536825|FG002|Overall Study|Withdrawal by Subject|6|||
129068383|NCT00262028|464536826|FG003|Overall Study|Withdrawal by Subject|5|||
129068384|NCT00262028|464536827|FG004|Overall Study|Withdrawal by Subject|2|||
129068385|NCT00262028|464536828|FG005|Overall Study|Withdrawal by Subject|3|||
129068386|NCT00262028|464536829|FG006|Overall Study|Withdrawal by Subject|5|||
128722613|NCT01324388|463282252|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
128722614|NCT01324388|463282253|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
128722615|NCT01324388|463282254|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
128722616|NCT01498640|463282255|FG000|Overall Study|Lost to Follow-up|1|||
128722617|NCT01498640|463282255|FG000|Overall Study|Death|1|||
128722618|NCT01498640|463282255|FG000|Overall Study|Other|3|||
128722619|NCT01524692|463282260|FG000|Overall Study|Withdrawal by Subject|3|||
128722620|NCT04007523|463282262|FG000|Overall Study|Withdrawal by Subject|0|||
128722621|NCT04007523|463282263|FG001|Overall Study|Withdrawal by Subject|1|||
128722622|NCT04007523|463282264|FG002|Overall Study|Withdrawal by Subject|1|||
128722623|NCT04007523|463282265|FG003|Overall Study|Withdrawal by Subject|0|||
128722624|NCT04007523|463282262|FG000|Overall Study|ICU Transfer|0|||
128722625|NCT04007523|463282263|FG001|Overall Study|ICU Transfer|1|||
128722626|NCT04007523|463282264|FG002|Overall Study|ICU Transfer|0|||
128722627|NCT04007523|463282265|FG003|Overall Study|ICU Transfer|0|||
128722628|NCT04007523|463282262|FG000|Overall Study|COVID hospital closure|0|||
128722629|NCT04007523|463282263|FG001|Overall Study|COVID hospital closure|0|||
128722630|NCT04007523|463282264|FG002|Overall Study|COVID hospital closure|1|||
128722631|NCT04007523|463282265|FG003|Overall Study|COVID hospital closure|2|||
128722632|NCT04007523|463282262|FG000|Overall Study|Surgery cancelled|0|||
128722633|NCT04007523|463282263|FG001|Overall Study|Surgery cancelled|0|||
128722634|NCT04007523|463282264|FG002|Overall Study|Surgery cancelled|1|||
128722635|NCT04007523|463282265|FG003|Overall Study|Surgery cancelled|1|||
128722636|NCT02197806|463282266|FG000|Overall Study|Adverse Event|0|||
128722637|NCT02197806|463282267|FG001|Overall Study|Adverse Event|1|||
128722638|NCT02197806|463282268|FG002|Overall Study|Adverse Event|0|||
128722639|NCT02197806|463282269|FG003|Overall Study|Adverse Event|1|||
128722640|NCT01894152|463282277|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
129068387|NCT00262028|464536830|FG007|Overall Study|Withdrawal by Subject|7|||
129068388|NCT00262028|464536831|FG008|Overall Study|Withdrawal by Subject|2|||
129068389|NCT00262028|464536823|FG000|Overall Study|Lost to Follow-up|7|||
129068390|NCT00262028|464536824|FG001|Overall Study|Lost to Follow-up|7|||
129068391|NCT00262028|464536825|FG002|Overall Study|Lost to Follow-up|5|||
129068392|NCT00262028|464536826|FG003|Overall Study|Lost to Follow-up|5|||
129068393|NCT00262028|464536827|FG004|Overall Study|Lost to Follow-up|4|||
129068394|NCT00262028|464536828|FG005|Overall Study|Lost to Follow-up|3|||
129068395|NCT00262028|464536829|FG006|Overall Study|Lost to Follow-up|3|||
129068396|NCT00262028|464536830|FG007|Overall Study|Lost to Follow-up|5|||
129068397|NCT00262028|464536831|FG008|Overall Study|Lost to Follow-up|6|||
129068398|NCT00262028|464536823|FG000|Overall Study|Administrative Reason|11|||
129068399|NCT00262028|464536824|FG001|Overall Study|Administrative Reason|14|||
129068400|NCT00262028|464536825|FG002|Overall Study|Administrative Reason|9|||
129068401|NCT00262028|464536826|FG003|Overall Study|Administrative Reason|12|||
129068402|NCT00262028|464536827|FG004|Overall Study|Administrative Reason|6|||
129068403|NCT00262028|464536828|FG005|Overall Study|Administrative Reason|7|||
129068404|NCT00262028|464536829|FG006|Overall Study|Administrative Reason|4|||
129068405|NCT00262028|464536830|FG007|Overall Study|Administrative Reason|6|||
129068406|NCT00262028|464536831|FG008|Overall Study|Administrative Reason|10|||
129068407|NCT00262028|464536823|FG000|Overall Study|Protocol Violation|0|||
129068408|NCT00262028|464536824|FG001|Overall Study|Protocol Violation|0|||
129068409|NCT00262028|464536825|FG002|Overall Study|Protocol Violation|0|||
129068410|NCT00262028|464536826|FG003|Overall Study|Protocol Violation|1|||
129068411|NCT00262028|464536827|FG004|Overall Study|Protocol Violation|0|||
129068412|NCT00262028|464536828|FG005|Overall Study|Protocol Violation|0|||
129068413|NCT00262028|464536829|FG006|Overall Study|Protocol Violation|0|||
129068414|NCT00262028|464536830|FG007|Overall Study|Protocol Violation|0|||
129068415|NCT00262028|464536831|FG008|Overall Study|Protocol Violation|0|||
129068416|NCT00262028|464536823|FG000|Overall Study|Unable to classify|0|||
129068417|NCT00262028|464536824|FG001|Overall Study|Unable to classify|3|||
129068418|NCT00262028|464536825|FG002|Overall Study|Unable to classify|0|||
129068419|NCT00262028|464536826|FG003|Overall Study|Unable to classify|0|||
129068420|NCT00262028|464536827|FG004|Overall Study|Unable to classify|0|||
129068421|NCT00262028|464536828|FG005|Overall Study|Unable to classify|0|||
129068422|NCT00262028|464536829|FG006|Overall Study|Unable to classify|0|||
129138682|NCT00098293|464800593|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
129138683|NCT00098293|464800594|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
129138684|NCT00098293|464800595|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
129138685|NCT00098293|464800591|FG000|Open-label (OL) Phase|Death|0|||
129138686|NCT00098293|464800592|FG001|Open-label (OL) Phase|Death|2|||
129138687|NCT00098293|464800593|FG002|Open-label (OL) Phase|Death|3|||
128722641|NCT00075582|463282278|FG000|Overall Study|Adverse Event|3|||
128722642|NCT00075582|463282279|FG001|Overall Study|Adverse Event|1|||
128722643|NCT00075582|463282278|FG000|Overall Study|Lack of Efficacy|4|||
128722644|NCT00075582|463282279|FG001|Overall Study|Lack of Efficacy|8|||
128722645|NCT00075582|463282278|FG000|Overall Study|Physician Decision|5|||
128722646|NCT00075582|463282279|FG001|Overall Study|Physician Decision|8|||
128722647|NCT00075582|463282278|FG000|Overall Study|Withdrawal by Subject|2|||
128722648|NCT00075582|463282279|FG001|Overall Study|Withdrawal by Subject|2|||
128722649|NCT00075582|463282278|FG000|Overall Study|Ineligible for study|36|||
128722650|NCT00075582|463282279|FG001|Overall Study|Ineligible for study|16|||
128722651|NCT02268812|463282280|FG000|Overall Study|Adverse Event|8|||
128722652|NCT02268812|463282281|FG001|Overall Study|Adverse Event|26|||
128722653|NCT02268812|463282282|FG002|Overall Study|Adverse Event|7|||
128722654|NCT02268812|463282283|FG003|Overall Study|Adverse Event|10|||
128722655|NCT02268812|463282280|FG000|Overall Study|Protocol deviation|0|||
128722656|NCT02268812|463282281|FG001|Overall Study|Protocol deviation|0|||
128722657|NCT02268812|463282282|FG002|Overall Study|Protocol deviation|1|||
128722658|NCT02268812|463282283|FG003|Overall Study|Protocol deviation|0|||
128722659|NCT02268812|463282280|FG000|Overall Study|Withdrawal by Subject|0|||
128722660|NCT02268812|463282281|FG001|Overall Study|Withdrawal by Subject|1|||
128722661|NCT02268812|463282282|FG002|Overall Study|Withdrawal by Subject|0|||
128722662|NCT02268812|463282283|FG003|Overall Study|Withdrawal by Subject|0|||
128722663|NCT02268812|463282280|FG000|Overall Study|Physician Decision|3|||
128722664|NCT02268812|463282281|FG001|Overall Study|Physician Decision|1|||
128722665|NCT02268812|463282282|FG002|Overall Study|Physician Decision|0|||
128722666|NCT02268812|463282283|FG003|Overall Study|Physician Decision|1|||
128722667|NCT02268812|463282280|FG000|Overall Study|Other|5|||
128722668|NCT02268812|463282281|FG001|Overall Study|Other|4|||
129138688|NCT00098293|464800594|FG003|Open-label (OL) Phase|Death|0|||
128722669|NCT02268812|463282282|FG002|Overall Study|Other|1|||
128722670|NCT02268812|463282283|FG003|Overall Study|Other|3|||
128722671|NCT05045144|463282284|FG000|Overall Study|Lost to Follow-up|3|||
128722672|NCT05045144|463282285|FG001|Overall Study|Lost to Follow-up|2|||
128722673|NCT05045144|463282286|FG002|Overall Study|Lost to Follow-up|3|||
128722674|NCT05045144|463282287|FG003|Overall Study|Lost to Follow-up|5|||
128722675|NCT05045144|463282288|FG004|Overall Study|Lost to Follow-up|13|||
128722676|NCT05045144|463282284|FG000|Overall Study|Withdrawal by Subject|0|||
129068423|NCT00262028|464536830|FG007|Overall Study|Unable to classify|0|||
129068424|NCT00262028|464536831|FG008|Overall Study|Unable to classify|1|||
129068425|NCT02308124|464536832|FG000|Overall Study|Lost to Follow-up|6|||
129068426|NCT02308124|464536833|FG001|Overall Study|Lost to Follow-up|6|||
129068427|NCT02308124|464536834|FG002|Overall Study|Lost to Follow-up|6|||
129068428|NCT02308124|464536832|FG000|Overall Study|Adverse Event|0|||
129068429|NCT02308124|464536833|FG001|Overall Study|Adverse Event|2|||
128722677|NCT05045144|463282285|FG001|Overall Study|Withdrawal by Subject|1|||
128722678|NCT05045144|463282286|FG002|Overall Study|Withdrawal by Subject|0|||
129068430|NCT02308124|464536834|FG002|Overall Study|Adverse Event|2|||
128722679|NCT05045144|463282287|FG003|Overall Study|Withdrawal by Subject|0|||
128722680|NCT05045144|463282288|FG004|Overall Study|Withdrawal by Subject|0|||
128722681|NCT05045144|463282284|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128722682|NCT05045144|463282285|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128722683|NCT05045144|463282286|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
128722684|NCT05045144|463282287|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128722685|NCT05045144|463282288|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128722686|NCT00744627|463282289|FG000|Overall Study|Adverse Event|6|||
128722687|NCT00744627|463282290|FG001|Overall Study|Adverse Event|9|||
128722688|NCT00744627|463282289|FG000|Overall Study|Lack of Efficacy|7|||
128722689|NCT00744627|463282290|FG001|Overall Study|Lack of Efficacy|3|||
128722690|NCT00744627|463282289|FG000|Overall Study|Noncompliance|0|||
128722691|NCT00744627|463282290|FG001|Overall Study|Noncompliance|1|||
128722692|NCT00744627|463282289|FG000|Overall Study|Protocol Deviations|0|||
128722693|NCT00744627|463282290|FG001|Overall Study|Protocol Deviations|2|||
128722694|NCT00744627|463282289|FG000|Overall Study|Voluntary Withdrawal|9|||
128722695|NCT00744627|463282290|FG001|Overall Study|Voluntary Withdrawal|6|||
128722696|NCT00744627|463282289|FG000|Overall Study|Lost to Follow-up|2|||
128722697|NCT00744627|463282290|FG001|Overall Study|Lost to Follow-up|1|||
128722698|NCT00744627|463282289|FG000|Overall Study|Other|1|||
128722699|NCT00744627|463282290|FG001|Overall Study|Other|0|||
128722700|NCT00768144|463282291|FG000|Overall Study|Adverse Event|13|||
128722701|NCT00768144|463282291|FG000|Overall Study|Progressive Disease|21|||
128722702|NCT00768144|463282291|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
128722703|NCT00768144|463282291|FG000|Overall Study|Pt Withdrew Consent|1|||
128722704|NCT04251221|463282292|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
128722705|NCT04251221|463282293|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
128722706|NCT02171260|463282294|FG000|Overall Study|Death|0|||
128722707|NCT02171260|463282295|FG001|Overall Study|Death|0|||
128722708|NCT02171260|463282296|FG002|Overall Study|Death|0|||
128722709|NCT02171260|463282297|FG003|Overall Study|Death|1|||
128722710|NCT02171260|463282294|FG000|Overall Study|Physician Decision|1|||
128722711|NCT02171260|463282295|FG001|Overall Study|Physician Decision|0|||
128722712|NCT02171260|463282296|FG002|Overall Study|Physician Decision|1|||
128722713|NCT02171260|463282297|FG003|Overall Study|Physician Decision|0|||
128722714|NCT02171260|463282294|FG000|Overall Study|Withdrawal by Subject|1|||
128722715|NCT02171260|463282295|FG001|Overall Study|Withdrawal by Subject|0|||
128722716|NCT02171260|463282296|FG002|Overall Study|Withdrawal by Subject|0|||
128722717|NCT02171260|463282297|FG003|Overall Study|Withdrawal by Subject|0|||
128722718|NCT02171260|463282294|FG000|Overall Study|Evidence of progressive disease|4|||
128722719|NCT02171260|463282295|FG001|Overall Study|Evidence of progressive disease|6|||
128722720|NCT02171260|463282296|FG002|Overall Study|Evidence of progressive disease|4|||
128722721|NCT02171260|463282297|FG003|Overall Study|Evidence of progressive disease|4|||
128722722|NCT00323492|463282298|FG000|Study Phase 1|Adverse Event|2|||
128722723|NCT00323492|463282299|FG001|Study Phase 1|Adverse Event|0|||
128722724|NCT00323492|463282300|FG002|Study Phase 1|Adverse Event|0|||
128722725|NCT00323492|463282298|FG000|Study Phase 2|Adverse Event|1|||
128722726|NCT00323492|463282299|FG001|Study Phase 2|Adverse Event|0|||
128722727|NCT00323492|463282300|FG002|Study Phase 2|Adverse Event|0|||
128722728|NCT00323492|463282298|FG000|Study Phase 2|Physician Decision|1|||
128722729|NCT00323492|463282299|FG001|Study Phase 2|Physician Decision|0|||
128722730|NCT00323492|463282300|FG002|Study Phase 2|Physician Decision|0|||
128722731|NCT00323492|463282298|FG000|Study Phase 2|Lost to Follow-up|1|||
128722732|NCT00323492|463282299|FG001|Study Phase 2|Lost to Follow-up|0|||
128722733|NCT00323492|463282300|FG002|Study Phase 2|Lost to Follow-up|0|||
128722734|NCT00323492|463282298|FG000|Study Phase 2|Withdrawal by Subject|0|||
128722735|NCT00323492|463282299|FG001|Study Phase 2|Withdrawal by Subject|1|||
128722736|NCT00323492|463282300|FG002|Study Phase 2|Withdrawal by Subject|0|||
128722737|NCT00323492|463282298|FG000|Study Phase 2|Noncompliance with study schedule|0|||
128722738|NCT00323492|463282299|FG001|Study Phase 2|Noncompliance with study schedule|0|||
128722739|NCT00323492|463282300|FG002|Study Phase 2|Noncompliance with study schedule|1|||
128722740|NCT00323492|463282298|FG000|Study Phase 2|Protocol Violation|1|||
128722741|NCT00323492|463282299|FG001|Study Phase 2|Protocol Violation|0|||
128722742|NCT00323492|463282300|FG002|Study Phase 2|Protocol Violation|0|||
128722743|NCT02486042|463282301|FG000|Overall Study|Physician Decision|1|||
128722744|NCT02486042|463282302|FG001|Overall Study|Physician Decision|7|||
128722745|NCT02486042|463282301|FG000|Overall Study|Hospital transfer|2|||
128722746|NCT02486042|463282302|FG001|Overall Study|Hospital transfer|2|||
128722747|NCT02486042|463282301|FG000|Overall Study|Withdrawal by Subject|0|||
128722748|NCT02486042|463282302|FG001|Overall Study|Withdrawal by Subject|2|||
128722749|NCT01466387|463282303|FG000|Overall Study|Adverse Event|0|||
128722750|NCT01466387|463282304|FG001|Overall Study|Adverse Event|0|||
128722751|NCT01466387|463282305|FG002|Overall Study|Adverse Event|1|||
128722752|NCT01466387|463282306|FG003|Overall Study|Adverse Event|1|||
128722753|NCT01466387|463282307|FG004|Overall Study|Adverse Event|0|||
128722754|NCT01466387|463282308|FG005|Overall Study|Adverse Event|0|||
128722755|NCT01466387|463282303|FG000|Overall Study|Lost to Follow-up|0|||
129138689|NCT00098293|464800595|FG004|Open-label (OL) Phase|Death|0|||
129138690|NCT00098293|464800591|FG000|Supplemental Phase (SP)|Death|0|||
129138691|NCT00098293|464800592|FG001|Supplemental Phase (SP)|Death|0|||
129138692|NCT00098293|464800593|FG002|Supplemental Phase (SP)|Death|0|||
129138693|NCT00098293|464800594|FG003|Supplemental Phase (SP)|Death|0|||
129138694|NCT00098293|464800595|FG004|Supplemental Phase (SP)|Death|1|||
129138695|NCT00098293|464800591|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
129138696|NCT00098293|464800592|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
129138697|NCT00098293|464800593|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
129138698|NCT00098293|464800594|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
129138699|NCT00098293|464800595|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
129138700|NCT00098293|464800591|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129138701|NCT00098293|464800592|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129138702|NCT00098293|464800593|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129138703|NCT00098293|464800594|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129138704|NCT00098293|464800595|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
129138705|NCT00098293|464800591|FG000|Supplemental Phase (SP)|Other|0|||
129138706|NCT00098293|464800592|FG001|Supplemental Phase (SP)|Other|0|||
129138707|NCT00098293|464800593|FG002|Supplemental Phase (SP)|Other|0|||
129138708|NCT00098293|464800594|FG003|Supplemental Phase (SP)|Other|0|||
129138709|NCT00098293|464800595|FG004|Supplemental Phase (SP)|Other|22|||
129138710|NCT01370642|464800596|FG000|Overall Study|Adverse Event|2|||
129138711|NCT01370642|464800597|FG001|Overall Study|Adverse Event|1|||
129138712|NCT01370642|464800598|FG002|Overall Study|Adverse Event|1|||
129138713|NCT01370642|464800596|FG000|Overall Study|Detectable HCV RNA|0|||
129138714|NCT01370642|464800597|FG001|Overall Study|Detectable HCV RNA|0|||
129138715|NCT01370642|464800598|FG002|Overall Study|Detectable HCV RNA|22|||
129138716|NCT01370642|464800596|FG000|Overall Study|Lost to Follow-up|0|||
129138717|NCT01370642|464800597|FG001|Overall Study|Lost to Follow-up|0|||
129138718|NCT01370642|464800598|FG002|Overall Study|Lost to Follow-up|1|||
129138719|NCT01370642|464800596|FG000|Overall Study|Physician Decision|4|||
129138720|NCT01370642|464800597|FG001|Overall Study|Physician Decision|1|||
129138721|NCT01370642|464800598|FG002|Overall Study|Physician Decision|2|||
129138722|NCT01370642|464800596|FG000|Overall Study|Withdrawal by Subject|2|||
129138723|NCT01370642|464800597|FG001|Overall Study|Withdrawal by Subject|4|||
129138724|NCT01370642|464800598|FG002|Overall Study|Withdrawal by Subject|3|||
129138725|NCT01796470|464800599|FG000|Overall Study|Adverse Event|4|||
129138726|NCT01796470|464800600|FG001|Overall Study|Adverse Event|2|||
129138727|NCT01796470|464800601|FG002|Overall Study|Adverse Event|2|||
129138728|NCT01796470|464800602|FG003|Overall Study|Adverse Event|1|||
129138729|NCT01796470|464800603|FG004|Overall Study|Adverse Event|3|||
129138730|NCT01796470|464800599|FG000|Overall Study|Death|2|||
129138731|NCT01796470|464800600|FG001|Overall Study|Death|0|||
129138732|NCT01796470|464800601|FG002|Overall Study|Death|0|||
129138733|NCT01796470|464800602|FG003|Overall Study|Death|0|||
129138734|NCT01796470|464800603|FG004|Overall Study|Death|1|||
129138735|NCT01796470|464800599|FG000|Overall Study|Initiated New Therapy|9|||
129138736|NCT01796470|464800600|FG001|Overall Study|Initiated New Therapy|0|||
129138737|NCT01796470|464800601|FG002|Overall Study|Initiated New Therapy|0|||
129138738|NCT01796470|464800602|FG003|Overall Study|Initiated New Therapy|0|||
129138739|NCT01796470|464800603|FG004|Overall Study|Initiated New Therapy|2|||
129138740|NCT01796470|464800599|FG000|Overall Study|Lost to Follow-up|0|||
129138741|NCT01796470|464800600|FG001|Overall Study|Lost to Follow-up|1|||
129138742|NCT01796470|464800601|FG002|Overall Study|Lost to Follow-up|0|||
129138743|NCT01796470|464800602|FG003|Overall Study|Lost to Follow-up|0|||
129138744|NCT01796470|464800603|FG004|Overall Study|Lost to Follow-up|0|||
129138745|NCT01796470|464800599|FG000|Overall Study|Physician Decision|5|||
129138746|NCT01796470|464800600|FG001|Overall Study|Physician Decision|4|||
129138747|NCT01796470|464800601|FG002|Overall Study|Physician Decision|1|||
129138748|NCT01796470|464800602|FG003|Overall Study|Physician Decision|0|||
129138749|NCT01796470|464800603|FG004|Overall Study|Physician Decision|1|||
129138750|NCT01796470|464800599|FG000|Overall Study|Progressive Disease|7|||
129138751|NCT01796470|464800600|FG001|Overall Study|Progressive Disease|7|||
129138752|NCT01796470|464800601|FG002|Overall Study|Progressive Disease|3|||
129138753|NCT01796470|464800602|FG003|Overall Study|Progressive Disease|2|||
129138754|NCT01796470|464800603|FG004|Overall Study|Progressive Disease|0|||
129138755|NCT01796470|464800599|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
129138756|NCT01796470|464800600|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
129138757|NCT01796470|464800601|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
129138758|NCT01796470|464800602|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
129138759|NCT01796470|464800603|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
129138760|NCT01796470|464800599|FG000|Overall Study|Withdrawal by Subject|7|||
129138761|NCT01796470|464800600|FG001|Overall Study|Withdrawal by Subject|0|||
129138762|NCT01796470|464800601|FG002|Overall Study|Withdrawal by Subject|0|||
129138763|NCT01796470|464800602|FG003|Overall Study|Withdrawal by Subject|0|||
129138764|NCT01796470|464800603|FG004|Overall Study|Withdrawal by Subject|1|||
129138765|NCT01927861|464800604|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
129138766|NCT01927861|464800605|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
128776067|NCT02018861|463470325|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776068|NCT02018861|463470326|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776069|NCT02018861|463470327|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776070|NCT02018861|463470328|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
128776071|NCT02018861|463470329|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
128776072|NCT02018861|463470330|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776073|NCT02018861|463470331|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776074|NCT02018861|463470332|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776075|NCT02018861|463470333|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776076|NCT02018861|463470334|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
128776077|NCT02018861|463470325|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776078|NCT02018861|463470326|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776079|NCT02018861|463470327|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776080|NCT02018861|463470328|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776081|NCT02018861|463470329|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776082|NCT02018861|463470330|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776083|NCT02018861|463470331|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
128776084|NCT02018861|463470332|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
128776085|NCT02018861|463470333|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776086|NCT02018861|463470334|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
128776087|NCT02018861|463470325|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776088|NCT02018861|463470326|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776089|NCT02018861|463470327|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776090|NCT02018861|463470328|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776091|NCT02018861|463470329|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776092|NCT02018861|463470330|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776093|NCT02018861|463470331|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
128776094|NCT02018861|463470332|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
128776095|NCT02018861|463470333|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776096|NCT02018861|463470334|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
128776097|NCT02018861|463470325|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776098|NCT02018861|463470326|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776099|NCT02018861|463470327|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776100|NCT02018861|463470328|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776101|NCT02018861|463470329|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776102|NCT02018861|463470330|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776103|NCT02018861|463470331|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776104|NCT02018861|463470332|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776105|NCT02018861|463470333|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
128776106|NCT02018861|463470334|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
128776107|NCT02018861|463470325|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776108|NCT02018861|463470326|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776109|NCT02018861|463470327|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776110|NCT02018861|463470328|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776111|NCT02018861|463470329|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129068431|NCT02553772|464536836|FG000|Overall Study|Adverse Event|2|||
129068432|NCT02553772|464536837|FG001|Overall Study|Adverse Event|3|||
129068433|NCT02553772|464536836|FG000|Overall Study|Lost to Follow-up|2|||
129068434|NCT02553772|464536837|FG001|Overall Study|Lost to Follow-up|1|||
129068435|NCT02553772|464536836|FG000|Overall Study|Withdrawal of Consent|1|||
129068436|NCT02553772|464536837|FG001|Overall Study|Withdrawal of Consent|1|||
129068437|NCT02553772|464536836|FG000|Overall Study|Lack of Efficacy|1|||
129068438|NCT02553772|464536837|FG001|Overall Study|Lack of Efficacy|0|||
129068439|NCT02553772|464536836|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129068440|NCT02553772|464536837|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129068441|NCT00786409|464536838|FG000|Overall Study|Withdrawal by Subject|2|||
129068442|NCT00786409|464536838|FG000|Overall Study|Adverse Event|2|||
129068443|NCT00786409|464536838|FG000|Overall Study|Pregnancy|2|||
129068444|NCT00786409|464536838|FG000|Overall Study|Lost to Follow-up|1|||
129068445|NCT00610129|464536839|FG000|Overall Study|Not treated since patients ineligible|3|||
129068446|NCT01184079|464536845|FG000|Overall Study|Lost to Follow-up|14|||
129068447|NCT01184079|464536846|FG001|Overall Study|Lost to Follow-up|2|||
129068448|NCT04233073|464536847|FG000|Overall Study|Death|5|||
129068449|NCT02603146|464539043|FG000|Overall Study|Lost to Follow-up|5|||
129068450|NCT02603146|464539044|FG001|Overall Study|Lost to Follow-up|6|||
129068451|NCT02603146|464539043|FG000|Overall Study|Withdrawal by Subject|8|||
129138767|NCT01927861|464800604|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
129138768|NCT01927861|464800605|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
129138769|NCT00987935|464800606|FG000|Overall Study|Progressive disease|3|||
129138770|NCT00987935|464800607|FG001|Overall Study|Progressive disease|2|||
129138771|NCT00987935|464800608|FG002|Overall Study|Progressive disease|3|||
129138772|NCT00987935|464800609|FG003|Overall Study|Progressive disease|2|||
129138773|NCT00987935|464800610|FG004|Overall Study|Progressive disease|5|||
129138774|NCT00987935|464800611|FG005|Overall Study|Progressive disease|3|||
129138775|NCT00987935|464800612|FG006|Overall Study|Progressive disease|9|||
129138776|NCT00987935|464800613|FG007|Overall Study|Progressive disease|48|||
129138777|NCT00987935|464800614|FG008|Overall Study|Progressive disease|23|||
129138778|NCT00987935|464800606|FG000|Overall Study|Adverse Event|0|||
129138779|NCT00987935|464800607|FG001|Overall Study|Adverse Event|1|||
129138780|NCT00987935|464800608|FG002|Overall Study|Adverse Event|0|||
129138781|NCT00987935|464800609|FG003|Overall Study|Adverse Event|1|||
129138782|NCT00987935|464800610|FG004|Overall Study|Adverse Event|1|||
128722756|NCT01466387|463282304|FG001|Overall Study|Lost to Follow-up|0|||
128722757|NCT01466387|463282305|FG002|Overall Study|Lost to Follow-up|0|||
128722758|NCT01466387|463282306|FG003|Overall Study|Lost to Follow-up|0|||
128722759|NCT01466387|463282307|FG004|Overall Study|Lost to Follow-up|0|||
128722760|NCT01466387|463282308|FG005|Overall Study|Lost to Follow-up|1|||
128722761|NCT01466387|463282303|FG000|Overall Study|Protocol Violation|1|||
128722762|NCT01466387|463282304|FG001|Overall Study|Protocol Violation|0|||
128722763|NCT01466387|463282305|FG002|Overall Study|Protocol Violation|0|||
128722764|NCT01466387|463282306|FG003|Overall Study|Protocol Violation|1|||
128722765|NCT01466387|463282307|FG004|Overall Study|Protocol Violation|0|||
128722766|NCT01466387|463282308|FG005|Overall Study|Protocol Violation|0|||
128722767|NCT01319877|463282311|FG000|Overall Study|Lost to Follow-up|100|||
128722768|NCT01319877|463282312|FG001|Overall Study|Lost to Follow-up|37|||
128722769|NCT01319877|463282311|FG000|Overall Study|Physician Decision|2|||
128722770|NCT01319877|463282312|FG001|Overall Study|Physician Decision|0|||
128722771|NCT01319877|463282311|FG000|Overall Study|Disease Progression|2|||
128722772|NCT01319877|463282312|FG001|Overall Study|Disease Progression|2|||
128722773|NCT01319877|463282311|FG000|Overall Study|Withdrawal by Subject|0|||
128722774|NCT01319877|463282312|FG001|Overall Study|Withdrawal by Subject|1|||
128722775|NCT01319877|463282311|FG000|Overall Study|Reason Not Specified|4|||
128722776|NCT01319877|463282312|FG001|Overall Study|Reason Not Specified|5|||
128722777|NCT02968979|463282313|FG000|Overall Study|Protocol Violation|7|||
128722778|NCT02968979|463282313|FG000|Overall Study|Withdrawal by Subject|1|||
128722779|NCT03745144|463282314|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
128722780|NCT03745144|463282315|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
128722781|NCT03745144|463282316|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
128722782|NCT03745144|463282314|FG000|Period 1|Other|0|||
128722783|NCT03745144|463282315|FG001|Period 1|Other|0|||
128722784|NCT03745144|463282316|FG002|Period 1|Other|1|||
128722785|NCT00896337|463282317|FG000|Overall Study|Death|7|||
128722786|NCT00896337|463282317|FG000|Overall Study|Withdrawal by Subject|7|||
128722787|NCT00896337|463282317|FG000|Overall Study|Lost to Follow-up|11|||
128722788|NCT04668950|463282318|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
128722789|NCT04668950|463282319|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
128722790|NCT04668950|463282318|FG000|Overall Study|Could not confirm started study medication|15|||
128722791|NCT04668950|463282319|FG001|Overall Study|Could not confirm started study medication|15|||
128722792|NCT04668950|463282318|FG000|Overall Study|Could not confirm baseline status|6|||
128722793|NCT04668950|463282319|FG001|Overall Study|Could not confirm baseline status|2|||
128722794|NCT04668950|463282318|FG000|Overall Study|Drop out and did not start medication|15|||
128722795|NCT04668950|463282319|FG001|Overall Study|Drop out and did not start medication|17|||
128722796|NCT04668950|463282318|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
128722797|NCT04668950|463282319|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
128722798|NCT04668950|463282318|FG000|Overall Study|Other|2|||
128722799|NCT04668950|463282319|FG001|Overall Study|Other|4|||
128722800|NCT00578942|463282320|FG000|Overall Study|Lost to Follow-up|1|||
128722801|NCT04220411|463282331|FG000|Overall Study|Adverse Event|0|||
129138783|NCT00987935|464800611|FG005|Overall Study|Adverse Event|0|||
129138784|NCT00987935|464800612|FG006|Overall Study|Adverse Event|2|||
128722802|NCT04220411|463282332|FG001|Overall Study|Adverse Event|0|||
128722803|NCT04220411|463282333|FG002|Overall Study|Adverse Event|0|||
128722804|NCT04220411|463282334|FG003|Overall Study|Adverse Event|1|||
128722805|NCT02028988|463282335|FG000|Overall Study|Withdrawal by Subject|2|||
128722806|NCT04059146|463282336|FG000|Overall Study|Withdrawal by Subject|0|||
128722807|NCT04059146|463282337|FG001|Overall Study|Withdrawal by Subject|1|||
129138785|NCT00987935|464800613|FG007|Overall Study|Adverse Event|10|||
129138786|NCT00987935|464800614|FG008|Overall Study|Adverse Event|6|||
128722808|NCT00851799|463282338|FG000|Overall Study|Death|1|||
128722809|NCT00851799|463282339|FG001|Overall Study|Death|0|||
128722810|NCT00851799|463282340|FG002|Overall Study|Death|1|||
129138787|NCT00987935|464800606|FG000|Overall Study|Refused to continue taking trial med.|1|||
129138788|NCT00987935|464800607|FG001|Overall Study|Refused to continue taking trial med.|0|||
129138789|NCT00987935|464800608|FG002|Overall Study|Refused to continue taking trial med.|0|||
129138790|NCT00987935|464800609|FG003|Overall Study|Refused to continue taking trial med.|0|||
129138791|NCT00987935|464800610|FG004|Overall Study|Refused to continue taking trial med.|1|||
129138792|NCT00987935|464800611|FG005|Overall Study|Refused to continue taking trial med.|0|||
129138793|NCT00987935|464800612|FG006|Overall Study|Refused to continue taking trial med.|4|||
128776112|NCT02018861|463470330|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776113|NCT02018861|463470331|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776114|NCT02018861|463470332|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776115|NCT02018861|463470333|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
128776116|NCT02018861|463470334|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
128776117|NCT02018861|463470325|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
128776118|NCT02018861|463470326|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
128776119|NCT02018861|463470327|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
128776120|NCT02018861|463470328|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
128776121|NCT02018861|463470329|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129138794|NCT00987935|464800613|FG007|Overall Study|Refused to continue taking trial med.|4|||
129138795|NCT00987935|464800614|FG008|Overall Study|Refused to continue taking trial med.|2|||
129138796|NCT00987935|464800606|FG000|Overall Study|Reason other than those specified above|0|||
129138797|NCT00987935|464800607|FG001|Overall Study|Reason other than those specified above|0|||
129138798|NCT00987935|464800608|FG002|Overall Study|Reason other than those specified above|0|||
129138799|NCT00987935|464800609|FG003|Overall Study|Reason other than those specified above|0|||
129138800|NCT00987935|464800610|FG004|Overall Study|Reason other than those specified above|0|||
129138801|NCT00987935|464800611|FG005|Overall Study|Reason other than those specified above|0|||
129138802|NCT00987935|464800612|FG006|Overall Study|Reason other than those specified above|0|||
129138803|NCT00987935|464800613|FG007|Overall Study|Reason other than those specified above|0|||
129138804|NCT00987935|464800614|FG008|Overall Study|Reason other than those specified above|1|||
129138805|NCT01089543|464800615|FG000|Overall Study|Withdrawal by Subject|2|||
129138806|NCT01089543|464800616|FG001|Overall Study|Withdrawal by Subject|3|||
129138807|NCT01089543|464800617|FG002|Overall Study|Withdrawal by Subject|3|||
129138808|NCT01089543|464800618|FG003|Overall Study|Withdrawal by Subject|1|||
129138809|NCT01089543|464800615|FG000|Overall Study|Physician Decision|1|||
129138810|NCT01089543|464800616|FG001|Overall Study|Physician Decision|0|||
129138811|NCT01089543|464800617|FG002|Overall Study|Physician Decision|0|||
129138812|NCT01089543|464800618|FG003|Overall Study|Physician Decision|1|||
129138813|NCT01089543|464800615|FG000|Overall Study|Adverse Event|0|||
129138814|NCT01089543|464800616|FG001|Overall Study|Adverse Event|1|||
129138815|NCT01089543|464800617|FG002|Overall Study|Adverse Event|0|||
129138816|NCT01089543|464800618|FG003|Overall Study|Adverse Event|0|||
129138817|NCT01248468|464800620|FG000|Overall Study|Administrative problem|1|||
129138818|NCT01248468|464800621|FG001|Overall Study|Administrative problem|0|||
129138819|NCT01248468|464800622|FG002|Overall Study|Administrative problem|0|||
129138820|NCT01248468|464800620|FG000|Overall Study|Lost to Follow-up|9|||
129138821|NCT01248468|464800621|FG001|Overall Study|Lost to Follow-up|12|||
129138822|NCT01248468|464800622|FG002|Overall Study|Lost to Follow-up|4|||
129138823|NCT01248468|464800620|FG000|Overall Study|Pregnancy|1|||
129138824|NCT01248468|464800621|FG001|Overall Study|Pregnancy|0|||
129138825|NCT01248468|464800622|FG002|Overall Study|Pregnancy|0|||
129138826|NCT01248468|464800620|FG000|Overall Study|Withdrawal by Subject|4|||
129138827|NCT01248468|464800621|FG001|Overall Study|Withdrawal by Subject|2|||
129138828|NCT01248468|464800622|FG002|Overall Study|Withdrawal by Subject|0|||
129138829|NCT02176525|464800623|FG000|Overall Study|Adverse Event|0|||
129138830|NCT02176525|464800624|FG001|Overall Study|Adverse Event|0|||
129138831|NCT02176525|464800625|FG002|Overall Study|Adverse Event|0|||
129138832|NCT02176525|464800626|FG003|Overall Study|Adverse Event|1|||
129138833|NCT02176525|464800627|FG004|Overall Study|Adverse Event|1|||
129138834|NCT02176525|464800628|FG005|Overall Study|Adverse Event|0|||
129138835|NCT02176525|464800629|FG006|Overall Study|Adverse Event|1|||
129138836|NCT02176525|464800630|FG007|Overall Study|Adverse Event|0|||
129138837|NCT02176525|464800623|FG000|Overall Study|not treated|1|||
129138838|NCT02176525|464800624|FG001|Overall Study|not treated|0|||
129138839|NCT02176525|464800625|FG002|Overall Study|not treated|0|||
129138840|NCT02176525|464800626|FG003|Overall Study|not treated|0|||
129138841|NCT02176525|464800627|FG004|Overall Study|not treated|0|||
128776122|NCT02018861|463470330|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
128776123|NCT02018861|463470331|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129138842|NCT02176525|464800628|FG005|Overall Study|not treated|1|||
129138843|NCT02176525|464800629|FG006|Overall Study|not treated|0|||
129138844|NCT02176525|464800630|FG007|Overall Study|not treated|0|||
129138845|NCT00468546|464800631|FG000|Week 24 Analysis|Lack of Efficacy|83|||
129138846|NCT00468546|464800632|FG001|Week 24 Analysis|Lack of Efficacy|37|||
129138847|NCT00468546|464800631|FG000|Week 24 Analysis|Refused treatment|5|||
129138848|NCT00468546|464800632|FG001|Week 24 Analysis|Refused treatment|5|||
129138849|NCT00468546|464800631|FG000|Week 24 Analysis|Adverse Event|1|||
129138850|NCT00468546|464800632|FG001|Week 24 Analysis|Adverse Event|8|||
129138851|NCT00468546|464800631|FG000|Week 24 Analysis|Failure to return|3|||
129138852|NCT00468546|464800632|FG001|Week 24 Analysis|Failure to return|4|||
128722811|NCT00851799|463282338|FG000|Overall Study|Lost to Follow-up|5|||
128722812|NCT00851799|463282339|FG001|Overall Study|Lost to Follow-up|3|||
128722813|NCT00851799|463282340|FG002|Overall Study|Lost to Follow-up|10|||
128722814|NCT00851799|463282338|FG000|Overall Study|Not able to get to clinic|8|||
128722815|NCT00851799|463282339|FG001|Overall Study|Not able to get to clinic|5|||
128722816|NCT00851799|463282340|FG002|Overall Study|Not able to get to clinic|9|||
128722817|NCT00851799|463282338|FG000|Overall Study|Not willing to adhere to requirements|1|||
128722818|NCT00851799|463282339|FG001|Overall Study|Not willing to adhere to requirements|2|||
128722819|NCT00851799|463282340|FG002|Overall Study|Not willing to adhere to requirements|2|||
128722820|NCT00851799|463282338|FG000|Overall Study|Withdrew consent prior study completion|1|||
128722821|NCT00851799|463282339|FG001|Overall Study|Withdrew consent prior study completion|2|||
128722822|NCT00851799|463282340|FG002|Overall Study|Withdrew consent prior study completion|1|||
128722823|NCT00851799|463282338|FG000|Overall Study|Severe Debilitation|0|||
128722824|NCT00851799|463282339|FG001|Overall Study|Severe Debilitation|1|||
128722825|NCT00851799|463282340|FG002|Overall Study|Severe Debilitation|0|||
128722826|NCT00851799|463282338|FG000|Overall Study|Completed protocol due to pregnancy|0|||
128722827|NCT00851799|463282339|FG001|Overall Study|Completed protocol due to pregnancy|0|||
128722828|NCT00851799|463282340|FG002|Overall Study|Completed protocol due to pregnancy|1|||
128722829|NCT01342510|463282349|FG000|Overall Study|Protocol Violation|12|||
128722830|NCT01342510|463282350|FG001|Overall Study|Protocol Violation|6|||
128722831|NCT01342510|463282351|FG002|Overall Study|Protocol Violation|13|||
128722832|NCT01342510|463282352|FG003|Overall Study|Protocol Violation|11|||
128722833|NCT01796197|463282358|FG000|Overall Study|Lost to Follow-up|1|||
128722834|NCT01796197|463282358|FG000|Overall Study|Lack of Efficacy|1|||
128722835|NCT04243538|463282359|FG000|Overall Study|Withdrawal by Subject|0|||
128722836|NCT04243538|463282360|FG001|Overall Study|Withdrawal by Subject|2|||
128722837|NCT04243538|463282359|FG000|Overall Study|Lost to Follow-up|0|||
128722838|NCT04243538|463282360|FG001|Overall Study|Lost to Follow-up|3|||
128722839|NCT04380857|463283525|FG000|Overall Study|Lost to Follow-up|3|||
128722840|NCT04380857|463283526|FG001|Overall Study|Lost to Follow-up|3|||
128722841|NCT02558790|463283527|FG000|Overall Study|Lost to Follow-up|2|||
128722842|NCT02558790|463283527|FG000|Overall Study|Physician Decision|1|||
128722843|NCT02558790|463283527|FG000|Overall Study|Withdrawal by Subject|1|||
128722844|NCT02558790|463283527|FG000|Overall Study|Screen Fail|3|||
128722845|NCT00838201|463283528|FG000|Overall Study|Investigator decision, or other reasons|2|||
128722846|NCT00838201|463283529|FG001|Overall Study|Investigator decision, or other reasons|3|||
128722847|NCT00838201|463283528|FG000|Overall Study|Noncompliance|0|||
128722848|NCT00838201|463283529|FG001|Overall Study|Noncompliance|1|||
128722849|NCT00838201|463283528|FG000|Overall Study|Administrative decision|1|||
128722850|NCT00838201|463283529|FG001|Overall Study|Administrative decision|2|||
128722851|NCT00838201|463283528|FG000|Overall Study|Disease progression|3|||
128722852|NCT00838201|463283529|FG001|Overall Study|Disease progression|3|||
128722853|NCT00838201|463283528|FG000|Overall Study|Consent withdrawn|16|||
128722854|NCT00838201|463283529|FG001|Overall Study|Consent withdrawn|19|||
128722855|NCT00838201|463283528|FG000|Overall Study|Lost to Follow-up|4|||
128722856|NCT00838201|463283529|FG001|Overall Study|Lost to Follow-up|3|||
128722857|NCT00838201|463283528|FG000|Overall Study|Adverse Event|5|||
128722858|NCT00838201|463283529|FG001|Overall Study|Adverse Event|9|||
128722859|NCT00838201|463283528|FG000|Overall Study|Death|11|||
128722860|NCT00838201|463283529|FG001|Overall Study|Death|13|||
128722861|NCT05228470|463283530|FG000|Overall Study|Death|6|||
128722862|NCT05228470|463283531|FG001|Overall Study|Death|11|||
128722863|NCT05228470|463283530|FG000|Overall Study|Withdrawal by Subject|1|||
128722864|NCT05228470|463283531|FG001|Overall Study|Withdrawal by Subject|8|||
128722865|NCT05228470|463283530|FG000|Overall Study|Ongoing|1|||
128722866|NCT05228470|463283531|FG001|Overall Study|Ongoing|11|||
128722867|NCT02449239|463283532|FG000|Induction Phase|Lack of Efficacy|64|||
128722868|NCT02449239|463283532|FG000|Induction Phase|Adverse Event|1|||
128722869|NCT02449239|463283532|FG000|Induction Phase|Lost to Follow-up|1|||
128722870|NCT02449239|463283532|FG000|Induction Phase|Protocol Violation|1|||
128722871|NCT02449239|463283532|FG000|Induction Phase|Physician Decision|1|||
128722872|NCT02449239|463283532|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
128722873|NCT02449239|463283532|FG000|Induction Phase|Withdrawal by Subject|1|||
128722874|NCT02449239|463283532|FG000|Maintenance Month 3|Lack of Efficacy|14|||
129138853|NCT00468546|464800631|FG000|Week 24 Analysis|Rescue therapy|2|||
128722875|NCT02449239|463283532|FG000|Maintenance Month 6|Lack of Efficacy|10|||
128722876|NCT02449239|463283532|FG000|Maintenance Month 6|Adverse Event|2|||
128722877|NCT02449239|463283532|FG000|Maintenance Month 6|Physician Decision|1|||
128722878|NCT02449239|463283532|FG000|Maintenance Month 9|Lack of Efficacy|2|||
128722879|NCT02449239|463283532|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
128722880|NCT02449239|463283532|FG000|Maintenance Month 12|Lack of Efficacy|5|||
129138854|NCT00468546|464800632|FG001|Week 24 Analysis|Rescue therapy|0|||
128722881|NCT02449239|463283532|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
128722882|NCT02449239|463283532|FG000|Maintenance Month 12|Subject moved from area|1|||
128722883|NCT02449239|463283532|FG000|Maintenance Month 15|Lack of Efficacy|1|||
128722884|NCT02449239|463283532|FG000|Maintenance Month 21|Lack of Efficacy|1|||
129138855|NCT00468546|464800631|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
129138856|NCT00468546|464800632|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
129138857|NCT00468546|464800631|FG000|Week 24 Analysis|Due to clinical hold|1|||
129138858|NCT00468546|464800632|FG001|Week 24 Analysis|Due to clinical hold|0|||
129138859|NCT00468546|464800631|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
129138860|NCT00468546|464800632|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
129138861|NCT00468546|464800631|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
129138862|NCT00468546|464800632|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
129138863|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
129138864|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
128722885|NCT02449239|463283532|FG000|Maintenance Month 21|Sponsor decision|1|||
128722886|NCT05620576|463283534|FG000|Overall Study|Adverse Event|1|||
128722887|NCT05620576|463283535|FG001|Overall Study|Adverse Event|1|||
128722888|NCT05620576|463283534|FG000|Overall Study|Lost to Follow-up|3|||
128722889|NCT05620576|463283535|FG001|Overall Study|Lost to Follow-up|1|||
128722890|NCT05620576|463283534|FG000|Overall Study|Physician Decision|0|||
128722891|NCT05620576|463283535|FG001|Overall Study|Physician Decision|1|||
128722892|NCT05620576|463283534|FG000|Overall Study|Protocol Deviation|1|||
128722893|NCT05620576|463283535|FG001|Overall Study|Protocol Deviation|1|||
128722894|NCT05620576|463283534|FG000|Overall Study|Withdrawal by Subject|2|||
128722895|NCT05620576|463283535|FG001|Overall Study|Withdrawal by Subject|3|||
128722896|NCT02622828|463283536|FG000|Overall Study|participant withdrew|3|||
128722897|NCT01723163|463283537|FG000|Treatment Phase|Withdrawal by Subject|14|||
128722898|NCT01723163|463283538|FG001|Treatment Phase|Withdrawal by Subject|6|||
128722899|NCT01723163|463283537|FG000|Treatment Phase|Withdrawal by PI|5|||
128722900|NCT01723163|463283538|FG001|Treatment Phase|Withdrawal by PI|1|||
128722901|NCT01723163|463283537|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
128722902|NCT01723163|463283538|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
128722903|NCT01723163|463283537|FG000|3-Month Follow-up|Unable to Contact|12|||
128722904|NCT01723163|463283538|FG001|3-Month Follow-up|Unable to Contact|19|||
128722905|NCT01723163|463283537|FG000|6-Month Follow-up|Death|1|||
128722906|NCT01723163|463283538|FG001|6-Month Follow-up|Death|0|||
128722907|NCT01723163|463283537|FG000|6-Month Follow-up|Unable to Contact|17|||
128722908|NCT01723163|463283538|FG001|6-Month Follow-up|Unable to Contact|15|||
128722909|NCT01723163|463283537|FG000|12-Month Follow-up|Death|1|||
128722910|NCT01723163|463283538|FG001|12-Month Follow-up|Death|0|||
128722911|NCT01723163|463283537|FG000|12-Month Follow-up|Unable to Contact|23|||
128722912|NCT01723163|463283538|FG001|12-Month Follow-up|Unable to Contact|28|||
128722913|NCT03314584|463283556|FG000|Overall Study|Withdrawal by Subject|3|||
128722914|NCT03314584|463283557|FG001|Overall Study|Withdrawal by Subject|3|||
128722915|NCT03314584|463283556|FG000|Overall Study|Lost to Follow-up|4|||
128722916|NCT03314584|463283557|FG001|Overall Study|Lost to Follow-up|0|||
128722917|NCT06134817|463283558|FG000|Overall Study|Physician Departure - termination of study|1|||
128722918|NCT04214288|463283560|FG000|Overall Study|Ongoing in the study|41|||
128722919|NCT04214288|463283561|FG001|Overall Study|Ongoing in the study|51|||
128722920|NCT04214288|463283562|FG002|Overall Study|Ongoing in the study|12|||
128722921|NCT04214288|463283563|FG003|Overall Study|Ongoing in the study|39|||
128722922|NCT04214288|463283560|FG000|Overall Study|Adverse Event|1|||
128722923|NCT04214288|463283561|FG001|Overall Study|Adverse Event|0|||
128722924|NCT04214288|463283562|FG002|Overall Study|Adverse Event|0|||
128722925|NCT04214288|463283563|FG003|Overall Study|Adverse Event|0|||
128722926|NCT04214288|463283560|FG000|Overall Study|Death|22|||
128722927|NCT04214288|463283561|FG001|Overall Study|Death|13|||
128722928|NCT04214288|463283562|FG002|Overall Study|Death|7|||
128722929|NCT04214288|463283563|FG003|Overall Study|Death|19|||
128722930|NCT04214288|463283560|FG000|Overall Study|Lost to Follow-up|1|||
128722931|NCT04214288|463283561|FG001|Overall Study|Lost to Follow-up|2|||
128722932|NCT04214288|463283562|FG002|Overall Study|Lost to Follow-up|1|||
128722933|NCT04214288|463283563|FG003|Overall Study|Lost to Follow-up|0|||
128722934|NCT04214288|463283560|FG000|Overall Study|Other|1|||
128722935|NCT04214288|463283561|FG001|Overall Study|Other|2|||
129138865|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Death|1|||
128722936|NCT04214288|463283562|FG002|Overall Study|Other|0|||
128722937|NCT04214288|463283563|FG003|Overall Study|Other|6|||
128722938|NCT04214288|463283560|FG000|Overall Study|Protocol Violation|0|||
128722939|NCT04214288|463283561|FG001|Overall Study|Protocol Violation|1|||
128722940|NCT04214288|463283562|FG002|Overall Study|Protocol Violation|0|||
128722941|NCT04214288|463283563|FG003|Overall Study|Protocol Violation|0|||
128722942|NCT04214288|463283560|FG000|Overall Study|Withdrawal by Subject|8|||
128722943|NCT04214288|463283561|FG001|Overall Study|Withdrawal by Subject|4|||
128722944|NCT04214288|463283562|FG002|Overall Study|Withdrawal by Subject|0|||
128722945|NCT04214288|463283563|FG003|Overall Study|Withdrawal by Subject|9|||
128722946|NCT02286193|463283574|FG000|Overall Study|Referred: CRS unable to make contact|62|||
128722947|NCT02286193|463283574|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
128722948|NCT02286193|463283574|FG000|Overall Study|Referred: Declined service|38|||
128722949|NCT02932904|463283575|FG000|Overall Study|Reason not Specified|1|||
128722950|NCT02932904|463283576|FG001|Overall Study|Reason not Specified|0|||
128776124|NCT02018861|463470332|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
128776125|NCT02018861|463470333|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
128776126|NCT02018861|463470334|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
128776127|NCT00504348|463470335|FG000|Overall Study|Adverse Event|3|||
128776128|NCT00504348|463470335|FG000|Overall Study|Lack of Efficacy|4|||
128776129|NCT00504348|463470335|FG000|Overall Study|Physician Decision|1|||
128776130|NCT03685708|463470344|FG000|Overall Study|Withdrawal by Subject|0|||
128776131|NCT03685708|463470345|FG001|Overall Study|Withdrawal by Subject|0|||
128776132|NCT03685708|463470346|FG002|Overall Study|Withdrawal by Subject|1|||
128776133|NCT03685708|463470344|FG000|Overall Study|Screen Fail|0|||
128776134|NCT03685708|463470345|FG001|Overall Study|Screen Fail|1|||
128776135|NCT03685708|463470346|FG002|Overall Study|Screen Fail|1|||
128776136|NCT03685708|463470344|FG000|Overall Study|COVID 19 Pandemic|1|||
128776137|NCT03685708|463470345|FG001|Overall Study|COVID 19 Pandemic|1|||
128776138|NCT03685708|463470346|FG002|Overall Study|COVID 19 Pandemic|6|||
128776139|NCT03685708|463470344|FG000|Overall Study|Disease Progression|0|||
129068452|NCT02603146|464539044|FG001|Overall Study|Withdrawal by Subject|10|||
129068453|NCT02603146|464539043|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
129068454|NCT02603146|464539044|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
129068455|NCT02603146|464539043|FG000|Overall Study|Participant moved|2|||
129068456|NCT02603146|464539044|FG001|Overall Study|Participant moved|0|||
129068457|NCT02603146|464539043|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
129068458|NCT02603146|464539044|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
129068459|NCT00265759|464539045|FG000|Overall Study|Withdrawal by Subject|0|||
129068460|NCT00265759|464539046|FG001|Overall Study|Withdrawal by Subject|1|||
129068461|NCT00265759|464539047|FG002|Overall Study|Withdrawal by Subject|2|||
129068462|NCT00265759|464539048|FG003|Overall Study|Withdrawal by Subject|2|||
129068463|NCT00265759|464539045|FG000|Overall Study|Cancel|0|||
129068464|NCT00265759|464539046|FG001|Overall Study|Cancel|0|||
129068465|NCT00265759|464539047|FG002|Overall Study|Cancel|0|||
129068466|NCT00265759|464539048|FG003|Overall Study|Cancel|3|||
129068467|NCT00265759|464539045|FG000|Overall Study|Ineligible|0|||
129068468|NCT00265759|464539046|FG001|Overall Study|Ineligible|0|||
129068469|NCT00265759|464539047|FG002|Overall Study|Ineligible|0|||
129068470|NCT00265759|464539048|FG003|Overall Study|Ineligible|1|||
129068471|NCT00265759|464539045|FG000|Overall Study|Bilateral disease|0|||
129068472|NCT00265759|464539046|FG001|Overall Study|Bilateral disease|0|||
129068473|NCT00265759|464539047|FG002|Overall Study|Bilateral disease|0|||
129068474|NCT00265759|464539048|FG003|Overall Study|Bilateral disease|2|||
129068475|NCT00265759|464539045|FG000|Overall Study|Discontinued due to intolerability|0|||
129068476|NCT00265759|464539046|FG001|Overall Study|Discontinued due to intolerability|0|||
129068477|NCT00265759|464539047|FG002|Overall Study|Discontinued due to intolerability|0|||
129068478|NCT00265759|464539048|FG003|Overall Study|Discontinued due to intolerability|1|||
129068479|NCT04467840|464539049|FG000|Overall Study|Death|35|||
129068480|NCT04467840|464539050|FG001|Overall Study|Death|39|||
129068481|NCT04467840|464539049|FG000|Overall Study|Withdrawal by Subject|8|||
129068482|NCT04467840|464539050|FG001|Overall Study|Withdrawal by Subject|4|||
129068483|NCT04467840|464539049|FG000|Overall Study|Adverse Event|2|||
129068484|NCT04467840|464539050|FG001|Overall Study|Adverse Event|0|||
129068485|NCT04467840|464539049|FG000|Overall Study|Lost to Follow-up|1|||
129068486|NCT04467840|464539050|FG001|Overall Study|Lost to Follow-up|3|||
129068487|NCT04467840|464539049|FG000|Overall Study|Physician Decision|1|||
129068488|NCT04467840|464539050|FG001|Overall Study|Physician Decision|0|||
129068489|NCT04467840|464539049|FG000|Overall Study|Other|1|||
128776140|NCT03685708|463470345|FG001|Overall Study|Disease Progression|0|||
128776141|NCT03685708|463470346|FG002|Overall Study|Disease Progression|1|||
129068490|NCT04467840|464539050|FG001|Overall Study|Other|5|||
129068491|NCT04467840|464539049|FG000|Overall Study|Missing study completion status|3|||
129068492|NCT04467840|464539050|FG001|Overall Study|Missing study completion status|1|||
129068493|NCT05201794|464539053|FG000|Overall Study|Withdrawal by Subject|13|||
129068494|NCT05201794|464539054|FG001|Overall Study|Withdrawal by Subject|12|||
129068495|NCT05201794|464539055|FG002|Overall Study|Withdrawal by Subject|14|||
129068496|NCT05201794|464539056|FG003|Overall Study|Withdrawal by Subject|0|||
129068497|NCT05201794|464539053|FG000|Overall Study|Adverse Event|5|||
129068498|NCT05201794|464539054|FG001|Overall Study|Adverse Event|5|||
129068499|NCT05201794|464539055|FG002|Overall Study|Adverse Event|4|||
129068500|NCT05201794|464539056|FG003|Overall Study|Adverse Event|0|||
128776142|NCT04006366|463470347|FG000|Overall Study|Withdrawal by Subject|1|||
129068501|NCT05201794|464539053|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
129068502|NCT05201794|464539054|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
128776143|NCT00627042|463470354|FG000|Overall Study|Withdrawal by Subject|2|||
129068503|NCT05201794|464539055|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
129068504|NCT05201794|464539056|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129068505|NCT05201794|464539053|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129068506|NCT05201794|464539054|FG001|Overall Study|Non-Compliance With Study Drug|3|||
129068507|NCT05201794|464539055|FG002|Overall Study|Non-Compliance With Study Drug|3|||
129068508|NCT05201794|464539056|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129068509|NCT05201794|464539053|FG000|Overall Study|Physician Decision|1|||
129068510|NCT05201794|464539054|FG001|Overall Study|Physician Decision|3|||
129068511|NCT05201794|464539055|FG002|Overall Study|Physician Decision|2|||
129068512|NCT05201794|464539056|FG003|Overall Study|Physician Decision|0|||
129068513|NCT05201794|464539053|FG000|Overall Study|Lost to Follow-up|2|||
129068514|NCT05201794|464539054|FG001|Overall Study|Lost to Follow-up|2|||
129068515|NCT05201794|464539055|FG002|Overall Study|Lost to Follow-up|0|||
129068516|NCT05201794|464539056|FG003|Overall Study|Lost to Follow-up|0|||
129138866|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Death|0|||
129138867|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
129138868|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
129138869|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
129138870|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
129138871|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
129138872|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
129138873|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
129138874|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
129138875|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
129138876|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
129138877|NCT00468546|464800631|FG000|Week 24 to Week 104 Analysis|Other|17|||
129138878|NCT00468546|464800632|FG001|Week 24 to Week 104 Analysis|Other|14|||
129138879|NCT00472641|464800633|FG000|Overall Study|Lack of Efficacy|3|||
129138880|NCT00472641|464800633|FG000|Overall Study|Adverse Event|3|||
129138881|NCT00472641|464800633|FG000|Overall Study|Lost to Follow-up|1|||
129138882|NCT01189227|464800634|FG000|Overall Study|Study terminated due to low accrual|6|||
129138883|NCT01189227|464800635|FG001|Overall Study|Study terminated due to low accrual|3|||
129138884|NCT03211832|464800636|FG000|Overall Study|No longer with agency|32|||
129138885|NCT03211832|464800637|FG001|Overall Study|No longer with agency|49|||
129138886|NCT03211832|464800638|FG002|Overall Study|No longer with agency|30|||
129138887|NCT03211832|464800636|FG000|Overall Study|Declined survey|3|||
129138888|NCT03211832|464800637|FG001|Overall Study|Declined survey|3|||
129138889|NCT03211832|464800638|FG002|Overall Study|Declined survey|2|||
129138890|NCT03211832|464800636|FG000|Overall Study|Not available during data collection|1|||
129138891|NCT03211832|464800637|FG001|Overall Study|Not available during data collection|0|||
129138892|NCT03211832|464800638|FG002|Overall Study|Not available during data collection|2|||
129138893|NCT01608308|464800640|FG000|Overall Study|pretreatment medical and billing reasons|0|||
129068517|NCT05201794|464539053|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
129068518|NCT05201794|464539054|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
129068519|NCT05201794|464539055|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
129068520|NCT05201794|464539056|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
129138894|NCT01608308|464800641|FG001|Overall Study|pretreatment medical and billing reasons|2|||
129138895|NCT06048705|464800644|FG000|Overall Study|Physician Decision|1|||
129138896|NCT06048705|464800645|FG001|Overall Study|Physician Decision|0|||
129138897|NCT06048705|464800646|FG002|Overall Study|Physician Decision|0|||
128722951|NCT02932904|463283577|FG002|Overall Study|Reason not Specified|2|||
128722952|NCT02932904|463283578|FG003|Overall Study|Reason not Specified|2|||
128722953|NCT02932904|463283575|FG000|Overall Study|Noncompliance with Study Drug|2|||
128722954|NCT02932904|463283576|FG001|Overall Study|Noncompliance with Study Drug|3|||
128722955|NCT02932904|463283577|FG002|Overall Study|Noncompliance with Study Drug|3|||
128722956|NCT02932904|463283578|FG003|Overall Study|Noncompliance with Study Drug|4|||
128722957|NCT02932904|463283575|FG000|Overall Study|Pregnancy|0|||
128722958|NCT02932904|463283576|FG001|Overall Study|Pregnancy|1|||
128722959|NCT02932904|463283577|FG002|Overall Study|Pregnancy|1|||
128722960|NCT02932904|463283578|FG003|Overall Study|Pregnancy|0|||
128722961|NCT02932904|463283575|FG000|Overall Study|Study Termination|0|||
128722962|NCT02932904|463283576|FG001|Overall Study|Study Termination|1|||
128722963|NCT02932904|463283577|FG002|Overall Study|Study Termination|0|||
128722964|NCT02932904|463283578|FG003|Overall Study|Study Termination|0|||
128722965|NCT02932904|463283575|FG000|Overall Study|Voluntary Withdrawal|2|||
128722966|NCT02932904|463283576|FG001|Overall Study|Voluntary Withdrawal|1|||
128722967|NCT02932904|463283577|FG002|Overall Study|Voluntary Withdrawal|4|||
128722968|NCT02932904|463283578|FG003|Overall Study|Voluntary Withdrawal|2|||
128722969|NCT02932904|463283575|FG000|Overall Study|Lost to Follow-up|5|||
128722970|NCT02932904|463283576|FG001|Overall Study|Lost to Follow-up|3|||
128722971|NCT02932904|463283577|FG002|Overall Study|Lost to Follow-up|6|||
128722972|NCT02932904|463283578|FG003|Overall Study|Lost to Follow-up|0|||
128722973|NCT02932904|463283575|FG000|Overall Study|Significant Protocol Deviation|2|||
128722974|NCT02932904|463283576|FG001|Overall Study|Significant Protocol Deviation|3|||
128722975|NCT02932904|463283577|FG002|Overall Study|Significant Protocol Deviation|6|||
128722976|NCT02932904|463283578|FG003|Overall Study|Significant Protocol Deviation|1|||
128722977|NCT02932904|463283575|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
128722978|NCT02932904|463283576|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
128722979|NCT02932904|463283577|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
128722980|NCT02932904|463283578|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
128722981|NCT02932904|463283575|FG000|Overall Study|Randomized But Not Treated|1|||
129068521|NCT05201794|464539053|FG000|Overall Study|Protocol Violation|2|||
129068522|NCT05201794|464539054|FG001|Overall Study|Protocol Violation|0|||
129068523|NCT05201794|464539055|FG002|Overall Study|Protocol Violation|1|||
129068524|NCT05201794|464539056|FG003|Overall Study|Protocol Violation|0|||
129068525|NCT05201794|464539053|FG000|Overall Study|Death|1|||
129068526|NCT05201794|464539054|FG001|Overall Study|Death|0|||
129068527|NCT05201794|464539055|FG002|Overall Study|Death|0|||
129068528|NCT05201794|464539056|FG003|Overall Study|Death|0|||
129068529|NCT05201794|464539053|FG000|Overall Study|Site Terminated By Sponsor|0|||
129068530|NCT05201794|464539054|FG001|Overall Study|Site Terminated By Sponsor|1|||
129068531|NCT05201794|464539055|FG002|Overall Study|Site Terminated By Sponsor|0|||
129068532|NCT05201794|464539056|FG003|Overall Study|Site Terminated By Sponsor|0|||
129068533|NCT05201794|464539053|FG000|Overall Study|Other|3|||
129068534|NCT05201794|464539054|FG001|Overall Study|Other|3|||
129068535|NCT05201794|464539055|FG002|Overall Study|Other|3|||
129068536|NCT05201794|464539056|FG003|Overall Study|Other|0|||
129068537|NCT05201794|464539053|FG000|Overall Study|Randomized But Not Treated|1|||
129068538|NCT05201794|464539054|FG001|Overall Study|Randomized But Not Treated|2|||
129068539|NCT05201794|464539055|FG002|Overall Study|Randomized But Not Treated|1|||
129068540|NCT05201794|464539056|FG003|Overall Study|Randomized But Not Treated|0|||
129068541|NCT06082843|464539062|FG000|Overall Study|Withdrawal by Subject|0|||
129068542|NCT06082843|464539063|FG001|Overall Study|Withdrawal by Subject|2|||
129068543|NCT06082843|464539062|FG000|Overall Study|Study terminated by sponsor|12|||
129068544|NCT06082843|464539063|FG001|Overall Study|Study terminated by sponsor|8|||
129068545|NCT04848480|464539067|FG000|Main Phase (26 Weeks)|Death|1|||
129068546|NCT04848480|464539068|FG001|Main Phase (26 Weeks)|Death|0|||
129068547|NCT04848480|464539067|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
128722982|NCT02932904|463283576|FG001|Overall Study|Randomized But Not Treated|1|||
128722983|NCT02932904|463283577|FG002|Overall Study|Randomized But Not Treated|0|||
128722984|NCT02932904|463283578|FG003|Overall Study|Randomized But Not Treated|2|||
129068548|NCT04848480|464539068|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
129068549|NCT04848480|464539067|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
129068550|NCT04848480|464539068|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
129068551|NCT04848480|464539067|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
129068552|NCT04848480|464539068|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
129068553|NCT04848480|464539067|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
129068554|NCT04848480|464539068|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
128722985|NCT00337103|463283579|FG000|Overall Study|Progressive Disease|414|||
128722986|NCT00337103|463283580|FG001|Overall Study|Progressive Disease|410|||
129068555|NCT04848480|464539067|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
129068556|NCT04848480|464539068|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
129068557|NCT03176134|464539069|FG000|Overall Study|Lost to Follow-up|0|||
129138898|NCT06048705|464800644|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
129138899|NCT06048705|464800645|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
129138900|NCT06048705|464800646|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
129138901|NCT06048705|464800644|FG000|Overall Study|Death prior to lymphodepletion|0|||
129138902|NCT06048705|464800645|FG001|Overall Study|Death prior to lymphodepletion|0|||
129138903|NCT06048705|464800646|FG002|Overall Study|Death prior to lymphodepletion|1|||
129138904|NCT01016015|464800647|FG000|Overall Study|Not Treated|3|||
129138905|NCT01016015|464800647|FG000|Overall Study|Withdrawal by Subject|1|||
129138906|NCT01016015|464800647|FG000|Overall Study|Adverse Event|15|||
129138907|NCT04648241|464800648|FG000|Overall Study|Lost to Follow-up|1|||
129138908|NCT04648241|464800649|FG001|Overall Study|Lost to Follow-up|0|||
129138909|NCT02057666|464800650|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
129138910|NCT02057666|464800651|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
129138911|NCT02057666|464800650|FG000|Double Blind Treatment Period|Poor tolerability|7|||
129138912|NCT02057666|464800651|FG001|Double Blind Treatment Period|Poor tolerability|2|||
129138913|NCT02057666|464800650|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
129138914|NCT02057666|464800651|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
129138915|NCT02057666|464800650|FG000|Double Blind Treatment Period|Physician Decision|1|||
129138916|NCT02057666|464800651|FG001|Double Blind Treatment Period|Physician Decision|0|||
129138917|NCT02057666|464800650|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
129138918|NCT02057666|464800651|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
129138919|NCT02057666|464800650|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
129138920|NCT02057666|464800651|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
129138921|NCT02057666|464800650|FG000|Double Blind Treatment Period|Sponsor's request|70|||
129138922|NCT02057666|464800651|FG001|Double Blind Treatment Period|Sponsor's request|34|||
129138923|NCT02057666|464800650|FG000|Open-Label Treatment Period|Poor tolerability|0|||
129138924|NCT02057666|464800651|FG001|Open-Label Treatment Period|Poor tolerability|1|||
129138925|NCT02057666|464800650|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
129138926|NCT02057666|464800651|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
129138927|NCT02057666|464800650|FG000|Open-Label Treatment Period|Sponsor's request|0|||
129138928|NCT02057666|464800651|FG001|Open-Label Treatment Period|Sponsor's request|4|||
129138929|NCT01793129|464802593|FG000|Overall Study|Lost to Follow-up|3|||
129138930|NCT01793129|464802594|FG001|Overall Study|Lost to Follow-up|7|||
129138931|NCT01793129|464802593|FG000|Overall Study|Withdrawal by Subject|0|||
129138932|NCT01793129|464802594|FG001|Overall Study|Withdrawal by Subject|2|||
129138933|NCT01428713|464802597|FG000|Overall Study|Non-compliance|2|||
129138934|NCT01428713|464802598|FG001|Overall Study|Non-compliance|2|||
129138935|NCT01428713|464802597|FG000|Overall Study|Withdrawal by Subject|1|||
129138936|NCT01428713|464802598|FG001|Overall Study|Withdrawal by Subject|1|||
129138937|NCT01428713|464802597|FG000|Overall Study|Adverse Event|0|||
129138938|NCT01428713|464802598|FG001|Overall Study|Adverse Event|2|||
129138939|NCT00862277|464802599|FG000|Overall Study|Protocol Violation|1|||
129138940|NCT00862277|464802600|FG001|Overall Study|Protocol Violation|2|||
129138941|NCT00862277|464802601|FG002|Overall Study|Protocol Violation|5|||
129138942|NCT00871000|464802602|FG000|Overall Study|Withdrawal by Subject|1|||
129138943|NCT00871000|464802603|FG001|Overall Study|Withdrawal by Subject|0|||
129138944|NCT01052428|464802604|FG000|Overall Study|Death|1|||
129138945|NCT01052428|464802605|FG001|Overall Study|Death|0|||
129138946|NCT01052428|464802604|FG000|Overall Study|Withdrawal by Subject|0|||
129138947|NCT01052428|464802605|FG001|Overall Study|Withdrawal by Subject|1|||
129138948|NCT04432298|464802606|FG000|Overall Study|Other than specified|1|||
129138949|NCT04432298|464802607|FG001|Overall Study|Other than specified|0|||
129138950|NCT04432298|464802606|FG000|Overall Study|Lost to Follow-up|0|||
129138951|NCT04432298|464802607|FG001|Overall Study|Lost to Follow-up|1|||
129138952|NCT04432298|464802606|FG000|Overall Study|Death|3|||
129138953|NCT04432298|464802607|FG001|Overall Study|Death|2|||
129138954|NCT04432298|464802606|FG000|Overall Study|Withdrawal by Subject|2|||
129138955|NCT04432298|464802607|FG001|Overall Study|Withdrawal by Subject|0|||
129138956|NCT02451007|464802608|FG000|Overall Study|Withdrawal by Subject|4|||
129138957|NCT02451007|464802608|FG000|Overall Study|Adverse Event|1|||
129138958|NCT02451007|464802608|FG000|Overall Study|Disease Progression|2|||
129138959|NCT00605657|464802610|FG000|Overall Study|Adverse Event|1|||
129138960|NCT00605657|464802610|FG000|Overall Study|Protocol Violation|1|||
129138961|NCT01034657|464802612|FG000|Core Phase|Withdrawal by Subject|1|||
129138962|NCT01034657|464802613|FG001|Core Phase|Withdrawal by Subject|0|||
129138963|NCT01034657|464802614|FG002|Core Phase|Withdrawal by Subject|0|||
129138964|NCT01034657|464802612|FG000|Core Phase|Lack of Efficacy|2|||
129138965|NCT01034657|464802613|FG001|Core Phase|Lack of Efficacy|0|||
129138966|NCT01034657|464802614|FG002|Core Phase|Lack of Efficacy|0|||
129138967|NCT01034657|464802612|FG000|Core Phase|Abnormal laboratory value|1|||
129138968|NCT01034657|464802613|FG001|Core Phase|Abnormal laboratory value|0|||
129138969|NCT01034657|464802614|FG002|Core Phase|Abnormal laboratory value|0|||
129138970|NCT01034657|464802612|FG000|Core Phase|Adverse Event|8|||
129138971|NCT01034657|464802613|FG001|Core Phase|Adverse Event|0|||
129138972|NCT01034657|464802614|FG002|Core Phase|Adverse Event|0|||
129068558|NCT03176134|464539070|FG001|Overall Study|Lost to Follow-up|2|||
129068559|NCT03176134|464539071|FG002|Overall Study|Lost to Follow-up|0|||
129068560|NCT03176134|464539072|FG003|Overall Study|Lost to Follow-up|0|||
129068561|NCT03176134|464539073|FG004|Overall Study|Lost to Follow-up|0|||
129068562|NCT03176134|464539074|FG005|Overall Study|Lost to Follow-up|0|||
129068563|NCT03176134|464539075|FG006|Overall Study|Lost to Follow-up|0|||
129068564|NCT03176134|464539076|FG007|Overall Study|Lost to Follow-up|0|||
129068565|NCT03176134|464539069|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129068566|NCT03176134|464539070|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129068567|NCT03176134|464539071|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129068568|NCT03176134|464539072|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129068569|NCT03176134|464539073|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129068570|NCT03176134|464539074|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129068571|NCT03176134|464539075|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
129068572|NCT03176134|464539076|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
128722987|NCT00337103|463283579|FG000|Overall Study|Adverse Event|45|||
128722988|NCT00337103|463283580|FG001|Overall Study|Adverse Event|59|||
128722989|NCT00337103|463283579|FG000|Overall Study|Subject Choice|34|||
128722990|NCT00337103|463283580|FG001|Overall Study|Subject Choice|27|||
128722991|NCT00337103|463283579|FG000|Overall Study|Clinical Progression|27|||
128722992|NCT00337103|463283580|FG001|Overall Study|Clinical Progression|24|||
128722993|NCT00337103|463283579|FG000|Overall Study|Physician Decision|15|||
128722994|NCT00337103|463283580|FG001|Overall Study|Physician Decision|14|||
128722995|NCT00337103|463283579|FG000|Overall Study|Withdrawal by Subject|8|||
128722996|NCT00337103|463283580|FG001|Overall Study|Withdrawal by Subject|5|||
128722997|NCT00337103|463283579|FG000|Overall Study|Other|5|||
128722998|NCT00337103|463283580|FG001|Overall Study|Other|6|||
128722999|NCT00337103|463283579|FG000|Overall Study|Entry Criteria Not Met|4|||
128723000|NCT00337103|463283580|FG001|Overall Study|Entry Criteria Not Met|1|||
128723001|NCT00337103|463283579|FG000|Overall Study|Lost to Follow-up|1|||
128723002|NCT00337103|463283580|FG001|Overall Study|Lost to Follow-up|2|||
128723003|NCT00337103|463283579|FG000|Overall Study|Death|1|||
128723004|NCT00337103|463283580|FG001|Overall Study|Death|0|||
128723005|NCT01577758|463283581|FG000|Dose Escalation Phase|Adverse Event|0|||
128723006|NCT01577758|463283582|FG001|Dose Escalation Phase|Adverse Event|0|||
128723007|NCT01577758|463283583|FG002|Dose Escalation Phase|Adverse Event|0|||
128723008|NCT01577758|463283584|FG003|Dose Escalation Phase|Adverse Event|0|||
128723009|NCT01577758|463283585|FG004|Dose Escalation Phase|Adverse Event|0|||
128723010|NCT01577758|463283586|FG005|Dose Escalation Phase|Adverse Event|2|||
128723011|NCT01577758|463283587|FG006|Dose Escalation Phase|Adverse Event|1|||
128723012|NCT01577758|463283588|FG007|Dose Escalation Phase|Adverse Event|0|||
128723013|NCT01577758|463283581|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
128723014|NCT01577758|463283582|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
128723015|NCT01577758|463283583|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
128723016|NCT01577758|463283584|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
128723017|NCT01577758|463283585|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
128723018|NCT01577758|463283586|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
128723019|NCT01577758|463283587|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
128723020|NCT01577758|463283588|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
128723021|NCT01577758|463283581|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
128723022|NCT01577758|463283582|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
128723023|NCT01577758|463283583|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
128723024|NCT01577758|463283584|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
128723025|NCT01577758|463283585|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
128723026|NCT01577758|463283586|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
128723027|NCT01577758|463283587|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
128723028|NCT01577758|463283588|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
128723029|NCT01577758|463283581|FG000|Dose Escalation Phase|Progression Disease|2|||
128723030|NCT01577758|463283582|FG001|Dose Escalation Phase|Progression Disease|2|||
128723031|NCT01577758|463283583|FG002|Dose Escalation Phase|Progression Disease|1|||
128723032|NCT01577758|463283584|FG003|Dose Escalation Phase|Progression Disease|2|||
128723033|NCT01577758|463283585|FG004|Dose Escalation Phase|Progression Disease|5|||
128723034|NCT01577758|463283586|FG005|Dose Escalation Phase|Progression Disease|0|||
128723035|NCT01577758|463283587|FG006|Dose Escalation Phase|Progression Disease|0|||
128723036|NCT01577758|463283588|FG007|Dose Escalation Phase|Progression Disease|0|||
128723037|NCT01577758|463283581|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
128723038|NCT01577758|463283582|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
128723039|NCT01577758|463283583|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
128723040|NCT01577758|463283584|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
128723041|NCT01577758|463283585|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129068573|NCT01368497|464539077|FG000|Overall Study|Lost to Follow-up|2|||
129068574|NCT05989672|464539079|FG000|Overall Study|Adverse Event|3|||
129068575|NCT05989672|464539080|FG001|Overall Study|Adverse Event|0|||
129068576|NCT05989672|464539081|FG002|Overall Study|Adverse Event|0|||
129068577|NCT00443729|464539082|FG000|Overall Study|Never Treated|0|||
129138973|NCT01034657|464802612|FG000|Core Phase|Protocol Violation|2|||
129138974|NCT01034657|464802613|FG001|Core Phase|Protocol Violation|0|||
129138975|NCT01034657|464802614|FG002|Core Phase|Protocol Violation|0|||
129138976|NCT01034657|464802612|FG000|Randomized Phase|Withdrawal by Subject|0|||
129138977|NCT01034657|464802613|FG001|Randomized Phase|Withdrawal by Subject|2|||
129138978|NCT01034657|464802614|FG002|Randomized Phase|Withdrawal by Subject|0|||
129138979|NCT01034657|464802612|FG000|Randomized Phase|Lack of Efficacy|5|||
129138980|NCT01034657|464802613|FG001|Randomized Phase|Lack of Efficacy|1|||
129138981|NCT01034657|464802614|FG002|Randomized Phase|Lack of Efficacy|0|||
129138982|NCT01034657|464802612|FG000|Randomized Phase|Abnormal laboratory value|0|||
129138983|NCT01034657|464802613|FG001|Randomized Phase|Abnormal laboratory value|1|||
129138984|NCT01034657|464802614|FG002|Randomized Phase|Abnormal laboratory value|0|||
129138985|NCT01034657|464802612|FG000|Randomized Phase|Adverse Event|0|||
129138986|NCT01034657|464802613|FG001|Randomized Phase|Adverse Event|2|||
129138987|NCT01034657|464802614|FG002|Randomized Phase|Adverse Event|1|||
129138988|NCT01791205|464802615|FG000|Phase II|Lack of Efficacy|6|||
129138989|NCT01791205|464802616|FG001|Phase II|Lack of Efficacy|0|||
129138990|NCT01791205|464802615|FG000|Phase II|Adverse Event|2|||
129138991|NCT01791205|464802616|FG001|Phase II|Adverse Event|0|||
129138992|NCT01791205|464802615|FG000|Phase II|Safety|1|||
129138993|NCT01791205|464802616|FG001|Phase II|Safety|0|||
129138994|NCT01791205|464802615|FG000|Phase II|Lost to Follow-up|1|||
129138995|NCT01791205|464802616|FG001|Phase II|Lost to Follow-up|0|||
129138996|NCT01791205|464802615|FG000|Phase II|Remission of disease|1|||
129138997|NCT01791205|464802616|FG001|Phase II|Remission of disease|0|||
129138998|NCT01791205|464802615|FG000|Phase II|Physician's decision|1|||
129138999|NCT01791205|464802616|FG001|Phase II|Physician's decision|0|||
129139000|NCT02242903|464802627|FG000|Overall Study|Withdrawal by Subject|1|||
129139001|NCT02242903|464802628|FG001|Overall Study|Withdrawal by Subject|0|||
129139002|NCT02242903|464802629|FG002|Overall Study|Withdrawal by Subject|0|||
129139003|NCT02242903|464802630|FG003|Overall Study|Withdrawal by Subject|0|||
129139004|NCT02242903|464802631|FG004|Overall Study|Withdrawal by Subject|0|||
129139005|NCT02242903|464802632|FG005|Overall Study|Withdrawal by Subject|0|||
129139006|NCT02242903|464802633|FG006|Overall Study|Withdrawal by Subject|0|||
129139007|NCT01546987|464802638|FG000|Overall Study|Protocol Violation|3|||
129139008|NCT01546987|464802639|FG001|Overall Study|Protocol Violation|4|||
129139009|NCT03596983|464802642|FG000|Overall Study|Withdrawal by Subject|3|||
129139010|NCT03473301|464802643|FG000|Overall Study|Protocol Violation|4|||
129139011|NCT03473301|464802644|FG001|Overall Study|Protocol Violation|0|||
129139012|NCT03473301|464802645|FG002|Overall Study|Protocol Violation|0|||
129139013|NCT03473301|464802643|FG000|Overall Study|Withdrawal by Subject|0|||
129139014|NCT03473301|464802644|FG001|Overall Study|Withdrawal by Subject|1|||
129139015|NCT03473301|464802645|FG002|Overall Study|Withdrawal by Subject|0|||
129139016|NCT03473301|464802643|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
128723042|NCT01577758|463283586|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
128723043|NCT01577758|463283587|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
128723044|NCT01577758|463283588|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
129068578|NCT00443729|464539083|FG001|Overall Study|Never Treated|1|||
129068579|NCT00443729|464539082|FG000|Overall Study|Lack of Efficacy|4|||
129068580|NCT00443729|464539083|FG001|Overall Study|Lack of Efficacy|2|||
129068581|NCT00443729|464539082|FG000|Overall Study|Lost to Follow-up|0|||
129068582|NCT00443729|464539083|FG001|Overall Study|Lost to Follow-up|1|||
129068583|NCT00443729|464539082|FG000|Overall Study|Physician Decision|2|||
129068584|NCT00443729|464539083|FG001|Overall Study|Physician Decision|1|||
129068585|NCT00443729|464539082|FG000|Overall Study|Protocol Violation|1|||
129068586|NCT00443729|464539083|FG001|Overall Study|Protocol Violation|1|||
129068587|NCT00443729|464539082|FG000|Overall Study|Withdrawal by Subject|3|||
129068588|NCT00443729|464539083|FG001|Overall Study|Withdrawal by Subject|1|||
129068589|NCT03718832|464539086|FG000|Analysis Sample|Withdrawal by Subject|18|||
129068590|NCT03718832|464539087|FG001|Analysis Sample|Withdrawal by Subject|15|||
129139017|NCT03473301|464802644|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
129139018|NCT03473301|464802645|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
129139019|NCT05287685|464802646|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
129139020|NCT05287685|464802647|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
129139021|NCT05287685|464802646|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
129139022|NCT05287685|464802647|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
129139023|NCT03093870|464802648|FG000|Overall Study|Withdrawal by Subject|2|||
129139024|NCT03093870|464802649|FG001|Overall Study|Withdrawal by Subject|6|||
128723045|NCT01577758|463283581|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
129139025|NCT03093870|464802650|FG002|Overall Study|Withdrawal by Subject|5|||
129139026|NCT03093870|464802648|FG000|Overall Study|Death|1|||
129139027|NCT03093870|464802649|FG001|Overall Study|Death|35|||
129139028|NCT03093870|464802650|FG002|Overall Study|Death|35|||
129139029|NCT03093870|464802648|FG000|Overall Study|Radiographic disease progression|10|||
129068591|NCT03718832|464539086|FG000|Analysis Sample|Legal hold on data|1|||
129068592|NCT03718832|464539087|FG001|Analysis Sample|Legal hold on data|0|||
129068593|NCT03718832|464539086|FG000|Analysis Sample|Participant from treated household|0|||
129068594|NCT03718832|464539087|FG001|Analysis Sample|Participant from treated household|1|||
129068595|NCT03718832|464539086|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
129068596|NCT03718832|464539087|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
129068597|NCT03288714|464539091|FG000|Overall Study|Lost to Follow-up|2|||
129068598|NCT03288714|464539092|FG001|Overall Study|Lost to Follow-up|1|||
129068599|NCT03288714|464539091|FG000|Overall Study|Non-compliance with study schedule|2|||
129068600|NCT03288714|464539092|FG001|Overall Study|Non-compliance with study schedule|0|||
129068601|NCT03288714|464539091|FG000|Overall Study|Withdrawal by Subject|3|||
129068602|NCT03288714|464539092|FG001|Overall Study|Withdrawal by Subject|1|||
129068603|NCT03288714|464539091|FG000|Overall Study|Clinical Worsening|2|||
129068604|NCT03288714|464539092|FG001|Overall Study|Clinical Worsening|1|||
129068605|NCT03288714|464539091|FG000|Overall Study|Adverse Event|1|||
129068606|NCT03288714|464539092|FG001|Overall Study|Adverse Event|0|||
129068607|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
129068608|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
129068609|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
129068610|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068611|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
129068612|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
129068613|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068614|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068615|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068616|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068617|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068618|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068619|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068620|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068621|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068622|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068623|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129068624|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
129068625|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068626|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
129068627|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
129068628|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
129068629|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
129068630|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068631|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068632|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068633|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068634|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068635|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068636|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068637|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068638|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068639|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068640|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129068641|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
129068642|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
129068643|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
129068644|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
129068645|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
129068646|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
129068647|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068648|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068649|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068650|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068651|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068652|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068653|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068654|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068655|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068656|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068657|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129068658|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
128776144|NCT02268552|463470355|FG000|Part 1|Death|1|||
128776145|NCT02268552|463470356|FG001|Part 1|Death|1|||
128776146|NCT02268552|463470357|FG002|Part 1|Death|1|||
128776147|NCT02268552|463470358|FG003|Part 1|Death|2|||
128776148|NCT02268552|463470359|FG004|Part 1|Death|0|||
128776149|NCT02268552|463470360|FG005|Part 1|Death|0|||
128776150|NCT02268552|463470361|FG006|Part 1|Death|0|||
128776151|NCT02268552|463470355|FG000|Part 1|Subject/guardian decision|0|||
128776152|NCT02268552|463470356|FG001|Part 1|Subject/guardian decision|0|||
128776153|NCT02268552|463470357|FG002|Part 1|Subject/guardian decision|0|||
128776154|NCT02268552|463470358|FG003|Part 1|Subject/guardian decision|1|||
128776155|NCT02268552|463470359|FG004|Part 1|Subject/guardian decision|0|||
128776156|NCT02268552|463470360|FG005|Part 1|Subject/guardian decision|0|||
128776157|NCT02268552|463470361|FG006|Part 1|Subject/guardian decision|0|||
128776158|NCT02268552|463470355|FG000|Part 2|Death|0|||
128776159|NCT02268552|463470356|FG001|Part 2|Death|0|||
129068659|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
129068660|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
129068661|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068662|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
129068663|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
129068664|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068665|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068666|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068667|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068668|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068669|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068670|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068671|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068672|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068673|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068674|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129068675|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068676|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068677|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
129068678|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
129068679|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068680|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068681|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068682|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068683|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068684|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068685|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068686|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068687|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068688|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068689|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068690|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068691|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129068692|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068693|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068694|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068695|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068696|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
129068697|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129139030|NCT03093870|464802649|FG001|Overall Study|Radiographic disease progression|0|||
129139031|NCT03093870|464802650|FG002|Overall Study|Radiographic disease progression|0|||
129139032|NCT03093870|464802648|FG000|Overall Study|Clinical disease progression|1|||
129139033|NCT03093870|464802649|FG001|Overall Study|Clinical disease progression|0|||
129139034|NCT03093870|464802650|FG002|Overall Study|Clinical disease progression|0|||
129139035|NCT03093870|464802648|FG000|Overall Study|Physician Decision|2|||
129139036|NCT03093870|464802649|FG001|Overall Study|Physician Decision|0|||
129139037|NCT03093870|464802650|FG002|Overall Study|Physician Decision|0|||
129139038|NCT03093870|464802648|FG000|Overall Study|Adverse Event|7|||
129139039|NCT03093870|464802649|FG001|Overall Study|Adverse Event|0|||
129139040|NCT03093870|464802650|FG002|Overall Study|Adverse Event|0|||
129139041|NCT03093870|464802648|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
129139042|NCT03093870|464802649|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
128776160|NCT02268552|463470357|FG002|Part 2|Death|0|||
128776161|NCT02268552|463470358|FG003|Part 2|Death|0|||
128776162|NCT02268552|463470359|FG004|Part 2|Death|0|||
128776163|NCT02268552|463470360|FG005|Part 2|Death|0|||
129068698|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068699|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068700|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068701|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068702|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068703|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068704|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068705|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068706|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068707|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068708|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129068709|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068710|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
129068711|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068712|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068713|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068714|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068715|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068716|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068717|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068718|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068719|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068720|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068721|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068722|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068723|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068724|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068725|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129068726|NCT00758524|464539093|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068727|NCT00758524|464539094|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
129068728|NCT00758524|464539095|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068729|NCT00758524|464539096|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068730|NCT00758524|464539097|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068731|NCT00758524|464539098|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068732|NCT00758524|464539099|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
128723046|NCT01577758|463283582|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
128723047|NCT01577758|463283583|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
128723048|NCT01577758|463283584|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
128723049|NCT01577758|463283585|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
128723050|NCT01577758|463283586|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
128723051|NCT01577758|463283587|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
128723052|NCT01577758|463283588|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
128723053|NCT01577758|463283581|FG000|mCRC Expansion Phase|Progression Disease|0|||
128723054|NCT01577758|463283582|FG001|mCRC Expansion Phase|Progression Disease|0|||
128723055|NCT01577758|463283583|FG002|mCRC Expansion Phase|Progression Disease|0|||
128723056|NCT01577758|463283584|FG003|mCRC Expansion Phase|Progression Disease|0|||
128723057|NCT01577758|463283585|FG004|mCRC Expansion Phase|Progression Disease|0|||
128723058|NCT01577758|463283586|FG005|mCRC Expansion Phase|Progression Disease|0|||
128723059|NCT01577758|463283587|FG006|mCRC Expansion Phase|Progression Disease|0|||
128723060|NCT01577758|463283588|FG007|mCRC Expansion Phase|Progression Disease|19|||
128723061|NCT04414553|463283591|FG000|Overall Study|Lost to Follow-up|20|||
128723062|NCT01085097|463283592|FG000|Overall Study|Adverse Event|0|||
128723063|NCT01085097|463283593|FG001|Overall Study|Adverse Event|0|||
128723064|NCT01085097|463283594|FG002|Overall Study|Adverse Event|2|||
128723065|NCT01085097|463283592|FG000|Overall Study|Treatment failure|2|||
128723066|NCT01085097|463283593|FG001|Overall Study|Treatment failure|0|||
128723067|NCT01085097|463283594|FG002|Overall Study|Treatment failure|0|||
128723068|NCT03519971|463283595|FG000|Overall Study|Death|142|||
128723069|NCT03519971|463283596|FG001|Overall Study|Death|69|||
128723070|NCT03519971|463283595|FG000|Overall Study|Lost to Follow-up|0|||
128723071|NCT03519971|463283596|FG001|Overall Study|Lost to Follow-up|1|||
128723072|NCT03519971|463283595|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
128723073|NCT03519971|463283596|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
128723074|NCT03519971|463283595|FG000|Overall Study|Withdrawal by Subject|3|||
128723075|NCT03519971|463283596|FG001|Overall Study|Withdrawal by Subject|2|||
128723076|NCT03519971|463283595|FG000|Overall Study|Other|1|||
129068733|NCT00758524|464539100|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
128723077|NCT03519971|463283596|FG001|Overall Study|Other|0|||
128723078|NCT03065244|463283601|FG000|Overall Study|Lost to Follow-up|1|||
129068734|NCT00758524|464539101|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068735|NCT00758524|464539102|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068736|NCT00758524|464539103|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068737|NCT00758524|464539104|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068738|NCT00758524|464539105|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068739|NCT00758524|464539106|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068740|NCT00758524|464539107|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068741|NCT00758524|464539108|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068742|NCT00758524|464539109|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129068743|NCT00758524|464539093|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068744|NCT00758524|464539094|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068745|NCT00758524|464539095|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068746|NCT00758524|464539096|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068747|NCT00758524|464539097|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068748|NCT00758524|464539098|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068749|NCT00758524|464539099|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068750|NCT00758524|464539100|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068751|NCT00758524|464539101|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
129068752|NCT00758524|464539102|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068753|NCT00758524|464539103|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068754|NCT00758524|464539104|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068755|NCT00758524|464539105|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068756|NCT00758524|464539106|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068757|NCT00758524|464539107|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068758|NCT00758524|464539108|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068759|NCT00758524|464539109|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129068760|NCT00758524|464539093|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
128723079|NCT03065244|463283602|FG001|Overall Study|Lost to Follow-up|1|||
128723080|NCT03065244|463283601|FG000|Overall Study|Diagnosed with a different disease|1|||
128723081|NCT03065244|463283602|FG001|Overall Study|Diagnosed with a different disease|1|||
128723082|NCT03065244|463283601|FG000|Overall Study|Protocol Violation|0|||
128723083|NCT03065244|463283602|FG001|Overall Study|Protocol Violation|1|||
128723084|NCT03065244|463283601|FG000|Overall Study|Withdrawal by Subject|1|||
128723085|NCT03065244|463283602|FG001|Overall Study|Withdrawal by Subject|1|||
128723086|NCT03717480|463283603|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
128723087|NCT01708174|463283606|FG000|Treatment Period|Withdrawal by Subject|1|||
128723088|NCT01708174|463283607|FG001|Treatment Period|Withdrawal by Subject|0|||
128723089|NCT01708174|463283608|FG002|Treatment Period|Withdrawal by Subject|0|||
128723090|NCT01708174|463283606|FG000|Treatment Period|Progressive disease|0|||
128723091|NCT01708174|463283607|FG001|Treatment Period|Progressive disease|1|||
128723092|NCT01708174|463283608|FG002|Treatment Period|Progressive disease|0|||
128723093|NCT01708174|463283606|FG000|Treatment Period|Death|0|||
128723094|NCT01708174|463283607|FG001|Treatment Period|Death|0|||
128723095|NCT01708174|463283608|FG002|Treatment Period|Death|1|||
128723096|NCT01708174|463283606|FG000|Treatment Period|Adverse Event|0|||
128723097|NCT01708174|463283607|FG001|Treatment Period|Adverse Event|1|||
128723098|NCT01708174|463283608|FG002|Treatment Period|Adverse Event|0|||
128723099|NCT01774786|463283609|FG000|Overall Study|Death|300|||
128723100|NCT01774786|463283610|FG001|Overall Study|Death|319|||
128723101|NCT01774786|463283609|FG000|Overall Study|Lost to Follow-up|6|||
128723102|NCT01774786|463283610|FG001|Overall Study|Lost to Follow-up|7|||
128723103|NCT01774786|463283609|FG000|Overall Study|Withdrawal by Subject|18|||
128723104|NCT01774786|463283610|FG001|Overall Study|Withdrawal by Subject|14|||
128723105|NCT01774786|463283609|FG000|Overall Study|Physician Decision|2|||
128723106|NCT01774786|463283610|FG001|Overall Study|Physician Decision|0|||
128723107|NCT01774786|463283609|FG000|Overall Study|Non-compliance|0|||
128723108|NCT01774786|463283610|FG001|Overall Study|Non-compliance|1|||
128723109|NCT01774786|463283609|FG000|Overall Study|Reason Not Specified|2|||
128723110|NCT01774786|463283610|FG001|Overall Study|Reason Not Specified|5|||
128723111|NCT02385084|463283611|FG000|Period 2|Protocol Violation|0|||
128723112|NCT02385084|463283612|FG001|Period 2|Protocol Violation|0|||
128723113|NCT02385084|463283613|FG002|Period 2|Protocol Violation|1|||
128723114|NCT02385084|463283614|FG003|Period 2|Protocol Violation|0|||
128723115|NCT02385084|463283615|FG004|Period 2|Protocol Violation|0|||
128723116|NCT02385084|463283616|FG005|Period 2|Protocol Violation|0|||
128723117|NCT02965703|463283622|FG000|Overall Study|Withdrawal by Subject|6|||
128723118|NCT02965703|463283623|FG001|Overall Study|Withdrawal by Subject|3|||
128723119|NCT02965703|463283624|FG002|Overall Study|Withdrawal by Subject|1|||
128723120|NCT02965703|463283622|FG000|Overall Study|Protocol Violation|1|||
128723121|NCT02965703|463283623|FG001|Overall Study|Protocol Violation|0|||
128723122|NCT02965703|463283624|FG002|Overall Study|Protocol Violation|0|||
129068761|NCT00758524|464539094|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068762|NCT00758524|464539095|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068763|NCT00758524|464539096|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068764|NCT00758524|464539097|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068765|NCT00758524|464539098|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068766|NCT00758524|464539099|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
129068767|NCT00758524|464539100|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068768|NCT00758524|464539101|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068769|NCT00758524|464539102|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068770|NCT00758524|464539103|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068771|NCT00758524|464539104|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068772|NCT00758524|464539105|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068773|NCT00758524|464539106|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068774|NCT00758524|464539107|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068775|NCT00758524|464539108|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068776|NCT00758524|464539109|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129068777|NCT00276484|464539110|FG000|Overall Study|Adverse Event|4|||
129068778|NCT00276484|464539111|FG001|Overall Study|Adverse Event|7|||
129068779|NCT00276484|464539110|FG000|Overall Study|Lost to Follow-up|1|||
129068780|NCT00276484|464539111|FG001|Overall Study|Lost to Follow-up|1|||
129068781|NCT00276484|464539110|FG000|Overall Study|Protocol Violation|0|||
129068782|NCT00276484|464539111|FG001|Overall Study|Protocol Violation|1|||
129068783|NCT00276484|464539110|FG000|Overall Study|Withdrawal by Subject|4|||
129068784|NCT00276484|464539111|FG001|Overall Study|Withdrawal by Subject|3|||
129068785|NCT00276484|464539110|FG000|Overall Study|Could not take time off work|0|||
128723123|NCT02965703|463283622|FG000|Overall Study|Adverse Event|1|||
128723124|NCT02965703|463283623|FG001|Overall Study|Adverse Event|1|||
129068786|NCT00276484|464539111|FG001|Overall Study|Could not take time off work|1|||
129068787|NCT01626690|464539115|FG000|Overall Study|Protocol Violation|1|||
129068788|NCT01626690|464539116|FG001|Overall Study|Protocol Violation|0|||
128723125|NCT02965703|463283624|FG002|Overall Study|Adverse Event|0|||
129139043|NCT03093870|464802650|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
129139044|NCT03093870|464802648|FG000|Overall Study|Lost to Follow-up|0|||
129139045|NCT03093870|464802649|FG001|Overall Study|Lost to Follow-up|0|||
129139046|NCT03093870|464802650|FG002|Overall Study|Lost to Follow-up|1|||
129139047|NCT03722030|464802656|FG000|Overall Study|Withdrawal by Subject|1|||
129139048|NCT03722030|464802657|FG001|Overall Study|Withdrawal by Subject|0|||
129139049|NCT02191397|464802659|FG000|Overall Study|Adverse Event|28|||
129139050|NCT02191397|464802660|FG001|Overall Study|Adverse Event|17|||
129139051|NCT02191397|464802659|FG000|Overall Study|Lack of Efficacy|10|||
129139052|NCT02191397|464802660|FG001|Overall Study|Lack of Efficacy|5|||
129139053|NCT02191397|464802659|FG000|Overall Study|Protocol Violation|0|||
129139054|NCT02191397|464802660|FG001|Overall Study|Protocol Violation|3|||
129139055|NCT02191397|464802659|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
129139056|NCT02191397|464802660|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
129139057|NCT02191397|464802659|FG000|Overall Study|Lost to Follow-up|10|||
129139058|NCT02191397|464802660|FG001|Overall Study|Lost to Follow-up|11|||
129139059|NCT02191397|464802659|FG000|Overall Study|Physician Decision|8|||
129139060|NCT02191397|464802660|FG001|Overall Study|Physician Decision|3|||
129139061|NCT02191397|464802659|FG000|Overall Study|Withdrawal by Subject|22|||
129139062|NCT02191397|464802660|FG001|Overall Study|Withdrawal by Subject|27|||
129139063|NCT01905267|464802661|FG000|Overall Study|Physician Decision|2|||
129139064|NCT01905267|464802662|FG001|Overall Study|Physician Decision|2|||
129139065|NCT03721107|464802663|FG000|Overall Study|Adverse Event|1|||
129139066|NCT03721107|464802664|FG001|Overall Study|Adverse Event|1|||
129139067|NCT03721107|464802665|FG002|Overall Study|Adverse Event|6|||
129139068|NCT03721107|464802666|FG003|Overall Study|Adverse Event|5|||
129139069|NCT03721107|464802663|FG000|Overall Study|Lost to Follow-up|2|||
129139070|NCT03721107|464802664|FG001|Overall Study|Lost to Follow-up|0|||
129139071|NCT03721107|464802665|FG002|Overall Study|Lost to Follow-up|3|||
129139072|NCT03721107|464802666|FG003|Overall Study|Lost to Follow-up|0|||
129139073|NCT03721107|464802663|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
129139074|NCT03721107|464802664|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
129139075|NCT03721107|464802665|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
129139076|NCT03721107|464802666|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
129139077|NCT03721107|464802663|FG000|Overall Study|Physician Decision|0|||
129139078|NCT03721107|464802664|FG001|Overall Study|Physician Decision|1|||
129139079|NCT03721107|464802665|FG002|Overall Study|Physician Decision|0|||
129139080|NCT03721107|464802666|FG003|Overall Study|Physician Decision|0|||
129139081|NCT03721107|464802663|FG000|Overall Study|Pregnancy|0|||
129139082|NCT03721107|464802664|FG001|Overall Study|Pregnancy|0|||
129139083|NCT03721107|464802665|FG002|Overall Study|Pregnancy|1|||
129139084|NCT03721107|464802666|FG003|Overall Study|Pregnancy|0|||
129139085|NCT03721107|464802663|FG000|Overall Study|Withdrawal by Subject|1|||
128723126|NCT02965703|463283622|FG000|Overall Study|Lost to Follow-up|2|||
128723127|NCT02965703|463283623|FG001|Overall Study|Lost to Follow-up|1|||
128723128|NCT02965703|463283624|FG002|Overall Study|Lost to Follow-up|1|||
128723129|NCT02268786|463283625|FG000|Overall Study|No Euploid Embryos available|42|||
128723130|NCT02268786|463283626|FG001|Overall Study|No Euploid Embryos available|0|||
128723131|NCT02268786|463283625|FG000|Overall Study|Withdrawal by Subject|7|||
128723132|NCT02268786|463283626|FG001|Overall Study|Withdrawal by Subject|14|||
128723133|NCT02268786|463283625|FG000|Overall Study|Thaw Failure|6|||
128723134|NCT02268786|463283626|FG001|Overall Study|Thaw Failure|4|||
128723135|NCT02268786|463283625|FG000|Overall Study|Protocol Violation|1|||
128723136|NCT02268786|463283626|FG001|Overall Study|Protocol Violation|0|||
128723137|NCT00642668|463283627|FG000|Overall Study|Lost to Follow-up|1|||
128723138|NCT00642668|463283627|FG000|Overall Study|Adverse Event|2|||
128723139|NCT00642668|463283627|FG000|Overall Study|Death|2|||
128723140|NCT00642668|463283627|FG000|Overall Study|Insufficient Therapeutic Response|1|||
128723141|NCT00642668|463283627|FG000|Overall Study|Failure to Return|1|||
128723142|NCT00642668|463283627|FG000|Overall Study|Dialysis Initiation|5|||
128723143|NCT00642668|463283627|FG000|Overall Study|Blood Transfusion|2|||
128723144|NCT02910167|463283633|FG000|Overall Study|Adverse Event|1|||
128723145|NCT02910167|463283633|FG000|Overall Study|Lost to Follow-up|18|||
128723146|NCT01449526|463283634|FG000|Overall Study|Lost to Follow-up|1|||
128723147|NCT01449526|463283635|FG001|Overall Study|Lost to Follow-up|2|||
128723148|NCT01449526|463283634|FG000|Overall Study|Withdrawal by Subject|1|||
128723149|NCT01449526|463283635|FG001|Overall Study|Withdrawal by Subject|1|||
128723150|NCT01449526|463283634|FG000|Overall Study|Symptoms/complaints|0|||
128723151|NCT01449526|463283635|FG001|Overall Study|Symptoms/complaints|1|||
129139086|NCT03721107|464802664|FG001|Overall Study|Withdrawal by Subject|1|||
129139087|NCT03721107|464802665|FG002|Overall Study|Withdrawal by Subject|5|||
128723152|NCT01449526|463283634|FG000|Overall Study|Lack of Motivation|0|||
128723153|NCT01449526|463283635|FG001|Overall Study|Lack of Motivation|1|||
128723154|NCT01449526|463283634|FG000|Overall Study|Cannot maintain visits|0|||
129139088|NCT03721107|464802666|FG003|Overall Study|Withdrawal by Subject|5|||
129139089|NCT03721107|464802663|FG000|Overall Study|Other|1|||
129139090|NCT03721107|464802664|FG001|Overall Study|Other|0|||
129139091|NCT03721107|464802665|FG002|Overall Study|Other|0|||
128723155|NCT01449526|463283635|FG001|Overall Study|Cannot maintain visits|1|||
128723156|NCT01400516|463283636|FG000|Primary Trial|Withdrawal by Subject|0|||
128723157|NCT01400516|463283637|FG001|Primary Trial|Withdrawal by Subject|2|||
128776164|NCT02268552|463470361|FG006|Part 2|Death|2|||
128776165|NCT02268552|463470355|FG000|Part 2|Subject/guardian decision|0|||
128776166|NCT02268552|463470356|FG001|Part 2|Subject/guardian decision|0|||
128776167|NCT02268552|463470357|FG002|Part 2|Subject/guardian decision|0|||
128776168|NCT02268552|463470358|FG003|Part 2|Subject/guardian decision|0|||
128776169|NCT02268552|463470359|FG004|Part 2|Subject/guardian decision|0|||
128776170|NCT02268552|463470360|FG005|Part 2|Subject/guardian decision|0|||
128776171|NCT02268552|463470361|FG006|Part 2|Subject/guardian decision|1|||
128776172|NCT02268552|463470355|FG000|Part 3 Extension|Death|0|||
128776173|NCT02268552|463470356|FG001|Part 3 Extension|Death|1|||
128776174|NCT02268552|463470357|FG002|Part 3 Extension|Death|1|||
128776175|NCT02268552|463470358|FG003|Part 3 Extension|Death|1|||
128776176|NCT02268552|463470359|FG004|Part 3 Extension|Death|1|||
128776177|NCT02268552|463470360|FG005|Part 3 Extension|Death|1|||
128776178|NCT02268552|463470361|FG006|Part 3 Extension|Death|0|||
128776179|NCT02268552|463470355|FG000|Part 3 Extension|Early termination of trial|1|||
128776180|NCT02268552|463470356|FG001|Part 3 Extension|Early termination of trial|0|||
128776181|NCT02268552|463470357|FG002|Part 3 Extension|Early termination of trial|0|||
128776182|NCT02268552|463470358|FG003|Part 3 Extension|Early termination of trial|0|||
128776183|NCT02268552|463470359|FG004|Part 3 Extension|Early termination of trial|2|||
128776184|NCT02268552|463470360|FG005|Part 3 Extension|Early termination of trial|9|||
128723158|NCT01132495|463283644|FG000|Overall Study|Various reasons|40|||
128723159|NCT01132495|463283645|FG001|Overall Study|Various reasons|38|||
128723160|NCT01132495|463283646|FG002|Overall Study|Various reasons|20|||
128723161|NCT01132495|463283647|FG003|Overall Study|Various reasons|12|||
128723162|NCT00082433|463283648|FG000|Overall Study|Adverse Event|12|||
128723163|NCT00082433|463283649|FG001|Overall Study|Adverse Event|17|||
128723164|NCT00082433|463283648|FG000|Overall Study|Death|8|||
128723165|NCT00082433|463283649|FG001|Overall Study|Death|18|||
128723166|NCT00082433|463283648|FG000|Overall Study|Disease Progression/Relapse|270|||
128723167|NCT00082433|463283649|FG001|Overall Study|Disease Progression/Relapse|388|||
128723168|NCT00082433|463283648|FG000|Overall Study|Physician Decision|50|||
128723169|NCT00082433|463283649|FG001|Overall Study|Physician Decision|61|||
128723170|NCT00082433|463283648|FG000|Overall Study|Lost to Follow-up|1|||
128723171|NCT00082433|463283649|FG001|Overall Study|Lost to Follow-up|2|||
128723172|NCT00082433|463283648|FG000|Overall Study|Study Drug Toxicity|179|||
128723173|NCT00082433|463283649|FG001|Overall Study|Study Drug Toxicity|66|||
128723174|NCT00082433|463283648|FG000|Overall Study|Withdrawal by Subject|55|||
128723175|NCT00082433|463283649|FG001|Overall Study|Withdrawal by Subject|30|||
128723176|NCT00082433|463283648|FG000|Overall Study|Still On Treatment|2|||
128723177|NCT00082433|463283649|FG001|Overall Study|Still On Treatment|1|||
128723178|NCT00082433|463283648|FG000|Overall Study|Not Treated|12|||
128723179|NCT00082433|463283649|FG001|Overall Study|Not Treated|11|||
128723180|NCT00082433|463283648|FG000|Overall Study|Ineligible|2|||
128723181|NCT00082433|463283649|FG001|Overall Study|Ineligible|1|||
128723182|NCT00082433|463283648|FG000|Overall Study|Noncompliance|2|||
128723183|NCT00082433|463283649|FG001|Overall Study|Noncompliance|1|||
128723184|NCT00082433|463283648|FG000|Overall Study|New primary cancer|1|||
128723185|NCT00082433|463283649|FG001|Overall Study|New primary cancer|0|||
128723186|NCT00082433|463283648|FG000|Overall Study|Impending surgery|0|||
128723187|NCT00082433|463283649|FG001|Overall Study|Impending surgery|1|||
128723188|NCT04097821|463283650|FG000|Overall Study|Subject Decision|0|||
128723189|NCT04097821|463283651|FG001|Overall Study|Subject Decision|0|||
128723190|NCT04097821|463283652|FG002|Overall Study|Subject Decision|0|||
128723191|NCT04097821|463283653|FG003|Overall Study|Subject Decision|1|||
128723192|NCT04097821|463283654|FG004|Overall Study|Subject Decision|2|||
128723193|NCT04097821|463283655|FG005|Overall Study|Subject Decision|2|||
128723194|NCT04097821|463283656|FG006|Overall Study|Subject Decision|0|||
128723195|NCT04097821|463283657|FG007|Overall Study|Subject Decision|1|||
128723196|NCT04097821|463283650|FG000|Overall Study|Death|0|||
128723197|NCT04097821|463283651|FG001|Overall Study|Death|0|||
128776185|NCT02268552|463470361|FG006|Part 3 Extension|Early termination of trial|11|||
128776186|NCT02268552|463470355|FG000|Part 3 Extension|Subject/guardian decision|0|||
128776187|NCT02268552|463470356|FG001|Part 3 Extension|Subject/guardian decision|0|||
128776188|NCT02268552|463470357|FG002|Part 3 Extension|Subject/guardian decision|0|||
128776189|NCT02268552|463470358|FG003|Part 3 Extension|Subject/guardian decision|0|||
128723198|NCT04097821|463283652|FG002|Overall Study|Death|3|||
128723199|NCT04097821|463283653|FG003|Overall Study|Death|1|||
128723200|NCT04097821|463283654|FG004|Overall Study|Death|0|||
128776190|NCT02268552|463470359|FG004|Part 3 Extension|Subject/guardian decision|0|||
128723201|NCT04097821|463283655|FG005|Overall Study|Death|0|||
128723202|NCT04097821|463283656|FG006|Overall Study|Death|0|||
128723203|NCT04097821|463283657|FG007|Overall Study|Death|0|||
128723204|NCT04097821|463283650|FG000|Overall Study|Physician Decision|1|||
128723205|NCT04097821|463283651|FG001|Overall Study|Physician Decision|2|||
128723206|NCT04097821|463283652|FG002|Overall Study|Physician Decision|0|||
128723207|NCT04097821|463283653|FG003|Overall Study|Physician Decision|0|||
128723208|NCT04097821|463283654|FG004|Overall Study|Physician Decision|0|||
128723209|NCT04097821|463283655|FG005|Overall Study|Physician Decision|0|||
128723210|NCT04097821|463283656|FG006|Overall Study|Physician Decision|0|||
128723211|NCT04097821|463283657|FG007|Overall Study|Physician Decision|0|||
128723212|NCT04097821|463283650|FG000|Overall Study|Adverse Event|0|||
128776191|NCT02268552|463470360|FG005|Part 3 Extension|Subject/guardian decision|0|||
128776192|NCT02268552|463470361|FG006|Part 3 Extension|Subject/guardian decision|1|||
128776193|NCT01154036|463470362|FG000|Phase I|Physician Decision|0|||
128776194|NCT01154036|463470363|FG001|Phase I|Physician Decision|1|||
128776195|NCT01154036|463470364|FG002|Phase I|Physician Decision|0|||
128776196|NCT01154036|463470365|FG003|Phase I|Physician Decision|0|||
128776197|NCT01154036|463470366|FG004|Phase I|Physician Decision|0|||
128776198|NCT01154036|463470367|FG005|Phase I|Physician Decision|0|||
128776199|NCT01154036|463470368|FG006|Phase I|Physician Decision|0|||
128776200|NCT01154036|463470369|FG007|Phase I|Physician Decision|0|||
128776201|NCT01154036|463470362|FG000|Phase I|Lost to Follow-up|0|||
128776202|NCT01154036|463470363|FG001|Phase I|Lost to Follow-up|3|||
128776203|NCT01154036|463470364|FG002|Phase I|Lost to Follow-up|6|||
128776204|NCT01154036|463470365|FG003|Phase I|Lost to Follow-up|0|||
128776205|NCT01154036|463470366|FG004|Phase I|Lost to Follow-up|0|||
128776206|NCT01154036|463470367|FG005|Phase I|Lost to Follow-up|0|||
128776207|NCT01154036|463470368|FG006|Phase I|Lost to Follow-up|0|||
128776208|NCT01154036|463470369|FG007|Phase I|Lost to Follow-up|0|||
128776209|NCT01154036|463470362|FG000|Phase I|Protocol Violation|0|||
128776210|NCT01154036|463470363|FG001|Phase I|Protocol Violation|3|||
128776211|NCT01154036|463470364|FG002|Phase I|Protocol Violation|9|||
128776212|NCT01154036|463470365|FG003|Phase I|Protocol Violation|0|||
128776213|NCT01154036|463470366|FG004|Phase I|Protocol Violation|0|||
128776214|NCT01154036|463470367|FG005|Phase I|Protocol Violation|0|||
128776215|NCT01154036|463470368|FG006|Phase I|Protocol Violation|0|||
128776216|NCT01154036|463470369|FG007|Phase I|Protocol Violation|0|||
128776217|NCT01154036|463470362|FG000|Phase I|Withdrawal by Subject|2|||
128776218|NCT01154036|463470363|FG001|Phase I|Withdrawal by Subject|10|||
128776219|NCT01154036|463470364|FG002|Phase I|Withdrawal by Subject|29|||
128776220|NCT01154036|463470365|FG003|Phase I|Withdrawal by Subject|0|||
128776221|NCT01154036|463470366|FG004|Phase I|Withdrawal by Subject|0|||
128776222|NCT01154036|463470367|FG005|Phase I|Withdrawal by Subject|0|||
128776223|NCT01154036|463470368|FG006|Phase I|Withdrawal by Subject|0|||
128776224|NCT01154036|463470369|FG007|Phase I|Withdrawal by Subject|0|||
128776225|NCT01154036|463470362|FG000|Phase I|Adverse Event|1|||
128776226|NCT01154036|463470363|FG001|Phase I|Adverse Event|11|||
128776227|NCT01154036|463470364|FG002|Phase I|Adverse Event|12|||
128776228|NCT01154036|463470365|FG003|Phase I|Adverse Event|0|||
128776229|NCT01154036|463470366|FG004|Phase I|Adverse Event|0|||
128776230|NCT01154036|463470367|FG005|Phase I|Adverse Event|0|||
128776231|NCT01154036|463470368|FG006|Phase I|Adverse Event|0|||
128776232|NCT01154036|463470369|FG007|Phase I|Adverse Event|0|||
128776233|NCT01154036|463470362|FG000|Phase II|Adverse Event|0|||
128776234|NCT01154036|463470363|FG001|Phase II|Adverse Event|0|||
128776235|NCT01154036|463470364|FG002|Phase II|Adverse Event|0|||
128776236|NCT01154036|463470365|FG003|Phase II|Adverse Event|0|||
128776237|NCT01154036|463470366|FG004|Phase II|Adverse Event|1|||
128776238|NCT01154036|463470367|FG005|Phase II|Adverse Event|1|||
128776239|NCT01154036|463470368|FG006|Phase II|Adverse Event|1|||
128776240|NCT01154036|463470369|FG007|Phase II|Adverse Event|1|||
128776241|NCT01154036|463470362|FG000|Phase II|Physician Decision|0|||
128776242|NCT01154036|463470363|FG001|Phase II|Physician Decision|0|||
128776243|NCT01154036|463470364|FG002|Phase II|Physician Decision|0|||
128776244|NCT01154036|463470365|FG003|Phase II|Physician Decision|0|||
129068789|NCT01626690|464539115|FG000|Overall Study|Adverse Event|1|||
129068790|NCT01626690|464539116|FG001|Overall Study|Adverse Event|0|||
129068791|NCT04688671|464539117|FG000|Overall Study|Adverse Event|3|||
129068792|NCT04688671|464539118|FG001|Overall Study|Adverse Event|1|||
129068793|NCT04688671|464539117|FG000|Overall Study|Withdrawal by Subject|3|||
128776245|NCT01154036|463470366|FG004|Phase II|Physician Decision|0|||
128776246|NCT01154036|463470367|FG005|Phase II|Physician Decision|0|||
128776247|NCT01154036|463470368|FG006|Phase II|Physician Decision|1|||
128776248|NCT01154036|463470369|FG007|Phase II|Physician Decision|0|||
129068794|NCT04688671|464539118|FG001|Overall Study|Withdrawal by Subject|1|||
128723213|NCT04097821|463283651|FG001|Overall Study|Adverse Event|0|||
128723214|NCT04097821|463283652|FG002|Overall Study|Adverse Event|1|||
128723215|NCT04097821|463283653|FG003|Overall Study|Adverse Event|1|||
128776249|NCT01154036|463470362|FG000|Phase II|Lost to Follow-up|0|||
129068795|NCT04688671|464539117|FG000|Overall Study|Lack of Efficacy|1|||
129068796|NCT04688671|464539118|FG001|Overall Study|Lack of Efficacy|1|||
128776250|NCT01154036|463470363|FG001|Phase II|Lost to Follow-up|0|||
128776251|NCT01154036|463470364|FG002|Phase II|Lost to Follow-up|0|||
128776252|NCT01154036|463470365|FG003|Phase II|Lost to Follow-up|1|||
128776253|NCT01154036|463470366|FG004|Phase II|Lost to Follow-up|2|||
128776254|NCT01154036|463470367|FG005|Phase II|Lost to Follow-up|0|||
128776255|NCT01154036|463470368|FG006|Phase II|Lost to Follow-up|2|||
129068797|NCT04688671|464539117|FG000|Overall Study|Protocol Violation|1|||
128723216|NCT04097821|463283654|FG004|Overall Study|Adverse Event|0|||
129068798|NCT04688671|464539118|FG001|Overall Study|Protocol Violation|0|||
129068799|NCT04688671|464539117|FG000|Overall Study|Lost to Follow-up|0|||
129068800|NCT04688671|464539118|FG001|Overall Study|Lost to Follow-up|1|||
129068801|NCT00476190|464539121|FG000|Overall Study|Ineligible|1|||
129068802|NCT00476190|464539122|FG001|Overall Study|Ineligible|1|||
129068803|NCT00476190|464539121|FG000|Overall Study|Induction Death|2|||
129068804|NCT00476190|464539122|FG001|Overall Study|Induction Death|0|||
129068805|NCT00476190|464539121|FG000|Overall Study|Induction Failure|2|||
129068806|NCT00476190|464539122|FG001|Overall Study|Induction Failure|4|||
129068807|NCT00476190|464539121|FG000|Overall Study|Lost to Follow-up|1|||
129139092|NCT03721107|464802666|FG003|Overall Study|Other|1|||
128723217|NCT04097821|463283655|FG005|Overall Study|Adverse Event|0|||
128723218|NCT04097821|463283656|FG006|Overall Study|Adverse Event|0|||
128723219|NCT04097821|463283657|FG007|Overall Study|Adverse Event|0|||
128723220|NCT04097821|463283650|FG000|Overall Study|New Therapy For Study Indication|0|||
128723221|NCT04097821|463283651|FG001|Overall Study|New Therapy For Study Indication|0|||
128723222|NCT04097821|463283652|FG002|Overall Study|New Therapy For Study Indication|0|||
128723223|NCT04097821|463283653|FG003|Overall Study|New Therapy For Study Indication|0|||
128723224|NCT04097821|463283654|FG004|Overall Study|New Therapy For Study Indication|0|||
128723225|NCT04097821|463283655|FG005|Overall Study|New Therapy For Study Indication|0|||
128723226|NCT04097821|463283656|FG006|Overall Study|New Therapy For Study Indication|1|||
128723227|NCT04097821|463283657|FG007|Overall Study|New Therapy For Study Indication|0|||
128723228|NCT04477304|463283658|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
128723229|NCT04477304|463283659|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
128723230|NCT05756790|463283662|FG000|Overall Study|Withdrawal by Subject|1|||
128723231|NCT05756790|463283663|FG001|Overall Study|Withdrawal by Subject|1|||
128723232|NCT05756790|463283664|FG002|Overall Study|Withdrawal by Subject|1|||
128723233|NCT05756790|463283665|FG003|Overall Study|Withdrawal by Subject|1|||
128723234|NCT05756790|463283666|FG004|Overall Study|Withdrawal by Subject|0|||
128723235|NCT05756790|463283667|FG005|Overall Study|Withdrawal by Subject|0|||
128723236|NCT05756790|463283662|FG000|Overall Study|Protocol Violation|0|||
128723237|NCT05756790|463283663|FG001|Overall Study|Protocol Violation|0|||
128723238|NCT05756790|463283664|FG002|Overall Study|Protocol Violation|1|||
128723239|NCT05756790|463283665|FG003|Overall Study|Protocol Violation|1|||
128723240|NCT05756790|463283666|FG004|Overall Study|Protocol Violation|0|||
128723241|NCT05756790|463283667|FG005|Overall Study|Protocol Violation|0|||
128723242|NCT05756790|463283662|FG000|Overall Study|Ineligible|0|||
128723243|NCT05756790|463283663|FG001|Overall Study|Ineligible|0|||
128723244|NCT05756790|463283664|FG002|Overall Study|Ineligible|0|||
128723245|NCT05756790|463283665|FG003|Overall Study|Ineligible|0|||
128723246|NCT05756790|463283666|FG004|Overall Study|Ineligible|2|||
128723247|NCT05756790|463283667|FG005|Overall Study|Ineligible|2|||
128723248|NCT00502697|463285490|FG000|Overall Study|Withdrawal by Subject|3|||
128723249|NCT00502697|463285491|FG001|Overall Study|Withdrawal by Subject|1|||
128723250|NCT00502697|463285490|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
128723251|NCT00502697|463285491|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
128723252|NCT00502697|463285490|FG000|Overall Study|found not to meet eligibility criteria|3|||
128723253|NCT00502697|463285491|FG001|Overall Study|found not to meet eligibility criteria|4|||
128723254|NCT00502697|463285490|FG000|Overall Study|did not meet assignment criteria|4|||
128723255|NCT00502697|463285491|FG001|Overall Study|did not meet assignment criteria|2|||
128723256|NCT01545817|463285493|FG000|Pazopanib|Disease progression|51|||
128723257|NCT01545817|463285494|FG001|Pazopanib|Disease progression|0|||
128723258|NCT01545817|463285493|FG000|Pazopanib|Adverse Event|19|||
128723259|NCT01545817|463285494|FG001|Pazopanib|Adverse Event|0|||
128723260|NCT01545817|463285493|FG000|Pazopanib|Other reason|4|||
128723261|NCT01545817|463285494|FG001|Pazopanib|Other reason|0|||
128723262|NCT01545817|463285493|FG000|Everolimus|Other reason|0|||
128723263|NCT01545817|463285494|FG001|Everolimus|Other reason|7|||
128723264|NCT01545817|463285493|FG000|Everolimus|Disease progression|0|||
128776256|NCT01154036|463470369|FG007|Phase II|Lost to Follow-up|1|||
128776257|NCT01154036|463470362|FG000|Phase II|Protocol Violation|0|||
128723265|NCT01545817|463285494|FG001|Everolimus|Disease progression|25|||
128723266|NCT01545817|463285493|FG000|Everolimus|Adverse Event|0|||
128723267|NCT01545817|463285494|FG001|Everolimus|Adverse Event|6|||
128723268|NCT00589108|463285498|FG000|Overall Study|Lost to Follow-up|1|||
128723269|NCT00589108|463285499|FG001|Overall Study|Lost to Follow-up|1|||
128723270|NCT00589108|463285500|FG002|Overall Study|Lost to Follow-up|1|||
128723271|NCT00589108|463285498|FG000|Overall Study|Death|3|||
129068808|NCT00476190|464539122|FG001|Overall Study|Lost to Follow-up|0|||
129068809|NCT00476190|464539121|FG000|Overall Study|Relapse/Progression|5|||
129068810|NCT00476190|464539122|FG001|Overall Study|Relapse/Progression|2|||
129068811|NCT00476190|464539121|FG000|Overall Study|Remission Death|0|||
128723272|NCT00589108|463285499|FG001|Overall Study|Death|3|||
128723273|NCT00589108|463285500|FG002|Overall Study|Death|4|||
128723274|NCT03256552|463285501|FG000|Overall Study|Protocol Violation|1|||
128723275|NCT03256552|463285501|FG000|Overall Study|Physician Decision|1|||
128723276|NCT03256552|463285501|FG000|Overall Study|Adverse Event|1|||
128723277|NCT03256552|463285501|FG000|Overall Study|Withdrawal by Subject|2|||
128776258|NCT01154036|463470363|FG001|Phase II|Protocol Violation|0|||
128776259|NCT01154036|463470364|FG002|Phase II|Protocol Violation|0|||
128776260|NCT01154036|463470365|FG003|Phase II|Protocol Violation|0|||
128776261|NCT01154036|463470366|FG004|Phase II|Protocol Violation|1|||
128776262|NCT01154036|463470367|FG005|Phase II|Protocol Violation|2|||
128776263|NCT01154036|463470368|FG006|Phase II|Protocol Violation|0|||
129068812|NCT00476190|464539122|FG001|Overall Study|Remission Death|1|||
129068813|NCT00476190|464539121|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
129068814|NCT00476190|464539122|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
128776264|NCT01154036|463470369|FG007|Phase II|Protocol Violation|0|||
128776265|NCT01154036|463470362|FG000|Phase II|Withdrawal by Subject|0|||
128776266|NCT01154036|463470363|FG001|Phase II|Withdrawal by Subject|0|||
128776267|NCT01154036|463470364|FG002|Phase II|Withdrawal by Subject|0|||
128776268|NCT01154036|463470365|FG003|Phase II|Withdrawal by Subject|0|||
128776269|NCT01154036|463470366|FG004|Phase II|Withdrawal by Subject|4|||
128776270|NCT01154036|463470367|FG005|Phase II|Withdrawal by Subject|2|||
128776271|NCT01154036|463470368|FG006|Phase II|Withdrawal by Subject|5|||
128776272|NCT01154036|463470369|FG007|Phase II|Withdrawal by Subject|4|||
128776273|NCT00997243|463470370|FG000|Overall Study|Early termination of study by sponsor|7|||
128776274|NCT01349907|463470371|FG000|Overall Study|Adverse Event|37|||
128776275|NCT01349907|463470372|FG001|Overall Study|Adverse Event|11|||
128776276|NCT01349907|463470371|FG000|Overall Study|Treatment failure|13|||
128776277|NCT01349907|463470372|FG001|Overall Study|Treatment failure|4|||
128776278|NCT01349907|463470371|FG000|Overall Study|Lost to Follow-up|25|||
128776279|NCT01349907|463470372|FG001|Overall Study|Lost to Follow-up|6|||
128776280|NCT01349907|463470371|FG000|Overall Study|Withdrawal by Subject|30|||
128776281|NCT01349907|463470372|FG001|Overall Study|Withdrawal by Subject|8|||
128776282|NCT01349907|463470371|FG000|Overall Study|Protocol Violation|33|||
128776283|NCT01349907|463470372|FG001|Overall Study|Protocol Violation|13|||
128776284|NCT01349907|463470371|FG000|Overall Study|Administrative|1|||
128776285|NCT01349907|463470372|FG001|Overall Study|Administrative|1|||
128776286|NCT03583541|463470377|FG000|Overall Study|Lost to Follow-up|31|||
128776287|NCT03583541|463470378|FG001|Overall Study|Lost to Follow-up|65|||
128776288|NCT04102540|463470379|FG000|Overall Study|Withdrawn by PI|2|||
128776289|NCT04102540|463470379|FG000|Overall Study|Lost to Follow-up|6|||
128776290|NCT00280293|463470382|FG000|Overall Study|Protocol Violation|3|||
128776291|NCT00280293|463470383|FG001|Overall Study|Protocol Violation|0|||
128776292|NCT00280293|463470382|FG000|Overall Study|Physician Decision|5|||
128776293|NCT00280293|463470383|FG001|Overall Study|Physician Decision|4|||
128776294|NCT00280293|463470382|FG000|Overall Study|Lost to Follow-up|14|||
128776295|NCT00280293|463470383|FG001|Overall Study|Lost to Follow-up|12|||
128776296|NCT00280293|463470382|FG000|Overall Study|Withdrawal by Subject|3|||
128776297|NCT00280293|463470383|FG001|Overall Study|Withdrawal by Subject|5|||
128776298|NCT00280293|463470382|FG000|Overall Study|Incarceration/Legal Reasons|1|||
128776299|NCT00280293|463470383|FG001|Overall Study|Incarceration/Legal Reasons|1|||
128776300|NCT00280293|463470382|FG000|Overall Study|Adverse Event|0|||
129068815|NCT00476190|464539121|FG000|Overall Study|Withdrawal by Subject|6|||
129068816|NCT00476190|464539122|FG001|Overall Study|Withdrawal by Subject|2|||
129068817|NCT00476190|464539121|FG000|Overall Study|Other|9|||
129068818|NCT00476190|464539122|FG001|Overall Study|Other|10|||
129139093|NCT03888482|464802667|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
129139094|NCT03888482|464802668|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
129139095|NCT03888482|464802667|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
129139096|NCT03888482|464802668|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
129139097|NCT02554474|464802669|FG000|Overall Study|Protocol Violation|1|||
129139098|NCT02554474|464802670|FG001|Overall Study|Protocol Violation|1|||
129139099|NCT02554474|464802669|FG000|Overall Study|Health issue not related to the study|1|||
129139100|NCT02554474|464802670|FG001|Overall Study|Health issue not related to the study|0|||
129139101|NCT02554474|464802669|FG000|Overall Study|Withdrawal by Subject|1|||
129139102|NCT02554474|464802670|FG001|Overall Study|Withdrawal by Subject|1|||
129139103|NCT02991859|464802671|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139104|NCT02991859|464802672|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
129139105|NCT02991859|464802673|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128776301|NCT00280293|463470383|FG001|Overall Study|Adverse Event|1|||
128776302|NCT01458249|463470384|FG000|Overall Study|Not treated|1|||
128776303|NCT01458249|463470384|FG000|Overall Study|Adverse Event|4|||
128776304|NCT01458249|463470384|FG000|Overall Study|Other|2|||
128776305|NCT01458249|463470384|FG000|Overall Study|Ongoing|1|||
128776306|NCT01348854|463470387|FG000|Overall Study|Lost to Follow-up|2|||
128776307|NCT01348854|463470388|FG001|Overall Study|Lost to Follow-up|1|||
128776308|NCT01348854|463470387|FG000|Overall Study|Withdrawal by Subject|1|||
129068819|NCT05724589|464539123|FG000|Overall Study|Lost to Follow-up|1|||
128776309|NCT01348854|463470388|FG001|Overall Study|Withdrawal by Subject|0|||
128776310|NCT04011384|463470391|FG000|Overall Study|Withdrawal by Subject|2|||
128776311|NCT04011384|463470392|FG001|Overall Study|Withdrawal by Subject|0|||
129068820|NCT01042093|464539126|FG000|Overall Study|Protocol Violation|2|||
129068821|NCT01042093|464539127|FG001|Overall Study|Protocol Violation|2|||
129068822|NCT01042093|464539128|FG002|Overall Study|Protocol Violation|2|||
129068823|NCT01042093|464539129|FG003|Overall Study|Protocol Violation|3|||
129068824|NCT01042093|464539126|FG000|Overall Study|Withdrawal by Subject|0|||
129068825|NCT01042093|464539127|FG001|Overall Study|Withdrawal by Subject|0|||
129068826|NCT01042093|464539128|FG002|Overall Study|Withdrawal by Subject|0|||
129068827|NCT01042093|464539129|FG003|Overall Study|Withdrawal by Subject|1|||
129068828|NCT02273388|464539130|FG000|Overall Study|Adverse Event|0|||
129139106|NCT02991859|464802674|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139107|NCT02991859|464802675|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
129139108|NCT02991859|464802676|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139109|NCT02991859|464802677|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139110|NCT02991859|464802678|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139111|NCT02991859|464802679|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139112|NCT02991859|464802680|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
128723278|NCT03026257|463285502|FG000|Overall Study|Adverse Event|3|||
128723279|NCT03026257|463285503|FG001|Overall Study|Adverse Event|0|||
128723280|NCT03026257|463285504|FG002|Overall Study|Adverse Event|0|||
128723281|NCT03026257|463285505|FG003|Overall Study|Adverse Event|0|||
128723282|NCT03026257|463285506|FG004|Overall Study|Adverse Event|0|||
128723283|NCT03026257|463285507|FG005|Overall Study|Adverse Event|0|||
128723284|NCT03026257|463285502|FG000|Overall Study|Lost to Follow-up|1|||
128723285|NCT03026257|463285503|FG001|Overall Study|Lost to Follow-up|0|||
128723286|NCT03026257|463285504|FG002|Overall Study|Lost to Follow-up|0|||
128723287|NCT03026257|463285505|FG003|Overall Study|Lost to Follow-up|0|||
128723288|NCT03026257|463285506|FG004|Overall Study|Lost to Follow-up|0|||
128723289|NCT03026257|463285507|FG005|Overall Study|Lost to Follow-up|0|||
128723290|NCT03026257|463285502|FG000|Overall Study|Protocol Violation|1|||
128723291|NCT03026257|463285503|FG001|Overall Study|Protocol Violation|0|||
128723292|NCT03026257|463285504|FG002|Overall Study|Protocol Violation|0|||
128723293|NCT03026257|463285505|FG003|Overall Study|Protocol Violation|1|||
128723294|NCT03026257|463285506|FG004|Overall Study|Protocol Violation|1|||
128723295|NCT03026257|463285507|FG005|Overall Study|Protocol Violation|0|||
128723296|NCT03026257|463285502|FG000|Overall Study|Withdrawal by Subject|1|||
128723297|NCT03026257|463285503|FG001|Overall Study|Withdrawal by Subject|1|||
128723298|NCT03026257|463285504|FG002|Overall Study|Withdrawal by Subject|0|||
128723299|NCT03026257|463285505|FG003|Overall Study|Withdrawal by Subject|0|||
128723300|NCT03026257|463285506|FG004|Overall Study|Withdrawal by Subject|0|||
128723301|NCT03026257|463285507|FG005|Overall Study|Withdrawal by Subject|0|||
128723302|NCT05083442|463285508|FG000|Overall Study|Lost to Follow-up|1|||
128723303|NCT05083442|463285509|FG001|Overall Study|Lost to Follow-up|0|||
128723304|NCT05083442|463285508|FG000|Overall Study|Lack of Efficacy|0|||
128723305|NCT05083442|463285509|FG001|Overall Study|Lack of Efficacy|1|||
128723306|NCT05083442|463285508|FG000|Overall Study|Withdrawal by Subject|1|||
128723307|NCT05083442|463285509|FG001|Overall Study|Withdrawal by Subject|3|||
128723308|NCT05083442|463285508|FG000|Overall Study|scheduling difficulties|1|||
128723309|NCT05083442|463285509|FG001|Overall Study|scheduling difficulties|2|||
128723310|NCT02256891|463285517|FG000|Overall Study|Death|0|||
128723311|NCT02256891|463285518|FG001|Overall Study|Death|2|||
128723312|NCT02256891|463285517|FG000|Overall Study|Lost to Follow-up|0|||
128723313|NCT02256891|463285518|FG001|Overall Study|Lost to Follow-up|3|||
128723314|NCT02256891|463285517|FG000|Overall Study|Physician Decision|7|||
128723315|NCT02256891|463285518|FG001|Overall Study|Physician Decision|3|||
128723316|NCT02256891|463285517|FG000|Overall Study|Screen Fail|5|||
128723317|NCT02256891|463285518|FG001|Overall Study|Screen Fail|4|||
128723318|NCT02256891|463285517|FG000|Overall Study|Equipment Malfunction|0|||
128723319|NCT02256891|463285518|FG001|Overall Study|Equipment Malfunction|1|||
128723320|NCT01344447|463285519|FG000|Overall Study|Adverse Event|1|||
128723321|NCT01344447|463285519|FG000|Overall Study|Protocol Violation|1|||
128723322|NCT01344447|463285519|FG000|Overall Study|Withdrawal by Subject|1|||
128723323|NCT01344447|463285519|FG000|Overall Study|The contrast was not seen|1|||
128723324|NCT01344447|463285519|FG000|Overall Study|Physician Decision|1|||
128723325|NCT01344447|463285519|FG000|Overall Study|MRA unsuccessful|1|||
128723326|NCT01344447|463285519|FG000|Overall Study|Bolus tracking failed|1|||
128723327|NCT01344447|463285519|FG000|Overall Study|Error of power injector|1|||
128723328|NCT01990495|463285529|FG000|Overall Study|Physician Decision|5|||
128723329|NCT01990495|463285530|FG001|Overall Study|Physician Decision|4|||
129068829|NCT02273388|464539131|FG001|Overall Study|Adverse Event|0|||
129068830|NCT02273388|464539132|FG002|Overall Study|Adverse Event|0|||
129068831|NCT02273388|464539133|FG003|Overall Study|Adverse Event|0|||
128723330|NCT01928862|463285531|FG000|Overall Study|Lost to Follow-up|1|||
128723331|NCT01928862|463285532|FG001|Overall Study|Lost to Follow-up|0|||
128723332|NCT01928862|463285533|FG002|Overall Study|Lost to Follow-up|0|||
128723333|NCT01928862|463285534|FG003|Overall Study|Lost to Follow-up|0|||
128723334|NCT01928862|463285535|FG004|Overall Study|Lost to Follow-up|1|||
128723335|NCT03168464|463285536|FG000|Overall Study|Death|9|||
128723336|NCT03168464|463285536|FG000|Overall Study|Progression of disease|6|||
128776312|NCT01094171|463470393|FG000|Overall Study|Lost to Follow-up|2|||
128776313|NCT01094171|463470393|FG000|Overall Study|Informed consent withdrawal|4|||
128776314|NCT01094171|463470393|FG000|Overall Study|Migration from the study area|3|||
128776315|NCT01094171|463470393|FG000|Overall Study|Other|1|||
128776316|NCT01364727|463470394|FG000|Overall Study|Not Eligible|2|||
128776317|NCT01009047|463470396|FG000|Overall Study|Adverse Event|5|||
128776318|NCT01009047|463470397|FG001|Overall Study|Adverse Event|0|||
128776319|NCT01009047|463470396|FG000|Overall Study|Lost to Follow-up|0|||
128776320|NCT01009047|463470397|FG001|Overall Study|Lost to Follow-up|2|||
128776321|NCT01009047|463470396|FG000|Overall Study|Lack of Efficacy|4|||
128776322|NCT01009047|463470397|FG001|Overall Study|Lack of Efficacy|11|||
128776323|NCT01009047|463470396|FG000|Overall Study|Withdrawal by consent|16|||
128776324|NCT01009047|463470397|FG001|Overall Study|Withdrawal by consent|11|||
128776325|NCT01009047|463470396|FG000|Overall Study|Other|3|||
128776326|NCT01009047|463470397|FG001|Overall Study|Other|2|||
128776327|NCT01676220|463470398|FG000|Overall Study|Randomized But Not Treated|4|||
128776328|NCT01676220|463470399|FG001|Overall Study|Randomized But Not Treated|1|||
128776329|NCT01676220|463470398|FG000|Overall Study|Adverse Event|10|||
128776330|NCT01676220|463470399|FG001|Overall Study|Adverse Event|8|||
128776331|NCT01676220|463470398|FG000|Overall Study|Lack of Efficacy|2|||
129068832|NCT02273388|464539134|FG004|Overall Study|Adverse Event|0|||
129068833|NCT02273388|464539135|FG005|Overall Study|Adverse Event|0|||
129068834|NCT02273388|464539136|FG006|Overall Study|Adverse Event|1|||
129068835|NCT02273388|464539137|FG007|Overall Study|Adverse Event|2|||
129068836|NCT02273388|464539138|FG008|Overall Study|Adverse Event|0|||
129068837|NCT02273388|464539139|FG009|Overall Study|Adverse Event|0|||
129068838|NCT02273388|464539140|FG010|Overall Study|Adverse Event|0|||
129068839|NCT02273388|464539141|FG011|Overall Study|Adverse Event|0|||
129068840|NCT02273388|464539130|FG000|Overall Study|Adverse Event study disease worse|4|||
129068841|NCT02273388|464539131|FG001|Overall Study|Adverse Event study disease worse|3|||
129068842|NCT02273388|464539132|FG002|Overall Study|Adverse Event study disease worse|3|||
129068843|NCT02273388|464539133|FG003|Overall Study|Adverse Event study disease worse|2|||
129068844|NCT02273388|464539134|FG004|Overall Study|Adverse Event study disease worse|4|||
129068845|NCT02273388|464539135|FG005|Overall Study|Adverse Event study disease worse|3|||
129068846|NCT02273388|464539136|FG006|Overall Study|Adverse Event study disease worse|14|||
129068847|NCT02273388|464539137|FG007|Overall Study|Adverse Event study disease worse|6|||
129068848|NCT02273388|464539138|FG008|Overall Study|Adverse Event study disease worse|6|||
129068849|NCT02273388|464539139|FG009|Overall Study|Adverse Event study disease worse|5|||
129068850|NCT02273388|464539140|FG010|Overall Study|Adverse Event study disease worse|10|||
129068851|NCT02273388|464539141|FG011|Overall Study|Adverse Event study disease worse|1|||
129068852|NCT02273388|464539130|FG000|Overall Study|Sponsor decision|0|||
129068853|NCT02273388|464539131|FG001|Overall Study|Sponsor decision|0|||
129068854|NCT02273388|464539132|FG002|Overall Study|Sponsor decision|0|||
129068855|NCT02273388|464539133|FG003|Overall Study|Sponsor decision|0|||
129068856|NCT02273388|464539134|FG004|Overall Study|Sponsor decision|0|||
129068857|NCT02273388|464539135|FG005|Overall Study|Sponsor decision|0|||
129068858|NCT02273388|464539136|FG006|Overall Study|Sponsor decision|0|||
129068859|NCT02273388|464539137|FG007|Overall Study|Sponsor decision|0|||
129068860|NCT02273388|464539138|FG008|Overall Study|Sponsor decision|0|||
129068861|NCT02273388|464539139|FG009|Overall Study|Sponsor decision|0|||
129068862|NCT02273388|464539140|FG010|Overall Study|Sponsor decision|0|||
129068863|NCT02273388|464539141|FG011|Overall Study|Sponsor decision|1|||
129068864|NCT04331808|464539142|FG000|Overall Study|Withdrew consent|1|||
129068865|NCT04331808|464539143|FG001|Overall Study|Withdrew consent|0|||
129068866|NCT04331808|464539144|FG002|Overall Study|Withdrew consent|2|||
129068867|NCT04331808|464539145|FG003|Overall Study|Withdrew consent|3|||
129068868|NCT01329900|464539146|FG000|Overall Study|Elevated creatinine/renal function|1|||
129068869|NCT02198963|464539147|FG000|Overall Study|Adverse Event|1|||
129068870|NCT02198963|464539147|FG000|Overall Study|Withdrawal by Subject|6|||
128776332|NCT01676220|463470399|FG001|Overall Study|Lack of Efficacy|5|||
128776333|NCT01676220|463470398|FG000|Overall Study|Protocol Violation|11|||
128776334|NCT01676220|463470399|FG001|Overall Study|Protocol Violation|12|||
128776335|NCT01676220|463470398|FG000|Overall Study|Received Rescue Therapy|14|||
128776336|NCT01676220|463470399|FG001|Overall Study|Received Rescue Therapy|22|||
128776337|NCT01676220|463470398|FG000|Overall Study|Personal Reason|34|||
128776338|NCT01676220|463470399|FG001|Overall Study|Personal Reason|45|||
128776339|NCT01676220|463470398|FG000|Overall Study|Lost to Follow-up|11|||
129068871|NCT01808573|464539151|FG000|Overall Study|Death|212|||
129068872|NCT01808573|464539152|FG001|Overall Study|Death|240|||
129068873|NCT01808573|464539151|FG000|Overall Study|Withdrawal by Subject|12|||
129068874|NCT01808573|464539152|FG001|Overall Study|Withdrawal by Subject|10|||
129068875|NCT01808573|464539151|FG000|Overall Study|Lost to Follow-up|3|||
129068876|NCT01808573|464539152|FG001|Overall Study|Lost to Follow-up|0|||
129068877|NCT01808573|464539151|FG000|Overall Study|Discontinuation of study by sponsor|79|||
129068878|NCT01808573|464539152|FG001|Overall Study|Discontinuation of study by sponsor|64|||
129068879|NCT01808573|464539151|FG000|Overall Study|Randomized in Error|1|||
129068880|NCT01808573|464539152|FG001|Overall Study|Randomized in Error|0|||
128776340|NCT01676220|463470399|FG001|Overall Study|Lost to Follow-up|18|||
128723337|NCT02053753|463285537|FG000|Overall Study|Withdrawal by Subject|2|||
128723338|NCT02053753|463285538|FG001|Overall Study|Withdrawal by Subject|4|||
128723339|NCT02053753|463285537|FG000|Overall Study|Decision by Sponsor|1|||
128723340|NCT02053753|463285538|FG001|Overall Study|Decision by Sponsor|1|||
128723341|NCT02053753|463285537|FG000|Overall Study|Lost to Follow-up|4|||
128723342|NCT02053753|463285538|FG001|Overall Study|Lost to Follow-up|3|||
128723343|NCT03387813|463285545|FG000|Overall Study|Death|40|||
128723344|NCT03387813|463285546|FG001|Overall Study|Death|37|||
128723345|NCT03387813|463285547|FG002|Overall Study|Death|190|||
128723346|NCT03387813|463285545|FG000|Overall Study|Withdrawal by Subject|9|||
128723347|NCT03387813|463285546|FG001|Overall Study|Withdrawal by Subject|19|||
128723348|NCT03387813|463285547|FG002|Overall Study|Withdrawal by Subject|32|||
128723349|NCT03387813|463285545|FG000|Overall Study|Lost to Follow-up|3|||
128723350|NCT03387813|463285546|FG001|Overall Study|Lost to Follow-up|9|||
128723351|NCT03387813|463285547|FG002|Overall Study|Lost to Follow-up|15|||
128723352|NCT03387813|463285545|FG000|Overall Study|Non-Compliance|6|||
128723353|NCT03387813|463285546|FG001|Overall Study|Non-Compliance|6|||
128723354|NCT03387813|463285547|FG002|Overall Study|Non-Compliance|31|||
128723355|NCT03387813|463285545|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
128723356|NCT03387813|463285546|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
128776341|NCT01676220|463470398|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
128776342|NCT01676220|463470399|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
129068881|NCT00995774|464539153|FG000|Training Period 2|Withdrawal by Subject|2|||
129068882|NCT00995774|464539154|FG001|Training Period 2|Withdrawal by Subject|0|||
129068883|NCT01256502|464539155|FG000|Overall Study|Had scaffold removed|4|||
129068884|NCT01256502|464539155|FG000|Overall Study|Personal reasons|5|||
129068885|NCT01256502|464539155|FG000|Overall Study|Protocol deviation|1|||
129068886|NCT01523002|464539156|FG000|Period 1|Withdrawal by Subject|1|||
129068887|NCT01523002|464539157|FG001|Period 1|Withdrawal by Subject|3|||
129068888|NCT01523002|464539156|FG000|Period 1|Lost to Follow-up|1|||
129068889|NCT01523002|464539157|FG001|Period 1|Lost to Follow-up|0|||
129068890|NCT01523002|464539156|FG000|Period 1|Adverse Event|0|||
129068891|NCT01523002|464539157|FG001|Period 1|Adverse Event|8|||
129068892|NCT01523002|464539156|FG000|Period 2|Withdrawal by Subject|4|||
129068893|NCT01523002|464539157|FG001|Period 2|Withdrawal by Subject|1|||
129068894|NCT01523002|464539156|FG000|Period 2|Adverse Event|2|||
129068895|NCT01523002|464539157|FG001|Period 2|Adverse Event|5|||
129068896|NCT01523002|464539156|FG000|Period 3|Withdrawal by Subject|1|||
129068897|NCT01523002|464539157|FG001|Period 3|Withdrawal by Subject|0|||
129068898|NCT01523002|464539156|FG000|Period 3|Adverse Event|3|||
129068899|NCT01523002|464539157|FG001|Period 3|Adverse Event|0|||
129068900|NCT03953612|464539159|FG000|Overall Study|Randomized but did not start|1|||
129068901|NCT03953612|464539160|FG001|Overall Study|Randomized but did not start|1|||
129068902|NCT03953612|464539161|FG002|Overall Study|Randomized but did not start|1|||
129068903|NCT03953612|464539159|FG000|Overall Study|Withdrawal by Subject|2|||
129068904|NCT03953612|464539160|FG001|Overall Study|Withdrawal by Subject|1|||
129068905|NCT03953612|464539161|FG002|Overall Study|Withdrawal by Subject|0|||
129068906|NCT03200717|464539179|FG000|Overall Study|Progressive disease|24|||
129068907|NCT03200717|464539180|FG001|Overall Study|Progressive disease|5|||
129068908|NCT03200717|464539179|FG000|Overall Study|Adverse Event|11|||
129068909|NCT03200717|464539180|FG001|Overall Study|Adverse Event|8|||
129068910|NCT03200717|464539179|FG000|Overall Study|Physician Decision|3|||
129068911|NCT03200717|464539180|FG001|Overall Study|Physician Decision|2|||
129068912|NCT03200717|464539179|FG000|Overall Study|Death|2|||
129068913|NCT03200717|464539180|FG001|Overall Study|Death|0|||
129068914|NCT03200717|464539179|FG000|Overall Study|Subject/Guardian Decision|1|||
129068915|NCT03200717|464539180|FG001|Overall Study|Subject/Guardian Decision|0|||
129068916|NCT01461538|464539181|FG000|Overall Study|Death|15|||
129068917|NCT01461538|464539182|FG001|Overall Study|Death|6|||
129068918|NCT01461538|464539183|FG002|Overall Study|Death|2|||
129068919|NCT01461538|464539181|FG000|Overall Study|Study Stopped by Sponsor|2|||
129068920|NCT01461538|464539182|FG001|Overall Study|Study Stopped by Sponsor|1|||
129068921|NCT01461538|464539183|FG002|Overall Study|Study Stopped by Sponsor|0|||
129068922|NCT01461538|464539181|FG000|Overall Study|Withdrawal by Subject|1|||
129068923|NCT01461538|464539182|FG001|Overall Study|Withdrawal by Subject|1|||
129068924|NCT01461538|464539183|FG002|Overall Study|Withdrawal by Subject|0|||
129068925|NCT00141778|464539184|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
129068926|NCT00141778|464539185|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
129068927|NCT00141778|464539186|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
129068928|NCT00141778|464539184|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
129068929|NCT00141778|464539185|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
129068930|NCT00141778|464539186|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
129068931|NCT00141778|464539184|FG000|Started Study Medication|Withdrawal by Subject|0|||
129068932|NCT00141778|464539185|FG001|Started Study Medication|Withdrawal by Subject|2|||
129068933|NCT00141778|464539186|FG002|Started Study Medication|Withdrawal by Subject|0|||
129068934|NCT00141778|464539184|FG000|Started Study Medication|Difficulty Swallowing|0|||
128723357|NCT03387813|463285547|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
128723358|NCT04327999|463285548|FG000|Overall Study|Protocol Violation|1|||
128723359|NCT03792672|463285549|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
128723360|NCT03792672|463285550|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
128723361|NCT03792672|463285551|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
128723362|NCT03792672|463285552|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
128723363|NCT03792672|463285553|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
128723364|NCT03792672|463285554|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
128723365|NCT03792672|463285549|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
128723366|NCT03792672|463285550|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
128723367|NCT03792672|463285551|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
128723368|NCT03792672|463285552|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
128723369|NCT03792672|463285553|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
128723370|NCT03792672|463285554|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
129068935|NCT00141778|464539185|FG001|Started Study Medication|Difficulty Swallowing|1|||
129068936|NCT00141778|464539186|FG002|Started Study Medication|Difficulty Swallowing|0|||
129068937|NCT00141778|464539184|FG000|Started Study Medication|Chest Discomfort|0|||
129068938|NCT00141778|464539185|FG001|Started Study Medication|Chest Discomfort|0|||
129068939|NCT00141778|464539186|FG002|Started Study Medication|Chest Discomfort|1|||
129068940|NCT01245283|464539191|FG000|Overall Study|Lost to Follow-up|14|||
129068941|NCT01245283|464539192|FG001|Overall Study|Lost to Follow-up|11|||
129068942|NCT01245283|464539193|FG002|Overall Study|Lost to Follow-up|11|||
129068943|NCT01610492|464539196|FG000|Overall Study|Adverse Event|1|||
129068944|NCT01610492|464539196|FG000|Overall Study|Lack of Efficacy|3|||
129068945|NCT01610492|464539196|FG000|Overall Study|Other: Reached stopping criteria|1|||
129068946|NCT01610492|464539196|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
129068947|NCT01982955|464539197|FG000|Overall Study|Randomized but not treated|0|||
129068948|NCT01982955|464539198|FG001|Overall Study|Randomized but not treated|0|||
129068949|NCT01982955|464539199|FG002|Overall Study|Randomized but not treated|0|||
129068950|NCT01982955|464539200|FG003|Overall Study|Randomized but not treated|1|||
129068951|NCT01982955|464539201|FG004|Overall Study|Randomized but not treated|0|||
129068952|NCT04211831|464539204|FG000|Overall Study|Withdrawal by Subject|4|||
129068953|NCT04211831|464539205|FG001|Overall Study|Withdrawal by Subject|1|||
129068954|NCT04211831|464539206|FG002|Overall Study|Withdrawal by Subject|1|||
129068955|NCT04211831|464539204|FG000|Overall Study|Protocol Violation|0|||
129068956|NCT04211831|464539205|FG001|Overall Study|Protocol Violation|0|||
129068957|NCT04211831|464539206|FG002|Overall Study|Protocol Violation|1|||
129068958|NCT04211831|464539204|FG000|Overall Study|Adverse Event|0|||
129068959|NCT04211831|464539205|FG001|Overall Study|Adverse Event|1|||
129068960|NCT04211831|464539206|FG002|Overall Study|Adverse Event|0|||
129068961|NCT04211831|464539204|FG000|Overall Study|Lack of Efficacy|0|||
129068962|NCT04211831|464539205|FG001|Overall Study|Lack of Efficacy|0|||
129068963|NCT04211831|464539206|FG002|Overall Study|Lack of Efficacy|1|||
129068964|NCT04211831|464539204|FG000|Overall Study|Lost to Follow-up|0|||
129068965|NCT04211831|464539205|FG001|Overall Study|Lost to Follow-up|0|||
129068966|NCT04211831|464539206|FG002|Overall Study|Lost to Follow-up|2|||
129068967|NCT04211831|464539204|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
129068968|NCT04211831|464539205|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
129068969|NCT04211831|464539206|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
129068970|NCT04211831|464539204|FG000|Overall Study|Other|0|||
129068971|NCT04211831|464539205|FG001|Overall Study|Other|1|||
129068972|NCT04211831|464539206|FG002|Overall Study|Other|0|||
129068973|NCT00640315|464539207|FG000|Overall Study|Withdrawal by Subject|0|||
129068974|NCT00640315|464539208|FG001|Overall Study|Withdrawal by Subject|1|||
129068975|NCT01256879|464539209|FG000|Overall Study|Withdrawal by Subject|1|||
129068976|NCT00397514|464539211|FG000|Overall Study|Withdrawal by Subject|1|||
129068977|NCT00397514|464539211|FG000|Overall Study|Pacing wire malfunction|1|||
129068978|NCT00397514|464539211|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
129068979|NCT00397514|464539211|FG000|Overall Study|early extubation|2|||
129068980|NCT00397514|464539211|FG000|Overall Study|poor echocardiographic windows|1|||
129068981|NCT05525520|464540785|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
129068982|NCT05525520|464540786|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
129068983|NCT05525520|464540785|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
129068984|NCT05525520|464540786|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
129068985|NCT03657797|464540787|FG000|Overall Study|Lost to Follow-up|0|||
129068986|NCT03657797|464540788|FG001|Overall Study|Lost to Follow-up|1|||
129068987|NCT03657797|464540789|FG002|Overall Study|Lost to Follow-up|1|||
129068988|NCT03657797|464540790|FG003|Overall Study|Lost to Follow-up|0|||
129068989|NCT03657797|464540787|FG000|Overall Study|Physician Decision|0|||
129068990|NCT03657797|464540788|FG001|Overall Study|Physician Decision|1|||
129068991|NCT03657797|464540789|FG002|Overall Study|Physician Decision|0|||
129068992|NCT03657797|464540790|FG003|Overall Study|Physician Decision|0|||
128723371|NCT03792672|463285549|FG000|Treatment Period 4 (2 Days)|Other|1|||
128723372|NCT03792672|463285550|FG001|Treatment Period 4 (2 Days)|Other|0|||
128723373|NCT03792672|463285551|FG002|Treatment Period 4 (2 Days)|Other|0|||
129068993|NCT03657797|464540787|FG000|Overall Study|Withdrawal by Subject|0|||
129068994|NCT03657797|464540788|FG001|Overall Study|Withdrawal by Subject|1|||
128723374|NCT03792672|463285552|FG003|Treatment Period 4 (2 Days)|Other|0|||
128723375|NCT03792672|463285553|FG004|Treatment Period 4 (2 Days)|Other|0|||
128723376|NCT03792672|463285554|FG005|Treatment Period 4 (2 Days)|Other|0|||
128723377|NCT03161483|463285561|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
128723378|NCT03161483|463285562|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
128723379|NCT03161483|463285563|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
128723380|NCT03161483|463285564|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
128723381|NCT03161483|463285561|FG000|Treatment Period|Death|1|||
128723382|NCT03161483|463285562|FG001|Treatment Period|Death|0|||
128723383|NCT03161483|463285563|FG002|Treatment Period|Death|0|||
128723384|NCT03161483|463285564|FG003|Treatment Period|Death|0|||
128723385|NCT03161483|463285561|FG000|Treatment Period|Adverse Event|5|||
128723386|NCT03161483|463285562|FG001|Treatment Period|Adverse Event|2|||
128723387|NCT03161483|463285563|FG002|Treatment Period|Adverse Event|1|||
128723388|NCT03161483|463285564|FG003|Treatment Period|Adverse Event|11|||
128723389|NCT03161483|463285561|FG000|Treatment Period|Pregnancy|1|||
128723390|NCT03161483|463285562|FG001|Treatment Period|Pregnancy|0|||
128723391|NCT03161483|463285563|FG002|Treatment Period|Pregnancy|0|||
128723392|NCT03161483|463285564|FG003|Treatment Period|Pregnancy|0|||
128723393|NCT03161483|463285561|FG000|Treatment Period|Lack of Efficacy|0|||
128723394|NCT03161483|463285562|FG001|Treatment Period|Lack of Efficacy|0|||
128723395|NCT03161483|463285563|FG002|Treatment Period|Lack of Efficacy|0|||
128723396|NCT03161483|463285564|FG003|Treatment Period|Lack of Efficacy|1|||
128723397|NCT03161483|463285561|FG000|Treatment Period|Withdrawal by Subject|2|||
128723398|NCT03161483|463285562|FG001|Treatment Period|Withdrawal by Subject|5|||
128723399|NCT03161483|463285563|FG002|Treatment Period|Withdrawal by Subject|2|||
128723400|NCT03161483|463285564|FG003|Treatment Period|Withdrawal by Subject|6|||
128723401|NCT03161483|463285561|FG000|Treatment Period|Lost to Follow-up|0|||
128723402|NCT03161483|463285562|FG001|Treatment Period|Lost to Follow-up|0|||
128723403|NCT03161483|463285563|FG002|Treatment Period|Lost to Follow-up|0|||
128723404|NCT03161483|463285564|FG003|Treatment Period|Lost to Follow-up|1|||
128723405|NCT03161483|463285561|FG000|Treatment Period|Protocol Violation|0|||
129068995|NCT03657797|464540789|FG002|Overall Study|Withdrawal by Subject|2|||
129068996|NCT03657797|464540790|FG003|Overall Study|Withdrawal by Subject|0|||
129068997|NCT03657797|464540787|FG000|Overall Study|Adverse Event|0|||
129068998|NCT03657797|464540788|FG001|Overall Study|Adverse Event|0|||
129068999|NCT03657797|464540789|FG002|Overall Study|Adverse Event|2|||
129069000|NCT03657797|464540790|FG003|Overall Study|Adverse Event|0|||
129069001|NCT00118157|464540791|FG000|Overall Study|Adverse Event|2|||
129069002|NCT00118157|464540791|FG000|Overall Study|Death|8|||
129069003|NCT00118157|464540791|FG000|Overall Study|Withdrawal by Subject|2|||
129069004|NCT00696423|464540792|FG000|Overall Study|Lost to Follow-up|0|||
129069005|NCT00696423|464540793|FG001|Overall Study|Lost to Follow-up|5|||
129069006|NCT03989102|464540794|FG000|Year 1|Withdrawal by Subject|6|||
129069007|NCT03989102|464540795|FG001|Year 1|Withdrawal by Subject|2|||
129069008|NCT03989102|464540796|FG002|Year 1|Withdrawal by Subject|7|||
129069009|NCT03989102|464540794|FG000|Year 1|Lost to Follow-up|5|||
129069010|NCT03989102|464540795|FG001|Year 1|Lost to Follow-up|2|||
129069011|NCT03989102|464540796|FG002|Year 1|Lost to Follow-up|5|||
129069012|NCT03989102|464540794|FG000|Year 1|Subject met withdrawal criteria|1|||
129069013|NCT03989102|464540795|FG001|Year 1|Subject met withdrawal criteria|0|||
129069014|NCT03989102|464540796|FG002|Year 1|Subject met withdrawal criteria|1|||
129069015|NCT03989102|464540794|FG000|Year 2|Lost to Follow-up|7|||
129069016|NCT03989102|464540795|FG001|Year 2|Lost to Follow-up|3|||
129139113|NCT02991859|464802681|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139114|NCT02991859|464802682|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139115|NCT02991859|464802683|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139116|NCT02991859|464802684|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139117|NCT02991859|464802685|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129069017|NCT03989102|464540796|FG002|Year 2|Lost to Follow-up|4|||
129069018|NCT03989102|464540794|FG000|Year 2|Withdrawal by Subject|3|||
128723406|NCT03161483|463285562|FG001|Treatment Period|Protocol Violation|0|||
128723407|NCT03161483|463285563|FG002|Treatment Period|Protocol Violation|0|||
128723408|NCT03161483|463285564|FG003|Treatment Period|Protocol Violation|1|||
128723409|NCT03161483|463285561|FG000|Treatment Period|Other reasons|1|||
128723410|NCT03161483|463285562|FG001|Treatment Period|Other reasons|1|||
128723411|NCT03161483|463285563|FG002|Treatment Period|Other reasons|0|||
129069019|NCT03989102|464540795|FG001|Year 2|Withdrawal by Subject|1|||
129069020|NCT03989102|464540796|FG002|Year 2|Withdrawal by Subject|2|||
129069021|NCT03989102|464540794|FG000|Year 2|Subject non-compliant|3|||
129069022|NCT03989102|464540795|FG001|Year 2|Subject non-compliant|2|||
129069023|NCT03989102|464540796|FG002|Year 2|Subject non-compliant|0|||
129069024|NCT03989102|464540794|FG000|Year 2|Travel|1|||
129069025|NCT03989102|464540795|FG001|Year 2|Travel|0|||
128723412|NCT03161483|463285564|FG003|Treatment Period|Other reasons|0|||
129069026|NCT03989102|464540796|FG002|Year 2|Travel|1|||
128723413|NCT04238728|463285573|FG000|Overall Study|Withdrawal by Subject|1|||
128723414|NCT04238728|463285573|FG000|Overall Study|Lost to Follow-up|2|||
128723415|NCT05389657|463285575|FG000|Overall Study|Lost to Follow-up|7|||
128723416|NCT05389657|463285576|FG001|Overall Study|Lost to Follow-up|8|||
128723417|NCT01907828|463285577|FG000|Overall Study|Exclusion criteria not met|0|||
128723418|NCT01907828|463285578|FG001|Overall Study|Exclusion criteria not met|1|||
128723419|NCT01907828|463285577|FG000|Overall Study|Withdrawal by Subject|3|||
128723420|NCT01907828|463285578|FG001|Overall Study|Withdrawal by Subject|4|||
128723421|NCT01907828|463285577|FG000|Overall Study|Lost to Follow-up|3|||
128723422|NCT01907828|463285578|FG001|Overall Study|Lost to Follow-up|0|||
128723423|NCT01907828|463285577|FG000|Overall Study|Participant refused 24-month follow-up|1|||
128723424|NCT01907828|463285578|FG001|Overall Study|Participant refused 24-month follow-up|0|||
128723425|NCT01907828|463285577|FG000|Overall Study|Participant met exclusion criteria|0|||
128723426|NCT01907828|463285578|FG001|Overall Study|Participant met exclusion criteria|1|||
128723427|NCT00600756|463285581|FG000|Analysis After 6 Months|Adverse Event|43|||
128723428|NCT00600756|463285582|FG001|Analysis After 6 Months|Adverse Event|33|||
128723429|NCT00600756|463285581|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
128723430|NCT00600756|463285582|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
128723431|NCT00600756|463285581|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
128723432|NCT00600756|463285582|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
128723433|NCT00600756|463285581|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
128723434|NCT00600756|463285582|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
128723435|NCT00600756|463285581|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
128723436|NCT00600756|463285582|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
128723437|NCT00600756|463285581|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
128723438|NCT00600756|463285582|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
128723439|NCT00600756|463285581|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
128723440|NCT00600756|463285582|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
128723441|NCT00600756|463285581|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
128723442|NCT00600756|463285582|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
128723443|NCT00600756|463285581|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
128723444|NCT00600756|463285582|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
128723445|NCT00600756|463285581|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
128723446|NCT00600756|463285582|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
128723447|NCT00600756|463285581|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
128723448|NCT00600756|463285582|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
128723449|NCT00600756|463285581|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
128723450|NCT00600756|463285582|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
128723451|NCT00600756|463285581|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
128723452|NCT00600756|463285582|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
128723453|NCT00600756|463285581|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
128723454|NCT00600756|463285582|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
128723455|NCT01256593|463285583|FG000|Overall Study|Protocol Violation|26|||
128723456|NCT01256593|463285583|FG000|Overall Study|No Drug Administration Information|2|||
128723457|NCT01256593|463285583|FG000|Overall Study|No Visit After Treatment|186|||
128723458|NCT03261947|463285586|FG000|Overall Study|Death|10|||
128723459|NCT03261947|463285587|FG001|Overall Study|Death|13|||
128723460|NCT03261947|463285588|FG002|Overall Study|Death|17|||
128723461|NCT03261947|463285589|FG003|Overall Study|Death|12|||
128723462|NCT03261947|463285590|FG004|Overall Study|Death|8|||
128723463|NCT03261947|463285586|FG000|Overall Study|Lost to Follow-up|0|||
128723464|NCT03261947|463285587|FG001|Overall Study|Lost to Follow-up|0|||
128723465|NCT03261947|463285588|FG002|Overall Study|Lost to Follow-up|2|||
128723466|NCT03261947|463285589|FG003|Overall Study|Lost to Follow-up|1|||
128723467|NCT03261947|463285590|FG004|Overall Study|Lost to Follow-up|0|||
128723468|NCT03261947|463285586|FG000|Overall Study|Withdrawal by Subject|0|||
128723469|NCT03261947|463285587|FG001|Overall Study|Withdrawal by Subject|0|||
128723470|NCT03261947|463285588|FG002|Overall Study|Withdrawal by Subject|3|||
128723471|NCT03261947|463285589|FG003|Overall Study|Withdrawal by Subject|0|||
128723472|NCT03261947|463285590|FG004|Overall Study|Withdrawal by Subject|1|||
128723473|NCT03261947|463285586|FG000|Overall Study|Site Terminated by Sponsor|0|||
128776343|NCT01676220|463470398|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
128723474|NCT03261947|463285587|FG001|Overall Study|Site Terminated by Sponsor|0|||
128723475|NCT03261947|463285588|FG002|Overall Study|Site Terminated by Sponsor|4|||
128776344|NCT01676220|463470399|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
129069027|NCT03989102|464540794|FG000|Year 2|P16 missing|4|||
128723476|NCT03261947|463285589|FG003|Overall Study|Site Terminated by Sponsor|7|||
128776345|NCT01676220|463470398|FG000|Overall Study|Perceived Lack of Efficacy|3|||
129069028|NCT03989102|464540795|FG001|Year 2|P16 missing|2|||
128723477|NCT03261947|463285590|FG004|Overall Study|Site Terminated by Sponsor|5|||
128723478|NCT03261947|463285586|FG000|Overall Study|Reason not Specified|2|||
128776346|NCT01676220|463470399|FG001|Overall Study|Perceived Lack of Efficacy|1|||
128776347|NCT01676220|463470398|FG000|Overall Study|Non Serious Hypoglycemia|2|||
128776348|NCT01676220|463470399|FG001|Overall Study|Non Serious Hypoglycemia|0|||
128776349|NCT01676220|463470398|FG000|Overall Study|No More Need of Insulin|1|||
128776350|NCT01676220|463470399|FG001|Overall Study|No More Need of Insulin|0|||
128776351|NCT03875911|463470402|FG000|Overall Study|Lost to Follow-up|3|||
128776352|NCT03875911|463470403|FG001|Overall Study|Lost to Follow-up|6|||
128776353|NCT03875911|463470404|FG002|Overall Study|Lost to Follow-up|2|||
128776354|NCT03875911|463470402|FG000|Overall Study|Surgery cancelled|1|||
128776355|NCT03875911|463470403|FG001|Overall Study|Surgery cancelled|0|||
128776356|NCT03875911|463470404|FG002|Overall Study|Surgery cancelled|1|||
128776357|NCT03875911|463470402|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
128776358|NCT03875911|463470403|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
128776359|NCT03875911|463470404|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
128776360|NCT03824938|463470407|FG000|Overall Study|Withdrawal by Subject|2|||
129069029|NCT03989102|464540796|FG002|Year 2|P16 missing|1|||
129069030|NCT03989102|464540794|FG000|Year 2|P11 missing|1|||
129069031|NCT03989102|464540795|FG001|Year 2|P11 missing|3|||
129069032|NCT03989102|464540796|FG002|Year 2|P11 missing|7|||
129069033|NCT03989102|464540794|FG000|Year 2|Definitive displacement outside the study site|0|||
129069034|NCT03989102|464540795|FG001|Year 2|Definitive displacement outside the study site|1|||
129069035|NCT03989102|464540796|FG002|Year 2|Definitive displacement outside the study site|0|||
129069036|NCT03989102|464540794|FG000|Year 2|Subject missed last study visit|0|||
129069037|NCT03989102|464540795|FG001|Year 2|Subject missed last study visit|1|||
129069038|NCT03989102|464540796|FG002|Year 2|Subject missed last study visit|0|||
129069039|NCT03989102|464540794|FG000|Year 2|Death|0|||
129069040|NCT03989102|464540795|FG001|Year 2|Death|1|||
129069041|NCT03989102|464540796|FG002|Year 2|Death|0|||
129069042|NCT03989102|464540794|FG000|Year 2|Subject not reachable|0|||
129069043|NCT03989102|464540795|FG001|Year 2|Subject not reachable|0|||
129069044|NCT03989102|464540796|FG002|Year 2|Subject not reachable|1|||
129069045|NCT03989102|464540794|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
129069046|NCT03989102|464540795|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
129069047|NCT03989102|464540796|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
129069048|NCT03989102|464540794|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
129069049|NCT03989102|464540795|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
129069050|NCT03989102|464540796|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
129069051|NCT03989102|464540794|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
129069052|NCT03989102|464540795|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
129069053|NCT03989102|464540796|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
129069054|NCT03989102|464540794|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
129069055|NCT03989102|464540795|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
128776361|NCT03824938|463470408|FG001|Overall Study|Withdrawal by Subject|1|||
129069056|NCT03989102|464540796|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
129069057|NCT03989102|464540794|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
129069058|NCT03989102|464540795|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
129069059|NCT03989102|464540796|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
129069060|NCT03989102|464540794|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
129069061|NCT03989102|464540795|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
129069062|NCT03989102|464540796|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
129069063|NCT03642262|464540797|FG000|Period 1|Withdrawal by Subject|1|||
129069064|NCT03642262|464540798|FG001|Period 1|Withdrawal by Subject|1|||
129069065|NCT03642262|464540797|FG000|Period 1|Adverse Event|0|||
129069066|NCT03642262|464540798|FG001|Period 1|Adverse Event|1|||
129069067|NCT02760004|464540803|FG000|Overall Study|Lost to Follow-up|13|||
129069068|NCT02760004|464540804|FG001|Overall Study|Lost to Follow-up|22|||
129069069|NCT01431079|464540807|FG000|Overall Study|Lost to Follow-up|35|||
129069070|NCT01431079|464540808|FG001|Overall Study|Lost to Follow-up|39|||
129069071|NCT02038010|464540812|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
129069072|NCT02038010|464540813|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
129069073|NCT02038010|464540814|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
129069074|NCT02038010|464540815|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
128776362|NCT03824938|463470409|FG002|Overall Study|Withdrawal by Subject|0|||
129069075|NCT02038010|464540812|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
129069076|NCT02038010|464540813|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
129069077|NCT02038010|464540814|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
129069078|NCT02038010|464540815|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
129069079|NCT02038010|464540812|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
129069080|NCT02038010|464540813|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
128776363|NCT03824938|463470410|FG003|Overall Study|Withdrawal by Subject|2|||
128776364|NCT03824938|463470411|FG004|Overall Study|Withdrawal by Subject|0|||
129069081|NCT02038010|464540814|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
129069082|NCT02038010|464540815|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
129069083|NCT02038010|464540812|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
129069084|NCT02038010|464540813|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
129069085|NCT02038010|464540814|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
129069086|NCT02038010|464540815|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
129069087|NCT02038010|464540812|FG000|Follow Up|Death|4|||
129069088|NCT02038010|464540813|FG001|Follow Up|Death|3|||
129069089|NCT02038010|464540814|FG002|Follow Up|Death|0|||
129069090|NCT02038010|464540815|FG003|Follow Up|Death|0|||
129069091|NCT02038010|464540812|FG000|Follow Up|Other|3|||
129069092|NCT02038010|464540813|FG001|Follow Up|Other|0|||
129069093|NCT02038010|464540814|FG002|Follow Up|Other|0|||
129069094|NCT02038010|464540815|FG003|Follow Up|Other|0|||
129069095|NCT00110396|464540816|FG000|Overall Study|Adverse Event|15|||
129069096|NCT00110396|464540816|FG000|Overall Study|Lost to Follow-up|1|||
129069097|NCT00110396|464540816|FG000|Overall Study|Administration of plasmapheresis|1|||
129069098|NCT00110396|464540816|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
129069099|NCT00110396|464540816|FG000|Overall Study|Lack of Efficacy|1|||
129069100|NCT00110396|464540816|FG000|Overall Study|Decided not to continue treatment|1|||
129069101|NCT00110396|464540816|FG000|Overall Study|Patient non-compliance|1|||
129069102|NCT00110396|464540816|FG000|Overall Study|Patient refused to continue|1|||
129069103|NCT00110396|464540816|FG000|Overall Study|Patient refused to participate|1|||
129069104|NCT00110396|464540816|FG000|Overall Study|Patient will|1|||
129069105|NCT00110396|464540816|FG000|Overall Study|Patient's decision|1|||
129069106|NCT00110396|464540816|FG000|Overall Study|Participation in MS vaccine study|1|||
129069107|NCT00110396|464540816|FG000|Overall Study|Pregnancy|1|||
129069108|NCT00110396|464540816|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
129069109|NCT00110396|464540816|FG000|Overall Study|Protocol Violation|2|||
129069110|NCT00110396|464540816|FG000|Overall Study|Patient refused to come back|1|||
129069111|NCT00110396|464540816|FG000|Overall Study|The patient has refused|2|||
129069112|NCT00110396|464540816|FG000|Overall Study|The patient has refused to visit site|1|||
129069113|NCT00110396|464540816|FG000|Overall Study|Patient is to be administered copaxone|1|||
129069114|NCT02414958|464540817|FG000|Overall Study|Adverse Event|6|||
129069115|NCT02414958|464540818|FG001|Overall Study|Adverse Event|6|||
129069116|NCT02414958|464540819|FG002|Overall Study|Adverse Event|3|||
129069117|NCT02414958|464540817|FG000|Overall Study|Protocol Violation|10|||
129069118|NCT02414958|464540818|FG001|Overall Study|Protocol Violation|3|||
129069119|NCT02414958|464540819|FG002|Overall Study|Protocol Violation|1|||
129069120|NCT02414958|464540817|FG000|Overall Study|Lost to Follow-up|7|||
129069121|NCT02414958|464540818|FG001|Overall Study|Lost to Follow-up|4|||
129069122|NCT02414958|464540819|FG002|Overall Study|Lost to Follow-up|0|||
129069123|NCT02414958|464540817|FG000|Overall Study|Withdrawal by Subject|5|||
129069124|NCT02414958|464540818|FG001|Overall Study|Withdrawal by Subject|3|||
129069125|NCT02414958|464540819|FG002|Overall Study|Withdrawal by Subject|5|||
129069126|NCT02414958|464540817|FG000|Overall Study|Other than specified|4|||
129069127|NCT02414958|464540818|FG001|Overall Study|Other than specified|4|||
129069128|NCT02414958|464540819|FG002|Overall Study|Other than specified|5|||
129069129|NCT00245466|464540821|FG000|Overall Study|Adverse Event|2|||
129069130|NCT00245466|464540822|FG001|Overall Study|Adverse Event|8|||
129069131|NCT00245466|464540823|FG002|Overall Study|Adverse Event|4|||
129069132|NCT00245466|464540821|FG000|Overall Study|Low prostate specific antigen suppr|16|||
129069133|NCT00245466|464540822|FG001|Overall Study|Low prostate specific antigen suppr|14|||
129069134|NCT00245466|464540823|FG002|Overall Study|Low prostate specific antigen suppr|5|||
129069135|NCT00245466|464540821|FG000|Overall Study|Insufficient testosterone suppr|12|||
129069136|NCT00245466|464540822|FG001|Overall Study|Insufficient testosterone suppr|12|||
129139118|NCT02991859|464802686|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139119|NCT02991859|464802687|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129139120|NCT02991859|464802671|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139121|NCT02991859|464802672|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139122|NCT02991859|464802673|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139123|NCT02991859|464802674|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139124|NCT02991859|464802675|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139125|NCT02991859|464802676|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139126|NCT02991859|464802677|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128723479|NCT03261947|463285587|FG001|Overall Study|Reason not Specified|0|||
128723480|NCT03261947|463285588|FG002|Overall Study|Reason not Specified|4|||
129069137|NCT00245466|464540823|FG002|Overall Study|Insufficient testosterone suppr|21|||
129069138|NCT00245466|464540821|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
129069139|NCT00245466|464540822|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
129069140|NCT00245466|464540823|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
129069141|NCT00245466|464540821|FG000|Overall Study|Withdrawal by Subject|2|||
129069142|NCT00245466|464540822|FG001|Overall Study|Withdrawal by Subject|2|||
128723481|NCT03261947|463285589|FG003|Overall Study|Reason not Specified|1|||
128723482|NCT03261947|463285590|FG004|Overall Study|Reason not Specified|3|||
128723483|NCT02319031|463285600|FG000|Treatment Period|Death|1|||
128723484|NCT02319031|463285601|FG001|Treatment Period|Death|0|||
128723485|NCT02871739|463285604|FG000|Overall Study|Lost to Follow-up|3|||
128723486|NCT02871739|463285605|FG001|Overall Study|Lost to Follow-up|2|||
128723487|NCT02871739|463285606|FG002|Overall Study|Lost to Follow-up|0|||
128723488|NCT02871739|463285607|FG003|Overall Study|Lost to Follow-up|2|||
128723489|NCT00439556|463285608|FG000|Overall Study|Patient was taken off study for non-comp|0|||
128723490|NCT00439556|463285609|FG001|Overall Study|Patient was taken off study for non-comp|1|||
128723491|NCT00439556|463285610|FG002|Overall Study|Patient was taken off study for non-comp|0|||
128723492|NCT02907359|463285613|FG000|Overall Study|Death|234|||
129069143|NCT00245466|464540823|FG002|Overall Study|Withdrawal by Subject|1|||
129069144|NCT00245466|464540821|FG000|Overall Study|Lost to Follow-up|3|||
129069145|NCT00245466|464540822|FG001|Overall Study|Lost to Follow-up|0|||
129069146|NCT00245466|464540823|FG002|Overall Study|Lost to Follow-up|0|||
129069147|NCT00245466|464540821|FG000|Overall Study|Disease progression|0|||
129069148|NCT00245466|464540822|FG001|Overall Study|Disease progression|3|||
129069149|NCT00245466|464540823|FG002|Overall Study|Disease progression|1|||
129069150|NCT00245466|464540821|FG000|Overall Study|Protocol Violation|1|||
129069151|NCT00245466|464540822|FG001|Overall Study|Protocol Violation|2|||
129069152|NCT00245466|464540823|FG002|Overall Study|Protocol Violation|2|||
129069153|NCT00245466|464540821|FG000|Overall Study|Death|0|||
129069154|NCT00245466|464540822|FG001|Overall Study|Death|2|||
129069155|NCT00245466|464540823|FG002|Overall Study|Death|0|||
129069156|NCT00245466|464540821|FG000|Overall Study|Administrative reasons|0|||
129069157|NCT00245466|464540822|FG001|Overall Study|Administrative reasons|1|||
129069158|NCT00245466|464540823|FG002|Overall Study|Administrative reasons|0|||
129069159|NCT01958437|464540824|FG000|Overall Study|Incidental MRI findings|0|||
129069160|NCT01958437|464540825|FG001|Overall Study|Incidental MRI findings|0|||
129069161|NCT01958437|464540826|FG002|Overall Study|Incidental MRI findings|1|||
129069162|NCT01958437|464540827|FG003|Overall Study|Incidental MRI findings|1|||
129069163|NCT04886596|464540830|FG000|Overall Study|Adverse Event|442|||
129069164|NCT04886596|464540831|FG001|Overall Study|Adverse Event|441|||
129069165|NCT04886596|464540830|FG000|Overall Study|Lost to Follow-up|448|||
129069166|NCT04886596|464540831|FG001|Overall Study|Lost to Follow-up|465|||
129069167|NCT04886596|464540830|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
129069168|NCT04886596|464540831|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
129069169|NCT04886596|464540830|FG000|Overall Study|Migrated/moved from the study area|201|||
129069170|NCT04886596|464540831|FG001|Overall Study|Migrated/moved from the study area|184|||
129069171|NCT04886596|464540830|FG000|Overall Study|Other|298|||
128723493|NCT02907359|463285614|FG001|Overall Study|Death|117|||
128723494|NCT02907359|463285613|FG000|Overall Study|Withdrawal by Subject|6|||
128723495|NCT02907359|463285614|FG001|Overall Study|Withdrawal by Subject|11|||
128723496|NCT02907359|463285613|FG000|Overall Study|Lost to Follow-up|1|||
128723497|NCT02907359|463285614|FG001|Overall Study|Lost to Follow-up|0|||
128723498|NCT01405963|463285615|FG000|Overall Study|Moved Away|2|||
128723499|NCT01405963|463285616|FG001|Overall Study|Moved Away|0|||
128723500|NCT01405963|463285615|FG000|Overall Study|Adverse Event|0|||
128723501|NCT01405963|463285616|FG001|Overall Study|Adverse Event|1|||
128723502|NCT01405963|463285615|FG000|Overall Study|Lost to Follow-up|0|||
128723503|NCT01405963|463285616|FG001|Overall Study|Lost to Follow-up|1|||
128723504|NCT04544293|463285623|FG000|Double-blind|Adverse Event|2|||
128723505|NCT04544293|463285624|FG001|Double-blind|Adverse Event|1|||
129069172|NCT04886596|464540831|FG001|Overall Study|Other|326|||
129069173|NCT00948155|464540834|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
129069174|NCT00948155|464540835|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
129069175|NCT00948155|464540834|FG000|Washout 14 Days|Lost to Follow-up|1|||
129069176|NCT00948155|464540835|FG001|Washout 14 Days|Lost to Follow-up|2|||
129069177|NCT03473925|464540836|FG000|Overall Study|Death|48|||
129069178|NCT03473925|464540837|FG001|Overall Study|Death|44|||
129069179|NCT03473925|464540836|FG000|Overall Study|Sponsor Decision|2|||
129069180|NCT03473925|464540837|FG001|Overall Study|Sponsor Decision|7|||
129069181|NCT03473925|464540836|FG000|Overall Study|Withdrawal by Subject|1|||
129069182|NCT03473925|464540837|FG001|Overall Study|Withdrawal by Subject|3|||
128723506|NCT04544293|463285623|FG000|Double-blind|Pregnancy|0|||
128776365|NCT03824938|463470412|FG005|Overall Study|Withdrawal by Subject|1|||
129069183|NCT03473925|464540836|FG000|Overall Study|Not Treated|1|||
129069184|NCT03473925|464540837|FG001|Overall Study|Not Treated|1|||
129069185|NCT04661150|464540842|FG000|Overall Study|Ongoing in study|19|||
129069186|NCT04661150|464540843|FG001|Overall Study|Ongoing in study|20|||
128723507|NCT04544293|463285624|FG001|Double-blind|Pregnancy|1|||
128723508|NCT04544293|463285623|FG000|Double-blind|Lost to Follow-up|0|||
128723509|NCT04544293|463285624|FG001|Double-blind|Lost to Follow-up|1|||
129069187|NCT04661150|464540842|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
129069188|NCT04661150|464540843|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
129069189|NCT04661150|464540842|FG000|Overall Study|Death|2|||
129069190|NCT04661150|464540843|FG001|Overall Study|Death|0|||
128776366|NCT03824938|463470407|FG000|Overall Study|Lost to Follow-up|0|||
128723510|NCT04544293|463285623|FG000|Open-Label Extension|Study ongoing|79|||
128723511|NCT04544293|463285624|FG001|Open-Label Extension|Study ongoing|81|||
128723512|NCT00329407|463285625|FG000|Overall Study|Withdrawal by Subject|1|||
128723513|NCT03560531|463285626|FG000|Overall Study|Death|4|||
128723514|NCT03560531|463285627|FG001|Overall Study|Death|1|||
129069191|NCT05767905|464540844|FG000|Overall Study|Adverse Event|0|||
129069192|NCT05767905|464540845|FG001|Overall Study|Adverse Event|0|||
129069193|NCT05767905|464540846|FG002|Overall Study|Adverse Event|1|||
129069194|NCT03762239|464540847|FG000|Overall Study|Appointment to the doctor|1|||
129069195|NCT03762239|464540848|FG001|Overall Study|Appointment to the doctor|1|||
129069196|NCT03645863|464540849|FG000|Overall Study|Withdrawal by Subject|1|||
129069197|NCT03645863|464540850|FG001|Overall Study|Withdrawal by Subject|0|||
129069198|NCT03645863|464540851|FG002|Overall Study|Withdrawal by Subject|0|||
129069199|NCT03624192|464540861|FG000|Overall Study|Lost to Follow-up|1|||
129069200|NCT03624192|464540862|FG001|Overall Study|Lost to Follow-up|1|||
129069201|NCT04660331|464540867|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
129069202|NCT04660331|464540868|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
129069203|NCT04660331|464540869|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
129069204|NCT02635984|464540870|FG000|Overall Study|Lost to Follow-up|2|||
129069205|NCT02635984|464540871|FG001|Overall Study|Lost to Follow-up|4|||
129069206|NCT02635984|464540870|FG000|Overall Study|Study Arm Closed|1|||
129069207|NCT02635984|464540871|FG001|Overall Study|Study Arm Closed|0|||
129069208|NCT01640249|464540872|FG000|Period 1|Withdrawal by Subject|1|||
129069209|NCT01640249|464540873|FG001|Period 1|Withdrawal by Subject|0|||
129069210|NCT01640249|464540874|FG002|Period 1|Withdrawal by Subject|0|||
129069211|NCT01640249|464540875|FG003|Period 1|Withdrawal by Subject|0|||
129069212|NCT01640249|464540876|FG004|Period 1|Withdrawal by Subject|0|||
129069213|NCT01640249|464540877|FG005|Period 1|Withdrawal by Subject|1|||
129069214|NCT01640249|464540878|FG006|Period 1|Withdrawal by Subject|0|||
129069215|NCT00065156|464540882|FG000|Overall Study|Adverse Event|37|||
129069216|NCT00065156|464540882|FG000|Overall Study|Lack of Efficacy|52|||
129069217|NCT00065156|464540882|FG000|Overall Study|Withdrawal by Subject|8|||
129069218|NCT00065156|464540882|FG000|Overall Study|Lost to Follow-up|1|||
129069219|NCT00065156|464540882|FG000|Overall Study|Death|11|||
129069220|NCT00065156|464540882|FG000|Overall Study|Study Closed by Sponsor|2|||
129069221|NCT00065156|464540882|FG000|Overall Study|Disease Progression|7|||
129069222|NCT00065156|464540882|FG000|Overall Study|Investigator Decision|2|||
129069223|NCT00065156|464540882|FG000|Overall Study|Non-Compliance|2|||
129069224|NCT00065156|464540882|FG000|Overall Study|Loss of Response|1|||
129069225|NCT00065156|464540882|FG000|Overall Study|Secondary Malign Disease|1|||
129069226|NCT01215136|464540883|FG000|Overall Study|Adverse Event|2|||
129069227|NCT01215136|464540884|FG001|Overall Study|Adverse Event|9|||
129069228|NCT01215136|464540883|FG000|Overall Study|Disease Progression|3|||
129069229|NCT01215136|464540884|FG001|Overall Study|Disease Progression|14|||
129069230|NCT01215136|464540883|FG000|Overall Study|Symptomatic Deterioration|1|||
129069231|NCT01215136|464540884|FG001|Overall Study|Symptomatic Deterioration|1|||
129069232|NCT01215136|464540883|FG000|Overall Study|Death|0|||
129069233|NCT01215136|464540884|FG001|Overall Study|Death|2|||
129069234|NCT01215136|464540883|FG000|Overall Study|Withdrawal by Subject|0|||
129069235|NCT01215136|464540884|FG001|Overall Study|Withdrawal by Subject|1|||
129069236|NCT00951496|464540889|FG000|Overall Study|Did not initiate study treatment|10|||
129069237|NCT00951496|464540890|FG001|Overall Study|Did not initiate study treatment|8|||
129069238|NCT00951496|464540891|FG002|Overall Study|Did not initiate study treatment|13|||
129069239|NCT01526057|464540893|FG000|Overall Study|Withdrawal by Subject|3|||
129069240|NCT01526057|464540894|FG001|Overall Study|Withdrawal by Subject|2|||
129069241|NCT01526057|464540895|FG002|Overall Study|Withdrawal by Subject|2|||
129069242|NCT01526057|464540893|FG000|Overall Study|Adverse Event|3|||
129069243|NCT01526057|464540894|FG001|Overall Study|Adverse Event|1|||
129069244|NCT01526057|464540895|FG002|Overall Study|Adverse Event|1|||
129069245|NCT01526057|464540893|FG000|Overall Study|Death|1|||
129069246|NCT01526057|464540894|FG001|Overall Study|Death|0|||
129069247|NCT01526057|464540895|FG002|Overall Study|Death|0|||
128723515|NCT03560531|463285628|FG002|Overall Study|Death|1|||
129069248|NCT01526057|464540893|FG000|Overall Study|Lost to Follow-up|1|||
129069249|NCT01526057|464540894|FG001|Overall Study|Lost to Follow-up|0|||
129069250|NCT01526057|464540895|FG002|Overall Study|Lost to Follow-up|1|||
129069251|NCT01526057|464540893|FG000|Overall Study|Other|1|||
129069252|NCT01526057|464540894|FG001|Overall Study|Other|0|||
129069253|NCT01526057|464540895|FG002|Overall Study|Other|1|||
128723516|NCT03560531|463285629|FG003|Overall Study|Death|2|||
129069254|NCT01526057|464540893|FG000|Overall Study|Protocol Violation|0|||
129069255|NCT01526057|464540894|FG001|Overall Study|Protocol Violation|0|||
129069256|NCT01526057|464540895|FG002|Overall Study|Protocol Violation|1|||
129069257|NCT02289729|464540906|FG000|Overall Study|Lack of Efficacy|3|||
129069258|NCT02289729|464540906|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
128723517|NCT03560531|463285630|FG004|Overall Study|Death|6|||
129069259|NCT02289729|464540906|FG000|Overall Study|Withdrawal by Subject|1|||
128723518|NCT03560531|463285631|FG005|Overall Study|Death|1|||
129069260|NCT02289729|464540906|FG000|Overall Study|Death|1|||
129139127|NCT02991859|464802678|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139128|NCT02991859|464802679|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139129|NCT02991859|464802680|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139130|NCT02991859|464802681|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139131|NCT02991859|464802682|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139132|NCT02991859|464802683|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
129069261|NCT04870710|464540910|FG000|Overall Study|Lost to Follow-up|3|||
129069262|NCT00281957|464540925|FG000|Overall Study|Adverse Event|7|||
129069263|NCT00281957|464540926|FG001|Overall Study|Adverse Event|2|||
129069264|NCT00281957|464540925|FG000|Overall Study|Death|1|||
129069265|NCT00281957|464540926|FG001|Overall Study|Death|0|||
129069266|NCT00281957|464540925|FG000|Overall Study|Progression/relapse|47|||
129069267|NCT00281957|464540926|FG001|Overall Study|Progression/relapse|35|||
129069268|NCT00281957|464540925|FG000|Overall Study|Not protocol specified|8|||
129069269|NCT00281957|464540926|FG001|Overall Study|Not protocol specified|1|||
129069270|NCT00281957|464540925|FG000|Overall Study|Not eligible|1|||
129069271|NCT00281957|464540926|FG001|Overall Study|Not eligible|2|||
129069272|NCT00281957|464540925|FG000|Overall Study|Did not start treatment|3|||
129069273|NCT00281957|464540926|FG001|Overall Study|Did not start treatment|1|||
129069274|NCT00281957|464540925|FG000|Overall Study|Refusal unrelated to adverse events|0|||
129069275|NCT00281957|464540926|FG001|Overall Study|Refusal unrelated to adverse events|1|||
129069276|NCT01876446|464540927|FG000|Overall Study|Death|0|||
129069277|NCT01876446|464540928|FG001|Overall Study|Death|1|||
129069278|NCT01876446|464540927|FG000|Overall Study|Withdrawal by Subject|1|||
129069279|NCT01876446|464540928|FG001|Overall Study|Withdrawal by Subject|2|||
129069280|NCT01876446|464540927|FG000|Overall Study|Physician Decision|1|||
129069281|NCT01876446|464540928|FG001|Overall Study|Physician Decision|3|||
129069282|NCT00822692|464540931|FG000|Overall Study|Lost to Follow-up|17|||
129069283|NCT00822692|464540932|FG001|Overall Study|Lost to Follow-up|25|||
129069284|NCT03629184|464540937|FG000|Overall Study|Withdrawal by Subject|2|||
129069285|NCT03629184|464540938|FG001|Overall Study|Withdrawal by Subject|1|||
129069286|NCT03629184|464540937|FG000|Overall Study|Physician Decision|1|||
129069287|NCT03629184|464540938|FG001|Overall Study|Physician Decision|0|||
129069288|NCT02905032|464540940|FG000|Overall Study|Withdrawal by Subject|2|||
129069289|NCT02905032|464540941|FG001|Overall Study|Withdrawal by Subject|0|||
129069290|NCT02905032|464540942|FG002|Overall Study|Withdrawal by Subject|0|||
129069291|NCT02905032|464540940|FG000|Overall Study|Protocol Violation|6|||
129069292|NCT02905032|464540941|FG001|Overall Study|Protocol Violation|12|||
129069293|NCT02905032|464540942|FG002|Overall Study|Protocol Violation|0|||
129069294|NCT02203357|464542674|FG000|Overall Study|Lost to Follow-up|58|||
129069295|NCT02203357|464542675|FG001|Overall Study|Lost to Follow-up|66|||
129069296|NCT02203357|464542676|FG002|Overall Study|Lost to Follow-up|70|||
129069297|NCT01050530|464542677|FG000|Overall Study|Adverse Event|6|||
129069298|NCT01050530|464542678|FG001|Overall Study|Adverse Event|3|||
129069299|NCT01050530|464542677|FG000|Overall Study|Lack of Efficacy|1|||
129069300|NCT01050530|464542678|FG001|Overall Study|Lack of Efficacy|4|||
129069301|NCT01050530|464542677|FG000|Overall Study|Withdrawal by Subject|0|||
129069302|NCT01050530|464542678|FG001|Overall Study|Withdrawal by Subject|3|||
129069303|NCT01050530|464542677|FG000|Overall Study|Protocol Violation|1|||
129069304|NCT01050530|464542678|FG001|Overall Study|Protocol Violation|0|||
129069305|NCT02288312|464542679|FG000|Overall Study|Pregnancy|1|||
129069306|NCT02288312|464542680|FG001|Overall Study|Pregnancy|0|||
129069307|NCT02288312|464542681|FG002|Overall Study|Pregnancy|0|||
129069308|NCT01276041|464542682|FG000|Overall Study|Adverse Event|2|||
129069309|NCT01276041|464542682|FG000|Overall Study|Protocol Violation|1|||
129069310|NCT00485264|464542689|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
129069311|NCT00485264|464542690|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
129069312|NCT00485264|464542691|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
129069313|NCT00485264|464542692|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
129069314|NCT00485264|464542693|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
129069315|NCT00485264|464542694|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
129069316|NCT00485264|464542689|FG000|Overall Study|Death|1|||
129069317|NCT00485264|464542690|FG001|Overall Study|Death|0|||
129069318|NCT00485264|464542691|FG002|Overall Study|Death|0|||
129069319|NCT00485264|464542692|FG003|Overall Study|Death|0|||
129069320|NCT00485264|464542693|FG004|Overall Study|Death|1|||
129069321|NCT00485264|464542694|FG005|Overall Study|Death|0|||
129139133|NCT02991859|464802684|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
129139134|NCT02991859|464802685|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
128776367|NCT03824938|463470408|FG001|Overall Study|Lost to Follow-up|1|||
129139135|NCT02991859|464802686|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129139136|NCT02991859|464802687|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129069322|NCT00485264|464542689|FG000|Overall Study|Adverse Event|1|||
129069323|NCT00485264|464542690|FG001|Overall Study|Adverse Event|0|||
129069324|NCT00485264|464542691|FG002|Overall Study|Adverse Event|2|||
129069325|NCT00485264|464542692|FG003|Overall Study|Adverse Event|3|||
129069326|NCT00485264|464542693|FG004|Overall Study|Adverse Event|1|||
129069327|NCT00485264|464542694|FG005|Overall Study|Adverse Event|3|||
129069328|NCT00485264|464542689|FG000|Overall Study|Pregnancy|4|||
129069329|NCT00485264|464542690|FG001|Overall Study|Pregnancy|0|||
129069330|NCT00485264|464542691|FG002|Overall Study|Pregnancy|0|||
129069331|NCT00485264|464542692|FG003|Overall Study|Pregnancy|0|||
129069332|NCT00485264|464542693|FG004|Overall Study|Pregnancy|0|||
129069333|NCT00485264|464542694|FG005|Overall Study|Pregnancy|0|||
129139137|NCT02991859|464802671|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139138|NCT02991859|464802672|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139139|NCT02991859|464802673|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139140|NCT02991859|464802674|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139141|NCT02991859|464802675|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139142|NCT02991859|464802676|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
129139143|NCT02991859|464802677|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139144|NCT02991859|464802678|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139145|NCT02991859|464802679|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139146|NCT02991859|464802680|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139147|NCT02991859|464802681|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139148|NCT02991859|464802682|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139149|NCT02991859|464802683|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139150|NCT02991859|464802684|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139151|NCT02991859|464802685|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139152|NCT02991859|464802686|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139153|NCT02991859|464802687|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129139154|NCT02991859|464802671|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139155|NCT02991859|464802672|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139156|NCT02991859|464802673|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139157|NCT02991859|464802674|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139158|NCT02991859|464802675|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139159|NCT02991859|464802676|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139160|NCT02991859|464802677|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139161|NCT02991859|464802678|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139162|NCT02991859|464802679|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139163|NCT02991859|464802680|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
129139164|NCT02991859|464802681|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139165|NCT02991859|464802682|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139166|NCT02991859|464802683|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139167|NCT02991859|464802684|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139168|NCT02991859|464802685|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139169|NCT02991859|464802686|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139170|NCT02991859|464802687|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129139171|NCT02991859|464802671|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139172|NCT02991859|464802672|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139173|NCT02991859|464802673|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139174|NCT02991859|464802674|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139175|NCT02991859|464802675|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139176|NCT02991859|464802676|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139177|NCT02991859|464802677|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139178|NCT02991859|464802678|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139179|NCT02991859|464802679|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
129139180|NCT02991859|464802680|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139181|NCT02991859|464802681|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139182|NCT02991859|464802682|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139183|NCT02991859|464802683|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139184|NCT02991859|464802684|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139185|NCT02991859|464802685|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139186|NCT02991859|464802686|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139187|NCT02991859|464802687|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129139188|NCT04223687|464802693|FG000|Overall Study|Missing primary outcome|1|||
129139189|NCT04223687|464802694|FG001|Overall Study|Missing primary outcome|0|||
128776368|NCT03824938|463470409|FG002|Overall Study|Lost to Follow-up|0|||
129069334|NCT00485264|464542689|FG000|Overall Study|Disallowed Medication|0|||
129069335|NCT00485264|464542690|FG001|Overall Study|Disallowed Medication|0|||
129139190|NCT00425854|464802695|FG000|Overall Study|Progressive Disease|19|||
129139191|NCT00425854|464802696|FG001|Overall Study|Progressive Disease|12|||
129139192|NCT00425854|464802695|FG000|Overall Study|Dose reduction toxicity AE|8|||
129139193|NCT00425854|464802696|FG001|Overall Study|Dose reduction toxicity AE|7|||
129069336|NCT00485264|464542691|FG002|Overall Study|Disallowed Medication|0|||
129139194|NCT00425854|464802695|FG000|Overall Study|Other Adverse Event|2|||
129139195|NCT00425854|464802696|FG001|Overall Study|Other Adverse Event|2|||
129139196|NCT05652140|464802702|FG000|Overall Study|Lost to Follow-up|7|||
129139197|NCT05652140|464802703|FG001|Overall Study|Lost to Follow-up|16|||
129139198|NCT05652140|464802704|FG002|Overall Study|Lost to Follow-up|22|||
129139199|NCT05652140|464802705|FG003|Overall Study|Lost to Follow-up|31|||
129139200|NCT03163264|464802706|FG000|Overall Study|Withdrawal by Subject|13|||
129139201|NCT03163264|464802707|FG001|Overall Study|Withdrawal by Subject|3|||
129139202|NCT03163264|464802708|FG002|Overall Study|Withdrawal by Subject|4|||
129139203|NCT03163264|464802709|FG003|Overall Study|Withdrawal by Subject|2|||
129139204|NCT03163264|464802706|FG000|Overall Study|Lost to Follow-up|17|||
129139205|NCT03163264|464802707|FG001|Overall Study|Lost to Follow-up|20|||
129139206|NCT03163264|464802708|FG002|Overall Study|Lost to Follow-up|0|||
129139207|NCT03163264|464802709|FG003|Overall Study|Lost to Follow-up|0|||
129139208|NCT03163264|464802706|FG000|Overall Study|Death|0|||
129139209|NCT03163264|464802707|FG001|Overall Study|Death|2|||
129139210|NCT03163264|464802708|FG002|Overall Study|Death|0|||
129139211|NCT03163264|464802709|FG003|Overall Study|Death|0|||
129139212|NCT05259722|464802710|FG000|Overall Study|Adverse Event|2|||
129139213|NCT05259722|464802711|FG001|Overall Study|Adverse Event|24|||
129139214|NCT05259722|464802710|FG000|Overall Study|Lost to Follow-up|5|||
129139215|NCT05259722|464802711|FG001|Overall Study|Lost to Follow-up|1|||
129139216|NCT05259722|464802710|FG000|Overall Study|Lack of Efficacy|8|||
129139217|NCT05259722|464802711|FG001|Overall Study|Lack of Efficacy|26|||
129139218|NCT05259722|464802710|FG000|Overall Study|Withdrawal by Subject|15|||
129139219|NCT05259722|464802711|FG001|Overall Study|Withdrawal by Subject|33|||
129139220|NCT05259722|464802710|FG000|Overall Study|Various reasons|3|||
129139221|NCT05259722|464802711|FG001|Overall Study|Various reasons|9|||
129139222|NCT05259722|464802710|FG000|Overall Study|Not exposed to IMP|1|||
129139223|NCT05259722|464802711|FG001|Overall Study|Not exposed to IMP|12|||
129139224|NCT05259722|464802710|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
129139225|NCT05259722|464802711|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
129139226|NCT00962650|464802712|FG000|Overall Study|Transgastric DP was not completed|2|||
129139227|NCT01185366|464802714|FG000|First Line Therapy|Insurance Coverage Denied|1|||
129139228|NCT01185366|464802715|FG001|First Line Therapy|Insurance Coverage Denied|1|||
129139229|NCT01185366|464802714|FG000|First Line Therapy|Withdrawal by Subject|1|||
129139230|NCT01185366|464802715|FG001|First Line Therapy|Withdrawal by Subject|0|||
129139231|NCT01185366|464802714|FG000|First Line Therapy|Lack of Metastatic Site|1|||
129139232|NCT01185366|464802715|FG001|First Line Therapy|Lack of Metastatic Site|0|||
129139233|NCT01185366|464802714|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
129139234|NCT01185366|464802715|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
129139235|NCT01185366|464802714|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
129139236|NCT01185366|464802715|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
129139237|NCT01185366|464802714|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
129139238|NCT01185366|464802715|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
129139239|NCT01185366|464802714|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
129139240|NCT01185366|464802715|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
129139241|NCT02774278|464802716|FG000|Overall Study|Lack of Efficacy|199|||
129069337|NCT00485264|464542692|FG003|Overall Study|Disallowed Medication|0|||
129069338|NCT00485264|464542693|FG004|Overall Study|Disallowed Medication|0|||
129069339|NCT00485264|464542694|FG005|Overall Study|Disallowed Medication|1|||
129069340|NCT00485264|464542689|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
129069341|NCT00485264|464542690|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
129069342|NCT00485264|464542691|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
129069343|NCT00485264|464542692|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
129069344|NCT00485264|464542693|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
129069345|NCT00485264|464542694|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
129069346|NCT00485264|464542689|FG000|Overall Study|Lack of Efficacy|0|||
129069347|NCT00485264|464542690|FG001|Overall Study|Lack of Efficacy|1|||
129069348|NCT00485264|464542691|FG002|Overall Study|Lack of Efficacy|0|||
129069349|NCT00485264|464542692|FG003|Overall Study|Lack of Efficacy|0|||
129069350|NCT00485264|464542693|FG004|Overall Study|Lack of Efficacy|0|||
129069351|NCT00485264|464542694|FG005|Overall Study|Lack of Efficacy|0|||
129069352|NCT00485264|464542689|FG000|Overall Study|Guardian Consent Withdrawn|1|||
129069353|NCT00485264|464542690|FG001|Overall Study|Guardian Consent Withdrawn|0|||
129069354|NCT00485264|464542691|FG002|Overall Study|Guardian Consent Withdrawn|0|||
129069355|NCT00485264|464542692|FG003|Overall Study|Guardian Consent Withdrawn|0|||
129069356|NCT00485264|464542693|FG004|Overall Study|Guardian Consent Withdrawn|1|||
129139242|NCT02774278|464802716|FG000|Overall Study|Death|29|||
129139243|NCT02774278|464802716|FG000|Overall Study|Adverse event/intercurrent illness|16|||
129139244|NCT02774278|464802716|FG000|Overall Study|Refused treatment/did not cooperate|9|||
129139245|NCT02774278|464802716|FG000|Overall Study|Administrative reasons|6|||
129139246|NCT02774278|464802716|FG000|Overall Study|Withdrawal by Subject|3|||
129139247|NCT02774278|464802716|FG000|Overall Study|Protocol Violation|2|||
129139248|NCT00127933|464802723|FG000|Overall Study|Randomized but not dosed|1|||
129139249|NCT00127933|464802724|FG001|Overall Study|Randomized but not dosed|0|||
129139250|NCT01783938|464802726|FG000|Overall Study|Disease Progression|18|||
128723519|NCT03560531|463285632|FG006|Overall Study|Death|4|||
128723520|NCT03560531|463285633|FG007|Overall Study|Death|8|||
128723521|NCT03560531|463285634|FG008|Overall Study|Death|1|||
128723522|NCT03560531|463285635|FG009|Overall Study|Death|3|||
128723523|NCT03560531|463285636|FG010|Overall Study|Death|2|||
128723524|NCT03560531|463285637|FG011|Overall Study|Death|0|||
128723525|NCT03560531|463285638|FG012|Overall Study|Death|4|||
128723526|NCT03560531|463285639|FG013|Overall Study|Death|1|||
128723527|NCT03560531|463285626|FG000|Overall Study|Lost to Follow-up|1|||
128723528|NCT03560531|463285627|FG001|Overall Study|Lost to Follow-up|1|||
128723529|NCT03560531|463285628|FG002|Overall Study|Lost to Follow-up|0|||
128723530|NCT03560531|463285629|FG003|Overall Study|Lost to Follow-up|0|||
128723531|NCT03560531|463285630|FG004|Overall Study|Lost to Follow-up|0|||
128723532|NCT03560531|463285631|FG005|Overall Study|Lost to Follow-up|0|||
128723533|NCT03560531|463285632|FG006|Overall Study|Lost to Follow-up|1|||
128723534|NCT03560531|463285633|FG007|Overall Study|Lost to Follow-up|0|||
128723535|NCT03560531|463285634|FG008|Overall Study|Lost to Follow-up|0|||
128723536|NCT03560531|463285635|FG009|Overall Study|Lost to Follow-up|0|||
128723537|NCT03560531|463285636|FG010|Overall Study|Lost to Follow-up|0|||
128723538|NCT03560531|463285637|FG011|Overall Study|Lost to Follow-up|0|||
128723539|NCT03560531|463285638|FG012|Overall Study|Lost to Follow-up|0|||
128723540|NCT03560531|463285639|FG013|Overall Study|Lost to Follow-up|0|||
128723541|NCT03560531|463285626|FG000|Overall Study|Withdrawal by Subject|1|||
128723542|NCT03560531|463285627|FG001|Overall Study|Withdrawal by Subject|0|||
128723543|NCT03560531|463285628|FG002|Overall Study|Withdrawal by Subject|0|||
128723544|NCT03560531|463285629|FG003|Overall Study|Withdrawal by Subject|0|||
128723545|NCT03560531|463285630|FG004|Overall Study|Withdrawal by Subject|0|||
128723546|NCT03560531|463285631|FG005|Overall Study|Withdrawal by Subject|0|||
128723547|NCT03560531|463285632|FG006|Overall Study|Withdrawal by Subject|0|||
128723548|NCT03560531|463285633|FG007|Overall Study|Withdrawal by Subject|3|||
128723549|NCT03560531|463285634|FG008|Overall Study|Withdrawal by Subject|2|||
128723550|NCT03560531|463285635|FG009|Overall Study|Withdrawal by Subject|0|||
128723551|NCT03560531|463285636|FG010|Overall Study|Withdrawal by Subject|0|||
128723552|NCT03560531|463285637|FG011|Overall Study|Withdrawal by Subject|0|||
128723553|NCT03560531|463285638|FG012|Overall Study|Withdrawal by Subject|2|||
128723554|NCT03560531|463285639|FG013|Overall Study|Withdrawal by Subject|0|||
128723555|NCT03560531|463285626|FG000|Overall Study|Study end per-protocol|1|||
128723556|NCT03560531|463285627|FG001|Overall Study|Study end per-protocol|1|||
128723557|NCT03560531|463285628|FG002|Overall Study|Study end per-protocol|2|||
128723558|NCT03560531|463285629|FG003|Overall Study|Study end per-protocol|0|||
128723559|NCT03560531|463285630|FG004|Overall Study|Study end per-protocol|1|||
128723560|NCT03560531|463285631|FG005|Overall Study|Study end per-protocol|0|||
128723561|NCT03560531|463285632|FG006|Overall Study|Study end per-protocol|0|||
128723562|NCT03560531|463285633|FG007|Overall Study|Study end per-protocol|0|||
128723563|NCT03560531|463285634|FG008|Overall Study|Study end per-protocol|0|||
128723564|NCT03560531|463285635|FG009|Overall Study|Study end per-protocol|0|||
129069357|NCT00485264|464542694|FG005|Overall Study|Guardian Consent Withdrawn|0|||
129069358|NCT00485264|464542689|FG000|Overall Study|Physician Decision|0|||
129069359|NCT00485264|464542690|FG001|Overall Study|Physician Decision|2|||
129069360|NCT00485264|464542691|FG002|Overall Study|Physician Decision|0|||
129069361|NCT00485264|464542692|FG003|Overall Study|Physician Decision|0|||
129069362|NCT00485264|464542693|FG004|Overall Study|Physician Decision|0|||
129069363|NCT00485264|464542694|FG005|Overall Study|Physician Decision|0|||
129069364|NCT00485264|464542689|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129069365|NCT00485264|464542690|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129069366|NCT00485264|464542691|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
129069367|NCT00485264|464542692|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129069368|NCT00485264|464542693|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129069369|NCT00485264|464542694|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129069370|NCT00485264|464542689|FG000|Overall Study|Not Able to Attend Clinic|5|||
129069371|NCT00485264|464542690|FG001|Overall Study|Not Able to Attend Clinic|0|||
128723565|NCT03560531|463285636|FG010|Overall Study|Study end per-protocol|0|||
128723566|NCT03560531|463285637|FG011|Overall Study|Study end per-protocol|0|||
128723567|NCT03560531|463285638|FG012|Overall Study|Study end per-protocol|0|||
129069372|NCT00485264|464542691|FG002|Overall Study|Not Able to Attend Clinic|0|||
129069373|NCT00485264|464542692|FG003|Overall Study|Not Able to Attend Clinic|1|||
128723568|NCT03560531|463285639|FG013|Overall Study|Study end per-protocol|0|||
128723569|NCT03560531|463285626|FG000|Overall Study|Early study termination by sponsor|9|||
128723570|NCT03560531|463285627|FG001|Overall Study|Early study termination by sponsor|0|||
128723571|NCT03560531|463285628|FG002|Overall Study|Early study termination by sponsor|0|||
128723572|NCT03560531|463285629|FG003|Overall Study|Early study termination by sponsor|4|||
128723573|NCT03560531|463285630|FG004|Overall Study|Early study termination by sponsor|8|||
128723574|NCT03560531|463285631|FG005|Overall Study|Early study termination by sponsor|2|||
128723575|NCT03560531|463285632|FG006|Overall Study|Early study termination by sponsor|5|||
128723576|NCT03560531|463285633|FG007|Overall Study|Early study termination by sponsor|64|||
128723577|NCT03560531|463285634|FG008|Overall Study|Early study termination by sponsor|7|||
128723578|NCT03560531|463285635|FG009|Overall Study|Early study termination by sponsor|2|||
129069374|NCT00485264|464542693|FG004|Overall Study|Not Able to Attend Clinic|1|||
129069375|NCT00485264|464542694|FG005|Overall Study|Not Able to Attend Clinic|2|||
129069376|NCT00485264|464542689|FG000|Overall Study|Non-Compliant|17|||
129069377|NCT00485264|464542690|FG001|Overall Study|Non-Compliant|2|||
129069378|NCT00485264|464542691|FG002|Overall Study|Non-Compliant|1|||
129069379|NCT00485264|464542692|FG003|Overall Study|Non-Compliant|0|||
129069380|NCT00485264|464542693|FG004|Overall Study|Non-Compliant|1|||
129069381|NCT00485264|464542694|FG005|Overall Study|Non-Compliant|0|||
129069382|NCT00485264|464542689|FG000|Overall Study|Lost to Follow-up|2|||
129069383|NCT00485264|464542690|FG001|Overall Study|Lost to Follow-up|1|||
129069384|NCT00485264|464542691|FG002|Overall Study|Lost to Follow-up|1|||
129069385|NCT00485264|464542692|FG003|Overall Study|Lost to Follow-up|0|||
129069386|NCT00485264|464542693|FG004|Overall Study|Lost to Follow-up|0|||
129069387|NCT00485264|464542694|FG005|Overall Study|Lost to Follow-up|1|||
129069388|NCT00485264|464542689|FG000|Overall Study|Other Reason|3|||
129069389|NCT00485264|464542690|FG001|Overall Study|Other Reason|0|||
129069390|NCT00485264|464542691|FG002|Overall Study|Other Reason|0|||
129069391|NCT00485264|464542692|FG003|Overall Study|Other Reason|0|||
129069392|NCT00485264|464542693|FG004|Overall Study|Other Reason|0|||
129069393|NCT00485264|464542694|FG005|Overall Study|Other Reason|0|||
129069394|NCT00654095|464542696|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
129069395|NCT00654095|464542696|FG000|Overall Study|Elevated triglyceride level (2)|1|||
129069396|NCT00654095|464542696|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
129069397|NCT00654095|464542696|FG000|Overall Study|Adverse Event|11|||
129069398|NCT00654095|464542696|FG000|Overall Study|Withdrawal by Subject|5|||
129069399|NCT00654095|464542696|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
129069400|NCT00654095|464542696|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
129069401|NCT00654095|464542696|FG000|Overall Study|Did not meet inclusion criteria|1|||
129069402|NCT02440464|464542697|FG000|Overall Study|Withdrawal by Subject|3|||
129069403|NCT02440464|464542698|FG001|Overall Study|Withdrawal by Subject|2|||
129069404|NCT03535740|464542704|FG000|Overall Study|Death|44|||
129069405|NCT03535740|464542704|FG000|Overall Study|Lost to Follow-up|1|||
129069406|NCT03535740|464542704|FG000|Overall Study|Withdrawal by Subject|13|||
129069407|NCT03535740|464542704|FG000|Overall Study|Site terminated by Sponsor|45|||
129069408|NCT05198518|464542709|FG000|Screening Visit|Deemed unable to participate|58|||
129069409|NCT05198518|464542710|FG001|Screening Visit|Deemed unable to participate|0|||
129069410|NCT05198518|464542711|FG002|Screening Visit|Deemed unable to participate|0|||
129069411|NCT02756611|464542714|FG000|Overall Study|Death|70|||
129069412|NCT02756611|464542714|FG000|Overall Study|Withdrawal by Subject|2|||
129069413|NCT02756611|464542714|FG000|Overall Study|Lost to Follow-up|3|||
129069414|NCT02756611|464542714|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
129069415|NCT02756611|464542714|FG000|Overall Study|Other|10|||
129069416|NCT03125798|464542716|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
129069417|NCT03125798|464542717|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
129069418|NCT03125798|464542716|FG000|Overall Study|Conversion to thoracotomy|7|||
129069419|NCT03125798|464542717|FG001|Overall Study|Conversion to thoracotomy|7|||
129069420|NCT00100828|464542721|FG000|Overall Study|Physician Decision|6|||
129069421|NCT03518008|464542722|FG000|Period 2, Second Week of Wear|Family emergency|0|||
129069422|NCT03518008|464542723|FG001|Period 2, Second Week of Wear|Family emergency|1|||
129069423|NCT00613171|464542724|FG000|Overall Study|Adverse Event|7|||
129069424|NCT00613171|464542724|FG000|Overall Study|Withdrawal by Subject|3|||
129069425|NCT00613171|464542724|FG000|Overall Study|Reason not Specified|4|||
129069426|NCT01197911|464542725|FG000|Overall Study|Adverse Event|0|||
129069427|NCT01197911|464542726|FG001|Overall Study|Adverse Event|0|||
128723579|NCT03560531|463285636|FG010|Overall Study|Early study termination by sponsor|16|||
128723580|NCT03560531|463285637|FG011|Overall Study|Early study termination by sponsor|2|||
128723581|NCT03560531|463285638|FG012|Overall Study|Early study termination by sponsor|6|||
128723582|NCT03560531|463285639|FG013|Overall Study|Early study termination by sponsor|2|||
128723583|NCT01200797|463285642|FG000|Overall Study|symptomatic deterioration|2|||
128723584|NCT01200797|463285642|FG000|Overall Study|Adverse Event|4|||
128723585|NCT01200797|463285642|FG000|Overall Study|Disease Progression|13|||
128723586|NCT03608774|463285647|FG000|Overall Study|Lost to Follow-up|5|||
128723587|NCT03608774|463285648|FG001|Overall Study|Lost to Follow-up|5|||
129069428|NCT01197911|464542727|FG002|Overall Study|Adverse Event|1|||
129069429|NCT01169350|464542728|FG000|Overall Study|Physician Decision|3|||
129069430|NCT01169350|464542728|FG000|Overall Study|Lost to Follow-up|2|||
129069431|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
129069432|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
129069433|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
128723588|NCT03608774|463285647|FG000|Overall Study|Withdrawal by Subject|1|||
129139251|NCT01783938|464802727|FG001|Overall Study|Disease Progression|41|||
129139252|NCT01783938|464802726|FG000|Overall Study|Study Drug Toxicity|27|||
128723589|NCT03608774|463285648|FG001|Overall Study|Withdrawal by Subject|0|||
128723590|NCT03608774|463285647|FG000|Overall Study|Protocol Violation|1|||
128723591|NCT03608774|463285648|FG001|Overall Study|Protocol Violation|0|||
128723592|NCT03608774|463285647|FG000|Overall Study|Not eligible at enrollment|0|||
128723593|NCT03608774|463285648|FG001|Overall Study|Not eligible at enrollment|1|||
128723594|NCT03608774|463285647|FG000|Overall Study|Health related event|0|||
128723595|NCT03608774|463285648|FG001|Overall Study|Health related event|1|||
128723596|NCT01177540|463285649|FG000|Overall Study|Adverse Event|1|||
128723597|NCT01177540|463285650|FG001|Overall Study|Adverse Event|0|||
128723598|NCT00026793|463285660|FG000|Overall Study|Death on study due to underlying disease|4|||
128723599|NCT00026793|463285660|FG000|Overall Study|Physician Decision|2|||
128723600|NCT00026793|463285660|FG000|Overall Study|Off study|2|||
128723601|NCT04151290|463285661|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
128723602|NCT00136084|463287150|FG000|Overall Study|Death|12|||
128723603|NCT00136084|463287151|FG001|Overall Study|Death|5|||
128723604|NCT00136084|463287150|FG000|Overall Study|Unacceptable toxicity|8|||
128723605|NCT00136084|463287151|FG001|Overall Study|Unacceptable toxicity|11|||
128723606|NCT00136084|463287150|FG000|Overall Study|Relapse|20|||
128723607|NCT00136084|463287151|FG001|Overall Study|Relapse|23|||
128723608|NCT00136084|463287150|FG000|Overall Study|Lost to Follow-up|2|||
128723609|NCT00136084|463287151|FG001|Overall Study|Lost to Follow-up|0|||
128723610|NCT00136084|463287150|FG000|Overall Study|No Response|1|||
128723611|NCT00136084|463287151|FG001|Overall Study|No Response|2|||
128723612|NCT00136084|463287150|FG000|Overall Study|Withdrawal by Subject|5|||
128723613|NCT00136084|463287151|FG001|Overall Study|Withdrawal by Subject|1|||
128723614|NCT02780804|463287154|FG000|Overall Study|Death|1|||
128723615|NCT02780804|463287155|FG001|Overall Study|Death|0|||
128723616|NCT02780804|463287156|FG002|Overall Study|Death|0|||
128723617|NCT02780804|463287154|FG000|Overall Study|Lack of Efficacy|5|||
128723618|NCT02780804|463287155|FG001|Overall Study|Lack of Efficacy|8|||
128723619|NCT02780804|463287156|FG002|Overall Study|Lack of Efficacy|4|||
128723620|NCT02780804|463287154|FG000|Overall Study|Physician Decision|0|||
128723621|NCT02780804|463287155|FG001|Overall Study|Physician Decision|0|||
129069434|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
129069435|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
129069436|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
129069437|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
129069438|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
129069439|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
129069440|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
129069441|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
129069442|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
129069443|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
129069444|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
129069445|NCT04338022|464542729|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
129069446|NCT04338022|464542730|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
129069447|NCT04338022|464542729|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
129069448|NCT04338022|464542730|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
129069449|NCT04338022|464542729|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
129069450|NCT04338022|464542730|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
129069451|NCT04338022|464542729|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
129069452|NCT04338022|464542730|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
129069453|NCT04338022|464542729|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
129069454|NCT04338022|464542730|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
129139253|NCT01783938|464802727|FG001|Overall Study|Study Drug Toxicity|14|||
128723622|NCT02780804|463287156|FG002|Overall Study|Physician Decision|2|||
128723623|NCT02780804|463287154|FG000|Overall Study|Withdrawal by Subject|0|||
128723624|NCT02780804|463287155|FG001|Overall Study|Withdrawal by Subject|1|||
128723625|NCT02780804|463287156|FG002|Overall Study|Withdrawal by Subject|0|||
128723626|NCT02476968|463287157|FG000|Overall Study|Other|0|||
128723627|NCT02476968|463287158|FG001|Overall Study|Other|2|||
128723628|NCT02476968|463287159|FG002|Overall Study|Other|0|||
128723629|NCT02476968|463287157|FG000|Overall Study|Lost to Follow-up|10|||
128723630|NCT02476968|463287158|FG001|Overall Study|Lost to Follow-up|0|||
128723631|NCT02476968|463287159|FG002|Overall Study|Lost to Follow-up|1|||
128723632|NCT02476968|463287157|FG000|Overall Study|Death|48|||
128776369|NCT03824938|463470410|FG003|Overall Study|Lost to Follow-up|0|||
129139254|NCT01783938|464802726|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
129139255|NCT01783938|464802727|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129139256|NCT01783938|464802726|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
128723633|NCT02476968|463287158|FG001|Overall Study|Death|8|||
128723634|NCT02476968|463287159|FG002|Overall Study|Death|1|||
128723635|NCT02476968|463287157|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128723636|NCT02476968|463287158|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128723637|NCT02476968|463287159|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
128723638|NCT02476968|463287157|FG000|Overall Study|Patient decision|37|||
128776370|NCT03824938|463470411|FG004|Overall Study|Lost to Follow-up|1|||
129069455|NCT04338022|464542729|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
129069456|NCT04338022|464542730|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
129069457|NCT04338022|464542729|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
129069458|NCT04338022|464542730|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
129069459|NCT02860546|464542732|FG000|Overall Study|Clinical Progression|6|||
129069460|NCT02860546|464542732|FG000|Overall Study|Radiological Progression|12|||
129069461|NCT02466321|464542733|FG000|Overall Study|Death|26|||
129069462|NCT02466321|464542733|FG000|Overall Study|Revision|6|||
129069463|NCT02466321|464542733|FG000|Overall Study|Lost to Follow-up|60|||
129069464|NCT02466321|464542733|FG000|Overall Study|Did not receive study device|1|||
129069465|NCT06071754|464542734|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
129069466|NCT02189837|464542738|FG000|Overall Study|Withdrawal by Subject|2|||
129069467|NCT02189837|464542739|FG001|Overall Study|Withdrawal by Subject|1|||
129069468|NCT02189837|464542740|FG002|Overall Study|Withdrawal by Subject|3|||
129069469|NCT02189837|464542741|FG003|Overall Study|Withdrawal by Subject|1|||
129069470|NCT02189837|464542738|FG000|Overall Study|Sponsor Decision|0|||
129069471|NCT02189837|464542739|FG001|Overall Study|Sponsor Decision|0|||
129069472|NCT02189837|464542740|FG002|Overall Study|Sponsor Decision|0|||
129069473|NCT02189837|464542741|FG003|Overall Study|Sponsor Decision|1|||
129069474|NCT02443740|464542745|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069475|NCT02443740|464542746|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069476|NCT02443740|464542747|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069477|NCT02443740|464542748|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069478|NCT02443740|464542749|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069479|NCT02443740|464542750|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
129069480|NCT02443740|464542751|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069481|NCT02443740|464542752|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069482|NCT02443740|464542753|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069483|NCT02443740|464542754|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069484|NCT02443740|464542755|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
129069485|NCT02443740|464542745|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
129069486|NCT02443740|464542746|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069487|NCT02443740|464542747|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069488|NCT02443740|464542748|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069489|NCT02443740|464542749|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069490|NCT02443740|464542750|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069491|NCT02443740|464542751|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
129069492|NCT02443740|464542752|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069493|NCT02443740|464542753|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069494|NCT02443740|464542754|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069495|NCT02443740|464542755|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129069496|NCT02443740|464542745|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069497|NCT02443740|464542746|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069498|NCT02443740|464542747|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069499|NCT02443740|464542748|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069500|NCT02443740|464542749|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069501|NCT02443740|464542750|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
129069502|NCT02443740|464542751|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069503|NCT02443740|464542752|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069504|NCT02443740|464542753|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069505|NCT02443740|464542754|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
128723639|NCT02476968|463287158|FG001|Overall Study|Patient decision|8|||
128723640|NCT02476968|463287159|FG002|Overall Study|Patient decision|0|||
128723641|NCT01859507|463287160|FG000|Overall Study|left the country|4|||
128723642|NCT01921829|463287161|FG000|Overall Study|Withdrawal by Subject|0|||
129069506|NCT02443740|464542755|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129069507|NCT00456300|464542756|FG000|Overall Study|Adverse Event|1|||
129069508|NCT00456300|464542757|FG001|Overall Study|Adverse Event|0|||
129069509|NCT01478373|464542759|FG000|Treatment Phase|Protocol Violation|1|||
129069510|NCT01478373|464542759|FG000|Survival Phase|Adverse Event|8|||
129139257|NCT01783938|464802727|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
129139258|NCT01783938|464802726|FG000|Overall Study|Participant Withdrew Consent|2|||
129069511|NCT01478373|464542759|FG000|Survival Phase|Protocol Violation|1|||
129069512|NCT01478373|464542759|FG000|Survival Phase|crossover to another study|2|||
129069513|NCT01478373|464542759|FG000|Survival Phase|Progressive Disease|27|||
129069514|NCT01074944|464542762|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
129069515|NCT01074944|464542763|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129069516|NCT01074944|464542764|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129069517|NCT01074944|464542765|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129139259|NCT01783938|464802727|FG001|Overall Study|Participant Withdrew Consent|0|||
128723643|NCT01921829|463287162|FG001|Overall Study|Withdrawal by Subject|1|||
129069518|NCT01074944|464542766|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129069519|NCT01074944|464542762|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
129069520|NCT01074944|464542763|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129069521|NCT01074944|464542764|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129069522|NCT01074944|464542765|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129069523|NCT01074944|464542766|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129069524|NCT01074944|464542762|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
129069525|NCT01074944|464542763|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129069526|NCT01074944|464542764|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129069527|NCT01074944|464542765|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129069528|NCT01074944|464542766|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129069529|NCT01074944|464542762|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
129069530|NCT01074944|464542763|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129069531|NCT01074944|464542764|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129069532|NCT01074944|464542765|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129069533|NCT01074944|464542766|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129069534|NCT01074944|464542762|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
129069535|NCT01074944|464542763|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
129069536|NCT01074944|464542764|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
129069537|NCT01074944|464542765|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
129069538|NCT01074944|464542766|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
129069539|NCT01074944|464542762|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
129069540|NCT01074944|464542763|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
129069541|NCT01074944|464542764|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
129069542|NCT01074944|464542765|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
129069543|NCT01074944|464542766|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
129069544|NCT01074944|464542762|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129069545|NCT01074944|464542763|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
129069546|NCT01074944|464542764|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
129069547|NCT01074944|464542765|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129069548|NCT01074944|464542766|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129069549|NCT01074944|464542762|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129069550|NCT01074944|464542763|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
129069551|NCT01074944|464542764|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129069552|NCT01074944|464542765|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129069553|NCT01074944|464542766|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129069554|NCT01074944|464542762|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
129069555|NCT01074944|464542763|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
129069556|NCT01074944|464542764|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
129069557|NCT01074944|464542765|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
129069558|NCT01074944|464542766|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
129069559|NCT01074944|464542762|FG000|Long Term Treatment|Adverse Event|0|||
129069560|NCT01074944|464542763|FG001|Long Term Treatment|Adverse Event|0|||
129069561|NCT01074944|464542764|FG002|Long Term Treatment|Adverse Event|0|||
129069562|NCT01074944|464542765|FG003|Long Term Treatment|Adverse Event|3|||
129069563|NCT01074944|464542766|FG004|Long Term Treatment|Adverse Event|0|||
129069564|NCT01074944|464542762|FG000|Long Term Treatment|Lost to Follow-up|0|||
129069565|NCT01074944|464542763|FG001|Long Term Treatment|Lost to Follow-up|0|||
129069566|NCT01074944|464542764|FG002|Long Term Treatment|Lost to Follow-up|0|||
129069567|NCT01074944|464542765|FG003|Long Term Treatment|Lost to Follow-up|2|||
129069568|NCT01074944|464542766|FG004|Long Term Treatment|Lost to Follow-up|0|||
129069569|NCT01074944|464542762|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129069570|NCT01074944|464542763|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129069571|NCT01074944|464542764|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129069572|NCT01074944|464542765|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
129069573|NCT01074944|464542766|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129069574|NCT01074944|464542762|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
129069575|NCT01074944|464542763|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
129069576|NCT01074944|464542764|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
129069577|NCT01074944|464542765|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
129069578|NCT01074944|464542766|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
129069579|NCT01074944|464542762|FG000|Long Term Treatment|Withdrawal by Subject|0|||
128776371|NCT03824938|463470412|FG005|Overall Study|Lost to Follow-up|0|||
129069580|NCT01074944|464542763|FG001|Long Term Treatment|Withdrawal by Subject|0|||
129069581|NCT01074944|464542764|FG002|Long Term Treatment|Withdrawal by Subject|0|||
129069582|NCT01074944|464542765|FG003|Long Term Treatment|Withdrawal by Subject|2|||
129069583|NCT01074944|464542766|FG004|Long Term Treatment|Withdrawal by Subject|0|||
129069584|NCT01074944|464542762|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129069585|NCT01074944|464542763|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129069586|NCT01074944|464542764|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129069587|NCT01074944|464542765|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129069588|NCT01074944|464542766|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
129069589|NCT01074944|464542762|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129069590|NCT01074944|464542763|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129069591|NCT01074944|464542764|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129069592|NCT01074944|464542765|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129069593|NCT01074944|464542766|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
129069594|NCT02348112|464542767|FG000|Overall Study|Withdrawal by Subject|32|||
129069595|NCT02348112|464542768|FG001|Overall Study|Withdrawal by Subject|29|||
129069596|NCT02348112|464542767|FG000|Overall Study|Lost to Follow-up|24|||
129069597|NCT02348112|464542768|FG001|Overall Study|Lost to Follow-up|20|||
129069598|NCT02348112|464542767|FG000|Overall Study|Physician Decision|17|||
129069599|NCT02348112|464542768|FG001|Overall Study|Physician Decision|15|||
129069600|NCT02348112|464542767|FG000|Overall Study|Site closed due to PI leaving|0|||
129069601|NCT02348112|464542768|FG001|Overall Study|Site closed due to PI leaving|30|||
129069602|NCT02348112|464542767|FG000|Overall Study|Sponsor withdrawal|0|||
129069603|NCT02348112|464542768|FG001|Overall Study|Sponsor withdrawal|7|||
129069604|NCT02348112|464542767|FG000|Overall Study|Death|0|||
129069605|NCT02348112|464542768|FG001|Overall Study|Death|1|||
129069606|NCT01998841|464542775|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
129069607|NCT01998841|464542776|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
129069608|NCT01998841|464542777|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
129069609|NCT01998841|464542778|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129069610|NCT01998841|464542779|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129069611|NCT01998841|464542775|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129069612|NCT01998841|464542776|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129069613|NCT01998841|464542777|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129069614|NCT01998841|464542778|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
129069615|NCT01998841|464542779|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
129069616|NCT03447743|464542780|FG000|Overall Study|Withdrawal by Subject|2|||
129069617|NCT03447743|464542780|FG000|Overall Study|Lost to Follow-up|3|||
129069618|NCT03447743|464542780|FG000|Overall Study|Adverse Event|1|||
129069619|NCT03447743|464542780|FG000|Overall Study|Did not meet criteria to continue|1|||
129069620|NCT02046603|464542781|FG000|Overall Study|Other|11|||
129069621|NCT02046603|464542782|FG001|Overall Study|Other|66|||
129069622|NCT02046603|464542781|FG000|Overall Study|Protocol Violation|0|||
129069623|NCT02046603|464542782|FG001|Overall Study|Protocol Violation|1|||
129069624|NCT02046603|464542781|FG000|Overall Study|Participant/legal guardian decision|1|||
129069625|NCT02046603|464542782|FG001|Overall Study|Participant/legal guardian decision|3|||
129069626|NCT02046603|464542781|FG000|Overall Study|Physician Decision|2|||
129069627|NCT02046603|464542782|FG001|Overall Study|Physician Decision|1|||
129069628|NCT02046603|464542781|FG000|Overall Study|Lost to Follow-up|1|||
129069629|NCT02046603|464542782|FG001|Overall Study|Lost to Follow-up|2|||
129069630|NCT02046603|464542781|FG000|Overall Study|Death|0|||
129069631|NCT02046603|464542782|FG001|Overall Study|Death|1|||
129069632|NCT02046603|464542781|FG000|Overall Study|Adverse Event|0|||
129069633|NCT02046603|464542782|FG001|Overall Study|Adverse Event|1|||
129069634|NCT05101343|464542783|FG000|Overall Study|Withdrawal by Subject|2|||
129069635|NCT05101343|464542784|FG001|Overall Study|Withdrawal by Subject|1|||
129069636|NCT00193050|464542785|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
129069637|NCT00193050|464542785|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
128723644|NCT04476030|463287163|FG000|Overall Study|Withdrawal by Subject|20|||
128723645|NCT04476030|463287164|FG001|Overall Study|Withdrawal by Subject|16|||
128723646|NCT04476030|463287163|FG000|Overall Study|Adverse Event|10|||
128723647|NCT04476030|463287164|FG001|Overall Study|Adverse Event|11|||
129069638|NCT00193050|464542785|FG000|Neoadjuvant Treatment|Physician Decision|2|||
129069639|NCT00193050|464542785|FG000|Neoadjuvant Treatment|Adverse Event|2|||
129069640|NCT00193050|464542785|FG000|Adjuvant|Physician Decision|5|||
129069641|NCT00193050|464542785|FG000|Adjuvant|Intercurrent Hospitalization|3|||
129069642|NCT00193050|464542785|FG000|Adjuvant|Lack of Efficacy|2|||
129069643|NCT00061932|464542786|FG000|Overall Study|Withdrawal by Subject|13|||
129069644|NCT00061932|464542787|FG001|Overall Study|Withdrawal by Subject|4|||
129069645|NCT03093259|464542788|FG000|Overall Study|Adverse Event|1|||
129069646|NCT03093259|464542789|FG001|Overall Study|Adverse Event|0|||
129069647|NCT03093259|464542788|FG000|Overall Study|Withdrawal by Subject|1|||
128723648|NCT04476030|463287163|FG000|Overall Study|Lost to Follow-up|7|||
129069648|NCT03093259|464542789|FG001|Overall Study|Withdrawal by Subject|0|||
128723649|NCT04476030|463287164|FG001|Overall Study|Lost to Follow-up|4|||
129069649|NCT02575833|464542790|FG000|Overall Study|Withdrawal by Subject|0|||
129069650|NCT02575833|464542791|FG001|Overall Study|Withdrawal by Subject|1|||
129069651|NCT02575833|464542790|FG000|Overall Study|Lost to Follow-up|1|||
129069652|NCT02575833|464542791|FG001|Overall Study|Lost to Follow-up|0|||
129069653|NCT00445146|464542792|FG000|Overall Study|Withdrew Consent|29|||
129069654|NCT00445146|464542792|FG000|Overall Study|Lack of Efficacy|28|||
129069655|NCT00445146|464542792|FG000|Overall Study|Investigator's Discretion|22|||
129069656|NCT00445146|464542792|FG000|Overall Study|Adverse Event|13|||
129069657|NCT00445146|464542792|FG000|Overall Study|Lost to Follow-up|13|||
129069658|NCT00445146|464542792|FG000|Overall Study|Death|9|||
129069659|NCT00445146|464542792|FG000|Overall Study|Protocol Violation|4|||
129069660|NCT00445146|464542792|FG000|Overall Study|Pregnancy|1|||
129069661|NCT00625820|464542793|FG000|Overall Study|Withdrawal by Subject|1|||
129069662|NCT00967330|464542794|FG000|Overall Study|Protocol Violation|3|||
129069663|NCT00967330|464542795|FG001|Overall Study|Protocol Violation|4|||
129069664|NCT00967330|464542794|FG000|Overall Study|Regular|10|||
129069665|NCT00967330|464542795|FG001|Overall Study|Regular|3|||
129069666|NCT00967330|464542794|FG000|Overall Study|Withdrawal by Subject|6|||
129069667|NCT00967330|464542795|FG001|Overall Study|Withdrawal by Subject|0|||
129069668|NCT00967330|464542794|FG000|Overall Study|Lost to Follow-up|1|||
129069669|NCT00967330|464542795|FG001|Overall Study|Lost to Follow-up|1|||
129069670|NCT00967330|464542794|FG000|Overall Study|Death|102|||
129069671|NCT00967330|464542795|FG001|Overall Study|Death|51|||
129069672|NCT00967330|464542794|FG000|Overall Study|Severe protocol deviation|0|||
129069673|NCT00967330|464542795|FG001|Overall Study|Severe protocol deviation|1|||
129069674|NCT03759392|464542796|FG000|Overall Study|Adverse Event|12|||
129069675|NCT03759392|464542797|FG001|Overall Study|Adverse Event|4|||
129069676|NCT03759392|464542796|FG000|Overall Study|Death|2|||
129069677|NCT03759392|464542797|FG001|Overall Study|Death|1|||
129069678|NCT03759392|464542796|FG000|Overall Study|Withdrawal by Subject|2|||
129069679|NCT03759392|464542797|FG001|Overall Study|Withdrawal by Subject|0|||
129069680|NCT03759392|464542796|FG000|Overall Study|Protocol Violation|2|||
129069681|NCT03759392|464542797|FG001|Overall Study|Protocol Violation|0|||
129069682|NCT03759392|464542796|FG000|Overall Study|Physician Decision|0|||
129069683|NCT03759392|464542797|FG001|Overall Study|Physician Decision|1|||
129069684|NCT03759392|464542796|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
129069685|NCT03759392|464542797|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
129069686|NCT03759392|464542796|FG000|Overall Study|No longer able to take medicines|1|||
129069687|NCT03759392|464542797|FG001|Overall Study|No longer able to take medicines|0|||
129069688|NCT03759392|464542796|FG000|Overall Study|Stopped taking study drug|1|||
129069689|NCT03759392|464542797|FG001|Overall Study|Stopped taking study drug|0|||
129069690|NCT02623725|464542798|FG000|Overall Study|Non compliance with protocol|9|||
129069691|NCT02623725|464542799|FG001|Overall Study|Non compliance with protocol|3|||
129069692|NCT02623725|464542798|FG000|Overall Study|Serious adverse event|0|||
129069693|NCT02623725|464542799|FG001|Overall Study|Serious adverse event|2|||
129069694|NCT02623725|464542798|FG000|Overall Study|Withdrawal by Subject|7|||
128723650|NCT04476030|463287163|FG000|Overall Study|Physician Decision|1|||
128723651|NCT04476030|463287164|FG001|Overall Study|Physician Decision|1|||
129069695|NCT02623725|464542799|FG001|Overall Study|Withdrawal by Subject|1|||
129069696|NCT02548143|464542801|FG000|Overall Study|Adverse Event|1|||
129069697|NCT02548143|464542802|FG001|Overall Study|Adverse Event|0|||
129069698|NCT02548143|464542801|FG000|Overall Study|Withdrawal by Subject|0|||
129069699|NCT02548143|464542802|FG001|Overall Study|Withdrawal by Subject|1|||
129069700|NCT05620082|464542808|FG000|Overall Study|Discharged before study end|1|||
129069701|NCT05620082|464542809|FG001|Overall Study|Discharged before study end|4|||
129069702|NCT05620082|464542810|FG002|Overall Study|Discharged before study end|0|||
129069703|NCT05620082|464542808|FG000|Overall Study|Moved to a different ward|1|||
129069704|NCT05620082|464542809|FG001|Overall Study|Moved to a different ward|0|||
129069705|NCT05620082|464542810|FG002|Overall Study|Moved to a different ward|0|||
129069706|NCT05620082|464542808|FG000|Overall Study|Feeling too unwell|1|||
129069707|NCT05620082|464542809|FG001|Overall Study|Feeling too unwell|0|||
129069708|NCT05620082|464542810|FG002|Overall Study|Feeling too unwell|0|||
129069709|NCT02721732|464545661|FG000|Overall Study|Adverse Event|2|||
129069710|NCT02721732|464545662|FG001|Overall Study|Adverse Event|0|||
129069711|NCT02721732|464545663|FG002|Overall Study|Adverse Event|2|||
129069712|NCT02721732|464545664|FG003|Overall Study|Adverse Event|0|||
129069713|NCT02721732|464545665|FG004|Overall Study|Adverse Event|1|||
128723652|NCT04476030|463287163|FG000|Overall Study|Protocol Deviation|2|||
128723653|NCT04476030|463287164|FG001|Overall Study|Protocol Deviation|0|||
128723654|NCT04476030|463287163|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
129069714|NCT02721732|464545666|FG005|Overall Study|Adverse Event|0|||
129069715|NCT02721732|464545667|FG006|Overall Study|Adverse Event|1|||
129069716|NCT02721732|464545668|FG007|Overall Study|Adverse Event|0|||
129069717|NCT02721732|464545669|FG008|Overall Study|Adverse Event|1|||
129069718|NCT02721732|464545670|FG009|Overall Study|Adverse Event|1|||
129069719|NCT02721732|464545661|FG000|Overall Study|Death|0|||
129069720|NCT02721732|464545662|FG001|Overall Study|Death|0|||
129069721|NCT02721732|464545663|FG002|Overall Study|Death|0|||
129069722|NCT02721732|464545664|FG003|Overall Study|Death|0|||
129069723|NCT02721732|464545665|FG004|Overall Study|Death|1|||
129069724|NCT02721732|464545666|FG005|Overall Study|Death|0|||
129069725|NCT02721732|464545667|FG006|Overall Study|Death|1|||
129069726|NCT02721732|464545668|FG007|Overall Study|Death|0|||
129069727|NCT02721732|464545669|FG008|Overall Study|Death|0|||
129069728|NCT02721732|464545670|FG009|Overall Study|Death|1|||
129069729|NCT02721732|464545661|FG000|Overall Study|Lack of Efficacy|12|||
129069730|NCT02721732|464545662|FG001|Overall Study|Lack of Efficacy|11|||
129069731|NCT02721732|464545663|FG002|Overall Study|Lack of Efficacy|18|||
129069732|NCT02721732|464545664|FG003|Overall Study|Lack of Efficacy|5|||
129069733|NCT02721732|464545665|FG004|Overall Study|Lack of Efficacy|21|||
129069734|NCT02721732|464545666|FG005|Overall Study|Lack of Efficacy|2|||
129069735|NCT02721732|464545667|FG006|Overall Study|Lack of Efficacy|8|||
129069736|NCT02721732|464545668|FG007|Overall Study|Lack of Efficacy|11|||
129069737|NCT02721732|464545669|FG008|Overall Study|Lack of Efficacy|10|||
129069738|NCT02721732|464545670|FG009|Overall Study|Lack of Efficacy|20|||
129069739|NCT02721732|464545661|FG000|Overall Study|Physician Decision|0|||
129069740|NCT02721732|464545662|FG001|Overall Study|Physician Decision|0|||
129069741|NCT02721732|464545663|FG002|Overall Study|Physician Decision|1|||
129069742|NCT02721732|464545664|FG003|Overall Study|Physician Decision|0|||
129069743|NCT02721732|464545665|FG004|Overall Study|Physician Decision|0|||
129069744|NCT02721732|464545666|FG005|Overall Study|Physician Decision|0|||
129069745|NCT02721732|464545667|FG006|Overall Study|Physician Decision|0|||
129069746|NCT02721732|464545668|FG007|Overall Study|Physician Decision|0|||
129069747|NCT02721732|464545669|FG008|Overall Study|Physician Decision|0|||
129069748|NCT02721732|464545670|FG009|Overall Study|Physician Decision|0|||
129069749|NCT02721732|464545661|FG000|Overall Study|Withdrawal by Subject|1|||
129069750|NCT02721732|464545662|FG001|Overall Study|Withdrawal by Subject|0|||
129069751|NCT02721732|464545663|FG002|Overall Study|Withdrawal by Subject|0|||
129069752|NCT02721732|464545664|FG003|Overall Study|Withdrawal by Subject|0|||
129069753|NCT02721732|464545665|FG004|Overall Study|Withdrawal by Subject|3|||
129069754|NCT02721732|464545666|FG005|Overall Study|Withdrawal by Subject|0|||
129069755|NCT02721732|464545667|FG006|Overall Study|Withdrawal by Subject|1|||
129069756|NCT02721732|464545668|FG007|Overall Study|Withdrawal by Subject|1|||
129069757|NCT02721732|464545669|FG008|Overall Study|Withdrawal by Subject|0|||
129069758|NCT02721732|464545670|FG009|Overall Study|Withdrawal by Subject|1|||
129069759|NCT02721732|464545661|FG000|Overall Study|Participant Choice|1|||
129069760|NCT02721732|464545662|FG001|Overall Study|Participant Choice|0|||
129069761|NCT02721732|464545663|FG002|Overall Study|Participant Choice|0|||
129069762|NCT02721732|464545664|FG003|Overall Study|Participant Choice|0|||
129069763|NCT02721732|464545665|FG004|Overall Study|Participant Choice|0|||
129069764|NCT02721732|464545666|FG005|Overall Study|Participant Choice|0|||
129069765|NCT02721732|464545667|FG006|Overall Study|Participant Choice|0|||
129069766|NCT02721732|464545668|FG007|Overall Study|Participant Choice|0|||
129069767|NCT02721732|464545669|FG008|Overall Study|Participant Choice|0|||
129069768|NCT02721732|464545670|FG009|Overall Study|Participant Choice|1|||
129069769|NCT02721732|464545661|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069770|NCT02721732|464545662|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069771|NCT02721732|464545663|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
129069772|NCT02721732|464545664|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069773|NCT02721732|464545665|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129139260|NCT01783938|464802726|FG000|Overall Study|Maximum Clinical Benefit|1|||
129139261|NCT01783938|464802727|FG001|Overall Study|Maximum Clinical Benefit|0|||
129139262|NCT01783938|464802726|FG000|Overall Study|Other Reasons|3|||
129069774|NCT02721732|464545666|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069775|NCT02721732|464545667|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069776|NCT02721732|464545668|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069777|NCT02721732|464545669|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069778|NCT02721732|464545670|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129069779|NCT02721732|464545661|FG000|Overall Study|Progression and withdrew consent|1|||
129139263|NCT01783938|464802727|FG001|Overall Study|Other Reasons|1|||
128723655|NCT04476030|463287164|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
128723656|NCT04476030|463287163|FG000|Overall Study|Randomized but not Dosed|2|||
129069780|NCT02721732|464545662|FG001|Overall Study|Progression and withdrew consent|1|||
129069781|NCT02721732|464545663|FG002|Overall Study|Progression and withdrew consent|0|||
129069782|NCT02721732|464545664|FG003|Overall Study|Progression and withdrew consent|0|||
129069783|NCT02721732|464545665|FG004|Overall Study|Progression and withdrew consent|0|||
129069784|NCT02721732|464545666|FG005|Overall Study|Progression and withdrew consent|0|||
129069785|NCT02721732|464545667|FG006|Overall Study|Progression and withdrew consent|0|||
129139264|NCT00498485|464802728|FG000|Overall Study|Adverse Event|1|||
129139265|NCT00498485|464802729|FG001|Overall Study|Adverse Event|5|||
129139266|NCT03072875|464802734|FG000|Overall Study|Lost to Follow-up|1|||
128723657|NCT04476030|463287164|FG001|Overall Study|Randomized but not Dosed|8|||
129069786|NCT02721732|464545668|FG007|Overall Study|Progression and withdrew consent|0|||
129069787|NCT02721732|464545669|FG008|Overall Study|Progression and withdrew consent|0|||
129069788|NCT02721732|464545670|FG009|Overall Study|Progression and withdrew consent|1|||
129069789|NCT02721732|464545661|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
129069790|NCT02721732|464545662|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
129069791|NCT02721732|464545663|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
129069792|NCT02721732|464545664|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
129069793|NCT02721732|464545665|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
129069794|NCT02721732|464545666|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
129069795|NCT02721732|464545667|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
129069796|NCT02721732|464545668|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
129069797|NCT02721732|464545669|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
129069798|NCT02721732|464545670|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
129069799|NCT02848001|464545671|FG000|Overall Study|other reasons|0|||
129069800|NCT02848001|464545672|FG001|Overall Study|other reasons|0|||
129069801|NCT02848001|464545673|FG002|Overall Study|other reasons|1|||
129069802|NCT02848001|464545674|FG003|Overall Study|other reasons|0|||
129069803|NCT02848001|464545675|FG004|Overall Study|other reasons|4|||
129069804|NCT02848001|464545676|FG005|Overall Study|other reasons|1|||
129069805|NCT02848001|464545677|FG006|Overall Study|other reasons|0|||
129069806|NCT02848001|464545678|FG007|Overall Study|other reasons|2|||
129069807|NCT02848001|464545679|FG008|Overall Study|other reasons|2|||
129069808|NCT02848001|464545680|FG009|Overall Study|other reasons|3|||
129069809|NCT02848001|464545681|FG010|Overall Study|other reasons|0|||
129069810|NCT02848001|464545682|FG011|Overall Study|other reasons|1|||
129069811|NCT02848001|464545683|FG012|Overall Study|other reasons|1|||
129069812|NCT02848001|464545684|FG013|Overall Study|other reasons|0|||
129069813|NCT02848001|464545685|FG014|Overall Study|other reasons|0|||
129069814|NCT02848001|464545686|FG015|Overall Study|other reasons|2|||
129069815|NCT02848001|464545687|FG016|Overall Study|other reasons|1|||
129069816|NCT02848001|464545671|FG000|Overall Study|Lack of Efficacy|0|||
129069817|NCT02848001|464545672|FG001|Overall Study|Lack of Efficacy|1|||
129069818|NCT02848001|464545673|FG002|Overall Study|Lack of Efficacy|1|||
129069819|NCT02848001|464545674|FG003|Overall Study|Lack of Efficacy|2|||
129069820|NCT02848001|464545675|FG004|Overall Study|Lack of Efficacy|3|||
129069821|NCT02848001|464545676|FG005|Overall Study|Lack of Efficacy|0|||
129069822|NCT02848001|464545677|FG006|Overall Study|Lack of Efficacy|1|||
129069823|NCT02848001|464545678|FG007|Overall Study|Lack of Efficacy|0|||
129069824|NCT02848001|464545679|FG008|Overall Study|Lack of Efficacy|0|||
129069825|NCT02848001|464545680|FG009|Overall Study|Lack of Efficacy|1|||
129069826|NCT02848001|464545681|FG010|Overall Study|Lack of Efficacy|0|||
129069827|NCT02848001|464545682|FG011|Overall Study|Lack of Efficacy|2|||
129069828|NCT02848001|464545683|FG012|Overall Study|Lack of Efficacy|0|||
129069829|NCT02848001|464545684|FG013|Overall Study|Lack of Efficacy|2|||
129069830|NCT02848001|464545685|FG014|Overall Study|Lack of Efficacy|2|||
129069831|NCT02848001|464545686|FG015|Overall Study|Lack of Efficacy|0|||
129069832|NCT02848001|464545687|FG016|Overall Study|Lack of Efficacy|0|||
129069833|NCT02848001|464545671|FG000|Overall Study|Progressive Disease|2|||
129069834|NCT02848001|464545672|FG001|Overall Study|Progressive Disease|1|||
129069835|NCT02848001|464545673|FG002|Overall Study|Progressive Disease|0|||
129069836|NCT02848001|464545674|FG003|Overall Study|Progressive Disease|4|||
129069837|NCT02848001|464545675|FG004|Overall Study|Progressive Disease|3|||
129069838|NCT02848001|464545676|FG005|Overall Study|Progressive Disease|0|||
129069839|NCT02848001|464545677|FG006|Overall Study|Progressive Disease|4|||
129069840|NCT02848001|464545678|FG007|Overall Study|Progressive Disease|1|||
129069841|NCT02848001|464545679|FG008|Overall Study|Progressive Disease|0|||
129069842|NCT02848001|464545680|FG009|Overall Study|Progressive Disease|2|||
129069843|NCT02848001|464545681|FG010|Overall Study|Progressive Disease|3|||
129069844|NCT02848001|464545682|FG011|Overall Study|Progressive Disease|2|||
129069845|NCT02848001|464545683|FG012|Overall Study|Progressive Disease|1|||
129069846|NCT02848001|464545684|FG013|Overall Study|Progressive Disease|0|||
129069847|NCT02848001|464545685|FG014|Overall Study|Progressive Disease|2|||
129069848|NCT02848001|464545686|FG015|Overall Study|Progressive Disease|4|||
129069849|NCT02848001|464545687|FG016|Overall Study|Progressive Disease|0|||
129069850|NCT02848001|464545671|FG000|Overall Study|Adverse Event|0|||
129069851|NCT02848001|464545672|FG001|Overall Study|Adverse Event|0|||
129069852|NCT02848001|464545673|FG002|Overall Study|Adverse Event|0|||
129069853|NCT02848001|464545674|FG003|Overall Study|Adverse Event|0|||
129069854|NCT02848001|464545675|FG004|Overall Study|Adverse Event|2|||
129069855|NCT02848001|464545676|FG005|Overall Study|Adverse Event|0|||
129069856|NCT02848001|464545677|FG006|Overall Study|Adverse Event|0|||
129069857|NCT02848001|464545678|FG007|Overall Study|Adverse Event|0|||
128723658|NCT01478321|463287165|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
128723659|NCT01478321|463287165|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
129069858|NCT02848001|464545679|FG008|Overall Study|Adverse Event|0|||
129069859|NCT02848001|464545680|FG009|Overall Study|Adverse Event|1|||
129069860|NCT02848001|464545681|FG010|Overall Study|Adverse Event|0|||
129069861|NCT02848001|464545682|FG011|Overall Study|Adverse Event|1|||
129069862|NCT02848001|464545683|FG012|Overall Study|Adverse Event|1|||
129069863|NCT02848001|464545684|FG013|Overall Study|Adverse Event|0|||
129069864|NCT02848001|464545685|FG014|Overall Study|Adverse Event|2|||
129069865|NCT02848001|464545686|FG015|Overall Study|Adverse Event|0|||
129069866|NCT02848001|464545687|FG016|Overall Study|Adverse Event|0|||
129069867|NCT02848001|464545671|FG000|Overall Study|Death|0|||
129069868|NCT02848001|464545672|FG001|Overall Study|Death|0|||
129069869|NCT02848001|464545673|FG002|Overall Study|Death|0|||
129069870|NCT02848001|464545674|FG003|Overall Study|Death|1|||
129069871|NCT02848001|464545675|FG004|Overall Study|Death|3|||
129069872|NCT02848001|464545676|FG005|Overall Study|Death|1|||
129069873|NCT02848001|464545677|FG006|Overall Study|Death|2|||
129069874|NCT02848001|464545678|FG007|Overall Study|Death|3|||
129069875|NCT02848001|464545679|FG008|Overall Study|Death|4|||
129069876|NCT02848001|464545680|FG009|Overall Study|Death|1|||
129069877|NCT02848001|464545681|FG010|Overall Study|Death|0|||
129069878|NCT02848001|464545682|FG011|Overall Study|Death|1|||
129069879|NCT02848001|464545683|FG012|Overall Study|Death|3|||
129069880|NCT02848001|464545684|FG013|Overall Study|Death|0|||
129069881|NCT02848001|464545685|FG014|Overall Study|Death|2|||
129069882|NCT02848001|464545686|FG015|Overall Study|Death|3|||
129069883|NCT02848001|464545687|FG016|Overall Study|Death|0|||
129069884|NCT02848001|464545671|FG000|Overall Study|Physician Decision|0|||
129069885|NCT02848001|464545672|FG001|Overall Study|Physician Decision|0|||
129069886|NCT02848001|464545673|FG002|Overall Study|Physician Decision|0|||
129069887|NCT02848001|464545674|FG003|Overall Study|Physician Decision|0|||
129069888|NCT02848001|464545675|FG004|Overall Study|Physician Decision|0|||
129069889|NCT02848001|464545676|FG005|Overall Study|Physician Decision|0|||
129069890|NCT02848001|464545677|FG006|Overall Study|Physician Decision|0|||
129069891|NCT02848001|464545678|FG007|Overall Study|Physician Decision|0|||
129139267|NCT03478787|464802735|FG000|Overall Study|Adverse Event|5|||
129139268|NCT03478787|464802736|FG001|Overall Study|Adverse Event|1|||
129139269|NCT03478787|464802735|FG000|Overall Study|Protocol Violation|3|||
129139270|NCT03478787|464802736|FG001|Overall Study|Protocol Violation|0|||
129139271|NCT03478787|464802735|FG000|Overall Study|Lack of Efficacy|7|||
129139272|NCT03478787|464802736|FG001|Overall Study|Lack of Efficacy|1|||
129139273|NCT03478787|464802735|FG000|Overall Study|Lost to Follow-up|9|||
129139274|NCT03478787|464802736|FG001|Overall Study|Lost to Follow-up|5|||
129139275|NCT03478787|464802735|FG000|Overall Study|Withdrawal by Subject|2|||
129139276|NCT03478787|464802736|FG001|Overall Study|Withdrawal by Subject|6|||
129139277|NCT03478787|464802735|FG000|Overall Study|Other, Not Specified|3|||
129139278|NCT03478787|464802736|FG001|Overall Study|Other, Not Specified|0|||
129139279|NCT01539525|464802737|FG000|Overall Study|Lost to Follow-up|19|||
129139280|NCT01539525|464802738|FG001|Overall Study|Lost to Follow-up|12|||
129139281|NCT01539525|464802739|FG002|Overall Study|Lost to Follow-up|11|||
129139282|NCT01539525|464802737|FG000|Overall Study|Withdrawal by Subject|0|||
129139283|NCT01539525|464802738|FG001|Overall Study|Withdrawal by Subject|3|||
129139284|NCT01539525|464802739|FG002|Overall Study|Withdrawal by Subject|2|||
129139285|NCT01539525|464802737|FG000|Overall Study|Protocol Violation|1|||
129139286|NCT01539525|464802738|FG001|Overall Study|Protocol Violation|1|||
129139287|NCT01539525|464802739|FG002|Overall Study|Protocol Violation|4|||
129139288|NCT01712074|464802740|FG000|Placebo Run-in Period|Adverse Event|2|||
129139289|NCT01712074|464802741|FG001|Placebo Run-in Period|Adverse Event|0|||
129139290|NCT01712074|464802742|FG002|Placebo Run-in Period|Adverse Event|0|||
129139291|NCT01712074|464802740|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
129139292|NCT01712074|464802741|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
128723660|NCT01478321|463287165|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
128723661|NCT01478321|463287165|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
128723662|NCT01478321|463287165|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
129069892|NCT02848001|464545679|FG008|Overall Study|Physician Decision|1|||
129069893|NCT02848001|464545680|FG009|Overall Study|Physician Decision|1|||
129069894|NCT02848001|464545681|FG010|Overall Study|Physician Decision|0|||
129069895|NCT02848001|464545682|FG011|Overall Study|Physician Decision|0|||
129069896|NCT02848001|464545683|FG012|Overall Study|Physician Decision|2|||
128723663|NCT01478321|463287165|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
129069897|NCT02848001|464545684|FG013|Overall Study|Physician Decision|0|||
129069898|NCT02848001|464545685|FG014|Overall Study|Physician Decision|0|||
129139293|NCT01712074|464802742|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
129139294|NCT01712074|464802740|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
129139295|NCT01712074|464802741|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
129139296|NCT01712074|464802742|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
129139297|NCT01712074|464802740|FG000|Placebo Run-in Period|Other|1|||
129069899|NCT02848001|464545686|FG015|Overall Study|Physician Decision|0|||
129069900|NCT02848001|464545687|FG016|Overall Study|Physician Decision|0|||
129139298|NCT01712074|464802741|FG001|Placebo Run-in Period|Other|0|||
129139299|NCT01712074|464802742|FG002|Placebo Run-in Period|Other|0|||
129139300|NCT01712074|464802740|FG000|Placebo Run-in Period|No longer willing to participate|1|||
129139301|NCT01712074|464802741|FG001|Placebo Run-in Period|No longer willing to participate|0|||
129139302|NCT01712074|464802742|FG002|Placebo Run-in Period|No longer willing to participate|0|||
129139303|NCT01712074|464802740|FG000|Double Blind Period|Adverse Event|0|||
129139304|NCT01712074|464802741|FG001|Double Blind Period|Adverse Event|2|||
129139305|NCT01712074|464802742|FG002|Double Blind Period|Adverse Event|1|||
129139306|NCT01712074|464802740|FG000|Double Blind Period|No longer willing to participate|0|||
129139307|NCT01712074|464802741|FG001|Double Blind Period|No longer willing to participate|2|||
129139308|NCT01712074|464802742|FG002|Double Blind Period|No longer willing to participate|4|||
129139309|NCT01712074|464802740|FG000|Double Blind Period|Death|0|||
129139310|NCT01712074|464802741|FG001|Double Blind Period|Death|1|||
129139311|NCT01712074|464802742|FG002|Double Blind Period|Death|0|||
129139312|NCT01712074|464802740|FG000|Double Blind Period|Lost to Follow-up|0|||
129139313|NCT01712074|464802741|FG001|Double Blind Period|Lost to Follow-up|2|||
129139314|NCT01712074|464802742|FG002|Double Blind Period|Lost to Follow-up|1|||
129139315|NCT01712074|464802740|FG000|Double Blind Period|Other|0|||
129139316|NCT01712074|464802741|FG001|Double Blind Period|Other|4|||
129139317|NCT01712074|464802742|FG002|Double Blind Period|Other|1|||
129139318|NCT01712074|464802740|FG000|Double Blind Period|Protocol Violation|0|||
129139319|NCT01712074|464802741|FG001|Double Blind Period|Protocol Violation|0|||
129139320|NCT01712074|464802742|FG002|Double Blind Period|Protocol Violation|1|||
129139321|NCT01712074|464802740|FG000|Double Blind Period|No longer met eligibility criteria|0|||
129139322|NCT01712074|464802741|FG001|Double Blind Period|No longer met eligibility criteria|3|||
129139323|NCT01712074|464802742|FG002|Double Blind Period|No longer met eligibility criteria|0|||
129139324|NCT02268851|464802743|FG000|Overall Study|Death|0|||
129139325|NCT02268851|464802744|FG001|Overall Study|Death|0|||
129139326|NCT02268851|464802745|FG002|Overall Study|Death|0|||
129139327|NCT02268851|464802746|FG003|Overall Study|Death|1|||
129139328|NCT02268851|464802747|FG004|Overall Study|Death|2|||
129139329|NCT02268851|464802748|FG005|Overall Study|Death|1|||
129139330|NCT02268851|464802743|FG000|Overall Study|Adverse Event|0|||
129139331|NCT02268851|464802744|FG001|Overall Study|Adverse Event|0|||
129139332|NCT02268851|464802745|FG002|Overall Study|Adverse Event|0|||
129139333|NCT02268851|464802746|FG003|Overall Study|Adverse Event|0|||
129139334|NCT02268851|464802747|FG004|Overall Study|Adverse Event|2|||
129139335|NCT02268851|464802748|FG005|Overall Study|Adverse Event|2|||
129139336|NCT02268851|464802743|FG000|Overall Study|Withdrawal by Subject|0|||
129139337|NCT02268851|464802744|FG001|Overall Study|Withdrawal by Subject|0|||
129139338|NCT02268851|464802745|FG002|Overall Study|Withdrawal by Subject|0|||
129139339|NCT02268851|464802746|FG003|Overall Study|Withdrawal by Subject|2|||
129139340|NCT02268851|464802747|FG004|Overall Study|Withdrawal by Subject|0|||
129139341|NCT02268851|464802748|FG005|Overall Study|Withdrawal by Subject|1|||
129139342|NCT02268851|464802743|FG000|Overall Study|Progressive Disease|1|||
129139343|NCT02268851|464802744|FG001|Overall Study|Progressive Disease|3|||
129139344|NCT02268851|464802745|FG002|Overall Study|Progressive Disease|0|||
129139345|NCT02268851|464802746|FG003|Overall Study|Progressive Disease|0|||
129139346|NCT02268851|464802747|FG004|Overall Study|Progressive Disease|1|||
129139347|NCT02268851|464802748|FG005|Overall Study|Progressive Disease|4|||
129139348|NCT02268851|464802743|FG000|Overall Study|Physician Decision|0|||
129139349|NCT02268851|464802744|FG001|Overall Study|Physician Decision|0|||
129139350|NCT02268851|464802745|FG002|Overall Study|Physician Decision|1|||
129139351|NCT02268851|464802746|FG003|Overall Study|Physician Decision|0|||
129139352|NCT02268851|464802747|FG004|Overall Study|Physician Decision|0|||
129139353|NCT02268851|464802748|FG005|Overall Study|Physician Decision|1|||
129139354|NCT02268851|464802743|FG000|Overall Study|Patient Compliance|0|||
129139355|NCT02268851|464802744|FG001|Overall Study|Patient Compliance|0|||
129139356|NCT02268851|464802745|FG002|Overall Study|Patient Compliance|0|||
129139357|NCT02268851|464802746|FG003|Overall Study|Patient Compliance|0|||
129139358|NCT02268851|464802747|FG004|Overall Study|Patient Compliance|1|||
129139359|NCT02268851|464802748|FG005|Overall Study|Patient Compliance|1|||
129139360|NCT02268851|464802743|FG000|Overall Study|Co-Morbid Condition|0|||
129139361|NCT02268851|464802744|FG001|Overall Study|Co-Morbid Condition|0|||
128723664|NCT01478321|463287165|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
129139362|NCT02268851|464802745|FG002|Overall Study|Co-Morbid Condition|0|||
129139363|NCT02268851|464802746|FG003|Overall Study|Co-Morbid Condition|0|||
129139364|NCT02268851|464802747|FG004|Overall Study|Co-Morbid Condition|1|||
129139365|NCT02268851|464802748|FG005|Overall Study|Co-Morbid Condition|1|||
129139366|NCT01472835|464802751|FG000|Overall Study|Lost to Follow-up|2|||
129139367|NCT01472835|464802752|FG001|Overall Study|Lost to Follow-up|0|||
129139368|NCT02539394|464802753|FG000|Overall Study|Protocol Violation|1|||
129139369|NCT02539394|464802754|FG001|Overall Study|Protocol Violation|3|||
129139370|NCT02539394|464802753|FG000|Overall Study|Lost to Follow-up|1|||
129139371|NCT02539394|464802754|FG001|Overall Study|Lost to Follow-up|2|||
129139372|NCT02539394|464802753|FG000|Overall Study|Incomplete dataset|6|||
129139373|NCT02539394|464802754|FG001|Overall Study|Incomplete dataset|6|||
129139374|NCT02205359|464802771|FG000|Overall Study|Death|293|||
129069901|NCT02848001|464545671|FG000|Overall Study|Withdrawal by Subject|0|||
129069902|NCT02848001|464545672|FG001|Overall Study|Withdrawal by Subject|0|||
129069903|NCT02848001|464545673|FG002|Overall Study|Withdrawal by Subject|0|||
129069904|NCT02848001|464545674|FG003|Overall Study|Withdrawal by Subject|0|||
129069905|NCT02848001|464545675|FG004|Overall Study|Withdrawal by Subject|0|||
129069906|NCT02848001|464545676|FG005|Overall Study|Withdrawal by Subject|1|||
129069907|NCT02848001|464545677|FG006|Overall Study|Withdrawal by Subject|1|||
129069908|NCT02848001|464545678|FG007|Overall Study|Withdrawal by Subject|1|||
129069909|NCT02848001|464545679|FG008|Overall Study|Withdrawal by Subject|0|||
129069910|NCT02848001|464545680|FG009|Overall Study|Withdrawal by Subject|0|||
129069911|NCT02848001|464545681|FG010|Overall Study|Withdrawal by Subject|0|||
129069912|NCT02848001|464545682|FG011|Overall Study|Withdrawal by Subject|0|||
129069913|NCT02848001|464545683|FG012|Overall Study|Withdrawal by Subject|0|||
129069914|NCT02848001|464545684|FG013|Overall Study|Withdrawal by Subject|0|||
129069915|NCT02848001|464545685|FG014|Overall Study|Withdrawal by Subject|0|||
129069916|NCT02848001|464545686|FG015|Overall Study|Withdrawal by Subject|0|||
129069917|NCT02848001|464545687|FG016|Overall Study|Withdrawal by Subject|0|||
129069918|NCT00711243|464545691|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
129069919|NCT00711243|464545692|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
129069920|NCT00711243|464545693|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
128723665|NCT01478321|463287165|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
128723666|NCT04649164|463287166|FG000|Overall Study|Withdrawal by Subject|1|||
128723667|NCT04649164|463287167|FG001|Overall Study|Withdrawal by Subject|1|||
128723668|NCT04649164|463287168|FG002|Overall Study|Withdrawal by Subject|2|||
128723669|NCT04649164|463287166|FG000|Overall Study|Participant's care recipient expired|0|||
128723670|NCT04649164|463287167|FG001|Overall Study|Participant's care recipient expired|0|||
128723671|NCT04649164|463287168|FG002|Overall Study|Participant's care recipient expired|2|||
128723672|NCT01203072|463287171|FG000|Overall Study|Adverse Event|5|||
128723673|NCT01203072|463287172|FG001|Overall Study|Adverse Event|3|||
128723674|NCT01203072|463287173|FG002|Overall Study|Adverse Event|2|||
128723675|NCT01203072|463287174|FG003|Overall Study|Adverse Event|4|||
129069921|NCT00711243|464545694|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
129069922|NCT00711243|464545695|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
129069923|NCT00711243|464545696|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
129069924|NCT00711243|464545691|FG000|Reached First Response/4 Cycles|Death|0|||
129069925|NCT00711243|464545692|FG001|Reached First Response/4 Cycles|Death|0|||
129069926|NCT00711243|464545693|FG002|Reached First Response/4 Cycles|Death|0|||
129069927|NCT00711243|464545694|FG003|Reached First Response/4 Cycles|Death|0|||
129069928|NCT00711243|464545695|FG004|Reached First Response/4 Cycles|Death|0|||
129069929|NCT00711243|464545696|FG005|Reached First Response/4 Cycles|Death|2|||
129069930|NCT00711243|464545691|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
129069931|NCT00711243|464545692|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
129069932|NCT00711243|464545693|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
129069933|NCT00711243|464545694|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
129069934|NCT00711243|464545695|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
129069935|NCT00711243|464545696|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
129069936|NCT00711243|464545691|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
129069937|NCT00711243|464545692|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
128723676|NCT01203072|463287175|FG004|Overall Study|Adverse Event|2|||
128723677|NCT01203072|463287171|FG000|Overall Study|Lack of Efficacy|1|||
128723678|NCT01203072|463287172|FG001|Overall Study|Lack of Efficacy|0|||
128723679|NCT01203072|463287173|FG002|Overall Study|Lack of Efficacy|0|||
129139375|NCT02205359|464802772|FG001|Overall Study|Death|327|||
129139376|NCT02205359|464802771|FG000|Overall Study|Lost to Follow-up|182|||
129139377|NCT02205359|464802772|FG001|Overall Study|Lost to Follow-up|162|||
129139378|NCT02205359|464802771|FG000|Overall Study|Physician Decision|51|||
129139379|NCT02205359|464802772|FG001|Overall Study|Physician Decision|53|||
129139380|NCT02205359|464802771|FG000|Overall Study|Withdrawal by Subject|167|||
129139381|NCT02205359|464802772|FG001|Overall Study|Withdrawal by Subject|169|||
129139382|NCT00236197|464802775|FG000|Overall Study|Withdrawal by Subject|3|||
129139383|NCT00236197|464802776|FG001|Overall Study|Withdrawal by Subject|2|||
129139384|NCT00236197|464802775|FG000|Overall Study|Lost to Follow-up|1|||
129139385|NCT00236197|464802776|FG001|Overall Study|Lost to Follow-up|5|||
129139386|NCT00236197|464802775|FG000|Overall Study|Protocol Violation|0|||
129139387|NCT00236197|464802776|FG001|Overall Study|Protocol Violation|3|||
129139388|NCT00236197|464802775|FG000|Overall Study|Medication non-compliance|1|||
129139389|NCT00236197|464802776|FG001|Overall Study|Medication non-compliance|2|||
129139390|NCT00236197|464802775|FG000|Overall Study|Other|0|||
129139391|NCT00236197|464802776|FG001|Overall Study|Other|2|||
129139392|NCT02792257|464802781|FG000|Overall Study|Lost to Follow-up|3|||
129139393|NCT02792257|464802782|FG001|Overall Study|Lost to Follow-up|4|||
129139394|NCT02792257|464802781|FG000|Overall Study|Allergy|0|||
129139395|NCT02792257|464802782|FG001|Overall Study|Allergy|1|||
129139396|NCT02792257|464802781|FG000|Overall Study|Protocol Violation|2|||
129139397|NCT02792257|464802782|FG001|Overall Study|Protocol Violation|0|||
129139398|NCT02792257|464802781|FG000|Overall Study|Excessive Agitation|0|||
128723680|NCT01203072|463287174|FG003|Overall Study|Lack of Efficacy|0|||
128723681|NCT01203072|463287175|FG004|Overall Study|Lack of Efficacy|0|||
128723682|NCT01203072|463287171|FG000|Overall Study|Lost to Follow-up|0|||
128723683|NCT01203072|463287172|FG001|Overall Study|Lost to Follow-up|1|||
128723684|NCT01203072|463287173|FG002|Overall Study|Lost to Follow-up|0|||
128723685|NCT01203072|463287174|FG003|Overall Study|Lost to Follow-up|0|||
128723686|NCT01203072|463287175|FG004|Overall Study|Lost to Follow-up|0|||
128723687|NCT01203072|463287171|FG000|Overall Study|Protocol Violation|2|||
128723688|NCT01203072|463287172|FG001|Overall Study|Protocol Violation|0|||
128723689|NCT01203072|463287173|FG002|Overall Study|Protocol Violation|0|||
128723690|NCT01203072|463287174|FG003|Overall Study|Protocol Violation|0|||
128723691|NCT01203072|463287175|FG004|Overall Study|Protocol Violation|1|||
128723692|NCT01203072|463287171|FG000|Overall Study|Withdrawal by Subject|2|||
128723693|NCT01203072|463287172|FG001|Overall Study|Withdrawal by Subject|2|||
128723694|NCT01203072|463287173|FG002|Overall Study|Withdrawal by Subject|1|||
128723695|NCT01203072|463287174|FG003|Overall Study|Withdrawal by Subject|2|||
128723696|NCT01203072|463287175|FG004|Overall Study|Withdrawal by Subject|3|||
128723697|NCT00006478|463287186|FG000|Overall Study|Vaccine could not be produced|1|||
128723698|NCT00006478|463287186|FG000|Overall Study|Physician Decision|6|||
128723699|NCT01987427|463287193|FG000|Overall Study|Adverse Event|4|||
128723700|NCT01987427|463287194|FG001|Overall Study|Adverse Event|2|||
128723701|NCT01987427|463287195|FG002|Overall Study|Adverse Event|8|||
128723702|NCT01987427|463287193|FG000|Overall Study|Lost to Follow-up|6|||
128723703|NCT01987427|463287194|FG001|Overall Study|Lost to Follow-up|6|||
128723704|NCT01987427|463287195|FG002|Overall Study|Lost to Follow-up|9|||
128723705|NCT01987427|463287193|FG000|Overall Study|Withdrawal by Subject|2|||
128723706|NCT01987427|463287194|FG001|Overall Study|Withdrawal by Subject|1|||
128723707|NCT01987427|463287195|FG002|Overall Study|Withdrawal by Subject|3|||
128723708|NCT01987427|463287193|FG000|Overall Study|Lack of Efficacy|1|||
128723709|NCT01987427|463287194|FG001|Overall Study|Lack of Efficacy|0|||
128723710|NCT01987427|463287195|FG002|Overall Study|Lack of Efficacy|0|||
128723711|NCT01987427|463287193|FG000|Overall Study|Other|1|||
128723712|NCT01987427|463287194|FG001|Overall Study|Other|1|||
128723713|NCT01987427|463287195|FG002|Overall Study|Other|0|||
128723714|NCT01073865|463287196|FG000|Overall Study|Reasons other than below|19|||
128723715|NCT01073865|463287197|FG001|Overall Study|Reasons other than below|31|||
128723716|NCT01073865|463287196|FG000|Overall Study|Lost to Follow-up|1|||
128723717|NCT01073865|463287197|FG001|Overall Study|Lost to Follow-up|1|||
128723718|NCT01073865|463287196|FG000|Overall Study|Death|3|||
128723719|NCT01073865|463287197|FG001|Overall Study|Death|2|||
128723720|NCT01073865|463287196|FG000|Overall Study|Withdrawal by Subject|5|||
128723721|NCT01073865|463287197|FG001|Overall Study|Withdrawal by Subject|5|||
128723722|NCT02547129|463287201|FG000|Overall Study|Difficulty with ongoing infection|1|||
128723723|NCT02547129|463287202|FG001|Overall Study|Difficulty with ongoing infection|0|||
128723724|NCT00805766|463287203|FG000|Screening Period|Adverse Event|1|||
128723725|NCT00805766|463287203|FG000|Screening Period|Lack of Efficacy|2|||
128723726|NCT00805766|463287203|FG000|Screening Period|Pregnancy|1|||
128723727|NCT00805766|463287203|FG000|Screening Period|Responder|2|||
128723728|NCT00805766|463287203|FG000|Increased Dose Period|Adverse Event|4|||
128723729|NCT00805766|463287203|FG000|Increased Dose Period|Lack of Efficacy|7|||
128723730|NCT00805766|463287203|FG000|Increased Dose Period|Pregnancy|1|||
128723731|NCT00805766|463287203|FG000|Increased Dose Period|Withdrawal by Subject|1|||
128723732|NCT03969992|463287208|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
128723733|NCT03969992|463287209|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
128723734|NCT03969992|463287210|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
128723735|NCT03969992|463287208|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
128723736|NCT03969992|463287209|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
128723737|NCT03969992|463287210|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
128723738|NCT03969992|463287208|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
128723739|NCT03969992|463287209|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
128723740|NCT03969992|463287210|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
128723741|NCT03969992|463287208|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
128723742|NCT03969992|463287209|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
128723743|NCT03969992|463287210|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
128723744|NCT03969992|463287208|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
128723745|NCT03969992|463287209|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
128723746|NCT03969992|463287210|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
128723747|NCT00228917|463287211|FG000|Overall Study|Migrated/moved from study area|0|||
128723748|NCT00228917|463287212|FG001|Overall Study|Migrated/moved from study area|0|||
128723749|NCT00228917|463287213|FG002|Overall Study|Migrated/moved from study area|0|||
128723750|NCT00228917|463287214|FG003|Overall Study|Migrated/moved from study area|0|||
128723751|NCT00228917|463287215|FG004|Overall Study|Migrated/moved from study area|0|||
128723752|NCT00228917|463287216|FG005|Overall Study|Migrated/moved from study area|2|||
128723753|NCT00228917|463287217|FG006|Overall Study|Migrated/moved from study area|0|||
128723754|NCT00228917|463287218|FG007|Overall Study|Migrated/moved from study area|0|||
128723755|NCT00409617|463287219|FG000|Overall Study|Adverse Event|57|||
128723756|NCT00409617|463287219|FG000|Overall Study|Lack of Efficacy|54|||
128723757|NCT00409617|463287219|FG000|Overall Study|Lost to Follow-up|2|||
128723758|NCT00409617|463287219|FG000|Overall Study|Protocol Violation|24|||
128723759|NCT00409617|463287219|FG000|Overall Study|Withdrawal by Subject|8|||
128723760|NCT00409617|463287219|FG000|Overall Study|Administrative reasons|1|||
128723761|NCT00409617|463287219|FG000|Overall Study|Not described|14|||
128723762|NCT02063737|463287222|FG000|Overall Study|Lost to Follow-up|11|||
129069938|NCT00711243|464545693|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
129069939|NCT00711243|464545694|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
129069940|NCT00711243|464545695|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
129069941|NCT00711243|464545696|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
129069942|NCT00711243|464545691|FG000|Treated Cycle 5 After First Response|Death|0|||
129069943|NCT00711243|464545692|FG001|Treated Cycle 5 After First Response|Death|0|||
129069944|NCT00711243|464545693|FG002|Treated Cycle 5 After First Response|Death|0|||
129069945|NCT00711243|464545694|FG003|Treated Cycle 5 After First Response|Death|0|||
129069946|NCT00711243|464545695|FG004|Treated Cycle 5 After First Response|Death|0|||
128723763|NCT02063737|463287223|FG001|Overall Study|Lost to Follow-up|4|||
128723764|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
128723765|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
128723766|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
128723767|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
128723768|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
128723769|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
128723770|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
128723771|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
128723772|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
128723773|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
128723774|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
129069947|NCT00711243|464545696|FG005|Treated Cycle 5 After First Response|Death|2|||
129069948|NCT00711243|464545691|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
129069949|NCT00711243|464545692|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
129069950|NCT00711243|464545693|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
129069951|NCT00711243|464545694|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
129069952|NCT00711243|464545695|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
129069953|NCT00711243|464545696|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
129069954|NCT00711243|464545691|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129069955|NCT00711243|464545692|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129069956|NCT00711243|464545693|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129069957|NCT00711243|464545694|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129069958|NCT00711243|464545695|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
128723775|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
128723776|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
128723777|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
128723778|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
128723779|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
128723780|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
128723781|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
128723782|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
128723783|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
128723784|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
128723785|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
128723786|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
128723787|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
128723788|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
128723789|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
128723790|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
128723791|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
128723792|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
128723793|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
128723794|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
128723795|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
129069959|NCT00711243|464545696|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
129069960|NCT01402570|464545699|FG000|Overall Study|Adverse Event|1|||
129069961|NCT01962103|464545703|FG000|Phase 1|Adverse Event|4|||
129069962|NCT01962103|464545704|FG001|Phase 1|Adverse Event|0|||
129069963|NCT01962103|464545705|FG002|Phase 1|Adverse Event|2|||
128723796|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
128723797|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
129069964|NCT01962103|464545706|FG003|Phase 1|Adverse Event|1|||
128776372|NCT01990300|463470416|FG000|Overall Study|Case Report Forms Uncollected|89|||
128776373|NCT01990300|463470416|FG000|Overall Study|Protocol Deviation|53|||
128776374|NCT02269943|463470419|FG000|Treatment Period|Death|0|||
128776375|NCT02269943|463470420|FG001|Treatment Period|Death|1|||
128776376|NCT02269943|463470419|FG000|Treatment Period|Adverse Event|1|||
128776377|NCT02269943|463470420|FG001|Treatment Period|Adverse Event|10|||
128776378|NCT02269943|463470419|FG000|Treatment Period|Progressive Disease|5|||
128776379|NCT02269943|463470420|FG001|Treatment Period|Progressive Disease|17|||
128776380|NCT02269943|463470419|FG000|Treatment Period|Symptomatic Deterioration|0|||
128776381|NCT02269943|463470420|FG001|Treatment Period|Symptomatic Deterioration|2|||
128776382|NCT02269943|463470419|FG000|Follow-Up Survival Period|Death|3|||
129069965|NCT01962103|464545707|FG004|Phase 1|Adverse Event|2|||
129069966|NCT01962103|464545708|FG005|Phase 1|Adverse Event|2|||
129069967|NCT01962103|464545709|FG006|Phase 1|Adverse Event|0|||
129069968|NCT01962103|464545710|FG007|Phase 1|Adverse Event|0|||
129069969|NCT01962103|464545711|FG008|Phase 1|Adverse Event|0|||
129069970|NCT01962103|464545703|FG000|Phase 1|Progressive Disease|8|||
129069971|NCT01962103|464545704|FG001|Phase 1|Progressive Disease|6|||
129069972|NCT01962103|464545705|FG002|Phase 1|Progressive Disease|8|||
129069973|NCT01962103|464545706|FG003|Phase 1|Progressive Disease|4|||
129069974|NCT01962103|464545707|FG004|Phase 1|Progressive Disease|5|||
129069975|NCT01962103|464545708|FG005|Phase 1|Progressive Disease|4|||
129069976|NCT01962103|464545709|FG006|Phase 1|Progressive Disease|0|||
129069977|NCT01962103|464545710|FG007|Phase 1|Progressive Disease|0|||
129069978|NCT01962103|464545711|FG008|Phase 1|Progressive Disease|0|||
129069979|NCT01962103|464545703|FG000|Phase 1|Withdrawal by Subject|0|||
129069980|NCT01962103|464545704|FG001|Phase 1|Withdrawal by Subject|0|||
129069981|NCT01962103|464545705|FG002|Phase 1|Withdrawal by Subject|0|||
129069982|NCT01962103|464545706|FG003|Phase 1|Withdrawal by Subject|2|||
129069983|NCT01962103|464545707|FG004|Phase 1|Withdrawal by Subject|0|||
129069984|NCT01962103|464545708|FG005|Phase 1|Withdrawal by Subject|0|||
129069985|NCT01962103|464545709|FG006|Phase 1|Withdrawal by Subject|0|||
129069986|NCT01962103|464545710|FG007|Phase 1|Withdrawal by Subject|0|||
129069987|NCT01962103|464545711|FG008|Phase 1|Withdrawal by Subject|0|||
129069988|NCT01962103|464545703|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
129069989|NCT01962103|464545704|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
129069990|NCT01962103|464545705|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
129069991|NCT01962103|464545706|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
129069992|NCT01962103|464545707|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
129069993|NCT01962103|464545708|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
129069994|NCT01962103|464545709|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
129069995|NCT01962103|464545710|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
129069996|NCT01962103|464545711|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
129069997|NCT01962103|464545703|FG000|Phase 1|Physician Decision|0|||
129069998|NCT01962103|464545704|FG001|Phase 1|Physician Decision|0|||
129069999|NCT01962103|464545705|FG002|Phase 1|Physician Decision|0|||
129070000|NCT01962103|464545706|FG003|Phase 1|Physician Decision|1|||
129070001|NCT01962103|464545707|FG004|Phase 1|Physician Decision|0|||
129070002|NCT01962103|464545708|FG005|Phase 1|Physician Decision|0|||
129070003|NCT01962103|464545709|FG006|Phase 1|Physician Decision|0|||
129070004|NCT01962103|464545710|FG007|Phase 1|Physician Decision|0|||
129070005|NCT01962103|464545711|FG008|Phase 1|Physician Decision|0|||
129070006|NCT01962103|464545703|FG000|Phase 1|Symptomatic Deterioration|3|||
129070007|NCT01962103|464545704|FG001|Phase 1|Symptomatic Deterioration|2|||
129070008|NCT01962103|464545705|FG002|Phase 1|Symptomatic Deterioration|2|||
129070009|NCT01962103|464545706|FG003|Phase 1|Symptomatic Deterioration|2|||
129070010|NCT01962103|464545707|FG004|Phase 1|Symptomatic Deterioration|1|||
129070011|NCT01962103|464545708|FG005|Phase 1|Symptomatic Deterioration|1|||
129070012|NCT01962103|464545709|FG006|Phase 1|Symptomatic Deterioration|0|||
129070013|NCT01962103|464545710|FG007|Phase 1|Symptomatic Deterioration|0|||
129070014|NCT01962103|464545711|FG008|Phase 1|Symptomatic Deterioration|0|||
129070015|NCT01962103|464545703|FG000|Phase 1|Miscellaneous|1|||
129070016|NCT01962103|464545704|FG001|Phase 1|Miscellaneous|0|||
129070017|NCT01962103|464545705|FG002|Phase 1|Miscellaneous|0|||
129070018|NCT01962103|464545706|FG003|Phase 1|Miscellaneous|0|||
129070019|NCT01962103|464545707|FG004|Phase 1|Miscellaneous|0|||
129070020|NCT01962103|464545708|FG005|Phase 1|Miscellaneous|0|||
129070021|NCT01962103|464545709|FG006|Phase 1|Miscellaneous|0|||
129070022|NCT01962103|464545710|FG007|Phase 1|Miscellaneous|0|||
128776383|NCT02269943|463470420|FG001|Follow-Up Survival Period|Death|16|||
128776384|NCT02269943|463470419|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
129070023|NCT01962103|464545711|FG008|Phase 1|Miscellaneous|0|||
129070024|NCT01962103|464545703|FG000|Phase 2|Adverse Event|0|||
129070025|NCT01962103|464545704|FG001|Phase 2|Adverse Event|0|||
129070026|NCT01962103|464545705|FG002|Phase 2|Adverse Event|0|||
129070027|NCT01962103|464545706|FG003|Phase 2|Adverse Event|0|||
129070028|NCT01962103|464545707|FG004|Phase 2|Adverse Event|0|||
129070029|NCT01962103|464545708|FG005|Phase 2|Adverse Event|0|||
129070030|NCT01962103|464545709|FG006|Phase 2|Adverse Event|1|||
129070031|NCT01962103|464545710|FG007|Phase 2|Adverse Event|0|||
129070032|NCT01962103|464545711|FG008|Phase 2|Adverse Event|3|||
129070033|NCT01962103|464545703|FG000|Phase 2|Progressive Disease|0|||
129139399|NCT02792257|464802782|FG001|Overall Study|Excessive Agitation|1|||
129139400|NCT02792257|464802781|FG000|Overall Study|Not Feeling Well|0|||
129139401|NCT02792257|464802782|FG001|Overall Study|Not Feeling Well|1|||
129139402|NCT00553475|464802783|FG000|Overall Study|Adverse Event|7|||
129139403|NCT00553475|464802784|FG001|Overall Study|Adverse Event|17|||
129139404|NCT00553475|464802785|FG002|Overall Study|Adverse Event|13|||
129139405|NCT00553475|464802783|FG000|Overall Study|Lack of Efficacy|7|||
129139406|NCT00553475|464802784|FG001|Overall Study|Lack of Efficacy|1|||
129139407|NCT00553475|464802785|FG002|Overall Study|Lack of Efficacy|0|||
129139408|NCT00553475|464802783|FG000|Overall Study|Withdrawal by Subject|1|||
129139409|NCT00553475|464802784|FG001|Overall Study|Withdrawal by Subject|1|||
129139410|NCT00553475|464802785|FG002|Overall Study|Withdrawal by Subject|0|||
129139411|NCT00553475|464802783|FG000|Overall Study|Physician Decision|1|||
129139412|NCT00553475|464802784|FG001|Overall Study|Physician Decision|0|||
129139413|NCT00553475|464802785|FG002|Overall Study|Physician Decision|0|||
129139414|NCT00553475|464802783|FG000|Overall Study|Due to moving|0|||
129139415|NCT00553475|464802784|FG001|Overall Study|Due to moving|1|||
129139416|NCT00553475|464802785|FG002|Overall Study|Due to moving|0|||
129139417|NCT01926509|464804477|FG000|Overall Study|vital sign met discontinuation criteria|1|||
129139418|NCT01926509|464804478|FG001|Overall Study|vital sign met discontinuation criteria|0|||
129139419|NCT01926509|464804479|FG002|Overall Study|vital sign met discontinuation criteria|0|||
129139420|NCT01926509|464804480|FG003|Overall Study|vital sign met discontinuation criteria|0|||
129139421|NCT03681093|464804481|FG000|Overall Study|Subject decision|0|||
129139422|NCT03681093|464804482|FG001|Overall Study|Subject decision|2|||
129139423|NCT03681093|464804483|FG002|Overall Study|Subject decision|1|||
129139424|NCT01882829|464804487|FG000|Overall Study|Adverse Event|4|||
129139425|NCT01882829|464804487|FG000|Overall Study|Protocol Violation|1|||
129139426|NCT01882829|464804487|FG000|Overall Study|Withdrawal by Subject|1|||
128776385|NCT02269943|463470420|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
128776386|NCT02269943|463470419|FG000|Follow-Up Survival Period|Alive|2|||
128776387|NCT02269943|463470420|FG001|Follow-Up Survival Period|Alive|8|||
128776388|NCT02213055|463470421|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
128776389|NCT02213055|463470422|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
128776390|NCT02213055|463470421|FG000|Overall Study|Protocol was not Followed during Study|1|||
128776391|NCT02213055|463470422|FG001|Overall Study|Protocol was not Followed during Study|0|||
128776392|NCT02213055|463470421|FG000|Overall Study|Documentation Issue at Enrollment|1|||
128776393|NCT02213055|463470422|FG001|Overall Study|Documentation Issue at Enrollment|0|||
128776394|NCT02213055|463470421|FG000|Overall Study|Documentation Issue during Study|10|||
128776395|NCT02213055|463470422|FG001|Overall Study|Documentation Issue during Study|0|||
128776396|NCT02213055|463470421|FG000|Overall Study|Did not have Live Lice|8|||
128776397|NCT02213055|463470422|FG001|Overall Study|Did not have Live Lice|0|||
128776398|NCT02213055|463470421|FG000|Overall Study|Had another Treatment during the Study|3|||
128776399|NCT02213055|463470422|FG001|Overall Study|Had another Treatment during the Study|0|||
128776400|NCT02213055|463470421|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
128776401|NCT02213055|463470422|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
128776402|NCT02213055|463470421|FG000|Overall Study|Did not Return to School|5|||
128776403|NCT02213055|463470422|FG001|Overall Study|Did not Return to School|0|||
128776404|NCT00231894|463470423|FG000|Overall Study|Withdrawal by Subject|1|||
128776405|NCT00231894|463470424|FG001|Overall Study|Withdrawal by Subject|1|||
128776406|NCT02025205|463470425|FG000|Overall Study|Withdrawal by Subject|1|||
128776407|NCT02025205|463470426|FG001|Overall Study|Withdrawal by Subject|1|||
128776408|NCT02025205|463470425|FG000|Overall Study|Protocol Violation|2|||
128776409|NCT02025205|463470426|FG001|Overall Study|Protocol Violation|1|||
128776410|NCT02025205|463470425|FG000|Overall Study|Death|0|||
128776411|NCT02025205|463470426|FG001|Overall Study|Death|1|||
128776412|NCT01767129|463470427|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
128776413|NCT01767129|463470428|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129139427|NCT02469961|464804489|FG000|Overall Study|Physician Decision|4|||
129139428|NCT02469961|464804490|FG001|Overall Study|Physician Decision|1|||
129139429|NCT05130281|464804494|FG000|Overall Study|Withdrawal by Subject|0|||
129139430|NCT05130281|464804495|FG001|Overall Study|Withdrawal by Subject|0|||
129139431|NCT05130281|464804496|FG002|Overall Study|Withdrawal by Subject|1|||
129139432|NCT06844812|464804497|FG000|Overall Study|Lost to Follow-up|5|||
129139433|NCT06844812|464804497|FG000|Overall Study|stigmatization concerns|2|||
129139434|NCT06844812|464804497|FG000|Overall Study|medication refusal|2|||
129139435|NCT06844812|464804497|FG000|Overall Study|concerns about possible side effects|2|||
129139436|NCT06844812|464804497|FG000|Overall Study|wanting to seek another specialist opinion|2|||
129139437|NCT06844812|464804497|FG000|Overall Study|side effects (dizziness)|1|||
129139438|NCT00368849|464804500|FG000|Overall Study|Withdrawal by Subject|0|||
129139439|NCT00368849|464804501|FG001|Overall Study|Withdrawal by Subject|1|||
129139440|NCT00368849|464804500|FG000|Overall Study|Physician Decision|0|||
128776414|NCT03389893|463470429|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
128776415|NCT03389893|463470430|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
128776416|NCT03389893|463470431|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
128776417|NCT03389893|463470432|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
128776418|NCT03389893|463470429|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
128776419|NCT03389893|463470430|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
128776420|NCT03389893|463470431|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
128776421|NCT03389893|463470432|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
128776422|NCT03389893|463470429|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
128776423|NCT03389893|463470430|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
128776424|NCT03389893|463470431|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
128776425|NCT03389893|463470432|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
128776426|NCT03389893|463470429|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
128776427|NCT03389893|463470430|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
128776428|NCT03389893|463470431|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
128776429|NCT03389893|463470432|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
128776430|NCT01024751|463470436|FG000|Enrolled Participants|Ineligible at baseline|3|||
128776431|NCT01024751|463470437|FG001|Enrolled Participants|Ineligible at baseline|4|||
128776432|NCT01024751|463470436|FG000|Eligible Participants|Withdrawal by Subject|0|||
128776433|NCT01024751|463470437|FG001|Eligible Participants|Withdrawal by Subject|1|||
128776434|NCT01024751|463470436|FG000|Eligible Participants|Lost to Follow-up|0|||
128776435|NCT01024751|463470437|FG001|Eligible Participants|Lost to Follow-up|1|||
128776436|NCT01024751|463470436|FG000|Eligible Participants|Ineligible|0|||
128776437|NCT01024751|463470437|FG001|Eligible Participants|Ineligible|1|||
128776438|NCT02448719|463470438|FG000|Overall Study|Withdrawal by Subject|0|||
128776439|NCT02448719|463470439|FG001|Overall Study|Withdrawal by Subject|0|||
128776440|NCT02448719|463470440|FG002|Overall Study|Withdrawal by Subject|0|||
128776441|NCT02448719|463470441|FG003|Overall Study|Withdrawal by Subject|0|||
128776442|NCT02448719|463470442|FG004|Overall Study|Withdrawal by Subject|1|||
128776443|NCT02448719|463470443|FG005|Overall Study|Withdrawal by Subject|0|||
128776444|NCT02448719|463470444|FG006|Overall Study|Withdrawal by Subject|0|||
128776445|NCT02448719|463470445|FG007|Overall Study|Withdrawal by Subject|0|||
128776446|NCT02448719|463470446|FG008|Overall Study|Withdrawal by Subject|0|||
128776447|NCT02448719|463470447|FG009|Overall Study|Withdrawal by Subject|0|||
128776448|NCT02448719|463470448|FG010|Overall Study|Withdrawal by Subject|0|||
128776449|NCT01232556|463470449|FG000|Overall Study|Withdrawal by Subject|21|||
128776450|NCT01232556|463470450|FG001|Overall Study|Withdrawal by Subject|17|||
128776451|NCT01232556|463470449|FG000|Overall Study|Death|97|||
128776452|NCT01232556|463470450|FG001|Overall Study|Death|97|||
128776453|NCT01232556|463470449|FG000|Overall Study|Lost to Follow-up|0|||
128776454|NCT01232556|463470450|FG001|Overall Study|Lost to Follow-up|2|||
128776455|NCT01232556|463470449|FG000|Overall Study|Terminated by Sponsor|35|||
128776456|NCT01232556|463470450|FG001|Overall Study|Terminated by Sponsor|51|||
128776457|NCT01232556|463470449|FG000|Overall Study|Other|6|||
128776458|NCT01232556|463470450|FG001|Overall Study|Other|4|||
128776459|NCT01349660|463470452|FG000|Overall Study|Still Receiving Study Treatment|0|||
128776460|NCT01349660|463470453|FG001|Overall Study|Still Receiving Study Treatment|0|||
128776461|NCT01349660|463470454|FG002|Overall Study|Still Receiving Study Treatment|1|||
128776462|NCT01349660|463470452|FG000|Overall Study|Disease Progression|2|||
128776463|NCT01349660|463470453|FG001|Overall Study|Disease Progression|4|||
128776464|NCT01349660|463470454|FG002|Overall Study|Disease Progression|50|||
128776465|NCT01349660|463470452|FG000|Overall Study|Adverse Event|1|||
128776466|NCT01349660|463470453|FG001|Overall Study|Adverse Event|1|||
128776467|NCT01349660|463470454|FG002|Overall Study|Adverse Event|12|||
128776468|NCT01349660|463470452|FG000|Overall Study|Withdrawal by Subject|2|||
128776469|NCT01349660|463470453|FG001|Overall Study|Withdrawal by Subject|0|||
128776470|NCT01349660|463470454|FG002|Overall Study|Withdrawal by Subject|9|||
128776471|NCT01349660|463470452|FG000|Overall Study|Death|1|||
128776472|NCT01349660|463470453|FG001|Overall Study|Death|1|||
128776473|NCT01349660|463470454|FG002|Overall Study|Death|0|||
128776474|NCT01349660|463470452|FG000|Overall Study|Non-Permitted Interventions|0|||
128776475|NCT01349660|463470453|FG001|Overall Study|Non-Permitted Interventions|0|||
128776476|NCT01349660|463470454|FG002|Overall Study|Non-Permitted Interventions|2|||
128776477|NCT01349660|463470452|FG000|Overall Study|Study Compliance|0|||
128776478|NCT01349660|463470453|FG001|Overall Study|Study Compliance|0|||
128776479|NCT01349660|463470454|FG002|Overall Study|Study Compliance|1|||
129139441|NCT00368849|464804501|FG001|Overall Study|Physician Decision|1|||
128776480|NCT01349660|463470452|FG000|Overall Study|Declining Performance Status|0|||
128776481|NCT01349660|463470453|FG001|Overall Study|Declining Performance Status|0|||
128776482|NCT01349660|463470454|FG002|Overall Study|Declining Performance Status|1|||
128776483|NCT00519636|463470455|FG000|Treatment Period 1|Adverse Event|1|||
128776484|NCT00519636|463470456|FG001|Treatment Period 1|Adverse Event|0|||
128776485|NCT00519636|463470457|FG002|Treatment Period 1|Adverse Event|1|||
128776486|NCT00519636|463470458|FG003|Treatment Period 1|Adverse Event|0|||
128776487|NCT00519636|463470455|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
128776488|NCT00519636|463470456|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
128776489|NCT00519636|463470457|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
129139442|NCT01699685|464804505|FG000|Period 1|Adverse Event|1|||
129070034|NCT01962103|464545704|FG001|Phase 2|Progressive Disease|0|||
129070035|NCT01962103|464545705|FG002|Phase 2|Progressive Disease|0|||
129070036|NCT01962103|464545706|FG003|Phase 2|Progressive Disease|0|||
129070037|NCT01962103|464545707|FG004|Phase 2|Progressive Disease|0|||
129070038|NCT01962103|464545708|FG005|Phase 2|Progressive Disease|0|||
129070039|NCT01962103|464545709|FG006|Phase 2|Progressive Disease|11|||
129070040|NCT01962103|464545710|FG007|Phase 2|Progressive Disease|12|||
129070041|NCT01962103|464545711|FG008|Phase 2|Progressive Disease|11|||
129070042|NCT01962103|464545703|FG000|Phase 2|Symptomatic Deterioration|0|||
129070043|NCT01962103|464545704|FG001|Phase 2|Symptomatic Deterioration|0|||
129070044|NCT01962103|464545705|FG002|Phase 2|Symptomatic Deterioration|0|||
129070045|NCT01962103|464545706|FG003|Phase 2|Symptomatic Deterioration|0|||
129070046|NCT01962103|464545707|FG004|Phase 2|Symptomatic Deterioration|0|||
129070047|NCT01962103|464545708|FG005|Phase 2|Symptomatic Deterioration|0|||
129070048|NCT01962103|464545709|FG006|Phase 2|Symptomatic Deterioration|2|||
129070049|NCT01962103|464545710|FG007|Phase 2|Symptomatic Deterioration|2|||
129139443|NCT01699685|464804506|FG001|Period 1|Adverse Event|1|||
129139444|NCT01699685|464804505|FG000|Period 1|Medical or ethical, noncompliance|2|||
129139445|NCT01699685|464804506|FG001|Period 1|Medical or ethical, noncompliance|0|||
129139446|NCT01699685|464804505|FG000|Period 1|Other|0|||
129139447|NCT01699685|464804506|FG001|Period 1|Other|1|||
129139448|NCT01699685|464804505|FG000|Period 1|Patient request|0|||
129139449|NCT01699685|464804506|FG001|Period 1|Patient request|1|||
129139450|NCT01699685|464804505|FG000|Period 2|Lost to Follow-up|1|||
129139451|NCT01699685|464804506|FG001|Period 2|Lost to Follow-up|0|||
129139452|NCT03635996|464804507|FG000|Overall Study|Study terminated by Sponsor|94|||
129139453|NCT03635996|464804507|FG000|Overall Study|Withdrawal by Subject|20|||
129139454|NCT03635996|464804507|FG000|Overall Study|Ablation|26|||
129139455|NCT03635996|464804507|FG000|Overall Study|Adverse Event|7|||
129139456|NCT03635996|464804507|FG000|Overall Study|Physician Decision|3|||
129139457|NCT03635996|464804507|FG000|Overall Study|Prohibited medication|5|||
129139458|NCT03635996|464804507|FG000|Overall Study|Did not meet eligibility criteria|5|||
129139459|NCT03635996|464804507|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
129139460|NCT03635996|464804507|FG000|Overall Study|Protocol Violation|1|||
129139461|NCT03635996|464804507|FG000|Overall Study|Lost to Follow-up|1|||
129139462|NCT05058456|464804508|FG000|Overall Study|Death|1|||
129139463|NCT05058456|464804508|FG000|Overall Study|End of Study data not yet due for release|34|||
129139464|NCT01832038|464804509|FG000|Overall Study|Death|5|||
129139465|NCT01832038|464804509|FG000|Overall Study|Adverse Event|50|||
129139466|NCT01832038|464804509|FG000|Overall Study|Lack of Efficacy|81|||
129139467|NCT01832038|464804509|FG000|Overall Study|Protocol Violation|7|||
129139468|NCT01832038|464804509|FG000|Overall Study|Lost to Follow-up|10|||
129139469|NCT01832038|464804509|FG000|Overall Study|Withdrawal by Subject|49|||
129139470|NCT01832038|464804509|FG000|Overall Study|Visit non-compliance|2|||
129139471|NCT01832038|464804509|FG000|Overall Study|Subject refused to return visit|2|||
129139472|NCT01832038|464804509|FG000|Overall Study|Not convenient to come back to site|2|||
129139473|NCT01832038|464804509|FG000|Overall Study|Participant was asked to quit|5|||
129139474|NCT01832038|464804509|FG000|Overall Study|Back home|1|||
129139475|NCT01832038|464804509|FG000|Overall Study|Pregnancy|1|||
129139476|NCT01832038|464804509|FG000|Overall Study|Low compliance|3|||
129139477|NCT01832038|464804509|FG000|Overall Study|Prohibit procedure|2|||
129070050|NCT01962103|464545711|FG008|Phase 2|Symptomatic Deterioration|0|||
129070051|NCT01321749|464545712|FG000|Overall Study|Lost to Follow-up|4|||
129070052|NCT01321749|464545713|FG001|Overall Study|Lost to Follow-up|11|||
129070053|NCT01321749|464545712|FG000|Overall Study|Protocol Violation|4|||
129070054|NCT01321749|464545713|FG001|Overall Study|Protocol Violation|7|||
129070055|NCT01321749|464545712|FG000|Overall Study|Withdrawal by Subject|5|||
129070056|NCT01321749|464545713|FG001|Overall Study|Withdrawal by Subject|4|||
129139478|NCT01832038|464804509|FG000|Overall Study|Not possible to visit the hospital|1|||
129139479|NCT01832038|464804509|FG000|Overall Study|Changes of implementation system|3|||
129139480|NCT01832038|464804509|FG000|Overall Study|Plan to pregnancy|7|||
129139481|NCT01832038|464804509|FG000|Overall Study|Bad mood and has suicidal thought|1|||
129139482|NCT01832038|464804509|FG000|Overall Study|Prohibited concomitant medication|1|||
129139483|NCT01832038|464804509|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
129139484|NCT01832038|464804509|FG000|Overall Study|Subject considered the efficacy was poor|1|||
129139485|NCT00101400|464804516|FG000|Survival Follow-Up|Alive|7|||
129139486|NCT05333965|464804537|FG000|First Intervention|Adverse Event|0|||
129139487|NCT05333965|464804538|FG001|First Intervention|Adverse Event|1|||
129139488|NCT05333965|464804537|FG000|First Intervention|Withdrawal by Subject|0|||
129139489|NCT05333965|464804538|FG001|First Intervention|Withdrawal by Subject|1|||
129070057|NCT04179838|464545717|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129070058|NCT04179838|464545718|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
129139490|NCT00382863|464804539|FG000|Overall Study|Death|9|||
129139491|NCT00382863|464804540|FG001|Overall Study|Death|9|||
129139492|NCT00382863|464804539|FG000|Overall Study|Lost to Follow-up|1|||
129139493|NCT00382863|464804540|FG001|Overall Study|Lost to Follow-up|2|||
129139494|NCT00382863|464804539|FG000|Overall Study|Withdrawal by Subject|5|||
129139495|NCT00382863|464804540|FG001|Overall Study|Withdrawal by Subject|25|||
128776490|NCT00519636|463470458|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
128776491|NCT00519636|463470455|FG000|Washout Period|Adverse Event|2|||
128776492|NCT00519636|463470456|FG001|Washout Period|Adverse Event|1|||
128776493|NCT00519636|463470457|FG002|Washout Period|Adverse Event|1|||
128776494|NCT00519636|463470458|FG003|Washout Period|Adverse Event|0|||
128776495|NCT00519636|463470455|FG000|Washout Period|Lost to Follow-up|1|||
128776496|NCT00519636|463470456|FG001|Washout Period|Lost to Follow-up|0|||
128776497|NCT00519636|463470457|FG002|Washout Period|Lost to Follow-up|0|||
128776498|NCT00519636|463470458|FG003|Washout Period|Lost to Follow-up|0|||
128776499|NCT00519636|463470455|FG000|Washout Period|Protocol Violation|0|||
128776500|NCT00519636|463470456|FG001|Washout Period|Protocol Violation|0|||
129139496|NCT02168439|464804541|FG000|Overall Study|Protocol Violation|0|||
129139497|NCT02168439|464804542|FG001|Overall Study|Protocol Violation|2|||
129139498|NCT02180672|464804545|FG000|Overall Study|Lost to Follow-up|5|||
129139499|NCT02180672|464804546|FG001|Overall Study|Lost to Follow-up|7|||
129139500|NCT02837952|464804547|FG000|Overall Study|Adverse Event|0|||
129139501|NCT02837952|464804548|FG001|Overall Study|Adverse Event|1|||
129139502|NCT02837952|464804547|FG000|Overall Study|Withdrawal by Subject|4|||
129139503|NCT02837952|464804548|FG001|Overall Study|Withdrawal by Subject|5|||
129139504|NCT02837952|464804547|FG000|Overall Study|Medication Error|1|||
129139505|NCT02837952|464804548|FG001|Overall Study|Medication Error|0|||
129139506|NCT01362530|464804549|FG000|Base Study (Cycle 1)|Adverse Event|2|||
129139507|NCT01362530|464804550|FG001|Base Study (Cycle 1)|Adverse Event|0|||
129139508|NCT01362530|464804549|FG000|Base Study (Cycle 1)|Physician Decision|0|||
129139509|NCT01362530|464804550|FG001|Base Study (Cycle 1)|Physician Decision|1|||
129139510|NCT01362530|464804549|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
129139511|NCT01362530|464804550|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
129139512|NCT01362530|464804549|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
129139513|NCT01362530|464804550|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
129139514|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
129139515|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
129139516|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
129139517|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
129139518|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
129139519|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
129139520|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
129139521|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
129139522|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
129139523|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
129139524|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
129139525|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
129139526|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
129139527|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
129139528|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
129139529|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
129139530|NCT01362530|464804549|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
129139531|NCT01362530|464804550|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
129139532|NCT03021005|464804552|FG000|Overall Study|Lost to Follow-up|39|||
129139533|NCT03021005|464804553|FG001|Overall Study|Lost to Follow-up|26|||
129139534|NCT00276380|464804556|FG000|Overall Study|Adverse Event|5|||
129139535|NCT00276380|464804557|FG001|Overall Study|Adverse Event|3|||
129139536|NCT00276380|464804556|FG000|Overall Study|Lost to Follow-up|1|||
129139537|NCT00276380|464804557|FG001|Overall Study|Lost to Follow-up|1|||
129139538|NCT00276380|464804556|FG000|Overall Study|Withdrawal by Subject|3|||
129139539|NCT00276380|464804557|FG001|Overall Study|Withdrawal by Subject|6|||
129139540|NCT00276380|464804556|FG000|Overall Study|Death|5|||
129139541|NCT00276380|464804557|FG001|Overall Study|Death|3|||
129139542|NCT00276380|464804556|FG000|Overall Study|Abnormal aPPT Levels|0|||
129139543|NCT00276380|464804557|FG001|Overall Study|Abnormal aPPT Levels|1|||
129139544|NCT04829214|464804558|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
129139545|NCT04829214|464804559|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
129139546|NCT04829214|464804558|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
129139547|NCT04829214|464804559|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
129139548|NCT02571244|464804560|FG000|Overall Study|Lost to Follow-up|0|||
129139549|NCT02571244|464804561|FG001|Overall Study|Lost to Follow-up|1|||
129139550|NCT02571244|464804560|FG000|Overall Study|Unable to reach out post discharge|3|||
128776501|NCT00519636|463470457|FG002|Washout Period|Protocol Violation|1|||
128776502|NCT00519636|463470458|FG003|Washout Period|Protocol Violation|2|||
129139551|NCT02571244|464804561|FG001|Overall Study|Unable to reach out post discharge|0|||
128776503|NCT00519636|463470455|FG000|Washout Period|Withdrawal by Subject|1|||
128776504|NCT00519636|463470456|FG001|Washout Period|Withdrawal by Subject|0|||
128776505|NCT00519636|463470457|FG002|Washout Period|Withdrawal by Subject|1|||
129139552|NCT04629521|464804562|FG000|Overall Study|Death|1|||
128776506|NCT00519636|463470458|FG003|Washout Period|Withdrawal by Subject|0|||
128723798|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
128723799|NCT03373383|463287226|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
128776507|NCT00519636|463470455|FG000|Washout Period|Failed to meet continuation criteria|14|||
129139553|NCT04629521|464804562|FG000|Overall Study|Lost to Follow-up|3|||
129139554|NCT04629521|464804562|FG000|Overall Study|Subject withdrew consent|3|||
129139555|NCT04629521|464804562|FG000|Overall Study|Enrolled in error|1|||
129139556|NCT01065766|464804571|FG000|Overall Study|Assessed before the contracted date|1|||
129139557|NCT01065766|464804571|FG000|Overall Study|Contraindication to administration|6|||
129139558|NCT01065766|464804571|FG000|Overall Study|Violated dosage/administration|25|||
129139559|NCT04128228|464804574|FG000|Overall Study|Withdrawal by Subject|3|||
129139560|NCT04128228|464804575|FG001|Overall Study|Withdrawal by Subject|3|||
129139561|NCT04128228|464804576|FG002|Overall Study|Withdrawal by Subject|0|||
129139562|NCT04128228|464804577|FG003|Overall Study|Withdrawal by Subject|0|||
129139563|NCT04128228|464804574|FG000|Overall Study|noncompliance|2|||
129139564|NCT04128228|464804575|FG001|Overall Study|noncompliance|2|||
129139565|NCT04128228|464804576|FG002|Overall Study|noncompliance|0|||
129139566|NCT04128228|464804577|FG003|Overall Study|noncompliance|0|||
129139567|NCT01602666|464804578|FG000|Induction Chemotherapy|Death|2|||
129139568|NCT01602666|464804579|FG001|Induction Chemotherapy|Death|1|||
129139569|NCT01602666|464804578|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
129139570|NCT01602666|464804579|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
129139571|NCT01602666|464804578|FG000|Induction Chemotherapy|Physician Decision|12|||
129139572|NCT01602666|464804579|FG001|Induction Chemotherapy|Physician Decision|5|||
129139573|NCT01602666|464804578|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
129139574|NCT01602666|464804579|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
129139575|NCT01602666|464804578|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
129139576|NCT01602666|464804579|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
129139577|NCT01602666|464804578|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
129139578|NCT01602666|464804579|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
129139579|NCT01602666|464804578|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
129139580|NCT01602666|464804579|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
129139581|NCT01602666|464804578|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
129139582|NCT01602666|464804579|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
129139583|NCT01602666|464804578|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
129139584|NCT01602666|464804579|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
129139585|NCT01602666|464804578|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
129139586|NCT01602666|464804579|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
129139587|NCT01602666|464804578|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
129139588|NCT01602666|464804579|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
129139589|NCT00215657|464804584|FG000|Overall Study|Adverse Event|5|||
129139590|NCT00215657|464804585|FG001|Overall Study|Adverse Event|1|||
129139591|NCT00215657|464804586|FG002|Overall Study|Adverse Event|3|||
129139592|NCT00215657|464804587|FG003|Overall Study|Adverse Event|0|||
129139593|NCT00215657|464804588|FG004|Overall Study|Adverse Event|3|||
129139594|NCT00215657|464804589|FG005|Overall Study|Adverse Event|1|||
129139595|NCT00215657|464804590|FG006|Overall Study|Adverse Event|0|||
129139596|NCT00215657|464804591|FG007|Overall Study|Adverse Event|3|||
129139597|NCT00215657|464804584|FG000|Overall Study|Withdrawal by Subject|6|||
129139598|NCT00215657|464804585|FG001|Overall Study|Withdrawal by Subject|3|||
129139599|NCT00215657|464804586|FG002|Overall Study|Withdrawal by Subject|3|||
129139600|NCT00215657|464804587|FG003|Overall Study|Withdrawal by Subject|1|||
129139601|NCT00215657|464804588|FG004|Overall Study|Withdrawal by Subject|6|||
129139602|NCT00215657|464804589|FG005|Overall Study|Withdrawal by Subject|1|||
128723800|NCT03373383|463287227|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
128723801|NCT03373383|463287228|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
129139603|NCT00215657|464804590|FG006|Overall Study|Withdrawal by Subject|10|||
129139604|NCT00215657|464804591|FG007|Overall Study|Withdrawal by Subject|3|||
129139605|NCT00215657|464804584|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
129139606|NCT00215657|464804585|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
129139607|NCT00215657|464804586|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
129139608|NCT00215657|464804587|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
129139609|NCT00215657|464804588|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
129139610|NCT00215657|464804589|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
129139611|NCT00215657|464804590|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
129139612|NCT00215657|464804591|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
129139613|NCT00215657|464804584|FG000|Overall Study|Insufficient testosterone response|5|||
129139614|NCT00215657|464804585|FG001|Overall Study|Insufficient testosterone response|4|||
129070059|NCT04179838|464545717|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
129070060|NCT04179838|464545718|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
129070061|NCT01290068|464545723|FG000|Overall Study|Adverse Event|1|||
129070062|NCT01290068|464545724|FG001|Overall Study|Adverse Event|3|||
129070063|NCT01290068|464545723|FG000|Overall Study|Lost to Follow-up|3|||
129070064|NCT01290068|464545724|FG001|Overall Study|Lost to Follow-up|0|||
129070065|NCT01290068|464545723|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
128776508|NCT00519636|463470456|FG001|Washout Period|Failed to meet continuation criteria|11|||
129070066|NCT01290068|464545724|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
129070067|NCT01290068|464545723|FG000|Overall Study|Other|3|||
129070068|NCT01290068|464545724|FG001|Overall Study|Other|1|||
129070069|NCT01417156|464545729|FG000|Overall Study|Adverse Event|12|||
129070070|NCT01417156|464545729|FG000|Overall Study|Protocol Violation|2|||
129070071|NCT00818766|464545732|FG000|Overall Study|Could not be Contacted on Day 28|11|||
129070072|NCT00818766|464545733|FG001|Overall Study|Could not be Contacted on Day 28|10|||
129070073|NCT00818766|464545732|FG000|Overall Study|Death|1|||
129070074|NCT00818766|464545733|FG001|Overall Study|Death|0|||
129070075|NCT00818766|464545732|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
129139615|NCT00215657|464804586|FG002|Overall Study|Insufficient testosterone response|1|||
129139616|NCT00215657|464804587|FG003|Overall Study|Insufficient testosterone response|12|||
129139617|NCT00215657|464804588|FG004|Overall Study|Insufficient testosterone response|8|||
129139618|NCT00215657|464804589|FG005|Overall Study|Insufficient testosterone response|12|||
129139619|NCT00215657|464804590|FG006|Overall Study|Insufficient testosterone response|4|||
129139620|NCT00215657|464804591|FG007|Overall Study|Insufficient testosterone response|7|||
129139621|NCT00215657|464804584|FG000|Overall Study|Other|3|||
129139622|NCT00215657|464804585|FG001|Overall Study|Other|1|||
129139623|NCT00215657|464804586|FG002|Overall Study|Other|2|||
129139624|NCT00215657|464804587|FG003|Overall Study|Other|3|||
129139625|NCT00215657|464804588|FG004|Overall Study|Other|5|||
129139626|NCT00215657|464804589|FG005|Overall Study|Other|4|||
129139627|NCT00215657|464804590|FG006|Overall Study|Other|6|||
129139628|NCT00215657|464804591|FG007|Overall Study|Other|1|||
129139629|NCT03769467|464804592|FG000|Overall Study|Adverse Event|1|||
129139630|NCT03769467|464804593|FG001|Overall Study|Adverse Event|1|||
129139631|NCT03769467|464804594|FG002|Overall Study|Adverse Event|0|||
129139632|NCT03769467|464804592|FG000|Overall Study|Death|3|||
129139633|NCT03769467|464804593|FG001|Overall Study|Death|3|||
129139634|NCT03769467|464804594|FG002|Overall Study|Death|0|||
129139635|NCT03769467|464804592|FG000|Overall Study|Study Terminated By Sponsor|2|||
129139636|NCT03769467|464804593|FG001|Overall Study|Study Terminated By Sponsor|1|||
129139637|NCT03769467|464804594|FG002|Overall Study|Study Terminated By Sponsor|0|||
129139638|NCT03769467|464804592|FG000|Overall Study|Withdrawal by Subject|0|||
129139639|NCT03769467|464804593|FG001|Overall Study|Withdrawal by Subject|1|||
129139640|NCT03769467|464804594|FG002|Overall Study|Withdrawal by Subject|0|||
129139641|NCT04754399|464804595|FG000|Overall Study|Adverse Event|5|||
129139642|NCT04754399|464804595|FG000|Overall Study|Withdrawal by Subject|6|||
129139643|NCT02614066|464804596|FG000|Overall Study|Death|6|||
129139644|NCT02614066|464804597|FG001|Overall Study|Death|14|||
129139645|NCT02614066|464804598|FG002|Overall Study|Death|11|||
129139646|NCT02614066|464804599|FG003|Overall Study|Death|29|||
129139647|NCT02614066|464804596|FG000|Overall Study|Full consent withdrawn|0|||
129139648|NCT02614066|464804597|FG001|Overall Study|Full consent withdrawn|1|||
129139649|NCT02614066|464804598|FG002|Overall Study|Full consent withdrawn|0|||
129139650|NCT02614066|464804599|FG003|Overall Study|Full consent withdrawn|8|||
129139651|NCT02614066|464804596|FG000|Overall Study|Lost to Follow-up|0|||
129139652|NCT02614066|464804597|FG001|Overall Study|Lost to Follow-up|2|||
129139653|NCT02614066|464804598|FG002|Overall Study|Lost to Follow-up|2|||
129139654|NCT02614066|464804599|FG003|Overall Study|Lost to Follow-up|2|||
129139655|NCT02614066|464804596|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
129139656|NCT02614066|464804597|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
129139657|NCT02614066|464804598|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
129139658|NCT02614066|464804599|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
129139659|NCT02614066|464804596|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
129139660|NCT02614066|464804597|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
129139661|NCT02614066|464804598|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
129139662|NCT02614066|464804599|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
129139663|NCT02614066|464804596|FG000|Overall Study|Reason not specified|0|||
129139664|NCT02614066|464804597|FG001|Overall Study|Reason not specified|2|||
129139665|NCT02614066|464804598|FG002|Overall Study|Reason not specified|1|||
129139666|NCT02614066|464804599|FG003|Overall Study|Reason not specified|1|||
129139667|NCT04565756|464804600|FG000|Overall Study|Withdrawal by Subject|0|||
129139668|NCT04565756|464804601|FG001|Overall Study|Withdrawal by Subject|0|||
129139669|NCT04565756|464804602|FG002|Overall Study|Withdrawal by Subject|0|||
129139670|NCT04565756|464804603|FG003|Overall Study|Withdrawal by Subject|0|||
129070076|NCT00818766|464545733|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
129070077|NCT01996241|464545735|FG000|Overall Study|Lost to Follow-up|252|||
129070078|NCT01996241|464545736|FG001|Overall Study|Lost to Follow-up|235|||
129070079|NCT00086684|464545737|FG000|Overall Study|Adverse Event|12|||
129070080|NCT00086684|464545738|FG001|Overall Study|Adverse Event|17|||
129070081|NCT00086684|464545739|FG002|Overall Study|Adverse Event|14|||
129070082|NCT00086684|464545737|FG000|Overall Study|Lack of Efficacy|6|||
129070083|NCT00086684|464545738|FG001|Overall Study|Lack of Efficacy|6|||
129070084|NCT00086684|464545739|FG002|Overall Study|Lack of Efficacy|5|||
129070085|NCT00086684|464545737|FG000|Overall Study|Lost to Follow-up|15|||
129070086|NCT00086684|464545738|FG001|Overall Study|Lost to Follow-up|8|||
129070087|NCT00086684|464545739|FG002|Overall Study|Lost to Follow-up|10|||
129070088|NCT00086684|464545737|FG000|Overall Study|Protocol Violation|8|||
129070089|NCT00086684|464545738|FG001|Overall Study|Protocol Violation|3|||
129070090|NCT00086684|464545739|FG002|Overall Study|Protocol Violation|0|||
129070091|NCT00086684|464545737|FG000|Overall Study|Withdrawal by Subject|0|||
129070092|NCT00086684|464545738|FG001|Overall Study|Withdrawal by Subject|4|||
129139671|NCT04565756|464804604|FG004|Overall Study|Withdrawal by Subject|1|||
129139672|NCT04565756|464804605|FG005|Overall Study|Withdrawal by Subject|0|||
129139673|NCT04565756|464804600|FG000|Overall Study|Protocol Violation|0|||
129070093|NCT00086684|464545739|FG002|Overall Study|Withdrawal by Subject|10|||
129070094|NCT00086684|464545737|FG000|Overall Study|NONCOMPLIANCE|5|||
129070095|NCT00086684|464545738|FG001|Overall Study|NONCOMPLIANCE|7|||
129070096|NCT00086684|464545739|FG002|Overall Study|NONCOMPLIANCE|6|||
129070097|NCT00086684|464545737|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129070098|NCT00086684|464545738|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
129070099|NCT00086684|464545739|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129070100|NCT00086684|464545737|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
129139674|NCT04565756|464804601|FG001|Overall Study|Protocol Violation|0|||
129139675|NCT04565756|464804602|FG002|Overall Study|Protocol Violation|0|||
129139676|NCT04565756|464804603|FG003|Overall Study|Protocol Violation|0|||
129139677|NCT04565756|464804604|FG004|Overall Study|Protocol Violation|0|||
129139678|NCT04565756|464804605|FG005|Overall Study|Protocol Violation|1|||
129139679|NCT03069937|464804614|FG000|Overall Study|Second primary malignancy noted|1|||
129139680|NCT00231465|464804615|FG000|Overall Study|Completed only one cycle|1|||
129139681|NCT00231465|464804615|FG000|Overall Study|Did not have follow up CT scans|1|||
129139682|NCT00968968|464804616|FG000|Overall Study|Study closed/terminated|10|||
129139683|NCT00968968|464804617|FG001|Overall Study|Study closed/terminated|10|||
129139684|NCT00968968|464804616|FG000|Overall Study|Protocol defined stopping criteria|3|||
129139685|NCT00968968|464804617|FG001|Overall Study|Protocol defined stopping criteria|1|||
129139686|NCT00968968|464804616|FG000|Overall Study|Withdrawal by Subject|2|||
129139687|NCT00968968|464804617|FG001|Overall Study|Withdrawal by Subject|0|||
129139688|NCT00968968|464804616|FG000|Overall Study|Physician Decision|1|||
129139689|NCT00968968|464804617|FG001|Overall Study|Physician Decision|2|||
129139690|NCT00968968|464804616|FG000|Overall Study|Lost to Follow-up|0|||
129139691|NCT00968968|464804617|FG001|Overall Study|Lost to Follow-up|1|||
129139692|NCT03624036|464804618|FG000|Overall Study|Death|2|||
129139693|NCT03624036|464804619|FG001|Overall Study|Death|3|||
129139694|NCT03624036|464804620|FG002|Overall Study|Death|0|||
129139695|NCT03624036|464804621|FG003|Overall Study|Death|1|||
129139696|NCT03624036|464804618|FG000|Overall Study|Withdrawal by Subject|1|||
129139697|NCT03624036|464804619|FG001|Overall Study|Withdrawal by Subject|0|||
129139698|NCT03624036|464804620|FG002|Overall Study|Withdrawal by Subject|1|||
129139699|NCT03624036|464804621|FG003|Overall Study|Withdrawal by Subject|0|||
129139700|NCT03624036|464804618|FG000|Overall Study|Enrolled but Never Treated|1|||
129139701|NCT03624036|464804619|FG001|Overall Study|Enrolled but Never Treated|0|||
129139702|NCT03624036|464804620|FG002|Overall Study|Enrolled but Never Treated|0|||
129139703|NCT03624036|464804621|FG003|Overall Study|Enrolled but Never Treated|0|||
129139704|NCT03624036|464804618|FG000|Overall Study|Reason not Specified|3|||
129139705|NCT03624036|464804619|FG001|Overall Study|Reason not Specified|0|||
129139706|NCT03624036|464804620|FG002|Overall Study|Reason not Specified|2|||
129139707|NCT03624036|464804621|FG003|Overall Study|Reason not Specified|2|||
129139708|NCT00930176|464804627|FG000|Overall Study|Death|1|||
129139709|NCT02413346|464804628|FG000|Overall Study|Adverse Event|6|||
129139710|NCT02413346|464804629|FG001|Overall Study|Adverse Event|6|||
129139711|NCT02413346|464804628|FG000|Overall Study|Withdrawal by Subject|30|||
129139712|NCT02413346|464804629|FG001|Overall Study|Withdrawal by Subject|40|||
129139713|NCT02413346|464804628|FG000|Overall Study|Lost to Follow-up|17|||
129139714|NCT02413346|464804629|FG001|Overall Study|Lost to Follow-up|21|||
129139715|NCT02413346|464804628|FG000|Overall Study|Protocol Violation|2|||
129139716|NCT02413346|464804629|FG001|Overall Study|Protocol Violation|0|||
129139717|NCT02413346|464804628|FG000|Overall Study|Other Miscellaneous Reasons|4|||
129139718|NCT02413346|464804629|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129139719|NCT00954538|464804635|FG000|Part III|Withdrawal by Subject|0|||
129139720|NCT00954538|464804636|FG001|Part III|Withdrawal by Subject|0|||
129139721|NCT00954538|464804637|FG002|Part III|Withdrawal by Subject|0|||
129139722|NCT00954538|464804638|FG003|Part III|Withdrawal by Subject|0|||
129139723|NCT00954538|464804639|FG004|Part III|Withdrawal by Subject|1|||
129139724|NCT00954538|464804640|FG005|Part III|Withdrawal by Subject|0|||
129139725|NCT01905683|464804641|FG000|Overall Study|Protocol Violation|1|||
129139726|NCT01905683|464804641|FG000|Overall Study|Re-injection criteria not met; others|13|||
129139727|NCT01905683|464804641|FG000|Overall Study|Physician Decision|1|||
129139728|NCT01905683|464804641|FG000|Overall Study|Lack of Efficacy|8|||
129139729|NCT01905683|464804641|FG000|Overall Study|Withdrawal by Subject|20|||
129139730|NCT01905683|464804641|FG000|Overall Study|Adverse Event|4|||
129139731|NCT01905683|464804641|FG000|Overall Study|Lost to Follow-up|4|||
129139732|NCT00992394|464804642|FG000|Overall Study|Lack of Efficacy|6|||
129139733|NCT00992394|464804643|FG001|Overall Study|Lack of Efficacy|3|||
129139734|NCT00992394|464804642|FG000|Overall Study|Adverse Event|4|||
129139735|NCT00992394|464804643|FG001|Overall Study|Adverse Event|5|||
129139736|NCT00992394|464804642|FG000|Overall Study|Withdrawal by Subject|8|||
129070101|NCT00086684|464545738|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
129139737|NCT00992394|464804643|FG001|Overall Study|Withdrawal by Subject|2|||
129139738|NCT00992394|464804642|FG000|Overall Study|Physician Decision|1|||
129139739|NCT00992394|464804643|FG001|Overall Study|Physician Decision|0|||
129139740|NCT00992394|464804642|FG000|Overall Study|Protocol Violation|2|||
129139741|NCT00992394|464804643|FG001|Overall Study|Protocol Violation|4|||
129070102|NCT00086684|464545739|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
129070103|NCT00086684|464545737|FG000|Overall Study|Other|4|||
129070104|NCT00086684|464545738|FG001|Overall Study|Other|2|||
129070105|NCT00086684|464545739|FG002|Overall Study|Other|3|||
129070106|NCT04515147|464545740|FG000|Overall Study|Withdrawal by Subject|1|||
129070107|NCT04515147|464545741|FG001|Overall Study|Withdrawal by Subject|0|||
129070108|NCT04515147|464545742|FG002|Overall Study|Withdrawal by Subject|10|||
129070109|NCT04515147|464545743|FG003|Overall Study|Withdrawal by Subject|18|||
129070110|NCT04515147|464545744|FG004|Overall Study|Withdrawal by Subject|1|||
129070111|NCT04515147|464545745|FG005|Overall Study|Withdrawal by Subject|8|||
129070112|NCT04515147|464545740|FG000|Overall Study|Lost to Follow-up|0|||
129070113|NCT04515147|464545741|FG001|Overall Study|Lost to Follow-up|1|||
129070114|NCT04515147|464545742|FG002|Overall Study|Lost to Follow-up|5|||
129070115|NCT04515147|464545743|FG003|Overall Study|Lost to Follow-up|6|||
129070116|NCT04515147|464545744|FG004|Overall Study|Lost to Follow-up|2|||
129070117|NCT04515147|464545745|FG005|Overall Study|Lost to Follow-up|1|||
128776509|NCT00519636|463470457|FG002|Washout Period|Failed to meet continuation criteria|9|||
129070118|NCT04515147|464545740|FG000|Overall Study|Adverse Event|0|||
129070119|NCT04515147|464545741|FG001|Overall Study|Adverse Event|0|||
129070120|NCT04515147|464545742|FG002|Overall Study|Adverse Event|0|||
129070121|NCT04515147|464545743|FG003|Overall Study|Adverse Event|2|||
129139742|NCT00992394|464804642|FG000|Overall Study|Lost to Follow-up|2|||
129139743|NCT00992394|464804643|FG001|Overall Study|Lost to Follow-up|0|||
129139744|NCT00992394|464804642|FG000|Overall Study|Other event|1|||
129139745|NCT00992394|464804643|FG001|Overall Study|Other event|0|||
129070122|NCT04515147|464545744|FG004|Overall Study|Adverse Event|0|||
129070123|NCT04515147|464545745|FG005|Overall Study|Adverse Event|0|||
129070124|NCT04515147|464545740|FG000|Overall Study|Miscellaneous|0|||
129070125|NCT04515147|464545741|FG001|Overall Study|Miscellaneous|0|||
129070126|NCT04515147|464545742|FG002|Overall Study|Miscellaneous|0|||
129070127|NCT04515147|464545743|FG003|Overall Study|Miscellaneous|1|||
129070128|NCT04515147|464545744|FG004|Overall Study|Miscellaneous|0|||
129070129|NCT04515147|464545745|FG005|Overall Study|Miscellaneous|1|||
129070130|NCT03052751|464545746|FG000|Dosing Period 1|Adverse Event|0|||
129070131|NCT03052751|464545747|FG001|Dosing Period 1|Adverse Event|1|||
129070132|NCT03052751|464545748|FG002|Dosing Period 1|Adverse Event|0|||
129070133|NCT03052751|464545749|FG003|Dosing Period 1|Adverse Event|0|||
129070134|NCT03052751|464545750|FG004|Dosing Period 1|Adverse Event|0|||
129070135|NCT03052751|464545751|FG005|Dosing Period 1|Adverse Event|0|||
129070136|NCT03052751|464545746|FG000|Dosing Period 2|Adverse Event|0|||
129070137|NCT03052751|464545747|FG001|Dosing Period 2|Adverse Event|0|||
129070138|NCT03052751|464545748|FG002|Dosing Period 2|Adverse Event|3|||
129070139|NCT03052751|464545749|FG003|Dosing Period 2|Adverse Event|0|||
129070140|NCT03052751|464545750|FG004|Dosing Period 2|Adverse Event|0|||
129070141|NCT03052751|464545751|FG005|Dosing Period 2|Adverse Event|0|||
129070142|NCT03052751|464545746|FG000|Observation Period|Adverse Event|0|||
129139746|NCT00537082|464804646|FG000|Overall Study|Adverse Event|6|||
129139747|NCT00537082|464804647|FG001|Overall Study|Adverse Event|6|||
129139748|NCT00537082|464804648|FG002|Overall Study|Adverse Event|3|||
129139749|NCT00537082|464804646|FG000|Overall Study|Protocol Violation|0|||
129139750|NCT00537082|464804647|FG001|Overall Study|Protocol Violation|2|||
129139751|NCT00537082|464804648|FG002|Overall Study|Protocol Violation|1|||
129139752|NCT00537082|464804646|FG000|Overall Study|Lack of Efficacy|0|||
129139753|NCT00537082|464804647|FG001|Overall Study|Lack of Efficacy|0|||
129139754|NCT00537082|464804648|FG002|Overall Study|Lack of Efficacy|2|||
129139755|NCT00537082|464804646|FG000|Overall Study|Withdrawal by Subject|0|||
129139756|NCT00537082|464804647|FG001|Overall Study|Withdrawal by Subject|1|||
129070143|NCT03052751|464545747|FG001|Observation Period|Adverse Event|0|||
128776510|NCT00519636|463470458|FG003|Washout Period|Failed to meet continuation criteria|3|||
129070144|NCT03052751|464545748|FG002|Observation Period|Adverse Event|0|||
129070145|NCT03052751|464545749|FG003|Observation Period|Adverse Event|0|||
129070146|NCT03052751|464545750|FG004|Observation Period|Adverse Event|1|||
129070147|NCT03052751|464545751|FG005|Observation Period|Adverse Event|0|||
129070148|NCT02719184|464545752|FG000|Overall Study|Other than listed|1|||
129139757|NCT00537082|464804648|FG002|Overall Study|Withdrawal by Subject|0|||
129139758|NCT00537082|464804646|FG000|Overall Study|Discontinued before initiating treatment|3|||
129070149|NCT02719184|464545753|FG001|Overall Study|Other than listed|12|||
129070150|NCT02719184|464545754|FG002|Overall Study|Other than listed|13|||
129070151|NCT02719184|464545755|FG003|Overall Study|Other than listed|22|||
129070152|NCT02719184|464545756|FG004|Overall Study|Other than listed|9|||
129070153|NCT02719184|464545752|FG000|Overall Study|Withdrawal by Subject|5|||
129070154|NCT02719184|464545753|FG001|Overall Study|Withdrawal by Subject|3|||
129070155|NCT02719184|464545754|FG002|Overall Study|Withdrawal by Subject|6|||
129070156|NCT02719184|464545755|FG003|Overall Study|Withdrawal by Subject|6|||
129070157|NCT02719184|464545756|FG004|Overall Study|Withdrawal by Subject|0|||
129070158|NCT02719184|464545752|FG000|Overall Study|Lost to Follow-up|0|||
129070159|NCT02719184|464545753|FG001|Overall Study|Lost to Follow-up|4|||
129070160|NCT02719184|464545754|FG002|Overall Study|Lost to Follow-up|1|||
129070161|NCT02719184|464545755|FG003|Overall Study|Lost to Follow-up|3|||
129070162|NCT02719184|464545756|FG004|Overall Study|Lost to Follow-up|0|||
129070163|NCT02719184|464545752|FG000|Overall Study|Protocol Violation|0|||
129070164|NCT02719184|464545753|FG001|Overall Study|Protocol Violation|3|||
129070165|NCT02719184|464545754|FG002|Overall Study|Protocol Violation|0|||
129070166|NCT02719184|464545755|FG003|Overall Study|Protocol Violation|2|||
129070167|NCT02719184|464545756|FG004|Overall Study|Protocol Violation|0|||
129070168|NCT02719184|464545752|FG000|Overall Study|Adverse Event|0|||
128776511|NCT00519636|463470455|FG000|Washout Period|Out of pollen area > 48 hours|1|||
129070169|NCT02719184|464545753|FG001|Overall Study|Adverse Event|0|||
129070170|NCT02719184|464545754|FG002|Overall Study|Adverse Event|0|||
128723802|NCT03373383|463287229|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
128723803|NCT03373383|463287230|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
128723804|NCT03373383|463287226|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
128723805|NCT03373383|463287227|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
128723806|NCT03373383|463287228|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
128723807|NCT03373383|463287229|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
128723808|NCT03373383|463287230|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
128723809|NCT03818516|463287236|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
128723810|NCT04372602|463287237|FG000|Overall Study|Withdrawal by Subject|1|||
128723811|NCT04372602|463287238|FG001|Overall Study|Withdrawal by Subject|1|||
128723812|NCT04372602|463287237|FG000|Overall Study|Adverse Event|0|||
128723813|NCT04372602|463287238|FG001|Overall Study|Adverse Event|1|||
128723814|NCT04372602|463287237|FG000|Overall Study|Transitioned to comfort care|0|||
128723815|NCT04372602|463287238|FG001|Overall Study|Transitioned to comfort care|1|||
128723816|NCT04371380|463287239|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
128723817|NCT04371380|463287240|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
128723818|NCT04371380|463287241|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
128723819|NCT01951157|463287244|FG000|Overall Study|Progressive Disease|12|||
128723820|NCT01951157|463287245|FG001|Overall Study|Progressive Disease|13|||
128776512|NCT00519636|463470456|FG001|Washout Period|Out of pollen area > 48 hours|0|||
129070171|NCT02719184|464545755|FG003|Overall Study|Adverse Event|3|||
129070172|NCT02719184|464545756|FG004|Overall Study|Adverse Event|0|||
129070173|NCT02439216|464545757|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
129070174|NCT02439216|464545758|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070175|NCT02439216|464545759|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070176|NCT02439216|464545760|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070177|NCT02439216|464545761|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070178|NCT02439216|464545762|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070179|NCT02439216|464545763|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070180|NCT02439216|464545764|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070181|NCT02439216|464545765|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129070182|NCT02439216|464545757|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070183|NCT02439216|464545758|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070184|NCT02439216|464545759|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070185|NCT02439216|464545760|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070186|NCT02439216|464545761|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070187|NCT02439216|464545762|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070188|NCT02439216|464545763|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070189|NCT02439216|464545764|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
129070190|NCT02439216|464545765|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129070191|NCT02439216|464545757|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129070192|NCT02439216|464545758|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129070193|NCT02439216|464545759|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129070194|NCT02439216|464545760|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129070195|NCT02439216|464545761|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129070196|NCT02439216|464545762|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129070197|NCT02439216|464545763|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129070198|NCT02439216|464545764|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
129070199|NCT02439216|464545765|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
129070200|NCT02439216|464545757|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070201|NCT02439216|464545758|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070202|NCT02439216|464545759|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070203|NCT02439216|464545760|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070204|NCT02439216|464545761|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070205|NCT02439216|464545762|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070206|NCT02439216|464545763|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070207|NCT02439216|464545764|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129070208|NCT02439216|464545765|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
129070209|NCT02439216|464545757|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129070210|NCT02439216|464545758|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129070211|NCT02439216|464545759|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129070212|NCT02439216|464545760|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129070213|NCT02439216|464545761|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129070214|NCT02439216|464545762|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129070215|NCT02439216|464545763|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129070216|NCT02439216|464545764|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
129070217|NCT02439216|464545765|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
129070218|NCT02094300|464545770|FG000|Overall Study|Death|7|||
129070219|NCT02094300|464545770|FG000|Overall Study|Lost to Follow-up|10|||
129070220|NCT02094300|464545770|FG000|Overall Study|Still be eligible for follow-up|3|||
129070221|NCT00725491|464545777|FG000|Overall Study|Adverse Event|3|||
129070222|NCT00725491|464545778|FG001|Overall Study|Adverse Event|2|||
129070223|NCT00725491|464545777|FG000|Overall Study|Pregnancy|0|||
129070224|NCT00725491|464545778|FG001|Overall Study|Pregnancy|3|||
129070225|NCT00725491|464545777|FG000|Overall Study|Risk for hyperstimulation|2|||
129070226|NCT00725491|464545778|FG001|Overall Study|Risk for hyperstimulation|9|||
129070227|NCT00725491|464545777|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
129070228|NCT00725491|464545778|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
129070229|NCT00725491|464545777|FG000|Overall Study|Fertilization failure|0|||
129070230|NCT00725491|464545778|FG001|Overall Study|Fertilization failure|1|||
129070231|NCT00725491|464545777|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
129070232|NCT00725491|464545778|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
129070233|NCT00882518|464545790|FG000|Overall Study|Adverse Event|9|||
129070234|NCT00882518|464545791|FG001|Overall Study|Adverse Event|18|||
129070235|NCT00882518|464545790|FG000|Overall Study|Withdrawal by Subject|9|||
129070236|NCT00882518|464545791|FG001|Overall Study|Withdrawal by Subject|13|||
129070237|NCT00882518|464545790|FG000|Overall Study|Lack of Efficacy|12|||
129070238|NCT00882518|464545791|FG001|Overall Study|Lack of Efficacy|9|||
128723821|NCT01951157|463287246|FG002|Overall Study|Progressive Disease|10|||
128723822|NCT01951157|463287244|FG000|Overall Study|Treatment-unrelated AE|1|||
128723823|NCT01951157|463287245|FG001|Overall Study|Treatment-unrelated AE|0|||
128723824|NCT01951157|463287246|FG002|Overall Study|Treatment-unrelated AE|3|||
128723825|NCT01951157|463287244|FG000|Overall Study|Study Termination|0|||
128723826|NCT01951157|463287245|FG001|Overall Study|Study Termination|0|||
128723827|NCT01951157|463287246|FG002|Overall Study|Study Termination|1|||
128723828|NCT01951157|463287244|FG000|Overall Study|Physician Decision|5|||
128723829|NCT01951157|463287245|FG001|Overall Study|Physician Decision|3|||
128723830|NCT01951157|463287246|FG002|Overall Study|Physician Decision|2|||
128723831|NCT01951157|463287244|FG000|Overall Study|Non-treatmentrelated death|2|||
128723832|NCT01951157|463287245|FG001|Overall Study|Non-treatmentrelated death|2|||
128723833|NCT01951157|463287246|FG002|Overall Study|Non-treatmentrelated death|2|||
128723834|NCT01951157|463287244|FG000|Overall Study|No treated|0|||
128723835|NCT01951157|463287245|FG001|Overall Study|No treated|1|||
128723836|NCT01951157|463287246|FG002|Overall Study|No treated|0|||
128723837|NCT01951157|463287244|FG000|Overall Study|Treatment-related AE|2|||
128723838|NCT01951157|463287245|FG001|Overall Study|Treatment-related AE|0|||
128723839|NCT01951157|463287246|FG002|Overall Study|Treatment-related AE|4|||
128723840|NCT01951157|463287244|FG000|Overall Study|Consent withdrawn by subject|0|||
128723841|NCT01951157|463287245|FG001|Overall Study|Consent withdrawn by subject|1|||
128723842|NCT01951157|463287246|FG002|Overall Study|Consent withdrawn by subject|3|||
128723843|NCT01951157|463287244|FG000|Overall Study|Treatment-related death|0|||
128723844|NCT01951157|463287245|FG001|Overall Study|Treatment-related death|2|||
128723845|NCT01951157|463287246|FG002|Overall Study|Treatment-related death|0|||
128723846|NCT04809220|463287247|FG000|Overall Study|Adverse Event|4|||
128723847|NCT04809220|463287248|FG001|Overall Study|Adverse Event|0|||
128723848|NCT04809220|463287247|FG000|Overall Study|Death|1|||
128723849|NCT04809220|463287248|FG001|Overall Study|Death|0|||
128723850|NCT04809220|463287247|FG000|Overall Study|Lost to Follow-up|3|||
128723851|NCT04809220|463287248|FG001|Overall Study|Lost to Follow-up|0|||
128723852|NCT04809220|463287247|FG000|Overall Study|Physician Decision|0|||
128723853|NCT04809220|463287248|FG001|Overall Study|Physician Decision|1|||
128723854|NCT04809220|463287247|FG000|Overall Study|Withdrawal by Subject|9|||
128723855|NCT04809220|463287248|FG001|Overall Study|Withdrawal by Subject|5|||
128723856|NCT04809220|463287247|FG000|Overall Study|Due to long-term overseas business trips|1|||
128723857|NCT04809220|463287248|FG001|Overall Study|Due to long-term overseas business trips|0|||
128723858|NCT01062555|463287254|FG000|Phase 1|Death|10|||
128723859|NCT01062555|463287255|FG001|Phase 1|Death|17|||
128723860|NCT01062555|463287256|FG002|Phase 1|Death|0|||
128723861|NCT01062555|463287257|FG003|Phase 1|Death|0|||
128723862|NCT01062555|463287254|FG000|Phase 1|Graft Failure|12|||
128723863|NCT01062555|463287255|FG001|Phase 1|Graft Failure|8|||
128723864|NCT01062555|463287256|FG002|Phase 1|Graft Failure|0|||
128723865|NCT01062555|463287257|FG003|Phase 1|Graft Failure|0|||
128723866|NCT01062555|463287254|FG000|Phase 1|Withdrawal by Subject|1|||
128723867|NCT01062555|463287255|FG001|Phase 1|Withdrawal by Subject|1|||
128723868|NCT01062555|463287256|FG002|Phase 1|Withdrawal by Subject|0|||
128723869|NCT01062555|463287257|FG003|Phase 1|Withdrawal by Subject|0|||
128723870|NCT01062555|463287254|FG000|Phase 2|Death|0|||
128723871|NCT01062555|463287255|FG001|Phase 2|Death|0|||
128723872|NCT01062555|463287256|FG002|Phase 2|Death|8|||
128723873|NCT01062555|463287257|FG003|Phase 2|Death|3|||
128723874|NCT01062555|463287254|FG000|Phase 2|Graft failure|0|||
128723875|NCT01062555|463287255|FG001|Phase 2|Graft failure|0|||
128723876|NCT01062555|463287256|FG002|Phase 2|Graft failure|7|||
128723877|NCT01062555|463287257|FG003|Phase 2|Graft failure|4|||
128723878|NCT01062555|463287254|FG000|Phase 2|Withdrawal by Subject|0|||
128723879|NCT01062555|463287255|FG001|Phase 2|Withdrawal by Subject|0|||
128723880|NCT01062555|463287256|FG002|Phase 2|Withdrawal by Subject|0|||
128723881|NCT01062555|463287257|FG003|Phase 2|Withdrawal by Subject|7|||
128723882|NCT01062555|463287254|FG000|Phase 2|Protocol Violation|0|||
128723883|NCT01062555|463287255|FG001|Phase 2|Protocol Violation|0|||
128723884|NCT01062555|463287256|FG002|Phase 2|Protocol Violation|0|||
128723885|NCT01062555|463287257|FG003|Phase 2|Protocol Violation|3|||
128723886|NCT01062555|463287254|FG000|Phase 2|Physician Decision|0|||
128723887|NCT01062555|463287255|FG001|Phase 2|Physician Decision|0|||
129139759|NCT00537082|464804647|FG001|Overall Study|Discontinued before initiating treatment|0|||
129139760|NCT00537082|464804648|FG002|Overall Study|Discontinued before initiating treatment|0|||
129139761|NCT02568254|464804650|FG000|Period 2|Adverse Event|0|||
129139762|NCT02568254|464804651|FG001|Period 2|Adverse Event|0|||
129139763|NCT02568254|464804652|FG002|Period 2|Adverse Event|1|||
129139764|NCT02568254|464804653|FG003|Period 2|Adverse Event|0|||
129139765|NCT02568254|464804654|FG004|Period 2|Adverse Event|0|||
129139766|NCT02568254|464804655|FG005|Period 2|Adverse Event|0|||
129139767|NCT02568254|464804650|FG000|Period 3|Unstatisfactory Lens fitting|0|||
129139768|NCT02568254|464804651|FG001|Period 3|Unstatisfactory Lens fitting|0|||
129139769|NCT02568254|464804652|FG002|Period 3|Unstatisfactory Lens fitting|0|||
129139770|NCT02568254|464804653|FG003|Period 3|Unstatisfactory Lens fitting|0|||
129139771|NCT02568254|464804654|FG004|Period 3|Unstatisfactory Lens fitting|1|||
129139772|NCT02568254|464804655|FG005|Period 3|Unstatisfactory Lens fitting|0|||
129139773|NCT02931539|464804656|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
129139774|NCT02931539|464804657|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
129139775|NCT02931539|464804658|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
128723888|NCT01062555|463287256|FG002|Phase 2|Physician Decision|0|||
128723889|NCT01062555|463287257|FG003|Phase 2|Physician Decision|17|||
129070239|NCT00882518|464545790|FG000|Overall Study|Severe non-compliance to protocol|3|||
129070240|NCT00882518|464545791|FG001|Overall Study|Severe non-compliance to protocol|1|||
129070241|NCT00882518|464545790|FG000|Overall Study|Incorrect enrolment|4|||
129070242|NCT00882518|464545791|FG001|Overall Study|Incorrect enrolment|2|||
129070243|NCT00882518|464545790|FG000|Overall Study|Central lab closure for National day|1|||
129070244|NCT00882518|464545791|FG001|Overall Study|Central lab closure for National day|0|||
129070245|NCT00882518|464545790|FG000|Overall Study|Allocating random number by mistake|0|||
129070246|NCT00882518|464545791|FG001|Overall Study|Allocating random number by mistake|1|||
129070247|NCT02137252|464545792|FG000|Overall Study|trial terminated early|2|||
129070248|NCT02137252|464545793|FG001|Overall Study|trial terminated early|1|||
129070249|NCT04620746|464545795|FG000|Overall Study|Adverse Event|2|||
129139776|NCT02931539|464804656|FG000|Period 1: Treatment Phase|Adverse Event|5|||
128723890|NCT00978068|463287260|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
128723891|NCT00978068|463287261|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
128723892|NCT00978068|463287260|FG000|Overall Study|Death|1|||
129139777|NCT02931539|464804657|FG001|Period 1: Treatment Phase|Adverse Event|1|||
129139778|NCT02931539|464804658|FG002|Period 1: Treatment Phase|Adverse Event|0|||
129139779|NCT02931539|464804656|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
129139780|NCT02931539|464804657|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
129139781|NCT02931539|464804658|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
129139782|NCT02931539|464804656|FG000|Period 1: Treatment Phase|Death|8|||
129139783|NCT02931539|464804657|FG001|Period 1: Treatment Phase|Death|24|||
128723893|NCT00978068|463287261|FG001|Overall Study|Death|2|||
128723894|NCT00978068|463287260|FG000|Overall Study|Lost to Follow-up|1|||
129070250|NCT04620746|464545796|FG001|Overall Study|Adverse Event|0|||
129139784|NCT02931539|464804658|FG002|Period 1: Treatment Phase|Death|0|||
129139785|NCT02931539|464804656|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
129139786|NCT02931539|464804657|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
129139787|NCT02931539|464804658|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
129139788|NCT02931539|464804656|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
129139789|NCT02931539|464804657|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
129139790|NCT02931539|464804658|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
129139791|NCT02931539|464804656|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
129139792|NCT02931539|464804657|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
129139793|NCT02931539|464804658|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
129139794|NCT02931539|464804656|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
129139795|NCT02931539|464804657|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
129139796|NCT02931539|464804658|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
129139797|NCT00655746|464804659|FG000|Overall Study|Withdrawal by Subject|1|||
129139798|NCT03178942|464804662|FG000|Overall Study|Withdrawal by Subject|2|||
129139799|NCT03178942|464804663|FG001|Overall Study|Withdrawal by Subject|0|||
129139800|NCT03178942|464804662|FG000|Overall Study|Lost to Follow-up|1|||
129139801|NCT03178942|464804663|FG001|Overall Study|Lost to Follow-up|2|||
129139802|NCT03061214|464804668|FG000|Overall Study|Withdrawal by Subject|21|||
129139803|NCT03061214|464804669|FG001|Overall Study|Withdrawal by Subject|26|||
129139804|NCT03061214|464804670|FG002|Overall Study|Withdrawal by Subject|9|||
129139805|NCT03061214|464804668|FG000|Overall Study|Lost to Follow-up|3|||
129139806|NCT03061214|464804669|FG001|Overall Study|Lost to Follow-up|1|||
129139807|NCT03061214|464804670|FG002|Overall Study|Lost to Follow-up|1|||
129139808|NCT03061214|464804668|FG000|Overall Study|Death|1|||
129139809|NCT03061214|464804669|FG001|Overall Study|Death|1|||
129139810|NCT03061214|464804670|FG002|Overall Study|Death|0|||
129139811|NCT03810365|464806716|FG000|Overall Study|Lost to Follow-up|2|||
129139812|NCT03810365|464806717|FG001|Overall Study|Lost to Follow-up|2|||
129139813|NCT03810365|464806716|FG000|Overall Study|Withdrawal by Subject|4|||
129139814|NCT03810365|464806717|FG001|Overall Study|Withdrawal by Subject|5|||
129139815|NCT00107614|464806724|FG000|Overall Study|Physician Decision|10|||
129139816|NCT00107614|464806724|FG000|Overall Study|Death|2|||
129139817|NCT02402907|464806731|FG000|Overall Study|Delivered vaginally|9|||
129139818|NCT02402907|464806732|FG001|Overall Study|Delivered vaginally|3|||
129139819|NCT02402907|464806731|FG000|Overall Study|Delivered outside of Sinai|1|||
129139820|NCT02402907|464806732|FG001|Overall Study|Delivered outside of Sinai|1|||
129139821|NCT02402907|464806731|FG000|Overall Study|Lost to follow up after C-Section|10|||
129139822|NCT02402907|464806732|FG001|Overall Study|Lost to follow up after C-Section|23|||
129139823|NCT02094885|464806735|FG000|Overall Study|Death|1|||
129139824|NCT02094885|464806736|FG001|Overall Study|Death|5|||
129139825|NCT02094885|464806735|FG000|Overall Study|Withdrawn due to age|1|||
129139826|NCT02094885|464806736|FG001|Overall Study|Withdrawn due to age|0|||
129139827|NCT03707821|464806739|FG000|Overall Study|Protocol Violation|0|||
129139828|NCT03707821|464806740|FG001|Overall Study|Protocol Violation|1|||
129139829|NCT03707821|464806739|FG000|Overall Study|Unsatisfactory Visual Response|1|||
129139830|NCT03707821|464806740|FG001|Overall Study|Unsatisfactory Visual Response|0|||
129139831|NCT03707821|464806739|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
129139832|NCT03707821|464806740|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
129139833|NCT00215553|464806745|FG000|Overall Study|Adverse Event|0|||
129139834|NCT00215553|464806746|FG001|Overall Study|Adverse Event|1|||
129139835|NCT00215553|464806747|FG002|Overall Study|Adverse Event|2|||
129139836|NCT00215553|464806748|FG003|Overall Study|Adverse Event|1|||
129139837|NCT00215553|464806749|FG004|Overall Study|Adverse Event|2|||
129139838|NCT00215553|464806750|FG005|Overall Study|Adverse Event|6|||
129139839|NCT00215553|464806751|FG006|Overall Study|Adverse Event|0|||
129139840|NCT00756314|464806752|FG000|Overall Study|Lost to Follow-up|2|||
129139841|NCT00756314|464806753|FG001|Overall Study|Lost to Follow-up|59|||
129139842|NCT02605967|464806755|FG000|Overall Study|subject / guardian decision|1|||
129139843|NCT02605967|464806756|FG001|Overall Study|subject / guardian decision|2|||
129139844|NCT02605967|464806755|FG000|Overall Study|Physician Decision|10|||
129139845|NCT02605967|464806756|FG001|Overall Study|Physician Decision|1|||
129139846|NCT02605967|464806755|FG000|Overall Study|Death|4|||
129139847|NCT02605967|464806756|FG001|Overall Study|Death|2|||
129139848|NCT02605967|464806755|FG000|Overall Study|Adverse Event|1|||
129139849|NCT02605967|464806756|FG001|Overall Study|Adverse Event|0|||
129139850|NCT02605967|464806755|FG000|Overall Study|progressive disease|66|||
129139851|NCT02605967|464806756|FG001|Overall Study|progressive disease|35|||
129139852|NCT00159874|464806762|FG000|Overall Study|Adverse Event|2|||
129139853|NCT00159874|464806763|FG001|Overall Study|Adverse Event|2|||
129139854|NCT00159874|464806764|FG002|Overall Study|Adverse Event|5|||
128776513|NCT00519636|463470457|FG002|Washout Period|Out of pollen area > 48 hours|0|||
128776514|NCT00519636|463470458|FG003|Washout Period|Out of pollen area > 48 hours|0|||
129070251|NCT04620746|464545795|FG000|Overall Study|Uniterpretable skin test|1|||
129070252|NCT04620746|464545796|FG001|Overall Study|Uniterpretable skin test|0|||
129070253|NCT04620746|464545795|FG000|Overall Study|Withdrawal by Subject|0|||
129070254|NCT04620746|464545796|FG001|Overall Study|Withdrawal by Subject|1|||
129070255|NCT03411863|464545797|FG000|Overall Study|Withdrawal by Subject|3|||
129070256|NCT03411863|464545798|FG001|Overall Study|Withdrawal by Subject|1|||
129070257|NCT03411863|464545797|FG000|Overall Study|Physician Decision|0|||
129070258|NCT03411863|464545798|FG001|Overall Study|Physician Decision|1|||
129070259|NCT04583735|464545799|FG000|Double-masked Treatment Period|Adverse Event|0|||
129070260|NCT04583735|464545800|FG001|Double-masked Treatment Period|Adverse Event|1|||
129070261|NCT04583735|464545799|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
129070262|NCT04583735|464545800|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
129070263|NCT04583735|464545799|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
129070264|NCT04583735|464545800|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
129070265|NCT04583735|464545799|FG000|Open-label Treatment Period|Adverse Event|1|||
129070266|NCT04583735|464545800|FG001|Open-label Treatment Period|Adverse Event|1|||
129070267|NCT04583735|464545799|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
129070268|NCT04583735|464545800|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129070269|NCT04583735|464545799|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129070270|NCT04583735|464545800|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
129070271|NCT00124917|464545801|FG000|Overall Study|Physician Decision|3|||
129070272|NCT04421131|464545804|FG000|Overall Study|Lost to Follow-up|1|||
129070273|NCT04421131|464545804|FG000|Overall Study|Protocol Violation|2|||
129070274|NCT04421131|464545804|FG000|Overall Study|App crashed|5|||
129070275|NCT00729937|464545805|FG000|Overall Study|Lost to Follow-up|49|||
129070276|NCT00729937|464545806|FG001|Overall Study|Lost to Follow-up|58|||
129070277|NCT00729937|464545807|FG002|Overall Study|Lost to Follow-up|18|||
129070278|NCT00729937|464545808|FG003|Overall Study|Lost to Follow-up|33|||
129070279|NCT00729937|464545809|FG004|Overall Study|Lost to Follow-up|18|||
129070280|NCT00729937|464545810|FG005|Overall Study|Lost to Follow-up|23|||
129070281|NCT00729937|464545805|FG000|Overall Study|Physician Decision|7|||
129070282|NCT00729937|464545806|FG001|Overall Study|Physician Decision|16|||
129070283|NCT00729937|464545807|FG002|Overall Study|Physician Decision|2|||
129070284|NCT00729937|464545808|FG003|Overall Study|Physician Decision|0|||
129070285|NCT00729937|464545809|FG004|Overall Study|Physician Decision|5|||
129070286|NCT00729937|464545810|FG005|Overall Study|Physician Decision|8|||
129070287|NCT00729937|464545805|FG000|Overall Study|Death|1|||
129070288|NCT00729937|464545806|FG001|Overall Study|Death|0|||
129070289|NCT00729937|464545807|FG002|Overall Study|Death|1|||
129070290|NCT00729937|464545808|FG003|Overall Study|Death|0|||
129070291|NCT00729937|464545809|FG004|Overall Study|Death|0|||
129070292|NCT00729937|464545810|FG005|Overall Study|Death|1|||
129070293|NCT00729937|464545805|FG000|Overall Study|Withdrawal by Subject|3|||
129070294|NCT00729937|464545806|FG001|Overall Study|Withdrawal by Subject|5|||
129070295|NCT00729937|464545807|FG002|Overall Study|Withdrawal by Subject|6|||
129070296|NCT00729937|464545808|FG003|Overall Study|Withdrawal by Subject|0|||
129070297|NCT00729937|464545809|FG004|Overall Study|Withdrawal by Subject|4|||
129070298|NCT00729937|464545810|FG005|Overall Study|Withdrawal by Subject|2|||
129070299|NCT00729937|464545805|FG000|Overall Study|Randomized but not treated|12|||
129070300|NCT00729937|464545806|FG001|Overall Study|Randomized but not treated|6|||
129070301|NCT00729937|464545807|FG002|Overall Study|Randomized but not treated|1|||
129070302|NCT00729937|464545808|FG003|Overall Study|Randomized but not treated|0|||
129070303|NCT00729937|464545809|FG004|Overall Study|Randomized but not treated|1|||
129070304|NCT00729937|464545810|FG005|Overall Study|Randomized but not treated|3|||
129070305|NCT00729937|464545805|FG000|Overall Study|Did not meet eligibility criteria|2|||
129070306|NCT00729937|464545806|FG001|Overall Study|Did not meet eligibility criteria|1|||
129070307|NCT00729937|464545807|FG002|Overall Study|Did not meet eligibility criteria|0|||
129070308|NCT00729937|464545808|FG003|Overall Study|Did not meet eligibility criteria|0|||
128723895|NCT00978068|463287261|FG001|Overall Study|Lost to Follow-up|2|||
129070309|NCT00729937|464545809|FG004|Overall Study|Did not meet eligibility criteria|0|||
129070310|NCT00729937|464545810|FG005|Overall Study|Did not meet eligibility criteria|0|||
129070311|NCT00729937|464545805|FG000|Overall Study|Incarcerated|0|||
128723896|NCT00978068|463287260|FG000|Overall Study|Physician Decision|0|||
128723897|NCT00978068|463287261|FG001|Overall Study|Physician Decision|1|||
129070312|NCT00729937|464545806|FG001|Overall Study|Incarcerated|2|||
129070313|NCT00729937|464545807|FG002|Overall Study|Incarcerated|1|||
129070314|NCT00729937|464545808|FG003|Overall Study|Incarcerated|1|||
129070315|NCT00729937|464545809|FG004|Overall Study|Incarcerated|0|||
129070316|NCT00729937|464545810|FG005|Overall Study|Incarcerated|0|||
129070317|NCT00243412|464545812|FG000|Overall Study|Death|0|||
129070318|NCT00243412|464545813|FG001|Overall Study|Death|1|||
129070319|NCT00243412|464545812|FG000|Overall Study|Adverse Event|4|||
129070320|NCT00243412|464545813|FG001|Overall Study|Adverse Event|2|||
129070321|NCT00243412|464545812|FG000|Overall Study|Lost to Follow-up|0|||
129070322|NCT00243412|464545813|FG001|Overall Study|Lost to Follow-up|1|||
129070323|NCT00243412|464545812|FG000|Overall Study|Physician Decision|1|||
129070324|NCT00243412|464545813|FG001|Overall Study|Physician Decision|1|||
129070325|NCT00243412|464545812|FG000|Overall Study|Withdrawal by Subject|4|||
129070326|NCT00243412|464545813|FG001|Overall Study|Withdrawal by Subject|5|||
129070327|NCT00243412|464545812|FG000|Overall Study|Other|1|||
129070328|NCT00243412|464545813|FG001|Overall Study|Other|1|||
129070329|NCT03281876|464545821|FG000|Overall Study|Adverse Event|4|||
129070330|NCT03281876|464545822|FG001|Overall Study|Adverse Event|15|||
129070331|NCT03281876|464545821|FG000|Overall Study|Lost to Follow-up|1|||
129070332|NCT03281876|464545822|FG001|Overall Study|Lost to Follow-up|4|||
129070333|NCT03281876|464545821|FG000|Overall Study|Withdrawal by Subject|11|||
129070334|NCT03281876|464545822|FG001|Overall Study|Withdrawal by Subject|15|||
129070335|NCT03281876|464545821|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129070336|NCT03281876|464545822|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129070337|NCT03281876|464545821|FG000|Overall Study|OTHER|5|||
129070338|NCT03281876|464545822|FG001|Overall Study|OTHER|5|||
129070339|NCT02208089|464545823|FG000|Overall Study|Withdrawal by Subject|1|||
129070340|NCT02208089|464545824|FG001|Overall Study|Withdrawal by Subject|0|||
129070341|NCT02208089|464545823|FG000|Overall Study|Lost to Follow-up|6|||
129070342|NCT02208089|464545824|FG001|Overall Study|Lost to Follow-up|0|||
129070343|NCT00683657|464545828|FG000|Overall Study|Adverse Event|0|||
129070344|NCT00683657|464545829|FG001|Overall Study|Adverse Event|1|||
129070345|NCT00683657|464545828|FG000|Overall Study|Subject Withdrew Consent|1|||
129070346|NCT00683657|464545829|FG001|Overall Study|Subject Withdrew Consent|0|||
129070347|NCT01408043|464545834|FG000|Overall Study|unable to collect cells|1|||
129070348|NCT02586155|464545835|FG000|Overall Study|Adverse Event|2|||
129070349|NCT02586155|464545836|FG001|Overall Study|Adverse Event|3|||
129139855|NCT00159874|464806765|FG003|Overall Study|Adverse Event|1|||
129139856|NCT00159874|464806766|FG004|Overall Study|Adverse Event|1|||
129139857|NCT00159874|464806767|FG005|Overall Study|Adverse Event|2|||
129139858|NCT00159874|464806768|FG006|Overall Study|Adverse Event|0|||
129139859|NCT00159874|464806762|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
129139860|NCT00159874|464806763|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
129139861|NCT00159874|464806764|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
129139862|NCT00159874|464806765|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
129139863|NCT00159874|464806766|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
129139864|NCT00159874|464806767|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
129139865|NCT00159874|464806768|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
129139866|NCT00159874|464806762|FG000|Overall Study|Lack of Efficacy|2|||
129139867|NCT00159874|464806763|FG001|Overall Study|Lack of Efficacy|0|||
129139868|NCT00159874|464806764|FG002|Overall Study|Lack of Efficacy|1|||
129139869|NCT00159874|464806765|FG003|Overall Study|Lack of Efficacy|1|||
129139870|NCT00159874|464806766|FG004|Overall Study|Lack of Efficacy|0|||
129139871|NCT00159874|464806767|FG005|Overall Study|Lack of Efficacy|3|||
128723898|NCT00978068|463287260|FG000|Overall Study|Unable to Comply with Study|0|||
129070350|NCT02586155|464545835|FG000|Overall Study|Withdrawal by Subject|31|||
129070351|NCT02586155|464545836|FG001|Overall Study|Withdrawal by Subject|24|||
129070352|NCT02586155|464545835|FG000|Overall Study|Lost to Follow-up|7|||
129070353|NCT02586155|464545836|FG001|Overall Study|Lost to Follow-up|13|||
129070354|NCT02586155|464545835|FG000|Overall Study|Death|61|||
129070355|NCT02586155|464545836|FG001|Overall Study|Death|72|||
129070356|NCT02586155|464545835|FG000|Overall Study|Other reasons|26|||
129070357|NCT02586155|464545836|FG001|Overall Study|Other reasons|15|||
129070358|NCT00972595|464545837|FG000|Period 1|Adverse Event|1|||
128723899|NCT00978068|463287261|FG001|Overall Study|Unable to Comply with Study|2|||
128723900|NCT04964128|463287262|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
128723901|NCT04964128|463287262|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
128723902|NCT01471379|463287263|FG000|Overall Study|Adverse Event|1|||
128723903|NCT01471379|463287264|FG001|Overall Study|Adverse Event|0|||
128723904|NCT01471379|463287265|FG002|Overall Study|Adverse Event|0|||
128723905|NCT01471379|463287263|FG000|Overall Study|Study terminated|0|||
128723906|NCT01471379|463287264|FG001|Overall Study|Study terminated|1|||
128723907|NCT01471379|463287265|FG002|Overall Study|Study terminated|0|||
128723908|NCT02120794|463287266|FG000|Overall Study|Withdrawal by Subject|43|||
128723909|NCT02120794|463287266|FG000|Overall Study|Adverse Event|10|||
128723910|NCT02120794|463287266|FG000|Overall Study|Physician Decision|4|||
129070359|NCT00972595|464545838|FG001|Period 1|Adverse Event|0|||
129070360|NCT02552121|464545839|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
129070361|NCT02552121|464545840|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129070362|NCT02552121|464545841|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129070363|NCT02552121|464545842|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129070364|NCT02552121|464545843|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129070365|NCT02552121|464545844|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129070366|NCT02552121|464545845|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129070367|NCT02552121|464545846|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129070368|NCT02552121|464545839|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
129070369|NCT02552121|464545840|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129070370|NCT02552121|464545841|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129070371|NCT02552121|464545842|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129070372|NCT02552121|464545843|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129070373|NCT02552121|464545844|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129070374|NCT02552121|464545845|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129070375|NCT02552121|464545846|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129070376|NCT02552121|464545839|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129070377|NCT02552121|464545840|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
129070378|NCT02552121|464545841|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129070379|NCT02552121|464545842|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129070380|NCT02552121|464545843|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129070381|NCT02552121|464545844|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129070382|NCT02552121|464545845|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129070383|NCT02552121|464545846|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129070384|NCT02552121|464545839|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129070385|NCT02552121|464545840|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
129070386|NCT02552121|464545841|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129070387|NCT02552121|464545842|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129070388|NCT02552121|464545843|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129070389|NCT02552121|464545844|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129070390|NCT02552121|464545845|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129070391|NCT02552121|464545846|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129139872|NCT00159874|464806768|FG006|Overall Study|Lack of Efficacy|0|||
129139873|NCT00159874|464806762|FG000|Overall Study|Lost to Follow-up|1|||
129139874|NCT00159874|464806763|FG001|Overall Study|Lost to Follow-up|0|||
129139875|NCT00159874|464806764|FG002|Overall Study|Lost to Follow-up|3|||
129139876|NCT00159874|464806765|FG003|Overall Study|Lost to Follow-up|0|||
129139877|NCT00159874|464806766|FG004|Overall Study|Lost to Follow-up|1|||
129139878|NCT00159874|464806767|FG005|Overall Study|Lost to Follow-up|2|||
129139879|NCT00159874|464806768|FG006|Overall Study|Lost to Follow-up|1|||
129139880|NCT00159874|464806762|FG000|Overall Study|Other|8|||
129139881|NCT00159874|464806763|FG001|Overall Study|Other|8|||
129139882|NCT00159874|464806764|FG002|Overall Study|Other|8|||
129139883|NCT00159874|464806765|FG003|Overall Study|Other|0|||
129139884|NCT00159874|464806766|FG004|Overall Study|Other|2|||
129139885|NCT00159874|464806767|FG005|Overall Study|Other|1|||
129139886|NCT00159874|464806768|FG006|Overall Study|Other|3|||
129139887|NCT00159874|464806762|FG000|Overall Study|Protocol Violation|0|||
129139888|NCT00159874|464806763|FG001|Overall Study|Protocol Violation|5|||
129139889|NCT00159874|464806764|FG002|Overall Study|Protocol Violation|2|||
129139890|NCT00159874|464806765|FG003|Overall Study|Protocol Violation|0|||
129139891|NCT00159874|464806766|FG004|Overall Study|Protocol Violation|0|||
129139892|NCT00159874|464806767|FG005|Overall Study|Protocol Violation|0|||
129139893|NCT00159874|464806768|FG006|Overall Study|Protocol Violation|0|||
129139894|NCT00159874|464806762|FG000|Overall Study|Death|3|||
129139895|NCT00159874|464806763|FG001|Overall Study|Death|8|||
129139896|NCT00159874|464806764|FG002|Overall Study|Death|15|||
129139897|NCT00159874|464806765|FG003|Overall Study|Death|0|||
129139898|NCT00159874|464806766|FG004|Overall Study|Death|1|||
129139899|NCT00159874|464806767|FG005|Overall Study|Death|2|||
129139900|NCT00159874|464806768|FG006|Overall Study|Death|0|||
129139901|NCT00159874|464806762|FG000|Overall Study|Withdrawal by Subject|2|||
128723911|NCT02120794|463287266|FG000|Overall Study|Due to insurance coverage|1|||
129070392|NCT02552121|464545839|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129070393|NCT02552121|464545840|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
129070394|NCT02552121|464545841|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129070395|NCT02552121|464545842|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129070396|NCT02552121|464545843|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129070397|NCT02552121|464545844|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129070398|NCT02552121|464545845|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129070399|NCT02552121|464545846|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129070400|NCT02552121|464545839|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129070401|NCT02552121|464545840|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
129070402|NCT02552121|464545841|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129070403|NCT02552121|464545842|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129070404|NCT02552121|464545843|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129070405|NCT02552121|464545844|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129070406|NCT02552121|464545845|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129070407|NCT02552121|464545846|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129070408|NCT02552121|464545839|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
129070409|NCT02552121|464545840|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
129070410|NCT02552121|464545841|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
129070411|NCT02552121|464545842|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
129070412|NCT02552121|464545843|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
129070413|NCT02552121|464545844|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
129070414|NCT02552121|464545845|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
129070415|NCT02552121|464545846|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
129070416|NCT02552121|464545839|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
129070417|NCT02552121|464545840|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
129070418|NCT02552121|464545841|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
129070419|NCT02552121|464545842|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
129070420|NCT02552121|464545843|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
129070421|NCT02552121|464545844|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
129070422|NCT02552121|464545845|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
129070423|NCT02552121|464545846|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
129070424|NCT02552121|464545839|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
129070425|NCT02552121|464545840|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
129070426|NCT02552121|464545841|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
129070427|NCT02552121|464545842|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
129070428|NCT02552121|464545843|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
129070429|NCT02552121|464545844|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
129070430|NCT02552121|464545845|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
129070431|NCT02552121|464545846|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
129070432|NCT02552121|464545839|FG000|Part 2: Cohort Expansion|Death|0|||
129070433|NCT02552121|464545840|FG001|Part 2: Cohort Expansion|Death|0|||
129070434|NCT02552121|464545841|FG002|Part 2: Cohort Expansion|Death|1|||
129070435|NCT02552121|464545842|FG003|Part 2: Cohort Expansion|Death|0|||
129070436|NCT02552121|464545843|FG004|Part 2: Cohort Expansion|Death|0|||
129070437|NCT02552121|464545844|FG005|Part 2: Cohort Expansion|Death|0|||
128723912|NCT02818777|463287270|FG000|Overall Study|Adverse Event|3|||
129070438|NCT02552121|464545845|FG006|Part 2: Cohort Expansion|Death|0|||
129070439|NCT02552121|464545846|FG007|Part 2: Cohort Expansion|Death|0|||
129070440|NCT00739063|464545849|FG000|Overall Study|Screen failures|8|||
129070441|NCT04779879|464545850|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129070442|NCT04779879|464545851|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129070443|NCT04779879|464545852|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
128723913|NCT01623596|463287282|FG000|Overall Study|Abnormal laboratory values|2|||
129070444|NCT04779879|464545853|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
129070445|NCT04779879|464545854|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129139902|NCT00159874|464806763|FG001|Overall Study|Withdrawal by Subject|6|||
129139903|NCT00159874|464806764|FG002|Overall Study|Withdrawal by Subject|8|||
129139904|NCT00159874|464806765|FG003|Overall Study|Withdrawal by Subject|4|||
129139905|NCT00159874|464806766|FG004|Overall Study|Withdrawal by Subject|3|||
129139906|NCT00159874|464806767|FG005|Overall Study|Withdrawal by Subject|2|||
129139907|NCT00159874|464806768|FG006|Overall Study|Withdrawal by Subject|1|||
129139908|NCT00159874|464806762|FG000|Overall Study|Pregnancy|1|||
129139909|NCT00159874|464806763|FG001|Overall Study|Pregnancy|1|||
129139910|NCT00159874|464806764|FG002|Overall Study|Pregnancy|0|||
129139911|NCT00159874|464806765|FG003|Overall Study|Pregnancy|0|||
129139912|NCT00159874|464806766|FG004|Overall Study|Pregnancy|0|||
129139913|NCT00159874|464806767|FG005|Overall Study|Pregnancy|0|||
129139914|NCT00159874|464806768|FG006|Overall Study|Pregnancy|0|||
129139915|NCT05122143|464806772|FG000|Overall Study|Adverse Event|1|||
129139916|NCT05122143|464806773|FG001|Overall Study|Adverse Event|0|||
129139917|NCT05122143|464806774|FG002|Overall Study|Adverse Event|0|||
129139918|NCT05122143|464806775|FG003|Overall Study|Adverse Event|0|||
129139919|NCT05122143|464806776|FG004|Overall Study|Adverse Event|1|||
129139920|NCT05122143|464806777|FG005|Overall Study|Adverse Event|0|||
129139921|NCT05122143|464806772|FG000|Overall Study|Protocol non-compliance|0|||
129139922|NCT05122143|464806773|FG001|Overall Study|Protocol non-compliance|0|||
129139923|NCT05122143|464806774|FG002|Overall Study|Protocol non-compliance|1|||
129139924|NCT05122143|464806775|FG003|Overall Study|Protocol non-compliance|0|||
129139925|NCT05122143|464806776|FG004|Overall Study|Protocol non-compliance|0|||
129139926|NCT05122143|464806777|FG005|Overall Study|Protocol non-compliance|0|||
129139927|NCT05122143|464806772|FG000|Overall Study|Covid contact|0|||
129139928|NCT05122143|464806773|FG001|Overall Study|Covid contact|0|||
129139929|NCT05122143|464806774|FG002|Overall Study|Covid contact|0|||
129139930|NCT05122143|464806775|FG003|Overall Study|Covid contact|0|||
129139931|NCT05122143|464806776|FG004|Overall Study|Covid contact|1|||
129139932|NCT05122143|464806777|FG005|Overall Study|Covid contact|0|||
129139933|NCT01475825|464806778|FG000|Overall Study|Adverse Event|41|||
129139934|NCT01475825|464806779|FG001|Overall Study|Adverse Event|15|||
129139935|NCT01475825|464806780|FG002|Overall Study|Adverse Event|27|||
129139936|NCT01475825|464806781|FG003|Overall Study|Adverse Event|11|||
129139937|NCT01475825|464806778|FG000|Overall Study|Death|1|||
129139938|NCT01475825|464806779|FG001|Overall Study|Death|0|||
129139939|NCT01475825|464806780|FG002|Overall Study|Death|1|||
129139940|NCT01475825|464806781|FG003|Overall Study|Death|0|||
129139941|NCT01475825|464806778|FG000|Overall Study|Lack of Efficacy|0|||
129139942|NCT01475825|464806779|FG001|Overall Study|Lack of Efficacy|0|||
129139943|NCT01475825|464806780|FG002|Overall Study|Lack of Efficacy|1|||
129139944|NCT01475825|464806781|FG003|Overall Study|Lack of Efficacy|0|||
129139945|NCT01475825|464806778|FG000|Overall Study|Lost to Follow-up|0|||
129139946|NCT01475825|464806779|FG001|Overall Study|Lost to Follow-up|0|||
129139947|NCT01475825|464806780|FG002|Overall Study|Lost to Follow-up|3|||
129139948|NCT01475825|464806781|FG003|Overall Study|Lost to Follow-up|1|||
129139949|NCT01475825|464806778|FG000|Overall Study|Non-compliance with Study Drug|1|||
129139950|NCT01475825|464806779|FG001|Overall Study|Non-compliance with Study Drug|2|||
129139951|NCT01475825|464806780|FG002|Overall Study|Non-compliance with Study Drug|4|||
129139952|NCT01475825|464806781|FG003|Overall Study|Non-compliance with Study Drug|0|||
129139953|NCT01475825|464806778|FG000|Overall Study|Other: Not available|0|||
129139954|NCT01475825|464806779|FG001|Overall Study|Other: Not available|0|||
129139955|NCT01475825|464806780|FG002|Overall Study|Other: Not available|2|||
129139956|NCT01475825|464806781|FG003|Overall Study|Other: Not available|0|||
129139957|NCT01475825|464806778|FG000|Overall Study|Protocol Violation|1|||
129139958|NCT01475825|464806779|FG001|Overall Study|Protocol Violation|0|||
129139959|NCT01475825|464806780|FG002|Overall Study|Protocol Violation|0|||
129139960|NCT01475825|464806781|FG003|Overall Study|Protocol Violation|0|||
129139961|NCT01475825|464806778|FG000|Overall Study|Physician Decision|0|||
129139962|NCT01475825|464806779|FG001|Overall Study|Physician Decision|1|||
129139963|NCT01475825|464806780|FG002|Overall Study|Physician Decision|0|||
129139964|NCT01475825|464806781|FG003|Overall Study|Physician Decision|0|||
129139965|NCT01475825|464806778|FG000|Overall Study|Withdrawal by Subject|8|||
129139966|NCT01475825|464806779|FG001|Overall Study|Withdrawal by Subject|3|||
129139967|NCT01475825|464806780|FG002|Overall Study|Withdrawal by Subject|11|||
129139968|NCT01475825|464806781|FG003|Overall Study|Withdrawal by Subject|7|||
129139969|NCT01475825|464806778|FG000|Overall Study|Did not enter OLC|15|||
129139970|NCT01475825|464806779|FG001|Overall Study|Did not enter OLC|11|||
129139971|NCT01475825|464806780|FG002|Overall Study|Did not enter OLC|15|||
129139972|NCT01475825|464806781|FG003|Overall Study|Did not enter OLC|11|||
129139973|NCT00309946|464806784|FG000|Overall Study|Withdrawal by Subject|1|||
129139974|NCT02662582|464806788|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
129139975|NCT02662582|464806789|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
129139976|NCT02662582|464806788|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
129139977|NCT02662582|464806789|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
129139978|NCT02662582|464806788|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
129139979|NCT02662582|464806789|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
129139980|NCT02662582|464806788|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129139981|NCT02662582|464806789|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129139982|NCT04135352|464806791|FG000|Overall Study|Not treated-randomization error|0|||
129139983|NCT04135352|464806792|FG001|Overall Study|Not treated-randomization error|0|||
129139984|NCT04135352|464806793|FG002|Overall Study|Not treated-randomization error|1|||
129139985|NCT04135352|464806794|FG003|Overall Study|Not treated-randomization error|0|||
129139986|NCT04135352|464806795|FG004|Overall Study|Not treated-randomization error|0|||
129139987|NCT04135352|464806796|FG005|Overall Study|Not treated-randomization error|0|||
129139988|NCT04135352|464806797|FG006|Overall Study|Not treated-randomization error|0|||
129139989|NCT04135352|464806798|FG007|Overall Study|Not treated-randomization error|0|||
129139990|NCT04135352|464806791|FG000|Overall Study|Withdrawal by Subject|0|||
129139991|NCT04135352|464806792|FG001|Overall Study|Withdrawal by Subject|0|||
129139992|NCT04135352|464806793|FG002|Overall Study|Withdrawal by Subject|2|||
129139993|NCT04135352|464806794|FG003|Overall Study|Withdrawal by Subject|0|||
129139994|NCT04135352|464806795|FG004|Overall Study|Withdrawal by Subject|0|||
129139995|NCT04135352|464806796|FG005|Overall Study|Withdrawal by Subject|0|||
129139996|NCT04135352|464806797|FG006|Overall Study|Withdrawal by Subject|0|||
129139997|NCT04135352|464806798|FG007|Overall Study|Withdrawal by Subject|0|||
129139998|NCT04135352|464806791|FG000|Overall Study|Sponsor Decision|0|||
129139999|NCT04135352|464806792|FG001|Overall Study|Sponsor Decision|0|||
129140000|NCT04135352|464806793|FG002|Overall Study|Sponsor Decision|2|||
129140001|NCT04135352|464806794|FG003|Overall Study|Sponsor Decision|5|||
129140002|NCT04135352|464806795|FG004|Overall Study|Sponsor Decision|1|||
129140003|NCT04135352|464806796|FG005|Overall Study|Sponsor Decision|4|||
129140004|NCT04135352|464806797|FG006|Overall Study|Sponsor Decision|0|||
129140005|NCT04135352|464806798|FG007|Overall Study|Sponsor Decision|0|||
129140006|NCT04135352|464806791|FG000|Overall Study|Physician Decision|0|||
129140007|NCT04135352|464806792|FG001|Overall Study|Physician Decision|0|||
129140008|NCT04135352|464806793|FG002|Overall Study|Physician Decision|1|||
129140009|NCT04135352|464806794|FG003|Overall Study|Physician Decision|0|||
129140010|NCT04135352|464806795|FG004|Overall Study|Physician Decision|1|||
129140011|NCT04135352|464806796|FG005|Overall Study|Physician Decision|0|||
129140012|NCT04135352|464806797|FG006|Overall Study|Physician Decision|0|||
129140013|NCT04135352|464806798|FG007|Overall Study|Physician Decision|0|||
129140014|NCT04135352|464806791|FG000|Overall Study|Death|3|||
129140015|NCT04135352|464806792|FG001|Overall Study|Death|4|||
129140016|NCT04135352|464806793|FG002|Overall Study|Death|7|||
129140017|NCT04135352|464806794|FG003|Overall Study|Death|0|||
129140018|NCT04135352|464806795|FG004|Overall Study|Death|3|||
129140019|NCT04135352|464806796|FG005|Overall Study|Death|1|||
129140020|NCT04135352|464806797|FG006|Overall Study|Death|0|||
129140021|NCT04135352|464806798|FG007|Overall Study|Death|0|||
129140022|NCT00511199|464806799|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
129140023|NCT00511199|464806800|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
129140024|NCT00511199|464806799|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
129140025|NCT00511199|464806800|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
129140026|NCT00511199|464806799|FG000|Overall Study|Withdrawal of Informed Consent|19|||
129140027|NCT00511199|464806800|FG001|Overall Study|Withdrawal of Informed Consent|4|||
129140028|NCT00511199|464806799|FG000|Overall Study|Pregnancy|6|||
129140029|NCT00511199|464806800|FG001|Overall Study|Pregnancy|3|||
129140030|NCT00511199|464806799|FG000|Overall Study|Pregnancy Wish|16|||
129140031|NCT00511199|464806800|FG001|Overall Study|Pregnancy Wish|8|||
129140032|NCT00511199|464806799|FG000|Overall Study|Lost to Follow-up|40|||
129140033|NCT00511199|464806800|FG001|Overall Study|Lost to Follow-up|17|||
129140034|NCT00511199|464806799|FG000|Overall Study|Other Reason|78|||
129140035|NCT00511199|464806800|FG001|Overall Study|Other Reason|37|||
129140036|NCT02739828|464806806|FG000|Overall Study|Adverse Event|1|||
129140037|NCT02739828|464806806|FG000|Overall Study|Lost to Follow-up|4|||
129140038|NCT01953354|464806807|FG000|Overall Study|Withdrawal by Subject|0|||
129140039|NCT01953354|464806808|FG001|Overall Study|Withdrawal by Subject|1|||
129140040|NCT01953354|464806807|FG000|Overall Study|Decision of Sponsor|0|||
129140041|NCT01953354|464806808|FG001|Overall Study|Decision of Sponsor|1|||
129140042|NCT01953354|464806807|FG000|Overall Study|Disease Exacerbation|1|||
129140043|NCT01953354|464806808|FG001|Overall Study|Disease Exacerbation|0|||
129140044|NCT01392495|464806809|FG000|Overall Study|Death|3|||
129140045|NCT01392495|464806809|FG000|Overall Study|Administrative problems|8|||
129140046|NCT01392495|464806809|FG000|Overall Study|Withdrawal by Subject|2|||
129140047|NCT01392495|464806809|FG000|Overall Study|Adverse Event|3|||
129140048|NCT01696214|464806810|FG000|Overall Study|Lost to Follow-up|1|||
129140049|NCT01696214|464806811|FG001|Overall Study|Lost to Follow-up|0|||
129140050|NCT01696214|464806812|FG002|Overall Study|Lost to Follow-up|0|||
129140051|NCT01696214|464806813|FG003|Overall Study|Lost to Follow-up|0|||
129140052|NCT01570192|464806814|FG000|Overall Study|no qualifying organism|6|||
129070446|NCT04779879|464545855|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129070447|NCT04779879|464545850|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
129070448|NCT04779879|464545851|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
129070449|NCT04779879|464545852|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
129070450|NCT04779879|464545853|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
129070451|NCT04779879|464545854|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
129070452|NCT04779879|464545855|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
129070453|NCT04779879|464545850|FG000|Part C: Up to Week 36|Death|0|||
129070454|NCT04779879|464545851|FG001|Part C: Up to Week 36|Death|0|||
129070455|NCT04779879|464545852|FG002|Part C: Up to Week 36|Death|0|||
129070456|NCT04779879|464545853|FG003|Part C: Up to Week 36|Death|0|||
129070457|NCT04779879|464545854|FG004|Part C: Up to Week 36|Death|0|||
129070458|NCT04779879|464545855|FG005|Part C: Up to Week 36|Death|1|||
129070459|NCT04779879|464545850|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
129070460|NCT04779879|464545851|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
129070461|NCT04779879|464545852|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
129070462|NCT04779879|464545853|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
129070463|NCT04779879|464545854|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
129070464|NCT04779879|464545855|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
129070465|NCT02461160|464545856|FG000|Overall Study|Lost to Follow-up|0|||
129070466|NCT02461160|464545857|FG001|Overall Study|Lost to Follow-up|0|||
129070467|NCT02461160|464545858|FG002|Overall Study|Lost to Follow-up|0|||
129070468|NCT02461160|464545859|FG003|Overall Study|Lost to Follow-up|0|||
129070469|NCT02461160|464545860|FG004|Overall Study|Lost to Follow-up|0|||
129070470|NCT02461160|464545861|FG005|Overall Study|Lost to Follow-up|0|||
129070471|NCT02461160|464545862|FG006|Overall Study|Lost to Follow-up|0|||
129070472|NCT02461160|464545863|FG007|Overall Study|Lost to Follow-up|1|||
129070473|NCT02461160|464545864|FG008|Overall Study|Lost to Follow-up|0|||
129070474|NCT02461160|464545865|FG009|Overall Study|Lost to Follow-up|0|||
129070475|NCT02461160|464545866|FG010|Overall Study|Lost to Follow-up|0|||
129070476|NCT02461160|464545867|FG011|Overall Study|Lost to Follow-up|0|||
129070477|NCT02461160|464545868|FG012|Overall Study|Lost to Follow-up|0|||
129070478|NCT02854527|464545869|FG000|Overall Study|Adverse Event|0|||
129070479|NCT02854527|464545870|FG001|Overall Study|Adverse Event|0|||
129070480|NCT02854527|464545871|FG002|Overall Study|Adverse Event|0|||
129070481|NCT02854527|464545872|FG003|Overall Study|Adverse Event|0|||
129070482|NCT02854527|464545873|FG004|Overall Study|Adverse Event|1|||
129070483|NCT02854527|464545874|FG005|Overall Study|Adverse Event|0|||
129070484|NCT02854527|464545875|FG006|Overall Study|Adverse Event|0|||
129070485|NCT02854527|464545876|FG007|Overall Study|Adverse Event|0|||
129070486|NCT02854527|464545877|FG008|Overall Study|Adverse Event|0|||
129070487|NCT02854527|464545878|FG009|Overall Study|Adverse Event|0|||
129070488|NCT02854527|464545869|FG000|Overall Study|Lost to Follow-up|0|||
129070489|NCT02854527|464545870|FG001|Overall Study|Lost to Follow-up|0|||
129070490|NCT02854527|464545871|FG002|Overall Study|Lost to Follow-up|0|||
129070491|NCT02854527|464545872|FG003|Overall Study|Lost to Follow-up|1|||
129140053|NCT01570192|464806815|FG001|Overall Study|no qualifying organism|12|||
129140054|NCT01570192|464806814|FG000|Overall Study|changed to palliative care|1|||
129140055|NCT01570192|464806815|FG001|Overall Study|changed to palliative care|0|||
129140056|NCT01570192|464806814|FG000|Overall Study|Physician Decision|0|||
129140057|NCT01570192|464806815|FG001|Overall Study|Physician Decision|1|||
129140058|NCT00806026|464806816|FG000|Overall Study|Death|0|||
129140059|NCT00806026|464806817|FG001|Overall Study|Death|0|||
129140060|NCT00806026|464806818|FG002|Overall Study|Death|0|||
129140061|NCT00806026|464806819|FG003|Overall Study|Death|1|||
129140062|NCT00806026|464806820|FG004|Overall Study|Death|0|||
129140063|NCT00806026|464806821|FG005|Overall Study|Death|0|||
129140064|NCT00806026|464806816|FG000|Overall Study|Did not meet entrance criteria|4|||
129140065|NCT00806026|464806817|FG001|Overall Study|Did not meet entrance criteria|1|||
129140066|NCT00806026|464806818|FG002|Overall Study|Did not meet entrance criteria|2|||
129140067|NCT00806026|464806819|FG003|Overall Study|Did not meet entrance criteria|1|||
129140068|NCT00806026|464806820|FG004|Overall Study|Did not meet entrance criteria|0|||
129140069|NCT00806026|464806821|FG005|Overall Study|Did not meet entrance criteria|0|||
129140070|NCT00806026|464806816|FG000|Overall Study|Lack of Efficacy|5|||
129140071|NCT00806026|464806817|FG001|Overall Study|Lack of Efficacy|18|||
129140072|NCT00806026|464806818|FG002|Overall Study|Lack of Efficacy|13|||
129140073|NCT00806026|464806819|FG003|Overall Study|Lack of Efficacy|4|||
129140074|NCT00806026|464806820|FG004|Overall Study|Lack of Efficacy|8|||
129140075|NCT00806026|464806821|FG005|Overall Study|Lack of Efficacy|7|||
129140076|NCT00806026|464806816|FG000|Overall Study|Lost to Follow-up|8|||
129140077|NCT00806026|464806817|FG001|Overall Study|Lost to Follow-up|15|||
129070492|NCT02854527|464545873|FG004|Overall Study|Lost to Follow-up|0|||
129070493|NCT02854527|464545874|FG005|Overall Study|Lost to Follow-up|0|||
129070494|NCT02854527|464545875|FG006|Overall Study|Lost to Follow-up|0|||
129070495|NCT02854527|464545876|FG007|Overall Study|Lost to Follow-up|0|||
129070496|NCT02854527|464545877|FG008|Overall Study|Lost to Follow-up|0|||
129070497|NCT02854527|464545878|FG009|Overall Study|Lost to Follow-up|0|||
129140078|NCT00806026|464806818|FG002|Overall Study|Lost to Follow-up|8|||
129140079|NCT00806026|464806819|FG003|Overall Study|Lost to Follow-up|2|||
129140080|NCT00806026|464806820|FG004|Overall Study|Lost to Follow-up|6|||
129140081|NCT00806026|464806821|FG005|Overall Study|Lost to Follow-up|6|||
129140082|NCT00806026|464806816|FG000|Overall Study|Withdrawal by Subject|14|||
129140083|NCT00806026|464806817|FG001|Overall Study|Withdrawal by Subject|17|||
129140084|NCT00806026|464806818|FG002|Overall Study|Withdrawal by Subject|9|||
129070498|NCT02899962|464545879|FG000|Open-label Phase|Adverse Event|2|||
129140085|NCT00806026|464806819|FG003|Overall Study|Withdrawal by Subject|2|||
129140086|NCT00806026|464806820|FG004|Overall Study|Withdrawal by Subject|5|||
129140087|NCT00806026|464806821|FG005|Overall Study|Withdrawal by Subject|3|||
129140088|NCT00806026|464806816|FG000|Overall Study|Other|3|||
129140089|NCT00806026|464806817|FG001|Overall Study|Other|6|||
129140090|NCT00806026|464806818|FG002|Overall Study|Other|8|||
129140091|NCT00806026|464806819|FG003|Overall Study|Other|2|||
129140092|NCT00806026|464806820|FG004|Overall Study|Other|0|||
129140093|NCT00806026|464806821|FG005|Overall Study|Other|4|||
129140094|NCT00806026|464806816|FG000|Overall Study|Protocol Violation|6|||
129140095|NCT00806026|464806817|FG001|Overall Study|Protocol Violation|9|||
129140096|NCT00806026|464806818|FG002|Overall Study|Protocol Violation|9|||
129140097|NCT00806026|464806819|FG003|Overall Study|Protocol Violation|0|||
129140098|NCT00806026|464806820|FG004|Overall Study|Protocol Violation|2|||
129140099|NCT00806026|464806821|FG005|Overall Study|Protocol Violation|3|||
129140100|NCT00806026|464806816|FG000|Overall Study|Adverse Event|52|||
129140101|NCT00806026|464806817|FG001|Overall Study|Adverse Event|35|||
129140102|NCT00806026|464806818|FG002|Overall Study|Adverse Event|44|||
129140103|NCT00806026|464806819|FG003|Overall Study|Adverse Event|17|||
129140104|NCT00806026|464806820|FG004|Overall Study|Adverse Event|9|||
129140105|NCT00806026|464806821|FG005|Overall Study|Adverse Event|9|||
129140106|NCT03180138|464806822|FG000|Overall Study|Mobile-phone could not be verified|2|||
129140107|NCT03180138|464806823|FG001|Overall Study|Mobile-phone could not be verified|13|||
129140108|NCT03180138|464806824|FG002|Overall Study|Mobile-phone could not be verified|15|||
129070499|NCT02899962|464545880|FG001|Open-label Phase|Adverse Event|0|||
129070500|NCT02899962|464545881|FG002|Open-label Phase|Adverse Event|0|||
129070501|NCT02899962|464545879|FG000|Open-label Phase|Lost to Follow-up|9|||
129070502|NCT02899962|464545880|FG001|Open-label Phase|Lost to Follow-up|0|||
129070503|NCT02899962|464545881|FG002|Open-label Phase|Lost to Follow-up|0|||
129070504|NCT02899962|464545879|FG000|Open-label Phase|Other reasons|9|||
129070505|NCT02899962|464545880|FG001|Open-label Phase|Other reasons|0|||
129070506|NCT02899962|464545881|FG002|Open-label Phase|Other reasons|0|||
129070507|NCT02899962|464545879|FG000|Open-label Phase|Withdrawal by Subject|7|||
129070508|NCT02899962|464545880|FG001|Open-label Phase|Withdrawal by Subject|0|||
129070509|NCT02899962|464545881|FG002|Open-label Phase|Withdrawal by Subject|0|||
129140109|NCT03180138|464806822|FG000|Overall Study|No prior immunization records|17|||
129140110|NCT03180138|464806823|FG001|Overall Study|No prior immunization records|0|||
129140111|NCT03180138|464806824|FG002|Overall Study|No prior immunization records|6|||
129140112|NCT03180138|464806822|FG000|Overall Study|Found to be >24 mon after randomization|3|||
129140113|NCT03180138|464806823|FG001|Overall Study|Found to be >24 mon after randomization|0|||
129140114|NCT03180138|464806824|FG002|Overall Study|Found to be >24 mon after randomization|3|||
129140115|NCT00452530|464806826|FG000|Overall Study|Death|1|||
129070510|NCT02899962|464545879|FG000|Maintenance Phase|Adverse Event|0|||
129070511|NCT02899962|464545880|FG001|Maintenance Phase|Adverse Event|2|||
129140116|NCT00452530|464806827|FG001|Overall Study|Death|0|||
129140117|NCT00452530|464806826|FG000|Overall Study|Adverse Event|40|||
129070512|NCT02899962|464545881|FG002|Maintenance Phase|Adverse Event|1|||
129070513|NCT02899962|464545879|FG000|Maintenance Phase|Death|0|||
129070514|NCT02899962|464545880|FG001|Maintenance Phase|Death|0|||
129070515|NCT02899962|464545881|FG002|Maintenance Phase|Death|1|||
129070516|NCT02899962|464545879|FG000|Maintenance Phase|Lack of Efficacy|0|||
129070517|NCT02899962|464545880|FG001|Maintenance Phase|Lack of Efficacy|20|||
129070518|NCT02899962|464545881|FG002|Maintenance Phase|Lack of Efficacy|16|||
129070519|NCT02899962|464545879|FG000|Maintenance Phase|Lost to Follow-up|0|||
129070520|NCT02899962|464545880|FG001|Maintenance Phase|Lost to Follow-up|12|||
129070521|NCT02899962|464545881|FG002|Maintenance Phase|Lost to Follow-up|14|||
129070522|NCT02899962|464545879|FG000|Maintenance Phase|Other reasons|0|||
129070523|NCT02899962|464545880|FG001|Maintenance Phase|Other reasons|9|||
129070524|NCT02899962|464545881|FG002|Maintenance Phase|Other reasons|13|||
129070525|NCT02899962|464545879|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
129070526|NCT02899962|464545880|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
129070527|NCT02899962|464545881|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
129070528|NCT02899962|464545879|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
129070529|NCT02899962|464545880|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
129070530|NCT02899962|464545881|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
129070531|NCT02899962|464545879|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129070532|NCT02899962|464545880|FG001|Maintenance Phase|Withdrawal by Subject|30|||
129070533|NCT02899962|464545881|FG002|Maintenance Phase|Withdrawal by Subject|36|||
129070534|NCT03567980|464545888|FG000|Overall Study|Adverse Event|1|||
129070535|NCT01821807|464545890|FG000|Overall Study|Lost to Follow-up|3|||
129070536|NCT01821807|464545891|FG001|Overall Study|Lost to Follow-up|1|||
129070537|NCT02633787|464545893|FG000|Overall Study|Withdrawal by Subject|1|||
129070538|NCT00550459|464545894|FG000|Overall Study|Adverse Event|0|||
129070539|NCT00550459|464545895|FG001|Overall Study|Adverse Event|2|||
129070540|NCT00550459|464545894|FG000|Overall Study|Withdrawal by Subject|1|||
129070541|NCT00550459|464545895|FG001|Overall Study|Withdrawal by Subject|1|||
129070542|NCT02404805|464545896|FG000|Overall Study|Withdrawal by Subject|1|||
129070543|NCT02404805|464545897|FG001|Overall Study|Withdrawal by Subject|0|||
129070544|NCT02404805|464545898|FG002|Overall Study|Withdrawal by Subject|0|||
129070545|NCT02404805|464545899|FG003|Overall Study|Withdrawal by Subject|0|||
129070546|NCT02404805|464545900|FG004|Overall Study|Withdrawal by Subject|0|||
129070547|NCT02404805|464545901|FG005|Overall Study|Withdrawal by Subject|0|||
129070548|NCT01742897|464545902|FG000|Overall Study|Adverse Event|3|||
129070549|NCT01742897|464545902|FG000|Overall Study|Withdrawal by Subject|1|||
129070550|NCT01742897|464545902|FG000|Overall Study|Other|1|||
129070551|NCT02456740|464545904|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
129070552|NCT02456740|464545905|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
129070553|NCT02456740|464545906|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
129070554|NCT02456740|464545907|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129070555|NCT02456740|464545908|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129070556|NCT02456740|464545909|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129070557|NCT02456740|464545910|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129070558|NCT02456740|464545911|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129070559|NCT02456740|464545912|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129070560|NCT02456740|464545904|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
129070561|NCT02456740|464545905|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
129070562|NCT02456740|464545906|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
129070563|NCT02456740|464545907|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129070564|NCT02456740|464545908|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129070565|NCT02456740|464545909|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129070566|NCT02456740|464545910|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129070567|NCT02456740|464545911|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129070568|NCT02456740|464545912|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129070569|NCT02456740|464545904|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
129070570|NCT02456740|464545905|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
129070571|NCT02456740|464545906|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
129070572|NCT02456740|464545907|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129070573|NCT02456740|464545908|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129070574|NCT02456740|464545909|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129070575|NCT02456740|464545910|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129070576|NCT02456740|464545911|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129070577|NCT02456740|464545912|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129070578|NCT02456740|464545904|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129070579|NCT02456740|464545905|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129070580|NCT02456740|464545906|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129070581|NCT02456740|464545907|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
129070582|NCT02456740|464545908|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
129070583|NCT02456740|464545909|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129070584|NCT02456740|464545910|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129070585|NCT02456740|464545911|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129070586|NCT02456740|464545912|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
129070587|NCT02456740|464545904|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129070588|NCT02456740|464545905|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129070589|NCT02456740|464545906|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129070590|NCT02456740|464545907|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
129070591|NCT02456740|464545908|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
129070592|NCT02456740|464545909|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
129070593|NCT02456740|464545910|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
129070594|NCT02456740|464545911|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
129070595|NCT02456740|464545912|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
129070596|NCT02456740|464545904|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129070597|NCT02456740|464545905|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129070598|NCT02456740|464545906|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129140118|NCT00452530|464806827|FG001|Overall Study|Adverse Event|44|||
129140119|NCT00452530|464806826|FG000|Overall Study|Withdrawal by Subject|68|||
129140120|NCT00452530|464806827|FG001|Overall Study|Withdrawal by Subject|57|||
129140121|NCT00452530|464806826|FG000|Overall Study|Lost to Follow-up|1|||
129140122|NCT00452530|464806827|FG001|Overall Study|Lost to Follow-up|0|||
129070599|NCT02456740|464545907|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129070600|NCT02456740|464545908|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129140123|NCT00452530|464806826|FG000|Overall Study|Poor compliance/noncompliance|1|||
129140124|NCT00452530|464806827|FG001|Overall Study|Poor compliance/noncompliance|2|||
129140125|NCT00452530|464806826|FG000|Overall Study|No longer met study criteria|18|||
129140126|NCT00452530|464806827|FG001|Overall Study|No longer met study criteria|22|||
129140127|NCT00452530|464806826|FG000|Overall Study|Other|7|||
129140128|NCT00452530|464806827|FG001|Overall Study|Other|11|||
129070601|NCT02456740|464545909|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129070602|NCT02456740|464545910|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129070603|NCT02456740|464545911|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
129070604|NCT02456740|464545912|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129070605|NCT02456740|464545904|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129070606|NCT02456740|464545905|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129070607|NCT02456740|464545906|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129070608|NCT02456740|464545907|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
129070609|NCT02456740|464545908|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
129070610|NCT02456740|464545909|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
129070611|NCT02456740|464545910|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
129070612|NCT02456740|464545911|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
129070613|NCT02456740|464545912|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
129070614|NCT04720105|464545913|FG000|Overall Study|Lack of Efficacy|1|||
129070615|NCT04720105|464545913|FG000|Overall Study|Lost to Follow-up|1|||
129070616|NCT04720105|464545913|FG000|Overall Study|Withdrawal by Subject|3|||
129070617|NCT04871776|464545916|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
129070618|NCT04871776|464545917|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
129070619|NCT04871776|464545918|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
129070620|NCT04871776|464545916|FG000|Overall Study|Did not meet eligibility criteria|1|||
129070621|NCT04871776|464545917|FG001|Overall Study|Did not meet eligibility criteria|1|||
129070622|NCT04871776|464545918|FG002|Overall Study|Did not meet eligibility criteria|1|||
129070623|NCT04075487|464547323|FG000|Overall Study|Withdrawal by Subject|1|||
129070624|NCT00725283|464547328|FG000|Overall Study|Missing Code|3|||
129070625|NCT00725283|464547328|FG000|Overall Study|Death|5|||
129070626|NCT00725283|464547328|FG000|Overall Study|Other|6|||
129070627|NCT00725283|464547328|FG000|Overall Study|Withdrawal by Subject|10|||
129070628|NCT00513695|464547329|FG000|Overall Study|Discontinued therapy|2|||
129070629|NCT00513695|464547329|FG000|Overall Study|Progression prior to surgery|3|||
129070630|NCT01067105|464547334|FG000|Overall Study|Adverse Event|14|||
129070631|NCT01067105|464547334|FG000|Overall Study|Protocol Violation|48|||
129070632|NCT01067105|464547334|FG000|Overall Study|Withdrawal by Subject|36|||
129070633|NCT01067105|464547334|FG000|Overall Study|Lost to Follow-up|6|||
129070634|NCT01067105|464547334|FG000|Overall Study|Physician Decision|6|||
129070635|NCT01067105|464547334|FG000|Overall Study|Other|31|||
129070636|NCT02302833|464547337|FG000|Overall Study|Lost to Follow-up|3|||
129070637|NCT04878432|464547338|FG000|Overall Study|Adverse Event|1|||
129070638|NCT04878432|464547338|FG000|Overall Study|Death|2|||
129070639|NCT04878432|464547338|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129070640|NCT04878432|464547338|FG000|Overall Study|Withdrawal by Subject|6|||
129070641|NCT04878432|464547338|FG000|Overall Study|Progressive Disease|7|||
129070642|NCT04878432|464547338|FG000|Overall Study|New Therapy for Study Indication|7|||
129070643|NCT04878432|464547338|FG000|Overall Study|Physician Decision|11|||
129070644|NCT01495000|464547341|FG000|Overall Study|Lost to Follow-up|2|||
129070645|NCT01495000|464547342|FG001|Overall Study|Lost to Follow-up|2|||
129070646|NCT01495000|464547341|FG000|Overall Study|Protocol Violation|1|||
129070647|NCT01495000|464547342|FG001|Overall Study|Protocol Violation|0|||
129070648|NCT01495000|464547341|FG000|Overall Study|Withdrawal by Subject|10|||
129140129|NCT02100644|464806828|FG000|LTG Escalation Phase|Adverse Event|9|||
129140130|NCT02100644|464806829|FG001|LTG Escalation Phase|Adverse Event|0|||
129070649|NCT01495000|464547342|FG001|Overall Study|Withdrawal by Subject|10|||
129070650|NCT03499067|464547343|FG000|First Intervention|Physician Decision|2|||
129070651|NCT03499067|464547344|FG001|First Intervention|Physician Decision|1|||
129140131|NCT02100644|464806830|FG002|LTG Escalation Phase|Adverse Event|0|||
129140132|NCT02100644|464806828|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
129140133|NCT02100644|464806829|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
129140134|NCT02100644|464806830|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
129140135|NCT02100644|464806828|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
129140136|NCT02100644|464806829|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
129140137|NCT02100644|464806830|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
129070652|NCT03499067|464547343|FG000|First Intervention|Withdrawal by Subject|3|||
129070653|NCT03499067|464547344|FG001|First Intervention|Withdrawal by Subject|6|||
129070654|NCT02548832|464547345|FG000|Overall Study|Lost to Follow-up|2|||
129070655|NCT02548832|464547346|FG001|Overall Study|Lost to Follow-up|2|||
129070656|NCT02548832|464547347|FG002|Overall Study|Lost to Follow-up|2|||
129070657|NCT03565900|464547348|FG000|Overall Study|Disposition Unknown|4|||
129070658|NCT03565900|464547349|FG001|Overall Study|Disposition Unknown|1|||
129070659|NCT03565900|464547348|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129070660|NCT03565900|464547349|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
129070661|NCT03565900|464547348|FG000|Overall Study|Withdrawal by Subject|4|||
129070662|NCT03565900|464547349|FG001|Overall Study|Withdrawal by Subject|5|||
129070663|NCT03565900|464547348|FG000|Overall Study|Randomized By Mistake|0|||
129070664|NCT03565900|464547349|FG001|Overall Study|Randomized By Mistake|2|||
129070665|NCT03565900|464547348|FG000|Overall Study|Physician Decision|7|||
129070666|NCT03565900|464547349|FG001|Overall Study|Physician Decision|11|||
129070667|NCT03565900|464547348|FG000|Overall Study|Death|9|||
129070668|NCT03565900|464547349|FG001|Overall Study|Death|7|||
129070669|NCT03359850|464547352|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
129070670|NCT03359850|464547353|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
129070671|NCT03359850|464547352|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
129070672|NCT03359850|464547353|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
129070673|NCT03359850|464547352|FG000|Extension Phase (Up to 28 Months)|Death|2|||
129070674|NCT03359850|464547353|FG001|Extension Phase (Up to 28 Months)|Death|4|||
129070675|NCT03359850|464547352|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
129070676|NCT03359850|464547353|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
129070677|NCT03359850|464547352|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
129070678|NCT03359850|464547353|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
129070679|NCT00942357|464547354|FG000|Overall Study|Ineligible|37|||
129070680|NCT00942357|464547355|FG001|Overall Study|Ineligible|40|||
129070681|NCT01960257|464547358|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
129070682|NCT01960257|464547359|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
129070683|NCT01960257|464547360|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
129070684|NCT01960257|464547358|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
129070685|NCT01960257|464547359|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
129070686|NCT01960257|464547360|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
129070687|NCT01960257|464547358|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
129070688|NCT01960257|464547359|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
129070689|NCT01960257|464547360|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
129070690|NCT02002221|464547361|FG000|Overall Study|Adverse Event|2|||
129070691|NCT02002221|464547362|FG001|Overall Study|Adverse Event|1|||
129070692|NCT02002221|464547361|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129070693|NCT02002221|464547362|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129070694|NCT02002221|464547361|FG000|Overall Study|Patient withdrew consent|0|||
129070695|NCT02002221|464547362|FG001|Overall Study|Patient withdrew consent|1|||
129070696|NCT03347110|464547363|FG000|Overall Study|Other (Participant is incarcerated)|1|||
129070697|NCT03347110|464547363|FG000|Overall Study|Withdrawal by Subject|9|||
129070698|NCT03347110|464547363|FG000|Overall Study|Lost to Follow-up|1|||
129070699|NCT03347110|464547363|FG000|Overall Study|Lack of Efficacy|2|||
129070700|NCT03347110|464547363|FG000|Overall Study|Adverse Event, non-fatal|9|||
129070701|NCT02105467|464547364|FG000|Period 1|Lost to Follow-up|1|||
129070702|NCT02105467|464547365|FG001|Period 1|Lost to Follow-up|0|||
129070703|NCT02105467|464547364|FG000|Period 1|Death|1|||
129070704|NCT02105467|464547365|FG001|Period 1|Death|0|||
129070705|NCT02105467|464547364|FG000|Period 2|Lost to Follow-up|1|||
129070706|NCT02105467|464547365|FG001|Period 2|Lost to Follow-up|0|||
129070707|NCT02105467|464547364|FG000|Period 2|Death|1|||
129070708|NCT02105467|464547365|FG001|Period 2|Death|0|||
129070709|NCT02105467|464547364|FG000|Period 2|Withdrawal by Subject|0|||
129070710|NCT02105467|464547365|FG001|Period 2|Withdrawal by Subject|2|||
129070711|NCT02105467|464547364|FG000|Period 3|Lost to Follow-up|0|||
129070712|NCT02105467|464547365|FG001|Period 3|Lost to Follow-up|1|||
129070713|NCT01518322|464547367|FG000|Overall Study|FeNO measurement was missing|13|||
129140138|NCT00728182|464806831|FG000|Overall Study|Adverse Event|1|||
129140139|NCT00728182|464806832|FG001|Overall Study|Adverse Event|0|||
129140140|NCT00728182|464806831|FG000|Overall Study|Lost to Follow-up|2|||
129140141|NCT00728182|464806832|FG001|Overall Study|Lost to Follow-up|0|||
129140142|NCT00728182|464806831|FG000|Overall Study|Death|0|||
129140143|NCT00728182|464806832|FG001|Overall Study|Death|2|||
129140144|NCT00728182|464806831|FG000|Overall Study|Protocol Noncompliance|0|||
129140145|NCT00728182|464806832|FG001|Overall Study|Protocol Noncompliance|1|||
129140146|NCT01898091|464806834|FG000|Overall Study|Lost to Follow-up|1|||
129140147|NCT01898091|464806835|FG001|Overall Study|Lost to Follow-up|1|||
129070714|NCT02792517|464547372|FG000|Overall Study|Withdrawal by Subject|10|||
129070715|NCT02792517|464547372|FG000|Overall Study|Decision by Sponsor|7|||
129070716|NCT02792517|464547372|FG000|Overall Study|Lost to Follow-up|3|||
129140148|NCT01898091|464806834|FG000|Overall Study|Withdrawal by Subject|1|||
129140149|NCT01898091|464806835|FG001|Overall Study|Withdrawal by Subject|5|||
129140150|NCT01618708|464806836|FG000|Overall Study|Adverse Event|10|||
129070717|NCT00856193|464547375|FG000|Period 2|Abnormal test procedure results|0|||
129070718|NCT00856193|464547376|FG001|Period 2|Abnormal test procedure results|1|||
129070719|NCT00856193|464547375|FG000|Period 2|Lost to Follow-up|0|||
129070720|NCT00856193|464547376|FG001|Period 2|Lost to Follow-up|1|||
129070721|NCT02766335|464547378|FG000|Initial Registration|Adverse Event|6|||
129070722|NCT02766335|464547379|FG001|Initial Registration|Adverse Event|3|||
129070723|NCT02766335|464547380|FG002|Initial Registration|Adverse Event|0|||
129070724|NCT02766335|464547378|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
129070725|NCT02766335|464547379|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
129070726|NCT02766335|464547380|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
129070727|NCT02766335|464547378|FG000|Initial Registration|Progression/relapse|49|||
129070728|NCT02766335|464547379|FG001|Initial Registration|Progression/relapse|15|||
129070729|NCT02766335|464547380|FG002|Initial Registration|Progression/relapse|0|||
129070730|NCT02766335|464547378|FG000|Initial Registration|Death|1|||
129070731|NCT02766335|464547379|FG001|Initial Registration|Death|3|||
129070732|NCT02766335|464547380|FG002|Initial Registration|Death|0|||
129070733|NCT02766335|464547378|FG000|Initial Registration|not protocol specified|1|||
129070734|NCT02766335|464547379|FG001|Initial Registration|not protocol specified|9|||
129070735|NCT02766335|464547380|FG002|Initial Registration|not protocol specified|0|||
129070736|NCT02766335|464547378|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
129070737|NCT02766335|464547379|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
129070738|NCT02766335|464547380|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
129070739|NCT02766335|464547378|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
129070740|NCT02766335|464547379|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
129070741|NCT02766335|464547380|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
129070742|NCT01515423|464547394|FG000|Open Label Phase|Adverse Event|57|||
129070743|NCT01515423|464547395|FG001|Open Label Phase|Adverse Event|0|||
129070744|NCT01515423|464547396|FG002|Open Label Phase|Adverse Event|0|||
129070745|NCT01515423|464547394|FG000|Open Label Phase|Death|2|||
129070746|NCT01515423|464547395|FG001|Open Label Phase|Death|0|||
129070747|NCT01515423|464547396|FG002|Open Label Phase|Death|0|||
129070748|NCT01515423|464547394|FG000|Open Label Phase|Lack of Efficacy|117|||
129070749|NCT01515423|464547395|FG001|Open Label Phase|Lack of Efficacy|0|||
129070750|NCT01515423|464547396|FG002|Open Label Phase|Lack of Efficacy|0|||
129070751|NCT01515423|464547394|FG000|Open Label Phase|Lost to Follow-up|21|||
129070752|NCT01515423|464547395|FG001|Open Label Phase|Lost to Follow-up|0|||
129070753|NCT01515423|464547396|FG002|Open Label Phase|Lost to Follow-up|0|||
129070754|NCT01515423|464547394|FG000|Open Label Phase|Withdrawal by Subject|118|||
129070755|NCT01515423|464547395|FG001|Open Label Phase|Withdrawal by Subject|0|||
129070756|NCT01515423|464547396|FG002|Open Label Phase|Withdrawal by Subject|0|||
129070757|NCT01515423|464547394|FG000|Open Label Phase|excluded from DB Phase|70|||
129070758|NCT01515423|464547395|FG001|Open Label Phase|excluded from DB Phase|0|||
129070759|NCT01515423|464547396|FG002|Open Label Phase|excluded from DB Phase|0|||
129070760|NCT01515423|464547394|FG000|Open Label Phase|Other|28|||
129070761|NCT01515423|464547395|FG001|Open Label Phase|Other|0|||
129070762|NCT01515423|464547396|FG002|Open Label Phase|Other|0|||
129070763|NCT01515423|464547394|FG000|DOUBLE BLIND|Adverse Event|0|||
129070764|NCT01515423|464547395|FG001|DOUBLE BLIND|Adverse Event|15|||
129070765|NCT01515423|464547396|FG002|DOUBLE BLIND|Adverse Event|13|||
129070766|NCT01515423|464547394|FG000|DOUBLE BLIND|Death|0|||
129070767|NCT01515423|464547395|FG001|DOUBLE BLIND|Death|1|||
129070768|NCT01515423|464547396|FG002|DOUBLE BLIND|Death|2|||
129070769|NCT01515423|464547394|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
129070770|NCT01515423|464547395|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
129070771|NCT01515423|464547396|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
129070772|NCT01515423|464547394|FG000|DOUBLE BLIND|Pregnancy|0|||
129070773|NCT01515423|464547395|FG001|DOUBLE BLIND|Pregnancy|2|||
129070774|NCT01515423|464547396|FG002|DOUBLE BLIND|Pregnancy|0|||
129070775|NCT01515423|464547394|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
129070776|NCT01515423|464547395|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
129070777|NCT01515423|464547396|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
129070778|NCT01515423|464547394|FG000|DOUBLE BLIND|Other|0|||
129070779|NCT01515423|464547395|FG001|DOUBLE BLIND|Other|6|||
129070780|NCT01515423|464547396|FG002|DOUBLE BLIND|Other|12|||
129070781|NCT01515423|464547394|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
129070782|NCT01515423|464547395|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
129070783|NCT01515423|464547396|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
129070784|NCT01125917|464547399|FG000|Overall Study|Adverse Event|43|||
129070785|NCT01125917|464547399|FG000|Overall Study|Lost to Follow-up|23|||
129070786|NCT01125917|464547399|FG000|Overall Study|Withdrawal by Subject|31|||
129070787|NCT01125917|464547399|FG000|Overall Study|Administrative|223|||
129070788|NCT01125917|464547399|FG000|Overall Study|Lack of Efficacy|19|||
129070789|NCT02501928|464547400|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129070790|NCT02501928|464547401|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
129070791|NCT02501928|464547402|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
129070792|NCT02501928|464547403|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
129070793|NCT02501928|464547404|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
129070794|NCT02501928|464547405|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
129070795|NCT00838526|464547413|FG000|Overall Study|Adverse Event|3|||
129070796|NCT00838526|464547414|FG001|Overall Study|Adverse Event|12|||
129070797|NCT00838526|464547413|FG000|Overall Study|Lost to Follow-up|4|||
129070798|NCT00838526|464547414|FG001|Overall Study|Lost to Follow-up|12|||
129070799|NCT00838526|464547413|FG000|Overall Study|Withdrawal by Subject|4|||
129140151|NCT01618708|464806837|FG001|Overall Study|Adverse Event|10|||
129140152|NCT01618708|464806836|FG000|Overall Study|Lost to Follow-up|3|||
129140153|NCT01618708|464806837|FG001|Overall Study|Lost to Follow-up|3|||
129140154|NCT01618708|464806836|FG000|Overall Study|Withdrawal by Subject|17|||
129140155|NCT01618708|464806837|FG001|Overall Study|Withdrawal by Subject|22|||
129140156|NCT01618708|464806836|FG000|Overall Study|Lack of Efficacy|8|||
129140157|NCT01618708|464806837|FG001|Overall Study|Lack of Efficacy|8|||
129140158|NCT01618708|464806836|FG000|Overall Study|Technical problems|2|||
129140159|NCT01618708|464806837|FG001|Overall Study|Technical problems|0|||
129140160|NCT01618708|464806836|FG000|Overall Study|Other than specified above|1|||
129140161|NCT01618708|464806837|FG001|Overall Study|Other than specified above|1|||
128723914|NCT01623596|463287283|FG001|Overall Study|Abnormal laboratory values|0|||
128723915|NCT01623596|463287282|FG000|Overall Study|Administrative problems|9|||
129070800|NCT00838526|464547414|FG001|Overall Study|Withdrawal by Subject|5|||
129070801|NCT00838526|464547413|FG000|Overall Study|Lack of Efficacy|2|||
129140162|NCT01618708|464806836|FG000|Overall Study|Randomized but not treated|3|||
128723916|NCT01623596|463287283|FG001|Overall Study|Administrative problems|13|||
128723917|NCT01623596|463287282|FG000|Overall Study|Adverse Event|20|||
128723918|NCT01623596|463287283|FG001|Overall Study|Adverse Event|29|||
128723919|NCT01623596|463287282|FG000|Overall Study|Death|0|||
128723920|NCT01623596|463287283|FG001|Overall Study|Death|2|||
128723921|NCT01623596|463287282|FG000|Overall Study|Lost to Follow-up|12|||
128723922|NCT01623596|463287283|FG001|Overall Study|Lost to Follow-up|16|||
128723923|NCT01623596|463287282|FG000|Overall Study|Withdrawal by Subject|13|||
128723924|NCT01623596|463287283|FG001|Overall Study|Withdrawal by Subject|31|||
128723925|NCT01623596|463287282|FG000|Overall Study|Patient no longer requires study drug|1|||
128723926|NCT01623596|463287283|FG001|Overall Study|Patient no longer requires study drug|0|||
128723927|NCT01623596|463287282|FG000|Overall Study|Protocol Violation|0|||
128723928|NCT01623596|463287283|FG001|Overall Study|Protocol Violation|6|||
128723929|NCT01623596|463287282|FG000|Overall Study|Lack of Efficacy|5|||
128723930|NCT01623596|463287283|FG001|Overall Study|Lack of Efficacy|3|||
128723931|NCT01324349|463287284|FG000|Overall Study|Death|1|||
128723932|NCT01324349|463287285|FG001|Overall Study|Death|1|||
128723933|NCT01324349|463287284|FG000|Overall Study|Withdrawal by Subject|0|||
128723934|NCT01324349|463287285|FG001|Overall Study|Withdrawal by Subject|1|||
128723935|NCT01070316|463287286|FG000|Extension Phase|Lack of Efficacy|3|||
128723936|NCT01070316|463287286|FG000|Extension Phase|Withdrawal by Subject|1|||
128723937|NCT00748215|463287287|FG000|Overall Study|Withdrawal by Subject|7|||
128723938|NCT00748215|463287288|FG001|Overall Study|Withdrawal by Subject|7|||
128723939|NCT00748215|463287287|FG000|Overall Study|Treatment change|2|||
128776515|NCT00519636|463470455|FG000|Washout Period|Participating in study at another site|1|||
128723940|NCT00748215|463287288|FG001|Overall Study|Treatment change|1|||
129070802|NCT00838526|464547414|FG001|Overall Study|Lack of Efficacy|3|||
129070803|NCT00838526|464547413|FG000|Overall Study|Other|11|||
128723941|NCT00748215|463287287|FG000|Overall Study|Change in patient condition|0|||
128723942|NCT00748215|463287288|FG001|Overall Study|Change in patient condition|3|||
128723943|NCT00748215|463287287|FG000|Overall Study|Non-compliant|0|||
128723944|NCT00748215|463287288|FG001|Overall Study|Non-compliant|2|||
128723945|NCT00748215|463287287|FG000|Overall Study|Adverse Event|0|||
128723946|NCT00748215|463287288|FG001|Overall Study|Adverse Event|5|||
128723947|NCT03200899|463287295|FG000|Overall Study|Lost to Follow-up|10|||
128723948|NCT03200899|463287296|FG001|Overall Study|Lost to Follow-up|23|||
128723949|NCT03913091|463287297|FG000|Overall Study|Lost to Follow-up|18|||
128723950|NCT03913091|463287298|FG001|Overall Study|Lost to Follow-up|11|||
128723951|NCT03913091|463287297|FG000|Overall Study|Required additional meds/surgery|1|||
129070804|NCT00838526|464547414|FG001|Overall Study|Other|7|||
128723952|NCT03913091|463287298|FG001|Overall Study|Required additional meds/surgery|2|||
129070805|NCT01320293|464547415|FG000|Overall Study|Lack of Efficacy|1|||
129070806|NCT01320293|464547415|FG000|Overall Study|Adverse Event|1|||
129070807|NCT00931411|464547416|FG000|First Intervention - 42 Days|Adverse Event|2|||
129070808|NCT00931411|464547417|FG001|First Intervention - 42 Days|Adverse Event|3|||
129070809|NCT00931411|464547416|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
129070810|NCT00931411|464547417|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
129070811|NCT00931411|464547416|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
129070812|NCT00931411|464547417|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
129070813|NCT03483012|464547420|FG000|Overall Study|Lack of Efficacy|6|||
129070814|NCT04782076|464547421|FG000|Overall Study|Family Emergency|1|||
129070815|NCT01949662|464547432|FG000|Overall Study|Death|9|||
129070816|NCT01949662|464547433|FG001|Overall Study|Death|7|||
129070817|NCT01949662|464547432|FG000|Overall Study|Discharged before an agitation event|8|||
129070818|NCT01949662|464547433|FG001|Overall Study|Discharged before an agitation event|3|||
129070819|NCT01949662|464547432|FG000|Overall Study|Dropped out|1|||
129070820|NCT01949662|464547433|FG001|Overall Study|Dropped out|3|||
129070821|NCT01949662|464547432|FG000|Overall Study|Ineligible|0|||
129070822|NCT01949662|464547433|FG001|Overall Study|Ineligible|1|||
129070823|NCT04135937|464547435|FG000|Overall Study|Lost to Follow-up|2|||
129070824|NCT04135937|464547435|FG000|Overall Study|Withdrawal by Subject|1|||
129070825|NCT00856492|464547438|FG000|Overall Study|Ineligible or withdrew consent|1|||
129070826|NCT00856492|464547439|FG001|Overall Study|Ineligible or withdrew consent|1|||
129070827|NCT00856492|464547440|FG002|Overall Study|Ineligible or withdrew consent|2|||
129070828|NCT00955617|464547443|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
129070829|NCT00955617|464547444|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
129070830|NCT00955617|464547443|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
129070831|NCT00955617|464547444|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
129070832|NCT00955617|464547443|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
129070833|NCT00955617|464547444|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
129070834|NCT00955617|464547443|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
129070835|NCT00955617|464547444|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
129070836|NCT00070564|464548475|FG000|Overall Study|Progression|2|||
129070837|NCT00070564|464548476|FG001|Overall Study|Progression|4|||
129070838|NCT00070564|464548477|FG002|Overall Study|Progression|7|||
129070839|NCT00070564|464548478|FG003|Overall Study|Progression|7|||
129070840|NCT00070564|464548479|FG004|Overall Study|Progression|1|||
129070841|NCT00070564|464548480|FG005|Overall Study|Progression|0|||
129070842|NCT00070564|464548475|FG000|Overall Study|Delinquent|1|||
129070843|NCT00070564|464548476|FG001|Overall Study|Delinquent|4|||
129070844|NCT00070564|464548477|FG002|Overall Study|Delinquent|2|||
129070845|NCT00070564|464548478|FG003|Overall Study|Delinquent|0|||
129070846|NCT00070564|464548479|FG004|Overall Study|Delinquent|0|||
129070847|NCT00070564|464548480|FG005|Overall Study|Delinquent|0|||
129140163|NCT01618708|464806837|FG001|Overall Study|Randomized but not treated|2|||
129140164|NCT01630811|464806839|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
129140165|NCT01630811|464806840|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129140166|NCT04818086|464806843|FG000|Overall Study|Physician Decision|1|||
129140167|NCT04818086|464806844|FG001|Overall Study|Physician Decision|0|||
129140168|NCT04818086|464806843|FG000|Overall Study|Withdrawal by Subject|0|||
129140169|NCT04818086|464806844|FG001|Overall Study|Withdrawal by Subject|1|||
129140170|NCT01725308|464806845|FG000|Treatment Period I|Did Not Receive Drug|1|||
129140171|NCT01725308|464806846|FG001|Treatment Period I|Did Not Receive Drug|0|||
129140172|NCT01725308|464806847|FG002|Treatment Period I|Did Not Receive Drug|0|||
129140173|NCT01725308|464806845|FG000|Treatment Period I|Adverse Event|5|||
129140174|NCT01725308|464806846|FG001|Treatment Period I|Adverse Event|4|||
129140175|NCT01725308|464806847|FG002|Treatment Period I|Adverse Event|21|||
129070848|NCT00070564|464548475|FG000|Overall Study|Adverse Event|150|||
129070849|NCT00070564|464548476|FG001|Overall Study|Adverse Event|142|||
129070850|NCT00070564|464548477|FG002|Overall Study|Adverse Event|120|||
129070851|NCT00070564|464548478|FG003|Overall Study|Adverse Event|108|||
129070852|NCT00070564|464548479|FG004|Overall Study|Adverse Event|63|||
129070853|NCT00070564|464548480|FG005|Overall Study|Adverse Event|36|||
129070854|NCT00070564|464548475|FG000|Overall Study|Death|4|||
129070855|NCT00070564|464548476|FG001|Overall Study|Death|1|||
129070856|NCT00070564|464548477|FG002|Overall Study|Death|5|||
129070857|NCT00070564|464548478|FG003|Overall Study|Death|3|||
129070858|NCT00070564|464548479|FG004|Overall Study|Death|0|||
129070859|NCT00070564|464548480|FG005|Overall Study|Death|1|||
129070860|NCT00070564|464548475|FG000|Overall Study|Other, not protocol specified|17|||
129070861|NCT00070564|464548476|FG001|Overall Study|Other, not protocol specified|15|||
129140176|NCT01725308|464806845|FG000|Treatment Period I|Insufficient Response|7|||
129140177|NCT01725308|464806846|FG001|Treatment Period I|Insufficient Response|0|||
129140178|NCT01725308|464806847|FG002|Treatment Period I|Insufficient Response|5|||
129140179|NCT01725308|464806845|FG000|Treatment Period I|Worsening of the Target Disease|8|||
129140180|NCT01725308|464806846|FG001|Treatment Period I|Worsening of the Target Disease|0|||
129140181|NCT01725308|464806847|FG002|Treatment Period I|Worsening of the Target Disease|2|||
129140182|NCT01725308|464806845|FG000|Treatment Period I|Changes in the Episodes|3|||
129140183|NCT01725308|464806846|FG001|Treatment Period I|Changes in the Episodes|0|||
129140184|NCT01725308|464806847|FG002|Treatment Period I|Changes in the Episodes|2|||
129140185|NCT01725308|464806845|FG000|Treatment Period I|Withdrawal of Consent|12|||
129140186|NCT01725308|464806846|FG001|Treatment Period I|Withdrawal of Consent|7|||
129140187|NCT01725308|464806847|FG002|Treatment Period I|Withdrawal of Consent|5|||
129140188|NCT01725308|464806845|FG000|Treatment Period I|Lost to Follow-up|3|||
129140189|NCT01725308|464806846|FG001|Treatment Period I|Lost to Follow-up|2|||
129140190|NCT01725308|464806847|FG002|Treatment Period I|Lost to Follow-up|2|||
129140191|NCT01725308|464806845|FG000|Treatment Period I|Protocol Deviations|3|||
129140192|NCT01725308|464806846|FG001|Treatment Period I|Protocol Deviations|1|||
129140193|NCT01725308|464806847|FG002|Treatment Period I|Protocol Deviations|1|||
129140194|NCT01725308|464806845|FG000|Treatment Period I|Miscellaneous|2|||
129140195|NCT01725308|464806846|FG001|Treatment Period I|Miscellaneous|0|||
129140196|NCT01725308|464806847|FG002|Treatment Period I|Miscellaneous|3|||
129140197|NCT01725308|464806845|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
129140198|NCT01725308|464806846|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
129140199|NCT01725308|464806847|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
129140200|NCT01725308|464806845|FG000|Treatment Period II|Did Not Receive Drug|4|||
129140201|NCT01725308|464806846|FG001|Treatment Period II|Did Not Receive Drug|0|||
129140202|NCT01725308|464806847|FG002|Treatment Period II|Did Not Receive Drug|0|||
129140203|NCT01725308|464806845|FG000|Treatment Period II|Adverse Event|13|||
129140204|NCT01725308|464806846|FG001|Treatment Period II|Adverse Event|8|||
129140205|NCT01725308|464806847|FG002|Treatment Period II|Adverse Event|20|||
129140206|NCT01725308|464806845|FG000|Treatment Period II|Insufficient Response|2|||
129140207|NCT01725308|464806846|FG001|Treatment Period II|Insufficient Response|4|||
129140208|NCT01725308|464806847|FG002|Treatment Period II|Insufficient Response|6|||
129140209|NCT01725308|464806845|FG000|Treatment Period II|Worsening of the Target Disease|1|||
129140210|NCT01725308|464806846|FG001|Treatment Period II|Worsening of the Target Disease|4|||
129140211|NCT01725308|464806847|FG002|Treatment Period II|Worsening of the Target Disease|2|||
129140212|NCT01725308|464806845|FG000|Treatment Period II|Changes in the Episodes|1|||
129140213|NCT01725308|464806846|FG001|Treatment Period II|Changes in the Episodes|0|||
129070862|NCT00070564|464548477|FG002|Overall Study|Other, not protocol specified|14|||
129070863|NCT00070564|464548478|FG003|Overall Study|Other, not protocol specified|19|||
129070864|NCT00070564|464548479|FG004|Overall Study|Other, not protocol specified|6|||
129070865|NCT00070564|464548480|FG005|Overall Study|Other, not protocol specified|7|||
129070866|NCT00070564|464548475|FG000|Overall Study|Withdrawal by Subject|26|||
129070867|NCT00070564|464548476|FG001|Overall Study|Withdrawal by Subject|37|||
129070868|NCT00070564|464548477|FG002|Overall Study|Withdrawal by Subject|23|||
129070869|NCT00070564|464548478|FG003|Overall Study|Withdrawal by Subject|30|||
129070870|NCT00070564|464548479|FG004|Overall Study|Withdrawal by Subject|8|||
129140214|NCT01725308|464806847|FG002|Treatment Period II|Changes in the Episodes|5|||
129140215|NCT01725308|464806845|FG000|Treatment Period II|Withdrawal of Consent|28|||
129140216|NCT01725308|464806846|FG001|Treatment Period II|Withdrawal of Consent|2|||
129140217|NCT01725308|464806847|FG002|Treatment Period II|Withdrawal of Consent|16|||
129140218|NCT01725308|464806845|FG000|Treatment Period II|Lost to Follow-up|1|||
129140219|NCT01725308|464806846|FG001|Treatment Period II|Lost to Follow-up|5|||
129140220|NCT01725308|464806847|FG002|Treatment Period II|Lost to Follow-up|3|||
129140221|NCT01725308|464806845|FG000|Treatment Period II|Protocol Deviations|0|||
129140222|NCT01725308|464806846|FG001|Treatment Period II|Protocol Deviations|0|||
129140223|NCT01725308|464806847|FG002|Treatment Period II|Protocol Deviations|1|||
129140224|NCT01725308|464806845|FG000|Treatment Period II|Miscellaneous|5|||
129140225|NCT01725308|464806846|FG001|Treatment Period II|Miscellaneous|3|||
129140226|NCT01725308|464806847|FG002|Treatment Period II|Miscellaneous|7|||
129140227|NCT03511209|464806851|FG000|Overall Study|Withdrawal by Subject|2|||
129140228|NCT03511209|464806852|FG001|Overall Study|Withdrawal by Subject|4|||
129140229|NCT03511209|464806851|FG000|Overall Study|Death|1|||
129140230|NCT03511209|464806852|FG001|Overall Study|Death|0|||
129140231|NCT03511209|464806851|FG000|Overall Study|Lost to Follow-up|0|||
129140232|NCT03511209|464806852|FG001|Overall Study|Lost to Follow-up|2|||
129140233|NCT00401830|464806856|FG000|Overall Study|Adverse Event|10|||
129140234|NCT00401830|464806857|FG001|Overall Study|Adverse Event|18|||
129140235|NCT00401830|464806856|FG000|Overall Study|Lack of Efficacy|11|||
129140236|NCT00401830|464806857|FG001|Overall Study|Lack of Efficacy|5|||
129140237|NCT00401830|464806856|FG000|Overall Study|Withdrawal by Subject|4|||
129140238|NCT00401830|464806857|FG001|Overall Study|Withdrawal by Subject|3|||
129140239|NCT00401830|464806856|FG000|Overall Study|Protocol Violation|3|||
129140240|NCT00401830|464806857|FG001|Overall Study|Protocol Violation|3|||
129140241|NCT00401830|464806856|FG000|Overall Study|Non-compliance with drug study|1|||
129140242|NCT00401830|464806857|FG001|Overall Study|Non-compliance with drug study|0|||
129140243|NCT00401830|464806856|FG000|Overall Study|Lost to Follow-up|1|||
129140244|NCT00401830|464806857|FG001|Overall Study|Lost to Follow-up|3|||
129140245|NCT00401830|464806856|FG000|Overall Study|Other: Personal / Family problems|1|||
129140246|NCT00401830|464806857|FG001|Overall Study|Other: Personal / Family problems|0|||
129140247|NCT03378635|464806861|FG000|Overall Study|Adverse Event|1|||
129140248|NCT03378635|464806862|FG001|Overall Study|Adverse Event|0|||
129140249|NCT03378635|464806863|FG002|Overall Study|Adverse Event|0|||
129140250|NCT03378635|464806861|FG000|Overall Study|Withdrawal by Subject|1|||
129140251|NCT03378635|464806862|FG001|Overall Study|Withdrawal by Subject|0|||
129140252|NCT03378635|464806863|FG002|Overall Study|Withdrawal by Subject|0|||
129140253|NCT01316900|464806867|FG000|Overall Study|Adverse Event|10|||
129140254|NCT01316900|464806868|FG001|Overall Study|Adverse Event|10|||
129140255|NCT01316900|464806869|FG002|Overall Study|Adverse Event|15|||
129140256|NCT01316900|464806870|FG003|Overall Study|Adverse Event|9|||
129140257|NCT01316900|464806867|FG000|Overall Study|Lack of Efficacy|17|||
129140258|NCT01316900|464806868|FG001|Overall Study|Lack of Efficacy|9|||
129140259|NCT01316900|464806869|FG002|Overall Study|Lack of Efficacy|5|||
129140260|NCT01316900|464806870|FG003|Overall Study|Lack of Efficacy|7|||
129140261|NCT01316900|464806867|FG000|Overall Study|Protocol Violation|7|||
129140262|NCT01316900|464806868|FG001|Overall Study|Protocol Violation|1|||
129140263|NCT01316900|464806869|FG002|Overall Study|Protocol Violation|4|||
129140264|NCT01316900|464806870|FG003|Overall Study|Protocol Violation|0|||
129140265|NCT01316900|464806867|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
129140266|NCT01316900|464806868|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
129140267|NCT01316900|464806869|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
129140268|NCT01316900|464806870|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
129140269|NCT01316900|464806867|FG000|Overall Study|Lost to Follow-up|1|||
129140270|NCT01316900|464806868|FG001|Overall Study|Lost to Follow-up|0|||
129140271|NCT01316900|464806869|FG002|Overall Study|Lost to Follow-up|1|||
129140272|NCT01316900|464806870|FG003|Overall Study|Lost to Follow-up|1|||
129140273|NCT01316900|464806867|FG000|Overall Study|Withdrawal by Subject|7|||
129140274|NCT01316900|464806868|FG001|Overall Study|Withdrawal by Subject|8|||
129140275|NCT01316900|464806869|FG002|Overall Study|Withdrawal by Subject|6|||
129140276|NCT01316900|464806870|FG003|Overall Study|Withdrawal by Subject|9|||
129140277|NCT01684033|464806871|FG000|Period 1, First 30 Days|Adverse Event|1|||
129140278|NCT01684033|464806872|FG001|Period 1, First 30 Days|Adverse Event|1|||
129140279|NCT01684033|464806871|FG000|Period 1, First 30 Days|Noncompliance|1|||
129140280|NCT01684033|464806872|FG001|Period 1, First 30 Days|Noncompliance|0|||
129140281|NCT01684033|464806871|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
129140282|NCT01684033|464806872|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
129140283|NCT01684033|464806871|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
129140284|NCT01684033|464806872|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
129140285|NCT01684033|464806871|FG000|Period 2, Second 30 Days|Adverse Event|1|||
129140286|NCT01684033|464806872|FG001|Period 2, Second 30 Days|Adverse Event|0|||
129140287|NCT02496156|464806873|FG000|Overall Study|Lost to Follow-up|5|||
129140288|NCT02496156|464806874|FG001|Overall Study|Lost to Follow-up|0|||
129140289|NCT02496156|464806873|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
129140290|NCT02496156|464806874|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
129070871|NCT00070564|464548480|FG005|Overall Study|Withdrawal by Subject|8|||
129070872|NCT00070564|464548475|FG000|Overall Study|Not reported|0|||
129070873|NCT00070564|464548476|FG001|Overall Study|Not reported|0|||
128723953|NCT03913091|463287297|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
128723954|NCT03913091|463287298|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
128723955|NCT00969553|463287299|FG000|Overall Study|Progressive disease (PD)|2|||
128723956|NCT00969553|463287300|FG001|Overall Study|Progressive disease (PD)|2|||
129070874|NCT00070564|464548477|FG002|Overall Study|Not reported|0|||
129070875|NCT00070564|464548478|FG003|Overall Study|Not reported|0|||
128723957|NCT00969553|463287301|FG002|Overall Study|Progressive disease (PD)|6|||
128723958|NCT00969553|463287302|FG003|Overall Study|Progressive disease (PD)|9|||
129070876|NCT00070564|464548479|FG004|Overall Study|Not reported|1|||
129070877|NCT00070564|464548480|FG005|Overall Study|Not reported|0|||
129070878|NCT00931528|464548481|FG000|Overall Study|Protocol Violation|9|||
129070879|NCT00931528|464548482|FG001|Overall Study|Protocol Violation|12|||
129070880|NCT00931528|464548481|FG000|Overall Study|Withdrawal by Subject|4|||
129070881|NCT00931528|464548482|FG001|Overall Study|Withdrawal by Subject|12|||
129070882|NCT00931528|464548481|FG000|Overall Study|Lost to Follow-up|6|||
129070883|NCT00931528|464548482|FG001|Overall Study|Lost to Follow-up|13|||
129070884|NCT00931528|464548481|FG000|Overall Study|Assessment outside of Time Frame|22|||
129070885|NCT00931528|464548482|FG001|Overall Study|Assessment outside of Time Frame|23|||
129070886|NCT02115269|464548483|FG000|Overall Study|Lost to Follow-up|43|||
129070887|NCT02115269|464548483|FG000|Overall Study|Did not complete patient diary|3|||
129070888|NCT02115269|464548483|FG000|Overall Study|Moved to another city|7|||
129070889|NCT02115269|464548483|FG000|Overall Study|Withdrawal by Subject|2|||
129070890|NCT02115269|464548483|FG000|Overall Study|Didn't take study drug|2|||
129070891|NCT01557504|464548484|FG000|Overall Study|Physician Decision|1|||
129070892|NCT01557504|464548485|FG001|Overall Study|Physician Decision|0|||
129070893|NCT02750618|464548486|FG000|Overall Study|Withdrawal by Subject|1|||
129070894|NCT02572570|464548492|FG000|Overall Study|Study Terminated|27|||
129070895|NCT02763046|464548493|FG000|Overall Study|Adverse Event|5|||
129070896|NCT02763046|464548494|FG001|Overall Study|Adverse Event|4|||
129070897|NCT02763046|464548495|FG002|Overall Study|Adverse Event|0|||
129070898|NCT02763046|464548493|FG000|Overall Study|Lack of Efficacy|1|||
129070899|NCT02763046|464548494|FG001|Overall Study|Lack of Efficacy|1|||
129070900|NCT02763046|464548495|FG002|Overall Study|Lack of Efficacy|3|||
129070901|NCT02763046|464548493|FG000|Overall Study|Physician Decision|1|||
129070902|NCT02763046|464548494|FG001|Overall Study|Physician Decision|0|||
129070903|NCT02763046|464548495|FG002|Overall Study|Physician Decision|1|||
129070904|NCT02763046|464548493|FG000|Overall Study|Subject/guardian decision|2|||
129070905|NCT02763046|464548494|FG001|Overall Study|Subject/guardian decision|0|||
129070906|NCT02763046|464548495|FG002|Overall Study|Subject/guardian decision|4|||
129070907|NCT05017246|464548496|FG000|Overall Study|Withdrawal by Subject|5|||
129070908|NCT05017246|464548497|FG001|Overall Study|Withdrawal by Subject|3|||
129070909|NCT05017246|464548496|FG000|Overall Study|Determined to be ineligible|0|||
129070910|NCT05017246|464548497|FG001|Overall Study|Determined to be ineligible|1|||
129070911|NCT05017246|464548496|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
129070912|NCT05017246|464548497|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
129140291|NCT00089583|464806875|FG000|Overall Study|Adverse Event|0|||
129140292|NCT00089583|464806876|FG001|Overall Study|Adverse Event|3|||
129140293|NCT00089583|464806875|FG000|Overall Study|Insufficient Viral Load Response|5|||
129140294|NCT00089583|464806876|FG001|Overall Study|Insufficient Viral Load Response|5|||
129140295|NCT00089583|464806875|FG000|Overall Study|Withdrawal by Subject|0|||
129140296|NCT00089583|464806876|FG001|Overall Study|Withdrawal by Subject|4|||
129140297|NCT00089583|464806875|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
129140298|NCT00089583|464806876|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
129140299|NCT00089583|464806875|FG000|Overall Study|Participant Refused Study Medication|0|||
129140300|NCT00089583|464806876|FG001|Overall Study|Participant Refused Study Medication|2|||
129140301|NCT00089583|464806875|FG000|Overall Study|Non-Compliance|0|||
129140302|NCT00089583|464806876|FG001|Overall Study|Non-Compliance|4|||
128723959|NCT00969553|463287303|FG004|Overall Study|Progressive disease (PD)|2|||
128723960|NCT00969553|463287304|FG005|Overall Study|Progressive disease (PD)|4|||
128723961|NCT00969553|463287305|FG006|Overall Study|Progressive disease (PD)|2|||
128723962|NCT00969553|463287306|FG007|Overall Study|Progressive disease (PD)|12|||
129070913|NCT05017246|464548496|FG000|Overall Study|Technical failure|1|||
129070914|NCT05017246|464548497|FG001|Overall Study|Technical failure|3|||
129070915|NCT01514461|464548498|FG000|Overall Study|Adverse Event|2|||
129070916|NCT01514461|464548499|FG001|Overall Study|Adverse Event|1|||
129070917|NCT01514461|464548500|FG002|Overall Study|Adverse Event|3|||
129070918|NCT01514461|464548498|FG000|Overall Study|Physician Decision|1|||
129070919|NCT01514461|464548499|FG001|Overall Study|Physician Decision|1|||
129070920|NCT01514461|464548500|FG002|Overall Study|Physician Decision|0|||
129140303|NCT00089583|464806875|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
129140304|NCT00089583|464806876|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
129140305|NCT00089583|464806875|FG000|Overall Study|Participant Management Criteria Met|0|||
129070921|NCT01514461|464548498|FG000|Overall Study|Patient/guardian decision|1|||
129070922|NCT01514461|464548499|FG001|Overall Study|Patient/guardian decision|1|||
129070923|NCT01514461|464548500|FG002|Overall Study|Patient/guardian decision|1|||
129070924|NCT01514461|464548498|FG000|Overall Study|Death|1|||
129140306|NCT00089583|464806876|FG001|Overall Study|Participant Management Criteria Met|1|||
129070925|NCT01514461|464548499|FG001|Overall Study|Death|0|||
129070926|NCT01514461|464548500|FG002|Overall Study|Death|0|||
129070927|NCT02058069|464548501|FG000|Overall Study|Exclusion due to implant size|5|||
129070928|NCT02058069|464548501|FG000|Overall Study|Withdrawal by Subject|6|||
129070929|NCT02676882|464548517|FG000|Overall Study|Adverse Event|1|||
128723963|NCT00969553|463287307|FG008|Overall Study|Progressive disease (PD)|3|||
128723964|NCT00969553|463287299|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
128723965|NCT00969553|463287300|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
128723966|NCT00969553|463287301|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
129070930|NCT02676882|464548518|FG001|Overall Study|Adverse Event|0|||
129070931|NCT02676882|464548517|FG000|Overall Study|Lost to Follow-up|1|||
129070932|NCT02676882|464548518|FG001|Overall Study|Lost to Follow-up|0|||
129070933|NCT02676882|464548517|FG000|Overall Study|Withdrawal by Subject|1|||
129070934|NCT02676882|464548518|FG001|Overall Study|Withdrawal by Subject|2|||
129070935|NCT02568072|464548519|FG000|Overall Study|Unavailable for appointment|23|||
129070936|NCT02568072|464548519|FG000|Overall Study|Unable to contact|3|||
129070937|NCT02568072|464548519|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
129070938|NCT02568072|464548519|FG000|Overall Study|Withdrawal by Subject|1|||
129070939|NCT02568072|464548519|FG000|Overall Study|Sustained injury, marathon not run|24|||
129070940|NCT00958828|464548521|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
129070941|NCT00958828|464548522|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
129070942|NCT00958828|464548521|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
129070943|NCT00958828|464548522|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
129070944|NCT02687451|464548529|FG000|Overall Study|Withdrawal by Subject|1|||
129070945|NCT02687451|464548530|FG001|Overall Study|Withdrawal by Subject|0|||
129070946|NCT02687451|464548531|FG002|Overall Study|Withdrawal by Subject|0|||
129070947|NCT02687451|464548532|FG003|Overall Study|Withdrawal by Subject|0|||
129070948|NCT02687451|464548533|FG004|Overall Study|Withdrawal by Subject|0|||
129070949|NCT02687451|464548534|FG005|Overall Study|Withdrawal by Subject|1|||
129070950|NCT00927589|464548535|FG000|Overall Study|Death|1|||
129070951|NCT00927589|464548535|FG000|Overall Study|Physician Decision|1|||
129070952|NCT00927589|464548535|FG000|Overall Study|Withdrawal by Subject|3|||
129070953|NCT00927589|464548535|FG000|Overall Study|Adverse Event|2|||
129070954|NCT00927589|464548535|FG000|Overall Study|Disease Progression|8|||
129070955|NCT00927589|464548535|FG000|Overall Study|Non-compliance|1|||
129070956|NCT01125189|464548536|FG000|Treatment Period|Lack of Efficacy|15|||
129070957|NCT01125189|464548537|FG001|Treatment Period|Lack of Efficacy|18|||
129070958|NCT01125189|464548538|FG002|Treatment Period|Lack of Efficacy|25|||
129070959|NCT01125189|464548536|FG000|Treatment Period|Adverse Event|7|||
129070960|NCT01125189|464548537|FG001|Treatment Period|Adverse Event|8|||
129070961|NCT01125189|464548538|FG002|Treatment Period|Adverse Event|8|||
129070962|NCT01125189|464548536|FG000|Treatment Period|Withdrawal by Subject|3|||
129070963|NCT01125189|464548537|FG001|Treatment Period|Withdrawal by Subject|1|||
129070964|NCT01125189|464548538|FG002|Treatment Period|Withdrawal by Subject|1|||
129070965|NCT01125189|464548536|FG000|Treatment Period|Death|1|||
129070966|NCT01125189|464548537|FG001|Treatment Period|Death|0|||
129070967|NCT01125189|464548538|FG002|Treatment Period|Death|0|||
129070968|NCT01125189|464548536|FG000|Treatment Period|Lost to Follow-up|1|||
129070969|NCT01125189|464548537|FG001|Treatment Period|Lost to Follow-up|2|||
129070970|NCT01125189|464548538|FG002|Treatment Period|Lost to Follow-up|1|||
129070971|NCT01125189|464548536|FG000|Treatment Period|Poor compliance/noncompliance|0|||
129070972|NCT01125189|464548537|FG001|Treatment Period|Poor compliance/noncompliance|1|||
129070973|NCT01125189|464548538|FG002|Treatment Period|Poor compliance/noncompliance|0|||
129070974|NCT01125189|464548536|FG000|Treatment Period|Participants requested to discontinue|1|||
129070975|NCT01125189|464548537|FG001|Treatment Period|Participants requested to discontinue|3|||
129070976|NCT01125189|464548538|FG002|Treatment Period|Participants requested to discontinue|4|||
129070977|NCT01125189|464548536|FG000|Treatment Period|Other reasons|1|||
129070978|NCT01125189|464548537|FG001|Treatment Period|Other reasons|1|||
129070979|NCT01125189|464548538|FG002|Treatment Period|Other reasons|0|||
129070980|NCT01125189|464548536|FG000|Treatment Period|Completed 24 week treatment period only|2|||
129070981|NCT01125189|464548537|FG001|Treatment Period|Completed 24 week treatment period only|1|||
129070982|NCT01125189|464548538|FG002|Treatment Period|Completed 24 week treatment period only|2|||
129070983|NCT01125189|464548536|FG000|Follow up Period|Withdrawal by Subject|3|||
129070984|NCT01125189|464548537|FG001|Follow up Period|Withdrawal by Subject|2|||
129070985|NCT01125189|464548538|FG002|Follow up Period|Withdrawal by Subject|5|||
129070986|NCT01125189|464548536|FG000|Follow up Period|Death|1|||
129070987|NCT01125189|464548537|FG001|Follow up Period|Death|0|||
129070988|NCT01125189|464548538|FG002|Follow up Period|Death|0|||
129070989|NCT01125189|464548536|FG000|Follow up Period|Lost to Follow-up|12|||
129070990|NCT01125189|464548537|FG001|Follow up Period|Lost to Follow-up|9|||
129070991|NCT01125189|464548538|FG002|Follow up Period|Lost to Follow-up|6|||
129070992|NCT01125189|464548536|FG000|Follow up Period|Other reasons|4|||
129070993|NCT01125189|464548537|FG001|Follow up Period|Other reasons|4|||
129070994|NCT01125189|464548538|FG002|Follow up Period|Other reasons|5|||
129070995|NCT00707239|464548539|FG000|Overall Study|Adverse Event|5|||
129070996|NCT00707239|464548540|FG001|Overall Study|Adverse Event|3|||
129070997|NCT00707239|464548541|FG002|Overall Study|Adverse Event|2|||
129070998|NCT00707239|464548539|FG000|Overall Study|Death|3|||
129070999|NCT00707239|464548540|FG001|Overall Study|Death|1|||
129071000|NCT00707239|464548541|FG002|Overall Study|Death|3|||
129071001|NCT00707239|464548539|FG000|Overall Study|Physician Decision|1|||
129071002|NCT00707239|464548540|FG001|Overall Study|Physician Decision|1|||
129071003|NCT00707239|464548541|FG002|Overall Study|Physician Decision|2|||
129140307|NCT00089583|464806875|FG000|Overall Study|Reason Not Provided|0|||
129140308|NCT00089583|464806876|FG001|Overall Study|Reason Not Provided|1|||
129140309|NCT00089583|464806875|FG000|Overall Study|Protocol Violation|0|||
129071004|NCT00707239|464548539|FG000|Overall Study|Protocol Violation|0|||
129071005|NCT00707239|464548540|FG001|Overall Study|Protocol Violation|0|||
129071006|NCT00707239|464548541|FG002|Overall Study|Protocol Violation|1|||
129071007|NCT00707239|464548539|FG000|Overall Study|Lack of Efficacy|1|||
129071008|NCT00707239|464548540|FG001|Overall Study|Lack of Efficacy|2|||
129071009|NCT00707239|464548541|FG002|Overall Study|Lack of Efficacy|0|||
129071010|NCT00707239|464548539|FG000|Overall Study|Randomized, but not treated|1|||
129071011|NCT00707239|464548540|FG001|Overall Study|Randomized, but not treated|1|||
129071012|NCT00707239|464548541|FG002|Overall Study|Randomized, but not treated|1|||
129071013|NCT00707239|464548539|FG000|Overall Study|Other|8|||
129140310|NCT00089583|464806876|FG001|Overall Study|Protocol Violation|3|||
129071014|NCT00707239|464548540|FG001|Overall Study|Other|3|||
129071015|NCT00707239|464548541|FG002|Overall Study|Other|5|||
129071016|NCT02088177|464548542|FG000|Overall Study|Lost to Follow-up|3|||
129071017|NCT03472014|464548543|FG000|Overall Study|Lost to Follow-up|4|||
129071018|NCT03743051|464548544|FG000|Overall Study|Adverse Event|5|||
129071019|NCT03743051|464548545|FG001|Overall Study|Adverse Event|9|||
129071020|NCT03743051|464548544|FG000|Overall Study|Death|27|||
129071021|NCT03743051|464548545|FG001|Overall Study|Death|26|||
129071022|NCT03743051|464548544|FG000|Overall Study|Lost to Follow-up|4|||
129071023|NCT03743051|464548545|FG001|Overall Study|Lost to Follow-up|8|||
129071024|NCT03743051|464548544|FG000|Overall Study|Withdrawal by Subject|32|||
129140311|NCT00089583|464806875|FG000|Overall Study|Principal Investigator Decision|0|||
129140312|NCT00089583|464806876|FG001|Overall Study|Principal Investigator Decision|10|||
129140313|NCT00089583|464806875|FG000|Overall Study|Start of Disallowed Medication|0|||
129140314|NCT00089583|464806876|FG001|Overall Study|Start of Disallowed Medication|1|||
129140315|NCT00089583|464806875|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
129140316|NCT00089583|464806876|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
129140317|NCT00089583|464806875|FG000|Overall Study|Participant Incarcerated|0|||
129140318|NCT00089583|464806876|FG001|Overall Study|Participant Incarcerated|1|||
129140319|NCT00507507|464806877|FG000|Treatment Period|Lost to Follow-up|0|||
129140320|NCT00507507|464806878|FG001|Treatment Period|Lost to Follow-up|2|||
129140321|NCT00507507|464806877|FG000|Treatment Period|Physician Decision|4|||
129140322|NCT00507507|464806878|FG001|Treatment Period|Physician Decision|1|||
129140323|NCT00507507|464806877|FG000|Treatment Period|Protocol Violation|1|||
129140324|NCT00507507|464806878|FG001|Treatment Period|Protocol Violation|2|||
129140325|NCT00507507|464806877|FG000|Treatment Period|Adverse Event|1|||
129140326|NCT00507507|464806878|FG001|Treatment Period|Adverse Event|1|||
129140327|NCT00507507|464806877|FG000|Treatment Period|Withdrawal by Subject|46|||
129140328|NCT00507507|464806878|FG001|Treatment Period|Withdrawal by Subject|47|||
129140329|NCT00507507|464806877|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
129140330|NCT00507507|464806878|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
129140331|NCT00507507|464806877|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
129140332|NCT00507507|464806878|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
129140333|NCT00507507|464806877|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
129140334|NCT00507507|464806878|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
129140335|NCT02916433|464806879|FG000|Overall Study|Withdrawal by Subject|1|||
129140336|NCT02916433|464806880|FG001|Overall Study|Withdrawal by Subject|0|||
129140337|NCT02916433|464806879|FG000|Overall Study|Physician Decision|1|||
129140338|NCT02916433|464806880|FG001|Overall Study|Physician Decision|0|||
129140339|NCT03760666|464806881|FG000|Overall Study|Adverse Event|2|||
129140340|NCT03760666|464806882|FG001|Overall Study|Adverse Event|4|||
129140341|NCT03760666|464806883|FG002|Overall Study|Adverse Event|1|||
129140342|NCT03760666|464806881|FG000|Overall Study|AML Disease Progression|3|||
129140343|NCT03760666|464806882|FG001|Overall Study|AML Disease Progression|3|||
129140344|NCT03760666|464806883|FG002|Overall Study|AML Disease Progression|0|||
129140345|NCT03760666|464806881|FG000|Overall Study|Physician Decision|0|||
129140346|NCT03760666|464806882|FG001|Overall Study|Physician Decision|3|||
129140347|NCT03760666|464806883|FG002|Overall Study|Physician Decision|0|||
129140348|NCT03760666|464806881|FG000|Overall Study|Withdrawal by Subject|0|||
129140349|NCT03760666|464806882|FG001|Overall Study|Withdrawal by Subject|1|||
129140350|NCT03760666|464806883|FG002|Overall Study|Withdrawal by Subject|0|||
129140351|NCT01623154|464806884|FG000|Overall Study|Did not drink Pranactin Citric|4|||
129140352|NCT00890097|464806885|FG000|Overall Study|Adverse Event|21|||
129140353|NCT00890097|464806886|FG001|Overall Study|Adverse Event|32|||
129140354|NCT00890097|464806887|FG002|Overall Study|Adverse Event|28|||
129140355|NCT00890097|464806885|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
129140356|NCT00890097|464806886|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
129140357|NCT00890097|464806887|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
129140358|NCT00890097|464806885|FG000|Overall Study|Withdrew Consent|9|||
129140359|NCT00890097|464806886|FG001|Overall Study|Withdrew Consent|6|||
129140360|NCT00890097|464806887|FG002|Overall Study|Withdrew Consent|9|||
129140361|NCT00890097|464806885|FG000|Overall Study|Lost to Follow-up|5|||
129140362|NCT00890097|464806886|FG001|Overall Study|Lost to Follow-up|5|||
129140363|NCT00890097|464806887|FG002|Overall Study|Lost to Follow-up|5|||
129140364|NCT00890097|464806885|FG000|Overall Study|Noncompliance|0|||
128723967|NCT00969553|463287302|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
128723968|NCT00969553|463287303|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
128723969|NCT00969553|463287304|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
128723970|NCT00969553|463287305|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
128723971|NCT00969553|463287306|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
129071025|NCT03743051|464548545|FG001|Overall Study|Withdrawal by Subject|19|||
129071026|NCT03743051|464548544|FG000|Overall Study|Physician Decision|10|||
129071027|NCT03743051|464548545|FG001|Overall Study|Physician Decision|15|||
129071028|NCT03743051|464548544|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
129071029|NCT03743051|464548545|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
129071030|NCT00711087|464548548|FG000|Overall Study|Lost to Follow-up|1|||
129071031|NCT00711087|464548549|FG001|Overall Study|Lost to Follow-up|0|||
129071032|NCT00811733|464548550|FG000|Overall Study|Investigator Discretion|10|||
129071033|NCT00811733|464548551|FG001|Overall Study|Investigator Discretion|8|||
129071034|NCT00811733|464548550|FG000|Overall Study|Withdrawal by Subject|1|||
129071035|NCT00811733|464548551|FG001|Overall Study|Withdrawal by Subject|2|||
129071036|NCT00793871|464548552|FG000|Overall Study|Death|50|||
129071037|NCT00793871|464548552|FG000|Overall Study|Lost to Follow-up|3|||
129071038|NCT00793871|464548552|FG000|Overall Study|Study terminated by the Sponsor|7|||
129071039|NCT01113892|464548555|FG000|Overall Study|Lost to Follow-up|2|||
129071040|NCT01113892|464548556|FG001|Overall Study|Lost to Follow-up|2|||
129071041|NCT01113892|464548555|FG000|Overall Study|Withdrawal by Subject|1|||
129071042|NCT01113892|464548556|FG001|Overall Study|Withdrawal by Subject|1|||
129071043|NCT01113892|464548555|FG000|Overall Study|Death|2|||
129071044|NCT01113892|464548556|FG001|Overall Study|Death|4|||
129140365|NCT00890097|464806886|FG001|Overall Study|Noncompliance|4|||
129140366|NCT00890097|464806887|FG002|Overall Study|Noncompliance|4|||
129140367|NCT00890097|464806885|FG000|Overall Study|Sponsor Decision|7|||
129140368|NCT00890097|464806886|FG001|Overall Study|Sponsor Decision|11|||
129140369|NCT00890097|464806887|FG002|Overall Study|Sponsor Decision|7|||
129140370|NCT00890097|464806885|FG000|Overall Study|Did not attend final visit|2|||
129140371|NCT00890097|464806886|FG001|Overall Study|Did not attend final visit|3|||
129140372|NCT00890097|464806887|FG002|Overall Study|Did not attend final visit|0|||
129071045|NCT01113892|464548555|FG000|Overall Study|Graft no longer evaluable|9|||
129071046|NCT01113892|464548556|FG001|Overall Study|Graft no longer evaluable|9|||
129071047|NCT02569801|464548557|FG000|Overall Study|Withdrawal by Subject|9|||
129071048|NCT02569801|464548558|FG001|Overall Study|Withdrawal by Subject|9|||
129071049|NCT02569801|464548557|FG000|Overall Study|Sponsor Decision|13|||
129071050|NCT02569801|464548558|FG001|Overall Study|Sponsor Decision|14|||
129140373|NCT00890097|464806885|FG000|Overall Study|Subject Decision|3|||
129140374|NCT00890097|464806886|FG001|Overall Study|Subject Decision|2|||
129140375|NCT00890097|464806887|FG002|Overall Study|Subject Decision|6|||
129140376|NCT00890097|464806885|FG000|Overall Study|Randomization Error|2|||
129140377|NCT00890097|464806886|FG001|Overall Study|Randomization Error|0|||
129140378|NCT00890097|464806887|FG002|Overall Study|Randomization Error|0|||
129140379|NCT00890097|464806885|FG000|Overall Study|Failed inclusion criteria|3|||
129140380|NCT00890097|464806886|FG001|Overall Study|Failed inclusion criteria|4|||
129140381|NCT00890097|464806887|FG002|Overall Study|Failed inclusion criteria|0|||
129140382|NCT00890097|464806885|FG000|Overall Study|Transportation|0|||
129140383|NCT00890097|464806886|FG001|Overall Study|Transportation|2|||
129140384|NCT00890097|464806887|FG002|Overall Study|Transportation|0|||
129140385|NCT00890097|464806885|FG000|Overall Study|Subject Moved|0|||
129140386|NCT00890097|464806886|FG001|Overall Study|Subject Moved|4|||
129140387|NCT00890097|464806887|FG002|Overall Study|Subject Moved|0|||
129140388|NCT00890097|464806885|FG000|Overall Study|Protocol Deviation|1|||
129140389|NCT00890097|464806886|FG001|Overall Study|Protocol Deviation|1|||
129140390|NCT00890097|464806887|FG002|Overall Study|Protocol Deviation|1|||
129140391|NCT02656173|464806891|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
129140392|NCT02656173|464806892|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
129140393|NCT02656173|464806891|FG000|Overall Study|Adverse Event|7|||
129140394|NCT02656173|464806892|FG001|Overall Study|Adverse Event|5|||
129140395|NCT02656173|464806891|FG000|Overall Study|Withdrawal by Subject|1|||
129140396|NCT02656173|464806892|FG001|Overall Study|Withdrawal by Subject|3|||
129140397|NCT02656173|464806891|FG000|Overall Study|Protocol Violation|0|||
129140398|NCT02656173|464806892|FG001|Overall Study|Protocol Violation|1|||
129140399|NCT02656173|464806891|FG000|Overall Study|Miscellaneous|2|||
129140400|NCT02656173|464806892|FG001|Overall Study|Miscellaneous|0|||
129140401|NCT01064622|464806893|FG000|Randomized Phase II|Withdrawal by Subject|2|||
129140402|NCT01064622|464806894|FG001|Randomized Phase II|Withdrawal by Subject|2|||
129140403|NCT01064622|464806893|FG000|Randomized Phase II|Protocol Violation|0|||
129140404|NCT01064622|464806894|FG001|Randomized Phase II|Protocol Violation|1|||
129140405|NCT03449147|464806895|FG000|52-week Treatment Period|Death|0|||
129140406|NCT03449147|464806896|FG001|52-week Treatment Period|Death|1|||
128723972|NCT00969553|463287307|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
129071051|NCT02569801|464548557|FG000|Overall Study|Progressive Disease|2|||
129140407|NCT03449147|464806897|FG002|52-week Treatment Period|Death|0|||
129140408|NCT03449147|464806895|FG000|52-week Treatment Period|Lost to Follow-up|6|||
129071052|NCT02569801|464548558|FG001|Overall Study|Progressive Disease|7|||
129071053|NCT02569801|464548557|FG000|Overall Study|Lost to Follow-up|0|||
129071054|NCT02569801|464548558|FG001|Overall Study|Lost to Follow-up|1|||
129071055|NCT02569801|464548557|FG000|Overall Study|Death|12|||
129071056|NCT02569801|464548558|FG001|Overall Study|Death|4|||
129071057|NCT00428246|464548559|FG000|Overall Study|Withdrawal by Subject|0|||
129071058|NCT00428246|464548560|FG001|Overall Study|Withdrawal by Subject|0|||
129071059|NCT00428246|464548561|FG002|Overall Study|Withdrawal by Subject|1|||
129071060|NCT00428246|464548559|FG000|Overall Study|Adverse Event|1|||
129071061|NCT00428246|464548560|FG001|Overall Study|Adverse Event|0|||
129071062|NCT00428246|464548561|FG002|Overall Study|Adverse Event|0|||
129071063|NCT03442751|464548563|FG000|Overall Study|Withdrawal by Subject|3|||
129071064|NCT03442751|464548564|FG001|Overall Study|Withdrawal by Subject|1|||
129071065|NCT03442751|464548563|FG000|Overall Study|Lost to Follow-up|3|||
129071066|NCT03442751|464548564|FG001|Overall Study|Lost to Follow-up|0|||
129071067|NCT02603887|464548565|FG000|Stage 1|Adverse Event|4|||
129071068|NCT02603887|464548565|FG000|Stage 1|Disease progression|1|||
129071069|NCT02603887|464548565|FG000|Stage 2|FDA guidance|1|||
129071070|NCT03164551|464548566|FG000|Overall Study|Imaging discontinued prior completion|8|||
129071071|NCT03164551|464548567|FG001|Overall Study|Imaging discontinued prior completion|0|||
129071072|NCT03164551|464548566|FG000|Overall Study|Participant was non-compliant|1|||
129071073|NCT03164551|464548567|FG001|Overall Study|Participant was non-compliant|0|||
129071074|NCT03164551|464548566|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
129071075|NCT03164551|464548567|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
129071076|NCT03164551|464548566|FG000|Overall Study|Other|8|||
129071077|NCT03164551|464548567|FG001|Overall Study|Other|2|||
129071078|NCT00470470|464548576|FG000|Overall Study|Adverse Event|2|||
129071079|NCT00470470|464548576|FG000|Overall Study|Death|2|||
129071080|NCT00470470|464548576|FG000|Overall Study|Not treated|1|||
129071081|NCT02072980|464548583|FG000|Period 2, Second Wear|Adverse Event|0|||
129071082|NCT02072980|464548584|FG001|Period 2, Second Wear|Adverse Event|1|||
129071083|NCT01757275|464548585|FG000|Overall Study|Lost to Follow-up|1|||
129071084|NCT01757275|464548586|FG001|Overall Study|Lost to Follow-up|2|||
129071085|NCT01757275|464548585|FG000|Overall Study|Adverse Event|3|||
129071086|NCT01757275|464548586|FG001|Overall Study|Adverse Event|3|||
129071087|NCT01757275|464548585|FG000|Overall Study|Withdrawal by Subject|2|||
129071088|NCT01757275|464548586|FG001|Overall Study|Withdrawal by Subject|4|||
129071089|NCT01757275|464548585|FG000|Overall Study|Not treated|3|||
129071090|NCT01757275|464548586|FG001|Overall Study|Not treated|4|||
129071091|NCT01401452|464548589|FG000|Overall Study|Adverse reaction|9|||
129071092|NCT01401452|464548589|FG000|Overall Study|Lost to Follow-up|12|||
129071093|NCT01401452|464548589|FG000|Overall Study|Lack of Efficacy|30|||
129071094|NCT01401452|464548589|FG000|Overall Study|Participant developed breast cancer|1|||
129071095|NCT01401452|464548589|FG000|Overall Study|Tx stopped due to financial reasons|1|||
129071096|NCT01401452|464548589|FG000|Overall Study|Tx stopped by psychiatrist|1|||
129071097|NCT01401452|464548589|FG000|Overall Study|No more visits within the 36 wk followup|4|||
129071098|NCT01401452|464548589|FG000|Overall Study|Subject did not come to follow up visits|2|||
129071099|NCT01401452|464548589|FG000|Overall Study|Subject didn't return for routine visits|1|||
129071100|NCT01401452|464548589|FG000|Overall Study|Subject moved to another city|1|||
129071101|NCT01401452|464548589|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
129071102|NCT01401452|464548589|FG000|Overall Study|Psoriatic arthritis|1|||
129071103|NCT01401452|464548589|FG000|Overall Study|Participant stopped Tx|2|||
129071104|NCT01401452|464548589|FG000|Overall Study|Discontinuation for personal reasons|1|||
129071105|NCT01401452|464548589|FG000|Overall Study|Treatment failure|1|||
129071106|NCT01401452|464548589|FG000|Overall Study|Unsatisfactory output|1|||
129071107|NCT01401452|464548589|FG000|Overall Study|Subject withdrew because of Tx success|1|||
129071108|NCT01401452|464548589|FG000|Overall Study|Subject chose to discontinue treatment|1|||
129071109|NCT01401452|464548589|FG000|Overall Study|Participant withdrew consent|1|||
129071110|NCT02601014|464548590|FG000|Overall Study|Adverse Event|3|||
129071111|NCT02601014|464548591|FG001|Overall Study|Adverse Event|3|||
129071112|NCT02601014|464548590|FG000|Overall Study|Death|3|||
129071113|NCT02601014|464548591|FG001|Overall Study|Death|1|||
129071114|NCT02601014|464548590|FG000|Overall Study|Disease progression|4|||
129071115|NCT02601014|464548591|FG001|Overall Study|Disease progression|8|||
129071116|NCT01168427|464548592|FG000|Overall Study|Patient exited prior to implant|1|||
129071117|NCT01133067|464548597|FG000|Overall Study|Death|136|||
129071118|NCT01133067|464548597|FG000|Overall Study|Lost to Follow-up|3|||
129071119|NCT00273182|464548599|FG000|Overall Study|Death|450|||
129071120|NCT00273182|464548599|FG000|Overall Study|Lost to Follow-up|88|||
129071121|NCT00273182|464548599|FG000|Overall Study|Withdrawal by Subject|257|||
129071122|NCT00273182|464548599|FG000|Overall Study|Device/System Explant|154|||
129071123|NCT00273182|464548599|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
129071124|NCT00420420|464548600|FG000|Overall Study|Adverse Event|5|||
129071125|NCT00420420|464548601|FG001|Overall Study|Adverse Event|3|||
129071126|NCT00420420|464548600|FG000|Overall Study|Protocol Violation|1|||
129071127|NCT00420420|464548601|FG001|Overall Study|Protocol Violation|1|||
129071128|NCT00420420|464548600|FG000|Overall Study|Withdrawal by Subject|1|||
129071129|NCT00420420|464548601|FG001|Overall Study|Withdrawal by Subject|0|||
129071130|NCT00420420|464548600|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
129071131|NCT00420420|464548601|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
129071132|NCT00868530|464548602|FG000|Overall Study|Adverse Event|3|||
129071133|NCT00868530|464548602|FG000|Overall Study|Lost to Follow-up|1|||
129071134|NCT00858273|464548603|FG000|Overall Study|Protocol Violation|3|||
129071135|NCT00858273|464548604|FG001|Overall Study|Protocol Violation|5|||
129071136|NCT02562235|464550650|FG000|Overall Study|Adverse Event|3|||
129071137|NCT01168232|464550653|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
129071138|NCT01168232|464550653|FG000|Overall Study|Ineligible- Wrong cell type|6|||
129071139|NCT01168232|464550653|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
129071140|NCT05012098|464550657|FG000|Overall Study|Disease progression|5|||
129071141|NCT05012098|464550658|FG001|Overall Study|Disease progression|2|||
129140409|NCT03449147|464806896|FG001|52-week Treatment Period|Lost to Follow-up|2|||
129140410|NCT03449147|464806897|FG002|52-week Treatment Period|Lost to Follow-up|5|||
129140411|NCT03449147|464806895|FG000|52-week Treatment Period|Other|0|||
129140412|NCT03449147|464806896|FG001|52-week Treatment Period|Other|1|||
129140413|NCT03449147|464806897|FG002|52-week Treatment Period|Other|2|||
129140414|NCT03449147|464806895|FG000|52-week Treatment Period|Physician Decision|1|||
129140415|NCT03449147|464806896|FG001|52-week Treatment Period|Physician Decision|0|||
129140416|NCT03449147|464806897|FG002|52-week Treatment Period|Physician Decision|3|||
129140417|NCT03449147|464806895|FG000|52-week Treatment Period|Screen Failure|1|||
129140418|NCT03449147|464806896|FG001|52-week Treatment Period|Screen Failure|2|||
129140419|NCT03449147|464806897|FG002|52-week Treatment Period|Screen Failure|0|||
129140420|NCT03449147|464806895|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
129140421|NCT03449147|464806896|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
129140422|NCT03449147|464806897|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
129140423|NCT03449147|464806895|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
129140424|NCT03449147|464806896|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
129140425|NCT03449147|464806897|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
129140426|NCT03449147|464806895|FG000|12-Week Off-Treatment Durability Period|Other|0|||
129140427|NCT03449147|464806896|FG001|12-Week Off-Treatment Durability Period|Other|1|||
129140428|NCT03449147|464806897|FG002|12-Week Off-Treatment Durability Period|Other|0|||
129140429|NCT00974233|464806901|FG000|Induction Chemoimmunotherapy|Death|2|||
129140430|NCT00974233|464806901|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
129140431|NCT00974233|464806901|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
129140432|NCT00974233|464806901|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
129140433|NCT00974233|464806901|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
129140434|NCT00974233|464806901|FG000|Maintenance Lenalidomide|Adverse Event|8|||
129140435|NCT01691092|464806902|FG000|Overall Study|Lost to Follow-up|10|||
129140436|NCT01691092|464806902|FG000|Overall Study|Physician Decision|4|||
129140437|NCT01691092|464806902|FG000|Overall Study|Withdrawal by Subject|3|||
129140438|NCT01691092|464806902|FG000|Overall Study|non-compliance|3|||
129140439|NCT01691092|464806902|FG000|Overall Study|used for different study|2|||
129140440|NCT01691092|464806902|FG000|Overall Study|screen fail|19|||
129071142|NCT05012098|464550657|FG000|Overall Study|Adverse Event|1|||
129071143|NCT05012098|464550658|FG001|Overall Study|Adverse Event|0|||
129071144|NCT05012098|464550657|FG000|Overall Study|Withdrawal by Subject|1|||
129071145|NCT05012098|464550658|FG001|Overall Study|Withdrawal by Subject|0|||
129071146|NCT05012098|464550657|FG000|Overall Study|Discontinuation per protocol|1|||
129071147|NCT05012098|464550658|FG001|Overall Study|Discontinuation per protocol|0|||
129071148|NCT01490086|464550659|FG000|Overall Study|Consent withdrawn|4|||
129140441|NCT01657942|464806903|FG000|Overall Study|Alternative Treatment|7|||
129140442|NCT01657942|464806903|FG000|Overall Study|Lost to Follow-up|1|||
129140443|NCT01569763|464808687|FG000|Overall Study|Lack of Efficacy|2|||
129140444|NCT01569763|464808688|FG001|Overall Study|Lack of Efficacy|7|||
129140445|NCT01569763|464808687|FG000|Overall Study|Adverse Event|1|||
129140446|NCT01569763|464808688|FG001|Overall Study|Adverse Event|0|||
129140447|NCT03211858|464808695|FG000|Overall Study|Adverse Event|8|||
129140448|NCT03211858|464808696|FG001|Overall Study|Adverse Event|6|||
129071149|NCT01490086|464550660|FG001|Overall Study|Consent withdrawn|4|||
129071150|NCT01490086|464550661|FG002|Overall Study|Consent withdrawn|3|||
129071151|NCT01490086|464550662|FG003|Overall Study|Consent withdrawn|0|||
129071152|NCT01490086|464550663|FG004|Overall Study|Consent withdrawn|1|||
129140449|NCT03211858|464808695|FG000|Overall Study|Lack of Efficacy|0|||
129140450|NCT03211858|464808696|FG001|Overall Study|Lack of Efficacy|4|||
129071153|NCT01490086|464550659|FG000|Overall Study|Non-compliance|0|||
129071154|NCT01490086|464550660|FG001|Overall Study|Non-compliance|1|||
129071155|NCT01490086|464550661|FG002|Overall Study|Non-compliance|0|||
129071156|NCT01490086|464550662|FG003|Overall Study|Non-compliance|0|||
129071157|NCT01490086|464550663|FG004|Overall Study|Non-compliance|0|||
129071158|NCT01490086|464550659|FG000|Overall Study|Abnormal laboratory findings|1|||
129071159|NCT01490086|464550660|FG001|Overall Study|Abnormal laboratory findings|0|||
129071160|NCT01490086|464550661|FG002|Overall Study|Abnormal laboratory findings|0|||
129071161|NCT01490086|464550662|FG003|Overall Study|Abnormal laboratory findings|0|||
129071162|NCT01490086|464550663|FG004|Overall Study|Abnormal laboratory findings|0|||
129071163|NCT01490086|464550659|FG000|Overall Study|Lost to Follow-up|0|||
129071164|NCT01490086|464550660|FG001|Overall Study|Lost to Follow-up|0|||
129071165|NCT01490086|464550661|FG002|Overall Study|Lost to Follow-up|0|||
129071166|NCT01490086|464550662|FG003|Overall Study|Lost to Follow-up|0|||
129071167|NCT01490086|464550663|FG004|Overall Study|Lost to Follow-up|1|||
129071168|NCT01490086|464550659|FG000|Overall Study|Physician Decision|3|||
129071169|NCT01490086|464550660|FG001|Overall Study|Physician Decision|4|||
129071170|NCT01490086|464550661|FG002|Overall Study|Physician Decision|2|||
129071171|NCT01490086|464550662|FG003|Overall Study|Physician Decision|3|||
129071172|NCT01490086|464550663|FG004|Overall Study|Physician Decision|1|||
129071173|NCT01490086|464550659|FG000|Overall Study|Adverse Event|0|||
129071174|NCT01490086|464550660|FG001|Overall Study|Adverse Event|0|||
129071175|NCT01490086|464550661|FG002|Overall Study|Adverse Event|1|||
129071176|NCT01490086|464550662|FG003|Overall Study|Adverse Event|2|||
129071177|NCT01490086|464550663|FG004|Overall Study|Adverse Event|0|||
129071178|NCT01490086|464550659|FG000|Overall Study|Lack of Efficacy|0|||
129071179|NCT01490086|464550660|FG001|Overall Study|Lack of Efficacy|3|||
129071180|NCT01490086|464550661|FG002|Overall Study|Lack of Efficacy|1|||
129071181|NCT01490086|464550662|FG003|Overall Study|Lack of Efficacy|0|||
129071182|NCT01490086|464550663|FG004|Overall Study|Lack of Efficacy|8|||
129071183|NCT01490086|464550659|FG000|Overall Study|Worsening of symptoms|0|||
129071184|NCT01490086|464550660|FG001|Overall Study|Worsening of symptoms|1|||
129071185|NCT01490086|464550661|FG002|Overall Study|Worsening of symptoms|0|||
129071186|NCT01490086|464550662|FG003|Overall Study|Worsening of symptoms|1|||
129071187|NCT01490086|464550663|FG004|Overall Study|Worsening of symptoms|0|||
129071188|NCT01490086|464550659|FG000|Overall Study|Subject uncontrollable and abusive|0|||
129071189|NCT01490086|464550660|FG001|Overall Study|Subject uncontrollable and abusive|1|||
129071190|NCT01490086|464550661|FG002|Overall Study|Subject uncontrollable and abusive|0|||
129071191|NCT01490086|464550662|FG003|Overall Study|Subject uncontrollable and abusive|0|||
129071192|NCT01490086|464550663|FG004|Overall Study|Subject uncontrollable and abusive|0|||
129071193|NCT01490086|464550659|FG000|Overall Study|Subject left hospital|0|||
129071194|NCT01490086|464550660|FG001|Overall Study|Subject left hospital|1|||
129071195|NCT01490086|464550661|FG002|Overall Study|Subject left hospital|0|||
129071196|NCT01490086|464550662|FG003|Overall Study|Subject left hospital|1|||
129071197|NCT01490086|464550663|FG004|Overall Study|Subject left hospital|0|||
129071198|NCT02157935|464550664|FG000|Overall Study|Withdrawal by Subject|25|||
129071199|NCT02157935|464550665|FG001|Overall Study|Withdrawal by Subject|39|||
129071200|NCT02157935|464550664|FG000|Overall Study|Screen failure|1|||
129071201|NCT02157935|464550665|FG001|Overall Study|Screen failure|2|||
129071202|NCT02157935|464550664|FG000|Overall Study|Protocol Violation|1|||
129140451|NCT03211858|464808695|FG000|Overall Study|Poor compliance to protocol|6|||
129140452|NCT03211858|464808696|FG001|Overall Study|Poor compliance to protocol|2|||
129140453|NCT03211858|464808695|FG000|Overall Study|Non-serious Hypoglycemia|1|||
129140454|NCT03211858|464808696|FG001|Overall Study|Non-serious Hypoglycemia|0|||
129140455|NCT03211858|464808695|FG000|Overall Study|Other than specified above|22|||
129071203|NCT02157935|464550665|FG001|Overall Study|Protocol Violation|0|||
129071204|NCT02157935|464550664|FG000|Overall Study|Progressive disease|0|||
129071205|NCT02157935|464550665|FG001|Overall Study|Progressive disease|2|||
129071206|NCT02157935|464550664|FG000|Overall Study|Other|5|||
129071207|NCT02157935|464550665|FG001|Overall Study|Other|12|||
129071208|NCT02157935|464550664|FG000|Overall Study|Lack of Efficacy|0|||
129071209|NCT02157935|464550665|FG001|Overall Study|Lack of Efficacy|1|||
129071210|NCT02157935|464550664|FG000|Overall Study|Death|4|||
129071211|NCT02157935|464550665|FG001|Overall Study|Death|4|||
129071212|NCT02157935|464550664|FG000|Overall Study|Adverse Event|3|||
129071213|NCT02157935|464550665|FG001|Overall Study|Adverse Event|5|||
129071214|NCT01103180|464550674|FG000|Overall Study|Withdrawal by Subject|8|||
129071215|NCT01103180|464550675|FG001|Overall Study|Withdrawal by Subject|13|||
129071216|NCT01103180|464550674|FG000|Overall Study|Lost to Follow-up|13|||
129071217|NCT01103180|464550675|FG001|Overall Study|Lost to Follow-up|7|||
129071218|NCT01103180|464550674|FG000|Overall Study|Physician Decision|1|||
129140456|NCT03211858|464808696|FG001|Overall Study|Other than specified above|21|||
129140457|NCT00185614|464808697|FG000|Inter-treatment Period|Physician Decision|1|||
129071219|NCT01103180|464550675|FG001|Overall Study|Physician Decision|0|||
129071220|NCT01103180|464550674|FG000|Overall Study|Protocol Violation|0|||
129071221|NCT01103180|464550675|FG001|Overall Study|Protocol Violation|1|||
129071222|NCT02493660|464550676|FG000|Overall Study|Physician Decision|0|||
129071223|NCT02493660|464550677|FG001|Overall Study|Physician Decision|1|||
129071224|NCT02493660|464550676|FG000|Overall Study|Adverse Event|4|||
129071225|NCT02493660|464550677|FG001|Overall Study|Adverse Event|2|||
129071226|NCT02493660|464550676|FG000|Overall Study|Withdrawal by Subject|2|||
129071227|NCT02493660|464550677|FG001|Overall Study|Withdrawal by Subject|3|||
129071228|NCT02493660|464550676|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
129071229|NCT02493660|464550677|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
129071230|NCT02493660|464550676|FG000|Overall Study|Protocol Violation|0|||
129071231|NCT02493660|464550677|FG001|Overall Study|Protocol Violation|1|||
129071232|NCT02493660|464550676|FG000|Overall Study|Death|0|||
129071233|NCT02493660|464550677|FG001|Overall Study|Death|1|||
129071234|NCT02493660|464550676|FG000|Overall Study|Lost to Follow-up|2|||
129071235|NCT02493660|464550677|FG001|Overall Study|Lost to Follow-up|4|||
129071236|NCT02392481|464550681|FG000|Overall Study|Adverse Event|0|||
129071237|NCT02392481|464550682|FG001|Overall Study|Adverse Event|0|||
129071238|NCT02392481|464550683|FG002|Overall Study|Adverse Event|1|||
129071239|NCT02392481|464550684|FG003|Overall Study|Adverse Event|2|||
129071240|NCT02392481|464550681|FG000|Overall Study|Withdrawal by Subject|0|||
129071241|NCT02392481|464550682|FG001|Overall Study|Withdrawal by Subject|0|||
129071242|NCT02392481|464550683|FG002|Overall Study|Withdrawal by Subject|1|||
129071243|NCT02392481|464550684|FG003|Overall Study|Withdrawal by Subject|0|||
129071244|NCT02502149|464550686|FG000|Intermediate|Discontinued prematurely|1|||
129071245|NCT02502149|464550687|FG001|Intermediate|Discontinued prematurely|0|||
129071246|NCT02502149|464550688|FG002|Intermediate|Discontinued prematurely|0|||
129071247|NCT02502149|464550689|FG003|Intermediate|Discontinued prematurely|0|||
129071248|NCT02502149|464550690|FG004|Intermediate|Discontinued prematurely|0|||
129071249|NCT02968576|464550691|FG000|Overall Study|Pregnancy|0|||
129071250|NCT02968576|464550692|FG001|Overall Study|Pregnancy|1|||
129071251|NCT02222922|464550693|FG000|Overall Study|Death|0|||
129071252|NCT02222922|464550694|FG001|Overall Study|Death|0|||
129071253|NCT02222922|464550695|FG002|Overall Study|Death|0|||
129071254|NCT02222922|464550696|FG003|Overall Study|Death|0|||
129071255|NCT02222922|464550697|FG004|Overall Study|Death|13|||
129071256|NCT02222922|464550698|FG005|Overall Study|Death|0|||
129071257|NCT02222922|464550699|FG006|Overall Study|Death|0|||
129071258|NCT02222922|464550700|FG007|Overall Study|Death|0|||
129071259|NCT02222922|464550701|FG008|Overall Study|Death|2|||
129071260|NCT02222922|464550693|FG000|Overall Study|Lost to Follow-up|0|||
129071261|NCT02222922|464550694|FG001|Overall Study|Lost to Follow-up|0|||
129071262|NCT02222922|464550695|FG002|Overall Study|Lost to Follow-up|1|||
129071263|NCT02222922|464550696|FG003|Overall Study|Lost to Follow-up|0|||
129071264|NCT02222922|464550697|FG004|Overall Study|Lost to Follow-up|9|||
129071265|NCT02222922|464550698|FG005|Overall Study|Lost to Follow-up|1|||
129071266|NCT02222922|464550699|FG006|Overall Study|Lost to Follow-up|0|||
129071267|NCT02222922|464550700|FG007|Overall Study|Lost to Follow-up|0|||
129071268|NCT02222922|464550701|FG008|Overall Study|Lost to Follow-up|0|||
129071269|NCT02222922|464550693|FG000|Overall Study|Other|0|||
129071270|NCT02222922|464550694|FG001|Overall Study|Other|0|||
129071271|NCT02222922|464550695|FG002|Overall Study|Other|0|||
129071272|NCT02222922|464550696|FG003|Overall Study|Other|2|||
129071273|NCT02222922|464550697|FG004|Overall Study|Other|10|||
129071274|NCT02222922|464550698|FG005|Overall Study|Other|2|||
129071275|NCT02222922|464550699|FG006|Overall Study|Other|2|||
129071276|NCT02222922|464550700|FG007|Overall Study|Other|4|||
129071277|NCT02222922|464550701|FG008|Overall Study|Other|1|||
129071278|NCT02222922|464550693|FG000|Overall Study|Participant refused further follow-up|1|||
129071279|NCT02222922|464550694|FG001|Overall Study|Participant refused further follow-up|0|||
129071280|NCT02222922|464550695|FG002|Overall Study|Participant refused further follow-up|0|||
129071281|NCT02222922|464550696|FG003|Overall Study|Participant refused further follow-up|1|||
128776516|NCT00519636|463470456|FG001|Washout Period|Participating in study at another site|0|||
129071282|NCT02222922|464550697|FG004|Overall Study|Participant refused further follow-up|6|||
129071283|NCT02222922|464550698|FG005|Overall Study|Participant refused further follow-up|0|||
129071284|NCT02222922|464550699|FG006|Overall Study|Participant refused further follow-up|0|||
129071285|NCT02222922|464550700|FG007|Overall Study|Participant refused further follow-up|0|||
129071286|NCT02222922|464550701|FG008|Overall Study|Participant refused further follow-up|3|||
129071287|NCT01254643|464550702|FG000|Overall Study|Withdrawal by Subject|1|||
129071288|NCT00116779|464550708|FG000|Overall Study|Adverse Event|4|||
129071289|NCT00116779|464550709|FG001|Overall Study|Adverse Event|2|||
129071290|NCT00116779|464550708|FG000|Overall Study|Protocol Violation|1|||
129071291|NCT00116779|464550709|FG001|Overall Study|Protocol Violation|4|||
129071292|NCT00116779|464550708|FG000|Overall Study|Withdrawal by Subject|4|||
129071293|NCT00116779|464550709|FG001|Overall Study|Withdrawal by Subject|1|||
129071294|NCT00116779|464550708|FG000|Overall Study|Inadequate testosterone suppression|7|||
129071295|NCT00116779|464550709|FG001|Overall Study|Inadequate testosterone suppression|9|||
129071296|NCT00116779|464550708|FG000|Overall Study|Physician Decision|3|||
129071297|NCT00116779|464550709|FG001|Overall Study|Physician Decision|1|||
129071298|NCT00116779|464550708|FG000|Overall Study|Elevated PSA levels|2|||
129071299|NCT00116779|464550709|FG001|Overall Study|Elevated PSA levels|2|||
129071300|NCT01037218|464550714|FG000|Overall Study|Adverse Event|4|||
129071301|NCT01037218|464550715|FG001|Overall Study|Adverse Event|2|||
129071302|NCT01037218|464550716|FG002|Overall Study|Adverse Event|2|||
129071303|NCT01037218|464550717|FG003|Overall Study|Adverse Event|1|||
129071304|NCT01037218|464550714|FG000|Overall Study|Lack of Efficacy|0|||
129071305|NCT01037218|464550715|FG001|Overall Study|Lack of Efficacy|2|||
129071306|NCT01037218|464550716|FG002|Overall Study|Lack of Efficacy|1|||
129071307|NCT01037218|464550717|FG003|Overall Study|Lack of Efficacy|5|||
129071308|NCT01037218|464550714|FG000|Overall Study|Lost to Follow-up|3|||
129071309|NCT01037218|464550715|FG001|Overall Study|Lost to Follow-up|5|||
129071310|NCT01037218|464550716|FG002|Overall Study|Lost to Follow-up|4|||
129071311|NCT01037218|464550717|FG003|Overall Study|Lost to Follow-up|2|||
129071312|NCT01037218|464550714|FG000|Overall Study|Withdrawal by Subject|6|||
129071313|NCT01037218|464550715|FG001|Overall Study|Withdrawal by Subject|7|||
129071314|NCT01037218|464550716|FG002|Overall Study|Withdrawal by Subject|7|||
129071315|NCT01037218|464550717|FG003|Overall Study|Withdrawal by Subject|4|||
129071316|NCT01037218|464550714|FG000|Overall Study|Partner Withdrew Consent|0|||
129071317|NCT01037218|464550715|FG001|Overall Study|Partner Withdrew Consent|3|||
129071318|NCT01037218|464550716|FG002|Overall Study|Partner Withdrew Consent|2|||
129071319|NCT01037218|464550717|FG003|Overall Study|Partner Withdrew Consent|1|||
129071320|NCT01037218|464550714|FG000|Overall Study|Protocol Violation|0|||
129071321|NCT01037218|464550715|FG001|Overall Study|Protocol Violation|0|||
129071322|NCT01037218|464550716|FG002|Overall Study|Protocol Violation|2|||
129071323|NCT01037218|464550717|FG003|Overall Study|Protocol Violation|2|||
129071324|NCT01037218|464550714|FG000|Overall Study|Various|3|||
129071325|NCT01037218|464550715|FG001|Overall Study|Various|2|||
129071326|NCT01037218|464550716|FG002|Overall Study|Various|3|||
129071327|NCT01037218|464550717|FG003|Overall Study|Various|1|||
129071328|NCT01651117|464550723|FG000|Overall Study|Death|2|||
129071329|NCT01651117|464550724|FG001|Overall Study|Death|3|||
129071330|NCT01651117|464550725|FG002|Overall Study|Death|2|||
129071331|NCT01651117|464550726|FG003|Overall Study|Death|2|||
129071332|NCT02714218|464550727|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129071333|NCT02714218|464550728|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129071334|NCT02714218|464550729|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129071335|NCT02714218|464550727|FG000|Pre-Treatment Period|Other reasons|0|||
129071336|NCT02714218|464550728|FG001|Pre-Treatment Period|Other reasons|1|||
129071337|NCT02714218|464550729|FG002|Pre-Treatment Period|Other reasons|0|||
129071338|NCT02714218|464550727|FG000|Treatment Period|Disease Progression|55|||
129071339|NCT02714218|464550728|FG001|Treatment Period|Disease Progression|52|||
129071340|NCT02714218|464550729|FG002|Treatment Period|Disease Progression|14|||
129071341|NCT02714218|464550727|FG000|Treatment Period|Study drug toxicity|46|||
129071342|NCT02714218|464550728|FG001|Treatment Period|Study drug toxicity|70|||
129071343|NCT02714218|464550729|FG002|Treatment Period|Study drug toxicity|6|||
129071344|NCT02714218|464550727|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
129071345|NCT02714218|464550728|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
129071346|NCT02714218|464550729|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
129071347|NCT02714218|464550727|FG000|Treatment Period|Request to discontinue treatment|1|||
129071348|NCT02714218|464550728|FG001|Treatment Period|Request to discontinue treatment|4|||
129071349|NCT02714218|464550729|FG002|Treatment Period|Request to discontinue treatment|1|||
129071350|NCT02714218|464550727|FG000|Treatment Period|Participant withdrew consent|2|||
129071351|NCT02714218|464550728|FG001|Treatment Period|Participant withdrew consent|2|||
129071352|NCT02714218|464550729|FG002|Treatment Period|Participant withdrew consent|0|||
129071353|NCT02714218|464550727|FG000|Treatment Period|Maximum clinical benefit|4|||
129071354|NCT02714218|464550728|FG001|Treatment Period|Maximum clinical benefit|2|||
129071355|NCT02714218|464550729|FG002|Treatment Period|Maximum clinical benefit|0|||
129071356|NCT02714218|464550727|FG000|Treatment Period|Administrative reason by sponsor|2|||
129071357|NCT02714218|464550728|FG001|Treatment Period|Administrative reason by sponsor|1|||
129071358|NCT02714218|464550729|FG002|Treatment Period|Administrative reason by sponsor|0|||
129071359|NCT02714218|464550727|FG000|Treatment Period|Other reasons|6|||
129071360|NCT02714218|464550728|FG001|Treatment Period|Other reasons|6|||
129071361|NCT02714218|464550729|FG002|Treatment Period|Other reasons|0|||
129071362|NCT02714218|464550727|FG000|Treatment Period|Completed treatment as per protocol|36|||
129071363|NCT02714218|464550728|FG001|Treatment Period|Completed treatment as per protocol|27|||
129071364|NCT02714218|464550729|FG002|Treatment Period|Completed treatment as per protocol|3|||
129071365|NCT02714218|464550727|FG000|Treatment Period|Not reported|9|||
129071366|NCT02714218|464550728|FG001|Treatment Period|Not reported|6|||
129071367|NCT02714218|464550729|FG002|Treatment Period|Not reported|0|||
129071368|NCT01778530|464550733|FG000|Overall Study|Progression on study|1|||
129071369|NCT01778530|464550733|FG000|Overall Study|Adverse event/side effect|1|||
129071370|NCT01199939|464550734|FG000|Overall Study|Adverse Event|4|||
129071371|NCT01199939|464550734|FG000|Overall Study|Protocol Violation|3|||
129071372|NCT01199939|464550734|FG000|Overall Study|Lost to Follow-up|2|||
129071373|NCT01199939|464550734|FG000|Overall Study|Reached a virologic endpoint|4|||
129071374|NCT01894919|464550735|FG000|Overall Study|Withdrawal by Subject|1|||
129071375|NCT01894919|464550736|FG001|Overall Study|Withdrawal by Subject|0|||
129071376|NCT01894919|464550737|FG002|Overall Study|Withdrawal by Subject|0|||
129140458|NCT00185614|464808697|FG000|Inter-treatment Period|Relapse|2|||
129140459|NCT00185614|464808697|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
129140460|NCT03160573|464808698|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
129140461|NCT03160573|464808699|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
129140462|NCT03160573|464808700|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
129140463|NCT03160573|464808701|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
129140464|NCT00449787|464808702|FG000|Overall Study|Lost to Follow-up|10|||
129140465|NCT00449787|464808703|FG001|Overall Study|Lost to Follow-up|8|||
129140466|NCT00449787|464808702|FG000|Overall Study|Did not require medication|95|||
129140467|NCT00449787|464808703|FG001|Overall Study|Did not require medication|92|||
129140468|NCT03701074|464808704|FG000|Overall Study|Physician Decision|1|||
129071377|NCT01894919|464550738|FG003|Overall Study|Withdrawal by Subject|0|||
129071378|NCT01894919|464550739|FG004|Overall Study|Withdrawal by Subject|1|||
129071379|NCT01894919|464550740|FG005|Overall Study|Withdrawal by Subject|0|||
129071380|NCT01894919|464550741|FG006|Overall Study|Withdrawal by Subject|0|||
129071381|NCT01894919|464550742|FG007|Overall Study|Withdrawal by Subject|0|||
129071382|NCT01894919|464550743|FG008|Overall Study|Withdrawal by Subject|0|||
129071383|NCT01894919|464550744|FG009|Overall Study|Withdrawal by Subject|1|||
129071384|NCT01894919|464550745|FG010|Overall Study|Withdrawal by Subject|1|||
129071385|NCT01894919|464550746|FG011|Overall Study|Withdrawal by Subject|0|||
129071386|NCT01894919|464550747|FG012|Overall Study|Withdrawal by Subject|0|||
129071387|NCT01894919|464550735|FG000|Overall Study|Adverse Event|0|||
129071388|NCT01894919|464550736|FG001|Overall Study|Adverse Event|0|||
129071389|NCT01894919|464550737|FG002|Overall Study|Adverse Event|0|||
129071390|NCT01894919|464550738|FG003|Overall Study|Adverse Event|0|||
129071391|NCT01894919|464550739|FG004|Overall Study|Adverse Event|0|||
129071392|NCT01894919|464550740|FG005|Overall Study|Adverse Event|0|||
129071393|NCT01894919|464550741|FG006|Overall Study|Adverse Event|0|||
129071394|NCT01894919|464550742|FG007|Overall Study|Adverse Event|0|||
129071395|NCT01894919|464550743|FG008|Overall Study|Adverse Event|0|||
129071396|NCT01894919|464550744|FG009|Overall Study|Adverse Event|0|||
129071397|NCT01894919|464550745|FG010|Overall Study|Adverse Event|1|||
129071398|NCT01894919|464550746|FG011|Overall Study|Adverse Event|0|||
129071399|NCT01894919|464550747|FG012|Overall Study|Adverse Event|0|||
129071400|NCT01894919|464550735|FG000|Overall Study|Other-Unspecified|1|||
129071401|NCT01894919|464550736|FG001|Overall Study|Other-Unspecified|0|||
129071402|NCT01894919|464550737|FG002|Overall Study|Other-Unspecified|0|||
129071403|NCT01894919|464550738|FG003|Overall Study|Other-Unspecified|0|||
129071404|NCT01894919|464550739|FG004|Overall Study|Other-Unspecified|0|||
129071405|NCT01894919|464550740|FG005|Overall Study|Other-Unspecified|0|||
129071406|NCT01894919|464550741|FG006|Overall Study|Other-Unspecified|0|||
129071407|NCT01894919|464550742|FG007|Overall Study|Other-Unspecified|0|||
129071408|NCT01894919|464550743|FG008|Overall Study|Other-Unspecified|0|||
129071409|NCT01894919|464550744|FG009|Overall Study|Other-Unspecified|0|||
129071410|NCT01894919|464550745|FG010|Overall Study|Other-Unspecified|0|||
129071411|NCT01894919|464550746|FG011|Overall Study|Other-Unspecified|0|||
129140469|NCT03701074|464808705|FG001|Overall Study|Physician Decision|0|||
129140470|NCT01423084|464808709|FG000|Overall Study|Adverse Event|0|||
128723973|NCT00969553|463287299|FG000|Overall Study|Other Adverse Event|0|||
128723974|NCT00969553|463287300|FG001|Overall Study|Other Adverse Event|0|||
128723975|NCT00969553|463287301|FG002|Overall Study|Other Adverse Event|0|||
129071412|NCT01894919|464550747|FG012|Overall Study|Other-Unspecified|0|||
129140471|NCT01423084|464808710|FG001|Overall Study|Adverse Event|1|||
128723976|NCT00969553|463287302|FG003|Overall Study|Other Adverse Event|1|||
129071413|NCT01894919|464550735|FG000|Overall Study|Lost to Follow-up|0|||
129071414|NCT01894919|464550736|FG001|Overall Study|Lost to Follow-up|0|||
129071415|NCT01894919|464550737|FG002|Overall Study|Lost to Follow-up|0|||
129071416|NCT01894919|464550738|FG003|Overall Study|Lost to Follow-up|0|||
129071417|NCT01894919|464550739|FG004|Overall Study|Lost to Follow-up|2|||
129071418|NCT01894919|464550740|FG005|Overall Study|Lost to Follow-up|0|||
129071419|NCT01894919|464550741|FG006|Overall Study|Lost to Follow-up|0|||
129071420|NCT01894919|464550742|FG007|Overall Study|Lost to Follow-up|0|||
129071421|NCT01894919|464550743|FG008|Overall Study|Lost to Follow-up|0|||
129071422|NCT01894919|464550744|FG009|Overall Study|Lost to Follow-up|0|||
129071423|NCT01894919|464550745|FG010|Overall Study|Lost to Follow-up|0|||
129071424|NCT01894919|464550746|FG011|Overall Study|Lost to Follow-up|0|||
129071425|NCT01894919|464550747|FG012|Overall Study|Lost to Follow-up|0|||
129071426|NCT01433471|464550748|FG000|Overall Study|Withdrawal by Subject|0|||
129071427|NCT01433471|464550749|FG001|Overall Study|Withdrawal by Subject|1|||
129071428|NCT03711188|464550750|FG000|Overall Study|Disease progression|11|||
129071429|NCT03711188|464550750|FG000|Overall Study|Adverse Event|1|||
129071430|NCT03238651|464550755|FG000|Overall Study|Other|0|||
129071431|NCT03238651|464550756|FG001|Overall Study|Other|0|||
129071432|NCT03238651|464550757|FG002|Overall Study|Other|0|||
129071433|NCT03238651|464550758|FG003|Overall Study|Other|0|||
129071434|NCT03238651|464550759|FG004|Overall Study|Other|1|||
129071435|NCT03238651|464550755|FG000|Overall Study|Progressive Disease|2|||
129071436|NCT03238651|464550756|FG001|Overall Study|Progressive Disease|2|||
129071437|NCT03238651|464550757|FG002|Overall Study|Progressive Disease|2|||
129071438|NCT03238651|464550758|FG003|Overall Study|Progressive Disease|2|||
129071439|NCT03238651|464550759|FG004|Overall Study|Progressive Disease|0|||
129071440|NCT03238651|464550755|FG000|Overall Study|Withdrawal by Subject|0|||
129071441|NCT03238651|464550756|FG001|Overall Study|Withdrawal by Subject|1|||
129071442|NCT03238651|464550757|FG002|Overall Study|Withdrawal by Subject|0|||
129071443|NCT03238651|464550758|FG003|Overall Study|Withdrawal by Subject|1|||
129071444|NCT03238651|464550759|FG004|Overall Study|Withdrawal by Subject|0|||
129071445|NCT03238651|464550755|FG000|Overall Study|Adverse Event|1|||
129071446|NCT03238651|464550756|FG001|Overall Study|Adverse Event|3|||
129071447|NCT03238651|464550757|FG002|Overall Study|Adverse Event|2|||
129071448|NCT03238651|464550758|FG003|Overall Study|Adverse Event|0|||
129071449|NCT03238651|464550759|FG004|Overall Study|Adverse Event|0|||
129071450|NCT03875508|464550760|FG000|Overall Study|Adverse Event|1|||
129071451|NCT03875508|464550760|FG000|Overall Study|Lost to Follow-up|8|||
129140472|NCT01423084|464808709|FG000|Overall Study|Withdrawal by Subject|2|||
129140473|NCT01423084|464808710|FG001|Overall Study|Withdrawal by Subject|3|||
129140474|NCT00661687|464808711|FG000|Overall Study|Study related symptoms and complaints|5|||
129140475|NCT00661687|464808711|FG000|Overall Study|Positive slit lamp findings|4|||
129140476|NCT00661687|464808711|FG000|Overall Study|Inability to maintain wearing schedule|3|||
129140477|NCT00661687|464808711|FG000|Overall Study|Physician Decision|1|||
129140478|NCT00661687|464808711|FG000|Overall Study|Adverse Event|2|||
129140479|NCT03574389|464808712|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
129140480|NCT03574389|464808713|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
129140481|NCT03574389|464808714|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
129140482|NCT03574389|464808715|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
129140483|NCT03574389|464808716|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
129140484|NCT03574389|464808717|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
129140485|NCT03574389|464808718|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
129140486|NCT03574389|464808712|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
129140487|NCT03574389|464808713|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
129140488|NCT03574389|464808714|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
129140489|NCT03574389|464808715|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
129140490|NCT03574389|464808716|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
129140491|NCT03574389|464808717|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
129140492|NCT03574389|464808718|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
129140493|NCT03574389|464808712|FG000|Vaccination Period|Other|6|||
129071452|NCT03875508|464550760|FG000|Overall Study|Lack of Efficacy|1|||
129071453|NCT03875508|464550760|FG000|Overall Study|Other, not specified|2|||
129071454|NCT02500589|464550764|FG000|Overall Study|Withdrawal by Subject|11|||
129071455|NCT02500589|464550765|FG001|Overall Study|Withdrawal by Subject|14|||
129071456|NCT02500589|464550764|FG000|Overall Study|Lost to Follow-up|10|||
129071457|NCT02500589|464550765|FG001|Overall Study|Lost to Follow-up|12|||
129071458|NCT02500589|464550764|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
129071459|NCT02500589|464550765|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
129140494|NCT03574389|464808713|FG001|Vaccination Period|Other|0|||
129071460|NCT02500589|464550764|FG000|Overall Study|Death|7|||
129071461|NCT02500589|464550765|FG001|Overall Study|Death|5|||
129071462|NCT03652051|464550766|FG000|Stage 1|Adverse Event|0|||
129071463|NCT03652051|464550767|FG001|Stage 1|Adverse Event|5|||
129071464|NCT03652051|464550768|FG002|Stage 1|Adverse Event|7|||
129071465|NCT03652051|464550769|FG003|Stage 1|Adverse Event|1|||
129071466|NCT03652051|464550766|FG000|Stage 1|Withdrawal by Subject|0|||
129071467|NCT03652051|464550767|FG001|Stage 1|Withdrawal by Subject|0|||
129071468|NCT03652051|464550768|FG002|Stage 1|Withdrawal by Subject|1|||
129071469|NCT03652051|464550769|FG003|Stage 1|Withdrawal by Subject|0|||
129071470|NCT03652051|464550766|FG000|Stage 2|Adverse Event|0|||
129071471|NCT03652051|464550767|FG001|Stage 2|Adverse Event|2|||
129071472|NCT03652051|464550768|FG002|Stage 2|Adverse Event|1|||
129071473|NCT03652051|464550769|FG003|Stage 2|Adverse Event|0|||
129071474|NCT03652051|464550766|FG000|Stage 2|Protocol Violation|0|||
129071475|NCT03652051|464550767|FG001|Stage 2|Protocol Violation|1|||
129071476|NCT03652051|464550768|FG002|Stage 2|Protocol Violation|6|||
129071477|NCT03652051|464550769|FG003|Stage 2|Protocol Violation|0|||
129071478|NCT03652051|464550766|FG000|Stage 2|Lost to Follow-up|0|||
129071479|NCT03652051|464550767|FG001|Stage 2|Lost to Follow-up|2|||
129071480|NCT03652051|464550768|FG002|Stage 2|Lost to Follow-up|0|||
129071481|NCT03652051|464550769|FG003|Stage 2|Lost to Follow-up|3|||
129071482|NCT03652051|464550766|FG000|Stage 2|Withdrawal by Subject|0|||
129071483|NCT03652051|464550767|FG001|Stage 2|Withdrawal by Subject|11|||
129071484|NCT03652051|464550768|FG002|Stage 2|Withdrawal by Subject|9|||
129071485|NCT03652051|464550769|FG003|Stage 2|Withdrawal by Subject|3|||
129071486|NCT02550561|464550770|FG000|Overall Study|Lost to Follow-up|5|||
129071487|NCT02550561|464550770|FG000|Overall Study|Withdrawal by Subject|1|||
129071488|NCT02394600|464550775|FG000|Overall Study|Adverse Event|3|||
129071489|NCT02394600|464550776|FG001|Overall Study|Adverse Event|0|||
129071490|NCT02394600|464550775|FG000|Overall Study|Lost to Follow-up|0|||
129071491|NCT02394600|464550776|FG001|Overall Study|Lost to Follow-up|1|||
129071492|NCT02394600|464550775|FG000|Overall Study|Withdrawal by Subject|0|||
129071493|NCT02394600|464550776|FG001|Overall Study|Withdrawal by Subject|1|||
128723977|NCT00969553|463287303|FG004|Overall Study|Other Adverse Event|0|||
128723978|NCT00969553|463287304|FG005|Overall Study|Other Adverse Event|0|||
129071494|NCT02394600|464550775|FG000|Overall Study|Protocol Violation|1|||
129071495|NCT02394600|464550776|FG001|Overall Study|Protocol Violation|0|||
129071496|NCT01686373|464550777|FG000|Overall Study|Lost to Follow-up|3|||
129071497|NCT01686373|464550778|FG001|Overall Study|Lost to Follow-up|0|||
129071498|NCT01686373|464550777|FG000|Overall Study|Withdrawal by Subject|0|||
129071499|NCT01686373|464550778|FG001|Overall Study|Withdrawal by Subject|1|||
129071500|NCT01686373|464550777|FG000|Overall Study|Adverse Event|0|||
129071501|NCT01686373|464550778|FG001|Overall Study|Adverse Event|1|||
128723979|NCT00969553|463287305|FG006|Overall Study|Other Adverse Event|1|||
129071502|NCT02452476|464550780|FG000|Overall Study|Death|4|||
129071503|NCT02452476|464550781|FG001|Overall Study|Death|7|||
129071504|NCT02452476|464550780|FG000|Overall Study|Lost to Follow-up|1|||
129071505|NCT02452476|464550781|FG001|Overall Study|Lost to Follow-up|1|||
129071506|NCT02452476|464550780|FG000|Overall Study|Physician Decision|1|||
129071507|NCT02452476|464550781|FG001|Overall Study|Physician Decision|1|||
129071508|NCT02452476|464550780|FG000|Overall Study|Not treated|5|||
129071509|NCT02452476|464550781|FG001|Overall Study|Not treated|1|||
129071510|NCT04052620|464550782|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
129071511|NCT04052620|464550783|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
129071512|NCT04052620|464550782|FG000|Overall Study|Withdrawal by Subject|1|||
129071513|NCT04052620|464550783|FG001|Overall Study|Withdrawal by Subject|0|||
129071514|NCT04052620|464550782|FG000|Overall Study|Lost to Follow-up|1|||
129071515|NCT04052620|464550783|FG001|Overall Study|Lost to Follow-up|1|||
129071516|NCT04052620|464550782|FG000|Overall Study|Adverse Event|1|||
129071517|NCT04052620|464550783|FG001|Overall Study|Adverse Event|0|||
129071518|NCT04052620|464550782|FG000|Overall Study|Subject did not meet study Criteria|0|||
129071519|NCT04052620|464550783|FG001|Overall Study|Subject did not meet study Criteria|1|||
129071520|NCT04052620|464550782|FG000|Overall Study|Screened failure, randomized by mistake|0|||
129071521|NCT04052620|464550783|FG001|Overall Study|Screened failure, randomized by mistake|1|||
129071522|NCT04052620|464550782|FG000|Overall Study|Personal reasons|2|||
129071523|NCT04052620|464550783|FG001|Overall Study|Personal reasons|4|||
129071524|NCT04052620|464550782|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
129071525|NCT04052620|464550783|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
129071526|NCT03552380|464550784|FG000|Study Treatment|Disease Progression|3|||
129071527|NCT03552380|464550785|FG001|Study Treatment|Disease Progression|4|||
129071528|NCT03552380|464550784|FG000|Study Treatment|Adverse Event|2|||
129071529|NCT03552380|464550785|FG001|Study Treatment|Adverse Event|2|||
129071530|NCT03552380|464550784|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
129071531|NCT03552380|464550785|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
129071532|NCT03552380|464550784|FG000|Follow up|Death|3|||
129071533|NCT03552380|464550785|FG001|Follow up|Death|4|||
129071534|NCT03552380|464550784|FG000|Follow up|Site IRB terminated|0|||
129071535|NCT03552380|464550785|FG001|Follow up|Site IRB terminated|1|||
129071536|NCT02201784|464550786|FG000|Overall Study|Failure to achieve adequate block|2|||
129071537|NCT02201784|464550787|FG001|Overall Study|Failure to achieve adequate block|0|||
129071538|NCT02431364|464550788|FG000|Overall Study|Adverse Event|0|||
129071539|NCT02431364|464550789|FG001|Overall Study|Adverse Event|1|||
129071540|NCT02431364|464550790|FG002|Overall Study|Adverse Event|0|||
129071541|NCT02431364|464550791|FG003|Overall Study|Adverse Event|0|||
129071542|NCT02431364|464550792|FG004|Overall Study|Adverse Event|0|||
129071543|NCT02431364|464550788|FG000|Overall Study|Randomized but never treated|0|||
129071544|NCT02431364|464550789|FG001|Overall Study|Randomized but never treated|0|||
129071545|NCT02431364|464550790|FG002|Overall Study|Randomized but never treated|0|||
129071546|NCT02431364|464550791|FG003|Overall Study|Randomized but never treated|1|||
129071547|NCT02431364|464550792|FG004|Overall Study|Randomized but never treated|0|||
129071548|NCT00916383|464550793|FG000|Overall Study|Adverse Event|1|||
129071549|NCT00916383|464550793|FG000|Overall Study|Death|1|||
129071550|NCT00916383|464550793|FG000|Overall Study|Protocol Violation|1|||
129071551|NCT00258960|464550794|FG000|Overall Study|Death|2|||
129071552|NCT00258960|464550794|FG000|Overall Study|Disease Progression|7|||
129071553|NCT00258960|464550794|FG000|Overall Study|Adverse Event|4|||
129071554|NCT00258960|464550794|FG000|Overall Study|Physician Decision|1|||
129071555|NCT00258960|464550794|FG000|Overall Study|Withdrawal by Subject|1|||
129071556|NCT00258960|464550794|FG000|Overall Study|Mistake|2|||
129071557|NCT01112059|464550795|FG000|Overall Study|Withdrawal by Subject|1|||
129071558|NCT01112059|464550796|FG001|Overall Study|Withdrawal by Subject|0|||
129071559|NCT02654054|464550799|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
129071560|NCT02654054|464550800|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
129071561|NCT02654054|464550801|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
129071562|NCT02654054|464550799|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129071563|NCT02654054|464550800|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129071564|NCT02654054|464550801|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
129071565|NCT02654054|464550799|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
129071566|NCT02654054|464550800|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
129071567|NCT02654054|464550801|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
129071568|NCT02654054|464550799|FG000|Post-Treatment Follow-Up Period|Other|1|||
129071569|NCT02654054|464550800|FG001|Post-Treatment Follow-Up Period|Other|0|||
129071570|NCT02654054|464550801|FG002|Post-Treatment Follow-Up Period|Other|4|||
129071571|NCT02654054|464550799|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129071572|NCT02654054|464550800|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129071573|NCT02654054|464550801|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
129071574|NCT03323398|464550802|FG000|Overall Study|Other than Specified|0|||
129071575|NCT03323398|464550803|FG001|Overall Study|Other than Specified|1|||
129071576|NCT03323398|464550804|FG002|Overall Study|Other than Specified|2|||
129071577|NCT03323398|464550805|FG003|Overall Study|Other than Specified|0|||
129071578|NCT03323398|464550806|FG004|Overall Study|Other than Specified|0|||
129071579|NCT03323398|464550807|FG005|Overall Study|Other than Specified|0|||
129071580|NCT03323398|464550808|FG006|Overall Study|Other than Specified|1|||
129071581|NCT03323398|464550809|FG007|Overall Study|Other than Specified|0|||
129071582|NCT03323398|464550810|FG008|Overall Study|Other than Specified|2|||
129071583|NCT03323398|464550802|FG000|Overall Study|Lost to Follow-up|1|||
129071584|NCT03323398|464550803|FG001|Overall Study|Lost to Follow-up|2|||
129071585|NCT03323398|464550804|FG002|Overall Study|Lost to Follow-up|1|||
129071586|NCT03323398|464550805|FG003|Overall Study|Lost to Follow-up|0|||
129071587|NCT03323398|464550806|FG004|Overall Study|Lost to Follow-up|0|||
129071588|NCT03323398|464550807|FG005|Overall Study|Lost to Follow-up|0|||
129071589|NCT03323398|464550808|FG006|Overall Study|Lost to Follow-up|0|||
129071590|NCT03323398|464550809|FG007|Overall Study|Lost to Follow-up|0|||
129071591|NCT03323398|464550810|FG008|Overall Study|Lost to Follow-up|0|||
129071592|NCT03323398|464550802|FG000|Overall Study|Death|4|||
129071593|NCT03323398|464550803|FG001|Overall Study|Death|6|||
129071594|NCT03323398|464550804|FG002|Overall Study|Death|2|||
129071595|NCT03323398|464550805|FG003|Overall Study|Death|2|||
129071596|NCT03323398|464550806|FG004|Overall Study|Death|1|||
129071597|NCT03323398|464550807|FG005|Overall Study|Death|2|||
129071598|NCT03323398|464550808|FG006|Overall Study|Death|0|||
129071599|NCT03323398|464550809|FG007|Overall Study|Death|0|||
129071600|NCT03323398|464550810|FG008|Overall Study|Death|6|||
129071601|NCT03323398|464550802|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
129071602|NCT03323398|464550803|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
129071603|NCT03323398|464550804|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
129071604|NCT03323398|464550805|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
129071605|NCT03323398|464550806|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
129071606|NCT03323398|464550807|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
129071607|NCT03323398|464550808|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
129071608|NCT03323398|464550809|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
129071609|NCT03323398|464550810|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
129071610|NCT03323398|464550802|FG000|Overall Study|Withdrawal by Subject|2|||
129071611|NCT03323398|464550803|FG001|Overall Study|Withdrawal by Subject|1|||
129071612|NCT03323398|464550804|FG002|Overall Study|Withdrawal by Subject|3|||
129071613|NCT03323398|464550805|FG003|Overall Study|Withdrawal by Subject|0|||
129071614|NCT03323398|464550806|FG004|Overall Study|Withdrawal by Subject|0|||
129071615|NCT03323398|464550807|FG005|Overall Study|Withdrawal by Subject|1|||
129071616|NCT03323398|464550808|FG006|Overall Study|Withdrawal by Subject|0|||
129071617|NCT03323398|464550809|FG007|Overall Study|Withdrawal by Subject|0|||
129071618|NCT03323398|464550810|FG008|Overall Study|Withdrawal by Subject|0|||
129071619|NCT03323398|464550802|FG000|Overall Study|Participant was Put on Hospice|0|||
129071620|NCT03323398|464550803|FG001|Overall Study|Participant was Put on Hospice|0|||
129071621|NCT03323398|464550804|FG002|Overall Study|Participant was Put on Hospice|0|||
129071622|NCT03323398|464550805|FG003|Overall Study|Participant was Put on Hospice|0|||
129071623|NCT03323398|464550806|FG004|Overall Study|Participant was Put on Hospice|0|||
129071624|NCT03323398|464550807|FG005|Overall Study|Participant was Put on Hospice|0|||
129071625|NCT03323398|464550808|FG006|Overall Study|Participant was Put on Hospice|1|||
129071626|NCT03323398|464550809|FG007|Overall Study|Participant was Put on Hospice|0|||
129071627|NCT03323398|464550810|FG008|Overall Study|Participant was Put on Hospice|0|||
129071628|NCT03323398|464550802|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
129071629|NCT03323398|464550803|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
129071630|NCT03323398|464550804|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
129071631|NCT03323398|464550805|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
129071632|NCT03323398|464550806|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
129071633|NCT03323398|464550807|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
129071634|NCT03323398|464550808|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
129071635|NCT03323398|464550809|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
129071636|NCT03323398|464550810|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
129071637|NCT02235454|464550811|FG000|Overall Study|Withdrawal by Subject|2|||
129071638|NCT03641469|464550812|FG000|Overall Study|Ineligible|2|||
129071639|NCT03641469|464550812|FG000|Overall Study|Withdrawal by Subject|5|||
129071640|NCT03641469|464550812|FG000|Overall Study|Physician Decision|1|||
129071641|NCT03641469|464550812|FG000|Overall Study|Protocol Violation|1|||
129071642|NCT03641469|464550812|FG000|Overall Study|Lost to Follow-up|2|||
129071643|NCT04199104|464552082|FG000|Overall Study|Death|148|||
129071644|NCT04199104|464552083|FG001|Overall Study|Death|134|||
129071645|NCT04199104|464552082|FG000|Overall Study|Lost to Follow-up|1|||
129071646|NCT04199104|464552083|FG001|Overall Study|Lost to Follow-up|1|||
129071647|NCT04199104|464552082|FG000|Overall Study|Withdrawal by Subject|4|||
129071648|NCT04199104|464552083|FG001|Overall Study|Withdrawal by Subject|4|||
129071649|NCT04199104|464552082|FG000|Overall Study|Participants Ongoing|103|||
129071650|NCT04199104|464552083|FG001|Overall Study|Participants Ongoing|116|||
129071651|NCT05655546|464552088|FG000|Overall Study|Withdrawal by Subject|2|||
129071652|NCT05655546|464552089|FG001|Overall Study|Withdrawal by Subject|4|||
129071653|NCT04576507|464552092|FG000|Overall Study|Adverse Event|4|||
129071654|NCT04576507|464552092|FG000|Overall Study|Withdrawal by Subject|1|||
129071655|NCT05825404|464552098|FG000|First Intervention (Weeks 2-5)|Death|0|||
129071656|NCT05825404|464552099|FG001|First Intervention (Weeks 2-5)|Death|1|||
129071657|NCT05825404|464552098|FG000|Second Intervention (Weeks 8-11)|Death|0|||
129071658|NCT05825404|464552099|FG001|Second Intervention (Weeks 8-11)|Death|1|||
129071659|NCT01749826|464552100|FG000|Overall Study|Study Terminated|20|||
129071660|NCT01749826|464552101|FG001|Overall Study|Study Terminated|0|||
129071661|NCT05842967|464552102|FG000|Period 1: SSA|Adverse Event|1|||
129071662|NCT05842967|464552103|FG001|Period 1: SSA|Adverse Event|1|||
129071663|NCT05842967|464552104|FG002|Period 1: SSA|Adverse Event|0|||
129071664|NCT05842967|464552105|FG003|Period 1: SSA|Adverse Event|0|||
129071665|NCT05842967|464552102|FG000|Period 1: SSA|Death|1|||
129071666|NCT05842967|464552103|FG001|Period 1: SSA|Death|0|||
129071667|NCT05842967|464552104|FG002|Period 1: SSA|Death|0|||
129071668|NCT05842967|464552105|FG003|Period 1: SSA|Death|0|||
129071669|NCT05842967|464552102|FG000|Period 1: SSA|Lost to Follow-up|16|||
129071670|NCT05842967|464552103|FG001|Period 1: SSA|Lost to Follow-up|4|||
129071671|NCT05842967|464552104|FG002|Period 1: SSA|Lost to Follow-up|0|||
129071672|NCT05842967|464552105|FG003|Period 1: SSA|Lost to Follow-up|0|||
129071673|NCT05842967|464552102|FG000|Period 1: SSA|Physician Decision|1|||
129071674|NCT05842967|464552103|FG001|Period 1: SSA|Physician Decision|0|||
129071675|NCT05842967|464552104|FG002|Period 1: SSA|Physician Decision|0|||
129071676|NCT05842967|464552105|FG003|Period 1: SSA|Physician Decision|0|||
129071677|NCT05842967|464552102|FG000|Period 1: SSA|Withdrawal by Subject|2|||
129071678|NCT05842967|464552103|FG001|Period 1: SSA|Withdrawal by Subject|2|||
129071679|NCT05842967|464552104|FG002|Period 1: SSA|Withdrawal by Subject|0|||
129071680|NCT05842967|464552105|FG003|Period 1: SSA|Withdrawal by Subject|0|||
129071681|NCT05842967|464552102|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
129071682|NCT05842967|464552103|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
129071683|NCT05842967|464552104|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
129071684|NCT05842967|464552105|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
129071685|NCT05842967|464552102|FG000|Period 2: SSB|Adverse Event|0|||
129071686|NCT05842967|464552103|FG001|Period 2: SSB|Adverse Event|0|||
129071687|NCT05842967|464552104|FG002|Period 2: SSB|Adverse Event|2|||
129071688|NCT05842967|464552105|FG003|Period 2: SSB|Adverse Event|0|||
129071689|NCT05842967|464552102|FG000|Period 2: SSB|Lost to Follow-up|0|||
129071690|NCT05842967|464552103|FG001|Period 2: SSB|Lost to Follow-up|0|||
129071691|NCT05842967|464552104|FG002|Period 2: SSB|Lost to Follow-up|4|||
129071692|NCT05842967|464552105|FG003|Period 2: SSB|Lost to Follow-up|3|||
129071693|NCT05842967|464552102|FG000|Period 2: SSB|Withdrawal by Subject|0|||
129071694|NCT05842967|464552103|FG001|Period 2: SSB|Withdrawal by Subject|0|||
129071695|NCT05842967|464552104|FG002|Period 2: SSB|Withdrawal by Subject|1|||
129071696|NCT05842967|464552105|FG003|Period 2: SSB|Withdrawal by Subject|0|||
129071697|NCT05842967|464552102|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
129071698|NCT05842967|464552103|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
129071699|NCT05842967|464552104|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
129071700|NCT05842967|464552105|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
129071701|NCT05842967|464552102|FG000|Period 2: SSB|Protocol Violation|0|||
129071702|NCT05842967|464552103|FG001|Period 2: SSB|Protocol Violation|0|||
129071703|NCT05842967|464552104|FG002|Period 2: SSB|Protocol Violation|0|||
129071704|NCT05842967|464552105|FG003|Period 2: SSB|Protocol Violation|1|||
129140495|NCT03574389|464808714|FG002|Vaccination Period|Other|0|||
129071705|NCT01823328|464552107|FG000|Overall Study|Withdrawal by Subject|8|||
129071706|NCT01823328|464552108|FG001|Overall Study|Withdrawal by Subject|6|||
129071707|NCT02547428|464552109|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
129071708|NCT02547428|464552110|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
129071709|NCT02547428|464552109|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
129071710|NCT02547428|464552110|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
129071711|NCT02547428|464552109|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
129071712|NCT02547428|464552110|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
129071713|NCT02547428|464552109|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
129071714|NCT02547428|464552110|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
129071715|NCT02547428|464552109|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
129071716|NCT02547428|464552110|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
129071717|NCT02547428|464552109|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
129071718|NCT02547428|464552110|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
129071719|NCT02547428|464552109|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
129071720|NCT02547428|464552110|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
129071721|NCT02547428|464552109|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
129071722|NCT02547428|464552110|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
129071723|NCT01479465|464552111|FG000|Overall Study|Disease Progression|9|||
129071724|NCT01479465|464552112|FG001|Overall Study|Disease Progression|61|||
129071725|NCT01479465|464552113|FG002|Overall Study|Disease Progression|65|||
129071726|NCT01479465|464552114|FG003|Overall Study|Disease Progression|70|||
129071727|NCT01479465|464552111|FG000|Overall Study|Study Discontinued by Sponsor|0|||
129071728|NCT01479465|464552112|FG001|Overall Study|Study Discontinued by Sponsor|7|||
129071729|NCT01479465|464552113|FG002|Overall Study|Study Discontinued by Sponsor|5|||
129071730|NCT01479465|464552114|FG003|Overall Study|Study Discontinued by Sponsor|3|||
129071731|NCT01479465|464552111|FG000|Overall Study|Adverse Event|0|||
129071732|NCT01479465|464552112|FG001|Overall Study|Adverse Event|3|||
129071733|NCT01479465|464552113|FG002|Overall Study|Adverse Event|6|||
129071734|NCT01479465|464552114|FG003|Overall Study|Adverse Event|4|||
129071735|NCT01479465|464552111|FG000|Overall Study|Investigator Discretion|1|||
129071736|NCT01479465|464552112|FG001|Overall Study|Investigator Discretion|4|||
129071737|NCT01479465|464552113|FG002|Overall Study|Investigator Discretion|2|||
129071738|NCT01479465|464552114|FG003|Overall Study|Investigator Discretion|4|||
129071739|NCT01479465|464552111|FG000|Overall Study|Subject Request|1|||
129071740|NCT01479465|464552112|FG001|Overall Study|Subject Request|3|||
129071741|NCT01479465|464552113|FG002|Overall Study|Subject Request|4|||
129071742|NCT01479465|464552114|FG003|Overall Study|Subject Request|2|||
129071743|NCT01479465|464552111|FG000|Overall Study|Subject Withdrew Consent|0|||
129071744|NCT01479465|464552112|FG001|Overall Study|Subject Withdrew Consent|5|||
129071745|NCT01479465|464552113|FG002|Overall Study|Subject Withdrew Consent|2|||
129071746|NCT01479465|464552114|FG003|Overall Study|Subject Withdrew Consent|1|||
129071747|NCT01479465|464552111|FG000|Overall Study|Protocol Violation|0|||
129071748|NCT01479465|464552112|FG001|Overall Study|Protocol Violation|1|||
129071749|NCT01479465|464552113|FG002|Overall Study|Protocol Violation|1|||
129071750|NCT01479465|464552114|FG003|Overall Study|Protocol Violation|0|||
129071751|NCT01479465|464552111|FG000|Overall Study|Death|0|||
129071752|NCT01479465|464552112|FG001|Overall Study|Death|0|||
129071753|NCT01479465|464552113|FG002|Overall Study|Death|0|||
129071754|NCT01479465|464552114|FG003|Overall Study|Death|1|||
129071755|NCT01479465|464552111|FG000|Overall Study|Lost to Follow-up|0|||
129071756|NCT01479465|464552112|FG001|Overall Study|Lost to Follow-up|0|||
129071757|NCT01479465|464552113|FG002|Overall Study|Lost to Follow-up|1|||
129071758|NCT01479465|464552114|FG003|Overall Study|Lost to Follow-up|0|||
129140496|NCT03574389|464808715|FG003|Vaccination Period|Other|0|||
129140497|NCT03574389|464808716|FG004|Vaccination Period|Other|0|||
129140498|NCT03574389|464808717|FG005|Vaccination Period|Other|0|||
129140499|NCT03574389|464808718|FG006|Vaccination Period|Other|0|||
129140500|NCT03574389|464808712|FG000|Vaccination Period|Adverse Event|0|||
129140501|NCT03574389|464808713|FG001|Vaccination Period|Adverse Event|1|||
129140502|NCT03574389|464808714|FG002|Vaccination Period|Adverse Event|0|||
129071759|NCT01173523|464552115|FG000|Overall Study|Clinical Progression|1|||
129071760|NCT01173523|464552116|FG001|Overall Study|Clinical Progression|1|||
129071761|NCT01173523|464552115|FG000|Overall Study|Progressive Disease|10|||
129071762|NCT01173523|464552116|FG001|Overall Study|Progressive Disease|8|||
129140503|NCT03574389|464808715|FG003|Vaccination Period|Adverse Event|0|||
129140504|NCT03574389|464808716|FG004|Vaccination Period|Adverse Event|0|||
129140505|NCT03574389|464808717|FG005|Vaccination Period|Adverse Event|0|||
129071763|NCT01173523|464552115|FG000|Overall Study|Other|2|||
129140506|NCT03574389|464808718|FG006|Vaccination Period|Adverse Event|0|||
129140507|NCT03574389|464808712|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
129140508|NCT03574389|464808713|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
129071764|NCT01173523|464552116|FG001|Overall Study|Other|3|||
129071765|NCT01439802|464552121|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
129071766|NCT01439802|464552121|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
129071767|NCT01866826|464552122|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
129071768|NCT01866826|464552123|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
129071769|NCT01866826|464552122|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
129071770|NCT01866826|464552123|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
129071771|NCT01866826|464552122|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
129071772|NCT01866826|464552123|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
129071773|NCT00709995|464552124|FG000|Overall Study|Adverse Event|4|||
129071774|NCT00709995|464552125|FG001|Overall Study|Adverse Event|2|||
129071775|NCT00709995|464552124|FG000|Overall Study|Withdrawal by Subject|1|||
129071776|NCT00709995|464552125|FG001|Overall Study|Withdrawal by Subject|3|||
129071777|NCT00742209|464552130|FG000|Overall Study|Adverse Event|11|||
129071778|NCT00742209|464552131|FG001|Overall Study|Adverse Event|4|||
129071779|NCT00742209|464552132|FG002|Overall Study|Adverse Event|17|||
129071780|NCT00742209|464552133|FG003|Overall Study|Adverse Event|16|||
129071781|NCT00742209|464552134|FG004|Overall Study|Adverse Event|13|||
129071782|NCT00742209|464552130|FG000|Overall Study|Participant Withdrew Consent|8|||
129071783|NCT00742209|464552131|FG001|Overall Study|Participant Withdrew Consent|4|||
129071784|NCT00742209|464552132|FG002|Overall Study|Participant Withdrew Consent|14|||
129071785|NCT00742209|464552133|FG003|Overall Study|Participant Withdrew Consent|7|||
129071786|NCT00742209|464552134|FG004|Overall Study|Participant Withdrew Consent|4|||
129071787|NCT00742209|464552130|FG000|Overall Study|Protocol Violation|6|||
129071788|NCT00742209|464552131|FG001|Overall Study|Protocol Violation|5|||
129071789|NCT00742209|464552132|FG002|Overall Study|Protocol Violation|4|||
129071790|NCT00742209|464552133|FG003|Overall Study|Protocol Violation|5|||
129071791|NCT00742209|464552134|FG004|Overall Study|Protocol Violation|3|||
129071792|NCT00742209|464552130|FG000|Overall Study|Lost to Follow-up|3|||
129071793|NCT00742209|464552131|FG001|Overall Study|Lost to Follow-up|4|||
129071794|NCT00742209|464552132|FG002|Overall Study|Lost to Follow-up|5|||
129071795|NCT00742209|464552133|FG003|Overall Study|Lost to Follow-up|5|||
129071796|NCT00742209|464552134|FG004|Overall Study|Lost to Follow-up|3|||
129071797|NCT00742209|464552130|FG000|Overall Study|Lack of Efficacy|6|||
129071798|NCT00742209|464552131|FG001|Overall Study|Lack of Efficacy|1|||
129071799|NCT00742209|464552132|FG002|Overall Study|Lack of Efficacy|1|||
129071800|NCT00742209|464552133|FG003|Overall Study|Lack of Efficacy|3|||
129071801|NCT00742209|464552134|FG004|Overall Study|Lack of Efficacy|1|||
129071802|NCT00742209|464552130|FG000|Overall Study|Investigator Discretion|0|||
129071803|NCT00742209|464552131|FG001|Overall Study|Investigator Discretion|0|||
129071804|NCT00742209|464552132|FG002|Overall Study|Investigator Discretion|5|||
129071805|NCT00742209|464552133|FG003|Overall Study|Investigator Discretion|1|||
129071806|NCT00742209|464552134|FG004|Overall Study|Investigator Discretion|1|||
129071807|NCT00595621|464552138|FG000|Open Label Run in|Adverse Event|1|||
129071808|NCT00595621|464552139|FG001|Open Label Run in|Adverse Event|0|||
129071809|NCT00595621|464552138|FG000|Open Label Run in|Physician Decision|1|||
129071810|NCT00595621|464552139|FG001|Open Label Run in|Physician Decision|0|||
129071811|NCT00595621|464552138|FG000|Open Label Run in|Withdrawal by Subject|1|||
129071812|NCT00595621|464552139|FG001|Open Label Run in|Withdrawal by Subject|0|||
129071813|NCT00595621|464552138|FG000|Randomization and Study|Adverse Event|2|||
129071814|NCT00595621|464552139|FG001|Randomization and Study|Adverse Event|0|||
129071815|NCT00595621|464552138|FG000|Randomization and Study|Withdrawal by Subject|0|||
129071816|NCT00595621|464552139|FG001|Randomization and Study|Withdrawal by Subject|1|||
129071817|NCT00324987|464552140|FG000|Overall Study|Adverse Event|2|||
129071818|NCT00324987|464552141|FG001|Overall Study|Adverse Event|1|||
129071819|NCT00324987|464552140|FG000|Overall Study|Withdrawal by Subject|1|||
129071820|NCT00324987|464552141|FG001|Overall Study|Withdrawal by Subject|1|||
129140509|NCT03574389|464808714|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
129140510|NCT03574389|464808715|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
129140511|NCT03574389|464808716|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
129140512|NCT03574389|464808717|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
129140513|NCT03574389|464808718|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
129071821|NCT00324987|464552140|FG000|Overall Study|Progression|1|||
129071822|NCT00324987|464552141|FG001|Overall Study|Progression|1|||
129071823|NCT00324987|464552140|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
129071824|NCT00324987|464552141|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
129071825|NCT03817125|464552142|FG000|Overall Study|Adverse Event|1|||
129071826|NCT03817125|464552143|FG001|Overall Study|Adverse Event|0|||
129071827|NCT03817125|464552142|FG000|Overall Study|Physician Decision|0|||
129140514|NCT02715856|464808719|FG000|Overall Study|Software Issues|12|||
129140515|NCT02715856|464808720|FG001|Overall Study|Software Issues|7|||
129140516|NCT02715856|464808719|FG000|Overall Study|Death|6|||
129140517|NCT02715856|464808720|FG001|Overall Study|Death|5|||
129140518|NCT02715856|464808719|FG000|Overall Study|Non- Compliant|0|||
129140519|NCT02715856|464808720|FG001|Overall Study|Non- Compliant|40|||
129071828|NCT03817125|464552143|FG001|Overall Study|Physician Decision|1|||
129071829|NCT03817125|464552142|FG000|Overall Study|Lack of Efficacy|1|||
129071830|NCT03817125|464552143|FG001|Overall Study|Lack of Efficacy|5|||
129071831|NCT01998919|464552144|FG000|Overall Study|Death|2|||
129071832|NCT01998919|464552145|FG001|Overall Study|Death|2|||
129071833|NCT01998919|464552144|FG000|Overall Study|Adverse Event|0|||
129071834|NCT01998919|464552145|FG001|Overall Study|Adverse Event|5|||
129071835|NCT01998919|464552144|FG000|Overall Study|Disease progression|31|||
129071836|NCT01998919|464552145|FG001|Overall Study|Disease progression|22|||
129071837|NCT01998919|464552144|FG000|Overall Study|Withdrawal by Subject|2|||
129071838|NCT01998919|464552145|FG001|Overall Study|Withdrawal by Subject|4|||
129071839|NCT01998919|464552144|FG000|Overall Study|Lost to Follow-up|2|||
129071840|NCT01998919|464552145|FG001|Overall Study|Lost to Follow-up|0|||
129071841|NCT01998919|464552144|FG000|Overall Study|Other|5|||
129071842|NCT01998919|464552145|FG001|Overall Study|Other|2|||
129071843|NCT00897715|464552149|FG000|Overall Study|Lost to Follow-up|0|||
129071844|NCT00897715|464552150|FG001|Overall Study|Lost to Follow-up|1|||
129071845|NCT00897715|464552149|FG000|Overall Study|Physician Decision|1|||
129071846|NCT00897715|464552150|FG001|Overall Study|Physician Decision|0|||
129071847|NCT00897715|464552149|FG000|Overall Study|increased risk of infection|1|||
129071848|NCT00897715|464552150|FG001|Overall Study|increased risk of infection|0|||
129071849|NCT00791778|464552151|FG000|Double-blind Treatment|Adverse Event|49|||
129071850|NCT00791778|464552152|FG001|Double-blind Treatment|Adverse Event|9|||
129071851|NCT00791778|464552151|FG000|Double-blind Treatment|Physician Decision|6|||
129071852|NCT00791778|464552152|FG001|Double-blind Treatment|Physician Decision|26|||
129071853|NCT00791778|464552151|FG000|Double-blind Treatment|Protocol Violation|0|||
129071854|NCT00791778|464552152|FG001|Double-blind Treatment|Protocol Violation|4|||
129071855|NCT00791778|464552151|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
129071856|NCT00791778|464552152|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
129071857|NCT00791778|464552151|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
129071858|NCT00791778|464552152|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
129071859|NCT00791778|464552151|FG000|Follow-up|Withdrawal by Subject|3|||
129071860|NCT00791778|464552152|FG001|Follow-up|Withdrawal by Subject|0|||
129071861|NCT00791778|464552151|FG000|Follow-up|Lost to Follow-up|2|||
129071862|NCT00791778|464552152|FG001|Follow-up|Lost to Follow-up|1|||
129071863|NCT05921903|464552153|FG000|Overall Study|Unsolicited non-SAE|0|||
129140520|NCT02462057|464808721|FG000|Overall Study|Left Vitality|32|||
129140521|NCT02462057|464808722|FG001|Overall Study|Left Vitality|27|||
129140522|NCT02462057|464808723|FG002|Overall Study|Left Vitality|23|||
129140523|NCT02462057|464808724|FG003|Overall Study|Left Vitality|35|||
129140524|NCT02462057|464808725|FG004|Overall Study|Left Vitality|33|||
129140525|NCT02462057|464808721|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
129140526|NCT02462057|464808722|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
129140527|NCT02462057|464808723|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
129140528|NCT02462057|464808724|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
129140529|NCT02462057|464808725|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
129140530|NCT01959919|464808726|FG000|Overall Study|Did not meet the eligibility criteria|2|||
129140531|NCT01697501|464808727|FG000|Overall Study|Protocol Violation|2|||
129140532|NCT00128492|464808728|FG000|Overall Study|AE unrelated to study|2|||
129140533|NCT00128492|464808729|FG001|Overall Study|AE unrelated to study|9|||
129140534|NCT00128492|464808728|FG000|Overall Study|Study drug intolerance (AE)|2|||
129140535|NCT00128492|464808729|FG001|Overall Study|Study drug intolerance (AE)|8|||
129140536|NCT00128492|464808728|FG000|Overall Study|AE related to study|1|||
129140537|NCT00128492|464808729|FG001|Overall Study|AE related to study|4|||
129140538|NCT00128492|464808728|FG000|Overall Study|Death|1|||
129140539|NCT00128492|464808729|FG001|Overall Study|Death|0|||
129140540|NCT00128492|464808728|FG000|Overall Study|Lost to Follow-up|1|||
129140541|NCT00128492|464808729|FG001|Overall Study|Lost to Follow-up|5|||
129071864|NCT05921903|464552154|FG001|Overall Study|Unsolicited non-SAE|1|||
129140542|NCT00128492|464808728|FG000|Overall Study|Noncompliance|0|||
129140543|NCT00128492|464808729|FG001|Overall Study|Noncompliance|5|||
129071865|NCT05921903|464552155|FG002|Overall Study|Unsolicited non-SAE|0|||
129071866|NCT05921903|464552153|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
129071867|NCT05921903|464552154|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
129071868|NCT05921903|464552155|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
129140544|NCT00128492|464808728|FG000|Overall Study|Personal or administrative|10|||
129140545|NCT00128492|464808729|FG001|Overall Study|Personal or administrative|22|||
129140546|NCT00128492|464808728|FG000|Overall Study|Withdrawal by Subject|3|||
129140547|NCT00128492|464808729|FG001|Overall Study|Withdrawal by Subject|5|||
129140548|NCT00128492|464808728|FG000|Overall Study|Pregnancy|0|||
129140549|NCT00128492|464808729|FG001|Overall Study|Pregnancy|1|||
129140550|NCT00692237|464808731|FG000|Overall Study|Withdrawal by Subject|1|||
129140551|NCT00692237|464808732|FG001|Overall Study|Withdrawal by Subject|3|||
129140552|NCT00692237|464808731|FG000|Overall Study|Adverse Event|0|||
129140553|NCT00692237|464808732|FG001|Overall Study|Adverse Event|1|||
129140554|NCT01347086|464808733|FG000|Overall Study|failed screening visit|0|||
129140555|NCT01347086|464808734|FG001|Overall Study|failed screening visit|0|||
128723980|NCT00969553|463287306|FG007|Overall Study|Other Adverse Event|0|||
129071869|NCT05921903|464552153|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
129071870|NCT05921903|464552154|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
129071871|NCT05921903|464552155|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
129071872|NCT05317312|464552158|FG000|Overall Study|Withdrawal by Subject|0|||
129071873|NCT05317312|464552159|FG001|Overall Study|Withdrawal by Subject|1|||
129071874|NCT05317312|464552160|FG002|Overall Study|Withdrawal by Subject|0|||
129071875|NCT05317312|464552161|FG003|Overall Study|Withdrawal by Subject|0|||
129071876|NCT05317312|464552158|FG000|Overall Study|Lost to Follow-up|0|||
129071877|NCT05317312|464552159|FG001|Overall Study|Lost to Follow-up|0|||
129071878|NCT05317312|464552160|FG002|Overall Study|Lost to Follow-up|0|||
129071879|NCT05317312|464552161|FG003|Overall Study|Lost to Follow-up|1|||
129071880|NCT05317312|464552158|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
129071881|NCT05317312|464552159|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
129071882|NCT05317312|464552160|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
129071883|NCT05317312|464552161|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
129071884|NCT00235755|464552162|FG000|4-Week Titration Phase|Adverse Event|6|||
129071885|NCT00235755|464552163|FG001|4-Week Titration Phase|Adverse Event|14|||
129071886|NCT00235755|464552164|FG002|4-Week Titration Phase|Adverse Event|20|||
129071887|NCT00235755|464552162|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
129071888|NCT00235755|464552163|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
129071889|NCT00235755|464552164|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
129071890|NCT00235755|464552162|FG000|4-Week Titration Phase|Protocol Violation|2|||
129071891|NCT00235755|464552163|FG001|4-Week Titration Phase|Protocol Violation|2|||
129071892|NCT00235755|464552164|FG002|4-Week Titration Phase|Protocol Violation|1|||
129071893|NCT00235755|464552162|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
129071894|NCT00235755|464552163|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
129071895|NCT00235755|464552164|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
129071896|NCT00235755|464552162|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
129071897|NCT00235755|464552163|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
129071898|NCT00235755|464552164|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
129071899|NCT00235755|464552162|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
129071900|NCT00235755|464552163|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
129071901|NCT00235755|464552164|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
129071902|NCT00235755|464552162|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
129071903|NCT00235755|464552163|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
129071904|NCT00235755|464552164|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
129071905|NCT00235755|464552162|FG000|12-Week Maintenance Phase|Adverse Event|8|||
129071906|NCT00235755|464552163|FG001|12-Week Maintenance Phase|Adverse Event|12|||
129071907|NCT00235755|464552164|FG002|12-Week Maintenance Phase|Adverse Event|26|||
129071908|NCT00235755|464552162|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
129071909|NCT00235755|464552163|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
129071910|NCT00235755|464552164|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
129071911|NCT00235755|464552162|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
129071912|NCT00235755|464552163|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
129071913|NCT00235755|464552164|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
129071914|NCT00235755|464552162|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
129071915|NCT00235755|464552163|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
129071916|NCT00235755|464552164|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
129071917|NCT00235755|464552162|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
129071918|NCT00235755|464552163|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
129071919|NCT00235755|464552164|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
129071920|NCT00235755|464552162|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
129071921|NCT00235755|464552163|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
129071922|NCT00235755|464552164|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
129071923|NCT02314026|464552165|FG000|Overall Study|Protocol Violation|28|||
129071924|NCT01532934|464552166|FG000|Overall Study|Lost to Follow-up|11|||
129071925|NCT01532934|464552167|FG001|Overall Study|Lost to Follow-up|11|||
129071926|NCT01532934|464552166|FG000|Overall Study|In controlled environment|3|||
129071927|NCT01532934|464552167|FG001|Overall Study|In controlled environment|2|||
129140556|NCT01347086|464808735|FG002|Overall Study|failed screening visit|1|||
129140557|NCT01347086|464808736|FG003|Overall Study|failed screening visit|0|||
129140558|NCT01347086|464808737|FG004|Overall Study|failed screening visit|0|||
129140559|NCT01347086|464808738|FG005|Overall Study|failed screening visit|0|||
129140560|NCT01347086|464808739|FG006|Overall Study|failed screening visit|1|||
129140561|NCT01347086|464808740|FG007|Overall Study|failed screening visit|1|||
129140562|NCT01347086|464808741|FG008|Overall Study|failed screening visit|0|||
129140563|NCT01347086|464808742|FG009|Overall Study|failed screening visit|1|||
129140564|NCT00395447|464808743|FG000|Overall Study|Death|37|||
129140565|NCT00395447|464808744|FG001|Overall Study|Death|32|||
129140566|NCT00395447|464808743|FG000|Overall Study|Lost to Follow-up|52|||
129140567|NCT00395447|464808744|FG001|Overall Study|Lost to Follow-up|43|||
129140568|NCT00395447|464808743|FG000|Overall Study|Withdrawal by Subject|24|||
129140569|NCT00395447|464808744|FG001|Overall Study|Withdrawal by Subject|19|||
129071928|NCT02291237|464552168|FG000|Overall Study|Study Terminated by Sponsor|72|||
129071929|NCT02291237|464552169|FG001|Overall Study|Study Terminated by Sponsor|67|||
129071930|NCT02291237|464552168|FG000|Overall Study|Adverse Event|1|||
129071931|NCT02291237|464552169|FG001|Overall Study|Adverse Event|3|||
129071932|NCT02291237|464552168|FG000|Overall Study|Investigator's Discretion|0|||
129071933|NCT02291237|464552169|FG001|Overall Study|Investigator's Discretion|3|||
129071934|NCT02291237|464552168|FG000|Overall Study|Withdrew Consent|11|||
129071935|NCT02291237|464552169|FG001|Overall Study|Withdrew Consent|11|||
129071936|NCT02291237|464552168|FG000|Overall Study|Lost to Follow-up|0|||
129071937|NCT02291237|464552169|FG001|Overall Study|Lost to Follow-up|2|||
129071938|NCT02291237|464552168|FG000|Overall Study|Subject Required Prohibited Medication|2|||
129071939|NCT02291237|464552169|FG001|Overall Study|Subject Required Prohibited Medication|0|||
129071940|NCT01149863|464552170|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
129071941|NCT01306305|464552171|FG000|Overall Study|Lost to Follow-up|1|||
129071942|NCT01306305|464552172|FG001|Overall Study|Lost to Follow-up|0|||
129071943|NCT01306305|464552171|FG000|Overall Study|Withdrew consent|1|||
129071944|NCT01306305|464552172|FG001|Overall Study|Withdrew consent|0|||
129071945|NCT03326193|464552173|FG000|Overall Study|Sponsor decision|35|||
129071946|NCT00699998|464552175|FG000|Overall Study|Withdrawal by Subject|194|||
129071947|NCT00699998|464552176|FG001|Overall Study|Withdrawal by Subject|83|||
129071948|NCT00699998|464552177|FG002|Overall Study|Withdrawal by Subject|202|||
129071949|NCT00699998|464552178|FG003|Overall Study|Withdrawal by Subject|80|||
129071950|NCT00699998|464552175|FG000|Overall Study|Physician Decision|3|||
129071951|NCT00699998|464552176|FG001|Overall Study|Physician Decision|2|||
129071952|NCT00699998|464552177|FG002|Overall Study|Physician Decision|1|||
129071953|NCT00699998|464552178|FG003|Overall Study|Physician Decision|1|||
129071954|NCT00699998|464552175|FG000|Overall Study|Lost to Follow-up|2|||
129071955|NCT00699998|464552176|FG001|Overall Study|Lost to Follow-up|1|||
129071956|NCT00699998|464552177|FG002|Overall Study|Lost to Follow-up|3|||
129071957|NCT00699998|464552178|FG003|Overall Study|Lost to Follow-up|1|||
129071958|NCT01406574|464552179|FG000|Overall Study|Adverse Event|0|||
129071959|NCT01406574|464552180|FG001|Overall Study|Adverse Event|0|||
129071960|NCT01406574|464552181|FG002|Overall Study|Adverse Event|1|||
129071961|NCT01406574|464552182|FG003|Overall Study|Adverse Event|3|||
129071962|NCT01406574|464552179|FG000|Overall Study|Physician Decision|0|||
129071963|NCT01406574|464552180|FG001|Overall Study|Physician Decision|0|||
129071964|NCT01406574|464552181|FG002|Overall Study|Physician Decision|0|||
129071965|NCT01406574|464552182|FG003|Overall Study|Physician Decision|1|||
129071966|NCT01406574|464552179|FG000|Overall Study|Withdrawal by Subject|0|||
129071967|NCT01406574|464552180|FG001|Overall Study|Withdrawal by Subject|1|||
129071968|NCT01406574|464552181|FG002|Overall Study|Withdrawal by Subject|0|||
129071969|NCT01406574|464552182|FG003|Overall Study|Withdrawal by Subject|0|||
129071970|NCT01406574|464552179|FG000|Overall Study|Definite progression of primary disease|1|||
129071971|NCT01406574|464552180|FG001|Overall Study|Definite progression of primary disease|0|||
129071972|NCT01406574|464552181|FG002|Overall Study|Definite progression of primary disease|0|||
129071973|NCT01406574|464552182|FG003|Overall Study|Definite progression of primary disease|0|||
129071974|NCT00473590|464552187|FG000|Overall Study|Adverse Event|3|||
129071975|NCT00473590|464552188|FG001|Overall Study|Adverse Event|3|||
129140570|NCT00395447|464808743|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
129140571|NCT00395447|464808744|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
129140572|NCT02624687|464808746|FG000|Overall Study|Withdrawal by Subject|1|||
129140573|NCT02624687|464808747|FG001|Overall Study|Withdrawal by Subject|1|||
129140574|NCT02624687|464808746|FG000|Overall Study|medical leave from work|0|||
129071976|NCT00473590|464552187|FG000|Overall Study|Death|4|||
129071977|NCT00473590|464552188|FG001|Overall Study|Death|2|||
129071978|NCT00473590|464552187|FG000|Overall Study|Progression not resulting in death|24|||
129071979|NCT00473590|464552188|FG001|Overall Study|Progression not resulting in death|20|||
129071980|NCT00473590|464552187|FG000|Overall Study|Non-protocol-specified therapy|7|||
129071981|NCT00473590|464552188|FG001|Overall Study|Non-protocol-specified therapy|5|||
129071982|NCT00473590|464552187|FG000|Overall Study|Physician Decision|2|||
129071983|NCT00473590|464552188|FG001|Overall Study|Physician Decision|4|||
129071984|NCT00473590|464552187|FG000|Overall Study|Withdrawal by Subject|5|||
129140575|NCT02624687|464808747|FG001|Overall Study|medical leave from work|1|||
129140576|NCT03111108|464808748|FG000|Overall Study|Death|0|||
129140577|NCT03111108|464808749|FG001|Overall Study|Death|1|||
129071985|NCT00473590|464552188|FG001|Overall Study|Withdrawal by Subject|3|||
129071986|NCT00473590|464552187|FG000|Overall Study|Other|0|||
129071987|NCT00473590|464552188|FG001|Overall Study|Other|1|||
129071988|NCT03367819|464552191|FG000|Overall Study|Adverse Event|4|||
129071989|NCT03367819|464552192|FG001|Overall Study|Adverse Event|4|||
129071990|NCT03367819|464552191|FG000|Overall Study|Progressive Disease|15|||
129071991|NCT03367819|464552192|FG001|Overall Study|Progressive Disease|13|||
129071992|NCT03367819|464552191|FG000|Overall Study|Withdrawal by Subject|1|||
129071993|NCT03367819|464552192|FG001|Overall Study|Withdrawal by Subject|0|||
129071994|NCT03367819|464552191|FG000|Overall Study|Other|4|||
129071995|NCT03367819|464552192|FG001|Overall Study|Other|2|||
129071996|NCT00584454|464552193|FG000|Overall Study|Adverse Event|1|||
129071997|NCT00584454|464552193|FG000|Overall Study|Relocation|1|||
129071998|NCT00584454|464552193|FG000|Overall Study|Clinical Hold|2|||
129071999|NCT00982657|464552194|FG000|Overall Study|Death|1|||
129072000|NCT00982657|464552195|FG001|Overall Study|Death|0|||
129072001|NCT00982657|464552196|FG002|Overall Study|Death|1|||
129072002|NCT00982657|464552197|FG003|Overall Study|Death|1|||
129072003|NCT00982657|464552194|FG000|Overall Study|Withdrawal by Subject|0|||
129072004|NCT00982657|464552195|FG001|Overall Study|Withdrawal by Subject|0|||
129072005|NCT00982657|464552196|FG002|Overall Study|Withdrawal by Subject|1|||
129072006|NCT00982657|464552197|FG003|Overall Study|Withdrawal by Subject|3|||
129072007|NCT00982657|464552194|FG000|Overall Study|Other|0|||
129072008|NCT00982657|464552195|FG001|Overall Study|Other|0|||
129072009|NCT00982657|464552196|FG002|Overall Study|Other|0|||
129072010|NCT00982657|464552197|FG003|Overall Study|Other|4|||
129072011|NCT00982657|464552194|FG000|Overall Study|On going at date of cut-off|0|||
129072012|NCT00982657|464552195|FG001|Overall Study|On going at date of cut-off|0|||
129072013|NCT00982657|464552196|FG002|Overall Study|On going at date of cut-off|0|||
129072014|NCT00982657|464552197|FG003|Overall Study|On going at date of cut-off|1|||
129072015|NCT00725920|464552198|FG000|Overall Study|Lack of Efficacy|3|||
129072016|NCT00725920|464552199|FG001|Overall Study|Lack of Efficacy|6|||
129072017|NCT05373108|464552200|FG000|Overall Study|Withdrawal by Subject|2|||
129072018|NCT02513160|464554092|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
129072019|NCT02513160|464554093|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
129072020|NCT02513160|464554094|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
129072021|NCT02513160|464554095|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
129072022|NCT02513160|464554092|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
129072023|NCT02513160|464554093|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
129072024|NCT02513160|464554094|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
129072025|NCT02513160|464554095|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
129072026|NCT02513160|464554092|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
129072027|NCT02513160|464554093|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
129072028|NCT02513160|464554094|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
129072029|NCT02513160|464554095|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
129072030|NCT02513160|464554092|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
129072031|NCT02513160|464554093|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
129072032|NCT02513160|464554094|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
129072033|NCT02513160|464554095|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
129072034|NCT02513160|464554092|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
129072035|NCT02513160|464554093|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
129072036|NCT02513160|464554094|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
129072037|NCT02513160|464554095|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
129072038|NCT02513160|464554092|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
129072039|NCT02513160|464554093|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
129072040|NCT02513160|464554094|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
129072041|NCT02513160|464554095|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
129072042|NCT02513160|464554092|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
129072043|NCT02513160|464554093|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
129072044|NCT02513160|464554094|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
129072045|NCT02513160|464554095|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
129072046|NCT02513160|464554092|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
129072047|NCT02513160|464554093|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
129072048|NCT02513160|464554094|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
129072049|NCT02513160|464554095|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
129072050|NCT02513160|464554092|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
129072051|NCT02513160|464554093|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
129072052|NCT02513160|464554094|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
129072053|NCT02513160|464554095|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
129072054|NCT02513160|464554092|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
129072055|NCT02513160|464554093|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
129072056|NCT02513160|464554094|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
129072057|NCT02513160|464554095|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
129072058|NCT02513160|464554092|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
129072059|NCT02513160|464554093|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
129072060|NCT02513160|464554094|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
129072061|NCT02513160|464554095|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
129072062|NCT02513160|464554092|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
129072063|NCT02513160|464554093|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
129072064|NCT02513160|464554094|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
129072065|NCT02513160|464554095|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
129072066|NCT03428958|464554098|FG000|Overall Study|Adverse Event|0|||
129072067|NCT03428958|464554099|FG001|Overall Study|Adverse Event|0|||
129072068|NCT03428958|464554100|FG002|Overall Study|Adverse Event|0|||
129072069|NCT03428958|464554101|FG003|Overall Study|Adverse Event|1|||
129072070|NCT03428958|464554102|FG004|Overall Study|Adverse Event|0|||
129072071|NCT03428958|464554103|FG005|Overall Study|Adverse Event|2|||
129072072|NCT03428958|464554104|FG006|Overall Study|Adverse Event|1|||
129072073|NCT03428958|464554105|FG007|Overall Study|Adverse Event|0|||
129072074|NCT03428958|464554106|FG008|Overall Study|Adverse Event|0|||
129072075|NCT03428958|464554107|FG009|Overall Study|Adverse Event|0|||
129072076|NCT03428958|464554108|FG010|Overall Study|Adverse Event|0|||
129072077|NCT03428958|464554109|FG011|Overall Study|Adverse Event|0|||
129072078|NCT03428958|464554110|FG012|Overall Study|Adverse Event|0|||
129072079|NCT03428958|464554111|FG013|Overall Study|Adverse Event|0|||
129072080|NCT03428958|464554112|FG014|Overall Study|Adverse Event|0|||
129072081|NCT03428958|464554113|FG015|Overall Study|Adverse Event|0|||
129072082|NCT03428958|464554114|FG016|Overall Study|Adverse Event|0|||
129072083|NCT03428958|464554098|FG000|Overall Study|Clinical Progression|2|||
129072084|NCT03428958|464554099|FG001|Overall Study|Clinical Progression|3|||
129072085|NCT03428958|464554100|FG002|Overall Study|Clinical Progression|2|||
129072086|NCT03428958|464554101|FG003|Overall Study|Clinical Progression|1|||
129072087|NCT03428958|464554102|FG004|Overall Study|Clinical Progression|0|||
129072088|NCT03428958|464554103|FG005|Overall Study|Clinical Progression|2|||
129072089|NCT03428958|464554104|FG006|Overall Study|Clinical Progression|0|||
129072090|NCT03428958|464554105|FG007|Overall Study|Clinical Progression|0|||
129072091|NCT03428958|464554106|FG008|Overall Study|Clinical Progression|0|||
129072092|NCT03428958|464554107|FG009|Overall Study|Clinical Progression|0|||
129072093|NCT03428958|464554108|FG010|Overall Study|Clinical Progression|0|||
129072094|NCT03428958|464554109|FG011|Overall Study|Clinical Progression|0|||
129072095|NCT03428958|464554110|FG012|Overall Study|Clinical Progression|0|||
129072096|NCT03428958|464554111|FG013|Overall Study|Clinical Progression|0|||
129072097|NCT03428958|464554112|FG014|Overall Study|Clinical Progression|0|||
129072098|NCT03428958|464554113|FG015|Overall Study|Clinical Progression|0|||
129072099|NCT03428958|464554114|FG016|Overall Study|Clinical Progression|0|||
129072100|NCT03428958|464554098|FG000|Overall Study|Progression per RECIST|6|||
129072101|NCT03428958|464554099|FG001|Overall Study|Progression per RECIST|6|||
129072102|NCT03428958|464554100|FG002|Overall Study|Progression per RECIST|7|||
129072103|NCT03428958|464554101|FG003|Overall Study|Progression per RECIST|4|||
129072104|NCT03428958|464554102|FG004|Overall Study|Progression per RECIST|0|||
129072105|NCT03428958|464554103|FG005|Overall Study|Progression per RECIST|7|||
129072106|NCT03428958|464554104|FG006|Overall Study|Progression per RECIST|8|||
129072107|NCT03428958|464554105|FG007|Overall Study|Progression per RECIST|0|||
129072108|NCT03428958|464554106|FG008|Overall Study|Progression per RECIST|0|||
129072109|NCT03428958|464554107|FG009|Overall Study|Progression per RECIST|0|||
129072110|NCT03428958|464554108|FG010|Overall Study|Progression per RECIST|0|||
129072111|NCT03428958|464554109|FG011|Overall Study|Progression per RECIST|0|||
129072112|NCT03428958|464554110|FG012|Overall Study|Progression per RECIST|1|||
129072113|NCT03428958|464554111|FG013|Overall Study|Progression per RECIST|0|||
129072114|NCT03428958|464554112|FG014|Overall Study|Progression per RECIST|0|||
129072115|NCT03428958|464554113|FG015|Overall Study|Progression per RECIST|0|||
129072116|NCT03428958|464554114|FG016|Overall Study|Progression per RECIST|0|||
129072117|NCT03428958|464554098|FG000|Overall Study|Death|2|||
129072118|NCT03428958|464554099|FG001|Overall Study|Death|2|||
129072119|NCT03428958|464554100|FG002|Overall Study|Death|0|||
129072120|NCT03428958|464554101|FG003|Overall Study|Death|0|||
129072121|NCT03428958|464554102|FG004|Overall Study|Death|0|||
129072122|NCT03428958|464554103|FG005|Overall Study|Death|7|||
129072123|NCT03428958|464554104|FG006|Overall Study|Death|9|||
129072124|NCT03428958|464554105|FG007|Overall Study|Death|6|||
129072125|NCT03428958|464554106|FG008|Overall Study|Death|0|||
129072126|NCT03428958|464554107|FG009|Overall Study|Death|0|||
129072127|NCT03428958|464554108|FG010|Overall Study|Death|3|||
129140578|NCT03111108|464808748|FG000|Overall Study|Withdrawal by Subject|1|||
129140579|NCT03111108|464808749|FG001|Overall Study|Withdrawal by Subject|0|||
129072128|NCT03428958|464554109|FG011|Overall Study|Death|0|||
129072129|NCT03428958|464554110|FG012|Overall Study|Death|4|||
129072130|NCT03428958|464554111|FG013|Overall Study|Death|0|||
129072131|NCT03428958|464554112|FG014|Overall Study|Death|0|||
129072132|NCT03428958|464554113|FG015|Overall Study|Death|0|||
129072133|NCT03428958|464554114|FG016|Overall Study|Death|0|||
129072134|NCT03428958|464554098|FG000|Overall Study|Lost to Follow-up|0|||
129072135|NCT03428958|464554099|FG001|Overall Study|Lost to Follow-up|0|||
129072136|NCT03428958|464554100|FG002|Overall Study|Lost to Follow-up|0|||
129072137|NCT03428958|464554101|FG003|Overall Study|Lost to Follow-up|0|||
129072138|NCT03428958|464554102|FG004|Overall Study|Lost to Follow-up|0|||
129072139|NCT03428958|464554103|FG005|Overall Study|Lost to Follow-up|1|||
129072140|NCT03428958|464554104|FG006|Overall Study|Lost to Follow-up|1|||
129072141|NCT03428958|464554105|FG007|Overall Study|Lost to Follow-up|0|||
129072142|NCT03428958|464554106|FG008|Overall Study|Lost to Follow-up|0|||
129072143|NCT03428958|464554107|FG009|Overall Study|Lost to Follow-up|0|||
129072144|NCT03428958|464554108|FG010|Overall Study|Lost to Follow-up|0|||
129072145|NCT03428958|464554109|FG011|Overall Study|Lost to Follow-up|0|||
129072146|NCT03428958|464554110|FG012|Overall Study|Lost to Follow-up|0|||
129072147|NCT03428958|464554111|FG013|Overall Study|Lost to Follow-up|0|||
129072148|NCT03428958|464554112|FG014|Overall Study|Lost to Follow-up|0|||
129072149|NCT03428958|464554113|FG015|Overall Study|Lost to Follow-up|0|||
129072150|NCT03428958|464554114|FG016|Overall Study|Lost to Follow-up|0|||
129072151|NCT03428958|464554098|FG000|Overall Study|Physician/Sponsor Decision|1|||
129072152|NCT03428958|464554099|FG001|Overall Study|Physician/Sponsor Decision|0|||
129072153|NCT03428958|464554100|FG002|Overall Study|Physician/Sponsor Decision|1|||
129072154|NCT03428958|464554101|FG003|Overall Study|Physician/Sponsor Decision|0|||
129072155|NCT03428958|464554102|FG004|Overall Study|Physician/Sponsor Decision|0|||
129072156|NCT03428958|464554103|FG005|Overall Study|Physician/Sponsor Decision|2|||
129072157|NCT03428958|464554104|FG006|Overall Study|Physician/Sponsor Decision|2|||
129072158|NCT03428958|464554105|FG007|Overall Study|Physician/Sponsor Decision|2|||
129072159|NCT03428958|464554106|FG008|Overall Study|Physician/Sponsor Decision|0|||
129072160|NCT03428958|464554107|FG009|Overall Study|Physician/Sponsor Decision|0|||
129072161|NCT03428958|464554108|FG010|Overall Study|Physician/Sponsor Decision|2|||
129072162|NCT03428958|464554109|FG011|Overall Study|Physician/Sponsor Decision|0|||
129072163|NCT03428958|464554110|FG012|Overall Study|Physician/Sponsor Decision|4|||
129072164|NCT03428958|464554111|FG013|Overall Study|Physician/Sponsor Decision|0|||
129072165|NCT03428958|464554112|FG014|Overall Study|Physician/Sponsor Decision|0|||
129072166|NCT03428958|464554113|FG015|Overall Study|Physician/Sponsor Decision|0|||
129072167|NCT03428958|464554114|FG016|Overall Study|Physician/Sponsor Decision|0|||
129072168|NCT03428958|464554098|FG000|Overall Study|Withdrawal by Subject|0|||
129072169|NCT03428958|464554099|FG001|Overall Study|Withdrawal by Subject|0|||
129072170|NCT03428958|464554100|FG002|Overall Study|Withdrawal by Subject|2|||
129072171|NCT03428958|464554101|FG003|Overall Study|Withdrawal by Subject|0|||
129072172|NCT03428958|464554102|FG004|Overall Study|Withdrawal by Subject|0|||
129072173|NCT03428958|464554103|FG005|Overall Study|Withdrawal by Subject|2|||
129072174|NCT03428958|464554104|FG006|Overall Study|Withdrawal by Subject|4|||
129072175|NCT03428958|464554105|FG007|Overall Study|Withdrawal by Subject|1|||
129072176|NCT03428958|464554106|FG008|Overall Study|Withdrawal by Subject|0|||
129072177|NCT03428958|464554107|FG009|Overall Study|Withdrawal by Subject|0|||
129072178|NCT03428958|464554108|FG010|Overall Study|Withdrawal by Subject|0|||
129072179|NCT03428958|464554109|FG011|Overall Study|Withdrawal by Subject|0|||
129072180|NCT03428958|464554110|FG012|Overall Study|Withdrawal by Subject|0|||
129072181|NCT03428958|464554111|FG013|Overall Study|Withdrawal by Subject|0|||
129072182|NCT03428958|464554112|FG014|Overall Study|Withdrawal by Subject|0|||
129072183|NCT03428958|464554113|FG015|Overall Study|Withdrawal by Subject|0|||
129072184|NCT03428958|464554114|FG016|Overall Study|Withdrawal by Subject|0|||
129072185|NCT03874117|464554115|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
129072186|NCT03874117|464554116|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
129072187|NCT03874117|464554115|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
129072188|NCT03874117|464554116|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
129072189|NCT03874117|464554115|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129072190|NCT03874117|464554116|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129072191|NCT03874117|464554115|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
129072192|NCT03874117|464554116|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
129072193|NCT03874117|464554115|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129072194|NCT03874117|464554116|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129140580|NCT02771145|464808750|FG000|Overall Study|Adverse Event|3|||
129140581|NCT02771145|464808750|FG000|Overall Study|Lost to Follow-up|1|||
129072195|NCT05258773|464554117|FG000|Overall Study|Screen Failure|1|||
129072196|NCT05258773|464554118|FG001|Overall Study|Screen Failure|1|||
129072197|NCT05258773|464554117|FG000|Overall Study|Adverse Event|1|||
129072198|NCT05258773|464554118|FG001|Overall Study|Adverse Event|0|||
129072199|NCT05258773|464554117|FG000|Overall Study|Withdrawal by Subject|0|||
129072200|NCT05258773|464554118|FG001|Overall Study|Withdrawal by Subject|1|||
129072201|NCT03018288|464554121|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
129140582|NCT02264821|464808751|FG000|Overall Study|Protocol Violation|1|||
129072202|NCT03018288|464554122|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
129072203|NCT03018288|464554123|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
129072204|NCT03018288|464554124|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
129072205|NCT03018288|464554121|FG000|Overall Study|Participant withdrew consent.|0|||
129072206|NCT03018288|464554122|FG001|Overall Study|Participant withdrew consent.|0|||
129072207|NCT03018288|464554123|FG002|Overall Study|Participant withdrew consent.|1|||
129072208|NCT03018288|464554124|FG003|Overall Study|Participant withdrew consent.|0|||
129072209|NCT03018288|464554121|FG000|Overall Study|Switched to alternative treatment.|0|||
129072210|NCT03018288|464554122|FG001|Overall Study|Switched to alternative treatment.|0|||
129072211|NCT03018288|464554123|FG002|Overall Study|Switched to alternative treatment.|1|||
129072212|NCT03018288|464554124|FG003|Overall Study|Switched to alternative treatment.|0|||
129072213|NCT03018288|464554121|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
129072214|NCT03018288|464554122|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
129072215|NCT03018288|464554123|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
129072216|NCT03018288|464554124|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
129072217|NCT03018288|464554121|FG000|Overall Study|Screen failures|0|||
129072218|NCT03018288|464554122|FG001|Overall Study|Screen failures|0|||
129072219|NCT03018288|464554123|FG002|Overall Study|Screen failures|0|||
129072220|NCT03018288|464554124|FG003|Overall Study|Screen failures|51|||
129072221|NCT03018288|464554121|FG000|Overall Study|Chose treatment outside of UNC|0|||
129072222|NCT03018288|464554122|FG001|Overall Study|Chose treatment outside of UNC|0|||
129072223|NCT03018288|464554123|FG002|Overall Study|Chose treatment outside of UNC|0|||
129072224|NCT03018288|464554124|FG003|Overall Study|Chose treatment outside of UNC|1|||
129072225|NCT03018288|464554121|FG000|Overall Study|Unable to comply with protocol requirements|1|||
129072226|NCT03018288|464554122|FG001|Overall Study|Unable to comply with protocol requirements|1|||
129072227|NCT03018288|464554123|FG002|Overall Study|Unable to comply with protocol requirements|0|||
129072228|NCT03018288|464554124|FG003|Overall Study|Unable to comply with protocol requirements|1|||
129072229|NCT03018288|464554121|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
129072230|NCT03018288|464554122|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
129072231|NCT03018288|464554123|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
129072232|NCT03018288|464554124|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
129072233|NCT03018288|464554121|FG000|Overall Study|Physician Decision|0|||
129072234|NCT03018288|464554122|FG001|Overall Study|Physician Decision|0|||
129072235|NCT03018288|464554123|FG002|Overall Study|Physician Decision|0|||
129072236|NCT03018288|464554124|FG003|Overall Study|Physician Decision|1|||
129072237|NCT06025721|464554127|FG000|Overall Study|Physician Decision|1|||
129072238|NCT06025721|464554127|FG000|Overall Study|Protocol Violation|1|||
129072239|NCT06025721|464554127|FG000|Overall Study|Incarceration|1|||
129072240|NCT04510090|464554128|FG000|FE-HS|Withdrawal by Subject|0|||
129072241|NCT04510090|464554129|FG001|FE-HS|Withdrawal by Subject|0|||
129072242|NCT04510090|464554130|FG002|FE-HS|Withdrawal by Subject|0|||
129072243|NCT04510090|464554131|FG003|FE-HS|Withdrawal by Subject|0|||
129072244|NCT04510090|464554132|FG004|FE-HS|Withdrawal by Subject|1|||
129072245|NCT04510090|464554133|FG005|FE-HS|Withdrawal by Subject|0|||
129072246|NCT04510090|464554134|FG006|FE-HS|Withdrawal by Subject|0|||
129072247|NCT04510090|464554135|FG007|FE-HS|Withdrawal by Subject|0|||
129072248|NCT01127256|464554136|FG000|Overall Study|Adverse Event|13|||
129140583|NCT02264821|464808752|FG001|Overall Study|Protocol Violation|3|||
129140584|NCT02264821|464808753|FG002|Overall Study|Protocol Violation|6|||
129140585|NCT00552279|464808754|FG000|Overall Study|Adverse Event|0|||
129140586|NCT00552279|464808755|FG001|Overall Study|Adverse Event|1|||
129140587|NCT00552279|464808754|FG000|Overall Study|Withdrawal by Subject|12|||
129140588|NCT00552279|464808755|FG001|Overall Study|Withdrawal by Subject|1|||
129140589|NCT00552279|464808754|FG000|Overall Study|Lost to Follow-up|1|||
129140590|NCT00552279|464808755|FG001|Overall Study|Lost to Follow-up|0|||
129140591|NCT00552279|464808754|FG000|Overall Study|Other|1|||
129140592|NCT00552279|464808755|FG001|Overall Study|Other|1|||
129140593|NCT02150863|464808757|FG000|Overall Study|Lost to Follow-up|0|||
129140594|NCT02150863|464808758|FG001|Overall Study|Lost to Follow-up|1|||
129140595|NCT02150863|464808759|FG002|Overall Study|Lost to Follow-up|0|||
129140596|NCT01651208|464808760|FG000|Overall Study|Lost to Follow-up|14|||
129140597|NCT01651208|464808761|FG001|Overall Study|Lost to Follow-up|16|||
129140598|NCT05071027|464808765|FG000|Overall Study|Lost to Follow-up|1|||
129140599|NCT05071027|464808766|FG001|Overall Study|Lost to Follow-up|4|||
129140600|NCT02314247|464808771|FG000|Overall Study|Adverse Event|2|||
129140601|NCT02314247|464808772|FG001|Overall Study|Adverse Event|1|||
129140602|NCT02314247|464808773|FG002|Overall Study|Adverse Event|0|||
129140603|NCT02314247|464808771|FG000|Overall Study|Withdrawal by Subject|1|||
129140604|NCT02314247|464808772|FG001|Overall Study|Withdrawal by Subject|3|||
129140605|NCT02314247|464808773|FG002|Overall Study|Withdrawal by Subject|1|||
129140606|NCT02314247|464808771|FG000|Overall Study|Progression of Disease|6|||
129140607|NCT02314247|464808772|FG001|Overall Study|Progression of Disease|2|||
129140608|NCT02314247|464808773|FG002|Overall Study|Progression of Disease|0|||
129140609|NCT02965976|464808774|FG000|Overall Study|Withdrawal by Subject|2|||
129072249|NCT01127256|464554137|FG001|Overall Study|Adverse Event|13|||
129140610|NCT02965976|464808775|FG001|Overall Study|Withdrawal by Subject|0|||
129140611|NCT01687595|464808776|FG000|Overall Study|Withdrawal by Subject|8|||
129140612|NCT01687595|464808777|FG001|Overall Study|Withdrawal by Subject|0|||
129140613|NCT01687595|464808776|FG000|Overall Study|Lost to Follow-up|3|||
129140614|NCT01687595|464808777|FG001|Overall Study|Lost to Follow-up|1|||
129140615|NCT01687595|464808776|FG000|Overall Study|Investigator's decision|1|||
129140616|NCT01687595|464808777|FG001|Overall Study|Investigator's decision|0|||
129140617|NCT01687595|464808776|FG000|Overall Study|Sponsor's decision|1|||
129140618|NCT01687595|464808777|FG001|Overall Study|Sponsor's decision|0|||
129140619|NCT01687595|464808776|FG000|Overall Study|Noncompliance|1|||
129140620|NCT01687595|464808777|FG001|Overall Study|Noncompliance|2|||
129140621|NCT01687595|464808776|FG000|Overall Study|Other than specified|56|||
129140622|NCT01687595|464808777|FG001|Overall Study|Other than specified|7|||
129140623|NCT00489359|464808780|FG000|Overall Study|Death|0|||
129140624|NCT00489359|464808781|FG001|Overall Study|Death|2|||
129140625|NCT00489359|464808780|FG000|Overall Study|Progressive Disease|5|||
129140626|NCT00489359|464808781|FG001|Overall Study|Progressive Disease|6|||
129140627|NCT00489359|464808780|FG000|Overall Study|Lost to Follow-up|1|||
129140628|NCT00489359|464808781|FG001|Overall Study|Lost to Follow-up|0|||
129140629|NCT00489359|464808780|FG000|Overall Study|Withdrawal by Subject|1|||
129140630|NCT00489359|464808781|FG001|Overall Study|Withdrawal by Subject|5|||
129140631|NCT00489359|464808780|FG000|Overall Study|Adverse Event|0|||
129140632|NCT00489359|464808781|FG001|Overall Study|Adverse Event|16|||
129140633|NCT04191733|464808783|FG000|Overall Study|Withdrawn due to study closure|13|||
129140634|NCT04191733|464808784|FG001|Overall Study|Withdrawn due to study closure|14|||
129140635|NCT04191733|464808783|FG000|Overall Study|Withdrawal by Subject|2|||
129140636|NCT04191733|464808784|FG001|Overall Study|Withdrawal by Subject|4|||
129140637|NCT04191733|464808783|FG000|Overall Study|Physician Decision|1|||
129140638|NCT04191733|464808784|FG001|Overall Study|Physician Decision|1|||
129140639|NCT04191733|464808783|FG000|Overall Study|Lost to Follow-up|5|||
129140640|NCT04191733|464808784|FG001|Overall Study|Lost to Follow-up|6|||
129140641|NCT04191733|464808783|FG000|Overall Study|Death|0|||
129140642|NCT04191733|464808784|FG001|Overall Study|Death|1|||
129140643|NCT01903733|464808787|FG000|Overall Study|Death|23|||
129140644|NCT01903733|464808788|FG001|Overall Study|Death|54|||
129072250|NCT01127256|464554136|FG000|Overall Study|Lack of Efficacy|4|||
129072251|NCT01127256|464554137|FG001|Overall Study|Lack of Efficacy|0|||
129072252|NCT01127256|464554136|FG000|Overall Study|Lost to Follow-up|16|||
129072253|NCT01127256|464554137|FG001|Overall Study|Lost to Follow-up|17|||
129072254|NCT01127256|464554136|FG000|Overall Study|Withdrawal by Subject|5|||
129072255|NCT01127256|464554137|FG001|Overall Study|Withdrawal by Subject|9|||
129072256|NCT01127256|464554136|FG000|Overall Study|Protocol Violation|1|||
129072257|NCT01127256|464554137|FG001|Overall Study|Protocol Violation|0|||
129072258|NCT01415518|464554138|FG000|Overall Study|Withdrawal by Subject|2|||
129072259|NCT01415518|464554139|FG001|Overall Study|Withdrawal by Subject|12|||
129072260|NCT01415518|464554138|FG000|Overall Study|Protocol Violation|6|||
129072261|NCT01415518|464554139|FG001|Overall Study|Protocol Violation|8|||
129072262|NCT01415518|464554138|FG000|Overall Study|Lost to Follow-up|3|||
129072263|NCT01415518|464554139|FG001|Overall Study|Lost to Follow-up|5|||
129072264|NCT01415518|464554138|FG000|Overall Study|Adverse Event|3|||
129072265|NCT01415518|464554139|FG001|Overall Study|Adverse Event|4|||
129072266|NCT01415518|464554138|FG000|Overall Study|Death|1|||
129072267|NCT01415518|464554139|FG001|Overall Study|Death|1|||
129072268|NCT01415518|464554138|FG000|Overall Study|Condition under Investigation Worsened|1|||
129072269|NCT01415518|464554139|FG001|Overall Study|Condition under Investigation Worsened|1|||
129072270|NCT00679211|464554140|FG000|Overall Study|Progressive disease|82|||
129072271|NCT00679211|464554140|FG000|Overall Study|Adverse Event|7|||
129140645|NCT01903733|464808789|FG002|Overall Study|Death|30|||
129140646|NCT01903733|464808790|FG003|Overall Study|Death|98|||
129140647|NCT01903733|464808787|FG000|Overall Study|Participant refused further follow-up|35|||
129140648|NCT01903733|464808788|FG001|Overall Study|Participant refused further follow-up|38|||
129140649|NCT01903733|464808789|FG002|Overall Study|Participant refused further follow-up|13|||
129140650|NCT01903733|464808790|FG003|Overall Study|Participant refused further follow-up|9|||
129140651|NCT01903733|464808787|FG000|Overall Study|Lost to Follow-up|18|||
129140652|NCT01903733|464808788|FG001|Overall Study|Lost to Follow-up|19|||
129140653|NCT01903733|464808789|FG002|Overall Study|Lost to Follow-up|6|||
129140654|NCT01903733|464808790|FG003|Overall Study|Lost to Follow-up|9|||
129140655|NCT01903733|464808787|FG000|Overall Study|Other|10|||
129140656|NCT01903733|464808788|FG001|Overall Study|Other|15|||
129140657|NCT01903733|464808789|FG002|Overall Study|Other|12|||
129140658|NCT01903733|464808790|FG003|Overall Study|Other|3|||
129140659|NCT01903733|464808787|FG000|Overall Study|Missing|2|||
129140660|NCT01903733|464808788|FG001|Overall Study|Missing|0|||
129072272|NCT00679211|464554140|FG000|Overall Study|Withdrawal by Subject|2|||
129140661|NCT01903733|464808789|FG002|Overall Study|Missing|0|||
129072273|NCT00679211|464554140|FG000|Overall Study|Physician Decision|5|||
129072274|NCT00679211|464554140|FG000|Overall Study|Refused to undergo protocol procedures|1|||
129140662|NCT01903733|464808790|FG003|Overall Study|Missing|0|||
129072275|NCT00679211|464554140|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
129072276|NCT00679211|464554140|FG000|Overall Study|Other|1|||
129072277|NCT01922037|464554141|FG000|Overall Study|Withdrawal by Subject|2|||
129072278|NCT01922037|464554142|FG001|Overall Study|Withdrawal by Subject|44|||
129072279|NCT01922037|464554141|FG000|Overall Study|Adverse Event|1|||
129072280|NCT01922037|464554142|FG001|Overall Study|Adverse Event|7|||
129072281|NCT01922037|464554141|FG000|Overall Study|Death|0|||
129072282|NCT01922037|464554142|FG001|Overall Study|Death|5|||
129072283|NCT01922037|464554141|FG000|Overall Study|Pregnancy|0|||
129072284|NCT01922037|464554142|FG001|Overall Study|Pregnancy|2|||
129072285|NCT01922037|464554141|FG000|Overall Study|Participant non-compliance|4|||
129072286|NCT01922037|464554142|FG001|Overall Study|Participant non-compliance|46|||
129072287|NCT01922037|464554141|FG000|Overall Study|Investigator/Sponsor decision|1|||
129072288|NCT01922037|464554142|FG001|Overall Study|Investigator/Sponsor decision|4|||
129072289|NCT01922037|464554141|FG000|Overall Study|Other unspecified|2|||
129072290|NCT01922037|464554142|FG001|Overall Study|Other unspecified|66|||
129072291|NCT01730053|464554144|FG000|Overall Study|Participant moved|0|||
129072292|NCT01730053|464554145|FG001|Overall Study|Participant moved|0|||
129072293|NCT01730053|464554146|FG002|Overall Study|Participant moved|1|||
129072294|NCT01730053|464554147|FG003|Overall Study|Participant moved|0|||
129072295|NCT01730053|464554148|FG004|Overall Study|Participant moved|0|||
129072296|NCT01730053|464554149|FG005|Overall Study|Participant moved|0|||
129072297|NCT01730053|464554144|FG000|Overall Study|Physician Decision|0|||
129072298|NCT01730053|464554145|FG001|Overall Study|Physician Decision|0|||
129072299|NCT01730053|464554146|FG002|Overall Study|Physician Decision|0|||
129072300|NCT01730053|464554147|FG003|Overall Study|Physician Decision|1|||
129072301|NCT01730053|464554148|FG004|Overall Study|Physician Decision|0|||
129072302|NCT01730053|464554149|FG005|Overall Study|Physician Decision|0|||
129072303|NCT01730053|464554144|FG000|Overall Study|Adverse Event|2|||
129072304|NCT01730053|464554145|FG001|Overall Study|Adverse Event|6|||
129072305|NCT01730053|464554146|FG002|Overall Study|Adverse Event|3|||
129072306|NCT01730053|464554147|FG003|Overall Study|Adverse Event|3|||
129072307|NCT01730053|464554148|FG004|Overall Study|Adverse Event|2|||
129072308|NCT01730053|464554149|FG005|Overall Study|Adverse Event|2|||
129072309|NCT01730053|464554144|FG000|Overall Study|Poor compliance to protocol|1|||
129072310|NCT01730053|464554145|FG001|Overall Study|Poor compliance to protocol|2|||
129072311|NCT01730053|464554146|FG002|Overall Study|Poor compliance to protocol|2|||
129072312|NCT01730053|464554147|FG003|Overall Study|Poor compliance to protocol|0|||
129072313|NCT01730053|464554148|FG004|Overall Study|Poor compliance to protocol|0|||
129072314|NCT01730053|464554149|FG005|Overall Study|Poor compliance to protocol|2|||
129072315|NCT01730053|464554144|FG000|Overall Study|Other than specified|2|||
129072316|NCT01730053|464554145|FG001|Overall Study|Other than specified|6|||
129072317|NCT01730053|464554146|FG002|Overall Study|Other than specified|5|||
129072318|NCT01730053|464554147|FG003|Overall Study|Other than specified|4|||
129072319|NCT01730053|464554148|FG004|Overall Study|Other than specified|7|||
129072320|NCT01730053|464554149|FG005|Overall Study|Other than specified|9|||
129072321|NCT01470248|464554150|FG000|Overall Study|Withdrawal by Subject|1|||
129072322|NCT05085834|464554151|FG000|Overall Study|Lost to Follow-up|9|||
129072323|NCT05085834|464554152|FG001|Overall Study|Lost to Follow-up|2|||
129072324|NCT05085834|464554151|FG000|Overall Study|Adverse Event|6|||
129072325|NCT05085834|464554152|FG001|Overall Study|Adverse Event|0|||
129072326|NCT05085834|464554151|FG000|Overall Study|Death|1|||
129072327|NCT05085834|464554152|FG001|Overall Study|Death|0|||
129072328|NCT05085834|464554151|FG000|Overall Study|Inability to swallow the pill|0|||
129072329|NCT05085834|464554152|FG001|Overall Study|Inability to swallow the pill|1|||
129072330|NCT02243605|464554155|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
129072331|NCT02243605|464554156|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
129072332|NCT02243605|464554155|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
129072333|NCT02243605|464554156|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
129072334|NCT02243605|464554155|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
129072335|NCT02243605|464554156|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
129072336|NCT02243605|464554155|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
129072337|NCT02243605|464554156|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
129072338|NCT02243605|464554155|FG000|Stage 2 - Final Analysis Population|Progression|0|||
129072339|NCT02243605|464554156|FG001|Stage 2 - Final Analysis Population|Progression|1|||
129072340|NCT02019472|464554157|FG000|Overall Study|Adverse Event|14|||
129072341|NCT02019472|464554158|FG001|Overall Study|Adverse Event|23|||
129072342|NCT02019472|464554159|FG002|Overall Study|Adverse Event|17|||
129072343|NCT02019472|464554157|FG000|Overall Study|Death|0|||
129072344|NCT02019472|464554158|FG001|Overall Study|Death|1|||
129072345|NCT02019472|464554159|FG002|Overall Study|Death|1|||
129072346|NCT02019472|464554157|FG000|Overall Study|Lack of Efficacy|7|||
129072347|NCT02019472|464554158|FG001|Overall Study|Lack of Efficacy|4|||
129072348|NCT02019472|464554159|FG002|Overall Study|Lack of Efficacy|4|||
129072349|NCT02019472|464554157|FG000|Overall Study|Lost to Follow-up|0|||
129072350|NCT02019472|464554158|FG001|Overall Study|Lost to Follow-up|2|||
129072351|NCT02019472|464554159|FG002|Overall Study|Lost to Follow-up|1|||
129072352|NCT02019472|464554157|FG000|Overall Study|Physician Decision|1|||
129072353|NCT02019472|464554158|FG001|Overall Study|Physician Decision|2|||
129072354|NCT02019472|464554159|FG002|Overall Study|Physician Decision|0|||
129072355|NCT02019472|464554157|FG000|Overall Study|Pregnancy|1|||
129072356|NCT02019472|464554158|FG001|Overall Study|Pregnancy|2|||
129072357|NCT02019472|464554159|FG002|Overall Study|Pregnancy|2|||
129072358|NCT02019472|464554157|FG000|Overall Study|Withdrawal by Subject|11|||
129072359|NCT02019472|464554158|FG001|Overall Study|Withdrawal by Subject|10|||
129072360|NCT02019472|464554159|FG002|Overall Study|Withdrawal by Subject|11|||
129072361|NCT02019472|464554157|FG000|Overall Study|Other|3|||
129072362|NCT02019472|464554158|FG001|Overall Study|Other|8|||
129072363|NCT02019472|464554159|FG002|Overall Study|Other|6|||
129072364|NCT04429503|464554164|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
129072365|NCT04429503|464554165|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
129072366|NCT04429503|464554166|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129072367|NCT04429503|464554167|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129072368|NCT04429503|464554168|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129072369|NCT04429503|464554169|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129072370|NCT04429503|464554164|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
129072371|NCT04429503|464554165|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
129072372|NCT04429503|464554166|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
129072373|NCT04429503|464554167|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
129072374|NCT04429503|464554168|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
129072375|NCT04429503|464554169|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
129072376|NCT04429503|464554164|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
129072377|NCT04429503|464554165|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
129072378|NCT04429503|464554166|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
129072379|NCT04429503|464554167|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
129072380|NCT04429503|464554168|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
129072381|NCT04429503|464554169|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
129072382|NCT04429503|464554164|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
129072383|NCT04429503|464554165|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
129072384|NCT04429503|464554166|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
129072385|NCT04429503|464554167|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
129072386|NCT04429503|464554168|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
129072387|NCT04429503|464554169|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
129072388|NCT04429503|464554164|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
129072389|NCT04429503|464554165|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
129072390|NCT04429503|464554166|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
129072391|NCT04429503|464554167|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
128723981|NCT00969553|463287307|FG008|Overall Study|Other Adverse Event|0|||
128723982|NCT00969553|463287299|FG000|Overall Study|Refused cont. medication|1|||
129072392|NCT04429503|464554168|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
129072393|NCT04429503|464554169|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
129072394|NCT04429503|464554164|FG000|Main Study (Up to Wk 96)|Death|9|||
129072395|NCT04429503|464554165|FG001|Main Study (Up to Wk 96)|Death|18|||
129072396|NCT04429503|464554166|FG002|Main Study (Up to Wk 96)|Death|5|||
129072397|NCT04429503|464554167|FG003|Main Study (Up to Wk 96)|Death|0|||
129072398|NCT04429503|464554168|FG004|Main Study (Up to Wk 96)|Death|0|||
129072399|NCT04429503|464554169|FG005|Main Study (Up to Wk 96)|Death|0|||
129072400|NCT04429503|464554164|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129072401|NCT04429503|464554165|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129072402|NCT04429503|464554166|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129072403|NCT04429503|464554167|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
129072404|NCT04429503|464554168|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129072405|NCT04429503|464554169|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
128723983|NCT00969553|463287300|FG001|Overall Study|Refused cont. medication|1|||
129072406|NCT04429503|464554164|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
129072407|NCT04429503|464554165|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
129072408|NCT04429503|464554166|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
129072409|NCT04429503|464554167|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
129072410|NCT04429503|464554168|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
129072411|NCT04429503|464554169|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
129072412|NCT04429503|464554164|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129072413|NCT04429503|464554165|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129072414|NCT04429503|464554166|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129072415|NCT04429503|464554167|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129072416|NCT04429503|464554168|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
129072417|NCT04429503|464554169|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
129072418|NCT04429503|464554164|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
129072419|NCT04429503|464554165|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
129072420|NCT04429503|464554166|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
129072421|NCT04429503|464554167|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
129072422|NCT04429503|464554168|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
129072423|NCT04429503|464554169|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
129072424|NCT04429503|464554164|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
129072425|NCT04429503|464554165|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
129072426|NCT04429503|464554166|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
129072427|NCT04429503|464554167|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
129072428|NCT04429503|464554168|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
129072429|NCT04429503|464554169|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
129072430|NCT04429503|464554164|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
129072431|NCT04429503|464554165|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
129072432|NCT04429503|464554166|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
129072433|NCT04429503|464554167|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
129072434|NCT04429503|464554168|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
129072435|NCT04429503|464554169|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
129072436|NCT05516108|464554170|FG000|Overall Study|Time Commitment|3|||
129072437|NCT05516108|464554171|FG001|Overall Study|Time Commitment|1|||
129072438|NCT05516108|464554170|FG000|Overall Study|Reason Unknown|2|||
129072439|NCT05516108|464554171|FG001|Overall Study|Reason Unknown|4|||
129072440|NCT02717507|464554172|FG000|Overall Study|Lost to Follow-up|5|||
129072441|NCT02717507|464554173|FG001|Overall Study|Lost to Follow-up|8|||
129072442|NCT02717507|464554172|FG000|Overall Study|Pregnancy|1|||
129072443|NCT02717507|464554173|FG001|Overall Study|Pregnancy|1|||
129072444|NCT02717507|464554172|FG000|Overall Study|Protocol Violation|2|||
129072445|NCT02717507|464554173|FG001|Overall Study|Protocol Violation|2|||
129072446|NCT02717507|464554172|FG000|Overall Study|Withdrawal by Subject|20|||
129072447|NCT02717507|464554173|FG001|Overall Study|Withdrawal by Subject|20|||
129072448|NCT02717507|464554172|FG000|Overall Study|Relapse|1|||
129072449|NCT02717507|464554173|FG001|Overall Study|Relapse|1|||
129072450|NCT02717507|464554172|FG000|Overall Study|Cardiac Event|2|||
129072451|NCT02717507|464554173|FG001|Overall Study|Cardiac Event|6|||
129072452|NCT02003209|464554174|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
129072453|NCT02003209|464554175|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
129072454|NCT00638508|464554176|FG000|Overall Study|Physician Decision|5|||
129072455|NCT00638508|464554177|FG001|Overall Study|Physician Decision|2|||
129072456|NCT00370552|464554178|FG000|Overall Study|Adverse Event|2|||
129072457|NCT00370552|464554179|FG001|Overall Study|Adverse Event|2|||
129072458|NCT00370552|464554180|FG002|Overall Study|Adverse Event|2|||
129072459|NCT00370552|464554178|FG000|Overall Study|Disease progression|23|||
129072460|NCT00370552|464554179|FG001|Overall Study|Disease progression|23|||
129072461|NCT00370552|464554180|FG002|Overall Study|Disease progression|15|||
129072462|NCT00370552|464554178|FG000|Overall Study|Maximum clinical benefit|3|||
129072463|NCT00370552|464554179|FG001|Overall Study|Maximum clinical benefit|5|||
129072464|NCT00370552|464554180|FG002|Overall Study|Maximum clinical benefit|5|||
129072465|NCT00370552|464554178|FG000|Overall Study|Poor or noncompliance|0|||
129072466|NCT00370552|464554179|FG001|Overall Study|Poor or noncompliance|0|||
129072467|NCT00370552|464554180|FG002|Overall Study|Poor or noncompliance|1|||
129072468|NCT00370552|464554178|FG000|Overall Study|Study drug toxicity|11|||
129072469|NCT00370552|464554179|FG001|Overall Study|Study drug toxicity|8|||
129072470|NCT00370552|464554180|FG002|Overall Study|Study drug toxicity|6|||
129072471|NCT00370552|464554178|FG000|Overall Study|Withdrawal by Subject|2|||
129072472|NCT00370552|464554179|FG001|Overall Study|Withdrawal by Subject|0|||
129072473|NCT00370552|464554180|FG002|Overall Study|Withdrawal by Subject|1|||
129072474|NCT00370552|464554178|FG000|Overall Study|Still on treatment|1|||
129072475|NCT00370552|464554179|FG001|Overall Study|Still on treatment|3|||
129072476|NCT00370552|464554180|FG002|Overall Study|Still on treatment|2|||
129072477|NCT00370552|464554178|FG000|Overall Study|Never treated|1|||
129072478|NCT00370552|464554179|FG001|Overall Study|Never treated|0|||
129072479|NCT00370552|464554180|FG002|Overall Study|Never treated|0|||
129072480|NCT00370552|464554178|FG000|Overall Study|Physician Decision|1|||
129072481|NCT00370552|464554179|FG001|Overall Study|Physician Decision|1|||
129072482|NCT00370552|464554180|FG002|Overall Study|Physician Decision|0|||
129072483|NCT00370552|464554178|FG000|Overall Study|Investigator decision|2|||
129072484|NCT00370552|464554179|FG001|Overall Study|Investigator decision|1|||
129072485|NCT00370552|464554180|FG002|Overall Study|Investigator decision|0|||
129072486|NCT00370552|464554178|FG000|Overall Study|High risk of allergic reaction|0|||
129072487|NCT00370552|464554179|FG001|Overall Study|High risk of allergic reaction|1|||
129072488|NCT00370552|464554180|FG002|Overall Study|High risk of allergic reaction|0|||
129072489|NCT00370552|464554178|FG000|Overall Study|Planned radiation for palliation|0|||
129072490|NCT00370552|464554179|FG001|Overall Study|Planned radiation for palliation|1|||
129072491|NCT00370552|464554180|FG002|Overall Study|Planned radiation for palliation|0|||
129072492|NCT03500198|464554181|FG000|Overall Study|Lost to Follow-up|0|||
129072493|NCT03500198|464554182|FG001|Overall Study|Lost to Follow-up|1|||
129072494|NCT00942084|464554194|FG000|Overall Study|Death|2|||
129072495|NCT04341363|464554195|FG000|Overall Study|Adverse Event|1|||
129072496|NCT04341363|464554195|FG000|Overall Study|Withdrawal by Subject|1|||
129072497|NCT00063934|464554196|FG000|Overall Study|Ineligible|1|||
129072498|NCT00840749|464554197|FG000|Overall Study|Death|1|||
129072499|NCT00840749|464554198|FG001|Overall Study|Death|2|||
129072500|NCT00840749|464554197|FG000|Overall Study|not treated on study arm|11|||
129072501|NCT00840749|464554198|FG001|Overall Study|not treated on study arm|11|||
129072502|NCT00840749|464554197|FG000|Overall Study|study closed|19|||
129072503|NCT00840749|464554198|FG001|Overall Study|study closed|14|||
129072504|NCT01836471|464554199|FG000|Overall Study|Pregnancy|1|||
129072505|NCT01836471|464554200|FG001|Overall Study|Pregnancy|0|||
129072506|NCT01836471|464554201|FG002|Overall Study|Pregnancy|0|||
129072507|NCT01836471|464554202|FG003|Overall Study|Pregnancy|0|||
129072508|NCT01836471|464554203|FG004|Overall Study|Pregnancy|0|||
129072509|NCT01836471|464554199|FG000|Overall Study|Withdrawal by Subject|3|||
129072510|NCT01836471|464554200|FG001|Overall Study|Withdrawal by Subject|4|||
129072511|NCT01836471|464554201|FG002|Overall Study|Withdrawal by Subject|1|||
129072512|NCT01836471|464554202|FG003|Overall Study|Withdrawal by Subject|0|||
129072513|NCT01836471|464554203|FG004|Overall Study|Withdrawal by Subject|2|||
129072514|NCT01836471|464554199|FG000|Overall Study|Physician Decision|0|||
129072515|NCT01836471|464554200|FG001|Overall Study|Physician Decision|1|||
129072516|NCT01836471|464554201|FG002|Overall Study|Physician Decision|0|||
129072517|NCT01836471|464554202|FG003|Overall Study|Physician Decision|0|||
129072518|NCT01836471|464554203|FG004|Overall Study|Physician Decision|0|||
129072519|NCT01836471|464554199|FG000|Overall Study|Lost to Follow-up|0|||
129072520|NCT01836471|464554200|FG001|Overall Study|Lost to Follow-up|0|||
129072521|NCT01836471|464554201|FG002|Overall Study|Lost to Follow-up|0|||
129072522|NCT01836471|464554202|FG003|Overall Study|Lost to Follow-up|1|||
129072523|NCT01836471|464554203|FG004|Overall Study|Lost to Follow-up|1|||
129072524|NCT01836471|464554199|FG000|Overall Study|Adverse Event|6|||
129072525|NCT01836471|464554200|FG001|Overall Study|Adverse Event|3|||
129072526|NCT01836471|464554201|FG002|Overall Study|Adverse Event|1|||
129072527|NCT01836471|464554202|FG003|Overall Study|Adverse Event|1|||
129072528|NCT01836471|464554203|FG004|Overall Study|Adverse Event|2|||
129072529|NCT01836471|464554199|FG000|Overall Study|Non compliance with tx|1|||
129072530|NCT01836471|464554200|FG001|Overall Study|Non compliance with tx|1|||
129072531|NCT01836471|464554201|FG002|Overall Study|Non compliance with tx|0|||
129072532|NCT01836471|464554202|FG003|Overall Study|Non compliance with tx|0|||
129072533|NCT01836471|464554203|FG004|Overall Study|Non compliance with tx|0|||
129072534|NCT01960413|464554206|FG000|Overall Study|Withdrawal by Subject|1|||
129072535|NCT01960413|464554207|FG001|Overall Study|Withdrawal by Subject|1|||
129072536|NCT01960413|464554206|FG000|Overall Study|Physician Decision|1|||
129072537|NCT01960413|464554207|FG001|Overall Study|Physician Decision|0|||
129072538|NCT01960413|464554206|FG000|Overall Study|Lost to Follow-up|2|||
129072539|NCT01960413|464554207|FG001|Overall Study|Lost to Follow-up|0|||
129072540|NCT02285361|464554211|FG000|Overall Study|Protocol Violation|43|||
129072541|NCT02285361|464554211|FG000|Overall Study|Lost to Follow-up|5|||
129072542|NCT02285361|464554211|FG000|Overall Study|Not taken GIOTRIF|2|||
129072543|NCT02285361|464554211|FG000|Overall Study|Consented prior to the contract date|1|||
129072544|NCT03776357|464554214|FG000|Overall Study|Lost to Follow-up|3|||
129072545|NCT03335475|464554215|FG000|Overall Study|Did not wear accelerometer|4|||
129072546|NCT03335475|464554216|FG001|Overall Study|Did not wear accelerometer|0|||
129072547|NCT03335475|464554215|FG000|Overall Study|Withdrawal by Subject|0|||
129072548|NCT03335475|464554216|FG001|Overall Study|Withdrawal by Subject|1|||
129072549|NCT02755103|464554217|FG000|Overall Study|Lost to Follow-up|17|||
129072550|NCT02755103|464554218|FG001|Overall Study|Lost to Follow-up|15|||
129072551|NCT02755103|464554217|FG000|Overall Study|Death|0|||
129072552|NCT02755103|464554218|FG001|Overall Study|Death|1|||
129072553|NCT02755103|464554217|FG000|Overall Study|Physician Decision|0|||
129072554|NCT02755103|464554218|FG001|Overall Study|Physician Decision|1|||
129072555|NCT02755103|464554217|FG000|Overall Study|Pregnancy|0|||
129072556|NCT02755103|464554218|FG001|Overall Study|Pregnancy|1|||
129072557|NCT02755103|464554217|FG000|Overall Study|Withdrawal by Subject|3|||
129072558|NCT02755103|464554218|FG001|Overall Study|Withdrawal by Subject|0|||
129072559|NCT05366010|464554225|FG000|Overall Study|Withdrawal by Subject|1|||
129072560|NCT05366010|464554225|FG000|Overall Study|Protocol Violation|1|||
128723984|NCT00969553|463287301|FG002|Overall Study|Refused cont. medication|0|||
129072561|NCT05366010|464554225|FG000|Overall Study|Lost to Follow-up|2|||
129072562|NCT05366010|464554225|FG000|Overall Study|Screen Failure|2|||
129072563|NCT05271175|464554226|FG000|One Week Follow up|Lost to Follow-up|10|||
129072564|NCT05271175|464554227|FG001|One Week Follow up|Lost to Follow-up|7|||
129072565|NCT05271175|464554228|FG002|One Week Follow up|Lost to Follow-up|5|||
129072566|NCT05271175|464554226|FG000|One Month Follow up|Lost to Follow-up|12|||
129072567|NCT05271175|464554227|FG001|One Month Follow up|Lost to Follow-up|7|||
129072568|NCT05271175|464554228|FG002|One Month Follow up|Lost to Follow-up|9|||
129072569|NCT05271175|464554226|FG000|Six Months Follow up|Lost to Follow-up|8|||
129072570|NCT05271175|464554227|FG001|Six Months Follow up|Lost to Follow-up|2|||
129072571|NCT05271175|464554228|FG002|Six Months Follow up|Lost to Follow-up|2|||
129072572|NCT00991887|464554229|FG000|Overall Study|Lost to Follow-up|2|||
129072573|NCT00991887|464554230|FG001|Overall Study|Lost to Follow-up|1|||
129072574|NCT01964976|464554231|FG000|Overall Study|Protocol Violation|31|||
129072575|NCT01891864|464554234|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
129072576|NCT01891864|464554235|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
129072577|NCT01891864|464554236|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129072578|NCT01891864|464554237|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129072579|NCT01891864|464554238|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129072580|NCT01891864|464554239|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129072581|NCT01891864|464554234|FG000|Treatment Period 1|Physician Decision|0|||
129072582|NCT01891864|464554235|FG001|Treatment Period 1|Physician Decision|1|||
129072583|NCT01891864|464554236|FG002|Treatment Period 1|Physician Decision|0|||
129072584|NCT01891864|464554237|FG003|Treatment Period 1|Physician Decision|0|||
129072585|NCT01891864|464554238|FG004|Treatment Period 1|Physician Decision|0|||
129072586|NCT01891864|464554239|FG005|Treatment Period 1|Physician Decision|0|||
129072587|NCT01891864|464554234|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129072588|NCT01891864|464554235|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
129072589|NCT01891864|464554236|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129072590|NCT01891864|464554237|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129072591|NCT01891864|464554238|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129072592|NCT01891864|464554239|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129072593|NCT01891864|464554234|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
129072594|NCT01891864|464554235|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
129072595|NCT01891864|464554236|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129072596|NCT01891864|464554237|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129072597|NCT01891864|464554238|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129072598|NCT01891864|464554239|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129072599|NCT01891864|464554234|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129072600|NCT01891864|464554235|FG001|Treatment Period 1|Withdrawal by Subject|5|||
129072601|NCT01891864|464554236|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129072602|NCT01891864|464554237|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129072603|NCT01891864|464554238|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129072604|NCT01891864|464554239|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129072605|NCT01891864|464554234|FG000|Treatment Period 1|Lost to Follow-up|1|||
129072606|NCT01891864|464554235|FG001|Treatment Period 1|Lost to Follow-up|0|||
129072607|NCT01891864|464554236|FG002|Treatment Period 1|Lost to Follow-up|0|||
129072608|NCT01891864|464554237|FG003|Treatment Period 1|Lost to Follow-up|0|||
129072609|NCT01891864|464554238|FG004|Treatment Period 1|Lost to Follow-up|0|||
129072610|NCT01891864|464554239|FG005|Treatment Period 1|Lost to Follow-up|0|||
129140663|NCT01903733|464808787|FG000|Overall Study|Investigator request|18|||
129140664|NCT01903733|464808788|FG001|Overall Study|Investigator request|0|||
129140665|NCT01903733|464808789|FG002|Overall Study|Investigator request|0|||
129140666|NCT01903733|464808790|FG003|Overall Study|Investigator request|0|||
129140667|NCT01714063|464808791|FG000|Overall Study|Equipment malfunction|2|||
129140668|NCT02294019|464808793|FG000|Overall Study|Adverse Event|2|||
129140669|NCT02294019|464808793|FG000|Overall Study|Protocol Violation|68|||
129140670|NCT02294019|464808793|FG000|Overall Study|Lost to Follow-up|31|||
129140671|NCT02294019|464808793|FG000|Overall Study|Other|1|||
129140672|NCT02294019|464808793|FG000|Overall Study|Withdrawal by Subject|1|||
129140673|NCT02369159|464808794|FG000|Overall Study|Adverse Event|0|||
129140674|NCT02369159|464808795|FG001|Overall Study|Adverse Event|1|||
129140675|NCT02369159|464808794|FG000|Overall Study|Lost to Follow-up|1|||
129140676|NCT02369159|464808795|FG001|Overall Study|Lost to Follow-up|1|||
129140677|NCT02369159|464808794|FG000|Overall Study|Withdrawal by Subject|7|||
129140678|NCT02369159|464808795|FG001|Overall Study|Withdrawal by Subject|0|||
129140679|NCT03769116|464808796|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
129140680|NCT03769116|464808797|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
129072611|NCT01891864|464554234|FG000|Treatment Period 2|Protocol Violation|0|||
129072612|NCT01891864|464554235|FG001|Treatment Period 2|Protocol Violation|0|||
129072613|NCT01891864|464554236|FG002|Treatment Period 2|Protocol Violation|0|||
129140681|NCT03769116|464808796|FG000|Part 3 - Open Label|Physician Decision|1|||
129072614|NCT01891864|464554237|FG003|Treatment Period 2|Protocol Violation|1|||
129072615|NCT01891864|464554238|FG004|Treatment Period 2|Protocol Violation|0|||
129072616|NCT01891864|464554239|FG005|Treatment Period 2|Protocol Violation|0|||
129072617|NCT01891864|464554234|FG000|Treatment Period 2|Physician Decision|0|||
129072618|NCT01891864|464554235|FG001|Treatment Period 2|Physician Decision|0|||
129072619|NCT01891864|464554236|FG002|Treatment Period 2|Physician Decision|1|||
129072620|NCT01891864|464554237|FG003|Treatment Period 2|Physician Decision|0|||
129072621|NCT01891864|464554238|FG004|Treatment Period 2|Physician Decision|0|||
129072622|NCT01891864|464554239|FG005|Treatment Period 2|Physician Decision|0|||
129072623|NCT01891864|464554234|FG000|Treatment Period 2|Site Termination|0|||
129072624|NCT01891864|464554235|FG001|Treatment Period 2|Site Termination|0|||
129072625|NCT01891864|464554236|FG002|Treatment Period 2|Site Termination|1|||
129072626|NCT01891864|464554237|FG003|Treatment Period 2|Site Termination|2|||
129072627|NCT01891864|464554238|FG004|Treatment Period 2|Site Termination|0|||
129072628|NCT01891864|464554239|FG005|Treatment Period 2|Site Termination|0|||
129072629|NCT01891864|464554234|FG000|Treatment Period 2|Lack of Efficacy|0|||
129072630|NCT01891864|464554235|FG001|Treatment Period 2|Lack of Efficacy|0|||
129072631|NCT01891864|464554236|FG002|Treatment Period 2|Lack of Efficacy|1|||
129072632|NCT01891864|464554237|FG003|Treatment Period 2|Lack of Efficacy|0|||
129072633|NCT01891864|464554238|FG004|Treatment Period 2|Lack of Efficacy|1|||
129072634|NCT01891864|464554239|FG005|Treatment Period 2|Lack of Efficacy|0|||
129072635|NCT01891864|464554234|FG000|Treatment Period 2|Adverse Event|0|||
129072636|NCT01891864|464554235|FG001|Treatment Period 2|Adverse Event|0|||
129072637|NCT01891864|464554236|FG002|Treatment Period 2|Adverse Event|1|||
129072638|NCT01891864|464554237|FG003|Treatment Period 2|Adverse Event|2|||
129072639|NCT01891864|464554238|FG004|Treatment Period 2|Adverse Event|0|||
129072640|NCT01891864|464554239|FG005|Treatment Period 2|Adverse Event|4|||
129072641|NCT01891864|464554234|FG000|Treatment Period 2|Termination of Site|0|||
129072642|NCT01891864|464554235|FG001|Treatment Period 2|Termination of Site|0|||
129072643|NCT01891864|464554236|FG002|Treatment Period 2|Termination of Site|0|||
129072644|NCT01891864|464554237|FG003|Treatment Period 2|Termination of Site|0|||
129072645|NCT01891864|464554238|FG004|Treatment Period 2|Termination of Site|2|||
129072646|NCT01891864|464554239|FG005|Treatment Period 2|Termination of Site|0|||
129072647|NCT01891864|464554234|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129072648|NCT01891864|464554235|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129072649|NCT01891864|464554236|FG002|Treatment Period 2|Withdrawal by Subject|3|||
129072650|NCT01891864|464554237|FG003|Treatment Period 2|Withdrawal by Subject|4|||
129072651|NCT01891864|464554238|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129072652|NCT01891864|464554239|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129072653|NCT01891864|464554234|FG000|Extension Period|Lack of Efficacy|0|||
129072654|NCT01891864|464554235|FG001|Extension Period|Lack of Efficacy|0|||
129072655|NCT01891864|464554236|FG002|Extension Period|Lack of Efficacy|0|||
129072656|NCT01891864|464554237|FG003|Extension Period|Lack of Efficacy|1|||
129072657|NCT01891864|464554238|FG004|Extension Period|Lack of Efficacy|1|||
129072658|NCT01891864|464554239|FG005|Extension Period|Lack of Efficacy|0|||
129072659|NCT01891864|464554234|FG000|Extension Period|Pregnancy|0|||
129072660|NCT01891864|464554235|FG001|Extension Period|Pregnancy|0|||
129072661|NCT01891864|464554236|FG002|Extension Period|Pregnancy|1|||
129072662|NCT01891864|464554237|FG003|Extension Period|Pregnancy|0|||
129072663|NCT01891864|464554238|FG004|Extension Period|Pregnancy|0|||
129072664|NCT01891864|464554239|FG005|Extension Period|Pregnancy|0|||
129072665|NCT01891864|464554234|FG000|Extension Period|Adverse Event|0|||
129072666|NCT01891864|464554235|FG001|Extension Period|Adverse Event|0|||
129072667|NCT01891864|464554236|FG002|Extension Period|Adverse Event|4|||
129072668|NCT01891864|464554237|FG003|Extension Period|Adverse Event|2|||
129072669|NCT01891864|464554238|FG004|Extension Period|Adverse Event|2|||
129072670|NCT01891864|464554239|FG005|Extension Period|Adverse Event|0|||
129072671|NCT01891864|464554234|FG000|Extension Period|Withdrawal by Subject|0|||
129072672|NCT01891864|464554235|FG001|Extension Period|Withdrawal by Subject|0|||
129072673|NCT01891864|464554236|FG002|Extension Period|Withdrawal by Subject|1|||
129072674|NCT01891864|464554237|FG003|Extension Period|Withdrawal by Subject|2|||
129072675|NCT01891864|464554238|FG004|Extension Period|Withdrawal by Subject|4|||
129072676|NCT01891864|464554239|FG005|Extension Period|Withdrawal by Subject|0|||
129072677|NCT01891864|464554234|FG000|Extension Period|Lost to Follow-up|0|||
129072678|NCT01891864|464554235|FG001|Extension Period|Lost to Follow-up|0|||
129072679|NCT01891864|464554236|FG002|Extension Period|Lost to Follow-up|2|||
129072680|NCT01891864|464554237|FG003|Extension Period|Lost to Follow-up|0|||
129072681|NCT01891864|464554238|FG004|Extension Period|Lost to Follow-up|0|||
129072682|NCT01891864|464554239|FG005|Extension Period|Lost to Follow-up|0|||
129072683|NCT02698163|464554240|FG000|Overall Study|Lost to Follow-up|0|||
129072684|NCT02698163|464554241|FG001|Overall Study|Lost to Follow-up|1|||
129072685|NCT02892331|464554242|FG000|Overall Study|Withdrawal by Subject|0|||
129072686|NCT02892331|464554243|FG001|Overall Study|Withdrawal by Subject|1|||
129072687|NCT02892331|464554244|FG002|Overall Study|Withdrawal by Subject|1|||
129072688|NCT02892331|464554242|FG000|Overall Study|Sick family member|0|||
129072689|NCT02892331|464554243|FG001|Overall Study|Sick family member|0|||
129072690|NCT02892331|464554244|FG002|Overall Study|Sick family member|1|||
129072691|NCT02892331|464554242|FG000|Overall Study|Corona virus pandemic|1|||
129072692|NCT02892331|464554243|FG001|Overall Study|Corona virus pandemic|0|||
129072693|NCT02892331|464554244|FG002|Overall Study|Corona virus pandemic|1|||
129072694|NCT02892331|464554242|FG000|Overall Study|Lost to Follow-up|1|||
129072695|NCT02892331|464554243|FG001|Overall Study|Lost to Follow-up|0|||
129072696|NCT02892331|464554244|FG002|Overall Study|Lost to Follow-up|1|||
129072697|NCT02892331|464554242|FG000|Overall Study|Blood pressure was too elevated|0|||
129072698|NCT02892331|464554243|FG001|Overall Study|Blood pressure was too elevated|1|||
129072699|NCT02892331|464554244|FG002|Overall Study|Blood pressure was too elevated|0|||
129072700|NCT02892331|464554242|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
129072701|NCT02892331|464554243|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
129072702|NCT02892331|464554244|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
129072703|NCT00752128|464554245|FG000|Overall Study|Withdrawal by Subject|4|||
129072704|NCT00349973|464554249|FG000|Overall Study|Adverse Event|3|||
129072705|NCT00349973|464554250|FG001|Overall Study|Adverse Event|3|||
129072706|NCT00349973|464554249|FG000|Overall Study|Withdrawal by Subject|1|||
129072707|NCT00349973|464554250|FG001|Overall Study|Withdrawal by Subject|0|||
129072708|NCT02286713|464554251|FG000|One Week Follow-Up|Death|1|||
129072709|NCT02286713|464554252|FG001|One Week Follow-Up|Death|0|||
129072710|NCT02286713|464554251|FG000|One Week Follow-Up|Lost to Follow-up|17|||
129072711|NCT02286713|464554252|FG001|One Week Follow-Up|Lost to Follow-up|21|||
129072712|NCT02286713|464554251|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
129072713|NCT02286713|464554252|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
129072714|NCT02286713|464554251|FG000|Three Month Follow-Up|Death|1|||
129072715|NCT02286713|464554252|FG001|Three Month Follow-Up|Death|1|||
129072716|NCT02286713|464554251|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
129072717|NCT02286713|464554252|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
129072718|NCT02286713|464554251|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
129072719|NCT02286713|464554252|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
129072720|NCT02286713|464554251|FG000|Six Month Follow-Up|Death|2|||
129072721|NCT02286713|464554252|FG001|Six Month Follow-Up|Death|0|||
129072722|NCT02286713|464554251|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
129072723|NCT02286713|464554252|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
129072724|NCT04314037|464554253|FG000|Treatment Period 2|Adverse Event|1|||
129072725|NCT04314037|464554254|FG001|Treatment Period 2|Adverse Event|0|||
129072726|NCT04314037|464554253|FG000|Treatment Period 3|Protocol Violation|1|||
129072727|NCT04314037|464554254|FG001|Treatment Period 3|Protocol Violation|0|||
129072728|NCT04314037|464554253|FG000|Treatment Period 3|Adverse Event|0|||
129072729|NCT04314037|464554254|FG001|Treatment Period 3|Adverse Event|1|||
129072730|NCT03832686|464554257|FG000|Overall Study|Lost to Follow-up|6|||
129072731|NCT03832686|464554258|FG001|Overall Study|Lost to Follow-up|9|||
129072732|NCT03832686|464554257|FG000|Overall Study|Discontinued Intervention|5|||
129072733|NCT03832686|464554258|FG001|Overall Study|Discontinued Intervention|4|||
129072734|NCT05479435|464554259|FG000|Overall Study|Withdrawal by Subject|1|||
129072735|NCT05479435|464554260|FG001|Overall Study|Withdrawal by Subject|0|||
129072736|NCT05479435|464554261|FG002|Overall Study|Withdrawal by Subject|0|||
129072737|NCT05479435|464554259|FG000|Overall Study|Covid 19|0|||
129072738|NCT05479435|464554260|FG001|Overall Study|Covid 19|0|||
129072739|NCT05479435|464554261|FG002|Overall Study|Covid 19|2|||
129072740|NCT02546986|464556502|FG000|Treatment Period|Progressive Disease|20|||
129072741|NCT02546986|464556503|FG001|Treatment Period|Progressive Disease|22|||
129072742|NCT02546986|464556502|FG000|Treatment Period|Adverse Event|14|||
129072743|NCT02546986|464556503|FG001|Treatment Period|Adverse Event|6|||
129072744|NCT02546986|464556502|FG000|Treatment Period|Symptomatic Deterioration|4|||
129072745|NCT02546986|464556503|FG001|Treatment Period|Symptomatic Deterioration|3|||
129072746|NCT02546986|464556502|FG000|Treatment Period|Death|3|||
129072747|NCT02546986|464556503|FG001|Treatment Period|Death|4|||
129072748|NCT02546986|464556502|FG000|Treatment Period|Physician Decision|1|||
129072749|NCT02546986|464556503|FG001|Treatment Period|Physician Decision|2|||
129072750|NCT02546986|464556502|FG000|Treatment Period|Protocol Violation|1|||
129072751|NCT02546986|464556503|FG001|Treatment Period|Protocol Violation|0|||
129072752|NCT02546986|464556502|FG000|Treatment Period|Withdrawal by Subject|1|||
129140682|NCT03769116|464808797|FG001|Part 3 - Open Label|Physician Decision|0|||
129140683|NCT03769116|464808796|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
129140684|NCT03769116|464808797|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
129140685|NCT01887600|464808799|FG000|Overall Study|Death|39|||
129140686|NCT01887600|464808800|FG001|Overall Study|Death|16|||
129140687|NCT01887600|464808799|FG000|Overall Study|Lack of Efficacy|3|||
129140688|NCT01887600|464808800|FG001|Overall Study|Lack of Efficacy|26|||
129140689|NCT01887600|464808799|FG000|Overall Study|Lost to Follow-up|5|||
129140690|NCT01887600|464808800|FG001|Overall Study|Lost to Follow-up|1|||
129140691|NCT01887600|464808799|FG000|Overall Study|Physician Decision|7|||
129072753|NCT02546986|464556503|FG001|Treatment Period|Withdrawal by Subject|1|||
129072754|NCT02546986|464556502|FG000|Treatment Period|Non-compliance with Study Drug|0|||
129072755|NCT02546986|464556503|FG001|Treatment Period|Non-compliance with Study Drug|1|||
129140692|NCT01887600|464808800|FG001|Overall Study|Physician Decision|8|||
129072756|NCT02546986|464556502|FG000|Treatment Period|Study Terminated by Sponsor|0|||
129072757|NCT02546986|464556503|FG001|Treatment Period|Study Terminated by Sponsor|1|||
129072758|NCT02546986|464556502|FG000|Treatment Period|Miscellaneous|7|||
129072759|NCT02546986|464556503|FG001|Treatment Period|Miscellaneous|9|||
129072760|NCT02546986|464556502|FG000|Survival Follow-Up Phase|Missing Status|3|||
129072761|NCT02546986|464556503|FG001|Survival Follow-Up Phase|Missing Status|5|||
129072762|NCT02546986|464556502|FG000|Survival Follow-Up Phase|Death|18|||
129072763|NCT02546986|464556503|FG001|Survival Follow-Up Phase|Death|12|||
129072764|NCT02546986|464556502|FG000|Survival Follow-Up Phase|Alive|13|||
129072765|NCT02546986|464556503|FG001|Survival Follow-Up Phase|Alive|16|||
129072766|NCT02546986|464556502|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
129072767|NCT02546986|464556503|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
129072768|NCT05016960|464556504|FG000|Overall Study|Withdrawal by Subject|1|||
129072769|NCT05016960|464556505|FG001|Overall Study|Withdrawal by Subject|9|||
129072770|NCT04796961|464556506|FG000|Overall Study|Lost to Follow-up|10|||
129072771|NCT04796961|464556506|FG000|Overall Study|Withdrawal by Subject|3|||
129072772|NCT04796961|464556506|FG000|Overall Study|Left Organization|10|||
129072773|NCT02325973|464556507|FG000|Overall Study|Death|5|||
129072774|NCT02325973|464556507|FG000|Overall Study|Withdrawal by subject or investigator|16|||
129072775|NCT02068508|464556508|FG000|Overall Study|Case report forms uncollected|27|||
129072776|NCT02068508|464556508|FG000|Overall Study|Patient did not visit the study site|1|||
129072777|NCT02068508|464556508|FG000|Overall Study|Protocol Violation|4|||
129072778|NCT03511105|464556512|FG000|Overall Study|Adverse Event|1|||
129072779|NCT03511105|464556513|FG001|Overall Study|Adverse Event|0|||
129072780|NCT03511105|464556512|FG000|Overall Study|Withdrew consent|1|||
129072781|NCT03511105|464556513|FG001|Overall Study|Withdrew consent|0|||
129072782|NCT02810457|464556514|FG000|Overall Study|Randomised but no treatment received|2|||
129072783|NCT02810457|464556515|FG001|Overall Study|Randomised but no treatment received|1|||
129072784|NCT02810457|464556514|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
129072785|NCT02810457|464556515|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
129072786|NCT02810457|464556514|FG000|Overall Study|Adverse Event|37|||
129072787|NCT02810457|464556515|FG001|Overall Study|Adverse Event|43|||
129072788|NCT02810457|464556514|FG000|Overall Study|Patient decision|31|||
129072789|NCT02810457|464556515|FG001|Overall Study|Patient decision|35|||
129072790|NCT02810457|464556514|FG000|Overall Study|Patient lost to follow-up|2|||
129072791|NCT02810457|464556515|FG001|Overall Study|Patient lost to follow-up|2|||
129072792|NCT02810457|464556514|FG000|Overall Study|Death|39|||
129072793|NCT02810457|464556515|FG001|Overall Study|Death|28|||
129072794|NCT02810457|464556514|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
129072795|NCT02810457|464556515|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
129072796|NCT02810457|464556514|FG000|Overall Study|Clinical progression|15|||
129072797|NCT02810457|464556515|FG001|Overall Study|Clinical progression|16|||
129072798|NCT02810457|464556514|FG000|Overall Study|Investigator decision|3|||
129072799|NCT02810457|464556515|FG001|Overall Study|Investigator decision|2|||
129072800|NCT02810457|464556514|FG000|Overall Study|Patient ineligibility|3|||
129072801|NCT02810457|464556515|FG001|Overall Study|Patient ineligibility|0|||
129072802|NCT02810457|464556514|FG000|Overall Study|Miscalculated PD|1|||
129072803|NCT02810457|464556515|FG001|Overall Study|Miscalculated PD|0|||
129072804|NCT02810457|464556514|FG000|Overall Study|Physician Decision|0|||
129072805|NCT02810457|464556515|FG001|Overall Study|Physician Decision|1|||
129072806|NCT04173507|464556516|FG000|Overall Study|On Treatment|3|||
129072807|NCT04173507|464556516|FG000|Overall Study|Adverse Event|3|||
129072808|NCT04173507|464556516|FG000|Overall Study|Progression/Relapse|34|||
129072809|NCT04173507|464556516|FG000|Overall Study|Death|2|||
129072810|NCT01217112|464556519|FG000|Overall Study|Adverse Event|0|||
129140693|NCT01887600|464808799|FG000|Overall Study|Protocol Deviation|3|||
129140694|NCT01887600|464808800|FG001|Overall Study|Protocol Deviation|0|||
129140695|NCT01887600|464808799|FG000|Overall Study|Withdrawal by Subject|58|||
129072811|NCT01217112|464556520|FG001|Overall Study|Adverse Event|2|||
129072812|NCT01217112|464556521|FG002|Overall Study|Adverse Event|0|||
129140696|NCT01887600|464808800|FG001|Overall Study|Withdrawal by Subject|52|||
129072813|NCT01217112|464556522|FG003|Overall Study|Adverse Event|2|||
129072814|NCT01217112|464556523|FG004|Overall Study|Adverse Event|0|||
129072815|NCT01217112|464556519|FG000|Overall Study|Withdrawal by Subject|0|||
129072816|NCT01217112|464556520|FG001|Overall Study|Withdrawal by Subject|0|||
129072817|NCT01217112|464556521|FG002|Overall Study|Withdrawal by Subject|1|||
129072818|NCT01217112|464556522|FG003|Overall Study|Withdrawal by Subject|0|||
129072819|NCT01217112|464556523|FG004|Overall Study|Withdrawal by Subject|0|||
129072820|NCT01217112|464556519|FG000|Overall Study|Physician Decision|0|||
129072821|NCT01217112|464556520|FG001|Overall Study|Physician Decision|0|||
129072822|NCT01217112|464556521|FG002|Overall Study|Physician Decision|0|||
129072823|NCT01217112|464556522|FG003|Overall Study|Physician Decision|0|||
129072824|NCT01217112|464556523|FG004|Overall Study|Physician Decision|1|||
129072825|NCT03192488|464556524|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
129072826|NCT03192488|464556525|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
129072827|NCT03192488|464556526|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
129140697|NCT01887600|464808799|FG000|Overall Study|Adverse Event|21|||
129072828|NCT03192488|464556527|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
129072829|NCT03192488|464556528|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
129072830|NCT03192488|464556529|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
129072831|NCT03192488|464556524|FG000|Third Intervention (d1)|Adverse Event|0|||
129072832|NCT03192488|464556525|FG001|Third Intervention (d1)|Adverse Event|0|||
129072833|NCT03192488|464556526|FG002|Third Intervention (d1)|Adverse Event|0|||
129072834|NCT03192488|464556527|FG003|Third Intervention (d1)|Adverse Event|0|||
129072835|NCT03192488|464556528|FG004|Third Intervention (d1)|Adverse Event|1|||
129072836|NCT03192488|464556529|FG005|Third Intervention (d1)|Adverse Event|0|||
129072837|NCT01401361|464556530|FG000|Overall Study|Withdrawal by Subject|16|||
129072838|NCT01401361|464556530|FG000|Overall Study|Lack of Efficacy|6|||
129072839|NCT01401361|464556530|FG000|Overall Study|Physician Decision|1|||
129072840|NCT01401361|464556530|FG000|Overall Study|Lost to Follow-up|3|||
129072841|NCT01401361|464556530|FG000|Overall Study|Subject/family decision post procedure|2|||
129072842|NCT02512302|464556532|FG000|Period 1|Adverse Event|0|||
129072843|NCT02512302|464556533|FG001|Period 1|Adverse Event|1|||
129072844|NCT02512302|464556534|FG002|Period 1|Adverse Event|0|||
129072845|NCT02512302|464556535|FG003|Period 1|Adverse Event|0|||
129072846|NCT02512302|464556536|FG004|Period 1|Adverse Event|0|||
129072847|NCT02512302|464556537|FG005|Period 1|Adverse Event|0|||
129072848|NCT02512302|464556538|FG006|Period 1|Adverse Event|0|||
129072849|NCT02512302|464556539|FG007|Period 1|Adverse Event|0|||
129072850|NCT02512302|464556540|FG008|Period 1|Adverse Event|0|||
129072851|NCT02512302|464556541|FG009|Period 1|Adverse Event|0|||
129072852|NCT02512302|464556532|FG000|Period 2|Adverse Event|0|||
129072853|NCT02512302|464556533|FG001|Period 2|Adverse Event|0|||
129072854|NCT02512302|464556534|FG002|Period 2|Adverse Event|0|||
129072855|NCT02512302|464556535|FG003|Period 2|Adverse Event|0|||
129072856|NCT02512302|464556536|FG004|Period 2|Adverse Event|0|||
129072857|NCT02512302|464556537|FG005|Period 2|Adverse Event|0|||
129072858|NCT02512302|464556538|FG006|Period 2|Adverse Event|0|||
129072859|NCT02512302|464556539|FG007|Period 2|Adverse Event|0|||
129072860|NCT02512302|464556540|FG008|Period 2|Adverse Event|0|||
129072861|NCT02512302|464556541|FG009|Period 2|Adverse Event|1|||
129072862|NCT02512302|464556532|FG000|Period 3|Lost to Follow-up|0|||
129072863|NCT02512302|464556533|FG001|Period 3|Lost to Follow-up|0|||
129072864|NCT02512302|464556534|FG002|Period 3|Lost to Follow-up|1|||
129072865|NCT02512302|464556535|FG003|Period 3|Lost to Follow-up|0|||
129072866|NCT02512302|464556536|FG004|Period 3|Lost to Follow-up|0|||
129072867|NCT02512302|464556537|FG005|Period 3|Lost to Follow-up|0|||
129072868|NCT02512302|464556538|FG006|Period 3|Lost to Follow-up|0|||
129072869|NCT02512302|464556539|FG007|Period 3|Lost to Follow-up|0|||
129072870|NCT02512302|464556540|FG008|Period 3|Lost to Follow-up|0|||
129072871|NCT02512302|464556541|FG009|Period 3|Lost to Follow-up|0|||
129072872|NCT02512302|464556532|FG000|Period 4|Adverse Event|0|||
129072873|NCT02512302|464556533|FG001|Period 4|Adverse Event|0|||
129072874|NCT02512302|464556534|FG002|Period 4|Adverse Event|0|||
129072875|NCT02512302|464556535|FG003|Period 4|Adverse Event|0|||
129072876|NCT02512302|464556536|FG004|Period 4|Adverse Event|0|||
129072877|NCT02512302|464556537|FG005|Period 4|Adverse Event|0|||
129072878|NCT02512302|464556538|FG006|Period 4|Adverse Event|1|||
129072879|NCT02512302|464556539|FG007|Period 4|Adverse Event|0|||
129072880|NCT02512302|464556540|FG008|Period 4|Adverse Event|0|||
129072881|NCT02512302|464556541|FG009|Period 4|Adverse Event|0|||
129072882|NCT02764762|464556545|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129072883|NCT02764762|464556545|FG000|Overall Study|Lost to Follow-up|4|||
129072884|NCT02764762|464556545|FG000|Overall Study|Voluntary Withdrawal|8|||
129072885|NCT02764762|464556545|FG000|Overall Study|Site Termination|1|||
129072886|NCT02764762|464556545|FG000|Overall Study|Lack of Efficacy|16|||
129072887|NCT02764762|464556545|FG000|Overall Study|Reason not Specified|1|||
129072888|NCT01002989|464556546|FG000|Overall Study|exclusion criteria, no consent|5|||
129072889|NCT01892501|464556547|FG000|Overall Study|Protocol Violation|2|||
129072890|NCT01892501|464556547|FG000|Overall Study|Puncture not carried out|9|||
129072891|NCT01892501|464556547|FG000|Overall Study|Radiological monitoring not carried out|5|||
129072892|NCT01892501|464556547|FG000|Overall Study|Non-contributory histological result|12|||
129072893|NCT01068860|464556549|FG000|Overall Study|Withdrawal by Subject|0|||
129072894|NCT01068860|464556550|FG001|Overall Study|Withdrawal by Subject|0|||
129072895|NCT01068860|464556551|FG002|Overall Study|Withdrawal by Subject|0|||
129072896|NCT01068860|464556552|FG003|Overall Study|Withdrawal by Subject|0|||
129072897|NCT01068860|464556553|FG004|Overall Study|Withdrawal by Subject|0|||
129072898|NCT01068860|464556554|FG005|Overall Study|Withdrawal by Subject|2|||
129072899|NCT01068860|464556555|FG006|Overall Study|Withdrawal by Subject|0|||
129072900|NCT01068860|464556556|FG007|Overall Study|Withdrawal by Subject|0|||
129072901|NCT01068860|464556557|FG008|Overall Study|Withdrawal by Subject|0|||
129072902|NCT01068860|464556558|FG009|Overall Study|Withdrawal by Subject|3|||
129072903|NCT01068860|464556549|FG000|Overall Study|Administrative problems; misrandomized|0|||
129072904|NCT01068860|464556550|FG001|Overall Study|Administrative problems; misrandomized|0|||
129072905|NCT01068860|464556551|FG002|Overall Study|Administrative problems; misrandomized|0|||
129072906|NCT01068860|464556552|FG003|Overall Study|Administrative problems; misrandomized|1|||
129072907|NCT01068860|464556553|FG004|Overall Study|Administrative problems; misrandomized|0|||
129072908|NCT01068860|464556554|FG005|Overall Study|Administrative problems; misrandomized|0|||
129072909|NCT01068860|464556555|FG006|Overall Study|Administrative problems; misrandomized|0|||
129072910|NCT01068860|464556556|FG007|Overall Study|Administrative problems; misrandomized|0|||
129072911|NCT01068860|464556557|FG008|Overall Study|Administrative problems; misrandomized|0|||
129072912|NCT01068860|464556558|FG009|Overall Study|Administrative problems; misrandomized|1|||
129072913|NCT01068860|464556549|FG000|Overall Study|Lost to Follow-up|0|||
129072914|NCT01068860|464556550|FG001|Overall Study|Lost to Follow-up|1|||
129072915|NCT01068860|464556551|FG002|Overall Study|Lost to Follow-up|0|||
129072916|NCT01068860|464556552|FG003|Overall Study|Lost to Follow-up|0|||
129072917|NCT01068860|464556553|FG004|Overall Study|Lost to Follow-up|0|||
129072918|NCT01068860|464556554|FG005|Overall Study|Lost to Follow-up|0|||
129072919|NCT01068860|464556555|FG006|Overall Study|Lost to Follow-up|0|||
129072920|NCT01068860|464556556|FG007|Overall Study|Lost to Follow-up|0|||
129072921|NCT01068860|464556557|FG008|Overall Study|Lost to Follow-up|0|||
129072922|NCT01068860|464556558|FG009|Overall Study|Lost to Follow-up|0|||
129072923|NCT01321879|464556559|FG000|Overall Study|Lack of Efficacy|5|||
129072924|NCT01321879|464556559|FG000|Overall Study|Adverse Event|5|||
129072925|NCT01321879|464556559|FG000|Overall Study|Death|3|||
129072926|NCT01321879|464556559|FG000|Overall Study|Withdrawal by Subject|1|||
129072927|NCT01641640|464556560|FG000|Overall Study|Enrolled but not treated|1|||
129072928|NCT01641640|464556560|FG000|Overall Study|Efficacy failure|29|||
129072929|NCT01641640|464556560|FG000|Overall Study|Lost to Follow-up|3|||
129072930|NCT01641640|464556560|FG000|Overall Study|Withdrawal by Subject|2|||
129072931|NCT01641640|464556560|FG000|Overall Study|Adverse Event|1|||
129072932|NCT01234350|464556561|FG000|Overall Study|Adverse Event|277|||
129072933|NCT01234350|464556562|FG001|Overall Study|Adverse Event|92|||
129072934|NCT01234350|464556561|FG000|Overall Study|Withdrawal by Subject|61|||
129072935|NCT01234350|464556562|FG001|Overall Study|Withdrawal by Subject|36|||
129072936|NCT01234350|464556561|FG000|Overall Study|Lost to Follow-up|115|||
129072937|NCT01234350|464556562|FG001|Overall Study|Lost to Follow-up|47|||
129072938|NCT01234350|464556561|FG000|Overall Study|Covers a diverse set of reasons|234|||
129072939|NCT01234350|464556562|FG001|Overall Study|Covers a diverse set of reasons|92|||
129072940|NCT01930162|464556565|FG000|Overall Study|Abnormal test procedure result(s)|4|||
129072941|NCT01930162|464556565|FG000|Overall Study|Death|1|||
129072942|NCT01051960|464556566|FG000|Overall Study|Adverse Event|1|||
129072943|NCT02069015|464556576|FG000|Overall Study|Lost to Follow-up|39|||
129072944|NCT02069015|464556577|FG001|Overall Study|Lost to Follow-up|32|||
129072945|NCT02069015|464556576|FG000|Overall Study|Withdrawal by Subject|1|||
129072946|NCT02069015|464556577|FG001|Overall Study|Withdrawal by Subject|1|||
129072947|NCT01082328|464556578|FG000|Overall Study|Adverse Event|1|||
129072948|NCT00031590|464556579|FG000|Overall Study|Adverse Event|1|||
129072949|NCT00031590|464556579|FG000|Overall Study|Withdrawal by parents|2|||
129072950|NCT05506046|464556580|FG000|Overall Study|Lost to Follow-up|89|||
129072951|NCT05506046|464556581|FG001|Overall Study|Lost to Follow-up|101|||
129072952|NCT05506046|464556582|FG002|Overall Study|Lost to Follow-up|102|||
129072953|NCT05506046|464556583|FG003|Overall Study|Lost to Follow-up|99|||
129072954|NCT03051100|464556585|FG000|Overall Study|Withdrawal by Subject|1|||
129072955|NCT03051100|464556586|FG001|Overall Study|Withdrawal by Subject|0|||
129072956|NCT02059135|464556587|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
129072957|NCT02059135|464556588|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
129072958|NCT02059135|464556587|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
129072959|NCT02059135|464556588|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
129072960|NCT02059135|464556587|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
129072961|NCT02059135|464556588|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
129072962|NCT02059135|464556587|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
129072963|NCT02059135|464556588|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
129072964|NCT02059135|464556587|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
129072965|NCT02059135|464556588|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
129072966|NCT02059135|464556587|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
129072967|NCT02059135|464556588|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
129072968|NCT02059135|464556587|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
129072969|NCT02059135|464556588|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
129072970|NCT02059135|464556587|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
129072971|NCT02059135|464556588|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
129072972|NCT00658723|464556594|FG000|Overall Study|Lost to Follow-up|0|||
129072973|NCT00658723|464556595|FG001|Overall Study|Lost to Follow-up|2|||
129072974|NCT00658723|464556596|FG002|Overall Study|Lost to Follow-up|2|||
129072975|NCT00658723|464556594|FG000|Overall Study|Death|2|||
129072976|NCT00658723|464556595|FG001|Overall Study|Death|1|||
129072977|NCT00658723|464556596|FG002|Overall Study|Death|4|||
129072978|NCT00658723|464556594|FG000|Overall Study|Scheduling Issue|1|||
129072979|NCT00658723|464556595|FG001|Overall Study|Scheduling Issue|1|||
129072980|NCT00658723|464556596|FG002|Overall Study|Scheduling Issue|0|||
129072981|NCT00658723|464556594|FG000|Overall Study|Withdrawal by Subject|1|||
129072982|NCT00658723|464556595|FG001|Overall Study|Withdrawal by Subject|0|||
129072983|NCT00658723|464556596|FG002|Overall Study|Withdrawal by Subject|1|||
129072984|NCT02411656|464556597|FG000|Overall Study|Adverse Event|4|||
129072985|NCT02411656|464556597|FG000|Overall Study|Clinical Progression|33|||
129072986|NCT06481709|464556598|FG000|Overall Study|Withdrawal by Subject|0|||
129072987|NCT06481709|464556599|FG001|Overall Study|Withdrawal by Subject|0|||
129072988|NCT06481709|464556600|FG002|Overall Study|Withdrawal by Subject|2|||
129072989|NCT06481709|464556601|FG003|Overall Study|Withdrawal by Subject|0|||
129072990|NCT03305848|464556602|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
129072991|NCT03305848|464556602|FG000|Overall Study|Physician Decision|2|||
129072992|NCT00789854|464556605|FG000|Overall Study|Adverse Event|28|||
129072993|NCT00789854|464556606|FG001|Overall Study|Adverse Event|23|||
129072994|NCT00789854|464556607|FG002|Overall Study|Adverse Event|18|||
129072995|NCT00789854|464556605|FG000|Overall Study|Lost to Follow-up|1|||
129072996|NCT00789854|464556606|FG001|Overall Study|Lost to Follow-up|1|||
129072997|NCT00789854|464556607|FG002|Overall Study|Lost to Follow-up|4|||
129072998|NCT00789854|464556605|FG000|Overall Study|Withdrawal by Subject|9|||
129072999|NCT00789854|464556606|FG001|Overall Study|Withdrawal by Subject|6|||
129073000|NCT00789854|464556607|FG002|Overall Study|Withdrawal by Subject|17|||
129073001|NCT00789854|464556605|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129073002|NCT00789854|464556606|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
129073003|NCT00789854|464556607|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129073004|NCT00789854|464556605|FG000|Overall Study|Severe non-compliance to the protocol|3|||
129073005|NCT00789854|464556606|FG001|Overall Study|Severe non-compliance to the protocol|0|||
129073006|NCT00789854|464556607|FG002|Overall Study|Severe non-compliance to the protocol|0|||
129073007|NCT00789854|464556605|FG000|Overall Study|Safety reasons|0|||
129073008|NCT00789854|464556606|FG001|Overall Study|Safety reasons|0|||
129073009|NCT00789854|464556607|FG002|Overall Study|Safety reasons|2|||
129073010|NCT00789854|464556605|FG000|Overall Study|Other|6|||
129073011|NCT00789854|464556606|FG001|Overall Study|Other|0|||
129073012|NCT00789854|464556607|FG002|Overall Study|Other|5|||
129073013|NCT00923013|464556608|FG000|Overall Study|Refused further treatment|0|||
129073014|NCT00923013|464556609|FG001|Overall Study|Refused further treatment|1|||
129073015|NCT00923013|464556610|FG002|Overall Study|Refused further treatment|2|||
129073016|NCT00923013|464556611|FG003|Overall Study|Refused further treatment|0|||
129073017|NCT00923013|464556612|FG004|Overall Study|Refused further treatment|0|||
129073018|NCT00923013|464556613|FG005|Overall Study|Refused further treatment|0|||
129073019|NCT00923013|464556608|FG000|Overall Study|Switched to alternative treatment|0|||
129073020|NCT00923013|464556609|FG001|Overall Study|Switched to alternative treatment|1|||
129073021|NCT00923013|464556610|FG002|Overall Study|Switched to alternative treatment|0|||
129073022|NCT00923013|464556611|FG003|Overall Study|Switched to alternative treatment|0|||
129073023|NCT00923013|464556612|FG004|Overall Study|Switched to alternative treatment|0|||
129073024|NCT00923013|464556613|FG005|Overall Study|Switched to alternative treatment|0|||
129073025|NCT00923013|464556608|FG000|Overall Study|Death on study|2|||
129073026|NCT00923013|464556609|FG001|Overall Study|Death on study|2|||
129073027|NCT00923013|464556610|FG002|Overall Study|Death on study|0|||
129073028|NCT00923013|464556611|FG003|Overall Study|Death on study|1|||
129073029|NCT00923013|464556612|FG004|Overall Study|Death on study|0|||
129073030|NCT00923013|464556613|FG005|Overall Study|Death on study|0|||
129073031|NCT02224157|464556615|FG000|Overall Study|Severe non-compliance to protocol|2|||
129073032|NCT02224157|464556616|FG001|Overall Study|Severe non-compliance to protocol|2|||
129073033|NCT02224157|464556615|FG000|Overall Study|Other|13|||
129073034|NCT02224157|464556616|FG001|Overall Study|Other|10|||
129073035|NCT02224157|464556615|FG000|Overall Study|Subject decision|58|||
129073036|NCT02224157|464556616|FG001|Overall Study|Subject decision|50|||
129073037|NCT02224157|464556615|FG000|Overall Study|Prematurely closed site|4|||
129073038|NCT02224157|464556616|FG001|Overall Study|Prematurely closed site|2|||
129073039|NCT02224157|464556615|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
129073040|NCT02224157|464556616|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
129073041|NCT02224157|464556615|FG000|Overall Study|Lost to Follow-up|27|||
129073042|NCT02224157|464556616|FG001|Overall Study|Lost to Follow-up|35|||
129073043|NCT02224157|464556615|FG000|Overall Study|Death|1|||
129073044|NCT02224157|464556616|FG001|Overall Study|Death|1|||
129073045|NCT02224157|464556615|FG000|Overall Study|Adverse Event|1|||
129073046|NCT02224157|464556616|FG001|Overall Study|Adverse Event|3|||
129073047|NCT05906628|464556619|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
129073048|NCT05906628|464556620|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
129073049|NCT05906628|464556619|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
129073050|NCT05906628|464556620|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
129073051|NCT05906628|464556619|FG000|16-Week DBVC Period|Protocol Violation|4|||
129073052|NCT05906628|464556620|FG001|16-Week DBVC Period|Protocol Violation|2|||
129073053|NCT05906628|464556619|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
129073054|NCT05906628|464556620|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
129073055|NCT05906628|464556619|FG000|16-Week OLE Period|Death|1|||
129073056|NCT05906628|464556620|FG001|16-Week OLE Period|Death|0|||
129073057|NCT05906628|464556619|FG000|16-Week OLE Period|Lost to Follow-up|1|||
129073058|NCT05906628|464556620|FG001|16-Week OLE Period|Lost to Follow-up|1|||
129073059|NCT05906628|464556619|FG000|16-Week OLE Period|Protocol Violation|0|||
129073060|NCT05906628|464556620|FG001|16-Week OLE Period|Protocol Violation|1|||
129073061|NCT05906628|464556619|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
129073062|NCT05906628|464556620|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
129073063|NCT04578535|464556621|FG000|Overall Study|Lost to Follow-up|1|||
129073064|NCT04578535|464556622|FG001|Overall Study|Lost to Follow-up|0|||
129073065|NCT04578535|464556623|FG002|Overall Study|Lost to Follow-up|0|||
129073066|NCT04578535|464556624|FG003|Overall Study|Lost to Follow-up|1|||
129073067|NCT04578535|464556625|FG004|Overall Study|Lost to Follow-up|0|||
129073068|NCT04578535|464556626|FG005|Overall Study|Lost to Follow-up|2|||
129073069|NCT04578535|464556621|FG000|Overall Study|Pregnancy|1|||
129073070|NCT04578535|464556622|FG001|Overall Study|Pregnancy|0|||
129073071|NCT04578535|464556623|FG002|Overall Study|Pregnancy|0|||
129073072|NCT04578535|464556624|FG003|Overall Study|Pregnancy|0|||
129073073|NCT04578535|464556625|FG004|Overall Study|Pregnancy|0|||
129073074|NCT04578535|464556626|FG005|Overall Study|Pregnancy|0|||
129073075|NCT04578535|464556621|FG000|Overall Study|Withdrawal by Subject|0|||
129073076|NCT04578535|464556622|FG001|Overall Study|Withdrawal by Subject|0|||
129073077|NCT04578535|464556623|FG002|Overall Study|Withdrawal by Subject|0|||
129073078|NCT04578535|464556624|FG003|Overall Study|Withdrawal by Subject|1|||
129073079|NCT04578535|464556625|FG004|Overall Study|Withdrawal by Subject|1|||
129073080|NCT04578535|464556626|FG005|Overall Study|Withdrawal by Subject|5|||
129073081|NCT04578535|464556621|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
129073082|NCT04578535|464556622|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
129073083|NCT04578535|464556623|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
129073084|NCT04578535|464556624|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
129073085|NCT04578535|464556625|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
129073086|NCT04578535|464556626|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
129073087|NCT01060072|464556627|FG000|Overall Study|Adverse Event|1|||
129073088|NCT01060072|464556628|FG001|Overall Study|Adverse Event|1|||
129073089|NCT01060072|464556627|FG000|Overall Study|Physician Decision|0|||
129073090|NCT01060072|464556628|FG001|Overall Study|Physician Decision|2|||
129073091|NCT01060072|464556627|FG000|Overall Study|Protocol Violation|0|||
129073092|NCT01060072|464556628|FG001|Overall Study|Protocol Violation|1|||
129073093|NCT01060072|464556627|FG000|Overall Study|Acute cholecystitis|1|||
129073094|NCT01060072|464556628|FG001|Overall Study|Acute cholecystitis|0|||
129073095|NCT01060072|464556627|FG000|Overall Study|Excluded Medications|0|||
129073096|NCT01060072|464556628|FG001|Overall Study|Excluded Medications|1|||
129073097|NCT00837148|464556629|FG000|Overall Study|Adverse Event|1|||
129073098|NCT00837148|464556629|FG000|Overall Study|Death|1|||
129073099|NCT00380874|464556630|FG000|Overall Study|Adverse Event|7|||
129073100|NCT00380874|464556631|FG001|Overall Study|Adverse Event|7|||
129073101|NCT00380874|464556630|FG000|Overall Study|Death|1|||
129073102|NCT00380874|464556631|FG001|Overall Study|Death|0|||
129073103|NCT00380874|464556630|FG000|Overall Study|Withdrawal by Subject|2|||
129073104|NCT00380874|464556631|FG001|Overall Study|Withdrawal by Subject|1|||
129073105|NCT00380874|464556630|FG000|Overall Study|Not related to study drug|3|||
129073106|NCT00380874|464556631|FG001|Overall Study|Not related to study drug|2|||
129073107|NCT03839628|464556632|FG000|Overall Study|Withdrawal by Subject|1|||
129073108|NCT01707290|464556633|FG000|Overall Study|Adverse event (AE)|1|||
129073109|NCT01707290|464556634|FG001|Overall Study|Adverse event (AE)|0|||
129073110|NCT01707290|464556633|FG000|Overall Study|Physician Decision|1|||
129073111|NCT01707290|464556634|FG001|Overall Study|Physician Decision|0|||
129073112|NCT01707290|464556633|FG000|Overall Study|Lost to Follow-up|3|||
129073113|NCT01707290|464556634|FG001|Overall Study|Lost to Follow-up|0|||
129073114|NCT01707290|464556633|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
129073115|NCT01707290|464556634|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
129073116|NCT01707290|464556633|FG000|Overall Study|Commercial drug available|60|||
129073117|NCT01707290|464556634|FG001|Overall Study|Commercial drug available|1|||
129073118|NCT01707290|464556633|FG000|Overall Study|Other unspecified|17|||
129073119|NCT01707290|464556634|FG001|Overall Study|Other unspecified|0|||
129073120|NCT00586703|464556635|FG000|Overall Study|Death|12|||
129073121|NCT02857816|464556636|FG000|Overall Study|Screen Failure|33|||
129073122|NCT02857816|464556636|FG000|Overall Study|Withdrawal by Subject|4|||
129073123|NCT02857816|464556636|FG000|Overall Study|Lost to Follow-up|1|||
129073124|NCT01147068|464556639|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
129140698|NCT01887600|464808800|FG001|Overall Study|Adverse Event|9|||
129073125|NCT01147068|464556640|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129073126|NCT01147068|464556641|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129073127|NCT01147068|464556642|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129073128|NCT01147068|464556643|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129073129|NCT01147068|464556644|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
129073130|NCT01147068|464556645|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129073131|NCT01147068|464556639|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
129073132|NCT01147068|464556640|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
129073133|NCT01147068|464556641|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
129073134|NCT01147068|464556642|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
129073135|NCT01147068|464556643|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
129073136|NCT01147068|464556644|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
129073137|NCT01147068|464556645|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
129073138|NCT01147068|464556639|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
129073139|NCT01147068|464556640|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
129073140|NCT01147068|464556641|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
129073141|NCT01147068|464556642|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
129073142|NCT01147068|464556643|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
129073143|NCT01147068|464556644|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
129073144|NCT01147068|464556645|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
129073145|NCT01147068|464556639|FG000|Subjects That Received 2nd Dose|Other|0|||
129073146|NCT01147068|464556640|FG001|Subjects That Received 2nd Dose|Other|3|||
129073147|NCT01147068|464556641|FG002|Subjects That Received 2nd Dose|Other|3|||
129073148|NCT01147068|464556642|FG003|Subjects That Received 2nd Dose|Other|0|||
129073149|NCT01147068|464556643|FG004|Subjects That Received 2nd Dose|Other|1|||
129140699|NCT01887600|464808799|FG000|Overall Study|Non-compliance with study drug|3|||
129140700|NCT01887600|464808800|FG001|Overall Study|Non-compliance with study drug|0|||
129140701|NCT01887600|464808799|FG000|Overall Study|Miscellaneous|6|||
129140702|NCT01887600|464808800|FG001|Overall Study|Miscellaneous|2|||
129140703|NCT01887600|464808799|FG000|Overall Study|Progressive Disease|1|||
129140704|NCT01887600|464808800|FG001|Overall Study|Progressive Disease|0|||
129140705|NCT03688139|464808801|FG000|Overall Study|Lost to Follow-up|2|||
129140706|NCT03688139|464808802|FG001|Overall Study|Lost to Follow-up|0|||
129140707|NCT03688139|464808801|FG000|Overall Study|Physician Decision|0|||
129140708|NCT03688139|464808802|FG001|Overall Study|Physician Decision|1|||
129140709|NCT03688139|464808801|FG000|Overall Study|Withdrawal by Subject|2|||
129073150|NCT01147068|464556644|FG005|Subjects That Received 2nd Dose|Other|0|||
129073151|NCT01147068|464556645|FG006|Subjects That Received 2nd Dose|Other|0|||
129073152|NCT01147068|464556639|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
129073153|NCT01147068|464556640|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129073154|NCT01147068|464556641|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129073155|NCT01147068|464556642|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129073156|NCT01147068|464556643|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129073157|NCT01147068|464556644|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
129073158|NCT01147068|464556645|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
129073159|NCT01147068|464556639|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129073160|NCT01147068|464556640|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129073161|NCT01147068|464556641|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129073162|NCT01147068|464556642|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
129073163|NCT01147068|464556643|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129073164|NCT01147068|464556644|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129073165|NCT01147068|464556645|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129073166|NCT01147068|464556639|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
129073167|NCT01147068|464556640|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
129073168|NCT01147068|464556641|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
129073169|NCT01147068|464556642|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
129073170|NCT01147068|464556643|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
129140710|NCT03688139|464808802|FG001|Overall Study|Withdrawal by Subject|3|||
129073171|NCT01147068|464556644|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
129073172|NCT01147068|464556645|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
129073173|NCT04837196|464556655|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
129140711|NCT00025233|464808806|FG000|Overall Study|Ineligible: wrong cell type|1|||
129140712|NCT00025233|464808806|FG000|Overall Study|Ineligible: wrong primary|1|||
129073174|NCT04837196|464556656|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
129073175|NCT04837196|464556657|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
129073176|NCT04837196|464556658|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
129073177|NCT04837196|464556659|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
129073178|NCT04837196|464556655|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
129073179|NCT04837196|464556656|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
129073180|NCT04837196|464556657|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
129073181|NCT04837196|464556658|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
129073182|NCT04837196|464556659|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
129073183|NCT04837196|464556655|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129073184|NCT04837196|464556656|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
129073185|NCT04837196|464556657|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129073186|NCT04837196|464556658|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129073187|NCT04837196|464556659|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129073188|NCT04837196|464556655|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129073189|NCT04837196|464556656|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129073190|NCT04837196|464556657|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
129073191|NCT04837196|464556658|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129073192|NCT04837196|464556659|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129073193|NCT04837196|464556655|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129073194|NCT04837196|464556656|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129073195|NCT04837196|464556657|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
129073196|NCT04837196|464556658|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129073197|NCT04837196|464556659|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129073198|NCT01522456|464556660|FG000|Overall Study|Adverse Event|2|||
129073199|NCT01522456|464556660|FG000|Overall Study|Lost to Follow-up|2|||
129073200|NCT01522456|464556660|FG000|Overall Study|Withdrawal by Subject|2|||
129073201|NCT01522456|464556660|FG000|Overall Study|Pregnancy|1|||
129073202|NCT01522456|464556660|FG000|Overall Study|Tolerability Assessment|1|||
129073203|NCT01565889|464556664|FG000|Part A|Withdrawal by Subject|1|||
129073204|NCT01565889|464556665|FG001|Part A|Withdrawal by Subject|0|||
129073205|NCT01565889|464556666|FG002|Part A|Withdrawal by Subject|0|||
129073206|NCT01565889|464556667|FG003|Part A|Withdrawal by Subject|0|||
129073207|NCT01565889|464556668|FG004|Part A|Withdrawal by Subject|0|||
129073208|NCT01565889|464556669|FG005|Part A|Withdrawal by Subject|0|||
129073209|NCT01565889|464556664|FG000|Part B|Withdrawal by Subject|0|||
129073210|NCT01565889|464556665|FG001|Part B|Withdrawal by Subject|0|||
129073211|NCT01565889|464556666|FG002|Part B|Withdrawal by Subject|0|||
129073212|NCT01565889|464556667|FG003|Part B|Withdrawal by Subject|0|||
129073213|NCT01565889|464556668|FG004|Part B|Withdrawal by Subject|0|||
129073214|NCT01565889|464556669|FG005|Part B|Withdrawal by Subject|1|||
129073215|NCT01565889|464556664|FG000|Part B|Lack of Efficacy|0|||
129073216|NCT01565889|464556665|FG001|Part B|Lack of Efficacy|0|||
129073217|NCT01565889|464556666|FG002|Part B|Lack of Efficacy|0|||
129073218|NCT01565889|464556667|FG003|Part B|Lack of Efficacy|0|||
129073219|NCT01565889|464556668|FG004|Part B|Lack of Efficacy|0|||
129073220|NCT01565889|464556669|FG005|Part B|Lack of Efficacy|2|||
129140713|NCT00025233|464808806|FG000|Overall Study|Ineligible: improper prior treatment|1|||
129140714|NCT00025233|464808806|FG000|Overall Study|Never treated|1|||
129140715|NCT03425188|464808807|FG000|Overall Study|Withdrawal by Subject|1|||
129140716|NCT01412983|464808808|FG000|1st Period|Ineligible|0|||
129140717|NCT01412983|464808809|FG001|1st Period|Ineligible|1|||
129073221|NCT01565889|464556664|FG000|Part B|Lost to Follow-up|0|||
129140718|NCT01412983|464808808|FG000|1st Period|Positive slit lamp finding|0|||
129140719|NCT01412983|464808809|FG001|1st Period|Positive slit lamp finding|1|||
129140720|NCT01412983|464808808|FG000|1st Period|Unacceptable lens movement|0|||
129140721|NCT01412983|464808809|FG001|1st Period|Unacceptable lens movement|1|||
129140722|NCT01412983|464808808|FG000|1st Period|Inability to maintain wear|0|||
129140723|NCT01412983|464808809|FG001|1st Period|Inability to maintain wear|1|||
129073222|NCT01565889|464556665|FG001|Part B|Lost to Follow-up|0|||
129073223|NCT01565889|464556666|FG002|Part B|Lost to Follow-up|0|||
129073224|NCT01565889|464556667|FG003|Part B|Lost to Follow-up|0|||
129073225|NCT01565889|464556668|FG004|Part B|Lost to Follow-up|0|||
129073226|NCT01565889|464556669|FG005|Part B|Lost to Follow-up|1|||
129073227|NCT02723344|464556671|FG000|Overall Study|Lost to Follow-up|0|||
129073228|NCT02723344|464556672|FG001|Overall Study|Lost to Follow-up|4|||
129073229|NCT01326845|464556674|FG000|Overall Study|Administrative Problems|5|||
129073230|NCT01326845|464556675|FG001|Overall Study|Administrative Problems|2|||
129073231|NCT01326845|464556674|FG000|Overall Study|Adverse Event|1|||
129140724|NCT01694771|464808810|FG000|Overall Study|Adverse Event|18|||
129140725|NCT01694771|464808811|FG001|Overall Study|Adverse Event|16|||
129140726|NCT01694771|464808810|FG000|Overall Study|Lack of Efficacy|1|||
129140727|NCT01694771|464808811|FG001|Overall Study|Lack of Efficacy|0|||
129073232|NCT01326845|464556675|FG001|Overall Study|Adverse Event|0|||
129073233|NCT01326845|464556674|FG000|Overall Study|Misisng|1|||
129073234|NCT01326845|464556675|FG001|Overall Study|Misisng|3|||
129073235|NCT02964247|464556676|FG000|Overall Study|Lost to Follow-up|2|||
129073236|NCT02964247|464556677|FG001|Overall Study|Lost to Follow-up|0|||
129073237|NCT02964247|464556676|FG000|Overall Study|Withdrawal by Subject|1|||
129073238|NCT02964247|464556677|FG001|Overall Study|Withdrawal by Subject|2|||
129073239|NCT03918629|464556678|FG000|Overall Study|Adverse Event|19|||
129073240|NCT03918629|464556679|FG001|Overall Study|Adverse Event|20|||
129073241|NCT03918629|464556678|FG000|Overall Study|Death|14|||
129073242|NCT03918629|464556679|FG001|Overall Study|Death|7|||
129073243|NCT03918629|464556678|FG000|Overall Study|Lost to Follow-up|36|||
129073244|NCT03918629|464556679|FG001|Overall Study|Lost to Follow-up|28|||
129073245|NCT03918629|464556678|FG000|Overall Study|Physician Decision|1|||
129073246|NCT03918629|464556679|FG001|Overall Study|Physician Decision|0|||
129073247|NCT03918629|464556678|FG000|Overall Study|Protocol Violation|7|||
129073248|NCT03918629|464556679|FG001|Overall Study|Protocol Violation|4|||
129073249|NCT03918629|464556678|FG000|Overall Study|Withdrawal by Subject|47|||
129073250|NCT03918629|464556679|FG001|Overall Study|Withdrawal by Subject|47|||
129073251|NCT03918629|464556678|FG000|Overall Study|Other|7|||
129073252|NCT03918629|464556679|FG001|Overall Study|Other|11|||
129073253|NCT03918629|464556678|FG000|Overall Study|Randomized but not vaccinated|2|||
129073254|NCT03918629|464556679|FG001|Overall Study|Randomized but not vaccinated|1|||
129073255|NCT01709500|464556683|FG000|Overall Study|Randomized but not treated|0|||
129073256|NCT01709500|464556684|FG001|Overall Study|Randomized but not treated|1|||
129073257|NCT01709500|464556683|FG000|Overall Study|Adverse Event|5|||
129073258|NCT01709500|464556684|FG001|Overall Study|Adverse Event|1|||
129073259|NCT01709500|464556683|FG000|Overall Study|Poor compliance to protocol|2|||
129073260|NCT01709500|464556684|FG001|Overall Study|Poor compliance to protocol|1|||
129073261|NCT01709500|464556683|FG000|Overall Study|Other|3|||
129073262|NCT01709500|464556684|FG001|Overall Study|Other|1|||
129073263|NCT01709500|464556683|FG000|Overall Study|Related to IMP administration|1|||
129073264|NCT01709500|464556684|FG001|Overall Study|Related to IMP administration|0|||
129073265|NCT01709500|464556683|FG000|Overall Study|Treatment ongoing|156|||
129073266|NCT01709500|464556684|FG001|Overall Study|Treatment ongoing|78|||
129073267|NCT00740636|464556686|FG000|Overall Study|Adverse Event|0|||
129073268|NCT00740636|464556687|FG001|Overall Study|Adverse Event|2|||
129073269|NCT00740636|464556686|FG000|Overall Study|Patient Ineligible|0|||
129073270|NCT00740636|464556687|FG001|Overall Study|Patient Ineligible|1|||
129073271|NCT00740636|464556686|FG000|Overall Study|Patient Not Treated|0|||
129073272|NCT00740636|464556687|FG001|Overall Study|Patient Not Treated|1|||
129073273|NCT00740636|464556686|FG000|Overall Study|Progressive Disease|1|||
129073274|NCT00740636|464556687|FG001|Overall Study|Progressive Disease|0|||
129073275|NCT00740636|464556686|FG000|Overall Study|Death|1|||
129073276|NCT00740636|464556687|FG001|Overall Study|Death|0|||
129073277|NCT02844543|464558386|FG000|Overall Study|Withdrawal by Subject|4|||
129073278|NCT02844543|464558386|FG000|Overall Study|Did not meet eligibility criteria|1|||
129073279|NCT04710576|464558392|FG000|Overall Study|Participants still in the study|73|||
129073280|NCT04710576|464558393|FG001|Overall Study|Participants still in the study|70|||
129073281|NCT04710576|464558394|FG002|Overall Study|Participants still in the study|60|||
129073282|NCT04710576|464558392|FG000|Overall Study|Death|2|||
129073283|NCT04710576|464558393|FG001|Overall Study|Death|7|||
129073284|NCT04710576|464558394|FG002|Overall Study|Death|12|||
129073285|NCT04710576|464558392|FG000|Overall Study|Withdrawal by Subject|4|||
129073286|NCT04710576|464558393|FG001|Overall Study|Withdrawal by Subject|3|||
129073287|NCT04710576|464558394|FG002|Overall Study|Withdrawal by Subject|7|||
129073288|NCT04710576|464558392|FG000|Overall Study|Sponsor decision|1|||
129073289|NCT04710576|464558393|FG001|Overall Study|Sponsor decision|0|||
129073290|NCT04710576|464558394|FG002|Overall Study|Sponsor decision|0|||
129073291|NCT04581824|464558395|FG000|Overall Study|Lost to Follow-up|1|||
129073292|NCT04581824|464558396|FG001|Overall Study|Lost to Follow-up|0|||
129073293|NCT04581824|464558395|FG000|Overall Study|Withdrawal by Subject|2|||
129073294|NCT04581824|464558396|FG001|Overall Study|Withdrawal by Subject|7|||
129073295|NCT04581824|464558395|FG000|Overall Study|Study terminated by sponsor|37|||
129073296|NCT04581824|464558396|FG001|Overall Study|Study terminated by sponsor|23|||
129073297|NCT04796909|464558397|FG000|Overall Study|Withdrawal by Subject|1|||
129073298|NCT04796909|464558398|FG001|Overall Study|Withdrawal by Subject|1|||
129073299|NCT03879135|464558399|FG000|Overall Study|Physician Decision|0|||
129073300|NCT03879135|464558400|FG001|Overall Study|Physician Decision|0|||
129073301|NCT03879135|464558401|FG002|Overall Study|Physician Decision|0|||
129073302|NCT03879135|464558402|FG003|Overall Study|Physician Decision|1|||
129073303|NCT03879135|464558403|FG004|Overall Study|Physician Decision|0|||
129073304|NCT03879135|464558404|FG005|Overall Study|Physician Decision|0|||
129073305|NCT03879135|464558399|FG000|Overall Study|Withdrawal by Subject|0|||
129073306|NCT03879135|464558400|FG001|Overall Study|Withdrawal by Subject|0|||
129073307|NCT03879135|464558401|FG002|Overall Study|Withdrawal by Subject|0|||
129073308|NCT03879135|464558402|FG003|Overall Study|Withdrawal by Subject|0|||
129140728|NCT01694771|464808810|FG000|Overall Study|Non compliance protocol|7|||
129073309|NCT03879135|464558403|FG004|Overall Study|Withdrawal by Subject|0|||
129073310|NCT03879135|464558404|FG005|Overall Study|Withdrawal by Subject|1|||
129073311|NCT03879135|464558399|FG000|Overall Study|Site Closed by Sponsor|0|||
129073312|NCT03879135|464558400|FG001|Overall Study|Site Closed by Sponsor|0|||
129073313|NCT03879135|464558401|FG002|Overall Study|Site Closed by Sponsor|0|||
129073314|NCT03879135|464558402|FG003|Overall Study|Site Closed by Sponsor|1|||
129073315|NCT03879135|464558403|FG004|Overall Study|Site Closed by Sponsor|1|||
129073316|NCT03879135|464558404|FG005|Overall Study|Site Closed by Sponsor|0|||
129073317|NCT04162847|464558405|FG000|Overall Study|Withdrawal by Subject|7|||
129073318|NCT04162847|464558406|FG001|Overall Study|Withdrawal by Subject|1|||
129073319|NCT00813150|464558407|FG000|Treatment Period|Adverse Event|16|||
129140729|NCT01694771|464808811|FG001|Overall Study|Non compliance protocol|6|||
129140730|NCT01694771|464808810|FG000|Overall Study|Lost to Follow-up|2|||
129140731|NCT01694771|464808811|FG001|Overall Study|Lost to Follow-up|3|||
129140732|NCT01694771|464808810|FG000|Overall Study|Consent withdrawn|7|||
129140733|NCT01694771|464808811|FG001|Overall Study|Consent withdrawn|9|||
129140734|NCT01694771|464808810|FG000|Overall Study|Other reasons|5|||
129140735|NCT01694771|464808811|FG001|Overall Study|Other reasons|6|||
129140736|NCT00289900|464808812|FG000|Overall Study|Adverse Event|28|||
129140737|NCT00289900|464808813|FG001|Overall Study|Adverse Event|40|||
129140738|NCT00289900|464808814|FG002|Overall Study|Adverse Event|13|||
129073320|NCT00813150|464558408|FG001|Treatment Period|Adverse Event|15|||
129073321|NCT00813150|464558407|FG000|Treatment Period|Death|2|||
129073322|NCT00813150|464558408|FG001|Treatment Period|Death|0|||
129073323|NCT00813150|464558407|FG000|Treatment Period|Progressive disease|1|||
129073324|NCT00813150|464558408|FG001|Treatment Period|Progressive disease|0|||
129073325|NCT00813150|464558407|FG000|Treatment Period|Complete response|0|||
129073326|NCT00813150|464558408|FG001|Treatment Period|Complete response|1|||
129073327|NCT00813150|464558407|FG000|Treatment Period|Stable disease|1|||
129073328|NCT00813150|464558408|FG001|Treatment Period|Stable disease|2|||
129073329|NCT00813150|464558407|FG000|Treatment Period|Protocol Violation|3|||
129073330|NCT00813150|464558408|FG001|Treatment Period|Protocol Violation|4|||
129073331|NCT00813150|464558407|FG000|Treatment Period|Withdrawal by Subject|5|||
129073332|NCT00813150|464558408|FG001|Treatment Period|Withdrawal by Subject|3|||
129073333|NCT00813150|464558407|FG000|Treatment Period|Non compliance|0|||
129073334|NCT00813150|464558408|FG001|Treatment Period|Non compliance|1|||
129073335|NCT00813150|464558407|FG000|Treatment Period|Reason not specified|3|||
129073336|NCT00813150|464558408|FG001|Treatment Period|Reason not specified|4|||
129073337|NCT00813150|464558407|FG000|Treatment Period|Data not available|1|||
129073338|NCT00813150|464558408|FG001|Treatment Period|Data not available|2|||
129073339|NCT00813150|464558407|FG000|Long Term Follow-up|Death|0|||
129073340|NCT00813150|464558408|FG001|Long Term Follow-up|Death|4|||
129073341|NCT00813150|464558407|FG000|Long Term Follow-up|Other|0|||
129073342|NCT00813150|464558408|FG001|Long Term Follow-up|Other|3|||
129073343|NCT00813150|464558407|FG000|Long Term Follow-up|Lost to Follow-up|2|||
129073344|NCT00813150|464558408|FG001|Long Term Follow-up|Lost to Follow-up|0|||
129073345|NCT00813150|464558407|FG000|Long Term Follow-up|Progression/Relapse|22|||
129073346|NCT00813150|464558408|FG001|Long Term Follow-up|Progression/Relapse|24|||
129073347|NCT02832687|464558409|FG000|Overall Study|Adverse Event|0|||
129073348|NCT02832687|464558410|FG001|Overall Study|Adverse Event|2|||
129073349|NCT00471822|464558411|FG000|Overall Study|Protocol Violation|2|||
129073350|NCT03664232|464558412|FG000|Overall Study|Withdrawal by Subject|0|||
129073351|NCT03664232|464558413|FG001|Overall Study|Withdrawal by Subject|1|||
129073352|NCT03664232|464558414|FG002|Overall Study|Withdrawal by Subject|0|||
129073353|NCT03664232|464558415|FG003|Overall Study|Withdrawal by Subject|1|||
129073354|NCT03664232|464558412|FG000|Overall Study|Adverse Event|0|||
129073355|NCT03664232|464558413|FG001|Overall Study|Adverse Event|0|||
129073356|NCT03664232|464558414|FG002|Overall Study|Adverse Event|1|||
129073357|NCT03664232|464558415|FG003|Overall Study|Adverse Event|0|||
129073358|NCT03664232|464558412|FG000|Overall Study|Other-Non-compliance with study drug|0|||
129073359|NCT03664232|464558413|FG001|Overall Study|Other-Non-compliance with study drug|1|||
129073360|NCT03664232|464558414|FG002|Overall Study|Other-Non-compliance with study drug|0|||
129140739|NCT00289900|464808815|FG003|Overall Study|Adverse Event|19|||
129140740|NCT00289900|464808816|FG004|Overall Study|Adverse Event|20|||
129140741|NCT00289900|464808817|FG005|Overall Study|Adverse Event|33|||
129140742|NCT00289900|464808812|FG000|Overall Study|Lost to Follow-up|7|||
129140743|NCT00289900|464808813|FG001|Overall Study|Lost to Follow-up|7|||
129073361|NCT03664232|464558415|FG003|Overall Study|Other-Non-compliance with study drug|2|||
129073362|NCT03664232|464558412|FG000|Overall Study|Other-Unspecified|0|||
129140744|NCT00289900|464808814|FG002|Overall Study|Lost to Follow-up|8|||
129073363|NCT03664232|464558413|FG001|Overall Study|Other-Unspecified|3|||
129073364|NCT03664232|464558414|FG002|Overall Study|Other-Unspecified|0|||
129140745|NCT00289900|464808815|FG003|Overall Study|Lost to Follow-up|8|||
129140746|NCT00289900|464808816|FG004|Overall Study|Lost to Follow-up|4|||
129073365|NCT03664232|464558415|FG003|Overall Study|Other-Unspecified|1|||
129073366|NCT03664232|464558412|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
129073367|NCT03664232|464558413|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
129073368|NCT03664232|464558414|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
129140747|NCT00289900|464808817|FG005|Overall Study|Lost to Follow-up|8|||
129073369|NCT03664232|464558415|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
129073370|NCT03334435|464558416|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
129073371|NCT03334435|464558417|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
129073372|NCT03334435|464558418|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
129073373|NCT03334435|464558419|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
129073374|NCT03334435|464558420|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
129073375|NCT03334435|464558421|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073376|NCT03334435|464558422|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073377|NCT03334435|464558423|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073378|NCT03334435|464558424|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073379|NCT03334435|464558425|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073380|NCT03334435|464558426|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073381|NCT03334435|464558427|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073382|NCT03334435|464558428|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073383|NCT03334435|464558429|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073384|NCT03334435|464558430|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129073385|NCT03334435|464558416|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
129073386|NCT03334435|464558417|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
129073387|NCT03334435|464558418|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
129073388|NCT03334435|464558419|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
129073389|NCT03334435|464558420|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
129073390|NCT03334435|464558421|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073391|NCT03334435|464558422|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073392|NCT03334435|464558423|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073393|NCT03334435|464558424|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073394|NCT03334435|464558425|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073395|NCT03334435|464558426|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073396|NCT03334435|464558427|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073397|NCT03334435|464558428|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073398|NCT03334435|464558429|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073399|NCT03334435|464558430|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129073400|NCT03334435|464558416|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
129073401|NCT03334435|464558417|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
129073402|NCT03334435|464558418|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
129073403|NCT03334435|464558419|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
129073404|NCT03334435|464558420|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
129073405|NCT03334435|464558421|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073406|NCT03334435|464558422|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073407|NCT03334435|464558423|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073408|NCT03334435|464558424|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073409|NCT03334435|464558425|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073410|NCT03334435|464558426|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073411|NCT03334435|464558427|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073412|NCT03334435|464558428|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073413|NCT03334435|464558429|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073414|NCT03334435|464558430|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129073415|NCT03334435|464558416|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
129073416|NCT03334435|464558417|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
129073417|NCT03334435|464558418|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
129073418|NCT03334435|464558419|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
129073419|NCT03334435|464558420|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
129073420|NCT03334435|464558421|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073421|NCT03334435|464558422|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073422|NCT03334435|464558423|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073423|NCT03334435|464558424|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073424|NCT03334435|464558425|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073425|NCT03334435|464558426|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073426|NCT03334435|464558427|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073427|NCT03334435|464558428|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073428|NCT03334435|464558429|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073429|NCT03334435|464558430|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129073430|NCT03334435|464558416|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
129073431|NCT03334435|464558417|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073432|NCT03334435|464558418|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
129073433|NCT03334435|464558419|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
129073434|NCT03334435|464558420|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
129073435|NCT03334435|464558421|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073436|NCT03334435|464558422|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073437|NCT03334435|464558423|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073438|NCT03334435|464558424|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073439|NCT03334435|464558425|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073440|NCT03334435|464558426|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073441|NCT03334435|464558427|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073442|NCT03334435|464558428|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073443|NCT03334435|464558429|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073444|NCT03334435|464558430|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129073445|NCT03334435|464558416|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073446|NCT03334435|464558417|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073447|NCT03334435|464558418|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073448|NCT03334435|464558419|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
129073449|NCT03334435|464558420|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073450|NCT03334435|464558421|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073451|NCT03334435|464558422|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073452|NCT03334435|464558423|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073453|NCT03334435|464558424|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073454|NCT03334435|464558425|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073455|NCT03334435|464558426|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073456|NCT03334435|464558427|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073457|NCT03334435|464558428|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073458|NCT03334435|464558429|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073459|NCT03334435|464558430|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
129073460|NCT03334435|464558416|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073461|NCT03334435|464558417|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
129073462|NCT03334435|464558418|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
129073463|NCT03334435|464558419|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
129073464|NCT03334435|464558420|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
129073465|NCT03334435|464558421|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073466|NCT03334435|464558422|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073467|NCT03334435|464558423|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073468|NCT03334435|464558424|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073469|NCT03334435|464558425|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073470|NCT03334435|464558426|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073471|NCT03334435|464558427|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073472|NCT03334435|464558428|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073473|NCT03334435|464558429|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
129140748|NCT00289900|464808812|FG000|Overall Study|Participant had flushing|18|||
129140749|NCT00289900|464808813|FG001|Overall Study|Participant had flushing|42|||
129140750|NCT00289900|464808814|FG002|Overall Study|Participant had flushing|1|||
129140751|NCT00289900|464808815|FG003|Overall Study|Participant had flushing|2|||
129140752|NCT00289900|464808816|FG004|Overall Study|Participant had flushing|0|||
129140753|NCT00289900|464808817|FG005|Overall Study|Participant had flushing|4|||
129140754|NCT00289900|464808812|FG000|Overall Study|Other|0|||
129140755|NCT00289900|464808813|FG001|Overall Study|Other|0|||
129140756|NCT00289900|464808814|FG002|Overall Study|Other|0|||
129140757|NCT00289900|464808815|FG003|Overall Study|Other|5|||
129140758|NCT00289900|464808816|FG004|Overall Study|Other|1|||
129140759|NCT00289900|464808817|FG005|Overall Study|Other|0|||
129073474|NCT03334435|464558430|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
129073475|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129073476|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129073477|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129073478|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129073479|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129073480|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
129073481|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
129073482|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
129073483|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
129073484|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
129073485|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
129073486|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
129073487|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
129073488|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
129073489|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
129073490|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129073491|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129073492|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129073493|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129073494|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129073495|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
129073496|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
129073497|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
129073498|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
129073499|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
129073500|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
129073501|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
129073502|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
129073503|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
129073504|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
129073505|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129073506|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129073507|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129073508|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129073509|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129073510|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
129073511|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
129073512|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
129073513|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
129073514|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
129073515|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
129073516|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
129073517|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129073518|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
129073519|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
129073520|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129073521|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129073522|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129073523|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129073524|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129073525|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
129073526|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
129073527|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
129140760|NCT00289900|464808812|FG000|Overall Study|Participant moved|1|||
129140761|NCT00289900|464808813|FG001|Overall Study|Participant moved|0|||
129140762|NCT00289900|464808814|FG002|Overall Study|Participant moved|0|||
129140763|NCT00289900|464808815|FG003|Overall Study|Participant moved|1|||
129140764|NCT00289900|464808816|FG004|Overall Study|Participant moved|1|||
129140765|NCT00289900|464808817|FG005|Overall Study|Participant moved|1|||
129140766|NCT00289900|464808812|FG000|Overall Study|Withdrawal by Subject|10|||
129140767|NCT00289900|464808813|FG001|Overall Study|Withdrawal by Subject|21|||
129073528|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
129140768|NCT00289900|464808814|FG002|Overall Study|Withdrawal by Subject|8|||
128776517|NCT00519636|463470457|FG002|Washout Period|Participating in study at another site|0|||
129073529|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
129073530|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
129073531|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
129073532|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
129073533|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
129073534|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
129073535|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129073536|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129073537|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129073538|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129073539|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129073540|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129073541|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
129073542|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
129073543|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
129073544|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
129073545|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
129073546|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
129073547|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129073548|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
129073549|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
129073550|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073551|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073552|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073553|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073554|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073555|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073556|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073557|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073558|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073559|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073560|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073561|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
129073562|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073563|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
129073564|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129073565|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073566|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073567|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073568|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073569|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073570|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
129073571|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073572|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073573|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073574|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
129140769|NCT00289900|464808815|FG003|Overall Study|Withdrawal by Subject|18|||
129140770|NCT00289900|464808816|FG004|Overall Study|Withdrawal by Subject|12|||
129140771|NCT00289900|464808817|FG005|Overall Study|Withdrawal by Subject|11|||
129140772|NCT00289900|464808812|FG000|Overall Study|Protocol Violation|3|||
129140773|NCT00289900|464808813|FG001|Overall Study|Protocol Violation|9|||
129140774|NCT00289900|464808814|FG002|Overall Study|Protocol Violation|2|||
129140775|NCT00289900|464808815|FG003|Overall Study|Protocol Violation|6|||
129140776|NCT00289900|464808816|FG004|Overall Study|Protocol Violation|7|||
129140777|NCT00289900|464808817|FG005|Overall Study|Protocol Violation|4|||
129140778|NCT00289900|464808812|FG000|Overall Study|site terminated|1|||
129140779|NCT00289900|464808813|FG001|Overall Study|site terminated|0|||
129140780|NCT00289900|464808814|FG002|Overall Study|site terminated|1|||
129140781|NCT00289900|464808815|FG003|Overall Study|site terminated|0|||
129140782|NCT00289900|464808816|FG004|Overall Study|site terminated|0|||
129140783|NCT00289900|464808817|FG005|Overall Study|site terminated|0|||
129140784|NCT00289900|464808812|FG000|Overall Study|Not treated|0|||
129140785|NCT00289900|464808813|FG001|Overall Study|Not treated|1|||
129140786|NCT00289900|464808814|FG002|Overall Study|Not treated|0|||
129140787|NCT00289900|464808815|FG003|Overall Study|Not treated|0|||
129140788|NCT00289900|464808816|FG004|Overall Study|Not treated|0|||
129073575|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073576|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073577|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073578|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
129073579|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
129073580|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073581|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073582|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073583|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073584|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073585|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129073586|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129073587|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129073588|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129073589|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
129073590|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129073591|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129073592|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073593|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073594|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129073595|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073596|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073597|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073598|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073599|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073600|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129073601|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129073602|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073603|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073604|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073605|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129073606|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129073607|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129073608|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
129073609|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
129073610|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073611|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073612|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073613|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073614|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073615|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
129073616|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073617|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073618|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073619|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073620|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
129073621|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073622|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073623|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129073624|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
129073625|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073626|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073627|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073628|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073629|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073630|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073631|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129140789|NCT00289900|464808817|FG005|Overall Study|Not treated|0|||
129140790|NCT01152385|464808818|FG000|Overall Study|Withdrawal by Subject|3|||
129140791|NCT01152385|464808819|FG001|Overall Study|Withdrawal by Subject|1|||
129140792|NCT01152385|464808820|FG002|Overall Study|Withdrawal by Subject|1|||
129140793|NCT01152385|464808821|FG003|Overall Study|Withdrawal by Subject|1|||
129140794|NCT01152385|464808818|FG000|Overall Study|Protocol Violation|0|||
129140795|NCT01152385|464808819|FG001|Overall Study|Protocol Violation|0|||
129073632|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129073633|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129073634|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073635|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129073636|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
129073637|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129073638|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073639|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129073640|NCT03334435|464558416|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073641|NCT03334435|464558417|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073642|NCT03334435|464558418|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073643|NCT03334435|464558419|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073644|NCT03334435|464558420|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073645|NCT03334435|464558421|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073646|NCT03334435|464558422|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073647|NCT03334435|464558423|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073648|NCT03334435|464558424|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073649|NCT03334435|464558425|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073650|NCT03334435|464558426|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073651|NCT03334435|464558427|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
129073652|NCT03334435|464558428|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129073653|NCT03334435|464558429|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
129073654|NCT03334435|464558430|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
129073655|NCT03922321|464558431|FG000|Overall Study|Participant Moved|1|||
129073656|NCT03922321|464558431|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
129073657|NCT04067050|464558432|FG000|One Month|Lost to Follow-up|4|||
129073658|NCT04067050|464558433|FG001|One Month|Lost to Follow-up|0|||
129073659|NCT04067050|464558432|FG000|Two Month|Lost to Follow-up|1|||
129073660|NCT04067050|464558433|FG001|Two Month|Lost to Follow-up|0|||
129073661|NCT04067050|464558432|FG000|Two Month|Adverse Event|1|||
129073662|NCT04067050|464558433|FG001|Two Month|Adverse Event|0|||
129073663|NCT01062425|464558438|FG000|Overall Study|Protocol Violation|3|||
129073664|NCT01062425|464558439|FG001|Overall Study|Protocol Violation|6|||
129073665|NCT02342678|464558440|FG000|Overall Study|Lost to Follow-up|0|||
129073666|NCT02342678|464558441|FG001|Overall Study|Lost to Follow-up|1|||
129073667|NCT02342678|464558440|FG000|Overall Study|Too busy to complete study|0|||
129073668|NCT02342678|464558441|FG001|Overall Study|Too busy to complete study|2|||
129073669|NCT02342678|464558440|FG000|Overall Study|Family illness/emergency|0|||
129073670|NCT02342678|464558441|FG001|Overall Study|Family illness/emergency|1|||
129073671|NCT02342678|464558440|FG000|Overall Study|Illness/medical reason|1|||
129073672|NCT02342678|464558441|FG001|Overall Study|Illness/medical reason|1|||
129073673|NCT02383017|464558442|FG000|Overall Study|Injury Sustained Outside Study|1|||
129073674|NCT02383017|464558443|FG001|Overall Study|Injury Sustained Outside Study|0|||
129073675|NCT02383017|464558442|FG000|Overall Study|Compliance|3|||
129073676|NCT02383017|464558443|FG001|Overall Study|Compliance|2|||
129073677|NCT02383017|464558442|FG000|Overall Study|Found to be Hypogonadal|1|||
129073678|NCT02383017|464558443|FG001|Overall Study|Found to be Hypogonadal|0|||
129073679|NCT00460603|464558444|FG000|Phase 1|Death|1|||
129073680|NCT00460603|464558445|FG001|Phase 1|Death|0|||
129073681|NCT00460603|464558446|FG002|Phase 1|Death|0|||
129073682|NCT00460603|464558447|FG003|Phase 1|Death|2|||
129073683|NCT00460603|464558448|FG004|Phase 1|Death|0|||
129073684|NCT00460603|464558449|FG005|Phase 1|Death|0|||
129073685|NCT00460603|464558450|FG006|Phase 1|Death|0|||
129073686|NCT00460603|464558451|FG007|Phase 1|Death|0|||
129073687|NCT00460603|464558452|FG008|Phase 1|Death|1|||
129073688|NCT00460603|464558453|FG009|Phase 1|Death|0|||
129073689|NCT00460603|464558454|FG010|Phase 1|Death|0|||
129073690|NCT00460603|464558455|FG011|Phase 1|Death|0|||
129073691|NCT00460603|464558444|FG000|Phase 1|Adverse Event|3|||
129073692|NCT00460603|464558445|FG001|Phase 1|Adverse Event|1|||
129073693|NCT00460603|464558446|FG002|Phase 1|Adverse Event|1|||
129073694|NCT00460603|464558447|FG003|Phase 1|Adverse Event|2|||
129073695|NCT00460603|464558448|FG004|Phase 1|Adverse Event|0|||
129073696|NCT00460603|464558449|FG005|Phase 1|Adverse Event|0|||
129073697|NCT00460603|464558450|FG006|Phase 1|Adverse Event|3|||
129073698|NCT00460603|464558451|FG007|Phase 1|Adverse Event|0|||
129073699|NCT00460603|464558452|FG008|Phase 1|Adverse Event|4|||
129073700|NCT00460603|464558453|FG009|Phase 1|Adverse Event|0|||
129073701|NCT00460603|464558454|FG010|Phase 1|Adverse Event|0|||
129073702|NCT00460603|464558455|FG011|Phase 1|Adverse Event|0|||
129073703|NCT00460603|464558444|FG000|Phase 1|Lack of Efficacy|1|||
129073704|NCT00460603|464558445|FG001|Phase 1|Lack of Efficacy|0|||
129073705|NCT00460603|464558446|FG002|Phase 1|Lack of Efficacy|1|||
129073706|NCT00460603|464558447|FG003|Phase 1|Lack of Efficacy|2|||
129073707|NCT00460603|464558448|FG004|Phase 1|Lack of Efficacy|2|||
129073708|NCT00460603|464558449|FG005|Phase 1|Lack of Efficacy|2|||
129073709|NCT00460603|464558450|FG006|Phase 1|Lack of Efficacy|2|||
129073710|NCT00460603|464558451|FG007|Phase 1|Lack of Efficacy|2|||
129073711|NCT00460603|464558452|FG008|Phase 1|Lack of Efficacy|11|||
129073712|NCT00460603|464558453|FG009|Phase 1|Lack of Efficacy|0|||
129073713|NCT00460603|464558454|FG010|Phase 1|Lack of Efficacy|0|||
129073714|NCT00460603|464558455|FG011|Phase 1|Lack of Efficacy|0|||
129073715|NCT00460603|464558444|FG000|Phase 1|Withdrawal by Subject|1|||
129073716|NCT00460603|464558445|FG001|Phase 1|Withdrawal by Subject|2|||
129073717|NCT00460603|464558446|FG002|Phase 1|Withdrawal by Subject|1|||
129073718|NCT00460603|464558447|FG003|Phase 1|Withdrawal by Subject|1|||
129073719|NCT00460603|464558448|FG004|Phase 1|Withdrawal by Subject|3|||
129073720|NCT00460603|464558449|FG005|Phase 1|Withdrawal by Subject|0|||
129073721|NCT00460603|464558450|FG006|Phase 1|Withdrawal by Subject|1|||
129073722|NCT00460603|464558451|FG007|Phase 1|Withdrawal by Subject|0|||
129073723|NCT00460603|464558452|FG008|Phase 1|Withdrawal by Subject|2|||
129073724|NCT00460603|464558453|FG009|Phase 1|Withdrawal by Subject|0|||
129073725|NCT00460603|464558454|FG010|Phase 1|Withdrawal by Subject|0|||
129073726|NCT00460603|464558455|FG011|Phase 1|Withdrawal by Subject|0|||
129073727|NCT00460603|464558444|FG000|Phase 1|Other|0|||
129073728|NCT00460603|464558445|FG001|Phase 1|Other|3|||
129073729|NCT00460603|464558446|FG002|Phase 1|Other|1|||
129073730|NCT00460603|464558447|FG003|Phase 1|Other|1|||
129073731|NCT00460603|464558448|FG004|Phase 1|Other|1|||
129073732|NCT00460603|464558449|FG005|Phase 1|Other|2|||
129073733|NCT00460603|464558450|FG006|Phase 1|Other|0|||
129073734|NCT00460603|464558451|FG007|Phase 1|Other|1|||
129073735|NCT00460603|464558452|FG008|Phase 1|Other|0|||
129073736|NCT00460603|464558453|FG009|Phase 1|Other|0|||
129073737|NCT00460603|464558454|FG010|Phase 1|Other|0|||
129073738|NCT00460603|464558455|FG011|Phase 1|Other|0|||
129073739|NCT00460603|464558444|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073740|NCT00460603|464558445|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129140796|NCT01152385|464808820|FG002|Overall Study|Protocol Violation|0|||
129073741|NCT00460603|464558446|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073742|NCT00460603|464558447|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073743|NCT00460603|464558448|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073744|NCT00460603|464558449|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073745|NCT00460603|464558450|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073746|NCT00460603|464558451|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073747|NCT00460603|464558452|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073748|NCT00460603|464558453|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
129073749|NCT00460603|464558454|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073750|NCT00460603|464558455|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129073751|NCT00460603|464558444|FG000|Phase 2|Adverse Event|0|||
129073752|NCT00460603|464558445|FG001|Phase 2|Adverse Event|0|||
129140797|NCT01152385|464808821|FG003|Overall Study|Protocol Violation|1|||
129140798|NCT01152385|464808818|FG000|Overall Study|Adverse Event|1|||
129140799|NCT01152385|464808819|FG001|Overall Study|Adverse Event|1|||
129140800|NCT01152385|464808820|FG002|Overall Study|Adverse Event|0|||
129140801|NCT01152385|464808821|FG003|Overall Study|Adverse Event|0|||
129140802|NCT01152385|464808818|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129140803|NCT01152385|464808819|FG001|Overall Study|Study-specific withdrawal criteria|1|||
129140804|NCT01152385|464808820|FG002|Overall Study|Study-specific withdrawal criteria|2|||
129140805|NCT01152385|464808821|FG003|Overall Study|Study-specific withdrawal criteria|0|||
129140806|NCT01152385|464808818|FG000|Overall Study|Other|4|||
129140807|NCT01152385|464808819|FG001|Overall Study|Other|3|||
129140808|NCT01152385|464808820|FG002|Overall Study|Other|2|||
129140809|NCT01152385|464808821|FG003|Overall Study|Other|3|||
129140810|NCT05486065|464808822|FG000|Overall Study|Withdrawal by Subject|1|||
129140811|NCT05486065|464808823|FG001|Overall Study|Withdrawal by Subject|5|||
129140812|NCT05486065|464808824|FG002|Overall Study|Withdrawal by Subject|4|||
129140813|NCT05486065|464808825|FG003|Overall Study|Withdrawal by Subject|3|||
129140814|NCT05486065|464808822|FG000|Overall Study|Lost to Follow-up|4|||
129073753|NCT00460603|464558446|FG002|Phase 2|Adverse Event|0|||
128776518|NCT00519636|463470458|FG003|Washout Period|Participating in study at another site|0|||
129073754|NCT00460603|464558447|FG003|Phase 2|Adverse Event|0|||
129073755|NCT00460603|464558448|FG004|Phase 2|Adverse Event|0|||
129073756|NCT00460603|464558449|FG005|Phase 2|Adverse Event|0|||
129073757|NCT00460603|464558450|FG006|Phase 2|Adverse Event|0|||
129073758|NCT00460603|464558451|FG007|Phase 2|Adverse Event|0|||
129073759|NCT00460603|464558452|FG008|Phase 2|Adverse Event|0|||
129073760|NCT00460603|464558453|FG009|Phase 2|Adverse Event|12|||
129073761|NCT00460603|464558454|FG010|Phase 2|Adverse Event|9|||
129073762|NCT00460603|464558455|FG011|Phase 2|Adverse Event|10|||
129073763|NCT00460603|464558444|FG000|Phase 2|Death|0|||
129073764|NCT00460603|464558445|FG001|Phase 2|Death|0|||
129073765|NCT00460603|464558446|FG002|Phase 2|Death|0|||
129073766|NCT00460603|464558447|FG003|Phase 2|Death|0|||
129073767|NCT00460603|464558448|FG004|Phase 2|Death|0|||
129073768|NCT00460603|464558449|FG005|Phase 2|Death|0|||
129073769|NCT00460603|464558450|FG006|Phase 2|Death|0|||
128776519|NCT00519636|463470455|FG000|Washout Period|Non-compliant|0|||
129140815|NCT05486065|464808823|FG001|Overall Study|Lost to Follow-up|2|||
129140816|NCT05486065|464808824|FG002|Overall Study|Lost to Follow-up|2|||
129140817|NCT05486065|464808825|FG003|Overall Study|Lost to Follow-up|2|||
129073770|NCT00460603|464558451|FG007|Phase 2|Death|0|||
129073771|NCT00460603|464558452|FG008|Phase 2|Death|0|||
129073772|NCT00460603|464558453|FG009|Phase 2|Death|4|||
129073773|NCT00460603|464558454|FG010|Phase 2|Death|2|||
129073774|NCT00460603|464558455|FG011|Phase 2|Death|2|||
129073775|NCT00460603|464558444|FG000|Phase 2|Protocol Violation|0|||
129140818|NCT05486065|464808822|FG000|Overall Study|Physician Decision|0|||
129073776|NCT00460603|464558445|FG001|Phase 2|Protocol Violation|0|||
129073777|NCT00460603|464558446|FG002|Phase 2|Protocol Violation|0|||
129073778|NCT00460603|464558447|FG003|Phase 2|Protocol Violation|0|||
129073779|NCT00460603|464558448|FG004|Phase 2|Protocol Violation|0|||
129073780|NCT00460603|464558449|FG005|Phase 2|Protocol Violation|0|||
129073781|NCT00460603|464558450|FG006|Phase 2|Protocol Violation|0|||
129073782|NCT00460603|464558451|FG007|Phase 2|Protocol Violation|0|||
129073783|NCT00460603|464558452|FG008|Phase 2|Protocol Violation|0|||
129073784|NCT00460603|464558453|FG009|Phase 2|Protocol Violation|1|||
129073785|NCT00460603|464558454|FG010|Phase 2|Protocol Violation|1|||
129073786|NCT00460603|464558455|FG011|Phase 2|Protocol Violation|0|||
129073787|NCT00460603|464558444|FG000|Phase 2|Lost to Follow-up|0|||
129073788|NCT00460603|464558445|FG001|Phase 2|Lost to Follow-up|0|||
129073789|NCT00460603|464558446|FG002|Phase 2|Lost to Follow-up|0|||
129073790|NCT00460603|464558447|FG003|Phase 2|Lost to Follow-up|0|||
129073791|NCT00460603|464558448|FG004|Phase 2|Lost to Follow-up|0|||
129073792|NCT00460603|464558449|FG005|Phase 2|Lost to Follow-up|0|||
129073793|NCT00460603|464558450|FG006|Phase 2|Lost to Follow-up|0|||
128776520|NCT00519636|463470456|FG001|Washout Period|Non-compliant|1|||
128776521|NCT00519636|463470457|FG002|Washout Period|Non-compliant|0|||
128776522|NCT00519636|463470458|FG003|Washout Period|Non-compliant|0|||
128776523|NCT00519636|463470455|FG000|Washout Period|Per doctors request|0|||
128776524|NCT00519636|463470456|FG001|Washout Period|Per doctors request|1|||
128776525|NCT00519636|463470457|FG002|Washout Period|Per doctors request|0|||
128776526|NCT00519636|463470458|FG003|Washout Period|Per doctors request|0|||
128776527|NCT00519636|463470455|FG000|Washout Period|Subject randomized in error|0|||
128776528|NCT00519636|463470456|FG001|Washout Period|Subject randomized in error|0|||
128776529|NCT00519636|463470457|FG002|Washout Period|Subject randomized in error|1|||
128776530|NCT00519636|463470458|FG003|Washout Period|Subject randomized in error|0|||
128776531|NCT00519636|463470455|FG000|Washout Period|Prohibited medications|0|||
128776532|NCT00519636|463470456|FG001|Washout Period|Prohibited medications|0|||
128776533|NCT00519636|463470457|FG002|Washout Period|Prohibited medications|1|||
128776534|NCT00519636|463470458|FG003|Washout Period|Prohibited medications|0|||
128776535|NCT00519636|463470455|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
128776536|NCT00519636|463470456|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
128776537|NCT00519636|463470457|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
128776538|NCT00519636|463470458|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
128776539|NCT00519636|463470455|FG000|Treatment Period 2|Subject randomized in error|0|||
128776540|NCT00519636|463470456|FG001|Treatment Period 2|Subject randomized in error|1|||
128776541|NCT00519636|463470457|FG002|Treatment Period 2|Subject randomized in error|0|||
128776542|NCT00519636|463470458|FG003|Treatment Period 2|Subject randomized in error|0|||
128776543|NCT00519636|463470455|FG000|Treatment Period 2|Per doctors request|0|||
128776544|NCT00519636|463470456|FG001|Treatment Period 2|Per doctors request|0|||
128776545|NCT00519636|463470457|FG002|Treatment Period 2|Per doctors request|1|||
128776546|NCT00519636|463470458|FG003|Treatment Period 2|Per doctors request|0|||
128776547|NCT00519636|463470455|FG000|Treatment Period 2|Subject misrandomized|0|||
128776548|NCT00519636|463470456|FG001|Treatment Period 2|Subject misrandomized|0|||
128776549|NCT00519636|463470457|FG002|Treatment Period 2|Subject misrandomized|0|||
128776550|NCT00519636|463470458|FG003|Treatment Period 2|Subject misrandomized|1|||
128776551|NCT00519636|463470455|FG000|Post Study Period|Subject randomized in error|0|||
128776552|NCT00519636|463470456|FG001|Post Study Period|Subject randomized in error|0|||
128776553|NCT00519636|463470457|FG002|Post Study Period|Subject randomized in error|0|||
128776554|NCT00519636|463470458|FG003|Post Study Period|Subject randomized in error|1|||
128776555|NCT02846558|463470463|FG000|Overall Study|Adverse Event|1|||
128776556|NCT02846558|463470464|FG001|Overall Study|Adverse Event|0|||
129073794|NCT00460603|464558451|FG007|Phase 2|Lost to Follow-up|0|||
129073795|NCT00460603|464558452|FG008|Phase 2|Lost to Follow-up|0|||
129073796|NCT00460603|464558453|FG009|Phase 2|Lost to Follow-up|1|||
129073797|NCT00460603|464558454|FG010|Phase 2|Lost to Follow-up|0|||
129073798|NCT00460603|464558455|FG011|Phase 2|Lost to Follow-up|0|||
129073799|NCT00460603|464558444|FG000|Phase 2|Other|0|||
129073800|NCT00460603|464558445|FG001|Phase 2|Other|0|||
129073801|NCT00460603|464558446|FG002|Phase 2|Other|0|||
129073802|NCT00460603|464558447|FG003|Phase 2|Other|0|||
129073803|NCT00460603|464558448|FG004|Phase 2|Other|0|||
129073804|NCT00460603|464558449|FG005|Phase 2|Other|0|||
129073805|NCT00460603|464558450|FG006|Phase 2|Other|0|||
129073806|NCT00460603|464558451|FG007|Phase 2|Other|0|||
129073807|NCT00460603|464558452|FG008|Phase 2|Other|0|||
129073808|NCT00460603|464558453|FG009|Phase 2|Other|6|||
129073809|NCT00460603|464558454|FG010|Phase 2|Other|16|||
129073810|NCT00460603|464558455|FG011|Phase 2|Other|7|||
129073811|NCT00460603|464558444|FG000|Phase 2|Objective Progression or Relapse|0|||
129073812|NCT00460603|464558445|FG001|Phase 2|Objective Progression or Relapse|0|||
129073813|NCT00460603|464558446|FG002|Phase 2|Objective Progression or Relapse|0|||
129073814|NCT00460603|464558447|FG003|Phase 2|Objective Progression or Relapse|0|||
129073815|NCT00460603|464558448|FG004|Phase 2|Objective Progression or Relapse|0|||
129073816|NCT00460603|464558449|FG005|Phase 2|Objective Progression or Relapse|0|||
129073817|NCT00460603|464558450|FG006|Phase 2|Objective Progression or Relapse|0|||
129073818|NCT00460603|464558451|FG007|Phase 2|Objective Progression or Relapse|0|||
129073819|NCT00460603|464558452|FG008|Phase 2|Objective Progression or Relapse|0|||
129073820|NCT00460603|464558453|FG009|Phase 2|Objective Progression or Relapse|9|||
129073821|NCT00460603|464558454|FG010|Phase 2|Objective Progression or Relapse|10|||
129073822|NCT00460603|464558455|FG011|Phase 2|Objective Progression or Relapse|17|||
129073823|NCT00460603|464558444|FG000|Phase 2|Global Deterioration of Health Status|0|||
129073824|NCT00460603|464558445|FG001|Phase 2|Global Deterioration of Health Status|0|||
129073825|NCT00460603|464558446|FG002|Phase 2|Global Deterioration of Health Status|0|||
129073826|NCT00460603|464558447|FG003|Phase 2|Global Deterioration of Health Status|0|||
129073827|NCT00460603|464558448|FG004|Phase 2|Global Deterioration of Health Status|0|||
129073828|NCT00460603|464558449|FG005|Phase 2|Global Deterioration of Health Status|0|||
129073829|NCT00460603|464558450|FG006|Phase 2|Global Deterioration of Health Status|0|||
129073830|NCT00460603|464558451|FG007|Phase 2|Global Deterioration of Health Status|0|||
129073831|NCT00460603|464558452|FG008|Phase 2|Global Deterioration of Health Status|0|||
129073832|NCT00460603|464558453|FG009|Phase 2|Global Deterioration of Health Status|0|||
129073833|NCT00460603|464558454|FG010|Phase 2|Global Deterioration of Health Status|1|||
129073834|NCT00460603|464558455|FG011|Phase 2|Global Deterioration of Health Status|0|||
129073835|NCT00460603|464558444|FG000|Phase 2|Withdrawal by Subject|0|||
129073836|NCT00460603|464558445|FG001|Phase 2|Withdrawal by Subject|0|||
129073837|NCT00460603|464558446|FG002|Phase 2|Withdrawal by Subject|0|||
129073838|NCT00460603|464558447|FG003|Phase 2|Withdrawal by Subject|0|||
129073839|NCT00460603|464558448|FG004|Phase 2|Withdrawal by Subject|0|||
129140819|NCT05486065|464808823|FG001|Overall Study|Physician Decision|1|||
129140820|NCT05486065|464808824|FG002|Overall Study|Physician Decision|1|||
129140821|NCT05486065|464808825|FG003|Overall Study|Physician Decision|0|||
129140822|NCT05486065|464808822|FG000|Overall Study|Failure to meet randomization criteria|0|||
129140823|NCT05486065|464808823|FG001|Overall Study|Failure to meet randomization criteria|0|||
129140824|NCT05486065|464808824|FG002|Overall Study|Failure to meet randomization criteria|0|||
129140825|NCT05486065|464808825|FG003|Overall Study|Failure to meet randomization criteria|1|||
129140826|NCT03810495|464808830|FG000|Overall Study|Lost to Follow-up|2|||
129140827|NCT03810495|464808830|FG000|Overall Study|Withdrawal by Subject|1|||
129140828|NCT03289741|464808831|FG000|Overall Study|Adverse Event|1|||
129140829|NCT03289741|464808832|FG001|Overall Study|Adverse Event|1|||
129140830|NCT03289741|464808831|FG000|Overall Study|Physician Decision|2|||
129140831|NCT03289741|464808832|FG001|Overall Study|Physician Decision|2|||
129140832|NCT03289741|464808831|FG000|Overall Study|Withdrawal by Subject|1|||
129140833|NCT03289741|464808832|FG001|Overall Study|Withdrawal by Subject|0|||
129140834|NCT02536339|464808834|FG000|Overall Study|Death|20|||
129140835|NCT02536339|464808834|FG000|Overall Study|Withdrawal by Subject|3|||
129140836|NCT02536339|464808834|FG000|Overall Study|Lost to Follow-up|2|||
129140837|NCT02536339|464808834|FG000|Overall Study|Treatment discontinued|2|||
129140838|NCT02536339|464808834|FG000|Overall Study|Physician Decision|1|||
129140839|NCT02037984|464808835|FG000|Overall Study|Lack of Efficacy|0|||
129140840|NCT02037984|464808836|FG001|Overall Study|Lack of Efficacy|0|||
129140841|NCT02037984|464808837|FG002|Overall Study|Lack of Efficacy|3|||
129140842|NCT02037984|464808838|FG003|Overall Study|Lack of Efficacy|10|||
129140843|NCT02037984|464808839|FG004|Overall Study|Lack of Efficacy|2|||
129140844|NCT02037984|464808840|FG005|Overall Study|Lack of Efficacy|2|||
129140845|NCT02037984|464808841|FG006|Overall Study|Lack of Efficacy|4|||
129140846|NCT02037984|464808842|FG007|Overall Study|Lack of Efficacy|3|||
129140847|NCT02037984|464808835|FG000|Overall Study|Lost to Follow-up|1|||
129140848|NCT02037984|464808836|FG001|Overall Study|Lost to Follow-up|0|||
129140849|NCT02037984|464808837|FG002|Overall Study|Lost to Follow-up|3|||
129140850|NCT02037984|464808838|FG003|Overall Study|Lost to Follow-up|5|||
129140851|NCT02037984|464808839|FG004|Overall Study|Lost to Follow-up|2|||
129140852|NCT02037984|464808840|FG005|Overall Study|Lost to Follow-up|2|||
129140853|NCT02037984|464808841|FG006|Overall Study|Lost to Follow-up|2|||
129073840|NCT00460603|464558449|FG005|Phase 2|Withdrawal by Subject|0|||
129073841|NCT00460603|464558450|FG006|Phase 2|Withdrawal by Subject|0|||
129073842|NCT00460603|464558451|FG007|Phase 2|Withdrawal by Subject|0|||
129073843|NCT00460603|464558452|FG008|Phase 2|Withdrawal by Subject|0|||
129073844|NCT00460603|464558453|FG009|Phase 2|Withdrawal by Subject|5|||
129073845|NCT00460603|464558454|FG010|Phase 2|Withdrawal by Subject|4|||
129140854|NCT02037984|464808842|FG007|Overall Study|Lost to Follow-up|4|||
129140855|NCT02037984|464808835|FG000|Overall Study|Physician Decision|0|||
129140856|NCT02037984|464808836|FG001|Overall Study|Physician Decision|0|||
129140857|NCT02037984|464808837|FG002|Overall Study|Physician Decision|0|||
129140858|NCT02037984|464808838|FG003|Overall Study|Physician Decision|0|||
129140859|NCT02037984|464808839|FG004|Overall Study|Physician Decision|0|||
129073846|NCT00460603|464558455|FG011|Phase 2|Withdrawal by Subject|5|||
129073847|NCT00460603|464558444|FG000|Phase 2|Randomized, but not treated|0|||
129073848|NCT00460603|464558445|FG001|Phase 2|Randomized, but not treated|0|||
129073849|NCT00460603|464558446|FG002|Phase 2|Randomized, but not treated|0|||
129073850|NCT00460603|464558447|FG003|Phase 2|Randomized, but not treated|0|||
129073851|NCT00460603|464558448|FG004|Phase 2|Randomized, but not treated|0|||
129073852|NCT00460603|464558449|FG005|Phase 2|Randomized, but not treated|0|||
129073853|NCT00460603|464558450|FG006|Phase 2|Randomized, but not treated|0|||
129073854|NCT00460603|464558451|FG007|Phase 2|Randomized, but not treated|0|||
129073855|NCT00460603|464558452|FG008|Phase 2|Randomized, but not treated|0|||
129073856|NCT00460603|464558453|FG009|Phase 2|Randomized, but not treated|3|||
129073857|NCT00460603|464558454|FG010|Phase 2|Randomized, but not treated|0|||
129073858|NCT00460603|464558455|FG011|Phase 2|Randomized, but not treated|0|||
129073859|NCT00513240|464558457|FG000|Overall Study|Did not have intended surgery|3|||
129073860|NCT00513240|464558458|FG001|Overall Study|Did not have intended surgery|0|||
129073861|NCT00513240|464558457|FG000|Overall Study|Death|3|||
129073862|NCT00513240|464558458|FG001|Overall Study|Death|3|||
129073863|NCT00513240|464558457|FG000|Overall Study|Withdrawal by Subject|7|||
129073864|NCT00513240|464558458|FG001|Overall Study|Withdrawal by Subject|4|||
129073865|NCT05263908|464558459|FG000|Overall Study|No informed consent for publication of study results|397|||
129073866|NCT05263908|464558459|FG000|Overall Study|CRF not collected|1|||
129073867|NCT00289848|464558461|FG000|Overall Study|Adverse Event|6|||
129073868|NCT00289848|464558462|FG001|Overall Study|Adverse Event|4|||
129073869|NCT00289848|464558461|FG000|Overall Study|Death|1|||
129073870|NCT00289848|464558462|FG001|Overall Study|Death|0|||
129073871|NCT00289848|464558461|FG000|Overall Study|Lack of Efficacy|20|||
129073872|NCT00289848|464558462|FG001|Overall Study|Lack of Efficacy|24|||
129073873|NCT00289848|464558461|FG000|Overall Study|Lost to Follow-up|3|||
129073874|NCT00289848|464558462|FG001|Overall Study|Lost to Follow-up|1|||
129073875|NCT00289848|464558461|FG000|Overall Study|Protocol Violation|5|||
129073876|NCT00289848|464558462|FG001|Overall Study|Protocol Violation|2|||
129073877|NCT00289848|464558461|FG000|Overall Study|Withdrawal by Subject|5|||
129073878|NCT00289848|464558462|FG001|Overall Study|Withdrawal by Subject|11|||
129073879|NCT00289848|464558461|FG000|Overall Study|Patient Moved|6|||
129073880|NCT00289848|464558462|FG001|Overall Study|Patient Moved|2|||
129073881|NCT00289848|464558461|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
129073882|NCT00289848|464558462|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
129073883|NCT03871543|464558465|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
129073884|NCT03871543|464558465|FG000|Period 1|Investigator Error|1|||
129073885|NCT03871543|464558465|FG000|Period 1|Protocol Violation|2|||
129073886|NCT03871543|464558465|FG000|Period 1|COVID-19 Related|1|||
129073887|NCT03871543|464558465|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
129073888|NCT03871543|464558465|FG000|Period 1|Withdrawal by Subject|10|||
129073889|NCT03871543|464558465|FG000|Period 2|Adverse Event|1|||
129073890|NCT03871543|464558465|FG000|Period 2|Withdrawal by Subject|1|||
129073891|NCT00395629|464558470|FG000|Core Study|Adverse Event|0|||
129073892|NCT00395629|464558471|FG001|Core Study|Adverse Event|3|||
129073893|NCT00395629|464558472|FG002|Core Study|Adverse Event|4|||
129073894|NCT00395629|464558470|FG000|Core Study|Abnormal laboratory value(s)|0|||
129073895|NCT00395629|464558471|FG001|Core Study|Abnormal laboratory value(s)|0|||
129073896|NCT00395629|464558472|FG002|Core Study|Abnormal laboratory value(s)|1|||
129073897|NCT00395629|464558470|FG000|Core Study|Protocol Violation|1|||
129073898|NCT00395629|464558471|FG001|Core Study|Protocol Violation|0|||
129073899|NCT00395629|464558472|FG002|Core Study|Protocol Violation|0|||
129073900|NCT00395629|464558470|FG000|Core Study|Withdrawal by Subject|0|||
129073901|NCT00395629|464558471|FG001|Core Study|Withdrawal by Subject|1|||
129073902|NCT00395629|464558472|FG002|Core Study|Withdrawal by Subject|1|||
129073903|NCT00395629|464558470|FG000|Core Study|Lost to Follow-up|0|||
129073904|NCT00395629|464558471|FG001|Core Study|Lost to Follow-up|0|||
129073905|NCT00395629|464558472|FG002|Core Study|Lost to Follow-up|1|||
129073906|NCT00395629|464558470|FG000|Extension Study|Adverse Event|0|||
129073907|NCT00395629|464558471|FG001|Extension Study|Adverse Event|0|||
129073908|NCT00395629|464558472|FG002|Extension Study|Adverse Event|2|||
129073909|NCT00395629|464558470|FG000|Extension Study|Administrative problems|0|||
129073910|NCT00395629|464558471|FG001|Extension Study|Administrative problems|0|||
129073911|NCT00395629|464558472|FG002|Extension Study|Administrative problems|1|||
129073912|NCT03534687|464558473|FG000|Overall Study|Lost to Follow-up|7|||
129073913|NCT03534687|464558474|FG001|Overall Study|Lost to Follow-up|2|||
129073914|NCT02301169|464558477|FG000|Overall Study|Adverse Event|1|||
129073915|NCT02301169|464558478|FG001|Overall Study|Adverse Event|0|||
129073916|NCT01198470|464558483|FG000|Overall Study|Adverse Event|2|||
129073917|NCT02949973|464558484|FG000|Overall Study|Physician Decision|1|||
129073918|NCT01422213|464558485|FG000|Overall Study|Adverse Event|8|||
129073919|NCT01422213|464558486|FG001|Overall Study|Adverse Event|7|||
129073920|NCT01422213|464558487|FG002|Overall Study|Adverse Event|11|||
129073921|NCT01422213|464558485|FG000|Overall Study|Lack of Efficacy|10|||
129073922|NCT01422213|464558486|FG001|Overall Study|Lack of Efficacy|2|||
129073923|NCT01422213|464558487|FG002|Overall Study|Lack of Efficacy|2|||
129140860|NCT02037984|464808840|FG005|Overall Study|Physician Decision|0|||
129073924|NCT01422213|464558485|FG000|Overall Study|Non-compliance with study drug|0|||
129073925|NCT01422213|464558486|FG001|Overall Study|Non-compliance with study drug|1|||
129073926|NCT01422213|464558487|FG002|Overall Study|Non-compliance with study drug|0|||
129073927|NCT01422213|464558485|FG000|Overall Study|Protocol Violation|0|||
129073928|NCT01422213|464558486|FG001|Overall Study|Protocol Violation|2|||
129073929|NCT01422213|464558487|FG002|Overall Study|Protocol Violation|4|||
129073930|NCT01422213|464558485|FG000|Overall Study|Withdrawal of Consent|7|||
129073931|NCT01422213|464558486|FG001|Overall Study|Withdrawal of Consent|3|||
129073932|NCT01422213|464558487|FG002|Overall Study|Withdrawal of Consent|5|||
129073933|NCT01422213|464558485|FG000|Overall Study|Lost to Follow-up|3|||
129073934|NCT01422213|464558486|FG001|Overall Study|Lost to Follow-up|3|||
129073935|NCT01422213|464558487|FG002|Overall Study|Lost to Follow-up|5|||
129073936|NCT01422213|464558485|FG000|Overall Study|Administrative or Other Reason(s)|5|||
129073937|NCT01422213|464558486|FG001|Overall Study|Administrative or Other Reason(s)|4|||
129073938|NCT01422213|464558487|FG002|Overall Study|Administrative or Other Reason(s)|2|||
129073939|NCT00765102|464558488|FG000|Overall Study|Progressive disease|18|||
129073940|NCT00765102|464558488|FG000|Overall Study|Adverse Event|6|||
129073941|NCT00765102|464558488|FG000|Overall Study|Physician Decision|4|||
129073942|NCT00765102|464558488|FG000|Overall Study|Withdrawal by Subject|2|||
129073943|NCT00765102|464558488|FG000|Overall Study|Protocol Violation|1|||
129073944|NCT04129125|464558495|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
129073945|NCT04129125|464558495|FG000|Overall Study|Study device was not used|3|||
129073946|NCT04484142|464558496|FG000|Overall Study|Adverse Event|13|||
129073947|NCT04484142|464558496|FG000|Overall Study|Progressive Disease|87|||
129073948|NCT04484142|464558496|FG000|Overall Study|Clinical Progression|10|||
129073949|NCT04484142|464558496|FG000|Overall Study|Withdrawal by Subject|6|||
129073950|NCT04484142|464558496|FG000|Overall Study|Physician Decision|1|||
129073951|NCT03181633|464558499|FG000|Overall Study|Withdrawal by Subject|1|||
129073952|NCT03181633|464558499|FG000|Overall Study|Missing follow-up visit|1|||
129073953|NCT02962648|464558500|FG000|Overall Study|Withdrawal by Subject|3|||
129073954|NCT02962648|464558500|FG000|Overall Study|Lost to Follow-up|3|||
129073955|NCT02962648|464558500|FG000|Overall Study|Physician Decision|1|||
129073956|NCT02962648|464558500|FG000|Overall Study|Subject had problems with transportation|2|||
129073957|NCT01597778|464558501|FG000|Overall Study|Death|7|||
129073958|NCT01597778|464558502|FG001|Overall Study|Death|10|||
129073959|NCT01597778|464558501|FG000|Overall Study|Withdrawal by Subject|3|||
129073960|NCT01597778|464558502|FG001|Overall Study|Withdrawal by Subject|4|||
129073961|NCT01597778|464558501|FG000|Overall Study|Adverse Event|1|||
129073962|NCT01597778|464558502|FG001|Overall Study|Adverse Event|1|||
129073963|NCT01597778|464558501|FG000|Overall Study|Protocol Violation|1|||
129073964|NCT01597778|464558502|FG001|Overall Study|Protocol Violation|11|||
129073965|NCT01597778|464558501|FG000|Overall Study|Transplanted off protocol|2|||
129073966|NCT01597778|464558502|FG001|Overall Study|Transplanted off protocol|3|||
129073967|NCT04383327|464558504|FG000|Overall Study|Lost to Follow-up|112|||
129073968|NCT04383327|464558505|FG001|Overall Study|Lost to Follow-up|14|||
129073969|NCT04383327|464558506|FG002|Overall Study|Lost to Follow-up|78|||
129073970|NCT04383327|464558507|FG003|Overall Study|Lost to Follow-up|13|||
129073971|NCT04383327|464558508|FG004|Overall Study|Lost to Follow-up|110|||
129073972|NCT04383327|464558509|FG005|Overall Study|Lost to Follow-up|13|||
129073973|NCT04383327|464558510|FG006|Overall Study|Lost to Follow-up|74|||
129073974|NCT04383327|464558511|FG007|Overall Study|Lost to Follow-up|13|||
129073975|NCT04383327|464558512|FG008|Overall Study|Lost to Follow-up|78|||
129073976|NCT04383327|464558513|FG009|Overall Study|Lost to Follow-up|10|||
129073977|NCT04383327|464558514|FG010|Overall Study|Lost to Follow-up|160|||
129073978|NCT04383327|464558515|FG011|Overall Study|Lost to Follow-up|13|||
129073979|NCT05303194|464558516|FG000|Overall Study|Lost to Follow-up|1|||
129073980|NCT05303194|464558517|FG001|Overall Study|Lost to Follow-up|1|||
129073981|NCT05303194|464558516|FG000|Overall Study|Withdrawal by Subject|0|||
129073982|NCT05303194|464558517|FG001|Overall Study|Withdrawal by Subject|1|||
129073983|NCT01289678|464558518|FG000|Overall Study|Physician Decision|6|||
129073984|NCT04030299|464558519|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
129073985|NCT04030299|464558519|FG000|Overall Study|Withdrawal by Subject|3|||
129073986|NCT01530464|464558522|FG000|Washout (24h)|Withdrawal by Subject|1|||
129073987|NCT01530464|464558523|FG001|Washout (24h)|Withdrawal by Subject|0|||
129073988|NCT01530464|464558522|FG000|Washout (24h)|Withdrawal by Subject|0|||
129073989|NCT01530464|464558523|FG001|Washout (24h)|Withdrawal by Subject|1|||
129073990|NCT00908544|464558524|FG000|Overall Study|Withdrawal by Subject|2|||
129073991|NCT00908544|464558525|FG001|Overall Study|Withdrawal by Subject|4|||
129073992|NCT00908544|464558524|FG000|Overall Study|Lack of Efficacy|0|||
129073993|NCT00908544|464558525|FG001|Overall Study|Lack of Efficacy|1|||
129073994|NCT00908544|464558524|FG000|Overall Study|Pregnancy|1|||
129073995|NCT00908544|464558525|FG001|Overall Study|Pregnancy|0|||
129073996|NCT00908544|464558524|FG000|Overall Study|Relocation abroad|1|||
129073997|NCT00908544|464558525|FG001|Overall Study|Relocation abroad|1|||
129073998|NCT00908544|464558524|FG000|Overall Study|Unable to visit sutdy center|1|||
129073999|NCT00908544|464558525|FG001|Overall Study|Unable to visit sutdy center|0|||
129074000|NCT03539302|464558531|FG000|Overall Study|Spontaneous cardio version|0|||
129074001|NCT03539302|464558532|FG001|Overall Study|Spontaneous cardio version|0|||
129074002|NCT03539302|464558533|FG002|Overall Study|Spontaneous cardio version|0|||
129074003|NCT03539302|464558534|FG003|Overall Study|Spontaneous cardio version|0|||
129074004|NCT03539302|464558535|FG004|Overall Study|Spontaneous cardio version|0|||
129074005|NCT03539302|464558536|FG005|Overall Study|Spontaneous cardio version|1|||
129074006|NCT03539302|464558537|FG006|Overall Study|Spontaneous cardio version|1|||
129074007|NCT02107131|464558539|FG000|Overall Study|Lost to Follow-up|4|||
129074008|NCT02107131|464558540|FG001|Overall Study|Lost to Follow-up|4|||
129074009|NCT02107131|464558539|FG000|Overall Study|Physician Decision|1|||
129074010|NCT02107131|464558540|FG001|Overall Study|Physician Decision|0|||
129074011|NCT02107131|464558539|FG000|Overall Study|Withdrawal by Subject|2|||
129074012|NCT02107131|464558540|FG001|Overall Study|Withdrawal by Subject|0|||
129074013|NCT02107131|464558539|FG000|Overall Study|mental instability|1|||
129074014|NCT02107131|464558540|FG001|Overall Study|mental instability|0|||
129074015|NCT02107131|464558539|FG000|Overall Study|Death|0|||
129074016|NCT02107131|464558540|FG001|Overall Study|Death|1|||
129074017|NCT02107131|464558539|FG000|Overall Study|Protocol Violation|0|||
129074018|NCT02107131|464558540|FG001|Overall Study|Protocol Violation|4|||
129074019|NCT01609790|464558543|FG000|Overall Study|Protocol Violation|1|||
129074020|NCT01609790|464558544|FG001|Overall Study|Protocol Violation|7|||
129074021|NCT01609790|464558545|FG002|Overall Study|Protocol Violation|8|||
129074022|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Adverse Event|7|||
129074023|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
129074024|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Non-compliance|3|||
129074025|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Other|17|||
129074026|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Physician Decision|2|||
129074027|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Pregnancy|1|||
129074028|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
129074029|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
129074030|NCT05207865|464560218|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
129074031|NCT05207865|464560218|FG000|Follow-up Phase|Lost to Follow-up|1|||
129074032|NCT05207865|464560218|FG000|Follow-up Phase|Non-compliance|1|||
129074033|NCT05207865|464560218|FG000|Follow-up Phase|Not reported|2|||
129074034|NCT05207865|464560218|FG000|Follow-up Phase|Not collected|11|||
129074035|NCT05423093|464560236|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
129074036|NCT05423093|464560236|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
129074037|NCT05423093|464560236|FG000|Attended Intervention Session|Lost to Follow-up|3|||
129074038|NCT05423093|464560236|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
129074039|NCT05423093|464560236|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
129074040|NCT05364931|464560237|FG000|Overall Study|Adverse Event|0|||
129074041|NCT05364931|464560238|FG001|Overall Study|Adverse Event|2|||
129074042|NCT05364931|464560239|FG002|Overall Study|Adverse Event|1|||
129074043|NCT05364931|464560240|FG003|Overall Study|Adverse Event|0|||
129074044|NCT05364931|464560237|FG000|Overall Study|Lost to Follow-up|1|||
129074045|NCT05364931|464560238|FG001|Overall Study|Lost to Follow-up|0|||
129074046|NCT05364931|464560239|FG002|Overall Study|Lost to Follow-up|0|||
129074047|NCT05364931|464560240|FG003|Overall Study|Lost to Follow-up|0|||
129074048|NCT05364931|464560237|FG000|Overall Study|Withdrawal by Subject|1|||
129074049|NCT05364931|464560238|FG001|Overall Study|Withdrawal by Subject|1|||
129074050|NCT05364931|464560239|FG002|Overall Study|Withdrawal by Subject|3|||
129074051|NCT05364931|464560240|FG003|Overall Study|Withdrawal by Subject|2|||
129074052|NCT05364931|464560237|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
129074053|NCT05364931|464560238|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
129074054|NCT05364931|464560239|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
129074055|NCT05364931|464560240|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
129074056|NCT05364931|464560237|FG000|Overall Study|Discontinued|1|||
129074057|NCT05364931|464560238|FG001|Overall Study|Discontinued|0|||
129074058|NCT05364931|464560239|FG002|Overall Study|Discontinued|0|||
129074059|NCT05364931|464560240|FG003|Overall Study|Discontinued|0|||
129074060|NCT03593525|464560241|FG000|Overall Study|Withdrawal by Subject|1|||
129074061|NCT03593525|464560242|FG001|Overall Study|Withdrawal by Subject|0|||
129074062|NCT03593525|464560241|FG000|Overall Study|Lost to Follow-up|7|||
129074063|NCT03593525|464560242|FG001|Overall Study|Lost to Follow-up|5|||
129074064|NCT03103087|464560250|FG000|Overall Study|Did not receive any study drug|1|||
129074065|NCT03103087|464560251|FG001|Overall Study|Did not receive any study drug|0|||
129074066|NCT03103087|464560252|FG002|Overall Study|Did not receive any study drug|0|||
129074067|NCT03103087|464560250|FG000|Overall Study|Protocol Violation|1|||
129074068|NCT03103087|464560251|FG001|Overall Study|Protocol Violation|2|||
129074069|NCT03103087|464560252|FG002|Overall Study|Protocol Violation|1|||
129074070|NCT03103087|464560250|FG000|Overall Study|Lack of Efficacy|2|||
129074071|NCT03103087|464560251|FG001|Overall Study|Lack of Efficacy|1|||
129074072|NCT03103087|464560252|FG002|Overall Study|Lack of Efficacy|1|||
129074073|NCT03103087|464560250|FG000|Overall Study|Pregnancy|0|||
129074074|NCT03103087|464560251|FG001|Overall Study|Pregnancy|0|||
129074075|NCT03103087|464560252|FG002|Overall Study|Pregnancy|1|||
129074076|NCT03103087|464560250|FG000|Overall Study|Adverse Event|2|||
129074077|NCT03103087|464560251|FG001|Overall Study|Adverse Event|15|||
129074078|NCT03103087|464560252|FG002|Overall Study|Adverse Event|6|||
129074079|NCT03103087|464560250|FG000|Overall Study|Withdrawal by Subject|13|||
129074080|NCT03103087|464560251|FG001|Overall Study|Withdrawal by Subject|6|||
129074081|NCT03103087|464560252|FG002|Overall Study|Withdrawal by Subject|6|||
129074082|NCT03103087|464560250|FG000|Overall Study|Lost to Follow-up|4|||
129074083|NCT03103087|464560251|FG001|Overall Study|Lost to Follow-up|2|||
129074084|NCT03103087|464560252|FG002|Overall Study|Lost to Follow-up|7|||
129074085|NCT03103087|464560250|FG000|Overall Study|Other reason not reported|1|||
129074086|NCT03103087|464560251|FG001|Overall Study|Other reason not reported|3|||
129074087|NCT03103087|464560252|FG002|Overall Study|Other reason not reported|5|||
129074088|NCT03504397|464560253|FG000|Overall Study|Progressive Disease|151|||
129074089|NCT03504397|464560254|FG001|Overall Study|Progressive Disease|199|||
129074090|NCT03504397|464560253|FG000|Overall Study|Withdrawal by Subject|29|||
129074091|NCT03504397|464560254|FG001|Overall Study|Withdrawal by Subject|17|||
129074092|NCT03504397|464560253|FG000|Overall Study|Lost to Follow-up|1|||
129074093|NCT03504397|464560254|FG001|Overall Study|Lost to Follow-up|0|||
129074094|NCT03504397|464560253|FG000|Overall Study|Death|14|||
129074095|NCT03504397|464560254|FG001|Overall Study|Death|16|||
129074096|NCT03504397|464560253|FG000|Overall Study|Adverse Event|40|||
129074097|NCT03504397|464560254|FG001|Overall Study|Adverse Event|14|||
129074098|NCT03504397|464560253|FG000|Overall Study|miscellaneous|17|||
129074099|NCT03504397|464560254|FG001|Overall Study|miscellaneous|15|||
129074100|NCT03504397|464560253|FG000|Overall Study|Protocol deviation|1|||
129074101|NCT03504397|464560254|FG001|Overall Study|Protocol deviation|0|||
129074102|NCT03504397|464560253|FG000|Overall Study|Participants who did not take the study drug|4|||
129074103|NCT03504397|464560254|FG001|Overall Study|Participants who did not take the study drug|4|||
129074104|NCT00413699|464560255|FG000|Initial Period|Death|25|||
129074105|NCT00413699|464560256|FG001|Initial Period|Death|30|||
129074106|NCT00413699|464560257|FG002|Initial Period|Death|0|||
129074107|NCT00413699|464560255|FG000|Initial Period|Lack of Efficacy|59|||
129074108|NCT00413699|464560256|FG001|Initial Period|Lack of Efficacy|115|||
129074109|NCT00413699|464560257|FG002|Initial Period|Lack of Efficacy|0|||
129074110|NCT00413699|464560255|FG000|Initial Period|Lost to Follow-up|31|||
129074111|NCT00413699|464560256|FG001|Initial Period|Lost to Follow-up|101|||
129074112|NCT00413699|464560257|FG002|Initial Period|Lost to Follow-up|0|||
129074113|NCT00413699|464560255|FG000|Initial Period|Protocol Violation|38|||
129074114|NCT00413699|464560256|FG001|Initial Period|Protocol Violation|89|||
129074115|NCT00413699|464560257|FG002|Initial Period|Protocol Violation|0|||
129074116|NCT00413699|464560255|FG000|Initial Period|Pregnancy|10|||
129074117|NCT00413699|464560256|FG001|Initial Period|Pregnancy|8|||
129074118|NCT00413699|464560257|FG002|Initial Period|Pregnancy|0|||
129074119|NCT00413699|464560255|FG000|Initial Period|Did not meet entrance criteria|2|||
129074120|NCT00413699|464560256|FG001|Initial Period|Did not meet entrance criteria|2|||
129074121|NCT00413699|464560257|FG002|Initial Period|Did not meet entrance criteria|0|||
129074122|NCT00413699|464560255|FG000|Initial Period|Medication error without adverse event|0|||
129074123|NCT00413699|464560256|FG001|Initial Period|Medication error without adverse event|1|||
129074124|NCT00413699|464560257|FG002|Initial Period|Medication error without adverse event|0|||
129074125|NCT00413699|464560255|FG000|Initial Period|Study terminated by Sponsor|0|||
129074126|NCT00413699|464560256|FG001|Initial Period|Study terminated by Sponsor|1|||
129074127|NCT00413699|464560257|FG002|Initial Period|Study terminated by Sponsor|0|||
129074128|NCT00413699|464560255|FG000|Initial Period|Other|67|||
129074129|NCT00413699|464560256|FG001|Initial Period|Other|211|||
129074130|NCT00413699|464560257|FG002|Initial Period|Other|0|||
129074131|NCT00413699|464560255|FG000|Initial Period|Adverse event related to study drug|178|||
129074132|NCT00413699|464560256|FG001|Initial Period|Adverse event related to study drug|527|||
129074133|NCT00413699|464560257|FG002|Initial Period|Adverse event related to study drug|0|||
129074134|NCT00413699|464560255|FG000|Initial Period|Adverse event not related to study drug|113|||
129074135|NCT00413699|464560256|FG001|Initial Period|Adverse event not related to study drug|248|||
129074136|NCT00413699|464560257|FG002|Initial Period|Adverse event not related to study drug|0|||
129074137|NCT00413699|464560255|FG000|Initial Period|Missing end of study page|0|||
129074138|NCT00413699|464560256|FG001|Initial Period|Missing end of study page|4|||
129074139|NCT00413699|464560257|FG002|Initial Period|Missing end of study page|0|||
129074140|NCT00413699|464560255|FG000|Initial Period|No longer willing to participate|116|||
129074141|NCT00413699|464560256|FG001|Initial Period|No longer willing to participate|368|||
129074142|NCT00413699|464560257|FG002|Initial Period|No longer willing to participate|0|||
129074143|NCT00413699|464560255|FG000|Extension Period|No Longer Willing to Participate|0|||
129074144|NCT00413699|464560256|FG001|Extension Period|No Longer Willing to Participate|0|||
129074145|NCT00413699|464560257|FG002|Extension Period|No Longer Willing to Participate|2|||
129074146|NCT00413699|464560255|FG000|Extension Period|Protocol Violation|0|||
129074147|NCT00413699|464560256|FG001|Extension Period|Protocol Violation|0|||
129074148|NCT00413699|464560257|FG002|Extension Period|Protocol Violation|1|||
129074149|NCT00413699|464560255|FG000|Extension Period|Adverse Event|0|||
129074150|NCT00413699|464560256|FG001|Extension Period|Adverse Event|0|||
129074151|NCT00413699|464560257|FG002|Extension Period|Adverse Event|2|||
129074152|NCT00075816|464560258|FG000|Overall Study|Did not undergo transplantation|14|||
129074153|NCT00075816|464560259|FG001|Overall Study|Did not undergo transplantation|11|||
129074154|NCT04231825|464560260|FG000|Overall Study|Protocol Violation|3|||
129074155|NCT04231825|464560261|FG001|Overall Study|Protocol Violation|3|||
129074156|NCT04231825|464560260|FG000|Overall Study|Lost to Follow-up|0|||
129074157|NCT04231825|464560261|FG001|Overall Study|Lost to Follow-up|1|||
129074158|NCT01662635|464560262|FG000|Overall Study|scarce samples for evaluation|30|||
129074159|NCT02445248|464560263|FG000|Overall Study|Death|45|||
129074160|NCT02445248|464560264|FG001|Overall Study|Death|12|||
129074161|NCT02445248|464560263|FG000|Overall Study|Progressive disease|13|||
129074162|NCT02445248|464560264|FG001|Overall Study|Progressive disease|1|||
129074163|NCT02445248|464560263|FG000|Overall Study|Subject decision|8|||
129074164|NCT02445248|464560264|FG001|Overall Study|Subject decision|0|||
129074165|NCT02445248|464560263|FG000|Overall Study|Physician Decision|5|||
129074166|NCT02445248|464560264|FG001|Overall Study|Physician Decision|0|||
129074167|NCT02445248|464560263|FG000|Overall Study|Adverse Event|1|||
129074168|NCT02445248|464560264|FG001|Overall Study|Adverse Event|0|||
129074169|NCT02445248|464560263|FG000|Overall Study|Lost to Follow-up|1|||
129074170|NCT02445248|464560264|FG001|Overall Study|Lost to Follow-up|0|||
129074171|NCT02596971|464560267|FG000|Overall Study|Death|5|||
129074172|NCT02596971|464560268|FG001|Overall Study|Death|1|||
129074173|NCT02596971|464560269|FG002|Overall Study|Death|5|||
129074174|NCT02596971|464560267|FG000|Overall Study|Withdrawal by Subject|5|||
129074175|NCT02596971|464560268|FG001|Overall Study|Withdrawal by Subject|1|||
129074176|NCT02596971|464560269|FG002|Overall Study|Withdrawal by Subject|4|||
129074177|NCT00595920|464560270|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
129074178|NCT00351468|464560271|FG000|Overall Study|Adverse Event|42|||
129074179|NCT00351468|464560271|FG000|Overall Study|Withdrawal by Subject|39|||
129074180|NCT00351468|464560271|FG000|Overall Study|Various -follow up w clinical team|39|||
129074181|NCT00351468|464560271|FG000|Overall Study|Lack of Efficacy|32|||
129074182|NCT00351468|464560271|FG000|Overall Study|Non-compliance|8|||
129074183|NCT00351468|464560271|FG000|Overall Study|Lost to Follow-up|4|||
129074184|NCT00351468|464560271|FG000|Overall Study|Protocol Violation|3|||
129074185|NCT03588910|464560272|FG000|Overall Study|Withdrawal by Subject|1|||
129074186|NCT03588910|464560273|FG001|Overall Study|Withdrawal by Subject|0|||
129074187|NCT03588910|464560272|FG000|Overall Study|Allergy|2|||
129140861|NCT02037984|464808841|FG006|Overall Study|Physician Decision|1|||
129140862|NCT02037984|464808842|FG007|Overall Study|Physician Decision|0|||
129140863|NCT02037984|464808835|FG000|Overall Study|Protocol Violation|0|||
129140864|NCT02037984|464808836|FG001|Overall Study|Protocol Violation|0|||
129140865|NCT02037984|464808837|FG002|Overall Study|Protocol Violation|0|||
129074188|NCT03588910|464560273|FG001|Overall Study|Allergy|0|||
129140866|NCT02037984|464808838|FG003|Overall Study|Protocol Violation|0|||
129140867|NCT02037984|464808839|FG004|Overall Study|Protocol Violation|0|||
129140868|NCT02037984|464808840|FG005|Overall Study|Protocol Violation|1|||
129074189|NCT03588910|464560272|FG000|Overall Study|Protocol Violation|0|||
129074190|NCT03588910|464560273|FG001|Overall Study|Protocol Violation|3|||
129074191|NCT03588910|464560272|FG000|Overall Study|Did not complete Day 1 Survey|5|||
129074192|NCT03588910|464560273|FG001|Overall Study|Did not complete Day 1 Survey|10|||
129074193|NCT03588910|464560272|FG000|Overall Study|Did not complete Day 7 Survey|5|||
129074194|NCT03588910|464560273|FG001|Overall Study|Did not complete Day 7 Survey|2|||
129074195|NCT00611923|464560274|FG000|Overall Study|Withdrawal by Subject|2|||
129074196|NCT00611923|464560275|FG001|Overall Study|Withdrawal by Subject|2|||
129074197|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
129140869|NCT02037984|464808841|FG006|Overall Study|Protocol Violation|2|||
129140870|NCT02037984|464808842|FG007|Overall Study|Protocol Violation|0|||
129140871|NCT02037984|464808835|FG000|Overall Study|Technical Problems|0|||
129140872|NCT02037984|464808836|FG001|Overall Study|Technical Problems|0|||
129140873|NCT02037984|464808837|FG002|Overall Study|Technical Problems|3|||
129074198|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
129074199|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
129074200|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
129140874|NCT02037984|464808838|FG003|Overall Study|Technical Problems|3|||
129074201|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
129074202|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
129074203|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
129074204|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
129074205|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
129074206|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
129074207|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
129074208|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
129074209|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
129074210|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
129074211|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
129074212|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
129074213|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
129074214|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
129074215|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
129074216|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
129074217|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
129074218|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
129074219|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
129074220|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
129074221|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
129074222|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
129074223|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
129074224|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
129074225|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
129074226|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
129074227|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
129074228|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
129074229|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
129074230|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
129074231|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
129074232|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
129074233|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
129074234|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
129074235|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
129074236|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
129074237|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
129074238|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
129074239|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
129074240|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
129074241|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
129074242|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
129074243|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
129074244|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
129074245|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
129074246|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
129074247|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
129074248|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
129074249|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Site closed|0|||
129074250|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Site closed|0|||
129074251|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Site closed|1|||
129074252|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Site closed|0|||
129074253|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
129074254|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
129074255|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
129074256|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
129074257|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
129074258|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
129074259|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
129074260|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
129074261|NCT00838903|464560276|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
129074262|NCT00838903|464560277|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
129074263|NCT00838903|464560278|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
129074264|NCT00838903|464560279|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
129074265|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
129074266|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
129074267|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
129074268|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
129074269|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
129074270|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
129074271|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
129074272|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
129074273|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
129074274|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
129074275|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
129074276|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
129074277|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
129074278|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
129074279|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
129074280|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
129074281|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
129074282|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
129074283|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
129074284|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
129074285|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
129074286|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
129074287|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
129074288|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
129074289|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
129074290|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
129074291|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
129074292|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
129074293|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
129074294|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
129074295|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
129074296|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
129074297|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
129074298|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
129074299|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
129074300|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
129074301|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
129074302|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
129074303|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
129074304|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
129074305|NCT00838903|464560276|FG000|Follow-up Period (8 Weeks)|Missing|1|||
129074306|NCT00838903|464560277|FG001|Follow-up Period (8 Weeks)|Missing|2|||
129074307|NCT00838903|464560278|FG002|Follow-up Period (8 Weeks)|Missing|1|||
129074308|NCT00838903|464560279|FG003|Follow-up Period (8 Weeks)|Missing|1|||
129074309|NCT04565145|464560280|FG000|Overall Study|Withdrawal by Subject|1|||
129074310|NCT04565145|464560281|FG001|Overall Study|Withdrawal by Subject|1|||
129074311|NCT00683618|464560282|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
129074312|NCT00683618|464560283|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
129074313|NCT00683618|464560284|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
129074314|NCT00683618|464560282|FG000|Randomised Treatment Period|Protocol Violation|0|||
129074315|NCT00683618|464560283|FG001|Randomised Treatment Period|Protocol Violation|1|||
129074316|NCT00683618|464560284|FG002|Randomised Treatment Period|Protocol Violation|0|||
129074317|NCT00683618|464560282|FG000|Randomised Treatment Period|Adverse Event|2|||
129074318|NCT00683618|464560283|FG001|Randomised Treatment Period|Adverse Event|0|||
129074319|NCT00683618|464560284|FG002|Randomised Treatment Period|Adverse Event|2|||
129074320|NCT00683618|464560282|FG000|Randomised Treatment Period|Reason not provided|0|||
129074321|NCT00683618|464560283|FG001|Randomised Treatment Period|Reason not provided|0|||
129074322|NCT00683618|464560284|FG002|Randomised Treatment Period|Reason not provided|2|||
129074323|NCT00683618|464560282|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
129074324|NCT00683618|464560283|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129074325|NCT00683618|464560284|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129074326|NCT00683618|464560282|FG000|Extension Treatment Period|Adverse Event|1|||
129074327|NCT00683618|464560283|FG001|Extension Treatment Period|Adverse Event|0|||
129074328|NCT00683618|464560284|FG002|Extension Treatment Period|Adverse Event|0|||
129074329|NCT00683618|464560282|FG000|Extension Treatment Period|Protocol Violation|1|||
129074330|NCT00683618|464560283|FG001|Extension Treatment Period|Protocol Violation|0|||
129074331|NCT00683618|464560284|FG002|Extension Treatment Period|Protocol Violation|0|||
129074332|NCT04570670|464560285|FG000|Overall Study|Withdrawal by Subject|1|||
129074333|NCT04570670|464560286|FG001|Overall Study|Withdrawal by Subject|0|||
129074334|NCT02549859|464560287|FG000|Long-term 60 Hz DBS|Study Closed|1|||
129140875|NCT02037984|464808839|FG004|Overall Study|Technical Problems|2|||
129140876|NCT02037984|464808840|FG005|Overall Study|Technical Problems|3|||
129140877|NCT02037984|464808841|FG006|Overall Study|Technical Problems|4|||
129140878|NCT02037984|464808842|FG007|Overall Study|Technical Problems|2|||
129074335|NCT03003962|464560296|FG000|Overall Study|Withdrawal by Subject|5|||
129074336|NCT03003962|464560297|FG001|Overall Study|Withdrawal by Subject|17|||
129074337|NCT03003962|464560296|FG000|Overall Study|Death|274|||
129074338|NCT03003962|464560297|FG001|Overall Study|Death|277|||
129074339|NCT03003962|464560296|FG000|Overall Study|Participants ongoing at DCO|55|||
129074340|NCT03003962|464560297|FG001|Overall Study|Participants ongoing at DCO|40|||
129074341|NCT03802825|464560298|FG000|Overall Study|Lost to follow-up for intervention|12|||
129074342|NCT03802825|464560299|FG001|Overall Study|Lost to follow-up for intervention|3|||
129074343|NCT03802825|464560298|FG000|Overall Study|Received only 1 component of intervention|0|||
129074344|NCT03802825|464560299|FG001|Overall Study|Received only 1 component of intervention|13|||
129074345|NCT03428152|464560300|FG000|Overall Study|Physician Decision|4|||
129074346|NCT03428152|464560301|FG001|Overall Study|Physician Decision|2|||
129074347|NCT03428152|464560300|FG000|Overall Study|Protocol Violation|3|||
129074348|NCT03428152|464560301|FG001|Overall Study|Protocol Violation|5|||
129074349|NCT03428152|464560300|FG000|Overall Study|Lack of Efficacy|0|||
129074350|NCT03428152|464560301|FG001|Overall Study|Lack of Efficacy|4|||
129074351|NCT02570308|464560302|FG000|Overall Study|Death|1|||
129074352|NCT02570308|464560303|FG001|Overall Study|Death|5|||
129074353|NCT02570308|464560304|FG002|Overall Study|Death|4|||
129074354|NCT02570308|464560305|FG003|Overall Study|Death|4|||
129074355|NCT02570308|464560306|FG004|Overall Study|Death|69|||
129074356|NCT02570308|464560302|FG000|Overall Study|Lost to Follow-up|0|||
129074357|NCT02570308|464560303|FG001|Overall Study|Lost to Follow-up|0|||
129074358|NCT02570308|464560304|FG002|Overall Study|Lost to Follow-up|0|||
129074359|NCT02570308|464560305|FG003|Overall Study|Lost to Follow-up|0|||
129074360|NCT02570308|464560306|FG004|Overall Study|Lost to Follow-up|2|||
129074361|NCT02570308|464560302|FG000|Overall Study|Withdrawal by Subject|0|||
129074362|NCT02570308|464560303|FG001|Overall Study|Withdrawal by Subject|0|||
129074363|NCT02570308|464560304|FG002|Overall Study|Withdrawal by Subject|0|||
129074364|NCT02570308|464560305|FG003|Overall Study|Withdrawal by Subject|0|||
129074365|NCT02570308|464560306|FG004|Overall Study|Withdrawal by Subject|1|||
129074366|NCT02570308|464560302|FG000|Overall Study|Other|0|||
129074367|NCT02570308|464560303|FG001|Overall Study|Other|0|||
129074368|NCT02570308|464560304|FG002|Overall Study|Other|0|||
129074369|NCT02570308|464560305|FG003|Overall Study|Other|0|||
129074370|NCT02570308|464560306|FG004|Overall Study|Other|2|||
129074371|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
129074372|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
129074373|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
129074374|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074375|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074376|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074377|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074378|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129074379|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129140879|NCT02037984|464808835|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129140880|NCT02037984|464808836|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129074380|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
129074381|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129074382|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129074383|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129074384|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129074385|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
129074386|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074387|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
129140881|NCT02037984|464808837|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
129140882|NCT02037984|464808838|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
129074388|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074389|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074390|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074391|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074392|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
129074393|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074394|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
128776557|NCT02846558|463470465|FG002|Overall Study|Adverse Event|0|||
129074395|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074396|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074397|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129140883|NCT02037984|464808839|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
129074398|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074399|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
129074400|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
129074401|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
129074402|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074403|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074404|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074405|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074406|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129074407|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129074408|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
129074409|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129074410|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129074411|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129074412|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129074413|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129074414|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129074415|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
129074416|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129074417|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129074418|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129074419|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129074420|NCT04242498|464560307|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074421|NCT04242498|464560308|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
129074422|NCT04242498|464560309|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
129074423|NCT04242498|464560310|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074424|NCT04242498|464560311|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074425|NCT04242498|464560312|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074426|NCT04242498|464560313|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074427|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129074428|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129074429|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129074430|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129074431|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
129074432|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
129074433|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
129074434|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129074435|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129074436|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129074437|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129074438|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
129074439|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
129074440|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
129074441|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074442|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074443|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074444|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074445|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074446|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
129074447|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
129074448|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129074449|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129074450|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129074451|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
129074452|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
129074453|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
129074454|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
129074455|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129074456|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129074457|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129074458|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
129074459|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
129074460|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
129074461|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
129074462|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129074463|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129074464|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129074465|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129074466|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
129074467|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129074468|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129074469|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129074470|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129074471|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129074472|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129074473|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129074474|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
129074475|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129074476|NCT04242498|464560307|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129074477|NCT04242498|464560308|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129074478|NCT04242498|464560309|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129074479|NCT04242498|464560310|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129074480|NCT04242498|464560311|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129074481|NCT04242498|464560312|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
129074482|NCT04242498|464560313|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
129074483|NCT00468819|464560314|FG000|Overall Study|Withdrawal by Subject|4|||
129074484|NCT00468819|464560315|FG001|Overall Study|Withdrawal by Subject|0|||
129074485|NCT00468819|464560316|FG002|Overall Study|Withdrawal by Subject|1|||
129074486|NCT00468819|464560314|FG000|Overall Study|Lost to Follow-up|0|||
129074487|NCT00468819|464560315|FG001|Overall Study|Lost to Follow-up|0|||
129074488|NCT00468819|464560316|FG002|Overall Study|Lost to Follow-up|1|||
129074489|NCT00468819|464560314|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
129074490|NCT00468819|464560315|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
129074491|NCT00468819|464560316|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
129074492|NCT04616612|464560319|FG000|Overall Study|Lost to Follow-up|6|||
129074493|NCT04616612|464560320|FG001|Overall Study|Lost to Follow-up|3|||
129074494|NCT04740918|464560321|FG000|Overall Study|Study Terminated by Sponsor|41|||
129074495|NCT04740918|464560322|FG001|Overall Study|Study Terminated by Sponsor|32|||
129074496|NCT04740918|464560321|FG000|Overall Study|Death|3|||
129074497|NCT04740918|464560322|FG001|Overall Study|Death|6|||
129074498|NCT04740918|464560321|FG000|Overall Study|Withdrawal by Subject|5|||
129074499|NCT04740918|464560322|FG001|Overall Study|Withdrawal by Subject|4|||
129074500|NCT04740918|464560321|FG000|Overall Study|Lost to Follow-up|1|||
129074501|NCT04740918|464560322|FG001|Overall Study|Lost to Follow-up|3|||
129074502|NCT04740918|464560321|FG000|Overall Study|Progressive disease|0|||
129074503|NCT04740918|464560322|FG001|Overall Study|Progressive disease|1|||
129140884|NCT02037984|464808840|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
129140885|NCT02037984|464808841|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
129074504|NCT02524847|464560323|FG000|Overall Study|Adverse Event|4|||
129074505|NCT02524847|464560323|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
129074506|NCT02524847|464560323|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
129074507|NCT02524847|464560323|FG000|Overall Study|Death|1|||
129074508|NCT02524847|464560323|FG000|Overall Study|Reason not Specified|1|||
129074509|NCT04352101|464560324|FG000|Overall Study|Physician Decision|2|||
129074510|NCT04352101|464560325|FG001|Overall Study|Physician Decision|1|||
129074511|NCT01288079|464560331|FG000|Overall Study|Withdrawal by Subject|2|||
129074512|NCT01288079|464560332|FG001|Overall Study|Withdrawal by Subject|4|||
129140886|NCT02037984|464808842|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
129140887|NCT02037984|464808835|FG000|Overall Study|Withdrawal by Subject|0|||
129140888|NCT02037984|464808836|FG001|Overall Study|Withdrawal by Subject|0|||
129140889|NCT02037984|464808837|FG002|Overall Study|Withdrawal by Subject|0|||
129074513|NCT01288079|464560333|FG002|Overall Study|Withdrawal by Subject|1|||
129140890|NCT02037984|464808838|FG003|Overall Study|Withdrawal by Subject|1|||
129140891|NCT02037984|464808839|FG004|Overall Study|Withdrawal by Subject|1|||
129074514|NCT01288079|464560334|FG003|Overall Study|Withdrawal by Subject|0|||
129074515|NCT01288079|464560331|FG000|Overall Study|Adverse Event|2|||
129074516|NCT01288079|464560332|FG001|Overall Study|Adverse Event|1|||
129074517|NCT01288079|464560333|FG002|Overall Study|Adverse Event|2|||
129074518|NCT01288079|464560334|FG003|Overall Study|Adverse Event|3|||
129074519|NCT01288079|464560331|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
129074520|NCT01288079|464560332|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
129074521|NCT01288079|464560333|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
129074522|NCT01288079|464560334|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
129074523|NCT01288079|464560331|FG000|Overall Study|Condition under Investigation Worsened|0|||
129074524|NCT01288079|464560332|FG001|Overall Study|Condition under Investigation Worsened|0|||
129074525|NCT01288079|464560333|FG002|Overall Study|Condition under Investigation Worsened|0|||
129074526|NCT01288079|464560334|FG003|Overall Study|Condition under Investigation Worsened|1|||
129074527|NCT01288079|464560331|FG000|Overall Study|Lack of Efficacy|2|||
129074528|NCT01288079|464560332|FG001|Overall Study|Lack of Efficacy|2|||
129074529|NCT01288079|464560333|FG002|Overall Study|Lack of Efficacy|0|||
129074530|NCT01288079|464560334|FG003|Overall Study|Lack of Efficacy|2|||
129074531|NCT01288079|464560331|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
129074532|NCT01288079|464560332|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129074533|NCT01288079|464560333|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
129074534|NCT01288079|464560334|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
129074535|NCT01288079|464560331|FG000|Overall Study|Lost to Follow-up|1|||
129074536|NCT01288079|464560332|FG001|Overall Study|Lost to Follow-up|1|||
129074537|NCT01288079|464560333|FG002|Overall Study|Lost to Follow-up|1|||
129074538|NCT01288079|464560334|FG003|Overall Study|Lost to Follow-up|0|||
129074539|NCT01288079|464560331|FG000|Overall Study|Other or Study Termination|11|||
129074540|NCT01288079|464560332|FG001|Overall Study|Other or Study Termination|15|||
129074541|NCT01288079|464560333|FG002|Overall Study|Other or Study Termination|14|||
129074542|NCT01288079|464560334|FG003|Overall Study|Other or Study Termination|8|||
129074543|NCT02387840|464560335|FG000|Overall Study|Death|0|||
129074544|NCT02387840|464560336|FG001|Overall Study|Death|0|||
129074545|NCT02387840|464560337|FG002|Overall Study|Death|0|||
129074546|NCT02387840|464560338|FG003|Overall Study|Death|0|||
129074547|NCT02387840|464560339|FG004|Overall Study|Death|0|||
129074548|NCT02387840|464560340|FG005|Overall Study|Death|1|||
129074549|NCT03170544|464560341|FG000|Part 1|Lost to Follow-up|1|||
129074550|NCT03170544|464560342|FG001|Part 1|Lost to Follow-up|0|||
129074551|NCT03170544|464560343|FG002|Part 1|Lost to Follow-up|0|||
129074552|NCT03170544|464560344|FG003|Part 1|Lost to Follow-up|0|||
129074553|NCT03170544|464560345|FG004|Part 1|Lost to Follow-up|0|||
129074554|NCT03170544|464560346|FG005|Part 1|Lost to Follow-up|0|||
129074555|NCT03170544|464560347|FG006|Part 1|Lost to Follow-up|0|||
129074556|NCT03170544|464560348|FG007|Part 1|Lost to Follow-up|0|||
129074557|NCT03170544|464560349|FG008|Part 1|Lost to Follow-up|0|||
129074558|NCT03170544|464560350|FG009|Part 1|Lost to Follow-up|0|||
129074559|NCT03170544|464560351|FG010|Part 1|Lost to Follow-up|0|||
129074560|NCT03170544|464560352|FG011|Part 1|Lost to Follow-up|0|||
129074561|NCT03170544|464560341|FG000|Part 1|Not treated|0|||
129074562|NCT03170544|464560342|FG001|Part 1|Not treated|0|||
129074563|NCT03170544|464560343|FG002|Part 1|Not treated|0|||
129074564|NCT03170544|464560344|FG003|Part 1|Not treated|1|||
129074565|NCT03170544|464560345|FG004|Part 1|Not treated|0|||
129074566|NCT03170544|464560346|FG005|Part 1|Not treated|0|||
129140892|NCT02037984|464808840|FG005|Overall Study|Withdrawal by Subject|3|||
129140893|NCT02037984|464808841|FG006|Overall Study|Withdrawal by Subject|0|||
129140894|NCT02037984|464808842|FG007|Overall Study|Withdrawal by Subject|1|||
129140895|NCT02730169|464810685|FG000|Overall Study|Protocol Violation|1|||
129140896|NCT02730169|464810686|FG001|Overall Study|Protocol Violation|0|||
129140897|NCT02730169|464810687|FG002|Overall Study|Protocol Violation|0|||
129140898|NCT02730169|464810688|FG003|Overall Study|Protocol Violation|1|||
129140899|NCT02730169|464810685|FG000|Overall Study|Adverse Event|2|||
129074567|NCT03170544|464560347|FG006|Part 1|Not treated|0|||
129074568|NCT03170544|464560348|FG007|Part 1|Not treated|0|||
129074569|NCT03170544|464560349|FG008|Part 1|Not treated|0|||
129074570|NCT03170544|464560350|FG009|Part 1|Not treated|0|||
129074571|NCT03170544|464560351|FG010|Part 1|Not treated|0|||
129074572|NCT03170544|464560352|FG011|Part 1|Not treated|0|||
129074573|NCT02174627|464560355|FG000|Overall Study|Missing|0|||
129074574|NCT02174627|464560356|FG001|Overall Study|Missing|1|||
129074575|NCT02174627|464560355|FG000|Overall Study|Incorrect enrolment before randomization|0|||
129074576|NCT02174627|464560356|FG001|Overall Study|Incorrect enrolment before randomization|1|||
129074577|NCT02174627|464560355|FG000|Overall Study|Participant decision|84|||
129140900|NCT02730169|464810686|FG001|Overall Study|Adverse Event|3|||
129140901|NCT02730169|464810687|FG002|Overall Study|Adverse Event|3|||
129140902|NCT02730169|464810688|FG003|Overall Study|Adverse Event|0|||
129140903|NCT02730169|464810685|FG000|Overall Study|Adverse Event of Special Interest|0|||
129140904|NCT02730169|464810686|FG001|Overall Study|Adverse Event of Special Interest|1|||
129140905|NCT02730169|464810687|FG002|Overall Study|Adverse Event of Special Interest|2|||
129140906|NCT02730169|464810688|FG003|Overall Study|Adverse Event of Special Interest|0|||
129074578|NCT02174627|464560356|FG001|Overall Study|Participant decision|128|||
129074579|NCT04564092|464560357|FG000|Overall Study|Withdrawal by Subject|1|||
129074580|NCT00071110|464560358|FG000|Overall Study|Protocol Violation|0|||
129074581|NCT00071110|464560359|FG001|Overall Study|Protocol Violation|4|||
129074582|NCT02259010|464560365|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
129074583|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
129074584|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
129074585|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
129074586|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074587|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074588|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074589|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129074590|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074591|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
129074592|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
129074593|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074594|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074595|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074596|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129074597|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
129074598|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
129074599|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
129074600|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074601|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074602|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074603|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129074604|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
129074605|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
129074606|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
129074607|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074608|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074609|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074610|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129074611|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
129074612|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129074613|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129074614|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129074615|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129074616|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129074617|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129074618|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129074619|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129074620|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
129074621|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129074622|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129074623|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129074624|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129074625|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129074626|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129074627|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
129074628|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129074629|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129074630|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129074631|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129074632|NCT04242446|464561687|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074633|NCT04242446|464561688|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
129074634|NCT04242446|464561689|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
129140907|NCT02730169|464810685|FG000|Overall Study|Withdrawal by Subject|6|||
129140908|NCT02730169|464810686|FG001|Overall Study|Withdrawal by Subject|11|||
129140909|NCT02730169|464810687|FG002|Overall Study|Withdrawal by Subject|6|||
129140910|NCT02730169|464810688|FG003|Overall Study|Withdrawal by Subject|8|||
129140911|NCT02730169|464810685|FG000|Overall Study|Lost to Follow-up|5|||
129140912|NCT02730169|464810686|FG001|Overall Study|Lost to Follow-up|6|||
129074635|NCT04242446|464561690|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074636|NCT04242446|464561691|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074637|NCT04242446|464561692|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074638|NCT04242446|464561693|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129074639|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129074640|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129074641|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129074642|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
129074643|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
129074644|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
129074645|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
129074646|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129074647|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129074648|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129074649|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
129074650|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
129074651|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
129074652|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
129074653|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074654|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074655|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129074656|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
129074657|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
129074658|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
129074659|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
129074660|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129074661|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129074662|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129074663|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
129074664|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
129074665|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
129074666|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
129074667|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129074668|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129074669|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129140913|NCT02730169|464810687|FG002|Overall Study|Lost to Follow-up|5|||
129140914|NCT02730169|464810688|FG003|Overall Study|Lost to Follow-up|6|||
129140915|NCT02730169|464810685|FG000|Overall Study|Other|0|||
129140916|NCT02730169|464810686|FG001|Overall Study|Other|0|||
129140917|NCT02730169|464810687|FG002|Overall Study|Other|1|||
129140918|NCT02730169|464810688|FG003|Overall Study|Other|1|||
129140919|NCT02144337|464810689|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
129140920|NCT02144337|464810690|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
129140921|NCT02144337|464810689|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
129140922|NCT02144337|464810690|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
129140923|NCT02144337|464810689|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
129140924|NCT02144337|464810690|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
129140925|NCT02144337|464810689|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
129140926|NCT02144337|464810690|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
129140927|NCT02144337|464810689|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
129140928|NCT02144337|464810690|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
129140929|NCT01730729|464810693|FG000|Overall Study|Adverse Event|1|||
129140930|NCT01730729|464810693|FG000|Overall Study|Death|1|||
129140931|NCT01730729|464810693|FG000|Overall Study|Progressive Disease|12|||
129140932|NCT01661595|464810694|FG000|Phase 1: Week 0-4|Adverse Event|1|||
129140933|NCT01661595|464810695|FG001|Phase 1: Week 0-4|Adverse Event|0|||
129140934|NCT01661595|464810696|FG002|Phase 1: Week 0-4|Adverse Event|0|||
129140935|NCT01661595|464810697|FG003|Phase 1: Week 0-4|Adverse Event|0|||
129140936|NCT01661595|464810694|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
129140937|NCT01661595|464810695|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
129140938|NCT01661595|464810696|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
129140939|NCT01661595|464810697|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
129140940|NCT00912509|464810698|FG000|Overall Study|Lost to Follow-up|1|||
129140941|NCT00912509|464810699|FG001|Overall Study|Lost to Follow-up|0|||
129140942|NCT00912509|464810698|FG000|Overall Study|Lack of Efficacy|4|||
129140943|NCT00912509|464810699|FG001|Overall Study|Lack of Efficacy|3|||
129140944|NCT01682603|464810700|FG000|Overall Study|Lost to Follow-up|3|||
129074670|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
129074671|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
129074672|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
129074673|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
129074674|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129074675|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129074676|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129074677|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
129074678|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129074679|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129074680|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129074681|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129074682|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129074683|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129074684|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129074685|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
129074686|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129074687|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129074688|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129074689|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129074690|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129074691|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129074692|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
129074693|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129074694|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129074695|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129074696|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129074697|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129074698|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129074699|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
129074700|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129074701|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129074702|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129074703|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129074704|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129074705|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129074706|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
129074707|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129074708|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129074709|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129074710|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129074711|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129074712|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129074713|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
129074714|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129074715|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129074716|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129074717|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129074718|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129074719|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129074720|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129074721|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
129074722|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129074723|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129074724|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129074725|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129074726|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129074727|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129074728|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
129074729|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129074730|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129074731|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129074732|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129074733|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129074734|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129074735|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129074736|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
129074737|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129074738|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129074739|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129074740|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129074741|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129074742|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129074743|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
129074744|NCT04242446|464561687|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129074745|NCT04242446|464561688|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129074746|NCT04242446|464561689|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129074747|NCT04242446|464561690|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129074748|NCT04242446|464561691|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129074749|NCT04242446|464561692|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129074750|NCT04242446|464561693|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
129074751|NCT00739882|464561699|FG000|Double-blind Period|Adverse Event|1|||
129074752|NCT00739882|464561700|FG001|Double-blind Period|Adverse Event|2|||
129074753|NCT00739882|464561699|FG000|Double-blind Period|Protocol Violation|1|||
129074754|NCT00739882|464561700|FG001|Double-blind Period|Protocol Violation|0|||
129074755|NCT00739882|464561699|FG000|Double-blind Period|Lack of Efficacy|1|||
129074756|NCT00739882|464561700|FG001|Double-blind Period|Lack of Efficacy|1|||
129074757|NCT00739882|464561699|FG000|Double-blind Period|Other|16|||
129074758|NCT00739882|464561700|FG001|Double-blind Period|Other|8|||
129074759|NCT00739882|464561699|FG000|Open-label Period|Adverse Event|1|||
129074760|NCT00739882|464561700|FG001|Open-label Period|Adverse Event|0|||
129074761|NCT00739882|464561699|FG000|Open-label Period|Other|9|||
129074762|NCT00739882|464561700|FG001|Open-label Period|Other|5|||
129074763|NCT04021914|464561701|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
129074764|NCT00485732|464561702|FG000|Overall Study|Protocol Violation|1|||
129074765|NCT00485732|464561703|FG001|Overall Study|Protocol Violation|3|||
129074766|NCT00485732|464561702|FG000|Overall Study|Withdrawal by Subject|5|||
129074767|NCT00485732|464561703|FG001|Overall Study|Withdrawal by Subject|4|||
129074768|NCT00485732|464561702|FG000|Overall Study|Lost to Follow-up|2|||
129074769|NCT00485732|464561703|FG001|Overall Study|Lost to Follow-up|2|||
129074770|NCT03985800|464561704|FG000|Overall Study|Death|1|||
129074771|NCT03985800|464561705|FG001|Overall Study|Death|2|||
129074772|NCT03985800|464561704|FG000|Overall Study|Withdrawal by Subject|3|||
129074773|NCT03985800|464561705|FG001|Overall Study|Withdrawal by Subject|6|||
129074774|NCT03985800|464561704|FG000|Overall Study|Protocol Violation|2|||
129074775|NCT03985800|464561705|FG001|Overall Study|Protocol Violation|0|||
129074776|NCT04281485|464561706|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
129074777|NCT04281485|464561707|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
129074778|NCT04281485|464561706|FG000|Overall Study|Ongoing (Safety data collection)|10|||
129074779|NCT04281485|464561707|FG001|Overall Study|Ongoing (Safety data collection)|5|||
129074780|NCT03096314|464561710|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
129074781|NCT03096314|464561711|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
129074782|NCT01293695|464561726|FG000|Overall Study|Withdrawal by Subject|7|||
129074783|NCT01293695|464561727|FG001|Overall Study|Withdrawal by Subject|1|||
129140945|NCT02336555|464810701|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129140946|NCT02336555|464810702|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129074784|NCT01293695|464561726|FG000|Overall Study|Lost to Follow-up|8|||
129074785|NCT01293695|464561727|FG001|Overall Study|Lost to Follow-up|6|||
129074786|NCT00957801|464561728|FG000|Overall Study|Withdrawal by Subject|0|||
129074787|NCT00957801|464561729|FG001|Overall Study|Withdrawal by Subject|0|||
129074788|NCT00957801|464561730|FG002|Overall Study|Withdrawal by Subject|0|||
129074789|NCT00957801|464561731|FG003|Overall Study|Withdrawal by Subject|1|||
129074790|NCT01058642|464561736|FG000|Treatment Period 1|Adverse Event|0|||
129074791|NCT01058642|464561737|FG001|Treatment Period 1|Adverse Event|1|||
129074792|NCT01058642|464561738|FG002|Treatment Period 1|Adverse Event|1|||
129074793|NCT01058642|464561739|FG003|Treatment Period 1|Adverse Event|0|||
129074794|NCT01058642|464561736|FG000|Treatment Period 1|Physician Decision|0|||
129074795|NCT01058642|464561737|FG001|Treatment Period 1|Physician Decision|0|||
129074796|NCT01058642|464561738|FG002|Treatment Period 1|Physician Decision|1|||
129074797|NCT01058642|464561739|FG003|Treatment Period 1|Physician Decision|0|||
129074798|NCT01058642|464561736|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129074799|NCT01058642|464561737|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129074800|NCT01058642|464561738|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129074801|NCT01058642|464561739|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129074802|NCT01058642|464561736|FG000|Treatment Period 1|Lack of Efficacy|0|||
129074803|NCT01058642|464561737|FG001|Treatment Period 1|Lack of Efficacy|0|||
129074804|NCT01058642|464561738|FG002|Treatment Period 1|Lack of Efficacy|0|||
129074805|NCT01058642|464561739|FG003|Treatment Period 1|Lack of Efficacy|1|||
129074806|NCT01058642|464561736|FG000|Treatment Period 1|Protocol Violation|0|||
129074807|NCT01058642|464561737|FG001|Treatment Period 1|Protocol Violation|0|||
129074808|NCT01058642|464561738|FG002|Treatment Period 1|Protocol Violation|0|||
129074809|NCT01058642|464561739|FG003|Treatment Period 1|Protocol Violation|1|||
129074810|NCT01058642|464561736|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
129074811|NCT01058642|464561737|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
129074812|NCT01058642|464561738|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
129074813|NCT01058642|464561739|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
129074814|NCT01108718|464561740|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
129074815|NCT01108718|464561741|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
129074816|NCT03380429|464561742|FG000|Overall Study|Physician Decision|0|||
129074817|NCT03380429|464561743|FG001|Overall Study|Physician Decision|1|||
129074818|NCT03380429|464561744|FG002|Overall Study|Physician Decision|0|||
129074819|NCT03380429|464561745|FG003|Overall Study|Physician Decision|1|||
129074820|NCT03380429|464561746|FG004|Overall Study|Physician Decision|1|||
129074821|NCT03380429|464561742|FG000|Overall Study|Withdrawal by Subject|3|||
129074822|NCT03380429|464561743|FG001|Overall Study|Withdrawal by Subject|3|||
129074823|NCT03380429|464561744|FG002|Overall Study|Withdrawal by Subject|5|||
129074824|NCT03380429|464561745|FG003|Overall Study|Withdrawal by Subject|2|||
129074825|NCT03380429|464561746|FG004|Overall Study|Withdrawal by Subject|1|||
129074826|NCT03380429|464561742|FG000|Overall Study|Lost to Follow-up|0|||
129074827|NCT03380429|464561743|FG001|Overall Study|Lost to Follow-up|2|||
129074828|NCT03380429|464561744|FG002|Overall Study|Lost to Follow-up|4|||
129074829|NCT03380429|464561745|FG003|Overall Study|Lost to Follow-up|3|||
129074830|NCT03380429|464561746|FG004|Overall Study|Lost to Follow-up|1|||
129074831|NCT03380429|464561742|FG000|Overall Study|Protocol Violation|1|||
129074832|NCT03380429|464561743|FG001|Overall Study|Protocol Violation|0|||
129074833|NCT03380429|464561744|FG002|Overall Study|Protocol Violation|1|||
129074834|NCT03380429|464561745|FG003|Overall Study|Protocol Violation|0|||
129074835|NCT03380429|464561746|FG004|Overall Study|Protocol Violation|1|||
129074836|NCT03380429|464561742|FG000|Overall Study|Lack of Efficacy|0|||
129074837|NCT03380429|464561743|FG001|Overall Study|Lack of Efficacy|0|||
129074838|NCT03380429|464561744|FG002|Overall Study|Lack of Efficacy|0|||
129074839|NCT03380429|464561745|FG003|Overall Study|Lack of Efficacy|2|||
129074840|NCT03380429|464561746|FG004|Overall Study|Lack of Efficacy|1|||
129074841|NCT03380429|464561742|FG000|Overall Study|Adverse Event|1|||
129074842|NCT03380429|464561743|FG001|Overall Study|Adverse Event|1|||
129074843|NCT03380429|464561744|FG002|Overall Study|Adverse Event|1|||
129074844|NCT03380429|464561745|FG003|Overall Study|Adverse Event|2|||
129074845|NCT03380429|464561746|FG004|Overall Study|Adverse Event|0|||
129074846|NCT04760626|464561749|FG000|Overall Study|Withdrawal by Subject|24|||
129074847|NCT04760626|464561750|FG001|Overall Study|Withdrawal by Subject|20|||
129074848|NCT04760626|464561749|FG000|Overall Study|Lost to Follow-up|14|||
129074849|NCT04760626|464561750|FG001|Overall Study|Lost to Follow-up|19|||
129074850|NCT04760626|464561749|FG000|Overall Study|Physician Decision|3|||
129074851|NCT04760626|464561750|FG001|Overall Study|Physician Decision|5|||
129074852|NCT04760626|464561749|FG000|Overall Study|Death|3|||
129074853|NCT04760626|464561750|FG001|Overall Study|Death|6|||
129074854|NCT04760626|464561749|FG000|Overall Study|Site closure|1|||
129074855|NCT04760626|464561750|FG001|Overall Study|Site closure|0|||
129074856|NCT03762265|464561753|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
129074857|NCT03762265|464561754|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
129074858|NCT03762265|464561753|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
129074859|NCT03762265|464561754|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
129074860|NCT03762265|464561753|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
129074861|NCT03762265|464561754|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
129074862|NCT03762265|464561753|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
129074863|NCT03762265|464561754|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
129074864|NCT03762265|464561753|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
129074865|NCT03762265|464561754|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
129074866|NCT03762265|464561753|FG000|BT Period: Weeks 1 to 37|Other|0|||
129074867|NCT03762265|464561754|FG001|BT Period: Weeks 1 to 37|Other|1|||
129074868|NCT03762265|464561753|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
129074869|NCT03762265|464561754|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
129074870|NCT03762265|464561753|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
129074871|NCT03762265|464561754|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
129074872|NCT03762265|464561753|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
129074873|NCT03762265|464561754|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
129074874|NCT03762265|464561753|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
129074875|NCT03762265|464561754|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
129074876|NCT03762265|464561753|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
129074877|NCT03762265|464561754|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
129074878|NCT03762265|464561753|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
129074879|NCT03762265|464561754|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
129074880|NCT03762265|464561753|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
129074881|NCT03762265|464561754|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
129074882|NCT03762265|464561753|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
129074883|NCT03762265|464561754|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
129074884|NCT03762265|464561753|FG000|LTE Period: Weeks 61 to 109|Other|1|||
129074885|NCT03762265|464561754|FG001|LTE Period: Weeks 61 to 109|Other|0|||
129074886|NCT00806403|464561757|FG000|Overall Study|Death|4|||
129074887|NCT00806403|464561758|FG001|Overall Study|Death|3|||
129074888|NCT01882985|464561759|FG000|Overall Study|Lost to Follow-up|1|||
129074889|NCT01882985|464561759|FG000|Overall Study|Withdrawal by Subject|1|||
129074890|NCT01383174|464561760|FG000|3 Month Assessment|Death|0|||
129074891|NCT01383174|464561761|FG001|3 Month Assessment|Death|1|||
129074892|NCT01383174|464561760|FG000|3 Month Assessment|Lost to Follow-up|2|||
129074893|NCT01383174|464561761|FG001|3 Month Assessment|Lost to Follow-up|0|||
129074894|NCT01383174|464561760|FG000|3 Month Assessment|Refused to complete|4|||
129074895|NCT01383174|464561761|FG001|3 Month Assessment|Refused to complete|0|||
129074896|NCT01383174|464561760|FG000|6 Month Assessment|Lost to Follow-up|1|||
129074897|NCT01383174|464561761|FG001|6 Month Assessment|Lost to Follow-up|1|||
129074898|NCT01383174|464561760|FG000|6 Month Assessment|Refused to complete|4|||
129074899|NCT01383174|464561761|FG001|6 Month Assessment|Refused to complete|0|||
129074900|NCT01787292|464561762|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
129074901|NCT01787292|464561763|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
129074902|NCT01787292|464561762|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
129074903|NCT01787292|464561763|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
129074904|NCT01827111|464561764|FG000|Overall Study|Disease Progression|1|||
129074905|NCT02169271|464561765|FG000|Overall Study|Protocol Violation|1|||
129074906|NCT02169271|464561766|FG001|Overall Study|Protocol Violation|2|||
129074907|NCT01924689|464561769|FG000|Overall Study|Death|0|||
129140947|NCT02336555|464810701|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
129140948|NCT02336555|464810702|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
129140949|NCT02336555|464810701|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
129140950|NCT02336555|464810702|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
129140951|NCT00993473|464810703|FG000|Overall Study|Adverse Event|0|||
129140952|NCT00993473|464810704|FG001|Overall Study|Adverse Event|2|||
129140953|NCT00993473|464810703|FG000|Overall Study|Protocol Violation|1|||
129140954|NCT00993473|464810704|FG001|Overall Study|Protocol Violation|2|||
129140955|NCT00993473|464810703|FG000|Overall Study|Lost to Follow-up|1|||
129140956|NCT00993473|464810704|FG001|Overall Study|Lost to Follow-up|0|||
129140957|NCT00993473|464810703|FG000|Overall Study|Withdrawal by Subject|1|||
129140958|NCT00993473|464810704|FG001|Overall Study|Withdrawal by Subject|5|||
129140959|NCT00993473|464810703|FG000|Overall Study|Technical problem with CGM device|0|||
129140960|NCT00993473|464810704|FG001|Overall Study|Technical problem with CGM device|1|||
129140961|NCT00993473|464810703|FG000|Overall Study|Family event|1|||
129140962|NCT00993473|464810704|FG001|Overall Study|Family event|0|||
129074908|NCT01924689|464561770|FG001|Overall Study|Death|1|||
129140963|NCT01772693|464810705|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
129140964|NCT01772693|464810706|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
129140965|NCT01772693|464810705|FG000|Overall Study|Withdrawal by Subject|2|||
129074909|NCT01924689|464561771|FG002|Overall Study|Death|0|||
129074910|NCT01924689|464561772|FG003|Overall Study|Death|1|||
129074911|NCT01924689|464561773|FG004|Overall Study|Death|0|||
129074912|NCT01924689|464561774|FG005|Overall Study|Death|0|||
129074913|NCT01924689|464561769|FG000|Overall Study|Disease progression|0|||
129074914|NCT01924689|464561770|FG001|Overall Study|Disease progression|0|||
129074915|NCT01924689|464561771|FG002|Overall Study|Disease progression|2|||
129074916|NCT01924689|464561772|FG003|Overall Study|Disease progression|0|||
129074917|NCT01924689|464561773|FG004|Overall Study|Disease progression|3|||
129074918|NCT01924689|464561774|FG005|Overall Study|Disease progression|2|||
129074919|NCT01924689|464561769|FG000|Overall Study|New therapy or study|3|||
129074920|NCT01924689|464561770|FG001|Overall Study|New therapy or study|2|||
129074921|NCT01924689|464561771|FG002|Overall Study|New therapy or study|1|||
129074922|NCT01924689|464561772|FG003|Overall Study|New therapy or study|4|||
129074923|NCT01924689|464561773|FG004|Overall Study|New therapy or study|2|||
129074924|NCT01924689|464561774|FG005|Overall Study|New therapy or study|0|||
129074925|NCT01924689|464561769|FG000|Overall Study|Withdrawal of consent|0|||
129140966|NCT01772693|464810706|FG001|Overall Study|Withdrawal by Subject|0|||
129140967|NCT01772693|464810705|FG000|Overall Study|Alternative Treatment|2|||
129140968|NCT01772693|464810706|FG001|Overall Study|Alternative Treatment|0|||
129140969|NCT01633112|464810707|FG000|Overall Study|Lack of Efficacy|1|||
129140970|NCT01633112|464810708|FG001|Overall Study|Lack of Efficacy|6|||
129140971|NCT01633112|464810709|FG002|Overall Study|Lack of Efficacy|13|||
129140972|NCT01633112|464810707|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129140973|NCT01633112|464810708|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129140974|NCT01633112|464810709|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129140975|NCT01633112|464810707|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129140976|NCT01633112|464810708|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129074926|NCT01924689|464561770|FG001|Overall Study|Withdrawal of consent|0|||
129074927|NCT01924689|464561771|FG002|Overall Study|Withdrawal of consent|1|||
129074928|NCT01924689|464561772|FG003|Overall Study|Withdrawal of consent|1|||
129140977|NCT01633112|464810709|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129140978|NCT01633112|464810707|FG000|Overall Study|Administrative problems|1|||
129074929|NCT01924689|464561773|FG004|Overall Study|Withdrawal of consent|0|||
129074930|NCT01924689|464561774|FG005|Overall Study|Withdrawal of consent|0|||
129074931|NCT01924689|464561769|FG000|Overall Study|Other|0|||
129074932|NCT01924689|464561770|FG001|Overall Study|Other|0|||
129074933|NCT01924689|464561771|FG002|Overall Study|Other|0|||
129074934|NCT01924689|464561772|FG003|Overall Study|Other|0|||
129074935|NCT01924689|464561773|FG004|Overall Study|Other|1|||
129074936|NCT01924689|464561774|FG005|Overall Study|Other|0|||
129074937|NCT03267212|464561775|FG000|First Intervention|Lost to Follow-up|0|||
129074938|NCT03267212|464561776|FG001|First Intervention|Lost to Follow-up|2|||
129074939|NCT03267212|464561775|FG000|First Intervention|Withdrawal by Subject|1|||
129074940|NCT03267212|464561776|FG001|First Intervention|Withdrawal by Subject|1|||
129074941|NCT03267212|464561775|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
129074942|NCT03267212|464561776|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
129074943|NCT00226499|464561779|FG000|Overall Study|Adverse Event|10|||
129074944|NCT00226499|464561780|FG001|Overall Study|Adverse Event|6|||
129074945|NCT00226499|464561781|FG002|Overall Study|Adverse Event|3|||
129074946|NCT00226499|464561779|FG000|Overall Study|Others|1064|||
129074947|NCT00226499|464561780|FG001|Overall Study|Others|1066|||
129074948|NCT00226499|464561781|FG002|Overall Study|Others|356|||
129074949|NCT00946920|464561782|FG000|Overall Study|Withdrawal by Subject|28|||
129074950|NCT00946920|464561783|FG001|Overall Study|Withdrawal by Subject|15|||
129074951|NCT00946920|464561782|FG000|Overall Study|Lost to Follow-up|2|||
129074952|NCT00946920|464561783|FG001|Overall Study|Lost to Follow-up|2|||
129074953|NCT00946920|464561782|FG000|Overall Study|Physician Decision|5|||
129074954|NCT00946920|464561783|FG001|Overall Study|Physician Decision|2|||
129074955|NCT00946920|464561782|FG000|Overall Study|Adverse Event|41|||
129074956|NCT00946920|464561783|FG001|Overall Study|Adverse Event|14|||
129074957|NCT00946920|464561782|FG000|Overall Study|Protocol Violation|16|||
129074958|NCT00946920|464561783|FG001|Overall Study|Protocol Violation|8|||
129074959|NCT00946920|464561782|FG000|Overall Study|Miscellaneous reasons|18|||
129074960|NCT00946920|464561783|FG001|Overall Study|Miscellaneous reasons|3|||
129074961|NCT01597973|464561784|FG000|Overall Study|Found ineligible before study medication started|4|||
129074962|NCT01597973|464561785|FG001|Overall Study|Found ineligible before study medication started|2|||
129140979|NCT01633112|464810708|FG001|Overall Study|Administrative problems|2|||
129140980|NCT01633112|464810709|FG002|Overall Study|Administrative problems|5|||
129140981|NCT01633112|464810707|FG000|Overall Study|Adverse Event|16|||
129140982|NCT01633112|464810708|FG001|Overall Study|Adverse Event|18|||
129140983|NCT01633112|464810709|FG002|Overall Study|Adverse Event|20|||
129140984|NCT01633112|464810707|FG000|Overall Study|Lost to Follow-up|7|||
129140985|NCT01633112|464810708|FG001|Overall Study|Lost to Follow-up|19|||
129140986|NCT01633112|464810709|FG002|Overall Study|Lost to Follow-up|6|||
129140987|NCT01633112|464810707|FG000|Overall Study|Protocol Violation|4|||
129140988|NCT01633112|464810708|FG001|Overall Study|Protocol Violation|0|||
129140989|NCT01633112|464810709|FG002|Overall Study|Protocol Violation|2|||
129140990|NCT01633112|464810707|FG000|Overall Study|Subject no longer requires study drug|0|||
129140991|NCT01633112|464810708|FG001|Overall Study|Subject no longer requires study drug|0|||
129140992|NCT01633112|464810709|FG002|Overall Study|Subject no longer requires study drug|1|||
129140993|NCT01633112|464810707|FG000|Overall Study|Withdrawal by Subject|20|||
129140994|NCT01633112|464810708|FG001|Overall Study|Withdrawal by Subject|12|||
128776558|NCT02846558|463470466|FG003|Overall Study|Adverse Event|0|||
129074963|NCT01597973|464561784|FG000|Overall Study|Eligible pathogen not confirmed|14|||
129074964|NCT01597973|464561785|FG001|Overall Study|Eligible pathogen not confirmed|15|||
129074965|NCT01597973|464561784|FG000|Overall Study|LAR not authorized to consent|0|||
129074966|NCT01597973|464561785|FG001|Overall Study|LAR not authorized to consent|1|||
129074967|NCT01597973|464561784|FG000|Overall Study|Ineligible due to early seizures|1|||
129074968|NCT01597973|464561785|FG001|Overall Study|Ineligible due to early seizures|0|||
129074969|NCT01597973|464561784|FG000|Overall Study|Ineligible due to non-target infection|1|||
129074970|NCT01597973|464561785|FG001|Overall Study|Ineligible due to non-target infection|1|||
129140995|NCT01633112|464810709|FG002|Overall Study|Withdrawal by Subject|41|||
129140996|NCT01633112|464810707|FG000|Overall Study|missing Study Completion CRF|1|||
129140997|NCT01633112|464810708|FG001|Overall Study|missing Study Completion CRF|1|||
129140998|NCT01633112|464810709|FG002|Overall Study|missing Study Completion CRF|4|||
129074971|NCT02389829|464561792|FG000|Overall Study|Lost to Follow-up|0|||
129074972|NCT02389829|464561793|FG001|Overall Study|Lost to Follow-up|1|||
129074973|NCT02362360|464561794|FG000|Period 1|Lack of Efficacy|1|||
129074974|NCT02362360|464561795|FG001|Period 1|Lack of Efficacy|0|||
129074975|NCT02362360|464561794|FG000|Period 1|Withdrawal by Subject|2|||
129074976|NCT02362360|464561795|FG001|Period 1|Withdrawal by Subject|1|||
129074977|NCT02208362|464561796|FG000|Overall Study|Participant did not complete treatment|0|||
129074978|NCT02208362|464561797|FG001|Overall Study|Participant did not complete treatment|1|||
129074979|NCT02208362|464561798|FG002|Overall Study|Participant did not complete treatment|0|||
129074980|NCT02208362|464561799|FG003|Overall Study|Participant did not complete treatment|0|||
129074981|NCT02208362|464561800|FG004|Overall Study|Participant did not complete treatment|0|||
129074982|NCT02208362|464561801|FG005|Overall Study|Participant did not complete treatment|0|||
129074983|NCT02208362|464561802|FG006|Overall Study|Participant did not complete treatment|1|||
129074984|NCT02208362|464561803|FG007|Overall Study|Participant did not complete treatment|1|||
129074985|NCT02208362|464561804|FG008|Overall Study|Participant did not complete treatment|2|||
129074986|NCT02208362|464561805|FG009|Overall Study|Participant did not complete treatment|0|||
129074987|NCT02208362|464561806|FG010|Overall Study|Participant did not complete treatment|1|||
129074988|NCT02208362|464561807|FG011|Overall Study|Participant did not complete treatment|0|||
129074989|NCT02208362|464561796|FG000|Overall Study|Participant received disallowed treatment|0|||
129074990|NCT02208362|464561797|FG001|Overall Study|Participant received disallowed treatment|0|||
129074991|NCT02208362|464561798|FG002|Overall Study|Participant received disallowed treatment|0|||
129074992|NCT02208362|464561799|FG003|Overall Study|Participant received disallowed treatment|0|||
129074993|NCT02208362|464561800|FG004|Overall Study|Participant received disallowed treatment|0|||
129074994|NCT02208362|464561801|FG005|Overall Study|Participant received disallowed treatment|0|||
129074995|NCT02208362|464561802|FG006|Overall Study|Participant received disallowed treatment|0|||
129074996|NCT02208362|464561803|FG007|Overall Study|Participant received disallowed treatment|0|||
129074997|NCT02208362|464561804|FG008|Overall Study|Participant received disallowed treatment|1|||
129074998|NCT02208362|464561805|FG009|Overall Study|Participant received disallowed treatment|0|||
129074999|NCT02208362|464561806|FG010|Overall Study|Participant received disallowed treatment|0|||
129075000|NCT02208362|464561807|FG011|Overall Study|Participant received disallowed treatment|0|||
129075001|NCT03578367|464561810|FG000|Overall Study|Adverse Event|0|||
129075002|NCT03578367|464561811|FG001|Overall Study|Adverse Event|3|||
129075003|NCT03578367|464561812|FG002|Overall Study|Adverse Event|0|||
129075004|NCT03578367|464561813|FG003|Overall Study|Adverse Event|5|||
129075005|NCT03578367|464561810|FG000|Overall Study|Withdrawal by Subject|2|||
129075006|NCT03578367|464561811|FG001|Overall Study|Withdrawal by Subject|2|||
129075007|NCT03578367|464561812|FG002|Overall Study|Withdrawal by Subject|1|||
129075008|NCT03578367|464561813|FG003|Overall Study|Withdrawal by Subject|3|||
129075009|NCT03578367|464561810|FG000|Overall Study|Physician Decision|0|||
129075010|NCT03578367|464561811|FG001|Overall Study|Physician Decision|0|||
129075011|NCT03578367|464561812|FG002|Overall Study|Physician Decision|14|||
129075012|NCT03578367|464561813|FG003|Overall Study|Physician Decision|0|||
129075013|NCT03578367|464561810|FG000|Overall Study|Death|1|||
129075014|NCT03578367|464561811|FG001|Overall Study|Death|0|||
129075015|NCT03578367|464561812|FG002|Overall Study|Death|0|||
129075016|NCT03578367|464561813|FG003|Overall Study|Death|0|||
129075017|NCT03578367|464561810|FG000|Overall Study|Not treated|0|||
129075018|NCT03578367|464561811|FG001|Overall Study|Not treated|0|||
129075019|NCT03578367|464561812|FG002|Overall Study|Not treated|1|||
129075020|NCT03578367|464561813|FG003|Overall Study|Not treated|0|||
129075021|NCT02729025|464561817|FG000|Overall Study|Sponsor Decision|0|||
129075022|NCT02729025|464561818|FG001|Overall Study|Sponsor Decision|1|||
129075023|NCT05966584|464561821|FG000|Overall Study|Lost to Follow-up|1|||
129075024|NCT03349060|464563234|FG000|Overall Study|Adverse Event|9|||
129075025|NCT03349060|464563235|FG001|Overall Study|Adverse Event|9|||
129075026|NCT03349060|464563236|FG002|Overall Study|Adverse Event|7|||
129075027|NCT03349060|464563234|FG000|Overall Study|Lack of Efficacy|1|||
129075028|NCT03349060|464563235|FG001|Overall Study|Lack of Efficacy|0|||
129075029|NCT03349060|464563236|FG002|Overall Study|Lack of Efficacy|2|||
129075030|NCT03349060|464563234|FG000|Overall Study|Lost to Follow-up|2|||
129075031|NCT03349060|464563235|FG001|Overall Study|Lost to Follow-up|1|||
129075032|NCT03349060|464563236|FG002|Overall Study|Lost to Follow-up|1|||
129075033|NCT03349060|464563234|FG000|Overall Study|Protocol Violation|2|||
129075034|NCT03349060|464563235|FG001|Overall Study|Protocol Violation|2|||
129075035|NCT03349060|464563236|FG002|Overall Study|Protocol Violation|1|||
129075036|NCT03349060|464563234|FG000|Overall Study|Withdrawal by Subject|5|||
129075037|NCT03349060|464563235|FG001|Overall Study|Withdrawal by Subject|3|||
129075038|NCT03349060|464563236|FG002|Overall Study|Withdrawal by Subject|4|||
129075039|NCT03349060|464563234|FG000|Overall Study|Medication error,no linked adverse event|0|||
129075040|NCT03349060|464563235|FG001|Overall Study|Medication error,no linked adverse event|0|||
129075041|NCT03349060|464563236|FG002|Overall Study|Medication error,no linked adverse event|1|||
129075042|NCT03349060|464563234|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129075043|NCT03349060|464563235|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
129075044|NCT03349060|464563236|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
129075045|NCT03349060|464563234|FG000|Overall Study|Other|2|||
129075046|NCT03349060|464563235|FG001|Overall Study|Other|1|||
129075047|NCT03349060|464563236|FG002|Overall Study|Other|0|||
129075048|NCT02861586|464563237|FG000|Overall Study|Withdrawal by Subject|1|||
129075049|NCT02861586|464563238|FG001|Overall Study|Withdrawal by Subject|2|||
129075050|NCT02861586|464563239|FG002|Overall Study|Withdrawal by Subject|0|||
129075051|NCT02861586|464563240|FG003|Overall Study|Withdrawal by Subject|0|||
129075052|NCT02861586|464563241|FG004|Overall Study|Withdrawal by Subject|0|||
129075053|NCT02861586|464563242|FG005|Overall Study|Withdrawal by Subject|1|||
129140999|NCT01908699|464810710|FG000|Overall Study|Adverse Event|8|||
129141000|NCT01908699|464810711|FG001|Overall Study|Adverse Event|12|||
129141001|NCT01908699|464810710|FG000|Overall Study|Lack of Efficacy|2|||
129141002|NCT01908699|464810711|FG001|Overall Study|Lack of Efficacy|2|||
128723985|NCT00969553|463287302|FG003|Overall Study|Refused cont. medication|2|||
128723986|NCT00969553|463287303|FG004|Overall Study|Refused cont. medication|0|||
128723987|NCT00969553|463287304|FG005|Overall Study|Refused cont. medication|0|||
128723988|NCT00969553|463287305|FG006|Overall Study|Refused cont. medication|0|||
128723989|NCT00969553|463287306|FG007|Overall Study|Refused cont. medication|1|||
128723990|NCT00969553|463287307|FG008|Overall Study|Refused cont. medication|0|||
129075054|NCT02861586|464563243|FG006|Overall Study|Withdrawal by Subject|1|||
129075055|NCT02861586|464563244|FG007|Overall Study|Withdrawal by Subject|0|||
129075056|NCT02861586|464563237|FG000|Overall Study|Lost to Follow-up|3|||
129141003|NCT01908699|464810710|FG000|Overall Study|Lost to Follow-up|2|||
129141004|NCT01908699|464810711|FG001|Overall Study|Lost to Follow-up|4|||
129141005|NCT01908699|464810710|FG000|Overall Study|Physician Decision|8|||
129141006|NCT01908699|464810711|FG001|Overall Study|Physician Decision|8|||
129141007|NCT01908699|464810710|FG000|Overall Study|Withdrawal by Subject|15|||
129141008|NCT01908699|464810711|FG001|Overall Study|Withdrawal by Subject|10|||
129141009|NCT01908699|464810710|FG000|Overall Study|Pregnancy|0|||
129141010|NCT01908699|464810711|FG001|Overall Study|Pregnancy|1|||
129141011|NCT01908699|464810710|FG000|Overall Study|Randomized in Error|1|||
129141012|NCT01908699|464810711|FG001|Overall Study|Randomized in Error|0|||
129141013|NCT01908699|464810710|FG000|Overall Study|Death|9|||
129141014|NCT01908699|464810711|FG001|Overall Study|Death|12|||
129141015|NCT01908699|464810710|FG000|Overall Study|Progressive Disease|30|||
129141016|NCT01908699|464810711|FG001|Overall Study|Progressive Disease|29|||
129141017|NCT03439072|464810712|FG000|Overall Study|Withdrawal by Subject|2|||
129141018|NCT03439072|464810713|FG001|Overall Study|Withdrawal by Subject|3|||
129141019|NCT03439072|464810712|FG000|Overall Study|Physician Decision|0|||
129141020|NCT03439072|464810713|FG001|Overall Study|Physician Decision|1|||
129141021|NCT01537432|464810717|FG000|Overall Study|Lost to Follow-up|3|||
129141022|NCT01537432|464810718|FG001|Overall Study|Lost to Follow-up|1|||
129075057|NCT02861586|464563238|FG001|Overall Study|Lost to Follow-up|1|||
129075058|NCT02861586|464563239|FG002|Overall Study|Lost to Follow-up|1|||
129075059|NCT02861586|464563240|FG003|Overall Study|Lost to Follow-up|0|||
129075060|NCT02861586|464563241|FG004|Overall Study|Lost to Follow-up|0|||
129075061|NCT02861586|464563242|FG005|Overall Study|Lost to Follow-up|3|||
128723991|NCT00969553|463287299|FG000|Overall Study|Not specified above|0|||
129075062|NCT02861586|464563243|FG006|Overall Study|Lost to Follow-up|0|||
129075063|NCT02861586|464563244|FG007|Overall Study|Lost to Follow-up|0|||
129141023|NCT01537432|464810717|FG000|Overall Study|Withdrawal by Subject|0|||
129141024|NCT01537432|464810718|FG001|Overall Study|Withdrawal by Subject|1|||
129141025|NCT01537432|464810717|FG000|Overall Study|Administrative problems|1|||
129141026|NCT01537432|464810718|FG001|Overall Study|Administrative problems|0|||
129141027|NCT01537432|464810717|FG000|Overall Study|Adverse Event|1|||
129141028|NCT01537432|464810718|FG001|Overall Study|Adverse Event|0|||
128723992|NCT00969553|463287300|FG001|Overall Study|Not specified above|0|||
129075064|NCT02861586|464563237|FG000|Overall Study|Adverse Event|0|||
129075065|NCT02861586|464563238|FG001|Overall Study|Adverse Event|0|||
129075066|NCT02861586|464563239|FG002|Overall Study|Adverse Event|0|||
129075067|NCT02861586|464563240|FG003|Overall Study|Adverse Event|0|||
129075068|NCT02861586|464563241|FG004|Overall Study|Adverse Event|0|||
129075069|NCT02861586|464563242|FG005|Overall Study|Adverse Event|1|||
129075070|NCT02861586|464563243|FG006|Overall Study|Adverse Event|0|||
129075071|NCT02861586|464563244|FG007|Overall Study|Adverse Event|0|||
129075072|NCT00955409|464563245|FG000|Overall Study|Lack of Efficacy|1|||
129075073|NCT00955409|464563246|FG001|Overall Study|Lack of Efficacy|0|||
129075074|NCT00955409|464563247|FG002|Overall Study|Lack of Efficacy|0|||
129075075|NCT00955409|464563248|FG003|Overall Study|Lack of Efficacy|0|||
129075076|NCT00955409|464563249|FG004|Overall Study|Lack of Efficacy|0|||
129075077|NCT00955409|464563250|FG005|Overall Study|Lack of Efficacy|0|||
129075078|NCT00955409|464563251|FG006|Overall Study|Lack of Efficacy|0|||
129075079|NCT00955409|464563252|FG007|Overall Study|Lack of Efficacy|0|||
129075080|NCT00955409|464563253|FG008|Overall Study|Lack of Efficacy|0|||
129075081|NCT00955409|464563254|FG009|Overall Study|Lack of Efficacy|0|||
129075082|NCT00955409|464563245|FG000|Overall Study|Withdrawal by Subject|1|||
129075083|NCT00955409|464563246|FG001|Overall Study|Withdrawal by Subject|0|||
129075084|NCT00955409|464563247|FG002|Overall Study|Withdrawal by Subject|5|||
129075085|NCT00955409|464563248|FG003|Overall Study|Withdrawal by Subject|2|||
129075086|NCT00955409|464563249|FG004|Overall Study|Withdrawal by Subject|0|||
129075087|NCT00955409|464563250|FG005|Overall Study|Withdrawal by Subject|0|||
129075088|NCT00955409|464563251|FG006|Overall Study|Withdrawal by Subject|2|||
129075089|NCT00955409|464563252|FG007|Overall Study|Withdrawal by Subject|0|||
129075090|NCT00955409|464563253|FG008|Overall Study|Withdrawal by Subject|1|||
129075091|NCT00955409|464563254|FG009|Overall Study|Withdrawal by Subject|0|||
129075092|NCT00955409|464563245|FG000|Overall Study|Caregiver Request|2|||
129075093|NCT00955409|464563246|FG001|Overall Study|Caregiver Request|0|||
129075094|NCT00955409|464563247|FG002|Overall Study|Caregiver Request|6|||
129075095|NCT00955409|464563248|FG003|Overall Study|Caregiver Request|5|||
129075096|NCT00955409|464563249|FG004|Overall Study|Caregiver Request|0|||
129075097|NCT00955409|464563250|FG005|Overall Study|Caregiver Request|2|||
129075098|NCT00955409|464563251|FG006|Overall Study|Caregiver Request|3|||
129075099|NCT00955409|464563252|FG007|Overall Study|Caregiver Request|1|||
129075100|NCT00955409|464563253|FG008|Overall Study|Caregiver Request|3|||
129075101|NCT00955409|464563254|FG009|Overall Study|Caregiver Request|0|||
129075102|NCT00955409|464563245|FG000|Overall Study|Investigator Request|0|||
129075103|NCT00955409|464563246|FG001|Overall Study|Investigator Request|0|||
129075104|NCT00955409|464563247|FG002|Overall Study|Investigator Request|1|||
129075105|NCT00955409|464563248|FG003|Overall Study|Investigator Request|0|||
129075106|NCT00955409|464563249|FG004|Overall Study|Investigator Request|0|||
129075107|NCT00955409|464563250|FG005|Overall Study|Investigator Request|0|||
129075108|NCT00955409|464563251|FG006|Overall Study|Investigator Request|0|||
129075109|NCT00955409|464563252|FG007|Overall Study|Investigator Request|0|||
129075110|NCT00955409|464563253|FG008|Overall Study|Investigator Request|0|||
129075111|NCT00955409|464563254|FG009|Overall Study|Investigator Request|0|||
129075112|NCT00955409|464563245|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
129075113|NCT00955409|464563246|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129075114|NCT00955409|464563247|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
129075115|NCT00955409|464563248|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129075116|NCT00955409|464563249|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
129075117|NCT00955409|464563250|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
129075118|NCT00955409|464563251|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
129075119|NCT00955409|464563252|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
129075120|NCT00955409|464563253|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
129075121|NCT00955409|464563254|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
129075122|NCT00955409|464563245|FG000|Overall Study|Lost to Follow-up|0|||
129075123|NCT00955409|464563246|FG001|Overall Study|Lost to Follow-up|0|||
129075124|NCT00955409|464563247|FG002|Overall Study|Lost to Follow-up|1|||
129075125|NCT00955409|464563248|FG003|Overall Study|Lost to Follow-up|0|||
129141029|NCT01537432|464810717|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129141030|NCT01537432|464810718|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128776559|NCT02846558|463470463|FG000|Overall Study|Withdrawal by Subject|5|||
129075126|NCT00955409|464563249|FG004|Overall Study|Lost to Follow-up|0|||
129075127|NCT00955409|464563250|FG005|Overall Study|Lost to Follow-up|0|||
129075128|NCT00955409|464563251|FG006|Overall Study|Lost to Follow-up|1|||
129075129|NCT00955409|464563252|FG007|Overall Study|Lost to Follow-up|0|||
129075130|NCT00955409|464563253|FG008|Overall Study|Lost to Follow-up|0|||
129075131|NCT00955409|464563254|FG009|Overall Study|Lost to Follow-up|0|||
129075132|NCT00955409|464563245|FG000|Overall Study|Failed to Return|2|||
129075133|NCT00955409|464563246|FG001|Overall Study|Failed to Return|0|||
129075134|NCT00955409|464563247|FG002|Overall Study|Failed to Return|0|||
129075135|NCT00955409|464563248|FG003|Overall Study|Failed to Return|0|||
129075136|NCT00955409|464563249|FG004|Overall Study|Failed to Return|0|||
129075137|NCT00955409|464563250|FG005|Overall Study|Failed to Return|0|||
129075138|NCT00955409|464563251|FG006|Overall Study|Failed to Return|0|||
129075139|NCT00955409|464563252|FG007|Overall Study|Failed to Return|2|||
129075140|NCT00955409|464563253|FG008|Overall Study|Failed to Return|0|||
129075141|NCT00955409|464563254|FG009|Overall Study|Failed to Return|0|||
129075142|NCT00955409|464563245|FG000|Overall Study|Adverse Event (AE)|2|||
129075143|NCT00955409|464563246|FG001|Overall Study|Adverse Event (AE)|0|||
129075144|NCT00955409|464563247|FG002|Overall Study|Adverse Event (AE)|0|||
129075145|NCT00955409|464563248|FG003|Overall Study|Adverse Event (AE)|0|||
129075146|NCT00955409|464563249|FG004|Overall Study|Adverse Event (AE)|0|||
129075147|NCT00955409|464563250|FG005|Overall Study|Adverse Event (AE)|1|||
129075148|NCT00955409|464563251|FG006|Overall Study|Adverse Event (AE)|2|||
129075149|NCT00955409|464563252|FG007|Overall Study|Adverse Event (AE)|0|||
129075150|NCT00955409|464563253|FG008|Overall Study|Adverse Event (AE)|2|||
129075151|NCT00955409|464563254|FG009|Overall Study|Adverse Event (AE)|0|||
129075152|NCT00955409|464563245|FG000|Overall Study|Reason not Specified|2|||
129075153|NCT00955409|464563246|FG001|Overall Study|Reason not Specified|1|||
129075154|NCT00955409|464563247|FG002|Overall Study|Reason not Specified|13|||
129075155|NCT00955409|464563248|FG003|Overall Study|Reason not Specified|1|||
129075156|NCT00955409|464563249|FG004|Overall Study|Reason not Specified|2|||
129075157|NCT00955409|464563250|FG005|Overall Study|Reason not Specified|0|||
129075158|NCT00955409|464563251|FG006|Overall Study|Reason not Specified|16|||
129075159|NCT00955409|464563252|FG007|Overall Study|Reason not Specified|0|||
129075160|NCT00955409|464563253|FG008|Overall Study|Reason not Specified|8|||
129075161|NCT00955409|464563254|FG009|Overall Study|Reason not Specified|1|||
129075162|NCT00803790|464563255|FG000|Period 1|Adverse Event|0|||
129075163|NCT00803790|464563256|FG001|Period 1|Adverse Event|1|||
129075164|NCT00803790|464563257|FG002|Period 1|Adverse Event|0|||
129075165|NCT00803790|464563258|FG003|Period 1|Adverse Event|0|||
129075166|NCT00803790|464563255|FG000|Period 1|Lost to Follow-up|1|||
129075167|NCT00803790|464563256|FG001|Period 1|Lost to Follow-up|2|||
129075168|NCT00803790|464563257|FG002|Period 1|Lost to Follow-up|0|||
129075169|NCT00803790|464563258|FG003|Period 1|Lost to Follow-up|0|||
129075170|NCT00803790|464563255|FG000|Period 1|Withdrawal by Subject|8|||
129075171|NCT00803790|464563256|FG001|Period 1|Withdrawal by Subject|6|||
129075172|NCT00803790|464563257|FG002|Period 1|Withdrawal by Subject|0|||
129075173|NCT00803790|464563258|FG003|Period 1|Withdrawal by Subject|0|||
129075174|NCT00803790|464563255|FG000|Period 1|positive drug screen or personal reasons|0|||
129075175|NCT00803790|464563256|FG001|Period 1|positive drug screen or personal reasons|3|||
129075176|NCT00803790|464563257|FG002|Period 1|positive drug screen or personal reasons|0|||
129075177|NCT00803790|464563258|FG003|Period 1|positive drug screen or personal reasons|4|||
129075178|NCT00803790|464563255|FG000|Period 1|Protocol Violation|0|||
129075179|NCT00803790|464563256|FG001|Period 1|Protocol Violation|0|||
129075180|NCT00803790|464563257|FG002|Period 1|Protocol Violation|1|||
129075181|NCT00803790|464563258|FG003|Period 1|Protocol Violation|0|||
129075182|NCT00803790|464563255|FG000|Period 2|Adverse Event|0|||
129075183|NCT00803790|464563256|FG001|Period 2|Adverse Event|0|||
129075184|NCT00803790|464563257|FG002|Period 2|Adverse Event|1|||
129141031|NCT00889005|464810719|FG000|Overall Study|Lost to Follow-up|4|||
129141032|NCT00889005|464810720|FG001|Overall Study|Lost to Follow-up|2|||
129141033|NCT00889005|464810719|FG000|Overall Study|Withdrawal by Subject|4|||
129141034|NCT00889005|464810720|FG001|Overall Study|Withdrawal by Subject|0|||
129141035|NCT05166902|464810721|FG000|First Intervention|Lost to Follow-up|0|||
129141036|NCT05166902|464810722|FG001|First Intervention|Lost to Follow-up|1|||
129141037|NCT01998477|464810723|FG000|Overall Study|Lost to Follow-up|4|||
129141038|NCT01998477|464810724|FG001|Overall Study|Lost to Follow-up|5|||
129141039|NCT01998477|464810723|FG000|Overall Study|Withdrawal by Subject|6|||
129141040|NCT01998477|464810724|FG001|Overall Study|Withdrawal by Subject|0|||
129141041|NCT00779909|464810725|FG000|Overall Study|Lost to Follow-up|1|||
129141042|NCT00779909|464810726|FG001|Overall Study|Lost to Follow-up|0|||
129141043|NCT00779909|464810727|FG002|Overall Study|Lost to Follow-up|0|||
129141044|NCT00779909|464810728|FG003|Overall Study|Lost to Follow-up|1|||
129075185|NCT00803790|464563258|FG003|Period 2|Adverse Event|1|||
129141045|NCT00779909|464810725|FG000|Overall Study|Withdrawal by Subject|0|||
129075186|NCT00803790|464563255|FG000|Period 2|Withdrawal by Subject|1|||
129075187|NCT00803790|464563256|FG001|Period 2|Withdrawal by Subject|0|||
129075188|NCT00803790|464563257|FG002|Period 2|Withdrawal by Subject|0|||
129075189|NCT00803790|464563258|FG003|Period 2|Withdrawal by Subject|0|||
129075190|NCT00803790|464563255|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
129075191|NCT00803790|464563256|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
129075192|NCT00803790|464563257|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
129075193|NCT00803790|464563258|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
129141046|NCT00779909|464810726|FG001|Overall Study|Withdrawal by Subject|1|||
129141047|NCT00779909|464810727|FG002|Overall Study|Withdrawal by Subject|0|||
129075194|NCT01880554|464563259|FG000|Overall Study|Protocol Violation|14|||
129075195|NCT01880554|464563259|FG000|Overall Study|Simon's design requirements|2|||
129075196|NCT05161481|464563260|FG000|Overall Study|Withdrawal of consent|0|||
129141048|NCT00779909|464810728|FG003|Overall Study|Withdrawal by Subject|0|||
129075197|NCT05161481|464563261|FG001|Overall Study|Withdrawal of consent|1|||
129075198|NCT05161481|464563262|FG002|Overall Study|Withdrawal of consent|1|||
129075199|NCT05161481|464563260|FG000|Overall Study|Study terminated by sponsor|3|||
129075200|NCT05161481|464563261|FG001|Overall Study|Study terminated by sponsor|3|||
129075201|NCT05161481|464563262|FG002|Overall Study|Study terminated by sponsor|2|||
129075202|NCT05161481|464563260|FG000|Overall Study|Adverse Event|3|||
129075203|NCT05161481|464563261|FG001|Overall Study|Adverse Event|0|||
129075204|NCT05161481|464563262|FG002|Overall Study|Adverse Event|6|||
129075205|NCT05161481|464563260|FG000|Overall Study|Randomised in error and was not treated|1|||
129075206|NCT05161481|464563261|FG001|Overall Study|Randomised in error and was not treated|0|||
129075207|NCT05161481|464563262|FG002|Overall Study|Randomised in error and was not treated|0|||
129075208|NCT05161481|464563260|FG000|Overall Study|Subject decision|0|||
129075209|NCT05161481|464563261|FG001|Overall Study|Subject decision|0|||
129075210|NCT05161481|464563262|FG002|Overall Study|Subject decision|1|||
129075211|NCT04815083|464563263|FG000|Overall Study|Physician Decision|1|||
129075212|NCT04815083|464563263|FG000|Overall Study|Study pause|2|||
129075213|NCT04815083|464563263|FG000|Overall Study|Screening failure|4|||
129075214|NCT04335123|464563265|FG000|Overall Study|Withdrawal by Subject|2|||
129075215|NCT04335123|464563266|FG001|Overall Study|Withdrawal by Subject|0|||
129075216|NCT04335123|464563265|FG000|Overall Study|Physician Decision|2|||
129075217|NCT04335123|464563266|FG001|Overall Study|Physician Decision|0|||
129075218|NCT01283464|464563269|FG000|Overall Study|Lost to Follow-up|0|||
129075219|NCT01283464|464563270|FG001|Overall Study|Lost to Follow-up|1|||
129075220|NCT01283464|464563269|FG000|Overall Study|Withdrawal by Subject|1|||
129075221|NCT01283464|464563270|FG001|Overall Study|Withdrawal by Subject|0|||
129075222|NCT01283464|464563269|FG000|Overall Study|Physician Decision|1|||
129141049|NCT03523585|464810729|FG000|Overall Study|Progressive Disease|174|||
129141050|NCT03523585|464810730|FG001|Overall Study|Progressive Disease|64|||
129141051|NCT03523585|464810731|FG002|Overall Study|Progressive Disease|77|||
129075223|NCT01283464|464563270|FG001|Overall Study|Physician Decision|0|||
129075224|NCT02626026|464563271|FG000|Overall Study|Randomized but Never Treated|0|||
129075225|NCT02626026|464563272|FG001|Overall Study|Randomized but Never Treated|0|||
129075226|NCT02626026|464563273|FG002|Overall Study|Randomized but Never Treated|0|||
129075227|NCT02626026|464563274|FG003|Overall Study|Randomized but Never Treated|0|||
129075228|NCT02626026|464563275|FG004|Overall Study|Randomized but Never Treated|1|||
129075229|NCT02626026|464563276|FG005|Overall Study|Randomized but Never Treated|0|||
129075230|NCT01778855|464563277|FG000|Overall Study|Death|0|||
129075231|NCT01778855|464563278|FG001|Overall Study|Death|1|||
129075232|NCT00191477|464563279|FG000|Overall Study|Tumor Recurrence|49|||
129075233|NCT00191477|464563280|FG001|Overall Study|Tumor Recurrence|48|||
129075234|NCT00191477|464563279|FG000|Overall Study|Death, Study Disease|1|||
129075235|NCT00191477|464563280|FG001|Overall Study|Death, Study Disease|1|||
129075236|NCT00191477|464563279|FG000|Overall Study|Death, Other Cause|3|||
129075237|NCT00191477|464563280|FG001|Overall Study|Death, Other Cause|6|||
129075238|NCT00191477|464563279|FG000|Overall Study|Lost to Follow-up|23|||
129075239|NCT00191477|464563280|FG001|Overall Study|Lost to Follow-up|21|||
129075240|NCT00191477|464563279|FG000|Overall Study|Protocol Violation|1|||
129075241|NCT00191477|464563280|FG001|Overall Study|Protocol Violation|1|||
129075242|NCT00191477|464563279|FG000|Overall Study|Treatment Change|2|||
129075243|NCT00191477|464563280|FG001|Overall Study|Treatment Change|0|||
129075244|NCT00191477|464563279|FG000|Overall Study|Withdrawal by Subject|2|||
129075245|NCT00191477|464563280|FG001|Overall Study|Withdrawal by Subject|0|||
129075246|NCT00191477|464563279|FG000|Overall Study|Other|2|||
129075247|NCT00191477|464563280|FG001|Overall Study|Other|0|||
129075248|NCT00191477|464563279|FG000|Overall Study|Not Eligible|41|||
129075249|NCT00191477|464563280|FG001|Overall Study|Not Eligible|38|||
129141052|NCT03523585|464810729|FG000|Overall Study|Adverse Event|74|||
129141053|NCT03523585|464810730|FG001|Overall Study|Adverse Event|5|||
129141054|NCT03523585|464810731|FG002|Overall Study|Adverse Event|9|||
129141055|NCT03523585|464810729|FG000|Overall Study|Withdrawal by Subject|30|||
129141056|NCT03523585|464810730|FG001|Overall Study|Withdrawal by Subject|11|||
129075250|NCT00191477|464563279|FG000|Overall Study|Pathological Specimen Lost|1|||
129075251|NCT00191477|464563280|FG001|Overall Study|Pathological Specimen Lost|0|||
129075252|NCT00191477|464563279|FG000|Overall Study|Discontinued Prior to Instillation|13|||
129075253|NCT00191477|464563280|FG001|Overall Study|Discontinued Prior to Instillation|14|||
129075254|NCT01286467|464563281|FG000|Overall Study|Death|1|||
129075255|NCT01286467|464563282|FG001|Overall Study|Death|1|||
129141057|NCT03523585|464810731|FG002|Overall Study|Withdrawal by Subject|6|||
129141058|NCT03523585|464810729|FG000|Overall Study|Clinical Progression|23|||
129075256|NCT01286467|464563283|FG002|Overall Study|Death|1|||
129075257|NCT01286467|464563284|FG003|Overall Study|Death|0|||
129075258|NCT01286467|464563281|FG000|Overall Study|Lost to Follow-up|0|||
129075259|NCT01286467|464563282|FG001|Overall Study|Lost to Follow-up|0|||
129075260|NCT01286467|464563283|FG002|Overall Study|Lost to Follow-up|0|||
129141059|NCT03523585|464810730|FG001|Overall Study|Clinical Progression|5|||
129075261|NCT01286467|464563284|FG003|Overall Study|Lost to Follow-up|1|||
129075262|NCT01286467|464563281|FG000|Overall Study|Withdrawal by Subject|0|||
129075263|NCT01286467|464563282|FG001|Overall Study|Withdrawal by Subject|0|||
129075264|NCT01286467|464563283|FG002|Overall Study|Withdrawal by Subject|1|||
129075265|NCT01286467|464563284|FG003|Overall Study|Withdrawal by Subject|0|||
129075266|NCT01286467|464563281|FG000|Overall Study|Physician Decision|0|||
129075267|NCT01286467|464563282|FG001|Overall Study|Physician Decision|0|||
129075268|NCT01286467|464563283|FG002|Overall Study|Physician Decision|0|||
129075269|NCT01286467|464563284|FG003|Overall Study|Physician Decision|1|||
129075270|NCT01286467|464563281|FG000|Overall Study|Disease progression|3|||
129075271|NCT01286467|464563282|FG001|Overall Study|Disease progression|2|||
129075272|NCT01286467|464563283|FG002|Overall Study|Disease progression|2|||
129075273|NCT01286467|464563284|FG003|Overall Study|Disease progression|3|||
129075274|NCT01286467|464563281|FG000|Overall Study|Adverse Event|0|||
129075275|NCT01286467|464563282|FG001|Overall Study|Adverse Event|1|||
129075276|NCT01286467|464563283|FG002|Overall Study|Adverse Event|2|||
129075277|NCT01286467|464563284|FG003|Overall Study|Adverse Event|3|||
129075278|NCT01286467|464563281|FG000|Overall Study|Study drug stop longer than 14 days|0|||
129075279|NCT01286467|464563282|FG001|Overall Study|Study drug stop longer than 14 days|0|||
129075280|NCT01286467|464563283|FG002|Overall Study|Study drug stop longer than 14 days|1|||
129075281|NCT01286467|464563284|FG003|Overall Study|Study drug stop longer than 14 days|0|||
129075282|NCT03876743|464563285|FG000|Overall Study|Lost to Follow-up|6|||
129075283|NCT03876743|464563286|FG001|Overall Study|Lost to Follow-up|4|||
129075284|NCT03876743|464563287|FG002|Overall Study|Lost to Follow-up|4|||
129075285|NCT03876743|464563288|FG003|Overall Study|Lost to Follow-up|7|||
129075286|NCT00092118|464563289|FG000|Overall Study|Adverse Event|35|||
129075287|NCT00092118|464563290|FG001|Overall Study|Adverse Event|32|||
129075288|NCT00092118|464563289|FG000|Overall Study|Lack of Efficacy|12|||
129075289|NCT00092118|464563290|FG001|Overall Study|Lack of Efficacy|14|||
129075290|NCT00092118|464563289|FG000|Overall Study|Lost to Follow-up|4|||
129075291|NCT00092118|464563290|FG001|Overall Study|Lost to Follow-up|3|||
129075292|NCT00092118|464563289|FG000|Overall Study|Protocol Violation|23|||
129075293|NCT00092118|464563290|FG001|Overall Study|Protocol Violation|25|||
129075294|NCT00092118|464563289|FG000|Overall Study|Withdrawal by Subject|4|||
129075295|NCT00092118|464563290|FG001|Overall Study|Withdrawal by Subject|10|||
129075296|NCT00092118|464563289|FG000|Overall Study|Other|6|||
129075297|NCT00092118|464563290|FG001|Overall Study|Other|5|||
129075298|NCT01139125|464563291|FG000|Overall Study|Withdrawal by Subject|1|||
129075299|NCT03751098|464563292|FG000|Overall Study|Withdrawal by Subject|0|||
129075300|NCT03751098|464563293|FG001|Overall Study|Withdrawal by Subject|1|||
129075301|NCT04426006|464563296|FG000|Inclusion|Protocol Violation|1|||
129075302|NCT04426006|464563296|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
129075303|NCT04426006|464563296|FG000|Inclusion|Blood sample at inclusion not done|1|||
129141060|NCT03523585|464810731|FG002|Overall Study|Clinical Progression|10|||
129141061|NCT03523585|464810729|FG000|Overall Study|Death|4|||
129141062|NCT03523585|464810730|FG001|Overall Study|Death|0|||
129141063|NCT03523585|464810731|FG002|Overall Study|Death|1|||
129141064|NCT03523585|464810729|FG000|Overall Study|Physician Decision|2|||
129141065|NCT03523585|464810730|FG001|Overall Study|Physician Decision|1|||
129141066|NCT03523585|464810731|FG002|Overall Study|Physician Decision|0|||
129141067|NCT03523585|464810729|FG000|Overall Study|Lost to Follow-up|1|||
129141068|NCT03523585|464810730|FG001|Overall Study|Lost to Follow-up|0|||
129141069|NCT03523585|464810731|FG002|Overall Study|Lost to Follow-up|0|||
129141070|NCT03523585|464810729|FG000|Overall Study|Miscellaneous|1|||
129141071|NCT03523585|464810730|FG001|Overall Study|Miscellaneous|0|||
129075304|NCT04426006|464563296|FG000|3 Months|Lost to Follow-up|17|||
129075305|NCT04426006|464563296|FG000|12 Months|Lost to Follow-up|38|||
129075306|NCT02946463|464563297|FG000|Primary Evaluation Period|Physician Decision|0|||
129075307|NCT02946463|464563298|FG001|Primary Evaluation Period|Physician Decision|1|||
129075308|NCT02946463|464563299|FG002|Primary Evaluation Period|Physician Decision|0|||
129075309|NCT02946463|464563300|FG003|Primary Evaluation Period|Physician Decision|0|||
129075310|NCT02946463|464563297|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
129075311|NCT02946463|464563298|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
129141072|NCT03523585|464810731|FG002|Overall Study|Miscellaneous|0|||
129141073|NCT03523585|464810729|FG000|Overall Study|Protocol Deviation|1|||
129141074|NCT03523585|464810730|FG001|Overall Study|Protocol Deviation|0|||
129141075|NCT03523585|464810731|FG002|Overall Study|Protocol Deviation|1|||
128723993|NCT00969553|463287301|FG002|Overall Study|Not specified above|0|||
129075312|NCT02946463|464563299|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
129075313|NCT02946463|464563300|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
129075314|NCT02946463|464563297|FG000|Extension Period|Death|4|||
129075315|NCT02946463|464563298|FG001|Extension Period|Death|4|||
129075316|NCT02946463|464563299|FG002|Extension Period|Death|0|||
129075317|NCT02946463|464563300|FG003|Extension Period|Death|0|||
129075318|NCT02946463|464563297|FG000|Extension Period|Withdrawal by Subject|4|||
128723994|NCT00969553|463287302|FG003|Overall Study|Not specified above|4|||
128723995|NCT00969553|463287303|FG004|Overall Study|Not specified above|0|||
129075319|NCT02946463|464563298|FG001|Extension Period|Withdrawal by Subject|3|||
129075320|NCT02946463|464563299|FG002|Extension Period|Withdrawal by Subject|0|||
129075321|NCT02946463|464563300|FG003|Extension Period|Withdrawal by Subject|0|||
129075322|NCT02946463|464563297|FG000|Extension Period|Other than specified|2|||
129075323|NCT02946463|464563298|FG001|Extension Period|Other than specified|3|||
129075324|NCT02946463|464563299|FG002|Extension Period|Other than specified|2|||
129075325|NCT02946463|464563300|FG003|Extension Period|Other than specified|0|||
129075326|NCT02946463|464563297|FG000|Extension Period|Physician Decision|1|||
129075327|NCT02946463|464563298|FG001|Extension Period|Physician Decision|4|||
129075328|NCT02946463|464563299|FG002|Extension Period|Physician Decision|0|||
129075329|NCT02946463|464563300|FG003|Extension Period|Physician Decision|0|||
129075330|NCT02946463|464563297|FG000|Extension Period|Pregnancy|3|||
129075331|NCT02946463|464563298|FG001|Extension Period|Pregnancy|1|||
129075332|NCT02946463|464563299|FG002|Extension Period|Pregnancy|0|||
129075333|NCT02946463|464563300|FG003|Extension Period|Pregnancy|0|||
129075334|NCT02946463|464563297|FG000|Extension Period|Adverse Event|1|||
129075335|NCT02946463|464563298|FG001|Extension Period|Adverse Event|2|||
129075336|NCT02946463|464563299|FG002|Extension Period|Adverse Event|0|||
129075337|NCT02946463|464563300|FG003|Extension Period|Adverse Event|0|||
129075338|NCT02946463|464563297|FG000|Extension Period|Lost to Follow-up|1|||
129075339|NCT02946463|464563298|FG001|Extension Period|Lost to Follow-up|0|||
129075340|NCT02946463|464563299|FG002|Extension Period|Lost to Follow-up|0|||
129075341|NCT02946463|464563300|FG003|Extension Period|Lost to Follow-up|0|||
129075342|NCT05691712|464563301|FG000|Overall Study|Adverse Event|0|||
129075343|NCT05691712|464563302|FG001|Overall Study|Adverse Event|1|||
129075344|NCT05691712|464563303|FG002|Overall Study|Adverse Event|2|||
129075345|NCT05691712|464563304|FG003|Overall Study|Adverse Event|1|||
129075346|NCT05691712|464563301|FG000|Overall Study|Withdrawal by Subject|2|||
129075347|NCT05691712|464563302|FG001|Overall Study|Withdrawal by Subject|3|||
129075348|NCT05691712|464563303|FG002|Overall Study|Withdrawal by Subject|3|||
129075349|NCT05691712|464563304|FG003|Overall Study|Withdrawal by Subject|1|||
129075350|NCT05691712|464563301|FG000|Overall Study|Death|1|||
129075351|NCT05691712|464563302|FG001|Overall Study|Death|0|||
129075352|NCT05691712|464563303|FG002|Overall Study|Death|0|||
129075353|NCT05691712|464563304|FG003|Overall Study|Death|0|||
129075354|NCT05691712|464563301|FG000|Overall Study|Pregnancy|0|||
129075355|NCT05691712|464563302|FG001|Overall Study|Pregnancy|1|||
128723996|NCT00969553|463287304|FG005|Overall Study|Not specified above|0|||
129075356|NCT05691712|464563303|FG002|Overall Study|Pregnancy|0|||
129075357|NCT05691712|464563304|FG003|Overall Study|Pregnancy|0|||
129075358|NCT05691712|464563301|FG000|Overall Study|Assigned Treatment by Mistake|1|||
129075359|NCT05691712|464563302|FG001|Overall Study|Assigned Treatment by Mistake|0|||
129075360|NCT05691712|464563303|FG002|Overall Study|Assigned Treatment by Mistake|0|||
129075361|NCT05691712|464563304|FG003|Overall Study|Assigned Treatment by Mistake|1|||
129075362|NCT02166333|464563308|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
129075363|NCT02166333|464563309|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
129075364|NCT02166333|464563310|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
129075365|NCT02166333|464563311|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
129075366|NCT02166333|464563312|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
129075367|NCT02166333|464563313|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
129075368|NCT02166333|464563308|FG000|Stage 1|Death|4|||
129075369|NCT02166333|464563309|FG001|Stage 1|Death|0|||
129075370|NCT02166333|464563310|FG002|Stage 1|Death|2|||
129075371|NCT02166333|464563311|FG003|Stage 1|Death|0|||
129075372|NCT02166333|464563312|FG004|Stage 1|Death|3|||
129075373|NCT02166333|464563313|FG005|Stage 1|Death|2|||
129075374|NCT02166333|464563308|FG000|Stage 1|Lost to Follow-up|12|||
129075375|NCT02166333|464563309|FG001|Stage 1|Lost to Follow-up|0|||
129075376|NCT02166333|464563310|FG002|Stage 1|Lost to Follow-up|6|||
129075377|NCT02166333|464563311|FG003|Stage 1|Lost to Follow-up|0|||
129075378|NCT02166333|464563312|FG004|Stage 1|Lost to Follow-up|3|||
129075379|NCT02166333|464563313|FG005|Stage 1|Lost to Follow-up|3|||
129075380|NCT02166333|464563308|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
129075381|NCT02166333|464563309|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
129075382|NCT02166333|464563310|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
129075383|NCT02166333|464563311|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
129075384|NCT02166333|464563312|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
129075385|NCT02166333|464563313|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
129075386|NCT02166333|464563308|FG000|Stage 2|Death|4|||
129075387|NCT02166333|464563309|FG001|Stage 2|Death|2|||
129075388|NCT02166333|464563310|FG002|Stage 2|Death|1|||
129075389|NCT02166333|464563311|FG003|Stage 2|Death|0|||
129075390|NCT02166333|464563312|FG004|Stage 2|Death|0|||
129075391|NCT02166333|464563313|FG005|Stage 2|Death|1|||
129075392|NCT02166333|464563308|FG000|Stage 2|Lost to Follow-up|23|||
129075393|NCT02166333|464563309|FG001|Stage 2|Lost to Follow-up|4|||
129075394|NCT02166333|464563310|FG002|Stage 2|Lost to Follow-up|11|||
129075395|NCT02166333|464563311|FG003|Stage 2|Lost to Follow-up|9|||
129075396|NCT02166333|464563312|FG004|Stage 2|Lost to Follow-up|3|||
129075397|NCT02166333|464563313|FG005|Stage 2|Lost to Follow-up|6|||
129075398|NCT00682786|464563314|FG000|Overall Study|Withdrawal by Subject|2|||
129075399|NCT00682786|464563315|FG001|Overall Study|Withdrawal by Subject|2|||
129075400|NCT00682786|464563314|FG000|Overall Study|Did not receive irinotecan|0|||
129075401|NCT00682786|464563315|FG001|Overall Study|Did not receive irinotecan|1|||
129075402|NCT00359424|464563316|FG000|Overall Study|Death|99|||
129075403|NCT00359424|464563317|FG001|Overall Study|Death|58|||
129075404|NCT00359424|464563316|FG000|Overall Study|Lost to Follow-up|19|||
129075405|NCT00359424|464563317|FG001|Overall Study|Lost to Follow-up|7|||
129075406|NCT00359424|464563316|FG000|Overall Study|Withdrawal by Subject|10|||
129075407|NCT00359424|464563317|FG001|Overall Study|Withdrawal by Subject|2|||
129075408|NCT00359424|464563316|FG000|Overall Study|follow up not conducted|2|||
129075409|NCT00359424|464563317|FG001|Overall Study|follow up not conducted|0|||
129075410|NCT01831635|464563318|FG000|Overall Study|Withdrawal by Subject|0|||
129075411|NCT01831635|464563319|FG001|Overall Study|Withdrawal by Subject|2|||
129075412|NCT01831635|464563320|FG002|Overall Study|Withdrawal by Subject|0|||
129075413|NCT03830333|464563323|FG000|Overall Study|Death|0|||
129075414|NCT03830333|464563324|FG001|Overall Study|Death|1|||
129075415|NCT03830333|464563323|FG000|Overall Study|Withdrawal by Subject|5|||
129075416|NCT03830333|464563324|FG001|Overall Study|Withdrawal by Subject|1|||
129075417|NCT03830333|464563323|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
129075418|NCT03830333|464563324|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
129075419|NCT03805412|464563325|FG000|Overall Study|Lost to Follow-up|0|||
129075420|NCT03805412|464563326|FG001|Overall Study|Lost to Follow-up|1|||
129075421|NCT03525678|464563341|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
129075422|NCT03525678|464563342|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
129075423|NCT03525678|464563343|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
129075424|NCT03525678|464563344|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
129075425|NCT03525678|464563345|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
129075426|NCT03525678|464563341|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
129075427|NCT03525678|464563342|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
129075428|NCT03525678|464563343|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
129075429|NCT03525678|464563344|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
129075430|NCT03525678|464563345|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
129075431|NCT03525678|464563341|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
129075432|NCT03525678|464563342|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
129075433|NCT03525678|464563343|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
129075434|NCT03525678|464563344|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
129075435|NCT03525678|464563345|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
129075436|NCT03525678|464563341|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
129075437|NCT03525678|464563342|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
129075438|NCT03525678|464563343|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
129075439|NCT03525678|464563344|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
129075440|NCT03525678|464563345|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
129075441|NCT03525678|464563341|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
129075442|NCT03525678|464563342|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
129075443|NCT03525678|464563343|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
129075444|NCT03525678|464563344|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
129075445|NCT03525678|464563345|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
129075446|NCT03525678|464563341|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
129075447|NCT03525678|464563342|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
129075448|NCT03525678|464563343|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
129075449|NCT03525678|464563344|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
129075450|NCT03525678|464563345|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
129075451|NCT02747108|464563346|FG000|Overall Study|Death|2|||
129075452|NCT02747108|464563347|FG001|Overall Study|Death|2|||
129075453|NCT02747108|464563346|FG000|Overall Study|Withdrawal by Subject|1|||
129075454|NCT02747108|464563347|FG001|Overall Study|Withdrawal by Subject|0|||
129075455|NCT02747108|464563346|FG000|Overall Study|Protocol Violation|2|||
129075456|NCT02747108|464563347|FG001|Overall Study|Protocol Violation|0|||
129075457|NCT04563754|464564451|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
129075458|NCT04563754|464564452|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
129075459|NCT04563754|464564453|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
129075460|NCT04563754|464564451|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
129075461|NCT04563754|464564452|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
129075462|NCT04563754|464564453|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
129075463|NCT04563754|464564451|FG000|Follow up|Lost to Follow-up|61|||
129075464|NCT04563754|464564452|FG001|Follow up|Lost to Follow-up|23|||
129075465|NCT04563754|464564453|FG002|Follow up|Lost to Follow-up|5|||
129075466|NCT04563754|464564451|FG000|Follow up|Death|0|||
129075467|NCT04563754|464564452|FG001|Follow up|Death|2|||
129075468|NCT04563754|464564453|FG002|Follow up|Death|0|||
129075469|NCT04563754|464564451|FG000|Follow up|Ongoing|0|||
129075470|NCT04563754|464564452|FG001|Follow up|Ongoing|28|||
129075471|NCT04563754|464564453|FG002|Follow up|Ongoing|0|||
129075472|NCT04023396|464564454|FG000|Overall Study|Adverse Event|16|||
129075473|NCT04023396|464564454|FG000|Overall Study|Death|1|||
129075474|NCT04023396|464564454|FG000|Overall Study|Lost to Follow-up|1|||
129075475|NCT04023396|464564454|FG000|Overall Study|Withdrawal by Subject|14|||
129075476|NCT04023396|464564454|FG000|Overall Study|Pregnancy|4|||
129075477|NCT04023396|464564454|FG000|Overall Study|Lack of Efficacy|3|||
129075478|NCT04023396|464564454|FG000|Overall Study|Physician Decision|4|||
129075479|NCT04023396|464564454|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
129075480|NCT04075825|464564455|FG000|Overall Study|Withdrawal by Subject|6|||
129075481|NCT04075825|464564456|FG001|Overall Study|Withdrawal by Subject|8|||
129075482|NCT04075825|464564455|FG000|Overall Study|Physician Decision|3|||
129075483|NCT04075825|464564456|FG001|Overall Study|Physician Decision|1|||
129075484|NCT04075825|464564455|FG000|Overall Study|Lost to Follow-up|5|||
129075485|NCT04075825|464564456|FG001|Overall Study|Lost to Follow-up|1|||
129075486|NCT04075825|464564455|FG000|Overall Study|Participation in New Clinical Trial|1|||
129075487|NCT04075825|464564456|FG001|Overall Study|Participation in New Clinical Trial|1|||
129075488|NCT04075825|464564455|FG000|Overall Study|Reason Not Specified|2|||
129075489|NCT04075825|464564456|FG001|Overall Study|Reason Not Specified|2|||
129075490|NCT04225715|464564457|FG000|Overall Study|Reason not Specified|1|||
129075491|NCT04225715|464564458|FG001|Overall Study|Reason not Specified|0|||
129075492|NCT04225715|464564459|FG002|Overall Study|Reason not Specified|0|||
129075493|NCT04225715|464564460|FG003|Overall Study|Reason not Specified|0|||
129075494|NCT04225715|464564461|FG004|Overall Study|Reason not Specified|0|||
129075495|NCT04225715|464564462|FG005|Overall Study|Reason not Specified|0|||
129075496|NCT04225715|464564463|FG006|Overall Study|Reason not Specified|0|||
129075497|NCT04225715|464564464|FG007|Overall Study|Reason not Specified|0|||
129075498|NCT04225715|464564465|FG008|Overall Study|Reason not Specified|0|||
129075499|NCT04225715|464564457|FG000|Overall Study|Protocol Violation|1|||
129075500|NCT04225715|464564458|FG001|Overall Study|Protocol Violation|0|||
129075501|NCT04225715|464564459|FG002|Overall Study|Protocol Violation|0|||
129075502|NCT04225715|464564460|FG003|Overall Study|Protocol Violation|0|||
129075503|NCT04225715|464564461|FG004|Overall Study|Protocol Violation|0|||
129075504|NCT04225715|464564462|FG005|Overall Study|Protocol Violation|9|||
129075505|NCT04225715|464564463|FG006|Overall Study|Protocol Violation|0|||
129075506|NCT04225715|464564464|FG007|Overall Study|Protocol Violation|0|||
129075507|NCT04225715|464564465|FG008|Overall Study|Protocol Violation|0|||
129075508|NCT04225715|464564457|FG000|Overall Study|Withdrawal by Subject|4|||
129075509|NCT04225715|464564458|FG001|Overall Study|Withdrawal by Subject|1|||
129075510|NCT04225715|464564459|FG002|Overall Study|Withdrawal by Subject|1|||
129075511|NCT04225715|464564460|FG003|Overall Study|Withdrawal by Subject|0|||
129075512|NCT04225715|464564461|FG004|Overall Study|Withdrawal by Subject|3|||
129075513|NCT04225715|464564462|FG005|Overall Study|Withdrawal by Subject|1|||
129075514|NCT04225715|464564463|FG006|Overall Study|Withdrawal by Subject|1|||
129075515|NCT04225715|464564464|FG007|Overall Study|Withdrawal by Subject|1|||
129075516|NCT04225715|464564465|FG008|Overall Study|Withdrawal by Subject|0|||
129075517|NCT04225715|464564457|FG000|Overall Study|Adverse Event|0|||
129075518|NCT04225715|464564458|FG001|Overall Study|Adverse Event|0|||
129075519|NCT04225715|464564459|FG002|Overall Study|Adverse Event|0|||
129075520|NCT04225715|464564460|FG003|Overall Study|Adverse Event|0|||
129075521|NCT04225715|464564461|FG004|Overall Study|Adverse Event|0|||
129075522|NCT04225715|464564462|FG005|Overall Study|Adverse Event|0|||
129075523|NCT04225715|464564463|FG006|Overall Study|Adverse Event|0|||
129075524|NCT04225715|464564464|FG007|Overall Study|Adverse Event|0|||
129075525|NCT04225715|464564465|FG008|Overall Study|Adverse Event|1|||
129075526|NCT04225715|464564457|FG000|Overall Study|Arm Terminated By Sponsor|0|||
129075527|NCT04225715|464564458|FG001|Overall Study|Arm Terminated By Sponsor|0|||
129075528|NCT04225715|464564459|FG002|Overall Study|Arm Terminated By Sponsor|0|||
129075529|NCT04225715|464564460|FG003|Overall Study|Arm Terminated By Sponsor|0|||
129075530|NCT04225715|464564461|FG004|Overall Study|Arm Terminated By Sponsor|0|||
129075531|NCT04225715|464564462|FG005|Overall Study|Arm Terminated By Sponsor|0|||
129075532|NCT04225715|464564463|FG006|Overall Study|Arm Terminated By Sponsor|0|||
129075533|NCT04225715|464564464|FG007|Overall Study|Arm Terminated By Sponsor|17|||
129075534|NCT04225715|464564465|FG008|Overall Study|Arm Terminated By Sponsor|18|||
129075535|NCT03318861|464564473|FG000|Overall Study|Death|2|||
129075536|NCT03318861|464564474|FG001|Overall Study|Death|3|||
129075537|NCT03318861|464564475|FG002|Overall Study|Death|3|||
129075538|NCT03318861|464564476|FG003|Overall Study|Death|2|||
129075539|NCT03318861|464564477|FG004|Overall Study|Death|2|||
129075540|NCT03318861|464564473|FG000|Overall Study|Enrolled But Never Treated|0|||
129075541|NCT03318861|464564474|FG001|Overall Study|Enrolled But Never Treated|1|||
129075542|NCT03318861|464564475|FG002|Overall Study|Enrolled But Never Treated|0|||
129075543|NCT03318861|464564476|FG003|Overall Study|Enrolled But Never Treated|1|||
129075544|NCT03318861|464564477|FG004|Overall Study|Enrolled But Never Treated|1|||
129075545|NCT03318861|464564473|FG000|Overall Study|Informed Consent Withdraw|0|||
129075546|NCT03318861|464564474|FG001|Overall Study|Informed Consent Withdraw|0|||
129075547|NCT03318861|464564475|FG002|Overall Study|Informed Consent Withdraw|0|||
129075548|NCT03318861|464564476|FG003|Overall Study|Informed Consent Withdraw|1|||
129075549|NCT03318861|464564477|FG004|Overall Study|Informed Consent Withdraw|0|||
129075550|NCT03318861|464564473|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
129075551|NCT03318861|464564474|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129075552|NCT03318861|464564475|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129075553|NCT03318861|464564476|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129075554|NCT03318861|464564477|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129075555|NCT00917852|464564478|FG000|Overall Study|Death|6|||
129075556|NCT00471081|464564479|FG000|Active Phase|Protocol Violation|1|||
129075557|NCT00471081|464564480|FG001|Active Phase|Protocol Violation|1|||
129075558|NCT00471081|464564479|FG000|Active Phase|Withdrawal by Subject|0|||
129075559|NCT00471081|464564480|FG001|Active Phase|Withdrawal by Subject|3|||
129075560|NCT00471081|464564479|FG000|Active Phase|Lost to Follow-up|0|||
129075561|NCT00471081|464564480|FG001|Active Phase|Lost to Follow-up|1|||
129075562|NCT00471081|464564479|FG000|Active Phase|Lost health plan/insurance|1|||
129075563|NCT00471081|464564480|FG001|Active Phase|Lost health plan/insurance|8|||
129075564|NCT00471081|464564479|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
129075565|NCT00471081|464564480|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
129075566|NCT00471081|464564479|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
129075567|NCT00471081|464564480|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
129075568|NCT00471081|464564479|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
129075569|NCT00471081|464564480|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
129075570|NCT02844933|464564481|FG000|Overall Study|Discontinued due to premature termination of study|3|||
129075571|NCT02844933|464564482|FG001|Overall Study|Discontinued due to premature termination of study|2|||
129075572|NCT04537078|464564483|FG000|Overall Study|Protocol Violation|3|||
129075573|NCT04537078|464564484|FG001|Overall Study|Protocol Violation|2|||
129075574|NCT04537078|464564483|FG000|Overall Study|Lost to Follow-up|1|||
128723997|NCT00969553|463287305|FG006|Overall Study|Not specified above|1|||
129075575|NCT04537078|464564484|FG001|Overall Study|Lost to Follow-up|0|||
129075576|NCT04537078|464564483|FG000|Overall Study|Withdrawal by Subject|0|||
129075577|NCT04537078|464564484|FG001|Overall Study|Withdrawal by Subject|1|||
129075578|NCT01568892|464564486|FG000|Open-label Phase|Adverse Event|2|||
129075579|NCT01568892|464564487|FG001|Open-label Phase|Adverse Event|0|||
129075580|NCT01568892|464564486|FG000|Open-label Phase|Lack of Efficacy|4|||
129075581|NCT01568892|464564487|FG001|Open-label Phase|Lack of Efficacy|2|||
129075582|NCT01568892|464564486|FG000|Open-label Phase|Lost to Follow-up|0|||
129075583|NCT01568892|464564487|FG001|Open-label Phase|Lost to Follow-up|1|||
129141076|NCT03523585|464810729|FG000|Overall Study|Randomized But Not Treated|2|||
129141077|NCT03523585|464810730|FG001|Overall Study|Randomized But Not Treated|4|||
129141078|NCT03523585|464810731|FG002|Overall Study|Randomized But Not Treated|3|||
129141079|NCT02872142|464810737|FG000|Overall Study|Adverse Event|2|||
129141080|NCT02872142|464810737|FG000|Overall Study|Death|1|||
129141081|NCT02872142|464810737|FG000|Overall Study|Participant Decision|3|||
129141082|NCT01903720|464810738|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
129141083|NCT01903720|464810738|FG000|Overall Study|Adverse Event|1|||
129141084|NCT01903720|464810738|FG000|Overall Study|Rescinding of informed consent|2|||
129141085|NCT01903720|464810738|FG000|Overall Study|Lost to Follow-up|2|||
129141086|NCT01903720|464810738|FG000|Overall Study|Treatment with alternative drug|1|||
129141087|NCT02244957|464810739|FG000|Overall Study|Lack of Efficacy|1|||
129141088|NCT02244957|464810740|FG001|Overall Study|Lack of Efficacy|0|||
129141089|NCT00836901|464810741|FG000|First Intervention|Withdrawal by Subject|1|||
129141090|NCT00836901|464810742|FG001|First Intervention|Withdrawal by Subject|0|||
129141091|NCT00830336|464810743|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
129141092|NCT00830336|464810744|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
129141093|NCT00104884|464810749|FG000|Overall Study|Disease progression|4|||
129141094|NCT03760081|464810750|FG000|Overall Study|Miscellaneous|0|||
129141095|NCT03760081|464810751|FG001|Overall Study|Miscellaneous|1|||
129141096|NCT03760081|464810750|FG000|Overall Study|Progressive Disease|5|||
129141097|NCT03760081|464810751|FG001|Overall Study|Progressive Disease|10|||
129141098|NCT03760081|464810750|FG000|Overall Study|Death|1|||
129141099|NCT03760081|464810751|FG001|Overall Study|Death|1|||
129141100|NCT05261490|464810752|FG000|Overall Study|Other|1|||
129141101|NCT05261490|464810753|FG001|Overall Study|Other|0|||
129141102|NCT05261490|464810754|FG002|Overall Study|Other|0|||
129141103|NCT05261490|464810752|FG000|Overall Study|Study Terminated by Sponsor|1|||
129141104|NCT05261490|464810753|FG001|Overall Study|Study Terminated by Sponsor|1|||
129075584|NCT03922308|464564494|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
129075585|NCT03922308|464564495|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
129075586|NCT03922308|464564496|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
129075587|NCT03922308|464564494|FG000|Overall Study|Lost to Follow-up|1|||
129075588|NCT03922308|464564495|FG001|Overall Study|Lost to Follow-up|0|||
129075589|NCT03922308|464564496|FG002|Overall Study|Lost to Follow-up|0|||
129075590|NCT03922308|464564494|FG000|Overall Study|Reason not Specified|0|||
129075591|NCT03922308|464564495|FG001|Overall Study|Reason not Specified|2|||
129075592|NCT03922308|464564496|FG002|Overall Study|Reason not Specified|1|||
129075593|NCT01256450|464564497|FG000|Open-label Titration|Adverse Event|39|||
129075594|NCT01256450|464564498|FG001|Open-label Titration|Adverse Event|0|||
129075595|NCT01256450|464564499|FG002|Open-label Titration|Adverse Event|0|||
129075596|NCT01256450|464564497|FG000|Open-label Titration|Lost to Follow-up|7|||
129075597|NCT01256450|464564498|FG001|Open-label Titration|Lost to Follow-up|0|||
129075598|NCT01256450|464564499|FG002|Open-label Titration|Lost to Follow-up|0|||
129075599|NCT01256450|464564497|FG000|Open-label Titration|Lack of analgesic effect|30|||
129075600|NCT01256450|464564498|FG001|Open-label Titration|Lack of analgesic effect|0|||
129075601|NCT01256450|464564499|FG002|Open-label Titration|Lack of analgesic effect|0|||
129075602|NCT01256450|464564497|FG000|Open-label Titration|Non-compliance|9|||
129075603|NCT01256450|464564498|FG001|Open-label Titration|Non-compliance|0|||
129075604|NCT01256450|464564499|FG002|Open-label Titration|Non-compliance|0|||
129075605|NCT01256450|464564497|FG000|Open-label Titration|Screen failure|1|||
129075606|NCT01256450|464564498|FG001|Open-label Titration|Screen failure|0|||
129075607|NCT01256450|464564499|FG002|Open-label Titration|Screen failure|0|||
129075608|NCT01256450|464564497|FG000|Open-label Titration|Other|13|||
129141105|NCT05261490|464810754|FG002|Overall Study|Study Terminated by Sponsor|4|||
129141106|NCT05261490|464810752|FG000|Overall Study|Death|1|||
129141107|NCT05261490|464810753|FG001|Overall Study|Death|2|||
129141108|NCT05261490|464810754|FG002|Overall Study|Death|0|||
129141109|NCT01646216|464810763|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
129141110|NCT01646216|464810764|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
128723998|NCT00969553|463287306|FG007|Overall Study|Not specified above|1|||
129075609|NCT01256450|464564498|FG001|Open-label Titration|Other|0|||
129141111|NCT01646216|464810763|FG000|Overall Study|Did not complete training|0|||
129141112|NCT01646216|464810764|FG001|Overall Study|Did not complete training|2|||
129141113|NCT01646216|464810763|FG000|Overall Study|Investigator decision|1|||
129141114|NCT01646216|464810764|FG001|Overall Study|Investigator decision|1|||
129141115|NCT02395627|464810765|FG000|Overall Study|Withdrawal by Subject|0|||
129141116|NCT02395627|464810766|FG001|Overall Study|Withdrawal by Subject|2|||
129141117|NCT02395627|464810767|FG002|Overall Study|Withdrawal by Subject|0|||
129075610|NCT01256450|464564499|FG002|Open-label Titration|Other|0|||
129141118|NCT02395627|464810765|FG000|Overall Study|Did not receive pembrolizumab|3|||
129141119|NCT02395627|464810766|FG001|Overall Study|Did not receive pembrolizumab|1|||
129075611|NCT01256450|464564497|FG000|Double-blind Treatment|Adverse Event|0|||
129075612|NCT01256450|464564498|FG001|Double-blind Treatment|Adverse Event|8|||
129075613|NCT01256450|464564499|FG002|Double-blind Treatment|Adverse Event|6|||
129075614|NCT01256450|464564497|FG000|Double-blind Treatment|Lost to Follow-up|0|||
129075615|NCT01256450|464564498|FG001|Double-blind Treatment|Lost to Follow-up|1|||
129075616|NCT01256450|464564499|FG002|Double-blind Treatment|Lost to Follow-up|7|||
129075617|NCT01256450|464564497|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
129075618|NCT01256450|464564498|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
129075619|NCT01256450|464564499|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
129075620|NCT01256450|464564497|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
129075621|NCT01256450|464564498|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
129075622|NCT01256450|464564499|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
129075623|NCT01256450|464564497|FG000|Double-blind Treatment|Non-compliance|0|||
129075624|NCT01256450|464564498|FG001|Double-blind Treatment|Non-compliance|5|||
129075625|NCT01256450|464564499|FG002|Double-blind Treatment|Non-compliance|4|||
129075626|NCT01256450|464564497|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
129075627|NCT01256450|464564498|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
129075628|NCT01256450|464564499|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
129075629|NCT01256450|464564497|FG000|Double-blind Treatment|Other|0|||
129075630|NCT01256450|464564498|FG001|Double-blind Treatment|Other|9|||
129075631|NCT01256450|464564499|FG002|Double-blind Treatment|Other|12|||
129075632|NCT03376789|464564500|FG000|Overall Study|Withdrawal by Subject|3|||
129075633|NCT03376789|464564501|FG001|Overall Study|Withdrawal by Subject|5|||
129075634|NCT03376789|464564500|FG000|Overall Study|Protocol Violation|0|||
129141120|NCT02395627|464810767|FG002|Overall Study|Did not receive pembrolizumab|0|||
129141121|NCT02633527|464810768|FG000|Overall Study|Failed to meet eligibility|0|||
129141122|NCT02633527|464810769|FG001|Overall Study|Failed to meet eligibility|1|||
129141123|NCT02633527|464810770|FG002|Overall Study|Failed to meet eligibility|1|||
129141124|NCT02633527|464810771|FG003|Overall Study|Failed to meet eligibility|0|||
129141125|NCT02633527|464810772|FG004|Overall Study|Failed to meet eligibility|1|||
129141126|NCT02633527|464810768|FG000|Overall Study|Adverse Event|0|||
129141127|NCT02633527|464810769|FG001|Overall Study|Adverse Event|4|||
129141128|NCT02633527|464810770|FG002|Overall Study|Adverse Event|3|||
129141129|NCT02633527|464810771|FG003|Overall Study|Adverse Event|1|||
129141130|NCT02633527|464810772|FG004|Overall Study|Adverse Event|5|||
129141131|NCT02633527|464810768|FG000|Overall Study|Lost to Follow-up|1|||
129141132|NCT02633527|464810769|FG001|Overall Study|Lost to Follow-up|2|||
129141133|NCT02633527|464810770|FG002|Overall Study|Lost to Follow-up|5|||
129141134|NCT02633527|464810771|FG003|Overall Study|Lost to Follow-up|5|||
129141135|NCT02633527|464810772|FG004|Overall Study|Lost to Follow-up|4|||
129141136|NCT02633527|464810768|FG000|Overall Study|Withdrawal by Subject|0|||
129141137|NCT02633527|464810769|FG001|Overall Study|Withdrawal by Subject|3|||
129141138|NCT02633527|464810770|FG002|Overall Study|Withdrawal by Subject|5|||
129141139|NCT02633527|464810771|FG003|Overall Study|Withdrawal by Subject|4|||
129141140|NCT02633527|464810772|FG004|Overall Study|Withdrawal by Subject|4|||
129141141|NCT02633527|464810768|FG000|Overall Study|Protocol Violation|0|||
129141142|NCT02633527|464810769|FG001|Overall Study|Protocol Violation|1|||
129141143|NCT02633527|464810770|FG002|Overall Study|Protocol Violation|1|||
129141144|NCT02633527|464810771|FG003|Overall Study|Protocol Violation|1|||
129141145|NCT02633527|464810772|FG004|Overall Study|Protocol Violation|1|||
129141146|NCT02633527|464810768|FG000|Overall Study|Physician Decision|0|||
129141147|NCT02633527|464810769|FG001|Overall Study|Physician Decision|0|||
129141148|NCT02633527|464810770|FG002|Overall Study|Physician Decision|0|||
129141149|NCT02633527|464810771|FG003|Overall Study|Physician Decision|0|||
129141150|NCT02633527|464810772|FG004|Overall Study|Physician Decision|1|||
129141151|NCT02633527|464810768|FG000|Overall Study|Administrative reason|1|||
129141152|NCT02633527|464810769|FG001|Overall Study|Administrative reason|0|||
129141153|NCT02633527|464810770|FG002|Overall Study|Administrative reason|0|||
129141154|NCT02633527|464810771|FG003|Overall Study|Administrative reason|1|||
129141155|NCT02633527|464810772|FG004|Overall Study|Administrative reason|0|||
129141156|NCT02633527|464810768|FG000|Overall Study|Multiple reasons|1|||
129141157|NCT02633527|464810769|FG001|Overall Study|Multiple reasons|0|||
129141158|NCT02633527|464810770|FG002|Overall Study|Multiple reasons|2|||
129141159|NCT02633527|464810771|FG003|Overall Study|Multiple reasons|2|||
129075635|NCT03376789|464564501|FG001|Overall Study|Protocol Violation|1|||
129141160|NCT02633527|464810772|FG004|Overall Study|Multiple reasons|1|||
129141161|NCT01681849|464810773|FG000|Overall Study|Protocol Violation|2|||
129141162|NCT01681849|464810774|FG001|Overall Study|Protocol Violation|0|||
129141163|NCT01681849|464810775|FG002|Overall Study|Protocol Violation|0|||
129141164|NCT01681849|464810773|FG000|Overall Study|Withdrawal by Subject|3|||
129141165|NCT01681849|464810774|FG001|Overall Study|Withdrawal by Subject|5|||
129075636|NCT03376789|464564500|FG000|Overall Study|Adverse Event|0|||
129075637|NCT03376789|464564501|FG001|Overall Study|Adverse Event|1|||
129075638|NCT03376789|464564500|FG000|Overall Study|Lost to Follow-up|1|||
129075639|NCT03376789|464564501|FG001|Overall Study|Lost to Follow-up|1|||
129141166|NCT01681849|464810775|FG002|Overall Study|Withdrawal by Subject|33|||
129141167|NCT01681849|464810773|FG000|Overall Study|Lost to Follow-up|3|||
129141168|NCT01681849|464810774|FG001|Overall Study|Lost to Follow-up|2|||
129075640|NCT03376789|464564500|FG000|Overall Study|Per sponsor due to noncompliance|1|||
129075641|NCT03376789|464564501|FG001|Overall Study|Per sponsor due to noncompliance|0|||
129075642|NCT03376789|464564500|FG000|Overall Study|Subject off study medication|0|||
129075643|NCT03376789|464564501|FG001|Overall Study|Subject off study medication|1|||
129075644|NCT04177095|464564509|FG000|Overall Study|Withdrawal by Subject|3|||
129075645|NCT04177095|464564509|FG000|Overall Study|Screen Failure|3|||
129075646|NCT04177095|464564509|FG000|Overall Study|Problems with the Trugraf assay|1|||
129075647|NCT00777296|464564510|FG000|Overall Study|Adverse Event|0|||
129075648|NCT00777296|464564511|FG001|Overall Study|Adverse Event|1|||
129075649|NCT00777296|464564512|FG002|Overall Study|Adverse Event|0|||
129075650|NCT00777296|464564513|FG003|Overall Study|Adverse Event|1|||
129075651|NCT00777296|464564510|FG000|Overall Study|Withdrawal by Subject|1|||
129075652|NCT00777296|464564511|FG001|Overall Study|Withdrawal by Subject|0|||
129075653|NCT00777296|464564512|FG002|Overall Study|Withdrawal by Subject|0|||
129075654|NCT00777296|464564513|FG003|Overall Study|Withdrawal by Subject|0|||
129075655|NCT00777296|464564510|FG000|Overall Study|CRF form not completed|0|||
129075656|NCT00777296|464564511|FG001|Overall Study|CRF form not completed|0|||
129075657|NCT00777296|464564512|FG002|Overall Study|CRF form not completed|2|||
129075658|NCT00777296|464564513|FG003|Overall Study|CRF form not completed|0|||
129075659|NCT03889418|464564516|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
129075660|NCT03889418|464564517|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075661|NCT03889418|464564518|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075662|NCT03889418|464564519|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075663|NCT03889418|464564520|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075664|NCT03889418|464564521|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075665|NCT03889418|464564522|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075666|NCT03889418|464564523|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075667|NCT03889418|464564524|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075668|NCT03889418|464564525|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129075669|NCT03889418|464564516|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129075670|NCT03889418|464564517|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
129075671|NCT03889418|464564518|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
129075672|NCT03889418|464564519|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129075673|NCT03889418|464564520|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129075674|NCT03889418|464564521|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129141169|NCT01681849|464810775|FG002|Overall Study|Lost to Follow-up|6|||
129141170|NCT02852005|464810776|FG000|Overall Study|Lost to Follow-up|0|||
129141171|NCT02852005|464810777|FG001|Overall Study|Lost to Follow-up|0|||
129141172|NCT02852005|464810778|FG002|Overall Study|Lost to Follow-up|0|||
129141173|NCT02852005|464810779|FG003|Overall Study|Lost to Follow-up|0|||
129141174|NCT02852005|464810780|FG004|Overall Study|Lost to Follow-up|1|||
129141175|NCT02852005|464810776|FG000|Overall Study|Withdrawal by Subject|1|||
129141176|NCT02852005|464810777|FG001|Overall Study|Withdrawal by Subject|0|||
129141177|NCT02852005|464810778|FG002|Overall Study|Withdrawal by Subject|0|||
129141178|NCT02852005|464810779|FG003|Overall Study|Withdrawal by Subject|0|||
129141179|NCT02852005|464810780|FG004|Overall Study|Withdrawal by Subject|0|||
129141180|NCT02420314|464810783|FG000|Overall Study|Withdrawal by Subject|1|||
129141181|NCT02420314|464810783|FG000|Overall Study|Protocol Violation|1|||
129141182|NCT03760068|464810785|FG000|Overall Study|Withdrawal by Subject|7|||
129141183|NCT03760068|464810786|FG001|Overall Study|Withdrawal by Subject|8|||
129141184|NCT03760068|464810785|FG000|Overall Study|Adverse Event|1|||
129141185|NCT03760068|464810786|FG001|Overall Study|Adverse Event|2|||
129141186|NCT03760068|464810785|FG000|Overall Study|Administrative Decision by Sponsor|0|||
129141187|NCT03760068|464810786|FG001|Overall Study|Administrative Decision by Sponsor|2|||
129141188|NCT03760068|464810785|FG000|Overall Study|Physician Decision|1|||
129141189|NCT03760068|464810786|FG001|Overall Study|Physician Decision|2|||
129075675|NCT03889418|464564522|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129075676|NCT03889418|464564523|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129141190|NCT03760068|464810785|FG000|Overall Study|Lost to Follow-up|4|||
129141191|NCT03760068|464810786|FG001|Overall Study|Lost to Follow-up|9|||
129141192|NCT03760068|464810785|FG000|Overall Study|Subject Moved Out of State|1|||
129075677|NCT03889418|464564524|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129075678|NCT03889418|464564525|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129075679|NCT03889418|464564516|FG000|October-December 2019 (Month 7-9)|Death|0|||
129141193|NCT03760068|464810786|FG001|Overall Study|Subject Moved Out of State|0|||
129141194|NCT03460704|464810790|FG000|Overall Study|Withdrawal by Subject|11|||
129141195|NCT03460704|464810791|FG001|Overall Study|Withdrawal by Subject|14|||
129141196|NCT03460704|464810790|FG000|Overall Study|Study terminated by the Sponsor|29|||
129141197|NCT03460704|464810791|FG001|Overall Study|Study terminated by the Sponsor|19|||
129075680|NCT03889418|464564517|FG001|October-December 2019 (Month 7-9)|Death|0|||
129075681|NCT03889418|464564518|FG002|October-December 2019 (Month 7-9)|Death|0|||
129075682|NCT03889418|464564519|FG003|October-December 2019 (Month 7-9)|Death|0|||
129075683|NCT03889418|464564520|FG004|October-December 2019 (Month 7-9)|Death|0|||
129075684|NCT03889418|464564521|FG005|October-December 2019 (Month 7-9)|Death|0|||
129075685|NCT03889418|464564522|FG006|October-December 2019 (Month 7-9)|Death|0|||
129075686|NCT03889418|464564523|FG007|October-December 2019 (Month 7-9)|Death|0|||
129075687|NCT03889418|464564524|FG008|October-December 2019 (Month 7-9)|Death|1|||
129075688|NCT03889418|464564525|FG009|October-December 2019 (Month 7-9)|Death|0|||
129075689|NCT03889418|464564516|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075690|NCT03889418|464564517|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075691|NCT03889418|464564518|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075692|NCT03889418|464564519|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
129075693|NCT03889418|464564520|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075694|NCT03889418|464564521|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075695|NCT03889418|464564522|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075696|NCT03889418|464564523|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
129075697|NCT03889418|464564524|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075698|NCT03889418|464564525|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129075699|NCT03889418|464564516|FG000|April - June 2020 (Month 13-15)|Death|0|||
129075700|NCT03889418|464564517|FG001|April - June 2020 (Month 13-15)|Death|1|||
129075701|NCT03889418|464564518|FG002|April - June 2020 (Month 13-15)|Death|0|||
129075702|NCT03889418|464564519|FG003|April - June 2020 (Month 13-15)|Death|0|||
129075703|NCT03889418|464564520|FG004|April - June 2020 (Month 13-15)|Death|0|||
129075704|NCT03889418|464564521|FG005|April - June 2020 (Month 13-15)|Death|0|||
129075705|NCT03889418|464564522|FG006|April - June 2020 (Month 13-15)|Death|0|||
129075706|NCT03889418|464564523|FG007|April - June 2020 (Month 13-15)|Death|0|||
129075707|NCT03889418|464564524|FG008|April - June 2020 (Month 13-15)|Death|0|||
129075708|NCT03889418|464564525|FG009|April - June 2020 (Month 13-15)|Death|0|||
129075709|NCT03889418|464564516|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075710|NCT03889418|464564517|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075711|NCT03889418|464564518|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075712|NCT03889418|464564519|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
129075713|NCT03889418|464564520|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075714|NCT03889418|464564521|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075715|NCT03889418|464564522|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075716|NCT03889418|464564523|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075717|NCT03889418|464564524|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075718|NCT03889418|464564525|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129075719|NCT03889418|464564516|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
129075720|NCT03889418|464564517|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
129075721|NCT03889418|464564518|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
129075722|NCT03889418|464564519|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
129075723|NCT03889418|464564520|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
129075724|NCT03889418|464564521|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
129075725|NCT03889418|464564522|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
129075726|NCT03889418|464564523|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
129075727|NCT03889418|464564524|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
129075728|NCT03889418|464564525|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
129075729|NCT03889418|464564516|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129075730|NCT03889418|464564517|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
129075731|NCT03889418|464564518|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
129075732|NCT03889418|464564519|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
129075733|NCT03889418|464564520|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129075734|NCT03889418|464564521|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129075735|NCT03889418|464564522|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129075736|NCT03889418|464564523|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
129075737|NCT03889418|464564524|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129075738|NCT03889418|464564525|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
129075739|NCT01592786|464564527|FG000|Overall Study|Adverse Event|60|||
129075740|NCT01592786|464564527|FG000|Overall Study|Lack of Efficacy|19|||
129075741|NCT01592786|464564527|FG000|Overall Study|Protocol Violation|14|||
129075742|NCT01592786|464564527|FG000|Overall Study|Withdrawal by Subject|23|||
129075743|NCT01592786|464564527|FG000|Overall Study|Lost to Follow-up|19|||
129075744|NCT01592786|464564527|FG000|Overall Study|Other|3|||
129075745|NCT02172664|464564533|FG000|Overall Study|Lost to Follow-up|4|||
129075746|NCT02172664|464564534|FG001|Overall Study|Lost to Follow-up|4|||
129075747|NCT02172664|464564533|FG000|Overall Study|Death|1|||
129075748|NCT02172664|464564534|FG001|Overall Study|Death|1|||
129075749|NCT02172664|464564533|FG000|Overall Study|Moved out of area|1|||
129141198|NCT03460704|464810790|FG000|Overall Study|Adverse Event|10|||
129075750|NCT02172664|464564534|FG001|Overall Study|Moved out of area|1|||
129075751|NCT01909934|464564535|FG000|Overall Study|Withdrawal by Subject|3|||
129075752|NCT01909934|464564535|FG000|Overall Study|Lost to Follow-up|1|||
129075753|NCT01909934|464564535|FG000|Overall Study|Death|25|||
129075754|NCT01909934|464564535|FG000|Overall Study|Withdrawal of Informed Consent|1|||
129075755|NCT01909934|464564535|FG000|Overall Study|Reason Not Specified|1|||
129075756|NCT03810092|464564536|FG000|Overall Study|no ground support|17|||
129075757|NCT03810092|464564536|FG000|Overall Study|ADL not done at J0|16|||
129075758|NCT03810092|464564536|FG000|Overall Study|No hemoglobin measure at J5|27|||
129075759|NCT01139775|464564542|FG000|Overall Study|Adverse Event|0|||
129075760|NCT01139775|464564543|FG001|Overall Study|Adverse Event|6|||
129075761|NCT01139775|464564544|FG002|Overall Study|Adverse Event|2|||
129075762|NCT01139775|464564542|FG000|Overall Study|Protocol Violation|0|||
129075763|NCT01139775|464564543|FG001|Overall Study|Protocol Violation|5|||
129075764|NCT01139775|464564544|FG002|Overall Study|Protocol Violation|0|||
129075765|NCT01139775|464564542|FG000|Overall Study|Withdrawal by Subject|1|||
129075766|NCT01139775|464564543|FG001|Overall Study|Withdrawal by Subject|0|||
129075767|NCT01139775|464564544|FG002|Overall Study|Withdrawal by Subject|2|||
129075768|NCT01139775|464564542|FG000|Overall Study|Physician Decision|0|||
129075769|NCT01139775|464564543|FG001|Overall Study|Physician Decision|2|||
129075770|NCT01139775|464564544|FG002|Overall Study|Physician Decision|2|||
129075771|NCT01753310|464564547|FG000|Overall Study|Entered into open label extension study|25|||
129075772|NCT01753310|464564548|FG001|Overall Study|Entered into open label extension study|22|||
129075773|NCT01753310|464564547|FG000|Overall Study|Adverse Event|1|||
129075774|NCT01753310|464564548|FG001|Overall Study|Adverse Event|0|||
129075775|NCT01753310|464564547|FG000|Overall Study|Lost to Follow-up|2|||
129075776|NCT01753310|464564548|FG001|Overall Study|Lost to Follow-up|0|||
129075777|NCT01753310|464564547|FG000|Overall Study|Subject decision|2|||
129075778|NCT01753310|464564548|FG001|Overall Study|Subject decision|2|||
129075779|NCT01753310|464564547|FG000|Overall Study|Sponsor decision|1|||
129075780|NCT01753310|464564548|FG001|Overall Study|Sponsor decision|0|||
129075781|NCT01753310|464564547|FG000|Overall Study|Withdrawal by Subject|1|||
129075782|NCT01753310|464564548|FG001|Overall Study|Withdrawal by Subject|0|||
129075783|NCT03193853|464564549|FG000|Overall Study|Death|6|||
129075784|NCT02022202|464564550|FG000|Overall Study|Withdrawal by Subject|2|||
129075785|NCT02022202|464564550|FG000|Overall Study|Disease Progression|3|||
129075786|NCT02022202|464564550|FG000|Overall Study|Desire go to immediately to surgery|3|||
129075787|NCT05581641|464564554|FG000|Overall Study|Withdrawal by Subject|0|||
129075788|NCT05581641|464564555|FG001|Overall Study|Withdrawal by Subject|1|||
129075789|NCT05581641|464564556|FG002|Overall Study|Withdrawal by Subject|3|||
129075790|NCT05581641|464564557|FG003|Overall Study|Withdrawal by Subject|1|||
129075791|NCT05581641|464564554|FG000|Overall Study|Lost to Follow-up|0|||
129075792|NCT05581641|464564555|FG001|Overall Study|Lost to Follow-up|1|||
129075793|NCT05581641|464564556|FG002|Overall Study|Lost to Follow-up|0|||
129075794|NCT05581641|464564557|FG003|Overall Study|Lost to Follow-up|1|||
129075795|NCT05581641|464564554|FG000|Overall Study|Protocol Violation|1|||
129075796|NCT05581641|464564555|FG001|Overall Study|Protocol Violation|0|||
129075797|NCT05581641|464564556|FG002|Overall Study|Protocol Violation|0|||
129075798|NCT05581641|464564557|FG003|Overall Study|Protocol Violation|0|||
129075799|NCT05581641|464564554|FG000|Overall Study|Other|1|||
129075800|NCT05581641|464564555|FG001|Overall Study|Other|0|||
129075801|NCT05581641|464564556|FG002|Overall Study|Other|2|||
129075802|NCT05581641|464564557|FG003|Overall Study|Other|1|||
129075803|NCT00503698|464564566|FG000|Overall Study|Protocol Violation|5|||
129075804|NCT00503698|464564567|FG001|Overall Study|Protocol Violation|6|||
129075805|NCT00503698|464564566|FG000|Overall Study|Adverse Event|52|||
129075806|NCT00503698|464564567|FG001|Overall Study|Adverse Event|41|||
129075807|NCT00503698|464564566|FG000|Overall Study|Death|1|||
129075808|NCT00503698|464564567|FG001|Overall Study|Death|0|||
129075809|NCT00503698|464564566|FG000|Overall Study|Lack of Efficacy|3|||
129075810|NCT00503698|464564567|FG001|Overall Study|Lack of Efficacy|4|||
129075811|NCT00503698|464564566|FG000|Overall Study|Trial terminated|216|||
129075812|NCT00503698|464564567|FG001|Overall Study|Trial terminated|253|||
129075813|NCT00503698|464564566|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
129075814|NCT00503698|464564567|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
128723999|NCT00969553|463287307|FG008|Overall Study|Not specified above|0|||
129075815|NCT00503698|464564566|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
129075816|NCT00503698|464564567|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
129075817|NCT00503698|464564566|FG000|Overall Study|Any condition in exclusion criteria|4|||
129075818|NCT00503698|464564567|FG001|Overall Study|Any condition in exclusion criteria|6|||
129075819|NCT00503698|464564566|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
129075820|NCT00503698|464564567|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
129075821|NCT00503698|464564566|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
129075822|NCT00503698|464564567|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
129075823|NCT00503698|464564566|FG000|Overall Study|Critically ill|2|||
129075824|NCT00503698|464564567|FG001|Overall Study|Critically ill|0|||
129075825|NCT00503698|464564566|FG000|Overall Study|Unclassified|48|||
129075826|NCT00503698|464564567|FG001|Overall Study|Unclassified|32|||
129075827|NCT00503698|464564566|FG000|Overall Study|Not exposed to trial drug|11|||
129075828|NCT00503698|464564567|FG001|Overall Study|Not exposed to trial drug|6|||
129075829|NCT02462603|464564575|FG000|Overall Study|Investigator Decision|1|||
129075830|NCT02462603|464564575|FG000|Overall Study|Non-Compliance|1|||
129075831|NCT02462603|464564575|FG000|Overall Study|Withdrawal by Subject|2|||
129075832|NCT01591096|464564577|FG000|Overall Study|Adverse Event|1|||
129075833|NCT01445730|464564578|FG000|Overall Study|Adverse Event|1|||
129075834|NCT01445730|464564578|FG000|Overall Study|For the advice of a dentist|1|||
129075835|NCT01445730|464564578|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
129075836|NCT01546025|464564579|FG000|Overall Study|Lost to Follow-up|0|||
129075837|NCT01546025|464564580|FG001|Overall Study|Lost to Follow-up|1|||
129075838|NCT05514873|464564581|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
129075839|NCT05514873|464564581|FG000|Main Treatment Period|Adverse Event|2|||
129075840|NCT05514873|464564581|FG000|Extension Treatment Period|Lost to Follow-up|3|||
129075841|NCT05177484|464565781|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
129075842|NCT05177484|464565782|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
129075843|NCT05177484|464565781|FG000|Overall Study|Inadvertently withdrawn|3|||
129075844|NCT05177484|464565782|FG001|Overall Study|Inadvertently withdrawn|1|||
129075845|NCT05177484|464565781|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
129075846|NCT05177484|464565782|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
129075847|NCT02393950|464565787|FG000|Overall Study|Adverse Event|1|||
129075848|NCT02393950|464565788|FG001|Overall Study|Adverse Event|0|||
129075849|NCT02393950|464565787|FG000|Overall Study|Withdrawal by Subject|0|||
129075850|NCT02393950|464565788|FG001|Overall Study|Withdrawal by Subject|1|||
129075851|NCT05486091|464565789|FG000|Overall Study|Withdrawal by Subject|1|||
129075852|NCT05486091|464565789|FG000|Overall Study|Lost to Follow-up|2|||
129075853|NCT03971071|464565790|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129075854|NCT03971071|464565791|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
129075855|NCT03971071|464565792|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129075856|NCT03971071|464565793|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129075857|NCT03971071|464565794|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129075858|NCT03971071|464565790|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
129075859|NCT03971071|464565791|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
129075860|NCT03971071|464565792|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
129075861|NCT03971071|464565793|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129075862|NCT03971071|464565794|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129075863|NCT03971071|464565790|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
129075864|NCT03971071|464565791|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
129075865|NCT03971071|464565792|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
129075866|NCT03971071|464565793|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
129075867|NCT03971071|464565794|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
129075868|NCT03971071|464565790|FG000|Open-label Treatment Period|Sponsor decision|0|||
129075869|NCT03971071|464565791|FG001|Open-label Treatment Period|Sponsor decision|0|||
129075870|NCT03971071|464565792|FG002|Open-label Treatment Period|Sponsor decision|0|||
129075871|NCT03971071|464565793|FG003|Open-label Treatment Period|Sponsor decision|0|||
129075872|NCT03971071|464565794|FG004|Open-label Treatment Period|Sponsor decision|1|||
129075873|NCT03971071|464565790|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
129075874|NCT03971071|464565791|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129075875|NCT03971071|464565792|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129075876|NCT03971071|464565793|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
129075877|NCT03971071|464565794|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
129075878|NCT03971071|464565790|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129075879|NCT03971071|464565791|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
129075880|NCT03971071|464565792|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129075881|NCT03971071|464565793|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
129075882|NCT03971071|464565794|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
129075883|NCT01697748|464565795|FG000|Overall Study|ineligible skin incision|1|||
129075884|NCT01697748|464565796|FG001|Overall Study|ineligible skin incision|2|||
129075885|NCT01697748|464565795|FG000|Overall Study|ineligible uterine incision|4|||
129075886|NCT01697748|464565796|FG001|Overall Study|ineligible uterine incision|1|||
129075887|NCT01697748|464565795|FG000|Overall Study|Lost to Follow-up|53|||
129075888|NCT01697748|464565796|FG001|Overall Study|Lost to Follow-up|65|||
129075889|NCT01704495|464565800|FG000|Subjects Randomized|Other Reason|3|||
129075890|NCT01704495|464565801|FG001|Subjects Randomized|Other Reason|2|||
129075891|NCT01704495|464565802|FG002|Subjects Randomized|Other Reason|3|||
129075892|NCT01704495|464565803|FG003|Subjects Randomized|Other Reason|2|||
129075893|NCT01704495|464565800|FG000|Subjects Randomized|Discontinuation criteria met|4|||
129075894|NCT01704495|464565801|FG001|Subjects Randomized|Discontinuation criteria met|2|||
129075895|NCT01704495|464565802|FG002|Subjects Randomized|Discontinuation criteria met|2|||
129075896|NCT01704495|464565803|FG003|Subjects Randomized|Discontinuation criteria met|0|||
129075897|NCT01704495|464565800|FG000|Subjects Randomized|Adverse Event|8|||
129075898|NCT01704495|464565801|FG001|Subjects Randomized|Adverse Event|2|||
129075899|NCT01704495|464565802|FG002|Subjects Randomized|Adverse Event|0|||
129075900|NCT01704495|464565803|FG003|Subjects Randomized|Adverse Event|7|||
129075901|NCT01704495|464565800|FG000|Subjects Randomized|Withdrawal by Subject|5|||
129075902|NCT01704495|464565801|FG001|Subjects Randomized|Withdrawal by Subject|5|||
129075903|NCT01704495|464565802|FG002|Subjects Randomized|Withdrawal by Subject|5|||
129075904|NCT01704495|464565803|FG003|Subjects Randomized|Withdrawal by Subject|5|||
129075905|NCT01704495|464565800|FG000|Subjects Randomized|Protocol Violation|1|||
129075906|NCT01704495|464565801|FG001|Subjects Randomized|Protocol Violation|1|||
129075907|NCT01704495|464565802|FG002|Subjects Randomized|Protocol Violation|2|||
129075908|NCT01704495|464565803|FG003|Subjects Randomized|Protocol Violation|0|||
129075909|NCT01704495|464565800|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
129075910|NCT01704495|464565801|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
129075911|NCT01704495|464565802|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
129075912|NCT01704495|464565803|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
129075913|NCT01704495|464565800|FG000|Optional Safety Extension|Adverse Event|0|||
129075914|NCT01704495|464565801|FG001|Optional Safety Extension|Adverse Event|4|||
129075915|NCT01704495|464565802|FG002|Optional Safety Extension|Adverse Event|0|||
129075916|NCT01704495|464565803|FG003|Optional Safety Extension|Adverse Event|1|||
129075917|NCT01704495|464565800|FG000|Optional Safety Extension|Other reason|27|||
129075918|NCT01704495|464565801|FG001|Optional Safety Extension|Other reason|29|||
129075919|NCT01704495|464565802|FG002|Optional Safety Extension|Other reason|30|||
129075920|NCT01704495|464565803|FG003|Optional Safety Extension|Other reason|28|||
129075921|NCT01704495|464565800|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
129075922|NCT01704495|464565801|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
129075923|NCT01704495|464565802|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
129075924|NCT01704495|464565803|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
129075925|NCT03866512|464565804|FG000|Overall Study|Lost to Follow-up|1|||
129075926|NCT03866512|464565805|FG001|Overall Study|Lost to Follow-up|2|||
129075927|NCT03866512|464565806|FG002|Overall Study|Lost to Follow-up|1|||
129075928|NCT03866512|464565804|FG000|Overall Study|Cannulation issues|0|||
129075929|NCT03866512|464565805|FG001|Overall Study|Cannulation issues|1|||
129075930|NCT03866512|464565806|FG002|Overall Study|Cannulation issues|2|||
129075931|NCT00997373|464565811|FG000|Overall Study|Withdrawal by Subject|5|||
129075932|NCT00997373|464565812|FG001|Overall Study|Withdrawal by Subject|0|||
129075933|NCT00997373|464565811|FG000|Overall Study|wrong tumor type|4|||
129075934|NCT00997373|464565812|FG001|Overall Study|wrong tumor type|0|||
129075935|NCT00997373|464565811|FG000|Overall Study|could not have hysterectomy|6|||
129075936|NCT00997373|464565812|FG001|Overall Study|could not have hysterectomy|0|||
129075937|NCT03210714|464565818|FG000|Overall Study|Adverse Event|6|||
129075938|NCT03210714|464565818|FG000|Overall Study|Physician Decision|1|||
129075939|NCT03210714|464565818|FG000|Overall Study|Progressive disease|11|||
129075940|NCT03210714|464565818|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
129075941|NCT01956773|464565819|FG000|Overall Study|Lost to Follow-up|628|||
129075942|NCT01956773|464565820|FG001|Overall Study|Lost to Follow-up|1|||
129075943|NCT00450437|464565821|FG000|Overall Study|Withdrawal by Subject|10|||
129075944|NCT00450437|464565822|FG001|Overall Study|Withdrawal by Subject|2|||
129075945|NCT00450437|464565823|FG002|Overall Study|Withdrawal by Subject|0|||
129075946|NCT00450437|464565824|FG003|Overall Study|Withdrawal by Subject|1|||
129075947|NCT00450437|464565821|FG000|Overall Study|Lost to Follow-up|31|||
129075948|NCT00450437|464565822|FG001|Overall Study|Lost to Follow-up|12|||
129075949|NCT00450437|464565823|FG002|Overall Study|Lost to Follow-up|19|||
129075950|NCT00450437|464565824|FG003|Overall Study|Lost to Follow-up|9|||
129075951|NCT00450437|464565821|FG000|Overall Study|Protocol Violation|0|||
129075952|NCT00450437|464565822|FG001|Overall Study|Protocol Violation|1|||
129075953|NCT00450437|464565823|FG002|Overall Study|Protocol Violation|0|||
129075954|NCT00450437|464565824|FG003|Overall Study|Protocol Violation|1|||
129075955|NCT00450437|464565821|FG000|Overall Study|Inappropriate enrollment|4|||
129075956|NCT00450437|464565822|FG001|Overall Study|Inappropriate enrollment|1|||
129075957|NCT00450437|464565823|FG002|Overall Study|Inappropriate enrollment|3|||
129075958|NCT00450437|464565824|FG003|Overall Study|Inappropriate enrollment|0|||
129075959|NCT00450437|464565821|FG000|Overall Study|Administrative reason|0|||
129075960|NCT00450437|464565822|FG001|Overall Study|Administrative reason|0|||
129075961|NCT00450437|464565823|FG002|Overall Study|Administrative reason|1|||
129075962|NCT00450437|464565824|FG003|Overall Study|Administrative reason|0|||
129075963|NCT00450437|464565821|FG000|Overall Study|Unable to Classify|1|||
129075964|NCT00450437|464565822|FG001|Overall Study|Unable to Classify|0|||
129075965|NCT00450437|464565823|FG002|Overall Study|Unable to Classify|1|||
129075966|NCT00450437|464565824|FG003|Overall Study|Unable to Classify|0|||
129075967|NCT02492867|464565825|FG000|Overall Study|Alternate therapy|1|||
129075968|NCT02492867|464565825|FG000|Overall Study|Withdrawal by Subject|2|||
129075969|NCT02492867|464565825|FG000|Overall Study|Disease progression after treatment started|1|||
129075970|NCT02492867|464565825|FG000|Overall Study|Death|1|||
129075971|NCT03296527|464565826|FG000|Overall Study|Adverse Event|15|||
129075972|NCT03296527|464565827|FG001|Overall Study|Adverse Event|33|||
129075973|NCT03296527|464565826|FG000|Overall Study|Protocol Deviation|4|||
129075974|NCT03296527|464565827|FG001|Overall Study|Protocol Deviation|0|||
129075975|NCT03296527|464565826|FG000|Overall Study|Participant withdrew consent|3|||
129075976|NCT03296527|464565827|FG001|Overall Study|Participant withdrew consent|1|||
129075977|NCT03296527|464565826|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
129075978|NCT03296527|464565827|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
129075979|NCT03296527|464565826|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
129075980|NCT03296527|464565827|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
129075981|NCT03296527|464565826|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
129075982|NCT03296527|464565827|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
129075983|NCT03296527|464565826|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
129075984|NCT03296527|464565827|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
129075985|NCT03296527|464565826|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
129075986|NCT03296527|464565827|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
129075987|NCT00122382|464565828|FG000|Double-Blind Study|Adverse Event|9|||
129075988|NCT00122382|464565829|FG001|Double-Blind Study|Adverse Event|11|||
129075989|NCT00122382|464565830|FG002|Double-Blind Study|Adverse Event|0|||
129075990|NCT00122382|464565828|FG000|Double-Blind Study|Death|2|||
129075991|NCT00122382|464565829|FG001|Double-Blind Study|Death|2|||
129075992|NCT00122382|464565830|FG002|Double-Blind Study|Death|0|||
129075993|NCT00122382|464565828|FG000|Double-Blind Study|Lack of Efficacy|0|||
129075994|NCT00122382|464565829|FG001|Double-Blind Study|Lack of Efficacy|8|||
129075995|NCT00122382|464565830|FG002|Double-Blind Study|Lack of Efficacy|0|||
129075996|NCT00122382|464565828|FG000|Double-Blind Study|Lost to Follow-up|2|||
129075997|NCT00122382|464565829|FG001|Double-Blind Study|Lost to Follow-up|1|||
129075998|NCT00122382|464565830|FG002|Double-Blind Study|Lost to Follow-up|0|||
129075999|NCT00122382|464565828|FG000|Double-Blind Study|Pregnancy|2|||
129076000|NCT00122382|464565829|FG001|Double-Blind Study|Pregnancy|0|||
129076001|NCT00122382|464565830|FG002|Double-Blind Study|Pregnancy|0|||
129076002|NCT00122382|464565828|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
129076003|NCT00122382|464565829|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
129076004|NCT00122382|464565830|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
129076005|NCT00122382|464565828|FG000|Double-Blind Study|Withdrawal of Consent|7|||
129076006|NCT00122382|464565829|FG001|Double-Blind Study|Withdrawal of Consent|3|||
129076007|NCT00122382|464565830|FG002|Double-Blind Study|Withdrawal of Consent|0|||
129076008|NCT00122382|464565828|FG000|Double-Blind Study|Protocol Violation|1|||
129076009|NCT00122382|464565829|FG001|Double-Blind Study|Protocol Violation|0|||
129076010|NCT00122382|464565830|FG002|Double-Blind Study|Protocol Violation|0|||
129076011|NCT00122382|464565828|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
129076012|NCT00122382|464565829|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
129076013|NCT00122382|464565830|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
129076014|NCT00122382|464565828|FG000|Double-Blind Study|Randomized but not treated|0|||
129076015|NCT00122382|464565829|FG001|Double-Blind Study|Randomized but not treated|2|||
129076016|NCT00122382|464565830|FG002|Double-Blind Study|Randomized but not treated|0|||
129076017|NCT00122382|464565828|FG000|Open-Label Study|Adverse Event|0|||
129076018|NCT00122382|464565829|FG001|Open-Label Study|Adverse Event|0|||
129076019|NCT00122382|464565830|FG002|Open-Label Study|Adverse Event|11|||
129076020|NCT00122382|464565828|FG000|Open-Label Study|Death|0|||
129076021|NCT00122382|464565829|FG001|Open-Label Study|Death|0|||
129076022|NCT00122382|464565830|FG002|Open-Label Study|Death|2|||
129076023|NCT00122382|464565828|FG000|Open-Label Study|Lack of Efficacy|0|||
129141199|NCT03460704|464810791|FG001|Overall Study|Adverse Event|5|||
129141200|NCT03460704|464810790|FG000|Overall Study|Death|3|||
129141201|NCT03460704|464810791|FG001|Overall Study|Death|2|||
129076024|NCT00122382|464565829|FG001|Open-Label Study|Lack of Efficacy|0|||
129076025|NCT00122382|464565830|FG002|Open-Label Study|Lack of Efficacy|3|||
129076026|NCT00122382|464565828|FG000|Open-Label Study|Lost to Follow-up|0|||
129076027|NCT00122382|464565829|FG001|Open-Label Study|Lost to Follow-up|0|||
129076028|NCT00122382|464565830|FG002|Open-Label Study|Lost to Follow-up|3|||
129141202|NCT03460704|464810790|FG000|Overall Study|Non-Compliance with Study Drug|3|||
129076029|NCT00122382|464565828|FG000|Open-Label Study|Pregnancy|0|||
129076030|NCT00122382|464565829|FG001|Open-Label Study|Pregnancy|0|||
129076031|NCT00122382|464565830|FG002|Open-Label Study|Pregnancy|2|||
129076032|NCT00122382|464565828|FG000|Open-Label Study|Poor/Non-Compliance|0|||
129076033|NCT00122382|464565829|FG001|Open-Label Study|Poor/Non-Compliance|0|||
129076034|NCT00122382|464565830|FG002|Open-Label Study|Poor/Non-Compliance|1|||
129076035|NCT00122382|464565828|FG000|Open-Label Study|Withdrawal of Consent|0|||
129076036|NCT00122382|464565829|FG001|Open-Label Study|Withdrawal of Consent|0|||
129076037|NCT00122382|464565830|FG002|Open-Label Study|Withdrawal of Consent|4|||
129076038|NCT02040805|464565831|FG000|Overall Study|Lost to Follow-up|14|||
129076039|NCT02040805|464565832|FG001|Overall Study|Lost to Follow-up|9|||
129076040|NCT02040805|464565831|FG000|Overall Study|Withdrawal by Subject|28|||
129076041|NCT02040805|464565832|FG001|Overall Study|Withdrawal by Subject|41|||
129141203|NCT03460704|464810791|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129141204|NCT03460704|464810790|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129076042|NCT01213966|464565834|FG000|Overall Study|Protocol Violation|1|||
129076043|NCT01213966|464565835|FG001|Overall Study|Protocol Violation|0|||
129076044|NCT01213966|464565836|FG002|Overall Study|Protocol Violation|3|||
129076045|NCT01213966|464565837|FG003|Overall Study|Protocol Violation|1|||
129076046|NCT03591874|464565838|FG000|Overall Study|Adverse Event|4|||
129076047|NCT03591874|464565839|FG001|Overall Study|Adverse Event|0|||
129076048|NCT03591874|464565838|FG000|Overall Study|Withdrawal by Subject|2|||
129076049|NCT03591874|464565839|FG001|Overall Study|Withdrawal by Subject|1|||
129076050|NCT03591874|464565838|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
129076051|NCT03591874|464565839|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
129076052|NCT03591874|464565838|FG000|Overall Study|On Study at Time of Study Termination|12|||
129076053|NCT03591874|464565839|FG001|Overall Study|On Study at Time of Study Termination|6|||
129076054|NCT03644342|464565842|FG000|Overall Study|Adverse Event|2|||
129076055|NCT03644342|464565843|FG001|Overall Study|Adverse Event|0|||
129076056|NCT03644342|464565842|FG000|Overall Study|Protocol Violation|0|||
129076057|NCT03644342|464565843|FG001|Overall Study|Protocol Violation|1|||
129076058|NCT03655405|464565844|FG000|Overall Study|Death after initial data collection|4|||
129076059|NCT03655405|464565845|FG001|Overall Study|Death after initial data collection|2|||
129076060|NCT03655405|464565844|FG000|Overall Study|Died before initial data collection|1|||
129076061|NCT03655405|464565845|FG001|Overall Study|Died before initial data collection|2|||
129076062|NCT03655405|464565844|FG000|Overall Study|Protocol Violation|0|||
129076063|NCT03655405|464565845|FG001|Overall Study|Protocol Violation|1|||
129076064|NCT01991743|464565846|FG000|Overall Study|external cephalic version not performed|0|||
129076065|NCT01991743|464565847|FG001|Overall Study|external cephalic version not performed|0|||
129076066|NCT01991743|464565848|FG002|Overall Study|external cephalic version not performed|1|||
129076067|NCT01991743|464565849|FG003|Overall Study|external cephalic version not performed|0|||
129076068|NCT02859337|464565852|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
129076069|NCT02859337|464565853|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
129076070|NCT02859337|464565854|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
129076071|NCT02859337|464565852|FG000|Overall Study|Withdrawal by Subject|3|||
129076072|NCT02859337|464565853|FG001|Overall Study|Withdrawal by Subject|1|||
129076073|NCT02859337|464565854|FG002|Overall Study|Withdrawal by Subject|0|||
129076074|NCT02859337|464565852|FG000|Overall Study|Lost to Follow-up|1|||
129076075|NCT02859337|464565853|FG001|Overall Study|Lost to Follow-up|0|||
129076076|NCT02859337|464565854|FG002|Overall Study|Lost to Follow-up|0|||
129076077|NCT01167140|464565857|FG000|Overall Study|Withdrawal by Subject|1|||
129076078|NCT00030901|464565858|FG000|Initial Registration|Ineligible|167|||
129076079|NCT00030901|464565859|FG001|Initial Registration|Ineligible|0|||
129076080|NCT00030901|464565860|FG002|Initial Registration|Ineligible|0|||
129076081|NCT00030901|464565858|FG000|Randomization|Adverse Event|0|||
129076082|NCT00030901|464565859|FG001|Randomization|Adverse Event|11|||
129076083|NCT00030901|464565860|FG002|Randomization|Adverse Event|7|||
129076084|NCT00030901|464565858|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
129076085|NCT00030901|464565859|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
129076086|NCT00030901|464565860|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
129076087|NCT00030901|464565858|FG000|Randomization|Progression/Relapse|0|||
129076088|NCT00030901|464565859|FG001|Randomization|Progression/Relapse|22|||
129076089|NCT00030901|464565860|FG002|Randomization|Progression/Relapse|21|||
129076090|NCT00030901|464565858|FG000|Randomization|Death|0|||
129076091|NCT00030901|464565859|FG001|Randomization|Death|1|||
129076092|NCT00030901|464565860|FG002|Randomization|Death|3|||
129076093|NCT00030901|464565858|FG000|Randomization|Other|0|||
129076094|NCT00030901|464565859|FG001|Randomization|Other|36|||
129076095|NCT00030901|464565860|FG002|Randomization|Other|33|||
129076096|NCT00030901|464565858|FG000|Randomization|Ineligible|0|||
129141205|NCT03460704|464810791|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
129141206|NCT03460704|464810790|FG000|Overall Study|Other|2|||
129141207|NCT03460704|464810791|FG001|Overall Study|Other|1|||
129141208|NCT02913326|464810796|FG000|Overall Study|Reason not listed|0|||
129141209|NCT02913326|464810797|FG001|Overall Study|Reason not listed|1|||
129141210|NCT02913326|464810796|FG000|Overall Study|Lost to Follow-up|0|||
129141211|NCT02913326|464810797|FG001|Overall Study|Lost to Follow-up|1|||
129141212|NCT02913326|464810796|FG000|Overall Study|Adverse Event|1|||
129141213|NCT02913326|464810797|FG001|Overall Study|Adverse Event|0|||
129076097|NCT00030901|464565859|FG001|Randomization|Ineligible|15|||
129076098|NCT00030901|464565860|FG002|Randomization|Ineligible|14|||
129076099|NCT01806051|464565863|FG000|Overall Study|Withdrawal by Subject|6|||
129076100|NCT02576847|464565864|FG000|Overall Study|Adverse Event|27|||
129076101|NCT02576847|464565864|FG000|Overall Study|Lost to Follow-up|22|||
129076102|NCT02576847|464565864|FG000|Overall Study|Physician Decision|1|||
129076103|NCT02576847|464565864|FG000|Overall Study|Pregnancy|1|||
129076104|NCT02576847|464565864|FG000|Overall Study|Protocol Violation|3|||
129076105|NCT02576847|464565864|FG000|Overall Study|Withdrawal by Subject|78|||
129076106|NCT02576847|464565864|FG000|Overall Study|Other|5|||
129076107|NCT01205776|464565865|FG000|Overall Study|Lost to Follow-up|53|||
129076108|NCT01205776|464565866|FG001|Overall Study|Lost to Follow-up|61|||
129141214|NCT01767857|464810798|FG000|Overall Study|Adverse Event|27|||
129141215|NCT01767857|464810799|FG001|Overall Study|Adverse Event|7|||
129076109|NCT01205776|464565865|FG000|Overall Study|Withdrawal by Subject|11|||
129076110|NCT01205776|464565866|FG001|Overall Study|Withdrawal by Subject|34|||
129076111|NCT00734994|464565867|FG000|Overall Study|Withdrawal by Subject|1|||
129076112|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
129076113|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129076114|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
129076115|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129076116|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
129076117|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129076118|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129076119|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129076120|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129076121|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129076122|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
129076123|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129076124|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129076125|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
129076126|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129076127|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129076128|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129076129|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129076130|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
129076131|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129076132|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129076133|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
129076134|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129076135|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
129076136|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129076137|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129076138|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129141216|NCT01767857|464810798|FG000|Overall Study|Death|28|||
129141217|NCT01767857|464810799|FG001|Overall Study|Death|13|||
129141218|NCT01767857|464810798|FG000|Overall Study|Lack of Efficacy|299|||
129141219|NCT01767857|464810799|FG001|Overall Study|Lack of Efficacy|151|||
129141220|NCT01767857|464810798|FG000|Overall Study|Lost to Follow-up|1|||
129141221|NCT01767857|464810799|FG001|Overall Study|Lost to Follow-up|1|||
129141222|NCT01767857|464810798|FG000|Overall Study|Withdrawal by Subject|38|||
129141223|NCT01767857|464810799|FG001|Overall Study|Withdrawal by Subject|18|||
129141224|NCT01767857|464810798|FG000|Overall Study|Physician Decision|17|||
129141225|NCT01767857|464810799|FG001|Overall Study|Physician Decision|10|||
129141226|NCT01767857|464810798|FG000|Overall Study|Protocol Terminated|1|||
129141227|NCT01767857|464810799|FG001|Overall Study|Protocol Terminated|0|||
129141228|NCT01767857|464810798|FG000|Overall Study|Randomized But Never Treated|19|||
129141229|NCT01767857|464810799|FG001|Overall Study|Randomized But Never Treated|13|||
129141230|NCT00420056|464810818|FG000|Overall Study|Objective progression or relapse|17|||
129141231|NCT01390584|464810824|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
129141232|NCT01390584|464810825|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
129141233|NCT01390584|464810826|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
129141234|NCT01720602|464810827|FG000|Overall Study|Adverse Event|3|||
129141235|NCT01720602|464810827|FG000|Overall Study|Progressive disease on therapy|2|||
129141236|NCT00452400|464810828|FG000|Overall Study|Adverse Event|1|||
129141237|NCT00452400|464810829|FG001|Overall Study|Adverse Event|1|||
129141238|NCT00452400|464810830|FG002|Overall Study|Adverse Event|5|||
129141239|NCT00452400|464810831|FG003|Overall Study|Adverse Event|0|||
129141240|NCT00452400|464810832|FG004|Overall Study|Adverse Event|2|||
129141241|NCT00452400|464810828|FG000|Overall Study|Protocol Violation|0|||
129141242|NCT00452400|464810829|FG001|Overall Study|Protocol Violation|0|||
129141243|NCT00452400|464810830|FG002|Overall Study|Protocol Violation|1|||
129141244|NCT00452400|464810831|FG003|Overall Study|Protocol Violation|0|||
129141245|NCT00452400|464810832|FG004|Overall Study|Protocol Violation|0|||
129141246|NCT00452400|464810828|FG000|Overall Study|Lost to Follow-up|1|||
129141247|NCT00452400|464810829|FG001|Overall Study|Lost to Follow-up|0|||
129141248|NCT00452400|464810830|FG002|Overall Study|Lost to Follow-up|0|||
129141249|NCT00452400|464810831|FG003|Overall Study|Lost to Follow-up|0|||
129141250|NCT00452400|464810832|FG004|Overall Study|Lost to Follow-up|0|||
129141251|NCT00452400|464810828|FG000|Overall Study|Withdrawal by Subject|1|||
129141252|NCT00452400|464810829|FG001|Overall Study|Withdrawal by Subject|0|||
129076139|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129076140|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129076141|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129076142|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129076143|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129076144|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076145|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076146|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
129076147|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076148|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076149|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076150|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
129076151|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076152|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129141253|NCT00452400|464810830|FG002|Overall Study|Withdrawal by Subject|1|||
129076153|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129076154|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
129076155|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129076156|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129076157|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
129076158|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129076159|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
129076160|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
129076161|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
129076162|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129076163|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129076164|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129076165|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129076166|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129076167|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129076168|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129076169|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
129076170|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129076171|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129076172|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129076173|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129076174|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129076175|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129076176|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129076177|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129076178|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129076179|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129076180|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
129076181|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129076182|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129076183|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129076184|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076185|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076186|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076187|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129141254|NCT00452400|464810831|FG003|Overall Study|Withdrawal by Subject|0|||
129141255|NCT00452400|464810832|FG004|Overall Study|Withdrawal by Subject|0|||
129141256|NCT00452400|464810828|FG000|Overall Study|Lack of Efficacy|2|||
129141257|NCT00452400|464810829|FG001|Overall Study|Lack of Efficacy|0|||
129141258|NCT00452400|464810830|FG002|Overall Study|Lack of Efficacy|0|||
129141259|NCT00452400|464810831|FG003|Overall Study|Lack of Efficacy|0|||
129141260|NCT00452400|464810832|FG004|Overall Study|Lack of Efficacy|0|||
129141261|NCT00452400|464810828|FG000|Overall Study|Other reasons not listed above|0|||
129141262|NCT00452400|464810829|FG001|Overall Study|Other reasons not listed above|0|||
129141263|NCT00452400|464810830|FG002|Overall Study|Other reasons not listed above|0|||
129141264|NCT00452400|464810831|FG003|Overall Study|Other reasons not listed above|1|||
129141265|NCT00452400|464810832|FG004|Overall Study|Other reasons not listed above|1|||
129141266|NCT01943825|464810833|FG000|Overall Study|Lost to Follow-up|9|||
129141267|NCT01943825|464810834|FG001|Overall Study|Lost to Follow-up|3|||
129141268|NCT01943825|464810835|FG002|Overall Study|Lost to Follow-up|12|||
129141269|NCT01943825|464810836|FG003|Overall Study|Lost to Follow-up|8|||
129141270|NCT01943825|464810833|FG000|Overall Study|Withdrawal by Subject|1|||
129141271|NCT01943825|464810834|FG001|Overall Study|Withdrawal by Subject|0|||
129076188|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076189|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
129076190|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076191|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129076192|NCT03896503|464566846|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129076193|NCT03896503|464566847|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129076194|NCT03896503|464566848|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129076195|NCT03896503|464566849|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129076196|NCT03896503|464566850|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129076197|NCT03896503|464566851|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
129076198|NCT03896503|464566852|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
129141272|NCT01943825|464810835|FG002|Overall Study|Withdrawal by Subject|3|||
129141273|NCT01943825|464810836|FG003|Overall Study|Withdrawal by Subject|2|||
129141274|NCT01943825|464810833|FG000|Overall Study|Other than specified above|0|||
129141275|NCT01943825|464810834|FG001|Overall Study|Other than specified above|1|||
129141276|NCT01943825|464810835|FG002|Overall Study|Other than specified above|0|||
129141277|NCT01943825|464810836|FG003|Overall Study|Other than specified above|1|||
129076199|NCT03896503|464566853|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129076200|NCT05734157|464566854|FG000|Overall Study|Death|3|||
129141278|NCT01835431|464810837|FG000|Overall Study|Adverse Event|1|||
129141279|NCT01835431|464810838|FG001|Overall Study|Adverse Event|0|||
129141280|NCT01835431|464810837|FG000|Overall Study|other|0|||
129141281|NCT01835431|464810838|FG001|Overall Study|other|2|||
129141282|NCT01835431|464810837|FG000|Overall Study|Withdrawal by Subject|6|||
129141283|NCT01835431|464810838|FG001|Overall Study|Withdrawal by Subject|10|||
129141284|NCT01835431|464810837|FG000|Overall Study|Protocol Violation|1|||
129141285|NCT01835431|464810838|FG001|Overall Study|Protocol Violation|0|||
129141286|NCT00562861|464810841|FG000|Overall Study|Adverse Event|1|||
129141287|NCT00562861|464810842|FG001|Overall Study|Adverse Event|1|||
129141288|NCT00562861|464810841|FG000|Overall Study|Lack of Efficacy|5|||
129141289|NCT00562861|464810842|FG001|Overall Study|Lack of Efficacy|5|||
129141290|NCT00562861|464810841|FG000|Overall Study|noncompliance, moved|7|||
129141291|NCT00562861|464810842|FG001|Overall Study|noncompliance, moved|2|||
129141292|NCT00562861|464810841|FG000|Overall Study|Lost to Follow-up|7|||
129141293|NCT00562861|464810842|FG001|Overall Study|Lost to Follow-up|3|||
129141294|NCT00655356|464810843|FG000|Overall Study|Withdrawal by Subject|3|||
129141295|NCT00655356|464810844|FG001|Overall Study|Withdrawal by Subject|4|||
129141296|NCT00655356|464810843|FG000|Overall Study|Sponsor Request|10|||
129141297|NCT00655356|464810844|FG001|Overall Study|Sponsor Request|4|||
129141298|NCT00655356|464810843|FG000|Overall Study|Adverse Event|1|||
129141299|NCT00655356|464810844|FG001|Overall Study|Adverse Event|1|||
129141300|NCT00655356|464810843|FG000|Overall Study|Protocol Violation|2|||
129141301|NCT00655356|464810844|FG001|Overall Study|Protocol Violation|1|||
129141302|NCT00655356|464810843|FG000|Overall Study|Other Reason|1|||
129141303|NCT00655356|464810844|FG001|Overall Study|Other Reason|0|||
129141304|NCT04349098|464810845|FG000|Overall Study|Death|16|||
129141305|NCT04349098|464810846|FG001|Overall Study|Death|8|||
129141306|NCT04349098|464810845|FG000|Overall Study|Lost to Follow-up|11|||
129141307|NCT04349098|464810846|FG001|Overall Study|Lost to Follow-up|8|||
129141308|NCT04349098|464810845|FG000|Overall Study|Withdrawal by Subject|8|||
129141309|NCT04349098|464810846|FG001|Overall Study|Withdrawal by Subject|5|||
129141310|NCT04349098|464810845|FG000|Overall Study|Other|3|||
129141311|NCT04349098|464810846|FG001|Overall Study|Other|5|||
129141312|NCT01703221|464810847|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
129141313|NCT01703221|464810848|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
129141314|NCT01703221|464810849|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129141315|NCT01703221|464810847|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
129141316|NCT01703221|464810848|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
129141317|NCT01703221|464810849|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
129141318|NCT01703221|464810847|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
129141319|NCT01703221|464810848|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129141320|NCT01703221|464810849|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129141321|NCT01703221|464810847|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
129141322|NCT01703221|464810848|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129141323|NCT01703221|464810849|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129141324|NCT01703221|464810847|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129076201|NCT05734157|464566854|FG000|Overall Study|Withdrawal by Subject|2|||
129076202|NCT05734157|464566854|FG000|Overall Study|Lost to Follow-up|1|||
129076203|NCT05734157|464566854|FG000|Overall Study|Telephone call|3|||
129076204|NCT01467713|464566856|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
129076205|NCT01467713|464566857|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
129076206|NCT01467713|464566858|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
129076207|NCT01467713|464566859|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
129076208|NCT01467713|464566856|FG000|Overall Study|Major Protocol Deviation|2|||
129076209|NCT01467713|464566857|FG001|Overall Study|Major Protocol Deviation|4|||
129076210|NCT01467713|464566858|FG002|Overall Study|Major Protocol Deviation|4|||
129076211|NCT01467713|464566859|FG003|Overall Study|Major Protocol Deviation|1|||
129076212|NCT01467713|464566856|FG000|Overall Study|Lost to Follow-up|9|||
129076213|NCT01467713|464566857|FG001|Overall Study|Lost to Follow-up|12|||
129076214|NCT01467713|464566858|FG002|Overall Study|Lost to Follow-up|6|||
129076215|NCT01467713|464566859|FG003|Overall Study|Lost to Follow-up|9|||
129076216|NCT01467713|464566856|FG000|Overall Study|Voluntary Withdrawal|18|||
129076217|NCT01467713|464566857|FG001|Overall Study|Voluntary Withdrawal|14|||
129076218|NCT01467713|464566858|FG002|Overall Study|Voluntary Withdrawal|21|||
129076219|NCT01467713|464566859|FG003|Overall Study|Voluntary Withdrawal|20|||
129076220|NCT01467713|464566856|FG000|Overall Study|Study Termination|23|||
129076221|NCT01467713|464566857|FG001|Overall Study|Study Termination|33|||
129076222|NCT01467713|464566858|FG002|Overall Study|Study Termination|28|||
129076223|NCT01467713|464566859|FG003|Overall Study|Study Termination|29|||
129076224|NCT01467713|464566856|FG000|Overall Study|Pregnancy|0|||
129076225|NCT01467713|464566857|FG001|Overall Study|Pregnancy|1|||
129076226|NCT01467713|464566858|FG002|Overall Study|Pregnancy|1|||
129076227|NCT01467713|464566859|FG003|Overall Study|Pregnancy|3|||
129076228|NCT01467713|464566856|FG000|Overall Study|Relapse|35|||
129076229|NCT01467713|464566857|FG001|Overall Study|Relapse|25|||
129076230|NCT01467713|464566858|FG002|Overall Study|Relapse|28|||
129076231|NCT01467713|464566859|FG003|Overall Study|Relapse|35|||
129076232|NCT01467713|464566856|FG000|Overall Study|Reason not Specified|6|||
129076233|NCT01467713|464566857|FG001|Overall Study|Reason not Specified|11|||
129076234|NCT01467713|464566858|FG002|Overall Study|Reason not Specified|8|||
129076235|NCT01467713|464566859|FG003|Overall Study|Reason not Specified|7|||
129076236|NCT00210210|464566860|FG000|Overall Study|Withdrawal by Subject|3|||
129076237|NCT00210210|464566861|FG001|Overall Study|Withdrawal by Subject|2|||
129076238|NCT00210210|464566860|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
129141325|NCT01703221|464810848|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129141326|NCT01703221|464810849|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
129141327|NCT01703221|464810847|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
129141328|NCT01703221|464810848|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
129141329|NCT01703221|464810849|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
129141330|NCT01703221|464810847|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
129141331|NCT01703221|464810848|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
129141332|NCT01703221|464810849|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
129141333|NCT01703221|464810847|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
129141334|NCT01703221|464810848|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
129141335|NCT01703221|464810849|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
129076239|NCT00210210|464566861|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
129076240|NCT01100086|464566863|FG000|Period 1|Withdrawal by Subject|1|||
129076241|NCT01100086|464566864|FG001|Period 1|Withdrawal by Subject|0|||
129076242|NCT01611935|464566867|FG000|Overall Study|Family Declined Participation|1|||
129076243|NCT01611935|464566868|FG001|Overall Study|Family Declined Participation|0|||
129076244|NCT02275546|464566879|FG000|Treatment Period 2|Withdrawal by Subject|2|||
129076245|NCT02275546|464566880|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129141336|NCT03927846|464810851|FG000|Overall Study|Lost to Follow-up|10|||
129141337|NCT03927846|464810852|FG001|Overall Study|Lost to Follow-up|11|||
129076246|NCT02275546|464566879|FG000|Treatment Period 2|Protocol Violation|0|||
129076247|NCT02275546|464566880|FG001|Treatment Period 2|Protocol Violation|1|||
129076248|NCT02955355|464566881|FG000|Overall Study|Adverse Event|4|||
129076249|NCT02955355|464566881|FG000|Overall Study|Death|1|||
129076250|NCT02955355|464566881|FG000|Overall Study|Physician Decision|21|||
129076251|NCT02955355|464566881|FG000|Overall Study|Site Terminated by Sponsor|35|||
129076252|NCT02955355|464566881|FG000|Overall Study|Withdrawal by Subject|19|||
129076253|NCT02955355|464566881|FG000|Overall Study|Reason Not Specified|5|||
129076254|NCT02612623|464566882|FG000|Overall Study|Withdrawal by Subject|0|||
129076255|NCT02612623|464566883|FG001|Overall Study|Withdrawal by Subject|1|||
129076256|NCT02612623|464566884|FG002|Overall Study|Withdrawal by Subject|0|||
129076257|NCT02612623|464566885|FG003|Overall Study|Withdrawal by Subject|0|||
129076258|NCT02612623|464566882|FG000|Overall Study|Adverse Event|1|||
129076259|NCT02612623|464566883|FG001|Overall Study|Adverse Event|0|||
129076260|NCT02612623|464566884|FG002|Overall Study|Adverse Event|1|||
129076261|NCT02612623|464566885|FG003|Overall Study|Adverse Event|0|||
129076262|NCT05344560|464566889|FG000|Period 1|Subject out of visit window|1|||
129076263|NCT05344560|464566890|FG001|Period 1|Subject out of visit window|1|||
129076264|NCT05344560|464566889|FG000|Period 2|Covid-19 Related|1|||
129076265|NCT05344560|464566890|FG001|Period 2|Covid-19 Related|0|||
129076266|NCT05344560|464566889|FG000|Period 2|Adverse Event|1|||
129076267|NCT05344560|464566890|FG001|Period 2|Adverse Event|0|||
129076268|NCT05344560|464566889|FG000|Period 2|Subject out of visit window|1|||
129076269|NCT05344560|464566890|FG001|Period 2|Subject out of visit window|1|||
129076270|NCT05344560|464566889|FG000|Period 3|Subject out of visit window|1|||
129076271|NCT05344560|464566890|FG001|Period 3|Subject out of visit window|0|||
129076272|NCT00360282|464566891|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
129076273|NCT00360282|464566892|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
129076274|NCT00360282|464566893|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
129076275|NCT00360282|464566894|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
129076276|NCT00360282|464566891|FG000|Second Intervention|Adverse Event|0|||
129076277|NCT00360282|464566892|FG001|Second Intervention|Adverse Event|1|||
129076278|NCT00360282|464566893|FG002|Second Intervention|Adverse Event|0|||
129076279|NCT00360282|464566894|FG003|Second Intervention|Adverse Event|0|||
129076280|NCT03817853|464566895|FG000|Induction Phase|Adverse Event|5|||
129076281|NCT03817853|464566896|FG001|Induction Phase|Adverse Event|0|||
129076282|NCT03817853|464566897|FG002|Induction Phase|Adverse Event|0|||
129076283|NCT03817853|464566895|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
129076284|NCT03817853|464566896|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
129076285|NCT03817853|464566897|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
129076286|NCT03817853|464566895|FG000|Induction Phase|Physician Decision|2|||
129076287|NCT03817853|464566896|FG001|Induction Phase|Physician Decision|0|||
129076288|NCT03817853|464566897|FG002|Induction Phase|Physician Decision|0|||
129076289|NCT03817853|464566895|FG000|Induction Phase|Progressive Disease|6|||
129076290|NCT03817853|464566896|FG001|Induction Phase|Progressive Disease|0|||
129076291|NCT03817853|464566897|FG002|Induction Phase|Progressive Disease|0|||
129076292|NCT03817853|464566895|FG000|Induction Phase|Withdrawal by Subject|4|||
129076293|NCT03817853|464566896|FG001|Induction Phase|Withdrawal by Subject|0|||
129076294|NCT03817853|464566897|FG002|Induction Phase|Withdrawal by Subject|0|||
129076295|NCT03817853|464566895|FG000|Maintenance Phase|Adverse Event|0|||
129076296|NCT03817853|464566896|FG001|Maintenance Phase|Adverse Event|8|||
129076297|NCT03817853|464566897|FG002|Maintenance Phase|Adverse Event|0|||
129076298|NCT03817853|464566895|FG000|Maintenance Phase|Death|0|||
129076299|NCT03817853|464566896|FG001|Maintenance Phase|Death|5|||
129076300|NCT03817853|464566897|FG002|Maintenance Phase|Death|0|||
129076301|NCT03817853|464566895|FG000|Maintenance Phase|Progressive Disease|0|||
129076302|NCT03817853|464566896|FG001|Maintenance Phase|Progressive Disease|7|||
129076303|NCT03817853|464566897|FG002|Maintenance Phase|Progressive Disease|0|||
129141338|NCT03878069|464810853|FG000|Overall Study|Death|0|||
129141339|NCT03878069|464810854|FG001|Overall Study|Death|1|||
129141340|NCT03878069|464810855|FG002|Overall Study|Death|0|||
129141341|NCT00834587|464810856|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129141342|NCT00834587|464810857|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129141343|NCT02457546|464812164|FG000|Overall Study|Other reasons|4|||
129076304|NCT03817853|464566895|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129076305|NCT03817853|464566896|FG001|Maintenance Phase|Withdrawal by Subject|2|||
129076306|NCT03817853|464566897|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129076307|NCT03817853|464566895|FG000|Maintenance Phase|Physician Decision|0|||
129076308|NCT03817853|464566896|FG001|Maintenance Phase|Physician Decision|1|||
129076309|NCT03817853|464566897|FG002|Maintenance Phase|Physician Decision|0|||
129076310|NCT03817853|464566895|FG000|Maintenance Phase|Various reasons|0|||
129076311|NCT03817853|464566896|FG001|Maintenance Phase|Various reasons|4|||
129076312|NCT03817853|464566897|FG002|Maintenance Phase|Various reasons|0|||
129076313|NCT03817853|464566895|FG000|Maintenance Phase|Protocol Deviation|0|||
129076314|NCT03817853|464566896|FG001|Maintenance Phase|Protocol Deviation|1|||
129076315|NCT03817853|464566897|FG002|Maintenance Phase|Protocol Deviation|0|||
129076316|NCT03817853|464566895|FG000|Follow-up Phase|Adverse Event|0|||
129076317|NCT03817853|464566896|FG001|Follow-up Phase|Adverse Event|0|||
129076318|NCT03817853|464566897|FG002|Follow-up Phase|Adverse Event|2|||
129076319|NCT03817853|464566895|FG000|Follow-up Phase|Death|0|||
129076320|NCT03817853|464566896|FG001|Follow-up Phase|Death|0|||
129076321|NCT03817853|464566897|FG002|Follow-up Phase|Death|1|||
129076322|NCT03817853|464566895|FG000|Follow-up Phase|Progressive Disease|0|||
129076323|NCT03817853|464566896|FG001|Follow-up Phase|Progressive Disease|0|||
129076324|NCT03817853|464566897|FG002|Follow-up Phase|Progressive Disease|3|||
129076325|NCT03817853|464566895|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129141344|NCT02457546|464812165|FG001|Overall Study|Other reasons|1|||
129141345|NCT02457546|464812164|FG000|Overall Study|Refused to complete study/procedures|1|||
129141346|NCT02457546|464812165|FG001|Overall Study|Refused to complete study/procedures|1|||
129141347|NCT02457546|464812164|FG000|Overall Study|Lost to Follow-up|4|||
129141348|NCT02457546|464812165|FG001|Overall Study|Lost to Follow-up|1|||
129076326|NCT03817853|464566896|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129076327|NCT03817853|464566897|FG002|Follow-up Phase|Withdrawal by Subject|1|||
129076328|NCT00314340|464566898|FG000|Overall Study|lost interest|1|||
129141349|NCT02457546|464812164|FG000|Overall Study|Adverse Event|0|||
129141350|NCT02457546|464812165|FG001|Overall Study|Adverse Event|1|||
129076329|NCT01620138|464566901|FG000|Overall Study|Withdrawal by Subject|3|||
129076330|NCT01620138|464566902|FG001|Overall Study|Withdrawal by Subject|0|||
129076331|NCT01620138|464566901|FG000|Overall Study|Lack of Efficacy|1|||
129076332|NCT01620138|464566902|FG001|Overall Study|Lack of Efficacy|0|||
129076333|NCT01620138|464566901|FG000|Overall Study|Adverse Event|2|||
129076334|NCT01620138|464566902|FG001|Overall Study|Adverse Event|0|||
129076335|NCT00449865|464566905|FG000|Overall Study|Withdrawal by Subject|110|||
129076336|NCT00449865|464566906|FG001|Overall Study|Withdrawal by Subject|110|||
129076337|NCT00449865|464566905|FG000|Overall Study|Lost to Follow-up|36|||
129076338|NCT00449865|464566906|FG001|Overall Study|Lost to Follow-up|37|||
129076339|NCT00449865|464566905|FG000|Overall Study|Physician Decision|13|||
129076340|NCT00449865|464566906|FG001|Overall Study|Physician Decision|12|||
129076341|NCT00449865|464566905|FG000|Overall Study|Death|31|||
129076342|NCT00449865|464566906|FG001|Overall Study|Death|40|||
129076343|NCT00449865|464566905|FG000|Overall Study|Protocol Violation|8|||
129076344|NCT00449865|464566906|FG001|Overall Study|Protocol Violation|7|||
129076345|NCT00449865|464566905|FG000|Overall Study|Study was stopped|324|||
129076346|NCT00449865|464566906|FG001|Overall Study|Study was stopped|328|||
129076347|NCT03252535|464566907|FG000|Overall Study|Withdrawal by Subject|1|||
129076348|NCT03252535|464566908|FG001|Overall Study|Withdrawal by Subject|0|||
129076349|NCT03252535|464566909|FG002|Overall Study|Withdrawal by Subject|0|||
129076350|NCT03252535|464566907|FG000|Overall Study|Physician Decision|0|||
129076351|NCT03252535|464566908|FG001|Overall Study|Physician Decision|1|||
129076352|NCT03252535|464566909|FG002|Overall Study|Physician Decision|0|||
129141351|NCT05069415|464812166|FG000|Overall Study|Withdrawal by Subject|2|||
129141352|NCT05069415|464812167|FG001|Overall Study|Withdrawal by Subject|0|||
129141353|NCT05069415|464812166|FG000|Overall Study|Adverse Event|2|||
129141354|NCT05069415|464812167|FG001|Overall Study|Adverse Event|0|||
129141355|NCT00203242|464812168|FG000|Overall Study|Lost to Follow-up|1|||
129141356|NCT00866775|464812169|FG000|Overall Study|Adverse Event|5|||
129141357|NCT00866775|464812170|FG001|Overall Study|Adverse Event|19|||
129141358|NCT00866775|464812169|FG000|Overall Study|Death|1|||
129141359|NCT00866775|464812170|FG001|Overall Study|Death|0|||
129141360|NCT00866775|464812169|FG000|Overall Study|Lost to Follow-up|0|||
129141361|NCT00866775|464812170|FG001|Overall Study|Lost to Follow-up|4|||
129141362|NCT00866775|464812169|FG000|Overall Study|Physician Decision|0|||
129141363|NCT00866775|464812170|FG001|Overall Study|Physician Decision|3|||
129141364|NCT00866775|464812169|FG000|Overall Study|Protocol Violation|3|||
129141365|NCT00866775|464812170|FG001|Overall Study|Protocol Violation|4|||
129141366|NCT00866775|464812169|FG000|Overall Study|Withdrawal by Subject|4|||
129141367|NCT00866775|464812170|FG001|Overall Study|Withdrawal by Subject|4|||
129141368|NCT00866775|464812169|FG000|Overall Study|met exit criteria|23|||
129076353|NCT03252535|464566907|FG000|Overall Study|Met discontinuation criteria|0|||
129076354|NCT03252535|464566908|FG001|Overall Study|Met discontinuation criteria|1|||
129076355|NCT03252535|464566909|FG002|Overall Study|Met discontinuation criteria|0|||
129076356|NCT05600283|464566910|FG000|Overall Study|Withdrawal by Subject|3|||
129076357|NCT05600283|464566911|FG001|Overall Study|Withdrawal by Subject|8|||
129076358|NCT05600283|464566910|FG000|Overall Study|invalid individual swab|1|||
129076359|NCT05600283|464566911|FG001|Overall Study|invalid individual swab|0|||
129141369|NCT00866775|464812170|FG001|Overall Study|met exit criteria|17|||
129141370|NCT00866775|464812169|FG000|Overall Study|discontinued due to communication error|0|||
129141371|NCT00866775|464812170|FG001|Overall Study|discontinued due to communication error|1|||
129076360|NCT05600283|464566910|FG000|Overall Study|missing clinician collection|3|||
129141372|NCT01500135|464812171|FG000|Overall Study|Withdrawal of Consent|4|||
129141373|NCT01500135|464812172|FG001|Overall Study|Withdrawal of Consent|0|||
129141374|NCT01500135|464812171|FG000|Overall Study|Lost to Follow-up|6|||
129141375|NCT01500135|464812172|FG001|Overall Study|Lost to Follow-up|4|||
129141376|NCT01500135|464812171|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
129141377|NCT01500135|464812172|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
129141378|NCT01500135|464812171|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
129141379|NCT01500135|464812172|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
129141380|NCT01500135|464812171|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
129141381|NCT01500135|464812172|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
129141382|NCT01500135|464812171|FG000|Overall Study|Participant was a Safety Concern|1|||
129141383|NCT01500135|464812172|FG001|Overall Study|Participant was a Safety Concern|0|||
129141384|NCT01500135|464812171|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
129141385|NCT01500135|464812172|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
129141386|NCT05345405|464812173|FG000|Overall Study|Withdrawal by Subject|2|||
129141387|NCT05345405|464812174|FG001|Overall Study|Withdrawal by Subject|0|||
129141388|NCT05345405|464812175|FG002|Overall Study|Withdrawal by Subject|0|||
129141389|NCT05345405|464812173|FG000|Overall Study|Did not meet eligibility criteria|0|||
129141390|NCT05345405|464812174|FG001|Overall Study|Did not meet eligibility criteria|2|||
129141391|NCT05345405|464812175|FG002|Overall Study|Did not meet eligibility criteria|0|||
129141392|NCT05345405|464812173|FG000|Overall Study|Lost to Follow-up|0|||
129141393|NCT05345405|464812174|FG001|Overall Study|Lost to Follow-up|0|||
129141394|NCT05345405|464812175|FG002|Overall Study|Lost to Follow-up|1|||
129141395|NCT03766906|464812177|FG000|Overall Study|Withdrawal by Subject|6|||
129141396|NCT03268499|464812182|FG000|Overall Study|Withdrawal by Subject|2|||
129141397|NCT03268499|464812183|FG001|Overall Study|Withdrawal by Subject|1|||
129141398|NCT03533491|464812184|FG000|Overall Study|Lost to Follow-up|2|||
129141399|NCT01725282|464812187|FG000|Overall Study|Adverse Event|1|||
129141400|NCT01725282|464812188|FG001|Overall Study|Adverse Event|3|||
129141401|NCT01725282|464812189|FG002|Overall Study|Adverse Event|6|||
129141402|NCT01725282|464812190|FG003|Overall Study|Adverse Event|4|||
129141403|NCT01725282|464812187|FG000|Overall Study|Exacerbation of Target Disease|1|||
129141404|NCT01725282|464812188|FG001|Overall Study|Exacerbation of Target Disease|0|||
129141405|NCT01725282|464812189|FG002|Overall Study|Exacerbation of Target Disease|0|||
129141406|NCT01725282|464812190|FG003|Overall Study|Exacerbation of Target Disease|1|||
129141407|NCT01725282|464812187|FG000|Overall Study|Met Exclusion Criteria|0|||
129141408|NCT01725282|464812188|FG001|Overall Study|Met Exclusion Criteria|0|||
129141409|NCT01725282|464812189|FG002|Overall Study|Met Exclusion Criteria|1|||
129141410|NCT01725282|464812190|FG003|Overall Study|Met Exclusion Criteria|0|||
129141411|NCT01725282|464812187|FG000|Overall Study|Study Site Withdrawal|0|||
129141412|NCT01725282|464812188|FG001|Overall Study|Study Site Withdrawal|1|||
129141413|NCT01725282|464812189|FG002|Overall Study|Study Site Withdrawal|0|||
129076361|NCT05600283|464566911|FG001|Overall Study|missing clinician collection|0|||
129076362|NCT05600283|464566910|FG000|Overall Study|screening failure|0|||
129076363|NCT05600283|464566911|FG001|Overall Study|screening failure|2|||
129076364|NCT03907488|464566916|FG000|Overall Study|Adverse Event|20|||
129076365|NCT03907488|464566917|FG001|Overall Study|Adverse Event|20|||
129076366|NCT03907488|464566916|FG000|Overall Study|Withdrawal by Subject|9|||
129076367|NCT03907488|464566917|FG001|Overall Study|Withdrawal by Subject|13|||
129076368|NCT03907488|464566916|FG000|Overall Study|Lack of Efficacy|0|||
129076369|NCT03907488|464566917|FG001|Overall Study|Lack of Efficacy|9|||
129076370|NCT03907488|464566916|FG000|Overall Study|Death|3|||
129076371|NCT03907488|464566917|FG001|Overall Study|Death|8|||
129076372|NCT03907488|464566916|FG000|Overall Study|not protocol specified|5|||
129076373|NCT03907488|464566917|FG001|Overall Study|not protocol specified|8|||
129076374|NCT03907488|464566916|FG000|Overall Study|Ineligible|9|||
129076375|NCT03907488|464566917|FG001|Overall Study|Ineligible|15|||
129076376|NCT02269098|464566918|FG000|Overall Study|Lost to Follow-up|14|||
129076377|NCT02269098|464566919|FG001|Overall Study|Lost to Follow-up|9|||
129076378|NCT03194542|464566922|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
129076379|NCT03194542|464566923|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
129076380|NCT03194542|464566924|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
129141414|NCT01725282|464812190|FG003|Overall Study|Study Site Withdrawal|0|||
129141415|NCT01725282|464812187|FG000|Overall Study|Withdrawal by Subject|0|||
129141416|NCT01725282|464812188|FG001|Overall Study|Withdrawal by Subject|0|||
129141417|NCT01725282|464812189|FG002|Overall Study|Withdrawal by Subject|1|||
129141418|NCT01725282|464812190|FG003|Overall Study|Withdrawal by Subject|1|||
129141419|NCT01725282|464812187|FG000|Overall Study|Lack of Efficacy|0|||
129141420|NCT01725282|464812188|FG001|Overall Study|Lack of Efficacy|1|||
129141421|NCT01725282|464812189|FG002|Overall Study|Lack of Efficacy|0|||
129076381|NCT03194542|464566925|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
129076382|NCT03194542|464566922|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
129076383|NCT03194542|464566923|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
129076384|NCT03194542|464566924|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
129076385|NCT03194542|464566925|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
129076386|NCT03194542|464566922|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
129076387|NCT03194542|464566923|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
129076388|NCT03194542|464566924|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
129076389|NCT03194542|464566925|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
129076390|NCT03194542|464566922|FG000|Overall Study|Loss of Response|4|||
129076391|NCT03194542|464566923|FG001|Overall Study|Loss of Response|2|||
129076392|NCT03194542|464566924|FG002|Overall Study|Loss of Response|3|||
129076393|NCT03194542|464566925|FG003|Overall Study|Loss of Response|4|||
129076394|NCT03194542|464566922|FG000|Overall Study|Physician Decision|0|||
129076395|NCT03194542|464566923|FG001|Overall Study|Physician Decision|1|||
129076396|NCT03194542|464566924|FG002|Overall Study|Physician Decision|0|||
129076397|NCT03194542|464566925|FG003|Overall Study|Physician Decision|0|||
129076398|NCT03194542|464566922|FG000|Overall Study|Lack of Efficacy|2|||
129076399|NCT03194542|464566923|FG001|Overall Study|Lack of Efficacy|2|||
129076400|NCT03194542|464566924|FG002|Overall Study|Lack of Efficacy|2|||
129076401|NCT03194542|464566925|FG003|Overall Study|Lack of Efficacy|6|||
129076402|NCT03194542|464566922|FG000|Overall Study|Withdrawal by Subject|2|||
129076403|NCT03194542|464566923|FG001|Overall Study|Withdrawal by Subject|1|||
129076404|NCT03194542|464566924|FG002|Overall Study|Withdrawal by Subject|5|||
129076405|NCT03194542|464566925|FG003|Overall Study|Withdrawal by Subject|4|||
129076406|NCT03194542|464566922|FG000|Overall Study|Progressive Disease|1|||
129076407|NCT03194542|464566923|FG001|Overall Study|Progressive Disease|0|||
129076408|NCT03194542|464566924|FG002|Overall Study|Progressive Disease|1|||
129076409|NCT03194542|464566925|FG003|Overall Study|Progressive Disease|1|||
129076410|NCT03194542|464566922|FG000|Overall Study|Adverse Event|1|||
129076411|NCT03194542|464566923|FG001|Overall Study|Adverse Event|2|||
129076412|NCT03194542|464566924|FG002|Overall Study|Adverse Event|0|||
129076413|NCT03194542|464566925|FG003|Overall Study|Adverse Event|5|||
129076414|NCT03194542|464566922|FG000|Overall Study|Death|1|||
129076415|NCT03194542|464566923|FG001|Overall Study|Death|2|||
129076416|NCT03194542|464566924|FG002|Overall Study|Death|0|||
129076417|NCT03194542|464566925|FG003|Overall Study|Death|5|||
129076418|NCT03194542|464566922|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
129076419|NCT03194542|464566923|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
129076420|NCT03194542|464566924|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
129076421|NCT03194542|464566925|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
129076422|NCT04762160|464566926|FG000|Overall Study|Study terminated early due to business reasons|5|||
129076423|NCT04390113|464566933|FG000|Overall Study|Not Treated|0|||
129076424|NCT04390113|464566934|FG001|Overall Study|Not Treated|1|||
129076425|NCT04390113|464566933|FG000|Overall Study|Adverse Event|1|||
129076426|NCT04390113|464566934|FG001|Overall Study|Adverse Event|0|||
129076427|NCT04390113|464566933|FG000|Overall Study|Death|2|||
129076428|NCT04390113|464566934|FG001|Overall Study|Death|1|||
129076429|NCT04390113|464566933|FG000|Overall Study|Physician Decision|1|||
129076430|NCT04390113|464566934|FG001|Overall Study|Physician Decision|3|||
129076431|NCT04390113|464566933|FG000|Overall Study|Study Terminated by Sponsor|5|||
129076432|NCT04390113|464566934|FG001|Overall Study|Study Terminated by Sponsor|3|||
129076433|NCT04390113|464566933|FG000|Overall Study|Withdrawal by Subject|10|||
129076434|NCT04390113|464566934|FG001|Overall Study|Withdrawal by Subject|5|||
129076435|NCT04390113|464566933|FG000|Overall Study|Other|1|||
129076436|NCT04390113|464566934|FG001|Overall Study|Other|0|||
129076437|NCT04390113|464566933|FG000|Overall Study|Missing|0|||
129076438|NCT04390113|464566934|FG001|Overall Study|Missing|1|||
129076439|NCT01611883|464566935|FG000|Overall Study|Adverse Event|1|||
129076440|NCT01611883|464566936|FG001|Overall Study|Adverse Event|1|||
129076441|NCT04146012|464566937|FG000|Overall Study|Study Terminated|30|||
129076442|NCT04146012|464566938|FG001|Overall Study|Study Terminated|15|||
129076443|NCT03817190|464566941|FG000|Overall Study|Early Termination|13|||
129076444|NCT03817190|464566942|FG001|Overall Study|Early Termination|20|||
129141422|NCT01725282|464812190|FG003|Overall Study|Lack of Efficacy|1|||
129076445|NCT03817190|464566941|FG000|Overall Study|Adverse Event|10|||
129076446|NCT03817190|464566942|FG001|Overall Study|Adverse Event|17|||
129076447|NCT03817190|464566941|FG000|Overall Study|Withdrawal by Subject|12|||
129141423|NCT04064567|464812191|FG000|Overall Study|Lost to Follow-up|23|||
129141424|NCT04064567|464812192|FG001|Overall Study|Lost to Follow-up|22|||
129076448|NCT03817190|464566942|FG001|Overall Study|Withdrawal by Subject|8|||
129076449|NCT03817190|464566941|FG000|Overall Study|Lost to Follow-up|11|||
129076450|NCT03817190|464566942|FG001|Overall Study|Lost to Follow-up|7|||
129141425|NCT04064567|464812191|FG000|Overall Study|Withdrawal by Subject|0|||
129076451|NCT03817190|464566941|FG000|Overall Study|Lack of Efficacy|7|||
129141426|NCT04064567|464812192|FG001|Overall Study|Withdrawal by Subject|1|||
129141427|NCT04064567|464812191|FG000|Overall Study|Reincarcerated|7|||
129141428|NCT04064567|464812192|FG001|Overall Study|Reincarcerated|10|||
129141429|NCT04064567|464812191|FG000|Overall Study|Moved out of U.S.|0|||
129141430|NCT04064567|464812192|FG001|Overall Study|Moved out of U.S.|1|||
129141431|NCT04576481|464812194|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
129141432|NCT04576481|464812195|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
129141433|NCT04576481|464812196|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
129141434|NCT04576481|464812197|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
129141435|NCT01682720|464812198|FG000|Overall Study|Randomized but Not Treated|0|||
129076452|NCT03817190|464566942|FG001|Overall Study|Lack of Efficacy|5|||
129076453|NCT03817190|464566941|FG000|Overall Study|Investigator Decision|5|||
129076454|NCT03817190|464566942|FG001|Overall Study|Investigator Decision|1|||
129076455|NCT03817190|464566941|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
129076456|NCT03817190|464566942|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
129076457|NCT03817190|464566941|FG000|Overall Study|Lack of Contact|1|||
129076458|NCT03817190|464566942|FG001|Overall Study|Lack of Contact|0|||
129076459|NCT03817190|464566941|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
129076460|NCT03817190|464566942|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
129076461|NCT01622673|464566943|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129076462|NCT01622673|464566944|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129076463|NCT01622673|464566945|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129076464|NCT01622673|464566946|FG003|Treatment Period 1|Withdrawal by Subject|1|||
129076465|NCT01622673|464566947|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129076466|NCT01622673|464566948|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129076467|NCT01622673|464566943|FG000|Treatment Period 1|Protocol Violation|0|||
129076468|NCT01622673|464566944|FG001|Treatment Period 1|Protocol Violation|1|||
129076469|NCT01622673|464566945|FG002|Treatment Period 1|Protocol Violation|0|||
129076470|NCT01622673|464566946|FG003|Treatment Period 1|Protocol Violation|0|||
129076471|NCT01622673|464566947|FG004|Treatment Period 1|Protocol Violation|0|||
129076472|NCT01622673|464566948|FG005|Treatment Period 1|Protocol Violation|0|||
129076473|NCT01622673|464566943|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129076474|NCT01622673|464566944|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129076475|NCT01622673|464566945|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129076476|NCT01622673|464566946|FG003|Treatment Period 2|Withdrawal by Subject|1|||
129076477|NCT01622673|464566947|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129076478|NCT01622673|464566948|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129076479|NCT01622673|464566943|FG000|Treatment Period 3|Protocol Violation|0|||
129076480|NCT01622673|464566944|FG001|Treatment Period 3|Protocol Violation|1|||
129076481|NCT01622673|464566945|FG002|Treatment Period 3|Protocol Violation|0|||
129076482|NCT01622673|464566946|FG003|Treatment Period 3|Protocol Violation|0|||
129076483|NCT01622673|464566947|FG004|Treatment Period 3|Protocol Violation|0|||
129076484|NCT01622673|464566948|FG005|Treatment Period 3|Protocol Violation|0|||
129076485|NCT05142722|464568021|FG000|Overall Study|Lost to Follow-up|16|||
129076486|NCT05142722|464568022|FG001|Overall Study|Lost to Follow-up|38|||
129076487|NCT05142722|464568021|FG000|Overall Study|Withdrawal by Subject|20|||
129076488|NCT05142722|464568022|FG001|Overall Study|Withdrawal by Subject|27|||
129076489|NCT05142722|464568021|FG000|Overall Study|Death|11|||
129076490|NCT05142722|464568022|FG001|Overall Study|Death|17|||
129076491|NCT05142722|464568021|FG000|Overall Study|Physician Decision|0|||
129076492|NCT05142722|464568022|FG001|Overall Study|Physician Decision|1|||
129076493|NCT05142722|464568021|FG000|Overall Study|Participant Moved Away|0|||
129076494|NCT05142722|464568022|FG001|Overall Study|Participant Moved Away|2|||
129076495|NCT05142722|464568021|FG000|Overall Study|Adverse Event|2|||
129076496|NCT05142722|464568022|FG001|Overall Study|Adverse Event|1|||
129141436|NCT01682720|464812199|FG001|Overall Study|Randomized but Not Treated|1|||
129141437|NCT01682720|464812200|FG002|Overall Study|Randomized but Not Treated|1|||
129141438|NCT01682720|464812201|FG003|Overall Study|Randomized but Not Treated|0|||
129141439|NCT01682720|464812198|FG000|Overall Study|Terminated by Sponsor|83|||
129141440|NCT01682720|464812199|FG001|Overall Study|Terminated by Sponsor|0|||
129141441|NCT01682720|464812200|FG002|Overall Study|Terminated by Sponsor|0|||
129141442|NCT01682720|464812201|FG003|Overall Study|Terminated by Sponsor|0|||
129141443|NCT01682720|464812198|FG000|Overall Study|Efficacy Failure|0|||
129141444|NCT01682720|464812199|FG001|Overall Study|Efficacy Failure|3|||
129141445|NCT01682720|464812200|FG002|Overall Study|Efficacy Failure|3|||
129141446|NCT01682720|464812201|FG003|Overall Study|Efficacy Failure|30|||
129076497|NCT05731700|464568023|FG000|Overall Study|Death|1|||
129076498|NCT00437021|464568040|FG000|Overall Study|Adverse Event|0|||
129076499|NCT00437021|464568041|FG001|Overall Study|Adverse Event|0|||
129076500|NCT00437021|464568042|FG002|Overall Study|Adverse Event|0|||
129076501|NCT00437021|464568043|FG003|Overall Study|Adverse Event|0|||
129076502|NCT00437021|464568044|FG004|Overall Study|Adverse Event|0|||
129076503|NCT00437021|464568045|FG005|Overall Study|Adverse Event|0|||
129076504|NCT00437021|464568046|FG006|Overall Study|Adverse Event|1|||
129076505|NCT00437021|464568047|FG007|Overall Study|Adverse Event|0|||
129076506|NCT00437021|464568048|FG008|Overall Study|Adverse Event|0|||
129076507|NCT00437021|464568049|FG009|Overall Study|Adverse Event|0|||
129076508|NCT00437021|464568050|FG010|Overall Study|Adverse Event|0|||
129076509|NCT00437021|464568051|FG011|Overall Study|Adverse Event|0|||
129076510|NCT00437021|464568040|FG000|Overall Study|Lost to Follow-up|0|||
129076511|NCT00437021|464568041|FG001|Overall Study|Lost to Follow-up|3|||
129076512|NCT00437021|464568042|FG002|Overall Study|Lost to Follow-up|0|||
129076513|NCT00437021|464568043|FG003|Overall Study|Lost to Follow-up|0|||
129076514|NCT00437021|464568044|FG004|Overall Study|Lost to Follow-up|0|||
129076515|NCT00437021|464568045|FG005|Overall Study|Lost to Follow-up|2|||
129076516|NCT00437021|464568046|FG006|Overall Study|Lost to Follow-up|0|||
129076517|NCT00437021|464568047|FG007|Overall Study|Lost to Follow-up|1|||
129076518|NCT00437021|464568048|FG008|Overall Study|Lost to Follow-up|0|||
129076519|NCT00437021|464568049|FG009|Overall Study|Lost to Follow-up|0|||
129076520|NCT00437021|464568050|FG010|Overall Study|Lost to Follow-up|0|||
129076521|NCT00437021|464568051|FG011|Overall Study|Lost to Follow-up|0|||
129076522|NCT00437021|464568040|FG000|Overall Study|Withdrawal by Subject|2|||
129076523|NCT00437021|464568041|FG001|Overall Study|Withdrawal by Subject|1|||
129076524|NCT00437021|464568042|FG002|Overall Study|Withdrawal by Subject|0|||
129076525|NCT00437021|464568043|FG003|Overall Study|Withdrawal by Subject|0|||
129076526|NCT00437021|464568044|FG004|Overall Study|Withdrawal by Subject|0|||
129076527|NCT00437021|464568045|FG005|Overall Study|Withdrawal by Subject|0|||
129076528|NCT00437021|464568046|FG006|Overall Study|Withdrawal by Subject|0|||
129076529|NCT00437021|464568047|FG007|Overall Study|Withdrawal by Subject|0|||
129076530|NCT00437021|464568048|FG008|Overall Study|Withdrawal by Subject|0|||
129076531|NCT00437021|464568049|FG009|Overall Study|Withdrawal by Subject|0|||
129076532|NCT00437021|464568050|FG010|Overall Study|Withdrawal by Subject|0|||
129076533|NCT00437021|464568051|FG011|Overall Study|Withdrawal by Subject|0|||
129076534|NCT05468164|464568052|FG000|Treatment Period 4|Adverse Event|0|||
129076535|NCT05468164|464568053|FG001|Treatment Period 4|Adverse Event|0|||
129076536|NCT05468164|464568054|FG002|Treatment Period 4|Adverse Event|0|||
129076537|NCT05468164|464568055|FG003|Treatment Period 4|Adverse Event|1|||
129076538|NCT02954601|464568056|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
129076539|NCT02954601|464568057|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
129076540|NCT02954601|464568058|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
129076541|NCT02954601|464568059|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
129076542|NCT00333983|464568063|FG000|Overall Study|Lost to Follow-up|2|||
129076543|NCT00333983|464568064|FG001|Overall Study|Lost to Follow-up|1|||
129076544|NCT00333983|464568065|FG002|Overall Study|Lost to Follow-up|0|||
129076545|NCT00333983|464568063|FG000|Overall Study|Adverse Event|1|||
129076546|NCT00333983|464568064|FG001|Overall Study|Adverse Event|1|||
129076547|NCT00333983|464568065|FG002|Overall Study|Adverse Event|1|||
129076548|NCT00333983|464568063|FG000|Overall Study|Withdrawal by Subject|0|||
129076549|NCT00333983|464568064|FG001|Overall Study|Withdrawal by Subject|3|||
129076550|NCT00333983|464568065|FG002|Overall Study|Withdrawal by Subject|1|||
129076551|NCT04227197|464568066|FG000|Randomization|Protocol Violation|1|||
129141447|NCT01682720|464812198|FG000|Overall Study|Lost to Follow-up|1|||
129141448|NCT01682720|464812199|FG001|Overall Study|Lost to Follow-up|1|||
129141449|NCT01682720|464812200|FG002|Overall Study|Lost to Follow-up|0|||
129141450|NCT01682720|464812201|FG003|Overall Study|Lost to Follow-up|6|||
129141451|NCT01682720|464812198|FG000|Overall Study|Subject Withdrew Consent|0|||
129141452|NCT01682720|464812199|FG001|Overall Study|Subject Withdrew Consent|0|||
129141453|NCT01682720|464812200|FG002|Overall Study|Subject Withdrew Consent|2|||
129141454|NCT01682720|464812201|FG003|Overall Study|Subject Withdrew Consent|2|||
129141455|NCT01682720|464812198|FG000|Overall Study|Adverse Event|1|||
129141456|NCT01682720|464812199|FG001|Overall Study|Adverse Event|0|||
129141457|NCT01682720|464812200|FG002|Overall Study|Adverse Event|1|||
129141458|NCT01682720|464812201|FG003|Overall Study|Adverse Event|1|||
129141459|NCT00069953|464812205|FG000|Overall Study|Protocol Violation|2|||
129141460|NCT02034565|464812206|FG000|Overall Study|Adverse Event|1|||
129141461|NCT02034565|464812207|FG001|Overall Study|Adverse Event|0|||
129076552|NCT04227197|464568067|FG001|Randomization|Protocol Violation|0|||
129076553|NCT04227197|464568066|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
129076554|NCT04227197|464568067|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
129076555|NCT04227197|464568066|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
129076556|NCT04227197|464568067|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
129076557|NCT04227197|464568066|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
129076558|NCT04227197|464568067|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
129076559|NCT04227197|464568066|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
129141462|NCT00113373|464812208|FG000|Overall Study|Ineligible: wrong primary|1|||
129141463|NCT00113373|464812208|FG000|Overall Study|Ineligible: second primary|1|||
129141464|NCT00113373|464812208|FG000|Overall Study|Never Treated|1|||
129141465|NCT04525183|464812214|FG000|Overall Study|Withdrawal by Subject|0|||
129141466|NCT04525183|464812215|FG001|Overall Study|Withdrawal by Subject|0|||
129076560|NCT04227197|464568067|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
129076561|NCT04227197|464568066|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
129076562|NCT04227197|464568067|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
129076563|NCT04227197|464568066|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
129076564|NCT04227197|464568067|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
129076565|NCT00570141|464568068|FG000|Overall Study|Adverse Event|1|||
129076566|NCT00570141|464568068|FG000|Overall Study|Missed visits|1|||
129076567|NCT00570141|464568068|FG000|Overall Study|Lost to Follow-up|1|||
129076568|NCT01209949|464568078|FG000|Overall Study|Lost to Follow-up|3|||
129076569|NCT00729612|464568083|FG000|Overall Study|Non evaluable for response|10|||
129076570|NCT02075203|464568087|FG000|Overall Study|Withdrawal by Subject|1|||
129076571|NCT02075203|464568088|FG001|Overall Study|Withdrawal by Subject|0|||
129076572|NCT02075203|464568089|FG002|Overall Study|Withdrawal by Subject|1|||
129076573|NCT02075203|464568087|FG000|Overall Study|Adverse Event|1|||
129076574|NCT02075203|464568088|FG001|Overall Study|Adverse Event|0|||
129076575|NCT02075203|464568089|FG002|Overall Study|Adverse Event|0|||
129076576|NCT02075203|464568087|FG000|Overall Study|participant refused to use contraception|1|||
129076577|NCT02075203|464568088|FG001|Overall Study|participant refused to use contraception|0|||
129076578|NCT02075203|464568089|FG002|Overall Study|participant refused to use contraception|0|||
129076579|NCT05266053|464568090|FG000|Overall Study|Withdrawal by Subject|8|||
129076580|NCT05266053|464568091|FG001|Overall Study|Withdrawal by Subject|4|||
129076581|NCT02996968|464568092|FG000|Overall Study|Withdrawal by Subject|1|||
129076582|NCT02996968|464568093|FG001|Overall Study|Withdrawal by Subject|0|||
129076583|NCT00444535|464568096|FG000|Overall Study|Withdrawal by Subject|5|||
129076584|NCT00444535|464568096|FG000|Overall Study|Physician Decision|5|||
129076585|NCT00444535|464568096|FG000|Overall Study|progressive disease|1|||
129076586|NCT00444535|464568096|FG000|Overall Study|Adverse Event|2|||
129076587|NCT02556775|464568097|FG000|Overall Study|Withdrawal by Subject|1|||
129076588|NCT02556775|464568098|FG001|Overall Study|Withdrawal by Subject|0|||
129076589|NCT02556775|464568099|FG002|Overall Study|Withdrawal by Subject|1|||
129076590|NCT02556775|464568100|FG003|Overall Study|Withdrawal by Subject|0|||
129076591|NCT02556775|464568097|FG000|Overall Study|Lost to Follow-up|1|||
129076592|NCT02556775|464568098|FG001|Overall Study|Lost to Follow-up|0|||
129076593|NCT02556775|464568099|FG002|Overall Study|Lost to Follow-up|0|||
129076594|NCT02556775|464568100|FG003|Overall Study|Lost to Follow-up|0|||
129076595|NCT01346059|464568101|FG000|Overall Study|Withdrawal by Subject|1|||
129076596|NCT01346059|464568102|FG001|Overall Study|Withdrawal by Subject|0|||
129076597|NCT00558467|464568106|FG000|Overall Study|Adverse Event|1|||
129076598|NCT00558467|464568107|FG001|Overall Study|Adverse Event|2|||
129076599|NCT00558467|464568106|FG000|Overall Study|Lack of Efficacy|0|||
129076600|NCT00558467|464568107|FG001|Overall Study|Lack of Efficacy|1|||
129076601|NCT00558467|464568106|FG000|Overall Study|Patient moving out of state|0|||
129076602|NCT00558467|464568107|FG001|Overall Study|Patient moving out of state|1|||
129076603|NCT02025725|464568114|FG000|Overall Study|Adverse Event|5|||
129076604|NCT02025725|464568115|FG001|Overall Study|Adverse Event|0|||
129076605|NCT02025725|464568114|FG000|Overall Study|Lost to Follow-up|2|||
129076606|NCT02025725|464568115|FG001|Overall Study|Lost to Follow-up|0|||
129076607|NCT02025725|464568114|FG000|Overall Study|Protocol Violation|1|||
129076608|NCT02025725|464568115|FG001|Overall Study|Protocol Violation|1|||
129076609|NCT02025725|464568114|FG000|Overall Study|Withdrawal by Subject|3|||
129076610|NCT02025725|464568115|FG001|Overall Study|Withdrawal by Subject|2|||
129076611|NCT02025725|464568114|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
129076612|NCT02025725|464568115|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
129076613|NCT05047211|464568116|FG000|Overall Study|Lost to Follow-up|8|||
129076614|NCT05047211|464568117|FG001|Overall Study|Lost to Follow-up|5|||
129076615|NCT02867592|464568118|FG000|Overall Study|Adverse Event|3|||
129076616|NCT02867592|464568119|FG001|Overall Study|Adverse Event|0|||
129076617|NCT02867592|464568120|FG002|Overall Study|Adverse Event|2|||
129076618|NCT02867592|464568121|FG003|Overall Study|Adverse Event|1|||
129076619|NCT02867592|464568122|FG004|Overall Study|Adverse Event|1|||
129076620|NCT02867592|464568123|FG005|Overall Study|Adverse Event|5|||
129076621|NCT02867592|464568118|FG000|Overall Study|Death|0|||
129076622|NCT02867592|464568119|FG001|Overall Study|Death|0|||
129076623|NCT02867592|464568120|FG002|Overall Study|Death|0|||
129076624|NCT02867592|464568121|FG003|Overall Study|Death|1|||
129076625|NCT02867592|464568122|FG004|Overall Study|Death|0|||
129076626|NCT02867592|464568123|FG005|Overall Study|Death|1|||
129076627|NCT02867592|464568118|FG000|Overall Study|Lack of Efficacy|8|||
129076628|NCT02867592|464568119|FG001|Overall Study|Lack of Efficacy|10|||
129076629|NCT02867592|464568120|FG002|Overall Study|Lack of Efficacy|8|||
129076630|NCT02867592|464568121|FG003|Overall Study|Lack of Efficacy|8|||
129076631|NCT02867592|464568122|FG004|Overall Study|Lack of Efficacy|12|||
129076632|NCT02867592|464568123|FG005|Overall Study|Lack of Efficacy|17|||
129076633|NCT02867592|464568118|FG000|Overall Study|Physician Decision|1|||
129141467|NCT04525183|464812216|FG002|Overall Study|Withdrawal by Subject|3|||
129076634|NCT02867592|464568119|FG001|Overall Study|Physician Decision|2|||
129076635|NCT02867592|464568120|FG002|Overall Study|Physician Decision|2|||
129076636|NCT02867592|464568121|FG003|Overall Study|Physician Decision|0|||
129076637|NCT02867592|464568122|FG004|Overall Study|Physician Decision|5|||
129076638|NCT02867592|464568123|FG005|Overall Study|Physician Decision|1|||
129076639|NCT02867592|464568118|FG000|Overall Study|Protocol Violation|0|||
129076640|NCT02867592|464568119|FG001|Overall Study|Protocol Violation|0|||
129076641|NCT02867592|464568120|FG002|Overall Study|Protocol Violation|0|||
129076642|NCT02867592|464568121|FG003|Overall Study|Protocol Violation|0|||
129076643|NCT02867592|464568122|FG004|Overall Study|Protocol Violation|1|||
129076644|NCT02867592|464568123|FG005|Overall Study|Protocol Violation|1|||
129076645|NCT02867592|464568118|FG000|Overall Study|Withdrawal by Subject|0|||
129076646|NCT02867592|464568119|FG001|Overall Study|Withdrawal by Subject|1|||
129076647|NCT02867592|464568120|FG002|Overall Study|Withdrawal by Subject|0|||
129076648|NCT02867592|464568121|FG003|Overall Study|Withdrawal by Subject|1|||
129076649|NCT02867592|464568122|FG004|Overall Study|Withdrawal by Subject|3|||
129076650|NCT02867592|464568123|FG005|Overall Study|Withdrawal by Subject|3|||
129076651|NCT02867592|464568118|FG000|Overall Study|Ineligible|1|||
129076652|NCT02867592|464568119|FG001|Overall Study|Ineligible|1|||
129076653|NCT02867592|464568120|FG002|Overall Study|Ineligible|0|||
129076654|NCT02867592|464568121|FG003|Overall Study|Ineligible|0|||
129076655|NCT02867592|464568122|FG004|Overall Study|Ineligible|2|||
129076656|NCT02867592|464568123|FG005|Overall Study|Ineligible|0|||
129076657|NCT02867592|464568118|FG000|Overall Study|No Treatment|1|||
129076658|NCT02867592|464568119|FG001|Overall Study|No Treatment|0|||
129076659|NCT02867592|464568120|FG002|Overall Study|No Treatment|0|||
129076660|NCT02867592|464568121|FG003|Overall Study|No Treatment|0|||
129076661|NCT02867592|464568122|FG004|Overall Study|No Treatment|0|||
129076662|NCT02867592|464568123|FG005|Overall Study|No Treatment|0|||
129076663|NCT02867592|464568118|FG000|Overall Study|Still on Therapy|0|||
129076664|NCT02867592|464568119|FG001|Overall Study|Still on Therapy|0|||
129076665|NCT02867592|464568120|FG002|Overall Study|Still on Therapy|0|||
129076666|NCT02867592|464568121|FG003|Overall Study|Still on Therapy|0|||
129076667|NCT02867592|464568122|FG004|Overall Study|Still on Therapy|1|||
129076668|NCT02867592|464568123|FG005|Overall Study|Still on Therapy|0|||
129141468|NCT04525183|464812214|FG000|Overall Study|Study non-compliance|0|||
129141469|NCT04525183|464812215|FG001|Overall Study|Study non-compliance|0|||
129141470|NCT04525183|464812216|FG002|Overall Study|Study non-compliance|1|||
129141471|NCT04525183|464812214|FG000|Overall Study|Recurrent disease before starting on study|0|||
129141472|NCT04525183|464812215|FG001|Overall Study|Recurrent disease before starting on study|0|||
129141473|NCT04525183|464812216|FG002|Overall Study|Recurrent disease before starting on study|1|||
129141474|NCT00979407|464812217|FG000|Overall Study|Withdrawal by Subject|3|||
129141475|NCT00979407|464812218|FG001|Overall Study|Withdrawal by Subject|4|||
129141476|NCT00979407|464812217|FG000|Overall Study|Lost to Follow-up|3|||
129141477|NCT00979407|464812218|FG001|Overall Study|Lost to Follow-up|3|||
129141478|NCT01166646|464812219|FG000|Overall Study|Protocol Violation|0|||
129141479|NCT01166646|464812220|FG001|Overall Study|Protocol Violation|1|||
129141480|NCT01166646|464812219|FG000|Overall Study|Adverse Event|1|||
129141481|NCT01166646|464812220|FG001|Overall Study|Adverse Event|0|||
129141482|NCT01335685|464812224|FG000|Overall Study|Study Terminated by Sponsor|2|||
129141483|NCT01335685|464812225|FG001|Overall Study|Study Terminated by Sponsor|1|||
129141484|NCT01335685|464812226|FG002|Overall Study|Study Terminated by Sponsor|1|||
129141485|NCT01335685|464812227|FG003|Overall Study|Study Terminated by Sponsor|10|||
129141486|NCT01335685|464812228|FG004|Overall Study|Study Terminated by Sponsor|0|||
129141487|NCT01335685|464812229|FG005|Overall Study|Study Terminated by Sponsor|4|||
129141488|NCT01335685|464812230|FG006|Overall Study|Study Terminated by Sponsor|2|||
129141489|NCT01335685|464812231|FG007|Overall Study|Study Terminated by Sponsor|3|||
129141490|NCT01335685|464812224|FG000|Overall Study|Withdrawal by Subject|1|||
129141491|NCT01335685|464812225|FG001|Overall Study|Withdrawal by Subject|0|||
129076669|NCT02867592|464568118|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129076670|NCT02867592|464568119|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129076671|NCT02867592|464568120|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129141492|NCT01335685|464812226|FG002|Overall Study|Withdrawal by Subject|0|||
129141493|NCT01335685|464812227|FG003|Overall Study|Withdrawal by Subject|1|||
129141494|NCT01335685|464812228|FG004|Overall Study|Withdrawal by Subject|0|||
129141495|NCT01335685|464812229|FG005|Overall Study|Withdrawal by Subject|0|||
129141496|NCT01335685|464812230|FG006|Overall Study|Withdrawal by Subject|0|||
129141497|NCT01335685|464812231|FG007|Overall Study|Withdrawal by Subject|0|||
129076672|NCT02867592|464568121|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129076673|NCT02867592|464568122|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129076674|NCT02867592|464568123|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
129076675|NCT02867592|464568118|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
129076676|NCT02867592|464568119|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
129076677|NCT02867592|464568120|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
129076678|NCT02867592|464568121|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
129076679|NCT02867592|464568122|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
129076680|NCT02867592|464568123|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
129076681|NCT00594165|464568124|FG000|Overall Study|Major protocol violation|1|||
129076682|NCT00594165|464568124|FG000|Overall Study|Lack of Efficacy|12|||
129076683|NCT00594165|464568124|FG000|Overall Study|Adverse Event|52|||
129076684|NCT00594165|464568124|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
129076685|NCT00594165|464568124|FG000|Overall Study|Subject withdrew consent|27|||
129076686|NCT00594165|464568124|FG000|Overall Study|Study ended per sponsor|102|||
129076687|NCT00594165|464568124|FG000|Overall Study|Lost to Follow-up|4|||
129076688|NCT00594165|464568124|FG000|Overall Study|Other: PI discretion|5|||
129076689|NCT00594165|464568124|FG000|Overall Study|Other: Subject moving|3|||
129076690|NCT00594165|464568124|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
129076691|NCT00594165|464568124|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
129076692|NCT00594165|464568124|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
129076693|NCT00594165|464568124|FG000|Overall Study|Other: Site terminated participation|2|||
129076694|NCT00571727|464568129|FG000|Overall Study|Did not enter in this study|1|||
129076695|NCT00571727|464568129|FG000|Overall Study|Non-compliance|4|||
129076696|NCT00571727|464568129|FG000|Overall Study|Lost to Follow-up|30|||
129076697|NCT00571727|464568129|FG000|Overall Study|Poor growth|1|||
129076698|NCT00571727|464568129|FG000|Overall Study|Parent/patient decision|2|||
129076699|NCT00571727|464568129|FG000|Overall Study|Participant transferred to commercial drug|14|||
129076700|NCT00571727|464568129|FG000|Overall Study|Unable to provide study drug|6|||
129076701|NCT00571727|464568129|FG000|Overall Study|On-treatment at end of study|8|||
129076702|NCT03581292|464568130|FG000|Overall Study|Physician Decision|9|||
129076703|NCT03581292|464568131|FG001|Overall Study|Physician Decision|5|||
129076704|NCT03581292|464568130|FG000|Overall Study|Withdrawal by Subject|3|||
129076705|NCT03581292|464568131|FG001|Overall Study|Withdrawal by Subject|0|||
129076706|NCT03581292|464568130|FG000|Overall Study|Withdrawal before Therapy Start|1|||
129076707|NCT03581292|464568131|FG001|Overall Study|Withdrawal before Therapy Start|0|||
129076708|NCT05573464|464569573|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
129076709|NCT05573464|464569574|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
129076710|NCT05573464|464569573|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
129076711|NCT05573464|464569574|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
129076712|NCT05573464|464569573|FG000|12-week Treatment Period|Protocol Violation|3|||
129076713|NCT05573464|464569574|FG001|12-week Treatment Period|Protocol Violation|1|||
129076714|NCT05573464|464569573|FG000|12-week Treatment Period|Physician Decision|1|||
129076715|NCT05573464|464569574|FG001|12-week Treatment Period|Physician Decision|2|||
129076716|NCT05573464|464569573|FG000|12-week Treatment Period|Lost to Follow-up|2|||
129076717|NCT05573464|464569574|FG001|12-week Treatment Period|Lost to Follow-up|0|||
129076718|NCT05573464|464569573|FG000|12-week Treatment Period|Adverse Event|20|||
129076719|NCT05573464|464569574|FG001|12-week Treatment Period|Adverse Event|9|||
129076720|NCT05573464|464569573|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
129076721|NCT05573464|464569574|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
129076722|NCT05573464|464569573|FG000|12-week Treatment Period|Randomised, not treated|0|||
129076723|NCT05573464|464569574|FG001|12-week Treatment Period|Randomised, not treated|1|||
129076724|NCT05573464|464569573|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
129076725|NCT05573464|464569574|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
129076726|NCT05573464|464569573|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
129076727|NCT05573464|464569574|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
129076728|NCT05573464|464569573|FG000|52-week Treatment Period|Protocol Violation|1|||
129076729|NCT05573464|464569574|FG001|52-week Treatment Period|Protocol Violation|1|||
129076730|NCT05573464|464569573|FG000|52-week Treatment Period|Physician Decision|2|||
129076731|NCT05573464|464569574|FG001|52-week Treatment Period|Physician Decision|2|||
129076732|NCT05573464|464569573|FG000|52-week Treatment Period|Lost to Follow-up|1|||
129076733|NCT05573464|464569574|FG001|52-week Treatment Period|Lost to Follow-up|1|||
129076734|NCT05573464|464569573|FG000|52-week Treatment Period|Adverse Event|11|||
129076735|NCT05573464|464569574|FG001|52-week Treatment Period|Adverse Event|8|||
129076736|NCT05573464|464569573|FG000|52-week Treatment Period|Death|1|||
129076737|NCT05573464|464569574|FG001|52-week Treatment Period|Death|1|||
129076738|NCT04846569|464569575|FG000|Overall Study|Withdrawal by Subject|3|||
129076739|NCT04846569|464569576|FG001|Overall Study|Withdrawal by Subject|1|||
129076740|NCT00536939|464569581|FG000|Overall Study|Withdrawal by Subject|1|||
129076741|NCT00536939|464569582|FG001|Overall Study|Withdrawal by Subject|0|||
129076742|NCT00536939|464569581|FG000|Overall Study|Other Complicating Disease|1|||
129076743|NCT00536939|464569582|FG001|Overall Study|Other Complicating Disease|0|||
129076744|NCT01735916|464569583|FG000|Overall Study|Subject not eligible to be randomized|11|||
129076745|NCT01735916|464569584|FG001|Overall Study|Subject not eligible to be randomized|0|||
129076746|NCT01735916|464569585|FG002|Overall Study|Subject not eligible to be randomized|0|||
129076747|NCT01735916|464569583|FG000|Overall Study|Early termination of study by sponsor|4|||
129076748|NCT01735916|464569584|FG001|Overall Study|Early termination of study by sponsor|19|||
129076749|NCT01735916|464569585|FG002|Overall Study|Early termination of study by sponsor|7|||
129076750|NCT01735916|464569583|FG000|Overall Study|Withdrawal by Subject|3|||
129076751|NCT01735916|464569584|FG001|Overall Study|Withdrawal by Subject|0|||
129076752|NCT01735916|464569585|FG002|Overall Study|Withdrawal by Subject|0|||
129076753|NCT03214224|464569594|FG000|Overall Study|Protocol Violation|1|||
129076754|NCT03214224|464569594|FG000|Overall Study|Withdrawal by Subject|2|||
129076755|NCT03214224|464569594|FG000|Overall Study|Practice controls or therapists|6|||
129076756|NCT02712320|464569595|FG000|Overall Study|Lost to Follow-up|1|||
129076757|NCT02712320|464569595|FG000|Overall Study|Withdrawal by Subject|1|||
129076758|NCT02712320|464569595|FG000|Overall Study|Transferred to another facility|1|||
129076759|NCT02712320|464569595|FG000|Overall Study|Treating with the prohibited medications|2|||
129076760|NCT00568451|464569596|FG000|Overall Study|Disease Progression|0|||
129076761|NCT00568451|464569597|FG001|Overall Study|Disease Progression|0|||
129076762|NCT00568451|464569598|FG002|Overall Study|Disease Progression|2|||
129076763|NCT00568451|464569599|FG003|Overall Study|Disease Progression|7|||
129076764|NCT01343043|464569604|FG000|Overall Study|Disease progression before treatment|1|||
129076765|NCT01343043|464569605|FG001|Overall Study|Disease progression before treatment|0|||
129076766|NCT01343043|464569606|FG002|Overall Study|Disease progression before treatment|0|||
129076767|NCT01343043|464569607|FG003|Overall Study|Disease progression before treatment|0|||
129076768|NCT01343043|464569604|FG000|Overall Study|Withdrawal by Subject|1|||
129076769|NCT01343043|464569605|FG001|Overall Study|Withdrawal by Subject|0|||
129076770|NCT01343043|464569606|FG002|Overall Study|Withdrawal by Subject|0|||
129076771|NCT01343043|464569607|FG003|Overall Study|Withdrawal by Subject|0|||
129076772|NCT01343043|464569604|FG000|Overall Study|Death|1|||
129076773|NCT01343043|464569605|FG001|Overall Study|Death|1|||
129076774|NCT01343043|464569606|FG002|Overall Study|Death|0|||
129076775|NCT01343043|464569607|FG003|Overall Study|Death|1|||
129076776|NCT00925704|464569608|FG000|First Intervention|Withdrew consent|0|||
129076777|NCT00925704|464569609|FG001|First Intervention|Withdrew consent|0|||
129076778|NCT00925704|464569610|FG002|First Intervention|Withdrew consent|0|||
129076779|NCT00925704|464569611|FG003|First Intervention|Withdrew consent|1|||
129076780|NCT00925704|464569612|FG004|First Intervention|Withdrew consent|1|||
129076781|NCT00925704|464569613|FG005|First Intervention|Withdrew consent|0|||
129076782|NCT00925704|464569608|FG000|Second Intervention|Withdrawal by Subject|1|||
129076783|NCT00925704|464569609|FG001|Second Intervention|Withdrawal by Subject|0|||
129076784|NCT00925704|464569610|FG002|Second Intervention|Withdrawal by Subject|0|||
129076785|NCT00925704|464569611|FG003|Second Intervention|Withdrawal by Subject|0|||
129076786|NCT00925704|464569612|FG004|Second Intervention|Withdrawal by Subject|1|||
129076787|NCT00925704|464569613|FG005|Second Intervention|Withdrawal by Subject|0|||
129076788|NCT00925704|464569608|FG000|Third Intervention|Withdrew consent|0|||
129076789|NCT00925704|464569609|FG001|Third Intervention|Withdrew consent|0|||
129076790|NCT00925704|464569610|FG002|Third Intervention|Withdrew consent|0|||
129076791|NCT00925704|464569611|FG003|Third Intervention|Withdrew consent|0|||
129076792|NCT00925704|464569612|FG004|Third Intervention|Withdrew consent|0|||
129076793|NCT00925704|464569613|FG005|Third Intervention|Withdrew consent|1|||
129076794|NCT02044302|464569617|FG000|Overall Study|study terminated|2|||
129141498|NCT01335685|464812224|FG000|Overall Study|Reason not Specified|0|||
129141499|NCT01335685|464812225|FG001|Overall Study|Reason not Specified|0|||
129141500|NCT01335685|464812226|FG002|Overall Study|Reason not Specified|1|||
129141501|NCT01335685|464812227|FG003|Overall Study|Reason not Specified|0|||
129141502|NCT01335685|464812228|FG004|Overall Study|Reason not Specified|0|||
129141503|NCT01335685|464812229|FG005|Overall Study|Reason not Specified|1|||
129141504|NCT01335685|464812230|FG006|Overall Study|Reason not Specified|0|||
129141505|NCT01335685|464812231|FG007|Overall Study|Reason not Specified|0|||
129141506|NCT03777020|464812236|FG000|Overall Study|Withdrawal by Subject|4|||
129076795|NCT02044302|464569618|FG001|Overall Study|study terminated|0|||
129076796|NCT03207815|464569619|FG000|Overall Study|Protocol Violation|3|||
129076797|NCT03207815|464569620|FG001|Overall Study|Protocol Violation|1|||
129141507|NCT03777020|464812237|FG001|Overall Study|Withdrawal by Subject|4|||
129141508|NCT03777020|464812236|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
129076798|NCT03207815|464569619|FG000|Overall Study|Adverse Event|1|||
129076799|NCT03207815|464569620|FG001|Overall Study|Adverse Event|2|||
129076800|NCT03207815|464569619|FG000|Overall Study|Lost to Follow-up|1|||
129076801|NCT03207815|464569620|FG001|Overall Study|Lost to Follow-up|2|||
129076802|NCT03207815|464569619|FG000|Overall Study|Investigator's Discretion|1|||
129076803|NCT03207815|464569620|FG001|Overall Study|Investigator's Discretion|1|||
129076804|NCT03207815|464569619|FG000|Overall Study|Lack of Efficacy|0|||
129076805|NCT03207815|464569620|FG001|Overall Study|Lack of Efficacy|1|||
129076806|NCT03207815|464569619|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
129076807|NCT03207815|464569620|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
129076808|NCT03207815|464569619|FG000|Overall Study|Withdrew Consent|1|||
129076809|NCT03207815|464569620|FG001|Overall Study|Withdrew Consent|0|||
129076810|NCT01671007|464569621|FG000|Overall Study|Other reasons than listed|166|||
129076811|NCT01671007|464569622|FG001|Overall Study|Other reasons than listed|373|||
129076812|NCT01671007|464569623|FG002|Overall Study|Other reasons than listed|197|||
129076813|NCT01671007|464569624|FG003|Overall Study|Other reasons than listed|228|||
129076814|NCT01671007|464569625|FG004|Overall Study|Other reasons than listed|14|||
129076815|NCT01671007|464569626|FG005|Overall Study|Other reasons than listed|71|||
129076816|NCT01671007|464569627|FG006|Overall Study|Other reasons than listed|17|||
129076817|NCT01671007|464569628|FG007|Overall Study|Other reasons than listed|66|||
129076818|NCT01671007|464569629|FG008|Overall Study|Other reasons than listed|0|||
129076819|NCT01671007|464569621|FG000|Overall Study|Withdrawal by Subject|36|||
129076820|NCT01671007|464569622|FG001|Overall Study|Withdrawal by Subject|59|||
129076821|NCT01671007|464569623|FG002|Overall Study|Withdrawal by Subject|53|||
129076822|NCT01671007|464569624|FG003|Overall Study|Withdrawal by Subject|58|||
129076823|NCT01671007|464569625|FG004|Overall Study|Withdrawal by Subject|4|||
129076824|NCT01671007|464569626|FG005|Overall Study|Withdrawal by Subject|15|||
129076825|NCT01671007|464569627|FG006|Overall Study|Withdrawal by Subject|1|||
129076826|NCT01671007|464569628|FG007|Overall Study|Withdrawal by Subject|19|||
129076827|NCT01671007|464569629|FG008|Overall Study|Withdrawal by Subject|0|||
129076828|NCT01671007|464569621|FG000|Overall Study|Lost to Follow-up|93|||
129076829|NCT01671007|464569622|FG001|Overall Study|Lost to Follow-up|142|||
129076830|NCT01671007|464569623|FG002|Overall Study|Lost to Follow-up|91|||
129076831|NCT01671007|464569624|FG003|Overall Study|Lost to Follow-up|63|||
129076832|NCT01671007|464569625|FG004|Overall Study|Lost to Follow-up|7|||
129076833|NCT01671007|464569626|FG005|Overall Study|Lost to Follow-up|20|||
129076834|NCT01671007|464569627|FG006|Overall Study|Lost to Follow-up|2|||
129076835|NCT01671007|464569628|FG007|Overall Study|Lost to Follow-up|28|||
129076836|NCT01671007|464569629|FG008|Overall Study|Lost to Follow-up|0|||
129076837|NCT01671007|464569621|FG000|Overall Study|No end of study case report form|3|||
129076838|NCT01671007|464569622|FG001|Overall Study|No end of study case report form|1|||
129076839|NCT01671007|464569623|FG002|Overall Study|No end of study case report form|0|||
129076840|NCT01671007|464569624|FG003|Overall Study|No end of study case report form|2|||
129076841|NCT01671007|464569625|FG004|Overall Study|No end of study case report form|0|||
129076842|NCT01671007|464569626|FG005|Overall Study|No end of study case report form|0|||
129076843|NCT01671007|464569627|FG006|Overall Study|No end of study case report form|0|||
129076844|NCT01671007|464569628|FG007|Overall Study|No end of study case report form|0|||
129076845|NCT01671007|464569629|FG008|Overall Study|No end of study case report form|0|||
129076846|NCT01671007|464569621|FG000|Overall Study|Not eligible|23|||
129076847|NCT01671007|464569622|FG001|Overall Study|Not eligible|76|||
129076848|NCT01671007|464569623|FG002|Overall Study|Not eligible|25|||
129076849|NCT01671007|464569624|FG003|Overall Study|Not eligible|17|||
129076850|NCT01671007|464569625|FG004|Overall Study|Not eligible|0|||
129076851|NCT01671007|464569626|FG005|Overall Study|Not eligible|6|||
129076852|NCT01671007|464569627|FG006|Overall Study|Not eligible|1|||
129076853|NCT01671007|464569628|FG007|Overall Study|Not eligible|19|||
129076854|NCT01671007|464569629|FG008|Overall Study|Not eligible|0|||
129076855|NCT00391768|464569630|FG000|Overall Study|Withdrawal by Subject|0|||
129076856|NCT00391768|464569631|FG001|Overall Study|Withdrawal by Subject|0|||
129076857|NCT00391768|464569632|FG002|Overall Study|Withdrawal by Subject|1|||
129076858|NCT00391768|464569633|FG003|Overall Study|Withdrawal by Subject|0|||
129076859|NCT00391768|464569634|FG004|Overall Study|Withdrawal by Subject|0|||
129076860|NCT00391768|464569635|FG005|Overall Study|Withdrawal by Subject|1|||
129076861|NCT00391768|464569636|FG006|Overall Study|Withdrawal by Subject|1|||
129076862|NCT00391768|464569630|FG000|Overall Study|Lost to Follow-up|0|||
129076863|NCT00391768|464569631|FG001|Overall Study|Lost to Follow-up|0|||
129076864|NCT00391768|464569632|FG002|Overall Study|Lost to Follow-up|0|||
129141509|NCT03777020|464812237|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
129141510|NCT00489476|464812238|FG000|Overall Study|Lost to Follow-up|0|||
129141511|NCT00489476|464812239|FG001|Overall Study|Lost to Follow-up|1|||
129141512|NCT00489476|464812240|FG002|Overall Study|Lost to Follow-up|0|||
129076865|NCT00391768|464569633|FG003|Overall Study|Lost to Follow-up|1|||
129076866|NCT00391768|464569634|FG004|Overall Study|Lost to Follow-up|2|||
129076867|NCT00391768|464569635|FG005|Overall Study|Lost to Follow-up|2|||
129076868|NCT00391768|464569636|FG006|Overall Study|Lost to Follow-up|3|||
129076869|NCT00406367|464569637|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
129076870|NCT00406367|464569638|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
129076871|NCT00406367|464569637|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
129076872|NCT00406367|464569638|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
129076873|NCT00406367|464569637|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
129141513|NCT00489476|464812241|FG003|Overall Study|Lost to Follow-up|0|||
129141514|NCT00803049|464812242|FG000|Overall Study|Adverse Event|21|||
129076874|NCT00406367|464569638|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
129076875|NCT00406367|464569637|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
129076876|NCT00406367|464569638|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
129076877|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
129076878|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
129076879|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
129076880|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
129076881|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
129076882|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
129076883|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
129076884|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
129076885|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
129076886|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
129076887|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
129076888|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
129076889|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
129076890|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
129076891|NCT00406367|464569637|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
129076892|NCT00406367|464569638|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
129076893|NCT00171210|464569639|FG000|Overall Study|Adverse Event|16|||
129076894|NCT00171210|464569640|FG001|Overall Study|Adverse Event|27|||
129076895|NCT00171210|464569639|FG000|Overall Study|Abnormal laboratory value(s)|6|||
129076896|NCT00171210|464569640|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129076897|NCT00171210|464569639|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129076898|NCT00171210|464569640|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129076899|NCT00171210|464569639|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
129076900|NCT00171210|464569640|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
129076901|NCT00171210|464569639|FG000|Overall Study|Protocol Violation|0|||
129076902|NCT00171210|464569640|FG001|Overall Study|Protocol Violation|2|||
129076903|NCT00171210|464569639|FG000|Overall Study|Withdrawal by Subject|32|||
129076904|NCT00171210|464569640|FG001|Overall Study|Withdrawal by Subject|30|||
129076905|NCT00171210|464569639|FG000|Overall Study|Lost to Follow-up|1|||
129076906|NCT00171210|464569640|FG001|Overall Study|Lost to Follow-up|0|||
129076907|NCT00171210|464569639|FG000|Overall Study|Administrative problems|1|||
129076908|NCT00171210|464569640|FG001|Overall Study|Administrative problems|1|||
129076909|NCT00171210|464569639|FG000|Overall Study|Death|2|||
129076910|NCT00171210|464569640|FG001|Overall Study|Death|3|||
129076911|NCT00171210|464569639|FG000|Overall Study|Stopped at end of core|0|||
129076912|NCT00171210|464569640|FG001|Overall Study|Stopped at end of core|32|||
129076913|NCT00171210|464569639|FG000|Overall Study|Stopped at end of extension 1|0|||
129076914|NCT00171210|464569640|FG001|Overall Study|Stopped at end of extension 1|1|||
129076915|NCT03187301|464569643|FG000|Titration Period|Adverse Event|0|||
129076916|NCT03187301|464569644|FG001|Titration Period|Adverse Event|0|||
129076917|NCT03187301|464569645|FG002|Titration Period|Adverse Event|0|||
129076918|NCT03187301|464569646|FG003|Titration Period|Adverse Event|0|||
129076919|NCT03187301|464569647|FG004|Titration Period|Adverse Event|0|||
129076920|NCT03187301|464569648|FG005|Titration Period|Adverse Event|0|||
129076921|NCT03187301|464569649|FG006|Titration Period|Adverse Event|5|||
129076922|NCT03187301|464569643|FG000|Titration Period|Withdrawal by Subject|0|||
129076923|NCT03187301|464569644|FG001|Titration Period|Withdrawal by Subject|0|||
129076924|NCT03187301|464569645|FG002|Titration Period|Withdrawal by Subject|0|||
129076925|NCT03187301|464569646|FG003|Titration Period|Withdrawal by Subject|0|||
129076926|NCT03187301|464569647|FG004|Titration Period|Withdrawal by Subject|0|||
129076927|NCT03187301|464569648|FG005|Titration Period|Withdrawal by Subject|0|||
129076928|NCT03187301|464569649|FG006|Titration Period|Withdrawal by Subject|1|||
129076929|NCT03187301|464569643|FG000|Titration Period|Exclusion Criteria Met|0|||
129141515|NCT00803049|464812243|FG001|Overall Study|Adverse Event|33|||
129141516|NCT00803049|464812244|FG002|Overall Study|Adverse Event|13|||
129141517|NCT00803049|464812245|FG003|Overall Study|Adverse Event|27|||
129141518|NCT00803049|464812242|FG000|Overall Study|Lack of Efficacy|10|||
129141519|NCT00803049|464812243|FG001|Overall Study|Lack of Efficacy|19|||
129141520|NCT00803049|464812244|FG002|Overall Study|Lack of Efficacy|6|||
129141521|NCT00803049|464812245|FG003|Overall Study|Lack of Efficacy|13|||
129141522|NCT00803049|464812242|FG000|Overall Study|Lost to Follow-up|0|||
129141523|NCT00803049|464812243|FG001|Overall Study|Lost to Follow-up|2|||
129141524|NCT00803049|464812244|FG002|Overall Study|Lost to Follow-up|0|||
129076930|NCT03187301|464569644|FG001|Titration Period|Exclusion Criteria Met|0|||
129076931|NCT03187301|464569645|FG002|Titration Period|Exclusion Criteria Met|0|||
129076932|NCT03187301|464569646|FG003|Titration Period|Exclusion Criteria Met|0|||
129076933|NCT03187301|464569647|FG004|Titration Period|Exclusion Criteria Met|0|||
129076934|NCT03187301|464569648|FG005|Titration Period|Exclusion Criteria Met|0|||
129141525|NCT00803049|464812245|FG003|Overall Study|Lost to Follow-up|3|||
129141526|NCT00803049|464812242|FG000|Overall Study|Death|2|||
129141527|NCT00803049|464812243|FG001|Overall Study|Death|1|||
129076935|NCT03187301|464569649|FG006|Titration Period|Exclusion Criteria Met|1|||
129076936|NCT03187301|464569643|FG000|Pre-Intervention|Withdrawal by Subject|1|||
129076937|NCT03187301|464569644|FG001|Pre-Intervention|Withdrawal by Subject|0|||
129076938|NCT03187301|464569645|FG002|Pre-Intervention|Withdrawal by Subject|0|||
129076939|NCT03187301|464569646|FG003|Pre-Intervention|Withdrawal by Subject|0|||
129076940|NCT03187301|464569647|FG004|Pre-Intervention|Withdrawal by Subject|0|||
129076941|NCT03187301|464569648|FG005|Pre-Intervention|Withdrawal by Subject|0|||
129076942|NCT03187301|464569649|FG006|Pre-Intervention|Withdrawal by Subject|0|||
129076943|NCT05005507|464569655|FG000|Overall Study|Premature termination of study|1|||
129076944|NCT02182843|464569661|FG000|Overall Study|Withdrawal by Subject|7|||
129076945|NCT02182843|464569661|FG000|Overall Study|Lost to Follow-up|2|||
129076946|NCT02182843|464569661|FG000|Overall Study|Adverse Event|1|||
129076947|NCT02375971|464569662|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
129076948|NCT02375971|464569663|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
129076949|NCT02375971|464569664|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
129076950|NCT02375971|464569662|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
129076951|NCT02375971|464569663|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
129076952|NCT02375971|464569664|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
129076953|NCT02375971|464569662|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
129076954|NCT02375971|464569663|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
129076955|NCT02375971|464569664|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
129076956|NCT02375971|464569662|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
129076957|NCT02375971|464569663|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
129076958|NCT02375971|464569664|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
129076959|NCT02375971|464569662|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
129076960|NCT02375971|464569663|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
129076961|NCT02375971|464569664|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
129076962|NCT02375971|464569662|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
129076963|NCT02375971|464569663|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
129076964|NCT02375971|464569664|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
129076965|NCT02375971|464569662|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
129076966|NCT02375971|464569663|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
129076967|NCT02375971|464569664|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
129076968|NCT02375971|464569662|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
129076969|NCT02375971|464569663|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
129076970|NCT02375971|464569664|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
129076971|NCT00832455|464569666|FG000|Overall Study|Adverse Event|13|||
129076972|NCT00832455|464569666|FG000|Overall Study|Lost to Follow-up|26|||
129076973|NCT00832455|464569666|FG000|Overall Study|Protocol Violation|4|||
129076974|NCT00832455|464569666|FG000|Overall Study|Withdrawal by Subject|17|||
129076975|NCT00832455|464569666|FG000|Overall Study|Screening Failure|2|||
129076976|NCT00832455|464569666|FG000|Overall Study|Stopped Medication|4|||
129076977|NCT00832455|464569666|FG000|Overall Study|Parent misunderstood study|1|||
129076978|NCT00832455|464569666|FG000|Overall Study|Parent dissatisfied|1|||
129076979|NCT00832455|464569666|FG000|Overall Study|No improvement|3|||
129076980|NCT00832455|464569666|FG000|Overall Study|Patient moved|1|||
129076981|NCT00561392|464569670|FG000|Overall Study|Adverse Event|38|||
129076982|NCT00561392|464569670|FG000|Overall Study|Lack of Efficacy|2|||
129076983|NCT00561392|464569670|FG000|Overall Study|Protocol Violation|1|||
129076984|NCT00561392|464569670|FG000|Overall Study|Withdrawal by Subject|8|||
129076985|NCT00561392|464569670|FG000|Overall Study|Administrative problems|4|||
129076986|NCT01741688|464569671|FG000|Overall Study|Lack of insurance coverage|2|||
129076987|NCT01741688|464569671|FG000|Overall Study|Withdrawal by Subject|1|||
129076988|NCT01262872|464569676|FG000|Step 2|Death|0|||
129076989|NCT01262872|464569677|FG001|Step 2|Death|0|||
129076990|NCT01262872|464569678|FG002|Step 2|Death|0|||
129076991|NCT01262872|464569679|FG003|Step 2|Death|1|||
129076992|NCT01262872|464569680|FG004|Step 2|Death|0|||
129141528|NCT00803049|464812244|FG002|Overall Study|Death|0|||
129141529|NCT00803049|464812245|FG003|Overall Study|Death|2|||
129141530|NCT00803049|464812242|FG000|Overall Study|Progressive Disease|6|||
129141531|NCT00803049|464812243|FG001|Overall Study|Progressive Disease|10|||
129141532|NCT00803049|464812244|FG002|Overall Study|Progressive Disease|6|||
129076993|NCT01262872|464569681|FG005|Step 2|Death|2|||
129076994|NCT01262872|464569682|FG006|Step 2|Death|2|||
129076995|NCT01262872|464569683|FG007|Step 2|Death|1|||
129141533|NCT00803049|464812245|FG003|Overall Study|Progressive Disease|6|||
129076996|NCT01262872|464569676|FG000|Step 2|Protocol Violation|0|||
129076997|NCT01262872|464569677|FG001|Step 2|Protocol Violation|0|||
129076998|NCT01262872|464569678|FG002|Step 2|Protocol Violation|1|||
129076999|NCT01262872|464569679|FG003|Step 2|Protocol Violation|0|||
129077000|NCT01262872|464569680|FG004|Step 2|Protocol Violation|0|||
129077001|NCT01262872|464569681|FG005|Step 2|Protocol Violation|0|||
129077002|NCT01262872|464569682|FG006|Step 2|Protocol Violation|3|||
129077003|NCT01262872|464569683|FG007|Step 2|Protocol Violation|1|||
129141534|NCT00803049|464812242|FG000|Overall Study|Withdrawal by Subject|19|||
129141535|NCT00803049|464812243|FG001|Overall Study|Withdrawal by Subject|43|||
129077004|NCT01262872|464569676|FG000|Step 2|Withdrawal by Subject|0|||
129077005|NCT01262872|464569677|FG001|Step 2|Withdrawal by Subject|0|||
129077006|NCT01262872|464569678|FG002|Step 2|Withdrawal by Subject|4|||
129077007|NCT01262872|464569679|FG003|Step 2|Withdrawal by Subject|6|||
129077008|NCT01262872|464569680|FG004|Step 2|Withdrawal by Subject|3|||
129077009|NCT01262872|464569681|FG005|Step 2|Withdrawal by Subject|1|||
129077010|NCT01262872|464569682|FG006|Step 2|Withdrawal by Subject|2|||
129077011|NCT01262872|464569683|FG007|Step 2|Withdrawal by Subject|1|||
129077012|NCT01262872|464569676|FG000|Step 2|Migrated/moved from study area|0|||
129077013|NCT01262872|464569677|FG001|Step 2|Migrated/moved from study area|0|||
129077014|NCT01262872|464569678|FG002|Step 2|Migrated/moved from study area|4|||
129077015|NCT01262872|464569679|FG003|Step 2|Migrated/moved from study area|3|||
129077016|NCT01262872|464569680|FG004|Step 2|Migrated/moved from study area|2|||
129077017|NCT01262872|464569681|FG005|Step 2|Migrated/moved from study area|6|||
129077018|NCT01262872|464569682|FG006|Step 2|Migrated/moved from study area|2|||
129077019|NCT01262872|464569683|FG007|Step 2|Migrated/moved from study area|3|||
129077020|NCT00365794|464569686|FG000|Overall Study|Withdrawal by Subject|2|||
129077021|NCT00745901|464569687|FG000|Overall Study|Adverse Event|3|||
129077022|NCT00745901|464569688|FG001|Overall Study|Adverse Event|4|||
129077023|NCT00745901|464569687|FG000|Overall Study|Protocol Violation|0|||
129077024|NCT00745901|464569688|FG001|Overall Study|Protocol Violation|1|||
129077025|NCT00745901|464569687|FG000|Overall Study|Withdrawal by Subject|1|||
129077026|NCT00745901|464569688|FG001|Overall Study|Withdrawal by Subject|0|||
129077027|NCT00745901|464569687|FG000|Overall Study|Lost to Follow-up|7|||
129077028|NCT00745901|464569688|FG001|Overall Study|Lost to Follow-up|4|||
129077029|NCT00745901|464569687|FG000|Overall Study|Pregnancy|2|||
129077030|NCT00745901|464569688|FG001|Overall Study|Pregnancy|4|||
129077031|NCT00745901|464569687|FG000|Overall Study|Lack of compliance|2|||
129077032|NCT00745901|464569688|FG001|Overall Study|Lack of compliance|2|||
129077033|NCT00745901|464569687|FG000|Overall Study|Patient's next menses did not start with|1|||
129077034|NCT00745901|464569688|FG001|Overall Study|Patient's next menses did not start with|0|||
129077035|NCT00745901|464569687|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
129077036|NCT00745901|464569688|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
129077037|NCT00745901|464569687|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
129077038|NCT00745901|464569688|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
129077039|NCT00745901|464569687|FG000|Overall Study|Patient didn't take any study medication|7|||
129077040|NCT00745901|464569688|FG001|Overall Study|Patient didn't take any study medication|3|||
129077041|NCT01804946|464569690|FG000|Overall Study|Protocol Violation|1|||
129077042|NCT01804946|464569691|FG001|Overall Study|Protocol Violation|0|||
129077043|NCT01804946|464569690|FG000|Overall Study|Adverse Event|0|||
129077044|NCT01804946|464569691|FG001|Overall Study|Adverse Event|1|||
129077045|NCT01804946|464569690|FG000|Overall Study|Insufficient data available|0|||
129077046|NCT01804946|464569691|FG001|Overall Study|Insufficient data available|1|||
129077047|NCT01804946|464569690|FG000|Overall Study|Do not meet inclusion criteria|1|||
129077048|NCT01804946|464569691|FG001|Overall Study|Do not meet inclusion criteria|2|||
129077049|NCT00722137|464569693|FG000|Overall Study|Overt Disease Progression|5|||
129077050|NCT00722137|464569694|FG001|Overall Study|Overt Disease Progression|4|||
129077051|NCT00722137|464569693|FG000|Overall Study|Adverse Event|17|||
129077052|NCT00722137|464569694|FG001|Overall Study|Adverse Event|21|||
129077053|NCT00722137|464569693|FG000|Overall Study|Death|12|||
129077054|NCT00722137|464569694|FG001|Overall Study|Death|7|||
129077055|NCT00722137|464569693|FG000|Overall Study|Withdrawal by Subject|6|||
129077056|NCT00722137|464569694|FG001|Overall Study|Withdrawal by Subject|9|||
129077057|NCT00722137|464569693|FG000|Overall Study|Other Reason Unknown|3|||
129077058|NCT00722137|464569694|FG001|Overall Study|Other Reason Unknown|4|||
129077059|NCT00722137|464569693|FG000|Overall Study|Randomized But Not Treated|2|||
129077060|NCT00722137|464569694|FG001|Overall Study|Randomized But Not Treated|3|||
129141536|NCT00803049|464812244|FG002|Overall Study|Withdrawal by Subject|16|||
129141537|NCT00803049|464812245|FG003|Overall Study|Withdrawal by Subject|44|||
129141538|NCT00803049|464812242|FG000|Overall Study|Protocol Violation|0|||
129141539|NCT00803049|464812243|FG001|Overall Study|Protocol Violation|1|||
129141540|NCT00803049|464812244|FG002|Overall Study|Protocol Violation|1|||
129141541|NCT00803049|464812245|FG003|Overall Study|Protocol Violation|0|||
129141542|NCT00803049|464812242|FG000|Overall Study|Randomized and Not Treated|0|||
129141543|NCT00803049|464812243|FG001|Overall Study|Randomized and Not Treated|0|||
129141544|NCT00803049|464812244|FG002|Overall Study|Randomized and Not Treated|0|||
129141545|NCT00803049|464812245|FG003|Overall Study|Randomized and Not Treated|2|||
129141546|NCT00803049|464812242|FG000|Overall Study|Other than Specified Above|3|||
129141547|NCT00803049|464812243|FG001|Overall Study|Other than Specified Above|9|||
129141548|NCT00803049|464812244|FG002|Overall Study|Other than Specified Above|2|||
129141549|NCT00803049|464812245|FG003|Overall Study|Other than Specified Above|5|||
129141550|NCT04126174|464812246|FG000|Overall Study|Lost to Follow-up|3|||
129141551|NCT04126174|464812247|FG001|Overall Study|Lost to Follow-up|3|||
129077061|NCT00848718|464569695|FG000|Overall Study|Adverse Event|2|||
129077062|NCT00848718|464569696|FG001|Overall Study|Adverse Event|2|||
129077063|NCT00848718|464569697|FG002|Overall Study|Adverse Event|1|||
129141552|NCT01514422|464812248|FG000|Overall Study|Lost to Follow-up|1|||
129077064|NCT00848718|464569698|FG003|Overall Study|Adverse Event|1|||
129077065|NCT00848718|464569699|FG004|Overall Study|Adverse Event|1|||
129077066|NCT00848718|464569700|FG005|Overall Study|Adverse Event|0|||
129077067|NCT00848718|464569701|FG006|Overall Study|Adverse Event|0|||
129077068|NCT00848718|464569702|FG007|Overall Study|Adverse Event|1|||
129077069|NCT00848718|464569703|FG008|Overall Study|Adverse Event|1|||
129077070|NCT00848718|464569704|FG009|Overall Study|Adverse Event|0|||
129077071|NCT00848718|464569705|FG010|Overall Study|Adverse Event|0|||
129077072|NCT00848718|464569706|FG011|Overall Study|Adverse Event|0|||
129077073|NCT00848718|464569707|FG012|Overall Study|Adverse Event|2|||
129077074|NCT00848718|464569695|FG000|Overall Study|Lack of Efficacy|0|||
129077075|NCT00848718|464569696|FG001|Overall Study|Lack of Efficacy|0|||
129077076|NCT00848718|464569697|FG002|Overall Study|Lack of Efficacy|1|||
129077077|NCT00848718|464569698|FG003|Overall Study|Lack of Efficacy|0|||
129077078|NCT00848718|464569699|FG004|Overall Study|Lack of Efficacy|0|||
129077079|NCT00848718|464569700|FG005|Overall Study|Lack of Efficacy|0|||
129077080|NCT00848718|464569701|FG006|Overall Study|Lack of Efficacy|1|||
129077081|NCT00848718|464569702|FG007|Overall Study|Lack of Efficacy|0|||
129077082|NCT00848718|464569703|FG008|Overall Study|Lack of Efficacy|0|||
129077083|NCT00848718|464569704|FG009|Overall Study|Lack of Efficacy|0|||
129077084|NCT00848718|464569705|FG010|Overall Study|Lack of Efficacy|0|||
129077085|NCT00848718|464569706|FG011|Overall Study|Lack of Efficacy|0|||
129077086|NCT00848718|464569707|FG012|Overall Study|Lack of Efficacy|0|||
129077087|NCT00848718|464569695|FG000|Overall Study|Physician Decision|0|||
129077088|NCT00848718|464569696|FG001|Overall Study|Physician Decision|1|||
129077089|NCT00848718|464569697|FG002|Overall Study|Physician Decision|0|||
129077090|NCT00848718|464569698|FG003|Overall Study|Physician Decision|0|||
129077091|NCT00848718|464569699|FG004|Overall Study|Physician Decision|1|||
129077092|NCT00848718|464569700|FG005|Overall Study|Physician Decision|1|||
129077093|NCT00848718|464569701|FG006|Overall Study|Physician Decision|0|||
129077094|NCT00848718|464569702|FG007|Overall Study|Physician Decision|0|||
129077095|NCT00848718|464569703|FG008|Overall Study|Physician Decision|1|||
129077096|NCT00848718|464569704|FG009|Overall Study|Physician Decision|2|||
129077097|NCT00848718|464569705|FG010|Overall Study|Physician Decision|0|||
129077098|NCT00848718|464569706|FG011|Overall Study|Physician Decision|0|||
129077099|NCT00848718|464569707|FG012|Overall Study|Physician Decision|1|||
129077100|NCT00848718|464569695|FG000|Overall Study|Progressive disease before treatment|1|||
129077101|NCT00848718|464569696|FG001|Overall Study|Progressive disease before treatment|5|||
129077102|NCT00848718|464569697|FG002|Overall Study|Progressive disease before treatment|1|||
129077103|NCT00848718|464569698|FG003|Overall Study|Progressive disease before treatment|3|||
129077104|NCT00848718|464569699|FG004|Overall Study|Progressive disease before treatment|4|||
129077105|NCT00848718|464569700|FG005|Overall Study|Progressive disease before treatment|4|||
129077106|NCT00848718|464569701|FG006|Overall Study|Progressive disease before treatment|2|||
129077107|NCT00848718|464569702|FG007|Overall Study|Progressive disease before treatment|1|||
129077108|NCT00848718|464569703|FG008|Overall Study|Progressive disease before treatment|2|||
129077109|NCT00848718|464569704|FG009|Overall Study|Progressive disease before treatment|7|||
129077110|NCT00848718|464569705|FG010|Overall Study|Progressive disease before treatment|3|||
129077111|NCT00848718|464569706|FG011|Overall Study|Progressive disease before treatment|6|||
129077112|NCT00848718|464569707|FG012|Overall Study|Progressive disease before treatment|2|||
129077113|NCT00848718|464569695|FG000|Overall Study|Protocol Violation|0|||
129077114|NCT00848718|464569696|FG001|Overall Study|Protocol Violation|1|||
129077115|NCT00848718|464569697|FG002|Overall Study|Protocol Violation|0|||
129077116|NCT00848718|464569698|FG003|Overall Study|Protocol Violation|0|||
129077117|NCT00848718|464569699|FG004|Overall Study|Protocol Violation|0|||
129077118|NCT00848718|464569700|FG005|Overall Study|Protocol Violation|0|||
129077119|NCT00848718|464569701|FG006|Overall Study|Protocol Violation|0|||
129077120|NCT00848718|464569702|FG007|Overall Study|Protocol Violation|1|||
129077121|NCT00848718|464569703|FG008|Overall Study|Protocol Violation|0|||
129077122|NCT00848718|464569704|FG009|Overall Study|Protocol Violation|0|||
129077123|NCT00848718|464569705|FG010|Overall Study|Protocol Violation|0|||
129077124|NCT00848718|464569706|FG011|Overall Study|Protocol Violation|0|||
129077125|NCT00848718|464569707|FG012|Overall Study|Protocol Violation|1|||
129077126|NCT00848718|464569695|FG000|Overall Study|Withdrawal by Subject|1|||
129077127|NCT00848718|464569696|FG001|Overall Study|Withdrawal by Subject|0|||
129077128|NCT00848718|464569697|FG002|Overall Study|Withdrawal by Subject|0|||
129077129|NCT00848718|464569698|FG003|Overall Study|Withdrawal by Subject|1|||
129077130|NCT00848718|464569699|FG004|Overall Study|Withdrawal by Subject|0|||
129077131|NCT00848718|464569700|FG005|Overall Study|Withdrawal by Subject|0|||
129077132|NCT00848718|464569701|FG006|Overall Study|Withdrawal by Subject|0|||
129077133|NCT00848718|464569702|FG007|Overall Study|Withdrawal by Subject|0|||
129077134|NCT00848718|464569703|FG008|Overall Study|Withdrawal by Subject|0|||
129077135|NCT00848718|464569704|FG009|Overall Study|Withdrawal by Subject|0|||
129077136|NCT00848718|464569705|FG010|Overall Study|Withdrawal by Subject|1|||
129077137|NCT00848718|464569706|FG011|Overall Study|Withdrawal by Subject|0|||
129077138|NCT00848718|464569707|FG012|Overall Study|Withdrawal by Subject|0|||
129077139|NCT00848718|464569695|FG000|Overall Study|Progressive disease during treatment|3|||
129077140|NCT00848718|464569696|FG001|Overall Study|Progressive disease during treatment|0|||
129077141|NCT00848718|464569697|FG002|Overall Study|Progressive disease during treatment|3|||
129077142|NCT00848718|464569698|FG003|Overall Study|Progressive disease during treatment|0|||
129077143|NCT00848718|464569699|FG004|Overall Study|Progressive disease during treatment|0|||
129077144|NCT00848718|464569700|FG005|Overall Study|Progressive disease during treatment|0|||
129077145|NCT00848718|464569701|FG006|Overall Study|Progressive disease during treatment|0|||
129077146|NCT00848718|464569702|FG007|Overall Study|Progressive disease during treatment|2|||
129077147|NCT00848718|464569703|FG008|Overall Study|Progressive disease during treatment|0|||
129077148|NCT00848718|464569704|FG009|Overall Study|Progressive disease during treatment|0|||
129077149|NCT00848718|464569705|FG010|Overall Study|Progressive disease during treatment|0|||
129077150|NCT00848718|464569706|FG011|Overall Study|Progressive disease during treatment|0|||
129077151|NCT00848718|464569707|FG012|Overall Study|Progressive disease during treatment|2|||
129077152|NCT00833105|464571467|FG000|Overall Study|Withdrawal by Subject|1|||
129077153|NCT00833105|464571467|FG000|Overall Study|Adverse Event|2|||
129077154|NCT00455403|464571472|FG000|Overall Study|Lost to Follow-up|2|||
129077155|NCT00455403|464571473|FG001|Overall Study|Lost to Follow-up|1|||
129077156|NCT00455403|464571472|FG000|Overall Study|Withdrawal by Subject|1|||
129077157|NCT00455403|464571473|FG001|Overall Study|Withdrawal by Subject|3|||
129077158|NCT00455403|464571472|FG000|Overall Study|Protocol Violation|0|||
129077159|NCT00455403|464571473|FG001|Overall Study|Protocol Violation|2|||
129077160|NCT00350207|464571474|FG000|Overall Study|Adverse Event|5|||
129077161|NCT00350207|464571475|FG001|Overall Study|Adverse Event|2|||
129077162|NCT00350207|464571476|FG002|Overall Study|Adverse Event|2|||
129077163|NCT00350207|464571474|FG000|Overall Study|Lack of Efficacy|1|||
129077164|NCT00350207|464571475|FG001|Overall Study|Lack of Efficacy|0|||
129077165|NCT00350207|464571476|FG002|Overall Study|Lack of Efficacy|2|||
129141553|NCT04003142|464812259|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
129141554|NCT04003142|464812260|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
129141555|NCT04003142|464812261|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
129141556|NCT04003142|464812262|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
129141557|NCT04003142|464812263|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
129141558|NCT04003142|464812259|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
129141559|NCT04003142|464812260|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
129141560|NCT04003142|464812261|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
129141561|NCT04003142|464812262|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
129077166|NCT00350207|464571474|FG000|Overall Study|Lost to Follow-up|1|||
129141562|NCT04003142|464812263|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
128724000|NCT00692770|463287309|FG000|Overall Study|Protocol Violation|2|||
129077167|NCT00350207|464571475|FG001|Overall Study|Lost to Follow-up|0|||
129077168|NCT00350207|464571476|FG002|Overall Study|Lost to Follow-up|1|||
129077169|NCT00350207|464571474|FG000|Overall Study|Withdrawal by Subject|0|||
129077170|NCT00350207|464571475|FG001|Overall Study|Withdrawal by Subject|1|||
129077171|NCT00350207|464571476|FG002|Overall Study|Withdrawal by Subject|1|||
129077172|NCT00350207|464571474|FG000|Overall Study|Other|1|||
129077173|NCT00350207|464571475|FG001|Overall Study|Other|3|||
129077174|NCT00350207|464571476|FG002|Overall Study|Other|1|||
129077175|NCT00495391|464571477|FG000|Overall Study|Lack of Efficacy|34|||
129077176|NCT00495391|464571478|FG001|Overall Study|Lack of Efficacy|18|||
129077177|NCT00495391|464571477|FG000|Overall Study|Withdrawal by Subject|2|||
129077178|NCT00495391|464571478|FG001|Overall Study|Withdrawal by Subject|3|||
129077179|NCT04509076|464571487|FG000|Overall Study|Withdrawal by Subject|1|||
129077180|NCT04509076|464571488|FG001|Overall Study|Withdrawal by Subject|2|||
129077181|NCT04509076|464571487|FG000|Overall Study|Lost to Follow-up|1|||
129077182|NCT04509076|464571488|FG001|Overall Study|Lost to Follow-up|2|||
129077183|NCT00502242|464571493|FG000|Overall Study|Lack of Efficacy|1|||
129077184|NCT00502242|464571494|FG001|Overall Study|Lack of Efficacy|11|||
129077185|NCT00502242|464571493|FG000|Overall Study|Adverse Event|31|||
129077186|NCT00502242|464571494|FG001|Overall Study|Adverse Event|20|||
129077187|NCT00502242|464571493|FG000|Overall Study|Physician Decision|2|||
129077188|NCT00502242|464571494|FG001|Overall Study|Physician Decision|3|||
129077189|NCT00502242|464571493|FG000|Overall Study|Other - Unspecified|8|||
129077190|NCT00502242|464571494|FG001|Overall Study|Other - Unspecified|14|||
129077191|NCT00502242|464571493|FG000|Overall Study|Protocol Violation|3|||
129077192|NCT00502242|464571494|FG001|Overall Study|Protocol Violation|1|||
129077193|NCT00502242|464571493|FG000|Overall Study|Withdrawal by Subject|6|||
129077194|NCT00502242|464571494|FG001|Overall Study|Withdrawal by Subject|7|||
129077195|NCT01812109|464571495|FG000|Overall Study|research personnel delay|16|||
129077196|NCT01812109|464571495|FG000|Overall Study|NIRS Unattainable|17|||
129077197|NCT03313180|464571496|FG000|Overall Study|Adverse Event|120|||
129077198|NCT03313180|464571496|FG000|Overall Study|Lost to Follow-up|3|||
129077199|NCT03313180|464571496|FG000|Overall Study|Withdrawal by Subject|39|||
129077200|NCT03313180|464571496|FG000|Overall Study|Other than listed above|15|||
129077201|NCT03313180|464571496|FG000|Overall Study|Covid-19 related|2|||
129077202|NCT01966120|464571497|FG000|Overall Study|Withdrawal by Subject|0|||
129077203|NCT01966120|464571498|FG001|Overall Study|Withdrawal by Subject|5|||
129077204|NCT01966120|464571497|FG000|Overall Study|Lost to Follow-up|1|||
129077205|NCT01966120|464571498|FG001|Overall Study|Lost to Follow-up|1|||
129077206|NCT00461630|464571499|FG000|Overall Study|Death|798|||
129077207|NCT00461630|464571500|FG001|Overall Study|Death|732|||
129077208|NCT00461630|464571499|FG000|Overall Study|Lost to Follow-up|108|||
129077209|NCT00461630|464571500|FG001|Overall Study|Lost to Follow-up|95|||
129077210|NCT04630002|464571501|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
129077211|NCT04630002|464571502|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129077212|NCT04630002|464571503|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129077213|NCT04630002|464571501|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
129077214|NCT04630002|464571502|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129077215|NCT04630002|464571503|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129077216|NCT04630002|464571501|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
129077217|NCT04630002|464571502|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129077218|NCT04630002|464571503|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129077219|NCT04630002|464571501|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129077220|NCT04630002|464571502|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
129077221|NCT04630002|464571503|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129141563|NCT04003142|464812259|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
129141564|NCT04003142|464812260|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
129141565|NCT04003142|464812261|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
129141566|NCT04003142|464812262|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
129141567|NCT04003142|464812263|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
129141568|NCT04003142|464812259|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
129141569|NCT04003142|464812260|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
129141570|NCT04003142|464812261|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
129141571|NCT04003142|464812262|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
129141572|NCT04003142|464812263|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
129141573|NCT04003142|464812259|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
129141574|NCT04003142|464812260|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
129141575|NCT04003142|464812261|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
129141576|NCT04003142|464812262|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
129141577|NCT04003142|464812263|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
129141578|NCT04003142|464812259|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
129141579|NCT04003142|464812260|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
129141580|NCT04003142|464812261|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
129141581|NCT04003142|464812262|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
129077222|NCT04630002|464571501|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129077223|NCT04630002|464571502|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
129077224|NCT04630002|464571503|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129077225|NCT04630002|464571501|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129077226|NCT04630002|464571502|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
129077227|NCT04630002|464571503|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129077228|NCT04630002|464571501|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
129077229|NCT04630002|464571502|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
129077230|NCT04630002|464571503|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
129077231|NCT04630002|464571501|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
129077232|NCT04630002|464571502|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
129077233|NCT04630002|464571503|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
129077234|NCT00442897|464571505|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
129077235|NCT00442897|464571506|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
129077236|NCT00442897|464571505|FG000|Base Study (12 Week Follow-up)|Death|0|||
129077237|NCT00442897|464571506|FG001|Base Study (12 Week Follow-up)|Death|1|||
128724001|NCT00692770|463287310|FG001|Overall Study|Protocol Violation|7|||
128724002|NCT00692770|463287309|FG000|Overall Study|Withdrawal by Subject|97|||
129077238|NCT00442897|464571505|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
129077239|NCT00442897|464571506|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
129077240|NCT00442897|464571505|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
129077241|NCT00442897|464571506|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
129077242|NCT00442897|464571505|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
129077243|NCT00442897|464571506|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
129077244|NCT00442897|464571505|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
129077245|NCT00442897|464571506|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
129077246|NCT00442897|464571505|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
129077247|NCT00442897|464571506|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
129077248|NCT00442897|464571505|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
129077249|NCT00442897|464571506|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
129077250|NCT04498182|464571507|FG000|Overall Study|Adverse Event|2|||
129077251|NCT04498182|464571508|FG001|Overall Study|Adverse Event|3|||
129077252|NCT04498182|464571509|FG002|Overall Study|Adverse Event|2|||
129077253|NCT04498182|464571507|FG000|Overall Study|Withdrawal of Consent|3|||
129077254|NCT04498182|464571508|FG001|Overall Study|Withdrawal of Consent|4|||
129077255|NCT04498182|464571509|FG002|Overall Study|Withdrawal of Consent|3|||
129077256|NCT04498182|464571507|FG000|Overall Study|Non-Compliant|1|||
129077257|NCT04498182|464571508|FG001|Overall Study|Non-Compliant|0|||
129077258|NCT04498182|464571509|FG002|Overall Study|Non-Compliant|1|||
129077259|NCT04498182|464571507|FG000|Overall Study|Lost to Follow-up|0|||
129077260|NCT04498182|464571508|FG001|Overall Study|Lost to Follow-up|0|||
129077261|NCT04498182|464571509|FG002|Overall Study|Lost to Follow-up|1|||
129077262|NCT04498182|464571507|FG000|Overall Study|Investigator Decision|0|||
128724003|NCT00692770|463287310|FG001|Overall Study|Withdrawal by Subject|36|||
128724004|NCT00692770|463287309|FG000|Overall Study|Adverse Event|136|||
128724005|NCT00692770|463287310|FG001|Overall Study|Adverse Event|41|||
128724006|NCT00692770|463287309|FG000|Overall Study|Death|10|||
129077263|NCT04498182|464571508|FG001|Overall Study|Investigator Decision|0|||
129077264|NCT04498182|464571509|FG002|Overall Study|Investigator Decision|1|||
129077265|NCT04498182|464571507|FG000|Overall Study|Protocol Violation|1|||
129077266|NCT04498182|464571508|FG001|Overall Study|Protocol Violation|0|||
129077267|NCT04498182|464571509|FG002|Overall Study|Protocol Violation|2|||
129077268|NCT00891020|464571514|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
129077269|NCT00891020|464571515|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
129077270|NCT00891020|464571516|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
129077271|NCT00891020|464571514|FG000|24 Week Treatment Period|Death|0|||
129077272|NCT00891020|464571515|FG001|24 Week Treatment Period|Death|2|||
129077273|NCT00891020|464571516|FG002|24 Week Treatment Period|Death|0|||
128724007|NCT00692770|463287310|FG001|Overall Study|Death|5|||
129141582|NCT04003142|464812263|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
129141583|NCT04003142|464812259|FG000|Extension Period (40 Weeks)|Death|0|||
129141584|NCT04003142|464812260|FG001|Extension Period (40 Weeks)|Death|0|||
129141585|NCT04003142|464812261|FG002|Extension Period (40 Weeks)|Death|0|||
129141586|NCT04003142|464812262|FG003|Extension Period (40 Weeks)|Death|0|||
129141587|NCT04003142|464812263|FG004|Extension Period (40 Weeks)|Death|1|||
129141588|NCT04003142|464812259|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
129141589|NCT04003142|464812260|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
129141590|NCT04003142|464812261|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
129141591|NCT04003142|464812262|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
129141592|NCT04003142|464812263|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
129141593|NCT04003142|464812259|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
129141594|NCT04003142|464812260|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
129141595|NCT04003142|464812261|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
129141596|NCT04003142|464812262|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
129141597|NCT04003142|464812263|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
129141598|NCT04003142|464812259|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
129141599|NCT04003142|464812260|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
129141600|NCT04003142|464812261|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
129141601|NCT04003142|464812262|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
129141602|NCT04003142|464812263|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
129141603|NCT04003142|464812259|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
129141604|NCT04003142|464812260|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
129141605|NCT04003142|464812261|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
129141606|NCT04003142|464812262|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
129141607|NCT04003142|464812263|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
129141608|NCT04042311|464812264|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
129141609|NCT04042311|464812264|FG000|Overall Study|Unable to tolerate|4|||
129141610|NCT04042311|464812264|FG000|Overall Study|Concurrent illness|2|||
129141611|NCT04042311|464812264|FG000|Overall Study|Adverse Event|2|||
129141612|NCT04042311|464812264|FG000|Overall Study|No longer meeting inclusion criteria|2|||
128724008|NCT00692770|463287309|FG000|Overall Study|Lost to Follow-up|7|||
128724009|NCT00692770|463287310|FG001|Overall Study|Lost to Follow-up|3|||
128724010|NCT00692770|463287309|FG000|Overall Study|Non-compliant with study medication|11|||
128724011|NCT00692770|463287310|FG001|Overall Study|Non-compliant with study medication|5|||
128724012|NCT00692770|463287309|FG000|Overall Study|Progression by clinical judgment|2|||
128724013|NCT00692770|463287310|FG001|Overall Study|Progression by clinical judgment|3|||
128724014|NCT00692770|463287309|FG000|Overall Study|Physician decision not protocol driven|10|||
129077274|NCT00891020|464571514|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
129077275|NCT00891020|464571515|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
129077276|NCT00891020|464571516|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
129077277|NCT00891020|464571514|FG000|24 Week Treatment Period|Failure to return|4|||
129077278|NCT00891020|464571515|FG001|24 Week Treatment Period|Failure to return|5|||
129077279|NCT00891020|464571516|FG002|24 Week Treatment Period|Failure to return|5|||
129077280|NCT00891020|464571514|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
129077281|NCT00891020|464571515|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
129077282|NCT00891020|464571516|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
129077283|NCT00891020|464571514|FG000|24 Week Treatment Period|Other protocol violation|1|||
129077284|NCT00891020|464571515|FG001|24 Week Treatment Period|Other protocol violation|1|||
129077285|NCT00891020|464571516|FG002|24 Week Treatment Period|Other protocol violation|2|||
129077286|NCT00891020|464571514|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
129077287|NCT00891020|464571515|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
129077288|NCT00891020|464571516|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
129077289|NCT00891020|464571514|FG000|24 Week Treatment Period|Withdrew consent|6|||
129077290|NCT00891020|464571515|FG001|24 Week Treatment Period|Withdrew consent|3|||
129077291|NCT00891020|464571516|FG002|24 Week Treatment Period|Withdrew consent|15|||
129077292|NCT00891020|464571514|FG000|24 Week Treatment Period|Administrative/Other|5|||
129077293|NCT00891020|464571515|FG001|24 Week Treatment Period|Administrative/Other|6|||
129077294|NCT00891020|464571516|FG002|24 Week Treatment Period|Administrative/Other|1|||
129077295|NCT00891020|464571514|FG000|Long-term Extension Period|Adverse Event|1|||
129077296|NCT00891020|464571515|FG001|Long-term Extension Period|Adverse Event|11|||
129077297|NCT00891020|464571516|FG002|Long-term Extension Period|Adverse Event|10|||
129077298|NCT00891020|464571514|FG000|Long-term Extension Period|Death|0|||
129141613|NCT04042311|464812264|FG000|Overall Study|No reason given|1|||
129141614|NCT04042311|464812264|FG000|Overall Study|Withdrawal by Subject|4|||
129141615|NCT03382873|464812265|FG000|Overall Study|Lost to Follow-up|9|||
129141616|NCT03382873|464812266|FG001|Overall Study|Lost to Follow-up|10|||
129141617|NCT03382873|464812265|FG000|Overall Study|Withdrawal by Subject|6|||
129077299|NCT00891020|464571515|FG001|Long-term Extension Period|Death|0|||
129077300|NCT00891020|464571516|FG002|Long-term Extension Period|Death|1|||
129077301|NCT00891020|464571514|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
129077302|NCT00891020|464571515|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
129077303|NCT00891020|464571516|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
129077304|NCT00891020|464571514|FG000|Long-term Extension Period|Protocol Violation|0|||
129077305|NCT00891020|464571515|FG001|Long-term Extension Period|Protocol Violation|1|||
129077306|NCT00891020|464571516|FG002|Long-term Extension Period|Protocol Violation|1|||
129077307|NCT00891020|464571514|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
129077308|NCT00891020|464571515|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
129077309|NCT00891020|464571516|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
129077310|NCT00891020|464571514|FG000|Long-term Extension Period|Failure to return|0|||
129141618|NCT03382873|464812266|FG001|Overall Study|Withdrawal by Subject|11|||
129141619|NCT03382873|464812265|FG000|Overall Study|Visit not completed due to pandemic|16|||
129141620|NCT03382873|464812266|FG001|Overall Study|Visit not completed due to pandemic|41|||
129141621|NCT01044459|464812277|FG000|Overall Study|Withdrawal by Subject|21|||
129141622|NCT01044459|464812278|FG001|Overall Study|Withdrawal by Subject|28|||
129141623|NCT01044459|464812277|FG000|Overall Study|Terminated by Sponsor|22|||
129141624|NCT01044459|464812278|FG001|Overall Study|Terminated by Sponsor|21|||
129141625|NCT01044459|464812277|FG000|Overall Study|Adverse Event|22|||
129141626|NCT01044459|464812278|FG001|Overall Study|Adverse Event|20|||
129141627|NCT01044459|464812277|FG000|Overall Study|Lack of Efficacy|23|||
129141628|NCT01044459|464812278|FG001|Overall Study|Lack of Efficacy|12|||
129141629|NCT01044459|464812277|FG000|Overall Study|Protocol Violation|11|||
129141630|NCT01044459|464812278|FG001|Overall Study|Protocol Violation|16|||
129141631|NCT01044459|464812277|FG000|Overall Study|Other Reason|7|||
129141632|NCT01044459|464812278|FG001|Overall Study|Other Reason|14|||
129141633|NCT01044459|464812277|FG000|Overall Study|COPD exacerbation|9|||
129141634|NCT01044459|464812278|FG001|Overall Study|COPD exacerbation|8|||
129141635|NCT01044459|464812277|FG000|Overall Study|Lost to Follow-up|18|||
129141636|NCT01044459|464812278|FG001|Overall Study|Lost to Follow-up|12|||
129141637|NCT04105725|464812279|FG000|Primary Intervention|Lost to Follow-up|0|||
129141638|NCT04105725|464812280|FG001|Primary Intervention|Lost to Follow-up|2|||
129141639|NCT04105725|464812279|FG000|Primary Intervention|Withdrawal by Subject|0|||
129141640|NCT04105725|464812280|FG001|Primary Intervention|Withdrawal by Subject|1|||
129141641|NCT05346640|464812281|FG000|Overall Study|Lack of Efficacy|2|||
129141642|NCT05346640|464812281|FG000|Overall Study|Lost to Follow-up|14|||
129141643|NCT05346640|464812281|FG000|Overall Study|Protocol Violation|4|||
129141644|NCT05346640|464812281|FG000|Overall Study|Withdrawal by Subject|2|||
129141645|NCT05346640|464812281|FG000|Overall Study|Physiological Complications|3|||
129141646|NCT05346640|464812281|FG000|Overall Study|Other Reason|3|||
129141647|NCT00480025|464812282|FG000|Overall Study|Protocol Violation|12|||
129141648|NCT00480025|464812283|FG001|Overall Study|Protocol Violation|7|||
129141649|NCT00480025|464812282|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
129141650|NCT00480025|464812283|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
129141651|NCT00480025|464812282|FG000|Overall Study|Disease Progression / Recurrence|449|||
129141652|NCT00480025|464812283|FG001|Overall Study|Disease Progression / Recurrence|224|||
129141653|NCT00480025|464812282|FG000|Overall Study|Adverse Event|44|||
129141654|NCT00480025|464812283|FG001|Overall Study|Adverse Event|12|||
129141655|NCT00480025|464812282|FG000|Overall Study|Other|70|||
129141656|NCT00480025|464812283|FG001|Overall Study|Other|29|||
129141657|NCT00480025|464812282|FG000|Overall Study|SAE including intercurrent illness|76|||
129141658|NCT00480025|464812283|FG001|Overall Study|SAE including intercurrent illness|42|||
129141659|NCT04634331|464812287|FG000|Overall Study|Withdrawal by Subject|2|||
129141660|NCT04634331|464812288|FG001|Overall Study|Withdrawal by Subject|2|||
129141661|NCT03726879|464812290|FG000|Overall Study|Death|11|||
129141662|NCT03726879|464812291|FG001|Overall Study|Death|13|||
129141663|NCT03726879|464812290|FG000|Overall Study|Physician Decision|0|||
129141664|NCT03726879|464812291|FG001|Overall Study|Physician Decision|2|||
129141665|NCT03726879|464812290|FG000|Overall Study|Protocol Violation|0|||
129141666|NCT03726879|464812291|FG001|Overall Study|Protocol Violation|1|||
129141667|NCT03726879|464812290|FG000|Overall Study|Withdrawal by Subject|5|||
129141668|NCT03726879|464812291|FG001|Overall Study|Withdrawal by Subject|6|||
129141669|NCT03726879|464812290|FG000|Overall Study|TSH result is unstable|0|||
129141670|NCT03726879|464812291|FG001|Overall Study|TSH result is unstable|1|||
129141671|NCT03726879|464812290|FG000|Overall Study|Disease relapse|1|||
129141672|NCT03726879|464812291|FG001|Overall Study|Disease relapse|0|||
129077311|NCT00891020|464571515|FG001|Long-term Extension Period|Failure to return|2|||
129141673|NCT03726879|464812290|FG000|Overall Study|Lost to Follow-up|3|||
129141674|NCT03726879|464812291|FG001|Overall Study|Lost to Follow-up|0|||
129077312|NCT00891020|464571516|FG002|Long-term Extension Period|Failure to return|3|||
129077313|NCT00891020|464571514|FG000|Long-term Extension Period|Administrative|1|||
129077314|NCT00891020|464571515|FG001|Long-term Extension Period|Administrative|2|||
129077315|NCT00891020|464571516|FG002|Long-term Extension Period|Administrative|2|||
129077316|NCT00320710|464571524|FG000|Overall Study|Disease progression|24|||
129077317|NCT00320710|464571525|FG001|Overall Study|Disease progression|19|||
129077318|NCT00320710|464571526|FG002|Overall Study|Disease progression|2|||
129077319|NCT00320710|464571524|FG000|Overall Study|Death|10|||
129077320|NCT00320710|464571525|FG001|Overall Study|Death|7|||
129077321|NCT00320710|464571526|FG002|Overall Study|Death|1|||
129077322|NCT00320710|464571524|FG000|Overall Study|Administrative problems|1|||
129077323|NCT00320710|464571525|FG001|Overall Study|Administrative problems|2|||
129077324|NCT00320710|464571526|FG002|Overall Study|Administrative problems|0|||
129077325|NCT00320710|464571524|FG000|Overall Study|Withdrawal by Subject|20|||
129077326|NCT00320710|464571525|FG001|Overall Study|Withdrawal by Subject|26|||
129077327|NCT00320710|464571526|FG002|Overall Study|Withdrawal by Subject|1|||
129077328|NCT00320710|464571524|FG000|Overall Study|Protocol Violation|6|||
129077329|NCT00320710|464571525|FG001|Overall Study|Protocol Violation|5|||
129077330|NCT00320710|464571526|FG002|Overall Study|Protocol Violation|0|||
129077331|NCT00320710|464571524|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129077332|NCT00320710|464571525|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129077333|NCT00320710|464571526|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129077334|NCT00320710|464571524|FG000|Overall Study|Abnormal laboratory value(s)|12|||
129077335|NCT00320710|464571525|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129077336|NCT00320710|464571526|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129077337|NCT00320710|464571524|FG000|Overall Study|Adverse Event|18|||
129077338|NCT00320710|464571525|FG001|Overall Study|Adverse Event|14|||
129077339|NCT00320710|464571526|FG002|Overall Study|Adverse Event|1|||
129077340|NCT00320710|464571524|FG000|Overall Study|Lost to Follow-up|1|||
129077341|NCT00320710|464571525|FG001|Overall Study|Lost to Follow-up|0|||
129077342|NCT00320710|464571526|FG002|Overall Study|Lost to Follow-up|0|||
129077343|NCT03448419|464571527|FG000|Overall Study|Adverse Event|10|||
129077344|NCT03448419|464571528|FG001|Overall Study|Adverse Event|9|||
129077345|NCT03448419|464571527|FG000|Overall Study|Lost to Follow-up|0|||
129077346|NCT03448419|464571528|FG001|Overall Study|Lost to Follow-up|2|||
129077347|NCT03448419|464571527|FG000|Overall Study|Withdrawal by Subject|3|||
129077348|NCT03448419|464571528|FG001|Overall Study|Withdrawal by Subject|1|||
129077349|NCT03448419|464571527|FG000|Overall Study|Not treated|0|||
129077350|NCT03448419|464571528|FG001|Overall Study|Not treated|1|||
129077351|NCT03448419|464571527|FG000|Overall Study|Patient did not attend all visits|0|||
129077352|NCT03448419|464571528|FG001|Overall Study|Patient did not attend all visits|2|||
129077353|NCT03448419|464571527|FG000|Overall Study|Withdrawn by Sponsor|0|||
129077354|NCT03448419|464571528|FG001|Overall Study|Withdrawn by Sponsor|1|||
129077355|NCT02841995|464571529|FG000|Overall Study|Disease progression|5|||
129077356|NCT02841995|464571530|FG001|Overall Study|Disease progression|11|||
129077357|NCT02841995|464571531|FG002|Overall Study|Disease progression|8|||
129077358|NCT02841995|464571529|FG000|Overall Study|Withdrawal by Subject|2|||
129077359|NCT02841995|464571530|FG001|Overall Study|Withdrawal by Subject|4|||
129077360|NCT02841995|464571531|FG002|Overall Study|Withdrawal by Subject|4|||
129077361|NCT02841995|464571529|FG000|Overall Study|Adverse Event|2|||
129077362|NCT02841995|464571530|FG001|Overall Study|Adverse Event|0|||
129077363|NCT02841995|464571531|FG002|Overall Study|Adverse Event|1|||
129077364|NCT02841995|464571529|FG000|Overall Study|Investigator decision|2|||
129077365|NCT02841995|464571530|FG001|Overall Study|Investigator decision|0|||
129077366|NCT02841995|464571531|FG002|Overall Study|Investigator decision|1|||
129077367|NCT02841995|464571529|FG000|Overall Study|Death|0|||
129077368|NCT02841995|464571530|FG001|Overall Study|Death|0|||
129077369|NCT02841995|464571531|FG002|Overall Study|Death|2|||
129077370|NCT02841995|464571529|FG000|Overall Study|Noncompliance to protocol|1|||
129077371|NCT02841995|464571530|FG001|Overall Study|Noncompliance to protocol|0|||
129077372|NCT02841995|464571531|FG002|Overall Study|Noncompliance to protocol|0|||
129077373|NCT02841995|464571529|FG000|Overall Study|Sponsor decision|1|||
129077374|NCT02841995|464571530|FG001|Overall Study|Sponsor decision|0|||
129077375|NCT02841995|464571531|FG002|Overall Study|Sponsor decision|0|||
129077376|NCT02841995|464571529|FG000|Overall Study|Other|4|||
129077377|NCT02841995|464571530|FG001|Overall Study|Other|1|||
129077378|NCT02841995|464571531|FG002|Overall Study|Other|5|||
129077379|NCT01703260|464571532|FG000|Overall Study|Adverse Event|1|||
129077380|NCT01703260|464571533|FG001|Overall Study|Adverse Event|2|||
129077381|NCT01703260|464571534|FG002|Overall Study|Adverse Event|2|||
129077382|NCT01703260|464571532|FG000|Overall Study|Lost to Follow-up|1|||
129077383|NCT01703260|464571533|FG001|Overall Study|Lost to Follow-up|0|||
129077384|NCT01703260|464571534|FG002|Overall Study|Lost to Follow-up|0|||
129077385|NCT01703260|464571532|FG000|Overall Study|Withdrawal by Subject|0|||
129077386|NCT01703260|464571533|FG001|Overall Study|Withdrawal by Subject|0|||
129077387|NCT01703260|464571534|FG002|Overall Study|Withdrawal by Subject|1|||
129077388|NCT01703260|464571532|FG000|Overall Study|Study Termination|1|||
129077389|NCT01703260|464571533|FG001|Overall Study|Study Termination|2|||
129077390|NCT01703260|464571534|FG002|Overall Study|Study Termination|0|||
129077391|NCT04548193|464571537|FG000|Overall Study|Lost to Follow-up|0|||
129077392|NCT04548193|464571538|FG001|Overall Study|Lost to Follow-up|1|||
129077393|NCT04548193|464571537|FG000|Overall Study|Death|0|||
129077394|NCT04548193|464571538|FG001|Overall Study|Death|1|||
129077395|NCT04548193|464571537|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
129077396|NCT04548193|464571538|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
129077397|NCT04548193|464571537|FG000|Overall Study|Withdrawal by Subject|2|||
129077398|NCT04548193|464571538|FG001|Overall Study|Withdrawal by Subject|2|||
129077399|NCT00630825|464571540|FG000|Overall Study|Adverse Event|4|||
129077400|NCT00630825|464571541|FG001|Overall Study|Adverse Event|4|||
129077401|NCT00630825|464571542|FG002|Overall Study|Adverse Event|3|||
129077402|NCT00630825|464571543|FG003|Overall Study|Adverse Event|1|||
129077403|NCT00630825|464571540|FG000|Overall Study|Entry Criteria Not Met|1|||
129077404|NCT00630825|464571541|FG001|Overall Study|Entry Criteria Not Met|0|||
129077405|NCT00630825|464571542|FG002|Overall Study|Entry Criteria Not Met|2|||
129077406|NCT00630825|464571543|FG003|Overall Study|Entry Criteria Not Met|1|||
129077407|NCT00630825|464571540|FG000|Overall Study|Lost to Follow-up|1|||
129077408|NCT00630825|464571541|FG001|Overall Study|Lost to Follow-up|1|||
129077409|NCT00630825|464571542|FG002|Overall Study|Lost to Follow-up|1|||
129077410|NCT00630825|464571543|FG003|Overall Study|Lost to Follow-up|1|||
129077411|NCT00630825|464571540|FG000|Overall Study|Physician Decision|1|||
129077412|NCT00630825|464571541|FG001|Overall Study|Physician Decision|0|||
129077413|NCT00630825|464571542|FG002|Overall Study|Physician Decision|0|||
129077414|NCT00630825|464571543|FG003|Overall Study|Physician Decision|0|||
129077415|NCT00630825|464571540|FG000|Overall Study|Withdrawal by Subject|2|||
129077416|NCT00630825|464571541|FG001|Overall Study|Withdrawal by Subject|2|||
129077417|NCT00630825|464571542|FG002|Overall Study|Withdrawal by Subject|2|||
129077418|NCT00630825|464571543|FG003|Overall Study|Withdrawal by Subject|3|||
129077419|NCT02275819|464571544|FG000|Overall Study|Adverse Event|0|||
129077420|NCT02275819|464571545|FG001|Overall Study|Adverse Event|1|||
129077421|NCT02211209|464571549|FG000|Overall Study|Investigator judgment|0|||
129077422|NCT02211209|464571550|FG001|Overall Study|Investigator judgment|1|||
129077423|NCT02211209|464571549|FG000|Overall Study|Voluntary withdrawal|1|||
129077424|NCT02211209|464571550|FG001|Overall Study|Voluntary withdrawal|4|||
129077425|NCT02211209|464571549|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
129077426|NCT02211209|464571550|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
129077427|NCT02211209|464571549|FG000|Overall Study|Reason Not Specified|1|||
129077428|NCT02211209|464571550|FG001|Overall Study|Reason Not Specified|0|||
129077429|NCT02792062|464571553|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
129077430|NCT02792062|464571554|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129077431|NCT02792062|464571555|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129077432|NCT02792062|464571556|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129077433|NCT02792062|464571557|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129077434|NCT02792062|464571558|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129077435|NCT00931255|464571561|FG000|Overall Study|Follow up biopsy not done|2|||
129077436|NCT00931255|464571562|FG001|Overall Study|Follow up biopsy not done|3|||
129077437|NCT01681212|464571568|FG000|Overall Study|No longer met study criteria|5|||
129077438|NCT01681212|464571568|FG000|Overall Study|Administrative reason by sponsor|1|||
129077439|NCT02220764|464571571|FG000|Overall Study|Lost to Follow-up|3|||
129077440|NCT02220764|464571572|FG001|Overall Study|Lost to Follow-up|1|||
129077441|NCT02220764|464571571|FG000|Overall Study|Death|1|||
129077442|NCT02220764|464571572|FG001|Overall Study|Death|0|||
129077443|NCT02198664|464571573|FG000|Overall Study|Adverse Event|2|||
129077444|NCT02198664|464571574|FG001|Overall Study|Adverse Event|0|||
129077445|NCT02198664|464571573|FG000|Overall Study|Withdrawal by Subject|11|||
129077446|NCT02198664|464571574|FG001|Overall Study|Withdrawal by Subject|8|||
129077447|NCT02198664|464571573|FG000|Overall Study|Failure to tolerate|2|||
129077448|NCT02198664|464571574|FG001|Overall Study|Failure to tolerate|0|||
129077449|NCT02198664|464571573|FG000|Overall Study|Not stated|1|||
129077450|NCT02198664|464571574|FG001|Overall Study|Not stated|0|||
129077451|NCT03859427|464571578|FG000|Overall Study|Withdrawal by Subject|4|||
129077452|NCT03859427|464571579|FG001|Overall Study|Withdrawal by Subject|7|||
129077453|NCT03859427|464571578|FG000|Overall Study|Decision by sponsor|0|||
129077454|NCT03859427|464571579|FG001|Overall Study|Decision by sponsor|3|||
129077455|NCT03859427|464571578|FG000|Overall Study|Lost to Follow-up|3|||
129077456|NCT03859427|464571579|FG001|Overall Study|Lost to Follow-up|2|||
129077457|NCT03859427|464571578|FG000|Overall Study|Death|22|||
129077458|NCT03859427|464571579|FG001|Overall Study|Death|25|||
129077459|NCT02503540|464571580|FG000|Overall Study|Death|2|||
129077460|NCT02503540|464571580|FG000|Overall Study|Withdrawal by Subject|1|||
129077461|NCT01662492|464571581|FG000|Overall Study|Other miscellaneous reasons.|1|||
129077462|NCT01662492|464571582|FG001|Overall Study|Other miscellaneous reasons.|0|||
129077463|NCT01662492|464571583|FG002|Overall Study|Other miscellaneous reasons.|1|||
129141675|NCT02766478|464812292|FG000|Overall Study|Withdrawal by Subject|1|||
129141676|NCT02766478|464812293|FG001|Overall Study|Withdrawal by Subject|1|||
129141677|NCT01093573|464812294|FG000|Overall Study|Physician Decision|0|||
129141678|NCT01093573|464812295|FG001|Overall Study|Physician Decision|0|||
129141679|NCT01093573|464812296|FG002|Overall Study|Physician Decision|1|||
129141680|NCT01093573|464812294|FG000|Overall Study|Insurance Denied|0|||
129141681|NCT01093573|464812295|FG001|Overall Study|Insurance Denied|0|||
129141682|NCT01093573|464812296|FG002|Overall Study|Insurance Denied|1|||
129141683|NCT05626686|464812297|FG000|Overall Study|Protocol Violation|3|||
129141684|NCT05626686|464812297|FG000|Overall Study|Withdrawal by Subject|3|||
129141685|NCT01197300|464813657|FG000|Overall Study|Lost to Follow-up|0|||
129141686|NCT01197300|464813658|FG001|Overall Study|Lost to Follow-up|1|||
129141687|NCT01197300|464813657|FG000|Overall Study|Protocol Violation|0|||
129141688|NCT01197300|464813658|FG001|Overall Study|Protocol Violation|1|||
129141689|NCT02113878|464813659|FG000|Overall Study|Adverse Event|1|||
129141690|NCT02113878|464813660|FG001|Overall Study|Adverse Event|0|||
129141691|NCT02113878|464813659|FG000|Overall Study|Withdrawal by Subject|1|||
129141692|NCT02113878|464813660|FG001|Overall Study|Withdrawal by Subject|0|||
129141693|NCT02113878|464813659|FG000|Overall Study|patient non-compliance|1|||
129141694|NCT02113878|464813660|FG001|Overall Study|patient non-compliance|0|||
129141695|NCT00581100|464813661|FG000|Overall Study|Death|1|||
129141696|NCT00581100|464813662|FG001|Overall Study|Death|0|||
129141697|NCT00581100|464813661|FG000|Overall Study|Adverse Event|2|||
129141698|NCT00581100|464813662|FG001|Overall Study|Adverse Event|1|||
129141699|NCT00581100|464813661|FG000|Overall Study|Withdrawal by Subject|1|||
129141700|NCT00581100|464813662|FG001|Overall Study|Withdrawal by Subject|4|||
129141701|NCT00581100|464813661|FG000|Overall Study|Other|3|||
129141702|NCT00581100|464813662|FG001|Overall Study|Other|0|||
129141703|NCT03058952|464813665|FG000|Overall Study|Adverse Event|1|||
129141704|NCT03058952|464813666|FG001|Overall Study|Adverse Event|0|||
129141705|NCT03058952|464813665|FG000|Overall Study|Lost to Follow-up|15|||
129141706|NCT03058952|464813666|FG001|Overall Study|Lost to Follow-up|15|||
129141707|NCT03058952|464813665|FG000|Overall Study|Withdrawal by Subject|7|||
129141708|NCT03058952|464813666|FG001|Overall Study|Withdrawal by Subject|11|||
129141709|NCT04744831|464813667|FG000|Overall Study|Progressive Disease|31|||
129141710|NCT04744831|464813668|FG001|Overall Study|Progressive Disease|27|||
129077464|NCT01662492|464571581|FG000|Overall Study|Withdrawal by Subject|0|||
129077465|NCT01662492|464571582|FG001|Overall Study|Withdrawal by Subject|0|||
129077466|NCT01662492|464571583|FG002|Overall Study|Withdrawal by Subject|1|||
129077467|NCT01662492|464571581|FG000|Overall Study|Protocol Violation|1|||
129077468|NCT01662492|464571582|FG001|Overall Study|Protocol Violation|0|||
129077469|NCT01662492|464571583|FG002|Overall Study|Protocol Violation|0|||
129077470|NCT01662492|464571581|FG000|Overall Study|Lost to Follow-up|0|||
129077471|NCT01662492|464571582|FG001|Overall Study|Lost to Follow-up|0|||
129077472|NCT01662492|464571583|FG002|Overall Study|Lost to Follow-up|2|||
129077473|NCT01662492|464571581|FG000|Overall Study|Lack of Efficacy|1|||
129077474|NCT01662492|464571582|FG001|Overall Study|Lack of Efficacy|1|||
129077475|NCT01662492|464571583|FG002|Overall Study|Lack of Efficacy|2|||
129077476|NCT02418182|464571588|FG000|Overall Study|Unable to re-consent|18|||
129077477|NCT02418182|464571589|FG001|Overall Study|Unable to re-consent|15|||
129141711|NCT04744831|464813669|FG002|Overall Study|Progressive Disease|25|||
129141712|NCT04744831|464813667|FG000|Overall Study|Adverse Event|3|||
129141713|NCT04744831|464813668|FG001|Overall Study|Adverse Event|3|||
129077478|NCT02418182|464571588|FG000|Overall Study|Lost to Follow-up|0|||
129141714|NCT04744831|464813669|FG002|Overall Study|Adverse Event|3|||
129141715|NCT04744831|464813667|FG000|Overall Study|Clinical Progression|3|||
129141716|NCT04744831|464813668|FG001|Overall Study|Clinical Progression|2|||
129141717|NCT04744831|464813669|FG002|Overall Study|Clinical Progression|5|||
129141718|NCT04744831|464813667|FG000|Overall Study|Other|0|||
129141719|NCT04744831|464813668|FG001|Overall Study|Other|2|||
129141720|NCT04744831|464813669|FG002|Overall Study|Other|1|||
129141721|NCT04744831|464813667|FG000|Overall Study|Death|0|||
129141722|NCT04744831|464813668|FG001|Overall Study|Death|2|||
129141723|NCT04744831|464813669|FG002|Overall Study|Death|1|||
129141724|NCT03837509|464813670|FG000|Phase 1|Death|5|||
129077479|NCT02418182|464571589|FG001|Overall Study|Lost to Follow-up|2|||
129077480|NCT02431676|464571592|FG000|Overall Study|no lab obtained|0|||
129077481|NCT02431676|464571593|FG001|Overall Study|no lab obtained|1|||
129077482|NCT02431676|464571594|FG002|Overall Study|no lab obtained|2|||
129077483|NCT00570687|464573593|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077484|NCT00570687|464573594|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077485|NCT00570687|464573595|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077486|NCT00570687|464573596|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077487|NCT00570687|464573597|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129077488|NCT00570687|464573598|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129077489|NCT00570687|464573599|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
129077490|NCT00570687|464573600|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129077491|NCT00570687|464573601|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
129077492|NCT00570687|464573602|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129077493|NCT00570687|464573593|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077494|NCT00570687|464573594|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077495|NCT00570687|464573595|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077496|NCT00570687|464573596|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077497|NCT00570687|464573597|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077498|NCT00570687|464573598|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077499|NCT00570687|464573599|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077500|NCT00570687|464573600|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077501|NCT00570687|464573601|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
129077502|NCT00570687|464573602|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077503|NCT00570687|464573593|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077504|NCT00570687|464573594|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077505|NCT00570687|464573595|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077506|NCT00570687|464573596|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077507|NCT00570687|464573597|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077508|NCT00570687|464573598|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077509|NCT00570687|464573599|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
129077510|NCT00570687|464573600|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077511|NCT00570687|464573601|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077512|NCT00570687|464573602|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129077513|NCT01102257|464573610|FG000|Overall Study|Adverse Event|1|||
129077514|NCT01102257|464573611|FG001|Overall Study|Adverse Event|0|||
129077515|NCT01102257|464573610|FG000|Overall Study|Adverse Event|1|||
129077516|NCT01102257|464573611|FG001|Overall Study|Adverse Event|0|||
129077517|NCT01120184|464573612|FG000|Overall Study|Adverse Event|0|||
129077518|NCT01120184|464573613|FG001|Overall Study|Adverse Event|1|||
129077519|NCT01120184|464573614|FG002|Overall Study|Adverse Event|0|||
129077520|NCT01120184|464573612|FG000|Overall Study|Lost to Follow-up|13|||
129077521|NCT01120184|464573613|FG001|Overall Study|Lost to Follow-up|13|||
129077522|NCT01120184|464573614|FG002|Overall Study|Lost to Follow-up|11|||
129077523|NCT01120184|464573612|FG000|Overall Study|Physician Decision|9|||
129077524|NCT01120184|464573613|FG001|Overall Study|Physician Decision|1|||
129077525|NCT01120184|464573614|FG002|Overall Study|Physician Decision|3|||
129077526|NCT01120184|464573612|FG000|Overall Study|Reason not Specified|8|||
129077527|NCT01120184|464573613|FG001|Overall Study|Reason not Specified|3|||
129077528|NCT01120184|464573614|FG002|Overall Study|Reason not Specified|12|||
129077529|NCT01120184|464573612|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
129077530|NCT01120184|464573613|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
129077531|NCT01120184|464573614|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
129077532|NCT01120184|464573612|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
129077533|NCT01120184|464573613|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
129077534|NCT01120184|464573614|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
129077535|NCT01120184|464573612|FG000|Overall Study|Death|170|||
129077536|NCT01120184|464573613|FG001|Overall Study|Death|176|||
129077537|NCT01120184|464573614|FG002|Overall Study|Death|169|||
129077538|NCT02525783|464573615|FG000|Overall Study|Lost to Follow-up|10|||
129077539|NCT04003636|464573616|FG000|Overall Study|Death|409|||
129077540|NCT04003636|464573617|FG001|Overall Study|Death|443|||
129077541|NCT04003636|464573616|FG000|Overall Study|Lost to Follow-up|0|||
129077542|NCT04003636|464573617|FG001|Overall Study|Lost to Follow-up|1|||
129077543|NCT04003636|464573616|FG000|Overall Study|Withdrawal by Subject|5|||
129077544|NCT04003636|464573617|FG001|Overall Study|Withdrawal by Subject|2|||
129077545|NCT04003636|464573616|FG000|Overall Study|Participant On-going|119|||
129077546|NCT04003636|464573617|FG001|Overall Study|Participant On-going|90|||
129077547|NCT03048747|464573618|FG000|Overall Study|Adverse Event|2|||
129077548|NCT03048747|464573618|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
129077549|NCT03048747|464573618|FG000|Overall Study|Physician Decision|1|||
129077550|NCT00824772|464573619|FG000|Overall Study|Withdrawal by Subject|8|||
129077551|NCT00866281|464573620|FG000|Overall Study|Adverse Event|1|||
129077552|NCT00866281|464573621|FG001|Overall Study|Adverse Event|0|||
129077553|NCT00866281|464573620|FG000|Overall Study|Withdrawal by participants|3|||
129077554|NCT00866281|464573621|FG001|Overall Study|Withdrawal by participants|0|||
129077555|NCT00866281|464573620|FG000|Overall Study|Disease progression|3|||
129077556|NCT00866281|464573621|FG001|Overall Study|Disease progression|11|||
129077557|NCT00866281|464573620|FG000|Overall Study|New cancer therapy|0|||
129077558|NCT00866281|464573621|FG001|Overall Study|New cancer therapy|4|||
129077559|NCT01894841|464573624|FG000|Overall Study|Withdrawal by Subject|9|||
129077560|NCT01894841|464573625|FG001|Overall Study|Withdrawal by Subject|4|||
129077561|NCT01894841|464573624|FG000|Overall Study|Withdrawn by investigator|2|||
129077562|NCT01894841|464573625|FG001|Overall Study|Withdrawn by investigator|2|||
129077563|NCT01894841|464573624|FG000|Overall Study|Lost to Follow-up|7|||
129077564|NCT01894841|464573625|FG001|Overall Study|Lost to Follow-up|3|||
129077565|NCT00529087|464573627|FG000|Overall Study|Adverse Event|10|||
129077566|NCT00529087|464573628|FG001|Overall Study|Adverse Event|13|||
129077567|NCT00529087|464573629|FG002|Overall Study|Adverse Event|4|||
129077568|NCT00529087|464573627|FG000|Overall Study|Lost to Follow-up|6|||
129077569|NCT00529087|464573628|FG001|Overall Study|Lost to Follow-up|4|||
129077570|NCT00529087|464573629|FG002|Overall Study|Lost to Follow-up|1|||
129077571|NCT00529087|464573627|FG000|Overall Study|Protocol Violation|8|||
129077572|NCT00529087|464573628|FG001|Overall Study|Protocol Violation|7|||
129077573|NCT00529087|464573629|FG002|Overall Study|Protocol Violation|6|||
129077574|NCT00529087|464573627|FG000|Overall Study|Withdrawal by Subject|3|||
129077575|NCT00529087|464573628|FG001|Overall Study|Withdrawal by Subject|3|||
129077576|NCT00529087|464573629|FG002|Overall Study|Withdrawal by Subject|3|||
129077577|NCT00529087|464573627|FG000|Overall Study|Protocol deviation|1|||
129077578|NCT00529087|464573628|FG001|Overall Study|Protocol deviation|1|||
129077579|NCT00529087|464573629|FG002|Overall Study|Protocol deviation|2|||
129077580|NCT00318474|464573630|FG000|Overall Study|Adverse Event|1|||
129077581|NCT00318474|464573631|FG001|Overall Study|Adverse Event|1|||
129077582|NCT00318474|464573630|FG000|Overall Study|Lost to Follow-up|0|||
129077583|NCT00318474|464573631|FG001|Overall Study|Lost to Follow-up|1|||
129077584|NCT00318474|464573630|FG000|Overall Study|Pregnancy|0|||
129077585|NCT00318474|464573631|FG001|Overall Study|Pregnancy|2|||
129077586|NCT00318474|464573630|FG000|Overall Study|Protocol Violation|1|||
129077587|NCT00318474|464573631|FG001|Overall Study|Protocol Violation|0|||
129077588|NCT00318474|464573630|FG000|Overall Study|Withdrawal by Subject|3|||
129077589|NCT00318474|464573631|FG001|Overall Study|Withdrawal by Subject|2|||
129077590|NCT00318474|464573630|FG000|Overall Study|Fall in GFR|3|||
129077591|NCT00318474|464573631|FG001|Overall Study|Fall in GFR|3|||
129077592|NCT00318474|464573630|FG000|Overall Study|Post-therapy hyperflycemia|0|||
129077593|NCT00318474|464573631|FG001|Overall Study|Post-therapy hyperflycemia|1|||
129077594|NCT00318474|464573630|FG000|Overall Study|Trial terminated|10|||
129077595|NCT00318474|464573631|FG001|Overall Study|Trial terminated|7|||
129077596|NCT03656068|464573641|FG000|Overall Study|Withdrawal by Subject|4|||
129077597|NCT03656068|464573641|FG000|Overall Study|Adverse Event|1|||
129077598|NCT05326529|464573642|FG000|Overall Study|Lack of Efficacy|0|||
129077599|NCT05326529|464573643|FG001|Overall Study|Lack of Efficacy|1|||
129077600|NCT05326529|464573644|FG002|Overall Study|Lack of Efficacy|0|||
129077601|NCT05326529|464573642|FG000|Overall Study|Physician Decision|0|||
129077602|NCT05326529|464573643|FG001|Overall Study|Physician Decision|0|||
129077603|NCT05326529|464573644|FG002|Overall Study|Physician Decision|2|||
129077604|NCT01379768|464573645|FG000|Overall Study|Adverse Event|1|||
129077605|NCT01379768|464573646|FG001|Overall Study|Adverse Event|1|||
129077606|NCT01379768|464573647|FG002|Overall Study|Adverse Event|0|||
129077607|NCT01379768|464573645|FG000|Overall Study|Lost to Follow-up|2|||
129077608|NCT01379768|464573646|FG001|Overall Study|Lost to Follow-up|0|||
129077609|NCT01379768|464573647|FG002|Overall Study|Lost to Follow-up|0|||
129077610|NCT00708552|464573648|FG000|Overall Study|Adverse Event|10|||
129077611|NCT00708552|464573649|FG001|Overall Study|Adverse Event|3|||
129077612|NCT00708552|464573650|FG002|Overall Study|Adverse Event|4|||
129077613|NCT00708552|464573651|FG003|Overall Study|Adverse Event|6|||
129077614|NCT00708552|464573648|FG000|Overall Study|Lack of Efficacy|0|||
129077615|NCT00708552|464573649|FG001|Overall Study|Lack of Efficacy|4|||
129077616|NCT00708552|464573650|FG002|Overall Study|Lack of Efficacy|1|||
129077617|NCT00708552|464573651|FG003|Overall Study|Lack of Efficacy|0|||
129077618|NCT00708552|464573648|FG000|Overall Study|Protocol Violation|0|||
129077619|NCT00708552|464573649|FG001|Overall Study|Protocol Violation|0|||
129077620|NCT00708552|464573650|FG002|Overall Study|Protocol Violation|2|||
129077621|NCT00708552|464573651|FG003|Overall Study|Protocol Violation|4|||
129077622|NCT00708552|464573648|FG000|Overall Study|Lost to Follow-up|4|||
129077623|NCT00708552|464573649|FG001|Overall Study|Lost to Follow-up|2|||
129077624|NCT00708552|464573650|FG002|Overall Study|Lost to Follow-up|0|||
129077625|NCT00708552|464573651|FG003|Overall Study|Lost to Follow-up|1|||
129077626|NCT00708552|464573648|FG000|Overall Study|Physician Decision|1|||
129077627|NCT00708552|464573649|FG001|Overall Study|Physician Decision|2|||
129141725|NCT03837509|464813671|FG001|Phase 1|Death|2|||
129141726|NCT03837509|464813672|FG002|Phase 1|Death|0|||
129141727|NCT03837509|464813673|FG003|Phase 1|Death|0|||
129141728|NCT03837509|464813674|FG004|Phase 1|Death|0|||
129141729|NCT03837509|464813670|FG000|Phase 2|Death|0|||
129141730|NCT03837509|464813671|FG001|Phase 2|Death|0|||
129141731|NCT03837509|464813672|FG002|Phase 2|Death|0|||
129141732|NCT03837509|464813673|FG003|Phase 2|Death|1|||
129141733|NCT03837509|464813674|FG004|Phase 2|Death|1|||
129141734|NCT00530257|464813686|FG000|Overall Study|Lost to Follow-up|1|||
129141735|NCT05520333|464813690|FG000|Overall Study|Lost to Follow-up|3|||
129141736|NCT05520333|464813691|FG001|Overall Study|Lost to Follow-up|6|||
129141737|NCT01897896|464813692|FG000|Overall Study|Death|1|||
129141738|NCT01897896|464813693|FG001|Overall Study|Death|0|||
129141739|NCT01897896|464813692|FG000|Overall Study|Adverse Event|11|||
129141740|NCT01897896|464813693|FG001|Overall Study|Adverse Event|1|||
129141741|NCT01897896|464813692|FG000|Overall Study|Lost to Follow-up|1|||
129141742|NCT01897896|464813693|FG001|Overall Study|Lost to Follow-up|0|||
129141743|NCT01897896|464813692|FG000|Overall Study|Non-compliance with study drug dosing|1|||
129141744|NCT01897896|464813693|FG001|Overall Study|Non-compliance with study drug dosing|1|||
129141745|NCT01897896|464813692|FG000|Overall Study|Withdrawal by Subject|7|||
129141746|NCT01897896|464813693|FG001|Overall Study|Withdrawal by Subject|1|||
129141747|NCT01897896|464813692|FG000|Overall Study|Require drug that interfere with study|1|||
129141748|NCT01897896|464813693|FG001|Overall Study|Require drug that interfere with study|4|||
129077628|NCT00708552|464573650|FG002|Overall Study|Physician Decision|0|||
129077629|NCT00708552|464573651|FG003|Overall Study|Physician Decision|0|||
129077630|NCT00708552|464573648|FG000|Overall Study|Withdrawal by Subject|12|||
129077631|NCT00708552|464573649|FG001|Overall Study|Withdrawal by Subject|7|||
129077632|NCT00708552|464573650|FG002|Overall Study|Withdrawal by Subject|8|||
129077633|NCT00708552|464573651|FG003|Overall Study|Withdrawal by Subject|10|||
129077634|NCT03270657|464573652|FG000|Overall Study|Withdrawal by Subject|1|||
129077635|NCT00162981|464573653|FG000|Overall Study|Adverse Event|2|||
129077636|NCT00162981|464573654|FG001|Overall Study|Adverse Event|5|||
129077637|NCT00162981|464573653|FG000|Overall Study|Withdrawal by Subject|1|||
129077638|NCT00162981|464573654|FG001|Overall Study|Withdrawal by Subject|1|||
129077639|NCT00162981|464573653|FG000|Overall Study|Physician Decision|1|||
129077640|NCT00162981|464573654|FG001|Overall Study|Physician Decision|0|||
129077641|NCT02588612|464573663|FG000|Overall Study|Physician Decision|1|||
129077642|NCT02588612|464573663|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
129077643|NCT02588612|464573663|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
129077644|NCT02588612|464573663|FG000|Overall Study|Death prior to T-cell infusion|1|||
129077645|NCT02042014|464573664|FG000|Overall Study|Adverse Event|1|||
129077646|NCT02042014|464573664|FG000|Overall Study|Physician Decision|7|||
129077647|NCT03309943|464573665|FG000|Overall Study|Withdrawal by Subject|0|||
129077648|NCT03309943|464573666|FG001|Overall Study|Withdrawal by Subject|1|||
129077649|NCT03309943|464573665|FG000|Overall Study|Inappropriate behavior towards staff|0|||
129077650|NCT03309943|464573666|FG001|Overall Study|Inappropriate behavior towards staff|1|||
129077651|NCT01372995|464573667|FG000|Overall Study|Spouse withdrew participant from study|0|||
129077652|NCT01372995|464573668|FG001|Overall Study|Spouse withdrew participant from study|1|||
129077653|NCT01372995|464573669|FG002|Overall Study|Spouse withdrew participant from study|0|||
129077654|NCT01372995|464573667|FG000|Overall Study|Physician Decision|0|||
129077655|NCT01372995|464573668|FG001|Overall Study|Physician Decision|0|||
129077656|NCT01372995|464573669|FG002|Overall Study|Physician Decision|1|||
129077657|NCT03123393|464573670|FG000|Overall Study|Study Terminated by Sponsor|6|||
129077658|NCT03123393|464573671|FG001|Overall Study|Study Terminated by Sponsor|9|||
129077659|NCT03123393|464573670|FG000|Overall Study|Withdrawal by Subject|2|||
129077660|NCT03123393|464573671|FG001|Overall Study|Withdrawal by Subject|1|||
129141749|NCT01897896|464813692|FG000|Overall Study|Protocol Violation|1|||
129141750|NCT01897896|464813693|FG001|Overall Study|Protocol Violation|1|||
129141751|NCT01897896|464813692|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
129141752|NCT01897896|464813693|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
129141753|NCT01897896|464813692|FG000|Overall Study|Caregiver can no longer participate|0|||
129141754|NCT01897896|464813693|FG001|Overall Study|Caregiver can no longer participate|2|||
129141755|NCT01897896|464813692|FG000|Overall Study|Other than specified|2|||
129141756|NCT01897896|464813693|FG001|Overall Study|Other than specified|1|||
129141757|NCT02003898|464813701|FG000|Overall Study|Death|3|||
129141758|NCT02003898|464813701|FG000|Overall Study|Lost to Follow-up|12|||
129141759|NCT02003898|464813701|FG000|Overall Study|Withdrawal by Subject|52|||
129141760|NCT03682367|464813704|FG000|Overall Study|Protocol Violation|2|||
129141761|NCT03682367|464813705|FG001|Overall Study|Protocol Violation|1|||
129077661|NCT03123393|464573670|FG000|Overall Study|Reason not Specified|13|||
129077662|NCT03123393|464573671|FG001|Overall Study|Reason not Specified|13|||
129077663|NCT00558701|464573675|FG000|Overall Study|Protocol Deviations|1|||
129077664|NCT00558701|464573676|FG001|Overall Study|Protocol Deviations|4|||
129077665|NCT00427648|464573677|FG000|Overall Study|Protocol Violation|1|||
129077666|NCT00427648|464573678|FG001|Overall Study|Protocol Violation|2|||
129141762|NCT03682367|464813704|FG000|Overall Study|Closed Study Early|0|||
129141763|NCT03682367|464813705|FG001|Overall Study|Closed Study Early|3|||
129141764|NCT00129974|464813706|FG000|Overall Study|Other|1|||
129141765|NCT00414609|464813707|FG000|Core Study|Adverse Event|9|||
129141766|NCT00414609|464813708|FG001|Core Study|Adverse Event|11|||
129141767|NCT00414609|464813709|FG002|Core Study|Adverse Event|0|||
129141768|NCT00414609|464813707|FG000|Core Study|Abnormal laboratory values|0|||
129141769|NCT00414609|464813708|FG001|Core Study|Abnormal laboratory values|1|||
129141770|NCT00414609|464813709|FG002|Core Study|Abnormal laboratory values|0|||
129141771|NCT00414609|464813707|FG000|Core Study|Abnormal test procedure results|1|||
129141772|NCT00414609|464813708|FG001|Core Study|Abnormal test procedure results|1|||
129141773|NCT00414609|464813709|FG002|Core Study|Abnormal test procedure results|0|||
129141774|NCT00414609|464813707|FG000|Core Study|Protocol deviation|0|||
129141775|NCT00414609|464813708|FG001|Core Study|Protocol deviation|1|||
129141776|NCT00414609|464813709|FG002|Core Study|Protocol deviation|0|||
129141777|NCT00414609|464813707|FG000|Core Study|Patient withdrew consent|10|||
129141778|NCT00414609|464813708|FG001|Core Study|Patient withdrew consent|11|||
129141779|NCT00414609|464813709|FG002|Core Study|Patient withdrew consent|0|||
129141780|NCT00414609|464813707|FG000|Core Study|Lost to Follow-up|7|||
129141781|NCT00414609|464813708|FG001|Core Study|Lost to Follow-up|4|||
129141782|NCT00414609|464813709|FG002|Core Study|Lost to Follow-up|0|||
129141783|NCT00414609|464813707|FG000|Core Study|Administrative problems|0|||
129141784|NCT00414609|464813708|FG001|Core Study|Administrative problems|2|||
129141785|NCT00414609|464813709|FG002|Core Study|Administrative problems|0|||
129141786|NCT00414609|464813707|FG000|Core Study|Death|7|||
129141787|NCT00414609|464813708|FG001|Core Study|Death|14|||
129141788|NCT00414609|464813709|FG002|Core Study|Death|0|||
129141789|NCT00414609|464813707|FG000|Extension Study|Adverse Event|0|||
129141790|NCT00414609|464813708|FG001|Extension Study|Adverse Event|0|||
129141791|NCT00414609|464813709|FG002|Extension Study|Adverse Event|14|||
129141792|NCT00414609|464813707|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
129141793|NCT00414609|464813708|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
129141794|NCT00414609|464813709|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
129141795|NCT00414609|464813707|FG000|Extension Study|Withdrawal by Subject|0|||
129141796|NCT00414609|464813708|FG001|Extension Study|Withdrawal by Subject|0|||
129141797|NCT00414609|464813709|FG002|Extension Study|Withdrawal by Subject|13|||
129141798|NCT00414609|464813707|FG000|Extension Study|Lost to Follow-up|0|||
129141799|NCT00414609|464813708|FG001|Extension Study|Lost to Follow-up|0|||
129141800|NCT00414609|464813709|FG002|Extension Study|Lost to Follow-up|10|||
129141801|NCT00414609|464813707|FG000|Extension Study|Administrative problems|0|||
129141802|NCT00414609|464813708|FG001|Extension Study|Administrative problems|0|||
129141803|NCT00414609|464813709|FG002|Extension Study|Administrative problems|1|||
129141804|NCT00414609|464813707|FG000|Extension Study|Death|0|||
129141805|NCT00414609|464813708|FG001|Extension Study|Death|0|||
129141806|NCT00414609|464813709|FG002|Extension Study|Death|17|||
129141807|NCT01853280|464813714|FG000|Overall Study|Lack of Efficacy|2|||
129141808|NCT01853280|464813715|FG001|Overall Study|Lack of Efficacy|2|||
129141809|NCT01853280|464813714|FG000|Overall Study|Lost to Follow-up|0|||
129141810|NCT01853280|464813715|FG001|Overall Study|Lost to Follow-up|1|||
129141811|NCT01853280|464813714|FG000|Overall Study|Physician Decision|0|||
129141812|NCT01853280|464813715|FG001|Overall Study|Physician Decision|1|||
129141813|NCT01853280|464813714|FG000|Overall Study|Withdrawal by Subject|0|||
129141814|NCT01853280|464813715|FG001|Overall Study|Withdrawal by Subject|1|||
129141815|NCT01853280|464813714|FG000|Overall Study|Ineligible|0|||
129141816|NCT01853280|464813715|FG001|Overall Study|Ineligible|1|||
129141817|NCT03032484|464813716|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
129141818|NCT03032484|464813717|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
129141819|NCT03032484|464813716|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
129141820|NCT03032484|464813717|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
129141821|NCT01229111|464813718|FG000|Overall Study|Death|1|||
129141822|NCT04893811|464813719|FG000|Vaccination Phase|Death|1|||
129141823|NCT04893811|464813720|FG001|Vaccination Phase|Death|0|||
129141824|NCT04893811|464813719|FG000|Vaccination Phase|Lost to Follow-up|1|||
129141825|NCT04893811|464813720|FG001|Vaccination Phase|Lost to Follow-up|1|||
129141826|NCT04893811|464813719|FG000|Vaccination Phase|Protocol Violation|2|||
129141827|NCT04893811|464813720|FG001|Vaccination Phase|Protocol Violation|0|||
129141828|NCT04893811|464813719|FG000|Vaccination Phase|Withdrawal by Subject|2|||
129141829|NCT04893811|464813720|FG001|Vaccination Phase|Withdrawal by Subject|1|||
129141830|NCT04893811|464813719|FG000|Vaccination Phase|Other|0|||
129141831|NCT04893811|464813720|FG001|Vaccination Phase|Other|1|||
129141832|NCT04893811|464813719|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
129141833|NCT04893811|464813720|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
129141834|NCT04893811|464813719|FG000|Follow-up Phase|Lost to Follow-up|0|||
129141835|NCT04893811|464813720|FG001|Follow-up Phase|Lost to Follow-up|1|||
129141836|NCT05463952|464813729|FG000|Treatment|Progressive disease|4|||
129141837|NCT05463952|464813729|FG000|Treatment|Ongoing|2|||
129141838|NCT01946880|464813730|FG000|Overall Study|Lost to Follow-up|1|||
129141839|NCT01946880|464813731|FG001|Overall Study|Lost to Follow-up|0|||
129141840|NCT01946880|464813730|FG000|Overall Study|Physician Decision|1|||
129141841|NCT01946880|464813731|FG001|Overall Study|Physician Decision|1|||
129077667|NCT00427648|464573677|FG000|Overall Study|Adverse Event|0|||
129077668|NCT00427648|464573678|FG001|Overall Study|Adverse Event|1|||
129077669|NCT00105079|464573679|FG000|Overall Study|Adverse Event|5|||
129077670|NCT00105079|464573680|FG001|Overall Study|Adverse Event|12|||
129077671|NCT00105079|464573679|FG000|Overall Study|Death|3|||
129077672|NCT00105079|464573680|FG001|Overall Study|Death|1|||
129077673|NCT00105079|464573679|FG000|Overall Study|Lost to Follow-up|12|||
129077674|NCT00105079|464573680|FG001|Overall Study|Lost to Follow-up|12|||
129077675|NCT00105079|464573679|FG000|Overall Study|Lack of Efficacy|9|||
129077676|NCT00105079|464573680|FG001|Overall Study|Lack of Efficacy|3|||
129077677|NCT00105079|464573679|FG000|Overall Study|Refused treatment|6|||
129077678|NCT00105079|464573680|FG001|Overall Study|Refused treatment|4|||
129077679|NCT00105079|464573679|FG000|Overall Study|Violation of selection criteria at entry|0|||
129077680|NCT00105079|464573680|FG001|Overall Study|Violation of selection criteria at entry|2|||
129077681|NCT00105079|464573679|FG000|Overall Study|Protocol Violation|1|||
129077682|NCT00105079|464573680|FG001|Overall Study|Protocol Violation|0|||
129077683|NCT00105079|464573679|FG000|Overall Study|Other|3|||
129077684|NCT00105079|464573680|FG001|Overall Study|Other|1|||
129077685|NCT00386360|464573683|FG000|Overall Study|Adverse Event|4|||
129077686|NCT00386360|464573684|FG001|Overall Study|Adverse Event|2|||
129077687|NCT00386360|464573683|FG000|Overall Study|Physician Decision|2|||
129077688|NCT00386360|464573684|FG001|Overall Study|Physician Decision|2|||
129077689|NCT00386360|464573683|FG000|Overall Study|Lost to Follow-up|0|||
129077690|NCT00386360|464573684|FG001|Overall Study|Lost to Follow-up|2|||
129077691|NCT00386360|464573683|FG000|Overall Study|Protocol Violation|0|||
129077692|NCT00386360|464573684|FG001|Overall Study|Protocol Violation|3|||
129077693|NCT00386360|464573683|FG000|Overall Study|Withdrawal by Subject|3|||
129077694|NCT00386360|464573684|FG001|Overall Study|Withdrawal by Subject|6|||
129077695|NCT00386360|464573683|FG000|Overall Study|Did not take any study medication|0|||
129077696|NCT00386360|464573684|FG001|Overall Study|Did not take any study medication|2|||
129077697|NCT01464424|464573685|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
129077698|NCT01464424|464573686|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
129077699|NCT01464333|464573688|FG000|Overall Study|Adverse Event|34|||
129077700|NCT01464333|464573688|FG000|Overall Study|Lack of Efficacy|72|||
129077701|NCT01464333|464573688|FG000|Overall Study|Withdrawal by Subject|11|||
129077702|NCT01464333|464573688|FG000|Overall Study|Other|4|||
129077703|NCT01464333|464573688|FG000|Overall Study|No Hospital Visit|42|||
129077704|NCT01532518|464573689|FG000|Overall Study|Withdrawal by Subject|0|||
129077705|NCT01532518|464573690|FG001|Overall Study|Withdrawal by Subject|0|||
129077706|NCT01532518|464573691|FG002|Overall Study|Withdrawal by Subject|1|||
129077707|NCT01575834|464573692|FG000|Overall Study|Withdrawal by Subject|352|||
129077708|NCT01575834|464573693|FG001|Overall Study|Withdrawal by Subject|390|||
129077709|NCT01575834|464573692|FG000|Overall Study|Death|81|||
129077710|NCT01575834|464573693|FG001|Overall Study|Death|74|||
129077711|NCT01575834|464573692|FG000|Overall Study|Other|70|||
129077712|NCT01575834|464573693|FG001|Overall Study|Other|70|||
129077713|NCT01575834|464573692|FG000|Overall Study|Adverse Event|63|||
129077714|NCT01575834|464573693|FG001|Overall Study|Adverse Event|61|||
129077715|NCT01575834|464573692|FG000|Overall Study|Lost to Follow-up|55|||
129077716|NCT01575834|464573693|FG001|Overall Study|Lost to Follow-up|68|||
129077717|NCT01575834|464573692|FG000|Overall Study|Noncompliance|52|||
129141842|NCT01946880|464813730|FG000|Overall Study|Withdrawal by Subject|3|||
129141843|NCT01946880|464813731|FG001|Overall Study|Withdrawal by Subject|2|||
129141844|NCT01946880|464813730|FG000|Overall Study|Met Primary Endpoint|1|||
129141845|NCT01946880|464813731|FG001|Overall Study|Met Primary Endpoint|0|||
129141846|NCT01946880|464813730|FG000|Overall Study|Personal and Family Issues|1|||
129141847|NCT01946880|464813731|FG001|Overall Study|Personal and Family Issues|0|||
129141848|NCT02758626|464813733|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
129141849|NCT02758626|464813734|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
129141850|NCT02758626|464813733|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
129141851|NCT02758626|464813734|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
129077718|NCT01575834|464573693|FG001|Overall Study|Noncompliance|27|||
129077719|NCT01575834|464573692|FG000|Overall Study|Administrative decision|15|||
129204717|NCT02079740|465046929|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
129077720|NCT01575834|464573693|FG001|Overall Study|Administrative decision|33|||
129077721|NCT01575834|464573692|FG000|Overall Study|Ineligibility Determined|5|||
129077722|NCT01575834|464573693|FG001|Overall Study|Ineligibility Determined|8|||
129204718|NCT02079740|465046930|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
129077723|NCT01575834|464573692|FG000|Overall Study|Protocol Deviation|4|||
129077724|NCT01575834|464573693|FG001|Overall Study|Protocol Deviation|3|||
129077725|NCT01575834|464573692|FG000|Overall Study|Requirement for Alternative Therapy|2|||
129204719|NCT02079740|465046931|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
129204720|NCT02079740|465046932|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
129204721|NCT02079740|465046933|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
129204722|NCT02079740|465046934|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
129204723|NCT02079740|465046922|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
129204724|NCT02079740|465046923|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
129077726|NCT01575834|464573693|FG001|Overall Study|Requirement for Alternative Therapy|4|||
129077727|NCT02155283|464573695|FG000|Overall Study|Lost to Follow-up|3|||
129077728|NCT02155283|464573695|FG000|Overall Study|Withdrawal by Subject|1|||
129077729|NCT02155283|464573695|FG000|Overall Study|Protocol Violation|3|||
129077730|NCT05000164|464573701|FG000|Overall Study|Adverse Event|1|||
129077731|NCT05000164|464573701|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129077732|NCT05000164|464573701|FG000|Overall Study|Lens Discomfort|3|||
129077733|NCT05000164|464573701|FG000|Overall Study|Withdrew Consent during Study|2|||
129077734|NCT05000164|464573701|FG000|Overall Study|Subject Withdrawn by PI|2|||
129077735|NCT05000164|464573701|FG000|Overall Study|Other Fractured Test Article|1|||
129077736|NCT06509438|464573707|FG000|Overall Study|Adverse Event|1|||
129077737|NCT06509438|464573707|FG000|Overall Study|Lost to Follow-up|3|||
129077738|NCT03331796|464573708|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
129077739|NCT03331796|464573709|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
129077740|NCT03331796|464573710|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
129077741|NCT03331796|464573708|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
129077742|NCT03331796|464573709|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
129077743|NCT03331796|464573710|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
129077744|NCT03331796|464573708|FG000|Extended Follow-up|Adverse Event|1|||
129077745|NCT03331796|464573709|FG001|Extended Follow-up|Adverse Event|0|||
129077746|NCT03331796|464573710|FG002|Extended Follow-up|Adverse Event|1|||
129077747|NCT03331796|464573708|FG000|Extended Follow-up|Lost to Follow-up|0|||
129077748|NCT03331796|464573709|FG001|Extended Follow-up|Lost to Follow-up|0|||
129077749|NCT03331796|464573710|FG002|Extended Follow-up|Lost to Follow-up|1|||
129077750|NCT03331796|464573708|FG000|Extended Follow-up|Withdrawal by Subject|1|||
129077751|NCT03331796|464573709|FG001|Extended Follow-up|Withdrawal by Subject|0|||
129077752|NCT03331796|464573710|FG002|Extended Follow-up|Withdrawal by Subject|0|||
129077753|NCT03331796|464573708|FG000|Extended Follow-up|Termination of Funding|0|||
129077754|NCT03331796|464573709|FG001|Extended Follow-up|Termination of Funding|1|||
129077755|NCT03331796|464573710|FG002|Extended Follow-up|Termination of Funding|0|||
129077756|NCT01753570|464573711|FG000|Overall Study|Adverse Event|1|||
129077757|NCT01753570|464573712|FG001|Overall Study|Adverse Event|0|||
129077758|NCT01753570|464573713|FG002|Overall Study|Adverse Event|1|||
129077759|NCT01753570|464573711|FG000|Overall Study|Physician Decision|0|||
129077760|NCT01753570|464573712|FG001|Overall Study|Physician Decision|1|||
129077761|NCT01753570|464573713|FG002|Overall Study|Physician Decision|0|||
129077762|NCT01753570|464573711|FG000|Overall Study|Withdrawal by Subject|1|||
129077763|NCT01753570|464573712|FG001|Overall Study|Withdrawal by Subject|4|||
129077764|NCT01753570|464573713|FG002|Overall Study|Withdrawal by Subject|0|||
129077765|NCT01000155|464573714|FG000|Overall Study|Withdrawal by Subject|1|||
129077766|NCT01000155|464573714|FG000|Overall Study|Adverse Event|1|||
129077767|NCT00720213|464573717|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
129077768|NCT00720213|464573718|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
129077769|NCT00720213|464573719|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
129077770|NCT01808066|464573722|FG000|Overall Study|Withdrawal by Subject|15|||
129077771|NCT01420068|464573723|FG000|Overall Study|Administrative problems|1|||
129077772|NCT01420068|464573724|FG001|Overall Study|Administrative problems|3|||
129077773|NCT01420068|464573723|FG000|Overall Study|Withdrawal by Subject|1|||
129077774|NCT01420068|464573724|FG001|Overall Study|Withdrawal by Subject|2|||
129077775|NCT00884117|464573727|FG000|Overall Study|Adverse Event|2|||
129077776|NCT00884117|464573727|FG000|Overall Study|Withdrawal by Subject|89|||
129077777|NCT00884117|464573727|FG000|Overall Study|Death|3|||
129077778|NCT00884117|464573727|FG000|Overall Study|Lost to Follow-up|143|||
129077779|NCT00884117|464573727|FG000|Overall Study|Other|12|||
129077780|NCT04830969|464573730|FG000|Overall Study|Withdrawal by Subject|6|||
129077781|NCT04830969|464573731|FG001|Overall Study|Withdrawal by Subject|2|||
129077782|NCT04830969|464573730|FG000|Overall Study|Protocol Violation|3|||
129077783|NCT04830969|464573731|FG001|Overall Study|Protocol Violation|9|||
129077784|NCT04830969|464573730|FG000|Overall Study|Lost to Follow-up|4|||
129077785|NCT04830969|464573731|FG001|Overall Study|Lost to Follow-up|4|||
129077786|NCT01153815|464573734|FG000|Overall Study|Adverse Event|3|||
129077787|NCT01153815|464573735|FG001|Overall Study|Adverse Event|1|||
129077788|NCT01153815|464573734|FG000|Overall Study|Withdrawal by Subject|6|||
129077789|NCT01153815|464573735|FG001|Overall Study|Withdrawal by Subject|4|||
129077790|NCT01786993|464573736|FG000|Overall Study|Death|6|||
129077791|NCT01786993|464573737|FG001|Overall Study|Death|7|||
129077792|NCT01786993|464573736|FG000|Overall Study|Withdrawal by Subject|3|||
129077793|NCT01786993|464573737|FG001|Overall Study|Withdrawal by Subject|2|||
129077794|NCT01786993|464573736|FG000|Overall Study|Lost to Follow-up|0|||
129077795|NCT01786993|464573737|FG001|Overall Study|Lost to Follow-up|1|||
129077796|NCT01786993|464573736|FG000|Overall Study|Subject Non-Compliance|1|||
129077797|NCT01786993|464573737|FG001|Overall Study|Subject Non-Compliance|0|||
129077798|NCT01786993|464573736|FG000|Overall Study|System Explant|1|||
129077799|NCT01786993|464573737|FG001|Overall Study|System Explant|0|||
129077800|NCT01786993|464573736|FG000|Overall Study|Hospice Admission|1|||
129077801|NCT01786993|464573737|FG001|Overall Study|Hospice Admission|0|||
129077802|NCT01890122|464573738|FG000|Overall Study|Adverse Event|1|||
129077803|NCT01890122|464573739|FG001|Overall Study|Adverse Event|1|||
129077804|NCT01890122|464573740|FG002|Overall Study|Adverse Event|1|||
129077805|NCT01890122|464573741|FG003|Overall Study|Adverse Event|2|||
129077806|NCT01890122|464573738|FG000|Overall Study|Major Protocol Deviation|3|||
129077807|NCT01890122|464573739|FG001|Overall Study|Major Protocol Deviation|1|||
129077808|NCT01890122|464573740|FG002|Overall Study|Major Protocol Deviation|0|||
129077809|NCT01890122|464573741|FG003|Overall Study|Major Protocol Deviation|1|||
129077810|NCT01890122|464573738|FG000|Overall Study|Lost to Follow-up|0|||
129077811|NCT01890122|464573739|FG001|Overall Study|Lost to Follow-up|1|||
129077812|NCT01890122|464573740|FG002|Overall Study|Lost to Follow-up|2|||
129077813|NCT01890122|464573741|FG003|Overall Study|Lost to Follow-up|2|||
129077814|NCT01890122|464573738|FG000|Overall Study|Voluntary Withdrawal|8|||
129077815|NCT01890122|464573739|FG001|Overall Study|Voluntary Withdrawal|8|||
129077816|NCT01890122|464573740|FG002|Overall Study|Voluntary Withdrawal|2|||
129077817|NCT01890122|464573741|FG003|Overall Study|Voluntary Withdrawal|11|||
129077818|NCT01890122|464573738|FG000|Overall Study|Lack of Efficacy|14|||
129077819|NCT01890122|464573739|FG001|Overall Study|Lack of Efficacy|24|||
129077820|NCT01890122|464573740|FG002|Overall Study|Lack of Efficacy|7|||
129077821|NCT01890122|464573741|FG003|Overall Study|Lack of Efficacy|41|||
129077822|NCT01890122|464573738|FG000|Overall Study|Reason not Specified|0|||
129077823|NCT01890122|464573739|FG001|Overall Study|Reason not Specified|1|||
129077824|NCT01890122|464573740|FG002|Overall Study|Reason not Specified|1|||
129077825|NCT01890122|464573741|FG003|Overall Study|Reason not Specified|2|||
129077826|NCT01890122|464573738|FG000|Overall Study|Randomized but not Treated|1|||
129077827|NCT01890122|464573739|FG001|Overall Study|Randomized but not Treated|1|||
129077828|NCT01890122|464573740|FG002|Overall Study|Randomized but not Treated|0|||
129077829|NCT01890122|464573741|FG003|Overall Study|Randomized but not Treated|0|||
129077830|NCT02505217|464573745|FG000|Overall Study|Withdrawal by Subject|1|||
129077831|NCT02505217|464573746|FG001|Overall Study|Withdrawal by Subject|2|||
129077832|NCT00153179|464573756|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
129077833|NCT00153179|464573757|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
129077834|NCT00153179|464573758|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
129077835|NCT00153179|464573759|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
129077836|NCT04495829|464573760|FG000|Overall Study|Lost to Follow-up|2|||
129077837|NCT04495829|464573760|FG000|Overall Study|Inclusion criterion not met|3|||
129077838|NCT02712554|464573763|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
129077839|NCT02712554|464573764|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
129077840|NCT02712554|464573763|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
129077841|NCT02712554|464573764|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
129077842|NCT02712554|464573763|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
129077843|NCT02712554|464573764|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
129077844|NCT02712554|464573763|FG000|Part B: Qualification Phase|Adverse Event|0|||
129077845|NCT02712554|464573764|FG001|Part B: Qualification Phase|Adverse Event|1|||
129077846|NCT02712554|464573763|FG000|Part B: Treatment Phase|Adverse Event|0|||
129077847|NCT02712554|464573764|FG001|Part B: Treatment Phase|Adverse Event|1|||
129077848|NCT02712554|464573763|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
129077849|NCT02712554|464573764|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
129077850|NCT02712554|464573763|FG000|Part B: Treatment Phase|Other|0|||
129077851|NCT02712554|464573764|FG001|Part B: Treatment Phase|Other|1|||
129077852|NCT00979654|464573765|FG000|Overall Study|Lost to Follow-up|1|||
129077853|NCT00979654|464573765|FG000|Overall Study|Withdrawal by Subject|22|||
129077854|NCT00979654|464573765|FG000|Overall Study|Death|1|||
129077855|NCT00979654|464573765|FG000|Overall Study|Lack of Efficacy|6|||
129077856|NCT00979654|464573765|FG000|Overall Study|Adverse Event|1|||
129077857|NCT00979654|464573765|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
129077858|NCT00979654|464573765|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
129077859|NCT00979654|464573765|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
129077860|NCT00979654|464573765|FG000|Overall Study|Serious Adverse Event|1|||
129077861|NCT00979654|464573765|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
129077862|NCT01129557|464573766|FG000|Overall Study|Adverse Event|1|||
129077863|NCT01129557|464573767|FG001|Overall Study|Adverse Event|2|||
129077864|NCT01129557|464573768|FG002|Overall Study|Adverse Event|2|||
129077865|NCT01129557|464573766|FG000|Overall Study|Novartis terminated study early|3|||
129077866|NCT01129557|464573767|FG001|Overall Study|Novartis terminated study early|3|||
129077867|NCT01129557|464573768|FG002|Overall Study|Novartis terminated study early|2|||
129077868|NCT00669669|464573769|FG000|Overall Study|To late to start treatment|1|||
129077869|NCT01068678|464575325|FG000|Overall Study|Lack of Efficacy|3|||
129077870|NCT01068678|464575326|FG001|Overall Study|Lack of Efficacy|2|||
129077871|NCT01068678|464575325|FG000|Overall Study|Protocol Violation|5|||
129077872|NCT01068678|464575326|FG001|Overall Study|Protocol Violation|1|||
129077873|NCT01068678|464575325|FG000|Overall Study|Withdrawal criteria|12|||
129077874|NCT01068678|464575326|FG001|Overall Study|Withdrawal criteria|6|||
129077875|NCT01068678|464575325|FG000|Overall Study|Unclassified|18|||
129077876|NCT01068678|464575326|FG001|Overall Study|Unclassified|15|||
129077877|NCT03055338|464575329|FG000|Overall Study|Lost to Follow-up|9|||
129077878|NCT03055338|464575330|FG001|Overall Study|Lost to Follow-up|2|||
129077879|NCT03055338|464575331|FG002|Overall Study|Lost to Follow-up|3|||
129077880|NCT03055338|464575329|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
129077881|NCT03055338|464575330|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
129077882|NCT03055338|464575331|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
129077883|NCT03055338|464575329|FG000|Overall Study|Physician Decision|0|||
129077884|NCT03055338|464575330|FG001|Overall Study|Physician Decision|0|||
129077885|NCT03055338|464575331|FG002|Overall Study|Physician Decision|2|||
129077886|NCT03055338|464575329|FG000|Overall Study|Withdrawal by Subject|9|||
129077887|NCT03055338|464575330|FG001|Overall Study|Withdrawal by Subject|8|||
129077888|NCT03055338|464575331|FG002|Overall Study|Withdrawal by Subject|7|||
129077889|NCT03058705|464575332|FG000|Overall Study|Withdrawal by Subject|2|||
129077890|NCT03058705|464575332|FG000|Overall Study|Physician Decision|2|||
129077891|NCT01682226|464575333|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
129077892|NCT01682226|464575333|FG000|Overall Study|Participants did not receive treatment|2|||
129077893|NCT01682226|464575333|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
129077894|NCT02159053|464575334|FG000|Overall Study|Death|2|||
129077895|NCT02159053|464575335|FG001|Overall Study|Death|0|||
129077896|NCT02159053|464575336|FG002|Overall Study|Death|1|||
129077897|NCT02159053|464575334|FG000|Overall Study|Physician Decision|0|||
129077898|NCT02159053|464575335|FG001|Overall Study|Physician Decision|1|||
129077899|NCT02159053|464575336|FG002|Overall Study|Physician Decision|1|||
129077900|NCT02159053|464575334|FG000|Overall Study|Lack of Efficacy|3|||
129077901|NCT02159053|464575335|FG001|Overall Study|Lack of Efficacy|4|||
129077902|NCT02159053|464575336|FG002|Overall Study|Lack of Efficacy|7|||
129077903|NCT02159053|464575334|FG000|Overall Study|Adverse Event|7|||
129077904|NCT02159053|464575335|FG001|Overall Study|Adverse Event|6|||
129077905|NCT02159053|464575336|FG002|Overall Study|Adverse Event|5|||
129077906|NCT02159053|464575334|FG000|Overall Study|Participants/guardian decision|8|||
129077907|NCT02159053|464575335|FG001|Overall Study|Participants/guardian decision|10|||
129077908|NCT02159053|464575336|FG002|Overall Study|Participants/guardian decision|6|||
129077909|NCT00457002|464575341|FG000|Overall Study|Death|40|||
129077910|NCT00457002|464575342|FG001|Overall Study|Death|47|||
129077911|NCT00457002|464575341|FG000|Overall Study|Adverse Event|284|||
129077912|NCT00457002|464575342|FG001|Overall Study|Adverse Event|260|||
129077913|NCT00457002|464575341|FG000|Overall Study|Withdrawal by Subject|299|||
129077914|NCT00457002|464575342|FG001|Overall Study|Withdrawal by Subject|271|||
129077915|NCT00457002|464575341|FG000|Overall Study|Lost to Follow-up|72|||
129077916|NCT00457002|464575342|FG001|Overall Study|Lost to Follow-up|71|||
129077917|NCT00457002|464575341|FG000|Overall Study|Poor/Non-compliance|46|||
129077918|NCT00457002|464575342|FG001|Overall Study|Poor/Non-compliance|33|||
129077919|NCT00457002|464575341|FG000|Overall Study|No longer met criteria|41|||
129077920|NCT00457002|464575342|FG001|Overall Study|No longer met criteria|37|||
129077921|NCT00457002|464575341|FG000|Overall Study|Administrative reason by Sponsor|1|||
129077922|NCT00457002|464575342|FG001|Overall Study|Administrative reason by Sponsor|0|||
129077923|NCT00457002|464575341|FG000|Overall Study|non-specified|29|||
129077924|NCT00457002|464575342|FG001|Overall Study|non-specified|38|||
129077925|NCT00457002|464575341|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
129077926|NCT00457002|464575342|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
129077927|NCT00454246|464575343|FG000|Overall Study|Adverse Event|2|||
129077928|NCT00454246|464575344|FG001|Overall Study|Adverse Event|2|||
129077929|NCT00454246|464575345|FG002|Overall Study|Adverse Event|0|||
129077930|NCT00454246|464575343|FG000|Overall Study|Violation of selection criteria at entry|6|||
129077931|NCT00454246|464575344|FG001|Overall Study|Violation of selection criteria at entry|0|||
129077932|NCT00454246|464575345|FG002|Overall Study|Violation of selection criteria at entry|0|||
129077933|NCT00454246|464575343|FG000|Overall Study|Protocol Violation|1|||
129077934|NCT00454246|464575344|FG001|Overall Study|Protocol Violation|0|||
129077935|NCT00454246|464575345|FG002|Overall Study|Protocol Violation|0|||
129141852|NCT02758626|464813733|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
129141853|NCT02758626|464813734|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
129141854|NCT02758626|464813733|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
129141855|NCT02758626|464813734|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
129141856|NCT04204902|464813737|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
129077936|NCT00454246|464575343|FG000|Overall Study|Refused Treatment|1|||
129077937|NCT00454246|464575344|FG001|Overall Study|Refused Treatment|1|||
129077938|NCT00454246|464575345|FG002|Overall Study|Refused Treatment|0|||
129077939|NCT00454246|464575343|FG000|Overall Study|Failure to return|1|||
129077940|NCT00454246|464575344|FG001|Overall Study|Failure to return|0|||
129077941|NCT00454246|464575345|FG002|Overall Study|Failure to return|0|||
129077942|NCT00454246|464575343|FG000|Overall Study|Early termination of study|62|||
129077943|NCT00454246|464575344|FG001|Overall Study|Early termination of study|26|||
129077944|NCT00454246|464575345|FG002|Overall Study|Early termination of study|9|||
129077945|NCT02283268|464575346|FG000|Overall Study|Withdrawal by Subject|1|||
129077946|NCT01085630|464575358|FG000|Overall Study|Insufficient data|1|||
129077947|NCT01085630|464575359|FG001|Overall Study|Insufficient data|0|||
129077948|NCT01085630|464575358|FG000|Overall Study|Ineligible|3|||
129077949|NCT01085630|464575359|FG001|Overall Study|Ineligible|0|||
129077950|NCT01017874|464575360|FG000|Overall Study|Withdrawal by Subject|23|||
129077951|NCT01017874|464575361|FG001|Overall Study|Withdrawal by Subject|20|||
129077952|NCT01017874|464575360|FG000|Overall Study|Sponsor decision|3|||
129077953|NCT01017874|464575361|FG001|Overall Study|Sponsor decision|1|||
129077954|NCT01017874|464575360|FG000|Overall Study|Lost to Follow-up|3|||
129077955|NCT01017874|464575361|FG001|Overall Study|Lost to Follow-up|2|||
129141857|NCT04204902|464813738|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
129141858|NCT00456365|464813741|FG000|Overall Study|Lost to Follow-up|1|||
129141859|NCT00456365|464813742|FG001|Overall Study|Lost to Follow-up|3|||
129141860|NCT00456365|464813741|FG000|Overall Study|Withdrawal by Subject|4|||
129141861|NCT00456365|464813742|FG001|Overall Study|Withdrawal by Subject|7|||
129141862|NCT00456365|464813741|FG000|Overall Study|Pregnancy|1|||
129141863|NCT00456365|464813742|FG001|Overall Study|Pregnancy|1|||
129141864|NCT00456365|464813741|FG000|Overall Study|oncologic diagnosis|1|||
129141865|NCT00456365|464813742|FG001|Overall Study|oncologic diagnosis|1|||
129141866|NCT05451329|464813743|FG000|Overall Study|Adverse Event|1|||
129141867|NCT05451329|464813744|FG001|Overall Study|Adverse Event|1|||
129141868|NCT05451329|464813745|FG002|Overall Study|Adverse Event|0|||
129141869|NCT05451329|464813743|FG000|Overall Study|Withdrawal by Subject|1|||
129141870|NCT05451329|464813744|FG001|Overall Study|Withdrawal by Subject|0|||
129077956|NCT01017874|464575360|FG000|Overall Study|Physician Decision|1|||
129141871|NCT05451329|464813745|FG002|Overall Study|Withdrawal by Subject|0|||
129141872|NCT05451329|464813743|FG000|Overall Study|Investigational Product Lot exchange|1|||
129141873|NCT05451329|464813744|FG001|Overall Study|Investigational Product Lot exchange|1|||
129141874|NCT05451329|464813745|FG002|Overall Study|Investigational Product Lot exchange|0|||
129141875|NCT02202577|464813746|FG000|Overall Study|Lost to Follow-up|6|||
129141876|NCT02202577|464813747|FG001|Overall Study|Lost to Follow-up|16|||
129141877|NCT02202577|464813746|FG000|Overall Study|Protocol Violation|7|||
129141878|NCT02202577|464813747|FG001|Overall Study|Protocol Violation|3|||
129141879|NCT00829868|464813748|FG000|Washout|Physician Decision|1|||
129141880|NCT00829868|464813749|FG001|Washout|Physician Decision|0|||
129141881|NCT02799043|464813750|FG000|Overall Study|Adverse Event|0|||
129141882|NCT02799043|464813751|FG001|Overall Study|Adverse Event|1|||
129141883|NCT02799043|464813750|FG000|Overall Study|Death|1|||
129141884|NCT02799043|464813751|FG001|Overall Study|Death|1|||
129141885|NCT02799043|464813750|FG000|Overall Study|Lost to Follow-up|3|||
129141886|NCT02799043|464813751|FG001|Overall Study|Lost to Follow-up|6|||
129141887|NCT02799043|464813750|FG000|Overall Study|Withdrawal by Subject|4|||
129141888|NCT02799043|464813751|FG001|Overall Study|Withdrawal by Subject|4|||
129141889|NCT02799043|464813750|FG000|Overall Study|Moved to different country|0|||
129141890|NCT02799043|464813751|FG001|Overall Study|Moved to different country|1|||
129141891|NCT02799043|464813750|FG000|Overall Study|Trial Screen Failure|1|||
129141892|NCT02799043|464813751|FG001|Overall Study|Trial Screen Failure|0|||
129141893|NCT02799043|464813750|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
129141894|NCT02799043|464813751|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
129141895|NCT06091956|464813752|FG000|Overall Study|Withdrawal by Subject|1|||
129141896|NCT06091956|464813752|FG000|Overall Study|Complicating Disease|1|||
129141897|NCT01421459|464813761|FG000|Overall Study|Adverse Event|6|||
129141898|NCT01421459|464813762|FG001|Overall Study|Adverse Event|10|||
129077957|NCT01017874|464575361|FG001|Overall Study|Physician Decision|3|||
129077958|NCT01346696|464575362|FG000|Overall Study|Death|1|||
129077959|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
129077960|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129077961|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129077962|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129077963|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
129077964|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
129077965|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
129077966|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
129077967|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
129077968|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
129077969|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
129077970|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
129077971|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
129077972|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129077973|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129077974|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129141899|NCT01421459|464813761|FG000|Overall Study|Death|1|||
129141900|NCT01421459|464813762|FG001|Overall Study|Death|1|||
129141901|NCT01421459|464813761|FG000|Overall Study|Lack of Efficacy|1|||
129141902|NCT01421459|464813762|FG001|Overall Study|Lack of Efficacy|2|||
129141903|NCT01421459|464813761|FG000|Overall Study|Lost to Follow-up|8|||
129077975|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
129141904|NCT01421459|464813762|FG001|Overall Study|Lost to Follow-up|9|||
129141905|NCT01421459|464813761|FG000|Overall Study|Physician Decision|9|||
129141906|NCT01421459|464813762|FG001|Overall Study|Physician Decision|9|||
129141907|NCT01421459|464813761|FG000|Overall Study|Protocol Violation|8|||
129141908|NCT01421459|464813762|FG001|Overall Study|Protocol Violation|5|||
129141909|NCT01421459|464813761|FG000|Overall Study|Withdrawal by Subject|12|||
129077976|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129077977|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129077978|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129077979|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
129077980|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129077981|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129077982|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129077983|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
129077984|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
129077985|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
129077986|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
129077987|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
129077988|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
129077989|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
129077990|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
129077991|NCT00506415|464575373|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
129077992|NCT00506415|464575374|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129077993|NCT00506415|464575375|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129077994|NCT00506415|464575376|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129077995|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
129077996|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
129077997|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
129077998|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
129077999|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
129078000|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
129078001|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
129078002|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
129078003|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
129078004|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
129078005|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
129078006|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
129078007|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
129078008|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
129078009|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
129078010|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
129078011|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
129078012|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
129078013|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
129078014|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
129078015|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
129078016|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
129078017|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
129078018|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
129078019|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
129078020|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
129078021|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
129078022|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
129078023|NCT00506415|464575373|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
129078024|NCT00506415|464575374|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
129078025|NCT00506415|464575375|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
129078026|NCT00506415|464575376|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
129078027|NCT00506415|464575373|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
129078028|NCT00506415|464575374|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
129078029|NCT00506415|464575375|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
129078030|NCT00506415|464575376|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
129078031|NCT00506415|464575373|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129078032|NCT00506415|464575374|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129078033|NCT00506415|464575375|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129078034|NCT00506415|464575376|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
129078035|NCT00506415|464575373|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129078036|NCT00506415|464575374|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129078037|NCT00506415|464575375|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129078038|NCT00506415|464575376|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
129078039|NCT00506415|464575373|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129078040|NCT00506415|464575374|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129078041|NCT00506415|464575375|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129078042|NCT00506415|464575376|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
129078043|NCT00506415|464575373|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129078044|NCT00506415|464575374|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129078045|NCT00506415|464575375|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129078046|NCT00506415|464575376|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
129078047|NCT00506415|464575373|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129078048|NCT00506415|464575374|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129078049|NCT00506415|464575375|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129078050|NCT00506415|464575376|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
129078051|NCT00506415|464575373|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
129078052|NCT00506415|464575374|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
129078053|NCT00506415|464575375|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
129078054|NCT00506415|464575376|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
129078055|NCT04578457|464575377|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
129078056|NCT04578457|464575377|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
129078057|NCT04578457|464575377|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
129078058|NCT04578457|464575377|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
129078059|NCT03809663|464575384|FG000|Overall Study|Decision by sponsor|24|||
129078060|NCT03809663|464575385|FG001|Overall Study|Decision by sponsor|18|||
129078061|NCT03809663|464575386|FG002|Overall Study|Decision by sponsor|20|||
129078062|NCT03809663|464575387|FG003|Overall Study|Decision by sponsor|20|||
129078063|NCT03809663|464575388|FG004|Overall Study|Decision by sponsor|0|||
129078064|NCT03809663|464575389|FG005|Overall Study|Decision by sponsor|0|||
129078065|NCT03809663|464575384|FG000|Overall Study|Withdrawal by Subject|26|||
129078066|NCT03809663|464575385|FG001|Overall Study|Withdrawal by Subject|22|||
129078067|NCT03809663|464575386|FG002|Overall Study|Withdrawal by Subject|27|||
129078068|NCT03809663|464575387|FG003|Overall Study|Withdrawal by Subject|26|||
129078069|NCT03809663|464575388|FG004|Overall Study|Withdrawal by Subject|0|||
129078070|NCT03809663|464575389|FG005|Overall Study|Withdrawal by Subject|0|||
129078071|NCT03809663|464575384|FG000|Overall Study|Lost to Follow-up|1|||
129078072|NCT03809663|464575385|FG001|Overall Study|Lost to Follow-up|4|||
129078073|NCT03809663|464575386|FG002|Overall Study|Lost to Follow-up|1|||
129078074|NCT03809663|464575387|FG003|Overall Study|Lost to Follow-up|1|||
129078075|NCT03809663|464575388|FG004|Overall Study|Lost to Follow-up|0|||
129078076|NCT03809663|464575389|FG005|Overall Study|Lost to Follow-up|0|||
129078077|NCT01297517|464575399|FG000|Overall Study|Adverse Event|21|||
129078078|NCT01297517|464575400|FG001|Overall Study|Adverse Event|7|||
129078079|NCT01297517|464575401|FG002|Overall Study|Adverse Event|16|||
129078080|NCT01297517|464575399|FG000|Overall Study|Lost to Follow-up|1|||
129078081|NCT01297517|464575400|FG001|Overall Study|Lost to Follow-up|0|||
129078082|NCT01297517|464575401|FG002|Overall Study|Lost to Follow-up|1|||
129078083|NCT01297517|464575399|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
129078084|NCT01297517|464575400|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
129078085|NCT01297517|464575401|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
129078086|NCT01297517|464575399|FG000|Overall Study|Noncompliance|1|||
129078087|NCT01297517|464575400|FG001|Overall Study|Noncompliance|0|||
129078088|NCT01297517|464575401|FG002|Overall Study|Noncompliance|0|||
129078089|NCT01297517|464575399|FG000|Overall Study|Protocol Violation|1|||
129078090|NCT01297517|464575400|FG001|Overall Study|Protocol Violation|1|||
129078091|NCT01297517|464575401|FG002|Overall Study|Protocol Violation|1|||
129078092|NCT01297517|464575399|FG000|Overall Study|Inadequate Control of IOP|1|||
129078093|NCT01297517|464575400|FG001|Overall Study|Inadequate Control of IOP|1|||
129078094|NCT01297517|464575401|FG002|Overall Study|Inadequate Control of IOP|2|||
129078095|NCT01609296|464575402|FG000|Overall Study|Death|253|||
129078096|NCT01609296|464575402|FG000|Overall Study|Withdrawal by Subject|151|||
129078097|NCT01609296|464575402|FG000|Overall Study|Lost to Follow-up|21|||
129078098|NCT01609296|464575402|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
129078099|NCT01609296|464575402|FG000|Overall Study|missed visit but known to be alive|28|||
129078100|NCT02230904|464575405|FG000|Overall Study|Safety follow up could not take place|0|||
129078101|NCT02230904|464575406|FG001|Overall Study|Safety follow up could not take place|1|||
129078102|NCT00628212|464575407|FG000|Overall Study|Adverse Event|2|||
129078103|NCT00628212|464575408|FG001|Overall Study|Adverse Event|0|||
129078104|NCT00628212|464575409|FG002|Overall Study|Adverse Event|1|||
129078105|NCT00628212|464575410|FG003|Overall Study|Adverse Event|2|||
129078106|NCT00628212|464575407|FG000|Overall Study|Physician Decision|1|||
129078107|NCT00628212|464575408|FG001|Overall Study|Physician Decision|1|||
129078108|NCT00628212|464575409|FG002|Overall Study|Physician Decision|2|||
129078109|NCT00628212|464575410|FG003|Overall Study|Physician Decision|3|||
129078110|NCT00789373|464575413|FG000|Induction|Adverse Event|64|||
129078111|NCT00789373|464575414|FG001|Induction|Adverse Event|0|||
129078112|NCT00789373|464575415|FG002|Induction|Adverse Event|0|||
129078113|NCT00789373|464575413|FG000|Induction|Death Due to study disease|24|||
129078114|NCT00789373|464575414|FG001|Induction|Death Due to study disease|0|||
129078115|NCT00789373|464575415|FG002|Induction|Death Due to study disease|0|||
129078116|NCT00789373|464575413|FG000|Induction|Death due to adverse event|19|||
129078117|NCT00789373|464575414|FG001|Induction|Death due to adverse event|0|||
129078118|NCT00789373|464575415|FG002|Induction|Death due to adverse event|0|||
129078119|NCT00789373|464575413|FG000|Induction|Death due to toxicity|11|||
129078120|NCT00789373|464575414|FG001|Induction|Death due to toxicity|0|||
129078121|NCT00789373|464575415|FG002|Induction|Death due to toxicity|0|||
129078122|NCT00789373|464575413|FG000|Induction|Death due to procedure|1|||
129078123|NCT00789373|464575414|FG001|Induction|Death due to procedure|0|||
129078124|NCT00789373|464575415|FG002|Induction|Death due to procedure|0|||
129078125|NCT00789373|464575413|FG000|Induction|Investigator decision|7|||
129078126|NCT00789373|464575414|FG001|Induction|Investigator decision|0|||
129078127|NCT00789373|464575415|FG002|Induction|Investigator decision|0|||
129078128|NCT00789373|464575413|FG000|Induction|Protocol entry criteria not met|9|||
129078129|NCT00789373|464575414|FG001|Induction|Protocol entry criteria not met|0|||
129078130|NCT00789373|464575415|FG002|Induction|Protocol entry criteria not met|0|||
129078131|NCT00789373|464575413|FG000|Induction|Lost to Follow-up|6|||
129078132|NCT00789373|464575414|FG001|Induction|Lost to Follow-up|0|||
129078133|NCT00789373|464575415|FG002|Induction|Lost to Follow-up|0|||
129078134|NCT00789373|464575413|FG000|Induction|Protocol Violation|1|||
129078135|NCT00789373|464575414|FG001|Induction|Protocol Violation|0|||
129078136|NCT00789373|464575415|FG002|Induction|Protocol Violation|0|||
129078137|NCT00789373|464575413|FG000|Induction|Progressive Disease|220|||
129078138|NCT00789373|464575414|FG001|Induction|Progressive Disease|0|||
129078139|NCT00789373|464575415|FG002|Induction|Progressive Disease|0|||
129078140|NCT00789373|464575413|FG000|Induction|Withdrawal by Subject|37|||
129078141|NCT00789373|464575414|FG001|Induction|Withdrawal by Subject|0|||
129078142|NCT00789373|464575415|FG002|Induction|Withdrawal by Subject|0|||
129078143|NCT00789373|464575413|FG000|Maintenance|Adverse Event|0|||
129078144|NCT00789373|464575414|FG001|Maintenance|Adverse Event|65|||
129078145|NCT00789373|464575415|FG002|Maintenance|Adverse Event|12|||
129078146|NCT00789373|464575413|FG000|Maintenance|Death due to study disease|0|||
129078147|NCT00789373|464575414|FG001|Maintenance|Death due to study disease|3|||
129078148|NCT00789373|464575415|FG002|Maintenance|Death due to study disease|1|||
129078149|NCT00789373|464575413|FG000|Maintenance|Death due to adverse event|0|||
129078150|NCT00789373|464575414|FG001|Maintenance|Death due to adverse event|4|||
129078151|NCT00789373|464575415|FG002|Maintenance|Death due to adverse event|1|||
129078152|NCT00789373|464575413|FG000|Maintenance|Death due to toxicity|0|||
129078153|NCT00789373|464575414|FG001|Maintenance|Death due to toxicity|1|||
129078154|NCT00789373|464575415|FG002|Maintenance|Death due to toxicity|2|||
129078155|NCT00789373|464575413|FG000|Maintenance|Investigator Decision|0|||
129078156|NCT00789373|464575414|FG001|Maintenance|Investigator Decision|4|||
129078157|NCT00789373|464575415|FG002|Maintenance|Investigator Decision|2|||
129078158|NCT00789373|464575413|FG000|Maintenance|Protocol entry criteria not met|0|||
129078159|NCT00789373|464575414|FG001|Maintenance|Protocol entry criteria not met|2|||
129078160|NCT00789373|464575415|FG002|Maintenance|Protocol entry criteria not met|0|||
129078161|NCT00789373|464575413|FG000|Maintenance|Lost to Follow-up|0|||
129078162|NCT00789373|464575414|FG001|Maintenance|Lost to Follow-up|2|||
129078163|NCT00789373|464575415|FG002|Maintenance|Lost to Follow-up|0|||
129078164|NCT00789373|464575413|FG000|Maintenance|Progressive Disease|0|||
129078165|NCT00789373|464575414|FG001|Maintenance|Progressive Disease|253|||
129078166|NCT00789373|464575415|FG002|Maintenance|Progressive Disease|152|||
129078167|NCT00789373|464575413|FG000|Maintenance|Withdrawal by Subject|0|||
129078168|NCT00789373|464575414|FG001|Maintenance|Withdrawal by Subject|21|||
129078169|NCT00789373|464575415|FG002|Maintenance|Withdrawal by Subject|8|||
129078170|NCT00789373|464575413|FG000|Maintenance|Sponsor Decision|0|||
129078171|NCT00789373|464575414|FG001|Maintenance|Sponsor Decision|0|||
129078172|NCT00789373|464575415|FG002|Maintenance|Sponsor Decision|2|||
129078173|NCT00789373|464575413|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
129078174|NCT00789373|464575414|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
129078175|NCT00789373|464575415|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
129078176|NCT02187198|464575418|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
129078177|NCT02187198|464575419|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
129078178|NCT02187198|464575418|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
129078179|NCT02187198|464575419|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
129078180|NCT00546377|464575420|FG000|Overall Study|Deemed ineligible|1|||
129078181|NCT00546377|464575420|FG000|Overall Study|Adverse Event|6|||
129078182|NCT03321968|464575421|FG000|Overall Study|Withdrawal by Subject|1|||
129078183|NCT03321968|464575422|FG001|Overall Study|Withdrawal by Subject|2|||
129078184|NCT03321968|464575423|FG002|Overall Study|Withdrawal by Subject|1|||
129078185|NCT03321968|464575421|FG000|Overall Study|Lost to Follow-up|2|||
129078186|NCT03321968|464575422|FG001|Overall Study|Lost to Follow-up|0|||
129078187|NCT03321968|464575423|FG002|Overall Study|Lost to Follow-up|1|||
129078188|NCT03321968|464575421|FG000|Overall Study|Other than specified|0|||
129078189|NCT03321968|464575422|FG001|Overall Study|Other than specified|0|||
129078190|NCT03321968|464575423|FG002|Overall Study|Other than specified|1|||
129078191|NCT02282813|464575429|FG000|Overall Study|Withdrawal by Subject|4|||
129078192|NCT02282813|464575430|FG001|Overall Study|Withdrawal by Subject|5|||
129078193|NCT02282813|464575431|FG002|Overall Study|Withdrawal by Subject|0|||
129078194|NCT02282813|464575429|FG000|Overall Study|Adverse Event|3|||
129078195|NCT02282813|464575430|FG001|Overall Study|Adverse Event|10|||
129078196|NCT02282813|464575431|FG002|Overall Study|Adverse Event|1|||
129078197|NCT02282813|464575429|FG000|Overall Study|Subject non-compliance|1|||
129078198|NCT02282813|464575430|FG001|Overall Study|Subject non-compliance|4|||
129078199|NCT02282813|464575431|FG002|Overall Study|Subject non-compliance|0|||
129078200|NCT02282813|464575429|FG000|Overall Study|Physician Decision|0|||
129078201|NCT02282813|464575430|FG001|Overall Study|Physician Decision|3|||
129078202|NCT02282813|464575431|FG002|Overall Study|Physician Decision|1|||
129078203|NCT02282813|464575429|FG000|Overall Study|Lost to Follow-up|2|||
129078204|NCT02282813|464575430|FG001|Overall Study|Lost to Follow-up|0|||
129078205|NCT02282813|464575431|FG002|Overall Study|Lost to Follow-up|1|||
129078206|NCT02282813|464575429|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
129078207|NCT02282813|464575430|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
129078208|NCT02282813|464575431|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
129078209|NCT02282813|464575429|FG000|Overall Study|Lack of Efficacy|1|||
129078210|NCT02282813|464575430|FG001|Overall Study|Lack of Efficacy|0|||
129078211|NCT02282813|464575431|FG002|Overall Study|Lack of Efficacy|0|||
129078212|NCT02282813|464575429|FG000|Overall Study|Administrative reasons|0|||
129078213|NCT02282813|464575430|FG001|Overall Study|Administrative reasons|1|||
129078214|NCT02282813|464575431|FG002|Overall Study|Administrative reasons|0|||
129078215|NCT00463047|464575432|FG000|Titration Period 1|Adverse Event|10|||
129078216|NCT00463047|464575433|FG001|Titration Period 1|Adverse Event|8|||
129078217|NCT00463047|464575432|FG000|Titration Period 1|Lack of Efficacy|10|||
129078218|NCT00463047|464575433|FG001|Titration Period 1|Lack of Efficacy|4|||
129078219|NCT00463047|464575432|FG000|Titration Period 1|Lost to Follow-up|2|||
129078220|NCT00463047|464575433|FG001|Titration Period 1|Lost to Follow-up|0|||
129078221|NCT00463047|464575432|FG000|Titration Period 1|Non-compliance with study medication|3|||
129078222|NCT00463047|464575433|FG001|Titration Period 1|Non-compliance with study medication|5|||
129078223|NCT00463047|464575432|FG000|Titration Period 1|Protocol Violation|5|||
129078224|NCT00463047|464575433|FG001|Titration Period 1|Protocol Violation|5|||
129078225|NCT00463047|464575432|FG000|Titration Period 1|Withdrawal by Subject|3|||
129078226|NCT00463047|464575433|FG001|Titration Period 1|Withdrawal by Subject|5|||
129078227|NCT00463047|464575432|FG000|Titration Period 1|Non-compliance procedures|4|||
129078228|NCT00463047|464575433|FG001|Titration Period 1|Non-compliance procedures|10|||
129078229|NCT00463047|464575432|FG000|Titration Period 1|Other|0|||
129078230|NCT00463047|464575433|FG001|Titration Period 1|Other|2|||
129078231|NCT00463047|464575432|FG000|Titration Period 2|Adverse Event|9|||
129078232|NCT00463047|464575433|FG001|Titration Period 2|Adverse Event|9|||
129078233|NCT00463047|464575432|FG000|Titration Period 2|Lack of Efficacy|6|||
129078234|NCT00463047|464575433|FG001|Titration Period 2|Lack of Efficacy|4|||
129078235|NCT00463047|464575432|FG000|Titration Period 2|Withdrawal by Subject|1|||
129078236|NCT00463047|464575433|FG001|Titration Period 2|Withdrawal by Subject|0|||
129078237|NCT00463047|464575432|FG000|Titration Period 2|Protocol Violation|2|||
129078238|NCT00463047|464575433|FG001|Titration Period 2|Protocol Violation|3|||
129078239|NCT00463047|464575432|FG000|Titration Period 2|Lost to Follow-up|1|||
129078240|NCT00463047|464575433|FG001|Titration Period 2|Lost to Follow-up|2|||
129078241|NCT00463047|464575432|FG000|Titration Period 2|Non-compliance study medication|4|||
129078242|NCT00463047|464575433|FG001|Titration Period 2|Non-compliance study medication|2|||
128724015|NCT00692770|463287310|FG001|Overall Study|Physician decision not protocol driven|14|||
128724016|NCT00692770|463287309|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
128724017|NCT00692770|463287310|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
129078243|NCT00463047|464575432|FG000|Titration Period 2|Non-compliance procedures|4|||
129078244|NCT00463047|464575433|FG001|Titration Period 2|Non-compliance procedures|1|||
129078245|NCT00463047|464575432|FG000|Titration Period 2|Other|3|||
129078246|NCT00463047|464575433|FG001|Titration Period 2|Other|2|||
129078247|NCT00463047|464575432|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
129078248|NCT00463047|464575433|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
129078249|NCT00463047|464575432|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
129078250|NCT00463047|464575433|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
129078251|NCT00463047|464575432|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
129078252|NCT00463047|464575433|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
129078253|NCT00463047|464575432|FG000|Double-Blind Treatment Period 1|Other|1|||
129078254|NCT00463047|464575433|FG001|Double-Blind Treatment Period 1|Other|0|||
129078255|NCT00463047|464575432|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
129078256|NCT00463047|464575433|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
129078257|NCT00463047|464575432|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
129078258|NCT00463047|464575433|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
129078259|NCT00463047|464575432|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
129078260|NCT00463047|464575433|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
129078261|NCT03020992|464575437|FG000|Overall Study|Adverse Event|5|||
129078262|NCT03020992|464575437|FG000|Overall Study|Withdrawal by Subject|1|||
129078263|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
129078264|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
129078265|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
129078266|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
129078267|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Pregnancy|0|||
129078268|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Pregnancy|1|||
129078269|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
129078270|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
129078271|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
129078272|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
129078273|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
129078274|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
129078275|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Other|3|||
129078276|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Other|0|||
129078277|NCT01006122|464575440|FG000|First Double-blind Intervention Period|Adverse Event|0|||
129078278|NCT01006122|464575441|FG001|First Double-blind Intervention Period|Adverse Event|4|||
129078279|NCT01006122|464575440|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
129078280|NCT01006122|464575441|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
129078281|NCT01006122|464575440|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
129078282|NCT01006122|464575441|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
129078283|NCT01006122|464575440|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
129078284|NCT01006122|464575441|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
129078285|NCT01006122|464575440|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
129078286|NCT01006122|464575441|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
129078287|NCT01006122|464575440|FG000|Second Double-blind Intervention Period|Death|0|||
129078288|NCT01006122|464575441|FG001|Second Double-blind Intervention Period|Death|1|||
129078289|NCT03493854|464575442|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
129078290|NCT03493854|464575443|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
129078291|NCT03493854|464575442|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
129078292|NCT03493854|464575443|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
129078293|NCT03493854|464575442|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
129078294|NCT03493854|464575443|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
129078295|NCT03493854|464575442|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
129078296|NCT03493854|464575443|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
129078297|NCT03493854|464575442|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
129078298|NCT03493854|464575443|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
129078299|NCT03493854|464575442|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
129078300|NCT03493854|464575443|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
129078301|NCT03493854|464575442|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
129078302|NCT03493854|464575443|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
129078303|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
129078304|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
129078305|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
129078306|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
129078307|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
129078308|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
129078309|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
129078310|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
129078311|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
129078312|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
129078313|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
129078314|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
129141910|NCT01421459|464813762|FG001|Overall Study|Withdrawal by Subject|16|||
129141911|NCT04439903|464813765|FG000|Overall Study|Withdrawal by Subject|2|||
129141912|NCT04439903|464813765|FG000|Overall Study|Screen Failure|1|||
129141913|NCT02899754|464813766|FG000|Overall Study|Lost to Follow-up|7|||
129141914|NCT02899754|464813767|FG001|Overall Study|Lost to Follow-up|9|||
129141915|NCT03996395|464813774|FG000|Overall Study|Lost to Follow-up|4|||
129141916|NCT03996395|464813774|FG000|Overall Study|Withdrawal by Subject|1|||
129141917|NCT03996395|464813774|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
129141918|NCT02097225|464813775|FG000|Dose Level 4|Adverse Event|0|||
129141919|NCT02097225|464813776|FG001|Dose Level 4|Adverse Event|0|||
129141920|NCT02097225|464813777|FG002|Dose Level 4|Adverse Event|0|||
129141921|NCT02097225|464813778|FG003|Dose Level 4|Adverse Event|0|||
129141922|NCT02097225|464813779|FG004|Dose Level 4|Adverse Event|1|||
129141923|NCT02757963|464813781|FG000|Overall Study|Adverse Event|3|||
129141924|NCT02757963|464813781|FG000|Overall Study|Reached Stopping Criteria|1054|||
129141925|NCT02757963|464813781|FG000|Overall Study|Lost to Follow-up|5|||
129141926|NCT02757963|464813781|FG000|Overall Study|Physician Decision|1|||
129141927|NCT02757963|464813781|FG000|Overall Study|Withdrawal by Subject|34|||
129141928|NCT00911157|464813782|FG000|Overall Study|Adverse Event|4|||
129141929|NCT00911157|464813783|FG001|Overall Study|Adverse Event|1|||
129141930|NCT00911157|464813782|FG000|Overall Study|Withdrawal by Subject|1|||
129141931|NCT00911157|464813783|FG001|Overall Study|Withdrawal by Subject|1|||
129141932|NCT00911157|464813782|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
129078315|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
129078316|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
129078317|NCT03493854|464575442|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
129078318|NCT03493854|464575443|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
129078319|NCT03493854|464575442|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
129078320|NCT03493854|464575443|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
129078321|NCT03493854|464575442|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
129078322|NCT03493854|464575443|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
129078323|NCT03493854|464575442|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
129078324|NCT03493854|464575443|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
129078325|NCT00739661|464575444|FG000|Overall Study|Adverse Event|2|||
129078326|NCT00739661|464575445|FG001|Overall Study|Adverse Event|0|||
129078327|NCT00739661|464575444|FG000|Overall Study|Physician decision to withdraw patient|1|||
129078328|NCT00739661|464575445|FG001|Overall Study|Physician decision to withdraw patient|0|||
129078329|NCT00739661|464575444|FG000|Overall Study|Patient decision to withdraw|9|||
129078330|NCT00739661|464575445|FG001|Overall Study|Patient decision to withdraw|4|||
129078331|NCT00739661|464575444|FG000|Overall Study|Disease progression, radiographic|33|||
129078332|NCT00739661|464575445|FG001|Overall Study|Disease progression, radiographic|37|||
129078333|NCT00739661|464575444|FG000|Overall Study|Reason for discontinuation not available|1|||
129078334|NCT00739661|464575445|FG001|Overall Study|Reason for discontinuation not available|1|||
129078335|NCT05343364|464575446|FG000|Overall Study|Miscellaneous|0|||
129078336|NCT05343364|464575447|FG001|Overall Study|Miscellaneous|1|||
129078337|NCT02105987|464575448|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
129078338|NCT02105987|464575449|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129078339|NCT02105987|464575450|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129078340|NCT02105987|464575451|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129078341|NCT02105987|464575452|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129078342|NCT02105987|464575453|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129078343|NCT02105987|464575448|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
129078344|NCT02105987|464575449|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
129078345|NCT02105987|464575450|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129078346|NCT02105987|464575451|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129078347|NCT02105987|464575452|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129078348|NCT02105987|464575453|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129078349|NCT02105987|464575448|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
129078350|NCT02105987|464575449|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
129078351|NCT02105987|464575450|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078352|NCT02105987|464575451|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078353|NCT02105987|464575452|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078354|NCT02105987|464575453|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078355|NCT02105987|464575448|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
129078356|NCT02105987|464575449|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
129078357|NCT02105987|464575450|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078358|NCT02105987|464575451|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078359|NCT02105987|464575452|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078360|NCT02105987|464575453|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078361|NCT02105987|464575448|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
129078362|NCT02105987|464575449|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
129078363|NCT02105987|464575450|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129078364|NCT02105987|464575451|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129078365|NCT02105987|464575452|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129078366|NCT02105987|464575453|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129078367|NCT02105987|464575448|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129078368|NCT02105987|464575449|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
129078369|NCT02105987|464575450|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129078370|NCT02105987|464575451|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129078371|NCT02105987|464575452|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129078372|NCT02105987|464575453|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129078373|NCT02105987|464575448|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129078374|NCT02105987|464575449|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129078375|NCT02105987|464575450|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
129078376|NCT02105987|464575451|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
129078377|NCT02105987|464575452|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129078378|NCT02105987|464575453|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129078379|NCT02105987|464575448|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129078380|NCT02105987|464575449|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129078381|NCT02105987|464575450|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
129078382|NCT02105987|464575451|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
129078383|NCT02105987|464575452|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129078384|NCT02105987|464575453|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129078385|NCT02105987|464575448|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078386|NCT02105987|464575449|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078387|NCT02105987|464575450|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
129078388|NCT02105987|464575451|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
129078389|NCT02105987|464575452|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078390|NCT02105987|464575453|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129078391|NCT02105987|464575448|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078392|NCT02105987|464575449|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078393|NCT02105987|464575450|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
129078394|NCT02105987|464575451|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
129078395|NCT02105987|464575452|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078396|NCT02105987|464575453|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129078397|NCT02105987|464575448|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129078398|NCT02105987|464575449|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129078399|NCT02105987|464575450|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
129078400|NCT02105987|464575451|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129078401|NCT02105987|464575452|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129078402|NCT02105987|464575453|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129078403|NCT02105987|464575448|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129078404|NCT02105987|464575449|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129078405|NCT02105987|464575450|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129078406|NCT02105987|464575451|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
129078407|NCT02105987|464575452|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129078408|NCT02105987|464575453|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129078409|NCT02105987|464575448|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129078410|NCT02105987|464575449|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129078411|NCT02105987|464575450|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
129078412|NCT02105987|464575451|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129078413|NCT02105987|464575452|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129078414|NCT02105987|464575453|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129078415|NCT02105987|464575448|FG000|Continuation Phase|Protocol Violation|0|||
129078416|NCT02105987|464575449|FG001|Continuation Phase|Protocol Violation|0|||
129078417|NCT02105987|464575450|FG002|Continuation Phase|Protocol Violation|0|||
129078418|NCT02105987|464575451|FG003|Continuation Phase|Protocol Violation|0|||
129078419|NCT02105987|464575452|FG004|Continuation Phase|Protocol Violation|1|||
129078420|NCT02105987|464575453|FG005|Continuation Phase|Protocol Violation|0|||
129078421|NCT01252095|464575455|FG000|Overall Study|Disease progression|1|||
129078422|NCT01252095|464575456|FG001|Overall Study|Disease progression|0|||
129078423|NCT02554682|464575457|FG000|Overall Study|Lost to Follow-up|11|||
129078424|NCT02554682|464575458|FG001|Overall Study|Lost to Follow-up|9|||
129078425|NCT02554682|464575459|FG002|Overall Study|Lost to Follow-up|4|||
129078426|NCT02554682|464575460|FG003|Overall Study|Lost to Follow-up|3|||
129078427|NCT02554682|464575461|FG004|Overall Study|Lost to Follow-up|2|||
129078428|NCT02554682|464575462|FG005|Overall Study|Lost to Follow-up|1|||
129078429|NCT02554682|464575463|FG006|Overall Study|Lost to Follow-up|6|||
129078430|NCT02554682|464575464|FG007|Overall Study|Lost to Follow-up|6|||
129078431|NCT02554682|464575465|FG008|Overall Study|Lost to Follow-up|2|||
129078432|NCT02554682|464575466|FG009|Overall Study|Lost to Follow-up|2|||
129078433|NCT02554682|464575457|FG000|Overall Study|Withdrawal by Subject|2|||
129078434|NCT02554682|464575458|FG001|Overall Study|Withdrawal by Subject|1|||
129078435|NCT02554682|464575459|FG002|Overall Study|Withdrawal by Subject|0|||
129078436|NCT02554682|464575460|FG003|Overall Study|Withdrawal by Subject|0|||
129078437|NCT02554682|464575461|FG004|Overall Study|Withdrawal by Subject|0|||
129078438|NCT02554682|464575462|FG005|Overall Study|Withdrawal by Subject|0|||
129078439|NCT02554682|464575463|FG006|Overall Study|Withdrawal by Subject|0|||
129078440|NCT02554682|464575464|FG007|Overall Study|Withdrawal by Subject|0|||
129078441|NCT02554682|464575465|FG008|Overall Study|Withdrawal by Subject|0|||
129078442|NCT02554682|464575466|FG009|Overall Study|Withdrawal by Subject|0|||
129078443|NCT02554682|464575457|FG000|Overall Study|Physician Decision|2|||
129078444|NCT02554682|464575458|FG001|Overall Study|Physician Decision|2|||
129078445|NCT02554682|464575459|FG002|Overall Study|Physician Decision|0|||
129078446|NCT02554682|464575460|FG003|Overall Study|Physician Decision|0|||
129078447|NCT02554682|464575461|FG004|Overall Study|Physician Decision|0|||
129078448|NCT02554682|464575462|FG005|Overall Study|Physician Decision|0|||
128776560|NCT02846558|463470464|FG001|Overall Study|Withdrawal by Subject|4|||
129078449|NCT02554682|464575463|FG006|Overall Study|Physician Decision|0|||
129078450|NCT02554682|464575464|FG007|Overall Study|Physician Decision|0|||
129078451|NCT02554682|464575465|FG008|Overall Study|Physician Decision|0|||
129078452|NCT02554682|464575466|FG009|Overall Study|Physician Decision|0|||
129078453|NCT00237458|464575468|FG000|Overall Study|Lack of Efficacy|1|||
129078454|NCT00237458|464575468|FG000|Overall Study|Adverse Event|1|||
129078455|NCT00237458|464575468|FG000|Overall Study|Withdrawal by Subject|1|||
129078456|NCT00952068|464575470|FG000|Overall Study|Adverse Event|3|||
129078457|NCT00952068|464575470|FG000|Overall Study|Withdrawal by Subject|4|||
129078458|NCT02062450|464575473|FG000|Overall Study|No follow-up visit|124|||
129078459|NCT02907177|464575476|FG000|Overall Study|Death|0|||
129078460|NCT02907177|464575477|FG001|Overall Study|Death|1|||
129078461|NCT02907177|464575476|FG000|Overall Study|Physician Decision|3|||
129078462|NCT02907177|464575477|FG001|Overall Study|Physician Decision|3|||
129078463|NCT02907177|464575476|FG000|Overall Study|Withdrawal by Subject|15|||
129078464|NCT02907177|464575477|FG001|Overall Study|Withdrawal by Subject|7|||
129078465|NCT02907177|464575476|FG000|Overall Study|Sponsor's Decision|50|||
129078466|NCT02907177|464575477|FG001|Overall Study|Sponsor's Decision|57|||
129078467|NCT01537042|464575483|FG000|Overall Study|Adverse Event|0|||
129078468|NCT01537042|464575484|FG001|Overall Study|Adverse Event|2|||
129078469|NCT01537042|464575483|FG000|Overall Study|Lack of Efficacy|0|||
129078470|NCT01537042|464575484|FG001|Overall Study|Lack of Efficacy|1|||
129078471|NCT01537042|464575483|FG000|Overall Study|Protocol Violation|0|||
129078472|NCT01537042|464575484|FG001|Overall Study|Protocol Violation|1|||
129078473|NCT01537042|464575483|FG000|Overall Study|Other|0|||
129078474|NCT01537042|464575484|FG001|Overall Study|Other|1|||
129078475|NCT00975611|464577237|FG000|Overall Study|Screen Fail|16|||
129078476|NCT00975611|464577237|FG000|Overall Study|Physician Decision|1|||
129078477|NCT02151851|464577238|FG000|Overall Study|Lack of Efficacy|67|||
129078478|NCT02151851|464577239|FG001|Overall Study|Lack of Efficacy|94|||
129078479|NCT02151851|464577238|FG000|Overall Study|Protocol Violation|0|||
129078480|NCT02151851|464577239|FG001|Overall Study|Protocol Violation|1|||
129078481|NCT02151851|464577238|FG000|Overall Study|Withdrawal by Subject|2|||
129078482|NCT02151851|464577239|FG001|Overall Study|Withdrawal by Subject|5|||
129078483|NCT02151851|464577238|FG000|Overall Study|Medical impairment|1|||
129078484|NCT02151851|464577239|FG001|Overall Study|Medical impairment|0|||
129078485|NCT02151851|464577238|FG000|Overall Study|Low compliance to study visits|0|||
129078486|NCT02151851|464577239|FG001|Overall Study|Low compliance to study visits|1|||
129078487|NCT02151851|464577238|FG000|Overall Study|Subject entered into study in error|0|||
129078488|NCT02151851|464577239|FG001|Overall Study|Subject entered into study in error|1|||
129078489|NCT02151851|464577238|FG000|Overall Study|Adverse Event|6|||
129078490|NCT02151851|464577239|FG001|Overall Study|Adverse Event|28|||
129078491|NCT01540487|464577240|FG000|Overall Study|Protocol Violation|1|||
129078492|NCT01540487|464577241|FG001|Overall Study|Protocol Violation|0|||
129078493|NCT03503370|464577244|FG000|Overall Study|Death|3|||
129078494|NCT03503370|464577245|FG001|Overall Study|Death|1|||
129078495|NCT00298272|464577250|FG000|Double-blind Phase|Adverse Event|2|||
129078496|NCT00298272|464577251|FG001|Double-blind Phase|Adverse Event|0|||
129078497|NCT00298272|464577250|FG000|Double-blind Phase|Failure to Return|2|||
129078498|NCT00298272|464577251|FG001|Double-blind Phase|Failure to Return|0|||
129078499|NCT00298272|464577250|FG000|Double-blind Phase|Protocol Violation|2|||
129078500|NCT00298272|464577251|FG001|Double-blind Phase|Protocol Violation|0|||
129078501|NCT00298272|464577250|FG000|Double-blind Phase|Withdrawal by Subject|2|||
129078502|NCT00298272|464577251|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129078503|NCT00298272|464577250|FG000|Open Label Retreatment Phase|Adverse Event|1|||
129078504|NCT00298272|464577251|FG001|Open Label Retreatment Phase|Adverse Event|2|||
129078505|NCT00298272|464577250|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
129078506|NCT00298272|464577251|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
129078507|NCT00298272|464577250|FG000|Open Label Retreatment Phase|Failure to Return|1|||
129078508|NCT00298272|464577251|FG001|Open Label Retreatment Phase|Failure to Return|0|||
129078509|NCT00298272|464577250|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
129078510|NCT00298272|464577251|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
129078511|NCT00298272|464577250|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
129078512|NCT00298272|464577251|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
129078513|NCT00298272|464577250|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
129078514|NCT00298272|464577251|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
129078515|NCT00298272|464577250|FG000|Safety Follow-up Phase|Failure to Return|1|||
129078516|NCT00298272|464577251|FG001|Safety Follow-up Phase|Failure to Return|1|||
129078517|NCT00298272|464577250|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
129078518|NCT00298272|464577251|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
129078519|NCT00298272|464577250|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
129078520|NCT00298272|464577251|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
129078521|NCT04168112|464577252|FG000|Overall Study|Lost to Follow-up|1|||
129078522|NCT04168112|464577253|FG001|Overall Study|Lost to Follow-up|0|||
129078523|NCT04168112|464577252|FG000|Overall Study|Withdrawal by Subject|1|||
129078524|NCT04168112|464577253|FG001|Overall Study|Withdrawal by Subject|0|||
129078525|NCT05253573|464577256|FG000|Overall Study|Death|1|||
129078526|NCT05253573|464577257|FG001|Overall Study|Death|0|||
129078527|NCT01436370|464577258|FG000|Overall Study|Lost to Follow-up|0|||
129078528|NCT01436370|464577259|FG001|Overall Study|Lost to Follow-up|0|||
129078529|NCT01436370|464577260|FG002|Overall Study|Lost to Follow-up|0|||
129078530|NCT01436370|464577261|FG003|Overall Study|Lost to Follow-up|0|||
129078531|NCT01436370|464577262|FG004|Overall Study|Lost to Follow-up|1|||
129078532|NCT01436370|464577263|FG005|Overall Study|Lost to Follow-up|0|||
129078533|NCT01436370|464577264|FG006|Overall Study|Lost to Follow-up|0|||
129078534|NCT01436370|464577265|FG007|Overall Study|Lost to Follow-up|0|||
129078535|NCT02126579|464577267|FG000|Overall Study|disease progression|0|||
129078536|NCT02126579|464577268|FG001|Overall Study|disease progression|0|||
129078537|NCT02126579|464577269|FG002|Overall Study|disease progression|0|||
129078538|NCT02126579|464577270|FG003|Overall Study|disease progression|1|||
129078539|NCT02126579|464577271|FG004|Overall Study|disease progression|0|||
129078540|NCT02126579|464577272|FG005|Overall Study|disease progression|0|||
129078541|NCT02126579|464577273|FG006|Overall Study|disease progression|1|||
129078542|NCT01780038|464577277|FG000|Overall Study|Lost to Follow-up|4|||
129078543|NCT01780038|464577278|FG001|Overall Study|Lost to Follow-up|1|||
129078544|NCT02609607|464577284|FG000|Overall Study|Lost to Follow-up|0|||
129078545|NCT02609607|464577285|FG001|Overall Study|Lost to Follow-up|1|||
129078546|NCT03168711|464577288|FG000|Overall Study|Adverse Event|2|||
129078547|NCT03168711|464577289|FG001|Overall Study|Adverse Event|0|||
129078548|NCT03168711|464577288|FG000|Overall Study|Withdrawal by Subject|0|||
129078549|NCT03168711|464577289|FG001|Overall Study|Withdrawal by Subject|1|||
129078550|NCT03168711|464577288|FG000|Overall Study|Death|0|||
129078551|NCT03168711|464577289|FG001|Overall Study|Death|1|||
129078552|NCT02877004|464577296|FG000|Overall Study|Pregnancy|0|||
129078553|NCT02877004|464577297|FG001|Overall Study|Pregnancy|0|||
129078554|NCT02877004|464577298|FG002|Overall Study|Pregnancy|1|||
129078555|NCT02633293|464577299|FG000|Overall Study|Death|56|||
129078556|NCT02633293|464577299|FG000|Overall Study|Progressive Disease|12|||
129078557|NCT02633293|464577299|FG000|Overall Study|Adverse Event|29|||
129078558|NCT02633293|464577299|FG000|Overall Study|Withdrawal by Subject|41|||
129078559|NCT02633293|464577299|FG000|Overall Study|Protocol Violation|1|||
129078560|NCT02633293|464577299|FG000|Overall Study|Lost to Follow-up|1|||
129078561|NCT02633293|464577299|FG000|Overall Study|Study Terminated by Sponsor|24|||
129078562|NCT02633293|464577299|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
129078563|NCT02633293|464577299|FG000|Overall Study|Lung Transplant|5|||
129078564|NCT02633293|464577299|FG000|Overall Study|Lack of Efficacy|2|||
129078565|NCT02633293|464577299|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
129078566|NCT00778817|464577300|FG000|Overall Study|Adverse Event|2|||
129078567|NCT00778817|464577300|FG000|Overall Study|Withdrawal by Subject|2|||
129078568|NCT02356588|464577301|FG000|Overall Study|Lack of Efficacy|4|||
129078569|NCT02356588|464577302|FG001|Overall Study|Lack of Efficacy|10|||
129078570|NCT02356588|464577301|FG000|Overall Study|Adverse Event|0|||
129078571|NCT02356588|464577302|FG001|Overall Study|Adverse Event|2|||
129078572|NCT02356588|464577301|FG000|Overall Study|Withdrawal by Subject|1|||
129078573|NCT02356588|464577302|FG001|Overall Study|Withdrawal by Subject|0|||
129078574|NCT02356588|464577301|FG000|Overall Study|Protocol Violation|0|||
129078575|NCT02356588|464577302|FG001|Overall Study|Protocol Violation|1|||
129078576|NCT01418378|464577303|FG000|Overall Study|Death|1|||
129078577|NCT01418378|464577304|FG001|Overall Study|Death|2|||
129078578|NCT01418378|464577303|FG000|Overall Study|Physician Decision|0|||
129078579|NCT01418378|464577304|FG001|Overall Study|Physician Decision|1|||
129078580|NCT01418378|464577303|FG000|Overall Study|ligament imbalance|0|||
129078581|NCT01418378|464577304|FG001|Overall Study|ligament imbalance|1|||
129078582|NCT01418378|464577303|FG000|Overall Study|developed chronic myopathy|0|||
129078583|NCT01418378|464577304|FG001|Overall Study|developed chronic myopathy|1|||
128776561|NCT02846558|463470465|FG002|Overall Study|Withdrawal by Subject|2|||
129078584|NCT01790984|464577305|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
129078585|NCT01790984|464577306|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
129078586|NCT01790984|464577307|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
129078587|NCT01790984|464577308|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
129078588|NCT01051791|464577311|FG000|Overall Study|Failed screening|3|||
129078589|NCT01051791|464577311|FG000|Overall Study|Withdrawal by Subject|1|||
129078590|NCT01081769|464577316|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
129078591|NCT01081769|464577317|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
129078592|NCT01081769|464577316|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
129078593|NCT01081769|464577317|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
129078594|NCT01081769|464577316|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
129078595|NCT01081769|464577317|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
129078596|NCT01081769|464577316|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
129078597|NCT01081769|464577317|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
129078598|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Adverse Event|14|||
129078599|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Adverse Event|11|||
129078600|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Death|1|||
129078601|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Death|1|||
129078602|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
129078603|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
129078604|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
129078605|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
129078606|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Pregnancy|1|||
129078607|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Pregnancy|0|||
129078608|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
129078609|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
129078610|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
129078611|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
129078612|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Other|0|||
129078613|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Other|1|||
129078614|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Ineligibility|3|||
129078615|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Ineligibility|4|||
129078616|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
129078617|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
129078618|NCT01081769|464577316|FG000|CORE Intent-To-Treat|Patient Moved|2|||
129078619|NCT01081769|464577317|FG001|CORE Intent-To-Treat|Patient Moved|2|||
129141933|NCT00911157|464813783|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
129141934|NCT00911157|464813782|FG000|Overall Study|Need to treat for lung cancer|1|||
129141935|NCT00911157|464813783|FG001|Overall Study|Need to treat for lung cancer|0|||
129141936|NCT00176254|464813787|FG000|Overall Study|Lost to Follow-up|1|||
129141937|NCT01251965|464815601|FG000|Overall Study|Participant/physician decision|1|||
129141938|NCT01251965|464815602|FG001|Overall Study|Participant/physician decision|2|||
129141939|NCT01251965|464815603|FG002|Overall Study|Participant/physician decision|0|||
129078620|NCT00507455|464577318|FG000|Overall Study|Adverse Event|3|||
129078621|NCT00507455|464577319|FG001|Overall Study|Adverse Event|3|||
129078622|NCT00507455|464577320|FG002|Overall Study|Adverse Event|6|||
129078623|NCT00507455|464577318|FG000|Overall Study|Withdrawal by Subject|2|||
129078624|NCT00507455|464577319|FG001|Overall Study|Withdrawal by Subject|1|||
129078625|NCT00507455|464577320|FG002|Overall Study|Withdrawal by Subject|2|||
129078626|NCT00507455|464577318|FG000|Overall Study|Protocol Violation|4|||
129078627|NCT00507455|464577319|FG001|Overall Study|Protocol Violation|1|||
129141940|NCT01251965|464815601|FG000|Overall Study|Death|0|||
129141941|NCT01251965|464815602|FG001|Overall Study|Death|0|||
129141942|NCT01251965|464815603|FG002|Overall Study|Death|11|||
129141943|NCT04616196|464815604|FG000|Overall Study|Progressive Disease|3|||
129141944|NCT04616196|464815605|FG001|Overall Study|Progressive Disease|0|||
129141945|NCT04616196|464815606|FG002|Overall Study|Progressive Disease|4|||
129141946|NCT04616196|464815607|FG003|Overall Study|Progressive Disease|1|||
129141947|NCT04616196|464815604|FG000|Overall Study|Death|2|||
129078628|NCT00507455|464577320|FG002|Overall Study|Protocol Violation|1|||
129078629|NCT00507455|464577318|FG000|Overall Study|Lost to Follow-up|2|||
129078630|NCT00507455|464577319|FG001|Overall Study|Lost to Follow-up|0|||
129078631|NCT00507455|464577320|FG002|Overall Study|Lost to Follow-up|2|||
129078632|NCT00507455|464577318|FG000|Overall Study|Lack of Efficacy|0|||
129078633|NCT00507455|464577319|FG001|Overall Study|Lack of Efficacy|1|||
129078634|NCT00507455|464577320|FG002|Overall Study|Lack of Efficacy|0|||
129078635|NCT00507455|464577318|FG000|Overall Study|Other - miscellaneous reason|1|||
129078636|NCT00507455|464577319|FG001|Overall Study|Other - miscellaneous reason|0|||
129078637|NCT00507455|464577320|FG002|Overall Study|Other - miscellaneous reason|1|||
129078638|NCT02861807|464577321|FG000|Overall Study|Lost to Follow-up|7|||
129078639|NCT02861807|464577322|FG001|Overall Study|Lost to Follow-up|6|||
129078640|NCT02861807|464577321|FG000|Overall Study|Withdrawal by Subject|5|||
129078641|NCT02861807|464577322|FG001|Overall Study|Withdrawal by Subject|8|||
129078642|NCT00529308|464577325|FG000|Overall Study|Withdrawal by Subject|1|||
129078643|NCT00529308|464577326|FG001|Overall Study|Withdrawal by Subject|1|||
129078644|NCT02199795|464577327|FG000|Overall Study|no longer met inclusion criteria|1|||
129078645|NCT02199795|464577328|FG001|Overall Study|no longer met inclusion criteria|0|||
129078646|NCT02199795|464577327|FG000|Overall Study|withdrew due to shoulder pain|1|||
129078647|NCT02199795|464577328|FG001|Overall Study|withdrew due to shoulder pain|0|||
129078648|NCT01791894|464577335|FG000|Overall Study|Adverse Event|1|||
129078649|NCT02268916|464577340|FG000|Overall Study|Lost to Follow-up|1|||
129078650|NCT02268916|464577341|FG001|Overall Study|Lost to Follow-up|1|||
129078651|NCT02268916|464577340|FG000|Overall Study|Withdrawal by Subject|6|||
129078652|NCT02268916|464577341|FG001|Overall Study|Withdrawal by Subject|5|||
129078653|NCT02268916|464577340|FG000|Overall Study|Participant did not have diabetes|1|||
129078654|NCT02268916|464577341|FG001|Overall Study|Participant did not have diabetes|0|||
129078655|NCT02268916|464577340|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
129078656|NCT02268916|464577341|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
129078657|NCT02418949|464577342|FG000|Overall Study|Withdrawal by Subject|1|||
129078658|NCT02418949|464577343|FG001|Overall Study|Withdrawal by Subject|0|||
129078659|NCT02418949|464577344|FG002|Overall Study|Withdrawal by Subject|1|||
129078660|NCT02418949|464577345|FG003|Overall Study|Withdrawal by Subject|1|||
129078661|NCT02418949|464577342|FG000|Overall Study|Lost to Follow-up|1|||
129078662|NCT02418949|464577343|FG001|Overall Study|Lost to Follow-up|0|||
129078663|NCT02418949|464577344|FG002|Overall Study|Lost to Follow-up|1|||
129078664|NCT02418949|464577345|FG003|Overall Study|Lost to Follow-up|0|||
129078665|NCT02418949|464577342|FG000|Overall Study|Physician Decision|1|||
129078666|NCT02418949|464577343|FG001|Overall Study|Physician Decision|1|||
129078667|NCT02418949|464577344|FG002|Overall Study|Physician Decision|1|||
129078668|NCT02418949|464577345|FG003|Overall Study|Physician Decision|0|||
129078669|NCT03926117|464577346|FG000|Overall Study|Unclassified|1|||
129078670|NCT03926117|464577347|FG001|Overall Study|Unclassified|4|||
129078671|NCT03926117|464577348|FG002|Overall Study|Unclassified|1|||
129078672|NCT03926117|464577349|FG003|Overall Study|Unclassified|4|||
129078673|NCT03926117|464577346|FG000|Overall Study|Withdrawal by Subject|3|||
129078674|NCT03926117|464577347|FG001|Overall Study|Withdrawal by Subject|0|||
129078675|NCT03926117|464577348|FG002|Overall Study|Withdrawal by Subject|1|||
129078676|NCT03926117|464577349|FG003|Overall Study|Withdrawal by Subject|1|||
129078677|NCT03926117|464577346|FG000|Overall Study|Lost to Follow-up|0|||
129078678|NCT03926117|464577347|FG001|Overall Study|Lost to Follow-up|2|||
129078679|NCT03926117|464577348|FG002|Overall Study|Lost to Follow-up|1|||
129078680|NCT03926117|464577349|FG003|Overall Study|Lost to Follow-up|0|||
129078681|NCT03926117|464577346|FG000|Overall Study|Adverse Event|1|||
129078682|NCT03926117|464577347|FG001|Overall Study|Adverse Event|2|||
129078683|NCT03926117|464577348|FG002|Overall Study|Adverse Event|3|||
129078684|NCT03926117|464577349|FG003|Overall Study|Adverse Event|1|||
129078685|NCT03926117|464577346|FG000|Overall Study|Randomized but not treated|1|||
129078686|NCT03926117|464577347|FG001|Overall Study|Randomized but not treated|1|||
129078687|NCT03926117|464577348|FG002|Overall Study|Randomized but not treated|0|||
129078688|NCT03926117|464577349|FG003|Overall Study|Randomized but not treated|1|||
129078689|NCT04526288|464577353|FG000|Overall Study|Disease Progression|1|||
129078690|NCT04526288|464577354|FG001|Overall Study|Disease Progression|0|||
129078691|NCT02684097|464577357|FG000|Overall Study|Lack of Efficacy|13|||
129078692|NCT02684097|464577358|FG001|Overall Study|Lack of Efficacy|6|||
129078693|NCT00460811|464577359|FG000|Overall Study|Adverse Event|4|||
129078694|NCT00460811|464577360|FG001|Overall Study|Adverse Event|6|||
129078695|NCT00460811|464577361|FG002|Overall Study|Adverse Event|3|||
129078696|NCT00460811|464577362|FG003|Overall Study|Adverse Event|10|||
129078697|NCT00460811|464577363|FG004|Overall Study|Adverse Event|2|||
129078698|NCT00460811|464577359|FG000|Overall Study|Noncompliance|1|||
129078699|NCT00460811|464577360|FG001|Overall Study|Noncompliance|0|||
129078700|NCT00460811|464577361|FG002|Overall Study|Noncompliance|0|||
129078701|NCT00460811|464577362|FG003|Overall Study|Noncompliance|2|||
129078702|NCT00460811|464577363|FG004|Overall Study|Noncompliance|1|||
129078703|NCT00460811|464577359|FG000|Overall Study|Withdrawal by Subject|7|||
129078704|NCT00460811|464577360|FG001|Overall Study|Withdrawal by Subject|7|||
129078705|NCT00460811|464577361|FG002|Overall Study|Withdrawal by Subject|6|||
129078706|NCT00460811|464577362|FG003|Overall Study|Withdrawal by Subject|3|||
129078707|NCT00460811|464577363|FG004|Overall Study|Withdrawal by Subject|11|||
129078708|NCT00460811|464577359|FG000|Overall Study|Physician Decision|1|||
129078709|NCT00460811|464577360|FG001|Overall Study|Physician Decision|0|||
129078710|NCT00460811|464577361|FG002|Overall Study|Physician Decision|0|||
129078711|NCT00460811|464577362|FG003|Overall Study|Physician Decision|0|||
129078712|NCT00460811|464577363|FG004|Overall Study|Physician Decision|0|||
129078713|NCT00460811|464577359|FG000|Overall Study|Lost to Follow-up|3|||
129078714|NCT00460811|464577360|FG001|Overall Study|Lost to Follow-up|2|||
129078715|NCT00460811|464577361|FG002|Overall Study|Lost to Follow-up|5|||
129078716|NCT00460811|464577362|FG003|Overall Study|Lost to Follow-up|3|||
129078717|NCT00460811|464577363|FG004|Overall Study|Lost to Follow-up|6|||
129078718|NCT02748356|464577364|FG000|Overall Study|Withdrawal by Subject|1|||
129078719|NCT00996125|464577365|FG000|Overall Study|Adverse Event|0|||
129078720|NCT00996125|464577366|FG001|Overall Study|Adverse Event|2|||
129078721|NCT00996125|464577365|FG000|Overall Study|Lost to Follow-up|1|||
129078722|NCT00996125|464577366|FG001|Overall Study|Lost to Follow-up|6|||
129078723|NCT00996125|464577365|FG000|Overall Study|Withdrawal by Subject|4|||
129078724|NCT00996125|464577366|FG001|Overall Study|Withdrawal by Subject|3|||
129078725|NCT04331067|464577367|FG000|Overall Study|Adverse Event|1|||
129078726|NCT04331067|464577368|FG001|Overall Study|Adverse Event|3|||
129078727|NCT04331067|464577369|FG002|Overall Study|Adverse Event|1|||
129078728|NCT04331067|464577367|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
129078729|NCT04331067|464577368|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
129078730|NCT04331067|464577369|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
129078731|NCT05870371|464577370|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
129078732|NCT05870371|464577371|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
129078733|NCT02203721|464577373|FG000|Overall Study|Lost to Follow-up|1|||
129078734|NCT02203721|464577374|FG001|Overall Study|Lost to Follow-up|0|||
129078735|NCT02203721|464577373|FG000|Overall Study|Death|0|||
129078736|NCT02203721|464577374|FG001|Overall Study|Death|2|||
129078737|NCT02203721|464577373|FG000|Overall Study|Illness|0|||
129078738|NCT02203721|464577374|FG001|Overall Study|Illness|1|||
129078739|NCT00708461|464577375|FG000|Overall Study|Lost to Follow-up|18|||
129078740|NCT00708461|464577376|FG001|Overall Study|Lost to Follow-up|11|||
129078741|NCT00708461|464577375|FG000|Overall Study|Withdrawal by Subject|8|||
129078742|NCT00708461|464577376|FG001|Overall Study|Withdrawal by Subject|9|||
129078743|NCT00708461|464577375|FG000|Overall Study|left workforce|115|||
129078744|NCT00708461|464577376|FG001|Overall Study|left workforce|180|||
129078745|NCT01796392|464577381|FG000|Overall Study|Withdrawal by Subject|2|||
129078746|NCT01796392|464577382|FG001|Overall Study|Withdrawal by Subject|0|||
129078747|NCT01796392|464577381|FG000|Overall Study|Death|5|||
129078748|NCT01796392|464577382|FG001|Overall Study|Death|1|||
129078749|NCT01796392|464577381|FG000|Overall Study|Excluded for medical reasons|1|||
129078750|NCT01796392|464577382|FG001|Overall Study|Excluded for medical reasons|2|||
129078751|NCT01796392|464577381|FG000|Overall Study|Lost to Follow-up|1|||
129078752|NCT01796392|464577382|FG001|Overall Study|Lost to Follow-up|0|||
129078753|NCT03517540|464577385|FG000|Overall Study|Protocol Violation|2|||
129078754|NCT03517540|464577386|FG001|Overall Study|Protocol Violation|0|||
129078755|NCT03517540|464577387|FG002|Overall Study|Protocol Violation|0|||
129078756|NCT03517540|464577388|FG003|Overall Study|Protocol Violation|1|||
129078757|NCT03517540|464577385|FG000|Overall Study|Adverse Event|9|||
129078758|NCT03517540|464577386|FG001|Overall Study|Adverse Event|3|||
129078759|NCT03517540|464577387|FG002|Overall Study|Adverse Event|8|||
129078760|NCT03517540|464577388|FG003|Overall Study|Adverse Event|1|||
129078761|NCT03517540|464577385|FG000|Overall Study|Withdrawal by Subject|3|||
129078762|NCT03517540|464577386|FG001|Overall Study|Withdrawal by Subject|4|||
129078763|NCT03517540|464577387|FG002|Overall Study|Withdrawal by Subject|1|||
129078764|NCT03517540|464577388|FG003|Overall Study|Withdrawal by Subject|3|||
129078765|NCT01779440|464577391|FG000|Overall Study|Withdrawal by Subject|3|||
129078766|NCT01779440|464577392|FG001|Overall Study|Withdrawal by Subject|5|||
129078767|NCT01205269|464577393|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129078768|NCT01205269|464577394|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129078769|NCT01205269|464577395|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129078770|NCT01205269|464577396|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
129078771|NCT01205269|464577397|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129078772|NCT01205269|464577398|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129078773|NCT01408303|464577399|FG000|Overall Study|Adverse Event|3|||
129078774|NCT01408303|464577400|FG001|Overall Study|Adverse Event|7|||
129078775|NCT01408303|464577401|FG002|Overall Study|Adverse Event|2|||
129078776|NCT01408303|464577399|FG000|Overall Study|Lost to Follow-up|0|||
129078777|NCT01408303|464577400|FG001|Overall Study|Lost to Follow-up|1|||
129078778|NCT01408303|464577401|FG002|Overall Study|Lost to Follow-up|2|||
129078779|NCT01408303|464577399|FG000|Overall Study|Withdrawal by Subject|2|||
129078780|NCT01408303|464577400|FG001|Overall Study|Withdrawal by Subject|3|||
129078781|NCT01408303|464577401|FG002|Overall Study|Withdrawal by Subject|1|||
129078782|NCT01408303|464577399|FG000|Overall Study|Protocol Violation|0|||
129078783|NCT01408303|464577400|FG001|Overall Study|Protocol Violation|1|||
129078784|NCT01408303|464577401|FG002|Overall Study|Protocol Violation|0|||
129078785|NCT01408303|464577399|FG000|Overall Study|Noncompliance|1|||
129078786|NCT01408303|464577400|FG001|Overall Study|Noncompliance|0|||
129078787|NCT01408303|464577401|FG002|Overall Study|Noncompliance|1|||
129078788|NCT01207687|464577402|FG000|Overall Study|Adverse Event|1|||
129078789|NCT01207687|464577402|FG000|Overall Study|Withdrawal by Subject|1|||
129078790|NCT01486446|464577403|FG000|Overall Study|Adverse Event|1|||
129078791|NCT01486446|464577404|FG001|Overall Study|Adverse Event|0|||
129078792|NCT00523848|464577405|FG000|Overall Study|Adverse Event|11|||
129078793|NCT00523848|464577405|FG000|Overall Study|Withdrawal by Subject|2|||
129078794|NCT00523848|464577405|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
129078795|NCT00523848|464577405|FG000|Overall Study|Disease Progression|5|||
129078796|NCT00523848|464577405|FG000|Overall Study|Other, unspecified|4|||
129078797|NCT01801865|464577406|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
129078798|NCT01801865|464577406|FG000|Overall Study|Physician Decision|7|||
129078799|NCT01367886|464577407|FG000|Overall Study|Lost to Follow-up|4|||
129078800|NCT01367886|464577407|FG000|Overall Study|Lack of Efficacy|2|||
129078801|NCT01367886|464577407|FG000|Overall Study|Death|1|||
129078802|NCT00985504|464577414|FG000|Acute Treatment Period|Adverse Event|3|||
129078803|NCT00985504|464577415|FG001|Acute Treatment Period|Adverse Event|4|||
129078804|NCT00985504|464577414|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
129078805|NCT00985504|464577415|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
129078806|NCT00985504|464577414|FG000|Acute Treatment Period|Protocol Violation|2|||
129078807|NCT00985504|464577415|FG001|Acute Treatment Period|Protocol Violation|0|||
129078808|NCT00985504|464577414|FG000|Acute Treatment Period|Sponsor Decision|0|||
129078809|NCT00985504|464577415|FG001|Acute Treatment Period|Sponsor Decision|1|||
129078810|NCT00985504|464577414|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
129078811|NCT00985504|464577415|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
129078812|NCT00985504|464577414|FG000|Optimization Period|Adverse Event|7|||
129078813|NCT00985504|464577415|FG001|Optimization Period|Adverse Event|9|||
129078814|NCT00985504|464577414|FG000|Optimization Period|Death|0|||
129078815|NCT00985504|464577415|FG001|Optimization Period|Death|1|||
129078816|NCT00985504|464577414|FG000|Optimization Period|Lack of Efficacy|5|||
129078817|NCT00985504|464577415|FG001|Optimization Period|Lack of Efficacy|3|||
129078818|NCT00985504|464577414|FG000|Optimization Period|Lost to Follow-up|0|||
129078819|NCT00985504|464577415|FG001|Optimization Period|Lost to Follow-up|1|||
129078820|NCT00985504|464577414|FG000|Optimization Period|Physician Decision|1|||
129078821|NCT00985504|464577415|FG001|Optimization Period|Physician Decision|0|||
129078822|NCT00985504|464577414|FG000|Optimization Period|Protocol Violation|3|||
129078823|NCT00985504|464577415|FG001|Optimization Period|Protocol Violation|1|||
129078824|NCT00985504|464577414|FG000|Optimization Period|Withdrawal by Subject|10|||
129078825|NCT00985504|464577415|FG001|Optimization Period|Withdrawal by Subject|8|||
129078826|NCT03711786|464577416|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
129078827|NCT03711786|464577417|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
129078828|NCT03711786|464577416|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
129078829|NCT03711786|464577417|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
129078830|NCT03711786|464577416|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
129078831|NCT03711786|464577417|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
129078832|NCT03711786|464577416|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
129078833|NCT03711786|464577417|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
129078834|NCT03711786|464577416|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
129078835|NCT03711786|464577417|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
129078836|NCT03711786|464577416|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
129078837|NCT03711786|464577417|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
129078838|NCT03379727|464577421|FG000|Overall Study|Lack of Efficacy|73|||
129078839|NCT03379727|464577421|FG000|Overall Study|Adverse Event|32|||
129078840|NCT03379727|464577421|FG000|Overall Study|Death|18|||
129078841|NCT03379727|464577421|FG000|Overall Study|Patient/guardian decision|17|||
129078842|NCT03379727|464577421|FG000|Overall Study|Physician Decision|104|||
129078843|NCT03379727|464577421|FG000|Overall Study|Protocol Violation|4|||
129078844|NCT03379727|464577421|FG000|Overall Study|Lost to Follow-up|1|||
129078845|NCT04031846|464577422|FG000|Overall Study|Lost to Follow-up|4|||
129078846|NCT04031846|464577423|FG001|Overall Study|Lost to Follow-up|4|||
129078847|NCT04031846|464577422|FG000|Overall Study|Physician Decision|0|||
129078848|NCT04031846|464577423|FG001|Overall Study|Physician Decision|1|||
129078849|NCT04031846|464577422|FG000|Overall Study|Protocol Violation|1|||
129078850|NCT04031846|464577423|FG001|Overall Study|Protocol Violation|1|||
129078851|NCT04031846|464577422|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
129078852|NCT04031846|464577423|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
129078853|NCT06868654|464577424|FG000|Overall Study|Death|4|||
129078854|NCT06868654|464577425|FG001|Overall Study|Death|14|||
129078855|NCT06868654|464577424|FG000|Overall Study|Lost to Follow-up|0|||
129078856|NCT06868654|464577425|FG001|Overall Study|Lost to Follow-up|1|||
129078857|NCT06868654|464577424|FG000|Overall Study|Withdrawal by Subject|5|||
129078858|NCT06868654|464577425|FG001|Overall Study|Withdrawal by Subject|3|||
129078859|NCT06868654|464577424|FG000|Overall Study|Physician Decision|0|||
129078860|NCT06868654|464577425|FG001|Overall Study|Physician Decision|1|||
129078861|NCT06868654|464577424|FG000|Overall Study|Ongoing|23|||
129078862|NCT06868654|464577425|FG001|Overall Study|Ongoing|21|||
129078863|NCT01777282|464577432|FG000|Overall Study|Persistent Hyperglycemia|0|||
129078864|NCT01777282|464577433|FG001|Overall Study|Persistent Hyperglycemia|0|||
129078865|NCT01777282|464577434|FG002|Overall Study|Persistent Hyperglycemia|1|||
129078866|NCT01777282|464577435|FG003|Overall Study|Persistent Hyperglycemia|0|||
129078867|NCT01777282|464577436|FG004|Overall Study|Persistent Hyperglycemia|0|||
129078868|NCT01777282|464577432|FG000|Overall Study|New Antidiabetic Medication|0|||
129078869|NCT01777282|464577433|FG001|Overall Study|New Antidiabetic Medication|0|||
129078870|NCT01777282|464577434|FG002|Overall Study|New Antidiabetic Medication|1|||
129078871|NCT01777282|464577435|FG003|Overall Study|New Antidiabetic Medication|0|||
129078872|NCT01777282|464577436|FG004|Overall Study|New Antidiabetic Medication|0|||
129078873|NCT01777282|464577432|FG000|Overall Study|Adverse Event|4|||
129078874|NCT01777282|464577433|FG001|Overall Study|Adverse Event|4|||
129078875|NCT01777282|464577434|FG002|Overall Study|Adverse Event|2|||
129078876|NCT01777282|464577435|FG003|Overall Study|Adverse Event|1|||
129078877|NCT01777282|464577436|FG004|Overall Study|Adverse Event|3|||
129078878|NCT01777282|464577432|FG000|Overall Study|Withdrawal by Subject|4|||
129078879|NCT01777282|464577433|FG001|Overall Study|Withdrawal by Subject|0|||
129078880|NCT01777282|464577434|FG002|Overall Study|Withdrawal by Subject|0|||
129078881|NCT01777282|464577435|FG003|Overall Study|Withdrawal by Subject|1|||
129078882|NCT01777282|464577436|FG004|Overall Study|Withdrawal by Subject|2|||
129078883|NCT01777282|464577432|FG000|Overall Study|Protocol Violation|2|||
129078884|NCT01777282|464577433|FG001|Overall Study|Protocol Violation|0|||
129078885|NCT01777282|464577434|FG002|Overall Study|Protocol Violation|1|||
129078886|NCT01777282|464577435|FG003|Overall Study|Protocol Violation|0|||
129078887|NCT01777282|464577436|FG004|Overall Study|Protocol Violation|2|||
129078888|NCT01777282|464577432|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
129078889|NCT01777282|464577433|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
129078890|NCT01777282|464577434|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
129078891|NCT01777282|464577435|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
129078892|NCT01777282|464577436|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
129078893|NCT01131455|464577437|FG000|Overall Study|Death of PI|6|||
129078894|NCT01131455|464577438|FG001|Overall Study|Death of PI|4|||
129078895|NCT01131455|464577439|FG002|Overall Study|Death of PI|0|||
129078896|NCT00764660|464577440|FG000|Overall Study|Adverse Event|6|||
129078897|NCT00764660|464577441|FG001|Overall Study|Adverse Event|3|||
129078898|NCT00764660|464577440|FG000|Overall Study|Lost to Follow-up|3|||
129078899|NCT00764660|464577441|FG001|Overall Study|Lost to Follow-up|4|||
129078900|NCT00764660|464577440|FG000|Overall Study|Withdrawal by Subject|7|||
129078901|NCT00764660|464577441|FG001|Overall Study|Withdrawal by Subject|3|||
129078902|NCT00764660|464577440|FG000|Overall Study|Noncompliance With Protocol|5|||
129078903|NCT00764660|464577441|FG001|Overall Study|Noncompliance With Protocol|1|||
129078904|NCT00764660|464577440|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
129078905|NCT00764660|464577441|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
129078906|NCT03103152|464577442|FG000|Overall Study|Physician Decision|5|||
129078907|NCT03103152|464577443|FG001|Overall Study|Physician Decision|2|||
129078908|NCT03103152|464577444|FG002|Overall Study|Physician Decision|6|||
129078909|NCT03103152|464577445|FG003|Overall Study|Physician Decision|3|||
129078910|NCT03103152|464577446|FG004|Overall Study|Physician Decision|3|||
129078911|NCT03103152|464577447|FG005|Overall Study|Physician Decision|1|||
129078912|NCT03103152|464577442|FG000|Overall Study|Protocol Violation|2|||
129078913|NCT03103152|464577443|FG001|Overall Study|Protocol Violation|2|||
129078914|NCT03103152|464577444|FG002|Overall Study|Protocol Violation|1|||
129078915|NCT03103152|464577445|FG003|Overall Study|Protocol Violation|2|||
129078916|NCT03103152|464577446|FG004|Overall Study|Protocol Violation|1|||
129078917|NCT03103152|464577447|FG005|Overall Study|Protocol Violation|1|||
129078918|NCT03103152|464577442|FG000|Overall Study|Inter-current illness|0|||
129078919|NCT03103152|464577443|FG001|Overall Study|Inter-current illness|0|||
129078920|NCT03103152|464577444|FG002|Overall Study|Inter-current illness|1|||
129078921|NCT03103152|464577445|FG003|Overall Study|Inter-current illness|0|||
129078922|NCT03103152|464577446|FG004|Overall Study|Inter-current illness|0|||
129078923|NCT03103152|464577447|FG005|Overall Study|Inter-current illness|0|||
129078924|NCT03103152|464577442|FG000|Overall Study|Death|0|||
129078925|NCT03103152|464577443|FG001|Overall Study|Death|1|||
129078926|NCT03103152|464577444|FG002|Overall Study|Death|0|||
129078927|NCT03103152|464577445|FG003|Overall Study|Death|0|||
129078928|NCT03103152|464577446|FG004|Overall Study|Death|0|||
129078929|NCT03103152|464577447|FG005|Overall Study|Death|0|||
129078930|NCT03103152|464577442|FG000|Overall Study|Adverse Event|0|||
129078931|NCT03103152|464577443|FG001|Overall Study|Adverse Event|0|||
129141948|NCT04616196|464815605|FG001|Overall Study|Death|4|||
129141949|NCT04616196|464815606|FG002|Overall Study|Death|1|||
129141950|NCT04616196|464815607|FG003|Overall Study|Death|0|||
129141951|NCT04616196|464815604|FG000|Overall Study|Withdrawal by Subject|0|||
129078932|NCT03103152|464577444|FG002|Overall Study|Adverse Event|1|||
129078933|NCT03103152|464577445|FG003|Overall Study|Adverse Event|0|||
129078934|NCT03103152|464577446|FG004|Overall Study|Adverse Event|0|||
129078935|NCT03103152|464577447|FG005|Overall Study|Adverse Event|1|||
129078936|NCT03103152|464577442|FG000|Overall Study|Withdrawal by Subject|1|||
129078937|NCT03103152|464577443|FG001|Overall Study|Withdrawal by Subject|0|||
129078938|NCT03103152|464577444|FG002|Overall Study|Withdrawal by Subject|1|||
129078939|NCT03103152|464577445|FG003|Overall Study|Withdrawal by Subject|1|||
129078940|NCT03103152|464577446|FG004|Overall Study|Withdrawal by Subject|1|||
129078941|NCT03103152|464577447|FG005|Overall Study|Withdrawal by Subject|1|||
129078942|NCT03103152|464577442|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
129078943|NCT03103152|464577443|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
129078944|NCT03103152|464577444|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
129078945|NCT03103152|464577445|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
129078946|NCT03103152|464577446|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
129078947|NCT03103152|464577447|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
129078948|NCT03103152|464577442|FG000|Overall Study|Unacceptable side effects|0|||
129078949|NCT03103152|464577443|FG001|Overall Study|Unacceptable side effects|0|||
129078950|NCT03103152|464577444|FG002|Overall Study|Unacceptable side effects|0|||
129078951|NCT03103152|464577445|FG003|Overall Study|Unacceptable side effects|0|||
129141952|NCT04616196|464815605|FG001|Overall Study|Withdrawal by Subject|2|||
129141953|NCT04616196|464815606|FG002|Overall Study|Withdrawal by Subject|0|||
129141954|NCT04616196|464815607|FG003|Overall Study|Withdrawal by Subject|0|||
129141955|NCT04616196|464815604|FG000|Overall Study|Lost to Follow-up|1|||
129141956|NCT04616196|464815605|FG001|Overall Study|Lost to Follow-up|0|||
129141957|NCT04616196|464815606|FG002|Overall Study|Lost to Follow-up|0|||
129141958|NCT04616196|464815607|FG003|Overall Study|Lost to Follow-up|0|||
129141959|NCT04616196|464815604|FG000|Overall Study|Sponsor request|2|||
129141960|NCT04616196|464815605|FG001|Overall Study|Sponsor request|1|||
129141961|NCT04616196|464815606|FG002|Overall Study|Sponsor request|1|||
129141962|NCT04616196|464815607|FG003|Overall Study|Sponsor request|2|||
129141963|NCT05401409|464815608|FG000|Overall Study|Lost to Follow-up|1|||
129141964|NCT05401409|464815609|FG001|Overall Study|Lost to Follow-up|0|||
129141965|NCT02371889|464815610|FG000|Overall Study|Adverse medication effect|11|||
129141966|NCT02371889|464815611|FG001|Overall Study|Adverse medication effect|2|||
129141967|NCT02371889|464815610|FG000|Overall Study|Lost to Follow-up|6|||
129078952|NCT03103152|464577446|FG004|Overall Study|Unacceptable side effects|0|||
129078953|NCT03103152|464577447|FG005|Overall Study|Unacceptable side effects|1|||
129078954|NCT03103152|464577442|FG000|Overall Study|Lost to Follow-up|0|||
129078955|NCT03103152|464577443|FG001|Overall Study|Lost to Follow-up|1|||
129078956|NCT03103152|464577444|FG002|Overall Study|Lost to Follow-up|0|||
129078957|NCT03103152|464577445|FG003|Overall Study|Lost to Follow-up|1|||
129078958|NCT03103152|464577446|FG004|Overall Study|Lost to Follow-up|0|||
129141968|NCT02371889|464815611|FG001|Overall Study|Lost to Follow-up|5|||
129141969|NCT02371889|464815610|FG000|Overall Study|Personal time constraints|2|||
129141970|NCT02371889|464815611|FG001|Overall Study|Personal time constraints|4|||
129141971|NCT02371889|464815610|FG000|Overall Study|Lack of Efficacy|0|||
129141972|NCT02371889|464815611|FG001|Overall Study|Lack of Efficacy|2|||
129141973|NCT02371889|464815610|FG000|Overall Study|Relapse|0|||
129078959|NCT03103152|464577447|FG005|Overall Study|Lost to Follow-up|1|||
129078960|NCT03103152|464577442|FG000|Overall Study|Testicular pain|0|||
129078961|NCT03103152|464577443|FG001|Overall Study|Testicular pain|0|||
129078962|NCT03103152|464577444|FG002|Overall Study|Testicular pain|0|||
129078963|NCT03103152|464577445|FG003|Overall Study|Testicular pain|1|||
129078964|NCT03103152|464577446|FG004|Overall Study|Testicular pain|0|||
129078965|NCT03103152|464577447|FG005|Overall Study|Testicular pain|0|||
129078966|NCT00684411|464578809|FG000|Overall Study|New Primary Cancer|1|||
129078967|NCT00684411|464578809|FG000|Overall Study|Disease Progression|10|||
129078968|NCT00684411|464578809|FG000|Overall Study|Adverse Event|1|||
129078969|NCT01344824|464578810|FG000|Overall Study|Adverse Event|15|||
129078970|NCT01344824|464578810|FG000|Overall Study|Withdrawal by Subject|6|||
129078971|NCT01344824|464578810|FG000|Overall Study|Other complicating disease|1|||
129078972|NCT01344824|464578810|FG000|Overall Study|Progression|15|||
129078973|NCT01295671|464578813|FG000|Overall Study|Lost to Follow-up|4|||
129078974|NCT01295671|464578814|FG001|Overall Study|Lost to Follow-up|6|||
129078975|NCT01295671|464578815|FG002|Overall Study|Lost to Follow-up|3|||
129078976|NCT01295671|464578813|FG000|Overall Study|Withdrawal by Subject|3|||
129078977|NCT01295671|464578814|FG001|Overall Study|Withdrawal by Subject|1|||
129078978|NCT01295671|464578815|FG002|Overall Study|Withdrawal by Subject|0|||
129078979|NCT02395848|464578816|FG000|Overall Study|Lost to Follow-up|2|||
129078980|NCT02276560|464578817|FG000|Overall Study|Adverse Event|1|||
129078981|NCT02276560|464578818|FG001|Overall Study|Adverse Event|0|||
129078982|NCT02276560|464578819|FG002|Overall Study|Adverse Event|0|||
129078983|NCT01754129|464578820|FG000|Overall Study|Death|13|||
129078984|NCT01754129|464578820|FG000|Overall Study|Duodopa discontinuation|9|||
129078985|NCT01754129|464578820|FG000|Overall Study|Lost to Follow-up|7|||
129078986|NCT01754129|464578820|FG000|Overall Study|Withdrew consent|1|||
129078987|NCT01754129|464578820|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
129078988|NCT02058537|464578821|FG000|Overall Study|Withdrawal by Subject|1|||
129078989|NCT00651261|464578822|FG000|Overall Study|Adverse Event|32|||
129078990|NCT00651261|464578823|FG001|Overall Study|Adverse Event|22|||
129078991|NCT00651261|464578822|FG000|Overall Study|Death|18|||
129078992|NCT00651261|464578823|FG001|Overall Study|Death|18|||
129078993|NCT00651261|464578822|FG000|Overall Study|Withdrawal by Subject|22|||
129078994|NCT00651261|464578823|FG001|Overall Study|Withdrawal by Subject|40|||
129078995|NCT00651261|464578822|FG000|Overall Study|Induction failure|24|||
129078996|NCT00651261|464578823|FG001|Overall Study|Induction failure|35|||
129078997|NCT00651261|464578822|FG000|Overall Study|Disease progression|58|||
129078998|NCT00651261|464578823|FG001|Overall Study|Disease progression|58|||
129078999|NCT00651261|464578822|FG000|Overall Study|Alternative therapy|109|||
129079000|NCT00651261|464578823|FG001|Overall Study|Alternative therapy|107|||
129079001|NCT00651261|464578822|FG000|Overall Study|Other disease or participant decisions|23|||
129079002|NCT00651261|464578823|FG001|Overall Study|Other disease or participant decisions|23|||
129079003|NCT00651261|464578822|FG000|Overall Study|Never treated|5|||
129079004|NCT00651261|464578823|FG001|Overall Study|Never treated|3|||
129079005|NCT01609010|464578824|FG000|Overall Study|Stable disease (SD)|22|||
129079006|NCT01609010|464578825|FG001|Overall Study|Stable disease (SD)|16|||
129079007|NCT01609010|464578824|FG000|Overall Study|Progressive disease (PD)|8|||
129079008|NCT01609010|464578825|FG001|Overall Study|Progressive disease (PD)|10|||
129079009|NCT01609010|464578824|FG000|Overall Study|Adverse Event|3|||
128724018|NCT00692770|463287309|FG000|Overall Study|Protocol driven decision point|3|||
128724019|NCT00692770|463287310|FG001|Overall Study|Protocol driven decision point|7|||
129079010|NCT01609010|464578825|FG001|Overall Study|Adverse Event|6|||
129079011|NCT01609010|464578824|FG000|Overall Study|Withdrawal by Subject|2|||
129079012|NCT01609010|464578825|FG001|Overall Study|Withdrawal by Subject|2|||
129079013|NCT01609010|464578824|FG000|Overall Study|Other|2|||
129079014|NCT01609010|464578825|FG001|Overall Study|Other|0|||
129079015|NCT01609010|464578824|FG000|Overall Study|Other malignancy|1|||
129079016|NCT01609010|464578825|FG001|Overall Study|Other malignancy|0|||
129079017|NCT01609010|464578824|FG000|Overall Study|Pathology review|2|||
129079018|NCT01609010|464578825|FG001|Overall Study|Pathology review|1|||
129079019|NCT01609010|464578824|FG000|Overall Study|Protocol Violation|1|||
129079020|NCT01609010|464578825|FG001|Overall Study|Protocol Violation|1|||
129079021|NCT01609010|464578824|FG000|Overall Study|New cancer|1|||
129079022|NCT01609010|464578825|FG001|Overall Study|New cancer|0|||
129079023|NCT01609010|464578824|FG000|Overall Study|Lost to Follow-up|1|||
129079024|NCT01609010|464578825|FG001|Overall Study|Lost to Follow-up|1|||
129079025|NCT00687271|464578826|FG000|Overall Study|Adverse Event|1|||
129079026|NCT00687271|464578827|FG001|Overall Study|Adverse Event|3|||
129079027|NCT00687271|464578828|FG002|Overall Study|Adverse Event|1|||
129079028|NCT00687271|464578829|FG003|Overall Study|Adverse Event|0|||
129079029|NCT00687271|464578826|FG000|Overall Study|Lost to Follow-up|0|||
129079030|NCT00687271|464578827|FG001|Overall Study|Lost to Follow-up|1|||
129079031|NCT00687271|464578828|FG002|Overall Study|Lost to Follow-up|0|||
129079032|NCT00687271|464578829|FG003|Overall Study|Lost to Follow-up|0|||
129079033|NCT00687271|464578826|FG000|Overall Study|Protocol Violation|2|||
129079034|NCT00687271|464578827|FG001|Overall Study|Protocol Violation|1|||
129079035|NCT00687271|464578828|FG002|Overall Study|Protocol Violation|1|||
129079036|NCT00687271|464578829|FG003|Overall Study|Protocol Violation|0|||
129079037|NCT00687271|464578826|FG000|Overall Study|Withdrawal by Subject|0|||
129079038|NCT00687271|464578827|FG001|Overall Study|Withdrawal by Subject|1|||
129079039|NCT00687271|464578828|FG002|Overall Study|Withdrawal by Subject|3|||
129079040|NCT00687271|464578829|FG003|Overall Study|Withdrawal by Subject|0|||
129079041|NCT05483686|464578836|FG000|Overall Study|Lost to Follow-up|5|||
129079042|NCT05483686|464578837|FG001|Overall Study|Lost to Follow-up|7|||
129079043|NCT03351608|464578841|FG000|Overall Study|Lost to Follow-up|0|||
129079044|NCT03351608|464578842|FG001|Overall Study|Lost to Follow-up|1|||
129079045|NCT03351608|464578843|FG002|Overall Study|Lost to Follow-up|1|||
129079046|NCT03351608|464578844|FG003|Overall Study|Lost to Follow-up|1|||
129079047|NCT03351608|464578845|FG004|Overall Study|Lost to Follow-up|1|||
129079048|NCT03351608|464578841|FG000|Overall Study|Physician Decision|1|||
129079049|NCT03351608|464578842|FG001|Overall Study|Physician Decision|0|||
129079050|NCT03351608|464578843|FG002|Overall Study|Physician Decision|0|||
129079051|NCT03351608|464578844|FG003|Overall Study|Physician Decision|2|||
129079052|NCT03351608|464578845|FG004|Overall Study|Physician Decision|1|||
129079053|NCT03351608|464578841|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
129079054|NCT03351608|464578842|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
129079055|NCT03351608|464578843|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
129079056|NCT03351608|464578844|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
129079057|NCT03351608|464578845|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
129079058|NCT03351608|464578841|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129079059|NCT03351608|464578842|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129079060|NCT03351608|464578843|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129079061|NCT03351608|464578844|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129079062|NCT03351608|464578845|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129079063|NCT03351608|464578841|FG000|Overall Study|Other|0|||
129079064|NCT03351608|464578842|FG001|Overall Study|Other|1|||
129079065|NCT03351608|464578843|FG002|Overall Study|Other|1|||
129079066|NCT03351608|464578844|FG003|Overall Study|Other|3|||
129079067|NCT03351608|464578845|FG004|Overall Study|Other|0|||
129079068|NCT02727478|464578846|FG000|Overall Study|Withdrawal by Subject|8|||
129079069|NCT02727478|464578847|FG001|Overall Study|Withdrawal by Subject|10|||
129079070|NCT00808210|464578848|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
129079071|NCT00808210|464578849|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
129079072|NCT00808210|464578848|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
129079073|NCT00808210|464578849|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
129079074|NCT00808210|464578848|FG000|Double-Blind TX Period|Adverse Event|0|||
129079075|NCT00808210|464578849|FG001|Double-Blind TX Period|Adverse Event|1|||
129079076|NCT00808210|464578848|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
129079077|NCT00808210|464578849|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
129079078|NCT00808210|464578848|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
129079079|NCT00808210|464578849|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
129079080|NCT00808210|464578848|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
129079081|NCT00808210|464578849|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
129079082|NCT03877068|464578853|FG000|Overall Study|Physician Decision|9|||
129079083|NCT03877068|464578854|FG001|Overall Study|Physician Decision|3|||
129079084|NCT03150719|464578857|FG000|Overall Study|Adverse Event|0|||
129079085|NCT03150719|464578858|FG001|Overall Study|Adverse Event|1|||
129079086|NCT03150719|464578857|FG000|Overall Study|Death|0|||
129079087|NCT03150719|464578858|FG001|Overall Study|Death|1|||
129079088|NCT03150719|464578857|FG000|Overall Study|Other|1|||
129079089|NCT03150719|464578858|FG001|Overall Study|Other|0|||
129079090|NCT00288626|464578863|FG000|Overall Study|Death|3|||
129079091|NCT00288626|464578863|FG000|Overall Study|Withdrawal by Subject|4|||
129079092|NCT02019264|464578865|FG000|Overall Study|Not treated|6|||
129079093|NCT02019264|464578866|FG001|Overall Study|Not treated|4|||
129079094|NCT02019264|464578865|FG000|Overall Study|Lost to Follow-up|50|||
129079095|NCT02019264|464578866|FG001|Overall Study|Lost to Follow-up|47|||
129079096|NCT02019264|464578865|FG000|Overall Study|Withdrawal by Subject|142|||
129079097|NCT02019264|464578866|FG001|Overall Study|Withdrawal by Subject|117|||
129079098|NCT02019264|464578865|FG000|Overall Study|Administrative reason|36|||
129079099|NCT02019264|464578866|FG001|Overall Study|Administrative reason|28|||
129079100|NCT02019264|464578865|FG000|Overall Study|Missing|14|||
129079101|NCT02019264|464578866|FG001|Overall Study|Missing|11|||
129079102|NCT01964222|464578867|FG000|Overall Study|Lost to Follow-up|7|||
129141974|NCT02371889|464815611|FG001|Overall Study|Relapse|1|||
129141975|NCT02579759|464815612|FG000|Overall Study|Protocol Violation|2|||
129141976|NCT02579759|464815613|FG001|Overall Study|Protocol Violation|0|||
129141977|NCT02579759|464815614|FG002|Overall Study|Protocol Violation|0|||
129141978|NCT02579759|464815612|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
129141979|NCT02579759|464815613|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
129141980|NCT02579759|464815614|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
129141981|NCT02579759|464815612|FG000|Overall Study|BfArM hold|13|||
129141982|NCT02579759|464815613|FG001|Overall Study|BfArM hold|12|||
129079103|NCT01964222|464578868|FG001|Overall Study|Lost to Follow-up|5|||
129079104|NCT01964222|464578867|FG000|Overall Study|Withdrawal by Subject|6|||
129079105|NCT01964222|464578868|FG001|Overall Study|Withdrawal by Subject|6|||
129079106|NCT01964222|464578867|FG000|Overall Study|Screening Failure|2|||
129079107|NCT01964222|464578868|FG001|Overall Study|Screening Failure|0|||
129079108|NCT01737710|464578869|FG000|Overall Study|Lost to Follow-up|0|||
129079109|NCT01737710|464578870|FG001|Overall Study|Lost to Follow-up|2|||
129079110|NCT01737710|464578871|FG002|Overall Study|Lost to Follow-up|2|||
129079111|NCT01737710|464578872|FG003|Overall Study|Lost to Follow-up|0|||
129079112|NCT01737710|464578873|FG004|Overall Study|Lost to Follow-up|0|||
129079113|NCT01737710|464578869|FG000|Overall Study|Withdrawal by Subject|1|||
129079114|NCT01737710|464578870|FG001|Overall Study|Withdrawal by Subject|1|||
129079115|NCT01737710|464578871|FG002|Overall Study|Withdrawal by Subject|1|||
129079116|NCT01737710|464578872|FG003|Overall Study|Withdrawal by Subject|0|||
129079117|NCT01737710|464578873|FG004|Overall Study|Withdrawal by Subject|0|||
129079118|NCT01737710|464578869|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
129079119|NCT01737710|464578870|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
129079120|NCT01737710|464578871|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
129079121|NCT01737710|464578872|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
129079122|NCT01737710|464578873|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
129079123|NCT03363776|464578874|FG000|Overall Study|Progressive disease|2|||
129079124|NCT03363776|464578875|FG001|Overall Study|Progressive disease|3|||
129079125|NCT03363776|464578876|FG002|Overall Study|Progressive disease|1|||
129079126|NCT03363776|464578874|FG000|Overall Study|Study drug toxicity|0|||
129079127|NCT03363776|464578875|FG001|Overall Study|Study drug toxicity|0|||
129079128|NCT03363776|464578876|FG002|Overall Study|Study drug toxicity|1|||
129079129|NCT03363776|464578874|FG000|Overall Study|Death|1|||
129079130|NCT03363776|464578875|FG001|Overall Study|Death|0|||
129079131|NCT03363776|464578876|FG002|Overall Study|Death|0|||
129079132|NCT00410813|464578884|FG000|Overall Study|Adverse Event|6|||
129079133|NCT00410813|464578885|FG001|Overall Study|Adverse Event|11|||
129079134|NCT00410813|464578884|FG000|Overall Study|Progression|32|||
129079135|NCT00410813|464578885|FG001|Overall Study|Progression|21|||
129079136|NCT00410813|464578884|FG000|Overall Study|Not protocol specified|3|||
129079137|NCT00410813|464578885|FG001|Overall Study|Not protocol specified|4|||
129141983|NCT02579759|464815614|FG002|Overall Study|BfArM hold|12|||
129141984|NCT02579759|464815612|FG000|Overall Study|Sponsor stopped Dose 2|0|||
129141985|NCT02579759|464815613|FG001|Overall Study|Sponsor stopped Dose 2|41|||
129141986|NCT02579759|464815614|FG002|Overall Study|Sponsor stopped Dose 2|0|||
129141987|NCT02579759|464815612|FG000|Overall Study|Non compliance|0|||
129141988|NCT02579759|464815613|FG001|Overall Study|Non compliance|1|||
129141989|NCT02579759|464815614|FG002|Overall Study|Non compliance|0|||
129141990|NCT02579759|464815612|FG000|Overall Study|Pregnancy|0|||
129141991|NCT02579759|464815613|FG001|Overall Study|Pregnancy|1|||
129141992|NCT02579759|464815614|FG002|Overall Study|Pregnancy|0|||
129141993|NCT02579759|464815612|FG000|Overall Study|Inclusion/exclusion criteria|0|||
129141994|NCT02579759|464815613|FG001|Overall Study|Inclusion/exclusion criteria|0|||
129141995|NCT02579759|464815614|FG002|Overall Study|Inclusion/exclusion criteria|1|||
129141996|NCT02579759|464815612|FG000|Overall Study|Adverse Event|4|||
129141997|NCT02579759|464815613|FG001|Overall Study|Adverse Event|3|||
129141998|NCT02579759|464815614|FG002|Overall Study|Adverse Event|1|||
129141999|NCT02579759|464815612|FG000|Overall Study|Withdrawal by Subject|3|||
129142000|NCT02579759|464815613|FG001|Overall Study|Withdrawal by Subject|3|||
129142001|NCT02579759|464815614|FG002|Overall Study|Withdrawal by Subject|5|||
129142002|NCT02579759|464815612|FG000|Overall Study|Lost to Follow-up|2|||
129142003|NCT02579759|464815613|FG001|Overall Study|Lost to Follow-up|2|||
129142004|NCT02579759|464815614|FG002|Overall Study|Lost to Follow-up|2|||
129142005|NCT02410200|464815617|FG000|Overall Study|Adverse Event|2|||
129142006|NCT02801578|464815622|FG000|Overall Study|Adverse Event|2|||
129142007|NCT00668642|464815623|FG000|First Off-cycle|Cancer progression|1|||
129142008|NCT00668642|464815624|FG001|First Off-cycle|Cancer progression|0|||
129142009|NCT00668642|464815623|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
129142010|NCT00668642|464815624|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
129142011|NCT03412591|464815625|FG000|Overall Study|Withdrawal by Subject|1|||
129142012|NCT03412591|464815626|FG001|Overall Study|Withdrawal by Subject|8|||
129142013|NCT03412591|464815625|FG000|Overall Study|Adverse Event|0|||
129142014|NCT03412591|464815626|FG001|Overall Study|Adverse Event|1|||
129142015|NCT02272985|464815627|FG000|Overall Study|Withdrawal by Subject|1|||
129142016|NCT02272985|464815627|FG000|Overall Study|hip fracture|1|||
129142017|NCT02272985|464815627|FG000|Overall Study|kidney transplantation|1|||
129142018|NCT00770679|464815628|FG000|Overall Study|Lost to Follow-up|3|||
129142019|NCT00770679|464815628|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
129142020|NCT00266032|464815634|FG000|Treatment|Adverse Event|42|||
129142021|NCT00266032|464815635|FG001|Treatment|Adverse Event|26|||
129142022|NCT00266032|464815636|FG002|Treatment|Adverse Event|10|||
129142023|NCT00266032|464815634|FG000|Treatment|Lost to Follow-up|19|||
129142024|NCT00266032|464815635|FG001|Treatment|Lost to Follow-up|4|||
129142025|NCT00266032|464815636|FG002|Treatment|Lost to Follow-up|2|||
129142026|NCT00266032|464815634|FG000|Treatment|Pregnancy|3|||
129142027|NCT00266032|464815635|FG001|Treatment|Pregnancy|2|||
129142028|NCT00266032|464815636|FG002|Treatment|Pregnancy|2|||
129142029|NCT00266032|464815634|FG000|Treatment|Protocol Violation|6|||
129142030|NCT00266032|464815635|FG001|Treatment|Protocol Violation|14|||
129142031|NCT00266032|464815636|FG002|Treatment|Protocol Violation|13|||
129142032|NCT00266032|464815634|FG000|Treatment|Withdrawal by Subject|28|||
129142033|NCT00266032|464815635|FG001|Treatment|Withdrawal by Subject|13|||
129142034|NCT00266032|464815636|FG002|Treatment|Withdrawal by Subject|12|||
129142035|NCT00266032|464815634|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
129142036|NCT00266032|464815635|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
129142037|NCT00266032|464815636|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
129142038|NCT00266032|464815634|FG000|Open-label Safety Extension|Adverse Event|5|||
129142039|NCT00266032|464815635|FG001|Open-label Safety Extension|Adverse Event|0|||
129142040|NCT00266032|464815636|FG002|Open-label Safety Extension|Adverse Event|4|||
129142041|NCT00266032|464815634|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
129142042|NCT00266032|464815635|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
129142043|NCT00266032|464815636|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
129142044|NCT00266032|464815634|FG000|Open-label Safety Extension|Pregnancy|4|||
129142045|NCT00266032|464815635|FG001|Open-label Safety Extension|Pregnancy|1|||
129142046|NCT00266032|464815636|FG002|Open-label Safety Extension|Pregnancy|2|||
129142047|NCT00266032|464815634|FG000|Open-label Safety Extension|Protocol Violation|1|||
129142048|NCT00266032|464815635|FG001|Open-label Safety Extension|Protocol Violation|3|||
129142049|NCT00266032|464815636|FG002|Open-label Safety Extension|Protocol Violation|2|||
129142050|NCT00266032|464815634|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
129142051|NCT00266032|464815635|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
129142052|NCT00266032|464815636|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
129142053|NCT00266032|464815634|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
129142054|NCT00266032|464815635|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
129142055|NCT00266032|464815636|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
129142056|NCT00814983|464815639|FG000|Overall Study|Screen failure|1|||
129142057|NCT00814983|464815640|FG001|Overall Study|Screen failure|0|||
129142058|NCT00814983|464815639|FG000|Overall Study|Withdrawal by Subject|1|||
129142059|NCT00814983|464815640|FG001|Overall Study|Withdrawal by Subject|0|||
129142060|NCT00814983|464815639|FG000|Overall Study|Graft failure|1|||
129142061|NCT00814983|464815640|FG001|Overall Study|Graft failure|0|||
129142062|NCT03627468|464815641|FG000|Overall Study|Adverse Event|5|||
129142063|NCT03627468|464815642|FG001|Overall Study|Adverse Event|33|||
129142064|NCT03627468|464815641|FG000|Overall Study|Withdrawal by Subject|13|||
129142065|NCT03627468|464815642|FG001|Overall Study|Withdrawal by Subject|23|||
129142066|NCT03627468|464815641|FG000|Overall Study|Physician Decision|1|||
129142067|NCT03627468|464815642|FG001|Overall Study|Physician Decision|0|||
129142068|NCT03627468|464815641|FG000|Overall Study|Protocol Violation|0|||
129142069|NCT03627468|464815642|FG001|Overall Study|Protocol Violation|2|||
129142070|NCT03627468|464815641|FG000|Overall Study|Lost to Follow-up|10|||
129142071|NCT03627468|464815642|FG001|Overall Study|Lost to Follow-up|16|||
129142072|NCT03627468|464815641|FG000|Overall Study|Death|1|||
129142073|NCT03627468|464815642|FG001|Overall Study|Death|0|||
129142074|NCT03627468|464815641|FG000|Overall Study|Pregnancy|1|||
129142075|NCT03627468|464815642|FG001|Overall Study|Pregnancy|1|||
129142076|NCT03627468|464815641|FG000|Overall Study|Lack of Efficacy|0|||
129142077|NCT03627468|464815642|FG001|Overall Study|Lack of Efficacy|2|||
129142078|NCT03627468|464815641|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
129142079|NCT03627468|464815642|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
129142080|NCT04157738|464815643|FG000|Overall Study|Moved out of state|0|||
129142081|NCT04157738|464815644|FG001|Overall Study|Moved out of state|2|||
129142082|NCT04157738|464815643|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
129142083|NCT04157738|464815644|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
129142084|NCT00160563|464815645|FG000|Overall Study|Adverse Event|1|||
129142085|NCT00160563|464815646|FG001|Overall Study|Adverse Event|1|||
129142086|NCT00160563|464815647|FG002|Overall Study|Adverse Event|1|||
129142087|NCT00160563|464815645|FG000|Overall Study|Lost to Follow-up|1|||
129142088|NCT00160563|464815646|FG001|Overall Study|Lost to Follow-up|1|||
129142089|NCT00160563|464815647|FG002|Overall Study|Lost to Follow-up|2|||
129142090|NCT00160563|464815645|FG000|Overall Study|Protocol Violation|0|||
129142091|NCT00160563|464815646|FG001|Overall Study|Protocol Violation|0|||
129142092|NCT00160563|464815647|FG002|Overall Study|Protocol Violation|3|||
129142093|NCT00160563|464815645|FG000|Overall Study|Withdrawal by Subject|1|||
129142094|NCT00160563|464815646|FG001|Overall Study|Withdrawal by Subject|2|||
129142095|NCT00160563|464815647|FG002|Overall Study|Withdrawal by Subject|3|||
129142096|NCT00160563|464815645|FG000|Overall Study|Other (listed in the study report)|48|||
129142097|NCT00160563|464815646|FG001|Overall Study|Other (listed in the study report)|40|||
129142098|NCT00160563|464815647|FG002|Overall Study|Other (listed in the study report)|81|||
129142099|NCT00160563|464815645|FG000|Overall Study|Missing reason|0|||
129142100|NCT00160563|464815646|FG001|Overall Study|Missing reason|1|||
129142101|NCT00160563|464815647|FG002|Overall Study|Missing reason|0|||
129142102|NCT01514357|464815651|FG000|Overall Study|Screen failure|2|||
129142103|NCT01514357|464815652|FG001|Overall Study|Screen failure|0|||
129142104|NCT01514357|464815651|FG000|Overall Study|Withdrawal by Subject|2|||
129142105|NCT01514357|464815652|FG001|Overall Study|Withdrawal by Subject|0|||
129142106|NCT00752219|464815653|FG000|Overall Study|Clinical failure|0|||
129142107|NCT00752219|464815654|FG001|Overall Study|Clinical failure|1|||
129142108|NCT00752219|464815653|FG000|Overall Study|Adverse Event|5|||
129142109|NCT00752219|464815654|FG001|Overall Study|Adverse Event|3|||
129142110|NCT00752219|464815653|FG000|Overall Study|Protocol deviation|1|||
129142111|NCT00752219|464815654|FG001|Overall Study|Protocol deviation|0|||
129142112|NCT00752219|464815653|FG000|Overall Study|Lost to Follow-up|1|||
129142113|NCT00752219|464815654|FG001|Overall Study|Lost to Follow-up|2|||
129142114|NCT00752219|464815653|FG000|Overall Study|Randomized but not treated|1|||
129142115|NCT00752219|464815654|FG001|Overall Study|Randomized but not treated|0|||
129142116|NCT00752219|464815653|FG000|Overall Study|Other|3|||
129142117|NCT00752219|464815654|FG001|Overall Study|Other|0|||
128776562|NCT02846558|463470466|FG003|Overall Study|Withdrawal by Subject|2|||
129142118|NCT01047540|464815658|FG000|Overall Study|Protocol Violation|1|||
129142119|NCT01047540|464815659|FG001|Overall Study|Protocol Violation|0|||
129142120|NCT01047540|464815660|FG002|Overall Study|Protocol Violation|0|||
129142121|NCT01047540|464815661|FG003|Overall Study|Protocol Violation|0|||
129142122|NCT01047540|464815662|FG004|Overall Study|Protocol Violation|0|||
129142123|NCT01047540|464815658|FG000|Overall Study|Lost to Follow-up|1|||
129142124|NCT01047540|464815659|FG001|Overall Study|Lost to Follow-up|0|||
129142125|NCT01047540|464815660|FG002|Overall Study|Lost to Follow-up|0|||
129142126|NCT01047540|464815661|FG003|Overall Study|Lost to Follow-up|0|||
129142127|NCT01047540|464815662|FG004|Overall Study|Lost to Follow-up|0|||
129142128|NCT01047540|464815658|FG000|Overall Study|Withdrawal by Subject|1|||
129142129|NCT01047540|464815659|FG001|Overall Study|Withdrawal by Subject|0|||
129142130|NCT01047540|464815660|FG002|Overall Study|Withdrawal by Subject|3|||
129142131|NCT01047540|464815661|FG003|Overall Study|Withdrawal by Subject|0|||
129142132|NCT01047540|464815662|FG004|Overall Study|Withdrawal by Subject|1|||
129142133|NCT01047540|464815658|FG000|Overall Study|Pregnancy|1|||
129079138|NCT00410813|464578884|FG000|Overall Study|Ineligible|2|||
129079139|NCT00410813|464578885|FG001|Overall Study|Ineligible|4|||
129079140|NCT00410813|464578884|FG000|Overall Study|Death|0|||
129079141|NCT00410813|464578885|FG001|Overall Study|Death|2|||
129079142|NCT00812981|464578886|FG000|Overall Study|Other|0|||
129079143|NCT00812981|464578887|FG001|Overall Study|Other|1|||
129079144|NCT02677922|464578892|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
129079145|NCT02677922|464578893|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
129079146|NCT02677922|464578894|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
129079147|NCT02677922|464578895|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
129079148|NCT02677922|464578896|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
129079149|NCT02677922|464578897|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
129079150|NCT02677922|464578892|FG000|Treatment Period|Adverse Event|0|||
129079151|NCT02677922|464578893|FG001|Treatment Period|Adverse Event|0|||
129079152|NCT02677922|464578894|FG002|Treatment Period|Adverse Event|1|||
129079153|NCT02677922|464578895|FG003|Treatment Period|Adverse Event|3|||
129079154|NCT02677922|464578896|FG004|Treatment Period|Adverse Event|5|||
129079155|NCT02677922|464578897|FG005|Treatment Period|Adverse Event|2|||
129079156|NCT02677922|464578892|FG000|Treatment Period|Progressive Disease|1|||
129079157|NCT02677922|464578893|FG001|Treatment Period|Progressive Disease|1|||
129079158|NCT02677922|464578894|FG002|Treatment Period|Progressive Disease|0|||
129079159|NCT02677922|464578895|FG003|Treatment Period|Progressive Disease|0|||
129079160|NCT02677922|464578896|FG004|Treatment Period|Progressive Disease|8|||
129079161|NCT02677922|464578897|FG005|Treatment Period|Progressive Disease|7|||
129079162|NCT02677922|464578892|FG000|Treatment Period|Lack of Efficacy|0|||
129079163|NCT02677922|464578893|FG001|Treatment Period|Lack of Efficacy|0|||
129079164|NCT02677922|464578894|FG002|Treatment Period|Lack of Efficacy|0|||
129079165|NCT02677922|464578895|FG003|Treatment Period|Lack of Efficacy|1|||
129079166|NCT02677922|464578896|FG004|Treatment Period|Lack of Efficacy|1|||
129079167|NCT02677922|464578897|FG005|Treatment Period|Lack of Efficacy|6|||
129079168|NCT02677922|464578892|FG000|Treatment Period|Withdrawal by Subject|0|||
129079169|NCT02677922|464578893|FG001|Treatment Period|Withdrawal by Subject|0|||
129079170|NCT02677922|464578894|FG002|Treatment Period|Withdrawal by Subject|1|||
129079171|NCT02677922|464578895|FG003|Treatment Period|Withdrawal by Subject|3|||
129079172|NCT02677922|464578896|FG004|Treatment Period|Withdrawal by Subject|5|||
129079173|NCT02677922|464578897|FG005|Treatment Period|Withdrawal by Subject|5|||
129079174|NCT02677922|464578892|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
129079175|NCT02677922|464578893|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
129079176|NCT02677922|464578894|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
129079177|NCT02677922|464578895|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
129079178|NCT02677922|464578896|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
129079179|NCT02677922|464578897|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
129079180|NCT02677922|464578892|FG000|Treatment Period|Disease Relapse|0|||
129079181|NCT02677922|464578893|FG001|Treatment Period|Disease Relapse|0|||
129079182|NCT02677922|464578894|FG002|Treatment Period|Disease Relapse|0|||
129079183|NCT02677922|464578895|FG003|Treatment Period|Disease Relapse|3|||
129079184|NCT02677922|464578896|FG004|Treatment Period|Disease Relapse|6|||
129079185|NCT02677922|464578897|FG005|Treatment Period|Disease Relapse|1|||
129079186|NCT02677922|464578892|FG000|Treatment Period|Allogeneic HSCT|1|||
129079187|NCT02677922|464578893|FG001|Treatment Period|Allogeneic HSCT|0|||
129079188|NCT02677922|464578894|FG002|Treatment Period|Allogeneic HSCT|0|||
129079189|NCT02677922|464578895|FG003|Treatment Period|Allogeneic HSCT|1|||
129079190|NCT02677922|464578896|FG004|Treatment Period|Allogeneic HSCT|4|||
129079191|NCT02677922|464578897|FG005|Treatment Period|Allogeneic HSCT|1|||
129079192|NCT02677922|464578892|FG000|Treatment Period|Other Reasons|0|||
129079193|NCT02677922|464578893|FG001|Treatment Period|Other Reasons|0|||
129079194|NCT02677922|464578894|FG002|Treatment Period|Other Reasons|0|||
129079195|NCT02677922|464578895|FG003|Treatment Period|Other Reasons|1|||
129079196|NCT02677922|464578896|FG004|Treatment Period|Other Reasons|3|||
129079197|NCT02677922|464578897|FG005|Treatment Period|Other Reasons|5|||
129079198|NCT02677922|464578892|FG000|Treatment Period|Death|0|||
129079199|NCT02677922|464578893|FG001|Treatment Period|Death|0|||
129079200|NCT02677922|464578894|FG002|Treatment Period|Death|0|||
129079201|NCT02677922|464578895|FG003|Treatment Period|Death|0|||
129142134|NCT01047540|464815659|FG001|Overall Study|Pregnancy|0|||
129142135|NCT01047540|464815660|FG002|Overall Study|Pregnancy|0|||
129079202|NCT02677922|464578896|FG004|Treatment Period|Death|12|||
129079203|NCT02677922|464578897|FG005|Treatment Period|Death|1|||
129079204|NCT02677922|464578892|FG000|Treatment Period|Non-compliance with Study Drug|0|||
129079205|NCT02677922|464578893|FG001|Treatment Period|Non-compliance with Study Drug|0|||
129079206|NCT02677922|464578894|FG002|Treatment Period|Non-compliance with Study Drug|0|||
129079207|NCT02677922|464578895|FG003|Treatment Period|Non-compliance with Study Drug|0|||
129079208|NCT02677922|464578896|FG004|Treatment Period|Non-compliance with Study Drug|1|||
129079209|NCT02677922|464578897|FG005|Treatment Period|Non-compliance with Study Drug|0|||
129079210|NCT02677922|464578892|FG000|Treatment Period|Physician Decision|0|||
129142136|NCT01047540|464815661|FG003|Overall Study|Pregnancy|0|||
129079211|NCT02677922|464578893|FG001|Treatment Period|Physician Decision|0|||
129142137|NCT01047540|464815662|FG004|Overall Study|Pregnancy|0|||
129142138|NCT01047540|464815658|FG000|Overall Study|Adverse Event|1|||
129142139|NCT01047540|464815659|FG001|Overall Study|Adverse Event|0|||
129142140|NCT01047540|464815660|FG002|Overall Study|Adverse Event|0|||
129142141|NCT01047540|464815661|FG003|Overall Study|Adverse Event|0|||
129142142|NCT01047540|464815662|FG004|Overall Study|Adverse Event|0|||
129142143|NCT01437189|464815666|FG000|Overall Study|Adverse Event|3|||
129142144|NCT01437189|464815666|FG000|Overall Study|Lack of Efficacy|4|||
129142145|NCT01437189|464815666|FG000|Overall Study|Withdrawal by Subject|8|||
129142146|NCT00347269|464815667|FG000|Overall Study|Lost to Follow-up|74|||
129142147|NCT00347269|464815668|FG001|Overall Study|Lost to Follow-up|65|||
129142148|NCT00347269|464815667|FG000|Overall Study|Withdrawal by Subject|18|||
129142149|NCT00347269|464815668|FG001|Overall Study|Withdrawal by Subject|38|||
129142150|NCT00347269|464815667|FG000|Overall Study|Death|2|||
129142151|NCT00347269|464815668|FG001|Overall Study|Death|3|||
129142152|NCT03654326|464815669|FG000|Overall Study|Withdrawal by Subject|5|||
129079212|NCT02677922|464578894|FG002|Treatment Period|Physician Decision|0|||
129079213|NCT02677922|464578895|FG003|Treatment Period|Physician Decision|0|||
129079214|NCT02677922|464578896|FG004|Treatment Period|Physician Decision|0|||
129079215|NCT02677922|464578897|FG005|Treatment Period|Physician Decision|1|||
129079216|NCT02677922|464578892|FG000|Treatment Period|Symptomatic Deterioration|0|||
129079217|NCT02677922|464578893|FG001|Treatment Period|Symptomatic Deterioration|0|||
129079218|NCT02677922|464578894|FG002|Treatment Period|Symptomatic Deterioration|0|||
129079219|NCT02677922|464578895|FG003|Treatment Period|Symptomatic Deterioration|0|||
129079220|NCT02677922|464578896|FG004|Treatment Period|Symptomatic Deterioration|1|||
129079221|NCT02677922|464578897|FG005|Treatment Period|Symptomatic Deterioration|0|||
129079222|NCT05310071|464578898|FG000|Overall Study|Death|0|||
129079223|NCT05310071|464578899|FG001|Overall Study|Death|3|||
129079224|NCT05310071|464578898|FG000|Overall Study|Adverse Event|4|||
129079225|NCT05310071|464578899|FG001|Overall Study|Adverse Event|31|||
129079226|NCT05310071|464578898|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
129079227|NCT05310071|464578899|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
129079228|NCT05310071|464578898|FG000|Overall Study|Protocol Deviation|2|||
129079229|NCT05310071|464578899|FG001|Overall Study|Protocol Deviation|0|||
129079230|NCT05310071|464578898|FG000|Overall Study|Randomized by Mistake|0|||
129079231|NCT05310071|464578899|FG001|Overall Study|Randomized by Mistake|1|||
129079232|NCT05310071|464578898|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
129079233|NCT05310071|464578899|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
129079234|NCT05310071|464578898|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
129079235|NCT05310071|464578899|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
129079236|NCT05310071|464578898|FG000|Overall Study|Site Terminated by Sponsor|0|||
129079237|NCT05310071|464578899|FG001|Overall Study|Site Terminated by Sponsor|2|||
129079238|NCT05310071|464578898|FG000|Overall Study|Study Terminated by Sponsor|282|||
129079239|NCT05310071|464578899|FG001|Overall Study|Study Terminated by Sponsor|559|||
129079240|NCT05310071|464578898|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
129079241|NCT05310071|464578899|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
129079242|NCT05310071|464578898|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
129079243|NCT05310071|464578899|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
129079244|NCT05310071|464578898|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
129079245|NCT05310071|464578899|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
129079246|NCT05310071|464578898|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
129079247|NCT05310071|464578899|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
129079248|NCT05310071|464578898|FG000|Overall Study|Withdrawal by Participant - Other|25|||
129079249|NCT05310071|464578899|FG001|Overall Study|Withdrawal by Participant - Other|30|||
129079250|NCT05310071|464578898|FG000|Overall Study|Lost to Follow-up|2|||
129079251|NCT05310071|464578899|FG001|Overall Study|Lost to Follow-up|4|||
129079252|NCT05310071|464578898|FG000|Overall Study|Reason Not Specified|1|||
129079253|NCT05310071|464578899|FG001|Overall Study|Reason Not Specified|3|||
129079254|NCT03515811|464578904|FG000|Overall Study|Lost to Follow-up|2|||
129079255|NCT03515811|464578905|FG001|Overall Study|Lost to Follow-up|1|||
129079256|NCT03515811|464578904|FG000|Overall Study|Protocol Violation|1|||
129079257|NCT03515811|464578905|FG001|Overall Study|Protocol Violation|1|||
129079258|NCT03515811|464578904|FG000|Overall Study|Death|1|||
129079259|NCT03515811|464578905|FG001|Overall Study|Death|1|||
129079260|NCT03515811|464578904|FG000|Overall Study|Withdrawal by Subject|0|||
129079261|NCT03515811|464578905|FG001|Overall Study|Withdrawal by Subject|2|||
129079262|NCT03515811|464578904|FG000|Overall Study|Technical Problems|1|||
129079263|NCT03515811|464578905|FG001|Overall Study|Technical Problems|0|||
129079264|NCT03515811|464578904|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
129079265|NCT03515811|464578905|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
129079266|NCT03515811|464578904|FG000|Overall Study|COVID-19|0|||
129079267|NCT03515811|464578905|FG001|Overall Study|COVID-19|1|||
129079268|NCT05107492|464578906|FG000|Overall Study|Lost to Follow-up|1|||
129079269|NCT05107492|464578907|FG001|Overall Study|Lost to Follow-up|0|||
129079270|NCT04339062|464578908|FG000|Overall Study|Death|0|||
129079271|NCT04339062|464578909|FG001|Overall Study|Death|1|||
129079272|NCT02968173|464578911|FG000|Overall Study|Withdrawal by Subject|1|||
129079273|NCT02670525|464578912|FG000|Overall Study|Death|94|||
129079274|NCT02670525|464578913|FG001|Overall Study|Death|14|||
129079275|NCT02670525|464578912|FG000|Overall Study|Lost to Follow-up|4|||
129079276|NCT02670525|464578913|FG001|Overall Study|Lost to Follow-up|1|||
129079277|NCT02670525|464578912|FG000|Overall Study|Subject withdrew consent|1|||
129079278|NCT02670525|464578913|FG001|Overall Study|Subject withdrew consent|0|||
129079279|NCT02670525|464578912|FG000|Overall Study|Unknown, data entry delayed|123|||
129079280|NCT02670525|464578913|FG001|Overall Study|Unknown, data entry delayed|78|||
129079281|NCT00591565|464578914|FG000|Overall Study|lost follow up, withdrawn|5|||
129079282|NCT03564119|464578918|FG000|Overall Study|Adverse Event|4|||
129079283|NCT03564119|464578919|FG001|Overall Study|Adverse Event|0|||
129079284|NCT03564119|464578918|FG000|Overall Study|Lost to Follow-up|1|||
129079285|NCT03564119|464578919|FG001|Overall Study|Lost to Follow-up|4|||
129079286|NCT03564119|464578918|FG000|Overall Study|Protocol Violation|1|||
129079287|NCT03564119|464578919|FG001|Overall Study|Protocol Violation|0|||
129079288|NCT03564119|464578918|FG000|Overall Study|Withdrawal by Subject|9|||
129079289|NCT03564119|464578919|FG001|Overall Study|Withdrawal by Subject|4|||
129142153|NCT03654326|464815670|FG001|Overall Study|Withdrawal by Subject|3|||
129142154|NCT03654326|464815669|FG000|Overall Study|Physician Decision|0|||
129079290|NCT03564119|464578918|FG000|Overall Study|Other Than Specified|0|||
129079291|NCT03564119|464578919|FG001|Overall Study|Other Than Specified|1|||
129079292|NCT00634036|464578920|FG000|Overall Study|Lost to Follow-up|1|||
129079293|NCT00634036|464578921|FG001|Overall Study|Lost to Follow-up|1|||
129079294|NCT00634036|464578920|FG000|Overall Study|Withdrawal by Subject|1|||
129079295|NCT00634036|464578921|FG001|Overall Study|Withdrawal by Subject|1|||
129142155|NCT03654326|464815670|FG001|Overall Study|Physician Decision|1|||
128724020|NCT00692770|463287309|FG000|Overall Study|Completed all planned assessments|79|||
128724021|NCT00692770|463287310|FG001|Overall Study|Completed all planned assessments|101|||
128724022|NCT00692770|463287309|FG000|Overall Study|Radiological and clinical progression|8|||
128724023|NCT00692770|463287310|FG001|Overall Study|Radiological and clinical progression|8|||
128724024|NCT00692770|463287309|FG000|Overall Study|Clinical endpoint reached|16|||
128724025|NCT00692770|463287310|FG001|Overall Study|Clinical endpoint reached|43|||
128724026|NCT00692770|463287309|FG000|Overall Study|Study terminated by sponsor|2|||
129142156|NCT03654326|464815669|FG000|Overall Study|Unable to adhere to study schedule|0|||
129142157|NCT03654326|464815670|FG001|Overall Study|Unable to adhere to study schedule|1|||
129142158|NCT03654326|464815669|FG000|Overall Study|Lost to Follow-up|1|||
129142159|NCT03654326|464815670|FG001|Overall Study|Lost to Follow-up|1|||
129142160|NCT04102514|464815671|FG000|Overall Study|Death|3|||
129142161|NCT04102514|464815672|FG001|Overall Study|Death|0|||
129142162|NCT04102514|464815673|FG002|Overall Study|Death|0|||
129142163|NCT04102514|464815674|FG003|Overall Study|Death|0|||
129142164|NCT04102514|464815671|FG000|Overall Study|Lost to Follow-up|0|||
129142165|NCT04102514|464815672|FG001|Overall Study|Lost to Follow-up|0|||
129142166|NCT04102514|464815673|FG002|Overall Study|Lost to Follow-up|3|||
129142167|NCT04102514|464815674|FG003|Overall Study|Lost to Follow-up|0|||
129142168|NCT04102514|464815671|FG000|Overall Study|Physician Decision|0|||
129142169|NCT04102514|464815672|FG001|Overall Study|Physician Decision|0|||
128724027|NCT00692770|463287310|FG001|Overall Study|Study terminated by sponsor|2|||
128724028|NCT00692770|463287309|FG000|Overall Study|Randomized but not treated|3|||
128724029|NCT00692770|463287310|FG001|Overall Study|Randomized but not treated|4|||
128724030|NCT01077804|463287312|FG000|Overall Study|Unreachable|102|||
128724031|NCT01077804|463287312|FG000|Overall Study|Refused to continue|79|||
128724032|NCT01077804|463287312|FG000|Overall Study|Other|18|||
128724033|NCT02620046|463287314|FG000|Overall Study|Adverse Event|22|||
128724034|NCT02620046|463287315|FG001|Overall Study|Adverse Event|42|||
128724035|NCT02620046|463287314|FG000|Overall Study|Lost to Follow-up|4|||
128724036|NCT02620046|463287315|FG001|Overall Study|Lost to Follow-up|10|||
128724037|NCT02620046|463287314|FG000|Overall Study|Withdrawal by Subject|36|||
128724038|NCT02620046|463287315|FG001|Overall Study|Withdrawal by Subject|66|||
128724039|NCT02620046|463287314|FG000|Overall Study|Site Termination|3|||
128724040|NCT02620046|463287315|FG001|Overall Study|Site Termination|3|||
128724041|NCT02620046|463287314|FG000|Overall Study|Pregnancy|3|||
129079296|NCT03896022|464578926|FG000|Overall Study|Withdrawal by Subject|1|||
129079297|NCT03896022|464578927|FG001|Overall Study|Withdrawal by Subject|0|||
129079298|NCT03896022|464578928|FG002|Overall Study|Withdrawal by Subject|0|||
129079299|NCT03896022|464578926|FG000|Overall Study|Did not have procedure|3|||
129079300|NCT03896022|464578927|FG001|Overall Study|Did not have procedure|0|||
129079301|NCT03896022|464578928|FG002|Overall Study|Did not have procedure|0|||
129079302|NCT00564850|464578934|FG000|Overall Study|Protocol Violation|2|||
129079303|NCT00314327|464578935|FG000|Overall Study|Withdrawal by Subject|1|||
129079304|NCT02741076|464578936|FG000|Overall Study|Adverse Event|0|||
129079305|NCT02741076|464578937|FG001|Overall Study|Adverse Event|1|||
129079306|NCT02741076|464578938|FG002|Overall Study|Adverse Event|1|||
129079307|NCT02741076|464578939|FG003|Overall Study|Adverse Event|0|||
129079308|NCT02741076|464578936|FG000|Overall Study|Lack of Efficacy|1|||
129079309|NCT02741076|464578937|FG001|Overall Study|Lack of Efficacy|0|||
129079310|NCT02741076|464578938|FG002|Overall Study|Lack of Efficacy|0|||
129079311|NCT02741076|464578939|FG003|Overall Study|Lack of Efficacy|0|||
129079312|NCT02741076|464578936|FG000|Overall Study|Withdrawal by Subject|0|||
129079313|NCT02741076|464578937|FG001|Overall Study|Withdrawal by Subject|1|||
129079314|NCT02741076|464578938|FG002|Overall Study|Withdrawal by Subject|0|||
129079315|NCT02741076|464578939|FG003|Overall Study|Withdrawal by Subject|0|||
129079316|NCT02741076|464578936|FG000|Overall Study|Sponsor Request|2|||
129079317|NCT02741076|464578937|FG001|Overall Study|Sponsor Request|3|||
129079318|NCT02741076|464578938|FG002|Overall Study|Sponsor Request|0|||
129079319|NCT02741076|464578939|FG003|Overall Study|Sponsor Request|1|||
129079320|NCT02741076|464578936|FG000|Overall Study|No additional information available|0|||
129079321|NCT02741076|464578937|FG001|Overall Study|No additional information available|0|||
129079322|NCT02741076|464578938|FG002|Overall Study|No additional information available|1|||
129079323|NCT02741076|464578939|FG003|Overall Study|No additional information available|1|||
129079324|NCT03668119|464580702|FG000|Pre-treatment|Disease Progression|1|||
129079325|NCT03668119|464580703|FG001|Pre-treatment|Disease Progression|0|||
129079326|NCT03668119|464580702|FG000|Treatment|Disease Progression|76|||
129079327|NCT03668119|464580703|FG001|Treatment|Disease Progression|57|||
129079328|NCT03668119|464580702|FG000|Treatment|Study drug toxicity|19|||
129079329|NCT03668119|464580703|FG001|Treatment|Study drug toxicity|1|||
129079330|NCT03668119|464580702|FG000|Treatment|Death|3|||
129079331|NCT03668119|464580703|FG001|Treatment|Death|0|||
129079332|NCT03668119|464580702|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
129079333|NCT03668119|464580703|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
129079334|NCT03668119|464580702|FG000|Treatment|Withdrawal by Subject|1|||
129079335|NCT03668119|464580703|FG001|Treatment|Withdrawal by Subject|1|||
129079336|NCT03668119|464580702|FG000|Treatment|Participant request to discontinue study treatment|3|||
129079337|NCT03668119|464580703|FG001|Treatment|Participant request to discontinue study treatment|1|||
129079338|NCT03668119|464580702|FG000|Treatment|Maximum Clinical Benefit|0|||
129079339|NCT03668119|464580703|FG001|Treatment|Maximum Clinical Benefit|1|||
129079340|NCT03668119|464580702|FG000|Treatment|Participants completed treatment|27|||
129079341|NCT03668119|464580703|FG001|Treatment|Participants completed treatment|11|||
129079342|NCT03668119|464580702|FG000|Treatment|Other reasons|2|||
129079343|NCT03668119|464580703|FG001|Treatment|Other reasons|1|||
129079344|NCT05336227|464580704|FG000|Overall Study|Adverse Event|1|||
128724042|NCT02620046|463287315|FG001|Overall Study|Pregnancy|7|||
129079345|NCT05336227|464580705|FG001|Overall Study|Adverse Event|0|||
129079346|NCT05336227|464580704|FG000|Overall Study|Lost to Follow-up|2|||
129079347|NCT05336227|464580705|FG001|Overall Study|Lost to Follow-up|0|||
129079348|NCT05336227|464580704|FG000|Overall Study|Withdrawal by Subject|1|||
129079349|NCT05336227|464580705|FG001|Overall Study|Withdrawal by Subject|0|||
129079350|NCT00347958|464580708|FG000|Overall Study|Adverse Event|1|||
129079351|NCT00347958|464580708|FG000|Overall Study|Protocol Violation|2|||
129079352|NCT00347958|464580708|FG000|Overall Study|Withdrawal by Subject|1|||
129079353|NCT00754234|464580709|FG000|Overall Study|Withdrawal by Subject|3|||
128724043|NCT02620046|463287314|FG000|Overall Study|Lack of Efficacy|81|||
128724044|NCT02620046|463287315|FG001|Overall Study|Lack of Efficacy|146|||
128724045|NCT02620046|463287314|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
129079354|NCT00915018|464580710|FG000|Overall Study|Death|75|||
129079355|NCT00915018|464580711|FG001|Overall Study|Death|70|||
129079356|NCT00915018|464580710|FG000|Overall Study|Lost to Follow-up|10|||
129079357|NCT00915018|464580711|FG001|Overall Study|Lost to Follow-up|5|||
129079358|NCT00915018|464580710|FG000|Overall Study|Withdrawal by Subject|38|||
129079359|NCT00915018|464580711|FG001|Overall Study|Withdrawal by Subject|27|||
129079360|NCT00915018|464580710|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
129079361|NCT00915018|464580711|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
129079362|NCT00326716|464580712|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
129079363|NCT00326716|464580713|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
129079364|NCT00326716|464580714|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
129079365|NCT00326716|464580715|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
129079366|NCT04134767|464580716|FG000|Overall Study|Death|0|||
129079367|NCT04134767|464580717|FG001|Overall Study|Death|1|||
129079368|NCT04134767|464580716|FG000|Overall Study|Removed for harassing staff|0|||
129079369|NCT04134767|464580717|FG001|Overall Study|Removed for harassing staff|1|||
129079370|NCT04134767|464580716|FG000|Overall Study|Lost to Follow-up|44|||
129079371|NCT04134767|464580717|FG001|Overall Study|Lost to Follow-up|40|||
129079372|NCT00300885|464580718|FG000|Treatment|Adverse Event|134|||
129079373|NCT00300885|464580719|FG001|Treatment|Adverse Event|82|||
129079374|NCT00300885|464580718|FG000|Treatment|Death|20|||
129079375|NCT00300885|464580719|FG001|Treatment|Death|7|||
129079376|NCT00300885|464580718|FG000|Treatment|Lack of Efficacy|1|||
129079377|NCT00300885|464580719|FG001|Treatment|Lack of Efficacy|1|||
129079378|NCT00300885|464580718|FG000|Treatment|Lost to Follow-up|3|||
129079379|NCT00300885|464580719|FG001|Treatment|Lost to Follow-up|2|||
129079380|NCT00300885|464580718|FG000|Treatment|Physician Decision|4|||
129079381|NCT00300885|464580719|FG001|Treatment|Physician Decision|5|||
129079382|NCT00300885|464580718|FG000|Treatment|Protocol Violation|11|||
129079383|NCT00300885|464580719|FG001|Treatment|Protocol Violation|11|||
129079384|NCT00300885|464580718|FG000|Treatment|Withdrawal by Subject|26|||
129079385|NCT00300885|464580719|FG001|Treatment|Withdrawal by Subject|23|||
129079386|NCT00300885|464580718|FG000|Treatment|Disease progression|171|||
129079387|NCT00300885|464580719|FG001|Treatment|Disease progression|238|||
129079388|NCT00300885|464580718|FG000|Treatment|Random code broken (subject died)|0|||
129079389|NCT00300885|464580719|FG001|Treatment|Random code broken (subject died)|1|||
129079390|NCT00300885|464580718|FG000|Treatment|Non-compliant with study medication|3|||
129079391|NCT00300885|464580719|FG001|Treatment|Non-compliant with study medication|4|||
129079392|NCT00300885|464580718|FG000|Follow-up|Death|141|||
129079393|NCT00300885|464580719|FG001|Follow-up|Death|163|||
129079394|NCT00300885|464580718|FG000|Follow-up|Lost to Follow-up|11|||
129079395|NCT00300885|464580719|FG001|Follow-up|Lost to Follow-up|7|||
129079396|NCT00300885|464580718|FG000|Follow-up|Withdrawal by Subject|26|||
129079397|NCT00300885|464580719|FG001|Follow-up|Withdrawal by Subject|25|||
129079398|NCT02366637|464580723|FG000|First Intervention Period|Adverse Event|0|||
129079399|NCT02366637|464580724|FG001|First Intervention Period|Adverse Event|1|||
129079400|NCT02366637|464580723|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
129079401|NCT02366637|464580724|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
129079402|NCT02366637|464580723|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
129079403|NCT02366637|464580724|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
129079404|NCT02309411|464580730|FG000|Overall Study|Physician Decision|1|||
129079405|NCT02309411|464580731|FG001|Overall Study|Physician Decision|0|||
129079406|NCT02309411|464580732|FG002|Overall Study|Physician Decision|0|||
129079407|NCT02309411|464580730|FG000|Overall Study|Withdrawal by Subject|1|||
129079408|NCT02309411|464580731|FG001|Overall Study|Withdrawal by Subject|1|||
129079409|NCT02309411|464580732|FG002|Overall Study|Withdrawal by Subject|0|||
129079410|NCT03656692|464580733|FG000|Overall Study|Worsening of disease activity|2|||
129079411|NCT03656692|464580733|FG000|Overall Study|Physician Decision|1|||
129079412|NCT01134107|464580734|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
129079413|NCT01134107|464580735|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
129079414|NCT01134107|464580734|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
129079415|NCT01134107|464580735|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
129079416|NCT01134107|464580734|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
129079417|NCT01134107|464580735|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
129079418|NCT01134107|464580734|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
129079419|NCT01134107|464580735|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
129079420|NCT01134107|464580734|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
129079421|NCT01134107|464580735|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
129079422|NCT01134107|464580734|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
129079423|NCT01134107|464580735|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
129079424|NCT01134107|464580734|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
129079425|NCT01134107|464580735|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
129079426|NCT02914613|464580736|FG000|Overall Study|Withdrawal by Subject|1|||
129079427|NCT02914613|464580737|FG001|Overall Study|Withdrawal by Subject|2|||
129079428|NCT02914613|464580736|FG000|Overall Study|Adverse Event|1|||
129079429|NCT02914613|464580737|FG001|Overall Study|Adverse Event|0|||
129079430|NCT03850496|464580752|FG000|Overall Study|Withdrawal by Subject|1|||
129079431|NCT03850496|464580753|FG001|Overall Study|Withdrawal by Subject|0|||
129079432|NCT03850496|464580754|FG002|Overall Study|Withdrawal by Subject|0|||
129079433|NCT03850496|464580752|FG000|Overall Study|Lost to Follow-up|0|||
129079434|NCT03850496|464580753|FG001|Overall Study|Lost to Follow-up|1|||
129079435|NCT03850496|464580754|FG002|Overall Study|Lost to Follow-up|4|||
129079436|NCT03674112|464580755|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
129079437|NCT03674112|464580756|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
129079438|NCT03674112|464580755|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
129079439|NCT03674112|464580756|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
129079440|NCT03674112|464580755|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
129079441|NCT03674112|464580756|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
129079442|NCT03674112|464580755|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
129079443|NCT03674112|464580756|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
129079444|NCT03674112|464580755|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
129079445|NCT03674112|464580756|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
129079446|NCT03674112|464580755|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
129079447|NCT03674112|464580756|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
129079448|NCT03674112|464580755|FG000|Follow-Up Period (≥3 Years)|Death|2|||
129079449|NCT03674112|464580756|FG001|Follow-Up Period (≥3 Years)|Death|0|||
129079450|NCT03674112|464580755|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
129079451|NCT03674112|464580756|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
129079452|NCT02097238|464580760|FG000|Overall Study|Death|1|||
129079453|NCT02097238|464580760|FG000|Overall Study|Physician Decision|1|||
129079454|NCT02097238|464580760|FG000|Overall Study|Progressive Disease|17|||
129079455|NCT01106911|464580761|FG000|Overall Study|Physician Decision|2|||
129142170|NCT04102514|464815673|FG002|Overall Study|Physician Decision|1|||
129142171|NCT04102514|464815674|FG003|Overall Study|Physician Decision|0|||
129142172|NCT04102514|464815671|FG000|Overall Study|Withdrawal by Subject|7|||
129142173|NCT04102514|464815672|FG001|Overall Study|Withdrawal by Subject|13|||
129142174|NCT04102514|464815673|FG002|Overall Study|Withdrawal by Subject|7|||
129142175|NCT04102514|464815674|FG003|Overall Study|Withdrawal by Subject|14|||
129142176|NCT04102514|464815671|FG000|Overall Study|Moved to longterm care facility|6|||
129142177|NCT04102514|464815672|FG001|Overall Study|Moved to longterm care facility|0|||
129142178|NCT04102514|464815673|FG002|Overall Study|Moved to longterm care facility|4|||
129142179|NCT04102514|464815674|FG003|Overall Study|Moved to longterm care facility|0|||
128724046|NCT02620046|463287315|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
128724047|NCT02620046|463287314|FG000|Overall Study|Reason Not Specified|13|||
128724048|NCT02620046|463287315|FG001|Overall Study|Reason Not Specified|21|||
128724049|NCT02620046|463287314|FG000|Overall Study|Significant Protocol Deviation|0|||
128724050|NCT02620046|463287315|FG001|Overall Study|Significant Protocol Deviation|1|||
128724051|NCT00394212|463288966|FG000|Overall Study|Lost to Follow-up|3|||
128724052|NCT00394212|463288967|FG001|Overall Study|Lost to Follow-up|0|||
128724053|NCT00394212|463288966|FG000|Overall Study|Withdrawal by Subject|4|||
128724054|NCT00394212|463288967|FG001|Overall Study|Withdrawal by Subject|1|||
128724055|NCT00588445|463288968|FG000|Overall Study|Protocol Violation|1|||
128724056|NCT00588445|463288968|FG000|Overall Study|Withdrawal by Subject|3|||
128724057|NCT00588445|463288968|FG000|Overall Study|Disease Progression|1|||
128724058|NCT00588445|463288968|FG000|Overall Study|Not Treated|10|||
128724059|NCT03240133|463288969|FG000|Overall Study|Withdrawal by Subject|0|||
128724060|NCT03240133|463288970|FG001|Overall Study|Withdrawal by Subject|1|||
128724061|NCT03240133|463288971|FG002|Overall Study|Withdrawal by Subject|0|||
128724062|NCT03240133|463288969|FG000|Overall Study|Adverse Event|1|||
128724063|NCT03240133|463288970|FG001|Overall Study|Adverse Event|1|||
128724064|NCT03240133|463288971|FG002|Overall Study|Adverse Event|0|||
128724065|NCT03240133|463288969|FG000|Overall Study|Rash|1|||
128724066|NCT03240133|463288970|FG001|Overall Study|Rash|0|||
128724067|NCT03240133|463288971|FG002|Overall Study|Rash|0|||
129079456|NCT01106911|464580761|FG000|Overall Study|deemed ineligible after screening|3|||
129079457|NCT01814696|464580769|FG000|Overall Study|Withdrawal by Subject|1|||
129079458|NCT01814696|464580770|FG001|Overall Study|Withdrawal by Subject|0|||
129142180|NCT01689649|464815675|FG000|Overall Study|Lack of Efficacy|3|||
129142181|NCT01689649|464815675|FG000|Overall Study|Non-compliance|11|||
128724068|NCT03240133|463288969|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
128724069|NCT03240133|463288970|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
129142182|NCT01689649|464815675|FG000|Overall Study|Protocol Violation|3|||
129079459|NCT01814696|464580769|FG000|Overall Study|Randomized to wrong group|1|||
129079460|NCT01814696|464580770|FG001|Overall Study|Randomized to wrong group|0|||
129079461|NCT00954941|464580771|FG000|Overall Study|Received treatment at home|1|||
129079462|NCT00954941|464580772|FG001|Overall Study|Received treatment at home|0|||
129079463|NCT00954941|464580771|FG000|Overall Study|Withdrawal by Subject|1|||
129079464|NCT00954941|464580772|FG001|Overall Study|Withdrawal by Subject|0|||
129079465|NCT00954941|464580771|FG000|Overall Study|Insurance Denial|2|||
129079466|NCT00954941|464580772|FG001|Overall Study|Insurance Denial|2|||
129079467|NCT00954941|464580771|FG000|Overall Study|Physician Decision|2|||
129079468|NCT00954941|464580772|FG001|Overall Study|Physician Decision|2|||
129079469|NCT00954941|464580771|FG000|Overall Study|Ineligible|2|||
129079470|NCT00954941|464580772|FG001|Overall Study|Ineligible|2|||
129079471|NCT00954941|464580771|FG000|Overall Study|Adverse Event|0|||
129079472|NCT00954941|464580772|FG001|Overall Study|Adverse Event|1|||
129079473|NCT00984542|464580789|FG000|Overall Study|disease progression|19|||
129079474|NCT00984542|464580789|FG000|Overall Study|toxicity|7|||
129079475|NCT00984542|464580789|FG000|Overall Study|Death|7|||
129079476|NCT00984542|464580789|FG000|Overall Study|complicating disease|3|||
129079477|NCT00984542|464580789|FG000|Overall Study|Withdrawal by Subject|3|||
129079478|NCT00984542|464580789|FG000|Overall Study|clinical deterioration|2|||
129079479|NCT01422889|464580790|FG000|Overall Study|No Data Entered for Study Stent|9|||
129079480|NCT00488644|464580795|FG000|Overall Study|Not Eligible|1|||
129079481|NCT00488644|464580795|FG000|Overall Study|Not Evaluable|1|||
129079482|NCT02977572|464580796|FG000|Overall Study|Exclusion criterion|2|||
129079483|NCT02977572|464580797|FG001|Overall Study|Exclusion criterion|2|||
129079484|NCT01197534|464580799|FG000|Overall Study|Not reported|16|||
129079485|NCT01197534|464580800|FG001|Overall Study|Not reported|10|||
129079486|NCT01197534|464580801|FG002|Overall Study|Not reported|16|||
129079487|NCT01197534|464580799|FG000|Overall Study|Enrolment in long term extension|57|||
129079488|NCT01197534|464580800|FG001|Overall Study|Enrolment in long term extension|66|||
129079489|NCT01197534|464580801|FG002|Overall Study|Enrolment in long term extension|119|||
129079490|NCT01197534|464580799|FG000|Overall Study|Severe non-compliance to protocol|3|||
129079491|NCT01197534|464580800|FG001|Overall Study|Severe non-compliance to protocol|4|||
129079492|NCT01197534|464580801|FG002|Overall Study|Severe non-compliance to protocol|1|||
129079493|NCT01197534|464580799|FG000|Overall Study|Lack of therapeutic response|9|||
129079494|NCT01197534|464580800|FG001|Overall Study|Lack of therapeutic response|4|||
129079495|NCT01197534|464580801|FG002|Overall Study|Lack of therapeutic response|9|||
129079496|NCT01197534|464580799|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
129079497|NCT01197534|464580800|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
129079498|NCT01197534|464580801|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
129079499|NCT01197534|464580799|FG000|Overall Study|Lost to Follow-up|1|||
129079500|NCT01197534|464580800|FG001|Overall Study|Lost to Follow-up|4|||
129079501|NCT01197534|464580801|FG002|Overall Study|Lost to Follow-up|2|||
129079502|NCT01197534|464580799|FG000|Overall Study|Adverse Event|35|||
129079503|NCT01197534|464580800|FG001|Overall Study|Adverse Event|36|||
129079504|NCT01197534|464580801|FG002|Overall Study|Adverse Event|24|||
129079505|NCT02589639|464580814|FG000|Overall Study|Lost to Follow-up|1|||
129079506|NCT02589639|464580815|FG001|Overall Study|Lost to Follow-up|0|||
129079507|NCT02589639|464580816|FG002|Overall Study|Lost to Follow-up|0|||
129079508|NCT02589639|464580814|FG000|Overall Study|Protocol Violation|1|||
129079509|NCT02589639|464580815|FG001|Overall Study|Protocol Violation|0|||
129079510|NCT02589639|464580816|FG002|Overall Study|Protocol Violation|0|||
129079511|NCT02589639|464580814|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
129079512|NCT02589639|464580815|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
129079513|NCT02589639|464580816|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
129079514|NCT02589639|464580814|FG000|Overall Study|Adverse Event|4|||
129079515|NCT02589639|464580815|FG001|Overall Study|Adverse Event|5|||
129079516|NCT02589639|464580816|FG002|Overall Study|Adverse Event|3|||
129079517|NCT02589639|464580814|FG000|Overall Study|Other reason than specified above|1|||
129079518|NCT02589639|464580815|FG001|Overall Study|Other reason than specified above|2|||
129079519|NCT02589639|464580816|FG002|Overall Study|Other reason than specified above|1|||
129079520|NCT02589639|464580814|FG000|Overall Study|Not Treated|0|||
129079521|NCT02589639|464580815|FG001|Overall Study|Not Treated|3|||
129079522|NCT02589639|464580816|FG002|Overall Study|Not Treated|0|||
129079523|NCT02593097|464580817|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
129079524|NCT02593097|464580818|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
129079525|NCT02593097|464580817|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129079526|NCT02593097|464580818|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
128724070|NCT03240133|463288971|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
129079527|NCT02593097|464580817|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
129079528|NCT02593097|464580818|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
129079529|NCT02593097|464580817|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
129079530|NCT02593097|464580818|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
129079531|NCT02593097|464580817|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
129079532|NCT02593097|464580818|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
129079533|NCT00703157|464580819|FG000|Overall Study|Lost to Follow-up|0|||
129079534|NCT00703157|464580820|FG001|Overall Study|Lost to Follow-up|1|||
129079535|NCT00703157|464580819|FG000|Overall Study|source data permanently lost/ other|4|||
129079536|NCT00703157|464580820|FG001|Overall Study|source data permanently lost/ other|1|||
129079537|NCT02522884|464580821|FG000|Overall Study|Withdrawal by Subject|6|||
129079538|NCT02522884|464580821|FG000|Overall Study|Death|3|||
129079539|NCT02522884|464580821|FG000|Overall Study|Missed 12-month Follow-up|9|||
129079540|NCT02630251|464580822|FG000|Overall Study|Physician Decision|0|||
129079541|NCT02630251|464580823|FG001|Overall Study|Physician Decision|0|||
129079542|NCT02630251|464580824|FG002|Overall Study|Physician Decision|1|||
129142183|NCT01689649|464815675|FG000|Overall Study|Lost to Follow-up|5|||
129142184|NCT00835549|464815676|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
129142185|NCT00835549|464815677|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129142186|NCT00835042|464815678|FG000|First Intervention|Withdrawal by Subject|3|||
129142187|NCT00835042|464815679|FG001|First Intervention|Withdrawal by Subject|0|||
129142188|NCT00835042|464815678|FG000|First Intervention|Adverse Event|1|||
129142189|NCT00835042|464815679|FG001|First Intervention|Adverse Event|2|||
129142190|NCT00835042|464815678|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
129142191|NCT00835042|464815679|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
129142192|NCT00619918|464815680|FG000|Overall Study|Withdrawal by Subject|4|||
129079543|NCT02630251|464580825|FG003|Overall Study|Physician Decision|0|||
129079544|NCT01863667|464580826|FG000|Overall Study|Adverse Event|1|||
129079545|NCT01863667|464580827|FG001|Overall Study|Adverse Event|0|||
129079546|NCT01863667|464580826|FG000|Overall Study|Study terminated by Sponsor|30|||
129079547|NCT01863667|464580827|FG001|Overall Study|Study terminated by Sponsor|30|||
129079548|NCT01863667|464580826|FG000|Overall Study|Withdrawal by Subject|2|||
129079549|NCT01863667|464580827|FG001|Overall Study|Withdrawal by Subject|2|||
129079550|NCT03627546|464580828|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
129079551|NCT03627546|464580829|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
129079552|NCT03627546|464580830|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
129079553|NCT03627546|464580828|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
129079554|NCT03627546|464580829|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
129079555|NCT03627546|464580830|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
129079556|NCT00615550|464580833|FG000|Overall Study|Lost to Follow-up|6|||
129079557|NCT00615550|464580834|FG001|Overall Study|Lost to Follow-up|1|||
129079558|NCT02640664|464580835|FG000|Epoch 1|Withdrawal of informed consent|1|||
129079559|NCT02640664|464580836|FG001|Epoch 1|Withdrawal of informed consent|0|||
129079560|NCT02640664|464580837|FG002|Epoch 1|Withdrawal of informed consent|0|||
129079561|NCT02640664|464580835|FG000|Epoch 1|Death|0|||
129079562|NCT02640664|464580836|FG001|Epoch 1|Death|0|||
129079563|NCT02640664|464580837|FG002|Epoch 1|Death|1|||
129079564|NCT02640664|464580835|FG000|Epoch 2|Withdrawal of informed consent|3|||
129079565|NCT02640664|464580836|FG001|Epoch 2|Withdrawal of informed consent|4|||
129079566|NCT02640664|464580837|FG002|Epoch 2|Withdrawal of informed consent|2|||
129079567|NCT02640664|464580835|FG000|Epoch 2|Subject/guardian decision|0|||
129079568|NCT02640664|464580836|FG001|Epoch 2|Subject/guardian decision|2|||
129079569|NCT02640664|464580837|FG002|Epoch 2|Subject/guardian decision|2|||
129079570|NCT02640664|464580835|FG000|Epoch 2|Lost to Follow-up|3|||
129079571|NCT02640664|464580836|FG001|Epoch 2|Lost to Follow-up|4|||
129079572|NCT02640664|464580837|FG002|Epoch 2|Lost to Follow-up|1|||
129079573|NCT02640664|464580835|FG000|Epoch 2|Death|0|||
129079574|NCT02640664|464580836|FG001|Epoch 2|Death|0|||
129142193|NCT00619918|464815681|FG001|Overall Study|Withdrawal by Subject|3|||
129142194|NCT00619918|464815680|FG000|Overall Study|Physician Decision|2|||
129142195|NCT00619918|464815681|FG001|Overall Study|Physician Decision|4|||
129142196|NCT00619918|464815680|FG000|Overall Study|Transfer to outside facility|3|||
129142197|NCT00619918|464815681|FG001|Overall Study|Transfer to outside facility|3|||
129142198|NCT00619918|464815680|FG000|Overall Study|Left before receiving first dose|7|||
129079575|NCT02640664|464580837|FG002|Epoch 2|Death|1|||
129079576|NCT02965573|464580838|FG000|Overall Study|Lack of Efficacy|1|||
129079577|NCT02965573|464580839|FG001|Overall Study|Lack of Efficacy|0|||
129079578|NCT00315458|464580841|FG000|Overall Study|Administrative|0|||
129079579|NCT00315458|464580842|FG001|Overall Study|Administrative|3|||
129079580|NCT00315458|464580843|FG002|Overall Study|Administrative|8|||
129079581|NCT00315458|464580844|FG003|Overall Study|Administrative|21|||
129079582|NCT00315458|464580841|FG000|Overall Study|Adverse Event|2|||
129079583|NCT00315458|464580842|FG001|Overall Study|Adverse Event|4|||
129079584|NCT00315458|464580843|FG002|Overall Study|Adverse Event|23|||
129079585|NCT00315458|464580844|FG003|Overall Study|Adverse Event|3|||
129142199|NCT00619918|464815681|FG001|Overall Study|Left before receiving first dose|6|||
129142200|NCT00619918|464815680|FG000|Overall Study|ICU admission|4|||
129079586|NCT00315458|464580841|FG000|Overall Study|Lost to Follow-up|1|||
129079587|NCT00315458|464580842|FG001|Overall Study|Lost to Follow-up|2|||
129079588|NCT00315458|464580843|FG002|Overall Study|Lost to Follow-up|0|||
129079589|NCT00315458|464580844|FG003|Overall Study|Lost to Follow-up|2|||
129079590|NCT00315458|464580841|FG000|Overall Study|Withdrawal by Subject|0|||
129079591|NCT00315458|464580842|FG001|Overall Study|Withdrawal by Subject|3|||
129079592|NCT00315458|464580843|FG002|Overall Study|Withdrawal by Subject|0|||
129079593|NCT00315458|464580844|FG003|Overall Study|Withdrawal by Subject|2|||
129079594|NCT00315458|464580841|FG000|Overall Study|Lack of Efficacy|0|||
129079595|NCT00315458|464580842|FG001|Overall Study|Lack of Efficacy|0|||
129079596|NCT00315458|464580843|FG002|Overall Study|Lack of Efficacy|20|||
129079597|NCT00315458|464580844|FG003|Overall Study|Lack of Efficacy|1|||
129079598|NCT00315458|464580841|FG000|Overall Study|Did not qualify|0|||
129079599|NCT00315458|464580842|FG001|Overall Study|Did not qualify|0|||
129079600|NCT00315458|464580843|FG002|Overall Study|Did not qualify|1|||
129079601|NCT00315458|464580844|FG003|Overall Study|Did not qualify|0|||
129079602|NCT00987337|464580845|FG000|Overall Study|Adverse Event|10|||
129079603|NCT00987337|464580846|FG001|Overall Study|Adverse Event|9|||
129079604|NCT00987337|464580847|FG002|Overall Study|Adverse Event|8|||
129079605|NCT00987337|464580845|FG000|Overall Study|Insufficient Virologic Response|10|||
129079606|NCT00987337|464580846|FG001|Overall Study|Insufficient Virologic Response|7|||
129079607|NCT00987337|464580847|FG002|Overall Study|Insufficient Virologic Response|12|||
129079608|NCT00987337|464580845|FG000|Overall Study|Virologic Breakthrough|2|||
129079609|NCT00987337|464580846|FG001|Overall Study|Virologic Breakthrough|2|||
129079610|NCT00987337|464580847|FG002|Overall Study|Virologic Breakthrough|8|||
129079611|NCT00987337|464580845|FG000|Overall Study|Lost to Follow-up|10|||
129079612|NCT00987337|464580846|FG001|Overall Study|Lost to Follow-up|6|||
129079613|NCT00987337|464580847|FG002|Overall Study|Lost to Follow-up|2|||
129079614|NCT00987337|464580845|FG000|Overall Study|Withdrawal by Subject|6|||
129079615|NCT00987337|464580846|FG001|Overall Study|Withdrawal by Subject|9|||
129079616|NCT00987337|464580847|FG002|Overall Study|Withdrawal by Subject|9|||
129079617|NCT00987337|464580845|FG000|Overall Study|Other|0|||
129079618|NCT00987337|464580846|FG001|Overall Study|Other|2|||
129079619|NCT00987337|464580847|FG002|Overall Study|Other|5|||
129079620|NCT00987337|464580845|FG000|Overall Study|Protocol Violation|1|||
129079621|NCT00987337|464580846|FG001|Overall Study|Protocol Violation|0|||
129079622|NCT00987337|464580847|FG002|Overall Study|Protocol Violation|2|||
129079623|NCT00987337|464580845|FG000|Overall Study|Participant Relapsed|18|||
129079624|NCT00987337|464580846|FG001|Overall Study|Participant Relapsed|20|||
129079625|NCT00987337|464580847|FG002|Overall Study|Participant Relapsed|5|||
129079626|NCT00086619|464580850|FG000|Overall Study|Withdrawal by Subject|6|||
129079627|NCT00086619|464580851|FG001|Overall Study|Withdrawal by Subject|6|||
129079628|NCT00086619|464580850|FG000|Overall Study|Adverse Event|8|||
129079629|NCT00086619|464580851|FG001|Overall Study|Adverse Event|10|||
129079630|NCT00086619|464580850|FG000|Overall Study|Protocol Violation|1|||
129142201|NCT00619918|464815681|FG001|Overall Study|ICU admission|6|||
129142202|NCT05524948|464815709|FG000|Overall Study|Withdrawal by Subject|1|||
129142203|NCT05524948|464815710|FG001|Overall Study|Withdrawal by Subject|0|||
129142204|NCT05524948|464815709|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
129142205|NCT05524948|464815710|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
129142206|NCT00595075|464815713|FG000|Overall Study|Withdrawal by Subject|1|||
129142207|NCT00595075|464815714|FG001|Overall Study|Withdrawal by Subject|0|||
129142208|NCT03715829|464815717|FG000|Dose Ranging Period|Adverse Event|2|||
129142209|NCT03715829|464815718|FG001|Dose Ranging Period|Adverse Event|4|||
129142210|NCT03715829|464815719|FG002|Dose Ranging Period|Adverse Event|5|||
129142211|NCT03715829|464815720|FG003|Dose Ranging Period|Adverse Event|2|||
129142212|NCT03715829|464815721|FG004|Dose Ranging Period|Adverse Event|3|||
129142213|NCT03715829|464815722|FG005|Dose Ranging Period|Adverse Event|3|||
129142214|NCT03715829|464815723|FG006|Dose Ranging Period|Adverse Event|0|||
129142215|NCT03715829|464815724|FG007|Dose Ranging Period|Adverse Event|0|||
129142216|NCT03715829|464815725|FG008|Dose Ranging Period|Adverse Event|0|||
129142217|NCT03715829|464815726|FG009|Dose Ranging Period|Adverse Event|0|||
129142218|NCT03715829|464815727|FG010|Dose Ranging Period|Adverse Event|0|||
129142219|NCT03715829|464815717|FG000|Dose Ranging Period|Lack of Efficacy|0|||
129079631|NCT00086619|464580851|FG001|Overall Study|Protocol Violation|1|||
129079632|NCT00489918|464580852|FG000|Overall Study|Withdrawal by Subject|2|||
129079633|NCT00489918|464580853|FG001|Overall Study|Withdrawal by Subject|1|||
129079634|NCT00489918|464580854|FG002|Overall Study|Withdrawal by Subject|1|||
129079635|NCT00489918|464580855|FG003|Overall Study|Withdrawal by Subject|0|||
129079636|NCT00489918|464580856|FG004|Overall Study|Withdrawal by Subject|1|||
129142220|NCT03715829|464815718|FG001|Dose Ranging Period|Lack of Efficacy|1|||
129142221|NCT03715829|464815719|FG002|Dose Ranging Period|Lack of Efficacy|0|||
129142222|NCT03715829|464815720|FG003|Dose Ranging Period|Lack of Efficacy|1|||
129142223|NCT03715829|464815721|FG004|Dose Ranging Period|Lack of Efficacy|0|||
129079637|NCT00489918|464580852|FG000|Overall Study|Adverse Event|0|||
129079638|NCT00489918|464580853|FG001|Overall Study|Adverse Event|1|||
129079639|NCT00489918|464580854|FG002|Overall Study|Adverse Event|1|||
129079640|NCT00489918|464580855|FG003|Overall Study|Adverse Event|0|||
129079641|NCT00489918|464580856|FG004|Overall Study|Adverse Event|0|||
129079642|NCT00489918|464580852|FG000|Overall Study|Lost to Follow-up|0|||
129079643|NCT00489918|464580853|FG001|Overall Study|Lost to Follow-up|0|||
129079644|NCT00489918|464580854|FG002|Overall Study|Lost to Follow-up|1|||
129079645|NCT00489918|464580855|FG003|Overall Study|Lost to Follow-up|1|||
129079646|NCT00489918|464580856|FG004|Overall Study|Lost to Follow-up|0|||
129079647|NCT00489918|464580852|FG000|Overall Study|Physician Decision|0|||
129079648|NCT00489918|464580853|FG001|Overall Study|Physician Decision|0|||
129079649|NCT00489918|464580854|FG002|Overall Study|Physician Decision|1|||
129079650|NCT00489918|464580855|FG003|Overall Study|Physician Decision|0|||
129079651|NCT00489918|464580856|FG004|Overall Study|Physician Decision|0|||
129079652|NCT02748213|464580857|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
129079653|NCT02748213|464580858|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
129079654|NCT02748213|464580857|FG000|Overall Study|Abnormal Laboratory Test|1|||
129079655|NCT02748213|464580858|FG001|Overall Study|Abnormal Laboratory Test|0|||
129079656|NCT02748213|464580857|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
129079657|NCT02748213|464580858|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
129079658|NCT02748213|464580857|FG000|Overall Study|Death|5|||
129079659|NCT02748213|464580858|FG001|Overall Study|Death|3|||
129079660|NCT02748213|464580857|FG000|Overall Study|Insufficient Therapeutic Response|56|||
129079661|NCT02748213|464580858|FG001|Overall Study|Insufficient Therapeutic Response|57|||
129079662|NCT02748213|464580857|FG000|Overall Study|Violation of Selection Criteria|2|||
129079663|NCT02748213|464580858|FG001|Overall Study|Violation of Selection Criteria|0|||
129079664|NCT02748213|464580857|FG000|Overall Study|Protocol Violation|6|||
129079665|NCT02748213|464580858|FG001|Overall Study|Protocol Violation|4|||
129079666|NCT02748213|464580857|FG000|Overall Study|Refused Treatment*|6|||
129079667|NCT02748213|464580858|FG001|Overall Study|Refused Treatment*|6|||
129079668|NCT02748213|464580857|FG000|Overall Study|Failure to Return|1|||
129079669|NCT02748213|464580858|FG001|Overall Study|Failure to Return|0|||
129079670|NCT02748213|464580857|FG000|Overall Study|Other|30|||
129079671|NCT02748213|464580858|FG001|Overall Study|Other|29|||
129079672|NCT01209520|464580860|FG000|Overall Study|Withdrawal by Subject|3|||
129079673|NCT00961350|464580861|FG000|Overall Study|Adverse Event|18|||
129079674|NCT00961350|464580862|FG001|Overall Study|Adverse Event|33|||
129079675|NCT00961350|464580861|FG000|Overall Study|Withdrawal by Subject|10|||
129079676|NCT00961350|464580862|FG001|Overall Study|Withdrawal by Subject|10|||
129079677|NCT00961350|464580861|FG000|Overall Study|Lost to Follow-up|3|||
129079678|NCT00961350|464580862|FG001|Overall Study|Lost to Follow-up|3|||
129079679|NCT00961350|464580861|FG000|Overall Study|Misc|16|||
129079680|NCT00961350|464580862|FG001|Overall Study|Misc|21|||
129079681|NCT01500382|464580863|FG000|Washout Period|Study site went out of business|0|||
129079682|NCT01500382|464580864|FG001|Washout Period|Study site went out of business|0|||
129079683|NCT01500382|464580865|FG002|Washout Period|Study site went out of business|1|||
129079684|NCT01500382|464580866|FG003|Washout Period|Study site went out of business|0|||
129079685|NCT02134015|464580867|FG000|Overall Study|Protocol Violation|0|||
129079686|NCT02134015|464580868|FG001|Overall Study|Protocol Violation|1|||
129079687|NCT02134015|464580867|FG000|Overall Study|Death|2|||
129079688|NCT02134015|464580868|FG001|Overall Study|Death|1|||
129079689|NCT02134015|464580867|FG000|Overall Study|Reason not provided|1|||
129079690|NCT02134015|464580868|FG001|Overall Study|Reason not provided|2|||
129079691|NCT02134015|464580867|FG000|Overall Study|Clinical progression|14|||
129079692|NCT02134015|464580868|FG001|Overall Study|Clinical progression|7|||
129079693|NCT02134015|464580867|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
129079694|NCT02134015|464580868|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
129079695|NCT02134015|464580867|FG000|Overall Study|Study terminated by sponsor|2|||
129079696|NCT02134015|464580868|FG001|Overall Study|Study terminated by sponsor|3|||
129079697|NCT02134015|464580867|FG000|Overall Study|Adverse Event|9|||
129079698|NCT02134015|464580868|FG001|Overall Study|Adverse Event|10|||
129079699|NCT02134015|464580867|FG000|Overall Study|Withdrawal by Subject|3|||
129079700|NCT02134015|464580868|FG001|Overall Study|Withdrawal by Subject|7|||
129142224|NCT03715829|464815722|FG005|Dose Ranging Period|Lack of Efficacy|0|||
129142225|NCT03715829|464815723|FG006|Dose Ranging Period|Lack of Efficacy|0|||
128776563|NCT02846558|463470463|FG000|Overall Study|Lost to Follow-up|2|||
129079701|NCT00617890|464582798|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
129079702|NCT00617890|464582799|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
129079703|NCT00617890|464582800|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
129079704|NCT00617890|464582801|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
129079705|NCT00617890|464582798|FG000|Overall Study|Lack of Efficacy|23|||
129079706|NCT00617890|464582799|FG001|Overall Study|Lack of Efficacy|26|||
129079707|NCT00617890|464582800|FG002|Overall Study|Lack of Efficacy|30|||
129079708|NCT00617890|464582801|FG003|Overall Study|Lack of Efficacy|97|||
129079709|NCT00617890|464582798|FG000|Overall Study|Lost to Follow-up|0|||
129079710|NCT00617890|464582799|FG001|Overall Study|Lost to Follow-up|0|||
129079711|NCT00617890|464582800|FG002|Overall Study|Lost to Follow-up|1|||
129079712|NCT00617890|464582801|FG003|Overall Study|Lost to Follow-up|2|||
129079713|NCT00617890|464582798|FG000|Overall Study|Withdrawal by Subject|4|||
129079714|NCT00617890|464582799|FG001|Overall Study|Withdrawal by Subject|1|||
129079715|NCT00617890|464582800|FG002|Overall Study|Withdrawal by Subject|0|||
129079716|NCT00617890|464582801|FG003|Overall Study|Withdrawal by Subject|2|||
129079717|NCT00617890|464582798|FG000|Overall Study|Protocol Violation|2|||
129079718|NCT00617890|464582799|FG001|Overall Study|Protocol Violation|1|||
129079719|NCT00617890|464582800|FG002|Overall Study|Protocol Violation|0|||
129079720|NCT00617890|464582801|FG003|Overall Study|Protocol Violation|0|||
129079721|NCT00617890|464582798|FG000|Overall Study|Adverse Event|1|||
129079722|NCT00617890|464582799|FG001|Overall Study|Adverse Event|0|||
129079723|NCT00617890|464582800|FG002|Overall Study|Adverse Event|3|||
129079724|NCT00617890|464582801|FG003|Overall Study|Adverse Event|8|||
129079725|NCT00617890|464582798|FG000|Overall Study|Not treated|1|||
129079726|NCT00617890|464582799|FG001|Overall Study|Not treated|0|||
129079727|NCT00617890|464582800|FG002|Overall Study|Not treated|1|||
129079728|NCT00617890|464582801|FG003|Overall Study|Not treated|1|||
129079729|NCT02640950|464582803|FG000|Overall Study|Adverse Event|1|||
129079730|NCT02640950|464582803|FG000|Overall Study|Withdrawal by Subject|1|||
129079731|NCT00154284|464582804|FG000|Overall Study|Adverse Event|6|||
129079732|NCT00154284|464582805|FG001|Overall Study|Adverse Event|9|||
129079733|NCT00154284|464582804|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129079734|NCT00154284|464582805|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129079735|NCT00154284|464582804|FG000|Overall Study|Lack of Efficacy|1|||
129079736|NCT00154284|464582805|FG001|Overall Study|Lack of Efficacy|2|||
129079737|NCT00154284|464582804|FG000|Overall Study|Protocol Violation|0|||
129079738|NCT00154284|464582805|FG001|Overall Study|Protocol Violation|1|||
129079739|NCT00566020|464582806|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
129079740|NCT00566020|464582807|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
129079741|NCT00566020|464582806|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
129079742|NCT00566020|464582807|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
129079743|NCT00566020|464582806|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
129079744|NCT00566020|464582807|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
129079745|NCT00566020|464582806|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
129079746|NCT00566020|464582807|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
129079747|NCT00566020|464582806|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
129079748|NCT00566020|464582807|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
129079749|NCT00566020|464582806|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
129079750|NCT00566020|464582807|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
129079751|NCT02582242|464582808|FG000|Overall Study|Adverse Event|4|||
129079752|NCT02582242|464582809|FG001|Overall Study|Adverse Event|3|||
129079753|NCT02582242|464582808|FG000|Overall Study|Protocol Violation|3|||
129079754|NCT02582242|464582809|FG001|Overall Study|Protocol Violation|1|||
129079755|NCT02582242|464582808|FG000|Overall Study|Lost to Follow-up|0|||
129079756|NCT02582242|464582809|FG001|Overall Study|Lost to Follow-up|1|||
129079757|NCT02582242|464582808|FG000|Overall Study|Withdrawal by Subject|11|||
129079758|NCT02582242|464582809|FG001|Overall Study|Withdrawal by Subject|11|||
129079759|NCT02582242|464582808|FG000|Overall Study|Unclassified|2|||
129079760|NCT02582242|464582809|FG001|Overall Study|Unclassified|1|||
129079761|NCT02101736|464582810|FG000|Overall Study|Protocol Violation|3|||
129079762|NCT02101736|464582811|FG001|Overall Study|Protocol Violation|0|||
129079763|NCT02101736|464582810|FG000|Overall Study|Withdrawal by Subject|1|||
129079764|NCT02101736|464582811|FG001|Overall Study|Withdrawal by Subject|1|||
129079765|NCT00459290|464582812|FG000|Overall Study|Adverse Event|3|||
129079766|NCT00459290|464582812|FG000|Overall Study|Ineligible|2|||
128724071|NCT03240133|463288969|FG000|Overall Study|Intercurrent illness.|0|||
128724072|NCT03240133|463288970|FG001|Overall Study|Intercurrent illness.|1|||
128724073|NCT03240133|463288971|FG002|Overall Study|Intercurrent illness.|0|||
128724074|NCT03240133|463288969|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
128724075|NCT03240133|463288970|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
128724076|NCT03240133|463288971|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
128724077|NCT01176292|463288972|FG000|Overall Study|Lost to Follow-up|2|||
128724078|NCT01176292|463288973|FG001|Overall Study|Lost to Follow-up|4|||
128724079|NCT01176292|463288972|FG000|Overall Study|Adverse Event|1|||
128724080|NCT01176292|463288973|FG001|Overall Study|Adverse Event|1|||
129079767|NCT02693106|464582813|FG000|Overall Study|No time|3|||
129079768|NCT00839800|464582814|FG000|Overall Study|Adverse Event|8|||
129079769|NCT00839800|464582815|FG001|Overall Study|Adverse Event|12|||
129079770|NCT00839800|464582814|FG000|Overall Study|Lost to Follow-up|31|||
129079771|NCT00839800|464582815|FG001|Overall Study|Lost to Follow-up|26|||
129079772|NCT00839800|464582814|FG000|Overall Study|Withdrawal by Subject|28|||
129079773|NCT00839800|464582815|FG001|Overall Study|Withdrawal by Subject|34|||
129079774|NCT00839800|464582814|FG000|Overall Study|Incorrect Enrolment|3|||
129079775|NCT00839800|464582815|FG001|Overall Study|Incorrect Enrolment|3|||
129079776|NCT00839800|464582814|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
129079777|NCT00839800|464582815|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
129079778|NCT00839800|464582814|FG000|Overall Study|Safety Reasons|2|||
129079779|NCT00839800|464582815|FG001|Overall Study|Safety Reasons|1|||
129079780|NCT00839800|464582814|FG000|Overall Study|Other|8|||
129079781|NCT00839800|464582815|FG001|Overall Study|Other|14|||
129079782|NCT00839800|464582814|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
129079783|NCT00839800|464582815|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
129079784|NCT02801617|464582819|FG000|Overall Study|Protocol Violation|2|||
129079785|NCT02801617|464582820|FG001|Overall Study|Protocol Violation|6|||
129079786|NCT01372618|464582821|FG000|Overall Study|PI Died. Study Terminated|9|||
129079787|NCT01954056|464582822|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
129079788|NCT01954056|464582823|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
129079789|NCT06110494|464582828|FG000|Overall Study|Protocol Violation|2|||
129079790|NCT06110494|464582829|FG001|Overall Study|Protocol Violation|0|||
129079791|NCT06110494|464582830|FG002|Overall Study|Protocol Violation|1|||
129079792|NCT06110494|464582828|FG000|Overall Study|Dixon's test for outlier analysis|1|||
129079793|NCT06110494|464582829|FG001|Overall Study|Dixon's test for outlier analysis|1|||
129079794|NCT06110494|464582830|FG002|Overall Study|Dixon's test for outlier analysis|0|||
129079795|NCT02476578|464582839|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
129079796|NCT02476578|464582840|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
129079797|NCT02476578|464582839|FG000|Overall Study|Lost to Follow-up|6|||
129079798|NCT02476578|464582840|FG001|Overall Study|Lost to Follow-up|13|||
129079799|NCT01684423|464582841|FG000|Overall Study|Withdrawal by Subject|0|||
129079800|NCT01684423|464582842|FG001|Overall Study|Withdrawal by Subject|0|||
129079801|NCT01684423|464582843|FG002|Overall Study|Withdrawal by Subject|1|||
129079802|NCT01684423|464582844|FG003|Overall Study|Withdrawal by Subject|0|||
129079803|NCT01684423|464582845|FG004|Overall Study|Withdrawal by Subject|0|||
129079804|NCT01455597|464582846|FG000|Overall Study|Adverse Event|7|||
129079805|NCT01455597|464582847|FG001|Overall Study|Adverse Event|0|||
129079806|NCT01455597|464582848|FG002|Overall Study|Adverse Event|5|||
129079807|NCT01455597|464582849|FG003|Overall Study|Adverse Event|1|||
128724081|NCT01176292|463288972|FG000|Overall Study|Physician Decision|0|||
129079808|NCT01455597|464582846|FG000|Overall Study|Lack of Efficacy|0|||
129079809|NCT01455597|464582847|FG001|Overall Study|Lack of Efficacy|1|||
129079810|NCT01455597|464582848|FG002|Overall Study|Lack of Efficacy|2|||
129079811|NCT01455597|464582849|FG003|Overall Study|Lack of Efficacy|0|||
129079812|NCT01455597|464582846|FG000|Overall Study|Lost to Follow-up|3|||
129079813|NCT01455597|464582847|FG001|Overall Study|Lost to Follow-up|0|||
129079814|NCT01455597|464582848|FG002|Overall Study|Lost to Follow-up|2|||
129079815|NCT01455597|464582849|FG003|Overall Study|Lost to Follow-up|1|||
129079816|NCT01455597|464582846|FG000|Overall Study|Withdrew Consent|6|||
129079817|NCT01455597|464582847|FG001|Overall Study|Withdrew Consent|5|||
129079818|NCT01455597|464582848|FG002|Overall Study|Withdrew Consent|8|||
129079819|NCT01455597|464582849|FG003|Overall Study|Withdrew Consent|5|||
129079820|NCT01455597|464582846|FG000|Overall Study|Reason not Specified|1|||
129079821|NCT01455597|464582847|FG001|Overall Study|Reason not Specified|2|||
129079822|NCT01455597|464582848|FG002|Overall Study|Reason not Specified|3|||
129079823|NCT01455597|464582849|FG003|Overall Study|Reason not Specified|3|||
129079824|NCT03412734|464582852|FG000|Overall Study|Incorrect labeling of samples|2|||
129079825|NCT03412734|464582853|FG001|Overall Study|Incorrect labeling of samples|0|||
129079826|NCT03412734|464582852|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
129079827|NCT03412734|464582853|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
129079828|NCT04747886|464582854|FG000|Overall Study|Withdrawal by Subject|1|||
129079829|NCT04747886|464582855|FG001|Overall Study|Withdrawal by Subject|4|||
129079830|NCT03777436|464582860|FG000|Placebo-controlled Phase|Adverse Event|8|||
129079831|NCT03777436|464582861|FG001|Placebo-controlled Phase|Adverse Event|10|||
129079832|NCT03777436|464582862|FG002|Placebo-controlled Phase|Adverse Event|0|||
129079833|NCT03777436|464582860|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
129079834|NCT03777436|464582861|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
129079835|NCT03777436|464582862|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
129079836|NCT03777436|464582860|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
129079837|NCT03777436|464582861|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
129079838|NCT03777436|464582862|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
129079839|NCT03777436|464582860|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
129079840|NCT03777436|464582861|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
129079841|NCT03777436|464582862|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
129079842|NCT03777436|464582860|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
129079843|NCT03777436|464582861|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
129079844|NCT03777436|464582862|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
129079845|NCT03777436|464582860|FG000|Placebo-controlled Phase|Physician Decision|0|||
129079846|NCT03777436|464582861|FG001|Placebo-controlled Phase|Physician Decision|1|||
129079847|NCT03777436|464582862|FG002|Placebo-controlled Phase|Physician Decision|0|||
129079848|NCT03777436|464582860|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
129079849|NCT03777436|464582861|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
129079850|NCT03777436|464582862|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
129079851|NCT03777436|464582860|FG000|Apremilast Extension Phase|Adverse Event|0|||
129079852|NCT03777436|464582861|FG001|Apremilast Extension Phase|Adverse Event|0|||
129079853|NCT03777436|464582862|FG002|Apremilast Extension Phase|Adverse Event|6|||
129079854|NCT03777436|464582860|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
129079855|NCT03777436|464582861|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
129079856|NCT03777436|464582862|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
129079857|NCT03777436|464582860|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
129079858|NCT03777436|464582861|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
129079859|NCT03777436|464582862|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
129079860|NCT03777436|464582860|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
129079861|NCT03777436|464582861|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
129079862|NCT03777436|464582862|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
129079863|NCT03777436|464582860|FG000|Apremilast Extension Phase|Miscellaneous|0|||
129079864|NCT03777436|464582861|FG001|Apremilast Extension Phase|Miscellaneous|0|||
129079865|NCT03777436|464582862|FG002|Apremilast Extension Phase|Miscellaneous|1|||
129079866|NCT00869999|464582867|FG000|Overall Study|Withdrawal by Subject|1|||
129079867|NCT00869999|464582867|FG000|Overall Study|removed prior to starting therapy|1|||
129079868|NCT04478695|464582868|FG000|Overall Study|Death|1|||
129079869|NCT04478695|464582869|FG001|Overall Study|Death|0|||
129079870|NCT00644917|464582870|FG000|Overall Study|Withdrawal by Subject|2|||
129079871|NCT01136356|464582871|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
129079872|NCT01136356|464582872|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
129079873|NCT01136356|464582871|FG000|First 18-day Withdrawal|Physician Decision|1|||
129079874|NCT01136356|464582872|FG001|First 18-day Withdrawal|Physician Decision|0|||
129079875|NCT01136356|464582871|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
129079876|NCT01136356|464582872|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
129079877|NCT00402688|464582873|FG000|Overall Study|Adverse Event|12|||
129079878|NCT00402688|464582874|FG001|Overall Study|Adverse Event|9|||
129079879|NCT00402688|464582875|FG002|Overall Study|Adverse Event|3|||
129079880|NCT00402688|464582873|FG000|Overall Study|Withdrawal by Subject|3|||
129079881|NCT00402688|464582874|FG001|Overall Study|Withdrawal by Subject|1|||
129079882|NCT00402688|464582875|FG002|Overall Study|Withdrawal by Subject|1|||
129079883|NCT00402688|464582873|FG000|Overall Study|Physician Decision|0|||
129079884|NCT00402688|464582874|FG001|Overall Study|Physician Decision|0|||
129079885|NCT00402688|464582875|FG002|Overall Study|Physician Decision|1|||
129079886|NCT00402688|464582873|FG000|Overall Study|Lack of Efficacy|4|||
129079887|NCT00402688|464582874|FG001|Overall Study|Lack of Efficacy|4|||
128724082|NCT01176292|463288973|FG001|Overall Study|Physician Decision|2|||
128724083|NCT01176292|463288972|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
129079888|NCT00402688|464582875|FG002|Overall Study|Lack of Efficacy|5|||
129079889|NCT00402688|464582873|FG000|Overall Study|Protocol Violation|1|||
129079890|NCT00402688|464582874|FG001|Overall Study|Protocol Violation|1|||
129079891|NCT00402688|464582875|FG002|Overall Study|Protocol Violation|1|||
129079892|NCT00402688|464582873|FG000|Overall Study|Lost to Follow-up|1|||
129079893|NCT00402688|464582874|FG001|Overall Study|Lost to Follow-up|0|||
129079894|NCT00402688|464582875|FG002|Overall Study|Lost to Follow-up|2|||
129079895|NCT00402688|464582873|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
129079896|NCT00402688|464582874|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
129079897|NCT00402688|464582875|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
129079898|NCT00402688|464582873|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
129079899|NCT00402688|464582874|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
129079900|NCT00402688|464582875|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
129079901|NCT00402688|464582873|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
129079902|NCT00402688|464582874|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
128724084|NCT01176292|463288973|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
128724085|NCT00997503|463288974|FG000|Overall Study|Death|53|||
128724086|NCT00997503|463288974|FG000|Overall Study|Withdrawal by Subject|76|||
128724087|NCT00997503|463288974|FG000|Overall Study|Lost to Follow-up|33|||
129079903|NCT00402688|464582875|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
129079904|NCT00758485|464582876|FG000|Overall Study|Lost to Follow-up|0|||
129079905|NCT00758485|464582877|FG001|Overall Study|Lost to Follow-up|1|||
129079906|NCT00758485|464582876|FG000|Overall Study|Not Treated|1|||
129079907|NCT00758485|464582877|FG001|Overall Study|Not Treated|2|||
129079908|NCT02347774|464582878|FG000|Study Participation|Lost to Follow-up|3|||
129079909|NCT02347774|464582879|FG001|Study Participation|Lost to Follow-up|6|||
129079910|NCT02347774|464582880|FG002|Study Participation|Lost to Follow-up|2|||
129079911|NCT02347774|464582878|FG000|Study Participation|Withdrawal by Subject|8|||
129079912|NCT02347774|464582879|FG001|Study Participation|Withdrawal by Subject|9|||
129079913|NCT02347774|464582880|FG002|Study Participation|Withdrawal by Subject|15|||
129079914|NCT02347774|464582878|FG000|Study Participation|Adverse Event|1|||
128776564|NCT02846558|463470464|FG001|Overall Study|Lost to Follow-up|0|||
128776565|NCT02846558|463470465|FG002|Overall Study|Lost to Follow-up|0|||
128776566|NCT02846558|463470466|FG003|Overall Study|Lost to Follow-up|0|||
129079915|NCT02347774|464582879|FG001|Study Participation|Adverse Event|4|||
129079916|NCT02347774|464582880|FG002|Study Participation|Adverse Event|6|||
129079917|NCT02347774|464582878|FG000|Study Participation|withdrew consent|1|||
129079918|NCT02347774|464582879|FG001|Study Participation|withdrew consent|1|||
129079919|NCT02347774|464582880|FG002|Study Participation|withdrew consent|1|||
129079920|NCT02347774|464582878|FG000|Study Participation|Met Prolonged QT criteria|1|||
129079921|NCT02347774|464582879|FG001|Study Participation|Met Prolonged QT criteria|0|||
129079922|NCT02347774|464582880|FG002|Study Participation|Met Prolonged QT criteria|0|||
129079923|NCT02347774|464582878|FG000|Study Participation|non-compliance with study drug|0|||
129079924|NCT02347774|464582879|FG001|Study Participation|non-compliance with study drug|1|||
129079925|NCT02347774|464582880|FG002|Study Participation|non-compliance with study drug|0|||
129079926|NCT02347774|464582878|FG000|Study Participation|incarceration|1|||
129079927|NCT02347774|464582879|FG001|Study Participation|incarceration|0|||
129079928|NCT02347774|464582880|FG002|Study Participation|incarceration|0|||
129079929|NCT02347774|464582878|FG000|Study Participation|randomized in error|0|||
129079930|NCT02347774|464582879|FG001|Study Participation|randomized in error|0|||
129079931|NCT02347774|464582880|FG002|Study Participation|randomized in error|1|||
129079932|NCT02347774|464582878|FG000|On Study Treatment|Adverse Event|9|||
129079933|NCT02347774|464582879|FG001|On Study Treatment|Adverse Event|15|||
129079934|NCT02347774|464582880|FG002|On Study Treatment|Adverse Event|19|||
129079935|NCT02347774|464582878|FG000|On Study Treatment|Lack of Efficacy|3|||
129079936|NCT02347774|464582879|FG001|On Study Treatment|Lack of Efficacy|0|||
129079937|NCT02347774|464582880|FG002|On Study Treatment|Lack of Efficacy|2|||
129079938|NCT02347774|464582878|FG000|On Study Treatment|non-complicance with study medication|0|||
129079939|NCT02347774|464582879|FG001|On Study Treatment|non-complicance with study medication|2|||
129079940|NCT02347774|464582880|FG002|On Study Treatment|non-complicance with study medication|0|||
129079941|NCT02347774|464582878|FG000|On Study Treatment|Protocol Violation|0|||
129079942|NCT02347774|464582879|FG001|On Study Treatment|Protocol Violation|0|||
129079943|NCT02347774|464582880|FG002|On Study Treatment|Protocol Violation|1|||
129079944|NCT02347774|464582878|FG000|On Study Treatment|withdrew consent|9|||
129079945|NCT02347774|464582879|FG001|On Study Treatment|withdrew consent|8|||
128724088|NCT00997503|463288974|FG000|Overall Study|Adverse Event|3|||
128724089|NCT00997503|463288974|FG000|Overall Study|Physician Decision|10|||
128724090|NCT00997503|463288974|FG000|Overall Study|Missed 12-month follow-up|85|||
128724091|NCT00997503|463288974|FG000|Overall Study|Other reason|13|||
128724092|NCT00116831|463288975|FG000|Overall Study|Adverse Event|14|||
128724093|NCT00116831|463288976|FG001|Overall Study|Adverse Event|16|||
128724094|NCT00116831|463288975|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
129079946|NCT02347774|464582880|FG002|On Study Treatment|withdrew consent|12|||
129079947|NCT02347774|464582878|FG000|On Study Treatment|Lost to Follow-up|2|||
129079948|NCT02347774|464582879|FG001|On Study Treatment|Lost to Follow-up|6|||
129079949|NCT02347774|464582880|FG002|On Study Treatment|Lost to Follow-up|1|||
129079950|NCT02347774|464582878|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
129079951|NCT02347774|464582879|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
129079952|NCT02347774|464582880|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
129079953|NCT02347774|464582878|FG000|On Study Treatment|ranomized in error|0|||
129079954|NCT02347774|464582879|FG001|On Study Treatment|ranomized in error|0|||
128724095|NCT00116831|463288976|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
129079955|NCT02347774|464582880|FG002|On Study Treatment|ranomized in error|1|||
129079956|NCT00656292|464582881|FG000|Overall Study|Withdrawal by Subject|2|||
129079957|NCT00656292|464582882|FG001|Overall Study|Withdrawal by Subject|3|||
128776567|NCT00904150|463470476|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
129079958|NCT00656292|464582881|FG000|Overall Study|Screen failure|1|||
129079959|NCT00656292|464582882|FG001|Overall Study|Screen failure|2|||
129079960|NCT00921557|464582883|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
129079961|NCT00921557|464582884|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
129079962|NCT00921557|464582885|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
129079963|NCT00921557|464582883|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
129079964|NCT00921557|464582884|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
129079965|NCT00921557|464582885|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
129079966|NCT00921557|464582883|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
129079967|NCT00921557|464582884|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
129079968|NCT00921557|464582885|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
129079969|NCT00921557|464582883|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
129079970|NCT00921557|464582884|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
129079971|NCT00921557|464582885|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
129079972|NCT00921557|464582883|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
129079973|NCT00921557|464582884|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
129079974|NCT00921557|464582885|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
129079975|NCT04112043|464582886|FG000|Overall Study|Withdrawal by Subject|1|||
129079976|NCT04112043|464582887|FG001|Overall Study|Withdrawal by Subject|1|||
129079977|NCT04112043|464582888|FG002|Overall Study|Withdrawal by Subject|1|||
129079978|NCT04112043|464582886|FG000|Overall Study|Taking NR supplement|1|||
129079979|NCT04112043|464582887|FG001|Overall Study|Taking NR supplement|0|||
129079980|NCT04112043|464582888|FG002|Overall Study|Taking NR supplement|0|||
129142226|NCT03715829|464815724|FG007|Dose Ranging Period|Lack of Efficacy|0|||
129142227|NCT03715829|464815725|FG008|Dose Ranging Period|Lack of Efficacy|0|||
129142228|NCT03715829|464815726|FG009|Dose Ranging Period|Lack of Efficacy|0|||
129142229|NCT03715829|464815727|FG010|Dose Ranging Period|Lack of Efficacy|0|||
129142230|NCT03715829|464815717|FG000|Dose Ranging Period|Lost to Follow-up|2|||
129142231|NCT03715829|464815718|FG001|Dose Ranging Period|Lost to Follow-up|0|||
129142232|NCT03715829|464815719|FG002|Dose Ranging Period|Lost to Follow-up|1|||
129142233|NCT03715829|464815720|FG003|Dose Ranging Period|Lost to Follow-up|1|||
129142234|NCT03715829|464815721|FG004|Dose Ranging Period|Lost to Follow-up|1|||
129142235|NCT03715829|464815722|FG005|Dose Ranging Period|Lost to Follow-up|2|||
129142236|NCT03715829|464815723|FG006|Dose Ranging Period|Lost to Follow-up|0|||
129142237|NCT03715829|464815724|FG007|Dose Ranging Period|Lost to Follow-up|0|||
129142238|NCT03715829|464815725|FG008|Dose Ranging Period|Lost to Follow-up|0|||
129142239|NCT03715829|464815726|FG009|Dose Ranging Period|Lost to Follow-up|0|||
129142240|NCT03715829|464815727|FG010|Dose Ranging Period|Lost to Follow-up|0|||
129142241|NCT03715829|464815717|FG000|Dose Ranging Period|Protocol Violation|0|||
129142242|NCT03715829|464815718|FG001|Dose Ranging Period|Protocol Violation|0|||
129142243|NCT03715829|464815719|FG002|Dose Ranging Period|Protocol Violation|0|||
129142244|NCT03715829|464815720|FG003|Dose Ranging Period|Protocol Violation|1|||
129142245|NCT03715829|464815721|FG004|Dose Ranging Period|Protocol Violation|0|||
129142246|NCT03715829|464815722|FG005|Dose Ranging Period|Protocol Violation|0|||
129142247|NCT03715829|464815723|FG006|Dose Ranging Period|Protocol Violation|0|||
129142248|NCT03715829|464815724|FG007|Dose Ranging Period|Protocol Violation|0|||
129142249|NCT03715829|464815725|FG008|Dose Ranging Period|Protocol Violation|0|||
129142250|NCT03715829|464815726|FG009|Dose Ranging Period|Protocol Violation|0|||
129142251|NCT03715829|464815727|FG010|Dose Ranging Period|Protocol Violation|0|||
129142252|NCT03715829|464815717|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
129142253|NCT03715829|464815718|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
129142254|NCT03715829|464815719|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
129142255|NCT03715829|464815720|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
129142256|NCT03715829|464815721|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
129142257|NCT03715829|464815722|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
129142258|NCT03715829|464815723|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
129142259|NCT03715829|464815724|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
129142260|NCT03715829|464815725|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
129142261|NCT03715829|464815726|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
129142262|NCT03715829|464815727|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
129142263|NCT03715829|464815717|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142264|NCT03715829|464815718|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142265|NCT03715829|464815719|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
129142266|NCT03715829|464815720|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142267|NCT03715829|464815721|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142268|NCT03715829|464815722|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142269|NCT03715829|464815723|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129079981|NCT04112043|464582886|FG000|Overall Study|Adverse Event|0|||
129079982|NCT04112043|464582887|FG001|Overall Study|Adverse Event|1|||
129079983|NCT04112043|464582888|FG002|Overall Study|Adverse Event|0|||
129142270|NCT03715829|464815724|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129079984|NCT03259425|464582889|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
129079985|NCT04157296|464582890|FG000|Overall Study|Withdrawal by Subject|0|||
129079986|NCT04157296|464582891|FG001|Overall Study|Withdrawal by Subject|1|||
129079987|NCT04157296|464582890|FG000|Overall Study|Did not obtain second fMRI.|0|||
129079988|NCT04157296|464582891|FG001|Overall Study|Did not obtain second fMRI.|1|||
129079989|NCT04157296|464582890|FG000|Overall Study|MRI failed/no second fMRI|0|||
129079990|NCT04157296|464582891|FG001|Overall Study|MRI failed/no second fMRI|1|||
129079991|NCT02091089|464582895|FG000|Overall Study|Lost to Follow-up|2|||
129079992|NCT01580670|464582896|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
129079993|NCT01580670|464582896|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
129079994|NCT02097745|464582897|FG000|Overall Study|Adverse Event|25|||
129079995|NCT02097745|464582897|FG000|Overall Study|Death|16|||
129079996|NCT02097745|464582897|FG000|Overall Study|Failure to Return|14|||
129079997|NCT02097745|464582897|FG000|Overall Study|Administrative/Other|27|||
129079998|NCT02097745|464582897|FG000|Overall Study|Reason Not Specified|96|||
129079999|NCT00425750|464582898|FG000|Overall Study|Death|1|||
129080000|NCT00425750|464582898|FG000|Overall Study|Withdrawal by Subject|3|||
129080001|NCT00425750|464582898|FG000|Overall Study|Adverse Event|3|||
129080002|NCT00425750|464582898|FG000|Overall Study|Progression of disease|18|||
129080003|NCT01757184|464582899|FG000|Double-blind Period|Adverse Event|1|||
129080004|NCT01757184|464582900|FG001|Double-blind Period|Adverse Event|0|||
129080005|NCT01757184|464582901|FG002|Double-blind Period|Adverse Event|0|||
129080006|NCT01757184|464582902|FG003|Double-blind Period|Adverse Event|0|||
129080007|NCT01757184|464582899|FG000|Open-label Period|Lost to Follow-up|0|||
129080008|NCT01757184|464582900|FG001|Open-label Period|Lost to Follow-up|0|||
129080009|NCT01757184|464582901|FG002|Open-label Period|Lost to Follow-up|2|||
129080010|NCT01757184|464582902|FG003|Open-label Period|Lost to Follow-up|0|||
129080011|NCT01757184|464582899|FG000|Open-label Period|Withdrawal by Subject|0|||
129080012|NCT01757184|464582900|FG001|Open-label Period|Withdrawal by Subject|0|||
128724096|NCT00116831|463288975|FG000|Overall Study|Lost to Follow-up|8|||
128724097|NCT00116831|463288976|FG001|Overall Study|Lost to Follow-up|6|||
129080013|NCT01757184|464582901|FG002|Open-label Period|Withdrawal by Subject|1|||
129080014|NCT01757184|464582902|FG003|Open-label Period|Withdrawal by Subject|1|||
129080015|NCT01757184|464582899|FG000|Open-label Period|Discontinued by Sponsor|0|||
129080016|NCT01757184|464582900|FG001|Open-label Period|Discontinued by Sponsor|0|||
129080017|NCT01757184|464582901|FG002|Open-label Period|Discontinued by Sponsor|1|||
129080018|NCT01757184|464582902|FG003|Open-label Period|Discontinued by Sponsor|2|||
129080019|NCT00554515|464582903|FG000|Overall Study|Withdrawal by Subject|3|||
129080020|NCT00554515|464582903|FG000|Overall Study|Disease progression|52|||
129080021|NCT00554515|464582903|FG000|Overall Study|Physician Decision|18|||
129080022|NCT00554515|464582903|FG000|Overall Study|Withdrawal by Subject|11|||
129080023|NCT00554515|464582903|FG000|Overall Study|Adverse Event|9|||
129080024|NCT00554515|464582903|FG000|Overall Study|Death|2|||
129080025|NCT00554515|464582903|FG000|Overall Study|Achieved Stable Disease|7|||
129080026|NCT00554515|464582903|FG000|Overall Study|Other|1|||
129080027|NCT00554515|464582903|FG000|Overall Study|Misc|15|||
129080028|NCT01276756|464582906|FG000|Overall Study|Lost to Follow-up|2|||
129080029|NCT01276756|464582907|FG001|Overall Study|Lost to Follow-up|0|||
129080030|NCT01276756|464582906|FG000|Overall Study|Adverse Event|3|||
129080031|NCT01276756|464582907|FG001|Overall Study|Adverse Event|2|||
129080032|NCT01554527|464582915|FG000|Overall Study|Withdrawal by Subject|1|||
129080033|NCT01554527|464582916|FG001|Overall Study|Withdrawal by Subject|0|||
129080034|NCT01554527|464582917|FG002|Overall Study|Withdrawal by Subject|3|||
129080035|NCT01554527|464582915|FG000|Overall Study|Lost to Follow-up|0|||
129080036|NCT01554527|464582916|FG001|Overall Study|Lost to Follow-up|0|||
129080037|NCT01554527|464582917|FG002|Overall Study|Lost to Follow-up|4|||
129080038|NCT01554527|464582915|FG000|Overall Study|Physician Decision|0|||
129080039|NCT01554527|464582916|FG001|Overall Study|Physician Decision|0|||
129080040|NCT01554527|464582917|FG002|Overall Study|Physician Decision|1|||
129080041|NCT01052480|464582918|FG000|Overall Study|Lost to Follow-up|3|||
129080042|NCT01052480|464582919|FG001|Overall Study|Lost to Follow-up|3|||
129080043|NCT01052480|464582918|FG000|Overall Study|Protocol Violation|1|||
129080044|NCT01052480|464582919|FG001|Overall Study|Protocol Violation|0|||
129080045|NCT01052480|464582918|FG000|Overall Study|Withdrawal by Subject|3|||
129080046|NCT01052480|464582919|FG001|Overall Study|Withdrawal by Subject|7|||
129080047|NCT01052480|464582918|FG000|Overall Study|Physician Decision|0|||
129080048|NCT01052480|464582919|FG001|Overall Study|Physician Decision|2|||
129080049|NCT01052480|464582918|FG000|Overall Study|Death|1|||
129080050|NCT01052480|464582919|FG001|Overall Study|Death|5|||
129080051|NCT00529373|464582926|FG000|Base Study|Adverse Event|525|||
129080052|NCT00529373|464582927|FG001|Base Study|Adverse Event|470|||
129080053|NCT00529373|464582926|FG000|Base Study|Lack of Efficacy|16|||
129080054|NCT00529373|464582927|FG001|Base Study|Lack of Efficacy|75|||
129080055|NCT00529373|464582926|FG000|Base Study|Lost to Follow-up|221|||
129080056|NCT00529373|464582927|FG001|Base Study|Lost to Follow-up|208|||
129080057|NCT00529373|464582926|FG000|Base Study|Other Protocol Specified Criteria|19|||
129080058|NCT00529373|464582927|FG001|Base Study|Other Protocol Specified Criteria|20|||
129080059|NCT00529373|464582926|FG000|Base Study|Physician Decision|60|||
129080060|NCT00529373|464582927|FG001|Base Study|Physician Decision|52|||
129080061|NCT00529373|464582926|FG000|Base Study|Protocol Violation|48|||
129080062|NCT00529373|464582927|FG001|Base Study|Protocol Violation|38|||
129080063|NCT00529373|464582926|FG000|Base Study|Withdrawal by Subject|1062|||
129080064|NCT00529373|464582927|FG001|Base Study|Withdrawal by Subject|967|||
129080065|NCT00529373|464582926|FG000|Base Study|Did not continue into Extension|1795|||
129080066|NCT00529373|464582927|FG001|Base Study|Did not continue into Extension|2238|||
129080067|NCT00529373|464582926|FG000|First Extension Study|Adverse Event|162|||
129080068|NCT00529373|464582927|FG001|First Extension Study|Adverse Event|142|||
129080069|NCT00529373|464582926|FG000|First Extension Study|Lack of Efficacy|65|||
129080070|NCT00529373|464582927|FG001|First Extension Study|Lack of Efficacy|427|||
129080071|NCT00529373|464582926|FG000|First Extension Study|Lost to Follow-up|41|||
129080072|NCT00529373|464582927|FG001|First Extension Study|Lost to Follow-up|37|||
129080073|NCT00529373|464582926|FG000|First Extension Study|Other|27|||
129080074|NCT00529373|464582927|FG001|First Extension Study|Other|47|||
129080075|NCT00529373|464582926|FG000|First Extension Study|Physician Decision|50|||
129080076|NCT00529373|464582927|FG001|First Extension Study|Physician Decision|45|||
129080077|NCT00529373|464582926|FG000|First Extension Study|Protocol Violation|16|||
129080078|NCT00529373|464582927|FG001|First Extension Study|Protocol Violation|13|||
129080079|NCT00529373|464582926|FG000|First Extension Study|Withdrawal by Subject|296|||
129080080|NCT00529373|464582927|FG001|First Extension Study|Withdrawal by Subject|287|||
129080081|NCT00529373|464582926|FG000|First Extension Study|Disposition record non-existing|0|||
129080082|NCT00529373|464582927|FG001|First Extension Study|Disposition record non-existing|1|||
129080083|NCT00529373|464582926|FG000|First Extension Study|Discontinued after 5 years completion|208|||
129080084|NCT00529373|464582927|FG001|First Extension Study|Discontinued after 5 years completion|346|||
129080085|NCT00529373|464582926|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
129080086|NCT00529373|464582927|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
129080087|NCT00529373|464582926|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
129080088|NCT00529373|464582927|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
129080089|NCT00529373|464582926|FG000|Second Extension Study|Adverse Event|101|||
129080090|NCT00529373|464582927|FG001|Second Extension Study|Adverse Event|51|||
129080091|NCT00529373|464582926|FG000|Second Extension Study|Lack of Efficacy|7|||
129080092|NCT00529373|464582927|FG001|Second Extension Study|Lack of Efficacy|15|||
129080093|NCT00529373|464582926|FG000|Second Extension Study|Lost to Follow-up|18|||
129080094|NCT00529373|464582927|FG001|Second Extension Study|Lost to Follow-up|12|||
129080095|NCT00529373|464582926|FG000|Second Extension Study|Other|7|||
129080096|NCT00529373|464582927|FG001|Second Extension Study|Other|12|||
129080097|NCT00529373|464582926|FG000|Second Extension Study|Physician Decision|63|||
129080098|NCT00529373|464582927|FG001|Second Extension Study|Physician Decision|26|||
129080099|NCT00529373|464582926|FG000|Second Extension Study|Protocol Violation|2|||
129080100|NCT00529373|464582927|FG001|Second Extension Study|Protocol Violation|1|||
129080101|NCT00529373|464582926|FG000|Second Extension Study|Withdrawal by Subject|97|||
129080102|NCT00529373|464582927|FG001|Second Extension Study|Withdrawal by Subject|75|||
129080103|NCT00529373|464582926|FG000|Second Extension Study|Status Missing|5|||
129080104|NCT00529373|464582927|FG001|Second Extension Study|Status Missing|5|||
129080105|NCT00757042|464582930|FG000|Overall Study|Lost to Follow-up|0|||
129080106|NCT00757042|464582931|FG001|Overall Study|Lost to Follow-up|0|||
129080107|NCT00757042|464582932|FG002|Overall Study|Lost to Follow-up|0|||
129080108|NCT00757042|464582933|FG003|Overall Study|Lost to Follow-up|0|||
129080109|NCT00757042|464582934|FG004|Overall Study|Lost to Follow-up|0|||
129080110|NCT00757042|464582935|FG005|Overall Study|Lost to Follow-up|0|||
129080111|NCT00757042|464582936|FG006|Overall Study|Lost to Follow-up|0|||
129080112|NCT00757042|464582937|FG007|Overall Study|Lost to Follow-up|0|||
129080113|NCT00757042|464582938|FG008|Overall Study|Lost to Follow-up|1|||
129080114|NCT00757042|464582939|FG009|Overall Study|Lost to Follow-up|0|||
129080115|NCT00757042|464582940|FG010|Overall Study|Lost to Follow-up|0|||
129080116|NCT00757042|464582930|FG000|Overall Study|Ineligibility Determined|0|||
129080117|NCT00757042|464582931|FG001|Overall Study|Ineligibility Determined|0|||
129080118|NCT00757042|464582932|FG002|Overall Study|Ineligibility Determined|0|||
129080119|NCT00757042|464582933|FG003|Overall Study|Ineligibility Determined|0|||
129080120|NCT00757042|464582934|FG004|Overall Study|Ineligibility Determined|0|||
129080121|NCT00757042|464582935|FG005|Overall Study|Ineligibility Determined|0|||
129080122|NCT00757042|464582936|FG006|Overall Study|Ineligibility Determined|0|||
129080123|NCT00757042|464582937|FG007|Overall Study|Ineligibility Determined|0|||
129080124|NCT00757042|464582938|FG008|Overall Study|Ineligibility Determined|0|||
129080125|NCT00757042|464582939|FG009|Overall Study|Ineligibility Determined|0|||
129080126|NCT00757042|464582940|FG010|Overall Study|Ineligibility Determined|1|||
129080127|NCT00757042|464582930|FG000|Overall Study|Withdrawal by Subject|0|||
129080128|NCT00757042|464582931|FG001|Overall Study|Withdrawal by Subject|0|||
129080129|NCT00757042|464582932|FG002|Overall Study|Withdrawal by Subject|0|||
129080130|NCT00757042|464582933|FG003|Overall Study|Withdrawal by Subject|0|||
129080131|NCT00757042|464582934|FG004|Overall Study|Withdrawal by Subject|0|||
129080132|NCT00757042|464582935|FG005|Overall Study|Withdrawal by Subject|0|||
129080133|NCT00757042|464582936|FG006|Overall Study|Withdrawal by Subject|0|||
129080134|NCT00757042|464582937|FG007|Overall Study|Withdrawal by Subject|0|||
129080135|NCT00757042|464582938|FG008|Overall Study|Withdrawal by Subject|0|||
129080136|NCT00757042|464582939|FG009|Overall Study|Withdrawal by Subject|1|||
129080137|NCT00757042|464582940|FG010|Overall Study|Withdrawal by Subject|0|||
129080138|NCT01870973|464582944|FG000|Overall Study|Lost to Follow-up|10|||
129080139|NCT01870973|464582945|FG001|Overall Study|Lost to Follow-up|3|||
129080140|NCT01266291|464582947|FG000|Overall Study|Adverse Event|1|||
129080141|NCT03291431|464582948|FG000|Overall Study|Protocol Violation|2|||
129080142|NCT03291431|464582949|FG001|Overall Study|Protocol Violation|1|||
129080143|NCT03291431|464582948|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
129080144|NCT03291431|464582949|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
129080145|NCT03291431|464582948|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
129080146|NCT03291431|464582949|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
129080147|NCT00550745|464582952|FG000|Overall Study|Death|20|||
129080148|NCT00550745|464582953|FG001|Overall Study|Death|16|||
129142271|NCT03715829|464815725|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142272|NCT03715829|464815726|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142273|NCT03715829|464815727|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129142274|NCT03715829|464815717|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142275|NCT03715829|464815718|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142276|NCT03715829|464815719|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
129142277|NCT03715829|464815720|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142278|NCT03715829|464815721|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
129142279|NCT03715829|464815722|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142280|NCT03715829|464815723|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142281|NCT03715829|464815724|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142282|NCT03715829|464815725|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129080149|NCT00550745|464582952|FG000|Overall Study|Lost to Follow-up|45|||
129080150|NCT00550745|464582953|FG001|Overall Study|Lost to Follow-up|30|||
129080151|NCT00550745|464582952|FG000|Overall Study|Physician Decision|0|||
129080152|NCT00550745|464582953|FG001|Overall Study|Physician Decision|2|||
129080153|NCT00550745|464582952|FG000|Overall Study|Protocol Violation|4|||
129080154|NCT00550745|464582953|FG001|Overall Study|Protocol Violation|2|||
129080155|NCT00550745|464582952|FG000|Overall Study|Withdrawal by Subject|17|||
129080156|NCT00550745|464582953|FG001|Overall Study|Withdrawal by Subject|10|||
129080157|NCT00550745|464582952|FG000|Overall Study|Screen failure|1|||
129080158|NCT00550745|464582953|FG001|Overall Study|Screen failure|0|||
129080159|NCT03850483|464582956|FG000|Treatment for Stage 1|Adverse Event|1|||
129080160|NCT03850483|464582957|FG001|Treatment for Stage 1|Adverse Event|1|||
129080161|NCT03850483|464582958|FG002|Treatment for Stage 1|Adverse Event|3|||
129080162|NCT03850483|464582959|FG003|Treatment for Stage 1|Adverse Event|0|||
129080163|NCT03850483|464582960|FG004|Treatment for Stage 1|Adverse Event|2|||
129080164|NCT03850483|464582961|FG005|Treatment for Stage 1|Adverse Event|0|||
129080165|NCT03850483|464582962|FG006|Treatment for Stage 1|Adverse Event|2|||
129080166|NCT03850483|464582963|FG007|Treatment for Stage 1|Adverse Event|2|||
129080167|NCT03850483|464582964|FG008|Treatment for Stage 1|Adverse Event|0|||
129080168|NCT03850483|464582965|FG009|Treatment for Stage 1|Adverse Event|0|||
129080169|NCT03850483|464582956|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
129080170|NCT03850483|464582957|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
129080171|NCT03850483|464582958|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
129080172|NCT03850483|464582959|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
129080173|NCT03850483|464582960|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
129080174|NCT03850483|464582961|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
129080175|NCT03850483|464582962|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
129080176|NCT03850483|464582963|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
129080177|NCT03850483|464582964|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
129080178|NCT03850483|464582965|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
129080179|NCT03850483|464582956|FG000|Treatment for Stage 1|Protocol Violation|1|||
129080180|NCT03850483|464582957|FG001|Treatment for Stage 1|Protocol Violation|0|||
129080181|NCT03850483|464582958|FG002|Treatment for Stage 1|Protocol Violation|0|||
129080182|NCT03850483|464582959|FG003|Treatment for Stage 1|Protocol Violation|0|||
129080183|NCT03850483|464582960|FG004|Treatment for Stage 1|Protocol Violation|0|||
129080184|NCT03850483|464582961|FG005|Treatment for Stage 1|Protocol Violation|0|||
129080185|NCT03850483|464582962|FG006|Treatment for Stage 1|Protocol Violation|1|||
129080186|NCT03850483|464582963|FG007|Treatment for Stage 1|Protocol Violation|0|||
129080187|NCT03850483|464582964|FG008|Treatment for Stage 1|Protocol Violation|0|||
129080188|NCT03850483|464582965|FG009|Treatment for Stage 1|Protocol Violation|0|||
129080189|NCT03850483|464582956|FG000|Treatment for Stage 1|Physician Decision|0|||
129080190|NCT03850483|464582957|FG001|Treatment for Stage 1|Physician Decision|0|||
129080191|NCT03850483|464582958|FG002|Treatment for Stage 1|Physician Decision|0|||
129080192|NCT03850483|464582959|FG003|Treatment for Stage 1|Physician Decision|0|||
129080193|NCT03850483|464582960|FG004|Treatment for Stage 1|Physician Decision|0|||
129080194|NCT03850483|464582961|FG005|Treatment for Stage 1|Physician Decision|1|||
129080195|NCT03850483|464582962|FG006|Treatment for Stage 1|Physician Decision|0|||
129080196|NCT03850483|464582963|FG007|Treatment for Stage 1|Physician Decision|0|||
129080197|NCT03850483|464582964|FG008|Treatment for Stage 1|Physician Decision|0|||
129080198|NCT03850483|464582965|FG009|Treatment for Stage 1|Physician Decision|0|||
129080199|NCT03850483|464582956|FG000|Treatment for Stage 1|Other|0|||
129080200|NCT03850483|464582957|FG001|Treatment for Stage 1|Other|0|||
129080201|NCT03850483|464582958|FG002|Treatment for Stage 1|Other|0|||
129080202|NCT03850483|464582959|FG003|Treatment for Stage 1|Other|0|||
129080203|NCT03850483|464582960|FG004|Treatment for Stage 1|Other|2|||
129080204|NCT03850483|464582961|FG005|Treatment for Stage 1|Other|1|||
129080205|NCT03850483|464582962|FG006|Treatment for Stage 1|Other|0|||
129080206|NCT03850483|464582963|FG007|Treatment for Stage 1|Other|0|||
129080207|NCT03850483|464582964|FG008|Treatment for Stage 1|Other|0|||
129080208|NCT03850483|464582965|FG009|Treatment for Stage 1|Other|0|||
129080209|NCT03850483|464582956|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129080210|NCT03850483|464582957|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129142283|NCT03715829|464815726|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142284|NCT03715829|464815727|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129142285|NCT03715829|464815717|FG000|Dose Ranging Period|Other|0|||
129080211|NCT03850483|464582958|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
129080212|NCT03850483|464582959|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129080213|NCT03850483|464582960|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129080214|NCT03850483|464582961|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129080215|NCT03850483|464582962|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129080216|NCT03850483|464582963|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129080217|NCT03850483|464582964|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129080218|NCT03850483|464582965|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
128724098|NCT00116831|463288975|FG000|Overall Study|Protocol Violation|3|||
128724099|NCT00116831|463288976|FG001|Overall Study|Protocol Violation|6|||
129080219|NCT03850483|464582956|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080220|NCT03850483|464582957|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080221|NCT03850483|464582958|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080222|NCT03850483|464582959|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080223|NCT03850483|464582960|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080224|NCT03850483|464582961|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
128724100|NCT00116831|463288975|FG000|Overall Study|Hypoglycaemic events|1|||
129080225|NCT03850483|464582962|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080226|NCT03850483|464582963|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080227|NCT03850483|464582964|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080228|NCT03850483|464582965|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129080229|NCT03850483|464582956|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
129080230|NCT03850483|464582957|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
129080231|NCT03850483|464582958|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
129080232|NCT03850483|464582959|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
129080233|NCT03850483|464582960|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
129080234|NCT03850483|464582961|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
129080235|NCT03850483|464582962|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
129080236|NCT03850483|464582963|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
129080237|NCT03850483|464582964|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
129080238|NCT03850483|464582965|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
129080239|NCT03850483|464582956|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
129080240|NCT03850483|464582957|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
129080241|NCT03850483|464582958|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
129080242|NCT03850483|464582959|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
129080243|NCT03850483|464582960|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
129080244|NCT03850483|464582961|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
129080245|NCT03850483|464582962|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
129080246|NCT03850483|464582963|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
129080247|NCT03850483|464582964|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
129080248|NCT03850483|464582965|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
129080249|NCT03850483|464582956|FG000|Treatment for Stage 1|Death|0|||
129080250|NCT03850483|464582957|FG001|Treatment for Stage 1|Death|0|||
129080251|NCT03850483|464582958|FG002|Treatment for Stage 1|Death|0|||
129080252|NCT03850483|464582959|FG003|Treatment for Stage 1|Death|0|||
129080253|NCT03850483|464582960|FG004|Treatment for Stage 1|Death|0|||
129080254|NCT03850483|464582961|FG005|Treatment for Stage 1|Death|1|||
129080255|NCT03850483|464582962|FG006|Treatment for Stage 1|Death|0|||
129080256|NCT03850483|464582963|FG007|Treatment for Stage 1|Death|0|||
129080257|NCT03850483|464582964|FG008|Treatment for Stage 1|Death|0|||
129080258|NCT03850483|464582965|FG009|Treatment for Stage 1|Death|0|||
129080259|NCT03850483|464582956|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
129080260|NCT03850483|464582957|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
129080261|NCT03850483|464582958|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
129080262|NCT03850483|464582959|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
129080263|NCT03850483|464582960|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
129080264|NCT03850483|464582961|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
129080265|NCT03850483|464582962|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
129080266|NCT03850483|464582963|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
129080267|NCT03850483|464582964|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
129080268|NCT03850483|464582965|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
129080269|NCT03850483|464582956|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
129080270|NCT03850483|464582957|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
129080271|NCT03850483|464582958|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
129080272|NCT03850483|464582959|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
129080273|NCT03850483|464582960|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
129080274|NCT03850483|464582961|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
129080275|NCT03850483|464582962|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
129080276|NCT03850483|464582963|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
129080277|NCT03850483|464582964|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
129080278|NCT03850483|464582965|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
129080279|NCT03850483|464582956|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
129080280|NCT03850483|464582957|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
129080281|NCT03850483|464582958|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
128724101|NCT00116831|463288976|FG001|Overall Study|Hypoglycaemic events|0|||
128724102|NCT00116831|463288975|FG000|Overall Study|Low haemoglobin on screening|1|||
129080282|NCT03850483|464582959|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
129080283|NCT03850483|464582960|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
129080284|NCT03850483|464582961|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
129080285|NCT03850483|464582962|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
129080286|NCT03850483|464582963|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
129080287|NCT03850483|464582964|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
129080288|NCT03850483|464582965|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
129080289|NCT03850483|464582956|FG000|Follow-up for Stage 1|Physician Decision|0|||
129080290|NCT03850483|464582957|FG001|Follow-up for Stage 1|Physician Decision|0|||
129080291|NCT03850483|464582958|FG002|Follow-up for Stage 1|Physician Decision|0|||
129080292|NCT03850483|464582959|FG003|Follow-up for Stage 1|Physician Decision|0|||
129080293|NCT03850483|464582960|FG004|Follow-up for Stage 1|Physician Decision|1|||
128724103|NCT00116831|463288976|FG001|Overall Study|Low haemoglobin on screening|0|||
129080294|NCT03850483|464582961|FG005|Follow-up for Stage 1|Physician Decision|0|||
129080295|NCT03850483|464582962|FG006|Follow-up for Stage 1|Physician Decision|1|||
129080296|NCT03850483|464582963|FG007|Follow-up for Stage 1|Physician Decision|0|||
129080297|NCT03850483|464582964|FG008|Follow-up for Stage 1|Physician Decision|0|||
129080298|NCT03850483|464582965|FG009|Follow-up for Stage 1|Physician Decision|0|||
129080299|NCT03850483|464582956|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
129080300|NCT03850483|464582957|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
129080301|NCT03850483|464582958|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
129080302|NCT03850483|464582959|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
129080303|NCT03850483|464582960|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
129080304|NCT03850483|464582961|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
129080305|NCT03850483|464582962|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
129080306|NCT03850483|464582963|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
129080307|NCT03850483|464582964|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
129080308|NCT03850483|464582965|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
129080309|NCT03850483|464582956|FG000|Follow-up for Stage 1|Adverse Event|0|||
129080310|NCT03850483|464582957|FG001|Follow-up for Stage 1|Adverse Event|0|||
129080311|NCT03850483|464582958|FG002|Follow-up for Stage 1|Adverse Event|1|||
129080312|NCT03850483|464582959|FG003|Follow-up for Stage 1|Adverse Event|0|||
129080313|NCT03850483|464582960|FG004|Follow-up for Stage 1|Adverse Event|0|||
129080314|NCT03850483|464582961|FG005|Follow-up for Stage 1|Adverse Event|1|||
129080315|NCT03850483|464582962|FG006|Follow-up for Stage 1|Adverse Event|0|||
129080316|NCT03850483|464582963|FG007|Follow-up for Stage 1|Adverse Event|0|||
129080317|NCT03850483|464582964|FG008|Follow-up for Stage 1|Adverse Event|0|||
129080318|NCT03850483|464582965|FG009|Follow-up for Stage 1|Adverse Event|0|||
129080319|NCT03850483|464582956|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129080320|NCT03850483|464582957|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
129080321|NCT03850483|464582958|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129080322|NCT03850483|464582959|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129080323|NCT03850483|464582960|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
129080324|NCT03850483|464582961|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
129080325|NCT03850483|464582962|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129080326|NCT03850483|464582963|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129080327|NCT03850483|464582964|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129080328|NCT03850483|464582965|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129080329|NCT03850483|464582956|FG000|Follow-up for Stage 1|Other|0|||
129080330|NCT03850483|464582957|FG001|Follow-up for Stage 1|Other|2|||
129080331|NCT03850483|464582958|FG002|Follow-up for Stage 1|Other|0|||
129080332|NCT03850483|464582959|FG003|Follow-up for Stage 1|Other|2|||
129080333|NCT03850483|464582960|FG004|Follow-up for Stage 1|Other|0|||
129080334|NCT03850483|464582961|FG005|Follow-up for Stage 1|Other|1|||
129080335|NCT03850483|464582962|FG006|Follow-up for Stage 1|Other|0|||
129080336|NCT03850483|464582963|FG007|Follow-up for Stage 1|Other|0|||
129080337|NCT03850483|464582964|FG008|Follow-up for Stage 1|Other|0|||
129142286|NCT03715829|464815718|FG001|Dose Ranging Period|Other|0|||
129142287|NCT03715829|464815719|FG002|Dose Ranging Period|Other|2|||
129142288|NCT03715829|464815720|FG003|Dose Ranging Period|Other|0|||
129142289|NCT03715829|464815721|FG004|Dose Ranging Period|Other|0|||
129142290|NCT03715829|464815722|FG005|Dose Ranging Period|Other|3|||
128724104|NCT00116831|463288975|FG000|Overall Study|Withdrawn investigational product|1|||
128724105|NCT00116831|463288976|FG001|Overall Study|Withdrawn investigational product|0|||
128724106|NCT00116831|463288975|FG000|Overall Study|Withdrawal by Subject|32|||
128724107|NCT00116831|463288976|FG001|Overall Study|Withdrawal by Subject|32|||
128724108|NCT00116831|463288975|FG000|Overall Study|Insufficient therapeutic effect|0|||
128724109|NCT00116831|463288976|FG001|Overall Study|Insufficient therapeutic effect|1|||
128724110|NCT00116831|463288975|FG000|Overall Study|Missing data for participant|1|||
129080338|NCT03850483|464582965|FG009|Follow-up for Stage 1|Other|0|||
129080339|NCT03850483|464582956|FG000|Treatment for Stage 2|Adverse Event|0|||
129080340|NCT03850483|464582957|FG001|Treatment for Stage 2|Adverse Event|0|||
129080341|NCT03850483|464582958|FG002|Treatment for Stage 2|Adverse Event|0|||
129080342|NCT03850483|464582959|FG003|Treatment for Stage 2|Adverse Event|0|||
129080343|NCT03850483|464582960|FG004|Treatment for Stage 2|Adverse Event|0|||
129080344|NCT03850483|464582961|FG005|Treatment for Stage 2|Adverse Event|0|||
129080345|NCT03850483|464582962|FG006|Treatment for Stage 2|Adverse Event|0|||
129080346|NCT03850483|464582963|FG007|Treatment for Stage 2|Adverse Event|0|||
129080347|NCT03850483|464582964|FG008|Treatment for Stage 2|Adverse Event|0|||
129080348|NCT03850483|464582965|FG009|Treatment for Stage 2|Adverse Event|1|||
129080349|NCT03850483|464582956|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
129080350|NCT03850483|464582957|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
129080351|NCT03850483|464582958|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
129080352|NCT03850483|464582959|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
129080353|NCT03850483|464582960|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
129080354|NCT03850483|464582961|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
129080355|NCT03850483|464582962|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
129142291|NCT03715829|464815723|FG006|Dose Ranging Period|Other|0|||
129080356|NCT03850483|464582963|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
129080357|NCT03850483|464582964|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
129080358|NCT03850483|464582965|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
129080359|NCT03850483|464582956|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
129080360|NCT03850483|464582957|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
129080361|NCT03850483|464582958|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
129080362|NCT03850483|464582959|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
129080363|NCT03850483|464582960|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
129080364|NCT03850483|464582961|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
129080365|NCT03850483|464582962|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
129080366|NCT03850483|464582963|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
129080367|NCT03850483|464582964|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
129080368|NCT03850483|464582965|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
129080369|NCT03850483|464582956|FG000|Treatment for Stage 2|Physician Decision|0|||
129080370|NCT03850483|464582957|FG001|Treatment for Stage 2|Physician Decision|0|||
129080371|NCT03850483|464582958|FG002|Treatment for Stage 2|Physician Decision|0|||
129080372|NCT03850483|464582959|FG003|Treatment for Stage 2|Physician Decision|0|||
129080373|NCT03850483|464582960|FG004|Treatment for Stage 2|Physician Decision|0|||
129080374|NCT03850483|464582961|FG005|Treatment for Stage 2|Physician Decision|0|||
129080375|NCT03850483|464582962|FG006|Treatment for Stage 2|Physician Decision|0|||
129080376|NCT03850483|464582963|FG007|Treatment for Stage 2|Physician Decision|0|||
129080377|NCT03850483|464582964|FG008|Treatment for Stage 2|Physician Decision|0|||
129080378|NCT03850483|464582965|FG009|Treatment for Stage 2|Physician Decision|1|||
129080379|NCT03850483|464582956|FG000|Treatment for Stage 2|Protocol Violation|0|||
129080380|NCT03850483|464582957|FG001|Treatment for Stage 2|Protocol Violation|0|||
129080381|NCT03850483|464582958|FG002|Treatment for Stage 2|Protocol Violation|0|||
129080382|NCT03850483|464582959|FG003|Treatment for Stage 2|Protocol Violation|0|||
129080383|NCT03850483|464582960|FG004|Treatment for Stage 2|Protocol Violation|0|||
129080384|NCT03850483|464582961|FG005|Treatment for Stage 2|Protocol Violation|0|||
129080385|NCT03850483|464582962|FG006|Treatment for Stage 2|Protocol Violation|0|||
129080386|NCT03850483|464582963|FG007|Treatment for Stage 2|Protocol Violation|0|||
129080387|NCT03850483|464582964|FG008|Treatment for Stage 2|Protocol Violation|1|||
129080388|NCT03850483|464582965|FG009|Treatment for Stage 2|Protocol Violation|0|||
129080389|NCT03850483|464582956|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
129080390|NCT03850483|464582957|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
129080391|NCT03850483|464582958|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
129080392|NCT03850483|464582959|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
129080393|NCT03850483|464582960|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
129080394|NCT03850483|464582961|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
129080395|NCT03850483|464582962|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
129080396|NCT03850483|464582963|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
129080397|NCT03850483|464582964|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
129080398|NCT03850483|464582965|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
129080399|NCT03850483|464582956|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080400|NCT03850483|464582957|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080401|NCT03850483|464582958|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080402|NCT03850483|464582959|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080403|NCT03850483|464582960|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080404|NCT03850483|464582961|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080405|NCT03850483|464582962|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080406|NCT03850483|464582963|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080407|NCT03850483|464582964|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129080408|NCT03850483|464582965|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
129080409|NCT03850483|464582956|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
129080410|NCT03850483|464582957|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
129080411|NCT03850483|464582958|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
129080412|NCT03850483|464582959|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
129080413|NCT03850483|464582960|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
129080414|NCT03850483|464582961|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
129080415|NCT03850483|464582962|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
128724111|NCT00116831|463288976|FG001|Overall Study|Missing data for participant|0|||
128724112|NCT00380393|463288977|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
129080416|NCT03850483|464582963|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
129080417|NCT03850483|464582964|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
129080418|NCT03850483|464582965|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
129080419|NCT03850483|464582956|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
129080420|NCT03850483|464582957|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
129080421|NCT03850483|464582958|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
129080422|NCT03850483|464582959|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
129080423|NCT03850483|464582960|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
129080424|NCT03850483|464582961|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
129080425|NCT03850483|464582962|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
129080426|NCT03850483|464582963|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
129080427|NCT03850483|464582964|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
129080428|NCT03850483|464582965|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
129080429|NCT03850483|464582956|FG000|Follow-up For Stage 2|Other|0|||
129080430|NCT03850483|464582957|FG001|Follow-up For Stage 2|Other|0|||
129080431|NCT03850483|464582958|FG002|Follow-up For Stage 2|Other|0|||
129080432|NCT03850483|464582959|FG003|Follow-up For Stage 2|Other|0|||
129080433|NCT03850483|464582960|FG004|Follow-up For Stage 2|Other|0|||
129080434|NCT03850483|464582961|FG005|Follow-up For Stage 2|Other|0|||
129080435|NCT03850483|464582962|FG006|Follow-up For Stage 2|Other|0|||
129080436|NCT03850483|464582963|FG007|Follow-up For Stage 2|Other|0|||
129080437|NCT03850483|464582964|FG008|Follow-up For Stage 2|Other|0|||
129080438|NCT03850483|464582965|FG009|Follow-up For Stage 2|Other|1|||
129080439|NCT04432831|464584758|FG000|Overall Study|Withdrawal by Subject|24|||
129080440|NCT04432831|464584759|FG001|Overall Study|Withdrawal by Subject|28|||
129080441|NCT04432831|464584760|FG002|Overall Study|Withdrawal by Subject|21|||
129080442|NCT04432831|464584758|FG000|Overall Study|Death|23|||
129080443|NCT04432831|464584759|FG001|Overall Study|Death|23|||
129080444|NCT04432831|464584760|FG002|Overall Study|Death|17|||
129080445|NCT04432831|464584758|FG000|Overall Study|Lost to Follow-up|15|||
129080446|NCT04432831|464584759|FG001|Overall Study|Lost to Follow-up|15|||
129080447|NCT04432831|464584760|FG002|Overall Study|Lost to Follow-up|12|||
129080448|NCT04432831|464584758|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
129080449|NCT04432831|464584759|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
129080450|NCT04432831|464584760|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
129080451|NCT04432831|464584758|FG000|Overall Study|Reason Not Specified|7|||
129080452|NCT04432831|464584759|FG001|Overall Study|Reason Not Specified|11|||
129080453|NCT04432831|464584760|FG002|Overall Study|Reason Not Specified|9|||
129080454|NCT04432831|464584758|FG000|Overall Study|Adverse Event|7|||
129080455|NCT04432831|464584759|FG001|Overall Study|Adverse Event|7|||
129080456|NCT04432831|464584760|FG002|Overall Study|Adverse Event|7|||
129080457|NCT04432831|464584758|FG000|Overall Study|Physician Decision|1|||
129080458|NCT04432831|464584759|FG001|Overall Study|Physician Decision|3|||
129080459|NCT04432831|464584760|FG002|Overall Study|Physician Decision|6|||
129080460|NCT04432831|464584758|FG000|Overall Study|Protocol Violation|1|||
129080461|NCT04432831|464584759|FG001|Overall Study|Protocol Violation|0|||
129080462|NCT04432831|464584760|FG002|Overall Study|Protocol Violation|2|||
129080463|NCT04432831|464584758|FG000|Overall Study|Pregnancy|0|||
129080464|NCT04432831|464584759|FG001|Overall Study|Pregnancy|1|||
129080465|NCT04432831|464584760|FG002|Overall Study|Pregnancy|0|||
129080466|NCT04432831|464584758|FG000|Overall Study|Lack of Efficacy|0|||
129080467|NCT04432831|464584759|FG001|Overall Study|Lack of Efficacy|0|||
129080468|NCT04432831|464584760|FG002|Overall Study|Lack of Efficacy|2|||
129080469|NCT00652626|464584763|FG000|Initial Treatment Phase|Adverse Event|0|||
129080470|NCT00652626|464584764|FG001|Initial Treatment Phase|Adverse Event|0|||
129080471|NCT00652626|464584765|FG002|Initial Treatment Phase|Adverse Event|0|||
129080472|NCT00652626|464584766|FG003|Initial Treatment Phase|Adverse Event|0|||
129080473|NCT00652626|464584767|FG004|Initial Treatment Phase|Adverse Event|1|||
129080474|NCT00652626|464584768|FG005|Initial Treatment Phase|Adverse Event|0|||
129080475|NCT00652626|464584769|FG006|Initial Treatment Phase|Adverse Event|0|||
129080476|NCT00652626|464584763|FG000|Initial Treatment Phase|Protocol Violation|0|||
129080477|NCT00652626|464584764|FG001|Initial Treatment Phase|Protocol Violation|0|||
129080478|NCT00652626|464584765|FG002|Initial Treatment Phase|Protocol Violation|0|||
129080479|NCT00652626|464584766|FG003|Initial Treatment Phase|Protocol Violation|1|||
129080480|NCT00652626|464584767|FG004|Initial Treatment Phase|Protocol Violation|0|||
129142292|NCT03715829|464815724|FG007|Dose Ranging Period|Other|0|||
129142293|NCT03715829|464815725|FG008|Dose Ranging Period|Other|0|||
129142294|NCT03715829|464815726|FG009|Dose Ranging Period|Other|0|||
129142295|NCT03715829|464815727|FG010|Dose Ranging Period|Other|0|||
129142296|NCT03715829|464815717|FG000|Extension Period|Adverse Event|0|||
129142297|NCT03715829|464815718|FG001|Extension Period|Adverse Event|0|||
129080481|NCT00652626|464584768|FG005|Initial Treatment Phase|Protocol Violation|0|||
129080482|NCT00652626|464584769|FG006|Initial Treatment Phase|Protocol Violation|0|||
129080483|NCT00652626|464584763|FG000|Initial Treatment Phase|Physician Decision|0|||
129080484|NCT00652626|464584764|FG001|Initial Treatment Phase|Physician Decision|0|||
129080485|NCT00652626|464584765|FG002|Initial Treatment Phase|Physician Decision|0|||
129080486|NCT00652626|464584766|FG003|Initial Treatment Phase|Physician Decision|0|||
129080487|NCT00652626|464584767|FG004|Initial Treatment Phase|Physician Decision|1|||
129080488|NCT00652626|464584768|FG005|Initial Treatment Phase|Physician Decision|0|||
129080489|NCT00652626|464584769|FG006|Initial Treatment Phase|Physician Decision|0|||
129080490|NCT00652626|464584763|FG000|Initial Treatment Phase|Sponsor Request|0|||
129080491|NCT00652626|464584764|FG001|Initial Treatment Phase|Sponsor Request|0|||
129142298|NCT03715829|464815719|FG002|Extension Period|Adverse Event|0|||
129080492|NCT00652626|464584765|FG002|Initial Treatment Phase|Sponsor Request|1|||
129080493|NCT00652626|464584766|FG003|Initial Treatment Phase|Sponsor Request|0|||
129080494|NCT00652626|464584767|FG004|Initial Treatment Phase|Sponsor Request|0|||
129080495|NCT00652626|464584768|FG005|Initial Treatment Phase|Sponsor Request|0|||
129080496|NCT00652626|464584769|FG006|Initial Treatment Phase|Sponsor Request|0|||
129080497|NCT00652626|464584763|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
129080498|NCT00652626|464584764|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
129080499|NCT00652626|464584765|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
129080500|NCT00652626|464584766|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
129080501|NCT00652626|464584767|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
129080502|NCT00652626|464584768|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
129080503|NCT00652626|464584769|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
129080504|NCT00652626|464584763|FG000|Extension Phase|Withdrawal by Subject|0|||
129080505|NCT00652626|464584764|FG001|Extension Phase|Withdrawal by Subject|0|||
129080506|NCT00652626|464584765|FG002|Extension Phase|Withdrawal by Subject|0|||
129080507|NCT00652626|464584766|FG003|Extension Phase|Withdrawal by Subject|0|||
129080508|NCT00652626|464584767|FG004|Extension Phase|Withdrawal by Subject|0|||
129080509|NCT00652626|464584768|FG005|Extension Phase|Withdrawal by Subject|2|||
129080510|NCT00652626|464584769|FG006|Extension Phase|Withdrawal by Subject|0|||
129080511|NCT00652626|464584763|FG000|Extension Phase|Adverse Event|0|||
129080512|NCT00652626|464584764|FG001|Extension Phase|Adverse Event|0|||
129080513|NCT00652626|464584765|FG002|Extension Phase|Adverse Event|0|||
129080514|NCT00652626|464584766|FG003|Extension Phase|Adverse Event|0|||
129080515|NCT00652626|464584767|FG004|Extension Phase|Adverse Event|0|||
129080516|NCT00652626|464584768|FG005|Extension Phase|Adverse Event|2|||
129080517|NCT00652626|464584769|FG006|Extension Phase|Adverse Event|1|||
129080518|NCT00652626|464584763|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129080519|NCT00652626|464584764|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129080520|NCT00652626|464584765|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129080521|NCT00652626|464584766|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129080522|NCT00652626|464584767|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129080523|NCT00652626|464584768|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
129080524|NCT00652626|464584769|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129080525|NCT00652626|464584763|FG000|Extension Phase|Physician Decision|0|||
129080526|NCT00652626|464584764|FG001|Extension Phase|Physician Decision|0|||
129080527|NCT00652626|464584765|FG002|Extension Phase|Physician Decision|0|||
129080528|NCT00652626|464584766|FG003|Extension Phase|Physician Decision|0|||
129080529|NCT00652626|464584767|FG004|Extension Phase|Physician Decision|0|||
129080530|NCT00652626|464584768|FG005|Extension Phase|Physician Decision|1|||
129080531|NCT00652626|464584769|FG006|Extension Phase|Physician Decision|1|||
129080532|NCT00652626|464584763|FG000|Extension Phase|Death|0|||
129080533|NCT00652626|464584764|FG001|Extension Phase|Death|0|||
129080534|NCT00652626|464584765|FG002|Extension Phase|Death|0|||
129080535|NCT00652626|464584766|FG003|Extension Phase|Death|0|||
129080536|NCT00652626|464584767|FG004|Extension Phase|Death|0|||
129080537|NCT00652626|464584768|FG005|Extension Phase|Death|1|||
129080538|NCT00652626|464584769|FG006|Extension Phase|Death|1|||
129080539|NCT01623310|464584770|FG000|Overall Study|Adverse Event|21|||
129080540|NCT01623310|464584770|FG000|Overall Study|Lost to Follow-up|18|||
129080541|NCT01623310|464584770|FG000|Overall Study|Lack of Efficacy|6|||
129080542|NCT01623310|464584770|FG000|Overall Study|Protocol Violation|6|||
129080543|NCT01623310|464584770|FG000|Overall Study|Withdrawal by Subject|25|||
129080544|NCT01623310|464584770|FG000|Overall Study|Became potentially child-bearing|1|||
129080545|NCT01623310|464584770|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
129080546|NCT01623310|464584770|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
129080547|NCT02898597|464584771|FG000|Overall Study|Protocol Violation|4|||
129080548|NCT02898597|464584772|FG001|Overall Study|Protocol Violation|2|||
129080549|NCT02898597|464584771|FG000|Overall Study|Lost to Follow-up|0|||
129080550|NCT02898597|464584772|FG001|Overall Study|Lost to Follow-up|9|||
129080551|NCT02898597|464584771|FG000|Overall Study|Death|0|||
129080552|NCT02898597|464584772|FG001|Overall Study|Death|1|||
129080553|NCT02530125|464584773|FG000|Completed Treatment|Early termination of study|1|||
129142299|NCT03715829|464815720|FG003|Extension Period|Adverse Event|0|||
129142300|NCT03715829|464815721|FG004|Extension Period|Adverse Event|0|||
129142301|NCT03715829|464815722|FG005|Extension Period|Adverse Event|0|||
129142302|NCT03715829|464815723|FG006|Extension Period|Adverse Event|3|||
129142303|NCT03715829|464815724|FG007|Extension Period|Adverse Event|1|||
129142304|NCT03715829|464815725|FG008|Extension Period|Adverse Event|6|||
129142305|NCT03715829|464815726|FG009|Extension Period|Adverse Event|0|||
129142306|NCT03715829|464815727|FG010|Extension Period|Adverse Event|0|||
129080554|NCT02530125|464584773|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
129080555|NCT01568034|464584774|FG000|Overall Study|Withdrawal by Subject|1|||
129080556|NCT01568034|464584775|FG001|Overall Study|Withdrawal by Subject|0|||
129080557|NCT01568034|464584776|FG002|Overall Study|Withdrawal by Subject|0|||
129142307|NCT03715829|464815717|FG000|Extension Period|Lack of Efficacy|0|||
129142308|NCT03715829|464815718|FG001|Extension Period|Lack of Efficacy|0|||
129142309|NCT03715829|464815719|FG002|Extension Period|Lack of Efficacy|0|||
129080558|NCT01568034|464584777|FG003|Overall Study|Withdrawal by Subject|0|||
129080559|NCT06098339|464584778|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
129080560|NCT06098339|464584779|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
129080561|NCT06098339|464584778|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
129080562|NCT06098339|464584779|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
129080563|NCT02492984|464584780|FG000|Overall Study|Adverse Event|1|||
129080564|NCT02492984|464584781|FG001|Overall Study|Adverse Event|0|||
129080565|NCT02492984|464584780|FG000|Overall Study|Protocol Violation|1|||
129080566|NCT02492984|464584781|FG001|Overall Study|Protocol Violation|0|||
129080567|NCT02492984|464584780|FG000|Overall Study|Withdrawal by Subject|1|||
129080568|NCT02492984|464584781|FG001|Overall Study|Withdrawal by Subject|0|||
129080569|NCT02498444|464584782|FG000|Overall Study|Withdrawal by Subject|3|||
129080570|NCT02498444|464584783|FG001|Overall Study|Withdrawal by Subject|0|||
129080571|NCT02498444|464584782|FG000|Overall Study|Physician Decision|1|||
129080572|NCT02498444|464584783|FG001|Overall Study|Physician Decision|0|||
129080573|NCT02027545|464584784|FG000|Overall Study|Failed to sign HIPAA|0|||
129080574|NCT02027545|464584785|FG001|Overall Study|Failed to sign HIPAA|2|||
129080575|NCT02027545|464584784|FG000|Overall Study|Failed to attend study visit|2|||
129080576|NCT02027545|464584785|FG001|Overall Study|Failed to attend study visit|0|||
129080577|NCT02027545|464584784|FG000|Overall Study|Protocol Violation|1|||
129080578|NCT02027545|464584785|FG001|Overall Study|Protocol Violation|0|||
129080579|NCT02453334|464584786|FG000|Overall Study|Death|15|||
129080580|NCT02453334|464584787|FG001|Overall Study|Death|13|||
129080581|NCT02453334|464584786|FG000|Overall Study|Adverse Event|2|||
129080582|NCT02453334|464584787|FG001|Overall Study|Adverse Event|1|||
129080583|NCT02453334|464584786|FG000|Overall Study|Lost to Follow-up|5|||
129080584|NCT02453334|464584787|FG001|Overall Study|Lost to Follow-up|9|||
129080585|NCT02453334|464584786|FG000|Overall Study|Physician Decision|1|||
129080586|NCT02453334|464584787|FG001|Overall Study|Physician Decision|0|||
129080587|NCT02453334|464584786|FG000|Overall Study|Withdrawal by Subject|17|||
129080588|NCT02453334|464584787|FG001|Overall Study|Withdrawal by Subject|13|||
129080589|NCT02453334|464584786|FG000|Overall Study|Other reason|1|||
129080590|NCT02453334|464584787|FG001|Overall Study|Other reason|4|||
129080591|NCT04090060|464584790|FG000|Overall Study|Lost to Follow-up|76|||
129080592|NCT04090060|464584791|FG001|Overall Study|Lost to Follow-up|77|||
129080593|NCT03337113|464584798|FG000|Overall Study|Adverse Event|1|||
129080594|NCT03337113|464584799|FG001|Overall Study|Adverse Event|1|||
129080595|NCT03337113|464584800|FG002|Overall Study|Adverse Event|0|||
129080596|NCT03337113|464584801|FG003|Overall Study|Adverse Event|1|||
129080597|NCT03337113|464584798|FG000|Overall Study|Physician Decision|0|||
129080598|NCT03337113|464584799|FG001|Overall Study|Physician Decision|2|||
129080599|NCT03337113|464584800|FG002|Overall Study|Physician Decision|0|||
129080600|NCT03337113|464584801|FG003|Overall Study|Physician Decision|1|||
129080601|NCT03337113|464584798|FG000|Overall Study|Withdrawal by Subject|0|||
129080602|NCT03337113|464584799|FG001|Overall Study|Withdrawal by Subject|0|||
129080603|NCT03337113|464584800|FG002|Overall Study|Withdrawal by Subject|1|||
129080604|NCT03337113|464584801|FG003|Overall Study|Withdrawal by Subject|0|||
129080605|NCT01164579|464584802|FG000|Overall Study|Lack of Efficacy|0|||
129080606|NCT01164579|464584803|FG001|Overall Study|Lack of Efficacy|0|||
129080607|NCT01164579|464584804|FG002|Overall Study|Lack of Efficacy|6|||
129080608|NCT01164579|464584802|FG000|Overall Study|Lost to Follow-up|1|||
129080609|NCT01164579|464584803|FG001|Overall Study|Lost to Follow-up|1|||
129080610|NCT01164579|464584804|FG002|Overall Study|Lost to Follow-up|0|||
129080611|NCT01164579|464584802|FG000|Overall Study|Withdrawal by Subject|2|||
129080612|NCT01164579|464584803|FG001|Overall Study|Withdrawal by Subject|5|||
129080613|NCT01164579|464584804|FG002|Overall Study|Withdrawal by Subject|3|||
129080614|NCT01164579|464584802|FG000|Overall Study|Protocol Violation|0|||
129080615|NCT01164579|464584803|FG001|Overall Study|Protocol Violation|1|||
129080616|NCT01164579|464584804|FG002|Overall Study|Protocol Violation|2|||
129080617|NCT01164579|464584802|FG000|Overall Study|Adverse Event|4|||
129080618|NCT01164579|464584803|FG001|Overall Study|Adverse Event|2|||
129080619|NCT01164579|464584804|FG002|Overall Study|Adverse Event|5|||
129080620|NCT01164579|464584802|FG000|Overall Study|Reason not specified|1|||
129080621|NCT01164579|464584803|FG001|Overall Study|Reason not specified|0|||
129080622|NCT01164579|464584804|FG002|Overall Study|Reason not specified|0|||
129080623|NCT02176655|464584810|FG000|Overall Study|Subjects did not treat|6|||
129080624|NCT01464593|464584811|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
129080625|NCT04938180|464584818|FG000|Overall Study|Adverse Event|1|||
129080626|NCT03491462|464584819|FG000|Overall Study|Lost to Follow-up|2|||
129080627|NCT03491462|464584820|FG001|Overall Study|Lost to Follow-up|0|||
129080628|NCT03491462|464584819|FG000|Overall Study|Adverse Event|11|||
129080629|NCT03491462|464584820|FG001|Overall Study|Adverse Event|1|||
129080630|NCT03491462|464584819|FG000|Overall Study|Physician Decision|3|||
129080631|NCT03491462|464584820|FG001|Overall Study|Physician Decision|0|||
129080632|NCT03491462|464584819|FG000|Overall Study|Withdrawal by Subject|22|||
129080633|NCT03491462|464584820|FG001|Overall Study|Withdrawal by Subject|15|||
129080634|NCT01019694|464584821|FG000|Overall Study|Adverse Event|12|||
129080635|NCT01019694|464584822|FG001|Overall Study|Adverse Event|16|||
129080636|NCT01019694|464584823|FG002|Overall Study|Adverse Event|19|||
129080637|NCT01019694|464584821|FG000|Overall Study|Protocol Violation|2|||
129080638|NCT01019694|464584822|FG001|Overall Study|Protocol Violation|6|||
129080639|NCT01019694|464584823|FG002|Overall Study|Protocol Violation|4|||
129080640|NCT01019694|464584821|FG000|Overall Study|Lost to Follow-up|5|||
129080641|NCT01019694|464584822|FG001|Overall Study|Lost to Follow-up|3|||
129080642|NCT01019694|464584823|FG002|Overall Study|Lost to Follow-up|3|||
129080643|NCT01019694|464584821|FG000|Overall Study|Withdrawal by Subject|4|||
129080644|NCT01019694|464584822|FG001|Overall Study|Withdrawal by Subject|6|||
129080645|NCT01019694|464584823|FG002|Overall Study|Withdrawal by Subject|12|||
129080646|NCT01019694|464584821|FG000|Overall Study|Not treated|0|||
129080647|NCT01019694|464584822|FG001|Overall Study|Not treated|2|||
129080648|NCT01019694|464584823|FG002|Overall Study|Not treated|3|||
129080649|NCT01019694|464584821|FG000|Overall Study|Other reason (not specified)|1|||
129080650|NCT01019694|464584822|FG001|Overall Study|Other reason (not specified)|5|||
129080651|NCT01019694|464584823|FG002|Overall Study|Other reason (not specified)|6|||
129080652|NCT00026494|464584830|FG000|Overall Study|Withdrawal by Subject|1|||
129080653|NCT00026494|464584831|FG001|Overall Study|Withdrawal by Subject|0|||
129080654|NCT00026494|464584832|FG002|Overall Study|Withdrawal by Subject|1|||
129080655|NCT00026494|464584833|FG003|Overall Study|Withdrawal by Subject|0|||
129080656|NCT00026494|464584830|FG000|Overall Study|Patient non-compliance|1|||
129080657|NCT00026494|464584831|FG001|Overall Study|Patient non-compliance|0|||
129080658|NCT00026494|464584832|FG002|Overall Study|Patient non-compliance|0|||
129080659|NCT00026494|464584833|FG003|Overall Study|Patient non-compliance|0|||
129080660|NCT00026494|464584830|FG000|Overall Study|Patient not treated|0|||
129080661|NCT00026494|464584831|FG001|Overall Study|Patient not treated|0|||
129080662|NCT00026494|464584832|FG002|Overall Study|Patient not treated|2|||
129080663|NCT00026494|464584833|FG003|Overall Study|Patient not treated|0|||
129080664|NCT00026494|464584830|FG000|Overall Study|Clinical progression|0|||
129080665|NCT00026494|464584831|FG001|Overall Study|Clinical progression|0|||
129080666|NCT00026494|464584832|FG002|Overall Study|Clinical progression|3|||
129080667|NCT00026494|464584833|FG003|Overall Study|Clinical progression|0|||
129080668|NCT00441129|464584834|FG000|Overall Study|Withdrawal by Subject|6|||
129080669|NCT00441129|464584835|FG001|Overall Study|Withdrawal by Subject|14|||
129080670|NCT00423332|464584837|FG000|Overall Study|Adverse Event|6|||
129080671|NCT00423332|464584838|FG001|Overall Study|Adverse Event|2|||
129080672|NCT00423332|464584837|FG000|Overall Study|Withdrawal by Subject|1|||
129080673|NCT00423332|464584838|FG001|Overall Study|Withdrawal by Subject|0|||
129080674|NCT00423332|464584837|FG000|Overall Study|Condition under investigation worsened|1|||
129080675|NCT00423332|464584838|FG001|Overall Study|Condition under investigation worsened|1|||
129080676|NCT00423332|464584837|FG000|Overall Study|Progressive at Week 6|0|||
129080677|NCT00423332|464584838|FG001|Overall Study|Progressive at Week 6|1|||
129080678|NCT00423332|464584837|FG000|Overall Study|Unblinded before 12 weeks|1|||
129080679|NCT00423332|464584838|FG001|Overall Study|Unblinded before 12 weeks|3|||
129080680|NCT00927862|464584839|FG000|Overall Study|Missing data needed for endpt analyses|27|||
129080681|NCT00927862|464584840|FG001|Overall Study|Missing data needed for endpt analyses|45|||
129080682|NCT00820248|464584841|FG000|Overall Study|No treated|4|||
129080683|NCT00820248|464584842|FG001|Overall Study|No treated|1|||
129080684|NCT02237196|464584844|FG000|Overall Study|Adverse Event|0|||
129080685|NCT02237196|464584845|FG001|Overall Study|Adverse Event|1|||
129080686|NCT02237196|464584846|FG002|Overall Study|Adverse Event|1|||
129080687|NCT02237196|464584847|FG003|Overall Study|Adverse Event|0|||
129080688|NCT02237196|464584844|FG000|Overall Study|Lost to Follow-up|4|||
129080689|NCT02237196|464584845|FG001|Overall Study|Lost to Follow-up|2|||
129080690|NCT02237196|464584846|FG002|Overall Study|Lost to Follow-up|4|||
129080691|NCT02237196|464584847|FG003|Overall Study|Lost to Follow-up|6|||
129080692|NCT02237196|464584844|FG000|Overall Study|Physician Decision|2|||
129080693|NCT02237196|464584845|FG001|Overall Study|Physician Decision|0|||
129080694|NCT02237196|464584846|FG002|Overall Study|Physician Decision|0|||
129080695|NCT02237196|464584847|FG003|Overall Study|Physician Decision|1|||
129142310|NCT03715829|464815720|FG003|Extension Period|Lack of Efficacy|0|||
129080696|NCT02237196|464584844|FG000|Overall Study|Pregnancy|0|||
129080697|NCT02237196|464584845|FG001|Overall Study|Pregnancy|0|||
129080698|NCT02237196|464584846|FG002|Overall Study|Pregnancy|1|||
129080699|NCT02237196|464584847|FG003|Overall Study|Pregnancy|1|||
129080700|NCT02237196|464584844|FG000|Overall Study|Withdrawal by Subject|1|||
129080701|NCT02237196|464584845|FG001|Overall Study|Withdrawal by Subject|1|||
129080702|NCT02237196|464584846|FG002|Overall Study|Withdrawal by Subject|4|||
129080703|NCT02237196|464584847|FG003|Overall Study|Withdrawal by Subject|1|||
129080704|NCT02237196|464584844|FG000|Overall Study|Site Error|1|||
129080705|NCT02237196|464584845|FG001|Overall Study|Site Error|2|||
129080706|NCT02237196|464584846|FG002|Overall Study|Site Error|0|||
129080707|NCT02237196|464584847|FG003|Overall Study|Site Error|2|||
129080708|NCT01282372|464584859|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
129080709|NCT01282372|464584859|FG000|Overall Study|Lost to Follow-up|23|||
129080710|NCT01282372|464584859|FG000|Overall Study|Withdrawal by Subject|11|||
129080711|NCT01282372|464584859|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
128724113|NCT00380393|463288978|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
128724114|NCT00380393|463288977|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
128724115|NCT00380393|463288978|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
128724116|NCT00380393|463288977|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
128724117|NCT00380393|463288978|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
128724118|NCT00380393|463288977|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
128724119|NCT00380393|463288978|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
128724120|NCT00380393|463288977|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
128724121|NCT00380393|463288978|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
128724122|NCT00380393|463288977|FG000|Month 14|Withdrawal by Subject|9|||
128724123|NCT00380393|463288978|FG001|Month 14|Withdrawal by Subject|7|||
128724124|NCT00380393|463288977|FG000|Month 14|Death|1|||
128724125|NCT00380393|463288978|FG001|Month 14|Death|0|||
128724126|NCT00380393|463288977|FG000|Month 14|Lost to Follow-up|0|||
128724127|NCT00380393|463288978|FG001|Month 14|Lost to Follow-up|1|||
128724128|NCT00380393|463288977|FG000|Month 14|Migrated/moved from study area|39|||
128724129|NCT00380393|463288978|FG001|Month 14|Migrated/moved from study area|42|||
128724130|NCT00380393|463288977|FG000|Month 14|Protocol Violation|2|||
128724131|NCT00380393|463288978|FG001|Month 14|Protocol Violation|0|||
128724132|NCT00380393|463288977|FG000|Month 14|Others|6|||
128724133|NCT00380393|463288978|FG001|Month 14|Others|6|||
128724134|NCT01933048|463288979|FG000|Overall Study|Lost to Follow-up|15|||
128724135|NCT01933048|463288980|FG001|Overall Study|Lost to Follow-up|18|||
129080712|NCT01282372|464584859|FG000|Overall Study|Death|1|||
129080713|NCT01282372|464584859|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
129080714|NCT01282372|464584859|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
129080715|NCT01282372|464584859|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
129080716|NCT01282372|464584859|FG000|Overall Study|Adverse Event|12|||
128724136|NCT01933048|463288979|FG000|Overall Study|personal reasons|1|||
129080717|NCT02993250|464584861|FG000|Overall Study|Lost to Follow-up|0|||
129080718|NCT02993250|464584862|FG001|Overall Study|Lost to Follow-up|1|||
129080719|NCT02527434|464584863|FG000|Overall Study|Lost to Follow-up|2|||
129142311|NCT03715829|464815721|FG004|Extension Period|Lack of Efficacy|0|||
129142312|NCT03715829|464815722|FG005|Extension Period|Lack of Efficacy|0|||
129142313|NCT03715829|464815723|FG006|Extension Period|Lack of Efficacy|1|||
129142314|NCT03715829|464815724|FG007|Extension Period|Lack of Efficacy|9|||
129142315|NCT03715829|464815725|FG008|Extension Period|Lack of Efficacy|2|||
129142316|NCT03715829|464815726|FG009|Extension Period|Lack of Efficacy|0|||
129142317|NCT03715829|464815727|FG010|Extension Period|Lack of Efficacy|0|||
129142318|NCT03715829|464815717|FG000|Extension Period|Lost to Follow-up|0|||
129142319|NCT03715829|464815718|FG001|Extension Period|Lost to Follow-up|0|||
129142320|NCT03715829|464815719|FG002|Extension Period|Lost to Follow-up|0|||
129142321|NCT03715829|464815720|FG003|Extension Period|Lost to Follow-up|0|||
129142322|NCT03715829|464815721|FG004|Extension Period|Lost to Follow-up|0|||
129142323|NCT03715829|464815722|FG005|Extension Period|Lost to Follow-up|0|||
129142324|NCT03715829|464815723|FG006|Extension Period|Lost to Follow-up|0|||
129142325|NCT03715829|464815724|FG007|Extension Period|Lost to Follow-up|0|||
129142326|NCT03715829|464815725|FG008|Extension Period|Lost to Follow-up|2|||
129142327|NCT03715829|464815726|FG009|Extension Period|Lost to Follow-up|0|||
129142328|NCT03715829|464815727|FG010|Extension Period|Lost to Follow-up|0|||
129142329|NCT03715829|464815717|FG000|Extension Period|Protocol Violation|0|||
129142330|NCT03715829|464815718|FG001|Extension Period|Protocol Violation|0|||
129142331|NCT03715829|464815719|FG002|Extension Period|Protocol Violation|0|||
129142332|NCT03715829|464815720|FG003|Extension Period|Protocol Violation|0|||
129142333|NCT03715829|464815721|FG004|Extension Period|Protocol Violation|0|||
129142334|NCT03715829|464815722|FG005|Extension Period|Protocol Violation|0|||
129142335|NCT03715829|464815723|FG006|Extension Period|Protocol Violation|0|||
129142336|NCT03715829|464815724|FG007|Extension Period|Protocol Violation|0|||
129142337|NCT03715829|464815725|FG008|Extension Period|Protocol Violation|1|||
129142338|NCT03715829|464815726|FG009|Extension Period|Protocol Violation|0|||
129142339|NCT03715829|464815727|FG010|Extension Period|Protocol Violation|0|||
128724137|NCT01933048|463288980|FG001|Overall Study|personal reasons|1|||
128724138|NCT01933048|463288979|FG000|Overall Study|Protocol Violation|7|||
128724139|NCT01933048|463288980|FG001|Overall Study|Protocol Violation|8|||
128724140|NCT01933048|463288979|FG000|Overall Study|Physician Decision|1|||
128724141|NCT01933048|463288980|FG001|Overall Study|Physician Decision|0|||
128724142|NCT01933048|463288979|FG000|Overall Study|unknown reasons|1|||
129080720|NCT02527434|464584864|FG001|Overall Study|Lost to Follow-up|2|||
129080721|NCT02527434|464584865|FG002|Overall Study|Lost to Follow-up|0|||
129142340|NCT03715829|464815717|FG000|Extension Period|Withdrawal by Subject|0|||
129142341|NCT03715829|464815718|FG001|Extension Period|Withdrawal by Subject|0|||
129142342|NCT03715829|464815719|FG002|Extension Period|Withdrawal by Subject|0|||
129080722|NCT02527434|464584863|FG000|Overall Study|Death|19|||
129080723|NCT02527434|464584864|FG001|Overall Study|Death|6|||
129080724|NCT02527434|464584865|FG002|Overall Study|Death|17|||
129080725|NCT02527434|464584863|FG000|Overall Study|Withdrawal by Subject|5|||
129080726|NCT02527434|464584864|FG001|Overall Study|Withdrawal by Subject|3|||
129080727|NCT02527434|464584865|FG002|Overall Study|Withdrawal by Subject|3|||
129080728|NCT02527434|464584863|FG000|Overall Study|Reason Not Specified|1|||
129080729|NCT02527434|464584864|FG001|Overall Study|Reason Not Specified|0|||
129080730|NCT02527434|464584865|FG002|Overall Study|Reason Not Specified|0|||
129080731|NCT02527434|464584863|FG000|Overall Study|Site closure|1|||
129080732|NCT02527434|464584864|FG001|Overall Study|Site closure|0|||
129080733|NCT02527434|464584865|FG002|Overall Study|Site closure|0|||
129080734|NCT01322490|464584866|FG000|Treatment Period|Adverse Event|12|||
129080735|NCT01322490|464584867|FG001|Treatment Period|Adverse Event|18|||
129080736|NCT01322490|464584868|FG002|Treatment Period|Adverse Event|15|||
129080737|NCT01322490|464584866|FG000|Treatment Period|Death|5|||
129080738|NCT01322490|464584867|FG001|Treatment Period|Death|7|||
129080739|NCT01322490|464584868|FG002|Treatment Period|Death|3|||
129080740|NCT01322490|464584866|FG000|Treatment Period|Lack of Efficacy|89|||
129080741|NCT01322490|464584867|FG001|Treatment Period|Lack of Efficacy|100|||
129080742|NCT01322490|464584868|FG002|Treatment Period|Lack of Efficacy|112|||
129080743|NCT01322490|464584866|FG000|Treatment Period|Physician Decision|0|||
129080744|NCT01322490|464584867|FG001|Treatment Period|Physician Decision|2|||
129080745|NCT01322490|464584868|FG002|Treatment Period|Physician Decision|1|||
129080746|NCT01322490|464584866|FG000|Treatment Period|Protocol Violation|7|||
129080747|NCT01322490|464584867|FG001|Treatment Period|Protocol Violation|5|||
129080748|NCT01322490|464584868|FG002|Treatment Period|Protocol Violation|4|||
129080749|NCT01322490|464584866|FG000|Treatment Period|Withdrawal by Subject|14|||
129080750|NCT01322490|464584867|FG001|Treatment Period|Withdrawal by Subject|16|||
129080751|NCT01322490|464584868|FG002|Treatment Period|Withdrawal by Subject|11|||
129080752|NCT01322490|464584866|FG000|Treatment Period|Non-compliance with study drug|0|||
129080753|NCT01322490|464584867|FG001|Treatment Period|Non-compliance with study drug|0|||
129080754|NCT01322490|464584868|FG002|Treatment Period|Non-compliance with study drug|1|||
129080755|NCT01322490|464584866|FG000|Treatment Period|Other per report|2|||
129080756|NCT01322490|464584867|FG001|Treatment Period|Other per report|2|||
129142343|NCT03715829|464815720|FG003|Extension Period|Withdrawal by Subject|0|||
129142344|NCT03715829|464815721|FG004|Extension Period|Withdrawal by Subject|0|||
129142345|NCT03715829|464815722|FG005|Extension Period|Withdrawal by Subject|0|||
129142346|NCT03715829|464815723|FG006|Extension Period|Withdrawal by Subject|3|||
129142347|NCT03715829|464815724|FG007|Extension Period|Withdrawal by Subject|3|||
129142348|NCT03715829|464815725|FG008|Extension Period|Withdrawal by Subject|12|||
129142349|NCT03715829|464815726|FG009|Extension Period|Withdrawal by Subject|3|||
129142350|NCT03715829|464815727|FG010|Extension Period|Withdrawal by Subject|0|||
129142351|NCT03715829|464815717|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142352|NCT03715829|464815718|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142353|NCT03715829|464815719|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142354|NCT03715829|464815720|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142355|NCT03715829|464815721|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142356|NCT03715829|464815722|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142357|NCT03715829|464815723|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142358|NCT03715829|464815724|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
129142359|NCT03715829|464815725|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
129142360|NCT03715829|464815726|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142361|NCT03715829|464815727|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
129142362|NCT03715829|464815717|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142363|NCT03715829|464815718|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142364|NCT03715829|464815719|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142365|NCT03715829|464815720|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
129080757|NCT01322490|464584868|FG002|Treatment Period|Other per report|1|||
129080758|NCT01322490|464584866|FG000|Treatment Period|Randomized but Not Treated|3|||
129080759|NCT01322490|464584867|FG001|Treatment Period|Randomized but Not Treated|3|||
129080760|NCT01322490|464584868|FG002|Treatment Period|Randomized but Not Treated|5|||
129080761|NCT01322490|464584866|FG000|Long Term Follow-up Period|Death|235|||
129080762|NCT01322490|464584867|FG001|Long Term Follow-up Period|Death|239|||
129080763|NCT01322490|464584868|FG002|Long Term Follow-up Period|Death|236|||
129080764|NCT01322490|464584866|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
129080765|NCT01322490|464584867|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
129080766|NCT01322490|464584868|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
129080767|NCT01322490|464584866|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
129142366|NCT03715829|464815721|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
129080768|NCT01322490|464584867|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
129080769|NCT01322490|464584868|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
129080770|NCT01322490|464584866|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
129080771|NCT01322490|464584867|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
129080772|NCT01322490|464584868|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
129080773|NCT01322490|464584866|FG000|Long Term Follow-up Period|Other per report|3|||
129080774|NCT01322490|464584867|FG001|Long Term Follow-up Period|Other per report|2|||
129080775|NCT01322490|464584868|FG002|Long Term Follow-up Period|Other per report|2|||
129080776|NCT01322490|464584866|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
129080777|NCT01322490|464584867|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
129080778|NCT01322490|464584868|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
129080779|NCT01431716|464584869|FG000|Overall Study|Withdrawal of consent|1|||
129080780|NCT00568061|464584870|FG000|Overall Study|Inclusion / exclusion criteria|5|||
129080781|NCT00568061|464584871|FG001|Overall Study|Inclusion / exclusion criteria|1|||
129080782|NCT00568061|464584870|FG000|Overall Study|Adverse Event|0|||
129080783|NCT00568061|464584871|FG001|Overall Study|Adverse Event|1|||
129080784|NCT05027451|464584872|FG000|Overall Study|Lost to Follow-up|1|||
129080785|NCT05027451|464584873|FG001|Overall Study|Lost to Follow-up|1|||
129080786|NCT01896128|464584874|FG000|Overall Study|Withdrawal by Subject|3|||
129080787|NCT01896128|464584875|FG001|Overall Study|Withdrawal by Subject|3|||
129080788|NCT00356148|464584878|FG000|Overall Study|Reoperation within 30 days|2|||
129080789|NCT00356148|464584879|FG001|Overall Study|Reoperation within 30 days|1|||
129080790|NCT02484456|464584880|FG000|Washout Period|Withdrawal by Subject|0|||
129080791|NCT02484456|464584881|FG001|Washout Period|Withdrawal by Subject|1|||
129080792|NCT02484456|464584880|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
129080793|NCT02484456|464584881|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
129080794|NCT02484456|464584880|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
129080795|NCT02484456|464584881|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
129080796|NCT02484456|464584880|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
129080797|NCT02484456|464584881|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
129142367|NCT03715829|464815722|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142368|NCT03715829|464815723|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142369|NCT03715829|464815724|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142370|NCT03715829|464815725|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
129142371|NCT03715829|464815726|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142372|NCT03715829|464815727|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
129142373|NCT03715829|464815717|FG000|Extension Period|Other|0|||
129142374|NCT03715829|464815718|FG001|Extension Period|Other|0|||
129142375|NCT03715829|464815719|FG002|Extension Period|Other|0|||
129142376|NCT03715829|464815720|FG003|Extension Period|Other|0|||
129142377|NCT03715829|464815721|FG004|Extension Period|Other|0|||
129142378|NCT03715829|464815722|FG005|Extension Period|Other|0|||
129142379|NCT03715829|464815723|FG006|Extension Period|Other|1|||
129142380|NCT03715829|464815724|FG007|Extension Period|Other|2|||
129080798|NCT01996254|464584884|FG000|Overall Study|Change in Eligibility|0|||
129080799|NCT01996254|464584885|FG001|Overall Study|Change in Eligibility|2|||
129080800|NCT01996254|464584886|FG002|Overall Study|Change in Eligibility|0|||
129080801|NCT01996254|464584884|FG000|Overall Study|Withdrawal by Subject|0|||
129080802|NCT01996254|464584885|FG001|Overall Study|Withdrawal by Subject|3|||
129080803|NCT01996254|464584886|FG002|Overall Study|Withdrawal by Subject|4|||
129080804|NCT01996254|464584884|FG000|Overall Study|Lost to Follow-up|1|||
129080805|NCT01996254|464584885|FG001|Overall Study|Lost to Follow-up|0|||
129080806|NCT01996254|464584886|FG002|Overall Study|Lost to Follow-up|4|||
129080807|NCT03348930|464584887|FG000|Washout (1 Week)|Lost to Follow-up|1|||
129080808|NCT03348930|464584888|FG001|Washout (1 Week)|Lost to Follow-up|1|||
129080809|NCT02929589|464584923|FG000|Overall Study|Withdrawal by Subject|1|||
129080810|NCT02929589|464584924|FG001|Overall Study|Withdrawal by Subject|0|||
129080811|NCT02929589|464584925|FG002|Overall Study|Withdrawal by Subject|0|||
129080812|NCT02929589|464584926|FG003|Overall Study|Withdrawal by Subject|0|||
129080813|NCT02929589|464584923|FG000|Overall Study|Physician Decision|2|||
129080814|NCT02929589|464584924|FG001|Overall Study|Physician Decision|0|||
129080815|NCT02929589|464584925|FG002|Overall Study|Physician Decision|0|||
129080816|NCT02929589|464584926|FG003|Overall Study|Physician Decision|0|||
129080817|NCT02343939|464584927|FG000|Overall Study|Death|0|||
129080818|NCT02343939|464584928|FG001|Overall Study|Death|15|||
129080819|NCT02343939|464584929|FG002|Overall Study|Death|4|||
129142381|NCT03715829|464815725|FG008|Extension Period|Other|4|||
129142382|NCT03715829|464815726|FG009|Extension Period|Other|0|||
129080820|NCT02343939|464584930|FG003|Overall Study|Death|2|||
129080821|NCT02343939|464584931|FG004|Overall Study|Death|5|||
129080822|NCT02343939|464584932|FG005|Overall Study|Death|11|||
129080823|NCT02343939|464584933|FG006|Overall Study|Death|8|||
129080824|NCT02343939|464584934|FG007|Overall Study|Death|22|||
129080825|NCT02343939|464584935|FG008|Overall Study|Death|1|||
129142383|NCT03715829|464815727|FG010|Extension Period|Other|0|||
129080826|NCT02343939|464584927|FG000|Overall Study|Study terminated by sponsor|0|||
129080827|NCT02343939|464584928|FG001|Overall Study|Study terminated by sponsor|27|||
129080828|NCT02343939|464584929|FG002|Overall Study|Study terminated by sponsor|0|||
129080829|NCT02343939|464584930|FG003|Overall Study|Study terminated by sponsor|1|||
129080830|NCT02343939|464584931|FG004|Overall Study|Study terminated by sponsor|1|||
129080831|NCT02343939|464584932|FG005|Overall Study|Study terminated by sponsor|5|||
129080832|NCT02343939|464584933|FG006|Overall Study|Study terminated by sponsor|3|||
129080833|NCT02343939|464584934|FG007|Overall Study|Study terminated by sponsor|4|||
129080834|NCT02343939|464584935|FG008|Overall Study|Study terminated by sponsor|0|||
129080835|NCT02343939|464584927|FG000|Overall Study|Withdrew consent|3|||
129080836|NCT02343939|464584928|FG001|Overall Study|Withdrew consent|6|||
129080837|NCT02343939|464584929|FG002|Overall Study|Withdrew consent|1|||
129080838|NCT02343939|464584930|FG003|Overall Study|Withdrew consent|2|||
129080839|NCT02343939|464584931|FG004|Overall Study|Withdrew consent|2|||
129142384|NCT03579719|464815728|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
129142385|NCT00855166|464815729|FG000|Overall Study|Adverse Event|0|||
129142386|NCT00855166|464815730|FG001|Overall Study|Adverse Event|2|||
129142387|NCT00855166|464815729|FG000|Overall Study|Death|0|||
129142388|NCT00855166|464815730|FG001|Overall Study|Death|1|||
129142389|NCT00855166|464815729|FG000|Overall Study|Withdrawal by Subject|1|||
129142390|NCT00855166|464815730|FG001|Overall Study|Withdrawal by Subject|4|||
129142391|NCT00855166|464815729|FG000|Overall Study|Poor/non-compliance|2|||
129142392|NCT00855166|464815730|FG001|Overall Study|Poor/non-compliance|0|||
129142393|NCT00855166|464815729|FG000|Overall Study|Administrative reasons by sponsor|1|||
129142394|NCT00855166|464815730|FG001|Overall Study|Administrative reasons by sponsor|0|||
129142395|NCT00855166|464815729|FG000|Overall Study|Subject no longer meets study criteria|1|||
129142396|NCT00855166|464815730|FG001|Overall Study|Subject no longer meets study criteria|1|||
129142397|NCT04818229|464815733|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
129142398|NCT04818229|464815734|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
129142399|NCT04818229|464815735|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
129142400|NCT04818229|464815733|FG000|Overall Study|Adverse Event|3|||
129142401|NCT04818229|464815734|FG001|Overall Study|Adverse Event|1|||
129142402|NCT04818229|464815735|FG002|Overall Study|Adverse Event|1|||
129142403|NCT04818229|464815733|FG000|Overall Study|Withdrawal by Subject|0|||
129142404|NCT04818229|464815734|FG001|Overall Study|Withdrawal by Subject|0|||
129142405|NCT04818229|464815735|FG002|Overall Study|Withdrawal by Subject|2|||
129142406|NCT04818229|464815733|FG000|Overall Study|Lost to Follow-up|0|||
129142407|NCT04818229|464815734|FG001|Overall Study|Lost to Follow-up|0|||
129142408|NCT04818229|464815735|FG002|Overall Study|Lost to Follow-up|1|||
129142409|NCT04082364|464815736|FG000|Overall Study|Death|23|||
129142410|NCT04082364|464815737|FG001|Overall Study|Death|1|||
129142411|NCT04082364|464815738|FG002|Overall Study|Death|1|||
129142412|NCT04082364|464815739|FG003|Overall Study|Death|2|||
129142413|NCT04082364|464815740|FG004|Overall Study|Death|1|||
129142414|NCT04082364|464815736|FG000|Overall Study|Lost to Follow-up|1|||
129142415|NCT04082364|464815737|FG001|Overall Study|Lost to Follow-up|0|||
129142416|NCT04082364|464815738|FG002|Overall Study|Lost to Follow-up|0|||
129142417|NCT04082364|464815739|FG003|Overall Study|Lost to Follow-up|0|||
129142418|NCT04082364|464815740|FG004|Overall Study|Lost to Follow-up|1|||
129142419|NCT04082364|464815736|FG000|Overall Study|Physician Decision|1|||
129142420|NCT04082364|464815737|FG001|Overall Study|Physician Decision|1|||
129142421|NCT04082364|464815738|FG002|Overall Study|Physician Decision|0|||
129142422|NCT04082364|464815739|FG003|Overall Study|Physician Decision|2|||
129142423|NCT04082364|464815740|FG004|Overall Study|Physician Decision|1|||
129142424|NCT04082364|464815736|FG000|Overall Study|Withdrawal by Subject|1|||
129142425|NCT04082364|464815737|FG001|Overall Study|Withdrawal by Subject|1|||
129142426|NCT04082364|464815738|FG002|Overall Study|Withdrawal by Subject|0|||
129142427|NCT04082364|464815739|FG003|Overall Study|Withdrawal by Subject|0|||
129142428|NCT04082364|464815740|FG004|Overall Study|Withdrawal by Subject|1|||
129142429|NCT04082364|464815736|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
129142430|NCT04082364|464815737|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
129080840|NCT02343939|464584932|FG005|Overall Study|Withdrew consent|0|||
129080841|NCT02343939|464584933|FG006|Overall Study|Withdrew consent|0|||
129080842|NCT02343939|464584934|FG007|Overall Study|Withdrew consent|8|||
129080843|NCT02343939|464584935|FG008|Overall Study|Withdrew consent|6|||
129080844|NCT02343939|464584927|FG000|Overall Study|Treatment failure|0|||
129142431|NCT04082364|464815738|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
129142432|NCT04082364|464815739|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
129142433|NCT04082364|464815740|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
129080845|NCT02343939|464584928|FG001|Overall Study|Treatment failure|0|||
129080846|NCT02343939|464584929|FG002|Overall Study|Treatment failure|0|||
129142434|NCT04082364|464815736|FG000|Overall Study|Disease progression|0|||
129142435|NCT04082364|464815737|FG001|Overall Study|Disease progression|0|||
129142436|NCT04082364|464815738|FG002|Overall Study|Disease progression|0|||
129142437|NCT04082364|464815739|FG003|Overall Study|Disease progression|1|||
129142438|NCT04082364|464815740|FG004|Overall Study|Disease progression|0|||
129080847|NCT02343939|464584930|FG003|Overall Study|Treatment failure|0|||
129142439|NCT03186378|464815741|FG000|Overall Study|Lost to Follow-up|1|||
128724143|NCT01933048|463288980|FG001|Overall Study|unknown reasons|1|||
128724144|NCT00110812|463288981|FG000|Main Study|Death|0|||
128724145|NCT00110812|463288982|FG001|Main Study|Death|0|||
128724146|NCT00110812|463288983|FG002|Main Study|Death|2|||
128724147|NCT00110812|463288981|FG000|Main Study|Withdrawal by Subject|0|||
128724148|NCT00110812|463288982|FG001|Main Study|Withdrawal by Subject|0|||
128724149|NCT00110812|463288983|FG002|Main Study|Withdrawal by Subject|1|||
128724150|NCT00110812|463288981|FG000|Main Study|Lost to Follow-up|8|||
128724151|NCT00110812|463288982|FG001|Main Study|Lost to Follow-up|11|||
128724152|NCT00110812|463288983|FG002|Main Study|Lost to Follow-up|10|||
128724153|NCT00110812|463288981|FG000|Extended Follow-up|Death|1|||
128724154|NCT00110812|463288982|FG001|Extended Follow-up|Death|0|||
128724155|NCT00110812|463288983|FG002|Extended Follow-up|Death|3|||
128724156|NCT00110812|463288981|FG000|Extended Follow-up|Withdrawal by Subject|0|||
128724157|NCT00110812|463288982|FG001|Extended Follow-up|Withdrawal by Subject|1|||
128724158|NCT00110812|463288983|FG002|Extended Follow-up|Withdrawal by Subject|0|||
128724159|NCT00110812|463288981|FG000|Extended Follow-up|Lost to Follow-up|1|||
128724160|NCT00110812|463288982|FG001|Extended Follow-up|Lost to Follow-up|3|||
128724161|NCT00110812|463288983|FG002|Extended Follow-up|Lost to Follow-up|1|||
128724162|NCT02404311|463288984|FG000|Part A: Month 0-18|Death|2|||
128724163|NCT02404311|463288985|FG001|Part A: Month 0-18|Death|0|||
128724164|NCT02404311|463288986|FG002|Part A: Month 0-18|Death|0|||
128724165|NCT02404311|463288987|FG003|Part A: Month 0-18|Death|0|||
128724166|NCT02404311|463288988|FG004|Part A: Month 0-18|Death|0|||
128724167|NCT02404311|463288984|FG000|Part A: Month 0-18|Physician Decision|1|||
128724168|NCT02404311|463288985|FG001|Part A: Month 0-18|Physician Decision|0|||
128724169|NCT02404311|463288986|FG002|Part A: Month 0-18|Physician Decision|0|||
128724170|NCT02404311|463288987|FG003|Part A: Month 0-18|Physician Decision|0|||
128724171|NCT02404311|463288988|FG004|Part A: Month 0-18|Physician Decision|0|||
128724172|NCT02404311|463288984|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
128724173|NCT02404311|463288985|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
128724174|NCT02404311|463288986|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
128724175|NCT02404311|463288987|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
128724176|NCT02404311|463288988|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
128724177|NCT02404311|463288984|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
128724178|NCT02404311|463288985|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
129080848|NCT02343939|464584931|FG004|Overall Study|Treatment failure|0|||
129080849|NCT02343939|464584932|FG005|Overall Study|Treatment failure|0|||
129080850|NCT02343939|464584933|FG006|Overall Study|Treatment failure|2|||
129080851|NCT02343939|464584934|FG007|Overall Study|Treatment failure|1|||
129080852|NCT02343939|464584935|FG008|Overall Study|Treatment failure|0|||
129080853|NCT02343939|464584927|FG000|Overall Study|Investigator's discretion|0|||
129080854|NCT02343939|464584928|FG001|Overall Study|Investigator's discretion|0|||
129080855|NCT02343939|464584929|FG002|Overall Study|Investigator's discretion|0|||
129080856|NCT02343939|464584930|FG003|Overall Study|Investigator's discretion|1|||
129080857|NCT02343939|464584931|FG004|Overall Study|Investigator's discretion|0|||
129080858|NCT02343939|464584932|FG005|Overall Study|Investigator's discretion|0|||
129142440|NCT03186378|464815742|FG001|Overall Study|Lost to Follow-up|0|||
129142441|NCT02514746|464815743|FG000|Overall Study|Chronically Ill|1|||
129142442|NCT02514746|464815744|FG001|Overall Study|Chronically Ill|2|||
129142443|NCT02514746|464815743|FG000|Overall Study|Physician Decision|4|||
129142444|NCT02514746|464815744|FG001|Overall Study|Physician Decision|2|||
129142445|NCT02514746|464815743|FG000|Overall Study|Withdrawal by Subject|12|||
129142446|NCT02514746|464815744|FG001|Overall Study|Withdrawal by Subject|10|||
129142447|NCT02514746|464815743|FG000|Overall Study|Other|5|||
129142448|NCT02514746|464815744|FG001|Overall Study|Other|1|||
129142449|NCT02181413|464815745|FG000|Overall Study|Withdrawal by Subject|45|||
129142450|NCT02181413|464815746|FG001|Overall Study|Withdrawal by Subject|61|||
129142451|NCT02181413|464815745|FG000|Overall Study|Reason Not Specified|2|||
129142452|NCT02181413|464815746|FG001|Overall Study|Reason Not Specified|5|||
129142453|NCT02181413|464815745|FG000|Overall Study|Lost to Follow-up|8|||
128724179|NCT02404311|463288986|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
128724180|NCT02404311|463288987|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
128724181|NCT02404311|463288988|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
128724182|NCT02404311|463288984|FG000|Part A: Month 0-18|HIV Infection|6|||
128724183|NCT02404311|463288985|FG001|Part A: Month 0-18|HIV Infection|2|||
129080859|NCT02343939|464584933|FG006|Overall Study|Investigator's discretion|1|||
129080860|NCT02343939|464584934|FG007|Overall Study|Investigator's discretion|0|||
129080861|NCT02343939|464584935|FG008|Overall Study|Investigator's discretion|0|||
129142454|NCT02181413|464815746|FG001|Overall Study|Lost to Follow-up|7|||
129142455|NCT03973489|464815754|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
129142456|NCT03973489|464815755|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
128724184|NCT02404311|463288986|FG002|Part A: Month 0-18|HIV Infection|0|||
128724185|NCT02404311|463288987|FG003|Part A: Month 0-18|HIV Infection|0|||
128724186|NCT02404311|463288988|FG004|Part A: Month 0-18|HIV Infection|0|||
128724187|NCT02404311|463288984|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
128724188|NCT02404311|463288985|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
128724189|NCT02404311|463288986|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
128724190|NCT02404311|463288987|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
129080862|NCT02343939|464584927|FG000|Overall Study|Adverse Event|0|||
129080863|NCT02343939|464584928|FG001|Overall Study|Adverse Event|0|||
129080864|NCT02343939|464584929|FG002|Overall Study|Adverse Event|0|||
129080865|NCT02343939|464584930|FG003|Overall Study|Adverse Event|0|||
129080866|NCT02343939|464584931|FG004|Overall Study|Adverse Event|0|||
129080867|NCT02343939|464584932|FG005|Overall Study|Adverse Event|1|||
129080868|NCT02343939|464584933|FG006|Overall Study|Adverse Event|0|||
129080869|NCT02343939|464584934|FG007|Overall Study|Adverse Event|0|||
129080870|NCT02343939|464584935|FG008|Overall Study|Adverse Event|0|||
129080871|NCT02343939|464584927|FG000|Overall Study|Never Treated With ENTO|0|||
129080872|NCT02343939|464584928|FG001|Overall Study|Never Treated With ENTO|0|||
129080873|NCT02343939|464584929|FG002|Overall Study|Never Treated With ENTO|0|||
129080874|NCT02343939|464584930|FG003|Overall Study|Never Treated With ENTO|0|||
129080875|NCT02343939|464584931|FG004|Overall Study|Never Treated With ENTO|0|||
129080876|NCT02343939|464584932|FG005|Overall Study|Never Treated With ENTO|0|||
129080877|NCT02343939|464584933|FG006|Overall Study|Never Treated With ENTO|1|||
129080878|NCT02343939|464584934|FG007|Overall Study|Never Treated With ENTO|2|||
129080879|NCT02343939|464584935|FG008|Overall Study|Never Treated With ENTO|0|||
129080880|NCT01303172|464584942|FG000|Overall Study|Physician Decision|9|||
129080881|NCT01303172|464584943|FG001|Overall Study|Physician Decision|6|||
129080882|NCT01303172|464584942|FG000|Overall Study|Adverse Event|5|||
129080883|NCT01303172|464584943|FG001|Overall Study|Adverse Event|2|||
129080884|NCT01303172|464584942|FG000|Overall Study|Withdrawal by Subject|4|||
129080885|NCT01303172|464584943|FG001|Overall Study|Withdrawal by Subject|2|||
129080886|NCT01303172|464584942|FG000|Overall Study|Death|20|||
129080887|NCT01303172|464584943|FG001|Overall Study|Death|7|||
129080888|NCT01303172|464584942|FG000|Overall Study|Lack of Efficacy|25|||
129080889|NCT01303172|464584943|FG001|Overall Study|Lack of Efficacy|17|||
129080890|NCT00462709|464584946|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
129080891|NCT00462709|464584946|FG000|Overall Study|Lost to Follow-up|10|||
129080892|NCT00462709|464584946|FG000|Overall Study|Withdrawal by Subject|8|||
129080893|NCT00462709|464584946|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
129080894|NCT00462709|464584946|FG000|Overall Study|Death|2|||
129080895|NCT00462709|464584946|FG000|Overall Study|Logistical reasons|2|||
129080896|NCT00462709|464584946|FG000|Overall Study|Physician Decision|1|||
129080897|NCT00462709|464584946|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
129080898|NCT04468347|464584947|FG000|Overall Study|Withdrawal by Subject|0|||
129080899|NCT04468347|464584948|FG001|Overall Study|Withdrawal by Subject|1|||
129080900|NCT04468347|464584949|FG002|Overall Study|Withdrawal by Subject|3|||
129080901|NCT04468347|464584950|FG003|Overall Study|Withdrawal by Subject|3|||
129080902|NCT04468347|464584947|FG000|Overall Study|Lost to Follow-up|0|||
129080903|NCT04468347|464584948|FG001|Overall Study|Lost to Follow-up|0|||
129080904|NCT04468347|464584949|FG002|Overall Study|Lost to Follow-up|1|||
129080905|NCT04468347|464584950|FG003|Overall Study|Lost to Follow-up|1|||
129080906|NCT04468347|464584947|FG000|Overall Study|Physician Decision|1|||
129080907|NCT04468347|464584948|FG001|Overall Study|Physician Decision|0|||
129080908|NCT04468347|464584949|FG002|Overall Study|Physician Decision|2|||
129080909|NCT04468347|464584950|FG003|Overall Study|Physician Decision|0|||
129080910|NCT04468347|464584947|FG000|Overall Study|Protocol Violation|1|||
129080911|NCT04468347|464584948|FG001|Overall Study|Protocol Violation|0|||
129080912|NCT04468347|464584949|FG002|Overall Study|Protocol Violation|0|||
129080913|NCT04468347|464584950|FG003|Overall Study|Protocol Violation|0|||
129080914|NCT00665431|464584951|FG000|Overall Study|Adverse Event|16|||
129080915|NCT00665431|464584952|FG001|Overall Study|Adverse Event|22|||
129080916|NCT00665431|464584953|FG002|Overall Study|Adverse Event|6|||
129080917|NCT00665431|464584951|FG000|Overall Study|Withdrawal by Subject|17|||
129080918|NCT00665431|464584952|FG001|Overall Study|Withdrawal by Subject|25|||
129080919|NCT00665431|464584953|FG002|Overall Study|Withdrawal by Subject|15|||
129080920|NCT00665431|464584951|FG000|Overall Study|Lost to Follow-up|3|||
129080921|NCT00665431|464584952|FG001|Overall Study|Lost to Follow-up|3|||
129080922|NCT00665431|464584953|FG002|Overall Study|Lost to Follow-up|1|||
129080923|NCT00665431|464584951|FG000|Overall Study|Other|4|||
129080924|NCT00665431|464584952|FG001|Overall Study|Other|7|||
129080925|NCT00665431|464584953|FG002|Overall Study|Other|2|||
129080926|NCT03483961|464586958|FG000|Overall Study|Lost to Follow-up|7|||
129080927|NCT03483961|464586959|FG001|Overall Study|Lost to Follow-up|6|||
129080928|NCT03483961|464586960|FG002|Overall Study|Lost to Follow-up|6|||
129080929|NCT03483961|464586961|FG003|Overall Study|Lost to Follow-up|6|||
129080930|NCT03483961|464586962|FG004|Overall Study|Lost to Follow-up|6|||
129080931|NCT03483961|464586963|FG005|Overall Study|Lost to Follow-up|4|||
129080932|NCT03483961|464586964|FG006|Overall Study|Lost to Follow-up|4|||
129080933|NCT03483961|464586965|FG007|Overall Study|Lost to Follow-up|11|||
129080934|NCT03483961|464586966|FG008|Overall Study|Lost to Follow-up|1|||
129080935|NCT03483961|464586967|FG009|Overall Study|Lost to Follow-up|0|||
129080936|NCT03483961|464586958|FG000|Overall Study|Withdrawal by Subject|3|||
129080937|NCT03483961|464586959|FG001|Overall Study|Withdrawal by Subject|4|||
129080938|NCT03483961|464586960|FG002|Overall Study|Withdrawal by Subject|5|||
129080939|NCT03483961|464586961|FG003|Overall Study|Withdrawal by Subject|3|||
128724191|NCT02404311|463288988|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
128724192|NCT00218296|463288997|FG000|Overall Study|Lost to Follow-up|9|||
129080940|NCT03483961|464586962|FG004|Overall Study|Withdrawal by Subject|4|||
129080941|NCT03483961|464586963|FG005|Overall Study|Withdrawal by Subject|2|||
129080942|NCT03483961|464586964|FG006|Overall Study|Withdrawal by Subject|1|||
129080943|NCT03483961|464586965|FG007|Overall Study|Withdrawal by Subject|2|||
129080944|NCT03483961|464586966|FG008|Overall Study|Withdrawal by Subject|1|||
129080945|NCT03483961|464586967|FG009|Overall Study|Withdrawal by Subject|0|||
129080946|NCT03483961|464586958|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
129080947|NCT03483961|464586959|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080948|NCT03483961|464586960|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080949|NCT03483961|464586961|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080950|NCT03483961|464586962|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080951|NCT03483961|464586963|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080952|NCT03483961|464586964|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080953|NCT03483961|464586965|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080954|NCT03483961|464586966|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080955|NCT03483961|464586967|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129080956|NCT03483961|464586958|FG000|Overall Study|Adverse Event|0|||
129080957|NCT03483961|464586959|FG001|Overall Study|Adverse Event|0|||
129080958|NCT03483961|464586960|FG002|Overall Study|Adverse Event|1|||
128724193|NCT00218296|463288998|FG001|Overall Study|Lost to Follow-up|7|||
128724194|NCT00218296|463288997|FG000|Overall Study|Withdrawal by Subject|36|||
128724195|NCT00218296|463288998|FG001|Overall Study|Withdrawal by Subject|47|||
129080959|NCT03483961|464586961|FG003|Overall Study|Adverse Event|0|||
129080960|NCT03483961|464586962|FG004|Overall Study|Adverse Event|0|||
129080961|NCT03483961|464586963|FG005|Overall Study|Adverse Event|0|||
129080962|NCT03483961|464586964|FG006|Overall Study|Adverse Event|0|||
129080963|NCT03483961|464586965|FG007|Overall Study|Adverse Event|0|||
129080964|NCT03483961|464586966|FG008|Overall Study|Adverse Event|0|||
129080965|NCT03483961|464586967|FG009|Overall Study|Adverse Event|0|||
129080966|NCT00356603|464586968|FG000|Overall Study|Other|6|||
129080967|NCT00356603|464586969|FG001|Overall Study|Other|3|||
129080968|NCT00728468|464586971|FG000|Overall Study|Enrolled but not treated|1|||
129080969|NCT00728468|464586971|FG000|Overall Study|Death|1|||
129080970|NCT00728468|464586971|FG000|Overall Study|Protocol Violation|4|||
129080971|NCT00728468|464586971|FG000|Overall Study|Objective progression or relapse|9|||
129080972|NCT00728468|464586971|FG000|Overall Study|Study terminated by sponsor|1|||
129080973|NCT01262287|464586972|FG000|Overall Study|Lost to Follow-up|2|||
129080974|NCT01262287|464586973|FG001|Overall Study|Lost to Follow-up|1|||
129080975|NCT00932373|464586974|FG000|Overall Study|Progressive disease|3|||
129080976|NCT00932373|464586975|FG001|Overall Study|Progressive disease|1|||
129080977|NCT00932373|464586976|FG002|Overall Study|Progressive disease|0|||
129080978|NCT00932373|464586977|FG003|Overall Study|Progressive disease|0|||
129080979|NCT00932373|464586978|FG004|Overall Study|Progressive disease|10|||
129080980|NCT00932373|464586979|FG005|Overall Study|Progressive disease|1|||
129080981|NCT00932373|464586980|FG006|Overall Study|Progressive disease|0|||
129080982|NCT00932373|464586981|FG007|Overall Study|Progressive disease|2|||
129080983|NCT00932373|464586982|FG008|Overall Study|Progressive disease|1|||
129080984|NCT00932373|464586983|FG009|Overall Study|Progressive disease|9|||
129080985|NCT00932373|464586984|FG010|Overall Study|Progressive disease|2|||
129080986|NCT00932373|464586974|FG000|Overall Study|Adverse Event|0|||
129080987|NCT00932373|464586975|FG001|Overall Study|Adverse Event|0|||
129080988|NCT00932373|464586976|FG002|Overall Study|Adverse Event|0|||
129080989|NCT00932373|464586977|FG003|Overall Study|Adverse Event|0|||
129080990|NCT00932373|464586978|FG004|Overall Study|Adverse Event|2|||
129080991|NCT00932373|464586979|FG005|Overall Study|Adverse Event|1|||
129080992|NCT00932373|464586980|FG006|Overall Study|Adverse Event|0|||
129080993|NCT00932373|464586981|FG007|Overall Study|Adverse Event|1|||
129080994|NCT00932373|464586982|FG008|Overall Study|Adverse Event|0|||
129080995|NCT00932373|464586983|FG009|Overall Study|Adverse Event|2|||
129080996|NCT00932373|464586984|FG010|Overall Study|Adverse Event|1|||
129080997|NCT00932373|464586974|FG000|Overall Study|Physician Decision|0|||
129080998|NCT00932373|464586975|FG001|Overall Study|Physician Decision|0|||
129080999|NCT00932373|464586976|FG002|Overall Study|Physician Decision|1|||
129081000|NCT00932373|464586977|FG003|Overall Study|Physician Decision|0|||
129081001|NCT00932373|464586978|FG004|Overall Study|Physician Decision|2|||
129081002|NCT00932373|464586979|FG005|Overall Study|Physician Decision|0|||
129081003|NCT00932373|464586980|FG006|Overall Study|Physician Decision|0|||
129081004|NCT00932373|464586981|FG007|Overall Study|Physician Decision|0|||
129081005|NCT00932373|464586982|FG008|Overall Study|Physician Decision|0|||
128724196|NCT00218296|463288997|FG000|Overall Study|Randomized but did not enter treatment|66|||
129081006|NCT00932373|464586983|FG009|Overall Study|Physician Decision|1|||
129081007|NCT00932373|464586984|FG010|Overall Study|Physician Decision|0|||
129081008|NCT00932373|464586974|FG000|Overall Study|Dose limiting toxicity|0|||
129081009|NCT00932373|464586975|FG001|Overall Study|Dose limiting toxicity|0|||
129081010|NCT00932373|464586976|FG002|Overall Study|Dose limiting toxicity|0|||
129081011|NCT00932373|464586977|FG003|Overall Study|Dose limiting toxicity|0|||
129081012|NCT00932373|464586978|FG004|Overall Study|Dose limiting toxicity|0|||
129081013|NCT00932373|464586979|FG005|Overall Study|Dose limiting toxicity|1|||
129081014|NCT00932373|464586980|FG006|Overall Study|Dose limiting toxicity|0|||
129081015|NCT00932373|464586981|FG007|Overall Study|Dose limiting toxicity|0|||
129081016|NCT00932373|464586982|FG008|Overall Study|Dose limiting toxicity|0|||
129081017|NCT00932373|464586983|FG009|Overall Study|Dose limiting toxicity|0|||
129081018|NCT00932373|464586984|FG010|Overall Study|Dose limiting toxicity|0|||
129081019|NCT00932373|464586974|FG000|Overall Study|Withdrawal by Subject|0|||
129081020|NCT00932373|464586975|FG001|Overall Study|Withdrawal by Subject|0|||
129081021|NCT00932373|464586976|FG002|Overall Study|Withdrawal by Subject|0|||
129142457|NCT03973489|464815756|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129142458|NCT03973489|464815757|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129142459|NCT03973489|464815758|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
129142460|NCT03973489|464815759|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129142461|NCT03973489|464815760|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129142462|NCT03973489|464815761|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129142463|NCT03973489|464815754|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129142464|NCT03973489|464815755|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129142465|NCT03973489|464815756|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129142466|NCT03973489|464815757|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
129142467|NCT03973489|464815758|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
129081022|NCT00932373|464586977|FG003|Overall Study|Withdrawal by Subject|0|||
129081023|NCT00932373|464586978|FG004|Overall Study|Withdrawal by Subject|0|||
129081024|NCT00932373|464586979|FG005|Overall Study|Withdrawal by Subject|0|||
129081025|NCT00932373|464586980|FG006|Overall Study|Withdrawal by Subject|0|||
129081026|NCT00932373|464586981|FG007|Overall Study|Withdrawal by Subject|0|||
129081027|NCT00932373|464586982|FG008|Overall Study|Withdrawal by Subject|1|||
129081028|NCT00932373|464586983|FG009|Overall Study|Withdrawal by Subject|0|||
129081029|NCT00932373|464586984|FG010|Overall Study|Withdrawal by Subject|0|||
129081030|NCT00932373|464586974|FG000|Overall Study|Clinical progression|0|||
129081031|NCT00932373|464586975|FG001|Overall Study|Clinical progression|0|||
129081032|NCT00932373|464586976|FG002|Overall Study|Clinical progression|0|||
129081033|NCT00932373|464586977|FG003|Overall Study|Clinical progression|0|||
129081034|NCT00932373|464586978|FG004|Overall Study|Clinical progression|0|||
129081035|NCT00932373|464586979|FG005|Overall Study|Clinical progression|0|||
129081036|NCT00932373|464586980|FG006|Overall Study|Clinical progression|1|||
129081037|NCT00932373|464586981|FG007|Overall Study|Clinical progression|0|||
129081038|NCT00932373|464586982|FG008|Overall Study|Clinical progression|0|||
129081039|NCT00932373|464586983|FG009|Overall Study|Clinical progression|0|||
129081040|NCT00932373|464586984|FG010|Overall Study|Clinical progression|0|||
129142468|NCT03973489|464815759|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129142469|NCT03973489|464815760|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129142470|NCT03973489|464815761|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
128724197|NCT00218296|463288998|FG001|Overall Study|Randomized but did not enter treatment|67|||
128724198|NCT00097721|463288999|FG000|Overall Study|Adverse Event|8|||
128724199|NCT00097721|463289000|FG001|Overall Study|Adverse Event|1|||
128724200|NCT00097721|463288999|FG000|Overall Study|Withdrawal by Subject|6|||
128724201|NCT00097721|463289000|FG001|Overall Study|Withdrawal by Subject|1|||
128724202|NCT00097721|463288999|FG000|Overall Study|Progressive Disease|55|||
129081041|NCT00932373|464586974|FG000|Overall Study|Lack of Efficacy|0|||
129081042|NCT00932373|464586975|FG001|Overall Study|Lack of Efficacy|0|||
129081043|NCT00932373|464586976|FG002|Overall Study|Lack of Efficacy|0|||
129081044|NCT00932373|464586977|FG003|Overall Study|Lack of Efficacy|0|||
129081045|NCT00932373|464586978|FG004|Overall Study|Lack of Efficacy|0|||
129081046|NCT00932373|464586979|FG005|Overall Study|Lack of Efficacy|0|||
129081047|NCT00932373|464586980|FG006|Overall Study|Lack of Efficacy|0|||
129142471|NCT03973489|464815754|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
128724203|NCT00097721|463289000|FG001|Overall Study|Progressive Disease|27|||
128724204|NCT00097721|463288999|FG000|Overall Study|Physician Decision|1|||
129081048|NCT00932373|464586981|FG007|Overall Study|Lack of Efficacy|0|||
129081049|NCT00932373|464586982|FG008|Overall Study|Lack of Efficacy|0|||
129081050|NCT00932373|464586983|FG009|Overall Study|Lack of Efficacy|1|||
129081051|NCT00932373|464586984|FG010|Overall Study|Lack of Efficacy|0|||
129081052|NCT01637922|464586985|FG000|Overall Study|Adverse Event|0|||
129081053|NCT01637922|464586986|FG001|Overall Study|Adverse Event|1|||
129081054|NCT01637922|464586985|FG000|Overall Study|Protocol Violation|0|||
129081055|NCT01637922|464586986|FG001|Overall Study|Protocol Violation|1|||
129081056|NCT01637922|464586985|FG000|Overall Study|Withdrawal by Subject|0|||
129081057|NCT01637922|464586986|FG001|Overall Study|Withdrawal by Subject|3|||
129081058|NCT01637922|464586985|FG000|Overall Study|Lost to Follow-up|2|||
129081059|NCT01637922|464586986|FG001|Overall Study|Lost to Follow-up|0|||
129081060|NCT00638404|464586987|FG000|Overall Study|Physician Decision|8|||
129081061|NCT00638404|464586988|FG001|Overall Study|Physician Decision|0|||
129081062|NCT02509507|464586989|FG000|Overall Study|Death|21|||
129081063|NCT02509507|464586990|FG001|Overall Study|Death|3|||
129081064|NCT02509507|464586991|FG002|Overall Study|Death|22|||
129081065|NCT02509507|464586992|FG003|Overall Study|Death|14|||
129081066|NCT02509507|464586993|FG004|Overall Study|Death|8|||
129081067|NCT02509507|464586994|FG005|Overall Study|Death|12|||
129081068|NCT02509507|464586995|FG006|Overall Study|Death|5|||
129081069|NCT02509507|464586996|FG007|Overall Study|Death|4|||
129081070|NCT02509507|464586997|FG008|Overall Study|Death|8|||
129081071|NCT02509507|464586989|FG000|Overall Study|Lost to Follow-up|0|||
129081072|NCT02509507|464586990|FG001|Overall Study|Lost to Follow-up|1|||
129081073|NCT02509507|464586991|FG002|Overall Study|Lost to Follow-up|0|||
129081074|NCT02509507|464586992|FG003|Overall Study|Lost to Follow-up|0|||
129081075|NCT02509507|464586993|FG004|Overall Study|Lost to Follow-up|0|||
129081076|NCT02509507|464586994|FG005|Overall Study|Lost to Follow-up|2|||
129081077|NCT02509507|464586995|FG006|Overall Study|Lost to Follow-up|0|||
129081078|NCT02509507|464586996|FG007|Overall Study|Lost to Follow-up|0|||
129081079|NCT02509507|464586997|FG008|Overall Study|Lost to Follow-up|0|||
129081080|NCT02509507|464586989|FG000|Overall Study|Withdrawal by Subject|2|||
129081081|NCT02509507|464586990|FG001|Overall Study|Withdrawal by Subject|0|||
129081082|NCT02509507|464586991|FG002|Overall Study|Withdrawal by Subject|1|||
129081083|NCT02509507|464586992|FG003|Overall Study|Withdrawal by Subject|4|||
129081084|NCT02509507|464586993|FG004|Overall Study|Withdrawal by Subject|1|||
129081085|NCT02509507|464586994|FG005|Overall Study|Withdrawal by Subject|3|||
129081086|NCT02509507|464586995|FG006|Overall Study|Withdrawal by Subject|4|||
129081087|NCT02509507|464586996|FG007|Overall Study|Withdrawal by Subject|0|||
129081088|NCT02509507|464586997|FG008|Overall Study|Withdrawal by Subject|1|||
129081089|NCT02510664|464587001|FG000|Overall Study|Transferred Care|9|||
129081090|NCT02510664|464587002|FG001|Overall Study|Transferred Care|9|||
129081091|NCT02510664|464587003|FG002|Overall Study|Transferred Care|0|||
129081092|NCT02510664|464587001|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
129081093|NCT02510664|464587002|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
129081094|NCT02510664|464587003|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
129081095|NCT02510664|464587001|FG000|Overall Study|Time Constraints|1|||
129142472|NCT03973489|464815755|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
129142473|NCT03973489|464815756|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
129142474|NCT03973489|464815757|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
129142475|NCT03973489|464815758|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
129142476|NCT03973489|464815759|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
129142477|NCT03973489|464815760|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
129142478|NCT03973489|464815761|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
129142479|NCT03973489|464815754|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
129142480|NCT03973489|464815755|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129142481|NCT03973489|464815756|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129142482|NCT03973489|464815757|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
129142483|NCT03973489|464815758|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129081096|NCT02510664|464587002|FG001|Overall Study|Time Constraints|1|||
129081097|NCT02510664|464587003|FG002|Overall Study|Time Constraints|0|||
129081098|NCT00302328|464587014|FG000|Overall Study|Physician Decision|0|||
129081099|NCT00302328|464587015|FG001|Overall Study|Physician Decision|1|||
129081100|NCT00302328|464587016|FG002|Overall Study|Physician Decision|0|||
129081101|NCT00912743|464587021|FG000|Overall Study|Adverse Event|3|||
129142484|NCT03973489|464815759|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129142485|NCT03973489|464815760|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129142486|NCT03973489|464815761|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129142487|NCT03973489|464815754|FG000|Second Intervention (1 Day)|Adverse Event|0|||
129142488|NCT03973489|464815755|FG001|Second Intervention (1 Day)|Adverse Event|0|||
129142489|NCT03973489|464815756|FG002|Second Intervention (1 Day)|Adverse Event|0|||
129142490|NCT03973489|464815757|FG003|Second Intervention (1 Day)|Adverse Event|1|||
129081102|NCT00912743|464587022|FG001|Overall Study|Adverse Event|1|||
129081103|NCT00912743|464587021|FG000|Overall Study|Lack of Efficacy|9|||
129081104|NCT00912743|464587022|FG001|Overall Study|Lack of Efficacy|18|||
129081105|NCT00912743|464587021|FG000|Overall Study|Toxicity|0|||
129081106|NCT00912743|464587022|FG001|Overall Study|Toxicity|1|||
129081107|NCT00912743|464587021|FG000|Overall Study|End of treatment form was not collected|1|||
129081108|NCT00912743|464587022|FG001|Overall Study|End of treatment form was not collected|0|||
129081109|NCT00685399|464587034|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129081110|NCT00685399|464587035|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129081111|NCT00685399|464587036|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129081112|NCT00685399|464587037|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129081113|NCT00685399|464587038|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129081114|NCT00685399|464587039|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129081115|NCT00685399|464587040|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129081116|NCT00685399|464587041|FG007|Treatment Period 1|Withdrawal by Subject|0|||
129081117|NCT00685399|464587034|FG000|Treatment Period 1|Protocol Violation|1|||
129081118|NCT00685399|464587035|FG001|Treatment Period 1|Protocol Violation|0|||
129081119|NCT00685399|464587036|FG002|Treatment Period 1|Protocol Violation|0|||
129081120|NCT00685399|464587037|FG003|Treatment Period 1|Protocol Violation|0|||
129081121|NCT00685399|464587038|FG004|Treatment Period 1|Protocol Violation|0|||
129081122|NCT00685399|464587039|FG005|Treatment Period 1|Protocol Violation|0|||
129081123|NCT00685399|464587040|FG006|Treatment Period 1|Protocol Violation|0|||
129081124|NCT00685399|464587041|FG007|Treatment Period 1|Protocol Violation|0|||
129081125|NCT00685399|464587034|FG000|Treatment Period 1|Administrative|2|||
129081126|NCT00685399|464587035|FG001|Treatment Period 1|Administrative|0|||
129081127|NCT00685399|464587036|FG002|Treatment Period 1|Administrative|0|||
129081128|NCT00685399|464587037|FG003|Treatment Period 1|Administrative|0|||
129081129|NCT00685399|464587038|FG004|Treatment Period 1|Administrative|0|||
129081130|NCT00685399|464587039|FG005|Treatment Period 1|Administrative|0|||
129081131|NCT00685399|464587040|FG006|Treatment Period 1|Administrative|0|||
129081132|NCT00685399|464587041|FG007|Treatment Period 1|Administrative|0|||
129081133|NCT00685399|464587034|FG000|Treatment Period 1|Lack of Efficacy|1|||
129081134|NCT00685399|464587035|FG001|Treatment Period 1|Lack of Efficacy|0|||
129081135|NCT00685399|464587036|FG002|Treatment Period 1|Lack of Efficacy|0|||
129081136|NCT00685399|464587037|FG003|Treatment Period 1|Lack of Efficacy|0|||
129081137|NCT00685399|464587038|FG004|Treatment Period 1|Lack of Efficacy|0|||
129081138|NCT00685399|464587039|FG005|Treatment Period 1|Lack of Efficacy|0|||
129081139|NCT00685399|464587040|FG006|Treatment Period 1|Lack of Efficacy|0|||
129081140|NCT00685399|464587041|FG007|Treatment Period 1|Lack of Efficacy|0|||
129081141|NCT00685399|464587034|FG000|Treatment Period 2|Administrative Problems|0|||
129081142|NCT00685399|464587035|FG001|Treatment Period 2|Administrative Problems|2|||
129081143|NCT00685399|464587036|FG002|Treatment Period 2|Administrative Problems|1|||
129081144|NCT00685399|464587037|FG003|Treatment Period 2|Administrative Problems|0|||
129081145|NCT00685399|464587038|FG004|Treatment Period 2|Administrative Problems|0|||
129081146|NCT00685399|464587039|FG005|Treatment Period 2|Administrative Problems|0|||
129081147|NCT00685399|464587040|FG006|Treatment Period 2|Administrative Problems|0|||
129081148|NCT00685399|464587041|FG007|Treatment Period 2|Administrative Problems|0|||
129081149|NCT00685399|464587034|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129081150|NCT00685399|464587035|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129081151|NCT00685399|464587036|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129081152|NCT00685399|464587037|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129081153|NCT00685399|464587038|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129081154|NCT00685399|464587039|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129081155|NCT00685399|464587040|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129081156|NCT00685399|464587041|FG007|Treatment Period 2|Withdrawal by Subject|2|||
129081157|NCT00685399|464587034|FG000|Treatment Period 2|Adverse Event|0|||
129081158|NCT00685399|464587035|FG001|Treatment Period 2|Adverse Event|0|||
129081159|NCT00685399|464587036|FG002|Treatment Period 2|Adverse Event|0|||
129081160|NCT00685399|464587037|FG003|Treatment Period 2|Adverse Event|0|||
129081161|NCT00685399|464587038|FG004|Treatment Period 2|Adverse Event|0|||
129081162|NCT00685399|464587039|FG005|Treatment Period 2|Adverse Event|1|||
129081163|NCT00685399|464587040|FG006|Treatment Period 2|Adverse Event|0|||
129081164|NCT00685399|464587041|FG007|Treatment Period 2|Adverse Event|0|||
129142491|NCT03973489|464815758|FG004|Second Intervention (1 Day)|Adverse Event|0|||
129142492|NCT03973489|464815759|FG005|Second Intervention (1 Day)|Adverse Event|0|||
129142493|NCT03973489|464815760|FG006|Second Intervention (1 Day)|Adverse Event|0|||
129142494|NCT03973489|464815761|FG007|Second Intervention (1 Day)|Adverse Event|0|||
129142495|NCT03301415|464815762|FG000|Overall Study|Lost to Follow-up|2|||
129142496|NCT03301415|464815762|FG000|Overall Study|Unable to comply with visit schedule|2|||
129081165|NCT00685399|464587034|FG000|Treatment Period 2|Lack of Efficacy|0|||
129081166|NCT00685399|464587035|FG001|Treatment Period 2|Lack of Efficacy|10|||
129081167|NCT00685399|464587036|FG002|Treatment Period 2|Lack of Efficacy|2|||
129142497|NCT03247673|464815763|FG000|Overall Study|Withdrawal by Subject|1|||
129142498|NCT03247673|464815764|FG001|Overall Study|Withdrawal by Subject|0|||
129081168|NCT00685399|464587037|FG003|Treatment Period 2|Lack of Efficacy|0|||
129081169|NCT00685399|464587038|FG004|Treatment Period 2|Lack of Efficacy|0|||
129081170|NCT00685399|464587039|FG005|Treatment Period 2|Lack of Efficacy|1|||
129081171|NCT00685399|464587040|FG006|Treatment Period 2|Lack of Efficacy|0|||
129081172|NCT00685399|464587041|FG007|Treatment Period 2|Lack of Efficacy|0|||
129081173|NCT00685399|464587034|FG000|Extension|Administrative Issues|0|||
128724205|NCT00097721|463289000|FG001|Overall Study|Physician Decision|3|||
128724206|NCT00097721|463288999|FG000|Overall Study|Reason not given|1|||
128724207|NCT00097721|463289000|FG001|Overall Study|Reason not given|1|||
128724208|NCT01752855|463289004|FG000|Overall Study|Adverse Event|1|||
129081174|NCT00685399|464587035|FG001|Extension|Administrative Issues|0|||
129081175|NCT00685399|464587036|FG002|Extension|Administrative Issues|0|||
129142499|NCT03247673|464815765|FG002|Overall Study|Withdrawal by Subject|3|||
129142500|NCT03247673|464815763|FG000|Overall Study|Lost to Follow-up|0|||
129142501|NCT03247673|464815764|FG001|Overall Study|Lost to Follow-up|0|||
129142502|NCT03247673|464815765|FG002|Overall Study|Lost to Follow-up|1|||
129142503|NCT00392288|464815766|FG000|Overall Study|Adverse Event|17|||
129142504|NCT00392288|464815767|FG001|Overall Study|Adverse Event|7|||
129142505|NCT00392288|464815768|FG002|Overall Study|Adverse Event|8|||
129142506|NCT00392288|464815766|FG000|Overall Study|Lack of Efficacy|8|||
129081176|NCT00685399|464587037|FG003|Extension|Administrative Issues|1|||
129081177|NCT00685399|464587038|FG004|Extension|Administrative Issues|0|||
129081178|NCT00685399|464587039|FG005|Extension|Administrative Issues|0|||
129081179|NCT00685399|464587040|FG006|Extension|Administrative Issues|0|||
129081180|NCT00685399|464587041|FG007|Extension|Administrative Issues|0|||
129081181|NCT00685399|464587034|FG000|Extension|Withdrawal by Subject|0|||
129081182|NCT00685399|464587035|FG001|Extension|Withdrawal by Subject|0|||
129081183|NCT00685399|464587036|FG002|Extension|Withdrawal by Subject|0|||
129081184|NCT00685399|464587037|FG003|Extension|Withdrawal by Subject|1|||
129081185|NCT00685399|464587038|FG004|Extension|Withdrawal by Subject|0|||
129081186|NCT00685399|464587039|FG005|Extension|Withdrawal by Subject|0|||
129081187|NCT00685399|464587040|FG006|Extension|Withdrawal by Subject|0|||
129081188|NCT00685399|464587041|FG007|Extension|Withdrawal by Subject|0|||
129081189|NCT00685399|464587034|FG000|Extension|Protocol Violation|0|||
129081190|NCT00685399|464587035|FG001|Extension|Protocol Violation|0|||
129081191|NCT00685399|464587036|FG002|Extension|Protocol Violation|0|||
129081192|NCT00685399|464587037|FG003|Extension|Protocol Violation|1|||
129081193|NCT00685399|464587038|FG004|Extension|Protocol Violation|0|||
129081194|NCT00685399|464587039|FG005|Extension|Protocol Violation|0|||
129081195|NCT00685399|464587040|FG006|Extension|Protocol Violation|0|||
129081196|NCT00685399|464587041|FG007|Extension|Protocol Violation|0|||
129081197|NCT00685399|464587034|FG000|Extension|Lack of Efficacy|0|||
129081198|NCT00685399|464587035|FG001|Extension|Lack of Efficacy|0|||
129081199|NCT00685399|464587036|FG002|Extension|Lack of Efficacy|0|||
129081200|NCT00685399|464587037|FG003|Extension|Lack of Efficacy|2|||
129081201|NCT00685399|464587038|FG004|Extension|Lack of Efficacy|0|||
129081202|NCT00685399|464587039|FG005|Extension|Lack of Efficacy|0|||
129081203|NCT00685399|464587040|FG006|Extension|Lack of Efficacy|0|||
129081204|NCT00685399|464587041|FG007|Extension|Lack of Efficacy|0|||
129081205|NCT00685399|464587034|FG000|Extension|Adverse Event|0|||
129081206|NCT00685399|464587035|FG001|Extension|Adverse Event|0|||
129081207|NCT00685399|464587036|FG002|Extension|Adverse Event|0|||
129081208|NCT00685399|464587037|FG003|Extension|Adverse Event|2|||
129081209|NCT00685399|464587038|FG004|Extension|Adverse Event|0|||
129081210|NCT00685399|464587039|FG005|Extension|Adverse Event|0|||
129081211|NCT00685399|464587040|FG006|Extension|Adverse Event|0|||
129081212|NCT00685399|464587041|FG007|Extension|Adverse Event|0|||
129081213|NCT01750697|464587042|FG000|Overall Study|Transferred Back to Local Hospital|1|||
129142507|NCT00392288|464815767|FG001|Overall Study|Lack of Efficacy|5|||
129142508|NCT00392288|464815768|FG002|Overall Study|Lack of Efficacy|3|||
129142509|NCT00392288|464815766|FG000|Overall Study|Protocol Violation|1|||
129142510|NCT00392288|464815767|FG001|Overall Study|Protocol Violation|3|||
129142511|NCT00392288|464815768|FG002|Overall Study|Protocol Violation|1|||
129142512|NCT00392288|464815766|FG000|Overall Study|Lost to Follow-up|1|||
129142513|NCT00392288|464815767|FG001|Overall Study|Lost to Follow-up|1|||
129142514|NCT00392288|464815768|FG002|Overall Study|Lost to Follow-up|1|||
128724209|NCT01752855|463289005|FG001|Overall Study|Adverse Event|0|||
128724210|NCT01752855|463289004|FG000|Overall Study|Withdrew Consent|0|||
129142515|NCT00392288|464815766|FG000|Overall Study|Withdrawal by Subject|1|||
129142516|NCT00392288|464815767|FG001|Overall Study|Withdrawal by Subject|0|||
128724211|NCT01752855|463289005|FG001|Overall Study|Withdrew Consent|2|||
128724212|NCT01752855|463289004|FG000|Overall Study|Lack of Efficacy|0|||
129081214|NCT01750697|464587042|FG000|Overall Study|Physician and Family Decision|1|||
129081215|NCT01750697|464587042|FG000|Overall Study|Transferred to Adult Services|5|||
129081216|NCT01750697|464587042|FG000|Overall Study|Physician Decision|1|||
129081217|NCT01750697|464587042|FG000|Overall Study|Withdrawal by Subject|1|||
129081218|NCT00862823|464587045|FG000|First Intervention|Withdrawal by Subject|1|||
129081219|NCT00862823|464587046|FG001|First Intervention|Withdrawal by Subject|1|||
129081220|NCT01562782|464587047|FG000|Overall Study|Withdrawal by Subject|3|||
129081221|NCT01562782|464587048|FG001|Overall Study|Withdrawal by Subject|3|||
129081222|NCT01562782|464587047|FG000|Overall Study|screen failure|1|||
129081223|NCT01562782|464587048|FG001|Overall Study|screen failure|2|||
129081224|NCT01421225|464587051|FG000|Overall Study|Withdrawal by Subject|0|||
129081225|NCT01421225|464587052|FG001|Overall Study|Withdrawal by Subject|1|||
129081226|NCT02049814|464587055|FG000|Overall Study|Reason not Specified|4|||
129142517|NCT00392288|464815768|FG002|Overall Study|Withdrawal by Subject|2|||
129081227|NCT02049814|464587056|FG001|Overall Study|Reason not Specified|3|||
129081228|NCT02049814|464587055|FG000|Overall Study|Pregnancy|1|||
129081229|NCT02049814|464587056|FG001|Overall Study|Pregnancy|0|||
129081230|NCT02049814|464587055|FG000|Overall Study|Lost to Follow-up|2|||
129081231|NCT02049814|464587056|FG001|Overall Study|Lost to Follow-up|3|||
129081232|NCT02049814|464587055|FG000|Overall Study|Serious Protocol Violation|5|||
129081233|NCT02049814|464587056|FG001|Overall Study|Serious Protocol Violation|7|||
129081234|NCT02049814|464587055|FG000|Overall Study|Study Termination|0|||
129081235|NCT02049814|464587056|FG001|Overall Study|Study Termination|1|||
129081236|NCT02049814|464587055|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
129081237|NCT02049814|464587056|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
129081238|NCT02049814|464587055|FG000|Overall Study|Voluntary withdrawal|9|||
129081239|NCT02049814|464587056|FG001|Overall Study|Voluntary withdrawal|8|||
129081240|NCT02714595|464587058|FG000|Overall Study|Lost to Follow-up|1|||
129081241|NCT02714595|464587059|FG001|Overall Study|Lost to Follow-up|0|||
129081242|NCT02714595|464587058|FG000|Overall Study|Withdrawal by Subject|1|||
129081243|NCT02714595|464587059|FG001|Overall Study|Withdrawal by Subject|2|||
129081244|NCT02714595|464587058|FG000|Overall Study|Lack of Efficacy|0|||
129081245|NCT02714595|464587059|FG001|Overall Study|Lack of Efficacy|1|||
129081246|NCT02714595|464587058|FG000|Overall Study|Death|30|||
129081247|NCT02714595|464587059|FG001|Overall Study|Death|9|||
129081248|NCT02714595|464587058|FG000|Overall Study|Other-Miscellaneous|0|||
129081249|NCT02714595|464587059|FG001|Overall Study|Other-Miscellaneous|1|||
129081250|NCT00713258|464587060|FG000|Overall Study|Adverse Event|2|||
129081251|NCT00713258|464587061|FG001|Overall Study|Adverse Event|4|||
129081252|NCT00713258|464587060|FG000|Overall Study|Non-Compliance|2|||
129081253|NCT00713258|464587061|FG001|Overall Study|Non-Compliance|1|||
129081254|NCT00713258|464587060|FG000|Overall Study|Other|1|||
129081255|NCT00713258|464587061|FG001|Overall Study|Other|1|||
129081256|NCT02693002|464587064|FG000|Overall Study|Withdrawal by Subject|1|||
129081257|NCT02693002|464587065|FG001|Overall Study|Withdrawal by Subject|0|||
129081258|NCT00708214|464587066|FG000|Overall Study|Other Adverse Event|3|||
129081259|NCT00708214|464587067|FG001|Overall Study|Other Adverse Event|6|||
129081260|NCT00708214|464587068|FG002|Overall Study|Other Adverse Event|2|||
129081261|NCT00708214|464587066|FG000|Overall Study|Other|0|||
129081262|NCT00708214|464587067|FG001|Overall Study|Other|1|||
129081263|NCT00708214|464587068|FG002|Overall Study|Other|1|||
129081264|NCT00708214|464587066|FG000|Overall Study|Progressive Disease|4|||
129081265|NCT00708214|464587067|FG001|Overall Study|Progressive Disease|6|||
129081266|NCT00708214|464587068|FG002|Overall Study|Progressive Disease|5|||
129081267|NCT02411396|464587069|FG000|Overall Study|Lost to Follow-up|31|||
129081268|NCT02411396|464587069|FG000|Overall Study|Death|10|||
129081269|NCT02865499|464587070|FG000|Baseline|Adverse Event|1|||
129081270|NCT02865499|464587070|FG000|Baseline|Withdrawal by Subject|1|||
129081271|NCT01931995|464587075|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
129081272|NCT01931995|464587076|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
129081273|NCT01931995|464587075|FG000|First Intervention (1 Day)|Physician Decision|1|||
129081274|NCT01931995|464587076|FG001|First Intervention (1 Day)|Physician Decision|1|||
129081275|NCT01931995|464587075|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
129081276|NCT01931995|464587076|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
129081277|NCT00014495|464587077|FG000|Overall Study|Death|0|||
129081278|NCT00014495|464587078|FG001|Overall Study|Death|0|||
129081279|NCT00014495|464587079|FG002|Overall Study|Death|1|||
129081280|NCT00014495|464587080|FG003|Overall Study|Death|0|||
129081281|NCT00014495|464587077|FG000|Overall Study|Clinical deterioration|0|||
129081282|NCT00014495|464587078|FG001|Overall Study|Clinical deterioration|0|||
129081283|NCT00014495|464587079|FG002|Overall Study|Clinical deterioration|0|||
129081284|NCT00014495|464587080|FG003|Overall Study|Clinical deterioration|1|||
129081285|NCT02099110|464587085|FG000|Overall Study|Protocol Violation|2|||
129081286|NCT02099110|464587086|FG001|Overall Study|Protocol Violation|1|||
129081287|NCT02099110|464587087|FG002|Overall Study|Protocol Violation|0|||
129081288|NCT02099110|464587088|FG003|Overall Study|Protocol Violation|3|||
129081289|NCT02099110|464587089|FG004|Overall Study|Protocol Violation|1|||
129081290|NCT02099110|464587085|FG000|Overall Study|Participant moved|1|||
129081291|NCT02099110|464587086|FG001|Overall Study|Participant moved|1|||
129081292|NCT02099110|464587087|FG002|Overall Study|Participant moved|1|||
129081293|NCT02099110|464587088|FG003|Overall Study|Participant moved|0|||
129081294|NCT02099110|464587089|FG004|Overall Study|Participant moved|2|||
129081295|NCT02099110|464587085|FG000|Overall Study|Withdrawal by Subject|7|||
129081296|NCT02099110|464587086|FG001|Overall Study|Withdrawal by Subject|11|||
129081297|NCT02099110|464587087|FG002|Overall Study|Withdrawal by Subject|13|||
129081298|NCT02099110|464587088|FG003|Overall Study|Withdrawal by Subject|9|||
129081299|NCT02099110|464587089|FG004|Overall Study|Withdrawal by Subject|13|||
129081300|NCT02099110|464587085|FG000|Overall Study|Adverse Event|3|||
129081301|NCT02099110|464587086|FG001|Overall Study|Adverse Event|5|||
129081302|NCT02099110|464587087|FG002|Overall Study|Adverse Event|2|||
129081303|NCT02099110|464587088|FG003|Overall Study|Adverse Event|3|||
129081304|NCT02099110|464587089|FG004|Overall Study|Adverse Event|2|||
129081305|NCT02099110|464587085|FG000|Overall Study|Lost to Follow-up|6|||
129081306|NCT02099110|464587086|FG001|Overall Study|Lost to Follow-up|12|||
129081307|NCT02099110|464587087|FG002|Overall Study|Lost to Follow-up|11|||
129081308|NCT02099110|464587088|FG003|Overall Study|Lost to Follow-up|5|||
129081309|NCT02099110|464587089|FG004|Overall Study|Lost to Follow-up|6|||
129081310|NCT02099110|464587085|FG000|Overall Study|Death|0|||
129081311|NCT02099110|464587086|FG001|Overall Study|Death|1|||
129081312|NCT02099110|464587087|FG002|Overall Study|Death|0|||
129081313|NCT02099110|464587088|FG003|Overall Study|Death|0|||
129081314|NCT02099110|464587089|FG004|Overall Study|Death|0|||
129081315|NCT02099110|464587085|FG000|Overall Study|Screen failure|0|||
129081316|NCT02099110|464587086|FG001|Overall Study|Screen failure|0|||
129081317|NCT02099110|464587087|FG002|Overall Study|Screen failure|0|||
129081318|NCT02099110|464587088|FG003|Overall Study|Screen failure|0|||
129081319|NCT02099110|464587089|FG004|Overall Study|Screen failure|1|||
129081320|NCT02099110|464587085|FG000|Overall Study|Non-compliance with study drug|2|||
129081321|NCT02099110|464587086|FG001|Overall Study|Non-compliance with study drug|0|||
129081322|NCT02099110|464587087|FG002|Overall Study|Non-compliance with study drug|0|||
129081323|NCT02099110|464587088|FG003|Overall Study|Non-compliance with study drug|0|||
129081324|NCT02099110|464587089|FG004|Overall Study|Non-compliance with study drug|1|||
129081325|NCT02099110|464587085|FG000|Overall Study|Physician Decision|3|||
129081326|NCT02099110|464587086|FG001|Overall Study|Physician Decision|0|||
129081327|NCT02099110|464587087|FG002|Overall Study|Physician Decision|1|||
129081328|NCT02099110|464587088|FG003|Overall Study|Physician Decision|2|||
129081329|NCT02099110|464587089|FG004|Overall Study|Physician Decision|1|||
129081330|NCT02064816|464587090|FG000|Overall Study|Adverse Event|3|||
129081331|NCT02064816|464587091|FG001|Overall Study|Adverse Event|2|||
129081332|NCT02064816|464587090|FG000|Overall Study|Withdrawal by Subject|2|||
129081333|NCT02064816|464587091|FG001|Overall Study|Withdrawal by Subject|1|||
129081334|NCT02064816|464587090|FG000|Overall Study|Lost to Follow-up|2|||
129081335|NCT02064816|464587091|FG001|Overall Study|Lost to Follow-up|1|||
129081336|NCT02064816|464587090|FG000|Overall Study|Therapeutic failure|0|||
129081337|NCT02064816|464587091|FG001|Overall Study|Therapeutic failure|1|||
129081338|NCT02064816|464587090|FG000|Overall Study|Other|1|||
129081339|NCT02064816|464587091|FG001|Overall Study|Other|3|||
129081340|NCT02887248|464587097|FG000|Overall Study|Withdrawal by Subject|1|||
129081341|NCT02887248|464587097|FG000|Overall Study|Adverse Event|1|||
129081342|NCT02887248|464587097|FG000|Overall Study|Progressive Disease|1|||
129081343|NCT03307252|464587098|FG000|Part 2, Period 1|Treatment not received|0|||
129081344|NCT03307252|464587099|FG001|Part 2, Period 1|Treatment not received|0|||
129081345|NCT03307252|464587100|FG002|Part 2, Period 1|Treatment not received|0|||
129081346|NCT03307252|464587101|FG003|Part 2, Period 1|Treatment not received|0|||
129081347|NCT03307252|464587102|FG004|Part 2, Period 1|Treatment not received|0|||
129081348|NCT03307252|464587103|FG005|Part 2, Period 1|Treatment not received|1|||
129081349|NCT03307252|464587104|FG006|Part 2, Period 1|Treatment not received|0|||
129081350|NCT03307252|464587105|FG007|Part 2, Period 1|Treatment not received|0|||
129081351|NCT03307252|464587106|FG008|Part 2, Period 1|Treatment not received|0|||
129081352|NCT03307252|464587107|FG009|Part 2, Period 1|Treatment not received|0|||
129081353|NCT03307252|464587108|FG010|Part 2, Period 1|Treatment not received|0|||
129081354|NCT03307252|464587098|FG000|Part 2, Period 3|Other than listed|0|||
129081355|NCT03307252|464587099|FG001|Part 2, Period 3|Other than listed|0|||
129081356|NCT03307252|464587100|FG002|Part 2, Period 3|Other than listed|0|||
129081357|NCT03307252|464587101|FG003|Part 2, Period 3|Other than listed|0|||
129081358|NCT03307252|464587102|FG004|Part 2, Period 3|Other than listed|1|||
129081359|NCT03307252|464587103|FG005|Part 2, Period 3|Other than listed|0|||
129081360|NCT03307252|464587104|FG006|Part 2, Period 3|Other than listed|0|||
129081361|NCT03307252|464587105|FG007|Part 2, Period 3|Other than listed|0|||
129081362|NCT03307252|464587106|FG008|Part 2, Period 3|Other than listed|0|||
129081363|NCT03307252|464587107|FG009|Part 2, Period 3|Other than listed|0|||
129081364|NCT03307252|464587108|FG010|Part 2, Period 3|Other than listed|0|||
129081365|NCT03307252|464587098|FG000|Part 2, Period 4|Other than listed|0|||
129081366|NCT03307252|464587099|FG001|Part 2, Period 4|Other than listed|0|||
129081367|NCT03307252|464587100|FG002|Part 2, Period 4|Other than listed|0|||
129081368|NCT03307252|464587101|FG003|Part 2, Period 4|Other than listed|0|||
129081369|NCT03307252|464587102|FG004|Part 2, Period 4|Other than listed|0|||
129081370|NCT03307252|464587103|FG005|Part 2, Period 4|Other than listed|0|||
129081371|NCT03307252|464587104|FG006|Part 2, Period 4|Other than listed|1|||
129081372|NCT03307252|464587105|FG007|Part 2, Period 4|Other than listed|0|||
129081373|NCT03307252|464587106|FG008|Part 2, Period 4|Other than listed|0|||
129081374|NCT03307252|464587107|FG009|Part 2, Period 4|Other than listed|0|||
129081375|NCT03307252|464587108|FG010|Part 2, Period 4|Other than listed|0|||
129081376|NCT03307252|464587098|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081377|NCT03307252|464587099|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081378|NCT03307252|464587100|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081379|NCT03307252|464587101|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081380|NCT03307252|464587102|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081381|NCT03307252|464587103|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081382|NCT03307252|464587104|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081383|NCT03307252|464587105|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081384|NCT03307252|464587106|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081385|NCT03307252|464587107|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129081386|NCT03307252|464587108|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
129081387|NCT03482453|464587109|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081388|NCT03482453|464587110|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081389|NCT03482453|464587111|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081390|NCT03482453|464587112|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081391|NCT03482453|464587113|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081392|NCT03482453|464587114|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081393|NCT03482453|464587115|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081394|NCT03482453|464587116|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081395|NCT03482453|464587117|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081396|NCT03482453|464587118|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081397|NCT03482453|464587119|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
129081398|NCT03482453|464587120|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129081399|NCT02568189|464587121|FG000|Overall Study|Protocol Violation|0|||
129081400|NCT02568189|464587122|FG001|Overall Study|Protocol Violation|0|||
129081401|NCT02568189|464587123|FG002|Overall Study|Protocol Violation|19|||
129081402|NCT02568189|464587124|FG003|Overall Study|Protocol Violation|18|||
129081403|NCT02157376|464587125|FG000|Overall Study|Death|10|||
129081404|NCT02157376|464587126|FG001|Overall Study|Death|4|||
129081405|NCT02157376|464587125|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129081406|NCT02157376|464587126|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129081407|NCT02157376|464587125|FG000|Overall Study|Withdrawal by Subject|3|||
129081408|NCT02157376|464587126|FG001|Overall Study|Withdrawal by Subject|8|||
129081409|NCT02157376|464587125|FG000|Overall Study|Not treated|8|||
129081410|NCT02157376|464587126|FG001|Overall Study|Not treated|3|||
129081411|NCT02157376|464587125|FG000|Overall Study|Investigator's misjudgement|1|||
129081412|NCT02157376|464587126|FG001|Overall Study|Investigator's misjudgement|2|||
129081413|NCT01074268|464587129|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
129081414|NCT01074268|464587130|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
129081415|NCT01074268|464587129|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
129081416|NCT01074268|464587130|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
129081417|NCT01074268|464587129|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
129081418|NCT01074268|464587130|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
129081419|NCT01074268|464587129|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
129081420|NCT01074268|464587130|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
129081421|NCT01074268|464587129|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
129081422|NCT01074268|464587130|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
129081423|NCT01074268|464587129|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
129081424|NCT01074268|464587130|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
129081425|NCT01074268|464587129|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
129081426|NCT01074268|464587130|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
129081427|NCT01074268|464587129|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
129081428|NCT01074268|464587130|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
129081429|NCT01074268|464587129|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
129081430|NCT01074268|464587130|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
129081431|NCT01578239|464587131|FG000|Treatment Period|Progressive Disease|19|||
129081432|NCT01578239|464587132|FG001|Treatment Period|Progressive Disease|64|||
129081433|NCT01578239|464587131|FG000|Treatment Period|Physician Decision|17|||
129081434|NCT01578239|464587132|FG001|Treatment Period|Physician Decision|17|||
129081435|NCT01578239|464587131|FG000|Treatment Period|Adverse Event|13|||
129081436|NCT01578239|464587132|FG001|Treatment Period|Adverse Event|10|||
129081437|NCT01578239|464587131|FG000|Treatment Period|Non-compliance|2|||
129081438|NCT01578239|464587132|FG001|Treatment Period|Non-compliance|0|||
129081439|NCT01578239|464587131|FG000|Treatment Period|Withdrawal by Subject|10|||
129081440|NCT01578239|464587132|FG001|Treatment Period|Withdrawal by Subject|9|||
129081441|NCT01578239|464587131|FG000|Treatment Period|Other|6|||
129081442|NCT01578239|464587132|FG001|Treatment Period|Other|1|||
129081443|NCT01578239|464587131|FG000|Long-term Follow-Up Period|Death|69|||
129081444|NCT01578239|464587132|FG001|Long-term Follow-Up Period|Death|64|||
129081445|NCT01578239|464587131|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
129081446|NCT01578239|464587132|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
129081447|NCT01578239|464587131|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
129081448|NCT01578239|464587132|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
129081449|NCT01578239|464587131|FG000|Long-term Follow-Up Period|Other|2|||
129081450|NCT01578239|464587132|FG001|Long-term Follow-Up Period|Other|2|||
129081451|NCT02347813|464587138|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
129081452|NCT02347813|464587139|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
129081453|NCT02347813|464587138|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
129081454|NCT02347813|464587139|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
129081455|NCT02837731|464587142|FG000|Allocation|Admitted to General Floor|3|||
129081456|NCT02837731|464587143|FG001|Allocation|Admitted to General Floor|4|||
129081457|NCT02837731|464587142|FG000|Allocation|Immediate surgery/withdrew|2|||
129081458|NCT02837731|464587143|FG001|Allocation|Immediate surgery/withdrew|0|||
129081459|NCT02837731|464587142|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
129081460|NCT02837731|464587143|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
129081461|NCT02837731|464587142|FG000|Allocation|Withdrawal by Subject|2|||
129081462|NCT02837731|464587143|FG001|Allocation|Withdrawal by Subject|0|||
129081463|NCT02837731|464587142|FG000|Allocation|Device not available|1|||
129081464|NCT02837731|464587143|FG001|Allocation|Device not available|0|||
129081465|NCT02837731|464587142|FG000|Allocation|Protocol not implemented|7|||
129081466|NCT02837731|464587143|FG001|Allocation|Protocol not implemented|0|||
129081467|NCT02837731|464587142|FG000|Allocation|Moribund/Do not resuscitate|2|||
129081468|NCT02837731|464587143|FG001|Allocation|Moribund/Do not resuscitate|0|||
129081469|NCT02837731|464587142|FG000|Allocation|Did not meet sepsis criteria|1|||
129081470|NCT02837731|464587143|FG001|Allocation|Did not meet sepsis criteria|2|||
129081471|NCT02837731|464587142|FG000|Allocation|Known aortic abnormalities|0|||
129081472|NCT02837731|464587143|FG001|Allocation|Known aortic abnormalities|1|||
129081473|NCT01119859|464587144|FG000|Overall Study|Adverse Event|9|||
129081474|NCT01119859|464587145|FG001|Overall Study|Adverse Event|10|||
129081475|NCT01119859|464587144|FG000|Overall Study|Death|2|||
129081476|NCT01119859|464587145|FG001|Overall Study|Death|0|||
129081477|NCT01119859|464587144|FG000|Overall Study|Insufficient therapeutic response|7|||
129081478|NCT01119859|464587145|FG001|Overall Study|Insufficient therapeutic response|14|||
129081479|NCT01119859|464587144|FG000|Overall Study|Refused treatment|3|||
129081480|NCT01119859|464587145|FG001|Overall Study|Refused treatment|6|||
129081481|NCT01119859|464587144|FG000|Overall Study|Failure to return|3|||
129081482|NCT01119859|464587145|FG001|Overall Study|Failure to return|0|||
129081483|NCT04200651|464587146|FG000|Overall Study|Moved to another country during follow-up|2|||
129081484|NCT04200651|464587147|FG001|Overall Study|Moved to another country during follow-up|2|||
129081485|NCT04200651|464587146|FG000|Overall Study|Lost to Follow-up|1|||
129081486|NCT04200651|464587147|FG001|Overall Study|Lost to Follow-up|3|||
129081487|NCT03225105|464587148|FG000|Overall Study|Withdrawal by Subject|1|||
129081488|NCT03225105|464587149|FG001|Overall Study|Withdrawal by Subject|0|||
129081489|NCT03225105|464587150|FG002|Overall Study|Withdrawal by Subject|0|||
129081490|NCT03225105|464587151|FG003|Overall Study|Withdrawal by Subject|0|||
129081491|NCT03225105|464587148|FG000|Overall Study|Death|0|||
129081492|NCT03225105|464587149|FG001|Overall Study|Death|4|||
129081493|NCT03225105|464587150|FG002|Overall Study|Death|2|||
129081494|NCT03225105|464587151|FG003|Overall Study|Death|0|||
129081495|NCT03225105|464587148|FG000|Overall Study|Study termination per Sponsor Decision|2|||
129081496|NCT03225105|464587149|FG001|Overall Study|Study termination per Sponsor Decision|0|||
129081497|NCT03225105|464587150|FG002|Overall Study|Study termination per Sponsor Decision|3|||
129081498|NCT03225105|464587151|FG003|Overall Study|Study termination per Sponsor Decision|3|||
129081499|NCT02887183|464587153|FG000|Overall Study|Adverse Event|44|||
129081500|NCT02887183|464587153|FG000|Overall Study|Death|30|||
129081501|NCT02887183|464587153|FG000|Overall Study|Pregnancy|1|||
129081502|NCT02887183|464587153|FG000|Overall Study|Protocol Violation|6|||
129081503|NCT02887183|464587153|FG000|Overall Study|Technical Problems|2|||
129081504|NCT02887183|464587153|FG000|Overall Study|Lost to Follow-up|13|||
129081505|NCT02887183|464587153|FG000|Overall Study|Physician Decision|10|||
129081506|NCT02887183|464587153|FG000|Overall Study|Withdrawal by Subject|35|||
129081507|NCT01031680|464587154|FG000|Overall Study|Adverse Event|8|||
129081508|NCT01031680|464587155|FG001|Overall Study|Adverse Event|3|||
129081509|NCT01031680|464587154|FG000|Overall Study|Lost to Follow-up|2|||
129081510|NCT01031680|464587155|FG001|Overall Study|Lost to Follow-up|10|||
129081511|NCT01031680|464587154|FG000|Overall Study|Withdrawal by Subject|12|||
129081512|NCT01031680|464587155|FG001|Overall Study|Withdrawal by Subject|16|||
129142518|NCT00392288|464815766|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
129142519|NCT00392288|464815767|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
129081513|NCT01031680|464587154|FG000|Overall Study|Death|2|||
129081514|NCT01031680|464587155|FG001|Overall Study|Death|1|||
129081515|NCT01031680|464587154|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
129081516|NCT01031680|464587155|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
129081517|NCT01031680|464587154|FG000|Overall Study|Poor/Non-compliance|5|||
129081518|NCT01031680|464587155|FG001|Overall Study|Poor/Non-compliance|6|||
129081519|NCT01031680|464587154|FG000|Overall Study|Safety|1|||
129081520|NCT01031680|464587155|FG001|Overall Study|Safety|0|||
129081521|NCT01031680|464587154|FG000|Overall Study|Incorrect Enrolment|1|||
129081522|NCT01031680|464587155|FG001|Overall Study|Incorrect Enrolment|2|||
129081523|NCT01031680|464587154|FG000|Overall Study|Administrative Reason by Sponsor|0|||
129081524|NCT01031680|464587155|FG001|Overall Study|Administrative Reason by Sponsor|1|||
129081525|NCT01031680|464587154|FG000|Overall Study|Various|0|||
129081526|NCT01031680|464587155|FG001|Overall Study|Various|2|||
129081527|NCT02654977|464587160|FG000|Overall Study|Death|1|||
129081528|NCT02654977|464587160|FG000|Overall Study|Lost to Follow-up|1|||
129081529|NCT02654977|464587160|FG000|Overall Study|Adverse Event|1|||
129081530|NCT02654977|464587160|FG000|Overall Study|Withdrawal by Subject|1|||
129081531|NCT02654977|464587160|FG000|Overall Study|Lack of Efficacy|3|||
129081532|NCT01921101|464587161|FG000|Overall Study|Death|16|||
129081533|NCT01921101|464587162|FG001|Overall Study|Death|6|||
129081534|NCT01483027|464587163|FG000|Overall Study|Administrative Reasons|2|||
129081535|NCT01483027|464587164|FG001|Overall Study|Administrative Reasons|1|||
129081536|NCT01483027|464587163|FG000|Overall Study|Withdrawal by Subject|21|||
129081537|NCT01483027|464587164|FG001|Overall Study|Withdrawal by Subject|32|||
129081538|NCT01483027|464587163|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
129081539|NCT01483027|464587164|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
129081540|NCT01483027|464587163|FG000|Overall Study|Lost to Follow-up|1|||
129081541|NCT01483027|464587164|FG001|Overall Study|Lost to Follow-up|1|||
129081542|NCT01483027|464587163|FG000|Overall Study|Adverse Event|0|||
129081543|NCT01483027|464587164|FG001|Overall Study|Adverse Event|1|||
129081544|NCT01483027|464587163|FG000|Overall Study|Withdrawal by Subject|0|||
129081545|NCT01483027|464587164|FG001|Overall Study|Withdrawal by Subject|1|||
129081546|NCT03691207|464588597|FG000|Overall Study|Death|41|||
129081547|NCT03691207|464588598|FG001|Overall Study|Death|26|||
129081548|NCT03691207|464588597|FG000|Overall Study|Lost to Follow-up|1|||
129081549|NCT03691207|464588598|FG001|Overall Study|Lost to Follow-up|1|||
129081550|NCT03691207|464588597|FG000|Overall Study|Withdrawal by Subject|2|||
129081551|NCT03691207|464588598|FG001|Overall Study|Withdrawal by Subject|8|||
129081552|NCT03691207|464588597|FG000|Overall Study|Sponsor decision|1|||
129081553|NCT03691207|464588598|FG001|Overall Study|Sponsor decision|7|||
129081554|NCT01288937|464588601|FG000|Overall Study|Adverse Event|1|||
129081555|NCT01288937|464588602|FG001|Overall Study|Adverse Event|0|||
129081556|NCT02490371|464588603|FG000|Overall Study|Lost to Follow-up|1|||
129081557|NCT02490371|464588604|FG001|Overall Study|Lost to Follow-up|1|||
129081558|NCT00610155|464588605|FG000|Period 1|Withdrawal by Subject|0|||
129081559|NCT00610155|464588606|FG001|Period 1|Withdrawal by Subject|0|||
129081560|NCT00610155|464588607|FG002|Period 1|Withdrawal by Subject|1|||
129081561|NCT00610155|464588608|FG003|Period 1|Withdrawal by Subject|0|||
129081562|NCT00610155|464588609|FG004|Period 1|Withdrawal by Subject|0|||
129081563|NCT00610155|464588610|FG005|Period 1|Withdrawal by Subject|0|||
129081564|NCT00610155|464588605|FG000|Period 3|Adverse Event|1|||
129081565|NCT00610155|464588606|FG001|Period 3|Adverse Event|0|||
129081566|NCT00610155|464588607|FG002|Period 3|Adverse Event|0|||
129081567|NCT00610155|464588608|FG003|Period 3|Adverse Event|0|||
129081568|NCT00610155|464588609|FG004|Period 3|Adverse Event|0|||
129081569|NCT00610155|464588610|FG005|Period 3|Adverse Event|0|||
129081570|NCT01718535|464588611|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
129081571|NCT01718535|464588612|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
129081572|NCT01718535|464588613|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
129081573|NCT01718535|464588614|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
129081574|NCT01718535|464588615|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
129081575|NCT01718535|464588616|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
129081576|NCT01718535|464588617|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
129081577|NCT01718535|464588618|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
129081578|NCT01718535|464588619|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
129081579|NCT01718535|464588620|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
129081580|NCT03018080|464588626|FG000|Overall Study|Death|12|||
129081581|NCT03018080|464588627|FG001|Overall Study|Death|19|||
129081582|NCT00740792|464588628|FG000|Overall Study|Adverse Event|3|||
129081583|NCT00740792|464588629|FG001|Overall Study|Adverse Event|1|||
129081584|NCT00740792|464588630|FG002|Overall Study|Adverse Event|1|||
129081585|NCT00740792|464588631|FG003|Overall Study|Adverse Event|3|||
129081586|NCT00740792|464588628|FG000|Overall Study|Lack of Efficacy|1|||
129081587|NCT00740792|464588629|FG001|Overall Study|Lack of Efficacy|1|||
129081588|NCT00740792|464588630|FG002|Overall Study|Lack of Efficacy|0|||
129081589|NCT00740792|464588631|FG003|Overall Study|Lack of Efficacy|3|||
129081590|NCT00740792|464588628|FG000|Overall Study|Lost to Follow-up|2|||
129081591|NCT00740792|464588629|FG001|Overall Study|Lost to Follow-up|1|||
129081592|NCT00740792|464588630|FG002|Overall Study|Lost to Follow-up|0|||
129142520|NCT00392288|464815768|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
129081593|NCT00740792|464588631|FG003|Overall Study|Lost to Follow-up|0|||
129081594|NCT00740792|464588628|FG000|Overall Study|Protocol Violation|0|||
129081595|NCT00740792|464588629|FG001|Overall Study|Protocol Violation|1|||
129081596|NCT00740792|464588630|FG002|Overall Study|Protocol Violation|0|||
129081597|NCT00740792|464588631|FG003|Overall Study|Protocol Violation|2|||
129081598|NCT00740792|464588628|FG000|Overall Study|Withdrawal by Subject|1|||
129081599|NCT00740792|464588629|FG001|Overall Study|Withdrawal by Subject|1|||
129081600|NCT00740792|464588630|FG002|Overall Study|Withdrawal by Subject|0|||
129081601|NCT00740792|464588631|FG003|Overall Study|Withdrawal by Subject|0|||
129081602|NCT00740792|464588628|FG000|Overall Study|administrative|3|||
129081603|NCT00740792|464588629|FG001|Overall Study|administrative|3|||
129081604|NCT00740792|464588630|FG002|Overall Study|administrative|8|||
129081605|NCT00740792|464588631|FG003|Overall Study|administrative|2|||
129081606|NCT00179660|464588632|FG000|Overall Study|Adverse Event|7|||
129081607|NCT00179660|464588632|FG000|Overall Study|Lack of therapeutic effect|28|||
129081608|NCT00179660|464588632|FG000|Overall Study|Withdrawal by Subject|2|||
129081609|NCT00179660|464588632|FG000|Overall Study|Lost to Follow-up|1|||
129081610|NCT00179660|464588632|FG000|Overall Study|Death|3|||
129081611|NCT00179660|464588632|FG000|Overall Study|Other - Unspecified|9|||
129081612|NCT02035202|464588635|FG000|Overall Study|Lost to Follow-up|8|||
129081613|NCT02035202|464588636|FG001|Overall Study|Lost to Follow-up|16|||
129081614|NCT02035202|464588637|FG002|Overall Study|Lost to Follow-up|2|||
129081615|NCT00178685|464588638|FG000|Overall Study|Death|3|||
129081616|NCT00178685|464588639|FG001|Overall Study|Death|3|||
129081617|NCT00178685|464588640|FG002|Overall Study|Death|6|||
129081618|NCT00178685|464588638|FG000|Overall Study|Lost to Follow-up|100|||
129081619|NCT00178685|464588639|FG001|Overall Study|Lost to Follow-up|187|||
129081620|NCT00178685|464588640|FG002|Overall Study|Lost to Follow-up|183|||
129081621|NCT00178685|464588638|FG000|Overall Study|Withdrawal by Subject|8|||
129081622|NCT00178685|464588639|FG001|Overall Study|Withdrawal by Subject|14|||
129081623|NCT00178685|464588640|FG002|Overall Study|Withdrawal by Subject|7|||
129081624|NCT00267969|464588652|FG000|Controlled Period|Adverse Event|6|||
129081625|NCT00267969|464588653|FG001|Controlled Period|Adverse Event|0|||
129142521|NCT00392288|464815766|FG000|Overall Study|Other|3|||
129142522|NCT00392288|464815767|FG001|Overall Study|Other|4|||
129081626|NCT00267969|464588654|FG002|Controlled Period|Adverse Event|2|||
129081627|NCT00267969|464588655|FG003|Controlled Period|Adverse Event|0|||
129081628|NCT00267969|464588656|FG004|Controlled Period|Adverse Event|0|||
129081629|NCT00267969|464588657|FG005|Controlled Period|Adverse Event|0|||
129081630|NCT00267969|464588658|FG006|Controlled Period|Adverse Event|0|||
129081631|NCT00267969|464588652|FG000|Controlled Period|Lack of Efficacy|3|||
129081632|NCT00267969|464588653|FG001|Controlled Period|Lack of Efficacy|0|||
129081633|NCT00267969|464588654|FG002|Controlled Period|Lack of Efficacy|1|||
129142523|NCT00392288|464815768|FG002|Overall Study|Other|1|||
129142524|NCT02544763|464815769|FG000|Overall Study|Adverse Event|8|||
129142525|NCT02544763|464815770|FG001|Overall Study|Adverse Event|8|||
129142526|NCT02544763|464815771|FG002|Overall Study|Adverse Event|0|||
129142527|NCT02544763|464815769|FG000|Overall Study|Withdrawn by parent/guardian|1|||
129142528|NCT02544763|464815770|FG001|Overall Study|Withdrawn by parent/guardian|1|||
129142529|NCT02544763|464815771|FG002|Overall Study|Withdrawn by parent/guardian|1|||
129142530|NCT02544763|464815769|FG000|Overall Study|Met withdrawal criteria|0|||
129142531|NCT02544763|464815770|FG001|Overall Study|Met withdrawal criteria|2|||
129142532|NCT02544763|464815771|FG002|Overall Study|Met withdrawal criteria|0|||
129142533|NCT02544763|464815769|FG000|Overall Study|Physician Decision|0|||
129142534|NCT02544763|464815770|FG001|Overall Study|Physician Decision|1|||
129142535|NCT02544763|464815771|FG002|Overall Study|Physician Decision|0|||
129081634|NCT00267969|464588655|FG003|Controlled Period|Lack of Efficacy|0|||
129081635|NCT00267969|464588656|FG004|Controlled Period|Lack of Efficacy|0|||
129081636|NCT00267969|464588657|FG005|Controlled Period|Lack of Efficacy|0|||
129081637|NCT00267969|464588658|FG006|Controlled Period|Lack of Efficacy|0|||
129081638|NCT00267969|464588652|FG000|Controlled Period|Lost to Follow-up|1|||
129081639|NCT00267969|464588653|FG001|Controlled Period|Lost to Follow-up|0|||
129081640|NCT00267969|464588654|FG002|Controlled Period|Lost to Follow-up|1|||
129081641|NCT00267969|464588655|FG003|Controlled Period|Lost to Follow-up|0|||
129142536|NCT02544763|464815769|FG000|Overall Study|Difficulties taking IMP|1|||
129081642|NCT00267969|464588656|FG004|Controlled Period|Lost to Follow-up|0|||
129142537|NCT02544763|464815770|FG001|Overall Study|Difficulties taking IMP|0|||
129081643|NCT00267969|464588657|FG005|Controlled Period|Lost to Follow-up|0|||
129081644|NCT00267969|464588658|FG006|Controlled Period|Lost to Follow-up|0|||
129081645|NCT00267969|464588652|FG000|Controlled Period|Randomized but not treated|0|||
129081646|NCT00267969|464588653|FG001|Controlled Period|Randomized but not treated|0|||
129081647|NCT00267969|464588654|FG002|Controlled Period|Randomized but not treated|1|||
129081648|NCT00267969|464588655|FG003|Controlled Period|Randomized but not treated|0|||
129081649|NCT00267969|464588656|FG004|Controlled Period|Randomized but not treated|0|||
129081650|NCT00267969|464588657|FG005|Controlled Period|Randomized but not treated|0|||
129081651|NCT00267969|464588658|FG006|Controlled Period|Randomized but not treated|0|||
129081652|NCT00267969|464588652|FG000|Controlled Period|Other|2|||
129081653|NCT00267969|464588653|FG001|Controlled Period|Other|1|||
129081654|NCT00267969|464588654|FG002|Controlled Period|Other|6|||
129081655|NCT00267969|464588655|FG003|Controlled Period|Other|0|||
129081656|NCT00267969|464588656|FG004|Controlled Period|Other|0|||
129081657|NCT00267969|464588657|FG005|Controlled Period|Other|0|||
129081658|NCT00267969|464588658|FG006|Controlled Period|Other|0|||
129081659|NCT00267969|464588652|FG000|After Controlled Period|Adverse Event|0|||
129081660|NCT00267969|464588653|FG001|After Controlled Period|Adverse Event|0|||
129081661|NCT00267969|464588654|FG002|After Controlled Period|Adverse Event|0|||
129142538|NCT02544763|464815771|FG002|Overall Study|Difficulties taking IMP|0|||
128724213|NCT01752855|463289005|FG001|Overall Study|Lack of Efficacy|2|||
129081662|NCT00267969|464588655|FG003|After Controlled Period|Adverse Event|7|||
129081663|NCT00267969|464588656|FG004|After Controlled Period|Adverse Event|8|||
129081664|NCT00267969|464588657|FG005|After Controlled Period|Adverse Event|23|||
129081665|NCT00267969|464588658|FG006|After Controlled Period|Adverse Event|21|||
129081666|NCT00267969|464588652|FG000|After Controlled Period|Death|0|||
129081667|NCT00267969|464588653|FG001|After Controlled Period|Death|0|||
129081668|NCT00267969|464588654|FG002|After Controlled Period|Death|0|||
129081669|NCT00267969|464588655|FG003|After Controlled Period|Death|1|||
129081670|NCT00267969|464588656|FG004|After Controlled Period|Death|2|||
129081671|NCT00267969|464588657|FG005|After Controlled Period|Death|0|||
129081672|NCT00267969|464588658|FG006|After Controlled Period|Death|1|||
129081673|NCT00267969|464588652|FG000|After Controlled Period|Lack of Efficacy|0|||
129081674|NCT00267969|464588653|FG001|After Controlled Period|Lack of Efficacy|0|||
129081675|NCT00267969|464588654|FG002|After Controlled Period|Lack of Efficacy|0|||
129081676|NCT00267969|464588655|FG003|After Controlled Period|Lack of Efficacy|10|||
129081677|NCT00267969|464588656|FG004|After Controlled Period|Lack of Efficacy|6|||
129081678|NCT00267969|464588657|FG005|After Controlled Period|Lack of Efficacy|28|||
129081679|NCT00267969|464588658|FG006|After Controlled Period|Lack of Efficacy|15|||
129081680|NCT00267969|464588652|FG000|After Controlled Period|Lost to Follow-up|0|||
129081681|NCT00267969|464588653|FG001|After Controlled Period|Lost to Follow-up|0|||
129081682|NCT00267969|464588654|FG002|After Controlled Period|Lost to Follow-up|0|||
129081683|NCT00267969|464588655|FG003|After Controlled Period|Lost to Follow-up|5|||
129081684|NCT00267969|464588656|FG004|After Controlled Period|Lost to Follow-up|8|||
129081685|NCT00267969|464588657|FG005|After Controlled Period|Lost to Follow-up|9|||
129081686|NCT00267969|464588658|FG006|After Controlled Period|Lost to Follow-up|10|||
129081687|NCT00267969|464588652|FG000|After Controlled Period|Other|0|||
129081688|NCT00267969|464588653|FG001|After Controlled Period|Other|0|||
129081689|NCT00267969|464588654|FG002|After Controlled Period|Other|0|||
129081690|NCT00267969|464588655|FG003|After Controlled Period|Other|13|||
129081691|NCT00267969|464588656|FG004|After Controlled Period|Other|11|||
129081692|NCT00267969|464588657|FG005|After Controlled Period|Other|22|||
129081693|NCT00267969|464588658|FG006|After Controlled Period|Other|25|||
129081694|NCT01053663|464588662|FG000|Overall Study|Death|2|||
129081695|NCT01053663|464588662|FG000|Overall Study|Lost to Follow-up|1|||
129081696|NCT01053663|464588662|FG000|Overall Study|Poor IV Access|1|||
129081697|NCT01053663|464588662|FG000|Overall Study|Transferred to Another Hospital|1|||
129081698|NCT01053663|464588662|FG000|Overall Study|Negative Influenza Diagnosis|1|||
129081699|NCT03533114|464588663|FG000|Overall|Adverse Event|16|||
129081700|NCT03533114|464588664|FG001|Overall|Adverse Event|11|||
129081701|NCT03533114|464588663|FG000|Overall|Consent Withdrawal by Participant|7|||
129081702|NCT03533114|464588664|FG001|Overall|Consent Withdrawal by Participant|6|||
129081703|NCT03533114|464588663|FG000|Overall|Lack of Efficacy|5|||
129081704|NCT03533114|464588664|FG001|Overall|Lack of Efficacy|3|||
129081705|NCT03533114|464588663|FG000|Overall|Lost to Follow-up|1|||
129081706|NCT03533114|464588664|FG001|Overall|Lost to Follow-up|1|||
129081707|NCT03533114|464588663|FG000|Overall|Physician Decision|0|||
129081708|NCT03533114|464588664|FG001|Overall|Physician Decision|2|||
129081709|NCT03533114|464588663|FG000|Overall|Protocol deviation|1|||
129081710|NCT03533114|464588664|FG001|Overall|Protocol deviation|1|||
129081711|NCT03533114|464588663|FG000|Overall|Failure to meet randomization criteria|1|||
129081712|NCT03533114|464588664|FG001|Overall|Failure to meet randomization criteria|2|||
129081713|NCT03533114|464588663|FG000|Overall|Non-Compliance with study drug|0|||
129081714|NCT03533114|464588664|FG001|Overall|Non-Compliance with study drug|1|||
129081715|NCT03533114|464588663|FG000|Overall|Other|0|||
129081716|NCT03533114|464588664|FG001|Overall|Other|1|||
129081717|NCT03533114|464588663|FG000|Open Label Titration and Optimization|Adverse Event|11|||
129081718|NCT03533114|464588664|FG001|Open Label Titration and Optimization|Adverse Event|8|||
129081719|NCT03533114|464588663|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
129081720|NCT03533114|464588664|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
128724214|NCT00634088|463289008|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
128724215|NCT00634088|463289009|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
128724216|NCT00634088|463289010|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
128724217|NCT00634088|463289011|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
128724218|NCT00634088|463289008|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
128724219|NCT00634088|463289009|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
129081721|NCT03533114|464588663|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
129081722|NCT03533114|464588664|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
129081723|NCT03533114|464588663|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
129081724|NCT03533114|464588664|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
129081725|NCT03533114|464588663|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
129081726|NCT03533114|464588664|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
129081727|NCT03533114|464588663|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
129081728|NCT03533114|464588664|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
129081729|NCT03533114|464588663|FG000|Stable Dose|Adverse Event|0|||
129081730|NCT03533114|464588664|FG001|Stable Dose|Adverse Event|2|||
129081731|NCT03533114|464588663|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
129081732|NCT03533114|464588664|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
129081733|NCT03533114|464588663|FG000|Stable Dose|Lack of Efficacy|1|||
129081734|NCT03533114|464588664|FG001|Stable Dose|Lack of Efficacy|0|||
129081735|NCT03533114|464588663|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
129081736|NCT03533114|464588664|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
129081737|NCT03533114|464588663|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
129081738|NCT03533114|464588664|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
129081739|NCT03533114|464588663|FG000|Open-Label Safety Extension|Adverse Event|3|||
129081740|NCT03533114|464588664|FG001|Open-Label Safety Extension|Adverse Event|0|||
129081741|NCT03533114|464588663|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
129081742|NCT03533114|464588664|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
129081743|NCT03533114|464588663|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
129081744|NCT03533114|464588664|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
129081745|NCT03533114|464588663|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
129081746|NCT03533114|464588664|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
129081747|NCT03533114|464588663|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
129081748|NCT03533114|464588664|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
129081749|NCT01862250|464588665|FG000|Overall Study|Adverse Event|4|||
129081750|NCT02423343|464588666|FG000|Overall Study|Withdrawal by Subject|0|||
129081751|NCT02423343|464588667|FG001|Overall Study|Withdrawal by Subject|1|||
129081752|NCT02423343|464588668|FG002|Overall Study|Withdrawal by Subject|0|||
129081753|NCT02423343|464588669|FG003|Overall Study|Withdrawal by Subject|0|||
129081754|NCT02423343|464588670|FG004|Overall Study|Withdrawal by Subject|0|||
129081755|NCT02423343|464588671|FG005|Overall Study|Withdrawal by Subject|0|||
129081756|NCT02423343|464588666|FG000|Overall Study|Progressive Disease|0|||
129081757|NCT02423343|464588667|FG001|Overall Study|Progressive Disease|0|||
129081758|NCT02423343|464588668|FG002|Overall Study|Progressive Disease|0|||
129081759|NCT02423343|464588669|FG003|Overall Study|Progressive Disease|0|||
129081760|NCT02423343|464588670|FG004|Overall Study|Progressive Disease|2|||
129081761|NCT02423343|464588671|FG005|Overall Study|Progressive Disease|0|||
129081762|NCT02423343|464588666|FG000|Overall Study|Adverse Event|0|||
129081763|NCT02423343|464588667|FG001|Overall Study|Adverse Event|0|||
129081764|NCT02423343|464588668|FG002|Overall Study|Adverse Event|0|||
129081765|NCT02423343|464588669|FG003|Overall Study|Adverse Event|0|||
129081766|NCT02423343|464588670|FG004|Overall Study|Adverse Event|2|||
129081767|NCT02423343|464588671|FG005|Overall Study|Adverse Event|0|||
128724220|NCT00634088|463289010|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
128724221|NCT00634088|463289011|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
128724222|NCT00634088|463289008|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
128724223|NCT00634088|463289009|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
128724224|NCT00634088|463289010|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
128724225|NCT00634088|463289011|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
129081768|NCT02423343|464588666|FG000|Overall Study|Death|0|||
129081769|NCT02423343|464588667|FG001|Overall Study|Death|0|||
129081770|NCT02423343|464588668|FG002|Overall Study|Death|0|||
129081771|NCT02423343|464588669|FG003|Overall Study|Death|0|||
129081772|NCT02423343|464588670|FG004|Overall Study|Death|1|||
129081773|NCT02423343|464588671|FG005|Overall Study|Death|0|||
129081774|NCT02016105|464588672|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
129081775|NCT02016105|464588673|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
129081776|NCT02016105|464588674|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
128724226|NCT00634088|463289008|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
129081777|NCT02016105|464588675|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
129081778|NCT02016105|464588676|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
129081779|NCT02016105|464588677|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
129081780|NCT02016105|464588672|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
129081781|NCT02016105|464588673|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
129081782|NCT02016105|464588674|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
129081783|NCT02016105|464588675|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
129081784|NCT02016105|464588676|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
129081785|NCT02016105|464588677|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
129081786|NCT02016105|464588672|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
129081787|NCT02016105|464588673|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
129081788|NCT02016105|464588674|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129081789|NCT02016105|464588675|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129081790|NCT02016105|464588676|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129081791|NCT02016105|464588677|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129081792|NCT02016105|464588672|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
129081793|NCT02016105|464588673|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
129081794|NCT02016105|464588674|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
129081795|NCT02016105|464588675|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
129081796|NCT02016105|464588676|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
129081797|NCT02016105|464588677|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
129081798|NCT02016105|464588672|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
129081799|NCT02016105|464588673|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
129081800|NCT02016105|464588674|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
129081801|NCT02016105|464588675|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
129081802|NCT02016105|464588676|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
129081803|NCT02016105|464588677|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
129081804|NCT02016105|464588672|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
129081805|NCT02016105|464588673|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
129081806|NCT02016105|464588674|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129081807|NCT02016105|464588675|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129081808|NCT02016105|464588676|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129081809|NCT02016105|464588677|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129081810|NCT02016105|464588672|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
129081811|NCT02016105|464588673|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
129081812|NCT02016105|464588674|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129081813|NCT02016105|464588675|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129081814|NCT02016105|464588676|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129081815|NCT02016105|464588677|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129081816|NCT02016105|464588672|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
129081817|NCT02016105|464588673|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
129081818|NCT02016105|464588674|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
129081819|NCT02016105|464588675|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
129081820|NCT02016105|464588676|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
129081821|NCT02016105|464588677|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
129081822|NCT02016105|464588672|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
129081823|NCT02016105|464588673|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
129081824|NCT02016105|464588674|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
129081825|NCT02016105|464588675|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
129081826|NCT02016105|464588676|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
129081827|NCT02016105|464588677|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
129081828|NCT02016105|464588672|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
129081829|NCT02016105|464588673|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
129081830|NCT02016105|464588674|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
129081831|NCT02016105|464588675|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
129081832|NCT02016105|464588676|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
129081833|NCT02016105|464588677|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
129081834|NCT02016105|464588672|FG000|TREATMENT PERIOD 2|Death|0|||
129081835|NCT02016105|464588673|FG001|TREATMENT PERIOD 2|Death|0|||
129081836|NCT02016105|464588674|FG002|TREATMENT PERIOD 2|Death|0|||
129081837|NCT02016105|464588675|FG003|TREATMENT PERIOD 2|Death|0|||
129081838|NCT02016105|464588676|FG004|TREATMENT PERIOD 2|Death|0|||
129081839|NCT02016105|464588677|FG005|TREATMENT PERIOD 2|Death|1|||
129081840|NCT02016105|464588672|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
129081841|NCT02016105|464588673|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
129081842|NCT02016105|464588674|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
129081843|NCT02016105|464588675|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
129081844|NCT02016105|464588676|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
129081845|NCT02016105|464588677|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
129081846|NCT02016105|464588672|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
129081847|NCT02016105|464588673|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
129081848|NCT02016105|464588674|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
129081849|NCT02016105|464588675|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
129081850|NCT02016105|464588676|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
129081851|NCT02016105|464588677|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
129081852|NCT02016105|464588672|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129081853|NCT02016105|464588673|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129142539|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
129081854|NCT02016105|464588674|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
129142540|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129081855|NCT02016105|464588675|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129081856|NCT02016105|464588676|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129081857|NCT02016105|464588677|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
129081858|NCT02016105|464588672|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
129081859|NCT02016105|464588673|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
129081860|NCT02016105|464588674|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
129081861|NCT02016105|464588675|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
129081862|NCT02016105|464588676|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
129081863|NCT02016105|464588677|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
129081864|NCT02016105|464588672|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
129081865|NCT02016105|464588673|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
129081866|NCT02016105|464588674|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
129081867|NCT02016105|464588675|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
129081868|NCT02016105|464588676|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
129081869|NCT02016105|464588677|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
129081870|NCT02016105|464588672|FG000|EXTENSION PERIOD|Adverse Event|0|||
129081871|NCT02016105|464588673|FG001|EXTENSION PERIOD|Adverse Event|0|||
129081872|NCT02016105|464588674|FG002|EXTENSION PERIOD|Adverse Event|2|||
129081873|NCT02016105|464588675|FG003|EXTENSION PERIOD|Adverse Event|0|||
129081874|NCT02016105|464588676|FG004|EXTENSION PERIOD|Adverse Event|1|||
129081875|NCT02016105|464588677|FG005|EXTENSION PERIOD|Adverse Event|0|||
129081876|NCT02016105|464588672|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
129081877|NCT02016105|464588673|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
129081878|NCT02016105|464588674|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
129081879|NCT02016105|464588675|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
129081880|NCT02016105|464588676|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
129081881|NCT02016105|464588677|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
129081882|NCT02016105|464588672|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
129081883|NCT02016105|464588673|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
129081884|NCT02016105|464588674|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
129081885|NCT02016105|464588675|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
129081886|NCT02016105|464588676|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
129081887|NCT02016105|464588677|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
129081888|NCT02016105|464588672|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
129081889|NCT02016105|464588673|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
129081890|NCT02016105|464588674|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
129081891|NCT02016105|464588675|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
129081892|NCT02016105|464588676|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
129081893|NCT02016105|464588677|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
129081894|NCT01860040|464588679|FG000|Overall Study|Withdrawal by Subject|1|||
129081895|NCT01860040|464588680|FG001|Overall Study|Withdrawal by Subject|0|||
129081896|NCT00403481|464588681|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
129081897|NCT00403481|464588681|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
129081898|NCT00403481|464588681|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
129081899|NCT00403481|464588681|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
129081900|NCT00403481|464588681|FG000|Olm 40 mg|Adverse Event|2|||
129081901|NCT00403481|464588681|FG000|Olm 40 mg|Protocol Violation|1|||
129081902|NCT00403481|464588681|FG000|Olm 40 mg|Withdrawal by Subject|1|||
129081903|NCT00403481|464588681|FG000|Olm 40 mg|Other|1|||
129081904|NCT00403481|464588681|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
129081905|NCT00403481|464588681|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
129081906|NCT00403481|464588681|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
129081907|NCT00403481|464588681|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
129081908|NCT00403481|464588681|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
129081909|NCT00403481|464588681|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
129081910|NCT01732458|464588694|FG000|Overall Study|Lost to Follow-up|0|||
129081911|NCT01732458|464588695|FG001|Overall Study|Lost to Follow-up|2|||
129081912|NCT01732458|464588696|FG002|Overall Study|Lost to Follow-up|0|||
129081913|NCT01732458|464588697|FG003|Overall Study|Lost to Follow-up|0|||
128724227|NCT00634088|463289009|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
128724228|NCT00634088|463289010|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
129081914|NCT01732458|464588694|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129081915|NCT01732458|464588695|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128724229|NCT00634088|463289011|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
128724230|NCT00634088|463289008|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
128724231|NCT00634088|463289009|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
128724232|NCT00634088|463289010|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
129081916|NCT01732458|464588696|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129081917|NCT01732458|464588697|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129081918|NCT01732458|464588694|FG000|Overall Study|Physician Decision|1|||
129081919|NCT01732458|464588695|FG001|Overall Study|Physician Decision|2|||
129081920|NCT01732458|464588696|FG002|Overall Study|Physician Decision|2|||
129081921|NCT01732458|464588697|FG003|Overall Study|Physician Decision|0|||
129081922|NCT01732458|464588694|FG000|Overall Study|Protocol Violation|2|||
129081923|NCT01732458|464588695|FG001|Overall Study|Protocol Violation|0|||
129081924|NCT01732458|464588696|FG002|Overall Study|Protocol Violation|0|||
129081925|NCT01732458|464588697|FG003|Overall Study|Protocol Violation|2|||
129081926|NCT01732458|464588694|FG000|Overall Study|Screen Failure|0|||
129081927|NCT01732458|464588695|FG001|Overall Study|Screen Failure|1|||
129081928|NCT01732458|464588696|FG002|Overall Study|Screen Failure|0|||
129081929|NCT01732458|464588697|FG003|Overall Study|Screen Failure|0|||
129081930|NCT00994461|464588698|FG000|Overall Study|Adverse Event|2|||
129081931|NCT00994461|464588699|FG001|Overall Study|Adverse Event|1|||
129081932|NCT00994461|464588700|FG002|Overall Study|Adverse Event|0|||
129081933|NCT03759587|464588701|FG000|Overall Study|Adverse Event|5|||
129081934|NCT03759587|464588701|FG000|Overall Study|Progressive Disease|10|||
129081935|NCT03759587|464588701|FG000|Overall Study|Site Terminated by Sponsor|3|||
129081936|NCT03759587|464588701|FG000|Overall Study|Withdrawal by Subject|1|||
129081937|NCT04615403|464588702|FG000|Overall Study|Death|1|||
129081938|NCT03170362|464588703|FG000|Overall Study|Death|2|||
129081939|NCT03170362|464588704|FG001|Overall Study|Death|2|||
129081940|NCT03170362|464588703|FG000|Overall Study|Withdrawal by Subject|23|||
129081941|NCT03170362|464588704|FG001|Overall Study|Withdrawal by Subject|22|||
129081942|NCT03170362|464588703|FG000|Overall Study|Lost to Follow-up|187|||
129081943|NCT03170362|464588704|FG001|Overall Study|Lost to Follow-up|167|||
129081944|NCT03682848|464588707|FG000|Overall Study|Withdrawal by Subject|2|||
129081945|NCT03682848|464588707|FG000|Overall Study|Site closed|5|||
129081946|NCT03682848|464588707|FG000|Overall Study|Protocol Deviation|1|||
129081947|NCT03682848|464588707|FG000|Overall Study|Adverse Event|1|||
129081948|NCT01464164|464588708|FG000|Overall Study|Screen failure|0|||
129081949|NCT01464164|464588709|FG001|Overall Study|Screen failure|1|||
129081950|NCT01464164|464588710|FG002|Overall Study|Screen failure|2|||
129081951|NCT01464164|464588711|FG003|Overall Study|Screen failure|0|||
129081952|NCT01464164|464588712|FG004|Overall Study|Screen failure|0|||
129081953|NCT01464164|464588713|FG005|Overall Study|Screen failure|0|||
129081954|NCT01464164|464588714|FG006|Overall Study|Screen failure|0|||
129081955|NCT01464164|464588708|FG000|Overall Study|Physician Decision|0|||
129081956|NCT01464164|464588709|FG001|Overall Study|Physician Decision|1|||
129081957|NCT01464164|464588710|FG002|Overall Study|Physician Decision|0|||
129081958|NCT01464164|464588711|FG003|Overall Study|Physician Decision|0|||
129081959|NCT01464164|464588712|FG004|Overall Study|Physician Decision|0|||
129081960|NCT01464164|464588713|FG005|Overall Study|Physician Decision|0|||
129081961|NCT01464164|464588714|FG006|Overall Study|Physician Decision|2|||
129081962|NCT00454363|464588715|FG000|Overall Study|Adverse Event|1|||
129081963|NCT00454363|464588716|FG001|Overall Study|Adverse Event|2|||
129081964|NCT00454363|464588715|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
129081965|NCT00454363|464588716|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
129081966|NCT00570063|464588717|FG000|Overall Study|Adverse Event|4|||
129081967|NCT00570063|464588718|FG001|Overall Study|Adverse Event|1|||
129081968|NCT00570063|464588717|FG000|Overall Study|Lack of Efficacy|0|||
129081969|NCT00570063|464588718|FG001|Overall Study|Lack of Efficacy|1|||
129081970|NCT00570063|464588717|FG000|Overall Study|Withdrawal by Subject|4|||
129081971|NCT00570063|464588718|FG001|Overall Study|Withdrawal by Subject|3|||
129081972|NCT00570063|464588717|FG000|Overall Study|Sponsor's Decision|7|||
129081973|NCT00570063|464588718|FG001|Overall Study|Sponsor's Decision|3|||
129081974|NCT00697463|464588719|FG000|Overall Study|Withdrawal by Subject|1|||
129081975|NCT00603473|464588720|FG000|Overall Study|Adverse Event|4|||
129081976|NCT00603473|464588720|FG000|Overall Study|Lack of Efficacy|4|||
129081977|NCT00603473|464588720|FG000|Overall Study|Protocol Violation|1|||
129081978|NCT02644668|464588724|FG000|Overall Study|Adverse Event|2|||
129081979|NCT02644668|464588725|FG001|Overall Study|Adverse Event|0|||
129081980|NCT02644668|464588726|FG002|Overall Study|Adverse Event|1|||
129081981|NCT02644668|464588724|FG000|Overall Study|Protocol Violation|0|||
129081982|NCT02644668|464588725|FG001|Overall Study|Protocol Violation|0|||
129081983|NCT02644668|464588726|FG002|Overall Study|Protocol Violation|1|||
129081984|NCT02644668|464588724|FG000|Overall Study|Withdrawal by Subject|0|||
129081985|NCT02644668|464588725|FG001|Overall Study|Withdrawal by Subject|0|||
129081986|NCT02644668|464588726|FG002|Overall Study|Withdrawal by Subject|1|||
129081987|NCT01134939|464588727|FG000|Overall Study|Adverse Event|9|||
129081988|NCT01134939|464588728|FG001|Overall Study|Adverse Event|3|||
128724233|NCT00634088|463289011|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
128724234|NCT00634088|463289008|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
129081989|NCT01134939|464588729|FG002|Overall Study|Adverse Event|4|||
129081990|NCT01134939|464588730|FG003|Overall Study|Adverse Event|5|||
129081991|NCT01134939|464588731|FG004|Overall Study|Adverse Event|5|||
129081992|NCT01134939|464588732|FG005|Overall Study|Adverse Event|5|||
129081993|NCT01134939|464588733|FG006|Overall Study|Adverse Event|1|||
129081994|NCT01134939|464588734|FG007|Overall Study|Adverse Event|0|||
129081995|NCT01134939|464588727|FG000|Overall Study|Lack of Efficacy|2|||
129081996|NCT01134939|464588728|FG001|Overall Study|Lack of Efficacy|5|||
129081997|NCT01134939|464588729|FG002|Overall Study|Lack of Efficacy|1|||
129081998|NCT01134939|464588730|FG003|Overall Study|Lack of Efficacy|0|||
129081999|NCT01134939|464588731|FG004|Overall Study|Lack of Efficacy|3|||
129082000|NCT01134939|464588732|FG005|Overall Study|Lack of Efficacy|0|||
129082001|NCT01134939|464588733|FG006|Overall Study|Lack of Efficacy|1|||
129082002|NCT01134939|464588734|FG007|Overall Study|Lack of Efficacy|0|||
129082003|NCT01134939|464588727|FG000|Overall Study|Lost to Follow-up|2|||
129082004|NCT01134939|464588728|FG001|Overall Study|Lost to Follow-up|3|||
129082005|NCT01134939|464588729|FG002|Overall Study|Lost to Follow-up|0|||
129082006|NCT01134939|464588730|FG003|Overall Study|Lost to Follow-up|1|||
129082007|NCT01134939|464588731|FG004|Overall Study|Lost to Follow-up|2|||
129082008|NCT01134939|464588732|FG005|Overall Study|Lost to Follow-up|1|||
129082009|NCT01134939|464588733|FG006|Overall Study|Lost to Follow-up|0|||
129082010|NCT01134939|464588734|FG007|Overall Study|Lost to Follow-up|0|||
129082011|NCT01134939|464588727|FG000|Overall Study|Death|0|||
129082012|NCT01134939|464588728|FG001|Overall Study|Death|1|||
129082013|NCT01134939|464588729|FG002|Overall Study|Death|0|||
129082014|NCT01134939|464588730|FG003|Overall Study|Death|0|||
129082015|NCT01134939|464588731|FG004|Overall Study|Death|0|||
129082016|NCT01134939|464588732|FG005|Overall Study|Death|0|||
129082017|NCT01134939|464588733|FG006|Overall Study|Death|0|||
129082018|NCT01134939|464588734|FG007|Overall Study|Death|0|||
129082019|NCT01134939|464588727|FG000|Overall Study|Termination page not available|4|||
129082020|NCT01134939|464588728|FG001|Overall Study|Termination page not available|6|||
129082021|NCT01134939|464588729|FG002|Overall Study|Termination page not available|5|||
129082022|NCT01134939|464588730|FG003|Overall Study|Termination page not available|8|||
129082023|NCT01134939|464588731|FG004|Overall Study|Termination page not available|0|||
129082024|NCT01134939|464588732|FG005|Overall Study|Termination page not available|3|||
129082025|NCT01134939|464588733|FG006|Overall Study|Termination page not available|7|||
129082026|NCT01134939|464588734|FG007|Overall Study|Termination page not available|0|||
129082027|NCT00733421|464588735|FG000|Overall Study|Withdrawal by Subject|1|||
129082028|NCT00733421|464588736|FG001|Overall Study|Withdrawal by Subject|1|||
129082029|NCT02547220|464588742|FG000|Overall Study|Withdrawal by Subject|1|||
129082030|NCT02547220|464588743|FG001|Overall Study|Withdrawal by Subject|0|||
129082031|NCT02547220|464588742|FG000|Overall Study|Study terminated by sponsor|18|||
129082032|NCT02547220|464588743|FG001|Overall Study|Study terminated by sponsor|20|||
129082033|NCT00550043|464588744|FG000|Overall Study|Adverse Event|0|||
129082034|NCT00550043|464588745|FG001|Overall Study|Adverse Event|0|||
129082035|NCT00550043|464588746|FG002|Overall Study|Adverse Event|0|||
129082036|NCT00550043|464588747|FG003|Overall Study|Adverse Event|1|||
129082037|NCT00550043|464588748|FG004|Overall Study|Adverse Event|1|||
129082038|NCT00550043|464588744|FG000|Overall Study|Subject Withdrew Consent|0|||
129082039|NCT00550043|464588745|FG001|Overall Study|Subject Withdrew Consent|2|||
129082040|NCT00550043|464588746|FG002|Overall Study|Subject Withdrew Consent|1|||
129082041|NCT00550043|464588747|FG003|Overall Study|Subject Withdrew Consent|0|||
129082042|NCT00550043|464588748|FG004|Overall Study|Subject Withdrew Consent|0|||
129082043|NCT00550043|464588744|FG000|Overall Study|Other Reasons- Unspecified|0|||
129082044|NCT00550043|464588745|FG001|Overall Study|Other Reasons- Unspecified|1|||
129082045|NCT00550043|464588746|FG002|Overall Study|Other Reasons- Unspecified|0|||
129082046|NCT00550043|464588747|FG003|Overall Study|Other Reasons- Unspecified|1|||
129082047|NCT00550043|464588748|FG004|Overall Study|Other Reasons- Unspecified|0|||
129142541|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129142542|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129142543|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129142544|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
129142545|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129142546|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129142547|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129142548|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129142549|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
129082048|NCT03478644|464588750|FG000|Phase 2|Withdrawal by Subject|2|||
129142550|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129142551|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129082049|NCT03478644|464588751|FG001|Phase 2|Withdrawal by Subject|1|||
129082050|NCT03478644|464588750|FG000|Phase 2|Lost to Follow-up|1|||
129082051|NCT03478644|464588751|FG001|Phase 2|Lost to Follow-up|0|||
129082052|NCT01029782|464588752|FG000|Overall Study|Lost to Follow-up|2|||
129082053|NCT01029782|464588753|FG001|Overall Study|Lost to Follow-up|2|||
129082054|NCT01029782|464588752|FG000|Overall Study|Diagnosis changed|1|||
129082055|NCT01029782|464588753|FG001|Overall Study|Diagnosis changed|1|||
129082056|NCT01029782|464588752|FG000|Overall Study|Adverse Event|0|||
129082057|NCT01029782|464588753|FG001|Overall Study|Adverse Event|1|||
129082058|NCT01029782|464588752|FG000|Overall Study|Physician Decision|0|||
129082059|NCT01029782|464588753|FG001|Overall Study|Physician Decision|1|||
129082060|NCT01029782|464588752|FG000|Overall Study|Protocol Violation|0|||
129082061|NCT01029782|464588753|FG001|Overall Study|Protocol Violation|2|||
129082062|NCT01029782|464588752|FG000|Overall Study|Withdrawal by Subject|0|||
129082063|NCT01029782|464588753|FG001|Overall Study|Withdrawal by Subject|1|||
129082064|NCT02195869|464588756|FG000|Overall Study|cGVHD Progression|5|||
129082065|NCT02195869|464588756|FG000|Overall Study|Malignancy Progression/relapse|2|||
129082066|NCT02195869|464588756|FG000|Overall Study|Adverse Event|15|||
129082067|NCT02195869|464588756|FG000|Overall Study|Withdrawal by Subject|7|||
129082068|NCT02195869|464588756|FG000|Overall Study|Physician Decision|4|||
129082069|NCT02195869|464588756|FG000|Overall Study|Study Terminated by Sponsor|7|||
129082070|NCT02195869|464588756|FG000|Overall Study|Noncompliance with study drug|2|||
129082071|NCT00789698|464588757|FG000|Overall Study|Lack of Efficacy|10|||
129082072|NCT00789698|464588758|FG001|Overall Study|Lack of Efficacy|4|||
129082073|NCT00789698|464588759|FG002|Overall Study|Lack of Efficacy|5|||
129082074|NCT00789698|464588760|FG003|Overall Study|Lack of Efficacy|18|||
129082075|NCT00789698|464588757|FG000|Overall Study|Adverse Event|5|||
129082076|NCT00789698|464588758|FG001|Overall Study|Adverse Event|5|||
129082077|NCT00789698|464588759|FG002|Overall Study|Adverse Event|3|||
129082078|NCT00789698|464588760|FG003|Overall Study|Adverse Event|4|||
129082079|NCT00789698|464588757|FG000|Overall Study|Lost to Follow-up|5|||
129082080|NCT00789698|464588758|FG001|Overall Study|Lost to Follow-up|5|||
129082081|NCT00789698|464588759|FG002|Overall Study|Lost to Follow-up|2|||
129082082|NCT00789698|464588760|FG003|Overall Study|Lost to Follow-up|9|||
129082083|NCT00789698|464588757|FG000|Overall Study|Protocol Violation|6|||
129082084|NCT00789698|464588758|FG001|Overall Study|Protocol Violation|1|||
129082085|NCT00789698|464588759|FG002|Overall Study|Protocol Violation|2|||
129082086|NCT00789698|464588760|FG003|Overall Study|Protocol Violation|1|||
129082087|NCT00789698|464588757|FG000|Overall Study|Withdrawal by Subject|14|||
129082088|NCT00789698|464588758|FG001|Overall Study|Withdrawal by Subject|15|||
129082089|NCT00789698|464588759|FG002|Overall Study|Withdrawal by Subject|12|||
129082090|NCT00789698|464588760|FG003|Overall Study|Withdrawal by Subject|19|||
129082091|NCT00789698|464588757|FG000|Overall Study|Administrative|0|||
129082092|NCT00789698|464588758|FG001|Overall Study|Administrative|3|||
129082093|NCT00789698|464588759|FG002|Overall Study|Administrative|3|||
129082094|NCT00789698|464588760|FG003|Overall Study|Administrative|1|||
129082095|NCT03300505|464590641|FG000|Overall Study|Death|0|||
129082096|NCT03300505|464590642|FG001|Overall Study|Death|1|||
129082097|NCT03300505|464590643|FG002|Overall Study|Death|0|||
129082098|NCT03300505|464590641|FG000|Overall Study|Withdrawal by Subject|0|||
129082099|NCT03300505|464590642|FG001|Overall Study|Withdrawal by Subject|1|||
129082100|NCT03300505|464590643|FG002|Overall Study|Withdrawal by Subject|1|||
129082101|NCT03300505|464590641|FG000|Overall Study|Sponsor Termination|0|||
129082102|NCT03300505|464590642|FG001|Overall Study|Sponsor Termination|1|||
129082103|NCT03300505|464590643|FG002|Overall Study|Sponsor Termination|0|||
129082104|NCT03300505|464590641|FG000|Overall Study|Adverse Event|0|||
129082105|NCT03300505|464590642|FG001|Overall Study|Adverse Event|0|||
129082106|NCT03300505|464590643|FG002|Overall Study|Adverse Event|2|||
129082107|NCT05119595|464590644|FG000|Overall Study|Death|1|||
129082108|NCT05119595|464590644|FG000|Overall Study|Lost to Follow-up|7|||
129082109|NCT03056638|464590647|FG000|Overall Study|Death|1|||
129082110|NCT03056638|464590648|FG001|Overall Study|Death|0|||
129082111|NCT00468481|464590649|FG000|Overall Study|Adverse Event|13|||
129082112|NCT00468481|464590650|FG001|Overall Study|Adverse Event|3|||
128724235|NCT00634088|463289009|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
129082113|NCT00468481|464590649|FG000|Overall Study|Lost to Follow-up|25|||
129082114|NCT00468481|464590650|FG001|Overall Study|Lost to Follow-up|8|||
129082115|NCT00468481|464590649|FG000|Overall Study|Pregnancy|2|||
128724236|NCT00634088|463289010|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
128724237|NCT00634088|463289011|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
129082116|NCT00468481|464590650|FG001|Overall Study|Pregnancy|0|||
129082117|NCT00468481|464590649|FG000|Overall Study|Protocol Violation|18|||
129082118|NCT00468481|464590650|FG001|Overall Study|Protocol Violation|8|||
129082119|NCT00468481|464590649|FG000|Overall Study|Withdrawal by Subject|12|||
129082120|NCT00468481|464590650|FG001|Overall Study|Withdrawal by Subject|3|||
128724238|NCT01293240|463289014|FG000|Overall Study|Noncompliance|2|||
129082121|NCT00468481|464590649|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
129082122|NCT00468481|464590650|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
129082123|NCT00468481|464590649|FG000|Overall Study|Prohibited Medication|1|||
129082124|NCT00468481|464590650|FG001|Overall Study|Prohibited Medication|1|||
129082125|NCT00468481|464590649|FG000|Overall Study|Egg Donor|1|||
129082126|NCT00468481|464590650|FG001|Overall Study|Egg Donor|0|||
129082127|NCT00468481|464590649|FG000|Overall Study|Moved out of area|4|||
129082128|NCT00468481|464590650|FG001|Overall Study|Moved out of area|1|||
129082129|NCT00468481|464590649|FG000|Overall Study|Non-Compliance|5|||
129082130|NCT00468481|464590650|FG001|Overall Study|Non-Compliance|0|||
129082131|NCT00468481|464590649|FG000|Overall Study|Other|6|||
129082132|NCT00468481|464590650|FG001|Overall Study|Other|0|||
129082133|NCT00734162|464590651|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
129082134|NCT00734162|464590652|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
129082135|NCT00734162|464590653|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
129082136|NCT00734162|464590654|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
129082137|NCT00734162|464590651|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
129082138|NCT00734162|464590652|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
129082139|NCT00734162|464590653|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
129082140|NCT00734162|464590654|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
129082141|NCT00734162|464590651|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
129082142|NCT00734162|464590652|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
129082143|NCT00734162|464590653|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
129082144|NCT00734162|464590654|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
129082145|NCT00734162|464590651|FG000|Open-Label Phase|Withdrew Consent|1|||
129082146|NCT00734162|464590652|FG001|Open-Label Phase|Withdrew Consent|0|||
129082147|NCT00734162|464590653|FG002|Open-Label Phase|Withdrew Consent|1|||
129082148|NCT00734162|464590654|FG003|Open-Label Phase|Withdrew Consent|1|||
129082149|NCT00734162|464590651|FG000|Open-Label Phase|Lost to Follow-up|1|||
129082150|NCT00734162|464590652|FG001|Open-Label Phase|Lost to Follow-up|2|||
129082151|NCT00734162|464590653|FG002|Open-Label Phase|Lost to Follow-up|0|||
129082152|NCT00734162|464590654|FG003|Open-Label Phase|Lost to Follow-up|1|||
129082153|NCT00734162|464590651|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129082154|NCT00734162|464590652|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129082155|NCT00734162|464590653|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129082156|NCT00734162|464590654|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
129082157|NCT03831113|464590655|FG000|Overall Study|Withdrawal by Subject|0|||
129082158|NCT03831113|464590656|FG001|Overall Study|Withdrawal by Subject|2|||
129082159|NCT03831113|464590655|FG000|Overall Study|Protocol Violation|0|||
129082160|NCT03831113|464590656|FG001|Overall Study|Protocol Violation|9|||
129082161|NCT03508726|464590657|FG000|Overall Study|Withdrawal by Subject|0|||
129082162|NCT03508726|464590658|FG001|Overall Study|Withdrawal by Subject|1|||
129082163|NCT01515865|464590660|FG000|Part A (Open-label)|Other|3|||
129082164|NCT01515865|464590661|FG001|Part A (Open-label)|Other|0|||
129082165|NCT01515865|464590662|FG002|Part A (Open-label)|Other|0|||
129082166|NCT01515865|464590660|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
129082167|NCT01515865|464590661|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
129082168|NCT01515865|464590662|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
129082169|NCT01515865|464590660|FG000|Part B (Open-label)|Other|1|||
129082170|NCT01515865|464590661|FG001|Part B (Open-label)|Other|0|||
129082171|NCT01515865|464590662|FG002|Part B (Open-label)|Other|0|||
129082172|NCT01073605|464590663|FG000|Overall Study|Ongoing at Cutoff Date|1|||
129082173|NCT01073605|464590664|FG001|Overall Study|Ongoing at Cutoff Date|1|||
129082174|NCT01073605|464590665|FG002|Overall Study|Ongoing at Cutoff Date|0|||
129082175|NCT01073605|464590663|FG000|Overall Study|Adverse Event|2|||
129082176|NCT01073605|464590664|FG001|Overall Study|Adverse Event|1|||
129082177|NCT01073605|464590665|FG002|Overall Study|Adverse Event|0|||
129082178|NCT01073605|464590663|FG000|Overall Study|Lost to Follow-up|3|||
129082179|NCT01073605|464590664|FG001|Overall Study|Lost to Follow-up|4|||
129082180|NCT01073605|464590665|FG002|Overall Study|Lost to Follow-up|9|||
129082181|NCT01073605|464590663|FG000|Overall Study|Other|25|||
129082182|NCT01073605|464590664|FG001|Overall Study|Other|21|||
129082183|NCT01073605|464590665|FG002|Overall Study|Other|29|||
129082184|NCT01073605|464590663|FG000|Overall Study|Withdrawal by Subject|31|||
129142552|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129142553|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
128724239|NCT03735667|463289018|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
128724240|NCT03735667|463289019|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
129082185|NCT01073605|464590664|FG001|Overall Study|Withdrawal by Subject|39|||
129082186|NCT01073605|464590665|FG002|Overall Study|Withdrawal by Subject|22|||
129142554|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
129142555|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
129082187|NCT01073605|464590663|FG000|Overall Study|Randomized But Not Treated|0|||
129082188|NCT01073605|464590664|FG001|Overall Study|Randomized But Not Treated|1|||
129082189|NCT01073605|464590665|FG002|Overall Study|Randomized But Not Treated|1|||
129082190|NCT02875613|464590668|FG000|Overall Study|Withdrawal by Subject|1|||
129082191|NCT02875613|464590668|FG000|Overall Study|Screen Failure|1|||
129082192|NCT02308540|464590670|FG000|Overall Study|Lost to Follow-up|0|||
129082193|NCT02308540|464590671|FG001|Overall Study|Lost to Follow-up|0|||
129082194|NCT02308540|464590672|FG002|Overall Study|Lost to Follow-up|0|||
129142556|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
129082195|NCT02308540|464590673|FG003|Overall Study|Lost to Follow-up|0|||
129082196|NCT02308540|464590674|FG004|Overall Study|Lost to Follow-up|0|||
129082197|NCT02308540|464590675|FG005|Overall Study|Lost to Follow-up|1|||
129082198|NCT00443079|464590676|FG000|Overall Study|Lost to Follow-up|0|||
129082199|NCT00443079|464590677|FG001|Overall Study|Lost to Follow-up|1|||
129082200|NCT02649439|464590678|FG000|Overall Study|Switched to alternative treatment|6|||
129082201|NCT02649439|464590679|FG001|Overall Study|Switched to alternative treatment|4|||
129082202|NCT02649439|464590678|FG000|Overall Study|Patient decision|1|||
129082203|NCT02649439|464590679|FG001|Overall Study|Patient decision|0|||
129082204|NCT02649439|464590678|FG000|Overall Study|Patient going out of country|1|||
129082205|NCT02649439|464590679|FG001|Overall Study|Patient going out of country|0|||
129082206|NCT02649439|464590678|FG000|Overall Study|To start finasteride|1|||
129082207|NCT02649439|464590679|FG001|Overall Study|To start finasteride|0|||
129082208|NCT02649439|464590678|FG000|Overall Study|Physician Decision|1|||
129082209|NCT02649439|464590679|FG001|Overall Study|Physician Decision|0|||
129082210|NCT02649439|464590678|FG000|Overall Study|Disease progression on study|12|||
129082211|NCT02649439|464590679|FG001|Overall Study|Disease progression on study|13|||
129082212|NCT02649439|464590678|FG000|Overall Study|Refused further treatment|1|||
129082213|NCT02649439|464590679|FG001|Overall Study|Refused further treatment|0|||
129082214|NCT02649439|464590678|FG000|Overall Study|Refused further follow up|2|||
129082215|NCT02649439|464590679|FG001|Overall Study|Refused further follow up|7|||
129082216|NCT02649439|464590678|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
129082217|NCT02649439|464590679|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
129082218|NCT02649439|464590678|FG000|Overall Study|No treatment, per protocol|1|||
129082219|NCT02649439|464590679|FG001|Overall Study|No treatment, per protocol|0|||
129082220|NCT02649439|464590678|FG000|Overall Study|PSA DT makes ineligible|0|||
129082221|NCT02649439|464590679|FG001|Overall Study|PSA DT makes ineligible|1|||
129082222|NCT02649439|464590678|FG000|Overall Study|Rising PSA No Mets|0|||
129082223|NCT02649439|464590679|FG001|Overall Study|Rising PSA No Mets|1|||
129082224|NCT02649439|464590678|FG000|Overall Study|Rising PSA|0|||
129082225|NCT02649439|464590679|FG001|Overall Study|Rising PSA|1|||
129082226|NCT02649439|464590678|FG000|Overall Study|Signed follow up protocol|0|||
129082227|NCT02649439|464590679|FG001|Overall Study|Signed follow up protocol|1|||
129082228|NCT00090493|464590682|FG000|Overall Study|Physician Decision|2|||
129082229|NCT02071706|464590683|FG000|Overall Study|Adverse Event|1|||
129082230|NCT02071706|464590683|FG000|Overall Study|Withdrawal by Subject|2|||
129082231|NCT01908829|464590689|FG000|Overall Study|Adverse Event|13|||
129082232|NCT01908829|464590690|FG001|Overall Study|Adverse Event|11|||
129082233|NCT01908829|464590691|FG002|Overall Study|Adverse Event|13|||
129082234|NCT01908829|464590689|FG000|Overall Study|Lost to Follow-up|4|||
129082235|NCT01908829|464590690|FG001|Overall Study|Lost to Follow-up|2|||
129082236|NCT01908829|464590691|FG002|Overall Study|Lost to Follow-up|1|||
129082237|NCT01908829|464590689|FG000|Overall Study|Randomized no double-blind drug received|1|||
129082238|NCT01908829|464590690|FG001|Overall Study|Randomized no double-blind drug received|0|||
129082239|NCT01908829|464590691|FG002|Overall Study|Randomized no double-blind drug received|1|||
129082240|NCT01908829|464590689|FG000|Overall Study|Discontinued (no EoT page)|2|||
129082241|NCT01908829|464590690|FG001|Overall Study|Discontinued (no EoT page)|0|||
129082242|NCT01908829|464590691|FG002|Overall Study|Discontinued (no EoT page)|0|||
129082243|NCT01908829|464590689|FG000|Overall Study|Miscellaneous|0|||
129082244|NCT01908829|464590690|FG001|Overall Study|Miscellaneous|2|||
129082245|NCT01908829|464590691|FG002|Overall Study|Miscellaneous|0|||
129082246|NCT01908829|464590689|FG000|Overall Study|Protocol Violation|2|||
129082247|NCT01908829|464590690|FG001|Overall Study|Protocol Violation|2|||
129082248|NCT01908829|464590691|FG002|Overall Study|Protocol Violation|0|||
129082249|NCT01908829|464590689|FG000|Overall Study|Lack of Efficacy|1|||
129082250|NCT01908829|464590690|FG001|Overall Study|Lack of Efficacy|3|||
129082251|NCT01908829|464590691|FG002|Overall Study|Lack of Efficacy|2|||
129082252|NCT01908829|464590689|FG000|Overall Study|Withdrawal by Subject|26|||
129082253|NCT01908829|464590690|FG001|Overall Study|Withdrawal by Subject|29|||
129082254|NCT01908829|464590691|FG002|Overall Study|Withdrawal by Subject|22|||
129082255|NCT02247440|464590692|FG000|Overall Study|Withdrawal by Subject|1|||
129082256|NCT02247440|464590692|FG000|Overall Study|Lack of Efficacy|3|||
129082257|NCT02792192|464590693|FG000|Overall Study|Death|1|||
129082258|NCT02792192|464590694|FG001|Overall Study|Death|0|||
129082259|NCT02792192|464590695|FG002|Overall Study|Death|0|||
129082260|NCT02792192|464590696|FG003|Overall Study|Death|0|||
129082261|NCT02792192|464590693|FG000|Overall Study|Informed Consent Withdrawn|4|||
129082262|NCT02792192|464590694|FG001|Overall Study|Informed Consent Withdrawn|0|||
129082263|NCT02792192|464590695|FG002|Overall Study|Informed Consent Withdrawn|0|||
129082264|NCT02792192|464590696|FG003|Overall Study|Informed Consent Withdrawn|0|||
129082265|NCT02792192|464590693|FG000|Overall Study|Physician Decision|1|||
129082266|NCT02792192|464590694|FG001|Overall Study|Physician Decision|0|||
129082267|NCT02792192|464590695|FG002|Overall Study|Physician Decision|0|||
129082268|NCT02792192|464590696|FG003|Overall Study|Physician Decision|0|||
129082269|NCT02792192|464590693|FG000|Overall Study|Progressive Disease|0|||
129082270|NCT02792192|464590694|FG001|Overall Study|Progressive Disease|1|||
129082271|NCT02792192|464590695|FG002|Overall Study|Progressive Disease|0|||
129082272|NCT02792192|464590696|FG003|Overall Study|Progressive Disease|0|||
129082273|NCT02792192|464590693|FG000|Overall Study|Study Terminated By Sponsor|6|||
129082274|NCT02792192|464590694|FG001|Overall Study|Study Terminated By Sponsor|10|||
129082275|NCT02792192|464590695|FG002|Overall Study|Study Terminated By Sponsor|0|||
129082276|NCT02792192|464590696|FG003|Overall Study|Study Terminated By Sponsor|0|||
129082277|NCT02320058|464590697|FG000|Overall Study|Death|25|||
129082278|NCT02320058|464590698|FG001|Overall Study|Death|10|||
129082279|NCT02320058|464590697|FG000|Overall Study|Lost to Follow-up|4|||
129082280|NCT02320058|464590698|FG001|Overall Study|Lost to Follow-up|0|||
129082281|NCT02320058|464590697|FG000|Overall Study|Other reasons|4|||
129082282|NCT02320058|464590698|FG001|Overall Study|Other reasons|1|||
129082283|NCT02320058|464590697|FG000|Overall Study|Withdrawal by Subject|8|||
129082284|NCT02320058|464590698|FG001|Overall Study|Withdrawal by Subject|2|||
129082285|NCT02320058|464590697|FG000|Overall Study|Not reported|1|||
129082286|NCT02320058|464590698|FG001|Overall Study|Not reported|0|||
129082287|NCT01339923|464590699|FG000|Overall Study|Adverse Event|1|||
129082288|NCT01339923|464590700|FG001|Overall Study|Adverse Event|1|||
129082289|NCT01339923|464590701|FG002|Overall Study|Adverse Event|1|||
129082290|NCT01339923|464590702|FG003|Overall Study|Adverse Event|0|||
129082291|NCT01339923|464590703|FG004|Overall Study|Adverse Event|0|||
129082292|NCT01339923|464590704|FG005|Overall Study|Adverse Event|0|||
129082293|NCT01339923|464590705|FG006|Overall Study|Adverse Event|1|||
129082294|NCT01339923|464590699|FG000|Overall Study|Inappropriate Enrollment|1|||
129082295|NCT01339923|464590700|FG001|Overall Study|Inappropriate Enrollment|0|||
129082296|NCT01339923|464590701|FG002|Overall Study|Inappropriate Enrollment|0|||
129082297|NCT01339923|464590702|FG003|Overall Study|Inappropriate Enrollment|0|||
129082298|NCT01339923|464590703|FG004|Overall Study|Inappropriate Enrollment|0|||
129082299|NCT01339923|464590704|FG005|Overall Study|Inappropriate Enrollment|1|||
129082300|NCT01339923|464590705|FG006|Overall Study|Inappropriate Enrollment|0|||
129082301|NCT01339923|464590699|FG000|Overall Study|Lost to Follow-up|4|||
129082302|NCT01339923|464590700|FG001|Overall Study|Lost to Follow-up|4|||
129082303|NCT01339923|464590701|FG002|Overall Study|Lost to Follow-up|0|||
129082304|NCT01339923|464590702|FG003|Overall Study|Lost to Follow-up|3|||
129082305|NCT01339923|464590703|FG004|Overall Study|Lost to Follow-up|1|||
129082306|NCT01339923|464590704|FG005|Overall Study|Lost to Follow-up|1|||
129082307|NCT01339923|464590705|FG006|Overall Study|Lost to Follow-up|5|||
129082308|NCT01339923|464590699|FG000|Overall Study|Protocol Violation|0|||
129082309|NCT01339923|464590700|FG001|Overall Study|Protocol Violation|0|||
129082310|NCT01339923|464590701|FG002|Overall Study|Protocol Violation|0|||
129082311|NCT01339923|464590702|FG003|Overall Study|Protocol Violation|0|||
129082312|NCT01339923|464590703|FG004|Overall Study|Protocol Violation|0|||
129082313|NCT01339923|464590704|FG005|Overall Study|Protocol Violation|3|||
129082314|NCT01339923|464590705|FG006|Overall Study|Protocol Violation|1|||
129082315|NCT01339923|464590699|FG000|Overall Study|Unable to Classify|1|||
129082316|NCT01339923|464590700|FG001|Overall Study|Unable to Classify|0|||
129082317|NCT01339923|464590701|FG002|Overall Study|Unable to Classify|1|||
129082318|NCT01339923|464590702|FG003|Overall Study|Unable to Classify|0|||
129082319|NCT01339923|464590703|FG004|Overall Study|Unable to Classify|0|||
129082320|NCT01339923|464590704|FG005|Overall Study|Unable to Classify|1|||
129082321|NCT01339923|464590705|FG006|Overall Study|Unable to Classify|5|||
129082322|NCT01339923|464590699|FG000|Overall Study|Withdrawal by Subject|7|||
129082323|NCT01339923|464590700|FG001|Overall Study|Withdrawal by Subject|11|||
129082324|NCT01339923|464590701|FG002|Overall Study|Withdrawal by Subject|6|||
129082325|NCT01339923|464590702|FG003|Overall Study|Withdrawal by Subject|1|||
129082326|NCT01339923|464590703|FG004|Overall Study|Withdrawal by Subject|4|||
129082327|NCT01339923|464590704|FG005|Overall Study|Withdrawal by Subject|3|||
128724241|NCT03735667|463289020|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
128724242|NCT03735667|463289018|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
129082328|NCT01339923|464590705|FG006|Overall Study|Withdrawal by Subject|2|||
129082329|NCT00729157|464590706|FG000|Overall Study|Withdrawal by Subject|1|||
129082330|NCT01430403|464590712|FG000|Overall Study|Lost to Follow-up|5|||
129142557|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
129142558|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
128724243|NCT03735667|463289019|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
129082331|NCT01430403|464590713|FG001|Overall Study|Lost to Follow-up|5|||
129082332|NCT01430403|464590714|FG002|Overall Study|Lost to Follow-up|3|||
129082333|NCT01430403|464590712|FG000|Overall Study|Physician Decision|1|||
129082334|NCT01430403|464590713|FG001|Overall Study|Physician Decision|0|||
129142559|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
129082335|NCT01430403|464590714|FG002|Overall Study|Physician Decision|0|||
129082336|NCT01430403|464590712|FG000|Overall Study|Protocol Violation|2|||
129142560|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
128724244|NCT03735667|463289020|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
129082337|NCT01430403|464590713|FG001|Overall Study|Protocol Violation|3|||
129082338|NCT01430403|464590714|FG002|Overall Study|Protocol Violation|2|||
129082339|NCT01430403|464590712|FG000|Overall Study|Withdrawal by Subject|9|||
129082340|NCT01430403|464590713|FG001|Overall Study|Withdrawal by Subject|1|||
129082341|NCT01430403|464590714|FG002|Overall Study|Withdrawal by Subject|3|||
129082342|NCT04481789|464590715|FG000|Period 1|Withdrawal by Subject|1|||
129082343|NCT04481789|464590716|FG001|Period 1|Withdrawal by Subject|0|||
129082344|NCT04481789|464590717|FG002|Period 1|Withdrawal by Subject|0|||
129082345|NCT04481789|464590718|FG003|Period 1|Withdrawal by Subject|0|||
129082346|NCT04481789|464590719|FG004|Period 1|Withdrawal by Subject|0|||
129082347|NCT04481789|464590720|FG005|Period 1|Withdrawal by Subject|0|||
129082348|NCT03124407|464590727|FG000|Overall Study|Lost to Follow-up|1|||
129082349|NCT03124407|464590728|FG001|Overall Study|Lost to Follow-up|0|||
129082350|NCT03124407|464590729|FG002|Overall Study|Lost to Follow-up|0|||
129082351|NCT03124407|464590730|FG003|Overall Study|Lost to Follow-up|0|||
129082352|NCT03124407|464590727|FG000|Overall Study|Adverse Event|0|||
129082353|NCT03124407|464590728|FG001|Overall Study|Adverse Event|0|||
129082354|NCT03124407|464590729|FG002|Overall Study|Adverse Event|1|||
129082355|NCT03124407|464590730|FG003|Overall Study|Adverse Event|0|||
129082356|NCT00396656|464590731|FG000|First Treatment Period|Withdrawal by Subject|0|||
129082357|NCT00396656|464590732|FG001|First Treatment Period|Withdrawal by Subject|2|||
129082358|NCT00396656|464590731|FG000|Second Treatment Period|Adverse Event|0|||
129082359|NCT00396656|464590732|FG001|Second Treatment Period|Adverse Event|1|||
129082360|NCT02821754|464590733|FG000|Overall Study|Procedure not required prior to amendment change|13|||
129082361|NCT02821754|464590734|FG001|Overall Study|Procedure not required prior to amendment change|11|||
129082362|NCT02821754|464590735|FG002|Overall Study|Procedure not required prior to amendment change|0|||
129082363|NCT02821754|464590733|FG000|Overall Study|Participant's Clinical status|2|||
129082364|NCT02821754|464590734|FG001|Overall Study|Participant's Clinical status|0|||
129082365|NCT02821754|464590735|FG002|Overall Study|Participant's Clinical status|0|||
129082366|NCT02821754|464590733|FG000|Overall Study|Participant removed for noncompliance|1|||
129082367|NCT02821754|464590734|FG001|Overall Study|Participant removed for noncompliance|0|||
129082368|NCT02821754|464590735|FG002|Overall Study|Participant removed for noncompliance|0|||
129082369|NCT02821754|464590733|FG000|Overall Study|Drug not available.|0|||
129082370|NCT02821754|464590734|FG001|Overall Study|Drug not available.|0|||
129082371|NCT02821754|464590735|FG002|Overall Study|Drug not available.|1|||
129082372|NCT02821754|464590733|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
129082373|NCT02821754|464590734|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
129082374|NCT02821754|464590735|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
129082375|NCT02477332|464590745|FG000|Overall Study|Adverse Event|0|||
129082376|NCT02477332|464590746|FG001|Overall Study|Adverse Event|1|||
129082377|NCT02477332|464590747|FG002|Overall Study|Adverse Event|1|||
129082378|NCT02477332|464590748|FG003|Overall Study|Adverse Event|2|||
129082379|NCT02477332|464590749|FG004|Overall Study|Adverse Event|1|||
129082380|NCT02477332|464590750|FG005|Overall Study|Adverse Event|2|||
129082381|NCT02477332|464590745|FG000|Overall Study|Lack of Efficacy|1|||
129082382|NCT02477332|464590746|FG001|Overall Study|Lack of Efficacy|2|||
129082383|NCT02477332|464590747|FG002|Overall Study|Lack of Efficacy|1|||
129082384|NCT02477332|464590748|FG003|Overall Study|Lack of Efficacy|2|||
129082385|NCT02477332|464590749|FG004|Overall Study|Lack of Efficacy|1|||
129082386|NCT02477332|464590750|FG005|Overall Study|Lack of Efficacy|1|||
129082387|NCT02477332|464590745|FG000|Overall Study|Non-compliance with study treatment|0|||
129082388|NCT02477332|464590746|FG001|Overall Study|Non-compliance with study treatment|1|||
129082389|NCT02477332|464590747|FG002|Overall Study|Non-compliance with study treatment|2|||
129082390|NCT02477332|464590748|FG003|Overall Study|Non-compliance with study treatment|0|||
129082391|NCT02477332|464590749|FG004|Overall Study|Non-compliance with study treatment|0|||
129082392|NCT02477332|464590750|FG005|Overall Study|Non-compliance with study treatment|0|||
129082393|NCT02477332|464590745|FG000|Overall Study|Pregnancy|0|||
129082394|NCT02477332|464590746|FG001|Overall Study|Pregnancy|0|||
129082395|NCT02477332|464590747|FG002|Overall Study|Pregnancy|0|||
129082396|NCT02477332|464590748|FG003|Overall Study|Pregnancy|1|||
129082397|NCT02477332|464590749|FG004|Overall Study|Pregnancy|0|||
129082398|NCT02477332|464590750|FG005|Overall Study|Pregnancy|0|||
129142561|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
129142562|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
129142563|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
129142564|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
129082399|NCT02477332|464590745|FG000|Overall Study|Protocol Violation|2|||
129082400|NCT02477332|464590746|FG001|Overall Study|Protocol Violation|0|||
129082401|NCT02477332|464590747|FG002|Overall Study|Protocol Violation|3|||
129082402|NCT02477332|464590748|FG003|Overall Study|Protocol Violation|3|||
129082403|NCT02477332|464590749|FG004|Overall Study|Protocol Violation|1|||
129082404|NCT02477332|464590750|FG005|Overall Study|Protocol Violation|1|||
129082405|NCT02477332|464590745|FG000|Overall Study|Technical problems|0|||
129082406|NCT02477332|464590746|FG001|Overall Study|Technical problems|0|||
129082407|NCT02477332|464590747|FG002|Overall Study|Technical problems|1|||
129082408|NCT02477332|464590748|FG003|Overall Study|Technical problems|0|||
129082409|NCT02477332|464590749|FG004|Overall Study|Technical problems|0|||
129142565|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129082410|NCT02477332|464590750|FG005|Overall Study|Technical problems|0|||
129082411|NCT02477332|464590745|FG000|Overall Study|Lost to Follow-up|0|||
129082412|NCT02477332|464590746|FG001|Overall Study|Lost to Follow-up|0|||
129082413|NCT02477332|464590747|FG002|Overall Study|Lost to Follow-up|2|||
129082414|NCT02477332|464590748|FG003|Overall Study|Lost to Follow-up|0|||
129082415|NCT02477332|464590749|FG004|Overall Study|Lost to Follow-up|0|||
129082416|NCT02477332|464590750|FG005|Overall Study|Lost to Follow-up|0|||
129082417|NCT02477332|464590745|FG000|Overall Study|Physician Decision|0|||
129082418|NCT02477332|464590746|FG001|Overall Study|Physician Decision|0|||
129082419|NCT02477332|464590747|FG002|Overall Study|Physician Decision|1|||
129082420|NCT02477332|464590748|FG003|Overall Study|Physician Decision|3|||
129082421|NCT02477332|464590749|FG004|Overall Study|Physician Decision|0|||
129082422|NCT02477332|464590750|FG005|Overall Study|Physician Decision|1|||
129082423|NCT02477332|464590745|FG000|Overall Study|Withdrawal by Subject|0|||
129082424|NCT02477332|464590746|FG001|Overall Study|Withdrawal by Subject|3|||
129082425|NCT02477332|464590747|FG002|Overall Study|Withdrawal by Subject|1|||
129082426|NCT02477332|464590748|FG003|Overall Study|Withdrawal by Subject|2|||
129082427|NCT02477332|464590749|FG004|Overall Study|Withdrawal by Subject|1|||
129082428|NCT02477332|464590750|FG005|Overall Study|Withdrawal by Subject|0|||
129082429|NCT03793842|464590751|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
129082430|NCT03793842|464590752|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
129082431|NCT03793842|464590751|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
129082432|NCT03793842|464590752|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
129082433|NCT02549287|464590753|FG000|Overall Study|Lost to Follow-up|65|||
129082434|NCT02549287|464590754|FG001|Overall Study|Lost to Follow-up|26|||
129082435|NCT02549287|464590753|FG000|Overall Study|Withdrawal by Subject|15|||
129082436|NCT02549287|464590754|FG001|Overall Study|Withdrawal by Subject|6|||
129082437|NCT00427921|464590755|FG000|Overall Study|Adverse Event|26|||
129082438|NCT00427921|464590755|FG000|Overall Study|Withdrawal by Subject|4|||
129082439|NCT00427921|464590755|FG000|Overall Study|Lost to Follow-up|2|||
129082440|NCT00427921|464590755|FG000|Overall Study|Other reason not specified|10|||
129082441|NCT00427921|464590755|FG000|Overall Study|Adverse Event + Hospitalization|1|||
129082442|NCT00427921|464590755|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
129082443|NCT00427921|464590755|FG000|Overall Study|Adverse Event + No Response|1|||
129082444|NCT00427921|464590755|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
129082445|NCT00427921|464590755|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
129082446|NCT00427921|464590755|FG000|Overall Study|Adverse Event + Lost Response|1|||
129082447|NCT00427921|464590755|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
129082448|NCT00427921|464590755|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
129082449|NCT00900159|464590756|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
129082450|NCT00900159|464590757|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
129082451|NCT01166438|464590758|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
129082452|NCT01166438|464590759|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
129082453|NCT01166438|464590758|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
129082454|NCT01166438|464590759|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
129082455|NCT01166438|464590758|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
129082456|NCT01166438|464590759|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
129082457|NCT01166438|464590758|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
129082458|NCT01166438|464590759|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
129082459|NCT01166438|464590758|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
129082460|NCT01166438|464590759|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
129082461|NCT01166438|464590758|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
129082462|NCT01166438|464590759|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
129082463|NCT01377922|464590766|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
129082464|NCT01377922|464590767|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
129082465|NCT00347009|464590768|FG000|Overall Study|Death|1|||
129082466|NCT00347009|464590768|FG000|Overall Study|Adverse Event|6|||
129082467|NCT00347009|464590768|FG000|Overall Study|Withdrawal by Subject|3|||
129082468|NCT00347009|464590768|FG000|Overall Study|Physician Decision|5|||
129082469|NCT00347009|464590768|FG000|Overall Study|Lost to Follow-up|4|||
129082470|NCT00347009|464590768|FG000|Overall Study|Protocol Violation|2|||
129082471|NCT00347009|464590768|FG000|Overall Study|Adverse Laboratory Experience|1|||
129082472|NCT00347009|464590768|FG000|Overall Study|Insufficient Viral Suppression|3|||
129082473|NCT00347009|464590768|FG000|Overall Study|Increased ALT/HBV DNA|1|||
129082474|NCT00347009|464590768|FG000|Overall Study|Serious Adverse Event|1|||
129082475|NCT03340454|464590770|FG000|Overall Study|Lost to Follow-up|0|||
129082476|NCT03340454|464590771|FG001|Overall Study|Lost to Follow-up|4|||
129082477|NCT01972438|464590772|FG000|Baseline-Month 3 Crossover Period|Death|1|||
129082478|NCT01972438|464590773|FG001|Baseline-Month 3 Crossover Period|Death|0|||
129082479|NCT01972438|464590772|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
129082480|NCT01972438|464590773|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
129082481|NCT01972438|464590772|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
129082482|NCT01972438|464590773|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
129082483|NCT01972438|464590772|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
129082484|NCT01972438|464590773|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
129082485|NCT01972438|464590772|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
129082486|NCT01972438|464590773|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
129082487|NCT01972438|464590772|FG000|Months 6-12 Study Period|Death|1|||
129082488|NCT01972438|464590773|FG001|Months 6-12 Study Period|Death|0|||
129082489|NCT01972438|464590772|FG000|Months 6-12 Study Period|Early Study Closure|2|||
129082490|NCT01972438|464590773|FG001|Months 6-12 Study Period|Early Study Closure|2|||
129082491|NCT01972438|464590772|FG000|Post Month 12 Study Period|Early Study Closure|3|||
129082492|NCT01972438|464590773|FG001|Post Month 12 Study Period|Early Study Closure|4|||
129082493|NCT04185220|464590776|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
129082494|NCT04185220|464590777|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
129082495|NCT04185220|464590776|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
129082496|NCT04185220|464590777|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
129082497|NCT00679029|464591973|FG000|Overall Study|Adverse Event|3|||
129082498|NCT00679029|464591973|FG000|Overall Study|Withdrawal by Subject|1|||
129082499|NCT00679029|464591973|FG000|Overall Study|Lost to Follow-up|1|||
129082500|NCT01108341|464591974|FG000|Overall Study|Death|2|||
129082501|NCT01108341|464591974|FG000|Overall Study|Withdrawal by Subject|1|||
129082502|NCT01108341|464591974|FG000|Overall Study|Lost to Follow-up|1|||
129082503|NCT01108341|464591974|FG000|Overall Study|Other|1|||
129082504|NCT04402138|464591975|FG000|Overall Study|Progressive Disease|2|||
129082505|NCT04402138|464591975|FG000|Overall Study|Adverse Event|1|||
129082506|NCT00596687|464591978|FG000|Overall Study|< 24 hours of insulin treatment|8|||
129082507|NCT00596687|464591979|FG001|Overall Study|< 24 hours of insulin treatment|6|||
129082508|NCT00596687|464591978|FG000|Overall Study|continuous insulin infusion during TPN|2|||
129082509|NCT00596687|464591979|FG001|Overall Study|continuous insulin infusion during TPN|1|||
129082510|NCT00596687|464591978|FG000|Overall Study|Withdrawal by Subject|3|||
129082511|NCT00596687|464591979|FG001|Overall Study|Withdrawal by Subject|1|||
129082512|NCT00596687|464591978|FG000|Overall Study|cancelled surgery|1|||
129082513|NCT00596687|464591979|FG001|Overall Study|cancelled surgery|1|||
129082514|NCT01284348|464591982|FG000|Overall Study|Death|1|||
129082515|NCT01284348|464591983|FG001|Overall Study|Death|1|||
129082516|NCT01284348|464591982|FG000|Overall Study|Withdrew consent|0|||
129082517|NCT01284348|464591983|FG001|Overall Study|Withdrew consent|1|||
129082518|NCT01284348|464591982|FG000|Overall Study|Status not recorded|9|||
129082519|NCT01284348|464591983|FG001|Overall Study|Status not recorded|10|||
129082520|NCT03645395|464591987|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
129082521|NCT03645395|464591988|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
129082522|NCT03645395|464591989|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
129142566|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129142567|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129142568|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129142569|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
129142570|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129142571|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129142572|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129142573|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129142574|NCT01111552|464815772|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
129142575|NCT01111552|464815773|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129142576|NCT01111552|464815774|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129142577|NCT01111552|464815775|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129142578|NCT01111552|464815776|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129142579|NCT01111552|464815772|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129142580|NCT01111552|464815773|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129142581|NCT01111552|464815774|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129142582|NCT01111552|464815775|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
129142583|NCT01111552|464815776|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129142584|NCT01111552|464815772|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
129142585|NCT01111552|464815773|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
129142586|NCT01111552|464815774|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
129142587|NCT01111552|464815775|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
129142588|NCT01111552|464815776|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
129142589|NCT01111552|464815772|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129142590|NCT01111552|464815773|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
129142591|NCT01111552|464815774|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129142592|NCT01111552|464815775|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129142593|NCT01111552|464815776|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129142594|NCT01111552|464815772|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129142595|NCT01111552|464815773|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
129142596|NCT01111552|464815774|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129142597|NCT01111552|464815775|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129142598|NCT01111552|464815776|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129142599|NCT01111552|464815772|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129142600|NCT01111552|464815773|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
129082523|NCT03645395|464591990|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
129082524|NCT03645395|464591987|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
129082525|NCT03645395|464591988|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
129082526|NCT03645395|464591989|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
129082527|NCT03645395|464591990|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
129082528|NCT03645395|464591987|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
129142601|NCT01111552|464815774|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129082529|NCT03645395|464591988|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
129082530|NCT03645395|464591989|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
129082531|NCT03645395|464591990|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
129082532|NCT03645395|464591987|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
129082533|NCT03645395|464591988|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
129082534|NCT03645395|464591989|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
129082535|NCT03645395|464591990|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
129082536|NCT01091662|464591991|FG000|Overall Study|Adverse Event|1|||
129082537|NCT01091662|464591992|FG001|Overall Study|Adverse Event|9|||
129082538|NCT01091662|464591991|FG000|Overall Study|Physician Decision|1|||
129082539|NCT01091662|464591992|FG001|Overall Study|Physician Decision|1|||
129082540|NCT01091662|464591991|FG000|Overall Study|Withdrawal by Subject|7|||
129082541|NCT01091662|464591992|FG001|Overall Study|Withdrawal by Subject|6|||
129082542|NCT01091662|464591991|FG000|Overall Study|met exit criteria|7|||
129082543|NCT01091662|464591992|FG001|Overall Study|met exit criteria|13|||
129082544|NCT01091662|464591991|FG000|Overall Study|met exclusion criteria|1|||
129082545|NCT01091662|464591992|FG001|Overall Study|met exclusion criteria|0|||
129082546|NCT01091662|464591991|FG000|Overall Study|Lost to Follow-up|0|||
129082547|NCT01091662|464591992|FG001|Overall Study|Lost to Follow-up|1|||
129082548|NCT01091662|464591991|FG000|Overall Study|Pregnancy|0|||
129082549|NCT01091662|464591992|FG001|Overall Study|Pregnancy|1|||
129082550|NCT01091662|464591991|FG000|Overall Study|Protocol Violation|0|||
129082551|NCT01091662|464591992|FG001|Overall Study|Protocol Violation|2|||
129082552|NCT01091662|464591991|FG000|Overall Study|unable to swallow capsule|0|||
129082553|NCT01091662|464591992|FG001|Overall Study|unable to swallow capsule|1|||
129082554|NCT01222520|464591993|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
129082555|NCT01222520|464591994|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
129082556|NCT01222520|464591993|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
129082557|NCT01222520|464591994|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
129082558|NCT01222520|464591993|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
129082559|NCT01222520|464591994|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
129082560|NCT01222520|464591993|FG000|Double-blind Period|Adverse Event|0|||
129082561|NCT01222520|464591994|FG001|Double-blind Period|Adverse Event|1|||
129082562|NCT01222520|464591993|FG000|Double-blind Period|Lack of Efficacy|0|||
129082563|NCT01222520|464591994|FG001|Double-blind Period|Lack of Efficacy|1|||
129082564|NCT01222520|464591993|FG000|Double-blind Period|Study medication stolen|1|||
129082565|NCT01222520|464591994|FG001|Double-blind Period|Study medication stolen|0|||
129082566|NCT04109391|464591995|FG000|Overall Study|Adverse Event|2|||
129082567|NCT04109391|464591996|FG001|Overall Study|Adverse Event|2|||
129082568|NCT04109391|464591997|FG002|Overall Study|Adverse Event|0|||
129082569|NCT04109391|464591995|FG000|Overall Study|Withdrawal by Subject|2|||
129082570|NCT04109391|464591996|FG001|Overall Study|Withdrawal by Subject|0|||
129082571|NCT04109391|464591997|FG002|Overall Study|Withdrawal by Subject|0|||
129082572|NCT04109391|464591995|FG000|Overall Study|Pregnancy|1|||
129082573|NCT04109391|464591996|FG001|Overall Study|Pregnancy|0|||
129082574|NCT04109391|464591997|FG002|Overall Study|Pregnancy|0|||
129082575|NCT04109391|464591995|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
129082576|NCT04109391|464591996|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
129082577|NCT04109391|464591997|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
129082578|NCT04109391|464591995|FG000|Overall Study|Lost to Follow-up|0|||
129082579|NCT04109391|464591996|FG001|Overall Study|Lost to Follow-up|0|||
129082580|NCT04109391|464591997|FG002|Overall Study|Lost to Follow-up|1|||
129082581|NCT04109391|464591995|FG000|Overall Study|Lack of Efficacy|2|||
129082582|NCT04109391|464591996|FG001|Overall Study|Lack of Efficacy|2|||
129082583|NCT04109391|464591997|FG002|Overall Study|Lack of Efficacy|3|||
129082584|NCT02285166|464591998|FG000|Overall Study|Case Report Forms Uncollected|564|||
129082585|NCT02285166|464591998|FG000|Overall Study|Protocol Deviation|402|||
129082586|NCT01089608|464592001|FG000|Overall Study|Adverse Event|0|||
129082587|NCT01089608|464592002|FG001|Overall Study|Adverse Event|4|||
129082588|NCT01089608|464592001|FG000|Overall Study|Lost to Follow-up|0|||
129082589|NCT01089608|464592002|FG001|Overall Study|Lost to Follow-up|2|||
129082590|NCT00384839|464592005|FG000|Overall Study|Adverse Event|4|||
129082591|NCT00384839|464592005|FG000|Overall Study|Investigator Request|1|||
129082592|NCT00384839|464592005|FG000|Overall Study|Patient Request|1|||
129082593|NCT00384839|464592005|FG000|Overall Study|Ineligible|2|||
129082594|NCT00280397|464592006|FG000|Overall Study|Adverse Event|1|||
129082595|NCT02257489|464592007|FG000|Overall Study|Withdrawal by Subject|0|||
129082596|NCT02257489|464592008|FG001|Overall Study|Withdrawal by Subject|0|||
129082597|NCT02257489|464592009|FG002|Overall Study|Withdrawal by Subject|0|||
129082598|NCT02257489|464592010|FG003|Overall Study|Withdrawal by Subject|1|||
129082599|NCT02257489|464592011|FG004|Overall Study|Withdrawal by Subject|0|||
129082600|NCT02257489|464592012|FG005|Overall Study|Withdrawal by Subject|0|||
129082601|NCT02257489|464592013|FG006|Overall Study|Withdrawal by Subject|0|||
129082602|NCT02257489|464592014|FG007|Overall Study|Withdrawal by Subject|0|||
129082603|NCT02257489|464592015|FG008|Overall Study|Withdrawal by Subject|0|||
129082604|NCT04606394|464592016|FG000|Overall Study|Withdrawal by Subject|3|||
129142602|NCT01111552|464815775|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129142603|NCT01111552|464815776|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129142604|NCT01111552|464815772|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129142605|NCT01111552|464815773|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129142606|NCT01111552|464815774|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
128724245|NCT03735667|463289018|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
129082605|NCT04606394|464592016|FG000|Overall Study|Exclusion criteria screen failure|12|||
129082606|NCT00955955|464592017|FG000|Overall Study|Lost to Follow-up|2|||
129082607|NCT00955955|464592018|FG001|Overall Study|Lost to Follow-up|0|||
129082608|NCT00955955|464592019|FG002|Overall Study|Lost to Follow-up|0|||
129082609|NCT03423173|464592020|FG000|Overall Study|Randomized but not vaccinated|1|||
128724246|NCT03735667|463289019|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
129082610|NCT03423173|464592021|FG001|Overall Study|Randomized but not vaccinated|0|||
129082611|NCT03423173|464592022|FG002|Overall Study|Randomized but not vaccinated|2|||
129082612|NCT03423173|464592023|FG003|Overall Study|Randomized but not vaccinated|1|||
129082613|NCT03423173|464592020|FG000|Overall Study|Adverse Event|1|||
129082614|NCT03423173|464592021|FG001|Overall Study|Adverse Event|1|||
129082615|NCT03423173|464592022|FG002|Overall Study|Adverse Event|1|||
129082616|NCT03423173|464592023|FG003|Overall Study|Adverse Event|1|||
129082617|NCT03423173|464592020|FG000|Overall Study|Lost to Follow-up|10|||
129082618|NCT03423173|464592021|FG001|Overall Study|Lost to Follow-up|19|||
129082619|NCT03423173|464592022|FG002|Overall Study|Lost to Follow-up|17|||
129082620|NCT03423173|464592023|FG003|Overall Study|Lost to Follow-up|22|||
129082621|NCT03423173|464592020|FG000|Overall Study|Withdrawal of consent|4|||
129082622|NCT03423173|464592021|FG001|Overall Study|Withdrawal of consent|10|||
129082623|NCT03423173|464592022|FG002|Overall Study|Withdrawal of consent|4|||
129082624|NCT03423173|464592023|FG003|Overall Study|Withdrawal of consent|5|||
129082625|NCT03423173|464592020|FG000|Overall Study|Death|1|||
129082626|NCT03423173|464592021|FG001|Overall Study|Death|0|||
129082627|NCT03423173|464592022|FG002|Overall Study|Death|0|||
129082628|NCT03423173|464592023|FG003|Overall Study|Death|0|||
129082629|NCT03423173|464592020|FG000|Overall Study|Reason not Specified|2|||
129082630|NCT03423173|464592021|FG001|Overall Study|Reason not Specified|5|||
129082631|NCT03423173|464592022|FG002|Overall Study|Reason not Specified|3|||
129082632|NCT03423173|464592023|FG003|Overall Study|Reason not Specified|1|||
129082633|NCT03852264|464592024|FG000|Third Research Visit|Lost to Follow-up|1|||
129082634|NCT03852264|464592025|FG001|Third Research Visit|Lost to Follow-up|0|||
129082635|NCT02217410|464592031|FG000|Overall Study|Graft Loss|0|||
129082636|NCT02217410|464592032|FG001|Overall Study|Graft Loss|0|||
129082637|NCT02217410|464592033|FG002|Overall Study|Graft Loss|2|||
129082638|NCT02217410|464592031|FG000|Overall Study|Withdrawal by Subject|0|||
129082639|NCT02217410|464592032|FG001|Overall Study|Withdrawal by Subject|0|||
129082640|NCT02217410|464592033|FG002|Overall Study|Withdrawal by Subject|2|||
129142607|NCT01111552|464815775|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129142608|NCT01111552|464815776|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129142609|NCT01027351|464815777|FG000|Overall Study|Withdrawal by Subject|1|||
129142610|NCT01027351|464815778|FG001|Overall Study|Withdrawal by Subject|0|||
129142611|NCT01027351|464815779|FG002|Overall Study|Withdrawal by Subject|1|||
129142612|NCT01027351|464815780|FG003|Overall Study|Withdrawal by Subject|0|||
129142613|NCT01027351|464815781|FG004|Overall Study|Withdrawal by Subject|3|||
129142614|NCT01027351|464815782|FG005|Overall Study|Withdrawal by Subject|5|||
129142615|NCT01027351|464815777|FG000|Overall Study|Lost to Follow-up|1|||
129142616|NCT01027351|464815778|FG001|Overall Study|Lost to Follow-up|1|||
129142617|NCT01027351|464815779|FG002|Overall Study|Lost to Follow-up|0|||
129142618|NCT01027351|464815780|FG003|Overall Study|Lost to Follow-up|1|||
129142619|NCT01027351|464815781|FG004|Overall Study|Lost to Follow-up|6|||
129082641|NCT02217410|464592031|FG000|Overall Study|Lost to Follow-up|0|||
129082642|NCT02217410|464592032|FG001|Overall Study|Lost to Follow-up|0|||
129082643|NCT02217410|464592033|FG002|Overall Study|Lost to Follow-up|1|||
129082644|NCT02217410|464592031|FG000|Overall Study|Lack of Efficacy|0|||
129082645|NCT02217410|464592032|FG001|Overall Study|Lack of Efficacy|1|||
129082646|NCT02217410|464592033|FG002|Overall Study|Lack of Efficacy|0|||
129082647|NCT02217410|464592031|FG000|Overall Study|Physician Decision|1|||
129082648|NCT02217410|464592032|FG001|Overall Study|Physician Decision|3|||
129082649|NCT02217410|464592033|FG002|Overall Study|Physician Decision|0|||
129082650|NCT00661609|464592035|FG000|Overall Study|Adverse Event|4|||
129082651|NCT00661609|464592035|FG000|Overall Study|Death|20|||
129082652|NCT00661609|464592035|FG000|Overall Study|Withdrawal by Subject|2|||
129082653|NCT00661609|464592035|FG000|Overall Study|PI Decision|1|||
129082654|NCT00661609|464592035|FG000|Overall Study|Survival follow up stage discontinued|11|||
129142620|NCT01027351|464815782|FG005|Overall Study|Lost to Follow-up|0|||
129082655|NCT00661609|464592035|FG000|Overall Study|Disease progression|3|||
129142621|NCT01027351|464815777|FG000|Overall Study|Inappropriate enrollment|0|||
129142622|NCT01027351|464815778|FG001|Overall Study|Inappropriate enrollment|0|||
129142623|NCT01027351|464815779|FG002|Overall Study|Inappropriate enrollment|0|||
129142624|NCT01027351|464815780|FG003|Overall Study|Inappropriate enrollment|0|||
129142625|NCT01027351|464815781|FG004|Overall Study|Inappropriate enrollment|1|||
129142626|NCT01027351|464815782|FG005|Overall Study|Inappropriate enrollment|0|||
129142627|NCT01027351|464815777|FG000|Overall Study|Protocol Violation|1|||
129142628|NCT01027351|464815778|FG001|Overall Study|Protocol Violation|0|||
129142629|NCT01027351|464815779|FG002|Overall Study|Protocol Violation|0|||
129082656|NCT00637000|464592036|FG000|Overall Study|Withdrawal by Subject|4|||
129082657|NCT00637000|464592037|FG001|Overall Study|Withdrawal by Subject|3|||
129142630|NCT01027351|464815780|FG003|Overall Study|Protocol Violation|1|||
129082658|NCT02751450|464592040|FG000|Overall Study|Adverse Event|1|||
129082659|NCT02751450|464592041|FG001|Overall Study|Adverse Event|0|||
129082660|NCT01290679|464592042|FG000|Overall Study|Adverse Event|2|||
129082661|NCT01290679|464592043|FG001|Overall Study|Adverse Event|0|||
129082662|NCT01290679|464592042|FG000|Overall Study|Lost to Follow-up|8|||
129082663|NCT01290679|464592043|FG001|Overall Study|Lost to Follow-up|10|||
129082664|NCT01290679|464592042|FG000|Overall Study|Protocol Violation|0|||
129082665|NCT01290679|464592043|FG001|Overall Study|Protocol Violation|1|||
129142631|NCT01027351|464815781|FG004|Overall Study|Protocol Violation|1|||
129142632|NCT01027351|464815782|FG005|Overall Study|Protocol Violation|0|||
129142633|NCT02971137|464815783|FG000|Overall Study|Lost to Follow-up|44|||
129082666|NCT01290679|464592042|FG000|Overall Study|Withdrawal by Subject|6|||
129082667|NCT01290679|464592043|FG001|Overall Study|Withdrawal by Subject|5|||
129082668|NCT01290679|464592042|FG000|Overall Study|Subject Entered Another Trial|0|||
129082669|NCT01290679|464592043|FG001|Overall Study|Subject Entered Another Trial|5|||
129082670|NCT00562302|464592044|FG000|Overall Study|Lost to Follow-up|3|||
129082671|NCT00562302|464592045|FG001|Overall Study|Lost to Follow-up|3|||
129082672|NCT00562302|464592044|FG000|Overall Study|Adverse Event|0|||
129082673|NCT00562302|464592045|FG001|Overall Study|Adverse Event|6|||
129082674|NCT00562302|464592044|FG000|Overall Study|Non-compliance|1|||
129082675|NCT00562302|464592045|FG001|Overall Study|Non-compliance|2|||
129082676|NCT00562302|464592044|FG000|Overall Study|Withdrawal by Subject|7|||
129082677|NCT00562302|464592045|FG001|Overall Study|Withdrawal by Subject|8|||
129082678|NCT00562302|464592044|FG000|Overall Study|Death|1|||
129082679|NCT00562302|464592045|FG001|Overall Study|Death|2|||
129082680|NCT00562302|464592044|FG000|Overall Study|Lung resection prior to study completion|7|||
129082681|NCT00562302|464592045|FG001|Overall Study|Lung resection prior to study completion|7|||
129082682|NCT00562302|464592044|FG000|Overall Study|Not stated|1|||
129082683|NCT00562302|464592045|FG001|Overall Study|Not stated|4|||
129082684|NCT01855243|464592046|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
129082685|NCT01855243|464592047|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
129082686|NCT01855243|464592048|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
129082687|NCT03315286|464592049|FG000|Overall Study|Lost to Follow-up|0|||
129082688|NCT03315286|464592050|FG001|Overall Study|Lost to Follow-up|3|||
129082689|NCT03315286|464592049|FG000|Overall Study|Withdrawal by Subject|1|||
129082690|NCT03315286|464592050|FG001|Overall Study|Withdrawal by Subject|0|||
129082691|NCT03315286|464592049|FG000|Overall Study|Protocol Violation|0|||
129082692|NCT03315286|464592050|FG001|Overall Study|Protocol Violation|1|||
129082693|NCT03075891|464592051|FG000|Overall Study|Withdrawal by Subject|3|||
129082694|NCT03075891|464592052|FG001|Overall Study|Withdrawal by Subject|6|||
129082695|NCT03075891|464592051|FG000|Overall Study|Lost to Follow-up|1|||
129082696|NCT03075891|464592052|FG001|Overall Study|Lost to Follow-up|0|||
129082697|NCT03075891|464592051|FG000|Overall Study|Pregnancy|3|||
129082698|NCT03075891|464592052|FG001|Overall Study|Pregnancy|1|||
129082699|NCT03075891|464592051|FG000|Overall Study|visits not performed (no time)|1|||
129082700|NCT03075891|464592052|FG001|Overall Study|visits not performed (no time)|0|||
129082701|NCT03075891|464592051|FG000|Overall Study|Drug abuse relapse issue|0|||
129082702|NCT03075891|464592052|FG001|Overall Study|Drug abuse relapse issue|1|||
129082703|NCT03075891|464592051|FG000|Overall Study|Participant requiring study withdrawal|0|||
129082704|NCT03075891|464592052|FG001|Overall Study|Participant requiring study withdrawal|1|||
129082705|NCT03075891|464592051|FG000|Overall Study|Adverse event, non-fatal|1|||
129082706|NCT03075891|464592052|FG001|Overall Study|Adverse event, non-fatal|4|||
129082707|NCT00828568|464592055|FG000|Randomized|Withdrawal by Subject|1|||
129082708|NCT00828568|464592056|FG001|Randomized|Withdrawal by Subject|0|||
129082709|NCT00828568|464592057|FG002|Randomized|Withdrawal by Subject|2|||
129082710|NCT00828568|464592055|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
129082711|NCT00828568|464592056|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
129082712|NCT00828568|464592057|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
129082713|NCT00828568|464592055|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
129082714|NCT00828568|464592056|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
129082715|NCT00828568|464592057|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
129082716|NCT00828568|464592055|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
129082717|NCT00828568|464592056|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
129082718|NCT00828568|464592057|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
129082719|NCT00828568|464592055|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
129082720|NCT00828568|464592056|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
129082721|NCT00828568|464592057|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
129082722|NCT03474731|464592058|FG000|Overall Study|Withdrawal by Subject|36|||
129082723|NCT03474731|464592059|FG001|Overall Study|Withdrawal by Subject|29|||
129082724|NCT03474731|464592060|FG002|Overall Study|Withdrawal by Subject|11|||
129142634|NCT02971137|464815784|FG001|Overall Study|Lost to Follow-up|56|||
129142635|NCT04755231|464815785|FG000|Overall Study|Lost to Follow-up|5|||
129082725|NCT03474731|464592061|FG003|Overall Study|Withdrawal by Subject|27|||
129082726|NCT03474731|464592058|FG000|Overall Study|COVID|0|||
129082727|NCT03474731|464592059|FG001|Overall Study|COVID|23|||
129082728|NCT03474731|464592060|FG002|Overall Study|COVID|0|||
129082729|NCT03474731|464592061|FG003|Overall Study|COVID|0|||
129082730|NCT03474731|464592058|FG000|Overall Study|Participant moved from area|1|||
129082731|NCT03474731|464592059|FG001|Overall Study|Participant moved from area|0|||
129082732|NCT03474731|464592060|FG002|Overall Study|Participant moved from area|0|||
129082733|NCT03474731|464592061|FG003|Overall Study|Participant moved from area|0|||
129082734|NCT03474731|464592058|FG000|Overall Study|Lost to Follow-up|11|||
129082735|NCT03474731|464592059|FG001|Overall Study|Lost to Follow-up|3|||
129082736|NCT03474731|464592060|FG002|Overall Study|Lost to Follow-up|18|||
129082737|NCT03474731|464592061|FG003|Overall Study|Lost to Follow-up|17|||
129142636|NCT04755231|464815785|FG000|Overall Study|Withdrawal by Subject|5|||
129082738|NCT03474731|464592058|FG000|Overall Study|Death|0|||
129082739|NCT03474731|464592059|FG001|Overall Study|Death|1|||
129142637|NCT04650893|464815786|FG000|Overall Study|Lost to Follow-up|11|||
129142638|NCT04650893|464815787|FG001|Overall Study|Lost to Follow-up|10|||
129142639|NCT04650893|464815788|FG002|Overall Study|Lost to Follow-up|11|||
129142640|NCT04129398|464817086|FG000|Overall Study|Physician Decision|2|||
129082740|NCT03474731|464592060|FG002|Overall Study|Death|0|||
129082741|NCT03474731|464592061|FG003|Overall Study|Death|0|||
129082742|NCT03474731|464592058|FG000|Overall Study|Participant Removed|0|||
129082743|NCT03474731|464592059|FG001|Overall Study|Participant Removed|0|||
129082744|NCT03474731|464592060|FG002|Overall Study|Participant Removed|0|||
129082745|NCT03474731|464592061|FG003|Overall Study|Participant Removed|1|||
129082746|NCT00766636|464592062|FG000|Overall Study|Withdrawal by Subject|1|||
129082747|NCT00766636|464592063|FG001|Overall Study|Withdrawal by Subject|1|||
129082748|NCT00766636|464592062|FG000|Overall Study|Incomplete Treatment|0|||
129082749|NCT00766636|464592063|FG001|Overall Study|Incomplete Treatment|1|||
129082750|NCT00766636|464592062|FG000|Overall Study|Adverse Event|1|||
129082751|NCT00766636|464592063|FG001|Overall Study|Adverse Event|0|||
129082752|NCT00766636|464592062|FG000|Overall Study|Disease Progression|1|||
129082753|NCT00766636|464592063|FG001|Overall Study|Disease Progression|0|||
129082754|NCT04657198|464592064|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
129082755|NCT04657198|464592065|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
129082756|NCT04657198|464592066|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
129082757|NCT01075256|464592069|FG000|Overall Study|Withdrawal by Subject|1|||
129082758|NCT01075256|464592070|FG001|Overall Study|Withdrawal by Subject|0|||
129082759|NCT01075256|464592071|FG002|Overall Study|Withdrawal by Subject|0|||
129082760|NCT00765336|464592072|FG000|Overall Study|Protocol Violation|4|||
129082761|NCT00765336|464592073|FG001|Overall Study|Protocol Violation|2|||
129082762|NCT00765336|464592072|FG000|Overall Study|Withdrawal by Subject|6|||
129082763|NCT00765336|464592073|FG001|Overall Study|Withdrawal by Subject|4|||
129082764|NCT00765336|464592072|FG000|Overall Study|Lost to Follow-up|7|||
129082765|NCT00765336|464592073|FG001|Overall Study|Lost to Follow-up|9|||
129082766|NCT00765336|464592072|FG000|Overall Study|Adverse Event|2|||
129082767|NCT00765336|464592073|FG001|Overall Study|Adverse Event|1|||
129082768|NCT02858583|464592074|FG000|Overall Study|Declined consent|1|||
129082769|NCT02858583|464592075|FG001|Overall Study|Declined consent|1|||
129082770|NCT01218087|464592076|FG000|Overall Study|Death|2|||
129082771|NCT01218087|464592077|FG001|Overall Study|Death|1|||
129082772|NCT01218087|464592076|FG000|Overall Study|Withdrawal by Subject|5|||
129082773|NCT01218087|464592077|FG001|Overall Study|Withdrawal by Subject|0|||
129082774|NCT01218087|464592076|FG000|Overall Study|Transferred|8|||
129082775|NCT01218087|464592077|FG001|Overall Study|Transferred|5|||
129082776|NCT01186692|464592083|FG000|Overall Study|Not Catheterized|11|||
129082777|NCT01186692|464592083|FG000|Overall Study|Futher testing contraindicated implant|19|||
129082778|NCT01186692|464592083|FG000|Overall Study|Adverse Event|2|||
129082779|NCT00596817|464592084|FG000|Open-label Period|Adverse Event|0|||
129082780|NCT00596817|464592085|FG001|Open-label Period|Adverse Event|49|||
129082781|NCT00596817|464592084|FG000|Open-label Period|Lack of Efficacy|0|||
129082782|NCT00596817|464592085|FG001|Open-label Period|Lack of Efficacy|33|||
129082783|NCT00596817|464592084|FG000|Open-label Period|Other Reasons|0|||
129082784|NCT00596817|464592085|FG001|Open-label Period|Other Reasons|65|||
129082785|NCT00596817|464592084|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
129082786|NCT00596817|464592085|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
129082787|NCT00596817|464592084|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
129082788|NCT00596817|464592085|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
129082789|NCT00596817|464592084|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
129082790|NCT00596817|464592085|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
129142641|NCT00590317|464817089|FG000|Overall Study|Lack of Efficacy|1|||
129142642|NCT00590317|464817090|FG001|Overall Study|Lack of Efficacy|5|||
129142643|NCT02363283|464817093|FG000|Overall Study|Withdrawal by Subject|1|||
129142644|NCT02363283|464817093|FG000|Overall Study|Not eligible due to transaminitis|1|||
128724247|NCT03735667|463289020|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
129082791|NCT00596817|464592084|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
129082792|NCT00596817|464592085|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
129082793|NCT00596817|464592084|FG000|Double-blind Period|Adverse Event|5|||
129082794|NCT00596817|464592085|FG001|Double-blind Period|Adverse Event|16|||
129142645|NCT00003907|464817100|FG000|Overall Study|Adverse Event|2|||
129082795|NCT00596817|464592084|FG000|Double-blind Period|Lack of Efficacy|52|||
129082796|NCT00596817|464592085|FG001|Double-blind Period|Lack of Efficacy|28|||
129082797|NCT00596817|464592084|FG000|Double-blind Period|Non-compliance With Study Product|3|||
129082798|NCT00596817|464592085|FG001|Double-blind Period|Non-compliance With Study Product|4|||
129082799|NCT00596817|464592084|FG000|Double-blind Period|Protocol Violation|11|||
129082800|NCT00596817|464592085|FG001|Double-blind Period|Protocol Violation|8|||
129082801|NCT00596817|464592084|FG000|Double-blind Period|Withdrawal of Consent|7|||
129082802|NCT00596817|464592085|FG001|Double-blind Period|Withdrawal of Consent|3|||
129142646|NCT00003907|464817101|FG001|Overall Study|Adverse Event|11|||
129142647|NCT00003907|464817100|FG000|Overall Study|Death|2|||
129142648|NCT00003907|464817101|FG001|Overall Study|Death|0|||
129082803|NCT00596817|464592084|FG000|Double-blind Period|Lost to Follow-up|0|||
129082804|NCT00596817|464592085|FG001|Double-blind Period|Lost to Follow-up|2|||
129082805|NCT00596817|464592084|FG000|Double-blind Period|Other Reasons|10|||
129082806|NCT00596817|464592085|FG001|Double-blind Period|Other Reasons|18|||
129082807|NCT03232931|464593305|FG000|Overall Study|Physician Decision|1|||
129082808|NCT03232931|464593306|FG001|Overall Study|Physician Decision|1|||
129082809|NCT03232931|464593305|FG000|Overall Study|Withdrawal by Subject|6|||
129082810|NCT03232931|464593306|FG001|Overall Study|Withdrawal by Subject|0|||
129082811|NCT03232931|464593305|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
129082812|NCT03232931|464593306|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
129082813|NCT03232931|464593305|FG000|Overall Study|Parent did not record voice|1|||
129082814|NCT03232931|464593306|FG001|Overall Study|Parent did not record voice|2|||
129082815|NCT03232931|464593305|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
129082816|NCT03232931|464593306|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
129082817|NCT04390503|464593309|FG000|Overall Study|Physician Decision|2|||
129082818|NCT04390503|464593310|FG001|Overall Study|Physician Decision|1|||
129082819|NCT04390503|464593309|FG000|Overall Study|Adverse Event|1|||
129082820|NCT04390503|464593310|FG001|Overall Study|Adverse Event|0|||
129082821|NCT01068730|464593312|FG000|Period 3|Personal reason|1|||
129082822|NCT01068730|464593313|FG001|Period 3|Personal reason|0|||
129082823|NCT01068730|464593314|FG002|Period 3|Personal reason|0|||
129082824|NCT01068730|464593315|FG003|Period 3|Personal reason|0|||
129082825|NCT01068730|464593312|FG000|Period 4|Family emergency|0|||
129082826|NCT01068730|464593313|FG001|Period 4|Family emergency|1|||
129082827|NCT01068730|464593314|FG002|Period 4|Family emergency|0|||
129082828|NCT01068730|464593315|FG003|Period 4|Family emergency|0|||
129082829|NCT02448537|464593319|FG000|Overall Study|Withdrawal by Subject|1|||
129082830|NCT02448537|464593320|FG001|Overall Study|Withdrawal by Subject|1|||
129082831|NCT02448537|464593321|FG002|Overall Study|Withdrawal by Subject|1|||
129082832|NCT04725812|464593324|FG000|Overall Study|Withdrawal by Subject|1|||
129082833|NCT04696055|464593329|FG000|Overall Study|Adverse Event|10|||
129082834|NCT04696055|464593330|FG001|Overall Study|Adverse Event|2|||
129082835|NCT04696055|464593329|FG000|Overall Study|Death|4|||
129082836|NCT04696055|464593330|FG001|Overall Study|Death|0|||
129082837|NCT04696055|464593329|FG000|Overall Study|Other|7|||
129082838|NCT04696055|464593330|FG001|Overall Study|Other|2|||
129082839|NCT04696055|464593329|FG000|Overall Study|Physician Decision|3|||
129082840|NCT04696055|464593330|FG001|Overall Study|Physician Decision|0|||
129082841|NCT04696055|464593329|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
129082842|NCT04696055|464593330|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
129082843|NCT04696055|464593329|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
129082844|NCT04696055|464593330|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
129082845|NCT04696055|464593329|FG000|Overall Study|Subject Decision|1|||
129082846|NCT04696055|464593330|FG001|Overall Study|Subject Decision|2|||
129082847|NCT03969901|464593331|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129082848|NCT03969901|464593332|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129082849|NCT03969901|464593333|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129082850|NCT03969901|464593334|FG003|Overall Study|Withdrawal by parent/guardian|0|||
129082851|NCT03969901|464593335|FG004|Overall Study|Withdrawal by parent/guardian|1|||
129082852|NCT03969901|464593336|FG005|Overall Study|Withdrawal by parent/guardian|0|||
129082853|NCT03969901|464593337|FG006|Overall Study|Withdrawal by parent/guardian|0|||
129082854|NCT03969901|464593338|FG007|Overall Study|Withdrawal by parent/guardian|1|||
129082855|NCT03969901|464593339|FG008|Overall Study|Withdrawal by parent/guardian|1|||
129082856|NCT03969901|464593340|FG009|Overall Study|Withdrawal by parent/guardian|0|||
129082857|NCT04411810|464593341|FG000|Overall Study|Screen failure|1|||
129142649|NCT00003907|464817100|FG000|Overall Study|Withdrawal by Subject|1|||
129142650|NCT00003907|464817101|FG001|Overall Study|Withdrawal by Subject|3|||
129142651|NCT00003907|464817100|FG000|Overall Study|Progressive disease|4|||
129142652|NCT00003907|464817101|FG001|Overall Study|Progressive disease|4|||
129142653|NCT00003907|464817100|FG000|Overall Study|Complicating disease|1|||
129142654|NCT00003907|464817101|FG001|Overall Study|Complicating disease|0|||
129082858|NCT04411810|464593341|FG000|Overall Study|Withdrawal by Subject|1|||
129082859|NCT01920958|464593342|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
129082860|NCT01560234|464593343|FG000|Overall Study|Lost to Follow-up|3|||
129082861|NCT01560234|464593344|FG001|Overall Study|Lost to Follow-up|0|||
129082862|NCT01560234|464593345|FG002|Overall Study|Lost to Follow-up|1|||
129082863|NCT01560234|464593346|FG003|Overall Study|Lost to Follow-up|0|||
129082864|NCT01560234|464593347|FG004|Overall Study|Lost to Follow-up|0|||
129082865|NCT01560234|464593348|FG005|Overall Study|Lost to Follow-up|2|||
129082866|NCT01560234|464593349|FG006|Overall Study|Lost to Follow-up|0|||
129082867|NCT01560234|464593350|FG007|Overall Study|Lost to Follow-up|2|||
129082868|NCT00083759|464593355|FG000|Overall Study|Adverse Event|5|||
129082869|NCT00083759|464593356|FG001|Overall Study|Adverse Event|3|||
129142655|NCT00003907|464817100|FG000|Overall Study|Other|1|||
129142656|NCT00003907|464817101|FG001|Overall Study|Other|3|||
129082870|NCT00083759|464593355|FG000|Overall Study|Lost to Follow-up|1|||
129082871|NCT00083759|464593356|FG001|Overall Study|Lost to Follow-up|0|||
129082872|NCT00083759|464593355|FG000|Overall Study|Death|1|||
129082873|NCT00083759|464593356|FG001|Overall Study|Death|1|||
129082874|NCT00083759|464593355|FG000|Overall Study|Inadequate Therapeutic Response|32|||
129082875|NCT00083759|464593356|FG001|Overall Study|Inadequate Therapeutic Response|35|||
129082876|NCT00083759|464593355|FG000|Overall Study|Subject Withdrew Consent|2|||
129082877|NCT00083759|464593356|FG001|Overall Study|Subject Withdrew Consent|2|||
129082878|NCT00083759|464593355|FG000|Overall Study|Non-Compliance|1|||
129082879|NCT00083759|464593356|FG001|Overall Study|Non-Compliance|0|||
129082880|NCT00083759|464593355|FG000|Overall Study|Sponsor's Discretion|28|||
129082881|NCT00083759|464593356|FG001|Overall Study|Sponsor's Discretion|29|||
129082882|NCT00083759|464593355|FG000|Overall Study|Other|14|||
129082883|NCT00083759|464593356|FG001|Overall Study|Other|13|||
129082884|NCT01057810|464593362|FG000|Overall Study|Disease progression|156|||
129082885|NCT01057810|464593363|FG001|Overall Study|Disease progression|197|||
129082886|NCT01057810|464593362|FG000|Overall Study|Study drug toxicity|5|||
129082887|NCT01057810|464593363|FG001|Overall Study|Study drug toxicity|114|||
129082888|NCT01057810|464593362|FG000|Overall Study|Adverse event unrelated to study drug|13|||
129082889|NCT01057810|464593363|FG001|Overall Study|Adverse event unrelated to study drug|29|||
129082890|NCT01057810|464593362|FG000|Overall Study|Withdrawal by Subject|10|||
129082891|NCT01057810|464593363|FG001|Overall Study|Withdrawal by Subject|25|||
129082892|NCT01057810|464593362|FG000|Overall Study|Death|2|||
129082893|NCT01057810|464593363|FG001|Overall Study|Death|12|||
129082894|NCT01057810|464593362|FG000|Overall Study|Maximum clinical benefit|5|||
129082895|NCT01057810|464593363|FG001|Overall Study|Maximum clinical benefit|5|||
129082896|NCT01057810|464593362|FG000|Overall Study|Poor/non-compliance|0|||
129082897|NCT01057810|464593363|FG001|Overall Study|Poor/non-compliance|1|||
129082898|NCT01057810|464593362|FG000|Overall Study|No longer met study criteria|0|||
129082899|NCT01057810|464593363|FG001|Overall Study|No longer met study criteria|1|||
129082900|NCT01057810|464593362|FG000|Overall Study|Other|7|||
129082901|NCT01057810|464593363|FG001|Overall Study|Other|14|||
129082902|NCT02088905|464593364|FG000|Overall Study|Withdrawal by Subject|5|||
129082903|NCT02088905|464593365|FG001|Overall Study|Withdrawal by Subject|1|||
129082904|NCT00887315|464593366|FG000|Overall Study|Study termination|7|||
129082905|NCT00887315|464593367|FG001|Overall Study|Study termination|4|||
129082906|NCT00379080|464593368|FG000|Overall Study|Withdrawal by Subject|0|||
129082907|NCT00379080|464593369|FG001|Overall Study|Withdrawal by Subject|4|||
129082908|NCT00379080|464593370|FG002|Overall Study|Withdrawal by Subject|0|||
129082909|NCT00619892|464593371|FG000|Overall Study|Adverse Event|3|||
129082910|NCT00619892|464593372|FG001|Overall Study|Adverse Event|0|||
129082911|NCT00619892|464593371|FG000|Overall Study|Lost to Follow-up|0|||
129082912|NCT00619892|464593372|FG001|Overall Study|Lost to Follow-up|1|||
129082913|NCT00619892|464593371|FG000|Overall Study|Intercurrent illness|0|||
129082914|NCT00619892|464593372|FG001|Overall Study|Intercurrent illness|1|||
129082915|NCT00857896|464593378|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
129082916|NCT02920008|464593383|FG000|Overall Study|Death|117|||
129082917|NCT02920008|464593384|FG001|Overall Study|Death|127|||
129082918|NCT02920008|464593383|FG000|Overall Study|Withdrawal by Subject|3|||
129082919|NCT02920008|464593384|FG001|Overall Study|Withdrawal by Subject|6|||
129082920|NCT02920008|464593383|FG000|Overall Study|Lost to Follow-up|0|||
129082921|NCT02920008|464593384|FG001|Overall Study|Lost to Follow-up|1|||
129082922|NCT02737930|464593385|FG000|Overall Study|Withdrawal by Subject|0|||
129082923|NCT02737930|464593386|FG001|Overall Study|Withdrawal by Subject|1|||
129142657|NCT00003907|464817100|FG000|Overall Study|ineligible or not treated|2|||
129142658|NCT00003907|464817101|FG001|Overall Study|ineligible or not treated|2|||
129142659|NCT01517178|464817102|FG000|Period 1|Adverse Event|1|||
129142660|NCT01517178|464817103|FG001|Period 1|Adverse Event|2|||
129142661|NCT01517178|464817102|FG000|Period 1|Lack of Efficacy|0|||
129082924|NCT03169881|464593387|FG000|Overall Study|Incomplete Follow-up|10|||
129082925|NCT03169881|464593388|FG001|Overall Study|Incomplete Follow-up|15|||
129082926|NCT03169881|464593387|FG000|Overall Study|Lost to Follow-up|18|||
129082927|NCT03169881|464593388|FG001|Overall Study|Lost to Follow-up|20|||
129082928|NCT03169881|464593387|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
129082929|NCT03169881|464593388|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
129082930|NCT01028014|464593389|FG000|Overall Study|Lost to Follow-up|1|||
129082931|NCT01028014|464593390|FG001|Overall Study|Lost to Follow-up|2|||
129082932|NCT01028014|464593391|FG002|Overall Study|Lost to Follow-up|0|||
129082933|NCT01028014|464593392|FG003|Overall Study|Lost to Follow-up|1|||
129082934|NCT01028014|464593393|FG004|Overall Study|Lost to Follow-up|1|||
129082935|NCT01028014|464593394|FG005|Overall Study|Lost to Follow-up|2|||
129142662|NCT01517178|464817103|FG001|Period 1|Lack of Efficacy|1|||
129142663|NCT01517178|464817102|FG000|Period 1|E.g. study termination|3|||
129142664|NCT01517178|464817103|FG001|Period 1|E.g. study termination|1|||
129082936|NCT01127451|464593404|FG000|Overall Study|Other|2|||
129082937|NCT01127451|464593405|FG001|Overall Study|Other|1|||
129082938|NCT01127451|464593404|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
129082939|NCT01127451|464593405|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
129082940|NCT01127451|464593404|FG000|Overall Study|Death|22|||
129082941|NCT01127451|464593405|FG001|Overall Study|Death|17|||
129082942|NCT01127451|464593404|FG000|Overall Study|Lost to Follow-up|3|||
129082943|NCT01127451|464593405|FG001|Overall Study|Lost to Follow-up|0|||
129082944|NCT01127451|464593404|FG000|Overall Study|Administrative Reason by Sponsor|2|||
129082945|NCT01127451|464593405|FG001|Overall Study|Administrative Reason by Sponsor|2|||
129082946|NCT00930774|464593406|FG000|Overall Study|Withdrawal by Subject|1|||
129082947|NCT00930774|464593407|FG001|Overall Study|Withdrawal by Subject|9|||
129082948|NCT00930774|464593408|FG002|Overall Study|Withdrawal by Subject|2|||
129082949|NCT00930774|464593409|FG003|Overall Study|Withdrawal by Subject|0|||
129082950|NCT03200704|464593410|FG000|Overall Study|Withdrawal by Subject|1|||
129082951|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
129082952|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
129082953|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
129082954|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
129082955|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
129082956|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
129082957|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
129082958|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
129082959|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
129082960|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
129082961|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
129082962|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
129082963|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
129082964|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
129082965|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
129082966|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
129082967|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
129082968|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
129082969|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
129082970|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
129082971|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
129082972|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
129082973|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
129082974|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
129082975|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
129082976|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
129082977|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
129082978|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
129082979|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
129082980|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
129082981|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
129082982|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
129082983|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
129082984|NCT00839527|464593412|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
129082985|NCT00839527|464593413|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
129082986|NCT00839527|464593414|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
129082987|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
129082988|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
129082989|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
129082990|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
129082991|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
129082992|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
129082993|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
129082994|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
129082995|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
129082996|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
129082997|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
129082998|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
129082999|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
129083000|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
129083001|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
129083002|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
129083003|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
129083004|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
129083005|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
129083006|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
129142665|NCT01517178|464817102|FG000|Period 1|Withdrawal by Subject|0|||
129083007|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
129083008|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
129083009|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
129083010|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
129083011|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
129083012|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
129083013|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
129083014|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
129083015|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
129083016|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
129083017|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
129083018|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
129083019|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
129083020|NCT00839527|464593412|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
129083021|NCT00839527|464593413|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
129083022|NCT00839527|464593414|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
129083023|NCT01704651|464593417|FG000|Overall Study|Pre-op withdrawal by subject|1|||
129083024|NCT01704651|464593418|FG001|Overall Study|Pre-op withdrawal by subject|1|||
129083025|NCT01704651|464593417|FG000|Overall Study|Pre-op change in treatment plan|1|||
129083026|NCT01704651|464593418|FG001|Overall Study|Pre-op change in treatment plan|4|||
129083027|NCT01704651|464593417|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
129083028|NCT01704651|464593418|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
129083029|NCT01704651|464593417|FG000|Overall Study|Post-op did not have laparotomy|2|||
129083030|NCT01704651|464593418|FG001|Overall Study|Post-op did not have laparotomy|1|||
129083031|NCT00634803|464593420|FG000|Overall Study|Lost to Follow-up|6|||
129083032|NCT00634803|464593421|FG001|Overall Study|Lost to Follow-up|7|||
129083033|NCT00634803|464593422|FG002|Overall Study|Lost to Follow-up|7|||
129083034|NCT00364923|464593424|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
129083035|NCT00364923|464593424|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
129083036|NCT04087720|464593428|FG000|Overall Study|Withdrawal by Subject|2|||
129083037|NCT04087720|464593428|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
129083038|NCT03706430|464593431|FG000|Overall Study|No A-Line placed|5|||
129083039|NCT03706430|464593431|FG000|Overall Study|Subject had gel nail polish|1|||
129083040|NCT03706430|464593431|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
129083041|NCT03706430|464593431|FG000|Overall Study|Cancelled Case|6|||
129083042|NCT03706430|464593431|FG000|Overall Study|Physician Decision|2|||
129083043|NCT00520533|464593432|FG000|Overall Study|Death|1|||
129083044|NCT00520533|464593432|FG000|Overall Study|Suspension of the study for safety reasons|1|||
129083045|NCT00520533|464593432|FG000|Overall Study|Withdrawal by Subject|1|||
129083046|NCT00520533|464593432|FG000|Overall Study|Physician Decision|1|||
129083047|NCT00478777|464593433|FG000|Overall Study|Adverse Event|29|||
129083048|NCT00478777|464593433|FG000|Overall Study|Lack of Efficacy|23|||
129083049|NCT00478777|464593433|FG000|Overall Study|Withdrawal by Subject|4|||
129083050|NCT00478777|464593433|FG000|Overall Study|Death|3|||
129142666|NCT01517178|464817103|FG001|Period 1|Withdrawal by Subject|1|||
129142667|NCT01517178|464817102|FG000|Period 2|Adverse Event|1|||
129142668|NCT01517178|464817103|FG001|Period 2|Adverse Event|0|||
129142669|NCT01517178|464817102|FG000|Period 2|Withdrawal by Subject|3|||
129142670|NCT01517178|464817103|FG001|Period 2|Withdrawal by Subject|0|||
129142671|NCT01517178|464817102|FG000|Period 2|E.g. study termination|2|||
129142672|NCT01517178|464817103|FG001|Period 2|E.g. study termination|2|||
129142673|NCT01050218|464817110|FG000|Overall Study|Adverse Event|37|||
129142674|NCT01050218|464817110|FG000|Overall Study|Lack of Efficacy|8|||
129142675|NCT01050218|464817110|FG000|Overall Study|Protocol Violation|3|||
129142676|NCT01050218|464817110|FG000|Overall Study|Withdrawal by Subject|18|||
129142677|NCT01050218|464817110|FG000|Overall Study|Discontinued by sponsor|18|||
129142678|NCT01050218|464817110|FG000|Overall Study|Compliance|2|||
129142679|NCT01050218|464817110|FG000|Overall Study|Failed to return|7|||
129083051|NCT00478777|464593433|FG000|Overall Study|Protocol Violation|3|||
129083052|NCT00478777|464593433|FG000|Overall Study|Lost to Follow-up|3|||
129083053|NCT00478777|464593433|FG000|Overall Study|Physician Decision|1|||
129083054|NCT00478777|464593433|FG000|Overall Study|Intolerance of therapy|1|||
129083055|NCT00478777|464593433|FG000|Overall Study|Lack of compliance|1|||
129083056|NCT00478777|464593433|FG000|Overall Study|Lymphocytes infusion|1|||
129083057|NCT00478777|464593433|FG000|Overall Study|End of therapy|2|||
129142680|NCT01050218|464817110|FG000|Overall Study|Serious Adverse Event|1|||
129142681|NCT01050218|464817110|FG000|Overall Study|Family emergency|1|||
129142682|NCT01149460|464817111|FG000|Overall Study|Withdrawal by Subject|0|||
129142683|NCT01149460|464817112|FG001|Overall Study|Withdrawal by Subject|2|||
129142684|NCT04691115|464817122|FG000|Overall Study|Withdrawal by Subject|0|||
129142685|NCT04691115|464817123|FG001|Overall Study|Withdrawal by Subject|0|||
129142686|NCT04691115|464817124|FG002|Overall Study|Withdrawal by Subject|0|||
129142687|NCT04691115|464817125|FG003|Overall Study|Withdrawal by Subject|0|||
129142688|NCT04691115|464817126|FG004|Overall Study|Withdrawal by Subject|0|||
129142689|NCT04691115|464817127|FG005|Overall Study|Withdrawal by Subject|1|||
129142690|NCT04691115|464817128|FG006|Overall Study|Withdrawal by Subject|0|||
129142691|NCT04691115|464817129|FG007|Overall Study|Withdrawal by Subject|0|||
129142692|NCT04691115|464817130|FG008|Overall Study|Withdrawal by Subject|0|||
129142693|NCT04691115|464817131|FG009|Overall Study|Withdrawal by Subject|0|||
129142694|NCT04691115|464817132|FG010|Overall Study|Withdrawal by Subject|0|||
129142695|NCT04691115|464817133|FG011|Overall Study|Withdrawal by Subject|0|||
129142696|NCT04691115|464817134|FG012|Overall Study|Withdrawal by Subject|0|||
129142697|NCT04691115|464817135|FG013|Overall Study|Withdrawal by Subject|0|||
129142698|NCT04661839|464817140|FG000|Overall Study|Not Treated|0|||
129142699|NCT04661839|464817141|FG001|Overall Study|Not Treated|0|||
129142700|NCT04661839|464817142|FG002|Overall Study|Not Treated|1|||
129142701|NCT04661839|464817143|FG003|Overall Study|Not Treated|0|||
129142702|NCT04661839|464817140|FG000|Overall Study|Lost to Follow-up|1|||
129142703|NCT04661839|464817141|FG001|Overall Study|Lost to Follow-up|0|||
129142704|NCT04661839|464817142|FG002|Overall Study|Lost to Follow-up|0|||
129142705|NCT04661839|464817143|FG003|Overall Study|Lost to Follow-up|1|||
129142706|NCT02096354|464817144|FG000|Overall Study|Physician Decision|4|||
129142707|NCT02096354|464817145|FG001|Overall Study|Physician Decision|5|||
129142708|NCT02096354|464817146|FG002|Overall Study|Physician Decision|0|||
129142709|NCT02096354|464817144|FG000|Overall Study|Withdrawal by Subject|3|||
129142710|NCT02096354|464817145|FG001|Overall Study|Withdrawal by Subject|1|||
129142711|NCT02096354|464817146|FG002|Overall Study|Withdrawal by Subject|0|||
129142712|NCT02096354|464817144|FG000|Overall Study|Adverse Event|7|||
129142713|NCT02096354|464817145|FG001|Overall Study|Adverse Event|4|||
129142714|NCT02096354|464817146|FG002|Overall Study|Adverse Event|0|||
129142715|NCT02096354|464817144|FG000|Overall Study|Ineligible|0|||
129142716|NCT02096354|464817145|FG001|Overall Study|Ineligible|0|||
129142717|NCT02096354|464817146|FG002|Overall Study|Ineligible|11|||
129142718|NCT03253627|464817149|FG000|Overall Study|Lost to Follow-up|1|||
129142719|NCT03253627|464817150|FG001|Overall Study|Lost to Follow-up|2|||
129142720|NCT03253627|464817149|FG000|Overall Study|Withdrawal by Subject|0|||
129142721|NCT03253627|464817150|FG001|Overall Study|Withdrawal by Subject|2|||
129142722|NCT03253627|464817149|FG000|Overall Study|Inability to complete MRI|1|||
129142723|NCT03253627|464817150|FG001|Overall Study|Inability to complete MRI|0|||
129142724|NCT01848457|464817156|FG000|Overall Study|Death|1|||
129142725|NCT01848457|464817157|FG001|Overall Study|Death|0|||
129142726|NCT01848457|464817158|FG002|Overall Study|Death|0|||
129142727|NCT01848457|464817159|FG003|Overall Study|Death|0|||
129142728|NCT02940223|464817162|FG000|Overall Study|Failed Requirement|2|||
129142729|NCT02940223|464817163|FG001|Overall Study|Failed Requirement|0|||
129142730|NCT01422382|464817166|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
129142731|NCT01813357|464817167|FG000|Overall Study|Lost to Follow-up|5|||
129142732|NCT01813357|464817168|FG001|Overall Study|Lost to Follow-up|6|||
129142733|NCT03773562|464817169|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
129142734|NCT03773562|464817169|FG000|Overall Study|Lost to Follow-up|10|||
129142735|NCT03773562|464817169|FG000|Overall Study|Withdrawal by Subject|1|||
129142736|NCT01272219|464817170|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
129142737|NCT01272219|464817171|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
129142738|NCT01272219|464817172|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
129142739|NCT01272219|464817173|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
129142740|NCT01272219|464817174|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
129142741|NCT01272219|464817175|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
129142742|NCT01272219|464817170|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
129142743|NCT01272219|464817171|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
129142744|NCT01272219|464817172|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
129142745|NCT01272219|464817173|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
129142746|NCT01272219|464817174|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
129142747|NCT01272219|464817175|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
129142748|NCT01272219|464817170|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
129142749|NCT01272219|464817171|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
129142750|NCT01272219|464817172|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
129083058|NCT00478777|464593433|FG000|Overall Study|Not treated with lenalidomide|6|||
129083059|NCT00552396|464593434|FG000|Overall Study|protocol withdrawal criteria|3|||
129083060|NCT00552396|464593435|FG001|Overall Study|protocol withdrawal criteria|3|||
129083061|NCT00552396|464593436|FG002|Overall Study|protocol withdrawal criteria|3|||
129083062|NCT00552396|464593437|FG003|Overall Study|protocol withdrawal criteria|6|||
129083063|NCT00552396|464593438|FG004|Overall Study|protocol withdrawal criteria|3|||
129083064|NCT00552396|464593439|FG005|Overall Study|protocol withdrawal criteria|3|||
129083065|NCT00552396|464593440|FG006|Overall Study|protocol withdrawal criteria|9|||
129083066|NCT02553499|464593441|FG000|Overall Study|Adverse Event|0|||
129083067|NCT02553499|464593442|FG001|Overall Study|Adverse Event|0|||
129083068|NCT02553499|464593443|FG002|Overall Study|Adverse Event|0|||
129083069|NCT02553499|464593444|FG003|Overall Study|Adverse Event|0|||
129083070|NCT02553499|464593445|FG004|Overall Study|Adverse Event|0|||
129083071|NCT02553499|464593446|FG005|Overall Study|Adverse Event|0|||
129083072|NCT02553499|464593447|FG006|Overall Study|Adverse Event|1|||
129083073|NCT02553499|464593448|FG007|Overall Study|Adverse Event|1|||
129083074|NCT02553499|464593449|FG008|Overall Study|Adverse Event|0|||
129083075|NCT02553499|464593450|FG009|Overall Study|Adverse Event|0|||
129083076|NCT02553499|464593451|FG010|Overall Study|Adverse Event|0|||
129083077|NCT02553499|464593452|FG011|Overall Study|Adverse Event|0|||
129083078|NCT02553499|464593453|FG012|Overall Study|Adverse Event|0|||
129083079|NCT02553499|464593454|FG013|Overall Study|Adverse Event|1|||
129083080|NCT02553499|464593441|FG000|Overall Study|Death|0|||
129083081|NCT02553499|464593442|FG001|Overall Study|Death|1|||
129083082|NCT02553499|464593443|FG002|Overall Study|Death|1|||
129083083|NCT02553499|464593444|FG003|Overall Study|Death|0|||
129083084|NCT02553499|464593445|FG004|Overall Study|Death|1|||
129083085|NCT02553499|464593446|FG005|Overall Study|Death|2|||
129083086|NCT02553499|464593447|FG006|Overall Study|Death|0|||
129083087|NCT02553499|464593448|FG007|Overall Study|Death|0|||
129083088|NCT02553499|464593449|FG008|Overall Study|Death|0|||
129083089|NCT02553499|464593450|FG009|Overall Study|Death|0|||
129083090|NCT02553499|464593451|FG010|Overall Study|Death|1|||
129083091|NCT02553499|464593452|FG011|Overall Study|Death|0|||
129083092|NCT02553499|464593453|FG012|Overall Study|Death|0|||
129083093|NCT02553499|464593454|FG013|Overall Study|Death|0|||
129083094|NCT02553499|464593441|FG000|Overall Study|Lost to Follow-up|0|||
129083095|NCT02553499|464593442|FG001|Overall Study|Lost to Follow-up|0|||
129083096|NCT02553499|464593443|FG002|Overall Study|Lost to Follow-up|0|||
129083097|NCT02553499|464593444|FG003|Overall Study|Lost to Follow-up|0|||
129083098|NCT02553499|464593445|FG004|Overall Study|Lost to Follow-up|0|||
129083099|NCT02553499|464593446|FG005|Overall Study|Lost to Follow-up|0|||
129083100|NCT02553499|464593447|FG006|Overall Study|Lost to Follow-up|1|||
129083101|NCT02553499|464593448|FG007|Overall Study|Lost to Follow-up|0|||
129083102|NCT02553499|464593449|FG008|Overall Study|Lost to Follow-up|0|||
129083103|NCT02553499|464593450|FG009|Overall Study|Lost to Follow-up|0|||
129083104|NCT02553499|464593451|FG010|Overall Study|Lost to Follow-up|0|||
129083105|NCT02553499|464593452|FG011|Overall Study|Lost to Follow-up|0|||
129083106|NCT02553499|464593453|FG012|Overall Study|Lost to Follow-up|0|||
129142751|NCT01272219|464817173|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
129142752|NCT01272219|464817174|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
129142753|NCT01272219|464817175|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
129142754|NCT01272219|464817170|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
129142755|NCT01272219|464817171|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
129142756|NCT01272219|464817172|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
129142757|NCT01272219|464817173|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
129142758|NCT01272219|464817174|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
129083107|NCT02553499|464593454|FG013|Overall Study|Lost to Follow-up|0|||
129083108|NCT02553499|464593441|FG000|Overall Study|Physician Decision|0|||
129083109|NCT02553499|464593442|FG001|Overall Study|Physician Decision|1|||
129083110|NCT02553499|464593443|FG002|Overall Study|Physician Decision|1|||
129083111|NCT02553499|464593444|FG003|Overall Study|Physician Decision|0|||
129083112|NCT02553499|464593445|FG004|Overall Study|Physician Decision|1|||
129083113|NCT02553499|464593446|FG005|Overall Study|Physician Decision|0|||
129083114|NCT02553499|464593447|FG006|Overall Study|Physician Decision|0|||
129083115|NCT02553499|464593448|FG007|Overall Study|Physician Decision|1|||
129083116|NCT02553499|464593449|FG008|Overall Study|Physician Decision|1|||
129142759|NCT01272219|464817175|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
129083117|NCT02553499|464593450|FG009|Overall Study|Physician Decision|2|||
129083118|NCT02553499|464593451|FG010|Overall Study|Physician Decision|1|||
129142760|NCT01272219|464817170|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
129083119|NCT02553499|464593452|FG011|Overall Study|Physician Decision|3|||
129083120|NCT02553499|464593453|FG012|Overall Study|Physician Decision|1|||
129083121|NCT02553499|464593454|FG013|Overall Study|Physician Decision|0|||
129083122|NCT02553499|464593441|FG000|Overall Study|Progressive Disease|0|||
129083123|NCT02553499|464593442|FG001|Overall Study|Progressive Disease|0|||
129083124|NCT02553499|464593443|FG002|Overall Study|Progressive Disease|0|||
129083125|NCT02553499|464593444|FG003|Overall Study|Progressive Disease|2|||
129083126|NCT02553499|464593445|FG004|Overall Study|Progressive Disease|1|||
129083127|NCT02553499|464593446|FG005|Overall Study|Progressive Disease|1|||
129083128|NCT02553499|464593447|FG006|Overall Study|Progressive Disease|1|||
129083129|NCT02553499|464593448|FG007|Overall Study|Progressive Disease|0|||
129083130|NCT02553499|464593449|FG008|Overall Study|Progressive Disease|0|||
129083131|NCT02553499|464593450|FG009|Overall Study|Progressive Disease|1|||
129083132|NCT02553499|464593451|FG010|Overall Study|Progressive Disease|0|||
129083133|NCT02553499|464593452|FG011|Overall Study|Progressive Disease|0|||
129142761|NCT01272219|464817171|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
129142762|NCT01272219|464817172|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
129142763|NCT01272219|464817173|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
129142764|NCT01272219|464817174|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
129142765|NCT01272219|464817175|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
129142766|NCT01272219|464817170|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
129142767|NCT01272219|464817171|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
129142768|NCT01272219|464817172|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
129142769|NCT01272219|464817173|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
129142770|NCT01272219|464817174|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
129142771|NCT01272219|464817175|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
129142772|NCT01272219|464817170|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129142773|NCT01272219|464817171|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129142774|NCT01272219|464817172|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129142775|NCT01272219|464817173|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
129142776|NCT01272219|464817174|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129142777|NCT01272219|464817175|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129142778|NCT01272219|464817170|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129142779|NCT01272219|464817171|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
129142780|NCT01272219|464817172|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129142781|NCT01272219|464817173|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
129142782|NCT01272219|464817174|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129142783|NCT01272219|464817175|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129142784|NCT01272219|464817170|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
129142785|NCT01272219|464817171|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
129142786|NCT01272219|464817172|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
129142787|NCT01272219|464817173|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
129142788|NCT01272219|464817174|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
129142789|NCT01272219|464817175|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
129142790|NCT01272219|464817170|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
129142791|NCT01272219|464817171|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
129142792|NCT01272219|464817172|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
129142793|NCT01272219|464817173|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
129142794|NCT01272219|464817174|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
129142795|NCT01272219|464817175|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
129142796|NCT01272219|464817170|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
129142797|NCT01272219|464817171|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
129142798|NCT01272219|464817172|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
129142799|NCT01272219|464817173|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
129142800|NCT01272219|464817174|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
129142801|NCT01272219|464817175|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
129142802|NCT01272219|464817170|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129083134|NCT02553499|464593453|FG012|Overall Study|Progressive Disease|2|||
129083135|NCT02553499|464593454|FG013|Overall Study|Progressive Disease|1|||
129083136|NCT02553499|464593441|FG000|Overall Study|Study Terminated by Sponsor|0|||
129142803|NCT01272219|464817171|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129083137|NCT02553499|464593442|FG001|Overall Study|Study Terminated by Sponsor|0|||
129083138|NCT02553499|464593443|FG002|Overall Study|Study Terminated by Sponsor|0|||
129083139|NCT02553499|464593444|FG003|Overall Study|Study Terminated by Sponsor|0|||
129083140|NCT02553499|464593445|FG004|Overall Study|Study Terminated by Sponsor|0|||
129083141|NCT02553499|464593446|FG005|Overall Study|Study Terminated by Sponsor|0|||
129083142|NCT02553499|464593447|FG006|Overall Study|Study Terminated by Sponsor|0|||
129083143|NCT02553499|464593448|FG007|Overall Study|Study Terminated by Sponsor|0|||
129083144|NCT02553499|464593449|FG008|Overall Study|Study Terminated by Sponsor|1|||
129083145|NCT02553499|464593450|FG009|Overall Study|Study Terminated by Sponsor|0|||
129083146|NCT02553499|464593451|FG010|Overall Study|Study Terminated by Sponsor|0|||
129083147|NCT02553499|464593452|FG011|Overall Study|Study Terminated by Sponsor|0|||
129083148|NCT02553499|464593453|FG012|Overall Study|Study Terminated by Sponsor|0|||
129083149|NCT02553499|464593454|FG013|Overall Study|Study Terminated by Sponsor|0|||
129083150|NCT02553499|464593441|FG000|Overall Study|Withdrawal by Subject|2|||
129083151|NCT02553499|464593442|FG001|Overall Study|Withdrawal by Subject|0|||
129083152|NCT02553499|464593443|FG002|Overall Study|Withdrawal by Subject|0|||
129083153|NCT02553499|464593444|FG003|Overall Study|Withdrawal by Subject|0|||
129083154|NCT02553499|464593445|FG004|Overall Study|Withdrawal by Subject|0|||
129083155|NCT02553499|464593446|FG005|Overall Study|Withdrawal by Subject|0|||
129083156|NCT02553499|464593447|FG006|Overall Study|Withdrawal by Subject|0|||
129083157|NCT02553499|464593448|FG007|Overall Study|Withdrawal by Subject|1|||
129083158|NCT02553499|464593449|FG008|Overall Study|Withdrawal by Subject|1|||
129083159|NCT02553499|464593450|FG009|Overall Study|Withdrawal by Subject|0|||
129083160|NCT02553499|464593451|FG010|Overall Study|Withdrawal by Subject|1|||
129083161|NCT02553499|464593452|FG011|Overall Study|Withdrawal by Subject|0|||
129083162|NCT02553499|464593453|FG012|Overall Study|Withdrawal by Subject|0|||
129083163|NCT02553499|464593454|FG013|Overall Study|Withdrawal by Subject|0|||
129083164|NCT04925557|464594998|FG000|Overall Study|Study closed|5|||
129083165|NCT04925557|464594999|FG001|Overall Study|Study closed|3|||
129083166|NCT05488470|464595000|FG000|Overall Study|Physician Decision|2|||
129083167|NCT05488470|464595000|FG000|Overall Study|Withdrawal by Subject|1|||
129083168|NCT05488470|464595000|FG000|Overall Study|Death|1|||
129083169|NCT00068393|464595005|FG000|Overall Study|Adverse Event|2|||
129083170|NCT00068393|464595005|FG000|Overall Study|Death|3|||
129083171|NCT00068393|464595005|FG000|Overall Study|Withdrawal by Subject|3|||
129083172|NCT00068393|464595005|FG000|Overall Study|Alternative treatment|1|||
129083173|NCT00068393|464595005|FG000|Overall Study|Quality of life worsening|1|||
129083174|NCT04981470|464595009|FG000|Overall Study|Device failure in all 4 patients|4|||
129083175|NCT00593684|464595010|FG000|Overall Study|Death|2|||
129083176|NCT00593684|464595011|FG001|Overall Study|Death|1|||
129083177|NCT00078767|464595012|FG000|Overall Study|Withdrawal by Subject|1|||
129083178|NCT00078767|464595013|FG001|Overall Study|Withdrawal by Subject|1|||
129083179|NCT02282631|464595018|FG000|Overall Study|Lost to Follow-up|2|||
129083180|NCT02282631|464595019|FG001|Overall Study|Lost to Follow-up|0|||
129083181|NCT01736397|464595020|FG000|Overall Study|Lack of Efficacy|1|||
129083182|NCT01736397|464595021|FG001|Overall Study|Lack of Efficacy|11|||
129083183|NCT01736397|464595020|FG000|Overall Study|Withdrawal by Subject|6|||
129083184|NCT01736397|464595021|FG001|Overall Study|Withdrawal by Subject|5|||
129083185|NCT01736397|464595020|FG000|Overall Study|Lost to Follow-up|0|||
129083186|NCT01736397|464595021|FG001|Overall Study|Lost to Follow-up|1|||
129083187|NCT01736397|464595020|FG000|Overall Study|Adverse Event|6|||
129083188|NCT01736397|464595021|FG001|Overall Study|Adverse Event|3|||
129083189|NCT01736397|464595020|FG000|Overall Study|Not stated|1|||
129083190|NCT01736397|464595021|FG001|Overall Study|Not stated|4|||
129142804|NCT01272219|464817172|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129142805|NCT01272219|464817173|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129142806|NCT01272219|464817174|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
129142807|NCT01272219|464817175|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
129142808|NCT01272219|464817170|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129083191|NCT05088603|464595022|FG000|Overall Study|Protocol Violation|6|||
129083192|NCT05088603|464595023|FG001|Overall Study|Protocol Violation|1|||
129083193|NCT01841762|464595025|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
129083194|NCT01841762|464595025|FG000|Treatment Period|Adverse Event|16|||
129083195|NCT01841762|464595025|FG000|Treatment Period|Death|1|||
129083196|NCT01841762|464595025|FG000|Treatment Period|Withdrawal by Subject|7|||
129083197|NCT01841762|464595025|FG000|Treatment Period|Lost to Follow-up|1|||
129083198|NCT01841762|464595025|FG000|Treatment Period|Physician Decision|2|||
129083199|NCT01841762|464595025|FG000|Treatment Period|Other, including non-compliance|5|||
129083200|NCT01841762|464595025|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
129083201|NCT01841762|464595025|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
129083202|NCT01841762|464595025|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
129083203|NCT01841762|464595025|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
129083204|NCT00594100|464595030|FG000|Procedure|Technical Failure|9|||
129083205|NCT00594100|464595030|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
129083206|NCT00594100|464595030|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
129083207|NCT00594100|464595030|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
129083208|NCT01270464|464595031|FG000|Overall Study|Protocol Violation|4|||
129083209|NCT01270464|464595032|FG001|Overall Study|Protocol Violation|3|||
129083210|NCT01270464|464595033|FG002|Overall Study|Protocol Violation|2|||
129083211|NCT01270464|464595031|FG000|Overall Study|Lack of Efficacy|2|||
129083212|NCT01270464|464595032|FG001|Overall Study|Lack of Efficacy|3|||
129083213|NCT01270464|464595033|FG002|Overall Study|Lack of Efficacy|1|||
129083214|NCT01270464|464595031|FG000|Overall Study|Adverse Event|9|||
129083215|NCT01270464|464595032|FG001|Overall Study|Adverse Event|1|||
129083216|NCT01270464|464595033|FG002|Overall Study|Adverse Event|7|||
129083217|NCT01270464|464595031|FG000|Overall Study|Withdrawal by Subject|2|||
129083218|NCT01270464|464595032|FG001|Overall Study|Withdrawal by Subject|1|||
129083219|NCT01270464|464595033|FG002|Overall Study|Withdrawal by Subject|4|||
129083220|NCT01270464|464595031|FG000|Overall Study|Lost to Follow-up|2|||
129083221|NCT01270464|464595032|FG001|Overall Study|Lost to Follow-up|3|||
129083222|NCT01270464|464595033|FG002|Overall Study|Lost to Follow-up|1|||
129083223|NCT01270464|464595031|FG000|Overall Study|Other|1|||
129083224|NCT01270464|464595032|FG001|Overall Study|Other|1|||
129083225|NCT01270464|464595033|FG002|Overall Study|Other|3|||
129083226|NCT03981900|464595035|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
129083227|NCT03981900|464595035|FG000|Overall Study|Adverse Event|5|||
129083228|NCT03981900|464595035|FG000|Overall Study|Protocol Violation|1|||
129083229|NCT03981900|464595035|FG000|Overall Study|Withdrawal by Subject|7|||
129083230|NCT03981900|464595035|FG000|Overall Study|Lost to Follow-up|46|||
129083231|NCT03981900|464595035|FG000|Overall Study|Decision of the researcher|3|||
129083232|NCT03981900|464595035|FG000|Overall Study|Death|3|||
129083233|NCT03981900|464595035|FG000|Overall Study|Other|5|||
129083234|NCT02162719|464595036|FG000|Overall Study|Death|41|||
129083235|NCT02162719|464595037|FG001|Overall Study|Death|46|||
129083236|NCT02162719|464595036|FG000|Overall Study|Lost to Follow-up|1|||
129083237|NCT02162719|464595037|FG001|Overall Study|Lost to Follow-up|3|||
129083238|NCT02162719|464595036|FG000|Overall Study|Disease Progression|2|||
129083239|NCT02162719|464595037|FG001|Overall Study|Disease Progression|1|||
129083240|NCT02162719|464595036|FG000|Overall Study|Withdrawal by Subject|8|||
129083241|NCT02162719|464595037|FG001|Overall Study|Withdrawal by Subject|2|||
129083242|NCT02162719|464595036|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
129083243|NCT02162719|464595037|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
129083244|NCT03555565|464595039|FG000|Overall Study|Case Report Forms Uncollected|2|||
129083245|NCT03555565|464595039|FG000|Overall Study|Protocol Deviation|13|||
129083246|NCT02589626|464595041|FG000|Overall Study|Other than the reason specified|1|||
129083247|NCT02589626|464595042|FG001|Overall Study|Other than the reason specified|0|||
129083248|NCT02589626|464595041|FG000|Overall Study|Withdrawal by Subject|1|||
129083249|NCT02589626|464595042|FG001|Overall Study|Withdrawal by Subject|1|||
129083250|NCT02589626|464595041|FG000|Overall Study|Adverse Event|1|||
129083251|NCT02589626|464595042|FG001|Overall Study|Adverse Event|1|||
129083252|NCT02564900|464595043|FG000|Dose Escalation|Progressive disease per RECIST|2|||
129083253|NCT02564900|464595044|FG001|Dose Escalation|Progressive disease per RECIST|3|||
129083254|NCT02564900|464595045|FG002|Dose Escalation|Progressive disease per RECIST|3|||
129083255|NCT02564900|464595046|FG003|Dose Escalation|Progressive disease per RECIST|3|||
129083256|NCT02564900|464595047|FG004|Dose Escalation|Progressive disease per RECIST|3|||
129083257|NCT02564900|464595048|FG005|Dose Escalation|Progressive disease per RECIST|1|||
129083258|NCT02564900|464595049|FG006|Dose Escalation|Progressive disease per RECIST|0|||
129083259|NCT02564900|464595050|FG007|Dose Escalation|Progressive disease per RECIST|0|||
129083260|NCT02564900|464595051|FG008|Dose Escalation|Progressive disease per RECIST|0|||
129083261|NCT02564900|464595052|FG009|Dose Escalation|Progressive disease per RECIST|0|||
129083262|NCT02564900|464595053|FG010|Dose Escalation|Progressive disease per RECIST|0|||
129083263|NCT02564900|464595054|FG011|Dose Escalation|Progressive disease per RECIST|0|||
129083264|NCT02564900|464595055|FG012|Dose Escalation|Progressive disease per RECIST|0|||
129083265|NCT02564900|464595056|FG013|Dose Escalation|Progressive disease per RECIST|0|||
129083266|NCT02564900|464595057|FG014|Dose Escalation|Progressive disease per RECIST|0|||
129083267|NCT02564900|464595043|FG000|Dose Escalation|Ongoing|1|||
129083268|NCT02564900|464595044|FG001|Dose Escalation|Ongoing|0|||
129083269|NCT02564900|464595045|FG002|Dose Escalation|Ongoing|0|||
129083270|NCT02564900|464595046|FG003|Dose Escalation|Ongoing|2|||
129083271|NCT02564900|464595047|FG004|Dose Escalation|Ongoing|2|||
129083272|NCT02564900|464595048|FG005|Dose Escalation|Ongoing|2|||
129083273|NCT02564900|464595049|FG006|Dose Escalation|Ongoing|0|||
129083274|NCT02564900|464595050|FG007|Dose Escalation|Ongoing|0|||
129083275|NCT02564900|464595051|FG008|Dose Escalation|Ongoing|0|||
129083276|NCT02564900|464595052|FG009|Dose Escalation|Ongoing|0|||
129083277|NCT02564900|464595053|FG010|Dose Escalation|Ongoing|0|||
129083278|NCT02564900|464595054|FG011|Dose Escalation|Ongoing|0|||
129083279|NCT02564900|464595055|FG012|Dose Escalation|Ongoing|0|||
129083280|NCT02564900|464595056|FG013|Dose Escalation|Ongoing|0|||
129083281|NCT02564900|464595057|FG014|Dose Escalation|Ongoing|0|||
129083282|NCT02564900|464595043|FG000|Dose Escalation|Adverse Event|0|||
129083283|NCT02564900|464595044|FG001|Dose Escalation|Adverse Event|0|||
129083284|NCT02564900|464595045|FG002|Dose Escalation|Adverse Event|0|||
129083285|NCT02564900|464595046|FG003|Dose Escalation|Adverse Event|1|||
129083286|NCT02564900|464595047|FG004|Dose Escalation|Adverse Event|1|||
129083287|NCT02564900|464595048|FG005|Dose Escalation|Adverse Event|3|||
129083288|NCT02564900|464595049|FG006|Dose Escalation|Adverse Event|0|||
129083289|NCT02564900|464595050|FG007|Dose Escalation|Adverse Event|0|||
129083290|NCT02564900|464595051|FG008|Dose Escalation|Adverse Event|0|||
129083291|NCT02564900|464595052|FG009|Dose Escalation|Adverse Event|0|||
129083292|NCT02564900|464595053|FG010|Dose Escalation|Adverse Event|0|||
129083293|NCT02564900|464595054|FG011|Dose Escalation|Adverse Event|0|||
129083294|NCT02564900|464595055|FG012|Dose Escalation|Adverse Event|0|||
129083295|NCT02564900|464595056|FG013|Dose Escalation|Adverse Event|0|||
129083296|NCT02564900|464595057|FG014|Dose Escalation|Adverse Event|0|||
129083297|NCT02564900|464595043|FG000|Dose Expansion|Progressive disease per RECIST|0|||
129083298|NCT02564900|464595044|FG001|Dose Expansion|Progressive disease per RECIST|0|||
129083299|NCT02564900|464595045|FG002|Dose Expansion|Progressive disease per RECIST|0|||
129083300|NCT02564900|464595046|FG003|Dose Expansion|Progressive disease per RECIST|0|||
129083301|NCT02564900|464595047|FG004|Dose Expansion|Progressive disease per RECIST|0|||
129083302|NCT02564900|464595048|FG005|Dose Expansion|Progressive disease per RECIST|0|||
129083303|NCT02564900|464595049|FG006|Dose Expansion|Progressive disease per RECIST|19|||
129083304|NCT02564900|464595050|FG007|Dose Expansion|Progressive disease per RECIST|17|||
129083305|NCT02564900|464595051|FG008|Dose Expansion|Progressive disease per RECIST|8|||
129083306|NCT02564900|464595052|FG009|Dose Expansion|Progressive disease per RECIST|16|||
129083307|NCT02564900|464595053|FG010|Dose Expansion|Progressive disease per RECIST|13|||
129083308|NCT02564900|464595054|FG011|Dose Expansion|Progressive disease per RECIST|19|||
129083309|NCT02564900|464595055|FG012|Dose Expansion|Progressive disease per RECIST|10|||
129083310|NCT02564900|464595056|FG013|Dose Expansion|Progressive disease per RECIST|13|||
129083311|NCT02564900|464595057|FG014|Dose Expansion|Progressive disease per RECIST|11|||
129083312|NCT02564900|464595043|FG000|Dose Expansion|Clinical progression|0|||
129083313|NCT02564900|464595044|FG001|Dose Expansion|Clinical progression|0|||
129083314|NCT02564900|464595045|FG002|Dose Expansion|Clinical progression|0|||
129083315|NCT02564900|464595046|FG003|Dose Expansion|Clinical progression|0|||
129083316|NCT02564900|464595047|FG004|Dose Expansion|Clinical progression|0|||
129083317|NCT02564900|464595048|FG005|Dose Expansion|Clinical progression|0|||
129083318|NCT02564900|464595049|FG006|Dose Expansion|Clinical progression|5|||
129083319|NCT02564900|464595050|FG007|Dose Expansion|Clinical progression|12|||
129083320|NCT02564900|464595051|FG008|Dose Expansion|Clinical progression|0|||
129083321|NCT02564900|464595052|FG009|Dose Expansion|Clinical progression|3|||
129083322|NCT02564900|464595053|FG010|Dose Expansion|Clinical progression|2|||
129083323|NCT02564900|464595054|FG011|Dose Expansion|Clinical progression|0|||
129083324|NCT02564900|464595055|FG012|Dose Expansion|Clinical progression|1|||
129083325|NCT02564900|464595056|FG013|Dose Expansion|Clinical progression|3|||
129083326|NCT02564900|464595057|FG014|Dose Expansion|Clinical progression|1|||
129083327|NCT02564900|464595043|FG000|Dose Expansion|Adverse Event|0|||
129083328|NCT02564900|464595044|FG001|Dose Expansion|Adverse Event|0|||
129083329|NCT02564900|464595045|FG002|Dose Expansion|Adverse Event|0|||
129083330|NCT02564900|464595046|FG003|Dose Expansion|Adverse Event|0|||
129083331|NCT02564900|464595047|FG004|Dose Expansion|Adverse Event|0|||
129083332|NCT02564900|464595048|FG005|Dose Expansion|Adverse Event|0|||
129083333|NCT02564900|464595049|FG006|Dose Expansion|Adverse Event|9|||
129083334|NCT02564900|464595050|FG007|Dose Expansion|Adverse Event|22|||
129083335|NCT02564900|464595051|FG008|Dose Expansion|Adverse Event|0|||
129083336|NCT02564900|464595052|FG009|Dose Expansion|Adverse Event|11|||
129083337|NCT02564900|464595053|FG010|Dose Expansion|Adverse Event|0|||
129083338|NCT02564900|464595054|FG011|Dose Expansion|Adverse Event|5|||
129083339|NCT02564900|464595055|FG012|Dose Expansion|Adverse Event|2|||
129083340|NCT02564900|464595056|FG013|Dose Expansion|Adverse Event|2|||
129083341|NCT02564900|464595057|FG014|Dose Expansion|Adverse Event|1|||
129083342|NCT02564900|464595043|FG000|Dose Expansion|Ongoing|0|||
129083343|NCT02564900|464595044|FG001|Dose Expansion|Ongoing|0|||
129083344|NCT02564900|464595045|FG002|Dose Expansion|Ongoing|0|||
129083345|NCT02564900|464595046|FG003|Dose Expansion|Ongoing|0|||
129083346|NCT02564900|464595047|FG004|Dose Expansion|Ongoing|0|||
129083347|NCT02564900|464595048|FG005|Dose Expansion|Ongoing|0|||
129083348|NCT02564900|464595049|FG006|Dose Expansion|Ongoing|9|||
129083349|NCT02564900|464595050|FG007|Dose Expansion|Ongoing|10|||
129083350|NCT02564900|464595051|FG008|Dose Expansion|Ongoing|11|||
129083351|NCT02564900|464595052|FG009|Dose Expansion|Ongoing|3|||
129083352|NCT02564900|464595053|FG010|Dose Expansion|Ongoing|0|||
129083353|NCT02564900|464595054|FG011|Dose Expansion|Ongoing|0|||
129083354|NCT02564900|464595055|FG012|Dose Expansion|Ongoing|4|||
129083355|NCT02564900|464595056|FG013|Dose Expansion|Ongoing|0|||
129083356|NCT02564900|464595057|FG014|Dose Expansion|Ongoing|6|||
129083357|NCT02564900|464595043|FG000|Dose Expansion|Death|0|||
129083358|NCT02564900|464595044|FG001|Dose Expansion|Death|0|||
129083359|NCT02564900|464595045|FG002|Dose Expansion|Death|0|||
129083360|NCT02564900|464595046|FG003|Dose Expansion|Death|0|||
129083361|NCT02564900|464595047|FG004|Dose Expansion|Death|0|||
129083362|NCT02564900|464595048|FG005|Dose Expansion|Death|0|||
129083363|NCT02564900|464595049|FG006|Dose Expansion|Death|1|||
129083364|NCT02564900|464595050|FG007|Dose Expansion|Death|0|||
129083365|NCT02564900|464595051|FG008|Dose Expansion|Death|0|||
129083366|NCT02564900|464595052|FG009|Dose Expansion|Death|0|||
129083367|NCT02564900|464595053|FG010|Dose Expansion|Death|1|||
129083368|NCT02564900|464595054|FG011|Dose Expansion|Death|0|||
129083369|NCT02564900|464595055|FG012|Dose Expansion|Death|1|||
129083370|NCT02564900|464595056|FG013|Dose Expansion|Death|1|||
129083371|NCT02564900|464595057|FG014|Dose Expansion|Death|0|||
129083372|NCT02564900|464595043|FG000|Dose Expansion|Withdrawal by Subject|0|||
129083373|NCT02564900|464595044|FG001|Dose Expansion|Withdrawal by Subject|0|||
129083374|NCT02564900|464595045|FG002|Dose Expansion|Withdrawal by Subject|0|||
129083375|NCT02564900|464595046|FG003|Dose Expansion|Withdrawal by Subject|0|||
129083376|NCT02564900|464595047|FG004|Dose Expansion|Withdrawal by Subject|0|||
129083377|NCT02564900|464595048|FG005|Dose Expansion|Withdrawal by Subject|0|||
129083378|NCT02564900|464595049|FG006|Dose Expansion|Withdrawal by Subject|4|||
129083379|NCT02564900|464595050|FG007|Dose Expansion|Withdrawal by Subject|0|||
129083380|NCT02564900|464595051|FG008|Dose Expansion|Withdrawal by Subject|0|||
129083381|NCT02564900|464595052|FG009|Dose Expansion|Withdrawal by Subject|0|||
129083382|NCT02564900|464595053|FG010|Dose Expansion|Withdrawal by Subject|1|||
129083383|NCT02564900|464595054|FG011|Dose Expansion|Withdrawal by Subject|0|||
129083384|NCT02564900|464595055|FG012|Dose Expansion|Withdrawal by Subject|0|||
129083385|NCT02564900|464595056|FG013|Dose Expansion|Withdrawal by Subject|1|||
129083386|NCT02564900|464595057|FG014|Dose Expansion|Withdrawal by Subject|1|||
129083387|NCT02564900|464595043|FG000|Dose Expansion|Other|0|||
129083388|NCT02564900|464595044|FG001|Dose Expansion|Other|0|||
129083389|NCT02564900|464595045|FG002|Dose Expansion|Other|0|||
129083390|NCT02564900|464595046|FG003|Dose Expansion|Other|0|||
129083391|NCT02564900|464595047|FG004|Dose Expansion|Other|0|||
129083392|NCT02564900|464595048|FG005|Dose Expansion|Other|0|||
129083393|NCT02564900|464595049|FG006|Dose Expansion|Other|1|||
129083394|NCT02564900|464595050|FG007|Dose Expansion|Other|0|||
129083395|NCT02564900|464595051|FG008|Dose Expansion|Other|1|||
129083396|NCT02564900|464595052|FG009|Dose Expansion|Other|0|||
129083397|NCT02564900|464595053|FG010|Dose Expansion|Other|0|||
129083398|NCT02564900|464595054|FG011|Dose Expansion|Other|0|||
129083399|NCT02564900|464595055|FG012|Dose Expansion|Other|0|||
129083400|NCT02564900|464595056|FG013|Dose Expansion|Other|0|||
129083401|NCT02564900|464595057|FG014|Dose Expansion|Other|1|||
129083402|NCT02564900|464595043|FG000|Dose Expansion|Did not receive treatment|0|||
129083403|NCT02564900|464595044|FG001|Dose Expansion|Did not receive treatment|0|||
129083404|NCT02564900|464595045|FG002|Dose Expansion|Did not receive treatment|0|||
129083405|NCT02564900|464595046|FG003|Dose Expansion|Did not receive treatment|0|||
129083406|NCT02564900|464595047|FG004|Dose Expansion|Did not receive treatment|0|||
129083407|NCT02564900|464595048|FG005|Dose Expansion|Did not receive treatment|0|||
129083408|NCT02564900|464595049|FG006|Dose Expansion|Did not receive treatment|1|||
129083409|NCT02564900|464595050|FG007|Dose Expansion|Did not receive treatment|1|||
129083410|NCT02564900|464595051|FG008|Dose Expansion|Did not receive treatment|0|||
129083411|NCT02564900|464595052|FG009|Dose Expansion|Did not receive treatment|0|||
129083412|NCT02564900|464595053|FG010|Dose Expansion|Did not receive treatment|0|||
129083413|NCT02564900|464595054|FG011|Dose Expansion|Did not receive treatment|0|||
129083414|NCT02564900|464595055|FG012|Dose Expansion|Did not receive treatment|0|||
129083415|NCT02564900|464595056|FG013|Dose Expansion|Did not receive treatment|0|||
129083416|NCT02564900|464595057|FG014|Dose Expansion|Did not receive treatment|1|||
129083417|NCT01931475|464595059|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
129083418|NCT01931475|464595060|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
129083419|NCT01931475|464595059|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
129083420|NCT01931475|464595060|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
129083421|NCT01931475|464595059|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
129083422|NCT01931475|464595060|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
129083423|NCT01931475|464595059|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
129083424|NCT01931475|464595060|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
129083425|NCT01931475|464595059|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
129083426|NCT01931475|464595060|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
129083427|NCT01931475|464595059|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
129083428|NCT01931475|464595060|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
129083429|NCT01931475|464595059|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
129083430|NCT01931475|464595060|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
129083431|NCT01931475|464595059|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
129083432|NCT01931475|464595060|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
129083433|NCT01931475|464595059|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
129083434|NCT01931475|464595060|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
129083435|NCT01931475|464595059|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
129083436|NCT01931475|464595060|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
129083437|NCT01931475|464595059|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
129083438|NCT01931475|464595060|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
129083439|NCT02475265|464595070|FG000|Overall Study|Physician Decision|1|||
129083440|NCT02475265|464595070|FG000|Overall Study|Withdrawal by Subject|2|||
128724248|NCT03735667|463289018|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
129083441|NCT01323387|464595074|FG000|Overall Study|Withdrawal by Subject|41|||
129083442|NCT01323387|464595074|FG000|Overall Study|Radiographic Data Unavailable|1|||
129083443|NCT01323387|464595074|FG000|Overall Study|Revision|14|||
129083444|NCT01323387|464595074|FG000|Overall Study|Protocol Violation|12|||
129083445|NCT01323387|464595074|FG000|Overall Study|Randomized but Never Treated|16|||
129083446|NCT01726270|464595075|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
129083447|NCT01726270|464595075|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
129083448|NCT01726270|464595075|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
129083449|NCT01726270|464595075|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
129083450|NCT01726270|464595075|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
129083451|NCT01726270|464595075|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
129083452|NCT00582608|464595076|FG000|Overall Study|Not Treated|7|||
129083453|NCT00582608|464595076|FG000|Overall Study|Patient Ineligible|1|||
129083454|NCT00582608|464595076|FG000|Overall Study|Lack of accrual|4|||
129083455|NCT02073929|464595092|FG000|Overall Study|Lost to Follow-up|2|||
129083456|NCT02073929|464595093|FG001|Overall Study|Lost to Follow-up|1|||
129083457|NCT02073929|464595092|FG000|Overall Study|Adverse Event|2|||
129083458|NCT02073929|464595093|FG001|Overall Study|Adverse Event|1|||
129083459|NCT02073929|464595092|FG000|Overall Study|Withdrawal by Subject|0|||
129083460|NCT02073929|464595093|FG001|Overall Study|Withdrawal by Subject|1|||
129083461|NCT03319732|464595097|FG000|Overall Study|Adverse Event|40|||
129083462|NCT03319732|464595097|FG000|Overall Study|Withdrawal by Subject|50|||
129083463|NCT03319732|464595097|FG000|Overall Study|MS relapse|10|||
129083464|NCT03319732|464595097|FG000|Overall Study|reason not specified|5|||
129083465|NCT00767455|464595098|FG000|Overall Study|Investigator error|19|||
129083466|NCT00430573|464595099|FG000|Overall Study|Withdrawal by Subject|5|||
129083467|NCT04463251|464595102|FG000|Overall Study|Death|1|||
129083468|NCT04463251|464595103|FG001|Overall Study|Death|0|||
129083469|NCT04463251|464595104|FG002|Overall Study|Death|1|||
129142809|NCT01272219|464817171|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129142810|NCT01272219|464817172|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129142811|NCT01272219|464817173|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129142812|NCT01272219|464817174|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
129142813|NCT01272219|464817175|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
129142814|NCT01272219|464817170|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129142815|NCT01272219|464817171|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129142816|NCT01272219|464817172|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129142817|NCT01272219|464817173|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129142818|NCT01272219|464817174|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
129142819|NCT01272219|464817175|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
129142820|NCT01272219|464817170|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
129142821|NCT01272219|464817171|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
129142822|NCT01272219|464817172|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
129142823|NCT01272219|464817173|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
129142824|NCT01272219|464817174|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
129142825|NCT01272219|464817175|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
129142826|NCT01272219|464817170|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
129142827|NCT01272219|464817171|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
129142828|NCT01272219|464817172|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
129142829|NCT01272219|464817173|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
129142830|NCT01272219|464817174|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
129142831|NCT01272219|464817175|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
128724249|NCT03735667|463289019|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
129083470|NCT04463251|464595102|FG000|Overall Study|Adverse Event|0|||
129083471|NCT04463251|464595103|FG001|Overall Study|Adverse Event|1|||
129083472|NCT04463251|464595104|FG002|Overall Study|Adverse Event|0|||
129083473|NCT04463251|464595102|FG000|Overall Study|Lost to Follow-up|0|||
129083474|NCT04463251|464595103|FG001|Overall Study|Lost to Follow-up|1|||
129083475|NCT04463251|464595104|FG002|Overall Study|Lost to Follow-up|0|||
129083476|NCT04463251|464595102|FG000|Overall Study|Withdrawal by Subject|0|||
129083477|NCT04463251|464595103|FG001|Overall Study|Withdrawal by Subject|2|||
129083478|NCT04463251|464595104|FG002|Overall Study|Withdrawal by Subject|2|||
129083479|NCT05020665|464595105|FG000|Overall Study|Study terminated by Sponsor|5|||
129083480|NCT05020665|464595106|FG001|Overall Study|Study terminated by Sponsor|4|||
129083481|NCT05020665|464595105|FG000|Overall Study|Death|2|||
129083482|NCT05020665|464595106|FG001|Overall Study|Death|1|||
129083483|NCT05020665|464595105|FG000|Overall Study|Physician Decision|0|||
129142832|NCT03131479|464817176|FG000|Overall Study|Adverse Event|0|||
129142833|NCT03131479|464817177|FG001|Overall Study|Adverse Event|0|||
129142834|NCT03131479|464817178|FG002|Overall Study|Adverse Event|1|||
129142835|NCT03131479|464817179|FG003|Overall Study|Adverse Event|1|||
129142836|NCT03131479|464817180|FG004|Overall Study|Adverse Event|0|||
129142837|NCT03131479|464817176|FG000|Overall Study|Subject/Guardian Decision|0|||
129142838|NCT03131479|464817177|FG001|Overall Study|Subject/Guardian Decision|0|||
129142839|NCT03131479|464817178|FG002|Overall Study|Subject/Guardian Decision|0|||
129142840|NCT03131479|464817179|FG003|Overall Study|Subject/Guardian Decision|1|||
129142841|NCT03131479|464817180|FG004|Overall Study|Subject/Guardian Decision|0|||
129142842|NCT00050011|464817182|FG000|Overall Study|Adverse Event|41|||
129142843|NCT00050011|464817183|FG001|Overall Study|Adverse Event|46|||
129142844|NCT00050011|464817182|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128724250|NCT03735667|463289020|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
128724251|NCT03735667|463289018|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
129083484|NCT05020665|464595106|FG001|Overall Study|Physician Decision|1|||
129083485|NCT05020665|464595105|FG000|Overall Study|Withdrawal by Subject|0|||
129083486|NCT05020665|464595106|FG001|Overall Study|Withdrawal by Subject|1|||
129083487|NCT05020665|464595105|FG000|Overall Study|Reason not specified|1|||
129083488|NCT05020665|464595106|FG001|Overall Study|Reason not specified|0|||
129083489|NCT03386994|464595107|FG000|Overall Study|Lung transplant|1|||
129083490|NCT03386994|464595107|FG000|Overall Study|Adverse Event|14|||
129083491|NCT03386994|464595107|FG000|Overall Study|Lost to Follow-up|4|||
129083492|NCT03386994|464595107|FG000|Overall Study|Withdrawal by Subject|3|||
129083493|NCT03386994|464595107|FG000|Overall Study|Death|16|||
129083494|NCT01732640|464595108|FG000|Overall Study|Adverse Event|0|||
129083495|NCT01732640|464595109|FG001|Overall Study|Adverse Event|1|||
129083496|NCT01732640|464595108|FG000|Overall Study|Death|0|||
129083497|NCT01732640|464595109|FG001|Overall Study|Death|1|||
129083498|NCT03070002|464595110|FG000|Follow up for 2 Years|Death|1|||
129083499|NCT02147158|464595111|FG000|Treatment Course 1|Adverse Event|1|||
129083500|NCT02147158|464595112|FG001|Treatment Course 1|Adverse Event|4|||
129083501|NCT02147158|464595113|FG002|Treatment Course 1|Adverse Event|3|||
129083502|NCT02147158|464595114|FG003|Treatment Course 1|Adverse Event|4|||
129083503|NCT02147158|464595115|FG004|Treatment Course 1|Adverse Event|1|||
129083504|NCT02147158|464595116|FG005|Treatment Course 1|Adverse Event|2|||
129142845|NCT00050011|464817183|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129142846|NCT00050011|464817182|FG000|Overall Study|Abnormal test procedure results|0|||
129142847|NCT00050011|464817183|FG001|Overall Study|Abnormal test procedure results|1|||
129142848|NCT00050011|464817182|FG000|Overall Study|Lack of Efficacy|16|||
129142849|NCT00050011|464817183|FG001|Overall Study|Lack of Efficacy|21|||
129142850|NCT00050011|464817182|FG000|Overall Study|Participant condition no longer required|1|||
129142851|NCT00050011|464817183|FG001|Overall Study|Participant condition no longer required|0|||
129142852|NCT00050011|464817182|FG000|Overall Study|Protocol Violation|4|||
129142853|NCT00050011|464817183|FG001|Overall Study|Protocol Violation|10|||
129142854|NCT00050011|464817182|FG000|Overall Study|Withdrawal by Subject|34|||
129142855|NCT00050011|464817183|FG001|Overall Study|Withdrawal by Subject|26|||
129142856|NCT00050011|464817182|FG000|Overall Study|Lost to Follow-up|7|||
129142857|NCT00050011|464817183|FG001|Overall Study|Lost to Follow-up|9|||
129142858|NCT00050011|464817182|FG000|Overall Study|Administrative problems|10|||
129142859|NCT00050011|464817183|FG001|Overall Study|Administrative problems|6|||
129142860|NCT00050011|464817182|FG000|Overall Study|Death|7|||
129142861|NCT00050011|464817183|FG001|Overall Study|Death|4|||
129142862|NCT00050011|464817182|FG000|Overall Study|Unknown - Reason is missing|0|||
129142863|NCT00050011|464817183|FG001|Overall Study|Unknown - Reason is missing|2|||
129142864|NCT04806373|464817185|FG000|Overall Study|Withdrawal by Subject|1|||
129142865|NCT04806373|464817186|FG001|Overall Study|Withdrawal by Subject|1|||
129142866|NCT05810597|464817187|FG000|Period 1|Adverse Event|2|||
129142867|NCT05810597|464817188|FG001|Period 1|Adverse Event|0|||
129142868|NCT05810597|464817187|FG000|Period 1|Physician Decision|1|||
129142869|NCT05810597|464817188|FG001|Period 1|Physician Decision|0|||
129142870|NCT05021224|464817191|FG000|Overall Study|Did not complete all survey items|4|||
129083505|NCT02147158|464595111|FG000|Treatment Course 1|Lost to Follow-up|2|||
129142871|NCT05021224|464817192|FG001|Overall Study|Did not complete all survey items|1|||
129142872|NCT05021224|464817193|FG002|Overall Study|Did not complete all survey items|0|||
129142873|NCT05021224|464817194|FG003|Overall Study|Did not complete all survey items|2|||
129142874|NCT02061085|464817197|FG000|Overall Study|Adverse Event|8|||
129142875|NCT04903093|464817202|FG000|Overall Study|Withdrawal by Subject|0|||
129142876|NCT04903093|464817203|FG001|Overall Study|Withdrawal by Subject|0|||
129142877|NCT04903093|464817204|FG002|Overall Study|Withdrawal by Subject|0|||
129142878|NCT04903093|464817205|FG003|Overall Study|Withdrawal by Subject|1|||
129083506|NCT02147158|464595112|FG001|Treatment Course 1|Lost to Follow-up|4|||
129083507|NCT02147158|464595113|FG002|Treatment Course 1|Lost to Follow-up|3|||
129083508|NCT02147158|464595114|FG003|Treatment Course 1|Lost to Follow-up|3|||
129083509|NCT02147158|464595115|FG004|Treatment Course 1|Lost to Follow-up|2|||
129083510|NCT02147158|464595116|FG005|Treatment Course 1|Lost to Follow-up|4|||
129083511|NCT02147158|464595111|FG000|Treatment Course 1|Protocol Violation|0|||
129142879|NCT04903093|464817206|FG004|Overall Study|Withdrawal by Subject|0|||
129142880|NCT04903093|464817207|FG005|Overall Study|Withdrawal by Subject|0|||
129083512|NCT02147158|464595112|FG001|Treatment Course 1|Protocol Violation|0|||
129083513|NCT02147158|464595113|FG002|Treatment Course 1|Protocol Violation|1|||
129083514|NCT02147158|464595114|FG003|Treatment Course 1|Protocol Violation|1|||
129083515|NCT02147158|464595115|FG004|Treatment Course 1|Protocol Violation|0|||
129083516|NCT02147158|464595116|FG005|Treatment Course 1|Protocol Violation|0|||
129083517|NCT02147158|464595111|FG000|Treatment Course 1|Withdrawal of Consent|1|||
129083518|NCT02147158|464595112|FG001|Treatment Course 1|Withdrawal of Consent|1|||
129083519|NCT02147158|464595113|FG002|Treatment Course 1|Withdrawal of Consent|1|||
129083520|NCT02147158|464595114|FG003|Treatment Course 1|Withdrawal of Consent|5|||
129083521|NCT02147158|464595115|FG004|Treatment Course 1|Withdrawal of Consent|3|||
129083522|NCT02147158|464595116|FG005|Treatment Course 1|Withdrawal of Consent|2|||
129083523|NCT02147158|464595111|FG000|Off-Treatment Interval 1|Adverse Event|1|||
129083524|NCT02147158|464595112|FG001|Off-Treatment Interval 1|Adverse Event|0|||
129083525|NCT02147158|464595113|FG002|Off-Treatment Interval 1|Adverse Event|0|||
129083526|NCT02147158|464595114|FG003|Off-Treatment Interval 1|Adverse Event|1|||
129083527|NCT02147158|464595115|FG004|Off-Treatment Interval 1|Adverse Event|0|||
129083528|NCT02147158|464595116|FG005|Off-Treatment Interval 1|Adverse Event|0|||
129083529|NCT02147158|464595111|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
129083530|NCT02147158|464595112|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
129083531|NCT02147158|464595113|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
129083532|NCT02147158|464595114|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
129083533|NCT02147158|464595115|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
129083534|NCT02147158|464595116|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
129083535|NCT02147158|464595111|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
129083536|NCT02147158|464595112|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
129083537|NCT02147158|464595113|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
129083538|NCT02147158|464595114|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
129083539|NCT02147158|464595115|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
129083540|NCT02147158|464595116|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
129083541|NCT02147158|464595111|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
129083542|NCT02147158|464595112|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
129083543|NCT02147158|464595113|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
129083544|NCT02147158|464595114|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
129083545|NCT02147158|464595115|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
129083546|NCT02147158|464595116|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
129083547|NCT02147158|464595111|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
129083548|NCT02147158|464595112|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
129083549|NCT02147158|464595113|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
129083550|NCT02147158|464595114|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
129083551|NCT02147158|464595115|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
129083552|NCT02147158|464595116|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
129083553|NCT02147158|464595111|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
129083554|NCT02147158|464595112|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
129083555|NCT02147158|464595113|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
129083556|NCT02147158|464595114|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
129083557|NCT02147158|464595115|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
129083558|NCT02147158|464595116|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
129083559|NCT02147158|464595111|FG000|Treatment Course 2|Adverse Event|0|||
129083560|NCT02147158|464595112|FG001|Treatment Course 2|Adverse Event|4|||
129083561|NCT02147158|464595113|FG002|Treatment Course 2|Adverse Event|2|||
129083562|NCT02147158|464595114|FG003|Treatment Course 2|Adverse Event|1|||
129083563|NCT02147158|464595115|FG004|Treatment Course 2|Adverse Event|0|||
129083564|NCT02147158|464595116|FG005|Treatment Course 2|Adverse Event|1|||
129083565|NCT02147158|464595111|FG000|Treatment Course 2|Withdrawal of Consent|0|||
129083566|NCT02147158|464595112|FG001|Treatment Course 2|Withdrawal of Consent|1|||
129083567|NCT02147158|464595113|FG002|Treatment Course 2|Withdrawal of Consent|2|||
129083568|NCT02147158|464595114|FG003|Treatment Course 2|Withdrawal of Consent|3|||
129083569|NCT02147158|464595115|FG004|Treatment Course 2|Withdrawal of Consent|0|||
129083570|NCT02147158|464595116|FG005|Treatment Course 2|Withdrawal of Consent|0|||
129083571|NCT02147158|464595111|FG000|Treatment Course 2|Lost to Follow-up|1|||
129083572|NCT02147158|464595112|FG001|Treatment Course 2|Lost to Follow-up|0|||
129083573|NCT02147158|464595113|FG002|Treatment Course 2|Lost to Follow-up|1|||
129083574|NCT02147158|464595114|FG003|Treatment Course 2|Lost to Follow-up|1|||
128724252|NCT03735667|463289019|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
129083575|NCT02147158|464595115|FG004|Treatment Course 2|Lost to Follow-up|0|||
129083576|NCT02147158|464595116|FG005|Treatment Course 2|Lost to Follow-up|1|||
129083577|NCT02147158|464595111|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
129083578|NCT02147158|464595112|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
129083579|NCT02147158|464595113|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
129083580|NCT02147158|464595114|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
129083581|NCT02147158|464595115|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
129083582|NCT02147158|464595116|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
129083583|NCT02147158|464595111|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
129083584|NCT02147158|464595112|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
129083585|NCT02147158|464595113|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
129083586|NCT02147158|464595114|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
129083587|NCT02147158|464595115|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
129083588|NCT02147158|464595116|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
129083589|NCT02147158|464595111|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
129083590|NCT02147158|464595112|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
129083591|NCT02147158|464595113|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
129083592|NCT02147158|464595114|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
129083593|NCT02147158|464595115|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
129083594|NCT02147158|464595116|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
129083595|NCT02147158|464595111|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
129083596|NCT02147158|464595112|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
129083597|NCT02147158|464595113|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
129083598|NCT02147158|464595114|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
129083599|NCT02147158|464595115|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
129083600|NCT02147158|464595116|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
129083601|NCT02147158|464595111|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
129083602|NCT02147158|464595112|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
129083603|NCT02147158|464595113|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
129083604|NCT02147158|464595114|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
129083605|NCT02147158|464595115|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
129083606|NCT02147158|464595116|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
129083607|NCT03425396|464595117|FG000|Overall Study|Lost to Follow-up|2|||
129083608|NCT03425396|464595118|FG001|Overall Study|Lost to Follow-up|5|||
129083609|NCT03425396|464595119|FG002|Overall Study|Lost to Follow-up|2|||
129083610|NCT03425396|464595120|FG003|Overall Study|Lost to Follow-up|0|||
129083611|NCT03425396|464595121|FG004|Overall Study|Lost to Follow-up|0|||
129083612|NCT03425396|464595117|FG000|Overall Study|Withdrawal by Subject|0|||
129083613|NCT03425396|464595118|FG001|Overall Study|Withdrawal by Subject|1|||
129083614|NCT03425396|464595119|FG002|Overall Study|Withdrawal by Subject|0|||
129083615|NCT03425396|464595120|FG003|Overall Study|Withdrawal by Subject|1|||
129083616|NCT03425396|464595121|FG004|Overall Study|Withdrawal by Subject|0|||
129083617|NCT03425396|464595117|FG000|Overall Study|Other|0|||
129083618|NCT03425396|464595118|FG001|Overall Study|Other|1|||
129083619|NCT03425396|464595119|FG002|Overall Study|Other|1|||
129083620|NCT03425396|464595120|FG003|Overall Study|Other|0|||
129083621|NCT03425396|464595121|FG004|Overall Study|Other|1|||
129083622|NCT01441765|464595123|FG000|Overall Study|Death|1|||
129083623|NCT01441765|464595124|FG001|Overall Study|Death|0|||
129083624|NCT04520997|464595125|FG000|Overall Study|Lost to Follow-up|1|||
129083625|NCT04520997|464595126|FG001|Overall Study|Lost to Follow-up|1|||
129083626|NCT04520997|464595125|FG000|Overall Study|Withdrawal by Subject|1|||
129083627|NCT04520997|464595126|FG001|Overall Study|Withdrawal by Subject|0|||
129083628|NCT04520997|464595125|FG000|Overall Study|Not Treated|0|||
129083629|NCT04520997|464595126|FG001|Overall Study|Not Treated|1|||
129083630|NCT02981082|464595129|FG000|Overall Study|Withdrawal by Subject|2|||
129083631|NCT02981082|464595130|FG001|Overall Study|Withdrawal by Subject|0|||
129083632|NCT02981082|464595129|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
129083633|NCT02981082|464595130|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
129083634|NCT02981082|464595129|FG000|Overall Study|Adverse Event|0|||
129083635|NCT02981082|464595130|FG001|Overall Study|Adverse Event|1|||
129083636|NCT03689374|464595131|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
129083637|NCT03689374|464595132|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
129083638|NCT03689374|464595133|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
129083639|NCT03689374|464595131|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
129083640|NCT03689374|464595132|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
129083641|NCT03689374|464595133|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
129083642|NCT03689374|464595131|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
129083643|NCT03689374|464595132|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
129083644|NCT03689374|464595133|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
129083645|NCT03689374|464595131|FG000|Treatment Period (Week 0 to 52)|Death|0|||
129083646|NCT03689374|464595132|FG001|Treatment Period (Week 0 to 52)|Death|11|||
129083647|NCT03689374|464595133|FG002|Treatment Period (Week 0 to 52)|Death|1|||
129083648|NCT05367973|464595134|FG000|Overall Study|Adverse Event|0|||
129083649|NCT05367973|464595135|FG001|Overall Study|Adverse Event|2|||
129083650|NCT02805660|464595136|FG000|Overall Study|Death|5|||
129083651|NCT02805660|464595137|FG001|Overall Study|Death|2|||
129083652|NCT02805660|464595138|FG002|Overall Study|Death|9|||
129083653|NCT02805660|464595139|FG003|Overall Study|Death|5|||
129083654|NCT02805660|464595140|FG004|Overall Study|Death|0|||
129083655|NCT02805660|464595141|FG005|Overall Study|Death|14|||
129083656|NCT02805660|464595142|FG006|Overall Study|Death|12|||
129083657|NCT02805660|464595136|FG000|Overall Study|Lost to Follow-up|0|||
129083658|NCT02805660|464595137|FG001|Overall Study|Lost to Follow-up|1|||
129083659|NCT02805660|464595138|FG002|Overall Study|Lost to Follow-up|1|||
129083660|NCT02805660|464595139|FG003|Overall Study|Lost to Follow-up|2|||
129083661|NCT02805660|464595140|FG004|Overall Study|Lost to Follow-up|0|||
129083662|NCT02805660|464595141|FG005|Overall Study|Lost to Follow-up|0|||
129083663|NCT02805660|464595142|FG006|Overall Study|Lost to Follow-up|0|||
129083664|NCT02805660|464595136|FG000|Overall Study|Withdrawal by Subject|0|||
129083665|NCT02805660|464595137|FG001|Overall Study|Withdrawal by Subject|0|||
129083666|NCT02805660|464595138|FG002|Overall Study|Withdrawal by Subject|0|||
129083667|NCT02805660|464595139|FG003|Overall Study|Withdrawal by Subject|3|||
129083668|NCT02805660|464595140|FG004|Overall Study|Withdrawal by Subject|1|||
129083669|NCT02805660|464595141|FG005|Overall Study|Withdrawal by Subject|0|||
129083670|NCT02805660|464595142|FG006|Overall Study|Withdrawal by Subject|2|||
129083671|NCT02805660|464595136|FG000|Overall Study|Study terminated by Sponsor|0|||
129083672|NCT02805660|464595137|FG001|Overall Study|Study terminated by Sponsor|0|||
129083673|NCT02805660|464595138|FG002|Overall Study|Study terminated by Sponsor|1|||
129083674|NCT02805660|464595139|FG003|Overall Study|Study terminated by Sponsor|4|||
129083675|NCT02805660|464595140|FG004|Overall Study|Study terminated by Sponsor|2|||
129083676|NCT02805660|464595141|FG005|Overall Study|Study terminated by Sponsor|3|||
129083677|NCT02805660|464595142|FG006|Overall Study|Study terminated by Sponsor|1|||
129083678|NCT02805660|464595136|FG000|Overall Study|Miscellaneous|0|||
129083679|NCT02805660|464595137|FG001|Overall Study|Miscellaneous|1|||
129083680|NCT02805660|464595138|FG002|Overall Study|Miscellaneous|0|||
129083681|NCT02805660|464595139|FG003|Overall Study|Miscellaneous|4|||
129083682|NCT02805660|464595140|FG004|Overall Study|Miscellaneous|0|||
129083683|NCT02805660|464595141|FG005|Overall Study|Miscellaneous|6|||
129083684|NCT02805660|464595142|FG006|Overall Study|Miscellaneous|4|||
129083685|NCT01314872|464595146|FG000|Treatment Period 1|Protocol Violation|2|||
129083686|NCT01314872|464595147|FG001|Treatment Period 1|Protocol Violation|1|||
129083687|NCT01314872|464595148|FG002|Treatment Period 1|Protocol Violation|1|||
129083688|NCT01314872|464595149|FG003|Treatment Period 1|Protocol Violation|0|||
129083689|NCT01314872|464595150|FG004|Treatment Period 1|Protocol Violation|1|||
129083690|NCT01314872|464595151|FG005|Treatment Period 1|Protocol Violation|0|||
129083691|NCT01314872|464595152|FG006|Treatment Period 1|Protocol Violation|0|||
129083692|NCT01314872|464595153|FG007|Treatment Period 1|Protocol Violation|0|||
129083693|NCT01314872|464595154|FG008|Treatment Period 1|Protocol Violation|0|||
129083694|NCT01314872|464595155|FG009|Treatment Period 1|Protocol Violation|1|||
129083695|NCT01314872|464595156|FG010|Treatment Period 1|Protocol Violation|1|||
129083696|NCT01314872|464595157|FG011|Treatment Period 1|Protocol Violation|0|||
129083697|NCT01314872|464595158|FG012|Treatment Period 1|Protocol Violation|0|||
129083698|NCT01314872|464595159|FG013|Treatment Period 1|Protocol Violation|0|||
129083699|NCT01314872|464595160|FG014|Treatment Period 1|Protocol Violation|0|||
129083700|NCT01314872|464595146|FG000|Treatment Period 1|Physician Decision|0|||
129083701|NCT01314872|464595147|FG001|Treatment Period 1|Physician Decision|1|||
129083702|NCT01314872|464595148|FG002|Treatment Period 1|Physician Decision|0|||
129083703|NCT01314872|464595149|FG003|Treatment Period 1|Physician Decision|1|||
129083704|NCT01314872|464595150|FG004|Treatment Period 1|Physician Decision|0|||
129083705|NCT01314872|464595151|FG005|Treatment Period 1|Physician Decision|0|||
129083706|NCT01314872|464595152|FG006|Treatment Period 1|Physician Decision|0|||
129083707|NCT01314872|464595153|FG007|Treatment Period 1|Physician Decision|0|||
129083708|NCT01314872|464595154|FG008|Treatment Period 1|Physician Decision|0|||
129083709|NCT01314872|464595155|FG009|Treatment Period 1|Physician Decision|1|||
129083710|NCT01314872|464595156|FG010|Treatment Period 1|Physician Decision|0|||
129083711|NCT01314872|464595157|FG011|Treatment Period 1|Physician Decision|0|||
129083712|NCT01314872|464595158|FG012|Treatment Period 1|Physician Decision|0|||
129083713|NCT01314872|464595159|FG013|Treatment Period 1|Physician Decision|0|||
129083714|NCT01314872|464595160|FG014|Treatment Period 1|Physician Decision|0|||
129083715|NCT01314872|464595146|FG000|Treatment Period 1|Lack of Efficacy|1|||
128724253|NCT03735667|463289020|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
128724254|NCT03735667|463289018|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
128724255|NCT03735667|463289019|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
128724256|NCT03735667|463289020|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
128724257|NCT03735667|463289018|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
128724258|NCT03735667|463289019|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
129083716|NCT01314872|464595147|FG001|Treatment Period 1|Lack of Efficacy|0|||
129083717|NCT01314872|464595148|FG002|Treatment Period 1|Lack of Efficacy|0|||
129083718|NCT01314872|464595149|FG003|Treatment Period 1|Lack of Efficacy|0|||
129083719|NCT01314872|464595150|FG004|Treatment Period 1|Lack of Efficacy|0|||
129083720|NCT01314872|464595151|FG005|Treatment Period 1|Lack of Efficacy|1|||
129083721|NCT01314872|464595152|FG006|Treatment Period 1|Lack of Efficacy|0|||
129083722|NCT01314872|464595153|FG007|Treatment Period 1|Lack of Efficacy|2|||
129083723|NCT01314872|464595154|FG008|Treatment Period 1|Lack of Efficacy|0|||
129083724|NCT01314872|464595155|FG009|Treatment Period 1|Lack of Efficacy|0|||
129083725|NCT01314872|464595156|FG010|Treatment Period 1|Lack of Efficacy|0|||
129083726|NCT01314872|464595157|FG011|Treatment Period 1|Lack of Efficacy|0|||
129083727|NCT01314872|464595158|FG012|Treatment Period 1|Lack of Efficacy|0|||
129083728|NCT01314872|464595159|FG013|Treatment Period 1|Lack of Efficacy|0|||
129142881|NCT02412436|464817208|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
129142882|NCT02412436|464817208|FG000|Overall Study|Lost to Follow-up|6|||
129142883|NCT02412436|464817208|FG000|Overall Study|Unable to get to clinic|3|||
129142884|NCT02412436|464817208|FG000|Overall Study|Death|1|||
129142885|NCT02412436|464817208|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
129142886|NCT02184442|464817214|FG000|Overall Study|Death|61|||
129142887|NCT02184442|464817215|FG001|Overall Study|Death|65|||
129142888|NCT02184442|464817214|FG000|Overall Study|Withdrawal by Subject|3|||
129142889|NCT02184442|464817215|FG001|Overall Study|Withdrawal by Subject|11|||
129142890|NCT01852214|464817216|FG000|Period 1|Adverse Event|1|||
129142891|NCT01852214|464817217|FG001|Period 1|Adverse Event|2|||
129142892|NCT01852214|464817216|FG000|Period 1|Withdrawal by Subject|0|||
129142893|NCT01852214|464817217|FG001|Period 1|Withdrawal by Subject|1|||
129142894|NCT01852214|464817216|FG000|Washout Period|Withdrawal by Subject|0|||
129142895|NCT01852214|464817217|FG001|Washout Period|Withdrawal by Subject|1|||
129142896|NCT04091438|464817218|FG000|Treatment Period 1 (1 Day)|Other|1|||
129142897|NCT04091438|464817219|FG001|Treatment Period 1 (1 Day)|Other|0|||
129142898|NCT04091438|464817218|FG000|Washout Period (1 Day)|Protocol deviation|0|||
129142899|NCT04091438|464817219|FG001|Washout Period (1 Day)|Protocol deviation|1|||
129142900|NCT04091438|464817218|FG000|Washout Period (1 Day)|Other|0|||
129142901|NCT04091438|464817219|FG001|Washout Period (1 Day)|Other|1|||
129142902|NCT00421408|464817220|FG000|Overall Study|Lost to Follow-up|30|||
129142903|NCT00421408|464817221|FG001|Overall Study|Lost to Follow-up|20|||
129142904|NCT00421408|464817220|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
129142905|NCT00421408|464817221|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
129142906|NCT03249558|464817228|FG000|Overall Study|Lost to Follow-up|2|||
129142907|NCT03249558|464817229|FG001|Overall Study|Lost to Follow-up|1|||
129142908|NCT03249558|464817230|FG002|Overall Study|Lost to Follow-up|4|||
129142909|NCT03249558|464817228|FG000|Overall Study|Physician Decision|1|||
129142910|NCT03249558|464817229|FG001|Overall Study|Physician Decision|0|||
129142911|NCT03249558|464817230|FG002|Overall Study|Physician Decision|0|||
129142912|NCT03249558|464817228|FG000|Overall Study|Withdrawal by Subject|6|||
129142913|NCT03249558|464817229|FG001|Overall Study|Withdrawal by Subject|5|||
129142914|NCT03249558|464817230|FG002|Overall Study|Withdrawal by Subject|7|||
129142915|NCT03249558|464817228|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
129142916|NCT03249558|464817229|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
129142917|NCT03249558|464817230|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
129142918|NCT03249558|464817228|FG000|Overall Study|Protocol Violation|1|||
129142919|NCT03249558|464817229|FG001|Overall Study|Protocol Violation|1|||
129142920|NCT03249558|464817230|FG002|Overall Study|Protocol Violation|2|||
129142921|NCT02613507|464817232|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
129142922|NCT02613507|464817233|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
129142923|NCT02613507|464817232|FG000|Pre-Treamtent|Participant withdrew consent|0|||
129142924|NCT02613507|464817233|FG001|Pre-Treamtent|Participant withdrew consent|4|||
129142925|NCT02613507|464817232|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
129142926|NCT02613507|464817233|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
129142927|NCT02613507|464817232|FG000|Treatment|Not reported|3|||
129142928|NCT02613507|464817233|FG001|Treatment|Not reported|0|||
129142929|NCT02613507|464817232|FG000|Treatment|Other reasons|8|||
129142930|NCT02613507|464817233|FG001|Treatment|Other reasons|0|||
129142931|NCT02613507|464817232|FG000|Treatment|Participant no longer meets criteria|3|||
129142932|NCT02613507|464817233|FG001|Treatment|Participant no longer meets criteria|0|||
129142933|NCT02613507|464817232|FG000|Treatment|Maximum clinical benefit|5|||
129142934|NCT02613507|464817233|FG001|Treatment|Maximum clinical benefit|10|||
129142935|NCT02613507|464817232|FG000|Treatment|Lost to Follow-up|1|||
129142936|NCT02613507|464817233|FG001|Treatment|Lost to Follow-up|0|||
129142937|NCT02613507|464817232|FG000|Treatment|Participant withdrew consent|0|||
129142938|NCT02613507|464817233|FG001|Treatment|Participant withdrew consent|2|||
129142939|NCT02613507|464817232|FG000|Treatment|Participant request to discontinue study treatment|13|||
129142940|NCT02613507|464817233|FG001|Treatment|Participant request to discontinue study treatment|17|||
129142941|NCT02613507|464817232|FG000|Treatment|Adverse event unrelated to study drug|20|||
129142942|NCT02613507|464817233|FG001|Treatment|Adverse event unrelated to study drug|3|||
129142943|NCT02613507|464817232|FG000|Treatment|Death|2|||
129142944|NCT02613507|464817233|FG001|Treatment|Death|0|||
129142945|NCT02613507|464817232|FG000|Treatment|Study drug toxicity|19|||
129142946|NCT02613507|464817233|FG001|Treatment|Study drug toxicity|14|||
129142947|NCT02613507|464817232|FG000|Treatment|Disease progression|263|||
128724259|NCT03735667|463289020|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
129142948|NCT02613507|464817233|FG001|Treatment|Disease progression|110|||
129142949|NCT03941093|464817234|FG000|Overall Study|Protocol Violation|0|||
129142950|NCT03941093|464817235|FG001|Overall Study|Protocol Violation|1|||
129142951|NCT03941093|464817234|FG000|Overall Study|Withdrawal by Subject|9|||
129142952|NCT03941093|464817235|FG001|Overall Study|Withdrawal by Subject|6|||
129142953|NCT00561821|464817237|FG000|Overall Study|Not treated|0|||
129142954|NCT00561821|464817238|FG001|Overall Study|Not treated|0|||
129142955|NCT00561821|464817239|FG002|Overall Study|Not treated|1|||
128724260|NCT03735667|463289018|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
129083729|NCT01314872|464595160|FG014|Treatment Period 1|Lack of Efficacy|0|||
129083730|NCT01314872|464595146|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
129083731|NCT01314872|464595147|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
129083732|NCT01314872|464595148|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
129083733|NCT01314872|464595149|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
129083734|NCT01314872|464595150|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
129083735|NCT01314872|464595151|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
129083736|NCT01314872|464595152|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
129083737|NCT01314872|464595153|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
129083738|NCT01314872|464595154|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
129083739|NCT01314872|464595155|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
129083740|NCT01314872|464595156|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
129083741|NCT01314872|464595157|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
129083742|NCT01314872|464595158|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
129083743|NCT01314872|464595159|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
129083744|NCT01314872|464595160|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
129083745|NCT01314872|464595146|FG000|Treatment Period 1|Withdrawal by Subject|3|||
129083746|NCT01314872|464595147|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129083747|NCT01314872|464595148|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129083748|NCT01314872|464595149|FG003|Treatment Period 1|Withdrawal by Subject|2|||
129083749|NCT01314872|464595150|FG004|Treatment Period 1|Withdrawal by Subject|3|||
129083750|NCT01314872|464595151|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129083751|NCT01314872|464595152|FG006|Treatment Period 1|Withdrawal by Subject|3|||
129083752|NCT01314872|464595153|FG007|Treatment Period 1|Withdrawal by Subject|2|||
129083753|NCT01314872|464595154|FG008|Treatment Period 1|Withdrawal by Subject|2|||
129083754|NCT01314872|464595155|FG009|Treatment Period 1|Withdrawal by Subject|2|||
129083755|NCT01314872|464595156|FG010|Treatment Period 1|Withdrawal by Subject|1|||
129083756|NCT01314872|464595157|FG011|Treatment Period 1|Withdrawal by Subject|0|||
129083757|NCT01314872|464595158|FG012|Treatment Period 1|Withdrawal by Subject|0|||
129083758|NCT01314872|464595159|FG013|Treatment Period 1|Withdrawal by Subject|0|||
129083759|NCT01314872|464595160|FG014|Treatment Period 1|Withdrawal by Subject|0|||
129083760|NCT01314872|464595146|FG000|Treatment Period 1|Lost to Follow-up|0|||
129083761|NCT01314872|464595147|FG001|Treatment Period 1|Lost to Follow-up|1|||
129083762|NCT01314872|464595148|FG002|Treatment Period 1|Lost to Follow-up|2|||
129083763|NCT01314872|464595149|FG003|Treatment Period 1|Lost to Follow-up|2|||
129083764|NCT01314872|464595150|FG004|Treatment Period 1|Lost to Follow-up|1|||
129083765|NCT01314872|464595151|FG005|Treatment Period 1|Lost to Follow-up|1|||
129083766|NCT01314872|464595152|FG006|Treatment Period 1|Lost to Follow-up|1|||
129083767|NCT01314872|464595153|FG007|Treatment Period 1|Lost to Follow-up|1|||
129083768|NCT01314872|464595154|FG008|Treatment Period 1|Lost to Follow-up|1|||
129083769|NCT01314872|464595155|FG009|Treatment Period 1|Lost to Follow-up|0|||
129083770|NCT01314872|464595156|FG010|Treatment Period 1|Lost to Follow-up|0|||
129083771|NCT01314872|464595157|FG011|Treatment Period 1|Lost to Follow-up|0|||
129083772|NCT01314872|464595158|FG012|Treatment Period 1|Lost to Follow-up|0|||
129083773|NCT01314872|464595159|FG013|Treatment Period 1|Lost to Follow-up|0|||
129083774|NCT01314872|464595160|FG014|Treatment Period 1|Lost to Follow-up|0|||
129083775|NCT01314872|464595146|FG000|Period 2|Protocol Violation|0|||
129083776|NCT01314872|464595147|FG001|Period 2|Protocol Violation|0|||
129083777|NCT01314872|464595148|FG002|Period 2|Protocol Violation|0|||
129083778|NCT01314872|464595149|FG003|Period 2|Protocol Violation|0|||
129083779|NCT01314872|464595150|FG004|Period 2|Protocol Violation|0|||
129083780|NCT01314872|464595151|FG005|Period 2|Protocol Violation|0|||
129083781|NCT01314872|464595152|FG006|Period 2|Protocol Violation|0|||
129083782|NCT01314872|464595153|FG007|Period 2|Protocol Violation|0|||
129083783|NCT01314872|464595154|FG008|Period 2|Protocol Violation|0|||
129083784|NCT01314872|464595155|FG009|Period 2|Protocol Violation|0|||
129083785|NCT01314872|464595156|FG010|Period 2|Protocol Violation|0|||
129083786|NCT01314872|464595157|FG011|Period 2|Protocol Violation|3|||
129083787|NCT01314872|464595158|FG012|Period 2|Protocol Violation|3|||
129083788|NCT01314872|464595159|FG013|Period 2|Protocol Violation|2|||
129083789|NCT01314872|464595160|FG014|Period 2|Protocol Violation|0|||
129083790|NCT01314872|464595146|FG000|Period 2|Non-compliance with study drug|0|||
129083791|NCT01314872|464595147|FG001|Period 2|Non-compliance with study drug|0|||
129083792|NCT01314872|464595148|FG002|Period 2|Non-compliance with study drug|0|||
129083793|NCT01314872|464595149|FG003|Period 2|Non-compliance with study drug|0|||
129083794|NCT01314872|464595150|FG004|Period 2|Non-compliance with study drug|0|||
129083795|NCT01314872|464595151|FG005|Period 2|Non-compliance with study drug|0|||
129083796|NCT01314872|464595152|FG006|Period 2|Non-compliance with study drug|0|||
129083797|NCT01314872|464595153|FG007|Period 2|Non-compliance with study drug|0|||
129083798|NCT01314872|464595154|FG008|Period 2|Non-compliance with study drug|0|||
129083799|NCT01314872|464595155|FG009|Period 2|Non-compliance with study drug|0|||
129083800|NCT01314872|464595156|FG010|Period 2|Non-compliance with study drug|0|||
129083801|NCT01314872|464595157|FG011|Period 2|Non-compliance with study drug|3|||
129083802|NCT01314872|464595158|FG012|Period 2|Non-compliance with study drug|3|||
129083803|NCT01314872|464595159|FG013|Period 2|Non-compliance with study drug|1|||
129083804|NCT01314872|464595160|FG014|Period 2|Non-compliance with study drug|2|||
129083805|NCT01314872|464595146|FG000|Period 2|Lack of Efficacy|0|||
129083806|NCT01314872|464595147|FG001|Period 2|Lack of Efficacy|0|||
129083807|NCT01314872|464595148|FG002|Period 2|Lack of Efficacy|0|||
129083808|NCT01314872|464595149|FG003|Period 2|Lack of Efficacy|0|||
129083809|NCT01314872|464595150|FG004|Period 2|Lack of Efficacy|0|||
129083810|NCT01314872|464595151|FG005|Period 2|Lack of Efficacy|0|||
129083811|NCT01314872|464595152|FG006|Period 2|Lack of Efficacy|0|||
129083812|NCT01314872|464595153|FG007|Period 2|Lack of Efficacy|0|||
129083813|NCT01314872|464595154|FG008|Period 2|Lack of Efficacy|0|||
129083814|NCT01314872|464595155|FG009|Period 2|Lack of Efficacy|0|||
129083815|NCT01314872|464595156|FG010|Period 2|Lack of Efficacy|0|||
129083816|NCT01314872|464595157|FG011|Period 2|Lack of Efficacy|7|||
129083817|NCT01314872|464595158|FG012|Period 2|Lack of Efficacy|12|||
129083818|NCT01314872|464595159|FG013|Period 2|Lack of Efficacy|9|||
129083819|NCT01314872|464595160|FG014|Period 2|Lack of Efficacy|2|||
129083820|NCT01314872|464595146|FG000|Period 2|Pregnancy|0|||
129083821|NCT01314872|464595147|FG001|Period 2|Pregnancy|0|||
129083822|NCT01314872|464595148|FG002|Period 2|Pregnancy|0|||
129083823|NCT01314872|464595149|FG003|Period 2|Pregnancy|0|||
129083824|NCT01314872|464595150|FG004|Period 2|Pregnancy|0|||
129083825|NCT01314872|464595151|FG005|Period 2|Pregnancy|0|||
129083826|NCT01314872|464595152|FG006|Period 2|Pregnancy|0|||
129083827|NCT01314872|464595153|FG007|Period 2|Pregnancy|0|||
129083828|NCT01314872|464595154|FG008|Period 2|Pregnancy|0|||
129083829|NCT01314872|464595155|FG009|Period 2|Pregnancy|0|||
129083830|NCT01314872|464595156|FG010|Period 2|Pregnancy|0|||
129083831|NCT01314872|464595157|FG011|Period 2|Pregnancy|0|||
129083832|NCT01314872|464595158|FG012|Period 2|Pregnancy|0|||
129083833|NCT01314872|464595159|FG013|Period 2|Pregnancy|0|||
129083834|NCT01314872|464595160|FG014|Period 2|Pregnancy|1|||
129083835|NCT01314872|464595146|FG000|Period 2|Study terminated by Sponsor|0|||
129083836|NCT01314872|464595147|FG001|Period 2|Study terminated by Sponsor|0|||
129083837|NCT01314872|464595148|FG002|Period 2|Study terminated by Sponsor|0|||
129083838|NCT01314872|464595149|FG003|Period 2|Study terminated by Sponsor|0|||
129083839|NCT01314872|464595150|FG004|Period 2|Study terminated by Sponsor|0|||
129083840|NCT01314872|464595151|FG005|Period 2|Study terminated by Sponsor|0|||
129083841|NCT01314872|464595152|FG006|Period 2|Study terminated by Sponsor|0|||
129083842|NCT01314872|464595153|FG007|Period 2|Study terminated by Sponsor|0|||
129083843|NCT01314872|464595154|FG008|Period 2|Study terminated by Sponsor|0|||
129083844|NCT01314872|464595155|FG009|Period 2|Study terminated by Sponsor|0|||
129083845|NCT01314872|464595156|FG010|Period 2|Study terminated by Sponsor|0|||
129083846|NCT01314872|464595157|FG011|Period 2|Study terminated by Sponsor|2|||
129083847|NCT01314872|464595158|FG012|Period 2|Study terminated by Sponsor|2|||
129083848|NCT01314872|464595159|FG013|Period 2|Study terminated by Sponsor|3|||
129083849|NCT01314872|464595160|FG014|Period 2|Study terminated by Sponsor|0|||
129083850|NCT01314872|464595146|FG000|Period 2|Adverse event, non-fatal|0|||
129083851|NCT01314872|464595147|FG001|Period 2|Adverse event, non-fatal|0|||
129083852|NCT01314872|464595148|FG002|Period 2|Adverse event, non-fatal|0|||
129083853|NCT01314872|464595149|FG003|Period 2|Adverse event, non-fatal|0|||
129083854|NCT01314872|464595150|FG004|Period 2|Adverse event, non-fatal|0|||
129083855|NCT01314872|464595151|FG005|Period 2|Adverse event, non-fatal|0|||
129083856|NCT01314872|464595152|FG006|Period 2|Adverse event, non-fatal|0|||
129083857|NCT01314872|464595153|FG007|Period 2|Adverse event, non-fatal|0|||
129083858|NCT01314872|464595154|FG008|Period 2|Adverse event, non-fatal|0|||
129083859|NCT01314872|464595155|FG009|Period 2|Adverse event, non-fatal|0|||
129142956|NCT00561821|464817240|FG003|Overall Study|Not treated|0|||
129083860|NCT01314872|464595156|FG010|Period 2|Adverse event, non-fatal|0|||
129142957|NCT00561821|464817237|FG000|Overall Study|Withdrawal by Subject|0|||
129083861|NCT01314872|464595157|FG011|Period 2|Adverse event, non-fatal|13|||
129083862|NCT01314872|464595158|FG012|Period 2|Adverse event, non-fatal|16|||
129142958|NCT00561821|464817238|FG001|Overall Study|Withdrawal by Subject|1|||
129142959|NCT00561821|464817239|FG002|Overall Study|Withdrawal by Subject|0|||
129083863|NCT01314872|464595159|FG013|Period 2|Adverse event, non-fatal|24|||
129083864|NCT01314872|464595160|FG014|Period 2|Adverse event, non-fatal|9|||
129083865|NCT01314872|464595146|FG000|Period 2|Withdrawal by Subject|0|||
129083866|NCT01314872|464595147|FG001|Period 2|Withdrawal by Subject|0|||
129083867|NCT01314872|464595148|FG002|Period 2|Withdrawal by Subject|0|||
129083868|NCT01314872|464595149|FG003|Period 2|Withdrawal by Subject|0|||
129083869|NCT01314872|464595150|FG004|Period 2|Withdrawal by Subject|0|||
129083870|NCT01314872|464595151|FG005|Period 2|Withdrawal by Subject|0|||
129083871|NCT01314872|464595152|FG006|Period 2|Withdrawal by Subject|0|||
129083872|NCT01314872|464595153|FG007|Period 2|Withdrawal by Subject|0|||
129083873|NCT01314872|464595154|FG008|Period 2|Withdrawal by Subject|0|||
129083874|NCT01314872|464595155|FG009|Period 2|Withdrawal by Subject|0|||
129083875|NCT01314872|464595156|FG010|Period 2|Withdrawal by Subject|0|||
129083876|NCT01314872|464595157|FG011|Period 2|Withdrawal by Subject|14|||
129083877|NCT01314872|464595158|FG012|Period 2|Withdrawal by Subject|17|||
129083878|NCT01314872|464595159|FG013|Period 2|Withdrawal by Subject|12|||
129083879|NCT01314872|464595160|FG014|Period 2|Withdrawal by Subject|4|||
129083880|NCT01314872|464595146|FG000|Period 2|Lost to Follow-up|0|||
129083881|NCT01314872|464595147|FG001|Period 2|Lost to Follow-up|0|||
129083882|NCT01314872|464595148|FG002|Period 2|Lost to Follow-up|0|||
129083883|NCT01314872|464595149|FG003|Period 2|Lost to Follow-up|0|||
129083884|NCT01314872|464595150|FG004|Period 2|Lost to Follow-up|0|||
129083885|NCT01314872|464595151|FG005|Period 2|Lost to Follow-up|0|||
129083886|NCT01314872|464595152|FG006|Period 2|Lost to Follow-up|0|||
129083887|NCT01314872|464595153|FG007|Period 2|Lost to Follow-up|0|||
129083888|NCT01314872|464595154|FG008|Period 2|Lost to Follow-up|0|||
129083889|NCT01314872|464595155|FG009|Period 2|Lost to Follow-up|0|||
129083890|NCT01314872|464595156|FG010|Period 2|Lost to Follow-up|0|||
129083891|NCT01314872|464595157|FG011|Period 2|Lost to Follow-up|6|||
129083892|NCT01314872|464595158|FG012|Period 2|Lost to Follow-up|7|||
129083893|NCT01314872|464595159|FG013|Period 2|Lost to Follow-up|2|||
129083894|NCT01314872|464595160|FG014|Period 2|Lost to Follow-up|6|||
129083895|NCT00809471|464596390|FG000|Overall Study|Protocol non-compliance|15|||
129083896|NCT00809471|464596391|FG001|Overall Study|Protocol non-compliance|15|||
129083897|NCT00809471|464596392|FG002|Overall Study|Protocol non-compliance|6|||
129083898|NCT00809471|464596390|FG000|Overall Study|Lost to Follow-up|4|||
129083899|NCT00809471|464596391|FG001|Overall Study|Lost to Follow-up|2|||
129083900|NCT00809471|464596392|FG002|Overall Study|Lost to Follow-up|9|||
129083901|NCT00809471|464596390|FG000|Overall Study|Adverse Event|0|||
129083902|NCT00809471|464596391|FG001|Overall Study|Adverse Event|2|||
129083903|NCT00809471|464596392|FG002|Overall Study|Adverse Event|2|||
129083904|NCT00809471|464596390|FG000|Overall Study|Requirement for restricted medication|1|||
129083905|NCT00809471|464596391|FG001|Overall Study|Requirement for restricted medication|1|||
129083906|NCT00809471|464596392|FG002|Overall Study|Requirement for restricted medication|0|||
129083907|NCT00831311|464596393|FG000|Overall Study|Definitive Contraindication|3|||
129083908|NCT00831311|464596394|FG001|Overall Study|Definitive Contraindication|3|||
129083909|NCT00831311|464596393|FG000|Overall Study|Lost to Follow-up|3|||
129083910|NCT00831311|464596394|FG001|Overall Study|Lost to Follow-up|0|||
129083911|NCT00831311|464596393|FG000|Overall Study|Physician Decision|0|||
129083912|NCT00831311|464596394|FG001|Overall Study|Physician Decision|1|||
129083913|NCT00831311|464596393|FG000|Overall Study|Withdrawal by Subject|6|||
129083914|NCT00831311|464596394|FG001|Overall Study|Withdrawal by Subject|4|||
129083915|NCT03260244|464596395|FG000|Overall Study|Death|19|||
129083916|NCT03260244|464596395|FG000|Overall Study|Lost to Follow-up|60|||
129083917|NCT03260244|464596395|FG000|Overall Study|Withdrawal by Subject|48|||
129083918|NCT03260244|464596395|FG000|Overall Study|Procedure Not Performed|21|||
129083919|NCT03260244|464596395|FG000|Overall Study|Enrollment Criteria Not Met|31|||
129083920|NCT03260244|464596395|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
129083921|NCT03260244|464596395|FG000|Overall Study|Subject Noncompliance|6|||
129083922|NCT03260244|464596395|FG000|Overall Study|No inducible Arrhythmia|2|||
129083923|NCT03260244|464596395|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
129083924|NCT03260244|464596395|FG000|Overall Study|Screen Failure|2|||
129083925|NCT03260244|464596395|FG000|Overall Study|Treated Off Label|69|||
129083926|NCT03260244|464596395|FG000|Overall Study|No Radiofrequency Ablation|14|||
129083927|NCT03528369|464596398|FG000|Overall Study|Withdrawal by Subject|2|||
129083928|NCT03528369|464596399|FG001|Overall Study|Withdrawal by Subject|0|||
129083929|NCT03528369|464596400|FG002|Overall Study|Withdrawal by Subject|0|||
129083930|NCT03528369|464596398|FG000|Overall Study|Lost to Follow-up|1|||
129083931|NCT03528369|464596399|FG001|Overall Study|Lost to Follow-up|0|||
129083932|NCT03528369|464596400|FG002|Overall Study|Lost to Follow-up|0|||
129083933|NCT03528369|464596398|FG000|Overall Study|Adverse Event|0|||
129083934|NCT03528369|464596399|FG001|Overall Study|Adverse Event|1|||
129083935|NCT03528369|464596400|FG002|Overall Study|Adverse Event|0|||
129083936|NCT01163851|464596405|FG000|Overall Study|Site Closure|0|||
129083937|NCT01163851|464596406|FG001|Overall Study|Site Closure|1|||
129083938|NCT01163851|464596405|FG000|Overall Study|Enrolled but not treated|1|||
129083939|NCT01163851|464596406|FG001|Overall Study|Enrolled but not treated|0|||
129083940|NCT03192306|464596409|FG000|Overall Study|Did not treat cold sore during study|149|||
129083941|NCT03192306|464596410|FG001|Overall Study|Did not treat cold sore during study|143|||
129083942|NCT03192306|464596409|FG000|Overall Study|Withdrawal by Subject|1|||
129083943|NCT03192306|464596410|FG001|Overall Study|Withdrawal by Subject|1|||
129083944|NCT03192306|464596409|FG000|Overall Study|Lost to Follow-up|1|||
129083945|NCT03192306|464596410|FG001|Overall Study|Lost to Follow-up|0|||
129083946|NCT03192306|464596409|FG000|Overall Study|Protocol Violation|1|||
129083947|NCT03192306|464596410|FG001|Overall Study|Protocol Violation|1|||
129083948|NCT00892151|464596415|FG000|Overall Study|Protocol Violation|1|||
129083949|NCT04075682|464596418|FG000|Overall Study|Lost to Follow-up|5|||
129083950|NCT04075682|464596419|FG001|Overall Study|Lost to Follow-up|5|||
129083951|NCT04075682|464596420|FG002|Overall Study|Lost to Follow-up|2|||
129083952|NCT04075682|464596421|FG003|Overall Study|Lost to Follow-up|2|||
129083953|NCT04075682|464596418|FG000|Overall Study|Withdrawal by Subject|1|||
129083954|NCT04075682|464596419|FG001|Overall Study|Withdrawal by Subject|0|||
129083955|NCT04075682|464596420|FG002|Overall Study|Withdrawal by Subject|1|||
129083956|NCT04075682|464596421|FG003|Overall Study|Withdrawal by Subject|0|||
129083957|NCT04075682|464596418|FG000|Overall Study|Protocol Violation|0|||
129083958|NCT04075682|464596419|FG001|Overall Study|Protocol Violation|1|||
129083959|NCT04075682|464596420|FG002|Overall Study|Protocol Violation|1|||
129083960|NCT04075682|464596421|FG003|Overall Study|Protocol Violation|0|||
129083961|NCT04075682|464596418|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
129083962|NCT04075682|464596419|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
129083963|NCT04075682|464596420|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
129083964|NCT04075682|464596421|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
129083965|NCT04075682|464596418|FG000|Overall Study|Lost study phone the first day of study participation|0|||
129083966|NCT04075682|464596419|FG001|Overall Study|Lost study phone the first day of study participation|1|||
129083967|NCT04075682|464596420|FG002|Overall Study|Lost study phone the first day of study participation|0|||
129083968|NCT04075682|464596421|FG003|Overall Study|Lost study phone the first day of study participation|0|||
129083969|NCT01289639|464596422|FG000|Overall Study|Lost to Follow-up|1|||
129083970|NCT01289639|464596423|FG001|Overall Study|Lost to Follow-up|0|||
129083971|NCT01289639|464596424|FG002|Overall Study|Lost to Follow-up|0|||
129083972|NCT04292912|464596425|FG000|Overall Study|Physician Decision|1|||
129142960|NCT00561821|464817240|FG003|Overall Study|Withdrawal by Subject|2|||
129142961|NCT00561821|464817237|FG000|Overall Study|Reasons not related to trial|2|||
129142962|NCT00561821|464817238|FG001|Overall Study|Reasons not related to trial|1|||
129142963|NCT00561821|464817239|FG002|Overall Study|Reasons not related to trial|0|||
129142964|NCT00561821|464817240|FG003|Overall Study|Reasons not related to trial|0|||
129142965|NCT00561821|464817237|FG000|Overall Study|Other (reason not specified)|1|||
129142966|NCT00561821|464817238|FG001|Overall Study|Other (reason not specified)|1|||
129142967|NCT00561821|464817239|FG002|Overall Study|Other (reason not specified)|0|||
129142968|NCT00561821|464817240|FG003|Overall Study|Other (reason not specified)|0|||
129142969|NCT00561821|464817237|FG000|Overall Study|Adverse Event|2|||
129142970|NCT00561821|464817238|FG001|Overall Study|Adverse Event|3|||
129142971|NCT00561821|464817239|FG002|Overall Study|Adverse Event|1|||
129142972|NCT00561821|464817240|FG003|Overall Study|Adverse Event|1|||
129142973|NCT03379870|464818526|FG000|Overall Study|Lost to Follow-up|1|||
129142974|NCT03379870|464818527|FG001|Overall Study|Lost to Follow-up|0|||
129142975|NCT03379870|464818526|FG000|Overall Study|Protocol Violation|1|||
129142976|NCT03379870|464818527|FG001|Overall Study|Protocol Violation|1|||
129142977|NCT01394185|464818528|FG000|Overall Study|Withdrawal by Subject|2|||
129142978|NCT01394185|464818529|FG001|Overall Study|Withdrawal by Subject|0|||
129142979|NCT01394185|464818530|FG002|Overall Study|Withdrawal by Subject|0|||
129142980|NCT01394185|464818531|FG003|Overall Study|Withdrawal by Subject|0|||
129142981|NCT01394185|464818532|FG004|Overall Study|Withdrawal by Subject|1|||
129142982|NCT01394185|464818533|FG005|Overall Study|Withdrawal by Subject|0|||
129142983|NCT01394185|464818528|FG000|Overall Study|Change in protocol|3|||
129142984|NCT01394185|464818529|FG001|Overall Study|Change in protocol|0|||
129142985|NCT01394185|464818530|FG002|Overall Study|Change in protocol|0|||
129142986|NCT01394185|464818531|FG003|Overall Study|Change in protocol|0|||
129142987|NCT01394185|464818532|FG004|Overall Study|Change in protocol|3|||
129142988|NCT01394185|464818533|FG005|Overall Study|Change in protocol|0|||
129142989|NCT01394185|464818528|FG000|Overall Study|Protocol Violation|1|||
129142990|NCT01394185|464818529|FG001|Overall Study|Protocol Violation|0|||
129142991|NCT01394185|464818530|FG002|Overall Study|Protocol Violation|0|||
129142992|NCT01394185|464818531|FG003|Overall Study|Protocol Violation|1|||
129142993|NCT01394185|464818532|FG004|Overall Study|Protocol Violation|0|||
129142994|NCT01394185|464818533|FG005|Overall Study|Protocol Violation|1|||
129142995|NCT01557569|464818540|FG000|Overall Study|Adverse Event|2|||
129142996|NCT01557569|464818541|FG001|Overall Study|Adverse Event|0|||
129142997|NCT01557569|464818540|FG000|Overall Study|high blood pressure|0|||
129142998|NCT01557569|464818541|FG001|Overall Study|high blood pressure|1|||
129142999|NCT01557569|464818540|FG000|Overall Study|Withdrawal by Subject|3|||
129143000|NCT01557569|464818541|FG001|Overall Study|Withdrawal by Subject|5|||
129143001|NCT01557569|464818540|FG000|Overall Study|noncompliance with rules of residential|0|||
129083973|NCT04292912|464596425|FG000|Overall Study|Protocol Violation|6|||
129083974|NCT03575793|464596430|FG000|Overall Study|Withdrawal by Subject|0|||
129083975|NCT03575793|464596431|FG001|Overall Study|Withdrawal by Subject|1|||
129083976|NCT03575793|464596430|FG000|Overall Study|Never Treated|0|||
129083977|NCT03575793|464596431|FG001|Overall Study|Never Treated|2|||
129143002|NCT01557569|464818541|FG001|Overall Study|noncompliance with rules of residential|1|||
129143003|NCT00267488|464818542|FG000|Overall Study|Sponsor Terminated Study|9|||
129143004|NCT00267488|464818542|FG000|Overall Study|Protocol Violation|1|||
129143005|NCT00267488|464818542|FG000|Overall Study|Other (Disease Progression)|1|||
129083978|NCT01250873|464596432|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
129143006|NCT00831389|464818543|FG000|Overall Study|Withdrawal by Subject|0|||
129143007|NCT00831389|464818544|FG001|Overall Study|Withdrawal by Subject|1|||
129143008|NCT00278161|464818546|FG000|Overall Study|Death|11|||
129143009|NCT01592747|464818547|FG000|Overall Study|Loss of Therapeutic Response|107|||
129083979|NCT01250873|464596432|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
129083980|NCT01680861|464596433|FG000|Early Post-transplant Period|Protocol Violation|1|||
129083981|NCT01680861|464596434|FG001|Early Post-transplant Period|Protocol Violation|1|||
129083982|NCT02111577|464596435|FG000|Overall Study|Protocol Violation|2|||
129083983|NCT02111577|464596436|FG001|Overall Study|Protocol Violation|0|||
129083984|NCT02111577|464596435|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
129083985|NCT02111577|464596436|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
129083986|NCT02111577|464596435|FG000|Overall Study|Failure to produce study treatment|6|||
129083987|NCT02111577|464596436|FG001|Overall Study|Failure to produce study treatment|0|||
129083988|NCT02111577|464596435|FG000|Overall Study|Death|518|||
129083989|NCT02111577|464596436|FG001|Overall Study|Death|254|||
129083990|NCT02111577|464596435|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
129083991|NCT02111577|464596436|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
129083992|NCT02111577|464596435|FG000|Overall Study|Adverse Event|1|||
129083993|NCT02111577|464596436|FG001|Overall Study|Adverse Event|1|||
129083994|NCT02111577|464596435|FG000|Overall Study|Withdrawal by Subject|51|||
129083995|NCT02111577|464596436|FG001|Overall Study|Withdrawal by Subject|23|||
129083996|NCT02111577|464596435|FG000|Overall Study|Disease progression|0|||
129083997|NCT02111577|464596436|FG001|Overall Study|Disease progression|1|||
129083998|NCT02111577|464596435|FG000|Overall Study|Lost to Follow-up|19|||
129083999|NCT02111577|464596436|FG001|Overall Study|Lost to Follow-up|10|||
129084000|NCT00654875|464596437|FG000|Overall Study|Adverse Event|5|||
129084001|NCT00654875|464596438|FG001|Overall Study|Adverse Event|5|||
129084002|NCT00654875|464596437|FG000|Overall Study|Withdrawal by Subject|4|||
129084003|NCT00654875|464596438|FG001|Overall Study|Withdrawal by Subject|4|||
129084004|NCT00654875|464596437|FG000|Overall Study|Protocol Violation|3|||
129084005|NCT00654875|464596438|FG001|Overall Study|Protocol Violation|3|||
129084006|NCT00654875|464596437|FG000|Overall Study|Lack of Efficacy|2|||
129084007|NCT00654875|464596438|FG001|Overall Study|Lack of Efficacy|2|||
129084008|NCT00654875|464596437|FG000|Overall Study|Lost to Follow-up|1|||
129084009|NCT00654875|464596438|FG001|Overall Study|Lost to Follow-up|3|||
129084010|NCT00654875|464596437|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
129084011|NCT00654875|464596438|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129084012|NCT00654875|464596437|FG000|Overall Study|Administrative Problems|1|||
129084013|NCT00654875|464596438|FG001|Overall Study|Administrative Problems|0|||
129084014|NCT04967885|464596439|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
129084015|NCT04967885|464596440|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
129084016|NCT04967885|464596439|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
129084017|NCT04967885|464596440|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
129084018|NCT04967885|464596439|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
129084019|NCT04967885|464596440|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
129084020|NCT04967885|464596439|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
129084021|NCT04967885|464596440|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
129084022|NCT04967885|464596439|FG000|EMI-II Intervention|Lost to Follow-up|14|||
129084023|NCT04967885|464596440|FG001|EMI-II Intervention|Lost to Follow-up|10|||
129084024|NCT00886743|464596441|FG000|Overall Study|Adverse Event|3|||
129084025|NCT00886743|464596441|FG000|Overall Study|Other|1|||
129084026|NCT02429778|464596443|FG000|Overall Study|Lost to Follow-up|2|||
129084027|NCT02429778|464596444|FG001|Overall Study|Lost to Follow-up|0|||
129084028|NCT02429778|464596443|FG000|Overall Study|Withdrawal by Subject|5|||
129084029|NCT02429778|464596444|FG001|Overall Study|Withdrawal by Subject|0|||
129084030|NCT04791319|464596448|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
129084031|NCT04791319|464596449|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
129084032|NCT04791319|464596450|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
129084033|NCT04791319|464596451|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
129084034|NCT04791319|464596452|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129084035|NCT04791319|464596453|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129084036|NCT04791319|464596454|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129084037|NCT04791319|464596455|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129084038|NCT04791319|464596456|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129084039|NCT04791319|464596457|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129084040|NCT04791319|464596458|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129084041|NCT04791319|464596448|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
129084042|NCT04791319|464596449|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084043|NCT04791319|464596450|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
129084044|NCT04791319|464596451|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
129084045|NCT04791319|464596452|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084046|NCT04791319|464596453|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084047|NCT04791319|464596454|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084048|NCT04791319|464596455|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084049|NCT04791319|464596456|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084050|NCT04791319|464596457|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084051|NCT04791319|464596458|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129084052|NCT04791319|464596448|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
129084053|NCT04791319|464596449|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
129084054|NCT04791319|464596450|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
129084055|NCT04791319|464596451|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
129084056|NCT04791319|464596452|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129084057|NCT04791319|464596453|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129084058|NCT04791319|464596454|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129084059|NCT04791319|464596455|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129084060|NCT04791319|464596456|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129084061|NCT04791319|464596457|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129084062|NCT04791319|464596458|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129084063|NCT04791319|464596448|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
129084064|NCT04791319|464596449|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
129084065|NCT04791319|464596450|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
129084066|NCT04791319|464596451|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
129084067|NCT04791319|464596452|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129084068|NCT04791319|464596453|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129084069|NCT04791319|464596454|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129084070|NCT04791319|464596455|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129084071|NCT04791319|464596456|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129084072|NCT04791319|464596457|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129084073|NCT04791319|464596458|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129084074|NCT04791319|464596448|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084075|NCT04791319|464596449|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084076|NCT04791319|464596450|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084077|NCT04791319|464596451|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
129084078|NCT04791319|464596452|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084079|NCT04791319|464596453|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084080|NCT04791319|464596454|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084081|NCT04791319|464596455|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084082|NCT04791319|464596456|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129143010|NCT01592747|464818548|FG001|Overall Study|Loss of Therapeutic Response|108|||
129143011|NCT01592747|464818549|FG002|Overall Study|Loss of Therapeutic Response|100|||
129143012|NCT01592747|464818547|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
129143013|NCT01592747|464818548|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
129143014|NCT01592747|464818549|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
129143015|NCT01592747|464818547|FG000|Overall Study|Adverse Event|1|||
129143016|NCT01592747|464818548|FG001|Overall Study|Adverse Event|0|||
129143017|NCT01592747|464818549|FG002|Overall Study|Adverse Event|0|||
129143018|NCT01592747|464818547|FG000|Overall Study|Protocol Violation|4|||
129143019|NCT01592747|464818548|FG001|Overall Study|Protocol Violation|0|||
129143020|NCT01592747|464818549|FG002|Overall Study|Protocol Violation|4|||
129143021|NCT01592747|464818547|FG000|Overall Study|Lack of Efficacy|0|||
129143022|NCT01592747|464818548|FG001|Overall Study|Lack of Efficacy|1|||
129143023|NCT01592747|464818549|FG002|Overall Study|Lack of Efficacy|0|||
129143024|NCT01592747|464818547|FG000|Overall Study|Withdrawal by Subject|2|||
129143025|NCT01592747|464818548|FG001|Overall Study|Withdrawal by Subject|0|||
129143026|NCT01592747|464818549|FG002|Overall Study|Withdrawal by Subject|2|||
129143027|NCT01592747|464818547|FG000|Overall Study|Lost to Follow-up|1|||
129143028|NCT01592747|464818548|FG001|Overall Study|Lost to Follow-up|0|||
129143029|NCT01592747|464818549|FG002|Overall Study|Lost to Follow-up|1|||
129143030|NCT01592747|464818547|FG000|Overall Study|Other Reasons|1|||
129143031|NCT01592747|464818548|FG001|Overall Study|Other Reasons|1|||
129143032|NCT01592747|464818549|FG002|Overall Study|Other Reasons|0|||
129084083|NCT04791319|464596457|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129084084|NCT04791319|464596458|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129143033|NCT03829683|464818553|FG000|Overall Study|Lost to Follow-up|1|||
129143034|NCT03829683|464818554|FG001|Overall Study|Lost to Follow-up|0|||
129143035|NCT03829683|464818553|FG000|Overall Study|Physician Decision|3|||
129143036|NCT03829683|464818554|FG001|Overall Study|Physician Decision|1|||
129143037|NCT03829683|464818553|FG000|Overall Study|Withdrawal by Subject|0|||
129143038|NCT03829683|464818554|FG001|Overall Study|Withdrawal by Subject|1|||
129143039|NCT03829683|464818553|FG000|Overall Study|Discharge from hospital|1|||
129143040|NCT03829683|464818554|FG001|Overall Study|Discharge from hospital|0|||
129143041|NCT01922895|464818555|FG000|Overall Study|Death|0|||
129084085|NCT04791319|464596448|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129084086|NCT04791319|464596449|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129084087|NCT04791319|464596450|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129084088|NCT04791319|464596451|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129084089|NCT04791319|464596452|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
129084090|NCT04791319|464596453|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
129084091|NCT04791319|464596454|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
129084092|NCT04791319|464596455|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129084093|NCT04791319|464596456|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129084094|NCT04791319|464596457|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129084095|NCT04791319|464596458|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
129084096|NCT04791319|464596448|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084097|NCT04791319|464596449|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084098|NCT04791319|464596450|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084099|NCT04791319|464596451|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084100|NCT04791319|464596452|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084101|NCT04791319|464596453|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084102|NCT04791319|464596454|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084103|NCT04791319|464596455|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084104|NCT04791319|464596456|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084105|NCT04791319|464596457|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
129084106|NCT04791319|464596458|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129084107|NCT04791319|464596448|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129084108|NCT04791319|464596449|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129084109|NCT04791319|464596450|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129084110|NCT04791319|464596451|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129084111|NCT04791319|464596452|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
129084112|NCT04791319|464596453|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
129084113|NCT04791319|464596454|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
129084114|NCT04791319|464596455|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129084115|NCT04791319|464596456|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
129084116|NCT04791319|464596457|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
129084117|NCT04791319|464596458|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
129084118|NCT04791319|464596448|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129084119|NCT04791319|464596449|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129084120|NCT04791319|464596450|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129084121|NCT04791319|464596451|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129084122|NCT04791319|464596452|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
129084123|NCT04791319|464596453|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
129084124|NCT04791319|464596454|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
129084125|NCT04791319|464596455|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
129084126|NCT04791319|464596456|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
129084127|NCT04791319|464596457|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
129084128|NCT04791319|464596458|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
129084129|NCT00355147|464596463|FG000|Overall Study|Lost to Follow-up|10|||
129084130|NCT00355147|464596464|FG001|Overall Study|Lost to Follow-up|8|||
129084131|NCT00355147|464596463|FG000|Overall Study|Withdrawal by Subject|8|||
129084132|NCT00355147|464596464|FG001|Overall Study|Withdrawal by Subject|12|||
129084133|NCT00072280|464596471|FG000|Treatment|Found ineligible|1|||
129084134|NCT00072280|464596472|FG001|Treatment|Found ineligible|2|||
129084135|NCT00072280|464596471|FG000|Follow-up|Early termination of study|2|||
129143042|NCT01922895|464818556|FG001|Overall Study|Death|1|||
129143043|NCT01922895|464818555|FG000|Overall Study|Withdrawal by Subject|1|||
129143044|NCT01922895|464818556|FG001|Overall Study|Withdrawal by Subject|2|||
129143045|NCT01922895|464818555|FG000|Overall Study|Lost to Follow-up|5|||
129143046|NCT01922895|464818556|FG001|Overall Study|Lost to Follow-up|11|||
129143047|NCT01916226|464818557|FG000|Overall Study|Adverse Event|1|||
129143048|NCT01916226|464818558|FG001|Overall Study|Adverse Event|0|||
129143049|NCT01916226|464818559|FG002|Overall Study|Adverse Event|1|||
129143050|NCT01916226|464818560|FG003|Overall Study|Adverse Event|1|||
129143051|NCT01916226|464818557|FG000|Overall Study|Lack of Efficacy|0|||
129143052|NCT01916226|464818558|FG001|Overall Study|Lack of Efficacy|0|||
129084136|NCT00072280|464596472|FG001|Follow-up|Early termination of study|2|||
129084137|NCT00022698|464596478|FG000|Overall Study|Adverse Event|5|||
129084138|NCT00022698|464596479|FG001|Overall Study|Adverse Event|9|||
129084139|NCT00022698|464596478|FG000|Overall Study|Death|0|||
129084140|NCT00022698|464596479|FG001|Overall Study|Death|2|||
129084141|NCT00022698|464596478|FG000|Overall Study|Failure to return|0|||
129084142|NCT00022698|464596479|FG001|Overall Study|Failure to return|1|||
129084143|NCT00022698|464596478|FG000|Overall Study|Refused treatment|0|||
129084144|NCT00022698|464596479|FG001|Overall Study|Refused treatment|2|||
129084145|NCT00022698|464596478|FG000|Overall Study|Insufficient therapeutic response|2|||
129084146|NCT00022698|464596479|FG001|Overall Study|Insufficient therapeutic response|14|||
129084147|NCT00022698|464596478|FG000|Overall Study|Administrative /other|1|||
129084148|NCT00022698|464596479|FG001|Overall Study|Administrative /other|7|||
129084149|NCT02504827|464596480|FG000|Overall Study|Could not produce sputum|1|||
129084150|NCT00877487|464596489|FG000|Open-label Treatment Phase|Adverse Event|1|||
129084151|NCT00877487|464596490|FG001|Open-label Treatment Phase|Adverse Event|0|||
129084152|NCT00877487|464596489|FG000|Open-label Treatment Phase|Protocol Violation|3|||
129084153|NCT00877487|464596490|FG001|Open-label Treatment Phase|Protocol Violation|0|||
129084154|NCT00877487|464596489|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
129084155|NCT00877487|464596490|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
129084156|NCT00877487|464596489|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
129084157|NCT00877487|464596490|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
129084158|NCT00877487|464596489|FG000|Open-label Treatment Phase|Out of country for business|1|||
129084159|NCT00877487|464596490|FG001|Open-label Treatment Phase|Out of country for business|0|||
129084160|NCT00877487|464596489|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
129084161|NCT00877487|464596490|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
129084162|NCT00877487|464596489|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
129084163|NCT00877487|464596490|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
129084164|NCT00877487|464596489|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
129084165|NCT00877487|464596490|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
129084166|NCT00877487|464596489|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
129084167|NCT00877487|464596490|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
129084168|NCT00712543|464596493|FG000|Day 8-14|Lost to Follow-up|0|||
129084169|NCT00712543|464596494|FG001|Day 8-14|Lost to Follow-up|2|||
129084170|NCT02729051|464596497|FG000|Overall Study|Adverse Event|21|||
129084171|NCT02729051|464596498|FG001|Overall Study|Adverse Event|11|||
129084172|NCT02729051|464596497|FG000|Overall Study|Lack of Efficacy|1|||
129084173|NCT02729051|464596498|FG001|Overall Study|Lack of Efficacy|1|||
129084174|NCT02729051|464596497|FG000|Overall Study|Lost to Follow-up|1|||
129084175|NCT02729051|464596498|FG001|Overall Study|Lost to Follow-up|2|||
129084176|NCT02729051|464596497|FG000|Overall Study|Physician Decision|1|||
129084177|NCT02729051|464596498|FG001|Overall Study|Physician Decision|1|||
129084178|NCT02729051|464596497|FG000|Overall Study|Withdrawal by Subject|6|||
129084179|NCT02729051|464596498|FG001|Overall Study|Withdrawal by Subject|17|||
129084180|NCT02702388|464596499|FG000|Overall Study|Disease Progression|18|||
129084181|NCT02702388|464596500|FG001|Overall Study|Disease Progression|25|||
129084182|NCT02702388|464596499|FG000|Overall Study|Withdrawal by Subject|9|||
129084183|NCT02702388|464596500|FG001|Overall Study|Withdrawal by Subject|7|||
129084184|NCT02702388|464596499|FG000|Overall Study|Adverse Event|11|||
129084185|NCT02702388|464596500|FG001|Overall Study|Adverse Event|15|||
129084186|NCT02702388|464596499|FG000|Overall Study|Other|2|||
129084187|NCT02702388|464596500|FG001|Overall Study|Other|4|||
129084188|NCT04740827|464596512|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
129084189|NCT04740827|464596513|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
129084190|NCT04740827|464596512|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
129084191|NCT04740827|464596513|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
129084192|NCT04740827|464596512|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
129084193|NCT04740827|464596513|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
129084194|NCT04740827|464596512|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
129084195|NCT04740827|464596513|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
129084196|NCT04740827|464596512|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
129084197|NCT04740827|464596513|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
129084198|NCT04740827|464596512|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
129084199|NCT04740827|464596513|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
129084200|NCT01190410|464598318|FG000|Overall Study|Adverse Event|0|||
129084201|NCT01190410|464598319|FG001|Overall Study|Adverse Event|3|||
129084202|NCT01190410|464598318|FG000|Overall Study|Lack of Efficacy|0|||
129084203|NCT01190410|464598319|FG001|Overall Study|Lack of Efficacy|2|||
129084204|NCT01190410|464598318|FG000|Overall Study|Withdrawal by Subject|0|||
129084205|NCT01190410|464598319|FG001|Overall Study|Withdrawal by Subject|2|||
129084206|NCT01190410|464598318|FG000|Overall Study|Administrative decision|1|||
129084207|NCT01190410|464598319|FG001|Overall Study|Administrative decision|0|||
129084208|NCT01190410|464598318|FG000|Overall Study|PI discretion|0|||
129084209|NCT01190410|464598319|FG001|Overall Study|PI discretion|2|||
129084210|NCT03652636|464598320|FG000|Overall Study|Withdrawal by Subject|7|||
129084211|NCT00504725|464598329|FG000|Overall Study|Protocol Violation|1|||
129084212|NCT00504725|464598330|FG001|Overall Study|Protocol Violation|0|||
129084213|NCT01435018|464598332|FG000|Overall Study|Death|37|||
129084214|NCT01435018|464598333|FG001|Overall Study|Death|18|||
129084215|NCT01435018|464598334|FG002|Overall Study|Death|25|||
129084216|NCT01435018|464598332|FG000|Overall Study|Site is closing|4|||
129084217|NCT01435018|464598333|FG001|Overall Study|Site is closing|9|||
129084218|NCT01435018|464598334|FG002|Overall Study|Site is closing|7|||
129084219|NCT01435018|464598332|FG000|Overall Study|Withdrew consent|0|||
129084220|NCT01435018|464598333|FG001|Overall Study|Withdrew consent|3|||
129084221|NCT01435018|464598334|FG002|Overall Study|Withdrew consent|1|||
129084222|NCT01435018|464598332|FG000|Overall Study|Not willing to adhere to requirements|0|||
129084223|NCT01435018|464598333|FG001|Overall Study|Not willing to adhere to requirements|2|||
129084224|NCT01435018|464598334|FG002|Overall Study|Not willing to adhere to requirements|3|||
129084225|NCT01435018|464598332|FG000|Overall Study|Not able to get to clinic|2|||
129084226|NCT01435018|464598333|FG001|Overall Study|Not able to get to clinic|0|||
129084227|NCT01435018|464598334|FG002|Overall Study|Not able to get to clinic|2|||
129084228|NCT01435018|464598332|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129084229|NCT01435018|464598333|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129084230|NCT01435018|464598334|FG002|Overall Study|Severe debilitation, unable to continue|1|||
129084231|NCT01435018|464598332|FG000|Overall Study|Unable to contact participant/parent|1|||
129084232|NCT01435018|464598333|FG001|Overall Study|Unable to contact participant/parent|1|||
129084233|NCT01435018|464598334|FG002|Overall Study|Unable to contact participant/parent|1|||
129084234|NCT01435018|464598332|FG000|Overall Study|Enrollment Violation|0|||
129084235|NCT01435018|464598333|FG001|Overall Study|Enrollment Violation|1|||
129084236|NCT01435018|464598334|FG002|Overall Study|Enrollment Violation|0|||
129084237|NCT01435018|464598332|FG000|Overall Study|Never started chemotherapy|3|||
129084238|NCT01435018|464598333|FG001|Overall Study|Never started chemotherapy|0|||
129084239|NCT01435018|464598334|FG002|Overall Study|Never started chemotherapy|1|||
129084240|NCT00769067|464598335|FG000|Overall Study|Death|89|||
129084241|NCT00769067|464598336|FG001|Overall Study|Death|86|||
129084242|NCT00769067|464598335|FG000|Overall Study|Lost to Follow-up|3|||
129084243|NCT00769067|464598336|FG001|Overall Study|Lost to Follow-up|1|||
129084244|NCT00769067|464598335|FG000|Overall Study|Study terminated by sponsor|1|||
129084245|NCT00769067|464598336|FG001|Overall Study|Study terminated by sponsor|3|||
129084246|NCT00769067|464598335|FG000|Overall Study|Other|1|||
129084247|NCT00769067|464598336|FG001|Overall Study|Other|3|||
129084248|NCT00769067|464598335|FG000|Overall Study|Withdrawal by Subject|0|||
129084249|NCT00769067|464598336|FG001|Overall Study|Withdrawal by Subject|1|||
129084250|NCT03806933|464598337|FG000|Main Period|Physician Decision|0|||
129084251|NCT03806933|464598338|FG001|Main Period|Physician Decision|0|||
129084252|NCT03806933|464598339|FG002|Main Period|Physician Decision|0|||
129084253|NCT03806933|464598340|FG003|Main Period|Physician Decision|1|||
129084254|NCT03806933|464598337|FG000|Main Period|Pregnancy|0|||
129084255|NCT03806933|464598338|FG001|Main Period|Pregnancy|0|||
129084256|NCT03806933|464598339|FG002|Main Period|Pregnancy|1|||
129084257|NCT03806933|464598340|FG003|Main Period|Pregnancy|0|||
129084258|NCT03806933|464598337|FG000|Main Period|Withdrawal by Subject|2|||
129084259|NCT03806933|464598338|FG001|Main Period|Withdrawal by Subject|1|||
129084260|NCT03806933|464598339|FG002|Main Period|Withdrawal by Subject|1|||
129084261|NCT03806933|464598340|FG003|Main Period|Withdrawal by Subject|2|||
129084262|NCT03806933|464598337|FG000|Main Period|Lost to Follow-up|2|||
129084263|NCT03806933|464598338|FG001|Main Period|Lost to Follow-up|2|||
129084264|NCT03806933|464598339|FG002|Main Period|Lost to Follow-up|0|||
129084265|NCT03806933|464598340|FG003|Main Period|Lost to Follow-up|0|||
129084266|NCT03806933|464598337|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
128776568|NCT00904150|463470477|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
129084267|NCT03806933|464598338|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
129084268|NCT03806933|464598339|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
129084269|NCT03806933|464598340|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
129084270|NCT03625466|464598341|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
129084271|NCT03625466|464598342|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
129084272|NCT03625466|464598343|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
129084273|NCT03625466|464598341|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
129084274|NCT03625466|464598342|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
129084275|NCT03625466|464598343|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
128724261|NCT03735667|463289019|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
128724262|NCT03735667|463289020|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
128724263|NCT03735667|463289018|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
128724264|NCT03735667|463289019|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
128724265|NCT03735667|463289020|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
129084276|NCT03625466|464598341|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
129084277|NCT03625466|464598342|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
129084278|NCT03625466|464598343|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
129084279|NCT01868438|464598346|FG000|First Intervention|Withdrawal by Subject|5|||
129084280|NCT01868438|464598347|FG001|First Intervention|Withdrawal by Subject|1|||
129084281|NCT01868438|464598346|FG000|First Intervention|Lost to Follow-up|2|||
129084282|NCT01868438|464598347|FG001|First Intervention|Lost to Follow-up|3|||
129084283|NCT01868438|464598346|FG000|First Intervention|Meeting the non-redosing criteria|0|||
129084284|NCT01868438|464598347|FG001|First Intervention|Meeting the non-redosing criteria|1|||
129084285|NCT01868438|464598346|FG000|Second Intervention|Adverse Event|3|||
129084286|NCT01868438|464598347|FG001|Second Intervention|Adverse Event|3|||
129084287|NCT00956592|464598351|FG000|Overall Study|Protocol Violation|1|||
129084288|NCT00956592|464598352|FG001|Overall Study|Protocol Violation|3|||
129084289|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
129084290|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
129084291|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
129084292|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
129084293|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
129084294|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
129084295|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
129084296|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
129084297|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Death|0|||
129084298|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Death|1|||
129084299|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
129084300|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
129084301|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
129084302|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
129084303|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
129084304|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
129084305|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
129084306|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
129084307|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
129084308|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
129084309|NCT00394836|464598353|FG000|Teatment or Follow-up Phase|Non compliance|0|||
129084310|NCT00394836|464598354|FG001|Teatment or Follow-up Phase|Non compliance|1|||
129084311|NCT00394836|464598353|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
129084312|NCT00394836|464598354|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
129084313|NCT00394836|464598353|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
129084314|NCT00394836|464598354|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
129084315|NCT00394836|464598353|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
129084316|NCT00394836|464598354|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
129084317|NCT00394836|464598353|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
129084318|NCT00394836|464598354|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
129084319|NCT02028767|464598355|FG000|Treatment Period 2|Non compliant with protocol|1|||
129084320|NCT02028767|464598356|FG001|Treatment Period 2|Non compliant with protocol|0|||
129084321|NCT02028767|464598355|FG000|Treatment Period 2|Reason other than those specified above|1|||
129084322|NCT02028767|464598356|FG001|Treatment Period 2|Reason other than those specified above|0|||
129084323|NCT02780713|464598360|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129084324|NCT02780713|464598361|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129084325|NCT02780713|464598362|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
129084326|NCT02780713|464598363|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129084327|NCT02780713|464598364|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129084328|NCT05338502|464598365|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
128724266|NCT03735667|463289018|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
129084329|NCT05338502|464598366|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
128724267|NCT03735667|463289019|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
128724268|NCT03735667|463289020|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
128724269|NCT03735667|463289018|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
128776569|NCT00904150|463470476|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
129084330|NCT05338502|464598367|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
129084331|NCT05338502|464598365|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
129084332|NCT05338502|464598366|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
129084333|NCT05338502|464598367|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
128724270|NCT03735667|463289019|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
128724271|NCT03735667|463289020|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
128724272|NCT03735667|463289018|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
128724273|NCT03735667|463289019|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
128724274|NCT03735667|463289020|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
128724275|NCT01364428|463289023|FG000|Overall Study|Adverse Event|1|||
128724276|NCT01364428|463289024|FG001|Overall Study|Adverse Event|2|||
129084334|NCT02278939|464598368|FG000|Overall Study|lack of time|1|||
129084335|NCT02278939|464598369|FG001|Overall Study|lack of time|0|||
129084336|NCT02278939|464598368|FG000|Overall Study|Lost to Follow-up|1|||
129084337|NCT02278939|464598369|FG001|Overall Study|Lost to Follow-up|1|||
129084338|NCT02278939|464598368|FG000|Overall Study|death in family|1|||
129084339|NCT02278939|464598369|FG001|Overall Study|death in family|0|||
129084340|NCT02278939|464598368|FG000|Overall Study|family emergency unable to commit|2|||
129084341|NCT02278939|464598369|FG001|Overall Study|family emergency unable to commit|0|||
129084342|NCT03436693|464598372|FG000|Overall Study|Adverse Event|22|||
129084343|NCT03436693|464598373|FG001|Overall Study|Adverse Event|10|||
129084344|NCT03436693|464598372|FG000|Overall Study|Physician Decision|3|||
129084345|NCT03436693|464598373|FG001|Overall Study|Physician Decision|3|||
129084346|NCT03436693|464598372|FG000|Overall Study|Withdrawal by Subject|4|||
129084347|NCT03436693|464598373|FG001|Overall Study|Withdrawal by Subject|13|||
129084348|NCT03436693|464598372|FG000|Overall Study|Progressive Disease|1|||
129084349|NCT03436693|464598373|FG001|Overall Study|Progressive Disease|1|||
129084350|NCT02042950|464598376|FG000|Overall Study|Progressive Disease|4|||
129084351|NCT01940887|464598379|FG000|Year 1|Protocol Violation|0|||
129084352|NCT01940887|464598380|FG001|Year 1|Protocol Violation|1|||
129084353|NCT01940887|464598379|FG000|Year 1|Physician Decision|7|||
129084354|NCT01940887|464598380|FG001|Year 1|Physician Decision|3|||
129084355|NCT01940887|464598379|FG000|Year 1|Death|5|||
129084356|NCT01940887|464598380|FG001|Year 1|Death|3|||
129084357|NCT01940887|464598379|FG000|Year 1|Adverse Event|7|||
129084358|NCT01940887|464598380|FG001|Year 1|Adverse Event|6|||
129084359|NCT01940887|464598379|FG000|Year 1|Withdrawal by Subject|18|||
129084360|NCT01940887|464598380|FG001|Year 1|Withdrawal by Subject|9|||
129084361|NCT01940887|464598379|FG000|Year 1|Lost to Follow-up|2|||
129084362|NCT01940887|464598380|FG001|Year 1|Lost to Follow-up|1|||
129084363|NCT01940887|464598379|FG000|Year 2|Physician Decision|8|||
129084364|NCT01940887|464598380|FG001|Year 2|Physician Decision|1|||
129084365|NCT01940887|464598379|FG000|Year 2|Death|0|||
129084366|NCT01940887|464598380|FG001|Year 2|Death|2|||
129084367|NCT01940887|464598379|FG000|Year 2|Sponsor Decision, early termination|192|||
129084368|NCT01940887|464598380|FG001|Year 2|Sponsor Decision, early termination|203|||
129084369|NCT01940887|464598379|FG000|Year 2|Adverse Event|8|||
129084370|NCT01940887|464598380|FG001|Year 2|Adverse Event|2|||
129084371|NCT01940887|464598379|FG000|Year 2|Withdrawal by Subject|8|||
129084372|NCT01940887|464598380|FG001|Year 2|Withdrawal by Subject|8|||
129084373|NCT01940887|464598379|FG000|Year 2|Lost to Follow-up|1|||
129084374|NCT01940887|464598380|FG001|Year 2|Lost to Follow-up|6|||
129084375|NCT02632409|464598381|FG000|Randomized|AE unrelated to study Drug|0|||
129084376|NCT02632409|464598382|FG001|Randomized|AE unrelated to study Drug|1|||
129084377|NCT02632409|464598381|FG000|Randomized|Participant withdrew consent|2|||
129084378|NCT02632409|464598382|FG001|Randomized|Participant withdrew consent|1|||
129084379|NCT02632409|464598381|FG000|Randomized|No Longer meets study criteria|5|||
129084380|NCT02632409|464598382|FG001|Randomized|No Longer meets study criteria|0|||
129084381|NCT02632409|464598381|FG000|Randomized|other reasons|1|||
129084382|NCT02632409|464598382|FG001|Randomized|other reasons|0|||
129084383|NCT02632409|464598381|FG000|Treatment Period|Ongoing Treatment|20|||
129084384|NCT02632409|464598382|FG001|Treatment Period|Ongoing Treatment|21|||
129084385|NCT02632409|464598381|FG000|Treatment Period|Disease Recurrence|147|||
129084386|NCT02632409|464598382|FG001|Treatment Period|Disease Recurrence|90|||
129084387|NCT02632409|464598381|FG000|Treatment Period|Study Drug Toxicity|8|||
129084388|NCT02632409|464598382|FG001|Treatment Period|Study Drug Toxicity|49|||
129084389|NCT02632409|464598381|FG000|Treatment Period|Death|1|||
129084390|NCT02632409|464598382|FG001|Treatment Period|Death|0|||
129084391|NCT02632409|464598381|FG000|Treatment Period|AE unrelated to study drug|15|||
129084392|NCT02632409|464598382|FG001|Treatment Period|AE unrelated to study drug|16|||
129084393|NCT02632409|464598381|FG000|Treatment Period|Request to discontinue treatment|4|||
129084394|NCT02632409|464598382|FG001|Treatment Period|Request to discontinue treatment|19|||
129084395|NCT02632409|464598381|FG000|Treatment Period|Participant withdrew consent|7|||
129084396|NCT02632409|464598382|FG001|Treatment Period|Participant withdrew consent|5|||
129084397|NCT02632409|464598381|FG000|Treatment Period|Lost to Follow-up|0|||
129084398|NCT02632409|464598382|FG001|Treatment Period|Lost to Follow-up|1|||
129084399|NCT02632409|464598381|FG000|Treatment Period|Maximum clinical benefit|1|||
129084400|NCT02632409|464598382|FG001|Treatment Period|Maximum clinical benefit|0|||
129084401|NCT02632409|464598381|FG000|Treatment Period|No longer meets study criteria|3|||
129084402|NCT02632409|464598382|FG001|Treatment Period|No longer meets study criteria|0|||
129084403|NCT02632409|464598381|FG000|Treatment Period|Administrative Reason by sponsor|0|||
129084404|NCT02632409|464598382|FG001|Treatment Period|Administrative Reason by sponsor|1|||
129084405|NCT02632409|464598381|FG000|Treatment Period|Other Reasons|10|||
129143053|NCT01916226|464818559|FG002|Overall Study|Lack of Efficacy|2|||
129143054|NCT01916226|464818560|FG003|Overall Study|Lack of Efficacy|1|||
129143055|NCT01916226|464818557|FG000|Overall Study|Protocol Violation|0|||
129143056|NCT01916226|464818558|FG001|Overall Study|Protocol Violation|1|||
129143057|NCT01916226|464818559|FG002|Overall Study|Protocol Violation|0|||
129143058|NCT01916226|464818560|FG003|Overall Study|Protocol Violation|1|||
129143059|NCT01916226|464818557|FG000|Overall Study|Physician Decision|0|||
129143060|NCT01916226|464818558|FG001|Overall Study|Physician Decision|0|||
129143061|NCT01916226|464818559|FG002|Overall Study|Physician Decision|0|||
129143062|NCT01916226|464818560|FG003|Overall Study|Physician Decision|1|||
129143063|NCT03163667|464818561|FG000|Overall Study|Death|15|||
129143064|NCT03163667|464818562|FG001|Overall Study|Death|27|||
129143065|NCT03163667|464818561|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
129143066|NCT03163667|464818562|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
129143067|NCT05430919|464818563|FG000|Overall Study|Protocol Violation|0|||
129084406|NCT02632409|464598382|FG001|Treatment Period|Other Reasons|6|||
129084407|NCT03521115|464598383|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
129084408|NCT03521115|464598384|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
129084409|NCT03521115|464598383|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
129084410|NCT03521115|464598384|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
129084411|NCT01981954|464598389|FG000|Titration Period|Protocol Deviation|1|||
129084412|NCT01981954|464598389|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
129084413|NCT03655470|464598390|FG000|Overall Study|Lost to Follow-up|6|||
129084414|NCT03655470|464598391|FG001|Overall Study|Lost to Follow-up|7|||
129084415|NCT03063086|464598395|FG000|Overall Study|technical problems|1|||
129084416|NCT03063086|464598396|FG001|Overall Study|technical problems|0|||
129084417|NCT03063086|464598397|FG002|Overall Study|technical problems|0|||
129084418|NCT03063086|464598398|FG003|Overall Study|technical problems|0|||
129084419|NCT03063086|464598399|FG004|Overall Study|technical problems|0|||
129084420|NCT03063086|464598400|FG005|Overall Study|technical problems|0|||
129084421|NCT03063086|464598395|FG000|Overall Study|Adverse Event|1|||
129084422|NCT03063086|464598396|FG001|Overall Study|Adverse Event|1|||
129084423|NCT03063086|464598397|FG002|Overall Study|Adverse Event|1|||
129084424|NCT03063086|464598398|FG003|Overall Study|Adverse Event|1|||
129084425|NCT03063086|464598399|FG004|Overall Study|Adverse Event|0|||
129084426|NCT03063086|464598400|FG005|Overall Study|Adverse Event|0|||
129084427|NCT03063086|464598395|FG000|Overall Study|subject/guardian decision|1|||
129084428|NCT03063086|464598396|FG001|Overall Study|subject/guardian decision|0|||
129084429|NCT03063086|464598397|FG002|Overall Study|subject/guardian decision|0|||
129084430|NCT03063086|464598398|FG003|Overall Study|subject/guardian decision|0|||
129084431|NCT03063086|464598399|FG004|Overall Study|subject/guardian decision|0|||
129084432|NCT03063086|464598400|FG005|Overall Study|subject/guardian decision|0|||
129084433|NCT03063086|464598395|FG000|Overall Study|Non-compliance with study treatment|0|||
129084434|NCT03063086|464598396|FG001|Overall Study|Non-compliance with study treatment|0|||
129084435|NCT03063086|464598397|FG002|Overall Study|Non-compliance with study treatment|0|||
129084436|NCT03063086|464598398|FG003|Overall Study|Non-compliance with study treatment|1|||
129084437|NCT03063086|464598399|FG004|Overall Study|Non-compliance with study treatment|0|||
129084438|NCT03063086|464598400|FG005|Overall Study|Non-compliance with study treatment|1|||
129084439|NCT03063086|464598395|FG000|Overall Study|Physician Decision|0|||
129084440|NCT03063086|464598396|FG001|Overall Study|Physician Decision|0|||
129084441|NCT03063086|464598397|FG002|Overall Study|Physician Decision|0|||
129084442|NCT03063086|464598398|FG003|Overall Study|Physician Decision|1|||
129084443|NCT03063086|464598399|FG004|Overall Study|Physician Decision|0|||
129084444|NCT03063086|464598400|FG005|Overall Study|Physician Decision|0|||
129084445|NCT04590586|464598401|FG000|Overall Study|Death|7|||
129084446|NCT04590586|464598402|FG001|Overall Study|Death|1|||
129143068|NCT05430919|464818564|FG001|Overall Study|Protocol Violation|0|||
129143069|NCT05430919|464818565|FG002|Overall Study|Protocol Violation|1|||
129143070|NCT05430919|464818566|FG003|Overall Study|Protocol Violation|0|||
129084447|NCT04590586|464598403|FG002|Overall Study|Death|37|||
129084448|NCT04590586|464598404|FG003|Overall Study|Death|34|||
129084449|NCT04590586|464598405|FG004|Overall Study|Death|19|||
129084450|NCT04590586|464598406|FG005|Overall Study|Death|3|||
129084451|NCT04590586|464598401|FG000|Overall Study|Lost to Follow-up|3|||
129084452|NCT04590586|464598402|FG001|Overall Study|Lost to Follow-up|0|||
129084453|NCT04590586|464598403|FG002|Overall Study|Lost to Follow-up|11|||
129084454|NCT04590586|464598404|FG003|Overall Study|Lost to Follow-up|11|||
129143071|NCT05430919|464818563|FG000|Overall Study|Lost to Follow-up|0|||
129084455|NCT04590586|464598405|FG004|Overall Study|Lost to Follow-up|6|||
129084456|NCT04590586|464598406|FG005|Overall Study|Lost to Follow-up|0|||
129084457|NCT04590586|464598401|FG000|Overall Study|Withdrawal by Subject|0|||
129084458|NCT04590586|464598402|FG001|Overall Study|Withdrawal by Subject|0|||
129084459|NCT04590586|464598403|FG002|Overall Study|Withdrawal by Subject|6|||
129084460|NCT04590586|464598404|FG003|Overall Study|Withdrawal by Subject|0|||
129084461|NCT04590586|464598405|FG004|Overall Study|Withdrawal by Subject|3|||
129084462|NCT04590586|464598406|FG005|Overall Study|Withdrawal by Subject|0|||
129084463|NCT04590586|464598401|FG000|Overall Study|Other|3|||
129084464|NCT04590586|464598402|FG001|Overall Study|Other|0|||
129084465|NCT04590586|464598403|FG002|Overall Study|Other|1|||
129084466|NCT04590586|464598404|FG003|Overall Study|Other|1|||
129084467|NCT04590586|464598405|FG004|Overall Study|Other|2|||
129084468|NCT04590586|464598406|FG005|Overall Study|Other|1|||
129084469|NCT01893281|464598407|FG000|Overall Study|Adverse Event|1|||
129084470|NCT01893281|464598407|FG000|Overall Study|Protocol Violation|1|||
129084471|NCT01893281|464598407|FG000|Overall Study|Withdrawal by Subject|1|||
129084472|NCT02218736|464598408|FG000|Overall Study|Withdrawal by Subject|10|||
129084473|NCT02218736|464598409|FG001|Overall Study|Withdrawal by Subject|9|||
129084474|NCT02218736|464598408|FG000|Overall Study|Protocol Violation|2|||
129084475|NCT02218736|464598409|FG001|Overall Study|Protocol Violation|0|||
129084476|NCT05481125|464598412|FG000|Overall Study|Adverse Event|1|||
129084477|NCT05481125|464598413|FG001|Overall Study|Adverse Event|0|||
129084478|NCT05481125|464598412|FG000|Overall Study|Lost to Follow-up|0|||
129084479|NCT05481125|464598413|FG001|Overall Study|Lost to Follow-up|1|||
129084480|NCT05481125|464598412|FG000|Overall Study|Withdrawal by Subject|0|||
129084481|NCT05481125|464598413|FG001|Overall Study|Withdrawal by Subject|1|||
129084482|NCT02244463|464598414|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
129084483|NCT02244463|464598415|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129084484|NCT02244463|464598416|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129084485|NCT02244463|464598417|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129084486|NCT02244463|464598418|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129084487|NCT02244463|464598419|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129084488|NCT02244463|464598414|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
129084489|NCT02244463|464598415|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
129084490|NCT02244463|464598416|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
129084491|NCT02244463|464598417|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
129084492|NCT02244463|464598418|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
129084493|NCT02244463|464598419|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
129084494|NCT02244463|464598414|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129084495|NCT02244463|464598415|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
129084496|NCT02244463|464598416|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129084497|NCT02244463|464598417|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129084498|NCT02244463|464598418|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129084499|NCT02244463|464598419|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129084500|NCT02244463|464598414|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129084501|NCT02244463|464598415|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129084502|NCT02244463|464598416|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
129084503|NCT02244463|464598417|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129084504|NCT02244463|464598418|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129084505|NCT02244463|464598419|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129084506|NCT02244463|464598414|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129084507|NCT02244463|464598415|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129084508|NCT02244463|464598416|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129084509|NCT02244463|464598417|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
129084510|NCT02244463|464598418|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129084511|NCT02244463|464598419|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129084512|NCT02244463|464598414|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129084513|NCT02244463|464598415|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129084514|NCT02244463|464598416|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129084515|NCT02244463|464598417|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
129084516|NCT02244463|464598418|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129084517|NCT02244463|464598419|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129084518|NCT02244463|464598414|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129084519|NCT02244463|464598415|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129084520|NCT02244463|464598416|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129084521|NCT02244463|464598417|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
129084522|NCT02244463|464598418|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129084523|NCT02244463|464598419|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129084524|NCT02244463|464598414|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129084525|NCT02244463|464598415|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129143072|NCT05430919|464818564|FG001|Overall Study|Lost to Follow-up|1|||
129084526|NCT02244463|464598416|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129084527|NCT02244463|464598417|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
129084528|NCT02244463|464598418|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129084529|NCT02244463|464598419|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129084530|NCT02244463|464598414|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129084531|NCT02244463|464598415|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129084532|NCT02244463|464598416|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129084533|NCT02244463|464598417|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
129084534|NCT02244463|464598418|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129084535|NCT02244463|464598419|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129084536|NCT02244463|464598414|FG000|Period 5: Phase II|Disease Progression|0|||
129084537|NCT02244463|464598415|FG001|Period 5: Phase II|Disease Progression|0|||
129084538|NCT02244463|464598416|FG002|Period 5: Phase II|Disease Progression|0|||
129084539|NCT02244463|464598417|FG003|Period 5: Phase II|Disease Progression|0|||
129084540|NCT02244463|464598418|FG004|Period 5: Phase II|Disease Progression|10|||
129084541|NCT02244463|464598419|FG005|Period 5: Phase II|Disease Progression|11|||
129084542|NCT02244463|464598414|FG000|Period 5: Phase II|Physician Decision|0|||
129084543|NCT02244463|464598415|FG001|Period 5: Phase II|Physician Decision|0|||
129084544|NCT02244463|464598416|FG002|Period 5: Phase II|Physician Decision|0|||
129084545|NCT02244463|464598417|FG003|Period 5: Phase II|Physician Decision|0|||
129084546|NCT02244463|464598418|FG004|Period 5: Phase II|Physician Decision|3|||
129084547|NCT02244463|464598419|FG005|Period 5: Phase II|Physician Decision|2|||
129084548|NCT02244463|464598414|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
129084549|NCT02244463|464598415|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
129084550|NCT02244463|464598416|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
129084551|NCT02244463|464598417|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
129084552|NCT02244463|464598418|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
129084553|NCT02244463|464598419|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
129084554|NCT02244463|464598414|FG000|Period 5: Phase II|Intercurrent Illness|0|||
129084555|NCT02244463|464598415|FG001|Period 5: Phase II|Intercurrent Illness|0|||
129084556|NCT02244463|464598416|FG002|Period 5: Phase II|Intercurrent Illness|0|||
129084557|NCT02244463|464598417|FG003|Period 5: Phase II|Intercurrent Illness|0|||
129084558|NCT02244463|464598418|FG004|Period 5: Phase II|Intercurrent Illness|2|||
129084559|NCT02244463|464598419|FG005|Period 5: Phase II|Intercurrent Illness|0|||
129084560|NCT02244463|464598414|FG000|Period 5: Phase II|Adverse Event|0|||
129084561|NCT02244463|464598415|FG001|Period 5: Phase II|Adverse Event|0|||
129084562|NCT02244463|464598416|FG002|Period 5: Phase II|Adverse Event|0|||
129084563|NCT02244463|464598417|FG003|Period 5: Phase II|Adverse Event|0|||
129084564|NCT02244463|464598418|FG004|Period 5: Phase II|Adverse Event|0|||
129084565|NCT02244463|464598419|FG005|Period 5: Phase II|Adverse Event|2|||
129084566|NCT02244463|464598414|FG000|Period 5: Phase II|Still On treatment|0|||
129084567|NCT02244463|464598415|FG001|Period 5: Phase II|Still On treatment|0|||
129084568|NCT02244463|464598416|FG002|Period 5: Phase II|Still On treatment|0|||
129084569|NCT02244463|464598417|FG003|Period 5: Phase II|Still On treatment|0|||
129084570|NCT02244463|464598418|FG004|Period 5: Phase II|Still On treatment|0|||
129084571|NCT02244463|464598419|FG005|Period 5: Phase II|Still On treatment|3|||
129084572|NCT01769508|464598420|FG000|Overall Study|Death|3|||
129084573|NCT01769508|464598420|FG000|Overall Study|Withdrawal by Subject|1|||
129143073|NCT05430919|464818565|FG002|Overall Study|Lost to Follow-up|0|||
129143074|NCT05430919|464818566|FG003|Overall Study|Lost to Follow-up|0|||
129143075|NCT05430919|464818563|FG000|Overall Study|Withdrawal by Subject|3|||
129143076|NCT05430919|464818564|FG001|Overall Study|Withdrawal by Subject|0|||
129143077|NCT05430919|464818565|FG002|Overall Study|Withdrawal by Subject|0|||
129143078|NCT05430919|464818566|FG003|Overall Study|Withdrawal by Subject|1|||
129143079|NCT04090749|464818568|FG000|Open Label Pilot|Lost to Follow-up|1|||
129143080|NCT04090749|464818569|FG001|Open Label Pilot|Lost to Follow-up|0|||
129143081|NCT04090749|464818570|FG002|Open Label Pilot|Lost to Follow-up|0|||
129143082|NCT04090749|464818568|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
129143083|NCT04090749|464818569|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
129143084|NCT04090749|464818570|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
129143085|NCT04090749|464818568|FG000|Pilot Trial|Lost to Follow-up|0|||
129084574|NCT01769508|464598420|FG000|Overall Study|Adverse Event|1|||
129084575|NCT01769508|464598420|FG000|Overall Study|Lost to Follow-up|1|||
129084576|NCT01598090|464598424|FG000|Treatment Period|Poor/non-compliance|0|||
129084577|NCT01598090|464598425|FG001|Treatment Period|Poor/non-compliance|2|||
129143086|NCT04090749|464818569|FG001|Pilot Trial|Lost to Follow-up|1|||
129084578|NCT01598090|464598426|FG002|Treatment Period|Poor/non-compliance|0|||
129084579|NCT01598090|464598424|FG000|Treatment Period|No longer meet study criteria|0|||
129084580|NCT01598090|464598425|FG001|Treatment Period|No longer meet study criteria|1|||
129084581|NCT01598090|464598426|FG002|Treatment Period|No longer meet study criteria|0|||
129084582|NCT01598090|464598424|FG000|Treatment Period|Lack of Efficacy|5|||
129084583|NCT01598090|464598425|FG001|Treatment Period|Lack of Efficacy|14|||
129084584|NCT01598090|464598426|FG002|Treatment Period|Lack of Efficacy|6|||
129084585|NCT01598090|464598424|FG000|Treatment Period|Adverse Event|2|||
129084586|NCT01598090|464598425|FG001|Treatment Period|Adverse Event|33|||
129084587|NCT01598090|464598426|FG002|Treatment Period|Adverse Event|17|||
129084588|NCT01598090|464598424|FG000|Treatment Period|Other reasons|0|||
129084589|NCT01598090|464598425|FG001|Treatment Period|Other reasons|4|||
129084590|NCT01598090|464598426|FG002|Treatment Period|Other reasons|1|||
129084591|NCT01598090|464598424|FG000|Treatment Period|Withdrawal by Subject|3|||
129084592|NCT01598090|464598425|FG001|Treatment Period|Withdrawal by Subject|13|||
129084593|NCT01598090|464598426|FG002|Treatment Period|Withdrawal by Subject|10|||
129084594|NCT01598090|464598424|FG000|Treatment Period|Lost to Follow-up|1|||
129084595|NCT01598090|464598425|FG001|Treatment Period|Lost to Follow-up|5|||
129084596|NCT01598090|464598426|FG002|Treatment Period|Lost to Follow-up|1|||
129084597|NCT01598090|464598424|FG000|Follow-up Period|Death|0|||
129084598|NCT01598090|464598425|FG001|Follow-up Period|Death|1|||
129084599|NCT01598090|464598426|FG002|Follow-up Period|Death|0|||
129084600|NCT01598090|464598424|FG000|Follow-up Period|No longer required per protocol|1|||
129084601|NCT01598090|464598425|FG001|Follow-up Period|No longer required per protocol|3|||
129084602|NCT01598090|464598426|FG002|Follow-up Period|No longer required per protocol|2|||
129084603|NCT01598090|464598424|FG000|Follow-up Period|Not reported|0|||
129084604|NCT01598090|464598425|FG001|Follow-up Period|Not reported|10|||
129084605|NCT01598090|464598426|FG002|Follow-up Period|Not reported|4|||
129084606|NCT01598090|464598424|FG000|Follow-up Period|Withdrawal by Subject|0|||
129084607|NCT01598090|464598425|FG001|Follow-up Period|Withdrawal by Subject|3|||
129084608|NCT01598090|464598426|FG002|Follow-up Period|Withdrawal by Subject|2|||
129084609|NCT01598090|464598424|FG000|Follow-up Period|Other reasons|2|||
129084610|NCT01598090|464598425|FG001|Follow-up Period|Other reasons|8|||
129084611|NCT01598090|464598426|FG002|Follow-up Period|Other reasons|8|||
129084612|NCT01598090|464598424|FG000|Follow-up Period|Lost to Follow-up|2|||
129084613|NCT01598090|464598425|FG001|Follow-up Period|Lost to Follow-up|10|||
129084614|NCT01598090|464598426|FG002|Follow-up Period|Lost to Follow-up|12|||
129084615|NCT03615144|464598427|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
129084616|NCT03615144|464598428|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
129084617|NCT02587598|464598431|FG000|Overall Study|Death|4|||
129084618|NCT02587598|464598432|FG001|Overall Study|Death|8|||
129084619|NCT02587598|464598433|FG002|Overall Study|Death|4|||
129084620|NCT02587598|464598434|FG003|Overall Study|Death|16|||
129084621|NCT02587598|464598435|FG004|Overall Study|Death|9|||
129084622|NCT02587598|464598436|FG005|Overall Study|Death|4|||
129084623|NCT02587598|464598437|FG006|Overall Study|Death|6|||
129084624|NCT02587598|464598438|FG007|Overall Study|Death|7|||
129084625|NCT02587598|464598439|FG008|Overall Study|Death|9|||
129084626|NCT02587598|464598440|FG009|Overall Study|Death|1|||
129084627|NCT02587598|464598441|FG010|Overall Study|Death|3|||
129084628|NCT02587598|464598431|FG000|Overall Study|Study Terminated by the Sponsor|0|||
129084629|NCT02587598|464598432|FG001|Overall Study|Study Terminated by the Sponsor|1|||
129084630|NCT02587598|464598433|FG002|Overall Study|Study Terminated by the Sponsor|0|||
129084631|NCT02587598|464598434|FG003|Overall Study|Study Terminated by the Sponsor|3|||
129084632|NCT02587598|464598435|FG004|Overall Study|Study Terminated by the Sponsor|0|||
129084633|NCT02587598|464598436|FG005|Overall Study|Study Terminated by the Sponsor|1|||
129084634|NCT02587598|464598437|FG006|Overall Study|Study Terminated by the Sponsor|0|||
129084635|NCT02587598|464598438|FG007|Overall Study|Study Terminated by the Sponsor|0|||
129084636|NCT02587598|464598439|FG008|Overall Study|Study Terminated by the Sponsor|0|||
129084637|NCT02587598|464598440|FG009|Overall Study|Study Terminated by the Sponsor|1|||
129084638|NCT02587598|464598441|FG010|Overall Study|Study Terminated by the Sponsor|6|||
129084639|NCT02587598|464598431|FG000|Overall Study|Reason for study withdrawal not specified|0|||
129084640|NCT02587598|464598432|FG001|Overall Study|Reason for study withdrawal not specified|1|||
129084641|NCT02587598|464598433|FG002|Overall Study|Reason for study withdrawal not specified|0|||
129084642|NCT02587598|464598434|FG003|Overall Study|Reason for study withdrawal not specified|0|||
129084643|NCT02587598|464598435|FG004|Overall Study|Reason for study withdrawal not specified|0|||
129143087|NCT04090749|464818570|FG002|Pilot Trial|Lost to Follow-up|1|||
129084644|NCT02587598|464598436|FG005|Overall Study|Reason for study withdrawal not specified|0|||
129084645|NCT02587598|464598437|FG006|Overall Study|Reason for study withdrawal not specified|0|||
129084646|NCT02587598|464598438|FG007|Overall Study|Reason for study withdrawal not specified|0|||
129084647|NCT02587598|464598439|FG008|Overall Study|Reason for study withdrawal not specified|0|||
129084648|NCT02587598|464598440|FG009|Overall Study|Reason for study withdrawal not specified|0|||
129084649|NCT02587598|464598441|FG010|Overall Study|Reason for study withdrawal not specified|0|||
129084650|NCT02587598|464598431|FG000|Overall Study|Withdrawal by Subject|0|||
129084651|NCT02587598|464598432|FG001|Overall Study|Withdrawal by Subject|1|||
129084652|NCT02587598|464598433|FG002|Overall Study|Withdrawal by Subject|0|||
129084653|NCT02587598|464598434|FG003|Overall Study|Withdrawal by Subject|2|||
129084654|NCT02587598|464598435|FG004|Overall Study|Withdrawal by Subject|3|||
129084655|NCT02587598|464598436|FG005|Overall Study|Withdrawal by Subject|1|||
129084656|NCT02587598|464598437|FG006|Overall Study|Withdrawal by Subject|0|||
129084657|NCT02587598|464598438|FG007|Overall Study|Withdrawal by Subject|0|||
129084658|NCT02587598|464598439|FG008|Overall Study|Withdrawal by Subject|0|||
129084659|NCT02587598|464598440|FG009|Overall Study|Withdrawal by Subject|1|||
129143088|NCT02528305|464818571|FG000|Overall Study|Withdrawal by Subject|1|||
129143089|NCT02528305|464818571|FG000|Overall Study|Adverse Event|1|||
129143090|NCT02528305|464818571|FG000|Overall Study|Physician Decision|1|||
129143091|NCT02691494|464818572|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
129143092|NCT02691494|464818573|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
129084660|NCT02587598|464598441|FG010|Overall Study|Withdrawal by Subject|2|||
129084661|NCT02587598|464598431|FG000|Overall Study|Physician Decision|0|||
129084662|NCT02587598|464598432|FG001|Overall Study|Physician Decision|0|||
129084663|NCT02587598|464598433|FG002|Overall Study|Physician Decision|0|||
129084664|NCT02587598|464598434|FG003|Overall Study|Physician Decision|0|||
129084665|NCT02587598|464598435|FG004|Overall Study|Physician Decision|0|||
129084666|NCT02587598|464598436|FG005|Overall Study|Physician Decision|0|||
129084667|NCT02587598|464598437|FG006|Overall Study|Physician Decision|0|||
129084668|NCT02587598|464598438|FG007|Overall Study|Physician Decision|0|||
129084669|NCT02587598|464598439|FG008|Overall Study|Physician Decision|0|||
129084670|NCT02587598|464598440|FG009|Overall Study|Physician Decision|0|||
129084671|NCT02587598|464598441|FG010|Overall Study|Physician Decision|3|||
129084672|NCT02828124|464598442|FG000|Overall Study|Disease Progression|1|||
129084673|NCT02828124|464598443|FG001|Overall Study|Disease Progression|2|||
129084674|NCT02828124|464598444|FG002|Overall Study|Disease Progression|1|||
129084675|NCT02828124|464598445|FG003|Overall Study|Disease Progression|4|||
129084676|NCT02828124|464598442|FG000|Overall Study|AE Unrelated to Study Drug|0|||
129084677|NCT02828124|464598443|FG001|Overall Study|AE Unrelated to Study Drug|0|||
129084678|NCT02828124|464598444|FG002|Overall Study|AE Unrelated to Study Drug|0|||
129084679|NCT02828124|464598445|FG003|Overall Study|AE Unrelated to Study Drug|1|||
129084680|NCT02828124|464598442|FG000|Overall Study|Subject Withdrew Consent|0|||
129084681|NCT02828124|464598443|FG001|Overall Study|Subject Withdrew Consent|0|||
129084682|NCT02828124|464598444|FG002|Overall Study|Subject Withdrew Consent|0|||
129084683|NCT02828124|464598445|FG003|Overall Study|Subject Withdrew Consent|1|||
129084684|NCT02353442|464598446|FG000|Overall Study|Withdrawal by Subject|3|||
129084685|NCT02353442|464598447|FG001|Overall Study|Withdrawal by Subject|4|||
129084686|NCT03514485|464598448|FG000|Overall Study|Lost to Follow-up|5|||
129084687|NCT03514485|464598449|FG001|Overall Study|Lost to Follow-up|3|||
129084688|NCT03514485|464598450|FG002|Overall Study|Lost to Follow-up|2|||
129084689|NCT03514485|464598451|FG003|Overall Study|Lost to Follow-up|0|||
129084690|NCT03514485|464598452|FG004|Overall Study|Lost to Follow-up|1|||
129084691|NCT03514485|464598453|FG005|Overall Study|Lost to Follow-up|4|||
129084692|NCT03514485|464598448|FG000|Overall Study|Withdrawal by Subject|0|||
129084693|NCT03514485|464598449|FG001|Overall Study|Withdrawal by Subject|1|||
129084694|NCT03514485|464598450|FG002|Overall Study|Withdrawal by Subject|3|||
129084695|NCT03514485|464598451|FG003|Overall Study|Withdrawal by Subject|1|||
129084696|NCT03514485|464598452|FG004|Overall Study|Withdrawal by Subject|2|||
129143093|NCT02691494|464818574|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
129143094|NCT02691494|464818572|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129143095|NCT02691494|464818573|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129143096|NCT02691494|464818574|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
129143097|NCT02691494|464818572|FG000|Post-Treatment Follow-Up Period|Other|2|||
129143098|NCT02691494|464818573|FG001|Post-Treatment Follow-Up Period|Other|1|||
129143099|NCT02691494|464818574|FG002|Post-Treatment Follow-Up Period|Other|1|||
129143100|NCT02691494|464818572|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
129143101|NCT02691494|464818573|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
129143102|NCT02691494|464818574|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
129143103|NCT02691494|464818572|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129143104|NCT02691494|464818573|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
129143105|NCT02691494|464818574|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
129143106|NCT00787800|464818575|FG000|Overall Study|Withdrawal by Subject|3|||
129143107|NCT00787800|464818576|FG001|Overall Study|Withdrawal by Subject|5|||
129143108|NCT00787800|464818575|FG000|Overall Study|Death|0|||
129143109|NCT00787800|464818576|FG001|Overall Study|Death|2|||
129143110|NCT04309500|464818580|FG000|Overall Study|Lost to Follow-up|1|||
129143111|NCT04309500|464818581|FG001|Overall Study|Lost to Follow-up|0|||
129143112|NCT04309500|464818582|FG002|Overall Study|Lost to Follow-up|0|||
129143113|NCT04309500|464818583|FG003|Overall Study|Lost to Follow-up|0|||
129084697|NCT03514485|464598453|FG005|Overall Study|Withdrawal by Subject|1|||
129084698|NCT02294396|464598454|FG000|Overall Study|Adverse Event|26|||
129084699|NCT02294396|464598455|FG001|Overall Study|Adverse Event|25|||
129084700|NCT02294396|464598456|FG002|Overall Study|Adverse Event|21|||
129084701|NCT02294396|464598457|FG003|Overall Study|Adverse Event|24|||
129084702|NCT02294396|464598454|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
129084703|NCT02294396|464598455|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
129084704|NCT02294396|464598456|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
129084705|NCT02294396|464598457|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
129084706|NCT02294396|464598454|FG000|Overall Study|Withdrawal by Subject|8|||
129143114|NCT00913835|464818584|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
128724277|NCT01364428|463289023|FG000|Overall Study|Protocol Violation|2|||
128724278|NCT01364428|463289024|FG001|Overall Study|Protocol Violation|0|||
129084707|NCT02294396|464598455|FG001|Overall Study|Withdrawal by Subject|6|||
129084708|NCT02294396|464598456|FG002|Overall Study|Withdrawal by Subject|6|||
129084709|NCT02294396|464598457|FG003|Overall Study|Withdrawal by Subject|8|||
129084710|NCT02294396|464598454|FG000|Overall Study|Lost to Follow-up|0|||
129084711|NCT02294396|464598455|FG001|Overall Study|Lost to Follow-up|0|||
129084712|NCT02294396|464598456|FG002|Overall Study|Lost to Follow-up|1|||
129084713|NCT02294396|464598457|FG003|Overall Study|Lost to Follow-up|1|||
129084714|NCT02294396|464598454|FG000|Overall Study|Protocol Deviation|3|||
129084715|NCT02294396|464598455|FG001|Overall Study|Protocol Deviation|2|||
129084716|NCT02294396|464598456|FG002|Overall Study|Protocol Deviation|2|||
129084717|NCT02294396|464598457|FG003|Overall Study|Protocol Deviation|1|||
129084718|NCT02294396|464598454|FG000|Overall Study|Miscellaneous|2|||
129084719|NCT02294396|464598455|FG001|Overall Study|Miscellaneous|0|||
129084720|NCT02294396|464598456|FG002|Overall Study|Miscellaneous|5|||
129084721|NCT02294396|464598457|FG003|Overall Study|Miscellaneous|2|||
129084722|NCT02120833|464598458|FG000|Overall Study|Adverse Event|1|||
129084723|NCT02120833|464598459|FG001|Overall Study|Adverse Event|0|||
129084724|NCT02120833|464598458|FG000|Overall Study|Withdrawal by Subject|2|||
129084725|NCT02120833|464598459|FG001|Overall Study|Withdrawal by Subject|0|||
129084726|NCT02120833|464598458|FG000|Overall Study|Lost to Follow-up|1|||
129084727|NCT02120833|464598459|FG001|Overall Study|Lost to Follow-up|1|||
129084728|NCT02438826|464598460|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
129084729|NCT02438826|464598461|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
129084730|NCT02438826|464598462|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129084731|NCT02438826|464598463|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129084732|NCT02438826|464598460|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
129084733|NCT02438826|464598461|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129084734|NCT02438826|464598462|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129084735|NCT02438826|464598463|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129084736|NCT02438826|464598460|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
129084737|NCT02438826|464598461|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
129084738|NCT02438826|464598462|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129084739|NCT02438826|464598463|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129084740|NCT02438826|464598460|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
129084741|NCT02438826|464598461|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
129084742|NCT02438826|464598462|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
129084743|NCT02438826|464598463|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
129084744|NCT02438826|464598460|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
129084745|NCT02438826|464598461|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
129084746|NCT02438826|464598462|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
129084747|NCT02438826|464598463|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
129084748|NCT02438826|464598460|FG000|Open-Label Treatment Phase|Adverse Event|11|||
129084749|NCT02438826|464598461|FG001|Open-Label Treatment Phase|Adverse Event|6|||
129084750|NCT02438826|464598462|FG002|Open-Label Treatment Phase|Adverse Event|0|||
129084751|NCT02438826|464598463|FG003|Open-Label Treatment Phase|Adverse Event|0|||
129084752|NCT02438826|464598460|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
129084753|NCT02438826|464598461|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
129084754|NCT02438826|464598462|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
129084755|NCT02438826|464598463|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
129084756|NCT02438826|464598460|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
129084757|NCT02438826|464598461|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
129084758|NCT02438826|464598462|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
129084759|NCT02438826|464598463|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
129084760|NCT02438826|464598460|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
129084761|NCT02438826|464598461|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
129084762|NCT02438826|464598462|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
129084763|NCT02438826|464598463|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
129084764|NCT02438826|464598460|FG000|Post-Treatment Phase|Adverse Event|3|||
129084765|NCT02438826|464598461|FG001|Post-Treatment Phase|Adverse Event|0|||
128724279|NCT01364428|463289023|FG000|Overall Study|Withdrawal Criteria|14|||
128724280|NCT01364428|463289024|FG001|Overall Study|Withdrawal Criteria|10|||
129084766|NCT02438826|464598462|FG002|Post-Treatment Phase|Adverse Event|0|||
129084767|NCT02438826|464598463|FG003|Post-Treatment Phase|Adverse Event|0|||
129084768|NCT02438826|464598460|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
128724281|NCT01364428|463289023|FG000|Overall Study|Other|3|||
129084769|NCT02438826|464598461|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
129084770|NCT02438826|464598462|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
129084771|NCT02438826|464598463|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
129084772|NCT02438826|464598460|FG000|Post-Treatment Phase|Physician Decision|1|||
129143115|NCT00913835|464818585|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
129143116|NCT00913835|464818584|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
129143117|NCT00913835|464818585|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
129143118|NCT00913835|464818584|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
129143119|NCT00913835|464818585|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
129143120|NCT00913835|464818584|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
129143121|NCT00913835|464818585|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
129143122|NCT00913835|464818584|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
129084773|NCT02438826|464598461|FG001|Post-Treatment Phase|Physician Decision|0|||
129084774|NCT02438826|464598462|FG002|Post-Treatment Phase|Physician Decision|0|||
129084775|NCT02438826|464598463|FG003|Post-Treatment Phase|Physician Decision|0|||
129084776|NCT02438826|464598460|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
129084777|NCT02438826|464598461|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
129084778|NCT02438826|464598462|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
129084779|NCT02438826|464598463|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
129084780|NCT04105218|464598469|FG000|Overall Study|Withdrawal by Subject|3|||
129084781|NCT04105218|464598470|FG001|Overall Study|Withdrawal by Subject|2|||
129084782|NCT04105218|464598469|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
129084783|NCT04105218|464598470|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
129084784|NCT04105218|464598469|FG000|Overall Study|Failed screening tests|2|||
129084785|NCT04105218|464598470|FG001|Overall Study|Failed screening tests|1|||
129084786|NCT01435460|464598473|FG000|Overall Study|Adverse Event|2|||
129084787|NCT01435460|464598474|FG001|Overall Study|Adverse Event|1|||
129084788|NCT01435460|464598473|FG000|Overall Study|Lost to Follow-up|6|||
129084789|NCT01435460|464598474|FG001|Overall Study|Lost to Follow-up|1|||
129143123|NCT00913835|464818585|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
129143124|NCT00637156|464818586|FG000|Overall Study|Withdrawal by Subject|0|||
129143125|NCT00637156|464818587|FG001|Overall Study|Withdrawal by Subject|7|||
128724282|NCT01364428|463289024|FG001|Overall Study|Other|3|||
129084790|NCT01435460|464598473|FG000|Overall Study|Withdrawal by Subject|1|||
129084791|NCT01435460|464598474|FG001|Overall Study|Withdrawal by Subject|3|||
129084792|NCT01435460|464598473|FG000|Overall Study|Protocol Violation|0|||
129143126|NCT00637156|464818586|FG000|Overall Study|Death|0|||
129143127|NCT00637156|464818587|FG001|Overall Study|Death|1|||
129084793|NCT01435460|464598474|FG001|Overall Study|Protocol Violation|1|||
129143128|NCT00637156|464818586|FG000|Overall Study|Lost to Follow-up|10|||
129143129|NCT00637156|464818587|FG001|Overall Study|Lost to Follow-up|16|||
129143130|NCT00461812|464818588|FG000|Overall Study|study terminated|10|||
129143131|NCT01308788|464818589|FG000|2-year Treatment|medication change by treating physician|4|||
129143132|NCT01308788|464818590|FG001|2-year Treatment|medication change by treating physician|11|||
129143133|NCT03193437|464818591|FG000|Overall Study|Adverse Event|4|||
129143134|NCT03193437|464818591|FG000|Overall Study|Withdrawal by Subject|2|||
129143135|NCT03193437|464818591|FG000|Overall Study|Disease Progression|2|||
129143136|NCT05487378|464818592|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
129143137|NCT05487378|464818593|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
129143138|NCT05487378|464818592|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
128724283|NCT03925324|463289025|FG000|Overall Study|Death|1|||
129084794|NCT01435460|464598473|FG000|Overall Study|Did not meet eligibility criteria|2|||
129084795|NCT01435460|464598474|FG001|Overall Study|Did not meet eligibility criteria|0|||
129084796|NCT01706939|464598475|FG000|Pre Randomization|Screen Failure|1|||
129084797|NCT01706939|464598476|FG001|Pre Randomization|Screen Failure|0|||
129084798|NCT01706939|464598477|FG002|Pre Randomization|Screen Failure|0|||
129084799|NCT01706939|464598475|FG000|Pre Randomization|Ineligible for Randomization|1|||
129084800|NCT01706939|464598476|FG001|Pre Randomization|Ineligible for Randomization|0|||
129084801|NCT01706939|464598477|FG002|Pre Randomization|Ineligible for Randomization|0|||
129084802|NCT01706939|464598475|FG000|Pre Randomization|Withdrawal by Subject|1|||
129084803|NCT01706939|464598476|FG001|Pre Randomization|Withdrawal by Subject|0|||
129084804|NCT01706939|464598477|FG002|Pre Randomization|Withdrawal by Subject|0|||
129084805|NCT01706939|464598475|FG000|Randomization|Insufficient QoL survey compliance|0|||
129084806|NCT01706939|464598476|FG001|Randomization|Insufficient QoL survey compliance|1|||
129084807|NCT01706939|464598477|FG002|Randomization|Insufficient QoL survey compliance|1|||
129084808|NCT01706939|464598475|FG000|Randomization|Progression of disease|0|||
129084809|NCT01706939|464598476|FG001|Randomization|Progression of disease|2|||
129084810|NCT01706939|464598477|FG002|Randomization|Progression of disease|1|||
129084811|NCT01046903|464598479|FG000|Overall Study|Lost to Follow-up|16|||
129084812|NCT01046903|464598479|FG000|Overall Study|Adverse Event|4|||
129084813|NCT01046903|464598479|FG000|Overall Study|Withdrawal by Subject|3|||
129084814|NCT01046903|464598479|FG000|Overall Study|Other|5|||
129084815|NCT04152837|464598491|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
129084816|NCT04152837|464598491|FG000|Maintenance Period|Adverse Event|1|||
129084817|NCT04152837|464598491|FG000|Maintenance Period|Withdrawal by Subject|1|||
128724284|NCT03925324|463289026|FG001|Overall Study|Death|1|||
128724285|NCT02689258|463289028|FG000|Overall Study|Subject Non-Compliance|0|||
128724286|NCT02689258|463289029|FG001|Overall Study|Subject Non-Compliance|1|||
128724287|NCT02689258|463289030|FG002|Overall Study|Subject Non-Compliance|0|||
129084818|NCT04152837|464598491|FG000|Maintenance Period|Sponsor Termination of Study|2|||
129084819|NCT00101166|464598494|FG000|Overall Study|progressive disease|10|||
129084820|NCT00686829|464598495|FG000|Overall Study|Adverse Event|5|||
129084821|NCT00686829|464598495|FG000|Overall Study|Lack of Efficacy|6|||
129084822|NCT00686829|464598495|FG000|Overall Study|Lost to Follow-up|4|||
129084823|NCT00686829|464598495|FG000|Overall Study|Withdrawal by Subject|14|||
129084824|NCT00686829|464598495|FG000|Overall Study|Protocol Violation|3|||
129084825|NCT00686829|464598495|FG000|Overall Study|Sponsor discontinued VCV|47|||
129084826|NCT01217476|464598498|FG000|Overall Study|Adverse Event|6|||
129084827|NCT01217476|464598499|FG001|Overall Study|Adverse Event|1|||
129084828|NCT01217476|464598498|FG000|Overall Study|Physician Decision|0|||
129084829|NCT01217476|464598499|FG001|Overall Study|Physician Decision|1|||
129084830|NCT01217476|464598498|FG000|Overall Study|Withdrawal by Subject|3|||
129084831|NCT01217476|464598499|FG001|Overall Study|Withdrawal by Subject|3|||
129084832|NCT01217476|464598498|FG000|Overall Study|Surgery on the Target Limb|0|||
129084833|NCT01217476|464598499|FG001|Overall Study|Surgery on the Target Limb|2|||
129084834|NCT01217476|464598498|FG000|Overall Study|Protocol Deviation|1|||
129084835|NCT01217476|464598499|FG001|Overall Study|Protocol Deviation|0|||
129084836|NCT01217476|464598498|FG000|Overall Study|Other|2|||
129084837|NCT01217476|464598499|FG001|Overall Study|Other|0|||
129084838|NCT03033602|464598500|FG000|Overall Study|Withdrawal by Subject|11|||
129084839|NCT03033602|464598501|FG001|Overall Study|Withdrawal by Subject|21|||
128724288|NCT02689258|463289031|FG003|Overall Study|Subject Non-Compliance|0|||
128724289|NCT02689258|463289032|FG004|Overall Study|Subject Non-Compliance|0|||
128724290|NCT02689258|463289033|FG005|Overall Study|Subject Non-Compliance|0|||
129084840|NCT03033602|464598500|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
129084841|NCT03033602|464598501|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
129084842|NCT04445714|464598502|FG000|Overall Study|Discontinuation of the study|14|||
128724291|NCT02689258|463289034|FG006|Overall Study|Subject Non-Compliance|0|||
128724292|NCT02689258|463289035|FG007|Overall Study|Subject Non-Compliance|0|||
129084843|NCT04445714|464598502|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
129084844|NCT04445714|464598502|FG000|Overall Study|Withdrawal of Informed Consent|8|||
129084845|NCT01672710|464598503|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
129084846|NCT01672710|464598504|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
129084847|NCT01672710|464598503|FG000|3 Month Follow up|Lost to Follow-up|2|||
129084848|NCT01672710|464598504|FG001|3 Month Follow up|Lost to Follow-up|3|||
129084849|NCT01672710|464598503|FG000|3 Month Follow up|follow up due after termination date|4|||
129084850|NCT01672710|464598504|FG001|3 Month Follow up|follow up due after termination date|1|||
129084851|NCT04999163|464598505|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
129084852|NCT04999163|464598506|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
129084853|NCT04999163|464598505|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
129084854|NCT04999163|464598506|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
129084855|NCT04999163|464598505|FG000|Overall Study|Withdrawal by Subject|1|||
129084856|NCT04999163|464598506|FG001|Overall Study|Withdrawal by Subject|0|||
129084857|NCT01399047|464600670|FG000|Overall Study|Withdrawal by Subject|0|||
129084858|NCT01399047|464600671|FG001|Overall Study|Withdrawal by Subject|1|||
129084859|NCT01283334|464600679|FG000|Overall Study|Withdrawal by Subject|1|||
129084860|NCT01283334|464600679|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
129084861|NCT01283334|464600679|FG000|Overall Study|Adverse Event|4|||
129084862|NCT01283334|464600679|FG000|Overall Study|Physician Decision|1|||
129084863|NCT03467217|464600680|FG000|Overall Study|Trial stopped early|5|||
129084864|NCT03467217|464600681|FG001|Overall Study|Trial stopped early|2|||
129084865|NCT03467217|464600680|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
129084866|NCT03467217|464600681|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
129084867|NCT03467217|464600680|FG000|Overall Study|Lost to Follow-up|0|||
129084868|NCT03467217|464600681|FG001|Overall Study|Lost to Follow-up|2|||
129084869|NCT03233529|464600685|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
129084870|NCT03233529|464600685|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
129084871|NCT01177293|464600686|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
129084872|NCT01177293|464600687|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
129084873|NCT00160706|464600689|FG000|Overall Study|Adverse Event|53|||
129084874|NCT00160706|464600689|FG000|Overall Study|Adverse Event and Other Reason|105|||
129084875|NCT00160706|464600689|FG000|Overall Study|Protocol Violation|3|||
129084876|NCT00160706|464600689|FG000|Overall Study|Withdrawal by Subject|41|||
129084877|NCT00160706|464600689|FG000|Overall Study|Withdrawal by Subject and Other|12|||
129084878|NCT00160706|464600689|FG000|Overall Study|Physician Decision|10|||
129084879|NCT00160706|464600689|FG000|Overall Study|Physician Decision and Other|3|||
129084880|NCT00160706|464600689|FG000|Overall Study|Lost to Follow-up|4|||
129084881|NCT00160706|464600689|FG000|Overall Study|Lost to Follow-up and Other|1|||
129084882|NCT00160706|464600689|FG000|Overall Study|Lack of Efficacy|42|||
129084883|NCT00160706|464600689|FG000|Overall Study|Lack of Efficacy and Other|1|||
129084884|NCT00160706|464600689|FG000|Overall Study|Other Reason|11|||
129084885|NCT03214380|464600690|FG000|Lead-in|Adverse Event|3|||
129084886|NCT03214380|464600691|FG001|Lead-in|Adverse Event|0|||
129084887|NCT03214380|464600692|FG002|Lead-in|Adverse Event|0|||
129084888|NCT03214380|464600693|FG003|Lead-in|Adverse Event|1|||
129084889|NCT03214380|464600694|FG004|Lead-in|Adverse Event|0|||
129084890|NCT03214380|464600695|FG005|Lead-in|Adverse Event|0|||
129084891|NCT03214380|464600690|FG000|Lead-in|Lost to Follow-up|4|||
129084892|NCT03214380|464600691|FG001|Lead-in|Lost to Follow-up|0|||
129084893|NCT03214380|464600692|FG002|Lead-in|Lost to Follow-up|0|||
129084894|NCT03214380|464600693|FG003|Lead-in|Lost to Follow-up|1|||
129084895|NCT03214380|464600694|FG004|Lead-in|Lost to Follow-up|0|||
129084896|NCT03214380|464600695|FG005|Lead-in|Lost to Follow-up|0|||
129084897|NCT03214380|464600690|FG000|Lead-in|Eligibility Criteria|3|||
129143139|NCT05487378|464818593|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
129143140|NCT02414841|464818594|FG000|Overall Study|Withdrawal by Subject|7|||
129143141|NCT02414841|464818595|FG001|Overall Study|Withdrawal by Subject|5|||
129143142|NCT02414841|464818594|FG000|Overall Study|Lost to Follow-up|13|||
129143143|NCT02414841|464818595|FG001|Overall Study|Lost to Follow-up|6|||
129143144|NCT02414841|464818594|FG000|Overall Study|Death|17|||
129143145|NCT02414841|464818595|FG001|Overall Study|Death|14|||
129084898|NCT03214380|464600691|FG001|Lead-in|Eligibility Criteria|0|||
129084899|NCT03214380|464600692|FG002|Lead-in|Eligibility Criteria|0|||
129084900|NCT03214380|464600693|FG003|Lead-in|Eligibility Criteria|0|||
129084901|NCT03214380|464600694|FG004|Lead-in|Eligibility Criteria|0|||
129084902|NCT03214380|464600695|FG005|Lead-in|Eligibility Criteria|0|||
129084903|NCT03214380|464600690|FG000|Lead-in|Physician Decision|6|||
129084904|NCT03214380|464600691|FG001|Lead-in|Physician Decision|0|||
129084905|NCT03214380|464600692|FG002|Lead-in|Physician Decision|0|||
129084906|NCT03214380|464600693|FG003|Lead-in|Physician Decision|0|||
129084907|NCT03214380|464600694|FG004|Lead-in|Physician Decision|0|||
129084908|NCT03214380|464600695|FG005|Lead-in|Physician Decision|0|||
129143146|NCT02414841|464818594|FG000|Overall Study|Received a Kidney Transplant|13|||
129143147|NCT02414841|464818595|FG001|Overall Study|Received a Kidney Transplant|4|||
129143148|NCT02414841|464818594|FG000|Overall Study|Randomized But Not Treated|6|||
129143149|NCT02414841|464818595|FG001|Overall Study|Randomized But Not Treated|4|||
129143150|NCT00964678|464818613|FG000|Overall Study|Physician Decision|4|||
129143151|NCT03359395|464818616|FG000|First Intervention A / B|Withdrawal by Subject|1|||
129143152|NCT03359395|464818617|FG001|First Intervention A / B|Withdrawal by Subject|0|||
129143153|NCT03359395|464818616|FG000|First Intervention A / B|Lost to Follow-up|2|||
129143154|NCT03359395|464818617|FG001|First Intervention A / B|Lost to Follow-up|3|||
129143155|NCT03359395|464818616|FG000|Second Intervention B/A|Exclusion criteria|0|||
129143156|NCT03359395|464818617|FG001|Second Intervention B/A|Exclusion criteria|1|||
129084909|NCT03214380|464600690|FG000|Lead-in|Protocol Deviation|7|||
129143157|NCT03359395|464818616|FG000|Second Intervention B/A|Lost to Follow-up|3|||
129084910|NCT03214380|464600691|FG001|Lead-in|Protocol Deviation|0|||
129084911|NCT03214380|464600692|FG002|Lead-in|Protocol Deviation|0|||
129084912|NCT03214380|464600693|FG003|Lead-in|Protocol Deviation|3|||
129084913|NCT03214380|464600694|FG004|Lead-in|Protocol Deviation|0|||
129084914|NCT03214380|464600695|FG005|Lead-in|Protocol Deviation|0|||
129084915|NCT03214380|464600690|FG000|Lead-in|Withdrawal by Subject|41|||
129084916|NCT03214380|464600691|FG001|Lead-in|Withdrawal by Subject|0|||
129084917|NCT03214380|464600692|FG002|Lead-in|Withdrawal by Subject|0|||
129084918|NCT03214380|464600693|FG003|Lead-in|Withdrawal by Subject|14|||
129084919|NCT03214380|464600694|FG004|Lead-in|Withdrawal by Subject|0|||
129084920|NCT03214380|464600695|FG005|Lead-in|Withdrawal by Subject|0|||
129084921|NCT03214380|464600690|FG000|Lead-in|Family Emergency|1|||
129084922|NCT03214380|464600691|FG001|Lead-in|Family Emergency|0|||
129084923|NCT03214380|464600692|FG002|Lead-in|Family Emergency|0|||
129084924|NCT03214380|464600693|FG003|Lead-in|Family Emergency|0|||
129084925|NCT03214380|464600694|FG004|Lead-in|Family Emergency|0|||
129084926|NCT03214380|464600695|FG005|Lead-in|Family Emergency|0|||
129084927|NCT03214380|464600690|FG000|Lead-in|Natural Disaster|9|||
129084928|NCT03214380|464600691|FG001|Lead-in|Natural Disaster|0|||
129084929|NCT03214380|464600692|FG002|Lead-in|Natural Disaster|0|||
129084930|NCT03214380|464600693|FG003|Lead-in|Natural Disaster|0|||
129084931|NCT03214380|464600694|FG004|Lead-in|Natural Disaster|0|||
129084932|NCT03214380|464600695|FG005|Lead-in|Natural Disaster|0|||
129084933|NCT03214380|464600690|FG000|Lead-in|Non Compliance|1|||
129084934|NCT03214380|464600691|FG001|Lead-in|Non Compliance|0|||
129084935|NCT03214380|464600692|FG002|Lead-in|Non Compliance|0|||
129084936|NCT03214380|464600693|FG003|Lead-in|Non Compliance|0|||
129084937|NCT03214380|464600694|FG004|Lead-in|Non Compliance|0|||
129084938|NCT03214380|464600695|FG005|Lead-in|Non Compliance|0|||
129084939|NCT03214380|464600690|FG000|Lead-in|Participant Schedule|2|||
129084940|NCT03214380|464600691|FG001|Lead-in|Participant Schedule|0|||
129084941|NCT03214380|464600692|FG002|Lead-in|Participant Schedule|0|||
129084942|NCT03214380|464600693|FG003|Lead-in|Participant Schedule|0|||
129084943|NCT03214380|464600694|FG004|Lead-in|Participant Schedule|0|||
129084944|NCT03214380|464600695|FG005|Lead-in|Participant Schedule|0|||
129084945|NCT03214380|464600690|FG000|Treatment Period|Adverse Event|0|||
129084946|NCT03214380|464600691|FG001|Treatment Period|Adverse Event|1|||
129084947|NCT03214380|464600692|FG002|Treatment Period|Adverse Event|1|||
129084948|NCT03214380|464600693|FG003|Treatment Period|Adverse Event|0|||
129084949|NCT03214380|464600694|FG004|Treatment Period|Adverse Event|1|||
129084950|NCT03214380|464600695|FG005|Treatment Period|Adverse Event|0|||
129084951|NCT03214380|464600690|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
129084952|NCT03214380|464600691|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
129143158|NCT03359395|464818617|FG001|Second Intervention B/A|Lost to Follow-up|2|||
129143159|NCT03164356|464818618|FG000|Overall Study|Lost to Follow-up|1|||
129143160|NCT03164356|464818619|FG001|Overall Study|Lost to Follow-up|1|||
129143161|NCT03164356|464818620|FG002|Overall Study|Lost to Follow-up|2|||
129143162|NCT03164356|464818621|FG003|Overall Study|Lost to Follow-up|1|||
129143163|NCT03164356|464818618|FG000|Overall Study|Physician Decision|0|||
129143164|NCT03164356|464818619|FG001|Overall Study|Physician Decision|0|||
129143165|NCT03164356|464818620|FG002|Overall Study|Physician Decision|3|||
129143166|NCT03164356|464818621|FG003|Overall Study|Physician Decision|0|||
128724293|NCT02689258|463289036|FG008|Overall Study|Subject Non-Compliance|0|||
128724294|NCT02689258|463289037|FG009|Overall Study|Subject Non-Compliance|0|||
129084953|NCT03214380|464600692|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
129084954|NCT03214380|464600693|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
129084955|NCT03214380|464600694|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
129084956|NCT03214380|464600695|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
129084957|NCT03214380|464600690|FG000|Treatment Period|Withdrawal by Subject|0|||
129084958|NCT03214380|464600691|FG001|Treatment Period|Withdrawal by Subject|10|||
128724295|NCT02689258|463289038|FG010|Overall Study|Subject Non-Compliance|0|||
129084959|NCT03214380|464600692|FG002|Treatment Period|Withdrawal by Subject|8|||
129084960|NCT03214380|464600693|FG003|Treatment Period|Withdrawal by Subject|0|||
129084961|NCT03214380|464600694|FG004|Treatment Period|Withdrawal by Subject|7|||
129084962|NCT03214380|464600695|FG005|Treatment Period|Withdrawal by Subject|11|||
129084963|NCT03214380|464600690|FG000|Treatment Period|Death|0|||
129143167|NCT03164356|464818618|FG000|Overall Study|Protocol Violation|2|||
129084964|NCT03214380|464600691|FG001|Treatment Period|Death|1|||
129084965|NCT03214380|464600692|FG002|Treatment Period|Death|2|||
129084966|NCT03214380|464600693|FG003|Treatment Period|Death|0|||
129084967|NCT03214380|464600694|FG004|Treatment Period|Death|0|||
129084968|NCT03214380|464600695|FG005|Treatment Period|Death|0|||
129084969|NCT03214380|464600690|FG000|Treatment Period|Lost to Follow-up|0|||
129084970|NCT03214380|464600691|FG001|Treatment Period|Lost to Follow-up|6|||
129084971|NCT03214380|464600692|FG002|Treatment Period|Lost to Follow-up|3|||
129084972|NCT03214380|464600693|FG003|Treatment Period|Lost to Follow-up|0|||
129084973|NCT03214380|464600694|FG004|Treatment Period|Lost to Follow-up|0|||
129084974|NCT03214380|464600695|FG005|Treatment Period|Lost to Follow-up|0|||
129084975|NCT03214380|464600690|FG000|Treatment Period|Participant schedule|0|||
129084976|NCT03214380|464600691|FG001|Treatment Period|Participant schedule|0|||
129084977|NCT03214380|464600692|FG002|Treatment Period|Participant schedule|1|||
129084978|NCT03214380|464600693|FG003|Treatment Period|Participant schedule|0|||
129084979|NCT03214380|464600694|FG004|Treatment Period|Participant schedule|0|||
128724296|NCT02689258|463289039|FG011|Overall Study|Subject Non-Compliance|0|||
128724297|NCT02689258|463289028|FG000|Overall Study|Subject Refusal to Continue|0|||
128724298|NCT02689258|463289029|FG001|Overall Study|Subject Refusal to Continue|1|||
129084980|NCT03214380|464600695|FG005|Treatment Period|Participant schedule|0|||
128724299|NCT02689258|463289030|FG002|Overall Study|Subject Refusal to Continue|0|||
129084981|NCT03214380|464600690|FG000|Treatment Period|Treatment Interruption|0|||
129084982|NCT03214380|464600691|FG001|Treatment Period|Treatment Interruption|0|||
129084983|NCT03214380|464600692|FG002|Treatment Period|Treatment Interruption|1|||
129084984|NCT03214380|464600693|FG003|Treatment Period|Treatment Interruption|0|||
129084985|NCT03214380|464600694|FG004|Treatment Period|Treatment Interruption|0|||
129084986|NCT03214380|464600695|FG005|Treatment Period|Treatment Interruption|0|||
129084987|NCT01905553|464600702|FG000|Period 2|Adverse Event|1|||
129084988|NCT01905553|464600703|FG001|Period 2|Adverse Event|0|||
129084989|NCT00076752|464600709|FG000|Overall Study|Death|2|||
129084990|NCT00076752|464600709|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
129084991|NCT01014988|464600715|FG000|Overall Study|Adverse Event|20|||
129084992|NCT01014988|464600716|FG001|Overall Study|Adverse Event|0|||
129084993|NCT01014988|464600717|FG002|Overall Study|Adverse Event|1|||
129084994|NCT01014988|464600718|FG003|Overall Study|Adverse Event|0|||
129084995|NCT01014988|464600719|FG004|Overall Study|Adverse Event|1|||
129084996|NCT01014988|464600720|FG005|Overall Study|Adverse Event|3|||
129084997|NCT01014988|464600715|FG000|Overall Study|Lost to Follow-up|1|||
129084998|NCT01014988|464600716|FG001|Overall Study|Lost to Follow-up|0|||
129084999|NCT01014988|464600717|FG002|Overall Study|Lost to Follow-up|1|||
129085000|NCT01014988|464600718|FG003|Overall Study|Lost to Follow-up|0|||
129085001|NCT01014988|464600719|FG004|Overall Study|Lost to Follow-up|0|||
129085002|NCT01014988|464600720|FG005|Overall Study|Lost to Follow-up|0|||
129085003|NCT01014988|464600715|FG000|Overall Study|Physician Decision|1|||
129085004|NCT01014988|464600716|FG001|Overall Study|Physician Decision|0|||
129085005|NCT01014988|464600717|FG002|Overall Study|Physician Decision|0|||
129085006|NCT01014988|464600718|FG003|Overall Study|Physician Decision|0|||
129085007|NCT01014988|464600719|FG004|Overall Study|Physician Decision|0|||
129085008|NCT01014988|464600720|FG005|Overall Study|Physician Decision|0|||
129143168|NCT03164356|464818619|FG001|Overall Study|Protocol Violation|1|||
129143169|NCT03164356|464818620|FG002|Overall Study|Protocol Violation|0|||
129143170|NCT03164356|464818621|FG003|Overall Study|Protocol Violation|0|||
129143171|NCT03164356|464818618|FG000|Overall Study|Withdrawal by Subject|1|||
129143172|NCT03164356|464818619|FG001|Overall Study|Withdrawal by Subject|0|||
129143173|NCT03164356|464818620|FG002|Overall Study|Withdrawal by Subject|0|||
129143174|NCT03164356|464818621|FG003|Overall Study|Withdrawal by Subject|0|||
129143175|NCT03164356|464818618|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
129143176|NCT03164356|464818619|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
129143177|NCT03164356|464818620|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
129143178|NCT03164356|464818621|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
129143179|NCT03164356|464818618|FG000|Overall Study|Subject Incarcerated|0|||
129143180|NCT03164356|464818619|FG001|Overall Study|Subject Incarcerated|1|||
128724300|NCT02689258|463289031|FG003|Overall Study|Subject Refusal to Continue|0|||
129085009|NCT01014988|464600715|FG000|Overall Study|Withdrawal by Subject|1|||
129085010|NCT01014988|464600716|FG001|Overall Study|Withdrawal by Subject|0|||
129085011|NCT01014988|464600717|FG002|Overall Study|Withdrawal by Subject|0|||
129085012|NCT01014988|464600718|FG003|Overall Study|Withdrawal by Subject|0|||
129085013|NCT01014988|464600719|FG004|Overall Study|Withdrawal by Subject|0|||
129085014|NCT01014988|464600720|FG005|Overall Study|Withdrawal by Subject|0|||
129085015|NCT01683266|464600721|FG000|Overall Study|Adverse Event|5|||
129085016|NCT01683266|464600722|FG001|Overall Study|Adverse Event|4|||
129085017|NCT01683266|464600721|FG000|Overall Study|Lack of Efficacy|5|||
129085018|NCT01683266|464600722|FG001|Overall Study|Lack of Efficacy|2|||
129085019|NCT01683266|464600721|FG000|Overall Study|Protocol Violation|13|||
129085020|NCT01683266|464600722|FG001|Overall Study|Protocol Violation|6|||
129085021|NCT01683266|464600721|FG000|Overall Study|Personal Reason|17|||
129085022|NCT01683266|464600722|FG001|Overall Study|Personal Reason|25|||
129085023|NCT01683266|464600721|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
129085024|NCT01683266|464600722|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
129085025|NCT01683266|464600721|FG000|Overall Study|Lost to Follow-up|5|||
129085026|NCT01683266|464600722|FG001|Overall Study|Lost to Follow-up|0|||
129085027|NCT01683266|464600721|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
129085028|NCT01683266|464600722|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
129085029|NCT01683266|464600721|FG000|Overall Study|Nonserious Hypoglycemia|0|||
129085030|NCT01683266|464600722|FG001|Overall Study|Nonserious Hypoglycemia|3|||
129085031|NCT01683266|464600721|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129085032|NCT01683266|464600722|FG001|Overall Study|Perceived Lack of Efficacy|1|||
129085033|NCT01683266|464600721|FG000|Overall Study|Possibly Hypoglycemia|1|||
129085034|NCT01683266|464600722|FG001|Overall Study|Possibly Hypoglycemia|0|||
129085035|NCT01683266|464600721|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
129085036|NCT01683266|464600722|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
129085037|NCT00626821|464600729|FG000|Overall Study|Adverse Event|44|||
129085038|NCT00626821|464600729|FG000|Overall Study|Protocol Violation|33|||
129085039|NCT00626821|464600729|FG000|Overall Study|Withdrawal by Subject|10|||
129085040|NCT00626821|464600729|FG000|Overall Study|Physician Decision|9|||
129085041|NCT00626821|464600729|FG000|Overall Study|Product dysfunction|21|||
129085042|NCT00626821|464600729|FG000|Overall Study|other/unknown reason|104|||
129085043|NCT05217641|464600733|FG000|Overall Study|Lost to Follow-up|1|||
129085044|NCT05217641|464600734|FG001|Overall Study|Lost to Follow-up|1|||
129085045|NCT05217641|464600735|FG002|Overall Study|Lost to Follow-up|0|||
129085046|NCT05217641|464600736|FG003|Overall Study|Lost to Follow-up|1|||
129085047|NCT05217641|464600737|FG004|Overall Study|Lost to Follow-up|1|||
129085048|NCT05217641|464600738|FG005|Overall Study|Lost to Follow-up|0|||
129085049|NCT05217641|464600733|FG000|Overall Study|Withdrawal by Subject|0|||
129085050|NCT05217641|464600734|FG001|Overall Study|Withdrawal by Subject|0|||
129085051|NCT05217641|464600735|FG002|Overall Study|Withdrawal by Subject|0|||
129085052|NCT05217641|464600736|FG003|Overall Study|Withdrawal by Subject|3|||
129085053|NCT05217641|464600737|FG004|Overall Study|Withdrawal by Subject|1|||
129085054|NCT05217641|464600738|FG005|Overall Study|Withdrawal by Subject|0|||
129085055|NCT05217641|464600733|FG000|Overall Study|Other: participant did not specify reason|0|||
129085056|NCT05217641|464600734|FG001|Overall Study|Other: participant did not specify reason|0|||
129085057|NCT05217641|464600735|FG002|Overall Study|Other: participant did not specify reason|0|||
129085058|NCT05217641|464600736|FG003|Overall Study|Other: participant did not specify reason|0|||
129085059|NCT05217641|464600737|FG004|Overall Study|Other: participant did not specify reason|1|||
129085060|NCT05217641|464600738|FG005|Overall Study|Other: participant did not specify reason|0|||
129085061|NCT05217641|464600733|FG000|Overall Study|Extended Follow up|1|||
129085062|NCT05217641|464600734|FG001|Overall Study|Extended Follow up|1|||
129143181|NCT03164356|464818620|FG002|Overall Study|Subject Incarcerated|0|||
129143182|NCT03164356|464818621|FG003|Overall Study|Subject Incarcerated|0|||
129143183|NCT03164356|464818618|FG000|Overall Study|Prosthetist unable to participate|0|||
129143184|NCT03164356|464818619|FG001|Overall Study|Prosthetist unable to participate|2|||
129143185|NCT03164356|464818620|FG002|Overall Study|Prosthetist unable to participate|1|||
129143186|NCT03164356|464818621|FG003|Overall Study|Prosthetist unable to participate|0|||
129143187|NCT05943990|464818624|FG000|Overall Study|Study Terminated by Sponsor|0|||
129143188|NCT05943990|464818625|FG001|Overall Study|Study Terminated by Sponsor|0|||
129143189|NCT05943990|464818626|FG002|Overall Study|Study Terminated by Sponsor|1|||
129143190|NCT02657356|464819567|FG000|Overall Study|Death|1|||
129143191|NCT02657356|464819568|FG001|Overall Study|Death|0|||
129143192|NCT02657356|464819567|FG000|Overall Study|Withdrawal by Subject|5|||
129143193|NCT02657356|464819568|FG001|Overall Study|Withdrawal by Subject|6|||
129143194|NCT02657356|464819567|FG000|Overall Study|Terminated by Sponsor|8|||
129143195|NCT02657356|464819568|FG001|Overall Study|Terminated by Sponsor|5|||
129085063|NCT05217641|464600735|FG002|Overall Study|Extended Follow up|0|||
129085064|NCT05217641|464600736|FG003|Overall Study|Extended Follow up|0|||
129085065|NCT05217641|464600737|FG004|Overall Study|Extended Follow up|1|||
129085066|NCT05217641|464600738|FG005|Overall Study|Extended Follow up|0|||
129085067|NCT01867710|464600739|FG000|Overall Study|Death|25|||
129085068|NCT01867710|464600740|FG001|Overall Study|Death|15|||
129085069|NCT01867710|464600741|FG002|Overall Study|Death|27|||
129085070|NCT01867710|464600742|FG003|Overall Study|Death|20|||
129085071|NCT01867710|464600739|FG000|Overall Study|Lost to Follow-up|3|||
129143196|NCT02657356|464819567|FG000|Overall Study|Rolled over to EAP study|6|||
129143197|NCT02657356|464819568|FG001|Overall Study|Rolled over to EAP study|4|||
129143198|NCT03443401|464819575|FG000|Overall Study|Lost to Follow-up|13|||
129143199|NCT03443401|464819575|FG000|Overall Study|Influential outlier|1|||
129143200|NCT00980044|464819576|FG000|Overall Study|Withdrawal by Subject|5|||
129085072|NCT01867710|464600740|FG001|Overall Study|Lost to Follow-up|4|||
129085073|NCT01867710|464600741|FG002|Overall Study|Lost to Follow-up|3|||
129085074|NCT01867710|464600742|FG003|Overall Study|Lost to Follow-up|2|||
129085075|NCT01867710|464600739|FG000|Overall Study|Withdrawal of consent|2|||
129085076|NCT01867710|464600740|FG001|Overall Study|Withdrawal of consent|5|||
129085077|NCT01867710|464600741|FG002|Overall Study|Withdrawal of consent|1|||
129085078|NCT01867710|464600742|FG003|Overall Study|Withdrawal of consent|2|||
128724301|NCT02689258|463289032|FG004|Overall Study|Subject Refusal to Continue|0|||
128724302|NCT02689258|463289033|FG005|Overall Study|Subject Refusal to Continue|0|||
128724303|NCT02689258|463289034|FG006|Overall Study|Subject Refusal to Continue|0|||
128724304|NCT02689258|463289035|FG007|Overall Study|Subject Refusal to Continue|0|||
129085079|NCT01867710|464600739|FG000|Overall Study|Study Terminated by Sponsor|9|||
129085080|NCT01867710|464600740|FG001|Overall Study|Study Terminated by Sponsor|13|||
129085081|NCT01867710|464600741|FG002|Overall Study|Study Terminated by Sponsor|8|||
129085082|NCT01867710|464600742|FG003|Overall Study|Study Terminated by Sponsor|16|||
129085083|NCT01867710|464600739|FG000|Overall Study|Biochemical progression|0|||
129085084|NCT01867710|464600740|FG001|Overall Study|Biochemical progression|1|||
129085085|NCT01867710|464600741|FG002|Overall Study|Biochemical progression|0|||
129085086|NCT01867710|464600742|FG003|Overall Study|Biochemical progression|0|||
129085087|NCT01867710|464600739|FG000|Overall Study|Clinical progression|0|||
129085088|NCT01867710|464600740|FG001|Overall Study|Clinical progression|0|||
129085089|NCT01867710|464600741|FG002|Overall Study|Clinical progression|1|||
129085090|NCT01867710|464600742|FG003|Overall Study|Clinical progression|0|||
129085091|NCT01867710|464600739|FG000|Overall Study|Disease progression|1|||
129085092|NCT01867710|464600740|FG001|Overall Study|Disease progression|0|||
129085093|NCT01867710|464600741|FG002|Overall Study|Disease progression|0|||
129085094|NCT01867710|464600742|FG003|Overall Study|Disease progression|0|||
129085095|NCT01867710|464600739|FG000|Overall Study|Patient decision|0|||
129085096|NCT01867710|464600740|FG001|Overall Study|Patient decision|0|||
129085097|NCT01867710|464600741|FG002|Overall Study|Patient decision|0|||
129085098|NCT01867710|464600742|FG003|Overall Study|Patient decision|1|||
129085099|NCT01867710|464600739|FG000|Overall Study|Patient to follow subsequent treatment|0|||
129085100|NCT01867710|464600740|FG001|Overall Study|Patient to follow subsequent treatment|1|||
129085101|NCT01867710|464600741|FG002|Overall Study|Patient to follow subsequent treatment|0|||
129085102|NCT01867710|464600742|FG003|Overall Study|Patient to follow subsequent treatment|0|||
129085103|NCT01867710|464600739|FG000|Overall Study|Progressive disease|1|||
129085104|NCT01867710|464600740|FG001|Overall Study|Progressive disease|0|||
129085105|NCT01867710|464600741|FG002|Overall Study|Progressive disease|0|||
129085106|NCT01867710|464600742|FG003|Overall Study|Progressive disease|0|||
129085107|NCT01867710|464600739|FG000|Overall Study|Protocol Violation|0|||
129085108|NCT01867710|464600740|FG001|Overall Study|Protocol Violation|0|||
129085109|NCT01867710|464600741|FG002|Overall Study|Protocol Violation|0|||
129085110|NCT01867710|464600742|FG003|Overall Study|Protocol Violation|1|||
129085111|NCT01867710|464600739|FG000|Overall Study|PSA-progression|0|||
129085112|NCT01867710|464600740|FG001|Overall Study|PSA-progression|1|||
129085113|NCT01867710|464600741|FG002|Overall Study|PSA-progression|0|||
129085114|NCT01867710|464600742|FG003|Overall Study|PSA-progression|0|||
129085115|NCT01867710|464600739|FG000|Overall Study|Study medication no longer effective|0|||
129085116|NCT01867710|464600740|FG001|Overall Study|Study medication no longer effective|1|||
129085117|NCT01867710|464600741|FG002|Overall Study|Study medication no longer effective|0|||
129085118|NCT01867710|464600742|FG003|Overall Study|Study medication no longer effective|0|||
129085119|NCT01062113|464600743|FG000|Overall Study|Adverse Event|1|||
129085120|NCT01062113|464600744|FG001|Overall Study|Adverse Event|0|||
129085121|NCT01062113|464600745|FG002|Overall Study|Adverse Event|0|||
129085122|NCT01062113|464600743|FG000|Overall Study|Lack of Efficacy|38|||
129085123|NCT01062113|464600744|FG001|Overall Study|Lack of Efficacy|22|||
129085124|NCT01062113|464600745|FG002|Overall Study|Lack of Efficacy|31|||
129085125|NCT01062113|464600743|FG000|Overall Study|Withdrawal by Subject|1|||
129143201|NCT00980044|464819577|FG001|Overall Study|Withdrawal by Subject|7|||
129143202|NCT00980044|464819578|FG002|Overall Study|Withdrawal by Subject|3|||
129143203|NCT00980044|464819576|FG000|Overall Study|Protocol Violation|0|||
129143204|NCT00980044|464819577|FG001|Overall Study|Protocol Violation|0|||
129143205|NCT00980044|464819578|FG002|Overall Study|Protocol Violation|2|||
128724305|NCT02689258|463289036|FG008|Overall Study|Subject Refusal to Continue|1|||
129085126|NCT01062113|464600744|FG001|Overall Study|Withdrawal by Subject|0|||
129085127|NCT01062113|464600745|FG002|Overall Study|Withdrawal by Subject|0|||
129085128|NCT01471340|464600746|FG000|Overall Study|Death|5|||
129085129|NCT01471340|464600747|FG001|Overall Study|Death|4|||
129085130|NCT01471340|464600746|FG000|Overall Study|Lost to Follow-up|0|||
129085131|NCT01471340|464600747|FG001|Overall Study|Lost to Follow-up|1|||
129085132|NCT01471340|464600746|FG000|Overall Study|Investigational site closure|0|||
129085133|NCT01471340|464600747|FG001|Overall Study|Investigational site closure|1|||
129085134|NCT01471340|464600746|FG000|Overall Study|Invalid informed consent|1|||
129085135|NCT01471340|464600747|FG001|Overall Study|Invalid informed consent|0|||
129085136|NCT00526669|464600750|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
129085137|NCT00526669|464600751|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
129085138|NCT00526669|464600750|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
129085139|NCT00526669|464600751|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
129085140|NCT00526669|464600750|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
129085141|NCT00526669|464600751|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
129085142|NCT00526669|464600750|FG000|Combined Treatment Phase|Death|0|||
129085143|NCT00526669|464600751|FG001|Combined Treatment Phase|Death|2|||
128724306|NCT02689258|463289037|FG009|Overall Study|Subject Refusal to Continue|0|||
129085144|NCT03499899|464600752|FG000|Overall Study|Adverse Event|2|||
129085145|NCT03499899|464600753|FG001|Overall Study|Adverse Event|3|||
129085146|NCT03499899|464600754|FG002|Overall Study|Adverse Event|3|||
129085147|NCT03499899|464600752|FG000|Overall Study|Death|0|||
129085148|NCT03499899|464600753|FG001|Overall Study|Death|0|||
129085149|NCT03499899|464600754|FG002|Overall Study|Death|1|||
129085150|NCT03499899|464600752|FG000|Overall Study|Physician Decision|3|||
129085151|NCT03499899|464600753|FG001|Overall Study|Physician Decision|6|||
129085152|NCT03499899|464600754|FG002|Overall Study|Physician Decision|6|||
129085153|NCT03499899|464600752|FG000|Overall Study|Progressive disease|15|||
129085154|NCT03499899|464600753|FG001|Overall Study|Progressive disease|23|||
129085155|NCT03499899|464600754|FG002|Overall Study|Progressive disease|23|||
129085156|NCT03499899|464600752|FG000|Overall Study|Patient decision|0|||
129085157|NCT03499899|464600753|FG001|Overall Study|Patient decision|1|||
129085158|NCT03499899|464600754|FG002|Overall Study|Patient decision|1|||
129085159|NCT03499899|464600752|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
129085160|NCT03499899|464600753|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
129085161|NCT03499899|464600754|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
129085162|NCT01082211|464600756|FG000|Overall Study|Protocol Violation|4|||
129085163|NCT01082211|464600756|FG000|Overall Study|No protocol treatment received|3|||
129085164|NCT04016779|464600769|FG000|Overall Study|Adverse Event|9|||
129085165|NCT04016779|464600770|FG001|Overall Study|Adverse Event|17|||
129085166|NCT04016779|464600769|FG000|Overall Study|Lack of Efficacy|4|||
129085167|NCT04016779|464600770|FG001|Overall Study|Lack of Efficacy|1|||
129085168|NCT04016779|464600769|FG000|Overall Study|Lost to Follow-up|5|||
129085169|NCT04016779|464600770|FG001|Overall Study|Lost to Follow-up|14|||
129085170|NCT04016779|464600769|FG000|Overall Study|Physician Decision|1|||
129085171|NCT04016779|464600770|FG001|Overall Study|Physician Decision|3|||
129085172|NCT04016779|464600769|FG000|Overall Study|Withdrawal by Subject|6|||
129085173|NCT04016779|464600770|FG001|Overall Study|Withdrawal by Subject|8|||
129085174|NCT04016779|464600769|FG000|Overall Study|Non-compliance with Study Drug|2|||
129085175|NCT04016779|464600770|FG001|Overall Study|Non-compliance with Study Drug|3|||
129085176|NCT04016779|464600769|FG000|Overall Study|Other, Multiple categories|17|||
129085177|NCT04016779|464600770|FG001|Overall Study|Other, Multiple categories|17|||
129085178|NCT02295020|464600771|FG000|Overall Study|Adverse Event|0|||
129085179|NCT02295020|464600772|FG001|Overall Study|Adverse Event|1|||
129085180|NCT02295020|464600771|FG000|Overall Study|Withdrawal by Subject|3|||
129085181|NCT02295020|464600772|FG001|Overall Study|Withdrawal by Subject|2|||
129085182|NCT02394340|464600777|FG000|Overall Study|Failed drug screen test|1|||
129085183|NCT02394340|464600777|FG000|Overall Study|Adverse Event|1|||
129085184|NCT00256854|464600779|FG000|Overall Study|Withdrawal by Subject|2|||
129085185|NCT00256854|464600780|FG001|Overall Study|Withdrawal by Subject|3|||
129085186|NCT00256854|464600781|FG002|Overall Study|Withdrawal by Subject|0|||
129085187|NCT00256854|464600782|FG003|Overall Study|Withdrawal by Subject|0|||
129085188|NCT00256854|464600783|FG004|Overall Study|Withdrawal by Subject|0|||
129085189|NCT00256854|464600784|FG005|Overall Study|Withdrawal by Subject|0|||
129085190|NCT00256854|464600779|FG000|Overall Study|Lack of Efficacy|1|||
129085191|NCT00256854|464600780|FG001|Overall Study|Lack of Efficacy|0|||
129085192|NCT00256854|464600781|FG002|Overall Study|Lack of Efficacy|0|||
129085193|NCT00256854|464600782|FG003|Overall Study|Lack of Efficacy|0|||
129085194|NCT00256854|464600783|FG004|Overall Study|Lack of Efficacy|0|||
129085195|NCT00256854|464600784|FG005|Overall Study|Lack of Efficacy|0|||
129085196|NCT00256854|464600779|FG000|Overall Study|Protocol Violation|0|||
129085197|NCT00256854|464600780|FG001|Overall Study|Protocol Violation|1|||
129085198|NCT00256854|464600781|FG002|Overall Study|Protocol Violation|1|||
129085199|NCT00256854|464600782|FG003|Overall Study|Protocol Violation|1|||
129085200|NCT00256854|464600783|FG004|Overall Study|Protocol Violation|0|||
129143206|NCT02254460|464819579|FG000|Overall Study|Adverse Event|1|||
129143207|NCT02254460|464819580|FG001|Overall Study|Adverse Event|0|||
129143208|NCT01356940|464819585|FG000|First Intervention (28 Days)|Adverse Event|1|||
129143209|NCT01356940|464819586|FG001|First Intervention (28 Days)|Adverse Event|0|||
129143210|NCT01356940|464819585|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
129085201|NCT00256854|464600784|FG005|Overall Study|Protocol Violation|0|||
129085202|NCT00256854|464600779|FG000|Overall Study|Adverse Event|0|||
129143211|NCT01356940|464819586|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
129085203|NCT00256854|464600780|FG001|Overall Study|Adverse Event|0|||
129085204|NCT00256854|464600781|FG002|Overall Study|Adverse Event|2|||
129085205|NCT00256854|464600782|FG003|Overall Study|Adverse Event|2|||
129143212|NCT00505687|464819587|FG000|Overall Study|Important protocol violation|2|||
128776570|NCT00904150|463470477|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
129085206|NCT00256854|464600783|FG004|Overall Study|Adverse Event|0|||
129085207|NCT00256854|464600784|FG005|Overall Study|Adverse Event|1|||
129085208|NCT00256854|464600779|FG000|Overall Study|Not compliant with the study drug|0|||
129085209|NCT00256854|464600780|FG001|Overall Study|Not compliant with the study drug|0|||
129085210|NCT00256854|464600781|FG002|Overall Study|Not compliant with the study drug|0|||
129085211|NCT00256854|464600782|FG003|Overall Study|Not compliant with the study drug|0|||
129085212|NCT00256854|464600783|FG004|Overall Study|Not compliant with the study drug|1|||
128724307|NCT02689258|463289038|FG010|Overall Study|Subject Refusal to Continue|0|||
128724308|NCT02689258|463289039|FG011|Overall Study|Subject Refusal to Continue|1|||
128724309|NCT02689258|463289028|FG000|Overall Study|Other|0|||
128724310|NCT02689258|463289029|FG001|Overall Study|Other|2|||
128724311|NCT02689258|463289030|FG002|Overall Study|Other|0|||
128724312|NCT02689258|463289031|FG003|Overall Study|Other|0|||
129085213|NCT00256854|464600784|FG005|Overall Study|Not compliant with the study drug|0|||
129085214|NCT06586788|464600785|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
129085215|NCT00791661|464600787|FG000|7 Day Wash-out|Adverse Event|0|||
129085216|NCT00791661|464600788|FG001|7 Day Wash-out|Adverse Event|0|||
129085217|NCT00791661|464600789|FG002|7 Day Wash-out|Adverse Event|1|||
129085218|NCT00791661|464600787|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
129085219|NCT00791661|464600788|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
129085220|NCT00791661|464600789|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
129085221|NCT00679289|464600790|FG000|Overall Study|Progressive disease|4|||
129085222|NCT00679289|464600791|FG001|Overall Study|Progressive disease|5|||
129085223|NCT00679289|464600792|FG002|Overall Study|Progressive disease|18|||
129085224|NCT00679289|464600790|FG000|Overall Study|Withdrawal by Subject|0|||
129085225|NCT00679289|464600791|FG001|Overall Study|Withdrawal by Subject|1|||
129085226|NCT00679289|464600792|FG002|Overall Study|Withdrawal by Subject|1|||
129085227|NCT00679289|464600790|FG000|Overall Study|Adverse Event|0|||
129085228|NCT00679289|464600791|FG001|Overall Study|Adverse Event|0|||
129085229|NCT00679289|464600792|FG002|Overall Study|Adverse Event|3|||
129085230|NCT00679289|464600790|FG000|Overall Study|Physician Decision|1|||
129085231|NCT00679289|464600791|FG001|Overall Study|Physician Decision|0|||
129085232|NCT00679289|464600792|FG002|Overall Study|Physician Decision|1|||
129085233|NCT00937040|464600793|FG000|Overall Study|Adverse Event|5|||
129085234|NCT00937040|464600794|FG001|Overall Study|Adverse Event|8|||
129085235|NCT00937040|464600793|FG000|Overall Study|Lost to Follow-up|12|||
129085236|NCT00937040|464600794|FG001|Overall Study|Lost to Follow-up|12|||
129085237|NCT00937040|464600793|FG000|Overall Study|Protocol Violation|3|||
129085238|NCT00937040|464600794|FG001|Overall Study|Protocol Violation|0|||
129085239|NCT00937040|464600793|FG000|Overall Study|Withdrawal by Subject|13|||
129085240|NCT00937040|464600794|FG001|Overall Study|Withdrawal by Subject|7|||
129085241|NCT00937040|464600793|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
129085242|NCT00937040|464600794|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
129085243|NCT00937040|464600793|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
129085244|NCT00937040|464600794|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
129085245|NCT00638443|464600795|FG000|First Intervention|Adverse Event|2|||
129085246|NCT00638443|464600796|FG001|First Intervention|Adverse Event|1|||
129085247|NCT01355575|464600799|FG000|Overall Study|Withdrawal by Subject|2|||
129085248|NCT03502070|464600801|FG000|Overall Study|Withdrawal by Subject|1|||
129085249|NCT03502070|464600801|FG000|Overall Study|Screen Failure|1|||
129085250|NCT00595517|464600804|FG000|Overall Study|Adverse Event|6|||
129085251|NCT00595517|464600804|FG000|Overall Study|Withdrawal by Subject|4|||
129085252|NCT00595517|464600804|FG000|Overall Study|Protocol Violation|2|||
129085253|NCT00595517|464600804|FG000|Overall Study|Recurrence of ulcer|5|||
129085254|NCT00595517|464600804|FG000|Overall Study|usage of prohibited treatment|1|||
129085255|NCT00595517|464600804|FG000|Overall Study|No intention to attend regularly|1|||
129085256|NCT01167881|464600807|FG000|Overall Study|Adverse Event|47|||
129085257|NCT01167881|464600808|FG001|Overall Study|Adverse Event|51|||
129085258|NCT01167881|464600807|FG000|Overall Study|Lack of Efficacy|4|||
129085259|NCT01167881|464600808|FG001|Overall Study|Lack of Efficacy|7|||
129085260|NCT01167881|464600807|FG000|Overall Study|Non compliant with protocol|9|||
129085261|NCT01167881|464600808|FG001|Overall Study|Non compliant with protocol|18|||
129085262|NCT01167881|464600807|FG000|Overall Study|Lost to Follow-up|19|||
129085263|NCT01167881|464600808|FG001|Overall Study|Lost to Follow-up|20|||
129085264|NCT01167881|464600807|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
129085265|NCT01167881|464600808|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
129085266|NCT01167881|464600807|FG000|Overall Study|Not treated|4|||
129085267|NCT01167881|464600808|FG001|Overall Study|Not treated|0|||
129085268|NCT01167881|464600807|FG000|Overall Study|Other not defined above|31|||
129085269|NCT01167881|464600808|FG001|Overall Study|Other not defined above|55|||
129085270|NCT01684943|464600809|FG000|Overall Study|Inadequate Venous Access|3|||
129085271|NCT01684943|464600810|FG001|Overall Study|Inadequate Venous Access|0|||
129085272|NCT01684943|464600811|FG002|Overall Study|Inadequate Venous Access|0|||
129085273|NCT01684943|464600809|FG000|Overall Study|Principal Investigator Determination|1|||
129085274|NCT01684943|464600810|FG001|Overall Study|Principal Investigator Determination|0|||
129143213|NCT00505687|464819587|FG000|Overall Study|Lack of Efficacy|15|||
128724313|NCT02689258|463289032|FG004|Overall Study|Other|1|||
128724314|NCT02689258|463289033|FG005|Overall Study|Other|0|||
128724315|NCT02689258|463289034|FG006|Overall Study|Other|0|||
128724316|NCT02689258|463289035|FG007|Overall Study|Other|0|||
129085275|NCT01684943|464600811|FG002|Overall Study|Principal Investigator Determination|0|||
129085276|NCT01684943|464600809|FG000|Overall Study|Excluded from Analysis|1|||
129085277|NCT01684943|464600810|FG001|Overall Study|Excluded from Analysis|1|||
129085278|NCT01684943|464600811|FG002|Overall Study|Excluded from Analysis|1|||
129143214|NCT00505687|464819587|FG000|Overall Study|Adverse Event|48|||
129143215|NCT00505687|464819587|FG000|Overall Study|Subject withdrew consent|15|||
129143216|NCT00505687|464819587|FG000|Overall Study|Lost to Follow-up|1|||
129143217|NCT00505687|464819587|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
129143218|NCT00505687|464819587|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
129143219|NCT00505687|464819587|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
129143220|NCT00505687|464819587|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
129143221|NCT00505687|464819587|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
129143222|NCT00505687|464819587|FG000|Overall Study|Other: Disease Progression|1|||
129143223|NCT00505687|464819587|FG000|Overall Study|Other: As Per Sponsor|8|||
129143224|NCT00480532|464819588|FG000|Overall Study|Withdrawal by Subject|2|||
129143225|NCT00480532|464819589|FG001|Overall Study|Withdrawal by Subject|4|||
129143226|NCT00480532|464819590|FG002|Overall Study|Withdrawal by Subject|3|||
129143227|NCT00480532|464819591|FG003|Overall Study|Withdrawal by Subject|1|||
129143228|NCT00480532|464819588|FG000|Overall Study|Protocol Violation|0|||
129143229|NCT00480532|464819589|FG001|Overall Study|Protocol Violation|0|||
129143230|NCT00480532|464819590|FG002|Overall Study|Protocol Violation|1|||
129143231|NCT00480532|464819591|FG003|Overall Study|Protocol Violation|0|||
129143232|NCT01817777|464819592|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
129143233|NCT01817777|464819593|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
129143234|NCT01817777|464819594|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
129143235|NCT01817777|464819592|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
129143236|NCT01817777|464819593|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
129143237|NCT01817777|464819594|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
129085279|NCT01684943|464600809|FG000|Overall Study|Lost to Follow-up|3|||
129085280|NCT01684943|464600810|FG001|Overall Study|Lost to Follow-up|0|||
129085281|NCT01684943|464600811|FG002|Overall Study|Lost to Follow-up|0|||
129085282|NCT01684943|464600809|FG000|Overall Study|Planning Pregnancy|1|||
129085283|NCT01684943|464600810|FG001|Overall Study|Planning Pregnancy|0|||
129085284|NCT01684943|464600811|FG002|Overall Study|Planning Pregnancy|0|||
129085285|NCT00972816|464603102|FG000|Overall Study|Adverse Event|0|||
129085286|NCT00972816|464603103|FG001|Overall Study|Adverse Event|0|||
129085287|NCT00972816|464603104|FG002|Overall Study|Adverse Event|1|||
129085288|NCT00972816|464603105|FG003|Overall Study|Adverse Event|0|||
129085289|NCT00972816|464603106|FG004|Overall Study|Adverse Event|0|||
129085290|NCT00972816|464603107|FG005|Overall Study|Adverse Event|0|||
129085291|NCT00972816|464603108|FG006|Overall Study|Adverse Event|0|||
129085292|NCT00972816|464603109|FG007|Overall Study|Adverse Event|0|||
129085293|NCT00972816|464603102|FG000|Overall Study|Withdrawal by Subject|4|||
129085294|NCT00972816|464603103|FG001|Overall Study|Withdrawal by Subject|2|||
129085295|NCT00972816|464603104|FG002|Overall Study|Withdrawal by Subject|1|||
129085296|NCT00972816|464603105|FG003|Overall Study|Withdrawal by Subject|3|||
129085297|NCT00972816|464603106|FG004|Overall Study|Withdrawal by Subject|0|||
129085298|NCT00972816|464603107|FG005|Overall Study|Withdrawal by Subject|1|||
129085299|NCT00972816|464603108|FG006|Overall Study|Withdrawal by Subject|1|||
129085300|NCT00972816|464603109|FG007|Overall Study|Withdrawal by Subject|2|||
129085301|NCT00972816|464603102|FG000|Overall Study|Lost to Follow-up|11|||
129085302|NCT00972816|464603103|FG001|Overall Study|Lost to Follow-up|9|||
129085303|NCT00972816|464603104|FG002|Overall Study|Lost to Follow-up|7|||
129085304|NCT00972816|464603105|FG003|Overall Study|Lost to Follow-up|5|||
129085305|NCT00972816|464603106|FG004|Overall Study|Lost to Follow-up|11|||
129085306|NCT00972816|464603107|FG005|Overall Study|Lost to Follow-up|10|||
129085307|NCT00972816|464603108|FG006|Overall Study|Lost to Follow-up|7|||
129085308|NCT00972816|464603109|FG007|Overall Study|Lost to Follow-up|7|||
129085309|NCT00972816|464603102|FG000|Overall Study|Inappropriate enrolment|0|||
129085310|NCT00972816|464603103|FG001|Overall Study|Inappropriate enrolment|0|||
129085311|NCT00972816|464603104|FG002|Overall Study|Inappropriate enrolment|0|||
129085312|NCT00972816|464603105|FG003|Overall Study|Inappropriate enrolment|0|||
129085313|NCT00972816|464603106|FG004|Overall Study|Inappropriate enrolment|0|||
129143238|NCT01817777|464819592|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
129143239|NCT01817777|464819593|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
129143240|NCT01817777|464819594|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
129085314|NCT00972816|464603107|FG005|Overall Study|Inappropriate enrolment|0|||
129085315|NCT00972816|464603108|FG006|Overall Study|Inappropriate enrolment|2|||
129085316|NCT00972816|464603109|FG007|Overall Study|Inappropriate enrolment|0|||
129085317|NCT00972816|464603102|FG000|Overall Study|Unable to classify|2|||
129085318|NCT00972816|464603103|FG001|Overall Study|Unable to classify|0|||
129085319|NCT00972816|464603104|FG002|Overall Study|Unable to classify|0|||
129143241|NCT01817777|464819592|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
129143242|NCT01817777|464819593|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
129143243|NCT01817777|464819594|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
129143244|NCT01817777|464819592|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
129085320|NCT00972816|464603105|FG003|Overall Study|Unable to classify|0|||
129085321|NCT00972816|464603106|FG004|Overall Study|Unable to classify|1|||
129085322|NCT00972816|464603107|FG005|Overall Study|Unable to classify|0|||
129085323|NCT00972816|464603108|FG006|Overall Study|Unable to classify|0|||
129085324|NCT00972816|464603109|FG007|Overall Study|Unable to classify|0|||
129085325|NCT03854370|464603112|FG000|Overall Study|samples not collected|1|||
129085326|NCT03854370|464603113|FG001|Overall Study|samples not collected|1|||
129085327|NCT03854370|464603114|FG002|Overall Study|samples not collected|1|||
129085328|NCT03854370|464603115|FG003|Overall Study|samples not collected|1|||
129085329|NCT00452673|464603116|FG000|Dose Escalation Period|Disease Progression|6|||
129085330|NCT00452673|464603117|FG001|Dose Escalation Period|Disease Progression|6|||
129085331|NCT00452673|464603118|FG002|Dose Escalation Period|Disease Progression|2|||
129085332|NCT00452673|464603119|FG003|Dose Escalation Period|Disease Progression|6|||
129085333|NCT00452673|464603120|FG004|Dose Escalation Period|Disease Progression|0|||
129085334|NCT00452673|464603116|FG000|Dose Escalation Period|study drug toxicity|1|||
129085335|NCT00452673|464603117|FG001|Dose Escalation Period|study drug toxicity|3|||
129085336|NCT00452673|464603118|FG002|Dose Escalation Period|study drug toxicity|3|||
129085337|NCT00452673|464603119|FG003|Dose Escalation Period|study drug toxicity|1|||
129085338|NCT00452673|464603120|FG004|Dose Escalation Period|study drug toxicity|0|||
129085339|NCT00452673|464603116|FG000|Dose Escalation Period|Other|0|||
129085340|NCT00452673|464603117|FG001|Dose Escalation Period|Other|0|||
129085341|NCT00452673|464603118|FG002|Dose Escalation Period|Other|1|||
129085342|NCT00452673|464603119|FG003|Dose Escalation Period|Other|0|||
129085343|NCT00452673|464603120|FG004|Dose Escalation Period|Other|0|||
129085344|NCT00452673|464603116|FG000|Dose Escalation Period|Adverse Event|0|||
129085345|NCT00452673|464603117|FG001|Dose Escalation Period|Adverse Event|0|||
129085346|NCT00452673|464603118|FG002|Dose Escalation Period|Adverse Event|0|||
129085347|NCT00452673|464603119|FG003|Dose Escalation Period|Adverse Event|1|||
129085348|NCT00452673|464603120|FG004|Dose Escalation Period|Adverse Event|0|||
129085349|NCT00452673|464603116|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
129085350|NCT00452673|464603117|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
129085351|NCT00452673|464603118|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
129085352|NCT00452673|464603119|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
129085353|NCT00452673|464603120|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
129085354|NCT00452673|464603116|FG000|Dose Expansion Period|Disease Progression|0|||
129085355|NCT00452673|464603117|FG001|Dose Expansion Period|Disease Progression|0|||
129085356|NCT00452673|464603118|FG002|Dose Expansion Period|Disease Progression|0|||
129085357|NCT00452673|464603119|FG003|Dose Expansion Period|Disease Progression|0|||
129085358|NCT00452673|464603120|FG004|Dose Expansion Period|Disease Progression|19|||
129085359|NCT00452673|464603116|FG000|Dose Expansion Period|Other|0|||
129085360|NCT00452673|464603117|FG001|Dose Expansion Period|Other|0|||
129085361|NCT00452673|464603118|FG002|Dose Expansion Period|Other|0|||
129085362|NCT00452673|464603119|FG003|Dose Expansion Period|Other|0|||
129085363|NCT00452673|464603120|FG004|Dose Expansion Period|Other|2|||
129085364|NCT02656290|464603121|FG000|Overall Study|Lost to Follow-up|1|||
129085365|NCT02656290|464603121|FG000|Overall Study|Reintervention|3|||
129085366|NCT01608087|464603124|FG000|Overall Study|Lost to Follow-up|0|||
129085367|NCT01608087|464603125|FG001|Overall Study|Lost to Follow-up|1|||
129085368|NCT01608087|464603126|FG002|Overall Study|Lost to Follow-up|0|||
129085369|NCT01608087|464603124|FG000|Overall Study|Other Reason|0|||
129085370|NCT01608087|464603125|FG001|Overall Study|Other Reason|1|||
129085371|NCT01608087|464603126|FG002|Overall Study|Other Reason|0|||
129085372|NCT00348595|464603127|FG000|Overall Study|Adverse Event|5|||
129085373|NCT00348595|464603128|FG001|Overall Study|Adverse Event|8|||
129085374|NCT01942486|464603137|FG000|Overall Study|Lost to Follow-up|27|||
129085375|NCT03728426|464603138|FG000|Overall Study|Death|3|||
129085376|NCT00231114|464603141|FG000|Randomized|Withdrawal by Subject|6|||
129085377|NCT00231114|464603142|FG001|Randomized|Withdrawal by Subject|3|||
129085378|NCT00231114|464603141|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
129085379|NCT00231114|464603142|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
129085380|NCT00231114|464603141|FG000|Post-Treatment Period|Lost to Follow-up|6|||
129085381|NCT00231114|464603142|FG001|Post-Treatment Period|Lost to Follow-up|1|||
129085382|NCT00231114|464603141|FG000|Post-Treatment Period|Physician Decision|1|||
129085383|NCT00231114|464603142|FG001|Post-Treatment Period|Physician Decision|0|||
129085384|NCT00231114|464603141|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
129085385|NCT00231114|464603142|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
129085386|NCT02048826|464603143|FG000|Overall Study|Withdrawal by Subject|1|||
129085387|NCT02048826|464603144|FG001|Overall Study|Withdrawal by Subject|0|||
129085388|NCT04470544|464603145|FG000|Overall Study|Withdrawal by Subject|4|||
129085389|NCT04470544|464603146|FG001|Overall Study|Withdrawal by Subject|6|||
129085390|NCT00712881|464603147|FG000|Overall Study|Adverse Event|3|||
129085391|NCT00712881|464603148|FG001|Overall Study|Adverse Event|3|||
129085392|NCT00712881|464603147|FG000|Overall Study|Withdrawal by Subject|1|||
129085393|NCT00712881|464603148|FG001|Overall Study|Withdrawal by Subject|1|||
129085394|NCT00712881|464603147|FG000|Overall Study|Disease Progression|2|||
129085395|NCT00712881|464603148|FG001|Overall Study|Disease Progression|1|||
129085396|NCT00712881|464603147|FG000|Overall Study|Lost to Follow-up|1|||
129085397|NCT00712881|464603148|FG001|Overall Study|Lost to Follow-up|1|||
129085398|NCT00712881|464603147|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
129085399|NCT00712881|464603148|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
129085400|NCT00712881|464603147|FG000|Overall Study|Protocol Violation|1|||
129085401|NCT00712881|464603148|FG001|Overall Study|Protocol Violation|1|||
129085402|NCT00712881|464603147|FG000|Overall Study|Randomized but not treated|1|||
129085403|NCT00712881|464603148|FG001|Overall Study|Randomized but not treated|0|||
129085404|NCT01194999|464603150|FG000|Overall Study|Lost to Follow-up|17|||
129085405|NCT01011465|464603151|FG000|Overall Study|Withdrawal by Subject|2|||
129085406|NCT01011465|464603152|FG001|Overall Study|Withdrawal by Subject|1|||
129085407|NCT01011465|464603153|FG002|Overall Study|Withdrawal by Subject|0|||
129085408|NCT01011465|464603154|FG003|Overall Study|Withdrawal by Subject|0|||
129085409|NCT01011465|464603155|FG004|Overall Study|Withdrawal by Subject|1|||
129085410|NCT01011465|464603156|FG005|Overall Study|Withdrawal by Subject|0|||
129085411|NCT01011465|464603157|FG006|Overall Study|Withdrawal by Subject|1|||
129085412|NCT01011465|464603158|FG007|Overall Study|Withdrawal by Subject|0|||
129085413|NCT00723008|464603160|FG000|Enrollment|Lost to Follow-up|1|||
129085414|NCT00723008|464603161|FG001|Enrollment|Lost to Follow-up|0|||
129085415|NCT00723008|464603160|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
129085416|NCT00723008|464603161|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
129085417|NCT00723008|464603160|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
129085418|NCT00723008|464603161|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
129085419|NCT00723008|464603160|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
129085420|NCT00723008|464603161|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
129085421|NCT00723008|464603160|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
129085422|NCT00723008|464603161|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
129085423|NCT00723008|464603160|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
129085424|NCT00723008|464603161|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
129085425|NCT05835011|464603163|FG000|Overall Study|Study Terminated by the Sponsor|1|||
129085426|NCT05835011|464603163|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
129085427|NCT03702010|464603174|FG000|Follow-up (30days)|Lack of Efficacy|2|||
129085428|NCT03702010|464603175|FG001|Follow-up (30days)|Lack of Efficacy|2|||
129085429|NCT03557931|464603176|FG000|Overall Study|Adverse Event|4|||
128724317|NCT02689258|463289036|FG008|Overall Study|Other|1|||
128724318|NCT02689258|463289037|FG009|Overall Study|Other|0|||
128724319|NCT02689258|463289038|FG010|Overall Study|Other|0|||
128724320|NCT02689258|463289039|FG011|Overall Study|Other|0|||
128724321|NCT02159521|463289040|FG000|Overall Study|Enrolled but not treated|3|||
128724322|NCT02159521|463289040|FG000|Overall Study|Withdrawal by Subject|7|||
128724323|NCT02159521|463289040|FG000|Overall Study|Lost to Follow-up|6|||
128724324|NCT02159521|463289040|FG000|Overall Study|Death|1|||
128724325|NCT02159521|463289040|FG000|Overall Study|Other than specified|1|||
128724326|NCT00694369|463289045|FG000|Overall Study|Adverse Event|0|||
129085430|NCT03557931|464603177|FG001|Overall Study|Adverse Event|6|||
129085431|NCT03557931|464603178|FG002|Overall Study|Adverse Event|1|||
129085432|NCT03557931|464603176|FG000|Overall Study|Lost to Follow-up|4|||
129085433|NCT03557931|464603177|FG001|Overall Study|Lost to Follow-up|4|||
129085434|NCT03557931|464603178|FG002|Overall Study|Lost to Follow-up|1|||
129085435|NCT03557931|464603176|FG000|Overall Study|Protocol Violation|1|||
129085436|NCT03557931|464603177|FG001|Overall Study|Protocol Violation|4|||
129085437|NCT03557931|464603178|FG002|Overall Study|Protocol Violation|1|||
129085438|NCT03557931|464603176|FG000|Overall Study|Withdrawal by Subject|14|||
129085439|NCT03557931|464603177|FG001|Overall Study|Withdrawal by Subject|0|||
129085440|NCT03557931|464603178|FG002|Overall Study|Withdrawal by Subject|7|||
129085441|NCT03557931|464603176|FG000|Overall Study|Miscellaneous|8|||
129085442|NCT03557931|464603177|FG001|Overall Study|Miscellaneous|5|||
128724327|NCT00694369|463289046|FG001|Overall Study|Adverse Event|1|||
128724328|NCT00694369|463289047|FG002|Overall Study|Adverse Event|0|||
128724329|NCT00694369|463289048|FG003|Overall Study|Adverse Event|1|||
129085443|NCT03557931|464603178|FG002|Overall Study|Miscellaneous|3|||
129085444|NCT02829723|464603179|FG000|Overall Study|Adverse Event|0|||
129085445|NCT02829723|464603180|FG001|Overall Study|Adverse Event|0|||
129085446|NCT02829723|464603181|FG002|Overall Study|Adverse Event|1|||
129085447|NCT02829723|464603182|FG003|Overall Study|Adverse Event|1|||
129085448|NCT02829723|464603183|FG004|Overall Study|Adverse Event|0|||
129085449|NCT02829723|464603184|FG005|Overall Study|Adverse Event|0|||
129085450|NCT02829723|464603185|FG006|Overall Study|Adverse Event|0|||
129085451|NCT02829723|464603186|FG007|Overall Study|Adverse Event|1|||
129085452|NCT02829723|464603187|FG008|Overall Study|Adverse Event|0|||
129085453|NCT02829723|464603188|FG009|Overall Study|Adverse Event|0|||
129085454|NCT02829723|464603189|FG010|Overall Study|Adverse Event|0|||
129085455|NCT02829723|464603190|FG011|Overall Study|Adverse Event|0|||
129085456|NCT02829723|464603191|FG012|Overall Study|Adverse Event|0|||
129085457|NCT02829723|464603192|FG013|Overall Study|Adverse Event|0|||
129085458|NCT02829723|464603193|FG014|Overall Study|Adverse Event|1|||
129085459|NCT02829723|464603194|FG015|Overall Study|Adverse Event|1|||
129085460|NCT02829723|464603195|FG016|Overall Study|Adverse Event|1|||
129085461|NCT02829723|464603196|FG017|Overall Study|Adverse Event|2|||
129085462|NCT02829723|464603197|FG018|Overall Study|Adverse Event|1|||
129085463|NCT02829723|464603198|FG019|Overall Study|Adverse Event|1|||
129085464|NCT02829723|464603199|FG020|Overall Study|Adverse Event|3|||
129085465|NCT02829723|464603200|FG021|Overall Study|Adverse Event|0|||
129085466|NCT02829723|464603201|FG022|Overall Study|Adverse Event|0|||
129085467|NCT02829723|464603202|FG023|Overall Study|Adverse Event|1|||
129085468|NCT02829723|464603203|FG024|Overall Study|Adverse Event|1|||
129085469|NCT02829723|464603204|FG025|Overall Study|Adverse Event|3|||
129085470|NCT02829723|464603205|FG026|Overall Study|Adverse Event|5|||
129085471|NCT02829723|464603179|FG000|Overall Study|Death|1|||
129085472|NCT02829723|464603180|FG001|Overall Study|Death|0|||
129085473|NCT02829723|464603181|FG002|Overall Study|Death|1|||
129085474|NCT02829723|464603182|FG003|Overall Study|Death|1|||
129085475|NCT02829723|464603183|FG004|Overall Study|Death|0|||
129085476|NCT02829723|464603184|FG005|Overall Study|Death|0|||
129085477|NCT02829723|464603185|FG006|Overall Study|Death|2|||
129085478|NCT02829723|464603186|FG007|Overall Study|Death|0|||
129085479|NCT02829723|464603187|FG008|Overall Study|Death|1|||
129085480|NCT02829723|464603188|FG009|Overall Study|Death|0|||
129085481|NCT02829723|464603189|FG010|Overall Study|Death|0|||
129085482|NCT02829723|464603190|FG011|Overall Study|Death|0|||
129085483|NCT02829723|464603191|FG012|Overall Study|Death|2|||
129085484|NCT02829723|464603192|FG013|Overall Study|Death|1|||
129085485|NCT02829723|464603193|FG014|Overall Study|Death|0|||
129085486|NCT02829723|464603194|FG015|Overall Study|Death|0|||
129085487|NCT02829723|464603195|FG016|Overall Study|Death|0|||
129085488|NCT02829723|464603196|FG017|Overall Study|Death|0|||
129085489|NCT02829723|464603197|FG018|Overall Study|Death|0|||
129085490|NCT02829723|464603198|FG019|Overall Study|Death|0|||
129085491|NCT02829723|464603199|FG020|Overall Study|Death|0|||
129085492|NCT02829723|464603200|FG021|Overall Study|Death|2|||
129085493|NCT02829723|464603201|FG022|Overall Study|Death|0|||
129085494|NCT02829723|464603202|FG023|Overall Study|Death|0|||
129085495|NCT02829723|464603203|FG024|Overall Study|Death|0|||
129085496|NCT02829723|464603204|FG025|Overall Study|Death|1|||
129085497|NCT02829723|464603205|FG026|Overall Study|Death|2|||
129085498|NCT02829723|464603179|FG000|Overall Study|Physician Decision|0|||
129085499|NCT02829723|464603180|FG001|Overall Study|Physician Decision|0|||
129085500|NCT02829723|464603181|FG002|Overall Study|Physician Decision|0|||
129085501|NCT02829723|464603182|FG003|Overall Study|Physician Decision|0|||
129085502|NCT02829723|464603183|FG004|Overall Study|Physician Decision|0|||
129085503|NCT02829723|464603184|FG005|Overall Study|Physician Decision|0|||
129085504|NCT02829723|464603185|FG006|Overall Study|Physician Decision|0|||
129085505|NCT02829723|464603186|FG007|Overall Study|Physician Decision|0|||
129085506|NCT02829723|464603187|FG008|Overall Study|Physician Decision|0|||
129085507|NCT02829723|464603188|FG009|Overall Study|Physician Decision|1|||
129085508|NCT02829723|464603189|FG010|Overall Study|Physician Decision|1|||
129085509|NCT02829723|464603190|FG011|Overall Study|Physician Decision|0|||
129085510|NCT02829723|464603191|FG012|Overall Study|Physician Decision|0|||
129085511|NCT02829723|464603192|FG013|Overall Study|Physician Decision|1|||
129085512|NCT02829723|464603193|FG014|Overall Study|Physician Decision|0|||
129085513|NCT02829723|464603194|FG015|Overall Study|Physician Decision|0|||
129085514|NCT02829723|464603195|FG016|Overall Study|Physician Decision|2|||
129085515|NCT02829723|464603196|FG017|Overall Study|Physician Decision|0|||
129085516|NCT02829723|464603197|FG018|Overall Study|Physician Decision|0|||
129085517|NCT02829723|464603198|FG019|Overall Study|Physician Decision|0|||
129085518|NCT02829723|464603199|FG020|Overall Study|Physician Decision|0|||
129085519|NCT02829723|464603200|FG021|Overall Study|Physician Decision|0|||
129085520|NCT02829723|464603201|FG022|Overall Study|Physician Decision|1|||
129085521|NCT02829723|464603202|FG023|Overall Study|Physician Decision|1|||
129085522|NCT02829723|464603203|FG024|Overall Study|Physician Decision|1|||
129085523|NCT02829723|464603204|FG025|Overall Study|Physician Decision|1|||
129085524|NCT02829723|464603205|FG026|Overall Study|Physician Decision|3|||
129085525|NCT02829723|464603179|FG000|Overall Study|Progressive disease|4|||
129085526|NCT02829723|464603180|FG001|Overall Study|Progressive disease|6|||
129085527|NCT02829723|464603181|FG002|Overall Study|Progressive disease|3|||
129085528|NCT02829723|464603182|FG003|Overall Study|Progressive disease|3|||
129085529|NCT02829723|464603183|FG004|Overall Study|Progressive disease|3|||
129085530|NCT02829723|464603184|FG005|Overall Study|Progressive disease|5|||
129085531|NCT02829723|464603185|FG006|Overall Study|Progressive disease|4|||
129085532|NCT02829723|464603186|FG007|Overall Study|Progressive disease|6|||
129085533|NCT02829723|464603187|FG008|Overall Study|Progressive disease|8|||
129085534|NCT02829723|464603188|FG009|Overall Study|Progressive disease|4|||
129085535|NCT02829723|464603189|FG010|Overall Study|Progressive disease|9|||
129085536|NCT02829723|464603190|FG011|Overall Study|Progressive disease|0|||
129085537|NCT02829723|464603191|FG012|Overall Study|Progressive disease|3|||
129085538|NCT02829723|464603192|FG013|Overall Study|Progressive disease|4|||
129085539|NCT02829723|464603193|FG014|Overall Study|Progressive disease|2|||
129085540|NCT02829723|464603194|FG015|Overall Study|Progressive disease|4|||
129085541|NCT02829723|464603195|FG016|Overall Study|Progressive disease|5|||
129085542|NCT02829723|464603196|FG017|Overall Study|Progressive disease|3|||
129085543|NCT02829723|464603197|FG018|Overall Study|Progressive disease|4|||
129085544|NCT02829723|464603198|FG019|Overall Study|Progressive disease|4|||
129085545|NCT02829723|464603199|FG020|Overall Study|Progressive disease|7|||
129085546|NCT02829723|464603200|FG021|Overall Study|Progressive disease|6|||
129085547|NCT02829723|464603201|FG022|Overall Study|Progressive disease|3|||
129085548|NCT02829723|464603202|FG023|Overall Study|Progressive disease|3|||
129085549|NCT02829723|464603203|FG024|Overall Study|Progressive disease|3|||
129085550|NCT02829723|464603204|FG025|Overall Study|Progressive disease|16|||
129085551|NCT02829723|464603205|FG026|Overall Study|Progressive disease|10|||
129085552|NCT02829723|464603179|FG000|Overall Study|Subject/guardian decision|0|||
129085553|NCT02829723|464603180|FG001|Overall Study|Subject/guardian decision|1|||
129085554|NCT02829723|464603181|FG002|Overall Study|Subject/guardian decision|0|||
129085555|NCT02829723|464603182|FG003|Overall Study|Subject/guardian decision|1|||
129085556|NCT02829723|464603183|FG004|Overall Study|Subject/guardian decision|0|||
129085557|NCT02829723|464603184|FG005|Overall Study|Subject/guardian decision|0|||
129085558|NCT02829723|464603185|FG006|Overall Study|Subject/guardian decision|0|||
129085559|NCT02829723|464603186|FG007|Overall Study|Subject/guardian decision|1|||
129085560|NCT02829723|464603187|FG008|Overall Study|Subject/guardian decision|0|||
129085561|NCT02829723|464603188|FG009|Overall Study|Subject/guardian decision|0|||
129085562|NCT02829723|464603189|FG010|Overall Study|Subject/guardian decision|0|||
129085563|NCT02829723|464603190|FG011|Overall Study|Subject/guardian decision|0|||
129085564|NCT02829723|464603191|FG012|Overall Study|Subject/guardian decision|0|||
129085565|NCT02829723|464603192|FG013|Overall Study|Subject/guardian decision|0|||
129085566|NCT02829723|464603193|FG014|Overall Study|Subject/guardian decision|1|||
129085567|NCT02829723|464603194|FG015|Overall Study|Subject/guardian decision|0|||
129085568|NCT02829723|464603195|FG016|Overall Study|Subject/guardian decision|1|||
129085569|NCT02829723|464603196|FG017|Overall Study|Subject/guardian decision|0|||
129085570|NCT02829723|464603197|FG018|Overall Study|Subject/guardian decision|1|||
129085571|NCT02829723|464603198|FG019|Overall Study|Subject/guardian decision|0|||
129085572|NCT02829723|464603199|FG020|Overall Study|Subject/guardian decision|1|||
129085573|NCT02829723|464603200|FG021|Overall Study|Subject/guardian decision|0|||
129085574|NCT02829723|464603201|FG022|Overall Study|Subject/guardian decision|0|||
129085575|NCT02829723|464603202|FG023|Overall Study|Subject/guardian decision|1|||
129085576|NCT02829723|464603203|FG024|Overall Study|Subject/guardian decision|0|||
129085577|NCT02829723|464603204|FG025|Overall Study|Subject/guardian decision|1|||
129085578|NCT02829723|464603205|FG026|Overall Study|Subject/guardian decision|1|||
129085579|NCT02829723|464603179|FG000|Overall Study|Study terminated by sponsor|0|||
129085580|NCT02829723|464603180|FG001|Overall Study|Study terminated by sponsor|0|||
129085581|NCT02829723|464603181|FG002|Overall Study|Study terminated by sponsor|0|||
129085582|NCT02829723|464603182|FG003|Overall Study|Study terminated by sponsor|0|||
129085583|NCT02829723|464603183|FG004|Overall Study|Study terminated by sponsor|0|||
129085584|NCT02829723|464603184|FG005|Overall Study|Study terminated by sponsor|0|||
129085585|NCT02829723|464603185|FG006|Overall Study|Study terminated by sponsor|0|||
129085586|NCT02829723|464603186|FG007|Overall Study|Study terminated by sponsor|0|||
129085587|NCT02829723|464603187|FG008|Overall Study|Study terminated by sponsor|0|||
129085588|NCT02829723|464603188|FG009|Overall Study|Study terminated by sponsor|0|||
129085589|NCT02829723|464603189|FG010|Overall Study|Study terminated by sponsor|0|||
129085590|NCT02829723|464603190|FG011|Overall Study|Study terminated by sponsor|0|||
129085591|NCT02829723|464603191|FG012|Overall Study|Study terminated by sponsor|0|||
129085592|NCT02829723|464603192|FG013|Overall Study|Study terminated by sponsor|0|||
129085593|NCT02829723|464603193|FG014|Overall Study|Study terminated by sponsor|0|||
129143245|NCT01817777|464819593|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
129143246|NCT01817777|464819594|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
129143247|NCT00443456|464819595|FG000|Overall Study|Adverse Event|16|||
129143248|NCT00443456|464819595|FG000|Overall Study|Move|1|||
129143249|NCT00443456|464819595|FG000|Overall Study|Withdrawal by Subject|1|||
129085594|NCT02829723|464603194|FG015|Overall Study|Study terminated by sponsor|0|||
129085595|NCT02829723|464603195|FG016|Overall Study|Study terminated by sponsor|0|||
129085596|NCT02829723|464603196|FG017|Overall Study|Study terminated by sponsor|0|||
129085597|NCT02829723|464603197|FG018|Overall Study|Study terminated by sponsor|0|||
129085598|NCT02829723|464603198|FG019|Overall Study|Study terminated by sponsor|0|||
129085599|NCT02829723|464603199|FG020|Overall Study|Study terminated by sponsor|0|||
129143250|NCT00557440|464819596|FG000|Treatment Period 1|Adverse Event|0|||
129085600|NCT02829723|464603200|FG021|Overall Study|Study terminated by sponsor|1|||
129085601|NCT02829723|464603201|FG022|Overall Study|Study terminated by sponsor|0|||
129143251|NCT00557440|464819597|FG001|Treatment Period 1|Adverse Event|0|||
129085602|NCT02829723|464603202|FG023|Overall Study|Study terminated by sponsor|0|||
129085603|NCT02829723|464603203|FG024|Overall Study|Study terminated by sponsor|0|||
129085604|NCT02829723|464603204|FG025|Overall Study|Study terminated by sponsor|0|||
129085605|NCT02829723|464603205|FG026|Overall Study|Study terminated by sponsor|0|||
129143252|NCT00557440|464819598|FG002|Treatment Period 1|Adverse Event|1|||
129143253|NCT03524157|464819599|FG000|Overall Study|cytology not readable|0|||
129143254|NCT03524157|464819600|FG001|Overall Study|cytology not readable|0|||
129143255|NCT03524157|464819601|FG002|Overall Study|cytology not readable|1|||
129143256|NCT02157610|464819602|FG000|Overall Study|Death|4|||
129143257|NCT02157610|464819603|FG001|Overall Study|Death|4|||
129143258|NCT00124657|464819604|FG000|Overall Study|Toxicity|0|||
129143259|NCT00124657|464819605|FG001|Overall Study|Toxicity|0|||
129143260|NCT00124657|464819606|FG002|Overall Study|Toxicity|1|||
129143261|NCT00124657|464819604|FG000|Overall Study|Non-compliance|1|||
129143262|NCT00124657|464819605|FG001|Overall Study|Non-compliance|0|||
129143263|NCT00124657|464819606|FG002|Overall Study|Non-compliance|4|||
129143264|NCT00124657|464819604|FG000|Overall Study|Progressive disease|14|||
129143265|NCT00124657|464819605|FG001|Overall Study|Progressive disease|5|||
129143266|NCT00124657|464819606|FG002|Overall Study|Progressive disease|27|||
129143267|NCT00124657|464819604|FG000|Overall Study|Intercurrent illness|1|||
129143268|NCT00124657|464819605|FG001|Overall Study|Intercurrent illness|0|||
129143269|NCT00124657|464819606|FG002|Overall Study|Intercurrent illness|0|||
129143270|NCT01935947|464819607|FG000|Overall Study|Adverse Event|0|||
129143271|NCT01935947|464819608|FG001|Overall Study|Adverse Event|2|||
129143272|NCT01935947|464819609|FG002|Overall Study|Adverse Event|0|||
129143273|NCT01935947|464819607|FG000|Overall Study|Diease Progression|2|||
129143274|NCT01935947|464819608|FG001|Overall Study|Diease Progression|2|||
129143275|NCT01935947|464819609|FG002|Overall Study|Diease Progression|2|||
129143276|NCT01935947|464819607|FG000|Overall Study|Death|1|||
129143277|NCT01935947|464819608|FG001|Overall Study|Death|0|||
129143278|NCT01935947|464819609|FG002|Overall Study|Death|0|||
129143279|NCT01378195|464819610|FG000|Overall Study|Lost to Follow-up|29|||
129143280|NCT01378195|464819611|FG001|Overall Study|Lost to Follow-up|18|||
129143281|NCT00425555|464819612|FG000|Overall Study|Withdrawal by Subject|11|||
129143282|NCT00425555|464819613|FG001|Overall Study|Withdrawal by Subject|8|||
129085606|NCT02989649|464603206|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
129085607|NCT02989649|464603206|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
129085608|NCT02989649|464603206|FG000|Overall Study|Lost For Observation During Study|3|||
129085609|NCT02989649|464603206|FG000|Overall Study|Reason Not Specified|13|||
129085610|NCT02004886|464603207|FG000|Overall Study|Adverse Event|0|||
129085611|NCT02004886|464603208|FG001|Overall Study|Adverse Event|1|||
129085612|NCT02004886|464603209|FG002|Overall Study|Adverse Event|0|||
129085613|NCT02004886|464603210|FG003|Overall Study|Adverse Event|0|||
129085614|NCT02004886|464603207|FG000|Overall Study|Unable to attend future visits|1|||
129085615|NCT02004886|464603208|FG001|Overall Study|Unable to attend future visits|0|||
129085616|NCT02004886|464603209|FG002|Overall Study|Unable to attend future visits|0|||
129085617|NCT02004886|464603210|FG003|Overall Study|Unable to attend future visits|0|||
129085618|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
129085619|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
129085620|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
129085621|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
129085622|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
129085623|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
129085624|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
129085625|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
129085626|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
129085627|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
129085628|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Death|1|||
129085629|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Death|0|||
129085630|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
129085631|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
129143283|NCT00425555|464819612|FG000|Overall Study|Lost to Follow-up|0|||
129085632|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
129085633|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
129085634|NCT01876784|464603213|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
129085635|NCT01876784|464603214|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
129085636|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
129085637|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
129143284|NCT00425555|464819613|FG001|Overall Study|Lost to Follow-up|1|||
129143285|NCT00425555|464819612|FG000|Overall Study|Administrative problems|3|||
129143286|NCT00425555|464819613|FG001|Overall Study|Administrative problems|0|||
129143287|NCT00425555|464819612|FG000|Overall Study|Death|1|||
129143288|NCT00425555|464819613|FG001|Overall Study|Death|2|||
129143289|NCT00425555|464819612|FG000|Overall Study|New cancer therapy|2|||
129143290|NCT00425555|464819613|FG001|Overall Study|New cancer therapy|1|||
129143291|NCT00425555|464819612|FG000|Overall Study|Disease progression|36|||
129143292|NCT00425555|464819613|FG001|Overall Study|Disease progression|33|||
129143293|NCT00425555|464819612|FG000|Overall Study|Adverse Event|25|||
129143294|NCT00425555|464819613|FG001|Overall Study|Adverse Event|15|||
129143295|NCT00425555|464819612|FG000|Overall Study|Protocol Violation|1|||
129143296|NCT00425555|464819613|FG001|Overall Study|Protocol Violation|0|||
129143297|NCT01148771|464819614|FG000|Washout Period|Withdrawal by Subject|0|||
129143298|NCT01148771|464819615|FG001|Washout Period|Withdrawal by Subject|1|||
129143299|NCT05418426|464819616|FG000|Overall Study|Adverse Event|0|||
129143300|NCT05418426|464819617|FG001|Overall Study|Adverse Event|1|||
129143301|NCT05418426|464819618|FG002|Overall Study|Adverse Event|0|||
129143302|NCT05418426|464819616|FG000|Overall Study|Withdrawal by Subject|0|||
129143303|NCT05418426|464819617|FG001|Overall Study|Withdrawal by Subject|1|||
129143304|NCT05418426|464819618|FG002|Overall Study|Withdrawal by Subject|0|||
129143305|NCT05418426|464819616|FG000|Overall Study|Protocol Violation|0|||
129143306|NCT05418426|464819617|FG001|Overall Study|Protocol Violation|0|||
129143307|NCT05418426|464819618|FG002|Overall Study|Protocol Violation|1|||
129143308|NCT01674062|464819619|FG000|Overall Study|Insufficient Therapeutic Response|56|||
129143309|NCT01674062|464819620|FG001|Overall Study|Insufficient Therapeutic Response|26|||
129143310|NCT01674062|464819619|FG000|Overall Study|Other|8|||
129143311|NCT01674062|464819620|FG001|Overall Study|Other|1|||
129143312|NCT01674062|464819619|FG000|Overall Study|Adverse Event|1|||
129143313|NCT01674062|464819620|FG001|Overall Study|Adverse Event|1|||
129143314|NCT01674062|464819619|FG000|Overall Study|Death|0|||
129143315|NCT01674062|464819620|FG001|Overall Study|Death|1|||
129143316|NCT01674062|464819619|FG000|Overall Study|Programming Error|1|||
129143317|NCT01674062|464819620|FG001|Overall Study|Programming Error|0|||
129143318|NCT04620668|464819621|FG000|Overall Study|Withdrawal by Subject|2|||
129143319|NCT04620668|464819622|FG001|Overall Study|Withdrawal by Subject|0|||
129143320|NCT04620668|464819621|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
129143321|NCT04620668|464819622|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
129143322|NCT04620668|464819621|FG000|Overall Study|Removed before analysis: missing data|2|||
129143323|NCT04620668|464819622|FG001|Overall Study|Removed before analysis: missing data|0|||
129143324|NCT04620668|464819621|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
129143325|NCT04620668|464819622|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
129143326|NCT04620668|464819621|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
129143327|NCT04620668|464819622|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
129143328|NCT02951819|464819627|FG000|Overall Study|Death|9|||
129143329|NCT02951819|464819628|FG001|Overall Study|Death|7|||
129143330|NCT02951819|464819627|FG000|Overall Study|Withdrawal by Subject|3|||
129143331|NCT02951819|464819628|FG001|Overall Study|Withdrawal by Subject|0|||
129143332|NCT02951819|464819627|FG000|Overall Study|Adverse Event|1|||
129143333|NCT02951819|464819628|FG001|Overall Study|Adverse Event|0|||
129143334|NCT02951819|464819627|FG000|Overall Study|Lack of Efficacy|4|||
129143335|NCT02951819|464819628|FG001|Overall Study|Lack of Efficacy|0|||
129143336|NCT02951819|464819627|FG000|Overall Study|Lost to Follow-up|1|||
129143337|NCT02951819|464819628|FG001|Overall Study|Lost to Follow-up|0|||
129143338|NCT02951819|464819627|FG000|Overall Study|Progressive Disease|1|||
129143339|NCT02951819|464819628|FG001|Overall Study|Progressive Disease|0|||
129143340|NCT02951819|464819627|FG000|Overall Study|Other|9|||
129143341|NCT02951819|464819628|FG001|Overall Study|Other|0|||
129143342|NCT03647137|464819630|FG000|Overall Study|Scan Limitation|2|||
129143343|NCT03647137|464819631|FG001|Overall Study|Scan Limitation|1|||
129143344|NCT03647137|464819632|FG002|Overall Study|Scan Limitation|1|||
129143345|NCT03647137|464819633|FG003|Overall Study|Scan Limitation|2|||
129143346|NCT01443026|464819638|FG000|Overall Study|Physician Decision|1|||
129143347|NCT01443026|464819639|FG001|Overall Study|Physician Decision|0|||
128724330|NCT00694369|463289049|FG004|Overall Study|Adverse Event|3|||
129143348|NCT01443026|464819638|FG000|Overall Study|Death|0|||
129143349|NCT01443026|464819639|FG001|Overall Study|Death|1|||
129143350|NCT01443026|464819638|FG000|Overall Study|Withdrawal by Subject|0|||
129143351|NCT01443026|464819639|FG001|Overall Study|Withdrawal by Subject|3|||
129143352|NCT01443026|464819638|FG000|Overall Study|Lost to Follow-up|2|||
129143353|NCT01443026|464819639|FG001|Overall Study|Lost to Follow-up|1|||
129143354|NCT00581919|464819640|FG000|Overall Study|Adverse Event|8|||
129143355|NCT00581919|464819640|FG000|Overall Study|Death|1|||
128724331|NCT00694369|463289045|FG000|Overall Study|Lost to Follow-up|0|||
128724332|NCT00694369|463289046|FG001|Overall Study|Lost to Follow-up|0|||
129143356|NCT00581919|464819640|FG000|Overall Study|Disease Progression|10|||
129143357|NCT00581919|464819640|FG000|Overall Study|Physician Decision|1|||
129143358|NCT00581919|464819640|FG000|Overall Study|Other Complicating Disease|1|||
129143359|NCT00581919|464819640|FG000|Overall Study|Started Non-Protocol Therapy|2|||
129143360|NCT00581919|464819640|FG000|Overall Study|Withdrawal by Subject|1|||
129143361|NCT02655601|464819641|FG000|Overall Study|Adverse Event|0|||
129143362|NCT02655601|464819642|FG001|Overall Study|Adverse Event|0|||
129143363|NCT02655601|464819643|FG002|Overall Study|Adverse Event|0|||
129143364|NCT02655601|464819644|FG003|Overall Study|Adverse Event|1|||
129143365|NCT02655601|464819645|FG004|Overall Study|Adverse Event|1|||
129143366|NCT02655601|464819646|FG005|Overall Study|Adverse Event|0|||
129143367|NCT02655601|464819641|FG000|Overall Study|Physician Decision|0|||
129143368|NCT02655601|464819642|FG001|Overall Study|Physician Decision|0|||
129143369|NCT02655601|464819643|FG002|Overall Study|Physician Decision|0|||
129143370|NCT02655601|464819644|FG003|Overall Study|Physician Decision|0|||
129143371|NCT02655601|464819645|FG004|Overall Study|Physician Decision|1|||
129143372|NCT02655601|464819646|FG005|Overall Study|Physician Decision|1|||
129143373|NCT02655601|464819641|FG000|Overall Study|Withdrawal by Subject|0|||
129143374|NCT02655601|464819642|FG001|Overall Study|Withdrawal by Subject|0|||
129143375|NCT02655601|464819643|FG002|Overall Study|Withdrawal by Subject|0|||
129143376|NCT02655601|464819644|FG003|Overall Study|Withdrawal by Subject|0|||
129143377|NCT02655601|464819645|FG004|Overall Study|Withdrawal by Subject|4|||
129143378|NCT02655601|464819646|FG005|Overall Study|Withdrawal by Subject|8|||
129143379|NCT02655601|464819641|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
129143380|NCT02655601|464819642|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129143381|NCT02655601|464819643|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129143382|NCT02655601|464819644|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129143383|NCT02655601|464819645|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129143384|NCT02655601|464819646|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129143385|NCT02796651|464819652|FG000|Overall Study|Adverse Event|6|||
129143386|NCT02796651|464819652|FG000|Overall Study|Lost to Follow-up|1|||
129143387|NCT02796651|464819652|FG000|Overall Study|Withdrawal by Subject|4|||
129143388|NCT02796651|464819652|FG000|Overall Study|Protocol Violation|4|||
129143389|NCT02796651|464819652|FG000|Overall Study|Lack of Efficacy|1|||
129143390|NCT02796651|464819652|FG000|Overall Study|Other|10|||
129143391|NCT05014919|464819653|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
129143392|NCT05014919|464819654|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
129143393|NCT05014919|464819655|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
129143394|NCT05014919|464819653|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
129143395|NCT05014919|464819654|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
129143396|NCT05014919|464819655|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
129143397|NCT05014919|464819653|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
129143398|NCT05014919|464819654|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
129143399|NCT05014919|464819655|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
129143400|NCT05014919|464819653|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
129143401|NCT05014919|464819654|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
129143402|NCT05014919|464819655|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
129143403|NCT05014919|464819653|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
129143404|NCT05014919|464819654|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
129143405|NCT05014919|464819655|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
129143406|NCT05014919|464819653|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
129143407|NCT05014919|464819654|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
129143408|NCT05014919|464819655|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
129143409|NCT05014919|464819653|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
129143410|NCT05014919|464819654|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
129143411|NCT05014919|464819655|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
129143412|NCT05014919|464819653|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
129085638|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Adverse Event|2|||
129085639|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Adverse Event|6|||
129085640|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
129085641|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
129085642|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Progressive disease|4|||
129085643|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Progressive disease|35|||
129085644|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
129085645|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
129085646|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
129085647|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
129085648|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Death|0|||
129085649|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Death|1|||
129085650|NCT01876784|464603213|FG000|Open-label Period (31 Months)|Other than specified above|9|||
129085651|NCT01876784|464603214|FG001|Open-label Period (31 Months)|Other than specified above|18|||
129085652|NCT03605862|464603215|FG000|Overall Study|Withdrawal by Subject|12|||
129085653|NCT03605862|464603216|FG001|Overall Study|Withdrawal by Subject|9|||
129085654|NCT03605862|464603215|FG000|Overall Study|Adverse Event|2|||
129085655|NCT03605862|464603216|FG001|Overall Study|Adverse Event|1|||
129085656|NCT03605862|464603215|FG000|Overall Study|Physician Decision|3|||
129085657|NCT03605862|464603216|FG001|Overall Study|Physician Decision|1|||
129085658|NCT03605862|464603215|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
129085659|NCT03605862|464603216|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
129085660|NCT03891862|464603217|FG000|Open-label Period|Adverse Event|2|||
129085661|NCT03891862|464603218|FG001|Open-label Period|Adverse Event|0|||
129085662|NCT03891862|464603219|FG002|Open-label Period|Adverse Event|0|||
129085663|NCT03891862|464603217|FG000|Open-label Period|Protocol Violation|5|||
129085664|NCT03891862|464603218|FG001|Open-label Period|Protocol Violation|0|||
129085665|NCT03891862|464603219|FG002|Open-label Period|Protocol Violation|0|||
129085666|NCT03891862|464603217|FG000|Open-label Period|Withdrawal by Subject|6|||
129085667|NCT03891862|464603218|FG001|Open-label Period|Withdrawal by Subject|0|||
129085668|NCT03891862|464603219|FG002|Open-label Period|Withdrawal by Subject|0|||
129085669|NCT03891862|464603217|FG000|Open-label Period|Death|1|||
129085670|NCT03891862|464603218|FG001|Open-label Period|Death|0|||
129085671|NCT03891862|464603219|FG002|Open-label Period|Death|0|||
129085672|NCT03891862|464603217|FG000|Open-label Period|Lost to Follow-up|2|||
129085673|NCT03891862|464603218|FG001|Open-label Period|Lost to Follow-up|0|||
129085674|NCT03891862|464603219|FG002|Open-label Period|Lost to Follow-up|0|||
129085675|NCT03891862|464603217|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
129085676|NCT03891862|464603218|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
129085677|NCT03891862|464603219|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
129085678|NCT03891862|464603217|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
129085679|NCT03891862|464603218|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
129085680|NCT03891862|464603219|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
129085681|NCT03891862|464603217|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
129085682|NCT03891862|464603218|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
129085683|NCT03891862|464603219|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
129085684|NCT03891862|464603217|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
129085685|NCT03891862|464603218|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
129085686|NCT03891862|464603219|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
129085687|NCT05239494|464603220|FG000|Overall Study|Lost to Follow-up|1|||
129085688|NCT01194531|464603221|FG000|Overall Study|Withdrawal by Subject|1|||
129085689|NCT01194531|464603222|FG001|Overall Study|Withdrawal by Subject|0|||
129085690|NCT01194531|464603221|FG000|Overall Study|Protocol Violation|4|||
129085691|NCT01194531|464603222|FG001|Overall Study|Protocol Violation|1|||
129085692|NCT01194531|464603221|FG000|Overall Study|Physician Decision|0|||
129085693|NCT01194531|464603222|FG001|Overall Study|Physician Decision|2|||
129085694|NCT01053962|464603223|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
129143413|NCT05014919|464819654|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
129143414|NCT05014919|464819655|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
129143415|NCT00680914|464819656|FG000|Overall Study|Consent withdrawal|6|||
129143416|NCT00680914|464819657|FG001|Overall Study|Consent withdrawal|3|||
129143417|NCT00680914|464819656|FG000|Overall Study|Lost to Follow-up|4|||
129143418|NCT00680914|464819657|FG001|Overall Study|Lost to Follow-up|0|||
128724333|NCT00694369|463289047|FG002|Overall Study|Lost to Follow-up|1|||
128724334|NCT00694369|463289048|FG003|Overall Study|Lost to Follow-up|1|||
129085695|NCT01053962|464603224|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
129085696|NCT01053962|464603225|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
129085697|NCT01053962|464603226|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
129085698|NCT01053962|464603227|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
129085699|NCT01053962|464603223|FG000|Pretreatment Period|Venipuncture Failure|0|||
129143419|NCT00680914|464819656|FG000|Overall Study|serious adverse event (SAE)|0|||
129143420|NCT00680914|464819657|FG001|Overall Study|serious adverse event (SAE)|1|||
129143421|NCT02971163|464819658|FG000|Overall Study|Lost to Follow-up|4|||
129143422|NCT02971163|464819659|FG001|Overall Study|Lost to Follow-up|2|||
129143423|NCT00539500|464819660|FG000|Overall Study|Disease Progression|1|||
129143424|NCT00539500|464819660|FG000|Overall Study|Lost to Follow-up|2|||
129143425|NCT01491919|464819663|FG000|Overall Study|Insufficient PK sampling|1|||
129143426|NCT01491919|464819664|FG001|Overall Study|Insufficient PK sampling|2|||
129143427|NCT01491919|464819665|FG002|Overall Study|Insufficient PK sampling|1|||
129143428|NCT02871219|464819666|FG000|Overall Study|Adverse Event|15|||
129143429|NCT02871219|464819666|FG000|Overall Study|Death|3|||
129143430|NCT02871219|464819666|FG000|Overall Study|Progression|3|||
129143431|NCT02871219|464819666|FG000|Overall Study|Infections|7|||
129143432|NCT02871219|464819666|FG000|Overall Study|Infusion Related|4|||
129143433|NCT05375929|464819674|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
129143434|NCT05375929|464819675|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
129143435|NCT05375929|464819676|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
129143436|NCT05375929|464819677|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
129143437|NCT05375929|464819674|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129085700|NCT01053962|464603224|FG001|Pretreatment Period|Venipuncture Failure|0|||
129085701|NCT01053962|464603225|FG002|Pretreatment Period|Venipuncture Failure|1|||
129085702|NCT01053962|464603226|FG003|Pretreatment Period|Venipuncture Failure|0|||
129085703|NCT01053962|464603227|FG004|Pretreatment Period|Venipuncture Failure|0|||
129085704|NCT01053962|464603223|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129085705|NCT01053962|464603224|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
129085706|NCT01053962|464603225|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129085707|NCT01053962|464603226|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129085708|NCT01053962|464603227|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129085709|NCT01053962|464603223|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129085710|NCT01053962|464603224|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129085711|NCT01053962|464603225|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129085712|NCT01053962|464603226|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
129085713|NCT01053962|464603227|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129085714|NCT01053962|464603223|FG000|Treatment Period|Lack of Efficacy|0|||
129085715|NCT01053962|464603224|FG001|Treatment Period|Lack of Efficacy|0|||
129085716|NCT01053962|464603225|FG002|Treatment Period|Lack of Efficacy|0|||
129085717|NCT01053962|464603226|FG003|Treatment Period|Lack of Efficacy|0|||
129085718|NCT01053962|464603227|FG004|Treatment Period|Lack of Efficacy|1|||
129085719|NCT01053962|464603223|FG000|Treatment Period|Adverse Event|0|||
129085720|NCT01053962|464603224|FG001|Treatment Period|Adverse Event|0|||
129085721|NCT01053962|464603225|FG002|Treatment Period|Adverse Event|0|||
129085722|NCT01053962|464603226|FG003|Treatment Period|Adverse Event|0|||
129085723|NCT01053962|464603227|FG004|Treatment Period|Adverse Event|1|||
129085724|NCT01053962|464603223|FG000|Treatment Period|Withdrawal by Subject|0|||
129085725|NCT01053962|464603224|FG001|Treatment Period|Withdrawal by Subject|0|||
129085726|NCT01053962|464603225|FG002|Treatment Period|Withdrawal by Subject|0|||
129085727|NCT01053962|464603226|FG003|Treatment Period|Withdrawal by Subject|0|||
129085728|NCT01053962|464603227|FG004|Treatment Period|Withdrawal by Subject|1|||
129085729|NCT01053962|464603223|FG000|Treatment Period|Noncompliance with protocol|1|||
129085730|NCT01053962|464603224|FG001|Treatment Period|Noncompliance with protocol|0|||
129085731|NCT01053962|464603225|FG002|Treatment Period|Noncompliance with protocol|0|||
129085732|NCT01053962|464603226|FG003|Treatment Period|Noncompliance with protocol|0|||
129085733|NCT01053962|464603227|FG004|Treatment Period|Noncompliance with protocol|0|||
129085734|NCT01894100|464603229|FG000|Overall Study|Lost to Follow-up|0|||
129085735|NCT01894100|464603230|FG001|Overall Study|Lost to Follow-up|1|||
129085736|NCT01894100|464603229|FG000|Overall Study|Withdrawal by Subject|3|||
129085737|NCT01894100|464603230|FG001|Overall Study|Withdrawal by Subject|0|||
129085738|NCT01094301|464603231|FG000|Trial Stage|Withdrawal by Subject|1|||
129085739|NCT01094301|464603231|FG000|Implant Stage|Adverse Event|1|||
129085740|NCT01094301|464603231|FG000|Implant Stage|Protocol Violation|1|||
129085741|NCT01094301|464603231|FG000|Implant Stage|Withdrawal by Subject|2|||
129085742|NCT01094301|464603231|FG000|Implant Stage|No return of pain|4|||
129143438|NCT05375929|464819675|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129143439|NCT05375929|464819676|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129085743|NCT02235077|464603232|FG000|Overall Study|Death|5|||
129085744|NCT02235077|464603233|FG001|Overall Study|Death|7|||
129085745|NCT02235077|464603232|FG000|Overall Study|Lost to Follow-up|5|||
129085746|NCT02235077|464603233|FG001|Overall Study|Lost to Follow-up|6|||
129085747|NCT02235077|464603232|FG000|Overall Study|Withdrawal by Subject|8|||
128724335|NCT00694369|463289049|FG004|Overall Study|Lost to Follow-up|0|||
129085748|NCT02235077|464603233|FG001|Overall Study|Withdrawal by Subject|5|||
129143440|NCT05375929|464819677|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129143441|NCT05375929|464819674|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
129143442|NCT05375929|464819675|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
129143443|NCT05375929|464819676|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
129143444|NCT05375929|464819677|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
129143445|NCT05375929|464819674|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
129143446|NCT05375929|464819675|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
129143447|NCT05375929|464819676|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
129143448|NCT05375929|464819677|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
129143449|NCT05375929|464819674|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
129143450|NCT05375929|464819675|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
129143451|NCT05375929|464819676|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
129143452|NCT05375929|464819677|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
129143453|NCT05375929|464819674|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
129143454|NCT05375929|464819675|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
129143455|NCT05375929|464819676|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
129143456|NCT05375929|464819677|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
129143457|NCT05375929|464819674|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
129143458|NCT05375929|464819675|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
129143459|NCT05375929|464819676|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
129143460|NCT05375929|464819677|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
129143461|NCT05375929|464819674|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
129143462|NCT05375929|464819675|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
129143463|NCT05375929|464819676|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
129143464|NCT05375929|464819677|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
129143465|NCT05375929|464819674|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
129143466|NCT05375929|464819675|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
129143467|NCT05375929|464819676|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
129143468|NCT05375929|464819677|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
129143469|NCT05375929|464819674|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
129143470|NCT05375929|464819675|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
129143471|NCT05375929|464819676|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
129143472|NCT05375929|464819677|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
129143473|NCT00773461|464819682|FG000|Overall Study|Adverse Event|1|||
129143474|NCT00773461|464819683|FG001|Overall Study|Adverse Event|3|||
129143475|NCT00773461|464819682|FG000|Overall Study|Withdrawal by Subject|4|||
129143476|NCT00773461|464819683|FG001|Overall Study|Withdrawal by Subject|1|||
129143477|NCT00322218|464819686|FG000|Overall Study|Death|3|||
129143478|NCT00322218|464819687|FG001|Overall Study|Death|6|||
129143479|NCT00908141|464819689|FG000|Overall Study|Withdrawal by Subject|0|||
129143480|NCT00908141|464819690|FG001|Overall Study|Withdrawal by Subject|1|||
129143481|NCT02520154|464819691|FG000|Overall Study|Death|1|||
129143482|NCT02520154|464819691|FG000|Overall Study|Withdrawal by Subject|2|||
129143483|NCT02520154|464819691|FG000|Overall Study|Physician Decision|2|||
129143484|NCT02254291|464820903|FG000|Overall Study|Withdrawal by Subject|0|||
129143485|NCT02254291|464820904|FG001|Overall Study|Withdrawal by Subject|3|||
129143486|NCT02254291|464820905|FG002|Overall Study|Withdrawal by Subject|1|||
129143487|NCT02254291|464820903|FG000|Overall Study|Missing follow-up information|0|||
129143488|NCT02254291|464820904|FG001|Overall Study|Missing follow-up information|0|||
129143489|NCT02254291|464820905|FG002|Overall Study|Missing follow-up information|1|||
129143490|NCT02904265|464820908|FG000|Overall Study|Physician Decision|1|||
129143491|NCT02904265|464820909|FG001|Overall Study|Physician Decision|2|||
129143492|NCT00488293|464820913|FG000|Overall Study|Lost to Follow-up|28|||
129143493|NCT00488293|464820914|FG001|Overall Study|Lost to Follow-up|25|||
129143494|NCT00488293|464820913|FG000|Overall Study|Withdrawal by Subject|5|||
129143495|NCT00488293|464820914|FG001|Overall Study|Withdrawal by Subject|3|||
129143496|NCT00488293|464820913|FG000|Overall Study|Death|2|||
129143497|NCT00488293|464820914|FG001|Overall Study|Death|1|||
129143498|NCT00488293|464820913|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
129143499|NCT00488293|464820914|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
129143500|NCT00500331|464820915|FG000|Overall Study|Adverse Event|0|||
129143501|NCT00500331|464820916|FG001|Overall Study|Adverse Event|2|||
129143502|NCT00500331|464820917|FG002|Overall Study|Adverse Event|0|||
129143503|NCT00500331|464820918|FG003|Overall Study|Adverse Event|1|||
129143504|NCT00500331|464820919|FG004|Overall Study|Adverse Event|2|||
129143505|NCT00500331|464820920|FG005|Overall Study|Adverse Event|2|||
129143506|NCT00500331|464820921|FG006|Overall Study|Adverse Event|0|||
129143507|NCT00500331|464820915|FG000|Overall Study|Lost to Follow-up|1|||
129143508|NCT00500331|464820916|FG001|Overall Study|Lost to Follow-up|1|||
129143509|NCT00500331|464820917|FG002|Overall Study|Lost to Follow-up|1|||
129085749|NCT02235077|464603232|FG000|Overall Study|Physician Decision|0|||
129085750|NCT02235077|464603233|FG001|Overall Study|Physician Decision|1|||
129085751|NCT04013672|464603235|FG000|Overall Study|Withdrawal by Subject|3|||
129085752|NCT04013672|464603236|FG001|Overall Study|Withdrawal by Subject|0|||
129085753|NCT04013672|464603235|FG000|Overall Study|Death|1|||
129085754|NCT04013672|464603236|FG001|Overall Study|Death|0|||
129085755|NCT04013672|464603235|FG000|Overall Study|Physician Decision|5|||
129085756|NCT04013672|464603236|FG001|Overall Study|Physician Decision|0|||
129085757|NCT00586820|464603237|FG000|Overall Study|Unsuccessful PCI|1|||
129085758|NCT00586820|464603238|FG001|Overall Study|Unsuccessful PCI|0|||
129085759|NCT03887442|464603239|FG000|Overall Study|Adverse Event|1|||
129085760|NCT03887442|464603240|FG001|Overall Study|Adverse Event|0|||
129085761|NCT01868022|464603241|FG000|Overall Study|Withdrawal by Subject|0|||
129085762|NCT01868022|464603242|FG001|Overall Study|Withdrawal by Subject|0|||
129085763|NCT01868022|464603243|FG002|Overall Study|Withdrawal by Subject|1|||
129085764|NCT01868022|464603244|FG003|Overall Study|Withdrawal by Subject|1|||
129085765|NCT01868022|464603245|FG004|Overall Study|Withdrawal by Subject|0|||
129085766|NCT01868022|464603246|FG005|Overall Study|Withdrawal by Subject|0|||
129085767|NCT01868022|464603247|FG006|Overall Study|Withdrawal by Subject|0|||
129085768|NCT01868022|464603248|FG007|Overall Study|Withdrawal by Subject|1|||
129085769|NCT01868022|464603249|FG008|Overall Study|Withdrawal by Subject|0|||
129085770|NCT01868022|464603241|FG000|Overall Study|Adverse Event|0|||
129085771|NCT01868022|464603242|FG001|Overall Study|Adverse Event|0|||
129085772|NCT01868022|464603243|FG002|Overall Study|Adverse Event|0|||
129085773|NCT01868022|464603244|FG003|Overall Study|Adverse Event|0|||
129085774|NCT01868022|464603245|FG004|Overall Study|Adverse Event|2|||
129085775|NCT01868022|464603246|FG005|Overall Study|Adverse Event|0|||
129085776|NCT01868022|464603247|FG006|Overall Study|Adverse Event|0|||
129085777|NCT01868022|464603248|FG007|Overall Study|Adverse Event|2|||
129085778|NCT01868022|464603249|FG008|Overall Study|Adverse Event|2|||
129085779|NCT01868022|464603241|FG000|Overall Study|Physician Decision|0|||
129085780|NCT01868022|464603242|FG001|Overall Study|Physician Decision|0|||
129085781|NCT01868022|464603243|FG002|Overall Study|Physician Decision|0|||
129085782|NCT01868022|464603244|FG003|Overall Study|Physician Decision|0|||
129085783|NCT01868022|464603245|FG004|Overall Study|Physician Decision|0|||
129085784|NCT01868022|464603246|FG005|Overall Study|Physician Decision|1|||
129085785|NCT01868022|464603247|FG006|Overall Study|Physician Decision|0|||
129085786|NCT01868022|464603248|FG007|Overall Study|Physician Decision|2|||
129085787|NCT01868022|464603249|FG008|Overall Study|Physician Decision|0|||
129085788|NCT01868022|464603241|FG000|Overall Study|Study closed/terminated|0|||
129085789|NCT01868022|464603242|FG001|Overall Study|Study closed/terminated|0|||
129085790|NCT01868022|464603243|FG002|Overall Study|Study closed/terminated|0|||
129085791|NCT01868022|464603244|FG003|Overall Study|Study closed/terminated|0|||
129085792|NCT01868022|464603245|FG004|Overall Study|Study closed/terminated|0|||
129085793|NCT01868022|464603246|FG005|Overall Study|Study closed/terminated|0|||
129085794|NCT01868022|464603247|FG006|Overall Study|Study closed/terminated|0|||
129085795|NCT01868022|464603248|FG007|Overall Study|Study closed/terminated|1|||
129085796|NCT01868022|464603249|FG008|Overall Study|Study closed/terminated|0|||
129085797|NCT01868022|464603241|FG000|Overall Study|Ongoing|0|||
129085798|NCT01868022|464603242|FG001|Overall Study|Ongoing|0|||
129085799|NCT01868022|464603243|FG002|Overall Study|Ongoing|0|||
129085800|NCT01868022|464603244|FG003|Overall Study|Ongoing|0|||
129085801|NCT01868022|464603245|FG004|Overall Study|Ongoing|0|||
129085802|NCT01868022|464603246|FG005|Overall Study|Ongoing|0|||
129085803|NCT01868022|464603247|FG006|Overall Study|Ongoing|0|||
129085804|NCT01868022|464603248|FG007|Overall Study|Ongoing|3|||
129085805|NCT01868022|464603249|FG008|Overall Study|Ongoing|0|||
129085806|NCT01628198|464603250|FG000|Overall Study|Lost to Follow-up|7|||
129085807|NCT01628198|464603250|FG000|Overall Study|Withdrawal by Subject|10|||
129143510|NCT00500331|464820918|FG003|Overall Study|Lost to Follow-up|2|||
129143511|NCT00500331|464820919|FG004|Overall Study|Lost to Follow-up|1|||
129085808|NCT01628198|464603250|FG000|Overall Study|Screen failure|1|||
129085809|NCT01827267|464603251|FG000|Overall Study|Did not receive study drug|1|||
129085810|NCT01827267|464603252|FG001|Overall Study|Did not receive study drug|1|||
129143512|NCT00500331|464820920|FG005|Overall Study|Lost to Follow-up|0|||
129085811|NCT01827267|464603251|FG000|Overall Study|Physician Decision|1|||
129085812|NCT01827267|464603252|FG001|Overall Study|Physician Decision|0|||
129143513|NCT00500331|464820921|FG006|Overall Study|Lost to Follow-up|0|||
129143514|NCT00500331|464820915|FG000|Overall Study|Protocol Violation|3|||
129085813|NCT01827267|464603251|FG000|Overall Study|Disease Progression|1|||
129085814|NCT01827267|464603252|FG001|Overall Study|Disease Progression|1|||
129085815|NCT01827267|464603251|FG000|Overall Study|Sponsor Discontinued Study|2|||
129143515|NCT00500331|464820916|FG001|Overall Study|Protocol Violation|1|||
129143516|NCT00500331|464820917|FG002|Overall Study|Protocol Violation|1|||
129085816|NCT01827267|464603252|FG001|Overall Study|Sponsor Discontinued Study|8|||
129085817|NCT01827267|464603251|FG000|Overall Study|Still on study|0|||
129085818|NCT01827267|464603252|FG001|Overall Study|Still on study|2|||
129085819|NCT00986921|464603265|FG000|Overall Study|Physician Decision|1|||
129085820|NCT00986921|464603266|FG001|Overall Study|Physician Decision|0|||
129085821|NCT00813813|464603267|FG000|Overall Study|Withdrawal by Subject|1|||
129085822|NCT00813813|464603268|FG001|Overall Study|Withdrawal by Subject|1|||
129085823|NCT00813813|464603267|FG000|Overall Study|Lost to Follow-up|2|||
129085824|NCT00813813|464603268|FG001|Overall Study|Lost to Follow-up|7|||
129085825|NCT00813813|464603267|FG000|Overall Study|Other|0|||
129085826|NCT00813813|464603268|FG001|Overall Study|Other|1|||
129085827|NCT00833482|464603269|FG000|Days 11-20|Adverse Event|0|||
129085828|NCT00833482|464603270|FG001|Days 11-20|Adverse Event|2|||
129085829|NCT00833482|464603271|FG002|Days 11-20|Adverse Event|0|||
129085830|NCT00833482|464603272|FG003|Days 11-20|Adverse Event|0|||
129085831|NCT00833482|464603273|FG004|Days 11-20|Adverse Event|0|||
129085832|NCT00833482|464603274|FG005|Days 11-20|Adverse Event|0|||
129085833|NCT00833482|464603269|FG000|Days 11-20|Withdrawal by Subject|0|||
129085834|NCT00833482|464603270|FG001|Days 11-20|Withdrawal by Subject|1|||
129085835|NCT00833482|464603271|FG002|Days 11-20|Withdrawal by Subject|0|||
129085836|NCT00833482|464603272|FG003|Days 11-20|Withdrawal by Subject|0|||
129085837|NCT00833482|464603273|FG004|Days 11-20|Withdrawal by Subject|0|||
129085838|NCT00833482|464603274|FG005|Days 11-20|Withdrawal by Subject|0|||
129085839|NCT00833482|464603269|FG000|Days 21-30|Adverse Event|0|||
129085840|NCT00833482|464603270|FG001|Days 21-30|Adverse Event|0|||
129085841|NCT00833482|464603271|FG002|Days 21-30|Adverse Event|1|||
129085842|NCT00833482|464603272|FG003|Days 21-30|Adverse Event|0|||
129085843|NCT00833482|464603273|FG004|Days 21-30|Adverse Event|0|||
129085844|NCT00833482|464603274|FG005|Days 21-30|Adverse Event|0|||
129085845|NCT00833482|464603269|FG000|Days 21-30|Withdrawal by Subject|0|||
129085846|NCT00833482|464603270|FG001|Days 21-30|Withdrawal by Subject|0|||
129085847|NCT00833482|464603271|FG002|Days 21-30|Withdrawal by Subject|0|||
129085848|NCT00833482|464603272|FG003|Days 21-30|Withdrawal by Subject|0|||
129085849|NCT00833482|464603273|FG004|Days 21-30|Withdrawal by Subject|1|||
129085850|NCT00833482|464603274|FG005|Days 21-30|Withdrawal by Subject|0|||
129085851|NCT02778074|464603275|FG000|Overall Study|Lost to Follow-up|7|||
129085852|NCT02778074|464603276|FG001|Overall Study|Lost to Follow-up|10|||
129085853|NCT03489707|464603277|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
129143517|NCT00500331|464820918|FG003|Overall Study|Protocol Violation|0|||
129143518|NCT00500331|464820919|FG004|Overall Study|Protocol Violation|1|||
129143519|NCT00500331|464820920|FG005|Overall Study|Protocol Violation|1|||
129143520|NCT00500331|464820921|FG006|Overall Study|Protocol Violation|1|||
129143521|NCT00500331|464820915|FG000|Overall Study|Withdrawal by Subject|4|||
129143522|NCT00500331|464820916|FG001|Overall Study|Withdrawal by Subject|0|||
129143523|NCT00500331|464820917|FG002|Overall Study|Withdrawal by Subject|1|||
129143524|NCT00500331|464820918|FG003|Overall Study|Withdrawal by Subject|5|||
129143525|NCT00500331|464820919|FG004|Overall Study|Withdrawal by Subject|0|||
129143526|NCT00500331|464820920|FG005|Overall Study|Withdrawal by Subject|1|||
129143527|NCT00500331|464820921|FG006|Overall Study|Withdrawal by Subject|1|||
129143528|NCT00500331|464820915|FG000|Overall Study|Lack of Efficacy|3|||
129143529|NCT00500331|464820916|FG001|Overall Study|Lack of Efficacy|1|||
129143530|NCT00500331|464820917|FG002|Overall Study|Lack of Efficacy|0|||
129143531|NCT00500331|464820918|FG003|Overall Study|Lack of Efficacy|0|||
129143532|NCT00500331|464820919|FG004|Overall Study|Lack of Efficacy|0|||
129143533|NCT00500331|464820920|FG005|Overall Study|Lack of Efficacy|0|||
129143534|NCT00500331|464820921|FG006|Overall Study|Lack of Efficacy|0|||
129143535|NCT00500331|464820915|FG000|Overall Study|Liver function test abnormality|0|||
129143536|NCT00500331|464820916|FG001|Overall Study|Liver function test abnormality|0|||
129143537|NCT00500331|464820917|FG002|Overall Study|Liver function test abnormality|1|||
129143538|NCT00500331|464820918|FG003|Overall Study|Liver function test abnormality|0|||
129143539|NCT00500331|464820919|FG004|Overall Study|Liver function test abnormality|0|||
129143540|NCT00500331|464820920|FG005|Overall Study|Liver function test abnormality|0|||
129143541|NCT00500331|464820921|FG006|Overall Study|Liver function test abnormality|0|||
129143542|NCT00500331|464820915|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
129143543|NCT00500331|464820916|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
129143544|NCT00500331|464820917|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
129143545|NCT00500331|464820918|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
129143546|NCT00500331|464820919|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
129143547|NCT00500331|464820920|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
129143548|NCT00500331|464820921|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
129143549|NCT00500331|464820915|FG000|Overall Study|Didn't return for continuation of study|1|||
129143550|NCT00500331|464820916|FG001|Overall Study|Didn't return for continuation of study|0|||
129143551|NCT00500331|464820917|FG002|Overall Study|Didn't return for continuation of study|0|||
129143552|NCT00500331|464820918|FG003|Overall Study|Didn't return for continuation of study|0|||
129085854|NCT03489707|464603278|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
129085855|NCT03489707|464603277|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
129085856|NCT03489707|464603278|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
129085857|NCT01817582|464603279|FG000|Overall Study|Withdrawal by Subject|0|||
129085858|NCT01817582|464603280|FG001|Overall Study|Withdrawal by Subject|1|||
129085859|NCT01817582|464603281|FG002|Overall Study|Withdrawal by Subject|0|||
129085860|NCT01817582|464603279|FG000|Overall Study|Participant revealed masked treatment|1|||
129143553|NCT00500331|464820919|FG004|Overall Study|Didn't return for continuation of study|0|||
129143554|NCT00500331|464820920|FG005|Overall Study|Didn't return for continuation of study|0|||
129143555|NCT00500331|464820921|FG006|Overall Study|Didn't return for continuation of study|0|||
129143556|NCT00500331|464820915|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
129143557|NCT00500331|464820916|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
129143558|NCT00500331|464820917|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
129143559|NCT00500331|464820918|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
129143560|NCT00500331|464820919|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
129143561|NCT00500331|464820920|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
129143562|NCT00500331|464820921|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
129143563|NCT00500331|464820915|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
129143564|NCT00500331|464820916|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
129143565|NCT00500331|464820917|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
129143566|NCT00500331|464820918|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
129143567|NCT00500331|464820919|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
129143568|NCT00500331|464820920|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
129143569|NCT00500331|464820921|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
129143570|NCT00500331|464820915|FG000|Overall Study|Participant was randomized by mistake|1|||
129143571|NCT00500331|464820916|FG001|Overall Study|Participant was randomized by mistake|0|||
129143572|NCT00500331|464820917|FG002|Overall Study|Participant was randomized by mistake|0|||
129143573|NCT00500331|464820918|FG003|Overall Study|Participant was randomized by mistake|0|||
129143574|NCT00500331|464820919|FG004|Overall Study|Participant was randomized by mistake|0|||
129143575|NCT00500331|464820920|FG005|Overall Study|Participant was randomized by mistake|0|||
129143576|NCT00500331|464820921|FG006|Overall Study|Participant was randomized by mistake|0|||
129143577|NCT00500331|464820915|FG000|Overall Study|Diabetologist nurse in the study|0|||
129143578|NCT00500331|464820916|FG001|Overall Study|Diabetologist nurse in the study|0|||
129143579|NCT00500331|464820917|FG002|Overall Study|Diabetologist nurse in the study|1|||
129143580|NCT00500331|464820918|FG003|Overall Study|Diabetologist nurse in the study|0|||
129143581|NCT00500331|464820919|FG004|Overall Study|Diabetologist nurse in the study|0|||
129143582|NCT00500331|464820920|FG005|Overall Study|Diabetologist nurse in the study|0|||
129143583|NCT00500331|464820921|FG006|Overall Study|Diabetologist nurse in the study|0|||
129143584|NCT00500331|464820915|FG000|Overall Study|State ban of biological samples export|0|||
129143585|NCT00500331|464820916|FG001|Overall Study|State ban of biological samples export|0|||
129143586|NCT00500331|464820917|FG002|Overall Study|State ban of biological samples export|0|||
129143587|NCT00500331|464820918|FG003|Overall Study|State ban of biological samples export|1|||
129143588|NCT00500331|464820919|FG004|Overall Study|State ban of biological samples export|0|||
129143589|NCT00500331|464820920|FG005|Overall Study|State ban of biological samples export|0|||
129143590|NCT00500331|464820921|FG006|Overall Study|State ban of biological samples export|0|||
129143591|NCT00500331|464820915|FG000|Overall Study|Protocol violated|0|||
129143592|NCT00500331|464820916|FG001|Overall Study|Protocol violated|0|||
129143593|NCT00500331|464820917|FG002|Overall Study|Protocol violated|0|||
129143594|NCT00500331|464820918|FG003|Overall Study|Protocol violated|1|||
129143595|NCT00500331|464820919|FG004|Overall Study|Protocol violated|0|||
129143596|NCT00500331|464820920|FG005|Overall Study|Protocol violated|0|||
129143597|NCT00500331|464820921|FG006|Overall Study|Protocol violated|0|||
129143598|NCT03436732|464820922|FG000|Overall Study|Not treated-enrolled in different study|1|||
129143599|NCT03436732|464820923|FG001|Overall Study|Not treated-enrolled in different study|0|||
129143600|NCT03436732|464820922|FG000|Overall Study|Off study after cycle 1|1|||
129143601|NCT03436732|464820923|FG001|Overall Study|Off study after cycle 1|0|||
129143602|NCT03436732|464820922|FG000|Overall Study|Adverse Event|2|||
129143603|NCT03436732|464820923|FG001|Overall Study|Adverse Event|0|||
128724336|NCT00694369|463289045|FG000|Overall Study|Physician Decision|0|||
128724337|NCT00694369|463289046|FG001|Overall Study|Physician Decision|0|||
128724338|NCT00694369|463289047|FG002|Overall Study|Physician Decision|0|||
128724339|NCT00694369|463289048|FG003|Overall Study|Physician Decision|0|||
128724340|NCT00694369|463289049|FG004|Overall Study|Physician Decision|1|||
129085861|NCT01817582|464603280|FG001|Overall Study|Participant revealed masked treatment|0|||
129085862|NCT01817582|464603281|FG002|Overall Study|Participant revealed masked treatment|0|||
129085863|NCT01817582|464603279|FG000|Overall Study|Randomized but exclusion criteria met|1|||
129085864|NCT01817582|464603280|FG001|Overall Study|Randomized but exclusion criteria met|0|||
129085865|NCT01817582|464603281|FG002|Overall Study|Randomized but exclusion criteria met|0|||
129085866|NCT02122887|464603284|FG000|Overall Study|Withdrawal by Subject|20|||
129085867|NCT02122887|464603285|FG001|Overall Study|Withdrawal by Subject|2|||
129085868|NCT00378508|464604921|FG000|Overall Study|Withdrawal by Subject|1|||
129085869|NCT00378508|464604922|FG001|Overall Study|Withdrawal by Subject|3|||
129085870|NCT00378508|464604921|FG000|Overall Study|Lost to Follow-up|1|||
129085871|NCT00378508|464604922|FG001|Overall Study|Lost to Follow-up|0|||
129085872|NCT03917472|464604926|FG000|Overall Study|Physician Decision|4|||
129085873|NCT03917472|464604927|FG001|Overall Study|Physician Decision|0|||
129085874|NCT03917472|464604926|FG000|Overall Study|Adverse Event|3|||
129085875|NCT03917472|464604927|FG001|Overall Study|Adverse Event|1|||
129085876|NCT03917472|464604926|FG000|Overall Study|Death|7|||
129085877|NCT03917472|464604927|FG001|Overall Study|Death|5|||
129085878|NCT03917472|464604926|FG000|Overall Study|Withdrawal by Subject|11|||
129085879|NCT03917472|464604927|FG001|Overall Study|Withdrawal by Subject|4|||
129085880|NCT03917472|464604926|FG000|Overall Study|Lost to Follow-up|10|||
129085881|NCT03917472|464604927|FG001|Overall Study|Lost to Follow-up|5|||
129085882|NCT01953601|464604931|FG000|Part 1 (Base Study)|Adverse Event|24|||
129085883|NCT01953601|464604932|FG001|Part 1 (Base Study)|Adverse Event|37|||
129085884|NCT01953601|464604933|FG002|Part 1 (Base Study)|Adverse Event|15|||
129085885|NCT01953601|464604931|FG000|Part 1 (Base Study)|Death|2|||
129085886|NCT01953601|464604932|FG001|Part 1 (Base Study)|Death|0|||
129085887|NCT01953601|464604933|FG002|Part 1 (Base Study)|Death|3|||
129085888|NCT01953601|464604931|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
129085889|NCT01953601|464604932|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
129085890|NCT01953601|464604933|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
129085891|NCT01953601|464604931|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
129085892|NCT01953601|464604932|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
129085893|NCT01953601|464604933|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
129085894|NCT01953601|464604931|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
129085895|NCT01953601|464604932|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
129085896|NCT01953601|464604933|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
129085897|NCT01953601|464604931|FG000|Part 1 (Base Study)|Physician Decision|3|||
129085898|NCT01953601|464604932|FG001|Part 1 (Base Study)|Physician Decision|7|||
129085899|NCT01953601|464604933|FG002|Part 1 (Base Study)|Physician Decision|4|||
129085900|NCT01953601|464604931|FG000|Part 1 (Base Study)|Screen failure|1|||
129085901|NCT01953601|464604932|FG001|Part 1 (Base Study)|Screen failure|0|||
129085902|NCT01953601|464604933|FG002|Part 1 (Base Study)|Screen failure|1|||
129085903|NCT01953601|464604931|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
129085904|NCT01953601|464604932|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
129085905|NCT01953601|464604933|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
129085906|NCT01953601|464604931|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
129085907|NCT01953601|464604932|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
129085908|NCT01953601|464604933|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
129085909|NCT01953601|464604931|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
129085910|NCT01953601|464604932|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
129085911|NCT01953601|464604933|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
129085912|NCT01953601|464604931|FG000|Part 1 (Base Study)|Subject moved|2|||
129085913|NCT01953601|464604932|FG001|Part 1 (Base Study)|Subject moved|2|||
129085914|NCT01953601|464604933|FG002|Part 1 (Base Study)|Subject moved|1|||
129085915|NCT01953601|464604931|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
129085916|NCT01953601|464604932|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
129085917|NCT01953601|464604933|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
129085918|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Adverse Event|1|||
129085919|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Adverse Event|1|||
129085920|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Adverse Event|10|||
129085921|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Death|0|||
129085922|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Death|3|||
129085923|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Death|0|||
129085924|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
129085925|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
129085926|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
129085927|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
129085928|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
129085929|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
129085930|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Physician Decision|2|||
129085931|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Physician Decision|0|||
128724341|NCT00694369|463289045|FG000|Overall Study|Protocol Violation|0|||
128724342|NCT00694369|463289046|FG001|Overall Study|Protocol Violation|1|||
129085932|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Physician Decision|2|||
128724343|NCT00694369|463289047|FG002|Overall Study|Protocol Violation|0|||
128724344|NCT00694369|463289048|FG003|Overall Study|Protocol Violation|0|||
128724345|NCT00694369|463289049|FG004|Overall Study|Protocol Violation|0|||
128724346|NCT00694369|463289045|FG000|Overall Study|Withdrawal by Subject|1|||
128724347|NCT00694369|463289046|FG001|Overall Study|Withdrawal by Subject|1|||
128724348|NCT00694369|463289047|FG002|Overall Study|Withdrawal by Subject|1|||
128724349|NCT00694369|463289048|FG003|Overall Study|Withdrawal by Subject|1|||
129085933|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
129085934|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
129085935|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
129085936|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
129085937|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
129085938|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
129085939|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
129085940|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
129085941|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
129085942|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Subject moved|0|||
129143604|NCT03436732|464820922|FG000|Overall Study|Death|0|||
129143605|NCT03436732|464820923|FG001|Overall Study|Death|1|||
129143606|NCT03345550|464820924|FG000|Overall Study|Withdrawal by Subject|1|||
129143607|NCT03345550|464820925|FG001|Overall Study|Withdrawal by Subject|0|||
129143608|NCT03345550|464820924|FG000|Overall Study|Lost to Follow-up|4|||
129143609|NCT03345550|464820925|FG001|Overall Study|Lost to Follow-up|5|||
129143610|NCT00833703|464820926|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
129143611|NCT00833703|464820927|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
129143612|NCT05538728|464820928|FG000|Overall Study|Withdrawal by Subject|1|||
129143613|NCT05538728|464820929|FG001|Overall Study|Withdrawal by Subject|1|||
129143614|NCT01904279|464820930|FG000|Overall Study|Lack of Efficacy|2|||
129143615|NCT01904279|464820931|FG001|Overall Study|Lack of Efficacy|3|||
129143616|NCT01904279|464820930|FG000|Overall Study|Withdrawal by Subject|1|||
129143617|NCT01904279|464820931|FG001|Overall Study|Withdrawal by Subject|0|||
129143618|NCT00959049|464820932|FG000|Overall Study|Adverse Event|1|||
129143619|NCT00959049|464820933|FG001|Overall Study|Adverse Event|0|||
129143620|NCT00959049|464820934|FG002|Overall Study|Adverse Event|0|||
129143621|NCT00959049|464820935|FG003|Overall Study|Adverse Event|0|||
129143622|NCT00959049|464820936|FG004|Overall Study|Adverse Event|0|||
129143623|NCT00959049|464820937|FG005|Overall Study|Adverse Event|0|||
129143624|NCT00959049|464820932|FG000|Overall Study|Lost to Follow-up|17|||
129143625|NCT00959049|464820933|FG001|Overall Study|Lost to Follow-up|5|||
129143626|NCT00959049|464820934|FG002|Overall Study|Lost to Follow-up|1|||
129143627|NCT00959049|464820935|FG003|Overall Study|Lost to Follow-up|10|||
129143628|NCT00959049|464820936|FG004|Overall Study|Lost to Follow-up|9|||
129143629|NCT00959049|464820937|FG005|Overall Study|Lost to Follow-up|1|||
129143630|NCT00959049|464820932|FG000|Overall Study|Contraindicated medication|0|||
129143631|NCT00959049|464820933|FG001|Overall Study|Contraindicated medication|0|||
129143632|NCT00959049|464820934|FG002|Overall Study|Contraindicated medication|0|||
129143633|NCT00959049|464820935|FG003|Overall Study|Contraindicated medication|1|||
129143634|NCT00959049|464820936|FG004|Overall Study|Contraindicated medication|0|||
129143635|NCT00959049|464820937|FG005|Overall Study|Contraindicated medication|0|||
129143636|NCT00959049|464820932|FG000|Overall Study|Withdrawal by Subject|0|||
129143637|NCT00959049|464820933|FG001|Overall Study|Withdrawal by Subject|2|||
129143638|NCT00959049|464820934|FG002|Overall Study|Withdrawal by Subject|0|||
129143639|NCT00959049|464820935|FG003|Overall Study|Withdrawal by Subject|0|||
129143640|NCT00959049|464820936|FG004|Overall Study|Withdrawal by Subject|0|||
129143641|NCT00959049|464820937|FG005|Overall Study|Withdrawal by Subject|0|||
129143642|NCT00137449|464820938|FG000|Overall Study|Disease Progression|8|||
129143643|NCT00137449|464820939|FG001|Overall Study|Disease Progression|13|||
129143644|NCT00137449|464820938|FG000|Overall Study|Death|4|||
129143645|NCT00137449|464820939|FG001|Overall Study|Death|3|||
129143646|NCT00137449|464820938|FG000|Overall Study|Adverse Event|3|||
129143647|NCT00137449|464820939|FG001|Overall Study|Adverse Event|1|||
129143648|NCT00137449|464820938|FG000|Overall Study|Withdrawal by Subject|1|||
129143649|NCT00137449|464820939|FG001|Overall Study|Withdrawal by Subject|1|||
129143650|NCT02489279|464820940|FG000|Overall Study|Lost to Follow-up|12|||
129143651|NCT02489279|464820941|FG001|Overall Study|Lost to Follow-up|10|||
129143652|NCT02263547|464820942|FG000|Overall Study|Adverse Event|1|||
129143653|NCT02263547|464820942|FG000|Overall Study|Lost to Follow-up|2|||
129143654|NCT00095576|464820945|FG000|Overall Study|Adverse Event|5|||
129143655|NCT00095576|464820946|FG001|Overall Study|Adverse Event|3|||
129143656|NCT00095576|464820945|FG000|Overall Study|Lost to Follow-up|233|||
129143657|NCT00095576|464820946|FG001|Overall Study|Lost to Follow-up|229|||
129143658|NCT00095576|464820945|FG000|Overall Study|Protocol Violation|1|||
129085943|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Subject moved|0|||
129085944|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Subject moved|1|||
129085945|NCT01953601|464604931|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
129085946|NCT01953601|464604932|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
129085947|NCT01953601|464604933|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
129085948|NCT03991299|464604938|FG000|Overall Study|Study closed, sponsor decision|3|||
129085949|NCT03991299|464604938|FG000|Overall Study|Withdrawal by Subject|1|||
129085950|NCT01137110|464604943|FG000|Overall Study|Protocol Violation|1|||
129085951|NCT01137110|464604944|FG001|Overall Study|Protocol Violation|0|||
129085952|NCT00281632|464604947|FG000|Overall Study|Adverse Event|7|||
129085953|NCT00281632|464604947|FG000|Overall Study|Withdrawal by Subject|2|||
129085954|NCT00281632|464604947|FG000|Overall Study|Disease Progression|22|||
129085955|NCT00281632|464604947|FG000|Overall Study|Death|1|||
129085956|NCT00281632|464604947|FG000|Overall Study|Physician Decision|1|||
129085957|NCT00281632|464604947|FG000|Overall Study|Ongoing|3|||
129085958|NCT03990571|464604948|FG000|Overall Study|Withdrawal by Subject|1|||
129085959|NCT03990571|464604948|FG000|Overall Study|Insurance Issues|3|||
129085960|NCT03990571|464604948|FG000|Overall Study|Covid Restrictions|2|||
129085961|NCT00782184|464604955|FG000|Overall Study|Adverse Event|1|||
129085962|NCT00782184|464604956|FG001|Overall Study|Adverse Event|2|||
129085963|NCT00782184|464604955|FG000|Overall Study|Protocol Violation|0|||
129085964|NCT00782184|464604956|FG001|Overall Study|Protocol Violation|1|||
129085965|NCT00782184|464604955|FG000|Overall Study|Withdrawal by Subject|3|||
129085966|NCT00782184|464604956|FG001|Overall Study|Withdrawal by Subject|2|||
129085967|NCT03614078|464604957|FG000|Overall Study|Withdrawal by Subject|2|||
129085968|NCT03614078|464604958|FG001|Overall Study|Withdrawal by Subject|2|||
129085969|NCT03614078|464604959|FG002|Overall Study|Withdrawal by Subject|3|||
129085970|NCT03614078|464604957|FG000|Overall Study|Participant Did Not Return for Visit|0|||
129085971|NCT03614078|464604958|FG001|Overall Study|Participant Did Not Return for Visit|1|||
129085972|NCT03614078|464604959|FG002|Overall Study|Participant Did Not Return for Visit|0|||
129085973|NCT03614078|464604957|FG000|Overall Study|High Neutrophils|0|||
129085974|NCT03614078|464604958|FG001|Overall Study|High Neutrophils|0|||
129085975|NCT03614078|464604959|FG002|Overall Study|High Neutrophils|2|||
129085976|NCT03614078|464604957|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
129085977|NCT03614078|464604958|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
129085978|NCT03614078|464604959|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
129085979|NCT03614078|464604957|FG000|Overall Study|Exacerbation of Psoriasis|0|||
129085980|NCT03614078|464604958|FG001|Overall Study|Exacerbation of Psoriasis|1|||
129085981|NCT03614078|464604959|FG002|Overall Study|Exacerbation of Psoriasis|0|||
129085982|NCT03614078|464604957|FG000|Overall Study|Adverse Event|0|||
129085983|NCT03614078|464604958|FG001|Overall Study|Adverse Event|2|||
129085984|NCT03614078|464604959|FG002|Overall Study|Adverse Event|0|||
129085985|NCT03614078|464604957|FG000|Overall Study|Dizziness and Rash|0|||
129085986|NCT03614078|464604958|FG001|Overall Study|Dizziness and Rash|1|||
129085987|NCT03614078|464604959|FG002|Overall Study|Dizziness and Rash|0|||
129085988|NCT04143594|464604962|FG000|Overall Study|Withdrew consent|3|||
129085989|NCT04143594|464604963|FG001|Overall Study|Withdrew consent|10|||
129085990|NCT04143594|464604964|FG002|Overall Study|Withdrew consent|3|||
129085991|NCT04143594|464604965|FG003|Overall Study|Withdrew consent|1|||
129085992|NCT04143594|464604962|FG000|Overall Study|Lost to Follow-up|3|||
129085993|NCT04143594|464604963|FG001|Overall Study|Lost to Follow-up|5|||
129085994|NCT04143594|464604964|FG002|Overall Study|Lost to Follow-up|11|||
129085995|NCT04143594|464604965|FG003|Overall Study|Lost to Follow-up|0|||
129085996|NCT04143594|464604962|FG000|Overall Study|Investigator's discretion|2|||
129085997|NCT04143594|464604963|FG001|Overall Study|Investigator's discretion|2|||
129085998|NCT04143594|464604964|FG002|Overall Study|Investigator's discretion|0|||
129085999|NCT04143594|464604965|FG003|Overall Study|Investigator's discretion|0|||
129143659|NCT00095576|464820946|FG001|Overall Study|Protocol Violation|0|||
129143660|NCT00095576|464820945|FG000|Overall Study|Withdrawal by Subject|34|||
129143661|NCT00095576|464820946|FG001|Overall Study|Withdrawal by Subject|47|||
129143662|NCT00095576|464820945|FG000|Overall Study|Option to switch to a rollover study|1097|||
129143663|NCT00095576|464820946|FG001|Overall Study|Option to switch to a rollover study|1099|||
129143664|NCT00095576|464820945|FG000|Overall Study|Site terminated|75|||
129143665|NCT00095576|464820946|FG001|Overall Study|Site terminated|67|||
129086000|NCT04143594|464604962|FG000|Overall Study|Randomized but never treated|0|||
129086001|NCT04143594|464604963|FG001|Overall Study|Randomized but never treated|0|||
129086002|NCT04143594|464604964|FG002|Overall Study|Randomized but never treated|0|||
129086003|NCT04143594|464604965|FG003|Overall Study|Randomized but never treated|1|||
129086004|NCT04143594|464604962|FG000|Overall Study|Death|1|||
129086005|NCT04143594|464604963|FG001|Overall Study|Death|0|||
129086006|NCT04143594|464604964|FG002|Overall Study|Death|1|||
129086007|NCT04143594|464604965|FG003|Overall Study|Death|0|||
129086008|NCT04143594|464604962|FG000|Overall Study|Adverse Event|1|||
129086009|NCT04143594|464604963|FG001|Overall Study|Adverse Event|0|||
129086010|NCT04143594|464604964|FG002|Overall Study|Adverse Event|0|||
129086011|NCT04143594|464604965|FG003|Overall Study|Adverse Event|0|||
129086012|NCT04143594|464604962|FG000|Overall Study|Pregnancy|0|||
129086013|NCT04143594|464604963|FG001|Overall Study|Pregnancy|0|||
129086014|NCT04143594|464604964|FG002|Overall Study|Pregnancy|1|||
129086015|NCT04143594|464604965|FG003|Overall Study|Pregnancy|0|||
129086016|NCT04143594|464604962|FG000|Overall Study|Lack of Efficacy|1|||
129086017|NCT04143594|464604963|FG001|Overall Study|Lack of Efficacy|1|||
129086018|NCT04143594|464604964|FG002|Overall Study|Lack of Efficacy|0|||
129086019|NCT04143594|464604965|FG003|Overall Study|Lack of Efficacy|0|||
129086020|NCT04603482|464604966|FG000|Overall Study|Lost to Follow-up|15|||
129086021|NCT04603482|464604967|FG001|Overall Study|Lost to Follow-up|15|||
129086022|NCT04603482|464604968|FG002|Overall Study|Lost to Follow-up|15|||
129086023|NCT01054196|464604969|FG000|Overall Study|Physician Decision|0|||
129086024|NCT01054196|464604970|FG001|Overall Study|Physician Decision|0|||
129086025|NCT01054196|464604971|FG002|Overall Study|Physician Decision|0|||
129086026|NCT01054196|464604972|FG003|Overall Study|Physician Decision|1|||
129086027|NCT01054196|464604973|FG004|Overall Study|Physician Decision|0|||
129086028|NCT01054196|464604974|FG005|Overall Study|Physician Decision|0|||
129086029|NCT01054196|464604975|FG006|Overall Study|Physician Decision|1|||
129086030|NCT00179673|464604976|FG000|Overall Study|Adverse Event|7|||
129086031|NCT00179673|464604976|FG000|Overall Study|Lack of Efficacy|15|||
129086032|NCT00179673|464604976|FG000|Overall Study|Withdrawal by Subject|3|||
129086033|NCT00179673|464604976|FG000|Overall Study|Death|4|||
129086034|NCT00179673|464604976|FG000|Overall Study|Other Observations and options|14|||
129086035|NCT00492648|464604977|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
129086036|NCT00492648|464604978|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
129086037|NCT00282113|464604979|FG000|Overall Study|Removed at parents request|1|||
129086038|NCT00282113|464604980|FG001|Overall Study|Removed at parents request|0|||
129086039|NCT00282113|464604981|FG002|Overall Study|Removed at parents request|0|||
129086040|NCT02949843|464604984|FG000|Overall Study|Withdrawal by Subject|0|||
129086041|NCT02949843|464604985|FG001|Overall Study|Withdrawal by Subject|1|||
129086042|NCT02949843|464604986|FG002|Overall Study|Withdrawal by Subject|1|||
129086043|NCT01500187|464604988|FG000|Overall Study|Lost to Follow-up|6|||
129086044|NCT01500187|464604989|FG001|Overall Study|Lost to Follow-up|0|||
129086045|NCT02107859|464605001|FG000|Overall Study|Withdrawal by Subject|14|||
129086046|NCT02107859|464605001|FG000|Overall Study|Adverse Event|3|||
129086047|NCT02107859|464605001|FG000|Overall Study|Study closure|41|||
129086048|NCT02107859|464605001|FG000|Overall Study|Other than specified|3|||
129086049|NCT00977314|464605002|FG000|Overall Study|Withdrawal by Subject|1|||
129086050|NCT00977314|464605003|FG001|Overall Study|Withdrawal by Subject|0|||
129086051|NCT00977314|464605002|FG000|Overall Study|Physician Decision|1|||
129086052|NCT00977314|464605003|FG001|Overall Study|Physician Decision|0|||
129086053|NCT01343277|464605009|FG000|Overall Study|Other|3|||
129086054|NCT01343277|464605010|FG001|Overall Study|Other|3|||
129086055|NCT01343277|464605009|FG000|Overall Study|Withdrawal by Subject|18|||
129086056|NCT01343277|464605010|FG001|Overall Study|Withdrawal by Subject|13|||
129086057|NCT01343277|464605009|FG000|Overall Study|Physician Decision|1|||
129086058|NCT01343277|464605010|FG001|Overall Study|Physician Decision|2|||
129086059|NCT01343277|464605009|FG000|Overall Study|Death|10|||
129086060|NCT01343277|464605010|FG001|Overall Study|Death|1|||
129086061|NCT01343277|464605009|FG000|Overall Study|Adverse Event|67|||
129086062|NCT01343277|464605010|FG001|Overall Study|Adverse Event|13|||
129086063|NCT01343277|464605009|FG000|Overall Study|Disease progression|270|||
129086064|NCT01343277|464605010|FG001|Overall Study|Disease progression|138|||
129086065|NCT01343277|464605009|FG000|Overall Study|Randomized not treated|6|||
129086066|NCT01343277|464605010|FG001|Overall Study|Randomized not treated|21|||
129086067|NCT01343277|464605009|FG000|Overall Study|Treatment ongoing|8|||
129086068|NCT01343277|464605010|FG001|Overall Study|Treatment ongoing|2|||
129086069|NCT01343277|464605009|FG000|Overall Study|Subsequent anticancer therapy|1|||
129086070|NCT01343277|464605010|FG001|Overall Study|Subsequent anticancer therapy|0|||
129086071|NCT00135512|464605013|FG000|Overall Study|Adverse Event|56|||
129143666|NCT00095576|464820945|FG000|Overall Study|Subject moved|30|||
129143667|NCT00095576|464820946|FG001|Overall Study|Subject moved|36|||
129143668|NCT01344356|464820947|FG000|Overall Study|Physician Decision|0|||
129143669|NCT01344356|464820948|FG001|Overall Study|Physician Decision|3|||
129086072|NCT00135512|464605013|FG000|Overall Study|Lack of Efficacy|25|||
129086073|NCT00135512|464605013|FG000|Overall Study|Other|42|||
129086074|NCT01582178|464605014|FG000|Overall Study|Physician Decision|6|||
129086075|NCT01582178|464605015|FG001|Overall Study|Physician Decision|5|||
129086076|NCT03852628|464605016|FG000|Overall Study|Lost to Follow-up|7|||
129086077|NCT03852628|464605017|FG001|Overall Study|Lost to Follow-up|6|||
129086078|NCT03852628|464605016|FG000|Overall Study|Lack of Efficacy|6|||
129086079|NCT03852628|464605017|FG001|Overall Study|Lack of Efficacy|6|||
129086080|NCT00556933|464605025|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
129086081|NCT00556933|464605026|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
129086082|NCT00556933|464605027|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
129086083|NCT00556933|464605028|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
129086084|NCT00556933|464605025|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
129143670|NCT01344356|464820947|FG000|Overall Study|Lost to Follow-up|0|||
129143671|NCT01344356|464820948|FG001|Overall Study|Lost to Follow-up|6|||
129143672|NCT00586157|464820949|FG000|First Intervention|Worsening behavior|1|||
128724350|NCT00694369|463289049|FG004|Overall Study|Withdrawal by Subject|2|||
129086085|NCT00556933|464605026|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
129086086|NCT00556933|464605027|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
129086087|NCT00556933|464605028|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
129086088|NCT00556933|464605025|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
129086089|NCT00556933|464605026|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
129086090|NCT00556933|464605027|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
129086091|NCT00556933|464605028|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
129086092|NCT00556933|464605025|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
129086093|NCT00556933|464605026|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
129086094|NCT00556933|464605027|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
129086095|NCT00556933|464605028|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
129086096|NCT00556933|464605025|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
129086097|NCT00556933|464605026|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
129086098|NCT00556933|464605027|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
129086099|NCT00556933|464605028|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
129086100|NCT00556933|464605025|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
129086101|NCT00556933|464605026|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
129086102|NCT00556933|464605027|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
129086103|NCT00556933|464605028|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
129086104|NCT00556933|464605025|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
129086105|NCT00556933|464605026|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
129086106|NCT00556933|464605027|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
129086107|NCT00556933|464605028|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
129086108|NCT00556933|464605025|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
129086109|NCT00556933|464605026|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
129086110|NCT00556933|464605027|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
129086111|NCT00556933|464605028|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
129086112|NCT00556933|464605025|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
129086113|NCT00556933|464605026|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
129086114|NCT00556933|464605027|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
129086115|NCT00556933|464605028|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
129086116|NCT00556933|464605025|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
129086117|NCT00556933|464605026|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
129086118|NCT00556933|464605027|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
129086119|NCT00556933|464605028|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
129086120|NCT00556933|464605025|FG000|CNI Withdrawal vs. Minimization|Death|0|||
129086121|NCT00556933|464605026|FG001|CNI Withdrawal vs. Minimization|Death|0|||
129086122|NCT00556933|464605027|FG002|CNI Withdrawal vs. Minimization|Death|0|||
129086123|NCT00556933|464605028|FG003|CNI Withdrawal vs. Minimization|Death|1|||
129086124|NCT01295827|464605031|FG000|Overall Study|Adverse Event|1|||
129086125|NCT01295827|464605032|FG001|Overall Study|Adverse Event|2|||
129086126|NCT01295827|464605033|FG002|Overall Study|Adverse Event|2|||
129086127|NCT01295827|464605034|FG003|Overall Study|Adverse Event|1|||
129086128|NCT01295827|464605035|FG004|Overall Study|Adverse Event|1|||
129086129|NCT01295827|464605036|FG005|Overall Study|Adverse Event|4|||
129086130|NCT01295827|464605037|FG006|Overall Study|Adverse Event|15|||
129086131|NCT01295827|464605038|FG007|Overall Study|Adverse Event|49|||
129086132|NCT01295827|464605039|FG008|Overall Study|Adverse Event|22|||
129086133|NCT01295827|464605040|FG009|Overall Study|Adverse Event|7|||
129086134|NCT01295827|464605041|FG010|Overall Study|Adverse Event|50|||
129086135|NCT01295827|464605042|FG011|Overall Study|Adverse Event|21|||
129086136|NCT01295827|464605043|FG012|Overall Study|Adverse Event|0|||
129086137|NCT01295827|464605044|FG013|Overall Study|Adverse Event|0|||
129086138|NCT01295827|464605045|FG014|Overall Study|Adverse Event|0|||
129086139|NCT01295827|464605031|FG000|Overall Study|Lost to Follow-up|0|||
129086140|NCT01295827|464605032|FG001|Overall Study|Lost to Follow-up|0|||
129086141|NCT01295827|464605033|FG002|Overall Study|Lost to Follow-up|3|||
129086142|NCT01295827|464605034|FG003|Overall Study|Lost to Follow-up|0|||
129086143|NCT01295827|464605035|FG004|Overall Study|Lost to Follow-up|1|||
129086144|NCT01295827|464605036|FG005|Overall Study|Lost to Follow-up|0|||
129086145|NCT01295827|464605037|FG006|Overall Study|Lost to Follow-up|4|||
129086146|NCT01295827|464605038|FG007|Overall Study|Lost to Follow-up|8|||
129086147|NCT01295827|464605039|FG008|Overall Study|Lost to Follow-up|7|||
129086148|NCT01295827|464605040|FG009|Overall Study|Lost to Follow-up|4|||
129086149|NCT01295827|464605041|FG010|Overall Study|Lost to Follow-up|7|||
129086150|NCT01295827|464605042|FG011|Overall Study|Lost to Follow-up|3|||
129086151|NCT01295827|464605043|FG012|Overall Study|Lost to Follow-up|0|||
129086152|NCT01295827|464605044|FG013|Overall Study|Lost to Follow-up|0|||
129086153|NCT01295827|464605045|FG014|Overall Study|Lost to Follow-up|0|||
129086154|NCT01295827|464605031|FG000|Overall Study|Not Reported|0|||
129086155|NCT01295827|464605032|FG001|Overall Study|Not Reported|0|||
129086156|NCT01295827|464605033|FG002|Overall Study|Not Reported|0|||
129086157|NCT01295827|464605034|FG003|Overall Study|Not Reported|1|||
129086158|NCT01295827|464605035|FG004|Overall Study|Not Reported|0|||
129086159|NCT01295827|464605036|FG005|Overall Study|Not Reported|0|||
129086160|NCT01295827|464605037|FG006|Overall Study|Not Reported|24|||
129086161|NCT01295827|464605038|FG007|Overall Study|Not Reported|58|||
129086162|NCT01295827|464605039|FG008|Overall Study|Not Reported|41|||
129086163|NCT01295827|464605040|FG009|Overall Study|Not Reported|2|||
129086164|NCT01295827|464605041|FG010|Overall Study|Not Reported|23|||
129086165|NCT01295827|464605042|FG011|Overall Study|Not Reported|13|||
129086166|NCT01295827|464605043|FG012|Overall Study|Not Reported|0|||
129086167|NCT01295827|464605044|FG013|Overall Study|Not Reported|0|||
129086168|NCT01295827|464605045|FG014|Overall Study|Not Reported|0|||
129086169|NCT01295827|464605031|FG000|Overall Study|Progressive Disease|2|||
129086170|NCT01295827|464605032|FG001|Overall Study|Progressive Disease|1|||
129086171|NCT01295827|464605033|FG002|Overall Study|Progressive Disease|5|||
129086172|NCT01295827|464605034|FG003|Overall Study|Progressive Disease|2|||
129086173|NCT01295827|464605035|FG004|Overall Study|Progressive Disease|0|||
129086174|NCT01295827|464605036|FG005|Overall Study|Progressive Disease|1|||
129086175|NCT01295827|464605037|FG006|Overall Study|Progressive Disease|87|||
129086176|NCT01295827|464605038|FG007|Overall Study|Progressive Disease|144|||
129086177|NCT01295827|464605039|FG008|Overall Study|Progressive Disease|85|||
129086178|NCT01295827|464605040|FG009|Overall Study|Progressive Disease|40|||
129086179|NCT01295827|464605041|FG010|Overall Study|Progressive Disease|175|||
129086180|NCT01295827|464605042|FG011|Overall Study|Progressive Disease|136|||
129086181|NCT01295827|464605043|FG012|Overall Study|Progressive Disease|0|||
129086182|NCT01295827|464605044|FG013|Overall Study|Progressive Disease|0|||
129086183|NCT01295827|464605045|FG014|Overall Study|Progressive Disease|0|||
129086184|NCT01295827|464605031|FG000|Overall Study|Screen Failure|0|||
129086185|NCT01295827|464605032|FG001|Overall Study|Screen Failure|0|||
129086186|NCT01295827|464605033|FG002|Overall Study|Screen Failure|0|||
129086187|NCT01295827|464605034|FG003|Overall Study|Screen Failure|0|||
129086188|NCT01295827|464605035|FG004|Overall Study|Screen Failure|0|||
129086189|NCT01295827|464605036|FG005|Overall Study|Screen Failure|0|||
129086190|NCT01295827|464605037|FG006|Overall Study|Screen Failure|2|||
129086191|NCT01295827|464605038|FG007|Overall Study|Screen Failure|2|||
129086192|NCT01295827|464605039|FG008|Overall Study|Screen Failure|2|||
129086193|NCT01295827|464605040|FG009|Overall Study|Screen Failure|0|||
129086194|NCT01295827|464605041|FG010|Overall Study|Screen Failure|1|||
129086195|NCT01295827|464605042|FG011|Overall Study|Screen Failure|0|||
129086196|NCT01295827|464605043|FG012|Overall Study|Screen Failure|0|||
129086197|NCT01295827|464605044|FG013|Overall Study|Screen Failure|0|||
129086198|NCT01295827|464605045|FG014|Overall Study|Screen Failure|0|||
129086199|NCT01295827|464605031|FG000|Overall Study|Withdrawal by Subject|1|||
129086200|NCT01295827|464605032|FG001|Overall Study|Withdrawal by Subject|0|||
129086201|NCT01295827|464605033|FG002|Overall Study|Withdrawal by Subject|2|||
129086202|NCT01295827|464605034|FG003|Overall Study|Withdrawal by Subject|0|||
129086203|NCT01295827|464605035|FG004|Overall Study|Withdrawal by Subject|0|||
129086204|NCT01295827|464605036|FG005|Overall Study|Withdrawal by Subject|1|||
129086205|NCT01295827|464605037|FG006|Overall Study|Withdrawal by Subject|13|||
129086206|NCT01295827|464605038|FG007|Overall Study|Withdrawal by Subject|35|||
129086207|NCT01295827|464605039|FG008|Overall Study|Withdrawal by Subject|11|||
129086208|NCT01295827|464605040|FG009|Overall Study|Withdrawal by Subject|2|||
129086209|NCT01295827|464605041|FG010|Overall Study|Withdrawal by Subject|18|||
129086210|NCT01295827|464605042|FG011|Overall Study|Withdrawal by Subject|13|||
129086211|NCT01295827|464605043|FG012|Overall Study|Withdrawal by Subject|0|||
129086212|NCT01295827|464605044|FG013|Overall Study|Withdrawal by Subject|0|||
129086213|NCT01295827|464605045|FG014|Overall Study|Withdrawal by Subject|0|||
129086214|NCT01295827|464605031|FG000|Overall Study|Other|0|||
129086215|NCT01295827|464605032|FG001|Overall Study|Other|0|||
129086216|NCT01295827|464605033|FG002|Overall Study|Other|0|||
129086217|NCT01295827|464605034|FG003|Overall Study|Other|0|||
129086218|NCT01295827|464605035|FG004|Overall Study|Other|0|||
129086219|NCT01295827|464605036|FG005|Overall Study|Other|0|||
129086220|NCT01295827|464605037|FG006|Overall Study|Other|1|||
129086221|NCT01295827|464605038|FG007|Overall Study|Other|1|||
129086222|NCT01295827|464605039|FG008|Overall Study|Other|1|||
129086223|NCT01295827|464605040|FG009|Overall Study|Other|0|||
129086224|NCT01295827|464605041|FG010|Overall Study|Other|2|||
129086225|NCT01295827|464605042|FG011|Overall Study|Other|0|||
129086226|NCT01295827|464605043|FG012|Overall Study|Other|0|||
129086227|NCT01295827|464605044|FG013|Overall Study|Other|0|||
129086228|NCT01295827|464605045|FG014|Overall Study|Other|0|||
129086229|NCT01668173|464605046|FG000|Overall Study|Adverse Event|3|||
129086230|NCT01668173|464605046|FG000|Overall Study|Trial suspension|4|||
129086231|NCT00746564|464605049|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
129086232|NCT02640677|464605053|FG000|Overall Study|Lost to Follow-up|1|||
129086233|NCT02640677|464605053|FG000|Overall Study|Withdrawal by Subject|1|||
129086234|NCT01516008|464605054|FG000|Overall Study|Adverse Event|0|||
129086235|NCT01516008|464605055|FG001|Overall Study|Adverse Event|2|||
128724351|NCT00907374|463289050|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
128724352|NCT00907374|463289051|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
128724353|NCT00594464|463289054|FG000|Overall Study|Withdrawal by Subject|1|||
128724354|NCT00594464|463289054|FG000|Overall Study|Delay in operation|2|||
128724355|NCT00775437|463289055|FG000|Overall Study|Loss of efficacy|2|||
128724356|NCT00775437|463289055|FG000|Overall Study|Withdrawal by Subject|3|||
129086236|NCT01516008|464605056|FG002|Overall Study|Adverse Event|7|||
129086237|NCT01516008|464605054|FG000|Overall Study|Lack of Efficacy|44|||
129086238|NCT01516008|464605055|FG001|Overall Study|Lack of Efficacy|14|||
129086239|NCT01516008|464605056|FG002|Overall Study|Lack of Efficacy|10|||
129086240|NCT01516008|464605054|FG000|Overall Study|Protocol Violation|1|||
129086241|NCT01516008|464605055|FG001|Overall Study|Protocol Violation|0|||
129086242|NCT01516008|464605056|FG002|Overall Study|Protocol Violation|0|||
129086243|NCT01516008|464605054|FG000|Overall Study|Reason not specified|0|||
129086244|NCT01516008|464605055|FG001|Overall Study|Reason not specified|0|||
129086245|NCT01516008|464605056|FG002|Overall Study|Reason not specified|1|||
129086246|NCT00356135|464605060|FG000|Overall Study|Protocol Violation|1|||
129086247|NCT00356135|464605061|FG001|Overall Study|Protocol Violation|0|||
129086248|NCT00356135|464605062|FG002|Overall Study|Protocol Violation|0|||
129086249|NCT00356135|464605060|FG000|Overall Study|Adverse Event|1|||
129086250|NCT00356135|464605061|FG001|Overall Study|Adverse Event|0|||
129086251|NCT00356135|464605062|FG002|Overall Study|Adverse Event|0|||
129086252|NCT00356135|464605060|FG000|Overall Study|Lost to Follow-up|0|||
129086253|NCT00356135|464605061|FG001|Overall Study|Lost to Follow-up|0|||
129086254|NCT00356135|464605062|FG002|Overall Study|Lost to Follow-up|1|||
129086255|NCT00356135|464605060|FG000|Overall Study|Physician Decision|1|||
129086256|NCT00356135|464605061|FG001|Overall Study|Physician Decision|1|||
129086257|NCT00356135|464605062|FG002|Overall Study|Physician Decision|1|||
129086258|NCT00356135|464605060|FG000|Overall Study|Subject non-compliance|1|||
129086259|NCT00356135|464605061|FG001|Overall Study|Subject non-compliance|1|||
129086260|NCT00356135|464605062|FG002|Overall Study|Subject non-compliance|3|||
129086261|NCT03963232|464605063|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129086262|NCT03963232|464605064|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
129086263|NCT03963232|464605063|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
129086264|NCT03963232|464605064|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
129086265|NCT03963232|464605063|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
129086266|NCT03963232|464605064|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
129086267|NCT03963232|464605063|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
129086268|NCT03963232|464605064|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
129086269|NCT03963232|464605063|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
129086270|NCT03963232|464605064|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
129086271|NCT03963232|464605063|FG000|Open-Label Treatment Phase|Adverse Event|1|||
129086272|NCT03963232|464605064|FG001|Open-Label Treatment Phase|Adverse Event|2|||
129086273|NCT03963232|464605063|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
129086274|NCT03963232|464605064|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
129086275|NCT03963232|464605063|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
129086276|NCT03963232|464605064|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
129086277|NCT03963232|464605063|FG000|Open-Label Treatment Phase|Pregnancy|1|||
129086278|NCT03963232|464605064|FG001|Open-Label Treatment Phase|Pregnancy|0|||
129086279|NCT03963232|464605063|FG000|Follow-up Phase|Withdrawal by Subject|7|||
129086280|NCT03963232|464605064|FG001|Follow-up Phase|Withdrawal by Subject|5|||
129086281|NCT03963232|464605063|FG000|Follow-up Phase|Protocol Violation|0|||
129086282|NCT03963232|464605064|FG001|Follow-up Phase|Protocol Violation|2|||
129086283|NCT03963232|464605063|FG000|Follow-up Phase|Adverse Event|0|||
129086284|NCT03963232|464605064|FG001|Follow-up Phase|Adverse Event|1|||
129086285|NCT03963232|464605063|FG000|Follow-up Phase|Lost to Follow-up|0|||
129086286|NCT03963232|464605064|FG001|Follow-up Phase|Lost to Follow-up|1|||
129086287|NCT03617770|464605065|FG000|Overall Study|Lost to Follow-up|1|||
128724357|NCT00775437|463289055|FG000|Overall Study|Lost to Follow-up|1|||
129086288|NCT03617770|464605066|FG001|Overall Study|Lost to Follow-up|0|||
129086289|NCT03512210|464605068|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
129086290|NCT03512210|464605068|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
128724358|NCT03131440|463289056|FG000|Overall Study|Withdrawal by Subject|1|||
128724359|NCT03131440|463289057|FG001|Overall Study|Withdrawal by Subject|3|||
129086291|NCT03512210|464605068|FG000|Step 2:Post-MINMON|Death|2|||
129086292|NCT03512210|464605068|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
129086293|NCT03512210|464605068|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
129086294|NCT03725761|464605069|FG000|Overall Study|still on study|1|||
129086295|NCT02836236|464607695|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
129086296|NCT02836236|464607696|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
129086297|NCT02836236|464607697|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
129086298|NCT02836236|464607698|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
129086299|NCT02836236|464607695|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
129086300|NCT02836236|464607696|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
129086301|NCT02836236|464607697|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129086302|NCT02836236|464607698|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129086303|NCT02836236|464607695|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
128724360|NCT03131440|463289058|FG002|Overall Study|Withdrawal by Subject|0|||
128724361|NCT03131440|463289059|FG003|Overall Study|Withdrawal by Subject|0|||
128724362|NCT03131440|463289060|FG004|Overall Study|Withdrawal by Subject|1|||
128724363|NCT03131440|463289061|FG005|Overall Study|Withdrawal by Subject|0|||
128776571|NCT04129580|463471962|FG000|Overall Study|Lost to Follow-up|14|||
129086304|NCT02836236|464607696|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
129086305|NCT02836236|464607697|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129086306|NCT02836236|464607698|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129086307|NCT02836236|464607695|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
129086308|NCT02836236|464607696|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129086309|NCT02836236|464607697|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129086310|NCT02836236|464607698|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129086311|NCT02836236|464607695|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
129086312|NCT02836236|464607696|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
129086313|NCT02836236|464607697|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
129086314|NCT02836236|464607698|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
129086315|NCT02836236|464607695|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129086316|NCT02836236|464607696|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129086317|NCT02836236|464607697|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
129086318|NCT02836236|464607698|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
129086319|NCT02836236|464607695|FG000|Open-Label TAF Treatment Phase|Death|0|||
129086320|NCT02836236|464607696|FG001|Open-Label TAF Treatment Phase|Death|0|||
129086321|NCT02836236|464607697|FG002|Open-Label TAF Treatment Phase|Death|1|||
129086322|NCT02836236|464607698|FG003|Open-Label TAF Treatment Phase|Death|1|||
129086323|NCT02836236|464607695|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
129086324|NCT02836236|464607696|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
129086325|NCT02836236|464607697|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
129086326|NCT02836236|464607698|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
129086327|NCT01806961|464607699|FG000|Overall Study|sponsor decision|16|||
129086328|NCT00784238|464607700|FG000|Overall Study|Adverse Event|14|||
129086329|NCT00784238|464607700|FG000|Overall Study|Death|2|||
129086330|NCT00784238|464607700|FG000|Overall Study|Lack of Efficacy|33|||
129086331|NCT00784238|464607700|FG000|Overall Study|Lost to Follow-up|29|||
129086332|NCT00784238|464607700|FG000|Overall Study|Pregnancy|1|||
129086333|NCT00784238|464607700|FG000|Overall Study|Withdrawal by Subject|26|||
129086334|NCT00784238|464607700|FG000|Overall Study|Other|14|||
129086335|NCT03693612|464607701|FG000|Overall Study|Lost to Follow-up|0|||
129086336|NCT03693612|464607702|FG001|Overall Study|Lost to Follow-up|0|||
129086337|NCT03693612|464607703|FG002|Overall Study|Lost to Follow-up|0|||
129086338|NCT03693612|464607704|FG003|Overall Study|Lost to Follow-up|0|||
129086339|NCT03693612|464607705|FG004|Overall Study|Lost to Follow-up|1|||
129086340|NCT03693612|464607706|FG005|Overall Study|Lost to Follow-up|0|||
129086341|NCT03693612|464607707|FG006|Overall Study|Lost to Follow-up|0|||
129086342|NCT03693612|464607701|FG000|Overall Study|Withdrawal by Subject|0|||
129086343|NCT03693612|464607702|FG001|Overall Study|Withdrawal by Subject|0|||
129086344|NCT03693612|464607703|FG002|Overall Study|Withdrawal by Subject|1|||
129086345|NCT03693612|464607704|FG003|Overall Study|Withdrawal by Subject|0|||
129086346|NCT03693612|464607705|FG004|Overall Study|Withdrawal by Subject|2|||
129086347|NCT03693612|464607706|FG005|Overall Study|Withdrawal by Subject|0|||
129086348|NCT03693612|464607707|FG006|Overall Study|Withdrawal by Subject|0|||
129086349|NCT03693612|464607701|FG000|Overall Study|Study Terminated by Sponsor|0|||
129086350|NCT03693612|464607702|FG001|Overall Study|Study Terminated by Sponsor|1|||
129143673|NCT00586157|464820950|FG001|First Intervention|Worsening behavior|0|||
129143674|NCT00586157|464820949|FG000|Second Intervention|Withdrawal by Subject|1|||
129143675|NCT00586157|464820950|FG001|Second Intervention|Withdrawal by Subject|0|||
129143676|NCT00586157|464820949|FG000|Second Intervention|Worsening behavior|1|||
129143677|NCT00586157|464820950|FG001|Second Intervention|Worsening behavior|0|||
129143678|NCT00586157|464820949|FG000|Second Intervention|Adverse Event|0|||
129143679|NCT00586157|464820950|FG001|Second Intervention|Adverse Event|1|||
129143680|NCT02378480|464820952|FG000|Overall Study|Physician Decision|1|||
129143681|NCT02378480|464820953|FG001|Overall Study|Physician Decision|1|||
129143682|NCT02378480|464820952|FG000|Overall Study|Death|1|||
129143683|NCT02378480|464820953|FG001|Overall Study|Death|2|||
129143684|NCT02378480|464820952|FG000|Overall Study|Randomized, but Not Treated|6|||
129143685|NCT02378480|464820953|FG001|Overall Study|Randomized, but Not Treated|4|||
129143686|NCT02378480|464820952|FG000|Overall Study|Adverse Event|0|||
129143687|NCT02378480|464820953|FG001|Overall Study|Adverse Event|1|||
129086351|NCT03693612|464607703|FG002|Overall Study|Study Terminated by Sponsor|0|||
129086352|NCT03693612|464607704|FG003|Overall Study|Study Terminated by Sponsor|0|||
129143688|NCT02378480|464820952|FG000|Overall Study|Missed EOT/PTE Visit|1|||
129143689|NCT02378480|464820953|FG001|Overall Study|Missed EOT/PTE Visit|2|||
129143690|NCT02378480|464820952|FG000|Overall Study|Withdrawal by Subject|9|||
129086353|NCT03693612|464607705|FG004|Overall Study|Study Terminated by Sponsor|3|||
129086354|NCT03693612|464607706|FG005|Overall Study|Study Terminated by Sponsor|0|||
129086355|NCT03693612|464607707|FG006|Overall Study|Study Terminated by Sponsor|0|||
129086356|NCT05318092|464607708|FG000|Overall Study|Lost to Follow-up|3|||
129086357|NCT05318092|464607708|FG000|Overall Study|Withdrawal by Subject|1|||
129086358|NCT04434469|464607709|FG000|Overall Study|Death|2|||
129086359|NCT04434469|464607710|FG001|Overall Study|Death|3|||
129086360|NCT04434469|464607711|FG002|Overall Study|Death|2|||
129086361|NCT04434469|464607712|FG003|Overall Study|Death|2|||
129086362|NCT04434469|464607713|FG004|Overall Study|Death|2|||
129086363|NCT04434469|464607714|FG005|Overall Study|Death|0|||
129086364|NCT04434469|464607709|FG000|Overall Study|Lost to Follow-up|0|||
129086365|NCT04434469|464607710|FG001|Overall Study|Lost to Follow-up|0|||
129086366|NCT04434469|464607711|FG002|Overall Study|Lost to Follow-up|0|||
129086367|NCT04434469|464607712|FG003|Overall Study|Lost to Follow-up|1|||
129086368|NCT04434469|464607713|FG004|Overall Study|Lost to Follow-up|1|||
129086369|NCT04434469|464607714|FG005|Overall Study|Lost to Follow-up|0|||
129086370|NCT04434469|464607709|FG000|Overall Study|Study terminated by sponsor|1|||
129086371|NCT04434469|464607710|FG001|Overall Study|Study terminated by sponsor|1|||
129086372|NCT04434469|464607711|FG002|Overall Study|Study terminated by sponsor|1|||
129086373|NCT04434469|464607712|FG003|Overall Study|Study terminated by sponsor|2|||
129086374|NCT04434469|464607713|FG004|Overall Study|Study terminated by sponsor|3|||
129086375|NCT04434469|464607714|FG005|Overall Study|Study terminated by sponsor|3|||
129086376|NCT04434469|464607709|FG000|Overall Study|Withdrawal by Subject|0|||
129086377|NCT04434469|464607710|FG001|Overall Study|Withdrawal by Subject|0|||
129086378|NCT04434469|464607711|FG002|Overall Study|Withdrawal by Subject|1|||
129086379|NCT04434469|464607712|FG003|Overall Study|Withdrawal by Subject|0|||
129086380|NCT04434469|464607713|FG004|Overall Study|Withdrawal by Subject|0|||
129086381|NCT04434469|464607714|FG005|Overall Study|Withdrawal by Subject|0|||
129086382|NCT01154296|464607717|FG000|Randomization and Intervention|Decided to decline|1|||
129086383|NCT01154296|464607718|FG001|Randomization and Intervention|Decided to decline|1|||
129086384|NCT01154296|464607717|FG000|Randomization and Intervention|Declined by staff|1|||
129086385|NCT01154296|464607718|FG001|Randomization and Intervention|Declined by staff|0|||
129086386|NCT01154296|464607717|FG000|Randomization and Intervention|Did not return|1|||
129086387|NCT01154296|464607718|FG001|Randomization and Intervention|Did not return|0|||
129086388|NCT01154296|464607717|FG000|Randomization and Intervention|Left before test|0|||
129086389|NCT01154296|464607718|FG001|Randomization and Intervention|Left before test|1|||
129086390|NCT01154296|464607717|FG000|Randomization and Intervention|Left clinic early|2|||
129086391|NCT01154296|464607718|FG001|Randomization and Intervention|Left clinic early|0|||
129086392|NCT01154296|464607717|FG000|6-month Follow-up|Lost contact|269|||
129086393|NCT01154296|464607718|FG001|6-month Follow-up|Lost contact|275|||
129086394|NCT01154296|464607717|FG000|6-month Follow-up|Incarcerated|37|||
129086395|NCT01154296|464607718|FG001|6-month Follow-up|Incarcerated|32|||
129086396|NCT01154296|464607717|FG000|6-month Follow-up|Withdrew consent|14|||
129086397|NCT01154296|464607718|FG001|6-month Follow-up|Withdrew consent|15|||
129086398|NCT01154296|464607717|FG000|6-month Follow-up|Death|3|||
129086399|NCT01154296|464607718|FG001|6-month Follow-up|Death|2|||
129086400|NCT01154296|464607717|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
129086401|NCT01154296|464607718|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
129086402|NCT02759055|464607719|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
129086403|NCT02759055|464607720|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
129086404|NCT03692325|464607732|FG000|Overall Study|Adverse Event|2|||
129086405|NCT03692325|464607732|FG000|Overall Study|Progression/Recurrence|2|||
129086406|NCT01936181|464607735|FG000|Randomised, Double-blind|Adverse Event|27|||
129086407|NCT01936181|464607736|FG001|Randomised, Double-blind|Adverse Event|21|||
129086408|NCT01936181|464607737|FG002|Randomised, Double-blind|Adverse Event|0|||
129086409|NCT01936181|464607738|FG003|Randomised, Double-blind|Adverse Event|0|||
129086410|NCT01936181|464607735|FG000|Randomised, Double-blind|Protocol Violation|1|||
128724364|NCT03131440|463289062|FG006|Overall Study|Withdrawal by Subject|0|||
128724365|NCT03131440|463289063|FG007|Overall Study|Withdrawal by Subject|1|||
128724366|NCT03131440|463289064|FG008|Overall Study|Withdrawal by Subject|1|||
128724367|NCT03131440|463289065|FG009|Overall Study|Withdrawal by Subject|1|||
128724368|NCT03131440|463289066|FG010|Overall Study|Withdrawal by Subject|0|||
129086411|NCT01936181|464607736|FG001|Randomised, Double-blind|Protocol Violation|5|||
129086412|NCT01936181|464607737|FG002|Randomised, Double-blind|Protocol Violation|0|||
129086413|NCT01936181|464607738|FG003|Randomised, Double-blind|Protocol Violation|0|||
128724369|NCT03131440|463289067|FG011|Overall Study|Withdrawal by Subject|1|||
129086414|NCT01936181|464607735|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
128724370|NCT03131440|463289068|FG012|Overall Study|Withdrawal by Subject|1|||
128724371|NCT03131440|463289069|FG013|Overall Study|Withdrawal by Subject|0|||
129086415|NCT01936181|464607736|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
129086416|NCT01936181|464607737|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
129086417|NCT01936181|464607738|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
129086418|NCT01936181|464607735|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
129086419|NCT01936181|464607736|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
129086420|NCT01936181|464607737|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
129086421|NCT01936181|464607738|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
129086422|NCT01936181|464607735|FG000|Randomised, Double-blind|Pregnancy|0|||
129086423|NCT01936181|464607736|FG001|Randomised, Double-blind|Pregnancy|1|||
129086424|NCT01936181|464607737|FG002|Randomised, Double-blind|Pregnancy|0|||
129086425|NCT01936181|464607738|FG003|Randomised, Double-blind|Pregnancy|0|||
129086426|NCT01936181|464607735|FG000|Randomised, Double-blind|Physician Decision|4|||
129086427|NCT01936181|464607736|FG001|Randomised, Double-blind|Physician Decision|4|||
129086428|NCT01936181|464607737|FG002|Randomised, Double-blind|Physician Decision|0|||
129086429|NCT01936181|464607738|FG003|Randomised, Double-blind|Physician Decision|0|||
129086430|NCT01936181|464607735|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
129086431|NCT01936181|464607736|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
129086432|NCT01936181|464607737|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
129086433|NCT01936181|464607738|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
129086434|NCT01936181|464607735|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
129086435|NCT01936181|464607736|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
129086436|NCT01936181|464607737|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
129086437|NCT01936181|464607738|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
129086438|NCT01936181|464607735|FG000|Transition-extension|Adverse Event|3|||
129086439|NCT01936181|464607736|FG001|Transition-extension|Adverse Event|0|||
129086440|NCT01936181|464607737|FG002|Transition-extension|Adverse Event|3|||
129086441|NCT01936181|464607738|FG003|Transition-extension|Adverse Event|1|||
129086442|NCT01936181|464607735|FG000|Transition-extension|Lost to Follow-up|3|||
129086443|NCT01936181|464607736|FG001|Transition-extension|Lost to Follow-up|0|||
129086444|NCT01936181|464607737|FG002|Transition-extension|Lost to Follow-up|1|||
129086445|NCT01936181|464607738|FG003|Transition-extension|Lost to Follow-up|2|||
129086446|NCT01936181|464607735|FG000|Transition-extension|Physician Decision|2|||
129086447|NCT01936181|464607736|FG001|Transition-extension|Physician Decision|0|||
129086448|NCT01936181|464607737|FG002|Transition-extension|Physician Decision|0|||
129086449|NCT01936181|464607738|FG003|Transition-extension|Physician Decision|1|||
129086450|NCT01936181|464607735|FG000|Transition-extension|Withdrawal by Subject|7|||
129086451|NCT01936181|464607736|FG001|Transition-extension|Withdrawal by Subject|0|||
129086452|NCT01936181|464607737|FG002|Transition-extension|Withdrawal by Subject|2|||
129086453|NCT01936181|464607738|FG003|Transition-extension|Withdrawal by Subject|1|||
129086454|NCT02817516|464607739|FG000|Overall Study|Other|0|||
129086455|NCT02817516|464607740|FG001|Overall Study|Other|0|||
129086456|NCT02817516|464607741|FG002|Overall Study|Other|1|||
129086457|NCT02817516|464607742|FG003|Overall Study|Other|0|||
129086458|NCT00664859|464607743|FG000|Overall Study|Adverse Event|2|||
129086459|NCT00664859|464607744|FG001|Overall Study|Adverse Event|1|||
129143691|NCT02378480|464820953|FG001|Overall Study|Withdrawal by Subject|4|||
129143692|NCT02378480|464820952|FG000|Overall Study|Lost to Follow-up|10|||
129143693|NCT02378480|464820953|FG001|Overall Study|Lost to Follow-up|18|||
129143694|NCT02014467|464820959|FG000|Overall Study|Adverse Event|4|||
129143695|NCT02014467|464820960|FG001|Overall Study|Adverse Event|0|||
129143696|NCT02014467|464820959|FG000|Overall Study|Protocol Violation|3|||
129143697|NCT02014467|464820960|FG001|Overall Study|Protocol Violation|0|||
129143698|NCT02014467|464820959|FG000|Overall Study|Physician Decision|2|||
129143699|NCT02014467|464820960|FG001|Overall Study|Physician Decision|3|||
129143700|NCT02014467|464820959|FG000|Overall Study|Withdrawal by Subject|16|||
129143701|NCT02014467|464820960|FG001|Overall Study|Withdrawal by Subject|4|||
129143702|NCT01230060|464820961|FG000|Overall Study|Withdrawal by Subject|1|||
129143703|NCT01217892|464820963|FG000|Overall Study|Adverse Event|1|||
129143704|NCT01217892|464820964|FG001|Overall Study|Adverse Event|1|||
129143705|NCT01217892|464820965|FG002|Overall Study|Adverse Event|1|||
129143706|NCT01217892|464820966|FG003|Overall Study|Adverse Event|0|||
129143707|NCT01217892|464820963|FG000|Overall Study|Withdrawal by Subject|0|||
129143708|NCT01217892|464820964|FG001|Overall Study|Withdrawal by Subject|2|||
129143709|NCT01217892|464820965|FG002|Overall Study|Withdrawal by Subject|1|||
129143710|NCT01217892|464820966|FG003|Overall Study|Withdrawal by Subject|0|||
129143711|NCT01217892|464820963|FG000|Overall Study|Lab value|1|||
129143712|NCT01217892|464820964|FG001|Overall Study|Lab value|0|||
129143713|NCT01217892|464820965|FG002|Overall Study|Lab value|1|||
129143714|NCT01217892|464820966|FG003|Overall Study|Lab value|0|||
129143715|NCT01217892|464820963|FG000|Overall Study|Subject no longer meets study criteria|5|||
129143716|NCT01217892|464820964|FG001|Overall Study|Subject no longer meets study criteria|2|||
129143717|NCT01217892|464820965|FG002|Overall Study|Subject no longer meets study criteria|4|||
129086460|NCT00664859|464607745|FG002|Overall Study|Adverse Event|3|||
129086461|NCT00664859|464607743|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
129086462|NCT00664859|464607744|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
129086463|NCT00664859|464607745|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
129086464|NCT00664859|464607743|FG000|Overall Study|Noncompliance with protocol|1|||
129143718|NCT01217892|464820966|FG003|Overall Study|Subject no longer meets study criteria|8|||
129143719|NCT01217892|464820963|FG000|Overall Study|Incorrect enrollment|0|||
129086465|NCT00664859|464607744|FG001|Overall Study|Noncompliance with protocol|0|||
129086466|NCT00664859|464607745|FG002|Overall Study|Noncompliance with protocol|4|||
129086467|NCT00664859|464607743|FG000|Overall Study|Laboratory abnormality|2|||
129086468|NCT00664859|464607744|FG001|Overall Study|Laboratory abnormality|1|||
129086469|NCT00664859|464607745|FG002|Overall Study|Laboratory abnormality|4|||
129086470|NCT00664859|464607743|FG000|Overall Study|Withdrawal by Subject|4|||
129086471|NCT00664859|464607744|FG001|Overall Study|Withdrawal by Subject|1|||
129086472|NCT00664859|464607745|FG002|Overall Study|Withdrawal by Subject|3|||
129086473|NCT00664859|464607743|FG000|Overall Study|Lost to Follow-up|2|||
129086474|NCT00664859|464607744|FG001|Overall Study|Lost to Follow-up|2|||
129086475|NCT00664859|464607745|FG002|Overall Study|Lost to Follow-up|1|||
129086476|NCT00664859|464607743|FG000|Overall Study|Other|0|||
129086477|NCT00664859|464607744|FG001|Overall Study|Other|1|||
129086478|NCT00664859|464607745|FG002|Overall Study|Other|2|||
129086479|NCT01943851|464607746|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086480|NCT01943851|464607747|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086481|NCT01943851|464607748|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086482|NCT01943851|464607749|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129086483|NCT01943851|464607750|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086484|NCT01943851|464607751|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086485|NCT01943851|464607752|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129086486|NCT01943851|464607753|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129086487|NCT01943851|464607754|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129086488|NCT01943851|464607755|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086489|NCT01943851|464607756|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086490|NCT01943851|464607757|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086491|NCT01943851|464607758|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086492|NCT01943851|464607759|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086493|NCT01943851|464607760|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086494|NCT01943851|464607761|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086495|NCT01943851|464607762|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086496|NCT01943851|464607763|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129086497|NCT01943851|464607746|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086498|NCT01943851|464607747|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086499|NCT01943851|464607748|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086500|NCT01943851|464607749|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086501|NCT01943851|464607750|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
129086502|NCT01943851|464607751|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086503|NCT01943851|464607752|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086504|NCT01943851|464607753|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
129086505|NCT01943851|464607754|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086506|NCT01943851|464607755|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086507|NCT01943851|464607756|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086508|NCT01943851|464607757|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086509|NCT01943851|464607758|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086510|NCT01943851|464607759|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086511|NCT01943851|464607760|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086512|NCT01943851|464607761|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086513|NCT01943851|464607762|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086514|NCT01943851|464607763|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129086515|NCT01943851|464607746|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086516|NCT01943851|464607747|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086517|NCT01943851|464607748|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086518|NCT01943851|464607749|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086519|NCT01943851|464607750|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086520|NCT01943851|464607751|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086521|NCT01943851|464607752|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086522|NCT01943851|464607753|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086523|NCT01943851|464607754|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129143720|NCT01217892|464820964|FG001|Overall Study|Incorrect enrollment|1|||
129143721|NCT01217892|464820965|FG002|Overall Study|Incorrect enrollment|1|||
129143722|NCT01217892|464820966|FG003|Overall Study|Incorrect enrollment|0|||
129143723|NCT01217892|464820963|FG000|Overall Study|Poor/Non-Compliance|0|||
129143724|NCT01217892|464820964|FG001|Overall Study|Poor/Non-Compliance|0|||
129143725|NCT01217892|464820965|FG002|Overall Study|Poor/Non-Compliance|1|||
129086524|NCT01943851|464607755|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086525|NCT01943851|464607756|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086526|NCT01943851|464607757|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129143726|NCT01217892|464820966|FG003|Overall Study|Poor/Non-Compliance|0|||
129143727|NCT01052779|464820967|FG000|Overall Study|Adverse Event|1|||
129143728|NCT01052779|464820968|FG001|Overall Study|Adverse Event|4|||
129143729|NCT01052779|464820967|FG000|Overall Study|Withdrawal by Subject|1|||
129143730|NCT01052779|464820968|FG001|Overall Study|Withdrawal by Subject|2|||
129086527|NCT01943851|464607758|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086528|NCT01943851|464607759|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
129086529|NCT01943851|464607760|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086530|NCT01943851|464607761|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086531|NCT01943851|464607762|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086532|NCT01943851|464607763|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129086533|NCT01943851|464607746|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086534|NCT01943851|464607747|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086535|NCT01943851|464607748|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086536|NCT01943851|464607749|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086537|NCT01943851|464607750|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086538|NCT01943851|464607751|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086539|NCT01943851|464607752|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086540|NCT01943851|464607753|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086541|NCT01943851|464607754|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086542|NCT01943851|464607755|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086543|NCT01943851|464607756|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086544|NCT01943851|464607757|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086545|NCT01943851|464607758|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086546|NCT01943851|464607759|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086547|NCT01943851|464607760|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086548|NCT01943851|464607761|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
129086549|NCT01943851|464607762|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086550|NCT01943851|464607763|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129086551|NCT01943851|464607746|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086552|NCT01943851|464607747|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086553|NCT01943851|464607748|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086554|NCT01943851|464607749|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086555|NCT01943851|464607750|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086556|NCT01943851|464607751|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086557|NCT01943851|464607752|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086558|NCT01943851|464607753|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129143731|NCT01052779|464820967|FG000|Overall Study|Other-Protocol Violation|1|||
129143732|NCT01052779|464820968|FG001|Overall Study|Other-Protocol Violation|1|||
129143733|NCT01052779|464820967|FG000|Overall Study|Other-Surgery|0|||
129143734|NCT01052779|464820968|FG001|Overall Study|Other-Surgery|2|||
129143735|NCT01052779|464820967|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
129143736|NCT01052779|464820968|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
129143737|NCT03802916|464820969|FG000|Overall Study|Adverse Event|0|||
129143738|NCT03802916|464820970|FG001|Overall Study|Adverse Event|1|||
129143739|NCT03802916|464820969|FG000|Overall Study|Withdrawal by Subject|0|||
129143740|NCT03802916|464820970|FG001|Overall Study|Withdrawal by Subject|1|||
129143741|NCT03663582|464820971|FG000|Overall Study|Physician Decision|1|||
129143742|NCT03242434|464820974|FG000|Overall Study|Death|0|||
129143743|NCT03242434|464820975|FG001|Overall Study|Death|2|||
129143744|NCT04507763|464820976|FG000|Overall Study|Participants did not meet entrance criteria|201|||
129143745|NCT03427619|464820977|FG000|Overall Study|Physician Decision|3|||
129143746|NCT03427619|464820977|FG000|Overall Study|Withdrawal by Subject|4|||
129143747|NCT03427619|464820977|FG000|Overall Study|Lost to Follow-up|5|||
129143748|NCT03427619|464820977|FG000|Overall Study|Administrative|4|||
129143749|NCT03427619|464820977|FG000|Overall Study|Other|2|||
129143750|NCT03427619|464820977|FG000|Overall Study|Unknown or Missing Completion Status|48|||
129143751|NCT05763381|464820978|FG000|Overall Study|Lost to Follow-up|2|||
129143752|NCT05763381|464820979|FG001|Overall Study|Lost to Follow-up|3|||
129143753|NCT05763381|464820978|FG000|Overall Study|Withdrawal by Subject|1|||
129143754|NCT05763381|464820979|FG001|Overall Study|Withdrawal by Subject|2|||
129143755|NCT02853136|464820980|FG000|Wash-out|Adverse Event|0|||
129143756|NCT02853136|464820981|FG001|Wash-out|Adverse Event|0|||
129143757|NCT02853136|464820982|FG002|Wash-out|Adverse Event|0|||
129143758|NCT02853136|464820983|FG003|Wash-out|Adverse Event|1|||
129143759|NCT00841815|464820984|FG000|Washout|Withdrawal by Subject|0|||
129143760|NCT00841815|464820985|FG001|Washout|Withdrawal by Subject|1|||
129143761|NCT00867334|464820987|FG000|Overall Study|Withdrawal by Subject|0|||
129143762|NCT00867334|464820988|FG001|Overall Study|Withdrawal by Subject|1|||
129143763|NCT00867334|464820987|FG000|Overall Study|Withdrawal by Subject|1|||
129143764|NCT00867334|464820988|FG001|Overall Study|Withdrawal by Subject|0|||
129143765|NCT00867334|464820987|FG000|Overall Study|Withdrawal by Subject|1|||
129143766|NCT00867334|464820988|FG001|Overall Study|Withdrawal by Subject|0|||
129143767|NCT03787615|464820989|FG000|Overall Study|Withdrawal by Subject|2|||
129143768|NCT03787615|464820989|FG000|Overall Study|Lost to Follow-up|2|||
129143769|NCT02697448|464820990|FG000|Overall Study|Protocol Violation|2|||
129143770|NCT02697448|464820991|FG001|Overall Study|Protocol Violation|4|||
128776572|NCT04129580|463471963|FG001|Overall Study|Lost to Follow-up|25|||
129143771|NCT02697448|464820990|FG000|Overall Study|Clinical concerns during ablation|1|||
129143772|NCT02697448|464820991|FG001|Overall Study|Clinical concerns during ablation|1|||
128724372|NCT03131440|463289070|FG014|Overall Study|Withdrawal by Subject|1|||
128724373|NCT03131440|463289071|FG015|Overall Study|Withdrawal by Subject|0|||
128724374|NCT03131440|463289072|FG016|Overall Study|Withdrawal by Subject|0|||
128724375|NCT03131440|463289073|FG017|Overall Study|Withdrawal by Subject|0|||
128724376|NCT03131440|463289074|FG018|Overall Study|Withdrawal by Subject|1|||
128724377|NCT03131440|463289075|FG019|Overall Study|Withdrawal by Subject|0|||
128724378|NCT03131440|463289076|FG020|Overall Study|Withdrawal by Subject|1|||
129086559|NCT01943851|464607754|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086560|NCT01943851|464607755|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086561|NCT01943851|464607756|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086562|NCT01943851|464607757|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086563|NCT01943851|464607758|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086564|NCT01943851|464607759|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086565|NCT01943851|464607760|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129086566|NCT01943851|464607761|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
129143773|NCT02697448|464820990|FG000|Overall Study|No data collected|2|||
129143774|NCT02697448|464820991|FG001|Overall Study|No data collected|0|||
129143775|NCT03464461|464820992|FG000|Overall Study|exclusionary medication given ,|1|||
129143776|NCT03464461|464820993|FG001|Overall Study|exclusionary medication given ,|2|||
129143777|NCT03464461|464820994|FG002|Overall Study|exclusionary medication given ,|0|||
129143778|NCT03464461|464820992|FG000|Overall Study|Physician Decision|0|||
129143779|NCT03464461|464820993|FG001|Overall Study|Physician Decision|1|||
129143780|NCT03464461|464820994|FG002|Overall Study|Physician Decision|0|||
129143781|NCT03685149|464820996|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
129143782|NCT03685149|464820997|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
129143783|NCT03685149|464820996|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129143784|NCT03685149|464820997|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129143785|NCT03685149|464820996|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
129143786|NCT03685149|464820997|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
129143787|NCT04876391|464820998|FG000|Overall Study|Withdrawal by Subject|1|||
129143788|NCT04876391|464820999|FG001|Overall Study|Withdrawal by Subject|10|||
129143789|NCT04876391|464820998|FG000|Overall Study|Lost to Follow-up|2|||
129143790|NCT04876391|464820999|FG001|Overall Study|Lost to Follow-up|4|||
129143791|NCT04876391|464820998|FG000|Overall Study|Lack of Efficacy|0|||
129143792|NCT04876391|464820999|FG001|Overall Study|Lack of Efficacy|2|||
129143793|NCT04876391|464820998|FG000|Overall Study|Adverse Event|3|||
129143794|NCT04876391|464820999|FG001|Overall Study|Adverse Event|1|||
129143795|NCT04876391|464820998|FG000|Overall Study|Patient non-compliance|0|||
129143796|NCT04876391|464820999|FG001|Overall Study|Patient non-compliance|1|||
129143797|NCT04876391|464820998|FG000|Overall Study|Personal reasons|0|||
129143798|NCT04876391|464820999|FG001|Overall Study|Personal reasons|1|||
129143799|NCT04876391|464820998|FG000|Overall Study|Withdrawn as per protocol|2|||
129143800|NCT04876391|464820999|FG001|Overall Study|Withdrawn as per protocol|2|||
129143801|NCT00209131|464821004|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
129143802|NCT00209131|464821005|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
129143803|NCT05360784|464821006|FG000|Overall Study|Discontinued|25|||
129143804|NCT05360784|464821007|FG001|Overall Study|Discontinued|11|||
129143805|NCT05142306|464821011|FG000|Overall Study|Withdrawal by Subject|0|||
129143806|NCT05142306|464821012|FG001|Overall Study|Withdrawal by Subject|0|||
129143807|NCT05142306|464821013|FG002|Overall Study|Withdrawal by Subject|1|||
129143808|NCT02251041|464821014|FG000|Overall Study|Did not receive intervention|15|||
129143809|NCT02251041|464821015|FG001|Overall Study|Did not receive intervention|4|||
129143810|NCT04079920|464821016|FG000|Overall Study|Adverse event, not related to study drug|2|||
129143811|NCT04079920|464821016|FG000|Overall Study|Adverse event related to study drug|10|||
129143812|NCT04079920|464821016|FG000|Overall Study|Death|2|||
129143813|NCT04079920|464821016|FG000|Overall Study|Lost to Follow-up|22|||
129143814|NCT04079920|464821016|FG000|Overall Study|Physician Decision|1|||
129143815|NCT04079920|464821016|FG000|Overall Study|Withdrawal by Subject|11|||
129143816|NCT04918771|464821017|FG000|Overall Study|Withdrawal by Subject|4|||
129143817|NCT04918771|464821018|FG001|Overall Study|Withdrawal by Subject|5|||
129143818|NCT04918771|464821017|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
129143819|NCT04918771|464821018|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
129143820|NCT01299961|464821027|FG000|Overall Study|Adverse Event|3|||
129143821|NCT01299961|464821027|FG000|Overall Study|Lack of Efficacy|2|||
129143822|NCT01299961|464821027|FG000|Overall Study|Lost to Follow-up|1|||
129143823|NCT02904096|464821028|FG000|Overall Study|Adverse Event|1|||
129143824|NCT02904096|464821029|FG001|Overall Study|Adverse Event|0|||
128724379|NCT03131440|463289077|FG021|Overall Study|Withdrawal by Subject|1|||
128724380|NCT03131440|463289078|FG022|Overall Study|Withdrawal by Subject|1|||
128724381|NCT03131440|463289079|FG023|Overall Study|Withdrawal by Subject|0|||
128724382|NCT03131440|463289080|FG024|Overall Study|Withdrawal by Subject|0|||
128724383|NCT03131440|463289081|FG025|Overall Study|Withdrawal by Subject|0|||
129143825|NCT02904096|464821028|FG000|Overall Study|Withdrawal by Subject|4|||
129143826|NCT02904096|464821029|FG001|Overall Study|Withdrawal by Subject|3|||
129143827|NCT02904096|464821028|FG000|Overall Study|Lost to Follow-up|10|||
129143828|NCT02904096|464821029|FG001|Overall Study|Lost to Follow-up|17|||
129143829|NCT02904096|464821028|FG000|Overall Study|Non-compliant|3|||
129143830|NCT02904096|464821029|FG001|Overall Study|Non-compliant|1|||
129143831|NCT02904096|464821028|FG000|Overall Study|Sponsor instructed|1|||
129143832|NCT02904096|464821029|FG001|Overall Study|Sponsor instructed|0|||
129143833|NCT05305651|464821030|FG000|Overall Study|Death|1|||
129143834|NCT05305651|464821030|FG000|Overall Study|Withdrawal by Subject|4|||
129143835|NCT05305651|464821030|FG000|Overall Study|Lost to Follow-up|4|||
129143836|NCT00526799|464821031|FG000|Overall Study|Withdrawal by Subject|1|||
129143837|NCT00526799|464821032|FG001|Overall Study|Withdrawal by Subject|0|||
129143838|NCT00526799|464821031|FG000|Overall Study|Intercurrent Complicating Disease|0|||
129143839|NCT00526799|464821032|FG001|Overall Study|Intercurrent Complicating Disease|1|||
129143840|NCT04003389|464821033|FG000|Overall Study|Adverse Event|27|||
129143841|NCT04003389|464821034|FG001|Overall Study|Adverse Event|34|||
129143842|NCT04003389|464821035|FG002|Overall Study|Adverse Event|28|||
129143843|NCT04003389|464821033|FG000|Overall Study|Lost to Follow-up|39|||
129143844|NCT04003389|464821034|FG001|Overall Study|Lost to Follow-up|30|||
129143845|NCT04003389|464821035|FG002|Overall Study|Lost to Follow-up|33|||
129143846|NCT04003389|464821033|FG000|Overall Study|Protocol Violation|1|||
129143847|NCT04003389|464821034|FG001|Overall Study|Protocol Violation|6|||
129143848|NCT04003389|464821035|FG002|Overall Study|Protocol Violation|5|||
129143849|NCT04003389|464821033|FG000|Overall Study|Withdrawal by Subject|119|||
129143850|NCT04003389|464821034|FG001|Overall Study|Withdrawal by Subject|79|||
129143851|NCT04003389|464821035|FG002|Overall Study|Withdrawal by Subject|85|||
129143852|NCT04003389|464821033|FG000|Overall Study|Miscellaneous|14|||
129143853|NCT04003389|464821034|FG001|Overall Study|Miscellaneous|11|||
129143854|NCT04003389|464821035|FG002|Overall Study|Miscellaneous|14|||
129143855|NCT04003389|464821033|FG000|Overall Study|Participant did not receive study drug|1|||
129143856|NCT04003389|464821034|FG001|Overall Study|Participant did not receive study drug|0|||
129143857|NCT04003389|464821035|FG002|Overall Study|Participant did not receive study drug|0|||
129143858|NCT02298946|464821036|FG000|Overall Study|Did not receive treatment|2|||
129143859|NCT02298946|464821037|FG001|Overall Study|Did not receive treatment|0|||
129143860|NCT02298946|464821036|FG000|Overall Study|Unevaluable|2|||
129143861|NCT02298946|464821037|FG001|Overall Study|Unevaluable|1|||
129086567|NCT01943851|464607762|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
129086568|NCT01943851|464607763|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
129086569|NCT00900757|464607764|FG000|Overall Study|screen failure|19|||
129086570|NCT00748189|464607765|FG000|Overall Study|Death|99|||
129086571|NCT00748189|464607766|FG001|Overall Study|Death|84|||
129086572|NCT00748189|464607765|FG000|Overall Study|Withdrawal by Subject|23|||
129086573|NCT00748189|464607766|FG001|Overall Study|Withdrawal by Subject|29|||
129086574|NCT00748189|464607765|FG000|Overall Study|Physician Decision|16|||
129086575|NCT00748189|464607766|FG001|Overall Study|Physician Decision|5|||
129086576|NCT00748189|464607765|FG000|Overall Study|Lost to Follow-up|8|||
129086577|NCT00748189|464607766|FG001|Overall Study|Lost to Follow-up|15|||
129086578|NCT00748189|464607765|FG000|Overall Study|Study terminated by Sponsor|70|||
129086579|NCT00748189|464607766|FG001|Overall Study|Study terminated by Sponsor|79|||
129086580|NCT03320850|464607767|FG000|Overall Study|Lost to Follow-up|0|||
129086581|NCT03320850|464607768|FG001|Overall Study|Lost to Follow-up|0|||
129086582|NCT03320850|464607769|FG002|Overall Study|Lost to Follow-up|0|||
129086583|NCT03320850|464607770|FG003|Overall Study|Lost to Follow-up|0|||
129086584|NCT03320850|464607771|FG004|Overall Study|Lost to Follow-up|1|||
129086585|NCT03320850|464607772|FG005|Overall Study|Lost to Follow-up|2|||
129086586|NCT03320850|464607773|FG006|Overall Study|Lost to Follow-up|2|||
129086587|NCT03320850|464607774|FG007|Overall Study|Lost to Follow-up|0|||
129086588|NCT03320850|464607775|FG008|Overall Study|Lost to Follow-up|6|||
129143862|NCT04280783|464822699|FG000|Overall Study|Family issues unrelated to the study.|1|||
128724384|NCT03131440|463289082|FG026|Overall Study|Withdrawal by Subject|0|||
129086589|NCT03320850|464607776|FG009|Overall Study|Lost to Follow-up|4|||
128724385|NCT03131440|463289083|FG027|Overall Study|Withdrawal by Subject|0|||
129086590|NCT03320850|464607767|FG000|Overall Study|Withdrawal by Subject|0|||
129086591|NCT03320850|464607768|FG001|Overall Study|Withdrawal by Subject|0|||
129086592|NCT03320850|464607769|FG002|Overall Study|Withdrawal by Subject|0|||
129086593|NCT03320850|464607770|FG003|Overall Study|Withdrawal by Subject|0|||
129086594|NCT03320850|464607771|FG004|Overall Study|Withdrawal by Subject|1|||
129143863|NCT04280783|464822700|FG001|Overall Study|Family issues unrelated to the study.|0|||
129143864|NCT04280783|464822699|FG000|Overall Study|Withdrawal by Subject|0|||
129143865|NCT04280783|464822700|FG001|Overall Study|Withdrawal by Subject|1|||
129086595|NCT03320850|464607772|FG005|Overall Study|Withdrawal by Subject|2|||
129143866|NCT05654181|464822701|FG000|Overall Study|Adverse Event|1|||
128724386|NCT03131440|463289084|FG028|Overall Study|Withdrawal by Subject|0|||
129143867|NCT05654181|464822702|FG001|Overall Study|Adverse Event|0|||
129143868|NCT05654181|464822703|FG002|Overall Study|Adverse Event|0|||
129086596|NCT03320850|464607773|FG006|Overall Study|Withdrawal by Subject|4|||
129086597|NCT03320850|464607774|FG007|Overall Study|Withdrawal by Subject|5|||
129143869|NCT05654181|464822704|FG003|Overall Study|Adverse Event|0|||
129143870|NCT05654181|464822705|FG004|Overall Study|Adverse Event|0|||
129143871|NCT05654181|464822706|FG005|Overall Study|Adverse Event|0|||
129086598|NCT03320850|464607775|FG008|Overall Study|Withdrawal by Subject|2|||
129086599|NCT03320850|464607776|FG009|Overall Study|Withdrawal by Subject|1|||
129086600|NCT03320850|464607767|FG000|Overall Study|Lack of Efficacy|0|||
129086601|NCT03320850|464607768|FG001|Overall Study|Lack of Efficacy|0|||
129086602|NCT03320850|464607769|FG002|Overall Study|Lack of Efficacy|0|||
129086603|NCT03320850|464607770|FG003|Overall Study|Lack of Efficacy|1|||
129086604|NCT03320850|464607771|FG004|Overall Study|Lack of Efficacy|0|||
129086605|NCT03320850|464607772|FG005|Overall Study|Lack of Efficacy|1|||
129086606|NCT03320850|464607773|FG006|Overall Study|Lack of Efficacy|0|||
129086607|NCT03320850|464607774|FG007|Overall Study|Lack of Efficacy|2|||
129086608|NCT03320850|464607775|FG008|Overall Study|Lack of Efficacy|0|||
129086609|NCT03320850|464607776|FG009|Overall Study|Lack of Efficacy|3|||
129086610|NCT03320850|464607767|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129086611|NCT03320850|464607768|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129086612|NCT03320850|464607769|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
129086613|NCT03320850|464607770|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
129086614|NCT03320850|464607771|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
129086615|NCT03320850|464607772|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
129086616|NCT03320850|464607773|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
129086617|NCT03320850|464607774|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
129086618|NCT03320850|464607775|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
129086619|NCT03320850|464607776|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
129086620|NCT03320850|464607767|FG000|Overall Study|Adverse Event|0|||
129086621|NCT03320850|464607768|FG001|Overall Study|Adverse Event|0|||
129086622|NCT03320850|464607769|FG002|Overall Study|Adverse Event|0|||
129086623|NCT03320850|464607770|FG003|Overall Study|Adverse Event|0|||
129086624|NCT03320850|464607771|FG004|Overall Study|Adverse Event|0|||
129086625|NCT03320850|464607772|FG005|Overall Study|Adverse Event|2|||
129086626|NCT03320850|464607773|FG006|Overall Study|Adverse Event|1|||
129086627|NCT03320850|464607774|FG007|Overall Study|Adverse Event|0|||
129086628|NCT03320850|464607775|FG008|Overall Study|Adverse Event|2|||
129086629|NCT03320850|464607776|FG009|Overall Study|Adverse Event|0|||
129086630|NCT03320850|464607767|FG000|Overall Study|Reason Not Specified|0|||
129086631|NCT03320850|464607768|FG001|Overall Study|Reason Not Specified|0|||
129086632|NCT03320850|464607769|FG002|Overall Study|Reason Not Specified|0|||
129086633|NCT03320850|464607770|FG003|Overall Study|Reason Not Specified|0|||
129086634|NCT03320850|464607771|FG004|Overall Study|Reason Not Specified|0|||
129086635|NCT03320850|464607772|FG005|Overall Study|Reason Not Specified|1|||
129086636|NCT03320850|464607773|FG006|Overall Study|Reason Not Specified|0|||
129086637|NCT03320850|464607774|FG007|Overall Study|Reason Not Specified|0|||
129086638|NCT03320850|464607775|FG008|Overall Study|Reason Not Specified|0|||
129086639|NCT03320850|464607776|FG009|Overall Study|Reason Not Specified|1|||
129086640|NCT01424514|464607777|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
129086641|NCT01424514|464607778|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
129086642|NCT01424514|464607777|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
129086643|NCT01424514|464607778|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
129086644|NCT00546117|464607779|FG000|Overall Study|Withdrawal by Subject|3|||
129086645|NCT00546117|464607780|FG001|Overall Study|Withdrawal by Subject|0|||
129086646|NCT00546117|464607779|FG000|Overall Study|Inability to schedule follow-up visit|1|||
129086647|NCT00546117|464607780|FG001|Overall Study|Inability to schedule follow-up visit|0|||
129086648|NCT02653170|464607783|FG000|Overall Study|Withdrawal by Subject|3|||
129086649|NCT02653170|464607784|FG001|Overall Study|Withdrawal by Subject|8|||
129086650|NCT02653170|464607785|FG002|Overall Study|Withdrawal by Subject|3|||
128776573|NCT00224133|463471966|FG000|Overall Study|Adverse Event|93|||
129086651|NCT02653170|464607783|FG000|Overall Study|withdrawn by study team|2|||
129086652|NCT02653170|464607784|FG001|Overall Study|withdrawn by study team|4|||
129086653|NCT02653170|464607785|FG002|Overall Study|withdrawn by study team|5|||
129086654|NCT02653170|464607783|FG000|Overall Study|Lost to Follow-up|12|||
129086655|NCT02653170|464607784|FG001|Overall Study|Lost to Follow-up|4|||
129086656|NCT02653170|464607785|FG002|Overall Study|Lost to Follow-up|10|||
129086657|NCT04304235|464607796|FG000|Overall Study|incomplete triage data|0|||
129086658|NCT04304235|464607797|FG001|Overall Study|incomplete triage data|69|||
129086659|NCT04304235|464607798|FG002|Overall Study|incomplete triage data|0|||
129086660|NCT04304235|464607799|FG003|Overall Study|incomplete triage data|0|||
129086661|NCT04304235|464607800|FG004|Overall Study|incomplete triage data|289|||
129086662|NCT04304235|464607801|FG005|Overall Study|incomplete triage data|123|||
129086663|NCT04304235|464607802|FG006|Overall Study|incomplete triage data|65|||
129086664|NCT04429555|464607803|FG000|Overall Study|Death|0|||
129086665|NCT04429555|464607804|FG001|Overall Study|Death|2|||
129086666|NCT04429555|464607803|FG000|Overall Study|Other|2|||
129086667|NCT04429555|464607804|FG001|Overall Study|Other|0|||
129086668|NCT00425061|464607805|FG000|Overall Study|Adverse Event|1|||
129086669|NCT00425061|464607806|FG001|Overall Study|Adverse Event|0|||
129086670|NCT00425061|464607807|FG002|Overall Study|Adverse Event|0|||
129086671|NCT00425061|464607808|FG003|Overall Study|Adverse Event|2|||
129086672|NCT00425061|464607809|FG004|Overall Study|Adverse Event|2|||
129086673|NCT00425061|464607810|FG005|Overall Study|Adverse Event|0|||
129086674|NCT00425061|464607811|FG006|Overall Study|Adverse Event|0|||
129086675|NCT00425061|464607805|FG000|Overall Study|Lost to Follow-up|0|||
129086676|NCT00425061|464607806|FG001|Overall Study|Lost to Follow-up|1|||
129086677|NCT00425061|464607807|FG002|Overall Study|Lost to Follow-up|0|||
129086678|NCT00425061|464607808|FG003|Overall Study|Lost to Follow-up|0|||
129086679|NCT00425061|464607809|FG004|Overall Study|Lost to Follow-up|0|||
129086680|NCT00425061|464607810|FG005|Overall Study|Lost to Follow-up|0|||
129086681|NCT00425061|464607811|FG006|Overall Study|Lost to Follow-up|0|||
129086682|NCT00425061|464607805|FG000|Overall Study|Protocol Violation|1|||
129086683|NCT00425061|464607806|FG001|Overall Study|Protocol Violation|0|||
129086684|NCT00425061|464607807|FG002|Overall Study|Protocol Violation|0|||
129086685|NCT00425061|464607808|FG003|Overall Study|Protocol Violation|0|||
129086686|NCT00425061|464607809|FG004|Overall Study|Protocol Violation|0|||
129086687|NCT00425061|464607810|FG005|Overall Study|Protocol Violation|0|||
129086688|NCT00425061|464607811|FG006|Overall Study|Protocol Violation|0|||
129086689|NCT00425061|464607805|FG000|Overall Study|Withdrawal by Subject|0|||
129086690|NCT00425061|464607806|FG001|Overall Study|Withdrawal by Subject|1|||
129086691|NCT00425061|464607807|FG002|Overall Study|Withdrawal by Subject|0|||
129086692|NCT00425061|464607808|FG003|Overall Study|Withdrawal by Subject|0|||
129086693|NCT00425061|464607809|FG004|Overall Study|Withdrawal by Subject|1|||
129086694|NCT00425061|464607810|FG005|Overall Study|Withdrawal by Subject|0|||
129086695|NCT00425061|464607811|FG006|Overall Study|Withdrawal by Subject|3|||
129086696|NCT00425061|464607805|FG000|Overall Study|Sponsor's request|0|||
129086697|NCT00425061|464607806|FG001|Overall Study|Sponsor's request|0|||
129086698|NCT00425061|464607807|FG002|Overall Study|Sponsor's request|0|||
129086699|NCT00425061|464607808|FG003|Overall Study|Sponsor's request|0|||
129086700|NCT00425061|464607809|FG004|Overall Study|Sponsor's request|19|||
129086701|NCT00425061|464607810|FG005|Overall Study|Sponsor's request|4|||
129086702|NCT00425061|464607811|FG006|Overall Study|Sponsor's request|15|||
129086703|NCT00425061|464607805|FG000|Overall Study|Physician Decision|0|||
129086704|NCT00425061|464607806|FG001|Overall Study|Physician Decision|0|||
129086705|NCT00425061|464607807|FG002|Overall Study|Physician Decision|0|||
129086706|NCT00425061|464607808|FG003|Overall Study|Physician Decision|0|||
129086707|NCT00425061|464607809|FG004|Overall Study|Physician Decision|1|||
129086708|NCT00425061|464607810|FG005|Overall Study|Physician Decision|0|||
129086709|NCT00425061|464607811|FG006|Overall Study|Physician Decision|0|||
129086710|NCT00425061|464607805|FG000|Overall Study|Other|0|||
129086711|NCT00425061|464607806|FG001|Overall Study|Other|0|||
129086712|NCT00425061|464607807|FG002|Overall Study|Other|0|||
129086713|NCT00425061|464607808|FG003|Overall Study|Other|0|||
129086714|NCT00425061|464607809|FG004|Overall Study|Other|3|||
129086715|NCT00425061|464607810|FG005|Overall Study|Other|0|||
129086716|NCT00425061|464607811|FG006|Overall Study|Other|1|||
129086717|NCT04720911|464607814|FG000|Overall Study|Withdrawal by Subject|0|||
129086718|NCT04720911|464607815|FG001|Overall Study|Withdrawal by Subject|1|||
129086719|NCT04720911|464607816|FG002|Overall Study|Withdrawal by Subject|0|||
129086720|NCT00090220|464607817|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
129086721|NCT00090220|464607818|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
129086722|NCT00090220|464607819|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129086723|NCT00090220|464607820|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129086724|NCT00090220|464607821|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129086725|NCT00090220|464607822|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129086726|NCT00090220|464607817|FG000|Base Study Vaccination Period|Adverse Event|6|||
129086727|NCT00090220|464607818|FG001|Base Study Vaccination Period|Adverse Event|1|||
129086728|NCT00090220|464607819|FG002|Base Study Vaccination Period|Adverse Event|0|||
129086729|NCT00090220|464607820|FG003|Base Study Vaccination Period|Adverse Event|0|||
129086730|NCT00090220|464607821|FG004|Base Study Vaccination Period|Adverse Event|0|||
129086731|NCT00090220|464607822|FG005|Base Study Vaccination Period|Adverse Event|0|||
129086732|NCT00090220|464607817|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
129086733|NCT00090220|464607818|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
129086734|NCT00090220|464607819|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
129143872|NCT05654181|464822707|FG006|Overall Study|Adverse Event|0|||
129143873|NCT05654181|464822708|FG007|Overall Study|Adverse Event|1|||
129143874|NCT05654181|464822709|FG008|Overall Study|Adverse Event|0|||
129143875|NCT05654181|464822710|FG009|Overall Study|Adverse Event|0|||
129143876|NCT05654181|464822701|FG000|Overall Study|Withdrawal by Subject|0|||
129143877|NCT05654181|464822702|FG001|Overall Study|Withdrawal by Subject|0|||
129143878|NCT05654181|464822703|FG002|Overall Study|Withdrawal by Subject|0|||
129143879|NCT05654181|464822704|FG003|Overall Study|Withdrawal by Subject|0|||
129143880|NCT05654181|464822705|FG004|Overall Study|Withdrawal by Subject|0|||
129143881|NCT05654181|464822706|FG005|Overall Study|Withdrawal by Subject|0|||
129143882|NCT05654181|464822707|FG006|Overall Study|Withdrawal by Subject|0|||
129143883|NCT05654181|464822708|FG007|Overall Study|Withdrawal by Subject|1|||
129143884|NCT05654181|464822709|FG008|Overall Study|Withdrawal by Subject|0|||
129143885|NCT05654181|464822710|FG009|Overall Study|Withdrawal by Subject|0|||
129143886|NCT05654181|464822701|FG000|Overall Study|Other|0|||
129143887|NCT05654181|464822702|FG001|Overall Study|Other|0|||
129143888|NCT05654181|464822703|FG002|Overall Study|Other|0|||
129143889|NCT05654181|464822704|FG003|Overall Study|Other|0|||
129143890|NCT05654181|464822705|FG004|Overall Study|Other|1|||
129143891|NCT05654181|464822706|FG005|Overall Study|Other|1|||
129143892|NCT05654181|464822707|FG006|Overall Study|Other|0|||
129143893|NCT05654181|464822708|FG007|Overall Study|Other|0|||
129143894|NCT05654181|464822709|FG008|Overall Study|Other|0|||
129143895|NCT05654181|464822710|FG009|Overall Study|Other|0|||
129143896|NCT04101331|464822711|FG000|Overall Study|Adverse Event|9|||
129143897|NCT04101331|464822711|FG000|Overall Study|Disease progression|82|||
129143898|NCT04101331|464822711|FG000|Overall Study|Withdrawal by Subject|1|||
129143899|NCT04101331|464822711|FG000|Overall Study|Investigator decision|6|||
129143900|NCT04101331|464822711|FG000|Overall Study|Death|6|||
129143901|NCT04101331|464822711|FG000|Overall Study|Allogenic transplant|1|||
129143902|NCT04110145|464822712|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129143903|NCT04110145|464822713|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129143904|NCT04110145|464822714|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129143905|NCT04110145|464822715|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
129143906|NCT04110145|464822716|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129143907|NCT00567502|464822724|FG000|Overall Study|Lost to Follow-up|91|||
129143908|NCT00567502|464822725|FG001|Overall Study|Lost to Follow-up|14|||
129143909|NCT00567502|464822726|FG002|Overall Study|Lost to Follow-up|351|||
129143910|NCT00567502|464822727|FG003|Overall Study|Lost to Follow-up|2|||
129143911|NCT00567502|464822724|FG000|Overall Study|Death|65|||
129143912|NCT00567502|464822725|FG001|Overall Study|Death|16|||
129143913|NCT00567502|464822726|FG002|Overall Study|Death|360|||
129143914|NCT00567502|464822727|FG003|Overall Study|Death|5|||
129143915|NCT00567502|464822724|FG000|Overall Study|Other|64|||
129143916|NCT00567502|464822725|FG001|Overall Study|Other|2|||
129143917|NCT00567502|464822726|FG002|Overall Study|Other|134|||
129143918|NCT00567502|464822727|FG003|Overall Study|Other|6|||
129143919|NCT00567502|464822724|FG000|Overall Study|Participant request|12|||
129143920|NCT00567502|464822725|FG001|Overall Study|Participant request|1|||
129143921|NCT00567502|464822726|FG002|Overall Study|Participant request|33|||
129143922|NCT00567502|464822727|FG003|Overall Study|Participant request|1|||
129143923|NCT00567502|464822724|FG000|Overall Study|Sponsor request|9|||
129143924|NCT00567502|464822725|FG001|Overall Study|Sponsor request|0|||
129143925|NCT00567502|464822726|FG002|Overall Study|Sponsor request|30|||
129143926|NCT00567502|464822727|FG003|Overall Study|Sponsor request|1|||
129143927|NCT00567502|464822724|FG000|Overall Study|Never Initiated Treatment|0|||
129143928|NCT00567502|464822725|FG001|Overall Study|Never Initiated Treatment|0|||
129143929|NCT00567502|464822726|FG002|Overall Study|Never Initiated Treatment|0|||
129143930|NCT00567502|464822727|FG003|Overall Study|Never Initiated Treatment|72|||
129143931|NCT00337168|464822728|FG000|Overall Study|Death|5|||
129143932|NCT00337168|464822728|FG000|Overall Study|Not protocol specified|2|||
129143933|NCT00337168|464822728|FG000|Overall Study|Did not start therapy|1|||
129143934|NCT03283241|464822729|FG000|Overall Study|Adverse Event|4|||
129143935|NCT03283241|464822730|FG001|Overall Study|Adverse Event|1|||
129143936|NCT03283241|464822729|FG000|Overall Study|Withdrawal by Subject|0|||
129143937|NCT03283241|464822730|FG001|Overall Study|Withdrawal by Subject|1|||
129143938|NCT03283241|464822729|FG000|Overall Study|Subject relocated to Finland|0|||
129143939|NCT03283241|464822730|FG001|Overall Study|Subject relocated to Finland|1|||
129143940|NCT00666263|464822733|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
129143941|NCT00666263|464822734|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
129143942|NCT00666263|464822733|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
129143943|NCT00666263|464822734|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
129143944|NCT00666263|464822733|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
129143945|NCT00666263|464822734|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
129143946|NCT01225952|464822735|FG000|Overall Study|Lost to Follow-up|1|||
129143947|NCT01225952|464822736|FG001|Overall Study|Lost to Follow-up|0|||
129143948|NCT01225952|464822737|FG002|Overall Study|Lost to Follow-up|0|||
129086735|NCT00090220|464607820|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
129086736|NCT00090220|464607821|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
129086737|NCT00090220|464607822|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
129086738|NCT00090220|464607817|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
129086739|NCT00090220|464607818|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
129086740|NCT00090220|464607819|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
129143949|NCT01225952|464822735|FG000|Overall Study|Study Eye Explanted|0|||
129143950|NCT01225952|464822736|FG001|Overall Study|Study Eye Explanted|0|||
129143951|NCT01225952|464822737|FG002|Overall Study|Study Eye Explanted|1|||
129143952|NCT01225952|464822735|FG000|Overall Study|Withdrawal by Subject|4|||
129143953|NCT01225952|464822736|FG001|Overall Study|Withdrawal by Subject|4|||
129143954|NCT01225952|464822737|FG002|Overall Study|Withdrawal by Subject|5|||
129143955|NCT01225952|464822735|FG000|Overall Study|Surgical complications|1|||
129143956|NCT01225952|464822736|FG001|Overall Study|Surgical complications|0|||
129143957|NCT01225952|464822737|FG002|Overall Study|Surgical complications|0|||
129143958|NCT01285102|464822739|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
129143959|NCT03729609|464822755|FG000|Overall Study|Protocol Violation|1|||
129143960|NCT00605189|464822761|FG000|Overall Study|Adverse Event|1|||
129143961|NCT00605189|464822762|FG001|Overall Study|Adverse Event|0|||
129143962|NCT00605189|464822763|FG002|Overall Study|Adverse Event|0|||
129143963|NCT00605189|464822761|FG000|Overall Study|Other|2|||
129143964|NCT00605189|464822762|FG001|Overall Study|Other|2|||
129143965|NCT00605189|464822763|FG002|Overall Study|Other|0|||
129143966|NCT02919618|464822764|FG000|Overall Study|Death|1|||
129143967|NCT02592863|464822765|FG000|Overall Study|Withdrawal by Subject|2|||
129143968|NCT02592863|464822766|FG001|Overall Study|Withdrawal by Subject|2|||
129143969|NCT02592863|464822765|FG000|Overall Study|Lost to Follow-up|1|||
129143970|NCT02592863|464822766|FG001|Overall Study|Lost to Follow-up|1|||
129143971|NCT02743221|464822767|FG000|Overall Study|Progressive disease|29|||
129143972|NCT02743221|464822768|FG001|Overall Study|Progressive disease|38|||
129143973|NCT02743221|464822767|FG000|Overall Study|Adverse Event|17|||
129143974|NCT02743221|464822768|FG001|Overall Study|Adverse Event|14|||
129143975|NCT02743221|464822767|FG000|Overall Study|non medical reason|8|||
129143976|NCT02743221|464822768|FG001|Overall Study|non medical reason|2|||
129143977|NCT02743221|464822767|FG000|Overall Study|Physician Decision|2|||
129143978|NCT02743221|464822768|FG001|Overall Study|Physician Decision|5|||
129143979|NCT02743221|464822767|FG000|Overall Study|Patient not eligible, not treated|0|||
129143980|NCT02743221|464822768|FG001|Overall Study|Patient not eligible, not treated|1|||
129143981|NCT03411044|464822770|FG000|Overall Study|Death|30|||
129143982|NCT03411044|464822770|FG000|Overall Study|Withdrawal by Subject|48|||
129143983|NCT03411044|464822770|FG000|Overall Study|Lost to Follow-up|78|||
129143984|NCT03411044|464822770|FG000|Overall Study|Adverse Event|30|||
129143985|NCT03411044|464822770|FG000|Overall Study|Missing status|4|||
129143986|NCT02609503|464822771|FG000|Overall Study|Adverse Event|1|||
129143987|NCT02609503|464822771|FG000|Overall Study|Death|1|||
129143988|NCT02609503|464822771|FG000|Overall Study|Withdrawal by Subject|1|||
129143989|NCT02609503|464822771|FG000|Overall Study|Disease progression|1|||
129143990|NCT01969409|464822774|FG000|Overall Study|Death|2|||
129143991|NCT01969409|464822775|FG001|Overall Study|Death|2|||
129143992|NCT01969409|464822774|FG000|Overall Study|Transplant|1|||
129143993|NCT01969409|464822775|FG001|Overall Study|Transplant|1|||
129143994|NCT01969409|464822774|FG000|Overall Study|Withdrawal by Subject|0|||
129143995|NCT01969409|464822775|FG001|Overall Study|Withdrawal by Subject|1|||
129143996|NCT02226653|464822779|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
129143997|NCT02226653|464822780|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
129143998|NCT02226653|464822779|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
129143999|NCT02226653|464822780|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
129144000|NCT03078868|464822782|FG000|Overall Study|Physician Decision|3|||
129144001|NCT04629196|464822788|FG000|Overall Study|Subject discontinued study drug|1|||
129144002|NCT04629196|464822789|FG001|Overall Study|Subject discontinued study drug|0|||
129144003|NCT04629196|464822788|FG000|Overall Study|Subject study drug dosing increased|1|||
129144004|NCT04629196|464822789|FG001|Overall Study|Subject study drug dosing increased|1|||
129086741|NCT00090220|464607820|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
129144005|NCT04629196|464822788|FG000|Overall Study|Withdrawal by Subject|1|||
129144006|NCT04629196|464822789|FG001|Overall Study|Withdrawal by Subject|2|||
129144007|NCT01450631|464822793|FG000|Overall Study|Lost to Follow-up|2|||
129144008|NCT01450631|464822794|FG001|Overall Study|Lost to Follow-up|4|||
129144009|NCT01450631|464822793|FG000|Overall Study|Withdrawal by Subject|1|||
129086742|NCT00090220|464607821|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
129086743|NCT00090220|464607822|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
129144010|NCT01450631|464822794|FG001|Overall Study|Withdrawal by Subject|0|||
129144011|NCT00835354|464822795|FG000|First Intervention|Adverse Event|0|||
129144012|NCT00835354|464822796|FG001|First Intervention|Adverse Event|1|||
129144013|NCT03204812|464822797|FG000|Overall Study|Adverse Event|3|||
129144014|NCT01385995|464822799|FG000|Period 1, 2 Months|Physician Decision|1|||
129144015|NCT01385995|464822800|FG001|Period 1, 2 Months|Physician Decision|0|||
129086744|NCT00090220|464607817|FG000|Base Study Vaccination Period|Patient Moved|6|||
129086745|NCT00090220|464607818|FG001|Base Study Vaccination Period|Patient Moved|2|||
129086746|NCT00090220|464607819|FG002|Base Study Vaccination Period|Patient Moved|0|||
129086747|NCT00090220|464607820|FG003|Base Study Vaccination Period|Patient Moved|0|||
129086748|NCT00090220|464607821|FG004|Base Study Vaccination Period|Patient Moved|0|||
129086749|NCT00090220|464607822|FG005|Base Study Vaccination Period|Patient Moved|0|||
129086750|NCT00090220|464607817|FG000|Base Study Vaccination Period|Other|4|||
129086751|NCT00090220|464607818|FG001|Base Study Vaccination Period|Other|4|||
129086752|NCT00090220|464607819|FG002|Base Study Vaccination Period|Other|0|||
129086753|NCT00090220|464607820|FG003|Base Study Vaccination Period|Other|0|||
129086754|NCT00090220|464607821|FG004|Base Study Vaccination Period|Other|0|||
129086755|NCT00090220|464607822|FG005|Base Study Vaccination Period|Other|0|||
129086756|NCT00090220|464607817|FG000|Base Study Follow-up Period|Adverse Event|6|||
129086757|NCT00090220|464607818|FG001|Base Study Follow-up Period|Adverse Event|1|||
129086758|NCT00090220|464607819|FG002|Base Study Follow-up Period|Adverse Event|0|||
129086759|NCT00090220|464607820|FG003|Base Study Follow-up Period|Adverse Event|0|||
129086760|NCT00090220|464607821|FG004|Base Study Follow-up Period|Adverse Event|0|||
129086761|NCT00090220|464607822|FG005|Base Study Follow-up Period|Adverse Event|0|||
129086762|NCT00090220|464607817|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
129086763|NCT00090220|464607818|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
129086764|NCT00090220|464607819|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
129086765|NCT00090220|464607820|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
129086766|NCT00090220|464607821|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
129086767|NCT00090220|464607822|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
129086768|NCT00090220|464607817|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
129086769|NCT00090220|464607818|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
129086770|NCT00090220|464607819|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
129086771|NCT00090220|464607820|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
129086772|NCT00090220|464607821|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
129086773|NCT00090220|464607822|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
129086774|NCT00090220|464607817|FG000|Base Study Follow-up Period|Patient Moved|20|||
129086775|NCT00090220|464607818|FG001|Base Study Follow-up Period|Patient Moved|28|||
129086776|NCT00090220|464607819|FG002|Base Study Follow-up Period|Patient Moved|0|||
129086777|NCT00090220|464607820|FG003|Base Study Follow-up Period|Patient Moved|0|||
129086778|NCT00090220|464607821|FG004|Base Study Follow-up Period|Patient Moved|0|||
129086779|NCT00090220|464607822|FG005|Base Study Follow-up Period|Patient Moved|0|||
129086780|NCT00090220|464607817|FG000|Base Study Follow-up Period|Other|19|||
129086781|NCT00090220|464607818|FG001|Base Study Follow-up Period|Other|21|||
129086782|NCT00090220|464607819|FG002|Base Study Follow-up Period|Other|0|||
129086783|NCT00090220|464607820|FG003|Base Study Follow-up Period|Other|0|||
129086784|NCT00090220|464607821|FG004|Base Study Follow-up Period|Other|0|||
129086785|NCT00090220|464607822|FG005|Base Study Follow-up Period|Other|0|||
129086786|NCT00090220|464607817|FG000|Extension 1 (EXT1)|Adverse Event|0|||
129086787|NCT00090220|464607818|FG001|Extension 1 (EXT1)|Adverse Event|0|||
129086788|NCT00090220|464607819|FG002|Extension 1 (EXT1)|Adverse Event|4|||
129086789|NCT00090220|464607820|FG003|Extension 1 (EXT1)|Adverse Event|0|||
129086790|NCT00090220|464607821|FG004|Extension 1 (EXT1)|Adverse Event|0|||
129086791|NCT00090220|464607822|FG005|Extension 1 (EXT1)|Adverse Event|0|||
129086792|NCT00090220|464607817|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
129086793|NCT00090220|464607818|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
129086794|NCT00090220|464607819|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
129086795|NCT00090220|464607820|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
129086796|NCT00090220|464607821|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
129086797|NCT00090220|464607822|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
129086798|NCT00090220|464607817|FG000|Extension 1 (EXT1)|Moved|0|||
129144016|NCT00112385|464822801|FG000|Overall Study|Lost to Follow-up|1|||
129144017|NCT00112385|464822802|FG001|Overall Study|Lost to Follow-up|0|||
129144018|NCT00112385|464822801|FG000|Overall Study|Withdrawal by Subject|0|||
129144019|NCT00112385|464822802|FG001|Overall Study|Withdrawal by Subject|1|||
129144020|NCT03648372|464822814|FG000|Overall Study|Withdrawal by Subject|2|||
129144021|NCT03648372|464822815|FG001|Overall Study|Withdrawal by Subject|0|||
129144022|NCT03648372|464822816|FG002|Overall Study|Withdrawal by Subject|0|||
129086799|NCT00090220|464607818|FG001|Extension 1 (EXT1)|Moved|0|||
129086800|NCT00090220|464607819|FG002|Extension 1 (EXT1)|Moved|2|||
129086801|NCT00090220|464607820|FG003|Extension 1 (EXT1)|Moved|1|||
129086802|NCT00090220|464607821|FG004|Extension 1 (EXT1)|Moved|0|||
129086803|NCT00090220|464607822|FG005|Extension 1 (EXT1)|Moved|0|||
129086804|NCT00090220|464607817|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129086805|NCT00090220|464607818|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129086806|NCT00090220|464607819|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
129144023|NCT03648372|464822817|FG003|Overall Study|Withdrawal by Subject|0|||
129086807|NCT00090220|464607820|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129086808|NCT00090220|464607821|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129086809|NCT00090220|464607822|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129086810|NCT00090220|464607817|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
129144024|NCT03648372|464822818|FG004|Overall Study|Withdrawal by Subject|0|||
129086811|NCT00090220|464607818|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
129086812|NCT00090220|464607819|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
129086813|NCT00090220|464607820|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
129086814|NCT00090220|464607821|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
129086815|NCT00090220|464607822|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
129086816|NCT00090220|464607817|FG000|Extension 1 (EXT1)|Other reason|0|||
129086817|NCT00090220|464607818|FG001|Extension 1 (EXT1)|Other reason|0|||
129086818|NCT00090220|464607819|FG002|Extension 1 (EXT1)|Other reason|2|||
129086819|NCT00090220|464607820|FG003|Extension 1 (EXT1)|Other reason|0|||
129086820|NCT00090220|464607821|FG004|Extension 1 (EXT1)|Other reason|0|||
129086821|NCT00090220|464607822|FG005|Extension 1 (EXT1)|Other reason|0|||
129086822|NCT00090220|464607817|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129086823|NCT00090220|464607818|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129086824|NCT00090220|464607819|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129086825|NCT00090220|464607820|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129086826|NCT00090220|464607821|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
129086827|NCT00090220|464607822|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
129086828|NCT00090220|464607817|FG000|Long-term Follow-up (EXT2)|Death|0|||
129086829|NCT00090220|464607818|FG001|Long-term Follow-up (EXT2)|Death|0|||
129086830|NCT00090220|464607819|FG002|Long-term Follow-up (EXT2)|Death|0|||
129086831|NCT00090220|464607820|FG003|Long-term Follow-up (EXT2)|Death|0|||
129086832|NCT00090220|464607821|FG004|Long-term Follow-up (EXT2)|Death|1|||
129086833|NCT00090220|464607822|FG005|Long-term Follow-up (EXT2)|Death|1|||
129086834|NCT00090220|464607817|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129086835|NCT00090220|464607818|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129086836|NCT00090220|464607819|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129086837|NCT00090220|464607820|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129086838|NCT00090220|464607821|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
129086839|NCT00090220|464607822|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
129086840|NCT00090220|464607817|FG000|Long-term Follow-up (EXT2)|Other|0|||
129086841|NCT00090220|464607818|FG001|Long-term Follow-up (EXT2)|Other|0|||
129086842|NCT00090220|464607819|FG002|Long-term Follow-up (EXT2)|Other|0|||
129086843|NCT00090220|464607820|FG003|Long-term Follow-up (EXT2)|Other|0|||
129086844|NCT00090220|464607821|FG004|Long-term Follow-up (EXT2)|Other|1|||
129086845|NCT00090220|464607822|FG005|Long-term Follow-up (EXT2)|Other|0|||
129086846|NCT00941863|464607823|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
129086847|NCT00941863|464607824|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
129086848|NCT00941863|464607825|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
129086849|NCT00941863|464607826|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
129086850|NCT00941863|464607827|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
129086851|NCT00941863|464607823|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
129086852|NCT00941863|464607824|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
129086853|NCT00941863|464607825|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
129086854|NCT00941863|464607826|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
129086855|NCT00941863|464607827|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
129144025|NCT03648372|464822819|FG005|Overall Study|Withdrawal by Subject|1|||
129144026|NCT03648372|464822820|FG006|Overall Study|Withdrawal by Subject|2|||
129144027|NCT03648372|464822821|FG007|Overall Study|Withdrawal by Subject|0|||
129144028|NCT03648372|464822822|FG008|Overall Study|Withdrawal by Subject|0|||
129144029|NCT03648372|464822823|FG009|Overall Study|Withdrawal by Subject|0|||
129144030|NCT03648372|464822824|FG010|Overall Study|Withdrawal by Subject|2|||
129086856|NCT00941863|464607823|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
129086857|NCT00941863|464607824|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
129086858|NCT00941863|464607825|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
129086859|NCT00941863|464607826|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
129086860|NCT00941863|464607827|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
129086861|NCT00941863|464607823|FG000|Until Primary Completion Date (PCD)|Death|0|||
129086862|NCT00941863|464607824|FG001|Until Primary Completion Date (PCD)|Death|0|||
129144031|NCT03648372|464822825|FG011|Overall Study|Withdrawal by Subject|0|||
129144032|NCT03648372|464822826|FG012|Overall Study|Withdrawal by Subject|2|||
129144033|NCT03648372|464822827|FG013|Overall Study|Withdrawal by Subject|0|||
129086863|NCT00941863|464607825|FG002|Until Primary Completion Date (PCD)|Death|1|||
129086864|NCT00941863|464607826|FG003|Until Primary Completion Date (PCD)|Death|2|||
129086865|NCT00941863|464607827|FG004|Until Primary Completion Date (PCD)|Death|7|||
129086866|NCT00941863|464607823|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
129086867|NCT00941863|464607824|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
129086868|NCT00941863|464607825|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
129144034|NCT03648372|464822828|FG014|Overall Study|Withdrawal by Subject|0|||
128776574|NCT00224133|463471966|FG000|Overall Study|Protocol Violation|6|||
129086869|NCT00941863|464607826|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
129086870|NCT00941863|464607827|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
129086871|NCT00941863|464607823|FG000|Continued After PCD|Withdrawal by Subject|0|||
129086872|NCT00941863|464607824|FG001|Continued After PCD|Withdrawal by Subject|0|||
129086873|NCT00941863|464607825|FG002|Continued After PCD|Withdrawal by Subject|0|||
129086874|NCT00941863|464607826|FG003|Continued After PCD|Withdrawal by Subject|0|||
129086875|NCT00941863|464607827|FG004|Continued After PCD|Withdrawal by Subject|1|||
129086876|NCT00941863|464607823|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
129086877|NCT00941863|464607824|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
129086878|NCT00941863|464607825|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
129086879|NCT00941863|464607826|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
129086880|NCT00941863|464607827|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
129086881|NCT02137850|464607828|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
129086882|NCT02137850|464607829|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
129086883|NCT02137850|464607830|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
129086884|NCT02137850|464607828|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
129086885|NCT02137850|464607829|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
129086886|NCT02137850|464607830|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
129086887|NCT02137850|464607828|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
129086888|NCT02137850|464607829|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
129086889|NCT02137850|464607830|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
129086890|NCT02137850|464607828|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
129086891|NCT02137850|464607829|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
129086892|NCT02137850|464607830|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
129086893|NCT02137850|464607828|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
129086894|NCT02137850|464607829|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
129086895|NCT02137850|464607830|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
129086896|NCT02137850|464607828|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
129086897|NCT02137850|464607829|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
129086898|NCT02137850|464607830|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
129086899|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129086900|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
129086901|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129086902|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
129086903|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
129086904|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
129086905|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
129086906|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
129086907|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
129086908|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
129086909|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
129086910|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
129086911|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Other|0|||
129086912|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Other|1|||
129086913|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Other|0|||
129086914|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
129086915|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
129086916|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
129086917|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Early site closure|0|||
129086918|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Early site closure|2|||
129086919|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Early site closure|0|||
129086920|NCT02137850|464607828|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
129086921|NCT02137850|464607829|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
129086922|NCT02137850|464607830|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
129086923|NCT02137850|464607828|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
129086924|NCT02137850|464607829|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
129086925|NCT02137850|464607830|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
129086926|NCT02137850|464607828|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
129086927|NCT02137850|464607829|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
129086928|NCT02137850|464607830|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
129086929|NCT02137850|464607828|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
129086930|NCT02137850|464607829|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
129086931|NCT02137850|464607830|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
129086932|NCT02137850|464607828|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
129086933|NCT02137850|464607829|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
129086934|NCT02137850|464607830|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
129086935|NCT02137850|464607828|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
129086936|NCT02137850|464607829|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
129086937|NCT02137850|464607830|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
129086938|NCT02137850|464607828|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129086939|NCT02137850|464607829|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
129086940|NCT02137850|464607830|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129086941|NCT02137850|464607828|FG000|Extension Phase: Prophylaxis|Other|0|||
129086942|NCT02137850|464607829|FG001|Extension Phase: Prophylaxis|Other|1|||
129086943|NCT02137850|464607830|FG002|Extension Phase: Prophylaxis|Other|0|||
129086944|NCT02137850|464607828|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
129086945|NCT02137850|464607829|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
129086946|NCT02137850|464607830|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
129086947|NCT00537316|464607831|FG000|Part 1|Adverse Event|7|||
129086948|NCT00537316|464607832|FG001|Part 1|Adverse Event|11|||
129086949|NCT00537316|464607833|FG002|Part 1|Adverse Event|8|||
129086950|NCT00537316|464607834|FG003|Part 1|Adverse Event|0|||
129086951|NCT00537316|464607835|FG004|Part 1|Adverse Event|0|||
129086952|NCT00537316|464607836|FG005|Part 1|Adverse Event|0|||
129086953|NCT00537316|464607837|FG006|Part 1|Adverse Event|0|||
129086954|NCT00537316|464607831|FG000|Part 1|Protocol defined clinical event|1|||
129086955|NCT00537316|464607832|FG001|Part 1|Protocol defined clinical event|0|||
129086956|NCT00537316|464607833|FG002|Part 1|Protocol defined clinical event|0|||
129086957|NCT00537316|464607834|FG003|Part 1|Protocol defined clinical event|0|||
129086958|NCT00537316|464607835|FG004|Part 1|Protocol defined clinical event|0|||
129086959|NCT00537316|464607836|FG005|Part 1|Protocol defined clinical event|0|||
129086960|NCT00537316|464607837|FG006|Part 1|Protocol defined clinical event|0|||
129086961|NCT00537316|464607831|FG000|Part 1|Lost to Follow-up|1|||
129086962|NCT00537316|464607832|FG001|Part 1|Lost to Follow-up|0|||
129086963|NCT00537316|464607833|FG002|Part 1|Lost to Follow-up|0|||
129086964|NCT00537316|464607834|FG003|Part 1|Lost to Follow-up|0|||
129086965|NCT00537316|464607835|FG004|Part 1|Lost to Follow-up|0|||
129086966|NCT00537316|464607836|FG005|Part 1|Lost to Follow-up|0|||
129086967|NCT00537316|464607837|FG006|Part 1|Lost to Follow-up|0|||
129086968|NCT00537316|464607831|FG000|Part 1|Withdrawal by Subject|3|||
129086969|NCT00537316|464607832|FG001|Part 1|Withdrawal by Subject|8|||
129086970|NCT00537316|464607833|FG002|Part 1|Withdrawal by Subject|4|||
129086971|NCT00537316|464607834|FG003|Part 1|Withdrawal by Subject|0|||
129086972|NCT00537316|464607835|FG004|Part 1|Withdrawal by Subject|0|||
129086973|NCT00537316|464607836|FG005|Part 1|Withdrawal by Subject|0|||
129086974|NCT00537316|464607837|FG006|Part 1|Withdrawal by Subject|0|||
129144035|NCT03648372|464822829|FG015|Overall Study|Withdrawal by Subject|0|||
129144036|NCT03648372|464822830|FG016|Overall Study|Withdrawal by Subject|1|||
129144037|NCT03648372|464822831|FG017|Overall Study|Withdrawal by Subject|0|||
129144038|NCT03648372|464822832|FG018|Overall Study|Withdrawal by Subject|0|||
129144039|NCT03648372|464822833|FG019|Overall Study|Withdrawal by Subject|0|||
129144040|NCT03648372|464822834|FG020|Overall Study|Withdrawal by Subject|0|||
129144041|NCT03648372|464822814|FG000|Overall Study|Progressive Disease|2|||
129144042|NCT03648372|464822815|FG001|Overall Study|Progressive Disease|3|||
129144043|NCT03648372|464822816|FG002|Overall Study|Progressive Disease|4|||
129144044|NCT03648372|464822817|FG003|Overall Study|Progressive Disease|3|||
128724387|NCT03131440|463289085|FG029|Overall Study|Withdrawal by Subject|0|||
128724388|NCT03131440|463289086|FG030|Overall Study|Withdrawal by Subject|1|||
129086975|NCT00537316|464607831|FG000|Part 1|Protocol Violation|1|||
129086976|NCT00537316|464607832|FG001|Part 1|Protocol Violation|5|||
129086977|NCT00537316|464607833|FG002|Part 1|Protocol Violation|1|||
129144045|NCT03648372|464822818|FG004|Overall Study|Progressive Disease|2|||
129144046|NCT03648372|464822819|FG005|Overall Study|Progressive Disease|2|||
129144047|NCT03648372|464822820|FG006|Overall Study|Progressive Disease|3|||
128724389|NCT03131440|463289087|FG031|Overall Study|Withdrawal by Subject|0|||
129086978|NCT00537316|464607834|FG003|Part 1|Protocol Violation|0|||
129086979|NCT00537316|464607835|FG004|Part 1|Protocol Violation|0|||
129086980|NCT00537316|464607836|FG005|Part 1|Protocol Violation|0|||
129086981|NCT00537316|464607837|FG006|Part 1|Protocol Violation|0|||
129086982|NCT00537316|464607831|FG000|Part 1|Did not meet protocol eligibility|1|||
129086983|NCT00537316|464607832|FG001|Part 1|Did not meet protocol eligibility|3|||
129086984|NCT00537316|464607833|FG002|Part 1|Did not meet protocol eligibility|2|||
129144048|NCT03648372|464822821|FG007|Overall Study|Progressive Disease|3|||
129144049|NCT03648372|464822822|FG008|Overall Study|Progressive Disease|5|||
129144050|NCT03648372|464822823|FG009|Overall Study|Progressive Disease|5|||
129144051|NCT03648372|464822824|FG010|Overall Study|Progressive Disease|2|||
128724390|NCT03131440|463289056|FG000|Overall Study|Lost to Follow-up|0|||
128724391|NCT03131440|463289057|FG001|Overall Study|Lost to Follow-up|0|||
128724392|NCT03131440|463289058|FG002|Overall Study|Lost to Follow-up|0|||
128724393|NCT03131440|463289059|FG003|Overall Study|Lost to Follow-up|0|||
128724394|NCT03131440|463289060|FG004|Overall Study|Lost to Follow-up|0|||
128724395|NCT03131440|463289061|FG005|Overall Study|Lost to Follow-up|1|||
128724396|NCT03131440|463289062|FG006|Overall Study|Lost to Follow-up|0|||
128724397|NCT03131440|463289063|FG007|Overall Study|Lost to Follow-up|0|||
128724398|NCT03131440|463289064|FG008|Overall Study|Lost to Follow-up|0|||
128724399|NCT03131440|463289065|FG009|Overall Study|Lost to Follow-up|0|||
128724400|NCT03131440|463289066|FG010|Overall Study|Lost to Follow-up|0|||
128724401|NCT03131440|463289067|FG011|Overall Study|Lost to Follow-up|0|||
128724402|NCT03131440|463289068|FG012|Overall Study|Lost to Follow-up|0|||
129086985|NCT00537316|464607834|FG003|Part 1|Did not meet protocol eligibility|0|||
129086986|NCT00537316|464607835|FG004|Part 1|Did not meet protocol eligibility|0|||
129086987|NCT00537316|464607836|FG005|Part 1|Did not meet protocol eligibility|0|||
129086988|NCT00537316|464607837|FG006|Part 1|Did not meet protocol eligibility|0|||
128724403|NCT03131440|463289069|FG013|Overall Study|Lost to Follow-up|0|||
128724404|NCT03131440|463289070|FG014|Overall Study|Lost to Follow-up|0|||
128724405|NCT03131440|463289071|FG015|Overall Study|Lost to Follow-up|0|||
128724406|NCT03131440|463289072|FG016|Overall Study|Lost to Follow-up|0|||
129086989|NCT00537316|464607831|FG000|Part 1|Administrative|0|||
129086990|NCT00537316|464607832|FG001|Part 1|Administrative|0|||
129086991|NCT00537316|464607833|FG002|Part 1|Administrative|2|||
129086992|NCT00537316|464607834|FG003|Part 1|Administrative|0|||
129086993|NCT00537316|464607835|FG004|Part 1|Administrative|0|||
129086994|NCT00537316|464607836|FG005|Part 1|Administrative|0|||
129086995|NCT00537316|464607837|FG006|Part 1|Administrative|0|||
129086996|NCT00537316|464607831|FG000|Part 2|Never entered follow-up|0|||
129086997|NCT00537316|464607832|FG001|Part 2|Never entered follow-up|0|||
128724407|NCT03131440|463289073|FG017|Overall Study|Lost to Follow-up|0|||
129086998|NCT00537316|464607833|FG002|Part 2|Never entered follow-up|0|||
129086999|NCT00537316|464607834|FG003|Part 2|Never entered follow-up|0|||
129087000|NCT00537316|464607835|FG004|Part 2|Never entered follow-up|0|||
129087001|NCT00537316|464607836|FG005|Part 2|Never entered follow-up|0|||
129087002|NCT00537316|464607837|FG006|Part 2|Never entered follow-up|1|||
129087003|NCT00537316|464607831|FG000|Part 2|Adverse Event|4|||
129087004|NCT00537316|464607832|FG001|Part 2|Adverse Event|0|||
129087005|NCT00537316|464607833|FG002|Part 2|Adverse Event|2|||
129087006|NCT00537316|464607834|FG003|Part 2|Adverse Event|0|||
129087007|NCT00537316|464607835|FG004|Part 2|Adverse Event|0|||
129087008|NCT00537316|464607836|FG005|Part 2|Adverse Event|0|||
129087009|NCT00537316|464607837|FG006|Part 2|Adverse Event|0|||
129087010|NCT00537316|464607831|FG000|Part 2|Lost to Follow-up|1|||
128724408|NCT03131440|463289074|FG018|Overall Study|Lost to Follow-up|0|||
128724409|NCT03131440|463289075|FG019|Overall Study|Lost to Follow-up|2|||
128724410|NCT03131440|463289076|FG020|Overall Study|Lost to Follow-up|1|||
128724411|NCT03131440|463289077|FG021|Overall Study|Lost to Follow-up|0|||
128724412|NCT03131440|463289078|FG022|Overall Study|Lost to Follow-up|1|||
129087011|NCT00537316|464607832|FG001|Part 2|Lost to Follow-up|0|||
128724413|NCT03131440|463289079|FG023|Overall Study|Lost to Follow-up|0|||
129087012|NCT00537316|464607833|FG002|Part 2|Lost to Follow-up|2|||
129087013|NCT00537316|464607834|FG003|Part 2|Lost to Follow-up|0|||
129087014|NCT00537316|464607835|FG004|Part 2|Lost to Follow-up|0|||
129087015|NCT00537316|464607836|FG005|Part 2|Lost to Follow-up|0|||
129144052|NCT03648372|464822825|FG011|Overall Study|Progressive Disease|3|||
129144053|NCT03648372|464822826|FG012|Overall Study|Progressive Disease|3|||
129144054|NCT03648372|464822827|FG013|Overall Study|Progressive Disease|3|||
129144055|NCT03648372|464822828|FG014|Overall Study|Progressive Disease|6|||
129144056|NCT03648372|464822829|FG015|Overall Study|Progressive Disease|0|||
129144057|NCT03648372|464822830|FG016|Overall Study|Progressive Disease|0|||
129144058|NCT03648372|464822831|FG017|Overall Study|Progressive Disease|0|||
129144059|NCT03648372|464822832|FG018|Overall Study|Progressive Disease|0|||
129144060|NCT03648372|464822833|FG019|Overall Study|Progressive Disease|0|||
129144061|NCT03648372|464822834|FG020|Overall Study|Progressive Disease|0|||
129144062|NCT03648372|464822814|FG000|Overall Study|Other|0|||
129144063|NCT03648372|464822815|FG001|Overall Study|Other|0|||
129144064|NCT03648372|464822816|FG002|Overall Study|Other|0|||
129144065|NCT03648372|464822817|FG003|Overall Study|Other|0|||
129144066|NCT03648372|464822818|FG004|Overall Study|Other|1|||
129144067|NCT03648372|464822819|FG005|Overall Study|Other|0|||
129144068|NCT03648372|464822820|FG006|Overall Study|Other|0|||
129144069|NCT03648372|464822821|FG007|Overall Study|Other|0|||
129144070|NCT03648372|464822822|FG008|Overall Study|Other|0|||
129144071|NCT03648372|464822823|FG009|Overall Study|Other|0|||
128724414|NCT03131440|463289080|FG024|Overall Study|Lost to Follow-up|1|||
128724415|NCT03131440|463289081|FG025|Overall Study|Lost to Follow-up|0|||
129087016|NCT00537316|464607837|FG006|Part 2|Lost to Follow-up|0|||
129087017|NCT00537316|464607831|FG000|Part 2|Withdrawal by Subject|5|||
129087018|NCT00537316|464607832|FG001|Part 2|Withdrawal by Subject|1|||
129087019|NCT00537316|464607833|FG002|Part 2|Withdrawal by Subject|4|||
129087020|NCT00537316|464607834|FG003|Part 2|Withdrawal by Subject|0|||
129144072|NCT03648372|464822824|FG010|Overall Study|Other|1|||
129144073|NCT03648372|464822825|FG011|Overall Study|Other|2|||
129087021|NCT00537316|464607835|FG004|Part 2|Withdrawal by Subject|0|||
129087022|NCT00537316|464607836|FG005|Part 2|Withdrawal by Subject|0|||
129087023|NCT00537316|464607837|FG006|Part 2|Withdrawal by Subject|0|||
129087024|NCT00537316|464607831|FG000|Part 2|Administrative|16|||
129087025|NCT00537316|464607832|FG001|Part 2|Administrative|8|||
129087026|NCT00537316|464607833|FG002|Part 2|Administrative|24|||
129087027|NCT00537316|464607834|FG003|Part 2|Administrative|3|||
129087028|NCT00537316|464607835|FG004|Part 2|Administrative|1|||
129087029|NCT00537316|464607836|FG005|Part 2|Administrative|4|||
129087030|NCT00537316|464607837|FG006|Part 2|Administrative|1|||
129087031|NCT04533412|464607838|FG000|Overall Study|Withdrawal by Subject|1|||
129087032|NCT04533412|464607839|FG001|Overall Study|Withdrawal by Subject|1|||
129087033|NCT04533412|464607838|FG000|Overall Study|Lost to Follow-up|1|||
129087034|NCT04533412|464607839|FG001|Overall Study|Lost to Follow-up|4|||
129087035|NCT05113979|464607843|FG000|Overall Study|Death|2|||
129087036|NCT05113979|464607843|FG000|Overall Study|Lost to Follow-up|1|||
129087037|NCT00968981|464607846|FG000|Overall Study|Adverse Event|2|||
129087038|NCT00968981|464607847|FG001|Overall Study|Adverse Event|0|||
129087039|NCT00968981|464607848|FG002|Overall Study|Adverse Event|0|||
129087040|NCT00968981|464607846|FG000|Overall Study|Disease Progression|14|||
129087041|NCT00968981|464607847|FG001|Overall Study|Disease Progression|16|||
129087042|NCT00968981|464607848|FG002|Overall Study|Disease Progression|13|||
129087043|NCT00968981|464607846|FG000|Overall Study|Lost to Follow-up|0|||
129087044|NCT00968981|464607847|FG001|Overall Study|Lost to Follow-up|0|||
129087045|NCT00968981|464607848|FG002|Overall Study|Lost to Follow-up|1|||
129087046|NCT00968981|464607846|FG000|Overall Study|Physician Decision|5|||
129087047|NCT00968981|464607847|FG001|Overall Study|Physician Decision|3|||
129087048|NCT00968981|464607848|FG002|Overall Study|Physician Decision|5|||
129087049|NCT00968981|464607846|FG000|Overall Study|Withdrawal by Subject|1|||
129087050|NCT00968981|464607847|FG001|Overall Study|Withdrawal by Subject|3|||
129087051|NCT00968981|464607848|FG002|Overall Study|Withdrawal by Subject|3|||
129087052|NCT01489254|464607851|FG000|Double-blind Part|Adverse Event|7|||
129087053|NCT01489254|464607852|FG001|Double-blind Part|Adverse Event|2|||
129087054|NCT01489254|464607853|FG002|Double-blind Part|Adverse Event|2|||
129087055|NCT01489254|464607854|FG003|Double-blind Part|Adverse Event|0|||
129087056|NCT01489254|464607851|FG000|Double-blind Part|Pregnancy|1|||
129087057|NCT01489254|464607852|FG001|Double-blind Part|Pregnancy|3|||
129087058|NCT01489254|464607853|FG002|Double-blind Part|Pregnancy|0|||
129087059|NCT01489254|464607854|FG003|Double-blind Part|Pregnancy|0|||
129087060|NCT01489254|464607851|FG000|Double-blind Part|Withdrawal by Subject|12|||
129087061|NCT01489254|464607852|FG001|Double-blind Part|Withdrawal by Subject|20|||
129087062|NCT01489254|464607853|FG002|Double-blind Part|Withdrawal by Subject|1|||
129087063|NCT01489254|464607854|FG003|Double-blind Part|Withdrawal by Subject|0|||
129087064|NCT01489254|464607851|FG000|Double-blind Part|Lost to Follow-up|1|||
129087065|NCT01489254|464607852|FG001|Double-blind Part|Lost to Follow-up|2|||
129087066|NCT01489254|464607853|FG002|Double-blind Part|Lost to Follow-up|0|||
129087067|NCT01489254|464607854|FG003|Double-blind Part|Lost to Follow-up|0|||
129087068|NCT01489254|464607851|FG000|Double-blind Part|Other reasons for not completing study|4|||
129087069|NCT01489254|464607852|FG001|Double-blind Part|Other reasons for not completing study|6|||
129087070|NCT01489254|464607853|FG002|Double-blind Part|Other reasons for not completing study|0|||
129087071|NCT01489254|464607854|FG003|Double-blind Part|Other reasons for not completing study|0|||
129087072|NCT01489254|464607851|FG000|Open-label Extension Part|Adverse Event|0|||
129087073|NCT01489254|464607852|FG001|Open-label Extension Part|Adverse Event|0|||
129087074|NCT01489254|464607853|FG002|Open-label Extension Part|Adverse Event|0|||
129087075|NCT01489254|464607854|FG003|Open-label Extension Part|Adverse Event|10|||
129087076|NCT01489254|464607851|FG000|Open-label Extension Part|Pregnancy|0|||
129087077|NCT01489254|464607852|FG001|Open-label Extension Part|Pregnancy|0|||
129087078|NCT01489254|464607853|FG002|Open-label Extension Part|Pregnancy|0|||
129087079|NCT01489254|464607854|FG003|Open-label Extension Part|Pregnancy|3|||
129087080|NCT01489254|464607851|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
129087081|NCT01489254|464607852|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
129087082|NCT01489254|464607853|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
129087083|NCT01489254|464607854|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
129087084|NCT01489254|464607851|FG000|Open-label Extension Part|Protocol Violation|0|||
129087085|NCT01489254|464607852|FG001|Open-label Extension Part|Protocol Violation|0|||
129087086|NCT01489254|464607853|FG002|Open-label Extension Part|Protocol Violation|0|||
129087087|NCT01489254|464607854|FG003|Open-label Extension Part|Protocol Violation|1|||
128724416|NCT03131440|463289082|FG026|Overall Study|Lost to Follow-up|0|||
129087088|NCT01489254|464607851|FG000|Open-label Extension Part|Lost to Follow-up|0|||
129087089|NCT01489254|464607852|FG001|Open-label Extension Part|Lost to Follow-up|0|||
129087090|NCT01489254|464607853|FG002|Open-label Extension Part|Lost to Follow-up|0|||
129087091|NCT01489254|464607854|FG003|Open-label Extension Part|Lost to Follow-up|9|||
129087092|NCT01489254|464607851|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
129087093|NCT01489254|464607852|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
129087094|NCT01489254|464607853|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
129087095|NCT01489254|464607854|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
129087096|NCT01609543|464607860|FG000|Overall Study|Disease Progression|28|||
129087097|NCT01609543|464607860|FG000|Overall Study|Adverse Event|5|||
129087098|NCT01609543|464607860|FG000|Overall Study|Withdrawal by Subject|1|||
129087099|NCT01609543|464607860|FG000|Overall Study|Protocol Violation|1|||
129087100|NCT01609543|464607860|FG000|Overall Study|Death|7|||
129087101|NCT00507819|464607861|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
129087102|NCT00507819|464607862|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
129087103|NCT03452488|464607863|FG000|Overall Study|Adverse Event|4|||
129087104|NCT03452488|464607864|FG001|Overall Study|Adverse Event|6|||
129087105|NCT03452488|464607865|FG002|Overall Study|Adverse Event|1|||
129087106|NCT03452488|464607863|FG000|Overall Study|Death|0|||
129087107|NCT03452488|464607864|FG001|Overall Study|Death|0|||
129087108|NCT03452488|464607865|FG002|Overall Study|Death|1|||
129087109|NCT03452488|464607863|FG000|Overall Study|Lost to Follow-up|1|||
129087110|NCT03452488|464607864|FG001|Overall Study|Lost to Follow-up|2|||
129144074|NCT03648372|464822826|FG012|Overall Study|Other|1|||
129144075|NCT03648372|464822827|FG013|Overall Study|Other|3|||
129144076|NCT03648372|464822828|FG014|Overall Study|Other|0|||
129144077|NCT03648372|464822829|FG015|Overall Study|Other|5|||
129144078|NCT03648372|464822830|FG016|Overall Study|Other|1|||
129144079|NCT03648372|464822831|FG017|Overall Study|Other|5|||
129144080|NCT03648372|464822832|FG018|Overall Study|Other|0|||
129144081|NCT03648372|464822833|FG019|Overall Study|Other|1|||
129144082|NCT03648372|464822834|FG020|Overall Study|Other|0|||
129144083|NCT03648372|464822814|FG000|Overall Study|Lost to Follow-up|0|||
129144084|NCT03648372|464822815|FG001|Overall Study|Lost to Follow-up|0|||
129144085|NCT03648372|464822816|FG002|Overall Study|Lost to Follow-up|0|||
129144086|NCT03648372|464822817|FG003|Overall Study|Lost to Follow-up|0|||
129144087|NCT03648372|464822818|FG004|Overall Study|Lost to Follow-up|0|||
129144088|NCT03648372|464822819|FG005|Overall Study|Lost to Follow-up|0|||
129144089|NCT03648372|464822820|FG006|Overall Study|Lost to Follow-up|0|||
129144090|NCT03648372|464822821|FG007|Overall Study|Lost to Follow-up|0|||
129144091|NCT03648372|464822822|FG008|Overall Study|Lost to Follow-up|0|||
129144092|NCT03648372|464822823|FG009|Overall Study|Lost to Follow-up|0|||
129144093|NCT03648372|464822824|FG010|Overall Study|Lost to Follow-up|0|||
129144094|NCT03648372|464822825|FG011|Overall Study|Lost to Follow-up|0|||
129144095|NCT03648372|464822826|FG012|Overall Study|Lost to Follow-up|0|||
129144096|NCT03648372|464822827|FG013|Overall Study|Lost to Follow-up|1|||
129144097|NCT03648372|464822828|FG014|Overall Study|Lost to Follow-up|0|||
129144098|NCT03648372|464822829|FG015|Overall Study|Lost to Follow-up|1|||
129144099|NCT03648372|464822830|FG016|Overall Study|Lost to Follow-up|0|||
129144100|NCT03648372|464822831|FG017|Overall Study|Lost to Follow-up|1|||
129144101|NCT03648372|464822832|FG018|Overall Study|Lost to Follow-up|0|||
129144102|NCT03648372|464822833|FG019|Overall Study|Lost to Follow-up|0|||
129144103|NCT03648372|464822834|FG020|Overall Study|Lost to Follow-up|0|||
129144104|NCT03648372|464822814|FG000|Overall Study|Start of a New Systemic Treatment|0|||
129144105|NCT03648372|464822815|FG001|Overall Study|Start of a New Systemic Treatment|0|||
129144106|NCT03648372|464822816|FG002|Overall Study|Start of a New Systemic Treatment|0|||
129144107|NCT03648372|464822817|FG003|Overall Study|Start of a New Systemic Treatment|0|||
129144108|NCT03648372|464822818|FG004|Overall Study|Start of a New Systemic Treatment|0|||
129144109|NCT03648372|464822819|FG005|Overall Study|Start of a New Systemic Treatment|0|||
129144110|NCT03648372|464822820|FG006|Overall Study|Start of a New Systemic Treatment|0|||
129144111|NCT03648372|464822821|FG007|Overall Study|Start of a New Systemic Treatment|2|||
129144112|NCT03648372|464822822|FG008|Overall Study|Start of a New Systemic Treatment|0|||
129144113|NCT03648372|464822823|FG009|Overall Study|Start of a New Systemic Treatment|0|||
129144114|NCT03648372|464822824|FG010|Overall Study|Start of a New Systemic Treatment|1|||
129144115|NCT03648372|464822825|FG011|Overall Study|Start of a New Systemic Treatment|0|||
129144116|NCT03648372|464822826|FG012|Overall Study|Start of a New Systemic Treatment|0|||
129144117|NCT03648372|464822827|FG013|Overall Study|Start of a New Systemic Treatment|0|||
129087111|NCT03452488|464607865|FG002|Overall Study|Lost to Follow-up|0|||
129087112|NCT03452488|464607863|FG000|Overall Study|PI Decision|1|||
129144118|NCT03648372|464822828|FG014|Overall Study|Start of a New Systemic Treatment|0|||
129144119|NCT03648372|464822829|FG015|Overall Study|Start of a New Systemic Treatment|0|||
129144120|NCT03648372|464822830|FG016|Overall Study|Start of a New Systemic Treatment|0|||
128776575|NCT00224133|463471966|FG000|Overall Study|Withdrawal by Subject|33|||
129144121|NCT03648372|464822831|FG017|Overall Study|Start of a New Systemic Treatment|0|||
129144122|NCT03648372|464822832|FG018|Overall Study|Start of a New Systemic Treatment|0|||
129144123|NCT03648372|464822833|FG019|Overall Study|Start of a New Systemic Treatment|0|||
128776576|NCT00224133|463471966|FG000|Overall Study|Lack of Efficacy|58|||
129144124|NCT03648372|464822834|FG020|Overall Study|Start of a New Systemic Treatment|0|||
128776577|NCT00224133|463471966|FG000|Overall Study|Lost to Follow-up|21|||
129087113|NCT03452488|464607864|FG001|Overall Study|PI Decision|0|||
129087114|NCT03452488|464607865|FG002|Overall Study|PI Decision|0|||
129144125|NCT03514134|464824410|FG000|Overall Study|Lost to Follow-up|0|||
129144126|NCT03514134|464824411|FG001|Overall Study|Lost to Follow-up|1|||
129144127|NCT02471144|464824412|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
129087115|NCT03452488|464607863|FG000|Overall Study|Withdrew consent|4|||
129087116|NCT03452488|464607864|FG001|Overall Study|Withdrew consent|2|||
129087117|NCT03452488|464607865|FG002|Overall Study|Withdrew consent|2|||
128724417|NCT03131440|463289083|FG027|Overall Study|Lost to Follow-up|2|||
128724418|NCT03131440|463289084|FG028|Overall Study|Lost to Follow-up|0|||
129087118|NCT03452488|464607863|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
129087119|NCT03452488|464607864|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
129087120|NCT03452488|464607865|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
129087121|NCT03452488|464607863|FG000|Overall Study|Other|0|||
129087122|NCT03452488|464607864|FG001|Overall Study|Other|2|||
129087123|NCT03452488|464607865|FG002|Overall Study|Other|2|||
129087124|NCT01254318|464607870|FG000|Overall Study|Lost to Follow-up|5|||
129144128|NCT02471144|464824413|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
129144129|NCT02471144|464824414|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
129144130|NCT02471144|464824415|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
129144131|NCT02471144|464824416|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
129144132|NCT02471144|464824417|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
129144133|NCT02471144|464824418|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
129144134|NCT02471144|464824419|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
129144135|NCT02471144|464824420|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
129144136|NCT02471144|464824421|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
129144137|NCT02471144|464824422|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
129144138|NCT02471144|464824412|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144139|NCT02471144|464824413|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144140|NCT02471144|464824414|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144141|NCT02471144|464824415|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
129144142|NCT02471144|464824416|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144143|NCT02471144|464824417|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144144|NCT02471144|464824418|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144145|NCT02471144|464824419|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144146|NCT02471144|464824420|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144147|NCT02471144|464824421|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144148|NCT02471144|464824422|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129144149|NCT02471144|464824412|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144150|NCT02471144|464824413|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144151|NCT02471144|464824414|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
129144152|NCT02471144|464824415|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144153|NCT02471144|464824416|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144154|NCT02471144|464824417|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144155|NCT02471144|464824418|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
128724419|NCT03131440|463289085|FG029|Overall Study|Lost to Follow-up|2|||
128724420|NCT03131440|463289086|FG030|Overall Study|Lost to Follow-up|0|||
128724421|NCT03131440|463289087|FG031|Overall Study|Lost to Follow-up|0|||
128724422|NCT03131440|463289056|FG000|Overall Study|Death|0|||
128724423|NCT03131440|463289057|FG001|Overall Study|Death|0|||
128724424|NCT03131440|463289058|FG002|Overall Study|Death|0|||
128724425|NCT03131440|463289059|FG003|Overall Study|Death|0|||
128724426|NCT03131440|463289060|FG004|Overall Study|Death|0|||
128724427|NCT03131440|463289061|FG005|Overall Study|Death|0|||
128724428|NCT03131440|463289062|FG006|Overall Study|Death|0|||
128724429|NCT03131440|463289063|FG007|Overall Study|Death|0|||
128724430|NCT03131440|463289064|FG008|Overall Study|Death|0|||
128724431|NCT03131440|463289065|FG009|Overall Study|Death|0|||
128724432|NCT03131440|463289066|FG010|Overall Study|Death|0|||
128724433|NCT03131440|463289067|FG011|Overall Study|Death|0|||
128724434|NCT03131440|463289068|FG012|Overall Study|Death|0|||
128724435|NCT03131440|463289069|FG013|Overall Study|Death|0|||
129087125|NCT01254318|464607870|FG000|Overall Study|Death|47|||
129087126|NCT00330343|464607875|FG000|Overall Study|Lost to Follow-up|5|||
129087127|NCT01992653|464607876|FG000|Overall Study|Death|0|||
129087128|NCT01992653|464607877|FG001|Overall Study|Death|0|||
129144156|NCT02471144|464824419|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144157|NCT02471144|464824420|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144158|NCT02471144|464824421|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129144159|NCT02471144|464824422|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129087129|NCT01992653|464607878|FG002|Overall Study|Death|1|||
129087130|NCT01992653|464607879|FG003|Overall Study|Death|0|||
129144160|NCT02471144|464824412|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
129144161|NCT02471144|464824413|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
129144162|NCT02471144|464824414|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144163|NCT02471144|464824415|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
128724436|NCT03131440|463289070|FG014|Overall Study|Death|0|||
128724437|NCT03131440|463289071|FG015|Overall Study|Death|0|||
128724438|NCT03131440|463289072|FG016|Overall Study|Death|0|||
128724439|NCT03131440|463289073|FG017|Overall Study|Death|0|||
129087131|NCT01992653|464607880|FG004|Overall Study|Death|1|||
128724440|NCT03131440|463289074|FG018|Overall Study|Death|0|||
128724441|NCT03131440|463289075|FG019|Overall Study|Death|0|||
129087132|NCT01992653|464607881|FG005|Overall Study|Death|0|||
129087133|NCT01992653|464607882|FG006|Overall Study|Death|4|||
129087134|NCT01992653|464607883|FG007|Overall Study|Death|2|||
129087135|NCT01992653|464607876|FG000|Overall Study|Lost to Follow-up|0|||
129087136|NCT01992653|464607877|FG001|Overall Study|Lost to Follow-up|0|||
128724442|NCT03131440|463289076|FG020|Overall Study|Death|0|||
128724443|NCT03131440|463289077|FG021|Overall Study|Death|0|||
128724444|NCT03131440|463289078|FG022|Overall Study|Death|0|||
128724445|NCT03131440|463289079|FG023|Overall Study|Death|0|||
128724446|NCT03131440|463289080|FG024|Overall Study|Death|0|||
128724447|NCT03131440|463289081|FG025|Overall Study|Death|1|||
129087137|NCT01992653|464607878|FG002|Overall Study|Lost to Follow-up|0|||
129087138|NCT01992653|464607879|FG003|Overall Study|Lost to Follow-up|0|||
129087139|NCT01992653|464607880|FG004|Overall Study|Lost to Follow-up|0|||
129087140|NCT01992653|464607881|FG005|Overall Study|Lost to Follow-up|0|||
129087141|NCT01992653|464607882|FG006|Overall Study|Lost to Follow-up|0|||
129087142|NCT01992653|464607883|FG007|Overall Study|Lost to Follow-up|1|||
129087143|NCT01992653|464607876|FG000|Overall Study|Study Completed|0|||
129087144|NCT01992653|464607877|FG001|Overall Study|Study Completed|0|||
129087145|NCT01992653|464607878|FG002|Overall Study|Study Completed|0|||
129087146|NCT01992653|464607879|FG003|Overall Study|Study Completed|0|||
129087147|NCT01992653|464607880|FG004|Overall Study|Study Completed|0|||
129087148|NCT01992653|464607881|FG005|Overall Study|Study Completed|0|||
129087149|NCT01992653|464607882|FG006|Overall Study|Study Completed|0|||
129144164|NCT02471144|464824416|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144165|NCT02471144|464824417|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144166|NCT02471144|464824418|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144167|NCT02471144|464824419|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144168|NCT02471144|464824420|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144169|NCT02471144|464824421|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144170|NCT02471144|464824422|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129144171|NCT02471144|464824412|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129144172|NCT02471144|464824413|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129144173|NCT02471144|464824414|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129144174|NCT02471144|464824415|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129087150|NCT01992653|464607883|FG007|Overall Study|Study Completed|1|||
128724448|NCT03131440|463289082|FG026|Overall Study|Death|0|||
129087151|NCT01992653|464607876|FG000|Overall Study|Disease Progression|0|||
129087152|NCT01992653|464607877|FG001|Overall Study|Disease Progression|0|||
129087153|NCT01992653|464607878|FG002|Overall Study|Disease Progression|0|||
129144175|NCT02471144|464824416|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
129144176|NCT02471144|464824417|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129144177|NCT02471144|464824418|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
129144178|NCT02471144|464824419|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129144179|NCT02471144|464824420|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
129144180|NCT02471144|464824421|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129087154|NCT01992653|464607879|FG003|Overall Study|Disease Progression|0|||
129087155|NCT01992653|464607880|FG004|Overall Study|Disease Progression|0|||
129087156|NCT01992653|464607881|FG005|Overall Study|Disease Progression|0|||
129087157|NCT01992653|464607882|FG006|Overall Study|Disease Progression|4|||
129087158|NCT01992653|464607883|FG007|Overall Study|Disease Progression|0|||
129087159|NCT02964208|464607886|FG000|Overall Study|Death|103|||
129087160|NCT02964208|464607886|FG000|Overall Study|Withdrawal by Subject|6|||
129087161|NCT02964208|464607886|FG000|Overall Study|Lost to Follow-up|6|||
129087162|NCT02964208|464607886|FG000|Overall Study|Unsuccessful Procedure|5|||
129087163|NCT02964208|464607886|FG000|Overall Study|Device Explant|1|||
129087164|NCT02964208|464607886|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
129087165|NCT01743560|464607887|FG000|Overall Study|Disease progression|26|||
129087166|NCT01743560|464607887|FG000|Overall Study|Adverse Event|8|||
129087167|NCT01743560|464607887|FG000|Overall Study|Death|3|||
129087168|NCT01743560|464607887|FG000|Overall Study|Withdrawal by Subject|2|||
129087169|NCT01743560|464607887|FG000|Overall Study|Protocol Violation|1|||
129087170|NCT01743560|464607887|FG000|Overall Study|>1 dose of study drug|3|||
129087171|NCT03226769|464607888|FG000|Overall Study|Withdrawal by Subject|0|||
129087172|NCT03226769|464607889|FG001|Overall Study|Withdrawal by Subject|1|||
129087173|NCT00940823|464607890|FG000|Overall Study|Death|8|||
129087174|NCT00940823|464607891|FG001|Overall Study|Death|12|||
129087175|NCT00940823|464607890|FG000|Overall Study|Lost to Follow-up|27|||
129087176|NCT00940823|464607891|FG001|Overall Study|Lost to Follow-up|20|||
129087177|NCT01758731|464607892|FG000|Overall Study|Physician Decision|1|||
129087178|NCT05270395|464607905|FG000|Overall Study|Lost to Follow-up|2|||
129087179|NCT05270395|464607906|FG001|Overall Study|Lost to Follow-up|2|||
129087180|NCT05270395|464607905|FG000|Overall Study|Death|1|||
129144181|NCT02471144|464824422|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129144182|NCT02471144|464824412|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144183|NCT02471144|464824413|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144184|NCT02471144|464824414|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144185|NCT02471144|464824415|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144186|NCT02471144|464824416|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144187|NCT02471144|464824417|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
129144188|NCT02471144|464824418|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144189|NCT02471144|464824419|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144190|NCT02471144|464824420|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
129144191|NCT02471144|464824421|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144192|NCT02471144|464824422|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129144193|NCT02471144|464824412|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144194|NCT02471144|464824413|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144195|NCT02471144|464824414|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144196|NCT02471144|464824415|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144197|NCT02471144|464824416|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144198|NCT02471144|464824417|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144199|NCT02471144|464824418|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144200|NCT02471144|464824419|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144201|NCT02471144|464824420|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
129144202|NCT02471144|464824421|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144203|NCT02471144|464824422|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129144204|NCT02471144|464824412|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129144205|NCT02471144|464824413|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129144206|NCT02471144|464824414|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129144207|NCT02471144|464824415|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129144208|NCT02471144|464824416|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129144209|NCT02471144|464824417|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
128724449|NCT03131440|463289083|FG027|Overall Study|Death|0|||
128724450|NCT03131440|463289084|FG028|Overall Study|Death|0|||
128724451|NCT03131440|463289085|FG029|Overall Study|Death|0|||
128724452|NCT03131440|463289086|FG030|Overall Study|Death|0|||
128724453|NCT03131440|463289087|FG031|Overall Study|Death|0|||
129087181|NCT05270395|464607906|FG001|Overall Study|Death|2|||
129087182|NCT05270395|464607905|FG000|Overall Study|Study Team Withdrew|1|||
129087183|NCT05270395|464607906|FG001|Overall Study|Study Team Withdrew|0|||
129087184|NCT00199797|464609937|FG000|Overall Study|Progressive Disease|1|||
129087185|NCT00199797|464609937|FG000|Overall Study|Adverse Event|1|||
129087186|NCT00199797|464609937|FG000|Overall Study|Physician Decision|1|||
129087187|NCT04250350|464609944|FG000|Overall Study|Withdrawal by Subject|13|||
129087188|NCT04250350|464609944|FG000|Overall Study|Lost to Follow-up|8|||
129087189|NCT04250350|464609944|FG000|Overall Study|Adverse Event|5|||
129087190|NCT04250350|464609944|FG000|Overall Study|Lack of Efficacy|4|||
129087191|NCT04250350|464609944|FG000|Overall Study|Physician Decision|1|||
129087192|NCT04250350|464609944|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
129087193|NCT00784550|464609945|FG000|Overall Study|Adverse Event|12|||
129087194|NCT00784550|464609946|FG001|Overall Study|Adverse Event|10|||
129087195|NCT00784550|464609945|FG000|Overall Study|Lack of Efficacy|0|||
129087196|NCT00784550|464609946|FG001|Overall Study|Lack of Efficacy|1|||
129087197|NCT00784550|464609945|FG000|Overall Study|Protocol Violation|10|||
129087198|NCT00784550|464609946|FG001|Overall Study|Protocol Violation|10|||
129087199|NCT00784550|464609945|FG000|Overall Study|Lost to Follow-up|8|||
129087200|NCT00784550|464609946|FG001|Overall Study|Lost to Follow-up|5|||
129087201|NCT00784550|464609945|FG000|Overall Study|Physician Decision|2|||
129087202|NCT00784550|464609946|FG001|Overall Study|Physician Decision|3|||
129087203|NCT00784550|464609945|FG000|Overall Study|Withdrawal by Subject|4|||
129087204|NCT00784550|464609946|FG001|Overall Study|Withdrawal by Subject|13|||
129087205|NCT00688701|464609947|FG000|Overall Study|Adverse Event|1|||
129087206|NCT00688701|464609948|FG001|Overall Study|Adverse Event|0|||
129087207|NCT00688701|464609949|FG002|Overall Study|Adverse Event|5|||
129087208|NCT00688701|464609950|FG003|Overall Study|Adverse Event|3|||
129087209|NCT00688701|464609947|FG000|Overall Study|Lack of Efficacy|0|||
129087210|NCT00688701|464609948|FG001|Overall Study|Lack of Efficacy|1|||
129087211|NCT00688701|464609949|FG002|Overall Study|Lack of Efficacy|0|||
129087212|NCT00688701|464609950|FG003|Overall Study|Lack of Efficacy|0|||
129087213|NCT00688701|464609947|FG000|Overall Study|Withdrawal by Subject|3|||
129087214|NCT00688701|464609948|FG001|Overall Study|Withdrawal by Subject|3|||
129087215|NCT00688701|464609949|FG002|Overall Study|Withdrawal by Subject|4|||
129087216|NCT00688701|464609950|FG003|Overall Study|Withdrawal by Subject|8|||
129087217|NCT00688701|464609947|FG000|Overall Study|Poor compliance to protocol|0|||
129087218|NCT00688701|464609948|FG001|Overall Study|Poor compliance to protocol|1|||
129087219|NCT00688701|464609949|FG002|Overall Study|Poor compliance to protocol|1|||
129087220|NCT00688701|464609950|FG003|Overall Study|Poor compliance to protocol|0|||
129087221|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
129087222|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
129087223|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
129087224|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
129087225|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Death|0|||
129087226|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Death|0|||
129087227|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Death|1|||
129087228|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Death|0|||
129087229|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
129087230|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
129087231|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
129087232|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
129087233|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
129087234|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
129087235|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
129087236|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
129087237|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
129087238|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
129087239|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
129087240|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
129087241|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
129087242|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
129087243|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
129087244|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
129087245|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
129087246|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
129087247|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
129087248|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
129144210|NCT02471144|464824418|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129087249|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
129087250|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
129087251|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
129087252|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
129087253|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129087254|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
129087255|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129087256|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129087257|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
129087258|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
129087259|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
129087260|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
129087261|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
129087262|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
129087263|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
129087264|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
129087265|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Other|8|||
129087266|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Other|14|||
129087267|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Other|8|||
129087268|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Other|23|||
129087269|NCT01106677|464609962|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
129087270|NCT01106677|464609963|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
129087271|NCT01106677|464609964|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
129087272|NCT01106677|464609965|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
129087273|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129087274|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129087275|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
129087276|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
129087277|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Death|0|||
129087278|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Death|0|||
129087279|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Death|0|||
129087280|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Death|1|||
129087281|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
129087282|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
129087283|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
129087284|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
129087285|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129087286|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
129087287|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
129087288|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
129087289|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129087290|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
129087291|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129087292|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
129087293|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129087294|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129087295|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129087296|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129087297|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129087298|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
129087299|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
129087300|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129087301|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
129087302|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
129087303|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
129087304|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
129087305|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129087306|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129087307|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129087308|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129087309|NCT01106677|464609962|FG000|Extension Period: Week 26 to Week 52|Other|6|||
129087310|NCT01106677|464609963|FG001|Extension Period: Week 26 to Week 52|Other|5|||
129087311|NCT01106677|464609964|FG002|Extension Period: Week 26 to Week 52|Other|8|||
129087312|NCT01106677|464609965|FG003|Extension Period: Week 26 to Week 52|Other|5|||
129087313|NCT03937908|464609966|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
129087314|NCT03937908|464609967|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
129144211|NCT02471144|464824419|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
129144212|NCT02471144|464824420|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
129144213|NCT02471144|464824421|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129144214|NCT02471144|464824422|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129144215|NCT02471144|464824412|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144216|NCT02471144|464824413|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144217|NCT02471144|464824414|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144218|NCT02471144|464824415|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144219|NCT02471144|464824416|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144220|NCT02471144|464824417|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144221|NCT02471144|464824418|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144222|NCT02471144|464824419|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144223|NCT02471144|464824420|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129144224|NCT02471144|464824421|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
129144225|NCT02471144|464824422|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
129144226|NCT02471144|464824412|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144227|NCT02471144|464824413|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144228|NCT02471144|464824414|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144229|NCT02471144|464824415|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144230|NCT02471144|464824416|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144231|NCT02471144|464824417|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144232|NCT02471144|464824418|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144233|NCT02471144|464824419|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144234|NCT02471144|464824420|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144235|NCT02471144|464824421|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
129144236|NCT02471144|464824422|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129144237|NCT02471144|464824412|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144238|NCT02471144|464824413|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144239|NCT02471144|464824414|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144240|NCT02471144|464824415|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144241|NCT02471144|464824416|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144242|NCT02471144|464824417|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144243|NCT02471144|464824418|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144244|NCT02471144|464824419|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144245|NCT02471144|464824420|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144246|NCT02471144|464824421|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129144247|NCT02471144|464824422|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
129144248|NCT02471144|464824412|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144249|NCT02471144|464824413|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144250|NCT02471144|464824414|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144251|NCT02471144|464824415|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144252|NCT02471144|464824416|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144253|NCT02471144|464824417|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144254|NCT02471144|464824418|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144255|NCT02471144|464824419|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144256|NCT02471144|464824420|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129144257|NCT02471144|464824421|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
129144258|NCT02471144|464824422|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
129144259|NCT02471144|464824412|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144260|NCT02471144|464824413|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144261|NCT02471144|464824414|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144262|NCT02471144|464824415|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144263|NCT02471144|464824416|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129087315|NCT03875092|464609968|FG000|Overall Study|Adverse Event|2|||
129087316|NCT03875092|464609969|FG001|Overall Study|Adverse Event|5|||
129087317|NCT03875092|464609968|FG000|Overall Study|Death|44|||
129087318|NCT03875092|464609969|FG001|Overall Study|Death|51|||
129087319|NCT03875092|464609968|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
129087320|NCT03875092|464609969|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
129087321|NCT03205761|464609970|FG000|Overall Study|Withdrawal by Subject|1|||
129087322|NCT03205761|464609970|FG000|Overall Study|Progressive Disease|10|||
129087323|NCT04420585|464609971|FG000|Overall Study|Adverse Event|1|||
129087324|NCT04420585|464609971|FG000|Overall Study|Never initiated medication|2|||
129087325|NCT03558152|464609972|FG000|Overall Study|Adverse Event|0|||
129087326|NCT03558152|464609973|FG001|Overall Study|Adverse Event|0|||
129087327|NCT03558152|464609974|FG002|Overall Study|Adverse Event|1|||
129087328|NCT03558152|464609975|FG003|Overall Study|Adverse Event|1|||
128724454|NCT00746941|463289090|FG000|Overall Study|Death|2|||
128724455|NCT00746941|463289091|FG001|Overall Study|Death|0|||
128724456|NCT00746941|463289092|FG002|Overall Study|Death|0|||
128724457|NCT00746941|463289093|FG003|Overall Study|Death|6|||
128724458|NCT00746941|463289090|FG000|Overall Study|Physician Decision|0|||
128724459|NCT00746941|463289091|FG001|Overall Study|Physician Decision|0|||
128724460|NCT00746941|463289092|FG002|Overall Study|Physician Decision|2|||
128724461|NCT00746941|463289093|FG003|Overall Study|Physician Decision|0|||
129087329|NCT03558152|464609976|FG004|Overall Study|Adverse Event|2|||
129087330|NCT03558152|464609977|FG005|Overall Study|Adverse Event|1|||
129087331|NCT03558152|464609978|FG006|Overall Study|Adverse Event|1|||
129087332|NCT03558152|464609979|FG007|Overall Study|Adverse Event|0|||
129087333|NCT03558152|464609972|FG000|Overall Study|Death|0|||
129087334|NCT03558152|464609973|FG001|Overall Study|Death|0|||
129087335|NCT03558152|464609974|FG002|Overall Study|Death|0|||
129087336|NCT03558152|464609975|FG003|Overall Study|Death|0|||
129087337|NCT03558152|464609976|FG004|Overall Study|Death|1|||
129087338|NCT03558152|464609977|FG005|Overall Study|Death|0|||
129087339|NCT03558152|464609978|FG006|Overall Study|Death|0|||
129087340|NCT03558152|464609979|FG007|Overall Study|Death|0|||
129087341|NCT03558152|464609972|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
129087342|NCT03558152|464609973|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129087343|NCT03558152|464609974|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129087344|NCT03558152|464609975|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129087345|NCT03558152|464609976|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129087346|NCT03558152|464609977|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129087347|NCT03558152|464609978|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129087348|NCT03558152|464609979|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129087349|NCT03558152|464609972|FG000|Overall Study|Miscalculation in mmcs|0|||
129087350|NCT03558152|464609973|FG001|Overall Study|Miscalculation in mmcs|0|||
129087351|NCT03558152|464609974|FG002|Overall Study|Miscalculation in mmcs|0|||
129087352|NCT03558152|464609975|FG003|Overall Study|Miscalculation in mmcs|0|||
129087353|NCT03558152|464609976|FG004|Overall Study|Miscalculation in mmcs|0|||
129087354|NCT03558152|464609977|FG005|Overall Study|Miscalculation in mmcs|0|||
129087355|NCT03558152|464609978|FG006|Overall Study|Miscalculation in mmcs|1|||
129087356|NCT03558152|464609979|FG007|Overall Study|Miscalculation in mmcs|0|||
129087357|NCT03558152|464609972|FG000|Overall Study|Mistake in calculation|0|||
129087358|NCT03558152|464609973|FG001|Overall Study|Mistake in calculation|0|||
129087359|NCT03558152|464609974|FG002|Overall Study|Mistake in calculation|0|||
129087360|NCT03558152|464609975|FG003|Overall Study|Mistake in calculation|1|||
129087361|NCT03558152|464609976|FG004|Overall Study|Mistake in calculation|0|||
129087362|NCT03558152|464609977|FG005|Overall Study|Mistake in calculation|0|||
129087363|NCT03558152|464609978|FG006|Overall Study|Mistake in calculation|0|||
129087364|NCT03558152|464609979|FG007|Overall Study|Mistake in calculation|0|||
129087365|NCT03558152|464609972|FG000|Overall Study|Mistake in evaluation of disease status|0|||
129087366|NCT03558152|464609973|FG001|Overall Study|Mistake in evaluation of disease status|0|||
129087367|NCT03558152|464609974|FG002|Overall Study|Mistake in evaluation of disease status|0|||
129087368|NCT03558152|464609975|FG003|Overall Study|Mistake in evaluation of disease status|0|||
129087369|NCT03558152|464609976|FG004|Overall Study|Mistake in evaluation of disease status|0|||
129087370|NCT03558152|464609977|FG005|Overall Study|Mistake in evaluation of disease status|0|||
129087371|NCT03558152|464609978|FG006|Overall Study|Mistake in evaluation of disease status|0|||
129087372|NCT03558152|464609979|FG007|Overall Study|Mistake in evaluation of disease status|1|||
129087373|NCT03558152|464609972|FG000|Overall Study|Physician Decision|0|||
129087374|NCT03558152|464609973|FG001|Overall Study|Physician Decision|0|||
129087375|NCT03558152|464609974|FG002|Overall Study|Physician Decision|0|||
129087376|NCT03558152|464609975|FG003|Overall Study|Physician Decision|0|||
129087377|NCT03558152|464609976|FG004|Overall Study|Physician Decision|0|||
129087378|NCT03558152|464609977|FG005|Overall Study|Physician Decision|0|||
129087379|NCT03558152|464609978|FG006|Overall Study|Physician Decision|1|||
129087380|NCT03558152|464609979|FG007|Overall Study|Physician Decision|0|||
129087381|NCT03558152|464609972|FG000|Overall Study|Withdrawal by Subject|2|||
129087382|NCT03558152|464609973|FG001|Overall Study|Withdrawal by Subject|3|||
129087383|NCT03558152|464609974|FG002|Overall Study|Withdrawal by Subject|2|||
129087384|NCT03558152|464609975|FG003|Overall Study|Withdrawal by Subject|1|||
129087385|NCT03558152|464609976|FG004|Overall Study|Withdrawal by Subject|1|||
129087386|NCT03558152|464609977|FG005|Overall Study|Withdrawal by Subject|1|||
129087387|NCT03558152|464609978|FG006|Overall Study|Withdrawal by Subject|3|||
128724462|NCT00746941|463289090|FG000|Overall Study|Withdrawal by Subject|3|||
128724463|NCT00746941|463289091|FG001|Overall Study|Withdrawal by Subject|0|||
128724464|NCT00746941|463289092|FG002|Overall Study|Withdrawal by Subject|0|||
129087388|NCT03558152|464609979|FG007|Overall Study|Withdrawal by Subject|2|||
129087389|NCT03558152|464609972|FG000|Overall Study|Lack of Efficacy|11|||
129087390|NCT03558152|464609973|FG001|Overall Study|Lack of Efficacy|11|||
129087391|NCT03558152|464609974|FG002|Overall Study|Lack of Efficacy|10|||
129087392|NCT03558152|464609975|FG003|Overall Study|Lack of Efficacy|11|||
129144264|NCT02471144|464824417|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129087393|NCT03558152|464609976|FG004|Overall Study|Lack of Efficacy|14|||
129087394|NCT03558152|464609977|FG005|Overall Study|Lack of Efficacy|12|||
129087395|NCT03558152|464609978|FG006|Overall Study|Lack of Efficacy|14|||
129087396|NCT03558152|464609979|FG007|Overall Study|Lack of Efficacy|13|||
129087397|NCT03558152|464609972|FG000|Overall Study|Protocol Violation|1|||
129087398|NCT03558152|464609973|FG001|Overall Study|Protocol Violation|1|||
129087399|NCT03558152|464609974|FG002|Overall Study|Protocol Violation|0|||
129087400|NCT03558152|464609975|FG003|Overall Study|Protocol Violation|1|||
129087401|NCT03558152|464609976|FG004|Overall Study|Protocol Violation|1|||
129144265|NCT02471144|464824418|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144266|NCT02471144|464824419|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144267|NCT02471144|464824420|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144268|NCT02471144|464824421|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
129144269|NCT02471144|464824422|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129144270|NCT02471144|464824412|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144271|NCT02471144|464824413|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144272|NCT02471144|464824414|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144273|NCT02471144|464824415|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144274|NCT02471144|464824416|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144275|NCT02471144|464824417|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144276|NCT02471144|464824418|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144277|NCT02471144|464824419|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144278|NCT02471144|464824420|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129144279|NCT02471144|464824421|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
129144280|NCT02471144|464824422|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
129144281|NCT00003645|464824423|FG000|Overall Study|Death|4|||
129144282|NCT00003645|464824424|FG001|Overall Study|Death|1|||
129144283|NCT00003645|464824423|FG000|Overall Study|Lost to Follow-up|7|||
129144284|NCT00003645|464824424|FG001|Overall Study|Lost to Follow-up|8|||
129144285|NCT00003645|464824423|FG000|Overall Study|Withdrawal by Subject|1|||
129144286|NCT00003645|464824424|FG001|Overall Study|Withdrawal by Subject|3|||
129144287|NCT03768336|464824427|FG000|Overall Study|Lost to Follow-up|3|||
129144288|NCT03768336|464824428|FG001|Overall Study|Lost to Follow-up|2|||
129144289|NCT03768336|464824427|FG000|Overall Study|Became Ineligible|2|||
129144290|NCT03768336|464824428|FG001|Overall Study|Became Ineligible|0|||
129144291|NCT03768336|464824427|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
129144292|NCT03768336|464824428|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
129144293|NCT03768336|464824427|FG000|Overall Study|Missed final survey (post-treatment|0|||
129144294|NCT03768336|464824428|FG001|Overall Study|Missed final survey (post-treatment|1|||
129144295|NCT03977155|464824429|FG000|Overall Study|Adverse Event|3|||
129144296|NCT03977155|464824430|FG001|Overall Study|Adverse Event|0|||
129144297|NCT03977155|464824431|FG002|Overall Study|Adverse Event|0|||
129144298|NCT03977155|464824429|FG000|Overall Study|Lost to Follow-up|0|||
129144299|NCT03977155|464824430|FG001|Overall Study|Lost to Follow-up|1|||
129144300|NCT03977155|464824431|FG002|Overall Study|Lost to Follow-up|0|||
129144301|NCT03977155|464824429|FG000|Overall Study|Withdrawal by Subject|1|||
129144302|NCT03977155|464824430|FG001|Overall Study|Withdrawal by Subject|1|||
129144303|NCT03977155|464824431|FG002|Overall Study|Withdrawal by Subject|2|||
129144304|NCT03977155|464824429|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
129144305|NCT03977155|464824430|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
129144306|NCT03977155|464824431|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
129144307|NCT03502681|464824434|FG000|Overall Study|Adverse Event|1|||
129144308|NCT03502681|464824435|FG001|Overall Study|Adverse Event|1|||
129144309|NCT03502681|464824434|FG000|Overall Study|Disease Progression|2|||
129144310|NCT03502681|464824435|FG001|Overall Study|Disease Progression|1|||
129144311|NCT06790303|464824436|FG000|Overall Study|Study Terminated by sponsor|4|||
129144312|NCT06790303|464824436|FG000|Overall Study|Death|4|||
129144313|NCT00321932|464824442|FG000|Overall Study|Death|3|||
129144314|NCT00321932|464824443|FG001|Overall Study|Death|6|||
129087402|NCT03558152|464609977|FG005|Overall Study|Protocol Violation|0|||
129087403|NCT03558152|464609978|FG006|Overall Study|Protocol Violation|2|||
129144315|NCT00321932|464824442|FG000|Overall Study|Withdrawal by Subject|3|||
129144316|NCT00321932|464824443|FG001|Overall Study|Withdrawal by Subject|6|||
129144317|NCT00321932|464824442|FG000|Overall Study|Early relapse|2|||
129144318|NCT00321932|464824443|FG001|Overall Study|Early relapse|8|||
129144319|NCT00321932|464824442|FG000|Overall Study|Missing data|2|||
129144320|NCT00321932|464824443|FG001|Overall Study|Missing data|1|||
129087404|NCT03558152|464609979|FG007|Overall Study|Protocol Violation|0|||
129144321|NCT03360344|464824446|FG000|Overall Study|Withdrawal by Subject|0|||
129144322|NCT03360344|464824447|FG001|Overall Study|Withdrawal by Subject|1|||
129144323|NCT03360344|464824448|FG002|Overall Study|Withdrawal by Subject|1|||
129144324|NCT03257657|464824453|FG000|Overall Study|Lost to Follow-up|0|||
129144325|NCT03257657|464824454|FG001|Overall Study|Lost to Follow-up|3|||
129144326|NCT03257657|464824453|FG000|Overall Study|Withdrawn|0|||
129144327|NCT03257657|464824454|FG001|Overall Study|Withdrawn|1|||
129144328|NCT03257657|464824453|FG000|Overall Study|Noted not eligible right after enrolled|0|||
129144329|NCT03257657|464824454|FG001|Overall Study|Noted not eligible right after enrolled|1|||
129144330|NCT01905540|464824469|FG000|Period 3|Other|1|||
129144331|NCT01905540|464824470|FG001|Period 3|Other|0|||
129144332|NCT01905540|464824471|FG002|Period 3|Other|1|||
129144333|NCT01905540|464824472|FG003|Period 3|Other|1|||
129144334|NCT02367885|464824473|FG000|Overall Study|Lost to Follow-up|1|||
129144335|NCT02367885|464824474|FG001|Overall Study|Lost to Follow-up|0|||
129144336|NCT02367885|464824475|FG002|Overall Study|Lost to Follow-up|0|||
129144337|NCT02367885|464824473|FG000|Overall Study|Withdrawal by Subject|1|||
129144338|NCT02367885|464824474|FG001|Overall Study|Withdrawal by Subject|0|||
129144339|NCT02367885|464824475|FG002|Overall Study|Withdrawal by Subject|0|||
129144340|NCT01602484|464824476|FG000|Overall Study|Airway issues unrelated to study|0|||
129144341|NCT01602484|464824477|FG001|Overall Study|Airway issues unrelated to study|1|||
129144342|NCT02743962|464824480|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
129144343|NCT02743962|464824481|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
129144344|NCT02327169|464824483|FG000|Overall Study|Progressive Disease|1|||
129144345|NCT02327169|464824484|FG001|Overall Study|Progressive Disease|3|||
129144346|NCT02327169|464824485|FG002|Overall Study|Progressive Disease|4|||
129144347|NCT02327169|464824486|FG003|Overall Study|Progressive Disease|3|||
129087405|NCT01300338|464609985|FG000|Overall Study|Lost to Follow-up|5|||
129087406|NCT01300338|464609986|FG001|Overall Study|Lost to Follow-up|0|||
129144348|NCT02327169|464824487|FG004|Overall Study|Progressive Disease|4|||
129144349|NCT02327169|464824488|FG005|Overall Study|Progressive Disease|3|||
129144350|NCT02327169|464824489|FG006|Overall Study|Progressive Disease|3|||
129144351|NCT02327169|464824490|FG007|Overall Study|Progressive Disease|3|||
129144352|NCT02327169|464824491|FG008|Overall Study|Progressive Disease|4|||
129144353|NCT02327169|464824492|FG009|Overall Study|Progressive Disease|4|||
129144354|NCT02327169|464824493|FG010|Overall Study|Progressive Disease|4|||
129144355|NCT02327169|464824494|FG011|Overall Study|Progressive Disease|3|||
129144356|NCT02327169|464824495|FG012|Overall Study|Progressive Disease|1|||
129144357|NCT02327169|464824496|FG013|Overall Study|Progressive Disease|3|||
129144358|NCT02327169|464824497|FG014|Overall Study|Progressive Disease|3|||
129144359|NCT02327169|464824483|FG000|Overall Study|Adverse Event|2|||
129144360|NCT02327169|464824484|FG001|Overall Study|Adverse Event|0|||
129144361|NCT02327169|464824485|FG002|Overall Study|Adverse Event|1|||
129144362|NCT02327169|464824486|FG003|Overall Study|Adverse Event|0|||
129144363|NCT02327169|464824487|FG004|Overall Study|Adverse Event|1|||
129144364|NCT02327169|464824488|FG005|Overall Study|Adverse Event|0|||
129144365|NCT02327169|464824489|FG006|Overall Study|Adverse Event|0|||
129144366|NCT02327169|464824490|FG007|Overall Study|Adverse Event|0|||
128724465|NCT00746941|463289093|FG003|Overall Study|Withdrawal by Subject|2|||
128724466|NCT00746941|463289090|FG000|Overall Study|Other, reason not provided|2|||
129087407|NCT02461524|464609987|FG000|Overall Study|Death|16|||
129087408|NCT02461524|464609987|FG000|Overall Study|Withdrawal by Subject|4|||
129087409|NCT02461524|464609987|FG000|Overall Study|Device Explanted|5|||
129087410|NCT02461524|464609987|FG000|Overall Study|Missed Visit|6|||
129087411|NCT00970632|464609992|FG000|Overall Study|Adverse Event|2|||
129087412|NCT00970632|464609993|FG001|Overall Study|Adverse Event|2|||
129087413|NCT00970632|464609994|FG002|Overall Study|Adverse Event|1|||
129087414|NCT00970632|464609992|FG000|Overall Study|Lack of Efficacy|3|||
129087415|NCT00970632|464609993|FG001|Overall Study|Lack of Efficacy|0|||
129087416|NCT00970632|464609994|FG002|Overall Study|Lack of Efficacy|0|||
129087417|NCT00970632|464609992|FG000|Overall Study|Lost to Follow-up|3|||
129087418|NCT00970632|464609993|FG001|Overall Study|Lost to Follow-up|0|||
129144367|NCT02327169|464824491|FG008|Overall Study|Adverse Event|0|||
129144368|NCT02327169|464824492|FG009|Overall Study|Adverse Event|2|||
129144369|NCT02327169|464824493|FG010|Overall Study|Adverse Event|0|||
129144370|NCT02327169|464824494|FG011|Overall Study|Adverse Event|3|||
129144371|NCT02327169|464824495|FG012|Overall Study|Adverse Event|0|||
129144372|NCT02327169|464824496|FG013|Overall Study|Adverse Event|2|||
129144373|NCT02327169|464824497|FG014|Overall Study|Adverse Event|1|||
129144374|NCT02327169|464824483|FG000|Overall Study|Symptomatic Deterioration|0|||
129144375|NCT02327169|464824484|FG001|Overall Study|Symptomatic Deterioration|0|||
129144376|NCT02327169|464824485|FG002|Overall Study|Symptomatic Deterioration|1|||
129144377|NCT02327169|464824486|FG003|Overall Study|Symptomatic Deterioration|0|||
128724467|NCT00746941|463289091|FG001|Overall Study|Other, reason not provided|4|||
129087419|NCT00970632|464609994|FG002|Overall Study|Lost to Follow-up|2|||
129144378|NCT02327169|464824487|FG004|Overall Study|Symptomatic Deterioration|1|||
129144379|NCT02327169|464824488|FG005|Overall Study|Symptomatic Deterioration|1|||
129144380|NCT02327169|464824489|FG006|Overall Study|Symptomatic Deterioration|0|||
129144381|NCT02327169|464824490|FG007|Overall Study|Symptomatic Deterioration|0|||
129144382|NCT02327169|464824491|FG008|Overall Study|Symptomatic Deterioration|2|||
128724468|NCT00746941|463289092|FG002|Overall Study|Other, reason not provided|0|||
129087420|NCT00970632|464609992|FG000|Overall Study|Protocol Violation|8|||
129087421|NCT00970632|464609993|FG001|Overall Study|Protocol Violation|5|||
129087422|NCT00970632|464609994|FG002|Overall Study|Protocol Violation|8|||
129087423|NCT00970632|464609992|FG000|Overall Study|Withdrawal by Subject|7|||
129087424|NCT00970632|464609993|FG001|Overall Study|Withdrawal by Subject|6|||
129087425|NCT00970632|464609994|FG002|Overall Study|Withdrawal by Subject|4|||
129087426|NCT00970632|464609992|FG000|Overall Study|Entry criteria not met|0|||
129087427|NCT00970632|464609993|FG001|Overall Study|Entry criteria not met|2|||
129087428|NCT00970632|464609994|FG002|Overall Study|Entry criteria not met|2|||
129087429|NCT00970632|464609992|FG000|Overall Study|Sponsor decision|1|||
129087430|NCT00970632|464609993|FG001|Overall Study|Sponsor decision|0|||
129087431|NCT00970632|464609994|FG002|Overall Study|Sponsor decision|1|||
129087432|NCT04481191|464610001|FG000|Overall Study|Withdrawn by parent/guardian|15|||
129087433|NCT04481191|464610002|FG001|Overall Study|Withdrawn by parent/guardian|10|||
129087434|NCT02487771|464610003|FG000|Overall Study|Lost to Follow-up|2|||
129087435|NCT02487771|464610004|FG001|Overall Study|Lost to Follow-up|3|||
129087436|NCT02487771|464610003|FG000|Overall Study|Moved out of area|5|||
129087437|NCT02487771|464610004|FG001|Overall Study|Moved out of area|6|||
129087438|NCT02487771|464610003|FG000|Overall Study|Withdrawal by Subject|3|||
129087439|NCT02487771|464610004|FG001|Overall Study|Withdrawal by Subject|5|||
129087440|NCT02002533|464610005|FG000|Overall Study|Withdrawal by Subject|6|||
129087441|NCT02002533|464610006|FG001|Overall Study|Withdrawal by Subject|13|||
129087442|NCT02002533|464610005|FG000|Overall Study|Protocol Violation|0|||
129087443|NCT02002533|464610006|FG001|Overall Study|Protocol Violation|1|||
129087444|NCT02002533|464610005|FG000|Overall Study|Adverse Event|0|||
129087445|NCT02002533|464610006|FG001|Overall Study|Adverse Event|3|||
129087446|NCT02002533|464610005|FG000|Overall Study|Lost to Follow-up|0|||
129087447|NCT02002533|464610006|FG001|Overall Study|Lost to Follow-up|1|||
129087448|NCT04984278|464610009|FG000|Period 1|Withdrawal by Subject|1|||
129087449|NCT04984278|464610010|FG001|Period 1|Withdrawal by Subject|0|||
129087450|NCT04984278|464610009|FG000|Period 1|Other|0|||
129087451|NCT04984278|464610010|FG001|Period 1|Other|1|||
129087452|NCT04984278|464610009|FG000|Period 2|Adverse Event|1|||
129087453|NCT04984278|464610010|FG001|Period 2|Adverse Event|0|||
129087454|NCT04984278|464610009|FG000|Period 2|Other|0|||
129087455|NCT04984278|464610010|FG001|Period 2|Other|1|||
129087456|NCT02651155|464610011|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129087457|NCT02651155|464610012|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129087458|NCT02651155|464610011|FG000|Overall Study|Voluntary Withdrawal|5|||
129087459|NCT02651155|464610012|FG001|Overall Study|Voluntary Withdrawal|0|||
129087460|NCT00976820|464610013|FG000|Overall Study|Lost to Follow-up|5|||
129087461|NCT00976820|464610014|FG001|Overall Study|Lost to Follow-up|16|||
129087462|NCT00976820|464610015|FG002|Overall Study|Lost to Follow-up|2|||
129087463|NCT00976820|464610016|FG003|Overall Study|Lost to Follow-up|3|||
129087464|NCT00976820|464610013|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
129087465|NCT00976820|464610014|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
129087466|NCT00976820|464610015|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
129087467|NCT00976820|464610016|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
129087468|NCT00976820|464610013|FG000|Overall Study|Withdrawal by Subject|2|||
129087469|NCT00976820|464610014|FG001|Overall Study|Withdrawal by Subject|4|||
129087470|NCT00976820|464610015|FG002|Overall Study|Withdrawal by Subject|1|||
129087471|NCT00976820|464610016|FG003|Overall Study|Withdrawal by Subject|4|||
129087472|NCT02691936|464610025|FG000|Overall Study|Withdrawal by Subject|2|||
129087473|NCT02691936|464610026|FG001|Overall Study|Withdrawal by Subject|5|||
129087474|NCT01878084|464610027|FG000|Overall Study|Physician Decision|2|||
129087475|NCT00749684|464610028|FG000|Overall Study|Death|1|||
129087476|NCT00749684|464610028|FG000|Overall Study|Adverse Event|27|||
129087477|NCT00749684|464610028|FG000|Overall Study|Participant's Wish|10|||
129087478|NCT00749684|464610028|FG000|Overall Study|Not Documented|1|||
129087479|NCT00749684|464610028|FG000|Overall Study|Progressive Desease|31|||
129087480|NCT00749684|464610028|FG000|Overall Study|Therapy according to protocol + AE|2|||
129087481|NCT00749684|464610028|FG000|Overall Study|AE+discontinuation on participants wish|1|||
129087482|NCT00749684|464610028|FG000|Overall Study|Missing|9|||
129087483|NCT02892422|464610030|FG000|Overall Study|Enrolled not treated|4|||
129087484|NCT02892422|464610030|FG000|Overall Study|Adverse Event|38|||
129087485|NCT02892422|464610030|FG000|Overall Study|Lack of Efficacy|32|||
129087486|NCT02892422|464610030|FG000|Overall Study|Non-compliance with study drug|11|||
129087487|NCT02892422|464610030|FG000|Overall Study|Protocol Violation|4|||
129087488|NCT02892422|464610030|FG000|Overall Study|Withdrawal by Subject|56|||
129087489|NCT02892422|464610030|FG000|Overall Study|Lost to Follow-up|5|||
129087490|NCT02892422|464610030|FG000|Overall Study|sponsor information 16159A results|21|||
129087491|NCT02892422|464610030|FG000|Overall Study|withdrawal of consent|13|||
129087492|NCT02892422|464610030|FG000|Overall Study|exclusion criteria met|3|||
129087493|NCT02892422|464610030|FG000|Overall Study|moving elsewhere|4|||
129087494|NCT02892422|464610030|FG000|Overall Study|non-compliance|10|||
129087495|NCT02892422|464610030|FG000|Overall Study|patient legally incapable|1|||
129087496|NCT02892422|464610030|FG000|Overall Study|patient decision|7|||
129087497|NCT02892422|464610030|FG000|Overall Study|Investigator decision|1|||
129087498|NCT01023256|464610031|FG000|Overall Study|Protocol Violation|2|||
129087499|NCT01023256|464610032|FG001|Overall Study|Protocol Violation|3|||
129087500|NCT01023256|464610033|FG002|Overall Study|Protocol Violation|0|||
129087501|NCT01023256|464610034|FG003|Overall Study|Protocol Violation|0|||
129087502|NCT01023256|464610031|FG000|Overall Study|Randomized but not treated|1|||
129087503|NCT01023256|464610032|FG001|Overall Study|Randomized but not treated|0|||
129087504|NCT01023256|464610033|FG002|Overall Study|Randomized but not treated|1|||
129087505|NCT01023256|464610034|FG003|Overall Study|Randomized but not treated|0|||
129087506|NCT01023256|464610031|FG000|Overall Study|Other|1|||
129087507|NCT01023256|464610032|FG001|Overall Study|Other|0|||
129087508|NCT01023256|464610033|FG002|Overall Study|Other|0|||
129087509|NCT01023256|464610034|FG003|Overall Study|Other|2|||
129087510|NCT01023256|464610031|FG000|Overall Study|Adverse Event|0|||
129087511|NCT01023256|464610032|FG001|Overall Study|Adverse Event|0|||
129087512|NCT01023256|464610033|FG002|Overall Study|Adverse Event|0|||
129087513|NCT01023256|464610034|FG003|Overall Study|Adverse Event|1|||
129087514|NCT01023256|464610031|FG000|Overall Study|Withdrawal by Subject|0|||
129087515|NCT01023256|464610032|FG001|Overall Study|Withdrawal by Subject|0|||
129087516|NCT01023256|464610033|FG002|Overall Study|Withdrawal by Subject|0|||
129087517|NCT01023256|464610034|FG003|Overall Study|Withdrawal by Subject|2|||
129087518|NCT03155178|464610035|FG000|Overall Study|Did not meet treatment day baseline|7|||
129087519|NCT03155178|464610036|FG001|Overall Study|Did not meet treatment day baseline|7|||
129087520|NCT03155178|464610037|FG002|Overall Study|Did not meet treatment day baseline|7|||
129087521|NCT03155178|464610038|FG003|Overall Study|Did not meet treatment day baseline|7|||
129087522|NCT03089697|464610039|FG000|Overall Study|Adverse Event|1|||
129087523|NCT03089697|464610040|FG001|Overall Study|Adverse Event|2|||
129087524|NCT03089697|464610039|FG000|Overall Study|Withdrawal by Subject|1|||
129087525|NCT03089697|464610040|FG001|Overall Study|Withdrawal by Subject|0|||
129087526|NCT04323306|464610041|FG000|Overall Study|Physician Decision|1|||
129087527|NCT04323306|464610042|FG001|Overall Study|Physician Decision|0|||
129087528|NCT04323306|464610043|FG002|Overall Study|Physician Decision|0|||
129087529|NCT04323306|464610044|FG003|Overall Study|Physician Decision|0|||
129087530|NCT04323306|464610045|FG004|Overall Study|Physician Decision|0|||
129087531|NCT04323306|464610046|FG005|Overall Study|Physician Decision|0|||
129087532|NCT04323306|464610047|FG006|Overall Study|Physician Decision|0|||
129087533|NCT04323306|464610048|FG007|Overall Study|Physician Decision|0|||
129087534|NCT04323306|464610049|FG008|Overall Study|Physician Decision|0|||
129087535|NCT04323306|464610041|FG000|Overall Study|Withdrawal by Subject|0|||
129087536|NCT04323306|464610042|FG001|Overall Study|Withdrawal by Subject|0|||
129087537|NCT04323306|464610043|FG002|Overall Study|Withdrawal by Subject|0|||
129087538|NCT04323306|464610044|FG003|Overall Study|Withdrawal by Subject|0|||
129087539|NCT04323306|464610045|FG004|Overall Study|Withdrawal by Subject|0|||
129087540|NCT04323306|464610046|FG005|Overall Study|Withdrawal by Subject|1|||
129087541|NCT04323306|464610047|FG006|Overall Study|Withdrawal by Subject|3|||
129087542|NCT04323306|464610048|FG007|Overall Study|Withdrawal by Subject|0|||
129087543|NCT04323306|464610049|FG008|Overall Study|Withdrawal by Subject|1|||
129087544|NCT00834639|464610050|FG000|Second Intervention|Physician Decision|0|||
129087545|NCT00834639|464610051|FG001|Second Intervention|Physician Decision|2|||
129087546|NCT05129137|464610052|FG000|Second Period|Adverse Event|1|||
129087547|NCT05129137|464610053|FG001|Second Period|Adverse Event|0|||
129087548|NCT05129137|464610054|FG002|Second Period|Adverse Event|0|||
129087549|NCT05129137|464610055|FG003|Second Period|Adverse Event|0|||
129087550|NCT05129137|464610052|FG000|Second Period|Protocol Violation|0|||
129087551|NCT05129137|464610053|FG001|Second Period|Protocol Violation|0|||
129087552|NCT05129137|464610054|FG002|Second Period|Protocol Violation|0|||
129087553|NCT05129137|464610055|FG003|Second Period|Protocol Violation|1|||
129144383|NCT02327169|464824492|FG009|Overall Study|Symptomatic Deterioration|1|||
129144384|NCT02327169|464824493|FG010|Overall Study|Symptomatic Deterioration|0|||
129144385|NCT02327169|464824494|FG011|Overall Study|Symptomatic Deterioration|0|||
129087554|NCT05129137|464610052|FG000|Third Period|Protocol Violation|0|||
129087555|NCT05129137|464610053|FG001|Third Period|Protocol Violation|0|||
129087556|NCT05129137|464610054|FG002|Third Period|Protocol Violation|0|||
129087557|NCT05129137|464610055|FG003|Third Period|Protocol Violation|1|||
129087558|NCT05129137|464610052|FG000|Forth Period|Protocol Violation|0|||
129144386|NCT02327169|464824495|FG012|Overall Study|Symptomatic Deterioration|0|||
129144387|NCT02327169|464824496|FG013|Overall Study|Symptomatic Deterioration|2|||
129144388|NCT02327169|464824497|FG014|Overall Study|Symptomatic Deterioration|1|||
129087559|NCT05129137|464610053|FG001|Forth Period|Protocol Violation|1|||
129087560|NCT05129137|464610054|FG002|Forth Period|Protocol Violation|0|||
129087561|NCT05129137|464610055|FG003|Forth Period|Protocol Violation|0|||
129087562|NCT05129137|464610052|FG000|Forth Period|Withdrawal by Subject|0|||
129087563|NCT05129137|464610053|FG001|Forth Period|Withdrawal by Subject|0|||
129087564|NCT05129137|464610054|FG002|Forth Period|Withdrawal by Subject|1|||
129087565|NCT05129137|464610055|FG003|Forth Period|Withdrawal by Subject|0|||
129087566|NCT03382834|464610068|FG000|Step 1|Lost to Follow-up|0|||
129087567|NCT03382834|464610069|FG001|Step 1|Lost to Follow-up|1|||
129087568|NCT03382834|464610068|FG000|Step 2|Death|1|||
129087569|NCT03382834|464610069|FG001|Step 2|Death|0|||
129087570|NCT03382834|464610068|FG000|Step 2|Lost to Follow-up|2|||
129087571|NCT03382834|464610069|FG001|Step 2|Lost to Follow-up|2|||
129087572|NCT03382834|464610068|FG000|Step 2|Site Terminated by Sponsor|1|||
129087573|NCT03382834|464610069|FG001|Step 2|Site Terminated by Sponsor|0|||
129087574|NCT02387957|464610070|FG000|Overall Study|The study was discontinued|21|||
129087575|NCT02387957|464610071|FG001|Overall Study|The study was discontinued|21|||
129087576|NCT02387957|464610072|FG002|Overall Study|The study was discontinued|20|||
129087577|NCT03613649|464610073|FG000|Second Treatment|Lost to Follow-up|0|||
129087578|NCT03613649|464610074|FG001|Second Treatment|Lost to Follow-up|0|||
129087579|NCT03613649|464610075|FG002|Second Treatment|Lost to Follow-up|1|||
129087580|NCT03613649|464610076|FG003|Second Treatment|Lost to Follow-up|0|||
129087581|NCT03613649|464610077|FG004|Second Treatment|Lost to Follow-up|0|||
129087582|NCT03613649|464610078|FG005|Second Treatment|Lost to Follow-up|0|||
129087583|NCT03613649|464610079|FG006|Second Treatment|Lost to Follow-up|0|||
129087584|NCT03613649|464610080|FG007|Second Treatment|Lost to Follow-up|0|||
129087585|NCT03613649|464610081|FG008|Second Treatment|Lost to Follow-up|0|||
129087586|NCT03613649|464610082|FG009|Second Treatment|Lost to Follow-up|0|||
129087587|NCT03613649|464610083|FG010|Second Treatment|Lost to Follow-up|0|||
129087588|NCT03613649|464610084|FG011|Second Treatment|Lost to Follow-up|0|||
129087589|NCT03613649|464610073|FG000|Second Treatment|Withdrawal by Subject|0|||
129087590|NCT03613649|464610074|FG001|Second Treatment|Withdrawal by Subject|0|||
129087591|NCT03613649|464610075|FG002|Second Treatment|Withdrawal by Subject|0|||
129087592|NCT03613649|464610076|FG003|Second Treatment|Withdrawal by Subject|0|||
129087593|NCT03613649|464610077|FG004|Second Treatment|Withdrawal by Subject|1|||
129087594|NCT03613649|464610078|FG005|Second Treatment|Withdrawal by Subject|0|||
129087595|NCT03613649|464610079|FG006|Second Treatment|Withdrawal by Subject|0|||
129087596|NCT03613649|464610080|FG007|Second Treatment|Withdrawal by Subject|0|||
129087597|NCT03613649|464610081|FG008|Second Treatment|Withdrawal by Subject|0|||
129087598|NCT03613649|464610082|FG009|Second Treatment|Withdrawal by Subject|0|||
129087599|NCT03613649|464610083|FG010|Second Treatment|Withdrawal by Subject|0|||
129087600|NCT03613649|464610084|FG011|Second Treatment|Withdrawal by Subject|0|||
129087601|NCT03613649|464610073|FG000|Third Treatment|Lost to Follow-up|0|||
129087602|NCT03613649|464610074|FG001|Third Treatment|Lost to Follow-up|0|||
129087603|NCT03613649|464610075|FG002|Third Treatment|Lost to Follow-up|0|||
129087604|NCT03613649|464610076|FG003|Third Treatment|Lost to Follow-up|0|||
129087605|NCT03613649|464610077|FG004|Third Treatment|Lost to Follow-up|1|||
129087606|NCT03613649|464610078|FG005|Third Treatment|Lost to Follow-up|0|||
129087607|NCT03613649|464610079|FG006|Third Treatment|Lost to Follow-up|0|||
129087608|NCT03613649|464610080|FG007|Third Treatment|Lost to Follow-up|0|||
129087609|NCT03613649|464610081|FG008|Third Treatment|Lost to Follow-up|0|||
129087610|NCT03613649|464610082|FG009|Third Treatment|Lost to Follow-up|0|||
129087611|NCT03613649|464610083|FG010|Third Treatment|Lost to Follow-up|0|||
129087612|NCT03613649|464610084|FG011|Third Treatment|Lost to Follow-up|1|||
129087613|NCT03613649|464610073|FG000|Third Treatment|Protocol Violation|0|||
129087614|NCT03613649|464610074|FG001|Third Treatment|Protocol Violation|0|||
129087615|NCT03613649|464610075|FG002|Third Treatment|Protocol Violation|0|||
129087616|NCT03613649|464610076|FG003|Third Treatment|Protocol Violation|0|||
129087617|NCT03613649|464610077|FG004|Third Treatment|Protocol Violation|0|||
129087618|NCT03613649|464610078|FG005|Third Treatment|Protocol Violation|0|||
129087619|NCT03613649|464610079|FG006|Third Treatment|Protocol Violation|1|||
129087620|NCT03613649|464610080|FG007|Third Treatment|Protocol Violation|0|||
129087621|NCT03613649|464610081|FG008|Third Treatment|Protocol Violation|0|||
129087622|NCT03613649|464610082|FG009|Third Treatment|Protocol Violation|0|||
129087623|NCT03613649|464610083|FG010|Third Treatment|Protocol Violation|0|||
129087624|NCT03613649|464610084|FG011|Third Treatment|Protocol Violation|1|||
129087625|NCT03613649|464610073|FG000|Fourth Treatment|Protocol Violation|1|||
129087626|NCT03613649|464610074|FG001|Fourth Treatment|Protocol Violation|0|||
129087627|NCT03613649|464610075|FG002|Fourth Treatment|Protocol Violation|0|||
129087628|NCT03613649|464610076|FG003|Fourth Treatment|Protocol Violation|0|||
128724469|NCT00746941|463289093|FG003|Overall Study|Other, reason not provided|4|||
129087629|NCT03613649|464610077|FG004|Fourth Treatment|Protocol Violation|1|||
129087630|NCT03613649|464610078|FG005|Fourth Treatment|Protocol Violation|0|||
129087631|NCT03613649|464610079|FG006|Fourth Treatment|Protocol Violation|0|||
129087632|NCT03613649|464610080|FG007|Fourth Treatment|Protocol Violation|0|||
129087633|NCT03613649|464610081|FG008|Fourth Treatment|Protocol Violation|0|||
128724470|NCT00746941|463289090|FG000|Overall Study|Adverse Event|0|||
129087634|NCT03613649|464610082|FG009|Fourth Treatment|Protocol Violation|0|||
129087635|NCT03613649|464610083|FG010|Fourth Treatment|Protocol Violation|0|||
129087636|NCT03613649|464610084|FG011|Fourth Treatment|Protocol Violation|0|||
129087637|NCT03613649|464610073|FG000|Fourth Treatment|Physician Decision|0|||
129087638|NCT03613649|464610074|FG001|Fourth Treatment|Physician Decision|0|||
129087639|NCT03613649|464610075|FG002|Fourth Treatment|Physician Decision|0|||
129087640|NCT03613649|464610076|FG003|Fourth Treatment|Physician Decision|0|||
129087641|NCT03613649|464610077|FG004|Fourth Treatment|Physician Decision|0|||
129087642|NCT03613649|464610078|FG005|Fourth Treatment|Physician Decision|0|||
129087643|NCT03613649|464610079|FG006|Fourth Treatment|Physician Decision|1|||
129087644|NCT03613649|464610080|FG007|Fourth Treatment|Physician Decision|0|||
129087645|NCT03613649|464610081|FG008|Fourth Treatment|Physician Decision|0|||
129087646|NCT03613649|464610082|FG009|Fourth Treatment|Physician Decision|0|||
129087647|NCT03613649|464610083|FG010|Fourth Treatment|Physician Decision|0|||
129087648|NCT03613649|464610084|FG011|Fourth Treatment|Physician Decision|0|||
129087649|NCT00675428|464610085|FG000|Overall Study|Disease Progression|2|||
129087650|NCT00675428|464610086|FG001|Overall Study|Disease Progression|2|||
129087651|NCT00675428|464610085|FG000|Overall Study|No Disease Response After Cycle 6|0|||
129087652|NCT00675428|464610086|FG001|Overall Study|No Disease Response After Cycle 6|1|||
129087653|NCT00675428|464610085|FG000|Overall Study|Physician Decision|1|||
129087654|NCT00675428|464610086|FG001|Overall Study|Physician Decision|0|||
129087655|NCT00319592|464610087|FG000|Overall Study|Protocol Violation|1|||
129087656|NCT00319592|464610088|FG001|Overall Study|Protocol Violation|0|||
129087657|NCT00319592|464610087|FG000|Overall Study|Physician Decision|0|||
129144389|NCT02327169|464824483|FG000|Overall Study|Reason Not Specified|0|||
129144390|NCT02327169|464824484|FG001|Overall Study|Reason Not Specified|0|||
129144391|NCT02327169|464824485|FG002|Overall Study|Reason Not Specified|1|||
129144392|NCT02327169|464824486|FG003|Overall Study|Reason Not Specified|0|||
129144393|NCT02327169|464824487|FG004|Overall Study|Reason Not Specified|0|||
129144394|NCT02327169|464824488|FG005|Overall Study|Reason Not Specified|0|||
129144395|NCT02327169|464824489|FG006|Overall Study|Reason Not Specified|0|||
129144396|NCT02327169|464824490|FG007|Overall Study|Reason Not Specified|0|||
129144397|NCT02327169|464824491|FG008|Overall Study|Reason Not Specified|0|||
129144398|NCT02327169|464824492|FG009|Overall Study|Reason Not Specified|1|||
129144399|NCT02327169|464824493|FG010|Overall Study|Reason Not Specified|2|||
129144400|NCT02327169|464824494|FG011|Overall Study|Reason Not Specified|1|||
129144401|NCT02327169|464824495|FG012|Overall Study|Reason Not Specified|0|||
129144402|NCT02327169|464824496|FG013|Overall Study|Reason Not Specified|0|||
129144403|NCT02327169|464824497|FG014|Overall Study|Reason Not Specified|2|||
129144404|NCT02327169|464824483|FG000|Overall Study|Withdrawal by Subject|1|||
129144405|NCT02327169|464824484|FG001|Overall Study|Withdrawal by Subject|0|||
129144406|NCT02327169|464824485|FG002|Overall Study|Withdrawal by Subject|0|||
129144407|NCT02327169|464824486|FG003|Overall Study|Withdrawal by Subject|0|||
129144408|NCT02327169|464824487|FG004|Overall Study|Withdrawal by Subject|1|||
129144409|NCT02327169|464824488|FG005|Overall Study|Withdrawal by Subject|0|||
129144410|NCT02327169|464824489|FG006|Overall Study|Withdrawal by Subject|0|||
129144411|NCT02327169|464824490|FG007|Overall Study|Withdrawal by Subject|1|||
129144412|NCT02327169|464824491|FG008|Overall Study|Withdrawal by Subject|0|||
129144413|NCT02327169|464824492|FG009|Overall Study|Withdrawal by Subject|0|||
129144414|NCT02327169|464824493|FG010|Overall Study|Withdrawal by Subject|0|||
129144415|NCT02327169|464824494|FG011|Overall Study|Withdrawal by Subject|0|||
129144416|NCT02327169|464824495|FG012|Overall Study|Withdrawal by Subject|0|||
129144417|NCT02327169|464824496|FG013|Overall Study|Withdrawal by Subject|0|||
129144418|NCT02327169|464824497|FG014|Overall Study|Withdrawal by Subject|3|||
129144419|NCT02327169|464824483|FG000|Overall Study|Lost to Follow-up|0|||
129144420|NCT02327169|464824484|FG001|Overall Study|Lost to Follow-up|0|||
129144421|NCT02327169|464824485|FG002|Overall Study|Lost to Follow-up|0|||
129144422|NCT02327169|464824486|FG003|Overall Study|Lost to Follow-up|0|||
129144423|NCT02327169|464824487|FG004|Overall Study|Lost to Follow-up|1|||
129144424|NCT02327169|464824488|FG005|Overall Study|Lost to Follow-up|0|||
129144425|NCT02327169|464824489|FG006|Overall Study|Lost to Follow-up|0|||
129144426|NCT02327169|464824490|FG007|Overall Study|Lost to Follow-up|0|||
129144427|NCT02327169|464824491|FG008|Overall Study|Lost to Follow-up|0|||
129144428|NCT02327169|464824492|FG009|Overall Study|Lost to Follow-up|0|||
129087658|NCT00319592|464610088|FG001|Overall Study|Physician Decision|1|||
129087659|NCT00750139|464610091|FG000|Overall Study|Adverse Event|1|||
129144429|NCT02327169|464824493|FG010|Overall Study|Lost to Follow-up|0|||
129144430|NCT02327169|464824494|FG011|Overall Study|Lost to Follow-up|0|||
129144431|NCT02327169|464824495|FG012|Overall Study|Lost to Follow-up|0|||
129144432|NCT02327169|464824496|FG013|Overall Study|Lost to Follow-up|0|||
129144433|NCT02327169|464824497|FG014|Overall Study|Lost to Follow-up|0|||
129144434|NCT05473715|464824500|FG000|Overall Study|Trial terminate|2|||
129144435|NCT05473715|464824501|FG001|Overall Study|Trial terminate|1|||
129144436|NCT02014376|464824505|FG000|Overall Study|Adverse Event|1|||
129144437|NCT02014376|464824506|FG001|Overall Study|Adverse Event|1|||
129144438|NCT02014376|464824507|FG002|Overall Study|Adverse Event|0|||
129144439|NCT02014376|464824505|FG000|Overall Study|Lost to Follow-up|2|||
129144440|NCT02014376|464824506|FG001|Overall Study|Lost to Follow-up|0|||
129087660|NCT00750139|464610092|FG001|Overall Study|Adverse Event|2|||
129087661|NCT00750139|464610093|FG002|Overall Study|Adverse Event|0|||
129087662|NCT00750139|464610094|FG003|Overall Study|Adverse Event|1|||
129144441|NCT02014376|464824507|FG002|Overall Study|Lost to Follow-up|0|||
129144442|NCT00759395|464824508|FG000|Overall Study|Adverse Event|1|||
129144443|NCT00759395|464824509|FG001|Overall Study|Adverse Event|0|||
129144444|NCT00759395|464824508|FG000|Overall Study|Withdrawal by Subject|1|||
129144445|NCT00759395|464824509|FG001|Overall Study|Withdrawal by Subject|0|||
129144446|NCT00759395|464824508|FG000|Overall Study|Lack of Efficacy|0|||
129144447|NCT00759395|464824509|FG001|Overall Study|Lack of Efficacy|2|||
129144448|NCT01435356|464824510|FG000|Overall Study|Adverse Event|2|||
129144449|NCT01435356|464824511|FG001|Overall Study|Adverse Event|0|||
129144450|NCT01435356|464824510|FG000|Overall Study|Disease progression/recurrence|17|||
129144451|NCT01435356|464824511|FG001|Overall Study|Disease progression/recurrence|10|||
129144452|NCT01435356|464824510|FG000|Overall Study|Protocol Violation|0|||
129144453|NCT01435356|464824511|FG001|Overall Study|Protocol Violation|1|||
129144454|NCT01435356|464824510|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
129144455|NCT01435356|464824511|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
129144456|NCT01435356|464824510|FG000|Overall Study|Withdrawal by Subject|1|||
129144457|NCT01435356|464824511|FG001|Overall Study|Withdrawal by Subject|1|||
129144458|NCT01435356|464824510|FG000|Overall Study|Facial palsy|1|||
129144459|NCT01435356|464824511|FG001|Overall Study|Facial palsy|0|||
129144460|NCT01435356|464824510|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
129144461|NCT01435356|464824511|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
129144462|NCT01435356|464824510|FG000|Overall Study|Physician Decision|1|||
129144463|NCT01435356|464824511|FG001|Overall Study|Physician Decision|0|||
129144464|NCT01435356|464824510|FG000|Overall Study|Patient decision|3|||
129144465|NCT01435356|464824511|FG001|Overall Study|Patient decision|0|||
129144466|NCT01435356|464824510|FG000|Overall Study|Patient moved to another city|1|||
129144467|NCT01435356|464824511|FG001|Overall Study|Patient moved to another city|1|||
129144468|NCT00437073|464824512|FG000|Overall Study|Sponsor Terminated Study|1|||
129144469|NCT00437073|464824513|FG001|Overall Study|Sponsor Terminated Study|0|||
129144470|NCT00437073|464824512|FG000|Overall Study|Physician Decision|0|||
129144471|NCT00437073|464824513|FG001|Overall Study|Physician Decision|1|||
129144472|NCT04875533|464824514|FG000|Overall Study|Adverse Event|6|||
129144473|NCT04875533|464824515|FG001|Overall Study|Adverse Event|4|||
129144474|NCT04875533|464824514|FG000|Overall Study|Protocol Violation|4|||
129144475|NCT04875533|464824515|FG001|Overall Study|Protocol Violation|0|||
129144476|NCT04875533|464824514|FG000|Overall Study|Withdrawal by Subject|8|||
129144477|NCT04875533|464824515|FG001|Overall Study|Withdrawal by Subject|5|||
129144478|NCT04875533|464824514|FG000|Overall Study|No longer meets eligibility criteria|1|||
129144479|NCT04875533|464824515|FG001|Overall Study|No longer meets eligibility criteria|0|||
129144480|NCT04875533|464824514|FG000|Overall Study|Other|0|||
129144481|NCT04875533|464824515|FG001|Overall Study|Other|2|||
129144482|NCT02657343|464824518|FG000|Overall Study|Death|0|||
129144483|NCT02657343|464824519|FG001|Overall Study|Death|2|||
129144484|NCT02657343|464824520|FG002|Overall Study|Death|0|||
129144485|NCT02657343|464824521|FG003|Overall Study|Death|0|||
129144486|NCT02657343|464824522|FG004|Overall Study|Death|0|||
129144487|NCT02657343|464824523|FG005|Overall Study|Death|0|||
129144488|NCT02657343|464824518|FG000|Overall Study|Patient went to hospice|1|||
129144489|NCT02657343|464824519|FG001|Overall Study|Patient went to hospice|0|||
129144490|NCT02657343|464824520|FG002|Overall Study|Patient went to hospice|0|||
129144491|NCT02657343|464824521|FG003|Overall Study|Patient went to hospice|0|||
129144492|NCT02657343|464824522|FG004|Overall Study|Patient went to hospice|0|||
129144493|NCT02657343|464824523|FG005|Overall Study|Patient went to hospice|0|||
129144494|NCT02657343|464824518|FG000|Overall Study|Withdrawal by Subject|0|||
129144495|NCT02657343|464824519|FG001|Overall Study|Withdrawal by Subject|0|||
129144496|NCT02657343|464824520|FG002|Overall Study|Withdrawal by Subject|0|||
129144497|NCT02657343|464824521|FG003|Overall Study|Withdrawal by Subject|0|||
129144498|NCT02657343|464824522|FG004|Overall Study|Withdrawal by Subject|1|||
129144499|NCT02657343|464824523|FG005|Overall Study|Withdrawal by Subject|0|||
129144500|NCT02011542|464824525|FG000|Overall Study|Physician Decision|1|||
129144501|NCT00982280|464824529|FG000|Observation Period|Not eligible to be dosed|19|||
129144502|NCT00982280|464824529|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
129144503|NCT00982280|464824529|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
129144504|NCT00982280|464824529|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
129144505|NCT00982280|464824529|FG000|Maintenance Period|Adverse Event|1|||
129144506|NCT01979185|464824530|FG000|Period 2|Other|0|||
128724471|NCT00746941|463289091|FG001|Overall Study|Adverse Event|0|||
128724472|NCT00746941|463289092|FG002|Overall Study|Adverse Event|0|||
128724473|NCT00746941|463289093|FG003|Overall Study|Adverse Event|1|||
129144507|NCT01979185|464824531|FG001|Period 2|Other|1|||
129144508|NCT00980798|464824532|FG000|Overall Study|Adverse Event|7|||
129144509|NCT00980798|464824533|FG001|Overall Study|Adverse Event|36|||
129144510|NCT00980798|464824532|FG000|Overall Study|Lack of Efficacy|16|||
129144511|NCT00980798|464824533|FG001|Overall Study|Lack of Efficacy|5|||
129144512|NCT00980798|464824532|FG000|Overall Study|Lost to Follow-up|0|||
129144513|NCT00980798|464824533|FG001|Overall Study|Lost to Follow-up|1|||
129144514|NCT00980798|464824532|FG000|Overall Study|Physician Decision|2|||
129144515|NCT00980798|464824533|FG001|Overall Study|Physician Decision|1|||
129087663|NCT00750139|464610091|FG000|Overall Study|Lost to Follow-up|17|||
129087664|NCT00750139|464610092|FG001|Overall Study|Lost to Follow-up|12|||
129087665|NCT00750139|464610093|FG002|Overall Study|Lost to Follow-up|15|||
129087666|NCT00750139|464610094|FG003|Overall Study|Lost to Follow-up|6|||
129087667|NCT00750139|464610091|FG000|Overall Study|Withdrawal by Subject|3|||
129087668|NCT00750139|464610092|FG001|Overall Study|Withdrawal by Subject|2|||
129087669|NCT00750139|464610093|FG002|Overall Study|Withdrawal by Subject|6|||
129087670|NCT00750139|464610094|FG003|Overall Study|Withdrawal by Subject|2|||
129087671|NCT00750139|464610091|FG000|Overall Study|Physician Decision|1|||
129087672|NCT00750139|464610092|FG001|Overall Study|Physician Decision|1|||
129087673|NCT00750139|464610093|FG002|Overall Study|Physician Decision|0|||
129087674|NCT00750139|464610094|FG003|Overall Study|Physician Decision|0|||
129087675|NCT00750139|464610091|FG000|Overall Study|Non-compliance|1|||
129087676|NCT00750139|464610092|FG001|Overall Study|Non-compliance|0|||
129087677|NCT00750139|464610093|FG002|Overall Study|Non-compliance|1|||
129087678|NCT00750139|464610094|FG003|Overall Study|Non-compliance|3|||
129087679|NCT00750139|464610091|FG000|Overall Study|Termination by sponsor|4|||
129087680|NCT00750139|464610092|FG001|Overall Study|Termination by sponsor|0|||
129087681|NCT00750139|464610093|FG002|Overall Study|Termination by sponsor|0|||
129087682|NCT00750139|464610094|FG003|Overall Study|Termination by sponsor|1|||
129087683|NCT00750139|464610091|FG000|Overall Study|Non-specific|62|||
129087684|NCT00750139|464610092|FG001|Overall Study|Non-specific|42|||
129087685|NCT00750139|464610093|FG002|Overall Study|Non-specific|79|||
129087686|NCT00750139|464610094|FG003|Overall Study|Non-specific|33|||
129087687|NCT04439214|464610098|FG000|Overall Study|Adverse Event|13|||
129087688|NCT04439214|464610098|FG000|Overall Study|Disease progression|16|||
129087689|NCT04439214|464610098|FG000|Overall Study|Death|1|||
129087690|NCT04439214|464610098|FG000|Overall Study|Withdrawal by Subject|2|||
129087691|NCT04439214|464610098|FG000|Overall Study|Declining health|1|||
129087692|NCT04439214|464610098|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
129087693|NCT04439214|464610098|FG000|Overall Study|Ineligible|5|||
129087694|NCT04553471|464610099|FG000|Overall Study|Did not start treatment on protocol|3|||
129087695|NCT04553471|464610099|FG000|Overall Study|Death|1|||
129087696|NCT04114357|464611490|FG000|Baseline-Randomization|Adverse Event|2|||
129087697|NCT04114357|464611491|FG001|Baseline-Randomization|Adverse Event|1|||
129087698|NCT04114357|464611490|FG000|Baseline-Randomization|Lost to Follow-up|1|||
129087699|NCT04114357|464611491|FG001|Baseline-Randomization|Lost to Follow-up|1|||
129087700|NCT04114357|464611490|FG000|Cross-over|Adverse Event|0|||
129087701|NCT04114357|464611491|FG001|Cross-over|Adverse Event|1|||
129087702|NCT02163226|464611492|FG000|Overall Study|Death|2|||
129087703|NCT02163226|464611493|FG001|Overall Study|Death|1|||
129087704|NCT02163226|464611492|FG000|Overall Study|Withdrawal by Subject|5|||
129087705|NCT02163226|464611493|FG001|Overall Study|Withdrawal by Subject|2|||
129087706|NCT02163226|464611492|FG000|Overall Study|Returned home, local radiotherapy|3|||
129087707|NCT02163226|464611493|FG001|Overall Study|Returned home, local radiotherapy|0|||
129087708|NCT02163226|464611492|FG000|Overall Study|Repeat imaging showed no disease|2|||
129087709|NCT02163226|464611493|FG001|Overall Study|Repeat imaging showed no disease|0|||
129087710|NCT02163226|464611492|FG000|Overall Study|Incomplete radiotherapy|3|||
129087711|NCT02163226|464611493|FG001|Overall Study|Incomplete radiotherapy|0|||
129087712|NCT02163226|464611492|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
128724474|NCT03316885|463289094|FG000|Overall Study|Adverse Event|1|||
128724475|NCT03316885|463289094|FG000|Overall Study|Death|10|||
129087713|NCT02163226|464611493|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
129087714|NCT02163226|464611492|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
129087715|NCT02163226|464611493|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
129087716|NCT02163226|464611492|FG000|Overall Study|ineligible|0|||
129087717|NCT02163226|464611493|FG001|Overall Study|ineligible|3|||
129087718|NCT00477750|464611494|FG000|Overall Study|Currently Receiving Treatment|11|||
129087719|NCT00601172|464611495|FG000|Overall Study|Adverse Event|43|||
129087720|NCT00601172|464611496|FG001|Overall Study|Adverse Event|32|||
129087721|NCT00601172|464611495|FG000|Overall Study|Lack of Efficacy|11|||
129087722|NCT00601172|464611496|FG001|Overall Study|Lack of Efficacy|12|||
129087723|NCT00601172|464611495|FG000|Overall Study|Protocol Violation|2|||
129087724|NCT00601172|464611496|FG001|Overall Study|Protocol Violation|5|||
129087725|NCT00601172|464611495|FG000|Overall Study|Lost to Follow-up|4|||
129087726|NCT00601172|464611496|FG001|Overall Study|Lost to Follow-up|3|||
129087727|NCT00601172|464611495|FG000|Overall Study|Physician Decision|27|||
129087728|NCT00601172|464611496|FG001|Overall Study|Physician Decision|28|||
129087729|NCT00601172|464611495|FG000|Overall Study|Withdrawal by Subject|35|||
129087730|NCT00601172|464611496|FG001|Overall Study|Withdrawal by Subject|27|||
129087731|NCT00601172|464611495|FG000|Overall Study|Did not meet continuation criteria|19|||
129087732|NCT00601172|464611496|FG001|Overall Study|Did not meet continuation criteria|20|||
129087733|NCT03030989|464611497|FG000|Overall Study|Fever|2|||
129087734|NCT03030989|464611498|FG001|Overall Study|Fever|2|||
129087735|NCT03030989|464611497|FG000|Overall Study|Rash|2|||
129087736|NCT03030989|464611498|FG001|Overall Study|Rash|1|||
129087737|NCT03030989|464611497|FG000|Overall Study|Fatigue/Overwhelmed|1|||
129087738|NCT03030989|464611498|FG001|Overall Study|Fatigue/Overwhelmed|5|||
129087739|NCT03030989|464611497|FG000|Overall Study|Positive Blood Cultures|2|||
129087740|NCT03030989|464611498|FG001|Overall Study|Positive Blood Cultures|1|||
129087741|NCT03030989|464611497|FG000|Overall Study|Line Removed|0|||
129087742|NCT03030989|464611498|FG001|Overall Study|Line Removed|2|||
129087743|NCT03030989|464611497|FG000|Overall Study|No longer interested|5|||
129087744|NCT03030989|464611498|FG001|Overall Study|No longer interested|3|||
129087745|NCT02706886|464611499|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
129087746|NCT02706886|464611500|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
129087747|NCT02706886|464611501|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
129087748|NCT02706886|464611502|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
129087749|NCT02706886|464611503|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
129087750|NCT02706886|464611504|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
129087751|NCT02706886|464611505|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
129087752|NCT02706886|464611506|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
129087753|NCT02706886|464611507|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
129087754|NCT01669174|464611514|FG000|Overall Study|Subject withdrew consent|2|||
129087755|NCT01669174|464611515|FG001|Overall Study|Subject withdrew consent|2|||
129087756|NCT01669174|464611514|FG000|Overall Study|Lost to Follow-up|1|||
129087757|NCT01669174|464611515|FG001|Overall Study|Lost to Follow-up|0|||
129087758|NCT01669174|464611514|FG000|Overall Study|Adverse Event|2|||
129087759|NCT01669174|464611515|FG001|Overall Study|Adverse Event|2|||
129087760|NCT01669174|464611514|FG000|Overall Study|Administrative problems|1|||
129087761|NCT01669174|464611515|FG001|Overall Study|Administrative problems|2|||
129087762|NCT04310397|464611518|FG000|Overall Study|Lack of Efficacy|3|||
129087763|NCT04310397|464611518|FG000|Overall Study|Withdrawal by Subject|1|||
129087764|NCT00614523|464611519|FG000|Overall Study|Adverse Event|4|||
129087765|NCT00614523|464611520|FG001|Overall Study|Adverse Event|20|||
129087766|NCT00614523|464611519|FG000|Overall Study|Death|5|||
129087767|NCT00614523|464611520|FG001|Overall Study|Death|8|||
129087768|NCT00614523|464611519|FG000|Overall Study|Lack of Efficacy|9|||
129087769|NCT00614523|464611520|FG001|Overall Study|Lack of Efficacy|11|||
129087770|NCT00614523|464611519|FG000|Overall Study|Lost to Follow-up|0|||
129087771|NCT00614523|464611520|FG001|Overall Study|Lost to Follow-up|1|||
129087772|NCT00614523|464611519|FG000|Overall Study|Protocol Violation|3|||
129087773|NCT00614523|464611520|FG001|Overall Study|Protocol Violation|2|||
129087774|NCT00614523|464611519|FG000|Overall Study|Withdrawal by Subject|12|||
129087775|NCT00614523|464611520|FG001|Overall Study|Withdrawal by Subject|22|||
129087776|NCT00614523|464611519|FG000|Overall Study|Other|6|||
129087777|NCT00614523|464611520|FG001|Overall Study|Other|11|||
129087778|NCT00614523|464611519|FG000|Overall Study|Ineligibility Determined|1|||
129087779|NCT00614523|464611520|FG001|Overall Study|Ineligibility Determined|2|||
129087780|NCT00614523|464611519|FG000|Overall Study|Disease Progression|0|||
129087781|NCT00614523|464611520|FG001|Overall Study|Disease Progression|8|||
129087782|NCT00614523|464611519|FG000|Overall Study|Administrative Decision|23|||
129087783|NCT00614523|464611520|FG001|Overall Study|Administrative Decision|46|||
129087784|NCT00723255|464611521|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
129087785|NCT00723255|464611521|FG000|Overall Study|Ineligible: Second primary|1|||
129087786|NCT00723255|464611521|FG000|Overall Study|Ineligible: Wrong Primary|2|||
129087787|NCT01482065|464611529|FG000|Overall Study|Withdrawal by Subject|0|||
129087788|NCT01482065|464611530|FG001|Overall Study|Withdrawal by Subject|1|||
129087789|NCT02005692|464611533|FG000|Overall Study|Protocol Violation|1|||
129087790|NCT02005692|464611533|FG000|Overall Study|Withdrawal by Subject|1|||
129087791|NCT02005692|464611533|FG000|Overall Study|Discharged earlier than anticipated|5|||
129087792|NCT01895270|464611534|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
129087793|NCT01895270|464611535|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
129087794|NCT01895270|464611534|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
129087795|NCT01895270|464611535|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
129087796|NCT01895270|464611534|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
129087797|NCT01895270|464611535|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
129087798|NCT01895270|464611534|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
129087799|NCT01895270|464611535|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
129087800|NCT01895270|464611534|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
129087801|NCT01895270|464611535|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
129087802|NCT01895270|464611534|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
129087803|NCT01895270|464611535|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
129087804|NCT01895270|464611534|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
129087805|NCT01895270|464611535|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
129144516|NCT00980798|464824532|FG000|Overall Study|Withdrawal by Subject|8|||
129144517|NCT00980798|464824533|FG001|Overall Study|Withdrawal by Subject|11|||
129144518|NCT00980798|464824532|FG000|Overall Study|Other|0|||
129144519|NCT00980798|464824533|FG001|Overall Study|Other|1|||
129144520|NCT04221438|464824534|FG000|Overall Study|Adverse Event|1|||
129144521|NCT04221438|464824534|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
129144522|NCT04724837|464824537|FG000|Overall Study|Other|4|||
129144523|NCT04724837|464824538|FG001|Overall Study|Other|16|||
129144524|NCT04724837|464824539|FG002|Overall Study|Other|0|||
129144525|NCT04724837|464824537|FG000|Overall Study|Withdrawal by Subject|2|||
129144526|NCT04724837|464824538|FG001|Overall Study|Withdrawal by Subject|9|||
129144527|NCT04724837|464824539|FG002|Overall Study|Withdrawal by Subject|9|||
129144528|NCT04724837|464824537|FG000|Overall Study|Adverse Event|2|||
129144529|NCT04724837|464824538|FG001|Overall Study|Adverse Event|7|||
129144530|NCT04724837|464824539|FG002|Overall Study|Adverse Event|4|||
129144531|NCT04724837|464824537|FG000|Overall Study|Lost to Follow-up|0|||
129144532|NCT04724837|464824538|FG001|Overall Study|Lost to Follow-up|1|||
129144533|NCT04724837|464824539|FG002|Overall Study|Lost to Follow-up|3|||
129144534|NCT04724837|464824537|FG000|Overall Study|Physician Decision|1|||
129144535|NCT04724837|464824538|FG001|Overall Study|Physician Decision|2|||
129144536|NCT04724837|464824539|FG002|Overall Study|Physician Decision|0|||
129144537|NCT04724837|464824537|FG000|Overall Study|Death|0|||
129144538|NCT04724837|464824538|FG001|Overall Study|Death|0|||
129144539|NCT04724837|464824539|FG002|Overall Study|Death|1|||
129144540|NCT04724837|464824537|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129144541|NCT04724837|464824538|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
129144542|NCT04724837|464824539|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
129144543|NCT04724837|464824537|FG000|Overall Study|Study Terminated by Sponsor|0|||
129144544|NCT04724837|464824538|FG001|Overall Study|Study Terminated by Sponsor|1|||
129144545|NCT04724837|464824539|FG002|Overall Study|Study Terminated by Sponsor|0|||
129144546|NCT00522379|464824540|FG000|Overall Study|Adverse Event|12|||
129144547|NCT00522379|464824541|FG001|Overall Study|Adverse Event|15|||
129144548|NCT00522379|464824542|FG002|Overall Study|Adverse Event|12|||
129144549|NCT00522379|464824543|FG003|Overall Study|Adverse Event|5|||
129144550|NCT00522379|464824544|FG004|Overall Study|Adverse Event|17|||
129144551|NCT00522379|464824540|FG000|Overall Study|Lack of Efficacy|3|||
129144552|NCT00522379|464824541|FG001|Overall Study|Lack of Efficacy|0|||
129144553|NCT00522379|464824542|FG002|Overall Study|Lack of Efficacy|2|||
129144554|NCT00522379|464824543|FG003|Overall Study|Lack of Efficacy|2|||
129144555|NCT00522379|464824544|FG004|Overall Study|Lack of Efficacy|7|||
129144556|NCT00522379|464824540|FG000|Overall Study|Withdrawal by Subject|2|||
129144557|NCT00522379|464824541|FG001|Overall Study|Withdrawal by Subject|3|||
129144558|NCT00522379|464824542|FG002|Overall Study|Withdrawal by Subject|1|||
129144559|NCT00522379|464824543|FG003|Overall Study|Withdrawal by Subject|2|||
129144560|NCT00522379|464824544|FG004|Overall Study|Withdrawal by Subject|0|||
129144561|NCT00522379|464824540|FG000|Overall Study|Protocol Violation|1|||
129144562|NCT00522379|464824541|FG001|Overall Study|Protocol Violation|1|||
129144563|NCT00522379|464824542|FG002|Overall Study|Protocol Violation|2|||
129144564|NCT00522379|464824543|FG003|Overall Study|Protocol Violation|0|||
129144565|NCT00522379|464824544|FG004|Overall Study|Protocol Violation|0|||
129144566|NCT00522379|464824540|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
129144567|NCT00522379|464824541|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
129144568|NCT00522379|464824542|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
129144569|NCT00522379|464824543|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
129144570|NCT00522379|464824544|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
129144571|NCT00522379|464824540|FG000|Overall Study|Lost to Follow-up|1|||
129144572|NCT00522379|464824541|FG001|Overall Study|Lost to Follow-up|0|||
129144573|NCT00522379|464824542|FG002|Overall Study|Lost to Follow-up|4|||
129144574|NCT00522379|464824543|FG003|Overall Study|Lost to Follow-up|2|||
129144575|NCT00522379|464824544|FG004|Overall Study|Lost to Follow-up|2|||
129144576|NCT00522379|464824540|FG000|Overall Study|Randomization error|0|||
129144577|NCT00522379|464824541|FG001|Overall Study|Randomization error|0|||
129144578|NCT00522379|464824542|FG002|Overall Study|Randomization error|0|||
129144579|NCT00522379|464824543|FG003|Overall Study|Randomization error|0|||
129144580|NCT00522379|464824544|FG004|Overall Study|Randomization error|1|||
129144581|NCT00522379|464824540|FG000|Overall Study|Dispensing error|1|||
129144582|NCT00522379|464824541|FG001|Overall Study|Dispensing error|0|||
129144583|NCT00522379|464824542|FG002|Overall Study|Dispensing error|0|||
129144584|NCT00522379|464824543|FG003|Overall Study|Dispensing error|1|||
129144585|NCT00522379|464824544|FG004|Overall Study|Dispensing error|0|||
129144586|NCT00522379|464824540|FG000|Overall Study|Subject Moved|1|||
129144587|NCT00522379|464824541|FG001|Overall Study|Subject Moved|1|||
129144588|NCT00522379|464824542|FG002|Overall Study|Subject Moved|0|||
129144589|NCT00522379|464824543|FG003|Overall Study|Subject Moved|0|||
129144590|NCT00522379|464824544|FG004|Overall Study|Subject Moved|0|||
129144591|NCT00522379|464824540|FG000|Overall Study|Sponsor Request|0|||
129144592|NCT00522379|464824541|FG001|Overall Study|Sponsor Request|1|||
129144593|NCT00522379|464824542|FG002|Overall Study|Sponsor Request|0|||
129144594|NCT00522379|464824543|FG003|Overall Study|Sponsor Request|0|||
129087806|NCT02091375|464611537|FG000|Overall Study|Adverse Event|8|||
129087807|NCT02091375|464611538|FG001|Overall Study|Adverse Event|1|||
129087808|NCT02091375|464611537|FG000|Overall Study|Lost to Follow-up|0|||
129087809|NCT02091375|464611538|FG001|Overall Study|Lost to Follow-up|1|||
129087810|NCT02091375|464611537|FG000|Overall Study|Withdrawal by Subject|0|||
129087811|NCT02091375|464611538|FG001|Overall Study|Withdrawal by Subject|1|||
129087812|NCT02091375|464611537|FG000|Overall Study|Withdrawn by the investigator|1|||
129087813|NCT02091375|464611538|FG001|Overall Study|Withdrawn by the investigator|0|||
129087814|NCT01741792|464611539|FG000|Overall Study|Death|6|||
129087815|NCT01741792|464611540|FG001|Overall Study|Death|1|||
129087816|NCT01741792|464611541|FG002|Overall Study|Death|12|||
129087817|NCT03261674|464611542|FG000|Overall Study|Lost to Follow-up|6|||
129087818|NCT03261674|464611543|FG001|Overall Study|Lost to Follow-up|7|||
129087819|NCT03261674|464611542|FG000|Overall Study|Protocol Violation|1|||
129087820|NCT03261674|464611543|FG001|Overall Study|Protocol Violation|4|||
129087821|NCT03261674|464611542|FG000|Overall Study|Withdrawal by Subject|1|||
129087822|NCT03261674|464611543|FG001|Overall Study|Withdrawal by Subject|4|||
129087823|NCT03261674|464611542|FG000|Overall Study|Physician Decision|1|||
129087824|NCT03261674|464611543|FG001|Overall Study|Physician Decision|0|||
129087825|NCT00623935|464611546|FG000|Overall Study|Death|1|||
129087826|NCT00623935|464611546|FG000|Overall Study|Patient Declined Transplant|1|||
129087827|NCT00747474|464611549|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087828|NCT00747474|464611550|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087829|NCT00747474|464611551|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087830|NCT00747474|464611552|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087831|NCT00747474|464611553|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087832|NCT00747474|464611554|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087833|NCT00747474|464611555|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087834|NCT00747474|464611556|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
129087835|NCT00747474|464611557|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087836|NCT00747474|464611558|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087837|NCT00747474|464611559|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087838|NCT00747474|464611560|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129087839|NCT04507256|464611561|FG000|Overall Study|Withdrawal by Subject|1|||
129087840|NCT04507256|464611562|FG001|Overall Study|Withdrawal by Subject|0|||
129087841|NCT04507256|464611563|FG002|Overall Study|Withdrawal by Subject|0|||
129087842|NCT04507256|464611564|FG003|Overall Study|Withdrawal by Subject|1|||
129087843|NCT04507256|464611565|FG004|Overall Study|Withdrawal by Subject|0|||
129087844|NCT04507256|464611566|FG005|Overall Study|Withdrawal by Subject|0|||
129087845|NCT00631410|464611567|FG000|Overall Study|Adverse Event|1|||
129087846|NCT00631410|464611568|FG001|Overall Study|Adverse Event|3|||
129087847|NCT00631410|464611567|FG000|Overall Study|Objective Progression or Relapse|4|||
129087848|NCT00631410|464611568|FG001|Overall Study|Objective Progression or Relapse|3|||
129087849|NCT00631410|464611567|FG000|Overall Study|Surgery|1|||
129087850|NCT00631410|464611568|FG001|Overall Study|Surgery|0|||
129087851|NCT00890084|464611569|FG000|Overall Study|Adverse Event|16|||
129087852|NCT00890084|464611569|FG000|Overall Study|Lost to Follow-up|126|||
129087853|NCT01647516|464611574|FG000|Induction Period (IP)|Physician Decision|2|||
129087854|NCT01647516|464611575|FG001|Induction Period (IP)|Physician Decision|0|||
129087855|NCT01647516|464611576|FG002|Induction Period (IP)|Physician Decision|0|||
129087856|NCT01647516|464611577|FG003|Induction Period (IP)|Physician Decision|0|||
129087857|NCT01647516|464611578|FG004|Induction Period (IP)|Physician Decision|0|||
129087858|NCT01647516|464611579|FG005|Induction Period (IP)|Physician Decision|0|||
129087859|NCT01647516|464611574|FG000|Induction Period (IP)|Adverse Event|1|||
129087860|NCT01647516|464611575|FG001|Induction Period (IP)|Adverse Event|2|||
129087861|NCT01647516|464611576|FG002|Induction Period (IP)|Adverse Event|0|||
129087862|NCT01647516|464611577|FG003|Induction Period (IP)|Adverse Event|0|||
129087863|NCT01647516|464611578|FG004|Induction Period (IP)|Adverse Event|0|||
129087864|NCT01647516|464611579|FG005|Induction Period (IP)|Adverse Event|0|||
129087865|NCT01647516|464611574|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
129087866|NCT01647516|464611575|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
129087867|NCT01647516|464611576|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
129144595|NCT00522379|464824544|FG004|Overall Study|Sponsor Request|0|||
129144596|NCT00522379|464824540|FG000|Overall Study|Family Problem|0|||
128724476|NCT03316885|463289094|FG000|Overall Study|Lost to Follow-up|4|||
129087868|NCT01647516|464611577|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
129087869|NCT01647516|464611578|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
129087870|NCT01647516|464611579|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
129087871|NCT01647516|464611574|FG000|Induction Period (IP)|Participant Choice|0|||
129087872|NCT01647516|464611575|FG001|Induction Period (IP)|Participant Choice|0|||
129087873|NCT01647516|464611576|FG002|Induction Period (IP)|Participant Choice|1|||
129087874|NCT01647516|464611577|FG003|Induction Period (IP)|Participant Choice|0|||
129087875|NCT01647516|464611578|FG004|Induction Period (IP)|Participant Choice|0|||
129144597|NCT00522379|464824541|FG001|Overall Study|Family Problem|0|||
129144598|NCT00522379|464824542|FG002|Overall Study|Family Problem|1|||
129144599|NCT00522379|464824543|FG003|Overall Study|Family Problem|0|||
129144600|NCT00522379|464824544|FG004|Overall Study|Family Problem|0|||
129144601|NCT00522379|464824540|FG000|Overall Study|Site Closed|0|||
129144602|NCT00522379|464824541|FG001|Overall Study|Site Closed|0|||
129144603|NCT00522379|464824542|FG002|Overall Study|Site Closed|0|||
129144604|NCT00522379|464824543|FG003|Overall Study|Site Closed|1|||
129144605|NCT00522379|464824544|FG004|Overall Study|Site Closed|0|||
129144606|NCT00522379|464824540|FG000|Overall Study|Subject Withdrawal|0|||
129144607|NCT00522379|464824541|FG001|Overall Study|Subject Withdrawal|0|||
128724477|NCT03316885|463289094|FG000|Overall Study|Withdrawal by Subject|9|||
128724478|NCT03316885|463289094|FG000|Overall Study|COVID related|8|||
128724479|NCT02739269|463289111|FG000|Overall Study|Protocol Violation|5|||
128724480|NCT02739269|463289112|FG001|Overall Study|Protocol Violation|0|||
128724481|NCT02739269|463289111|FG000|Overall Study|Cycle cancellation|2|||
128724482|NCT02739269|463289112|FG001|Overall Study|Cycle cancellation|2|||
128724483|NCT02739269|463289111|FG000|Overall Study|Withdrawal by Subject|0|||
128724484|NCT02739269|463289112|FG001|Overall Study|Withdrawal by Subject|2|||
129144608|NCT00522379|464824542|FG002|Overall Study|Subject Withdrawal|0|||
129144609|NCT00522379|464824543|FG003|Overall Study|Subject Withdrawal|1|||
129144610|NCT00522379|464824544|FG004|Overall Study|Subject Withdrawal|0|||
129144611|NCT00967499|464824549|FG000|Overall Study|Adverse Event|0|||
129144612|NCT00967499|464824550|FG001|Overall Study|Adverse Event|1|||
129144613|NCT00967499|464824549|FG000|Overall Study|Protocol Violation|1|||
129144614|NCT00967499|464824550|FG001|Overall Study|Protocol Violation|0|||
129144615|NCT00967499|464824549|FG000|Overall Study|Sponsor Decision|1|||
129144616|NCT00967499|464824550|FG001|Overall Study|Sponsor Decision|0|||
129144617|NCT00967499|464824549|FG000|Overall Study|Randomized but not treated|63|||
129144618|NCT00967499|464824550|FG001|Overall Study|Randomized but not treated|59|||
129144619|NCT03034044|464824552|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
129144620|NCT05535972|464824553|FG000|Overall Study|Withdrawal by Subject|31|||
129144621|NCT05535972|464824553|FG000|Overall Study|Lost to Follow-up|5|||
129144622|NCT05535972|464824553|FG000|Overall Study|Adverse Event|6|||
129144623|NCT05535972|464824553|FG000|Overall Study|Protocol Deviation|2|||
129144624|NCT02402647|464824556|FG000|Overall Study|Lost to Follow-up|13|||
129144625|NCT02402647|464824557|FG001|Overall Study|Lost to Follow-up|7|||
129144626|NCT02402647|464824556|FG000|Overall Study|Protocol Violation|1|||
129144627|NCT02402647|464824557|FG001|Overall Study|Protocol Violation|1|||
129144628|NCT02402647|464824556|FG000|Overall Study|scheduled and timed out|2|||
129144629|NCT02402647|464824557|FG001|Overall Study|scheduled and timed out|1|||
129144630|NCT02402647|464824556|FG000|Overall Study|medical illness|2|||
129144631|NCT02402647|464824557|FG001|Overall Study|medical illness|4|||
129144632|NCT02402647|464824556|FG000|Overall Study|Moved|2|||
129144633|NCT02402647|464824557|FG001|Overall Study|Moved|0|||
129144634|NCT02402647|464824556|FG000|Overall Study|loved one illness|1|||
129144635|NCT02402647|464824557|FG001|Overall Study|loved one illness|0|||
129144636|NCT02402647|464824556|FG000|Overall Study|deceased preexisting condition|2|||
129144637|NCT02402647|464824557|FG001|Overall Study|deceased preexisting condition|0|||
129144638|NCT02402647|464824556|FG000|Overall Study|Other|2|||
129144639|NCT02402647|464824557|FG001|Overall Study|Other|1|||
129144640|NCT04197583|464824558|FG000|Overall Study|Study Stent Replacement|34|||
129144641|NCT04197583|464824559|FG001|Overall Study|Study Stent Replacement|8|||
129144642|NCT04197583|464824558|FG000|Overall Study|Lost to Follow-up|14|||
129144643|NCT04197583|464824559|FG001|Overall Study|Lost to Follow-up|3|||
129144644|NCT04197583|464824558|FG000|Overall Study|Death|3|||
129144645|NCT04197583|464824559|FG001|Overall Study|Death|0|||
129144646|NCT04197583|464824558|FG000|Overall Study|Physician Decision|1|||
129144647|NCT04197583|464824559|FG001|Overall Study|Physician Decision|0|||
129144648|NCT04197583|464824558|FG000|Overall Study|Withdrawal by Subject|1|||
129144649|NCT04197583|464824559|FG001|Overall Study|Withdrawal by Subject|1|||
129144650|NCT04197583|464824558|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
129144651|NCT04197583|464824559|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
129144652|NCT04197583|464824558|FG000|Overall Study|Screen Failure|0|||
129144653|NCT04197583|464824559|FG001|Overall Study|Screen Failure|20|||
129144654|NCT00323622|464824561|FG000|Overall Study|Other|30|||
129144655|NCT00323622|464824562|FG001|Overall Study|Other|91|||
129144656|NCT00323622|464824563|FG002|Overall Study|Other|4|||
129144657|NCT00323622|464824564|FG003|Overall Study|Other|12|||
129144658|NCT00323622|464824565|FG004|Overall Study|Other|32|||
129144659|NCT00323622|464824566|FG005|Overall Study|Other|74|||
129144660|NCT00323622|464824567|FG006|Overall Study|Other|5|||
129144661|NCT00323622|464824568|FG007|Overall Study|Other|13|||
129144662|NCT00323622|464824561|FG000|Overall Study|Death|1|||
129144663|NCT00323622|464824562|FG001|Overall Study|Death|1|||
128724485|NCT03190889|463289113|FG000|Overall Study|Lost to Follow-up|7|||
129144664|NCT00323622|464824563|FG002|Overall Study|Death|0|||
129144665|NCT00323622|464824564|FG003|Overall Study|Death|0|||
129144666|NCT00323622|464824565|FG004|Overall Study|Death|7|||
129144667|NCT00323622|464824566|FG005|Overall Study|Death|0|||
129144668|NCT00323622|464824567|FG006|Overall Study|Death|0|||
129144669|NCT00323622|464824568|FG007|Overall Study|Death|2|||
129144670|NCT04191135|464824585|FG000|Induction Treatment|Not Treated|2|||
129144671|NCT04191135|464824586|FG001|Induction Treatment|Not Treated|0|||
129144672|NCT04191135|464824587|FG002|Induction Treatment|Not Treated|0|||
129144673|NCT04191135|464824585|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
129144674|NCT04191135|464824586|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
129144675|NCT04191135|464824587|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
129144676|NCT04191135|464824585|FG000|Induction Treatment|Adverse Event|25|||
129144677|NCT04191135|464824586|FG001|Induction Treatment|Adverse Event|0|||
129144678|NCT04191135|464824587|FG002|Induction Treatment|Adverse Event|0|||
129144679|NCT04191135|464824585|FG000|Induction Treatment|Clinical Progression|8|||
129144680|NCT04191135|464824586|FG001|Induction Treatment|Clinical Progression|0|||
129144681|NCT04191135|464824587|FG002|Induction Treatment|Clinical Progression|0|||
129144682|NCT04191135|464824585|FG000|Induction Treatment|Excluded Medication|1|||
129144683|NCT04191135|464824586|FG001|Induction Treatment|Excluded Medication|0|||
129144684|NCT04191135|464824587|FG002|Induction Treatment|Excluded Medication|0|||
129144685|NCT04191135|464824585|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
129144686|NCT04191135|464824586|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
129144687|NCT04191135|464824587|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
129144688|NCT04191135|464824585|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
129144689|NCT04191135|464824586|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
129144690|NCT04191135|464824587|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
129144691|NCT04191135|464824585|FG000|Induction Treatment|Physician Decision|2|||
129144692|NCT04191135|464824586|FG001|Induction Treatment|Physician Decision|0|||
129144693|NCT04191135|464824587|FG002|Induction Treatment|Physician Decision|0|||
128724486|NCT03190889|463289114|FG001|Overall Study|Lost to Follow-up|7|||
128724487|NCT03190889|463289115|FG002|Overall Study|Lost to Follow-up|3|||
128724488|NCT03190889|463289113|FG000|Overall Study|Withdrawal by Subject|1|||
129144694|NCT04191135|464824585|FG000|Induction Treatment|Progressive Disease|135|||
129144695|NCT04191135|464824586|FG001|Induction Treatment|Progressive Disease|0|||
129144696|NCT04191135|464824587|FG002|Induction Treatment|Progressive Disease|0|||
129144697|NCT04191135|464824585|FG000|Induction Treatment|Protocol Violation|10|||
129144698|NCT04191135|464824586|FG001|Induction Treatment|Protocol Violation|0|||
129144699|NCT04191135|464824587|FG002|Induction Treatment|Protocol Violation|0|||
129144700|NCT04191135|464824585|FG000|Induction Treatment|Withdrawal by Subject|4|||
129144701|NCT04191135|464824586|FG001|Induction Treatment|Withdrawal by Subject|0|||
129144702|NCT04191135|464824587|FG002|Induction Treatment|Withdrawal by Subject|0|||
129144703|NCT04191135|464824585|FG000|Randomized Treatment|Death|0|||
129144704|NCT04191135|464824586|FG001|Randomized Treatment|Death|50|||
129144705|NCT04191135|464824587|FG002|Randomized Treatment|Death|54|||
129144706|NCT04191135|464824585|FG000|Randomized Treatment|Lost to Follow-up|0|||
129144707|NCT04191135|464824586|FG001|Randomized Treatment|Lost to Follow-up|0|||
129144708|NCT04191135|464824587|FG002|Randomized Treatment|Lost to Follow-up|1|||
129144709|NCT04191135|464824585|FG000|Randomized Treatment|Withdrawal by Subject|0|||
129144710|NCT04191135|464824586|FG001|Randomized Treatment|Withdrawal by Subject|2|||
129144711|NCT04191135|464824587|FG002|Randomized Treatment|Withdrawal by Subject|0|||
129144712|NCT04191135|464824585|FG000|Randomized Treatment|Ongoing in Trial|0|||
129144713|NCT04191135|464824586|FG001|Randomized Treatment|Ongoing in Trial|83|||
129144714|NCT04191135|464824587|FG002|Randomized Treatment|Ongoing in Trial|81|||
129144715|NCT01444781|464826286|FG000|Overall Study|Lost to Follow-up|0|||
129144716|NCT01444781|464826287|FG001|Overall Study|Lost to Follow-up|3|||
129144717|NCT01444781|464826288|FG002|Overall Study|Lost to Follow-up|1|||
129144718|NCT01444781|464826286|FG000|Overall Study|Withdrawal by Subject|3|||
129144719|NCT01444781|464826287|FG001|Overall Study|Withdrawal by Subject|1|||
129144720|NCT01444781|464826288|FG002|Overall Study|Withdrawal by Subject|2|||
129144721|NCT03033784|464826292|FG000|Overall Study|Anxiety related to MRI scanner|0|||
129144722|NCT03033784|464826293|FG001|Overall Study|Anxiety related to MRI scanner|1|||
129144723|NCT03033784|464826294|FG002|Overall Study|Anxiety related to MRI scanner|0|||
129144724|NCT03033784|464826295|FG003|Overall Study|Anxiety related to MRI scanner|0|||
129144725|NCT03033784|464826296|FG004|Overall Study|Anxiety related to MRI scanner|0|||
129144726|NCT03033784|464826297|FG005|Overall Study|Anxiety related to MRI scanner|0|||
129144727|NCT03033784|464826298|FG006|Overall Study|Anxiety related to MRI scanner|0|||
129144728|NCT03033784|464826299|FG007|Overall Study|Anxiety related to MRI scanner|0|||
129144729|NCT03033784|464826300|FG008|Overall Study|Anxiety related to MRI scanner|0|||
128724489|NCT03190889|463289114|FG001|Overall Study|Withdrawal by Subject|1|||
129144730|NCT03033784|464826301|FG009|Overall Study|Anxiety related to MRI scanner|0|||
129144731|NCT03033784|464826302|FG010|Overall Study|Anxiety related to MRI scanner|0|||
129144732|NCT03033784|464826303|FG011|Overall Study|Anxiety related to MRI scanner|0|||
129144733|NCT03033784|464826304|FG012|Overall Study|Anxiety related to MRI scanner|0|||
129144734|NCT03033784|464826292|FG000|Overall Study|Withdrawal by Subject|0|||
129144735|NCT03033784|464826293|FG001|Overall Study|Withdrawal by Subject|0|||
129144736|NCT03033784|464826294|FG002|Overall Study|Withdrawal by Subject|0|||
129144737|NCT03033784|464826295|FG003|Overall Study|Withdrawal by Subject|0|||
129144738|NCT03033784|464826296|FG004|Overall Study|Withdrawal by Subject|0|||
129144739|NCT03033784|464826297|FG005|Overall Study|Withdrawal by Subject|0|||
129144740|NCT03033784|464826298|FG006|Overall Study|Withdrawal by Subject|0|||
129144741|NCT03033784|464826299|FG007|Overall Study|Withdrawal by Subject|0|||
129144742|NCT03033784|464826300|FG008|Overall Study|Withdrawal by Subject|0|||
129144743|NCT03033784|464826301|FG009|Overall Study|Withdrawal by Subject|0|||
129144744|NCT03033784|464826302|FG010|Overall Study|Withdrawal by Subject|0|||
129144745|NCT03033784|464826303|FG011|Overall Study|Withdrawal by Subject|0|||
129144746|NCT03033784|464826304|FG012|Overall Study|Withdrawal by Subject|2|||
129144747|NCT02374255|464826306|FG000|Overall Study|Withdrawal by Subject|2|||
129144748|NCT02374255|464826307|FG001|Overall Study|Withdrawal by Subject|0|||
129144749|NCT02374255|464826308|FG002|Overall Study|Withdrawal by Subject|0|||
129144750|NCT02374255|464826309|FG003|Overall Study|Withdrawal by Subject|0|||
129144751|NCT03332056|464826310|FG000|Overall Study|Incomplete questionnaires|8|||
129144752|NCT03332056|464826311|FG001|Overall Study|Incomplete questionnaires|9|||
129144753|NCT03332056|464826310|FG000|Overall Study|Passed stone prior to surgery date|1|||
129144754|NCT03332056|464826311|FG001|Overall Study|Passed stone prior to surgery date|0|||
129144755|NCT03332056|464826310|FG000|Overall Study|Did not require a ureteral stent|0|||
129144756|NCT03332056|464826311|FG001|Overall Study|Did not require a ureteral stent|1|||
129144757|NCT02093520|464826312|FG000|Overall Study|Not treated|6|||
129144758|NCT02093520|464826313|FG001|Overall Study|Not treated|22|||
129144759|NCT03014089|464826314|FG000|Overall Study|Withdrawal by Subject|0|||
129144760|NCT03014089|464826315|FG001|Overall Study|Withdrawal by Subject|1|||
129144761|NCT03014089|464826316|FG002|Overall Study|Withdrawal by Subject|1|||
129144762|NCT03014089|464826317|FG003|Overall Study|Withdrawal by Subject|1|||
129144763|NCT03014089|464826314|FG000|Overall Study|Lost to Follow-up|1|||
129144764|NCT03014089|464826315|FG001|Overall Study|Lost to Follow-up|0|||
129144765|NCT03014089|464826316|FG002|Overall Study|Lost to Follow-up|0|||
129144766|NCT03014089|464826317|FG003|Overall Study|Lost to Follow-up|0|||
129144767|NCT03014089|464826314|FG000|Overall Study|Adverse Event|1|||
129144768|NCT03014089|464826315|FG001|Overall Study|Adverse Event|0|||
129144769|NCT03014089|464826316|FG002|Overall Study|Adverse Event|1|||
129144770|NCT03014089|464826317|FG003|Overall Study|Adverse Event|0|||
129144771|NCT01992757|464826326|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
129144772|NCT00688740|464826327|FG000|Overall Study|Adverse Event|45|||
129144773|NCT00688740|464826328|FG001|Overall Study|Adverse Event|8|||
129144774|NCT00688740|464826327|FG000|Overall Study|Death|2|||
129144775|NCT00688740|464826328|FG001|Overall Study|Death|2|||
129144776|NCT00688740|464826327|FG000|Overall Study|Lost to Follow-up|0|||
129144777|NCT00688740|464826328|FG001|Overall Study|Lost to Follow-up|1|||
129144778|NCT00688740|464826327|FG000|Overall Study|Consent Withdrawn|17|||
129144779|NCT00688740|464826328|FG001|Overall Study|Consent Withdrawn|17|||
129144780|NCT00688740|464826327|FG000|Overall Study|Breast Cancer Relapse|1|||
129144781|NCT00688740|464826328|FG001|Overall Study|Breast Cancer Relapse|4|||
129144782|NCT00688740|464826327|FG000|Overall Study|Violation of Inclusion Criteria|1|||
129144783|NCT00688740|464826328|FG001|Overall Study|Violation of Inclusion Criteria|3|||
129144784|NCT00856557|464826329|FG000|Overall Study|No patients with contextual flags|12|||
128724490|NCT03190889|463289115|FG002|Overall Study|Withdrawal by Subject|2|||
128724491|NCT03190889|463289113|FG000|Overall Study|Did not complete protocol|4|||
129144785|NCT00856557|464826330|FG001|Overall Study|No patients with contextual flags|16|||
129144786|NCT01432444|464826331|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
129144787|NCT01432444|464826332|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
129144788|NCT01432444|464826333|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
129144789|NCT01432444|464826331|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
129144790|NCT01432444|464826332|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
129144791|NCT01432444|464826333|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
129144792|NCT01432444|464826331|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
129144793|NCT01432444|464826332|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
129144794|NCT01432444|464826333|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
129144795|NCT01432444|464826331|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
129144796|NCT01432444|464826332|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
129144797|NCT01432444|464826333|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
128724492|NCT03190889|463289114|FG001|Overall Study|Did not complete protocol|9|||
128724493|NCT03190889|463289115|FG002|Overall Study|Did not complete protocol|0|||
129144798|NCT01432444|464826331|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
129144799|NCT01432444|464826332|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
129144800|NCT01432444|464826333|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
129144801|NCT01432444|464826331|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
129144802|NCT01432444|464826332|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
129144803|NCT01432444|464826333|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
128724494|NCT03190889|463289113|FG000|Overall Study|COVID-19|1|||
128724495|NCT03190889|463289114|FG001|Overall Study|COVID-19|0|||
128724496|NCT03190889|463289115|FG002|Overall Study|COVID-19|2|||
129144804|NCT01432444|464826331|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
129144805|NCT01432444|464826332|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
129144806|NCT01432444|464826333|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
129144807|NCT01432444|464826331|FG000|Treatment Phase|Lost to Follow-up|0|||
129144808|NCT01432444|464826332|FG001|Treatment Phase|Lost to Follow-up|33|||
129144809|NCT01432444|464826333|FG002|Treatment Phase|Lost to Follow-up|0|||
129144810|NCT01432444|464826331|FG000|Treatment Phase|Adverse Event|0|||
129144811|NCT01432444|464826332|FG001|Treatment Phase|Adverse Event|37|||
129144812|NCT01432444|464826333|FG002|Treatment Phase|Adverse Event|0|||
129144813|NCT01432444|464826331|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
129144814|NCT01432444|464826332|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
129144815|NCT01432444|464826333|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
129144816|NCT01432444|464826331|FG000|Treatment Phase|Physician Decision|0|||
129144817|NCT01432444|464826332|FG001|Treatment Phase|Physician Decision|5|||
129144818|NCT01432444|464826333|FG002|Treatment Phase|Physician Decision|0|||
129144819|NCT01432444|464826331|FG000|Treatment Phase|Withdrawal by Subject|0|||
129144820|NCT01432444|464826332|FG001|Treatment Phase|Withdrawal by Subject|41|||
129144821|NCT01432444|464826333|FG002|Treatment Phase|Withdrawal by Subject|0|||
129144822|NCT01432444|464826331|FG000|Treatment Phase|Protocol Deviation|0|||
129144823|NCT01432444|464826332|FG001|Treatment Phase|Protocol Deviation|3|||
129144824|NCT01432444|464826333|FG002|Treatment Phase|Protocol Deviation|0|||
129144825|NCT01432444|464826331|FG000|Treatment Phase|Lack of Efficacy|0|||
129144826|NCT01432444|464826332|FG001|Treatment Phase|Lack of Efficacy|10|||
129144827|NCT01432444|464826333|FG002|Treatment Phase|Lack of Efficacy|0|||
129144828|NCT01432444|464826331|FG000|Extension Phase|Lost to Follow-up|0|||
129144829|NCT01432444|464826332|FG001|Extension Phase|Lost to Follow-up|0|||
129144830|NCT01432444|464826333|FG002|Extension Phase|Lost to Follow-up|17|||
129144831|NCT01432444|464826331|FG000|Extension Phase|Adverse Event|0|||
129144832|NCT01432444|464826332|FG001|Extension Phase|Adverse Event|0|||
129144833|NCT01432444|464826333|FG002|Extension Phase|Adverse Event|10|||
129144834|NCT01432444|464826331|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
129144835|NCT01432444|464826332|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
129144836|NCT01432444|464826333|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
129144837|NCT01432444|464826331|FG000|Extension Phase|Met Withdrawal Criteria|0|||
129144838|NCT01432444|464826332|FG001|Extension Phase|Met Withdrawal Criteria|0|||
129144839|NCT01432444|464826333|FG002|Extension Phase|Met Withdrawal Criteria|144|||
129144840|NCT01432444|464826331|FG000|Extension Phase|Physician Decision|0|||
129144841|NCT01432444|464826332|FG001|Extension Phase|Physician Decision|0|||
129144842|NCT01432444|464826333|FG002|Extension Phase|Physician Decision|1|||
129144843|NCT01432444|464826331|FG000|Extension Phase|Withdrawal by Subject|0|||
129144844|NCT01432444|464826332|FG001|Extension Phase|Withdrawal by Subject|0|||
129144845|NCT01432444|464826333|FG002|Extension Phase|Withdrawal by Subject|13|||
129144846|NCT03673176|464826334|FG000|Overall Study|Death prior to intervention|1|||
129144847|NCT03673176|464826334|FG000|Overall Study|Death following intervention|3|||
129144848|NCT03673176|464826334|FG000|Overall Study|Withdrawal by Subject|1|||
129144849|NCT02301897|464826335|FG000|Treatment Course 1|Non-Compliance|0|||
129144850|NCT02301897|464826336|FG001|Treatment Course 1|Non-Compliance|0|||
129144851|NCT02301897|464826337|FG002|Treatment Course 1|Non-Compliance|1|||
129144852|NCT02301897|464826335|FG000|Treatment Course 1|Adverse Event|1|||
129144853|NCT02301897|464826336|FG001|Treatment Course 1|Adverse Event|1|||
129144854|NCT02301897|464826337|FG002|Treatment Course 1|Adverse Event|0|||
129144855|NCT02301897|464826335|FG000|Treatment Course 1|Lost to Follow-up|1|||
129144856|NCT02301897|464826336|FG001|Treatment Course 1|Lost to Follow-up|2|||
129144857|NCT02301897|464826337|FG002|Treatment Course 1|Lost to Follow-up|1|||
129144858|NCT02301897|464826335|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
129144859|NCT02301897|464826336|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
129144860|NCT02301897|464826337|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
129144861|NCT02301897|464826335|FG000|Treatment Course 1|Withdrawal by Subject|0|||
129144862|NCT02301897|464826336|FG001|Treatment Course 1|Withdrawal by Subject|0|||
129144863|NCT02301897|464826337|FG002|Treatment Course 1|Withdrawal by Subject|2|||
129144864|NCT02301897|464826335|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
129144865|NCT02301897|464826336|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
129144866|NCT02301897|464826337|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
129144867|NCT02301897|464826335|FG000|Treatment Course 2|Lost to Follow-up|0|||
129144868|NCT02301897|464826336|FG001|Treatment Course 2|Lost to Follow-up|2|||
129144869|NCT02301897|464826337|FG002|Treatment Course 2|Lost to Follow-up|0|||
129144870|NCT02301897|464826335|FG000|Treatment Course 2|Pregnancy|0|||
129144871|NCT02301897|464826336|FG001|Treatment Course 2|Pregnancy|1|||
129144872|NCT02301897|464826337|FG002|Treatment Course 2|Pregnancy|1|||
129144873|NCT02301897|464826335|FG000|Treatment Course 2|Withdrawal by Subject|0|||
129144874|NCT02301897|464826336|FG001|Treatment Course 2|Withdrawal by Subject|2|||
129144875|NCT02301897|464826337|FG002|Treatment Course 2|Withdrawal by Subject|0|||
129144876|NCT02301897|464826335|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
129144877|NCT02301897|464826336|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
129144878|NCT02301897|464826337|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
129144879|NCT02439957|464826338|FG000|Overall Study|Study Terminated|3|||
129144880|NCT02439957|464826339|FG001|Overall Study|Study Terminated|3|||
129144881|NCT00478257|464826344|FG000|Overall Study|Withdrawal by Subject|8|||
129087876|NCT01647516|464611579|FG005|Induction Period (IP)|Participant Choice|0|||
129087877|NCT01647516|464611574|FG000|Induction Period (IP)|Lack of Efficacy|1|||
129087878|NCT01647516|464611575|FG001|Induction Period (IP)|Lack of Efficacy|0|||
129087879|NCT01647516|464611576|FG002|Induction Period (IP)|Lack of Efficacy|0|||
129087880|NCT01647516|464611577|FG003|Induction Period (IP)|Lack of Efficacy|0|||
129087881|NCT01647516|464611578|FG004|Induction Period (IP)|Lack of Efficacy|0|||
129087882|NCT01647516|464611579|FG005|Induction Period (IP)|Lack of Efficacy|0|||
129087883|NCT01647516|464611574|FG000|Induction Period (IP)|No study drug received|1|||
129087884|NCT01647516|464611575|FG001|Induction Period (IP)|No study drug received|1|||
129087885|NCT01647516|464611576|FG002|Induction Period (IP)|No study drug received|0|||
129087886|NCT01647516|464611577|FG003|Induction Period (IP)|No study drug received|0|||
129087887|NCT01647516|464611578|FG004|Induction Period (IP)|No study drug received|0|||
129087888|NCT01647516|464611579|FG005|Induction Period (IP)|No study drug received|0|||
129087889|NCT01647516|464611574|FG000|Maintenance Period (MP)|Adverse Event|2|||
129087890|NCT01647516|464611575|FG001|Maintenance Period (MP)|Adverse Event|1|||
129087891|NCT01647516|464611576|FG002|Maintenance Period (MP)|Adverse Event|0|||
129087892|NCT01647516|464611577|FG003|Maintenance Period (MP)|Adverse Event|0|||
129087893|NCT01647516|464611578|FG004|Maintenance Period (MP)|Adverse Event|0|||
129087894|NCT01647516|464611579|FG005|Maintenance Period (MP)|Adverse Event|0|||
129087895|NCT01647516|464611574|FG000|Maintenance Period (MP)|Non-compliance|1|||
129087896|NCT01647516|464611575|FG001|Maintenance Period (MP)|Non-compliance|0|||
129087897|NCT01647516|464611576|FG002|Maintenance Period (MP)|Non-compliance|0|||
129087898|NCT01647516|464611577|FG003|Maintenance Period (MP)|Non-compliance|0|||
129087899|NCT01647516|464611578|FG004|Maintenance Period (MP)|Non-compliance|0|||
129087900|NCT01647516|464611579|FG005|Maintenance Period (MP)|Non-compliance|0|||
129087901|NCT01647516|464611574|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
129087902|NCT01647516|464611575|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
129087903|NCT01647516|464611576|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
129087904|NCT01647516|464611577|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
129087905|NCT01647516|464611578|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
129087906|NCT01647516|464611579|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
129087907|NCT01647516|464611574|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
129087908|NCT01647516|464611575|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
129087909|NCT01647516|464611576|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
129087910|NCT01647516|464611577|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
129087911|NCT01647516|464611578|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
129087912|NCT01647516|464611579|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
129087913|NCT01647516|464611574|FG000|Open-Label Period|Adverse Event|0|||
129087914|NCT01647516|464611575|FG001|Open-Label Period|Adverse Event|0|||
129087915|NCT01647516|464611576|FG002|Open-Label Period|Adverse Event|0|||
129087916|NCT01647516|464611577|FG003|Open-Label Period|Adverse Event|5|||
129087917|NCT01647516|464611578|FG004|Open-Label Period|Adverse Event|6|||
129087918|NCT01647516|464611579|FG005|Open-Label Period|Adverse Event|3|||
129087919|NCT01647516|464611574|FG000|Open-Label Period|Pregnancy|0|||
129087920|NCT01647516|464611575|FG001|Open-Label Period|Pregnancy|0|||
129087921|NCT01647516|464611576|FG002|Open-Label Period|Pregnancy|0|||
129087922|NCT01647516|464611577|FG003|Open-Label Period|Pregnancy|0|||
129087923|NCT01647516|464611578|FG004|Open-Label Period|Pregnancy|0|||
129087924|NCT01647516|464611579|FG005|Open-Label Period|Pregnancy|1|||
129087925|NCT01647516|464611574|FG000|Open-Label Period|Non-compliance|0|||
129087926|NCT01647516|464611575|FG001|Open-Label Period|Non-compliance|0|||
129087927|NCT01647516|464611576|FG002|Open-Label Period|Non-compliance|0|||
129087928|NCT01647516|464611577|FG003|Open-Label Period|Non-compliance|1|||
129087929|NCT01647516|464611578|FG004|Open-Label Period|Non-compliance|0|||
129087930|NCT01647516|464611579|FG005|Open-Label Period|Non-compliance|1|||
129087931|NCT01647516|464611574|FG000|Open-Label Period|Physician Decision|0|||
129087932|NCT01647516|464611575|FG001|Open-Label Period|Physician Decision|0|||
129087933|NCT01647516|464611576|FG002|Open-Label Period|Physician Decision|0|||
129087934|NCT01647516|464611577|FG003|Open-Label Period|Physician Decision|1|||
129087935|NCT01647516|464611578|FG004|Open-Label Period|Physician Decision|1|||
129087936|NCT01647516|464611579|FG005|Open-Label Period|Physician Decision|0|||
129144882|NCT00478257|464826345|FG001|Overall Study|Withdrawal by Subject|3|||
129144883|NCT03931330|464826346|FG000|Overall Study|Physician Decision|1|||
129144884|NCT03412929|464826347|FG000|Overall Study|Protocol Violation|3|||
129087937|NCT01647516|464611574|FG000|Open-Label Period|Withdrawal by Subject|0|||
129087938|NCT01647516|464611575|FG001|Open-Label Period|Withdrawal by Subject|0|||
129087939|NCT01647516|464611576|FG002|Open-Label Period|Withdrawal by Subject|0|||
129087940|NCT01647516|464611577|FG003|Open-Label Period|Withdrawal by Subject|9|||
129087941|NCT01647516|464611578|FG004|Open-Label Period|Withdrawal by Subject|11|||
129087942|NCT01647516|464611579|FG005|Open-Label Period|Withdrawal by Subject|6|||
129087943|NCT01647516|464611574|FG000|Open-Label Period|Lost to Follow-up|0|||
129087944|NCT01647516|464611575|FG001|Open-Label Period|Lost to Follow-up|0|||
129087945|NCT01647516|464611576|FG002|Open-Label Period|Lost to Follow-up|0|||
129087946|NCT01647516|464611577|FG003|Open-Label Period|Lost to Follow-up|1|||
129087947|NCT01647516|464611578|FG004|Open-Label Period|Lost to Follow-up|0|||
129087948|NCT01647516|464611579|FG005|Open-Label Period|Lost to Follow-up|1|||
129087949|NCT01647516|464611574|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
129087950|NCT01647516|464611575|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
129087951|NCT01647516|464611576|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
129087952|NCT01647516|464611577|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
129087953|NCT01647516|464611578|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
129087954|NCT01647516|464611579|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
129087955|NCT01647516|464611574|FG000|Open-Label Period|Lack of Efficacy|0|||
129087956|NCT01647516|464611575|FG001|Open-Label Period|Lack of Efficacy|0|||
129087957|NCT01647516|464611576|FG002|Open-Label Period|Lack of Efficacy|0|||
129087958|NCT01647516|464611577|FG003|Open-Label Period|Lack of Efficacy|7|||
129087959|NCT01647516|464611578|FG004|Open-Label Period|Lack of Efficacy|9|||
129087960|NCT01647516|464611579|FG005|Open-Label Period|Lack of Efficacy|10|||
129087961|NCT01647516|464611574|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
129087962|NCT01647516|464611575|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
129087963|NCT01647516|464611576|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
129087964|NCT01647516|464611577|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
129087965|NCT01647516|464611578|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
129087966|NCT01647516|464611579|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
129087967|NCT01647516|464611574|FG000|Open-Label Period|No completion / discontinuation visit|0|||
129087968|NCT01647516|464611575|FG001|Open-Label Period|No completion / discontinuation visit|0|||
129087969|NCT01647516|464611576|FG002|Open-Label Period|No completion / discontinuation visit|0|||
129087970|NCT01647516|464611577|FG003|Open-Label Period|No completion / discontinuation visit|0|||
129087971|NCT01647516|464611578|FG004|Open-Label Period|No completion / discontinuation visit|2|||
129087972|NCT01647516|464611579|FG005|Open-Label Period|No completion / discontinuation visit|1|||
129087973|NCT02980341|464611580|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
129087974|NCT02980341|464611581|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
129087975|NCT02980341|464611582|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
129087976|NCT02980341|464611583|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
129087977|NCT02980341|464611584|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
129087978|NCT02980341|464611585|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129087979|NCT02980341|464611586|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129087980|NCT02980341|464611587|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129087981|NCT02980341|464611588|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129087982|NCT02980341|464611589|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129087983|NCT02980341|464611590|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129087984|NCT02980341|464611580|FG000|Dose Escalation|Clinical progression|0|||
129087985|NCT02980341|464611581|FG001|Dose Escalation|Clinical progression|0|||
129087986|NCT02980341|464611582|FG002|Dose Escalation|Clinical progression|2|||
129087987|NCT02980341|464611583|FG003|Dose Escalation|Clinical progression|1|||
129087988|NCT02980341|464611584|FG004|Dose Escalation|Clinical progression|0|||
129087989|NCT02980341|464611585|FG005|Dose Escalation|Clinical progression|0|||
129087990|NCT02980341|464611586|FG006|Dose Escalation|Clinical progression|0|||
129087991|NCT02980341|464611587|FG007|Dose Escalation|Clinical progression|0|||
129087992|NCT02980341|464611588|FG008|Dose Escalation|Clinical progression|0|||
129087993|NCT02980341|464611589|FG009|Dose Escalation|Clinical progression|0|||
129087994|NCT02980341|464611590|FG010|Dose Escalation|Clinical progression|0|||
129087995|NCT02980341|464611580|FG000|Dose Escalation|Adverse Event|0|||
129087996|NCT02980341|464611581|FG001|Dose Escalation|Adverse Event|0|||
129087997|NCT02980341|464611582|FG002|Dose Escalation|Adverse Event|1|||
129087998|NCT02980341|464611583|FG003|Dose Escalation|Adverse Event|2|||
129087999|NCT02980341|464611584|FG004|Dose Escalation|Adverse Event|2|||
129088000|NCT02980341|464611585|FG005|Dose Escalation|Adverse Event|0|||
129088001|NCT02980341|464611586|FG006|Dose Escalation|Adverse Event|0|||
129088002|NCT02980341|464611587|FG007|Dose Escalation|Adverse Event|0|||
129088003|NCT02980341|464611588|FG008|Dose Escalation|Adverse Event|0|||
129088004|NCT02980341|464611589|FG009|Dose Escalation|Adverse Event|0|||
129088005|NCT02980341|464611590|FG010|Dose Escalation|Adverse Event|0|||
129088006|NCT02980341|464611580|FG000|Dose Escalation|Withdrawal by Subject|0|||
129088007|NCT02980341|464611581|FG001|Dose Escalation|Withdrawal by Subject|0|||
129088008|NCT02980341|464611582|FG002|Dose Escalation|Withdrawal by Subject|1|||
129144885|NCT01381679|464826352|FG000|Overall Study|Adverse Event|3|||
129144886|NCT01381679|464826352|FG000|Overall Study|Lost to Follow-up|885|||
129144887|NCT04023487|464826353|FG000|Overall Study|Lost to Follow-up|5|||
129144888|NCT04023487|464826354|FG001|Overall Study|Lost to Follow-up|4|||
129144889|NCT04023487|464826353|FG000|Overall Study|Pregnancy|1|||
129088009|NCT02980341|464611583|FG003|Dose Escalation|Withdrawal by Subject|0|||
129088010|NCT02980341|464611584|FG004|Dose Escalation|Withdrawal by Subject|0|||
129088011|NCT02980341|464611585|FG005|Dose Escalation|Withdrawal by Subject|0|||
129088012|NCT02980341|464611586|FG006|Dose Escalation|Withdrawal by Subject|0|||
129088013|NCT02980341|464611587|FG007|Dose Escalation|Withdrawal by Subject|0|||
129088014|NCT02980341|464611588|FG008|Dose Escalation|Withdrawal by Subject|0|||
129088015|NCT02980341|464611589|FG009|Dose Escalation|Withdrawal by Subject|0|||
129088016|NCT02980341|464611590|FG010|Dose Escalation|Withdrawal by Subject|0|||
129088017|NCT02980341|464611580|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088018|NCT02980341|464611581|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088019|NCT02980341|464611582|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088020|NCT02980341|464611583|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
129088021|NCT02980341|464611584|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088022|NCT02980341|464611585|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088023|NCT02980341|464611586|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088024|NCT02980341|464611587|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088025|NCT02980341|464611588|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088026|NCT02980341|464611589|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
129088027|NCT02980341|464611590|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
129144890|NCT04023487|464826354|FG001|Overall Study|Pregnancy|2|||
129144891|NCT04023487|464826353|FG000|Overall Study|Withdrawal by Subject|4|||
129144892|NCT04023487|464826354|FG001|Overall Study|Withdrawal by Subject|5|||
129144893|NCT04023487|464826353|FG000|Overall Study|Partially completed testing|8|||
129144894|NCT04023487|464826354|FG001|Overall Study|Partially completed testing|4|||
129144895|NCT04770285|464826357|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
129144896|NCT04770285|464826358|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
129144897|NCT04770285|464826357|FG000|Overall Study|Lack of Efficacy|0|||
129144898|NCT04770285|464826358|FG001|Overall Study|Lack of Efficacy|1|||
129144899|NCT04770285|464826357|FG000|Overall Study|Lost to Follow-up|11|||
129144900|NCT04770285|464826358|FG001|Overall Study|Lost to Follow-up|8|||
129144901|NCT04770285|464826357|FG000|Overall Study|Protocol Deviation|6|||
129144902|NCT04770285|464826358|FG001|Overall Study|Protocol Deviation|6|||
129144903|NCT04770285|464826357|FG000|Overall Study|Technical Problem|0|||
129144904|NCT04770285|464826358|FG001|Overall Study|Technical Problem|1|||
129144905|NCT04770285|464826357|FG000|Overall Study|Withdrawal by Subject|9|||
129144906|NCT04770285|464826358|FG001|Overall Study|Withdrawal by Subject|8|||
129144907|NCT04770285|464826357|FG000|Overall Study|Reason Not Specified|0|||
129144908|NCT04770285|464826358|FG001|Overall Study|Reason Not Specified|1|||
129144909|NCT03766399|464826359|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144910|NCT03766399|464826360|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144911|NCT03766399|464826361|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144912|NCT03766399|464826362|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144913|NCT03766399|464826363|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144914|NCT03766399|464826364|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144915|NCT03766399|464826365|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144916|NCT03766399|464826366|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144917|NCT03766399|464826367|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144918|NCT03766399|464826368|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144919|NCT03766399|464826369|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144920|NCT03766399|464826370|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144921|NCT03766399|464826371|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144922|NCT03766399|464826372|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
129144923|NCT03766399|464826373|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144924|NCT03766399|464826374|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144925|NCT03766399|464826375|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144926|NCT03766399|464826376|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129144927|NCT03895372|464826379|FG000|Investigational Treatment Period|Adverse Event|1|||
129144928|NCT03895372|464826380|FG001|Investigational Treatment Period|Adverse Event|0|||
129144929|NCT03895372|464826381|FG002|Investigational Treatment Period|Adverse Event|0|||
129144930|NCT03895372|464826382|FG003|Investigational Treatment Period|Adverse Event|0|||
129144931|NCT03895372|464826383|FG004|Investigational Treatment Period|Adverse Event|0|||
129144932|NCT03895372|464826384|FG005|Investigational Treatment Period|Adverse Event|0|||
129144933|NCT03895372|464826385|FG006|Investigational Treatment Period|Adverse Event|4|||
129144934|NCT03895372|464826386|FG007|Investigational Treatment Period|Adverse Event|3|||
129144935|NCT03895372|464826379|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
129144936|NCT03895372|464826380|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
129144937|NCT03895372|464826381|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
129144938|NCT03895372|464826382|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
128724497|NCT00680901|463289116|FG000|Overall Study|Ongoing: On Study Treatment|1|||
129088028|NCT02980341|464611580|FG000|Dose Escalation|Due to investigator's decision|0|||
129088029|NCT02980341|464611581|FG001|Dose Escalation|Due to investigator's decision|0|||
129088030|NCT02980341|464611582|FG002|Dose Escalation|Due to investigator's decision|0|||
129088031|NCT02980341|464611583|FG003|Dose Escalation|Due to investigator's decision|0|||
129088032|NCT02980341|464611584|FG004|Dose Escalation|Due to investigator's decision|1|||
129088033|NCT02980341|464611585|FG005|Dose Escalation|Due to investigator's decision|0|||
129088034|NCT02980341|464611586|FG006|Dose Escalation|Due to investigator's decision|0|||
129088035|NCT02980341|464611587|FG007|Dose Escalation|Due to investigator's decision|0|||
129088036|NCT02980341|464611588|FG008|Dose Escalation|Due to investigator's decision|0|||
129088037|NCT02980341|464611589|FG009|Dose Escalation|Due to investigator's decision|0|||
129088038|NCT02980341|464611590|FG010|Dose Escalation|Due to investigator's decision|0|||
129088039|NCT02980341|464611580|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088040|NCT02980341|464611581|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088041|NCT02980341|464611582|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088042|NCT02980341|464611583|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088043|NCT02980341|464611584|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088044|NCT02980341|464611585|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
129088045|NCT02980341|464611586|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
129088046|NCT02980341|464611587|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088047|NCT02980341|464611588|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088048|NCT02980341|464611589|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088049|NCT02980341|464611590|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
129088050|NCT02980341|464611580|FG000|Dose Finding|Adverse Event|0|||
129088051|NCT02980341|464611581|FG001|Dose Finding|Adverse Event|0|||
129088052|NCT02980341|464611582|FG002|Dose Finding|Adverse Event|0|||
129088053|NCT02980341|464611583|FG003|Dose Finding|Adverse Event|0|||
129088054|NCT02980341|464611584|FG004|Dose Finding|Adverse Event|0|||
129088055|NCT02980341|464611585|FG005|Dose Finding|Adverse Event|3|||
129088056|NCT02980341|464611586|FG006|Dose Finding|Adverse Event|0|||
129088057|NCT02980341|464611587|FG007|Dose Finding|Adverse Event|0|||
129088058|NCT02980341|464611588|FG008|Dose Finding|Adverse Event|0|||
129088059|NCT02980341|464611589|FG009|Dose Finding|Adverse Event|0|||
129088060|NCT02980341|464611590|FG010|Dose Finding|Adverse Event|0|||
129088061|NCT02980341|464611580|FG000|Dose Finding|Withdrawal by Subject|0|||
129088062|NCT02980341|464611581|FG001|Dose Finding|Withdrawal by Subject|0|||
129088063|NCT02980341|464611582|FG002|Dose Finding|Withdrawal by Subject|0|||
129088064|NCT02980341|464611583|FG003|Dose Finding|Withdrawal by Subject|0|||
129088065|NCT02980341|464611584|FG004|Dose Finding|Withdrawal by Subject|0|||
129088066|NCT02980341|464611585|FG005|Dose Finding|Withdrawal by Subject|1|||
129088067|NCT02980341|464611586|FG006|Dose Finding|Withdrawal by Subject|1|||
129088068|NCT02980341|464611587|FG007|Dose Finding|Withdrawal by Subject|0|||
129088069|NCT02980341|464611588|FG008|Dose Finding|Withdrawal by Subject|0|||
129144939|NCT03895372|464826383|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
129144940|NCT03895372|464826384|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
129144941|NCT03895372|464826385|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
129144942|NCT03895372|464826386|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
129144943|NCT03895372|464826379|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
129144944|NCT03895372|464826380|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
129144945|NCT03895372|464826381|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
129144946|NCT03895372|464826382|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
129144947|NCT03895372|464826383|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
129144948|NCT03895372|464826384|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
129144949|NCT03895372|464826385|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
129144950|NCT03895372|464826386|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
129144951|NCT03895372|464826379|FG000|Investigational Treatment Period|Other|0|||
129144952|NCT03895372|464826380|FG001|Investigational Treatment Period|Other|0|||
129144953|NCT03895372|464826381|FG002|Investigational Treatment Period|Other|0|||
129144954|NCT03895372|464826382|FG003|Investigational Treatment Period|Other|0|||
129144955|NCT03895372|464826383|FG004|Investigational Treatment Period|Other|0|||
129144956|NCT03895372|464826384|FG005|Investigational Treatment Period|Other|1|||
129144957|NCT03895372|464826385|FG006|Investigational Treatment Period|Other|0|||
129144958|NCT03895372|464826386|FG007|Investigational Treatment Period|Other|2|||
129144959|NCT03895372|464826379|FG000|Investigational Treatment Period|Protocol Violation|0|||
129144960|NCT03895372|464826380|FG001|Investigational Treatment Period|Protocol Violation|0|||
129144961|NCT03895372|464826381|FG002|Investigational Treatment Period|Protocol Violation|0|||
129144962|NCT03895372|464826382|FG003|Investigational Treatment Period|Protocol Violation|1|||
128724498|NCT00680901|463289117|FG001|Overall Study|Ongoing: On Study Treatment|0|||
128724499|NCT00680901|463289116|FG000|Overall Study|Ongoing: In Follow Up|1|||
129088070|NCT02980341|464611589|FG009|Dose Finding|Withdrawal by Subject|0|||
129088071|NCT02980341|464611590|FG010|Dose Finding|Withdrawal by Subject|0|||
129088072|NCT02980341|464611580|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129088073|NCT02980341|464611581|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129144963|NCT03895372|464826383|FG004|Investigational Treatment Period|Protocol Violation|0|||
129144964|NCT03895372|464826384|FG005|Investigational Treatment Period|Protocol Violation|0|||
129144965|NCT03895372|464826385|FG006|Investigational Treatment Period|Protocol Violation|0|||
129144966|NCT03895372|464826386|FG007|Investigational Treatment Period|Protocol Violation|0|||
129144967|NCT03895372|464826379|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
129144968|NCT03895372|464826380|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
129144969|NCT03895372|464826381|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
129144970|NCT03895372|464826382|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
129144971|NCT03895372|464826383|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
129144972|NCT03895372|464826384|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
129144973|NCT03895372|464826385|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
129144974|NCT03895372|464826386|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
129144975|NCT03895372|464826379|FG000|Extension Treatment Period|Adverse Event|0|||
129144976|NCT03895372|464826380|FG001|Extension Treatment Period|Adverse Event|1|||
129144977|NCT03895372|464826381|FG002|Extension Treatment Period|Adverse Event|0|||
129144978|NCT03895372|464826382|FG003|Extension Treatment Period|Adverse Event|1|||
129144979|NCT03895372|464826383|FG004|Extension Treatment Period|Adverse Event|0|||
129144980|NCT03895372|464826384|FG005|Extension Treatment Period|Adverse Event|0|||
129144981|NCT03895372|464826385|FG006|Extension Treatment Period|Adverse Event|3|||
129144982|NCT03895372|464826386|FG007|Extension Treatment Period|Adverse Event|3|||
129144983|NCT03895372|464826379|FG000|Extension Treatment Period|Other|1|||
129144984|NCT03895372|464826380|FG001|Extension Treatment Period|Other|3|||
129144985|NCT03895372|464826381|FG002|Extension Treatment Period|Other|0|||
129144986|NCT03895372|464826382|FG003|Extension Treatment Period|Other|0|||
129144987|NCT03895372|464826383|FG004|Extension Treatment Period|Other|1|||
129144988|NCT03895372|464826384|FG005|Extension Treatment Period|Other|0|||
129144989|NCT03895372|464826385|FG006|Extension Treatment Period|Other|0|||
129144990|NCT03895372|464826386|FG007|Extension Treatment Period|Other|2|||
129144991|NCT03895372|464826379|FG000|Extension Treatment Period|Pregnancy|0|||
129144992|NCT03895372|464826380|FG001|Extension Treatment Period|Pregnancy|0|||
129144993|NCT03895372|464826381|FG002|Extension Treatment Period|Pregnancy|0|||
129144994|NCT03895372|464826382|FG003|Extension Treatment Period|Pregnancy|0|||
129144995|NCT03895372|464826383|FG004|Extension Treatment Period|Pregnancy|1|||
129144996|NCT03895372|464826384|FG005|Extension Treatment Period|Pregnancy|0|||
129144997|NCT03895372|464826385|FG006|Extension Treatment Period|Pregnancy|0|||
129144998|NCT03895372|464826386|FG007|Extension Treatment Period|Pregnancy|0|||
129144999|NCT03895372|464826379|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
129145000|NCT03895372|464826380|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
129145001|NCT03895372|464826381|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129145002|NCT03895372|464826382|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
129145003|NCT03895372|464826383|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
129145004|NCT03895372|464826384|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
129145005|NCT03895372|464826385|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
129145006|NCT03895372|464826386|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
129145007|NCT01472185|464826391|FG000|Overall Study|Randomized but Not Treated|0|||
129145008|NCT01472185|464826392|FG001|Overall Study|Randomized but Not Treated|1|||
129145009|NCT01472185|464826391|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
129145010|NCT01472185|464826392|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
129145011|NCT01472185|464826391|FG000|Overall Study|Hyperglycemia|5|||
129145012|NCT01472185|464826392|FG001|Overall Study|Hyperglycemia|2|||
129145013|NCT01472185|464826391|FG000|Overall Study|Investigator's Discretion|3|||
129145014|NCT01472185|464826392|FG001|Overall Study|Investigator's Discretion|1|||
129145015|NCT01472185|464826391|FG000|Overall Study|Lost to Follow-up|4|||
129145016|NCT01472185|464826392|FG001|Overall Study|Lost to Follow-up|1|||
129145017|NCT01472185|464826391|FG000|Overall Study|Protocol Violation|5|||
129145018|NCT01472185|464826392|FG001|Overall Study|Protocol Violation|1|||
129145019|NCT01472185|464826391|FG000|Overall Study|Subject Noncompliance|8|||
129145020|NCT01472185|464826392|FG001|Overall Study|Subject Noncompliance|15|||
129145021|NCT01472185|464826391|FG000|Overall Study|Subject Withdrew Consent|6|||
129145022|NCT01472185|464826392|FG001|Overall Study|Subject Withdrew Consent|3|||
129145023|NCT05889468|464826393|FG000|Overall Study|Lost to Follow-up|9|||
129145024|NCT05889468|464826394|FG001|Overall Study|Lost to Follow-up|2|||
129145025|NCT05889468|464826393|FG000|Overall Study|Withdrawal by Subject|2|||
129145026|NCT05889468|464826394|FG001|Overall Study|Withdrawal by Subject|2|||
129145027|NCT01309230|464826395|FG000|Overall Study|Withdrawal by Subject|0|||
129145028|NCT01309230|464826396|FG001|Overall Study|Withdrawal by Subject|2|||
129145029|NCT01309230|464826395|FG000|Overall Study|Observation arm closed|0|||
129145030|NCT01309230|464826396|FG001|Overall Study|Observation arm closed|2|||
128724500|NCT00680901|463289117|FG001|Overall Study|Ongoing: In Follow Up|0|||
128724501|NCT00680901|463289116|FG000|Overall Study|Adverse Event|1|||
129145031|NCT00427700|464826403|FG000|Overall Study|Lost to Follow-up|2|||
129145032|NCT00427700|464826404|FG001|Overall Study|Lost to Follow-up|5|||
129145033|NCT00427700|464826403|FG000|Overall Study|no induction of menses|1|||
129145034|NCT00427700|464826404|FG001|Overall Study|no induction of menses|4|||
129088074|NCT02980341|464611582|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129088075|NCT02980341|464611583|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129088076|NCT02980341|464611584|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129088077|NCT02980341|464611585|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129088078|NCT02980341|464611586|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129088079|NCT02980341|464611587|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
129088080|NCT02980341|464611588|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
129088081|NCT02980341|464611589|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
129088082|NCT02980341|464611590|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
129088083|NCT02980341|464611580|FG000|Dose Expansion|Clinical progression|0|||
129088084|NCT02980341|464611581|FG001|Dose Expansion|Clinical progression|0|||
129088085|NCT02980341|464611582|FG002|Dose Expansion|Clinical progression|0|||
129088086|NCT02980341|464611583|FG003|Dose Expansion|Clinical progression|0|||
129088087|NCT02980341|464611584|FG004|Dose Expansion|Clinical progression|0|||
129088088|NCT02980341|464611585|FG005|Dose Expansion|Clinical progression|0|||
129088089|NCT02980341|464611586|FG006|Dose Expansion|Clinical progression|0|||
129088090|NCT02980341|464611587|FG007|Dose Expansion|Clinical progression|4|||
129088091|NCT02980341|464611588|FG008|Dose Expansion|Clinical progression|3|||
129088092|NCT02980341|464611589|FG009|Dose Expansion|Clinical progression|1|||
129088093|NCT02980341|464611590|FG010|Dose Expansion|Clinical progression|4|||
129088094|NCT02980341|464611580|FG000|Dose Expansion|Adverse Event|0|||
129088095|NCT02980341|464611581|FG001|Dose Expansion|Adverse Event|0|||
129088096|NCT02980341|464611582|FG002|Dose Expansion|Adverse Event|0|||
129088097|NCT02980341|464611583|FG003|Dose Expansion|Adverse Event|0|||
129088098|NCT02980341|464611584|FG004|Dose Expansion|Adverse Event|0|||
129088099|NCT02980341|464611585|FG005|Dose Expansion|Adverse Event|0|||
129088100|NCT02980341|464611586|FG006|Dose Expansion|Adverse Event|0|||
129088101|NCT02980341|464611587|FG007|Dose Expansion|Adverse Event|3|||
129088102|NCT02980341|464611588|FG008|Dose Expansion|Adverse Event|0|||
129088103|NCT02980341|464611589|FG009|Dose Expansion|Adverse Event|1|||
129088104|NCT02980341|464611590|FG010|Dose Expansion|Adverse Event|3|||
129088105|NCT02980341|464611580|FG000|Dose Expansion|Death|0|||
129088106|NCT02980341|464611581|FG001|Dose Expansion|Death|0|||
129088107|NCT02980341|464611582|FG002|Dose Expansion|Death|0|||
129088108|NCT02980341|464611583|FG003|Dose Expansion|Death|0|||
129088109|NCT02980341|464611584|FG004|Dose Expansion|Death|0|||
129088110|NCT02980341|464611585|FG005|Dose Expansion|Death|0|||
129088111|NCT02980341|464611586|FG006|Dose Expansion|Death|0|||
129088112|NCT02980341|464611587|FG007|Dose Expansion|Death|0|||
129088113|NCT02980341|464611588|FG008|Dose Expansion|Death|2|||
129088114|NCT02980341|464611589|FG009|Dose Expansion|Death|1|||
129088115|NCT02980341|464611590|FG010|Dose Expansion|Death|0|||
129088116|NCT02980341|464611580|FG000|Dose Expansion|Withdrawal by Subject|0|||
129088117|NCT02980341|464611581|FG001|Dose Expansion|Withdrawal by Subject|0|||
129088118|NCT02980341|464611582|FG002|Dose Expansion|Withdrawal by Subject|0|||
129088119|NCT02980341|464611583|FG003|Dose Expansion|Withdrawal by Subject|0|||
129088120|NCT02980341|464611584|FG004|Dose Expansion|Withdrawal by Subject|0|||
129088121|NCT02980341|464611585|FG005|Dose Expansion|Withdrawal by Subject|0|||
129088122|NCT02980341|464611586|FG006|Dose Expansion|Withdrawal by Subject|0|||
129088123|NCT02980341|464611587|FG007|Dose Expansion|Withdrawal by Subject|2|||
129088124|NCT02980341|464611588|FG008|Dose Expansion|Withdrawal by Subject|0|||
129088125|NCT02980341|464611589|FG009|Dose Expansion|Withdrawal by Subject|1|||
129088126|NCT02980341|464611590|FG010|Dose Expansion|Withdrawal by Subject|0|||
129088127|NCT02980341|464611580|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088128|NCT02980341|464611581|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088129|NCT02980341|464611582|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088130|NCT02980341|464611583|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088131|NCT02980341|464611584|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088132|NCT02980341|464611585|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088133|NCT02980341|464611586|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088134|NCT02980341|464611587|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
129088135|NCT02980341|464611588|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088136|NCT02980341|464611589|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088137|NCT02980341|464611590|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129088138|NCT02980341|464611580|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088139|NCT02980341|464611581|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088140|NCT02980341|464611582|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088141|NCT02980341|464611583|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088142|NCT02980341|464611584|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129145035|NCT00427700|464826403|FG000|Overall Study|Pregnancy|0|||
129088143|NCT02980341|464611585|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088144|NCT02980341|464611586|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088145|NCT02980341|464611587|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088146|NCT02980341|464611588|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
129088147|NCT02980341|464611589|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088148|NCT02980341|464611590|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129088149|NCT02980341|464611580|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088150|NCT02980341|464611581|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088151|NCT02980341|464611582|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088152|NCT02980341|464611583|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088153|NCT02980341|464611584|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088154|NCT02980341|464611585|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088155|NCT02980341|464611586|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088156|NCT02980341|464611587|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088157|NCT02980341|464611588|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
129088158|NCT02980341|464611589|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129088159|NCT02980341|464611590|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129145036|NCT00427700|464826404|FG001|Overall Study|Pregnancy|2|||
129145037|NCT01051661|464826409|FG000|Overall Study|Adverse Event|1|||
129145038|NCT01051661|464826410|FG001|Overall Study|Adverse Event|1|||
129145039|NCT01051661|464826411|FG002|Overall Study|Adverse Event|1|||
129145040|NCT01051661|464826412|FG003|Overall Study|Adverse Event|1|||
129145041|NCT01051661|464826413|FG004|Overall Study|Adverse Event|0|||
129145042|NCT01051661|464826414|FG005|Overall Study|Adverse Event|0|||
129145043|NCT01051661|464826409|FG000|Overall Study|Lost to Follow-up|13|||
129145044|NCT01051661|464826410|FG001|Overall Study|Lost to Follow-up|22|||
129145045|NCT01051661|464826411|FG002|Overall Study|Lost to Follow-up|15|||
129145046|NCT01051661|464826412|FG003|Overall Study|Lost to Follow-up|17|||
129145047|NCT01051661|464826413|FG004|Overall Study|Lost to Follow-up|10|||
129145048|NCT01051661|464826414|FG005|Overall Study|Lost to Follow-up|24|||
129145049|NCT01051661|464826409|FG000|Overall Study|Migrated/moved from study area|1|||
129145050|NCT01051661|464826410|FG001|Overall Study|Migrated/moved from study area|6|||
129145051|NCT01051661|464826411|FG002|Overall Study|Migrated/moved from study area|6|||
129145052|NCT01051661|464826412|FG003|Overall Study|Migrated/moved from study area|8|||
129145053|NCT01051661|464826413|FG004|Overall Study|Migrated/moved from study area|7|||
129145054|NCT01051661|464826414|FG005|Overall Study|Migrated/moved from study area|3|||
129145055|NCT01051661|464826409|FG000|Overall Study|Refused blood sampling|0|||
129145056|NCT01051661|464826410|FG001|Overall Study|Refused blood sampling|0|||
129145057|NCT01051661|464826411|FG002|Overall Study|Refused blood sampling|0|||
129145058|NCT01051661|464826412|FG003|Overall Study|Refused blood sampling|0|||
129145059|NCT01051661|464826413|FG004|Overall Study|Refused blood sampling|0|||
129145060|NCT01051661|464826414|FG005|Overall Study|Refused blood sampling|1|||
129145061|NCT01051661|464826409|FG000|Overall Study|Data not reliable|1|||
129145062|NCT01051661|464826410|FG001|Overall Study|Data not reliable|0|||
129145063|NCT01051661|464826411|FG002|Overall Study|Data not reliable|0|||
129145064|NCT01051661|464826412|FG003|Overall Study|Data not reliable|0|||
129145065|NCT01051661|464826413|FG004|Overall Study|Data not reliable|0|||
129145066|NCT01051661|464826414|FG005|Overall Study|Data not reliable|1|||
129145067|NCT01051661|464826409|FG000|Overall Study|Unable to attend visit(s)|2|||
129145068|NCT01051661|464826410|FG001|Overall Study|Unable to attend visit(s)|4|||
129145069|NCT01051661|464826411|FG002|Overall Study|Unable to attend visit(s)|2|||
129145070|NCT01051661|464826412|FG003|Overall Study|Unable to attend visit(s)|1|||
129145071|NCT01051661|464826413|FG004|Overall Study|Unable to attend visit(s)|3|||
129145072|NCT01051661|464826414|FG005|Overall Study|Unable to attend visit(s)|2|||
129145073|NCT01051661|464826409|FG000|Overall Study|Consent not received from both parents|0|||
129145074|NCT01051661|464826410|FG001|Overall Study|Consent not received from both parents|0|||
129145075|NCT01051661|464826411|FG002|Overall Study|Consent not received from both parents|0|||
129145076|NCT01051661|464826412|FG003|Overall Study|Consent not received from both parents|0|||
129145077|NCT01051661|464826413|FG004|Overall Study|Consent not received from both parents|0|||
129145078|NCT01051661|464826414|FG005|Overall Study|Consent not received from both parents|1|||
129145079|NCT01051661|464826409|FG000|Overall Study|Failure to comply with protocol|0|||
129145080|NCT01051661|464826410|FG001|Overall Study|Failure to comply with protocol|0|||
129145081|NCT01051661|464826411|FG002|Overall Study|Failure to comply with protocol|2|||
129145082|NCT01051661|464826412|FG003|Overall Study|Failure to comply with protocol|0|||
129145083|NCT01051661|464826413|FG004|Overall Study|Failure to comply with protocol|0|||
129145084|NCT01051661|464826414|FG005|Overall Study|Failure to comply with protocol|0|||
129145085|NCT01051661|464826409|FG000|Overall Study|Subject lost legal representation|0|||
129145086|NCT01051661|464826410|FG001|Overall Study|Subject lost legal representation|0|||
129145087|NCT01051661|464826411|FG002|Overall Study|Subject lost legal representation|0|||
129145088|NCT01051661|464826412|FG003|Overall Study|Subject lost legal representation|0|||
129145089|NCT01051661|464826413|FG004|Overall Study|Subject lost legal representation|1|||
129145090|NCT01051661|464826414|FG005|Overall Study|Subject lost legal representation|0|||
129145091|NCT01051661|464826409|FG000|Overall Study|Protocol Violation|0|||
129145092|NCT01051661|464826410|FG001|Overall Study|Protocol Violation|0|||
129145093|NCT01051661|464826411|FG002|Overall Study|Protocol Violation|0|||
129145094|NCT01051661|464826412|FG003|Overall Study|Protocol Violation|1|||
129145095|NCT01051661|464826413|FG004|Overall Study|Protocol Violation|2|||
129145096|NCT01051661|464826414|FG005|Overall Study|Protocol Violation|1|||
129145097|NCT01051661|464826409|FG000|Overall Study|Withdrawal by Subject|16|||
129145098|NCT01051661|464826410|FG001|Overall Study|Withdrawal by Subject|30|||
129145099|NCT01051661|464826411|FG002|Overall Study|Withdrawal by Subject|13|||
129145100|NCT01051661|464826412|FG003|Overall Study|Withdrawal by Subject|28|||
129145101|NCT01051661|464826413|FG004|Overall Study|Withdrawal by Subject|12|||
129145102|NCT01051661|464826414|FG005|Overall Study|Withdrawal by Subject|34|||
129145103|NCT04642079|464826415|FG000|Overall Study|Lost to Follow-up|2|||
129145104|NCT04642079|464826416|FG001|Overall Study|Lost to Follow-up|5|||
129145105|NCT04642079|464826417|FG002|Overall Study|Lost to Follow-up|2|||
129145106|NCT04642079|464826418|FG003|Overall Study|Lost to Follow-up|0|||
129145107|NCT04642079|464826415|FG000|Overall Study|Withdrawal by Subject|0|||
129145108|NCT04642079|464826416|FG001|Overall Study|Withdrawal by Subject|4|||
129145109|NCT04642079|464826417|FG002|Overall Study|Withdrawal by Subject|1|||
129145110|NCT04642079|464826418|FG003|Overall Study|Withdrawal by Subject|2|||
129145111|NCT04642079|464826415|FG000|Overall Study|Other|0|||
129145112|NCT04642079|464826416|FG001|Overall Study|Other|0|||
129145113|NCT04642079|464826417|FG002|Overall Study|Other|0|||
129145114|NCT04642079|464826418|FG003|Overall Study|Other|1|||
129145115|NCT04642079|464826415|FG000|Overall Study|No longer met eligibility criteria|1|||
129145116|NCT04642079|464826416|FG001|Overall Study|No longer met eligibility criteria|0|||
129145117|NCT04642079|464826417|FG002|Overall Study|No longer met eligibility criteria|1|||
129145118|NCT04642079|464826418|FG003|Overall Study|No longer met eligibility criteria|1|||
129145119|NCT00635050|464826423|FG000|Overall Study|Withdrawal by Subject|1|||
129145120|NCT03038620|464826424|FG000|Overall Study|Lost to Follow-up|18|||
129145121|NCT03038620|464826425|FG001|Overall Study|Lost to Follow-up|23|||
129145122|NCT03038620|464826424|FG000|Overall Study|Withdrawal by Subject|0|||
129145123|NCT03038620|464826425|FG001|Overall Study|Withdrawal by Subject|15|||
129145124|NCT03038620|464826424|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
129145125|NCT03038620|464826425|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
129145126|NCT00049543|464826431|FG000|Overall Study|still on treatment|2|||
129145127|NCT00049543|464826432|FG001|Overall Study|still on treatment|9|||
129145128|NCT04562090|464826433|FG000|Overall Study|Withdrawal by Subject|3|||
129145129|NCT04562090|464826434|FG001|Overall Study|Withdrawal by Subject|4|||
129145130|NCT04562090|464826433|FG000|Overall Study|Protocol Violation|2|||
129145131|NCT04562090|464826434|FG001|Overall Study|Protocol Violation|0|||
129145132|NCT04562090|464826433|FG000|Overall Study|Lack of Efficacy|0|||
129145133|NCT04562090|464826434|FG001|Overall Study|Lack of Efficacy|1|||
129145134|NCT04562090|464826433|FG000|Overall Study|Adverse Event|1|||
129145135|NCT04562090|464826434|FG001|Overall Study|Adverse Event|4|||
129145136|NCT04562090|464826433|FG000|Overall Study|Miscellaneous|0|||
129145137|NCT04562090|464826434|FG001|Overall Study|Miscellaneous|3|||
129145138|NCT03633058|464826435|FG000|Overall Study|Adverse Event|0|||
129145139|NCT03633058|464826436|FG001|Overall Study|Adverse Event|0|||
129145140|NCT03633058|464826437|FG002|Overall Study|Adverse Event|1|||
129145141|NCT03633058|464826438|FG003|Overall Study|Adverse Event|0|||
129145142|NCT03312543|464826439|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
129145143|NCT03312543|464826440|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
129145144|NCT03312543|464826439|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
129145145|NCT03312543|464826440|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
129145146|NCT03312543|464826439|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
129145147|NCT03312543|464826440|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
129145148|NCT03312543|464826439|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
129145149|NCT03312543|464826440|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
129145150|NCT03312543|464826439|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
129145151|NCT03312543|464826440|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
129145152|NCT03312543|464826439|FG000|Regression (Week 12 to Week 24)|Death|0|||
129145153|NCT03312543|464826440|FG001|Regression (Week 12 to Week 24)|Death|1|||
129145154|NCT04134936|464826441|FG000|Overall Study|Adverse Event|3|||
129145155|NCT04134936|464826442|FG001|Overall Study|Adverse Event|2|||
129088160|NCT02980341|464611580|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088161|NCT02980341|464611581|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088162|NCT02980341|464611582|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088163|NCT02980341|464611583|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088164|NCT02980341|464611584|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088165|NCT02980341|464611585|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088166|NCT02980341|464611586|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088167|NCT02980341|464611587|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088168|NCT02980341|464611588|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088169|NCT02980341|464611589|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129088170|NCT02980341|464611590|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
129088171|NCT03193801|464611593|FG000|Overall Study|Physician Decision|2|||
129088172|NCT03193801|464611593|FG000|Overall Study|Withdrawal by Subject|1|||
129088173|NCT04964544|464611596|FG000|Overall Study|Screen failure or other uncategorised|10|||
129088174|NCT04964544|464611596|FG000|Overall Study|Physician Decision|4|||
129088175|NCT04964544|464611596|FG000|Overall Study|Lost to Follow-up|9|||
129088176|NCT04964544|464611596|FG000|Overall Study|Withdrawal by Subject|18|||
129088177|NCT04964544|464611596|FG000|Overall Study|Death|1|||
129088178|NCT01613222|464611597|FG000|Overall Study|Physician Decision|1|||
129088179|NCT01613222|464611597|FG000|Overall Study|Unable to place arterial line|1|||
129088180|NCT01613222|464611597|FG000|Overall Study|Reused disposable sensors|10|||
129088181|NCT03696108|464611598|FG000|Overall Study|Physician Decision|1|||
129088182|NCT03696108|464611599|FG001|Overall Study|Physician Decision|0|||
129088183|NCT03696108|464611598|FG000|Overall Study|Withdrawal by Subject|3|||
129088184|NCT03696108|464611599|FG001|Overall Study|Withdrawal by Subject|6|||
129088185|NCT01899742|464611603|FG000|Overall Study|Adverse Event|5|||
129088186|NCT01899742|464611604|FG001|Overall Study|Adverse Event|4|||
129088187|NCT01899742|464611603|FG000|Overall Study|Lack of Efficacy|1|||
129088188|NCT01899742|464611604|FG001|Overall Study|Lack of Efficacy|5|||
129088189|NCT01899742|464611603|FG000|Overall Study|Protocol Violation|2|||
129088190|NCT01899742|464611604|FG001|Overall Study|Protocol Violation|2|||
129088191|NCT01899742|464611603|FG000|Overall Study|Withdrawal by Subject|9|||
129088192|NCT01899742|464611604|FG001|Overall Study|Withdrawal by Subject|5|||
128724502|NCT00680901|463289117|FG001|Overall Study|Adverse Event|1|||
128724503|NCT00680901|463289116|FG000|Overall Study|Lost to Follow-up|3|||
128724504|NCT00680901|463289117|FG001|Overall Study|Lost to Follow-up|5|||
128724505|NCT00680901|463289116|FG000|Overall Study|Subject decided to withdraw from the study|4|||
129088193|NCT01154088|464611607|FG000|Overall Study|Lost to Follow-up|4|||
129088194|NCT01154088|464611608|FG001|Overall Study|Lost to Follow-up|6|||
129088195|NCT01154088|464611609|FG002|Overall Study|Lost to Follow-up|7|||
129088196|NCT01104246|464611610|FG000|Overall Study|Withdrawal by Subject|1|||
129088197|NCT01104246|464611610|FG000|Overall Study|did not meet inclusion criteria|4|||
129088198|NCT01475851|464611611|FG000|Overall Study|Protocol defined stopping criteria|1|||
129088199|NCT01475851|464611612|FG001|Overall Study|Protocol defined stopping criteria|0|||
129088200|NCT01867294|464611613|FG000|Overall Study|Withdrawal by Subject|1|||
129088201|NCT01867294|464611614|FG001|Overall Study|Withdrawal by Subject|1|||
129088202|NCT01867294|464611615|FG002|Overall Study|Withdrawal by Subject|0|||
129145156|NCT04134936|464826441|FG000|Overall Study|Withdrawal by Subject|2|||
129145157|NCT04134936|464826442|FG001|Overall Study|Withdrawal by Subject|3|||
129145158|NCT04134936|464826441|FG000|Overall Study|Physician Decision|0|||
129145159|NCT04134936|464826442|FG001|Overall Study|Physician Decision|1|||
129145160|NCT04134936|464826441|FG000|Overall Study|Progressive disease, joined another trial|1|||
129145161|NCT04134936|464826442|FG001|Overall Study|Progressive disease, joined another trial|0|||
129145162|NCT04134936|464826441|FG000|Overall Study|Progressive disease|1|||
129145163|NCT04134936|464826442|FG001|Overall Study|Progressive disease|0|||
129145164|NCT02420717|464826445|FG000|Overall Study|Did not receive all study medication|2|||
129145165|NCT02420717|464826446|FG001|Overall Study|Did not receive all study medication|0|||
129145166|NCT02420717|464826447|FG002|Overall Study|Did not receive all study medication|0|||
129145167|NCT00936936|464828094|FG000|Overall Study|Adverse Event|7|||
129145168|NCT00936936|464828095|FG001|Overall Study|Adverse Event|1|||
128724506|NCT00680901|463289117|FG001|Overall Study|Subject decided to withdraw from the study|15|||
128724507|NCT00680901|463289116|FG000|Overall Study|Sponsor decision|1|||
128724508|NCT00680901|463289117|FG001|Overall Study|Sponsor decision|0|||
129088203|NCT01867294|464611616|FG003|Overall Study|Withdrawal by Subject|0|||
129088204|NCT02447497|464611619|FG000|Overall Study|Did not meet treatment day baseline.|6|||
129088205|NCT02447497|464611620|FG001|Overall Study|Did not meet treatment day baseline.|5|||
129088206|NCT02447497|464611621|FG002|Overall Study|Did not meet treatment day baseline.|2|||
129088207|NCT02447497|464611622|FG003|Overall Study|Did not meet treatment day baseline.|2|||
129145169|NCT00936936|464828094|FG000|Overall Study|Disease Progression|2|||
129145170|NCT00936936|464828095|FG001|Overall Study|Disease Progression|2|||
129145171|NCT00936936|464828094|FG000|Overall Study|Unrelated|3|||
129145172|NCT00936936|464828095|FG001|Overall Study|Unrelated|1|||
129088208|NCT02447497|464611619|FG000|Overall Study|Dressing was compromised|0|||
129088209|NCT02447497|464611620|FG001|Overall Study|Dressing was compromised|1|||
129088210|NCT02447497|464611621|FG002|Overall Study|Dressing was compromised|0|||
129088211|NCT02447497|464611622|FG003|Overall Study|Dressing was compromised|0|||
129088212|NCT02017912|464611623|FG000|Overall Study|Withdrawal by Subject|2|||
129088213|NCT02017912|464611624|FG001|Overall Study|Withdrawal by Subject|1|||
129088214|NCT02017912|464611623|FG000|Overall Study|miscellaneous|1|||
129088215|NCT02017912|464611624|FG001|Overall Study|miscellaneous|1|||
129088216|NCT01322035|464611625|FG000|Overall Study|Lost to Follow-up|8|||
129088217|NCT01322035|464611626|FG001|Overall Study|Lost to Follow-up|3|||
129088218|NCT02496091|464611627|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129088219|NCT02272842|464611628|FG000|Overall Study|Lost to Follow-up|8|||
129088220|NCT02272842|464611629|FG001|Overall Study|Lost to Follow-up|8|||
129088221|NCT02272842|464611628|FG000|Overall Study|Withdrawal by Subject|8|||
129088222|NCT02272842|464611629|FG001|Overall Study|Withdrawal by Subject|2|||
129088223|NCT05033262|464611632|FG000|Overall Study|Lost to Follow-up|1|||
129088224|NCT05033262|464611633|FG001|Overall Study|Lost to Follow-up|0|||
129088225|NCT05033262|464611634|FG002|Overall Study|Lost to Follow-up|0|||
129088226|NCT05033262|464611635|FG003|Overall Study|Lost to Follow-up|1|||
129088227|NCT01493284|464611638|FG000|Overall Study|Death|29|||
129088228|NCT01493284|464611638|FG000|Overall Study|Withdrawal by Subject|32|||
129088229|NCT00325156|464611641|FG000|Overall Study|Protocol Violation|8|||
129088230|NCT00325156|464611641|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
129088231|NCT00325156|464611641|FG000|Overall Study|Migrated/moved from study area|12|||
129088232|NCT00325156|464611641|FG000|Overall Study|Adverse event, non-fatal|3|||
129088233|NCT00325156|464611641|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
129088234|NCT00325156|464611641|FG000|Overall Study|Other|1|||
129088235|NCT00325156|464611641|FG000|Overall Study|Withdrawal by Subject|31|||
129088236|NCT03395184|464611642|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
129088237|NCT03395184|464611643|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
129088238|NCT03395184|464611644|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
129088239|NCT03395184|464611645|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129088240|NCT03395184|464611646|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129088241|NCT03395184|464611647|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129088242|NCT03395184|464611648|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129088243|NCT03395184|464611642|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129088244|NCT03395184|464611643|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
129088245|NCT03395184|464611644|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
129088246|NCT03395184|464611645|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129088247|NCT03395184|464611646|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129088248|NCT03395184|464611647|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129088249|NCT03395184|464611648|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129088250|NCT03395184|464611642|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
129088251|NCT03395184|464611643|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
129088252|NCT03395184|464611644|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129088253|NCT03395184|464611645|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129088254|NCT03395184|464611646|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129088255|NCT03395184|464611647|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129088256|NCT03395184|464611648|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129088257|NCT03395184|464611642|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129088258|NCT03395184|464611643|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
129088259|NCT03395184|464611644|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129088260|NCT03395184|464611645|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129088261|NCT03395184|464611646|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129088262|NCT03395184|464611647|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129088263|NCT03395184|464611648|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129088264|NCT03395184|464611642|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
129088265|NCT03395184|464611643|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129088266|NCT03395184|464611644|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
129088267|NCT03395184|464611645|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129088268|NCT03395184|464611646|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129088269|NCT03395184|464611647|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129088270|NCT03395184|464611648|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129088271|NCT03395184|464611642|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
129088272|NCT03395184|464611643|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
129088273|NCT03395184|464611644|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
129088274|NCT03395184|464611645|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
129088275|NCT03395184|464611646|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
129088276|NCT03395184|464611647|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
128724509|NCT00680901|463289116|FG000|Overall Study|Physician Decision|0|||
129088277|NCT03395184|464611648|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
129088278|NCT03395184|464611642|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
129088279|NCT03395184|464611643|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
129088280|NCT03395184|464611644|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
129088281|NCT03395184|464611645|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
129088282|NCT03395184|464611646|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
129088283|NCT03395184|464611647|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
129088284|NCT03395184|464611648|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
129088285|NCT03395184|464611642|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
129088286|NCT03395184|464611643|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
129088287|NCT03395184|464611644|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
129088288|NCT03395184|464611645|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
129088289|NCT03395184|464611646|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
129088290|NCT03395184|464611647|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
129088291|NCT03395184|464611648|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
129088292|NCT03395184|464611642|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129088293|NCT03395184|464611643|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129088294|NCT03395184|464611644|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129088295|NCT03395184|464611645|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129088296|NCT03395184|464611646|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
129088297|NCT03395184|464611647|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129088298|NCT03395184|464611648|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129088299|NCT03395184|464611642|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
129088300|NCT03395184|464611643|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
129088301|NCT03395184|464611644|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
129088302|NCT03395184|464611645|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
129088303|NCT03395184|464611646|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
129088304|NCT03395184|464611647|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
129088305|NCT03395184|464611648|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
129088306|NCT03395184|464611642|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129088307|NCT03395184|464611643|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129088308|NCT03395184|464611644|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129088309|NCT03395184|464611645|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
129088310|NCT03395184|464611646|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129088311|NCT03395184|464611647|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
129088312|NCT03395184|464611648|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129088313|NCT03395184|464611642|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
129088314|NCT03395184|464611643|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
129088315|NCT03395184|464611644|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
129088316|NCT03395184|464611645|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
129088317|NCT03395184|464611646|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
129088318|NCT03395184|464611647|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
129088319|NCT03395184|464611648|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
129088320|NCT03053063|464611654|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
129088321|NCT03053063|464611655|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
129088322|NCT03053063|464611656|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
129088323|NCT03053063|464611657|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
129088324|NCT03053063|464611654|FG000|Randomized Phase|Withdrew consent|8|||
129088325|NCT03053063|464611655|FG001|Randomized Phase|Withdrew consent|11|||
129088326|NCT03053063|464611656|FG002|Randomized Phase|Withdrew consent|5|||
129088327|NCT03053063|464611657|FG003|Randomized Phase|Withdrew consent|0|||
129088328|NCT03053063|464611654|FG000|Randomized Phase|Investigator's Discretion|8|||
129088329|NCT03053063|464611655|FG001|Randomized Phase|Investigator's Discretion|6|||
129088330|NCT03053063|464611656|FG002|Randomized Phase|Investigator's Discretion|2|||
129088331|NCT03053063|464611657|FG003|Randomized Phase|Investigator's Discretion|0|||
129088332|NCT03053063|464611654|FG000|Randomized Phase|Lost to Follow-up|3|||
129088333|NCT03053063|464611655|FG001|Randomized Phase|Lost to Follow-up|5|||
129088334|NCT03053063|464611656|FG002|Randomized Phase|Lost to Follow-up|1|||
129088335|NCT03053063|464611657|FG003|Randomized Phase|Lost to Follow-up|0|||
129088336|NCT03053063|464611654|FG000|Randomized Phase|Adverse Event|0|||
129088337|NCT03053063|464611655|FG001|Randomized Phase|Adverse Event|1|||
129088338|NCT03053063|464611656|FG002|Randomized Phase|Adverse Event|0|||
129088339|NCT03053063|464611657|FG003|Randomized Phase|Adverse Event|0|||
129088340|NCT03053063|464611654|FG000|Randomized Phase|Randomized but Never Treated|1|||
129088341|NCT03053063|464611655|FG001|Randomized Phase|Randomized but Never Treated|3|||
129088342|NCT03053063|464611656|FG002|Randomized Phase|Randomized but Never Treated|2|||
129088343|NCT03053063|464611657|FG003|Randomized Phase|Randomized but Never Treated|0|||
129088344|NCT03053063|464611654|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
129088345|NCT03053063|464611655|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
129088346|NCT03053063|464611656|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
129088347|NCT03053063|464611657|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
129145173|NCT01373281|464828096|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
129145174|NCT01373281|464828097|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
129145175|NCT01373281|464828096|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
129145176|NCT01373281|464828097|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
129145177|NCT01373281|464828096|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
129145178|NCT01373281|464828097|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
129145179|NCT01373281|464828096|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
129145180|NCT01373281|464828097|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
129145181|NCT01373281|464828096|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
129145182|NCT01373281|464828097|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
129145183|NCT01373281|464828096|FG000|Surveillance Expansion Period|Protocol Violation|9|||
129145184|NCT01373281|464828097|FG001|Surveillance Expansion Period|Protocol Violation|1|||
129145185|NCT01373281|464828096|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
129145186|NCT01373281|464828097|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
129145187|NCT01373281|464828096|FG000|Surveillance Expansion Period|Serious adverse event|3|||
129145188|NCT01373281|464828097|FG001|Surveillance Expansion Period|Serious adverse event|4|||
129145189|NCT00851084|464828098|FG000|Overall Study|Randomized but not treated|1|||
129145190|NCT00851084|464828099|FG001|Overall Study|Randomized but not treated|0|||
129145191|NCT00851084|464828098|FG000|Overall Study|Adverse Event|26|||
129145192|NCT00851084|464828099|FG001|Overall Study|Adverse Event|36|||
129145193|NCT00851084|464828098|FG000|Overall Study|Disease progression|52|||
129145194|NCT00851084|464828099|FG001|Overall Study|Disease progression|47|||
129145195|NCT00851084|464828098|FG000|Overall Study|Poor compliance to protocol|1|||
129145196|NCT00851084|464828099|FG001|Overall Study|Poor compliance to protocol|1|||
129145197|NCT00851084|464828098|FG000|Overall Study|Physician Decision|13|||
129145198|NCT00851084|464828099|FG001|Overall Study|Physician Decision|14|||
129145199|NCT00851084|464828098|FG000|Overall Study|Consent withdrawn|0|||
129145200|NCT00851084|464828099|FG001|Overall Study|Consent withdrawn|2|||
129145201|NCT00851084|464828098|FG000|Overall Study|Withdrawal by Subject|11|||
129145202|NCT00851084|464828099|FG001|Overall Study|Withdrawal by Subject|12|||
129145203|NCT00851084|464828098|FG000|Overall Study|Metastatic surgery|6|||
129145204|NCT00851084|464828099|FG001|Overall Study|Metastatic surgery|6|||
129145205|NCT00851084|464828098|FG000|Overall Study|Other|7|||
129145206|NCT00851084|464828099|FG001|Overall Study|Other|1|||
129145207|NCT00734032|464828100|FG000|Overall Study|Adverse Event|0|||
129145208|NCT00734032|464828101|FG001|Overall Study|Adverse Event|1|||
129088348|NCT03053063|464611654|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
129088349|NCT03053063|464611655|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
129088350|NCT03053063|464611656|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
129088351|NCT03053063|464611657|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
129088352|NCT03053063|464611654|FG000|Open-Label Phase|Death|0|||
129088353|NCT03053063|464611655|FG001|Open-Label Phase|Death|0|||
129088354|NCT03053063|464611656|FG002|Open-Label Phase|Death|0|||
129088355|NCT03053063|464611657|FG003|Open-Label Phase|Death|2|||
129088356|NCT03053063|464611654|FG000|Open-Label Phase|Investigator's discretion|0|||
129088357|NCT03053063|464611655|FG001|Open-Label Phase|Investigator's discretion|0|||
129088358|NCT03053063|464611656|FG002|Open-Label Phase|Investigator's discretion|0|||
129088359|NCT03053063|464611657|FG003|Open-Label Phase|Investigator's discretion|2|||
129088360|NCT01970475|464611659|FG000|Overall Study|Withdrawal by Subject|11|||
129088361|NCT01970475|464611660|FG001|Overall Study|Withdrawal by Subject|6|||
129088362|NCT01970475|464611659|FG000|Overall Study|Adverse Event|7|||
129088363|NCT01970475|464611660|FG001|Overall Study|Adverse Event|3|||
129088364|NCT01970475|464611659|FG000|Overall Study|Lost to Follow-up|2|||
129088365|NCT01970475|464611660|FG001|Overall Study|Lost to Follow-up|2|||
129088366|NCT01970475|464611659|FG000|Overall Study|Protocol Violation|1|||
129088367|NCT01970475|464611660|FG001|Overall Study|Protocol Violation|0|||
129088368|NCT01397786|464613068|FG000|Phase A|Lost to Follow-up|0|||
129088369|NCT01397786|464613069|FG001|Phase A|Lost to Follow-up|0|||
129088370|NCT01397786|464613070|FG002|Phase A|Lost to Follow-up|6|||
129088371|NCT01397786|464613068|FG000|Phase A|Adverse Event|0|||
129088372|NCT01397786|464613069|FG001|Phase A|Adverse Event|0|||
129088373|NCT01397786|464613070|FG002|Phase A|Adverse Event|8|||
129145209|NCT00734032|464828102|FG002|Overall Study|Adverse Event|0|||
129145210|NCT00734032|464828103|FG003|Overall Study|Adverse Event|0|||
129145211|NCT00133705|464828106|FG000|Overall Study|Withdrawal by Subject|2|||
129145212|NCT00133705|464828107|FG001|Overall Study|Withdrawal by Subject|3|||
129145213|NCT03440411|464828109|FG000|Overall Study|Adverse Event|0|||
129145214|NCT03440411|464828110|FG001|Overall Study|Adverse Event|0|||
129145215|NCT03440411|464828111|FG002|Overall Study|Adverse Event|1|||
129145216|NCT03440411|464828112|FG003|Overall Study|Adverse Event|0|||
129145217|NCT03440411|464828109|FG000|Overall Study|PD|2|||
129145218|NCT03440411|464828110|FG001|Overall Study|PD|1|||
129088374|NCT01397786|464613068|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
129088375|NCT01397786|464613069|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
129088376|NCT01397786|464613070|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
129088377|NCT01397786|464613068|FG000|Phase A|Physician Decision|0|||
129088378|NCT01397786|464613069|FG001|Phase A|Physician Decision|0|||
129088379|NCT01397786|464613070|FG002|Phase A|Physician Decision|1|||
129088380|NCT01397786|464613068|FG000|Phase A|Withdrawal by Subject|0|||
129088381|NCT01397786|464613069|FG001|Phase A|Withdrawal by Subject|0|||
129088382|NCT01397786|464613070|FG002|Phase A|Withdrawal by Subject|5|||
129088383|NCT01397786|464613068|FG000|Phase A|Lack of Efficacy|0|||
129088384|NCT01397786|464613069|FG001|Phase A|Lack of Efficacy|0|||
129088385|NCT01397786|464613070|FG002|Phase A|Lack of Efficacy|1|||
129088386|NCT01397786|464613068|FG000|Phase B|Lost to Follow-up|22|||
129088387|NCT01397786|464613069|FG001|Phase B|Lost to Follow-up|12|||
129088388|NCT01397786|464613070|FG002|Phase B|Lost to Follow-up|22|||
129088389|NCT01397786|464613068|FG000|Phase B|Adverse Event|109|||
129088390|NCT01397786|464613069|FG001|Phase B|Adverse Event|23|||
129088391|NCT01397786|464613070|FG002|Phase B|Adverse Event|27|||
129088392|NCT01397786|464613068|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
129088393|NCT01397786|464613069|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
129088394|NCT01397786|464613070|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
129088395|NCT01397786|464613068|FG000|Phase B|Physician Decision|9|||
129088396|NCT01397786|464613069|FG001|Phase B|Physician Decision|1|||
129088397|NCT01397786|464613070|FG002|Phase B|Physician Decision|3|||
129088398|NCT01397786|464613068|FG000|Phase B|Withdrawal by Subject|102|||
129088399|NCT01397786|464613069|FG001|Phase B|Withdrawal by Subject|45|||
129088400|NCT01397786|464613070|FG002|Phase B|Withdrawal by Subject|30|||
129088401|NCT01397786|464613068|FG000|Phase B|Protocol Deviation|1|||
129088402|NCT01397786|464613069|FG001|Phase B|Protocol Deviation|2|||
129088403|NCT01397786|464613070|FG002|Phase B|Protocol Deviation|4|||
129088404|NCT01397786|464613068|FG000|Phase B|Lack of Efficacy|22|||
129088405|NCT01397786|464613069|FG001|Phase B|Lack of Efficacy|7|||
129088406|NCT01397786|464613070|FG002|Phase B|Lack of Efficacy|14|||
129088407|NCT03339726|464613073|FG000|Overall Study|Withdrawal by Subject|1|||
129088408|NCT03339726|464613074|FG001|Overall Study|Withdrawal by Subject|0|||
129088409|NCT03339726|464613075|FG002|Overall Study|Withdrawal by Subject|0|||
129088410|NCT03339726|464613073|FG000|Overall Study|Lost to Follow-up|0|||
129088411|NCT03339726|464613074|FG001|Overall Study|Lost to Follow-up|1|||
129088412|NCT03339726|464613075|FG002|Overall Study|Lost to Follow-up|0|||
129088413|NCT01275755|464613076|FG000|Double-blind Treatment Period|Adverse Event|0|||
129088414|NCT01275755|464613077|FG001|Double-blind Treatment Period|Adverse Event|2|||
129088415|NCT01275755|464613076|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
129088416|NCT01275755|464613077|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
129088417|NCT01275755|464613076|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129088418|NCT01275755|464613077|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129088419|NCT01275755|464613076|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
129088420|NCT01275755|464613077|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
129088421|NCT00636194|464613084|FG000|Overall Study|Study related symptoms and complaints|1|||
129088422|NCT00636194|464613085|FG001|Overall Study|Study related symptoms and complaints|0|||
129088423|NCT00636194|464613084|FG000|Overall Study|Protocol Violation|2|||
129088424|NCT00636194|464613085|FG001|Overall Study|Protocol Violation|0|||
129088425|NCT03962790|464613090|FG000|Period 1|Adverse Event|0|||
129088426|NCT03962790|464613091|FG001|Period 1|Adverse Event|1|||
129088427|NCT03962790|464613090|FG000|Period 1|Failed to meet all eligibility criteria|1|||
129088428|NCT03962790|464613091|FG001|Period 1|Failed to meet all eligibility criteria|1|||
129088429|NCT03962790|464613090|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
129088430|NCT03962790|464613091|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
129088431|NCT03962790|464613090|FG000|Period 1|Withdrawal by Subject|1|||
129088432|NCT03962790|464613091|FG001|Period 1|Withdrawal by Subject|0|||
129088433|NCT04598451|464613092|FG000|Overall Study|Adverse Event|3|||
128724510|NCT00680901|463289117|FG001|Overall Study|Physician Decision|2|||
128724511|NCT00680901|463289116|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
129088434|NCT04598451|464613093|FG001|Overall Study|Adverse Event|2|||
129088435|NCT04598451|464613092|FG000|Overall Study|Withdrawal by Subject|3|||
129088436|NCT04598451|464613093|FG001|Overall Study|Withdrawal by Subject|7|||
129088437|NCT04598451|464613092|FG000|Overall Study|Lost to Follow-up|2|||
129088438|NCT04598451|464613093|FG001|Overall Study|Lost to Follow-up|0|||
129088439|NCT04598451|464613092|FG000|Overall Study|Physician Decision|4|||
129088440|NCT04598451|464613093|FG001|Overall Study|Physician Decision|1|||
129145219|NCT03440411|464828111|FG002|Overall Study|PD|1|||
129145220|NCT03440411|464828112|FG003|Overall Study|PD|1|||
129088441|NCT04598451|464613092|FG000|Overall Study|Requires Prohibited Medication|1|||
129088442|NCT04598451|464613093|FG001|Overall Study|Requires Prohibited Medication|0|||
129088443|NCT04598451|464613092|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
129088444|NCT04598451|464613093|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
129088445|NCT03535194|464613094|FG000|Induction Period|Adverse Event|2|||
129088446|NCT03535194|464613095|FG001|Induction Period|Adverse Event|2|||
129145221|NCT03440411|464828109|FG000|Overall Study|Withdrawal by Subject|1|||
129088447|NCT03535194|464613096|FG002|Induction Period|Adverse Event|1|||
129088448|NCT03535194|464613097|FG003|Induction Period|Adverse Event|3|||
129088449|NCT03535194|464613098|FG004|Induction Period|Adverse Event|0|||
129088450|NCT03535194|464613094|FG000|Induction Period|Death|0|||
129088451|NCT03535194|464613095|FG001|Induction Period|Death|1|||
129088452|NCT03535194|464613096|FG002|Induction Period|Death|0|||
129088453|NCT03535194|464613097|FG003|Induction Period|Death|0|||
129088454|NCT03535194|464613098|FG004|Induction Period|Death|0|||
129088455|NCT03535194|464613094|FG000|Induction Period|Lack of Efficacy|1|||
129088456|NCT03535194|464613095|FG001|Induction Period|Lack of Efficacy|3|||
129088457|NCT03535194|464613096|FG002|Induction Period|Lack of Efficacy|2|||
129088458|NCT03535194|464613097|FG003|Induction Period|Lack of Efficacy|2|||
129088459|NCT03535194|464613098|FG004|Induction Period|Lack of Efficacy|0|||
129088460|NCT03535194|464613094|FG000|Induction Period|Lost to Follow-up|3|||
129088461|NCT03535194|464613095|FG001|Induction Period|Lost to Follow-up|5|||
129088462|NCT03535194|464613096|FG002|Induction Period|Lost to Follow-up|2|||
129088463|NCT03535194|464613097|FG003|Induction Period|Lost to Follow-up|3|||
129088464|NCT03535194|464613098|FG004|Induction Period|Lost to Follow-up|0|||
129088465|NCT03535194|464613094|FG000|Induction Period|Physician Decision|1|||
129088466|NCT03535194|464613095|FG001|Induction Period|Physician Decision|1|||
129088467|NCT03535194|464613096|FG002|Induction Period|Physician Decision|0|||
129088468|NCT03535194|464613097|FG003|Induction Period|Physician Decision|0|||
129088469|NCT03535194|464613098|FG004|Induction Period|Physician Decision|0|||
129088470|NCT03535194|464613094|FG000|Induction Period|Protocol Violation|1|||
129088471|NCT03535194|464613095|FG001|Induction Period|Protocol Violation|0|||
129088472|NCT03535194|464613096|FG002|Induction Period|Protocol Violation|0|||
129088473|NCT03535194|464613097|FG003|Induction Period|Protocol Violation|1|||
129088474|NCT03535194|464613098|FG004|Induction Period|Protocol Violation|0|||
129088475|NCT03535194|464613094|FG000|Induction Period|Screen Failure|0|||
129088476|NCT03535194|464613095|FG001|Induction Period|Screen Failure|1|||
129088477|NCT03535194|464613096|FG002|Induction Period|Screen Failure|0|||
129088478|NCT03535194|464613097|FG003|Induction Period|Screen Failure|0|||
129088479|NCT03535194|464613098|FG004|Induction Period|Screen Failure|0|||
129088480|NCT03535194|464613094|FG000|Induction Period|Withdrawal by Subject|3|||
129088481|NCT03535194|464613095|FG001|Induction Period|Withdrawal by Subject|4|||
129088482|NCT03535194|464613096|FG002|Induction Period|Withdrawal by Subject|3|||
129088483|NCT03535194|464613097|FG003|Induction Period|Withdrawal by Subject|2|||
129088484|NCT03535194|464613098|FG004|Induction Period|Withdrawal by Subject|0|||
129088485|NCT03535194|464613094|FG000|Maintenance Period|Adverse Event|6|||
129088486|NCT03535194|464613095|FG001|Maintenance Period|Adverse Event|5|||
129088487|NCT03535194|464613096|FG002|Maintenance Period|Adverse Event|1|||
129088488|NCT03535194|464613097|FG003|Maintenance Period|Adverse Event|11|||
129088489|NCT03535194|464613098|FG004|Maintenance Period|Adverse Event|4|||
129088490|NCT03535194|464613094|FG000|Maintenance Period|Lack of Efficacy|3|||
129088491|NCT03535194|464613095|FG001|Maintenance Period|Lack of Efficacy|2|||
129088492|NCT03535194|464613096|FG002|Maintenance Period|Lack of Efficacy|5|||
129088493|NCT03535194|464613097|FG003|Maintenance Period|Lack of Efficacy|9|||
129088494|NCT03535194|464613098|FG004|Maintenance Period|Lack of Efficacy|0|||
129088495|NCT03535194|464613094|FG000|Maintenance Period|Lost to Follow-up|4|||
129088496|NCT03535194|464613095|FG001|Maintenance Period|Lost to Follow-up|2|||
129088497|NCT03535194|464613096|FG002|Maintenance Period|Lost to Follow-up|1|||
129088498|NCT03535194|464613097|FG003|Maintenance Period|Lost to Follow-up|5|||
129088499|NCT03535194|464613098|FG004|Maintenance Period|Lost to Follow-up|2|||
129088500|NCT03535194|464613094|FG000|Maintenance Period|Other|1|||
129088501|NCT03535194|464613095|FG001|Maintenance Period|Other|2|||
129088502|NCT03535194|464613096|FG002|Maintenance Period|Other|0|||
129088503|NCT03535194|464613097|FG003|Maintenance Period|Other|0|||
129088504|NCT03535194|464613098|FG004|Maintenance Period|Other|0|||
129088505|NCT03535194|464613094|FG000|Maintenance Period|Physician Decision|1|||
129088506|NCT03535194|464613095|FG001|Maintenance Period|Physician Decision|2|||
129145222|NCT03440411|464828110|FG001|Overall Study|Withdrawal by Subject|0|||
129088507|NCT03535194|464613096|FG002|Maintenance Period|Physician Decision|0|||
129088508|NCT03535194|464613097|FG003|Maintenance Period|Physician Decision|2|||
129088509|NCT03535194|464613098|FG004|Maintenance Period|Physician Decision|0|||
129088510|NCT03535194|464613094|FG000|Maintenance Period|Pregnancy|0|||
129088511|NCT03535194|464613095|FG001|Maintenance Period|Pregnancy|0|||
129088512|NCT03535194|464613096|FG002|Maintenance Period|Pregnancy|0|||
129088513|NCT03535194|464613097|FG003|Maintenance Period|Pregnancy|2|||
129088514|NCT03535194|464613098|FG004|Maintenance Period|Pregnancy|0|||
129088515|NCT03535194|464613094|FG000|Maintenance Period|Protocol Violation|0|||
129088516|NCT03535194|464613095|FG001|Maintenance Period|Protocol Violation|1|||
129088517|NCT03535194|464613096|FG002|Maintenance Period|Protocol Violation|0|||
129145223|NCT03440411|464828111|FG002|Overall Study|Withdrawal by Subject|0|||
129145224|NCT03440411|464828112|FG003|Overall Study|Withdrawal by Subject|0|||
129088518|NCT03535194|464613097|FG003|Maintenance Period|Protocol Violation|0|||
129088519|NCT03535194|464613098|FG004|Maintenance Period|Protocol Violation|0|||
129088520|NCT03535194|464613094|FG000|Maintenance Period|Withdrawal by Subject|7|||
129088521|NCT03535194|464613095|FG001|Maintenance Period|Withdrawal by Subject|2|||
129088522|NCT03535194|464613096|FG002|Maintenance Period|Withdrawal by Subject|1|||
129088523|NCT03535194|464613097|FG003|Maintenance Period|Withdrawal by Subject|8|||
129088524|NCT03535194|464613098|FG004|Maintenance Period|Withdrawal by Subject|0|||
129088525|NCT03535194|464613094|FG000|Post-Treatment Followup Period|Adverse Event|4|||
129088526|NCT03535194|464613095|FG001|Post-Treatment Followup Period|Adverse Event|5|||
129088527|NCT03535194|464613096|FG002|Post-Treatment Followup Period|Adverse Event|1|||
129088528|NCT03535194|464613097|FG003|Post-Treatment Followup Period|Adverse Event|8|||
129088529|NCT03535194|464613098|FG004|Post-Treatment Followup Period|Adverse Event|0|||
129088530|NCT03535194|464613094|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
129088531|NCT03535194|464613095|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
129088532|NCT03535194|464613096|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
129088533|NCT03535194|464613097|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
129088534|NCT03535194|464613098|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
129088535|NCT03535194|464613094|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
129088536|NCT03535194|464613095|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
129088537|NCT03535194|464613096|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
129088538|NCT03535194|464613097|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
129088539|NCT03535194|464613098|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
129088540|NCT03535194|464613094|FG000|Post-Treatment Followup Period|Other|1|||
129088541|NCT03535194|464613095|FG001|Post-Treatment Followup Period|Other|0|||
129088542|NCT03535194|464613096|FG002|Post-Treatment Followup Period|Other|0|||
129088543|NCT03535194|464613097|FG003|Post-Treatment Followup Period|Other|5|||
129088544|NCT03535194|464613098|FG004|Post-Treatment Followup Period|Other|0|||
129088545|NCT03535194|464613094|FG000|Post-Treatment Followup Period|Physician Decision|0|||
129088546|NCT03535194|464613095|FG001|Post-Treatment Followup Period|Physician Decision|2|||
129088547|NCT03535194|464613096|FG002|Post-Treatment Followup Period|Physician Decision|1|||
129088548|NCT03535194|464613097|FG003|Post-Treatment Followup Period|Physician Decision|1|||
129088549|NCT03535194|464613098|FG004|Post-Treatment Followup Period|Physician Decision|0|||
129088550|NCT03535194|464613094|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
129088551|NCT03535194|464613095|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
129088552|NCT03535194|464613096|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
129088553|NCT03535194|464613097|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
129088554|NCT03535194|464613098|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129088555|NCT01938430|464613103|FG000|Overall Study|Randomized but Not Treated|0|||
129088556|NCT01938430|464613104|FG001|Overall Study|Randomized but Not Treated|0|||
129088557|NCT01938430|464613105|FG002|Overall Study|Randomized but Not Treated|0|||
129088558|NCT01938430|464613106|FG003|Overall Study|Randomized but Not Treated|0|||
129088559|NCT01938430|464613107|FG004|Overall Study|Randomized but Not Treated|0|||
129088560|NCT01938430|464613108|FG005|Overall Study|Randomized but Not Treated|0|||
129088561|NCT01938430|464613109|FG006|Overall Study|Randomized but Not Treated|0|||
129088562|NCT01938430|464613110|FG007|Overall Study|Randomized but Not Treated|0|||
129088563|NCT01938430|464613111|FG008|Overall Study|Randomized but Not Treated|0|||
129088564|NCT01938430|464613112|FG009|Overall Study|Randomized but Not Treated|0|||
129088565|NCT01938430|464613113|FG010|Overall Study|Randomized but Not Treated|1|||
129088566|NCT01938430|464613114|FG011|Overall Study|Randomized but Not Treated|0|||
129088567|NCT01938430|464613115|FG012|Overall Study|Randomized but Not Treated|0|||
129088568|NCT01938430|464613116|FG013|Overall Study|Randomized but Not Treated|1|||
129088569|NCT01938430|464613103|FG000|Overall Study|Adverse Event|0|||
129088570|NCT01938430|464613104|FG001|Overall Study|Adverse Event|0|||
129088571|NCT01938430|464613105|FG002|Overall Study|Adverse Event|0|||
129088572|NCT01938430|464613106|FG003|Overall Study|Adverse Event|0|||
129088573|NCT01938430|464613107|FG004|Overall Study|Adverse Event|0|||
129088574|NCT01938430|464613108|FG005|Overall Study|Adverse Event|0|||
129088575|NCT01938430|464613109|FG006|Overall Study|Adverse Event|1|||
129088576|NCT01938430|464613110|FG007|Overall Study|Adverse Event|0|||
129088577|NCT01938430|464613111|FG008|Overall Study|Adverse Event|0|||
129088578|NCT01938430|464613112|FG009|Overall Study|Adverse Event|0|||
129088579|NCT01938430|464613113|FG010|Overall Study|Adverse Event|0|||
129088580|NCT01938430|464613114|FG011|Overall Study|Adverse Event|0|||
129145225|NCT03440411|464828109|FG000|Overall Study|Closed study by sponsor|0|||
129145226|NCT03440411|464828110|FG001|Overall Study|Closed study by sponsor|0|||
129088581|NCT01938430|464613115|FG012|Overall Study|Adverse Event|0|||
129088582|NCT01938430|464613116|FG013|Overall Study|Adverse Event|0|||
129088583|NCT01938430|464613103|FG000|Overall Study|Death|1|||
129088584|NCT01938430|464613104|FG001|Overall Study|Death|2|||
129088585|NCT01938430|464613105|FG002|Overall Study|Death|2|||
129088586|NCT01938430|464613106|FG003|Overall Study|Death|1|||
129088587|NCT01938430|464613107|FG004|Overall Study|Death|0|||
129088588|NCT01938430|464613108|FG005|Overall Study|Death|0|||
129088589|NCT01938430|464613109|FG006|Overall Study|Death|1|||
129088590|NCT01938430|464613110|FG007|Overall Study|Death|1|||
129088591|NCT01938430|464613111|FG008|Overall Study|Death|2|||
129145227|NCT03440411|464828111|FG002|Overall Study|Closed study by sponsor|0|||
129088592|NCT01938430|464613112|FG009|Overall Study|Death|3|||
129088593|NCT01938430|464613113|FG010|Overall Study|Death|0|||
129088594|NCT01938430|464613114|FG011|Overall Study|Death|0|||
129088595|NCT01938430|464613115|FG012|Overall Study|Death|0|||
129088596|NCT01938430|464613116|FG013|Overall Study|Death|0|||
129088597|NCT01938430|464613103|FG000|Overall Study|Investigator's Discretion|0|||
129145228|NCT03440411|464828112|FG003|Overall Study|Closed study by sponsor|1|||
129088598|NCT01938430|464613104|FG001|Overall Study|Investigator's Discretion|0|||
129088599|NCT01938430|464613105|FG002|Overall Study|Investigator's Discretion|1|||
129088600|NCT01938430|464613106|FG003|Overall Study|Investigator's Discretion|0|||
129088601|NCT01938430|464613107|FG004|Overall Study|Investigator's Discretion|0|||
129088602|NCT01938430|464613108|FG005|Overall Study|Investigator's Discretion|0|||
129088603|NCT01938430|464613109|FG006|Overall Study|Investigator's Discretion|0|||
129088604|NCT01938430|464613110|FG007|Overall Study|Investigator's Discretion|0|||
129088605|NCT01938430|464613111|FG008|Overall Study|Investigator's Discretion|0|||
129088606|NCT01938430|464613112|FG009|Overall Study|Investigator's Discretion|0|||
129088607|NCT01938430|464613113|FG010|Overall Study|Investigator's Discretion|0|||
129088608|NCT01938430|464613114|FG011|Overall Study|Investigator's Discretion|0|||
129088609|NCT01938430|464613115|FG012|Overall Study|Investigator's Discretion|0|||
129088610|NCT01938430|464613116|FG013|Overall Study|Investigator's Discretion|0|||
129088611|NCT01938430|464613103|FG000|Overall Study|Lack of Efficacy|3|||
129088612|NCT01938430|464613104|FG001|Overall Study|Lack of Efficacy|1|||
129088613|NCT01938430|464613105|FG002|Overall Study|Lack of Efficacy|1|||
129088614|NCT01938430|464613106|FG003|Overall Study|Lack of Efficacy|1|||
129088615|NCT01938430|464613107|FG004|Overall Study|Lack of Efficacy|0|||
129088616|NCT01938430|464613108|FG005|Overall Study|Lack of Efficacy|0|||
129088617|NCT01938430|464613109|FG006|Overall Study|Lack of Efficacy|0|||
129088618|NCT01938430|464613110|FG007|Overall Study|Lack of Efficacy|0|||
129088619|NCT01938430|464613111|FG008|Overall Study|Lack of Efficacy|1|||
129088620|NCT01938430|464613112|FG009|Overall Study|Lack of Efficacy|0|||
129088621|NCT01938430|464613113|FG010|Overall Study|Lack of Efficacy|2|||
129088622|NCT01938430|464613114|FG011|Overall Study|Lack of Efficacy|1|||
129088623|NCT01938430|464613115|FG012|Overall Study|Lack of Efficacy|0|||
129088624|NCT01938430|464613116|FG013|Overall Study|Lack of Efficacy|0|||
129088625|NCT01938430|464613103|FG000|Overall Study|Lost to Follow-up|0|||
129088626|NCT01938430|464613104|FG001|Overall Study|Lost to Follow-up|0|||
129088627|NCT01938430|464613105|FG002|Overall Study|Lost to Follow-up|1|||
129088628|NCT01938430|464613106|FG003|Overall Study|Lost to Follow-up|0|||
129088629|NCT01938430|464613107|FG004|Overall Study|Lost to Follow-up|0|||
129088630|NCT01938430|464613108|FG005|Overall Study|Lost to Follow-up|1|||
129088631|NCT01938430|464613109|FG006|Overall Study|Lost to Follow-up|0|||
129088632|NCT01938430|464613110|FG007|Overall Study|Lost to Follow-up|0|||
129088633|NCT01938430|464613111|FG008|Overall Study|Lost to Follow-up|0|||
129088634|NCT01938430|464613112|FG009|Overall Study|Lost to Follow-up|0|||
129088635|NCT01938430|464613113|FG010|Overall Study|Lost to Follow-up|0|||
129088636|NCT01938430|464613114|FG011|Overall Study|Lost to Follow-up|0|||
129088637|NCT01938430|464613115|FG012|Overall Study|Lost to Follow-up|0|||
129088638|NCT01938430|464613116|FG013|Overall Study|Lost to Follow-up|0|||
129088639|NCT01938430|464613103|FG000|Overall Study|Withdrew Consent|0|||
129088640|NCT01938430|464613104|FG001|Overall Study|Withdrew Consent|0|||
129088641|NCT01938430|464613105|FG002|Overall Study|Withdrew Consent|0|||
129088642|NCT01938430|464613106|FG003|Overall Study|Withdrew Consent|0|||
129088643|NCT01938430|464613107|FG004|Overall Study|Withdrew Consent|0|||
129088644|NCT01938430|464613108|FG005|Overall Study|Withdrew Consent|0|||
129088645|NCT01938430|464613109|FG006|Overall Study|Withdrew Consent|0|||
129088646|NCT01938430|464613110|FG007|Overall Study|Withdrew Consent|0|||
129088647|NCT01938430|464613111|FG008|Overall Study|Withdrew Consent|1|||
129088648|NCT01938430|464613112|FG009|Overall Study|Withdrew Consent|0|||
129088649|NCT01938430|464613113|FG010|Overall Study|Withdrew Consent|0|||
129088650|NCT01938430|464613114|FG011|Overall Study|Withdrew Consent|0|||
129088651|NCT01938430|464613115|FG012|Overall Study|Withdrew Consent|0|||
129145229|NCT04992273|464828113|FG000|Overall Study|Lost to Follow-up|0|||
129145230|NCT04992273|464828114|FG001|Overall Study|Lost to Follow-up|1|||
129145231|NCT00863304|464828117|FG000|Overall Study|Adverse Event|10|||
129145232|NCT00863304|464828118|FG001|Overall Study|Adverse Event|4|||
129145233|NCT00863304|464828119|FG002|Overall Study|Adverse Event|14|||
129145234|NCT00863304|464828120|FG003|Overall Study|Adverse Event|16|||
129145235|NCT00863304|464828117|FG000|Overall Study|Lost to Follow-up|1|||
129145236|NCT00863304|464828118|FG001|Overall Study|Lost to Follow-up|5|||
129145237|NCT00863304|464828119|FG002|Overall Study|Lost to Follow-up|4|||
129145238|NCT00863304|464828120|FG003|Overall Study|Lost to Follow-up|2|||
129145239|NCT00863304|464828117|FG000|Overall Study|Lack of Efficacy|57|||
129088652|NCT01938430|464613116|FG013|Overall Study|Withdrew Consent|0|||
129088653|NCT03505593|464613124|FG000|Overall Study|Withdrawal by Subject|1|||
129088654|NCT03505593|464613124|FG000|Overall Study|Died before procedure|1|||
129088655|NCT03505593|464613124|FG000|Overall Study|Anatomical abnormality|1|||
129088656|NCT03505593|464613124|FG000|Overall Study|Unable to pass through esophagus|1|||
129088657|NCT03505593|464613124|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
129088658|NCT02662764|464613125|FG000|Overall Study|Adverse Event|6|||
129088659|NCT02662764|464613125|FG000|Overall Study|Lack of Efficacy|8|||
129088660|NCT02662764|464613125|FG000|Overall Study|Protocol Violation|1|||
129088661|NCT02662764|464613125|FG000|Overall Study|Withdrawal by Subject|5|||
129145240|NCT00863304|464828118|FG001|Overall Study|Lack of Efficacy|26|||
129145241|NCT00863304|464828119|FG002|Overall Study|Lack of Efficacy|30|||
129145242|NCT00863304|464828120|FG003|Overall Study|Lack of Efficacy|28|||
129145243|NCT00863304|464828117|FG000|Overall Study|Withdrawal by Subject|19|||
128724512|NCT00680901|463289117|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
128724513|NCT00680901|463289116|FG000|Overall Study|Other protocol defined stopping criteria|17|||
128724514|NCT00680901|463289117|FG001|Overall Study|Other protocol defined stopping criteria|17|||
128724515|NCT00923559|463289118|FG000|Overall Study|Lost to Follow-up|2|||
128724516|NCT00923559|463289119|FG001|Overall Study|Lost to Follow-up|3|||
129088662|NCT02662764|464613125|FG000|Overall Study|Device failure|4|||
129088663|NCT02662764|464613125|FG000|Overall Study|Patient changed treatment|1|||
129088664|NCT02662764|464613125|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
129088665|NCT00089778|464613126|FG000|Overall Study|Protocol Violation|0|||
129088666|NCT00089778|464613127|FG001|Overall Study|Protocol Violation|0|||
129088667|NCT00089778|464613128|FG002|Overall Study|Protocol Violation|1|||
129088668|NCT05178641|464613129|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
129088669|NCT05178641|464613130|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
129088670|NCT05178641|464613129|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
129088671|NCT05178641|464613130|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
129088672|NCT01869699|464613131|FG000|Overall Study|Withdrawal by Subject|1|||
129088673|NCT01869699|464613132|FG001|Overall Study|Withdrawal by Subject|0|||
129088674|NCT00732758|464613133|FG000|Overall Study|Lost to Follow-up|8|||
129088675|NCT00732758|464613134|FG001|Overall Study|Lost to Follow-up|16|||
129088676|NCT04240457|464613137|FG000|Overall Study|Lost to Follow-up|5|||
129088677|NCT04240457|464613138|FG001|Overall Study|Lost to Follow-up|1|||
129088678|NCT01508130|464613142|FG000|Overall Study|Adverse Event|81|||
129088679|NCT01508130|464613143|FG001|Overall Study|Adverse Event|28|||
129088680|NCT01508130|464613142|FG000|Overall Study|Death|3|||
129088681|NCT01508130|464613143|FG001|Overall Study|Death|1|||
129088682|NCT01508130|464613142|FG000|Overall Study|Protocol Violation|2|||
129088683|NCT01508130|464613143|FG001|Overall Study|Protocol Violation|0|||
129088684|NCT01508130|464613142|FG000|Overall Study|Lost to Follow-up|25|||
129088685|NCT01508130|464613143|FG001|Overall Study|Lost to Follow-up|2|||
129088686|NCT01508130|464613142|FG000|Overall Study|Withdrawal by Subject|3|||
129088687|NCT01508130|464613143|FG001|Overall Study|Withdrawal by Subject|3|||
129088688|NCT01508130|464613142|FG000|Overall Study|Subject's substantial non-compliance|25|||
129088689|NCT01508130|464613143|FG001|Overall Study|Subject's substantial non-compliance|9|||
129088690|NCT01508130|464613142|FG000|Overall Study|Insufficient therapeutic response|74|||
129088691|NCT01508130|464613143|FG001|Overall Study|Insufficient therapeutic response|23|||
129088692|NCT01508130|464613142|FG000|Overall Study|Administrative|14|||
129088693|NCT01508130|464613143|FG001|Overall Study|Administrative|3|||
129088694|NCT01680159|464613144|FG000|Screening Period|Not meet criteria for dose-up period|7|||
129088695|NCT01680159|464613144|FG000|Increased Dose Period|Adverse Event|6|||
129088696|NCT01680159|464613144|FG000|Increased Dose Period|Withdrawal by Subject|2|||
129088697|NCT01252563|464613150|FG000|Overall Study|Contract Deviation|41|||
129088698|NCT01252563|464613150|FG000|Overall Study|Centralized Registration Deviation|30|||
129088699|NCT01252563|464613150|FG000|Overall Study|Lost to Follow-up|161|||
129088700|NCT01252563|464613150|FG000|Overall Study|No visit after first day of treatment|194|||
129088701|NCT01252563|464613150|FG000|Overall Study|No drug administration|6|||
129088702|NCT03429244|464613151|FG000|Overall Study|Withdrawal by Subject|2|||
129088703|NCT03429244|464613152|FG001|Overall Study|Withdrawal by Subject|1|||
129088704|NCT03429244|464613153|FG002|Overall Study|Withdrawal by Subject|1|||
129088705|NCT00658775|464613154|FG000|Overall Study|Adverse Event|4|||
129088706|NCT00658775|464613155|FG001|Overall Study|Adverse Event|6|||
129088707|NCT00658775|464613154|FG000|Overall Study|Lost to Follow-up|17|||
129088708|NCT00658775|464613155|FG001|Overall Study|Lost to Follow-up|18|||
129088709|NCT00658775|464613154|FG000|Overall Study|Withdrawal by Subject|6|||
129088710|NCT00658775|464613155|FG001|Overall Study|Withdrawal by Subject|4|||
129088711|NCT00658775|464613154|FG000|Overall Study|Withdrawal of consent|8|||
129088712|NCT00658775|464613155|FG001|Overall Study|Withdrawal of consent|7|||
129088713|NCT00658775|464613154|FG000|Overall Study|Other|7|||
129088714|NCT00658775|464613155|FG001|Overall Study|Other|8|||
129088715|NCT00387010|464613156|FG000|Dose Titration Period|Adverse Event|12|||
129088716|NCT00387010|464613156|FG000|Dose Titration Period|Lack of Efficacy|5|||
128724517|NCT00856908|463289132|FG000|Overall Study|Lost to Follow-up|1|||
128724518|NCT00856908|463289133|FG001|Overall Study|Lost to Follow-up|0|||
129088717|NCT00387010|464613156|FG000|Dose Titration Period|Withdrawal by Subject|3|||
129088718|NCT00387010|464613156|FG000|Dose Titration Period|Protocol Violation|1|||
129088719|NCT00387010|464613156|FG000|Dose Titration Period|Lost to Follow-up|2|||
129088720|NCT00387010|464613156|FG000|Dose Titration Period|Noncompliance with study medication|8|||
129088721|NCT00387010|464613156|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
129088722|NCT00387010|464613156|FG000|Treatment Period|Adverse Event|4|||
129088723|NCT00387010|464613156|FG000|Treatment Period|Withdrawal by Subject|1|||
129088724|NCT00387010|464613156|FG000|Treatment Period|Noncompliance with study medication|2|||
129088725|NCT00387010|464613156|FG000|Treatment Period|Noncompliance with study procedures|3|||
129088726|NCT00387010|464613156|FG000|Treatment Period|Participant reported study drug stolen|1|||
129088727|NCT02841280|464613161|FG000|Overall Study|Adverse Event|2|||
129088728|NCT02841280|464613162|FG001|Overall Study|Adverse Event|1|||
129088729|NCT02841280|464613161|FG000|Overall Study|Death|1|||
129088730|NCT02841280|464613162|FG001|Overall Study|Death|0|||
129088731|NCT02841280|464613161|FG000|Overall Study|Lost to Follow-up|2|||
129088732|NCT02841280|464613162|FG001|Overall Study|Lost to Follow-up|2|||
129088733|NCT02841280|464613161|FG000|Overall Study|Withdrawal by Subject|7|||
129088734|NCT02841280|464613162|FG001|Overall Study|Withdrawal by Subject|3|||
129088735|NCT02841280|464613161|FG000|Overall Study|Stop Point: BP above threshold|2|||
129088736|NCT02841280|464613162|FG001|Overall Study|Stop Point: BP above threshold|0|||
129088737|NCT02727777|464613163|FG000|Overall Study|Screen Failure|2|||
129088738|NCT02727777|464613164|FG001|Overall Study|Screen Failure|0|||
129088739|NCT02727777|464613165|FG002|Overall Study|Screen Failure|0|||
129088740|NCT02727777|464613163|FG000|Overall Study|Progressive disease|2|||
129088741|NCT02727777|464613164|FG001|Overall Study|Progressive disease|0|||
129088742|NCT02727777|464613165|FG002|Overall Study|Progressive disease|0|||
129088743|NCT03005327|464613167|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
129088744|NCT03005327|464613168|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
129088745|NCT03005327|464613169|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
129088746|NCT03005327|464613170|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
129088747|NCT03005327|464613167|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129088748|NCT03005327|464613168|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129088749|NCT03005327|464613169|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129088750|NCT03005327|464613170|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129088751|NCT00915876|464613171|FG000|Overall Study|Adverse Event|0|||
129145244|NCT00863304|464828118|FG001|Overall Study|Withdrawal by Subject|14|||
129145245|NCT00863304|464828119|FG002|Overall Study|Withdrawal by Subject|20|||
129145246|NCT00863304|464828120|FG003|Overall Study|Withdrawal by Subject|18|||
129145247|NCT00863304|464828117|FG000|Overall Study|Other|1|||
129145248|NCT00863304|464828118|FG001|Overall Study|Other|0|||
129088752|NCT00915876|464613172|FG001|Overall Study|Adverse Event|1|||
129088753|NCT02572076|464613179|FG000|Overall Study|Protocol Violation|1|||
129088754|NCT02396420|464613180|FG000|Overall Study|Death|1|||
129088755|NCT01273623|464613181|FG000|Overall Study|did not meet IVUS criteria|29|||
129088756|NCT00519428|464613182|FG000|Overall Study|Adverse Event|5|||
129088757|NCT00519428|464613183|FG001|Overall Study|Adverse Event|2|||
129088758|NCT00519428|464613184|FG002|Overall Study|Adverse Event|10|||
129088759|NCT00519428|464613182|FG000|Overall Study|Lost to Follow-up|7|||
129088760|NCT00519428|464613183|FG001|Overall Study|Lost to Follow-up|7|||
129088761|NCT00519428|464613184|FG002|Overall Study|Lost to Follow-up|6|||
129088762|NCT00519428|464613182|FG000|Overall Study|Withdrawal by Subject|8|||
129088763|NCT00519428|464613183|FG001|Overall Study|Withdrawal by Subject|3|||
129088764|NCT00519428|464613184|FG002|Overall Study|Withdrawal by Subject|7|||
129145249|NCT00863304|464828119|FG002|Overall Study|Other|0|||
129145250|NCT00863304|464828120|FG003|Overall Study|Other|1|||
129145251|NCT00863304|464828117|FG000|Overall Study|Protocol Violation|2|||
129145252|NCT00863304|464828118|FG001|Overall Study|Protocol Violation|6|||
129145253|NCT00863304|464828119|FG002|Overall Study|Protocol Violation|2|||
129145254|NCT00863304|464828120|FG003|Overall Study|Protocol Violation|0|||
129145255|NCT00863304|464828117|FG000|Overall Study|Randomized, but not Treated|3|||
129145256|NCT00863304|464828118|FG001|Overall Study|Randomized, but not Treated|1|||
129145257|NCT00863304|464828119|FG002|Overall Study|Randomized, but not Treated|4|||
129145258|NCT00863304|464828120|FG003|Overall Study|Randomized, but not Treated|1|||
129145259|NCT00863304|464828117|FG000|Overall Study|Entered extension study|101|||
129145260|NCT00863304|464828118|FG001|Overall Study|Entered extension study|129|||
129088765|NCT00519428|464613182|FG000|Overall Study|unstated|1|||
129088766|NCT00519428|464613183|FG001|Overall Study|unstated|3|||
129088767|NCT00519428|464613184|FG002|Overall Study|unstated|2|||
129088768|NCT04064411|464613185|FG000|Overall Study|Adverse Event|29|||
129145261|NCT00863304|464828119|FG002|Overall Study|Entered extension study|113|||
129145262|NCT00863304|464828120|FG003|Overall Study|Entered extension study|125|||
129145263|NCT03528902|464828123|FG000|Overall Study|Adverse Event|1|||
129145264|NCT03528902|464828124|FG001|Overall Study|Adverse Event|0|||
129145265|NCT05030766|464828125|FG000|Phase 1 Participants|Lost to Follow-up|12|||
129145266|NCT05030766|464828126|FG001|Phase 1 Participants|Lost to Follow-up|22|||
129145267|NCT05030766|464828127|FG002|Phase 1 Participants|Lost to Follow-up|0|||
129145268|NCT05030766|464828128|FG003|Phase 1 Participants|Lost to Follow-up|0|||
129145269|NCT05030766|464828125|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
129145270|NCT05030766|464828126|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
129145271|NCT05030766|464828127|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
129145272|NCT05030766|464828128|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
129088769|NCT04064411|464613186|FG001|Overall Study|Adverse Event|19|||
129088770|NCT04064411|464613185|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
129088771|NCT04064411|464613186|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
129088772|NCT04064411|464613185|FG000|Overall Study|Protocol Deviation|0|||
129088773|NCT04064411|464613186|FG001|Overall Study|Protocol Deviation|2|||
129088774|NCT04064411|464613185|FG000|Overall Study|Withdrawal by Subject|25|||
129088775|NCT04064411|464613186|FG001|Overall Study|Withdrawal by Subject|29|||
129088776|NCT04064411|464613185|FG000|Overall Study|Lost to Follow-up|5|||
129088777|NCT04064411|464613186|FG001|Overall Study|Lost to Follow-up|2|||
129088778|NCT04064411|464613185|FG000|Overall Study|Other than Specified|4|||
129088779|NCT04064411|464613186|FG001|Overall Study|Other than Specified|1|||
129088780|NCT04064411|464613185|FG000|Overall Study|Death|1|||
129088781|NCT04064411|464613186|FG001|Overall Study|Death|0|||
129088782|NCT00533702|464613189|FG000|Overall Study|Withdrawal by Subject|3|||
129088783|NCT00533702|464613190|FG001|Overall Study|Withdrawal by Subject|1|||
129088784|NCT00533702|464613189|FG000|Overall Study|Found ineligible after randomization|2|||
129088785|NCT00533702|464613190|FG001|Overall Study|Found ineligible after randomization|1|||
129088786|NCT06366087|464616101|FG000|Overall Study|Withdrawal by Subject|0|||
129088787|NCT06366087|464616102|FG001|Overall Study|Withdrawal by Subject|1|||
129088788|NCT00860249|464616104|FG000|Overall Study|trial was terminated prior to completion|21|||
129088789|NCT00860249|464616105|FG001|Overall Study|trial was terminated prior to completion|18|||
129088790|NCT00860249|464616106|FG002|Overall Study|trial was terminated prior to completion|21|||
129088791|NCT00174967|464616107|FG000|Overall Study|Adverse Event|1|||
129088792|NCT00174967|464616108|FG001|Overall Study|Adverse Event|2|||
129088793|NCT00174967|464616109|FG002|Overall Study|Adverse Event|2|||
129088794|NCT00174967|464616110|FG003|Overall Study|Adverse Event|1|||
129088795|NCT00174967|464616107|FG000|Overall Study|Gout Flare|0|||
129088796|NCT00174967|464616108|FG001|Overall Study|Gout Flare|0|||
129088797|NCT00174967|464616109|FG002|Overall Study|Gout Flare|0|||
129088798|NCT00174967|464616110|FG003|Overall Study|Gout Flare|1|||
129088799|NCT00174967|464616107|FG000|Overall Study|Other|0|||
129088800|NCT00174967|464616108|FG001|Overall Study|Other|1|||
129088801|NCT00174967|464616109|FG002|Overall Study|Other|0|||
129088802|NCT00174967|464616110|FG003|Overall Study|Other|0|||
129088803|NCT04934189|464616111|FG000|Overall Study|Lost to Follow-up|4|||
129088804|NCT04934189|464616111|FG000|Overall Study|Withdrawal by Subject|17|||
129088805|NCT01286168|464616119|FG000|Overall Study|Withdrawal by Subject|1|||
129088806|NCT01286168|464616119|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
129088807|NCT00381238|464616123|FG000|Overall Study|Adverse Event|3|||
129088808|NCT00381238|464616123|FG000|Overall Study|Protocol Violation|1|||
129088809|NCT00381238|464616123|FG000|Overall Study|Withdrawal by Subject|4|||
129088810|NCT00381238|464616123|FG000|Overall Study|Lack of Efficacy|2|||
129088811|NCT00381238|464616123|FG000|Overall Study|Withdrew by physician|1|||
129088812|NCT00381238|464616123|FG000|Overall Study|Disease progression|1|||
129088813|NCT02086448|464616128|FG000|Overall Study|Withdrawal by Subject|1|||
129088814|NCT02086448|464616129|FG001|Overall Study|Withdrawal by Subject|0|||
129088815|NCT02086448|464616130|FG002|Overall Study|Withdrawal by Subject|0|||
129088816|NCT02086448|464616131|FG003|Overall Study|Withdrawal by Subject|2|||
129088817|NCT00843037|464616132|FG000|Overall Study|Lost to Follow-up|1|||
129088818|NCT02091960|464616133|FG000|Overall Study|Death|7|||
129088819|NCT02091960|464616133|FG000|Overall Study|Withdrawal by Subject|1|||
129088820|NCT02091960|464616133|FG000|Overall Study|Miscellaneous Reasons|37|||
129088821|NCT02682823|464616144|FG000|Overall Study|Withdrawal by Subject|0|||
129088822|NCT02682823|464616145|FG001|Overall Study|Withdrawal by Subject|0|||
129088823|NCT02682823|464616146|FG002|Overall Study|Withdrawal by Subject|1|||
129088824|NCT02682823|464616147|FG003|Overall Study|Withdrawal by Subject|0|||
129088825|NCT02682823|464616148|FG004|Overall Study|Withdrawal by Subject|1|||
129088826|NCT02682823|464616144|FG000|Overall Study|Protocol Deviation|0|||
129088827|NCT02682823|464616145|FG001|Overall Study|Protocol Deviation|1|||
129088828|NCT02682823|464616146|FG002|Overall Study|Protocol Deviation|0|||
129088829|NCT02682823|464616147|FG003|Overall Study|Protocol Deviation|0|||
129088830|NCT02682823|464616148|FG004|Overall Study|Protocol Deviation|0|||
129088831|NCT02682823|464616144|FG000|Overall Study|Adverse Event|0|||
129088832|NCT02682823|464616145|FG001|Overall Study|Adverse Event|0|||
129088833|NCT02682823|464616146|FG002|Overall Study|Adverse Event|0|||
129088834|NCT02682823|464616147|FG003|Overall Study|Adverse Event|1|||
129088835|NCT02682823|464616148|FG004|Overall Study|Adverse Event|0|||
129088836|NCT02738879|464616149|FG000|Overall Study|Adverse Event|1|||
129088837|NCT02738879|464616150|FG001|Overall Study|Adverse Event|1|||
129088838|NCT02738879|464616149|FG000|Overall Study|Death|0|||
129088839|NCT02738879|464616150|FG001|Overall Study|Death|2|||
129088840|NCT02738879|464616149|FG000|Overall Study|Lost to Follow-up|1|||
129088841|NCT02738879|464616150|FG001|Overall Study|Lost to Follow-up|5|||
129088842|NCT02738879|464616149|FG000|Overall Study|Protocol Violation|1|||
129088843|NCT02738879|464616150|FG001|Overall Study|Protocol Violation|3|||
129088844|NCT02738879|464616149|FG000|Overall Study|Physician Decision|3|||
129088845|NCT02738879|464616150|FG001|Overall Study|Physician Decision|4|||
129088846|NCT02738879|464616149|FG000|Overall Study|Pregnancy|0|||
129088847|NCT02738879|464616150|FG001|Overall Study|Pregnancy|1|||
129088848|NCT02738879|464616149|FG000|Overall Study|Screen Failure|1|||
129088849|NCT02738879|464616150|FG001|Overall Study|Screen Failure|2|||
128776578|NCT00224133|463471966|FG000|Overall Study|Physician Decision|1|||
129088850|NCT02738879|464616149|FG000|Overall Study|Site Discontinued Study Participation|1|||
129088851|NCT02738879|464616150|FG001|Overall Study|Site Discontinued Study Participation|0|||
129088852|NCT02738879|464616149|FG000|Overall Study|Withdrawal by Subject|5|||
129088853|NCT02738879|464616150|FG001|Overall Study|Withdrawal by Subject|7|||
129088854|NCT01438294|464616151|FG000|Overall Study|Lost to Follow-up|3|||
129088855|NCT01438294|464616152|FG001|Overall Study|Lost to Follow-up|7|||
129088856|NCT01346189|464616155|FG000|Overall Study|Withdrawal by Subject|7|||
129088857|NCT01346189|464616156|FG001|Overall Study|Withdrawal by Subject|5|||
129088858|NCT01346189|464616157|FG002|Overall Study|Withdrawal by Subject|3|||
129088859|NCT01346189|464616158|FG003|Overall Study|Withdrawal by Subject|5|||
129088860|NCT01346189|464616155|FG000|Overall Study|Physician Decision|4|||
129088861|NCT01346189|464616156|FG001|Overall Study|Physician Decision|0|||
129088862|NCT01346189|464616157|FG002|Overall Study|Physician Decision|0|||
129088863|NCT01346189|464616158|FG003|Overall Study|Physician Decision|0|||
129088864|NCT01346189|464616155|FG000|Overall Study|Moved|3|||
129088865|NCT01346189|464616156|FG001|Overall Study|Moved|0|||
129088866|NCT01346189|464616157|FG002|Overall Study|Moved|4|||
129088867|NCT01346189|464616158|FG003|Overall Study|Moved|0|||
129088868|NCT01346189|464616155|FG000|Overall Study|Other|2|||
129088869|NCT01346189|464616156|FG001|Overall Study|Other|4|||
129088870|NCT01346189|464616157|FG002|Overall Study|Other|7|||
129088871|NCT01346189|464616158|FG003|Overall Study|Other|3|||
129088872|NCT01346189|464616155|FG000|Overall Study|Death|0|||
129088873|NCT01346189|464616156|FG001|Overall Study|Death|3|||
129088874|NCT01346189|464616157|FG002|Overall Study|Death|0|||
129088875|NCT01346189|464616158|FG003|Overall Study|Death|0|||
129088876|NCT01346189|464616155|FG000|Overall Study|Non-health system primary care physician|0|||
129088877|NCT01346189|464616156|FG001|Overall Study|Non-health system primary care physician|5|||
129088878|NCT01346189|464616157|FG002|Overall Study|Non-health system primary care physician|0|||
129088879|NCT01346189|464616158|FG003|Overall Study|Non-health system primary care physician|0|||
129088880|NCT01346189|464616155|FG000|Overall Study|Travel|0|||
129088881|NCT01346189|464616156|FG001|Overall Study|Travel|0|||
129088882|NCT01346189|464616157|FG002|Overall Study|Travel|0|||
129088883|NCT01346189|464616158|FG003|Overall Study|Travel|3|||
129088884|NCT01730534|464616159|FG000|Overall Study|Withdrawal by Subject|97|||
129088885|NCT01730534|464616160|FG001|Overall Study|Withdrawal by Subject|127|||
129088886|NCT01730534|464616159|FG000|Overall Study|Lost to Follow-up|12|||
129088887|NCT01730534|464616160|FG001|Overall Study|Lost to Follow-up|18|||
129088888|NCT01895608|464616161|FG000|Overall Study|change in health status|0|||
129088889|NCT01895608|464616162|FG001|Overall Study|change in health status|1|||
129088890|NCT01895608|464616163|FG002|Overall Study|change in health status|1|||
129088891|NCT01895608|464616164|FG003|Overall Study|change in health status|0|||
129088892|NCT01895608|464616161|FG000|Overall Study|Withdrawal by Subject|0|||
129088893|NCT01895608|464616162|FG001|Overall Study|Withdrawal by Subject|0|||
129088894|NCT01895608|464616163|FG002|Overall Study|Withdrawal by Subject|2|||
129088895|NCT01895608|464616164|FG003|Overall Study|Withdrawal by Subject|0|||
129088896|NCT02833844|464616165|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129088897|NCT02833844|464616166|FG001|Double-Blind Period|Withdrawal by Subject|3|||
129088898|NCT02833844|464616165|FG000|Double-Blind Period|Protocol Violation|0|||
129088899|NCT02833844|464616166|FG001|Double-Blind Period|Protocol Violation|4|||
129088900|NCT02833844|464616165|FG000|Open-Label Period|Death|0|||
129088901|NCT02833844|464616166|FG001|Open-Label Period|Death|2|||
129088902|NCT02833844|464616165|FG000|Open-Label Period|Lost to Follow-up|1|||
129088903|NCT02833844|464616166|FG001|Open-Label Period|Lost to Follow-up|0|||
129088904|NCT02833844|464616165|FG000|Open-Label Period|Withdrawal by Subject|1|||
129088905|NCT02833844|464616166|FG001|Open-Label Period|Withdrawal by Subject|0|||
129088906|NCT02541669|464616169|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
129088907|NCT02541669|464616170|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
129088908|NCT02541669|464616171|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
129088909|NCT02541669|464616172|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
129088910|NCT02541669|464616173|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
129088911|NCT01084668|464616175|FG000|Overall Study|Lack of Efficacy|5|||
129088912|NCT01084668|464616175|FG000|Overall Study|Withdrawal by Subject|2|||
129088913|NCT01084668|464616175|FG000|Overall Study|Pregnancy|1|||
129088914|NCT01084668|464616175|FG000|Overall Study|Non-compliance|1|||
129088915|NCT00655733|464616182|FG000|Overall Study|Lost to Follow-up|2|||
129088916|NCT00655733|464616183|FG001|Overall Study|Lost to Follow-up|2|||
129088917|NCT00655733|464616182|FG000|Overall Study|Adverse Event|2|||
129088918|NCT00655733|464616183|FG001|Overall Study|Adverse Event|2|||
129088919|NCT00655733|464616182|FG000|Overall Study|Withdrawal by Subject|3|||
129088920|NCT00655733|464616183|FG001|Overall Study|Withdrawal by Subject|3|||
129088921|NCT00655733|464616182|FG000|Overall Study|Physician Decision|0|||
129088922|NCT00655733|464616183|FG001|Overall Study|Physician Decision|1|||
129088923|NCT02122770|464616184|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
129088924|NCT02122770|464616185|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
129088925|NCT02122770|464616186|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
129088926|NCT02122770|464616187|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
129088927|NCT02122770|464616188|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
129088928|NCT02122770|464616189|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
129088929|NCT02122770|464616184|FG000|Part A: Drug-drug Interaction 2|Other|0|||
129088930|NCT02122770|464616185|FG001|Part A: Drug-drug Interaction 2|Other|0|||
129088931|NCT02122770|464616186|FG002|Part A: Drug-drug Interaction 2|Other|1|||
129088932|NCT02122770|464616187|FG003|Part A: Drug-drug Interaction 2|Other|0|||
129088933|NCT02122770|464616188|FG004|Part A: Drug-drug Interaction 2|Other|0|||
129088934|NCT02122770|464616189|FG005|Part A: Drug-drug Interaction 2|Other|0|||
129088935|NCT02122770|464616184|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129088936|NCT02122770|464616185|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
129088937|NCT02122770|464616186|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129088938|NCT02122770|464616187|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129088939|NCT02122770|464616188|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129088940|NCT02122770|464616189|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129088941|NCT02122770|464616184|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
129088942|NCT02122770|464616185|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
129088943|NCT02122770|464616186|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
129088944|NCT02122770|464616187|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
129088945|NCT02122770|464616188|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
129088946|NCT02122770|464616189|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
129088947|NCT02122770|464616184|FG000|Part B: Standard of Care|Adverse Event|0|||
129088948|NCT02122770|464616185|FG001|Part B: Standard of Care|Adverse Event|0|||
129088949|NCT02122770|464616186|FG002|Part B: Standard of Care|Adverse Event|0|||
129088950|NCT02122770|464616187|FG003|Part B: Standard of Care|Adverse Event|0|||
129088951|NCT02122770|464616188|FG004|Part B: Standard of Care|Adverse Event|4|||
129088952|NCT02122770|464616189|FG005|Part B: Standard of Care|Adverse Event|1|||
129088953|NCT02122770|464616184|FG000|Part B: Standard of Care|Other|0|||
129088954|NCT02122770|464616185|FG001|Part B: Standard of Care|Other|0|||
129088955|NCT02122770|464616186|FG002|Part B: Standard of Care|Other|0|||
129088956|NCT02122770|464616187|FG003|Part B: Standard of Care|Other|0|||
129088957|NCT02122770|464616188|FG004|Part B: Standard of Care|Other|0|||
129088958|NCT02122770|464616189|FG005|Part B: Standard of Care|Other|2|||
129088959|NCT02122770|464616184|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
129088960|NCT02122770|464616185|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
129088961|NCT02122770|464616186|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
129088962|NCT02122770|464616187|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
129088963|NCT02122770|464616188|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
129088964|NCT02122770|464616189|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
129088965|NCT02122770|464616184|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
129088966|NCT02122770|464616185|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
129088967|NCT02122770|464616186|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
129088968|NCT02122770|464616187|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
129088969|NCT02122770|464616188|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
129088970|NCT02122770|464616189|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
129088971|NCT02122770|464616184|FG000|Part B: Standard of Care|Progressive Disease|0|||
129088972|NCT02122770|464616185|FG001|Part B: Standard of Care|Progressive Disease|0|||
129088973|NCT02122770|464616186|FG002|Part B: Standard of Care|Progressive Disease|0|||
129088974|NCT02122770|464616187|FG003|Part B: Standard of Care|Progressive Disease|0|||
129088975|NCT02122770|464616188|FG004|Part B: Standard of Care|Progressive Disease|10|||
129088976|NCT02122770|464616189|FG005|Part B: Standard of Care|Progressive Disease|8|||
129088977|NCT02658734|464616190|FG000|Overall Study|Adverse Event|2|||
129088978|NCT02658734|464616190|FG000|Overall Study|Death|4|||
129088979|NCT02658734|464616190|FG000|Overall Study|Lost to Follow-up|7|||
129088980|NCT02658734|464616190|FG000|Overall Study|Withdrawal of Consent|16|||
129088981|NCT02658734|464616190|FG000|Overall Study|Disease Progression|28|||
129088982|NCT00459706|464616192|FG000|Overall Study|Adverse Event|19|||
129088983|NCT00459706|464616193|FG001|Overall Study|Adverse Event|13|||
129088984|NCT00459706|464616192|FG000|Overall Study|Withdrawal by Subject|1|||
129088985|NCT00459706|464616193|FG001|Overall Study|Withdrawal by Subject|6|||
129088986|NCT00459706|464616192|FG000|Overall Study|Physician Decision|2|||
129088987|NCT00459706|464616193|FG001|Overall Study|Physician Decision|0|||
129088988|NCT00459706|464616192|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
129088989|NCT00459706|464616193|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129088990|NCT00459706|464616192|FG000|Overall Study|Protocol Violation|2|||
129145273|NCT05030766|464828125|FG000|Phase 2 Participants|Lost to Follow-up|0|||
129145274|NCT05030766|464828126|FG001|Phase 2 Participants|Lost to Follow-up|0|||
129088991|NCT00459706|464616193|FG001|Overall Study|Protocol Violation|1|||
129088992|NCT00459706|464616192|FG000|Overall Study|Failed to Return|1|||
129088993|NCT00459706|464616193|FG001|Overall Study|Failed to Return|0|||
129088994|NCT00459706|464616192|FG000|Overall Study|Other|0|||
129088995|NCT00459706|464616193|FG001|Overall Study|Other|1|||
129088996|NCT00727844|464616194|FG000|Initial Randomization|Physician Decision|2|||
129088997|NCT00727844|464616195|FG001|Initial Randomization|Physician Decision|0|||
129088998|NCT00727844|464616196|FG002|Initial Randomization|Physician Decision|0|||
129088999|NCT00727844|464616197|FG003|Initial Randomization|Physician Decision|0|||
129089000|NCT00373958|464616198|FG000|Infant Series|Withdrawal by Subject|13|||
129089001|NCT00373958|464616199|FG001|Infant Series|Withdrawal by Subject|15|||
128724519|NCT02196324|463289136|FG000|Overall Study|Withdrawal by Subject|8|||
128724520|NCT02196324|463289137|FG001|Overall Study|Withdrawal by Subject|4|||
129089002|NCT00373958|464616198|FG000|Infant Series|Failed to return|8|||
129089003|NCT00373958|464616199|FG001|Infant Series|Failed to return|13|||
129089004|NCT00373958|464616198|FG000|Infant Series|Lost to Follow-up|6|||
129089005|NCT00373958|464616199|FG001|Infant Series|Lost to Follow-up|5|||
129089006|NCT00373958|464616198|FG000|Infant Series|Protocol Violation|3|||
129089007|NCT00373958|464616199|FG001|Infant Series|Protocol Violation|7|||
129089008|NCT00373958|464616198|FG000|Infant Series|Lost Kaiser coverage|4|||
129089009|NCT00373958|464616199|FG001|Infant Series|Lost Kaiser coverage|0|||
129089010|NCT00373958|464616198|FG000|Infant Series|Child relocated|1|||
129089011|NCT00373958|464616199|FG001|Infant Series|Child relocated|0|||
129089012|NCT00373958|464616198|FG000|Infant Series|Consent was not received|1|||
129089013|NCT00373958|464616199|FG001|Infant Series|Consent was not received|0|||
129089014|NCT00373958|464616198|FG000|Infant Series|Adverse Event|3|||
129089015|NCT00373958|464616199|FG001|Infant Series|Adverse Event|1|||
129089016|NCT00373958|464616198|FG000|Infant Series|Physician Decision|1|||
129089017|NCT00373958|464616199|FG001|Infant Series|Physician Decision|1|||
129089018|NCT00373958|464616198|FG000|Toddler Dose|Lost to Follow-up|5|||
129089019|NCT00373958|464616199|FG001|Toddler Dose|Lost to Follow-up|8|||
129089020|NCT00373958|464616198|FG000|Toddler Dose|Withdrawal by Subject|2|||
129089021|NCT00373958|464616199|FG001|Toddler Dose|Withdrawal by Subject|2|||
129089022|NCT00373958|464616198|FG000|Toddler Dose|Failed to return|1|||
129089023|NCT00373958|464616199|FG001|Toddler Dose|Failed to return|2|||
129089024|NCT00373958|464616198|FG000|Toddler Dose|Protocol Violation|0|||
129089025|NCT00373958|464616199|FG001|Toddler Dose|Protocol Violation|1|||
129089026|NCT00373958|464616198|FG000|Toddler Dose|Withdrawn after infant series|22|||
129089027|NCT00373958|464616199|FG001|Toddler Dose|Withdrawn after infant series|25|||
129089028|NCT01880086|464616200|FG000|Overall Study|Lost to Follow-up|1|||
129089029|NCT01880086|464616201|FG001|Overall Study|Lost to Follow-up|1|||
129089030|NCT03843632|464616211|FG000|Overall Study|Withdrawal by Subject|1|||
129089031|NCT03843632|464616212|FG001|Overall Study|Withdrawal by Subject|0|||
129089032|NCT03843632|464616213|FG002|Overall Study|Withdrawal by Subject|0|||
129089033|NCT03843632|464616214|FG003|Overall Study|Withdrawal by Subject|0|||
129089034|NCT03403751|464616215|FG000|Overall Study|Death|5|||
129089035|NCT03403751|464616216|FG001|Overall Study|Death|6|||
129089036|NCT03403751|464616215|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
129089037|NCT03403751|464616216|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
129089038|NCT01820572|464616218|FG000|Randomization|Not Treated|2|||
129089039|NCT01820572|464616219|FG001|Randomization|Not Treated|1|||
129089040|NCT01820572|464616218|FG000|Treatment Period|Adverse Event|12|||
129089041|NCT01820572|464616219|FG001|Treatment Period|Adverse Event|7|||
129089042|NCT01820572|464616218|FG000|Treatment Period|Death|3|||
129089043|NCT01820572|464616219|FG001|Treatment Period|Death|3|||
129089044|NCT01820572|464616218|FG000|Treatment Period|Lack of Efficacy|1|||
129089045|NCT01820572|464616219|FG001|Treatment Period|Lack of Efficacy|0|||
129089046|NCT01820572|464616218|FG000|Treatment Period|poor/non compliance|0|||
129089047|NCT01820572|464616219|FG001|Treatment Period|poor/non compliance|3|||
129089048|NCT01820572|464616218|FG000|Treatment Period|request to discontinue|6|||
129089049|NCT01820572|464616219|FG001|Treatment Period|request to discontinue|11|||
129089050|NCT01820572|464616218|FG000|Treatment Period|No longer meets study criteria|3|||
129089051|NCT01820572|464616219|FG001|Treatment Period|No longer meets study criteria|10|||
129145275|NCT05030766|464828127|FG002|Phase 2 Participants|Lost to Follow-up|6|||
128724521|NCT02196324|463289136|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
128724522|NCT02196324|463289137|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
128724523|NCT02196324|463289136|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
128724524|NCT02196324|463289137|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
128724525|NCT02196324|463289136|FG000|Overall Study|Other|1|||
128724526|NCT02196324|463289137|FG001|Overall Study|Other|0|||
129089052|NCT01820572|464616218|FG000|Treatment Period|withdrew consent|1|||
129089053|NCT01820572|464616219|FG001|Treatment Period|withdrew consent|2|||
129089054|NCT05036668|464616223|FG000|Overall Study|lost to follow Up|0|||
129089055|NCT05036668|464616224|FG001|Overall Study|lost to follow Up|0|||
128724527|NCT04248816|463289138|FG000|Overall Study|Ineligible post-randomization|7|||
129089056|NCT05036668|464616225|FG002|Overall Study|lost to follow Up|1|||
129089057|NCT00520481|464616228|FG000|Overall Study|Adverse Event|4|||
129089058|NCT00520481|464616229|FG001|Overall Study|Adverse Event|1|||
129089059|NCT00520481|464616228|FG000|Overall Study|Withdrawal by Subject|3|||
129089060|NCT00520481|464616229|FG001|Overall Study|Withdrawal by Subject|0|||
129089061|NCT01931956|464616232|FG000|Overall Study|Death|42|||
129089062|NCT01931956|464616233|FG001|Overall Study|Death|7|||
129089063|NCT01931956|464616234|FG002|Overall Study|Death|379|||
129089064|NCT01931956|464616235|FG003|Overall Study|Death|96|||
129089065|NCT01931956|464616232|FG000|Overall Study|Withdrawal by Subject|5|||
129089066|NCT01931956|464616233|FG001|Overall Study|Withdrawal by Subject|0|||
129089067|NCT01931956|464616234|FG002|Overall Study|Withdrawal by Subject|70|||
129089068|NCT01931956|464616235|FG003|Overall Study|Withdrawal by Subject|30|||
129089069|NCT01931956|464616232|FG000|Overall Study|Lost to Follow-up|2|||
129089070|NCT01931956|464616233|FG001|Overall Study|Lost to Follow-up|0|||
129089071|NCT01931956|464616234|FG002|Overall Study|Lost to Follow-up|11|||
129089072|NCT01931956|464616235|FG003|Overall Study|Lost to Follow-up|7|||
129089073|NCT01931956|464616232|FG000|Overall Study|Expected|2|||
129089074|NCT01931956|464616233|FG001|Overall Study|Expected|0|||
129089075|NCT01931956|464616234|FG002|Overall Study|Expected|6|||
129089076|NCT01931956|464616235|FG003|Overall Study|Expected|0|||
129089077|NCT01931956|464616232|FG000|Overall Study|Not due|0|||
129089078|NCT01931956|464616233|FG001|Overall Study|Not due|0|||
129089079|NCT01931956|464616234|FG002|Overall Study|Not due|21|||
129089080|NCT01931956|464616235|FG003|Overall Study|Not due|0|||
129089081|NCT02847494|464616240|FG000|Overall Study|Lost to Follow-up|8|||
129089082|NCT02847494|464616241|FG001|Overall Study|Lost to Follow-up|5|||
129089083|NCT01901653|464616242|FG000|Overall Study|Death|2|||
129089084|NCT01901653|464616243|FG001|Overall Study|Death|1|||
129089085|NCT01901653|464616244|FG002|Overall Study|Death|8|||
129089086|NCT01901653|464616245|FG003|Overall Study|Death|3|||
129089087|NCT01901653|464616246|FG004|Overall Study|Death|2|||
129089088|NCT01901653|464616247|FG005|Overall Study|Death|2|||
129089089|NCT01901653|464616248|FG006|Overall Study|Death|6|||
129089090|NCT01901653|464616249|FG007|Overall Study|Death|9|||
129089091|NCT01901653|464616250|FG008|Overall Study|Death|1|||
129089092|NCT01901653|464616251|FG009|Overall Study|Death|16|||
129089093|NCT01901653|464616252|FG010|Overall Study|Death|2|||
129089094|NCT01901653|464616253|FG011|Overall Study|Death|15|||
129089095|NCT01901653|464616254|FG012|Overall Study|Death|4|||
129089096|NCT01901653|464616242|FG000|Overall Study|Lost to Follow-up|1|||
128724528|NCT04248816|463289139|FG001|Overall Study|Ineligible post-randomization|21|||
128724529|NCT04248816|463289140|FG002|Overall Study|Ineligible post-randomization|25|||
128724530|NCT04327986|463289141|FG000|Overall Study|Physician Decision|2|||
129089097|NCT01901653|464616243|FG001|Overall Study|Lost to Follow-up|0|||
129089098|NCT01901653|464616244|FG002|Overall Study|Lost to Follow-up|2|||
129089099|NCT01901653|464616245|FG003|Overall Study|Lost to Follow-up|0|||
129089100|NCT01901653|464616246|FG004|Overall Study|Lost to Follow-up|0|||
129089101|NCT01901653|464616247|FG005|Overall Study|Lost to Follow-up|1|||
129089102|NCT01901653|464616248|FG006|Overall Study|Lost to Follow-up|0|||
129089103|NCT01901653|464616249|FG007|Overall Study|Lost to Follow-up|1|||
129089104|NCT01901653|464616250|FG008|Overall Study|Lost to Follow-up|0|||
129089105|NCT01901653|464616251|FG009|Overall Study|Lost to Follow-up|0|||
129089106|NCT01901653|464616252|FG010|Overall Study|Lost to Follow-up|0|||
129089107|NCT01901653|464616253|FG011|Overall Study|Lost to Follow-up|0|||
129089108|NCT01901653|464616254|FG012|Overall Study|Lost to Follow-up|0|||
129089109|NCT01901653|464616242|FG000|Overall Study|Withdrawal by Subject|0|||
129089110|NCT01901653|464616243|FG001|Overall Study|Withdrawal by Subject|0|||
129089111|NCT01901653|464616244|FG002|Overall Study|Withdrawal by Subject|0|||
128724531|NCT04327986|463289142|FG001|Overall Study|Physician Decision|0|||
128724532|NCT04327986|463289143|FG002|Overall Study|Physician Decision|0|||
129089112|NCT01901653|464616245|FG003|Overall Study|Withdrawal by Subject|0|||
129089113|NCT01901653|464616246|FG004|Overall Study|Withdrawal by Subject|0|||
129089114|NCT01901653|464616247|FG005|Overall Study|Withdrawal by Subject|0|||
129089115|NCT01901653|464616248|FG006|Overall Study|Withdrawal by Subject|1|||
128724533|NCT04327986|463289141|FG000|Overall Study|Death|1|||
128724534|NCT04327986|463289142|FG001|Overall Study|Death|0|||
128724535|NCT04327986|463289143|FG002|Overall Study|Death|0|||
128724536|NCT00655564|463289144|FG000|Overall Study|Adverse Event|1|||
128724537|NCT00655564|463289144|FG000|Overall Study|Lost to Follow-up|1|||
128724538|NCT00655564|463289144|FG000|Overall Study|Desired Alternate Therapy|1|||
129089116|NCT01901653|464616249|FG007|Overall Study|Withdrawal by Subject|0|||
129089117|NCT01901653|464616250|FG008|Overall Study|Withdrawal by Subject|0|||
129089118|NCT01901653|464616251|FG009|Overall Study|Withdrawal by Subject|0|||
129089119|NCT01901653|464616252|FG010|Overall Study|Withdrawal by Subject|0|||
129089120|NCT01901653|464616253|FG011|Overall Study|Withdrawal by Subject|0|||
129089121|NCT01901653|464616254|FG012|Overall Study|Withdrawal by Subject|0|||
129089122|NCT01901653|464616242|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
129089123|NCT01901653|464616243|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
129089124|NCT01901653|464616244|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
129089125|NCT01901653|464616245|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
129089126|NCT01901653|464616246|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
129089127|NCT01901653|464616247|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
129089128|NCT01901653|464616248|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
129089129|NCT01901653|464616249|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
128724539|NCT00560950|463289146|FG000|Overall Study|Lost to Follow-up|1|||
128724540|NCT00560950|463289147|FG001|Overall Study|Lost to Follow-up|0|||
129089130|NCT01901653|464616250|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
129089131|NCT01901653|464616251|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
129089132|NCT01901653|464616252|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
129089133|NCT01901653|464616253|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
129089134|NCT01901653|464616254|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
129089135|NCT02091986|464616255|FG000|Overall Study|7 rand in error 1 patient decision|2|||
129089136|NCT02091986|464616256|FG001|Overall Study|7 rand in error 1 patient decision|3|||
129089137|NCT02091986|464616257|FG002|Overall Study|7 rand in error 1 patient decision|3|||
129089138|NCT02091986|464616255|FG000|Overall Study|Lost to Follow-up|1|||
129089139|NCT02091986|464616256|FG001|Overall Study|Lost to Follow-up|0|||
129089140|NCT02091986|464616257|FG002|Overall Study|Lost to Follow-up|0|||
129089141|NCT02091986|464616255|FG000|Overall Study|Withdrawal by Subject|4|||
129089142|NCT02091986|464616256|FG001|Overall Study|Withdrawal by Subject|8|||
129089143|NCT02091986|464616257|FG002|Overall Study|Withdrawal by Subject|3|||
129089144|NCT02091986|464616255|FG000|Overall Study|Adverse Event|0|||
129089145|NCT02091986|464616256|FG001|Overall Study|Adverse Event|0|||
129089146|NCT02091986|464616257|FG002|Overall Study|Adverse Event|2|||
129089147|NCT02537431|464616261|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
129089148|NCT00957268|464616262|FG000|Overall Study|Voluntary Withdrawal|0|||
129089149|NCT00957268|464616263|FG001|Overall Study|Voluntary Withdrawal|0|||
129089150|NCT00957268|464616264|FG002|Overall Study|Voluntary Withdrawal|1|||
129089151|NCT00957268|464616265|FG003|Overall Study|Voluntary Withdrawal|0|||
129089152|NCT00957268|464616266|FG004|Overall Study|Voluntary Withdrawal|0|||
129089153|NCT01738503|464616267|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
129089154|NCT01738503|464616268|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
129089155|NCT01738503|464616269|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
129089156|NCT01738503|464616270|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
129089157|NCT01738503|464616271|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
129089158|NCT01738503|464616272|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
129089159|NCT01738503|464616273|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
129089160|NCT01738503|464616267|FG000|Treatment Period|Adverse Event|0|||
129089161|NCT01738503|464616268|FG001|Treatment Period|Adverse Event|1|||
129089162|NCT01738503|464616269|FG002|Treatment Period|Adverse Event|0|||
129089163|NCT01738503|464616270|FG003|Treatment Period|Adverse Event|1|||
129089164|NCT01738503|464616271|FG004|Treatment Period|Adverse Event|2|||
129089165|NCT01738503|464616272|FG005|Treatment Period|Adverse Event|2|||
129089166|NCT01738503|464616273|FG006|Treatment Period|Adverse Event|2|||
129089167|NCT01738503|464616267|FG000|Treatment Period|Lost to Follow-up|0|||
129089168|NCT01738503|464616268|FG001|Treatment Period|Lost to Follow-up|0|||
129089169|NCT01738503|464616269|FG002|Treatment Period|Lost to Follow-up|3|||
129089170|NCT01738503|464616270|FG003|Treatment Period|Lost to Follow-up|4|||
129089171|NCT01738503|464616271|FG004|Treatment Period|Lost to Follow-up|1|||
129089172|NCT01738503|464616272|FG005|Treatment Period|Lost to Follow-up|1|||
129089173|NCT01738503|464616273|FG006|Treatment Period|Lost to Follow-up|5|||
129089174|NCT01738503|464616267|FG000|Treatment Period|Withdrawal by Subject|0|||
129089175|NCT01738503|464616268|FG001|Treatment Period|Withdrawal by Subject|1|||
129089176|NCT01738503|464616269|FG002|Treatment Period|Withdrawal by Subject|0|||
129089177|NCT01738503|464616270|FG003|Treatment Period|Withdrawal by Subject|1|||
129089178|NCT01738503|464616271|FG004|Treatment Period|Withdrawal by Subject|1|||
129089179|NCT01738503|464616272|FG005|Treatment Period|Withdrawal by Subject|1|||
129089180|NCT01738503|464616273|FG006|Treatment Period|Withdrawal by Subject|1|||
129089181|NCT01738503|464616267|FG000|Treatment Period|Protocol Violation|0|||
129089182|NCT01738503|464616268|FG001|Treatment Period|Protocol Violation|3|||
129089183|NCT01738503|464616269|FG002|Treatment Period|Protocol Violation|1|||
129089184|NCT01738503|464616270|FG003|Treatment Period|Protocol Violation|0|||
129089185|NCT01738503|464616271|FG004|Treatment Period|Protocol Violation|4|||
129089186|NCT01738503|464616272|FG005|Treatment Period|Protocol Violation|2|||
129089187|NCT01738503|464616273|FG006|Treatment Period|Protocol Violation|0|||
129089188|NCT01738503|464616267|FG000|Treatment Period|Other|0|||
129089189|NCT01738503|464616268|FG001|Treatment Period|Other|0|||
129089190|NCT01738503|464616269|FG002|Treatment Period|Other|1|||
129089191|NCT01738503|464616270|FG003|Treatment Period|Other|0|||
129089192|NCT01738503|464616271|FG004|Treatment Period|Other|0|||
129089193|NCT01738503|464616272|FG005|Treatment Period|Other|0|||
129089194|NCT01738503|464616273|FG006|Treatment Period|Other|0|||
128724541|NCT02181556|463290840|FG000|Overall Study|Withdrawal by Subject|1|||
128724542|NCT01940120|463290841|FG000|Overall Study|Death|40|||
128724543|NCT01940120|463290841|FG000|Overall Study|Withdrawal by Subject|8|||
128724544|NCT00427635|463290842|FG000|Treatment Phase|Withdrawal by Subject|1|||
129089195|NCT01738503|464616267|FG000|PET Imaging Sub-study|Adverse Event|0|||
129089196|NCT01738503|464616268|FG001|PET Imaging Sub-study|Adverse Event|0|||
129089197|NCT01738503|464616269|FG002|PET Imaging Sub-study|Adverse Event|0|||
129089198|NCT01738503|464616270|FG003|PET Imaging Sub-study|Adverse Event|0|||
129089199|NCT01738503|464616271|FG004|PET Imaging Sub-study|Adverse Event|0|||
128724545|NCT00427635|463290843|FG001|Treatment Phase|Withdrawal by Subject|0|||
129089200|NCT01738503|464616272|FG005|PET Imaging Sub-study|Adverse Event|1|||
129089201|NCT01738503|464616273|FG006|PET Imaging Sub-study|Adverse Event|0|||
128724546|NCT00427635|463290842|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
128724547|NCT00427635|463290843|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
128724548|NCT01888497|463290845|FG000|Washout Period 1|Withdrawal by Subject|0|||
129089202|NCT01738503|464616267|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129089203|NCT01738503|464616268|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129089204|NCT01738503|464616269|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129089205|NCT01738503|464616270|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129089206|NCT01738503|464616271|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129089207|NCT01738503|464616272|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
129089208|NCT01738503|464616273|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
129089209|NCT00794040|464616274|FG000|Overall Study|Withdrawal by Subject|3|||
129089210|NCT00794040|464616275|FG001|Overall Study|Withdrawal by Subject|4|||
129089211|NCT00794040|464616274|FG000|Overall Study|Physician Decision|0|||
129089212|NCT00794040|464616275|FG001|Overall Study|Physician Decision|1|||
129089213|NCT01340027|464616276|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
129089214|NCT01340027|464616277|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
129089215|NCT01340027|464616278|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
129089216|NCT01340027|464616279|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
129089217|NCT01340027|464616280|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
129089218|NCT01340027|464616281|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
129089219|NCT01340027|464616282|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
129089220|NCT01340027|464616283|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
129089221|NCT01340027|464616284|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
129089222|NCT01340027|464616285|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
129089223|NCT01340027|464616286|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
129089224|NCT01340027|464616287|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
129089225|NCT01340027|464616276|FG000|Overall Study|Adverse Event|0|||
129089226|NCT01340027|464616277|FG001|Overall Study|Adverse Event|1|||
129089227|NCT01340027|464616278|FG002|Overall Study|Adverse Event|2|||
129089228|NCT01340027|464616279|FG003|Overall Study|Adverse Event|0|||
129089229|NCT01340027|464616280|FG004|Overall Study|Adverse Event|1|||
129089230|NCT01340027|464616281|FG005|Overall Study|Adverse Event|2|||
129089231|NCT01340027|464616282|FG006|Overall Study|Adverse Event|2|||
129089232|NCT01340027|464616283|FG007|Overall Study|Adverse Event|1|||
129089233|NCT01340027|464616284|FG008|Overall Study|Adverse Event|4|||
129089234|NCT01340027|464616285|FG009|Overall Study|Adverse Event|1|||
129089235|NCT01340027|464616286|FG010|Overall Study|Adverse Event|1|||
129145276|NCT05030766|464828128|FG003|Phase 2 Participants|Lost to Follow-up|2|||
129145277|NCT00645658|464828129|FG000|Overall Study|Withdrawal by Subject|1|||
129145278|NCT00645658|464828130|FG001|Overall Study|Withdrawal by Subject|0|||
129145279|NCT00645658|464828129|FG000|Overall Study|Did not complete all assesments|0|||
129145280|NCT00645658|464828130|FG001|Overall Study|Did not complete all assesments|2|||
129089236|NCT01340027|464616287|FG011|Overall Study|Adverse Event|3|||
129089237|NCT01340027|464616276|FG000|Overall Study|Lack of Efficacy|0|||
129089238|NCT01340027|464616277|FG001|Overall Study|Lack of Efficacy|0|||
129089239|NCT01340027|464616278|FG002|Overall Study|Lack of Efficacy|0|||
129089240|NCT01340027|464616279|FG003|Overall Study|Lack of Efficacy|0|||
129089241|NCT01340027|464616280|FG004|Overall Study|Lack of Efficacy|0|||
129145281|NCT00023595|464828131|FG000|5 Year Follow up|Lost to Follow-up|2|||
129145282|NCT00023595|464828132|FG001|5 Year Follow up|Lost to Follow-up|2|||
129145283|NCT00023595|464828133|FG002|5 Year Follow up|Lost to Follow-up|1|||
129145284|NCT00023595|464828134|FG003|5 Year Follow up|Lost to Follow-up|7|||
129145285|NCT00023595|464828135|FG004|5 Year Follow up|Lost to Follow-up|3|||
129145286|NCT00023595|464828131|FG000|10 Year Follow up|Lost to Follow-up|12|||
129145287|NCT00023595|464828132|FG001|10 Year Follow up|Lost to Follow-up|10|||
129145288|NCT00023595|464828133|FG002|10 Year Follow up|Lost to Follow-up|3|||
129145289|NCT00023595|464828134|FG003|10 Year Follow up|Lost to Follow-up|0|||
129145290|NCT00023595|464828135|FG004|10 Year Follow up|Lost to Follow-up|0|||
129145291|NCT03900650|464828136|FG000|Overall Study|Withdrawal by Subject|1|||
129145292|NCT03900650|464828137|FG001|Overall Study|Withdrawal by Subject|1|||
129145293|NCT03900650|464828138|FG002|Overall Study|Withdrawal by Subject|0|||
129145294|NCT03900650|464828139|FG003|Overall Study|Withdrawal by Subject|0|||
129145295|NCT03900650|464828136|FG000|Overall Study|Withdrawn by staff|1|||
129145296|NCT03900650|464828137|FG001|Overall Study|Withdrawn by staff|0|||
129145297|NCT03900650|464828138|FG002|Overall Study|Withdrawn by staff|0|||
129145298|NCT03900650|464828139|FG003|Overall Study|Withdrawn by staff|0|||
129145299|NCT02082977|464828140|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
129145300|NCT02082977|464828141|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
129145301|NCT02082977|464828142|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
129145302|NCT02082977|464828143|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
129145303|NCT02082977|464828144|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
129145304|NCT02082977|464828145|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
129145305|NCT02082977|464828146|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
129145306|NCT02082977|464828147|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
129145307|NCT02082977|464828148|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
129145308|NCT02082977|464828149|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
129089242|NCT01340027|464616281|FG005|Overall Study|Lack of Efficacy|0|||
129089243|NCT01340027|464616282|FG006|Overall Study|Lack of Efficacy|1|||
129089244|NCT01340027|464616283|FG007|Overall Study|Lack of Efficacy|1|||
129089245|NCT01340027|464616284|FG008|Overall Study|Lack of Efficacy|1|||
129089246|NCT01340027|464616285|FG009|Overall Study|Lack of Efficacy|0|||
129089247|NCT01340027|464616286|FG010|Overall Study|Lack of Efficacy|0|||
129089248|NCT01340027|464616287|FG011|Overall Study|Lack of Efficacy|0|||
129089249|NCT01340027|464616276|FG000|Overall Study|Lost to Follow-up|0|||
129089250|NCT01340027|464616277|FG001|Overall Study|Lost to Follow-up|1|||
129089251|NCT01340027|464616278|FG002|Overall Study|Lost to Follow-up|0|||
129089252|NCT01340027|464616279|FG003|Overall Study|Lost to Follow-up|0|||
129089253|NCT01340027|464616280|FG004|Overall Study|Lost to Follow-up|0|||
129089254|NCT01340027|464616281|FG005|Overall Study|Lost to Follow-up|0|||
129089255|NCT01340027|464616282|FG006|Overall Study|Lost to Follow-up|1|||
129089256|NCT01340027|464616283|FG007|Overall Study|Lost to Follow-up|0|||
129089257|NCT01340027|464616284|FG008|Overall Study|Lost to Follow-up|0|||
129089258|NCT01340027|464616285|FG009|Overall Study|Lost to Follow-up|1|||
129089259|NCT01340027|464616286|FG010|Overall Study|Lost to Follow-up|0|||
129089260|NCT01340027|464616287|FG011|Overall Study|Lost to Follow-up|0|||
129089261|NCT01340027|464616276|FG000|Overall Study|Protocol Violation|1|||
129089262|NCT01340027|464616277|FG001|Overall Study|Protocol Violation|2|||
129089263|NCT01340027|464616278|FG002|Overall Study|Protocol Violation|0|||
129089264|NCT01340027|464616279|FG003|Overall Study|Protocol Violation|0|||
129089265|NCT01340027|464616280|FG004|Overall Study|Protocol Violation|6|||
129089266|NCT01340027|464616281|FG005|Overall Study|Protocol Violation|0|||
129089267|NCT01340027|464616282|FG006|Overall Study|Protocol Violation|0|||
129089268|NCT01340027|464616283|FG007|Overall Study|Protocol Violation|1|||
129089269|NCT01340027|464616284|FG008|Overall Study|Protocol Violation|2|||
129089270|NCT01340027|464616285|FG009|Overall Study|Protocol Violation|2|||
129089271|NCT01340027|464616286|FG010|Overall Study|Protocol Violation|0|||
129089272|NCT01340027|464616287|FG011|Overall Study|Protocol Violation|0|||
129089273|NCT01340027|464616276|FG000|Overall Study|Withdrawal by Subject|4|||
129089274|NCT01340027|464616277|FG001|Overall Study|Withdrawal by Subject|3|||
129089275|NCT01340027|464616278|FG002|Overall Study|Withdrawal by Subject|1|||
129089276|NCT01340027|464616279|FG003|Overall Study|Withdrawal by Subject|3|||
129089277|NCT01340027|464616280|FG004|Overall Study|Withdrawal by Subject|3|||
129089278|NCT01340027|464616281|FG005|Overall Study|Withdrawal by Subject|2|||
129089279|NCT01340027|464616282|FG006|Overall Study|Withdrawal by Subject|3|||
129089280|NCT01340027|464616283|FG007|Overall Study|Withdrawal by Subject|4|||
129089281|NCT01340027|464616284|FG008|Overall Study|Withdrawal by Subject|1|||
129089282|NCT01340027|464616285|FG009|Overall Study|Withdrawal by Subject|2|||
129089283|NCT01340027|464616286|FG010|Overall Study|Withdrawal by Subject|0|||
129089284|NCT01340027|464616287|FG011|Overall Study|Withdrawal by Subject|1|||
129089285|NCT01340027|464616276|FG000|Overall Study|Miscellaneous|0|||
129089286|NCT01340027|464616277|FG001|Overall Study|Miscellaneous|0|||
129089287|NCT01340027|464616278|FG002|Overall Study|Miscellaneous|0|||
129089288|NCT01340027|464616279|FG003|Overall Study|Miscellaneous|1|||
129089289|NCT01340027|464616280|FG004|Overall Study|Miscellaneous|0|||
129089290|NCT01340027|464616281|FG005|Overall Study|Miscellaneous|0|||
129089291|NCT01340027|464616282|FG006|Overall Study|Miscellaneous|0|||
129089292|NCT01340027|464616283|FG007|Overall Study|Miscellaneous|0|||
129089293|NCT01340027|464616284|FG008|Overall Study|Miscellaneous|0|||
129089294|NCT01340027|464616285|FG009|Overall Study|Miscellaneous|0|||
129089295|NCT01340027|464616286|FG010|Overall Study|Miscellaneous|1|||
129089296|NCT01340027|464616287|FG011|Overall Study|Miscellaneous|0|||
129089297|NCT04687072|464616288|FG000|Overall Study|Adverse Event|2|||
129089298|NCT04687072|464616289|FG001|Overall Study|Adverse Event|0|||
129089299|NCT04687072|464616288|FG000|Overall Study|Death|1|||
129089300|NCT04687072|464616289|FG001|Overall Study|Death|0|||
129089301|NCT04687072|464616288|FG000|Overall Study|Lack of Efficacy|2|||
129089302|NCT04687072|464616289|FG001|Overall Study|Lack of Efficacy|1|||
129089303|NCT04687072|464616288|FG000|Overall Study|Physician Decision|1|||
129089304|NCT04687072|464616289|FG001|Overall Study|Physician Decision|0|||
129145309|NCT02082977|464828140|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129145310|NCT02082977|464828141|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129145311|NCT02082977|464828142|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129145312|NCT02082977|464828143|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129089305|NCT04687072|464616288|FG000|Overall Study|Pregnancy|1|||
129089306|NCT04687072|464616289|FG001|Overall Study|Pregnancy|0|||
129089307|NCT04687072|464616288|FG000|Overall Study|Requires Prohibited Medication|2|||
129089308|NCT04687072|464616289|FG001|Overall Study|Requires Prohibited Medication|0|||
129089309|NCT04687072|464616288|FG000|Overall Study|Withdrawal of Consent|11|||
129089310|NCT04687072|464616289|FG001|Overall Study|Withdrawal of Consent|6|||
129089311|NCT04687072|464616288|FG000|Overall Study|Miscellaneous|4|||
129089312|NCT04687072|464616289|FG001|Overall Study|Miscellaneous|1|||
129089313|NCT03626363|464616290|FG000|Overall Study|Protocol Violation|4|||
129089314|NCT03626363|464616291|FG001|Overall Study|Protocol Violation|0|||
129089315|NCT03626363|464616290|FG000|Overall Study|Lost to Follow-up|5|||
129089316|NCT03626363|464616291|FG001|Overall Study|Lost to Follow-up|7|||
128724549|NCT01888497|463290846|FG001|Washout Period 1|Withdrawal by Subject|0|||
128724550|NCT01888497|463290847|FG002|Washout Period 1|Withdrawal by Subject|1|||
128724551|NCT01888497|463290848|FG003|Washout Period 1|Withdrawal by Subject|1|||
128724552|NCT01888497|463290845|FG000|Washout Period 2|Adverse Event|0|||
128724553|NCT01888497|463290846|FG001|Washout Period 2|Adverse Event|0|||
128724554|NCT01888497|463290847|FG002|Washout Period 2|Adverse Event|0|||
128724555|NCT01888497|463290848|FG003|Washout Period 2|Adverse Event|1|||
128724556|NCT01888497|463290845|FG000|Washout Period 2|Withdrawal by Subject|0|||
129089317|NCT02600845|464616297|FG000|Overall Study|Reason Not Specified|3|||
129089318|NCT02600845|464616297|FG000|Overall Study|Non-compliance with Study Procedures|10|||
129089319|NCT02600845|464616297|FG000|Overall Study|Consent Withdrawal|5|||
129089320|NCT04413552|464616298|FG000|Overall Study|Adverse Event|0|||
129089321|NCT04413552|464616299|FG001|Overall Study|Adverse Event|0|||
129089322|NCT04413552|464616300|FG002|Overall Study|Adverse Event|0|||
129089323|NCT04413552|464616301|FG003|Overall Study|Adverse Event|0|||
129089324|NCT04413552|464616302|FG004|Overall Study|Adverse Event|0|||
129089325|NCT04413552|464616303|FG005|Overall Study|Adverse Event|0|||
129089326|NCT04413552|464616304|FG006|Overall Study|Adverse Event|1|||
129089327|NCT04413552|464616305|FG007|Overall Study|Adverse Event|0|||
129089328|NCT04413552|464616306|FG008|Overall Study|Adverse Event|0|||
129089329|NCT04413552|464616307|FG009|Overall Study|Adverse Event|0|||
129089330|NCT04852679|464616308|FG000|Main Intervention Period|Withdrawal by Subject|3|||
129089331|NCT04852679|464616308|FG000|Main Intervention Period|Adverse Event|1|||
129089332|NCT04852679|464616308|FG000|Main Intervention Period|Progressive Disease|16|||
129089333|NCT04852679|464616308|FG000|Main Intervention Period|Refused study visit|1|||
129089334|NCT04852679|464616308|FG000|Independent Injection Period|Missed study visit|1|||
129089335|NCT01294696|464616309|FG000|Overall Study|Screening failures|7|||
129089336|NCT01294696|464616309|FG000|Overall Study|Protocol Violation|8|||
129089337|NCT01294696|464616309|FG000|Overall Study|Missing BPI Response|7|||
129089338|NCT01294696|464616309|FG000|Overall Study|Site closure|52|||
129089339|NCT01871402|464617968|FG000|Overall Study|Lost to Follow-up|1|||
129089340|NCT01871402|464617969|FG001|Overall Study|Lost to Follow-up|0|||
129089341|NCT01871402|464617968|FG000|Overall Study|Withdrawal by Subject|0|||
129089342|NCT01871402|464617969|FG001|Overall Study|Withdrawal by Subject|2|||
128724557|NCT01888497|463290846|FG001|Washout Period 2|Withdrawal by Subject|0|||
128724558|NCT01888497|463290847|FG002|Washout Period 2|Withdrawal by Subject|0|||
129089343|NCT01871402|464617968|FG000|Overall Study|Non-compliance|0|||
129089344|NCT01871402|464617969|FG001|Overall Study|Non-compliance|1|||
129089345|NCT04594941|464617970|FG000|Overall Study|Other|0|||
129089346|NCT04594941|464617971|FG001|Overall Study|Other|3|||
129089347|NCT04594941|464617972|FG002|Overall Study|Other|1|||
129089348|NCT04594941|464617973|FG003|Overall Study|Other|0|||
129089349|NCT02424630|464617974|FG000|Overall Study|No rotator cuff tear|1|||
129089350|NCT02424630|464617975|FG001|Overall Study|No rotator cuff tear|2|||
129089351|NCT02424630|464617974|FG000|Overall Study|Open procedure|0|||
129089352|NCT02424630|464617975|FG001|Overall Study|Open procedure|1|||
129089353|NCT02703272|464617976|FG000|Overall Study|Death|4|||
129089354|NCT02703272|464617977|FG001|Overall Study|Death|9|||
129089355|NCT02703272|464617978|FG002|Overall Study|Death|19|||
129089356|NCT02703272|464617979|FG003|Overall Study|Death|10|||
128724559|NCT01888497|463290848|FG003|Washout Period 2|Withdrawal by Subject|1|||
128724560|NCT04152447|463290849|FG000|Overall Study|Lost to Follow-up|1|||
129089357|NCT02703272|464617976|FG000|Overall Study|Withdrawal by Subject|0|||
129089358|NCT02703272|464617977|FG001|Overall Study|Withdrawal by Subject|0|||
129089359|NCT02703272|464617978|FG002|Overall Study|Withdrawal by Subject|4|||
129089360|NCT02703272|464617979|FG003|Overall Study|Withdrawal by Subject|2|||
129089361|NCT02703272|464617976|FG000|Overall Study|Study Terminated by Sponsor|6|||
129089362|NCT02703272|464617977|FG001|Overall Study|Study Terminated by Sponsor|1|||
129089363|NCT02703272|464617978|FG002|Overall Study|Study Terminated by Sponsor|12|||
129089364|NCT02703272|464617979|FG003|Overall Study|Study Terminated by Sponsor|4|||
129089365|NCT02703272|464617976|FG000|Overall Study|Other|1|||
129089366|NCT02703272|464617977|FG001|Overall Study|Other|0|||
129089367|NCT02703272|464617978|FG002|Overall Study|Other|0|||
129089368|NCT02703272|464617979|FG003|Overall Study|Other|0|||
129089369|NCT02637895|464617980|FG000|Overall Study|Lost to Follow-up|4|||
129089370|NCT02637895|464617981|FG001|Overall Study|Lost to Follow-up|0|||
129089371|NCT02637895|464617980|FG000|Overall Study|Protocol Violation|0|||
129089372|NCT02637895|464617981|FG001|Overall Study|Protocol Violation|1|||
129089373|NCT02637895|464617980|FG000|Overall Study|Lack of Efficacy|1|||
129089374|NCT02637895|464617981|FG001|Overall Study|Lack of Efficacy|0|||
129089375|NCT02637895|464617980|FG000|Overall Study|Withdrawal by Subject|1|||
129089376|NCT02637895|464617981|FG001|Overall Study|Withdrawal by Subject|1|||
129089377|NCT02637895|464617980|FG000|Overall Study|Abnormal baseline lab|0|||
129089378|NCT02637895|464617981|FG001|Overall Study|Abnormal baseline lab|1|||
129089379|NCT02031640|464617982|FG000|Screening Period|Adverse Event|1|||
129089380|NCT02031640|464617983|FG001|Screening Period|Adverse Event|0|||
129089381|NCT02031640|464617984|FG002|Screening Period|Adverse Event|0|||
129089382|NCT02031640|464617985|FG003|Screening Period|Adverse Event|0|||
129089383|NCT02031640|464617986|FG004|Screening Period|Adverse Event|0|||
129089384|NCT02031640|464617987|FG005|Screening Period|Adverse Event|0|||
129089385|NCT02031640|464617982|FG000|Screening Period|Withdrawal by Subject|29|||
129089386|NCT02031640|464617983|FG001|Screening Period|Withdrawal by Subject|0|||
129089387|NCT02031640|464617984|FG002|Screening Period|Withdrawal by Subject|0|||
129089388|NCT02031640|464617985|FG003|Screening Period|Withdrawal by Subject|0|||
129089389|NCT02031640|464617986|FG004|Screening Period|Withdrawal by Subject|0|||
129089390|NCT02031640|464617987|FG005|Screening Period|Withdrawal by Subject|0|||
129089391|NCT02031640|464617982|FG000|Screening Period|Inclusion criteria not met|312|||
129089392|NCT02031640|464617983|FG001|Screening Period|Inclusion criteria not met|0|||
129089393|NCT02031640|464617984|FG002|Screening Period|Inclusion criteria not met|0|||
128724561|NCT04152447|463290850|FG001|Overall Study|Lost to Follow-up|0|||
128724562|NCT04152447|463290849|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
128724563|NCT04152447|463290850|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
128724564|NCT04152447|463290849|FG000|Overall Study|Withdrawal by Subject|0|||
129089394|NCT02031640|464617985|FG003|Screening Period|Inclusion criteria not met|0|||
129089395|NCT02031640|464617986|FG004|Screening Period|Inclusion criteria not met|0|||
129089396|NCT02031640|464617987|FG005|Screening Period|Inclusion criteria not met|0|||
129089397|NCT02031640|464617982|FG000|Screening Period|Exclusion criteria met|30|||
129089398|NCT02031640|464617983|FG001|Screening Period|Exclusion criteria met|0|||
129089399|NCT02031640|464617984|FG002|Screening Period|Exclusion criteria met|0|||
129089400|NCT02031640|464617985|FG003|Screening Period|Exclusion criteria met|0|||
129145313|NCT02082977|464828144|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129145314|NCT02082977|464828145|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129145315|NCT02082977|464828146|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129145316|NCT02082977|464828147|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
129089401|NCT02031640|464617986|FG004|Screening Period|Exclusion criteria met|0|||
128724565|NCT04152447|463290850|FG001|Overall Study|Withdrawal by Subject|1|||
128724566|NCT04152447|463290849|FG000|Overall Study|Found ineligible after enrolling|1|||
128724567|NCT04152447|463290850|FG001|Overall Study|Found ineligible after enrolling|1|||
128724568|NCT04152447|463290849|FG000|Overall Study|Did not receive VR headset in time.|0|||
129089402|NCT02031640|464617987|FG005|Screening Period|Exclusion criteria met|0|||
129145317|NCT02082977|464828148|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
128724569|NCT04152447|463290850|FG001|Overall Study|Did not receive VR headset in time.|2|||
129089403|NCT02031640|464617982|FG000|Screening Period|Lost to Follow-up|14|||
129089404|NCT02031640|464617983|FG001|Screening Period|Lost to Follow-up|0|||
129089405|NCT02031640|464617984|FG002|Screening Period|Lost to Follow-up|0|||
128724570|NCT03711162|463290853|FG000|Overall Study|Adverse Event|5|||
128724571|NCT03711162|463290854|FG001|Overall Study|Adverse Event|2|||
129089406|NCT02031640|464617985|FG003|Screening Period|Lost to Follow-up|0|||
129089407|NCT02031640|464617986|FG004|Screening Period|Lost to Follow-up|0|||
129089408|NCT02031640|464617987|FG005|Screening Period|Lost to Follow-up|0|||
129089409|NCT02031640|464617982|FG000|Screening Period|Enrollment closed|26|||
129089410|NCT02031640|464617983|FG001|Screening Period|Enrollment closed|0|||
129089411|NCT02031640|464617984|FG002|Screening Period|Enrollment closed|0|||
129089412|NCT02031640|464617985|FG003|Screening Period|Enrollment closed|0|||
129089413|NCT02031640|464617986|FG004|Screening Period|Enrollment closed|0|||
129089414|NCT02031640|464617987|FG005|Screening Period|Enrollment closed|0|||
129089415|NCT02031640|464617982|FG000|Run-In Period|Adverse Event|4|||
129089416|NCT02031640|464617983|FG001|Run-In Period|Adverse Event|0|||
129089417|NCT02031640|464617984|FG002|Run-In Period|Adverse Event|0|||
129089418|NCT02031640|464617985|FG003|Run-In Period|Adverse Event|0|||
129089419|NCT02031640|464617986|FG004|Run-In Period|Adverse Event|0|||
129089420|NCT02031640|464617987|FG005|Run-In Period|Adverse Event|0|||
129089421|NCT02031640|464617982|FG000|Run-In Period|Withdrawal by Subject|17|||
129089422|NCT02031640|464617983|FG001|Run-In Period|Withdrawal by Subject|0|||
129089423|NCT02031640|464617984|FG002|Run-In Period|Withdrawal by Subject|0|||
129089424|NCT02031640|464617985|FG003|Run-In Period|Withdrawal by Subject|0|||
129089425|NCT02031640|464617986|FG004|Run-In Period|Withdrawal by Subject|0|||
129089426|NCT02031640|464617987|FG005|Run-In Period|Withdrawal by Subject|0|||
129089427|NCT02031640|464617982|FG000|Run-In Period|Inclusion criteria not met|38|||
129089428|NCT02031640|464617983|FG001|Run-In Period|Inclusion criteria not met|0|||
129089429|NCT02031640|464617984|FG002|Run-In Period|Inclusion criteria not met|0|||
129089430|NCT02031640|464617985|FG003|Run-In Period|Inclusion criteria not met|0|||
129089431|NCT02031640|464617986|FG004|Run-In Period|Inclusion criteria not met|0|||
129089432|NCT02031640|464617987|FG005|Run-In Period|Inclusion criteria not met|0|||
129089433|NCT02031640|464617982|FG000|Run-In Period|Exclusion criteria met|8|||
129089434|NCT02031640|464617983|FG001|Run-In Period|Exclusion criteria met|0|||
129089435|NCT02031640|464617984|FG002|Run-In Period|Exclusion criteria met|0|||
129089436|NCT02031640|464617985|FG003|Run-In Period|Exclusion criteria met|0|||
129089437|NCT02031640|464617986|FG004|Run-In Period|Exclusion criteria met|0|||
129089438|NCT02031640|464617987|FG005|Run-In Period|Exclusion criteria met|0|||
129089439|NCT02031640|464617982|FG000|Run-In Period|Randomization criteria not met|85|||
129089440|NCT02031640|464617983|FG001|Run-In Period|Randomization criteria not met|0|||
129089441|NCT02031640|464617984|FG002|Run-In Period|Randomization criteria not met|0|||
129089442|NCT02031640|464617985|FG003|Run-In Period|Randomization criteria not met|0|||
129089443|NCT02031640|464617986|FG004|Run-In Period|Randomization criteria not met|0|||
129089444|NCT02031640|464617987|FG005|Run-In Period|Randomization criteria not met|0|||
129089445|NCT02031640|464617982|FG000|Run-In Period|Various administrative reasons|17|||
129089446|NCT02031640|464617983|FG001|Run-In Period|Various administrative reasons|0|||
129089447|NCT02031640|464617984|FG002|Run-In Period|Various administrative reasons|0|||
129089448|NCT02031640|464617985|FG003|Run-In Period|Various administrative reasons|0|||
129089449|NCT02031640|464617986|FG004|Run-In Period|Various administrative reasons|0|||
129089450|NCT02031640|464617987|FG005|Run-In Period|Various administrative reasons|0|||
129089451|NCT02031640|464617982|FG000|Double-blind Treatment Period|Protocol deviation|0|||
129089452|NCT02031640|464617983|FG001|Double-blind Treatment Period|Protocol deviation|2|||
129089453|NCT02031640|464617984|FG002|Double-blind Treatment Period|Protocol deviation|0|||
129089454|NCT02031640|464617985|FG003|Double-blind Treatment Period|Protocol deviation|1|||
129089455|NCT02031640|464617986|FG004|Double-blind Treatment Period|Protocol deviation|3|||
129089456|NCT02031640|464617987|FG005|Double-blind Treatment Period|Protocol deviation|1|||
129089457|NCT02031640|464617982|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129089458|NCT02031640|464617983|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
129089459|NCT02031640|464617984|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
129089460|NCT02031640|464617985|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
129089461|NCT02031640|464617986|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
129089462|NCT02031640|464617987|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
129089463|NCT02031640|464617982|FG000|Double-blind Treatment Period|Non-compliance|0|||
129089464|NCT02031640|464617983|FG001|Double-blind Treatment Period|Non-compliance|1|||
129089465|NCT02031640|464617984|FG002|Double-blind Treatment Period|Non-compliance|0|||
128724572|NCT03711162|463290855|FG002|Overall Study|Adverse Event|4|||
129089466|NCT02031640|464617985|FG003|Double-blind Treatment Period|Non-compliance|1|||
129089467|NCT02031640|464617986|FG004|Double-blind Treatment Period|Non-compliance|1|||
129089468|NCT02031640|464617987|FG005|Double-blind Treatment Period|Non-compliance|0|||
129089469|NCT02031640|464617982|FG000|Double-blind Treatment Period|Adverse Event|0|||
129089470|NCT02031640|464617983|FG001|Double-blind Treatment Period|Adverse Event|0|||
129089471|NCT02031640|464617984|FG002|Double-blind Treatment Period|Adverse Event|0|||
129089472|NCT02031640|464617985|FG003|Double-blind Treatment Period|Adverse Event|2|||
128724573|NCT03711162|463290853|FG000|Overall Study|Death|11|||
129089473|NCT02031640|464617986|FG004|Double-blind Treatment Period|Adverse Event|0|||
129089474|NCT02031640|464617987|FG005|Double-blind Treatment Period|Adverse Event|0|||
129089475|NCT02031640|464617982|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129089476|NCT02031640|464617983|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129089477|NCT02031640|464617984|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
129089478|NCT02031640|464617985|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
129089479|NCT02031640|464617986|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
129089480|NCT02031640|464617987|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
129089481|NCT02031640|464617982|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129089482|NCT02031640|464617983|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
129089483|NCT02031640|464617984|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
129089484|NCT02031640|464617985|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129089485|NCT02031640|464617986|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
129089486|NCT02031640|464617987|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
129089487|NCT03085238|464617992|FG000|Overall Study|Adverse Event|2|||
129089488|NCT03085238|464617992|FG000|Overall Study|Death|2|||
129089489|NCT05896527|464617993|FG000|Overall Study|Withdrawal by Subject|11|||
129089490|NCT05896527|464617994|FG001|Overall Study|Withdrawal by Subject|10|||
129089491|NCT05896527|464617995|FG002|Overall Study|Withdrawal by Subject|4|||
129089492|NCT05896527|464617996|FG003|Overall Study|Withdrawal by Subject|3|||
129089493|NCT05896527|464617997|FG004|Overall Study|Withdrawal by Subject|2|||
129089494|NCT05896527|464617993|FG000|Overall Study|Lost to Follow-up|0|||
129089495|NCT05896527|464617994|FG001|Overall Study|Lost to Follow-up|2|||
129089496|NCT05896527|464617995|FG002|Overall Study|Lost to Follow-up|2|||
129089497|NCT05896527|464617996|FG003|Overall Study|Lost to Follow-up|2|||
129089498|NCT05896527|464617997|FG004|Overall Study|Lost to Follow-up|1|||
129089499|NCT05896527|464617993|FG000|Overall Study|Significant protocol noncompliance|0|||
129089500|NCT05896527|464617994|FG001|Overall Study|Significant protocol noncompliance|1|||
129089501|NCT05896527|464617995|FG002|Overall Study|Significant protocol noncompliance|0|||
129089502|NCT05896527|464617996|FG003|Overall Study|Significant protocol noncompliance|0|||
129089503|NCT05896527|464617997|FG004|Overall Study|Significant protocol noncompliance|0|||
129089504|NCT05896527|464617993|FG000|Overall Study|Eligibility criteria not met|1|||
129089505|NCT05896527|464617994|FG001|Overall Study|Eligibility criteria not met|0|||
129089506|NCT05896527|464617995|FG002|Overall Study|Eligibility criteria not met|0|||
129089507|NCT05896527|464617996|FG003|Overall Study|Eligibility criteria not met|0|||
129089508|NCT05896527|464617997|FG004|Overall Study|Eligibility criteria not met|0|||
129089509|NCT05896527|464617993|FG000|Overall Study|Sponsor's decision|0|||
129089510|NCT05896527|464617994|FG001|Overall Study|Sponsor's decision|0|||
129089511|NCT05896527|464617995|FG002|Overall Study|Sponsor's decision|0|||
129089512|NCT05896527|464617996|FG003|Overall Study|Sponsor's decision|1|||
129089513|NCT05896527|464617997|FG004|Overall Study|Sponsor's decision|0|||
129089514|NCT05896527|464617993|FG000|Overall Study|Investigator's decision|0|||
129089515|NCT05896527|464617994|FG001|Overall Study|Investigator's decision|1|||
129089516|NCT05896527|464617995|FG002|Overall Study|Investigator's decision|0|||
129089517|NCT05896527|464617996|FG003|Overall Study|Investigator's decision|0|||
129089518|NCT05896527|464617997|FG004|Overall Study|Investigator's decision|0|||
129089519|NCT05896527|464617993|FG000|Overall Study|Pregnancy of his partner|0|||
129089520|NCT05896527|464617994|FG001|Overall Study|Pregnancy of his partner|0|||
129089521|NCT05896527|464617995|FG002|Overall Study|Pregnancy of his partner|0|||
129089522|NCT05896527|464617996|FG003|Overall Study|Pregnancy of his partner|1|||
129089523|NCT05896527|464617997|FG004|Overall Study|Pregnancy of his partner|0|||
129089524|NCT01279070|464617998|FG000|Overall Study|Withdrawal by Subject|2|||
129089525|NCT01279070|464617999|FG001|Overall Study|Withdrawal by Subject|3|||
129089526|NCT01279070|464617998|FG000|Overall Study|Acute exacerbation|3|||
129089527|NCT01279070|464617999|FG001|Overall Study|Acute exacerbation|1|||
129089528|NCT03781583|464618000|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
129089529|NCT03781583|464618001|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
129089530|NCT03781583|464618002|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
129089531|NCT03781583|464618003|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
129089532|NCT03781583|464618000|FG000|Overall Study|Technology did not work for that person in that environment|1|||
128724574|NCT03711162|463290854|FG001|Overall Study|Death|7|||
128724575|NCT03711162|463290855|FG002|Overall Study|Death|8|||
129089533|NCT03781583|464618001|FG001|Overall Study|Technology did not work for that person in that environment|0|||
129089534|NCT03781583|464618002|FG002|Overall Study|Technology did not work for that person in that environment|0|||
129089535|NCT03781583|464618003|FG003|Overall Study|Technology did not work for that person in that environment|0|||
129089536|NCT03781583|464618000|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
129089537|NCT03781583|464618001|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
129089538|NCT03781583|464618002|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
129089539|NCT03781583|464618003|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
128724576|NCT03711162|463290853|FG000|Overall Study|Lost to Follow-up|1|||
129089540|NCT03781583|464618000|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
129089541|NCT03781583|464618001|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
129089542|NCT03781583|464618002|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
129089543|NCT03781583|464618003|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
129089544|NCT05139303|464618004|FG000|Overall Study|Lost to Follow-up|3|||
129089545|NCT05139303|464618005|FG001|Overall Study|Lost to Follow-up|0|||
129089546|NCT05139303|464618004|FG000|Overall Study|Adverse Event|1|||
129089547|NCT05139303|464618005|FG001|Overall Study|Adverse Event|0|||
129089548|NCT02222545|464618006|FG000|Overall Study|Adverse Event|1|||
129089549|NCT02222545|464618007|FG001|Overall Study|Adverse Event|0|||
129089550|NCT02222545|464618008|FG002|Overall Study|Adverse Event|2|||
129089551|NCT02222545|464618006|FG000|Overall Study|Death|0|||
129089552|NCT02222545|464618007|FG001|Overall Study|Death|0|||
129089553|NCT02222545|464618008|FG002|Overall Study|Death|9|||
129089554|NCT02222545|464618006|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
129089555|NCT02222545|464618007|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
129089556|NCT02222545|464618008|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
129089557|NCT02222545|464618006|FG000|Overall Study|Withdrawal by Subject|0|||
129089558|NCT02222545|464618007|FG001|Overall Study|Withdrawal by Subject|0|||
129089559|NCT02222545|464618008|FG002|Overall Study|Withdrawal by Subject|3|||
129089560|NCT02222545|464618006|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
129089561|NCT02222545|464618007|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
129089562|NCT02222545|464618008|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
129089563|NCT00761280|464618009|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
129089564|NCT00761280|464618010|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
129089565|NCT00761280|464618009|FG000|Randomization to First Dose|Sponsor decision|1|||
129089566|NCT00761280|464618010|FG001|Randomization to First Dose|Sponsor decision|0|||
129089567|NCT00761280|464618009|FG000|Randomization to First Dose|Other|1|||
129089568|NCT00761280|464618010|FG001|Randomization to First Dose|Other|0|||
129089569|NCT00761280|464618009|FG000|First Dose to End of Study|End of trial|5|||
129089570|NCT00761280|464618010|FG001|First Dose to End of Study|End of trial|5|||
129089571|NCT00761280|464618009|FG000|First Dose to End of Study|Progressive disease|5|||
129089572|NCT00761280|464618010|FG001|First Dose to End of Study|Progressive disease|3|||
129089573|NCT00761280|464618009|FG000|First Dose to End of Study|Sponsor decision|1|||
129089574|NCT00761280|464618010|FG001|First Dose to End of Study|Sponsor decision|2|||
129089575|NCT00761280|464618009|FG000|First Dose to End of Study|Death|1|||
129089576|NCT00761280|464618010|FG001|First Dose to End of Study|Death|0|||
129089577|NCT00761280|464618009|FG000|First Dose to End of Study|Lost to Follow-up|0|||
129089578|NCT00761280|464618010|FG001|First Dose to End of Study|Lost to Follow-up|1|||
129089579|NCT03875482|464618011|FG000|Overall Study|Adverse Event|0|||
129089580|NCT03875482|464618012|FG001|Overall Study|Adverse Event|1|||
129089581|NCT03875482|464618011|FG000|Overall Study|Withdrew consent|5|||
129089582|NCT03875482|464618012|FG001|Overall Study|Withdrew consent|6|||
129089583|NCT03875482|464618011|FG000|Overall Study|Lost to Follow-up|8|||
129089584|NCT03875482|464618012|FG001|Overall Study|Lost to Follow-up|2|||
129089585|NCT03875482|464618011|FG000|Overall Study|Lack of Efficacy|0|||
129089586|NCT03875482|464618012|FG001|Overall Study|Lack of Efficacy|11|||
129089587|NCT02045862|464618014|FG000|Overall Study|Death|0|||
129089588|NCT02045862|464618015|FG001|Overall Study|Death|0|||
129089589|NCT02045862|464618016|FG002|Overall Study|Death|1|||
129089590|NCT02045862|464618014|FG000|Overall Study|Miscellaneous|5|||
129089591|NCT02045862|464618015|FG001|Overall Study|Miscellaneous|0|||
129089592|NCT02045862|464618016|FG002|Overall Study|Miscellaneous|8|||
129089593|NCT02045862|464618014|FG000|Overall Study|Withdrawal by Patient|18|||
129089594|NCT02045862|464618015|FG001|Overall Study|Withdrawal by Patient|27|||
129089595|NCT02045862|464618016|FG002|Overall Study|Withdrawal by Patient|57|||
129089596|NCT02045862|464618014|FG000|Overall Study|Protocol Violation|0|||
129089597|NCT02045862|464618015|FG001|Overall Study|Protocol Violation|0|||
129089598|NCT02045862|464618016|FG002|Overall Study|Protocol Violation|6|||
129089599|NCT02045862|464618014|FG000|Overall Study|Lack of Efficacy|8|||
129089600|NCT02045862|464618015|FG001|Overall Study|Lack of Efficacy|4|||
129089601|NCT02045862|464618016|FG002|Overall Study|Lack of Efficacy|13|||
129089602|NCT02045862|464618014|FG000|Overall Study|Randomized but not Received Study Drug|0|||
129089603|NCT02045862|464618015|FG001|Overall Study|Randomized but not Received Study Drug|2|||
129089604|NCT02045862|464618016|FG002|Overall Study|Randomized but not Received Study Drug|8|||
129089605|NCT02045862|464618014|FG000|Overall Study|Adverse Event|7|||
129089606|NCT02045862|464618015|FG001|Overall Study|Adverse Event|5|||
129089607|NCT02045862|464618016|FG002|Overall Study|Adverse Event|27|||
129089608|NCT02045862|464618014|FG000|Overall Study|Lost to Follow-up|1|||
129089609|NCT02045862|464618015|FG001|Overall Study|Lost to Follow-up|2|||
129089610|NCT02045862|464618016|FG002|Overall Study|Lost to Follow-up|6|||
129089611|NCT02691013|464618017|FG000|Overall Study|Withdrawal by Subject|3|||
129089612|NCT02691013|464618018|FG001|Overall Study|Withdrawal by Subject|0|||
129089613|NCT02111785|464618022|FG000|Overall Study|Death|0|||
129089614|NCT02111785|464618023|FG001|Overall Study|Death|1|||
129089615|NCT02111785|464618024|FG002|Overall Study|Death|0|||
129089616|NCT02111785|464618025|FG003|Overall Study|Death|0|||
129089617|NCT01075646|464618028|FG000|Overall Study|Lost to Follow-up|4|||
129089618|NCT01075646|464618029|FG001|Overall Study|Lost to Follow-up|3|||
129089619|NCT01075646|464618030|FG002|Overall Study|Lost to Follow-up|1|||
129089620|NCT01075646|464618031|FG003|Overall Study|Lost to Follow-up|2|||
129089621|NCT01676896|464618035|FG000|Overall Study|Withdrawal by Subject|12|||
129089622|NCT01676896|464618036|FG001|Overall Study|Withdrawal by Subject|7|||
129089623|NCT01676896|464618037|FG002|Overall Study|Withdrawal by Subject|19|||
129089624|NCT02256982|464618038|FG000|Overall Study|Disease Progression|0|||
129089625|NCT02256982|464618039|FG001|Overall Study|Disease Progression|1|||
129089626|NCT02822573|464618040|FG000|Overall Study|Lost to Follow-up|5|||
129089627|NCT02822573|464618041|FG001|Overall Study|Lost to Follow-up|3|||
129089628|NCT02822573|464618040|FG000|Overall Study|Physician Decision|1|||
129089629|NCT02822573|464618041|FG001|Overall Study|Physician Decision|1|||
129089630|NCT02822573|464618040|FG000|Overall Study|Withdrawal by Subject|9|||
129089631|NCT02822573|464618041|FG001|Overall Study|Withdrawal by Subject|5|||
129089632|NCT02822573|464618040|FG000|Overall Study|Protocol Violation|6|||
129089633|NCT02822573|464618041|FG001|Overall Study|Protocol Violation|4|||
129089634|NCT02822573|464618040|FG000|Overall Study|Too sick or ill|2|||
129089635|NCT02822573|464618041|FG001|Overall Study|Too sick or ill|1|||
129089636|NCT02822573|464618040|FG000|Overall Study|Disease Progression|1|||
129089637|NCT02822573|464618041|FG001|Overall Study|Disease Progression|1|||
129089638|NCT02822573|464618040|FG000|Overall Study|No reason given|6|||
129089639|NCT02822573|464618041|FG001|Overall Study|No reason given|4|||
129089640|NCT02855359|464618044|FG000|Overall Study|Death|2|||
129089641|NCT02855359|464618045|FG001|Overall Study|Death|2|||
129089642|NCT02855359|464618046|FG002|Overall Study|Death|0|||
129089643|NCT02855359|464618047|FG003|Overall Study|Death|0|||
129089644|NCT02855359|464618044|FG000|Overall Study|Study Termination by Sponsor|9|||
129089645|NCT02855359|464618045|FG001|Overall Study|Study Termination by Sponsor|11|||
129089646|NCT02855359|464618046|FG002|Overall Study|Study Termination by Sponsor|0|||
129089647|NCT02855359|464618047|FG003|Overall Study|Study Termination by Sponsor|0|||
129089648|NCT01044290|464618048|FG000|Follow-up 1|Death|3|||
129089649|NCT01044290|464618049|FG001|Follow-up 1|Death|3|||
129089650|NCT01044290|464618050|FG002|Follow-up 1|Death|1|||
129089651|NCT01044290|464618048|FG000|Follow-up 1|Withdrawal by Subject|2|||
129089652|NCT01044290|464618049|FG001|Follow-up 1|Withdrawal by Subject|2|||
129089653|NCT01044290|464618050|FG002|Follow-up 1|Withdrawal by Subject|0|||
129089654|NCT01044290|464618048|FG000|Follow-Up 2|Death|0|||
129089655|NCT01044290|464618049|FG001|Follow-Up 2|Death|1|||
129089656|NCT01044290|464618050|FG002|Follow-Up 2|Death|1|||
129089657|NCT01044290|464618048|FG000|Follow-Up 2|Withdrawal by Subject|0|||
129089658|NCT01044290|464618049|FG001|Follow-Up 2|Withdrawal by Subject|1|||
129089659|NCT01044290|464618050|FG002|Follow-Up 2|Withdrawal by Subject|1|||
129089660|NCT00759785|464618056|FG000|Overall Study|Participant sample not evaluable|11|||
129089661|NCT00759785|464618057|FG001|Overall Study|Participant sample not evaluable|2|||
129089662|NCT00759785|464618056|FG000|Overall Study|Participant sample lost|0|||
129089663|NCT00759785|464618057|FG001|Overall Study|Participant sample lost|1|||
129089664|NCT00759785|464618056|FG000|Overall Study|Protocol Violation|1|||
129089665|NCT00759785|464618057|FG001|Overall Study|Protocol Violation|0|||
129089666|NCT00759785|464618056|FG000|Overall Study|Physician Decision|0|||
129089667|NCT00759785|464618057|FG001|Overall Study|Physician Decision|1|||
129089668|NCT00759785|464618056|FG000|Overall Study|Withdrawal by Subject|0|||
129089669|NCT00759785|464618057|FG001|Overall Study|Withdrawal by Subject|1|||
129089670|NCT01646021|464618058|FG000|Overall Study|Death|77|||
129089671|NCT01646021|464618059|FG001|Overall Study|Death|83|||
128724577|NCT03711162|463290854|FG001|Overall Study|Lost to Follow-up|0|||
129089672|NCT01646021|464618058|FG000|Overall Study|Study Terminated by Sponsor|50|||
129089673|NCT01646021|464618059|FG001|Overall Study|Study Terminated by Sponsor|41|||
128724578|NCT03711162|463290855|FG002|Overall Study|Lost to Follow-up|1|||
129089674|NCT01646021|464618058|FG000|Overall Study|Lost to Follow-up|2|||
129089675|NCT01646021|464618059|FG001|Overall Study|Lost to Follow-up|2|||
129089676|NCT01646021|464618058|FG000|Overall Study|Withdrawal by Subject|10|||
129089677|NCT01646021|464618059|FG001|Overall Study|Withdrawal by Subject|15|||
129089678|NCT01967706|464618065|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
129089679|NCT01967706|464618066|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
129089680|NCT01967706|464618067|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129145318|NCT02082977|464828149|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129089681|NCT01967706|464618068|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
129089682|NCT02777970|464618069|FG000|Overall Study|Lost to Follow-up|0|||
129089683|NCT02777970|464618070|FG001|Overall Study|Lost to Follow-up|1|||
129089684|NCT02777970|464618071|FG002|Overall Study|Lost to Follow-up|0|||
129145319|NCT02082977|464828140|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129089685|NCT02777970|464618069|FG000|Overall Study|Protocol Violation|1|||
129089686|NCT02777970|464618070|FG001|Overall Study|Protocol Violation|0|||
129089687|NCT02777970|464618071|FG002|Overall Study|Protocol Violation|0|||
129089688|NCT02347891|464618077|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
128724579|NCT03711162|463290853|FG000|Overall Study|Study Terminated by Sponsor|139|||
128724580|NCT03711162|463290854|FG001|Overall Study|Study Terminated by Sponsor|152|||
128724581|NCT03711162|463290855|FG002|Overall Study|Study Terminated by Sponsor|146|||
128724582|NCT03711162|463290853|FG000|Overall Study|Withdrawal by Subject|17|||
128724583|NCT03711162|463290854|FG001|Overall Study|Withdrawal by Subject|10|||
128724584|NCT03711162|463290855|FG002|Overall Study|Withdrawal by Subject|10|||
128724585|NCT03711162|463290853|FG000|Overall Study|Miscellaneous|1|||
128724586|NCT03711162|463290854|FG001|Overall Study|Miscellaneous|2|||
129089689|NCT02347891|464618078|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
129089690|NCT02347891|464618077|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
129089691|NCT02347891|464618078|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
129089692|NCT01083186|464618081|FG000|Overall Study|Lost to Follow-up|48|||
129089693|NCT01083186|464618081|FG000|Overall Study|Consent Withdrawal|7|||
129089694|NCT01083186|464618081|FG000|Overall Study|Death|3|||
129089695|NCT01083186|464618081|FG000|Overall Study|Adverse Event|3|||
129089696|NCT01083186|464618081|FG000|Overall Study|Lack of Efficacy|2|||
129089697|NCT01083186|464618081|FG000|Overall Study|Hemodialysis Initiation|28|||
129089698|NCT01083186|464618081|FG000|Overall Study|Administrative Reasons|2|||
129089699|NCT01083186|464618081|FG000|Overall Study|Non-compliance to Study Treatment|1|||
129089700|NCT03419598|464618088|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
129089701|NCT01740128|464618089|FG000|Overall Study|Pregnancy|0|||
129089702|NCT01740128|464618090|FG001|Overall Study|Pregnancy|1|||
129089703|NCT01740128|464618089|FG000|Overall Study|Protocol Violation|1|||
129089704|NCT01740128|464618090|FG001|Overall Study|Protocol Violation|2|||
129089705|NCT01740128|464618089|FG000|Overall Study|Lost to Follow-up|2|||
129089706|NCT01740128|464618090|FG001|Overall Study|Lost to Follow-up|2|||
129145320|NCT02082977|464828141|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129145321|NCT02082977|464828142|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129145322|NCT02082977|464828143|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129145323|NCT02082977|464828144|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129089707|NCT01740128|464618089|FG000|Overall Study|Withdrawal by Subject|1|||
129089708|NCT01740128|464618090|FG001|Overall Study|Withdrawal by Subject|0|||
129089709|NCT01740128|464618089|FG000|Overall Study|Insufficient protocol compliance|2|||
129089710|NCT01740128|464618090|FG001|Overall Study|Insufficient protocol compliance|2|||
129089711|NCT02474589|464618091|FG000|Overall Study|Adverse Event|6|||
129089712|NCT02474589|464618092|FG001|Overall Study|Adverse Event|2|||
129089713|NCT02474589|464618091|FG000|Overall Study|Lost to Follow-up|6|||
129089714|NCT02474589|464618092|FG001|Overall Study|Lost to Follow-up|1|||
129089715|NCT02474589|464618091|FG000|Overall Study|Protocol Violation|4|||
129089716|NCT02474589|464618092|FG001|Overall Study|Protocol Violation|1|||
129089717|NCT02474589|464618091|FG000|Overall Study|Withdrawal by Subject|4|||
129089718|NCT02474589|464618092|FG001|Overall Study|Withdrawal by Subject|0|||
129089719|NCT02474589|464618091|FG000|Overall Study|Inability to complete study procedures|5|||
129089720|NCT02474589|464618092|FG001|Overall Study|Inability to complete study procedures|1|||
129089721|NCT00189306|464618095|FG000|Treatment Period|Withdrawal by Subject|2|||
129089722|NCT00189306|464618095|FG000|Treatment Period|Adverse Event|2|||
129089723|NCT00189306|464618095|FG000|Treatment Period|Protocol Violation|1|||
129089724|NCT00189306|464618095|FG000|Posttreatment Period|Death|1|||
129089725|NCT00189306|464618095|FG000|Posttreatment Period|Withdrawal by Subject|2|||
129089726|NCT00189306|464618095|FG000|Posttreatment Period|Noncompliance|1|||
129145324|NCT02082977|464828145|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
129145325|NCT02082977|464828146|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129145326|NCT02082977|464828147|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129145327|NCT02082977|464828148|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129145328|NCT02082977|464828149|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129145329|NCT02082977|464828140|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129145330|NCT02082977|464828141|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129145331|NCT02082977|464828142|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
128724587|NCT03711162|463290855|FG002|Overall Study|Miscellaneous|2|||
128724588|NCT03711162|463290853|FG000|Overall Study|Not Treated|1|||
128724589|NCT03711162|463290854|FG001|Overall Study|Not Treated|0|||
129089727|NCT00189306|464618095|FG000|Posttreatment Period|Target lesion excised|1|||
129089728|NCT00189306|464618095|FG000|Posttreatment Period|Protocol Violation|1|||
129145332|NCT02082977|464828143|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
128724590|NCT03711162|463290855|FG002|Overall Study|Not Treated|1|||
128724591|NCT03711162|463290853|FG000|Overall Study|Physician Decision|0|||
129089729|NCT00189306|464618095|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
129089730|NCT00189306|464618095|FG000|Posttreatment Period|Local skin reaction/sign|1|||
129089731|NCT00189306|464618095|FG000|Long-Term Follow-up|Adverse Event|2|||
129089732|NCT00189306|464618095|FG000|Long-Term Follow-up|Death|4|||
129089733|NCT00189306|464618095|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
129145333|NCT02082977|464828144|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
128724592|NCT03711162|463290854|FG001|Overall Study|Physician Decision|2|||
128724593|NCT03711162|463290855|FG002|Overall Study|Physician Decision|0|||
129089734|NCT00189306|464618095|FG000|Long-Term Follow-up|Intercurrent disease|2|||
129089735|NCT00189306|464618095|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
129089736|NCT00189306|464618095|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
129089737|NCT03640481|464618096|FG000|Overall Study|Death|14|||
129089738|NCT03640481|464618097|FG001|Overall Study|Death|14|||
129089739|NCT03640481|464618098|FG002|Overall Study|Death|0|||
129089740|NCT03640481|464618099|FG003|Overall Study|Death|0|||
129089741|NCT03640481|464618096|FG000|Overall Study|Lost to Follow-up|2|||
129089742|NCT03640481|464618097|FG001|Overall Study|Lost to Follow-up|0|||
129089743|NCT03640481|464618098|FG002|Overall Study|Lost to Follow-up|0|||
129089744|NCT03640481|464618099|FG003|Overall Study|Lost to Follow-up|0|||
129089745|NCT03640481|464618096|FG000|Overall Study|Site terminated by sponsor|1|||
129089746|NCT03640481|464618097|FG001|Overall Study|Site terminated by sponsor|3|||
129089747|NCT03640481|464618098|FG002|Overall Study|Site terminated by sponsor|0|||
129089748|NCT03640481|464618099|FG003|Overall Study|Site terminated by sponsor|0|||
129089749|NCT03640481|464618096|FG000|Overall Study|Study terminated by sponsor|29|||
129089750|NCT03640481|464618097|FG001|Overall Study|Study terminated by sponsor|42|||
129089751|NCT03640481|464618098|FG002|Overall Study|Study terminated by sponsor|1|||
129089752|NCT03640481|464618099|FG003|Overall Study|Study terminated by sponsor|0|||
129089753|NCT03640481|464618096|FG000|Overall Study|Withdrawal by Subject|5|||
129089754|NCT03640481|464618097|FG001|Overall Study|Withdrawal by Subject|4|||
129089755|NCT03640481|464618098|FG002|Overall Study|Withdrawal by Subject|0|||
129089756|NCT03640481|464618099|FG003|Overall Study|Withdrawal by Subject|1|||
129089757|NCT03640481|464618096|FG000|Overall Study|Other|26|||
129089758|NCT03640481|464618097|FG001|Overall Study|Other|12|||
129089759|NCT03640481|464618098|FG002|Overall Study|Other|1|||
129089760|NCT03640481|464618099|FG003|Overall Study|Other|0|||
129089761|NCT03640481|464618096|FG000|Overall Study|Randomized, but not treated|1|||
129089762|NCT03640481|464618097|FG001|Overall Study|Randomized, but not treated|3|||
129089763|NCT03640481|464618098|FG002|Overall Study|Randomized, but not treated|0|||
129089764|NCT03640481|464618099|FG003|Overall Study|Randomized, but not treated|0|||
129089765|NCT04569968|464618100|FG000|Overall Study|Lost to Follow-up|2|||
129089766|NCT04569968|464618101|FG001|Overall Study|Lost to Follow-up|5|||
129089767|NCT04569968|464618100|FG000|Overall Study|Story of head and/or neck surgery|2|||
129089768|NCT04569968|464618101|FG001|Overall Study|Story of head and/or neck surgery|2|||
129089769|NCT04569968|464618100|FG000|Overall Study|Time of stroke onset|8|||
129089770|NCT04569968|464618101|FG001|Overall Study|Time of stroke onset|7|||
129089771|NCT04569968|464618100|FG000|Overall Study|Type of strokr|12|||
129089772|NCT04569968|464618101|FG001|Overall Study|Type of strokr|8|||
129089773|NCT04569968|464618100|FG000|Overall Study|Cooperation|8|||
129089774|NCT04569968|464618101|FG001|Overall Study|Cooperation|8|||
129089775|NCT04569968|464618100|FG000|Overall Study|Age interval|17|||
129089776|NCT04569968|464618101|FG001|Overall Study|Age interval|6|||
129089777|NCT04569968|464618100|FG000|Overall Study|Denial of participation to the study|0|||
129089778|NCT04569968|464618101|FG001|Overall Study|Denial of participation to the study|3|||
129089779|NCT04569968|464618100|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
129089780|NCT04569968|464618101|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
129089781|NCT04569968|464618100|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
129089782|NCT04569968|464618101|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
129089783|NCT04569968|464618100|FG000|Overall Study|Quarantine|1|||
129089784|NCT04569968|464618101|FG001|Overall Study|Quarantine|0|||
129089785|NCT04569968|464618100|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
129089786|NCT04569968|464618101|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
129089787|NCT04569968|464618100|FG000|Overall Study|Repetitive stroke|8|||
129089788|NCT04569968|464618101|FG001|Overall Study|Repetitive stroke|0|||
129089789|NCT04569968|464618100|FG000|Overall Study|Insufficient mastication|1|||
129089790|NCT04569968|464618101|FG001|Overall Study|Insufficient mastication|0|||
129089791|NCT04569968|464618100|FG000|Overall Study|Infection|1|||
129089792|NCT04569968|464618101|FG001|Overall Study|Infection|0|||
129089793|NCT01552915|464618102|FG000|Overall Study|Adverse Event|3|||
129089794|NCT01552915|464618103|FG001|Overall Study|Adverse Event|14|||
129089795|NCT01552915|464618104|FG002|Overall Study|Adverse Event|3|||
129089796|NCT01552915|464618102|FG000|Overall Study|Lost to Follow-up|4|||
129089797|NCT01552915|464618103|FG001|Overall Study|Lost to Follow-up|6|||
129089798|NCT01552915|464618104|FG002|Overall Study|Lost to Follow-up|5|||
129089799|NCT01552915|464618102|FG000|Overall Study|Withdrawal by Subject|6|||
129089800|NCT01552915|464618103|FG001|Overall Study|Withdrawal by Subject|4|||
129089801|NCT01552915|464618104|FG002|Overall Study|Withdrawal by Subject|5|||
129089802|NCT01552915|464618102|FG000|Overall Study|Protocol Violation|0|||
129089803|NCT01552915|464618103|FG001|Overall Study|Protocol Violation|4|||
129145334|NCT02082977|464828145|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
129089804|NCT01552915|464618104|FG002|Overall Study|Protocol Violation|4|||
129089805|NCT01552915|464618102|FG000|Overall Study|Lack of Efficacy|8|||
129089806|NCT01552915|464618103|FG001|Overall Study|Lack of Efficacy|1|||
129089807|NCT01552915|464618104|FG002|Overall Study|Lack of Efficacy|4|||
129089808|NCT01552915|464618102|FG000|Overall Study|Other|2|||
129089809|NCT01552915|464618103|FG001|Overall Study|Other|0|||
129089810|NCT01552915|464618104|FG002|Overall Study|Other|6|||
129089811|NCT02370667|464618105|FG000|Overall Study|Lost to Follow-up|0|||
129089812|NCT02370667|464618106|FG001|Overall Study|Lost to Follow-up|1|||
129089813|NCT02370667|464618107|FG002|Overall Study|Lost to Follow-up|0|||
129089814|NCT02457832|464618110|FG000|Training|Lost to Follow-up|10|||
129089815|NCT02457832|464618111|FG001|Training|Lost to Follow-up|6|||
129089816|NCT02457832|464618112|FG002|Training|Lost to Follow-up|3|||
129089817|NCT02457832|464618110|FG000|One Month Washout|Lost to Follow-up|0|||
129089818|NCT02457832|464618111|FG001|One Month Washout|Lost to Follow-up|1|||
129089819|NCT02457832|464618112|FG002|One Month Washout|Lost to Follow-up|1|||
129089820|NCT00742508|464618113|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
129089821|NCT00742508|464618114|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
129089822|NCT00742508|464618113|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
129089823|NCT00742508|464618114|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
129089824|NCT00742508|464618113|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
129089825|NCT00742508|464618114|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
129089826|NCT00742508|464618113|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
129089827|NCT00742508|464618114|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
129089828|NCT00742508|464618113|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
129089829|NCT00742508|464618114|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
129089830|NCT04696354|464618117|FG000|Overall Study|Study termination|6|||
129089831|NCT04696354|464618118|FG001|Overall Study|Study termination|6|||
129089832|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Adverse Event|6|||
129089833|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Adverse Event|14|||
129089834|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Death|3|||
129089835|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Death|1|||
129089836|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
129089837|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
129089838|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
129089839|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
129089840|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
129089841|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
129089842|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
129089843|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
129089844|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
129089845|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
129089846|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Physician Decision|2|||
129089847|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Physician Decision|4|||
129089848|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Pregnancy|2|||
129089849|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Pregnancy|1|||
129089850|NCT02275780|464620408|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
129089851|NCT02275780|464620409|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
129089852|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
129089853|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
129089854|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
129089855|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
129089856|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
129089857|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
129089858|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
129089859|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
129089860|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
129089861|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
129089862|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
129089863|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
129089864|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
129089865|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
129089866|NCT02275780|464620408|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
129089867|NCT02275780|464620409|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
129089868|NCT02275780|464620408|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
129089869|NCT02275780|464620409|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
129089870|NCT02275780|464620408|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
129089871|NCT02275780|464620409|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
129089872|NCT02275780|464620408|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
129089873|NCT02275780|464620409|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
129089874|NCT02275780|464620408|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
129089875|NCT02275780|464620409|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
129089876|NCT02275780|464620408|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
129089877|NCT02275780|464620409|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
129089878|NCT02275780|464620408|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
129089879|NCT02275780|464620409|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
129089880|NCT02275780|464620408|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
129089881|NCT02275780|464620409|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
129089882|NCT02275780|464620408|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
129089883|NCT02275780|464620409|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
129089884|NCT02275780|464620408|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
129089885|NCT02275780|464620409|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
129089886|NCT02275780|464620408|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
129089887|NCT02275780|464620409|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
129089888|NCT02275780|464620408|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
129089889|NCT02275780|464620409|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
129089890|NCT02275780|464620408|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
129089891|NCT02275780|464620409|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
129089892|NCT02275780|464620408|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
129089893|NCT02275780|464620409|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
129089894|NCT00738881|464620412|FG000|Overall Study|Withdrawal by Subject|0|||
129089895|NCT00738881|464620413|FG001|Overall Study|Withdrawal by Subject|2|||
129089896|NCT00348790|464620414|FG000|Completed Treatment|Withdrawal by Subject|4|||
129089897|NCT00348790|464620414|FG000|Completed Treatment|Disease progression|14|||
129089898|NCT00348790|464620414|FG000|Completed Treatment|Adverse Event|4|||
129089899|NCT00348790|464620414|FG000|Completed Treatment|Required surgery|2|||
129089900|NCT00348790|464620414|FG000|Completed Treatment|Unable to travel to study site|1|||
129089901|NCT04712019|464620416|FG000|Overall Study|Withdrawal by Subject|2|||
129089902|NCT04712019|464620417|FG001|Overall Study|Withdrawal by Subject|2|||
129089903|NCT04712019|464620416|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
129089904|NCT04712019|464620417|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
129089905|NCT04521621|464620423|FG000|Overall Study|Death|17|||
129089906|NCT04521621|464620424|FG001|Overall Study|Death|8|||
129089907|NCT04521621|464620425|FG002|Overall Study|Death|8|||
129089908|NCT04521621|464620426|FG003|Overall Study|Death|5|||
129089909|NCT04521621|464620427|FG004|Overall Study|Death|2|||
129089910|NCT04521621|464620428|FG005|Overall Study|Death|7|||
129089911|NCT04521621|464620429|FG006|Overall Study|Death|0|||
129089912|NCT04521621|464620430|FG007|Overall Study|Death|0|||
129089913|NCT04521621|464620423|FG000|Overall Study|Study Terminated by Sponsor|4|||
129089914|NCT04521621|464620424|FG001|Overall Study|Study Terminated by Sponsor|6|||
129089915|NCT04521621|464620425|FG002|Overall Study|Study Terminated by Sponsor|8|||
129089916|NCT04521621|464620426|FG003|Overall Study|Study Terminated by Sponsor|0|||
129089917|NCT04521621|464620427|FG004|Overall Study|Study Terminated by Sponsor|1|||
129089918|NCT04521621|464620428|FG005|Overall Study|Study Terminated by Sponsor|7|||
129089919|NCT04521621|464620429|FG006|Overall Study|Study Terminated by Sponsor|0|||
129089920|NCT04521621|464620430|FG007|Overall Study|Study Terminated by Sponsor|0|||
129089921|NCT04521621|464620423|FG000|Overall Study|Withdrawal by Subject|0|||
129089922|NCT04521621|464620424|FG001|Overall Study|Withdrawal by Subject|0|||
129089923|NCT04521621|464620425|FG002|Overall Study|Withdrawal by Subject|1|||
129089924|NCT04521621|464620426|FG003|Overall Study|Withdrawal by Subject|1|||
129089925|NCT04521621|464620427|FG004|Overall Study|Withdrawal by Subject|0|||
129089926|NCT04521621|464620428|FG005|Overall Study|Withdrawal by Subject|0|||
129089927|NCT04521621|464620429|FG006|Overall Study|Withdrawal by Subject|0|||
129089928|NCT04521621|464620430|FG007|Overall Study|Withdrawal by Subject|0|||
129089929|NCT04521621|464620423|FG000|Overall Study|Allocated in error without study intervention|1|||
129089930|NCT04521621|464620424|FG001|Overall Study|Allocated in error without study intervention|0|||
129089931|NCT04521621|464620425|FG002|Overall Study|Allocated in error without study intervention|0|||
129089932|NCT04521621|464620426|FG003|Overall Study|Allocated in error without study intervention|0|||
129089933|NCT04521621|464620427|FG004|Overall Study|Allocated in error without study intervention|0|||
129089934|NCT04521621|464620428|FG005|Overall Study|Allocated in error without study intervention|0|||
129089935|NCT04521621|464620429|FG006|Overall Study|Allocated in error without study intervention|0|||
129089936|NCT04521621|464620430|FG007|Overall Study|Allocated in error without study intervention|0|||
129089937|NCT01282164|464620431|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
129089938|NCT01282164|464620432|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
129089939|NCT05845567|464620435|FG000|Overall Study|Withdrawal by Subject|1|||
129089940|NCT00725608|464620436|FG000|Overall Study|Lost to Follow-up|60|||
129089941|NCT00725608|464620436|FG000|Overall Study|Adverse Event|14|||
129089942|NCT00725608|464620436|FG000|Overall Study|Individual reasons|86|||
129089943|NCT00725608|464620436|FG000|Overall Study|Other|7|||
129089944|NCT03409107|464620437|FG000|Overall Study|Withdrawal by Subject|4|||
129089945|NCT03409107|464620438|FG001|Overall Study|Withdrawal by Subject|2|||
129089946|NCT03409107|464620437|FG000|Overall Study|Physician Decision|1|||
129089947|NCT03409107|464620438|FG001|Overall Study|Physician Decision|0|||
129089948|NCT03409107|464620437|FG000|Overall Study|Lost to Follow-up|7|||
129089949|NCT03409107|464620438|FG001|Overall Study|Lost to Follow-up|2|||
129089950|NCT03409107|464620437|FG000|Overall Study|Adverse Event|5|||
129089951|NCT03409107|464620438|FG001|Overall Study|Adverse Event|3|||
129089952|NCT00535847|464620440|FG000|Overall Study|Adverse Event|5|||
129089953|NCT00535847|464620441|FG001|Overall Study|Adverse Event|3|||
129089954|NCT00535847|464620442|FG002|Overall Study|Adverse Event|2|||
129089955|NCT00535847|464620440|FG000|Overall Study|Non compliance|1|||
129089956|NCT00535847|464620441|FG001|Overall Study|Non compliance|1|||
129089957|NCT00535847|464620442|FG002|Overall Study|Non compliance|0|||
129089958|NCT00535847|464620440|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
129089959|NCT00535847|464620441|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
129089960|NCT00535847|464620442|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
129089961|NCT00423189|464620443|FG000|Overall Study|Death|0|||
129089962|NCT00423189|464620444|FG001|Overall Study|Death|1|||
129089963|NCT00423189|464620445|FG002|Overall Study|Death|0|||
129089964|NCT01459718|464620448|FG000|Overall Study|Physician Decision|1|||
129089965|NCT01459718|464620448|FG000|Overall Study|Lost to Follow-up|1|||
129089966|NCT01459718|464620448|FG000|Overall Study|Adverse Event|1|||
129089967|NCT01258075|464620454|FG000|Overall Study|Adverse Event|8|||
129089968|NCT01258075|464620455|FG001|Overall Study|Adverse Event|3|||
129089969|NCT01258075|464620454|FG000|Overall Study|Lost to Follow-up|11|||
129089970|NCT01258075|464620455|FG001|Overall Study|Lost to Follow-up|6|||
129089971|NCT01258075|464620454|FG000|Overall Study|Withdrawal by Subject|10|||
129089972|NCT01258075|464620455|FG001|Overall Study|Withdrawal by Subject|7|||
129089973|NCT01258075|464620454|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
129089974|NCT01258075|464620455|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
129089975|NCT01258075|464620454|FG000|Overall Study|Other|12|||
129089976|NCT01258075|464620455|FG001|Overall Study|Other|5|||
129089977|NCT00976209|464620458|FG000|Treatment Period 1|Protocol Violation|1|||
129089978|NCT00976209|464620459|FG001|Treatment Period 1|Protocol Violation|0|||
129089979|NCT00976209|464620458|FG000|Treatment Period 1|Lost to Follow-up|2|||
129089980|NCT00976209|464620459|FG001|Treatment Period 1|Lost to Follow-up|0|||
129089981|NCT00976209|464620458|FG000|Treatment Period 1|Other|0|||
129089982|NCT00976209|464620459|FG001|Treatment Period 1|Other|1|||
129089983|NCT00976209|464620458|FG000|Wash-out Period|Adverse Event|1|||
129089984|NCT00976209|464620459|FG001|Wash-out Period|Adverse Event|2|||
129089985|NCT00976209|464620458|FG000|Wash-out Period|Lost to Follow-up|1|||
129089986|NCT00976209|464620459|FG001|Wash-out Period|Lost to Follow-up|0|||
129089987|NCT00976209|464620458|FG000|Wash-out Period|Protocol Violation|1|||
129089988|NCT00976209|464620459|FG001|Wash-out Period|Protocol Violation|0|||
129089989|NCT00976209|464620458|FG000|Wash-out Period|Other|1|||
129089990|NCT00976209|464620459|FG001|Wash-out Period|Other|0|||
129089991|NCT00976209|464620458|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129089992|NCT00976209|464620459|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129089993|NCT00976209|464620458|FG000|Treatment Period 2|Lost to Follow-up|0|||
129089994|NCT00976209|464620459|FG001|Treatment Period 2|Lost to Follow-up|1|||
129089995|NCT03197870|464620463|FG000|Overall Study|Adverse Event|9|||
129089996|NCT03197870|464620464|FG001|Overall Study|Adverse Event|4|||
129089997|NCT03197870|464620465|FG002|Overall Study|Adverse Event|6|||
129089998|NCT03197870|464620463|FG000|Overall Study|Withdrawal by Subject|2|||
129089999|NCT03197870|464620464|FG001|Overall Study|Withdrawal by Subject|3|||
129090000|NCT03197870|464620465|FG002|Overall Study|Withdrawal by Subject|0|||
129090001|NCT03197870|464620463|FG000|Overall Study|Lost to Follow-up|2|||
129090002|NCT03197870|464620464|FG001|Overall Study|Lost to Follow-up|2|||
129090003|NCT03197870|464620465|FG002|Overall Study|Lost to Follow-up|0|||
129090004|NCT03197870|464620463|FG000|Overall Study|data not available|1|||
129090005|NCT03197870|464620464|FG001|Overall Study|data not available|1|||
129090006|NCT03197870|464620465|FG002|Overall Study|data not available|0|||
129090007|NCT01618019|464620467|FG000|Overall Study|Withdrawal by Subject|14|||
129090008|NCT01618019|464620468|FG001|Overall Study|Withdrawal by Subject|14|||
129090009|NCT01542034|464620469|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
129090010|NCT01542034|464620470|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
129090011|NCT01542034|464620469|FG000|Overall Study|Administrative decision|0|||
129090012|NCT01542034|464620470|FG001|Overall Study|Administrative decision|3|||
129090013|NCT01542034|464620469|FG000|Overall Study|Subject Noncompliance|1|||
129090014|NCT01542034|464620470|FG001|Overall Study|Subject Noncompliance|0|||
129090015|NCT01542034|464620469|FG000|Overall Study|Adverse Event|2|||
129090016|NCT01542034|464620470|FG001|Overall Study|Adverse Event|2|||
129090017|NCT01542034|464620469|FG000|Overall Study|Lost to Follow-up|7|||
129090018|NCT01542034|464620470|FG001|Overall Study|Lost to Follow-up|6|||
129090019|NCT02612610|464620471|FG000|Overall Study|Withdrawal by Subject|1|||
129090020|NCT02612610|464620472|FG001|Overall Study|Withdrawal by Subject|1|||
129090021|NCT02612610|464620473|FG002|Overall Study|Withdrawal by Subject|0|||
129090022|NCT02612610|464620474|FG003|Overall Study|Withdrawal by Subject|2|||
129090023|NCT02612610|464620471|FG000|Overall Study|Adverse Event|2|||
129090024|NCT02612610|464620472|FG001|Overall Study|Adverse Event|2|||
129090025|NCT02612610|464620473|FG002|Overall Study|Adverse Event|3|||
129090026|NCT02612610|464620474|FG003|Overall Study|Adverse Event|10|||
129090027|NCT02612610|464620471|FG000|Overall Study|Lost to Follow-up|0|||
129090028|NCT02612610|464620472|FG001|Overall Study|Lost to Follow-up|1|||
129090029|NCT02612610|464620473|FG002|Overall Study|Lost to Follow-up|0|||
129090030|NCT02612610|464620474|FG003|Overall Study|Lost to Follow-up|0|||
129090031|NCT02612610|464620471|FG000|Overall Study|Protocol Violation|0|||
129090032|NCT02612610|464620472|FG001|Overall Study|Protocol Violation|1|||
129090033|NCT02612610|464620473|FG002|Overall Study|Protocol Violation|1|||
129090034|NCT02612610|464620474|FG003|Overall Study|Protocol Violation|0|||
129090035|NCT02612610|464620471|FG000|Overall Study|Lack of Efficacy|1|||
129090036|NCT02612610|464620472|FG001|Overall Study|Lack of Efficacy|2|||
129090037|NCT02612610|464620473|FG002|Overall Study|Lack of Efficacy|0|||
129090038|NCT02612610|464620474|FG003|Overall Study|Lack of Efficacy|1|||
129090039|NCT02612610|464620471|FG000|Overall Study|Physician Decision|0|||
129090040|NCT02612610|464620472|FG001|Overall Study|Physician Decision|1|||
129090041|NCT02612610|464620473|FG002|Overall Study|Physician Decision|0|||
129090042|NCT02612610|464620474|FG003|Overall Study|Physician Decision|0|||
129090043|NCT02612610|464620471|FG000|Overall Study|Noncompliance|1|||
129090044|NCT02612610|464620472|FG001|Overall Study|Noncompliance|0|||
129090045|NCT02612610|464620473|FG002|Overall Study|Noncompliance|0|||
129090046|NCT02612610|464620474|FG003|Overall Study|Noncompliance|0|||
129090047|NCT02612610|464620471|FG000|Overall Study|Cough Improvement|0|||
129090048|NCT02612610|464620472|FG001|Overall Study|Cough Improvement|0|||
129090049|NCT02612610|464620473|FG002|Overall Study|Cough Improvement|1|||
129090050|NCT02612610|464620474|FG003|Overall Study|Cough Improvement|0|||
129090051|NCT00176644|464620475|FG000|Overall Study|Withdrawal by Subject|1|||
129090052|NCT01801280|464620476|FG000|Period 1|Withdrawal by Subject|0|||
129090053|NCT01801280|464620477|FG001|Period 1|Withdrawal by Subject|1|||
129090054|NCT01801280|464620478|FG002|Period 1|Withdrawal by Subject|0|||
129090055|NCT01801280|464620479|FG003|Period 1|Withdrawal by Subject|0|||
129090056|NCT01801280|464620476|FG000|Period 2|Withdrawal by Subject|1|||
129090057|NCT01801280|464620477|FG001|Period 2|Withdrawal by Subject|0|||
129090058|NCT01801280|464620478|FG002|Period 2|Withdrawal by Subject|0|||
129090059|NCT01801280|464620479|FG003|Period 2|Withdrawal by Subject|0|||
129090060|NCT01801280|464620476|FG000|Period 4|Protocol Violation|0|||
129090061|NCT01801280|464620477|FG001|Period 4|Protocol Violation|0|||
129090062|NCT01801280|464620478|FG002|Period 4|Protocol Violation|1|||
129090063|NCT01801280|464620479|FG003|Period 4|Protocol Violation|0|||
129090064|NCT02783729|464620480|FG000|Overall Study|Lack of Efficacy|1|||
129090065|NCT02783729|464620481|FG001|Overall Study|Lack of Efficacy|0|||
129090066|NCT02783729|464620482|FG002|Overall Study|Lack of Efficacy|0|||
129090067|NCT02783729|464620483|FG003|Overall Study|Lack of Efficacy|0|||
129090068|NCT02783729|464620480|FG000|Overall Study|Adverse Event|2|||
129090069|NCT02783729|464620481|FG001|Overall Study|Adverse Event|6|||
129090070|NCT02783729|464620482|FG002|Overall Study|Adverse Event|2|||
129090071|NCT02783729|464620483|FG003|Overall Study|Adverse Event|3|||
129090072|NCT02783729|464620480|FG000|Overall Study|Other|1|||
129090073|NCT02783729|464620481|FG001|Overall Study|Other|6|||
129090074|NCT02783729|464620482|FG002|Overall Study|Other|2|||
129090075|NCT02783729|464620483|FG003|Overall Study|Other|3|||
129090076|NCT02783729|464620480|FG000|Overall Study|Withdrawal by Subject|2|||
129090077|NCT02783729|464620481|FG001|Overall Study|Withdrawal by Subject|3|||
129090078|NCT02783729|464620482|FG002|Overall Study|Withdrawal by Subject|1|||
129090079|NCT02783729|464620483|FG003|Overall Study|Withdrawal by Subject|2|||
129090080|NCT02783729|464620480|FG000|Overall Study|Participant's choice|2|||
129090081|NCT02783729|464620481|FG001|Overall Study|Participant's choice|1|||
129090082|NCT02783729|464620482|FG002|Overall Study|Participant's choice|2|||
129090083|NCT02783729|464620483|FG003|Overall Study|Participant's choice|1|||
129090084|NCT02783729|464620480|FG000|Overall Study|Lost to Follow-up|2|||
129090085|NCT02783729|464620481|FG001|Overall Study|Lost to Follow-up|1|||
129090086|NCT02783729|464620482|FG002|Overall Study|Lost to Follow-up|1|||
129090087|NCT02783729|464620483|FG003|Overall Study|Lost to Follow-up|0|||
129090088|NCT02693171|464620484|FG000|Overall Study|Adverse Event|1|||
129090089|NCT02693171|464620484|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
129090090|NCT01866657|464620487|FG000|Overall Study|Surgery canceled|2|||
129090091|NCT01866657|464620488|FG001|Overall Study|Surgery canceled|0|||
129090092|NCT02288091|464620501|FG000|Overall Study|Lost to Follow-up|1|||
129090093|NCT02288091|464620501|FG000|Overall Study|Screen fail|7|||
129090094|NCT04021121|464620502|FG000|Overall Study|Death|3|||
129090095|NCT04021121|464620503|FG001|Overall Study|Death|3|||
129090096|NCT04021121|464620504|FG002|Overall Study|Death|5|||
129090097|NCT04021121|464620505|FG003|Overall Study|Death|4|||
129090098|NCT03973918|464620512|FG000|Overall Study|Adverse Event|0|||
129090099|NCT03973918|464620513|FG001|Overall Study|Adverse Event|0|||
129090100|NCT03973918|464620514|FG002|Overall Study|Adverse Event|0|||
129090101|NCT03973918|464620515|FG003|Overall Study|Adverse Event|1|||
129090102|NCT03973918|464620512|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
129090103|NCT03973918|464620513|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
129090104|NCT03973918|464620514|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
129090105|NCT03973918|464620515|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
129090106|NCT00978250|464620516|FG000|Overall Study|Late determination of ineligibility|0|||
129090107|NCT00978250|464620517|FG001|Overall Study|Late determination of ineligibility|1|||
129090108|NCT00978250|464620518|FG002|Overall Study|Late determination of ineligibility|0|||
129090109|NCT00978250|464620519|FG003|Overall Study|Late determination of ineligibility|1|||
129090110|NCT05174949|464620522|FG000|Overall Study|Physician Decision|1|||
129090111|NCT05174949|464620523|FG001|Overall Study|Physician Decision|2|||
129090112|NCT05174949|464620524|FG002|Overall Study|Physician Decision|0|||
129090113|NCT05174949|464620525|FG003|Overall Study|Physician Decision|1|||
129090114|NCT05174949|464620526|FG004|Overall Study|Physician Decision|0|||
129090115|NCT05174949|464620527|FG005|Overall Study|Physician Decision|0|||
129090116|NCT05174949|464620522|FG000|Overall Study|Withdrawal by Subject|0|||
129090117|NCT05174949|464620523|FG001|Overall Study|Withdrawal by Subject|1|||
129090118|NCT05174949|464620524|FG002|Overall Study|Withdrawal by Subject|0|||
129090119|NCT05174949|464620525|FG003|Overall Study|Withdrawal by Subject|0|||
129090120|NCT05174949|464620526|FG004|Overall Study|Withdrawal by Subject|0|||
129090121|NCT05174949|464620527|FG005|Overall Study|Withdrawal by Subject|0|||
129090122|NCT05174949|464620522|FG000|Overall Study|Lost to Follow-up|0|||
129090123|NCT05174949|464620523|FG001|Overall Study|Lost to Follow-up|0|||
129090124|NCT05174949|464620524|FG002|Overall Study|Lost to Follow-up|0|||
129090125|NCT05174949|464620525|FG003|Overall Study|Lost to Follow-up|1|||
129090126|NCT05174949|464620526|FG004|Overall Study|Lost to Follow-up|0|||
129090127|NCT05174949|464620527|FG005|Overall Study|Lost to Follow-up|0|||
129090128|NCT02951533|464620528|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
129090129|NCT02951533|464620529|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
129090130|NCT02951533|464620530|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
129090131|NCT02951533|464620528|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
129090132|NCT02951533|464620529|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
129090133|NCT02951533|464620530|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
129090134|NCT02951533|464620528|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
129090135|NCT02951533|464620529|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
129090136|NCT02951533|464620530|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
129090137|NCT02951533|464620528|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
129090138|NCT02951533|464620529|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
129090139|NCT02951533|464620530|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
129090140|NCT02951533|464620528|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
129090141|NCT02951533|464620529|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
129090142|NCT02951533|464620530|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
129090143|NCT02951533|464620528|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
129090144|NCT02951533|464620529|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
129090145|NCT02951533|464620530|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
129090146|NCT02951533|464620528|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
129090147|NCT02951533|464620529|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
129090148|NCT02951533|464620530|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
129090149|NCT02951533|464620528|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
129090150|NCT02951533|464620529|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
129090151|NCT02951533|464620530|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
129090152|NCT02951533|464620528|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
129090153|NCT02951533|464620529|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
129090154|NCT02951533|464620530|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
129090155|NCT02951533|464620528|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
129090156|NCT02951533|464620529|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
129090157|NCT02951533|464620530|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
129090158|NCT02951533|464620528|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
129090159|NCT02951533|464620529|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
129090160|NCT02951533|464620530|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
129090161|NCT02029989|464620531|FG000|Overall Study|Withdrawal by Subject|1|||
129090162|NCT02029989|464620532|FG001|Overall Study|Withdrawal by Subject|0|||
129090163|NCT02029989|464620531|FG000|Overall Study|Withdrawal: Fear of needles|1|||
129090164|NCT02029989|464620532|FG001|Overall Study|Withdrawal: Fear of needles|0|||
129090165|NCT02029989|464620531|FG000|Overall Study|Change of location|2|||
129090166|NCT02029989|464620532|FG001|Overall Study|Change of location|3|||
129090167|NCT02029989|464620531|FG000|Overall Study|Physician Decision|2|||
129090168|NCT02029989|464620532|FG001|Overall Study|Physician Decision|0|||
129090169|NCT02029989|464620531|FG000|Overall Study|Lost to Follow-up|9|||
129090170|NCT02029989|464620532|FG001|Overall Study|Lost to Follow-up|7|||
129090171|NCT02029989|464620531|FG000|Overall Study|Death|0|||
129090172|NCT02029989|464620532|FG001|Overall Study|Death|1|||
129090173|NCT02029989|464620531|FG000|Overall Study|Protocol Violation|1|||
129090174|NCT02029989|464620532|FG001|Overall Study|Protocol Violation|0|||
129090175|NCT04351373|464620533|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
129090176|NCT03099694|464620549|FG000|Overall Study|Withdrawal by Subject|11|||
129090177|NCT03099694|464620550|FG001|Overall Study|Withdrawal by Subject|13|||
129090178|NCT03099694|464620549|FG000|Overall Study|Lost to Follow-up|9|||
129090179|NCT03099694|464620550|FG001|Overall Study|Lost to Follow-up|5|||
129090180|NCT00471718|464620556|FG000|Overall Study|Adverse Event|3|||
129090181|NCT00471718|464620556|FG000|Overall Study|other complicating disease|1|||
129090182|NCT00471718|464620556|FG000|Overall Study|disease progression|22|||
129090183|NCT00471718|464620556|FG000|Overall Study|Withdrawal by Subject|1|||
129090184|NCT02880865|464620557|FG000|Overall Study|Adverse Event|1|||
129090185|NCT02880865|464620558|FG001|Overall Study|Adverse Event|0|||
129090186|NCT02880865|464620557|FG000|Overall Study|Withdrawal by Subject|0|||
129090187|NCT02880865|464620558|FG001|Overall Study|Withdrawal by Subject|2|||
129090188|NCT02880865|464620557|FG000|Overall Study|Physician Decision|0|||
129090189|NCT02880865|464620558|FG001|Overall Study|Physician Decision|1|||
129090190|NCT01446237|464620562|FG000|Overall Study|Adverse Event|1|||
129090191|NCT01446237|464620562|FG000|Overall Study|Lost to Follow-up|2|||
129090192|NCT01446237|464620562|FG000|Overall Study|Withdrawal by Subject|7|||
129090193|NCT01190267|464620565|FG000|Overall Study|Adverse Event|10|||
129090194|NCT01190267|464620566|FG001|Overall Study|Adverse Event|0|||
129090195|NCT01190267|464620565|FG000|Overall Study|Treatment Failure|8|||
129090196|NCT01190267|464620566|FG001|Overall Study|Treatment Failure|2|||
129090197|NCT01190267|464620565|FG000|Overall Study|Lost to Follow-up|2|||
129090198|NCT01190267|464620566|FG001|Overall Study|Lost to Follow-up|0|||
129090199|NCT01190267|464620565|FG000|Overall Study|Withdrawal by Subject|13|||
129090200|NCT01190267|464620566|FG001|Overall Study|Withdrawal by Subject|1|||
129090201|NCT01190267|464620565|FG000|Overall Study|Protocol Violation|8|||
129090202|NCT01190267|464620566|FG001|Overall Study|Protocol Violation|1|||
129090203|NCT04017832|464620569|FG000|Overall Study|Withdrawal by Subject|13|||
129090204|NCT04017832|464620570|FG001|Overall Study|Withdrawal by Subject|12|||
129090205|NCT04017832|464620571|FG002|Overall Study|Withdrawal by Subject|21|||
129090206|NCT04017832|464620572|FG003|Overall Study|Withdrawal by Subject|7|||
129090207|NCT04017832|464620569|FG000|Overall Study|Lost to Follow-up|0|||
129090208|NCT04017832|464620570|FG001|Overall Study|Lost to Follow-up|3|||
129090209|NCT04017832|464620571|FG002|Overall Study|Lost to Follow-up|3|||
129090210|NCT04017832|464620572|FG003|Overall Study|Lost to Follow-up|1|||
129090211|NCT04017832|464620569|FG000|Overall Study|Physician Decision|1|||
129090212|NCT04017832|464620570|FG001|Overall Study|Physician Decision|1|||
129090213|NCT04017832|464620571|FG002|Overall Study|Physician Decision|1|||
129090214|NCT04017832|464620572|FG003|Overall Study|Physician Decision|1|||
129090215|NCT04017832|464620569|FG000|Overall Study|Death|2|||
129090216|NCT04017832|464620570|FG001|Overall Study|Death|2|||
129090217|NCT04017832|464620571|FG002|Overall Study|Death|1|||
129090218|NCT04017832|464620572|FG003|Overall Study|Death|0|||
129090219|NCT00965341|464620577|FG000|Overall Study|Withdrew consent|1|||
129090220|NCT00965341|464620578|FG001|Overall Study|Withdrew consent|5|||
129090221|NCT00965341|464620577|FG000|Overall Study|Lost to Follow-up|1|||
129090222|NCT00965341|464620578|FG001|Overall Study|Lost to Follow-up|0|||
129090223|NCT00965341|464620577|FG000|Overall Study|Transportation issues|4|||
129090224|NCT00965341|464620578|FG001|Overall Study|Transportation issues|3|||
129090225|NCT01077739|464620584|FG000|Overall Study|Premature withdrawal|1|||
129090226|NCT01077739|464620585|FG001|Overall Study|Premature withdrawal|3|||
129090227|NCT01077739|464620584|FG000|Overall Study|Withdrawal by Subject|1|||
129090228|NCT01077739|464620585|FG001|Overall Study|Withdrawal by Subject|0|||
129090229|NCT01077739|464620584|FG000|Overall Study|Death|0|||
129090230|NCT01077739|464620585|FG001|Overall Study|Death|3|||
129090231|NCT01077739|464620584|FG000|Overall Study|Unacceptable toxicity|1|||
129090232|NCT01077739|464620585|FG001|Overall Study|Unacceptable toxicity|2|||
129090233|NCT01077739|464620584|FG000|Overall Study|Other|2|||
129090234|NCT01077739|464620585|FG001|Overall Study|Other|2|||
129090235|NCT00960986|464620586|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
129090236|NCT00960986|464620587|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
129090237|NCT00960986|464620588|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
129090238|NCT00960986|464620589|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
129090239|NCT00960986|464620586|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
129090240|NCT00960986|464620587|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
129090241|NCT00960986|464620588|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
129090242|NCT00960986|464620589|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
129090243|NCT00960986|464620586|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
129090244|NCT00960986|464620587|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
129090245|NCT00960986|464620588|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
129090246|NCT00960986|464620589|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
129090247|NCT00960986|464620586|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
129090248|NCT00960986|464620587|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
129090249|NCT00960986|464620588|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
129090250|NCT00960986|464620589|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
129090251|NCT00960986|464620586|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
129090252|NCT00960986|464620587|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
129090253|NCT00960986|464620588|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
129090254|NCT00960986|464620589|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
129090255|NCT00960986|464620586|FG000|Period 3 (7-week Therapy Period)|Death|0|||
129090256|NCT00960986|464620587|FG001|Period 3 (7-week Therapy Period)|Death|0|||
129090257|NCT00960986|464620588|FG002|Period 3 (7-week Therapy Period)|Death|1|||
129090258|NCT00960986|464620589|FG003|Period 3 (7-week Therapy Period)|Death|0|||
129090259|NCT00960986|464620586|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
129090260|NCT00960986|464620587|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
129090261|NCT00960986|464620588|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
129090262|NCT00960986|464620589|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
129090263|NCT00960986|464620586|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
129090264|NCT00960986|464620587|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
129090265|NCT00960986|464620588|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
129090266|NCT00960986|464620589|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
129090267|NCT00960986|464620586|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
129090268|NCT00960986|464620587|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
129090269|NCT00960986|464620588|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
129090270|NCT00960986|464620589|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
129090271|NCT00960986|464620586|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
129090272|NCT00960986|464620587|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
129090273|NCT00960986|464620588|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
129090274|NCT00960986|464620589|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
129090275|NCT04464720|464620590|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
129090276|NCT00954512|464620596|FG000|Overall Study|Withdrawal by Subject|0|||
129090277|NCT00954512|464620597|FG001|Overall Study|Withdrawal by Subject|0|||
129090278|NCT00954512|464620598|FG002|Overall Study|Withdrawal by Subject|0|||
129090279|NCT00954512|464620599|FG003|Overall Study|Withdrawal by Subject|0|||
129090280|NCT00954512|464620600|FG004|Overall Study|Withdrawal by Subject|0|||
129090281|NCT00954512|464620601|FG005|Overall Study|Withdrawal by Subject|1|||
129090282|NCT00954512|464620596|FG000|Overall Study|Adverse Event|0|||
129090283|NCT00954512|464620597|FG001|Overall Study|Adverse Event|0|||
129090284|NCT00954512|464620598|FG002|Overall Study|Adverse Event|0|||
129090285|NCT00954512|464620599|FG003|Overall Study|Adverse Event|0|||
129090286|NCT00954512|464620600|FG004|Overall Study|Adverse Event|1|||
129090287|NCT00954512|464620601|FG005|Overall Study|Adverse Event|2|||
129090288|NCT00954512|464620596|FG000|Overall Study|Physician Decision|0|||
129090289|NCT00954512|464620597|FG001|Overall Study|Physician Decision|1|||
129090290|NCT00954512|464620598|FG002|Overall Study|Physician Decision|0|||
129090291|NCT00954512|464620599|FG003|Overall Study|Physician Decision|1|||
129090292|NCT00954512|464620600|FG004|Overall Study|Physician Decision|0|||
129090293|NCT00954512|464620601|FG005|Overall Study|Physician Decision|0|||
129090294|NCT00954512|464620596|FG000|Overall Study|Symptomatic Deterioration|0|||
129090295|NCT00954512|464620597|FG001|Overall Study|Symptomatic Deterioration|1|||
129090296|NCT00954512|464620598|FG002|Overall Study|Symptomatic Deterioration|0|||
129090297|NCT00954512|464620599|FG003|Overall Study|Symptomatic Deterioration|0|||
129090298|NCT00954512|464620600|FG004|Overall Study|Symptomatic Deterioration|2|||
129090299|NCT00954512|464620601|FG005|Overall Study|Symptomatic Deterioration|0|||
129090300|NCT00954512|464620596|FG000|Overall Study|Progression of Disease|2|||
129090301|NCT00954512|464620597|FG001|Overall Study|Progression of Disease|1|||
129090302|NCT00954512|464620598|FG002|Overall Study|Progression of Disease|0|||
129090303|NCT00954512|464620599|FG003|Overall Study|Progression of Disease|1|||
129090304|NCT00954512|464620600|FG004|Overall Study|Progression of Disease|1|||
129090305|NCT00954512|464620601|FG005|Overall Study|Progression of Disease|1|||
129090306|NCT01794793|464620603|FG000|Treatment Period|Withdrawal by Subject|24|||
129090307|NCT01794793|464620603|FG000|Treatment Period|Lack of Efficacy|22|||
129090308|NCT01794793|464620603|FG000|Treatment Period|Adverse Event|17|||
129090309|NCT01794793|464620603|FG000|Treatment Period|Physician Decision|14|||
129090310|NCT01794793|464620603|FG000|Treatment Period|Lost to Follow-up|7|||
129090311|NCT01794793|464620603|FG000|Treatment Period|Death|6|||
129145335|NCT02082977|464828146|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
129145336|NCT02082977|464828147|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
129145337|NCT02082977|464828148|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
129090312|NCT01794793|464620603|FG000|Treatment Period|Protocol Violation|5|||
129090313|NCT01794793|464620603|FG000|Treatment Period|administrative problem|3|||
129090314|NCT01794793|464620603|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
129090315|NCT01794793|464620603|FG000|Post-treatment Follow-up|Adverse Event|8|||
129090316|NCT01794793|464620603|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
129090317|NCT01794793|464620603|FG000|Post-treatment Follow-up|administrative problem|5|||
129090318|NCT01794793|464620603|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
129090319|NCT01794793|464620603|FG000|Post-treatment Follow-up|Protocol Violation|3|||
129090320|NCT03495154|464620604|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
129090321|NCT03495154|464620604|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
129090322|NCT03495154|464620604|FG000|Overall Study|Screen Failures During Surgery|6|||
129090323|NCT03495154|464620604|FG000|Overall Study|Death|2|||
129090324|NCT03495154|464620604|FG000|Overall Study|Lost to Follow-up|16|||
129090325|NCT03495154|464620604|FG000|Overall Study|Withdrawal by Subject|2|||
129090326|NCT03495154|464620604|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
129090327|NCT05685732|464620605|FG000|Overall Study|Withdrawal by Subject|2|||
129090328|NCT05685732|464620606|FG001|Overall Study|Withdrawal by Subject|0|||
129090329|NCT05685732|464620607|FG002|Overall Study|Withdrawal by Subject|2|||
129090330|NCT05685732|464620608|FG003|Overall Study|Withdrawal by Subject|3|||
129090331|NCT05685732|464620605|FG000|Overall Study|Protocol Violation|1|||
129090332|NCT05685732|464620606|FG001|Overall Study|Protocol Violation|2|||
129090333|NCT05685732|464620607|FG002|Overall Study|Protocol Violation|4|||
129090334|NCT05685732|464620608|FG003|Overall Study|Protocol Violation|1|||
129090335|NCT05685732|464620605|FG000|Overall Study|Lost to Follow-up|5|||
129090336|NCT05685732|464620606|FG001|Overall Study|Lost to Follow-up|1|||
129090337|NCT05685732|464620607|FG002|Overall Study|Lost to Follow-up|3|||
129090338|NCT05685732|464620608|FG003|Overall Study|Lost to Follow-up|1|||
129090339|NCT05685732|464620605|FG000|Overall Study|Adverse Event|2|||
129090340|NCT05685732|464620606|FG001|Overall Study|Adverse Event|1|||
129090341|NCT05685732|464620607|FG002|Overall Study|Adverse Event|0|||
129090342|NCT05685732|464620608|FG003|Overall Study|Adverse Event|0|||
129090343|NCT05685732|464620605|FG000|Overall Study|Physician Decision|1|||
129090344|NCT05685732|464620606|FG001|Overall Study|Physician Decision|0|||
129090345|NCT05685732|464620607|FG002|Overall Study|Physician Decision|0|||
129090346|NCT05685732|464620608|FG003|Overall Study|Physician Decision|0|||
129090347|NCT02640404|464620609|FG000|Overall Study|Protocol Violation|1|||
129090348|NCT02640404|464620610|FG001|Overall Study|Protocol Violation|0|||
129090349|NCT02640404|464620609|FG000|Overall Study|Withdrawal by Subject|1|||
129090350|NCT02640404|464620610|FG001|Overall Study|Withdrawal by Subject|0|||
129090351|NCT05397171|464620612|FG000|Overall Study|Death|2|||
129090352|NCT05397171|464620613|FG001|Overall Study|Death|3|||
129090353|NCT05397171|464620614|FG002|Overall Study|Death|3|||
129090354|NCT05397171|464620612|FG000|Overall Study|Study Terminated By Sponsor|1|||
129090355|NCT05397171|464620613|FG001|Overall Study|Study Terminated By Sponsor|2|||
129090356|NCT05397171|464620614|FG002|Overall Study|Study Terminated By Sponsor|3|||
129090357|NCT05397171|464620612|FG000|Overall Study|Withdrawal by Subject|0|||
129090358|NCT05397171|464620613|FG001|Overall Study|Withdrawal by Subject|1|||
129090359|NCT05397171|464620614|FG002|Overall Study|Withdrawal by Subject|1|||
129090360|NCT02100670|464620615|FG000|Overall Study|Adverse Event|10|||
129090361|NCT02100670|464620616|FG001|Overall Study|Adverse Event|3|||
129090362|NCT02100670|464620617|FG002|Overall Study|Adverse Event|3|||
129090363|NCT02100670|464620618|FG003|Overall Study|Adverse Event|0|||
129090364|NCT02100670|464620615|FG000|Overall Study|Lost to Follow-up|1|||
129090365|NCT02100670|464620616|FG001|Overall Study|Lost to Follow-up|0|||
129090366|NCT02100670|464620617|FG002|Overall Study|Lost to Follow-up|0|||
129090367|NCT02100670|464620618|FG003|Overall Study|Lost to Follow-up|0|||
129090368|NCT02100670|464620615|FG000|Overall Study|Protocol Violation|0|||
129090369|NCT02100670|464620616|FG001|Overall Study|Protocol Violation|1|||
129090370|NCT02100670|464620617|FG002|Overall Study|Protocol Violation|0|||
129090371|NCT02100670|464620618|FG003|Overall Study|Protocol Violation|1|||
129090372|NCT02100670|464620615|FG000|Overall Study|Withdrawal of Consent|0|||
129090373|NCT02100670|464620616|FG001|Overall Study|Withdrawal of Consent|1|||
129090374|NCT02100670|464620617|FG002|Overall Study|Withdrawal of Consent|1|||
129090375|NCT02100670|464620618|FG003|Overall Study|Withdrawal of Consent|0|||
129090376|NCT02100670|464620615|FG000|Overall Study|No swelling no pain|1|||
129090377|NCT02100670|464620616|FG001|Overall Study|No swelling no pain|0|||
129090378|NCT02100670|464620617|FG002|Overall Study|No swelling no pain|0|||
129090379|NCT02100670|464620618|FG003|Overall Study|No swelling no pain|0|||
129090380|NCT02100670|464620615|FG000|Overall Study|Poor Efficacy|0|||
129090381|NCT02100670|464620616|FG001|Overall Study|Poor Efficacy|1|||
129090382|NCT02100670|464620617|FG002|Overall Study|Poor Efficacy|0|||
129090383|NCT02100670|464620618|FG003|Overall Study|Poor Efficacy|0|||
129090384|NCT02100670|464620615|FG000|Overall Study|Physician Decision|0|||
129090385|NCT02100670|464620616|FG001|Overall Study|Physician Decision|1|||
129090386|NCT02100670|464620617|FG002|Overall Study|Physician Decision|0|||
129090387|NCT02100670|464620618|FG003|Overall Study|Physician Decision|0|||
129090388|NCT02100670|464620615|FG000|Overall Study|Withdrawal by Subject|1|||
129090389|NCT02100670|464620616|FG001|Overall Study|Withdrawal by Subject|0|||
129090390|NCT02100670|464620617|FG002|Overall Study|Withdrawal by Subject|0|||
129090391|NCT02100670|464620618|FG003|Overall Study|Withdrawal by Subject|0|||
129090392|NCT02234596|464620619|FG000|Overall Study|Participant not treated|2|||
129090393|NCT03634033|464622417|FG000|Overall Study|Did not have a post-assessment|384|||
129090394|NCT03634033|464622418|FG001|Overall Study|Did not have a post-assessment|291|||
129090395|NCT03634033|464622419|FG002|Overall Study|Did not have a post-assessment|114|||
129090396|NCT03634033|464622420|FG003|Overall Study|Did not have a post-assessment|161|||
129090397|NCT03634033|464622421|FG004|Overall Study|Did not have a post-assessment|5|||
129090398|NCT03634033|464622422|FG005|Overall Study|Did not have a post-assessment|0|||
129090399|NCT03634033|464622423|FG006|Overall Study|Did not have a post-assessment|0|||
129090400|NCT03634033|464622417|FG000|Overall Study|Death|0|||
129090401|NCT03634033|464622418|FG001|Overall Study|Death|0|||
129090402|NCT03634033|464622419|FG002|Overall Study|Death|0|||
129090403|NCT03634033|464622420|FG003|Overall Study|Death|0|||
129090404|NCT03634033|464622421|FG004|Overall Study|Death|0|||
129090405|NCT03634033|464622422|FG005|Overall Study|Death|7|||
129090406|NCT03634033|464622423|FG006|Overall Study|Death|7|||
129090407|NCT03634033|464622417|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129090408|NCT03634033|464622418|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129090409|NCT03634033|464622419|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129090410|NCT03634033|464622420|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129090411|NCT03634033|464622421|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129090412|NCT03634033|464622422|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
129090413|NCT03634033|464622423|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
129090414|NCT03634033|464622417|FG000|Overall Study|Lost to Follow-up|0|||
129090415|NCT03634033|464622418|FG001|Overall Study|Lost to Follow-up|0|||
129090416|NCT03634033|464622419|FG002|Overall Study|Lost to Follow-up|0|||
129090417|NCT03634033|464622420|FG003|Overall Study|Lost to Follow-up|0|||
129090418|NCT03634033|464622421|FG004|Overall Study|Lost to Follow-up|0|||
129090419|NCT03634033|464622422|FG005|Overall Study|Lost to Follow-up|1|||
129090420|NCT03634033|464622423|FG006|Overall Study|Lost to Follow-up|2|||
129090421|NCT03634033|464622417|FG000|Overall Study|Withdrawal by Subject|0|||
129090422|NCT03634033|464622418|FG001|Overall Study|Withdrawal by Subject|0|||
129090423|NCT03634033|464622419|FG002|Overall Study|Withdrawal by Subject|0|||
129090424|NCT03634033|464622420|FG003|Overall Study|Withdrawal by Subject|0|||
129090425|NCT03634033|464622421|FG004|Overall Study|Withdrawal by Subject|0|||
129090426|NCT03634033|464622422|FG005|Overall Study|Withdrawal by Subject|0|||
129090427|NCT03634033|464622423|FG006|Overall Study|Withdrawal by Subject|1|||
129090428|NCT01944670|464622426|FG000|Overall Study|Lost to Follow-up|2|||
129090429|NCT00743288|464622427|FG000|Overall Study|Adverse Event|1|||
129090430|NCT00743288|464622428|FG001|Overall Study|Adverse Event|1|||
129090431|NCT00743288|464622429|FG002|Overall Study|Adverse Event|2|||
129090432|NCT00743288|464622430|FG003|Overall Study|Adverse Event|2|||
129090433|NCT00743288|464622431|FG004|Overall Study|Adverse Event|1|||
129090434|NCT00743288|464622432|FG005|Overall Study|Adverse Event|1|||
129090435|NCT00743288|464622433|FG006|Overall Study|Adverse Event|2|||
129090436|NCT00743288|464622427|FG000|Overall Study|Withdrawal by Subject|0|||
129090437|NCT00743288|464622428|FG001|Overall Study|Withdrawal by Subject|0|||
129090438|NCT00743288|464622429|FG002|Overall Study|Withdrawal by Subject|1|||
129090439|NCT00743288|464622430|FG003|Overall Study|Withdrawal by Subject|0|||
129090440|NCT00743288|464622431|FG004|Overall Study|Withdrawal by Subject|0|||
129090441|NCT00743288|464622432|FG005|Overall Study|Withdrawal by Subject|1|||
129090442|NCT00743288|464622433|FG006|Overall Study|Withdrawal by Subject|1|||
129090443|NCT00743288|464622427|FG000|Overall Study|Progressive disease (PD)|2|||
129090444|NCT00743288|464622428|FG001|Overall Study|Progressive disease (PD)|0|||
129090445|NCT00743288|464622429|FG002|Overall Study|Progressive disease (PD)|1|||
129090446|NCT00743288|464622430|FG003|Overall Study|Progressive disease (PD)|4|||
129090447|NCT00743288|464622431|FG004|Overall Study|Progressive disease (PD)|5|||
129090448|NCT00743288|464622432|FG005|Overall Study|Progressive disease (PD)|3|||
129090449|NCT00743288|464622433|FG006|Overall Study|Progressive disease (PD)|6|||
129090450|NCT00743288|464622427|FG000|Overall Study|Worsening of condition (Not PD)|0|||
129090451|NCT00743288|464622428|FG001|Overall Study|Worsening of condition (Not PD)|2|||
129090452|NCT00743288|464622429|FG002|Overall Study|Worsening of condition (Not PD)|1|||
129090453|NCT00743288|464622430|FG003|Overall Study|Worsening of condition (Not PD)|1|||
129090454|NCT00743288|464622431|FG004|Overall Study|Worsening of condition (Not PD)|0|||
129090455|NCT00743288|464622432|FG005|Overall Study|Worsening of condition (Not PD)|0|||
129090456|NCT00743288|464622433|FG006|Overall Study|Worsening of condition (Not PD)|0|||
129090457|NCT05903924|464622434|FG000|Overall Study|Lost to Follow-up|1|||
129090458|NCT05903924|464622435|FG001|Overall Study|Lost to Follow-up|0|||
129090459|NCT05903924|464622436|FG002|Overall Study|Lost to Follow-up|0|||
129090460|NCT04338269|464622437|FG000|Overall Study|Death|86|||
129090461|NCT04338269|464622438|FG001|Overall Study|Death|89|||
129090462|NCT04338269|464622437|FG000|Overall Study|Lost to Follow-up|1|||
129090463|NCT04338269|464622438|FG001|Overall Study|Lost to Follow-up|2|||
129090464|NCT04338269|464622437|FG000|Overall Study|Physician Decision|1|||
129090465|NCT04338269|464622438|FG001|Overall Study|Physician Decision|0|||
129090466|NCT04338269|464622437|FG000|Overall Study|Withdrawal by Subject|14|||
129090467|NCT04338269|464622438|FG001|Overall Study|Withdrawal by Subject|11|||
129090468|NCT02730377|464622442|FG000|Overall Study|Other|5|||
129090469|NCT02730377|464622443|FG001|Overall Study|Other|4|||
129090470|NCT02730377|464622442|FG000|Overall Study|Death|1|||
129090471|NCT02730377|464622443|FG001|Overall Study|Death|8|||
129090472|NCT02730377|464622442|FG000|Overall Study|Inadequate glycaemic control|368|||
129090473|NCT02730377|464622443|FG001|Overall Study|Inadequate glycaemic control|473|||
129090474|NCT02730377|464622442|FG000|Overall Study|Adverse Event|79|||
129090475|NCT02730377|464622443|FG001|Overall Study|Adverse Event|41|||
129090476|NCT02730377|464622442|FG000|Overall Study|Protocol Violation|23|||
129090477|NCT02730377|464622443|FG001|Overall Study|Protocol Violation|30|||
129090478|NCT02730377|464622442|FG000|Overall Study|Lack of Efficacy|4|||
129090479|NCT02730377|464622443|FG001|Overall Study|Lack of Efficacy|13|||
129090480|NCT02730377|464622442|FG000|Overall Study|Pregnancy|0|||
129090481|NCT02730377|464622443|FG001|Overall Study|Pregnancy|1|||
129090482|NCT02730377|464622442|FG000|Overall Study|Withdrawal by Subject|45|||
129090483|NCT02730377|464622443|FG001|Overall Study|Withdrawal by Subject|42|||
129090484|NCT02730377|464622442|FG000|Overall Study|Lost to Follow-up|25|||
129090485|NCT02730377|464622443|FG001|Overall Study|Lost to Follow-up|21|||
129090486|NCT02203851|464622444|FG000|Overall Study|Lost to Follow-up|4|||
129090487|NCT02203851|464622444|FG000|Overall Study|Withdrawal by Subject|6|||
129090488|NCT02203851|464622444|FG000|Overall Study|Other|1|||
129090489|NCT04045132|464622447|FG000|Overall Study|Lost to Follow-up|3|||
129090490|NCT04045132|464622448|FG001|Overall Study|Lost to Follow-up|6|||
129090491|NCT01632150|464622452|FG000|Overall Study|Disease progression|27|||
129090492|NCT01632150|464622452|FG000|Overall Study|Study drug toxicity|1|||
129090493|NCT01632150|464622452|FG000|Overall Study|Unrelated adverse event|7|||
129090494|NCT01632150|464622452|FG000|Overall Study|Withdrawal by Subject|2|||
129090495|NCT01632150|464622452|FG000|Overall Study|Patient underwent autologous transplant|1|||
129090496|NCT01632150|464622452|FG000|Overall Study|Moved to compassionate program|2|||
129090497|NCT02143791|464622453|FG000|Enrolled|Withdrawal by Subject|4|||
129090498|NCT02143791|464622453|FG000|Trial Stimulation|Lack of Efficacy|21|||
129090499|NCT02143791|464622453|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
129090500|NCT02143791|464622453|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
129090501|NCT02143791|464622453|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
129090502|NCT02143791|464622453|FG000|Any Programming (3-6 Months)|Missing Data|1|||
129090503|NCT02143791|464622453|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
129090504|NCT00401544|464622454|FG000|Overall Study|Adverse Event|5|||
129090505|NCT00401544|464622455|FG001|Overall Study|Adverse Event|1|||
129090506|NCT00401544|464622456|FG002|Overall Study|Adverse Event|1|||
129090507|NCT00401544|464622457|FG003|Overall Study|Adverse Event|1|||
129090508|NCT00401544|464622454|FG000|Overall Study|Death|3|||
129090509|NCT00401544|464622455|FG001|Overall Study|Death|6|||
129090510|NCT00401544|464622456|FG002|Overall Study|Death|2|||
129090511|NCT00401544|464622457|FG003|Overall Study|Death|5|||
129090512|NCT00401544|464622454|FG000|Overall Study|Lost to Follow-up|2|||
129090513|NCT00401544|464622455|FG001|Overall Study|Lost to Follow-up|0|||
129090514|NCT00401544|464622456|FG002|Overall Study|Lost to Follow-up|1|||
129090515|NCT00401544|464622457|FG003|Overall Study|Lost to Follow-up|1|||
129090516|NCT00401544|464622454|FG000|Overall Study|Withdrawal by Subject|7|||
129090517|NCT00401544|464622455|FG001|Overall Study|Withdrawal by Subject|6|||
129090518|NCT00401544|464622456|FG002|Overall Study|Withdrawal by Subject|6|||
129090519|NCT00401544|464622457|FG003|Overall Study|Withdrawal by Subject|5|||
129090520|NCT00401544|464622454|FG000|Overall Study|Physician Decision|1|||
129090521|NCT00401544|464622455|FG001|Overall Study|Physician Decision|3|||
129090522|NCT00401544|464622456|FG002|Overall Study|Physician Decision|0|||
129090523|NCT00401544|464622457|FG003|Overall Study|Physician Decision|0|||
129090524|NCT00401544|464622454|FG000|Overall Study|Ineligibility determined|0|||
129090525|NCT00401544|464622455|FG001|Overall Study|Ineligibility determined|1|||
129090526|NCT00401544|464622456|FG002|Overall Study|Ineligibility determined|0|||
129090527|NCT00401544|464622457|FG003|Overall Study|Ineligibility determined|2|||
129090528|NCT00401544|464622454|FG000|Overall Study|Disease progression|0|||
129090529|NCT00401544|464622455|FG001|Overall Study|Disease progression|1|||
129090530|NCT00401544|464622456|FG002|Overall Study|Disease progression|0|||
129090531|NCT00401544|464622457|FG003|Overall Study|Disease progression|0|||
129090532|NCT00401544|464622454|FG000|Overall Study|Other|0|||
129090533|NCT00401544|464622455|FG001|Overall Study|Other|0|||
129090534|NCT00401544|464622456|FG002|Overall Study|Other|2|||
129090535|NCT00401544|464622457|FG003|Overall Study|Other|2|||
129090536|NCT01054300|464622474|FG000|Period 1|Adverse Event|1|||
129090537|NCT01054300|464622475|FG001|Period 1|Adverse Event|0|||
129145338|NCT02082977|464828149|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129145339|NCT02082977|464828140|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129145340|NCT02082977|464828141|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129090538|NCT01054300|464622476|FG002|Period 1|Adverse Event|0|||
129090539|NCT01054300|464622477|FG003|Period 1|Adverse Event|0|||
129090540|NCT01054300|464622474|FG000|Period 2|Withdrawal by Subject|0|||
129090541|NCT01054300|464622475|FG001|Period 2|Withdrawal by Subject|0|||
129090542|NCT01054300|464622476|FG002|Period 2|Withdrawal by Subject|1|||
129090543|NCT01054300|464622477|FG003|Period 2|Withdrawal by Subject|0|||
129090544|NCT00308087|464622480|FG000|Overall Study|Progressive Disease|19|||
129090545|NCT00308087|464622481|FG001|Overall Study|Progressive Disease|21|||
129090546|NCT00308087|464622480|FG000|Overall Study|Study Closure|11|||
129090547|NCT00308087|464622481|FG001|Overall Study|Study Closure|12|||
129090548|NCT00308087|464622480|FG000|Overall Study|Withdrawal by Subject|2|||
129090549|NCT00308087|464622481|FG001|Overall Study|Withdrawal by Subject|1|||
129090550|NCT00308087|464622480|FG000|Overall Study|Other|4|||
129090551|NCT00308087|464622481|FG001|Overall Study|Other|3|||
129090552|NCT00177307|464622484|FG000|Overall Study|Withdrawal by Subject|1|||
129090553|NCT02677038|464622488|FG000|Overall Study|Physician Decision|1|||
129090554|NCT02677038|464622488|FG000|Overall Study|Withdrawal by Subject|1|||
129090555|NCT03671564|464622489|FG000|Overall Study|Progressive Disease|3|||
129090556|NCT03671564|464622490|FG001|Overall Study|Progressive Disease|5|||
129090557|NCT03671564|464622491|FG002|Overall Study|Progressive Disease|3|||
129090558|NCT03671564|464622489|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
129090559|NCT03671564|464622490|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
129090560|NCT03671564|464622491|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
129090561|NCT03671564|464622489|FG000|Overall Study|Withdrawal by Subject|1|||
129090562|NCT03671564|464622490|FG001|Overall Study|Withdrawal by Subject|1|||
129090563|NCT03671564|464622491|FG002|Overall Study|Withdrawal by Subject|0|||
129090564|NCT00380081|464622492|FG000|Overall Study|Withdrawal by Subject|0|||
129090565|NCT00380081|464622493|FG001|Overall Study|Withdrawal by Subject|0|||
129090566|NCT00380081|464622494|FG002|Overall Study|Withdrawal by Subject|0|||
129090567|NCT00380081|464622495|FG003|Overall Study|Withdrawal by Subject|0|||
129090568|NCT00380081|464622496|FG004|Overall Study|Withdrawal by Subject|1|||
129090569|NCT00380081|464622497|FG005|Overall Study|Withdrawal by Subject|0|||
129090570|NCT00380081|464622492|FG000|Overall Study|Family Emergency|0|||
129090571|NCT00380081|464622493|FG001|Overall Study|Family Emergency|0|||
129090572|NCT00380081|464622494|FG002|Overall Study|Family Emergency|0|||
129090573|NCT00380081|464622495|FG003|Overall Study|Family Emergency|0|||
129090574|NCT00380081|464622496|FG004|Overall Study|Family Emergency|0|||
129090575|NCT00380081|464622497|FG005|Overall Study|Family Emergency|1|||
129090576|NCT05007041|464622498|FG000|Overall Study|Missing Diary Entries|0|||
129090577|NCT05007041|464622499|FG001|Overall Study|Missing Diary Entries|1|||
129090578|NCT01546168|464622502|FG000|Overall Study|Lost to Follow-up|1|||
129090579|NCT01546168|464622503|FG001|Overall Study|Lost to Follow-up|0|||
129090580|NCT01546168|464622502|FG000|Overall Study|Withdrawal by Subject|1|||
129090581|NCT01546168|464622503|FG001|Overall Study|Withdrawal by Subject|0|||
129090582|NCT01546168|464622502|FG000|Overall Study|ineligible after signing consent|2|||
129090583|NCT01546168|464622503|FG001|Overall Study|ineligible after signing consent|0|||
129090584|NCT02850016|464622504|FG000|Overall Study|Withdrawal by Subject|1|||
129090585|NCT02850016|464622505|FG001|Overall Study|Withdrawal by Subject|2|||
129090586|NCT02954653|464622506|FG000|Overall Study|Death|3|||
129090587|NCT02954653|464622507|FG001|Overall Study|Death|1|||
129090588|NCT02954653|464622508|FG002|Overall Study|Death|0|||
129090589|NCT02954653|464622509|FG003|Overall Study|Death|0|||
129090590|NCT02954653|464622510|FG004|Overall Study|Death|0|||
129090591|NCT02954653|464622511|FG005|Overall Study|Death|0|||
129090592|NCT02954653|464622512|FG006|Overall Study|Death|0|||
129090593|NCT02954653|464622513|FG007|Overall Study|Death|0|||
129090594|NCT02954653|464622514|FG008|Overall Study|Death|0|||
129090595|NCT02954653|464622506|FG000|Overall Study|Randomized but did not receive treatment|1|||
129090596|NCT02954653|464622507|FG001|Overall Study|Randomized but did not receive treatment|0|||
129090597|NCT02954653|464622508|FG002|Overall Study|Randomized but did not receive treatment|0|||
129090598|NCT02954653|464622509|FG003|Overall Study|Randomized but did not receive treatment|0|||
129090599|NCT02954653|464622510|FG004|Overall Study|Randomized but did not receive treatment|0|||
129090600|NCT02954653|464622511|FG005|Overall Study|Randomized but did not receive treatment|0|||
129090601|NCT02954653|464622512|FG006|Overall Study|Randomized but did not receive treatment|0|||
129090602|NCT02954653|464622513|FG007|Overall Study|Randomized but did not receive treatment|0|||
129090603|NCT02954653|464622514|FG008|Overall Study|Randomized but did not receive treatment|0|||
129090604|NCT02954653|464622506|FG000|Overall Study|Started another anti-cancer therapy|0|||
129090605|NCT02954653|464622507|FG001|Overall Study|Started another anti-cancer therapy|1|||
129090606|NCT02954653|464622508|FG002|Overall Study|Started another anti-cancer therapy|0|||
128724594|NCT03711162|463290853|FG000|Overall Study|Lack of Efficacy|0|||
128724595|NCT03711162|463290854|FG001|Overall Study|Lack of Efficacy|0|||
128724596|NCT03711162|463290855|FG002|Overall Study|Lack of Efficacy|2|||
129090607|NCT02954653|464622509|FG003|Overall Study|Started another anti-cancer therapy|0|||
128724597|NCT03711162|463290853|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
128724598|NCT03711162|463290854|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
128724599|NCT03711162|463290855|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
128724600|NCT03034954|463290856|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
128724601|NCT03034954|463290857|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
128776579|NCT00224133|463471966|FG000|Overall Study|Other|14|||
129090608|NCT02954653|464622510|FG004|Overall Study|Started another anti-cancer therapy|0|||
129090609|NCT02954653|464622511|FG005|Overall Study|Started another anti-cancer therapy|0|||
129090610|NCT02954653|464622512|FG006|Overall Study|Started another anti-cancer therapy|0|||
129090611|NCT02954653|464622513|FG007|Overall Study|Started another anti-cancer therapy|0|||
128724602|NCT04200248|463290865|FG000|Overall Study|Personal reasons|0|||
128724603|NCT04200248|463290866|FG001|Overall Study|Personal reasons|0|||
129090612|NCT02954653|464622514|FG008|Overall Study|Started another anti-cancer therapy|0|||
129090613|NCT02954653|464622506|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
129090614|NCT02954653|464622507|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
129090615|NCT02954653|464622508|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
129090616|NCT02954653|464622509|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
129090617|NCT02954653|464622510|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
129090618|NCT02954653|464622511|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
129090619|NCT02954653|464622512|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
129090620|NCT02954653|464622513|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
129090621|NCT02954653|464622514|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
129090622|NCT00070018|464622518|FG000|Overall Study|Adverse Event|2|||
129090623|NCT00070018|464622518|FG000|Overall Study|Lack of Efficacy|1|||
129090624|NCT00070018|464622518|FG000|Overall Study|Withdrawal by Subject|1|||
129090625|NCT02939716|464622519|FG000|Overall Study|scanner failure|0|||
129090626|NCT02939716|464622520|FG001|Overall Study|scanner failure|0|||
129090627|NCT02939716|464622521|FG002|Overall Study|scanner failure|0|||
129090628|NCT02939716|464622522|FG003|Overall Study|scanner failure|1|||
129090629|NCT02939716|464622523|FG004|Overall Study|scanner failure|1|||
129090630|NCT02939716|464622524|FG005|Overall Study|scanner failure|1|||
129090631|NCT02543892|464622530|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
129090632|NCT02543892|464622531|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
129090633|NCT02543892|464622532|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
129090634|NCT02543892|464622533|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
129090635|NCT02543892|464622534|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
129090636|NCT02543892|464622535|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
129090637|NCT02543892|464622536|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
129090638|NCT02543892|464622537|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
129090639|NCT02543892|464622530|FG000|Received Vaccination 2|Physician Decision|0|||
129090640|NCT02543892|464622531|FG001|Received Vaccination 2|Physician Decision|0|||
129090641|NCT02543892|464622532|FG002|Received Vaccination 2|Physician Decision|0|||
129090642|NCT02543892|464622533|FG003|Received Vaccination 2|Physician Decision|0|||
129090643|NCT02543892|464622534|FG004|Received Vaccination 2|Physician Decision|0|||
129090644|NCT02543892|464622535|FG005|Received Vaccination 2|Physician Decision|1|||
129090645|NCT02543892|464622536|FG006|Received Vaccination 2|Physician Decision|0|||
129090646|NCT02543892|464622537|FG007|Received Vaccination 2|Physician Decision|0|||
129090647|NCT02543892|464622530|FG000|Received Vaccination 2|Adverse Event|0|||
129090648|NCT02543892|464622531|FG001|Received Vaccination 2|Adverse Event|1|||
129090649|NCT02543892|464622532|FG002|Received Vaccination 2|Adverse Event|0|||
129090650|NCT02543892|464622533|FG003|Received Vaccination 2|Adverse Event|0|||
129090651|NCT02543892|464622534|FG004|Received Vaccination 2|Adverse Event|0|||
129090652|NCT02543892|464622535|FG005|Received Vaccination 2|Adverse Event|0|||
129090653|NCT02543892|464622536|FG006|Received Vaccination 2|Adverse Event|0|||
129090654|NCT02543892|464622537|FG007|Received Vaccination 2|Adverse Event|0|||
129090655|NCT02543892|464622530|FG000|Had Immunology Data|Withdrawal by Subject|0|||
129090656|NCT02543892|464622531|FG001|Had Immunology Data|Withdrawal by Subject|0|||
129090657|NCT02543892|464622532|FG002|Had Immunology Data|Withdrawal by Subject|0|||
129090658|NCT02543892|464622533|FG003|Had Immunology Data|Withdrawal by Subject|0|||
129090659|NCT02543892|464622534|FG004|Had Immunology Data|Withdrawal by Subject|0|||
129090660|NCT02543892|464622535|FG005|Had Immunology Data|Withdrawal by Subject|0|||
129090661|NCT02543892|464622536|FG006|Had Immunology Data|Withdrawal by Subject|1|||
129090662|NCT02543892|464622537|FG007|Had Immunology Data|Withdrawal by Subject|0|||
129090663|NCT01500213|464622538|FG000|Overall Study|Adverse Event|35|||
129090664|NCT01500213|464622539|FG001|Overall Study|Adverse Event|35|||
129090665|NCT01500213|464622538|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
129090666|NCT01500213|464622539|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
129090667|NCT01500213|464622538|FG000|Overall Study|Withdrawal by Subject|28|||
129090668|NCT01500213|464622539|FG001|Overall Study|Withdrawal by Subject|37|||
129090669|NCT01500213|464622538|FG000|Overall Study|Death|7|||
129090670|NCT01500213|464622539|FG001|Overall Study|Death|3|||
129090671|NCT01500213|464622538|FG000|Overall Study|Disease Progression|13|||
129090672|NCT01500213|464622539|FG001|Overall Study|Disease Progression|21|||
129090673|NCT01500213|464622538|FG000|Overall Study|Protocol Violation|19|||
129090674|NCT01500213|464622539|FG001|Overall Study|Protocol Violation|19|||
129090675|NCT01500213|464622538|FG000|Overall Study|Physician Decision|12|||
129090676|NCT01500213|464622539|FG001|Overall Study|Physician Decision|10|||
129090677|NCT01500213|464622538|FG000|Overall Study|Lack of Efficacy|9|||
129090678|NCT01500213|464622539|FG001|Overall Study|Lack of Efficacy|7|||
129090679|NCT01500213|464622538|FG000|Overall Study|Lost to Follow-up|3|||
129090680|NCT01500213|464622539|FG001|Overall Study|Lost to Follow-up|6|||
129090681|NCT01500213|464622538|FG000|Overall Study|Other Reasons|7|||
129090682|NCT01500213|464622539|FG001|Overall Study|Other Reasons|5|||
129090683|NCT00785213|464622540|FG000|Quinine Sulfate Alone|Adverse Event|4|||
129090684|NCT00785213|464622540|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
129090685|NCT00525902|464622541|FG000|Overall Study|Lack of Efficacy|1|||
129090686|NCT00985959|464622542|FG000|Overall Study|Adverse Event|0|||
129090687|NCT00985959|464622543|FG001|Overall Study|Adverse Event|0|||
129090688|NCT00985959|464622544|FG002|Overall Study|Adverse Event|19|||
129090689|NCT00985959|464622542|FG000|Overall Study|Withdrawal by Subject|0|||
129090690|NCT00985959|464622543|FG001|Overall Study|Withdrawal by Subject|0|||
129090691|NCT00985959|464622544|FG002|Overall Study|Withdrawal by Subject|8|||
129090692|NCT00985959|464622542|FG000|Overall Study|Progressive disease|1|||
129090693|NCT00985959|464622543|FG001|Overall Study|Progressive disease|2|||
129090694|NCT00985959|464622544|FG002|Overall Study|Progressive disease|8|||
129090695|NCT00985959|464622542|FG000|Overall Study|Unrecovered toxicity|0|||
129090696|NCT00985959|464622543|FG001|Overall Study|Unrecovered toxicity|0|||
129090697|NCT00985959|464622544|FG002|Overall Study|Unrecovered toxicity|7|||
129090698|NCT00985959|464622542|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
129090699|NCT00985959|464622543|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
129090700|NCT00985959|464622544|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
129090701|NCT00985959|464622542|FG000|Overall Study|Complete response observed over 2 cycles|0|||
129090702|NCT00985959|464622543|FG001|Overall Study|Complete response observed over 2 cycles|1|||
129090703|NCT00985959|464622544|FG002|Overall Study|Complete response observed over 2 cycles|4|||
129090704|NCT00985959|464622542|FG000|Overall Study|Other|0|||
129090705|NCT00985959|464622543|FG001|Overall Study|Other|0|||
129090706|NCT00985959|464622544|FG002|Overall Study|Other|11|||
129090707|NCT02858180|464622551|FG000|Overall Study|Lost to Follow-up|0|||
129090708|NCT02858180|464622552|FG001|Overall Study|Lost to Follow-up|2|||
129090709|NCT00844480|464622553|FG000|Overall Study|Withdrawal by Subject|2|||
129090710|NCT00844480|464622554|FG001|Overall Study|Withdrawal by Subject|3|||
129090711|NCT00526331|464622555|FG000|Overall Study|Sponsor Termination|55|||
129090712|NCT00979420|464622556|FG000|Overall Study|Adverse Event|1|||
129090713|NCT00979420|464622557|FG001|Overall Study|Adverse Event|0|||
129090714|NCT00979420|464622558|FG002|Overall Study|Adverse Event|0|||
129090715|NCT00979420|464622559|FG003|Overall Study|Adverse Event|0|||
129090716|NCT00979420|464622556|FG000|Overall Study|Lack of Efficacy|3|||
129090717|NCT00979420|464622557|FG001|Overall Study|Lack of Efficacy|0|||
129090718|NCT00979420|464622558|FG002|Overall Study|Lack of Efficacy|1|||
129090719|NCT00979420|464622559|FG003|Overall Study|Lack of Efficacy|1|||
129090720|NCT00979420|464622556|FG000|Overall Study|Other reasons not related to Viramune|3|||
129090721|NCT00979420|464622557|FG001|Overall Study|Other reasons not related to Viramune|0|||
129090722|NCT00979420|464622558|FG002|Overall Study|Other reasons not related to Viramune|0|||
129090723|NCT00979420|464622559|FG003|Overall Study|Other reasons not related to Viramune|1|||
129090724|NCT00574249|464622560|FG000|Overall Study|Adverse Event|6|||
129090725|NCT00574249|464622561|FG001|Overall Study|Adverse Event|18|||
129090726|NCT00574249|464622560|FG000|Overall Study|Lack of Efficacy|5|||
129090727|NCT00574249|464622561|FG001|Overall Study|Lack of Efficacy|3|||
129090728|NCT00574249|464622560|FG000|Overall Study|Lost to Follow-up|4|||
129090729|NCT00574249|464622561|FG001|Overall Study|Lost to Follow-up|3|||
129090730|NCT00574249|464622560|FG000|Overall Study|Protocol Violation|5|||
129090731|NCT00574249|464622561|FG001|Overall Study|Protocol Violation|2|||
129090732|NCT00574249|464622560|FG000|Overall Study|History of carcinoma|1|||
129090733|NCT00574249|464622561|FG001|Overall Study|History of carcinoma|0|||
129090734|NCT00574249|464622560|FG000|Overall Study|Withdrawal by Subject|3|||
129090735|NCT00574249|464622561|FG001|Overall Study|Withdrawal by Subject|0|||
129090736|NCT00574249|464622560|FG000|Overall Study|Physician Decision|1|||
129090737|NCT00574249|464622561|FG001|Overall Study|Physician Decision|0|||
129090738|NCT00574249|464622560|FG000|Overall Study|Pregnancy|1|||
129090739|NCT00574249|464622561|FG001|Overall Study|Pregnancy|0|||
129090740|NCT00574249|464622560|FG000|Overall Study|Excluded by company|0|||
129090741|NCT00574249|464622561|FG001|Overall Study|Excluded by company|1|||
129090742|NCT00574249|464622560|FG000|Overall Study|PPD test taken twice|0|||
129090743|NCT00574249|464622561|FG001|Overall Study|PPD test taken twice|1|||
129090744|NCT02294175|464622566|FG000|Overall Study|Withdrawal by Subject|1|||
129090745|NCT02294175|464622567|FG001|Overall Study|Withdrawal by Subject|2|||
129090746|NCT02294175|464622566|FG000|Overall Study|pt taking excluded medication|3|||
129090747|NCT02294175|464622567|FG001|Overall Study|pt taking excluded medication|1|||
129090748|NCT02294175|464622566|FG000|Overall Study|Protocol Violation|1|||
129145341|NCT02082977|464828142|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129145342|NCT02082977|464828143|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129145343|NCT02082977|464828144|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129090749|NCT02294175|464622567|FG001|Overall Study|Protocol Violation|0|||
129090750|NCT02294175|464622566|FG000|Overall Study|Lost to Follow-up|0|||
129090751|NCT02294175|464622567|FG001|Overall Study|Lost to Follow-up|1|||
129090752|NCT02294175|464622566|FG000|Overall Study|wound healed|0|||
129090753|NCT02294175|464622567|FG001|Overall Study|wound healed|2|||
129090754|NCT02548351|464622568|FG000|Overall Study|Withdrawal by Subject|149|||
129090755|NCT02548351|464622569|FG001|Overall Study|Withdrawal by Subject|154|||
129090756|NCT02548351|464622570|FG002|Overall Study|Withdrawal by Subject|152|||
129090757|NCT02548351|464622568|FG000|Overall Study|Death|11|||
129090758|NCT02548351|464622569|FG001|Overall Study|Death|15|||
129090759|NCT02548351|464622570|FG002|Overall Study|Death|12|||
129145344|NCT02082977|464828145|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129090760|NCT02548351|464622568|FG000|Overall Study|Adverse Event|22|||
129090761|NCT02548351|464622569|FG001|Overall Study|Adverse Event|56|||
129090762|NCT02548351|464622570|FG002|Overall Study|Adverse Event|36|||
129090763|NCT02548351|464622568|FG000|Overall Study|Study Terminated by Sponsor|549|||
129090764|NCT02548351|464622569|FG001|Overall Study|Study Terminated by Sponsor|509|||
129090765|NCT02548351|464622570|FG002|Overall Study|Study Terminated by Sponsor|528|||
129090766|NCT02548351|464622568|FG000|Overall Study|Site Closure|14|||
129090767|NCT02548351|464622569|FG001|Overall Study|Site Closure|5|||
129090768|NCT02548351|464622570|FG002|Overall Study|Site Closure|7|||
129090769|NCT02548351|464622568|FG000|Overall Study|Non-compliance with Study Drug|4|||
129090770|NCT02548351|464622569|FG001|Overall Study|Non-compliance with Study Drug|2|||
129090771|NCT02548351|464622570|FG002|Overall Study|Non-compliance with Study Drug|0|||
129090772|NCT02548351|464622568|FG000|Overall Study|Protocol Violation|2|||
129090773|NCT02548351|464622569|FG001|Overall Study|Protocol Violation|1|||
129090774|NCT02548351|464622570|FG002|Overall Study|Protocol Violation|2|||
129090775|NCT02548351|464622568|FG000|Overall Study|Physician Decision|11|||
129090776|NCT02548351|464622569|FG001|Overall Study|Physician Decision|18|||
129090777|NCT02548351|464622570|FG002|Overall Study|Physician Decision|11|||
129090778|NCT02548351|464622568|FG000|Overall Study|Lost to Follow-up|43|||
129090779|NCT02548351|464622569|FG001|Overall Study|Lost to Follow-up|50|||
129090780|NCT02548351|464622570|FG002|Overall Study|Lost to Follow-up|57|||
129090781|NCT02548351|464622568|FG000|Overall Study|Other|19|||
129090782|NCT02548351|464622569|FG001|Overall Study|Other|16|||
129090783|NCT02548351|464622570|FG002|Overall Study|Other|20|||
129090784|NCT02548351|464622568|FG000|Overall Study|Missing|1|||
129090785|NCT02548351|464622569|FG001|Overall Study|Missing|1|||
129090786|NCT02548351|464622570|FG002|Overall Study|Missing|0|||
129090787|NCT00125242|464622571|FG000|Overall Study|did not qualify|7|||
129090788|NCT00125242|464622572|FG001|Overall Study|did not qualify|2|||
129090789|NCT01664949|464622575|FG000|Overall Study|Adverse Event|11|||
129090790|NCT01664949|464622576|FG001|Overall Study|Adverse Event|12|||
129090791|NCT01664949|464622575|FG000|Overall Study|Lack of Efficacy|1|||
129090792|NCT01664949|464622576|FG001|Overall Study|Lack of Efficacy|1|||
129090793|NCT01664949|464622575|FG000|Overall Study|Lost to Follow-up|1|||
129090794|NCT01664949|464622576|FG001|Overall Study|Lost to Follow-up|2|||
129090795|NCT01664949|464622575|FG000|Overall Study|Personal Reasons|3|||
129090796|NCT01664949|464622576|FG001|Overall Study|Personal Reasons|4|||
129090797|NCT01664949|464622575|FG000|Overall Study|Protocol Violation|5|||
129090798|NCT01664949|464622576|FG001|Overall Study|Protocol Violation|5|||
129090799|NCT01664949|464622575|FG000|Overall Study|Other Miscellaneous Reasons|3|||
129090800|NCT01664949|464622576|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129090801|NCT03003494|464622578|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
129090802|NCT05238025|464622579|FG000|Overall Study|Adverse Event|2|||
129090803|NCT05238025|464622580|FG001|Overall Study|Adverse Event|2|||
129090804|NCT05238025|464622579|FG000|Overall Study|Lost to Follow-up|334|||
129090805|NCT05238025|464622580|FG001|Overall Study|Lost to Follow-up|339|||
129090806|NCT05238025|464622579|FG000|Overall Study|Withdrawal by Subject|203|||
129090807|NCT05238025|464622580|FG001|Overall Study|Withdrawal by Subject|222|||
129090808|NCT05238025|464622579|FG000|Overall Study|Physician Decision|20|||
129090809|NCT05238025|464622580|FG001|Overall Study|Physician Decision|8|||
129090810|NCT05238025|464622579|FG000|Overall Study|Protocol Violation|6|||
129090811|NCT05238025|464622580|FG001|Overall Study|Protocol Violation|2|||
129090812|NCT05238025|464622579|FG000|Overall Study|Death|38|||
129090813|NCT05238025|464622580|FG001|Overall Study|Death|32|||
129090814|NCT05238025|464622579|FG000|Overall Study|Study terminated by Sponsor|6358|||
129090815|NCT05238025|464622580|FG001|Overall Study|Study terminated by Sponsor|6358|||
129090816|NCT05238025|464622579|FG000|Overall Study|Other Reason|669|||
129090817|NCT05238025|464622580|FG001|Overall Study|Other Reason|690|||
129090818|NCT03814720|464622582|FG000|Overall Study|Lost to Follow-up|0|||
129090819|NCT03814720|464622583|FG001|Overall Study|Lost to Follow-up|1|||
129090820|NCT03814720|464622584|FG002|Overall Study|Lost to Follow-up|0|||
129090821|NCT03814720|464622585|FG003|Overall Study|Lost to Follow-up|0|||
129090822|NCT03814720|464622586|FG004|Overall Study|Lost to Follow-up|0|||
129090823|NCT03197324|464622587|FG000|Overall Study|Adverse Event|0|||
129145345|NCT02082977|464828146|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129090824|NCT03197324|464622588|FG001|Overall Study|Adverse Event|1|||
129090825|NCT00877071|464622589|FG000|Overall Study|disease progression|2|||
129090826|NCT01984892|464622590|FG000|Overall Study|Progressive disease|7|||
129090827|NCT05723328|464622592|FG000|Overall Study|Investigator's Decision|5|||
129090828|NCT05723328|464622593|FG001|Overall Study|Investigator's Decision|2|||
129090829|NCT04166591|464624043|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129090830|NCT04166591|464624044|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129090831|NCT04166591|464624045|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129090832|NCT04166591|464624046|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129090833|NCT04166591|464624043|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129090834|NCT04166591|464624044|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129090835|NCT04166591|464624045|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129090836|NCT04166591|464624046|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129090837|NCT04186806|464624054|FG000|Period 1: 7 Days|Adverse Event|1|||
129090838|NCT04186806|464624055|FG001|Period 1: 7 Days|Adverse Event|0|||
129090839|NCT04739722|464624060|FG000|Overall Study|Lost to Follow-up|5301|||
129090840|NCT04739722|464624060|FG000|Overall Study|Withdrawal by Subject|42|||
129090841|NCT04739722|464624060|FG000|Overall Study|Non Average-risk|1157|||
129090842|NCT01185509|464624064|FG000|Overall Study|Progression/Relapse|9|||
129090843|NCT01185509|464624065|FG001|Overall Study|Progression/Relapse|15|||
129090844|NCT01185509|464624064|FG000|Overall Study|Physician Decision|2|||
129090845|NCT01185509|464624065|FG001|Overall Study|Physician Decision|2|||
129090846|NCT01185509|464624064|FG000|Overall Study|Withdrawal by Subject|0|||
129090847|NCT01185509|464624065|FG001|Overall Study|Withdrawal by Subject|1|||
129090848|NCT01185509|464624064|FG000|Overall Study|Death|0|||
129090849|NCT01185509|464624065|FG001|Overall Study|Death|1|||
129090850|NCT01185509|464624064|FG000|Overall Study|Intercurrent Illness|0|||
129090851|NCT01185509|464624065|FG001|Overall Study|Intercurrent Illness|1|||
129090852|NCT03687372|464624066|FG000|Overall Study|Lost to Follow-up|12|||
129090853|NCT03687372|464624067|FG001|Overall Study|Lost to Follow-up|21|||
129090854|NCT03687372|464624066|FG000|Overall Study|Withdrawal by Subject|4|||
129090855|NCT03687372|464624067|FG001|Overall Study|Withdrawal by Subject|17|||
129090856|NCT03687372|464624066|FG000|Overall Study|Investigator Decision|1|||
129090857|NCT03687372|464624067|FG001|Overall Study|Investigator Decision|1|||
129090858|NCT00878969|464624072|FG000|Overall Study|Physician Decision|5|||
129090859|NCT00878969|464624073|FG001|Overall Study|Physician Decision|3|||
129090860|NCT00878969|464624074|FG002|Overall Study|Physician Decision|2|||
129090861|NCT00878969|464624072|FG000|Overall Study|Withdrawal by Subject|1|||
129090862|NCT00878969|464624073|FG001|Overall Study|Withdrawal by Subject|6|||
129090863|NCT00878969|464624074|FG002|Overall Study|Withdrawal by Subject|3|||
129090864|NCT00878969|464624072|FG000|Overall Study|kidney transplant|2|||
129090865|NCT00878969|464624073|FG001|Overall Study|kidney transplant|3|||
129090866|NCT00878969|464624074|FG002|Overall Study|kidney transplant|2|||
129090867|NCT00878969|464624072|FG000|Overall Study|Adverse Event|3|||
129090868|NCT00878969|464624073|FG001|Overall Study|Adverse Event|1|||
129090869|NCT00878969|464624074|FG002|Overall Study|Adverse Event|2|||
129090870|NCT00878969|464624072|FG000|Overall Study|Lost to Follow-up|2|||
129090871|NCT00878969|464624073|FG001|Overall Study|Lost to Follow-up|1|||
129090872|NCT00878969|464624074|FG002|Overall Study|Lost to Follow-up|0|||
129090873|NCT00878969|464624072|FG000|Overall Study|Protocol Violation|2|||
129090874|NCT00878969|464624073|FG001|Overall Study|Protocol Violation|0|||
129090875|NCT00878969|464624074|FG002|Overall Study|Protocol Violation|0|||
129090876|NCT00878969|464624072|FG000|Overall Study|Death|0|||
129090877|NCT00878969|464624073|FG001|Overall Study|Death|0|||
129090878|NCT00878969|464624074|FG002|Overall Study|Death|2|||
129090879|NCT00878969|464624072|FG000|Overall Study|Pregnancy|0|||
129090880|NCT00878969|464624073|FG001|Overall Study|Pregnancy|1|||
129090881|NCT00878969|464624074|FG002|Overall Study|Pregnancy|0|||
129090882|NCT03729570|464624075|FG000|Overall Study|Lost to Follow-up|16|||
129090883|NCT03729570|464624076|FG001|Overall Study|Lost to Follow-up|20|||
129090884|NCT03729570|464624075|FG000|Overall Study|Seroconversion|5|||
129090885|NCT03729570|464624076|FG001|Overall Study|Seroconversion|0|||
129090886|NCT03729570|464624075|FG000|Overall Study|Moved out of the city|1|||
129090887|NCT03729570|464624076|FG001|Overall Study|Moved out of the city|0|||
129090888|NCT03729570|464624075|FG000|Overall Study|Time Conflict|1|||
129090889|NCT03729570|464624076|FG001|Overall Study|Time Conflict|0|||
129090890|NCT03729570|464624075|FG000|Overall Study|Time Commitment|2|||
129090891|NCT03729570|464624076|FG001|Overall Study|Time Commitment|0|||
129090892|NCT03729570|464624075|FG000|Overall Study|Bad Experience|0|||
129090893|NCT03729570|464624076|FG001|Overall Study|Bad Experience|1|||
129090894|NCT03729570|464624075|FG000|Overall Study|No reason provided|2|||
129090895|NCT03729570|464624076|FG001|Overall Study|No reason provided|1|||
129090896|NCT03729570|464624075|FG000|Overall Study|Family Conflict|0|||
129090897|NCT03729570|464624076|FG001|Overall Study|Family Conflict|1|||
129090898|NCT03729570|464624075|FG000|Overall Study|Did not want to continue taking medications|0|||
129090899|NCT03729570|464624076|FG001|Overall Study|Did not want to continue taking medications|1|||
129090900|NCT03729570|464624075|FG000|Overall Study|Found another PrEP provider|1|||
129090901|NCT03729570|464624076|FG001|Overall Study|Found another PrEP provider|0|||
129090902|NCT03729570|464624075|FG000|Overall Study|Did not enjoy being in the control group|0|||
129090903|NCT03729570|464624076|FG001|Overall Study|Did not enjoy being in the control group|1|||
129090904|NCT01701193|464624079|FG000|Overall Study|Withdrawal by Subject|2|||
129090905|NCT01701193|464624080|FG001|Overall Study|Withdrawal by Subject|2|||
129090906|NCT01701193|464624081|FG002|Overall Study|Withdrawal by Subject|1|||
129090907|NCT01701193|464624082|FG003|Overall Study|Withdrawal by Subject|2|||
129090908|NCT01701193|464624079|FG000|Overall Study|Adverse Event|1|||
129090909|NCT01701193|464624080|FG001|Overall Study|Adverse Event|0|||
129090910|NCT01701193|464624081|FG002|Overall Study|Adverse Event|0|||
129090911|NCT01701193|464624082|FG003|Overall Study|Adverse Event|0|||
129090912|NCT00278148|464624083|FG000|Phase II - Expansion Phase|Disease progression|0|||
129090913|NCT00278148|464624084|FG001|Phase II - Expansion Phase|Disease progression|0|||
129090914|NCT00278148|464624085|FG002|Phase II - Expansion Phase|Disease progression|4|||
129090915|NCT00278148|464624083|FG000|Phase II - Expansion Phase|Adverse Event|0|||
129090916|NCT00278148|464624084|FG001|Phase II - Expansion Phase|Adverse Event|0|||
129090917|NCT00278148|464624085|FG002|Phase II - Expansion Phase|Adverse Event|2|||
129090918|NCT02407457|464624086|FG000|1 Month|Death|3|||
129090919|NCT02407457|464624087|FG001|1 Month|Death|0|||
129090920|NCT02407457|464624086|FG000|1 Month|Lost to Follow-up|1|||
129090921|NCT02407457|464624087|FG001|1 Month|Lost to Follow-up|1|||
129090922|NCT02407457|464624086|FG000|1 Month|missed visit|2|||
129090923|NCT02407457|464624087|FG001|1 Month|missed visit|5|||
129090924|NCT02407457|464624086|FG000|6-Month|Death|2|||
129090925|NCT02407457|464624087|FG001|6-Month|Death|8|||
129090926|NCT02407457|464624086|FG000|6-Month|Lost to Follow-up|2|||
129090927|NCT02407457|464624087|FG001|6-Month|Lost to Follow-up|2|||
129090928|NCT02407457|464624086|FG000|6-Month|missed visit|16|||
129090929|NCT02407457|464624087|FG001|6-Month|missed visit|14|||
129090930|NCT02407457|464624086|FG000|6-Month|Open Repair|0|||
129090931|NCT02407457|464624087|FG001|6-Month|Open Repair|1|||
129090932|NCT02407457|464624086|FG000|1 Year|Death|6|||
129090933|NCT02407457|464624087|FG001|1 Year|Death|11|||
129090934|NCT02407457|464624086|FG000|1 Year|Lost to Follow-up|3|||
129090935|NCT02407457|464624087|FG001|1 Year|Lost to Follow-up|2|||
129090936|NCT02407457|464624086|FG000|1 Year|Missed Visit|24|||
129090937|NCT02407457|464624087|FG001|1 Year|Missed Visit|14|||
129090938|NCT02407457|464624086|FG000|1 Year|Open Repair|0|||
129090939|NCT02407457|464624087|FG001|1 Year|Open Repair|1|||
129090940|NCT02407457|464624086|FG000|2-year|Death|14|||
129090941|NCT02407457|464624087|FG001|2-year|Death|8|||
129090942|NCT02407457|464624086|FG000|2-year|Lost to Follow-up|7|||
129090943|NCT02407457|464624087|FG001|2-year|Lost to Follow-up|10|||
129090944|NCT02407457|464624086|FG000|2-year|Missed Visit|13|||
129090945|NCT02407457|464624087|FG001|2-year|Missed Visit|15|||
129090946|NCT02407457|464624086|FG000|2-year|Open Repair|0|||
129090947|NCT02407457|464624087|FG001|2-year|Open Repair|2|||
129090948|NCT02407457|464624086|FG000|3-year|Death|11|||
129090949|NCT02407457|464624087|FG001|3-year|Death|10|||
129090950|NCT02407457|464624086|FG000|3-year|Lost to Follow-up|9|||
129090951|NCT02407457|464624087|FG001|3-year|Lost to Follow-up|10|||
129090952|NCT02407457|464624086|FG000|3-year|Missed Visit|19|||
129090953|NCT02407457|464624087|FG001|3-year|Missed Visit|16|||
129090954|NCT02407457|464624086|FG000|4-year|Death|18|||
129090955|NCT02407457|464624087|FG001|4-year|Death|10|||
129090956|NCT02407457|464624086|FG000|4-year|Lost to Follow-up|10|||
129090957|NCT02407457|464624087|FG001|4-year|Lost to Follow-up|12|||
129090958|NCT02407457|464624086|FG000|4-year|Missed Visit|18|||
129090959|NCT02407457|464624087|FG001|4-year|Missed Visit|16|||
129090960|NCT02407457|464624086|FG000|5-year|Death|10|||
129090961|NCT02407457|464624087|FG001|5-year|Death|3|||
129090962|NCT02407457|464624086|FG000|5-year|Lost to Follow-up|22|||
129090963|NCT02407457|464624087|FG001|5-year|Lost to Follow-up|13|||
129090964|NCT02407457|464624086|FG000|5-year|Missed Visit|9|||
129090965|NCT02407457|464624087|FG001|5-year|Missed Visit|1|||
129090966|NCT02083185|464624088|FG000|Overall Study|Lost to Follow-up|0|||
129090967|NCT02083185|464624089|FG001|Overall Study|Lost to Follow-up|3|||
129090968|NCT02083185|464624090|FG002|Overall Study|Lost to Follow-up|0|||
129090969|NCT02083185|464624088|FG000|Overall Study|Withdrawal by Subject|9|||
129090970|NCT02083185|464624089|FG001|Overall Study|Withdrawal by Subject|15|||
129090971|NCT02083185|464624090|FG002|Overall Study|Withdrawal by Subject|1|||
129090972|NCT02083185|464624088|FG000|Overall Study|Death|2|||
129090973|NCT02083185|464624089|FG001|Overall Study|Death|2|||
129090974|NCT02083185|464624090|FG002|Overall Study|Death|1|||
129090975|NCT02083185|464624088|FG000|Overall Study|Reason not Specified|9|||
129090976|NCT02083185|464624089|FG001|Overall Study|Reason not Specified|6|||
129090977|NCT02083185|464624090|FG002|Overall Study|Reason not Specified|5|||
129090978|NCT02083185|464624088|FG000|Overall Study|Study Terminated by Sponsor|0|||
129090979|NCT02083185|464624089|FG001|Overall Study|Study Terminated by Sponsor|1|||
129090980|NCT02083185|464624090|FG002|Overall Study|Study Terminated by Sponsor|0|||
129090981|NCT02083185|464624088|FG000|Overall Study|Did not Receive Study Drug|0|||
129090982|NCT02083185|464624089|FG001|Overall Study|Did not Receive Study Drug|2|||
129090983|NCT02083185|464624090|FG002|Overall Study|Did not Receive Study Drug|0|||
129145346|NCT02082977|464828147|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
129145347|NCT02082977|464828148|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129090984|NCT03054064|464624091|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
129090985|NCT03054064|464624091|FG000|Overall Study|Investigator Decision|2|||
129090986|NCT03054064|464624091|FG000|Overall Study|Bladder Issue|1|||
129090987|NCT03054064|464624091|FG000|Overall Study|High Blood Pressure|1|||
129090988|NCT03054064|464624091|FG000|Overall Study|Change in Status|1|||
129090989|NCT03787303|464624092|FG000|Overall Study|Death|1|||
129090990|NCT03787303|464624092|FG000|Overall Study|Premature Termination of Study|1|||
129090991|NCT01384019|464624095|FG000|Overall Study|Withdrawal by Subject|3|||
129090992|NCT01384019|464624096|FG001|Overall Study|Withdrawal by Subject|0|||
129090993|NCT01384019|464624095|FG000|Overall Study|Death|1|||
129090994|NCT01384019|464624096|FG001|Overall Study|Death|0|||
129090995|NCT01384019|464624095|FG000|Overall Study|MRI refusal|6|||
129145348|NCT02082977|464828149|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129145349|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
129090996|NCT01384019|464624096|FG001|Overall Study|MRI refusal|6|||
129090997|NCT00767039|464624099|FG000|Overall Study|Death|5|||
129090998|NCT00767039|464624100|FG001|Overall Study|Death|2|||
129090999|NCT01826370|464624101|FG000|Overall Study|Protocol Violation|6|||
129091000|NCT01826370|464624101|FG000|Overall Study|Lost to Follow-up|12|||
129091001|NCT01826370|464624101|FG000|Overall Study|Other reason not defined above|2|||
129091002|NCT04416737|464624103|FG000|Week 1 (First Injection)|Physician Decision|0|||
129091003|NCT04416737|464624104|FG001|Week 1 (First Injection)|Physician Decision|1|||
129091004|NCT03332628|464624105|FG000|Overall Study|Physician Decision|2|||
129091005|NCT01472757|464624106|FG000|Overall Study|Withdrawal by Subject|1|||
129091006|NCT01472757|464624107|FG001|Overall Study|Withdrawal by Subject|2|||
129091007|NCT01472757|464624108|FG002|Overall Study|Withdrawal by Subject|2|||
129091008|NCT01472757|464624109|FG003|Overall Study|Withdrawal by Subject|0|||
129091009|NCT01472757|464624106|FG000|Overall Study|Asthma exacerbation|4|||
129091010|NCT01472757|464624107|FG001|Overall Study|Asthma exacerbation|1|||
129091011|NCT01472757|464624108|FG002|Overall Study|Asthma exacerbation|2|||
129091012|NCT01472757|464624109|FG003|Overall Study|Asthma exacerbation|1|||
129091013|NCT01472757|464624106|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
129091014|NCT01472757|464624107|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
129091015|NCT01472757|464624108|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
129091016|NCT01472757|464624109|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
129091017|NCT01472757|464624106|FG000|Overall Study|Protocol Violation|3|||
129091018|NCT01472757|464624107|FG001|Overall Study|Protocol Violation|2|||
129091019|NCT01472757|464624108|FG002|Overall Study|Protocol Violation|4|||
129091020|NCT01472757|464624109|FG003|Overall Study|Protocol Violation|4|||
129091021|NCT01472757|464624106|FG000|Overall Study|Other reasons|1|||
129091022|NCT01472757|464624107|FG001|Overall Study|Other reasons|0|||
129091023|NCT01472757|464624108|FG002|Overall Study|Other reasons|2|||
129091024|NCT01472757|464624109|FG003|Overall Study|Other reasons|2|||
129091025|NCT04489381|464624114|FG000|Overall Study|Lost to Follow-up|2|||
129091026|NCT04489381|464624115|FG001|Overall Study|Lost to Follow-up|3|||
128776580|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
128776581|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
128776582|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
128776583|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
128776584|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
128776585|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
128776586|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
128776587|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
128776588|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
128776589|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
128776590|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
128776591|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
128776592|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
128776593|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
128776594|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
128776595|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
129091027|NCT04489381|464624114|FG000|Overall Study|Withdrawal by Subject|1|||
129091028|NCT04489381|464624115|FG001|Overall Study|Withdrawal by Subject|0|||
129091029|NCT01259375|464624121|FG000|Overall Study|Adverse Event|1|||
129091030|NCT00478699|464624124|FG000|Overall Study|Inclusion Error|1|||
129091031|NCT00478699|464624125|FG001|Overall Study|Inclusion Error|7|||
129091032|NCT00478699|464624124|FG000|Overall Study|Not receive study treatment|6|||
129091033|NCT00478699|464624125|FG001|Overall Study|Not receive study treatment|30|||
129091034|NCT01043705|464624130|FG000|Overall Study|Death|28|||
129091035|NCT01043705|464624131|FG001|Overall Study|Death|60|||
129091036|NCT01043705|464624132|FG002|Overall Study|Death|26|||
129091037|NCT01043705|464624130|FG000|Overall Study|Lost to Follow-up|27|||
129091038|NCT01043705|464624131|FG001|Overall Study|Lost to Follow-up|12|||
129091039|NCT01043705|464624132|FG002|Overall Study|Lost to Follow-up|0|||
129091040|NCT01043705|464624130|FG000|Overall Study|Multiple Reasons|4|||
129091041|NCT01043705|464624131|FG001|Overall Study|Multiple Reasons|7|||
129091042|NCT01043705|464624132|FG002|Overall Study|Multiple Reasons|0|||
129091043|NCT01043705|464624130|FG000|Overall Study|Protocol Violation|2|||
129091044|NCT01043705|464624131|FG001|Overall Study|Protocol Violation|1|||
129091045|NCT01043705|464624132|FG002|Overall Study|Protocol Violation|0|||
129091046|NCT01043705|464624130|FG000|Overall Study|Withdrawal by Subject|8|||
129091047|NCT01043705|464624131|FG001|Overall Study|Withdrawal by Subject|6|||
129091048|NCT01043705|464624132|FG002|Overall Study|Withdrawal by Subject|0|||
129091049|NCT01043705|464624130|FG000|Overall Study|Site Closure|8|||
129091050|NCT01043705|464624131|FG001|Overall Study|Site Closure|0|||
129091051|NCT01043705|464624132|FG002|Overall Study|Site Closure|0|||
129091052|NCT01043705|464624130|FG000|Overall Study|Subsequent Procedure|9|||
129091053|NCT01043705|464624131|FG001|Overall Study|Subsequent Procedure|24|||
129091054|NCT01043705|464624132|FG002|Overall Study|Subsequent Procedure|29|||
129091055|NCT01043705|464624130|FG000|Overall Study|Adverse Event|0|||
129091056|NCT01043705|464624131|FG001|Overall Study|Adverse Event|2|||
129091057|NCT01043705|464624132|FG002|Overall Study|Adverse Event|0|||
129091058|NCT01043705|464624130|FG000|Overall Study|Screen Fail|21|||
129091059|NCT01043705|464624131|FG001|Overall Study|Screen Fail|0|||
129091060|NCT01043705|464624132|FG002|Overall Study|Screen Fail|0|||
129091061|NCT01043705|464624130|FG000|Overall Study|Other|0|||
129091062|NCT01043705|464624131|FG001|Overall Study|Other|19|||
129091063|NCT01043705|464624132|FG002|Overall Study|Other|25|||
129091064|NCT01123941|464624135|FG000|Overall Study|Lost to Follow-up|2|||
129091065|NCT01123941|464624136|FG001|Overall Study|Lost to Follow-up|1|||
129091066|NCT04601103|464624137|FG000|Overall Study|Needed crown & cleaning|0|||
129091067|NCT04601103|464624138|FG001|Overall Study|Needed crown & cleaning|0|||
129091068|NCT04601103|464624139|FG002|Overall Study|Needed crown & cleaning|1|||
129091069|NCT04601103|464624137|FG000|Overall Study|study was terminated|18|||
129091070|NCT04601103|464624138|FG001|Overall Study|study was terminated|18|||
129091071|NCT04601103|464624139|FG002|Overall Study|study was terminated|16|||
129091072|NCT06011161|464624140|FG000|Overall Study|Withdrawal by Subject|2|||
129091073|NCT06011161|464624140|FG000|Overall Study|Lost to Follow-up|5|||
129091074|NCT00381043|464624141|FG000|Overall Study|Lost to Follow-up|8|||
129091075|NCT00381043|464624142|FG001|Overall Study|Lost to Follow-up|6|||
129091076|NCT00381043|464624141|FG000|Overall Study|Withdrawal by Subject|3|||
129091077|NCT00381043|464624142|FG001|Overall Study|Withdrawal by Subject|1|||
129091078|NCT00381043|464624141|FG000|Overall Study|wanted more care|0|||
129091079|NCT00381043|464624142|FG001|Overall Study|wanted more care|1|||
129091080|NCT00381043|464624141|FG000|Overall Study|incarcerated|1|||
129091081|NCT00381043|464624142|FG001|Overall Study|incarcerated|0|||
129091082|NCT03045276|464624145|FG000|Intervention Phase|Withdrawal by Subject|7|||
129091083|NCT03045276|464624146|FG001|Intervention Phase|Withdrawal by Subject|2|||
129091084|NCT03045276|464624147|FG002|Intervention Phase|Withdrawal by Subject|3|||
129091085|NCT03045276|464624148|FG003|Intervention Phase|Withdrawal by Subject|7|||
129091086|NCT03045276|464624145|FG000|Intervention Phase|Developed exclusionary criteria|3|||
129091087|NCT03045276|464624146|FG001|Intervention Phase|Developed exclusionary criteria|3|||
129091088|NCT03045276|464624147|FG002|Intervention Phase|Developed exclusionary criteria|0|||
129091089|NCT03045276|464624148|FG003|Intervention Phase|Developed exclusionary criteria|0|||
129091090|NCT03045276|464624145|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
129091091|NCT03045276|464624146|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
129091092|NCT03045276|464624147|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
129091093|NCT03045276|464624148|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
129091094|NCT03045276|464624145|FG000|Follow-Up Phase|Lost to Follow-up|0|||
129091095|NCT03045276|464624146|FG001|Follow-Up Phase|Lost to Follow-up|1|||
129091096|NCT03045276|464624147|FG002|Follow-Up Phase|Lost to Follow-up|0|||
129091097|NCT03045276|464624148|FG003|Follow-Up Phase|Lost to Follow-up|1|||
129091098|NCT03045276|464624145|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
129091099|NCT03045276|464624146|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
129091100|NCT03045276|464624147|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
129091101|NCT03045276|464624148|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
129091102|NCT01597375|464624149|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
129091103|NCT01597375|464624150|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
129091104|NCT01597375|464624149|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
129091105|NCT01597375|464624150|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
129091106|NCT01597375|464624149|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129091107|NCT01597375|464624150|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
129091108|NCT01597375|464624149|FG000|Washout (2 Weeks)|Adverse Event|1|||
129091109|NCT01597375|464624150|FG001|Washout (2 Weeks)|Adverse Event|0|||
129091110|NCT01597375|464624149|FG000|Second Intervention|Failed to react at both Aspirin|1|||
129091111|NCT01597375|464624150|FG001|Second Intervention|Failed to react at both Aspirin|1|||
129091112|NCT00347919|464624151|FG000|Overall Study|Lost to Follow-up|11|||
129091113|NCT00347919|464624152|FG001|Overall Study|Lost to Follow-up|13|||
129091114|NCT00347919|464624153|FG002|Overall Study|Lost to Follow-up|0|||
129091115|NCT00347919|464624151|FG000|Overall Study|Withdrawal by Subject|6|||
129091116|NCT00347919|464624152|FG001|Overall Study|Withdrawal by Subject|8|||
129091117|NCT00347919|464624153|FG002|Overall Study|Withdrawal by Subject|0|||
129091118|NCT00347919|464624151|FG000|Overall Study|Physician Decision|1|||
129091119|NCT00347919|464624152|FG001|Overall Study|Physician Decision|1|||
129145350|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
129145351|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
128776596|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
129091120|NCT00347919|464624153|FG002|Overall Study|Physician Decision|0|||
129091121|NCT00347919|464624151|FG000|Overall Study|Sponsor terminated study|15|||
129091122|NCT00347919|464624152|FG001|Overall Study|Sponsor terminated study|10|||
129091123|NCT00347919|464624153|FG002|Overall Study|Sponsor terminated study|16|||
129091124|NCT00347919|464624151|FG000|Overall Study|Death|35|||
129091125|NCT00347919|464624152|FG001|Overall Study|Death|42|||
129091126|NCT00347919|464624153|FG002|Overall Study|Death|19|||
129091127|NCT00347919|464624151|FG000|Overall Study|Par. Started Other Treatment|1|||
129091128|NCT00347919|464624152|FG001|Overall Study|Par. Started Other Treatment|1|||
129091129|NCT00347919|464624153|FG002|Overall Study|Par. Started Other Treatment|1|||
129091130|NCT00347919|464624151|FG000|Overall Study|Missing|2|||
129091131|NCT00347919|464624152|FG001|Overall Study|Missing|1|||
129091132|NCT00347919|464624153|FG002|Overall Study|Missing|2|||
129091133|NCT02225366|464624160|FG000|Overall Study|Lack of Efficacy|1|||
129091134|NCT02225366|464624161|FG001|Overall Study|Lack of Efficacy|0|||
129091135|NCT04713592|464624162|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
129091136|NCT04713592|464624163|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
129091137|NCT04713592|464624164|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
129091138|NCT04713592|464624165|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
129091139|NCT04713592|464624162|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
129091140|NCT04713592|464624163|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
129091141|NCT04713592|464624164|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
129091142|NCT04713592|464624165|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
129091143|NCT04713592|464624162|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
129091144|NCT04713592|464624163|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
129091145|NCT04713592|464624164|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
129091146|NCT04713592|464624165|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
129091147|NCT04713592|464624162|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129091148|NCT04713592|464624163|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129091149|NCT04713592|464624164|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
129091150|NCT04713592|464624165|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
129091151|NCT04713592|464624162|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
129091152|NCT04713592|464624163|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
129091153|NCT04713592|464624164|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
129091154|NCT04713592|464624165|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
129091155|NCT04713592|464624162|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129091156|NCT04713592|464624163|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129091157|NCT04713592|464624164|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129091158|NCT04713592|464624165|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129091159|NCT04713592|464624162|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
129091160|NCT04713592|464624163|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
129091161|NCT04713592|464624164|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
129091162|NCT04713592|464624165|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
129091163|NCT03782298|464624166|FG000|Overall Study|Protocol Deviation|4|||
129091164|NCT01382225|464624176|FG000|Overall Study|Adverse Event|3|||
129091165|NCT01382225|464624177|FG001|Overall Study|Adverse Event|2|||
129091166|NCT01382225|464624176|FG000|Overall Study|Protocol Violation|2|||
129091167|NCT01382225|464624177|FG001|Overall Study|Protocol Violation|1|||
129091168|NCT01382225|464624176|FG000|Overall Study|Subject Withdrew Consent|5|||
129091169|NCT01382225|464624177|FG001|Overall Study|Subject Withdrew Consent|2|||
129091170|NCT01382225|464624176|FG000|Overall Study|Other|4|||
129091171|NCT01382225|464624177|FG001|Overall Study|Other|2|||
129091172|NCT01797081|464624180|FG000|Overall Study|Adverse Event|1|||
129091173|NCT01797081|464624181|FG001|Overall Study|Adverse Event|0|||
129091174|NCT01797081|464624182|FG002|Overall Study|Adverse Event|1|||
129091175|NCT01797081|464624183|FG003|Overall Study|Adverse Event|0|||
129091176|NCT01797081|464624180|FG000|Overall Study|Pregnancy|1|||
129091177|NCT01797081|464624181|FG001|Overall Study|Pregnancy|0|||
129091178|NCT01797081|464624182|FG002|Overall Study|Pregnancy|0|||
129091179|NCT01797081|464624183|FG003|Overall Study|Pregnancy|0|||
129091180|NCT01797081|464624180|FG000|Overall Study|Personal Reasons|12|||
129091181|NCT01797081|464624181|FG001|Overall Study|Personal Reasons|4|||
129091182|NCT01797081|464624182|FG002|Overall Study|Personal Reasons|4|||
129091183|NCT01797081|464624183|FG003|Overall Study|Personal Reasons|8|||
129091184|NCT01797081|464624180|FG000|Overall Study|Protocol Violation|0|||
129091185|NCT01797081|464624181|FG001|Overall Study|Protocol Violation|0|||
129091186|NCT01797081|464624182|FG002|Overall Study|Protocol Violation|0|||
129091187|NCT01797081|464624183|FG003|Overall Study|Protocol Violation|1|||
129091188|NCT02484651|464624190|FG000|Overall Study|Patients' data files were corrupted.|1|||
129091189|NCT02484651|464624191|FG001|Overall Study|Patients' data files were corrupted.|1|||
129091190|NCT02484651|464624190|FG000|Overall Study|BIS monitoring failed.|1|||
129091191|NCT02484651|464624191|FG001|Overall Study|BIS monitoring failed.|1|||
129091192|NCT02484651|464624190|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
129091193|NCT02484651|464624191|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
129091194|NCT02375555|464624199|FG000|Induction Period|Adverse Event|7|||
129091195|NCT02375555|464624199|FG000|Induction Period|Withdrawal by Subject|2|||
129091196|NCT02375555|464624199|FG000|Induction Period|Other|1|||
129091197|NCT02375555|464624199|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
129091198|NCT02375555|464624199|FG000|Maintenance Period|Adverse Event|2|||
129145352|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
129145353|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
129091199|NCT02375555|464624199|FG000|Maintenance Period|Withdrawal by Subject|4|||
129091200|NCT02375555|464624199|FG000|Maintenance Period|Death|1|||
129091201|NCT02375555|464624199|FG000|Maintenance Period|Disease Progression|5|||
129091202|NCT02375555|464624199|FG000|Maintenance Period|Patient Non-compliance|1|||
129091203|NCT02375555|464624199|FG000|Maintenance Period|Still on maintenance|16|||
129091204|NCT01744184|464624211|FG000|Overall Study|Adverse Event|1|||
129091205|NCT01744184|464624212|FG001|Overall Study|Adverse Event|0|||
129091206|NCT01744184|464624211|FG000|Overall Study|Withdrawal by Subject|0|||
129145354|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
129145355|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
129145356|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
129145357|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
129145358|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
129145359|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
129145360|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
129145361|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
129145362|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
129145363|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
129145364|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
129091207|NCT01744184|464624212|FG001|Overall Study|Withdrawal by Subject|1|||
129091208|NCT01263782|464624217|FG000|Overall Study|Death|0|||
129091209|NCT01263782|464624218|FG001|Overall Study|Death|0|||
129091210|NCT01263782|464624219|FG002|Overall Study|Death|1|||
129091211|NCT01263782|464624220|FG003|Overall Study|Death|0|||
129091212|NCT01263782|464624217|FG000|Overall Study|Progressive disease|0|||
129091213|NCT01263782|464624218|FG001|Overall Study|Progressive disease|0|||
129091214|NCT01263782|464624219|FG002|Overall Study|Progressive disease|0|||
129091215|NCT01263782|464624220|FG003|Overall Study|Progressive disease|1|||
129091216|NCT01263782|464624217|FG000|Overall Study|Too early|0|||
129091217|NCT01263782|464624218|FG001|Overall Study|Too early|0|||
129091218|NCT01263782|464624219|FG002|Overall Study|Too early|1|||
129091219|NCT01263782|464624220|FG003|Overall Study|Too early|0|||
129091220|NCT01263782|464624217|FG000|Overall Study|Inevaluable|0|||
129091221|NCT01263782|464624218|FG001|Overall Study|Inevaluable|0|||
129091222|NCT01263782|464624219|FG002|Overall Study|Inevaluable|1|||
129091223|NCT01263782|464624220|FG003|Overall Study|Inevaluable|0|||
129091224|NCT04545567|464624222|FG000|Overall Study|tested positive for SARS-co-V2|1|||
129091225|NCT04545567|464624223|FG001|Overall Study|tested positive for SARS-co-V2|1|||
129091226|NCT04545567|464624222|FG000|Overall Study|Withdrawal by Subject|0|||
129091227|NCT04545567|464624223|FG001|Overall Study|Withdrawal by Subject|1|||
129091228|NCT01095978|464624226|FG000|Overall Study|Did not take Klacid SR|2|||
129091229|NCT01095978|464624226|FG000|Overall Study|Adverse Event|1|||
129091230|NCT02135107|464624227|FG000|Treatment Period|Withdrawal by Subject|11|||
129091231|NCT02135107|464624228|FG001|Treatment Period|Withdrawal by Subject|0|||
129091232|NCT02135107|464624229|FG002|Treatment Period|Withdrawal by Subject|0|||
129091233|NCT02135107|464624230|FG003|Treatment Period|Withdrawal by Subject|0|||
129091234|NCT02135107|464624227|FG000|Treatment Period|Adverse Event|5|||
129091235|NCT02135107|464624228|FG001|Treatment Period|Adverse Event|2|||
129091236|NCT02135107|464624229|FG002|Treatment Period|Adverse Event|0|||
129091237|NCT02135107|464624230|FG003|Treatment Period|Adverse Event|0|||
129091238|NCT02135107|464624227|FG000|Treatment Period|Pregnancy|1|||
129091239|NCT02135107|464624228|FG001|Treatment Period|Pregnancy|0|||
129091240|NCT02135107|464624229|FG002|Treatment Period|Pregnancy|0|||
129091241|NCT02135107|464624230|FG003|Treatment Period|Pregnancy|0|||
129091242|NCT02135107|464624227|FG000|Treatment Period|Other|115|||
129091243|NCT02135107|464624228|FG001|Treatment Period|Other|24|||
129091244|NCT02135107|464624229|FG002|Treatment Period|Other|0|||
129091245|NCT02135107|464624230|FG003|Treatment Period|Other|0|||
129091246|NCT02135107|464624227|FG000|Maintenance Therapy Period|Adverse Event|0|||
129091247|NCT02135107|464624228|FG001|Maintenance Therapy Period|Adverse Event|0|||
129091248|NCT02135107|464624229|FG002|Maintenance Therapy Period|Adverse Event|3|||
129091249|NCT02135107|464624230|FG003|Maintenance Therapy Period|Adverse Event|7|||
129091250|NCT02135107|464624227|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
129145365|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
129091251|NCT02135107|464624228|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
129091252|NCT02135107|464624229|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
129091253|NCT02135107|464624230|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
129091254|NCT02135107|464624227|FG000|Maintenance Therapy Period|Pregnancy|0|||
129091255|NCT02135107|464624228|FG001|Maintenance Therapy Period|Pregnancy|0|||
129091256|NCT02135107|464624229|FG002|Maintenance Therapy Period|Pregnancy|0|||
129091257|NCT02135107|464624230|FG003|Maintenance Therapy Period|Pregnancy|1|||
129091258|NCT02135107|464624227|FG000|Maintenance Therapy Period|Other|0|||
129091259|NCT02135107|464624228|FG001|Maintenance Therapy Period|Other|0|||
129091260|NCT02135107|464624229|FG002|Maintenance Therapy Period|Other|7|||
129091261|NCT02135107|464624230|FG003|Maintenance Therapy Period|Other|8|||
129091262|NCT00808639|464624234|FG000|Overall Study|Disease progression before surgery.|1|||
129091263|NCT03055494|464625881|FG000|Overall Study|Lost to Follow-up|6|||
129091264|NCT03055494|464625882|FG001|Overall Study|Lost to Follow-up|0|||
129091265|NCT03055494|464625881|FG000|Overall Study|Physician Decision|2|||
129091266|NCT03055494|464625882|FG001|Overall Study|Physician Decision|0|||
129091267|NCT03055494|464625881|FG000|Overall Study|Withdrawal by Subject|1|||
129091268|NCT03055494|464625882|FG001|Overall Study|Withdrawal by Subject|0|||
129091269|NCT03055494|464625881|FG000|Overall Study|Adverse Event|0|||
129091270|NCT03055494|464625882|FG001|Overall Study|Adverse Event|1|||
129091271|NCT03055494|464625881|FG000|Overall Study|Non-compliance with study treatment|1|||
129091272|NCT03055494|464625882|FG001|Overall Study|Non-compliance with study treatment|0|||
129091273|NCT00197002|464625883|FG000|Overall Study|Adverse Event|0|||
129091274|NCT00197002|464625884|FG001|Overall Study|Adverse Event|1|||
129091275|NCT00197002|464625885|FG002|Overall Study|Adverse Event|0|||
129091276|NCT00197002|464625883|FG000|Overall Study|Protocol Violation|1|||
129091277|NCT00197002|464625884|FG001|Overall Study|Protocol Violation|0|||
129091278|NCT00197002|464625885|FG002|Overall Study|Protocol Violation|2|||
129091279|NCT00197002|464625883|FG000|Overall Study|Withdrawal by Subject|9|||
129091280|NCT00197002|464625884|FG001|Overall Study|Withdrawal by Subject|5|||
129091281|NCT00197002|464625885|FG002|Overall Study|Withdrawal by Subject|7|||
129091282|NCT00197002|464625883|FG000|Overall Study|Migrated/moved from study area|3|||
129091283|NCT00197002|464625884|FG001|Overall Study|Migrated/moved from study area|5|||
129091284|NCT00197002|464625885|FG002|Overall Study|Migrated/moved from study area|1|||
129091285|NCT00197002|464625883|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
129091286|NCT00197002|464625884|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
129091287|NCT00197002|464625885|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
129091288|NCT00197002|464625883|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
129091289|NCT00197002|464625884|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
129091290|NCT00197002|464625885|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
129091291|NCT00197002|464625883|FG000|Overall Study|Others|3|||
129091292|NCT00197002|464625884|FG001|Overall Study|Others|1|||
129091293|NCT00197002|464625885|FG002|Overall Study|Others|1|||
129091294|NCT02017717|464625886|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129091295|NCT02017717|464625887|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129145366|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
129145367|NCT00086515|464828150|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
129145368|NCT00086515|464828151|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
129145369|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
129145370|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
129145371|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
129145372|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
129145373|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
129145374|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
129145375|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
129145376|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
129145377|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
129145378|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
129145379|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
129145380|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
129145381|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
129145382|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
129145383|NCT00086515|464828150|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
129145384|NCT00086515|464828151|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
129145385|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
129145386|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
129145387|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
129091296|NCT02017717|464625888|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129091297|NCT02017717|464625889|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129091298|NCT02017717|464625890|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129091299|NCT02017717|464625891|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129091300|NCT02017717|464625892|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129091301|NCT02017717|464625893|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
129091302|NCT02017717|464625894|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129091303|NCT02017717|464625886|FG000|Before Treatment Period|Participant request to stop therapy|0|||
129091304|NCT02017717|464625887|FG001|Before Treatment Period|Participant request to stop therapy|0|||
129091305|NCT02017717|464625888|FG002|Before Treatment Period|Participant request to stop therapy|0|||
129091306|NCT02017717|464625889|FG003|Before Treatment Period|Participant request to stop therapy|0|||
129091307|NCT02017717|464625890|FG004|Before Treatment Period|Participant request to stop therapy|0|||
129091308|NCT02017717|464625891|FG005|Before Treatment Period|Participant request to stop therapy|0|||
129091309|NCT02017717|464625892|FG006|Before Treatment Period|Participant request to stop therapy|0|||
129091310|NCT02017717|464625893|FG007|Before Treatment Period|Participant request to stop therapy|0|||
129091311|NCT02017717|464625894|FG008|Before Treatment Period|Participant request to stop therapy|5|||
129091312|NCT02017717|464625886|FG000|Before Treatment Period|Participant withdrew consent|0|||
129091313|NCT02017717|464625887|FG001|Before Treatment Period|Participant withdrew consent|0|||
129091314|NCT02017717|464625888|FG002|Before Treatment Period|Participant withdrew consent|0|||
129091315|NCT02017717|464625889|FG003|Before Treatment Period|Participant withdrew consent|0|||
129091316|NCT02017717|464625890|FG004|Before Treatment Period|Participant withdrew consent|0|||
129091317|NCT02017717|464625891|FG005|Before Treatment Period|Participant withdrew consent|0|||
129091318|NCT02017717|464625892|FG006|Before Treatment Period|Participant withdrew consent|2|||
129091319|NCT02017717|464625893|FG007|Before Treatment Period|Participant withdrew consent|0|||
129091320|NCT02017717|464625894|FG008|Before Treatment Period|Participant withdrew consent|11|||
129091321|NCT02017717|464625886|FG000|Before Treatment Period|Lost to Follow-up|0|||
129091322|NCT02017717|464625887|FG001|Before Treatment Period|Lost to Follow-up|0|||
129091323|NCT02017717|464625888|FG002|Before Treatment Period|Lost to Follow-up|0|||
129091324|NCT02017717|464625889|FG003|Before Treatment Period|Lost to Follow-up|0|||
129091325|NCT02017717|464625890|FG004|Before Treatment Period|Lost to Follow-up|0|||
129091326|NCT02017717|464625891|FG005|Before Treatment Period|Lost to Follow-up|0|||
129091327|NCT02017717|464625892|FG006|Before Treatment Period|Lost to Follow-up|0|||
129091328|NCT02017717|464625893|FG007|Before Treatment Period|Lost to Follow-up|0|||
129091329|NCT02017717|464625894|FG008|Before Treatment Period|Lost to Follow-up|1|||
129091330|NCT02017717|464625886|FG000|Before Treatment Period|Participant no longer met criteria|0|||
129091331|NCT02017717|464625887|FG001|Before Treatment Period|Participant no longer met criteria|0|||
129091332|NCT02017717|464625888|FG002|Before Treatment Period|Participant no longer met criteria|0|||
129091333|NCT02017717|464625889|FG003|Before Treatment Period|Participant no longer met criteria|0|||
129091334|NCT02017717|464625890|FG004|Before Treatment Period|Participant no longer met criteria|0|||
129091335|NCT02017717|464625891|FG005|Before Treatment Period|Participant no longer met criteria|1|||
129091336|NCT02017717|464625892|FG006|Before Treatment Period|Participant no longer met criteria|0|||
129091337|NCT02017717|464625893|FG007|Before Treatment Period|Participant no longer met criteria|1|||
129091338|NCT02017717|464625894|FG008|Before Treatment Period|Participant no longer met criteria|2|||
129091339|NCT02017717|464625886|FG000|Before Treatment Period|other reason|0|||
129091340|NCT02017717|464625887|FG001|Before Treatment Period|other reason|0|||
129091341|NCT02017717|464625888|FG002|Before Treatment Period|other reason|0|||
129091342|NCT02017717|464625889|FG003|Before Treatment Period|other reason|0|||
129091343|NCT02017717|464625890|FG004|Before Treatment Period|other reason|0|||
129091344|NCT02017717|464625891|FG005|Before Treatment Period|other reason|0|||
129091345|NCT02017717|464625892|FG006|Before Treatment Period|other reason|0|||
129091346|NCT02017717|464625893|FG007|Before Treatment Period|other reason|0|||
129091347|NCT02017717|464625894|FG008|Before Treatment Period|other reason|1|||
129091348|NCT02017717|464625886|FG000|Treatment Period|Disease progression|7|||
129091349|NCT02017717|464625887|FG001|Treatment Period|Disease progression|9|||
129091350|NCT02017717|464625888|FG002|Treatment Period|Disease progression|12|||
129091351|NCT02017717|464625889|FG003|Treatment Period|Disease progression|20|||
129091352|NCT02017717|464625890|FG004|Treatment Period|Disease progression|26|||
129091353|NCT02017717|464625891|FG005|Treatment Period|Disease progression|16|||
129091354|NCT02017717|464625892|FG006|Treatment Period|Disease progression|22|||
129091355|NCT02017717|464625893|FG007|Treatment Period|Disease progression|165|||
129091356|NCT02017717|464625894|FG008|Treatment Period|Disease progression|135|||
129091357|NCT02017717|464625886|FG000|Treatment Period|Study drug toxicity|3|||
129091358|NCT02017717|464625887|FG001|Treatment Period|Study drug toxicity|0|||
129091359|NCT02017717|464625888|FG002|Treatment Period|Study drug toxicity|1|||
129091360|NCT02017717|464625889|FG003|Treatment Period|Study drug toxicity|4|||
129091361|NCT02017717|464625890|FG004|Treatment Period|Study drug toxicity|4|||
129091362|NCT02017717|464625891|FG005|Treatment Period|Study drug toxicity|5|||
129091363|NCT02017717|464625892|FG006|Treatment Period|Study drug toxicity|3|||
129091364|NCT02017717|464625893|FG007|Treatment Period|Study drug toxicity|7|||
129091365|NCT02017717|464625894|FG008|Treatment Period|Study drug toxicity|11|||
129091366|NCT02017717|464625886|FG000|Treatment Period|Death|0|||
129091367|NCT02017717|464625887|FG001|Treatment Period|Death|0|||
129091368|NCT02017717|464625888|FG002|Treatment Period|Death|1|||
129091369|NCT02017717|464625889|FG003|Treatment Period|Death|0|||
129091370|NCT02017717|464625890|FG004|Treatment Period|Death|0|||
129091371|NCT02017717|464625891|FG005|Treatment Period|Death|2|||
129091372|NCT02017717|464625892|FG006|Treatment Period|Death|0|||
129091373|NCT02017717|464625893|FG007|Treatment Period|Death|0|||
129091374|NCT02017717|464625894|FG008|Treatment Period|Death|0|||
129091375|NCT02017717|464625886|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
129091376|NCT02017717|464625887|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
129091377|NCT02017717|464625888|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
129091378|NCT02017717|464625889|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
129091379|NCT02017717|464625890|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
129091380|NCT02017717|464625891|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
129091381|NCT02017717|464625892|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
129091382|NCT02017717|464625893|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
129091383|NCT02017717|464625894|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
129091384|NCT02017717|464625886|FG000|Treatment Period|Participant request to stop therapy|0|||
129091385|NCT02017717|464625887|FG001|Treatment Period|Participant request to stop therapy|0|||
129091386|NCT02017717|464625888|FG002|Treatment Period|Participant request to stop therapy|3|||
129091387|NCT02017717|464625889|FG003|Treatment Period|Participant request to stop therapy|6|||
129091388|NCT02017717|464625890|FG004|Treatment Period|Participant request to stop therapy|0|||
129091389|NCT02017717|464625891|FG005|Treatment Period|Participant request to stop therapy|2|||
129091390|NCT02017717|464625892|FG006|Treatment Period|Participant request to stop therapy|1|||
129091391|NCT02017717|464625893|FG007|Treatment Period|Participant request to stop therapy|4|||
129091392|NCT02017717|464625894|FG008|Treatment Period|Participant request to stop therapy|7|||
129091393|NCT02017717|464625886|FG000|Treatment Period|Participant withdrew consent|0|||
129091394|NCT02017717|464625887|FG001|Treatment Period|Participant withdrew consent|0|||
129091395|NCT02017717|464625888|FG002|Treatment Period|Participant withdrew consent|1|||
129091396|NCT02017717|464625889|FG003|Treatment Period|Participant withdrew consent|0|||
129091397|NCT02017717|464625890|FG004|Treatment Period|Participant withdrew consent|0|||
129091398|NCT02017717|464625891|FG005|Treatment Period|Participant withdrew consent|2|||
129091399|NCT02017717|464625892|FG006|Treatment Period|Participant withdrew consent|0|||
129091400|NCT02017717|464625893|FG007|Treatment Period|Participant withdrew consent|1|||
129091401|NCT02017717|464625894|FG008|Treatment Period|Participant withdrew consent|4|||
129091402|NCT02017717|464625886|FG000|Treatment Period|Participant no longer met criteria|0|||
129091403|NCT02017717|464625887|FG001|Treatment Period|Participant no longer met criteria|0|||
129091404|NCT02017717|464625888|FG002|Treatment Period|Participant no longer met criteria|0|||
129091405|NCT02017717|464625889|FG003|Treatment Period|Participant no longer met criteria|0|||
129091406|NCT02017717|464625890|FG004|Treatment Period|Participant no longer met criteria|0|||
129091407|NCT02017717|464625891|FG005|Treatment Period|Participant no longer met criteria|0|||
129091408|NCT02017717|464625892|FG006|Treatment Period|Participant no longer met criteria|0|||
129091409|NCT02017717|464625893|FG007|Treatment Period|Participant no longer met criteria|0|||
129091410|NCT02017717|464625894|FG008|Treatment Period|Participant no longer met criteria|1|||
129091411|NCT02017717|464625886|FG000|Treatment Period|Other reasons|0|||
129091412|NCT02017717|464625887|FG001|Treatment Period|Other reasons|0|||
129091413|NCT02017717|464625888|FG002|Treatment Period|Other reasons|0|||
129091414|NCT02017717|464625889|FG003|Treatment Period|Other reasons|1|||
129091415|NCT02017717|464625890|FG004|Treatment Period|Other reasons|0|||
129091416|NCT02017717|464625891|FG005|Treatment Period|Other reasons|1|||
129091417|NCT02017717|464625892|FG006|Treatment Period|Other reasons|1|||
129091418|NCT02017717|464625893|FG007|Treatment Period|Other reasons|1|||
129091419|NCT02017717|464625894|FG008|Treatment Period|Other reasons|1|||
129091420|NCT02017717|464625886|FG000|Treatment Period|Maximum clinical benefit|0|||
129091421|NCT02017717|464625887|FG001|Treatment Period|Maximum clinical benefit|0|||
129091422|NCT02017717|464625888|FG002|Treatment Period|Maximum clinical benefit|0|||
129091423|NCT02017717|464625889|FG003|Treatment Period|Maximum clinical benefit|0|||
129091424|NCT02017717|464625890|FG004|Treatment Period|Maximum clinical benefit|0|||
129091425|NCT02017717|464625891|FG005|Treatment Period|Maximum clinical benefit|0|||
129091426|NCT02017717|464625892|FG006|Treatment Period|Maximum clinical benefit|0|||
129091427|NCT02017717|464625893|FG007|Treatment Period|Maximum clinical benefit|0|||
129091428|NCT02017717|464625894|FG008|Treatment Period|Maximum clinical benefit|1|||
129091429|NCT02017717|464625886|FG000|Treatment Period|Not reported|0|||
129091430|NCT02017717|464625887|FG001|Treatment Period|Not reported|1|||
129091431|NCT02017717|464625888|FG002|Treatment Period|Not reported|0|||
129091432|NCT02017717|464625889|FG003|Treatment Period|Not reported|0|||
129091433|NCT02017717|464625890|FG004|Treatment Period|Not reported|0|||
129091434|NCT02017717|464625891|FG005|Treatment Period|Not reported|0|||
129091435|NCT02017717|464625892|FG006|Treatment Period|Not reported|0|||
129091436|NCT02017717|464625893|FG007|Treatment Period|Not reported|0|||
129145388|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
129145389|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
129145390|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
128724604|NCT04200248|463290867|FG002|Overall Study|Personal reasons|1|||
129091437|NCT02017717|464625894|FG008|Treatment Period|Not reported|0|||
129091438|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
129091439|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
129091440|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
129091441|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
129091442|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
129091443|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
129091444|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
129091445|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
129091446|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
129091447|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
129091448|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
129091449|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
129091450|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
129091451|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
129091452|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
129091453|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
129091454|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
129091455|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
129091456|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
129091457|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
129091458|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
129091459|NCT04488419|464625899|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
129145391|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
129145392|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
129145393|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
128724605|NCT04200248|463290865|FG000|Overall Study|Discontinued prior to treatment|3|||
128724606|NCT04200248|463290866|FG001|Overall Study|Discontinued prior to treatment|3|||
128724607|NCT04200248|463290867|FG002|Overall Study|Discontinued prior to treatment|2|||
128724608|NCT01828034|463290870|FG000|Overall Study|Withdrawal by Subject|0|||
128724609|NCT01828034|463290871|FG001|Overall Study|Withdrawal by Subject|0|||
128724610|NCT01828034|463290872|FG002|Overall Study|Withdrawal by Subject|0|||
128724611|NCT01828034|463290873|FG003|Overall Study|Withdrawal by Subject|1|||
128724612|NCT00453999|463290875|FG000|Overall Study|Adverse Event|1|||
128724613|NCT00453999|463290876|FG001|Overall Study|Adverse Event|2|||
129145394|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
129145395|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
129145396|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
129145397|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
128724614|NCT00453999|463290877|FG002|Overall Study|Adverse Event|1|||
128724615|NCT00453999|463290875|FG000|Overall Study|Lost to Follow-up|0|||
128724616|NCT00453999|463290876|FG001|Overall Study|Lost to Follow-up|1|||
128724617|NCT00453999|463290877|FG002|Overall Study|Lost to Follow-up|1|||
128724618|NCT00453999|463290875|FG000|Overall Study|Withdrawal by Subject|2|||
128724619|NCT00453999|463290876|FG001|Overall Study|Withdrawal by Subject|1|||
128724620|NCT00453999|463290877|FG002|Overall Study|Withdrawal by Subject|1|||
129145398|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
129145399|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
129145400|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
129145401|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
129145402|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
129145403|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
129145404|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
129145405|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
129145406|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
129145407|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
129145408|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
129145409|NCT00086515|464828150|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
129145410|NCT00086515|464828151|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
129145411|NCT02106832|464828152|FG000|Overall Study|Adverse Event|1|||
129145412|NCT02106832|464828153|FG001|Overall Study|Adverse Event|2|||
129145413|NCT02106832|464828154|FG002|Overall Study|Adverse Event|3|||
128724621|NCT00453999|463290875|FG000|Overall Study|Subject Request|2|||
128724622|NCT00453999|463290876|FG001|Overall Study|Subject Request|1|||
129145414|NCT02106832|464828155|FG003|Overall Study|Adverse Event|0|||
129145415|NCT02106832|464828152|FG000|Overall Study|Death|4|||
128724623|NCT00453999|463290877|FG002|Overall Study|Subject Request|0|||
128724624|NCT00743652|463290884|FG000|Overall Study|Parent/Legal Guardian Request|3|||
128724625|NCT00743652|463290885|FG001|Overall Study|Parent/Legal Guardian Request|2|||
128724626|NCT00743652|463290886|FG002|Overall Study|Parent/Legal Guardian Request|2|||
128724627|NCT00743652|463290887|FG003|Overall Study|Parent/Legal Guardian Request|2|||
128724628|NCT00743652|463290888|FG004|Overall Study|Parent/Legal Guardian Request|0|||
128724629|NCT00743652|463290884|FG000|Overall Study|Adverse Event|3|||
128724630|NCT00743652|463290885|FG001|Overall Study|Adverse Event|0|||
128724631|NCT00743652|463290886|FG002|Overall Study|Adverse Event|0|||
128724632|NCT00743652|463290887|FG003|Overall Study|Adverse Event|0|||
128724633|NCT00743652|463290888|FG004|Overall Study|Adverse Event|0|||
128724634|NCT00743652|463290884|FG000|Overall Study|Death|2|||
128724635|NCT00743652|463290885|FG001|Overall Study|Death|0|||
128724636|NCT00743652|463290886|FG002|Overall Study|Death|0|||
128724637|NCT00743652|463290887|FG003|Overall Study|Death|0|||
128724638|NCT00743652|463290888|FG004|Overall Study|Death|0|||
128724639|NCT00743652|463290884|FG000|Overall Study|Investigator Request|0|||
128724640|NCT00743652|463290885|FG001|Overall Study|Investigator Request|0|||
128724641|NCT00743652|463290886|FG002|Overall Study|Investigator Request|0|||
128724642|NCT00743652|463290887|FG003|Overall Study|Investigator Request|2|||
128724643|NCT00743652|463290888|FG004|Overall Study|Investigator Request|0|||
128724644|NCT00743652|463290884|FG000|Overall Study|Other|1|||
128724645|NCT00743652|463290885|FG001|Overall Study|Other|1|||
128724646|NCT00743652|463290886|FG002|Overall Study|Other|0|||
128724647|NCT00743652|463290887|FG003|Overall Study|Other|0|||
128724648|NCT00743652|463290888|FG004|Overall Study|Other|0|||
128724649|NCT00743652|463290884|FG000|Overall Study|Lost to Follow-up|1|||
128724650|NCT00743652|463290885|FG001|Overall Study|Lost to Follow-up|0|||
128724651|NCT00743652|463290886|FG002|Overall Study|Lost to Follow-up|0|||
128724652|NCT00743652|463290887|FG003|Overall Study|Lost to Follow-up|0|||
128724653|NCT00743652|463290888|FG004|Overall Study|Lost to Follow-up|0|||
128724654|NCT00149747|463290889|FG000|Overall Study|Death|1|||
128724655|NCT00149747|463290890|FG001|Overall Study|Death|0|||
128724656|NCT00149747|463290889|FG000|Overall Study|Withdrawal by Subject|3|||
128724657|NCT00149747|463290890|FG001|Overall Study|Withdrawal by Subject|3|||
128724658|NCT04753164|463290891|FG000|Overall Study|Adverse Event|0|||
128724659|NCT04753164|463290892|FG001|Overall Study|Adverse Event|2|||
128724660|NCT04753164|463290891|FG000|Overall Study|Withdrawal by Subject|9|||
128724661|NCT04753164|463290892|FG001|Overall Study|Withdrawal by Subject|7|||
128724662|NCT04753164|463290891|FG000|Overall Study|Lost to Follow-up|6|||
128724663|NCT04753164|463290892|FG001|Overall Study|Lost to Follow-up|6|||
128724664|NCT04753164|463290891|FG000|Overall Study|Other|12|||
128724665|NCT04753164|463290892|FG001|Overall Study|Other|5|||
128724666|NCT01183975|463290895|FG000|Overall Study|Lost to Follow-up|73|||
128724667|NCT06049043|463290897|FG000|Overall Study|Lost to Follow-up|11|||
128724668|NCT06049043|463290898|FG001|Overall Study|Lost to Follow-up|9|||
128724669|NCT01354496|463290900|FG000|Period 1|Adverse Event|0|||
128724670|NCT01354496|463290901|FG001|Period 1|Adverse Event|0|||
128724671|NCT01354496|463290902|FG002|Period 1|Adverse Event|1|||
128724672|NCT01354496|463290903|FG003|Period 1|Adverse Event|0|||
128724673|NCT01354496|463290904|FG004|Period 1|Adverse Event|0|||
128724674|NCT01354496|463290905|FG005|Period 1|Adverse Event|0|||
128724675|NCT01354496|463290900|FG000|Period 1|Physician Decision|0|||
128724676|NCT01354496|463290901|FG001|Period 1|Physician Decision|0|||
128724677|NCT01354496|463290902|FG002|Period 1|Physician Decision|1|||
128724678|NCT01354496|463290903|FG003|Period 1|Physician Decision|0|||
128724679|NCT01354496|463290904|FG004|Period 1|Physician Decision|0|||
128724680|NCT01354496|463290905|FG005|Period 1|Physician Decision|0|||
128724681|NCT01354496|463290900|FG000|Period 2|Adverse Event|0|||
128724682|NCT01354496|463290901|FG001|Period 2|Adverse Event|0|||
128724683|NCT01354496|463290902|FG002|Period 2|Adverse Event|0|||
128724684|NCT01354496|463290903|FG003|Period 2|Adverse Event|1|||
128724685|NCT01354496|463290904|FG004|Period 2|Adverse Event|0|||
128724686|NCT01354496|463290905|FG005|Period 2|Adverse Event|0|||
128724687|NCT01354496|463290900|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
128724688|NCT01354496|463290901|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
128724689|NCT01354496|463290902|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
128724690|NCT01354496|463290903|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
128724691|NCT01354496|463290904|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
128724692|NCT01354496|463290905|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
128724693|NCT03216850|463290906|FG000|Overall Study|Pre-analytical error|6|||
128724694|NCT00405548|463290907|FG000|Overall Study|Cognitive Memory problems on study day|1|||
128724695|NCT00405548|463290908|FG001|Overall Study|Cognitive Memory problems on study day|0|||
128724696|NCT00405548|463290907|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
128724697|NCT00405548|463290908|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
128724698|NCT00405548|463290907|FG000|Overall Study|Unable to self-administer shots|1|||
128724699|NCT00405548|463290908|FG001|Overall Study|Unable to self-administer shots|0|||
128724700|NCT00405548|463290907|FG000|Overall Study|Venous access failed during study day|1|||
128724701|NCT00405548|463290908|FG001|Overall Study|Venous access failed during study day|0|||
128724702|NCT00405548|463290907|FG000|Overall Study|Withdrawal by Subject|1|||
128724703|NCT00405548|463290908|FG001|Overall Study|Withdrawal by Subject|0|||
128724704|NCT03554291|463290909|FG000|Overall Study|Death|2|||
129145416|NCT02106832|464828153|FG001|Overall Study|Death|4|||
129145417|NCT02106832|464828154|FG002|Overall Study|Death|1|||
129145418|NCT02106832|464828155|FG003|Overall Study|Death|4|||
129145419|NCT02106832|464828152|FG000|Overall Study|Deterioration of general conditions|0|||
129145420|NCT02106832|464828153|FG001|Overall Study|Deterioration of general conditions|0|||
129145421|NCT02106832|464828154|FG002|Overall Study|Deterioration of general conditions|1|||
129145422|NCT02106832|464828155|FG003|Overall Study|Deterioration of general conditions|0|||
129145423|NCT02106832|464828152|FG000|Overall Study|Lost to Follow-up|0|||
129145424|NCT02106832|464828153|FG001|Overall Study|Lost to Follow-up|1|||
129145425|NCT02106832|464828154|FG002|Overall Study|Lost to Follow-up|1|||
129145426|NCT02106832|464828155|FG003|Overall Study|Lost to Follow-up|3|||
129145427|NCT02106832|464828152|FG000|Overall Study|Physician Decision|1|||
129145428|NCT02106832|464828153|FG001|Overall Study|Physician Decision|0|||
129091460|NCT04488419|464625900|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
129091461|NCT04488419|464625901|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
129091462|NCT04488419|464625899|FG000|Primary Analysis Population|Adverse Event|6|||
129091463|NCT04488419|464625900|FG001|Primary Analysis Population|Adverse Event|9|||
129091464|NCT04488419|464625901|FG002|Primary Analysis Population|Adverse Event|0|||
129091465|NCT04488419|464625899|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
129091466|NCT04488419|464625900|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
129091467|NCT04488419|464625901|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
129091468|NCT04488419|464625899|FG000|Primary Analysis Population|Protocol Violation|1|||
129091469|NCT04488419|464625900|FG001|Primary Analysis Population|Protocol Violation|1|||
129091470|NCT04488419|464625901|FG002|Primary Analysis Population|Protocol Violation|0|||
129091471|NCT04488419|464625899|FG000|Primary Analysis Population|Undetermined|7|||
129091472|NCT04488419|464625900|FG001|Primary Analysis Population|Undetermined|3|||
129091473|NCT04488419|464625901|FG002|Primary Analysis Population|Undetermined|0|||
129091474|NCT04488419|464625899|FG000|Primary Analysis Population|>1 Reason|2|||
129091475|NCT04488419|464625900|FG001|Primary Analysis Population|>1 Reason|4|||
128724705|NCT03554291|463290910|FG001|Overall Study|Death|1|||
129145429|NCT02106832|464828154|FG002|Overall Study|Physician Decision|0|||
128724706|NCT03554291|463290909|FG000|Overall Study|Lost to Follow-up|1|||
129145430|NCT02106832|464828155|FG003|Overall Study|Physician Decision|0|||
129145431|NCT02106832|464828152|FG000|Overall Study|Protocol Violation|0|||
129091476|NCT04488419|464625901|FG002|Primary Analysis Population|>1 Reason|0|||
129091477|NCT04161079|464625902|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
129091478|NCT00623597|464625903|FG000|Overall Study|Failed to return|1|||
129091479|NCT00623597|464625904|FG001|Overall Study|Failed to return|0|||
129091480|NCT02515994|464625905|FG000|Overall Study|Protocol Violation|3|||
129091481|NCT02515994|464625906|FG001|Overall Study|Protocol Violation|5|||
129091482|NCT02515994|464625905|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
129091483|NCT02515994|464625906|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
129091484|NCT02515994|464625905|FG000|Overall Study|Adverse Event|3|||
129091485|NCT02515994|464625906|FG001|Overall Study|Adverse Event|1|||
129091486|NCT02515994|464625905|FG000|Overall Study|Withdrawal by Subject|2|||
129091487|NCT02515994|464625906|FG001|Overall Study|Withdrawal by Subject|0|||
129091488|NCT02339155|464625912|FG000|Overall Study|Adverse Event|0|||
129091489|NCT02339155|464625913|FG001|Overall Study|Adverse Event|6|||
129091490|NCT02339155|464625912|FG000|Overall Study|Death|1|||
129091491|NCT02339155|464625913|FG001|Overall Study|Death|1|||
129091492|NCT02339155|464625912|FG000|Overall Study|Lost to Follow-up|8|||
129091493|NCT02339155|464625913|FG001|Overall Study|Lost to Follow-up|9|||
129091494|NCT02339155|464625912|FG000|Overall Study|Physician Decision|2|||
129091495|NCT02339155|464625913|FG001|Overall Study|Physician Decision|1|||
129091496|NCT02339155|464625912|FG000|Overall Study|Withdrawal by Subject|4|||
129091497|NCT02339155|464625913|FG001|Overall Study|Withdrawal by Subject|4|||
129091498|NCT01214252|464625916|FG000|Overall Study|Not eligible per protocol|82|||
129091499|NCT04327661|464625920|FG000|Overall Study|Withdrawal by Subject|1|||
129091500|NCT04327661|464625921|FG001|Overall Study|Withdrawal by Subject|0|||
129091501|NCT04327661|464625922|FG002|Overall Study|Withdrawal by Subject|0|||
129091502|NCT03427268|464625923|FG000|Overall Study|Progressive disease|25|||
129091503|NCT03427268|464625923|FG000|Overall Study|Never treated|2|||
129091504|NCT03427268|464625923|FG000|Overall Study|Compassionate use|1|||
129091505|NCT03427268|464625923|FG000|Overall Study|Withdrawal by Subject|1|||
129091506|NCT03427268|464625923|FG000|Overall Study|Adverse Event|3|||
129145432|NCT02106832|464828153|FG001|Overall Study|Protocol Violation|0|||
129145433|NCT02106832|464828154|FG002|Overall Study|Protocol Violation|0|||
129145434|NCT02106832|464828155|FG003|Overall Study|Protocol Violation|1|||
129145435|NCT02106832|464828152|FG000|Overall Study|Withdrawal by Subject|17|||
129145436|NCT02106832|464828153|FG001|Overall Study|Withdrawal by Subject|17|||
129145437|NCT02106832|464828154|FG002|Overall Study|Withdrawal by Subject|10|||
129145438|NCT02106832|464828155|FG003|Overall Study|Withdrawal by Subject|7|||
129145439|NCT02106832|464828152|FG000|Overall Study|Technical problems|0|||
129145440|NCT02106832|464828153|FG001|Overall Study|Technical problems|1|||
129145441|NCT02106832|464828154|FG002|Overall Study|Technical problems|0|||
129145442|NCT02106832|464828155|FG003|Overall Study|Technical problems|0|||
129145443|NCT03485157|464828156|FG000|Double Blind Phase|Lost to Follow-up|4|||
129145444|NCT03485157|464828157|FG001|Double Blind Phase|Lost to Follow-up|4|||
129145445|NCT03485157|464828156|FG000|Double Blind Phase|Adverse Event|2|||
129145446|NCT03485157|464828157|FG001|Double Blind Phase|Adverse Event|1|||
129145447|NCT03485157|464828156|FG000|Double Blind Phase|Withdrawal by Subject|6|||
129145448|NCT03485157|464828157|FG001|Double Blind Phase|Withdrawal by Subject|9|||
129145449|NCT03485157|464828156|FG000|Double Blind Phase|Removal by PI|3|||
129145450|NCT03485157|464828157|FG001|Double Blind Phase|Removal by PI|7|||
129145451|NCT03485157|464828156|FG000|Open Label Phase|Lost to Follow-up|1|||
129145452|NCT03485157|464828157|FG001|Open Label Phase|Lost to Follow-up|2|||
129145453|NCT03485157|464828156|FG000|Open Label Phase|Adverse Event|0|||
129145454|NCT03485157|464828157|FG001|Open Label Phase|Adverse Event|1|||
129091507|NCT00345878|464625925|FG000|Overall Study|Adverse Event|1|||
129091508|NCT00345878|464625926|FG001|Overall Study|Adverse Event|0|||
129091509|NCT00345878|464625925|FG000|Overall Study|Lost to Follow-up|2|||
129091510|NCT00345878|464625926|FG001|Overall Study|Lost to Follow-up|1|||
129091511|NCT00345878|464625925|FG000|Overall Study|Other|1|||
129091512|NCT00345878|464625926|FG001|Overall Study|Other|0|||
129091513|NCT03391232|464625927|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
129091514|NCT03391232|464625928|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
129091515|NCT03391232|464625927|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
129091516|NCT03391232|464625928|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
129091517|NCT00984061|464625933|FG000|Clarithromycin Alone|Protocol Violation|1|||
129091518|NCT02659514|464625936|FG000|Overall Study|Adverse Event|3|||
129091519|NCT02659514|464625937|FG001|Overall Study|Adverse Event|12|||
129091520|NCT02659514|464625936|FG000|Overall Study|Disease Progression|23|||
129145455|NCT03485157|464828156|FG000|Open Label Phase|Withdrawal by Subject|1|||
129145456|NCT03485157|464828157|FG001|Open Label Phase|Withdrawal by Subject|2|||
129145457|NCT03485157|464828156|FG000|Open Label Phase|Removal by PI|2|||
129091521|NCT02659514|464625937|FG001|Overall Study|Disease Progression|13|||
129091522|NCT02659514|464625936|FG000|Overall Study|Withdrawal by Subject|0|||
129145458|NCT03485157|464828157|FG001|Open Label Phase|Removal by PI|0|||
129145459|NCT00265122|464828158|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
129145460|NCT00265122|464828159|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
129145461|NCT00265122|464828160|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
129091523|NCT02659514|464625937|FG001|Overall Study|Withdrawal by Subject|4|||
129091524|NCT02659514|464625936|FG000|Overall Study|Lost to Follow-up|0|||
129091525|NCT02659514|464625937|FG001|Overall Study|Lost to Follow-up|1|||
129091526|NCT02659514|464625936|FG000|Overall Study|Death|6|||
129091527|NCT02659514|464625937|FG001|Overall Study|Death|1|||
129091528|NCT02659514|464625936|FG000|Overall Study|Reason Unspecified|0|||
129091529|NCT02659514|464625937|FG001|Overall Study|Reason Unspecified|3|||
129091530|NCT03047720|464625943|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
129091531|NCT03047720|464625944|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
129091532|NCT00614120|464625945|FG000|Overall Study|Adverse Event|9|||
129091533|NCT00614120|464625946|FG001|Overall Study|Adverse Event|22|||
129145462|NCT00265122|464828161|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
129145463|NCT00265122|464828162|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
129145464|NCT00265122|464828163|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
129145465|NCT00265122|464828158|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
129145466|NCT00265122|464828159|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129145467|NCT00265122|464828160|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129145468|NCT00265122|464828161|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
129145469|NCT00265122|464828162|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129145470|NCT00265122|464828163|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129145471|NCT00265122|464828158|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
129145472|NCT00265122|464828159|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
129145473|NCT00265122|464828160|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
129145474|NCT00265122|464828161|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
129145475|NCT00265122|464828162|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
129145476|NCT00265122|464828163|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
129145477|NCT00265122|464828158|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
129145478|NCT00265122|464828159|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
129145479|NCT00265122|464828160|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
129145480|NCT00265122|464828161|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
129145481|NCT00265122|464828162|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
129145482|NCT00265122|464828163|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
129145483|NCT00265122|464828158|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
129145484|NCT00265122|464828159|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
129145485|NCT00265122|464828160|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
129145486|NCT00265122|464828161|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
129145487|NCT00265122|464828162|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
129145488|NCT00265122|464828163|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
129145489|NCT00265122|464828158|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
129145490|NCT00265122|464828159|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
129145491|NCT00265122|464828160|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
129145492|NCT00265122|464828161|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
129145493|NCT00265122|464828162|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
129145494|NCT00265122|464828163|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
129145495|NCT05205616|464828170|FG000|Overall Study|Lost to Follow-up|4|||
129145496|NCT05205616|464828171|FG001|Overall Study|Lost to Follow-up|4|||
129145497|NCT00663260|464828180|FG000|Overall Study|Lack of Efficacy|2|||
129145498|NCT00663260|464828181|FG001|Overall Study|Lack of Efficacy|0|||
129145499|NCT00663260|464828182|FG002|Overall Study|Lack of Efficacy|0|||
129145500|NCT00663260|464828180|FG000|Overall Study|Adverse Event|12|||
129145501|NCT00663260|464828181|FG001|Overall Study|Adverse Event|7|||
129145502|NCT00663260|464828182|FG002|Overall Study|Adverse Event|6|||
129145503|NCT00663260|464828180|FG000|Overall Study|Withdrawal by Subject|3|||
129145504|NCT00663260|464828181|FG001|Overall Study|Withdrawal by Subject|1|||
129145505|NCT00663260|464828182|FG002|Overall Study|Withdrawal by Subject|6|||
129145506|NCT00663260|464828180|FG000|Overall Study|Death|1|||
129145507|NCT00663260|464828181|FG001|Overall Study|Death|0|||
128724707|NCT03554291|463290910|FG001|Overall Study|Lost to Follow-up|0|||
128724708|NCT03554291|463290909|FG000|Overall Study|Withdrawal by Subject|1|||
128724709|NCT03554291|463290910|FG001|Overall Study|Withdrawal by Subject|0|||
128724710|NCT03554291|463290909|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
128724711|NCT03554291|463290910|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
129091534|NCT00614120|464625947|FG002|Overall Study|Adverse Event|30|||
129091535|NCT00614120|464625948|FG003|Overall Study|Adverse Event|3|||
129091536|NCT00614120|464625945|FG000|Overall Study|Lack of Efficacy|3|||
129091537|NCT00614120|464625946|FG001|Overall Study|Lack of Efficacy|3|||
129091538|NCT00614120|464625947|FG002|Overall Study|Lack of Efficacy|2|||
129091539|NCT00614120|464625948|FG003|Overall Study|Lack of Efficacy|2|||
129091540|NCT00614120|464625945|FG000|Overall Study|Protocol Violation|2|||
129145508|NCT00663260|464828182|FG002|Overall Study|Death|1|||
129145509|NCT00663260|464828180|FG000|Overall Study|Lost to Follow-up|0|||
129091541|NCT00614120|464625946|FG001|Overall Study|Protocol Violation|5|||
129091542|NCT00614120|464625947|FG002|Overall Study|Protocol Violation|3|||
129091543|NCT00614120|464625948|FG003|Overall Study|Protocol Violation|1|||
129091544|NCT00614120|464625945|FG000|Overall Study|Withdrawal criteria|1|||
129091545|NCT00614120|464625946|FG001|Overall Study|Withdrawal criteria|0|||
129091546|NCT00614120|464625947|FG002|Overall Study|Withdrawal criteria|0|||
129091547|NCT00614120|464625948|FG003|Overall Study|Withdrawal criteria|0|||
129091548|NCT00614120|464625945|FG000|Overall Study|Withdrawal by Subject|9|||
129091549|NCT00614120|464625946|FG001|Overall Study|Withdrawal by Subject|10|||
129091550|NCT00614120|464625947|FG002|Overall Study|Withdrawal by Subject|16|||
129091551|NCT00614120|464625948|FG003|Overall Study|Withdrawal by Subject|3|||
129091552|NCT00614120|464625945|FG000|Overall Study|Did not meet trial criteria|0|||
129091553|NCT00614120|464625946|FG001|Overall Study|Did not meet trial criteria|1|||
129091554|NCT00614120|464625947|FG002|Overall Study|Did not meet trial criteria|1|||
129091555|NCT00614120|464625948|FG003|Overall Study|Did not meet trial criteria|1|||
128724712|NCT01228747|463290911|FG000|Overall Study|Adverse Event|8|||
128724713|NCT01228747|463290912|FG001|Overall Study|Adverse Event|4|||
128724714|NCT01228747|463290911|FG000|Overall Study|Lack of Efficacy|40|||
128724715|NCT01228747|463290912|FG001|Overall Study|Lack of Efficacy|27|||
128724716|NCT01228747|463290911|FG000|Overall Study|Protocol Violation|6|||
128724717|NCT01228747|463290912|FG001|Overall Study|Protocol Violation|5|||
128724718|NCT01228747|463290911|FG000|Overall Study|Lost to Follow-up|4|||
128724719|NCT01228747|463290912|FG001|Overall Study|Lost to Follow-up|3|||
128724720|NCT01228747|463290911|FG000|Overall Study|Withdrawal by Subject|5|||
128724721|NCT01228747|463290912|FG001|Overall Study|Withdrawal by Subject|1|||
128724722|NCT01228747|463290911|FG000|Overall Study|Other Reason|2|||
128724723|NCT01228747|463290912|FG001|Overall Study|Other Reason|5|||
128724724|NCT02036502|463290913|FG000|Part 1:Dose Determination/Escalation|Death|3|||
128724725|NCT02036502|463290914|FG001|Part 1:Dose Determination/Escalation|Death|2|||
128724726|NCT02036502|463290915|FG002|Part 1:Dose Determination/Escalation|Death|0|||
128724727|NCT02036502|463290916|FG003|Part 1:Dose Determination/Escalation|Death|0|||
129091556|NCT00614120|464625945|FG000|Overall Study|hCG positive (not pregnant)|0|||
129091557|NCT00614120|464625946|FG001|Overall Study|hCG positive (not pregnant)|0|||
129091558|NCT00614120|464625947|FG002|Overall Study|hCG positive (not pregnant)|1|||
129091559|NCT00614120|464625948|FG003|Overall Study|hCG positive (not pregnant)|0|||
129091560|NCT00614120|464625945|FG000|Overall Study|Hypoglycaemia|0|||
129091561|NCT00614120|464625946|FG001|Overall Study|Hypoglycaemia|0|||
129091562|NCT00614120|464625947|FG002|Overall Study|Hypoglycaemia|0|||
129091563|NCT00614120|464625948|FG003|Overall Study|Hypoglycaemia|1|||
129091564|NCT00614120|464625945|FG000|Overall Study|Lack of trial product|3|||
129091565|NCT00614120|464625946|FG001|Overall Study|Lack of trial product|3|||
129091566|NCT00614120|464625947|FG002|Overall Study|Lack of trial product|2|||
129091567|NCT00614120|464625948|FG003|Overall Study|Lack of trial product|0|||
129091568|NCT00614120|464625945|FG000|Overall Study|Late syphilis, latent|1|||
129091569|NCT00614120|464625946|FG001|Overall Study|Late syphilis, latent|0|||
129091570|NCT00614120|464625947|FG002|Overall Study|Late syphilis, latent|0|||
129091571|NCT00614120|464625948|FG003|Overall Study|Late syphilis, latent|0|||
129091572|NCT00614120|464625945|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
129091573|NCT00614120|464625946|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
129091574|NCT00614120|464625947|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
129091575|NCT00614120|464625948|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
129091576|NCT00614120|464625945|FG000|Overall Study|Lost to Follow-up|1|||
129091577|NCT00614120|464625946|FG001|Overall Study|Lost to Follow-up|2|||
129091578|NCT00614120|464625947|FG002|Overall Study|Lost to Follow-up|3|||
129091579|NCT00614120|464625948|FG003|Overall Study|Lost to Follow-up|4|||
129091580|NCT01968707|464625952|FG000|Overall Study|Did not meet treatment day baseline|49|||
129091581|NCT01968707|464625953|FG001|Overall Study|Did not meet treatment day baseline|12|||
129091582|NCT01968707|464625954|FG002|Overall Study|Did not meet treatment day baseline|41|||
129091583|NCT01968707|464625955|FG003|Overall Study|Did not meet treatment day baseline|44|||
129091584|NCT01968707|464625956|FG004|Overall Study|Did not meet treatment day baseline|36|||
129091585|NCT01968707|464625957|FG005|Overall Study|Did not meet treatment day baseline|11|||
129091586|NCT01968707|464625958|FG006|Overall Study|Did not meet treatment day baseline|34|||
128724728|NCT02036502|463290917|FG004|Part 1:Dose Determination/Escalation|Death|0|||
128724729|NCT02036502|463290918|FG005|Part 1:Dose Determination/Escalation|Death|0|||
128724730|NCT02036502|463290919|FG006|Part 1:Dose Determination/Escalation|Death|0|||
129091587|NCT01968707|464625959|FG007|Overall Study|Did not meet treatment day baseline|35|||
129091588|NCT00916344|464625960|FG000|Overall Study|Death|2|||
129091589|NCT00916344|464625960|FG000|Overall Study|ICD upgrade|1|||
129091590|NCT00916344|464625960|FG000|Overall Study|Drop-out|5|||
129091591|NCT00108485|464625977|FG000|Overall Study|Withdrawal by Subject|3|||
128724731|NCT02036502|463290920|FG007|Part 1:Dose Determination/Escalation|Death|0|||
128724732|NCT02036502|463290913|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
128724733|NCT02036502|463290914|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
128724734|NCT02036502|463290915|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129091592|NCT00108485|464625978|FG001|Overall Study|Withdrawal by Subject|0|||
129091593|NCT00108485|464625977|FG000|Overall Study|Lost to Follow-up|0|||
129091594|NCT00108485|464625978|FG001|Overall Study|Lost to Follow-up|2|||
129091595|NCT02062944|464625979|FG000|Overall Study|Lost to Follow-up|1|||
129091596|NCT02062944|464625979|FG000|Overall Study|New hemotological disorder identified|1|||
129091597|NCT02062944|464625979|FG000|Overall Study|Uncontrolled Hypertension|1|||
129091598|NCT02062944|464625979|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
129091599|NCT01088243|464625981|FG000|Overall Study|Adverse Event|1|||
129091600|NCT01088243|464625982|FG001|Overall Study|Adverse Event|0|||
129091601|NCT01041976|464625983|FG000|Overall Study|Withdrawal by Subject|3|||
129091602|NCT01041976|464625984|FG001|Overall Study|Withdrawal by Subject|0|||
129091603|NCT01041976|464625983|FG000|Overall Study|Incarceration|2|||
129091604|NCT01041976|464625984|FG001|Overall Study|Incarceration|0|||
129091605|NCT01041976|464625983|FG000|Overall Study|Death|0|||
129091606|NCT01041976|464625984|FG001|Overall Study|Death|4|||
129091607|NCT02231879|464625985|FG000|Overall Study|Adverse Event|2|||
129091608|NCT02231879|464625986|FG001|Overall Study|Adverse Event|1|||
129091609|NCT02231879|464625985|FG000|Overall Study|Lack of Efficacy|0|||
129091610|NCT02231879|464625986|FG001|Overall Study|Lack of Efficacy|1|||
129091611|NCT01210495|464625987|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
129091612|NCT01210495|464625988|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
129091613|NCT01210495|464625989|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
129091614|NCT01210495|464625990|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
129091615|NCT01210495|464625987|FG000|Overall Study|Death|14|||
129091616|NCT01210495|464625988|FG001|Overall Study|Death|7|||
129091617|NCT01210495|464625989|FG002|Overall Study|Death|112|||
129091618|NCT01210495|464625990|FG003|Overall Study|Death|54|||
129091619|NCT01210495|464625987|FG000|Overall Study|Study Terminated by Sponsor|0|||
129091620|NCT01210495|464625988|FG001|Overall Study|Study Terminated by Sponsor|0|||
129091621|NCT01210495|464625989|FG002|Overall Study|Study Terminated by Sponsor|4|||
129091622|NCT01210495|464625990|FG003|Overall Study|Study Terminated by Sponsor|11|||
129091623|NCT01210495|464625987|FG000|Overall Study|Lost to Follow-up|0|||
129091624|NCT01210495|464625988|FG001|Overall Study|Lost to Follow-up|0|||
129091625|NCT01210495|464625989|FG002|Overall Study|Lost to Follow-up|1|||
129091626|NCT01210495|464625990|FG003|Overall Study|Lost to Follow-up|1|||
129091627|NCT01210495|464625987|FG000|Overall Study|Other unspecified|0|||
129091628|NCT01210495|464625988|FG001|Overall Study|Other unspecified|0|||
129091629|NCT01210495|464625989|FG002|Overall Study|Other unspecified|6|||
129091630|NCT01210495|464625990|FG003|Overall Study|Other unspecified|0|||
129091631|NCT00454818|464625991|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
129091632|NCT00454818|464625992|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129091633|NCT00454818|464625993|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129091634|NCT00454818|464625994|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129091635|NCT00454818|464625995|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129091636|NCT00454818|464625991|FG000|Phase I: Open-label Dose-escalation|Death|0|||
129091637|NCT00454818|464625992|FG001|Phase I: Open-label Dose-escalation|Death|1|||
129091638|NCT00454818|464625993|FG002|Phase I: Open-label Dose-escalation|Death|0|||
129091639|NCT00454818|464625994|FG003|Phase I: Open-label Dose-escalation|Death|0|||
129091640|NCT00454818|464625995|FG004|Phase I: Open-label Dose-escalation|Death|0|||
129091641|NCT00454818|464625991|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
129091642|NCT00454818|464625992|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
129091643|NCT00454818|464625993|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
129091644|NCT00454818|464625994|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
129091645|NCT00454818|464625995|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
129091646|NCT00454818|464625991|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
129091647|NCT00454818|464625992|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
129091648|NCT00454818|464625993|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
129091649|NCT00454818|464625994|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
129091650|NCT00454818|464625995|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
129091651|NCT00454818|464625991|FG000|Phase 2: Randomized Double-blind|Death|0|||
129091652|NCT00454818|464625992|FG001|Phase 2: Randomized Double-blind|Death|1|||
129091653|NCT00454818|464625993|FG002|Phase 2: Randomized Double-blind|Death|0|||
129091654|NCT00454818|464625994|FG003|Phase 2: Randomized Double-blind|Death|0|||
129091655|NCT00454818|464625995|FG004|Phase 2: Randomized Double-blind|Death|1|||
129091656|NCT00454818|464625991|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
129091657|NCT00454818|464625992|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
129091658|NCT00454818|464625993|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
129091659|NCT00454818|464625994|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
129091660|NCT00454818|464625995|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
129091661|NCT00454818|464625991|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
129091662|NCT00454818|464625992|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
129091663|NCT00454818|464625993|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
129091664|NCT00454818|464625994|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
129091665|NCT00454818|464625995|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
129091666|NCT00581542|464625996|FG000|Overall Study|they met an exclusion criteria|2|||
129091667|NCT00581542|464625997|FG001|Overall Study|they met an exclusion criteria|2|||
128724735|NCT02036502|463290916|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
128724736|NCT02036502|463290917|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
128724737|NCT02036502|463290918|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
128724738|NCT02036502|463290919|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
128724739|NCT02036502|463290920|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
128724740|NCT02036502|463290913|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
128724741|NCT02036502|463290914|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
129091668|NCT00581542|464625996|FG000|Overall Study|Lost to Follow-up|9|||
129091669|NCT00581542|464625997|FG001|Overall Study|Lost to Follow-up|21|||
129091670|NCT00656851|464625998|FG000|Overall Study|Withdrawal by Subject|0|||
128724742|NCT02036502|463290915|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129091671|NCT00656851|464625999|FG001|Overall Study|Withdrawal by Subject|4|||
129091672|NCT02291601|464626000|FG000|Abdomen|Did not qualify|333|||
129091673|NCT02291601|464626001|FG001|Abdomen|Did not qualify|54|||
129091674|NCT02291601|464626002|FG002|Abdomen|Did not qualify|339|||
129091675|NCT02291601|464626000|FG000|Groin|Did not qualify|183|||
129091676|NCT02291601|464626001|FG001|Groin|Did not qualify|30|||
129091677|NCT02291601|464626002|FG002|Groin|Did not qualify|177|||
129091678|NCT03379753|464626003|FG000|Overall Study|Withdrawal by Subject|2|||
129091679|NCT03379753|464626004|FG001|Overall Study|Withdrawal by Subject|1|||
129091680|NCT03379753|464626003|FG000|Overall Study|not having correct procedure|1|||
129091681|NCT03379753|464626004|FG001|Overall Study|not having correct procedure|2|||
129091682|NCT03379753|464626003|FG000|Overall Study|No primary outcome|12|||
129091683|NCT03379753|464626004|FG001|Overall Study|No primary outcome|22|||
129091684|NCT01032239|464626005|FG000|Overall Study|Lost to Follow-up|3|||
129091685|NCT01032239|464626006|FG001|Overall Study|Lost to Follow-up|2|||
129091686|NCT01032239|464626005|FG000|Overall Study|Withdrawal by Subject|2|||
129091687|NCT01032239|464626006|FG001|Overall Study|Withdrawal by Subject|3|||
129091688|NCT01032239|464626005|FG000|Overall Study|Death|1|||
129091689|NCT01032239|464626006|FG001|Overall Study|Death|0|||
129091690|NCT01032239|464626005|FG000|Overall Study|Protocol Violation|1|||
129091691|NCT01032239|464626006|FG001|Overall Study|Protocol Violation|0|||
129091692|NCT01940900|464626009|FG000|Overall Study|Physician Decision|4|||
129091693|NCT01940900|464626010|FG001|Overall Study|Physician Decision|0|||
129091694|NCT01940900|464626009|FG000|Overall Study|Adverse Event|10|||
129091695|NCT01940900|464626010|FG001|Overall Study|Adverse Event|15|||
129091696|NCT01940900|464626009|FG000|Overall Study|Withdrawal by Subject|11|||
129091697|NCT01940900|464626010|FG001|Overall Study|Withdrawal by Subject|15|||
129091698|NCT01940900|464626009|FG000|Overall Study|Lost to Follow-up|1|||
129091699|NCT01940900|464626010|FG001|Overall Study|Lost to Follow-up|0|||
129091700|NCT01940900|464626009|FG000|Overall Study|Sponsor Decision|1|||
129091701|NCT01940900|464626010|FG001|Overall Study|Sponsor Decision|0|||
129091702|NCT01940900|464626009|FG000|Overall Study|subject non-compliance|1|||
129091703|NCT01940900|464626010|FG001|Overall Study|subject non-compliance|1|||
129091704|NCT01940900|464626009|FG000|Overall Study|other|1|||
129091705|NCT01940900|464626010|FG001|Overall Study|other|0|||
129091706|NCT02419612|464626015|FG000|Short-term Treatment Period|Adverse Event|1|||
129091707|NCT02419612|464626016|FG001|Short-term Treatment Period|Adverse Event|1|||
129091708|NCT02419612|464626015|FG000|Short-term Treatment Period|Death|0|||
129091709|NCT02419612|464626016|FG001|Short-term Treatment Period|Death|2|||
129091710|NCT02419612|464626015|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
129091711|NCT02419612|464626016|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
129091712|NCT02419612|464626015|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
129091713|NCT02419612|464626016|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
129091714|NCT02419612|464626015|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
128724743|NCT02036502|463290916|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
128724744|NCT02036502|463290917|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129091715|NCT02419612|464626016|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
129091716|NCT02419612|464626015|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
129091717|NCT02419612|464626016|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
129091718|NCT02419612|464626015|FG000|Short-term Treatment Period|Worsening of liver function|0|||
129091719|NCT02419612|464626016|FG001|Short-term Treatment Period|Worsening of liver function|1|||
129091720|NCT02419612|464626015|FG000|Short-term Treatment Period|Subject moved out of state|0|||
129091721|NCT02419612|464626016|FG001|Short-term Treatment Period|Subject moved out of state|1|||
129091722|NCT02419612|464626015|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
129091723|NCT02419612|464626016|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
128724745|NCT02036502|463290918|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129145510|NCT00663260|464828181|FG001|Overall Study|Lost to Follow-up|1|||
129091724|NCT02419612|464626015|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
129091725|NCT02419612|464626016|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
129091726|NCT02419612|464626015|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
129091727|NCT02419612|464626016|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
129091728|NCT02419612|464626015|FG000|Long-term Treatment Period|Death|0|||
129091729|NCT02419612|464626016|FG001|Long-term Treatment Period|Death|1|||
129091730|NCT02419612|464626015|FG000|Long-term Treatment Period|Adverse Event|0|||
129091731|NCT02419612|464626016|FG001|Long-term Treatment Period|Adverse Event|5|||
129091732|NCT02419612|464626015|FG000|Long-term Treatment Period|Other|4|||
129091733|NCT02419612|464626016|FG001|Long-term Treatment Period|Other|4|||
129091734|NCT02419612|464626015|FG000|Long-term Treatment Period|Subject Decision|2|||
129091735|NCT02419612|464626016|FG001|Long-term Treatment Period|Subject Decision|4|||
129091736|NCT02419612|464626015|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
129091737|NCT02419612|464626016|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
129091738|NCT00474045|464626023|FG000|Overall Study|Adverse Event|18|||
129091739|NCT00474045|464626024|FG001|Overall Study|Adverse Event|8|||
129091740|NCT00474045|464626023|FG000|Overall Study|Unclassified|1|||
129091741|NCT00474045|464626024|FG001|Overall Study|Unclassified|3|||
129091742|NCT00474045|464626023|FG000|Overall Study|Lack of Efficacy|0|||
129091743|NCT00474045|464626024|FG001|Overall Study|Lack of Efficacy|9|||
129091744|NCT00474045|464626023|FG000|Overall Study|Lost to Follow-up|1|||
129091745|NCT00474045|464626024|FG001|Overall Study|Lost to Follow-up|1|||
129091746|NCT00474045|464626023|FG000|Overall Study|Protocol Violation|10|||
129091747|NCT00474045|464626024|FG001|Overall Study|Protocol Violation|12|||
129091748|NCT00474045|464626023|FG000|Overall Study|Withdrawal by Subject|16|||
129091749|NCT00474045|464626024|FG001|Overall Study|Withdrawal by Subject|18|||
129091750|NCT00474045|464626023|FG000|Overall Study|Withdrawal criteria|60|||
129091751|NCT00474045|464626024|FG001|Overall Study|Withdrawal criteria|50|||
129091752|NCT02009397|464626025|FG000|Overall Study|Protocol Violation|6|||
129091753|NCT02009397|464626025|FG000|Overall Study|Death|8|||
129091754|NCT02009397|464626025|FG000|Overall Study|Lost to Follow-up|6|||
129091755|NCT02278120|464626028|FG000|Treatment Period|Progressive disease|234|||
129091756|NCT02278120|464626029|FG001|Treatment Period|Progressive disease|260|||
129091757|NCT02278120|464626028|FG000|Treatment Period|Subject/guardian decision|23|||
129091758|NCT02278120|464626029|FG001|Treatment Period|Subject/guardian decision|20|||
129091759|NCT02278120|464626028|FG000|Treatment Period|Adverse Event|16|||
129091760|NCT02278120|464626029|FG001|Treatment Period|Adverse Event|14|||
129091761|NCT02278120|464626028|FG000|Treatment Period|Physician Decision|14|||
129091762|NCT02278120|464626029|FG001|Treatment Period|Physician Decision|27|||
129091763|NCT02278120|464626028|FG000|Treatment Period|Death|3|||
129091764|NCT02278120|464626029|FG001|Treatment Period|Death|3|||
129091765|NCT02278120|464626028|FG000|Treatment Period|Lost to Follow-up|2|||
129091766|NCT02278120|464626029|FG001|Treatment Period|Lost to Follow-up|0|||
129091767|NCT02278120|464626028|FG000|Treatment Period|Protocol deviation|0|||
129091768|NCT02278120|464626029|FG001|Treatment Period|Protocol deviation|2|||
129091769|NCT02278120|464626028|FG000|Treatment Period|Study terminated as per protocol|43|||
129091770|NCT02278120|464626029|FG001|Treatment Period|Study terminated as per protocol|11|||
129091771|NCT02278120|464626028|FG000|Post-treatment Efficacy Follow-up|Death|0|||
129091772|NCT02278120|464626029|FG001|Post-treatment Efficacy Follow-up|Death|1|||
129091773|NCT02278120|464626028|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129091774|NCT02278120|464626029|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129091775|NCT02278120|464626028|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
129145511|NCT00663260|464828182|FG002|Overall Study|Lost to Follow-up|0|||
129145512|NCT00663260|464828180|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
129145513|NCT00663260|464828181|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
129091776|NCT02278120|464626029|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
129091777|NCT02278120|464626028|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
129091778|NCT02278120|464626029|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
129091779|NCT02278120|464626028|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129091780|NCT02278120|464626029|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129091781|NCT01966068|464626034|FG000|Overall Study|Withdrawal by Subject|57|||
129091782|NCT01966068|464626034|FG000|Overall Study|Lost to Follow-up|81|||
129091783|NCT00191282|464626039|FG000|Overall Study|Adverse Event|5|||
129091784|NCT00191282|464626040|FG001|Overall Study|Adverse Event|6|||
129091785|NCT00191282|464626039|FG000|Overall Study|Death|51|||
129091786|NCT00191282|464626040|FG001|Overall Study|Death|51|||
129091787|NCT00191282|464626039|FG000|Overall Study|Lack of Efficacy|11|||
129091788|NCT00191282|464626040|FG001|Overall Study|Lack of Efficacy|6|||
129145514|NCT00663260|464828182|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
129091789|NCT00191282|464626039|FG000|Overall Study|Noncompliance|14|||
129091790|NCT00191282|464626040|FG001|Overall Study|Noncompliance|17|||
129091791|NCT00191282|464626039|FG000|Overall Study|Patient moved|11|||
129145515|NCT02231580|464828191|FG000|Overall Study|Adverse Event|5|||
129091792|NCT00191282|464626040|FG001|Overall Study|Patient moved|14|||
128724746|NCT02036502|463290919|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
128724747|NCT02036502|463290920|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
128724748|NCT02036502|463290913|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
129091793|NCT00191282|464626039|FG000|Overall Study|Withdrawal by Subject|59|||
129091794|NCT00191282|464626040|FG001|Overall Study|Withdrawal by Subject|44|||
129091795|NCT00191282|464626039|FG000|Overall Study|Physician Decision|18|||
129091796|NCT00191282|464626040|FG001|Overall Study|Physician Decision|15|||
129091797|NCT00191282|464626039|FG000|Overall Study|Protocol entry criteria not met|14|||
129091798|NCT00191282|464626040|FG001|Overall Study|Protocol entry criteria not met|9|||
129091799|NCT00191282|464626039|FG000|Overall Study|Protocol Violation|9|||
129091800|NCT00191282|464626040|FG001|Overall Study|Protocol Violation|12|||
129091801|NCT00191282|464626039|FG000|Overall Study|Severity of outcome|2|||
129091802|NCT00191282|464626040|FG001|Overall Study|Severity of outcome|5|||
129091803|NCT00191282|464626039|FG000|Overall Study|Sponsor's decision|2|||
129091804|NCT00191282|464626040|FG001|Overall Study|Sponsor's decision|2|||
129091805|NCT00191282|464626039|FG000|Overall Study|Lost to Follow-up|24|||
129091806|NCT00191282|464626040|FG001|Overall Study|Lost to Follow-up|31|||
129091807|NCT00102531|464626041|FG000|Overall Study|Adverse Event|0|||
129091808|NCT00102531|464626042|FG001|Overall Study|Adverse Event|1|||
129091809|NCT00102531|464626041|FG000|Overall Study|Disease Progression|5|||
129091810|NCT00102531|464626042|FG001|Overall Study|Disease Progression|9|||
129091811|NCT00102531|464626041|FG000|Overall Study|Physician Decision|0|||
129091812|NCT00102531|464626042|FG001|Overall Study|Physician Decision|1|||
129091813|NCT04756154|464626043|FG000|Overall Study|Did not meet treatment day baseline|30|||
129091814|NCT04756154|464626044|FG001|Overall Study|Did not meet treatment day baseline|28|||
129091815|NCT04756154|464626045|FG002|Overall Study|Did not meet treatment day baseline|7|||
129091816|NCT04756154|464626043|FG000|Overall Study|Did not return for final sample collection|1|||
129091817|NCT04756154|464626044|FG001|Overall Study|Did not return for final sample collection|1|||
129091818|NCT04756154|464626045|FG002|Overall Study|Did not return for final sample collection|0|||
129091819|NCT01790828|464626046|FG000|Overall Study|Other|34|||
129091820|NCT03721835|464626047|FG000|Overall Study|Participant not able to return|1|||
129091821|NCT03721835|464626047|FG000|Overall Study|Lost to Follow-up|1|||
129091822|NCT03721835|464626047|FG000|Overall Study|Revision of the components of the study device|2|||
129091823|NCT03721835|464626047|FG000|Overall Study|Sponsor terminated study|6|||
129091824|NCT03721835|464626047|FG000|Overall Study|Death|1|||
129091825|NCT03721835|464626047|FG000|Overall Study|Sponsor decision|1|||
129091826|NCT01390428|464627567|FG000|Overall Study|Elective Surgery|0|||
129091827|NCT01390428|464627568|FG001|Overall Study|Elective Surgery|0|||
129091828|NCT01390428|464627569|FG002|Overall Study|Elective Surgery|0|||
129091829|NCT01390428|464627570|FG003|Overall Study|Elective Surgery|0|||
129091830|NCT01390428|464627571|FG004|Overall Study|Elective Surgery|1|||
129091831|NCT01390428|464627572|FG005|Overall Study|Elective Surgery|0|||
129091832|NCT01390428|464627567|FG000|Overall Study|Withdrawal by Subject|0|||
129091833|NCT01390428|464627568|FG001|Overall Study|Withdrawal by Subject|0|||
129091834|NCT01390428|464627569|FG002|Overall Study|Withdrawal by Subject|1|||
129091835|NCT01390428|464627570|FG003|Overall Study|Withdrawal by Subject|0|||
129091836|NCT01390428|464627571|FG004|Overall Study|Withdrawal by Subject|0|||
129091837|NCT01390428|464627572|FG005|Overall Study|Withdrawal by Subject|0|||
129091838|NCT05079750|464627573|FG000|Overall Study|Lost to Follow-up|0|||
129091839|NCT05079750|464627574|FG001|Overall Study|Lost to Follow-up|0|||
129091840|NCT05079750|464627575|FG002|Overall Study|Lost to Follow-up|1|||
129091841|NCT05897827|464627576|FG000|Overall Study|Lost to Follow-up|33|||
129091842|NCT05897827|464627577|FG001|Overall Study|Lost to Follow-up|14|||
129091843|NCT05897827|464627576|FG000|Overall Study|Withdrawal by Subject|1|||
129091844|NCT05897827|464627577|FG001|Overall Study|Withdrawal by Subject|1|||
129091845|NCT02276053|464627580|FG000|Overall Study|Death|2|||
129091846|NCT02276053|464627580|FG000|Overall Study|Adverse Event|5|||
129091847|NCT02276053|464627580|FG000|Overall Study|Lack of Efficacy|2|||
129091848|NCT02276053|464627580|FG000|Overall Study|Withdrawal by Subject|1|||
129091849|NCT02276053|464627580|FG000|Overall Study|Patient does not meet selection criteria|3|||
129091850|NCT02276053|464627580|FG000|Overall Study|Patient needs to increase baseline AED|1|||
128724749|NCT02036502|463290914|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
128724750|NCT02036502|463290915|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
128724751|NCT02036502|463290916|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
128724752|NCT02036502|463290917|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
129091851|NCT04542499|464627583|FG000|Overall Study|Adverse Event|23|||
129091852|NCT04542499|464627584|FG001|Overall Study|Adverse Event|43|||
129091853|NCT04542499|464627583|FG000|Overall Study|Lack of Efficacy|5|||
129091854|NCT04542499|464627584|FG001|Overall Study|Lack of Efficacy|2|||
129091855|NCT04542499|464627583|FG000|Overall Study|Lost to Follow-up|3|||
129091856|NCT04542499|464627584|FG001|Overall Study|Lost to Follow-up|4|||
129091857|NCT04542499|464627583|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
129091858|NCT04542499|464627584|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
129091859|NCT04542499|464627583|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
129145516|NCT02231580|464828192|FG001|Overall Study|Adverse Event|0|||
128724753|NCT02036502|463290918|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
129091860|NCT04542499|464627584|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
129091861|NCT04542499|464627583|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129091862|NCT04542499|464627584|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129091863|NCT04542499|464627583|FG000|Overall Study|Physician Decision|0|||
129091864|NCT04542499|464627584|FG001|Overall Study|Physician Decision|1|||
129091865|NCT04542499|464627583|FG000|Overall Study|Site Terminated by Sponsor|3|||
129091866|NCT04542499|464627584|FG001|Overall Study|Site Terminated by Sponsor|5|||
129145517|NCT03620981|464828193|FG000|Overall Study|Adverse Event|14|||
129145518|NCT03620981|464828194|FG001|Overall Study|Adverse Event|38|||
129145519|NCT03620981|464828195|FG002|Overall Study|Adverse Event|25|||
129145520|NCT03620981|464828193|FG000|Overall Study|Lack of Efficacy|2|||
129145521|NCT03620981|464828194|FG001|Overall Study|Lack of Efficacy|1|||
129145522|NCT03620981|464828195|FG002|Overall Study|Lack of Efficacy|1|||
129145523|NCT03620981|464828193|FG000|Overall Study|Physician Decision|7|||
129145524|NCT03620981|464828194|FG001|Overall Study|Physician Decision|4|||
129145525|NCT03620981|464828195|FG002|Overall Study|Physician Decision|4|||
129145526|NCT03620981|464828193|FG000|Overall Study|Protocol Violation|1|||
129145527|NCT03620981|464828194|FG001|Overall Study|Protocol Violation|2|||
129145528|NCT03620981|464828195|FG002|Overall Study|Protocol Violation|1|||
129145529|NCT03620981|464828193|FG000|Overall Study|Withdrawal by Legal Representative|2|||
129145530|NCT03620981|464828194|FG001|Overall Study|Withdrawal by Legal Representative|1|||
129145531|NCT03620981|464828195|FG002|Overall Study|Withdrawal by Legal Representative|1|||
129091867|NCT04542499|464627583|FG000|Overall Study|Withdrawal by Subject|12|||
129091868|NCT04542499|464627584|FG001|Overall Study|Withdrawal by Subject|33|||
129091869|NCT04542499|464627583|FG000|Overall Study|Other|2|||
129091870|NCT04542499|464627584|FG001|Overall Study|Other|2|||
129091871|NCT04322539|464627591|FG000|Overall Study|Adverse Event|2|||
129091872|NCT04322539|464627592|FG001|Overall Study|Adverse Event|0|||
129091873|NCT04322539|464627591|FG000|Overall Study|Death|411|||
129091874|NCT04322539|464627592|FG001|Overall Study|Death|203|||
129145532|NCT03620981|464828193|FG000|Overall Study|Withdrawal by Care Giver|2|||
129145533|NCT03620981|464828194|FG001|Overall Study|Withdrawal by Care Giver|0|||
129145534|NCT03620981|464828195|FG002|Overall Study|Withdrawal by Care Giver|1|||
128724754|NCT02036502|463290919|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
129091875|NCT04322539|464627591|FG000|Overall Study|Lost to Follow-up|3|||
129091876|NCT04322539|464627592|FG001|Overall Study|Lost to Follow-up|1|||
129091877|NCT04322539|464627591|FG000|Overall Study|Withdrawal of consent|14|||
129091878|NCT04322539|464627592|FG001|Overall Study|Withdrawal of consent|8|||
129091879|NCT04322539|464627591|FG000|Overall Study|Radiological Disease Progression|6|||
129091880|NCT04322539|464627592|FG001|Overall Study|Radiological Disease Progression|0|||
129091881|NCT04322539|464627591|FG000|Overall Study|Sponsor Decision|19|||
129091882|NCT04322539|464627592|FG001|Overall Study|Sponsor Decision|14|||
129091883|NCT04322539|464627591|FG000|Overall Study|Other|6|||
129091884|NCT04322539|464627592|FG001|Overall Study|Other|4|||
129091885|NCT03617861|464627595|FG000|Second Intervention (1 Day)|Adverse Event|0|||
129091886|NCT03617861|464627596|FG001|Second Intervention (1 Day)|Adverse Event|0|||
129091887|NCT03617861|464627597|FG002|Second Intervention (1 Day)|Adverse Event|1|||
129091888|NCT03617861|464627598|FG003|Second Intervention (1 Day)|Adverse Event|0|||
129091889|NCT01702532|464627599|FG000|Overall Study|Adverse Event|0|||
129091890|NCT01702532|464627600|FG001|Overall Study|Adverse Event|1|||
129091891|NCT01846221|464627610|FG000|Overall Study|Catheter Failure|2|||
129091892|NCT01846221|464627611|FG001|Overall Study|Catheter Failure|0|||
129091893|NCT01846221|464627610|FG000|Overall Study|Age Exclusion|1|||
129091894|NCT01846221|464627611|FG001|Overall Study|Age Exclusion|0|||
129091895|NCT01668966|464627612|FG000|Overall Study|Withdrawal by Subject|1|||
129091896|NCT01668966|464627612|FG000|Overall Study|Death|1|||
129091897|NCT01668966|464627612|FG000|Overall Study|Not treated|2|||
129091898|NCT02879994|464627613|FG000|Overall Study|off treatment early|7|||
129091899|NCT02879994|464627613|FG000|Overall Study|Adverse Event|2|||
129091900|NCT02879994|464627613|FG000|Overall Study|Death|2|||
129091901|NCT00552032|464627614|FG000|Overall Study|Withdrawal by Subject|2|||
129091902|NCT00552032|464627615|FG001|Overall Study|Withdrawal by Subject|2|||
129091903|NCT00552032|464627614|FG000|Overall Study|Protocol Violation|7|||
129145535|NCT03620981|464828193|FG000|Overall Study|Non-compliance with Study Drug|1|||
128724755|NCT02036502|463290920|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
128724756|NCT02036502|463290913|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129091904|NCT00552032|464627615|FG001|Overall Study|Protocol Violation|12|||
129091905|NCT00552032|464627614|FG000|Overall Study|Lost to Follow-up|8|||
129091906|NCT00552032|464627615|FG001|Overall Study|Lost to Follow-up|5|||
129091907|NCT01643798|464627616|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
129091908|NCT01643798|464627617|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
129091909|NCT01995175|464627621|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
129091910|NCT01995175|464627621|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
129145536|NCT03620981|464828194|FG001|Overall Study|Non-compliance with Study Drug|1|||
129145537|NCT03620981|464828195|FG002|Overall Study|Non-compliance with Study Drug|0|||
129145538|NCT02607722|464828198|FG000|Overall Study|No data reliability|1|||
129091911|NCT01995175|464627621|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
129091912|NCT01995175|464627621|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
129091913|NCT01995175|464627621|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
129091914|NCT01995175|464627621|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
129091915|NCT01995175|464627621|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
129091916|NCT01995175|464627621|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
129091917|NCT01995175|464627621|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
129091918|NCT01877551|464627622|FG000|Overall Study|Physician Decision|0|||
129091919|NCT01877551|464627623|FG001|Overall Study|Physician Decision|1|||
129091920|NCT03602391|464627625|FG000|Overall Study|COVID-19|7|||
129091921|NCT03602391|464627626|FG001|Overall Study|COVID-19|6|||
129091922|NCT01097421|464627627|FG000|Overall Study|Adverse Event|8|||
129091923|NCT01097421|464627627|FG000|Overall Study|Protocol Violation|2|||
129091924|NCT01097421|464627627|FG000|Overall Study|Lost to Follow-up|1|||
129091925|NCT01097421|464627627|FG000|Overall Study|Withdrawal by Subject|3|||
129091926|NCT02035748|464627635|FG000|Overall Study|Adverse Event|5|||
129091927|NCT02035748|464627635|FG000|Overall Study|Death|3|||
129091928|NCT02035748|464627635|FG000|Overall Study|Lost to Follow-up|2|||
129091929|NCT02035748|464627635|FG000|Overall Study|Physician Decision|3|||
129091930|NCT02035748|464627635|FG000|Overall Study|Withdrawal by Subject|6|||
129091931|NCT02035748|464627635|FG000|Overall Study|Progressive Disease|1|||
129091932|NCT04495816|464627636|FG000|Overall Study|Lost to Follow-up|10|||
129091933|NCT04495816|464627637|FG001|Overall Study|Lost to Follow-up|4|||
129091934|NCT04495816|464627636|FG000|Overall Study|Withdrawal by Subject|3|||
129091935|NCT04495816|464627637|FG001|Overall Study|Withdrawal by Subject|5|||
129091936|NCT02052596|464627638|FG000|Active Phase|Adverse Event|3|||
129091937|NCT02052596|464627639|FG001|Active Phase|Adverse Event|2|||
129091938|NCT02052596|464627638|FG000|Active Phase|Lost to Follow-up|8|||
129091939|NCT02052596|464627639|FG001|Active Phase|Lost to Follow-up|11|||
129091940|NCT02052596|464627638|FG000|Active Phase|Protocol Violation|1|||
129091941|NCT02052596|464627639|FG001|Active Phase|Protocol Violation|2|||
129091942|NCT02052596|464627638|FG000|Active Phase|Withdrawal by Subject|3|||
129091943|NCT02052596|464627639|FG001|Active Phase|Withdrawal by Subject|4|||
129091944|NCT02052596|464627638|FG000|Active Phase|Enrolled in error|1|||
129091945|NCT02052596|464627639|FG001|Active Phase|Enrolled in error|0|||
129091946|NCT02052596|464627638|FG000|Active Phase|Lost due to Crohn's disease|0|||
129091947|NCT02052596|464627639|FG001|Active Phase|Lost due to Crohn's disease|1|||
129091948|NCT02052596|464627638|FG000|Safety Phase|Adverse Event|6|||
129091949|NCT02052596|464627639|FG001|Safety Phase|Adverse Event|3|||
129091950|NCT02052596|464627638|FG000|Safety Phase|Lost to Follow-up|11|||
129091951|NCT02052596|464627639|FG001|Safety Phase|Lost to Follow-up|18|||
129091952|NCT02052596|464627638|FG000|Safety Phase|Protocol Violation|1|||
129091953|NCT02052596|464627639|FG001|Safety Phase|Protocol Violation|2|||
129091954|NCT02052596|464627638|FG000|Safety Phase|Withdrawal by Subject|8|||
129091955|NCT02052596|464627639|FG001|Safety Phase|Withdrawal by Subject|11|||
129091956|NCT02052596|464627638|FG000|Safety Phase|Enrolled in error|1|||
129091957|NCT02052596|464627639|FG001|Safety Phase|Enrolled in error|0|||
129091958|NCT02052596|464627638|FG000|Safety Phase|Lost due to Crohn's disease|0|||
129091959|NCT02052596|464627639|FG001|Safety Phase|Lost due to Crohn's disease|1|||
129091960|NCT00558896|464627640|FG000|Overall Study|Adverse Event|1|||
129091961|NCT00558896|464627641|FG001|Overall Study|Adverse Event|1|||
129091962|NCT00558896|464627642|FG002|Overall Study|Adverse Event|1|||
129091963|NCT00558896|464627643|FG003|Overall Study|Adverse Event|3|||
129091964|NCT00558896|464627644|FG004|Overall Study|Adverse Event|4|||
129091965|NCT00558896|464627645|FG005|Overall Study|Adverse Event|10|||
129091966|NCT00558896|464627646|FG006|Overall Study|Adverse Event|3|||
129091967|NCT00558896|464627640|FG000|Overall Study|Death|3|||
129091968|NCT00558896|464627641|FG001|Overall Study|Death|0|||
129091969|NCT00558896|464627642|FG002|Overall Study|Death|2|||
129091970|NCT00558896|464627643|FG003|Overall Study|Death|3|||
129091971|NCT00558896|464627644|FG004|Overall Study|Death|2|||
129091972|NCT00558896|464627645|FG005|Overall Study|Death|2|||
129091973|NCT00558896|464627646|FG006|Overall Study|Death|6|||
129091974|NCT00558896|464627640|FG000|Overall Study|Withdrawal by Subject|2|||
129091975|NCT00558896|464627641|FG001|Overall Study|Withdrawal by Subject|1|||
129091976|NCT00558896|464627642|FG002|Overall Study|Withdrawal by Subject|1|||
129091977|NCT00558896|464627643|FG003|Overall Study|Withdrawal by Subject|1|||
129091978|NCT00558896|464627644|FG004|Overall Study|Withdrawal by Subject|1|||
129091979|NCT00558896|464627645|FG005|Overall Study|Withdrawal by Subject|5|||
129091980|NCT00558896|464627646|FG006|Overall Study|Withdrawal by Subject|5|||
129091981|NCT00558896|464627640|FG000|Overall Study|Alternative Treatment|2|||
129091982|NCT00558896|464627641|FG001|Overall Study|Alternative Treatment|2|||
129091983|NCT00558896|464627642|FG002|Overall Study|Alternative Treatment|0|||
129091984|NCT00558896|464627643|FG003|Overall Study|Alternative Treatment|2|||
129091985|NCT00558896|464627644|FG004|Overall Study|Alternative Treatment|6|||
129091986|NCT00558896|464627645|FG005|Overall Study|Alternative Treatment|7|||
129091987|NCT00558896|464627646|FG006|Overall Study|Alternative Treatment|1|||
129091988|NCT00558896|464627640|FG000|Overall Study|Physician discretion|3|||
129091989|NCT00558896|464627641|FG001|Overall Study|Physician discretion|2|||
129091990|NCT00558896|464627642|FG002|Overall Study|Physician discretion|1|||
129091991|NCT00558896|464627643|FG003|Overall Study|Physician discretion|2|||
129091992|NCT00558896|464627644|FG004|Overall Study|Physician discretion|1|||
129091993|NCT00558896|464627645|FG005|Overall Study|Physician discretion|3|||
129091994|NCT00558896|464627646|FG006|Overall Study|Physician discretion|3|||
129091995|NCT00558896|464627640|FG000|Overall Study|Continues on treatment|10|||
129091996|NCT00558896|464627641|FG001|Overall Study|Continues on treatment|1|||
129091997|NCT00558896|464627642|FG002|Overall Study|Continues on treatment|0|||
129091998|NCT00558896|464627643|FG003|Overall Study|Continues on treatment|1|||
129091999|NCT00558896|464627644|FG004|Overall Study|Continues on treatment|9|||
129092000|NCT00558896|464627645|FG005|Overall Study|Continues on treatment|25|||
129092001|NCT00558896|464627646|FG006|Overall Study|Continues on treatment|6|||
129092002|NCT00705718|464627647|FG000|Overall Study|Death|6|||
129092003|NCT00705718|464627648|FG001|Overall Study|Death|6|||
129092004|NCT00705718|464627647|FG000|Overall Study|Not due for Visit|0|||
129092005|NCT00705718|464627648|FG001|Overall Study|Not due for Visit|12|||
129092006|NCT00705718|464627647|FG000|Overall Study|Follow up not done|1|||
129092007|NCT00705718|464627648|FG001|Overall Study|Follow up not done|4|||
129092008|NCT04329091|464627651|FG000|Overall Study|Physician Decision|5|||
129092009|NCT02505334|464627659|FG000|Main Treatment Period|Adverse Event|3|||
129092010|NCT02505334|464627660|FG001|Main Treatment Period|Adverse Event|3|||
129092011|NCT02505334|464627659|FG000|Main Treatment Period|Lack of Efficacy|7|||
129092012|NCT02505334|464627660|FG001|Main Treatment Period|Lack of Efficacy|17|||
129092013|NCT02505334|464627659|FG000|Main Treatment Period|Protocol Violation|0|||
129092014|NCT02505334|464627660|FG001|Main Treatment Period|Protocol Violation|1|||
129092015|NCT02505334|464627659|FG000|Main Treatment Period|Withdrawal by Subject|1|||
129092016|NCT02505334|464627660|FG001|Main Treatment Period|Withdrawal by Subject|8|||
129092017|NCT02505334|464627659|FG000|Main Treatment Period|Unclassified|4|||
129092018|NCT02505334|464627660|FG001|Main Treatment Period|Unclassified|10|||
129092019|NCT02505334|464627659|FG000|Extension Treatment Period|Adverse Event|5|||
129092020|NCT02505334|464627660|FG001|Extension Treatment Period|Adverse Event|0|||
129092021|NCT02505334|464627659|FG000|Extension Treatment Period|Lack of Efficacy|4|||
129092022|NCT02505334|464627660|FG001|Extension Treatment Period|Lack of Efficacy|0|||
129092023|NCT02505334|464627659|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
129092024|NCT02505334|464627660|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129092025|NCT02505334|464627659|FG000|Extension Treatment Period|Unclassified|3|||
129092026|NCT02505334|464627660|FG001|Extension Treatment Period|Unclassified|0|||
129092027|NCT03199612|464627661|FG000|Overall Study|Adverse Event|1|||
129092028|NCT03199612|464627662|FG001|Overall Study|Adverse Event|0|||
129092029|NCT00081731|464627667|FG000|Overall Study|scientific integrity issue|8|||
129092030|NCT00081731|464627668|FG001|Overall Study|scientific integrity issue|8|||
129092031|NCT02386345|464627669|FG000|Overall Study|Not treated|14|||
129092032|NCT02386345|464627669|FG000|Overall Study|Lost to Follow-up|1|||
129092033|NCT02386345|464627669|FG000|Overall Study|Adverse Event|5|||
129092034|NCT02386345|464627669|FG000|Overall Study|Repeat Procedure|10|||
129092035|NCT02386345|464627669|FG000|Overall Study|Did not complete 12-month follow-up|72|||
129092036|NCT02258542|464627670|FG000|Overall Study|eg. not made to the visit|7|||
129092037|NCT02258542|464627671|FG001|Overall Study|eg. not made to the visit|4|||
129092038|NCT02258542|464627672|FG002|Overall Study|eg. not made to the visit|0|||
129092039|NCT02258542|464627673|FG003|Overall Study|eg. not made to the visit|1|||
129092040|NCT02258542|464627670|FG000|Overall Study|study specific discount. criteria|1|||
129092041|NCT02258542|464627671|FG001|Overall Study|study specific discount. criteria|1|||
129092042|NCT02258542|464627672|FG002|Overall Study|study specific discount. criteria|0|||
129092043|NCT02258542|464627673|FG003|Overall Study|study specific discount. criteria|0|||
129092044|NCT02258542|464627670|FG000|Overall Study|Withdrawal by Subject|20|||
129092045|NCT02258542|464627671|FG001|Overall Study|Withdrawal by Subject|20|||
129092046|NCT02258542|464627672|FG002|Overall Study|Withdrawal by Subject|7|||
129092047|NCT02258542|464627673|FG003|Overall Study|Withdrawal by Subject|1|||
129092048|NCT02258542|464627670|FG000|Overall Study|Lost to Follow-up|5|||
129092049|NCT02258542|464627671|FG001|Overall Study|Lost to Follow-up|12|||
129092050|NCT02258542|464627672|FG002|Overall Study|Lost to Follow-up|1|||
129092051|NCT02258542|464627673|FG003|Overall Study|Lost to Follow-up|2|||
129092052|NCT02258542|464627670|FG000|Overall Study|Death|5|||
129092053|NCT02258542|464627671|FG001|Overall Study|Death|4|||
129092054|NCT02258542|464627672|FG002|Overall Study|Death|0|||
129092055|NCT02258542|464627673|FG003|Overall Study|Death|1|||
129092056|NCT02258542|464627670|FG000|Overall Study|Adverse Event|3|||
129092057|NCT02258542|464627671|FG001|Overall Study|Adverse Event|4|||
129092058|NCT02258542|464627672|FG002|Overall Study|Adverse Event|0|||
129092059|NCT02258542|464627673|FG003|Overall Study|Adverse Event|0|||
129092060|NCT02258542|464627670|FG000|Overall Study|Protocol Violation|1|||
129092061|NCT02258542|464627671|FG001|Overall Study|Protocol Violation|2|||
129092062|NCT02258542|464627672|FG002|Overall Study|Protocol Violation|0|||
129092063|NCT02258542|464627673|FG003|Overall Study|Protocol Violation|0|||
129092064|NCT02258542|464627670|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129092065|NCT02258542|464627671|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
129092066|NCT02258542|464627672|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129092067|NCT02258542|464627673|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
129092068|NCT04972968|464627683|FG000|Overall Study|Adverse Event|3|||
129092069|NCT04972968|464627684|FG001|Overall Study|Adverse Event|1|||
129092070|NCT04972968|464627685|FG002|Overall Study|Adverse Event|1|||
129092071|NCT04972968|464627686|FG003|Overall Study|Adverse Event|7|||
129092072|NCT04972968|464627683|FG000|Overall Study|Lack of Efficacy|2|||
129092073|NCT04972968|464627684|FG001|Overall Study|Lack of Efficacy|1|||
129092074|NCT04972968|464627685|FG002|Overall Study|Lack of Efficacy|0|||
129092075|NCT04972968|464627686|FG003|Overall Study|Lack of Efficacy|0|||
129092076|NCT04972968|464627683|FG000|Overall Study|Withdrawal by Subject|7|||
129092077|NCT04972968|464627684|FG001|Overall Study|Withdrawal by Subject|4|||
129092078|NCT04972968|464627685|FG002|Overall Study|Withdrawal by Subject|3|||
129092079|NCT04972968|464627686|FG003|Overall Study|Withdrawal by Subject|2|||
129092080|NCT04972968|464627683|FG000|Overall Study|Study Terminated by Sponsor|25|||
129092081|NCT04972968|464627684|FG001|Overall Study|Study Terminated by Sponsor|28|||
129092082|NCT04972968|464627685|FG002|Overall Study|Study Terminated by Sponsor|32|||
129092083|NCT04972968|464627686|FG003|Overall Study|Study Terminated by Sponsor|27|||
129092084|NCT04972968|464627683|FG000|Overall Study|Other|1|||
129092085|NCT04972968|464627684|FG001|Overall Study|Other|0|||
129092086|NCT04972968|464627685|FG002|Overall Study|Other|1|||
129092087|NCT04972968|464627686|FG003|Overall Study|Other|1|||
129092088|NCT01698879|464627687|FG000|Overall Study|Withdrawal by Subject|1|||
129092089|NCT01698879|464627688|FG001|Overall Study|Withdrawal by Subject|0|||
129092090|NCT01698879|464627689|FG002|Overall Study|Withdrawal by Subject|0|||
129092091|NCT03589976|464627695|FG000|Overall Study|Death|5|||
129092092|NCT03589976|464627696|FG001|Overall Study|Death|1|||
129092093|NCT03589976|464627695|FG000|Overall Study|Adverse Event|5|||
129092094|NCT03589976|464627696|FG001|Overall Study|Adverse Event|1|||
129092095|NCT03589976|464627695|FG000|Overall Study|Withdrawal by Subject|4|||
129092096|NCT03589976|464627696|FG001|Overall Study|Withdrawal by Subject|1|||
129092097|NCT03589976|464627695|FG000|Overall Study|Lost to Follow-up|1|||
129092098|NCT03589976|464627696|FG001|Overall Study|Lost to Follow-up|0|||
129092099|NCT03589976|464627695|FG000|Overall Study|Other|4|||
129092100|NCT03589976|464627696|FG001|Overall Study|Other|3|||
129092101|NCT00514904|464627700|FG000|Overall Study|Withdrawal by Subject|3|||
129092102|NCT00514904|464627701|FG001|Overall Study|Withdrawal by Subject|2|||
129092103|NCT00514904|464627700|FG000|Overall Study|Lost to Follow-up|21|||
129092104|NCT00514904|464627701|FG001|Overall Study|Lost to Follow-up|3|||
129092105|NCT03197467|464628843|FG000|Overall Study|Withdrawal by Subject|1|||
129092106|NCT03666533|464628845|FG000|Overall Study|Lost to Follow-up|2|||
129092107|NCT03666533|464628846|FG001|Overall Study|Lost to Follow-up|2|||
129092108|NCT04392167|464628863|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
129092109|NCT04063657|464628865|FG000|Overall Study|Lost to Follow-up|1|||
129092110|NCT04063657|464628866|FG001|Overall Study|Lost to Follow-up|0|||
129092111|NCT03408444|464628867|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
129092112|NCT03408444|464628868|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
129092113|NCT03408444|464628869|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
129092114|NCT03408444|464628870|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
129092115|NCT03408444|464628867|FG000|Overall Study|Lens Discomfort|0|||
129092116|NCT03408444|464628868|FG001|Overall Study|Lens Discomfort|1|||
129092117|NCT03408444|464628869|FG002|Overall Study|Lens Discomfort|0|||
129092118|NCT03408444|464628870|FG003|Overall Study|Lens Discomfort|0|||
129092119|NCT03408444|464628867|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
129092120|NCT03408444|464628868|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
129092121|NCT03408444|464628869|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129092122|NCT03408444|464628870|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
129092123|NCT03408444|464628867|FG000|Overall Study|Withdrawal by Subject|0|||
129092124|NCT03408444|464628868|FG001|Overall Study|Withdrawal by Subject|2|||
129092125|NCT03408444|464628869|FG002|Overall Study|Withdrawal by Subject|3|||
129092126|NCT03408444|464628870|FG003|Overall Study|Withdrawal by Subject|0|||
129092127|NCT03408444|464628867|FG000|Overall Study|Lost to Follow-up|0|||
129092128|NCT03408444|464628868|FG001|Overall Study|Lost to Follow-up|0|||
129092129|NCT03408444|464628869|FG002|Overall Study|Lost to Follow-up|1|||
129092130|NCT03408444|464628870|FG003|Overall Study|Lost to Follow-up|0|||
129092131|NCT03408444|464628867|FG000|Overall Study|Adverse Event|0|||
129092132|NCT03408444|464628868|FG001|Overall Study|Adverse Event|0|||
129092133|NCT03408444|464628869|FG002|Overall Study|Adverse Event|0|||
129092134|NCT03408444|464628870|FG003|Overall Study|Adverse Event|1|||
129092135|NCT03408444|464628867|FG000|Overall Study|Lens Handling Difficulties|0|||
129092136|NCT03408444|464628868|FG001|Overall Study|Lens Handling Difficulties|0|||
129092137|NCT03408444|464628869|FG002|Overall Study|Lens Handling Difficulties|1|||
129092138|NCT03408444|464628870|FG003|Overall Study|Lens Handling Difficulties|0|||
129092139|NCT03408444|464628867|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
129092140|NCT03408444|464628868|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
129092141|NCT03408444|464628869|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
129092142|NCT03408444|464628870|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
129092143|NCT04984681|464628871|FG000|Overall Study|Lost to Follow-up|3|||
129092144|NCT04984681|464628872|FG001|Overall Study|Lost to Follow-up|1|||
129092145|NCT01473394|464628875|FG000|Overall Study|Adverse Event|13|||
129092146|NCT01473394|464628876|FG001|Overall Study|Adverse Event|16|||
129092147|NCT01473394|464628875|FG000|Overall Study|Insufficient Therapeutic Response|4|||
129092148|NCT01473394|464628876|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129092149|NCT01473394|464628875|FG000|Overall Study|Protocol Violation|7|||
129092150|NCT01473394|464628876|FG001|Overall Study|Protocol Violation|5|||
129092151|NCT01473394|464628875|FG000|Overall Study|Withdrew Consent|12|||
129092152|NCT01473394|464628876|FG001|Overall Study|Withdrew Consent|10|||
129092153|NCT01473394|464628875|FG000|Overall Study|Lost to Follow-up|9|||
129092154|NCT01473394|464628876|FG001|Overall Study|Lost to Follow-up|11|||
129092155|NCT01482962|464628879|FG000|Overall Study|Progressive Disease|65|||
129092156|NCT01482962|464628880|FG001|Overall Study|Progressive Disease|53|||
129092157|NCT01482962|464628879|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
129092158|NCT01482962|464628880|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
129092159|NCT01482962|464628879|FG000|Overall Study|Adverse Event|18|||
129092160|NCT01482962|464628880|FG001|Overall Study|Adverse Event|22|||
129092161|NCT01482962|464628879|FG000|Overall Study|Withdrawal by Participant|8|||
129092162|NCT01482962|464628880|FG001|Overall Study|Withdrawal by Participant|13|||
129092163|NCT01482962|464628879|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
129092164|NCT01482962|464628880|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
129092165|NCT01482962|464628879|FG000|Overall Study|Other Reason|1|||
129092166|NCT01482962|464628880|FG001|Overall Study|Other Reason|5|||
129092167|NCT01482962|464628879|FG000|Overall Study|Study Terminated by Sponsor|5|||
129092168|NCT01482962|464628880|FG001|Overall Study|Study Terminated by Sponsor|2|||
129092169|NCT01482962|464628879|FG000|Overall Study|Did not Receive Study Drug|1|||
129092170|NCT01482962|464628880|FG001|Overall Study|Did not Receive Study Drug|6|||
129092171|NCT06137703|464628884|FG000|Overall Study|Other|0|||
129092172|NCT06137703|464628885|FG001|Overall Study|Other|1|||
129092173|NCT06137703|464628886|FG002|Overall Study|Other|0|||
129092174|NCT06137703|464628887|FG003|Overall Study|Other|0|||
129092175|NCT06137703|464628884|FG000|Overall Study|Adverse Event|0|||
129092176|NCT06137703|464628885|FG001|Overall Study|Adverse Event|0|||
129092177|NCT06137703|464628886|FG002|Overall Study|Adverse Event|1|||
129092178|NCT06137703|464628887|FG003|Overall Study|Adverse Event|0|||
129092179|NCT00741091|464628890|FG000|Overall Study|Death|13|||
129092180|NCT00741091|464628890|FG000|Overall Study|Lost to Follow-up|16|||
129092181|NCT00741091|464628890|FG000|Overall Study|Withdrawal by Subject|6|||
129092182|NCT00741091|464628890|FG000|Overall Study|Missed Visit|22|||
129092183|NCT01801358|464628891|FG000|Overall Study|Adverse Event|0|||
129092184|NCT01801358|464628892|FG001|Overall Study|Adverse Event|2|||
129092185|NCT01801358|464628893|FG002|Overall Study|Adverse Event|1|||
129092186|NCT01801358|464628894|FG003|Overall Study|Adverse Event|0|||
129092187|NCT01801358|464628895|FG004|Overall Study|Adverse Event|0|||
129092188|NCT01801358|464628896|FG005|Overall Study|Adverse Event|1|||
129092189|NCT01801358|464628891|FG000|Overall Study|Physician Decision|0|||
129092190|NCT01801358|464628892|FG001|Overall Study|Physician Decision|0|||
129092191|NCT01801358|464628893|FG002|Overall Study|Physician Decision|1|||
129092192|NCT01801358|464628894|FG003|Overall Study|Physician Decision|0|||
129092193|NCT01801358|464628895|FG004|Overall Study|Physician Decision|0|||
129092194|NCT01801358|464628896|FG005|Overall Study|Physician Decision|0|||
129092195|NCT01801358|464628891|FG000|Overall Study|Progressive Disease|6|||
129092196|NCT01801358|464628892|FG001|Overall Study|Progressive Disease|4|||
129092197|NCT01801358|464628893|FG002|Overall Study|Progressive Disease|4|||
129092198|NCT01801358|464628894|FG003|Overall Study|Progressive Disease|5|||
129092199|NCT01801358|464628895|FG004|Overall Study|Progressive Disease|6|||
129092200|NCT01801358|464628896|FG005|Overall Study|Progressive Disease|5|||
129092201|NCT01801358|464628891|FG000|Overall Study|Withdrawal by Subject|0|||
129092202|NCT01801358|464628892|FG001|Overall Study|Withdrawal by Subject|0|||
129092203|NCT01801358|464628893|FG002|Overall Study|Withdrawal by Subject|0|||
129092204|NCT01801358|464628894|FG003|Overall Study|Withdrawal by Subject|1|||
129092205|NCT01801358|464628895|FG004|Overall Study|Withdrawal by Subject|0|||
129092206|NCT01801358|464628896|FG005|Overall Study|Withdrawal by Subject|2|||
129092207|NCT01527487|464628897|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
129092208|NCT01527487|464628898|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
129092209|NCT01527487|464628897|FG000|Overall Study|Disease Progression|4|||
129092210|NCT01527487|464628898|FG001|Overall Study|Disease Progression|1|||
129092211|NCT01527487|464628897|FG000|Overall Study|Adverse Event|1|||
129092212|NCT01527487|464628898|FG001|Overall Study|Adverse Event|1|||
129092213|NCT01527487|464628897|FG000|Overall Study|Death|0|||
129092214|NCT01527487|464628898|FG001|Overall Study|Death|1|||
129092215|NCT00723190|464628900|FG000|Overall Study|Withdrawal by Subject|45|||
129092216|NCT00723190|464628900|FG000|Overall Study|Lost to Follow-up|37|||
129092217|NCT00723190|464628900|FG000|Overall Study|Adverse Event|18|||
129092218|NCT00723190|464628900|FG000|Overall Study|Lack of Efficacy|16|||
129092219|NCT00723190|464628900|FG000|Overall Study|Protocol Violation|15|||
129092220|NCT00723190|464628900|FG000|Overall Study|Other-Premature Discontinuation|9|||
129092221|NCT00723190|464628900|FG000|Overall Study|Other-Not included in safety population|2|||
129092222|NCT03181503|464628901|FG000|Overall Study|Adverse Event|2|||
129092223|NCT03181503|464628902|FG001|Overall Study|Adverse Event|2|||
129092224|NCT03181503|464628901|FG000|Overall Study|Protocol Violation|1|||
129092225|NCT03181503|464628902|FG001|Overall Study|Protocol Violation|0|||
129092226|NCT03181503|464628901|FG000|Overall Study|Withdrawal by Subject|3|||
129092227|NCT03181503|464628902|FG001|Overall Study|Withdrawal by Subject|0|||
129092228|NCT03181503|464628901|FG000|Overall Study|Lost to Follow-up|1|||
129092229|NCT03181503|464628902|FG001|Overall Study|Lost to Follow-up|1|||
129092230|NCT01549041|464628910|FG000|Overall Study|Lack of Efficacy|2|||
129092231|NCT01549041|464628911|FG001|Overall Study|Lack of Efficacy|4|||
129092232|NCT01549041|464628910|FG000|Overall Study|Adverse Event|0|||
129092233|NCT01549041|464628911|FG001|Overall Study|Adverse Event|4|||
129092234|NCT00597506|464628912|FG000|Overall Study|Subject is being followed for survival|1|||
129092235|NCT01537068|464628920|FG000|Overall Study|Lost to Follow-up|2|||
129092236|NCT01537068|464628921|FG001|Overall Study|Lost to Follow-up|1|||
129092237|NCT01537068|464628920|FG000|Overall Study|Adverse Event|0|||
129092238|NCT01537068|464628921|FG001|Overall Study|Adverse Event|1|||
129092239|NCT01537068|464628920|FG000|Overall Study|Withdrawal by Subject|1|||
129092240|NCT01537068|464628921|FG001|Overall Study|Withdrawal by Subject|1|||
129092241|NCT01537068|464628920|FG000|Overall Study|Lack of Efficacy|1|||
129092242|NCT01537068|464628921|FG001|Overall Study|Lack of Efficacy|0|||
129092243|NCT00483704|464628922|FG000|Randomization|Withdrawal by Subject|19|||
129092244|NCT00483704|464628923|FG001|Randomization|Withdrawal by Subject|28|||
129092245|NCT00483704|464628924|FG002|Randomization|Withdrawal by Subject|18|||
129092246|NCT00483704|464628922|FG000|Randomization|Protocol Violation|14|||
129092247|NCT00483704|464628923|FG001|Randomization|Protocol Violation|25|||
129092248|NCT00483704|464628924|FG002|Randomization|Protocol Violation|22|||
129092249|NCT00483704|464628922|FG000|Randomization|Lost to Follow-up|14|||
129092250|NCT00483704|464628923|FG001|Randomization|Lost to Follow-up|14|||
129092251|NCT00483704|464628924|FG002|Randomization|Lost to Follow-up|19|||
129092252|NCT00483704|464628922|FG000|Randomization|Pregnancy|1|||
129092253|NCT00483704|464628923|FG001|Randomization|Pregnancy|0|||
129092254|NCT00483704|464628924|FG002|Randomization|Pregnancy|0|||
129092255|NCT00483704|464628922|FG000|Randomization|Physician Decision|2|||
129092256|NCT00483704|464628923|FG001|Randomization|Physician Decision|4|||
129092257|NCT00483704|464628924|FG002|Randomization|Physician Decision|0|||
129092258|NCT00483704|464628922|FG000|Randomization|Progressive disease|0|||
129092259|NCT00483704|464628923|FG001|Randomization|Progressive disease|0|||
129092260|NCT00483704|464628924|FG002|Randomization|Progressive disease|1|||
129092261|NCT00483704|464628922|FG000|Randomization|Lack of qualifying migraines|21|||
129092262|NCT00483704|464628923|FG001|Randomization|Lack of qualifying migraines|25|||
129092263|NCT00483704|464628924|FG002|Randomization|Lack of qualifying migraines|31|||
129092264|NCT00483704|464628922|FG000|Treatment|Lack of qualifying migraines|101|||
129092265|NCT00483704|464628923|FG001|Treatment|Lack of qualifying migraines|99|||
129092266|NCT00483704|464628924|FG002|Treatment|Lack of qualifying migraines|116|||
129092267|NCT00483704|464628922|FG000|Treatment|Adverse Event|3|||
129092268|NCT00483704|464628923|FG001|Treatment|Adverse Event|5|||
129092269|NCT00483704|464628924|FG002|Treatment|Adverse Event|4|||
129092270|NCT00483704|464628922|FG000|Treatment|Withdrawal by Subject|16|||
129092271|NCT00483704|464628923|FG001|Treatment|Withdrawal by Subject|12|||
129092272|NCT00483704|464628924|FG002|Treatment|Withdrawal by Subject|21|||
129092273|NCT00483704|464628922|FG000|Treatment|Protocol Violation|6|||
129092274|NCT00483704|464628923|FG001|Treatment|Protocol Violation|3|||
129092275|NCT00483704|464628924|FG002|Treatment|Protocol Violation|5|||
129092276|NCT00483704|464628922|FG000|Treatment|Lost to Follow-up|2|||
129092277|NCT00483704|464628923|FG001|Treatment|Lost to Follow-up|7|||
129092278|NCT00483704|464628924|FG002|Treatment|Lost to Follow-up|5|||
129092279|NCT00483704|464628922|FG000|Treatment|Lack of Efficacy|1|||
129092280|NCT00483704|464628923|FG001|Treatment|Lack of Efficacy|1|||
129092281|NCT00483704|464628924|FG002|Treatment|Lack of Efficacy|1|||
129092282|NCT00483704|464628922|FG000|Treatment|Pregnancy|0|||
129092283|NCT00483704|464628923|FG001|Treatment|Pregnancy|1|||
129092284|NCT00483704|464628924|FG002|Treatment|Pregnancy|0|||
129092285|NCT00483704|464628922|FG000|Treatment|Physician Decision|0|||
129145539|NCT02607722|464828198|FG000|Overall Study|no patient visit|18|||
129092286|NCT00483704|464628923|FG001|Treatment|Physician Decision|1|||
129092287|NCT00483704|464628924|FG002|Treatment|Physician Decision|4|||
129092288|NCT04442269|464628925|FG000|Overall Study|Adverse Event|1|||
129092289|NCT04442269|464628926|FG001|Overall Study|Adverse Event|0|||
129092290|NCT04442269|464628925|FG000|Overall Study|Death|0|||
129092291|NCT04442269|464628926|FG001|Overall Study|Death|1|||
129092292|NCT04442269|464628925|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
129092293|NCT04442269|464628926|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
129092294|NCT04442269|464628925|FG000|Overall Study|Lost to Follow-up|1|||
129092295|NCT04442269|464628926|FG001|Overall Study|Lost to Follow-up|0|||
129092296|NCT04442269|464628925|FG000|Overall Study|Withdrawal by Subject|3|||
129145540|NCT02607722|464828198|FG000|Overall Study|missing info in CRF|13|||
129145541|NCT02607722|464828198|FG000|Overall Study|Withdrawal by Subject|616|||
129145542|NCT02607722|464828198|FG000|Overall Study|Lost to Follow-up|312|||
129145543|NCT02607722|464828198|FG000|Overall Study|Improved|22|||
129145544|NCT02607722|464828198|FG000|Overall Study|Lack of Efficacy|316|||
129145545|NCT02607722|464828198|FG000|Overall Study|Adverse Event|2553|||
129145546|NCT02607722|464828198|FG000|Overall Study|Not treated|1|||
129145547|NCT02607722|464828198|FG000|Overall Study|No CRF collected|138|||
129145548|NCT02607722|464828198|FG000|Overall Study|without CRF|4225|||
129145549|NCT02607722|464828198|FG000|Overall Study|Physician Decision|367|||
129145550|NCT04347538|464828199|FG000|Overall Study|Lost to Follow-up|4|||
129145551|NCT04347538|464828200|FG001|Overall Study|Lost to Follow-up|5|||
129145552|NCT04347538|464828201|FG002|Overall Study|Lost to Follow-up|7|||
129145553|NCT02135133|464828202|FG000|Overall Study|Adverse Event|10|||
129145554|NCT02135133|464828202|FG000|Overall Study|regulatory mandate|5|||
129145555|NCT03238196|464828203|FG000|Overall Study|Adverse Event|3|||
129145556|NCT03238196|464828204|FG001|Overall Study|Adverse Event|0|||
129145557|NCT03238196|464828205|FG002|Overall Study|Adverse Event|2|||
129145558|NCT03238196|464828206|FG003|Overall Study|Adverse Event|2|||
129145559|NCT03238196|464828203|FG000|Overall Study|Withdrawal by Subject|4|||
129145560|NCT03238196|464828204|FG001|Overall Study|Withdrawal by Subject|1|||
129145561|NCT03238196|464828205|FG002|Overall Study|Withdrawal by Subject|1|||
129145562|NCT03238196|464828206|FG003|Overall Study|Withdrawal by Subject|0|||
129145563|NCT03238196|464828203|FG000|Overall Study|Disease progression|14|||
129145564|NCT03238196|464828204|FG001|Overall Study|Disease progression|2|||
129145565|NCT03238196|464828205|FG002|Overall Study|Disease progression|3|||
129145566|NCT03238196|464828206|FG003|Overall Study|Disease progression|2|||
129145567|NCT03238196|464828203|FG000|Overall Study|Still on treatment|1|||
129145568|NCT03238196|464828204|FG001|Overall Study|Still on treatment|0|||
129145569|NCT03238196|464828205|FG002|Overall Study|Still on treatment|0|||
129145570|NCT03238196|464828206|FG003|Overall Study|Still on treatment|0|||
129145571|NCT05081843|464828207|FG000|Overall Study|Lost to Follow-up|135|||
129145572|NCT05081843|464828208|FG001|Overall Study|Lost to Follow-up|145|||
129145573|NCT02303821|464828209|FG000|Overall Study|Withdrawal by Subject|0|||
129145574|NCT02303821|464828210|FG001|Overall Study|Withdrawal by Subject|0|||
129145575|NCT02303821|464828211|FG002|Overall Study|Withdrawal by Subject|0|||
129145576|NCT02303821|464828212|FG003|Overall Study|Withdrawal by Subject|0|||
129145577|NCT02303821|464828213|FG004|Overall Study|Withdrawal by Subject|0|||
129145578|NCT02303821|464828214|FG005|Overall Study|Withdrawal by Subject|0|||
129145579|NCT02303821|464828215|FG006|Overall Study|Withdrawal by Subject|0|||
129145580|NCT02303821|464828216|FG007|Overall Study|Withdrawal by Subject|2|||
129145581|NCT02303821|464828209|FG000|Overall Study|Death|0|||
129145582|NCT02303821|464828210|FG001|Overall Study|Death|2|||
129145583|NCT02303821|464828211|FG002|Overall Study|Death|0|||
129145584|NCT02303821|464828212|FG003|Overall Study|Death|0|||
129145585|NCT02303821|464828213|FG004|Overall Study|Death|0|||
129145586|NCT02303821|464828214|FG005|Overall Study|Death|3|||
129145587|NCT02303821|464828215|FG006|Overall Study|Death|41|||
129145588|NCT02303821|464828216|FG007|Overall Study|Death|29|||
129092297|NCT04442269|464628926|FG001|Overall Study|Withdrawal by Subject|2|||
129092298|NCT04442269|464628925|FG000|Overall Study|Protocol Deviation|0|||
129092299|NCT04442269|464628926|FG001|Overall Study|Protocol Deviation|1|||
129092300|NCT04442269|464628925|FG000|Overall Study|Travel Limitations|1|||
129092301|NCT04442269|464628926|FG001|Overall Study|Travel Limitations|1|||
129092302|NCT01793688|464628927|FG000|Overall Study|Protocol Violation|2|||
129092303|NCT04450407|464628930|FG000|Overall Study|Withdrawal by Subject|10|||
129092304|NCT04450407|464628931|FG001|Overall Study|Withdrawal by Subject|1|||
129092305|NCT04450407|464628932|FG002|Overall Study|Withdrawal by Subject|4|||
129092306|NCT04450407|464628930|FG000|Overall Study|Adverse Event|0|||
129092307|NCT04450407|464628931|FG001|Overall Study|Adverse Event|0|||
129092308|NCT04450407|464628932|FG002|Overall Study|Adverse Event|1|||
129092309|NCT04450407|464628930|FG000|Overall Study|Lost to Follow-up|1|||
129092310|NCT04450407|464628931|FG001|Overall Study|Lost to Follow-up|0|||
129145589|NCT02303821|464828209|FG000|Overall Study|Lost to Follow-up|0|||
129145590|NCT02303821|464828210|FG001|Overall Study|Lost to Follow-up|0|||
129145591|NCT02303821|464828211|FG002|Overall Study|Lost to Follow-up|0|||
129145592|NCT02303821|464828212|FG003|Overall Study|Lost to Follow-up|0|||
129145593|NCT02303821|464828213|FG004|Overall Study|Lost to Follow-up|0|||
129092311|NCT04450407|464628932|FG002|Overall Study|Lost to Follow-up|0|||
129092312|NCT04450407|464628930|FG000|Overall Study|Physician Decision|0|||
129145594|NCT02303821|464828214|FG005|Overall Study|Lost to Follow-up|0|||
129145595|NCT02303821|464828215|FG006|Overall Study|Lost to Follow-up|1|||
129145596|NCT02303821|464828216|FG007|Overall Study|Lost to Follow-up|0|||
129145597|NCT02303821|464828209|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129145598|NCT02303821|464828210|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129145599|NCT02303821|464828211|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129145600|NCT02303821|464828212|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129145601|NCT02303821|464828213|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129145602|NCT02303821|464828214|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129145603|NCT02303821|464828215|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
129145604|NCT02303821|464828216|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129092313|NCT04450407|464628931|FG001|Overall Study|Physician Decision|0|||
129092314|NCT04450407|464628932|FG002|Overall Study|Physician Decision|1|||
129092315|NCT04450407|464628930|FG000|Overall Study|Pregnancy|1|||
129092316|NCT04450407|464628931|FG001|Overall Study|Pregnancy|0|||
129092317|NCT04450407|464628932|FG002|Overall Study|Pregnancy|0|||
129092318|NCT04450407|464628930|FG000|Overall Study|Protocol Violation|2|||
129092319|NCT04450407|464628931|FG001|Overall Study|Protocol Violation|0|||
129092320|NCT04450407|464628932|FG002|Overall Study|Protocol Violation|0|||
129092321|NCT04450407|464628930|FG000|Overall Study|Investigational site terminated by sponsor|3|||
129092322|NCT04450407|464628931|FG001|Overall Study|Investigational site terminated by sponsor|0|||
129092323|NCT04450407|464628932|FG002|Overall Study|Investigational site terminated by sponsor|2|||
129092324|NCT03430895|464628936|FG000|Overall Study|Not Treated|2|||
129092325|NCT01317797|464628937|FG000|Overall Study|Other|0|||
129092326|NCT01317797|464628938|FG001|Overall Study|Other|1|||
129092327|NCT01317797|464628939|FG002|Overall Study|Other|0|||
129092328|NCT01317797|464628937|FG000|Overall Study|Withdrawal of Patient|0|||
129092329|NCT01317797|464628938|FG001|Overall Study|Withdrawal of Patient|0|||
129092330|NCT01317797|464628939|FG002|Overall Study|Withdrawal of Patient|1|||
129092331|NCT01645891|464628946|FG000|Overall Study|Adverse Event|6|||
129092332|NCT01645891|464628947|FG001|Overall Study|Adverse Event|10|||
129092333|NCT01645891|464628946|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
129092334|NCT01645891|464628947|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
129092335|NCT01645891|464628946|FG000|Overall Study|Withdrawal by Subject|3|||
129145605|NCT02303821|464828209|FG000|Overall Study|Decision by sponsor|0|||
129145606|NCT02303821|464828210|FG001|Overall Study|Decision by sponsor|0|||
129145607|NCT02303821|464828211|FG002|Overall Study|Decision by sponsor|0|||
129145608|NCT02303821|464828212|FG003|Overall Study|Decision by sponsor|0|||
129145609|NCT02303821|464828213|FG004|Overall Study|Decision by sponsor|0|||
129145610|NCT02303821|464828214|FG005|Overall Study|Decision by sponsor|1|||
129145611|NCT02303821|464828215|FG006|Overall Study|Decision by sponsor|0|||
129145612|NCT02303821|464828216|FG007|Overall Study|Decision by sponsor|0|||
129145613|NCT02303821|464828209|FG000|Overall Study|Protocol-specified criteria|0|||
129145614|NCT02303821|464828210|FG001|Overall Study|Protocol-specified criteria|1|||
129145615|NCT02303821|464828211|FG002|Overall Study|Protocol-specified criteria|0|||
129145616|NCT02303821|464828212|FG003|Overall Study|Protocol-specified criteria|0|||
129145617|NCT02303821|464828213|FG004|Overall Study|Protocol-specified criteria|0|||
129145618|NCT02303821|464828214|FG005|Overall Study|Protocol-specified criteria|1|||
129145619|NCT02303821|464828215|FG006|Overall Study|Protocol-specified criteria|0|||
129145620|NCT02303821|464828216|FG007|Overall Study|Protocol-specified criteria|0|||
129145621|NCT04938427|464828219|FG000|Overall Study|Adverse Event|5|||
129145622|NCT04938427|464828220|FG001|Overall Study|Adverse Event|19|||
129145623|NCT04938427|464828219|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129145624|NCT04938427|464828220|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129145625|NCT04938427|464828219|FG000|Overall Study|Withdrawal by Subject|1|||
129092336|NCT01645891|464628947|FG001|Overall Study|Withdrawal by Subject|3|||
129092337|NCT01645891|464628946|FG000|Overall Study|Protocol Violation|4|||
129092338|NCT01645891|464628947|FG001|Overall Study|Protocol Violation|0|||
129092339|NCT01645891|464628946|FG000|Overall Study|Lost to Follow-up|4|||
129092340|NCT01645891|464628947|FG001|Overall Study|Lost to Follow-up|1|||
129092341|NCT01645891|464628946|FG000|Overall Study|Death|0|||
129092342|NCT01645891|464628947|FG001|Overall Study|Death|2|||
129092343|NCT03026530|464628948|FG000|Overall Study|Lost to Follow-up|19|||
129092344|NCT03026530|464628949|FG001|Overall Study|Lost to Follow-up|24|||
129092345|NCT03026530|464628948|FG000|Overall Study|Protocol Violation|2|||
129145626|NCT04938427|464828220|FG001|Overall Study|Withdrawal by Subject|0|||
129092346|NCT03026530|464628949|FG001|Overall Study|Protocol Violation|5|||
129092347|NCT00138073|464628950|FG000|Overall Study|lack of resources|55|||
129092348|NCT05072964|464628954|FG000|Overall Study|Withdrawal by Subject|4|||
129145627|NCT04938427|464828219|FG000|Overall Study|Reason Not Specified|2|||
129145628|NCT04938427|464828220|FG001|Overall Study|Reason Not Specified|1|||
129145629|NCT05852340|464828229|FG000|Period 5|Not completing the meal|0|||
129092349|NCT05072964|464628954|FG000|Overall Study|Death|1|||
129092350|NCT02417961|464630242|FG000|Overall Study|Adverse Event|1|||
129092351|NCT02417961|464630242|FG000|Overall Study|Lost to Follow-up|1|||
129092352|NCT02417961|464630242|FG000|Overall Study|Withdrawal by Subject|2|||
129092353|NCT00250458|464630245|FG000|Overall Study|Lost to Follow-up|4|||
129092354|NCT00250458|464630246|FG001|Overall Study|Lost to Follow-up|2|||
129092355|NCT00250458|464630245|FG000|Overall Study|Protocol Violation|0|||
129145630|NCT05852340|464828230|FG001|Period 5|Not completing the meal|1|||
129092356|NCT00250458|464630246|FG001|Overall Study|Protocol Violation|1|||
129092357|NCT00250458|464630245|FG000|Overall Study|Withdrawal by Subject|4|||
129145631|NCT05852340|464828231|FG002|Period 5|Not completing the meal|0|||
129145632|NCT05852340|464828232|FG003|Period 5|Not completing the meal|0|||
129145633|NCT05852340|464828229|FG000|Period 5|Adverse Event|0|||
129145634|NCT05852340|464828230|FG001|Period 5|Adverse Event|0|||
129145635|NCT05852340|464828231|FG002|Period 5|Adverse Event|0|||
129145636|NCT05852340|464828232|FG003|Period 5|Adverse Event|1|||
129145637|NCT05852470|464828233|FG000|Overall Study|Withdrawal by Subject|0|||
129145638|NCT05852470|464828234|FG001|Overall Study|Withdrawal by Subject|1|||
129145639|NCT01972659|464828239|FG000|Overall Study|Protocol Violation|2|||
129145640|NCT01972659|464828240|FG001|Overall Study|Protocol Violation|2|||
129145641|NCT01972659|464828239|FG000|Overall Study|problems realted to acceleromyograph|2|||
129145642|NCT01972659|464828240|FG001|Overall Study|problems realted to acceleromyograph|1|||
129145643|NCT04144517|464828243|FG000|Overall Study|Physician Decision|0|||
129145644|NCT04144517|464828244|FG001|Overall Study|Physician Decision|1|||
129145645|NCT04144517|464828243|FG000|Overall Study|Other|2|||
129145646|NCT04144517|464828244|FG001|Overall Study|Other|2|||
129145647|NCT04144517|464828243|FG000|Overall Study|Death|6|||
129145648|NCT04144517|464828244|FG001|Overall Study|Death|3|||
129145649|NCT00835367|464828250|FG000|Washout|Adverse Event|2|||
129145650|NCT00835367|464828251|FG001|Washout|Adverse Event|0|||
129145651|NCT00835367|464828250|FG000|Washout|Withdrawal by Subject|1|||
129145652|NCT00835367|464828251|FG001|Washout|Withdrawal by Subject|0|||
129145653|NCT00835367|464828250|FG000|Second Intervention|Adverse Event|1|||
129145654|NCT00835367|464828251|FG001|Second Intervention|Adverse Event|1|||
129145655|NCT01397253|464830066|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
129145656|NCT01397253|464830067|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
129145657|NCT01892189|464830068|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
129145658|NCT01892189|464830069|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
129145659|NCT01892189|464830070|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
129145660|NCT01892189|464830071|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
129145661|NCT01892189|464830072|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
129145662|NCT01892189|464830073|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
129145663|NCT01892189|464830074|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
129145664|NCT01892189|464830075|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
129145665|NCT01892189|464830076|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
129145666|NCT01892189|464830068|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129145667|NCT01892189|464830069|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129145668|NCT01892189|464830070|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
129145669|NCT01892189|464830071|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129145670|NCT01892189|464830072|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129092358|NCT00250458|464630246|FG001|Overall Study|Withdrawal by Subject|2|||
129092359|NCT00250458|464630245|FG000|Overall Study|Lack of Migraine Attack|20|||
129092360|NCT00250458|464630246|FG001|Overall Study|Lack of Migraine Attack|9|||
129092361|NCT00250458|464630245|FG000|Overall Study|Qualifying migraine but did not treat|3|||
129092362|NCT00250458|464630246|FG001|Overall Study|Qualifying migraine but did not treat|3|||
129092363|NCT00250458|464630245|FG000|Overall Study|Other|1|||
129092364|NCT00250458|464630246|FG001|Overall Study|Other|0|||
129092365|NCT01892085|464630249|FG000|Overall Study|Death|4|||
129092366|NCT01892085|464630250|FG001|Overall Study|Death|1|||
129092367|NCT01892085|464630251|FG002|Overall Study|Death|3|||
129092368|NCT01892085|464630249|FG000|Overall Study|Withdrawal by Subject|2|||
129092369|NCT01892085|464630250|FG001|Overall Study|Withdrawal by Subject|0|||
129092370|NCT01892085|464630251|FG002|Overall Study|Withdrawal by Subject|2|||
129092371|NCT01629823|464630252|FG000|Trial Period|Missed visit|11|||
129092372|NCT01629823|464630253|FG001|Trial Period|Missed visit|9|||
129092373|NCT01629823|464630254|FG002|Trial Period|Missed visit|8|||
129092374|NCT01629823|464630252|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
129092375|NCT01629823|464630253|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
129092376|NCT01629823|464630254|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
129092377|NCT01629823|464630252|FG000|Trial Period|Pregnancy|1|||
129092378|NCT01629823|464630253|FG001|Trial Period|Pregnancy|0|||
129145671|NCT01892189|464830073|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129145672|NCT01892189|464830074|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129145673|NCT01892189|464830075|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129145674|NCT01892189|464830076|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
128724757|NCT02036502|463290914|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129092379|NCT01629823|464630254|FG002|Trial Period|Pregnancy|0|||
129092380|NCT01629823|464630252|FG000|Trial Period|Adverse Event|0|||
129145675|NCT01892189|464830068|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129145676|NCT01892189|464830069|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129145677|NCT01892189|464830070|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129145678|NCT01892189|464830071|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129145679|NCT01892189|464830072|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129145680|NCT01892189|464830073|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
129145681|NCT01892189|464830074|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129092381|NCT01629823|464630253|FG001|Trial Period|Adverse Event|1|||
129092382|NCT01629823|464630254|FG002|Trial Period|Adverse Event|0|||
129092383|NCT01629823|464630252|FG000|Trial Period|Out-of-window visit|0|||
129092384|NCT01629823|464630253|FG001|Trial Period|Out-of-window visit|2|||
129092385|NCT01629823|464630254|FG002|Trial Period|Out-of-window visit|0|||
129092386|NCT01629823|464630252|FG000|Trial Period|Failed to hold medication|0|||
129092387|NCT01629823|464630253|FG001|Trial Period|Failed to hold medication|0|||
129092388|NCT01629823|464630254|FG002|Trial Period|Failed to hold medication|1|||
129092389|NCT01629823|464630252|FG000|Washout Period|Safety|2|||
129092390|NCT01629823|464630253|FG001|Washout Period|Safety|5|||
129092391|NCT01629823|464630254|FG002|Washout Period|Safety|0|||
129092392|NCT01629823|464630252|FG000|Washout Period|Pregnancy|1|||
129092393|NCT01629823|464630253|FG001|Washout Period|Pregnancy|0|||
129092394|NCT01629823|464630254|FG002|Washout Period|Pregnancy|0|||
129092395|NCT01629823|464630252|FG000|Washout Period|Protocol Violation|0|||
129092396|NCT01629823|464630253|FG001|Washout Period|Protocol Violation|1|||
129092397|NCT01629823|464630254|FG002|Washout Period|Protocol Violation|0|||
129092398|NCT02609724|464630255|FG000|Overall Study|Death|2|||
129092399|NCT02609724|464630256|FG001|Overall Study|Death|0|||
129092400|NCT02609724|464630257|FG002|Overall Study|Death|1|||
129092401|NCT02609724|464630255|FG000|Overall Study|Withdrawal by Subject|1|||
129092402|NCT02609724|464630256|FG001|Overall Study|Withdrawal by Subject|2|||
129092403|NCT02609724|464630257|FG002|Overall Study|Withdrawal by Subject|3|||
129092404|NCT02609724|464630255|FG000|Overall Study|Illness|2|||
129092405|NCT02609724|464630256|FG001|Overall Study|Illness|1|||
129092406|NCT02609724|464630257|FG002|Overall Study|Illness|0|||
129092407|NCT03077659|464630258|FG000|Overall Study|Withdrawal by Subject|0|||
129092408|NCT03077659|464630259|FG001|Overall Study|Withdrawal by Subject|0|||
129092409|NCT03077659|464630260|FG002|Overall Study|Withdrawal by Subject|1|||
129092410|NCT02844907|464630261|FG000|With Dexamethasone|No IV access|1|||
129092411|NCT00550862|464630262|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
129092412|NCT00550862|464630263|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
129092413|NCT00550862|464630264|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
129092414|NCT00550862|464630265|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
129092415|NCT00550862|464630266|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
129092416|NCT00550862|464630262|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
129092417|NCT00550862|464630263|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
129092418|NCT00550862|464630264|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
129092419|NCT00550862|464630265|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
129092420|NCT00550862|464630266|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
129092421|NCT00550862|464630262|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129092422|NCT00550862|464630263|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129092423|NCT00550862|464630264|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
129092424|NCT00550862|464630265|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129092425|NCT00550862|464630266|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129092426|NCT00550862|464630262|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129092427|NCT00550862|464630263|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129092428|NCT00550862|464630264|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
129092429|NCT00550862|464630265|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129092430|NCT00550862|464630266|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129092431|NCT00550862|464630262|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129092432|NCT00550862|464630263|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
129092433|NCT00550862|464630264|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129092434|NCT00550862|464630265|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129092435|NCT00550862|464630266|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129092436|NCT00550862|464630262|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129092437|NCT00550862|464630263|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129145682|NCT01892189|464830075|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129145683|NCT01892189|464830076|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129145684|NCT03322566|464830084|FG000|Overall Study|Death|34|||
129145685|NCT03322566|464830085|FG001|Overall Study|Death|35|||
129145686|NCT03322566|464830086|FG002|Overall Study|Death|23|||
129145687|NCT03322566|464830084|FG000|Overall Study|Physician Decision|6|||
129145688|NCT03322566|464830085|FG001|Overall Study|Physician Decision|7|||
129145689|NCT03322566|464830086|FG002|Overall Study|Physician Decision|2|||
129145690|NCT03322566|464830084|FG000|Overall Study|Withdrawal by Subject|4|||
129145691|NCT03322566|464830085|FG001|Overall Study|Withdrawal by Subject|3|||
129145692|NCT03322566|464830086|FG002|Overall Study|Withdrawal by Subject|6|||
129145693|NCT03322566|464830084|FG000|Overall Study|Lost to Follow-up|0|||
129145694|NCT03322566|464830085|FG001|Overall Study|Lost to Follow-up|0|||
129145695|NCT03322566|464830086|FG002|Overall Study|Lost to Follow-up|1|||
129092438|NCT00550862|464630264|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129092439|NCT00550862|464630265|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129092440|NCT00550862|464630266|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
129092441|NCT00550862|464630262|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129092442|NCT00550862|464630263|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129092443|NCT00550862|464630264|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129092444|NCT00550862|464630265|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129092445|NCT00550862|464630266|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
129092446|NCT00550862|464630262|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129092447|NCT00550862|464630263|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129092448|NCT00550862|464630264|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129092449|NCT00550862|464630265|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129092450|NCT00550862|464630266|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
129092451|NCT00550862|464630262|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
129092452|NCT00550862|464630263|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
129092453|NCT00550862|464630264|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
129092454|NCT00550862|464630265|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
129092455|NCT00550862|464630266|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
129092456|NCT00550862|464630262|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129092457|NCT00550862|464630263|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129092458|NCT00550862|464630264|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129092459|NCT00550862|464630265|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129092460|NCT00550862|464630266|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
129092461|NCT03488225|464630269|FG000|Overall Study|Off Protocol Therapy|2|||
129092462|NCT03488225|464630269|FG000|Overall Study|Stem Cell Transplant|2|||
129092463|NCT00986986|464630270|FG000|Overall Study|Lost to Follow-up|0|||
129092464|NCT00986986|464630271|FG001|Overall Study|Lost to Follow-up|1|||
129092465|NCT02003963|464630274|FG000|Overall Study|Lost to Follow-up|2|||
129092466|NCT02003963|464630275|FG001|Overall Study|Lost to Follow-up|1|||
129092467|NCT05020366|464630277|FG000|Overall Study|Lost to Follow-up|2|||
129092468|NCT05020366|464630278|FG001|Overall Study|Lost to Follow-up|0|||
129092469|NCT05020366|464630277|FG000|Overall Study|Withdrawal by Subject|2|||
129092470|NCT05020366|464630278|FG001|Overall Study|Withdrawal by Subject|0|||
129092471|NCT03589326|464630280|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
129092472|NCT03589326|464630281|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
129092473|NCT03589326|464630280|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
129092474|NCT03589326|464630281|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
129092475|NCT03589326|464630280|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
129092476|NCT03589326|464630281|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
129145696|NCT03322566|464830084|FG000|Overall Study|Study terminated by sponsor|1|||
129145697|NCT03322566|464830085|FG001|Overall Study|Study terminated by sponsor|0|||
129145698|NCT03322566|464830086|FG002|Overall Study|Study terminated by sponsor|1|||
129145699|NCT03847519|464830087|FG000|Overall Study|Death|5|||
128724758|NCT02036502|463290915|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
129092477|NCT03589326|464630280|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
129092478|NCT03589326|464630281|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
129092479|NCT03589326|464630280|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
129092480|NCT03589326|464630281|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
129092481|NCT04050124|464630282|FG000|Overall Study|Death|1|||
129092482|NCT04050124|464630283|FG001|Overall Study|Death|0|||
129092483|NCT00430352|464630285|FG000|Overall Study|Disease progression|58|||
129092484|NCT00430352|464630285|FG000|Overall Study|Withdrawal by Subject|11|||
129092485|NCT00430352|464630285|FG000|Overall Study|Adverse Event|16|||
129092486|NCT00430352|464630285|FG000|Overall Study|Death|5|||
129092487|NCT00430352|464630285|FG000|Overall Study|Other|48|||
129092488|NCT00819780|464630288|FG000|Overall Study|Did not receive study drug|3|||
129092489|NCT00819780|464630289|FG001|Overall Study|Did not receive study drug|4|||
129092490|NCT00819780|464630288|FG000|Overall Study|Still in treatment|25|||
129092491|NCT00819780|464630289|FG001|Overall Study|Still in treatment|17|||
129092492|NCT00150800|464630290|FG000|Overall Study|Adverse Event|89|||
129092493|NCT00150800|464630290|FG000|Overall Study|Death|18|||
129092494|NCT00150800|464630290|FG000|Overall Study|Lack of Efficacy|166|||
129145700|NCT03847519|464830088|FG001|Overall Study|Death|8|||
129145701|NCT03847519|464830089|FG002|Overall Study|Death|1|||
129145702|NCT03847519|464830087|FG000|Overall Study|Lost to Follow-up|1|||
129145703|NCT03847519|464830088|FG001|Overall Study|Lost to Follow-up|2|||
128724759|NCT02036502|463290916|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
129092495|NCT00150800|464630290|FG000|Overall Study|Lost to Follow-up|58|||
129092496|NCT00150800|464630290|FG000|Overall Study|Subject's choice|90|||
129092497|NCT00150800|464630290|FG000|Overall Study|No compliance|18|||
129092498|NCT00150800|464630290|FG000|Overall Study|IP misshandling|1|||
129092499|NCT00150800|464630290|FG000|Overall Study|Site closure|24|||
129092500|NCT00150800|464630290|FG000|Overall Study|Protocol non-adherence|2|||
129092501|NCT00150800|464630290|FG000|Overall Study|Nobody to accompany patient|1|||
129092502|NCT00150800|464630290|FG000|Overall Study|Distance too long for patient|1|||
129092503|NCT00150800|464630290|FG000|Overall Study|Neurosurgery|2|||
129092504|NCT00150800|464630290|FG000|Overall Study|BRV monotherapy|1|||
129092505|NCT00150800|464630290|FG000|Overall Study|Visit refusal|3|||
129092506|NCT00150800|464630290|FG000|Overall Study|Sponsor's request|2|||
129092507|NCT00150800|464630290|FG000|Overall Study|Generalized Epilepsy|1|||
129092508|NCT00150800|464630290|FG000|Overall Study|Moved from area/country|8|||
129092509|NCT00150800|464630290|FG000|Overall Study|PI retiring|2|||
129092510|NCT00150800|464630290|FG000|Overall Study|PI leaving site|2|||
129092511|NCT00150800|464630290|FG000|Overall Study|Patient insurance|1|||
129092512|NCT00150800|464630290|FG000|Overall Study|Surgical intervention|4|||
129092513|NCT00150800|464630290|FG000|Overall Study|Pregnancy planned|1|||
129092514|NCT00150800|464630290|FG000|Overall Study|PI discontinuation request|1|||
129092515|NCT02089334|464630291|FG000|Overall Study|Withdrawal by Subject|0|||
129092516|NCT02089334|464630292|FG001|Overall Study|Withdrawal by Subject|0|||
129092517|NCT02089334|464630293|FG002|Overall Study|Withdrawal by Subject|0|||
129092518|NCT02089334|464630294|FG003|Overall Study|Withdrawal by Subject|2|||
129092519|NCT02089334|464630291|FG000|Overall Study|Adverse Event|0|||
129092520|NCT02089334|464630292|FG001|Overall Study|Adverse Event|0|||
129092521|NCT02089334|464630293|FG002|Overall Study|Adverse Event|0|||
129092522|NCT02089334|464630294|FG003|Overall Study|Adverse Event|2|||
129092523|NCT02089334|464630291|FG000|Overall Study|Progressive disease|0|||
129092524|NCT02089334|464630292|FG001|Overall Study|Progressive disease|0|||
129092525|NCT02089334|464630293|FG002|Overall Study|Progressive disease|0|||
129092526|NCT02089334|464630294|FG003|Overall Study|Progressive disease|2|||
129092527|NCT02089334|464630291|FG000|Overall Study|Physician Decision|0|||
129092528|NCT02089334|464630292|FG001|Overall Study|Physician Decision|0|||
129092529|NCT02089334|464630293|FG002|Overall Study|Physician Decision|1|||
129092530|NCT02089334|464630294|FG003|Overall Study|Physician Decision|1|||
129092531|NCT02832375|464630295|FG000|Overall Study|Lost to Follow-up|1|||
129092532|NCT02832375|464630296|FG001|Overall Study|Lost to Follow-up|0|||
129092533|NCT02832375|464630295|FG000|Overall Study|Withdrawal of Consent|1|||
129092534|NCT02832375|464630296|FG001|Overall Study|Withdrawal of Consent|0|||
129092535|NCT00084318|464630299|FG000|Overall Study|Withdrawal by Subject|5|||
129092536|NCT00084318|464630300|FG001|Overall Study|Withdrawal by Subject|2|||
129092537|NCT00084318|464630299|FG000|Overall Study|Protocol Violation|15|||
129092538|NCT00084318|464630300|FG001|Overall Study|Protocol Violation|11|||
129092539|NCT00084318|464630299|FG000|Overall Study|No protocol treatment|2|||
129092540|NCT00084318|464630300|FG001|Overall Study|No protocol treatment|0|||
129092541|NCT03301740|464630302|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
129092542|NCT03301740|464630303|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
129092543|NCT03301740|464630302|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
129092544|NCT03301740|464630303|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
129092545|NCT01037127|464630304|FG000|Overall Study|Lost to Follow-up|2|||
129092546|NCT01037127|464630305|FG001|Overall Study|Lost to Follow-up|4|||
129092547|NCT01037127|464630304|FG000|Overall Study|Physician Decision|1|||
129092548|NCT01037127|464630305|FG001|Overall Study|Physician Decision|0|||
129092549|NCT01037127|464630304|FG000|Overall Study|Study Closed Terminated|2|||
129092550|NCT01037127|464630305|FG001|Overall Study|Study Closed Terminated|17|||
129092551|NCT02637713|464630312|FG000|Overall Study|Screen Failure|2|||
129092552|NCT02847182|464630313|FG000|Overall Study|Withdrawal by Subject|0|||
129092553|NCT02847182|464630314|FG001|Overall Study|Withdrawal by Subject|1|||
129092554|NCT02345889|464630315|FG000|Overall Study|Inadequate Bowel Prep|17|||
129092555|NCT02345889|464630316|FG001|Overall Study|Inadequate Bowel Prep|16|||
129092556|NCT02345889|464630317|FG002|Overall Study|Inadequate Bowel Prep|18|||
129092557|NCT02345889|464630318|FG003|Overall Study|Inadequate Bowel Prep|14|||
129092558|NCT02345889|464630315|FG000|Overall Study|Polyposis identified during procedure|1|||
129092559|NCT02345889|464630316|FG001|Overall Study|Polyposis identified during procedure|1|||
129092560|NCT02345889|464630317|FG002|Overall Study|Polyposis identified during procedure|0|||
129092561|NCT02345889|464630318|FG003|Overall Study|Polyposis identified during procedure|1|||
129092562|NCT02345889|464630315|FG000|Overall Study|Recognized ineligible post-randomization|1|||
129092563|NCT02345889|464630316|FG001|Overall Study|Recognized ineligible post-randomization|0|||
129145704|NCT03847519|464830089|FG002|Overall Study|Lost to Follow-up|0|||
129145705|NCT03847519|464830087|FG000|Overall Study|Study Terminated by Sponsor|0|||
129092564|NCT02345889|464630317|FG002|Overall Study|Recognized ineligible post-randomization|2|||
129092565|NCT02345889|464630318|FG003|Overall Study|Recognized ineligible post-randomization|1|||
129092566|NCT02345889|464630315|FG000|Overall Study|Ulcerative Colitis identified|1|||
129092567|NCT02345889|464630316|FG001|Overall Study|Ulcerative Colitis identified|0|||
129092568|NCT02345889|464630317|FG002|Overall Study|Ulcerative Colitis identified|0|||
129092569|NCT02345889|464630318|FG003|Overall Study|Ulcerative Colitis identified|0|||
129092570|NCT02345889|464630315|FG000|Overall Study|Cecum not intubated|1|||
129092571|NCT02345889|464630316|FG001|Overall Study|Cecum not intubated|0|||
129092572|NCT02345889|464630317|FG002|Overall Study|Cecum not intubated|0|||
129092573|NCT02345889|464630318|FG003|Overall Study|Cecum not intubated|0|||
129092574|NCT01173055|464630320|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
128724760|NCT02036502|463290917|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
128724761|NCT02036502|463290918|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
128724762|NCT02036502|463290919|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
128724763|NCT02036502|463290920|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
128724764|NCT02036502|463290913|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129092575|NCT01173055|464630321|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
129092576|NCT01173055|464630320|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
129092577|NCT01173055|464630321|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
129092578|NCT04325698|464630322|FG000|Overall Study|Study Terminated By Sponsor|1|||
129092579|NCT04325698|464630323|FG001|Overall Study|Study Terminated By Sponsor|1|||
129092580|NCT04325698|464630322|FG000|Overall Study|Withdrawal by Subject|0|||
129092581|NCT04325698|464630323|FG001|Overall Study|Withdrawal by Subject|2|||
129092582|NCT04253782|464630324|FG000|Overall Study|Death|2|||
129092583|NCT04253782|464630325|FG001|Overall Study|Death|0|||
129092584|NCT00962091|464630326|FG000|Overall Study|Withdrawal by Subject|1|||
129092585|NCT00962091|464630327|FG001|Overall Study|Withdrawal by Subject|2|||
129092586|NCT00962091|464630328|FG002|Overall Study|Withdrawal by Subject|1|||
129092587|NCT00962091|464630329|FG003|Overall Study|Withdrawal by Subject|1|||
129092588|NCT00962091|464630330|FG004|Overall Study|Withdrawal by Subject|0|||
129092589|NCT00962091|464630331|FG005|Overall Study|Withdrawal by Subject|1|||
129092590|NCT00962091|464630332|FG006|Overall Study|Withdrawal by Subject|0|||
129092591|NCT00962091|464630326|FG000|Overall Study|Adverse Event|0|||
129092592|NCT00962091|464630327|FG001|Overall Study|Adverse Event|0|||
129092593|NCT00962091|464630328|FG002|Overall Study|Adverse Event|0|||
129092594|NCT00962091|464630329|FG003|Overall Study|Adverse Event|0|||
129092595|NCT00962091|464630330|FG004|Overall Study|Adverse Event|0|||
129092596|NCT00962091|464630331|FG005|Overall Study|Adverse Event|0|||
129092597|NCT00962091|464630332|FG006|Overall Study|Adverse Event|1|||
129092598|NCT04216589|464630334|FG000|Overall Study|Withdrawal by Subject|2|||
129092599|NCT04216589|464630334|FG000|Overall Study|Protocol Violation|1|||
129092600|NCT04216589|464630334|FG000|Overall Study|Incarceration|1|||
129092601|NCT02326298|464630339|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092602|NCT02326298|464630340|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092603|NCT02326298|464630341|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
129092604|NCT02326298|464630342|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092605|NCT02326298|464630343|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092606|NCT02326298|464630344|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092607|NCT02326298|464630345|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092608|NCT02326298|464630346|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092609|NCT02326298|464630347|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092610|NCT02326298|464630348|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092611|NCT02326298|464630349|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092612|NCT02326298|464630350|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092613|NCT02326298|464630351|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092614|NCT02326298|464630352|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129092615|NCT02326298|464630339|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
129092616|NCT02326298|464630340|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092617|NCT02326298|464630341|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092618|NCT02326298|464630342|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092619|NCT02326298|464630343|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092620|NCT02326298|464630344|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092621|NCT02326298|464630345|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092622|NCT02326298|464630346|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092623|NCT02326298|464630347|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092624|NCT02326298|464630348|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092625|NCT02326298|464630349|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092626|NCT02326298|464630350|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092627|NCT02326298|464630351|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092628|NCT02326298|464630352|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129092629|NCT02326298|464630339|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
129092630|NCT02326298|464630340|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
129092631|NCT02326298|464630341|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092632|NCT02326298|464630342|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
128724765|NCT02036502|463290914|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
128724766|NCT02036502|463290915|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
128724767|NCT02036502|463290916|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129092633|NCT02326298|464630343|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092634|NCT02326298|464630344|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092635|NCT02326298|464630345|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
128724768|NCT02036502|463290917|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129092636|NCT02326298|464630346|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092637|NCT02326298|464630347|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092638|NCT02326298|464630348|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092639|NCT02326298|464630349|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092640|NCT02326298|464630350|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092641|NCT02326298|464630351|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092642|NCT02326298|464630352|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129092643|NCT02326298|464630339|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
129092644|NCT02326298|464630340|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
129092645|NCT02326298|464630341|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092646|NCT02326298|464630342|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092647|NCT02326298|464630343|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092648|NCT02326298|464630344|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092649|NCT02326298|464630345|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092650|NCT02326298|464630346|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092651|NCT02326298|464630347|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092652|NCT02326298|464630348|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092653|NCT02326298|464630349|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092654|NCT02326298|464630350|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092655|NCT02326298|464630351|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092656|NCT02326298|464630352|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129092657|NCT02326298|464630339|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092658|NCT02326298|464630340|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092659|NCT02326298|464630341|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
129092660|NCT02326298|464630342|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092661|NCT02326298|464630343|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092662|NCT02326298|464630344|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092663|NCT02326298|464630345|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129145706|NCT03847519|464830088|FG001|Overall Study|Study Terminated by Sponsor|3|||
129092664|NCT02326298|464630346|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092665|NCT02326298|464630347|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092666|NCT02326298|464630348|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092667|NCT02326298|464630349|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092668|NCT02326298|464630350|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092669|NCT02326298|464630351|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092670|NCT02326298|464630352|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129092671|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092672|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092673|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092674|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092675|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092676|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129092677|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
129092678|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129092679|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129092680|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129092681|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092682|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092683|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092684|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129092685|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092686|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092687|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092688|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092689|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092690|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
129092691|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
129092692|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092693|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
129092694|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129145707|NCT03847519|464830089|FG002|Overall Study|Study Terminated by Sponsor|2|||
129145708|NCT02314923|464830092|FG000|Overall Study|Death|0|||
129145709|NCT02314923|464830093|FG001|Overall Study|Death|0|||
129092695|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092696|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092697|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092698|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129092699|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092700|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092701|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092702|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092703|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092704|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
129092705|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092706|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092707|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092708|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092709|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092710|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092711|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092712|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129092713|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092714|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092715|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092716|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092717|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092718|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092719|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
129092720|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092721|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092722|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092723|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092724|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092725|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092726|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129092727|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092728|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092729|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092730|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092731|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092732|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092733|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092734|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
129092735|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092736|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092737|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092738|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092739|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092740|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129092741|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092742|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092743|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092744|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092745|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092746|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092747|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
129092748|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
129092749|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092750|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092751|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092752|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092753|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092754|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129092755|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092756|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129145710|NCT02314923|464830094|FG002|Overall Study|Death|0|||
129145711|NCT02314923|464830095|FG003|Overall Study|Death|1|||
129092757|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092758|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092759|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092760|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092761|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092762|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129092763|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092764|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092765|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092766|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092767|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092768|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129092769|NCT02326298|464630339|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092770|NCT02326298|464630340|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092771|NCT02326298|464630341|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092772|NCT02326298|464630342|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092773|NCT02326298|464630343|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092774|NCT02326298|464630344|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
129092775|NCT02326298|464630345|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092776|NCT02326298|464630346|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092777|NCT02326298|464630347|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092778|NCT02326298|464630348|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092779|NCT02326298|464630349|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092780|NCT02326298|464630350|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092781|NCT02326298|464630351|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092782|NCT02326298|464630352|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129092783|NCT02326298|464630339|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
129092784|NCT02326298|464630340|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
129092785|NCT02326298|464630341|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
129092786|NCT02326298|464630342|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
129092787|NCT02326298|464630343|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
129092788|NCT02326298|464630344|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
129092789|NCT02326298|464630345|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
129092790|NCT02326298|464630346|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
129092791|NCT02326298|464630347|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
129092792|NCT02326298|464630348|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
129092793|NCT02326298|464630349|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
129092794|NCT02326298|464630350|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
129092795|NCT02326298|464630351|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
129092796|NCT02326298|464630352|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
129092797|NCT02326298|464630339|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092798|NCT02326298|464630340|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092799|NCT02326298|464630341|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092800|NCT02326298|464630342|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092801|NCT02326298|464630343|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092802|NCT02326298|464630344|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092803|NCT02326298|464630345|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092804|NCT02326298|464630346|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092805|NCT02326298|464630347|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092806|NCT02326298|464630348|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092807|NCT02326298|464630349|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092808|NCT02326298|464630350|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
129092809|NCT02326298|464630351|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
129092810|NCT02326298|464630352|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129092811|NCT02326298|464630339|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092812|NCT02326298|464630340|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092813|NCT02326298|464630341|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092814|NCT02326298|464630342|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129145712|NCT02314923|464830096|FG004|Overall Study|Death|0|||
129145713|NCT02314923|464830097|FG005|Overall Study|Death|0|||
129145714|NCT02314923|464830098|FG006|Overall Study|Death|0|||
129092815|NCT02326298|464630343|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129145715|NCT02314923|464830099|FG007|Overall Study|Death|0|||
129092816|NCT02326298|464630344|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092817|NCT02326298|464630345|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092818|NCT02326298|464630346|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092819|NCT02326298|464630347|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092820|NCT02326298|464630348|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092821|NCT02326298|464630349|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092822|NCT02326298|464630350|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129092823|NCT02326298|464630351|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129092824|NCT02326298|464630352|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129092825|NCT02326298|464630339|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092826|NCT02326298|464630340|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092827|NCT02326298|464630341|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092828|NCT02326298|464630342|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092829|NCT02326298|464630343|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092830|NCT02326298|464630344|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092831|NCT02326298|464630345|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092832|NCT02326298|464630346|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092833|NCT02326298|464630347|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092834|NCT02326298|464630348|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092835|NCT02326298|464630349|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092836|NCT02326298|464630350|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092837|NCT02326298|464630351|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129092838|NCT02326298|464630352|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
129092839|NCT02326298|464630339|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092840|NCT02326298|464630340|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092841|NCT02326298|464630341|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092842|NCT02326298|464630342|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092843|NCT02326298|464630343|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092844|NCT02326298|464630344|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092845|NCT02326298|464630345|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092846|NCT02326298|464630346|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092847|NCT02326298|464630347|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092848|NCT02326298|464630348|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092849|NCT02326298|464630349|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129092850|NCT02326298|464630350|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
129092851|NCT02326298|464630351|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
129092852|NCT02326298|464630352|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129092853|NCT02326298|464630339|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092854|NCT02326298|464630340|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092855|NCT02326298|464630341|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092856|NCT02326298|464630342|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092857|NCT02326298|464630343|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092858|NCT02326298|464630344|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092859|NCT02326298|464630345|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092860|NCT02326298|464630346|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092861|NCT02326298|464630347|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092862|NCT02326298|464630348|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092863|NCT02326298|464630349|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129092864|NCT02326298|464630350|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
129092865|NCT02326298|464630351|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
129092866|NCT02326298|464630352|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
129092867|NCT02326298|464630339|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092868|NCT02326298|464630340|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092869|NCT02326298|464630341|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092870|NCT02326298|464630342|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092871|NCT02326298|464630343|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092872|NCT02326298|464630344|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092873|NCT02326298|464630345|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092874|NCT02326298|464630346|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092875|NCT02326298|464630347|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092876|NCT02326298|464630348|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092877|NCT02326298|464630349|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129092878|NCT02326298|464630350|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
129092879|NCT02326298|464630351|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
129092880|NCT02326298|464630352|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
129092881|NCT03191864|464630354|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
129092882|NCT03191864|464630355|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
129092883|NCT03191864|464630356|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
129092884|NCT03191864|464630357|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
129092885|NCT03191864|464630358|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
129092886|NCT03191864|464630359|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
129092887|NCT03191864|464630354|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129092888|NCT03191864|464630355|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129092889|NCT03191864|464630356|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129092890|NCT03191864|464630357|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129092891|NCT03191864|464630358|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129092892|NCT03191864|464630359|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
129092893|NCT03191864|464630354|FG000|Baseline Symptom Assessment|Adverse Event|0|||
129092894|NCT03191864|464630355|FG001|Baseline Symptom Assessment|Adverse Event|0|||
129092895|NCT03191864|464630356|FG002|Baseline Symptom Assessment|Adverse Event|0|||
129092896|NCT03191864|464630357|FG003|Baseline Symptom Assessment|Adverse Event|0|||
129092897|NCT03191864|464630358|FG004|Baseline Symptom Assessment|Adverse Event|0|||
129092898|NCT03191864|464630359|FG005|Baseline Symptom Assessment|Adverse Event|2|||
129092899|NCT03191864|464630354|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129092900|NCT03191864|464630355|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129092901|NCT03191864|464630356|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129092902|NCT03191864|464630357|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129092903|NCT03191864|464630358|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129092904|NCT03191864|464630359|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
129092905|NCT03191864|464630354|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129092906|NCT03191864|464630355|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129092907|NCT03191864|464630356|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129092908|NCT03191864|464630357|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129092909|NCT03191864|464630358|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129092910|NCT03191864|464630359|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
129092911|NCT03191864|464630354|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129092912|NCT03191864|464630355|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129092913|NCT03191864|464630356|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
129092914|NCT03191864|464630357|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129092915|NCT03191864|464630358|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129092916|NCT03191864|464630359|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
129092917|NCT03191864|464630354|FG000|Part 1 - Induction|Adverse Event|0|||
129092918|NCT03191864|464630355|FG001|Part 1 - Induction|Adverse Event|2|||
129092919|NCT03191864|464630356|FG002|Part 1 - Induction|Adverse Event|0|||
129092920|NCT03191864|464630357|FG003|Part 1 - Induction|Adverse Event|1|||
129092921|NCT03191864|464630358|FG004|Part 1 - Induction|Adverse Event|0|||
129092922|NCT03191864|464630359|FG005|Part 1 - Induction|Adverse Event|2|||
129092923|NCT03191864|464630354|FG000|Part 1 - Induction|Randomized but never dosed|0|||
129092924|NCT03191864|464630355|FG001|Part 1 - Induction|Randomized but never dosed|0|||
129092925|NCT03191864|464630356|FG002|Part 1 - Induction|Randomized but never dosed|1|||
129092926|NCT03191864|464630357|FG003|Part 1 - Induction|Randomized but never dosed|0|||
129092927|NCT03191864|464630358|FG004|Part 1 - Induction|Randomized but never dosed|0|||
129092928|NCT03191864|464630359|FG005|Part 1 - Induction|Randomized but never dosed|0|||
129092929|NCT03191864|464630354|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
129092930|NCT03191864|464630355|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
129092931|NCT03191864|464630356|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
129092932|NCT03191864|464630357|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
129092933|NCT03191864|464630358|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
129092934|NCT03191864|464630359|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
129092935|NCT03191864|464630354|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129092936|NCT03191864|464630355|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129092937|NCT03191864|464630356|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
129092938|NCT03191864|464630357|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129092939|NCT03191864|464630358|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129092940|NCT03191864|464630359|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129092941|NCT03191864|464630354|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
129092942|NCT03191864|464630355|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129092943|NCT03191864|464630356|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129092944|NCT03191864|464630357|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129092945|NCT03191864|464630358|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129092946|NCT03191864|464630359|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129092947|NCT03191864|464630354|FG000|Part 2 - Maintenance|Physician Decision|1|||
129092948|NCT03191864|464630355|FG001|Part 2 - Maintenance|Physician Decision|0|||
129092949|NCT03191864|464630356|FG002|Part 2 - Maintenance|Physician Decision|0|||
129092950|NCT03191864|464630357|FG003|Part 2 - Maintenance|Physician Decision|0|||
129092951|NCT03191864|464630358|FG004|Part 2 - Maintenance|Physician Decision|0|||
129092952|NCT03191864|464630359|FG005|Part 2 - Maintenance|Physician Decision|0|||
129092953|NCT03191864|464630354|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
129092954|NCT03191864|464630355|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
129092955|NCT03191864|464630356|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
129092956|NCT03191864|464630357|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
129092957|NCT03191864|464630358|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
129092958|NCT03191864|464630359|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
129092959|NCT03191864|464630354|FG000|Part 2 - Maintenance|Adverse Event|0|||
129092960|NCT03191864|464630355|FG001|Part 2 - Maintenance|Adverse Event|0|||
129092961|NCT03191864|464630356|FG002|Part 2 - Maintenance|Adverse Event|0|||
129092962|NCT03191864|464630357|FG003|Part 2 - Maintenance|Adverse Event|0|||
129092963|NCT03191864|464630358|FG004|Part 2 - Maintenance|Adverse Event|1|||
129092964|NCT03191864|464630359|FG005|Part 2 - Maintenance|Adverse Event|0|||
129092965|NCT03191864|464630354|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
129092966|NCT03191864|464630355|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
129092967|NCT03191864|464630356|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
129092968|NCT03191864|464630357|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
129092969|NCT03191864|464630358|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
129092970|NCT03191864|464630359|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
129092971|NCT03191864|464630354|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129092972|NCT03191864|464630355|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129092973|NCT03191864|464630356|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129092974|NCT03191864|464630357|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129092975|NCT03191864|464630358|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
129092976|NCT03191864|464630359|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129092977|NCT02342548|464630362|FG000|Overall Study|Adverse Event|12|||
129092978|NCT02342548|464630363|FG001|Overall Study|Adverse Event|17|||
129092979|NCT02342548|464630364|FG002|Overall Study|Adverse Event|13|||
129092980|NCT02342548|464630362|FG000|Overall Study|Lost to Follow-up|0|||
129092981|NCT02342548|464630363|FG001|Overall Study|Lost to Follow-up|1|||
129092982|NCT02342548|464630364|FG002|Overall Study|Lost to Follow-up|0|||
129092983|NCT02342548|464630362|FG000|Overall Study|Study terminated by sponsor|20|||
129092984|NCT02342548|464630363|FG001|Overall Study|Study terminated by sponsor|39|||
129092985|NCT02342548|464630364|FG002|Overall Study|Study terminated by sponsor|25|||
129092986|NCT02342548|464630362|FG000|Overall Study|Protocol Violation|0|||
129092987|NCT02342548|464630363|FG001|Overall Study|Protocol Violation|1|||
129092988|NCT02342548|464630364|FG002|Overall Study|Protocol Violation|0|||
129092989|NCT02342548|464630362|FG000|Overall Study|Withdrawal by Subject|1|||
129092990|NCT02342548|464630363|FG001|Overall Study|Withdrawal by Subject|3|||
129092991|NCT02342548|464630364|FG002|Overall Study|Withdrawal by Subject|4|||
129092992|NCT02342548|464630362|FG000|Overall Study|Other|1|||
129092993|NCT02342548|464630363|FG001|Overall Study|Other|1|||
129092994|NCT02342548|464630364|FG002|Overall Study|Other|1|||
129092995|NCT01047332|464630365|FG000|Overall Study|SEMS Obstruction|11|||
129092996|NCT01047332|464630366|FG001|Overall Study|SEMS Obstruction|20|||
129092997|NCT01047332|464630365|FG000|Overall Study|Died Unobstructed|38|||
129092998|NCT01047332|464630366|FG001|Overall Study|Died Unobstructed|41|||
129092999|NCT01047332|464630365|FG000|Overall Study|Lost to Follow-up|8|||
129093000|NCT01047332|464630366|FG001|Overall Study|Lost to Follow-up|3|||
129093001|NCT03521817|464630371|FG000|Overall Study|Protocol Violation|0|||
129093002|NCT03521817|464630372|FG001|Overall Study|Protocol Violation|1|||
129093003|NCT04743804|464631945|FG000|Overall Study|Other|1|||
129093004|NCT04743804|464631946|FG001|Overall Study|Other|0|||
129093005|NCT04743804|464631945|FG000|Overall Study|Withdrawal by Subject|0|||
129093006|NCT04743804|464631946|FG001|Overall Study|Withdrawal by Subject|1|||
129093007|NCT04743804|464631945|FG000|Overall Study|Study Terminated by Sponsor|1|||
129093008|NCT04743804|464631946|FG001|Overall Study|Study Terminated by Sponsor|4|||
129093009|NCT04743804|464631945|FG000|Overall Study|Physician Decision|0|||
129093010|NCT04743804|464631946|FG001|Overall Study|Physician Decision|1|||
129093011|NCT04743804|464631945|FG000|Overall Study|Death|3|||
129093012|NCT04743804|464631946|FG001|Overall Study|Death|0|||
129093013|NCT01632904|464631947|FG000|Overall Study|Adverse Event|4|||
129093014|NCT01632904|464631948|FG001|Overall Study|Adverse Event|1|||
129093015|NCT01632904|464631947|FG000|Overall Study|Physician Decision|0|||
129093016|NCT01632904|464631948|FG001|Overall Study|Physician Decision|1|||
129093017|NCT01632904|464631947|FG000|Overall Study|Subject decision|3|||
129093018|NCT01632904|464631948|FG001|Overall Study|Subject decision|2|||
129093019|NCT01632904|464631947|FG000|Overall Study|Disease Progression|0|||
129093020|NCT01632904|464631948|FG001|Overall Study|Disease Progression|1|||
129093021|NCT01632904|464631947|FG000|Overall Study|Reason for discontinuation not available|0|||
129093022|NCT01632904|464631948|FG001|Overall Study|Reason for discontinuation not available|1|||
129093023|NCT02059434|464631952|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
129093024|NCT02059434|464631953|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
129093025|NCT02059434|464631954|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
129093026|NCT02059434|464631955|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
129093027|NCT02059434|464631956|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
129093028|NCT02059434|464631957|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
129093029|NCT02059434|464631958|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
129093030|NCT02059434|464631959|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
129093031|NCT02059434|464631960|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
129093032|NCT02059434|464631952|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
129093033|NCT02059434|464631953|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
129093034|NCT02059434|464631954|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
129093035|NCT02059434|464631955|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
129093036|NCT02059434|464631956|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
129093037|NCT02059434|464631957|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
129093038|NCT02059434|464631958|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
129093039|NCT02059434|464631959|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
129093040|NCT02059434|464631960|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
129093041|NCT02059434|464631952|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
129093042|NCT02059434|464631953|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
129093043|NCT02059434|464631954|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
129093044|NCT02059434|464631955|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
129093045|NCT02059434|464631956|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
129093046|NCT02059434|464631957|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
129093047|NCT02059434|464631958|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
129093048|NCT02059434|464631959|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
129093049|NCT02059434|464631960|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
129093050|NCT02059434|464631952|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
129093051|NCT02059434|464631953|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
129093052|NCT02059434|464631954|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
129093053|NCT02059434|464631955|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
129093054|NCT02059434|464631956|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
129093055|NCT02059434|464631957|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
129093056|NCT02059434|464631958|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
129093057|NCT02059434|464631959|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
129093058|NCT02059434|464631960|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
129093059|NCT02059434|464631952|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093060|NCT02059434|464631953|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093061|NCT02059434|464631954|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093062|NCT02059434|464631955|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093063|NCT02059434|464631956|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093064|NCT02059434|464631957|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093065|NCT02059434|464631958|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093066|NCT02059434|464631959|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129093067|NCT02059434|464631960|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
129093068|NCT01004406|464631965|FG000|Overall Study|Withdrawal by Subject|2|||
129093069|NCT01004406|464631966|FG001|Overall Study|Withdrawal by Subject|0|||
129093070|NCT01004406|464631965|FG000|Overall Study|Lost to Follow-up|1|||
129093071|NCT01004406|464631966|FG001|Overall Study|Lost to Follow-up|0|||
129093072|NCT02928770|464631967|FG000|Overall Study|Withdrawal by Subject|2|||
129093073|NCT03201874|464631970|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
129093074|NCT03201874|464631971|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
129093075|NCT03201874|464631970|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
129093076|NCT03201874|464631971|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
129093077|NCT02907593|464631972|FG000|Overall Study|Withdrawal by Subject|0|||
129093078|NCT02907593|464631973|FG001|Overall Study|Withdrawal by Subject|0|||
129093079|NCT02907593|464631974|FG002|Overall Study|Withdrawal by Subject|1|||
129093080|NCT02907593|464631975|FG003|Overall Study|Withdrawal by Subject|0|||
129093081|NCT04618471|464631976|FG000|Overall Study|Screen Failure|62|||
129093082|NCT04618471|464631976|FG000|Overall Study|Withdrawal by Subject|6|||
129093083|NCT04618471|464631976|FG000|Overall Study|Physician Decision|2|||
129093084|NCT04618471|464631976|FG000|Overall Study|Lost to Follow-up|1|||
129093085|NCT04618471|464631976|FG000|Overall Study|Various other reasons|2|||
129093086|NCT04618471|464631976|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
129145716|NCT02314923|464830100|FG008|Overall Study|Death|0|||
129145717|NCT02314923|464830101|FG009|Overall Study|Death|0|||
129145718|NCT02314923|464830092|FG000|Overall Study|Lost to Follow-up|2|||
129145719|NCT02314923|464830093|FG001|Overall Study|Lost to Follow-up|3|||
129145720|NCT02314923|464830094|FG002|Overall Study|Lost to Follow-up|1|||
129145721|NCT02314923|464830095|FG003|Overall Study|Lost to Follow-up|0|||
129145722|NCT02314923|464830096|FG004|Overall Study|Lost to Follow-up|0|||
129145723|NCT02314923|464830097|FG005|Overall Study|Lost to Follow-up|0|||
129145724|NCT02314923|464830098|FG006|Overall Study|Lost to Follow-up|3|||
129145725|NCT02314923|464830099|FG007|Overall Study|Lost to Follow-up|4|||
129145726|NCT02314923|464830100|FG008|Overall Study|Lost to Follow-up|2|||
129145727|NCT02314923|464830101|FG009|Overall Study|Lost to Follow-up|0|||
129145728|NCT02314923|464830092|FG000|Overall Study|Withdrawal by Subject|0|||
129145729|NCT02314923|464830093|FG001|Overall Study|Withdrawal by Subject|0|||
129145730|NCT02314923|464830094|FG002|Overall Study|Withdrawal by Subject|1|||
129145731|NCT02314923|464830095|FG003|Overall Study|Withdrawal by Subject|0|||
129145732|NCT02314923|464830096|FG004|Overall Study|Withdrawal by Subject|1|||
129145733|NCT02314923|464830097|FG005|Overall Study|Withdrawal by Subject|0|||
129145734|NCT02314923|464830098|FG006|Overall Study|Withdrawal by Subject|1|||
129145735|NCT02314923|464830099|FG007|Overall Study|Withdrawal by Subject|0|||
129145736|NCT02314923|464830100|FG008|Overall Study|Withdrawal by Subject|0|||
129145737|NCT02314923|464830101|FG009|Overall Study|Withdrawal by Subject|0|||
129145738|NCT02314923|464830092|FG000|Overall Study|Physician Decision|0|||
129145739|NCT02314923|464830093|FG001|Overall Study|Physician Decision|1|||
129145740|NCT02314923|464830094|FG002|Overall Study|Physician Decision|0|||
129145741|NCT02314923|464830095|FG003|Overall Study|Physician Decision|0|||
128724769|NCT02036502|463290918|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
128724770|NCT02036502|463290919|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
128724771|NCT02036502|463290920|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129093087|NCT01752634|464631977|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
129093088|NCT01752634|464631978|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
129093089|NCT01752634|464631979|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
129093090|NCT01752634|464631980|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
129093091|NCT01752634|464631981|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
129093092|NCT01752634|464631982|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
129093093|NCT01752634|464631977|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129093094|NCT01752634|464631978|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
129093095|NCT01752634|464631979|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129093096|NCT01752634|464631980|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129093097|NCT01752634|464631981|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129093098|NCT01752634|464631982|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129093099|NCT01752634|464631977|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
129093100|NCT01752634|464631978|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
129093101|NCT01752634|464631979|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
129093102|NCT01752634|464631980|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
129093103|NCT01752634|464631981|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
129093104|NCT01752634|464631982|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
129093105|NCT01752634|464631977|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
129093106|NCT01752634|464631978|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
129093107|NCT01752634|464631979|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
129093108|NCT01752634|464631980|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
129093109|NCT01752634|464631981|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
129145742|NCT02314923|464830096|FG004|Overall Study|Physician Decision|0|||
129145743|NCT02314923|464830097|FG005|Overall Study|Physician Decision|0|||
129093110|NCT01752634|464631982|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
129093111|NCT01752634|464631977|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
129145744|NCT02314923|464830098|FG006|Overall Study|Physician Decision|0|||
129145745|NCT02314923|464830099|FG007|Overall Study|Physician Decision|0|||
129145746|NCT02314923|464830100|FG008|Overall Study|Physician Decision|0|||
129145747|NCT02314923|464830101|FG009|Overall Study|Physician Decision|0|||
129145748|NCT02314923|464830092|FG000|Overall Study|Participant unavailable|0|||
128724772|NCT02036502|463290913|FG000|Part 2:Dose Confirmation|Death|0|||
129145749|NCT02314923|464830093|FG001|Overall Study|Participant unavailable|0|||
129145750|NCT02314923|464830094|FG002|Overall Study|Participant unavailable|0|||
129145751|NCT02314923|464830095|FG003|Overall Study|Participant unavailable|0|||
129145752|NCT02314923|464830096|FG004|Overall Study|Participant unavailable|0|||
129093112|NCT01752634|464631978|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
129093113|NCT01752634|464631979|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
129093114|NCT01752634|464631980|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
129093115|NCT01752634|464631981|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
129093116|NCT01752634|464631982|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
129093117|NCT01752634|464631977|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
129093118|NCT01752634|464631978|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
129093119|NCT01752634|464631979|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
129093120|NCT01752634|464631980|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
129093121|NCT01752634|464631981|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
129093122|NCT01752634|464631982|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
129093123|NCT01752634|464631977|FG000|Week 24 to Week 260|Physician Decision|1|||
129093124|NCT01752634|464631978|FG001|Week 24 to Week 260|Physician Decision|2|||
129093125|NCT01752634|464631979|FG002|Week 24 to Week 260|Physician Decision|4|||
129093126|NCT01752634|464631980|FG003|Week 24 to Week 260|Physician Decision|2|||
129093127|NCT01752634|464631981|FG004|Week 24 to Week 260|Physician Decision|1|||
129093128|NCT01752634|464631982|FG005|Week 24 to Week 260|Physician Decision|0|||
129093129|NCT01752634|464631977|FG000|Week 24 to Week 260|Death|0|||
129093130|NCT01752634|464631978|FG001|Week 24 to Week 260|Death|1|||
129093131|NCT01752634|464631979|FG002|Week 24 to Week 260|Death|0|||
129093132|NCT01752634|464631980|FG003|Week 24 to Week 260|Death|0|||
129093133|NCT01752634|464631981|FG004|Week 24 to Week 260|Death|0|||
129093134|NCT01752634|464631982|FG005|Week 24 to Week 260|Death|0|||
129093135|NCT01752634|464631977|FG000|Week 24 to Week 260|Pregnancy|0|||
129093136|NCT01752634|464631978|FG001|Week 24 to Week 260|Pregnancy|0|||
129093137|NCT01752634|464631979|FG002|Week 24 to Week 260|Pregnancy|1|||
129093138|NCT01752634|464631980|FG003|Week 24 to Week 260|Pregnancy|0|||
129093139|NCT01752634|464631981|FG004|Week 24 to Week 260|Pregnancy|0|||
129093140|NCT01752634|464631982|FG005|Week 24 to Week 260|Pregnancy|0|||
129093141|NCT01752634|464631977|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
129093142|NCT01752634|464631978|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
129093143|NCT01752634|464631979|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
129093144|NCT01752634|464631980|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
129093145|NCT01752634|464631981|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
129093146|NCT01752634|464631982|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
129093147|NCT01752634|464631977|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
129093148|NCT01752634|464631978|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
129093149|NCT01752634|464631979|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
129093150|NCT01752634|464631980|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
129093151|NCT01752634|464631981|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
129093152|NCT01752634|464631982|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
129093153|NCT01752634|464631977|FG000|Week 24 to Week 260|Adverse Event|4|||
129093154|NCT01752634|464631978|FG001|Week 24 to Week 260|Adverse Event|8|||
129093155|NCT01752634|464631979|FG002|Week 24 to Week 260|Adverse Event|8|||
129093156|NCT01752634|464631980|FG003|Week 24 to Week 260|Adverse Event|4|||
129093157|NCT01752634|464631981|FG004|Week 24 to Week 260|Adverse Event|2|||
129093158|NCT01752634|464631982|FG005|Week 24 to Week 260|Adverse Event|0|||
129093159|NCT01451164|464631992|FG000|Overall Study|Adverse Event|19|||
129093160|NCT01451164|464631993|FG001|Overall Study|Adverse Event|12|||
129093161|NCT01451164|464631994|FG002|Overall Study|Adverse Event|18|||
129093162|NCT01451164|464631995|FG003|Overall Study|Adverse Event|21|||
129145753|NCT02314923|464830097|FG005|Overall Study|Participant unavailable|1|||
129145754|NCT02314923|464830098|FG006|Overall Study|Participant unavailable|0|||
128724773|NCT02036502|463290914|FG001|Part 2:Dose Confirmation|Death|0|||
129093163|NCT01451164|464631992|FG000|Overall Study|Withdrawal Criteria|1|||
129093164|NCT01451164|464631993|FG001|Overall Study|Withdrawal Criteria|1|||
129093165|NCT01451164|464631994|FG002|Overall Study|Withdrawal Criteria|1|||
129093166|NCT01451164|464631995|FG003|Overall Study|Withdrawal Criteria|1|||
129093167|NCT01451164|464631992|FG000|Overall Study|Physician Decision|2|||
129093168|NCT01451164|464631993|FG001|Overall Study|Physician Decision|0|||
129093169|NCT01451164|464631994|FG002|Overall Study|Physician Decision|1|||
129093170|NCT01451164|464631995|FG003|Overall Study|Physician Decision|0|||
129093171|NCT01451164|464631992|FG000|Overall Study|Withdrawal by Subject|14|||
129093172|NCT01451164|464631993|FG001|Overall Study|Withdrawal by Subject|11|||
129093173|NCT01451164|464631994|FG002|Overall Study|Withdrawal by Subject|16|||
129093174|NCT01451164|464631995|FG003|Overall Study|Withdrawal by Subject|17|||
129093175|NCT01451164|464631992|FG000|Overall Study|Protocol Violation|0|||
128724774|NCT02036502|463290915|FG002|Part 2:Dose Confirmation|Death|1|||
129093176|NCT01451164|464631993|FG001|Overall Study|Protocol Violation|1|||
129093177|NCT01451164|464631994|FG002|Overall Study|Protocol Violation|0|||
129093178|NCT01451164|464631995|FG003|Overall Study|Protocol Violation|0|||
129093179|NCT01451164|464631992|FG000|Overall Study|Lack of Efficacy|7|||
129093180|NCT01451164|464631993|FG001|Overall Study|Lack of Efficacy|9|||
129093181|NCT01451164|464631994|FG002|Overall Study|Lack of Efficacy|9|||
129093182|NCT01451164|464631995|FG003|Overall Study|Lack of Efficacy|7|||
129093183|NCT04599933|464631996|FG000|Overall Study|Adverse Event|4|||
129093184|NCT04599933|464631997|FG001|Overall Study|Adverse Event|1|||
129093185|NCT04599933|464631996|FG000|Overall Study|Withdrawal by Subject|4|||
129093186|NCT04599933|464631997|FG001|Overall Study|Withdrawal by Subject|2|||
129093187|NCT04599933|464631996|FG000|Overall Study|Lost to Follow-up|0|||
129093188|NCT04599933|464631997|FG001|Overall Study|Lost to Follow-up|1|||
129093189|NCT04599933|464631996|FG000|Overall Study|Physician Decision|0|||
129093190|NCT04599933|464631997|FG001|Overall Study|Physician Decision|1|||
129093191|NCT04599933|464631996|FG000|Overall Study|Screen Failure|1|||
129093192|NCT04599933|464631997|FG001|Overall Study|Screen Failure|2|||
129093193|NCT03226678|464632000|FG000|Part A (Core Study Phase)|Adverse Event|0|||
129093194|NCT03226678|464632001|FG001|Part A (Core Study Phase)|Adverse Event|1|||
129093195|NCT03226678|464632002|FG002|Part A (Core Study Phase)|Adverse Event|0|||
129093196|NCT03226678|464632003|FG003|Part A (Core Study Phase)|Adverse Event|0|||
129093197|NCT03226678|464632004|FG004|Part A (Core Study Phase)|Adverse Event|0|||
129093198|NCT03226678|464632005|FG005|Part A (Core Study Phase)|Adverse Event|0|||
129093199|NCT03226678|464632000|FG000|Part A (Core Study Phase)|Death|0|||
129093200|NCT03226678|464632001|FG001|Part A (Core Study Phase)|Death|0|||
129093201|NCT03226678|464632002|FG002|Part A (Core Study Phase)|Death|1|||
129093202|NCT03226678|464632003|FG003|Part A (Core Study Phase)|Death|0|||
129093203|NCT03226678|464632004|FG004|Part A (Core Study Phase)|Death|0|||
129093204|NCT03226678|464632005|FG005|Part A (Core Study Phase)|Death|0|||
129093205|NCT03226678|464632000|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
129093206|NCT03226678|464632001|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
129093207|NCT03226678|464632002|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
129093208|NCT03226678|464632003|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
129093209|NCT03226678|464632004|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
129093210|NCT03226678|464632005|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
129093211|NCT03226678|464632000|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129093212|NCT03226678|464632001|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129093213|NCT03226678|464632002|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
129093214|NCT03226678|464632003|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129093215|NCT03226678|464632004|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129093216|NCT03226678|464632005|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129093217|NCT03226678|464632000|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129093218|NCT03226678|464632001|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129093219|NCT03226678|464632002|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129093220|NCT03226678|464632003|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
129093221|NCT03226678|464632004|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129093222|NCT03226678|464632005|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129093223|NCT03226678|464632000|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
129093224|NCT03226678|464632001|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
129093225|NCT03226678|464632002|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129093226|NCT03226678|464632003|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129093227|NCT03226678|464632004|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129093228|NCT03226678|464632005|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129093229|NCT03226678|464632000|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129093230|NCT03226678|464632001|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129093231|NCT03226678|464632002|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129093232|NCT03226678|464632003|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129093233|NCT03226678|464632004|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
129093234|NCT03226678|464632005|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
129093235|NCT03226678|464632000|FG000|Part B (Long-Term Extension Phase)|Death|0|||
129093236|NCT03226678|464632001|FG001|Part B (Long-Term Extension Phase)|Death|0|||
129093237|NCT03226678|464632002|FG002|Part B (Long-Term Extension Phase)|Death|0|||
129093238|NCT03226678|464632003|FG003|Part B (Long-Term Extension Phase)|Death|0|||
129093239|NCT03226678|464632004|FG004|Part B (Long-Term Extension Phase)|Death|0|||
129093240|NCT03226678|464632005|FG005|Part B (Long-Term Extension Phase)|Death|1|||
128724775|NCT02036502|463290916|FG003|Part 2:Dose Confirmation|Death|0|||
129093241|NCT03226678|464632000|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129093242|NCT03226678|464632001|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129093243|NCT03226678|464632002|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129093244|NCT03226678|464632003|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129093245|NCT03226678|464632004|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129093246|NCT03226678|464632005|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
129093247|NCT03226678|464632000|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129093248|NCT03226678|464632001|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129093249|NCT03226678|464632002|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129093250|NCT03226678|464632003|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129093251|NCT03226678|464632004|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
129093252|NCT03226678|464632005|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
129093253|NCT03226678|464632000|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129093254|NCT03226678|464632001|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129093255|NCT03226678|464632002|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129093256|NCT03226678|464632003|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129093257|NCT03226678|464632004|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129093258|NCT03226678|464632005|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
129093259|NCT03117881|464632006|FG000|Baseline|Withdrawal by Subject|21|||
129093260|NCT03117881|464632007|FG001|Baseline|Withdrawal by Subject|10|||
129093261|NCT03117881|464632008|FG002|Baseline|Withdrawal by Subject|0|||
129093262|NCT03117881|464632006|FG000|Baseline|Lost to Follow-up|22|||
129093263|NCT03117881|464632007|FG001|Baseline|Lost to Follow-up|25|||
129093264|NCT03117881|464632008|FG002|Baseline|Lost to Follow-up|0|||
129093265|NCT03117881|464632006|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
129093266|NCT03117881|464632007|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
129093267|NCT03117881|464632008|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
129093268|NCT03117881|464632006|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
129093269|NCT03117881|464632007|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
129093270|NCT03117881|464632008|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
129093271|NCT03117881|464632006|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
129093272|NCT03117881|464632007|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
129093273|NCT03117881|464632008|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
129093274|NCT03117881|464632006|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
129093275|NCT03117881|464632007|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
129093276|NCT03117881|464632008|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
129093277|NCT03117881|464632006|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
129093278|NCT03117881|464632007|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
129093279|NCT03117881|464632008|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
129093280|NCT03117881|464632006|FG000|6-Month Follow-Up|Did not complete test|53|||
129093281|NCT03117881|464632007|FG001|6-Month Follow-Up|Did not complete test|25|||
129093282|NCT03117881|464632008|FG002|6-Month Follow-Up|Did not complete test|7|||
129093283|NCT03117881|464632006|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
129093284|NCT03117881|464632007|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
129093285|NCT03117881|464632008|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
129093286|NCT03117881|464632006|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
129093287|NCT03117881|464632007|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
129093288|NCT03117881|464632008|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
129093289|NCT03117881|464632006|FG000|12-Month Follow-Up|Did not complete test|40|||
129093290|NCT03117881|464632007|FG001|12-Month Follow-Up|Did not complete test|0|||
129093291|NCT03117881|464632008|FG002|12-Month Follow-Up|Did not complete test|0|||
129093292|NCT01027897|464632009|FG000|Overall Study|Protocol Violation|1|||
129093293|NCT01027897|464632009|FG000|Overall Study|Withdrawal by Subject|1|||
129093294|NCT02045732|464632012|FG000|Overall Study|At the discretion of the investigator|1|||
129093295|NCT02045732|464632013|FG001|Overall Study|At the discretion of the investigator|1|||
129093296|NCT00473824|464632014|FG000|Overall Study|Virologic Breakthrough|1|||
129093297|NCT00473824|464632015|FG001|Overall Study|Virologic Breakthrough|0|||
129093298|NCT00473824|464632014|FG000|Overall Study|Adverse Event|1|||
129093299|NCT00473824|464632015|FG001|Overall Study|Adverse Event|0|||
129093300|NCT00473824|464632014|FG000|Overall Study|Death|1|||
129093301|NCT00473824|464632015|FG001|Overall Study|Death|0|||
129093302|NCT00473824|464632014|FG000|Overall Study|Lost to Follow-up|1|||
129093303|NCT00473824|464632015|FG001|Overall Study|Lost to Follow-up|0|||
129093304|NCT00473824|464632014|FG000|Overall Study|Withdrawal by physician|1|||
129093305|NCT00473824|464632015|FG001|Overall Study|Withdrawal by physician|0|||
129093306|NCT02560623|464632016|FG000|Overall Study|Unable to swallow sponge|0|||
129093307|NCT02560623|464632017|FG001|Overall Study|Unable to swallow sponge|1|||
129093308|NCT02560623|464632018|FG002|Overall Study|Unable to swallow sponge|0|||
129145755|NCT02314923|464830099|FG007|Overall Study|Participant unavailable|0|||
128724776|NCT02036502|463290917|FG004|Part 2:Dose Confirmation|Death|0|||
128724777|NCT02036502|463290918|FG005|Part 2:Dose Confirmation|Death|0|||
128724778|NCT02036502|463290919|FG006|Part 2:Dose Confirmation|Death|0|||
129093309|NCT02560623|464632019|FG003|Overall Study|Unable to swallow sponge|0|||
129093310|NCT02560623|464632016|FG000|Overall Study|Intervention prior to sponge administration|0|||
129093311|NCT02560623|464632017|FG001|Overall Study|Intervention prior to sponge administration|1|||
129093312|NCT02560623|464632018|FG002|Overall Study|Intervention prior to sponge administration|0|||
129145756|NCT02314923|464830100|FG008|Overall Study|Participant unavailable|0|||
129093313|NCT02560623|464632019|FG003|Overall Study|Intervention prior to sponge administration|0|||
129093314|NCT05014815|464632020|FG000|Overall Study|Death|63|||
129093315|NCT05014815|464632021|FG001|Overall Study|Death|70|||
129093316|NCT05014815|464632020|FG000|Overall Study|Withdrawal by Subject|10|||
129093317|NCT05014815|464632021|FG001|Overall Study|Withdrawal by Subject|10|||
129093318|NCT05014815|464632020|FG000|Overall Study|Lost to Follow-up|4|||
129093319|NCT05014815|464632021|FG001|Overall Study|Lost to Follow-up|2|||
129093320|NCT05014815|464632020|FG000|Overall Study|Physician Decision|2|||
129093321|NCT05014815|464632021|FG001|Overall Study|Physician Decision|4|||
129093322|NCT04247880|464632022|FG000|Overall Study|Lost to Follow-up|24|||
129093323|NCT04247880|464632023|FG001|Overall Study|Lost to Follow-up|17|||
129093324|NCT04247880|464632022|FG000|Overall Study|Withdrawal by Subject|3|||
129093325|NCT04247880|464632023|FG001|Overall Study|Withdrawal by Subject|0|||
129093326|NCT06303167|464632024|FG000|Overall Study|Ineligible|1|||
129093327|NCT06303167|464632024|FG000|Overall Study|Never start protocol therapy|2|||
129093328|NCT06303167|464632024|FG000|Overall Study|Disease progression|16|||
129093329|NCT02453282|464632025|FG000|Overall Study|Death|275|||
129093330|NCT02453282|464632026|FG001|Overall Study|Death|277|||
129093331|NCT02453282|464632027|FG002|Overall Study|Death|296|||
129093332|NCT02453282|464632025|FG000|Overall Study|Lost to Follow-up|1|||
129093333|NCT02453282|464632026|FG001|Overall Study|Lost to Follow-up|0|||
129093334|NCT02453282|464632027|FG002|Overall Study|Lost to Follow-up|2|||
129093335|NCT02453282|464632025|FG000|Overall Study|Withdrawal by Subject|12|||
129093336|NCT02453282|464632026|FG001|Overall Study|Withdrawal by Subject|10|||
129093337|NCT02453282|464632027|FG002|Overall Study|Withdrawal by Subject|11|||
129093338|NCT02453282|464632025|FG000|Overall Study|Participants ongoing at data cut-off|85|||
129093339|NCT02453282|464632026|FG001|Overall Study|Participants ongoing at data cut-off|84|||
129093340|NCT02453282|464632027|FG002|Overall Study|Participants ongoing at data cut-off|62|||
129093341|NCT02453282|464632025|FG000|Overall Study|Other|1|||
129093342|NCT02453282|464632026|FG001|Overall Study|Other|1|||
129093343|NCT02453282|464632027|FG002|Overall Study|Other|1|||
129093344|NCT01661933|464632029|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
129093345|NCT01661933|464632029|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
129093346|NCT01120249|464632030|FG000|Overall Study|No protocol treatment received|21|||
129093347|NCT01120249|464632031|FG001|Overall Study|No protocol treatment received|15|||
129093348|NCT01120249|464632030|FG000|Overall Study|Disease recurrence|107|||
129093349|NCT01120249|464632031|FG001|Overall Study|Disease recurrence|57|||
129093350|NCT01120249|464632030|FG000|Overall Study|Death|1|||
129093351|NCT01120249|464632031|FG001|Overall Study|Death|0|||
129093352|NCT01120249|464632030|FG000|Overall Study|Adverse Event|40|||
129093353|NCT01120249|464632031|FG001|Overall Study|Adverse Event|276|||
129093354|NCT01120249|464632030|FG000|Overall Study|Participant refusal|34|||
129093355|NCT01120249|464632031|FG001|Overall Study|Participant refusal|42|||
129093356|NCT01120249|464632030|FG000|Overall Study|Other reasons, not protocol specified|29|||
129093357|NCT01120249|464632031|FG001|Overall Study|Other reasons, not protocol specified|22|||
129093358|NCT01447446|464632032|FG000|Overall Study|Death|6|||
129093359|NCT01447446|464632033|FG001|Overall Study|Death|3|||
129145757|NCT02314923|464830101|FG009|Overall Study|Participant unavailable|0|||
129145758|NCT02314923|464830092|FG000|Overall Study|Screen failure|0|||
129145759|NCT02314923|464830093|FG001|Overall Study|Screen failure|0|||
129145760|NCT02314923|464830094|FG002|Overall Study|Screen failure|0|||
129145761|NCT02314923|464830095|FG003|Overall Study|Screen failure|0|||
129145762|NCT02314923|464830096|FG004|Overall Study|Screen failure|0|||
129145763|NCT02314923|464830097|FG005|Overall Study|Screen failure|0|||
129145764|NCT02314923|464830098|FG006|Overall Study|Screen failure|1|||
129145765|NCT02314923|464830099|FG007|Overall Study|Screen failure|0|||
129145766|NCT02314923|464830100|FG008|Overall Study|Screen failure|0|||
129145767|NCT02314923|464830101|FG009|Overall Study|Screen failure|0|||
129093360|NCT01447446|464632034|FG002|Overall Study|Death|2|||
129093361|NCT01447446|464632035|FG003|Overall Study|Death|1|||
129093362|NCT01447446|464632036|FG004|Overall Study|Death|7|||
129093363|NCT01447446|464632037|FG005|Overall Study|Death|0|||
129093364|NCT01447446|464632032|FG000|Overall Study|Adverse Event|3|||
129093365|NCT01447446|464632033|FG001|Overall Study|Adverse Event|0|||
129093366|NCT01447446|464632034|FG002|Overall Study|Adverse Event|1|||
129093367|NCT01447446|464632035|FG003|Overall Study|Adverse Event|0|||
129093368|NCT01447446|464632036|FG004|Overall Study|Adverse Event|2|||
129093369|NCT01447446|464632037|FG005|Overall Study|Adverse Event|0|||
129093370|NCT01447446|464632032|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
129093371|NCT01447446|464632033|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
129145768|NCT02314923|464830092|FG000|Overall Study|Participant relocation|1|||
129145769|NCT02314923|464830093|FG001|Overall Study|Participant relocation|0|||
129093372|NCT01447446|464632034|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
128724779|NCT02036502|463290920|FG007|Part 2:Dose Confirmation|Death|0|||
128724780|NCT02036502|463290913|FG000|Part 2:Dose Confirmation|Not treated|0|||
128724781|NCT02036502|463290914|FG001|Part 2:Dose Confirmation|Not treated|0|||
128724782|NCT02036502|463290915|FG002|Part 2:Dose Confirmation|Not treated|0|||
129093373|NCT01447446|464632035|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
129093374|NCT01447446|464632036|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
129093375|NCT01447446|464632037|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
129093376|NCT01447446|464632032|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
129093377|NCT01447446|464632033|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
129093378|NCT01447446|464632034|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
129093379|NCT01447446|464632035|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
129093380|NCT01447446|464632036|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
129093381|NCT01447446|464632037|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
129093382|NCT01447446|464632032|FG000|Overall Study|Administrative/Other|34|||
129093383|NCT01447446|464632033|FG001|Overall Study|Administrative/Other|9|||
129093384|NCT01447446|464632034|FG002|Overall Study|Administrative/Other|10|||
129093385|NCT01447446|464632035|FG003|Overall Study|Administrative/Other|2|||
129093386|NCT01447446|464632036|FG004|Overall Study|Administrative/Other|33|||
129093387|NCT01447446|464632037|FG005|Overall Study|Administrative/Other|4|||
129093388|NCT01447446|464632032|FG000|Overall Study|SVR12 Assessment|13|||
129093389|NCT01447446|464632033|FG001|Overall Study|SVR12 Assessment|1|||
129093390|NCT01447446|464632034|FG002|Overall Study|SVR12 Assessment|2|||
129093391|NCT01447446|464632035|FG003|Overall Study|SVR12 Assessment|1|||
129093392|NCT01447446|464632036|FG004|Overall Study|SVR12 Assessment|5|||
129093393|NCT01447446|464632037|FG005|Overall Study|SVR12 Assessment|5|||
129093394|NCT01447446|464632032|FG000|Overall Study|New Treatment Started|8|||
129093395|NCT01447446|464632033|FG001|Overall Study|New Treatment Started|2|||
129093396|NCT01447446|464632034|FG002|Overall Study|New Treatment Started|1|||
129093397|NCT01447446|464632035|FG003|Overall Study|New Treatment Started|0|||
129093398|NCT01447446|464632036|FG004|Overall Study|New Treatment Started|2|||
129093399|NCT01447446|464632037|FG005|Overall Study|New Treatment Started|0|||
129093400|NCT01447446|464632032|FG000|Overall Study|Reason not Specified|1|||
129093401|NCT01447446|464632033|FG001|Overall Study|Reason not Specified|1|||
129093402|NCT01447446|464632034|FG002|Overall Study|Reason not Specified|1|||
129093403|NCT01447446|464632035|FG003|Overall Study|Reason not Specified|1|||
129093404|NCT01447446|464632036|FG004|Overall Study|Reason not Specified|1|||
129093405|NCT01447446|464632037|FG005|Overall Study|Reason not Specified|0|||
129093406|NCT03536949|464632053|FG000|Overall Study|Adverse Event|4|||
129093407|NCT03536949|464632054|FG001|Overall Study|Adverse Event|0|||
129093408|NCT03536949|464632053|FG000|Overall Study|Lost to Follow-up|2|||
129093409|NCT03536949|464632054|FG001|Overall Study|Lost to Follow-up|1|||
129093410|NCT03536949|464632053|FG000|Overall Study|Withdrawal by Subject|6|||
129093411|NCT03536949|464632054|FG001|Overall Study|Withdrawal by Subject|0|||
129093412|NCT03536949|464632053|FG000|Overall Study|Non-compliance|2|||
129093413|NCT03536949|464632054|FG001|Overall Study|Non-compliance|1|||
129093414|NCT00435487|464632071|FG000|Overall Study|Death|3|||
129093415|NCT00435487|464632072|FG001|Overall Study|Death|4|||
129093416|NCT00435487|464632071|FG000|Overall Study|Adverse Event|0|||
129093417|NCT00435487|464632072|FG001|Overall Study|Adverse Event|3|||
129093418|NCT00435487|464632071|FG000|Overall Study|Lost to Follow-up|2|||
129093419|NCT00435487|464632072|FG001|Overall Study|Lost to Follow-up|2|||
129093420|NCT00435487|464632071|FG000|Overall Study|Other|5|||
129093421|NCT00435487|464632072|FG001|Overall Study|Other|2|||
129093422|NCT00435487|464632071|FG000|Overall Study|Withdrawal by Subject|2|||
129093423|NCT00435487|464632072|FG001|Overall Study|Withdrawal by Subject|1|||
129093424|NCT00435487|464632071|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
129093425|NCT00435487|464632072|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
129093426|NCT00435487|464632071|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
129093427|NCT00435487|464632072|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
129093428|NCT03301844|464632073|FG000|Overall Study|suspected colon cancer|1|||
129093429|NCT03301844|464632074|FG001|Overall Study|suspected colon cancer|1|||
129093430|NCT05087966|464632075|FG000|Overall Study|Lost to Follow-up|1|||
129093431|NCT05087966|464632075|FG000|Overall Study|Withdrawal by Subject|5|||
129093432|NCT01267201|464632076|FG000|First Intervention Period|Withdrawal by Subject|1|||
128724783|NCT02036502|463290916|FG003|Part 2:Dose Confirmation|Not treated|1|||
129093433|NCT01267201|464632077|FG001|First Intervention Period|Withdrawal by Subject|0|||
129093434|NCT01267201|464632078|FG002|First Intervention Period|Withdrawal by Subject|0|||
129093435|NCT01267201|464632079|FG003|First Intervention Period|Withdrawal by Subject|0|||
129093436|NCT01267201|464632080|FG004|First Intervention Period|Withdrawal by Subject|0|||
129093437|NCT01267201|464632081|FG005|First Intervention Period|Withdrawal by Subject|0|||
129093438|NCT01267201|464632076|FG000|Second Intervention Period|Withdrawal by Subject|0|||
129093439|NCT01267201|464632077|FG001|Second Intervention Period|Withdrawal by Subject|1|||
128724784|NCT02036502|463290917|FG004|Part 2:Dose Confirmation|Not treated|0|||
129093440|NCT01267201|464632078|FG002|Second Intervention Period|Withdrawal by Subject|0|||
129093441|NCT01267201|464632079|FG003|Second Intervention Period|Withdrawal by Subject|0|||
129093442|NCT01267201|464632080|FG004|Second Intervention Period|Withdrawal by Subject|0|||
129093443|NCT01267201|464632081|FG005|Second Intervention Period|Withdrawal by Subject|0|||
129093444|NCT00501059|464632082|FG000|Overall Study|Protocol Violation|80|||
129093445|NCT00501059|464632083|FG001|Overall Study|Protocol Violation|69|||
129093446|NCT00501059|464632082|FG000|Overall Study|Death|140|||
129093447|NCT00501059|464632083|FG001|Overall Study|Death|137|||
129093448|NCT00501059|464632082|FG000|Overall Study|Other|236|||
129093449|NCT00501059|464632083|FG001|Overall Study|Other|239|||
129093450|NCT00501059|464632082|FG000|Overall Study|Missing end-of-study page|91|||
129093451|NCT00501059|464632083|FG001|Overall Study|Missing end-of-study page|92|||
129093452|NCT00501059|464632082|FG000|Overall Study|Clinical endpoint reached|110|||
129093453|NCT00501059|464632083|FG001|Overall Study|Clinical endpoint reached|123|||
129093454|NCT00501059|464632082|FG000|Overall Study|Insufficient therapeutic effect|4|||
129093455|NCT00501059|464632083|FG001|Overall Study|Insufficient therapeutic effect|5|||
129093456|NCT00501059|464632082|FG000|Overall Study|Consent withdrawn by subject|817|||
129093457|NCT00501059|464632083|FG001|Overall Study|Consent withdrawn by subject|873|||
129093458|NCT00501059|464632082|FG000|Overall Study|Non-compliant with study treatment|23|||
129093459|NCT00501059|464632083|FG001|Overall Study|Non-compliant with study treatment|16|||
129093460|NCT00501059|464632082|FG000|Overall Study|Reason not given|3|||
129093461|NCT00501059|464632083|FG001|Overall Study|Reason not given|1|||
129093462|NCT00501059|464632082|FG000|Overall Study|Adverse Event|129|||
129093463|NCT00501059|464632083|FG001|Overall Study|Adverse Event|122|||
129093464|NCT00501059|464632082|FG000|Overall Study|Lost to Follow-up|210|||
129093465|NCT00501059|464632083|FG001|Overall Study|Lost to Follow-up|198|||
129093466|NCT00501059|464632082|FG000|Overall Study|Not treated|25|||
129093467|NCT00501059|464632083|FG001|Overall Study|Not treated|17|||
129093468|NCT00955968|464632087|FG000|Overall Study|Death|2|||
129093469|NCT00955968|464632088|FG001|Overall Study|Death|4|||
129093470|NCT00955968|464632087|FG000|Overall Study|Withdrawal by Subject|35|||
129093471|NCT00955968|464632088|FG001|Overall Study|Withdrawal by Subject|31|||
129093472|NCT00955968|464632087|FG000|Overall Study|Lost to Follow-up|45|||
129093473|NCT00955968|464632088|FG001|Overall Study|Lost to Follow-up|39|||
129093474|NCT00955968|464632087|FG000|Overall Study|Site closed|55|||
129093475|NCT00955968|464632088|FG001|Overall Study|Site closed|52|||
129093476|NCT04326439|464632093|FG000|Overall Study|Withdrawal by Subject|1|||
129093477|NCT04326439|464632094|FG001|Overall Study|Withdrawal by Subject|0|||
129093478|NCT04326439|464632093|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
129093479|NCT04326439|464632094|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
129093480|NCT04326439|464632093|FG000|Overall Study|Relapse after Induction 2|0|||
129093481|NCT04326439|464632094|FG001|Overall Study|Relapse after Induction 2|1|||
129093482|NCT04326439|464632093|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
129093483|NCT04326439|464632094|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
129093484|NCT00204477|464632097|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
129093485|NCT00204477|464632098|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
129093486|NCT00204477|464632097|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
129093487|NCT00204477|464632098|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
129093488|NCT04272606|464632101|FG000|Overall Study|Protocol Violation|1|||
129093489|NCT04272606|464632102|FG001|Overall Study|Protocol Violation|1|||
129093490|NCT04272606|464632101|FG000|Overall Study|Physician Decision|0|||
129093491|NCT04272606|464632102|FG001|Overall Study|Physician Decision|1|||
129093492|NCT00710684|464632103|FG000|Overall Study|Adverse Event|11|||
129093493|NCT00710684|464632104|FG001|Overall Study|Adverse Event|19|||
129093494|NCT00710684|464632105|FG002|Overall Study|Adverse Event|16|||
129093495|NCT00710684|464632103|FG000|Overall Study|Lack of Efficacy|4|||
129093496|NCT00710684|464632104|FG001|Overall Study|Lack of Efficacy|3|||
129093497|NCT00710684|464632105|FG002|Overall Study|Lack of Efficacy|5|||
129093498|NCT00710684|464632103|FG000|Overall Study|Protocol Violation|5|||
129093499|NCT00710684|464632104|FG001|Overall Study|Protocol Violation|5|||
129093500|NCT00710684|464632105|FG002|Overall Study|Protocol Violation|5|||
129093501|NCT00710684|464632103|FG000|Overall Study|Lost to Follow-up|4|||
129093502|NCT00710684|464632104|FG001|Overall Study|Lost to Follow-up|6|||
129093503|NCT00710684|464632105|FG002|Overall Study|Lost to Follow-up|7|||
129093504|NCT00710684|464632103|FG000|Overall Study|Physician Decision|0|||
129093505|NCT00710684|464632104|FG001|Overall Study|Physician Decision|2|||
129093506|NCT00710684|464632105|FG002|Overall Study|Physician Decision|4|||
129093507|NCT00710684|464632103|FG000|Overall Study|Withdrawal by Subject|24|||
129093508|NCT00710684|464632104|FG001|Overall Study|Withdrawal by Subject|18|||
129093509|NCT00710684|464632105|FG002|Overall Study|Withdrawal by Subject|11|||
129093510|NCT00710684|464632103|FG000|Overall Study|Missing|1|||
129093511|NCT00710684|464632104|FG001|Overall Study|Missing|0|||
129093512|NCT00710684|464632105|FG002|Overall Study|Missing|0|||
129093513|NCT00710684|464632103|FG000|Overall Study|Did not continue after week 24|25|||
129093514|NCT00710684|464632104|FG001|Overall Study|Did not continue after week 24|21|||
129093515|NCT00710684|464632105|FG002|Overall Study|Did not continue after week 24|16|||
129093516|NCT04778059|464632106|FG000|Overall Study|Death|2|||
129093517|NCT04778059|464632107|FG001|Overall Study|Death|2|||
129093518|NCT04778059|464632108|FG002|Overall Study|Death|1|||
129093519|NCT04778059|464632109|FG003|Overall Study|Death|1|||
129093520|NCT04778059|464632110|FG004|Overall Study|Death|1|||
129093521|NCT04778059|464632106|FG000|Overall Study|Lost to Follow-up|0|||
129093522|NCT04778059|464632107|FG001|Overall Study|Lost to Follow-up|0|||
129093523|NCT04778059|464632108|FG002|Overall Study|Lost to Follow-up|0|||
129093524|NCT04778059|464632109|FG003|Overall Study|Lost to Follow-up|0|||
129093525|NCT04778059|464632110|FG004|Overall Study|Lost to Follow-up|1|||
129093526|NCT04778059|464632106|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
129093527|NCT04778059|464632107|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
129093528|NCT04778059|464632108|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
129093529|NCT04778059|464632109|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
129093530|NCT04778059|464632110|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
129093531|NCT00157248|464632114|FG000|Overall Study|Adverse Event|36|||
129093532|NCT00157248|464632115|FG001|Overall Study|Adverse Event|25|||
129093533|NCT00157248|464632116|FG002|Overall Study|Adverse Event|13|||
129093534|NCT00157248|464632117|FG003|Overall Study|Adverse Event|33|||
129093535|NCT00157248|464632114|FG000|Overall Study|Protocol Violation|4|||
129093536|NCT00157248|464632115|FG001|Overall Study|Protocol Violation|0|||
129093537|NCT00157248|464632116|FG002|Overall Study|Protocol Violation|2|||
129145770|NCT02314923|464830094|FG002|Overall Study|Participant relocation|0|||
129145771|NCT02314923|464830095|FG003|Overall Study|Participant relocation|0|||
129145772|NCT02314923|464830096|FG004|Overall Study|Participant relocation|0|||
129145773|NCT02314923|464830097|FG005|Overall Study|Participant relocation|0|||
129145774|NCT02314923|464830098|FG006|Overall Study|Participant relocation|0|||
129145775|NCT02314923|464830099|FG007|Overall Study|Participant relocation|1|||
129145776|NCT02314923|464830100|FG008|Overall Study|Participant relocation|0|||
129145777|NCT02314923|464830101|FG009|Overall Study|Participant relocation|0|||
129145778|NCT00725985|464830102|FG000|ITP- Treatment Disposition|Adverse Event|20|||
129145779|NCT00725985|464830103|FG001|ITP- Treatment Disposition|Adverse Event|10|||
129145780|NCT00725985|464830104|FG002|ITP- Treatment Disposition|Adverse Event|5|||
129145781|NCT00725985|464830105|FG003|ITP- Treatment Disposition|Adverse Event|0|||
129145782|NCT00725985|464830106|FG004|ITP- Treatment Disposition|Adverse Event|0|||
129145783|NCT00725985|464830107|FG005|ITP- Treatment Disposition|Adverse Event|0|||
129145784|NCT00725985|464830108|FG006|ITP- Treatment Disposition|Adverse Event|0|||
129145785|NCT00725985|464830109|FG007|ITP- Treatment Disposition|Adverse Event|0|||
129145786|NCT00725985|464830110|FG008|ITP- Treatment Disposition|Adverse Event|0|||
129145787|NCT00725985|464830111|FG009|ITP- Treatment Disposition|Adverse Event|0|||
129145788|NCT00725985|464830112|FG010|ITP- Treatment Disposition|Adverse Event|0|||
129145789|NCT00725985|464830113|FG011|ITP- Treatment Disposition|Adverse Event|0|||
129145790|NCT00725985|464830102|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145791|NCT00725985|464830103|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145792|NCT00725985|464830104|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
129145793|NCT00725985|464830105|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145794|NCT00725985|464830106|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145795|NCT00725985|464830107|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145796|NCT00725985|464830108|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145797|NCT00725985|464830109|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145798|NCT00725985|464830110|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145799|NCT00725985|464830111|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145800|NCT00725985|464830112|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145801|NCT00725985|464830113|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
129145802|NCT00725985|464830102|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
129145803|NCT00725985|464830103|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
129145804|NCT00725985|464830104|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
129145805|NCT00725985|464830105|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
129145806|NCT00725985|464830106|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
129145807|NCT00725985|464830107|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
129145808|NCT00725985|464830108|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
129145809|NCT00725985|464830109|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
128724785|NCT02036502|463290918|FG005|Part 2:Dose Confirmation|Not treated|0|||
128724786|NCT02036502|463290919|FG006|Part 2:Dose Confirmation|Not treated|0|||
129093538|NCT00157248|464632117|FG003|Overall Study|Protocol Violation|2|||
129093539|NCT00157248|464632114|FG000|Overall Study|Lost to Follow-up|0|||
129145810|NCT00725985|464830110|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
129145811|NCT00725985|464830111|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
129145812|NCT00725985|464830112|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
129145813|NCT00725985|464830113|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
129145814|NCT00725985|464830102|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
129145815|NCT00725985|464830103|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
129145816|NCT00725985|464830104|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
129145817|NCT00725985|464830105|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
128724787|NCT02036502|463290920|FG007|Part 2:Dose Confirmation|Not treated|0|||
129093540|NCT00157248|464632115|FG001|Overall Study|Lost to Follow-up|1|||
129093541|NCT00157248|464632116|FG002|Overall Study|Lost to Follow-up|0|||
129093542|NCT00157248|464632117|FG003|Overall Study|Lost to Follow-up|0|||
129093543|NCT00157248|464632114|FG000|Overall Study|Withdrawal by Subject|1|||
129093544|NCT00157248|464632115|FG001|Overall Study|Withdrawal by Subject|4|||
129093545|NCT00157248|464632116|FG002|Overall Study|Withdrawal by Subject|3|||
129093546|NCT00157248|464632117|FG003|Overall Study|Withdrawal by Subject|3|||
129093547|NCT00157248|464632114|FG000|Overall Study|site closures, subject moving|7|||
129093548|NCT00157248|464632115|FG001|Overall Study|site closures, subject moving|7|||
129093549|NCT00157248|464632116|FG002|Overall Study|site closures, subject moving|3|||
129093550|NCT00157248|464632117|FG003|Overall Study|site closures, subject moving|9|||
129093551|NCT01306045|464632120|FG000|Met General Eligibility Criteria|Screen failures|193|||
129093552|NCT01306045|464632121|FG001|Met General Eligibility Criteria|Screen failures|11|||
129093553|NCT01306045|464632122|FG002|Met General Eligibility Criteria|Screen failures|8|||
129093554|NCT00787917|464632124|FG000|Blinded Treatment|Adverse Event|1|||
129093555|NCT00787917|464632125|FG001|Blinded Treatment|Adverse Event|0|||
129093556|NCT00787917|464632124|FG000|Blinded Treatment|Lack of Efficacy|1|||
129093557|NCT00787917|464632125|FG001|Blinded Treatment|Lack of Efficacy|0|||
129093558|NCT00787917|464632124|FG000|Blinded Treatment|Administrative problems|3|||
129093559|NCT00787917|464632125|FG001|Blinded Treatment|Administrative problems|2|||
129093560|NCT00787917|464632124|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
129093561|NCT00787917|464632125|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
129093562|NCT00787917|464632124|FG000|Open Label|Administrative problems|3|||
129093563|NCT00787917|464632125|FG001|Open Label|Administrative problems|0|||
129093564|NCT00778102|464632126|FG000|Overall Study|Adverse Event|8|||
129093565|NCT00778102|464632127|FG001|Overall Study|Adverse Event|5|||
129093566|NCT00778102|464632126|FG000|Overall Study|Death|1|||
129093567|NCT00778102|464632127|FG001|Overall Study|Death|1|||
129093568|NCT00778102|464632126|FG000|Overall Study|Lost to Follow-up|1|||
129093569|NCT00778102|464632127|FG001|Overall Study|Lost to Follow-up|0|||
129093570|NCT00778102|464632126|FG000|Overall Study|Violation of Selection Criteria|1|||
129093571|NCT00778102|464632127|FG001|Overall Study|Violation of Selection Criteria|1|||
129093572|NCT00778102|464632126|FG000|Overall Study|Protocol Violation|0|||
129093573|NCT00778102|464632127|FG001|Overall Study|Protocol Violation|1|||
129093574|NCT00778102|464632126|FG000|Overall Study|Refused Treatment|2|||
129093575|NCT00778102|464632127|FG001|Overall Study|Refused Treatment|3|||
129093576|NCT00778102|464632126|FG000|Overall Study|Withdrawal by Subject|1|||
129093577|NCT00778102|464632127|FG001|Overall Study|Withdrawal by Subject|1|||
129093578|NCT00778102|464632126|FG000|Overall Study|Administrative Reason|7|||
129093579|NCT00778102|464632127|FG001|Overall Study|Administrative Reason|10|||
129093580|NCT01328548|464632128|FG000|Overall Study|Death|3|||
129093581|NCT01328548|464632129|FG001|Overall Study|Death|0|||
129093582|NCT01328548|464632128|FG000|Overall Study|Protocol Violation|1|||
129093583|NCT01328548|464632129|FG001|Overall Study|Protocol Violation|0|||
129145818|NCT00725985|464830106|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
129145819|NCT00725985|464830107|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
129145820|NCT00725985|464830108|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
129145821|NCT00725985|464830109|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
129145822|NCT00725985|464830110|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
129145823|NCT00725985|464830111|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
129145824|NCT00725985|464830112|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
129145825|NCT00725985|464830113|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
129145826|NCT00725985|464830102|FG000|ITP- Treatment Disposition|Other|50|||
129145827|NCT00725985|464830103|FG001|ITP- Treatment Disposition|Other|38|||
129145828|NCT00725985|464830104|FG002|ITP- Treatment Disposition|Other|24|||
129145829|NCT00725985|464830105|FG003|ITP- Treatment Disposition|Other|0|||
129145830|NCT00725985|464830106|FG004|ITP- Treatment Disposition|Other|0|||
129145831|NCT00725985|464830107|FG005|ITP- Treatment Disposition|Other|0|||
129145832|NCT00725985|464830108|FG006|ITP- Treatment Disposition|Other|0|||
129145833|NCT00725985|464830109|FG007|ITP- Treatment Disposition|Other|0|||
129145834|NCT00725985|464830110|FG008|ITP- Treatment Disposition|Other|0|||
129145835|NCT00725985|464830111|FG009|ITP- Treatment Disposition|Other|0|||
129145836|NCT00725985|464830112|FG010|ITP- Treatment Disposition|Other|0|||
129145837|NCT00725985|464830113|FG011|ITP- Treatment Disposition|Other|0|||
129145838|NCT00725985|464830102|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145839|NCT00725985|464830103|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145840|NCT00725985|464830104|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145841|NCT00725985|464830105|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
129145842|NCT00725985|464830106|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
129145843|NCT00725985|464830107|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
129145844|NCT00725985|464830108|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145845|NCT00725985|464830109|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145846|NCT00725985|464830110|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145847|NCT00725985|464830111|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145848|NCT00725985|464830112|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145849|NCT00725985|464830113|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129145850|NCT00725985|464830102|FG000|OLMP (Up to 96 Weeks)|Death|0|||
129145851|NCT00725985|464830103|FG001|OLMP (Up to 96 Weeks)|Death|0|||
129145852|NCT00725985|464830104|FG002|OLMP (Up to 96 Weeks)|Death|0|||
129145853|NCT00725985|464830105|FG003|OLMP (Up to 96 Weeks)|Death|0|||
129145854|NCT00725985|464830106|FG004|OLMP (Up to 96 Weeks)|Death|1|||
129145855|NCT00725985|464830107|FG005|OLMP (Up to 96 Weeks)|Death|0|||
129145856|NCT00725985|464830108|FG006|OLMP (Up to 96 Weeks)|Death|0|||
129145857|NCT00725985|464830109|FG007|OLMP (Up to 96 Weeks)|Death|0|||
128724788|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Adverse Event|0|||
128724789|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Adverse Event|0|||
129145858|NCT00725985|464830110|FG008|OLMP (Up to 96 Weeks)|Death|0|||
129145859|NCT00725985|464830111|FG009|OLMP (Up to 96 Weeks)|Death|0|||
129145860|NCT00725985|464830112|FG010|OLMP (Up to 96 Weeks)|Death|0|||
129145861|NCT00725985|464830113|FG011|OLMP (Up to 96 Weeks)|Death|0|||
129145862|NCT00725985|464830102|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145863|NCT00725985|464830103|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145864|NCT00725985|464830104|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145865|NCT00725985|464830105|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
129145866|NCT00725985|464830106|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145867|NCT00725985|464830107|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145868|NCT00725985|464830108|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145869|NCT00725985|464830109|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145870|NCT00725985|464830110|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145871|NCT00725985|464830111|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145872|NCT00725985|464830112|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145873|NCT00725985|464830113|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129145874|NCT00725985|464830102|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145875|NCT00725985|464830103|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145876|NCT00725985|464830104|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145877|NCT00725985|464830105|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145878|NCT00725985|464830106|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145879|NCT00725985|464830107|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
129145880|NCT00725985|464830108|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145881|NCT00725985|464830109|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145882|NCT00725985|464830110|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145883|NCT00725985|464830111|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145884|NCT00725985|464830112|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145885|NCT00725985|464830113|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
129145886|NCT00725985|464830102|FG000|OLMP (Up to 96 Weeks)|Other|0|||
129145887|NCT00725985|464830103|FG001|OLMP (Up to 96 Weeks)|Other|0|||
129145888|NCT00725985|464830104|FG002|OLMP (Up to 96 Weeks)|Other|0|||
129145889|NCT00725985|464830105|FG003|OLMP (Up to 96 Weeks)|Other|15|||
129145890|NCT00725985|464830106|FG004|OLMP (Up to 96 Weeks)|Other|20|||
129145891|NCT00725985|464830107|FG005|OLMP (Up to 96 Weeks)|Other|44|||
129145892|NCT00725985|464830108|FG006|OLMP (Up to 96 Weeks)|Other|0|||
129145893|NCT00725985|464830109|FG007|OLMP (Up to 96 Weeks)|Other|0|||
129145894|NCT00725985|464830110|FG008|OLMP (Up to 96 Weeks)|Other|0|||
129145895|NCT00725985|464830111|FG009|OLMP (Up to 96 Weeks)|Other|0|||
129145896|NCT00725985|464830112|FG010|OLMP (Up to 96 Weeks)|Other|0|||
129145897|NCT00725985|464830113|FG011|OLMP (Up to 96 Weeks)|Other|0|||
129145898|NCT00725985|464830102|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145899|NCT00725985|464830103|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145900|NCT00725985|464830104|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145901|NCT00725985|464830105|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145902|NCT00725985|464830106|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145903|NCT00725985|464830107|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145904|NCT00725985|464830108|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145905|NCT00725985|464830109|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
129145906|NCT00725985|464830110|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145907|NCT00725985|464830111|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145908|NCT00725985|464830112|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145909|NCT00725985|464830113|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129145910|NCT00725985|464830102|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145911|NCT00725985|464830103|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145912|NCT00725985|464830104|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145913|NCT00725985|464830105|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145914|NCT00725985|464830106|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145915|NCT00725985|464830107|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145916|NCT00725985|464830108|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145917|NCT00725985|464830109|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145918|NCT00725985|464830110|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
129145919|NCT00725985|464830111|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145920|NCT00725985|464830112|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
128724790|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Adverse Event|0|||
128724791|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Adverse Event|0|||
128724792|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Adverse Event|0|||
128724793|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Adverse Event|4|||
128724794|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Adverse Event|0|||
128724795|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Adverse Event|2|||
128724796|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Death|0|||
128724797|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Death|0|||
128724798|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Death|0|||
128724799|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Death|0|||
128724800|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Death|0|||
128724801|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Death|24|||
128724802|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Death|0|||
128724803|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Death|3|||
128724804|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
128724805|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
128724806|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
128724807|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
128724808|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
129145921|NCT00725985|464830113|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129145922|NCT00725985|464830102|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145923|NCT00725985|464830103|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145924|NCT00725985|464830104|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145925|NCT00725985|464830105|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145926|NCT00725985|464830106|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145927|NCT00725985|464830107|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145928|NCT00725985|464830108|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
129145929|NCT00725985|464830109|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
129145930|NCT00725985|464830110|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
129145931|NCT00725985|464830111|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145932|NCT00725985|464830112|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145933|NCT00725985|464830113|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129145934|NCT00725985|464830102|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145935|NCT00725985|464830103|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145936|NCT00725985|464830104|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145937|NCT00725985|464830105|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145938|NCT00725985|464830106|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145939|NCT00725985|464830107|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145940|NCT00725985|464830108|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145941|NCT00725985|464830109|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145942|NCT00725985|464830110|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129145943|NCT00725985|464830111|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
129145944|NCT00725985|464830112|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
129145945|NCT00725985|464830113|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
129145946|NCT02546323|464830114|FG000|Overall Study|Withdrawal by Subject|36|||
129145947|NCT02546323|464830115|FG001|Overall Study|Withdrawal by Subject|33|||
129145948|NCT02546323|464830114|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
129145949|NCT02546323|464830115|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
129145950|NCT02546323|464830114|FG000|Overall Study|Adverse Event|17|||
129145951|NCT02546323|464830115|FG001|Overall Study|Adverse Event|11|||
129145952|NCT02546323|464830114|FG000|Overall Study|Patient Specific Reasons|1|||
129145953|NCT02546323|464830115|FG001|Overall Study|Patient Specific Reasons|2|||
129145954|NCT02546323|464830114|FG000|Overall Study|Lost to Follow-up|2|||
129145955|NCT02546323|464830115|FG001|Overall Study|Lost to Follow-up|3|||
129145956|NCT02546323|464830114|FG000|Overall Study|Non-compliance with Study Drug|2|||
129145957|NCT02546323|464830115|FG001|Overall Study|Non-compliance with Study Drug|2|||
129145958|NCT02546323|464830114|FG000|Overall Study|Met Withdrawal Criteria|2|||
129145959|NCT02546323|464830115|FG001|Overall Study|Met Withdrawal Criteria|14|||
129145960|NCT04476784|464830116|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
129145961|NCT04476784|464830117|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
129145962|NCT03605693|464830124|FG000|Overall Study|Lost to Follow-up|4|||
129145963|NCT03605693|464830125|FG001|Overall Study|Lost to Follow-up|0|||
129145964|NCT03605693|464830124|FG000|Overall Study|Physician Decision|1|||
129145965|NCT03605693|464830125|FG001|Overall Study|Physician Decision|0|||
129145966|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
129145967|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
129145968|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
129145969|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
129145970|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
129145971|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
128724809|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
128724810|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
128724811|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
129145972|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
129145973|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
129145974|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
129145975|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
129145976|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
129145977|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
129145978|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
129145979|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
129145980|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
129145981|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
129145982|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
129145983|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
129145984|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
129145985|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
129145986|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
129145987|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
129145988|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
129145989|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
129145990|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
129145991|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
129145992|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
129145993|NCT03093415|464830126|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
129145994|NCT03093415|464830127|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
129145995|NCT03093415|464830128|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
129145996|NCT03093415|464830126|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
129145997|NCT03093415|464830127|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
129145998|NCT03093415|464830128|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
129145999|NCT04581395|464830133|FG000|Overall Study|Protocol Violation|4|||
129146000|NCT04581395|464830134|FG001|Overall Study|Protocol Violation|3|||
129146001|NCT04581395|464830135|FG002|Overall Study|Protocol Violation|2|||
129146002|NCT04581395|464830133|FG000|Overall Study|Physician Decision|0|||
129146003|NCT04581395|464830134|FG001|Overall Study|Physician Decision|1|||
129146004|NCT04581395|464830135|FG002|Overall Study|Physician Decision|0|||
129146005|NCT00815633|464830136|FG000|Overall Study|study terminated|1|||
129146006|NCT00721110|464830137|FG000|Overall Study|Ultram use|1|||
129146007|NCT00721110|464830138|FG001|Overall Study|Ultram use|0|||
129146008|NCT00721110|464830139|FG002|Overall Study|Ultram use|0|||
129146009|NCT00721110|464830140|FG003|Overall Study|Ultram use|0|||
129146010|NCT00721110|464830137|FG000|Overall Study|vertical incision|0|||
129146011|NCT00721110|464830138|FG001|Overall Study|vertical incision|0|||
129146012|NCT00721110|464830139|FG002|Overall Study|vertical incision|1|||
129146013|NCT00721110|464830140|FG003|Overall Study|vertical incision|0|||
129146014|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
129146015|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129146016|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129146017|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129146018|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129146019|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129146020|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129146021|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
129146022|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
129146023|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
129146024|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
129146025|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
129146026|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
129146027|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
129146028|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
129146029|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
129146030|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
129146031|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
129146032|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
129146033|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
129146034|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
129146035|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
129146036|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
129146037|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
129146038|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
129146039|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
129146040|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
129146041|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
129146042|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
129146043|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
129146044|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
129146045|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
129146046|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
129146047|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
129146048|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
129146049|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
129146050|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
129146051|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
129146052|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
129146053|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
129146054|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
129146055|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
129146056|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
129146057|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129146058|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129146059|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129146060|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129146061|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129146062|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129146063|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129146064|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
129146065|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129146066|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129146067|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129146068|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129146069|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129146070|NCT01362790|464830141|FG000|Pilot Phase & Phase 2|Death on study|0|||
129146071|NCT01362790|464830142|FG001|Pilot Phase & Phase 2|Death on study|0|||
129146072|NCT01362790|464830143|FG002|Pilot Phase & Phase 2|Death on study|0|||
129146073|NCT01362790|464830144|FG003|Pilot Phase & Phase 2|Death on study|1|||
129146074|NCT01362790|464830145|FG004|Pilot Phase & Phase 2|Death on study|0|||
129146075|NCT01362790|464830146|FG005|Pilot Phase & Phase 2|Death on study|0|||
129146076|NCT01362790|464830147|FG006|Pilot Phase & Phase 2|Death on study|0|||
129146077|NCT01362790|464830141|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
129146078|NCT01362790|464830142|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
129146079|NCT01362790|464830143|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
129146080|NCT01362790|464830144|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
129146081|NCT01362790|464830145|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
129146082|NCT01362790|464830146|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
129146083|NCT01362790|464830147|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
129146084|NCT01362790|464830141|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129146085|NCT01362790|464830142|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129146086|NCT01362790|464830143|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129146087|NCT01362790|464830144|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129146088|NCT01362790|464830145|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
129146089|NCT01362790|464830146|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129146090|NCT01362790|464830147|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129146091|NCT01362790|464830141|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
129146092|NCT01362790|464830142|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
129146093|NCT01362790|464830143|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
129146094|NCT01362790|464830144|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
129146095|NCT01362790|464830145|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
129146096|NCT01362790|464830146|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
129146097|NCT01362790|464830147|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
129146098|NCT02457065|464830148|FG000|Overall Study|Lost to Follow-up|9|||
129146099|NCT02457065|464830149|FG001|Overall Study|Lost to Follow-up|11|||
129146100|NCT01554904|464830150|FG000|Overall Study|Withdrawal by Subject|3|||
129146101|NCT01554904|464830150|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
129146102|NCT01605097|464830152|FG000|Overall Study|Protocol Violation|1|||
129146103|NCT02038647|464830153|FG000|Overall Study|Progressive Disease|50|||
129146104|NCT02038647|464830154|FG001|Overall Study|Progressive Disease|59|||
129146105|NCT02038647|464830153|FG000|Overall Study|Adverse Event|18|||
129146106|NCT02038647|464830154|FG001|Overall Study|Adverse Event|10|||
129146107|NCT02038647|464830153|FG000|Overall Study|Symptomatic Deterioration|7|||
129146108|NCT02038647|464830154|FG001|Overall Study|Symptomatic Deterioration|7|||
129146109|NCT02038647|464830153|FG000|Overall Study|Withdrawal by Subject|5|||
129146110|NCT02038647|464830154|FG001|Overall Study|Withdrawal by Subject|2|||
129146111|NCT02038647|464830153|FG000|Overall Study|Not Reported|0|||
129146112|NCT02038647|464830154|FG001|Overall Study|Not Reported|1|||
129146113|NCT02038647|464830153|FG000|Overall Study|Ongoing at Datacut|9|||
129146114|NCT02038647|464830154|FG001|Overall Study|Ongoing at Datacut|10|||
129146115|NCT02757430|464830155|FG000|Overall Study|Physician Decision|6|||
129146116|NCT02757430|464830155|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
129146117|NCT02757430|464830155|FG000|Overall Study|No informed consent|1|||
129146118|NCT02757430|464830155|FG000|Overall Study|No procedure performed|2|||
129146119|NCT04507269|464830159|FG000|Overall Study|Withdrawal by Subject|1|||
129146120|NCT04507269|464830160|FG001|Overall Study|Withdrawal by Subject|1|||
129146121|NCT04507269|464830161|FG002|Overall Study|Withdrawal by Subject|0|||
129146122|NCT04507269|464830162|FG003|Overall Study|Withdrawal by Subject|0|||
129146123|NCT04507269|464830163|FG004|Overall Study|Withdrawal by Subject|0|||
129146124|NCT04507269|464830164|FG005|Overall Study|Withdrawal by Subject|0|||
129146125|NCT04507269|464830159|FG000|Overall Study|Lost to Follow-up|0|||
129146126|NCT04507269|464830160|FG001|Overall Study|Lost to Follow-up|0|||
129146127|NCT04507269|464830161|FG002|Overall Study|Lost to Follow-up|0|||
129146128|NCT04507269|464830162|FG003|Overall Study|Lost to Follow-up|0|||
129146129|NCT04507269|464830163|FG004|Overall Study|Lost to Follow-up|1|||
129146130|NCT04507269|464830164|FG005|Overall Study|Lost to Follow-up|0|||
129146131|NCT00071032|464830168|FG000|Overall Study|Lost to Follow-up|1|||
129146132|NCT00071032|464830169|FG001|Overall Study|Lost to Follow-up|1|||
129146133|NCT00071032|464830168|FG000|Overall Study|Withdrawal by Subject|8|||
129146134|NCT00071032|464830169|FG001|Overall Study|Withdrawal by Subject|6|||
129146135|NCT00071032|464830168|FG000|Overall Study|Missing Primary Outcome|0|||
129146136|NCT00071032|464830169|FG001|Overall Study|Missing Primary Outcome|1|||
129146137|NCT06071104|464830170|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
129146138|NCT03518060|464830171|FG000|Overall Study|Death|1|||
129146139|NCT03518060|464830171|FG000|Overall Study|Poor adherence|1|||
129146140|NCT03518060|464830171|FG000|Overall Study|Withdrawal of informed consent|2|||
129146141|NCT03518060|464830171|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
129146142|NCT03518060|464830171|FG000|Overall Study|Physician Decision|7|||
129146143|NCT03518060|464830171|FG000|Overall Study|Adverse drug reactions|23|||
129146144|NCT03518060|464830171|FG000|Overall Study|Withdrawal by Subject|25|||
129146145|NCT03518060|464830171|FG000|Overall Study|Lost to Follow-up|13|||
129146146|NCT01903863|464830173|FG000|Overall Study|Physician Decision|2|||
129146147|NCT01903863|464830174|FG001|Overall Study|Physician Decision|0|||
129146148|NCT04727151|464830179|FG000|Overall Study|Death|0|||
129146149|NCT04727151|464830180|FG001|Overall Study|Death|0|||
129146150|NCT04727151|464830181|FG002|Overall Study|Death|0|||
129146151|NCT04727151|464830182|FG003|Overall Study|Death|0|||
129146152|NCT04727151|464830183|FG004|Overall Study|Death|3|||
129146153|NCT04727151|464830179|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129146154|NCT04727151|464830180|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129146155|NCT04727151|464830181|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129146156|NCT04727151|464830182|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129146157|NCT04727151|464830183|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
129146158|NCT01969058|464830184|FG000|Overall Study|Withdrawal by Subject|2|||
129146159|NCT01969058|464830185|FG001|Overall Study|Withdrawal by Subject|0|||
129146160|NCT01969058|464830184|FG000|Overall Study|Adverse Event|1|||
129146161|NCT01969058|464830185|FG001|Overall Study|Adverse Event|0|||
129146162|NCT01346592|464830187|FG000|Overall Study|Lost to Follow-up|62|||
129146163|NCT01346592|464830188|FG001|Overall Study|Lost to Follow-up|29|||
129146164|NCT01346592|464830189|FG002|Overall Study|Lost to Follow-up|29|||
129146165|NCT01346592|464830187|FG000|Overall Study|Protocol Violation|2|||
129146166|NCT01346592|464830188|FG001|Overall Study|Protocol Violation|1|||
129146167|NCT01346592|464830189|FG002|Overall Study|Protocol Violation|0|||
129146168|NCT01346592|464830187|FG000|Overall Study|Death|1|||
129146169|NCT01346592|464830188|FG001|Overall Study|Death|3|||
129146170|NCT01346592|464830189|FG002|Overall Study|Death|4|||
129146171|NCT01346592|464830187|FG000|Overall Study|Adverse Event|0|||
129146172|NCT01346592|464830188|FG001|Overall Study|Adverse Event|1|||
129146173|NCT01346592|464830189|FG002|Overall Study|Adverse Event|0|||
129146174|NCT01346592|464830187|FG000|Overall Study|Withdrawal by Subject|77|||
129146175|NCT01346592|464830188|FG001|Overall Study|Withdrawal by Subject|51|||
129146176|NCT01346592|464830189|FG002|Overall Study|Withdrawal by Subject|38|||
129146177|NCT01346592|464830187|FG000|Overall Study|Inappropriate enrollment|3|||
129146178|NCT01346592|464830188|FG001|Overall Study|Inappropriate enrollment|1|||
129146179|NCT01346592|464830189|FG002|Overall Study|Inappropriate enrollment|1|||
129146180|NCT01346592|464830187|FG000|Overall Study|Administrative reason|1|||
129146181|NCT01346592|464830188|FG001|Overall Study|Administrative reason|0|||
129146182|NCT01346592|464830189|FG002|Overall Study|Administrative reason|0|||
129146183|NCT01346592|464830187|FG000|Overall Study|Unable to Classify|7|||
129146184|NCT01346592|464830188|FG001|Overall Study|Unable to Classify|3|||
129146185|NCT01346592|464830189|FG002|Overall Study|Unable to Classify|6|||
129146186|NCT02679274|464830190|FG000|Overall Study|Withdrawal by Subject|1|||
129146187|NCT02679274|464830191|FG001|Overall Study|Withdrawal by Subject|0|||
129146188|NCT04976855|464830195|FG000|Part I|Withdrawal by Subject|0|||
129146189|NCT04976855|464830196|FG001|Part I|Withdrawal by Subject|1|||
129146190|NCT04976855|464830197|FG002|Part I|Withdrawal by Subject|0|||
129146191|NCT04976855|464830198|FG003|Part I|Withdrawal by Subject|0|||
129146192|NCT04976855|464830199|FG004|Part I|Withdrawal by Subject|0|||
129146193|NCT04976855|464830200|FG005|Part I|Withdrawal by Subject|0|||
129146194|NCT04976855|464830201|FG006|Part I|Withdrawal by Subject|0|||
129146195|NCT04976855|464830195|FG000|Part II|Adverse Event|0|||
129146196|NCT04976855|464830196|FG001|Part II|Adverse Event|0|||
129146197|NCT04976855|464830197|FG002|Part II|Adverse Event|0|||
129146198|NCT04976855|464830198|FG003|Part II|Adverse Event|1|||
129146199|NCT04976855|464830199|FG004|Part II|Adverse Event|0|||
129146200|NCT04976855|464830200|FG005|Part II|Adverse Event|0|||
129146201|NCT04976855|464830201|FG006|Part II|Adverse Event|0|||
129146202|NCT04976855|464830195|FG000|Part II|Withdrawal by Subject|0|||
129146203|NCT04976855|464830196|FG001|Part II|Withdrawal by Subject|0|||
129146204|NCT04976855|464830197|FG002|Part II|Withdrawal by Subject|0|||
129146205|NCT04976855|464830198|FG003|Part II|Withdrawal by Subject|0|||
129146206|NCT04976855|464830199|FG004|Part II|Withdrawal by Subject|1|||
129146207|NCT04976855|464830200|FG005|Part II|Withdrawal by Subject|0|||
129146208|NCT04976855|464830201|FG006|Part II|Withdrawal by Subject|0|||
129146209|NCT04976855|464830195|FG000|Part II|Lost to Follow-up|0|||
129146210|NCT04976855|464830196|FG001|Part II|Lost to Follow-up|0|||
129146211|NCT04976855|464830197|FG002|Part II|Lost to Follow-up|0|||
129146212|NCT04976855|464830198|FG003|Part II|Lost to Follow-up|0|||
129146213|NCT04976855|464830199|FG004|Part II|Lost to Follow-up|0|||
129146214|NCT04976855|464830200|FG005|Part II|Lost to Follow-up|1|||
129146215|NCT04976855|464830201|FG006|Part II|Lost to Follow-up|0|||
129146216|NCT02038036|464830203|FG000|Core Study|Adverse Event|7|||
129146217|NCT02038036|464830204|FG001|Core Study|Adverse Event|7|||
129146218|NCT02038036|464830203|FG000|Core Study|Death|1|||
129146219|NCT02038036|464830204|FG001|Core Study|Death|1|||
129146220|NCT02038036|464830203|FG000|Core Study|Disease progression|2|||
129146221|NCT02038036|464830204|FG001|Core Study|Disease progression|2|||
129146222|NCT02038036|464830203|FG000|Core Study|Lost to Follow-up|0|||
129146223|NCT02038036|464830204|FG001|Core Study|Lost to Follow-up|1|||
129146224|NCT02038036|464830203|FG000|Core Study|Physician Decision|2|||
129146225|NCT02038036|464830204|FG001|Core Study|Physician Decision|1|||
129146226|NCT02038036|464830203|FG000|Core Study|Subject/guardian decision|0|||
129146227|NCT02038036|464830204|FG001|Core Study|Subject/guardian decision|1|||
129146228|NCT02038036|464830203|FG000|Core Study|Withdrawal by Subject|3|||
129146229|NCT02038036|464830204|FG001|Core Study|Withdrawal by Subject|1|||
129146230|NCT02038036|464830203|FG000|Crossover Period|Withdrawal by Subject|0|||
129146231|NCT02038036|464830204|FG001|Crossover Period|Withdrawal by Subject|3|||
129146232|NCT02038036|464830203|FG000|Crossover Period|Adverse Event|0|||
129146233|NCT02038036|464830204|FG001|Crossover Period|Adverse Event|9|||
129146234|NCT02038036|464830203|FG000|Crossover Period|Death|0|||
129146235|NCT02038036|464830204|FG001|Crossover Period|Death|2|||
129146236|NCT02038036|464830203|FG000|Crossover Period|Disease progression|0|||
129146237|NCT02038036|464830204|FG001|Crossover Period|Disease progression|3|||
129146238|NCT02038036|464830203|FG000|Crossover Period|Lost to Follow-up|0|||
129146239|NCT02038036|464830204|FG001|Crossover Period|Lost to Follow-up|1|||
129146240|NCT02038036|464830203|FG000|Crossover Period|Physician Decision|0|||
129146241|NCT02038036|464830204|FG001|Crossover Period|Physician Decision|2|||
129146242|NCT03537508|464830212|FG000|Overall Study|Adverse Event|2|||
129146243|NCT03537508|464830213|FG001|Overall Study|Adverse Event|1|||
129146244|NCT03537508|464830212|FG000|Overall Study|Protocol Violation|65|||
129146245|NCT03537508|464830213|FG001|Overall Study|Protocol Violation|48|||
129146246|NCT03537508|464830212|FG000|Overall Study|Lost to Follow-up|86|||
129146247|NCT03537508|464830213|FG001|Overall Study|Lost to Follow-up|60|||
129146248|NCT03537508|464830212|FG000|Overall Study|Withdrawal by parent/guardian|263|||
129146249|NCT03537508|464830213|FG001|Overall Study|Withdrawal by parent/guardian|149|||
129146250|NCT02495883|464830229|FG000|Overall Study|Excessive head motion|1|||
129146251|NCT02495883|464830230|FG001|Overall Study|Excessive head motion|0|||
129146252|NCT02776735|464830231|FG000|Overall Study|Adverse Event|0|||
129146253|NCT02776735|464830232|FG001|Overall Study|Adverse Event|0|||
129146254|NCT02776735|464830233|FG002|Overall Study|Adverse Event|0|||
129146255|NCT02776735|464830234|FG003|Overall Study|Adverse Event|1|||
129146256|NCT02776735|464830235|FG004|Overall Study|Adverse Event|0|||
129146257|NCT02776735|464830236|FG005|Overall Study|Adverse Event|1|||
129146258|NCT02776735|464830231|FG000|Overall Study|Lost to Follow-up|0|||
129146259|NCT02776735|464830232|FG001|Overall Study|Lost to Follow-up|0|||
129146260|NCT02776735|464830233|FG002|Overall Study|Lost to Follow-up|0|||
129146261|NCT02776735|464830234|FG003|Overall Study|Lost to Follow-up|1|||
129146262|NCT02776735|464830235|FG004|Overall Study|Lost to Follow-up|0|||
129146263|NCT02776735|464830236|FG005|Overall Study|Lost to Follow-up|0|||
129146264|NCT02776735|464830231|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129146265|NCT02776735|464830232|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129146266|NCT02776735|464830233|FG002|Overall Study|Withdrawal by parent/guardian|2|||
129146267|NCT02776735|464830234|FG003|Overall Study|Withdrawal by parent/guardian|2|||
129146268|NCT02776735|464830235|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129146269|NCT02776735|464830236|FG005|Overall Study|Withdrawal by parent/guardian|0|||
129146270|NCT02776735|464830231|FG000|Overall Study|Withdrawal by Subject|1|||
129146271|NCT02776735|464830232|FG001|Overall Study|Withdrawal by Subject|0|||
129146272|NCT02776735|464830233|FG002|Overall Study|Withdrawal by Subject|0|||
129146273|NCT02776735|464830234|FG003|Overall Study|Withdrawal by Subject|0|||
129146274|NCT02776735|464830235|FG004|Overall Study|Withdrawal by Subject|0|||
129146275|NCT02776735|464830236|FG005|Overall Study|Withdrawal by Subject|1|||
129146276|NCT02776735|464830231|FG000|Overall Study|Other|0|||
129146277|NCT02776735|464830232|FG001|Overall Study|Other|0|||
129146278|NCT02776735|464830233|FG002|Overall Study|Other|3|||
129146279|NCT02776735|464830234|FG003|Overall Study|Other|0|||
129146280|NCT02776735|464830235|FG004|Overall Study|Other|0|||
129146281|NCT02776735|464830236|FG005|Overall Study|Other|0|||
129146282|NCT00791648|464831622|FG000|Overall Study|Physician Decision|0|||
129146283|NCT00791648|464831623|FG001|Overall Study|Physician Decision|1|||
129146284|NCT00791648|464831622|FG000|Overall Study|Withdrawal by Subject|0|||
129146285|NCT00791648|464831623|FG001|Overall Study|Withdrawal by Subject|1|||
129146286|NCT04976777|464831624|FG000|Overall Study|COVID-19 Infection|1|||
129146287|NCT04976777|464831625|FG001|Overall Study|COVID-19 Infection|0|||
129146288|NCT00462826|464831626|FG000|Overall Study|Ineligible - second primary|1|||
129146289|NCT00462826|464831626|FG000|Overall Study|Ineligible - wrong cell type|1|||
129146290|NCT00462826|464831626|FG000|Overall Study|Ineligible - wrong primary|2|||
129146291|NCT00462826|464831626|FG000|Overall Study|Never treated|1|||
129146292|NCT02332928|464831629|FG000|Overall Study|Withdrawal by Subject|0|||
129146293|NCT02332928|464831630|FG001|Overall Study|Withdrawal by Subject|2|||
129146294|NCT02332928|464831629|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
129146295|NCT02332928|464831630|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
129146296|NCT04484857|464831631|FG000|Overall Study|Adverse Event|2|||
129146297|NCT04484857|464831631|FG000|Overall Study|Death|10|||
129146298|NCT04484857|464831631|FG000|Overall Study|Withdrawal by Subject|3|||
129146299|NCT04484857|464831631|FG000|Overall Study|Transferred/Relocation|5|||
129146300|NCT04484857|464831631|FG000|Overall Study|Kidney Transplant|7|||
129146301|NCT04484857|464831631|FG000|Overall Study|Other than specified|4|||
129146302|NCT04484857|464831631|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
129146303|NCT01822925|464831632|FG000|Overall Study|Adverse Event|1|||
129146304|NCT01822925|464831633|FG001|Overall Study|Adverse Event|1|||
128724812|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Physician Decision|0|||
128724813|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Physician Decision|0|||
128724814|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Physician Decision|0|||
128724815|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Physician Decision|0|||
128724816|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Physician Decision|0|||
128724817|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Physician Decision|1|||
128724818|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Physician Decision|0|||
128724819|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Physician Decision|0|||
129146305|NCT01822925|464831634|FG002|Overall Study|Adverse Event|1|||
129146306|NCT01822925|464831635|FG003|Overall Study|Adverse Event|1|||
129146307|NCT01822925|464831632|FG000|Overall Study|Lost to Follow-up|0|||
129146308|NCT01822925|464831633|FG001|Overall Study|Lost to Follow-up|1|||
129146309|NCT01822925|464831634|FG002|Overall Study|Lost to Follow-up|0|||
129146310|NCT01822925|464831635|FG003|Overall Study|Lost to Follow-up|0|||
129146311|NCT01822925|464831632|FG000|Overall Study|Protocol Violation|1|||
129146312|NCT01822925|464831633|FG001|Overall Study|Protocol Violation|0|||
129146313|NCT01822925|464831634|FG002|Overall Study|Protocol Violation|0|||
129146314|NCT01822925|464831635|FG003|Overall Study|Protocol Violation|1|||
128724820|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
129146315|NCT01822925|464831632|FG000|Overall Study|Withdrawal by Subject|2|||
129146316|NCT01822925|464831633|FG001|Overall Study|Withdrawal by Subject|0|||
128724821|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
128724822|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
129146317|NCT01822925|464831634|FG002|Overall Study|Withdrawal by Subject|2|||
129146318|NCT01822925|464831635|FG003|Overall Study|Withdrawal by Subject|2|||
129146319|NCT01822925|464831632|FG000|Overall Study|Taking prohibited medication|2|||
129146320|NCT01822925|464831633|FG001|Overall Study|Taking prohibited medication|0|||
129146321|NCT01822925|464831634|FG002|Overall Study|Taking prohibited medication|0|||
129146322|NCT01822925|464831635|FG003|Overall Study|Taking prohibited medication|1|||
129146323|NCT04617860|464831640|FG000|Overall Study|Adverse Event|0|||
129146324|NCT04617860|464831641|FG001|Overall Study|Adverse Event|2|||
129146325|NCT04617860|464831642|FG002|Overall Study|Adverse Event|2|||
129146326|NCT04617860|464831640|FG000|Overall Study|Withdrawal by Subject|0|||
129146327|NCT04617860|464831641|FG001|Overall Study|Withdrawal by Subject|0|||
129146328|NCT04617860|464831642|FG002|Overall Study|Withdrawal by Subject|2|||
129146329|NCT04617860|464831640|FG000|Overall Study|Physician Decision|0|||
129146330|NCT04617860|464831641|FG001|Overall Study|Physician Decision|1|||
129146331|NCT04617860|464831642|FG002|Overall Study|Physician Decision|0|||
129146332|NCT04617860|464831640|FG000|Overall Study|Sponsor Decision|0|||
129146333|NCT04617860|464831641|FG001|Overall Study|Sponsor Decision|3|||
129146334|NCT04617860|464831642|FG002|Overall Study|Sponsor Decision|1|||
129146335|NCT04617860|464831640|FG000|Overall Study|Termination of Study by Sponsor|8|||
129146336|NCT04617860|464831641|FG001|Overall Study|Termination of Study by Sponsor|4|||
129146337|NCT04617860|464831642|FG002|Overall Study|Termination of Study by Sponsor|13|||
129146338|NCT01055028|464831643|FG000|Screening|Screen Failure|1|||
129146339|NCT01055028|464831644|FG001|Screening|Screen Failure|1|||
129146340|NCT01055028|464831643|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
129146341|NCT01055028|464831644|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
129146342|NCT01055028|464831643|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
129146343|NCT01055028|464831644|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
129146344|NCT01055028|464831643|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
129146345|NCT01055028|464831644|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
129146346|NCT06582732|464831645|FG000|Initial Study Period|Adverse Event|0|||
129146347|NCT06582732|464831646|FG001|Initial Study Period|Adverse Event|0|||
129146348|NCT06582732|464831647|FG002|Initial Study Period|Adverse Event|0|||
129146349|NCT06582732|464831648|FG003|Initial Study Period|Adverse Event|2|||
129146350|NCT06582732|464831649|FG004|Initial Study Period|Adverse Event|0|||
129146351|NCT06582732|464831650|FG005|Initial Study Period|Adverse Event|0|||
129146352|NCT06582732|464831651|FG006|Initial Study Period|Adverse Event|0|||
129146353|NCT06582732|464831645|FG000|Initial Study Period|Death|1|||
129146354|NCT06582732|464831646|FG001|Initial Study Period|Death|0|||
129146355|NCT06582732|464831647|FG002|Initial Study Period|Death|0|||
129146356|NCT06582732|464831648|FG003|Initial Study Period|Death|0|||
129146357|NCT06582732|464831649|FG004|Initial Study Period|Death|1|||
129146358|NCT06582732|464831650|FG005|Initial Study Period|Death|0|||
129146359|NCT06582732|464831651|FG006|Initial Study Period|Death|0|||
129146360|NCT06582732|464831645|FG000|Initial Study Period|Lost to Follow-up|0|||
129146361|NCT06582732|464831646|FG001|Initial Study Period|Lost to Follow-up|0|||
129146362|NCT06582732|464831647|FG002|Initial Study Period|Lost to Follow-up|2|||
129146363|NCT06582732|464831648|FG003|Initial Study Period|Lost to Follow-up|0|||
129146364|NCT06582732|464831649|FG004|Initial Study Period|Lost to Follow-up|0|||
129146365|NCT06582732|464831650|FG005|Initial Study Period|Lost to Follow-up|0|||
129146366|NCT06582732|464831651|FG006|Initial Study Period|Lost to Follow-up|0|||
129146367|NCT06582732|464831645|FG000|Initial Study Period|Withdrawal by Subject|0|||
129146368|NCT06582732|464831646|FG001|Initial Study Period|Withdrawal by Subject|1|||
129146369|NCT06582732|464831647|FG002|Initial Study Period|Withdrawal by Subject|0|||
129146370|NCT06582732|464831648|FG003|Initial Study Period|Withdrawal by Subject|1|||
129146371|NCT06582732|464831649|FG004|Initial Study Period|Withdrawal by Subject|3|||
129146372|NCT06582732|464831650|FG005|Initial Study Period|Withdrawal by Subject|1|||
129146373|NCT06582732|464831651|FG006|Initial Study Period|Withdrawal by Subject|2|||
129146374|NCT06582732|464831645|FG000|Initial Study Period|Moved Away|0|||
129146375|NCT06582732|464831646|FG001|Initial Study Period|Moved Away|0|||
129146376|NCT06582732|464831647|FG002|Initial Study Period|Moved Away|0|||
129146377|NCT06582732|464831648|FG003|Initial Study Period|Moved Away|0|||
129146378|NCT06582732|464831649|FG004|Initial Study Period|Moved Away|1|||
129146379|NCT06582732|464831650|FG005|Initial Study Period|Moved Away|0|||
129146380|NCT06582732|464831651|FG006|Initial Study Period|Moved Away|0|||
129146381|NCT01182350|464831652|FG000|Overall Study|Adverse Event|5|||
129146382|NCT01182350|464831653|FG001|Overall Study|Adverse Event|0|||
129146383|NCT01182350|464831654|FG002|Overall Study|Adverse Event|0|||
129146384|NCT01182350|464831655|FG003|Overall Study|Adverse Event|0|||
129146385|NCT01182350|464831656|FG004|Overall Study|Adverse Event|0|||
129146386|NCT01182350|464831652|FG000|Overall Study|Disease Progression|15|||
129146387|NCT01182350|464831653|FG001|Overall Study|Disease Progression|12|||
129146388|NCT01182350|464831654|FG002|Overall Study|Disease Progression|0|||
129146389|NCT01182350|464831655|FG003|Overall Study|Disease Progression|1|||
129146390|NCT01182350|464831656|FG004|Overall Study|Disease Progression|0|||
129146391|NCT01182350|464831652|FG000|Overall Study|Death|0|||
129146392|NCT01182350|464831653|FG001|Overall Study|Death|1|||
129146393|NCT01182350|464831654|FG002|Overall Study|Death|1|||
129146394|NCT01182350|464831655|FG003|Overall Study|Death|0|||
129146395|NCT01182350|464831656|FG004|Overall Study|Death|0|||
129146396|NCT01182350|464831652|FG000|Overall Study|Withdrawal by Subject|3|||
129146397|NCT01182350|464831653|FG001|Overall Study|Withdrawal by Subject|1|||
129146398|NCT01182350|464831654|FG002|Overall Study|Withdrawal by Subject|0|||
129146399|NCT01182350|464831655|FG003|Overall Study|Withdrawal by Subject|1|||
129146400|NCT01182350|464831656|FG004|Overall Study|Withdrawal by Subject|0|||
129146401|NCT01182350|464831652|FG000|Overall Study|Alternative Therapy|2|||
129146402|NCT01182350|464831653|FG001|Overall Study|Alternative Therapy|0|||
129146403|NCT01182350|464831654|FG002|Overall Study|Alternative Therapy|1|||
129146404|NCT01182350|464831655|FG003|Overall Study|Alternative Therapy|0|||
129146405|NCT01182350|464831656|FG004|Overall Study|Alternative Therapy|0|||
129146406|NCT01182350|464831652|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
129146407|NCT01182350|464831653|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
129146408|NCT01182350|464831654|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
129146409|NCT01182350|464831655|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
129146410|NCT01182350|464831656|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
129146411|NCT01182350|464831652|FG000|Overall Study|Unevaluable for Biopsy|0|||
129146412|NCT01182350|464831653|FG001|Overall Study|Unevaluable for Biopsy|0|||
129146413|NCT01182350|464831654|FG002|Overall Study|Unevaluable for Biopsy|0|||
129146414|NCT01182350|464831655|FG003|Overall Study|Unevaluable for Biopsy|0|||
129146415|NCT01182350|464831656|FG004|Overall Study|Unevaluable for Biopsy|3|||
129146416|NCT03898180|464831657|FG000|Overall Study|Death|178|||
129146417|NCT03898180|464831658|FG001|Overall Study|Death|173|||
129146418|NCT03898180|464831657|FG000|Overall Study|Physician Decision|1|||
129146419|NCT03898180|464831658|FG001|Overall Study|Physician Decision|0|||
129146420|NCT03898180|464831657|FG000|Overall Study|Sponsor Decision|3|||
129146421|NCT03898180|464831658|FG001|Overall Study|Sponsor Decision|0|||
129146422|NCT03898180|464831657|FG000|Overall Study|Lost to Follow-up|1|||
129146423|NCT03898180|464831658|FG001|Overall Study|Lost to Follow-up|0|||
129146424|NCT03898180|464831657|FG000|Overall Study|Withdrawal by Subject|5|||
129146425|NCT03898180|464831658|FG001|Overall Study|Withdrawal by Subject|4|||
129146426|NCT02507934|464831659|FG000|Overall Study|Lost to Follow-up|2|||
129146427|NCT02507934|464831660|FG001|Overall Study|Lost to Follow-up|0|||
129146428|NCT02507934|464831659|FG000|Overall Study|Withdrawal by Subject|2|||
129146429|NCT02507934|464831660|FG001|Overall Study|Withdrawal by Subject|0|||
129146430|NCT03559530|464831661|FG000|Overall Study|non-location of medical records|44|||
129146431|NCT03559530|464831662|FG001|Overall Study|non-location of medical records|0|||
129146432|NCT03559530|464831661|FG000|Overall Study|culture results not considered for treat|29|||
129146433|NCT03559530|464831662|FG001|Overall Study|culture results not considered for treat|0|||
129146434|NCT03559530|464831661|FG000|Overall Study|duplicate cases|8|||
129146435|NCT03559530|464831662|FG001|Overall Study|duplicate cases|0|||
129146436|NCT03559530|464831661|FG000|Overall Study|other species of Acinetobacte|7|||
129146437|NCT03559530|464831662|FG001|Overall Study|other species of Acinetobacte|0|||
129146438|NCT03559530|464831661|FG000|Overall Study|contamination / colonization|3|||
129146439|NCT03559530|464831662|FG001|Overall Study|contamination / colonization|0|||
129146440|NCT03331354|464831663|FG000|Overall Study|Withdrawal by Subject|1|||
129146441|NCT03331354|464831664|FG001|Overall Study|Withdrawal by Subject|3|||
129146442|NCT03331354|464831663|FG000|Overall Study|Lost to Follow-up|3|||
129146443|NCT03331354|464831664|FG001|Overall Study|Lost to Follow-up|3|||
129146444|NCT03331354|464831663|FG000|Overall Study|Found employment before initiated active intervention|0|||
129146445|NCT03331354|464831664|FG001|Overall Study|Found employment before initiated active intervention|4|||
129146446|NCT01646827|464831665|FG000|Overall Study|Lost to Follow-up|0|||
129146447|NCT01646827|464831666|FG001|Overall Study|Lost to Follow-up|3|||
129146448|NCT01646827|464831665|FG000|Overall Study|Physician Decision|1|||
129146449|NCT01646827|464831666|FG001|Overall Study|Physician Decision|2|||
129146450|NCT01646827|464831665|FG000|Overall Study|Withdrawal by Subject|1|||
129146451|NCT01646827|464831666|FG001|Overall Study|Withdrawal by Subject|0|||
129146452|NCT00928668|464831669|FG000|Overall Study|Adverse Event|1|||
129146453|NCT00928668|464831670|FG001|Overall Study|Adverse Event|0|||
129146454|NCT00928668|464831671|FG002|Overall Study|Adverse Event|0|||
129146455|NCT00928668|464831672|FG003|Overall Study|Adverse Event|0|||
129146456|NCT00928668|464831673|FG004|Overall Study|Adverse Event|0|||
129146457|NCT00928668|464831669|FG000|Overall Study|Protocol Violation|0|||
129146458|NCT00928668|464831670|FG001|Overall Study|Protocol Violation|0|||
129146459|NCT00928668|464831671|FG002|Overall Study|Protocol Violation|0|||
129146460|NCT00928668|464831672|FG003|Overall Study|Protocol Violation|0|||
129146461|NCT00928668|464831673|FG004|Overall Study|Protocol Violation|1|||
129146462|NCT00928668|464831669|FG000|Overall Study|Withdrawal by Subject|0|||
129146463|NCT00928668|464831670|FG001|Overall Study|Withdrawal by Subject|1|||
129146464|NCT00928668|464831671|FG002|Overall Study|Withdrawal by Subject|1|||
129146465|NCT00928668|464831672|FG003|Overall Study|Withdrawal by Subject|0|||
129146466|NCT00928668|464831673|FG004|Overall Study|Withdrawal by Subject|0|||
129146467|NCT00928668|464831669|FG000|Overall Study|Other reasons not listed above|0|||
129146468|NCT00928668|464831670|FG001|Overall Study|Other reasons not listed above|0|||
129146469|NCT00928668|464831671|FG002|Overall Study|Other reasons not listed above|0|||
129146470|NCT00928668|464831672|FG003|Overall Study|Other reasons not listed above|1|||
129146471|NCT00928668|464831673|FG004|Overall Study|Other reasons not listed above|0|||
129146472|NCT01767987|464831677|FG000|Overall Study|Physician Decision|4|||
129146473|NCT01767987|464831678|FG001|Overall Study|Physician Decision|1|||
129146474|NCT03232567|464831679|FG000|Overall Study|Withdrawal by Subject|0|||
129146475|NCT03232567|464831680|FG001|Overall Study|Withdrawal by Subject|1|||
129146476|NCT03232567|464831681|FG002|Overall Study|Withdrawal by Subject|0|||
129146477|NCT03232567|464831682|FG003|Overall Study|Withdrawal by Subject|0|||
129146478|NCT05837481|464831683|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
129146479|NCT05837481|464831684|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
129146480|NCT03038087|464831690|FG000|Overall Study|lost data|1|||
129146481|NCT00654355|464831691|FG000|Overall Study|Lost to Follow-up|2|||
129146482|NCT00654355|464831692|FG001|Overall Study|Lost to Follow-up|2|||
129146483|NCT05805150|464831699|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
129146484|NCT05805150|464831700|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
129146485|NCT02284893|464831701|FG000|26 Week (Short Term)|Adverse Event|1|||
129146486|NCT02284893|464831702|FG001|26 Week (Short Term)|Adverse Event|9|||
129146487|NCT02284893|464831701|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
129146488|NCT02284893|464831702|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
129146489|NCT02284893|464831701|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
129146490|NCT02284893|464831702|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
129146491|NCT02284893|464831701|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
129146492|NCT02284893|464831702|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
129146493|NCT02284893|464831701|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
129146494|NCT02284893|464831702|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
129146495|NCT02284893|464831701|FG000|26 Week (Short Term)|Other|1|||
129146496|NCT02284893|464831702|FG001|26 Week (Short Term)|Other|1|||
129146497|NCT02284893|464831701|FG000|52 Week (Long Term)|Adverse Event|3|||
129146498|NCT02284893|464831702|FG001|52 Week (Long Term)|Adverse Event|1|||
129146499|NCT02284893|464831701|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
129146500|NCT02284893|464831702|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
129146501|NCT02284893|464831701|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
129146502|NCT02284893|464831702|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
129146503|NCT02284893|464831701|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
129146504|NCT02284893|464831702|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
129146505|NCT02284893|464831701|FG000|52 Week (Long Term)|Non-Compliance|2|||
129146506|NCT02284893|464831702|FG001|52 Week (Long Term)|Non-Compliance|3|||
129146507|NCT00105066|464831709|FG000|Overall Study|Adverse Event|2|||
129146508|NCT00105066|464831710|FG001|Overall Study|Adverse Event|5|||
129146509|NCT04716894|464831737|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
129146510|NCT04716894|464831737|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
129146511|NCT01506726|464831738|FG000|Overall Study|Adverse Event|1|||
129146512|NCT01506726|464831739|FG001|Overall Study|Adverse Event|2|||
129146513|NCT02259231|464831749|FG000|Overall Study|Adverse Event|1|||
129146514|NCT02259231|464831750|FG001|Overall Study|Adverse Event|1|||
129146515|NCT02259231|464831751|FG002|Overall Study|Adverse Event|2|||
129146516|NCT02259231|464831752|FG003|Overall Study|Adverse Event|0|||
129146517|NCT02259231|464831753|FG004|Overall Study|Adverse Event|0|||
129146518|NCT02259231|464831754|FG005|Overall Study|Adverse Event|0|||
129146519|NCT02259231|464831755|FG006|Overall Study|Adverse Event|0|||
129146520|NCT02259231|464831749|FG000|Overall Study|Progressive Disease|4|||
129146521|NCT02259231|464831750|FG001|Overall Study|Progressive Disease|5|||
129146522|NCT02259231|464831751|FG002|Overall Study|Progressive Disease|4|||
129146523|NCT02259231|464831752|FG003|Overall Study|Progressive Disease|5|||
129146524|NCT02259231|464831753|FG004|Overall Study|Progressive Disease|4|||
129146525|NCT02259231|464831754|FG005|Overall Study|Progressive Disease|5|||
129146526|NCT02259231|464831755|FG006|Overall Study|Progressive Disease|4|||
129146527|NCT02259231|464831749|FG000|Overall Study|Sponsor termination of study|1|||
129146528|NCT02259231|464831750|FG001|Overall Study|Sponsor termination of study|0|||
129146529|NCT02259231|464831751|FG002|Overall Study|Sponsor termination of study|0|||
129146530|NCT02259231|464831752|FG003|Overall Study|Sponsor termination of study|1|||
129146531|NCT02259231|464831753|FG004|Overall Study|Sponsor termination of study|2|||
129146532|NCT02259231|464831754|FG005|Overall Study|Sponsor termination of study|1|||
129146533|NCT02259231|464831755|FG006|Overall Study|Sponsor termination of study|1|||
129146534|NCT00847730|464831759|FG000|Overall Study|Multiple interruptions in therapy|8|||
129146535|NCT04116489|464831762|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
129146536|NCT04116489|464831762|FG000|Overall Study|Withdrawal by Subject|1|||
129146537|NCT02255656|464831763|FG000|Overall Study|Adverse Event|11|||
129146538|NCT02255656|464831763|FG000|Overall Study|Poor compliance to protocol|3|||
129146539|NCT02255656|464831763|FG000|Overall Study|Lost to Follow-up|30|||
129146540|NCT02255656|464831763|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
129146541|NCT02255656|464831763|FG000|Overall Study|Other|126|||
129146542|NCT03734536|464831764|FG000|Overall Study|Withdrew Consent|1|||
129146543|NCT03734536|464831765|FG001|Overall Study|Withdrew Consent|5|||
129146544|NCT03734536|464831764|FG000|Overall Study|Lost to Follow-up|10|||
129146545|NCT03734536|464831765|FG001|Overall Study|Lost to Follow-up|7|||
129146546|NCT01877278|464831766|FG000|Overall Study|Lost to Follow-up|3|||
129146547|NCT01877278|464831767|FG001|Overall Study|Lost to Follow-up|3|||
129146548|NCT05318287|464831768|FG000|Overall Study|Lost to Follow-up|8|||
129146549|NCT05185453|464831769|FG000|Overall Study|Lost to Follow-up|13|||
129146550|NCT05185453|464831770|FG001|Overall Study|Lost to Follow-up|3|||
129146551|NCT00835172|464831790|FG000|Washout|Protocol Violation|0|||
129146552|NCT00835172|464831791|FG001|Washout|Protocol Violation|1|||
129146553|NCT02278003|464833379|FG000|Overall Study|Withdrawal by Subject|11|||
129146554|NCT02278003|464833380|FG001|Overall Study|Withdrawal by Subject|0|||
129146555|NCT02278003|464833379|FG000|Overall Study|Not Treated|1|||
129146556|NCT02278003|464833380|FG001|Overall Study|Not Treated|0|||
129146557|NCT02278003|464833379|FG000|Overall Study|Recognition task improperly completed|7|||
129146558|NCT02278003|464833380|FG001|Overall Study|Recognition task improperly completed|0|||
129146559|NCT00939185|464833383|FG000|Overall Study|Adverse Event|3|||
129146560|NCT00939185|464833383|FG000|Overall Study|Lack of Efficacy|1|||
129146561|NCT00939185|464833383|FG000|Overall Study|Lost to Follow-up|6|||
129146562|NCT00939185|464833383|FG000|Overall Study|Other|3|||
129146563|NCT00939185|464833383|FG000|Overall Study|Withdrawal by Subject|2|||
129146564|NCT00939185|464833383|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
129146565|NCT00363298|464833384|FG000|First Study Week|Lack of Efficacy|6|||
129146566|NCT00363298|464833385|FG001|First Study Week|Lack of Efficacy|5|||
129146567|NCT00363298|464833384|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
129146568|NCT00363298|464833385|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
129146569|NCT03552029|464833386|FG000|Overall Study|Death|3|||
129146570|NCT03552029|464833387|FG001|Overall Study|Death|0|||
129146571|NCT03552029|464833386|FG000|Overall Study|Adverse Event|1|||
129146572|NCT03552029|464833387|FG001|Overall Study|Adverse Event|0|||
129146573|NCT03552029|464833386|FG000|Overall Study|Lack of Efficacy|0|||
129146574|NCT03552029|464833387|FG001|Overall Study|Lack of Efficacy|2|||
128724823|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
128724824|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
128724825|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
128724826|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
128724827|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
129146575|NCT03552029|464833386|FG000|Overall Study|Physician Decision|0|||
129146576|NCT03552029|464833387|FG001|Overall Study|Physician Decision|1|||
129146577|NCT03552029|464833386|FG000|Overall Study|Study terminated by Sponsor|0|||
129146578|NCT03552029|464833387|FG001|Overall Study|Study terminated by Sponsor|1|||
129146579|NCT03552029|464833386|FG000|Overall Study|Other|0|||
129146580|NCT03552029|464833387|FG001|Overall Study|Other|2|||
129146581|NCT03468998|464833393|FG000|Overall Study|Withdrawal by Subject|1|||
129146582|NCT03468998|464833394|FG001|Overall Study|Withdrawal by Subject|1|||
129146583|NCT03468998|464833395|FG002|Overall Study|Withdrawal by Subject|0|||
129146584|NCT03468998|464833396|FG003|Overall Study|Withdrawal by Subject|4|||
129146585|NCT03468998|464833397|FG004|Overall Study|Withdrawal by Subject|1|||
129146586|NCT03468998|464833398|FG005|Overall Study|Withdrawal by Subject|0|||
129146587|NCT00836706|464833401|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
129146588|NCT00836706|464833402|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
129146589|NCT02989857|464833403|FG000|Randomization Phase|Not Treated|3|||
129146590|NCT02989857|464833404|FG001|Randomization Phase|Not Treated|2|||
129146591|NCT02989857|464833405|FG002|Randomization Phase|Not Treated|0|||
129146592|NCT00633126|464833410|FG000|Overall Study|Did not receive full dose|1|||
129146593|NCT02538614|464833419|FG000|Overall Study|Progressive Disease|2|||
129146594|NCT01425814|464833424|FG000|Period 1|Stability criteria not fulfilled|0|||
129146595|NCT01425814|464833425|FG001|Period 1|Stability criteria not fulfilled|1|||
129146596|NCT01425814|464833426|FG002|Period 1|Stability criteria not fulfilled|0|||
129146597|NCT01425814|464833427|FG003|Period 1|Stability criteria not fulfilled|0|||
129146598|NCT01425814|464833428|FG004|Period 1|Stability criteria not fulfilled|0|||
129146599|NCT01425814|464833429|FG005|Period 1|Stability criteria not fulfilled|0|||
129146600|NCT01425814|464833424|FG000|Period 2|Stability criteria not fulfilled|0|||
129146601|NCT01425814|464833425|FG001|Period 2|Stability criteria not fulfilled|1|||
129146602|NCT01425814|464833426|FG002|Period 2|Stability criteria not fulfilled|0|||
129146603|NCT01425814|464833427|FG003|Period 2|Stability criteria not fulfilled|0|||
129146604|NCT01425814|464833428|FG004|Period 2|Stability criteria not fulfilled|0|||
128724828|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129146605|NCT01425814|464833429|FG005|Period 2|Stability criteria not fulfilled|0|||
129146606|NCT01425814|464833424|FG000|Period 3|Adverse Event|0|||
129146607|NCT01425814|464833425|FG001|Period 3|Adverse Event|0|||
129146608|NCT01425814|464833426|FG002|Period 3|Adverse Event|0|||
129146609|NCT01425814|464833427|FG003|Period 3|Adverse Event|0|||
129146610|NCT01425814|464833428|FG004|Period 3|Adverse Event|0|||
129146611|NCT01425814|464833429|FG005|Period 3|Adverse Event|1|||
128724829|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129146612|NCT01425814|464833424|FG000|Period 4|Adverse Event|1|||
129146613|NCT01425814|464833425|FG001|Period 4|Adverse Event|0|||
129146614|NCT01425814|464833426|FG002|Period 4|Adverse Event|1|||
129146615|NCT01425814|464833427|FG003|Period 4|Adverse Event|0|||
129146616|NCT01425814|464833428|FG004|Period 4|Adverse Event|0|||
129146617|NCT01425814|464833429|FG005|Period 4|Adverse Event|0|||
129146618|NCT01425814|464833424|FG000|Period 5|Stability criteria not fulfilled|0|||
129146619|NCT01425814|464833425|FG001|Period 5|Stability criteria not fulfilled|0|||
129146620|NCT01425814|464833426|FG002|Period 5|Stability criteria not fulfilled|1|||
129146621|NCT01425814|464833427|FG003|Period 5|Stability criteria not fulfilled|0|||
129146622|NCT01425814|464833428|FG004|Period 5|Stability criteria not fulfilled|0|||
129146623|NCT01425814|464833429|FG005|Period 5|Stability criteria not fulfilled|1|||
129146624|NCT00565747|464833431|FG000|Overall Study|No embryo transfer|67|||
129146625|NCT00565747|464833432|FG001|Overall Study|No embryo transfer|73|||
129146626|NCT02684461|464833435|FG000|Overall Study|Adverse Event|1|||
129146627|NCT02684461|464833436|FG001|Overall Study|Adverse Event|0|||
129146628|NCT02684461|464833437|FG002|Overall Study|Adverse Event|0|||
129146629|NCT02684461|464833435|FG000|Overall Study|Lack of Efficacy|1|||
129146630|NCT02684461|464833436|FG001|Overall Study|Lack of Efficacy|2|||
129146631|NCT02684461|464833437|FG002|Overall Study|Lack of Efficacy|0|||
129146632|NCT02390076|464833438|FG000|Overall Study|Lost to Follow-up|2|||
129146633|NCT02390076|464833439|FG001|Overall Study|Lost to Follow-up|1|||
129146634|NCT02390076|464833440|FG002|Overall Study|Lost to Follow-up|4|||
129146635|NCT01358734|464833446|FG000|Overall Study|Adverse Event|4|||
129146636|NCT01358734|464833447|FG001|Overall Study|Adverse Event|7|||
129146637|NCT01358734|464833448|FG002|Overall Study|Adverse Event|3|||
129146638|NCT01358734|464833446|FG000|Overall Study|Lack of Efficacy|0|||
129146639|NCT01358734|464833447|FG001|Overall Study|Lack of Efficacy|1|||
129146640|NCT01358734|464833448|FG002|Overall Study|Lack of Efficacy|3|||
129146641|NCT01358734|464833446|FG000|Overall Study|Withdrawal by Subject|1|||
129146642|NCT01358734|464833447|FG001|Overall Study|Withdrawal by Subject|6|||
129146643|NCT01358734|464833448|FG002|Overall Study|Withdrawal by Subject|3|||
129146644|NCT01358734|464833446|FG000|Overall Study|Death|3|||
129146645|NCT01358734|464833447|FG001|Overall Study|Death|7|||
129146646|NCT01358734|464833448|FG002|Overall Study|Death|2|||
129146647|NCT01358734|464833446|FG000|Overall Study|Progressive Disease|5|||
129146648|NCT01358734|464833447|FG001|Overall Study|Progressive Disease|13|||
129146649|NCT01358734|464833448|FG002|Overall Study|Progressive Disease|16|||
129146650|NCT01358734|464833446|FG000|Overall Study|Non-compliance with study drug|0|||
129146651|NCT01358734|464833447|FG001|Overall Study|Non-compliance with study drug|0|||
129146652|NCT01358734|464833448|FG002|Overall Study|Non-compliance with study drug|1|||
129146653|NCT01358734|464833446|FG000|Overall Study|Other|2|||
129146654|NCT01358734|464833447|FG001|Overall Study|Other|5|||
129146655|NCT01358734|464833448|FG002|Overall Study|Other|4|||
129146656|NCT01358734|464833446|FG000|Overall Study|Protocol Violation|0|||
129146657|NCT01358734|464833447|FG001|Overall Study|Protocol Violation|0|||
129146658|NCT01358734|464833448|FG002|Overall Study|Protocol Violation|2|||
129146659|NCT03243084|464833452|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
129146660|NCT03243084|464833453|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
129146661|NCT02300233|464833454|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
129146662|NCT02300233|464833455|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
129146663|NCT02300233|464833456|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
129146664|NCT02300233|464833454|FG000|Overall Study|Withdrawal by Subject|1|||
129146665|NCT02300233|464833455|FG001|Overall Study|Withdrawal by Subject|0|||
129146666|NCT02300233|464833456|FG002|Overall Study|Withdrawal by Subject|3|||
129146667|NCT02300233|464833454|FG000|Overall Study|Investigator Judgement|0|||
129146668|NCT02300233|464833455|FG001|Overall Study|Investigator Judgement|0|||
129146669|NCT02300233|464833456|FG002|Overall Study|Investigator Judgement|1|||
129146670|NCT02300233|464833454|FG000|Overall Study|Reason Not Specified|0|||
129146671|NCT02300233|464833455|FG001|Overall Study|Reason Not Specified|0|||
129146672|NCT02300233|464833456|FG002|Overall Study|Reason Not Specified|5|||
129146673|NCT00833690|464833457|FG000|Overall Study|Withdrawal by Subject|1|||
129146674|NCT00833690|464833458|FG001|Overall Study|Withdrawal by Subject|0|||
129146675|NCT00833690|464833459|FG002|Overall Study|Withdrawal by Subject|0|||
129146676|NCT00833690|464833457|FG000|Overall Study|Discontinued study drug|3|||
129146677|NCT00833690|464833458|FG001|Overall Study|Discontinued study drug|2|||
129146678|NCT00833690|464833459|FG002|Overall Study|Discontinued study drug|0|||
129146679|NCT05448950|464833460|FG000|Overall Study|Death|2|||
129146680|NCT05448950|464833460|FG000|Overall Study|Withdrawal by Subject|1|||
129146681|NCT05448950|464833460|FG000|Overall Study|AVG abandoned|4|||
129146682|NCT04752566|464833461|FG000|Overall Study|Protocol Violation|0|||
129146683|NCT04752566|464833462|FG001|Overall Study|Protocol Violation|1|||
129146684|NCT04752566|464833461|FG000|Overall Study|Death|1|||
129146685|NCT04752566|464833462|FG001|Overall Study|Death|0|||
129146686|NCT04752566|464833461|FG000|Overall Study|Adverse Event|1|||
129146687|NCT04752566|464833462|FG001|Overall Study|Adverse Event|0|||
129146688|NCT04752566|464833461|FG000|Overall Study|Withdrawal by Subject|2|||
129146689|NCT04752566|464833462|FG001|Overall Study|Withdrawal by Subject|0|||
129146690|NCT04752566|464833461|FG000|Overall Study|Physician Decision|1|||
129146691|NCT04752566|464833462|FG001|Overall Study|Physician Decision|1|||
129146692|NCT01153516|464833463|FG000|Overall Study|Both subjects refused surgery|2|||
129146693|NCT01153516|464833464|FG001|Overall Study|Both subjects refused surgery|0|||
129146694|NCT03773484|464833477|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
129146695|NCT01889251|464833478|FG000|Overall Study|Adverse Event|1|||
129146696|NCT01889251|464833479|FG001|Overall Study|Adverse Event|0|||
129146697|NCT01344226|464833485|FG000|Overall Study|Protocol Violation|2|||
129146698|NCT01344226|464833485|FG000|Overall Study|Withdrawal by Subject|3|||
129146699|NCT01344226|464833485|FG000|Overall Study|Lack of Efficacy|3|||
129146700|NCT02302222|464833488|FG000|Overall Study|Physician Decision|0|||
129146701|NCT02302222|464833489|FG001|Overall Study|Physician Decision|4|||
129146702|NCT02302222|464833488|FG000|Overall Study|Lost to Follow-up|1|||
129146703|NCT02302222|464833489|FG001|Overall Study|Lost to Follow-up|0|||
129146704|NCT02302222|464833488|FG000|Overall Study|Treatment discontinued before day 5|0|||
129146705|NCT02302222|464833489|FG001|Overall Study|Treatment discontinued before day 5|1|||
129146706|NCT02302222|464833488|FG000|Overall Study|Withdrawn prior to any treatment|0|||
129146707|NCT02302222|464833489|FG001|Overall Study|Withdrawn prior to any treatment|1|||
129146708|NCT03781570|464833495|FG000|Overall Study|Technical Issues (equipment failure)|31|||
129146709|NCT03781570|464833495|FG000|Overall Study|Withdrawal by Subject|7|||
129146710|NCT03781570|464833495|FG000|Overall Study|Physical Constraints|11|||
129146711|NCT01107496|464833496|FG000|Overall Study|Adverse Event|1|||
129146712|NCT01107496|464833497|FG001|Overall Study|Adverse Event|0|||
129146713|NCT01107496|464833496|FG000|Overall Study|Lack of Efficacy|1|||
129146714|NCT01107496|464833497|FG001|Overall Study|Lack of Efficacy|0|||
129146715|NCT01107496|464833496|FG000|Overall Study|Protocol Violation|0|||
129146716|NCT01107496|464833497|FG001|Overall Study|Protocol Violation|1|||
129146717|NCT01107496|464833496|FG000|Overall Study|Lost to Follow-up|0|||
129146718|NCT01107496|464833497|FG001|Overall Study|Lost to Follow-up|1|||
129146719|NCT03709472|464833498|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
129146720|NCT03709472|464833499|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
129146721|NCT03709472|464833498|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
129146722|NCT03709472|464833499|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
129146723|NCT03559556|464833500|FG000|Overall Study|Withdrawal by Subject|1|||
129146724|NCT02496000|464833506|FG000|Overall Study|Withdrawal by Subject|1|||
129146725|NCT02496000|464833507|FG001|Overall Study|Withdrawal by Subject|2|||
129146726|NCT02496000|464833508|FG002|Overall Study|Withdrawal by Subject|0|||
129146727|NCT02496000|464833506|FG000|Overall Study|Lost to Follow-up|1|||
129146728|NCT02496000|464833507|FG001|Overall Study|Lost to Follow-up|0|||
129146729|NCT02496000|464833508|FG002|Overall Study|Lost to Follow-up|1|||
129146730|NCT02496000|464833506|FG000|Overall Study|Protocol Violation|0|||
129146731|NCT02496000|464833507|FG001|Overall Study|Protocol Violation|0|||
129146732|NCT02496000|464833508|FG002|Overall Study|Protocol Violation|1|||
129146733|NCT02496000|464833506|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
129146734|NCT02496000|464833507|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
129146735|NCT02496000|464833508|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
129146736|NCT02496000|464833506|FG000|Overall Study|undetermined|0|||
129146737|NCT02496000|464833507|FG001|Overall Study|undetermined|1|||
129146738|NCT02496000|464833508|FG002|Overall Study|undetermined|0|||
129146739|NCT02457793|464833515|FG000|Overall Study|Reason not specified|0|||
129146740|NCT02457793|464833516|FG001|Overall Study|Reason not specified|0|||
129146741|NCT02457793|464833517|FG002|Overall Study|Reason not specified|0|||
129146742|NCT02457793|464833518|FG003|Overall Study|Reason not specified|1|||
129146743|NCT02457793|464833519|FG004|Overall Study|Reason not specified|1|||
129146744|NCT02457793|464833520|FG005|Overall Study|Reason not specified|1|||
129146745|NCT02457793|464833515|FG000|Overall Study|Withdrawal by Subject|0|||
129146746|NCT02457793|464833516|FG001|Overall Study|Withdrawal by Subject|4|||
129146747|NCT02457793|464833517|FG002|Overall Study|Withdrawal by Subject|2|||
129146748|NCT02457793|464833518|FG003|Overall Study|Withdrawal by Subject|2|||
129146749|NCT02457793|464833519|FG004|Overall Study|Withdrawal by Subject|2|||
129146750|NCT02457793|464833520|FG005|Overall Study|Withdrawal by Subject|2|||
129146751|NCT02457793|464833515|FG000|Overall Study|Adverse Event|0|||
129146752|NCT02457793|464833516|FG001|Overall Study|Adverse Event|0|||
129146753|NCT02457793|464833517|FG002|Overall Study|Adverse Event|0|||
129146754|NCT02457793|464833518|FG003|Overall Study|Adverse Event|1|||
129146755|NCT02457793|464833519|FG004|Overall Study|Adverse Event|0|||
129146756|NCT02457793|464833520|FG005|Overall Study|Adverse Event|0|||
129146757|NCT02457793|464833515|FG000|Overall Study|Physician Decision|1|||
129146758|NCT02457793|464833516|FG001|Overall Study|Physician Decision|0|||
129146759|NCT02457793|464833517|FG002|Overall Study|Physician Decision|1|||
129146760|NCT02457793|464833518|FG003|Overall Study|Physician Decision|1|||
129146761|NCT02457793|464833519|FG004|Overall Study|Physician Decision|1|||
129146762|NCT02457793|464833520|FG005|Overall Study|Physician Decision|3|||
129146763|NCT02757768|464833525|FG000|Overall Study|Randomized Never Received Study Drug|3|||
129146764|NCT02757768|464833526|FG001|Overall Study|Randomized Never Received Study Drug|4|||
129146765|NCT02757768|464833525|FG000|Overall Study|Adverse Event|5|||
129146766|NCT02757768|464833526|FG001|Overall Study|Adverse Event|3|||
129146767|NCT02757768|464833525|FG000|Overall Study|Lack of Efficacy|2|||
129146768|NCT02757768|464833526|FG001|Overall Study|Lack of Efficacy|1|||
129146769|NCT02757768|464833525|FG000|Overall Study|Lost to Follow-up|1|||
129146770|NCT02757768|464833526|FG001|Overall Study|Lost to Follow-up|0|||
129146771|NCT02757768|464833525|FG000|Overall Study|Protocol Deviation|2|||
129146772|NCT02757768|464833526|FG001|Overall Study|Protocol Deviation|9|||
129146773|NCT02757768|464833525|FG000|Overall Study|Withdrawal by Subject|16|||
129146774|NCT02757768|464833526|FG001|Overall Study|Withdrawal by Subject|9|||
129146775|NCT02757768|464833525|FG000|Overall Study|Miscellaneous|4|||
129146776|NCT02757768|464833526|FG001|Overall Study|Miscellaneous|2|||
129146777|NCT05929326|464833527|FG000|Overall Study|unqualified sample|2|||
129146778|NCT05929326|464833528|FG001|Overall Study|unqualified sample|3|||
129146779|NCT05929326|464833529|FG002|Overall Study|unqualified sample|7|||
129146780|NCT04890509|464833530|FG000|Overall Study|Death|4|||
129146781|NCT04890509|464833531|FG001|Overall Study|Death|4|||
129146782|NCT03274466|464833540|FG000|Overall Study|Withdrawal by Subject|7|||
129146783|NCT03274466|464833541|FG001|Overall Study|Withdrawal by Subject|3|||
129146784|NCT03274466|464833540|FG000|Overall Study|Protocol Specified Withdrawal|5|||
129146785|NCT03274466|464833541|FG001|Overall Study|Protocol Specified Withdrawal|11|||
129146786|NCT03274466|464833540|FG000|Overall Study|Lost to Follow-up|5|||
129146787|NCT03274466|464833541|FG001|Overall Study|Lost to Follow-up|7|||
129146788|NCT03274466|464833540|FG000|Overall Study|Subject Non-compliance|0|||
129146789|NCT03274466|464833541|FG001|Overall Study|Subject Non-compliance|1|||
129146790|NCT03274466|464833540|FG000|Overall Study|Adverse Event|3|||
129146791|NCT03274466|464833541|FG001|Overall Study|Adverse Event|3|||
129146792|NCT03274466|464833540|FG000|Overall Study|Physician Decision|0|||
129146793|NCT03274466|464833541|FG001|Overall Study|Physician Decision|1|||
129146794|NCT03274466|464833540|FG000|Overall Study|Protocol Violation|3|||
129146795|NCT03274466|464833541|FG001|Overall Study|Protocol Violation|3|||
129146796|NCT00618787|464833544|FG000|Overall Study|Adverse Event|0|||
129146797|NCT00618787|464833545|FG001|Overall Study|Adverse Event|1|||
129146798|NCT00618787|464833544|FG000|Overall Study|Withdrawal by Subject|2|||
129146799|NCT00618787|464833545|FG001|Overall Study|Withdrawal by Subject|1|||
129146800|NCT00618787|464833544|FG000|Overall Study|Lost to Follow-up|1|||
129146801|NCT00618787|464833545|FG001|Overall Study|Lost to Follow-up|0|||
129146802|NCT01107886|464833546|FG000|Overall Study|Lost to Follow-up|15|||
129146803|NCT01107886|464833547|FG001|Overall Study|Lost to Follow-up|13|||
129146804|NCT01107886|464833546|FG000|Overall Study|Withdrawal by Subject|180|||
129146805|NCT01107886|464833547|FG001|Overall Study|Withdrawal by Subject|196|||
129146806|NCT01107886|464833546|FG000|Overall Study|Administrative withdrawal of consent|7|||
129146807|NCT01107886|464833547|FG001|Overall Study|Administrative withdrawal of consent|5|||
129146808|NCT01649869|464833552|FG000|Overall Study|Family member illness|1|||
129146809|NCT01649869|464833553|FG001|Overall Study|Family member illness|0|||
129146810|NCT01649869|464833552|FG000|Overall Study|Required treatment outside protocol|1|||
129146811|NCT01649869|464833553|FG001|Overall Study|Required treatment outside protocol|0|||
129146812|NCT01649869|464833552|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
129146813|NCT01649869|464833553|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
129146814|NCT02333799|464835464|FG000|Treatment Period|Withdrawal by Subject|1|||
129146815|NCT02333799|464835464|FG000|Treatment Period|Death|6|||
129146816|NCT02333799|464835464|FG000|6 Month Follow Up Period|Physician Decision|1|||
129146817|NCT02333799|464835464|FG000|6 Month Follow Up Period|Death|1|||
129146818|NCT02333799|464835464|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
129146819|NCT02333799|464835464|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
129146820|NCT01657370|464835468|FG000|Overall Study|Withdrawal by Subject|0|||
129146821|NCT01657370|464835469|FG001|Overall Study|Withdrawal by Subject|0|||
129146822|NCT01657370|464835470|FG002|Overall Study|Withdrawal by Subject|1|||
129146823|NCT01657370|464835471|FG003|Overall Study|Withdrawal by Subject|0|||
129146824|NCT01657370|464835472|FG004|Overall Study|Withdrawal by Subject|0|||
129146825|NCT01657370|464835473|FG005|Overall Study|Withdrawal by Subject|1|||
129146826|NCT01657370|464835468|FG000|Overall Study|Physician Decision|2|||
129146827|NCT01657370|464835469|FG001|Overall Study|Physician Decision|3|||
129146828|NCT01657370|464835470|FG002|Overall Study|Physician Decision|1|||
129146829|NCT01657370|464835471|FG003|Overall Study|Physician Decision|2|||
129146830|NCT01657370|464835472|FG004|Overall Study|Physician Decision|5|||
129146831|NCT01657370|464835473|FG005|Overall Study|Physician Decision|0|||
129146832|NCT01657370|464835468|FG000|Overall Study|Lack of Qualifying Event|1|||
129146833|NCT01657370|464835469|FG001|Overall Study|Lack of Qualifying Event|0|||
129146834|NCT01657370|464835470|FG002|Overall Study|Lack of Qualifying Event|3|||
129146835|NCT01657370|464835471|FG003|Overall Study|Lack of Qualifying Event|2|||
129146836|NCT01657370|464835472|FG004|Overall Study|Lack of Qualifying Event|1|||
129146837|NCT01657370|464835473|FG005|Overall Study|Lack of Qualifying Event|2|||
129146838|NCT01657370|464835468|FG000|Overall Study|Adverse Event|0|||
129146839|NCT01657370|464835469|FG001|Overall Study|Adverse Event|0|||
129146840|NCT01657370|464835470|FG002|Overall Study|Adverse Event|0|||
129146841|NCT01657370|464835471|FG003|Overall Study|Adverse Event|0|||
129146842|NCT01657370|464835472|FG004|Overall Study|Adverse Event|1|||
129146843|NCT01657370|464835473|FG005|Overall Study|Adverse Event|0|||
129146844|NCT01657370|464835468|FG000|Overall Study|Protocol Violation|1|||
129146845|NCT01657370|464835469|FG001|Overall Study|Protocol Violation|1|||
129146846|NCT01657370|464835470|FG002|Overall Study|Protocol Violation|1|||
129146847|NCT01657370|464835471|FG003|Overall Study|Protocol Violation|1|||
129146848|NCT01657370|464835472|FG004|Overall Study|Protocol Violation|0|||
129146849|NCT01657370|464835473|FG005|Overall Study|Protocol Violation|0|||
129146850|NCT01657370|464835468|FG000|Overall Study|Lost to Follow-up|2|||
129146851|NCT01657370|464835469|FG001|Overall Study|Lost to Follow-up|0|||
129146852|NCT01657370|464835470|FG002|Overall Study|Lost to Follow-up|1|||
129146853|NCT01657370|464835471|FG003|Overall Study|Lost to Follow-up|0|||
129146854|NCT01657370|464835472|FG004|Overall Study|Lost to Follow-up|0|||
129146855|NCT01657370|464835473|FG005|Overall Study|Lost to Follow-up|1|||
129146856|NCT03440385|464835484|FG000|Overall Study|Other Reason|4|||
129146857|NCT03440385|464835485|FG001|Overall Study|Other Reason|1|||
129146858|NCT03440385|464835484|FG000|Overall Study|Site Closed|1|||
129146859|NCT03440385|464835485|FG001|Overall Study|Site Closed|0|||
129146860|NCT03440385|464835484|FG000|Overall Study|Lost to Follow-up|2|||
129146861|NCT03440385|464835485|FG001|Overall Study|Lost to Follow-up|0|||
129146862|NCT03440385|464835484|FG000|Overall Study|Withdrawal by Subject|12|||
129146863|NCT03440385|464835485|FG001|Overall Study|Withdrawal by Subject|6|||
129146864|NCT03440385|464835484|FG000|Overall Study|Lack of Efficacy|9|||
129146865|NCT03440385|464835485|FG001|Overall Study|Lack of Efficacy|2|||
129146866|NCT03440385|464835484|FG000|Overall Study|Adverse Event|15|||
129146867|NCT03440385|464835485|FG001|Overall Study|Adverse Event|11|||
129146868|NCT04123704|464835486|FG000|Overall Study|Disease progression|2|||
129146869|NCT01168596|464835493|FG000|Overall Study|Withdrawal by Subject|3|||
129146870|NCT01168596|464835494|FG001|Overall Study|Withdrawal by Subject|1|||
129146871|NCT00876447|464835497|FG000|Overall Study|Other miscellaneous reasons|3|||
129146872|NCT00876447|464835498|FG001|Overall Study|Other miscellaneous reasons|8|||
129146873|NCT00876447|464835497|FG000|Overall Study|Site closure|19|||
129146874|NCT00876447|464835498|FG001|Overall Study|Site closure|14|||
129146875|NCT00876447|464835497|FG000|Overall Study|Protocol Violation|9|||
129146876|NCT00876447|464835498|FG001|Overall Study|Protocol Violation|3|||
129146877|NCT00876447|464835497|FG000|Overall Study|Personal reasons|30|||
129146878|NCT00876447|464835498|FG001|Overall Study|Personal reasons|28|||
129146879|NCT00876447|464835497|FG000|Overall Study|Lost to Follow-up|6|||
129146880|NCT00876447|464835498|FG001|Overall Study|Lost to Follow-up|15|||
129146881|NCT00876447|464835497|FG000|Overall Study|Pregnancy|4|||
129146882|NCT00876447|464835498|FG001|Overall Study|Pregnancy|2|||
129146883|NCT00876447|464835497|FG000|Overall Study|Lack of Efficacy|5|||
129146884|NCT00876447|464835498|FG001|Overall Study|Lack of Efficacy|3|||
129146885|NCT00876447|464835497|FG000|Overall Study|Adverse Event|4|||
128724830|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129146886|NCT00876447|464835498|FG001|Overall Study|Adverse Event|8|||
129146887|NCT00189423|464835508|FG000|Overall Study|Death|746|||
129146888|NCT00189423|464835509|FG001|Overall Study|Death|747|||
129146889|NCT00189423|464835508|FG000|Overall Study|Withdrawal by Subject|9|||
129146890|NCT00189423|464835509|FG001|Overall Study|Withdrawal by Subject|9|||
129146891|NCT00189423|464835508|FG000|Overall Study|Lost to Follow-up|10|||
129146892|NCT00189423|464835509|FG001|Overall Study|Lost to Follow-up|10|||
129146893|NCT02138825|464835511|FG000|Main Study Treatment|Adverse Event|11|||
128724831|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
128724832|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
128724833|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
129146894|NCT02138825|464835512|FG001|Main Study Treatment|Adverse Event|3|||
129146895|NCT02138825|464835511|FG000|Main Study Treatment|Death|1|||
129146896|NCT02138825|464835512|FG001|Main Study Treatment|Death|2|||
129146897|NCT02138825|464835511|FG000|Main Study Treatment|Protocol Violation|2|||
129146898|NCT02138825|464835512|FG001|Main Study Treatment|Protocol Violation|2|||
129146899|NCT02138825|464835511|FG000|Main Study Treatment|Sponsor decision|12|||
129146900|NCT02138825|464835512|FG001|Main Study Treatment|Sponsor decision|18|||
129146901|NCT02138825|464835511|FG000|Main Study Treatment|Study terminated by sponsor|10|||
129146902|NCT02138825|464835512|FG001|Main Study Treatment|Study terminated by sponsor|9|||
129146903|NCT02138825|464835511|FG000|Main Study Treatment|Withdrawal by Subject|3|||
129146904|NCT02138825|464835512|FG001|Main Study Treatment|Withdrawal by Subject|1|||
129146905|NCT02138825|464835511|FG000|Main Study Treatment|Medical decision|1|||
129146906|NCT02138825|464835512|FG001|Main Study Treatment|Medical decision|0|||
129146907|NCT02138825|464835511|FG000|Long-term Extension|Study termination by sponsor|32|||
129146908|NCT02138825|464835512|FG001|Long-term Extension|Study termination by sponsor|38|||
129146909|NCT02138825|464835511|FG000|Safety Follow-up|Adverse Event|4|||
129146910|NCT02138825|464835512|FG001|Safety Follow-up|Adverse Event|3|||
129146911|NCT02138825|464835511|FG000|Safety Follow-up|Death|11|||
129146912|NCT02138825|464835512|FG001|Safety Follow-up|Death|5|||
129146913|NCT02138825|464835511|FG000|Safety Follow-up|Withdrawal by Subject|5|||
129146914|NCT02138825|464835512|FG001|Safety Follow-up|Withdrawal by Subject|3|||
129146915|NCT02138825|464835511|FG000|Safety Follow-up|clinic worsening|1|||
129146916|NCT02138825|464835512|FG001|Safety Follow-up|clinic worsening|0|||
129146917|NCT02138825|464835511|FG000|Safety Follow-up|withdrawal by PI|1|||
129146918|NCT02138825|464835512|FG001|Safety Follow-up|withdrawal by PI|0|||
129146919|NCT02138825|464835511|FG000|Safety Follow-up|logistical difficulties|0|||
129146920|NCT02138825|464835512|FG001|Safety Follow-up|logistical difficulties|1|||
129146921|NCT02138825|464835511|FG000|Safety Follow-up|progressive disease|0|||
129146922|NCT02138825|464835512|FG001|Safety Follow-up|progressive disease|2|||
129146923|NCT02138825|464835511|FG000|Safety Follow-up|too unwell to attend the visit|0|||
129146924|NCT02138825|464835512|FG001|Safety Follow-up|too unwell to attend the visit|1|||
129146925|NCT02138825|464835511|FG000|Safety Follow-up|treatment unblinded|0|||
129146926|NCT02138825|464835512|FG001|Safety Follow-up|treatment unblinded|1|||
129146927|NCT02138825|464835511|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
129146928|NCT02138825|464835512|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
129146929|NCT00904371|464835513|FG000|Overall Study|Adverse Event|2|||
129146930|NCT00904371|464835513|FG000|Overall Study|Lost to Follow-up|4|||
129146931|NCT00904371|464835513|FG000|Overall Study|Discontinued at target blood pressure|2|||
129146932|NCT00904371|464835513|FG000|Overall Study|Continued with Tritace|1|||
129146933|NCT00583219|464835516|FG000|Phase 2|Withdrawal by Subject|1|||
129146934|NCT02090764|464835517|FG000|Overall Study|Adverse Event|1|||
129146935|NCT02090764|464835518|FG001|Overall Study|Adverse Event|3|||
129146936|NCT02090764|464835517|FG000|Overall Study|Lack of Efficacy|0|||
129146937|NCT02090764|464835518|FG001|Overall Study|Lack of Efficacy|13|||
129146938|NCT02090764|464835517|FG000|Overall Study|Withdrawal by Subject|2|||
129146939|NCT02090764|464835518|FG001|Overall Study|Withdrawal by Subject|1|||
129146940|NCT02090764|464835517|FG000|Overall Study|Intercurrent illness and other|1|||
129146941|NCT02090764|464835518|FG001|Overall Study|Intercurrent illness and other|1|||
129146942|NCT02090764|464835517|FG000|Overall Study|Lost to Follow-up|2|||
129146943|NCT02090764|464835518|FG001|Overall Study|Lost to Follow-up|2|||
129146944|NCT02836249|464835521|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129146945|NCT02836249|464835522|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
129146946|NCT02836249|464835523|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129146947|NCT02836249|464835524|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129146948|NCT02836249|464835521|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
129146949|NCT02836249|464835522|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
129146950|NCT02836249|464835523|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
129146951|NCT02836249|464835524|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
129146952|NCT02836249|464835521|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
129146953|NCT02836249|464835522|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
129146954|NCT02836249|464835523|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
129146955|NCT02836249|464835524|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
129146956|NCT02836249|464835521|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129146957|NCT02836249|464835522|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129146958|NCT02836249|464835523|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129146959|NCT02836249|464835524|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129146960|NCT02836249|464835521|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
129146961|NCT02836249|464835522|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
129146962|NCT02836249|464835523|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
129146963|NCT02836249|464835524|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
129146964|NCT02836249|464835521|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
129146965|NCT02836249|464835522|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
129146966|NCT02836249|464835523|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
129146967|NCT02836249|464835524|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
129146968|NCT02836249|464835521|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129146969|NCT02836249|464835522|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129146970|NCT02836249|464835523|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
129146971|NCT02836249|464835524|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
129146972|NCT02836249|464835521|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
128724834|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
128724835|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
128724836|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
128724837|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
128724838|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
128724839|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
128724840|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
128724841|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
129146973|NCT02836249|464835522|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
129146974|NCT02836249|464835523|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
129146975|NCT02836249|464835524|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
129146976|NCT02836249|464835521|FG000|Open-Label TAF Treatment Phase|Death|0|||
129146977|NCT02836249|464835522|FG001|Open-Label TAF Treatment Phase|Death|0|||
129146978|NCT02836249|464835523|FG002|Open-Label TAF Treatment Phase|Death|1|||
129146979|NCT02836249|464835524|FG003|Open-Label TAF Treatment Phase|Death|0|||
129146980|NCT02836249|464835521|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
129146981|NCT02836249|464835522|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
129146982|NCT02836249|464835523|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
129146983|NCT02836249|464835524|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
129146984|NCT02836249|464835521|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
129146985|NCT02836249|464835522|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
129146986|NCT02836249|464835523|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
129146987|NCT02836249|464835524|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
129146988|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129146989|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
129146990|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129146991|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
129146992|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
129146993|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
129146994|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
129146995|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129146996|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129146997|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129146998|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129146999|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129147000|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129147001|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129147002|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129147003|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129147004|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
129147005|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
129147006|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
129147007|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
129147008|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
129147009|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
129147010|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
129147011|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
129147012|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
129147013|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
129147014|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
129147015|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
129147016|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
129147017|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
129147018|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
129147019|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
129147020|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
129147021|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
129147022|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147023|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147024|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147025|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128724842|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
128724843|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
128724844|NCT02036502|463290913|FG000|Part 3:Dose Expansion|Not Treated|0|||
129147026|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147027|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147028|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
128724845|NCT02036502|463290914|FG001|Part 3:Dose Expansion|Not Treated|0|||
128724846|NCT02036502|463290915|FG002|Part 3:Dose Expansion|Not Treated|0|||
129147029|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147030|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147031|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147032|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147033|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147034|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147035|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129147036|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
129147037|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147038|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
129147039|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
128724847|NCT02036502|463290916|FG003|Part 3:Dose Expansion|Not Treated|0|||
129147040|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
129147041|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
129147042|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
129147043|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147044|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147045|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147046|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147047|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147048|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147049|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147050|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147051|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129147052|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147053|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147054|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147055|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
129147056|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147057|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147058|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
129147059|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147060|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147061|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147062|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147063|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147064|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147065|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147066|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147067|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129147068|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147069|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147070|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
129147071|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147072|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147073|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147074|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147075|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147076|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147077|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147078|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147079|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147080|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147081|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147082|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147083|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129147084|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129147085|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129147086|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129147087|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147088|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147089|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147090|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
128724848|NCT02036502|463290917|FG004|Part 3:Dose Expansion|Not Treated|0|||
128724849|NCT02036502|463290918|FG005|Part 3:Dose Expansion|Not Treated|2|||
129147091|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147092|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147093|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147094|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147095|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147096|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147097|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147098|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147099|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129147100|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
129147101|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
129147102|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
129147103|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
129147104|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
129147105|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
129147106|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
129147107|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
129147108|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
129147109|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
129147110|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
129147111|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
129147112|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
129147113|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
129147114|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
129147115|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
129147116|NCT02958865|464835525|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147117|NCT02958865|464835526|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147118|NCT02958865|464835527|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147119|NCT02958865|464835528|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147120|NCT02958865|464835529|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
129147121|NCT02958865|464835530|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147122|NCT02958865|464835531|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147123|NCT02958865|464835532|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147124|NCT02958865|464835533|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147125|NCT02958865|464835534|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147126|NCT02958865|464835535|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147127|NCT02958865|464835536|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147128|NCT02958865|464835537|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147129|NCT02958865|464835538|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147130|NCT02958865|464835539|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147131|NCT02958865|464835540|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129147132|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147133|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147134|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147135|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147136|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147137|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147138|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147139|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129147140|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129147141|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
128724850|NCT02036502|463290919|FG006|Part 3:Dose Expansion|Not Treated|0|||
128724851|NCT02036502|463290920|FG007|Part 3:Dose Expansion|Not Treated|0|||
128724852|NCT00500292|463290924|FG000|Overall Study|Adverse Event|3|||
128724853|NCT00500292|463290925|FG001|Overall Study|Adverse Event|6|||
128724854|NCT00500292|463290926|FG002|Overall Study|Adverse Event|4|||
128724855|NCT00500292|463290924|FG000|Overall Study|Condition under investigation worsened|21|||
128724856|NCT00500292|463290925|FG001|Overall Study|Condition under investigation worsened|23|||
128724857|NCT00500292|463290926|FG002|Overall Study|Condition under investigation worsened|19|||
128724858|NCT00500292|463290924|FG000|Overall Study|Withdrawal by Subject|0|||
128724859|NCT00500292|463290925|FG001|Overall Study|Withdrawal by Subject|1|||
128724860|NCT00500292|463290926|FG002|Overall Study|Withdrawal by Subject|0|||
129147142|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129147143|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129147144|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
129147145|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129147146|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
128724861|NCT00500292|463290924|FG000|Overall Study|Other|1|||
128724862|NCT00500292|463290925|FG001|Overall Study|Other|1|||
128724863|NCT00500292|463290926|FG002|Overall Study|Other|4|||
129147147|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
129147148|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147149|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147150|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147151|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147152|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147153|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147154|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147155|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147156|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
129147157|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
129147158|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147159|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
129147160|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147161|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
129147162|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129147163|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
129147164|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147165|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147166|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147167|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147168|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147169|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147170|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147171|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147172|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147173|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
129147174|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147175|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147176|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147177|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147178|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129147179|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
129147180|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147181|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147182|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147183|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147184|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147185|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147186|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147187|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147188|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147189|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147190|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129147191|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
129147192|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
129147193|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
129147194|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
129147195|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
129147196|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
129147197|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
129147198|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
129147199|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
129147200|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
129147201|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
129147202|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
129147203|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
129147204|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
129147205|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
129147206|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
129147207|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
129147208|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
129147209|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
129147210|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
129147211|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
129147212|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147213|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147214|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147215|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147216|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147217|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147218|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147219|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147220|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147221|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147222|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147223|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147224|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147225|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
129147226|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147227|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129147228|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147229|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147230|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147231|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147232|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147233|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147234|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147235|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147236|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147237|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147238|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147239|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147240|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147241|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
129147242|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147243|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129147244|NCT02958865|464835525|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147245|NCT02958865|464835526|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147246|NCT02958865|464835527|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147247|NCT02958865|464835528|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147248|NCT02958865|464835529|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147249|NCT02958865|464835530|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147250|NCT02958865|464835531|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147251|NCT02958865|464835532|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147252|NCT02958865|464835533|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147253|NCT02958865|464835534|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
129147254|NCT02958865|464835535|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147255|NCT02958865|464835536|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147256|NCT02958865|464835537|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147257|NCT02958865|464835538|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147258|NCT02958865|464835539|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147259|NCT02958865|464835540|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129147260|NCT02661815|464835541|FG000|Overall Study|Withdrawal by Subject|1|||
129147261|NCT02661815|464835542|FG001|Overall Study|Withdrawal by Subject|0|||
129147262|NCT02661815|464835543|FG002|Overall Study|Withdrawal by Subject|0|||
129147263|NCT02661815|464835544|FG003|Overall Study|Withdrawal by Subject|0|||
129147264|NCT01728246|464835547|FG000|Overall Study|Participant needed rescue medication|1|||
129147265|NCT01728246|464835548|FG001|Overall Study|Participant needed rescue medication|5|||
129147266|NCT01728246|464835547|FG000|Overall Study|Protocol Violation|1|||
129147267|NCT01728246|464835548|FG001|Overall Study|Protocol Violation|0|||
129147268|NCT01728246|464835547|FG000|Overall Study|Withdrawal by Subject|2|||
129147269|NCT01728246|464835548|FG001|Overall Study|Withdrawal by Subject|3|||
129147270|NCT01728246|464835547|FG000|Overall Study|Lost to Follow-up|23|||
129147271|NCT01728246|464835548|FG001|Overall Study|Lost to Follow-up|22|||
129147272|NCT01728246|464835547|FG000|Overall Study|Lack of Efficacy|1|||
129147273|NCT01728246|464835548|FG001|Overall Study|Lack of Efficacy|1|||
129147274|NCT01728246|464835547|FG000|Overall Study|Adverse Event|8|||
129147275|NCT01728246|464835548|FG001|Overall Study|Adverse Event|5|||
129147276|NCT01983111|464835549|FG000|Overall Study|Withdrawal by Subject|8|||
129147277|NCT01983111|464835550|FG001|Overall Study|Withdrawal by Subject|6|||
129147278|NCT01983111|464835549|FG000|Overall Study|Adverse Event|4|||
129147279|NCT01983111|464835550|FG001|Overall Study|Adverse Event|0|||
129147280|NCT01983111|464835549|FG000|Overall Study|Protocol Violation|0|||
129147281|NCT01983111|464835550|FG001|Overall Study|Protocol Violation|1|||
129147282|NCT03502200|464835551|FG000|Overall Study|Adverse Event|1|||
129147283|NCT03502200|464835552|FG001|Overall Study|Adverse Event|0|||
129147284|NCT03502200|464835551|FG000|Overall Study|Lost to Follow-up|36|||
129147285|NCT03502200|464835552|FG001|Overall Study|Lost to Follow-up|38|||
129147286|NCT03502200|464835551|FG000|Overall Study|Study Team Decision|1|||
129147287|NCT03502200|464835552|FG001|Overall Study|Study Team Decision|1|||
129147288|NCT03502200|464835551|FG000|Overall Study|Withdrawal by Subject|5|||
129147289|NCT03502200|464835552|FG001|Overall Study|Withdrawal by Subject|7|||
129147290|NCT03502200|464835551|FG000|Overall Study|Death|0|||
129147291|NCT03502200|464835552|FG001|Overall Study|Death|2|||
129147292|NCT00855335|464835553|FG000|Overall Study|Lost to Follow-up|0|||
129147293|NCT00855335|464835554|FG001|Overall Study|Lost to Follow-up|0|||
129147294|NCT00855335|464835555|FG002|Overall Study|Lost to Follow-up|3|||
129147295|NCT00855335|464835556|FG003|Overall Study|Lost to Follow-up|1|||
129147296|NCT00855335|464835557|FG004|Overall Study|Lost to Follow-up|0|||
129147297|NCT00855335|464835553|FG000|Overall Study|Withdrawal by Subject|0|||
129147298|NCT00855335|464835554|FG001|Overall Study|Withdrawal by Subject|0|||
129147299|NCT00855335|464835555|FG002|Overall Study|Withdrawal by Subject|0|||
129147300|NCT00855335|464835556|FG003|Overall Study|Withdrawal by Subject|1|||
129147301|NCT00855335|464835557|FG004|Overall Study|Withdrawal by Subject|0|||
129147302|NCT00855335|464835553|FG000|Overall Study|Adverse Event|2|||
129147303|NCT00855335|464835554|FG001|Overall Study|Adverse Event|0|||
129147304|NCT00855335|464835555|FG002|Overall Study|Adverse Event|0|||
129147305|NCT00855335|464835556|FG003|Overall Study|Adverse Event|0|||
129147306|NCT00855335|464835557|FG004|Overall Study|Adverse Event|0|||
129147307|NCT00855335|464835553|FG000|Overall Study|Physician Decision|1|||
129147308|NCT00855335|464835554|FG001|Overall Study|Physician Decision|1|||
129147309|NCT00855335|464835555|FG002|Overall Study|Physician Decision|0|||
129147310|NCT00855335|464835556|FG003|Overall Study|Physician Decision|0|||
129147311|NCT00855335|464835557|FG004|Overall Study|Physician Decision|0|||
129147312|NCT00855335|464835553|FG000|Overall Study|Other|2|||
129147313|NCT00855335|464835554|FG001|Overall Study|Other|1|||
129147314|NCT00855335|464835555|FG002|Overall Study|Other|2|||
129147315|NCT00855335|464835556|FG003|Overall Study|Other|5|||
129147316|NCT00855335|464835557|FG004|Overall Study|Other|1|||
129147317|NCT04380142|464835561|FG000|LD/CD Stabilization Period|Adverse Event|3|||
129147318|NCT04380142|464835562|FG001|LD/CD Stabilization Period|Adverse Event|0|||
129147319|NCT04380142|464835563|FG002|LD/CD Stabilization Period|Adverse Event|0|||
129147320|NCT04380142|464835561|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
129147321|NCT04380142|464835562|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
129147322|NCT04380142|464835563|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
129147323|NCT04380142|464835561|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
129147324|NCT04380142|464835562|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
129147325|NCT04380142|464835563|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
129147326|NCT04380142|464835561|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
129147327|NCT04380142|464835562|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
129147328|NCT04380142|464835563|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
129147329|NCT04380142|464835561|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
129147330|NCT04380142|464835562|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
129147331|NCT04380142|464835563|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
129147332|NCT04380142|464835561|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
129147333|NCT04380142|464835562|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
129147334|NCT04380142|464835563|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
129147335|NCT04380142|464835561|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129147336|NCT04380142|464835562|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129147337|NCT04380142|464835563|FG002|Double-Blind Treatment Period|Adverse Event|14|||
129147338|NCT04380142|464835561|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
129147339|NCT04380142|464835562|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
129147340|NCT04380142|464835563|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
129147341|NCT04380142|464835561|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129147342|NCT04380142|464835562|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
129147343|NCT04380142|464835563|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
129147344|NCT04380142|464835561|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
129147345|NCT04380142|464835562|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
129147346|NCT04380142|464835563|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
129147347|NCT04380142|464835561|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
129147348|NCT04380142|464835562|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
129147349|NCT04380142|464835563|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
129147350|NCT04380142|464835561|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
129147351|NCT04380142|464835562|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
129147352|NCT04380142|464835563|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
129147353|NCT00787150|464835566|FG000|Overall Study|Adverse Event|4|||
129147354|NCT00787150|464835567|FG001|Overall Study|Adverse Event|4|||
129147355|NCT00787150|464835568|FG002|Overall Study|Adverse Event|4|||
129147356|NCT00787150|464835566|FG000|Overall Study|Physician Decision|1|||
129147357|NCT00787150|464835567|FG001|Overall Study|Physician Decision|2|||
129147358|NCT00787150|464835568|FG002|Overall Study|Physician Decision|1|||
129147359|NCT00787150|464835566|FG000|Overall Study|Withdrawal by Subject|2|||
129147360|NCT00787150|464835567|FG001|Overall Study|Withdrawal by Subject|1|||
129147361|NCT00787150|464835568|FG002|Overall Study|Withdrawal by Subject|0|||
129147362|NCT00787150|464835566|FG000|Overall Study|Dosing incorrect study durg|2|||
129147363|NCT00787150|464835567|FG001|Overall Study|Dosing incorrect study durg|0|||
129147364|NCT00787150|464835568|FG002|Overall Study|Dosing incorrect study durg|0|||
129147365|NCT01849276|464835573|FG000|Followed for Survival for 5 Years|Death|1|||
129147366|NCT01849276|464835573|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
129147367|NCT00879398|464835576|FG000|Overall Study|Visit Stop|399|||
129147368|NCT00879398|464835576|FG000|Overall Study|Lack of Efficacy|64|||
129147369|NCT00879398|464835576|FG000|Overall Study|Adverse Event|41|||
129147370|NCT00879398|464835576|FG000|Overall Study|Other Reasons|171|||
129147371|NCT01380080|464835578|FG000|Overall Study|Death|36|||
129147372|NCT01380080|464835579|FG001|Overall Study|Death|44|||
129147373|NCT01380080|464835578|FG000|Overall Study|Site is closing|28|||
129147374|NCT01380080|464835579|FG001|Overall Study|Site is closing|31|||
129147375|NCT01380080|464835578|FG000|Overall Study|Not able to get to clinic|7|||
129147376|NCT01380080|464835579|FG001|Overall Study|Not able to get to clinic|1|||
129147377|NCT01380080|464835578|FG000|Overall Study|Not willing to adhere to requirements|6|||
129147378|NCT01380080|464835579|FG001|Overall Study|Not willing to adhere to requirements|2|||
129147379|NCT01380080|464835578|FG000|Overall Study|Withdrawal by Subject|5|||
129147380|NCT01380080|464835579|FG001|Overall Study|Withdrawal by Subject|2|||
129147381|NCT01380080|464835578|FG000|Overall Study|Lost to Follow-up|3|||
129147382|NCT01380080|464835579|FG001|Overall Study|Lost to Follow-up|3|||
129147383|NCT04251533|464835580|FG000|Overall Study|Progressive disease|33|||
129147384|NCT04251533|464835581|FG001|Overall Study|Progressive disease|29|||
129147385|NCT04251533|464835582|FG002|Overall Study|Progressive disease|22|||
129147386|NCT04251533|464835580|FG000|Overall Study|Death|5|||
129147387|NCT04251533|464835581|FG001|Overall Study|Death|1|||
129147388|NCT04251533|464835582|FG002|Overall Study|Death|3|||
128724864|NCT02741700|463290927|FG000|Overall Study|Lost to Follow-up|17|||
128724865|NCT02741700|463290928|FG001|Overall Study|Lost to Follow-up|8|||
128724866|NCT02741700|463290927|FG000|Overall Study|Withdrawal by Subject|2|||
128724867|NCT02741700|463290928|FG001|Overall Study|Withdrawal by Subject|5|||
128724868|NCT02741700|463290927|FG000|Overall Study|Physician Decision|3|||
128724869|NCT02741700|463290928|FG001|Overall Study|Physician Decision|0|||
129147389|NCT04251533|464835580|FG000|Overall Study|Physician Decision|3|||
129147390|NCT04251533|464835581|FG001|Overall Study|Physician Decision|2|||
128724870|NCT02741700|463290927|FG000|Overall Study|Moved out of State|0|||
128724871|NCT02741700|463290928|FG001|Overall Study|Moved out of State|1|||
128724872|NCT02741700|463290927|FG000|Overall Study|Death|4|||
128724873|NCT02741700|463290928|FG001|Overall Study|Death|5|||
129147391|NCT04251533|464835582|FG002|Overall Study|Physician Decision|4|||
129147392|NCT04251533|464835580|FG000|Overall Study|Participant decision|1|||
129147393|NCT04251533|464835581|FG001|Overall Study|Participant decision|3|||
129147394|NCT04251533|464835582|FG002|Overall Study|Participant decision|1|||
128776597|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
129147395|NCT04251533|464835580|FG000|Overall Study|Adverse Event|2|||
129147396|NCT04251533|464835581|FG001|Overall Study|Adverse Event|1|||
129147397|NCT04251533|464835582|FG002|Overall Study|Adverse Event|1|||
129147398|NCT00210132|464835587|FG000|Overall Study|Protocol Violation|1|||
129147399|NCT00210132|464835588|FG001|Overall Study|Protocol Violation|4|||
129147400|NCT01722669|464835593|FG000|Overall Study|Withdrawal by Subject|0|||
129147401|NCT01722669|464835594|FG001|Overall Study|Withdrawal by Subject|0|||
129147402|NCT01722669|464835595|FG002|Overall Study|Withdrawal by Subject|0|||
129147403|NCT01722669|464835596|FG003|Overall Study|Withdrawal by Subject|0|||
129147404|NCT01722669|464835597|FG004|Overall Study|Withdrawal by Subject|0|||
129147405|NCT01722669|464835598|FG005|Overall Study|Withdrawal by Subject|2|||
129147406|NCT03211416|464835599|FG000|Overall Study|Adverse Event|7|||
129147407|NCT03211416|464835599|FG000|Overall Study|Lack of Efficacy|2|||
129147408|NCT03211416|464835599|FG000|Overall Study|Physician Decision|1|||
129147409|NCT01587196|464835603|FG000|Overall Study|Lost to Follow-up|50|||
129147410|NCT01587196|464835603|FG000|Overall Study|Withdrawal by Subject|4|||
129147411|NCT00643279|464835609|FG000|Overall Study|Death|13|||
129147412|NCT00643279|464835610|FG001|Overall Study|Death|11|||
129147413|NCT00643279|464835609|FG000|Overall Study|Withdrawal by Subject|3|||
129147414|NCT00643279|464835610|FG001|Overall Study|Withdrawal by Subject|0|||
129147415|NCT00643279|464835609|FG000|Overall Study|Lost to Follow-up|0|||
129147416|NCT00643279|464835610|FG001|Overall Study|Lost to Follow-up|1|||
129147417|NCT00643279|464835609|FG000|Overall Study|Physician Decision|0|||
129147418|NCT00643279|464835610|FG001|Overall Study|Physician Decision|1|||
129147419|NCT05715827|464835611|FG000|Overall Study|Physician Decision|0|||
129147420|NCT05715827|464835612|FG001|Overall Study|Physician Decision|1|||
129147421|NCT05715827|464835611|FG000|Overall Study|console communication error|0|||
129147422|NCT05715827|464835612|FG001|Overall Study|console communication error|1|||
129147423|NCT03814044|464835613|FG000|Overall Study|Protocol deviation|1|||
129147424|NCT03557502|464835614|FG000|Protocol 2|Withdrawal by Subject|1|||
129147425|NCT03557502|464835615|FG001|Protocol 2|Withdrawal by Subject|1|||
129147426|NCT03557502|464835614|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
129147427|NCT03557502|464835615|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
129147428|NCT03021486|464837657|FG000|Overall Study|Withdrawal by Subject|1|||
129147429|NCT03021486|464837658|FG001|Overall Study|Withdrawal by Subject|1|||
129147430|NCT03021486|464837659|FG002|Overall Study|Withdrawal by Subject|3|||
129147431|NCT03021486|464837657|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
129147432|NCT03021486|464837658|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
129147433|NCT03021486|464837659|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
129147434|NCT04887831|464837660|FG000|Overall Study|Death|26|||
129147435|NCT04887831|464837661|FG001|Overall Study|Death|26|||
129147436|NCT04887831|464837660|FG000|Overall Study|Lost to Follow-up|0|||
129147437|NCT04887831|464837661|FG001|Overall Study|Lost to Follow-up|1|||
129147438|NCT04887831|464837660|FG000|Overall Study|Withdrawal by Subject|2|||
129147439|NCT04887831|464837661|FG001|Overall Study|Withdrawal by Subject|1|||
129147440|NCT04887831|464837660|FG000|Overall Study|Study Terminated by Sponsor|18|||
128776598|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
129147441|NCT04887831|464837661|FG001|Overall Study|Study Terminated by Sponsor|17|||
129147442|NCT04887831|464837660|FG000|Overall Study|Other|1|||
129147443|NCT04887831|464837661|FG001|Overall Study|Other|0|||
129147444|NCT00730327|464837662|FG000|Overall Study|Lost to Follow-up|14|||
129147445|NCT00730327|464837663|FG001|Overall Study|Lost to Follow-up|16|||
129147446|NCT00730327|464837662|FG000|Overall Study|Adverse Event|8|||
129147447|NCT00730327|464837663|FG001|Overall Study|Adverse Event|1|||
129147448|NCT00730327|464837662|FG000|Overall Study|Withdrawal by Subject|3|||
129147449|NCT00730327|464837663|FG001|Overall Study|Withdrawal by Subject|13|||
129147450|NCT00730327|464837662|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
129147451|NCT00730327|464837663|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
128724874|NCT00811577|463290929|FG000|Overall Study|Lost to Follow-up|7|||
128724875|NCT00811577|463290930|FG001|Overall Study|Lost to Follow-up|1|||
129147452|NCT02552225|464837664|FG000|Overall Study|Withdrawal by Subject|1|||
129147453|NCT02552225|464837665|FG001|Overall Study|Withdrawal by Subject|0|||
129147454|NCT02297516|464837666|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
129147455|NCT02297516|464837667|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
129147456|NCT02297516|464837666|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
129147457|NCT02297516|464837667|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
129147458|NCT02297516|464837666|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
129147459|NCT02297516|464837667|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
129147460|NCT00366457|464837668|FG000|Overall Study|never began study therapy|2|||
129147461|NCT04622592|464837670|FG000|Overall Study|Death|0|||
129147462|NCT04622592|464837671|FG001|Overall Study|Death|0|||
129147463|NCT04622592|464837672|FG002|Overall Study|Death|1|||
129147464|NCT04622592|464837673|FG003|Overall Study|Death|0|||
129147465|NCT04622592|464837674|FG004|Overall Study|Death|0|||
129147466|NCT04622592|464837675|FG005|Overall Study|Death|0|||
129147467|NCT04622592|464837676|FG006|Overall Study|Death|0|||
129147468|NCT04622592|464837677|FG007|Overall Study|Death|1|||
129147469|NCT04622592|464837670|FG000|Overall Study|Lost to Follow-up|0|||
129147470|NCT04622592|464837671|FG001|Overall Study|Lost to Follow-up|0|||
129147471|NCT04622592|464837672|FG002|Overall Study|Lost to Follow-up|0|||
129147472|NCT04622592|464837673|FG003|Overall Study|Lost to Follow-up|3|||
129147473|NCT04622592|464837674|FG004|Overall Study|Lost to Follow-up|1|||
129147474|NCT04622592|464837675|FG005|Overall Study|Lost to Follow-up|0|||
129147475|NCT04622592|464837676|FG006|Overall Study|Lost to Follow-up|2|||
129147476|NCT04622592|464837677|FG007|Overall Study|Lost to Follow-up|2|||
129147477|NCT04622592|464837670|FG000|Overall Study|Physician Decision|0|||
129147478|NCT04622592|464837671|FG001|Overall Study|Physician Decision|0|||
129147479|NCT04622592|464837672|FG002|Overall Study|Physician Decision|0|||
129147480|NCT04622592|464837673|FG003|Overall Study|Physician Decision|0|||
129147481|NCT04622592|464837674|FG004|Overall Study|Physician Decision|1|||
129147482|NCT04622592|464837675|FG005|Overall Study|Physician Decision|0|||
129147483|NCT04622592|464837676|FG006|Overall Study|Physician Decision|0|||
129147484|NCT04622592|464837677|FG007|Overall Study|Physician Decision|0|||
129147485|NCT04622592|464837670|FG000|Overall Study|Withdrawal by Subject|1|||
129147486|NCT04622592|464837671|FG001|Overall Study|Withdrawal by Subject|0|||
129147487|NCT04622592|464837672|FG002|Overall Study|Withdrawal by Subject|2|||
129147488|NCT04622592|464837673|FG003|Overall Study|Withdrawal by Subject|0|||
128724876|NCT00811577|463290929|FG000|Overall Study|Withdrawal by Subject|3|||
128724877|NCT00811577|463290930|FG001|Overall Study|Withdrawal by Subject|0|||
128724878|NCT01068509|463290933|FG000|Overall Study|Death|0|||
128724879|NCT01068509|463290934|FG001|Overall Study|Death|0|||
128724880|NCT01068509|463290935|FG002|Overall Study|Death|1|||
128724881|NCT01068509|463290933|FG000|Overall Study|Disease Progression|5|||
128724882|NCT01068509|463290934|FG001|Overall Study|Disease Progression|20|||
128724883|NCT01068509|463290935|FG002|Overall Study|Disease Progression|18|||
128724884|NCT01068509|463290933|FG000|Overall Study|Lost to Follow-up|1|||
128724885|NCT01068509|463290934|FG001|Overall Study|Lost to Follow-up|0|||
128724886|NCT01068509|463290935|FG002|Overall Study|Lost to Follow-up|0|||
128724887|NCT01068509|463290933|FG000|Overall Study|Withdrew Consent|0|||
128724888|NCT01068509|463290934|FG001|Overall Study|Withdrew Consent|1|||
128724889|NCT01068509|463290935|FG002|Overall Study|Withdrew Consent|2|||
128724890|NCT01068509|463290933|FG000|Overall Study|Reason Not Specified|0|||
128724891|NCT01068509|463290934|FG001|Overall Study|Reason Not Specified|1|||
128724892|NCT01068509|463290935|FG002|Overall Study|Reason Not Specified|0|||
128724893|NCT02442778|463290936|FG000|Overall Study|Adverse Event|2|||
128724894|NCT02442778|463290937|FG001|Overall Study|Adverse Event|6|||
128724895|NCT02442778|463290938|FG002|Overall Study|Adverse Event|6|||
129147489|NCT04622592|464837674|FG004|Overall Study|Withdrawal by Subject|0|||
129147490|NCT04622592|464837675|FG005|Overall Study|Withdrawal by Subject|0|||
129147491|NCT04622592|464837676|FG006|Overall Study|Withdrawal by Subject|1|||
129147492|NCT04622592|464837677|FG007|Overall Study|Withdrawal by Subject|4|||
129147493|NCT04622592|464837670|FG000|Overall Study|Other than specified above|0|||
129147494|NCT04622592|464837671|FG001|Overall Study|Other than specified above|0|||
129147495|NCT04622592|464837672|FG002|Overall Study|Other than specified above|1|||
129147496|NCT04622592|464837673|FG003|Overall Study|Other than specified above|0|||
129147497|NCT04622592|464837674|FG004|Overall Study|Other than specified above|0|||
129147498|NCT04622592|464837675|FG005|Overall Study|Other than specified above|0|||
129147499|NCT04622592|464837676|FG006|Overall Study|Other than specified above|0|||
129147500|NCT04622592|464837677|FG007|Overall Study|Other than specified above|0|||
129147501|NCT01497197|464837678|FG000|Overall Study|Lost to Follow-up|1|||
129147502|NCT01497197|464837679|FG001|Overall Study|Lost to Follow-up|0|||
128724896|NCT02442778|463290936|FG000|Overall Study|Death|0|||
128724897|NCT02442778|463290937|FG001|Overall Study|Death|2|||
128724898|NCT02442778|463290938|FG002|Overall Study|Death|0|||
129147503|NCT01497197|464837678|FG000|Overall Study|Protocol Violation|0|||
129147504|NCT01497197|464837679|FG001|Overall Study|Protocol Violation|2|||
129147505|NCT01497197|464837678|FG000|Overall Study|Withdrawal by Subject|2|||
129147506|NCT01497197|464837679|FG001|Overall Study|Withdrawal by Subject|1|||
129147507|NCT01497197|464837678|FG000|Overall Study|Excessive/lack of response to treatment|1|||
129147508|NCT01497197|464837679|FG001|Overall Study|Excessive/lack of response to treatment|0|||
129147509|NCT01497197|464837678|FG000|Overall Study|Risk of OHSS|1|||
129147510|NCT01497197|464837679|FG001|Overall Study|Risk of OHSS|0|||
129147511|NCT01497197|464837678|FG000|Overall Study|No oocytes retrieved|3|||
129147512|NCT01497197|464837679|FG001|Overall Study|No oocytes retrieved|2|||
129147513|NCT01497197|464837678|FG000|Overall Study|No fertilisation|6|||
129147514|NCT01497197|464837679|FG001|Overall Study|No fertilisation|5|||
128724899|NCT02442778|463290936|FG000|Overall Study|Lack of Efficacy|1|||
128724900|NCT02442778|463290937|FG001|Overall Study|Lack of Efficacy|0|||
128724901|NCT02442778|463290938|FG002|Overall Study|Lack of Efficacy|0|||
128724902|NCT02442778|463290936|FG000|Overall Study|Lost to Follow-up|1|||
129147515|NCT01497197|464837678|FG000|Overall Study|Intention to freeze all embryos|0|||
129147516|NCT01497197|464837679|FG001|Overall Study|Intention to freeze all embryos|1|||
129147517|NCT01497197|464837678|FG000|Overall Study|All embryos discarded|0|||
129147518|NCT01497197|464837679|FG001|Overall Study|All embryos discarded|3|||
129147519|NCT01497197|464837678|FG000|Overall Study|Other|3|||
129147520|NCT01497197|464837679|FG001|Overall Study|Other|1|||
129147521|NCT00183248|464837683|FG000|Overall Study|Lost to Follow-up|0|||
129147522|NCT00183248|464837684|FG001|Overall Study|Lost to Follow-up|1|||
129147523|NCT00183248|464837683|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
129147524|NCT00183248|464837684|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
129147525|NCT03309202|464837685|FG000|Overall Study|Lost to Follow-up|1|||
129147526|NCT03309202|464837686|FG001|Overall Study|Lost to Follow-up|0|||
129147527|NCT03309202|464837687|FG002|Overall Study|Lost to Follow-up|0|||
129147528|NCT03309202|464837688|FG003|Overall Study|Lost to Follow-up|0|||
129147529|NCT00415636|464837689|FG000|Overall Study|Symptomatic deterioration|1|||
129147530|NCT00415636|464837690|FG001|Overall Study|Symptomatic deterioration|0|||
129147531|NCT00415636|464837691|FG002|Overall Study|Symptomatic deterioration|1|||
129147532|NCT00415636|464837692|FG003|Overall Study|Symptomatic deterioration|2|||
129147533|NCT00415636|464837693|FG004|Overall Study|Symptomatic deterioration|0|||
129147534|NCT00415636|464837694|FG005|Overall Study|Symptomatic deterioration|1|||
129147535|NCT00415636|464837689|FG000|Overall Study|Adverse Event|0|||
129147536|NCT00415636|464837690|FG001|Overall Study|Adverse Event|0|||
129147537|NCT00415636|464837691|FG002|Overall Study|Adverse Event|0|||
129147538|NCT00415636|464837692|FG003|Overall Study|Adverse Event|1|||
129147539|NCT00415636|464837693|FG004|Overall Study|Adverse Event|1|||
129147540|NCT00415636|464837694|FG005|Overall Study|Adverse Event|0|||
129147541|NCT00415636|464837689|FG000|Overall Study|Withdrawal by Subject|0|||
129147542|NCT00415636|464837690|FG001|Overall Study|Withdrawal by Subject|0|||
129147543|NCT00415636|464837691|FG002|Overall Study|Withdrawal by Subject|0|||
129147544|NCT00415636|464837692|FG003|Overall Study|Withdrawal by Subject|0|||
129147545|NCT00415636|464837693|FG004|Overall Study|Withdrawal by Subject|1|||
129147546|NCT00415636|464837694|FG005|Overall Study|Withdrawal by Subject|0|||
129147547|NCT00415636|464837689|FG000|Overall Study|Disease progression|0|||
129147548|NCT00415636|464837690|FG001|Overall Study|Disease progression|0|||
129147549|NCT00415636|464837691|FG002|Overall Study|Disease progression|0|||
129147550|NCT00415636|464837692|FG003|Overall Study|Disease progression|3|||
129147551|NCT00415636|464837693|FG004|Overall Study|Disease progression|0|||
129147552|NCT00415636|464837694|FG005|Overall Study|Disease progression|1|||
129147553|NCT04734210|464837695|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
129147554|NCT04734210|464837696|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
129147555|NCT04734210|464837697|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
129147556|NCT04734210|464837695|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
129147557|NCT04734210|464837696|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
129147558|NCT04734210|464837697|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
129147559|NCT04734210|464837695|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
129147560|NCT04734210|464837696|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
129147561|NCT04734210|464837697|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
129147562|NCT04734210|464837695|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
128724903|NCT02442778|463290937|FG001|Overall Study|Lost to Follow-up|1|||
129147563|NCT04734210|464837696|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
129147564|NCT04734210|464837697|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
129147565|NCT05201807|464837700|FG000|Overall Study|Adverse Event|1|||
129147566|NCT05201807|464837700|FG000|Overall Study|COVID-19 Related|1|||
129147567|NCT01209767|464837704|FG000|Overall Study|Withdrawal by Subject|1|||
129147568|NCT01209767|464837704|FG000|Overall Study|Lost to Follow-up|3|||
128724904|NCT02442778|463290938|FG002|Overall Study|Lost to Follow-up|1|||
129147569|NCT01702298|464837705|FG000|Overall Study|Withdrawal by Subject|1|||
129147570|NCT04507204|464837706|FG000|Overall Study|Adverse Event|8|||
129147571|NCT04507204|464837707|FG001|Overall Study|Adverse Event|13|||
129147572|NCT04507204|464837706|FG000|Overall Study|Death|0|||
129147573|NCT04507204|464837707|FG001|Overall Study|Death|1|||
129147574|NCT04507204|464837706|FG000|Overall Study|Lost to Follow-up|15|||
129147575|NCT04507204|464837707|FG001|Overall Study|Lost to Follow-up|14|||
129147576|NCT04507204|464837706|FG000|Overall Study|Poor Compliance with Protocol|2|||
129147577|NCT04507204|464837707|FG001|Overall Study|Poor Compliance with Protocol|4|||
129147578|NCT04507204|464837706|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
129147579|NCT04507204|464837707|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
129147580|NCT04507204|464837706|FG000|Overall Study|Withdrawal of Patient Consent|21|||
129147581|NCT04507204|464837707|FG001|Overall Study|Withdrawal of Patient Consent|13|||
129147582|NCT01664624|464837711|FG000|Overall Study|Adverse Event|0|||
129147583|NCT01664624|464837712|FG001|Overall Study|Adverse Event|1|||
129147584|NCT01664624|464837713|FG002|Overall Study|Adverse Event|0|||
129147585|NCT01664624|464837714|FG003|Overall Study|Adverse Event|0|||
129147586|NCT01206517|464837715|FG000|Overall Study|Withdrawal by Subject|0|||
129147587|NCT01206517|464837716|FG001|Overall Study|Withdrawal by Subject|0|||
129147588|NCT01206517|464837717|FG002|Overall Study|Withdrawal by Subject|2|||
129147589|NCT01206517|464837718|FG003|Overall Study|Withdrawal by Subject|0|||
129147590|NCT01206517|464837719|FG004|Overall Study|Withdrawal by Subject|1|||
129147591|NCT01206517|464837720|FG005|Overall Study|Withdrawal by Subject|0|||
129147592|NCT03493958|464837721|FG000|Overall Study|Withdrawal by Subject|6|||
129147593|NCT03493958|464837721|FG000|Overall Study|Lost to Follow-up|7|||
129147594|NCT03493958|464837721|FG000|Overall Study|Did not complete all required study procedures|2|||
129147595|NCT01029535|464837722|FG000|Overall Study|Lost to Follow-up|24|||
129147596|NCT01029535|464837722|FG000|Overall Study|Protocol Violation|2|||
129147597|NCT01029535|464837722|FG000|Overall Study|Participant Withdrew Consent|2|||
129147598|NCT01029535|464837722|FG000|Overall Study|Adverse Event|1|||
129147599|NCT01029535|464837722|FG000|Overall Study|Use of Another Treatment|1|||
129147600|NCT01029535|464837722|FG000|Overall Study|Death|1|||
129147601|NCT01198587|464837727|FG000|Overall Study|Lost to Follow-up|8|||
129147602|NCT01198587|464837728|FG001|Overall Study|Lost to Follow-up|0|||
129147603|NCT01198587|464837729|FG002|Overall Study|Lost to Follow-up|9|||
129147604|NCT01198587|464837730|FG003|Overall Study|Lost to Follow-up|0|||
129147605|NCT00573768|464837731|FG000|Overall Study|Adverse Event|1|||
129147606|NCT00573768|464837732|FG001|Overall Study|Adverse Event|1|||
129147607|NCT00573768|464837733|FG002|Overall Study|Adverse Event|2|||
129147608|NCT00573768|464837731|FG000|Overall Study|Protocol Violation|1|||
129147609|NCT00573768|464837732|FG001|Overall Study|Protocol Violation|0|||
129147610|NCT00573768|464837733|FG002|Overall Study|Protocol Violation|1|||
129147611|NCT00573768|464837731|FG000|Overall Study|Withdrawal by Subject|0|||
129147612|NCT00573768|464837732|FG001|Overall Study|Withdrawal by Subject|1|||
129147613|NCT00573768|464837733|FG002|Overall Study|Withdrawal by Subject|0|||
129147614|NCT00573768|464837731|FG000|Overall Study|Lost to Follow-up|0|||
129147615|NCT00573768|464837732|FG001|Overall Study|Lost to Follow-up|0|||
129147616|NCT00573768|464837733|FG002|Overall Study|Lost to Follow-up|1|||
129147617|NCT02095106|464837738|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129147618|NCT02095106|464837739|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129147619|NCT00553254|464837742|FG000|Overall Study|Death|3|||
129147620|NCT00553254|464837743|FG001|Overall Study|Death|6|||
129147621|NCT00553254|464837744|FG002|Overall Study|Death|25|||
129147622|NCT00553254|464837742|FG000|Overall Study|Lost to Follow-up|0|||
129147623|NCT00553254|464837743|FG001|Overall Study|Lost to Follow-up|0|||
129147624|NCT00553254|464837744|FG002|Overall Study|Lost to Follow-up|2|||
129147625|NCT00553254|464837742|FG000|Overall Study|Withdrawal by Subject|2|||
129147626|NCT00553254|464837743|FG001|Overall Study|Withdrawal by Subject|0|||
128724905|NCT02442778|463290936|FG000|Overall Study|Non-compliance with study drug|2|||
128724906|NCT02442778|463290937|FG001|Overall Study|Non-compliance with study drug|0|||
128724907|NCT02442778|463290938|FG002|Overall Study|Non-compliance with study drug|1|||
129147627|NCT00553254|464837744|FG002|Overall Study|Withdrawal by Subject|2|||
129147628|NCT00553254|464837742|FG000|Overall Study|Study terminated by Sponsor|0|||
129147629|NCT00553254|464837743|FG001|Overall Study|Study terminated by Sponsor|0|||
129147630|NCT00553254|464837744|FG002|Overall Study|Study terminated by Sponsor|1|||
129147631|NCT00553254|464837742|FG000|Overall Study|Other|1|||
129147632|NCT00553254|464837743|FG001|Overall Study|Other|0|||
129147633|NCT00553254|464837744|FG002|Overall Study|Other|13|||
129147634|NCT00754572|464837752|FG000|Overall Study|Adverse Event|19|||
129147635|NCT00754572|464837752|FG000|Overall Study|Other|39|||
129147636|NCT00754572|464837752|FG000|Overall Study|Protocol Violation|3|||
129147637|NCT00754572|464837752|FG000|Overall Study|Withdrawal by Subject|3|||
129147638|NCT00754572|464837752|FG000|Overall Study|Lack of Efficacy|2|||
129147639|NCT00754572|464837752|FG000|Overall Study|Death|1|||
129147640|NCT00754572|464837752|FG000|Overall Study|Administrative Reason|3|||
129147641|NCT00754572|464837752|FG000|Overall Study|Lost to Follow-up|1|||
129147642|NCT01559935|464837753|FG000|Car Phase|Toxicity|4|||
129147643|NCT01559935|464837753|FG000|Car Phase|Death|1|||
129147644|NCT01559935|464837753|FG000|Car Phase|Lack of Efficacy|2|||
129147645|NCT01559935|464837753|FG000|Car Phase|Lost to Follow-up|1|||
129147646|NCT01559935|464837753|FG000|Car Phase|Physician Decision|1|||
129147647|NCT01559935|464837753|FG000|Car Phase|Withdrawal by Subject|2|||
129147648|NCT01559935|464837753|FG000|Car Phase|Per protocol|1|||
129147649|NCT01559935|464837753|FG000|Car Phase|Insurance|1|||
129147650|NCT01559935|464837753|FG000|Car Phase|non-compliance|1|||
129147651|NCT01559935|464837753|FG000|BiRD Phase|Toxicity|1|||
129147652|NCT01559935|464837753|FG000|BiRD Phase|Lack of Efficacy|1|||
129147653|NCT01559935|464837753|FG000|BiRD Phase|Withdrawal by Subject|2|||
129147654|NCT01559935|464837753|FG000|Maintenance Phase|Remains on study|28|||
129147655|NCT01559935|464837753|FG000|Maintenance Phase|Toxicity|1|||
129147656|NCT01559935|464837753|FG000|Maintenance Phase|Lack of Efficacy|18|||
129147657|NCT01559935|464837753|FG000|Maintenance Phase|Withdrawal by Subject|5|||
128724908|NCT02442778|463290936|FG000|Overall Study|Physician Decision|1|||
128724909|NCT02442778|463290937|FG001|Overall Study|Physician Decision|1|||
128724910|NCT02442778|463290938|FG002|Overall Study|Physician Decision|1|||
128724911|NCT02442778|463290936|FG000|Overall Study|Protocol Deviation|3|||
129147658|NCT01559935|464837753|FG000|Maintenance Phase|Non-compliance|2|||
129147659|NCT01143402|464837757|FG000|Overall Study|Rapid clinical decline|1|||
129147660|NCT01143402|464837758|FG001|Overall Study|Rapid clinical decline|1|||
129147661|NCT01143402|464837759|FG002|Overall Study|Rapid clinical decline|0|||
129147662|NCT01143402|464837757|FG000|Overall Study|Not Treated|0|||
129147663|NCT01143402|464837758|FG001|Overall Study|Not Treated|0|||
128724912|NCT02442778|463290937|FG001|Overall Study|Protocol Deviation|0|||
128724913|NCT02442778|463290938|FG002|Overall Study|Protocol Deviation|1|||
128724914|NCT02442778|463290936|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
128724915|NCT02442778|463290937|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
128724916|NCT02442778|463290938|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
128724917|NCT02442778|463290936|FG000|Overall Study|Withdrawal by Subject|4|||
128724918|NCT02442778|463290937|FG001|Overall Study|Withdrawal by Subject|4|||
128724919|NCT02442778|463290938|FG002|Overall Study|Withdrawal by Subject|3|||
128724920|NCT02442778|463290936|FG000|Overall Study|Reason not specified|1|||
128724921|NCT02442778|463290937|FG001|Overall Study|Reason not specified|4|||
128724922|NCT02442778|463290938|FG002|Overall Study|Reason not specified|0|||
128724923|NCT01165138|463290941|FG000|Overall Study|Adverse Event|0|||
128724924|NCT01165138|463290942|FG001|Overall Study|Adverse Event|1|||
128724925|NCT01165138|463290943|FG002|Overall Study|Adverse Event|0|||
128724926|NCT01165138|463290944|FG003|Overall Study|Adverse Event|2|||
128724927|NCT01165138|463290941|FG000|Overall Study|Lack of Efficacy|0|||
128724928|NCT01165138|463290942|FG001|Overall Study|Lack of Efficacy|32|||
128724929|NCT01165138|463290943|FG002|Overall Study|Lack of Efficacy|6|||
128724930|NCT01165138|463290944|FG003|Overall Study|Lack of Efficacy|7|||
128724931|NCT01165138|463290941|FG000|Overall Study|Protocol Violation|0|||
128724932|NCT01165138|463290942|FG001|Overall Study|Protocol Violation|7|||
128724933|NCT01165138|463290943|FG002|Overall Study|Protocol Violation|0|||
128724934|NCT01165138|463290944|FG003|Overall Study|Protocol Violation|2|||
128724935|NCT01165138|463290941|FG000|Overall Study|Lost to Follow-up|0|||
128724936|NCT01165138|463290942|FG001|Overall Study|Lost to Follow-up|0|||
128724937|NCT01165138|463290943|FG002|Overall Study|Lost to Follow-up|1|||
128724938|NCT01165138|463290944|FG003|Overall Study|Lost to Follow-up|2|||
128724939|NCT01165138|463290941|FG000|Overall Study|Physician Decision|0|||
128724940|NCT01165138|463290942|FG001|Overall Study|Physician Decision|6|||
128724941|NCT01165138|463290943|FG002|Overall Study|Physician Decision|7|||
128724942|NCT01165138|463290944|FG003|Overall Study|Physician Decision|6|||
128724943|NCT01165138|463290941|FG000|Overall Study|Withdrawal by Subject|0|||
128724944|NCT01165138|463290942|FG001|Overall Study|Withdrawal by Subject|6|||
128724945|NCT01165138|463290943|FG002|Overall Study|Withdrawal by Subject|6|||
128724946|NCT01165138|463290944|FG003|Overall Study|Withdrawal by Subject|3|||
128724947|NCT02641379|463290945|FG000|Overall Study|Exclusion criterion during screening|1|||
129147664|NCT01143402|464837759|FG002|Overall Study|Not Treated|1|||
129147665|NCT02526290|464837760|FG000|Overall Study|Adverse Event|3|||
129147666|NCT02526290|464837760|FG000|Overall Study|Withdrawal by Subject|4|||
129147667|NCT02526290|464837760|FG000|Overall Study|Physician Decision|1|||
128724948|NCT02641379|463290946|FG001|Overall Study|Exclusion criterion during screening|0|||
128724949|NCT02641379|463290947|FG002|Overall Study|Exclusion criterion during screening|0|||
128724950|NCT02641379|463290948|FG003|Overall Study|Exclusion criterion during screening|1|||
129147668|NCT02706392|464837761|FG000|Overall Study|Death|1|||
129147669|NCT02706392|464837762|FG001|Overall Study|Death|0|||
129147670|NCT02706392|464837763|FG002|Overall Study|Death|2|||
129147671|NCT02706392|464837764|FG003|Overall Study|Death|2|||
129147672|NCT02706392|464837765|FG004|Overall Study|Death|5|||
129147673|NCT02706392|464837766|FG005|Overall Study|Death|2|||
128724951|NCT02641379|463290949|FG004|Overall Study|Exclusion criterion during screening|2|||
129147674|NCT00619866|464837769|FG000|Weeks 1 - 12|Adverse Event|0|||
129147675|NCT00619866|464837770|FG001|Weeks 1 - 12|Adverse Event|1|||
129147676|NCT00619866|464837771|FG002|Weeks 1 - 12|Adverse Event|2|||
129147677|NCT00619866|464837772|FG003|Weeks 1 - 12|Adverse Event|0|||
129147678|NCT00619866|464837773|FG004|Weeks 1 - 12|Adverse Event|0|||
129147679|NCT00619866|464837769|FG000|Weeks 1 - 12|Non-compliance|0|||
128724952|NCT02641379|463290950|FG005|Overall Study|Exclusion criterion during screening|0|||
128724953|NCT02641379|463290951|FG006|Overall Study|Exclusion criterion during screening|0|||
128724954|NCT02641379|463290952|FG007|Overall Study|Exclusion criterion during screening|0|||
128724955|NCT02641379|463290953|FG008|Overall Study|Exclusion criterion during screening|0|||
128724956|NCT02641379|463290954|FG009|Overall Study|Exclusion criterion during screening|0|||
129147680|NCT00619866|464837770|FG001|Weeks 1 - 12|Non-compliance|0|||
129147681|NCT00619866|464837771|FG002|Weeks 1 - 12|Non-compliance|1|||
129147682|NCT00619866|464837772|FG003|Weeks 1 - 12|Non-compliance|0|||
129147683|NCT00619866|464837773|FG004|Weeks 1 - 12|Non-compliance|0|||
129147684|NCT00619866|464837769|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
129147685|NCT00619866|464837770|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
129147686|NCT00619866|464837771|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
129147687|NCT00619866|464837772|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
129147688|NCT00619866|464837773|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
129147689|NCT00619866|464837769|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
129147690|NCT00619866|464837770|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
129147691|NCT00619866|464837771|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
129147692|NCT00619866|464837772|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
129147693|NCT00619866|464837773|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
129147694|NCT00619866|464837769|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
129147695|NCT00619866|464837770|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
129147696|NCT00619866|464837771|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
129147697|NCT00619866|464837772|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
129147698|NCT00619866|464837773|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
129147699|NCT00619866|464837769|FG000|Weeks 1 - 12|Sponsor Decision|0|||
129147700|NCT00619866|464837770|FG001|Weeks 1 - 12|Sponsor Decision|1|||
129147701|NCT00619866|464837771|FG002|Weeks 1 - 12|Sponsor Decision|0|||
129147702|NCT00619866|464837772|FG003|Weeks 1 - 12|Sponsor Decision|0|||
129147703|NCT00619866|464837773|FG004|Weeks 1 - 12|Sponsor Decision|0|||
129147704|NCT00619866|464837769|FG000|Weeks 13 - 24|Adverse Event|0|||
129147705|NCT00619866|464837770|FG001|Weeks 13 - 24|Adverse Event|0|||
129147706|NCT00619866|464837771|FG002|Weeks 13 - 24|Adverse Event|2|||
129147707|NCT00619866|464837772|FG003|Weeks 13 - 24|Adverse Event|1|||
129147708|NCT00619866|464837773|FG004|Weeks 13 - 24|Adverse Event|0|||
129147709|NCT00619866|464837769|FG000|Weeks 13 - 24|Protocol Deviation|0|||
129147710|NCT00619866|464837770|FG001|Weeks 13 - 24|Protocol Deviation|0|||
129147711|NCT00619866|464837771|FG002|Weeks 13 - 24|Protocol Deviation|0|||
129147712|NCT00619866|464837772|FG003|Weeks 13 - 24|Protocol Deviation|1|||
129147713|NCT00619866|464837773|FG004|Weeks 13 - 24|Protocol Deviation|0|||
129147714|NCT00619866|464837769|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
129147715|NCT00619866|464837770|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
129147716|NCT00619866|464837771|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
129147717|NCT00619866|464837772|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
129147718|NCT00619866|464837773|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
129147719|NCT00619866|464837769|FG000|Weeks 13 - 24|Non-compliance|0|||
129147720|NCT00619866|464837770|FG001|Weeks 13 - 24|Non-compliance|1|||
129147721|NCT00619866|464837771|FG002|Weeks 13 - 24|Non-compliance|1|||
129147722|NCT00619866|464837772|FG003|Weeks 13 - 24|Non-compliance|0|||
129147723|NCT00619866|464837773|FG004|Weeks 13 - 24|Non-compliance|0|||
129147724|NCT00619866|464837769|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
129147725|NCT00619866|464837770|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
129147726|NCT00619866|464837771|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
129147727|NCT00619866|464837772|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
129147728|NCT00619866|464837773|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
129147729|NCT01968980|464837777|FG000|Overall Study|Death|0|||
129147730|NCT01968980|464837778|FG001|Overall Study|Death|1|||
129147731|NCT01968980|464837777|FG000|Overall Study|Adverse Event|1|||
128724957|NCT02641379|463290955|FG010|Overall Study|Exclusion criterion during screening|0|||
128724958|NCT02641379|463290945|FG000|Overall Study|Withdrawal of informed consent|0|||
128724959|NCT02641379|463290946|FG001|Overall Study|Withdrawal of informed consent|1|||
129147732|NCT01968980|464837778|FG001|Overall Study|Adverse Event|3|||
129147733|NCT01968980|464837777|FG000|Overall Study|Does not meet entry criteria|1|||
129147734|NCT01968980|464837778|FG001|Overall Study|Does not meet entry criteria|3|||
128724960|NCT02641379|463290947|FG002|Overall Study|Withdrawal of informed consent|0|||
128724961|NCT02641379|463290948|FG003|Overall Study|Withdrawal of informed consent|0|||
129147735|NCT01968980|464837777|FG000|Overall Study|Withdrawal by Subject|13|||
129147736|NCT01968980|464837778|FG001|Overall Study|Withdrawal by Subject|5|||
129147737|NCT01968980|464837777|FG000|Overall Study|Other unspecified|1|||
129147738|NCT01968980|464837778|FG001|Overall Study|Other unspecified|2|||
129147739|NCT02589938|464837784|FG000|Overall Study|Withdrawal by Subject|11|||
129147740|NCT02589938|464837785|FG001|Overall Study|Withdrawal by Subject|5|||
129147741|NCT02589938|464837786|FG002|Overall Study|Withdrawal by Subject|6|||
129147742|NCT02589938|464837784|FG000|Overall Study|Lost to Follow-up|3|||
129147743|NCT02589938|464837785|FG001|Overall Study|Lost to Follow-up|3|||
129147744|NCT02589938|464837786|FG002|Overall Study|Lost to Follow-up|3|||
129147745|NCT02589938|464837784|FG000|Overall Study|Death|1|||
129147746|NCT02589938|464837785|FG001|Overall Study|Death|0|||
129147747|NCT02589938|464837786|FG002|Overall Study|Death|1|||
129147748|NCT02589938|464837784|FG000|Overall Study|Protocol Violation|6|||
129147749|NCT02589938|464837785|FG001|Overall Study|Protocol Violation|2|||
129147750|NCT02589938|464837786|FG002|Overall Study|Protocol Violation|3|||
129147751|NCT02589938|464837784|FG000|Overall Study|Physician Decision|1|||
129147752|NCT02589938|464837785|FG001|Overall Study|Physician Decision|0|||
129147753|NCT02589938|464837786|FG002|Overall Study|Physician Decision|0|||
129147754|NCT02589938|464837784|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
129147755|NCT02589938|464837785|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
129147756|NCT02589938|464837786|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
129147757|NCT02521285|464837787|FG000|Overall Study|Lost to Follow-up|1|||
129147758|NCT02521285|464837788|FG001|Overall Study|Lost to Follow-up|1|||
129147759|NCT02521285|464837787|FG000|Overall Study|Withdrawal by Subject|1|||
129147760|NCT02521285|464837788|FG001|Overall Study|Withdrawal by Subject|1|||
129147761|NCT02521285|464837787|FG000|Overall Study|Adverse Event|0|||
129147762|NCT02521285|464837788|FG001|Overall Study|Adverse Event|1|||
129147763|NCT01121757|464837789|FG000|First Drug|Death|1|||
129147764|NCT01121757|464837790|FG001|First Drug|Death|0|||
129147765|NCT01121757|464837789|FG000|First Drug|Disease Progression|0|||
129147766|NCT01121757|464837790|FG001|First Drug|Disease Progression|2|||
129147767|NCT01121757|464837789|FG000|Combination|Physician Decision|0|||
129147768|NCT01121757|464837790|FG001|Combination|Physician Decision|1|||
129147769|NCT01121757|464837789|FG000|Combination|Disease Progression|2|||
129147770|NCT01121757|464837790|FG001|Combination|Disease Progression|0|||
129147771|NCT03636022|464837791|FG000|Overall Study|Withdrawal by Subject|1|||
129147772|NCT03636022|464837792|FG001|Overall Study|Withdrawal by Subject|3|||
129147773|NCT03189719|464837793|FG000|Overall Study|Death|325|||
129147774|NCT03189719|464837794|FG001|Overall Study|Death|361|||
129147775|NCT03189719|464837793|FG000|Overall Study|Physician Decision|1|||
129147776|NCT03189719|464837794|FG001|Overall Study|Physician Decision|0|||
129147777|NCT03189719|464837793|FG000|Overall Study|Sponsor Decision|40|||
129147778|NCT03189719|464837794|FG001|Overall Study|Sponsor Decision|12|||
129147779|NCT03189719|464837793|FG000|Overall Study|Withdrawal by Subject|7|||
129147780|NCT03189719|464837794|FG001|Overall Study|Withdrawal by Subject|3|||
129147781|NCT03448393|464837795|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129147782|NCT03448393|464837796|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129147783|NCT03448393|464837797|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
129147784|NCT03448393|464837798|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129147785|NCT03448393|464837799|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129147786|NCT03448393|464837800|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129147787|NCT03448393|464837801|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129147788|NCT03448393|464837802|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129147789|NCT03448393|464837803|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
129147790|NCT03448393|464837795|FG000|Dose Expansion|Not treated - screen failure|0|||
129147791|NCT03448393|464837796|FG001|Dose Expansion|Not treated - screen failure|0|||
129147792|NCT03448393|464837797|FG002|Dose Expansion|Not treated - screen failure|0|||
129147793|NCT03448393|464837798|FG003|Dose Expansion|Not treated - screen failure|0|||
129147794|NCT03448393|464837799|FG004|Dose Expansion|Not treated - screen failure|0|||
129147795|NCT03448393|464837800|FG005|Dose Expansion|Not treated - screen failure|0|||
129147796|NCT03448393|464837801|FG006|Dose Expansion|Not treated - screen failure|0|||
129147797|NCT03448393|464837802|FG007|Dose Expansion|Not treated - screen failure|0|||
129147798|NCT03448393|464837803|FG008|Dose Expansion|Not treated - screen failure|7|||
129147799|NCT03012880|464837804|FG000|Overall Study|Withdrawal by Subject|1|||
129147800|NCT03012880|464837805|FG001|Overall Study|Withdrawal by Subject|0|||
129147801|NCT03012880|464837804|FG000|Overall Study|Ineligible|1|||
129147802|NCT03012880|464837805|FG001|Overall Study|Ineligible|0|||
129147803|NCT04569084|464837806|FG000|Overall Study|Adverse Event|10|||
129147804|NCT04569084|464837807|FG001|Overall Study|Adverse Event|14|||
129147805|NCT04569084|464837806|FG000|Overall Study|Death|2|||
129147806|NCT04569084|464837807|FG001|Overall Study|Death|3|||
129147807|NCT04569084|464837806|FG000|Overall Study|Lost to Follow-up|1|||
129147808|NCT04569084|464837807|FG001|Overall Study|Lost to Follow-up|1|||
129147809|NCT04569084|464837806|FG000|Overall Study|Physician Decision|3|||
129147810|NCT04569084|464837807|FG001|Overall Study|Physician Decision|3|||
129147811|NCT04569084|464837806|FG000|Overall Study|Protocol Violation|2|||
129147812|NCT04569084|464837807|FG001|Overall Study|Protocol Violation|1|||
129147813|NCT04569084|464837806|FG000|Overall Study|Withdrawal by Subject|20|||
129147814|NCT04569084|464837807|FG001|Overall Study|Withdrawal by Subject|21|||
128724962|NCT02641379|463290949|FG004|Overall Study|Withdrawal of informed consent|0|||
128724963|NCT02641379|463290950|FG005|Overall Study|Withdrawal of informed consent|0|||
128724964|NCT02641379|463290951|FG006|Overall Study|Withdrawal of informed consent|0|||
129147815|NCT04569084|464837806|FG000|Overall Study|Study terminated by sponsor|26|||
129147816|NCT04569084|464837807|FG001|Overall Study|Study terminated by sponsor|23|||
129147817|NCT04569084|464837806|FG000|Overall Study|Other|3|||
129147818|NCT04569084|464837807|FG001|Overall Study|Other|5|||
129147819|NCT04795531|464839340|FG000|Overall Study|Withdrawal by Subject|4|||
129147820|NCT04795531|464839341|FG001|Overall Study|Withdrawal by Subject|4|||
129147821|NCT04795531|464839340|FG000|Overall Study|Lost to Follow-up|0|||
129147822|NCT04795531|464839341|FG001|Overall Study|Lost to Follow-up|1|||
129147823|NCT04795531|464839340|FG000|Overall Study|Physician Decision|0|||
129147824|NCT04795531|464839341|FG001|Overall Study|Physician Decision|2|||
129147825|NCT04795531|464839340|FG000|Overall Study|Death|2|||
129147826|NCT04795531|464839341|FG001|Overall Study|Death|1|||
129147827|NCT04043286|464839342|FG000|Overall Study|Withdrawal by Subject|2|||
129147828|NCT04043286|464839343|FG001|Overall Study|Withdrawal by Subject|2|||
129147829|NCT02296476|464839344|FG000|Overall Study|Disease Progression|6|||
129147830|NCT02296476|464839345|FG001|Overall Study|Disease Progression|4|||
129147831|NCT02296476|464839346|FG002|Overall Study|Disease Progression|2|||
129147832|NCT00442702|464839347|FG000|Titration Period|Adverse Event|2|||
129147833|NCT00442702|464839348|FG001|Titration Period|Adverse Event|0|||
129147834|NCT00442702|464839347|FG000|Titration Period|Death|3|||
129147835|NCT00442702|464839348|FG001|Titration Period|Death|2|||
129147836|NCT00442702|464839347|FG000|Titration Period|Insufficient Therapeutic Response|1|||
129147837|NCT00442702|464839348|FG001|Titration Period|Insufficient Therapeutic Response|0|||
129147838|NCT00442702|464839347|FG000|Titration Period|Refused Treatment|4|||
129147839|NCT00442702|464839348|FG001|Titration Period|Refused Treatment|1|||
129147840|NCT00442702|464839347|FG000|Titration Period|Failure to return|1|||
129147841|NCT00442702|464839348|FG001|Titration Period|Failure to return|0|||
129147842|NCT00442702|464839347|FG000|Titration Period|Hospitalized in another hospital|1|||
129147843|NCT00442702|464839348|FG001|Titration Period|Hospitalized in another hospital|0|||
129147844|NCT00442702|464839347|FG000|Evaluation Period|Adverse Event|1|||
129147845|NCT00442702|464839348|FG001|Evaluation Period|Adverse Event|0|||
129147846|NCT00442702|464839347|FG000|Evaluation Period|Death|1|||
129147847|NCT00442702|464839348|FG001|Evaluation Period|Death|1|||
129147848|NCT00442702|464839347|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
129147849|NCT00442702|464839348|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
129147850|NCT00442702|464839347|FG000|Evaluation Period|Refused treatment|1|||
129147851|NCT00442702|464839348|FG001|Evaluation Period|Refused treatment|1|||
129147852|NCT00442702|464839347|FG000|Evaluation Period|Renal transplant|0|||
129147853|NCT00442702|464839348|FG001|Evaluation Period|Renal transplant|1|||
129147854|NCT00442702|464839347|FG000|Evaluation Period|Failure to return|1|||
129147855|NCT00442702|464839348|FG001|Evaluation Period|Failure to return|0|||
129147856|NCT00442702|464839347|FG000|Evaluation Period|Site closure|0|||
129147857|NCT00442702|464839348|FG001|Evaluation Period|Site closure|1|||
129147858|NCT03122184|464839355|FG000|Overall Study|Lost to Follow-up|4|||
129147859|NCT03122184|464839356|FG001|Overall Study|Lost to Follow-up|6|||
129147860|NCT03122184|464839355|FG000|Overall Study|Withdrawal by Subject|3|||
129147861|NCT03122184|464839356|FG001|Overall Study|Withdrawal by Subject|0|||
129147862|NCT03122184|464839355|FG000|Overall Study|Terminated due to cognitive problem|1|||
129147863|NCT03122184|464839356|FG001|Overall Study|Terminated due to cognitive problem|0|||
129147864|NCT03674281|464839357|FG000|Overall Study|screen failure|2|||
129147865|NCT03674281|464839358|FG001|Overall Study|screen failure|0|||
129147866|NCT03674281|464839359|FG002|Overall Study|screen failure|0|||
129147867|NCT03674281|464839357|FG000|Overall Study|Withdrawal by Subject|1|||
129147868|NCT03674281|464839358|FG001|Overall Study|Withdrawal by Subject|3|||
129147869|NCT03674281|464839359|FG002|Overall Study|Withdrawal by Subject|3|||
129147870|NCT00710593|464839360|FG000|Overall Study|Incarceration|1|||
129147871|NCT00710593|464839361|FG001|Overall Study|Incarceration|0|||
129147872|NCT00710593|464839360|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
128724965|NCT02641379|463290952|FG007|Overall Study|Withdrawal of informed consent|1|||
128724966|NCT02641379|463290953|FG008|Overall Study|Withdrawal of informed consent|0|||
128724967|NCT02641379|463290954|FG009|Overall Study|Withdrawal of informed consent|0|||
128724968|NCT02641379|463290955|FG010|Overall Study|Withdrawal of informed consent|0|||
129147873|NCT00710593|464839361|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
129147874|NCT00710593|464839360|FG000|Overall Study|Lost to Follow-up|3|||
129147875|NCT00710593|464839361|FG001|Overall Study|Lost to Follow-up|1|||
129147876|NCT00710593|464839360|FG000|Overall Study|Moved out of area|1|||
129147877|NCT00710593|464839361|FG001|Overall Study|Moved out of area|0|||
129147878|NCT00710593|464839360|FG000|Overall Study|Failure to adhere or complete study eval|1|||
129147879|NCT00710593|464839361|FG001|Overall Study|Failure to adhere or complete study eval|1|||
128724969|NCT02641379|463290945|FG000|Overall Study|Adverse Event|7|||
128724970|NCT02641379|463290946|FG001|Overall Study|Adverse Event|8|||
129147880|NCT00710593|464839360|FG000|Overall Study|Protocol Violation|1|||
129147881|NCT00710593|464839361|FG001|Overall Study|Protocol Violation|1|||
129147882|NCT00710593|464839360|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
129147883|NCT00710593|464839361|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
129147884|NCT03186638|464839364|FG000|Overall Study|Withdrawal by Subject|4|||
129147885|NCT03186638|464839365|FG001|Overall Study|Withdrawal by Subject|4|||
129147886|NCT03186638|464839364|FG000|Overall Study|Withdrawn due to medical problem|3|||
129147887|NCT03186638|464839365|FG001|Overall Study|Withdrawn due to medical problem|2|||
129147888|NCT03186638|464839364|FG000|Overall Study|Lost to Follow-up|1|||
129147889|NCT03186638|464839365|FG001|Overall Study|Lost to Follow-up|0|||
129147890|NCT01263119|464839368|FG000|Period 1|Protocol Violation|2|||
129147891|NCT01263119|464839368|FG000|Period 2|Adverse Event|2|||
129147892|NCT03580044|464839369|FG000|Overall Study|Death|2|||
129147893|NCT03580044|464839370|FG001|Overall Study|Death|1|||
129147894|NCT03580044|464839369|FG000|Overall Study|Withdrawal by Subject|1|||
129147895|NCT03580044|464839370|FG001|Overall Study|Withdrawal by Subject|1|||
129147896|NCT04047446|464839373|FG000|Overall Study|Physician Decision|1|||
129147897|NCT04047446|464839374|FG001|Overall Study|Physician Decision|0|||
129147898|NCT02367456|464839375|FG000|Overall Study|Death|8|||
129147899|NCT02367456|464839376|FG001|Overall Study|Death|24|||
129147900|NCT02367456|464839377|FG002|Overall Study|Death|17|||
129147901|NCT02367456|464839375|FG000|Overall Study|Lost to Follow-up|1|||
129147902|NCT02367456|464839376|FG001|Overall Study|Lost to Follow-up|3|||
129147903|NCT02367456|464839377|FG002|Overall Study|Lost to Follow-up|1|||
129147904|NCT02367456|464839375|FG000|Overall Study|Other reason|3|||
129147905|NCT02367456|464839376|FG001|Overall Study|Other reason|3|||
129147906|NCT02367456|464839377|FG002|Overall Study|Other reason|9|||
129147907|NCT02367456|464839375|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
129147908|NCT02367456|464839376|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
129147909|NCT02367456|464839377|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
129147910|NCT04573972|464839381|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
129147911|NCT04573972|464839382|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
129147912|NCT01517984|464839383|FG000|Overall Study|Lost to Follow-up|0|||
129147913|NCT01517984|464839384|FG001|Overall Study|Lost to Follow-up|1|||
129147914|NCT01517984|464839385|FG002|Overall Study|Lost to Follow-up|0|||
129147915|NCT01517984|464839386|FG003|Overall Study|Lost to Follow-up|0|||
129147916|NCT01517984|464839383|FG000|Overall Study|Withdrawal by Subject|1|||
129147917|NCT01517984|464839384|FG001|Overall Study|Withdrawal by Subject|8|||
129147918|NCT01517984|464839385|FG002|Overall Study|Withdrawal by Subject|4|||
129147919|NCT01517984|464839386|FG003|Overall Study|Withdrawal by Subject|1|||
129147920|NCT01517984|464839383|FG000|Overall Study|Screen Failure|4|||
129147921|NCT01517984|464839384|FG001|Overall Study|Screen Failure|0|||
129147922|NCT01517984|464839385|FG002|Overall Study|Screen Failure|0|||
129147923|NCT01517984|464839386|FG003|Overall Study|Screen Failure|0|||
129147924|NCT01517984|464839383|FG000|Overall Study|Ineligible for randomization|0|||
129147925|NCT01517984|464839384|FG001|Overall Study|Ineligible for randomization|14|||
129147926|NCT01517984|464839385|FG002|Overall Study|Ineligible for randomization|0|||
129147927|NCT01517984|464839386|FG003|Overall Study|Ineligible for randomization|0|||
129147928|NCT00335829|464839387|FG000|Overall Study|Withdrawal by Subject|1|||
129147929|NCT00335829|464839387|FG000|Overall Study|Lost to Follow-up|1|||
129147930|NCT00335829|464839387|FG000|Overall Study|Adverse Event|1|||
129147931|NCT04067011|464839391|FG000|Overall Study|Not Treated|8|||
129147932|NCT04067011|464839392|FG001|Overall Study|Not Treated|7|||
129147933|NCT04067011|464839393|FG002|Overall Study|Not Treated|5|||
129147934|NCT04067011|464839391|FG000|Overall Study|Adverse Event|2|||
129147935|NCT04067011|464839392|FG001|Overall Study|Adverse Event|1|||
129147936|NCT04067011|464839393|FG002|Overall Study|Adverse Event|0|||
129147937|NCT04067011|464839391|FG000|Overall Study|Withdrawal by Subject|6|||
129147938|NCT04067011|464839392|FG001|Overall Study|Withdrawal by Subject|2|||
129147939|NCT04067011|464839393|FG002|Overall Study|Withdrawal by Subject|1|||
129147940|NCT04067011|464839391|FG000|Overall Study|Lost to Follow-up|0|||
129147941|NCT04067011|464839392|FG001|Overall Study|Lost to Follow-up|0|||
129147942|NCT04067011|464839393|FG002|Overall Study|Lost to Follow-up|1|||
129147943|NCT04067011|464839391|FG000|Overall Study|Physician Decision|1|||
129147944|NCT04067011|464839392|FG001|Overall Study|Physician Decision|1|||
129147945|NCT04067011|464839393|FG002|Overall Study|Physician Decision|0|||
129147946|NCT04067011|464839391|FG000|Overall Study|Other Reasons|2|||
129147947|NCT04067011|464839392|FG001|Overall Study|Other Reasons|0|||
129147948|NCT04067011|464839393|FG002|Overall Study|Other Reasons|1|||
129147949|NCT04067011|464839391|FG000|Overall Study|Missing|0|||
129147950|NCT04067011|464839392|FG001|Overall Study|Missing|2|||
129147951|NCT04067011|464839393|FG002|Overall Study|Missing|0|||
129147952|NCT03746015|464839394|FG000|Overall Study|Withdrawal of Consent|1|||
129147953|NCT03746015|464839395|FG001|Overall Study|Withdrawal of Consent|0|||
129147954|NCT03746015|464839396|FG002|Overall Study|Withdrawal of Consent|0|||
129147955|NCT05209386|464839397|FG000|Overall Study|Withdrawal by Subject|8|||
129147956|NCT05209386|464839397|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
129147957|NCT05134649|464839398|FG000|Overall Study|Lost to Follow-up|12|||
129147958|NCT05134649|464839398|FG000|Overall Study|Withdrawal by Subject|14|||
129147959|NCT05134649|464839398|FG000|Overall Study|Pregnancy|1|||
129147960|NCT05134649|464839398|FG000|Overall Study|Other, not specified|3|||
129147961|NCT01038323|464839401|FG000|Overall Study|Withdrawal by Subject|3|||
129147962|NCT01038323|464839402|FG001|Overall Study|Withdrawal by Subject|2|||
129147963|NCT01038323|464839403|FG002|Overall Study|Withdrawal by Subject|4|||
129147964|NCT05552859|464839405|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
129147965|NCT05552859|464839406|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
129147966|NCT05901636|464839407|FG000|Overall Study|Lost to Follow-up|0|||
129147967|NCT05901636|464839408|FG001|Overall Study|Lost to Follow-up|1|||
129147968|NCT05901636|464839409|FG002|Overall Study|Lost to Follow-up|0|||
129147969|NCT05901636|464839410|FG003|Overall Study|Lost to Follow-up|1|||
129147970|NCT05901636|464839411|FG004|Overall Study|Lost to Follow-up|1|||
129147971|NCT05901636|464839412|FG005|Overall Study|Lost to Follow-up|3|||
129147972|NCT05901636|464839413|FG006|Overall Study|Lost to Follow-up|1|||
129147973|NCT05901636|464839407|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
129147974|NCT05901636|464839408|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
129147975|NCT05901636|464839409|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
129147976|NCT05901636|464839410|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
129147977|NCT05901636|464839411|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
129147978|NCT05901636|464839412|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
129147979|NCT05901636|464839413|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
129147980|NCT05901636|464839407|FG000|Overall Study|Withdrawal by Subject|1|||
129147981|NCT05901636|464839408|FG001|Overall Study|Withdrawal by Subject|1|||
129147982|NCT05901636|464839409|FG002|Overall Study|Withdrawal by Subject|0|||
129147983|NCT05901636|464839410|FG003|Overall Study|Withdrawal by Subject|0|||
129147984|NCT05901636|464839411|FG004|Overall Study|Withdrawal by Subject|1|||
129147985|NCT05901636|464839412|FG005|Overall Study|Withdrawal by Subject|1|||
129147986|NCT05901636|464839413|FG006|Overall Study|Withdrawal by Subject|0|||
129147987|NCT05901636|464839407|FG000|Overall Study|Other|0|||
129147988|NCT05901636|464839408|FG001|Overall Study|Other|0|||
129147989|NCT05901636|464839409|FG002|Overall Study|Other|1|||
129147990|NCT05901636|464839410|FG003|Overall Study|Other|1|||
129147991|NCT05901636|464839411|FG004|Overall Study|Other|0|||
129147992|NCT05901636|464839412|FG005|Overall Study|Other|0|||
129147993|NCT05901636|464839413|FG006|Overall Study|Other|0|||
129147994|NCT00432965|464839414|FG000|Overall Study|Lost to Follow-up|22|||
129147995|NCT00432965|464839415|FG001|Overall Study|Lost to Follow-up|19|||
129147996|NCT00432965|464839414|FG000|Overall Study|Withdrawal by Subject|13|||
129147997|NCT00432965|464839415|FG001|Overall Study|Withdrawal by Subject|13|||
129147998|NCT00432965|464839414|FG000|Overall Study|Physician Decision|14|||
129147999|NCT00432965|464839415|FG001|Overall Study|Physician Decision|13|||
129148000|NCT00432965|464839414|FG000|Overall Study|Lack of Efficacy|8|||
129148001|NCT00432965|464839415|FG001|Overall Study|Lack of Efficacy|13|||
129148002|NCT00432965|464839414|FG000|Overall Study|Non-compliance|7|||
129148003|NCT00432965|464839415|FG001|Overall Study|Non-compliance|0|||
129148004|NCT00432965|464839414|FG000|Overall Study|Adverse Event|22|||
129148005|NCT00432965|464839415|FG001|Overall Study|Adverse Event|19|||
129148006|NCT00432965|464839414|FG000|Overall Study|Death|3|||
129148007|NCT00432965|464839415|FG001|Overall Study|Death|4|||
129148008|NCT00432965|464839414|FG000|Overall Study|Exclusionary Methods|1|||
129148009|NCT00432965|464839415|FG001|Overall Study|Exclusionary Methods|2|||
129148010|NCT00432965|464839414|FG000|Overall Study|Incomplete Data|4|||
129148011|NCT00432965|464839415|FG001|Overall Study|Incomplete Data|3|||
129148012|NCT03330847|464839423|FG000|Overall Study|Patients ongoing study|62|||
129148013|NCT03330847|464839424|FG001|Overall Study|Patients ongoing study|65|||
129148014|NCT03330847|464839425|FG002|Overall Study|Patients ongoing study|15|||
129148015|NCT01355627|464839426|FG000|Overall Study|Request By the Patient to Discontinue|5|||
129148016|NCT01355627|464839427|FG001|Overall Study|Request By the Patient to Discontinue|7|||
129148017|NCT01355627|464839426|FG000|Overall Study|Lost to Follow-up|8|||
129148018|NCT01355627|464839427|FG001|Overall Study|Lost to Follow-up|7|||
129148019|NCT01355627|464839426|FG000|Overall Study|Fatal Adverse Event|19|||
129148020|NCT01355627|464839427|FG001|Overall Study|Fatal Adverse Event|23|||
129148021|NCT01355627|464839426|FG000|Overall Study|Other|1|||
129148022|NCT01355627|464839427|FG001|Overall Study|Other|1|||
129148023|NCT02293551|464839430|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
129148024|NCT02293551|464839431|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
129148025|NCT02293551|464839432|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
129148026|NCT02293551|464839433|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
129148027|NCT02293551|464839434|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
129148028|NCT02293551|464839435|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
129148029|NCT02293551|464839430|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
129148030|NCT02293551|464839431|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
129148031|NCT02293551|464839432|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
129148032|NCT02293551|464839433|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
129148033|NCT02293551|464839434|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
129148034|NCT02293551|464839435|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
129148035|NCT02293551|464839430|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
129148036|NCT02293551|464839431|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
129148037|NCT02293551|464839432|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
129148038|NCT02293551|464839433|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
128724971|NCT02641379|463290947|FG002|Overall Study|Adverse Event|2|||
129148039|NCT02293551|464839434|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
129148040|NCT02293551|464839435|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
129148041|NCT04532749|464839436|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
129148042|NCT04532749|464839437|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
129148043|NCT04532749|464839436|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
129148044|NCT04532749|464839437|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
129148045|NCT04532749|464839436|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
129148046|NCT04532749|464839437|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
129148047|NCT04532749|464839436|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
129148048|NCT04532749|464839437|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
129148049|NCT04532749|464839436|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
129148050|NCT04532749|464839437|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
129148051|NCT04532749|464839436|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
129148052|NCT04532749|464839437|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
129148053|NCT04532749|464839436|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
129148054|NCT04532749|464839437|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
129148055|NCT04532749|464839436|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
129148056|NCT04532749|464839437|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
129148057|NCT04532749|464839436|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
129148058|NCT04532749|464839437|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
129148059|NCT04532749|464839436|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
129148060|NCT04532749|464839437|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
129148061|NCT02769481|464839438|FG000|Overall Study|Protocol Violation|1|||
129148062|NCT02769481|464839439|FG001|Overall Study|Protocol Violation|0|||
129148063|NCT02769481|464839438|FG000|Overall Study|Adverse Event|3|||
129148064|NCT02769481|464839439|FG001|Overall Study|Adverse Event|6|||
129148065|NCT02769481|464839438|FG000|Overall Study|Entry Criteria Not Met|1|||
129148066|NCT02769481|464839439|FG001|Overall Study|Entry Criteria Not Met|2|||
129148067|NCT02769481|464839438|FG000|Overall Study|Withdrawal by Subject|14|||
129148068|NCT02769481|464839439|FG001|Overall Study|Withdrawal by Subject|16|||
129148069|NCT02769481|464839438|FG000|Overall Study|Lost to Follow-up|9|||
129148070|NCT02769481|464839439|FG001|Overall Study|Lost to Follow-up|9|||
129148071|NCT02769481|464839438|FG000|Overall Study|Physician Decision|0|||
129148072|NCT02769481|464839439|FG001|Overall Study|Physician Decision|1|||
129148073|NCT02769481|464839438|FG000|Overall Study|Terminated by Sponsor|1|||
129148074|NCT02769481|464839439|FG001|Overall Study|Terminated by Sponsor|0|||
129148075|NCT02769481|464839438|FG000|Overall Study|Death|0|||
129148076|NCT02769481|464839439|FG001|Overall Study|Death|1|||
129148077|NCT02769481|464839438|FG000|Overall Study|Undefined|4|||
129148078|NCT02769481|464839439|FG001|Overall Study|Undefined|1|||
129148079|NCT00642759|464839440|FG000|Overall Study|Protocol Violation|1|||
129148080|NCT03510715|464839441|FG000|Overall Study|Adverse Event|1|||
129148081|NCT03510715|464839442|FG001|Overall Study|Adverse Event|0|||
129148082|NCT03612570|464839449|FG000|Overall Study|Lost to Follow-up|1|||
129148083|NCT04756531|464839450|FG000|Overall Study|Adverse Event|0|||
129148084|NCT04756531|464839451|FG001|Overall Study|Adverse Event|0|||
129148085|NCT04756531|464839452|FG002|Overall Study|Adverse Event|0|||
129148086|NCT04756531|464839453|FG003|Overall Study|Adverse Event|0|||
129148087|NCT04756531|464839454|FG004|Overall Study|Adverse Event|1|||
129148088|NCT04756531|464839455|FG005|Overall Study|Adverse Event|0|||
129148089|NCT04756531|464839456|FG006|Overall Study|Adverse Event|0|||
129148090|NCT04756531|464839457|FG007|Overall Study|Adverse Event|0|||
129148091|NCT04756531|464839458|FG008|Overall Study|Adverse Event|0|||
129148092|NCT04756531|464839459|FG009|Overall Study|Adverse Event|0|||
129148093|NCT04756531|464839460|FG010|Overall Study|Adverse Event|0|||
129148094|NCT04756531|464839461|FG011|Overall Study|Adverse Event|0|||
129148095|NCT04756531|464839462|FG012|Overall Study|Adverse Event|0|||
129148096|NCT04756531|464839463|FG013|Overall Study|Adverse Event|0|||
129148097|NCT04756531|464839464|FG014|Overall Study|Adverse Event|0|||
129148098|NCT04756531|464839465|FG015|Overall Study|Adverse Event|0|||
129148099|NCT04756531|464839466|FG016|Overall Study|Adverse Event|0|||
129148100|NCT04756531|464839467|FG017|Overall Study|Adverse Event|0|||
129148101|NCT04756531|464839450|FG000|Overall Study|Withdrawal by Subject|0|||
129148102|NCT04756531|464839451|FG001|Overall Study|Withdrawal by Subject|0|||
129148103|NCT04756531|464839452|FG002|Overall Study|Withdrawal by Subject|0|||
129148104|NCT04756531|464839453|FG003|Overall Study|Withdrawal by Subject|0|||
129148105|NCT04756531|464839454|FG004|Overall Study|Withdrawal by Subject|0|||
129148106|NCT04756531|464839455|FG005|Overall Study|Withdrawal by Subject|0|||
129148107|NCT04756531|464839456|FG006|Overall Study|Withdrawal by Subject|1|||
129148108|NCT04756531|464839457|FG007|Overall Study|Withdrawal by Subject|0|||
129148109|NCT04756531|464839458|FG008|Overall Study|Withdrawal by Subject|0|||
129148110|NCT04756531|464839459|FG009|Overall Study|Withdrawal by Subject|0|||
129148111|NCT04756531|464839460|FG010|Overall Study|Withdrawal by Subject|0|||
129148112|NCT04756531|464839461|FG011|Overall Study|Withdrawal by Subject|0|||
129148113|NCT04756531|464839462|FG012|Overall Study|Withdrawal by Subject|0|||
129148114|NCT04756531|464839463|FG013|Overall Study|Withdrawal by Subject|0|||
129148115|NCT04756531|464839464|FG014|Overall Study|Withdrawal by Subject|0|||
129148116|NCT04756531|464839465|FG015|Overall Study|Withdrawal by Subject|0|||
128724972|NCT02641379|463290948|FG003|Overall Study|Adverse Event|2|||
128724973|NCT02641379|463290949|FG004|Overall Study|Adverse Event|5|||
128724974|NCT02641379|463290950|FG005|Overall Study|Adverse Event|1|||
128724975|NCT02641379|463290951|FG006|Overall Study|Adverse Event|5|||
128724976|NCT02641379|463290952|FG007|Overall Study|Adverse Event|0|||
128724977|NCT02641379|463290953|FG008|Overall Study|Adverse Event|1|||
129148117|NCT04756531|464839466|FG016|Overall Study|Withdrawal by Subject|0|||
129148118|NCT04756531|464839467|FG017|Overall Study|Withdrawal by Subject|0|||
129148119|NCT01346176|464839468|FG000|Recruited|Protocol Violation|1|||
129148120|NCT01346176|464839469|FG001|Recruited|Protocol Violation|0|||
129148121|NCT01346176|464839470|FG002|Recruited|Protocol Violation|0|||
129148122|NCT01346176|464839468|FG000|Completed Advance Directive|Death|3|||
129148123|NCT01346176|464839469|FG001|Completed Advance Directive|Death|2|||
129148124|NCT01346176|464839470|FG002|Completed Advance Directive|Death|2|||
129148125|NCT01346176|464839468|FG000|Completed Advance Directive|Became Ineligible|3|||
129148126|NCT01346176|464839469|FG001|Completed Advance Directive|Became Ineligible|0|||
129148127|NCT01346176|464839470|FG002|Completed Advance Directive|Became Ineligible|1|||
129148128|NCT01346176|464839468|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
129148129|NCT01346176|464839469|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
129148130|NCT01346176|464839470|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
129148131|NCT01346176|464839468|FG000|Completed Satisfaction Survey|Death|3|||
129148132|NCT01346176|464839469|FG001|Completed Satisfaction Survey|Death|0|||
129148133|NCT01346176|464839470|FG002|Completed Satisfaction Survey|Death|2|||
129148134|NCT01346176|464839468|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
129148135|NCT01346176|464839469|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
129148136|NCT01346176|464839470|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
129148137|NCT01994876|464839471|FG000|Test Period 1|Withdrawal by Subject|0|||
129148138|NCT01994876|464839472|FG001|Test Period 1|Withdrawal by Subject|1|||
129148139|NCT01994876|464839471|FG000|Test Period 1|Adverse Event|0|||
129148140|NCT01994876|464839472|FG001|Test Period 1|Adverse Event|1|||
129148141|NCT01994876|464839471|FG000|Test Period 2|Adverse Event|1|||
129148142|NCT01994876|464839472|FG001|Test Period 2|Adverse Event|0|||
129148143|NCT01994876|464839471|FG000|Test Period 2|Protocol Violation|0|||
129148144|NCT01994876|464839472|FG001|Test Period 2|Protocol Violation|1|||
129148145|NCT01400412|464839473|FG000|Overall Study|Lost to Follow-up|4|||
129148146|NCT01400412|464839474|FG001|Overall Study|Lost to Follow-up|7|||
129148147|NCT01400412|464839473|FG000|Overall Study|Withdrawal by Subject|3|||
129148148|NCT01400412|464839474|FG001|Overall Study|Withdrawal by Subject|4|||
129148149|NCT01400412|464839473|FG000|Overall Study|Unable to complete|3|||
129148150|NCT01400412|464839474|FG001|Overall Study|Unable to complete|3|||
129148151|NCT01400412|464839473|FG000|Overall Study|Never started study treatment|0|||
129148152|NCT01400412|464839474|FG001|Overall Study|Never started study treatment|3|||
129148153|NCT01323192|464840417|FG000|Overall Study|Adverse Event|6|||
129148154|NCT01323192|464840418|FG001|Overall Study|Adverse Event|1|||
129148155|NCT01323192|464840417|FG000|Overall Study|Withdrawal by Subject|3|||
129148156|NCT01323192|464840418|FG001|Overall Study|Withdrawal by Subject|1|||
129148157|NCT01323192|464840417|FG000|Overall Study|Noncompliance with study medication|0|||
129148158|NCT01323192|464840418|FG001|Overall Study|Noncompliance with study medication|3|||
129148159|NCT01323192|464840417|FG000|Overall Study|Nonmedical reasons|0|||
129148160|NCT01323192|464840418|FG001|Overall Study|Nonmedical reasons|1|||
129148161|NCT02835690|464840419|FG000|Overall Study|Death|12|||
129148162|NCT02835690|464840420|FG001|Overall Study|Death|11|||
129148163|NCT02835690|464840421|FG002|Overall Study|Death|13|||
129148164|NCT02835690|464840419|FG000|Overall Study|Transferred to Extension Study|2|||
129148165|NCT02835690|464840420|FG001|Overall Study|Transferred to Extension Study|2|||
129148166|NCT02835690|464840421|FG002|Overall Study|Transferred to Extension Study|1|||
129148167|NCT02835690|464840419|FG000|Overall Study|Did Not Continue on Extension Study|0|||
129148168|NCT02835690|464840420|FG001|Overall Study|Did Not Continue on Extension Study|0|||
129148169|NCT02835690|464840421|FG002|Overall Study|Did Not Continue on Extension Study|1|||
129148170|NCT02835690|464840419|FG000|Overall Study|Not Treated|0|||
129148171|NCT02835690|464840420|FG001|Overall Study|Not Treated|2|||
129148172|NCT02835690|464840421|FG002|Overall Study|Not Treated|0|||
129148173|NCT04490278|464840422|FG000|Overall Study|Lost to Follow-up|6|||
128724978|NCT02641379|463290954|FG009|Overall Study|Adverse Event|1|||
129148174|NCT02829996|464840423|FG000|Overall Study|Withdrawal by Subject|1|||
129148175|NCT02829996|464840424|FG001|Overall Study|Withdrawal by Subject|0|||
129148176|NCT02829996|464840425|FG002|Overall Study|Withdrawal by Subject|0|||
129148177|NCT02829996|464840426|FG003|Overall Study|Withdrawal by Subject|0|||
128724979|NCT02641379|463290955|FG010|Overall Study|Adverse Event|5|||
128776599|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
129148178|NCT02829996|464840427|FG004|Overall Study|Withdrawal by Subject|0|||
129148179|NCT01441960|464840428|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
129148180|NCT01441960|464840429|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
129148181|NCT01441960|464840428|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
129148182|NCT01441960|464840429|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
129148183|NCT01441960|464840428|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
129148184|NCT01441960|464840429|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
129148185|NCT02986074|464840430|FG000|First Trial Period|Adverse Event|1|||
129148186|NCT02986074|464840431|FG001|First Trial Period|Adverse Event|0|||
129148187|NCT02986074|464840432|FG002|First Trial Period|Adverse Event|0|||
129148188|NCT02986074|464840433|FG003|First Trial Period|Adverse Event|0|||
129148189|NCT02986074|464840430|FG000|Follow up Period|system explant|0|||
129148190|NCT02986074|464840431|FG001|Follow up Period|system explant|0|||
129148191|NCT02986074|464840432|FG002|Follow up Period|system explant|1|||
129148192|NCT02986074|464840433|FG003|Follow up Period|system explant|2|||
129148193|NCT02986074|464840430|FG000|Follow up Period|Physician Decision|0|||
129148194|NCT02986074|464840431|FG001|Follow up Period|Physician Decision|0|||
129148195|NCT02986074|464840432|FG002|Follow up Period|Physician Decision|0|||
129148196|NCT02986074|464840433|FG003|Follow up Period|Physician Decision|1|||
129148197|NCT00069641|464840438|FG000|Overall Study|Death|1|||
129148198|NCT00069641|464840439|FG001|Overall Study|Death|0|||
129148199|NCT00069641|464840440|FG002|Overall Study|Death|1|||
129148200|NCT01500317|464840441|FG000|Overall Study|Withdrawal by Subject|3|||
129148201|NCT01500317|464840442|FG001|Overall Study|Withdrawal by Subject|2|||
129148202|NCT01500317|464840443|FG002|Overall Study|Withdrawal by Subject|0|||
129148203|NCT02303262|464840445|FG000|Overall Study|Withdrawal by Subject|2|||
129148204|NCT04462471|464840446|FG000|Overall Study|Adverse Event|0|||
129148205|NCT04462471|464840447|FG001|Overall Study|Adverse Event|1|||
129148206|NCT04462471|464840448|FG002|Overall Study|Adverse Event|0|||
129148207|NCT04462471|464840449|FG003|Overall Study|Adverse Event|0|||
129148208|NCT04462471|464840446|FG000|Overall Study|Disease progression|1|||
129148209|NCT04462471|464840447|FG001|Overall Study|Disease progression|0|||
129148210|NCT04462471|464840448|FG002|Overall Study|Disease progression|0|||
129148211|NCT04462471|464840449|FG003|Overall Study|Disease progression|0|||
129148212|NCT04138056|464840454|FG000|Primary Study|Lost to Follow-up|3|||
129148213|NCT04138056|464840455|FG001|Primary Study|Lost to Follow-up|4|||
129148214|NCT04138056|464840456|FG002|Primary Study|Lost to Follow-up|1|||
129148215|NCT04138056|464840457|FG003|Primary Study|Lost to Follow-up|1|||
129148216|NCT04138056|464840458|FG004|Primary Study|Lost to Follow-up|4|||
129148217|NCT04138056|464840454|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
129148218|NCT04138056|464840455|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
129148219|NCT04138056|464840456|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
129148220|NCT04138056|464840457|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
129148221|NCT04138056|464840458|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
129148222|NCT04138056|464840454|FG000|Extension Study|Lost to Follow-up|1|||
129148223|NCT04138056|464840455|FG001|Extension Study|Lost to Follow-up|2|||
129148224|NCT04138056|464840456|FG002|Extension Study|Lost to Follow-up|1|||
129148225|NCT04138056|464840457|FG003|Extension Study|Lost to Follow-up|0|||
129148226|NCT04138056|464840458|FG004|Extension Study|Lost to Follow-up|1|||
129148227|NCT01656161|464840459|FG000|Overall Study|Death|3|||
129148228|NCT01656161|464840459|FG000|Overall Study|Adverse Event|2|||
129148229|NCT01656161|464840459|FG000|Overall Study|Protocol Violation|1|||
129148230|NCT01656161|464840459|FG000|Overall Study|Withdrawal by Subject|1|||
129148231|NCT01215851|464840460|FG000|Treatment Period|Adverse Event|1|||
129148232|NCT01215851|464840461|FG001|Treatment Period|Adverse Event|1|||
129148233|NCT01215851|464840462|FG002|Treatment Period|Adverse Event|1|||
129148234|NCT01215851|464840463|FG003|Treatment Period|Adverse Event|3|||
129148235|NCT01215851|464840464|FG004|Treatment Period|Adverse Event|0|||
129148236|NCT01215851|464840465|FG005|Treatment Period|Adverse Event|1|||
129148237|NCT01215851|464840460|FG000|Follow up Period|Lost to Follow-up|0|||
129148238|NCT01215851|464840461|FG001|Follow up Period|Lost to Follow-up|0|||
129148239|NCT01215851|464840462|FG002|Follow up Period|Lost to Follow-up|0|||
129148240|NCT01215851|464840463|FG003|Follow up Period|Lost to Follow-up|0|||
129148241|NCT01215851|464840464|FG004|Follow up Period|Lost to Follow-up|0|||
129148242|NCT01215851|464840465|FG005|Follow up Period|Lost to Follow-up|1|||
129148243|NCT03510273|464840466|FG000|Overall Study|Withdrawal by Subject|2|||
129148244|NCT03510273|464840466|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
129148245|NCT03510273|464840466|FG000|Overall Study|Moved away from study area|4|||
129148246|NCT01276106|464840469|FG000|Overall Study|Adverse Event|3|||
129148247|NCT01276106|464840470|FG001|Overall Study|Adverse Event|3|||
129148248|NCT01276106|464840471|FG002|Overall Study|Adverse Event|11|||
129148249|NCT01276106|464840472|FG003|Overall Study|Adverse Event|3|||
129148250|NCT01276106|464840469|FG000|Overall Study|Withdrawal by Subject|6|||
129148251|NCT01276106|464840470|FG001|Overall Study|Withdrawal by Subject|3|||
129148252|NCT01276106|464840471|FG002|Overall Study|Withdrawal by Subject|1|||
129148253|NCT01276106|464840472|FG003|Overall Study|Withdrawal by Subject|6|||
129148254|NCT01276106|464840469|FG000|Overall Study|Lack of Efficacy|0|||
129148255|NCT01276106|464840470|FG001|Overall Study|Lack of Efficacy|1|||
129148256|NCT01276106|464840471|FG002|Overall Study|Lack of Efficacy|0|||
129148257|NCT01276106|464840472|FG003|Overall Study|Lack of Efficacy|1|||
129148258|NCT01276106|464840469|FG000|Overall Study|Lost to Follow-up|2|||
129148259|NCT01276106|464840470|FG001|Overall Study|Lost to Follow-up|1|||
129148260|NCT01276106|464840471|FG002|Overall Study|Lost to Follow-up|1|||
129148261|NCT01276106|464840472|FG003|Overall Study|Lost to Follow-up|0|||
129148262|NCT01276106|464840469|FG000|Overall Study|Physician Decision|0|||
129148263|NCT01276106|464840470|FG001|Overall Study|Physician Decision|0|||
129148264|NCT01276106|464840471|FG002|Overall Study|Physician Decision|1|||
129148265|NCT01276106|464840472|FG003|Overall Study|Physician Decision|1|||
129148266|NCT01276106|464840469|FG000|Overall Study|Protocol Violation|1|||
129148267|NCT01276106|464840470|FG001|Overall Study|Protocol Violation|1|||
129148268|NCT01276106|464840471|FG002|Overall Study|Protocol Violation|0|||
129148269|NCT01276106|464840472|FG003|Overall Study|Protocol Violation|2|||
129148270|NCT01276106|464840469|FG000|Overall Study|Insufficient therapeutic effects|0|||
129148271|NCT01276106|464840470|FG001|Overall Study|Insufficient therapeutic effects|0|||
129148272|NCT01276106|464840471|FG002|Overall Study|Insufficient therapeutic effects|2|||
129148273|NCT01276106|464840472|FG003|Overall Study|Insufficient therapeutic effects|0|||
129148274|NCT00862940|464840476|FG000|Overall Study|Adverse Event|15|||
129148275|NCT00862940|464840477|FG001|Overall Study|Adverse Event|12|||
129148276|NCT00862940|464840476|FG000|Overall Study|Lack of Efficacy|1|||
129148277|NCT00862940|464840477|FG001|Overall Study|Lack of Efficacy|3|||
129148278|NCT00862940|464840476|FG000|Overall Study|Protocol Violation|2|||
129148279|NCT00862940|464840477|FG001|Overall Study|Protocol Violation|5|||
129148280|NCT00862940|464840476|FG000|Overall Study|Withdrawal by Subject|4|||
129148281|NCT00862940|464840477|FG001|Overall Study|Withdrawal by Subject|6|||
129148282|NCT00862940|464840476|FG000|Overall Study|Non-compliance|4|||
129148283|NCT00862940|464840477|FG001|Overall Study|Non-compliance|0|||
129148284|NCT00862940|464840476|FG000|Overall Study|Lost to Follow-up|0|||
129148285|NCT00862940|464840477|FG001|Overall Study|Lost to Follow-up|1|||
129148286|NCT00862940|464840476|FG000|Overall Study|Administrative or other reason(s)|4|||
129148287|NCT00862940|464840477|FG001|Overall Study|Administrative or other reason(s)|3|||
129148288|NCT04583618|464840480|FG000|Overall Study|Adverse Event|0|||
129148289|NCT04583618|464840481|FG001|Overall Study|Adverse Event|0|||
129148290|NCT04583618|464840482|FG002|Overall Study|Adverse Event|1|||
129148291|NCT04583618|464840483|FG003|Overall Study|Adverse Event|0|||
129148292|NCT04583618|464840484|FG004|Overall Study|Adverse Event|0|||
129148293|NCT04583618|464840480|FG000|Overall Study|Protocol deviation|1|||
129148294|NCT04583618|464840481|FG001|Overall Study|Protocol deviation|1|||
129148295|NCT04583618|464840482|FG002|Overall Study|Protocol deviation|1|||
129148296|NCT04583618|464840483|FG003|Overall Study|Protocol deviation|0|||
129148297|NCT04583618|464840484|FG004|Overall Study|Protocol deviation|0|||
129148298|NCT04583618|464840480|FG000|Overall Study|Withdrawal by Subject|2|||
129148299|NCT04583618|464840481|FG001|Overall Study|Withdrawal by Subject|1|||
129148300|NCT04583618|464840482|FG002|Overall Study|Withdrawal by Subject|3|||
129148301|NCT04583618|464840483|FG003|Overall Study|Withdrawal by Subject|1|||
129148302|NCT04583618|464840484|FG004|Overall Study|Withdrawal by Subject|1|||
129148303|NCT04583618|464840480|FG000|Overall Study|Lost to Follow-up|0|||
129148304|NCT04583618|464840481|FG001|Overall Study|Lost to Follow-up|1|||
129148305|NCT04583618|464840482|FG002|Overall Study|Lost to Follow-up|3|||
129148306|NCT04583618|464840483|FG003|Overall Study|Lost to Follow-up|1|||
128724980|NCT02641379|463290945|FG000|Overall Study|Lack of Efficacy|0|||
128724981|NCT02641379|463290946|FG001|Overall Study|Lack of Efficacy|0|||
128724982|NCT02641379|463290947|FG002|Overall Study|Lack of Efficacy|2|||
128724983|NCT02641379|463290948|FG003|Overall Study|Lack of Efficacy|0|||
128724984|NCT02641379|463290949|FG004|Overall Study|Lack of Efficacy|0|||
128724985|NCT02641379|463290950|FG005|Overall Study|Lack of Efficacy|2|||
129148307|NCT04583618|464840484|FG004|Overall Study|Lost to Follow-up|1|||
129148308|NCT02711202|464840485|FG000|Overall Study|Adverse Event|3|||
129148309|NCT02711202|464840486|FG001|Overall Study|Adverse Event|0|||
129148310|NCT02711202|464840485|FG000|Overall Study|graft loss|1|||
129148311|NCT02711202|464840486|FG001|Overall Study|graft loss|0|||
129148312|NCT05643495|464840493|FG000|Overall Study|Adverse Event|0|||
129148313|NCT05643495|464840494|FG001|Overall Study|Adverse Event|1|||
129148314|NCT05643495|464840493|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129148315|NCT05643495|464840494|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
129148316|NCT02257528|464840495|FG000|Overall Study|Never received study treatment|1|||
129148317|NCT06272383|464840496|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
129148318|NCT06272383|464840497|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
129148319|NCT02661672|464840503|FG000|Overall Study|Lost to Follow-up|1|||
129148320|NCT02661672|464840503|FG000|Overall Study|Death|4|||
129148321|NCT02581930|464840504|FG000|Overall Study|Withdrawal by Subject|1|||
129148322|NCT02581930|464840504|FG000|Overall Study|patient declined further treatment|1|||
129148323|NCT04696146|464842657|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
129148324|NCT04696146|464842658|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
129148325|NCT04696146|464842657|FG000|Overall Study|Off hours issue with product|1|||
129148326|NCT04696146|464842658|FG001|Overall Study|Off hours issue with product|0|||
129148327|NCT00529633|464842663|FG000|Overall Study|Withdrawal by Subject|1|||
129148328|NCT00529633|464842664|FG001|Overall Study|Withdrawal by Subject|1|||
129148329|NCT01576783|464842668|FG000|Overall Study|Change in Medical Care|1|||
129148330|NCT01576783|464842669|FG001|Overall Study|Change in Medical Care|0|||
129148331|NCT01576783|464842668|FG000|Overall Study|Lost to Follow-up|14|||
129148332|NCT01576783|464842669|FG001|Overall Study|Lost to Follow-up|16|||
129148333|NCT01576783|464842668|FG000|Overall Study|Withdrawal by Subject|5|||
129148334|NCT01576783|464842669|FG001|Overall Study|Withdrawal by Subject|1|||
129148335|NCT01083602|464842670|FG000|Overall Study|Adverse Event|11|||
129148336|NCT01083602|464842670|FG000|Overall Study|New Cancer Therapy|2|||
129148337|NCT01083602|464842670|FG000|Overall Study|Death|1|||
129148338|NCT01083602|464842670|FG000|Overall Study|Withdrawal by Subject|5|||
129148339|NCT01083602|464842670|FG000|Overall Study|Lack of Efficacy|36|||
129148340|NCT03698279|464842673|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129148341|NCT03698279|464842674|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129148342|NCT03698279|464842675|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129148343|NCT03698279|464842676|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129148344|NCT03698279|464842677|FG004|Overall Study|Withdrawal by parent/guardian|0|||
128724986|NCT02641379|463290951|FG006|Overall Study|Lack of Efficacy|0|||
128724987|NCT02641379|463290952|FG007|Overall Study|Lack of Efficacy|5|||
128724988|NCT02641379|463290953|FG008|Overall Study|Lack of Efficacy|0|||
129148345|NCT03698279|464842678|FG005|Overall Study|Withdrawal by parent/guardian|0|||
129148346|NCT03698279|464842673|FG000|Overall Study|Protocol deviation|1|||
129148347|NCT03698279|464842674|FG001|Overall Study|Protocol deviation|0|||
129148348|NCT03698279|464842675|FG002|Overall Study|Protocol deviation|1|||
129148349|NCT03698279|464842676|FG003|Overall Study|Protocol deviation|0|||
129148350|NCT03698279|464842677|FG004|Overall Study|Protocol deviation|0|||
129148351|NCT03698279|464842678|FG005|Overall Study|Protocol deviation|0|||
129148352|NCT03698279|464842673|FG000|Overall Study|Withdrawal by Subject|0|||
129148353|NCT03698279|464842674|FG001|Overall Study|Withdrawal by Subject|0|||
129148354|NCT03698279|464842675|FG002|Overall Study|Withdrawal by Subject|1|||
129148355|NCT03698279|464842676|FG003|Overall Study|Withdrawal by Subject|0|||
129148356|NCT03698279|464842677|FG004|Overall Study|Withdrawal by Subject|0|||
129148357|NCT03698279|464842678|FG005|Overall Study|Withdrawal by Subject|0|||
129148358|NCT03698279|464842673|FG000|Overall Study|Lost to Follow-up|3|||
129148359|NCT03698279|464842674|FG001|Overall Study|Lost to Follow-up|1|||
129148360|NCT03698279|464842675|FG002|Overall Study|Lost to Follow-up|4|||
129148361|NCT03698279|464842676|FG003|Overall Study|Lost to Follow-up|5|||
129148362|NCT03698279|464842677|FG004|Overall Study|Lost to Follow-up|0|||
129148363|NCT03698279|464842678|FG005|Overall Study|Lost to Follow-up|0|||
129148364|NCT01276704|464842681|FG000|Overall Study|Lost to Follow-up|2|||
129148365|NCT01276704|464842682|FG001|Overall Study|Lost to Follow-up|3|||
129148366|NCT01276704|464842681|FG000|Overall Study|Non-compliant|2|||
129148367|NCT01276704|464842682|FG001|Overall Study|Non-compliant|2|||
129148368|NCT01276704|464842681|FG000|Overall Study|Withdrawal by Subject|7|||
129148369|NCT01276704|464842682|FG001|Overall Study|Withdrawal by Subject|1|||
129148370|NCT01276704|464842681|FG000|Overall Study|Physician Decision|3|||
129148371|NCT01276704|464842682|FG001|Overall Study|Physician Decision|5|||
129148372|NCT02276040|464842683|FG000|Overall Study|Physician Decision|15|||
129148373|NCT03801525|464842684|FG000|Overall Study|Adverse Event|17|||
129148374|NCT03801525|464842685|FG001|Overall Study|Adverse Event|1|||
129148375|NCT03801525|464842686|FG002|Overall Study|Adverse Event|0|||
129148376|NCT03801525|464842684|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
129148377|NCT03801525|464842685|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
129148378|NCT03801525|464842686|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
129148379|NCT03801525|464842684|FG000|Overall Study|Death|29|||
129148380|NCT03801525|464842685|FG001|Overall Study|Death|1|||
129148381|NCT03801525|464842686|FG002|Overall Study|Death|4|||
129148382|NCT03801525|464842684|FG000|Overall Study|Disease Progression|6|||
129148383|NCT03801525|464842685|FG001|Overall Study|Disease Progression|0|||
129148384|NCT03801525|464842686|FG002|Overall Study|Disease Progression|1|||
129148385|NCT03801525|464842684|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
129148386|NCT03801525|464842685|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
129148387|NCT03801525|464842686|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
129148388|NCT03801525|464842684|FG000|Overall Study|Investigator Decision|18|||
129148389|NCT03801525|464842685|FG001|Overall Study|Investigator Decision|1|||
129148390|NCT03801525|464842686|FG002|Overall Study|Investigator Decision|0|||
129148391|NCT03801525|464842684|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
129148392|NCT03801525|464842685|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
129148393|NCT03801525|464842686|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
129148394|NCT03801525|464842684|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
129148395|NCT03801525|464842685|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
129148396|NCT03801525|464842686|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
129148397|NCT03801525|464842684|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
129148398|NCT03801525|464842685|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
129148399|NCT03801525|464842686|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
129148400|NCT03801525|464842684|FG000|Overall Study|Withdrawal of Subject Consent|38|||
129148401|NCT03801525|464842685|FG001|Overall Study|Withdrawal of Subject Consent|2|||
129148402|NCT03801525|464842686|FG002|Overall Study|Withdrawal of Subject Consent|1|||
129148403|NCT03801525|464842684|FG000|Overall Study|Reason not Specified|4|||
129148404|NCT03801525|464842685|FG001|Overall Study|Reason not Specified|0|||
129148405|NCT03801525|464842686|FG002|Overall Study|Reason not Specified|4|||
129148406|NCT04388826|464842688|FG000|Overall Study|Lost to Follow-up|3|||
129148407|NCT04388826|464842689|FG001|Overall Study|Lost to Follow-up|2|||
129148408|NCT04388826|464842688|FG000|Overall Study|Adverse Event|1|||
129148409|NCT04388826|464842689|FG001|Overall Study|Adverse Event|0|||
129148410|NCT00329420|464842690|FG000|Re-induction Phase|Lack of Efficacy|0|||
129148411|NCT00329420|464842691|FG001|Re-induction Phase|Lack of Efficacy|1|||
129148412|NCT00329420|464842692|FG002|Re-induction Phase|Lack of Efficacy|0|||
129148413|NCT00329420|464842690|FG000|Re-induction Phase|Withdrawal of Consent|0|||
129148414|NCT00329420|464842691|FG001|Re-induction Phase|Withdrawal of Consent|0|||
129148415|NCT00329420|464842692|FG002|Re-induction Phase|Withdrawal of Consent|1|||
129148416|NCT00329420|464842690|FG000|Re-induction Phase|Did not respond to re-induction|6|||
129148417|NCT00329420|464842691|FG001|Re-induction Phase|Did not respond to re-induction|5|||
129148418|NCT00329420|464842692|FG002|Re-induction Phase|Did not respond to re-induction|7|||
129148419|NCT00329420|464842690|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
128724989|NCT02641379|463290954|FG009|Overall Study|Lack of Efficacy|0|||
128724990|NCT02641379|463290955|FG010|Overall Study|Lack of Efficacy|0|||
129148420|NCT00329420|464842691|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
129148421|NCT00329420|464842692|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
129148422|NCT00329420|464842690|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
129148423|NCT00329420|464842691|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
129148424|NCT00329420|464842692|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
129148425|NCT00329420|464842690|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
129148426|NCT00329420|464842691|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
129148427|NCT00329420|464842692|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
129148428|NCT02862574|464842693|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129148429|NCT02862574|464842694|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129148430|NCT02862574|464842695|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129148431|NCT02862574|464842693|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
129148432|NCT02862574|464842694|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
129148433|NCT02862574|464842695|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
129148434|NCT02862574|464842693|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
129148435|NCT02862574|464842694|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
129148436|NCT02862574|464842695|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
129148437|NCT03386773|464842696|FG000|Overall Study|Lost to Follow-up|24|||
129148438|NCT03386773|464842697|FG001|Overall Study|Lost to Follow-up|33|||
129148439|NCT03386773|464842696|FG000|Overall Study|Withdrawal by Subject|3|||
129148440|NCT03386773|464842697|FG001|Overall Study|Withdrawal by Subject|2|||
129148441|NCT03639610|464842698|FG000|Overall Study|Adverse Event|7|||
129148442|NCT03639610|464842699|FG001|Overall Study|Adverse Event|1|||
129148443|NCT03639610|464842700|FG002|Overall Study|Adverse Event|0|||
129148444|NCT03639610|464842698|FG000|Overall Study|Physician Decision|3|||
129148445|NCT03639610|464842699|FG001|Overall Study|Physician Decision|1|||
129148446|NCT03639610|464842700|FG002|Overall Study|Physician Decision|0|||
129148447|NCT03639610|464842698|FG000|Overall Study|Disease progression|8|||
129148448|NCT03639610|464842699|FG001|Overall Study|Disease progression|5|||
129148449|NCT03639610|464842700|FG002|Overall Study|Disease progression|3|||
129148450|NCT03639610|464842698|FG000|Overall Study|Study terminated by sponsor|2|||
129148451|NCT03639610|464842699|FG001|Overall Study|Study terminated by sponsor|1|||
129148452|NCT03639610|464842700|FG002|Overall Study|Study terminated by sponsor|1|||
129148453|NCT03639610|464842698|FG000|Overall Study|Patient request to stop treatment|1|||
129148454|NCT03639610|464842699|FG001|Overall Study|Patient request to stop treatment|2|||
129148455|NCT03639610|464842700|FG002|Overall Study|Patient request to stop treatment|0|||
129148456|NCT02410772|464842703|FG000|Overall Study|Death|3|||
129148457|NCT02410772|464842704|FG001|Overall Study|Death|4|||
129148458|NCT02410772|464842705|FG002|Overall Study|Death|8|||
129148459|NCT02410772|464842703|FG000|Overall Study|Lost to Follow-up|31|||
129148460|NCT02410772|464842704|FG001|Overall Study|Lost to Follow-up|23|||
129148461|NCT02410772|464842705|FG002|Overall Study|Lost to Follow-up|22|||
129148462|NCT02410772|464842703|FG000|Overall Study|Pregnancy|8|||
129148463|NCT02410772|464842704|FG001|Overall Study|Pregnancy|4|||
129148464|NCT02410772|464842705|FG002|Overall Study|Pregnancy|5|||
129148465|NCT02410772|464842703|FG000|Overall Study|Protocol Violation|8|||
129148466|NCT02410772|464842704|FG001|Overall Study|Protocol Violation|8|||
129148467|NCT02410772|464842705|FG002|Overall Study|Protocol Violation|4|||
129148468|NCT02410772|464842703|FG000|Overall Study|Baseline Drug Resistance|49|||
129148469|NCT02410772|464842704|FG001|Overall Study|Baseline Drug Resistance|40|||
129148470|NCT02410772|464842705|FG002|Overall Study|Baseline Drug Resistance|51|||
129148471|NCT02410772|464842703|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
129148472|NCT02410772|464842704|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
129148473|NCT02410772|464842705|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
129148474|NCT02410772|464842703|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
129148475|NCT02410772|464842704|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
129148476|NCT02410772|464842705|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
129148477|NCT05067335|464842706|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
129148478|NCT05067335|464842707|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
129148479|NCT05067335|464842708|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
129148480|NCT05067335|464842709|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
129148481|NCT05067335|464842706|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
129148482|NCT05067335|464842707|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
129148483|NCT05067335|464842708|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
129148484|NCT05067335|464842709|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
129148485|NCT05067335|464842706|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
129148486|NCT05067335|464842707|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
129148487|NCT05067335|464842708|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
129148488|NCT05067335|464842709|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
129148489|NCT05067335|464842706|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
129148490|NCT05067335|464842707|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
129148491|NCT05067335|464842708|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
129148492|NCT05067335|464842709|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
129148493|NCT05067335|464842706|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
129148494|NCT05067335|464842707|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
129148495|NCT05067335|464842708|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
129148496|NCT05067335|464842709|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
129148497|NCT05067335|464842706|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
129148498|NCT05067335|464842707|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
129148499|NCT05067335|464842708|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
129148500|NCT05067335|464842709|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
129148501|NCT05067335|464842706|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
129148502|NCT05067335|464842707|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
129148503|NCT05067335|464842708|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
129148504|NCT05067335|464842709|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
129148505|NCT05067335|464842706|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
129148506|NCT05067335|464842707|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
129148507|NCT05067335|464842708|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
129148508|NCT05067335|464842709|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
129148509|NCT05067335|464842706|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
129148510|NCT05067335|464842707|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
129148511|NCT05067335|464842708|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
129148512|NCT05067335|464842709|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
129148513|NCT05067335|464842706|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
129148514|NCT05067335|464842707|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
129148515|NCT05067335|464842708|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
129148516|NCT05067335|464842709|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
129148517|NCT01645176|464842710|FG000|Overall Study|Lack of Efficacy|4|||
129148518|NCT01645176|464842710|FG000|Overall Study|did not complete final MRI|1|||
129148519|NCT02234362|464842711|FG000|Overall Study|Not eligible after first screening visit|17|||
129148520|NCT02234362|464842711|FG000|Overall Study|Lost to Follow-up|6|||
129148521|NCT02234362|464842711|FG000|Overall Study|Withdrawal by Subject|3|||
129148522|NCT00560417|464842712|FG000|Overall Study|Adverse Event|3|||
129148523|NCT00560417|464842713|FG001|Overall Study|Adverse Event|2|||
129148524|NCT00560417|464842712|FG000|Overall Study|Entry Criteria Not Met|1|||
129148525|NCT00560417|464842713|FG001|Overall Study|Entry Criteria Not Met|0|||
129148526|NCT00560417|464842712|FG000|Overall Study|Lost to Follow-up|0|||
129148527|NCT00560417|464842713|FG001|Overall Study|Lost to Follow-up|1|||
129148528|NCT00560417|464842712|FG000|Overall Study|Physician Decision|2|||
129148529|NCT00560417|464842713|FG001|Overall Study|Physician Decision|6|||
129148530|NCT00560417|464842712|FG000|Overall Study|Protocol Violation|6|||
129148531|NCT00560417|464842713|FG001|Overall Study|Protocol Violation|5|||
129148532|NCT00560417|464842712|FG000|Overall Study|Sponsor Decision|2|||
129148533|NCT00560417|464842713|FG001|Overall Study|Sponsor Decision|0|||
129148534|NCT00560417|464842712|FG000|Overall Study|Withdrawal by Subject|3|||
129148535|NCT00560417|464842713|FG001|Overall Study|Withdrawal by Subject|3|||
129148536|NCT02164864|464842714|FG000|Overall Study|Trial disease worsening|7|||
129148537|NCT02164864|464842715|FG001|Overall Study|Trial disease worsening|5|||
129148538|NCT02164864|464842716|FG002|Overall Study|Trial disease worsening|1|||
129148539|NCT02164864|464842714|FG000|Overall Study|Other pre-existing disease worsening|6|||
129148540|NCT02164864|464842715|FG001|Overall Study|Other pre-existing disease worsening|4|||
129148541|NCT02164864|464842716|FG002|Overall Study|Other pre-existing disease worsening|9|||
129148542|NCT02164864|464842714|FG000|Overall Study|Other Adverse Event (AE)|52|||
129148543|NCT02164864|464842715|FG001|Overall Study|Other Adverse Event (AE)|32|||
129148544|NCT02164864|464842716|FG002|Overall Study|Other Adverse Event (AE)|49|||
129148545|NCT02164864|464842714|FG000|Overall Study|Protocol Violation|2|||
129148546|NCT02164864|464842715|FG001|Overall Study|Protocol Violation|4|||
129148547|NCT02164864|464842716|FG002|Overall Study|Protocol Violation|1|||
129148548|NCT02164864|464842714|FG000|Overall Study|Lost to Follow-up|4|||
129148549|NCT02164864|464842715|FG001|Overall Study|Lost to Follow-up|3|||
129148550|NCT02164864|464842716|FG002|Overall Study|Lost to Follow-up|2|||
129148551|NCT02164864|464842714|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
129148552|NCT02164864|464842715|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
129148553|NCT02164864|464842716|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
129148554|NCT02164864|464842714|FG000|Overall Study|Other than stated|3|||
129148555|NCT02164864|464842715|FG001|Overall Study|Other than stated|4|||
129148556|NCT02164864|464842716|FG002|Overall Study|Other than stated|14|||
129148557|NCT02569853|464842719|FG000|Overall Study|Adverse Event|2|||
129148558|NCT02569853|464842720|FG001|Overall Study|Adverse Event|0|||
129148559|NCT02569853|464842719|FG000|Overall Study|Withdrawal by Subject|3|||
129148560|NCT02569853|464842720|FG001|Overall Study|Withdrawal by Subject|2|||
129148561|NCT02569853|464842719|FG000|Overall Study|Lost to Follow-up|3|||
129148562|NCT02569853|464842720|FG001|Overall Study|Lost to Follow-up|3|||
129148563|NCT02569853|464842719|FG000|Overall Study|Protocol Violation|1|||
129148564|NCT02569853|464842720|FG001|Overall Study|Protocol Violation|1|||
129148565|NCT02569853|464842719|FG000|Overall Study|Did not experience migraine attack|10|||
129148566|NCT02569853|464842720|FG001|Overall Study|Did not experience migraine attack|7|||
129148567|NCT02569853|464842719|FG000|Overall Study|Physician Decision|1|||
129148568|NCT02569853|464842720|FG001|Overall Study|Physician Decision|1|||
129148569|NCT00261833|464842721|FG000|Overall Study|Death|1|||
129148570|NCT00261833|464842722|FG001|Overall Study|Death|3|||
129148571|NCT00261833|464842721|FG000|Overall Study|Adverse Event|1|||
129148572|NCT00261833|464842722|FG001|Overall Study|Adverse Event|4|||
129148573|NCT00261833|464842721|FG000|Overall Study|Withdrawal by Subject|5|||
129148574|NCT00261833|464842722|FG001|Overall Study|Withdrawal by Subject|7|||
129148575|NCT00261833|464842721|FG000|Overall Study|Protocol Violation|0|||
129148576|NCT00261833|464842722|FG001|Overall Study|Protocol Violation|1|||
129148577|NCT00261833|464842721|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
129148578|NCT00261833|464842722|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
129148579|NCT00261833|464842721|FG000|Overall Study|Lung transplantation|1|||
129148580|NCT00261833|464842722|FG001|Overall Study|Lung transplantation|1|||
129148581|NCT00261833|464842721|FG000|Overall Study|Missing reason|1|||
129148582|NCT00261833|464842722|FG001|Overall Study|Missing reason|0|||
129148583|NCT00261833|464842721|FG000|Overall Study|Not interested in being participant|0|||
129148584|NCT00261833|464842722|FG001|Overall Study|Not interested in being participant|1|||
129148585|NCT00622726|464842723|FG000|March, 2008 to August, 2010|Death|5|||
129148586|NCT00622726|464842724|FG001|March, 2008 to August, 2010|Death|2|||
129148587|NCT00622726|464842723|FG000|August, 2010 to April, 2013|Death|1|||
129148588|NCT00622726|464842724|FG001|August, 2010 to April, 2013|Death|5|||
129148589|NCT01948427|464842727|FG000|Overall Study|Serious Adverse Event|3|||
129148590|NCT01948427|464842728|FG001|Overall Study|Serious Adverse Event|0|||
129148591|NCT01948427|464842729|FG002|Overall Study|Serious Adverse Event|0|||
129148592|NCT01948427|464842730|FG003|Overall Study|Serious Adverse Event|0|||
129148593|NCT01948427|464842731|FG004|Overall Study|Serious Adverse Event|1|||
129148594|NCT01948427|464842727|FG000|Overall Study|Investigator Request|0|||
129148595|NCT01948427|464842728|FG001|Overall Study|Investigator Request|8|||
129148596|NCT01948427|464842729|FG002|Overall Study|Investigator Request|0|||
129148597|NCT01948427|464842730|FG003|Overall Study|Investigator Request|0|||
129148598|NCT01948427|464842731|FG004|Overall Study|Investigator Request|6|||
129148599|NCT01948427|464842727|FG000|Overall Study|Lost to Follow-up|1|||
129148600|NCT01948427|464842728|FG001|Overall Study|Lost to Follow-up|0|||
129148601|NCT01948427|464842729|FG002|Overall Study|Lost to Follow-up|0|||
129148602|NCT01948427|464842730|FG003|Overall Study|Lost to Follow-up|0|||
128724991|NCT02641379|463290945|FG000|Overall Study|Participant unable to attend study visit|4|||
128724992|NCT02641379|463290946|FG001|Overall Study|Participant unable to attend study visit|10|||
128724993|NCT02641379|463290947|FG002|Overall Study|Participant unable to attend study visit|1|||
128724994|NCT02641379|463290948|FG003|Overall Study|Participant unable to attend study visit|2|||
128724995|NCT02641379|463290949|FG004|Overall Study|Participant unable to attend study visit|5|||
129148603|NCT01948427|464842731|FG004|Overall Study|Lost to Follow-up|4|||
129148604|NCT01948427|464842727|FG000|Overall Study|Withdrawal by Subject|2|||
129148605|NCT01948427|464842728|FG001|Overall Study|Withdrawal by Subject|0|||
129148606|NCT01948427|464842729|FG002|Overall Study|Withdrawal by Subject|0|||
129148607|NCT01948427|464842730|FG003|Overall Study|Withdrawal by Subject|0|||
129148608|NCT01948427|464842731|FG004|Overall Study|Withdrawal by Subject|1|||
129148609|NCT01948427|464842727|FG000|Overall Study|Other, Not Specified|1|||
129148610|NCT01948427|464842728|FG001|Overall Study|Other, Not Specified|9|||
129148611|NCT01948427|464842729|FG002|Overall Study|Other, Not Specified|0|||
129148612|NCT01948427|464842730|FG003|Overall Study|Other, Not Specified|0|||
129148613|NCT01948427|464842731|FG004|Overall Study|Other, Not Specified|2|||
129148614|NCT00402987|464842732|FG000|Overall Study|Lack of Efficacy|0|||
129148615|NCT00402987|464842733|FG001|Overall Study|Lack of Efficacy|0|||
129148616|NCT00402987|464842734|FG002|Overall Study|Lack of Efficacy|1|||
129148617|NCT00402987|464842735|FG003|Overall Study|Lack of Efficacy|0|||
129148618|NCT02434081|464842736|FG000|Overall Study|Death (never started treatment)|2|||
129148619|NCT02434081|464842736|FG000|Overall Study|Death|2|||
129148620|NCT02434081|464842736|FG000|Overall Study|Progression|20|||
129148621|NCT02434081|464842736|FG000|Overall Study|Adverse Event|20|||
129148622|NCT02434081|464842736|FG000|Overall Study|Physician Decision|2|||
129148623|NCT02434081|464842736|FG000|Overall Study|Withdrawal by Subject|1|||
129148624|NCT02434081|464842736|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
129148625|NCT00419744|464842737|FG000|Overall Study|Adverse Event|39|||
129148626|NCT00419744|464842738|FG001|Overall Study|Adverse Event|40|||
129148627|NCT00419744|464842739|FG002|Overall Study|Adverse Event|50|||
129148628|NCT00419744|464842737|FG000|Overall Study|Withdrawal by Subject|45|||
129148629|NCT00419744|464842738|FG001|Overall Study|Withdrawal by Subject|49|||
129148630|NCT00419744|464842739|FG002|Overall Study|Withdrawal by Subject|52|||
129148631|NCT00419744|464842737|FG000|Overall Study|Lost to Follow-up|8|||
129148632|NCT00419744|464842738|FG001|Overall Study|Lost to Follow-up|10|||
129148633|NCT00419744|464842739|FG002|Overall Study|Lost to Follow-up|6|||
129148634|NCT00419744|464842737|FG000|Overall Study|Protocol Violation|4|||
129148635|NCT00419744|464842738|FG001|Overall Study|Protocol Violation|7|||
129148636|NCT00419744|464842739|FG002|Overall Study|Protocol Violation|8|||
129148637|NCT00419744|464842737|FG000|Overall Study|Randomized in error|9|||
129148638|NCT00419744|464842738|FG001|Overall Study|Randomized in error|6|||
129148639|NCT00419744|464842739|FG002|Overall Study|Randomized in error|7|||
129148640|NCT00419744|464842737|FG000|Overall Study|Moving out of state|2|||
129148641|NCT00419744|464842738|FG001|Overall Study|Moving out of state|0|||
129148642|NCT00419744|464842739|FG002|Overall Study|Moving out of state|1|||
129148643|NCT00419744|464842737|FG000|Overall Study|Physician Decision|10|||
129148644|NCT00419744|464842738|FG001|Overall Study|Physician Decision|5|||
129148645|NCT00419744|464842739|FG002|Overall Study|Physician Decision|6|||
129148646|NCT00419744|464842737|FG000|Overall Study|Spirometry mouthpiece issues|0|||
129148647|NCT00419744|464842738|FG001|Overall Study|Spirometry mouthpiece issues|1|||
129148648|NCT00419744|464842739|FG002|Overall Study|Spirometry mouthpiece issues|2|||
129148649|NCT00419744|464842737|FG000|Overall Study|Incorrect medication kit dispensed|0|||
129148650|NCT00419744|464842738|FG001|Overall Study|Incorrect medication kit dispensed|0|||
129148651|NCT00419744|464842739|FG002|Overall Study|Incorrect medication kit dispensed|1|||
129148652|NCT01668004|464842740|FG000|Overall Study|Adverse Event|7|||
129148653|NCT01668004|464842740|FG000|Overall Study|Withdrawal by Subject|2|||
129148654|NCT01668004|464842740|FG000|Overall Study|Lost to Follow-up|5|||
129148655|NCT01668004|464842740|FG000|Overall Study|Lack of Efficacy|9|||
129148656|NCT01668004|464842740|FG000|Overall Study|Non-compliance with treatment|2|||
129148657|NCT02448381|464842748|FG000|Overall Study|Adverse Event|2|||
129148658|NCT02448381|464842749|FG001|Overall Study|Adverse Event|0|||
129148659|NCT02448381|464842748|FG000|Overall Study|Lost to Follow-up|16|||
129148660|NCT02448381|464842749|FG001|Overall Study|Lost to Follow-up|9|||
129148661|NCT02448381|464842748|FG000|Overall Study|Physician Decision|1|||
129148662|NCT02448381|464842749|FG001|Overall Study|Physician Decision|1|||
129148663|NCT02448381|464842748|FG000|Overall Study|Pregnancy|1|||
129148664|NCT02448381|464842749|FG001|Overall Study|Pregnancy|0|||
129148665|NCT02448381|464842748|FG000|Overall Study|Withdrawal by Subject|13|||
129148666|NCT02448381|464842749|FG001|Overall Study|Withdrawal by Subject|9|||
129148667|NCT02448381|464842748|FG000|Overall Study|Noncompliance with Study Procedures|2|||
129148668|NCT02448381|464842749|FG001|Overall Study|Noncompliance with Study Procedures|0|||
129148669|NCT01170663|464842752|FG000|Overall Study|Lost to Follow-up|3|||
129148670|NCT01170663|464842753|FG001|Overall Study|Lost to Follow-up|9|||
129148671|NCT01170663|464842752|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
129148672|NCT01170663|464842753|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
129148673|NCT05200845|464842765|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
129148674|NCT05200845|464842766|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
129148675|NCT05200845|464842767|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
129148676|NCT05200845|464842768|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
129148677|NCT05200845|464842765|FG000|Overall Study|Withdrawal by Subject|0|||
129148678|NCT05200845|464842766|FG001|Overall Study|Withdrawal by Subject|1|||
129148679|NCT05200845|464842767|FG002|Overall Study|Withdrawal by Subject|1|||
129148680|NCT05200845|464842768|FG003|Overall Study|Withdrawal by Subject|0|||
129148681|NCT01911260|464842775|FG000|Supplementation Period|transference or evasion of school|7|||
129148682|NCT01911260|464842776|FG001|Supplementation Period|transference or evasion of school|9|||
129148683|NCT01911260|464842777|FG002|Supplementation Period|transference or evasion of school|7|||
129148684|NCT01911260|464842778|FG003|Supplementation Period|transference or evasion of school|6|||
129148685|NCT01911260|464842775|FG000|Supplementation Period|Adverse Event|2|||
129148686|NCT01911260|464842776|FG001|Supplementation Period|Adverse Event|0|||
129148687|NCT01911260|464842777|FG002|Supplementation Period|Adverse Event|1|||
129148688|NCT01911260|464842778|FG003|Supplementation Period|Adverse Event|0|||
129148689|NCT01911260|464842775|FG000|Supplementation Period|refused to receive supplement|1|||
129148690|NCT01911260|464842776|FG001|Supplementation Period|refused to receive supplement|0|||
129148691|NCT01911260|464842777|FG002|Supplementation Period|refused to receive supplement|1|||
129148692|NCT01911260|464842778|FG003|Supplementation Period|refused to receive supplement|0|||
129148693|NCT01911260|464842775|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
129148694|NCT01911260|464842776|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
129148695|NCT01911260|464842777|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
129148696|NCT01911260|464842778|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
129148697|NCT01911260|464842775|FG000|Follow-up Period|transference or evasion of school|13|||
129148698|NCT01911260|464842776|FG001|Follow-up Period|transference or evasion of school|20|||
129148699|NCT01911260|464842777|FG002|Follow-up Period|transference or evasion of school|15|||
129148700|NCT01911260|464842778|FG003|Follow-up Period|transference or evasion of school|12|||
129148701|NCT01242514|464842787|FG000|Overall Study|e.g., project closure|1042|||
129148702|NCT01242514|464842788|FG001|Overall Study|e.g., project closure|305|||
129148703|NCT01242514|464842789|FG002|Overall Study|e.g., project closure|171|||
129148704|NCT01242514|464842787|FG000|Overall Study|Subject decision|33|||
129148705|NCT01242514|464842788|FG001|Overall Study|Subject decision|8|||
129148706|NCT01242514|464842789|FG002|Overall Study|Subject decision|2|||
129148707|NCT01242514|464842787|FG000|Overall Study|Severe non-compliance to protocol|5|||
129148708|NCT01242514|464842788|FG001|Overall Study|Severe non-compliance to protocol|2|||
129148709|NCT01242514|464842789|FG002|Overall Study|Severe non-compliance to protocol|1|||
129148710|NCT01242514|464842787|FG000|Overall Study|Lack of therapeutic response|99|||
129148711|NCT01242514|464842788|FG001|Overall Study|Lack of therapeutic response|16|||
129148712|NCT01242514|464842789|FG002|Overall Study|Lack of therapeutic response|10|||
129148713|NCT01242514|464842787|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
129148714|NCT01242514|464842788|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
129148715|NCT01242514|464842789|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
129148716|NCT01242514|464842787|FG000|Overall Study|Lost to Follow-up|14|||
129148717|NCT01242514|464842788|FG001|Overall Study|Lost to Follow-up|5|||
129148718|NCT01242514|464842789|FG002|Overall Study|Lost to Follow-up|4|||
129148719|NCT01242514|464842787|FG000|Overall Study|Adverse Event|129|||
129148720|NCT01242514|464842788|FG001|Overall Study|Adverse Event|18|||
129148721|NCT01242514|464842789|FG002|Overall Study|Adverse Event|19|||
129148722|NCT04079738|464842803|FG000|Study Treatment|Death|1|||
129148723|NCT04079738|464842804|FG001|Study Treatment|Death|0|||
129148724|NCT04079738|464842805|FG002|Study Treatment|Death|0|||
129148725|NCT04079738|464842806|FG003|Study Treatment|Death|0|||
129148726|NCT04079738|464842803|FG000|Study Treatment|Adverse Event|2|||
129148727|NCT04079738|464842804|FG001|Study Treatment|Adverse Event|0|||
129148728|NCT04079738|464842805|FG002|Study Treatment|Adverse Event|0|||
129148729|NCT04079738|464842806|FG003|Study Treatment|Adverse Event|0|||
129148730|NCT04079738|464842803|FG000|Study Treatment|withdrawal before treatment|1|||
129148731|NCT04079738|464842804|FG001|Study Treatment|withdrawal before treatment|0|||
129148732|NCT04079738|464842805|FG002|Study Treatment|withdrawal before treatment|0|||
129148733|NCT04079738|464842806|FG003|Study Treatment|withdrawal before treatment|0|||
129148734|NCT04079738|464842803|FG000|Study Treatment|symptomatic deterioration|2|||
129148735|NCT04079738|464842804|FG001|Study Treatment|symptomatic deterioration|0|||
129148736|NCT04079738|464842805|FG002|Study Treatment|symptomatic deterioration|0|||
129148737|NCT04079738|464842806|FG003|Study Treatment|symptomatic deterioration|0|||
129148738|NCT04079738|464842803|FG000|Study Treatment|Disease Progression|1|||
129148739|NCT04079738|464842804|FG001|Study Treatment|Disease Progression|0|||
129148740|NCT04079738|464842805|FG002|Study Treatment|Disease Progression|0|||
129148741|NCT04079738|464842806|FG003|Study Treatment|Disease Progression|0|||
129148742|NCT04079738|464842803|FG000|Study Treatment|withdrawal after treatment|1|||
129148743|NCT04079738|464842804|FG001|Study Treatment|withdrawal after treatment|0|||
129148744|NCT04079738|464842805|FG002|Study Treatment|withdrawal after treatment|0|||
129148745|NCT04079738|464842806|FG003|Study Treatment|withdrawal after treatment|0|||
129148746|NCT04079738|464842803|FG000|Follow up|Withdrawal by Subject|3|||
129148747|NCT04079738|464842804|FG001|Follow up|Withdrawal by Subject|0|||
129148748|NCT04079738|464842805|FG002|Follow up|Withdrawal by Subject|0|||
129148749|NCT04079738|464842806|FG003|Follow up|Withdrawal by Subject|0|||
129148750|NCT04079738|464842803|FG000|Follow up|Death|5|||
129148751|NCT04079738|464842804|FG001|Follow up|Death|0|||
129148752|NCT04079738|464842805|FG002|Follow up|Death|0|||
129148753|NCT04079738|464842806|FG003|Follow up|Death|0|||
129148754|NCT00789555|464842807|FG000|Overall Study|Protocol Amendment|78|||
129148755|NCT00789555|464842808|FG001|Overall Study|Protocol Amendment|76|||
129148756|NCT00789555|464842809|FG002|Overall Study|Protocol Amendment|80|||
129148757|NCT00789555|464842807|FG000|Overall Study|Adverse Event|17|||
129148758|NCT00789555|464842808|FG001|Overall Study|Adverse Event|7|||
129148759|NCT00789555|464842809|FG002|Overall Study|Adverse Event|10|||
129148760|NCT00789555|464842807|FG000|Overall Study|Lost to Follow-up|9|||
129148761|NCT00789555|464842808|FG001|Overall Study|Lost to Follow-up|10|||
129148762|NCT00789555|464842809|FG002|Overall Study|Lost to Follow-up|18|||
129148763|NCT00789555|464842807|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
129148764|NCT00789555|464842808|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
129148765|NCT00789555|464842809|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
129148766|NCT00789555|464842807|FG000|Overall Study|Treatment failure|11|||
129148767|NCT00789555|464842808|FG001|Overall Study|Treatment failure|8|||
129148768|NCT00789555|464842809|FG002|Overall Study|Treatment failure|12|||
129148769|NCT00789555|464842807|FG000|Overall Study|Protocol Violation|6|||
129148770|NCT00789555|464842808|FG001|Overall Study|Protocol Violation|9|||
129148771|NCT00789555|464842809|FG002|Overall Study|Protocol Violation|13|||
129148772|NCT00404248|464842810|FG000|Overall Study|pts declining status|0|||
129148773|NCT00404248|464842811|FG001|Overall Study|pts declining status|1|||
129148774|NCT00404248|464842812|FG002|Overall Study|pts declining status|0|||
129148775|NCT00404248|464842813|FG003|Overall Study|pts declining status|0|||
129148776|NCT00404248|464842814|FG004|Overall Study|pts declining status|0|||
129148777|NCT00404248|464842815|FG005|Overall Study|pts declining status|0|||
129148778|NCT00404248|464842816|FG006|Overall Study|pts declining status|0|||
129148779|NCT00404248|464842817|FG007|Overall Study|pts declining status|0|||
129148780|NCT00404248|464842818|FG008|Overall Study|pts declining status|0|||
129148781|NCT04646005|464842819|FG000|Overall Study|Adverse Event|1|||
129148782|NCT04646005|464842819|FG000|Overall Study|Progressive Disease|71|||
129148783|NCT04646005|464842819|FG000|Overall Study|Death|20|||
129148784|NCT04646005|464842819|FG000|Overall Study|Withdrawal by Subject|12|||
129148785|NCT04646005|464842819|FG000|Overall Study|Sponsor Request|9|||
129148786|NCT04398706|464842820|FG000|Overall Study|Adverse Event|0|||
129148787|NCT04398706|464842821|FG001|Overall Study|Adverse Event|0|||
129148788|NCT04398706|464842822|FG002|Overall Study|Adverse Event|0|||
129148789|NCT04398706|464842823|FG003|Overall Study|Adverse Event|0|||
129148790|NCT04398706|464842824|FG004|Overall Study|Adverse Event|0|||
129148791|NCT04398706|464842825|FG005|Overall Study|Adverse Event|1|||
129148792|NCT04398706|464842826|FG006|Overall Study|Adverse Event|1|||
129148793|NCT04398706|464842827|FG007|Overall Study|Adverse Event|0|||
129148794|NCT04398706|464842820|FG000|Overall Study|Lost to Follow-up|0|||
129148795|NCT04398706|464842821|FG001|Overall Study|Lost to Follow-up|1|||
129148796|NCT04398706|464842822|FG002|Overall Study|Lost to Follow-up|2|||
129148797|NCT04398706|464842823|FG003|Overall Study|Lost to Follow-up|1|||
129148798|NCT04398706|464842824|FG004|Overall Study|Lost to Follow-up|6|||
129148799|NCT04398706|464842825|FG005|Overall Study|Lost to Follow-up|3|||
129148800|NCT04398706|464842826|FG006|Overall Study|Lost to Follow-up|8|||
129148801|NCT04398706|464842827|FG007|Overall Study|Lost to Follow-up|2|||
129148802|NCT04398706|464842820|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129148803|NCT04398706|464842821|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129148804|NCT04398706|464842822|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129148805|NCT04398706|464842823|FG003|Overall Study|Withdrawal by parent/guardian|2|||
129148806|NCT04398706|464842824|FG004|Overall Study|Withdrawal by parent/guardian|19|||
129148807|NCT04398706|464842825|FG005|Overall Study|Withdrawal by parent/guardian|23|||
129148808|NCT04398706|464842826|FG006|Overall Study|Withdrawal by parent/guardian|13|||
128776600|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
128776601|NCT02718417|463471968|FG000|Chemotherapy Phase (CP)|Other|2|||
128776602|NCT02718417|463471969|FG001|Chemotherapy Phase (CP)|Other|0|||
128776603|NCT02718417|463471970|FG002|Chemotherapy Phase (CP)|Other|1|||
128776604|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Adverse Event|21|||
128776605|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Adverse Event|26|||
128776606|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Adverse Event|0|||
128776607|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
128776608|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
128776609|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
128776610|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
128776611|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
128776612|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
128776613|NCT02718417|463471968|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
128776614|NCT02718417|463471969|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
128776615|NCT02718417|463471970|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
128776616|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Physician's decision|6|||
128776617|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Physician's decision|7|||
128776618|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Physician's decision|0|||
128776619|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Progressive disease|100|||
128776620|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Progressive disease|88|||
128776621|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Progressive disease|0|||
128776622|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Other|2|||
128776623|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Other|1|||
128776624|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Other|0|||
128776625|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
128776626|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
128776627|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
128776628|NCT02718417|463471968|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
128776629|NCT02718417|463471969|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
128776630|NCT02718417|463471970|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
128776631|NCT02718417|463471968|FG000|Observation Phase (OP)|Adverse Event|0|||
129148809|NCT04398706|464842827|FG007|Overall Study|Withdrawal by parent/guardian|11|||
129148810|NCT04398706|464842820|FG000|Overall Study|Protocol deviation|0|||
129148811|NCT04398706|464842821|FG001|Overall Study|Protocol deviation|1|||
129148812|NCT04398706|464842822|FG002|Overall Study|Protocol deviation|0|||
129148813|NCT04398706|464842823|FG003|Overall Study|Protocol deviation|0|||
129148814|NCT04398706|464842824|FG004|Overall Study|Protocol deviation|6|||
129148815|NCT04398706|464842825|FG005|Overall Study|Protocol deviation|4|||
129148816|NCT04398706|464842826|FG006|Overall Study|Protocol deviation|6|||
129148817|NCT04398706|464842827|FG007|Overall Study|Protocol deviation|3|||
129148818|NCT04237584|464842828|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
129148819|NCT04237584|464842829|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
129148820|NCT04237584|464842830|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
129148821|NCT04237584|464842831|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
129148822|NCT04237584|464842828|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
129148823|NCT04237584|464842829|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
129148824|NCT04237584|464842830|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
129148825|NCT04237584|464842831|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
129148826|NCT04237584|464842828|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
129148827|NCT04237584|464842829|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
129148828|NCT04237584|464842830|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
129148829|NCT04237584|464842831|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
129148830|NCT04237584|464842828|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
129148831|NCT04237584|464842829|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
129148832|NCT04237584|464842830|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
129148833|NCT04237584|464842831|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
129148834|NCT04237584|464842828|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
129148835|NCT04237584|464842829|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
129148836|NCT04237584|464842830|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
129148837|NCT04237584|464842831|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
129148838|NCT03586973|464842832|FG000|Overall Study|Death|15|||
129148839|NCT03586973|464842833|FG001|Overall Study|Death|8|||
129148840|NCT03586973|464842832|FG000|Overall Study|Site Terminated by Sponsor|3|||
129148841|NCT03586973|464842833|FG001|Overall Study|Site Terminated by Sponsor|6|||
129148842|NCT03586973|464842832|FG000|Overall Study|Withdrawal by Subject|1|||
129148843|NCT03586973|464842833|FG001|Overall Study|Withdrawal by Subject|0|||
129148844|NCT03586973|464842832|FG000|Overall Study|Lost to Follow-up|1|||
129148845|NCT03586973|464842833|FG001|Overall Study|Lost to Follow-up|0|||
129148846|NCT05239221|464842839|FG000|Overall Study|Adverse Event|0|||
129148847|NCT05239221|464842840|FG001|Overall Study|Adverse Event|0|||
129148848|NCT05239221|464842841|FG002|Overall Study|Adverse Event|0|||
129148849|NCT05239221|464842842|FG003|Overall Study|Adverse Event|0|||
129148850|NCT05239221|464842843|FG004|Overall Study|Adverse Event|0|||
129148851|NCT05239221|464842844|FG005|Overall Study|Adverse Event|0|||
129148852|NCT05239221|464842845|FG006|Overall Study|Adverse Event|1|||
129148853|NCT05239221|464842846|FG007|Overall Study|Adverse Event|0|||
129148854|NCT05239221|464842847|FG008|Overall Study|Adverse Event|0|||
129148855|NCT05239221|464842848|FG009|Overall Study|Adverse Event|0|||
129148856|NCT05239221|464842849|FG010|Overall Study|Adverse Event|1|||
129148857|NCT05239221|464842850|FG011|Overall Study|Adverse Event|1|||
129148858|NCT05239221|464842851|FG012|Overall Study|Adverse Event|0|||
129148859|NCT05239221|464842852|FG013|Overall Study|Adverse Event|0|||
129148860|NCT05239221|464842853|FG014|Overall Study|Adverse Event|0|||
129148861|NCT05239221|464842854|FG015|Overall Study|Adverse Event|0|||
129148862|NCT05239221|464842839|FG000|Overall Study|Withdrawal by Subject|0|||
129148863|NCT05239221|464842840|FG001|Overall Study|Withdrawal by Subject|0|||
129148864|NCT05239221|464842841|FG002|Overall Study|Withdrawal by Subject|0|||
129148865|NCT05239221|464842842|FG003|Overall Study|Withdrawal by Subject|0|||
129148866|NCT05239221|464842843|FG004|Overall Study|Withdrawal by Subject|0|||
129148867|NCT05239221|464842844|FG005|Overall Study|Withdrawal by Subject|0|||
129148868|NCT05239221|464842845|FG006|Overall Study|Withdrawal by Subject|0|||
129148869|NCT05239221|464842846|FG007|Overall Study|Withdrawal by Subject|0|||
129148870|NCT05239221|464842847|FG008|Overall Study|Withdrawal by Subject|0|||
129148871|NCT05239221|464842848|FG009|Overall Study|Withdrawal by Subject|0|||
129148872|NCT05239221|464842849|FG010|Overall Study|Withdrawal by Subject|1|||
129148873|NCT05239221|464842850|FG011|Overall Study|Withdrawal by Subject|0|||
129148874|NCT05239221|464842851|FG012|Overall Study|Withdrawal by Subject|0|||
129148875|NCT05239221|464842852|FG013|Overall Study|Withdrawal by Subject|0|||
129148876|NCT05239221|464842853|FG014|Overall Study|Withdrawal by Subject|0|||
128724996|NCT02641379|463290950|FG005|Overall Study|Participant unable to attend study visit|1|||
128724997|NCT02641379|463290951|FG006|Overall Study|Participant unable to attend study visit|1|||
128724998|NCT02641379|463290952|FG007|Overall Study|Participant unable to attend study visit|1|||
128724999|NCT02641379|463290953|FG008|Overall Study|Participant unable to attend study visit|0|||
128725000|NCT02641379|463290954|FG009|Overall Study|Participant unable to attend study visit|2|||
129148877|NCT05239221|464842854|FG015|Overall Study|Withdrawal by Subject|1|||
129148878|NCT01897493|464844342|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
129148879|NCT05489328|464844343|FG000|Overall Study|Lost to Follow-up|0|||
129148880|NCT05489328|464844344|FG001|Overall Study|Lost to Follow-up|0|||
129148881|NCT05489328|464844345|FG002|Overall Study|Lost to Follow-up|1|||
129148882|NCT05489328|464844346|FG003|Overall Study|Lost to Follow-up|0|||
129148883|NCT05489328|464844347|FG004|Overall Study|Lost to Follow-up|2|||
129148884|NCT05489328|464844348|FG005|Overall Study|Lost to Follow-up|0|||
129148885|NCT05489328|464844349|FG006|Overall Study|Lost to Follow-up|0|||
129148886|NCT05489328|464844350|FG007|Overall Study|Lost to Follow-up|1|||
129148887|NCT05489328|464844351|FG008|Overall Study|Lost to Follow-up|0|||
129148888|NCT05489328|464844343|FG000|Overall Study|Withdrawal by Subject|0|||
129148889|NCT05489328|464844344|FG001|Overall Study|Withdrawal by Subject|0|||
129148890|NCT05489328|464844345|FG002|Overall Study|Withdrawal by Subject|0|||
129148891|NCT05489328|464844346|FG003|Overall Study|Withdrawal by Subject|0|||
129148892|NCT05489328|464844347|FG004|Overall Study|Withdrawal by Subject|0|||
129148893|NCT05489328|464844348|FG005|Overall Study|Withdrawal by Subject|0|||
129148894|NCT05489328|464844349|FG006|Overall Study|Withdrawal by Subject|1|||
129148895|NCT05489328|464844350|FG007|Overall Study|Withdrawal by Subject|1|||
128725001|NCT02641379|463290955|FG010|Overall Study|Participant unable to attend study visit|0|||
129148896|NCT05489328|464844351|FG008|Overall Study|Withdrawal by Subject|0|||
129148897|NCT05489328|464844343|FG000|Overall Study|Other|0|||
129148898|NCT05489328|464844344|FG001|Overall Study|Other|0|||
129148899|NCT05489328|464844345|FG002|Overall Study|Other|0|||
129148900|NCT05489328|464844346|FG003|Overall Study|Other|0|||
129148901|NCT05489328|464844347|FG004|Overall Study|Other|0|||
129148902|NCT05489328|464844348|FG005|Overall Study|Other|0|||
129148903|NCT05489328|464844349|FG006|Overall Study|Other|0|||
129148904|NCT05489328|464844350|FG007|Overall Study|Other|1|||
129148905|NCT05489328|464844351|FG008|Overall Study|Other|1|||
129148906|NCT00805389|464844352|FG000|Overall Study|Adverse Event|0|||
129148907|NCT00805389|464844353|FG001|Overall Study|Adverse Event|0|||
129148908|NCT00805389|464844354|FG002|Overall Study|Adverse Event|1|||
129148909|NCT00805389|464844355|FG003|Overall Study|Adverse Event|2|||
129148910|NCT00805389|464844356|FG004|Overall Study|Adverse Event|0|||
129148911|NCT00805389|464844352|FG000|Overall Study|Lost to Follow-up|4|||
129148912|NCT00805389|464844353|FG001|Overall Study|Lost to Follow-up|3|||
129148913|NCT00805389|464844354|FG002|Overall Study|Lost to Follow-up|6|||
129148914|NCT00805389|464844355|FG003|Overall Study|Lost to Follow-up|10|||
129148915|NCT00805389|464844356|FG004|Overall Study|Lost to Follow-up|9|||
129148916|NCT00805389|464844352|FG000|Overall Study|Protocol Violation|0|||
129148917|NCT00805389|464844353|FG001|Overall Study|Protocol Violation|0|||
129148918|NCT00805389|464844354|FG002|Overall Study|Protocol Violation|1|||
129148919|NCT00805389|464844355|FG003|Overall Study|Protocol Violation|0|||
129148920|NCT00805389|464844356|FG004|Overall Study|Protocol Violation|0|||
129148921|NCT00805389|464844352|FG000|Overall Study|Withdrawal by Subject|3|||
129148922|NCT00805389|464844353|FG001|Overall Study|Withdrawal by Subject|2|||
129148923|NCT00805389|464844354|FG002|Overall Study|Withdrawal by Subject|4|||
129148924|NCT00805389|464844355|FG003|Overall Study|Withdrawal by Subject|5|||
129148925|NCT00805389|464844356|FG004|Overall Study|Withdrawal by Subject|4|||
129148926|NCT02239926|464844359|FG000|Overall Study|Withdrawal by Subject|0|||
129148927|NCT02239926|464844360|FG001|Overall Study|Withdrawal by Subject|1|||
129148928|NCT03983421|464844363|FG000|Overall Study|Lost to Follow-up|1|||
129148929|NCT00557193|464844366|FG000|Induction|Adverse Event|2|||
129148930|NCT00557193|464844367|FG001|Induction|Adverse Event|0|||
129148931|NCT00557193|464844368|FG002|Induction|Adverse Event|0|||
129148932|NCT00557193|464844369|FG003|Induction|Adverse Event|0|||
129148933|NCT00557193|464844370|FG004|Induction|Adverse Event|0|||
129148934|NCT00557193|464844371|FG005|Induction|Adverse Event|0|||
129148935|NCT00557193|464844366|FG000|Induction|Death|6|||
129148936|NCT00557193|464844367|FG001|Induction|Death|0|||
129148937|NCT00557193|464844368|FG002|Induction|Death|0|||
129148938|NCT00557193|464844369|FG003|Induction|Death|0|||
129148939|NCT00557193|464844370|FG004|Induction|Death|0|||
129148940|NCT00557193|464844371|FG005|Induction|Death|0|||
129148941|NCT00557193|464844366|FG000|Induction|Physician Decision|3|||
129148942|NCT00557193|464844367|FG001|Induction|Physician Decision|0|||
128725002|NCT02641379|463290945|FG000|Overall Study|Participant's compliance|0|||
128725003|NCT02641379|463290946|FG001|Overall Study|Participant's compliance|1|||
128725004|NCT02641379|463290947|FG002|Overall Study|Participant's compliance|0|||
128725005|NCT02641379|463290948|FG003|Overall Study|Participant's compliance|1|||
128725006|NCT02641379|463290949|FG004|Overall Study|Participant's compliance|0|||
128725007|NCT02641379|463290950|FG005|Overall Study|Participant's compliance|2|||
128725008|NCT02641379|463290951|FG006|Overall Study|Participant's compliance|0|||
128725009|NCT02641379|463290952|FG007|Overall Study|Participant's compliance|0|||
129148943|NCT00557193|464844368|FG002|Induction|Physician Decision|0|||
129148944|NCT00557193|464844369|FG003|Induction|Physician Decision|0|||
129148945|NCT00557193|464844370|FG004|Induction|Physician Decision|0|||
129148946|NCT00557193|464844371|FG005|Induction|Physician Decision|0|||
129148947|NCT00557193|464844366|FG000|Induction|Withdrawal by Subject|1|||
129148948|NCT00557193|464844367|FG001|Induction|Withdrawal by Subject|0|||
129148949|NCT00557193|464844368|FG002|Induction|Withdrawal by Subject|0|||
129148950|NCT00557193|464844369|FG003|Induction|Withdrawal by Subject|0|||
129148951|NCT00557193|464844370|FG004|Induction|Withdrawal by Subject|0|||
129148952|NCT00557193|464844371|FG005|Induction|Withdrawal by Subject|0|||
129148953|NCT00557193|464844366|FG000|Induction|Refusal of Further Protocol Therapy|2|||
129148954|NCT00557193|464844367|FG001|Induction|Refusal of Further Protocol Therapy|0|||
129148955|NCT00557193|464844368|FG002|Induction|Refusal of Further Protocol Therapy|0|||
129148956|NCT00557193|464844369|FG003|Induction|Refusal of Further Protocol Therapy|0|||
128725010|NCT02641379|463290953|FG008|Overall Study|Participant's compliance|1|||
128725011|NCT02641379|463290954|FG009|Overall Study|Participant's compliance|1|||
128725012|NCT02641379|463290955|FG010|Overall Study|Participant's compliance|1|||
128725013|NCT02641379|463290945|FG000|Overall Study|Participant cannot be reached|4|||
128725014|NCT02641379|463290946|FG001|Overall Study|Participant cannot be reached|4|||
128725015|NCT02641379|463290947|FG002|Overall Study|Participant cannot be reached|0|||
128725016|NCT02641379|463290948|FG003|Overall Study|Participant cannot be reached|8|||
128725017|NCT02641379|463290949|FG004|Overall Study|Participant cannot be reached|2|||
128725018|NCT02641379|463290950|FG005|Overall Study|Participant cannot be reached|1|||
128725019|NCT02641379|463290951|FG006|Overall Study|Participant cannot be reached|0|||
128725020|NCT02641379|463290952|FG007|Overall Study|Participant cannot be reached|1|||
128725021|NCT02641379|463290953|FG008|Overall Study|Participant cannot be reached|0|||
128725022|NCT02641379|463290954|FG009|Overall Study|Participant cannot be reached|2|||
128725023|NCT02641379|463290955|FG010|Overall Study|Participant cannot be reached|1|||
128725024|NCT02641379|463290945|FG000|Overall Study|PCR positive at Week 24|15|||
128725025|NCT02641379|463290946|FG001|Overall Study|PCR positive at Week 24|21|||
128725026|NCT02641379|463290947|FG002|Overall Study|PCR positive at Week 24|62|||
128725027|NCT02641379|463290948|FG003|Overall Study|PCR positive at Week 24|0|||
129148957|NCT00557193|464844370|FG004|Induction|Refusal of Further Protocol Therapy|0|||
129148958|NCT00557193|464844371|FG005|Induction|Refusal of Further Protocol Therapy|0|||
129148959|NCT00557193|464844366|FG000|Induction|Ineligible|8|||
129148960|NCT00557193|464844367|FG001|Induction|Ineligible|0|||
129148961|NCT00557193|464844368|FG002|Induction|Ineligible|0|||
129148962|NCT00557193|464844369|FG003|Induction|Ineligible|0|||
129148963|NCT00557193|464844370|FG004|Induction|Ineligible|0|||
129148964|NCT00557193|464844371|FG005|Induction|Ineligible|0|||
129148965|NCT00557193|464844366|FG000|Induction|Inevaluable for post Induction|2|||
129148966|NCT00557193|464844367|FG001|Induction|Inevaluable for post Induction|0|||
129148967|NCT00557193|464844368|FG002|Induction|Inevaluable for post Induction|0|||
129148968|NCT00557193|464844369|FG003|Induction|Inevaluable for post Induction|0|||
129148969|NCT00557193|464844370|FG004|Induction|Inevaluable for post Induction|0|||
129148970|NCT00557193|464844371|FG005|Induction|Inevaluable for post Induction|0|||
129148971|NCT00557193|464844366|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
129148972|NCT00557193|464844367|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129148973|NCT00557193|464844368|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129148974|NCT00557193|464844369|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129148975|NCT00557193|464844370|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129148976|NCT00557193|464844371|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129148977|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
129148978|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
129148979|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
129148980|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
129148981|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
129148982|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
129148983|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
129148984|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
129148985|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
129148986|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
129148987|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
129148988|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
129148989|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
129148990|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
128725028|NCT02641379|463290949|FG004|Overall Study|PCR positive at Week 24|0|||
128725029|NCT02641379|463290950|FG005|Overall Study|PCR positive at Week 24|6|||
128725030|NCT02641379|463290951|FG006|Overall Study|PCR positive at Week 24|3|||
128725031|NCT02641379|463290952|FG007|Overall Study|PCR positive at Week 24|8|||
128725032|NCT02641379|463290953|FG008|Overall Study|PCR positive at Week 24|0|||
128725033|NCT02641379|463290954|FG009|Overall Study|PCR positive at Week 24|1|||
128725034|NCT02641379|463290955|FG010|Overall Study|PCR positive at Week 24|0|||
128725035|NCT02641379|463290945|FG000|Overall Study|PCR positive at follow up 2|1|||
128725036|NCT02641379|463290946|FG001|Overall Study|PCR positive at follow up 2|0|||
128725037|NCT02641379|463290947|FG002|Overall Study|PCR positive at follow up 2|0|||
128725038|NCT02641379|463290948|FG003|Overall Study|PCR positive at follow up 2|0|||
128725039|NCT02641379|463290949|FG004|Overall Study|PCR positive at follow up 2|0|||
128725040|NCT02641379|463290950|FG005|Overall Study|PCR positive at follow up 2|0|||
129148991|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
129148992|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
129148993|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
129148994|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
128725041|NCT02641379|463290951|FG006|Overall Study|PCR positive at follow up 2|0|||
128725042|NCT02641379|463290952|FG007|Overall Study|PCR positive at follow up 2|0|||
128725043|NCT02641379|463290953|FG008|Overall Study|PCR positive at follow up 2|0|||
128725044|NCT02641379|463290954|FG009|Overall Study|PCR positive at follow up 2|0|||
128725045|NCT02641379|463290955|FG010|Overall Study|PCR positive at follow up 2|0|||
129148995|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
129148996|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
129148997|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
129148998|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
129148999|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
129149000|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
129149001|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
129149002|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
128725046|NCT02641379|463290945|FG000|Overall Study|Participant showed relapse|1|||
128725047|NCT02641379|463290946|FG001|Overall Study|Participant showed relapse|0|||
128725048|NCT02641379|463290947|FG002|Overall Study|Participant showed relapse|0|||
128725049|NCT02641379|463290948|FG003|Overall Study|Participant showed relapse|0|||
128725050|NCT02641379|463290949|FG004|Overall Study|Participant showed relapse|0|||
128725051|NCT02641379|463290950|FG005|Overall Study|Participant showed relapse|0|||
128725052|NCT02641379|463290951|FG006|Overall Study|Participant showed relapse|1|||
128725053|NCT02641379|463290952|FG007|Overall Study|Participant showed relapse|0|||
128725054|NCT02641379|463290953|FG008|Overall Study|Participant showed relapse|0|||
129149003|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
129149004|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
129149005|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
129149006|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
129149007|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129149008|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129149009|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
129149010|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129149011|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129149012|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129149013|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129149014|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129149015|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
129149016|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129149017|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129149018|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129149019|NCT00557193|464844366|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129149020|NCT00557193|464844367|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129149021|NCT00557193|464844368|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
129149022|NCT00557193|464844369|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129149023|NCT00557193|464844370|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129149024|NCT00557193|464844371|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
129149025|NCT03984825|464844372|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
129149026|NCT03984825|464844372|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
129149027|NCT03984825|464844372|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
129149028|NCT00976456|464844375|FG000|Overall Study|Adverse Event|17|||
129149029|NCT00976456|464844376|FG001|Overall Study|Adverse Event|22|||
129149030|NCT00976456|464844375|FG000|Overall Study|Death|7|||
129149031|NCT00976456|464844376|FG001|Overall Study|Death|9|||
129149032|NCT00976456|464844375|FG000|Overall Study|Lack of Efficacy|5|||
129149033|NCT00976456|464844376|FG001|Overall Study|Lack of Efficacy|2|||
129149034|NCT00976456|464844375|FG000|Overall Study|Withdrawal by Subject|3|||
129149035|NCT00976456|464844376|FG001|Overall Study|Withdrawal by Subject|1|||
129149036|NCT00976456|464844375|FG000|Overall Study|screening failure, unknown|11|||
129149037|NCT00976456|464844376|FG001|Overall Study|screening failure, unknown|4|||
129149038|NCT02037529|464844377|FG000|Overall Study|Withdrawal by Subject|1|||
129149039|NCT02037529|464844378|FG001|Overall Study|Withdrawal by Subject|3|||
129149040|NCT02037529|464844377|FG000|Overall Study|Adverse Event|0|||
129149041|NCT02037529|464844378|FG001|Overall Study|Adverse Event|1|||
129149042|NCT02131766|464844379|FG000|Overall Study|Withdrawal by Subject|4|||
128725055|NCT02641379|463290954|FG009|Overall Study|Participant showed relapse|0|||
128725056|NCT02641379|463290955|FG010|Overall Study|Participant showed relapse|0|||
128725057|NCT02641379|463290945|FG000|Overall Study|Participant stopped study/treatment|1|||
128725058|NCT02641379|463290946|FG001|Overall Study|Participant stopped study/treatment|3|||
128725059|NCT02641379|463290947|FG002|Overall Study|Participant stopped study/treatment|1|||
128725060|NCT02641379|463290948|FG003|Overall Study|Participant stopped study/treatment|0|||
128725061|NCT02641379|463290949|FG004|Overall Study|Participant stopped study/treatment|0|||
128776632|NCT02718417|463471969|FG001|Observation Phase (OP)|Adverse Event|0|||
129149043|NCT00718315|464844380|FG000|Overall Study|Adverse Event|1|||
129149044|NCT00718315|464844381|FG001|Overall Study|Adverse Event|2|||
129149045|NCT00718315|464844382|FG002|Overall Study|Adverse Event|3|||
129149046|NCT00718315|464844380|FG000|Overall Study|Death|6|||
129149047|NCT00718315|464844381|FG001|Overall Study|Death|6|||
129149048|NCT00718315|464844382|FG002|Overall Study|Death|5|||
129149049|NCT00718315|464844380|FG000|Overall Study|Lost to Follow-up|2|||
129149050|NCT00718315|464844381|FG001|Overall Study|Lost to Follow-up|3|||
129149051|NCT00718315|464844382|FG002|Overall Study|Lost to Follow-up|4|||
129149052|NCT00718315|464844380|FG000|Overall Study|Protocol Violation|5|||
129149053|NCT00718315|464844381|FG001|Overall Study|Protocol Violation|5|||
129149054|NCT00718315|464844382|FG002|Overall Study|Protocol Violation|3|||
129149055|NCT00718315|464844380|FG000|Overall Study|Erlotinib dose decreased|4|||
129149056|NCT00718315|464844381|FG001|Overall Study|Erlotinib dose decreased|3|||
129149057|NCT00718315|464844382|FG002|Overall Study|Erlotinib dose decreased|1|||
129149058|NCT00718315|464844380|FG000|Overall Study|Use of Minocyclin|1|||
129149059|NCT00718315|464844381|FG001|Overall Study|Use of Minocyclin|1|||
129149060|NCT00718315|464844382|FG002|Overall Study|Use of Minocyclin|1|||
129149061|NCT00718315|464844380|FG000|Overall Study|Disease progression|0|||
129149062|NCT00718315|464844381|FG001|Overall Study|Disease progression|1|||
129149063|NCT00718315|464844382|FG002|Overall Study|Disease progression|1|||
129149064|NCT00718315|464844380|FG000|Overall Study|Other|0|||
129149065|NCT00718315|464844381|FG001|Overall Study|Other|0|||
129149066|NCT00718315|464844382|FG002|Overall Study|Other|1|||
129149067|NCT00718315|464844380|FG000|Overall Study|Use of ATB and Corticoids|0|||
129149068|NCT00718315|464844381|FG001|Overall Study|Use of ATB and Corticoids|1|||
129149069|NCT00718315|464844382|FG002|Overall Study|Use of ATB and Corticoids|2|||
129149070|NCT02006927|464844386|FG000|Overall Study|Adverse Event|2|||
129149071|NCT02006927|464844386|FG000|Overall Study|Withdrawal by Subject|1|||
129149072|NCT02735200|464844389|FG000|Overall Study|Lost to Follow-up|0|||
129149073|NCT02735200|464844390|FG001|Overall Study|Lost to Follow-up|5|||
129149074|NCT02735200|464844389|FG000|Overall Study|Withdrawal by Subject|8|||
129149075|NCT02735200|464844390|FG001|Overall Study|Withdrawal by Subject|0|||
129149076|NCT02746809|464844391|FG000|Enrollment|Inclusion Exclusion not met|9|||
129149077|NCT02746809|464844391|FG000|Enrollment|Withdrawal by Subject|1|||
129149078|NCT02746809|464844391|FG000|Enrollment|Expected Enrollment Met|2|||
129149079|NCT02746809|464844391|FG000|Procedure|Death|1|||
129149080|NCT02746809|464844391|FG000|1-Month|Death|5|||
129149081|NCT02746809|464844391|FG000|6-Month|Death|2|||
129149082|NCT02746809|464844391|FG000|6-Month|Withdrawal by Subject|1|||
129149083|NCT02746809|464844391|FG000|12-Month|Death|3|||
129149084|NCT02746809|464844391|FG000|12-Month|Withdrawal by Subject|2|||
129149085|NCT02746809|464844391|FG000|24-Month|Death|1|||
129149086|NCT02746809|464844391|FG000|24-Month|Withdrawal by Subject|1|||
129149087|NCT02746809|464844391|FG000|36-Month|Death|8|||
129149088|NCT02746809|464844391|FG000|36-Month|Withdrawal by Subject|1|||
129149089|NCT02746809|464844391|FG000|48-Month|Death|7|||
129149090|NCT02746809|464844391|FG000|48-Month|Withdrawal by Subject|1|||
129149091|NCT02746809|464844391|FG000|60-Month|Death|1|||
129149092|NCT02746809|464844391|FG000|60-Month|Lost to Follow-up|2|||
129149093|NCT00673920|464844392|FG000|Baseline up to Week 48|Withdrew consent|1|||
129149094|NCT00673920|464844393|FG001|Baseline up to Week 48|Withdrew consent|0|||
129149095|NCT00673920|464844394|FG002|Baseline up to Week 48|Withdrew consent|2|||
129149096|NCT00673920|464844395|FG003|Baseline up to Week 48|Withdrew consent|0|||
129149097|NCT00673920|464844396|FG004|Baseline up to Week 48|Withdrew consent|0|||
129149098|NCT00673920|464844397|FG005|Baseline up to Week 48|Withdrew consent|0|||
129149099|NCT00673920|464844398|FG006|Baseline up to Week 48|Withdrew consent|0|||
129149100|NCT00673920|464844399|FG007|Baseline up to Week 48|Withdrew consent|0|||
129149101|NCT00673920|464844392|FG000|Baseline up to Week 48|Refused treatment|1|||
129149102|NCT00673920|464844393|FG001|Baseline up to Week 48|Refused treatment|0|||
129149103|NCT00673920|464844394|FG002|Baseline up to Week 48|Refused treatment|0|||
129149104|NCT00673920|464844395|FG003|Baseline up to Week 48|Refused treatment|0|||
129149105|NCT00673920|464844396|FG004|Baseline up to Week 48|Refused treatment|0|||
129149106|NCT00673920|464844397|FG005|Baseline up to Week 48|Refused treatment|0|||
129149107|NCT00673920|464844398|FG006|Baseline up to Week 48|Refused treatment|0|||
129149108|NCT00673920|464844399|FG007|Baseline up to Week 48|Refused treatment|0|||
129149109|NCT00673920|464844392|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
129149110|NCT00673920|464844393|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
129149111|NCT00673920|464844394|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
129149112|NCT00673920|464844395|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
129149113|NCT00673920|464844396|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
129149114|NCT00673920|464844397|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
129149115|NCT00673920|464844398|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
129149116|NCT00673920|464844399|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
129149117|NCT00673920|464844392|FG000|Baseline up to Week 48|Protocol Violation|0|||
129149118|NCT00673920|464844393|FG001|Baseline up to Week 48|Protocol Violation|0|||
129149119|NCT00673920|464844394|FG002|Baseline up to Week 48|Protocol Violation|1|||
129149120|NCT00673920|464844395|FG003|Baseline up to Week 48|Protocol Violation|0|||
128725062|NCT02641379|463290950|FG005|Overall Study|Participant stopped study/treatment|1|||
128725063|NCT02641379|463290951|FG006|Overall Study|Participant stopped study/treatment|2|||
128725064|NCT02641379|463290952|FG007|Overall Study|Participant stopped study/treatment|0|||
128725065|NCT02641379|463290953|FG008|Overall Study|Participant stopped study/treatment|1|||
128725066|NCT02641379|463290954|FG009|Overall Study|Participant stopped study/treatment|0|||
128725067|NCT02641379|463290955|FG010|Overall Study|Participant stopped study/treatment|0|||
128725068|NCT02641379|463290945|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
128725069|NCT02641379|463290946|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
128725070|NCT02641379|463290947|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
128725071|NCT02641379|463290948|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
128725072|NCT02641379|463290949|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
128725073|NCT02641379|463290950|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
128725074|NCT02641379|463290951|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
128725075|NCT02641379|463290952|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
128725076|NCT02641379|463290953|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
128725077|NCT02641379|463290954|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
128725078|NCT02641379|463290955|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
128725079|NCT02641379|463290945|FG000|Overall Study|Financial problems|0|||
129149121|NCT00673920|464844396|FG004|Baseline up to Week 48|Protocol Violation|0|||
129149122|NCT00673920|464844397|FG005|Baseline up to Week 48|Protocol Violation|0|||
129149123|NCT00673920|464844398|FG006|Baseline up to Week 48|Protocol Violation|0|||
129149124|NCT00673920|464844399|FG007|Baseline up to Week 48|Protocol Violation|0|||
129149125|NCT00673920|464844392|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129149126|NCT00673920|464844393|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129149127|NCT00673920|464844394|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
129149128|NCT00673920|464844395|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129149129|NCT00673920|464844396|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129149130|NCT00673920|464844397|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129149131|NCT00673920|464844398|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129149132|NCT00673920|464844399|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129149133|NCT00673920|464844392|FG000|Baseline up to Week 48|Administrative/Other|0|||
129149134|NCT00673920|464844393|FG001|Baseline up to Week 48|Administrative/Other|1|||
129149135|NCT00673920|464844394|FG002|Baseline up to Week 48|Administrative/Other|2|||
129149136|NCT00673920|464844395|FG003|Baseline up to Week 48|Administrative/Other|0|||
129149137|NCT00673920|464844396|FG004|Baseline up to Week 48|Administrative/Other|0|||
129149138|NCT00673920|464844397|FG005|Baseline up to Week 48|Administrative/Other|0|||
129149139|NCT00673920|464844398|FG006|Baseline up to Week 48|Administrative/Other|0|||
129149140|NCT00673920|464844399|FG007|Baseline up to Week 48|Administrative/Other|0|||
129149141|NCT00673920|464844392|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129149142|NCT00673920|464844393|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
129149143|NCT00673920|464844394|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
129149144|NCT00673920|464844395|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129149145|NCT00673920|464844396|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129149146|NCT00673920|464844397|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129149147|NCT00673920|464844398|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129149148|NCT00673920|464844399|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129149149|NCT00673920|464844392|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129149150|NCT00673920|464844393|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129149151|NCT00673920|464844394|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129149152|NCT00673920|464844395|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129149153|NCT00673920|464844396|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129149154|NCT00673920|464844397|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129149155|NCT00673920|464844398|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
129149156|NCT00673920|464844399|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129149157|NCT00673920|464844392|FG000|Week 24 to Week 48|Failure to return|0|||
129149158|NCT00673920|464844393|FG001|Week 24 to Week 48|Failure to return|0|||
129149159|NCT00673920|464844394|FG002|Week 24 to Week 48|Failure to return|0|||
129149160|NCT00673920|464844395|FG003|Week 24 to Week 48|Failure to return|0|||
129149161|NCT00673920|464844396|FG004|Week 24 to Week 48|Failure to return|0|||
129149162|NCT00673920|464844397|FG005|Week 24 to Week 48|Failure to return|1|||
128725080|NCT02641379|463290946|FG001|Overall Study|Financial problems|1|||
128725081|NCT02641379|463290947|FG002|Overall Study|Financial problems|0|||
128725082|NCT02641379|463290948|FG003|Overall Study|Financial problems|0|||
128725083|NCT02641379|463290949|FG004|Overall Study|Financial problems|0|||
128725084|NCT02641379|463290950|FG005|Overall Study|Financial problems|0|||
128725085|NCT02641379|463290951|FG006|Overall Study|Financial problems|0|||
128725086|NCT02641379|463290952|FG007|Overall Study|Financial problems|0|||
129149163|NCT00673920|464844398|FG006|Week 24 to Week 48|Failure to return|0|||
129149164|NCT00673920|464844399|FG007|Week 24 to Week 48|Failure to return|0|||
129149165|NCT00673920|464844392|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
129149166|NCT00673920|464844393|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
129149167|NCT00673920|464844394|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
129149168|NCT00673920|464844395|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
129149169|NCT00673920|464844396|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
129149170|NCT00673920|464844397|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
129149171|NCT00673920|464844398|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
129149172|NCT00673920|464844399|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
129149173|NCT00673920|464844392|FG000|Week 24 to Week 48|Death|0|||
129149174|NCT00673920|464844393|FG001|Week 24 to Week 48|Death|0|||
129149175|NCT00673920|464844394|FG002|Week 24 to Week 48|Death|0|||
129149176|NCT00673920|464844395|FG003|Week 24 to Week 48|Death|0|||
129149177|NCT00673920|464844396|FG004|Week 24 to Week 48|Death|0|||
129149178|NCT00673920|464844397|FG005|Week 24 to Week 48|Death|1|||
129149179|NCT00673920|464844398|FG006|Week 24 to Week 48|Death|0|||
129149180|NCT00673920|464844399|FG007|Week 24 to Week 48|Death|0|||
129149181|NCT00673920|464844392|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
129149182|NCT00673920|464844393|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
129149183|NCT00673920|464844394|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
129149184|NCT00673920|464844395|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
129149185|NCT00673920|464844396|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
129149186|NCT00673920|464844397|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
129149187|NCT00673920|464844398|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
129149188|NCT00673920|464844399|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
129149189|NCT01164007|464844402|FG000|Overall Study|Adverse Event|5|||
129149190|NCT01164007|464844402|FG000|Overall Study|Progression of Disease|30|||
129149191|NCT01164007|464844402|FG000|Overall Study|Protocol Violation|1|||
129149192|NCT01164007|464844402|FG000|Overall Study|Withdrawal by Subject|1|||
129149193|NCT01164007|464844402|FG000|Overall Study|Medical Decision|3|||
129149194|NCT00894387|464844403|FG000|Overall Study|Adverse Event|44|||
129149195|NCT00894387|464844404|FG001|Overall Study|Adverse Event|45|||
129149196|NCT00894387|464844403|FG000|Overall Study|Abnormal Laboratory values|2|||
129149197|NCT00894387|464844404|FG001|Overall Study|Abnormal Laboratory values|2|||
129149198|NCT00894387|464844403|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129149199|NCT00894387|464844404|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129149200|NCT00894387|464844403|FG000|Overall Study|Lost to Follow-up|3|||
129149201|NCT00894387|464844404|FG001|Overall Study|Lost to Follow-up|5|||
129149202|NCT00894387|464844403|FG000|Overall Study|Administrative problems|2|||
129149203|NCT00894387|464844404|FG001|Overall Study|Administrative problems|2|||
128725087|NCT02641379|463290953|FG008|Overall Study|Financial problems|0|||
128725088|NCT02641379|463290954|FG009|Overall Study|Financial problems|0|||
128725089|NCT02641379|463290955|FG010|Overall Study|Financial problems|0|||
128725090|NCT02641379|463290945|FG000|Overall Study|PCR positive at Week 68|0|||
128725091|NCT02641379|463290946|FG001|Overall Study|PCR positive at Week 68|1|||
128725092|NCT02641379|463290947|FG002|Overall Study|PCR positive at Week 68|0|||
128725093|NCT02641379|463290948|FG003|Overall Study|PCR positive at Week 68|0|||
128725094|NCT02641379|463290949|FG004|Overall Study|PCR positive at Week 68|0|||
128725095|NCT02641379|463290950|FG005|Overall Study|PCR positive at Week 68|0|||
128725096|NCT02641379|463290951|FG006|Overall Study|PCR positive at Week 68|0|||
128725097|NCT02641379|463290952|FG007|Overall Study|PCR positive at Week 68|0|||
128725098|NCT02641379|463290953|FG008|Overall Study|PCR positive at Week 68|0|||
128725099|NCT02641379|463290954|FG009|Overall Study|PCR positive at Week 68|0|||
128725100|NCT02641379|463290955|FG010|Overall Study|PCR positive at Week 68|0|||
128725101|NCT02641379|463290945|FG000|Overall Study|PCR positive at Week 48|0|||
128725102|NCT02641379|463290946|FG001|Overall Study|PCR positive at Week 48|1|||
128725103|NCT02641379|463290947|FG002|Overall Study|PCR positive at Week 48|0|||
128725104|NCT02641379|463290948|FG003|Overall Study|PCR positive at Week 48|0|||
128725105|NCT02641379|463290949|FG004|Overall Study|PCR positive at Week 48|0|||
128725106|NCT02641379|463290950|FG005|Overall Study|PCR positive at Week 48|0|||
128725107|NCT02641379|463290951|FG006|Overall Study|PCR positive at Week 48|0|||
128725108|NCT02641379|463290952|FG007|Overall Study|PCR positive at Week 48|0|||
128725109|NCT02641379|463290953|FG008|Overall Study|PCR positive at Week 48|0|||
128725110|NCT02641379|463290954|FG009|Overall Study|PCR positive at Week 48|0|||
128725111|NCT02641379|463290955|FG010|Overall Study|PCR positive at Week 48|0|||
128725112|NCT02641379|463290945|FG000|Overall Study|PCR not performed at Week 12|0|||
129149204|NCT00894387|464844403|FG000|Overall Study|Death|77|||
129149205|NCT00894387|464844404|FG001|Overall Study|Death|76|||
129149206|NCT00894387|464844403|FG000|Overall Study|Protocol Deviation|4|||
129149207|NCT00894387|464844404|FG001|Overall Study|Protocol Deviation|0|||
129149208|NCT00894387|464844403|FG000|Overall Study|Patient's request|25|||
128725113|NCT02641379|463290946|FG001|Overall Study|PCR not performed at Week 12|0|||
128725114|NCT02641379|463290947|FG002|Overall Study|PCR not performed at Week 12|1|||
128725115|NCT02641379|463290948|FG003|Overall Study|PCR not performed at Week 12|0|||
128725116|NCT02641379|463290949|FG004|Overall Study|PCR not performed at Week 12|0|||
128725117|NCT02641379|463290950|FG005|Overall Study|PCR not performed at Week 12|0|||
129149209|NCT00894387|464844404|FG001|Overall Study|Patient's request|30|||
128725118|NCT02641379|463290951|FG006|Overall Study|PCR not performed at Week 12|0|||
128725119|NCT02641379|463290952|FG007|Overall Study|PCR not performed at Week 12|0|||
128725120|NCT02641379|463290953|FG008|Overall Study|PCR not performed at Week 12|0|||
128725121|NCT02641379|463290954|FG009|Overall Study|PCR not performed at Week 12|0|||
128725122|NCT02641379|463290955|FG010|Overall Study|PCR not performed at Week 12|0|||
128725123|NCT02641379|463290945|FG000|Overall Study|No PCR at baseline|0|||
129149210|NCT00894387|464844403|FG000|Overall Study|Other (Missing)|5|||
129149211|NCT00894387|464844404|FG001|Overall Study|Other (Missing)|3|||
129149212|NCT00894387|464844403|FG000|Overall Study|Mis-randomized|13|||
129149213|NCT00894387|464844404|FG001|Overall Study|Mis-randomized|9|||
129149214|NCT00894387|464844403|FG000|Overall Study|GCP non-compliance|0|||
129149215|NCT00894387|464844404|FG001|Overall Study|GCP non-compliance|2|||
129149216|NCT04856527|464844405|FG000|Overall Study|Unable to complete experimental task|2|||
129149217|NCT04856527|464844406|FG001|Overall Study|Unable to complete experimental task|0|||
129149218|NCT01816295|464844407|FG000|Double Blind Phase|Adverse Event|11|||
129149219|NCT01816295|464844408|FG001|Double Blind Phase|Adverse Event|8|||
129149220|NCT01816295|464844407|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
129149221|NCT01816295|464844408|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
129149222|NCT01816295|464844407|FG000|Double Blind Phase|Lost to Follow-up|3|||
129149223|NCT01816295|464844408|FG001|Double Blind Phase|Lost to Follow-up|5|||
129149224|NCT01816295|464844407|FG000|Double Blind Phase|Physician Decision|2|||
129149225|NCT01816295|464844408|FG001|Double Blind Phase|Physician Decision|2|||
129149226|NCT01816295|464844407|FG000|Double Blind Phase|Protocol Violation|17|||
129149227|NCT01816295|464844408|FG001|Double Blind Phase|Protocol Violation|11|||
129149228|NCT01816295|464844407|FG000|Double Blind Phase|Sponsor Decision|8|||
129149229|NCT01816295|464844408|FG001|Double Blind Phase|Sponsor Decision|8|||
129149230|NCT01816295|464844407|FG000|Double Blind Phase|Withdrawal by Subject|22|||
129149231|NCT01816295|464844408|FG001|Double Blind Phase|Withdrawal by Subject|20|||
129149232|NCT01816295|464844407|FG000|OLE Phase|Adverse Event|17|||
129149233|NCT01816295|464844408|FG001|OLE Phase|Adverse Event|15|||
129149234|NCT01816295|464844407|FG000|OLE Phase|Death|1|||
129149235|NCT01816295|464844408|FG001|OLE Phase|Death|0|||
129149236|NCT01816295|464844407|FG000|OLE Phase|Entry Criteria Not Met|3|||
129149237|NCT01816295|464844408|FG001|OLE Phase|Entry Criteria Not Met|5|||
129149238|NCT01816295|464844407|FG000|OLE Phase|Lost to Follow-up|5|||
129149239|NCT01816295|464844408|FG001|OLE Phase|Lost to Follow-up|5|||
129149240|NCT01816295|464844407|FG000|OLE Phase|Physician Decision|3|||
129149241|NCT01816295|464844408|FG001|OLE Phase|Physician Decision|1|||
129149242|NCT01816295|464844407|FG000|OLE Phase|Protocol Violation|4|||
129149243|NCT01816295|464844408|FG001|OLE Phase|Protocol Violation|4|||
129149244|NCT01816295|464844407|FG000|OLE Phase|Sponsor Decision|7|||
129149245|NCT01816295|464844408|FG001|OLE Phase|Sponsor Decision|9|||
129149246|NCT01816295|464844407|FG000|OLE Phase|Withdrawal by Subject|10|||
129149247|NCT01816295|464844408|FG001|OLE Phase|Withdrawal by Subject|10|||
129149248|NCT01816295|464844407|FG000|OLE Phase|Lack of Efficacy|3|||
129149249|NCT01816295|464844408|FG001|OLE Phase|Lack of Efficacy|7|||
129149250|NCT04165824|464844409|FG000|Overall Study|Adverse Event|23|||
129149251|NCT04165824|464844409|FG000|Overall Study|Physician Decision|1|||
128725124|NCT02641379|463290946|FG001|Overall Study|No PCR at baseline|0|||
128725125|NCT02641379|463290947|FG002|Overall Study|No PCR at baseline|1|||
128725126|NCT02641379|463290948|FG003|Overall Study|No PCR at baseline|0|||
129149252|NCT04165824|464844409|FG000|Overall Study|Withdrawal by Subject|17|||
129149253|NCT04165824|464844409|FG000|Overall Study|Other|5|||
129149254|NCT04562116|464844411|FG000|Overall Study|Lost to Follow-up|1|||
129149255|NCT04562116|464844411|FG000|Overall Study|Withdrawal by Subject|3|||
129149256|NCT02412670|464844414|FG000|Overall Study|Adverse Event|4|||
129149257|NCT02412670|464844415|FG001|Overall Study|Adverse Event|1|||
129149258|NCT02412670|464844414|FG000|Overall Study|Physician Decision|1|||
129149259|NCT02412670|464844415|FG001|Overall Study|Physician Decision|0|||
129149260|NCT02412670|464844414|FG000|Overall Study|Withdrawal by Subject|1|||
129149261|NCT02412670|464844415|FG001|Overall Study|Withdrawal by Subject|0|||
129149262|NCT02412670|464844414|FG000|Overall Study|Ineligible|1|||
129149263|NCT02412670|464844415|FG001|Overall Study|Ineligible|0|||
129149264|NCT02921256|464844421|FG000|Arm 1a v. Arm II|Adverse Event|6|||
129149265|NCT02921256|464844422|FG001|Arm 1a v. Arm II|Adverse Event|15|||
129149266|NCT02921256|464844423|FG002|Arm 1a v. Arm II|Adverse Event|0|||
129149267|NCT02921256|464844421|FG000|Arm 1a v. Arm II|Death|0|||
129149268|NCT02921256|464844422|FG001|Arm 1a v. Arm II|Death|2|||
129149269|NCT02921256|464844423|FG002|Arm 1a v. Arm II|Death|0|||
129149270|NCT02921256|464844421|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
129149271|NCT02921256|464844422|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
129149272|NCT02921256|464844423|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
129149273|NCT02921256|464844421|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
129149274|NCT02921256|464844422|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
129149275|NCT02921256|464844423|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
129149276|NCT02921256|464844421|FG000|Arm 1a v. Arm II|Physician Decision|1|||
129149277|NCT02921256|464844422|FG001|Arm 1a v. Arm II|Physician Decision|1|||
129149278|NCT02921256|464844423|FG002|Arm 1a v. Arm II|Physician Decision|0|||
129149279|NCT02921256|464844421|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
129149280|NCT02921256|464844422|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
129149281|NCT02921256|464844423|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
129149282|NCT02921256|464844421|FG000|Arm Ib v Arm III|Adverse Event|9|||
129149283|NCT02921256|464844422|FG001|Arm Ib v Arm III|Adverse Event|0|||
129149284|NCT02921256|464844423|FG002|Arm Ib v Arm III|Adverse Event|4|||
129149285|NCT02921256|464844421|FG000|Arm Ib v Arm III|Death|1|||
129149286|NCT02921256|464844422|FG001|Arm Ib v Arm III|Death|0|||
129149287|NCT02921256|464844423|FG002|Arm Ib v Arm III|Death|1|||
129149288|NCT02921256|464844421|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
129149289|NCT02921256|464844422|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
129149290|NCT02921256|464844423|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
129149291|NCT02921256|464844421|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
129149292|NCT02921256|464844422|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
129149293|NCT02921256|464844423|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
129149294|NCT02921256|464844421|FG000|Arm Ib v Arm III|Physician Decision|4|||
129149295|NCT02921256|464844422|FG001|Arm Ib v Arm III|Physician Decision|0|||
129149296|NCT02921256|464844423|FG002|Arm Ib v Arm III|Physician Decision|1|||
129149297|NCT02921256|464844421|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
129149298|NCT02921256|464844422|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
129149299|NCT02921256|464844423|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
129149300|NCT02943473|464844424|FG000|Overall Study|enrolled but not dosed|1|||
129149301|NCT02943473|464844424|FG000|Overall Study|screen failure|1|||
129149302|NCT02943473|464844424|FG000|Overall Study|Physician Decision|4|||
129149303|NCT01734902|464844425|FG000|Overall Study|Other than listed|0|||
129149304|NCT01734902|464844426|FG001|Overall Study|Other than listed|2|||
129149305|NCT00060944|464844427|FG000|Overall Study|Adverse Event|12|||
129149306|NCT00060944|464844428|FG001|Overall Study|Adverse Event|10|||
129149307|NCT00060944|464844427|FG000|Overall Study|Death|2|||
129149308|NCT00060944|464844428|FG001|Overall Study|Death|3|||
129149309|NCT00060944|464844427|FG000|Overall Study|Withdrawal by Subject|18|||
129149310|NCT00060944|464844428|FG001|Overall Study|Withdrawal by Subject|5|||
129149311|NCT00060944|464844427|FG000|Overall Study|Disease Progression|93|||
129149312|NCT00060944|464844428|FG001|Overall Study|Disease Progression|94|||
129149313|NCT00060944|464844427|FG000|Overall Study|Lost to Follow-up|1|||
129149314|NCT00060944|464844428|FG001|Overall Study|Lost to Follow-up|0|||
129149315|NCT00060944|464844427|FG000|Overall Study|Subject Ineligible To Continue|2|||
129149316|NCT00060944|464844428|FG001|Overall Study|Subject Ineligible To Continue|1|||
129149317|NCT00060944|464844427|FG000|Overall Study|Treatment Switch|0|||
129149318|NCT00060944|464844428|FG001|Overall Study|Treatment Switch|13|||
129149319|NCT00060944|464844427|FG000|Overall Study|Other|2|||
129149320|NCT00060944|464844428|FG001|Overall Study|Other|4|||
129149321|NCT00060944|464844427|FG000|Overall Study|randomized but not treated|6|||
129149322|NCT00060944|464844428|FG001|Overall Study|randomized but not treated|4|||
129149323|NCT03213509|464844430|FG000|Overall Study|Did not consent for verbal autopsy|4|||
129149324|NCT03213509|464844431|FG001|Overall Study|Did not consent for verbal autopsy|5|||
129149325|NCT04549454|464844434|FG000|T1 to T2|Lost to Follow-up|22|||
129149326|NCT04549454|464844435|FG001|T1 to T2|Lost to Follow-up|26|||
129149327|NCT04549454|464844434|FG000|T1 to T3|Lost to Follow-up|31|||
129149328|NCT04549454|464844435|FG001|T1 to T3|Lost to Follow-up|36|||
129149329|NCT00867035|464844436|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
129149330|NCT00867035|464844437|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
129149331|NCT00867035|464844436|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
129149332|NCT00867035|464844437|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
129149333|NCT00016354|464844438|FG000|Overall Study|Lack of Efficacy|0|||
129149334|NCT00016354|464844439|FG001|Overall Study|Lack of Efficacy|0|||
129149335|NCT00016354|464844440|FG002|Overall Study|Lack of Efficacy|0|||
129149336|NCT00016354|464844441|FG003|Overall Study|Lack of Efficacy|0|||
129149337|NCT00016354|464844442|FG004|Overall Study|Lack of Efficacy|0|||
129149338|NCT00016354|464844443|FG005|Overall Study|Lack of Efficacy|0|||
129149339|NCT00016354|464844444|FG006|Overall Study|Lack of Efficacy|0|||
129149340|NCT00016354|464844445|FG007|Overall Study|Lack of Efficacy|1|||
129149341|NCT03110562|464844446|FG000|Initial Treatment Period|Disease Progression|1|||
129149342|NCT03110562|464844447|FG001|Initial Treatment Period|Disease Progression|1|||
129149343|NCT03110562|464844448|FG002|Initial Treatment Period|Disease Progression|0|||
129149344|NCT03110562|464844449|FG003|Initial Treatment Period|Disease Progression|0|||
129149345|NCT03110562|464844446|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
129149346|NCT03110562|464844447|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
128725127|NCT02641379|463290949|FG004|Overall Study|No PCR at baseline|0|||
129149347|NCT03110562|464844448|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
129149348|NCT03110562|464844449|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
129149349|NCT03110562|464844446|FG000|Initial Treatment Period|Adverse Event|1|||
129149350|NCT03110562|464844447|FG001|Initial Treatment Period|Adverse Event|0|||
129149351|NCT03110562|464844448|FG002|Initial Treatment Period|Adverse Event|0|||
129149352|NCT03110562|464844449|FG003|Initial Treatment Period|Adverse Event|0|||
129149353|NCT03110562|464844446|FG000|Initial Treatment Period|Death|74|||
129149354|NCT03110562|464844447|FG001|Initial Treatment Period|Death|82|||
129149355|NCT03110562|464844448|FG002|Initial Treatment Period|Death|0|||
129149356|NCT03110562|464844449|FG003|Initial Treatment Period|Death|0|||
129149357|NCT03110562|464844446|FG000|Initial Treatment Period|Lost to Follow-up|13|||
129149358|NCT03110562|464844447|FG001|Initial Treatment Period|Lost to Follow-up|8|||
129149359|NCT03110562|464844448|FG002|Initial Treatment Period|Lost to Follow-up|0|||
129149360|NCT03110562|464844449|FG003|Initial Treatment Period|Lost to Follow-up|0|||
129149361|NCT03110562|464844446|FG000|Initial Treatment Period|Protocol Deviation|1|||
129149362|NCT03110562|464844447|FG001|Initial Treatment Period|Protocol Deviation|0|||
129149363|NCT03110562|464844448|FG002|Initial Treatment Period|Protocol Deviation|0|||
129149364|NCT03110562|464844449|FG003|Initial Treatment Period|Protocol Deviation|0|||
129149365|NCT03110562|464844446|FG000|Initial Treatment Period|Physician Decision|2|||
129149366|NCT03110562|464844447|FG001|Initial Treatment Period|Physician Decision|1|||
129149367|NCT03110562|464844448|FG002|Initial Treatment Period|Physician Decision|0|||
129149368|NCT03110562|464844449|FG003|Initial Treatment Period|Physician Decision|0|||
129149369|NCT03110562|464844446|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
129149370|NCT03110562|464844447|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
129149371|NCT03110562|464844448|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
129149372|NCT03110562|464844449|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
129149373|NCT03110562|464844446|FG000|Initial Treatment Period|Other|5|||
129149374|NCT03110562|464844447|FG001|Initial Treatment Period|Other|4|||
129149375|NCT03110562|464844448|FG002|Initial Treatment Period|Other|0|||
129149376|NCT03110562|464844449|FG003|Initial Treatment Period|Other|0|||
129149377|NCT03110562|464844446|FG000|Initial Treatment Period|Randomized but never treated|0|||
129149378|NCT03110562|464844447|FG001|Initial Treatment Period|Randomized but never treated|3|||
129149379|NCT03110562|464844448|FG002|Initial Treatment Period|Randomized but never treated|0|||
128725128|NCT02641379|463290950|FG005|Overall Study|No PCR at baseline|0|||
128725129|NCT02641379|463290951|FG006|Overall Study|No PCR at baseline|0|||
128725130|NCT02641379|463290952|FG007|Overall Study|No PCR at baseline|0|||
129149380|NCT03110562|464844449|FG003|Initial Treatment Period|Randomized but never treated|0|||
129149381|NCT03110562|464844446|FG000|Crossover Period|Disease Progression|0|||
129149382|NCT03110562|464844447|FG001|Crossover Period|Disease Progression|0|||
129149383|NCT03110562|464844448|FG002|Crossover Period|Disease Progression|1|||
129149384|NCT03110562|464844449|FG003|Crossover Period|Disease Progression|0|||
129149385|NCT03110562|464844446|FG000|Crossover Period|Withdrawal by Subject|0|||
129149386|NCT03110562|464844447|FG001|Crossover Period|Withdrawal by Subject|0|||
129149387|NCT03110562|464844448|FG002|Crossover Period|Withdrawal by Subject|8|||
129149388|NCT03110562|464844449|FG003|Crossover Period|Withdrawal by Subject|6|||
129149389|NCT03110562|464844446|FG000|Crossover Period|Death|0|||
129149390|NCT03110562|464844447|FG001|Crossover Period|Death|0|||
129149391|NCT03110562|464844448|FG002|Crossover Period|Death|37|||
129149392|NCT03110562|464844449|FG003|Crossover Period|Death|3|||
129149393|NCT03110562|464844446|FG000|Crossover Period|Lost to Follow-up|0|||
129149394|NCT03110562|464844447|FG001|Crossover Period|Lost to Follow-up|0|||
129149395|NCT03110562|464844448|FG002|Crossover Period|Lost to Follow-up|0|||
129149396|NCT03110562|464844449|FG003|Crossover Period|Lost to Follow-up|1|||
129149397|NCT03110562|464844446|FG000|Crossover Period|Other|0|||
129149398|NCT03110562|464844447|FG001|Crossover Period|Other|0|||
129149399|NCT03110562|464844448|FG002|Crossover Period|Other|1|||
129149400|NCT03110562|464844449|FG003|Crossover Period|Other|1|||
129149401|NCT03110562|464844446|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
129149402|NCT03110562|464844447|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
129149403|NCT03110562|464844448|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
129149404|NCT03110562|464844449|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
129149405|NCT02936323|464844452|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129149406|NCT02936323|464844453|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129149407|NCT02936323|464844454|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129149408|NCT02936323|464844455|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129149409|NCT02936323|464844456|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129149410|NCT02936323|464844457|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129149411|NCT02936323|464844458|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129149412|NCT02936323|464844459|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
128725131|NCT02641379|463290953|FG008|Overall Study|No PCR at baseline|0|||
128725132|NCT02641379|463290954|FG009|Overall Study|No PCR at baseline|0|||
129149413|NCT02936323|464844460|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129149414|NCT02936323|464844461|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129149415|NCT02936323|464844452|FG000|Phase 1 Dose Escalation|Death|2|||
129149416|NCT02936323|464844453|FG001|Phase 1 Dose Escalation|Death|1|||
129149417|NCT02936323|464844454|FG002|Phase 1 Dose Escalation|Death|3|||
129149418|NCT02936323|464844455|FG003|Phase 1 Dose Escalation|Death|1|||
129149419|NCT02936323|464844456|FG004|Phase 1 Dose Escalation|Death|2|||
129149420|NCT02936323|464844457|FG005|Phase 1 Dose Escalation|Death|3|||
129149421|NCT02936323|464844458|FG006|Phase 1 Dose Escalation|Death|3|||
129149422|NCT02936323|464844459|FG007|Phase 1 Dose Escalation|Death|0|||
129149423|NCT02936323|464844460|FG008|Phase 1 Dose Escalation|Death|0|||
129149424|NCT02936323|464844461|FG009|Phase 1 Dose Escalation|Death|0|||
129149425|NCT02936323|464844452|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149426|NCT02936323|464844453|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149427|NCT02936323|464844454|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149428|NCT02936323|464844455|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149429|NCT02936323|464844456|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149430|NCT02936323|464844457|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
129149431|NCT02936323|464844458|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149432|NCT02936323|464844459|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149433|NCT02936323|464844460|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149434|NCT02936323|464844461|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129149435|NCT02936323|464844452|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129149436|NCT02936323|464844453|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129149437|NCT02936323|464844454|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129149438|NCT02936323|464844455|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129149439|NCT02936323|464844456|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129149440|NCT02936323|464844457|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129149441|NCT02936323|464844458|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129149442|NCT02936323|464844459|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
129149443|NCT02936323|464844460|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
129149444|NCT02936323|464844461|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
129149445|NCT02936323|464844452|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
129149446|NCT02936323|464844453|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
129149447|NCT02936323|464844454|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
129149448|NCT02936323|464844455|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
129149449|NCT02936323|464844456|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
129149450|NCT02936323|464844457|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
129149451|NCT02936323|464844458|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
129149452|NCT02936323|464844459|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
129149453|NCT02936323|464844460|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
129149454|NCT02936323|464844461|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
129149455|NCT02936323|464844452|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149456|NCT02936323|464844453|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149457|NCT02936323|464844454|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149458|NCT02936323|464844455|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149459|NCT02936323|464844456|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149460|NCT02936323|464844457|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149461|NCT02936323|464844458|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149462|NCT02936323|464844459|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
129149463|NCT02936323|464844460|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
129149464|NCT02936323|464844461|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129149465|NCT02936323|464844452|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149466|NCT02936323|464844453|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149467|NCT02936323|464844454|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149468|NCT02936323|464844455|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149469|NCT02936323|464844456|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149470|NCT02936323|464844457|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149471|NCT02936323|464844458|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149472|NCT02936323|464844459|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149473|NCT02936323|464844460|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129149474|NCT02936323|464844461|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
129149475|NCT02936323|464844452|FG000|Phase 2a Dose Expansion|Death|0|||
129149476|NCT02936323|464844453|FG001|Phase 2a Dose Expansion|Death|0|||
129149477|NCT02936323|464844454|FG002|Phase 2a Dose Expansion|Death|0|||
129149478|NCT02936323|464844455|FG003|Phase 2a Dose Expansion|Death|0|||
129149479|NCT02936323|464844456|FG004|Phase 2a Dose Expansion|Death|0|||
129149480|NCT02936323|464844457|FG005|Phase 2a Dose Expansion|Death|0|||
129149481|NCT02936323|464844458|FG006|Phase 2a Dose Expansion|Death|0|||
129149482|NCT02936323|464844459|FG007|Phase 2a Dose Expansion|Death|4|||
129149483|NCT02936323|464844460|FG008|Phase 2a Dose Expansion|Death|8|||
129149484|NCT02936323|464844461|FG009|Phase 2a Dose Expansion|Death|10|||
129149485|NCT04577404|464844462|FG000|Overall Study|Adverse Event|31|||
129149486|NCT04577404|464844462|FG000|Overall Study|Death|1|||
129149487|NCT04577404|464844462|FG000|Overall Study|Lack of Efficacy|3|||
129149488|NCT04577404|464844462|FG000|Overall Study|Physician Decision|7|||
129149489|NCT04577404|464844462|FG000|Overall Study|Withdrawal by Subject|21|||
129149490|NCT04577404|464844462|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
128725133|NCT02641379|463290955|FG010|Overall Study|No PCR at baseline|0|||
128725134|NCT02641379|463290945|FG000|Overall Study|PCR positive at Week 28|0|||
128725135|NCT02641379|463290946|FG001|Overall Study|PCR positive at Week 28|0|||
128725136|NCT02641379|463290947|FG002|Overall Study|PCR positive at Week 28|1|||
128725137|NCT02641379|463290948|FG003|Overall Study|PCR positive at Week 28|0|||
128725138|NCT02641379|463290949|FG004|Overall Study|PCR positive at Week 28|0|||
128725139|NCT02641379|463290950|FG005|Overall Study|PCR positive at Week 28|0|||
128725140|NCT02641379|463290951|FG006|Overall Study|PCR positive at Week 28|0|||
128725141|NCT02641379|463290952|FG007|Overall Study|PCR positive at Week 28|0|||
128725142|NCT02641379|463290953|FG008|Overall Study|PCR positive at Week 28|0|||
128725143|NCT02641379|463290954|FG009|Overall Study|PCR positive at Week 28|0|||
129149491|NCT03423979|464844472|FG000|Overall Study|Death|1|||
129149492|NCT01334918|464845440|FG000|Overall Study|Did not receive study drug|6|||
129149493|NCT01334918|464845441|FG001|Overall Study|Did not receive study drug|0|||
129149494|NCT01334918|464845440|FG000|Overall Study|Adverse Event|2|||
129149495|NCT01334918|464845441|FG001|Overall Study|Adverse Event|0|||
129149496|NCT01334918|464845440|FG000|Overall Study|Withdrawal by Subject|0|||
129149497|NCT01334918|464845441|FG001|Overall Study|Withdrawal by Subject|1|||
129149498|NCT02724839|464845442|FG000|Overall Study|Withdrawal by Subject|1|||
129149499|NCT02724839|464845443|FG001|Overall Study|Withdrawal by Subject|1|||
129149500|NCT02724839|464845444|FG002|Overall Study|Withdrawal by Subject|0|||
129149501|NCT02724839|464845442|FG000|Overall Study|Lost to Follow-up|0|||
129149502|NCT02724839|464845443|FG001|Overall Study|Lost to Follow-up|3|||
129149503|NCT02724839|464845444|FG002|Overall Study|Lost to Follow-up|2|||
129149504|NCT02724839|464845442|FG000|Overall Study|Physician Decision|0|||
129149505|NCT02724839|464845443|FG001|Overall Study|Physician Decision|0|||
129149506|NCT02724839|464845444|FG002|Overall Study|Physician Decision|3|||
129149507|NCT05878067|464845445|FG000|Overall Study|Lost to Follow-up|2|||
129149508|NCT01959529|464845446|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
129149509|NCT01959529|464845447|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
129149510|NCT01959529|464845446|FG000|Overall Study|Lost to Follow-up|4|||
129149511|NCT01959529|464845447|FG001|Overall Study|Lost to Follow-up|1|||
129149512|NCT01959529|464845446|FG000|Overall Study|Other|70|||
129149513|NCT01959529|464845447|FG001|Overall Study|Other|68|||
129149514|NCT01959529|464845446|FG000|Overall Study|Hypoglycaemia|1|||
129149515|NCT01959529|464845447|FG001|Overall Study|Hypoglycaemia|1|||
129149516|NCT01959529|464845446|FG000|Overall Study|Lack of glycaemic control|1|||
129149517|NCT01959529|464845447|FG001|Overall Study|Lack of glycaemic control|1|||
129149518|NCT00399035|464845455|FG000|Overall Study|Death|289|||
129149519|NCT00399035|464845456|FG001|Overall Study|Death|141|||
129149520|NCT00399035|464845457|FG002|Overall Study|Death|234|||
129149521|NCT00399035|464845455|FG000|Overall Study|Lost to Follow-up|2|||
129149522|NCT00399035|464845456|FG001|Overall Study|Lost to Follow-up|1|||
129149523|NCT00399035|464845457|FG002|Overall Study|Lost to Follow-up|5|||
129149524|NCT00399035|464845455|FG000|Overall Study|Withdrawal by Subject|19|||
129149525|NCT00399035|464845456|FG001|Overall Study|Withdrawal by Subject|15|||
129149526|NCT00399035|464845457|FG002|Overall Study|Withdrawal by Subject|12|||
129149527|NCT00399035|464845455|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
129149528|NCT00399035|464845456|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
129149529|NCT00399035|464845457|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
129149530|NCT00399035|464845455|FG000|Overall Study|Severe non-compliance with protocol|2|||
129149531|NCT00399035|464845456|FG001|Overall Study|Severe non-compliance with protocol|1|||
129149532|NCT00399035|464845457|FG002|Overall Study|Severe non-compliance with protocol|0|||
128725144|NCT02641379|463290955|FG010|Overall Study|PCR positive at Week 28|0|||
128725145|NCT02641379|463290945|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
128725146|NCT02641379|463290946|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
129149533|NCT01128569|464845461|FG000|Washout Period 1|Adverse Event|0|||
129149534|NCT01128569|464845462|FG001|Washout Period 1|Adverse Event|0|||
129149535|NCT01128569|464845463|FG002|Washout Period 1|Adverse Event|1|||
129149536|NCT01128569|464845464|FG003|Washout Period 1|Adverse Event|0|||
129149537|NCT01128569|464845465|FG004|Washout Period 1|Adverse Event|0|||
129149538|NCT01128569|464845466|FG005|Washout Period 1|Adverse Event|0|||
128725147|NCT02641379|463290947|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
129149539|NCT01128569|464845461|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129149540|NCT01128569|464845462|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129149541|NCT01128569|464845463|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129149542|NCT01128569|464845464|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129149543|NCT01128569|464845465|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129149544|NCT01128569|464845466|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129149545|NCT01561976|464845471|FG000|Period 1|Adverse Event|0|||
129149546|NCT01561976|464845472|FG001|Period 1|Adverse Event|0|||
129149547|NCT01561976|464845473|FG002|Period 1|Adverse Event|1|||
129149548|NCT01561976|464845474|FG003|Period 1|Adverse Event|0|||
129149549|NCT01561976|464845475|FG004|Period 1|Adverse Event|0|||
129149550|NCT01561976|464845476|FG005|Period 1|Adverse Event|0|||
129149551|NCT01561976|464845471|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
129149552|NCT01561976|464845472|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
129149553|NCT01561976|464845473|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
128725148|NCT02641379|463290948|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
128725149|NCT02641379|463290949|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
129149554|NCT01561976|464845474|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
129149555|NCT01561976|464845475|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
129149556|NCT01561976|464845476|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
129149557|NCT01561976|464845471|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129149558|NCT01561976|464845472|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129149559|NCT01561976|464845473|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129149560|NCT01561976|464845474|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129149561|NCT01561976|464845475|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129149562|NCT01561976|464845476|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129149563|NCT01561976|464845471|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
129149564|NCT01561976|464845472|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
129149565|NCT01561976|464845473|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
129149566|NCT01561976|464845474|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
129149567|NCT01561976|464845475|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
129149568|NCT01561976|464845476|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
129149569|NCT01463527|464845477|FG000|Overall Study|Protocol Violation|1|||
129149570|NCT01463527|464845478|FG001|Overall Study|Protocol Violation|1|||
129149571|NCT01463527|464845477|FG000|Overall Study|Crying >20% of sedation|5|||
129149572|NCT01463527|464845478|FG001|Overall Study|Crying >20% of sedation|6|||
129149573|NCT05136170|464845481|FG000|Overall Study|Withdrawal by Subject|2|||
129149574|NCT05136170|464845482|FG001|Overall Study|Withdrawal by Subject|2|||
129149575|NCT05136170|464845481|FG000|Overall Study|Can no longer make office visits|1|||
129149576|NCT05136170|464845482|FG001|Overall Study|Can no longer make office visits|0|||
129149577|NCT01493414|464845483|FG000|Overall Study|Adverse Event|405|||
129149578|NCT01493414|464845483|FG000|Overall Study|Disease progression|204|||
129149579|NCT01493414|464845483|FG000|Overall Study|Death|101|||
129149580|NCT01493414|464845483|FG000|Overall Study|Physician Decision|93|||
129149581|NCT01493414|464845483|FG000|Overall Study|Withdrawal by Subject|79|||
129149582|NCT01493414|464845483|FG000|Overall Study|Protocol deviation|27|||
129149583|NCT01493414|464845483|FG000|Overall Study|Administrative problems|25|||
129149584|NCT01493414|464845483|FG000|Overall Study|Lost to Follow-up|16|||
129149585|NCT01977222|464845488|FG000|Overall Study|Withdrawal by Subject|1|||
129149586|NCT01612676|464845491|FG000|Overall Study|Adverse Event|2|||
129149587|NCT01612676|464845492|FG001|Overall Study|Adverse Event|3|||
129149588|NCT01612676|464845493|FG002|Overall Study|Adverse Event|1|||
129149589|NCT01612676|464845494|FG003|Overall Study|Adverse Event|3|||
129149590|NCT01612676|464845491|FG000|Overall Study|Protocol Violation|0|||
129149591|NCT01612676|464845492|FG001|Overall Study|Protocol Violation|1|||
129149592|NCT01612676|464845493|FG002|Overall Study|Protocol Violation|0|||
129149593|NCT01612676|464845494|FG003|Overall Study|Protocol Violation|0|||
129149594|NCT00107276|464845498|FG000|Overall Study|Progression|46|||
129149595|NCT00107276|464845498|FG000|Overall Study|Adverse Event|6|||
129149596|NCT00107276|464845498|FG000|Overall Study|M.D. decision|2|||
129149597|NCT00107276|464845498|FG000|Overall Study|Patient refusal|1|||
129149598|NCT00107276|464845498|FG000|Overall Study|Death|1|||
129149599|NCT00107276|464845498|FG000|Overall Study|Ineligible|16|||
129149600|NCT04846231|464845499|FG000|Overall Study|Lost to Follow-up|1|||
129149601|NCT04846231|464845500|FG001|Overall Study|Lost to Follow-up|0|||
129149602|NCT04846231|464845501|FG002|Overall Study|Lost to Follow-up|0|||
129149603|NCT04846231|464845502|FG003|Overall Study|Lost to Follow-up|0|||
129149604|NCT04846231|464845503|FG004|Overall Study|Lost to Follow-up|0|||
129149605|NCT04846231|464845504|FG005|Overall Study|Lost to Follow-up|0|||
129149606|NCT04846231|464845505|FG006|Overall Study|Lost to Follow-up|0|||
129149607|NCT04846231|464845506|FG007|Overall Study|Lost to Follow-up|1|||
129149608|NCT04846231|464845499|FG000|Overall Study|Withdrawal by Subject|0|||
129149609|NCT04846231|464845500|FG001|Overall Study|Withdrawal by Subject|1|||
129149610|NCT04846231|464845501|FG002|Overall Study|Withdrawal by Subject|2|||
128725150|NCT02641379|463290950|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
128725151|NCT02641379|463290951|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
129149611|NCT04846231|464845502|FG003|Overall Study|Withdrawal by Subject|1|||
129149612|NCT04846231|464845503|FG004|Overall Study|Withdrawal by Subject|0|||
129149613|NCT04846231|464845504|FG005|Overall Study|Withdrawal by Subject|0|||
129149614|NCT04846231|464845505|FG006|Overall Study|Withdrawal by Subject|0|||
129149615|NCT04846231|464845506|FG007|Overall Study|Withdrawal by Subject|0|||
129149616|NCT04846231|464845499|FG000|Overall Study|Protocol Violation|0|||
129149617|NCT04846231|464845500|FG001|Overall Study|Protocol Violation|1|||
128725152|NCT02641379|463290952|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
129149618|NCT04846231|464845501|FG002|Overall Study|Protocol Violation|0|||
129149619|NCT04846231|464845502|FG003|Overall Study|Protocol Violation|0|||
129149620|NCT04846231|464845503|FG004|Overall Study|Protocol Violation|0|||
129149621|NCT04846231|464845504|FG005|Overall Study|Protocol Violation|0|||
129149622|NCT04846231|464845505|FG006|Overall Study|Protocol Violation|0|||
129149623|NCT04846231|464845506|FG007|Overall Study|Protocol Violation|0|||
129149624|NCT04846231|464845499|FG000|Overall Study|Adverse Event|0|||
129149625|NCT04846231|464845500|FG001|Overall Study|Adverse Event|0|||
129149626|NCT04846231|464845501|FG002|Overall Study|Adverse Event|0|||
129149627|NCT04846231|464845502|FG003|Overall Study|Adverse Event|0|||
129149628|NCT04846231|464845503|FG004|Overall Study|Adverse Event|0|||
129149629|NCT04846231|464845504|FG005|Overall Study|Adverse Event|0|||
129149630|NCT04846231|464845505|FG006|Overall Study|Adverse Event|1|||
129149631|NCT04846231|464845506|FG007|Overall Study|Adverse Event|1|||
129149632|NCT02980107|464845507|FG000|Overall Study|Withdrawal by Subject|51|||
129149633|NCT02980107|464845508|FG001|Overall Study|Withdrawal by Subject|62|||
129149634|NCT00945659|464845509|FG000|Overall Study|Lost to Follow-up|7|||
129149635|NCT00945659|464845510|FG001|Overall Study|Lost to Follow-up|20|||
129149636|NCT00945659|464845511|FG002|Overall Study|Lost to Follow-up|17|||
129149637|NCT04211363|464845514|FG000|Overall Study|Adverse Event|5|||
129149638|NCT04211363|464845515|FG001|Overall Study|Adverse Event|2|||
129149639|NCT04211363|464845514|FG000|Overall Study|Physician Decision|0|||
129149640|NCT04211363|464845515|FG001|Overall Study|Physician Decision|1|||
129149641|NCT04211363|464845514|FG000|Overall Study|Protocol Violation|1|||
129149642|NCT04211363|464845515|FG001|Overall Study|Protocol Violation|0|||
129149643|NCT04211363|464845514|FG000|Overall Study|Pregnancy|1|||
129149644|NCT04211363|464845515|FG001|Overall Study|Pregnancy|0|||
129149645|NCT04211363|464845514|FG000|Overall Study|Lost to Follow-up|12|||
129149646|NCT04211363|464845515|FG001|Overall Study|Lost to Follow-up|4|||
129149647|NCT04211363|464845514|FG000|Overall Study|Withdrawal by Subject|11|||
129149648|NCT04211363|464845515|FG001|Overall Study|Withdrawal by Subject|11|||
129149649|NCT04211363|464845514|FG000|Overall Study|Other|1|||
129149650|NCT04211363|464845515|FG001|Overall Study|Other|2|||
129149651|NCT03097289|464845516|FG000|Overall Study|Adverse Event|1|||
129149652|NCT03097289|464845516|FG000|Overall Study|Equipment failure|2|||
129149653|NCT03097289|464845516|FG000|Overall Study|Collected platelet product unusable|3|||
129149654|NCT01823289|464845517|FG000|Overall Study|Lost to Follow-up|5|||
129149655|NCT01823289|464845517|FG000|Overall Study|Adverse Event|5|||
129149656|NCT01823289|464845517|FG000|Overall Study|Lack of Efficacy|1|||
129149657|NCT01823289|464845517|FG000|Overall Study|Physician Decision|9|||
129149658|NCT01823289|464845517|FG000|Overall Study|Administered contraindicated medicine|1|||
129149659|NCT01823289|464845517|FG000|Overall Study|Transaminase increased more than 3 times|1|||
129149660|NCT01823289|464845517|FG000|Overall Study|Drug affected efficacy and safety|1|||
129149661|NCT01823289|464845517|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
129149662|NCT01736917|464845518|FG000|Overall Study|Adverse Event|1|||
129149663|NCT01736917|464845518|FG000|Overall Study|Protocol Violation|10|||
129149664|NCT00654732|464845519|FG000|Overall Study|Adverse Event|4|||
129149665|NCT00654732|464845520|FG001|Overall Study|Adverse Event|6|||
129149666|NCT01959932|464845521|FG000|Overall Study|Withdrawal by Subject|1|||
129149667|NCT01959932|464845522|FG001|Overall Study|Withdrawal by Subject|0|||
129149668|NCT01959932|464845523|FG002|Overall Study|Withdrawal by Subject|0|||
129149669|NCT00776230|464845526|FG000|Overall Study|Lost to Follow-up|2|||
129149670|NCT00776230|464845527|FG001|Overall Study|Lost to Follow-up|1|||
129149671|NCT00776230|464845528|FG002|Overall Study|Lost to Follow-up|5|||
129149672|NCT00776230|464845526|FG000|Overall Study|Not vaccinated at Day 0|1|||
129149673|NCT00776230|464845527|FG001|Overall Study|Not vaccinated at Day 0|0|||
129149674|NCT00776230|464845528|FG002|Overall Study|Not vaccinated at Day 0|0|||
129149675|NCT00776230|464845526|FG000|Overall Study|Withdrawal by Subject|0|||
129149676|NCT00776230|464845527|FG001|Overall Study|Withdrawal by Subject|1|||
129149677|NCT00776230|464845528|FG002|Overall Study|Withdrawal by Subject|0|||
129149678|NCT00776230|464845526|FG000|Overall Study|Subject missed Visit 4|0|||
129149679|NCT00776230|464845527|FG001|Overall Study|Subject missed Visit 4|1|||
129149680|NCT00776230|464845528|FG002|Overall Study|Subject missed Visit 4|0|||
129149681|NCT02993263|464845540|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
129149682|NCT00545779|464845541|FG000|Overall Study|Violation of selection criteria at entry|8|||
129149683|NCT00545779|464845541|FG000|Overall Study|Other protocol violation|1|||
129149684|NCT00545779|464845541|FG000|Overall Study|Did not cooperate|7|||
129149685|NCT00545779|464845541|FG000|Overall Study|Withdrawal by Subject|20|||
129149686|NCT00545779|464845541|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
129149687|NCT00545779|464845541|FG000|Overall Study|Failure to return|3|||
129149688|NCT01405196|464845542|FG000|Overall Study|Study Terminated by Sponsor|0|||
129149689|NCT01405196|464845543|FG001|Overall Study|Study Terminated by Sponsor|0|||
129149690|NCT01405196|464845544|FG002|Overall Study|Study Terminated by Sponsor|9|||
129149691|NCT01405196|464845545|FG003|Overall Study|Study Terminated by Sponsor|0|||
129149692|NCT01405196|464845542|FG000|Overall Study|Other|2|||
129149693|NCT01405196|464845543|FG001|Overall Study|Other|2|||
129149694|NCT01405196|464845544|FG002|Overall Study|Other|5|||
129149695|NCT01405196|464845545|FG003|Overall Study|Other|0|||
129149696|NCT01405196|464845542|FG000|Overall Study|Withdrawal by Subject|4|||
129149697|NCT01405196|464845543|FG001|Overall Study|Withdrawal by Subject|6|||
129149698|NCT01405196|464845544|FG002|Overall Study|Withdrawal by Subject|3|||
129149699|NCT01405196|464845545|FG003|Overall Study|Withdrawal by Subject|6|||
129149700|NCT01405196|464845542|FG000|Overall Study|Adverse Event|2|||
129149701|NCT01405196|464845543|FG001|Overall Study|Adverse Event|2|||
129149702|NCT01405196|464845544|FG002|Overall Study|Adverse Event|0|||
129149703|NCT01405196|464845545|FG003|Overall Study|Adverse Event|2|||
129149704|NCT01405196|464845542|FG000|Overall Study|Death|1|||
129149705|NCT01405196|464845543|FG001|Overall Study|Death|0|||
129149706|NCT01405196|464845544|FG002|Overall Study|Death|3|||
129149707|NCT01405196|464845545|FG003|Overall Study|Death|0|||
129149708|NCT01405196|464845542|FG000|Overall Study|Lost to Follow-up|2|||
129149709|NCT01405196|464845543|FG001|Overall Study|Lost to Follow-up|2|||
129149710|NCT01405196|464845544|FG002|Overall Study|Lost to Follow-up|3|||
129149711|NCT01405196|464845545|FG003|Overall Study|Lost to Follow-up|1|||
129149712|NCT01729039|464845548|FG000|Overall Study|disqualified|2|||
129149713|NCT01729039|464845549|FG001|Overall Study|disqualified|5|||
129149714|NCT01729039|464845548|FG000|Overall Study|Withdrawal by Subject|8|||
129149715|NCT01729039|464845549|FG001|Overall Study|Withdrawal by Subject|7|||
129149716|NCT00698841|464845550|FG000|Overall Study|Withdrawal by Subject|2|||
129149717|NCT00698841|464845550|FG000|Overall Study|Adverse Event|3|||
129149718|NCT00698841|464845550|FG000|Overall Study|Disease progression|7|||
129149719|NCT00698841|464845550|FG000|Overall Study|Failure to meet eligibility criteria|2|||
129149720|NCT00698841|464845550|FG000|Overall Study|Study drug toxicity|2|||
129149721|NCT00698841|464845550|FG000|Overall Study|Other|2|||
129149722|NCT02611037|464845551|FG000|Overall Study|Withdrawal prior to treatment|2|||
128725153|NCT02641379|463290953|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
128725154|NCT02641379|463290954|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
128725155|NCT02641379|463290955|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
129149723|NCT02611037|464845552|FG001|Overall Study|Withdrawal prior to treatment|0|||
129149724|NCT00829998|464845553|FG000|Washout|Adverse Event|0|||
129149725|NCT00829998|464845554|FG001|Washout|Adverse Event|1|||
129149726|NCT05788991|464845557|FG000|Overall Study|Not treated with study medication|1|||
129149727|NCT05788991|464845558|FG001|Overall Study|Not treated with study medication|3|||
129149728|NCT05788991|464845557|FG000|Overall Study|Withdrawal by Subject|1|||
129149729|NCT05788991|464845558|FG001|Overall Study|Withdrawal by Subject|0|||
129149730|NCT05788991|464845557|FG000|Overall Study|Lack of Efficacy|0|||
129149731|NCT05788991|464845558|FG001|Overall Study|Lack of Efficacy|1|||
129149732|NCT05788991|464845557|FG000|Overall Study|Protocol Violation|1|||
129149733|NCT05788991|464845558|FG001|Overall Study|Protocol Violation|2|||
129149734|NCT05270863|464845559|FG000|Visit 2 First Intervention|Randomization error|0|||
129149735|NCT05270863|464845560|FG001|Visit 2 First Intervention|Randomization error|0|||
129149736|NCT05270863|464845561|FG002|Visit 2 First Intervention|Randomization error|0|||
129149737|NCT05270863|464845562|FG003|Visit 2 First Intervention|Randomization error|1|||
129149738|NCT05270863|464845563|FG004|Visit 2 First Intervention|Randomization error|0|||
129149739|NCT05270863|464845564|FG005|Visit 2 First Intervention|Randomization error|0|||
129149740|NCT05270863|464845559|FG000|First Washout|Withdrawal by Subject|0|||
129149741|NCT05270863|464845560|FG001|First Washout|Withdrawal by Subject|0|||
129149742|NCT05270863|464845561|FG002|First Washout|Withdrawal by Subject|0|||
129149743|NCT05270863|464845562|FG003|First Washout|Withdrawal by Subject|0|||
129149744|NCT05270863|464845563|FG004|First Washout|Withdrawal by Subject|1|||
129149745|NCT05270863|464845564|FG005|First Washout|Withdrawal by Subject|1|||
129149746|NCT05270863|464845559|FG000|First Washout|Lost to Follow-up|0|||
129149747|NCT05270863|464845560|FG001|First Washout|Lost to Follow-up|0|||
129149748|NCT05270863|464845561|FG002|First Washout|Lost to Follow-up|0|||
129149749|NCT05270863|464845562|FG003|First Washout|Lost to Follow-up|0|||
129149750|NCT05270863|464845563|FG004|First Washout|Lost to Follow-up|0|||
129149751|NCT05270863|464845564|FG005|First Washout|Lost to Follow-up|1|||
129149752|NCT05270863|464845559|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
129149753|NCT05270863|464845560|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
129149754|NCT05270863|464845561|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
129149755|NCT05270863|464845562|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
129149756|NCT05270863|464845563|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
129149757|NCT05270863|464845564|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
129149758|NCT05270863|464845559|FG000|Second Washout|Withdrawal by Subject|1|||
129149759|NCT05270863|464845560|FG001|Second Washout|Withdrawal by Subject|1|||
129149760|NCT05270863|464845561|FG002|Second Washout|Withdrawal by Subject|0|||
129149761|NCT05270863|464845562|FG003|Second Washout|Withdrawal by Subject|0|||
129149762|NCT05270863|464845563|FG004|Second Washout|Withdrawal by Subject|0|||
129149763|NCT05270863|464845564|FG005|Second Washout|Withdrawal by Subject|0|||
129149764|NCT05270863|464845559|FG000|Second Washout|Lost to Follow-up|0|||
129149765|NCT05270863|464845560|FG001|Second Washout|Lost to Follow-up|0|||
129149766|NCT05270863|464845561|FG002|Second Washout|Lost to Follow-up|0|||
129149767|NCT05270863|464845562|FG003|Second Washout|Lost to Follow-up|1|||
129149768|NCT05270863|464845563|FG004|Second Washout|Lost to Follow-up|0|||
129149769|NCT05270863|464845564|FG005|Second Washout|Lost to Follow-up|0|||
129149770|NCT04464473|464845565|FG000|Overall Study|New piercing could not be removed for scanning|0|||
129149771|NCT04464473|464845566|FG001|Overall Study|New piercing could not be removed for scanning|0|||
129149772|NCT04464473|464845567|FG002|Overall Study|New piercing could not be removed for scanning|0|||
129149773|NCT04464473|464845568|FG003|Overall Study|New piercing could not be removed for scanning|1|||
129149774|NCT04464473|464845569|FG004|Overall Study|New piercing could not be removed for scanning|0|||
129149775|NCT04464473|464845570|FG005|Overall Study|New piercing could not be removed for scanning|0|||
129149776|NCT04464473|464845565|FG000|Overall Study|Adverse Event|0|||
129149777|NCT04464473|464845566|FG001|Overall Study|Adverse Event|0|||
129149778|NCT04464473|464845567|FG002|Overall Study|Adverse Event|0|||
129149779|NCT04464473|464845568|FG003|Overall Study|Adverse Event|1|||
129149780|NCT04464473|464845569|FG004|Overall Study|Adverse Event|0|||
129149781|NCT04464473|464845570|FG005|Overall Study|Adverse Event|0|||
129149782|NCT04464473|464845565|FG000|Overall Study|Lost to Follow-up|0|||
129149783|NCT04464473|464845566|FG001|Overall Study|Lost to Follow-up|0|||
129149784|NCT04464473|464845567|FG002|Overall Study|Lost to Follow-up|0|||
129149785|NCT04464473|464845568|FG003|Overall Study|Lost to Follow-up|1|||
129149786|NCT04464473|464845569|FG004|Overall Study|Lost to Follow-up|0|||
129149787|NCT04464473|464845570|FG005|Overall Study|Lost to Follow-up|0|||
129149788|NCT01585025|464847104|FG000|Overall Study|Withdrawal by Subject|0|||
129149789|NCT01585025|464847105|FG001|Overall Study|Withdrawal by Subject|3|||
129149790|NCT01585025|464847106|FG002|Overall Study|Withdrawal by Subject|4|||
129149791|NCT00503984|464847107|FG000|Overall Study|Protocol Violation|0|||
129149792|NCT00503984|464847108|FG001|Overall Study|Protocol Violation|1|||
129149793|NCT00503984|464847109|FG002|Overall Study|Protocol Violation|0|||
129149794|NCT00503984|464847110|FG003|Overall Study|Protocol Violation|0|||
129149795|NCT00503984|464847111|FG004|Overall Study|Protocol Violation|0|||
129149796|NCT00503984|464847112|FG005|Overall Study|Protocol Violation|0|||
129149797|NCT00503984|464847107|FG000|Overall Study|Adverse Event|0|||
129149798|NCT00503984|464847108|FG001|Overall Study|Adverse Event|1|||
129149799|NCT00503984|464847109|FG002|Overall Study|Adverse Event|0|||
129149800|NCT00503984|464847110|FG003|Overall Study|Adverse Event|0|||
129149801|NCT00503984|464847111|FG004|Overall Study|Adverse Event|0|||
129149802|NCT00503984|464847112|FG005|Overall Study|Adverse Event|0|||
129149803|NCT00503984|464847107|FG000|Overall Study|Death|0|||
129149804|NCT00503984|464847108|FG001|Overall Study|Death|0|||
129149805|NCT00503984|464847109|FG002|Overall Study|Death|0|||
129149806|NCT00503984|464847110|FG003|Overall Study|Death|0|||
129149807|NCT00503984|464847111|FG004|Overall Study|Death|1|||
129149808|NCT00503984|464847112|FG005|Overall Study|Death|0|||
129149809|NCT01246960|464847113|FG000|Overall Study|Lost to Follow-up|3|||
129149810|NCT01246960|464847114|FG001|Overall Study|Lost to Follow-up|1|||
129149811|NCT01246960|464847113|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
129149812|NCT01246960|464847114|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
129149813|NCT00140140|464847121|FG000|Overall Study|Unacceptable toxicity|1|||
129149814|NCT00140140|464847122|FG001|Overall Study|Unacceptable toxicity|1|||
129149815|NCT00140140|464847123|FG002|Overall Study|Unacceptable toxicity|2|||
129149816|NCT00140140|464847121|FG000|Overall Study|Physician Decision|1|||
129149817|NCT00140140|464847122|FG001|Overall Study|Physician Decision|1|||
129149818|NCT00140140|464847123|FG002|Overall Study|Physician Decision|0|||
129149819|NCT03376516|464847124|FG000|Overall Study|Not treated|1|||
129149820|NCT03376516|464847124|FG000|Overall Study|Consent withdrawn|1|||
129149821|NCT01359956|464847125|FG000|Overall Study|Death|58|||
129149822|NCT01359956|464847126|FG001|Overall Study|Death|60|||
129149823|NCT01359956|464847127|FG002|Overall Study|Death|66|||
129149824|NCT01359956|464847128|FG003|Overall Study|Death|57|||
129149825|NCT01359956|464847125|FG000|Overall Study|Lost to Follow-up|3|||
129149826|NCT01359956|464847126|FG001|Overall Study|Lost to Follow-up|4|||
129149827|NCT01359956|464847127|FG002|Overall Study|Lost to Follow-up|1|||
129149828|NCT01359956|464847128|FG003|Overall Study|Lost to Follow-up|1|||
129149829|NCT00582907|464847129|FG000|1st Course|Withdrawal by Subject|1|||
129149830|NCT00582907|464847130|FG001|1st Course|Withdrawal by Subject|0|||
129149831|NCT00582907|464847131|FG002|1st Course|Withdrawal by Subject|0|||
129149832|NCT00582907|464847132|FG003|1st Course|Withdrawal by Subject|0|||
129149833|NCT00582907|464847129|FG000|1st Course|Lost to Follow-up|0|||
129149834|NCT00582907|464847130|FG001|1st Course|Lost to Follow-up|0|||
129149835|NCT00582907|464847131|FG002|1st Course|Lost to Follow-up|0|||
129149836|NCT00582907|464847132|FG003|1st Course|Lost to Follow-up|1|||
129149837|NCT00582907|464847129|FG000|2nd Course|Lack of Efficacy|1|||
129149838|NCT00582907|464847130|FG001|2nd Course|Lack of Efficacy|0|||
129149839|NCT00582907|464847131|FG002|2nd Course|Lack of Efficacy|0|||
129149840|NCT00582907|464847132|FG003|2nd Course|Lack of Efficacy|0|||
129149841|NCT00370292|464847133|FG000|Overall Study|Disease Progression|4|||
129149842|NCT00370292|464847133|FG000|Overall Study|Adverse Event|7|||
129149843|NCT00370292|464847133|FG000|Overall Study|Physician Decision|2|||
129149844|NCT02704208|464847134|FG000|Overall Study|Lost to Follow-up|42|||
129149845|NCT02704208|464847135|FG001|Overall Study|Lost to Follow-up|37|||
129149846|NCT03545672|464847136|FG000|Overall Study|Uncertain diagnosis|2|||
129149847|NCT03545672|464847137|FG001|Overall Study|Uncertain diagnosis|1|||
129149848|NCT03545672|464847136|FG000|Overall Study|Protocol Violation|2|||
129149849|NCT03545672|464847137|FG001|Overall Study|Protocol Violation|2|||
129149850|NCT01628913|464847138|FG000|Overall Study|Adverse Event|12|||
129149851|NCT01628913|464847139|FG001|Overall Study|Adverse Event|5|||
129149852|NCT01628913|464847138|FG000|Overall Study|Disease Progression|11|||
129149853|NCT01628913|464847139|FG001|Overall Study|Disease Progression|14|||
129149854|NCT01628913|464847138|FG000|Overall Study|Protocol Violation|1|||
129149855|NCT01628913|464847139|FG001|Overall Study|Protocol Violation|0|||
129149856|NCT01628913|464847138|FG000|Overall Study|Death|1|||
129149857|NCT01628913|464847139|FG001|Overall Study|Death|0|||
129149858|NCT01628913|464847138|FG000|Overall Study|study terminated by Sponsor|4|||
129149859|NCT01628913|464847139|FG001|Overall Study|study terminated by Sponsor|9|||
129149860|NCT01628913|464847138|FG000|Overall Study|Withdrawal by Subject|1|||
129149861|NCT01628913|464847139|FG001|Overall Study|Withdrawal by Subject|0|||
129149862|NCT01628913|464847138|FG000|Overall Study|Physician Decision|1|||
129149863|NCT01628913|464847139|FG001|Overall Study|Physician Decision|3|||
129149864|NCT04102007|464847141|FG000|Overall Study|Adverse Event|4|||
129149865|NCT04102007|464847141|FG000|Overall Study|Lost to Follow-up|3|||
129149866|NCT04102007|464847141|FG000|Overall Study|Withdrawal by Subject|12|||
129149867|NCT04102007|464847141|FG000|Overall Study|Eligibility Violation|5|||
129149868|NCT04102007|464847141|FG000|Overall Study|Lack of Efficacy|6|||
129149869|NCT04102007|464847141|FG000|Overall Study|Protocol Deviation|5|||
129149870|NCT04102007|464847141|FG000|Overall Study|Protocol Compliance|1|||
129149871|NCT04102007|464847141|FG000|Overall Study|Withdrew Treatment|2|||
129149872|NCT04102007|464847141|FG000|Overall Study|Pregnancy|1|||
129149873|NCT00892008|464847147|FG000|Overall Study|Death|5|||
129149874|NCT00892008|464847147|FG000|Overall Study|Lack of Efficacy|3|||
129149875|NCT00892008|464847147|FG000|Overall Study|Lost to Follow-up|142|||
129149876|NCT00892008|464847147|FG000|Overall Study|Other|378|||
129149877|NCT00892008|464847147|FG000|Overall Study|Adverse Event|37|||
129149878|NCT03610048|464847151|FG000|Overall Study|Study terminated by sponsor|84|||
129149879|NCT03610048|464847151|FG000|Overall Study|Adverse Event|32|||
129149880|NCT03610048|464847151|FG000|Overall Study|Withdrawal by Subject|31|||
129149881|NCT03610048|464847151|FG000|Overall Study|Lost to Follow-up|8|||
129149882|NCT03610048|464847151|FG000|Overall Study|Other|4|||
129149883|NCT03610048|464847151|FG000|Overall Study|Physician Decision|1|||
129149884|NCT03610048|464847151|FG000|Overall Study|Pregnancy|1|||
129149885|NCT01155050|464847153|FG000|Overall Study|Lost to Follow-up|15|||
129149886|NCT01155050|464847154|FG001|Overall Study|Lost to Follow-up|20|||
129149887|NCT01155050|464847155|FG002|Overall Study|Lost to Follow-up|19|||
129149888|NCT01155050|464847156|FG003|Overall Study|Lost to Follow-up|22|||
129149889|NCT00949533|464847157|FG000|Overall Study|Lost to Follow-up|0|||
129149890|NCT00949533|464847158|FG001|Overall Study|Lost to Follow-up|1|||
129149891|NCT00652834|464847159|FG000|Overall Study|Withdrawal by Subject|3|||
129149892|NCT00652834|464847159|FG000|Overall Study|Lost to Follow-up|2|||
129149893|NCT00320606|464847160|FG000|Overall Study|Adverse Event|1|||
129149894|NCT00320606|464847160|FG000|Overall Study|Protocol Violation|1|||
129149895|NCT00320606|464847160|FG000|Overall Study|Withdrawal by Subject|1|||
129149896|NCT00854360|464847161|FG000|Overall Study|Adverse Event|0|||
129149897|NCT00854360|464847162|FG001|Overall Study|Adverse Event|1|||
129149898|NCT00854360|464847163|FG002|Overall Study|Adverse Event|2|||
129149899|NCT00854360|464847164|FG003|Overall Study|Adverse Event|6|||
129149900|NCT00854360|464847161|FG000|Overall Study|Withdrawal by Subject|0|||
129149901|NCT00854360|464847162|FG001|Overall Study|Withdrawal by Subject|0|||
128725156|NCT02641379|463290945|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
128725157|NCT02641379|463290946|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
128725158|NCT02641379|463290947|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
128725159|NCT02641379|463290948|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
128725160|NCT02641379|463290949|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
129149902|NCT00854360|464847163|FG002|Overall Study|Withdrawal by Subject|0|||
129149903|NCT00854360|464847164|FG003|Overall Study|Withdrawal by Subject|1|||
129149904|NCT00854360|464847161|FG000|Overall Study|Pregnancy|0|||
129149905|NCT00854360|464847162|FG001|Overall Study|Pregnancy|1|||
129149906|NCT00854360|464847163|FG002|Overall Study|Pregnancy|0|||
129149907|NCT00854360|464847164|FG003|Overall Study|Pregnancy|0|||
129149908|NCT00854360|464847161|FG000|Overall Study|Lack of Efficacy|2|||
129149909|NCT00854360|464847162|FG001|Overall Study|Lack of Efficacy|1|||
129149910|NCT00854360|464847163|FG002|Overall Study|Lack of Efficacy|0|||
129149911|NCT00854360|464847164|FG003|Overall Study|Lack of Efficacy|0|||
129149912|NCT00854360|464847161|FG000|Overall Study|Other|0|||
129149913|NCT00854360|464847162|FG001|Overall Study|Other|0|||
128725161|NCT02641379|463290950|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
128725162|NCT02641379|463290951|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
128725163|NCT02641379|463290952|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
129149914|NCT00854360|464847163|FG002|Overall Study|Other|0|||
129149915|NCT00854360|464847164|FG003|Overall Study|Other|3|||
129149916|NCT00806585|464847166|FG000|Overall Study|Study terminated by Sponsor|0|||
129149917|NCT00806585|464847167|FG001|Overall Study|Study terminated by Sponsor|0|||
129149918|NCT00806585|464847168|FG002|Overall Study|Study terminated by Sponsor|1|||
129149919|NCT00806585|464847169|FG003|Overall Study|Study terminated by Sponsor|2|||
129149920|NCT00806585|464847170|FG004|Overall Study|Study terminated by Sponsor|0|||
129149921|NCT00806585|464847166|FG000|Overall Study|Protocol Violation|3|||
129149922|NCT00806585|464847167|FG001|Overall Study|Protocol Violation|1|||
129149923|NCT00806585|464847168|FG002|Overall Study|Protocol Violation|2|||
129149924|NCT00806585|464847169|FG003|Overall Study|Protocol Violation|0|||
129149925|NCT00806585|464847170|FG004|Overall Study|Protocol Violation|0|||
129149926|NCT00806585|464847166|FG000|Overall Study|Physician Decision|0|||
129149927|NCT00806585|464847167|FG001|Overall Study|Physician Decision|2|||
129149928|NCT00806585|464847168|FG002|Overall Study|Physician Decision|3|||
128725164|NCT02641379|463290953|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
128725165|NCT02641379|463290954|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
128725166|NCT02641379|463290955|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
128725167|NCT02641379|463290945|FG000|Overall Study|Baseline viral load unavailable|0|||
128725168|NCT02641379|463290946|FG001|Overall Study|Baseline viral load unavailable|0|||
128725169|NCT02641379|463290947|FG002|Overall Study|Baseline viral load unavailable|0|||
128725170|NCT02641379|463290948|FG003|Overall Study|Baseline viral load unavailable|1|||
128725171|NCT02641379|463290949|FG004|Overall Study|Baseline viral load unavailable|0|||
128725172|NCT02641379|463290950|FG005|Overall Study|Baseline viral load unavailable|0|||
128725173|NCT02641379|463290951|FG006|Overall Study|Baseline viral load unavailable|0|||
128725174|NCT02641379|463290952|FG007|Overall Study|Baseline viral load unavailable|0|||
128725175|NCT02641379|463290953|FG008|Overall Study|Baseline viral load unavailable|0|||
128725176|NCT02641379|463290954|FG009|Overall Study|Baseline viral load unavailable|0|||
128725177|NCT02641379|463290955|FG010|Overall Study|Baseline viral load unavailable|0|||
128725178|NCT02641379|463290945|FG000|Overall Study|Blood could not be drawn|0|||
128725179|NCT02641379|463290946|FG001|Overall Study|Blood could not be drawn|0|||
128725180|NCT02641379|463290947|FG002|Overall Study|Blood could not be drawn|0|||
128725181|NCT02641379|463290948|FG003|Overall Study|Blood could not be drawn|0|||
128725182|NCT02641379|463290949|FG004|Overall Study|Blood could not be drawn|1|||
128725183|NCT02641379|463290950|FG005|Overall Study|Blood could not be drawn|0|||
128725184|NCT02641379|463290951|FG006|Overall Study|Blood could not be drawn|0|||
128725185|NCT02641379|463290952|FG007|Overall Study|Blood could not be drawn|0|||
128725186|NCT02641379|463290953|FG008|Overall Study|Blood could not be drawn|0|||
128725187|NCT02641379|463290954|FG009|Overall Study|Blood could not be drawn|0|||
128725188|NCT02641379|463290955|FG010|Overall Study|Blood could not be drawn|0|||
128725189|NCT02641379|463290945|FG000|Overall Study|Protocol Violation|0|||
128725190|NCT02641379|463290946|FG001|Overall Study|Protocol Violation|0|||
128725191|NCT02641379|463290947|FG002|Overall Study|Protocol Violation|0|||
128725192|NCT02641379|463290948|FG003|Overall Study|Protocol Violation|0|||
128725193|NCT02641379|463290949|FG004|Overall Study|Protocol Violation|2|||
128725194|NCT02641379|463290950|FG005|Overall Study|Protocol Violation|0|||
128725195|NCT02641379|463290951|FG006|Overall Study|Protocol Violation|0|||
128725196|NCT02641379|463290952|FG007|Overall Study|Protocol Violation|0|||
128725197|NCT02641379|463290953|FG008|Overall Study|Protocol Violation|1|||
128725198|NCT02641379|463290954|FG009|Overall Study|Protocol Violation|0|||
128725199|NCT02641379|463290955|FG010|Overall Study|Protocol Violation|0|||
128725200|NCT02641379|463290945|FG000|Overall Study|Participation in sili rescue study|0|||
128725201|NCT02641379|463290946|FG001|Overall Study|Participation in sili rescue study|0|||
128725202|NCT02641379|463290947|FG002|Overall Study|Participation in sili rescue study|0|||
129149929|NCT00806585|464847169|FG003|Overall Study|Physician Decision|0|||
129149930|NCT00806585|464847170|FG004|Overall Study|Physician Decision|1|||
129149931|NCT00806585|464847166|FG000|Overall Study|Lost to Follow-up|2|||
129149932|NCT00806585|464847167|FG001|Overall Study|Lost to Follow-up|1|||
129149933|NCT00806585|464847168|FG002|Overall Study|Lost to Follow-up|2|||
129149934|NCT00806585|464847169|FG003|Overall Study|Lost to Follow-up|2|||
129149935|NCT00806585|464847170|FG004|Overall Study|Lost to Follow-up|5|||
129149936|NCT00806585|464847166|FG000|Overall Study|Lack of Efficacy|1|||
129149937|NCT00806585|464847167|FG001|Overall Study|Lack of Efficacy|0|||
129149938|NCT00806585|464847168|FG002|Overall Study|Lack of Efficacy|0|||
129149939|NCT00806585|464847169|FG003|Overall Study|Lack of Efficacy|0|||
129149940|NCT00806585|464847170|FG004|Overall Study|Lack of Efficacy|0|||
129149941|NCT00806585|464847166|FG000|Overall Study|Adverse Event|1|||
129149942|NCT00806585|464847167|FG001|Overall Study|Adverse Event|5|||
129149943|NCT00806585|464847168|FG002|Overall Study|Adverse Event|3|||
129149944|NCT00806585|464847169|FG003|Overall Study|Adverse Event|4|||
129149945|NCT00806585|464847170|FG004|Overall Study|Adverse Event|2|||
129149946|NCT00806585|464847166|FG000|Overall Study|Withdrawal by Subject|10|||
129149947|NCT00806585|464847167|FG001|Overall Study|Withdrawal by Subject|8|||
129149948|NCT00806585|464847168|FG002|Overall Study|Withdrawal by Subject|9|||
129149949|NCT00806585|464847169|FG003|Overall Study|Withdrawal by Subject|3|||
129149950|NCT00806585|464847170|FG004|Overall Study|Withdrawal by Subject|11|||
129149951|NCT00806585|464847166|FG000|Overall Study|Completion status unknown|15|||
129149952|NCT00806585|464847167|FG001|Overall Study|Completion status unknown|14|||
129149953|NCT00806585|464847168|FG002|Overall Study|Completion status unknown|12|||
129149954|NCT00806585|464847169|FG003|Overall Study|Completion status unknown|4|||
128725203|NCT02641379|463290948|FG003|Overall Study|Participation in sili rescue study|0|||
128725204|NCT02641379|463290949|FG004|Overall Study|Participation in sili rescue study|0|||
128725205|NCT02641379|463290950|FG005|Overall Study|Participation in sili rescue study|1|||
128725206|NCT02641379|463290951|FG006|Overall Study|Participation in sili rescue study|0|||
128725207|NCT02641379|463290952|FG007|Overall Study|Participation in sili rescue study|0|||
129149955|NCT00806585|464847170|FG004|Overall Study|Completion status unknown|12|||
129149956|NCT00474903|464847171|FG000|Overall Study|Protocol Violation|1|||
129149957|NCT00474903|464847172|FG001|Overall Study|Protocol Violation|5|||
129149958|NCT00474903|464847173|FG002|Overall Study|Protocol Violation|2|||
129149959|NCT00399529|464847174|FG000|Overall Study|Off Study Prior to Treatment|2|||
129149960|NCT01936831|464847180|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149961|NCT01936831|464847181|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149962|NCT01936831|464847182|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149963|NCT01936831|464847183|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149964|NCT01936831|464847184|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149965|NCT01936831|464847185|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
129149966|NCT01936831|464847186|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149967|NCT01936831|464847187|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149968|NCT01936831|464847188|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129149969|NCT03435380|464847189|FG000|Overall Study|Death|1|||
129149970|NCT03435380|464847190|FG001|Overall Study|Death|2|||
129149971|NCT03435380|464847191|FG002|Overall Study|Death|1|||
129149972|NCT03435380|464847189|FG000|Overall Study|Lost to Follow-up|12|||
129149973|NCT03435380|464847190|FG001|Overall Study|Lost to Follow-up|8|||
129149974|NCT03435380|464847191|FG002|Overall Study|Lost to Follow-up|6|||
129149975|NCT03435380|464847189|FG000|Overall Study|Physician Decision|1|||
129149976|NCT03435380|464847190|FG001|Overall Study|Physician Decision|0|||
129149977|NCT03435380|464847191|FG002|Overall Study|Physician Decision|0|||
129149978|NCT03435380|464847189|FG000|Overall Study|Withdrawal by Subject|0|||
129149979|NCT03435380|464847190|FG001|Overall Study|Withdrawal by Subject|1|||
129149980|NCT03435380|464847191|FG002|Overall Study|Withdrawal by Subject|1|||
129149981|NCT03435380|464847189|FG000|Overall Study|Ineligible|0|||
129149982|NCT03435380|464847190|FG001|Overall Study|Ineligible|1|||
129149983|NCT03435380|464847191|FG002|Overall Study|Ineligible|1|||
129149984|NCT02133573|464847192|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
129149985|NCT02133573|464847193|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
129149986|NCT02133573|464847192|FG000|Overall Study|Child Deaths|3|||
129149987|NCT02133573|464847193|FG001|Overall Study|Child Deaths|5|||
129149988|NCT02133573|464847192|FG000|Overall Study|Child Declined Follow Ups|2|||
129149989|NCT02133573|464847193|FG001|Overall Study|Child Declined Follow Ups|1|||
129149990|NCT02133573|464847192|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
129149991|NCT02133573|464847193|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
129149992|NCT02519842|464847194|FG000|Base Study: Cycle 1|Screening Failure|1|||
129149993|NCT02519842|464847195|FG001|Base Study: Cycle 1|Screening Failure|1|||
129149994|NCT02519842|464847196|FG002|Base Study: Cycle 1|Screening Failure|0|||
129149995|NCT02519842|464847194|FG000|Base Study: Cycle 1|Adverse Event|1|||
129149996|NCT02519842|464847195|FG001|Base Study: Cycle 1|Adverse Event|0|||
129149997|NCT02519842|464847196|FG002|Base Study: Cycle 1|Adverse Event|0|||
129149998|NCT02519842|464847194|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
129149999|NCT02519842|464847195|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
129150000|NCT02519842|464847196|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
129150001|NCT02519842|464847194|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
129150002|NCT02519842|464847195|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
129150003|NCT02519842|464847196|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
129150004|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
129150005|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
129150006|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
129150007|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
129150008|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
129150009|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
129150010|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129150011|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129150012|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
129150013|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
129150014|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
129150015|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
129150016|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Death|0|||
129150017|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Death|0|||
129150018|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Death|1|||
129150019|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
129150020|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
129150021|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
129150022|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
129150023|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
129150024|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
129150025|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
129150026|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
129150027|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
129150028|NCT02519842|464847194|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
129150029|NCT02519842|464847195|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
129150030|NCT02519842|464847196|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
129150031|NCT02115321|464847199|FG000|Overall Study|Death|1|||
129150032|NCT02115321|464847200|FG001|Overall Study|Death|0|||
129150033|NCT02493764|464847202|FG000|Overall Study|Adverse Event|2|||
129150034|NCT02493764|464847203|FG001|Overall Study|Adverse Event|2|||
129150035|NCT02493764|464847202|FG000|Overall Study|Death|44|||
129150036|NCT02493764|464847203|FG001|Overall Study|Death|58|||
129150037|NCT02493764|464847202|FG000|Overall Study|Lost to Follow-up|2|||
129150038|NCT02493764|464847203|FG001|Overall Study|Lost to Follow-up|1|||
129150039|NCT02493764|464847202|FG000|Overall Study|Protocol Violation|6|||
129150040|NCT02493764|464847203|FG001|Overall Study|Protocol Violation|7|||
129150041|NCT02493764|464847202|FG000|Overall Study|Physician Decision|1|||
129150042|NCT02493764|464847203|FG001|Overall Study|Physician Decision|1|||
129150043|NCT02493764|464847202|FG000|Overall Study|Participant moved|17|||
129150044|NCT02493764|464847203|FG001|Overall Study|Participant moved|5|||
129150045|NCT02493764|464847202|FG000|Overall Study|Withdrawal parent/guardian|0|||
129150046|NCT02493764|464847203|FG001|Overall Study|Withdrawal parent/guardian|1|||
129150047|NCT02493764|464847202|FG000|Overall Study|Withdrawal by Subject|11|||
129150048|NCT02493764|464847203|FG001|Overall Study|Withdrawal by Subject|7|||
129150049|NCT01307449|464847204|FG000|Overall Study|Adverse Event|1|||
129150050|NCT01307449|464847205|FG001|Overall Study|Adverse Event|0|||
129150051|NCT01307449|464847206|FG002|Overall Study|Adverse Event|0|||
129150052|NCT01307449|464847207|FG003|Overall Study|Adverse Event|0|||
129150053|NCT03218917|464847208|FG000|Overall Study|Adverse Event|3|||
129150054|NCT03218917|464847209|FG001|Overall Study|Adverse Event|3|||
129150055|NCT03218917|464847210|FG002|Overall Study|Adverse Event|2|||
129150056|NCT03218917|464847208|FG000|Overall Study|Subject withdrew consent|2|||
129150057|NCT03218917|464847209|FG001|Overall Study|Subject withdrew consent|4|||
129150058|NCT03218917|464847210|FG002|Overall Study|Subject withdrew consent|10|||
129150059|NCT03218917|464847208|FG000|Overall Study|Physician Decision|0|||
129150060|NCT03218917|464847209|FG001|Overall Study|Physician Decision|1|||
129150061|NCT03218917|464847210|FG002|Overall Study|Physician Decision|1|||
129150062|NCT03218917|464847208|FG000|Overall Study|Lost to Follow-up|1|||
129150063|NCT03218917|464847209|FG001|Overall Study|Lost to Follow-up|0|||
129150064|NCT03218917|464847210|FG002|Overall Study|Lost to Follow-up|0|||
129150065|NCT03218917|464847208|FG000|Overall Study|Reason Missing|0|||
129150066|NCT03218917|464847209|FG001|Overall Study|Reason Missing|2|||
129150067|NCT03218917|464847210|FG002|Overall Study|Reason Missing|0|||
129150068|NCT03218917|464847208|FG000|Overall Study|Death|0|||
129150069|NCT03218917|464847209|FG001|Overall Study|Death|1|||
129150070|NCT03218917|464847210|FG002|Overall Study|Death|0|||
129150071|NCT03218917|464847208|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129150072|NCT03218917|464847209|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129150073|NCT03218917|464847210|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129150074|NCT01788943|464847213|FG000|Overall Study|Withdrawal by Subject|1|||
129150075|NCT01788943|464847214|FG001|Overall Study|Withdrawal by Subject|0|||
129150076|NCT01119287|464847215|FG000|Overall Study|Patient Decision, not related to AE|0|||
129150077|NCT01119287|464847216|FG001|Overall Study|Patient Decision, not related to AE|0|||
129150078|NCT01119287|464847217|FG002|Overall Study|Patient Decision, not related to AE|2|||
129150079|NCT01119287|464847218|FG003|Overall Study|Patient Decision, not related to AE|2|||
129150080|NCT01119287|464847219|FG004|Overall Study|Patient Decision, not related to AE|1|||
129150081|NCT01119287|464847220|FG005|Overall Study|Patient Decision, not related to AE|0|||
129150082|NCT04403919|464847225|FG000|Overall Study|Lost to Follow-up|0|||
129150083|NCT04403919|464847226|FG001|Overall Study|Lost to Follow-up|0|||
129150084|NCT04403919|464847227|FG002|Overall Study|Lost to Follow-up|0|||
129150085|NCT04403919|464847228|FG003|Overall Study|Lost to Follow-up|1|||
129150086|NCT01156844|464847229|FG000|Overall Study|Adverse Event|0|||
129150087|NCT01156844|464847230|FG001|Overall Study|Adverse Event|0|||
129150088|NCT01156844|464847231|FG002|Overall Study|Adverse Event|1|||
129150089|NCT01156844|464847232|FG003|Overall Study|Adverse Event|1|||
129150090|NCT01156844|464847229|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129150091|NCT01156844|464847230|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129150092|NCT01156844|464847231|FG002|Overall Study|Abnormal test procedure result(s)|2|||
129150093|NCT01156844|464847232|FG003|Overall Study|Abnormal test procedure result(s)|2|||
129150094|NCT01156844|464847229|FG000|Overall Study|Withdrawal by Subject|0|||
129150095|NCT01156844|464847230|FG001|Overall Study|Withdrawal by Subject|0|||
129150096|NCT01156844|464847231|FG002|Overall Study|Withdrawal by Subject|2|||
129150097|NCT01156844|464847232|FG003|Overall Study|Withdrawal by Subject|2|||
129150098|NCT01156844|464847229|FG000|Overall Study|Lost to Follow-up|0|||
129150099|NCT01156844|464847230|FG001|Overall Study|Lost to Follow-up|0|||
129150100|NCT01156844|464847231|FG002|Overall Study|Lost to Follow-up|1|||
129150101|NCT01156844|464847232|FG003|Overall Study|Lost to Follow-up|0|||
129150102|NCT01156844|464847229|FG000|Overall Study|Administrative problems|0|||
129150103|NCT01156844|464847230|FG001|Overall Study|Administrative problems|1|||
129150104|NCT01156844|464847231|FG002|Overall Study|Administrative problems|0|||
129150105|NCT01156844|464847232|FG003|Overall Study|Administrative problems|1|||
129150106|NCT01156844|464847229|FG000|Overall Study|Protocol deviation|2|||
129150107|NCT01156844|464847230|FG001|Overall Study|Protocol deviation|0|||
129150108|NCT01156844|464847231|FG002|Overall Study|Protocol deviation|0|||
129150109|NCT01156844|464847232|FG003|Overall Study|Protocol deviation|0|||
128725208|NCT02641379|463290953|FG008|Overall Study|Participation in sili rescue study|0|||
128725209|NCT02641379|463290954|FG009|Overall Study|Participation in sili rescue study|0|||
128725210|NCT02641379|463290955|FG010|Overall Study|Participation in sili rescue study|0|||
128725211|NCT02641379|463290945|FG000|Overall Study|Lost to Follow-up|0|||
128725212|NCT02641379|463290946|FG001|Overall Study|Lost to Follow-up|0|||
128725213|NCT02641379|463290947|FG002|Overall Study|Lost to Follow-up|0|||
128725214|NCT02641379|463290948|FG003|Overall Study|Lost to Follow-up|0|||
128725215|NCT02641379|463290949|FG004|Overall Study|Lost to Follow-up|0|||
128725216|NCT02641379|463290950|FG005|Overall Study|Lost to Follow-up|0|||
128725217|NCT02641379|463290951|FG006|Overall Study|Lost to Follow-up|0|||
128725218|NCT02641379|463290952|FG007|Overall Study|Lost to Follow-up|0|||
128725219|NCT02641379|463290953|FG008|Overall Study|Lost to Follow-up|1|||
128725220|NCT02641379|463290954|FG009|Overall Study|Lost to Follow-up|0|||
128725221|NCT02641379|463290955|FG010|Overall Study|Lost to Follow-up|0|||
129150110|NCT01448616|464847237|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
129150111|NCT01448616|464847238|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
129150112|NCT01448616|464847239|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
129150113|NCT01448616|464847240|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
129150114|NCT01448616|464847237|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
129150115|NCT01448616|464847238|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
129150116|NCT01448616|464847239|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
129150117|NCT01448616|464847240|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
129150118|NCT01448616|464847237|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
129150119|NCT01448616|464847238|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
129150120|NCT01448616|464847239|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
129150121|NCT01448616|464847240|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
129150122|NCT01448616|464847237|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
129150123|NCT01448616|464847238|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
129150124|NCT01448616|464847239|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
129150125|NCT01448616|464847240|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
129150126|NCT01448616|464847237|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
129150127|NCT01448616|464847238|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
129150128|NCT01448616|464847239|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
129150129|NCT01448616|464847240|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
129150130|NCT02170064|464847241|FG000|Overall Study|Withdrawal by Subject|5|||
129150131|NCT02170064|464847242|FG001|Overall Study|Withdrawal by Subject|1|||
129150132|NCT02170064|464847243|FG002|Overall Study|Withdrawal by Subject|1|||
129150133|NCT02170064|464847241|FG000|Overall Study|Physician Decision|1|||
129150134|NCT02170064|464847242|FG001|Overall Study|Physician Decision|1|||
129150135|NCT02170064|464847243|FG002|Overall Study|Physician Decision|0|||
129150136|NCT03323164|464847244|FG000|Overall Study|Poor quality imaging/scans|2|||
129150137|NCT03323164|464847245|FG001|Overall Study|Poor quality imaging/scans|2|||
129150138|NCT00397540|464847248|FG000|Overall Study|short follow-up duration < 12 months|1|||
129150139|NCT00397540|464847249|FG001|Overall Study|short follow-up duration < 12 months|0|||
129150140|NCT00485173|464847253|FG000|Overall Study|Death|4|||
129150141|NCT00485173|464847254|FG001|Overall Study|Death|3|||
129150142|NCT00485173|464847253|FG000|Overall Study|Lost to Follow-up|32|||
129150143|NCT00485173|464847254|FG001|Overall Study|Lost to Follow-up|61|||
129150144|NCT00746811|464847255|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
129150145|NCT00746811|464847256|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
129150146|NCT00829244|464847257|FG000|Overall Study|Adverse Event|1|||
129150147|NCT00829244|464847258|FG001|Overall Study|Adverse Event|3|||
129150148|NCT00829244|464847257|FG000|Overall Study|Protocol Violation|1|||
129150149|NCT00829244|464847258|FG001|Overall Study|Protocol Violation|0|||
129150150|NCT00829244|464847257|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
129150151|NCT00829244|464847258|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
129150152|NCT00829244|464847257|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
129150153|NCT00829244|464847258|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
129150154|NCT00829244|464847257|FG000|Overall Study|No fertilization|2|||
129150155|NCT00829244|464847258|FG001|Overall Study|No fertilization|2|||
129150156|NCT00829244|464847257|FG000|Overall Study|All embryos discarded|0|||
129150157|NCT00829244|464847258|FG001|Overall Study|All embryos discarded|3|||
129150158|NCT00829244|464847257|FG000|Overall Study|No embryo cleavage|0|||
128725222|NCT02641379|463290945|FG000|Overall Study|Source data not found|0|||
129150159|NCT00829244|464847258|FG001|Overall Study|No embryo cleavage|2|||
129150160|NCT03342560|464847259|FG000|Overall Study|Lost to Follow-up|2|||
129150161|NCT02604511|464847260|FG000|Overall Study|Adverse Event|3|||
128725223|NCT02641379|463290946|FG001|Overall Study|Source data not found|0|||
128725224|NCT02641379|463290947|FG002|Overall Study|Source data not found|0|||
128725225|NCT02641379|463290948|FG003|Overall Study|Source data not found|0|||
129150162|NCT02604511|464847260|FG000|Overall Study|Disease Progression|4|||
129150163|NCT02604511|464847260|FG000|Overall Study|Withdrawal by Subject|3|||
129150164|NCT02604511|464847260|FG000|Overall Study|Participant ineligible|1|||
128725226|NCT02641379|463290949|FG004|Overall Study|Source data not found|0|||
128725227|NCT02641379|463290950|FG005|Overall Study|Source data not found|1|||
128725228|NCT02641379|463290951|FG006|Overall Study|Source data not found|0|||
128725229|NCT02641379|463290952|FG007|Overall Study|Source data not found|0|||
129150165|NCT02604511|464847260|FG000|Overall Study|Intercurrent illness|1|||
129150166|NCT03770286|464847261|FG000|Overall Study|Lost to Follow-up|6|||
129150167|NCT03770286|464847262|FG001|Overall Study|Lost to Follow-up|4|||
129150168|NCT03770286|464847263|FG002|Overall Study|Lost to Follow-up|3|||
129150169|NCT03770286|464847261|FG000|Overall Study|Protocol Violation|1|||
129150170|NCT03770286|464847262|FG001|Overall Study|Protocol Violation|0|||
129150171|NCT03770286|464847263|FG002|Overall Study|Protocol Violation|2|||
129150172|NCT02297412|464847264|FG000|Overall Study|Canceled|1|||
129150173|NCT02297412|464847265|FG001|Overall Study|Canceled|1|||
129150174|NCT04712669|464847270|FG000|Double Blind Phase|Adverse Event|4|||
129150175|NCT04712669|464847271|FG001|Double Blind Phase|Adverse Event|4|||
129150176|NCT04712669|464847272|FG002|Double Blind Phase|Adverse Event|3|||
129150177|NCT04712669|464847273|FG003|Double Blind Phase|Adverse Event|0|||
129150178|NCT04712669|464847274|FG004|Double Blind Phase|Adverse Event|0|||
129150179|NCT04712669|464847275|FG005|Double Blind Phase|Adverse Event|0|||
129150180|NCT04712669|464847276|FG006|Double Blind Phase|Adverse Event|0|||
129150181|NCT04712669|464847277|FG007|Double Blind Phase|Adverse Event|0|||
129150182|NCT04712669|464847270|FG000|Double Blind Phase|Physician Decision|1|||
129150183|NCT04712669|464847271|FG001|Double Blind Phase|Physician Decision|0|||
129150184|NCT04712669|464847272|FG002|Double Blind Phase|Physician Decision|0|||
129150185|NCT04712669|464847273|FG003|Double Blind Phase|Physician Decision|0|||
129150186|NCT04712669|464847274|FG004|Double Blind Phase|Physician Decision|0|||
129150187|NCT04712669|464847275|FG005|Double Blind Phase|Physician Decision|0|||
129150188|NCT04712669|464847276|FG006|Double Blind Phase|Physician Decision|0|||
129150189|NCT04712669|464847277|FG007|Double Blind Phase|Physician Decision|0|||
129150190|NCT04712669|464847270|FG000|Double Blind Phase|Withdrawal by Subject|3|||
129150191|NCT04712669|464847271|FG001|Double Blind Phase|Withdrawal by Subject|6|||
129150192|NCT04712669|464847272|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129150193|NCT04712669|464847273|FG003|Double Blind Phase|Withdrawal by Subject|0|||
129150194|NCT04712669|464847274|FG004|Double Blind Phase|Withdrawal by Subject|0|||
129150195|NCT04712669|464847275|FG005|Double Blind Phase|Withdrawal by Subject|0|||
129150196|NCT04712669|464847276|FG006|Double Blind Phase|Withdrawal by Subject|0|||
129150197|NCT04712669|464847277|FG007|Double Blind Phase|Withdrawal by Subject|0|||
129150198|NCT04712669|464847270|FG000|Double Blind Phase|Termination by Sponsor|0|||
129150199|NCT04712669|464847271|FG001|Double Blind Phase|Termination by Sponsor|0|||
129150200|NCT04712669|464847272|FG002|Double Blind Phase|Termination by Sponsor|1|||
129150201|NCT04712669|464847273|FG003|Double Blind Phase|Termination by Sponsor|0|||
129150202|NCT04712669|464847274|FG004|Double Blind Phase|Termination by Sponsor|0|||
129150203|NCT04712669|464847275|FG005|Double Blind Phase|Termination by Sponsor|0|||
129150204|NCT04712669|464847276|FG006|Double Blind Phase|Termination by Sponsor|0|||
129150205|NCT04712669|464847277|FG007|Double Blind Phase|Termination by Sponsor|0|||
129150206|NCT04712669|464847270|FG000|Open Label Phase|Adverse Event|0|||
129150207|NCT04712669|464847271|FG001|Open Label Phase|Adverse Event|0|||
129150208|NCT04712669|464847272|FG002|Open Label Phase|Adverse Event|0|||
129150209|NCT04712669|464847273|FG003|Open Label Phase|Adverse Event|1|||
129150210|NCT04712669|464847274|FG004|Open Label Phase|Adverse Event|1|||
129150211|NCT04712669|464847275|FG005|Open Label Phase|Adverse Event|3|||
129150212|NCT04712669|464847276|FG006|Open Label Phase|Adverse Event|1|||
129150213|NCT04712669|464847277|FG007|Open Label Phase|Adverse Event|2|||
129150214|NCT04712669|464847270|FG000|Open Label Phase|Death|0|||
129150215|NCT04712669|464847271|FG001|Open Label Phase|Death|0|||
129150216|NCT04712669|464847272|FG002|Open Label Phase|Death|0|||
129150217|NCT04712669|464847273|FG003|Open Label Phase|Death|1|||
129150218|NCT04712669|464847274|FG004|Open Label Phase|Death|0|||
129150219|NCT04712669|464847275|FG005|Open Label Phase|Death|0|||
129150220|NCT04712669|464847276|FG006|Open Label Phase|Death|0|||
129150221|NCT04712669|464847277|FG007|Open Label Phase|Death|0|||
128725230|NCT02641379|463290953|FG008|Overall Study|Source data not found|0|||
128725231|NCT02641379|463290954|FG009|Overall Study|Source data not found|0|||
129150222|NCT04712669|464847270|FG000|Open Label Phase|Lack of Efficacy|0|||
129150223|NCT04712669|464847271|FG001|Open Label Phase|Lack of Efficacy|0|||
129150224|NCT04712669|464847272|FG002|Open Label Phase|Lack of Efficacy|0|||
129150225|NCT04712669|464847273|FG003|Open Label Phase|Lack of Efficacy|0|||
129150226|NCT04712669|464847274|FG004|Open Label Phase|Lack of Efficacy|1|||
129150227|NCT04712669|464847275|FG005|Open Label Phase|Lack of Efficacy|0|||
129150228|NCT04712669|464847276|FG006|Open Label Phase|Lack of Efficacy|0|||
129150229|NCT04712669|464847277|FG007|Open Label Phase|Lack of Efficacy|0|||
129150230|NCT04712669|464847270|FG000|Open Label Phase|Lost to Follow-up|0|||
128725232|NCT02641379|463290955|FG010|Overall Study|Source data not found|0|||
128725233|NCT02641379|463290945|FG000|Overall Study|Participant showed weight reduction|0|||
129150231|NCT04712669|464847271|FG001|Open Label Phase|Lost to Follow-up|0|||
129150232|NCT04712669|464847272|FG002|Open Label Phase|Lost to Follow-up|0|||
129150233|NCT04712669|464847273|FG003|Open Label Phase|Lost to Follow-up|0|||
129150234|NCT04712669|464847274|FG004|Open Label Phase|Lost to Follow-up|0|||
129150235|NCT04712669|464847275|FG005|Open Label Phase|Lost to Follow-up|0|||
129150236|NCT04712669|464847276|FG006|Open Label Phase|Lost to Follow-up|1|||
129150237|NCT04712669|464847277|FG007|Open Label Phase|Lost to Follow-up|1|||
129150238|NCT04712669|464847270|FG000|Open Label Phase|Physician Decision|0|||
129150239|NCT04712669|464847271|FG001|Open Label Phase|Physician Decision|0|||
129150240|NCT04712669|464847272|FG002|Open Label Phase|Physician Decision|0|||
129150241|NCT04712669|464847273|FG003|Open Label Phase|Physician Decision|1|||
129150242|NCT04712669|464847274|FG004|Open Label Phase|Physician Decision|0|||
129150243|NCT04712669|464847275|FG005|Open Label Phase|Physician Decision|0|||
129150244|NCT04712669|464847276|FG006|Open Label Phase|Physician Decision|0|||
129150245|NCT04712669|464847277|FG007|Open Label Phase|Physician Decision|0|||
129150246|NCT04712669|464847270|FG000|Open Label Phase|Withdrawal by Subject|0|||
129150247|NCT04712669|464847271|FG001|Open Label Phase|Withdrawal by Subject|0|||
129150248|NCT04712669|464847272|FG002|Open Label Phase|Withdrawal by Subject|0|||
129150249|NCT04712669|464847273|FG003|Open Label Phase|Withdrawal by Subject|1|||
129150250|NCT04712669|464847274|FG004|Open Label Phase|Withdrawal by Subject|5|||
129150251|NCT04712669|464847275|FG005|Open Label Phase|Withdrawal by Subject|5|||
129150252|NCT04712669|464847276|FG006|Open Label Phase|Withdrawal by Subject|0|||
129150253|NCT04712669|464847277|FG007|Open Label Phase|Withdrawal by Subject|4|||
129150254|NCT04712669|464847270|FG000|Open Label Phase|Termination by Sponsor|0|||
129150255|NCT04712669|464847271|FG001|Open Label Phase|Termination by Sponsor|0|||
129150256|NCT04712669|464847272|FG002|Open Label Phase|Termination by Sponsor|0|||
129150257|NCT04712669|464847273|FG003|Open Label Phase|Termination by Sponsor|11|||
129150258|NCT04712669|464847274|FG004|Open Label Phase|Termination by Sponsor|9|||
129150259|NCT04712669|464847275|FG005|Open Label Phase|Termination by Sponsor|14|||
129150260|NCT04712669|464847276|FG006|Open Label Phase|Termination by Sponsor|0|||
129150261|NCT04712669|464847277|FG007|Open Label Phase|Termination by Sponsor|14|||
129150262|NCT03802396|464847278|FG000|Overall Study|Withdrawal by Subject|2|||
129150263|NCT03802396|464847279|FG001|Overall Study|Withdrawal by Subject|0|||
129150264|NCT03802396|464847278|FG000|Overall Study|Surgery Cancelled|1|||
129150265|NCT03802396|464847279|FG001|Overall Study|Surgery Cancelled|0|||
129150266|NCT02561962|464847283|FG000|Overall Study|Withdrawal by Subject|1|||
129150267|NCT02561962|464847284|FG001|Overall Study|Withdrawal by Subject|0|||
129150268|NCT02561962|464847285|FG002|Overall Study|Withdrawal by Subject|0|||
129150269|NCT02561962|464847286|FG003|Overall Study|Withdrawal by Subject|0|||
129150270|NCT02561962|464847287|FG004|Overall Study|Withdrawal by Subject|1|||
129150271|NCT02561962|464847288|FG005|Overall Study|Withdrawal by Subject|1|||
129150272|NCT02561962|464847289|FG006|Overall Study|Withdrawal by Subject|2|||
129150273|NCT02561962|464847290|FG007|Overall Study|Withdrawal by Subject|1|||
129150274|NCT02561962|464847291|FG008|Overall Study|Withdrawal by Subject|0|||
129150275|NCT02561962|464847283|FG000|Overall Study|Decision by sponsor|0|||
129150276|NCT02561962|464847284|FG001|Overall Study|Decision by sponsor|0|||
129150277|NCT02561962|464847285|FG002|Overall Study|Decision by sponsor|0|||
129150278|NCT02561962|464847286|FG003|Overall Study|Decision by sponsor|0|||
129150279|NCT02561962|464847287|FG004|Overall Study|Decision by sponsor|1|||
129150280|NCT02561962|464847288|FG005|Overall Study|Decision by sponsor|1|||
129150281|NCT02561962|464847289|FG006|Overall Study|Decision by sponsor|0|||
129150282|NCT02561962|464847290|FG007|Overall Study|Decision by sponsor|3|||
129150283|NCT02561962|464847291|FG008|Overall Study|Decision by sponsor|0|||
129150284|NCT02561962|464847283|FG000|Overall Study|Lost to Follow-up|0|||
129150285|NCT02561962|464847284|FG001|Overall Study|Lost to Follow-up|0|||
129150286|NCT02561962|464847285|FG002|Overall Study|Lost to Follow-up|0|||
129150287|NCT02561962|464847286|FG003|Overall Study|Lost to Follow-up|0|||
129150288|NCT02561962|464847287|FG004|Overall Study|Lost to Follow-up|0|||
129150289|NCT02561962|464847288|FG005|Overall Study|Lost to Follow-up|1|||
129150290|NCT02561962|464847289|FG006|Overall Study|Lost to Follow-up|0|||
129150291|NCT02561962|464847290|FG007|Overall Study|Lost to Follow-up|0|||
129150292|NCT02561962|464847291|FG008|Overall Study|Lost to Follow-up|0|||
129150293|NCT01150357|464847292|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
129150294|NCT01150357|464847293|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
129150295|NCT01150357|464847294|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
129150296|NCT01150357|464847292|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
129150297|NCT01150357|464847293|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
129150298|NCT01150357|464847294|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
129150299|NCT01150357|464847292|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
129150300|NCT01150357|464847293|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
129150301|NCT01150357|464847294|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
129150302|NCT01150357|464847292|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
129150303|NCT01150357|464847293|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
129150304|NCT01150357|464847294|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
129150305|NCT01150357|464847292|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
129150306|NCT01150357|464847293|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
129150307|NCT01150357|464847294|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
129150308|NCT01150357|464847292|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
129150309|NCT01150357|464847293|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
129150310|NCT01150357|464847294|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
129150311|NCT01150357|464847292|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
129150312|NCT01150357|464847293|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
129150313|NCT01150357|464847294|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
129204725|NCT02079740|465046924|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
129204726|NCT02079740|465046925|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
129204727|NCT02079740|465046926|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
129204728|NCT02079740|465046927|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
129204729|NCT02079740|465046928|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
129204730|NCT02079740|465046929|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
129204731|NCT02079740|465046930|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
129204732|NCT02079740|465046931|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
129204733|NCT02079740|465046932|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
129204734|NCT02079740|465046933|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
129204735|NCT02079740|465046934|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
129204736|NCT02079740|465046922|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204737|NCT02079740|465046923|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204738|NCT02079740|465046924|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204739|NCT02079740|465046925|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204740|NCT02079740|465046926|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204741|NCT02079740|465046927|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204742|NCT02079740|465046928|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204743|NCT02079740|465046929|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
129204744|NCT02079740|465046930|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204745|NCT02079740|465046931|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204746|NCT02079740|465046932|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204747|NCT02079740|465046933|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204748|NCT02079740|465046934|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
129204749|NCT02079740|465046922|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204750|NCT02079740|465046923|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204751|NCT02079740|465046924|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204752|NCT02079740|465046925|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204753|NCT02079740|465046926|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204754|NCT02079740|465046927|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204755|NCT02079740|465046928|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204756|NCT02079740|465046929|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
129204757|NCT02079740|465046930|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204758|NCT02079740|465046931|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204759|NCT02079740|465046932|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204760|NCT02079740|465046933|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204761|NCT02079740|465046934|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129204762|NCT02079740|465046922|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204763|NCT02079740|465046923|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204764|NCT02079740|465046924|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204765|NCT02079740|465046925|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204766|NCT02079740|465046926|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204767|NCT02079740|465046927|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204768|NCT02079740|465046928|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204769|NCT02079740|465046929|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204770|NCT02079740|465046930|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204771|NCT02079740|465046931|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
129204772|NCT02079740|465046932|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129204773|NCT02079740|465046933|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
129204774|NCT02079740|465046934|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
129204775|NCT01405768|465046935|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
129204776|NCT01405768|465046936|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
129204777|NCT01690052|465046939|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
129204778|NCT01690052|465046940|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
129204779|NCT02421172|465046941|FG000|Period 1|Adverse Event|1|||
129204780|NCT02421172|465046942|FG001|Period 1|Adverse Event|0|||
129204781|NCT02421172|465046943|FG002|Period 1|Adverse Event|0|||
129204782|NCT02421172|465046944|FG003|Period 1|Adverse Event|0|||
129204783|NCT02421172|465046945|FG004|Period 1|Adverse Event|0|||
129204784|NCT02421172|465046941|FG000|Period 1|Lost to Follow-up|3|||
129204785|NCT02421172|465046942|FG001|Period 1|Lost to Follow-up|1|||
129204786|NCT02421172|465046943|FG002|Period 1|Lost to Follow-up|0|||
129204787|NCT02421172|465046944|FG003|Period 1|Lost to Follow-up|0|||
129204788|NCT02421172|465046945|FG004|Period 1|Lost to Follow-up|0|||
129204789|NCT02421172|465046941|FG000|Period 1|Patient/guardian decision|0|||
129150314|NCT02114177|464849185|FG000|Overall Study|Lost to Follow-up|1|||
129150315|NCT02114177|464849186|FG001|Overall Study|Lost to Follow-up|2|||
129150316|NCT02114177|464849185|FG000|Overall Study|Withdrawal by Subject|6|||
129150317|NCT02114177|464849186|FG001|Overall Study|Withdrawal by Subject|1|||
129150318|NCT02114177|464849185|FG000|Overall Study|Other|2|||
129150319|NCT02114177|464849186|FG001|Overall Study|Other|1|||
129150320|NCT01819272|464849187|FG000|Overall Study|Adverse Event|1|||
129150321|NCT01819272|464849188|FG001|Overall Study|Adverse Event|0|||
129150322|NCT01819272|464849189|FG002|Overall Study|Adverse Event|0|||
129150323|NCT01819272|464849190|FG003|Overall Study|Adverse Event|2|||
129150324|NCT01819272|464849191|FG004|Overall Study|Adverse Event|0|||
129150325|NCT01819272|464849192|FG005|Overall Study|Adverse Event|0|||
129150326|NCT01819272|464849187|FG000|Overall Study|Lost to Follow-up|3|||
129150327|NCT01819272|464849188|FG001|Overall Study|Lost to Follow-up|0|||
129150328|NCT01819272|464849189|FG002|Overall Study|Lost to Follow-up|1|||
129150329|NCT01819272|464849190|FG003|Overall Study|Lost to Follow-up|0|||
129150330|NCT01819272|464849191|FG004|Overall Study|Lost to Follow-up|0|||
129150331|NCT01819272|464849192|FG005|Overall Study|Lost to Follow-up|3|||
129150332|NCT01819272|464849187|FG000|Overall Study|Protocol Violation|0|||
129150333|NCT01819272|464849188|FG001|Overall Study|Protocol Violation|0|||
129150334|NCT01819272|464849189|FG002|Overall Study|Protocol Violation|0|||
129150335|NCT01819272|464849190|FG003|Overall Study|Protocol Violation|1|||
129150336|NCT01819272|464849191|FG004|Overall Study|Protocol Violation|2|||
129150337|NCT01819272|464849192|FG005|Overall Study|Protocol Violation|3|||
129150338|NCT01819272|464849187|FG000|Overall Study|Physician Decision|0|||
129150339|NCT01819272|464849188|FG001|Overall Study|Physician Decision|1|||
129150340|NCT01819272|464849189|FG002|Overall Study|Physician Decision|0|||
129150341|NCT01819272|464849190|FG003|Overall Study|Physician Decision|0|||
129150342|NCT01819272|464849191|FG004|Overall Study|Physician Decision|0|||
129150343|NCT01819272|464849192|FG005|Overall Study|Physician Decision|0|||
129150344|NCT01819272|464849187|FG000|Overall Study|Withdrawal of Consent|0|||
129150345|NCT01819272|464849188|FG001|Overall Study|Withdrawal of Consent|1|||
129150346|NCT01819272|464849189|FG002|Overall Study|Withdrawal of Consent|2|||
129150347|NCT01819272|464849190|FG003|Overall Study|Withdrawal of Consent|1|||
129150348|NCT01819272|464849191|FG004|Overall Study|Withdrawal of Consent|0|||
129150349|NCT01819272|464849192|FG005|Overall Study|Withdrawal of Consent|1|||
129150350|NCT01819272|464849187|FG000|Overall Study|Loss of Glucose Control|2|||
129150351|NCT01819272|464849188|FG001|Overall Study|Loss of Glucose Control|1|||
129150352|NCT01819272|464849189|FG002|Overall Study|Loss of Glucose Control|0|||
129150353|NCT01819272|464849190|FG003|Overall Study|Loss of Glucose Control|1|||
129150354|NCT01819272|464849191|FG004|Overall Study|Loss of Glucose Control|2|||
129150355|NCT01819272|464849192|FG005|Overall Study|Loss of Glucose Control|0|||
129150356|NCT01732536|464849193|FG000|Overall Study|Withdrawal by Subject|1|||
129150357|NCT01732536|464849194|FG001|Overall Study|Withdrawal by Subject|1|||
129150358|NCT01581684|464849195|FG000|Overall Study|Other reason not defined|0|||
129150359|NCT01581684|464849196|FG001|Overall Study|Other reason not defined|0|||
129150360|NCT01581684|464849197|FG002|Overall Study|Other reason not defined|0|||
129150361|NCT01581684|464849198|FG003|Overall Study|Other reason not defined|0|||
129150362|NCT01581684|464849199|FG004|Overall Study|Other reason not defined|0|||
129150363|NCT01581684|464849200|FG005|Overall Study|Other reason not defined|0|||
129150364|NCT01581684|464849201|FG006|Overall Study|Other reason not defined|0|||
129150365|NCT01581684|464849202|FG007|Overall Study|Other reason not defined|0|||
129150366|NCT01581684|464849203|FG008|Overall Study|Other reason not defined|1|||
129150367|NCT01581684|464849204|FG009|Overall Study|Other reason not defined|0|||
129150368|NCT03728933|464849205|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129150369|NCT03728933|464849206|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129150370|NCT03728933|464849207|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129150371|NCT03728933|464849205|FG000|Overall Study|Withdrawal by Subject|0|||
129150372|NCT03728933|464849206|FG001|Overall Study|Withdrawal by Subject|0|||
129150373|NCT03728933|464849207|FG002|Overall Study|Withdrawal by Subject|1|||
129150374|NCT03728933|464849205|FG000|Overall Study|Lost to Follow-up|0|||
129150375|NCT03728933|464849206|FG001|Overall Study|Lost to Follow-up|1|||
129150376|NCT03728933|464849207|FG002|Overall Study|Lost to Follow-up|0|||
129150377|NCT03728933|464849205|FG000|Overall Study|Adverse Event|1|||
129150378|NCT03728933|464849206|FG001|Overall Study|Adverse Event|0|||
129150379|NCT03728933|464849207|FG002|Overall Study|Adverse Event|0|||
129150380|NCT01784029|464849208|FG000|Overall Study|Lost to Follow-up|19|||
129150381|NCT01784029|464849209|FG001|Overall Study|Lost to Follow-up|20|||
129150382|NCT01784029|464849210|FG002|Overall Study|Lost to Follow-up|22|||
129150383|NCT00639457|464849211|FG000|Overall Study|Withdrawal by Subject|2|||
129150384|NCT00639457|464849212|FG001|Overall Study|Withdrawal by Subject|3|||
129150385|NCT03235050|464849213|FG000|Overall Study|Adverse Event|0|||
129150386|NCT03235050|464849214|FG001|Overall Study|Adverse Event|0|||
129150387|NCT03235050|464849215|FG002|Overall Study|Adverse Event|1|||
129150388|NCT03235050|464849216|FG003|Overall Study|Adverse Event|4|||
129150389|NCT03235050|464849217|FG004|Overall Study|Adverse Event|1|||
129150390|NCT03235050|464849213|FG000|Overall Study|Death|0|||
129150391|NCT03235050|464849214|FG001|Overall Study|Death|0|||
129150392|NCT03235050|464849215|FG002|Overall Study|Death|0|||
129150393|NCT03235050|464849216|FG003|Overall Study|Death|2|||
129150394|NCT03235050|464849217|FG004|Overall Study|Death|1|||
129150395|NCT03235050|464849213|FG000|Overall Study|Lost to Follow-up|1|||
129150396|NCT03235050|464849214|FG001|Overall Study|Lost to Follow-up|2|||
129150397|NCT03235050|464849215|FG002|Overall Study|Lost to Follow-up|1|||
129150398|NCT03235050|464849216|FG003|Overall Study|Lost to Follow-up|2|||
129150399|NCT03235050|464849217|FG004|Overall Study|Lost to Follow-up|0|||
129150400|NCT03235050|464849213|FG000|Overall Study|Withdrawal by Subject|3|||
129150401|NCT03235050|464849214|FG001|Overall Study|Withdrawal by Subject|2|||
129150402|NCT03235050|464849215|FG002|Overall Study|Withdrawal by Subject|2|||
129150403|NCT03235050|464849216|FG003|Overall Study|Withdrawal by Subject|5|||
129150404|NCT03235050|464849217|FG004|Overall Study|Withdrawal by Subject|7|||
129150405|NCT03235050|464849213|FG000|Overall Study|Other reasons|0|||
129150406|NCT03235050|464849214|FG001|Overall Study|Other reasons|1|||
129150407|NCT03235050|464849215|FG002|Overall Study|Other reasons|0|||
129150408|NCT03235050|464849216|FG003|Overall Study|Other reasons|1|||
129150409|NCT03235050|464849217|FG004|Overall Study|Other reasons|2|||
129150410|NCT00276419|464849218|FG000|First Intervention|Adverse Event|1|||
129150411|NCT00276419|464849219|FG001|First Intervention|Adverse Event|0|||
129150412|NCT00276419|464849218|FG000|First Intervention|Withdrawal by Subject|0|||
129150413|NCT00276419|464849219|FG001|First Intervention|Withdrawal by Subject|2|||
129150414|NCT00598650|464849220|FG000|Overall Study|Withdrawal by Subject|3|||
129150415|NCT00598650|464849220|FG000|Overall Study|Adverse Event|18|||
129150416|NCT00598650|464849220|FG000|Overall Study|No treatment for 3 weeks|1|||
129150417|NCT00598650|464849220|FG000|Overall Study|Not eligible|1|||
129150418|NCT00598650|464849220|FG000|Overall Study|Prohibited Concomitant Medication|2|||
129150419|NCT00598650|464849220|FG000|Overall Study|Physician Decision|2|||
129150420|NCT02415556|464849223|FG000|Overall Study|Adverse Event|3|||
129150421|NCT02415556|464849224|FG001|Overall Study|Adverse Event|4|||
129150422|NCT02415556|464849225|FG002|Overall Study|Adverse Event|2|||
129150423|NCT02415556|464849226|FG003|Overall Study|Adverse Event|4|||
129150424|NCT02415556|464849223|FG000|Overall Study|Lost to Follow-up|4|||
129150425|NCT02415556|464849224|FG001|Overall Study|Lost to Follow-up|5|||
129150426|NCT02415556|464849225|FG002|Overall Study|Lost to Follow-up|4|||
129150427|NCT02415556|464849226|FG003|Overall Study|Lost to Follow-up|1|||
129150428|NCT02415556|464849223|FG000|Overall Study|Withdrawal by Subject|13|||
129150429|NCT02415556|464849224|FG001|Overall Study|Withdrawal by Subject|4|||
129150430|NCT02415556|464849225|FG002|Overall Study|Withdrawal by Subject|14|||
129150431|NCT02415556|464849226|FG003|Overall Study|Withdrawal by Subject|12|||
129150432|NCT02415556|464849223|FG000|Overall Study|Physician Decision|1|||
129150433|NCT02415556|464849224|FG001|Overall Study|Physician Decision|3|||
129150434|NCT02415556|464849225|FG002|Overall Study|Physician Decision|1|||
129150435|NCT02415556|464849226|FG003|Overall Study|Physician Decision|2|||
129150436|NCT02415556|464849223|FG000|Overall Study|Censored - study completion|4|||
129150437|NCT02415556|464849224|FG001|Overall Study|Censored - study completion|5|||
129150438|NCT02415556|464849225|FG002|Overall Study|Censored - study completion|1|||
129150439|NCT02415556|464849226|FG003|Overall Study|Censored - study completion|0|||
129150440|NCT02415556|464849223|FG000|Overall Study|Family-related issues|0|||
129150441|NCT02415556|464849224|FG001|Overall Study|Family-related issues|0|||
129150442|NCT02415556|464849225|FG002|Overall Study|Family-related issues|0|||
129150443|NCT02415556|464849226|FG003|Overall Study|Family-related issues|1|||
129150444|NCT00105534|464849227|FG000|Overall Study|Adverse Event|2|||
129150445|NCT00105534|464849228|FG001|Overall Study|Adverse Event|5|||
129150446|NCT00105534|464849227|FG000|Overall Study|Protocol Violation|1|||
129150447|NCT00105534|464849228|FG001|Overall Study|Protocol Violation|4|||
129150448|NCT00105534|464849227|FG000|Overall Study|Withdrawal by Subject|6|||
129150449|NCT00105534|464849228|FG001|Overall Study|Withdrawal by Subject|6|||
129150450|NCT00105534|464849227|FG000|Overall Study|Lost to Follow-up|5|||
128725234|NCT02641379|463290946|FG001|Overall Study|Participant showed weight reduction|0|||
128725235|NCT02641379|463290947|FG002|Overall Study|Participant showed weight reduction|0|||
128725236|NCT02641379|463290948|FG003|Overall Study|Participant showed weight reduction|0|||
128725237|NCT02641379|463290949|FG004|Overall Study|Participant showed weight reduction|0|||
128725238|NCT02641379|463290950|FG005|Overall Study|Participant showed weight reduction|0|||
129150451|NCT00105534|464849228|FG001|Overall Study|Lost to Follow-up|1|||
129150452|NCT00105534|464849227|FG000|Overall Study|Lack of Efficacy|7|||
129150453|NCT00105534|464849228|FG001|Overall Study|Lack of Efficacy|15|||
129150454|NCT00105534|464849227|FG000|Overall Study|Treatment unmasked|1|||
129150455|NCT00105534|464849228|FG001|Overall Study|Treatment unmasked|0|||
128725239|NCT02641379|463290951|FG006|Overall Study|Participant showed weight reduction|0|||
129150456|NCT00105534|464849227|FG000|Overall Study|Other Reason|0|||
129150457|NCT00105534|464849228|FG001|Overall Study|Other Reason|2|||
129150458|NCT01621178|464849229|FG000|Overall Study|Adverse Event|5|||
129150459|NCT01621178|464849230|FG001|Overall Study|Adverse Event|2|||
129150460|NCT01621178|464849231|FG002|Overall Study|Adverse Event|8|||
129150461|NCT01621178|464849229|FG000|Overall Study|Death|6|||
129150462|NCT01621178|464849230|FG001|Overall Study|Death|7|||
129150463|NCT01621178|464849231|FG002|Overall Study|Death|2|||
129150464|NCT01621178|464849229|FG000|Overall Study|Lost to Follow-up|1|||
129150465|NCT01621178|464849230|FG001|Overall Study|Lost to Follow-up|2|||
129150466|NCT01621178|464849231|FG002|Overall Study|Lost to Follow-up|1|||
129150467|NCT01621178|464849229|FG000|Overall Study|Withdrawal by Subject|14|||
129150468|NCT01621178|464849230|FG001|Overall Study|Withdrawal by Subject|17|||
129150469|NCT01621178|464849231|FG002|Overall Study|Withdrawal by Subject|18|||
129150470|NCT01621178|464849229|FG000|Overall Study|Physician Decision|5|||
129150471|NCT01621178|464849230|FG001|Overall Study|Physician Decision|2|||
129150472|NCT01621178|464849231|FG002|Overall Study|Physician Decision|7|||
129150473|NCT02935192|464849232|FG000|Overall Study|Withdrawal by Subject|8|||
129150474|NCT02935192|464849233|FG001|Overall Study|Withdrawal by Subject|4|||
129150475|NCT02896257|464849235|FG000|Providers|Without eligible patients|21|||
129150476|NCT02896257|464849236|FG001|Providers|Without eligible patients|28|||
129150477|NCT02896257|464849235|FG000|Patients|PFT entry criteria not met|43|||
129150478|NCT02896257|464849236|FG001|Patients|PFT entry criteria not met|50|||
129150479|NCT02896257|464849235|FG000|Patients|No capacity to review|8|||
129150480|NCT02896257|464849236|FG001|Patients|No capacity to review|11|||
129150481|NCT02896257|464849235|FG000|Patients|Appointment rescheduled/cancelled|5|||
129150482|NCT02896257|464849236|FG001|Patients|Appointment rescheduled/cancelled|7|||
129150483|NCT02896257|464849235|FG000|Patients|PCP not assigned a clinic|4|||
129150484|NCT02896257|464849236|FG001|Patients|PCP not assigned a clinic|0|||
129150485|NCT02896257|464849235|FG000|Patients|No history of COPD|0|||
129150486|NCT02896257|464849236|FG001|Patients|No history of COPD|1|||
129150487|NCT02896257|464849235|FG000|Patients|Deceased between review and index date|0|||
129150488|NCT02896257|464849236|FG001|Patients|Deceased between review and index date|1|||
129150489|NCT02896257|464849235|FG000|Patients|No ICS Rx upon review|1|||
129150490|NCT02896257|464849236|FG001|Patients|No ICS Rx upon review|1|||
129150491|NCT02896257|464849235|FG000|Patients|Protocol Violation|2|||
129150492|NCT02896257|464849236|FG001|Patients|Protocol Violation|1|||
129150493|NCT02896257|464849235|FG000|Patients|Hospice care|0|||
129150494|NCT02896257|464849236|FG001|Patients|Hospice care|1|||
129150495|NCT04778592|464849240|FG000|Overall Study|Adverse Event|1|||
129150496|NCT04778592|464849241|FG001|Overall Study|Adverse Event|2|||
129150497|NCT04778592|464849240|FG000|Overall Study|Withdrawal by Subject|1|||
129150498|NCT04778592|464849241|FG001|Overall Study|Withdrawal by Subject|2|||
129150499|NCT00560508|464849242|FG000|12 Week Double-blind Period|Adverse Event|3|||
129150500|NCT00560508|464849243|FG001|12 Week Double-blind Period|Adverse Event|2|||
129150501|NCT00560508|464849242|FG000|12 Week Double-blind Period|Protocol Violation|1|||
129150502|NCT00560508|464849243|FG001|12 Week Double-blind Period|Protocol Violation|0|||
129150503|NCT00560508|464849242|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
129150504|NCT00560508|464849243|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
129150505|NCT00560508|464849242|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
129150506|NCT00560508|464849243|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
129150507|NCT00560508|464849242|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
129150508|NCT00560508|464849243|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
129150509|NCT00560508|464849242|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
129150510|NCT00560508|464849243|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
129150511|NCT00560508|464849242|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
129150512|NCT00560508|464849243|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
129150513|NCT01192126|464849244|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
129150514|NCT01192126|464849245|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
129150515|NCT01192126|464849244|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
129150516|NCT01192126|464849245|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
129150517|NCT02660229|464849246|FG000|Overall Study|Adverse Event|2|||
129150518|NCT02660229|464849247|FG001|Overall Study|Adverse Event|0|||
129150519|NCT02660229|464849246|FG000|Overall Study|Withdrawal by Subject|0|||
129150520|NCT02660229|464849247|FG001|Overall Study|Withdrawal by Subject|1|||
129150521|NCT01146613|464849248|FG000|Overall Study|Lost to Follow-up|3|||
129150522|NCT01146613|464849249|FG001|Overall Study|Lost to Follow-up|8|||
129150523|NCT01146613|464849248|FG000|Overall Study|Lack of Efficacy|0|||
129150524|NCT01146613|464849249|FG001|Overall Study|Lack of Efficacy|1|||
129150525|NCT01146613|464849248|FG000|Overall Study|Death|1|||
129150526|NCT01146613|464849249|FG001|Overall Study|Death|0|||
129150527|NCT01146613|464849248|FG000|Overall Study|Physician Decision|1|||
129150528|NCT01146613|464849249|FG001|Overall Study|Physician Decision|0|||
129150529|NCT01146613|464849248|FG000|Overall Study|Withdrawal by Subject|0|||
129150530|NCT01146613|464849249|FG001|Overall Study|Withdrawal by Subject|3|||
129150531|NCT01146613|464849248|FG000|Overall Study|schedule conflict|1|||
129150532|NCT01146613|464849249|FG001|Overall Study|schedule conflict|0|||
129150533|NCT01146613|464849248|FG000|Overall Study|Outpatient detox|1|||
129150534|NCT01146613|464849249|FG001|Overall Study|Outpatient detox|0|||
129150535|NCT02441218|464849256|FG000|Overall Study|Death|503|||
129150536|NCT02441218|464849257|FG001|Overall Study|Death|553|||
129150537|NCT02441218|464849256|FG000|Overall Study|Withdrawal by Subject|73|||
129150538|NCT02441218|464849257|FG001|Overall Study|Withdrawal by Subject|58|||
128725240|NCT02641379|463290952|FG007|Overall Study|Participant showed weight reduction|1|||
128725241|NCT02641379|463290953|FG008|Overall Study|Participant showed weight reduction|0|||
128725242|NCT02641379|463290954|FG009|Overall Study|Participant showed weight reduction|0|||
128725243|NCT02641379|463290955|FG010|Overall Study|Participant showed weight reduction|0|||
128725244|NCT02641379|463290945|FG000|Overall Study|Non-response Week 12|0|||
128725245|NCT02641379|463290946|FG001|Overall Study|Non-response Week 12|0|||
128725246|NCT02641379|463290947|FG002|Overall Study|Non-response Week 12|0|||
128725247|NCT02641379|463290948|FG003|Overall Study|Non-response Week 12|0|||
128725248|NCT02641379|463290949|FG004|Overall Study|Non-response Week 12|0|||
128725249|NCT02641379|463290950|FG005|Overall Study|Non-response Week 12|0|||
128725250|NCT02641379|463290951|FG006|Overall Study|Non-response Week 12|0|||
128725251|NCT02641379|463290952|FG007|Overall Study|Non-response Week 12|1|||
128725252|NCT02641379|463290953|FG008|Overall Study|Non-response Week 12|0|||
128725253|NCT02641379|463290954|FG009|Overall Study|Non-response Week 12|0|||
128725254|NCT02641379|463290955|FG010|Overall Study|Non-response Week 12|0|||
128725255|NCT02641379|463290945|FG000|Overall Study|No 2 Log drop at Week 12|0|||
128725256|NCT02641379|463290946|FG001|Overall Study|No 2 Log drop at Week 12|0|||
128725257|NCT02641379|463290947|FG002|Overall Study|No 2 Log drop at Week 12|0|||
128725258|NCT02641379|463290948|FG003|Overall Study|No 2 Log drop at Week 12|0|||
128725259|NCT02641379|463290949|FG004|Overall Study|No 2 Log drop at Week 12|0|||
128725260|NCT02641379|463290950|FG005|Overall Study|No 2 Log drop at Week 12|0|||
128725261|NCT02641379|463290951|FG006|Overall Study|No 2 Log drop at Week 12|0|||
128725262|NCT02641379|463290952|FG007|Overall Study|No 2 Log drop at Week 12|0|||
128725263|NCT02641379|463290953|FG008|Overall Study|No 2 Log drop at Week 12|0|||
128725264|NCT02641379|463290954|FG009|Overall Study|No 2 Log drop at Week 12|0|||
128725265|NCT02641379|463290955|FG010|Overall Study|No 2 Log drop at Week 12|1|||
128725266|NCT02641379|463290945|FG000|Overall Study|Negative PCR result|0|||
128725267|NCT02641379|463290946|FG001|Overall Study|Negative PCR result|0|||
128725268|NCT02641379|463290947|FG002|Overall Study|Negative PCR result|0|||
128725269|NCT02641379|463290948|FG003|Overall Study|Negative PCR result|0|||
128725270|NCT02641379|463290949|FG004|Overall Study|Negative PCR result|0|||
128725271|NCT02641379|463290950|FG005|Overall Study|Negative PCR result|0|||
128725272|NCT02641379|463290951|FG006|Overall Study|Negative PCR result|0|||
128725273|NCT02641379|463290952|FG007|Overall Study|Negative PCR result|0|||
128725274|NCT02641379|463290953|FG008|Overall Study|Negative PCR result|0|||
128725275|NCT02641379|463290954|FG009|Overall Study|Negative PCR result|1|||
128725276|NCT02641379|463290955|FG010|Overall Study|Negative PCR result|0|||
128725277|NCT02641379|463290945|FG000|Overall Study|Participant's PCR high|0|||
128725278|NCT02641379|463290946|FG001|Overall Study|Participant's PCR high|0|||
128725279|NCT02641379|463290947|FG002|Overall Study|Participant's PCR high|0|||
128725280|NCT02641379|463290948|FG003|Overall Study|Participant's PCR high|0|||
129150539|NCT02441218|464849256|FG000|Overall Study|Lost to Follow-up|2|||
129150540|NCT02441218|464849257|FG001|Overall Study|Lost to Follow-up|1|||
129150541|NCT01541371|464849258|FG000|Overall Study|Withdrawal by Subject|14|||
129150542|NCT01541371|464849258|FG000|Overall Study|Lost to Follow-up|21|||
129150543|NCT01541371|464849258|FG000|Overall Study|Adverse Event|15|||
129150544|NCT01541371|464849258|FG000|Overall Study|Lack of Efficacy|12|||
129150545|NCT01541371|464849258|FG000|Overall Study|Protocol Violation|6|||
129150546|NCT01541371|464849258|FG000|Overall Study|Study medication non-compliance|3|||
129150547|NCT01541371|464849258|FG000|Overall Study|Other|6|||
129150548|NCT02271880|464849261|FG000|Overall Study|Premature discontinuation of study|3|||
129150549|NCT02271880|464849262|FG001|Overall Study|Premature discontinuation of study|4|||
129150550|NCT02431325|464849263|FG000|Overall Study|Adverse Event|3|||
129150551|NCT02431325|464849264|FG001|Overall Study|Adverse Event|0|||
129150552|NCT02431325|464849263|FG000|Overall Study|Lost to Follow-up|0|||
128725281|NCT02641379|463290949|FG004|Overall Study|Participant's PCR high|0|||
128725282|NCT02641379|463290950|FG005|Overall Study|Participant's PCR high|0|||
128725283|NCT02641379|463290951|FG006|Overall Study|Participant's PCR high|0|||
128725284|NCT02641379|463290952|FG007|Overall Study|Participant's PCR high|1|||
128725285|NCT02641379|463290953|FG008|Overall Study|Participant's PCR high|0|||
128725286|NCT02641379|463290954|FG009|Overall Study|Participant's PCR high|0|||
128725287|NCT02641379|463290955|FG010|Overall Study|Participant's PCR high|0|||
128725288|NCT02641379|463290945|FG000|Overall Study|Participant treated after Week 24|0|||
128725289|NCT02641379|463290946|FG001|Overall Study|Participant treated after Week 24|0|||
128725290|NCT02641379|463290947|FG002|Overall Study|Participant treated after Week 24|0|||
128725291|NCT02641379|463290948|FG003|Overall Study|Participant treated after Week 24|0|||
128725292|NCT02641379|463290949|FG004|Overall Study|Participant treated after Week 24|0|||
128725293|NCT02641379|463290950|FG005|Overall Study|Participant treated after Week 24|0|||
128725294|NCT02641379|463290951|FG006|Overall Study|Participant treated after Week 24|0|||
129150553|NCT02431325|464849264|FG001|Overall Study|Lost to Follow-up|1|||
129150554|NCT02431325|464849263|FG000|Overall Study|Withdrawal by Subject|1|||
129150555|NCT02431325|464849264|FG001|Overall Study|Withdrawal by Subject|2|||
129150556|NCT02431325|464849263|FG000|Overall Study|Declined to take study medication|1|||
129150557|NCT02431325|464849264|FG001|Overall Study|Declined to take study medication|0|||
129150558|NCT02431325|464849263|FG000|Overall Study|Withdrew before starting study medication|1|||
129150559|NCT02431325|464849264|FG001|Overall Study|Withdrew before starting study medication|0|||
129150560|NCT02431325|464849263|FG000|Overall Study|Placebo shortage|2|||
129150561|NCT02431325|464849264|FG001|Overall Study|Placebo shortage|0|||
129150562|NCT00744861|464849265|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
129150563|NCT00744861|464849266|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
129150564|NCT00744861|464849267|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
129150565|NCT00744861|464849268|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
129150566|NCT00744861|464849265|FG000|Feasibility Stage 1|Pregnancy|0|||
129150567|NCT00744861|464849266|FG001|Feasibility Stage 1|Pregnancy|1|||
129150568|NCT00744861|464849267|FG002|Feasibility Stage 1|Pregnancy|0|||
129150569|NCT00744861|464849268|FG003|Feasibility Stage 1|Pregnancy|0|||
129150570|NCT00744861|464849265|FG000|Pivotal Stage 2|Adverse Event|0|||
129150571|NCT00744861|464849266|FG001|Pivotal Stage 2|Adverse Event|0|||
129150572|NCT00744861|464849267|FG002|Pivotal Stage 2|Adverse Event|6|||
129150573|NCT00744861|464849268|FG003|Pivotal Stage 2|Adverse Event|11|||
129150574|NCT00744861|464849265|FG000|Pivotal Stage 2|Death|0|||
129150575|NCT00744861|464849266|FG001|Pivotal Stage 2|Death|0|||
129150576|NCT00744861|464849267|FG002|Pivotal Stage 2|Death|0|||
129150577|NCT00744861|464849268|FG003|Pivotal Stage 2|Death|1|||
129150578|NCT00744861|464849265|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
129150579|NCT00744861|464849266|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
129150580|NCT00744861|464849267|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
129150581|NCT00744861|464849268|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
129150582|NCT00744861|464849265|FG000|Pivotal Stage 2|Physician Decision|0|||
129150583|NCT00744861|464849266|FG001|Pivotal Stage 2|Physician Decision|0|||
129150584|NCT00744861|464849267|FG002|Pivotal Stage 2|Physician Decision|3|||
129150585|NCT00744861|464849268|FG003|Pivotal Stage 2|Physician Decision|1|||
129150586|NCT00744861|464849265|FG000|Pivotal Stage 2|Protocol Violation|0|||
129150587|NCT00744861|464849266|FG001|Pivotal Stage 2|Protocol Violation|0|||
129150588|NCT00744861|464849267|FG002|Pivotal Stage 2|Protocol Violation|0|||
129150589|NCT00744861|464849268|FG003|Pivotal Stage 2|Protocol Violation|1|||
129150590|NCT00744861|464849265|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
129150591|NCT00744861|464849266|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
129150592|NCT00744861|464849267|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
129150593|NCT00744861|464849268|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
129150594|NCT00744861|464849265|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
129150595|NCT00744861|464849266|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
129150596|NCT00744861|464849267|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
129150597|NCT00744861|464849268|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
129150598|NCT00181844|464849269|FG000|Signed Consent|Withdrawal by Subject|5|||
129150599|NCT00181844|464849269|FG000|Signed Consent|Did not meet entrance criteria|7|||
129150600|NCT00181844|464849269|FG000|Exposed to Study Medication|Adverse Event|10|||
129150601|NCT00181844|464849269|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
129150602|NCT00181844|464849269|FG000|Exposed to Study Medication|Non-compliance|2|||
129150603|NCT00181844|464849269|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
129150604|NCT00181844|464849269|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
129150605|NCT04661033|464849270|FG000|Overall Study|Adverse Event|0|||
129150606|NCT04661033|464849271|FG001|Overall Study|Adverse Event|0|||
129150607|NCT04661033|464849272|FG002|Overall Study|Adverse Event|1|||
129150608|NCT04661033|464849273|FG003|Overall Study|Adverse Event|0|||
129150609|NCT04661033|464849270|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
129150610|NCT04661033|464849271|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
129150611|NCT04661033|464849272|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
129150612|NCT04661033|464849273|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
129150613|NCT04661033|464849270|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
129150614|NCT04661033|464849271|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
129150615|NCT04661033|464849272|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
129150616|NCT04661033|464849273|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
129150617|NCT04661033|464849270|FG000|Overall Study|Early discontinuation as per PI|1|||
129150618|NCT04661033|464849271|FG001|Overall Study|Early discontinuation as per PI|0|||
129150619|NCT04661033|464849272|FG002|Overall Study|Early discontinuation as per PI|0|||
129150620|NCT04661033|464849273|FG003|Overall Study|Early discontinuation as per PI|0|||
129150621|NCT00565409|464849276|FG000|Period 1 Open Label|Adverse Event|17|||
129150622|NCT00565409|464849277|FG001|Period 1 Open Label|Adverse Event|0|||
129150623|NCT00565409|464849278|FG002|Period 1 Open Label|Adverse Event|0|||
129150624|NCT00565409|464849279|FG003|Period 1 Open Label|Adverse Event|0|||
129150625|NCT00565409|464849276|FG000|Period 1 Open Label|Death|2|||
129150626|NCT00565409|464849277|FG001|Period 1 Open Label|Death|0|||
129150627|NCT00565409|464849278|FG002|Period 1 Open Label|Death|0|||
129150628|NCT00565409|464849279|FG003|Period 1 Open Label|Death|0|||
129150629|NCT00565409|464849276|FG000|Period 1 Open Label|Lost to Follow-up|1|||
129150630|NCT00565409|464849277|FG001|Period 1 Open Label|Lost to Follow-up|0|||
129150631|NCT00565409|464849278|FG002|Period 1 Open Label|Lost to Follow-up|0|||
129150632|NCT00565409|464849279|FG003|Period 1 Open Label|Lost to Follow-up|0|||
129150633|NCT00565409|464849276|FG000|Period 1 Open Label|Other|21|||
129150634|NCT00565409|464849277|FG001|Period 1 Open Label|Other|0|||
129150635|NCT00565409|464849278|FG002|Period 1 Open Label|Other|0|||
129150636|NCT00565409|464849279|FG003|Period 1 Open Label|Other|0|||
129150637|NCT00565409|464849276|FG000|Period 1 Open Label|Protocol Violation|14|||
129150638|NCT00565409|464849277|FG001|Period 1 Open Label|Protocol Violation|0|||
129150639|NCT00565409|464849278|FG002|Period 1 Open Label|Protocol Violation|0|||
129150640|NCT00565409|464849279|FG003|Period 1 Open Label|Protocol Violation|0|||
129150641|NCT00565409|464849276|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
129150642|NCT00565409|464849277|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
129150643|NCT00565409|464849278|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
129150644|NCT00565409|464849279|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
129150645|NCT00565409|464849276|FG000|Period 1 Open Label|no conclusion of participation record|1|||
129150646|NCT00565409|464849277|FG001|Period 1 Open Label|no conclusion of participation record|0|||
129150647|NCT00565409|464849278|FG002|Period 1 Open Label|no conclusion of participation record|0|||
129150648|NCT00565409|464849279|FG003|Period 1 Open Label|no conclusion of participation record|0|||
129150649|NCT00565409|464849276|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
129150650|NCT00565409|464849277|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
129150651|NCT00565409|464849278|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
129150652|NCT00565409|464849279|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
129150653|NCT00565409|464849276|FG000|Period 2 Double-Blind|Adverse Event|0|||
129150654|NCT00565409|464849277|FG001|Period 2 Double-Blind|Adverse Event|7|||
129150655|NCT00565409|464849278|FG002|Period 2 Double-Blind|Adverse Event|4|||
129150656|NCT00565409|464849279|FG003|Period 2 Double-Blind|Adverse Event|5|||
129150657|NCT00565409|464849276|FG000|Period 2 Double-Blind|Death|0|||
129150658|NCT00565409|464849277|FG001|Period 2 Double-Blind|Death|2|||
129150659|NCT00565409|464849278|FG002|Period 2 Double-Blind|Death|0|||
129150660|NCT00565409|464849279|FG003|Period 2 Double-Blind|Death|0|||
129150661|NCT00565409|464849276|FG000|Period 2 Double-Blind|Protocol Violation|0|||
129150662|NCT00565409|464849277|FG001|Period 2 Double-Blind|Protocol Violation|4|||
129150663|NCT00565409|464849278|FG002|Period 2 Double-Blind|Protocol Violation|6|||
129150664|NCT00565409|464849279|FG003|Period 2 Double-Blind|Protocol Violation|2|||
129150665|NCT00565409|464849276|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
129150666|NCT00565409|464849277|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
129150667|NCT00565409|464849278|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
129150668|NCT00565409|464849279|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
129150669|NCT00565409|464849276|FG000|Period 2 Double-Blind|Other|0|||
129150670|NCT00565409|464849277|FG001|Period 2 Double-Blind|Other|4|||
129150671|NCT00565409|464849278|FG002|Period 2 Double-Blind|Other|5|||
129150672|NCT00565409|464849279|FG003|Period 2 Double-Blind|Other|9|||
129150673|NCT00565409|464849276|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
129150674|NCT00565409|464849277|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
129150675|NCT00565409|464849278|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
129150676|NCT00565409|464849279|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
129150677|NCT02257684|464849280|FG000|Overall Study|Adverse Event|2|||
129150678|NCT02257684|464849280|FG000|Overall Study|Lack of Efficacy|1|||
129150679|NCT02257684|464849280|FG000|Overall Study|Sponsor's Decision|1|||
129150680|NCT01570387|464849281|FG000|Overall Study|Adverse Event|1|||
129150681|NCT01570387|464849282|FG001|Overall Study|Adverse Event|0|||
129150682|NCT01570387|464849283|FG002|Overall Study|Adverse Event|0|||
129150683|NCT01570387|464849284|FG003|Overall Study|Adverse Event|0|||
129150684|NCT01570387|464849281|FG000|Overall Study|Death|0|||
129150685|NCT01570387|464849282|FG001|Overall Study|Death|0|||
129150686|NCT01570387|464849283|FG002|Overall Study|Death|0|||
129150687|NCT01570387|464849284|FG003|Overall Study|Death|1|||
129150688|NCT01570387|464849281|FG000|Overall Study|Withdrawal by Subject|0|||
129150689|NCT01570387|464849282|FG001|Overall Study|Withdrawal by Subject|0|||
129150690|NCT01570387|464849283|FG002|Overall Study|Withdrawal by Subject|0|||
129150691|NCT01570387|464849284|FG003|Overall Study|Withdrawal by Subject|1|||
129150692|NCT01987557|464849285|FG000|Overall Study|Protocol Violation|1|||
129150693|NCT01987557|464849286|FG001|Overall Study|Protocol Violation|0|||
129150694|NCT01987557|464849287|FG002|Overall Study|Protocol Violation|1|||
129150695|NCT01987557|464849285|FG000|Overall Study|Withdrawal by Subject|2|||
129150696|NCT01987557|464849286|FG001|Overall Study|Withdrawal by Subject|1|||
129150697|NCT01987557|464849287|FG002|Overall Study|Withdrawal by Subject|2|||
129150698|NCT01987557|464849285|FG000|Overall Study|Adverse Event|0|||
129150699|NCT01987557|464849286|FG001|Overall Study|Adverse Event|2|||
129150700|NCT01987557|464849287|FG002|Overall Study|Adverse Event|0|||
129150701|NCT01567722|464849296|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
129150702|NCT01567722|464849297|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
129150703|NCT01567722|464849298|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
129150704|NCT01567722|464849296|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
129150705|NCT01567722|464849297|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
129150706|NCT01567722|464849298|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
129150707|NCT01567722|464849296|FG000|Overall Study|Protocol closure by the OCG|2|||
129150708|NCT01567722|464849297|FG001|Overall Study|Protocol closure by the OCG|0|||
129150709|NCT01567722|464849298|FG002|Overall Study|Protocol closure by the OCG|0|||
129150710|NCT01567722|464849296|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
129150711|NCT01567722|464849297|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
129150712|NCT01567722|464849298|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
129150713|NCT00431964|464849299|FG000|Overall Study|Adverse Event|1|||
129150714|NCT00431964|464849300|FG001|Overall Study|Adverse Event|0|||
129150715|NCT00431964|464849299|FG000|Overall Study|Lost to Follow-up|1|||
129150716|NCT00431964|464849300|FG001|Overall Study|Lost to Follow-up|2|||
129150717|NCT00431964|464849299|FG000|Overall Study|Physician Decision|2|||
129150718|NCT00431964|464849300|FG001|Overall Study|Physician Decision|2|||
129150719|NCT00431964|464849299|FG000|Overall Study|Withdrawal by Subject|2|||
129150720|NCT00431964|464849300|FG001|Overall Study|Withdrawal by Subject|1|||
129150721|NCT00431964|464849299|FG000|Overall Study|Parental Consent Withdrawn|0|||
129150722|NCT00431964|464849300|FG001|Overall Study|Parental Consent Withdrawn|2|||
129150723|NCT00431964|464849299|FG000|Overall Study|Due to Unstable Health|0|||
129150724|NCT00431964|464849300|FG001|Overall Study|Due to Unstable Health|1|||
129150725|NCT00382174|464849302|FG000|Overall Study|Lost to Follow-up|1|||
129150726|NCT00382174|464849303|FG001|Overall Study|Lost to Follow-up|4|||
129150727|NCT00382174|464849304|FG002|Overall Study|Lost to Follow-up|5|||
129150728|NCT00382174|464849302|FG000|Overall Study|Adverse Event|1|||
129150729|NCT00382174|464849303|FG001|Overall Study|Adverse Event|4|||
129150730|NCT00382174|464849304|FG002|Overall Study|Adverse Event|5|||
129150731|NCT00382174|464849302|FG000|Overall Study|Withdrawal by Subject|1|||
129150732|NCT00382174|464849303|FG001|Overall Study|Withdrawal by Subject|4|||
129150733|NCT00382174|464849304|FG002|Overall Study|Withdrawal by Subject|5|||
129150734|NCT00382174|464849302|FG000|Overall Study|Non compliance|1|||
129150735|NCT00382174|464849303|FG001|Overall Study|Non compliance|0|||
129150736|NCT00382174|464849304|FG002|Overall Study|Non compliance|1|||
129150737|NCT00382174|464849302|FG000|Overall Study|Physician Decision|0|||
129150738|NCT00382174|464849303|FG001|Overall Study|Physician Decision|2|||
129150739|NCT00382174|464849304|FG002|Overall Study|Physician Decision|2|||
129150740|NCT00382174|464849302|FG000|Overall Study|Failed to meet criteria|0|||
129150741|NCT00382174|464849303|FG001|Overall Study|Failed to meet criteria|1|||
129150742|NCT00382174|464849304|FG002|Overall Study|Failed to meet criteria|1|||
129150743|NCT00382174|464849302|FG000|Overall Study|Wounds merged|0|||
129150744|NCT00382174|464849303|FG001|Overall Study|Wounds merged|2|||
129150745|NCT00382174|464849304|FG002|Overall Study|Wounds merged|2|||
129150746|NCT03434834|464849310|FG000|Overall Study|unable to swallow OCT probe|16|||
129150747|NCT00518180|464849315|FG000|Overall Study|Withdrawal by Subject|29|||
129150748|NCT00518180|464849316|FG001|Overall Study|Withdrawal by Subject|30|||
129150749|NCT00518180|464849317|FG002|Overall Study|Withdrawal by Subject|42|||
129150750|NCT00518180|464849315|FG000|Overall Study|Lost to Follow-up|30|||
129150751|NCT00518180|464849316|FG001|Overall Study|Lost to Follow-up|28|||
129150752|NCT00518180|464849317|FG002|Overall Study|Lost to Follow-up|34|||
129150753|NCT00518180|464849315|FG000|Overall Study|Administrative reason|0|||
129150754|NCT00518180|464849316|FG001|Overall Study|Administrative reason|2|||
129150755|NCT00518180|464849317|FG002|Overall Study|Administrative reason|2|||
129150756|NCT00518180|464849315|FG000|Overall Study|Protocol Violation|5|||
129150757|NCT00518180|464849316|FG001|Overall Study|Protocol Violation|7|||
129150758|NCT00518180|464849317|FG002|Overall Study|Protocol Violation|4|||
129150759|NCT00518180|464849315|FG000|Overall Study|Unable to classify|0|||
129150760|NCT00518180|464849316|FG001|Overall Study|Unable to classify|2|||
129150761|NCT00518180|464849317|FG002|Overall Study|Unable to classify|0|||
129150762|NCT00518180|464849315|FG000|Overall Study|Adverse Event|1|||
129150763|NCT00518180|464849316|FG001|Overall Study|Adverse Event|0|||
129150764|NCT00518180|464849317|FG002|Overall Study|Adverse Event|0|||
129150765|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
128725295|NCT02641379|463290952|FG007|Overall Study|Participant treated after Week 24|0|||
129150766|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
129150767|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
129150768|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Death|0|||
129150769|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Death|0|||
129150770|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Death|1|||
129150771|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
129150772|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
129150773|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
129150774|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
129150775|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
129150776|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
129150777|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
129150778|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
129150779|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
129150780|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Graft loss|0|||
129150781|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Graft loss|0|||
129150782|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Graft loss|7|||
129150783|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
129150784|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
129150785|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
129150786|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
129150787|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
129150788|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
129150789|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
129150790|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
129150791|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
129150792|NCT00956293|464849322|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
129150793|NCT00956293|464849323|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
129150794|NCT00956293|464849324|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
129150795|NCT00956293|464849322|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
129150796|NCT00956293|464849323|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
129150797|NCT00956293|464849324|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
129150798|NCT00956293|464849322|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
129150799|NCT00956293|464849323|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
129150800|NCT00956293|464849324|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
129150801|NCT00956293|464849322|FG000|Main Period (Randomization)|Adverse Event|0|||
129150802|NCT00956293|464849323|FG001|Main Period (Randomization)|Adverse Event|15|||
129150803|NCT00956293|464849324|FG002|Main Period (Randomization)|Adverse Event|0|||
129150804|NCT00956293|464849322|FG000|Follow-up Period|Follow-up period was terminated.|20|||
129150805|NCT00956293|464849323|FG001|Follow-up Period|Follow-up period was terminated.|32|||
129150806|NCT00956293|464849324|FG002|Follow-up Period|Follow-up period was terminated.|0|||
129150807|NCT03383666|464849325|FG000|Overall Study|Withdrawal by Subject|2|||
129150808|NCT03383666|464849325|FG000|Overall Study|Lost to Follow-up|2|||
129150809|NCT02081586|464849326|FG000|Overall Study|Lost to Follow-up|0|||
129150810|NCT02081586|464849327|FG001|Overall Study|Lost to Follow-up|1|||
129150811|NCT02081586|464849328|FG002|Overall Study|Lost to Follow-up|0|||
129150812|NCT02081586|464849329|FG003|Overall Study|Lost to Follow-up|1|||
129150813|NCT02081586|464849326|FG000|Overall Study|Head injury not related to study|0|||
129150814|NCT02081586|464849327|FG001|Overall Study|Head injury not related to study|0|||
129150815|NCT02081586|464849328|FG002|Overall Study|Head injury not related to study|1|||
129150816|NCT02081586|464849329|FG003|Overall Study|Head injury not related to study|0|||
129150817|NCT01677988|464849332|FG000|Overall Study|Lack of Efficacy|2|||
129150818|NCT00659425|464849336|FG000|Overall Study|Disease progression|1|||
129150819|NCT00659425|464849337|FG001|Overall Study|Disease progression|0|||
129150820|NCT00659425|464849338|FG002|Overall Study|Disease progression|0|||
129150821|NCT00659425|464849339|FG003|Overall Study|Disease progression|1|||
129150822|NCT00659425|464849340|FG004|Overall Study|Disease progression|0|||
129150823|NCT00659425|464849341|FG005|Overall Study|Disease progression|2|||
129150824|NCT00659425|464849342|FG006|Overall Study|Disease progression|4|||
129150825|NCT00659425|464849343|FG007|Overall Study|Disease progression|3|||
129150826|NCT00659425|464849344|FG008|Overall Study|Disease progression|5|||
129150827|NCT00659425|464849345|FG009|Overall Study|Disease progression|3|||
129150828|NCT00659425|464849336|FG000|Overall Study|Death|0|||
129150829|NCT00659425|464849337|FG001|Overall Study|Death|0|||
129150830|NCT00659425|464849338|FG002|Overall Study|Death|0|||
129150831|NCT00659425|464849339|FG003|Overall Study|Death|1|||
129150832|NCT00659425|464849340|FG004|Overall Study|Death|0|||
129150833|NCT00659425|464849341|FG005|Overall Study|Death|0|||
129150834|NCT00659425|464849342|FG006|Overall Study|Death|1|||
129150835|NCT00659425|464849343|FG007|Overall Study|Death|0|||
129150836|NCT00659425|464849344|FG008|Overall Study|Death|0|||
129150837|NCT00659425|464849345|FG009|Overall Study|Death|0|||
129150838|NCT00659425|464849336|FG000|Overall Study|Adverse Event|0|||
129150839|NCT00659425|464849337|FG001|Overall Study|Adverse Event|0|||
129150840|NCT00659425|464849338|FG002|Overall Study|Adverse Event|0|||
129150841|NCT00659425|464849339|FG003|Overall Study|Adverse Event|0|||
129150842|NCT00659425|464849340|FG004|Overall Study|Adverse Event|0|||
129150843|NCT00659425|464849341|FG005|Overall Study|Adverse Event|1|||
129150844|NCT00659425|464849342|FG006|Overall Study|Adverse Event|0|||
129150845|NCT00659425|464849343|FG007|Overall Study|Adverse Event|3|||
129150846|NCT00659425|464849344|FG008|Overall Study|Adverse Event|1|||
129150847|NCT00659425|464849345|FG009|Overall Study|Adverse Event|4|||
129150848|NCT00659425|464849336|FG000|Overall Study|Investigator Discretion|0|||
129150849|NCT00659425|464849337|FG001|Overall Study|Investigator Discretion|0|||
129150850|NCT00659425|464849338|FG002|Overall Study|Investigator Discretion|0|||
129150851|NCT00659425|464849339|FG003|Overall Study|Investigator Discretion|0|||
129150852|NCT00659425|464849340|FG004|Overall Study|Investigator Discretion|0|||
129150853|NCT00659425|464849341|FG005|Overall Study|Investigator Discretion|1|||
129150854|NCT00659425|464849342|FG006|Overall Study|Investigator Discretion|0|||
129150855|NCT00659425|464849343|FG007|Overall Study|Investigator Discretion|3|||
129150856|NCT00659425|464849344|FG008|Overall Study|Investigator Discretion|0|||
129150857|NCT00659425|464849345|FG009|Overall Study|Investigator Discretion|0|||
129150858|NCT00659425|464849336|FG000|Overall Study|Other|0|||
129150859|NCT00659425|464849337|FG001|Overall Study|Other|1|||
129150860|NCT00659425|464849338|FG002|Overall Study|Other|1|||
129150861|NCT00659425|464849339|FG003|Overall Study|Other|2|||
129150862|NCT00659425|464849340|FG004|Overall Study|Other|4|||
129150863|NCT00659425|464849341|FG005|Overall Study|Other|0|||
129150864|NCT00659425|464849342|FG006|Overall Study|Other|3|||
129150865|NCT00659425|464849343|FG007|Overall Study|Other|2|||
129150866|NCT00659425|464849344|FG008|Overall Study|Other|0|||
129150867|NCT00659425|464849345|FG009|Overall Study|Other|6|||
129150868|NCT00271544|464849346|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
129150869|NCT00271544|464849346|FG000|Overall Study|Model 4196 lead not attempted|9|||
129150870|NCT00271544|464849346|FG000|Overall Study|Implant not attempted|4|||
129150871|NCT03358030|464849347|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
129150872|NCT03358030|464849348|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
129150873|NCT03358030|464849349|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
129150874|NCT03358030|464849350|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
129150875|NCT03358030|464849347|FG000|Overall Study|Ineligibility|0|||
129150876|NCT03358030|464849348|FG001|Overall Study|Ineligibility|0|||
129150877|NCT03358030|464849349|FG002|Overall Study|Ineligibility|0|||
129150878|NCT03358030|464849350|FG003|Overall Study|Ineligibility|2|||
129150879|NCT03358030|464849347|FG000|Overall Study|Voluntary Withdrawal|1|||
129150880|NCT03358030|464849348|FG001|Overall Study|Voluntary Withdrawal|1|||
129150881|NCT03358030|464849349|FG002|Overall Study|Voluntary Withdrawal|3|||
129150882|NCT03358030|464849350|FG003|Overall Study|Voluntary Withdrawal|1|||
129150883|NCT03358030|464849347|FG000|Overall Study|Other|0|||
129150884|NCT03358030|464849348|FG001|Overall Study|Other|0|||
129150885|NCT03358030|464849349|FG002|Overall Study|Other|1|||
129150886|NCT03358030|464849350|FG003|Overall Study|Other|0|||
129150887|NCT02505425|464849351|FG000|Overall Study|Lost to Follow-up|41|||
129150888|NCT02505425|464849352|FG001|Overall Study|Lost to Follow-up|61|||
129150889|NCT02505425|464849353|FG002|Overall Study|Lost to Follow-up|31|||
129150890|NCT02505425|464849354|FG003|Overall Study|Lost to Follow-up|19|||
129150891|NCT02505425|464849351|FG000|Overall Study|Withdrawal by Subject|39|||
129150892|NCT02505425|464849352|FG001|Overall Study|Withdrawal by Subject|9|||
129150893|NCT02505425|464849353|FG002|Overall Study|Withdrawal by Subject|19|||
129150894|NCT02505425|464849354|FG003|Overall Study|Withdrawal by Subject|7|||
129150895|NCT02505425|464849351|FG000|Overall Study|Death|8|||
129150896|NCT02505425|464849352|FG001|Overall Study|Death|12|||
129150897|NCT02505425|464849353|FG002|Overall Study|Death|0|||
129150898|NCT02505425|464849354|FG003|Overall Study|Death|0|||
129150899|NCT02781558|464849355|FG000|Overall Study|Lost to Follow-up|2|||
129150900|NCT02781558|464849356|FG001|Overall Study|Lost to Follow-up|2|||
129150901|NCT02781558|464849355|FG000|Overall Study|Adverse Event|1|||
129150902|NCT02781558|464849356|FG001|Overall Study|Adverse Event|0|||
129150903|NCT01492426|464850700|FG000|Treatment|Death|0|||
129150904|NCT01492426|464850701|FG001|Treatment|Death|1|||
129150905|NCT01492426|464850700|FG000|Treatment|Other|1|||
129150906|NCT01492426|464850701|FG001|Treatment|Other|0|||
129150907|NCT01492426|464850700|FG000|Treatment|Adverse Event|25|||
129150908|NCT01492426|464850701|FG001|Treatment|Adverse Event|25|||
129150909|NCT01492426|464850700|FG000|Treatment|Lack of Efficacy|38|||
129150910|NCT01492426|464850701|FG001|Treatment|Lack of Efficacy|5|||
129150911|NCT01492426|464850700|FG000|Treatment|Participant withdrew consent|1|||
129150912|NCT01492426|464850701|FG001|Treatment|Participant withdrew consent|2|||
129150913|NCT01492426|464850700|FG000|Treatment|Poor compliance/noncompliance|1|||
129150914|NCT01492426|464850701|FG001|Treatment|Poor compliance/noncompliance|0|||
129150915|NCT01492426|464850700|FG000|Treatment|Subject requested discontinue study drug|7|||
129150916|NCT01492426|464850701|FG001|Treatment|Subject requested discontinue study drug|3|||
129150917|NCT01492426|464850700|FG000|Treatment|Lost to Follow-up|9|||
129150918|NCT01492426|464850701|FG001|Treatment|Lost to Follow-up|4|||
129150919|NCT01492426|464850700|FG000|Treatment|Participant does not meet study criteria|1|||
129150920|NCT01492426|464850701|FG001|Treatment|Participant does not meet study criteria|0|||
128725296|NCT02641379|463290953|FG008|Overall Study|Participant treated after Week 24|1|||
128725297|NCT02641379|463290954|FG009|Overall Study|Participant treated after Week 24|0|||
128725298|NCT02641379|463290955|FG010|Overall Study|Participant treated after Week 24|0|||
128725299|NCT02641379|463290945|FG000|Overall Study|Missing PCR result at Week 8|0|||
128725300|NCT02641379|463290946|FG001|Overall Study|Missing PCR result at Week 8|0|||
128725301|NCT02641379|463290947|FG002|Overall Study|Missing PCR result at Week 8|0|||
128725302|NCT02641379|463290948|FG003|Overall Study|Missing PCR result at Week 8|0|||
128725303|NCT02641379|463290949|FG004|Overall Study|Missing PCR result at Week 8|0|||
128725304|NCT02641379|463290950|FG005|Overall Study|Missing PCR result at Week 8|0|||
128725305|NCT02641379|463290951|FG006|Overall Study|Missing PCR result at Week 8|0|||
128725306|NCT02641379|463290952|FG007|Overall Study|Missing PCR result at Week 8|0|||
128725307|NCT02641379|463290953|FG008|Overall Study|Missing PCR result at Week 8|0|||
128725308|NCT02641379|463290954|FG009|Overall Study|Missing PCR result at Week 8|1|||
128725309|NCT02641379|463290955|FG010|Overall Study|Missing PCR result at Week 8|0|||
128725310|NCT02641379|463290945|FG000|Overall Study|PCR positive|0|||
128725311|NCT02641379|463290946|FG001|Overall Study|PCR positive|0|||
128725312|NCT02641379|463290947|FG002|Overall Study|PCR positive|0|||
128725313|NCT02641379|463290948|FG003|Overall Study|PCR positive|0|||
128725314|NCT02641379|463290949|FG004|Overall Study|PCR positive|0|||
128725315|NCT02641379|463290950|FG005|Overall Study|PCR positive|0|||
128725316|NCT02641379|463290951|FG006|Overall Study|PCR positive|1|||
128725317|NCT02641379|463290952|FG007|Overall Study|PCR positive|0|||
128725318|NCT02641379|463290953|FG008|Overall Study|PCR positive|0|||
128725319|NCT02641379|463290954|FG009|Overall Study|PCR positive|0|||
128725320|NCT02641379|463290955|FG010|Overall Study|PCR positive|0|||
128725321|NCT04982250|463290956|FG000|Overall Study|Lost to Follow-up|0|||
128725322|NCT04982250|463290957|FG001|Overall Study|Lost to Follow-up|26|||
129150921|NCT01492426|464850700|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
129150922|NCT01492426|464850701|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
129150923|NCT01492426|464850700|FG000|Follow-Up|Death|1|||
129150924|NCT01492426|464850701|FG001|Follow-Up|Death|0|||
129150925|NCT01492426|464850700|FG000|Follow-Up|Other|4|||
129150926|NCT01492426|464850701|FG001|Follow-Up|Other|2|||
129150927|NCT01492426|464850700|FG000|Follow-Up|Participant Withdrew Consent|6|||
129150928|NCT01492426|464850701|FG001|Follow-Up|Participant Withdrew Consent|1|||
129150929|NCT01492426|464850700|FG000|Follow-Up|Lost to Follow-up|12|||
129150930|NCT01492426|464850701|FG001|Follow-Up|Lost to Follow-up|6|||
129150931|NCT01978145|464850702|FG000|Treatment Period 1|Adverse Event|1|||
129150932|NCT01978145|464850703|FG001|Treatment Period 1|Adverse Event|9|||
129150933|NCT01978145|464850702|FG000|Treatment Period 1|Physician Decision|1|||
129150934|NCT01978145|464850703|FG001|Treatment Period 1|Physician Decision|0|||
129150935|NCT01978145|464850702|FG000|Treatment Period 1|Withdrawal by Subject|5|||
129150936|NCT01978145|464850703|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129150937|NCT01978145|464850702|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
129150938|NCT01978145|464850703|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
129150939|NCT01978145|464850702|FG000|Washout Period 1|Adverse Event|0|||
129150940|NCT01978145|464850703|FG001|Washout Period 1|Adverse Event|1|||
129150941|NCT01978145|464850702|FG000|Washout Period 1|Withdrawal by Subject|1|||
129150942|NCT01978145|464850703|FG001|Washout Period 1|Withdrawal by Subject|1|||
129150943|NCT01978145|464850702|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
129150944|NCT01978145|464850703|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
129150945|NCT01978145|464850702|FG000|Treatment Period 2|Adverse Event|3|||
129150946|NCT01978145|464850703|FG001|Treatment Period 2|Adverse Event|3|||
129150947|NCT01978145|464850702|FG000|Treatment Period 2|Protocol Violation|0|||
129150948|NCT01978145|464850703|FG001|Treatment Period 2|Protocol Violation|1|||
128725323|NCT04982250|463290958|FG002|Overall Study|Lost to Follow-up|0|||
128725324|NCT04982250|463290959|FG003|Overall Study|Lost to Follow-up|0|||
128725325|NCT04982250|463290960|FG004|Overall Study|Lost to Follow-up|72|||
128725326|NCT04982250|463290961|FG005|Overall Study|Lost to Follow-up|69|||
128725327|NCT04982250|463290956|FG000|Overall Study|Not Eligible to Enroll|0|||
128725328|NCT04982250|463290957|FG001|Overall Study|Not Eligible to Enroll|0|||
128725329|NCT04982250|463290958|FG002|Overall Study|Not Eligible to Enroll|0|||
128725330|NCT04982250|463290959|FG003|Overall Study|Not Eligible to Enroll|0|||
128725331|NCT04982250|463290960|FG004|Overall Study|Not Eligible to Enroll|10|||
128725332|NCT04982250|463290961|FG005|Overall Study|Not Eligible to Enroll|7|||
129150949|NCT01978145|464850702|FG000|Treatment Period 2|Lost to Follow-up|1|||
129150950|NCT01978145|464850703|FG001|Treatment Period 2|Lost to Follow-up|1|||
129150951|NCT01978145|464850702|FG000|Treatment Period 2|Withdrawal by Subject|7|||
129150952|NCT01978145|464850703|FG001|Treatment Period 2|Withdrawal by Subject|4|||
129150953|NCT01978145|464850702|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
129150954|NCT01978145|464850703|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
129150955|NCT01173679|464850708|FG000|Overall Study|Death|1|||
129150956|NCT01250054|464850709|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
129150957|NCT01250054|464850710|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
129150958|NCT02777086|464850711|FG000|Overall Study|Lost to Follow-up|96|||
129150959|NCT02777086|464850712|FG001|Overall Study|Lost to Follow-up|99|||
129150960|NCT01133665|464850715|FG000|Overall Study|Physician Decision|2|||
129150961|NCT02122380|464850716|FG000|First Intervention (30 Days)|Adverse Event|1|||
129150962|NCT02122380|464850717|FG001|First Intervention (30 Days)|Adverse Event|0|||
129150963|NCT02122380|464850716|FG000|First Intervention (30 Days)|Physician Decision|0|||
129150964|NCT02122380|464850717|FG001|First Intervention (30 Days)|Physician Decision|1|||
129150965|NCT02122380|464850716|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
129150966|NCT02122380|464850717|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
129150967|NCT02122380|464850716|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
129150968|NCT02122380|464850717|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
129150969|NCT02122380|464850716|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
129150970|NCT02122380|464850717|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
129150971|NCT02465931|464850720|FG000|Overall Study|Lost to Follow-up|9|||
129150972|NCT02465931|464850721|FG001|Overall Study|Lost to Follow-up|11|||
129150973|NCT02465931|464850720|FG000|Overall Study|Protocol Violation|1|||
129150974|NCT02465931|464850721|FG001|Overall Study|Protocol Violation|0|||
129150975|NCT02465931|464850720|FG000|Overall Study|Withdrawal by Subject|1|||
129150976|NCT02465931|464850721|FG001|Overall Study|Withdrawal by Subject|0|||
129150977|NCT03423602|464850723|FG000|Overall Study|Death|1|||
129150978|NCT03423602|464850723|FG000|Overall Study|Lost to Follow-up|6|||
129150979|NCT03423602|464850723|FG000|Overall Study|Protocol Violation|1|||
129150980|NCT03423602|464850723|FG000|Overall Study|Withdrawal by Subject|4|||
129150981|NCT03423121|464850724|FG000|Overall Study|Lost to Follow-up|2|||
129150982|NCT03423121|464850725|FG001|Overall Study|Lost to Follow-up|6|||
129150983|NCT03423121|464850724|FG000|Overall Study|Adverse Event|1|||
129150984|NCT03423121|464850725|FG001|Overall Study|Adverse Event|0|||
129150985|NCT02136914|464850731|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
129150986|NCT02136914|464850732|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
129150987|NCT02136914|464850731|FG000|Overall Study|Withdrawal by Subject|3|||
129150988|NCT02136914|464850732|FG001|Overall Study|Withdrawal by Subject|10|||
129150989|NCT02136914|464850731|FG000|Overall Study|Subject Unwilling to Proceed|7|||
129150990|NCT02136914|464850732|FG001|Overall Study|Subject Unwilling to Proceed|2|||
129150991|NCT02136914|464850731|FG000|Overall Study|Lost to Follow-up|1|||
129150992|NCT02136914|464850732|FG001|Overall Study|Lost to Follow-up|1|||
129150993|NCT02136914|464850731|FG000|Overall Study|Did Not Receive Study Drug|2|||
129150994|NCT02136914|464850732|FG001|Overall Study|Did Not Receive Study Drug|0|||
129150995|NCT02136914|464850731|FG000|Overall Study|Lack of Efficacy|1|||
129150996|NCT02136914|464850732|FG001|Overall Study|Lack of Efficacy|0|||
129150997|NCT02136914|464850731|FG000|Overall Study|Death|0|||
129150998|NCT02136914|464850732|FG001|Overall Study|Death|1|||
129150999|NCT01493089|464850735|FG000|Overall Study|Protocol Violation|2|||
129151000|NCT01493089|464850736|FG001|Overall Study|Protocol Violation|2|||
129151001|NCT01493089|464850735|FG000|Overall Study|Withdrawal by Subject|1|||
129151002|NCT01493089|464850736|FG001|Overall Study|Withdrawal by Subject|0|||
129151003|NCT01493089|464850735|FG000|Overall Study|Physician Decision|0|||
129151004|NCT01493089|464850736|FG001|Overall Study|Physician Decision|1|||
129151005|NCT00329030|464850737|FG000|Overall Study|Withdrawal by Subject|1|||
129151006|NCT00329030|464850738|FG001|Overall Study|Withdrawal by Subject|3|||
129151007|NCT00329030|464850737|FG000|Overall Study|Progressive Disease|6|||
129151008|NCT00329030|464850738|FG001|Overall Study|Progressive Disease|2|||
129151009|NCT00329030|464850737|FG000|Overall Study|Ineligible Pathology|1|||
129151010|NCT00329030|464850738|FG001|Overall Study|Ineligible Pathology|1|||
129151011|NCT03012334|464850739|FG000|Period 1|Withdrawal by Subject|0|||
129151012|NCT03012334|464850740|FG001|Period 1|Withdrawal by Subject|0|||
129151013|NCT03012334|464850741|FG002|Period 1|Withdrawal by Subject|0|||
129151014|NCT03012334|464850742|FG003|Period 1|Withdrawal by Subject|0|||
129151015|NCT03012334|464850743|FG004|Period 1|Withdrawal by Subject|0|||
129151016|NCT03012334|464850744|FG005|Period 1|Withdrawal by Subject|0|||
129151017|NCT03012334|464850745|FG006|Period 1|Withdrawal by Subject|0|||
129151018|NCT03012334|464850746|FG007|Period 1|Withdrawal by Subject|0|||
129151019|NCT03012334|464850747|FG008|Period 1|Withdrawal by Subject|0|||
129151020|NCT03012334|464850748|FG009|Period 1|Withdrawal by Subject|1|||
129151021|NCT03012334|464850739|FG000|Period 2|Withdrawal by Subject|0|||
129151022|NCT03012334|464850740|FG001|Period 2|Withdrawal by Subject|1|||
129151023|NCT03012334|464850741|FG002|Period 2|Withdrawal by Subject|0|||
129151024|NCT03012334|464850742|FG003|Period 2|Withdrawal by Subject|0|||
129151025|NCT03012334|464850743|FG004|Period 2|Withdrawal by Subject|0|||
129151026|NCT03012334|464850744|FG005|Period 2|Withdrawal by Subject|0|||
129151027|NCT03012334|464850745|FG006|Period 2|Withdrawal by Subject|0|||
129151028|NCT03012334|464850746|FG007|Period 2|Withdrawal by Subject|0|||
129151029|NCT03012334|464850747|FG008|Period 2|Withdrawal by Subject|0|||
129151030|NCT03012334|464850748|FG009|Period 2|Withdrawal by Subject|0|||
129151031|NCT03012334|464850739|FG000|Period 2|Protocol Violation|0|||
129151032|NCT03012334|464850740|FG001|Period 2|Protocol Violation|0|||
129151033|NCT03012334|464850741|FG002|Period 2|Protocol Violation|1|||
129151034|NCT03012334|464850742|FG003|Period 2|Protocol Violation|0|||
129151035|NCT03012334|464850743|FG004|Period 2|Protocol Violation|0|||
129151036|NCT03012334|464850744|FG005|Period 2|Protocol Violation|0|||
129151037|NCT03012334|464850745|FG006|Period 2|Protocol Violation|0|||
129151038|NCT03012334|464850746|FG007|Period 2|Protocol Violation|1|||
129151039|NCT03012334|464850747|FG008|Period 2|Protocol Violation|0|||
129151040|NCT03012334|464850748|FG009|Period 2|Protocol Violation|0|||
129151041|NCT03012334|464850739|FG000|Period 4|Non-Compliance|0|||
129151042|NCT03012334|464850740|FG001|Period 4|Non-Compliance|0|||
129151043|NCT03012334|464850741|FG002|Period 4|Non-Compliance|0|||
129151044|NCT03012334|464850742|FG003|Period 4|Non-Compliance|0|||
129151045|NCT03012334|464850743|FG004|Period 4|Non-Compliance|0|||
129151046|NCT03012334|464850744|FG005|Period 4|Non-Compliance|0|||
129151047|NCT03012334|464850745|FG006|Period 4|Non-Compliance|1|||
129151048|NCT03012334|464850746|FG007|Period 4|Non-Compliance|0|||
129151049|NCT03012334|464850747|FG008|Period 4|Non-Compliance|0|||
129151050|NCT03012334|464850748|FG009|Period 4|Non-Compliance|0|||
129151051|NCT03012334|464850739|FG000|Period 4|Adverse Event|0|||
129151052|NCT03012334|464850740|FG001|Period 4|Adverse Event|0|||
129151053|NCT03012334|464850741|FG002|Period 4|Adverse Event|0|||
129151054|NCT03012334|464850742|FG003|Period 4|Adverse Event|0|||
129151055|NCT03012334|464850743|FG004|Period 4|Adverse Event|0|||
129151056|NCT03012334|464850744|FG005|Period 4|Adverse Event|0|||
129151057|NCT03012334|464850745|FG006|Period 4|Adverse Event|0|||
129151058|NCT03012334|464850746|FG007|Period 4|Adverse Event|0|||
129151059|NCT03012334|464850747|FG008|Period 4|Adverse Event|1|||
129151060|NCT03012334|464850748|FG009|Period 4|Adverse Event|0|||
129151061|NCT00325143|464850749|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
129151062|NCT00325143|464850749|FG000|Overall Study|Migrated/moved from study area|1|||
129151063|NCT00325143|464850749|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
129151064|NCT00325143|464850749|FG000|Overall Study|Withdrawal by Subject|8|||
129151065|NCT00256126|464850750|FG000|Overall Study|Adverse Event|1|||
129151066|NCT00256126|464850751|FG001|Overall Study|Adverse Event|0|||
129151067|NCT00256126|464850750|FG000|Overall Study|Other|1|||
129151068|NCT00256126|464850751|FG001|Overall Study|Other|2|||
129151069|NCT01008618|464850754|FG000|Period 1 (Titration Period)|Physician Decision|2|||
129151070|NCT01008618|464850755|FG001|Period 1 (Titration Period)|Physician Decision|0|||
129151071|NCT01008618|464850756|FG002|Period 1 (Titration Period)|Physician Decision|0|||
129151072|NCT01008618|464850754|FG000|Period 1 (Titration Period)|Adverse Event|33|||
129151073|NCT01008618|464850755|FG001|Period 1 (Titration Period)|Adverse Event|0|||
129151074|NCT01008618|464850756|FG002|Period 1 (Titration Period)|Adverse Event|0|||
129151075|NCT01008618|464850754|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
129151076|NCT01008618|464850755|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129151077|NCT01008618|464850756|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129151078|NCT01008618|464850754|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
129151079|NCT01008618|464850755|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129151080|NCT01008618|464850756|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129151081|NCT01008618|464850754|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
129151082|NCT01008618|464850755|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
129151083|NCT01008618|464850756|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
129151084|NCT01008618|464850754|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
129151085|NCT01008618|464850755|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
129151086|NCT01008618|464850756|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
129151087|NCT01008618|464850754|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
129151088|NCT01008618|464850755|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
129151089|NCT01008618|464850756|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
129151090|NCT01008618|464850754|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
129151091|NCT01008618|464850755|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
129151092|NCT01008618|464850756|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
129151093|NCT01008618|464850754|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
129151094|NCT01008618|464850755|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
129151095|NCT01008618|464850756|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
129151096|NCT01008618|464850754|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129151097|NCT01008618|464850755|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129151098|NCT01008618|464850756|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
129151099|NCT01008618|464850754|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
129151100|NCT01008618|464850755|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
129151101|NCT01008618|464850756|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
129151102|NCT01008618|464850754|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
129151103|NCT01008618|464850755|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
129151104|NCT01008618|464850756|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
129151105|NCT01627691|464850757|FG000|Overall Study|Death|11|||
129151106|NCT01627691|464850757|FG000|Overall Study|Lost to Follow-up|3|||
129151107|NCT01627691|464850757|FG000|Overall Study|Withdrawal by Subject|1|||
129151108|NCT01627691|464850757|FG000|Overall Study|Missed the visit|3|||
129151109|NCT00186628|464850762|FG000|Overall Study|Death|2|||
129151110|NCT00186628|464850762|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
129151111|NCT01076010|464850763|FG000|Overall Study|Death|15|||
129151112|NCT01076010|464850764|FG001|Overall Study|Death|1|||
129151113|NCT01076010|464850765|FG002|Overall Study|Death|0|||
129151114|NCT01076010|464850763|FG000|Overall Study|Adverse Event|7|||
129151115|NCT01076010|464850764|FG001|Overall Study|Adverse Event|2|||
129151116|NCT01076010|464850765|FG002|Overall Study|Adverse Event|0|||
129151117|NCT01076010|464850763|FG000|Overall Study|Progressive disease|90|||
129151118|NCT01076010|464850764|FG001|Overall Study|Progressive disease|30|||
128776633|NCT02718417|463471970|FG002|Observation Phase (OP)|Adverse Event|1|||
129151119|NCT01076010|464850765|FG002|Overall Study|Progressive disease|1|||
129151120|NCT01076010|464850763|FG000|Overall Study|Lack of Efficacy|4|||
129151121|NCT01076010|464850764|FG001|Overall Study|Lack of Efficacy|0|||
129151122|NCT01076010|464850765|FG002|Overall Study|Lack of Efficacy|0|||
129151123|NCT01076010|464850763|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
129151124|NCT01076010|464850764|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
129151125|NCT01076010|464850765|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
129151126|NCT01076010|464850763|FG000|Overall Study|Significant Surgical Procedure|0|||
129151127|NCT01076010|464850764|FG001|Overall Study|Significant Surgical Procedure|1|||
129151128|NCT01076010|464850765|FG002|Overall Study|Significant Surgical Procedure|0|||
129151129|NCT01076010|464850763|FG000|Overall Study|Protocol Violation|0|||
129151130|NCT01076010|464850764|FG001|Overall Study|Protocol Violation|1|||
129151131|NCT01076010|464850765|FG002|Overall Study|Protocol Violation|0|||
129151132|NCT01076010|464850763|FG000|Overall Study|Noncompliance|1|||
129151133|NCT01076010|464850764|FG001|Overall Study|Noncompliance|1|||
129151134|NCT01076010|464850765|FG002|Overall Study|Noncompliance|0|||
129151135|NCT01076010|464850763|FG000|Overall Study|Withdrawal by Subject|3|||
129151136|NCT01076010|464850764|FG001|Overall Study|Withdrawal by Subject|0|||
129151137|NCT01076010|464850765|FG002|Overall Study|Withdrawal by Subject|1|||
129151138|NCT01076010|464850763|FG000|Overall Study|Other|5|||
129151139|NCT01076010|464850764|FG001|Overall Study|Other|2|||
129151140|NCT01076010|464850765|FG002|Overall Study|Other|0|||
129151141|NCT04064905|464850785|FG000|Overall Study|Lost to Follow-up|0|||
129151142|NCT04064905|464850786|FG001|Overall Study|Lost to Follow-up|3|||
129151143|NCT04064905|464850787|FG002|Overall Study|Lost to Follow-up|1|||
129151144|NCT04064905|464850788|FG003|Overall Study|Lost to Follow-up|4|||
129151145|NCT04064905|464850789|FG004|Overall Study|Lost to Follow-up|2|||
129151146|NCT02536664|464850796|FG000|Overall Study|Inadequate completion of documentation|2|||
129151147|NCT02536664|464850797|FG001|Overall Study|Inadequate completion of documentation|4|||
129151148|NCT02536664|464850796|FG000|Overall Study|Progression|13|||
129151149|NCT02536664|464850797|FG001|Overall Study|Progression|18|||
129151150|NCT02536664|464850796|FG000|Overall Study|Death due to lymphoma|2|||
129151151|NCT02536664|464850797|FG001|Overall Study|Death due to lymphoma|1|||
129151152|NCT02536664|464850796|FG000|Overall Study|Death due to other reason|3|||
129151153|NCT02536664|464850797|FG001|Overall Study|Death due to other reason|2|||
129151154|NCT02536664|464850796|FG000|Overall Study|Intolerability|8|||
129151155|NCT02536664|464850797|FG001|Overall Study|Intolerability|6|||
129151156|NCT02536664|464850796|FG000|Overall Study|Withdrawal by Subject|8|||
129151157|NCT02536664|464850797|FG001|Overall Study|Withdrawal by Subject|5|||
129151158|NCT02536664|464850796|FG000|Overall Study|Other|18|||
129151159|NCT02536664|464850797|FG001|Overall Study|Other|24|||
129151160|NCT02536664|464850796|FG000|Overall Study|Missing|53|||
129151161|NCT02536664|464850797|FG001|Overall Study|Missing|20|||
129151162|NCT03507127|464850806|FG000|Overall Study|Withdrawal by Subject|1|||
129151163|NCT03507127|464850807|FG001|Overall Study|Withdrawal by Subject|0|||
129151164|NCT03507127|464850806|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
129151165|NCT03507127|464850807|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
129151166|NCT03508050|464850808|FG000|Overall Study|Pleural adhesions|1|||
129151167|NCT03508050|464850809|FG001|Overall Study|Pleural adhesions|0|||
129151168|NCT03508050|464850808|FG000|Overall Study|Mucus plug|1|||
129151169|NCT03508050|464850809|FG001|Overall Study|Mucus plug|0|||
129151170|NCT03508050|464850808|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
129151171|NCT03508050|464850809|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
129151172|NCT03508050|464850808|FG000|Overall Study|Sustained desaturation|0|||
129151173|NCT03508050|464850809|FG001|Overall Study|Sustained desaturation|1|||
129151174|NCT03961308|464850816|FG000|Overall Study|Withdrawal by Subject|1|||
129151175|NCT03961308|464850817|FG001|Overall Study|Withdrawal by Subject|0|||
129151176|NCT03961308|464850816|FG000|Overall Study|Other|1|||
129151177|NCT03961308|464850817|FG001|Overall Study|Other|0|||
128776634|NCT02718417|463471968|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
129151178|NCT03961308|464850816|FG000|Overall Study|Lost to Follow-up|0|||
129151179|NCT03961308|464850817|FG001|Overall Study|Lost to Follow-up|1|||
129151180|NCT03961308|464850816|FG000|Overall Study|Adverse Event|0|||
129151181|NCT03961308|464850817|FG001|Overall Study|Adverse Event|1|||
128776635|NCT02718417|463471969|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
128776636|NCT02718417|463471970|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
128776637|NCT02718417|463471968|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
128776638|NCT02718417|463471969|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
128776639|NCT02718417|463471970|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
128776640|NCT02718417|463471968|FG000|Observation Phase (OP)|Physician Decision|0|||
128776641|NCT02718417|463471969|FG001|Observation Phase (OP)|Physician Decision|0|||
128776642|NCT02718417|463471970|FG002|Observation Phase (OP)|Physician Decision|9|||
128776643|NCT02718417|463471968|FG000|Observation Phase (OP)|Progressive disease|0|||
128776644|NCT02718417|463471969|FG001|Observation Phase (OP)|Progressive disease|0|||
128776645|NCT02718417|463471970|FG002|Observation Phase (OP)|Progressive disease|92|||
128776646|NCT02718417|463471968|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
128776647|NCT02718417|463471969|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
128776648|NCT02718417|463471970|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
128776649|NCT02718417|463471968|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
128776650|NCT02718417|463471969|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
128776651|NCT02718417|463471970|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
128776652|NCT02718417|463471968|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
128776653|NCT02718417|463471969|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
128776654|NCT02718417|463471970|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
128776655|NCT02718417|463471968|FG000|Observation Phase (OP)|Other|0|||
128776656|NCT02718417|463471969|FG001|Observation Phase (OP)|Other|0|||
128776657|NCT02718417|463471970|FG002|Observation Phase (OP)|Other|7|||
128776658|NCT02718417|463471968|FG000|Follow-up Phase|Adverse Event|3|||
128776659|NCT02718417|463471969|FG001|Follow-up Phase|Adverse Event|1|||
128776660|NCT02718417|463471970|FG002|Follow-up Phase|Adverse Event|1|||
128776661|NCT02718417|463471968|FG000|Follow-up Phase|Other|4|||
128776662|NCT02718417|463471969|FG001|Follow-up Phase|Other|6|||
128776663|NCT02718417|463471970|FG002|Follow-up Phase|Other|4|||
128776664|NCT02718417|463471968|FG000|Follow-up Phase|Withdrawal by Subject|19|||
128776665|NCT02718417|463471969|FG001|Follow-up Phase|Withdrawal by Subject|17|||
128776666|NCT02718417|463471970|FG002|Follow-up Phase|Withdrawal by Subject|5|||
128776667|NCT02718417|463471968|FG000|Follow-up Phase|Study terminated by sponsor|100|||
128776668|NCT02718417|463471969|FG001|Follow-up Phase|Study terminated by sponsor|138|||
128776669|NCT02718417|463471970|FG002|Follow-up Phase|Study terminated by sponsor|6|||
128776670|NCT02718417|463471968|FG000|Follow-up Phase|Lost to Follow-up|2|||
128776671|NCT02718417|463471969|FG001|Follow-up Phase|Lost to Follow-up|3|||
128776672|NCT02718417|463471970|FG002|Follow-up Phase|Lost to Follow-up|0|||
128776673|NCT02718417|463471968|FG000|Follow-up Phase|Death leading to discontinuation|7|||
128776674|NCT02718417|463471969|FG001|Follow-up Phase|Death leading to discontinuation|7|||
128776675|NCT02718417|463471970|FG002|Follow-up Phase|Death leading to discontinuation|3|||
128776676|NCT02718417|463471968|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
128776677|NCT02718417|463471969|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
128776678|NCT02718417|463471970|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
128776679|NCT02718417|463471968|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
128776680|NCT02718417|463471969|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
128776681|NCT02718417|463471970|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
128776682|NCT02718417|463471968|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
128776683|NCT02718417|463471969|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
128776684|NCT02718417|463471970|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
129151182|NCT03710889|464850818|FG000|Overall Study|Adverse Event|2|||
129151183|NCT03710889|464850818|FG000|Overall Study|Protocol Deviation|1|||
129151184|NCT00570713|464850819|FG000|Overall Study|Adverse Event|16|||
129151185|NCT00570713|464850820|FG001|Overall Study|Adverse Event|9|||
129151186|NCT00570713|464850819|FG000|Overall Study|Death|7|||
129151187|NCT00570713|464850820|FG001|Overall Study|Death|7|||
129151188|NCT00570713|464850819|FG000|Overall Study|Lack of Efficacy|40|||
129151189|NCT00570713|464850820|FG001|Overall Study|Lack of Efficacy|49|||
129151190|NCT00570713|464850819|FG000|Overall Study|Physician Decision|2|||
129151191|NCT00570713|464850820|FG001|Overall Study|Physician Decision|2|||
129151192|NCT00570713|464850819|FG000|Overall Study|Withdrawal by Subject|3|||
129151193|NCT00570713|464850820|FG001|Overall Study|Withdrawal by Subject|3|||
129151194|NCT00570713|464850819|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
129151195|NCT00570713|464850820|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
129151196|NCT04881760|464850821|FG000|Overall Study|Adverse Event|0|||
129151197|NCT04881760|464850822|FG001|Overall Study|Adverse Event|1|||
129151198|NCT04881760|464850823|FG002|Overall Study|Adverse Event|1|||
129151199|NCT04881760|464850824|FG003|Overall Study|Adverse Event|0|||
129151200|NCT04881760|464850825|FG004|Overall Study|Adverse Event|1|||
128776685|NCT02718417|463471968|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
129151201|NCT04881760|464850826|FG005|Overall Study|Adverse Event|1|||
129151202|NCT04881760|464850827|FG006|Overall Study|Adverse Event|2|||
129151203|NCT04881760|464850821|FG000|Overall Study|Death|0|||
129151204|NCT04881760|464850822|FG001|Overall Study|Death|0|||
129151205|NCT04881760|464850823|FG002|Overall Study|Death|0|||
129151206|NCT04881760|464850824|FG003|Overall Study|Death|1|||
129151207|NCT04881760|464850825|FG004|Overall Study|Death|0|||
129151208|NCT04881760|464850826|FG005|Overall Study|Death|0|||
129151209|NCT04881760|464850827|FG006|Overall Study|Death|0|||
129151210|NCT04881760|464850821|FG000|Overall Study|Lost to Follow-up|5|||
129151211|NCT04881760|464850822|FG001|Overall Study|Lost to Follow-up|7|||
129151212|NCT04881760|464850823|FG002|Overall Study|Lost to Follow-up|5|||
129151213|NCT04881760|464850824|FG003|Overall Study|Lost to Follow-up|1|||
129151214|NCT04881760|464850825|FG004|Overall Study|Lost to Follow-up|2|||
129151215|NCT04881760|464850826|FG005|Overall Study|Lost to Follow-up|4|||
129151216|NCT04881760|464850827|FG006|Overall Study|Lost to Follow-up|4|||
129151217|NCT04881760|464850821|FG000|Overall Study|Withdrawal by Subject|13|||
129151218|NCT04881760|464850822|FG001|Overall Study|Withdrawal by Subject|1|||
129151219|NCT04881760|464850823|FG002|Overall Study|Withdrawal by Subject|1|||
129151220|NCT04881760|464850824|FG003|Overall Study|Withdrawal by Subject|4|||
129151221|NCT04881760|464850825|FG004|Overall Study|Withdrawal by Subject|2|||
129151222|NCT04881760|464850826|FG005|Overall Study|Withdrawal by Subject|1|||
129151223|NCT04881760|464850827|FG006|Overall Study|Withdrawal by Subject|2|||
129151224|NCT04881760|464850821|FG000|Overall Study|Randomized but Never Treated|0|||
129151225|NCT04881760|464850822|FG001|Overall Study|Randomized but Never Treated|0|||
129151226|NCT04881760|464850823|FG002|Overall Study|Randomized but Never Treated|0|||
129151227|NCT04881760|464850824|FG003|Overall Study|Randomized but Never Treated|1|||
129151228|NCT04881760|464850825|FG004|Overall Study|Randomized but Never Treated|0|||
129151229|NCT04881760|464850826|FG005|Overall Study|Randomized but Never Treated|0|||
129151230|NCT04881760|464850827|FG006|Overall Study|Randomized but Never Treated|0|||
129151231|NCT04881760|464850821|FG000|Overall Study|Inadvertent Enrollment|2|||
129151232|NCT04881760|464850822|FG001|Overall Study|Inadvertent Enrollment|0|||
129151233|NCT04881760|464850823|FG002|Overall Study|Inadvertent Enrollment|0|||
129151234|NCT04881760|464850824|FG003|Overall Study|Inadvertent Enrollment|0|||
129151235|NCT04881760|464850825|FG004|Overall Study|Inadvertent Enrollment|0|||
129151236|NCT04881760|464850826|FG005|Overall Study|Inadvertent Enrollment|0|||
129151237|NCT04881760|464850827|FG006|Overall Study|Inadvertent Enrollment|0|||
129151238|NCT04881760|464850821|FG000|Overall Study|Site Closure|0|||
129151239|NCT04881760|464850822|FG001|Overall Study|Site Closure|0|||
129151240|NCT04881760|464850823|FG002|Overall Study|Site Closure|0|||
129151241|NCT04881760|464850824|FG003|Overall Study|Site Closure|1|||
129151242|NCT04881760|464850825|FG004|Overall Study|Site Closure|0|||
129151243|NCT04881760|464850826|FG005|Overall Study|Site Closure|0|||
129151244|NCT04881760|464850827|FG006|Overall Study|Site Closure|0|||
129151245|NCT01538199|464850831|FG000|Overall Study|Lost to Follow-up|1|||
129151246|NCT01538199|464850832|FG001|Overall Study|Lost to Follow-up|2|||
129151247|NCT01538199|464850833|FG002|Overall Study|Lost to Follow-up|1|||
129151248|NCT01538199|464850834|FG003|Overall Study|Lost to Follow-up|0|||
129151249|NCT01538199|464850831|FG000|Overall Study|participant did not have time|1|||
129151250|NCT01538199|464850832|FG001|Overall Study|participant did not have time|0|||
129151251|NCT01538199|464850833|FG002|Overall Study|participant did not have time|0|||
129151252|NCT01538199|464850834|FG003|Overall Study|participant did not have time|2|||
129151253|NCT01538199|464850831|FG000|Overall Study|Lack of Efficacy|0|||
129151254|NCT01538199|464850832|FG001|Overall Study|Lack of Efficacy|1|||
129151255|NCT01538199|464850833|FG002|Overall Study|Lack of Efficacy|0|||
129151256|NCT01538199|464850834|FG003|Overall Study|Lack of Efficacy|0|||
129151257|NCT02031302|464850835|FG000|Overall Study|Death|115|||
129151258|NCT02031302|464850836|FG001|Overall Study|Death|0|||
129151259|NCT02031302|464850835|FG000|Overall Study|Not treated with study valve system|18|||
129151260|NCT02031302|464850836|FG001|Overall Study|Not treated with study valve system|0|||
129151261|NCT02031302|464850835|FG000|Overall Study|Missed Follow Up|27|||
129151262|NCT02031302|464850836|FG001|Overall Study|Missed Follow Up|0|||
129151263|NCT02031302|464850835|FG000|Overall Study|Lost to Follow-up|4|||
129151264|NCT02031302|464850836|FG001|Overall Study|Lost to Follow-up|0|||
129151265|NCT04704193|464850840|FG000|Overall Study|Withdrawal by Subject|1|||
129151266|NCT00542178|464850841|FG000|Overall Study|did not complete year 4 follow-up|75|||
129151267|NCT00542178|464850842|FG001|Overall Study|did not complete year 4 follow-up|80|||
129151268|NCT00542178|464850843|FG002|Overall Study|did not complete year 4 follow-up|74|||
129151269|NCT00542178|464850844|FG003|Overall Study|did not complete year 4 follow-up|62|||
129151270|NCT00542178|464850845|FG004|Overall Study|did not complete year 4 follow-up|64|||
129151271|NCT00542178|464850846|FG005|Overall Study|did not complete year 4 follow-up|89|||
129151272|NCT00542178|464850847|FG006|Overall Study|did not complete year 4 follow-up|87|||
129151273|NCT00542178|464850848|FG007|Overall Study|did not complete year 4 follow-up|85|||
129151274|NCT02336815|464852510|FG000|Overall Study|Disease Progression|45|||
129151275|NCT02336815|464852511|FG001|Overall Study|Disease Progression|70|||
129151276|NCT02336815|464852510|FG000|Overall Study|Adverse Event|18|||
129151277|NCT02336815|464852511|FG001|Overall Study|Adverse Event|39|||
129151278|NCT02336815|464852510|FG000|Overall Study|Physician Decision|11|||
129151279|NCT02336815|464852511|FG001|Overall Study|Physician Decision|4|||
129151280|NCT02336815|464852510|FG000|Overall Study|Withdrawal by Subject|3|||
129151281|NCT02336815|464852511|FG001|Overall Study|Withdrawal by Subject|2|||
129151282|NCT02336815|464852510|FG000|Overall Study|Lost to Follow-up|1|||
129151283|NCT02336815|464852511|FG001|Overall Study|Lost to Follow-up|3|||
129151284|NCT02336815|464852510|FG000|Overall Study|Other|1|||
129151285|NCT02336815|464852511|FG001|Overall Study|Other|5|||
129151286|NCT04099277|464852512|FG000|Overall Study|Physician Decision|1|||
129151287|NCT04099277|464852512|FG000|Overall Study|Withdrawal by Subject|1|||
129151288|NCT00492557|464852513|FG000|Overall Study|Subject request|12|||
129151289|NCT00492557|464852514|FG001|Overall Study|Subject request|11|||
129151290|NCT00492557|464852513|FG000|Overall Study|Protocol Violation|7|||
129151291|NCT00492557|464852514|FG001|Overall Study|Protocol Violation|8|||
129151292|NCT00492557|464852513|FG000|Overall Study|Other|2|||
129151293|NCT00492557|464852514|FG001|Overall Study|Other|2|||
129151294|NCT00492557|464852513|FG000|Overall Study|Death|1|||
129151295|NCT00492557|464852514|FG001|Overall Study|Death|1|||
129151296|NCT00492557|464852513|FG000|Overall Study|Adverse Event|1|||
129151297|NCT00492557|464852514|FG001|Overall Study|Adverse Event|0|||
129151298|NCT00492557|464852513|FG000|Overall Study|Failed to return|1|||
129151299|NCT00492557|464852514|FG001|Overall Study|Failed to return|0|||
129151300|NCT00492557|464852513|FG000|Overall Study|Lost to Follow-up|0|||
129151301|NCT00492557|464852514|FG001|Overall Study|Lost to Follow-up|1|||
129151302|NCT01354223|464852515|FG000|Overall Study|Withdrawal by Subject|3|||
129151303|NCT01354223|464852516|FG001|Overall Study|Withdrawal by Subject|1|||
129151304|NCT00948688|464852521|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
129151305|NCT00948688|464852522|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
129151306|NCT00948688|464852521|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
129151307|NCT00948688|464852522|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
129151308|NCT00948688|464852521|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
129151309|NCT00948688|464852522|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
129151310|NCT02852967|464852523|FG000|Overall Study|Adverse Event|3|||
129151311|NCT02852967|464852524|FG001|Overall Study|Adverse Event|1|||
129151312|NCT02852967|464852525|FG002|Overall Study|Adverse Event|0|||
129151313|NCT02852967|464852526|FG003|Overall Study|Adverse Event|1|||
129151314|NCT02852967|464852527|FG004|Overall Study|Adverse Event|0|||
129151315|NCT02852967|464852523|FG000|Overall Study|Death|1|||
129151316|NCT02852967|464852524|FG001|Overall Study|Death|0|||
129151317|NCT02852967|464852525|FG002|Overall Study|Death|0|||
129151318|NCT02852967|464852526|FG003|Overall Study|Death|0|||
129151319|NCT02852967|464852527|FG004|Overall Study|Death|0|||
129151320|NCT02852967|464852523|FG000|Overall Study|Lost to Follow-up|1|||
129151321|NCT02852967|464852524|FG001|Overall Study|Lost to Follow-up|2|||
129151322|NCT02852967|464852525|FG002|Overall Study|Lost to Follow-up|3|||
129151323|NCT02852967|464852526|FG003|Overall Study|Lost to Follow-up|4|||
129151324|NCT02852967|464852527|FG004|Overall Study|Lost to Follow-up|4|||
129151325|NCT02852967|464852523|FG000|Overall Study|Withdrawal by Subject|6|||
129151326|NCT02852967|464852524|FG001|Overall Study|Withdrawal by Subject|12|||
129151327|NCT02852967|464852525|FG002|Overall Study|Withdrawal by Subject|7|||
129151328|NCT02852967|464852526|FG003|Overall Study|Withdrawal by Subject|10|||
129151329|NCT02852967|464852527|FG004|Overall Study|Withdrawal by Subject|10|||
129151330|NCT02852967|464852523|FG000|Overall Study|SAE|0|||
129151331|NCT02852967|464852524|FG001|Overall Study|SAE|0|||
129151332|NCT02852967|464852525|FG002|Overall Study|SAE|0|||
129151333|NCT02852967|464852526|FG003|Overall Study|SAE|3|||
129151334|NCT02852967|464852527|FG004|Overall Study|SAE|0|||
129151335|NCT02852967|464852523|FG000|Overall Study|Elevated Liver Enzymes|2|||
129151336|NCT02852967|464852524|FG001|Overall Study|Elevated Liver Enzymes|0|||
129151337|NCT02852967|464852525|FG002|Overall Study|Elevated Liver Enzymes|0|||
129151338|NCT02852967|464852526|FG003|Overall Study|Elevated Liver Enzymes|2|||
129151339|NCT02852967|464852527|FG004|Overall Study|Elevated Liver Enzymes|2|||
129151340|NCT02852967|464852523|FG000|Overall Study|Physician Decision|0|||
129151341|NCT02852967|464852524|FG001|Overall Study|Physician Decision|0|||
129151342|NCT02852967|464852525|FG002|Overall Study|Physician Decision|0|||
129151343|NCT02852967|464852526|FG003|Overall Study|Physician Decision|1|||
129151344|NCT02852967|464852527|FG004|Overall Study|Physician Decision|0|||
129151345|NCT02852967|464852523|FG000|Overall Study|Lack of Efficacy|0|||
129151346|NCT02852967|464852524|FG001|Overall Study|Lack of Efficacy|1|||
129151347|NCT02852967|464852525|FG002|Overall Study|Lack of Efficacy|0|||
129151348|NCT02852967|464852526|FG003|Overall Study|Lack of Efficacy|0|||
129151349|NCT02852967|464852527|FG004|Overall Study|Lack of Efficacy|0|||
129151350|NCT02852967|464852523|FG000|Overall Study|Non-compliance|0|||
129151351|NCT02852967|464852524|FG001|Overall Study|Non-compliance|0|||
129151352|NCT02852967|464852525|FG002|Overall Study|Non-compliance|1|||
129151353|NCT02852967|464852526|FG003|Overall Study|Non-compliance|1|||
129151354|NCT02852967|464852527|FG004|Overall Study|Non-compliance|0|||
129151355|NCT02852967|464852523|FG000|Overall Study|Dispensing Drug Violation|0|||
129151356|NCT02852967|464852524|FG001|Overall Study|Dispensing Drug Violation|0|||
129151357|NCT02852967|464852525|FG002|Overall Study|Dispensing Drug Violation|1|||
129151358|NCT02852967|464852526|FG003|Overall Study|Dispensing Drug Violation|0|||
129151359|NCT02852967|464852527|FG004|Overall Study|Dispensing Drug Violation|0|||
129151360|NCT02852967|464852523|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
129151361|NCT02852967|464852524|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
129151362|NCT02852967|464852525|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
129151363|NCT02852967|464852526|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
129151364|NCT02852967|464852527|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
129151365|NCT01693367|464852528|FG000|Overall Study|Withdrawal by Subject|1|||
129151366|NCT01693367|464852529|FG001|Overall Study|Withdrawal by Subject|1|||
129151367|NCT01693367|464852528|FG000|Overall Study|Physician Decision|0|||
129151368|NCT01693367|464852529|FG001|Overall Study|Physician Decision|1|||
129151369|NCT02286895|464852530|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
129151370|NCT02286895|464852531|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
129151371|NCT02286895|464852530|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
129151372|NCT02286895|464852531|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
129151373|NCT02286895|464852530|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
129151374|NCT02286895|464852531|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
129151375|NCT01073293|464852532|FG000|Overall Study|Lost to Follow-up|0|||
129151376|NCT01073293|464852533|FG001|Overall Study|Lost to Follow-up|1|||
129151377|NCT01073293|464852532|FG000|Overall Study|Withdrawal by Subject|5|||
129151378|NCT01073293|464852533|FG001|Overall Study|Withdrawal by Subject|10|||
129151379|NCT02949011|464852536|FG000|Overall Study|Adverse Event|6|||
129151380|NCT02949011|464852537|FG001|Overall Study|Adverse Event|7|||
129151381|NCT02949011|464852538|FG002|Overall Study|Adverse Event|3|||
129151382|NCT02949011|464852536|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129151383|NCT02949011|464852537|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129151384|NCT02949011|464852538|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
129151385|NCT02949011|464852536|FG000|Overall Study|Protocol Deviation|5|||
129151386|NCT02949011|464852537|FG001|Overall Study|Protocol Deviation|3|||
129151387|NCT02949011|464852538|FG002|Overall Study|Protocol Deviation|3|||
129151388|NCT02949011|464852536|FG000|Overall Study|Lack of Efficacy|0|||
129151389|NCT02949011|464852537|FG001|Overall Study|Lack of Efficacy|2|||
129151390|NCT02949011|464852538|FG002|Overall Study|Lack of Efficacy|0|||
129151391|NCT02949011|464852536|FG000|Overall Study|Withdrawal by Subject|13|||
129151392|NCT02949011|464852537|FG001|Overall Study|Withdrawal by Subject|13|||
129151393|NCT02949011|464852538|FG002|Overall Study|Withdrawal by Subject|21|||
129151394|NCT02949011|464852536|FG000|Overall Study|Lost to Follow-up|7|||
129151395|NCT02949011|464852537|FG001|Overall Study|Lost to Follow-up|5|||
129151396|NCT02949011|464852538|FG002|Overall Study|Lost to Follow-up|5|||
129151397|NCT02949011|464852536|FG000|Overall Study|Death|0|||
129151398|NCT02949011|464852537|FG001|Overall Study|Death|0|||
129151399|NCT02949011|464852538|FG002|Overall Study|Death|1|||
129151400|NCT02949011|464852536|FG000|Overall Study|Miscellaneous|2|||
129151401|NCT02949011|464852537|FG001|Overall Study|Miscellaneous|4|||
129151402|NCT02949011|464852538|FG002|Overall Study|Miscellaneous|6|||
129151403|NCT00163189|464852539|FG000|Overall Study|Other|6|||
129151404|NCT00163189|464852539|FG000|Overall Study|Lost to Follow-up|1|||
129151405|NCT00163189|464852539|FG000|Overall Study|Protocol Violation|2|||
129151406|NCT00163189|464852539|FG000|Overall Study|Death|3|||
129151407|NCT00163189|464852539|FG000|Overall Study|Adverse Event|6|||
129151408|NCT00163189|464852539|FG000|Overall Study|Lack of Efficacy|7|||
129151409|NCT00163189|464852539|FG000|Overall Study|Study terminated by sponsor|11|||
129151410|NCT00163189|464852539|FG000|Overall Study|Withdrawal by Subject|11|||
129151411|NCT00163189|464852539|FG000|Overall Study|Did not meet continuation criterion|16|||
129151412|NCT00506142|464852540|FG000|Overall Study|Adverse Event|8|||
129151413|NCT00506142|464852541|FG001|Overall Study|Adverse Event|7|||
129151414|NCT00506142|464852540|FG000|Overall Study|Lack of Efficacy|21|||
129151415|NCT00506142|464852541|FG001|Overall Study|Lack of Efficacy|7|||
129151416|NCT00506142|464852540|FG000|Overall Study|Withdrawal by Subject|4|||
129151417|NCT00506142|464852541|FG001|Overall Study|Withdrawal by Subject|5|||
129151418|NCT00506142|464852540|FG000|Overall Study|Physician Decision|1|||
129151419|NCT00506142|464852541|FG001|Overall Study|Physician Decision|0|||
129151420|NCT00506142|464852540|FG000|Overall Study|New health condition|1|||
129151421|NCT00506142|464852541|FG001|Overall Study|New health condition|0|||
129151422|NCT02154061|464852542|FG000|Overall Study|Pregnancy|1|||
129151423|NCT02154061|464852543|FG001|Overall Study|Pregnancy|0|||
129151424|NCT02154061|464852542|FG000|Overall Study|enrolled but not vaccinated|1|||
129151425|NCT02154061|464852543|FG001|Overall Study|enrolled but not vaccinated|0|||
129151426|NCT00454116|464852544|FG000|Overall Study|Adverse Event|5|||
129151427|NCT00454116|464852545|FG001|Overall Study|Adverse Event|11|||
129151428|NCT00454116|464852546|FG002|Overall Study|Adverse Event|9|||
129151429|NCT00454116|464852544|FG000|Overall Study|Condition under investigation worsened|17|||
129151430|NCT00454116|464852545|FG001|Overall Study|Condition under investigation worsened|13|||
129151431|NCT00454116|464852546|FG002|Overall Study|Condition under investigation worsened|18|||
129151432|NCT00454116|464852544|FG000|Overall Study|Withdrawal by Subject|3|||
129151433|NCT00454116|464852545|FG001|Overall Study|Withdrawal by Subject|3|||
129151434|NCT00454116|464852546|FG002|Overall Study|Withdrawal by Subject|1|||
129151435|NCT00454116|464852544|FG000|Overall Study|Other|2|||
129151436|NCT00454116|464852545|FG001|Overall Study|Other|2|||
129151437|NCT00454116|464852546|FG002|Overall Study|Other|0|||
129151438|NCT01917318|464852549|FG000|First Treatment|Withdrawal by Subject|0|||
129151439|NCT01917318|464852550|FG001|First Treatment|Withdrawal by Subject|1|||
129151440|NCT00742625|464852551|FG000|Remission Induction|Progression|6|||
129151441|NCT00742625|464852551|FG000|Remission Induction|Failed induction|8|||
129151442|NCT00742625|464852551|FG000|Remission Induction|Adverse Event|3|||
129151443|NCT00742625|464852551|FG000|Remission Induction|Death|10|||
129151444|NCT00742625|464852551|FG000|Remission Induction|Refusal|5|||
129151445|NCT00742625|464852551|FG000|Remission Induction|Non protocol treatment|17|||
129151446|NCT00742625|464852551|FG000|Remission Induction|Other, not specified|5|||
129151447|NCT00742625|464852551|FG000|Consolidation|Progression|5|||
129151448|NCT00742625|464852551|FG000|Consolidation|Adverse Event|1|||
129151449|NCT00742625|464852551|FG000|Consolidation|Death|1|||
129151450|NCT00742625|464852551|FG000|Consolidation|Refused|1|||
129151451|NCT00742625|464852551|FG000|Consolidation|Non protocol therapy|13|||
129151452|NCT03338400|464852552|FG000|Overall Study|Lost to Follow-up|1|||
129151453|NCT03338400|464852553|FG001|Overall Study|Lost to Follow-up|2|||
129151454|NCT01865487|464852556|FG000|Overall Study|Lost to Follow-up|0|||
129151455|NCT01865487|464852557|FG001|Overall Study|Lost to Follow-up|0|||
129151456|NCT01865487|464852558|FG002|Overall Study|Lost to Follow-up|0|||
129151457|NCT01865487|464852559|FG003|Overall Study|Lost to Follow-up|1|||
129151458|NCT01865487|464852560|FG004|Overall Study|Lost to Follow-up|0|||
129151459|NCT01865487|464852561|FG005|Overall Study|Lost to Follow-up|0|||
129151460|NCT01865487|464852562|FG006|Overall Study|Lost to Follow-up|1|||
129151461|NCT01865487|464852563|FG007|Overall Study|Lost to Follow-up|0|||
129151462|NCT01865487|464852564|FG008|Overall Study|Lost to Follow-up|0|||
129151463|NCT01865487|464852565|FG009|Overall Study|Lost to Follow-up|0|||
129151464|NCT01865487|464852556|FG000|Overall Study|Withdrawal by Subject|0|||
129151465|NCT01865487|464852557|FG001|Overall Study|Withdrawal by Subject|0|||
129151466|NCT01865487|464852558|FG002|Overall Study|Withdrawal by Subject|0|||
129151467|NCT01865487|464852559|FG003|Overall Study|Withdrawal by Subject|0|||
129151468|NCT01865487|464852560|FG004|Overall Study|Withdrawal by Subject|1|||
129151469|NCT01865487|464852561|FG005|Overall Study|Withdrawal by Subject|0|||
129151470|NCT01865487|464852562|FG006|Overall Study|Withdrawal by Subject|0|||
129151471|NCT01865487|464852563|FG007|Overall Study|Withdrawal by Subject|0|||
129151472|NCT01865487|464852564|FG008|Overall Study|Withdrawal by Subject|0|||
129151473|NCT01865487|464852565|FG009|Overall Study|Withdrawal by Subject|0|||
129151474|NCT01213082|464852566|FG000|Overall Study|Lost to Follow-up|6|||
129151475|NCT01213082|464852567|FG001|Overall Study|Lost to Follow-up|7|||
129151476|NCT01213082|464852568|FG002|Overall Study|Lost to Follow-up|4|||
129151477|NCT01213082|464852566|FG000|Overall Study|Physician Decision|0|||
129151478|NCT01213082|464852567|FG001|Overall Study|Physician Decision|0|||
129151479|NCT01213082|464852568|FG002|Overall Study|Physician Decision|1|||
129151480|NCT03848416|464852574|FG000|Overall Study|Withdrawal by Subject|1|||
129151481|NCT03848416|464852575|FG001|Overall Study|Withdrawal by Subject|0|||
129151482|NCT03848416|464852576|FG002|Overall Study|Withdrawal by Subject|0|||
129151483|NCT03848416|464852574|FG000|Overall Study|Death|0|||
129151484|NCT03848416|464852575|FG001|Overall Study|Death|0|||
129151485|NCT03848416|464852576|FG002|Overall Study|Death|1|||
129151486|NCT02639390|464852577|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
129151487|NCT02639390|464852578|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
129151488|NCT01908140|464852579|FG000|Overall Study|Other or Progressive Disease|5|||
129151489|NCT01908140|464852580|FG001|Overall Study|Other or Progressive Disease|12|||
129151490|NCT01908140|464852579|FG000|Overall Study|Lack of Efficacy|7|||
129151491|NCT01908140|464852580|FG001|Overall Study|Lack of Efficacy|5|||
129151492|NCT01908140|464852579|FG000|Overall Study|Withdrawal by Subject|23|||
129151493|NCT01908140|464852580|FG001|Overall Study|Withdrawal by Subject|24|||
129151494|NCT01908140|464852579|FG000|Overall Study|Lost to Follow-up|1|||
129151495|NCT01908140|464852580|FG001|Overall Study|Lost to Follow-up|6|||
129151496|NCT01908140|464852579|FG000|Overall Study|Protocol Violation|8|||
129151497|NCT01908140|464852580|FG001|Overall Study|Protocol Violation|9|||
129151498|NCT01908140|464852579|FG000|Overall Study|Adverse Event|22|||
129151499|NCT01908140|464852580|FG001|Overall Study|Adverse Event|23|||
129151500|NCT02013609|464852581|FG000|Overall Study|Withdrawal by Subject|9|||
129151501|NCT02013609|464852581|FG000|Overall Study|Lost to Follow-up|3|||
129151502|NCT02013609|464852581|FG000|Overall Study|Adverse Event|3|||
129151503|NCT02013609|464852581|FG000|Overall Study|Met Withdrawal Criteria|3|||
129151504|NCT00783432|464852582|FG000|Overall Study|Adverse Event|22|||
129151505|NCT00783432|464852583|FG001|Overall Study|Adverse Event|17|||
129151506|NCT00783432|464852582|FG000|Overall Study|Lack of Efficacy|20|||
129151507|NCT00783432|464852583|FG001|Overall Study|Lack of Efficacy|21|||
129151508|NCT00783432|464852582|FG000|Overall Study|Lost to Follow-up|11|||
129151509|NCT00783432|464852583|FG001|Overall Study|Lost to Follow-up|6|||
129151510|NCT00783432|464852582|FG000|Overall Study|Withdrawal by Subject|23|||
129151511|NCT00783432|464852583|FG001|Overall Study|Withdrawal by Subject|20|||
129151512|NCT00783432|464852582|FG000|Overall Study|subject moved|3|||
129151513|NCT00783432|464852583|FG001|Overall Study|subject moved|5|||
129151514|NCT00783432|464852582|FG000|Overall Study|Protocol Violation|6|||
129151515|NCT00783432|464852583|FG001|Overall Study|Protocol Violation|9|||
129151516|NCT01436110|464852584|FG000|Overall Study|Lack of Efficacy|23|||
129151517|NCT01436110|464852585|FG001|Overall Study|Lack of Efficacy|14|||
129151518|NCT01436110|464852586|FG002|Overall Study|Lack of Efficacy|9|||
129151519|NCT01436110|464852584|FG000|Overall Study|Withdrawal by Subject|6|||
129151520|NCT01436110|464852585|FG001|Overall Study|Withdrawal by Subject|8|||
129151521|NCT01436110|464852586|FG002|Overall Study|Withdrawal by Subject|4|||
129151522|NCT01436110|464852584|FG000|Overall Study|Adverse Event|2|||
129151523|NCT01436110|464852585|FG001|Overall Study|Adverse Event|1|||
129151524|NCT01436110|464852586|FG002|Overall Study|Adverse Event|2|||
129151525|NCT01436110|464852584|FG000|Overall Study|Physician Decision|3|||
129151526|NCT01436110|464852585|FG001|Overall Study|Physician Decision|1|||
129151527|NCT01436110|464852586|FG002|Overall Study|Physician Decision|1|||
129151528|NCT01436110|464852584|FG000|Overall Study|Lost to Follow-up|1|||
129151529|NCT01436110|464852585|FG001|Overall Study|Lost to Follow-up|1|||
129151530|NCT01436110|464852586|FG002|Overall Study|Lost to Follow-up|3|||
129151531|NCT01436110|464852584|FG000|Overall Study|Protocol Violation|3|||
129151532|NCT01436110|464852585|FG001|Overall Study|Protocol Violation|1|||
129151533|NCT01436110|464852586|FG002|Overall Study|Protocol Violation|1|||
129151534|NCT01436110|464852584|FG000|Overall Study|Did Not Receive Trial Medication|1|||
129151535|NCT01436110|464852585|FG001|Overall Study|Did Not Receive Trial Medication|0|||
129151536|NCT01436110|464852586|FG002|Overall Study|Did Not Receive Trial Medication|3|||
129151537|NCT03273907|464852588|FG000|Overall Study|Death|1|||
129151538|NCT03273907|464852588|FG000|Overall Study|Lost to Follow-up|4|||
129151539|NCT03273907|464852588|FG000|Overall Study|Withdrawal by Subject|2|||
129151540|NCT03273907|464852588|FG000|Overall Study|COVID 19|2|||
129151541|NCT01531998|464852589|FG000|Overall Study|Withdrawal by Subject|3|||
129151542|NCT02927795|464852590|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
129151543|NCT02927795|464852590|FG000|Overall Study|Not Treated|4|||
129151544|NCT02581891|464852591|FG000|Overall Study|Adverse Event|4|||
129151545|NCT02581891|464852592|FG001|Overall Study|Adverse Event|6|||
129151546|NCT02581891|464852591|FG000|Overall Study|Death|3|||
129151547|NCT02581891|464852592|FG001|Overall Study|Death|4|||
129151548|NCT02581891|464852591|FG000|Overall Study|Lost to Follow-up|1|||
129151549|NCT02581891|464852592|FG001|Overall Study|Lost to Follow-up|2|||
129151550|NCT02581891|464852591|FG000|Overall Study|Physician Decision|0|||
129151551|NCT02581891|464852592|FG001|Overall Study|Physician Decision|1|||
129151552|NCT02581891|464852591|FG000|Overall Study|Withdrawal by Subject|4|||
129151553|NCT02581891|464852592|FG001|Overall Study|Withdrawal by Subject|5|||
129151554|NCT02581891|464852591|FG000|Overall Study|Other Reasons|3|||
129151555|NCT02581891|464852592|FG001|Overall Study|Other Reasons|1|||
129151556|NCT02581891|464852591|FG000|Overall Study|Discontinued during followup|1|||
129151557|NCT02581891|464852592|FG001|Overall Study|Discontinued during followup|0|||
129151558|NCT03440008|464852595|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
129151559|NCT03440008|464852596|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
129151560|NCT03440008|464852595|FG000|Overall Study|Withdrawal by Subject|1|||
129151561|NCT03440008|464852596|FG001|Overall Study|Withdrawal by Subject|0|||
129151562|NCT03498716|464852604|FG000|Overall Study|Withdrawal by Subject|88|||
129151563|NCT03498716|464852605|FG001|Overall Study|Withdrawal by Subject|73|||
129151564|NCT03498716|464852604|FG000|Overall Study|Study Terminated By Sponsor|933|||
129151565|NCT03498716|464852605|FG001|Overall Study|Study Terminated By Sponsor|927|||
129151566|NCT03498716|464852604|FG000|Overall Study|Lost to Follow-up|15|||
129151567|NCT03498716|464852605|FG001|Overall Study|Lost to Follow-up|26|||
129151568|NCT03498716|464852604|FG000|Overall Study|Disease Relapse|0|||
129151569|NCT03498716|464852605|FG001|Overall Study|Disease Relapse|1|||
129151570|NCT03498716|464852604|FG000|Overall Study|Death|58|||
129151571|NCT03498716|464852605|FG001|Overall Study|Death|72|||
129151572|NCT03498716|464852604|FG000|Overall Study|Physician Decision|4|||
129151573|NCT03498716|464852605|FG001|Overall Study|Physician Decision|2|||
129151574|NCT00760552|464852609|FG000|Overall Study|Death|2|||
129151575|NCT00760552|464852610|FG001|Overall Study|Death|0|||
129151576|NCT00760552|464852609|FG000|Overall Study|Lost to Follow-up|11|||
129151577|NCT00760552|464852610|FG001|Overall Study|Lost to Follow-up|10|||
129151578|NCT01657305|464852615|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
129151579|NCT01657305|464852615|FG000|Overall Study|Withdrawal by Subject|4|||
129151580|NCT01657305|464852615|FG000|Overall Study|Adverse Event|1|||
129151581|NCT01657305|464852615|FG000|Overall Study|Lost to Follow-up|1|||
129151582|NCT01657305|464852615|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
129151583|NCT04103450|464852616|FG000|Overall Study|Adverse Event|4|||
129151584|NCT04103450|464852617|FG001|Overall Study|Adverse Event|2|||
129151585|NCT04103450|464852616|FG000|Overall Study|Lack of Efficacy|3|||
129151586|NCT04103450|464852617|FG001|Overall Study|Lack of Efficacy|0|||
129151587|NCT04103450|464852616|FG000|Overall Study|Withdrawal by Subject|5|||
129151588|NCT04103450|464852617|FG001|Overall Study|Withdrawal by Subject|3|||
128776686|NCT02718417|463471969|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
129151589|NCT04103450|464852616|FG000|Overall Study|Lost to Follow-up|1|||
129151590|NCT04103450|464852617|FG001|Overall Study|Lost to Follow-up|2|||
129151591|NCT04103450|464852616|FG000|Overall Study|Physician Decision|1|||
129151592|NCT04103450|464852617|FG001|Overall Study|Physician Decision|2|||
129151593|NCT04103450|464852616|FG000|Overall Study|Protocol Violation|1|||
129151594|NCT04103450|464852617|FG001|Overall Study|Protocol Violation|0|||
129151595|NCT04103450|464852616|FG000|Overall Study|Other|1|||
129151596|NCT04103450|464852617|FG001|Overall Study|Other|1|||
129151597|NCT01696643|464852622|FG000|Overall Study|Adverse Event|15|||
129151598|NCT01696643|464852623|FG001|Overall Study|Adverse Event|7|||
129151599|NCT01696643|464852622|FG000|Overall Study|Death|1|||
129151600|NCT01696643|464852623|FG001|Overall Study|Death|2|||
129151601|NCT01696643|464852622|FG000|Overall Study|Lack of Efficacy|3|||
129151602|NCT01696643|464852623|FG001|Overall Study|Lack of Efficacy|0|||
129151603|NCT01696643|464852622|FG000|Overall Study|Lost to Follow-up|67|||
129151604|NCT01696643|464852623|FG001|Overall Study|Lost to Follow-up|67|||
129151605|NCT01696643|464852622|FG000|Overall Study|Physician Decision|3|||
129151606|NCT01696643|464852623|FG001|Overall Study|Physician Decision|2|||
129151607|NCT01696643|464852622|FG000|Overall Study|Pregnancy|0|||
129151608|NCT01696643|464852623|FG001|Overall Study|Pregnancy|1|||
128776687|NCT02718417|463471970|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
128776688|NCT02718417|463471968|FG000|Long-term Follow-up Phase|Other|0|||
128776689|NCT02718417|463471969|FG001|Long-term Follow-up Phase|Other|2|||
128776690|NCT02718417|463471970|FG002|Long-term Follow-up Phase|Other|0|||
128776691|NCT00795132|463471976|FG000|Overall Study|Death|1|||
128776692|NCT00795132|463471976|FG000|Overall Study|Relapse|2|||
128776693|NCT02451930|463471977|FG000|Overall Study|Death|0|||
128776694|NCT02451930|463471978|FG001|Overall Study|Death|15|||
128776695|NCT02451930|463471977|FG000|Overall Study|Lost to Follow-up|0|||
128776696|NCT02451930|463471978|FG001|Overall Study|Lost to Follow-up|3|||
128776697|NCT02451930|463471977|FG000|Overall Study|Sponsor Decision|2|||
128776698|NCT02451930|463471978|FG001|Overall Study|Sponsor Decision|10|||
128776699|NCT02451930|463471977|FG000|Overall Study|Withdrawal by Subject|0|||
128776700|NCT02451930|463471978|FG001|Overall Study|Withdrawal by Subject|1|||
128776701|NCT02451930|463471977|FG000|Overall Study|Other|0|||
128776702|NCT02451930|463471978|FG001|Overall Study|Other|1|||
128776703|NCT02056119|463471988|FG000|Overall Study|Death|1|||
128776704|NCT02056119|463471989|FG001|Overall Study|Death|2|||
128776705|NCT02056119|463471988|FG000|Overall Study|Intubated for less than 24 hrs|2|||
128776706|NCT02056119|463471989|FG001|Overall Study|Intubated for less than 24 hrs|7|||
128776707|NCT02056119|463471988|FG000|Overall Study|No aerosol treatments were given.|3|||
128776708|NCT02056119|463471989|FG001|Overall Study|No aerosol treatments were given.|2|||
128776709|NCT02056119|463471988|FG000|Overall Study|Received Metaneb treatment|0|||
128776710|NCT02056119|463471989|FG001|Overall Study|Received Metaneb treatment|2|||
128776711|NCT02056119|463471988|FG000|Overall Study|Protocol Violation|4|||
128776712|NCT02056119|463471989|FG001|Overall Study|Protocol Violation|7|||
128776713|NCT03220737|463471990|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
128776714|NCT03220737|463471991|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
128776715|NCT03220737|463471992|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
128776716|NCT03220737|463471993|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
128776717|NCT03220737|463471994|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
128776718|NCT03220737|463471995|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
128776719|NCT03220737|463471996|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
128776720|NCT03220737|463471990|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
128776721|NCT03220737|463471991|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
128776722|NCT03220737|463471992|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
128776723|NCT03220737|463471993|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
128776724|NCT03220737|463471994|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
128776725|NCT03220737|463471995|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
128776726|NCT03220737|463471996|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
128776727|NCT03220737|463471990|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
128776728|NCT03220737|463471991|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
128776729|NCT03220737|463471992|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
128776730|NCT03220737|463471993|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
128776731|NCT03220737|463471994|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
128776732|NCT03220737|463471995|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
128776733|NCT03220737|463471996|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
128776734|NCT03220737|463471990|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129151609|NCT01696643|464852622|FG000|Overall Study|Protocol Violation|7|||
129151610|NCT01696643|464852623|FG001|Overall Study|Protocol Violation|7|||
129151611|NCT01696643|464852622|FG000|Overall Study|Study Terminated by Sponsor|286|||
129151612|NCT01696643|464852623|FG001|Overall Study|Study Terminated by Sponsor|294|||
129151613|NCT01696643|464852622|FG000|Overall Study|Withdrawal by Subject|142|||
129151614|NCT01696643|464852623|FG001|Overall Study|Withdrawal by Subject|149|||
129151615|NCT01696643|464852622|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
129151616|NCT01696643|464852623|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
129151617|NCT01696643|464852622|FG000|Overall Study|Site Error|2|||
129151618|NCT01696643|464852623|FG001|Overall Study|Site Error|1|||
129151619|NCT01696643|464852622|FG000|Overall Study|Participant Incarcerated|0|||
129151620|NCT01696643|464852623|FG001|Overall Study|Participant Incarcerated|1|||
129151621|NCT01696643|464852622|FG000|Overall Study|Medical Monitor Decision|0|||
129151622|NCT01696643|464852623|FG001|Overall Study|Medical Monitor Decision|2|||
129151623|NCT01696643|464852622|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
129151624|NCT01696643|464852623|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
129151625|NCT02271529|464852624|FG000|Overall Study|Withdrawal by Subject|1|||
129151626|NCT01240863|464852625|FG000|Open-label Titration Period|Adverse Event|47|||
129151627|NCT01240863|464852626|FG001|Open-label Titration Period|Adverse Event|0|||
129151628|NCT01240863|464852627|FG002|Open-label Titration Period|Adverse Event|0|||
129151629|NCT01240863|464852625|FG000|Open-label Titration Period|Lack of Efficacy|19|||
129151630|NCT01240863|464852626|FG001|Open-label Titration Period|Lack of Efficacy|0|||
129151631|NCT01240863|464852627|FG002|Open-label Titration Period|Lack of Efficacy|0|||
129151632|NCT01240863|464852625|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
129151633|NCT01240863|464852626|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
129151634|NCT01240863|464852627|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
129151635|NCT01240863|464852625|FG000|Open-label Titration Period|Protocol Violation|7|||
129151636|NCT01240863|464852626|FG001|Open-label Titration Period|Protocol Violation|0|||
129151637|NCT01240863|464852627|FG002|Open-label Titration Period|Protocol Violation|0|||
129151638|NCT01240863|464852625|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
129151639|NCT01240863|464852626|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
129151640|NCT01240863|464852627|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
129151641|NCT01240863|464852625|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
129151642|NCT01240863|464852626|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
129151643|NCT01240863|464852627|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
129151644|NCT01240863|464852625|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
129151645|NCT01240863|464852626|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
129151646|NCT01240863|464852627|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
129151647|NCT01240863|464852625|FG000|Open-label Titration Period|Other|7|||
129151648|NCT01240863|464852626|FG001|Open-label Titration Period|Other|0|||
129151649|NCT01240863|464852627|FG002|Open-label Titration Period|Other|0|||
129151650|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
129151651|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
129151652|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
129151653|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129151654|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
129151655|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
129151656|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129151657|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
129151658|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
129151659|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129151660|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
129151661|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
129151662|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
129151663|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
129151664|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
129151665|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
129151666|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
129151667|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
129151668|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
129151669|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
129151670|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
129151671|NCT01240863|464852625|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
129151672|NCT01240863|464852626|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
129151673|NCT01240863|464852627|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
129151674|NCT03950856|464852630|FG000|Overall Study|Death|1|||
129151675|NCT03950856|464852631|FG001|Overall Study|Death|2|||
129151676|NCT03950856|464852632|FG002|Overall Study|Death|0|||
129151677|NCT03950856|464852633|FG003|Overall Study|Death|0|||
129151678|NCT03950856|464852630|FG000|Overall Study|Lost to Follow-up|5|||
129151679|NCT03950856|464852631|FG001|Overall Study|Lost to Follow-up|6|||
128725333|NCT01148511|463290963|FG000|Exposed to Study Drug|Protocol Violation|2|||
128725334|NCT01148511|463290964|FG001|Exposed to Study Drug|Protocol Violation|0|||
128725335|NCT01148511|463290965|FG002|Exposed to Study Drug|Protocol Violation|0|||
128725336|NCT01148511|463290963|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
128725337|NCT01148511|463290964|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
128725338|NCT01148511|463290965|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
128725339|NCT01148511|463290963|FG000|Randomized|Adverse Event|0|||
128725340|NCT01148511|463290964|FG001|Randomized|Adverse Event|1|||
128725341|NCT01148511|463290965|FG002|Randomized|Adverse Event|0|||
128725342|NCT01148511|463290963|FG000|Randomized|Protocol Violation|0|||
128725343|NCT01148511|463290964|FG001|Randomized|Protocol Violation|2|||
128725344|NCT01148511|463290965|FG002|Randomized|Protocol Violation|1|||
128725345|NCT01148511|463290963|FG000|Randomized|Lost to Follow-up|0|||
128725346|NCT01148511|463290964|FG001|Randomized|Lost to Follow-up|1|||
128725347|NCT01148511|463290965|FG002|Randomized|Lost to Follow-up|1|||
128725348|NCT01148511|463290963|FG000|Randomized|Consent withdrawal|0|||
128725349|NCT01148511|463290964|FG001|Randomized|Consent withdrawal|5|||
128725350|NCT01148511|463290965|FG002|Randomized|Consent withdrawal|3|||
128725351|NCT01148511|463290963|FG000|Randomized|Other|0|||
128725352|NCT01148511|463290964|FG001|Randomized|Other|1|||
128725353|NCT01148511|463290965|FG002|Randomized|Other|1|||
128725354|NCT01644175|463290968|FG000|Overall Study|Randomized But Not Treated|0|||
128725355|NCT01644175|463290969|FG001|Overall Study|Randomized But Not Treated|2|||
128725356|NCT01644175|463290968|FG000|Overall Study|Adverse Event|8|||
128725357|NCT01644175|463290969|FG001|Overall Study|Adverse Event|13|||
128725358|NCT01644175|463290968|FG000|Overall Study|Death|1|||
128725359|NCT01644175|463290969|FG001|Overall Study|Death|2|||
128725360|NCT01644175|463290968|FG000|Overall Study|Poor compliance to protocol|9|||
129151680|NCT03950856|464852632|FG002|Overall Study|Lost to Follow-up|8|||
129151681|NCT03950856|464852633|FG003|Overall Study|Lost to Follow-up|2|||
129151682|NCT03950856|464852630|FG000|Overall Study|Protocol Violation|2|||
129151683|NCT03950856|464852631|FG001|Overall Study|Protocol Violation|0|||
129151684|NCT03950856|464852632|FG002|Overall Study|Protocol Violation|0|||
129151685|NCT03950856|464852633|FG003|Overall Study|Protocol Violation|1|||
129151686|NCT03950856|464852630|FG000|Overall Study|Withdrawal by Subject|4|||
129151687|NCT03950856|464852631|FG001|Overall Study|Withdrawal by Subject|1|||
129151688|NCT03950856|464852632|FG002|Overall Study|Withdrawal by Subject|3|||
129151689|NCT03950856|464852633|FG003|Overall Study|Withdrawal by Subject|1|||
129151690|NCT03950856|464852630|FG000|Overall Study|Unable to phone|7|||
129151691|NCT03950856|464852631|FG001|Overall Study|Unable to phone|6|||
129151692|NCT03950856|464852632|FG002|Overall Study|Unable to phone|7|||
129151693|NCT03950856|464852633|FG003|Overall Study|Unable to phone|2|||
129151694|NCT05899829|464852636|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
129151695|NCT05899829|464852637|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
129151696|NCT05899829|464852636|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
129151697|NCT05899829|464852637|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
129151698|NCT02121509|464852638|FG000|Washout Period (35 Days)|Adverse Event|1|||
129151699|NCT02121509|464852639|FG001|Washout Period (35 Days)|Adverse Event|1|||
129151700|NCT02121509|464852640|FG002|Washout Period (35 Days)|Adverse Event|0|||
129151701|NCT02121509|464852641|FG003|Washout Period (35 Days)|Adverse Event|0|||
129151702|NCT02121509|464852638|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
129151703|NCT02121509|464852639|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
129151704|NCT02121509|464852640|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
129151705|NCT02121509|464852641|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
129151706|NCT02121509|464852638|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
129151707|NCT02121509|464852639|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
129151708|NCT02121509|464852640|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
129151709|NCT02121509|464852641|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
129151710|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
129151711|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
129151712|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
129151713|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
129151714|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
129151715|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
129151716|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
129151717|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
129151718|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
129151719|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
129151720|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
129151721|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
129151722|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
129151723|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
129151724|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
129151725|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
129151726|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
129151727|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
129151728|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
129151729|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
129151730|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
129151731|NCT04021290|464852644|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
129151732|NCT04021290|464852645|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
129151733|NCT04021290|464852646|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
129151734|NCT04021290|464852644|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
129151735|NCT04021290|464852645|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
129151736|NCT04021290|464852646|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
129151737|NCT04021290|464852644|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
129151738|NCT04021290|464852645|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
129151739|NCT04021290|464852646|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
129151740|NCT04021290|464852644|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
129151741|NCT04021290|464852645|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
129151742|NCT04021290|464852646|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
129151743|NCT04021290|464852644|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
129151744|NCT04021290|464852645|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
129151745|NCT04021290|464852646|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
129151746|NCT00636181|464852647|FG000|Overall Study|Withdrawal by Subject|8|||
129151747|NCT00636181|464852648|FG001|Overall Study|Withdrawal by Subject|6|||
129151748|NCT00636181|464852649|FG002|Overall Study|Withdrawal by Subject|10|||
129151749|NCT05076045|464852657|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
129151750|NCT05076045|464852658|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
129151751|NCT01174563|464852665|FG000|Overall Study|Progressive Disease|45|||
129151752|NCT01174563|464852665|FG000|Overall Study|Death|5|||
129151753|NCT01174563|464852665|FG000|Overall Study|Investigator's Discretion|5|||
129151754|NCT01174563|464852665|FG000|Overall Study|Participant Withdrew Consent|3|||
129151755|NCT01174563|464852665|FG000|Overall Study|Rash Adverse Event|1|||
129151756|NCT01174563|464852665|FG000|Overall Study|Sponsor's decision|1|||
129151757|NCT03402841|464852666|FG000|Overall Study|Withdrawal by Subject|3|||
129151758|NCT03402841|464852666|FG000|Overall Study|Lost to Follow-up|2|||
129151759|NCT03402841|464852666|FG000|Overall Study|Death|146|||
129151760|NCT01542788|464852671|FG000|Overall Study|Randomized but Not Treated|2|||
129151761|NCT01542788|464852672|FG001|Overall Study|Randomized but Not Treated|0|||
129151762|NCT01542788|464852671|FG000|Overall Study|Lack of Efficacy|41|||
129151763|NCT01542788|464852672|FG001|Overall Study|Lack of Efficacy|71|||
129151764|NCT01542788|464852671|FG000|Overall Study|Lost to Follow-up|5|||
129151765|NCT01542788|464852672|FG001|Overall Study|Lost to Follow-up|0|||
129151766|NCT01542788|464852671|FG000|Overall Study|Death|3|||
129151767|NCT01542788|464852672|FG001|Overall Study|Death|0|||
129151768|NCT01542788|464852671|FG000|Overall Study|Protocol Violation|2|||
129151769|NCT01542788|464852672|FG001|Overall Study|Protocol Violation|0|||
129151770|NCT01542788|464852671|FG000|Overall Study|Physician Decision|1|||
129151771|NCT01542788|464852672|FG001|Overall Study|Physician Decision|0|||
129151772|NCT01542788|464852671|FG000|Overall Study|Withdrawal by Subject|1|||
129151773|NCT01542788|464852672|FG001|Overall Study|Withdrawal by Subject|0|||
129151774|NCT01280968|464852673|FG000|Overall Study|Lost to Follow-up|8|||
129151775|NCT01280968|464852674|FG001|Overall Study|Lost to Follow-up|2|||
129151776|NCT01280968|464852673|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
129151777|NCT01280968|464852674|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
129151778|NCT01280968|464852673|FG000|Overall Study|Commuting Problems|2|||
129151779|NCT01280968|464852674|FG001|Overall Study|Commuting Problems|0|||
129151780|NCT01280968|464852673|FG000|Overall Study|Anxiety|2|||
129151781|NCT01280968|464852674|FG001|Overall Study|Anxiety|0|||
129151782|NCT01280968|464852673|FG000|Overall Study|Adverse Event|1|||
129151783|NCT01280968|464852674|FG001|Overall Study|Adverse Event|0|||
129151784|NCT01280968|464852673|FG000|Overall Study|Scheduling Conflicts|1|||
129151785|NCT01280968|464852674|FG001|Overall Study|Scheduling Conflicts|1|||
129151786|NCT01280968|464852673|FG000|Overall Study|Pre-existing Neurological Condition|1|||
129151787|NCT01280968|464852674|FG001|Overall Study|Pre-existing Neurological Condition|0|||
129151788|NCT01280968|464852673|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
129151789|NCT01280968|464852674|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
129151790|NCT03984188|464852675|FG000|Overall Study|Death|2|||
129151791|NCT03984188|464852676|FG001|Overall Study|Death|4|||
129151792|NCT03984188|464852675|FG000|Overall Study|Physician Decision|0|||
129151793|NCT03984188|464852676|FG001|Overall Study|Physician Decision|2|||
129151794|NCT03984188|464852675|FG000|Overall Study|Lost to Follow-up|3|||
129151795|NCT03984188|464852676|FG001|Overall Study|Lost to Follow-up|2|||
129151796|NCT03984188|464852675|FG000|Overall Study|Withdrawal by Subject|6|||
129151797|NCT03984188|464852676|FG001|Overall Study|Withdrawal by Subject|0|||
129151798|NCT00269113|464854709|FG000|Overall Study|Adverse Event|14|||
129151799|NCT00269113|464854710|FG001|Overall Study|Adverse Event|7|||
129151800|NCT00269113|464854709|FG000|Overall Study|Lack of Efficacy|35|||
129151801|NCT00269113|464854710|FG001|Overall Study|Lack of Efficacy|18|||
129151802|NCT00269113|464854709|FG000|Overall Study|Early Improvement|2|||
129151803|NCT00269113|464854710|FG001|Overall Study|Early Improvement|0|||
129151804|NCT00269113|464854709|FG000|Overall Study|Withdrawal by Subject|0|||
129151805|NCT00269113|464854710|FG001|Overall Study|Withdrawal by Subject|2|||
129151806|NCT00269113|464854709|FG000|Overall Study|Death|6|||
129151807|NCT00269113|464854710|FG001|Overall Study|Death|2|||
129151808|NCT00269113|464854709|FG000|Overall Study|Lost to Follow-up|2|||
129151809|NCT00269113|464854710|FG001|Overall Study|Lost to Follow-up|1|||
129151810|NCT00269113|464854709|FG000|Overall Study|Protocol Violation|15|||
129151811|NCT00269113|464854710|FG001|Overall Study|Protocol Violation|5|||
129151812|NCT00269113|464854709|FG000|Overall Study|Other|0|||
129151813|NCT00269113|464854710|FG001|Overall Study|Other|2|||
129151814|NCT00652743|464854711|FG000|Months 12-18|Lost to Follow-up|1|||
129151815|NCT00652743|464854712|FG001|Months 12-18|Lost to Follow-up|2|||
129151816|NCT00652743|464854713|FG002|Months 12-18|Lost to Follow-up|7|||
129151817|NCT00652743|464854711|FG000|Months 24-30|Other|5|||
129151818|NCT00652743|464854712|FG001|Months 24-30|Other|1|||
129151819|NCT00652743|464854713|FG002|Months 24-30|Other|11|||
129151820|NCT00652743|464854711|FG000|Months 36-42|Serious Adverse Events|0|||
129151821|NCT00652743|464854712|FG001|Months 36-42|Serious Adverse Events|1|||
129151822|NCT00652743|464854713|FG002|Months 36-42|Serious Adverse Events|1|||
129151823|NCT00652743|464854711|FG000|Months 36-42|Withdrawal by Subject|1|||
129151824|NCT00652743|464854712|FG001|Months 36-42|Withdrawal by Subject|1|||
129151825|NCT00652743|464854713|FG002|Months 36-42|Withdrawal by Subject|0|||
129151826|NCT00652743|464854711|FG000|Months 36-42|Lost to Follow-up|0|||
129151827|NCT00652743|464854712|FG001|Months 36-42|Lost to Follow-up|1|||
129151828|NCT00652743|464854713|FG002|Months 36-42|Lost to Follow-up|0|||
129151829|NCT00652743|464854711|FG000|Months 36-42|Migrated/moved from study area|1|||
129151830|NCT00652743|464854712|FG001|Months 36-42|Migrated/moved from study area|0|||
129151831|NCT00652743|464854713|FG002|Months 36-42|Migrated/moved from study area|0|||
129151832|NCT00652743|464854711|FG000|Months 36-42|Other|4|||
129151833|NCT00652743|464854712|FG001|Months 36-42|Other|2|||
129151834|NCT00652743|464854713|FG002|Months 36-42|Other|8|||
129151835|NCT00322049|464854714|FG000|Overall Study|Moved out of area|0|||
129151836|NCT00322049|464854715|FG001|Overall Study|Moved out of area|0|||
129151837|NCT00322049|464854716|FG002|Overall Study|Moved out of area|0|||
129151838|NCT00322049|464854717|FG003|Overall Study|Moved out of area|1|||
129151839|NCT00322049|464854714|FG000|Overall Study|Infected with Dengue during study|0|||
129151840|NCT00322049|464854715|FG001|Overall Study|Infected with Dengue during study|1|||
129151841|NCT00322049|464854716|FG002|Overall Study|Infected with Dengue during study|0|||
129151842|NCT00322049|464854717|FG003|Overall Study|Infected with Dengue during study|0|||
129151843|NCT02026011|464854718|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
129151844|NCT02026011|464854719|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
129151845|NCT02026011|464854718|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
129151846|NCT02026011|464854719|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
129151847|NCT02026011|464854718|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
129151848|NCT02026011|464854719|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
129151849|NCT02026011|464854718|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
129151850|NCT02026011|464854719|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
129151851|NCT01770743|464854720|FG000|Overall Study|Adverse Event|1|||
129151852|NCT01770743|464854721|FG001|Overall Study|Adverse Event|0|||
129151853|NCT01770743|464854722|FG002|Overall Study|Adverse Event|0|||
129151854|NCT01770743|464854723|FG003|Overall Study|Adverse Event|0|||
129151855|NCT01770743|464854724|FG004|Overall Study|Adverse Event|0|||
129151856|NCT01770743|464854720|FG000|Overall Study|Withdrawal by Subject|0|||
129151857|NCT01770743|464854721|FG001|Overall Study|Withdrawal by Subject|0|||
129151858|NCT01770743|464854722|FG002|Overall Study|Withdrawal by Subject|1|||
129151859|NCT01770743|464854723|FG003|Overall Study|Withdrawal by Subject|1|||
129151860|NCT01770743|464854724|FG004|Overall Study|Withdrawal by Subject|1|||
129151861|NCT01770743|464854720|FG000|Overall Study|Lost to Follow-up|0|||
129151862|NCT01770743|464854721|FG001|Overall Study|Lost to Follow-up|2|||
129151863|NCT01770743|464854722|FG002|Overall Study|Lost to Follow-up|0|||
129151864|NCT01770743|464854723|FG003|Overall Study|Lost to Follow-up|0|||
129151865|NCT01770743|464854724|FG004|Overall Study|Lost to Follow-up|1|||
129151866|NCT01770743|464854720|FG000|Overall Study|Sponsor Terminated Subject|1|||
129151867|NCT01770743|464854721|FG001|Overall Study|Sponsor Terminated Subject|0|||
129151868|NCT01770743|464854722|FG002|Overall Study|Sponsor Terminated Subject|0|||
129151869|NCT01770743|464854723|FG003|Overall Study|Sponsor Terminated Subject|1|||
129151870|NCT01770743|464854724|FG004|Overall Study|Sponsor Terminated Subject|0|||
129151871|NCT01770743|464854720|FG000|Overall Study|Moving Out of State|0|||
129151872|NCT01770743|464854721|FG001|Overall Study|Moving Out of State|1|||
129151873|NCT01770743|464854722|FG002|Overall Study|Moving Out of State|0|||
129151874|NCT01770743|464854723|FG003|Overall Study|Moving Out of State|0|||
129151875|NCT01770743|464854724|FG004|Overall Study|Moving Out of State|0|||
129151876|NCT00755807|464854727|FG000|Acute Phase|Adverse Event|16|||
129151877|NCT00755807|464854728|FG001|Acute Phase|Adverse Event|5|||
129151878|NCT00755807|464854727|FG000|Acute Phase|Protocol Violation|1|||
129151879|NCT00755807|464854728|FG001|Acute Phase|Protocol Violation|3|||
129151880|NCT00755807|464854727|FG000|Acute Phase|Withdrawal by Subject|1|||
129151881|NCT00755807|464854728|FG001|Acute Phase|Withdrawal by Subject|2|||
129151882|NCT00755807|464854727|FG000|Acute Phase|Lack of Efficacy|0|||
129151883|NCT00755807|464854728|FG001|Acute Phase|Lack of Efficacy|1|||
129151884|NCT00755807|464854727|FG000|Acute Phase|Physician Decision|0|||
129151885|NCT00755807|464854728|FG001|Acute Phase|Physician Decision|1|||
129151886|NCT00755807|464854727|FG000|Open-label Extension Phase|Adverse Event|7|||
129151887|NCT00755807|464854728|FG001|Open-label Extension Phase|Adverse Event|7|||
129151888|NCT00755807|464854727|FG000|Open-label Extension Phase|Protocol Violation|5|||
129151889|NCT00755807|464854728|FG001|Open-label Extension Phase|Protocol Violation|2|||
129151890|NCT00755807|464854727|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
129151891|NCT00755807|464854728|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
129151892|NCT00755807|464854727|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
129151893|NCT00755807|464854728|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
129151894|NCT00755807|464854727|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
129151895|NCT00755807|464854728|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
129151896|NCT00755807|464854727|FG000|Open-label Extension Phase|Sponsor Decision|0|||
129151897|NCT00755807|464854728|FG001|Open-label Extension Phase|Sponsor Decision|1|||
129151898|NCT00529243|464854733|FG000|Overall Study|Adverse Event|1|||
129151899|NCT00529243|464854733|FG000|Overall Study|Death|1|||
129151900|NCT00529243|464854733|FG000|Overall Study|Relocated|1|||
129151901|NCT00272792|464854738|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
129151902|NCT00272792|464854739|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
129151903|NCT00272792|464854738|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
129151904|NCT00272792|464854739|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
129151905|NCT00272792|464854738|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
129151906|NCT00272792|464854739|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
129151907|NCT00272792|464854738|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
129151908|NCT00272792|464854739|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
129151909|NCT05111145|464854740|FG000|Overall Study|Commercial drug is available for participant|76|||
129151910|NCT05111145|464854740|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
129151911|NCT00952705|464854741|FG000|Overall Study|Lost to Follow-up|24|||
129151912|NCT00952705|464854742|FG001|Overall Study|Lost to Follow-up|8|||
129151913|NCT00952705|464854743|FG002|Overall Study|Lost to Follow-up|9|||
129151914|NCT00952705|464854741|FG000|Overall Study|Withdrawal by Subject|2|||
129151915|NCT00952705|464854742|FG001|Overall Study|Withdrawal by Subject|1|||
129151916|NCT00952705|464854743|FG002|Overall Study|Withdrawal by Subject|1|||
129151917|NCT00952705|464854741|FG000|Overall Study|Death|2|||
129151918|NCT00952705|464854742|FG001|Overall Study|Death|0|||
129151919|NCT00952705|464854743|FG002|Overall Study|Death|0|||
129151920|NCT00952705|464854741|FG000|Overall Study|Incarcerated post dose|5|||
129151921|NCT00952705|464854742|FG001|Overall Study|Incarcerated post dose|0|||
129151922|NCT00952705|464854743|FG002|Overall Study|Incarcerated post dose|0|||
129151923|NCT00952705|464854741|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
129151924|NCT00952705|464854742|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
129151925|NCT00952705|464854743|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
129151926|NCT02921789|464854744|FG000|Overall Study|Adverse Event|0|||
129151927|NCT02921789|464854745|FG001|Overall Study|Adverse Event|1|||
129151928|NCT02921789|464854744|FG000|Overall Study|Lost to Follow-up|1|||
129151929|NCT02921789|464854745|FG001|Overall Study|Lost to Follow-up|0|||
129151930|NCT02921789|464854744|FG000|Overall Study|Protocol Deviation|2|||
129151931|NCT02921789|464854745|FG001|Overall Study|Protocol Deviation|0|||
129151932|NCT02921789|464854744|FG000|Overall Study|Withdrawal by Subject|2|||
129151933|NCT02921789|464854745|FG001|Overall Study|Withdrawal by Subject|1|||
129151934|NCT02921789|464854744|FG000|Overall Study|Miscellaneous|3|||
129151935|NCT02921789|464854745|FG001|Overall Study|Miscellaneous|2|||
129151936|NCT03759600|464854748|FG000|Overall Study|Adverse Event|2|||
129151937|NCT03759600|464854748|FG000|Overall Study|Progressive Disease|15|||
129151938|NCT03759600|464854748|FG000|Overall Study|Site Terminated by Sponsor|3|||
129151939|NCT05173974|464854749|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
129151940|NCT05173974|464854750|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
129151941|NCT05173974|464854751|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
129151942|NCT05173974|464854752|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
129151943|NCT05173974|464854749|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
129151944|NCT05173974|464854750|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
129151945|NCT05173974|464854751|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
129151946|NCT05173974|464854752|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
129151947|NCT03289143|464854754|FG000|Overall Study|Caregiver Unavailability|1|||
129151948|NCT03289143|464854755|FG001|Overall Study|Caregiver Unavailability|1|||
129151949|NCT03289143|464854756|FG002|Overall Study|Caregiver Unavailability|0|||
129151950|NCT03289143|464854757|FG003|Overall Study|Caregiver Unavailability|0|||
129151951|NCT03289143|464854754|FG000|Overall Study|Research Department Closure|0|||
129151952|NCT03289143|464854755|FG001|Overall Study|Research Department Closure|0|||
129151953|NCT03289143|464854756|FG002|Overall Study|Research Department Closure|1|||
129151954|NCT03289143|464854757|FG003|Overall Study|Research Department Closure|0|||
129151955|NCT03289143|464854754|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
129151956|NCT03289143|464854755|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
129151957|NCT03289143|464854756|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
129151958|NCT03289143|464854757|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
129151959|NCT03289143|464854754|FG000|Overall Study|Medical Monitor Decision|1|||
129151960|NCT03289143|464854755|FG001|Overall Study|Medical Monitor Decision|0|||
129151961|NCT03289143|464854756|FG002|Overall Study|Medical Monitor Decision|0|||
129151962|NCT03289143|464854757|FG003|Overall Study|Medical Monitor Decision|0|||
129151963|NCT03289143|464854754|FG000|Overall Study|Participant Non-Compliance|0|||
129151964|NCT03289143|464854755|FG001|Overall Study|Participant Non-Compliance|0|||
129151965|NCT03289143|464854756|FG002|Overall Study|Participant Non-Compliance|1|||
129151966|NCT03289143|464854757|FG003|Overall Study|Participant Non-Compliance|0|||
129151967|NCT03289143|464854754|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
129151968|NCT03289143|464854755|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
129151969|NCT03289143|464854756|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
129151970|NCT03289143|464854757|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
129151971|NCT03289143|464854754|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
129151972|NCT03289143|464854755|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
128776735|NCT03220737|463471991|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
128776736|NCT03220737|463471992|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
128776737|NCT03220737|463471993|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
128776738|NCT03220737|463471994|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
128776739|NCT03220737|463471995|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
128776740|NCT03220737|463471996|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
128776741|NCT03220737|463471990|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
128776742|NCT03220737|463471991|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
128776743|NCT03220737|463471992|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
128776744|NCT03220737|463471993|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
128776745|NCT03220737|463471994|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
128776746|NCT03220737|463471995|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
128776747|NCT03220737|463471996|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
128776748|NCT03220737|463471990|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
128776749|NCT03220737|463471991|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
128776750|NCT03220737|463471992|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
128776751|NCT03220737|463471993|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
128776752|NCT03220737|463471994|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
128776753|NCT03220737|463471995|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
128776754|NCT03220737|463471996|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
128776755|NCT03220737|463471990|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
128776756|NCT03220737|463471991|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
128776757|NCT03220737|463471992|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
128776758|NCT03220737|463471993|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
128776759|NCT03220737|463471994|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
128776760|NCT03220737|463471995|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
128776761|NCT03220737|463471996|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
128776762|NCT03220737|463471990|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
128776763|NCT03220737|463471991|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
128776764|NCT03220737|463471992|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
128776765|NCT03220737|463471993|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
128776766|NCT03220737|463471994|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
128776767|NCT03220737|463471995|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
128776768|NCT03220737|463471996|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
128776769|NCT00594932|463471999|FG000|First 3 Months|Withdrawal by Subject|1|||
128776770|NCT00594932|463472000|FG001|First 3 Months|Withdrawal by Subject|3|||
128776771|NCT00594932|463471999|FG000|Final 3 Months|Withdrawal by Subject|4|||
128776772|NCT00594932|463472000|FG001|Final 3 Months|Withdrawal by Subject|3|||
128776773|NCT04496167|463472001|FG000|Overall Study|Adverse Event|6|||
128776774|NCT04496167|463472002|FG001|Overall Study|Adverse Event|2|||
128776775|NCT04496167|463472001|FG000|Overall Study|Withdrawal by Subject|7|||
128776776|NCT04496167|463472002|FG001|Overall Study|Withdrawal by Subject|6|||
128776777|NCT04496167|463472001|FG000|Overall Study|Lost to Follow-up|3|||
128776778|NCT04496167|463472002|FG001|Overall Study|Lost to Follow-up|5|||
128776779|NCT04496167|463472001|FG000|Overall Study|Not Treated|1|||
128776780|NCT04496167|463472002|FG001|Overall Study|Not Treated|2|||
128776781|NCT04496167|463472001|FG000|Overall Study|Other Than Specified|1|||
128776782|NCT04496167|463472002|FG001|Overall Study|Other Than Specified|1|||
128776783|NCT03018106|463472003|FG000|Overall Study|Lost to Follow-up|0|||
128776784|NCT03018106|463472004|FG001|Overall Study|Lost to Follow-up|1|||
128776785|NCT03619174|463472005|FG000|Overall Study|Lost to Follow-up|3|||
128776786|NCT03619174|463472006|FG001|Overall Study|Lost to Follow-up|0|||
128776787|NCT03619174|463472005|FG000|Overall Study|Withdrawal by Subject|4|||
128776788|NCT03619174|463472006|FG001|Overall Study|Withdrawal by Subject|3|||
128776789|NCT03619174|463472005|FG000|Overall Study|Pregnancy|1|||
128776790|NCT03619174|463472006|FG001|Overall Study|Pregnancy|1|||
128776791|NCT03619174|463472005|FG000|Overall Study|Discomfort during treatment|1|||
128776792|NCT03619174|463472006|FG001|Overall Study|Discomfort during treatment|0|||
128776793|NCT03486899|463472007|FG000|Overall Study|Lost to Follow-up|4|||
128776794|NCT03486899|463472008|FG001|Overall Study|Lost to Follow-up|1|||
128776795|NCT03486899|463472009|FG002|Overall Study|Lost to Follow-up|4|||
128776796|NCT03486899|463472010|FG003|Overall Study|Lost to Follow-up|3|||
128776797|NCT03486899|463472007|FG000|Overall Study|Death|1|||
128776798|NCT03486899|463472008|FG001|Overall Study|Death|0|||
128776799|NCT03486899|463472009|FG002|Overall Study|Death|0|||
128776800|NCT03486899|463472010|FG003|Overall Study|Death|1|||
128776801|NCT03486899|463472007|FG000|Overall Study|Adverse Event|0|||
129204790|NCT02421172|465046942|FG001|Period 1|Patient/guardian decision|1|||
128776802|NCT03486899|463472008|FG001|Overall Study|Adverse Event|2|||
128776803|NCT03486899|463472009|FG002|Overall Study|Adverse Event|0|||
128776804|NCT03486899|463472010|FG003|Overall Study|Adverse Event|2|||
128776805|NCT03486899|463472007|FG000|Overall Study|Withdrawal by Subject|3|||
129151973|NCT03289143|464854756|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
129151974|NCT03289143|464854757|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
129151975|NCT03289143|464854754|FG000|Overall Study|Caregiver Passed Away|1|||
129151976|NCT03289143|464854755|FG001|Overall Study|Caregiver Passed Away|0|||
129151977|NCT03289143|464854756|FG002|Overall Study|Caregiver Passed Away|0|||
129151978|NCT03289143|464854757|FG003|Overall Study|Caregiver Passed Away|0|||
129151979|NCT03289143|464854754|FG000|Overall Study|Physician Decision|0|||
129151980|NCT03289143|464854755|FG001|Overall Study|Physician Decision|2|||
129151981|NCT03289143|464854756|FG002|Overall Study|Physician Decision|2|||
129151982|NCT03289143|464854757|FG003|Overall Study|Physician Decision|2|||
129151983|NCT03289143|464854754|FG000|Overall Study|Protocol Deviation|2|||
129151984|NCT03289143|464854755|FG001|Overall Study|Protocol Deviation|1|||
129151985|NCT03289143|464854756|FG002|Overall Study|Protocol Deviation|3|||
129151986|NCT03289143|464854757|FG003|Overall Study|Protocol Deviation|1|||
129151987|NCT03289143|464854754|FG000|Overall Study|Study Terminated By Sponsor|101|||
129151988|NCT03289143|464854755|FG001|Overall Study|Study Terminated By Sponsor|75|||
129151989|NCT03289143|464854756|FG002|Overall Study|Study Terminated By Sponsor|100|||
129151990|NCT03289143|464854757|FG003|Overall Study|Study Terminated By Sponsor|69|||
129151991|NCT03289143|464854754|FG000|Overall Study|Withdrawal by Subject|14|||
129151992|NCT03289143|464854755|FG001|Overall Study|Withdrawal by Subject|6|||
129151993|NCT03289143|464854756|FG002|Overall Study|Withdrawal by Subject|14|||
129151994|NCT03289143|464854757|FG003|Overall Study|Withdrawal by Subject|12|||
129151995|NCT03289143|464854754|FG000|Overall Study|Adverse Event|10|||
129151996|NCT03289143|464854755|FG001|Overall Study|Adverse Event|7|||
129151997|NCT03289143|464854756|FG002|Overall Study|Adverse Event|6|||
129151998|NCT03289143|464854757|FG003|Overall Study|Adverse Event|5|||
129151999|NCT03289143|464854754|FG000|Overall Study|Death|2|||
129152000|NCT03289143|464854755|FG001|Overall Study|Death|0|||
129152001|NCT03289143|464854756|FG002|Overall Study|Death|2|||
129152002|NCT03289143|464854757|FG003|Overall Study|Death|1|||
129152003|NCT03289143|464854754|FG000|Overall Study|Lost to Follow-up|2|||
129152004|NCT03289143|464854755|FG001|Overall Study|Lost to Follow-up|1|||
129152005|NCT03289143|464854756|FG002|Overall Study|Lost to Follow-up|1|||
129152006|NCT03289143|464854757|FG003|Overall Study|Lost to Follow-up|0|||
129152007|NCT03289143|464854754|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
129152008|NCT03289143|464854755|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
129152009|NCT03289143|464854756|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
129152010|NCT03289143|464854757|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
129152011|NCT03289143|464854754|FG000|Overall Study|Withdrawal by Caregiver|0|||
129152012|NCT03289143|464854755|FG001|Overall Study|Withdrawal by Caregiver|1|||
129152013|NCT03289143|464854756|FG002|Overall Study|Withdrawal by Caregiver|0|||
129152014|NCT03289143|464854757|FG003|Overall Study|Withdrawal by Caregiver|0|||
129152015|NCT03289143|464854754|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
129152016|NCT03289143|464854755|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
129152017|NCT03289143|464854756|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
129152018|NCT03289143|464854757|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
129152019|NCT03289143|464854754|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
129152020|NCT03289143|464854755|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
129152021|NCT03289143|464854756|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
129152022|NCT03289143|464854757|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
129152023|NCT00730756|464854758|FG000|Overall Study|Adverse Event|2|||
129152024|NCT00730756|464854759|FG001|Overall Study|Adverse Event|0|||
129152025|NCT00730756|464854758|FG000|Overall Study|Lack of Efficacy|1|||
129152026|NCT00730756|464854759|FG001|Overall Study|Lack of Efficacy|1|||
129152027|NCT00730756|464854758|FG000|Overall Study|Protocol Deviation|1|||
129152028|NCT00730756|464854759|FG001|Overall Study|Protocol Deviation|2|||
129152029|NCT00730756|464854758|FG000|Overall Study|Lost to Follow-up|0|||
129152030|NCT00730756|464854759|FG001|Overall Study|Lost to Follow-up|1|||
129152031|NCT00730756|464854758|FG000|Overall Study|Withdrew Consent|0|||
129152032|NCT00730756|464854759|FG001|Overall Study|Withdrew Consent|1|||
129152033|NCT00305877|464854760|FG000|Overall Study|Lack of Efficacy|6|||
129152034|NCT00305877|464854761|FG001|Overall Study|Lack of Efficacy|9|||
129152035|NCT00305877|464854760|FG000|Overall Study|Adverse Event|9|||
129152036|NCT00305877|464854761|FG001|Overall Study|Adverse Event|14|||
129152037|NCT00305877|464854760|FG000|Overall Study|Death|0|||
129152038|NCT00305877|464854761|FG001|Overall Study|Death|1|||
129152039|NCT00305877|464854760|FG000|Overall Study|Withdrawal by Subject|4|||
129152040|NCT00305877|464854761|FG001|Overall Study|Withdrawal by Subject|2|||
129152041|NCT00305877|464854760|FG000|Overall Study|Physician Decision|1|||
129152042|NCT00305877|464854761|FG001|Overall Study|Physician Decision|1|||
129152043|NCT00305877|464854760|FG000|Overall Study|Never start treatment|2|||
129152044|NCT00305877|464854761|FG001|Overall Study|Never start treatment|5|||
129152045|NCT00305877|464854760|FG000|Overall Study|Ineligible|2|||
129152046|NCT00305877|464854761|FG001|Overall Study|Ineligible|1|||
129152047|NCT00305877|464854760|FG000|Overall Study|Transportation issue with daily RT|0|||
129152048|NCT00305877|464854761|FG001|Overall Study|Transportation issue with daily RT|1|||
129152049|NCT01126190|464854762|FG000|Double-Blind Phase|Death|0|||
129152050|NCT01126190|464854763|FG001|Double-Blind Phase|Death|1|||
129152051|NCT01126190|464854764|FG002|Double-Blind Phase|Death|0|||
129152052|NCT01126190|464854762|FG000|Double-Blind Phase|Adverse Event|1|||
129152053|NCT01126190|464854763|FG001|Double-Blind Phase|Adverse Event|2|||
129152054|NCT01126190|464854764|FG002|Double-Blind Phase|Adverse Event|0|||
129152055|NCT01126190|464854762|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129152056|NCT01126190|464854763|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
129152057|NCT01126190|464854764|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129152058|NCT01126190|464854762|FG000|Double-Blind Phase|Request of Investigator|1|||
129152059|NCT01126190|464854763|FG001|Double-Blind Phase|Request of Investigator|0|||
129152060|NCT01126190|464854764|FG002|Double-Blind Phase|Request of Investigator|0|||
129152061|NCT01126190|464854762|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
129152062|NCT01126190|464854763|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
129152063|NCT01126190|464854764|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
129152064|NCT01126190|464854762|FG000|Double-Blind Phase|Non-compliance|1|||
129152065|NCT01126190|464854763|FG001|Double-Blind Phase|Non-compliance|0|||
129152066|NCT01126190|464854764|FG002|Double-Blind Phase|Non-compliance|0|||
129152067|NCT01126190|464854762|FG000|Double-Blind Phase|Lost to Follow-up|1|||
129152068|NCT01126190|464854763|FG001|Double-Blind Phase|Lost to Follow-up|3|||
129152069|NCT01126190|464854764|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129152070|NCT01126190|464854762|FG000|Open-Label Phase|Death|0|||
129152071|NCT01126190|464854763|FG001|Open-Label Phase|Death|0|||
129152072|NCT01126190|464854764|FG002|Open-Label Phase|Death|1|||
129152073|NCT01126190|464854762|FG000|Open-Label Phase|Adverse Event|0|||
129152074|NCT01126190|464854763|FG001|Open-Label Phase|Adverse Event|0|||
129152075|NCT01126190|464854764|FG002|Open-Label Phase|Adverse Event|4|||
129152076|NCT01126190|464854762|FG000|Open-Label Phase|Withdrawal by Subject|0|||
129152077|NCT01126190|464854763|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129152078|NCT01126190|464854764|FG002|Open-Label Phase|Withdrawal by Subject|6|||
129152079|NCT00524121|464854767|FG000|Overall Study|Disease progression|6|||
129152080|NCT00524121|464854767|FG000|Overall Study|Adverse Event|4|||
129152081|NCT00524121|464854767|FG000|Overall Study|Patient refused|2|||
129152082|NCT00524121|464854767|FG000|Overall Study|Other|1|||
129152083|NCT00524121|464854767|FG000|Overall Study|Death|1|||
129152084|NCT00524121|464854767|FG000|Overall Study|Not treated (became ineligible)|4|||
129152085|NCT00524121|464854767|FG000|Overall Study|Not treated (changed mind)|1|||
129152086|NCT01114737|464854768|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
129152087|NCT01114737|464854769|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
129152088|NCT01114737|464854768|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
129152089|NCT01114737|464854769|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
129152090|NCT01114737|464854768|FG000|Randomized Treatment Period|Pregnancy|1|||
129152091|NCT01114737|464854769|FG001|Randomized Treatment Period|Pregnancy|0|||
129152092|NCT01114737|464854768|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
129152093|NCT01114737|464854769|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
129152094|NCT01114737|464854768|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
129152095|NCT01114737|464854769|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
129152096|NCT01114737|464854768|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
129152097|NCT01114737|464854769|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
129152098|NCT01446874|464854770|FG000|Overall Study|Not eligible|1|||
129152099|NCT01446874|464854771|FG001|Overall Study|Not eligible|0|||
129152100|NCT01446874|464854772|FG002|Overall Study|Not eligible|0|||
128725361|NCT01644175|463290969|FG001|Overall Study|Poor compliance to protocol|10|||
128725362|NCT01644175|463290968|FG000|Overall Study|Physician Decision|1|||
128725363|NCT01644175|463290969|FG001|Overall Study|Physician Decision|2|||
128725364|NCT01644175|463290968|FG000|Overall Study|Participant Moved|1|||
128725365|NCT01644175|463290969|FG001|Overall Study|Participant Moved|2|||
129152101|NCT01446874|464854770|FG000|Overall Study|No surgery/No qualifying surgery|1|||
129152102|NCT01446874|464854771|FG001|Overall Study|No surgery/No qualifying surgery|0|||
129152103|NCT01446874|464854772|FG002|Overall Study|No surgery/No qualifying surgery|12|||
129152104|NCT01446874|464854770|FG000|Overall Study|Non-compliance|0|||
129152105|NCT01446874|464854771|FG001|Overall Study|Non-compliance|4|||
129152106|NCT01446874|464854772|FG002|Overall Study|Non-compliance|0|||
129152107|NCT01446874|464854770|FG000|Overall Study|Antibiotics for pre-op infection|0|||
129152108|NCT01446874|464854771|FG001|Overall Study|Antibiotics for pre-op infection|0|||
129152109|NCT01446874|464854772|FG002|Overall Study|Antibiotics for pre-op infection|2|||
129152110|NCT01446874|464854770|FG000|Overall Study|Withdrawal by Subject|0|||
129152111|NCT01446874|464854771|FG001|Overall Study|Withdrawal by Subject|0|||
129152112|NCT01446874|464854772|FG002|Overall Study|Withdrawal by Subject|4|||
129152113|NCT00457392|464854773|FG000|Overall Study|Objective Progression or Relapse|229|||
129152114|NCT00457392|464854774|FG001|Overall Study|Objective Progression or Relapse|296|||
129152115|NCT00457392|464854773|FG000|Overall Study|Death|106|||
129152116|NCT00457392|464854774|FG001|Overall Study|Death|106|||
129152117|NCT00457392|464854773|FG000|Overall Study|Adverse Event|84|||
129152118|NCT00457392|464854774|FG001|Overall Study|Adverse Event|41|||
129152119|NCT00457392|464854773|FG000|Overall Study|Global Deterioration of Health Status|22|||
129152120|NCT00457392|464854774|FG001|Overall Study|Global Deterioration of Health Status|8|||
129152121|NCT00457392|464854773|FG000|Overall Study|Withdrawal by Subject|14|||
129152122|NCT00457392|464854774|FG001|Overall Study|Withdrawal by Subject|8|||
129152123|NCT00457392|464854773|FG000|Overall Study|Lost to Follow-up|6|||
129152124|NCT00457392|464854774|FG001|Overall Study|Lost to Follow-up|7|||
129152125|NCT00457392|464854773|FG000|Overall Study|Protocol Violation|4|||
129152126|NCT00457392|464854774|FG001|Overall Study|Protocol Violation|3|||
129152127|NCT00457392|464854773|FG000|Overall Study|Other|7|||
129152128|NCT00457392|464854774|FG001|Overall Study|Other|4|||
129152129|NCT00457392|464854773|FG000|Overall Study|Study Terminated by Sponsor|1|||
129152130|NCT00457392|464854774|FG001|Overall Study|Study Terminated by Sponsor|4|||
129152131|NCT00457392|464854773|FG000|Overall Study|Randomized, Not Treated|7|||
129152132|NCT00457392|464854774|FG001|Overall Study|Randomized, Not Treated|3|||
129152133|NCT01135992|464854775|FG000|Overall Study|Adverse Event|1|||
129152134|NCT01135992|464854775|FG000|Overall Study|Lack of Efficacy|1|||
129152135|NCT01135992|464854775|FG000|Overall Study|Protocol Violation|2|||
129152136|NCT01135992|464854775|FG000|Overall Study|Withdrawal criteria|10|||
129152137|NCT01135992|464854775|FG000|Overall Study|Unclassified|7|||
129152138|NCT01466491|464854777|FG000|Overall Study|Protocol Violation|0|||
129152139|NCT01466491|464854778|FG001|Overall Study|Protocol Violation|3|||
129152140|NCT01466491|464854779|FG002|Overall Study|Protocol Violation|2|||
129152141|NCT01466491|464854780|FG003|Overall Study|Protocol Violation|0|||
129152142|NCT01466491|464854777|FG000|Overall Study|Missing Data|0|||
129152143|NCT01466491|464854778|FG001|Overall Study|Missing Data|0|||
129152144|NCT01466491|464854779|FG002|Overall Study|Missing Data|1|||
129152145|NCT01466491|464854780|FG003|Overall Study|Missing Data|0|||
129152146|NCT02727322|464854781|FG000|Overall Study|Withdrawal by Subject|1|||
129152147|NCT02727322|464854782|FG001|Overall Study|Withdrawal by Subject|1|||
129152148|NCT02727322|464854781|FG000|Overall Study|Protocol Violation|1|||
129152149|NCT02727322|464854782|FG001|Overall Study|Protocol Violation|0|||
129152150|NCT00339040|464854783|FG000|Stage I|Not able to attend clinic|1|||
129152151|NCT00339040|464854784|FG001|Stage I|Not able to attend clinic|0|||
129152152|NCT00339040|464854783|FG000|Stage I|Protocol Violation|1|||
129152153|NCT00339040|464854784|FG001|Stage I|Protocol Violation|1|||
129152154|NCT00339040|464854783|FG000|Stage II|Lost to Follow-up|3|||
129152155|NCT00339040|464854784|FG001|Stage II|Lost to Follow-up|0|||
129152156|NCT00339040|464854783|FG000|Stage II|Withdrawal by Subject|1|||
129152157|NCT00339040|464854784|FG001|Stage II|Withdrawal by Subject|2|||
129152158|NCT00339040|464854783|FG000|Stage II|Protocol Violation|3|||
129152159|NCT00339040|464854784|FG001|Stage II|Protocol Violation|0|||
129152160|NCT00339040|464854783|FG000|Stage II|Not able to attend clinic|1|||
129152161|NCT00339040|464854784|FG001|Stage II|Not able to attend clinic|0|||
129152162|NCT00339040|464854783|FG000|Stage II|Site closing|2|||
129152163|NCT00339040|464854784|FG001|Stage II|Site closing|0|||
129152164|NCT01870869|464854785|FG000|Overall Study|Implanted with nonstudy device|1|||
129152165|NCT01870869|464854786|FG001|Overall Study|Implanted with nonstudy device|3|||
129152166|NCT01870869|464854787|FG002|Overall Study|Implanted with nonstudy device|14|||
129152167|NCT01870869|464854788|FG003|Overall Study|Implanted with nonstudy device|4|||
129152168|NCT01870869|464854785|FG000|Overall Study|Death|0|||
129152169|NCT01870869|464854786|FG001|Overall Study|Death|0|||
129152170|NCT01870869|464854787|FG002|Overall Study|Death|7|||
129152171|NCT01870869|464854788|FG003|Overall Study|Death|1|||
129152172|NCT01870869|464854785|FG000|Overall Study|Subject choice|6|||
129152173|NCT01870869|464854786|FG001|Overall Study|Subject choice|2|||
129152174|NCT01870869|464854787|FG002|Overall Study|Subject choice|22|||
129152175|NCT01870869|464854788|FG003|Overall Study|Subject choice|8|||
129152176|NCT01870869|464854785|FG000|Overall Study|Lost to Follow-up|10|||
129152177|NCT01870869|464854786|FG001|Overall Study|Lost to Follow-up|2|||
129152178|NCT01870869|464854787|FG002|Overall Study|Lost to Follow-up|25|||
129152179|NCT01870869|464854788|FG003|Overall Study|Lost to Follow-up|3|||
129152180|NCT01870869|464854785|FG000|Overall Study|Reason not Specified|1|||
129152181|NCT01870869|464854786|FG001|Overall Study|Reason not Specified|2|||
129152182|NCT01870869|464854787|FG002|Overall Study|Reason not Specified|20|||
129152183|NCT01870869|464854788|FG003|Overall Study|Reason not Specified|4|||
129152184|NCT01870869|464854785|FG000|Overall Study|Not evaluable|10|||
129152185|NCT01870869|464854786|FG001|Overall Study|Not evaluable|5|||
129152186|NCT01870869|464854787|FG002|Overall Study|Not evaluable|42|||
129152187|NCT01870869|464854788|FG003|Overall Study|Not evaluable|10|||
129152188|NCT03036852|464854789|FG000|Overall Study|Death|2|||
129152189|NCT03036852|464854789|FG000|Overall Study|Lack of Efficacy|2|||
129152190|NCT03036852|464854789|FG000|Overall Study|Adverse Event|1|||
129152191|NCT03036852|464854789|FG000|Overall Study|Lost to Follow-up|1|||
129152192|NCT00002766|464854792|FG000|Overall Study|Withdrawal by Subject|0|||
129152193|NCT00002766|464854793|FG001|Overall Study|Withdrawal by Subject|1|||
129152194|NCT00002766|464854792|FG000|Overall Study|Patient Not Treated|1|||
128776806|NCT03486899|463472008|FG001|Overall Study|Withdrawal by Subject|7|||
128776807|NCT03486899|463472009|FG002|Overall Study|Withdrawal by Subject|4|||
129152195|NCT00002766|464854793|FG001|Overall Study|Patient Not Treated|2|||
129152196|NCT00002766|464854792|FG000|Overall Study|Adverse Event|1|||
129152197|NCT00002766|464854793|FG001|Overall Study|Adverse Event|1|||
129152198|NCT00002766|464854792|FG000|Overall Study|Protocol Violation|1|||
129152199|NCT00002766|464854793|FG001|Overall Study|Protocol Violation|0|||
129152200|NCT00077974|464854796|FG000|Overall Study|Adverse Event|22|||
129152201|NCT00077974|464854796|FG000|Overall Study|Protocol Violation|1|||
129152202|NCT00077974|464854796|FG000|Overall Study|Withdrawal by Subject|3|||
129152203|NCT00077974|464854796|FG000|Overall Study|Lack of Efficacy|76|||
129152204|NCT00077974|464854796|FG000|Overall Study|Decision of Sponsor|2|||
129152205|NCT00698828|464854803|FG000|Overall Study|Adverse Event|3|||
129152206|NCT00698828|464854804|FG001|Overall Study|Adverse Event|4|||
129152207|NCT00698828|464854805|FG002|Overall Study|Adverse Event|4|||
129152208|NCT00698828|464854803|FG000|Overall Study|Death|0|||
129152209|NCT00698828|464854804|FG001|Overall Study|Death|0|||
129152210|NCT00698828|464854805|FG002|Overall Study|Death|1|||
129152211|NCT00698828|464854803|FG000|Overall Study|Exacerbation of COPD|1|||
129152212|NCT00698828|464854804|FG001|Overall Study|Exacerbation of COPD|3|||
129152213|NCT00698828|464854805|FG002|Overall Study|Exacerbation of COPD|0|||
129152214|NCT00698828|464854803|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
129152215|NCT00698828|464854804|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
129152216|NCT00698828|464854805|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
129152217|NCT00698828|464854803|FG000|Overall Study|Investigator/Sponsor decision|1|||
129152218|NCT00698828|464854804|FG001|Overall Study|Investigator/Sponsor decision|0|||
129152219|NCT00698828|464854805|FG002|Overall Study|Investigator/Sponsor decision|2|||
128776808|NCT03486899|463472010|FG003|Overall Study|Withdrawal by Subject|3|||
128776809|NCT03486899|463472007|FG000|Overall Study|Other Reasons|0|||
128776810|NCT03486899|463472008|FG001|Overall Study|Other Reasons|1|||
128776811|NCT03486899|463472009|FG002|Overall Study|Other Reasons|0|||
128776812|NCT03486899|463472010|FG003|Overall Study|Other Reasons|1|||
128776813|NCT01010217|463472013|FG000|Overall Study|Lost to Follow-up|4|||
128776814|NCT01010217|463472014|FG001|Overall Study|Lost to Follow-up|5|||
128776815|NCT01010217|463472015|FG002|Overall Study|Lost to Follow-up|1|||
128776816|NCT01010217|463472016|FG003|Overall Study|Lost to Follow-up|0|||
128776817|NCT01010217|463472017|FG004|Overall Study|Lost to Follow-up|0|||
128776818|NCT01010217|463472013|FG000|Overall Study|Withdrawal by Subject|1|||
128776819|NCT01010217|463472014|FG001|Overall Study|Withdrawal by Subject|0|||
128776820|NCT01010217|463472015|FG002|Overall Study|Withdrawal by Subject|0|||
128776821|NCT01010217|463472016|FG003|Overall Study|Withdrawal by Subject|0|||
128776822|NCT01010217|463472017|FG004|Overall Study|Withdrawal by Subject|0|||
128776823|NCT01010217|463472013|FG000|Overall Study|Physician Decision|0|||
128776824|NCT01010217|463472014|FG001|Overall Study|Physician Decision|0|||
128776825|NCT01010217|463472015|FG002|Overall Study|Physician Decision|0|||
128776826|NCT01010217|463472016|FG003|Overall Study|Physician Decision|6|||
128776827|NCT01010217|463472017|FG004|Overall Study|Physician Decision|3|||
128776828|NCT01439711|463472018|FG000|Overall Study|Ineligible|13|||
128776829|NCT01439711|463472018|FG000|Overall Study|Cancel|3|||
128776830|NCT01439711|463472018|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
128776831|NCT01439711|463472018|FG000|Overall Study|Adverse Event|5|||
128776832|NCT01439711|463472018|FG000|Overall Study|Withdrawal by Subject|3|||
128776833|NCT01439711|463472018|FG000|Overall Study|Progression During Active Tx|3|||
128776834|NCT01439711|463472018|FG000|Overall Study|Noncompliance|3|||
128776835|NCT01439711|463472018|FG000|Overall Study|No MRI|9|||
128776836|NCT04242875|463472019|FG000|Overall Study|Adverse Event|2|||
128776837|NCT01012973|463472020|FG000|Overall Study|Adverse Event|5|||
128776838|NCT01012973|463472021|FG001|Overall Study|Adverse Event|5|||
128776839|NCT01012973|463472020|FG000|Overall Study|Lack of Efficacy|0|||
128776840|NCT01012973|463472021|FG001|Overall Study|Lack of Efficacy|5|||
128776841|NCT01012973|463472020|FG000|Overall Study|Lost to Follow-up|1|||
128776842|NCT01012973|463472021|FG001|Overall Study|Lost to Follow-up|0|||
128776843|NCT01012973|463472020|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
128776844|NCT01012973|463472021|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
128776845|NCT01012973|463472020|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
128776846|NCT01012973|463472021|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
128776847|NCT01012973|463472020|FG000|Overall Study|Protocol Violation|5|||
128776848|NCT01012973|463472021|FG001|Overall Study|Protocol Violation|2|||
128776849|NCT01012973|463472020|FG000|Overall Study|Withdrawal by Subject|4|||
129152220|NCT00698828|464854803|FG000|Overall Study|Lost to Follow-up|1|||
129152221|NCT00698828|464854804|FG001|Overall Study|Lost to Follow-up|1|||
129152222|NCT00698828|464854805|FG002|Overall Study|Lost to Follow-up|0|||
129152223|NCT00698828|464854803|FG000|Overall Study|Withdrew consent|0|||
129152224|NCT00698828|464854804|FG001|Overall Study|Withdrew consent|7|||
129152225|NCT00698828|464854805|FG002|Overall Study|Withdrew consent|4|||
129152226|NCT00698828|464854803|FG000|Overall Study|Withdrew consent (not treated)|2|||
128776850|NCT01012973|463472021|FG001|Overall Study|Withdrawal by Subject|6|||
128776851|NCT01782326|463472024|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
129152227|NCT00698828|464854804|FG001|Overall Study|Withdrew consent (not treated)|0|||
129152228|NCT00698828|464854805|FG002|Overall Study|Withdrew consent (not treated)|0|||
129152229|NCT00856609|464854806|FG000|Overall Study|Adverse Event|1|||
129152230|NCT00856609|464854807|FG001|Overall Study|Adverse Event|0|||
129152231|NCT00110214|464854808|FG000|Overall Study|Never started treatment|21|||
129152232|NCT00110214|464854809|FG001|Overall Study|Never started treatment|20|||
129152233|NCT00110214|464854808|FG000|Overall Study|Disease progression or death|260|||
129152234|NCT00110214|464854809|FG001|Overall Study|Disease progression or death|151|||
129152235|NCT00110214|464854808|FG000|Overall Study|Adverse Event|115|||
129152236|NCT00110214|464854809|FG001|Overall Study|Adverse Event|192|||
129152237|NCT00110214|464854808|FG000|Overall Study|Refused further treatment|52|||
129152238|NCT00110214|464854809|FG001|Overall Study|Refused further treatment|65|||
129152239|NCT00110214|464854808|FG000|Overall Study|Other (not specified)|61|||
129152240|NCT00110214|464854809|FG001|Overall Study|Other (not specified)|75|||
129152241|NCT01088503|464854810|FG000|Overall Study|Withdrawal by Subject|118|||
129152242|NCT01088503|464854811|FG001|Overall Study|Withdrawal by Subject|327|||
129152243|NCT01088503|464854812|FG002|Overall Study|Withdrawal by Subject|10|||
129152244|NCT01088503|464854810|FG000|Overall Study|Death|64|||
129152245|NCT01088503|464854811|FG001|Overall Study|Death|358|||
129152246|NCT01088503|464854812|FG002|Overall Study|Death|7|||
129152247|NCT01016067|464854813|FG000|Overall Study|Lost to Follow-up|1|||
129152248|NCT01016067|464854814|FG001|Overall Study|Lost to Follow-up|2|||
129152249|NCT01016067|464854813|FG000|Overall Study|Physician Decision|1|||
129152250|NCT01016067|464854814|FG001|Overall Study|Physician Decision|1|||
129152251|NCT01016067|464854813|FG000|Overall Study|Withdrew due to Relocation|0|||
129152252|NCT01016067|464854814|FG001|Overall Study|Withdrew due to Relocation|1|||
129152253|NCT01534481|464854821|FG000|Overall Study|Lost to Follow-up|29|||
129152254|NCT01534481|464854822|FG001|Overall Study|Lost to Follow-up|24|||
129152255|NCT01534481|464854821|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
129152256|NCT01534481|464854822|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
129152257|NCT01130337|464854823|FG000|Overall Study|Withdrawal by Subject|3|||
129152258|NCT01130337|464854823|FG000|Overall Study|Principal investigator decision|1|||
129152259|NCT01130337|464854823|FG000|Overall Study|Death|1|||
129152260|NCT01130337|464854823|FG000|Overall Study|Disease progression|1|||
129152261|NCT01130337|464854823|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
129152262|NCT01130337|464854823|FG000|Overall Study|Surgical resection (R2)|1|||
129152263|NCT05525910|464854824|FG000|Period 4|Per sponsor due to study timelines|0|||
129152264|NCT05525910|464854825|FG001|Period 4|Per sponsor due to study timelines|0|||
129152265|NCT05525910|464854826|FG002|Period 4|Per sponsor due to study timelines|1|||
129152266|NCT05525910|464854827|FG003|Period 4|Per sponsor due to study timelines|1|||
129152267|NCT05525910|464854828|FG004|Period 4|Per sponsor due to study timelines|1|||
129152268|NCT03886493|464854829|FG000|Overall Study|Adverse Event|1|||
129152269|NCT03179761|464854831|FG000|Overall Study|Death|2|||
129152270|NCT03179761|464854832|FG001|Overall Study|Death|5|||
129152271|NCT03179761|464854831|FG000|Overall Study|Lost to Follow-up|2|||
129152272|NCT03179761|464854832|FG001|Overall Study|Lost to Follow-up|2|||
129152273|NCT03179761|464854831|FG000|Overall Study|Protocol Violation|1|||
129152274|NCT03179761|464854832|FG001|Overall Study|Protocol Violation|0|||
129152275|NCT03179761|464854831|FG000|Overall Study|Withdrawal by Subject|1|||
129152276|NCT03179761|464854832|FG001|Overall Study|Withdrawal by Subject|4|||
129152277|NCT03179761|464854831|FG000|Overall Study|Investigator Request|0|||
129152278|NCT03179761|464854832|FG001|Overall Study|Investigator Request|2|||
129152279|NCT00448448|464854833|FG000|Overall Study|Withdrawal by Subject|13|||
129152280|NCT00448448|464854834|FG001|Overall Study|Withdrawal by Subject|2|||
129152281|NCT00448448|464854833|FG000|Overall Study|On protocol when study ended|83|||
129152282|NCT00448448|464854834|FG001|Overall Study|On protocol when study ended|36|||
129152283|NCT00448448|464854833|FG000|Overall Study|Lost to Follow-up|2|||
129152284|NCT00448448|464854834|FG001|Overall Study|Lost to Follow-up|1|||
129152285|NCT00448448|464854833|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
129152286|NCT00448448|464854834|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
129152287|NCT00448448|464854833|FG000|Overall Study|Signed consent lost|0|||
129152288|NCT00448448|464854834|FG001|Overall Study|Signed consent lost|1|||
129152289|NCT02284191|464854835|FG000|Overall Study|Withdrawal by Subject|1|||
129152290|NCT02284191|464854836|FG001|Overall Study|Withdrawal by Subject|3|||
129152291|NCT02284191|464854835|FG000|Overall Study|Lost to Follow-up|1|||
129152292|NCT02284191|464854836|FG001|Overall Study|Lost to Follow-up|0|||
129152293|NCT01188967|464854837|FG000|Overall Study|Withdrawal by Subject|1|||
129152294|NCT01188967|464854838|FG001|Overall Study|Withdrawal by Subject|1|||
129152295|NCT01188967|464854837|FG000|Overall Study|Physician Decision|1|||
129152296|NCT01188967|464854838|FG001|Overall Study|Physician Decision|1|||
129152297|NCT01188967|464854837|FG000|Overall Study|Lost to Follow-up|3|||
129152298|NCT01188967|464854838|FG001|Overall Study|Lost to Follow-up|2|||
129152299|NCT01832727|464854841|FG000|Overall Study|Adverse Event|4|||
129152300|NCT01832727|464854842|FG001|Overall Study|Adverse Event|6|||
129152301|NCT01832727|464854843|FG002|Overall Study|Adverse Event|1|||
129152302|NCT01832727|464854844|FG003|Overall Study|Adverse Event|0|||
129152303|NCT01832727|464854845|FG004|Overall Study|Adverse Event|1|||
129152304|NCT01832727|464854846|FG005|Overall Study|Adverse Event|1|||
129152305|NCT01832727|464854847|FG006|Overall Study|Adverse Event|2|||
129152306|NCT01832727|464854848|FG007|Overall Study|Adverse Event|1|||
129152307|NCT01832727|464854849|FG008|Overall Study|Adverse Event|9|||
129152308|NCT01832727|464854841|FG000|Overall Study|Disease progression|3|||
129152309|NCT01832727|464854842|FG001|Overall Study|Disease progression|0|||
129152310|NCT01832727|464854843|FG002|Overall Study|Disease progression|2|||
129152311|NCT01832727|464854844|FG003|Overall Study|Disease progression|1|||
129152312|NCT01832727|464854845|FG004|Overall Study|Disease progression|3|||
129152313|NCT01832727|464854846|FG005|Overall Study|Disease progression|3|||
129152314|NCT01832727|464854847|FG006|Overall Study|Disease progression|6|||
129152315|NCT01832727|464854848|FG007|Overall Study|Disease progression|2|||
129152316|NCT01832727|464854849|FG008|Overall Study|Disease progression|7|||
129152317|NCT01832727|464854841|FG000|Overall Study|Lost to Follow-up|0|||
129152318|NCT01832727|464854842|FG001|Overall Study|Lost to Follow-up|0|||
129152319|NCT01832727|464854843|FG002|Overall Study|Lost to Follow-up|0|||
129152320|NCT01832727|464854844|FG003|Overall Study|Lost to Follow-up|1|||
129152321|NCT01832727|464854845|FG004|Overall Study|Lost to Follow-up|0|||
129152322|NCT01832727|464854846|FG005|Overall Study|Lost to Follow-up|0|||
129152323|NCT01832727|464854847|FG006|Overall Study|Lost to Follow-up|0|||
129152324|NCT01832727|464854848|FG007|Overall Study|Lost to Follow-up|0|||
129152325|NCT01832727|464854849|FG008|Overall Study|Lost to Follow-up|0|||
129152326|NCT01832727|464854841|FG000|Overall Study|Physician Decision|1|||
129152327|NCT01832727|464854842|FG001|Overall Study|Physician Decision|0|||
129152328|NCT01832727|464854843|FG002|Overall Study|Physician Decision|0|||
129152329|NCT01832727|464854844|FG003|Overall Study|Physician Decision|1|||
129152330|NCT01832727|464854845|FG004|Overall Study|Physician Decision|0|||
129152331|NCT01832727|464854846|FG005|Overall Study|Physician Decision|1|||
129152332|NCT01832727|464854847|FG006|Overall Study|Physician Decision|0|||
129152333|NCT01832727|464854848|FG007|Overall Study|Physician Decision|0|||
129152334|NCT01832727|464854849|FG008|Overall Study|Physician Decision|0|||
129152335|NCT01832727|464854841|FG000|Overall Study|Withdrawal by Subject|1|||
129152336|NCT01832727|464854842|FG001|Overall Study|Withdrawal by Subject|1|||
129152337|NCT01832727|464854843|FG002|Overall Study|Withdrawal by Subject|0|||
129152338|NCT01832727|464854844|FG003|Overall Study|Withdrawal by Subject|1|||
129152339|NCT01832727|464854845|FG004|Overall Study|Withdrawal by Subject|0|||
129152340|NCT01832727|464854846|FG005|Overall Study|Withdrawal by Subject|1|||
129152341|NCT01832727|464854847|FG006|Overall Study|Withdrawal by Subject|0|||
129152342|NCT01832727|464854848|FG007|Overall Study|Withdrawal by Subject|2|||
129152343|NCT01832727|464854849|FG008|Overall Study|Withdrawal by Subject|1|||
129152344|NCT01832727|464854841|FG000|Overall Study|Study terminated by sponsor|0|||
129152345|NCT01832727|464854842|FG001|Overall Study|Study terminated by sponsor|0|||
129152346|NCT01832727|464854843|FG002|Overall Study|Study terminated by sponsor|0|||
129152347|NCT01832727|464854844|FG003|Overall Study|Study terminated by sponsor|0|||
129152348|NCT01832727|464854845|FG004|Overall Study|Study terminated by sponsor|0|||
129152349|NCT01832727|464854846|FG005|Overall Study|Study terminated by sponsor|0|||
129152350|NCT01832727|464854847|FG006|Overall Study|Study terminated by sponsor|0|||
129152351|NCT01832727|464854848|FG007|Overall Study|Study terminated by sponsor|1|||
129152352|NCT01832727|464854849|FG008|Overall Study|Study terminated by sponsor|1|||
129152353|NCT02216526|464854850|FG000|Overall Study|Adverse Event|1|||
129152354|NCT02216526|464854851|FG001|Overall Study|Adverse Event|1|||
129152355|NCT02216526|464854852|FG002|Overall Study|Adverse Event|0|||
129152356|NCT02216526|464854850|FG000|Overall Study|Death|0|||
129152357|NCT02216526|464854851|FG001|Overall Study|Death|1|||
129152358|NCT02216526|464854852|FG002|Overall Study|Death|3|||
129152359|NCT02216526|464854850|FG000|Overall Study|Protocol Violation|2|||
129152360|NCT02216526|464854851|FG001|Overall Study|Protocol Violation|0|||
129152361|NCT02216526|464854852|FG002|Overall Study|Protocol Violation|2|||
129152362|NCT02216526|464854850|FG000|Overall Study|Hospitalization|2|||
129152363|NCT02216526|464854851|FG001|Overall Study|Hospitalization|1|||
129152364|NCT02216526|464854852|FG002|Overall Study|Hospitalization|3|||
129152365|NCT01133847|464854856|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
129152366|NCT01133847|464854857|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
129152367|NCT01133847|464854858|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
129152368|NCT01133847|464854856|FG000|Follow-Up Phase|Lost to Follow-up|1|||
129152369|NCT01133847|464854857|FG001|Follow-Up Phase|Lost to Follow-up|3|||
129152370|NCT01133847|464854858|FG002|Follow-Up Phase|Lost to Follow-up|7|||
129152371|NCT04436744|464854859|FG000|Overall Study|Adverse Event|1|||
129152372|NCT04436744|464854860|FG001|Overall Study|Adverse Event|1|||
129152373|NCT04436744|464854859|FG000|Overall Study|Death|1|||
129152374|NCT04436744|464854860|FG001|Overall Study|Death|0|||
129152375|NCT04436744|464854859|FG000|Overall Study|Lost to Follow-up|0|||
129152376|NCT04436744|464854860|FG001|Overall Study|Lost to Follow-up|2|||
129152377|NCT04436744|464854859|FG000|Overall Study|Physician Decision|0|||
129152378|NCT04436744|464854860|FG001|Overall Study|Physician Decision|1|||
129152379|NCT04436744|464854859|FG000|Overall Study|Progressive Disease|0|||
129152380|NCT04436744|464854860|FG001|Overall Study|Progressive Disease|4|||
129152381|NCT04436744|464854859|FG000|Overall Study|Protocol Deviation|1|||
129152382|NCT04436744|464854860|FG001|Overall Study|Protocol Deviation|1|||
129152383|NCT04436744|464854859|FG000|Overall Study|Withdrawal by Subject|1|||
129152384|NCT04436744|464854860|FG001|Overall Study|Withdrawal by Subject|2|||
129152385|NCT01463033|464854864|FG000|Overall Study|Lost to Follow-up|4|||
129152386|NCT01463033|464854865|FG001|Overall Study|Lost to Follow-up|4|||
129152387|NCT01463033|464854864|FG000|Overall Study|Death|3|||
129152388|NCT01463033|464854865|FG001|Overall Study|Death|2|||
129152389|NCT00967616|464854866|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
129152390|NCT00967616|464854867|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
129152391|NCT00967616|464854866|FG000|Overall Study|Death|0|||
129152392|NCT00967616|464854867|FG001|Overall Study|Death|3|||
129152393|NCT00967616|464854866|FG000|Overall Study|Withdrawal by Subject|8|||
129152394|NCT00967616|464854867|FG001|Overall Study|Withdrawal by Subject|4|||
129152395|NCT00967616|464854866|FG000|Overall Study|Progressive Disease|31|||
129152396|NCT00967616|464854867|FG001|Overall Study|Progressive Disease|18|||
129152397|NCT00967616|464854866|FG000|Overall Study|Other|8|||
129152398|NCT00967616|464854867|FG001|Overall Study|Other|8|||
129152399|NCT00967616|464854866|FG000|Overall Study|Protocol Violation|1|||
129152400|NCT00967616|464854867|FG001|Overall Study|Protocol Violation|0|||
129152401|NCT01368614|464854868|FG000|Screening Period|Screen Failure|58|||
129152402|NCT01368614|464854869|FG001|Screening Period|Screen Failure|0|||
129152403|NCT01368614|464854870|FG002|Screening Period|Screen Failure|0|||
129152404|NCT01368614|464854871|FG003|Screening Period|Screen Failure|0|||
129152405|NCT01368614|464854868|FG000|Study Period|Withdrawal by Subject|0|||
129152406|NCT01368614|464854869|FG001|Study Period|Withdrawal by Subject|1|||
129152407|NCT01368614|464854870|FG002|Study Period|Withdrawal by Subject|1|||
129152408|NCT01368614|464854871|FG003|Study Period|Withdrawal by Subject|3|||
129152409|NCT01368614|464854868|FG000|Study Period|Lost to Follow-up|0|||
129152410|NCT01368614|464854869|FG001|Study Period|Lost to Follow-up|0|||
129152411|NCT01368614|464854870|FG002|Study Period|Lost to Follow-up|1|||
129152412|NCT01368614|464854871|FG003|Study Period|Lost to Follow-up|0|||
129152413|NCT02951780|464854872|FG000|Period 1|Adverse Event|0|||
129152414|NCT02951780|464854873|FG001|Period 1|Adverse Event|0|||
129152415|NCT02951780|464854874|FG002|Period 1|Adverse Event|0|||
129152416|NCT02951780|464854875|FG003|Period 1|Adverse Event|1|||
129152417|NCT02951780|464854876|FG004|Period 1|Adverse Event|0|||
129152418|NCT02951780|464854877|FG005|Period 1|Adverse Event|0|||
129152419|NCT02951780|464854878|FG006|Period 1|Adverse Event|0|||
129152420|NCT02951780|464854879|FG007|Period 1|Adverse Event|0|||
129152421|NCT02951780|464854880|FG008|Period 1|Adverse Event|0|||
129152422|NCT02951780|464854872|FG000|Period 1|Scheduling Conflicts|0|||
129152423|NCT02951780|464854873|FG001|Period 1|Scheduling Conflicts|0|||
129152424|NCT02951780|464854874|FG002|Period 1|Scheduling Conflicts|0|||
129152425|NCT02951780|464854875|FG003|Period 1|Scheduling Conflicts|0|||
129152426|NCT02951780|464854876|FG004|Period 1|Scheduling Conflicts|0|||
129152427|NCT02951780|464854877|FG005|Period 1|Scheduling Conflicts|0|||
129152428|NCT02951780|464854878|FG006|Period 1|Scheduling Conflicts|0|||
129152429|NCT02951780|464854879|FG007|Period 1|Scheduling Conflicts|1|||
129152430|NCT02951780|464854880|FG008|Period 1|Scheduling Conflicts|0|||
129152431|NCT02951780|464854872|FG000|Period 2|Scheduling Conflicts|0|||
129152432|NCT02951780|464854873|FG001|Period 2|Scheduling Conflicts|0|||
129152433|NCT02951780|464854874|FG002|Period 2|Scheduling Conflicts|0|||
129152434|NCT02951780|464854875|FG003|Period 2|Scheduling Conflicts|0|||
129152435|NCT02951780|464854876|FG004|Period 2|Scheduling Conflicts|0|||
129152436|NCT02951780|464854877|FG005|Period 2|Scheduling Conflicts|0|||
129152437|NCT02951780|464854878|FG006|Period 2|Scheduling Conflicts|0|||
129152438|NCT02951780|464854879|FG007|Period 2|Scheduling Conflicts|1|||
129152439|NCT02951780|464854880|FG008|Period 2|Scheduling Conflicts|0|||
129152440|NCT01374425|464854881|FG000|Overall Study|Radiographic Disease Progression|86|||
129152441|NCT01374425|464854882|FG001|Overall Study|Radiographic Disease Progression|81|||
129152442|NCT01374425|464854881|FG000|Overall Study|Clinical Disease Progression|9|||
129152443|NCT01374425|464854882|FG001|Overall Study|Clinical Disease Progression|6|||
129152444|NCT01374425|464854881|FG000|Overall Study|Adverse Event|29|||
129152445|NCT01374425|464854882|FG001|Overall Study|Adverse Event|18|||
129152446|NCT01374425|464854881|FG000|Overall Study|Death (Progression of Disease)|1|||
129152447|NCT01374425|464854882|FG001|Overall Study|Death (Progression of Disease)|0|||
129152448|NCT01374425|464854881|FG000|Overall Study|Death (Adverse Event)|2|||
129152449|NCT01374425|464854882|FG001|Overall Study|Death (Adverse Event)|4|||
129152450|NCT01374425|464854881|FG000|Overall Study|Withdrawal by Subject|6|||
129152451|NCT01374425|464854882|FG001|Overall Study|Withdrawal by Subject|7|||
129152452|NCT01374425|464854881|FG000|Overall Study|Refused Treatment|10|||
129152453|NCT01374425|464854882|FG001|Overall Study|Refused Treatment|24|||
129152454|NCT01374425|464854881|FG000|Overall Study|Protocol Violation|2|||
129152455|NCT01374425|464854882|FG001|Overall Study|Protocol Violation|3|||
129152456|NCT01374425|464854881|FG000|Overall Study|Sponsor Decision|0|||
129152457|NCT01374425|464854882|FG001|Overall Study|Sponsor Decision|1|||
129152458|NCT01374425|464854881|FG000|Overall Study|Lost to Follow-up|2|||
129152459|NCT01374425|464854882|FG001|Overall Study|Lost to Follow-up|1|||
129152460|NCT01374425|464854881|FG000|Overall Study|Other|41|||
129152461|NCT01374425|464854882|FG001|Overall Study|Other|43|||
129152462|NCT03783780|464854889|FG000|Overall Study|Withdrawn prior to completion|1|||
129152463|NCT03768427|464854890|FG000|Overall Study|Death|0|||
129152464|NCT03768427|464854891|FG001|Overall Study|Death|0|||
129152465|NCT03768427|464854892|FG002|Overall Study|Death|1|||
129152466|NCT03768427|464854893|FG003|Overall Study|Death|0|||
129152467|NCT03768427|464854890|FG000|Overall Study|Lost to Follow-up|2|||
129152468|NCT03768427|464854891|FG001|Overall Study|Lost to Follow-up|0|||
129152469|NCT03768427|464854892|FG002|Overall Study|Lost to Follow-up|0|||
129152470|NCT03768427|464854893|FG003|Overall Study|Lost to Follow-up|0|||
129152471|NCT03768427|464854890|FG000|Overall Study|Physician Decision|3|||
129152472|NCT03768427|464854891|FG001|Overall Study|Physician Decision|2|||
129152473|NCT03768427|464854892|FG002|Overall Study|Physician Decision|4|||
129152474|NCT03768427|464854893|FG003|Overall Study|Physician Decision|4|||
129152475|NCT03768427|464854890|FG000|Overall Study|Withdrawal by Subject|7|||
129152476|NCT03768427|464854891|FG001|Overall Study|Withdrawal by Subject|2|||
129152477|NCT03768427|464854892|FG002|Overall Study|Withdrawal by Subject|6|||
129152478|NCT03768427|464854893|FG003|Overall Study|Withdrawal by Subject|7|||
129152479|NCT02629861|464854898|FG000|Overall Study|Adverse Event|7|||
129152480|NCT02629861|464854899|FG001|Overall Study|Adverse Event|5|||
129152481|NCT02629861|464854900|FG002|Overall Study|Adverse Event|4|||
129152482|NCT02629861|464854898|FG000|Overall Study|Withdrawal by Subject|5|||
129152483|NCT02629861|464854899|FG001|Overall Study|Withdrawal by Subject|8|||
129152484|NCT02629861|464854900|FG002|Overall Study|Withdrawal by Subject|13|||
129152485|NCT02629861|464854898|FG000|Overall Study|Protocol Violation|2|||
129152486|NCT02629861|464854899|FG001|Overall Study|Protocol Violation|3|||
129152487|NCT02629861|464854900|FG002|Overall Study|Protocol Violation|7|||
129152488|NCT02629861|464854898|FG000|Overall Study|Lost to Follow-up|12|||
129152489|NCT02629861|464854899|FG001|Overall Study|Lost to Follow-up|9|||
129152490|NCT02629861|464854900|FG002|Overall Study|Lost to Follow-up|4|||
129152491|NCT02629861|464854898|FG000|Overall Study|Other|1|||
129152492|NCT02629861|464854899|FG001|Overall Study|Other|1|||
129152493|NCT02629861|464854900|FG002|Overall Study|Other|0|||
129152494|NCT02629861|464854898|FG000|Overall Study|Pregnancy|2|||
129152495|NCT02629861|464854899|FG001|Overall Study|Pregnancy|1|||
129152496|NCT02629861|464854900|FG002|Overall Study|Pregnancy|0|||
129152497|NCT00907621|464854904|FG000|Overall Study|Lost to Follow-up|6|||
129152498|NCT00907621|464854905|FG001|Overall Study|Lost to Follow-up|3|||
129152499|NCT00907621|464854904|FG000|Overall Study|intercurrent febrile illness|1|||
129152500|NCT00907621|464854905|FG001|Overall Study|intercurrent febrile illness|1|||
129152501|NCT00902330|464854908|FG000|Overall Study|Too overwhelmed by treatment|2|||
129152502|NCT00902330|464854909|FG001|Overall Study|Too overwhelmed by treatment|5|||
129152503|NCT00902330|464854908|FG000|Overall Study|Adverse Event|1|||
129152504|NCT00902330|464854909|FG001|Overall Study|Adverse Event|0|||
129152505|NCT00902330|464854908|FG000|Overall Study|No post baseline data|1|||
129152506|NCT00902330|464854909|FG001|Overall Study|No post baseline data|0|||
129152507|NCT01816048|464854910|FG000|Overall Study|Adverse Event|1|||
129152508|NCT01816048|464854910|FG000|Overall Study|Death|1|||
129152509|NCT01816048|464854910|FG000|Overall Study|Withdrawal by Subject|1|||
129152510|NCT01816048|464854910|FG000|Overall Study|Disease Progression|3|||
129152511|NCT01816984|464854911|FG000|Overall Study|declining health status|1|||
129152512|NCT00457626|464854915|FG000|Overall Study|Adverse Event|3|||
129152513|NCT00457626|464854915|FG000|Overall Study|Administrative Problems|2|||
129152514|NCT00457626|464854915|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
129152515|NCT03549338|464856958|FG000|Overall Study|Progressive Disease|1|||
128725366|NCT01644175|463290968|FG000|Overall Study|Consent withdrawn by participant|3|||
128725367|NCT01644175|463290969|FG001|Overall Study|Consent withdrawn by participant|4|||
128725368|NCT01644175|463290968|FG000|Overall Study|Related to Autoinjector Administration|2|||
128725369|NCT01644175|463290969|FG001|Overall Study|Related to Autoinjector Administration|1|||
128725370|NCT01644175|463290968|FG000|Overall Study|Last visit outside protocol visit window|4|||
128725371|NCT01644175|463290969|FG001|Overall Study|Last visit outside protocol visit window|11|||
128725372|NCT01644175|463290968|FG000|Overall Study|Selection criteria finally not met|0|||
128725373|NCT01644175|463290969|FG001|Overall Study|Selection criteria finally not met|1|||
128725374|NCT01644175|463290968|FG000|Overall Study|Site closure|2|||
128725375|NCT01644175|463290969|FG001|Overall Study|Site closure|2|||
128725376|NCT01644175|463290968|FG000|Overall Study|Lost to Follow-up|1|||
128725377|NCT01644175|463290969|FG001|Overall Study|Lost to Follow-up|0|||
129152516|NCT03549338|464856959|FG001|Overall Study|Progressive Disease|0|||
129152517|NCT03549338|464856960|FG002|Overall Study|Progressive Disease|0|||
129152518|NCT03549338|464856958|FG000|Overall Study|Clinical Progression|0|||
129152519|NCT03549338|464856959|FG001|Overall Study|Clinical Progression|1|||
129152520|NCT03549338|464856960|FG002|Overall Study|Clinical Progression|0|||
129152521|NCT01944020|464856962|FG000|Overall Study|Withdrawal by Subject|5|||
129152522|NCT01944020|464856963|FG001|Overall Study|Withdrawal by Subject|0|||
129152523|NCT03257358|464856968|FG000|Overall Study|Adverse Event|25|||
128725378|NCT01644175|463290968|FG000|Overall Study|Other than specified above|0|||
129152524|NCT03257358|464856969|FG001|Overall Study|Adverse Event|12|||
129152525|NCT03257358|464856968|FG000|Overall Study|Lack of Efficacy|1|||
129152526|NCT03257358|464856969|FG001|Overall Study|Lack of Efficacy|1|||
129152527|NCT03257358|464856968|FG000|Overall Study|Lost to Follow-up|12|||
129152528|NCT03257358|464856969|FG001|Overall Study|Lost to Follow-up|4|||
129152529|NCT03257358|464856968|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
129152530|NCT03257358|464856969|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
129152531|NCT03257358|464856968|FG000|Overall Study|Physician Decision|2|||
129152532|NCT03257358|464856969|FG001|Overall Study|Physician Decision|2|||
129152533|NCT03257358|464856968|FG000|Overall Study|Protocol Violation|5|||
129152534|NCT03257358|464856969|FG001|Overall Study|Protocol Violation|3|||
129152535|NCT03257358|464856968|FG000|Overall Study|Technical problems|4|||
129152536|NCT03257358|464856969|FG001|Overall Study|Technical problems|1|||
129152537|NCT03257358|464856968|FG000|Overall Study|Withdrawal by Subject|8|||
129152538|NCT03257358|464856969|FG001|Overall Study|Withdrawal by Subject|3|||
129152539|NCT03257358|464856968|FG000|Overall Study|Withdrawal of informed consent|9|||
129152540|NCT03257358|464856969|FG001|Overall Study|Withdrawal of informed consent|5|||
129152541|NCT03257358|464856968|FG000|Overall Study|New therapy for study indication|1|||
129152542|NCT03257358|464856969|FG001|Overall Study|New therapy for study indication|0|||
129152543|NCT03257358|464856968|FG000|Overall Study|No longer requires treatment|0|||
129152544|NCT03257358|464856969|FG001|Overall Study|No longer requires treatment|1|||
129152545|NCT01977898|464856970|FG000|Overall Study|Non functioning catheter|1|||
129152546|NCT01977898|464856971|FG001|Overall Study|Non functioning catheter|1|||
129152547|NCT01049373|464856972|FG000|Overall Study|Protocol Violation|9|||
129152548|NCT01049373|464856973|FG001|Overall Study|Protocol Violation|9|||
129152549|NCT01049373|464856972|FG000|Overall Study|Withdrawal by Subject|8|||
129152550|NCT01049373|464856973|FG001|Overall Study|Withdrawal by Subject|5|||
129152551|NCT01049373|464856972|FG000|Overall Study|Adverse Event|3|||
129152552|NCT01049373|464856973|FG001|Overall Study|Adverse Event|3|||
129152553|NCT01049373|464856972|FG000|Overall Study|Lost to Follow-up|9|||
129152554|NCT01049373|464856973|FG001|Overall Study|Lost to Follow-up|4|||
129152555|NCT01049373|464856972|FG000|Overall Study|no evaluable study values|9|||
129152556|NCT01049373|464856973|FG001|Overall Study|no evaluable study values|21|||
129152557|NCT01049373|464856972|FG000|Overall Study|Other|1|||
129152558|NCT01049373|464856973|FG001|Overall Study|Other|1|||
129152559|NCT01049373|464856972|FG000|Overall Study|Non-cooperation|0|||
129152560|NCT01049373|464856973|FG001|Overall Study|Non-cooperation|1|||
129152561|NCT02391311|464856974|FG000|Overall Study|Lost to Follow-up|2|||
129152562|NCT02391311|464856975|FG001|Overall Study|Lost to Follow-up|1|||
129152563|NCT02391311|464856974|FG000|Overall Study|deemed ineligible after baseline|1|||
129152564|NCT02391311|464856975|FG001|Overall Study|deemed ineligible after baseline|1|||
129152565|NCT03046446|464856978|FG000|Overall Study|Lack of Efficacy|7|||
129152566|NCT03046446|464856978|FG000|Overall Study|Adverse Event|6|||
129152567|NCT03046446|464856978|FG000|Overall Study|Lost to Follow-up|3|||
129152568|NCT03046446|464856978|FG000|Overall Study|Withdrawal by Subject|14|||
129152569|NCT03046446|464856978|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
129152570|NCT03046446|464856978|FG000|Overall Study|Disease Progression (see caveats)|25|||
129152571|NCT03046446|464856978|FG000|Overall Study|Non OA related knee surgery|1|||
129152572|NCT02808897|464856979|FG000|Overall Study|Lost to Follow-up|9|||
129152573|NCT02808897|464856980|FG001|Overall Study|Lost to Follow-up|11|||
129152574|NCT00305448|464856981|FG000|Overall Study|Protocol Violation|0|||
129152575|NCT00305448|464856982|FG001|Overall Study|Protocol Violation|1|||
129152576|NCT00305448|464856983|FG002|Overall Study|Protocol Violation|0|||
129152577|NCT00305448|464856981|FG000|Overall Study|Withdrawal by Subject|2|||
129152578|NCT00305448|464856982|FG001|Overall Study|Withdrawal by Subject|0|||
129152579|NCT00305448|464856983|FG002|Overall Study|Withdrawal by Subject|1|||
129152580|NCT00305448|464856981|FG000|Overall Study|Adverse Event|1|||
129152581|NCT00305448|464856982|FG001|Overall Study|Adverse Event|0|||
129152582|NCT00305448|464856983|FG002|Overall Study|Adverse Event|1|||
129152583|NCT00305448|464856981|FG000|Overall Study|Disease Progression|27|||
129152584|NCT00305448|464856982|FG001|Overall Study|Disease Progression|31|||
129152585|NCT00305448|464856983|FG002|Overall Study|Disease Progression|28|||
129152586|NCT00305448|464856981|FG000|Overall Study|Subjective Disease Progression|1|||
129152587|NCT00305448|464856982|FG001|Overall Study|Subjective Disease Progression|2|||
129152588|NCT00305448|464856983|FG002|Overall Study|Subjective Disease Progression|2|||
129152589|NCT00305448|464856981|FG000|Overall Study|Tumor Marker Elevation|0|||
129152590|NCT00305448|464856982|FG001|Overall Study|Tumor Marker Elevation|0|||
129152591|NCT00305448|464856983|FG002|Overall Study|Tumor Marker Elevation|1|||
129152592|NCT00328172|464856984|FG000|Overall Study|Adverse Event|3|||
129152593|NCT00328172|464856985|FG001|Overall Study|Adverse Event|2|||
129152594|NCT00328172|464856986|FG002|Overall Study|Adverse Event|1|||
129152595|NCT00328172|464856987|FG003|Overall Study|Adverse Event|2|||
129152596|NCT00328172|464856988|FG004|Overall Study|Adverse Event|1|||
129152597|NCT00328172|464856984|FG000|Overall Study|Protocol Violation|0|||
129152598|NCT00328172|464856985|FG001|Overall Study|Protocol Violation|1|||
129152599|NCT00328172|464856986|FG002|Overall Study|Protocol Violation|1|||
129152600|NCT00328172|464856987|FG003|Overall Study|Protocol Violation|0|||
129152601|NCT00328172|464856988|FG004|Overall Study|Protocol Violation|0|||
129152602|NCT00328172|464856984|FG000|Overall Study|Lost to Follow-up|1|||
129152603|NCT00328172|464856985|FG001|Overall Study|Lost to Follow-up|1|||
129152604|NCT00328172|464856986|FG002|Overall Study|Lost to Follow-up|2|||
129152605|NCT00328172|464856987|FG003|Overall Study|Lost to Follow-up|1|||
129152606|NCT00328172|464856988|FG004|Overall Study|Lost to Follow-up|1|||
129152607|NCT00328172|464856984|FG000|Overall Study|Withdrawal by Subject|1|||
129152608|NCT00328172|464856985|FG001|Overall Study|Withdrawal by Subject|1|||
129152609|NCT00328172|464856986|FG002|Overall Study|Withdrawal by Subject|1|||
129152610|NCT00328172|464856987|FG003|Overall Study|Withdrawal by Subject|6|||
129152611|NCT00328172|464856988|FG004|Overall Study|Withdrawal by Subject|0|||
129152612|NCT00328172|464856984|FG000|Overall Study|Lack of Efficacy|14|||
129152613|NCT00328172|464856985|FG001|Overall Study|Lack of Efficacy|9|||
129152614|NCT00328172|464856986|FG002|Overall Study|Lack of Efficacy|4|||
129152615|NCT00328172|464856987|FG003|Overall Study|Lack of Efficacy|4|||
129152616|NCT00328172|464856988|FG004|Overall Study|Lack of Efficacy|3|||
129152617|NCT00328172|464856984|FG000|Overall Study|Other reason (not specified)|3|||
129152618|NCT00328172|464856985|FG001|Overall Study|Other reason (not specified)|0|||
129152619|NCT00328172|464856986|FG002|Overall Study|Other reason (not specified)|1|||
129152620|NCT00328172|464856987|FG003|Overall Study|Other reason (not specified)|0|||
129152621|NCT00328172|464856988|FG004|Overall Study|Other reason (not specified)|0|||
129152622|NCT00558636|464856993|FG000|Treatment|Adverse Event|9|||
129152623|NCT00558636|464856994|FG001|Treatment|Adverse Event|2|||
129152624|NCT00558636|464856993|FG000|Treatment|Withdrawal by Subject|2|||
129152625|NCT00558636|464856994|FG001|Treatment|Withdrawal by Subject|0|||
129152626|NCT00558636|464856993|FG000|Treatment|Premature termination of the study|35|||
129152627|NCT00558636|464856994|FG001|Treatment|Premature termination of the study|37|||
129152628|NCT00558636|464856993|FG000|Treatment|Disease progression|1|||
129152629|NCT00558636|464856994|FG001|Treatment|Disease progression|5|||
129152630|NCT00558636|464856993|FG000|Follow-up|Premature termination of the study|12|||
129152631|NCT00558636|464856994|FG001|Follow-up|Premature termination of the study|7|||
129152632|NCT04108273|464856995|FG000|Overall Study|COVID Pandemic|1|||
129152633|NCT04108273|464856996|FG001|Overall Study|COVID Pandemic|0|||
129152634|NCT02897115|464856998|FG000|Overall Study|Early termination of study by sponsor|11|||
129152635|NCT02897115|464856999|FG001|Overall Study|Early termination of study by sponsor|8|||
129152636|NCT00487981|464857000|FG000|Overall Study|Hypothyroidism diagnosis|1|||
129152637|NCT00856323|464857001|FG000|Overall Study|Withdrawal by Subject|2|||
129152638|NCT02808429|464857006|FG000|Overall Study|Lost to Follow-up|1|||
129152639|NCT02808429|464857007|FG001|Overall Study|Lost to Follow-up|0|||
129152640|NCT02808429|464857008|FG002|Overall Study|Lost to Follow-up|0|||
129152641|NCT02808429|464857006|FG000|Overall Study|Protocol Violation|0|||
129152642|NCT02808429|464857007|FG001|Overall Study|Protocol Violation|1|||
129152643|NCT02808429|464857008|FG002|Overall Study|Protocol Violation|0|||
129152644|NCT02808429|464857006|FG000|Overall Study|Premature study termination by sponsor|2|||
129152645|NCT02808429|464857007|FG001|Overall Study|Premature study termination by sponsor|0|||
129152646|NCT02808429|464857008|FG002|Overall Study|Premature study termination by sponsor|1|||
129152647|NCT02808429|464857006|FG000|Overall Study|Relocation|0|||
129152648|NCT02808429|464857007|FG001|Overall Study|Relocation|0|||
129152649|NCT02808429|464857008|FG002|Overall Study|Relocation|1|||
129152650|NCT00811954|464857014|FG000|Overall Study|Death|10|||
129152651|NCT00811954|464857015|FG001|Overall Study|Death|6|||
129152652|NCT00811954|464857016|FG002|Overall Study|Death|13|||
129152653|NCT00811954|464857014|FG000|Overall Study|Lost to Follow-up|29|||
129152654|NCT00811954|464857015|FG001|Overall Study|Lost to Follow-up|23|||
129152655|NCT00811954|464857016|FG002|Overall Study|Lost to Follow-up|34|||
129152656|NCT00811954|464857014|FG000|Overall Study|Not able to get to clinic|28|||
129152657|NCT00811954|464857015|FG001|Overall Study|Not able to get to clinic|35|||
129152658|NCT00811954|464857016|FG002|Overall Study|Not able to get to clinic|30|||
129152659|NCT00811954|464857014|FG000|Overall Study|Not willing to adhere to requirements|12|||
129152660|NCT00811954|464857015|FG001|Overall Study|Not willing to adhere to requirements|2|||
129152661|NCT00811954|464857016|FG002|Overall Study|Not willing to adhere to requirements|16|||
129152662|NCT00811954|464857014|FG000|Overall Study|Withdraw consent prior study completion|4|||
129152663|NCT00811954|464857015|FG001|Overall Study|Withdraw consent prior study completion|6|||
129152664|NCT00811954|464857016|FG002|Overall Study|Withdraw consent prior study completion|5|||
129152665|NCT00811954|464857014|FG000|Overall Study|Site Closure|4|||
129152666|NCT00811954|464857015|FG001|Overall Study|Site Closure|0|||
129152667|NCT00811954|464857016|FG002|Overall Study|Site Closure|1|||
129152668|NCT00811954|464857014|FG000|Overall Study|Severe Debilitation|2|||
129152669|NCT00811954|464857015|FG001|Overall Study|Severe Debilitation|0|||
129152670|NCT00811954|464857016|FG002|Overall Study|Severe Debilitation|1|||
129152671|NCT00811954|464857014|FG000|Overall Study|Complete Protocol: No follow-up|0|||
129152672|NCT00811954|464857015|FG001|Overall Study|Complete Protocol: No follow-up|0|||
129152673|NCT00811954|464857016|FG002|Overall Study|Complete Protocol: No follow-up|1|||
129152674|NCT01063348|464857019|FG000|Overall Study|Lost to Follow-up|3|||
129152675|NCT01063348|464857020|FG001|Overall Study|Lost to Follow-up|10|||
129152676|NCT05518461|464857021|FG000|Overall Study|Lost to Follow-up|25|||
129152677|NCT04828707|464857022|FG000|Overall Study|Lost to Follow-up|3|||
129152678|NCT04828707|464857023|FG001|Overall Study|Lost to Follow-up|2|||
129152679|NCT04828707|464857022|FG000|Overall Study|Withdrawal by Subject|2|||
129152680|NCT04828707|464857023|FG001|Overall Study|Withdrawal by Subject|1|||
129152681|NCT03139448|464857024|FG000|Overall Study|Lack of Efficacy|6|||
129152682|NCT03139448|464857025|FG001|Overall Study|Lack of Efficacy|7|||
129152683|NCT03139448|464857024|FG000|Overall Study|Location of procedure changed|2|||
129152684|NCT03139448|464857025|FG001|Overall Study|Location of procedure changed|8|||
129152685|NCT03139448|464857024|FG000|Overall Study|Withdrawal by Subject|3|||
129152686|NCT03139448|464857025|FG001|Overall Study|Withdrawal by Subject|6|||
129152687|NCT03139448|464857024|FG000|Overall Study|Screen fail|1|||
129152688|NCT03139448|464857025|FG001|Overall Study|Screen fail|3|||
129152689|NCT03139448|464857024|FG000|Overall Study|Physician Decision|0|||
128725379|NCT01644175|463290969|FG001|Overall Study|Other than specified above|3|||
128725380|NCT04258605|463290971|FG000|Overall Study|Death|1|||
128725381|NCT04258605|463290972|FG001|Overall Study|Death|0|||
128725382|NCT04258605|463290971|FG000|Overall Study|Early study termination|21|||
128725383|NCT04258605|463290972|FG001|Overall Study|Early study termination|2|||
128725384|NCT01418937|463290979|FG000|Overall Study|Lost to Follow-up|5|||
128725385|NCT01418937|463290979|FG000|Overall Study|Protocol Violation|1|||
128725386|NCT01418937|463290979|FG000|Overall Study|Pregnancy|1|||
128725387|NCT01418937|463290979|FG000|Overall Study|Withdrawal by Subject|1|||
128725388|NCT01712256|463290980|FG000|Overall Study|Lost to Follow-up|1|||
128725389|NCT00962104|463290981|FG000|Overall Study|Adverse Event|10|||
128725390|NCT00962104|463290982|FG001|Overall Study|Adverse Event|3|||
128725391|NCT00962104|463290981|FG000|Overall Study|Entry Criteria Not Met|1|||
128725392|NCT00962104|463290982|FG001|Overall Study|Entry Criteria Not Met|2|||
128725393|NCT00962104|463290981|FG000|Overall Study|Lack of Efficacy|0|||
128725394|NCT00962104|463290982|FG001|Overall Study|Lack of Efficacy|1|||
128725395|NCT00962104|463290981|FG000|Overall Study|Lost to Follow-up|10|||
128725396|NCT00962104|463290982|FG001|Overall Study|Lost to Follow-up|4|||
128725397|NCT00962104|463290981|FG000|Overall Study|Physician Decision|1|||
128725398|NCT00962104|463290982|FG001|Overall Study|Physician Decision|0|||
128725399|NCT00962104|463290981|FG000|Overall Study|Protocol Violation|6|||
128725400|NCT00962104|463290982|FG001|Overall Study|Protocol Violation|8|||
128725401|NCT00962104|463290981|FG000|Overall Study|Sponsor Decision|0|||
129152690|NCT03139448|464857025|FG001|Overall Study|Physician Decision|2|||
129152691|NCT00523978|464857026|FG000|Overall Study|Withdrawal by Subject|3|||
129152692|NCT00523978|464857027|FG001|Overall Study|Withdrawal by Subject|7|||
129152693|NCT00523978|464857026|FG000|Overall Study|Screen Failures|5|||
129152694|NCT00523978|464857027|FG001|Overall Study|Screen Failures|1|||
129152695|NCT00523978|464857026|FG000|Overall Study|Death|1|||
129152696|NCT00523978|464857027|FG001|Overall Study|Death|0|||
129152697|NCT02750514|464857030|FG000|Track 1|Disease progression|20|||
129152698|NCT02750514|464857031|FG001|Track 1|Disease progression|1|||
129152699|NCT02750514|464857032|FG002|Track 1|Disease progression|0|||
129152700|NCT02750514|464857033|FG003|Track 1|Disease progression|1|||
129152701|NCT02750514|464857034|FG004|Track 1|Disease progression|0|||
129152702|NCT02750514|464857030|FG000|Track 1|Adverse event unrelated to study drug|1|||
129152703|NCT02750514|464857031|FG001|Track 1|Adverse event unrelated to study drug|0|||
129152704|NCT02750514|464857032|FG002|Track 1|Adverse event unrelated to study drug|0|||
129152705|NCT02750514|464857033|FG003|Track 1|Adverse event unrelated to study drug|0|||
129152706|NCT02750514|464857034|FG004|Track 1|Adverse event unrelated to study drug|0|||
129152707|NCT02750514|464857030|FG000|Track 1|Study drug toxicity|4|||
129152708|NCT02750514|464857031|FG001|Track 1|Study drug toxicity|1|||
129152709|NCT02750514|464857032|FG002|Track 1|Study drug toxicity|0|||
128725402|NCT00962104|463290982|FG001|Overall Study|Sponsor Decision|1|||
128725403|NCT00962104|463290981|FG000|Overall Study|Withdrawal by Subject|10|||
128725404|NCT00962104|463290982|FG001|Overall Study|Withdrawal by Subject|6|||
128725405|NCT00962104|463290981|FG000|Overall Study|Other|2|||
128725406|NCT00962104|463290982|FG001|Overall Study|Other|0|||
128725407|NCT02013167|463290983|FG000|Overall Study|Withdrawal by Subject|15|||
128725408|NCT02013167|463290984|FG001|Overall Study|Withdrawal by Subject|14|||
129152710|NCT02750514|464857033|FG003|Track 1|Study drug toxicity|1|||
129152711|NCT02750514|464857034|FG004|Track 1|Study drug toxicity|0|||
129152712|NCT02750514|464857030|FG000|Track 1|Participant request to discontinue|1|||
129152713|NCT02750514|464857031|FG001|Track 1|Participant request to discontinue|0|||
129152714|NCT02750514|464857032|FG002|Track 1|Participant request to discontinue|0|||
128725409|NCT02013167|463290983|FG000|Overall Study|Sponsor Decision|1|||
128725410|NCT02013167|463290984|FG001|Overall Study|Sponsor Decision|3|||
129152715|NCT02750514|464857033|FG003|Track 1|Participant request to discontinue|0|||
129152716|NCT02750514|464857034|FG004|Track 1|Participant request to discontinue|0|||
129152717|NCT02750514|464857030|FG000|Track 1|Other reasons|1|||
129152718|NCT02750514|464857031|FG001|Track 1|Other reasons|0|||
129152719|NCT02750514|464857032|FG002|Track 1|Other reasons|0|||
129152720|NCT02750514|464857033|FG003|Track 1|Other reasons|0|||
129152721|NCT02750514|464857034|FG004|Track 1|Other reasons|0|||
129152722|NCT02750514|464857030|FG000|Track 2|Disease progression|4|||
129152723|NCT02750514|464857031|FG001|Track 2|Disease progression|5|||
129152724|NCT02750514|464857032|FG002|Track 2|Disease progression|2|||
129152725|NCT02750514|464857033|FG003|Track 2|Disease progression|5|||
129152726|NCT02750514|464857034|FG004|Track 2|Disease progression|0|||
129152727|NCT02750514|464857030|FG000|Track 2|Adverse event unrelated to study drug|1|||
129152728|NCT02750514|464857031|FG001|Track 2|Adverse event unrelated to study drug|0|||
129152729|NCT02750514|464857032|FG002|Track 2|Adverse event unrelated to study drug|0|||
129152730|NCT02750514|464857033|FG003|Track 2|Adverse event unrelated to study drug|0|||
129152731|NCT02750514|464857034|FG004|Track 2|Adverse event unrelated to study drug|0|||
129152732|NCT02750514|464857030|FG000|Track 2|Study drug toxicity|1|||
129152733|NCT02750514|464857031|FG001|Track 2|Study drug toxicity|2|||
129152734|NCT02750514|464857032|FG002|Track 2|Study drug toxicity|0|||
129152735|NCT02750514|464857033|FG003|Track 2|Study drug toxicity|2|||
129152736|NCT02750514|464857034|FG004|Track 2|Study drug toxicity|0|||
129152737|NCT02750514|464857030|FG000|Track 2|Participant withdrew consent|0|||
129152738|NCT02750514|464857031|FG001|Track 2|Participant withdrew consent|1|||
129152739|NCT02750514|464857032|FG002|Track 2|Participant withdrew consent|0|||
129152740|NCT02750514|464857033|FG003|Track 2|Participant withdrew consent|0|||
129152741|NCT02750514|464857034|FG004|Track 2|Participant withdrew consent|0|||
129152742|NCT02750514|464857030|FG000|Track 3|Disease progression|0|||
129152743|NCT02750514|464857031|FG001|Track 3|Disease progression|24|||
129152744|NCT02750514|464857032|FG002|Track 3|Disease progression|13|||
129152745|NCT02750514|464857033|FG003|Track 3|Disease progression|14|||
129152746|NCT02750514|464857034|FG004|Track 3|Disease progression|0|||
129152747|NCT02750514|464857030|FG000|Track 3|Adverse event unrelated to study drug|0|||
129152748|NCT02750514|464857031|FG001|Track 3|Adverse event unrelated to study drug|1|||
129152749|NCT02750514|464857032|FG002|Track 3|Adverse event unrelated to study drug|1|||
129152750|NCT02750514|464857033|FG003|Track 3|Adverse event unrelated to study drug|1|||
129152751|NCT02750514|464857034|FG004|Track 3|Adverse event unrelated to study drug|0|||
129152752|NCT02750514|464857030|FG000|Track 3|Study drug toxicity|0|||
129152753|NCT02750514|464857031|FG001|Track 3|Study drug toxicity|3|||
129152754|NCT02750514|464857032|FG002|Track 3|Study drug toxicity|0|||
129152755|NCT02750514|464857033|FG003|Track 3|Study drug toxicity|1|||
129152756|NCT02750514|464857034|FG004|Track 3|Study drug toxicity|0|||
129152757|NCT02750514|464857030|FG000|Track 3|Participant request to discontinue|0|||
129152758|NCT02750514|464857031|FG001|Track 3|Participant request to discontinue|2|||
129152759|NCT02750514|464857032|FG002|Track 3|Participant request to discontinue|0|||
129152760|NCT02750514|464857033|FG003|Track 3|Participant request to discontinue|0|||
129152761|NCT02750514|464857034|FG004|Track 3|Participant request to discontinue|0|||
129152762|NCT02750514|464857030|FG000|Track 3|Participant withdrew consent|0|||
129152763|NCT02750514|464857031|FG001|Track 3|Participant withdrew consent|3|||
129152764|NCT02750514|464857032|FG002|Track 3|Participant withdrew consent|1|||
129152765|NCT02750514|464857033|FG003|Track 3|Participant withdrew consent|0|||
129152766|NCT02750514|464857034|FG004|Track 3|Participant withdrew consent|0|||
129152767|NCT02750514|464857030|FG000|Track 3|Other reasons|0|||
129152768|NCT02750514|464857031|FG001|Track 3|Other reasons|3|||
129152769|NCT02750514|464857032|FG002|Track 3|Other reasons|0|||
129152770|NCT02750514|464857033|FG003|Track 3|Other reasons|0|||
129152771|NCT02750514|464857034|FG004|Track 3|Other reasons|0|||
129152772|NCT02750514|464857030|FG000|Track 4|Study drug toxicity|0|||
129152773|NCT02750514|464857031|FG001|Track 4|Study drug toxicity|6|||
129152774|NCT02750514|464857032|FG002|Track 4|Study drug toxicity|0|||
129152775|NCT02750514|464857033|FG003|Track 4|Study drug toxicity|5|||
129152776|NCT02750514|464857034|FG004|Track 4|Study drug toxicity|0|||
129152777|NCT02750514|464857030|FG000|Track 4|Participant request to discontinue|0|||
129152778|NCT02750514|464857031|FG001|Track 4|Participant request to discontinue|1|||
129152779|NCT02750514|464857032|FG002|Track 4|Participant request to discontinue|0|||
129152780|NCT02750514|464857033|FG003|Track 4|Participant request to discontinue|1|||
129152781|NCT02750514|464857034|FG004|Track 4|Participant request to discontinue|0|||
129152782|NCT02750514|464857030|FG000|Track 4|Participant withdrew consent|0|||
129152783|NCT02750514|464857031|FG001|Track 4|Participant withdrew consent|1|||
129152784|NCT02750514|464857032|FG002|Track 4|Participant withdrew consent|0|||
129152785|NCT02750514|464857033|FG003|Track 4|Participant withdrew consent|0|||
129152786|NCT02750514|464857034|FG004|Track 4|Participant withdrew consent|0|||
129152787|NCT02750514|464857030|FG000|Track 4|Other reasons|0|||
129152788|NCT02750514|464857031|FG001|Track 4|Other reasons|5|||
129152789|NCT02750514|464857032|FG002|Track 4|Other reasons|0|||
129152790|NCT02750514|464857033|FG003|Track 4|Other reasons|3|||
129152791|NCT02750514|464857034|FG004|Track 4|Other reasons|0|||
129152792|NCT02750514|464857030|FG000|Track 4|Disease progression|0|||
129152793|NCT02750514|464857031|FG001|Track 4|Disease progression|33|||
129152794|NCT02750514|464857032|FG002|Track 4|Disease progression|0|||
129152795|NCT02750514|464857033|FG003|Track 4|Disease progression|32|||
129152796|NCT02750514|464857034|FG004|Track 4|Disease progression|0|||
129152797|NCT02750514|464857030|FG000|Track 4|Adverse event unrelated to study drug|0|||
128725411|NCT02013167|463290983|FG000|Overall Study|Lost to Follow-up|0|||
128725412|NCT02013167|463290984|FG001|Overall Study|Lost to Follow-up|1|||
128725413|NCT02013167|463290983|FG000|Overall Study|Death|85|||
128725414|NCT02013167|463290984|FG001|Overall Study|Death|160|||
128725415|NCT01113879|463290987|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
128725416|NCT01113879|463290988|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
128725417|NCT00615056|463290990|FG000|Overall Study|Death|31|||
128725418|NCT00615056|463290991|FG001|Overall Study|Death|31|||
128725419|NCT00615056|463290992|FG002|Overall Study|Death|21|||
128725420|NCT00615056|463290993|FG003|Overall Study|Death|23|||
128725421|NCT00615056|463290990|FG000|Overall Study|Lost to Follow-up|1|||
128725422|NCT00615056|463290991|FG001|Overall Study|Lost to Follow-up|2|||
128725423|NCT00615056|463290992|FG002|Overall Study|Lost to Follow-up|4|||
128725424|NCT00615056|463290993|FG003|Overall Study|Lost to Follow-up|5|||
128725425|NCT00615056|463290990|FG000|Overall Study|Other|13|||
128725426|NCT00615056|463290991|FG001|Overall Study|Other|15|||
128725427|NCT00615056|463290992|FG002|Overall Study|Other|10|||
128725428|NCT00615056|463290993|FG003|Overall Study|Other|7|||
128725429|NCT00615056|463290990|FG000|Overall Study|Objective progression or relapse|0|||
128725430|NCT00615056|463290991|FG001|Overall Study|Objective progression or relapse|2|||
128725431|NCT00615056|463290992|FG002|Overall Study|Objective progression or relapse|0|||
128725432|NCT00615056|463290993|FG003|Overall Study|Objective progression or relapse|0|||
128725433|NCT00615056|463290990|FG000|Overall Study|Withdrawal by Subject|0|||
128725434|NCT00615056|463290991|FG001|Overall Study|Withdrawal by Subject|1|||
128776852|NCT01782326|463472025|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
129152798|NCT02750514|464857031|FG001|Track 4|Adverse event unrelated to study drug|5|||
129152799|NCT02750514|464857032|FG002|Track 4|Adverse event unrelated to study drug|0|||
129152800|NCT02750514|464857033|FG003|Track 4|Adverse event unrelated to study drug|0|||
129152801|NCT02750514|464857034|FG004|Track 4|Adverse event unrelated to study drug|0|||
129152802|NCT02750514|464857030|FG000|Track 4|Death|0|||
129152803|NCT02750514|464857031|FG001|Track 4|Death|0|||
129152804|NCT02750514|464857032|FG002|Track 4|Death|0|||
129152805|NCT02750514|464857033|FG003|Track 4|Death|1|||
129152806|NCT02750514|464857034|FG004|Track 4|Death|0|||
129152807|NCT02750514|464857030|FG000|Track 5|Disease progression|0|||
129152808|NCT02750514|464857031|FG001|Track 5|Disease progression|0|||
129152809|NCT02750514|464857032|FG002|Track 5|Disease progression|0|||
129152810|NCT02750514|464857033|FG003|Track 5|Disease progression|0|||
129152811|NCT02750514|464857034|FG004|Track 5|Disease progression|34|||
129152812|NCT02750514|464857030|FG000|Track 5|Adverse event unrelated to study drug|0|||
129152813|NCT02750514|464857031|FG001|Track 5|Adverse event unrelated to study drug|0|||
129152814|NCT02750514|464857032|FG002|Track 5|Adverse event unrelated to study drug|0|||
129152815|NCT02750514|464857033|FG003|Track 5|Adverse event unrelated to study drug|0|||
129152816|NCT02750514|464857034|FG004|Track 5|Adverse event unrelated to study drug|2|||
129152817|NCT02750514|464857030|FG000|Track 5|Study drug toxicity|0|||
129152818|NCT02750514|464857031|FG001|Track 5|Study drug toxicity|0|||
129152819|NCT02750514|464857032|FG002|Track 5|Study drug toxicity|0|||
129152820|NCT02750514|464857033|FG003|Track 5|Study drug toxicity|0|||
129152821|NCT02750514|464857034|FG004|Track 5|Study drug toxicity|2|||
128725435|NCT00615056|463290992|FG002|Overall Study|Withdrawal by Subject|1|||
128725436|NCT00615056|463290993|FG003|Overall Study|Withdrawal by Subject|0|||
128725437|NCT00615056|463290990|FG000|Overall Study|Discontinued by Sponsor|1|||
128725438|NCT00615056|463290991|FG001|Overall Study|Discontinued by Sponsor|0|||
129152822|NCT02750514|464857030|FG000|Track 5|Participant request to discontinue|0|||
129152823|NCT02750514|464857031|FG001|Track 5|Participant request to discontinue|0|||
129152824|NCT02750514|464857032|FG002|Track 5|Participant request to discontinue|0|||
129152825|NCT02750514|464857033|FG003|Track 5|Participant request to discontinue|0|||
129152826|NCT02750514|464857034|FG004|Track 5|Participant request to discontinue|3|||
129152827|NCT02750514|464857030|FG000|Track 5|Other reasons|0|||
129152828|NCT02750514|464857031|FG001|Track 5|Other reasons|0|||
129152829|NCT02750514|464857032|FG002|Track 5|Other reasons|0|||
129152830|NCT02750514|464857033|FG003|Track 5|Other reasons|0|||
129152831|NCT02750514|464857034|FG004|Track 5|Other reasons|2|||
129152832|NCT02553629|464857035|FG000|Overall Study|Logistic reasons|3|||
129152833|NCT02553629|464857036|FG001|Overall Study|Logistic reasons|6|||
129152834|NCT00696878|464857039|FG000|Overall Study|Adverse Event|8|||
129152835|NCT00696878|464857039|FG000|Overall Study|Withdrawal by Subject|87|||
129152836|NCT00696878|464857039|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
129152837|NCT00696878|464857039|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
129152838|NCT00696878|464857039|FG000|Overall Study|Trial stopped|32|||
129152839|NCT00696878|464857039|FG000|Overall Study|Other reason (not specified)|55|||
129152840|NCT02259114|464857040|FG000|Overall Study|Progressive Disease|14|||
129152841|NCT02259114|464857041|FG001|Overall Study|Progressive Disease|2|||
129152842|NCT02259114|464857042|FG002|Overall Study|Progressive Disease|10|||
129152843|NCT02259114|464857043|FG003|Overall Study|Progressive Disease|2|||
129152844|NCT02259114|464857044|FG004|Overall Study|Progressive Disease|5|||
129152845|NCT02259114|464857040|FG000|Overall Study|Adverse Event|2|||
129152846|NCT02259114|464857041|FG001|Overall Study|Adverse Event|1|||
129152847|NCT02259114|464857042|FG002|Overall Study|Adverse Event|0|||
129152848|NCT02259114|464857043|FG003|Overall Study|Adverse Event|0|||
129152849|NCT02259114|464857044|FG004|Overall Study|Adverse Event|1|||
129152850|NCT02259114|464857040|FG000|Overall Study|Death|3|||
129152851|NCT02259114|464857041|FG001|Overall Study|Death|0|||
129152852|NCT02259114|464857042|FG002|Overall Study|Death|1|||
129152853|NCT02259114|464857043|FG003|Overall Study|Death|0|||
129152854|NCT02259114|464857044|FG004|Overall Study|Death|0|||
129152855|NCT02259114|464857040|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129152856|NCT02259114|464857041|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129152857|NCT02259114|464857042|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
129152858|NCT02259114|464857043|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129152859|NCT02259114|464857044|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129152860|NCT02259114|464857040|FG000|Overall Study|Withdrawal by Subject|0|||
129152861|NCT02259114|464857041|FG001|Overall Study|Withdrawal by Subject|0|||
129152862|NCT02259114|464857042|FG002|Overall Study|Withdrawal by Subject|1|||
129152863|NCT02259114|464857043|FG003|Overall Study|Withdrawal by Subject|1|||
129152864|NCT02259114|464857044|FG004|Overall Study|Withdrawal by Subject|0|||
129152865|NCT02259114|464857040|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
129152866|NCT02259114|464857041|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
129152867|NCT02259114|464857042|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
129152868|NCT02259114|464857043|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
129152869|NCT02259114|464857044|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
129152870|NCT02259114|464857040|FG000|Overall Study|Not Treated|1|||
129152871|NCT02259114|464857041|FG001|Overall Study|Not Treated|0|||
129152872|NCT02259114|464857042|FG002|Overall Study|Not Treated|0|||
129152873|NCT02259114|464857043|FG003|Overall Study|Not Treated|0|||
129152874|NCT02259114|464857044|FG004|Overall Study|Not Treated|0|||
129152875|NCT03937479|464857045|FG000|Overall Study|Adverse Event|2|||
129152876|NCT03937479|464857046|FG001|Overall Study|Adverse Event|3|||
129152877|NCT03937479|464857047|FG002|Overall Study|Adverse Event|0|||
129152878|NCT03937479|464857048|FG003|Overall Study|Adverse Event|0|||
129152879|NCT03937479|464857049|FG004|Overall Study|Adverse Event|1|||
129152880|NCT03937479|464857045|FG000|Overall Study|Withdrawal by Subject|3|||
128725439|NCT00615056|463290992|FG002|Overall Study|Discontinued by Sponsor|0|||
129152881|NCT03937479|464857046|FG001|Overall Study|Withdrawal by Subject|5|||
129152882|NCT03937479|464857047|FG002|Overall Study|Withdrawal by Subject|2|||
129152883|NCT03937479|464857048|FG003|Overall Study|Withdrawal by Subject|2|||
128725440|NCT00615056|463290993|FG003|Overall Study|Discontinued by Sponsor|0|||
128725441|NCT00615056|463290990|FG000|Overall Study|Randomized but not treated|3|||
129152884|NCT03937479|464857049|FG004|Overall Study|Withdrawal by Subject|1|||
129152885|NCT03937479|464857045|FG000|Overall Study|Protocol Violation|5|||
129152886|NCT03937479|464857046|FG001|Overall Study|Protocol Violation|6|||
129152887|NCT03937479|464857047|FG002|Overall Study|Protocol Violation|4|||
129152888|NCT03937479|464857048|FG003|Overall Study|Protocol Violation|3|||
129152889|NCT03937479|464857049|FG004|Overall Study|Protocol Violation|2|||
129152890|NCT03937479|464857045|FG000|Overall Study|Lost to Follow-up|0|||
129152891|NCT03937479|464857046|FG001|Overall Study|Lost to Follow-up|1|||
129152892|NCT03937479|464857047|FG002|Overall Study|Lost to Follow-up|0|||
129152893|NCT03937479|464857048|FG003|Overall Study|Lost to Follow-up|1|||
129152894|NCT03937479|464857049|FG004|Overall Study|Lost to Follow-up|0|||
129152895|NCT03937479|464857045|FG000|Overall Study|Physician Decision|0|||
129152896|NCT03937479|464857046|FG001|Overall Study|Physician Decision|0|||
129152897|NCT03937479|464857047|FG002|Overall Study|Physician Decision|1|||
129152898|NCT03937479|464857048|FG003|Overall Study|Physician Decision|0|||
129152899|NCT03937479|464857049|FG004|Overall Study|Physician Decision|1|||
129152900|NCT02712788|464857050|FG000|Overall Study|Physician Decision|1|||
129152901|NCT02712788|464857051|FG001|Overall Study|Physician Decision|0|||
129152902|NCT02712788|464857050|FG000|Overall Study|Protocol Violation|1|||
129152903|NCT02712788|464857051|FG001|Overall Study|Protocol Violation|0|||
129152904|NCT00940602|464857052|FG000|Overall Study|Administrative problems|1|||
129152905|NCT00940602|464857053|FG001|Overall Study|Administrative problems|1|||
129152906|NCT00940602|464857052|FG000|Overall Study|Patient/guardian decision|13|||
129152907|NCT00940602|464857053|FG001|Overall Study|Patient/guardian decision|28|||
129152908|NCT00940602|464857052|FG000|Overall Study|Physician Decision|8|||
129152909|NCT00940602|464857053|FG001|Overall Study|Physician Decision|5|||
129152910|NCT00940602|464857052|FG000|Overall Study|Pregnancy|1|||
129152911|NCT00940602|464857053|FG001|Overall Study|Pregnancy|0|||
129152912|NCT00940602|464857052|FG000|Overall Study|Protocol Deviation (untreated)|1|||
129152913|NCT00940602|464857053|FG001|Overall Study|Protocol Deviation (untreated)|0|||
129152914|NCT00940602|464857052|FG000|Overall Study|Disease progression|8|||
129152915|NCT00940602|464857053|FG001|Overall Study|Disease progression|2|||
129152916|NCT00940602|464857052|FG000|Overall Study|Death|38|||
129152917|NCT00940602|464857053|FG001|Overall Study|Death|19|||
129152918|NCT00940602|464857052|FG000|Overall Study|Lost to Follow-up|3|||
129152919|NCT00940602|464857053|FG001|Overall Study|Lost to Follow-up|1|||
129152920|NCT00940602|464857052|FG000|Overall Study|Patient withdrew consent|26|||
129152921|NCT00940602|464857053|FG001|Overall Study|Patient withdrew consent|13|||
129152922|NCT00940602|464857052|FG000|Overall Study|Adverse Event|7|||
129152923|NCT00940602|464857053|FG001|Overall Study|Adverse Event|2|||
129152924|NCT00940602|464857052|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
129152925|NCT00940602|464857053|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
129152926|NCT01880957|464857054|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
129152927|NCT01880957|464857055|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
129152928|NCT01880957|464857054|FG000|Overall Study|Lost to Follow-up|11|||
129152929|NCT01880957|464857055|FG001|Overall Study|Lost to Follow-up|0|||
129152930|NCT01880957|464857054|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
129152931|NCT01880957|464857055|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
129152932|NCT00575666|464857058|FG000|Overall Study|Withdrawal by Subject|3|||
129152933|NCT00575666|464857059|FG001|Overall Study|Withdrawal by Subject|2|||
129152934|NCT00575666|464857058|FG000|Overall Study|Physician Decision|1|||
129152935|NCT00575666|464857059|FG001|Overall Study|Physician Decision|1|||
129152936|NCT00508482|464857060|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
129152937|NCT00508482|464857061|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
129152938|NCT00508482|464857062|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
129152939|NCT00508482|464857060|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
129152940|NCT00508482|464857061|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
129152941|NCT00508482|464857062|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
129152942|NCT00508482|464857060|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
129152943|NCT00508482|464857061|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
129152944|NCT00508482|464857062|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
129152945|NCT02359903|464857063|FG000|Overall Study|Adverse Event|0|||
129152946|NCT02359903|464857064|FG001|Overall Study|Adverse Event|2|||
129152947|NCT02289469|464857065|FG000|Overall Study|Unable to match a control|6|||
129152948|NCT02289469|464857066|FG001|Overall Study|Unable to match a control|0|||
129152949|NCT00546481|464857067|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
129152950|NCT00546481|464857068|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
129152951|NCT00546481|464857069|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
129152952|NCT00546481|464857067|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
129152953|NCT00546481|464857068|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
129152954|NCT00546481|464857069|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
129152955|NCT00546481|464857067|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
129152956|NCT00546481|464857068|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
129152957|NCT00546481|464857069|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
129152958|NCT00546481|464857067|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
129152959|NCT00546481|464857068|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
129152960|NCT00546481|464857069|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
129152961|NCT00546481|464857067|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
129152962|NCT00546481|464857068|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
129152963|NCT00546481|464857069|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
129152964|NCT00546481|464857067|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
129152965|NCT00546481|464857068|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
129152966|NCT00546481|464857069|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
129152967|NCT00546481|464857067|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
129152968|NCT00546481|464857068|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
128725442|NCT00615056|463290991|FG001|Overall Study|Randomized but not treated|0|||
129152969|NCT00546481|464857069|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
129152970|NCT00546481|464857067|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
129152971|NCT00546481|464857068|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
129152972|NCT00546481|464857069|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
129152973|NCT00546481|464857067|FG000|Maintenance Phase (CERA)|Other Reason|0|||
129152974|NCT00546481|464857068|FG001|Maintenance Phase (CERA)|Other Reason|0|||
129152975|NCT00546481|464857069|FG002|Maintenance Phase (CERA)|Other Reason|1|||
129152976|NCT02750930|464857073|FG000|Overall Study|Study closed/terminated|8|||
129152977|NCT00776789|464857075|FG000|Overall Study|Consent refusal|2|||
129152978|NCT00776789|464857076|FG001|Overall Study|Consent refusal|2|||
129152979|NCT00776789|464857075|FG000|Overall Study|Poor quality video|1|||
129152980|NCT00776789|464857076|FG001|Overall Study|Poor quality video|1|||
129152981|NCT00165789|464857080|FG000|Overall Study|Adverse Event|0|||
129152982|NCT00165789|464857081|FG001|Overall Study|Adverse Event|3|||
129152983|NCT00165789|464857082|FG002|Overall Study|Adverse Event|0|||
129152984|NCT00165789|464857083|FG003|Overall Study|Adverse Event|12|||
129152985|NCT00165789|464857080|FG000|Overall Study|Withdrawal by Subject|0|||
129152986|NCT00165789|464857081|FG001|Overall Study|Withdrawal by Subject|1|||
129152987|NCT00165789|464857082|FG002|Overall Study|Withdrawal by Subject|1|||
129152988|NCT00165789|464857083|FG003|Overall Study|Withdrawal by Subject|2|||
129152989|NCT00656370|464857088|FG000|Overall Study|Screen Failures|7|||
129152990|NCT00656370|464857088|FG000|Overall Study|Alternates|3|||
129152991|NCT01342094|464857089|FG000|Overall Study|Adverse Event|5|||
129152992|NCT01342094|464857090|FG001|Overall Study|Adverse Event|0|||
129152993|NCT01342094|464857089|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129152994|NCT01342094|464857090|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
129152995|NCT01342094|464857089|FG000|Overall Study|Withdrawal by Subject|0|||
129152996|NCT01342094|464857090|FG001|Overall Study|Withdrawal by Subject|2|||
129152997|NCT03069716|464857095|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
129152998|NCT03069716|464857096|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
129152999|NCT03069716|464857097|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
129153000|NCT03069716|464857095|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
129153001|NCT03069716|464857096|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
129153002|NCT03069716|464857097|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
129153003|NCT03069716|464857095|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
129153004|NCT03069716|464857096|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
129153005|NCT03069716|464857097|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
129153006|NCT03069716|464857095|FG000|Randomized Treatment|Withdrawal by Subject|0|||
129153007|NCT03069716|464857096|FG001|Randomized Treatment|Withdrawal by Subject|2|||
129153008|NCT03069716|464857097|FG002|Randomized Treatment|Withdrawal by Subject|0|||
129153009|NCT03391882|464857098|FG000|Study Overall|Adverse Event|3|||
129153010|NCT03391882|464857099|FG001|Study Overall|Adverse Event|6|||
129153011|NCT03391882|464857100|FG002|Study Overall|Adverse Event|1|||
129153012|NCT03391882|464857101|FG003|Study Overall|Adverse Event|1|||
129153013|NCT03391882|464857102|FG004|Study Overall|Adverse Event|3|||
129153014|NCT03391882|464857103|FG005|Study Overall|Adverse Event|1|||
129153015|NCT03391882|464857098|FG000|Study Overall|Lack of Efficacy|13|||
129153016|NCT03391882|464857099|FG001|Study Overall|Lack of Efficacy|9|||
129153017|NCT03391882|464857100|FG002|Study Overall|Lack of Efficacy|0|||
129153018|NCT03391882|464857101|FG003|Study Overall|Lack of Efficacy|0|||
129153019|NCT03391882|464857102|FG004|Study Overall|Lack of Efficacy|0|||
129153020|NCT03391882|464857103|FG005|Study Overall|Lack of Efficacy|0|||
129153021|NCT03391882|464857098|FG000|Study Overall|Withdrawal by Subject|3|||
129153022|NCT03391882|464857099|FG001|Study Overall|Withdrawal by Subject|3|||
129153023|NCT03391882|464857100|FG002|Study Overall|Withdrawal by Subject|2|||
129153024|NCT03391882|464857101|FG003|Study Overall|Withdrawal by Subject|2|||
129153025|NCT03391882|464857102|FG004|Study Overall|Withdrawal by Subject|1|||
129153026|NCT03391882|464857103|FG005|Study Overall|Withdrawal by Subject|3|||
129153027|NCT03391882|464857098|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129153028|NCT03391882|464857099|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
129153029|NCT03391882|464857100|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129153030|NCT03391882|464857101|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129153031|NCT03391882|464857102|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129153032|NCT03391882|464857103|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129153033|NCT03391882|464857098|FG000|Study Overall|Protocol Violation|1|||
129153034|NCT03391882|464857099|FG001|Study Overall|Protocol Violation|0|||
129153035|NCT03391882|464857100|FG002|Study Overall|Protocol Violation|0|||
129153036|NCT03391882|464857101|FG003|Study Overall|Protocol Violation|0|||
129153037|NCT03391882|464857102|FG004|Study Overall|Protocol Violation|0|||
129153038|NCT03391882|464857103|FG005|Study Overall|Protocol Violation|0|||
129153039|NCT03391882|464857098|FG000|Part A - Titration Phase|Adverse Event|3|||
129153040|NCT03391882|464857099|FG001|Part A - Titration Phase|Adverse Event|6|||
129153041|NCT03391882|464857100|FG002|Part A - Titration Phase|Adverse Event|0|||
129153042|NCT03391882|464857101|FG003|Part A - Titration Phase|Adverse Event|0|||
129153043|NCT03391882|464857102|FG004|Part A - Titration Phase|Adverse Event|0|||
129153044|NCT03391882|464857103|FG005|Part A - Titration Phase|Adverse Event|0|||
129153045|NCT03391882|464857098|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
129153046|NCT03391882|464857099|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
129153047|NCT03391882|464857100|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
129153048|NCT03391882|464857101|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
129153049|NCT03391882|464857102|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
129153050|NCT03391882|464857103|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
129153051|NCT03391882|464857098|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
129153052|NCT03391882|464857099|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
129153053|NCT03391882|464857100|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
129153054|NCT03391882|464857101|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
129153055|NCT03391882|464857102|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
129153056|NCT03391882|464857103|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
129153057|NCT03391882|464857098|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129153058|NCT03391882|464857099|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
129153059|NCT03391882|464857100|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129153060|NCT03391882|464857101|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129153061|NCT03391882|464857102|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129153062|NCT03391882|464857103|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129153063|NCT03391882|464857098|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
129153064|NCT03391882|464857099|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
129153065|NCT03391882|464857100|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
129153066|NCT03391882|464857101|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
129153067|NCT03391882|464857102|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
129153068|NCT03391882|464857103|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
129153069|NCT03391882|464857098|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
129153070|NCT03391882|464857099|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
129153071|NCT03391882|464857100|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
129153072|NCT03391882|464857101|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
129153073|NCT03391882|464857102|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
129153074|NCT03391882|464857103|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
129153075|NCT03391882|464857098|FG000|Part B - Treatment Phase|Adverse Event|0|||
129153076|NCT03391882|464857099|FG001|Part B - Treatment Phase|Adverse Event|0|||
129153077|NCT03391882|464857100|FG002|Part B - Treatment Phase|Adverse Event|1|||
129153078|NCT03391882|464857101|FG003|Part B - Treatment Phase|Adverse Event|1|||
129153079|NCT03391882|464857102|FG004|Part B - Treatment Phase|Adverse Event|3|||
129153080|NCT03391882|464857103|FG005|Part B - Treatment Phase|Adverse Event|1|||
129153081|NCT03391882|464857098|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
129153082|NCT03391882|464857099|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
129153083|NCT03391882|464857100|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
129153084|NCT03391882|464857101|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
129153085|NCT03391882|464857102|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
129153086|NCT03391882|464857103|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
129153087|NCT03913130|464857104|FG000|Overall Study|Sponsor Decision|1|||
129153088|NCT01085214|464857107|FG000|Overall Study|Alternate treatment required|1|||
129153089|NCT01634152|464857108|FG000|Overall Study|Adverse Event|2|||
129153090|NCT01634152|464857109|FG001|Overall Study|Adverse Event|0|||
129153091|NCT01634152|464857110|FG002|Overall Study|Adverse Event|2|||
129153092|NCT01634152|464857108|FG000|Overall Study|Consent withdrawn not due to AE|1|||
129153093|NCT01634152|464857109|FG001|Overall Study|Consent withdrawn not due to AE|0|||
129153094|NCT01634152|464857110|FG002|Overall Study|Consent withdrawn not due to AE|1|||
129153095|NCT01634152|464857108|FG000|Overall Study|Not treated|0|||
129153096|NCT01634152|464857109|FG001|Overall Study|Not treated|1|||
129153097|NCT01634152|464857110|FG002|Overall Study|Not treated|0|||
129153098|NCT01634152|464857108|FG000|Overall Study|Other reason not defined above|1|||
129153099|NCT01634152|464857109|FG001|Overall Study|Other reason not defined above|0|||
129153100|NCT01634152|464857110|FG002|Overall Study|Other reason not defined above|1|||
129153101|NCT01985022|464857124|FG000|Overall Study|Lost to Follow-up|0|||
129153102|NCT01985022|464857125|FG001|Overall Study|Lost to Follow-up|1|||
129153103|NCT01985022|464857124|FG000|Overall Study|Protocol Violation|0|||
129153104|NCT01985022|464857125|FG001|Overall Study|Protocol Violation|1|||
129153105|NCT01985022|464857124|FG000|Overall Study|Withdrawal by Subject|4|||
129153106|NCT01985022|464857125|FG001|Overall Study|Withdrawal by Subject|1|||
129153107|NCT01152437|464857126|FG000|Overall Study|Other Adverse Event|8|||
129153108|NCT01152437|464857127|FG001|Overall Study|Other Adverse Event|1|||
129153109|NCT01152437|464857128|FG002|Overall Study|Other Adverse Event|7|||
129153110|NCT01152437|464857126|FG000|Overall Study|Not treated|0|||
129153111|NCT01152437|464857127|FG001|Overall Study|Not treated|1|||
129153112|NCT01152437|464857128|FG002|Overall Study|Not treated|2|||
129153113|NCT01152437|464857126|FG000|Overall Study|Progressive disease|27|||
129153114|NCT01152437|464857127|FG001|Overall Study|Progressive disease|13|||
129153115|NCT01152437|464857128|FG002|Overall Study|Progressive disease|32|||
129153116|NCT01152437|464857126|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
129153117|NCT01152437|464857127|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
129153118|NCT01152437|464857128|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
129153119|NCT02317627|464857131|FG000|Overall Study|Withdrawal by Subject|0|||
129153120|NCT02317627|464857132|FG001|Overall Study|Withdrawal by Subject|1|||
129153121|NCT02317627|464857133|FG002|Overall Study|Withdrawal by Subject|1|||
129153122|NCT02317627|464857131|FG000|Overall Study|Lost to Follow-up|2|||
129153123|NCT02317627|464857132|FG001|Overall Study|Lost to Follow-up|0|||
129153124|NCT02317627|464857133|FG002|Overall Study|Lost to Follow-up|0|||
129153125|NCT02317627|464857131|FG000|Overall Study|Stopped by Investigator|0|||
129153126|NCT02317627|464857132|FG001|Overall Study|Stopped by Investigator|1|||
129153127|NCT02317627|464857133|FG002|Overall Study|Stopped by Investigator|0|||
129153128|NCT02317627|464857131|FG000|Overall Study|Adverse Event|0|||
129153129|NCT02317627|464857132|FG001|Overall Study|Adverse Event|2|||
129153130|NCT02317627|464857133|FG002|Overall Study|Adverse Event|3|||
129153131|NCT02317627|464857131|FG000|Overall Study|Non-compliance with study drug|0|||
129153132|NCT02317627|464857132|FG001|Overall Study|Non-compliance with study drug|1|||
129153133|NCT02317627|464857133|FG002|Overall Study|Non-compliance with study drug|0|||
129153134|NCT00279214|464857134|FG000|Overall Study|Physician Decision|3|||
129153135|NCT00279214|464857135|FG001|Overall Study|Physician Decision|2|||
129153136|NCT01214837|464857137|FG000|Overall Study|Death|0|||
129153137|NCT01214837|464857138|FG001|Overall Study|Death|0|||
129153138|NCT01214837|464857139|FG002|Overall Study|Death|1|||
129153139|NCT01214837|464857137|FG000|Overall Study|Adverse Event|1|||
129153140|NCT01214837|464857138|FG001|Overall Study|Adverse Event|2|||
129153141|NCT01214837|464857139|FG002|Overall Study|Adverse Event|1|||
129153142|NCT01214837|464857137|FG000|Overall Study|Withdrawal by Subject|27|||
129153143|NCT01214837|464857138|FG001|Overall Study|Withdrawal by Subject|36|||
129153144|NCT01214837|464857139|FG002|Overall Study|Withdrawal by Subject|28|||
129153145|NCT01214837|464857137|FG000|Overall Study|Lost to Follow-up|20|||
129153146|NCT01214837|464857138|FG001|Overall Study|Lost to Follow-up|15|||
129153147|NCT01214837|464857139|FG002|Overall Study|Lost to Follow-up|21|||
129153148|NCT01214837|464857137|FG000|Overall Study|Inappropriate Enrolment|0|||
129153149|NCT01214837|464857138|FG001|Overall Study|Inappropriate Enrolment|1|||
129153150|NCT01214837|464857139|FG002|Overall Study|Inappropriate Enrolment|2|||
129153151|NCT01214837|464857137|FG000|Overall Study|Administrative Reason|2|||
129153152|NCT01214837|464857138|FG001|Overall Study|Administrative Reason|6|||
129153153|NCT01214837|464857139|FG002|Overall Study|Administrative Reason|4|||
129153154|NCT01214837|464857137|FG000|Overall Study|Protocol Violation|3|||
129153155|NCT01214837|464857138|FG001|Overall Study|Protocol Violation|1|||
129153156|NCT01214837|464857139|FG002|Overall Study|Protocol Violation|5|||
129153157|NCT01214837|464857137|FG000|Overall Study|Unable to Classify|1|||
129153158|NCT01214837|464857138|FG001|Overall Study|Unable to Classify|3|||
129153159|NCT01214837|464857139|FG002|Overall Study|Unable to Classify|0|||
129153160|NCT01088906|464857140|FG000|Overall Study|Inclusion error|1|||
129153161|NCT01088906|464857140|FG000|Overall Study|Did not receive study treatment|3|||
129153162|NCT01088906|464857140|FG000|Overall Study|Missing data|1|||
129153163|NCT00027560|464857141|FG000|Overall Study|Withdrawal by Subject|1|||
129153164|NCT03384875|464857142|FG000|Overall Study|Death|1|||
129153165|NCT03384875|464857143|FG001|Overall Study|Death|1|||
129153166|NCT03384875|464857144|FG002|Overall Study|Death|0|||
129153167|NCT03384875|464857142|FG000|Overall Study|Reason not provided|1|||
129153168|NCT03384875|464857143|FG001|Overall Study|Reason not provided|0|||
129153169|NCT03384875|464857144|FG002|Overall Study|Reason not provided|0|||
129153170|NCT01123148|464858801|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
129153171|NCT01123148|464858801|FG000|Overall Study|Didn't meet milestone criteria|1|||
129153172|NCT00355030|464858802|FG000|Study Period 1 Treatment|Adverse Event|1|||
129153173|NCT00355030|464858803|FG001|Study Period 1 Treatment|Adverse Event|1|||
129153174|NCT00355030|464858802|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
129153175|NCT00355030|464858803|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
129153176|NCT00355030|464858802|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
129153177|NCT00355030|464858803|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
129153178|NCT00355030|464858802|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
129153179|NCT00355030|464858803|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
129153180|NCT00355030|464858802|FG000|Study Period 1 Treatment|Physician Decision|0|||
129153181|NCT00355030|464858803|FG001|Study Period 1 Treatment|Physician Decision|1|||
129153182|NCT00355030|464858802|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
129153183|NCT00355030|464858803|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
129153184|NCT00355030|464858802|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
129153185|NCT00355030|464858803|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
129153186|NCT00355030|464858802|FG000|Study Period 1 Treatment|Other|2|||
129153187|NCT00355030|464858803|FG001|Study Period 1 Treatment|Other|6|||
128725443|NCT00615056|463290992|FG002|Overall Study|Randomized but not treated|0|||
128725444|NCT00615056|463290993|FG003|Overall Study|Randomized but not treated|0|||
128725445|NCT02276612|463290994|FG000|Overall Study|Death|1|||
128725446|NCT02276612|463290995|FG001|Overall Study|Death|0|||
128725447|NCT02276612|463290994|FG000|Overall Study|Pregnancy|1|||
129153188|NCT00355030|464858802|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
129153189|NCT00355030|464858803|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
129153190|NCT00355030|464858802|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
129153191|NCT00355030|464858803|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
129153192|NCT00812955|464858808|FG000|Overall Study|Adverse Event|7|||
129153193|NCT00812955|464858809|FG001|Overall Study|Adverse Event|6|||
129153194|NCT00812955|464858810|FG002|Overall Study|Adverse Event|3|||
129153195|NCT00812955|464858811|FG003|Overall Study|Adverse Event|4|||
129153196|NCT00812955|464858808|FG000|Overall Study|Lost to Follow-up|2|||
129153197|NCT00812955|464858809|FG001|Overall Study|Lost to Follow-up|1|||
129153198|NCT00812955|464858810|FG002|Overall Study|Lost to Follow-up|1|||
129153199|NCT00812955|464858811|FG003|Overall Study|Lost to Follow-up|2|||
129153200|NCT00812955|464858808|FG000|Overall Study|Withdrawal by Subject|1|||
129153201|NCT00812955|464858809|FG001|Overall Study|Withdrawal by Subject|0|||
129153202|NCT00812955|464858810|FG002|Overall Study|Withdrawal by Subject|1|||
129153203|NCT00812955|464858811|FG003|Overall Study|Withdrawal by Subject|2|||
129153204|NCT00812955|464858808|FG000|Overall Study|randomized in error|0|||
129153205|NCT00812955|464858809|FG001|Overall Study|randomized in error|0|||
129153206|NCT00812955|464858810|FG002|Overall Study|randomized in error|1|||
129153207|NCT00812955|464858811|FG003|Overall Study|randomized in error|0|||
129153208|NCT01815424|464858812|FG000|Week 0 to 16|Adverse Event|1|||
129153209|NCT01815424|464858813|FG001|Week 0 to 16|Adverse Event|3|||
129153210|NCT01815424|464858814|FG002|Week 0 to 16|Adverse Event|3|||
129153211|NCT01815424|464858815|FG003|Week 0 to 16|Adverse Event|0|||
129153212|NCT01815424|464858816|FG004|Week 0 to 16|Adverse Event|0|||
129153213|NCT01815424|464858812|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
129153214|NCT01815424|464858813|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129153215|NCT01815424|464858814|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129153216|NCT01815424|464858815|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129153217|NCT01815424|464858816|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129153218|NCT01815424|464858812|FG000|Week 0 to 16|Lost to Follow-up|0|||
129153219|NCT01815424|464858813|FG001|Week 0 to 16|Lost to Follow-up|1|||
129153220|NCT01815424|464858814|FG002|Week 0 to 16|Lost to Follow-up|0|||
129153221|NCT01815424|464858815|FG003|Week 0 to 16|Lost to Follow-up|0|||
129153222|NCT01815424|464858816|FG004|Week 0 to 16|Lost to Follow-up|0|||
129153223|NCT01815424|464858812|FG000|Week 0 to 16|Withdrawal by Subject|0|||
129153224|NCT01815424|464858813|FG001|Week 0 to 16|Withdrawal by Subject|0|||
129153225|NCT01815424|464858814|FG002|Week 0 to 16|Withdrawal by Subject|1|||
129153226|NCT01815424|464858815|FG003|Week 0 to 16|Withdrawal by Subject|0|||
129153227|NCT01815424|464858816|FG004|Week 0 to 16|Withdrawal by Subject|0|||
129153228|NCT01815424|464858812|FG000|Week 0 to 16|Other|1|||
129153229|NCT01815424|464858813|FG001|Week 0 to 16|Other|0|||
129153230|NCT01815424|464858814|FG002|Week 0 to 16|Other|3|||
129153231|NCT01815424|464858815|FG003|Week 0 to 16|Other|0|||
129153232|NCT01815424|464858816|FG004|Week 0 to 16|Other|0|||
129153233|NCT01815424|464858812|FG000|Week 0 to 16|Protocol Violation|1|||
129153234|NCT01815424|464858813|FG001|Week 0 to 16|Protocol Violation|0|||
129153235|NCT01815424|464858814|FG002|Week 0 to 16|Protocol Violation|0|||
129153236|NCT01815424|464858815|FG003|Week 0 to 16|Protocol Violation|0|||
129153237|NCT01815424|464858816|FG004|Week 0 to 16|Protocol Violation|0|||
129153238|NCT01815424|464858812|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
129153239|NCT01815424|464858813|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
129153240|NCT01815424|464858814|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
129153241|NCT01815424|464858815|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
129153242|NCT01815424|464858816|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
129153243|NCT01815424|464858812|FG000|Week 16 to 52|Other|0|||
128725448|NCT02276612|463290995|FG001|Overall Study|Pregnancy|0|||
128725449|NCT02276612|463290994|FG000|Overall Study|Withdrew Consent|1|||
128725450|NCT02276612|463290995|FG001|Overall Study|Withdrew Consent|0|||
129153244|NCT01815424|464858813|FG001|Week 16 to 52|Other|1|||
129153245|NCT01815424|464858814|FG002|Week 16 to 52|Other|0|||
129153246|NCT01815424|464858815|FG003|Week 16 to 52|Other|0|||
129153247|NCT01815424|464858816|FG004|Week 16 to 52|Other|0|||
129153248|NCT01815424|464858812|FG000|Week 16 to 52|Adverse Event|0|||
129153249|NCT01815424|464858813|FG001|Week 16 to 52|Adverse Event|0|||
129153250|NCT01815424|464858814|FG002|Week 16 to 52|Adverse Event|0|||
129153251|NCT01815424|464858815|FG003|Week 16 to 52|Adverse Event|0|||
129153252|NCT01815424|464858816|FG004|Week 16 to 52|Adverse Event|1|||
129153253|NCT01815424|464858812|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
129153254|NCT01815424|464858813|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
129153255|NCT01815424|464858814|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
129153256|NCT01815424|464858815|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
129153257|NCT01815424|464858816|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
129153258|NCT01815424|464858812|FG000|Week 16 to 52|Lost to Follow-up|0|||
129153259|NCT01815424|464858813|FG001|Week 16 to 52|Lost to Follow-up|2|||
129153260|NCT01815424|464858814|FG002|Week 16 to 52|Lost to Follow-up|0|||
129153261|NCT01815424|464858815|FG003|Week 16 to 52|Lost to Follow-up|2|||
129153262|NCT01815424|464858816|FG004|Week 16 to 52|Lost to Follow-up|1|||
129153263|NCT01815424|464858812|FG000|Week 16 to 52|Withdrawal by Subject|1|||
129153264|NCT01815424|464858813|FG001|Week 16 to 52|Withdrawal by Subject|2|||
129153265|NCT01815424|464858814|FG002|Week 16 to 52|Withdrawal by Subject|0|||
129153266|NCT01815424|464858815|FG003|Week 16 to 52|Withdrawal by Subject|0|||
129153267|NCT01815424|464858816|FG004|Week 16 to 52|Withdrawal by Subject|0|||
129153268|NCT01309204|464858817|FG000|Overall Study|Adverse Event|48|||
129153269|NCT01309204|464858818|FG001|Overall Study|Adverse Event|58|||
129153270|NCT01309204|464858817|FG000|Overall Study|Lost to Follow-up|2|||
129153271|NCT01309204|464858818|FG001|Overall Study|Lost to Follow-up|2|||
129153272|NCT01309204|464858817|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
129153273|NCT01309204|464858818|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
129153274|NCT01309204|464858817|FG000|Overall Study|Inadequate control of IOP|4|||
129153275|NCT01309204|464858818|FG001|Overall Study|Inadequate control of IOP|4|||
129153276|NCT01309204|464858817|FG000|Overall Study|Other|4|||
129153277|NCT01309204|464858818|FG001|Overall Study|Other|1|||
129153278|NCT03183063|464858819|FG000|Overall Study|Withdrawal by Subject|2|||
129153279|NCT03183063|464858820|FG001|Overall Study|Withdrawal by Subject|0|||
129153280|NCT03183063|464858821|FG002|Overall Study|Withdrawal by Subject|0|||
129153281|NCT03183063|464858819|FG000|Overall Study|Physician Decision|3|||
129153282|NCT03183063|464858820|FG001|Overall Study|Physician Decision|4|||
129153283|NCT03183063|464858821|FG002|Overall Study|Physician Decision|4|||
129153284|NCT01127633|464858822|FG000|Overall Study|Adverse Event|74|||
129153285|NCT01127633|464858823|FG001|Overall Study|Adverse Event|73|||
129153286|NCT01127633|464858822|FG000|Overall Study|Death|40|||
129153287|NCT01127633|464858823|FG001|Overall Study|Death|43|||
129153288|NCT01127633|464858822|FG000|Overall Study|Lost to Follow-up|4|||
129153289|NCT01127633|464858823|FG001|Overall Study|Lost to Follow-up|0|||
129153290|NCT01127633|464858822|FG000|Overall Study|Parent/Caregiver Decision|246|||
129153291|NCT01127633|464858823|FG001|Overall Study|Parent/Caregiver Decision|228|||
129153292|NCT01127633|464858822|FG000|Overall Study|Physician Decision|60|||
129153293|NCT01127633|464858823|FG001|Overall Study|Physician Decision|45|||
129153294|NCT01127633|464858822|FG000|Overall Study|Withdrawal by Subject|57|||
129153295|NCT01127633|464858823|FG001|Overall Study|Withdrawal by Subject|72|||
128725451|NCT02276612|463290994|FG000|Overall Study|Lost to Follow-up|1|||
128725452|NCT02276612|463290995|FG001|Overall Study|Lost to Follow-up|0|||
128725453|NCT00262067|463290996|FG000|Overall Study|Death|190|||
128725454|NCT00262067|463290997|FG001|Overall Study|Death|89|||
128725455|NCT00262067|463290998|FG002|Overall Study|Death|186|||
128725456|NCT00262067|463290999|FG003|Overall Study|Death|99|||
128725457|NCT00262067|463290996|FG000|Overall Study|Lost to Follow-up|5|||
128725458|NCT00262067|463290997|FG001|Overall Study|Lost to Follow-up|4|||
128725459|NCT00262067|463290998|FG002|Overall Study|Lost to Follow-up|7|||
128725460|NCT00262067|463290999|FG003|Overall Study|Lost to Follow-up|5|||
129153296|NCT01127633|464858822|FG000|Overall Study|Sponsor Decision|163|||
129153297|NCT01127633|464858823|FG001|Overall Study|Sponsor Decision|195|||
129153298|NCT01127633|464858822|FG000|Overall Study|Protocol Violation|8|||
129153299|NCT01127633|464858823|FG001|Overall Study|Protocol Violation|16|||
129153300|NCT01127633|464858822|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
129153301|NCT01127633|464858823|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
129153302|NCT01127633|464858822|FG000|Overall Study|Not treated|1|||
129153303|NCT01127633|464858823|FG001|Overall Study|Not treated|0|||
128725461|NCT00262067|463290996|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
128725462|NCT00262067|463290997|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
129153304|NCT00925002|464858824|FG000|Overall Study|Other|1|||
129153305|NCT00925002|464858825|FG001|Overall Study|Other|4|||
129153306|NCT00925002|464858826|FG002|Overall Study|Other|0|||
129153307|NCT00925002|464858824|FG000|Overall Study|Death|1|||
129153308|NCT00925002|464858825|FG001|Overall Study|Death|1|||
129153309|NCT00925002|464858826|FG002|Overall Study|Death|5|||
129153310|NCT00925002|464858824|FG000|Overall Study|Adverse Event|3|||
129153311|NCT00925002|464858825|FG001|Overall Study|Adverse Event|1|||
129153312|NCT00925002|464858826|FG002|Overall Study|Adverse Event|2|||
129153313|NCT00925002|464858824|FG000|Overall Study|Participant withdrew consent|1|||
129153314|NCT00925002|464858825|FG001|Overall Study|Participant withdrew consent|3|||
129153315|NCT00925002|464858826|FG002|Overall Study|Participant withdrew consent|3|||
129153316|NCT00690794|464858827|FG000|Overall Study|Adverse Event|12|||
129153317|NCT00690794|464858828|FG001|Overall Study|Adverse Event|10|||
129153318|NCT00690794|464858827|FG000|Overall Study|Lost to Follow-up|1|||
129153319|NCT00690794|464858828|FG001|Overall Study|Lost to Follow-up|4|||
128725463|NCT00262067|463290998|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
128725464|NCT00262067|463290999|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
129153320|NCT00690794|464858827|FG000|Overall Study|Withdrawal by Subject|0|||
129153321|NCT00690794|464858828|FG001|Overall Study|Withdrawal by Subject|9|||
129153322|NCT00690794|464858827|FG000|Overall Study|Protocol Violation|6|||
129153323|NCT00690794|464858828|FG001|Overall Study|Protocol Violation|7|||
129153324|NCT00690794|464858827|FG000|Overall Study|Noncompliance|1|||
129153325|NCT00690794|464858828|FG001|Overall Study|Noncompliance|2|||
129153326|NCT00690794|464858827|FG000|Overall Study|Other not specified|1|||
129153327|NCT00690794|464858828|FG001|Overall Study|Other not specified|3|||
129153328|NCT01496287|464858829|FG000|Overall Study|Lost to Follow-up|1|||
129153329|NCT01496287|464858829|FG000|Overall Study|Incomplete anesthesia|5|||
129153330|NCT01990742|464858830|FG000|Overall Study|Withdrawal by facility|407|||
129153331|NCT01990742|464858831|FG001|Overall Study|Withdrawal by facility|1083|||
129153332|NCT01990742|464858830|FG000|Overall Study|Facility closed|0|||
129153333|NCT01990742|464858831|FG001|Overall Study|Facility closed|270|||
129153334|NCT03443687|464858832|FG000|Overall Study|Lost to Follow-up|3|||
129153335|NCT03443687|464858833|FG001|Overall Study|Lost to Follow-up|5|||
129153336|NCT03443687|464858832|FG000|Overall Study|Withdrawal by Subject|1|||
129153337|NCT03443687|464858833|FG001|Overall Study|Withdrawal by Subject|0|||
129153338|NCT03443687|464858832|FG000|Overall Study|Discontinued intervention|1|||
129153339|NCT03443687|464858833|FG001|Overall Study|Discontinued intervention|1|||
129153340|NCT02805790|464858834|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
129153341|NCT02805790|464858835|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
129153342|NCT00800735|464858836|FG000|Overall Study|Administrative/Other|2|||
129153343|NCT00800735|464858836|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129153344|NCT00800735|464858836|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
129153345|NCT00800735|464858836|FG000|Overall Study|Withdrew Consent|3|||
129153346|NCT04460183|464858839|FG000|Overall Study|Lost to Follow-up|3|||
129153347|NCT04460183|464858840|FG001|Overall Study|Lost to Follow-up|1|||
129153348|NCT04460183|464858839|FG000|Overall Study|Withdrawal by Subject|1|||
129153349|NCT04460183|464858840|FG001|Overall Study|Withdrawal by Subject|0|||
129153350|NCT00825994|464858841|FG000|Overall Study|Withdrawal by Subject|2|||
129153351|NCT00825994|464858841|FG000|Overall Study|Lost to Follow-up|1|||
129153352|NCT00825994|464858841|FG000|Overall Study|Protocol Violation|1|||
129153353|NCT00825994|464858841|FG000|Overall Study|Placebo Responder at V2|1|||
129153354|NCT00501644|464858842|FG000|Overall Study|Adverse Event|4|||
129153355|NCT00501644|464858842|FG000|Overall Study|Withdrawal by Subject|1|||
129153356|NCT02394561|464858843|FG000|CORE Phase|Adverse Event|7|||
129153357|NCT02394561|464858844|FG001|CORE Phase|Adverse Event|9|||
129153358|NCT02394561|464858843|FG000|CORE Phase|Death|0|||
129153359|NCT02394561|464858844|FG001|CORE Phase|Death|1|||
129153360|NCT02394561|464858843|FG000|CORE Phase|Pregnancy|1|||
129153361|NCT02394561|464858844|FG001|CORE Phase|Pregnancy|0|||
129153362|NCT02394561|464858843|FG000|CORE Phase|Lost to Follow-up|1|||
129153363|NCT02394561|464858844|FG001|CORE Phase|Lost to Follow-up|0|||
129153364|NCT02394561|464858843|FG000|CORE Phase|Physician Decision|1|||
129153365|NCT02394561|464858844|FG001|CORE Phase|Physician Decision|1|||
129153366|NCT02394561|464858843|FG000|CORE Phase|Withdrawal by Subject|2|||
129153367|NCT02394561|464858844|FG001|CORE Phase|Withdrawal by Subject|2|||
129153368|NCT02394561|464858843|FG000|CORE Phase|Lack of Efficacy|1|||
129153369|NCT02394561|464858844|FG001|CORE Phase|Lack of Efficacy|6|||
129153370|NCT02394561|464858843|FG000|Extension Phase|Adverse Event|6|||
129153371|NCT02394561|464858844|FG001|Extension Phase|Adverse Event|1|||
129153372|NCT02394561|464858843|FG000|Extension Phase|Death|0|||
129153373|NCT02394561|464858844|FG001|Extension Phase|Death|1|||
129153374|NCT02394561|464858843|FG000|Extension Phase|Protocol Violation|1|||
129153375|NCT02394561|464858844|FG001|Extension Phase|Protocol Violation|0|||
129153376|NCT02394561|464858843|FG000|Extension Phase|Lost to Follow-up|1|||
129153377|NCT02394561|464858844|FG001|Extension Phase|Lost to Follow-up|0|||
129153378|NCT02394561|464858843|FG000|Extension Phase|Physician Decision|0|||
129153379|NCT02394561|464858844|FG001|Extension Phase|Physician Decision|2|||
129153380|NCT02394561|464858843|FG000|Extension Phase|Withdrawal by Subject|0|||
129153381|NCT02394561|464858844|FG001|Extension Phase|Withdrawal by Subject|5|||
129153382|NCT02394561|464858843|FG000|Extension Phase|Lack of Efficacy|3|||
129153383|NCT02394561|464858844|FG001|Extension Phase|Lack of Efficacy|3|||
129153384|NCT01812057|464858845|FG000|Overall Study|Protocol Violation|1|||
129153385|NCT01812057|464858846|FG001|Overall Study|Protocol Violation|0|||
129153386|NCT01812057|464858845|FG000|Overall Study|Physician Decision|1|||
129153387|NCT01812057|464858846|FG001|Overall Study|Physician Decision|0|||
129153388|NCT01882465|464858847|FG000|Period 1|Lens Discomfort|0|||
129153389|NCT01882465|464858848|FG001|Period 1|Lens Discomfort|0|||
129153390|NCT01882465|464858849|FG002|Period 1|Lens Discomfort|0|||
129153391|NCT01882465|464858850|FG003|Period 1|Lens Discomfort|1|||
129153392|NCT01882465|464858851|FG004|Period 1|Lens Discomfort|0|||
128776853|NCT01782326|463472024|FG000|Planned Treatment Epoch|Death|29|||
129153393|NCT01882465|464858852|FG005|Period 1|Lens Discomfort|0|||
129153394|NCT01882465|464858853|FG006|Period 1|Lens Discomfort|0|||
129153395|NCT01882465|464858847|FG000|Period 1|Withdrawal by Subject|0|||
129153396|NCT01882465|464858848|FG001|Period 1|Withdrawal by Subject|0|||
129153397|NCT01882465|464858849|FG002|Period 1|Withdrawal by Subject|0|||
129153398|NCT01882465|464858850|FG003|Period 1|Withdrawal by Subject|0|||
129153399|NCT01882465|464858851|FG004|Period 1|Withdrawal by Subject|0|||
129153400|NCT01882465|464858852|FG005|Period 1|Withdrawal by Subject|0|||
129153401|NCT01882465|464858853|FG006|Period 1|Withdrawal by Subject|1|||
129153402|NCT01882465|464858847|FG000|Period 2|Protocol Violation|0|||
129153403|NCT01882465|464858848|FG001|Period 2|Protocol Violation|0|||
129153404|NCT01882465|464858849|FG002|Period 2|Protocol Violation|0|||
129153405|NCT01882465|464858850|FG003|Period 2|Protocol Violation|0|||
129153406|NCT01882465|464858851|FG004|Period 2|Protocol Violation|1|||
129153407|NCT01882465|464858852|FG005|Period 2|Protocol Violation|0|||
129153408|NCT01882465|464858853|FG006|Period 2|Protocol Violation|0|||
129153409|NCT01378117|464858860|FG000|Overall Study|withdrawal|2|||
129153410|NCT01378117|464858861|FG001|Overall Study|withdrawal|1|||
129153411|NCT01378117|464858862|FG002|Overall Study|withdrawal|2|||
129153412|NCT01378117|464858860|FG000|Overall Study|discharged before med given|2|||
129153413|NCT01378117|464858861|FG001|Overall Study|discharged before med given|0|||
129153414|NCT01378117|464858862|FG002|Overall Study|discharged before med given|1|||
129153415|NCT02961244|464858864|FG000|Overall Study|Protocol Violation|0|||
129153416|NCT02961244|464858865|FG001|Overall Study|Protocol Violation|1|||
129153417|NCT02961244|464858864|FG000|Overall Study|Withdrawal by Subject|1|||
129153418|NCT02961244|464858865|FG001|Overall Study|Withdrawal by Subject|2|||
129153419|NCT02961244|464858864|FG000|Overall Study|Surgery plan change after study approval|0|||
128725465|NCT00262067|463290996|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
128725466|NCT00262067|463290997|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
128725467|NCT00262067|463290998|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
128725468|NCT00262067|463290999|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
128725469|NCT02357147|463291001|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
128725470|NCT02357147|463291002|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
128725471|NCT02357147|463291001|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
128725472|NCT02357147|463291002|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
128725473|NCT02357147|463291001|FG000|Combination Treatment Phase|Investigator Discretion|1|||
128725474|NCT02357147|463291002|FG001|Combination Treatment Phase|Investigator Discretion|1|||
128725475|NCT02357147|463291001|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
128725476|NCT02357147|463291002|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
128725477|NCT02357147|463291001|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
128725478|NCT02357147|463291002|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
128725479|NCT02357147|463291001|FG000|Combination Treatment Phase|Adverse Event|12|||
128725480|NCT02357147|463291002|FG001|Combination Treatment Phase|Adverse Event|4|||
129153420|NCT02961244|464858865|FG001|Overall Study|Surgery plan change after study approval|2|||
129153421|NCT02961244|464858864|FG000|Overall Study|Lost to Follow-up|0|||
129153422|NCT02961244|464858865|FG001|Overall Study|Lost to Follow-up|2|||
129153423|NCT02961244|464858864|FG000|Overall Study|İnadequate data|0|||
129153424|NCT02961244|464858865|FG001|Overall Study|İnadequate data|2|||
129153425|NCT01854528|464858866|FG000|Overall Study|Adverse Event|0|||
129153426|NCT01854528|464858867|FG001|Overall Study|Adverse Event|4|||
129153427|NCT01854528|464858866|FG000|Overall Study|Withdrawal by Subject|0|||
129153428|NCT01854528|464858867|FG001|Overall Study|Withdrawal by Subject|2|||
129153429|NCT01854528|464858866|FG000|Overall Study|Virologic Failure|0|||
129153430|NCT01854528|464858867|FG001|Overall Study|Virologic Failure|9|||
129153431|NCT03789292|464858868|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
129153432|NCT03789292|464858869|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
129153433|NCT03789292|464858870|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
129153434|NCT03789292|464858868|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
129153435|NCT03789292|464858869|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
129153436|NCT03789292|464858870|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
129153437|NCT03789292|464858868|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
129153438|NCT03789292|464858869|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
129153439|NCT03789292|464858870|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
129153440|NCT03789292|464858868|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
129153441|NCT03789292|464858869|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
129153442|NCT03789292|464858870|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
129153443|NCT03789292|464858868|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
129153444|NCT03789292|464858869|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
129153445|NCT03789292|464858870|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
129153446|NCT03789292|464858868|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
129153447|NCT03789292|464858869|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
129153448|NCT03789292|464858870|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
129153449|NCT03789292|464858868|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
129153450|NCT03789292|464858869|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
129153451|NCT03789292|464858870|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
129153452|NCT03789292|464858868|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
129153453|NCT03789292|464858869|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
129153454|NCT03789292|464858870|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
129153455|NCT03789292|464858868|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
129153456|NCT03789292|464858869|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
129153457|NCT03789292|464858870|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
129153458|NCT03789292|464858868|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
129153459|NCT03789292|464858869|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
129153460|NCT03789292|464858870|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
129153461|NCT03789292|464858868|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
129153462|NCT03789292|464858869|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
129153463|NCT03789292|464858870|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
129153464|NCT03789292|464858868|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
129153465|NCT03789292|464858869|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
129153466|NCT03789292|464858870|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
129153467|NCT03789292|464858868|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
129153468|NCT03789292|464858869|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
129153469|NCT03789292|464858870|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
129153470|NCT01904721|464858872|FG000|Overall Study|Other Reasons|0|||
129153471|NCT01904721|464858873|FG001|Overall Study|Other Reasons|0|||
129153472|NCT01904721|464858874|FG002|Overall Study|Other Reasons|1|||
129153473|NCT01904721|464858875|FG003|Overall Study|Other Reasons|1|||
129153474|NCT01904721|464858876|FG004|Overall Study|Other Reasons|2|||
129153475|NCT01904721|464858877|FG005|Overall Study|Other Reasons|2|||
129153476|NCT01904721|464858878|FG006|Overall Study|Other Reasons|2|||
129153477|NCT01904721|464858872|FG000|Overall Study|Personal Reasons|0|||
129153478|NCT01904721|464858873|FG001|Overall Study|Personal Reasons|0|||
129153479|NCT01904721|464858874|FG002|Overall Study|Personal Reasons|0|||
129153480|NCT01904721|464858875|FG003|Overall Study|Personal Reasons|0|||
129153481|NCT01904721|464858876|FG004|Overall Study|Personal Reasons|2|||
129153482|NCT01904721|464858877|FG005|Overall Study|Personal Reasons|3|||
129153483|NCT01904721|464858878|FG006|Overall Study|Personal Reasons|3|||
129153484|NCT01904721|464858872|FG000|Overall Study|Lost to Follow-up|0|||
129153485|NCT01904721|464858873|FG001|Overall Study|Lost to Follow-up|0|||
129153486|NCT01904721|464858874|FG002|Overall Study|Lost to Follow-up|0|||
129153487|NCT01904721|464858875|FG003|Overall Study|Lost to Follow-up|0|||
129153488|NCT01904721|464858876|FG004|Overall Study|Lost to Follow-up|1|||
129153489|NCT01904721|464858877|FG005|Overall Study|Lost to Follow-up|3|||
129153490|NCT01904721|464858878|FG006|Overall Study|Lost to Follow-up|1|||
129153491|NCT01904721|464858872|FG000|Overall Study|Lack of Efficacy|0|||
129153492|NCT01904721|464858873|FG001|Overall Study|Lack of Efficacy|0|||
129153493|NCT01904721|464858874|FG002|Overall Study|Lack of Efficacy|0|||
129153494|NCT01904721|464858875|FG003|Overall Study|Lack of Efficacy|0|||
129153495|NCT01904721|464858876|FG004|Overall Study|Lack of Efficacy|0|||
129153496|NCT01904721|464858877|FG005|Overall Study|Lack of Efficacy|0|||
129153497|NCT01904721|464858878|FG006|Overall Study|Lack of Efficacy|1|||
129153498|NCT01904721|464858872|FG000|Overall Study|Adverse Event|0|||
129153499|NCT01904721|464858873|FG001|Overall Study|Adverse Event|0|||
129153500|NCT01904721|464858874|FG002|Overall Study|Adverse Event|0|||
129153501|NCT01904721|464858875|FG003|Overall Study|Adverse Event|0|||
129153502|NCT01904721|464858876|FG004|Overall Study|Adverse Event|3|||
129153503|NCT01904721|464858877|FG005|Overall Study|Adverse Event|1|||
129153504|NCT01904721|464858878|FG006|Overall Study|Adverse Event|0|||
129153505|NCT01957865|464858879|FG000|Overall Study|Found HIV negative|0|||
129153506|NCT01957865|464858880|FG001|Overall Study|Found HIV negative|0|||
129153507|NCT01957865|464858881|FG002|Overall Study|Found HIV negative|1|||
129153508|NCT01957865|464858879|FG000|Overall Study|Lost to Follow-up|0|||
129153509|NCT01957865|464858880|FG001|Overall Study|Lost to Follow-up|2|||
129153510|NCT01957865|464858881|FG002|Overall Study|Lost to Follow-up|2|||
129153511|NCT01082614|464858882|FG000|Overall Study|Adverse Event|1|||
129153512|NCT01082614|464858883|FG001|Overall Study|Adverse Event|4|||
129153513|NCT01082614|464858882|FG000|Overall Study|Equipment Malfunction|0|||
129153514|NCT01082614|464858883|FG001|Overall Study|Equipment Malfunction|1|||
129153515|NCT01082614|464858882|FG000|Overall Study|Physician Decision|2|||
129153516|NCT01082614|464858883|FG001|Overall Study|Physician Decision|0|||
129153517|NCT00811720|464858887|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
129153518|NCT00811720|464858888|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
129153519|NCT00811720|464858887|FG000|All Treated Patients|Adverse Event|20|||
129153520|NCT00811720|464858888|FG001|All Treated Patients|Adverse Event|62|||
129153521|NCT00811720|464858887|FG000|All Treated Patients|Lack of Efficacy|22|||
129153522|NCT00811720|464858888|FG001|All Treated Patients|Lack of Efficacy|18|||
129153523|NCT00811720|464858887|FG000|All Treated Patients|Non-compliance|0|||
129153524|NCT00811720|464858888|FG001|All Treated Patients|Non-compliance|14|||
129153525|NCT00811720|464858887|FG000|All Treated Patients|Protocol Violation|9|||
129153526|NCT00811720|464858888|FG001|All Treated Patients|Protocol Violation|16|||
129153527|NCT00811720|464858887|FG000|All Treated Patients|Withdrawal by Subject|28|||
129153528|NCT00811720|464858888|FG001|All Treated Patients|Withdrawal by Subject|34|||
129153529|NCT00811720|464858887|FG000|All Treated Patients|Lost to Follow-up|10|||
129153530|NCT00811720|464858888|FG001|All Treated Patients|Lost to Follow-up|16|||
129153531|NCT00811720|464858887|FG000|All Treated Patients|Other Reason|7|||
129153532|NCT00811720|464858888|FG001|All Treated Patients|Other Reason|4|||
129153533|NCT01077063|464858889|FG000|Overall Study|Adverse Event|3|||
129153534|NCT01077063|464858890|FG001|Overall Study|Adverse Event|0|||
129153535|NCT01077063|464858889|FG000|Overall Study|Death|1|||
129153536|NCT01077063|464858890|FG001|Overall Study|Death|1|||
129153537|NCT01077063|464858889|FG000|Overall Study|Withdrawal by Subject|0|||
129153538|NCT01077063|464858890|FG001|Overall Study|Withdrawal by Subject|2|||
129153539|NCT00553631|464858891|FG000|Overall Study|Withdrawal by Subject|0|||
129153540|NCT00553631|464858892|FG001|Overall Study|Withdrawal by Subject|1|||
129153541|NCT00553631|464858891|FG000|Overall Study|Lost to Follow-up|1|||
129153542|NCT00553631|464858892|FG001|Overall Study|Lost to Follow-up|0|||
129153543|NCT02761642|464858893|FG000|Overall Study|Did not Receive Study Treatment|3|||
129153544|NCT02761642|464858893|FG000|Overall Study|Adverse Event|13|||
129153545|NCT02761642|464858893|FG000|Overall Study|Withdrawal by Subject|2|||
129153546|NCT02761642|464858893|FG000|Overall Study|Non-compliant|7|||
129153547|NCT02761642|464858893|FG000|Overall Study|Death|3|||
129153548|NCT02761642|464858893|FG000|Overall Study|Lack of Efficacy|20|||
129153549|NCT02761642|464858893|FG000|Overall Study|Physician Decision|1|||
129153550|NCT02761642|464858893|FG000|Overall Study|Reason Unspecified|21|||
129153551|NCT02756403|464858898|FG000|Overall Study|Unable to swallow medication|0|||
129153552|NCT02756403|464858899|FG001|Overall Study|Unable to swallow medication|1|||
129153553|NCT02756403|464858900|FG002|Overall Study|Unable to swallow medication|1|||
129153554|NCT02756403|464858901|FG003|Overall Study|Unable to swallow medication|1|||
129153555|NCT02756403|464858898|FG000|Overall Study|Did not complete Procedure|0|||
129153556|NCT02756403|464858899|FG001|Overall Study|Did not complete Procedure|1|||
129153557|NCT02756403|464858900|FG002|Overall Study|Did not complete Procedure|0|||
129153558|NCT02756403|464858901|FG003|Overall Study|Did not complete Procedure|0|||
129153559|NCT02756403|464858898|FG000|Overall Study|Changed Mind About Procedure|0|||
129153560|NCT02756403|464858899|FG001|Overall Study|Changed Mind About Procedure|0|||
129153561|NCT02756403|464858900|FG002|Overall Study|Changed Mind About Procedure|1|||
129153562|NCT02756403|464858901|FG003|Overall Study|Changed Mind About Procedure|0|||
129153563|NCT02756403|464858898|FG000|Overall Study|Protocol Violation|0|||
129153564|NCT02756403|464858899|FG001|Overall Study|Protocol Violation|1|||
129153565|NCT02756403|464858900|FG002|Overall Study|Protocol Violation|0|||
129153566|NCT02756403|464858901|FG003|Overall Study|Protocol Violation|1|||
129153567|NCT01644643|464858902|FG000|Overall Study|Death|1|||
129153568|NCT01644643|464858903|FG001|Overall Study|Death|0|||
129153569|NCT01644643|464858904|FG002|Overall Study|Death|3|||
129153570|NCT01644643|464858905|FG003|Overall Study|Death|3|||
129153571|NCT01644643|464858902|FG000|Overall Study|Lost to Follow-up|0|||
129153572|NCT01644643|464858903|FG001|Overall Study|Lost to Follow-up|0|||
129153573|NCT01644643|464858904|FG002|Overall Study|Lost to Follow-up|0|||
129153574|NCT01644643|464858905|FG003|Overall Study|Lost to Follow-up|4|||
129153575|NCT01644643|464858902|FG000|Overall Study|Withdrawal by Subject|1|||
129153576|NCT01644643|464858903|FG001|Overall Study|Withdrawal by Subject|0|||
129153577|NCT01644643|464858904|FG002|Overall Study|Withdrawal by Subject|2|||
129153578|NCT01644643|464858905|FG003|Overall Study|Withdrawal by Subject|1|||
129153579|NCT01644643|464858902|FG000|Overall Study|Other Eligibility criteria|0|||
129153580|NCT01644643|464858903|FG001|Overall Study|Other Eligibility criteria|0|||
129153581|NCT01644643|464858904|FG002|Overall Study|Other Eligibility criteria|0|||
129153582|NCT01644643|464858905|FG003|Overall Study|Other Eligibility criteria|2|||
129153583|NCT02850978|464858910|FG000|Overall Study|Uncollectable CRF|27|||
129153584|NCT02850978|464858910|FG000|Overall Study|No visit since the first visit|35|||
129153585|NCT02850978|464858910|FG000|Overall Study|Adverse Event|81|||
129153586|NCT02850978|464858910|FG000|Overall Study|Lack of Efficacy|40|||
129153587|NCT02850978|464858910|FG000|Overall Study|Improvement in condition|34|||
129153588|NCT02850978|464858910|FG000|Overall Study|Lost to Follow-up|121|||
129153589|NCT02850978|464858910|FG000|Overall Study|Reason not listed|88|||
129153590|NCT01055613|464858913|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
129153591|NCT01055613|464858914|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129153592|NCT01055613|464858913|FG000|Overall Study|Unacceptable lens fit|1|||
129153593|NCT01055613|464858914|FG001|Overall Study|Unacceptable lens fit|0|||
129153594|NCT01055613|464858913|FG000|Overall Study|Discomfort|2|||
129153595|NCT01055613|464858914|FG001|Overall Study|Discomfort|1|||
129153596|NCT01055613|464858913|FG000|Overall Study|Lost to Follow-up|1|||
129153597|NCT01055613|464858914|FG001|Overall Study|Lost to Follow-up|1|||
129153598|NCT01055613|464858913|FG000|Overall Study|Protocol Violation|1|||
129153599|NCT01055613|464858914|FG001|Overall Study|Protocol Violation|1|||
129153600|NCT01055613|464858913|FG000|Overall Study|Subject Disinterest|1|||
129153601|NCT01055613|464858914|FG001|Overall Study|Subject Disinterest|1|||
129153602|NCT02765399|464858915|FG000|Overall Study|Nausea|1|||
129153603|NCT02765399|464858916|FG001|Overall Study|Nausea|0|||
129153604|NCT01182298|464858923|FG000|Overall Study|Lack of Efficacy|4|||
129153605|NCT01182298|464858923|FG000|Overall Study|Withdrawal by Subject|2|||
129153606|NCT01822665|464858939|FG000|Overall Study|Adverse Event|3|||
129153607|NCT01822665|464858939|FG000|Overall Study|Other Reason|5|||
129153608|NCT04540367|464858940|FG000|Overall Study|Withdrawal by Subject|0|||
129153609|NCT04540367|464858941|FG001|Overall Study|Withdrawal by Subject|0|||
129153610|NCT04540367|464858942|FG002|Overall Study|Withdrawal by Subject|0|||
129153611|NCT04540367|464858943|FG003|Overall Study|Withdrawal by Subject|2|||
129153612|NCT04540367|464858940|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
129153613|NCT04540367|464858941|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
129153614|NCT04540367|464858942|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
129153615|NCT04540367|464858943|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
129153616|NCT04540367|464858940|FG000|Overall Study|Adverse Event|0|||
129153617|NCT04540367|464858941|FG001|Overall Study|Adverse Event|0|||
129153618|NCT04540367|464858942|FG002|Overall Study|Adverse Event|1|||
129153619|NCT04540367|464858943|FG003|Overall Study|Adverse Event|1|||
129153620|NCT00959907|464858946|FG000|Overall Study|Protocol Violation|0|||
129153621|NCT00959907|464858947|FG001|Overall Study|Protocol Violation|1|||
129153622|NCT00959907|464858946|FG000|Overall Study|Adverse Event|1|||
129153623|NCT00959907|464858947|FG001|Overall Study|Adverse Event|0|||
129153624|NCT00959907|464858946|FG000|Overall Study|Withdrawal by Subject|2|||
129153625|NCT00959907|464858947|FG001|Overall Study|Withdrawal by Subject|0|||
129153626|NCT03958331|464858948|FG000|Overall Study|Withdrawal by Subject|3|||
129153627|NCT03958331|464858949|FG001|Overall Study|Withdrawal by Subject|1|||
129153628|NCT03958331|464858950|FG002|Overall Study|Withdrawal by Subject|5|||
129153629|NCT03958331|464858948|FG000|Overall Study|Weaned from medicine|2|||
129153630|NCT03958331|464858949|FG001|Overall Study|Weaned from medicine|0|||
129153631|NCT03958331|464858950|FG002|Overall Study|Weaned from medicine|0|||
129153632|NCT03958331|464858948|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
129153633|NCT03958331|464858949|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
129153634|NCT03958331|464858950|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
129153635|NCT04290624|464858951|FG000|Overall Study|Adverse Event|1|||
129153636|NCT04290624|464858952|FG001|Overall Study|Adverse Event|0|||
129153637|NCT04422431|464858953|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
129153638|NCT04422431|464858953|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
129153639|NCT04422431|464858953|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
129153640|NCT04422431|464858953|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
129153641|NCT04422431|464858953|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
129153642|NCT04422431|464858953|FG000|Extension Period (48 Weeks)|Other than specified|2|||
128725481|NCT02357147|463291001|FG000|Combination Treatment Phase|Death|1|||
129153643|NCT02735421|464860407|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
129153644|NCT02735421|464860407|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
129153645|NCT02735421|464860407|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
129153646|NCT02735421|464860407|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
129153647|NCT02735421|464860407|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
129153648|NCT02735421|464860407|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
129153649|NCT02735421|464860407|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
129153650|NCT05010070|464860408|FG000|Overall Study|Lost to Follow-up|1|||
129153651|NCT05010070|464860408|FG000|Overall Study|Withdrawal by Subject|1|||
129153652|NCT00939107|464860409|FG000|Overall Study|Lost to Follow-up|14|||
129153653|NCT00939107|464860410|FG001|Overall Study|Lost to Follow-up|12|||
129153654|NCT03247829|464860412|FG000|Overall Study|Death|3|||
129153655|NCT03247829|464860413|FG001|Overall Study|Death|4|||
129153656|NCT03247829|464860412|FG000|Overall Study|Enter Hospice Care|1|||
128725482|NCT02357147|463291002|FG001|Combination Treatment Phase|Death|1|||
129153657|NCT03247829|464860413|FG001|Overall Study|Enter Hospice Care|0|||
129153658|NCT03247829|464860412|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
129153659|NCT03247829|464860413|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
129153660|NCT03247829|464860412|FG000|Overall Study|LVAD Explant|1|||
129153661|NCT03247829|464860413|FG001|Overall Study|LVAD Explant|1|||
129153662|NCT03247829|464860412|FG000|Overall Study|Transplant|1|||
129153663|NCT03247829|464860413|FG001|Overall Study|Transplant|1|||
128776854|NCT01782326|463472025|FG001|Planned Treatment Epoch|Death|30|||
129153664|NCT01783444|464860414|FG000|Treatment Phase|Adverse Event|9|||
129153665|NCT01783444|464860415|FG001|Treatment Phase|Adverse Event|20|||
129153666|NCT01783444|464860416|FG002|Treatment Phase|Adverse Event|19|||
129153667|NCT01783444|464860414|FG000|Treatment Phase|Disease Progression|76|||
129153668|NCT01783444|464860415|FG001|Treatment Phase|Disease Progression|66|||
129153669|NCT01783444|464860416|FG002|Treatment Phase|Disease Progression|64|||
129153670|NCT01783444|464860414|FG000|Treatment Phase|Death|2|||
129153671|NCT01783444|464860415|FG001|Treatment Phase|Death|2|||
129153672|NCT01783444|464860416|FG002|Treatment Phase|Death|2|||
129153673|NCT01783444|464860414|FG000|Treatment Phase|Protocol Violation|1|||
129153674|NCT01783444|464860415|FG001|Treatment Phase|Protocol Violation|1|||
129153675|NCT01783444|464860416|FG002|Treatment Phase|Protocol Violation|2|||
129153676|NCT01783444|464860414|FG000|Treatment Phase|Withdrawal by Subject|6|||
129153677|NCT01783444|464860415|FG001|Treatment Phase|Withdrawal by Subject|8|||
129153678|NCT01783444|464860416|FG002|Treatment Phase|Withdrawal by Subject|9|||
129153679|NCT01783444|464860414|FG000|Treatment Phase|Administrative problems|2|||
129153680|NCT01783444|464860415|FG001|Treatment Phase|Administrative problems|0|||
129153681|NCT01783444|464860416|FG002|Treatment Phase|Administrative problems|1|||
129153682|NCT01783444|464860414|FG000|Treatment Phase|Physician Decision|8|||
129153683|NCT01783444|464860415|FG001|Treatment Phase|Physician Decision|6|||
129153684|NCT01783444|464860416|FG002|Treatment Phase|Physician Decision|5|||
129153685|NCT01783444|464860414|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
129153686|NCT01783444|464860415|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
129153687|NCT01783444|464860416|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
129153688|NCT01783444|464860414|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
129153689|NCT01783444|464860415|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
129153690|NCT01783444|464860416|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
129153691|NCT01783444|464860414|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
129153692|NCT01783444|464860415|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
129153693|NCT01783444|464860416|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
129153694|NCT01783444|464860414|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
129153695|NCT01783444|464860415|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
129153696|NCT01783444|464860416|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
129153697|NCT01783444|464860414|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
129153698|NCT01783444|464860415|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
129153699|NCT01783444|464860416|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
129153700|NCT01783444|464860414|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
129153701|NCT01783444|464860415|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
129153702|NCT01783444|464860416|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
129153703|NCT01047007|464860422|FG000|Overall Study|Adverse Event|0|||
129153704|NCT01047007|464860423|FG001|Overall Study|Adverse Event|2|||
129153705|NCT01047007|464860424|FG002|Overall Study|Adverse Event|1|||
129153706|NCT01047007|464860425|FG003|Overall Study|Adverse Event|0|||
129153707|NCT01047007|464860422|FG000|Overall Study|Progressive Disease|2|||
129153708|NCT01047007|464860423|FG001|Overall Study|Progressive Disease|4|||
129153709|NCT01047007|464860424|FG002|Overall Study|Progressive Disease|1|||
129153710|NCT01047007|464860425|FG003|Overall Study|Progressive Disease|0|||
129153711|NCT01334554|464860426|FG000|Overall Study|Adverse Event|4|||
129153712|NCT01334554|464860427|FG001|Overall Study|Adverse Event|2|||
129153713|NCT02393859|464860428|FG000|Overall Study|Decision by Sponsor|2|||
129153714|NCT02393859|464860429|FG001|Overall Study|Decision by Sponsor|4|||
129153715|NCT02393859|464860428|FG000|Overall Study|Withdrawal by Subject|11|||
129153716|NCT02393859|464860429|FG001|Overall Study|Withdrawal by Subject|6|||
129153717|NCT02393859|464860428|FG000|Overall Study|Death|27|||
129153718|NCT02393859|464860429|FG001|Overall Study|Death|10|||
129153719|NCT02393859|464860428|FG000|Overall Study|Lost to Follow-up|1|||
129153720|NCT02393859|464860429|FG001|Overall Study|Lost to Follow-up|1|||
129153721|NCT00954447|464860430|FG000|Overall Study|Adverse Event|33|||
129153722|NCT00954447|464860431|FG001|Overall Study|Adverse Event|25|||
129153723|NCT00954447|464860430|FG000|Overall Study|Lack of Efficacy|17|||
129153724|NCT00954447|464860431|FG001|Overall Study|Lack of Efficacy|3|||
129153725|NCT00954447|464860430|FG000|Overall Study|Protocol Violation|5|||
129153726|NCT00954447|464860431|FG001|Overall Study|Protocol Violation|7|||
129153727|NCT00954447|464860430|FG000|Overall Study|Lost to Follow-up|8|||
129153728|NCT00954447|464860431|FG001|Overall Study|Lost to Follow-up|14|||
129153729|NCT00954447|464860430|FG000|Overall Study|Withdrawal by Subject|26|||
129153730|NCT00954447|464860431|FG001|Overall Study|Withdrawal by Subject|21|||
129153731|NCT00954447|464860430|FG000|Overall Study|Other|21|||
129153732|NCT00954447|464860431|FG001|Overall Study|Other|18|||
129153733|NCT04592341|464860432|FG000|Overall Study|Physician Decision|5|||
129153734|NCT04592341|464860432|FG000|Overall Study|Study Terminated by Sponsor|5|||
129153735|NCT04592341|464860432|FG000|Overall Study|Withdrawal by Subject|53|||
129153736|NCT04592341|464860432|FG000|Overall Study|Lost to Follow-up|3|||
129153737|NCT04592341|464860432|FG000|Overall Study|Death|1|||
129153738|NCT04592341|464860432|FG000|Overall Study|Adverse Event|5|||
129153739|NCT04592341|464860432|FG000|Overall Study|other|4|||
129153740|NCT00692003|464860433|FG000|Overall Study|Sponsor Decision|5|||
129153741|NCT00692003|464860434|FG001|Overall Study|Sponsor Decision|1|||
129153742|NCT01248793|464860435|FG000|Overall Study|Lost to Follow-up|0|||
129153743|NCT01248793|464860436|FG001|Overall Study|Lost to Follow-up|1|||
129153744|NCT01248793|464860435|FG000|Overall Study|Adverse Event|1|||
129153745|NCT01248793|464860436|FG001|Overall Study|Adverse Event|1|||
129153746|NCT01248793|464860435|FG000|Overall Study|Protocol Violation|0|||
129153747|NCT01248793|464860436|FG001|Overall Study|Protocol Violation|1|||
129153748|NCT01248793|464860435|FG000|Overall Study|Withdrawal by Subject|3|||
129153749|NCT01248793|464860436|FG001|Overall Study|Withdrawal by Subject|3|||
129153750|NCT01840943|464860437|FG000|Overall Study|Withdrawal by Subject|5|||
129153751|NCT01840943|464860438|FG001|Overall Study|Withdrawal by Subject|6|||
129153752|NCT01840943|464860437|FG000|Overall Study|Physician Decision|4|||
129153753|NCT01840943|464860438|FG001|Overall Study|Physician Decision|2|||
129153754|NCT01840943|464860437|FG000|Overall Study|Lost to Follow-up|4|||
129153755|NCT01840943|464860438|FG001|Overall Study|Lost to Follow-up|4|||
129153756|NCT02580877|464860441|FG000|Overall Study|Withdrawal by Subject|1|||
129153757|NCT02580877|464860442|FG001|Overall Study|Withdrawal by Subject|3|||
129153758|NCT02580877|464860441|FG000|Overall Study|Adverse Event|0|||
129153759|NCT02580877|464860442|FG001|Overall Study|Adverse Event|1|||
129153760|NCT02903823|464860443|FG000|Overall Study|Physician Decision|5|||
129153761|NCT02903823|464860443|FG000|Overall Study|Could not advance catheter|1|||
129153762|NCT02903823|464860443|FG000|Overall Study|Catheter dislodgement|1|||
129153763|NCT01747915|464860444|FG000|Overall Study|Other|1|||
129153764|NCT01747915|464860445|FG001|Overall Study|Other|1|||
128725483|NCT02357147|463291001|FG000|Combination Treatment Phase|Sponsor Decision|0|||
128725484|NCT02357147|463291002|FG001|Combination Treatment Phase|Sponsor Decision|12|||
128725485|NCT02357147|463291001|FG000|Combination Treatment Phase|Other|1|||
128725486|NCT02357147|463291002|FG001|Combination Treatment Phase|Other|0|||
128725487|NCT02357147|463291001|FG000|Combination Treatment Phase|Not treated|0|||
128725488|NCT02357147|463291002|FG001|Combination Treatment Phase|Not treated|2|||
128725489|NCT02357147|463291001|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
128725490|NCT02357147|463291002|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
128725491|NCT02357147|463291001|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
128725492|NCT02357147|463291002|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
128725493|NCT02357147|463291001|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
128725494|NCT02357147|463291002|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
128725495|NCT02357147|463291001|FG000|Maintenance Treatment Phase|Adverse Event|0|||
128725496|NCT02357147|463291002|FG001|Maintenance Treatment Phase|Adverse Event|3|||
128725497|NCT02357147|463291001|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
128725498|NCT02357147|463291002|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
128725499|NCT02357147|463291001|FG000|Maintenance Treatment Phase|Not Treated|1|||
128725500|NCT02357147|463291002|FG001|Maintenance Treatment Phase|Not Treated|0|||
128725501|NCT03962543|463291003|FG000|Treatment Phase|Death|0|||
128725502|NCT03962543|463291004|FG001|Treatment Phase|Death|1|||
128725503|NCT03962543|463291003|FG000|Treatment Phase|Withdrawal by Subject|3|||
128725504|NCT03962543|463291004|FG001|Treatment Phase|Withdrawal by Subject|0|||
129153765|NCT01747915|464860446|FG002|Overall Study|Other|1|||
129153766|NCT01747915|464860444|FG000|Overall Study|Adverse Event|8|||
129153767|NCT01747915|464860445|FG001|Overall Study|Adverse Event|5|||
129153768|NCT01747915|464860446|FG002|Overall Study|Adverse Event|2|||
129153769|NCT01747915|464860444|FG000|Overall Study|Death|0|||
129153770|NCT01747915|464860445|FG001|Overall Study|Death|0|||
129153771|NCT01747915|464860446|FG002|Overall Study|Death|1|||
129153772|NCT01747915|464860444|FG000|Overall Study|Lack of Efficacy|0|||
129153773|NCT01747915|464860445|FG001|Overall Study|Lack of Efficacy|1|||
129153774|NCT01747915|464860446|FG002|Overall Study|Lack of Efficacy|0|||
129153775|NCT01747915|464860444|FG000|Overall Study|Lost to Follow-up|1|||
129153776|NCT01747915|464860445|FG001|Overall Study|Lost to Follow-up|0|||
128725505|NCT03962543|463291003|FG000|Treatment Phase|Adverse Event|3|||
128725506|NCT03962543|463291004|FG001|Treatment Phase|Adverse Event|12|||
128725507|NCT03962543|463291003|FG000|Treatment Phase|Lost to Follow-up|1|||
128725508|NCT03962543|463291004|FG001|Treatment Phase|Lost to Follow-up|2|||
129153777|NCT01747915|464860446|FG002|Overall Study|Lost to Follow-up|0|||
129153778|NCT01747915|464860444|FG000|Overall Study|Withdrawal by Subject|4|||
129153779|NCT01747915|464860445|FG001|Overall Study|Withdrawal by Subject|4|||
129153780|NCT01747915|464860446|FG002|Overall Study|Withdrawal by Subject|1|||
129153781|NCT01747915|464860444|FG000|Overall Study|Protocol Violation|1|||
129153782|NCT01747915|464860445|FG001|Overall Study|Protocol Violation|0|||
129153783|NCT01747915|464860446|FG002|Overall Study|Protocol Violation|0|||
129153784|NCT01747915|464860444|FG000|Overall Study|Pregnancy|0|||
129153785|NCT01747915|464860445|FG001|Overall Study|Pregnancy|0|||
129153786|NCT01747915|464860446|FG002|Overall Study|Pregnancy|1|||
129153787|NCT03341637|464860447|FG000|Overall Study|Lost to Follow-up|1|||
129153788|NCT03341637|464860448|FG001|Overall Study|Lost to Follow-up|0|||
129153789|NCT03341637|464860447|FG000|Overall Study|Withdrawal by Subject|3|||
129153790|NCT03341637|464860448|FG001|Overall Study|Withdrawal by Subject|3|||
129153791|NCT03341637|464860447|FG000|Overall Study|Reason not Specified|1|||
129153792|NCT03341637|464860448|FG001|Overall Study|Reason not Specified|1|||
129153793|NCT00887159|464860455|FG000|Overall Study|Disease progression|6|||
129153794|NCT00887159|464860456|FG001|Overall Study|Disease progression|39|||
129153795|NCT00887159|464860457|FG002|Overall Study|Disease progression|33|||
129153796|NCT00887159|464860455|FG000|Overall Study|Adverse Event|3|||
129153797|NCT00887159|464860456|FG001|Overall Study|Adverse Event|4|||
129153798|NCT00887159|464860457|FG002|Overall Study|Adverse Event|17|||
129153799|NCT00887159|464860455|FG000|Overall Study|Death|2|||
129153800|NCT00887159|464860456|FG001|Overall Study|Death|2|||
129153801|NCT00887159|464860457|FG002|Overall Study|Death|0|||
129153802|NCT00887159|464860455|FG000|Overall Study|Withdrawal by Subject|4|||
129153803|NCT00887159|464860456|FG001|Overall Study|Withdrawal by Subject|4|||
129153804|NCT00887159|464860457|FG002|Overall Study|Withdrawal by Subject|2|||
129153805|NCT00887159|464860455|FG000|Overall Study|Alternative therapy|2|||
129153806|NCT00887159|464860456|FG001|Overall Study|Alternative therapy|0|||
129153807|NCT00887159|464860457|FG002|Overall Study|Alternative therapy|0|||
129153808|NCT00887159|464860455|FG000|Overall Study|Physician Decision|1|||
129153809|NCT00887159|464860456|FG001|Overall Study|Physician Decision|1|||
129153810|NCT00887159|464860457|FG002|Overall Study|Physician Decision|0|||
129153811|NCT00887159|464860455|FG000|Overall Study|Sympomatic deterioration|1|||
129153812|NCT00887159|464860456|FG001|Overall Study|Sympomatic deterioration|0|||
129153813|NCT00887159|464860457|FG002|Overall Study|Sympomatic deterioration|0|||
129153814|NCT00887159|464860455|FG000|Overall Study|Treatment delayed|1|||
129153815|NCT00887159|464860456|FG001|Overall Study|Treatment delayed|1|||
129153816|NCT00887159|464860457|FG002|Overall Study|Treatment delayed|0|||
129153817|NCT00887159|464860455|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
129153818|NCT00887159|464860456|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
129153819|NCT00887159|464860457|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
129153820|NCT00887159|464860455|FG000|Overall Study|Received more tx instead of observation|1|||
129153821|NCT00887159|464860456|FG001|Overall Study|Received more tx instead of observation|0|||
129153822|NCT00887159|464860457|FG002|Overall Study|Received more tx instead of observation|0|||
129153823|NCT00887159|464860455|FG000|Overall Study|Ineligible|5|||
129153824|NCT00887159|464860456|FG001|Overall Study|Ineligible|1|||
129153825|NCT00887159|464860457|FG002|Overall Study|Ineligible|0|||
129153826|NCT00887159|464860455|FG000|Overall Study|Never started assigned therapy|3|||
129153827|NCT00887159|464860456|FG001|Overall Study|Never started assigned therapy|3|||
129153828|NCT00887159|464860457|FG002|Overall Study|Never started assigned therapy|4|||
129153829|NCT01772550|464860461|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
129153830|NCT01772550|464860462|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
129153831|NCT01772550|464860463|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
129153832|NCT01772550|464860461|FG000|Overall Study|Adverse Event|0|||
129153833|NCT01772550|464860462|FG001|Overall Study|Adverse Event|0|||
129153834|NCT01772550|464860463|FG002|Overall Study|Adverse Event|1|||
129153835|NCT03374358|464860467|FG000|Overall Study|Withdrawal by Subject|0|||
129153836|NCT03374358|464860468|FG001|Overall Study|Withdrawal by Subject|2|||
129153837|NCT00688467|464860469|FG000|Treatment Period 1|Adverse Event|2|||
129153838|NCT00688467|464860470|FG001|Treatment Period 1|Adverse Event|1|||
129153839|NCT00688467|464860469|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
129153840|NCT00688467|464860470|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
129153841|NCT00688467|464860469|FG000|Treatment Period 2|Protocol Violation|0|||
129153842|NCT00688467|464860470|FG001|Treatment Period 2|Protocol Violation|1|||
129153843|NCT00688467|464860469|FG000|Treatment Period 2|Adverse Event|0|||
129153844|NCT00688467|464860470|FG001|Treatment Period 2|Adverse Event|1|||
129153845|NCT01823107|464860474|FG000|Overall Study|Withdrawal by Subject|1|||
129153846|NCT01343888|464860475|FG000|Overall Study|Adverse Event|12|||
129153847|NCT01343888|464860476|FG001|Overall Study|Adverse Event|22|||
129153848|NCT01343888|464860477|FG002|Overall Study|Adverse Event|5|||
129153849|NCT01343888|464860475|FG000|Overall Study|Lack of Efficacy|9|||
129153850|NCT01343888|464860476|FG001|Overall Study|Lack of Efficacy|9|||
129153851|NCT01343888|464860477|FG002|Overall Study|Lack of Efficacy|13|||
129153852|NCT01343888|464860475|FG000|Overall Study|Lost to Follow-up|0|||
129153853|NCT01343888|464860476|FG001|Overall Study|Lost to Follow-up|2|||
129153854|NCT01343888|464860477|FG002|Overall Study|Lost to Follow-up|1|||
129153855|NCT01343888|464860475|FG000|Overall Study|Protocol Violation|0|||
129153856|NCT01343888|464860476|FG001|Overall Study|Protocol Violation|2|||
129153857|NCT01343888|464860477|FG002|Overall Study|Protocol Violation|0|||
129153858|NCT01343888|464860475|FG000|Overall Study|Withdrawal by Subject|4|||
129153859|NCT01343888|464860476|FG001|Overall Study|Withdrawal by Subject|4|||
129153860|NCT01343888|464860477|FG002|Overall Study|Withdrawal by Subject|2|||
129153861|NCT01343888|464860475|FG000|Overall Study|other than stated above|0|||
129153862|NCT01343888|464860476|FG001|Overall Study|other than stated above|0|||
129153863|NCT01343888|464860477|FG002|Overall Study|other than stated above|1|||
129153864|NCT01847092|464860480|FG000|Overall Study|Adverse Event|12|||
129153865|NCT01847092|464860481|FG001|Overall Study|Adverse Event|3|||
129153866|NCT01847092|464860480|FG000|Overall Study|Withdrawal by Subject|5|||
129153867|NCT01847092|464860481|FG001|Overall Study|Withdrawal by Subject|5|||
129153868|NCT01847092|464860480|FG000|Overall Study|Protocol Specified|8|||
129153869|NCT01847092|464860481|FG001|Overall Study|Protocol Specified|0|||
129153870|NCT01847092|464860480|FG000|Overall Study|Physician Decision|1|||
129153871|NCT01847092|464860481|FG001|Overall Study|Physician Decision|1|||
129153872|NCT01847092|464860480|FG000|Overall Study|Protocol Violation|0|||
129153873|NCT01847092|464860481|FG001|Overall Study|Protocol Violation|2|||
129153874|NCT01331681|464860482|FG000|Overall Study|Adverse Event|10|||
129153875|NCT01331681|464860483|FG001|Overall Study|Adverse Event|13|||
129153876|NCT01331681|464860484|FG002|Overall Study|Adverse Event|10|||
129153877|NCT01331681|464860482|FG000|Overall Study|Death|6|||
129153878|NCT01331681|464860483|FG001|Overall Study|Death|6|||
129153879|NCT01331681|464860484|FG002|Overall Study|Death|2|||
129153880|NCT01331681|464860482|FG000|Overall Study|Lack of Efficacy|0|||
129153881|NCT01331681|464860483|FG001|Overall Study|Lack of Efficacy|1|||
129153882|NCT01331681|464860484|FG002|Overall Study|Lack of Efficacy|0|||
129153883|NCT01331681|464860482|FG000|Overall Study|Withdrawal by Subject|12|||
129153884|NCT01331681|464860483|FG001|Overall Study|Withdrawal by Subject|8|||
129153885|NCT01331681|464860484|FG002|Overall Study|Withdrawal by Subject|15|||
129153886|NCT01331681|464860482|FG000|Overall Study|Protocol Violation|1|||
129153887|NCT01331681|464860483|FG001|Overall Study|Protocol Violation|1|||
129153888|NCT01331681|464860484|FG002|Overall Study|Protocol Violation|0|||
129153889|NCT01331681|464860482|FG000|Overall Study|Lost to Follow-up|2|||
129153890|NCT01331681|464860483|FG001|Overall Study|Lost to Follow-up|4|||
129153891|NCT01331681|464860484|FG002|Overall Study|Lost to Follow-up|1|||
129153892|NCT01331681|464860482|FG000|Overall Study|Physician Decision|2|||
129153893|NCT01331681|464860483|FG001|Overall Study|Physician Decision|0|||
129153894|NCT01331681|464860484|FG002|Overall Study|Physician Decision|4|||
129153895|NCT01331681|464860482|FG000|Overall Study|Therapeutic procedure required|1|||
129153896|NCT01331681|464860483|FG001|Overall Study|Therapeutic procedure required|0|||
129153897|NCT01331681|464860484|FG002|Overall Study|Therapeutic procedure required|0|||
129153898|NCT01331681|464860482|FG000|Overall Study|Sponsor decision|1|||
129153899|NCT01331681|464860483|FG001|Overall Study|Sponsor decision|1|||
129153900|NCT01331681|464860484|FG002|Overall Study|Sponsor decision|0|||
129153901|NCT01331681|464860482|FG000|Overall Study|Switching to other therapy|0|||
129153902|NCT01331681|464860483|FG001|Overall Study|Switching to other therapy|0|||
129153903|NCT01331681|464860484|FG002|Overall Study|Switching to other therapy|1|||
129153904|NCT01331681|464860482|FG000|Overall Study|Not Received Study Treatment|0|||
129153905|NCT01331681|464860483|FG001|Overall Study|Not Received Study Treatment|0|||
129153906|NCT01331681|464860484|FG002|Overall Study|Not Received Study Treatment|2|||
129153907|NCT00658541|464860486|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
129153908|NCT00658541|464860487|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129153909|NCT00658541|464860486|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129153910|NCT00658541|464860487|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129153911|NCT03326063|464860488|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
129153912|NCT03326063|464860489|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
129153913|NCT01876381|464860490|FG000|Overall Study|Lack of Efficacy|5|||
129153914|NCT01876381|464860490|FG000|Overall Study|Physician Decision|1|||
129153915|NCT01876381|464860490|FG000|Overall Study|Withdrawal by Subject|1|||
129153916|NCT00332696|464860491|FG000|Overall Study|Death|24|||
129153917|NCT00332696|464860492|FG001|Overall Study|Death|14|||
129153918|NCT00332696|464860491|FG000|Overall Study|Insufficient therapeutic effect|4|||
129153919|NCT00332696|464860492|FG001|Overall Study|Insufficient therapeutic effect|11|||
129153920|NCT00332696|464860491|FG000|Overall Study|Adverse Event|1|||
129153921|NCT00332696|464860492|FG001|Overall Study|Adverse Event|2|||
129153922|NCT00332696|464860491|FG000|Overall Study|Condition does not justify treatment|0|||
129153923|NCT00332696|464860492|FG001|Overall Study|Condition does not justify treatment|2|||
129153924|NCT00332696|464860491|FG000|Overall Study|Lost to Follow-up|0|||
129153925|NCT00332696|464860492|FG001|Overall Study|Lost to Follow-up|1|||
129153926|NCT00332696|464860491|FG000|Overall Study|Withdrawal by Subject|1|||
128725509|NCT03962543|463291003|FG000|Treatment Phase|Radiographic PD|9|||
129153927|NCT00332696|464860492|FG001|Overall Study|Withdrawal by Subject|0|||
129153928|NCT00461708|464860494|FG000|Overall Study|Adverse Event|17|||
129153929|NCT00461708|464860495|FG001|Overall Study|Adverse Event|7|||
129153930|NCT00461708|464860494|FG000|Overall Study|Lack of Efficacy|68|||
129153931|NCT00461708|464860495|FG001|Overall Study|Lack of Efficacy|20|||
129153932|NCT00461708|464860494|FG000|Overall Study|Physician Decision|10|||
129153933|NCT00461708|464860495|FG001|Overall Study|Physician Decision|4|||
129153934|NCT00461708|464860494|FG000|Overall Study|Withdrawal by Subject|8|||
129153935|NCT00461708|464860495|FG001|Overall Study|Withdrawal by Subject|2|||
129153936|NCT00461708|464860494|FG000|Overall Study|Other|4|||
129153937|NCT00461708|464860495|FG001|Overall Study|Other|4|||
129153938|NCT00461708|464860494|FG000|Overall Study|Death|8|||
129153939|NCT00461708|464860495|FG001|Overall Study|Death|1|||
129153940|NCT02803203|464860496|FG000|Overall Study|Adverse Event|4|||
129153941|NCT02803203|464860496|FG000|Overall Study|Death|4|||
129153942|NCT02803203|464860496|FG000|Overall Study|Progressive disease|29|||
129153943|NCT02803203|464860496|FG000|Overall Study|Withdrawal by Subject|8|||
129153944|NCT02803203|464860496|FG000|Overall Study|Complete resection of target disease|2|||
129153945|NCT02803203|464860496|FG000|Overall Study|Switched to commercial Osi|1|||
129153946|NCT02803203|464860496|FG000|Overall Study|Participant moved away|1|||
129153947|NCT04577781|464860497|FG000|Overall Study|Adverse Event|2|||
129153948|NCT04577781|464860498|FG001|Overall Study|Adverse Event|2|||
129153949|NCT04577781|464860497|FG000|Overall Study|Physician Decision|1|||
129153950|NCT04577781|464860498|FG001|Overall Study|Physician Decision|0|||
129153951|NCT03894891|464860499|FG000|Overall Study|Withdrawal by Subject|1|||
129153952|NCT03894891|464860499|FG000|Overall Study|Completed protocol treatment per protocol|5|||
129153953|NCT00950651|464860503|FG000|Overall Study|Adverse Event|17|||
129153954|NCT00950651|464860504|FG001|Overall Study|Adverse Event|20|||
129153955|NCT00950651|464860503|FG000|Overall Study|Death|1|||
129153956|NCT00950651|464860504|FG001|Overall Study|Death|0|||
128725510|NCT03962543|463291004|FG001|Treatment Phase|Radiographic PD|3|||
129153957|NCT00950651|464860503|FG000|Overall Study|Lack of Efficacy|2|||
129153958|NCT00950651|464860504|FG001|Overall Study|Lack of Efficacy|2|||
129153959|NCT00950651|464860503|FG000|Overall Study|Protocol Violation|3|||
129153960|NCT00950651|464860504|FG001|Overall Study|Protocol Violation|4|||
129153961|NCT00950651|464860503|FG000|Overall Study|Withdrawal by Subject|8|||
129153962|NCT00950651|464860504|FG001|Overall Study|Withdrawal by Subject|9|||
129153963|NCT00114127|464860506|FG000|Overall Study|Adverse Event|2|||
129153964|NCT00114127|464860507|FG001|Overall Study|Adverse Event|1|||
129153965|NCT00114127|464860506|FG000|Overall Study|Lost to Follow-up|1|||
129153966|NCT00114127|464860507|FG001|Overall Study|Lost to Follow-up|0|||
129153967|NCT00114127|464860506|FG000|Overall Study|Withdrawal by Subject|1|||
129153968|NCT00114127|464860507|FG001|Overall Study|Withdrawal by Subject|3|||
129153969|NCT03188263|464860508|FG000|Overall Study|Withdrawal by Subject|3|||
129153970|NCT03188263|464860509|FG001|Overall Study|Withdrawal by Subject|0|||
129153971|NCT03188263|464860508|FG000|Overall Study|Physician Decision|1|||
129153972|NCT03188263|464860509|FG001|Overall Study|Physician Decision|0|||
129153973|NCT00881894|464860510|FG000|Overall Study|Consent withdrawn|0|||
129153974|NCT00881894|464860511|FG001|Overall Study|Consent withdrawn|1|||
129153975|NCT00881894|464860510|FG000|Overall Study|Other reasons for premature termination|1|||
129153976|NCT00881894|464860511|FG001|Overall Study|Other reasons for premature termination|2|||
129153977|NCT00421148|464860512|FG000|Overall Study|Lost to Follow-up|0|||
129153978|NCT00421148|464860513|FG001|Overall Study|Lost to Follow-up|0|||
129153979|NCT00421148|464860514|FG002|Overall Study|Lost to Follow-up|0|||
129153980|NCT00421148|464860515|FG003|Overall Study|Lost to Follow-up|0|||
129153981|NCT00421148|464860516|FG004|Overall Study|Lost to Follow-up|0|||
129153982|NCT00421148|464860517|FG005|Overall Study|Lost to Follow-up|0|||
129153983|NCT00421148|464860518|FG006|Overall Study|Lost to Follow-up|0|||
129153984|NCT00421148|464860519|FG007|Overall Study|Lost to Follow-up|0|||
129153985|NCT00421148|464860520|FG008|Overall Study|Lost to Follow-up|0|||
129153986|NCT00421148|464860521|FG009|Overall Study|Lost to Follow-up|0|||
129153987|NCT00421148|464860522|FG010|Overall Study|Lost to Follow-up|0|||
129153988|NCT00421148|464860523|FG011|Overall Study|Lost to Follow-up|0|||
129153989|NCT00421148|464860524|FG012|Overall Study|Lost to Follow-up|0|||
129153990|NCT00421148|464860525|FG013|Overall Study|Lost to Follow-up|0|||
129153991|NCT00421148|464860526|FG014|Overall Study|Lost to Follow-up|0|||
129153992|NCT00421148|464860527|FG015|Overall Study|Lost to Follow-up|0|||
129153993|NCT00421148|464860528|FG016|Overall Study|Lost to Follow-up|0|||
129153994|NCT00421148|464860529|FG017|Overall Study|Lost to Follow-up|1|||
129153995|NCT00421148|464860530|FG018|Overall Study|Lost to Follow-up|0|||
129153996|NCT00421148|464860531|FG019|Overall Study|Lost to Follow-up|0|||
129153997|NCT00421148|464860512|FG000|Overall Study|Withdrawal by Subject|0|||
128725511|NCT03962543|463291003|FG000|Treatment Phase|Participant Decision|3|||
129153998|NCT00421148|464860513|FG001|Overall Study|Withdrawal by Subject|0|||
129153999|NCT00421148|464860514|FG002|Overall Study|Withdrawal by Subject|0|||
129154000|NCT00421148|464860515|FG003|Overall Study|Withdrawal by Subject|0|||
129154001|NCT00421148|464860516|FG004|Overall Study|Withdrawal by Subject|0|||
128725512|NCT03962543|463291004|FG001|Treatment Phase|Participant Decision|8|||
128725513|NCT03962543|463291003|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
129154002|NCT00421148|464860517|FG005|Overall Study|Withdrawal by Subject|0|||
129154003|NCT00421148|464860518|FG006|Overall Study|Withdrawal by Subject|0|||
129154004|NCT00421148|464860519|FG007|Overall Study|Withdrawal by Subject|0|||
129154005|NCT00421148|464860520|FG008|Overall Study|Withdrawal by Subject|0|||
129154006|NCT00421148|464860521|FG009|Overall Study|Withdrawal by Subject|0|||
129154007|NCT00421148|464860522|FG010|Overall Study|Withdrawal by Subject|0|||
129154008|NCT00421148|464860523|FG011|Overall Study|Withdrawal by Subject|0|||
129154009|NCT00421148|464860524|FG012|Overall Study|Withdrawal by Subject|0|||
129154010|NCT00421148|464860525|FG013|Overall Study|Withdrawal by Subject|0|||
129154011|NCT00421148|464860526|FG014|Overall Study|Withdrawal by Subject|0|||
129154012|NCT00421148|464860527|FG015|Overall Study|Withdrawal by Subject|0|||
129154013|NCT00421148|464860528|FG016|Overall Study|Withdrawal by Subject|0|||
129154014|NCT00421148|464860529|FG017|Overall Study|Withdrawal by Subject|1|||
129154015|NCT00421148|464860530|FG018|Overall Study|Withdrawal by Subject|0|||
129154016|NCT00421148|464860531|FG019|Overall Study|Withdrawal by Subject|0|||
129154017|NCT00421148|464860512|FG000|Overall Study|Protocol Violation|0|||
129154018|NCT00421148|464860513|FG001|Overall Study|Protocol Violation|0|||
129154019|NCT00421148|464860514|FG002|Overall Study|Protocol Violation|0|||
129154020|NCT00421148|464860515|FG003|Overall Study|Protocol Violation|0|||
129154021|NCT00421148|464860516|FG004|Overall Study|Protocol Violation|0|||
129154022|NCT00421148|464860517|FG005|Overall Study|Protocol Violation|1|||
129154023|NCT00421148|464860518|FG006|Overall Study|Protocol Violation|0|||
129154024|NCT00421148|464860519|FG007|Overall Study|Protocol Violation|0|||
129154025|NCT00421148|464860520|FG008|Overall Study|Protocol Violation|0|||
129154026|NCT00421148|464860521|FG009|Overall Study|Protocol Violation|0|||
129154027|NCT00421148|464860522|FG010|Overall Study|Protocol Violation|0|||
129154028|NCT00421148|464860523|FG011|Overall Study|Protocol Violation|0|||
129154029|NCT00421148|464860524|FG012|Overall Study|Protocol Violation|0|||
129154030|NCT00421148|464860525|FG013|Overall Study|Protocol Violation|0|||
129154031|NCT00421148|464860526|FG014|Overall Study|Protocol Violation|0|||
129154032|NCT00421148|464860527|FG015|Overall Study|Protocol Violation|0|||
129154033|NCT00421148|464860528|FG016|Overall Study|Protocol Violation|0|||
129154034|NCT00421148|464860529|FG017|Overall Study|Protocol Violation|0|||
129154035|NCT00421148|464860530|FG018|Overall Study|Protocol Violation|1|||
129154036|NCT00421148|464860531|FG019|Overall Study|Protocol Violation|0|||
129154037|NCT00469833|464860532|FG000|Overall Study|No IV access|2|||
129154038|NCT01253369|464860533|FG000|Overall Study|Adverse Event|4|||
129154039|NCT01253369|464860533|FG000|Overall Study|Withdrawal by Subject|2|||
129154040|NCT01253369|464860533|FG000|Overall Study|Death|1|||
129154041|NCT01253369|464860533|FG000|Overall Study|Progressive disease|23|||
129154042|NCT01253369|464860533|FG000|Overall Study|Not Evaluable|3|||
129154043|NCT03289533|464860534|FG000|Overall Study|Death|12|||
129154044|NCT03289533|464860534|FG000|Overall Study|Terminated from study by sponsor|10|||
129154045|NCT01030822|464860535|FG000|Overall Study|Moved/migrated from study area|6|||
129154046|NCT01030822|464860536|FG001|Overall Study|Moved/migrated from study area|7|||
129154047|NCT01030822|464860537|FG002|Overall Study|Moved/migrated from study area|3|||
129154048|NCT01030822|464860535|FG000|Overall Study|Withdrawal by Subject|16|||
129154049|NCT01030822|464860536|FG001|Overall Study|Withdrawal by Subject|13|||
128725514|NCT03962543|463291004|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
129154050|NCT01030822|464860537|FG002|Overall Study|Withdrawal by Subject|16|||
129154051|NCT01030822|464860535|FG000|Overall Study|Lost to Follow-up|9|||
129154052|NCT01030822|464860536|FG001|Overall Study|Lost to Follow-up|4|||
129154053|NCT01030822|464860537|FG002|Overall Study|Lost to Follow-up|7|||
129154054|NCT00539240|464860538|FG000|Overall Study|Withdrawal by Subject|0|||
129154055|NCT00539240|464860539|FG001|Overall Study|Withdrawal by Subject|2|||
129154056|NCT00539240|464860540|FG002|Overall Study|Withdrawal by Subject|0|||
129154057|NCT00539240|464860538|FG000|Overall Study|Protocol Violation|1|||
129154058|NCT00539240|464860539|FG001|Overall Study|Protocol Violation|1|||
129154059|NCT00539240|464860540|FG002|Overall Study|Protocol Violation|4|||
129154060|NCT00539240|464860538|FG000|Overall Study|Lost to Follow-up|2|||
129154061|NCT00539240|464860539|FG001|Overall Study|Lost to Follow-up|3|||
129154062|NCT00539240|464860540|FG002|Overall Study|Lost to Follow-up|1|||
129154063|NCT00539240|464860538|FG000|Overall Study|Adverse Event|3|||
129154064|NCT00539240|464860539|FG001|Overall Study|Adverse Event|1|||
129154065|NCT00539240|464860540|FG002|Overall Study|Adverse Event|10|||
129154066|NCT01595529|464860541|FG000|Overall Study|Adverse Event|2|||
129154067|NCT01595529|464860542|FG001|Overall Study|Adverse Event|0|||
129154068|NCT01595529|464860541|FG000|Overall Study|Subject Non-Compliant|2|||
129154069|NCT01595529|464860542|FG001|Overall Study|Subject Non-Compliant|0|||
129154070|NCT01595529|464860541|FG000|Overall Study|Lost to Follow-up|8|||
129154071|NCT01595529|464860542|FG001|Overall Study|Lost to Follow-up|14|||
128725515|NCT03962543|463291003|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
128725516|NCT03962543|463291004|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
129154072|NCT01595529|464860541|FG000|Overall Study|Protocol Violation|1|||
129154073|NCT01595529|464860542|FG001|Overall Study|Protocol Violation|2|||
129154074|NCT01595529|464860541|FG000|Overall Study|Physician Decision|1|||
129154075|NCT01595529|464860542|FG001|Overall Study|Physician Decision|0|||
129154076|NCT01595529|464860541|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
129154077|NCT01595529|464860542|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
129154078|NCT01595529|464860541|FG000|Overall Study|Administrative Decision|1|||
129154079|NCT01595529|464860542|FG001|Overall Study|Administrative Decision|0|||
129154080|NCT01595529|464860541|FG000|Overall Study|Entry Failure/Screening Failure|6|||
129154081|NCT01595529|464860542|FG001|Overall Study|Entry Failure/Screening Failure|1|||
129154082|NCT04016714|464860543|FG000|Overall Study|Death|1|||
129154083|NCT04016714|464860544|FG001|Overall Study|Death|0|||
129154084|NCT04016714|464860543|FG000|Overall Study|Lost to Follow-up|3|||
129154085|NCT04016714|464860544|FG001|Overall Study|Lost to Follow-up|1|||
129154086|NCT04016714|464860543|FG000|Overall Study|Physician Decision|3|||
129154087|NCT04016714|464860544|FG001|Overall Study|Physician Decision|3|||
129154088|NCT04016714|464860543|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
129154089|NCT04016714|464860544|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
129154090|NCT00730886|464860547|FG000|Overall Study|Lost to Follow-up|1|||
129154091|NCT00730886|464860548|FG001|Overall Study|Lost to Follow-up|0|||
129154092|NCT00730886|464860547|FG000|Overall Study|Physician Decision|1|||
129154093|NCT00730886|464860548|FG001|Overall Study|Physician Decision|0|||
129154094|NCT01991483|464860549|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
129154095|NCT01991483|464860550|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
129154096|NCT01991483|464860551|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
129154097|NCT01991483|464860552|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
129154098|NCT01991483|464860549|FG000|Dose Level 600 mg|Physician Decision|0|||
129154099|NCT01991483|464860550|FG001|Dose Level 600 mg|Physician Decision|0|||
129154100|NCT01991483|464860551|FG002|Dose Level 600 mg|Physician Decision|1|||
129154101|NCT01991483|464860552|FG003|Dose Level 600 mg|Physician Decision|0|||
129154102|NCT01991483|464860549|FG000|Dose Level 1000 mg|Protocol Violation|0|||
129154103|NCT01991483|464860550|FG001|Dose Level 1000 mg|Protocol Violation|0|||
129154104|NCT01991483|464860551|FG002|Dose Level 1000 mg|Protocol Violation|0|||
129154105|NCT01991483|464860552|FG003|Dose Level 1000 mg|Protocol Violation|1|||
129154106|NCT01932788|464860560|FG000|Overall Study|Protocol Violation|18|||
129154107|NCT01932788|464860561|FG001|Overall Study|Protocol Violation|0|||
129154108|NCT01932788|464860560|FG000|Overall Study|Lost to Follow-up|18|||
129154109|NCT01932788|464860561|FG001|Overall Study|Lost to Follow-up|46|||
129154110|NCT01932788|464860560|FG000|Overall Study|Lack of Efficacy|2|||
129154111|NCT01932788|464860561|FG001|Overall Study|Lack of Efficacy|0|||
129154112|NCT01932788|464860560|FG000|Overall Study|Withdrawal by Subject|0|||
129154113|NCT01932788|464860561|FG001|Overall Study|Withdrawal by Subject|5|||
129154114|NCT01171677|464860562|FG000|Overall Study|Withdrawal by Subject|0|||
129154115|NCT01171677|464860563|FG001|Overall Study|Withdrawal by Subject|3|||
129154116|NCT01171677|464860562|FG000|Overall Study|Adverse Event|1|||
129154117|NCT01171677|464860563|FG001|Overall Study|Adverse Event|0|||
129154118|NCT01171677|464860562|FG000|Overall Study|completed <70% IntenSati classes|5|||
129154119|NCT01171677|464860563|FG001|Overall Study|completed <70% IntenSati classes|0|||
129154120|NCT01847443|464860564|FG000|Study Period 1|Withdrawal by Subject|0|||
129154121|NCT01847443|464860565|FG001|Study Period 1|Withdrawal by Subject|1|||
129154122|NCT01847443|464860566|FG002|Study Period 1|Withdrawal by Subject|0|||
129154123|NCT01847443|464860567|FG003|Study Period 1|Withdrawal by Subject|0|||
129154124|NCT01847443|464860564|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
129154125|NCT01847443|464860565|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
129154126|NCT01847443|464860566|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
129154127|NCT01847443|464860567|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
129154128|NCT01847443|464860564|FG000|Washout Period Before Study Period 2|Other reason|1|||
129154129|NCT01847443|464860565|FG001|Washout Period Before Study Period 2|Other reason|0|||
129154130|NCT01847443|464860566|FG002|Washout Period Before Study Period 2|Other reason|0|||
129154131|NCT01847443|464860567|FG003|Washout Period Before Study Period 2|Other reason|0|||
129154132|NCT01847443|464860564|FG000|Washout Period Before Study Period 3|Other reason|1|||
129154133|NCT01847443|464860565|FG001|Washout Period Before Study Period 3|Other reason|0|||
129154134|NCT01847443|464860566|FG002|Washout Period Before Study Period 3|Other reason|0|||
129154135|NCT01847443|464860567|FG003|Washout Period Before Study Period 3|Other reason|0|||
129154136|NCT01847443|464860564|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
129154137|NCT01847443|464860565|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
129154138|NCT01847443|464860566|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
129154139|NCT01847443|464860567|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
129154140|NCT01847443|464860564|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
129154141|NCT01847443|464860565|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
129154142|NCT01847443|464860566|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
129154143|NCT01847443|464860567|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
129154144|NCT03571971|464860568|FG000|Overall Study|Lost to Follow-up|2|||
129154145|NCT03571971|464860569|FG001|Overall Study|Lost to Follow-up|2|||
129154146|NCT03571971|464860568|FG000|Overall Study|Protocol Violation|2|||
129154147|NCT03571971|464860569|FG001|Overall Study|Protocol Violation|3|||
129154148|NCT03571971|464860568|FG000|Overall Study|Withdrawal by Subject|2|||
129154149|NCT03571971|464860569|FG001|Overall Study|Withdrawal by Subject|0|||
129154150|NCT03571971|464860568|FG000|Overall Study|Incomplete primary outcome data|2|||
129154151|NCT03571971|464860569|FG001|Overall Study|Incomplete primary outcome data|0|||
129154152|NCT00937495|464861746|FG000|Overall Study|Protocol Violation|2|||
129154153|NCT00441272|464861747|FG000|Overall Study|Study terminated prior to enrollment|25|||
129154154|NCT00441272|464861748|FG001|Overall Study|Study terminated prior to enrollment|25|||
129154155|NCT01856322|464861749|FG000|Overall Study|off study due to lack of accrual|0|||
129154156|NCT01856322|464861750|FG001|Overall Study|off study due to lack of accrual|0|||
129154157|NCT01856322|464861751|FG002|Overall Study|off study due to lack of accrual|3|||
129154158|NCT00427011|464861752|FG000|Overall Study|Adverse Event|10|||
129154159|NCT00427011|464861752|FG000|Overall Study|Withdrawal by Subject|1|||
129154160|NCT00427011|464861752|FG000|Overall Study|Lack of Efficacy|2|||
129154161|NCT00427011|464861752|FG000|Overall Study|Other|12|||
129154162|NCT00288015|464861756|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
129154163|NCT00288015|464861756|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
129154164|NCT00288015|464861756|FG000|First Response Assessment|Withdrawal by Subject|1|||
129154165|NCT00288015|464861756|FG000|First Response Assessment|Death|1|||
129154166|NCT00288015|464861756|FG000|First Response Assessment|Physician Decision|2|||
129154167|NCT00288015|464861756|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
129154168|NCT00288015|464861756|FG000|Follow up for Survival x 2 Years|Death|13|||
129154169|NCT00288015|464861756|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
129154170|NCT00288015|464861756|FG000|Follow up for Survival x 2 Years|Other|9|||
129154171|NCT01333722|464861757|FG000|Overall Study|Lack of Efficacy|0|||
129154172|NCT01333722|464861758|FG001|Overall Study|Lack of Efficacy|2|||
129154173|NCT01333722|464861757|FG000|Overall Study|Withdrawal by Subject|0|||
129154174|NCT01333722|464861758|FG001|Overall Study|Withdrawal by Subject|1|||
129154175|NCT00443703|464861759|FG000|Overall Study|Never Treated|3|||
129154176|NCT00443703|464861760|FG001|Overall Study|Never Treated|1|||
129154177|NCT00443703|464861759|FG000|Overall Study|Adverse Event|7|||
129154178|NCT00443703|464861760|FG001|Overall Study|Adverse Event|3|||
129154179|NCT00443703|464861759|FG000|Overall Study|Lack of Efficacy|3|||
129154180|NCT00443703|464861760|FG001|Overall Study|Lack of Efficacy|1|||
129154181|NCT00443703|464861759|FG000|Overall Study|Lost to Follow-up|0|||
129154182|NCT00443703|464861760|FG001|Overall Study|Lost to Follow-up|4|||
129154183|NCT00443703|464861759|FG000|Overall Study|Physician Decision|4|||
129154184|NCT00443703|464861760|FG001|Overall Study|Physician Decision|2|||
129154185|NCT00443703|464861759|FG000|Overall Study|Protocol Violation|1|||
129154186|NCT00443703|464861760|FG001|Overall Study|Protocol Violation|1|||
129154187|NCT00443703|464861759|FG000|Overall Study|Withdrawal by Subject|9|||
129154188|NCT00443703|464861760|FG001|Overall Study|Withdrawal by Subject|6|||
129154189|NCT00443703|464861759|FG000|Overall Study|Progressive Disease|1|||
129154190|NCT00443703|464861760|FG001|Overall Study|Progressive Disease|0|||
129154191|NCT04776161|464861762|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
129154192|NCT04776161|464861763|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
129154193|NCT04776161|464861764|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
129154194|NCT04776161|464861762|FG000|Overall Study|Withdrawal by Subject|1|||
129154195|NCT04776161|464861763|FG001|Overall Study|Withdrawal by Subject|0|||
129154196|NCT04776161|464861764|FG002|Overall Study|Withdrawal by Subject|1|||
129154197|NCT04776161|464861762|FG000|Overall Study|Adverse Event|0|||
129154198|NCT04776161|464861763|FG001|Overall Study|Adverse Event|1|||
129154199|NCT04776161|464861764|FG002|Overall Study|Adverse Event|1|||
129154200|NCT00661830|464861768|FG000|Overall Study|Death|37|||
129154201|NCT00661830|464861769|FG001|Overall Study|Death|33|||
129154202|NCT00661830|464861768|FG000|Overall Study|Lost to Follow-up|1|||
129154203|NCT00661830|464861769|FG001|Overall Study|Lost to Follow-up|3|||
129154204|NCT00661830|464861768|FG000|Overall Study|Withdrawal by Subject|1|||
129154205|NCT00661830|464861769|FG001|Overall Study|Withdrawal by Subject|1|||
129154206|NCT00661830|464861768|FG000|Overall Study|Other reason|1|||
129154207|NCT00661830|464861769|FG001|Overall Study|Other reason|5|||
129154208|NCT00488514|464861770|FG000|Overall Study|Adverse Event|41|||
129154209|NCT00488514|464861770|FG000|Overall Study|Lost to Follow-up|44|||
129154210|NCT00488514|464861770|FG000|Overall Study|Protocol Violation|32|||
129154211|NCT00488514|464861770|FG000|Overall Study|Withdrawal by Subject|106|||
129154212|NCT00488514|464861770|FG000|Overall Study|Lack of Efficacy|28|||
129154213|NCT00488514|464861770|FG000|Overall Study|Did not meet criteria for treatment|30|||
129154214|NCT00488514|464861770|FG000|Overall Study|Postive drug screen|1|||
129154215|NCT00488514|464861770|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
129154216|NCT00488514|464861770|FG000|Overall Study|Investigator decision|1|||
129154217|NCT00488514|464861770|FG000|Overall Study|Participant had too few migraines|5|||
129154218|NCT00488514|464861770|FG000|Overall Study|Increase in number of migraines|2|||
129154219|NCT00488514|464861770|FG000|Overall Study|Increased use of concomitant medication|1|||
129154220|NCT00517699|464861771|FG000|Overall Study|Withdrawal by Subject|1|||
129154221|NCT00517699|464861771|FG000|Overall Study|Lack of Efficacy|1|||
129154222|NCT00517699|464861771|FG000|Overall Study|Administrative error|1|||
129154223|NCT00517699|464861771|FG000|Overall Study|Study terminated by Sponsor|2|||
129154224|NCT02332187|464861772|FG000|Overall Study|Withdrawal by Subject|2|||
128776855|NCT01782326|463472024|FG000|Planned Treatment Epoch|Physician Decision|18|||
128776856|NCT01782326|463472025|FG001|Planned Treatment Epoch|Physician Decision|16|||
129154225|NCT02332187|464861773|FG001|Overall Study|Withdrawal by Subject|2|||
129154226|NCT02332187|464861772|FG000|Overall Study|Adverse Event|0|||
129154227|NCT02332187|464861773|FG001|Overall Study|Adverse Event|1|||
129154228|NCT00980148|464861774|FG000|Overall Study|Discharged from facility|89|||
129154229|NCT00980148|464861775|FG001|Overall Study|Discharged from facility|96|||
129154230|NCT00980148|464861774|FG000|Overall Study|Received other antichlamydia treatment|20|||
129154231|NCT00980148|464861775|FG001|Overall Study|Received other antichlamydia treatment|14|||
129154232|NCT00980148|464861774|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
129154233|NCT00980148|464861775|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
129154234|NCT00980148|464861774|FG000|Overall Study|Various other reasons|8|||
129154235|NCT00980148|464861775|FG001|Overall Study|Various other reasons|9|||
129154236|NCT03500211|464861776|FG000|Overall Study|Withdrawal by Subject|1|||
129154237|NCT03500211|464861777|FG001|Overall Study|Withdrawal by Subject|1|||
129154238|NCT00775268|464861782|FG000|Baseline|Drug not synthesize dose|1|||
129154239|NCT00775268|464861783|FG001|Baseline|Drug not synthesize dose|0|||
129154240|NCT00775268|464861782|FG000|Baseline|Not treated-ineligible per CT|0|||
129154241|NCT00775268|464861783|FG001|Baseline|Not treated-ineligible per CT|1|||
129154242|NCT00775268|464861782|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
129154243|NCT00775268|464861783|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
129154244|NCT00775268|464861782|FG000|After Completion|Participant missed scan appointment|1|||
129154245|NCT00775268|464861783|FG001|After Completion|Participant missed scan appointment|0|||
129154246|NCT03604497|464861784|FG000|Overall Study|Protocol Violation|52|||
129154247|NCT01194245|464861786|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
129154248|NCT01194245|464861787|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129154249|NCT01194245|464861788|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129154250|NCT01194245|464861789|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129154251|NCT01194245|464861790|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129154252|NCT01194245|464861786|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
129154253|NCT01194245|464861787|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129154254|NCT01194245|464861788|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129154255|NCT01194245|464861789|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129154256|NCT01194245|464861790|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129154257|NCT01194245|464861786|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
129154258|NCT01194245|464861787|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129154259|NCT01194245|464861788|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129154260|NCT01194245|464861789|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129154261|NCT01194245|464861790|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129154262|NCT01194245|464861786|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
129154263|NCT01194245|464861787|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129154264|NCT01194245|464861788|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129154265|NCT01194245|464861789|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129154266|NCT01194245|464861790|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129154267|NCT01194245|464861786|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129154268|NCT01194245|464861787|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129154269|NCT01194245|464861788|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129154270|NCT01194245|464861789|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129154271|NCT01194245|464861790|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
129154272|NCT01194245|464861786|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129154273|NCT01194245|464861787|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129154274|NCT01194245|464861788|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
129154275|NCT01194245|464861789|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
129154276|NCT01194245|464861790|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
129154277|NCT00269087|464861791|FG000|Overall Study|Adverse Event|20|||
129154278|NCT00269087|464861791|FG000|Overall Study|Withdrawal by Subject|1|||
129154279|NCT00269087|464861791|FG000|Overall Study|Exacerbation of COPD|13|||
129154280|NCT00041470|464861800|FG000|Overall Study|Loss of Funding|38|||
129154281|NCT01193101|464861806|FG000|Overall Study|Adverse Event|0|||
129154282|NCT01193101|464861807|FG001|Overall Study|Adverse Event|1|||
129154283|NCT01193101|464861808|FG002|Overall Study|Adverse Event|1|||
129154284|NCT01193101|464861809|FG003|Overall Study|Adverse Event|3|||
129154285|NCT01193101|464861806|FG000|Overall Study|Lack of Efficacy|3|||
129154286|NCT01193101|464861807|FG001|Overall Study|Lack of Efficacy|1|||
129154287|NCT01193101|464861808|FG002|Overall Study|Lack of Efficacy|0|||
129154288|NCT01193101|464861809|FG003|Overall Study|Lack of Efficacy|8|||
129154289|NCT01193101|464861806|FG000|Overall Study|Withdrawal by Subject|2|||
129154290|NCT01193101|464861807|FG001|Overall Study|Withdrawal by Subject|4|||
129154291|NCT01193101|464861808|FG002|Overall Study|Withdrawal by Subject|1|||
129154292|NCT01193101|464861809|FG003|Overall Study|Withdrawal by Subject|1|||
129154293|NCT01193101|464861806|FG000|Overall Study|Administrative problems|0|||
129154294|NCT01193101|464861807|FG001|Overall Study|Administrative problems|0|||
129154295|NCT01193101|464861808|FG002|Overall Study|Administrative problems|1|||
129154296|NCT01193101|464861809|FG003|Overall Study|Administrative problems|0|||
129154297|NCT01193101|464861806|FG000|Overall Study|Abnormal test procedure results|0|||
129154298|NCT01193101|464861807|FG001|Overall Study|Abnormal test procedure results|1|||
129154299|NCT01193101|464861808|FG002|Overall Study|Abnormal test procedure results|0|||
129154300|NCT01193101|464861809|FG003|Overall Study|Abnormal test procedure results|0|||
129154301|NCT02347085|464861810|FG000|Overall Study|Adverse Event|2|||
129154302|NCT02347085|464861810|FG000|Overall Study|Lack of Efficacy|1|||
129154303|NCT02347085|464861810|FG000|Overall Study|Withdrawal by Subject|4|||
129154304|NCT02347085|464861810|FG000|Overall Study|Lost to Follow-up|1|||
129154305|NCT02347085|464861810|FG000|Overall Study|Protocol Criteria|2|||
129154306|NCT01824290|464861812|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
129154307|NCT01824290|464861813|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
129154308|NCT01824290|464861814|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
129154309|NCT01824290|464861815|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
129154310|NCT01824290|464861812|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
129154311|NCT01824290|464861813|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
129154312|NCT01824290|464861814|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
129154313|NCT01824290|464861815|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
129154314|NCT01824290|464861812|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
129154315|NCT01824290|464861813|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
129154316|NCT01824290|464861814|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
129154317|NCT01824290|464861815|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
129154318|NCT01824290|464861812|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
129154319|NCT01824290|464861813|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
129154320|NCT01824290|464861814|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
129154321|NCT01824290|464861815|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
129154322|NCT01824290|464861812|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
129154323|NCT01824290|464861813|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
129154324|NCT01824290|464861814|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
129154325|NCT01824290|464861815|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
129154326|NCT01824290|464861812|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
129154327|NCT01824290|464861813|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
129154328|NCT01824290|464861814|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
129154329|NCT01824290|464861815|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
129154330|NCT00800982|464861816|FG000|Overall Study|Lost to Follow-up|1|||
129154331|NCT00800982|464861817|FG001|Overall Study|Lost to Follow-up|2|||
129154332|NCT00800982|464861816|FG000|Overall Study|Withdrawal by Subject|0|||
129154333|NCT00800982|464861817|FG001|Overall Study|Withdrawal by Subject|1|||
129154334|NCT00800982|464861816|FG000|Overall Study|Patient moved out of state|1|||
129154335|NCT00800982|464861817|FG001|Overall Study|Patient moved out of state|0|||
129154336|NCT00527618|464861818|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
129154337|NCT00527618|464861819|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
129154338|NCT00527618|464861818|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
129154339|NCT00527618|464861819|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
129154340|NCT00527618|464861818|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
129154341|NCT00527618|464861819|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
129154342|NCT00527618|464861818|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
129154343|NCT00527618|464861819|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
129154344|NCT00527618|464861818|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
129154345|NCT00527618|464861819|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
129154346|NCT00527618|464861818|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
129154347|NCT00527618|464861819|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
129154348|NCT00648037|464861822|FG000|Overall Study|Not Treated|1|||
129154349|NCT00648037|464861822|FG000|Overall Study|Withdrawal by Subject|1|||
129154350|NCT00648037|464861822|FG000|Overall Study|Adverse Event|11|||
129154351|NCT00648037|464861822|FG000|Overall Study|Relapse|2|||
129154352|NCT00648037|464861822|FG000|Overall Study|Other|1|||
129154353|NCT00699413|464861833|FG000|Overall Study|Withdrawal by Subject|0|||
129154354|NCT00699413|464861834|FG001|Overall Study|Withdrawal by Subject|2|||
129154355|NCT00699413|464861833|FG000|Overall Study|Study terminated by sponsor|4|||
129154356|NCT00699413|464861834|FG001|Overall Study|Study terminated by sponsor|2|||
129154357|NCT00363311|464861836|FG000|Overall Study|Adverse Event|6|||
129154358|NCT00363311|464861837|FG001|Overall Study|Adverse Event|4|||
129154359|NCT00363311|464861836|FG000|Overall Study|Lost to Follow-up|3|||
129154360|NCT00363311|464861837|FG001|Overall Study|Lost to Follow-up|0|||
129154361|NCT00363311|464861836|FG000|Overall Study|Protocol Violation|1|||
129154362|NCT00363311|464861837|FG001|Overall Study|Protocol Violation|2|||
129154363|NCT00363311|464861836|FG000|Overall Study|Withdrawal by Subject|12|||
129154364|NCT00363311|464861837|FG001|Overall Study|Withdrawal by Subject|6|||
129154365|NCT00363311|464861836|FG000|Overall Study|Physician Decision|1|||
129154366|NCT00363311|464861837|FG001|Overall Study|Physician Decision|1|||
128725517|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
129154367|NCT00363311|464861836|FG000|Overall Study|Sponsor Terminated Study|2|||
129154368|NCT00363311|464861837|FG001|Overall Study|Sponsor Terminated Study|2|||
129154369|NCT00363311|464861836|FG000|Overall Study|Disease Progression|46|||
129154370|NCT00363311|464861837|FG001|Overall Study|Disease Progression|26|||
129154371|NCT00363311|464861836|FG000|Overall Study|Non-Compliance|1|||
129154372|NCT00363311|464861837|FG001|Overall Study|Non-Compliance|1|||
129154373|NCT00363311|464861836|FG000|Overall Study|Participant Refused Biopsy|1|||
129154374|NCT00363311|464861837|FG001|Overall Study|Participant Refused Biopsy|0|||
129154375|NCT00363311|464861836|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
129154376|NCT00363311|464861837|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
129154377|NCT00363311|464861836|FG000|Overall Study|Participant Opted for Treatment|1|||
129154378|NCT00363311|464861837|FG001|Overall Study|Participant Opted for Treatment|0|||
129154379|NCT00363311|464861836|FG000|Overall Study|Participant Moved to Another Country|1|||
129154380|NCT00363311|464861837|FG001|Overall Study|Participant Moved to Another Country|0|||
129154381|NCT00363311|464861836|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
129154382|NCT00363311|464861837|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
129154383|NCT00363311|464861836|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
129154384|NCT00363311|464861837|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
129154385|NCT00363311|464861836|FG000|Overall Study|Participant Moved to Louisiana|0|||
129154386|NCT00363311|464861837|FG001|Overall Study|Participant Moved to Louisiana|1|||
129154387|NCT02806414|464861842|FG000|Overall Study|Lost to Follow-up|2|||
129154388|NCT03092479|464861849|FG000|Overall Study|Lost to Follow-up|3|||
129154389|NCT03092479|464861850|FG001|Overall Study|Lost to Follow-up|2|||
129154390|NCT03092479|464861849|FG000|Overall Study|Withdrawal by Subject|4|||
129154391|NCT03092479|464861850|FG001|Overall Study|Withdrawal by Subject|0|||
129154392|NCT00543985|464861853|FG000|Overall Study|Withdrawal by Subject|4|||
129154393|NCT04046939|464861857|FG000|Primary Assessment Period|Adverse Event|1|||
129154394|NCT04046939|464861858|FG001|Primary Assessment Period|Adverse Event|0|||
129154395|NCT04046939|464861859|FG002|Primary Assessment Period|Adverse Event|0|||
129154396|NCT04046939|464861860|FG003|Primary Assessment Period|Adverse Event|0|||
129154397|NCT04046939|464861857|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
129154398|NCT04046939|464861858|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
129154399|NCT04046939|464861859|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
129154400|NCT04046939|464861860|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
129154401|NCT04046939|464861857|FG000|Primary Assessment Period|Physician Decision|0|||
129154402|NCT04046939|464861858|FG001|Primary Assessment Period|Physician Decision|0|||
129154403|NCT04046939|464861859|FG002|Primary Assessment Period|Physician Decision|1|||
129154404|NCT04046939|464861860|FG003|Primary Assessment Period|Physician Decision|0|||
129154405|NCT04046939|464861857|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
129154406|NCT04046939|464861858|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
129154407|NCT04046939|464861859|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
129154408|NCT04046939|464861860|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
129154409|NCT00403130|464861861|FG000|2 Years From Start of Treatment|Not Eligible|3|||
129154410|NCT00403130|464861861|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
129154411|NCT00403130|464861861|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
129154412|NCT00403130|464861861|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
129154413|NCT00806260|464861862|FG000|Period 1 (1 Day)|Adverse Event|0|||
129154414|NCT00806260|464861863|FG001|Period 1 (1 Day)|Adverse Event|0|||
129154415|NCT00806260|464861864|FG002|Period 1 (1 Day)|Adverse Event|0|||
129154416|NCT00806260|464861865|FG003|Period 1 (1 Day)|Adverse Event|0|||
129154417|NCT00806260|464861866|FG004|Period 1 (1 Day)|Adverse Event|3|||
129154418|NCT00806260|464861867|FG005|Period 1 (1 Day)|Adverse Event|0|||
129154419|NCT00806260|464861862|FG000|Period 2|Adverse Event|0|||
129154420|NCT00806260|464861863|FG001|Period 2|Adverse Event|0|||
129154421|NCT00806260|464861864|FG002|Period 2|Adverse Event|0|||
129154422|NCT00806260|464861865|FG003|Period 2|Adverse Event|1|||
129154423|NCT00806260|464861866|FG004|Period 2|Adverse Event|0|||
129154424|NCT00806260|464861867|FG005|Period 2|Adverse Event|0|||
129154425|NCT00806260|464861862|FG000|Period 2|Protocol Violation|1|||
129154426|NCT00806260|464861863|FG001|Period 2|Protocol Violation|0|||
129154427|NCT00806260|464861864|FG002|Period 2|Protocol Violation|1|||
129154428|NCT00806260|464861865|FG003|Period 2|Protocol Violation|0|||
129154429|NCT00806260|464861866|FG004|Period 2|Protocol Violation|0|||
129154430|NCT00806260|464861867|FG005|Period 2|Protocol Violation|0|||
129154431|NCT00806260|464861862|FG000|Period 2|Need to take concomitant medication|1|||
129154432|NCT00806260|464861863|FG001|Period 2|Need to take concomitant medication|0|||
129154433|NCT00806260|464861864|FG002|Period 2|Need to take concomitant medication|0|||
129154434|NCT00806260|464861865|FG003|Period 2|Need to take concomitant medication|0|||
129154435|NCT00806260|464861866|FG004|Period 2|Need to take concomitant medication|0|||
129154436|NCT00806260|464861867|FG005|Period 2|Need to take concomitant medication|0|||
129154437|NCT00806260|464861862|FG000|Period 2|sponsor request|0|||
129154438|NCT00806260|464861863|FG001|Period 2|sponsor request|0|||
129154439|NCT00806260|464861864|FG002|Period 2|sponsor request|1|||
129154440|NCT00806260|464861865|FG003|Period 2|sponsor request|1|||
129154441|NCT00806260|464861866|FG004|Period 2|sponsor request|0|||
129154442|NCT00806260|464861867|FG005|Period 2|sponsor request|0|||
129154443|NCT00806260|464861862|FG000|Period 3|Protocol Violation|0|||
129154444|NCT00806260|464861863|FG001|Period 3|Protocol Violation|1|||
129154445|NCT00806260|464861864|FG002|Period 3|Protocol Violation|1|||
129154446|NCT00806260|464861865|FG003|Period 3|Protocol Violation|0|||
129154447|NCT00806260|464861866|FG004|Period 3|Protocol Violation|0|||
129154448|NCT00806260|464861867|FG005|Period 3|Protocol Violation|0|||
129154449|NCT00806260|464861862|FG000|Period 3|Pregnancy|1|||
129154450|NCT00806260|464861863|FG001|Period 3|Pregnancy|0|||
129154451|NCT00806260|464861864|FG002|Period 3|Pregnancy|0|||
129154452|NCT00806260|464861865|FG003|Period 3|Pregnancy|0|||
129154453|NCT00806260|464861866|FG004|Period 3|Pregnancy|0|||
129154454|NCT00806260|464861867|FG005|Period 3|Pregnancy|0|||
129154455|NCT00237042|464861868|FG000|Treatment|Became ineligible post-randomization|0|||
129154456|NCT00237042|464861869|FG001|Treatment|Became ineligible post-randomization|1|||
129154457|NCT00237042|464861870|FG002|Treatment|Became ineligible post-randomization|16|||
129154458|NCT00237042|464861868|FG000|Treatment|Moved out of state|1|||
129154459|NCT00237042|464861869|FG001|Treatment|Moved out of state|1|||
129154460|NCT00237042|464861870|FG002|Treatment|Moved out of state|1|||
129154461|NCT00237042|464861868|FG000|Treatment|Completed no treatment|5|||
129154462|NCT00237042|464861869|FG001|Treatment|Completed no treatment|5|||
129154463|NCT00237042|464861870|FG002|Treatment|Completed no treatment|21|||
129154464|NCT00237042|464861868|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
129154465|NCT00237042|464861869|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
129154466|NCT00237042|464861870|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
129154467|NCT00237042|464861868|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
129154468|NCT00237042|464861869|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
129154469|NCT00237042|464861870|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
129154470|NCT01897532|464861871|FG000|Discontinuation From Treatment|Not Treated|7|||
129154471|NCT01897532|464861872|FG001|Discontinuation From Treatment|Not Treated|5|||
129154472|NCT01897532|464861871|FG000|Discontinuation From Treatment|Other reason than specified|196|||
129154473|NCT01897532|464861872|FG001|Discontinuation From Treatment|Other reason than specified|176|||
129154474|NCT01897532|464861871|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
129154475|NCT01897532|464861872|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
129154476|NCT01897532|464861871|FG000|Discontinuation From Treatment|Non compliance|24|||
129154477|NCT01897532|464861872|FG001|Discontinuation From Treatment|Non compliance|15|||
129154478|NCT01897532|464861871|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
129154479|NCT01897532|464861872|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
129154480|NCT01897532|464861871|FG000|Discontinuation From Trial|Not Treated|7|||
129154481|NCT01897532|464861872|FG001|Discontinuation From Trial|Not Treated|5|||
129154482|NCT01897532|464861871|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
129154483|NCT01897532|464861872|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
129154484|NCT03132467|464861873|FG000|Overall Study|Adverse Event|2|||
129154485|NCT03132467|464861873|FG000|Overall Study|Withdrawal by Subject|2|||
129154486|NCT00038948|464861874|FG000|Overall Study|Adverse Event|131|||
129154487|NCT00038948|464861875|FG001|Overall Study|Adverse Event|43|||
129154488|NCT00038948|464861874|FG000|Overall Study|Lost to Follow-up|4|||
129154489|NCT00038948|464861875|FG001|Overall Study|Lost to Follow-up|4|||
129154490|NCT00038948|464861874|FG000|Overall Study|Nonmedical event|5|||
129154491|NCT00038948|464861875|FG001|Overall Study|Nonmedical event|7|||
129154492|NCT00038948|464861874|FG000|Overall Study|Withdrawal by Subject|23|||
129154493|NCT00038948|464861875|FG001|Overall Study|Withdrawal by Subject|10|||
129154494|NCT00038948|464861874|FG000|Overall Study|Protocol Violation|3|||
129154495|NCT00038948|464861875|FG001|Overall Study|Protocol Violation|7|||
129154496|NCT00038948|464861874|FG000|Overall Study|Lack of Efficacy|3|||
129154497|NCT00038948|464861875|FG001|Overall Study|Lack of Efficacy|6|||
129154498|NCT05223673|464861878|FG000|Overall Study|Protocol Violation|1|||
129154499|NCT05223673|464861878|FG000|Overall Study|Study termination|6|||
129154500|NCT03559270|464861879|FG000|Overall Study|Adverse Event|6|||
129154501|NCT03559270|464861880|FG001|Overall Study|Adverse Event|5|||
129154502|NCT03559270|464861881|FG002|Overall Study|Adverse Event|3|||
129154503|NCT03559270|464861882|FG003|Overall Study|Adverse Event|0|||
129154504|NCT03559270|464861879|FG000|Overall Study|Lack of Efficacy|34|||
129154505|NCT03559270|464861880|FG001|Overall Study|Lack of Efficacy|52|||
129154506|NCT03559270|464861881|FG002|Overall Study|Lack of Efficacy|37|||
129154507|NCT03559270|464861882|FG003|Overall Study|Lack of Efficacy|2|||
129154508|NCT03559270|464861879|FG000|Overall Study|Death|0|||
129154509|NCT03559270|464861880|FG001|Overall Study|Death|2|||
129154510|NCT03559270|464861881|FG002|Overall Study|Death|0|||
129154511|NCT03559270|464861882|FG003|Overall Study|Death|0|||
129154512|NCT03559270|464861879|FG000|Overall Study|Lost to Follow-up|16|||
129154513|NCT03559270|464861880|FG001|Overall Study|Lost to Follow-up|4|||
129154514|NCT03559270|464861881|FG002|Overall Study|Lost to Follow-up|12|||
129154515|NCT03559270|464861882|FG003|Overall Study|Lost to Follow-up|3|||
129154516|NCT03559270|464861879|FG000|Overall Study|Sponsor Decision|38|||
129154517|NCT03559270|464861880|FG001|Overall Study|Sponsor Decision|31|||
129154518|NCT03559270|464861881|FG002|Overall Study|Sponsor Decision|35|||
129154519|NCT03559270|464861882|FG003|Overall Study|Sponsor Decision|18|||
129154520|NCT03559270|464861879|FG000|Overall Study|Withdrawal by Subject|19|||
129154521|NCT03559270|464861880|FG001|Overall Study|Withdrawal by Subject|21|||
129154522|NCT03559270|464861881|FG002|Overall Study|Withdrawal by Subject|18|||
129154523|NCT03559270|464861882|FG003|Overall Study|Withdrawal by Subject|7|||
129154524|NCT03559270|464861879|FG000|Overall Study|Physician Decision|3|||
129154525|NCT03559270|464861880|FG001|Overall Study|Physician Decision|2|||
129154526|NCT03559270|464861881|FG002|Overall Study|Physician Decision|1|||
129154527|NCT03559270|464861882|FG003|Overall Study|Physician Decision|0|||
129154528|NCT03559270|464861879|FG000|Overall Study|Pregnancy|0|||
129154529|NCT03559270|464861880|FG001|Overall Study|Pregnancy|1|||
129154530|NCT03559270|464861881|FG002|Overall Study|Pregnancy|0|||
129154531|NCT03559270|464861882|FG003|Overall Study|Pregnancy|0|||
129154532|NCT03559270|464861879|FG000|Overall Study|Protocol Violation|1|||
129154533|NCT03559270|464861880|FG001|Overall Study|Protocol Violation|0|||
129154534|NCT03559270|464861881|FG002|Overall Study|Protocol Violation|2|||
129154535|NCT03559270|464861882|FG003|Overall Study|Protocol Violation|0|||
129154536|NCT04472650|464864123|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
129154537|NCT04472650|464864124|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
129154538|NCT01669902|464864129|FG000|Overall Study|Adverse Event|11|||
129154539|NCT01669902|464864129|FG000|Overall Study|Lack of Efficacy|10|||
129154540|NCT01669902|464864129|FG000|Overall Study|Other|8|||
129154541|NCT01535287|464864130|FG000|Overall Study|drug not prepared in time|5|||
129154542|NCT01535287|464864131|FG001|Overall Study|drug not prepared in time|6|||
128725518|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
129154543|NCT00551031|464864136|FG000|Overall Study|Adverse Event|0|||
129154544|NCT00551031|464864137|FG001|Overall Study|Adverse Event|1|||
129154545|NCT00551031|464864138|FG002|Overall Study|Adverse Event|0|||
129154546|NCT00551031|464864139|FG003|Overall Study|Adverse Event|0|||
129154547|NCT00551031|464864140|FG004|Overall Study|Adverse Event|0|||
129154548|NCT00551031|464864136|FG000|Overall Study|Protocol Violation|1|||
129154549|NCT00551031|464864137|FG001|Overall Study|Protocol Violation|1|||
129154550|NCT00551031|464864138|FG002|Overall Study|Protocol Violation|0|||
128725519|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
129154551|NCT00551031|464864139|FG003|Overall Study|Protocol Violation|0|||
129154552|NCT00551031|464864140|FG004|Overall Study|Protocol Violation|0|||
129154553|NCT00551031|464864136|FG000|Overall Study|Lost to Follow-up|0|||
129154554|NCT00551031|464864137|FG001|Overall Study|Lost to Follow-up|1|||
129154555|NCT00551031|464864138|FG002|Overall Study|Lost to Follow-up|0|||
129154556|NCT00551031|464864139|FG003|Overall Study|Lost to Follow-up|1|||
129154557|NCT00551031|464864140|FG004|Overall Study|Lost to Follow-up|1|||
129154558|NCT00551031|464864136|FG000|Overall Study|Withdrawal by Subject|0|||
129154559|NCT00551031|464864137|FG001|Overall Study|Withdrawal by Subject|4|||
129154560|NCT00551031|464864138|FG002|Overall Study|Withdrawal by Subject|1|||
129154561|NCT00551031|464864139|FG003|Overall Study|Withdrawal by Subject|2|||
129154562|NCT00551031|464864140|FG004|Overall Study|Withdrawal by Subject|0|||
129154563|NCT00551031|464864136|FG000|Overall Study|Serious Adverse Event|0|||
129154564|NCT00551031|464864137|FG001|Overall Study|Serious Adverse Event|2|||
129154565|NCT00551031|464864138|FG002|Overall Study|Serious Adverse Event|1|||
129154566|NCT00551031|464864139|FG003|Overall Study|Serious Adverse Event|0|||
129154567|NCT00551031|464864140|FG004|Overall Study|Serious Adverse Event|0|||
129154568|NCT00551031|464864136|FG000|Overall Study|Did not receive vaccine|1|||
129154569|NCT00551031|464864137|FG001|Overall Study|Did not receive vaccine|2|||
129154570|NCT00551031|464864138|FG002|Overall Study|Did not receive vaccine|0|||
129154571|NCT00551031|464864139|FG003|Overall Study|Did not receive vaccine|0|||
129154572|NCT00551031|464864140|FG004|Overall Study|Did not receive vaccine|0|||
129154573|NCT04567524|464864141|FG000|Overall Study|Adverse Event|1|||
129154574|NCT04567524|464864142|FG001|Overall Study|Adverse Event|1|||
129154575|NCT04567524|464864143|FG002|Overall Study|Adverse Event|0|||
129154576|NCT04567524|464864144|FG003|Overall Study|Adverse Event|0|||
129154577|NCT04567524|464864141|FG000|Overall Study|Withdrawal by Subject|2|||
129154578|NCT04567524|464864142|FG001|Overall Study|Withdrawal by Subject|0|||
129154579|NCT04567524|464864143|FG002|Overall Study|Withdrawal by Subject|0|||
129154580|NCT04567524|464864144|FG003|Overall Study|Withdrawal by Subject|1|||
129154581|NCT01119443|464864154|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
129154582|NCT01119443|464864155|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
129154583|NCT02329743|464864156|FG000|Overall Study|Adverse Event|1|||
129154584|NCT02329743|464864157|FG001|Overall Study|Adverse Event|1|||
129154585|NCT02329743|464864158|FG002|Overall Study|Adverse Event|3|||
129154586|NCT02329743|464864156|FG000|Overall Study|Lost to Follow-up|1|||
129154587|NCT02329743|464864157|FG001|Overall Study|Lost to Follow-up|0|||
129154588|NCT02329743|464864158|FG002|Overall Study|Lost to Follow-up|1|||
129154589|NCT02329743|464864156|FG000|Overall Study|Withdrawal by Subject|4|||
129154590|NCT02329743|464864157|FG001|Overall Study|Withdrawal by Subject|4|||
129154591|NCT02329743|464864158|FG002|Overall Study|Withdrawal by Subject|1|||
129154592|NCT02329743|464864156|FG000|Overall Study|Other|0|||
129154593|NCT02329743|464864157|FG001|Overall Study|Other|2|||
129154594|NCT02329743|464864158|FG002|Overall Study|Other|3|||
129154595|NCT02078752|464864159|FG000|Overall Study|Death|0|||
129154596|NCT02078752|464864160|FG001|Overall Study|Death|3|||
129154597|NCT02078752|464864161|FG002|Overall Study|Death|0|||
129154598|NCT02078752|464864162|FG003|Overall Study|Death|0|||
129154599|NCT02078752|464864163|FG004|Overall Study|Death|0|||
129154600|NCT02078752|464864164|FG005|Overall Study|Death|1|||
129154601|NCT02078752|464864165|FG006|Overall Study|Death|0|||
129154602|NCT02078752|464864166|FG007|Overall Study|Death|1|||
129154603|NCT02078752|464864167|FG008|Overall Study|Death|0|||
129154604|NCT02078752|464864168|FG009|Overall Study|Death|4|||
129154605|NCT02078752|464864159|FG000|Overall Study|Lost to Follow-up|1|||
129154606|NCT02078752|464864160|FG001|Overall Study|Lost to Follow-up|0|||
129154607|NCT02078752|464864161|FG002|Overall Study|Lost to Follow-up|0|||
129154608|NCT02078752|464864162|FG003|Overall Study|Lost to Follow-up|1|||
129154609|NCT02078752|464864163|FG004|Overall Study|Lost to Follow-up|0|||
129154610|NCT02078752|464864164|FG005|Overall Study|Lost to Follow-up|0|||
129154611|NCT02078752|464864165|FG006|Overall Study|Lost to Follow-up|0|||
129154612|NCT02078752|464864166|FG007|Overall Study|Lost to Follow-up|0|||
129154613|NCT02078752|464864167|FG008|Overall Study|Lost to Follow-up|0|||
129154614|NCT02078752|464864168|FG009|Overall Study|Lost to Follow-up|0|||
129154615|NCT02078752|464864159|FG000|Overall Study|Withdrawal by Subject|1|||
129154616|NCT02078752|464864160|FG001|Overall Study|Withdrawal by Subject|1|||
129154617|NCT02078752|464864161|FG002|Overall Study|Withdrawal by Subject|1|||
129154618|NCT02078752|464864162|FG003|Overall Study|Withdrawal by Subject|1|||
129154619|NCT02078752|464864163|FG004|Overall Study|Withdrawal by Subject|0|||
129154620|NCT02078752|464864164|FG005|Overall Study|Withdrawal by Subject|3|||
129154621|NCT02078752|464864165|FG006|Overall Study|Withdrawal by Subject|2|||
129154622|NCT02078752|464864166|FG007|Overall Study|Withdrawal by Subject|1|||
129154623|NCT02078752|464864167|FG008|Overall Study|Withdrawal by Subject|0|||
129154624|NCT02078752|464864168|FG009|Overall Study|Withdrawal by Subject|1|||
129154625|NCT02078752|464864159|FG000|Overall Study|Other|0|||
129154626|NCT02078752|464864160|FG001|Overall Study|Other|3|||
129154627|NCT02078752|464864161|FG002|Overall Study|Other|0|||
129154628|NCT02078752|464864162|FG003|Overall Study|Other|0|||
129154629|NCT02078752|464864163|FG004|Overall Study|Other|1|||
129154630|NCT02078752|464864164|FG005|Overall Study|Other|0|||
129154631|NCT02078752|464864165|FG006|Overall Study|Other|0|||
129154632|NCT02078752|464864166|FG007|Overall Study|Other|1|||
129154633|NCT02078752|464864167|FG008|Overall Study|Other|0|||
129154634|NCT02078752|464864168|FG009|Overall Study|Other|0|||
129154635|NCT02078752|464864159|FG000|Overall Study|Study terminated by sponsor|0|||
129154636|NCT02078752|464864160|FG001|Overall Study|Study terminated by sponsor|0|||
129154637|NCT02078752|464864161|FG002|Overall Study|Study terminated by sponsor|0|||
129154638|NCT02078752|464864162|FG003|Overall Study|Study terminated by sponsor|0|||
129154639|NCT02078752|464864163|FG004|Overall Study|Study terminated by sponsor|0|||
129154640|NCT02078752|464864164|FG005|Overall Study|Study terminated by sponsor|0|||
129154641|NCT02078752|464864165|FG006|Overall Study|Study terminated by sponsor|0|||
129154642|NCT02078752|464864166|FG007|Overall Study|Study terminated by sponsor|0|||
129154643|NCT02078752|464864167|FG008|Overall Study|Study terminated by sponsor|0|||
129154644|NCT02078752|464864168|FG009|Overall Study|Study terminated by sponsor|5|||
129154645|NCT00616642|464864179|FG000|Overall Study|Withdrawal by Subject|0|||
129154646|NCT00616642|464864180|FG001|Overall Study|Withdrawal by Subject|1|||
129154647|NCT01023217|464864189|FG000|Overall Study|Withdrawal by Subject|1|||
129154648|NCT01023217|464864190|FG001|Overall Study|Withdrawal by Subject|0|||
129154649|NCT00589797|464864191|FG000|Overall Study|Death|1|||
129154650|NCT00589797|464864192|FG001|Overall Study|Death|0|||
129154651|NCT00589797|464864191|FG000|Overall Study|Lost to Follow-up|12|||
129154652|NCT00589797|464864192|FG001|Overall Study|Lost to Follow-up|9|||
129154653|NCT00589797|464864191|FG000|Overall Study|Physician Decision|8|||
129154654|NCT00589797|464864192|FG001|Overall Study|Physician Decision|3|||
129154655|NCT00589797|464864191|FG000|Overall Study|Withdrawal by Subject|6|||
129154656|NCT00589797|464864192|FG001|Overall Study|Withdrawal by Subject|5|||
129154657|NCT00589797|464864191|FG000|Overall Study|Non-Randomized Training Subjects|46|||
129154658|NCT00589797|464864192|FG001|Overall Study|Non-Randomized Training Subjects|6|||
129154659|NCT01881009|464864193|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
129154660|NCT01881009|464864194|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
129154661|NCT02651116|464864197|FG000|Overall Study|Adverse Event|0|||
129154662|NCT02651116|464864198|FG001|Overall Study|Adverse Event|1|||
129154663|NCT02651116|464864197|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
129154664|NCT02651116|464864198|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
129154665|NCT02457247|464864199|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
129154666|NCT02457247|464864200|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
129154667|NCT02457247|464864201|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
129154668|NCT02457247|464864202|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
129154669|NCT02457247|464864199|FG000|Period 1|Significant Protocol Deviation|1|||
129154670|NCT02457247|464864200|FG001|Period 1|Significant Protocol Deviation|1|||
129154671|NCT02457247|464864201|FG002|Period 1|Significant Protocol Deviation|0|||
129154672|NCT02457247|464864202|FG003|Period 1|Significant Protocol Deviation|0|||
129154673|NCT02457247|464864199|FG000|Period 1|Voluntary Withdrawal|1|||
129154674|NCT02457247|464864200|FG001|Period 1|Voluntary Withdrawal|0|||
129154675|NCT02457247|464864201|FG002|Period 1|Voluntary Withdrawal|0|||
129154676|NCT02457247|464864202|FG003|Period 1|Voluntary Withdrawal|0|||
129154677|NCT02457247|464864199|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
129154678|NCT02457247|464864200|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
129154679|NCT02457247|464864201|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
129154680|NCT02457247|464864202|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
129154681|NCT02457247|464864199|FG000|Period 2|Significant Protocol Deviation|1|||
129154682|NCT02457247|464864200|FG001|Period 2|Significant Protocol Deviation|0|||
129154683|NCT02457247|464864201|FG002|Period 2|Significant Protocol Deviation|0|||
129154684|NCT02457247|464864202|FG003|Period 2|Significant Protocol Deviation|0|||
129154685|NCT02457247|464864199|FG000|Period 2|Lost to Follow-up|0|||
129154686|NCT02457247|464864200|FG001|Period 2|Lost to Follow-up|1|||
129154687|NCT02457247|464864201|FG002|Period 2|Lost to Follow-up|0|||
129154688|NCT02457247|464864202|FG003|Period 2|Lost to Follow-up|0|||
129154689|NCT02457247|464864199|FG000|Period 2|Voluntary Withdrawal|1|||
129154690|NCT02457247|464864200|FG001|Period 2|Voluntary Withdrawal|1|||
129154691|NCT02457247|464864201|FG002|Period 2|Voluntary Withdrawal|0|||
129154692|NCT02457247|464864202|FG003|Period 2|Voluntary Withdrawal|0|||
129154693|NCT01061385|464864203|FG000|Overall Study|Lost to Follow-up|1|||
129154694|NCT01061385|464864204|FG001|Overall Study|Lost to Follow-up|0|||
129154695|NCT01061385|464864203|FG000|Overall Study|subject decision not related to AE|0|||
129154696|NCT01061385|464864204|FG001|Overall Study|subject decision not related to AE|1|||
129154697|NCT01492088|464864205|FG000|Overall Study|Withdrawal by Patient|0|||
129154698|NCT01492088|464864206|FG001|Overall Study|Withdrawal by Patient|2|||
129154699|NCT01492088|464864207|FG002|Overall Study|Withdrawal by Patient|0|||
129154700|NCT01492088|464864205|FG000|Overall Study|Death|1|||
129154701|NCT01492088|464864206|FG001|Overall Study|Death|6|||
129154702|NCT01492088|464864207|FG002|Overall Study|Death|2|||
129154703|NCT01492088|464864205|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
129154704|NCT01492088|464864206|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
129154705|NCT01492088|464864207|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
129154706|NCT01492088|464864205|FG000|Overall Study|Alive at Last Follow-up|0|||
129154707|NCT01492088|464864206|FG001|Overall Study|Alive at Last Follow-up|6|||
129154708|NCT01492088|464864207|FG002|Overall Study|Alive at Last Follow-up|11|||
129154709|NCT00533429|464864208|FG000|Overall Study|Adverse Event|3|||
129154710|NCT00533429|464864209|FG001|Overall Study|Adverse Event|1|||
129154711|NCT00533429|464864208|FG000|Overall Study|Death|1|||
129154712|NCT00533429|464864209|FG001|Overall Study|Death|0|||
129154713|NCT00533429|464864208|FG000|Overall Study|Withdrawal by Subject|2|||
129154714|NCT00533429|464864209|FG001|Overall Study|Withdrawal by Subject|0|||
129154715|NCT00533429|464864208|FG000|Overall Study|Progressive Disease|12|||
129154716|NCT00533429|464864209|FG001|Overall Study|Progressive Disease|13|||
129154717|NCT00533429|464864208|FG000|Overall Study|Symptomatic deterioration|1|||
129154718|NCT00533429|464864209|FG001|Overall Study|Symptomatic deterioration|2|||
129154719|NCT01464879|464864210|FG000|Overall Study|Physician Decision|1|||
129154720|NCT01464879|464864210|FG000|Overall Study|Non-compliance|1|||
129154721|NCT02230189|464864217|FG000|Overall Study|Withdrawal by Subject|3|||
129154722|NCT02230189|464864218|FG001|Overall Study|Withdrawal by Subject|0|||
129154723|NCT02230189|464864219|FG002|Overall Study|Withdrawal by Subject|1|||
129154724|NCT02230189|464864217|FG000|Overall Study|Lost to Follow-up|1|||
129154725|NCT02230189|464864218|FG001|Overall Study|Lost to Follow-up|0|||
129154726|NCT02230189|464864219|FG002|Overall Study|Lost to Follow-up|0|||
129154727|NCT02230189|464864217|FG000|Overall Study|Physician Decision|1|||
129154728|NCT02230189|464864218|FG001|Overall Study|Physician Decision|0|||
129154729|NCT02230189|464864219|FG002|Overall Study|Physician Decision|0|||
129154730|NCT03824392|464864220|FG000|Overall Study|Adverse Event|1|||
129154731|NCT03824392|464864221|FG001|Overall Study|Adverse Event|0|||
129154732|NCT03824392|464864222|FG002|Overall Study|Adverse Event|0|||
129154733|NCT03824392|464864223|FG003|Overall Study|Adverse Event|0|||
129154734|NCT03824392|464864220|FG000|Overall Study|Investigator Decision|0|||
129154735|NCT03824392|464864221|FG001|Overall Study|Investigator Decision|1|||
129154736|NCT03824392|464864222|FG002|Overall Study|Investigator Decision|0|||
129154737|NCT03824392|464864223|FG003|Overall Study|Investigator Decision|0|||
129154738|NCT03824392|464864220|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
129154739|NCT03824392|464864221|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
129154740|NCT03824392|464864222|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
129154741|NCT03824392|464864223|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
129154742|NCT01887717|464864224|FG000|Overall Study|Withdrawal by Subject|1|||
129154743|NCT01887717|464864225|FG001|Overall Study|Withdrawal by Subject|7|||
129154744|NCT01887717|464864224|FG000|Overall Study|Physician Decision|0|||
129154745|NCT01887717|464864225|FG001|Overall Study|Physician Decision|2|||
129154746|NCT01887717|464864224|FG000|Overall Study|Administrative reasons|5|||
129154747|NCT01887717|464864225|FG001|Overall Study|Administrative reasons|2|||
129154748|NCT00244621|464864226|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129154749|NCT00244621|464864227|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129154750|NCT00244621|464864228|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
129154751|NCT00244621|464864226|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129154752|NCT00244621|464864227|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129154753|NCT00244621|464864228|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129154754|NCT00244621|464864226|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129154755|NCT00244621|464864227|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
129154756|NCT00244621|464864228|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
129154757|NCT00244621|464864226|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
129154758|NCT00244621|464864227|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
129154759|NCT00244621|464864228|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
129154760|NCT00244621|464864226|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129154761|NCT00244621|464864227|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
129154762|NCT00244621|464864228|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129154763|NCT00244621|464864226|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
129154764|NCT00244621|464864227|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129154765|NCT00244621|464864228|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129154766|NCT00244621|464864226|FG000|Open-label Treatment Period|Adverse Event|0|||
129154767|NCT00244621|464864227|FG001|Open-label Treatment Period|Adverse Event|0|||
129154768|NCT00244621|464864228|FG002|Open-label Treatment Period|Adverse Event|1|||
129154769|NCT00244621|464864226|FG000|Open-label Treatment Period|Moved abroad|0|||
129154770|NCT00244621|464864227|FG001|Open-label Treatment Period|Moved abroad|0|||
129154771|NCT00244621|464864228|FG002|Open-label Treatment Period|Moved abroad|1|||
129154772|NCT02834819|464864229|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
129154773|NCT02834819|464864230|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
129154774|NCT04389866|464864232|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
129154775|NCT04389866|464864233|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
129154776|NCT01490918|464864237|FG000|Overall Study|Lost to Follow-up|2|||
129154777|NCT01490918|464864238|FG001|Overall Study|Lost to Follow-up|1|||
129154778|NCT01490918|464864239|FG002|Overall Study|Lost to Follow-up|0|||
129154779|NCT01490918|464864237|FG000|Overall Study|Withdrawal by Subject|7|||
129154780|NCT01490918|464864238|FG001|Overall Study|Withdrawal by Subject|8|||
129154781|NCT01490918|464864239|FG002|Overall Study|Withdrawal by Subject|3|||
129154782|NCT01490918|464864237|FG000|Overall Study|Adverse Event|0|||
129154783|NCT01490918|464864238|FG001|Overall Study|Adverse Event|0|||
129154784|NCT01490918|464864239|FG002|Overall Study|Adverse Event|1|||
129154785|NCT01490918|464864237|FG000|Overall Study|other cause|4|||
129154786|NCT01490918|464864238|FG001|Overall Study|other cause|5|||
129154787|NCT01490918|464864239|FG002|Overall Study|other cause|8|||
129154788|NCT02967679|464864240|FG000|Overall Study|Adverse Event|1|||
129154789|NCT00003631|464864243|FG000|Overall Study|Patient not treated|1|||
129154790|NCT00003631|464864244|FG001|Overall Study|Patient not treated|0|||
129154791|NCT00003631|464864245|FG002|Overall Study|Patient not treated|1|||
129154792|NCT00003631|464864243|FG000|Overall Study|Protocol Violation|1|||
129154793|NCT00003631|464864244|FG001|Overall Study|Protocol Violation|0|||
129154794|NCT00003631|464864245|FG002|Overall Study|Protocol Violation|0|||
129154795|NCT00003631|464864243|FG000|Overall Study|Adverse Event|1|||
129154796|NCT00003631|464864244|FG001|Overall Study|Adverse Event|1|||
129154797|NCT00003631|464864245|FG002|Overall Study|Adverse Event|5|||
129154798|NCT00003631|464864243|FG000|Overall Study|Death|0|||
129154799|NCT00003631|464864244|FG001|Overall Study|Death|0|||
129154800|NCT00003631|464864245|FG002|Overall Study|Death|1|||
129154801|NCT00003631|464864243|FG000|Overall Study|Evaluable for toxicity only|0|||
129154802|NCT00003631|464864244|FG001|Overall Study|Evaluable for toxicity only|0|||
129154803|NCT00003631|464864245|FG002|Overall Study|Evaluable for toxicity only|2|||
129154804|NCT00600067|464864246|FG000|Overall Study|Adverse Event|0|||
129154805|NCT00600067|464864247|FG001|Overall Study|Adverse Event|1|||
129154806|NCT00600067|464864246|FG000|Overall Study|Lost to Follow-up|2|||
129154807|NCT00600067|464864247|FG001|Overall Study|Lost to Follow-up|3|||
129154808|NCT00600067|464864246|FG000|Overall Study|protocol non-compliance|0|||
129154809|NCT00600067|464864247|FG001|Overall Study|protocol non-compliance|3|||
129154810|NCT00600067|464864246|FG000|Overall Study|Lack of Efficacy|1|||
129154811|NCT00600067|464864247|FG001|Overall Study|Lack of Efficacy|0|||
129154812|NCT04339413|464864248|FG000|Overall Study|Reason Not Specified|2|||
129154813|NCT04339413|464864249|FG001|Overall Study|Reason Not Specified|7|||
129154814|NCT04339413|464864248|FG000|Overall Study|Study Terminated by Sponsor|30|||
129154815|NCT04339413|464864249|FG001|Overall Study|Study Terminated by Sponsor|33|||
129154816|NCT04339413|464864248|FG000|Overall Study|Progressive Disease|9|||
129154817|NCT04339413|464864249|FG001|Overall Study|Progressive Disease|6|||
129154818|NCT04339413|464864248|FG000|Overall Study|Withdrawal by Subject|9|||
129154819|NCT04339413|464864249|FG001|Overall Study|Withdrawal by Subject|10|||
129154820|NCT04339413|464864248|FG000|Overall Study|Physician Decision|3|||
129154821|NCT04339413|464864249|FG001|Overall Study|Physician Decision|1|||
129154822|NCT04339413|464864248|FG000|Overall Study|Death|2|||
129154823|NCT04339413|464864249|FG001|Overall Study|Death|0|||
129154824|NCT04339413|464864248|FG000|Overall Study|Adverse Event|3|||
129154825|NCT04339413|464864249|FG001|Overall Study|Adverse Event|0|||
129154826|NCT00251693|464864255|FG000|Overall Study|Adverse Event|17|||
128725520|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
129154827|NCT00251693|464864256|FG001|Overall Study|Adverse Event|9|||
129154828|NCT00251693|464864257|FG002|Overall Study|Adverse Event|9|||
128725521|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
129154829|NCT00251693|464864255|FG000|Overall Study|Protocol Violation|2|||
128725522|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
129154830|NCT00251693|464864256|FG001|Overall Study|Protocol Violation|0|||
129154831|NCT00251693|464864257|FG002|Overall Study|Protocol Violation|2|||
129154832|NCT00251693|464864255|FG000|Overall Study|Lost to Follow-up|12|||
129154833|NCT00251693|464864256|FG001|Overall Study|Lost to Follow-up|7|||
129154834|NCT00251693|464864257|FG002|Overall Study|Lost to Follow-up|8|||
129154835|NCT00251693|464864255|FG000|Overall Study|Withdrawal by Subject|11|||
129154836|NCT00251693|464864256|FG001|Overall Study|Withdrawal by Subject|17|||
129154837|NCT00251693|464864257|FG002|Overall Study|Withdrawal by Subject|14|||
129154838|NCT00251693|464864255|FG000|Overall Study|Lack of Efficacy|0|||
129154839|NCT00251693|464864256|FG001|Overall Study|Lack of Efficacy|1|||
129154840|NCT00251693|464864257|FG002|Overall Study|Lack of Efficacy|0|||
129154841|NCT00251693|464864255|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
129154842|NCT00251693|464864256|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
129154843|NCT00251693|464864257|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
128725523|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
128725524|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
128725525|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
128725526|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
128725527|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
128725528|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
129154844|NCT00251693|464864255|FG000|Overall Study|Noncompliant|0|||
128725529|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
128725530|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
128725531|NCT03962543|463291003|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
128725532|NCT03962543|463291004|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
128725533|NCT03264404|463292472|FG000|Overall Study|Death|2|||
128725534|NCT03264404|463292472|FG000|Overall Study|Physician Decision|1|||
128725535|NCT03264404|463292472|FG000|Overall Study|Disease Progression|28|||
128725536|NCT03264404|463292472|FG000|Overall Study|Adverse Event|1|||
128725537|NCT03264404|463292472|FG000|Overall Study|Off study prior to treatment|2|||
128725538|NCT03036566|463292473|FG000|Overall Study|Lost to Follow-up|3|||
128725539|NCT03277846|463292475|FG000|Overall Study|Inpatient stay too brief|12|||
128725540|NCT03277846|463292476|FG001|Overall Study|Inpatient stay too brief|11|||
128725541|NCT01572038|463292477|FG000|Overall Study|Death|648|||
128725542|NCT01572038|463292477|FG000|Overall Study|Withdrawal by Subject|204|||
128725543|NCT01572038|463292477|FG000|Overall Study|Lost to Follow-up|81|||
128725544|NCT01572038|463292477|FG000|Overall Study|Physician Decision|20|||
128725545|NCT01572038|463292477|FG000|Overall Study|Patient Decision|14|||
128725546|NCT01572038|463292477|FG000|Overall Study|Progressive Disease|8|||
128725547|NCT01572038|463292477|FG000|Overall Study|Site Closed Before Completing Form|6|||
128725548|NCT01572038|463292477|FG000|Overall Study|Enrolled into Another Trial|3|||
128725549|NCT01572038|463292477|FG000|Overall Study|Participated in Another Trial|3|||
128725550|NCT01572038|463292477|FG000|Overall Study|Termination by Sponsor|2|||
128725551|NCT01572038|463292477|FG000|Overall Study|Patient Deterioration|1|||
128725552|NCT01572038|463292477|FG000|Overall Study|Sponsor Decision|1|||
128725553|NCT04013191|463292478|FG000|Overall Study|Adverse Event|1|||
129154845|NCT00251693|464864256|FG001|Overall Study|Noncompliant|0|||
129154846|NCT00251693|464864257|FG002|Overall Study|Noncompliant|2|||
129154847|NCT00251693|464864255|FG000|Overall Study|Possible Barrett's esophagus|3|||
129154848|NCT00251693|464864256|FG001|Overall Study|Possible Barrett's esophagus|5|||
129154849|NCT00251693|464864257|FG002|Overall Study|Possible Barrett's esophagus|2|||
129154850|NCT00251693|464864255|FG000|Overall Study|Subject request/subject unavailable|1|||
129154851|NCT00251693|464864256|FG001|Overall Study|Subject request/subject unavailable|2|||
129154852|NCT00251693|464864257|FG002|Overall Study|Subject request/subject unavailable|0|||
129154853|NCT00251693|464864255|FG000|Overall Study|Abnormal laboratory findings|0|||
129154854|NCT00251693|464864256|FG001|Overall Study|Abnormal laboratory findings|0|||
129154855|NCT00251693|464864257|FG002|Overall Study|Abnormal laboratory findings|1|||
129154856|NCT00401843|464864258|FG000|Overall Study|Achieved Complete Response|1|||
129154857|NCT00401843|464864259|FG001|Overall Study|Achieved Complete Response|5|||
129154858|NCT00401843|464864260|FG002|Overall Study|Achieved Complete Response|11|||
129154859|NCT00401843|464864258|FG000|Overall Study|Adverse Event|7|||
129154860|NCT00401843|464864259|FG001|Overall Study|Adverse Event|26|||
129154861|NCT00401843|464864260|FG002|Overall Study|Adverse Event|27|||
129154862|NCT00401843|464864258|FG000|Overall Study|Death|0|||
129154863|NCT00401843|464864259|FG001|Overall Study|Death|8|||
129154864|NCT00401843|464864260|FG002|Overall Study|Death|10|||
129154865|NCT00401843|464864258|FG000|Overall Study|Disease progression|10|||
129154866|NCT00401843|464864259|FG001|Overall Study|Disease progression|60|||
129154867|NCT00401843|464864260|FG002|Overall Study|Disease progression|49|||
129154868|NCT00401843|464864258|FG000|Overall Study|End of Study|1|||
129154869|NCT00401843|464864259|FG001|Overall Study|End of Study|1|||
129154870|NCT00401843|464864260|FG002|Overall Study|End of Study|2|||
129154871|NCT00401843|464864258|FG000|Overall Study|Lost to Follow-up|0|||
129154872|NCT00401843|464864259|FG001|Overall Study|Lost to Follow-up|0|||
129154873|NCT00401843|464864260|FG002|Overall Study|Lost to Follow-up|2|||
129154874|NCT00401843|464864258|FG000|Overall Study|Other Unspecified|0|||
128725554|NCT04013191|463292479|FG001|Overall Study|Adverse Event|0|||
128725555|NCT01275066|463292488|FG000|Overall Study|Withdrawal by Subject|0|||
128725556|NCT01275066|463292489|FG001|Overall Study|Withdrawal by Subject|0|||
129154875|NCT00401843|464864259|FG001|Overall Study|Other Unspecified|3|||
129154876|NCT00401843|464864260|FG002|Overall Study|Other Unspecified|5|||
129154877|NCT00401843|464864258|FG000|Overall Study|Physician Decision|0|||
129154878|NCT00401843|464864259|FG001|Overall Study|Physician Decision|16|||
129154879|NCT00401843|464864260|FG002|Overall Study|Physician Decision|10|||
129154880|NCT00401843|464864258|FG000|Overall Study|Protocol Violation|0|||
129154881|NCT00401843|464864259|FG001|Overall Study|Protocol Violation|0|||
129154882|NCT00401843|464864260|FG002|Overall Study|Protocol Violation|1|||
128725557|NCT01275066|463292490|FG002|Overall Study|Withdrawal by Subject|1|||
128725558|NCT01275066|463292488|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
129154883|NCT00401843|464864258|FG000|Overall Study|Withdrawal by Subject|1|||
129154884|NCT00401843|464864259|FG001|Overall Study|Withdrawal by Subject|5|||
129154885|NCT00401843|464864260|FG002|Overall Study|Withdrawal by Subject|5|||
129154886|NCT00401843|464864258|FG000|Overall Study|Withdrawal of consent to study agent|1|||
129154887|NCT00401843|464864259|FG001|Overall Study|Withdrawal of consent to study agent|15|||
129154888|NCT00401843|464864260|FG002|Overall Study|Withdrawal of consent to study agent|17|||
129154889|NCT00401843|464864258|FG000|Overall Study|Randomized but not Treated|0|||
129154890|NCT00401843|464864259|FG001|Overall Study|Randomized but not Treated|2|||
129154891|NCT00401843|464864260|FG002|Overall Study|Randomized but not Treated|3|||
129154892|NCT00401843|464864258|FG000|Overall Study|Received incorrect treatment|0|||
129154893|NCT00401843|464864259|FG001|Overall Study|Received incorrect treatment|3|||
129154894|NCT00401843|464864260|FG002|Overall Study|Received incorrect treatment|0|||
129154895|NCT02103062|464864263|FG000|Overall Study|Adverse Event|1|||
129154896|NCT02103062|464864264|FG001|Overall Study|Adverse Event|2|||
129154897|NCT02103062|464864263|FG000|Overall Study|Progressive Disease|17|||
129154898|NCT02103062|464864264|FG001|Overall Study|Progressive Disease|20|||
129154899|NCT02103062|464864263|FG000|Overall Study|Death|0|||
129154900|NCT02103062|464864264|FG001|Overall Study|Death|1|||
129154901|NCT00120627|464864265|FG000|Overall Study|Withdrawal by Subject|5|||
129154902|NCT00120627|464864266|FG001|Overall Study|Withdrawal by Subject|5|||
129154903|NCT01508910|464864267|FG000|Treatment|Death|2|||
129154904|NCT01508910|464864268|FG001|Treatment|Death|3|||
129154905|NCT01508910|464864269|FG002|Treatment|Death|2|||
129154906|NCT01508910|464864270|FG003|Treatment|Death|0|||
129154907|NCT01508910|464864267|FG000|Treatment|Lost to Follow-up|0|||
129154908|NCT01508910|464864268|FG001|Treatment|Lost to Follow-up|0|||
129154909|NCT01508910|464864269|FG002|Treatment|Lost to Follow-up|2|||
129154910|NCT01508910|464864270|FG003|Treatment|Lost to Follow-up|1|||
129154911|NCT01508910|464864267|FG000|Treatment|Withdrawal by Subject|0|||
129154912|NCT01508910|464864268|FG001|Treatment|Withdrawal by Subject|1|||
129154913|NCT01508910|464864269|FG002|Treatment|Withdrawal by Subject|6|||
129154914|NCT01508910|464864270|FG003|Treatment|Withdrawal by Subject|1|||
129154915|NCT01508910|464864267|FG000|Treatment|Sponsor Decision|0|||
129154916|NCT01508910|464864268|FG001|Treatment|Sponsor Decision|0|||
129154917|NCT01508910|464864269|FG002|Treatment|Sponsor Decision|0|||
129154918|NCT01508910|464864270|FG003|Treatment|Sponsor Decision|1|||
129154919|NCT02030821|464864274|FG000|Overall Study|Physician Decision|2|||
129154920|NCT02030821|464864275|FG001|Overall Study|Physician Decision|2|||
129154921|NCT02030821|464864276|FG002|Overall Study|Physician Decision|5|||
129154922|NCT02030821|464864277|FG003|Overall Study|Physician Decision|2|||
129154923|NCT03192137|464864278|FG000|Overall Study|Adverse Event|10|||
129154924|NCT03192137|464864279|FG001|Overall Study|Adverse Event|11|||
129154925|NCT03192137|464864278|FG000|Overall Study|Physician Decision|1|||
129154926|NCT03192137|464864279|FG001|Overall Study|Physician Decision|0|||
129154927|NCT03192137|464864278|FG000|Overall Study|Lack of Efficacy|20|||
129154928|NCT03192137|464864279|FG001|Overall Study|Lack of Efficacy|37|||
129154929|NCT03192137|464864278|FG000|Overall Study|Withdrawal by Subject|3|||
129154930|NCT03192137|464864279|FG001|Overall Study|Withdrawal by Subject|3|||
129154931|NCT03192137|464864278|FG000|Overall Study|Protocol Violation|4|||
129154932|NCT03192137|464864279|FG001|Overall Study|Protocol Violation|3|||
129154933|NCT03192137|464864278|FG000|Overall Study|Surgery Cancelled|4|||
129154934|NCT03192137|464864279|FG001|Overall Study|Surgery Cancelled|1|||
129154935|NCT03192137|464864278|FG000|Overall Study|Other - Various Administrative Reasons|8|||
129154936|NCT03192137|464864279|FG001|Overall Study|Other - Various Administrative Reasons|3|||
129154937|NCT00657267|464864282|FG000|Overall Study|Progressive disease|45|||
129154938|NCT00657267|464864282|FG000|Overall Study|Adverse Event|9|||
129154939|NCT02737501|464864286|FG000|Randomized Phase|Died|41|||
129154940|NCT02737501|464864287|FG001|Randomized Phase|Died|29|||
129154941|NCT02737501|464864288|FG002|Randomized Phase|Died|0|||
129154942|NCT02737501|464864286|FG000|Randomized Phase|Withdrawal by Subject|16|||
129154943|NCT02737501|464864287|FG001|Randomized Phase|Withdrawal by Subject|6|||
129154944|NCT02737501|464864288|FG002|Randomized Phase|Withdrawal by Subject|0|||
129154945|NCT02737501|464864286|FG000|Randomized Phase|Lost to Follow-up|0|||
129154946|NCT02737501|464864287|FG001|Randomized Phase|Lost to Follow-up|1|||
129154947|NCT02737501|464864288|FG002|Randomized Phase|Lost to Follow-up|0|||
129154948|NCT02737501|464864286|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
129154949|NCT02737501|464864287|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
129154950|NCT02737501|464864288|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
129154951|NCT02737501|464864286|FG000|Randomized Phase|Reason not Specified|1|||
129154952|NCT02737501|464864287|FG001|Randomized Phase|Reason not Specified|1|||
129154953|NCT02737501|464864288|FG002|Randomized Phase|Reason not Specified|0|||
129154954|NCT02737501|464864286|FG000|Randomized Phase|Never Treated|1|||
129154955|NCT02737501|464864287|FG001|Randomized Phase|Never Treated|1|||
129154956|NCT02737501|464864288|FG002|Randomized Phase|Never Treated|0|||
129154957|NCT02737501|464864286|FG000|Crossover Phase|Died|0|||
129154958|NCT02737501|464864287|FG001|Crossover Phase|Died|0|||
129154959|NCT02737501|464864288|FG002|Crossover Phase|Died|22|||
129154960|NCT02737501|464864286|FG000|Crossover Phase|Withdrew Consent|0|||
129154961|NCT02737501|464864287|FG001|Crossover Phase|Withdrew Consent|0|||
129154962|NCT02737501|464864288|FG002|Crossover Phase|Withdrew Consent|9|||
129154963|NCT02737501|464864286|FG000|Crossover Phase|Physician Decision|0|||
129154964|NCT02737501|464864287|FG001|Crossover Phase|Physician Decision|0|||
129154965|NCT02737501|464864288|FG002|Crossover Phase|Physician Decision|1|||
129154966|NCT02737501|464864286|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
129154967|NCT02737501|464864287|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
129154968|NCT02737501|464864288|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
129154969|NCT01261975|464864289|FG000|Overall Study|Surgical complication|1|||
129154970|NCT00716274|464864290|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
129154971|NCT00716274|464864291|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129154972|NCT00716274|464864292|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129154973|NCT00716274|464864293|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129154974|NCT00716274|464864294|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129154975|NCT00716274|464864295|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129154976|NCT00716274|464864290|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
129154977|NCT00716274|464864291|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
129154978|NCT00716274|464864292|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
129154979|NCT00716274|464864293|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
129154980|NCT00716274|464864294|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
129154981|NCT00716274|464864295|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
129154982|NCT00716274|464864290|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
129154983|NCT00716274|464864291|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129154984|NCT00716274|464864292|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129154985|NCT00716274|464864293|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129154986|NCT00716274|464864294|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129154987|NCT00716274|464864295|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129154988|NCT00716274|464864290|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
129154989|NCT00716274|464864291|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
129154990|NCT00716274|464864292|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
129154991|NCT00716274|464864293|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
129154992|NCT00716274|464864294|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
129154993|NCT00716274|464864295|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
128725559|NCT01275066|463292489|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
129154994|NCT00716274|464864290|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
129154995|NCT00716274|464864291|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
129154996|NCT00716274|464864292|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129154997|NCT00716274|464864293|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129154998|NCT00716274|464864294|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129154999|NCT00716274|464864295|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129155000|NCT00716274|464864290|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129155001|NCT00716274|464864291|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
129155002|NCT00716274|464864292|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129155003|NCT00716274|464864293|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129155004|NCT00716274|464864294|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129155005|NCT00716274|464864295|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129155006|NCT00716274|464864290|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129155007|NCT00716274|464864291|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129155008|NCT00716274|464864292|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
129155009|NCT00716274|464864293|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129155010|NCT00716274|464864294|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129155011|NCT00716274|464864295|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129155012|NCT00716274|464864290|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
129155013|NCT00716274|464864291|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
129155014|NCT00716274|464864292|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
129155015|NCT00716274|464864293|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
129155016|NCT00716274|464864294|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
129155017|NCT00716274|464864295|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
129155018|NCT00716274|464864290|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
129155019|NCT00716274|464864291|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
129155020|NCT00716274|464864292|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
129155021|NCT00716274|464864293|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
129155022|NCT00716274|464864294|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
129155023|NCT00716274|464864295|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
128725560|NCT01275066|463292490|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
128725561|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
129155024|NCT00716274|464864290|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
129155025|NCT00716274|464864291|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
129155026|NCT00716274|464864292|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
129155027|NCT00716274|464864293|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
129155028|NCT00716274|464864294|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
129155029|NCT00716274|464864295|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
129155030|NCT04819113|464864298|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129155031|NCT04819113|464864298|FG000|Overall Study|Lost to Follow-up|1|||
129155032|NCT04819113|464864298|FG000|Overall Study|Withdrawn before vaccination|2|||
129155033|NCT04067492|464864299|FG000|Overall Study|Lost to Follow-up|0|||
129155034|NCT04067492|464864300|FG001|Overall Study|Lost to Follow-up|0|||
129155035|NCT04067492|464864301|FG002|Overall Study|Lost to Follow-up|0|||
129155036|NCT04067492|464864302|FG003|Overall Study|Lost to Follow-up|0|||
129155037|NCT04067492|464864303|FG004|Overall Study|Lost to Follow-up|0|||
129155038|NCT04067492|464864304|FG005|Overall Study|Lost to Follow-up|1|||
129155039|NCT04067492|464864299|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129155040|NCT04067492|464864300|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
129155041|NCT04067492|464864301|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129155042|NCT04067492|464864302|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129155043|NCT04067492|464864303|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129155044|NCT04067492|464864304|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129155045|NCT04067492|464864299|FG000|Overall Study|COVID-19 epidemiological situation|0|||
129155046|NCT04067492|464864300|FG001|Overall Study|COVID-19 epidemiological situation|0|||
129155047|NCT04067492|464864301|FG002|Overall Study|COVID-19 epidemiological situation|0|||
129155048|NCT04067492|464864302|FG003|Overall Study|COVID-19 epidemiological situation|1|||
129155049|NCT04067492|464864303|FG004|Overall Study|COVID-19 epidemiological situation|0|||
129155050|NCT04067492|464864304|FG005|Overall Study|COVID-19 epidemiological situation|0|||
129155051|NCT00833027|464864305|FG000|Overall Study|Adverse Event|33|||
129155052|NCT00833027|464864305|FG000|Overall Study|Death|1|||
129155053|NCT00833027|464864305|FG000|Overall Study|Lack of Efficacy|12|||
129155054|NCT00833027|464864305|FG000|Overall Study|Lost to Follow-up|24|||
129155055|NCT00833027|464864305|FG000|Overall Study|Protocol Violation|115|||
129155056|NCT00833027|464864305|FG000|Overall Study|Withdrawal by Subject|16|||
129155057|NCT00833027|464864305|FG000|Overall Study|Missing|10|||
129155058|NCT00786422|464864307|FG000|Rivaroxaban Treatment|Death|2|||
129155059|NCT00786422|464864307|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
129155060|NCT00786422|464864307|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
129155061|NCT00786422|464864307|FG000|Rivaroxaban Treatment|Physician Decision|1|||
129155062|NCT00786422|464864307|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
129155063|NCT00786422|464864307|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
129155064|NCT00786422|464864307|FG000|Rivaroxaban Treatment|Adverse Event|2|||
129155065|NCT00786422|464864307|FG000|Follow-up Period|Death|1|||
129155066|NCT00786422|464864307|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
129155067|NCT02015039|464864310|FG000|Overall Study|Not eligible|0|||
129155068|NCT02015039|464864311|FG001|Overall Study|Not eligible|1|||
129155069|NCT04570384|464864312|FG000|Overall Study|Adverse Event|2|||
129155070|NCT04570384|464864313|FG001|Overall Study|Adverse Event|1|||
129155071|NCT04570384|464864312|FG000|Overall Study|Death|2|||
129155072|NCT04570384|464864313|FG001|Overall Study|Death|5|||
129155073|NCT04570384|464864312|FG000|Overall Study|Lost to Follow-up|1|||
129155074|NCT04570384|464864313|FG001|Overall Study|Lost to Follow-up|0|||
129155075|NCT04570384|464864312|FG000|Overall Study|Other|1|||
129155076|NCT04570384|464864313|FG001|Overall Study|Other|0|||
129155077|NCT04570384|464864312|FG000|Overall Study|Protocol Violation|0|||
129155078|NCT04570384|464864313|FG001|Overall Study|Protocol Violation|1|||
129155079|NCT04570384|464864312|FG000|Overall Study|Sponsor Decision|1|||
129155080|NCT04570384|464864313|FG001|Overall Study|Sponsor Decision|0|||
129155081|NCT04570384|464864312|FG000|Overall Study|Withdrawal by Subject|4|||
129155082|NCT04570384|464864313|FG001|Overall Study|Withdrawal by Subject|2|||
129155083|NCT01673126|464864314|FG000|Overall Study|change of diagnosis|4|||
129155084|NCT01673126|464864315|FG001|Overall Study|change of diagnosis|3|||
129155085|NCT02670473|464864322|FG000|Overall Study|Withdrawal by Subject|1|||
129155086|NCT01404234|464864323|FG000|Overall Study|Withdrawal by Subject|2|||
129155087|NCT01475721|464866013|FG000|Overall Study|Death|3|||
129155088|NCT01475721|464866014|FG001|Overall Study|Death|6|||
129155089|NCT01475721|464866013|FG000|Overall Study|Withdrawal by Subject|8|||
129155090|NCT01475721|464866014|FG001|Overall Study|Withdrawal by Subject|8|||
129155091|NCT00803738|464866016|FG000|Overall Study|Adverse Event|3|||
129155092|NCT00803738|464866017|FG001|Overall Study|Adverse Event|5|||
129155093|NCT00803738|464866016|FG000|Overall Study|Lost to Follow-up|4|||
129155094|NCT00803738|464866017|FG001|Overall Study|Lost to Follow-up|4|||
129155095|NCT00803738|464866016|FG000|Overall Study|Protocol Violation|18|||
129155096|NCT00803738|464866017|FG001|Overall Study|Protocol Violation|10|||
129155097|NCT00803738|464866016|FG000|Overall Study|Withdrawal by Subject|1|||
129155098|NCT00803738|464866017|FG001|Overall Study|Withdrawal by Subject|4|||
129155099|NCT00803738|464866016|FG000|Overall Study|Lack of Efficacy|10|||
129155100|NCT00803738|464866017|FG001|Overall Study|Lack of Efficacy|16|||
129155101|NCT00803738|464866016|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
129155102|NCT00803738|464866017|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
129155103|NCT00803738|464866016|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
129155104|NCT00803738|464866017|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
129155105|NCT02364037|464866018|FG000|Overall Study|Withdrawal by Subject|7|||
129155106|NCT02364037|464866019|FG001|Overall Study|Withdrawal by Subject|4|||
129155107|NCT02364037|464866018|FG000|Overall Study|Lost to Follow-up|37|||
129155108|NCT02364037|464866019|FG001|Overall Study|Lost to Follow-up|49|||
129155109|NCT00387088|464866022|FG000|Overall Study|Adverse Event|143|||
129155110|NCT00387088|464866023|FG001|Overall Study|Adverse Event|156|||
129155111|NCT00387088|464866022|FG000|Overall Study|Protocol Violation|47|||
129155112|NCT00387088|464866023|FG001|Overall Study|Protocol Violation|35|||
129155113|NCT00387088|464866022|FG000|Overall Study|Withdrawal by Subject|20|||
129155114|NCT00387088|464866023|FG001|Overall Study|Withdrawal by Subject|35|||
129155115|NCT00387088|464866022|FG000|Overall Study|Lack of Efficacy|28|||
129155116|NCT00387088|464866023|FG001|Overall Study|Lack of Efficacy|67|||
129155117|NCT00387088|464866022|FG000|Overall Study|Lost to Follow-up|22|||
129155118|NCT00387088|464866023|FG001|Overall Study|Lost to Follow-up|28|||
129155119|NCT00387088|464866022|FG000|Overall Study|Other|58|||
129155120|NCT00387088|464866023|FG001|Overall Study|Other|52|||
129155121|NCT02848092|464866026|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
129155122|NCT02848092|464866027|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
129155123|NCT02848092|464866026|FG000|1-month Post-training Follow-up|Adverse Event|2|||
129155124|NCT02848092|464866027|FG001|1-month Post-training Follow-up|Adverse Event|1|||
129155125|NCT02848092|464866026|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
129155126|NCT02848092|464866027|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
129155127|NCT02848092|464866026|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
129155128|NCT02848092|464866027|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
129155129|NCT02848092|464866026|FG000|1-month Post-training Follow-up|fatigue|0|||
129155130|NCT02848092|464866027|FG001|1-month Post-training Follow-up|fatigue|1|||
129155131|NCT02848092|464866026|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
129155132|NCT02848092|464866027|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
129155133|NCT02848092|464866026|FG000|6-month Post-training Follow-up|Adverse Event|1|||
129155134|NCT02848092|464866027|FG001|6-month Post-training Follow-up|Adverse Event|1|||
129155135|NCT02848092|464866026|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
129155136|NCT02848092|464866027|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
129155137|NCT02848092|464866026|FG000|6-month Post-training Follow-up|frustrated with task|1|||
129155138|NCT02848092|464866027|FG001|6-month Post-training Follow-up|frustrated with task|0|||
129155139|NCT02848092|464866026|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
129155140|NCT02848092|464866027|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
129155141|NCT02848092|464866026|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
129155142|NCT02848092|464866027|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
129155143|NCT01639469|464866029|FG000|Overall Study|Death|4|||
129155144|NCT01639469|464866030|FG001|Overall Study|Death|2|||
129155145|NCT01639469|464866029|FG000|Overall Study|Lost to Follow-up|1|||
129155146|NCT01639469|464866030|FG001|Overall Study|Lost to Follow-up|1|||
129155147|NCT00420381|464866031|FG000|Overall Study|Protocol Violation|1|||
129155148|NCT02383862|464866035|FG000|3 Month Follow up|Lost to Follow-up|23|||
129155149|NCT02383862|464866036|FG001|3 Month Follow up|Lost to Follow-up|21|||
129155150|NCT01833494|464866037|FG000|Overall Study|Adverse Event|24|||
129155151|NCT01833494|464866037|FG000|Overall Study|Physician Decision|6|||
129155152|NCT01833494|464866037|FG000|Overall Study|Withdrawal by Subject|6|||
129155153|NCT01833494|464866037|FG000|Overall Study|Decrease in serum phosphorus|4|||
129155154|NCT01833494|464866037|FG000|Overall Study|Decrease in serum calcium|4|||
129155155|NCT01833494|464866037|FG000|Overall Study|Increase in serum ferritin|1|||
129155156|NCT00374595|464866040|FG000|Overall Study|Death|23|||
129155157|NCT00374595|464866040|FG000|Overall Study|Withdrawal by Subject|39|||
129155158|NCT00374595|464866040|FG000|Overall Study|Lost to Follow-up|3|||
129155159|NCT00374595|464866040|FG000|Overall Study|too much time commitment|1|||
129155160|NCT00374595|464866040|FG000|Overall Study|transfer care to other clinical site|1|||
129155161|NCT00374595|464866040|FG000|Overall Study|relocation|3|||
129155162|NCT03745768|464866042|FG000|Overall Study|discontinued study|2|||
129155163|NCT03745768|464866043|FG001|Overall Study|discontinued study|0|||
129155164|NCT00443118|464866044|FG000|Overall Study|unknown primary outcome|3|||
129155165|NCT00443118|464866045|FG001|Overall Study|unknown primary outcome|1|||
129155166|NCT00443118|464866046|FG002|Overall Study|unknown primary outcome|0|||
129155167|NCT00443118|464866044|FG000|Overall Study|Withdrawal by Subject|1|||
129155168|NCT00443118|464866045|FG001|Overall Study|Withdrawal by Subject|0|||
129155169|NCT00443118|464866046|FG002|Overall Study|Withdrawal by Subject|0|||
129155170|NCT01664247|464866049|FG000|Overall Study|Adverse Event|5|||
129155171|NCT01664247|464866050|FG001|Overall Study|Adverse Event|3|||
129155172|NCT01664247|464866049|FG000|Overall Study|Protocol Violation|3|||
129155173|NCT01664247|464866050|FG001|Overall Study|Protocol Violation|5|||
129155174|NCT01664247|464866049|FG000|Overall Study|Withdrawal Criteria|1|||
129155175|NCT01664247|464866050|FG001|Overall Study|Withdrawal Criteria|4|||
129155176|NCT01664247|464866049|FG000|Overall Study|Unclassified|5|||
129155177|NCT01664247|464866050|FG001|Overall Study|Unclassified|29|||
129155178|NCT01106157|464866051|FG000|Overall Study|Withdrawal by Subject|1|||
129155179|NCT01106157|464866052|FG001|Overall Study|Withdrawal by Subject|0|||
129155180|NCT01673646|464866056|FG000|Overall Study|Adverse Event|2|||
128725562|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
128725563|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
128725564|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
129155181|NCT01673646|464866057|FG001|Overall Study|Adverse Event|1|||
129155182|NCT01673646|464866058|FG002|Overall Study|Adverse Event|1|||
129155183|NCT01673646|464866056|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129155184|NCT01673646|464866057|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129155185|NCT01673646|464866058|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129155186|NCT01673646|464866056|FG000|Overall Study|Condition no longer requires study drug|0|||
129155187|NCT01673646|464866057|FG001|Overall Study|Condition no longer requires study drug|1|||
129155188|NCT01673646|464866058|FG002|Overall Study|Condition no longer requires study drug|0|||
129155189|NCT01673646|464866056|FG000|Overall Study|Withdrawal by Subject|0|||
129155190|NCT01673646|464866057|FG001|Overall Study|Withdrawal by Subject|2|||
129155191|NCT01673646|464866058|FG002|Overall Study|Withdrawal by Subject|2|||
129155192|NCT01673646|464866056|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
129155193|NCT01673646|464866057|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
129155194|NCT01673646|464866058|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
129155195|NCT03064074|464866059|FG000|Overall Study|Physician Decision|0|||
129155196|NCT03064074|464866060|FG001|Overall Study|Physician Decision|0|||
129155197|NCT03064074|464866061|FG002|Overall Study|Physician Decision|0|||
129155198|NCT03064074|464866062|FG003|Overall Study|Physician Decision|1|||
129155199|NCT02141672|464866066|FG000|Overall Study|Adverse Event|0|||
129155200|NCT02141672|464866067|FG001|Overall Study|Adverse Event|1|||
129155201|NCT02141672|464866068|FG002|Overall Study|Adverse Event|0|||
129155202|NCT02141672|464866066|FG000|Overall Study|Death|10|||
129155203|NCT02141672|464866067|FG001|Overall Study|Death|2|||
129155204|NCT02141672|464866068|FG002|Overall Study|Death|1|||
129155205|NCT02141672|464866066|FG000|Overall Study|Lack of Efficacy|0|||
129155206|NCT02141672|464866067|FG001|Overall Study|Lack of Efficacy|0|||
129155207|NCT02141672|464866068|FG002|Overall Study|Lack of Efficacy|2|||
129155208|NCT02141672|464866066|FG000|Overall Study|Lost to Follow-up|1|||
129155209|NCT02141672|464866067|FG001|Overall Study|Lost to Follow-up|1|||
129155210|NCT02141672|464866068|FG002|Overall Study|Lost to Follow-up|3|||
129155211|NCT02141672|464866066|FG000|Overall Study|Physician Decision|1|||
129155212|NCT02141672|464866067|FG001|Overall Study|Physician Decision|2|||
129155213|NCT02141672|464866068|FG002|Overall Study|Physician Decision|5|||
129155214|NCT02141672|464866066|FG000|Overall Study|Protocol Violation|0|||
129155215|NCT02141672|464866067|FG001|Overall Study|Protocol Violation|0|||
129155216|NCT02141672|464866068|FG002|Overall Study|Protocol Violation|1|||
129155217|NCT02141672|464866066|FG000|Overall Study|Withdrawal by Subject|3|||
129155218|NCT02141672|464866067|FG001|Overall Study|Withdrawal by Subject|2|||
129155219|NCT02141672|464866068|FG002|Overall Study|Withdrawal by Subject|5|||
129155220|NCT02141672|464866066|FG000|Overall Study|refused to follow-up|1|||
129155221|NCT02141672|464866067|FG001|Overall Study|refused to follow-up|0|||
129155222|NCT02141672|464866068|FG002|Overall Study|refused to follow-up|1|||
129155223|NCT01118780|464866069|FG000|Overall Study|Adverse Event|15|||
129155224|NCT01118780|464866070|FG001|Overall Study|Adverse Event|15|||
129155225|NCT01118780|464866069|FG000|Overall Study|Death|1|||
129155226|NCT01118780|464866070|FG001|Overall Study|Death|0|||
129155227|NCT01118780|464866069|FG000|Overall Study|Lack of Efficacy|2|||
129155228|NCT01118780|464866070|FG001|Overall Study|Lack of Efficacy|6|||
129155229|NCT01118780|464866069|FG000|Overall Study|Physician Decision|2|||
129155230|NCT01118780|464866070|FG001|Overall Study|Physician Decision|0|||
129155231|NCT01118780|464866069|FG000|Overall Study|Protocol Violation|3|||
129155232|NCT01118780|464866070|FG001|Overall Study|Protocol Violation|6|||
129155233|NCT01118780|464866069|FG000|Overall Study|Withdrawal by Subject|13|||
129155234|NCT01118780|464866070|FG001|Overall Study|Withdrawal by Subject|8|||
129155235|NCT03962855|464866078|FG000|Overall Study|Death|0|||
129155236|NCT03962855|464866079|FG001|Overall Study|Death|1|||
129155237|NCT03962855|464866078|FG000|Overall Study|Lost to Follow-up|0|||
129155238|NCT03962855|464866079|FG001|Overall Study|Lost to Follow-up|1|||
129155239|NCT03962855|464866078|FG000|Overall Study|Adverse Event|0|||
129155240|NCT03962855|464866079|FG001|Overall Study|Adverse Event|1|||
128725565|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
129155241|NCT03962855|464866078|FG000|Overall Study|Physician Decision|0|||
128725566|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
129155242|NCT03962855|464866079|FG001|Overall Study|Physician Decision|2|||
129155243|NCT00127855|464866080|FG000|Primary Vaccination Course|Adverse Event|0|||
129155244|NCT00127855|464866081|FG001|Primary Vaccination Course|Adverse Event|0|||
129155245|NCT00127855|464866082|FG002|Primary Vaccination Course|Adverse Event|1|||
129155246|NCT00127855|464866083|FG003|Primary Vaccination Course|Adverse Event|0|||
129155247|NCT00127855|464866084|FG004|Primary Vaccination Course|Adverse Event|0|||
129155248|NCT00127855|464866080|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
129155249|NCT00127855|464866081|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
129155250|NCT00127855|464866082|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
129155251|NCT00127855|464866083|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
129155252|NCT00127855|464866084|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
129155253|NCT00127855|464866080|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
129155254|NCT00127855|464866081|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
129155255|NCT00127855|464866082|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
129155256|NCT00127855|464866083|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
129155257|NCT00127855|464866084|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
129155258|NCT00127855|464866080|FG000|Primary Vaccination Course|Other|0|||
129155259|NCT00127855|464866081|FG001|Primary Vaccination Course|Other|0|||
129155260|NCT00127855|464866082|FG002|Primary Vaccination Course|Other|0|||
129155261|NCT00127855|464866083|FG003|Primary Vaccination Course|Other|0|||
129155262|NCT00127855|464866084|FG004|Primary Vaccination Course|Other|1|||
129155263|NCT02343302|464866085|FG000|Overall Study|Physician Decision|1|||
129155264|NCT02343302|464866086|FG001|Overall Study|Physician Decision|1|||
129155265|NCT02655887|464866087|FG000|Overall Study|Lost to Follow-up|3|||
129155266|NCT02655887|464866087|FG000|Overall Study|Death|4|||
129155267|NCT02655887|464866087|FG000|Overall Study|Withdrawal by Subject|3|||
129155268|NCT02655887|464866087|FG000|Overall Study|Missed 12-month follow-up visit|4|||
129155269|NCT03465722|464866093|FG000|Overall Study|Withdrawal by Subject|21|||
129155270|NCT03465722|464866094|FG001|Overall Study|Withdrawal by Subject|14|||
129155271|NCT03465722|464866093|FG000|Overall Study|Death|89|||
129155272|NCT03465722|464866094|FG001|Overall Study|Death|87|||
129155273|NCT03465722|464866093|FG000|Overall Study|Lost to Follow-up|5|||
129155274|NCT03465722|464866094|FG001|Overall Study|Lost to Follow-up|3|||
129155275|NCT03465722|464866093|FG000|Overall Study|Administrative/Other|33|||
129155276|NCT03465722|464866094|FG001|Overall Study|Administrative/Other|32|||
129155277|NCT03465722|464866093|FG000|Overall Study|Not treated|1|||
129155278|NCT03465722|464866094|FG001|Overall Study|Not treated|2|||
129155279|NCT03465722|464866093|FG000|Overall Study|Sponsor decision|91|||
129155280|NCT03465722|464866094|FG001|Overall Study|Sponsor decision|98|||
129155281|NCT04940130|464866097|FG000|Overall Study|Travel|1|||
129155282|NCT04940130|464866098|FG001|Overall Study|Travel|0|||
129155283|NCT04940130|464866099|FG002|Overall Study|Travel|2|||
129155284|NCT04940130|464866097|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
129155285|NCT04940130|464866098|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
129155286|NCT04940130|464866099|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
129155287|NCT04940130|464866097|FG000|Overall Study|Adverse Event|0|||
129155288|NCT04940130|464866098|FG001|Overall Study|Adverse Event|0|||
129155289|NCT04940130|464866099|FG002|Overall Study|Adverse Event|2|||
129155290|NCT04940130|464866097|FG000|Overall Study|Disease progression/treatment failure|0|||
129155291|NCT04940130|464866098|FG001|Overall Study|Disease progression/treatment failure|0|||
129155292|NCT04940130|464866099|FG002|Overall Study|Disease progression/treatment failure|1|||
129155293|NCT04940130|464866097|FG000|Overall Study|Participant refusal|0|||
129155294|NCT04940130|464866098|FG001|Overall Study|Participant refusal|0|||
129155295|NCT04940130|464866099|FG002|Overall Study|Participant refusal|1|||
129155296|NCT02240121|464866102|FG000|Overall Study|Protocol Violation|1|||
129155297|NCT02240121|464866103|FG001|Overall Study|Protocol Violation|2|||
129155298|NCT02240121|464866102|FG000|Overall Study|Physician Decision|0|||
129155299|NCT02240121|464866103|FG001|Overall Study|Physician Decision|1|||
129155300|NCT02240121|464866102|FG000|Overall Study|Change in protocol interpretation|1|||
129155301|NCT02240121|464866103|FG001|Overall Study|Change in protocol interpretation|0|||
129155302|NCT02240121|464866102|FG000|Overall Study|Lack of Efficacy|2|||
129155303|NCT02240121|464866103|FG001|Overall Study|Lack of Efficacy|3|||
129155304|NCT02240121|464866102|FG000|Overall Study|Site closed|1|||
129155305|NCT02240121|464866103|FG001|Overall Study|Site closed|1|||
129155306|NCT02240121|464866102|FG000|Overall Study|Pregnancy|1|||
129155307|NCT02240121|464866103|FG001|Overall Study|Pregnancy|0|||
129155308|NCT02240121|464866102|FG000|Overall Study|Adverse Event|2|||
129155309|NCT02240121|464866103|FG001|Overall Study|Adverse Event|4|||
129155310|NCT02240121|464866102|FG000|Overall Study|Withdrawal by Subject|6|||
129155311|NCT02240121|464866103|FG001|Overall Study|Withdrawal by Subject|2|||
129155312|NCT02240121|464866102|FG000|Overall Study|Lost to Follow-up|3|||
129155313|NCT02240121|464866103|FG001|Overall Study|Lost to Follow-up|4|||
129155314|NCT02240121|464866102|FG000|Overall Study|Other than specified|1|||
129155315|NCT02240121|464866103|FG001|Overall Study|Other than specified|3|||
128725567|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
129155316|NCT04419467|464866106|FG000|Overall Study|Not treated with IP|0|||
129155317|NCT04419467|464866107|FG001|Overall Study|Not treated with IP|0|||
128725568|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
129155318|NCT04419467|464866108|FG002|Overall Study|Not treated with IP|2|||
129155319|NCT04419467|464866106|FG000|Overall Study|Adverse Event|0|||
129155320|NCT04419467|464866107|FG001|Overall Study|Adverse Event|2|||
129155321|NCT04419467|464866108|FG002|Overall Study|Adverse Event|0|||
129155322|NCT04419467|464866106|FG000|Overall Study|Death|1|||
129155323|NCT04419467|464866107|FG001|Overall Study|Death|0|||
129155324|NCT04419467|464866108|FG002|Overall Study|Death|0|||
129155325|NCT04419467|464866106|FG000|Overall Study|Lost to Follow-up|0|||
129155326|NCT04419467|464866107|FG001|Overall Study|Lost to Follow-up|1|||
129155327|NCT04419467|464866108|FG002|Overall Study|Lost to Follow-up|2|||
129155328|NCT04419467|464866106|FG000|Overall Study|Withdrawal by Subject|0|||
129155329|NCT04419467|464866107|FG001|Overall Study|Withdrawal by Subject|0|||
129155330|NCT04419467|464866108|FG002|Overall Study|Withdrawal by Subject|4|||
129155331|NCT04419467|464866106|FG000|Overall Study|Pandemic related|0|||
129155332|NCT04419467|464866107|FG001|Overall Study|Pandemic related|0|||
129155333|NCT04419467|464866108|FG002|Overall Study|Pandemic related|1|||
129155334|NCT04419467|464866106|FG000|Overall Study|Reason not known|1|||
129155335|NCT04419467|464866107|FG001|Overall Study|Reason not known|0|||
129155336|NCT04419467|464866108|FG002|Overall Study|Reason not known|0|||
129155337|NCT01925768|464866109|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129155338|NCT01925768|464866110|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129155339|NCT01925768|464866109|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129155340|NCT01925768|464866110|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
129155341|NCT01925768|464866109|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
129155342|NCT01925768|464866110|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
129155343|NCT01925768|464866109|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
129155344|NCT01925768|464866110|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
129155345|NCT01925768|464866109|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
129155346|NCT01925768|464866110|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
129155347|NCT01925768|464866109|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
129155348|NCT01925768|464866110|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
129155349|NCT01925768|464866109|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
129155350|NCT01925768|464866110|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
129155351|NCT01925768|464866109|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
129155352|NCT01925768|464866110|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
129155353|NCT01925768|464866109|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
129155354|NCT01925768|464866110|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
129155355|NCT01925768|464866109|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
129155356|NCT01925768|464866110|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
129155357|NCT01925768|464866109|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
129155358|NCT01925768|464866110|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
129155359|NCT02779777|464866113|FG000|Overall Study|Disease Progression|1|||
129155360|NCT02779777|464866114|FG001|Overall Study|Disease Progression|0|||
129155361|NCT02779777|464866115|FG002|Overall Study|Disease Progression|0|||
128725569|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
128725570|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
128725571|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
129155362|NCT02779777|464866113|FG000|Overall Study|Adverse Event|3|||
129155363|NCT02779777|464866114|FG001|Overall Study|Adverse Event|1|||
129155364|NCT02779777|464866115|FG002|Overall Study|Adverse Event|0|||
129155365|NCT02779777|464866113|FG000|Overall Study|Physician Decision|9|||
129155366|NCT02779777|464866114|FG001|Overall Study|Physician Decision|0|||
129155367|NCT02779777|464866115|FG002|Overall Study|Physician Decision|1|||
129155368|NCT02779777|464866113|FG000|Overall Study|Withdrawal by Subject|1|||
129155369|NCT02779777|464866114|FG001|Overall Study|Withdrawal by Subject|0|||
129155370|NCT02779777|464866115|FG002|Overall Study|Withdrawal by Subject|0|||
129155371|NCT04571060|464866116|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
129155372|NCT04571060|464866117|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
129155373|NCT04571060|464866116|FG000|Overall Study|Never treated migraine|47|||
129155374|NCT04571060|464866117|FG001|Overall Study|Never treated migraine|36|||
129155375|NCT04571060|464866116|FG000|Overall Study|Protocol Violation|4|||
129155376|NCT04571060|464866117|FG001|Overall Study|Protocol Violation|2|||
129155377|NCT04571060|464866116|FG000|Overall Study|Withdrawal by Subject|6|||
129155378|NCT04571060|464866117|FG001|Overall Study|Withdrawal by Subject|2|||
129155379|NCT04571060|464866116|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
129155380|NCT04571060|464866117|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
129155381|NCT00442416|464866118|FG000|Overall Study|Adverse Event|4|||
129155382|NCT00442416|464866119|FG001|Overall Study|Adverse Event|1|||
129155383|NCT00442416|464866118|FG000|Overall Study|Death|1|||
129155384|NCT00442416|464866119|FG001|Overall Study|Death|0|||
129155385|NCT00442416|464866118|FG000|Overall Study|Lack of Efficacy|2|||
129155386|NCT00442416|464866119|FG001|Overall Study|Lack of Efficacy|0|||
129155387|NCT00442416|464866118|FG000|Overall Study|Protocol Violation|2|||
129155388|NCT00442416|464866119|FG001|Overall Study|Protocol Violation|3|||
129155389|NCT00442416|464866118|FG000|Overall Study|Withdrew consent|1|||
129155390|NCT00442416|464866119|FG001|Overall Study|Withdrew consent|2|||
129155391|NCT00442416|464866118|FG000|Overall Study|Administrative/Other|27|||
129155392|NCT00442416|464866119|FG001|Overall Study|Administrative/Other|33|||
129155393|NCT00087698|464866120|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
129155394|NCT00087698|464866120|FG000|Overall Study|Death from Other Causes|3|||
129155395|NCT00087698|464866120|FG000|Overall Study|Adverse Event|4|||
129155396|NCT00087698|464866120|FG000|Overall Study|Withdrawal by Subject|4|||
129155397|NCT00087698|464866120|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
129155398|NCT00087698|464866120|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
129155399|NCT00087698|464866120|FG000|Overall Study|Clinical Relapse|1|||
129155400|NCT00087698|464866120|FG000|Overall Study|Death from Study Disease|2|||
129155401|NCT00087698|464866120|FG000|Overall Study|Death from Study Drug Toxicity|2|||
129155402|NCT00087698|464866120|FG000|Overall Study|Protocol Violation|1|||
129155403|NCT00142792|464866124|FG000|Overall Study|Death|0|||
129155404|NCT00142792|464866125|FG001|Overall Study|Death|0|||
129155405|NCT00142792|464866126|FG002|Overall Study|Death|1|||
129155406|NCT00142792|464866124|FG000|Overall Study|Withdrawal by Subject|3|||
129155407|NCT00142792|464866125|FG001|Overall Study|Withdrawal by Subject|2|||
129155408|NCT00142792|464866126|FG002|Overall Study|Withdrawal by Subject|3|||
129155409|NCT00142792|464866124|FG000|Overall Study|Lost to Follow-up|8|||
129155410|NCT00142792|464866125|FG001|Overall Study|Lost to Follow-up|11|||
129155411|NCT00142792|464866126|FG002|Overall Study|Lost to Follow-up|7|||
129155412|NCT00142792|464866124|FG000|Overall Study|No category|1|||
129155413|NCT00142792|464866125|FG001|Overall Study|No category|2|||
129155414|NCT00142792|464866126|FG002|Overall Study|No category|1|||
129155415|NCT00444106|464866138|FG000|Overall Study|Lost to Follow-up|2|||
129155416|NCT00444106|464866139|FG001|Overall Study|Lost to Follow-up|1|||
129155417|NCT00444106|464866140|FG002|Overall Study|Lost to Follow-up|0|||
129155418|NCT00444106|464866138|FG000|Overall Study|Abnormal Test Procedure Results|0|||
129155419|NCT00444106|464866139|FG001|Overall Study|Abnormal Test Procedure Results|0|||
129155420|NCT00444106|464866140|FG002|Overall Study|Abnormal Test Procedure Results|1|||
129155421|NCT01900665|464866141|FG000|Placebo Controlled Period|Death|9|||
129155422|NCT01900665|464866142|FG001|Placebo Controlled Period|Death|16|||
129155423|NCT01900665|464866141|FG000|Placebo Controlled Period|Adverse Event|48|||
129155424|NCT01900665|464866142|FG001|Placebo Controlled Period|Adverse Event|39|||
129155425|NCT01900665|464866141|FG000|Placebo Controlled Period|Protocol Violation|1|||
129155426|NCT01900665|464866142|FG001|Placebo Controlled Period|Protocol Violation|7|||
129155427|NCT01900665|464866141|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
129155428|NCT01900665|464866142|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
129155429|NCT01900665|464866141|FG000|Placebo Controlled Period|Physician Decision|11|||
129155430|NCT01900665|464866142|FG001|Placebo Controlled Period|Physician Decision|7|||
129155431|NCT01900665|464866141|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
129155432|NCT01900665|464866142|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
129155433|NCT01900665|464866141|FG000|Placebo Controlled Period|Caregiver Decision|33|||
129155434|NCT01900665|464866142|FG001|Placebo Controlled Period|Caregiver Decision|41|||
129155435|NCT01900665|464866141|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
129155436|NCT01900665|464866142|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
129155437|NCT01900665|464866141|FG000|Open Label Period|Adverse Event|16|||
129155438|NCT01900665|464866142|FG001|Open Label Period|Adverse Event|20|||
129155439|NCT01900665|464866141|FG000|Open Label Period|Death|5|||
129155440|NCT01900665|464866142|FG001|Open Label Period|Death|6|||
129155441|NCT01900665|464866141|FG000|Open Label Period|Lost to Follow-up|1|||
129155442|NCT01900665|464866142|FG001|Open Label Period|Lost to Follow-up|1|||
129155443|NCT01900665|464866141|FG000|Open Label Period|Parent/Caregiver Decision|33|||
129155444|NCT01900665|464866142|FG001|Open Label Period|Parent/Caregiver Decision|34|||
129155445|NCT01900665|464866141|FG000|Open Label Period|Physician Decision|4|||
129155446|NCT01900665|464866142|FG001|Open Label Period|Physician Decision|4|||
129155447|NCT01900665|464866141|FG000|Open Label Period|Protocol Violation|0|||
129155448|NCT01900665|464866142|FG001|Open Label Period|Protocol Violation|1|||
129155449|NCT01900665|464866141|FG000|Open Label Period|Sponsor Decision|802|||
129155450|NCT01900665|464866142|FG001|Open Label Period|Sponsor Decision|765|||
129155451|NCT01900665|464866141|FG000|Open Label Period|Withdrawal by Subject|20|||
129155452|NCT01900665|464866142|FG001|Open Label Period|Withdrawal by Subject|28|||
129155453|NCT04749914|464866145|FG000|Period 1|Adverse Event|1|||
129155454|NCT04749914|464866146|FG001|Period 1|Adverse Event|0|||
129155455|NCT04749914|464866147|FG002|Period 1|Adverse Event|0|||
129155456|NCT04749914|464866148|FG003|Period 1|Adverse Event|0|||
129155457|NCT04749914|464866145|FG000|Period 1|Withdrawal by Subject|1|||
129155458|NCT04749914|464866146|FG001|Period 1|Withdrawal by Subject|0|||
129155459|NCT04749914|464866147|FG002|Period 1|Withdrawal by Subject|1|||
129155460|NCT04749914|464866148|FG003|Period 1|Withdrawal by Subject|0|||
129155461|NCT01074931|464866149|FG000|Overall Study|Economic reasons|1|||
129155462|NCT01074931|464866149|FG000|Overall Study|Death|5|||
129155463|NCT00953706|464866150|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
129155464|NCT00953706|464866151|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
129155465|NCT00953706|464866152|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
129155466|NCT00953706|464866153|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
129155467|NCT00953706|464866150|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
129155468|NCT00953706|464866151|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
129155469|NCT00953706|464866152|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
129155470|NCT00953706|464866153|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
129155471|NCT00953706|464866150|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
129155472|NCT00953706|464866151|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
129155473|NCT00953706|464866152|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
129155474|NCT00953706|464866153|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
129155475|NCT00953706|464866150|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
129155476|NCT00953706|464866151|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
129155477|NCT00953706|464866152|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
129155478|NCT00953706|464866153|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
129155479|NCT00953706|464866150|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
129155480|NCT00953706|464866151|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
129155481|NCT00953706|464866152|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
129155482|NCT00953706|464866153|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
129155483|NCT00953706|464866150|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
129155484|NCT00953706|464866151|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
129155485|NCT00953706|464866152|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
129155486|NCT00953706|464866153|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
129155487|NCT00953706|464866150|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
129155488|NCT00953706|464866151|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
129155489|NCT00953706|464866152|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
129155490|NCT00953706|464866153|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
129155491|NCT00953706|464866150|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
129155492|NCT00953706|464866151|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
129155493|NCT00953706|464866152|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
129155494|NCT00953706|464866153|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
129155495|NCT00953706|464866150|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
129155496|NCT00953706|464866151|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
129155497|NCT00953706|464866152|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
129155498|NCT00953706|464866153|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
129155499|NCT00953706|464866150|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
129155500|NCT00953706|464866151|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
129155501|NCT00953706|464866152|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
129155502|NCT00953706|464866153|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
129155503|NCT00953706|464866150|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
129155504|NCT00953706|464866151|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
129155505|NCT00953706|464866152|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
129155506|NCT00953706|464866153|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
129155507|NCT03816176|464866154|FG000|Overall Study|Miscellaneous|5|||
129155508|NCT03816176|464866154|FG000|Overall Study|Lack of Efficacy|4|||
129155509|NCT03816176|464866154|FG000|Overall Study|Adverse Event|3|||
129155510|NCT00756275|464867250|FG000|Overall Study|Lost to Follow-up|25|||
129155511|NCT00756275|464867251|FG001|Overall Study|Lost to Follow-up|21|||
129155512|NCT00756275|464867250|FG000|Overall Study|Withdrawal by Subject|4|||
129155513|NCT00756275|464867251|FG001|Overall Study|Withdrawal by Subject|7|||
129155514|NCT00938912|464867252|FG000|Overall Study|Withdrawal by Subject|28|||
129155515|NCT00938912|464867252|FG000|Overall Study|Lost to Follow-up|4|||
129155516|NCT00938912|464867252|FG000|Overall Study|Lack of Efficacy|43|||
129155517|NCT00938912|464867252|FG000|Overall Study|Adverse event, non-fatal|24|||
129155518|NCT00938912|464867252|FG000|Overall Study|Adverse event, fatal|1|||
129155519|NCT00938912|464867252|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
129155520|NCT00938912|464867252|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
129155521|NCT00938912|464867252|FG000|Overall Study|Participant needed prohibit medication|1|||
129155522|NCT00938912|464867252|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
129155523|NCT00938912|464867252|FG000|Overall Study|Did not meet Eligibility criteria|1|||
129155524|NCT00938912|464867252|FG000|Overall Study|Participant relocated not related to AE|1|||
129155525|NCT00938912|464867252|FG000|Overall Study|Participant moved to another city|1|||
129155526|NCT00938912|464867252|FG000|Overall Study|Participant experienced break through seizures|1|||
129155527|NCT00938912|464867252|FG000|Overall Study|No longer wished to participate in the study|1|||
129155528|NCT00938912|464867252|FG000|Overall Study|Protocol Deviation|2|||
129155529|NCT00456755|464867256|FG000|Overall Study|Lost to Follow-up|2|||
129155530|NCT00456755|464867257|FG001|Overall Study|Lost to Follow-up|1|||
129155531|NCT06164691|464867258|FG000|Overall Study|Withdrawal by Subject|2|||
129155532|NCT06164691|464867259|FG001|Overall Study|Withdrawal by Subject|0|||
129155533|NCT06164691|464867260|FG002|Overall Study|Withdrawal by Subject|0|||
129155534|NCT02477527|464867263|FG000|Overall Study|Lost to Follow-up|2|||
129155535|NCT02477527|464867263|FG000|Overall Study|Withdrawal by Subject|1|||
129155536|NCT02477527|464867263|FG000|Overall Study|Screen Failure|3|||
128725572|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
128725573|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
128776857|NCT01782326|463472024|FG000|Planned Treatment Epoch|Protocol deviation|2|||
129155537|NCT01428219|464867273|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
129155538|NCT00592631|464867274|FG000|Overall Study|Lost to Follow-up|0|||
129155539|NCT00592631|464867275|FG001|Overall Study|Lost to Follow-up|2|||
129155540|NCT01694433|464867277|FG000|Overall Study|Adverse Event|7|||
129155541|NCT01694433|464867278|FG001|Overall Study|Adverse Event|0|||
129155542|NCT01694433|464867277|FG000|Overall Study|Physician Decision|1|||
129155543|NCT01694433|464867278|FG001|Overall Study|Physician Decision|0|||
129155544|NCT01694433|464867277|FG000|Overall Study|Withdrawal by Subject|3|||
129155545|NCT01694433|464867278|FG001|Overall Study|Withdrawal by Subject|4|||
129155546|NCT02379052|464867280|FG000|Overall Study|Protocol Violation|0|||
129155547|NCT02379052|464867281|FG001|Overall Study|Protocol Violation|1|||
129155548|NCT02379052|464867280|FG000|Overall Study|Adverse Event|0|||
129155549|NCT02379052|464867281|FG001|Overall Study|Adverse Event|1|||
129155550|NCT02379052|464867280|FG000|Overall Study|Physician Decision|1|||
129155551|NCT02379052|464867281|FG001|Overall Study|Physician Decision|1|||
129155552|NCT02379052|464867280|FG000|Overall Study|Withdrawal by Subject|2|||
129155553|NCT02379052|464867281|FG001|Overall Study|Withdrawal by Subject|0|||
129155554|NCT02379052|464867280|FG000|Overall Study|Lost to Follow-up|2|||
129155555|NCT02379052|464867281|FG001|Overall Study|Lost to Follow-up|1|||
129155556|NCT02379052|464867280|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
129155557|NCT02379052|464867281|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
129155558|NCT02379052|464867280|FG000|Overall Study|Subject was Incarcerated|0|||
129155559|NCT02379052|464867281|FG001|Overall Study|Subject was Incarcerated|1|||
129155560|NCT03637491|464867282|FG000|Overall Study|Death|9|||
129155561|NCT03637491|464867283|FG001|Overall Study|Death|9|||
129155562|NCT03637491|464867284|FG002|Overall Study|Death|5|||
129155563|NCT03637491|464867285|FG003|Overall Study|Death|3|||
129155564|NCT03637491|464867282|FG000|Overall Study|Lost to Follow-up|0|||
129155565|NCT03637491|464867283|FG001|Overall Study|Lost to Follow-up|1|||
129155566|NCT03637491|464867284|FG002|Overall Study|Lost to Follow-up|0|||
129155567|NCT03637491|464867285|FG003|Overall Study|Lost to Follow-up|1|||
129155568|NCT03637491|464867282|FG000|Overall Study|Study Terminated By Sponsor|0|||
129155569|NCT03637491|464867283|FG001|Overall Study|Study Terminated By Sponsor|2|||
129155570|NCT03637491|464867284|FG002|Overall Study|Study Terminated By Sponsor|1|||
129155571|NCT03637491|464867285|FG003|Overall Study|Study Terminated By Sponsor|0|||
129155572|NCT03637491|464867282|FG000|Overall Study|Withdrawal by Subject|1|||
129155573|NCT03637491|464867283|FG001|Overall Study|Withdrawal by Subject|0|||
129155574|NCT03637491|464867284|FG002|Overall Study|Withdrawal by Subject|1|||
129155575|NCT03637491|464867285|FG003|Overall Study|Withdrawal by Subject|2|||
129155576|NCT00532844|464867286|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
129155577|NCT00532844|464867287|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
129155578|NCT00532844|464867286|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
129155579|NCT00532844|464867287|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
129155580|NCT00532844|464867286|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
129155581|NCT00532844|464867287|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
129155582|NCT00532844|464867286|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
129155583|NCT00532844|464867287|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
129155584|NCT00532844|464867286|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
129155585|NCT00532844|464867287|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
129155586|NCT01284959|464867302|FG000|Overall Study|Withdrawal by Subject|1|||
129155587|NCT01284959|464867303|FG001|Overall Study|Withdrawal by Subject|0|||
129155588|NCT01284959|464867304|FG002|Overall Study|Withdrawal by Subject|0|||
129155589|NCT01284959|464867302|FG000|Overall Study|Adverse Event|0|||
129155590|NCT01284959|464867303|FG001|Overall Study|Adverse Event|0|||
129155591|NCT01284959|464867304|FG002|Overall Study|Adverse Event|1|||
129155592|NCT00003869|464867306|FG000|Overall Study|Adverse Event|14|||
129155593|NCT00003869|464867307|FG001|Overall Study|Adverse Event|3|||
129155594|NCT00003869|464867306|FG000|Overall Study|Withdrawal by Subject|21|||
129155595|NCT00003869|464867307|FG001|Overall Study|Withdrawal by Subject|3|||
129155596|NCT00003869|464867306|FG000|Overall Study|Death|1|||
129155597|NCT00003869|464867307|FG001|Overall Study|Death|2|||
129155598|NCT00003869|464867306|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
129155599|NCT00003869|464867307|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
129155600|NCT03364231|464867308|FG000|Overall Study|Adverse Event|1|||
129155601|NCT03364231|464867309|FG001|Overall Study|Adverse Event|4|||
129155602|NCT03364231|464867308|FG000|Overall Study|Death|1|||
129155603|NCT03364231|464867309|FG001|Overall Study|Death|0|||
129155604|NCT03364231|464867308|FG000|Overall Study|Investigator Decision|2|||
129155605|NCT03364231|464867309|FG001|Overall Study|Investigator Decision|2|||
129155606|NCT03364231|464867308|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
129155607|NCT03364231|464867309|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
129155608|NCT03364231|464867308|FG000|Overall Study|Withdrawal of Subject Consent|1|||
129155609|NCT03364231|464867309|FG001|Overall Study|Withdrawal of Subject Consent|0|||
129155610|NCT03364231|464867308|FG000|Overall Study|Reason Not Specified|1|||
129155611|NCT03364231|464867309|FG001|Overall Study|Reason Not Specified|0|||
129155612|NCT03364231|464867308|FG000|Overall Study|Disease Progression|0|||
129155613|NCT03364231|464867309|FG001|Overall Study|Disease Progression|6|||
129155614|NCT04068922|464867310|FG000|Overall Study|Lost to Follow-up|5|||
129155615|NCT04068922|464867310|FG000|Overall Study|Withdrawal by Subject|7|||
129155616|NCT04068922|464867310|FG000|Overall Study|Adverse Event|1|||
129155617|NCT03542266|464867311|FG000|Treatment Phase|Withdrawal by Subject|1|||
129155618|NCT03542266|464867311|FG000|Treatment Phase|Adverse Event|1|||
129155619|NCT03542266|464867311|FG000|Treatment Phase|PD|1|||
129155620|NCT01070979|464867319|FG000|Overall Study|Adverse Event|2|||
129155621|NCT01070979|464867320|FG001|Overall Study|Adverse Event|3|||
129155622|NCT01070979|464867321|FG002|Overall Study|Adverse Event|3|||
129155623|NCT01070979|464867319|FG000|Overall Study|Lost to Follow-up|2|||
129155624|NCT01070979|464867320|FG001|Overall Study|Lost to Follow-up|1|||
129155625|NCT01070979|464867321|FG002|Overall Study|Lost to Follow-up|1|||
129155626|NCT01070979|464867319|FG000|Overall Study|Protocol Violation|0|||
129155627|NCT01070979|464867320|FG001|Overall Study|Protocol Violation|2|||
129155628|NCT01070979|464867321|FG002|Overall Study|Protocol Violation|6|||
129155629|NCT01070979|464867319|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
129155630|NCT01070979|464867320|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
129155631|NCT01070979|464867321|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
129155632|NCT01070979|464867319|FG000|Overall Study|Withdrawal by Subject|3|||
129155633|NCT01070979|464867320|FG001|Overall Study|Withdrawal by Subject|1|||
129155634|NCT01070979|464867321|FG002|Overall Study|Withdrawal by Subject|1|||
129155635|NCT01070979|464867319|FG000|Overall Study|No study drug taken|0|||
129155636|NCT01070979|464867320|FG001|Overall Study|No study drug taken|1|||
129155637|NCT01070979|464867321|FG002|Overall Study|No study drug taken|0|||
128725574|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
128725575|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
128725576|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
128725577|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
128725578|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
128725579|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
128725580|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
128725581|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
128725582|NCT00934544|463292498|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
128725583|NCT00934544|463292499|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
128725584|NCT00934544|463292500|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
128725585|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
128725586|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
128725587|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
128725588|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
128725589|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
128725590|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
128725591|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
128725592|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
128725593|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
128725594|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
128725595|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
129155638|NCT03484429|464867323|FG000|Overall Study|Withdrawal by Subject|1|||
128725596|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
129155639|NCT03484429|464867324|FG001|Overall Study|Withdrawal by Subject|0|||
129155640|NCT03484429|464867323|FG000|Overall Study|Adverse Event|2|||
129155641|NCT03484429|464867324|FG001|Overall Study|Adverse Event|0|||
129155642|NCT05653700|464867325|FG000|Overall Study|Non Responders|9|||
129155643|NCT05653700|464867326|FG001|Overall Study|Non Responders|0|||
129155644|NCT02573948|464867329|FG000|Longitudinal Cohort|Death|9|||
128725597|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
129155645|NCT02573948|464867329|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
129155646|NCT02573948|464867329|FG000|Longitudinal Cohort|Incarcerated|25|||
129155647|NCT00707993|464867330|FG000|Overall Study|Adverse Event|16|||
129155648|NCT00707993|464867331|FG001|Overall Study|Adverse Event|20|||
129155649|NCT00707993|464867330|FG000|Overall Study|Protocol Violation|4|||
129155650|NCT00707993|464867331|FG001|Overall Study|Protocol Violation|7|||
129155651|NCT00707993|464867330|FG000|Overall Study|Lost to Follow-up|0|||
129155652|NCT00707993|464867331|FG001|Overall Study|Lost to Follow-up|4|||
129155653|NCT00707993|464867330|FG000|Overall Study|Withdrawal by Subject|12|||
129155654|NCT00707993|464867331|FG001|Overall Study|Withdrawal by Subject|16|||
129155655|NCT00707993|464867330|FG000|Overall Study|Hyperglycemic Rescue|55|||
129155656|NCT00707993|464867331|FG001|Overall Study|Hyperglycemic Rescue|47|||
128725598|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
128725599|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
128725600|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
128725601|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
128725602|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
128725603|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
128725604|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
128725605|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
128725606|NCT00934544|463292498|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
128725607|NCT00934544|463292499|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
128725608|NCT00934544|463292500|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
128725609|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
128725610|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
128725611|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
128725612|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
128725613|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
128725614|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
129155657|NCT00707993|464867330|FG000|Overall Study|Other|2|||
129155658|NCT00707993|464867331|FG001|Overall Study|Other|0|||
129155659|NCT01913327|464867336|FG000|Overall Study|Withdrawal by Subject|0|||
129155660|NCT01913327|464867337|FG001|Overall Study|Withdrawal by Subject|1|||
129155661|NCT05414175|464867344|FG000|Overall Study|Withdrawal by Subject|1|||
129155662|NCT05414175|464867344|FG000|Overall Study|Other Reasons|1|||
129155663|NCT02112656|464867347|FG000|Overall Study|Death|78|||
128725615|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
128725616|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
128725617|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
128725618|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
128725619|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
128725620|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
128725621|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
128725622|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
128725623|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
128725624|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
128725625|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
129155664|NCT02112656|464867348|FG001|Overall Study|Death|82|||
129155665|NCT02112656|464867347|FG000|Overall Study|Withdrawal by Subject|9|||
129155666|NCT02112656|464867348|FG001|Overall Study|Withdrawal by Subject|11|||
129155667|NCT02112656|464867347|FG000|Overall Study|Lost to Follow-up|2|||
128725626|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
128725627|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
128725628|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
128725629|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
128725630|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
128725631|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
128725632|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
128725633|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
128725634|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
128725635|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
128725636|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
128725637|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
128725638|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
128776858|NCT01782326|463472025|FG001|Planned Treatment Epoch|Protocol deviation|3|||
128776859|NCT01782326|463472024|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
128776860|NCT01782326|463472025|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
128776861|NCT01782326|463472024|FG000|Planned Treatment Epoch|Technical problems|0|||
128776862|NCT01782326|463472025|FG001|Planned Treatment Epoch|Technical problems|4|||
128776863|NCT01782326|463472024|FG000|Double-blind Treatment|Adverse Event|129|||
129155668|NCT02112656|464867348|FG001|Overall Study|Lost to Follow-up|4|||
129155669|NCT02112656|464867347|FG000|Overall Study|Noncompliance|1|||
129155670|NCT02112656|464867348|FG001|Overall Study|Noncompliance|2|||
129155671|NCT03761056|464867349|FG000|Overall Study|Death|8|||
129155672|NCT03761056|464867349|FG000|Overall Study|Enrolled but never treated|2|||
129155673|NCT03761056|464867349|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
129155674|NCT03761056|464867349|FG000|Overall Study|Investigator decision|1|||
128725639|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
128725640|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
128725641|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
128725642|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
128725643|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
128725644|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
128725645|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
128725646|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
128725647|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
128725648|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
128725649|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
128725650|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
128725651|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
128725652|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
129155675|NCT04749745|464867350|FG000|Overall Study|Withdrawal by Subject|1|||
129155676|NCT04749745|464867351|FG001|Overall Study|Withdrawal by Subject|0|||
129155677|NCT03965403|464867358|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
129155678|NCT00552071|464868593|FG000|Overall Study|Adverse Event|1|||
129155679|NCT00552071|464868594|FG001|Overall Study|Adverse Event|0|||
129155680|NCT00552071|464868593|FG000|Overall Study|Lack of Efficacy|1|||
129155681|NCT00552071|464868594|FG001|Overall Study|Lack of Efficacy|0|||
129155682|NCT00552071|464868593|FG000|Overall Study|Physician Decision|1|||
129155683|NCT00552071|464868594|FG001|Overall Study|Physician Decision|0|||
129155684|NCT00552071|464868593|FG000|Overall Study|Pregnancy|1|||
129155685|NCT00552071|464868594|FG001|Overall Study|Pregnancy|0|||
129155686|NCT00552071|464868593|FG000|Overall Study|Death|0|||
129155687|NCT00552071|464868594|FG001|Overall Study|Death|1|||
129155688|NCT00552071|464868593|FG000|Overall Study|Withdrawal by Subject|0|||
129155689|NCT00552071|464868594|FG001|Overall Study|Withdrawal by Subject|1|||
129155690|NCT01979614|464868595|FG000|Overall Study|Adverse Event|1|||
129155691|NCT01979614|464868596|FG001|Overall Study|Adverse Event|1|||
129155692|NCT03333928|464868597|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
129155693|NCT03333928|464868598|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
129155694|NCT03333928|464868599|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
129155695|NCT03333928|464868597|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
129155696|NCT03333928|464868598|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
129155697|NCT03333928|464868599|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
129155698|NCT03333928|464868597|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
129155699|NCT03333928|464868598|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
129155700|NCT03333928|464868599|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
129155701|NCT03333928|464868597|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
129155702|NCT03333928|464868598|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
129155703|NCT03333928|464868599|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
129155704|NCT03333928|464868597|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
129155705|NCT03333928|464868598|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
129155706|NCT03333928|464868599|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
129155707|NCT03333928|464868597|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
129155708|NCT03333928|464868598|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
129155709|NCT03333928|464868599|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
129155710|NCT03333928|464868597|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
129155711|NCT03333928|464868598|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
129155712|NCT03333928|464868599|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
129155713|NCT03333928|464868597|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
129155714|NCT03333928|464868598|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
129155715|NCT03333928|464868599|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
129155716|NCT04072835|464868600|FG000|Overall Study|Overall trial ended|603|||
129155717|NCT04072835|464868600|FG000|Overall Study|Ablation|97|||
129155718|NCT04072835|464868600|FG000|Overall Study|Withdrawal of consent|66|||
129155719|NCT04072835|464868600|FG000|Overall Study|Physician Decision|50|||
129155720|NCT04072835|464868600|FG000|Overall Study|Lost to Follow-up|39|||
129155721|NCT04072835|464868600|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
129155722|NCT04072835|464868600|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
128725653|NCT01218516|463292501|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
129155723|NCT04072835|464868600|FG000|Overall Study|Adverse Event|25|||
129155724|NCT04072835|464868600|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
129155725|NCT04072835|464868600|FG000|Overall Study|Death|11|||
129155726|NCT04072835|464868600|FG000|Overall Study|Participant felt the drug did not work|8|||
129155727|NCT04072835|464868600|FG000|Overall Study|Participant tolerability|5|||
129155728|NCT04072835|464868600|FG000|Overall Study|Missing|5|||
129155729|NCT04072835|464868600|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
129155730|NCT04072835|464868600|FG000|Overall Study|Pregnancy|3|||
129155731|NCT04723355|464868601|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
129155732|NCT04723355|464868601|FG000|Overall Study|Errors in the informed consent form|2|||
129155733|NCT00841776|464868604|FG000|Overall Study|Lack of Efficacy|0|||
129155734|NCT00841776|464868605|FG001|Overall Study|Lack of Efficacy|1|||
129155735|NCT00841776|464868604|FG000|Overall Study|Lost to Follow-up|2|||
129155736|NCT00841776|464868605|FG001|Overall Study|Lost to Follow-up|1|||
129155737|NCT00841776|464868604|FG000|Overall Study|Withdrawal by Subject|0|||
129155738|NCT00841776|464868605|FG001|Overall Study|Withdrawal by Subject|1|||
129155739|NCT02479880|464868614|FG000|Overall Study|Study Terminated by Sponsor|13|||
129155740|NCT02479880|464868615|FG001|Overall Study|Study Terminated by Sponsor|12|||
129155741|NCT02479880|464868614|FG000|Overall Study|Pregnancy|0|||
129155742|NCT02479880|464868615|FG001|Overall Study|Pregnancy|1|||
129155743|NCT03432494|464868629|FG000|Overall Study|Death|1|||
129155744|NCT03432494|464868629|FG000|Overall Study|Noncompliance|1|||
129155745|NCT00856635|464868630|FG000|Overall Study|Lost to Follow-up|2|||
129155746|NCT00856635|464868631|FG001|Overall Study|Lost to Follow-up|5|||
129155747|NCT00856635|464868630|FG000|Overall Study|Pregnancy|1|||
129155748|NCT00856635|464868631|FG001|Overall Study|Pregnancy|0|||
129155749|NCT00856635|464868630|FG000|Overall Study|Withdrawal by Subject|3|||
129155750|NCT00856635|464868631|FG001|Overall Study|Withdrawal by Subject|1|||
129155751|NCT00856635|464868630|FG000|Overall Study|Serious Adverse Event|1|||
129155752|NCT00856635|464868631|FG001|Overall Study|Serious Adverse Event|0|||
129155753|NCT00856635|464868630|FG000|Overall Study|Other|1|||
129155754|NCT00856635|464868631|FG001|Overall Study|Other|0|||
129155755|NCT00856635|464868630|FG000|Overall Study|Discontinued at Randomization|2|||
129155756|NCT00856635|464868631|FG001|Overall Study|Discontinued at Randomization|2|||
129155757|NCT01244035|464868632|FG000|Part 1: Period 1|Adverse Event|0|||
129155758|NCT01244035|464868633|FG001|Part 1: Period 1|Adverse Event|0|||
129155759|NCT01244035|464868634|FG002|Part 1: Period 1|Adverse Event|0|||
129155760|NCT01244035|464868635|FG003|Part 1: Period 1|Adverse Event|0|||
129155761|NCT01244035|464868636|FG004|Part 1: Period 1|Adverse Event|0|||
129155762|NCT01244035|464868637|FG005|Part 1: Period 1|Adverse Event|1|||
129155763|NCT01244035|464868632|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
129155764|NCT01244035|464868633|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
129155765|NCT01244035|464868634|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
129155766|NCT01244035|464868635|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
129155767|NCT01244035|464868636|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
129155768|NCT01244035|464868637|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
129155769|NCT01244035|464868632|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
129155770|NCT01244035|464868633|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
129155771|NCT01244035|464868634|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
129155772|NCT01244035|464868635|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
129155773|NCT01244035|464868636|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
129155774|NCT01244035|464868637|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
129155775|NCT01244035|464868632|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129155776|NCT01244035|464868633|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129155777|NCT01244035|464868634|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
129155778|NCT01244035|464868635|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129155779|NCT01244035|464868636|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129155780|NCT01244035|464868637|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129155781|NCT01244035|464868632|FG000|Part 1: Period 3|Adverse Event|0|||
129155782|NCT01244035|464868633|FG001|Part 1: Period 3|Adverse Event|0|||
129155783|NCT01244035|464868634|FG002|Part 1: Period 3|Adverse Event|0|||
129155784|NCT01244035|464868635|FG003|Part 1: Period 3|Adverse Event|0|||
129155785|NCT01244035|464868636|FG004|Part 1: Period 3|Adverse Event|0|||
129155786|NCT01244035|464868637|FG005|Part 1: Period 3|Adverse Event|1|||
129155787|NCT01244035|464868632|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
129155788|NCT01244035|464868633|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
129155789|NCT01244035|464868634|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
128725654|NCT01218516|463292502|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
129155790|NCT01244035|464868635|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
129155791|NCT01244035|464868636|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
129155792|NCT01244035|464868637|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
129155793|NCT01244035|464868632|FG000|Part 1: Period 3|Protocol Deviation|0|||
129155794|NCT01244035|464868633|FG001|Part 1: Period 3|Protocol Deviation|1|||
129155795|NCT01244035|464868634|FG002|Part 1: Period 3|Protocol Deviation|0|||
129155796|NCT01244035|464868635|FG003|Part 1: Period 3|Protocol Deviation|0|||
129155797|NCT01244035|464868636|FG004|Part 1: Period 3|Protocol Deviation|0|||
129155798|NCT01244035|464868637|FG005|Part 1: Period 3|Protocol Deviation|0|||
129155799|NCT01696773|464868638|FG000|Days 15-27, Washout|Adverse Event|1|||
129155800|NCT01696773|464868639|FG001|Days 15-27, Washout|Adverse Event|0|||
129155801|NCT03688919|464868644|FG000|Overall Study|Lost to Follow-up|2|||
129155802|NCT03688919|464868645|FG001|Overall Study|Lost to Follow-up|1|||
129155803|NCT03688919|464868644|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
129155804|NCT03688919|464868645|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
129155805|NCT02370368|464868646|FG000|Overall Study|Adverse Event|1|||
129155806|NCT02370368|464868647|FG001|Overall Study|Adverse Event|2|||
129155807|NCT02370368|464868646|FG000|Overall Study|Withdrawal by Subject|5|||
129155808|NCT02370368|464868647|FG001|Overall Study|Withdrawal by Subject|4|||
129155809|NCT00347932|464868650|FG000|Overall Study|Adverse Event|4|||
129155810|NCT00347932|464868651|FG001|Overall Study|Adverse Event|5|||
129155811|NCT00347932|464868650|FG000|Overall Study|Lack of Efficacy|3|||
129155812|NCT00347932|464868651|FG001|Overall Study|Lack of Efficacy|14|||
129155813|NCT00347932|464868650|FG000|Overall Study|Lost to Follow-up|10|||
129155814|NCT00347932|464868651|FG001|Overall Study|Lost to Follow-up|9|||
129155815|NCT00347932|464868650|FG000|Overall Study|Withdrawal by Subject|10|||
129155816|NCT00347932|464868651|FG001|Overall Study|Withdrawal by Subject|16|||
129155817|NCT00347932|464868650|FG000|Overall Study|Did not meet inclusion criteria|4|||
129155818|NCT00347932|464868651|FG001|Overall Study|Did not meet inclusion criteria|8|||
129155819|NCT04512001|464868652|FG000|Week 0 to Week 24|Adverse Event|14|||
129155820|NCT04512001|464868653|FG001|Week 0 to Week 24|Adverse Event|10|||
129155821|NCT04512001|464868654|FG002|Week 0 to Week 24|Adverse Event|0|||
129155822|NCT04512001|464868655|FG003|Week 0 to Week 24|Adverse Event|0|||
129155823|NCT04512001|464868656|FG004|Week 0 to Week 24|Adverse Event|0|||
129155824|NCT04512001|464868652|FG000|Week 0 to Week 24|Death|0|||
129155825|NCT04512001|464868653|FG001|Week 0 to Week 24|Death|2|||
129155826|NCT04512001|464868654|FG002|Week 0 to Week 24|Death|0|||
129155827|NCT04512001|464868655|FG003|Week 0 to Week 24|Death|0|||
129155828|NCT04512001|464868656|FG004|Week 0 to Week 24|Death|0|||
129155829|NCT04512001|464868652|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
129155830|NCT04512001|464868653|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
129155831|NCT04512001|464868654|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
129155832|NCT04512001|464868655|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
129155833|NCT04512001|464868656|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
129155834|NCT04512001|464868652|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
129155835|NCT04512001|464868653|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
129155836|NCT04512001|464868654|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
129155837|NCT04512001|464868655|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
129155838|NCT04512001|464868656|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
129155839|NCT04512001|464868652|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
129155840|NCT04512001|464868653|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129155841|NCT04512001|464868654|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129155842|NCT04512001|464868655|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129155843|NCT04512001|464868656|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129155844|NCT04512001|464868652|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129155845|NCT04512001|464868653|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
129155846|NCT04512001|464868654|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129155847|NCT04512001|464868655|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129155848|NCT04512001|464868656|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129155849|NCT04512001|464868652|FG000|Week 24 to Week 63|Adverse Event|0|||
129155850|NCT04512001|464868653|FG001|Week 24 to Week 63|Adverse Event|0|||
129155851|NCT04512001|464868654|FG002|Week 24 to Week 63|Adverse Event|13|||
129155852|NCT04512001|464868655|FG003|Week 24 to Week 63|Adverse Event|8|||
129155853|NCT04512001|464868656|FG004|Week 24 to Week 63|Adverse Event|6|||
129155854|NCT04512001|464868652|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
129155855|NCT04512001|464868653|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
129155856|NCT04512001|464868654|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
129155857|NCT04512001|464868655|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
129155858|NCT04512001|464868656|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
129155859|NCT04512001|464868652|FG000|Week 24 to Week 63|Death|0|||
129155860|NCT04512001|464868653|FG001|Week 24 to Week 63|Death|0|||
129155861|NCT04512001|464868654|FG002|Week 24 to Week 63|Death|0|||
129155862|NCT04512001|464868655|FG003|Week 24 to Week 63|Death|1|||
129155863|NCT04512001|464868656|FG004|Week 24 to Week 63|Death|1|||
129155864|NCT04512001|464868652|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
129155865|NCT04512001|464868653|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
129155866|NCT04512001|464868654|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
129155867|NCT04512001|464868655|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
129155868|NCT04512001|464868656|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
129155869|NCT04512001|464868652|FG000|Week 24 to Week 63|Miscellaneous|0|||
129155870|NCT04512001|464868653|FG001|Week 24 to Week 63|Miscellaneous|0|||
129155871|NCT04512001|464868654|FG002|Week 24 to Week 63|Miscellaneous|3|||
129155872|NCT04512001|464868655|FG003|Week 24 to Week 63|Miscellaneous|2|||
129155873|NCT04512001|464868656|FG004|Week 24 to Week 63|Miscellaneous|1|||
129155874|NCT02776683|464868657|FG000|Pre-switch Period|Protocol Violation|1|||
128725655|NCT01218516|463292503|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
129155875|NCT02776683|464868658|FG001|Pre-switch Period|Protocol Violation|0|||
129155876|NCT02776683|464868657|FG000|Pre-switch Period|Adverse Event|21|||
129155877|NCT02776683|464868658|FG001|Pre-switch Period|Adverse Event|0|||
129155878|NCT02776683|464868657|FG000|Pre-switch Period|Withdrawal by Subject|9|||
129155879|NCT02776683|464868658|FG001|Pre-switch Period|Withdrawal by Subject|0|||
129155880|NCT02776683|464868657|FG000|Pre-switch Period|Physician Decision|7|||
129155881|NCT02776683|464868658|FG001|Pre-switch Period|Physician Decision|0|||
129155882|NCT02776683|464868657|FG000|Pre-switch Period|Progressive disease|39|||
129155883|NCT02776683|464868658|FG001|Pre-switch Period|Progressive disease|0|||
129155884|NCT02776683|464868657|FG000|Pre-switch Period|Other than listed|3|||
129155885|NCT02776683|464868658|FG001|Pre-switch Period|Other than listed|0|||
129155886|NCT02776683|464868657|FG000|Post-switch Period|Adverse Event|0|||
128776864|NCT01782326|463472025|FG001|Double-blind Treatment|Adverse Event|145|||
128776865|NCT01782326|463472024|FG000|Double-blind Treatment|Subject/guardian decision|111|||
128776866|NCT01782326|463472025|FG001|Double-blind Treatment|Subject/guardian decision|125|||
129155887|NCT02776683|464868658|FG001|Post-switch Period|Adverse Event|3|||
129155888|NCT02776683|464868657|FG000|Post-switch Period|Withdrawal by Subject|0|||
129155889|NCT02776683|464868658|FG001|Post-switch Period|Withdrawal by Subject|2|||
129155890|NCT02776683|464868657|FG000|Post-switch Period|Physician Decision|0|||
129155891|NCT02776683|464868658|FG001|Post-switch Period|Physician Decision|3|||
129155892|NCT02776683|464868657|FG000|Post-switch Period|Progressive disease|0|||
129155893|NCT02776683|464868658|FG001|Post-switch Period|Progressive disease|20|||
129155894|NCT02776683|464868657|FG000|Post-switch Period|Other than listed|0|||
129155895|NCT02776683|464868658|FG001|Post-switch Period|Other than listed|15|||
129155896|NCT03389308|464868661|FG000|Overall Study|Withdrawal by Subject|5|||
129155897|NCT03389308|464868661|FG000|Overall Study|Lost to Follow-up|3|||
129155898|NCT03389308|464868661|FG000|Overall Study|Adverse Event|2|||
129155899|NCT03389308|464868661|FG000|Overall Study|Sponsor Request|2|||
129155900|NCT03198767|464868664|FG000|Overall Study|Protocol Violation|0|||
129155901|NCT03198767|464868665|FG001|Overall Study|Protocol Violation|0|||
129155902|NCT03198767|464868666|FG002|Overall Study|Protocol Violation|0|||
129155903|NCT03198767|464868667|FG003|Overall Study|Protocol Violation|6|||
129155904|NCT03198767|464868668|FG004|Overall Study|Protocol Violation|0|||
129155905|NCT03198767|464868669|FG005|Overall Study|Protocol Violation|0|||
129155906|NCT03198767|464868670|FG006|Overall Study|Protocol Violation|0|||
129155907|NCT00570323|464868671|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
128725656|NCT01218516|463292504|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
128725657|NCT04033003|463292506|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
128725658|NCT04033003|463292507|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
128725659|NCT04033003|463292506|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
128725660|NCT04033003|463292507|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
128725661|NCT04033003|463292506|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
128725662|NCT04033003|463292507|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
128725663|NCT04033003|463292506|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
128725664|NCT04033003|463292507|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
128725665|NCT04033003|463292506|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
128725666|NCT04033003|463292507|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
128725667|NCT04033003|463292506|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
128725668|NCT04033003|463292507|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
128725669|NCT04033003|463292506|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
128725670|NCT04033003|463292507|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
128725671|NCT04033003|463292506|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
128725672|NCT04033003|463292507|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
128725673|NCT04033003|463292506|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
128725674|NCT04033003|463292507|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
128725675|NCT04033003|463292506|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
129155908|NCT00570323|464868672|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
129155909|NCT00570323|464868671|FG000|Started Treatment After Randomization|Protocol Violation|1|||
129155910|NCT00570323|464868672|FG001|Started Treatment After Randomization|Protocol Violation|0|||
128725676|NCT04033003|463292507|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
128725677|NCT04033003|463292506|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
128725678|NCT04033003|463292507|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
128725679|NCT04033003|463292506|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
129155911|NCT00570323|464868671|FG000|Started Treatment After Randomization|Physician Decision|1|||
129155912|NCT00570323|464868672|FG001|Started Treatment After Randomization|Physician Decision|0|||
129155913|NCT00570323|464868671|FG000|Complete Study After Start|Lost to Follow-up|0|||
129155914|NCT00570323|464868672|FG001|Complete Study After Start|Lost to Follow-up|1|||
128725680|NCT04033003|463292507|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
128725681|NCT04033003|463292506|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
128725682|NCT04033003|463292507|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
128725683|NCT04171414|463292508|FG000|Overall Study|Death|1|||
128725684|NCT04171414|463292508|FG000|Overall Study|Withdrawal by Subject|1|||
129155915|NCT00570323|464868671|FG000|Complete Study After Start|Withdrawal by Subject|2|||
129155916|NCT00570323|464868672|FG001|Complete Study After Start|Withdrawal by Subject|0|||
129155917|NCT00570323|464868671|FG000|Complete Study After Start|Physician Decision|1|||
129155918|NCT00570323|464868672|FG001|Complete Study After Start|Physician Decision|0|||
129155919|NCT04232943|464868673|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
129155920|NCT04232943|464868674|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
129155921|NCT04232943|464868675|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
129155922|NCT04232943|464868673|FG000|Overall Study|Withdrawal by Subject|1|||
129155923|NCT04232943|464868674|FG001|Overall Study|Withdrawal by Subject|1|||
129155924|NCT04232943|464868675|FG002|Overall Study|Withdrawal by Subject|0|||
129155925|NCT03896477|464868676|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
129155926|NCT03896477|464868677|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
129155927|NCT03896477|464868678|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
129155928|NCT03896477|464868676|FG000|Overall Study|Parent Requested Withdrawal|8|||
129155929|NCT03896477|464868677|FG001|Overall Study|Parent Requested Withdrawal|12|||
129155930|NCT03896477|464868678|FG002|Overall Study|Parent Requested Withdrawal|9|||
129155931|NCT03896477|464868676|FG000|Overall Study|Adverse Event|0|||
129155932|NCT03896477|464868677|FG001|Overall Study|Adverse Event|0|||
129155933|NCT03896477|464868678|FG002|Overall Study|Adverse Event|1|||
129155934|NCT03896477|464868676|FG000|Overall Study|Death|1|||
129155935|NCT03896477|464868677|FG001|Overall Study|Death|0|||
129155936|NCT03896477|464868678|FG002|Overall Study|Death|0|||
129155937|NCT03896477|464868676|FG000|Overall Study|Other|5|||
129155938|NCT03896477|464868677|FG001|Overall Study|Other|6|||
129155939|NCT03896477|464868678|FG002|Overall Study|Other|7|||
129155940|NCT03896477|464868676|FG000|Overall Study|Lost to Follow-up|2|||
129155941|NCT03896477|464868677|FG001|Overall Study|Lost to Follow-up|1|||
129155942|NCT03896477|464868678|FG002|Overall Study|Lost to Follow-up|1|||
129155943|NCT01791517|464868679|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
129155944|NCT01791517|464868680|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
129155945|NCT01791517|464868681|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
129155946|NCT01791517|464868682|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
129155947|NCT01791517|464868683|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
129155948|NCT01791517|464868684|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
129155949|NCT01791517|464868685|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
129155950|NCT01791517|464868686|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
129155951|NCT01791517|464868687|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
129155952|NCT01791517|464868688|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
129155953|NCT01791517|464868689|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
129155954|NCT01791517|464868690|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
129155955|NCT01791517|464868679|FG000|Phase I: Period 1|Adverse Event|0|||
129155956|NCT01791517|464868680|FG001|Phase I: Period 1|Adverse Event|0|||
129155957|NCT01791517|464868681|FG002|Phase I: Period 1|Adverse Event|1|||
129155958|NCT01791517|464868682|FG003|Phase I: Period 1|Adverse Event|1|||
129155959|NCT01791517|464868683|FG004|Phase I: Period 1|Adverse Event|0|||
129155960|NCT01791517|464868684|FG005|Phase I: Period 1|Adverse Event|0|||
129155961|NCT01791517|464868685|FG006|Phase I: Period 1|Adverse Event|0|||
129155962|NCT01791517|464868686|FG007|Phase I: Period 1|Adverse Event|0|||
129155963|NCT01791517|464868687|FG008|Phase I: Period 1|Adverse Event|0|||
129155964|NCT01791517|464868688|FG009|Phase I: Period 1|Adverse Event|0|||
129155965|NCT01791517|464868689|FG010|Phase I: Period 1|Adverse Event|0|||
129155966|NCT01791517|464868690|FG011|Phase I: Period 1|Adverse Event|0|||
129155967|NCT01791517|464868679|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
129155968|NCT01791517|464868680|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155969|NCT01791517|464868681|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155970|NCT01791517|464868682|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
128725685|NCT01714310|463292509|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
128725686|NCT01714310|463292510|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
128725687|NCT01714310|463292511|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
129155971|NCT01791517|464868683|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155972|NCT01791517|464868684|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155973|NCT01791517|464868685|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155974|NCT01791517|464868686|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155975|NCT01791517|464868687|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155976|NCT01791517|464868688|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155977|NCT01791517|464868689|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155978|NCT01791517|464868690|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129155979|NCT01791517|464868679|FG000|Phase I: Period 1|Protocol Violation|0|||
129155980|NCT01791517|464868680|FG001|Phase I: Period 1|Protocol Violation|1|||
129155981|NCT01791517|464868681|FG002|Phase I: Period 1|Protocol Violation|0|||
129155982|NCT01791517|464868682|FG003|Phase I: Period 1|Protocol Violation|0|||
128725688|NCT01714310|463292509|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
129155983|NCT01791517|464868683|FG004|Phase I: Period 1|Protocol Violation|0|||
129155984|NCT01791517|464868684|FG005|Phase I: Period 1|Protocol Violation|0|||
129155985|NCT01791517|464868685|FG006|Phase I: Period 1|Protocol Violation|0|||
129155986|NCT01791517|464868686|FG007|Phase I: Period 1|Protocol Violation|0|||
129155987|NCT01791517|464868687|FG008|Phase I: Period 1|Protocol Violation|0|||
129155988|NCT01791517|464868688|FG009|Phase I: Period 1|Protocol Violation|0|||
129155989|NCT01791517|464868689|FG010|Phase I: Period 1|Protocol Violation|0|||
129155990|NCT01791517|464868690|FG011|Phase I: Period 1|Protocol Violation|0|||
129155991|NCT01791517|464868679|FG000|Phase I: Period 1|Lost to Follow-up|0|||
129155992|NCT01791517|464868680|FG001|Phase I: Period 1|Lost to Follow-up|0|||
129155993|NCT01791517|464868681|FG002|Phase I: Period 1|Lost to Follow-up|0|||
129155994|NCT01791517|464868682|FG003|Phase I: Period 1|Lost to Follow-up|1|||
129155995|NCT01791517|464868683|FG004|Phase I: Period 1|Lost to Follow-up|0|||
129155996|NCT01791517|464868684|FG005|Phase I: Period 1|Lost to Follow-up|0|||
129155997|NCT01791517|464868685|FG006|Phase I: Period 1|Lost to Follow-up|1|||
129155998|NCT01791517|464868686|FG007|Phase I: Period 1|Lost to Follow-up|0|||
129155999|NCT01791517|464868687|FG008|Phase I: Period 1|Lost to Follow-up|1|||
129156000|NCT01791517|464868688|FG009|Phase I: Period 1|Lost to Follow-up|1|||
129156001|NCT01791517|464868689|FG010|Phase I: Period 1|Lost to Follow-up|0|||
129156002|NCT01791517|464868690|FG011|Phase I: Period 1|Lost to Follow-up|0|||
129156003|NCT01791517|464868679|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156004|NCT01791517|464868680|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156005|NCT01791517|464868681|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156006|NCT01791517|464868682|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156007|NCT01791517|464868683|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156008|NCT01791517|464868684|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156009|NCT01791517|464868685|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156010|NCT01791517|464868686|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156011|NCT01791517|464868687|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156012|NCT01791517|464868688|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156013|NCT01791517|464868689|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
129156014|NCT01791517|464868690|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
129156015|NCT01791517|464868679|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
129156016|NCT01791517|464868680|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156017|NCT01791517|464868681|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156018|NCT01791517|464868682|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156019|NCT01791517|464868683|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156020|NCT01791517|464868684|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156021|NCT01791517|464868685|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156022|NCT01791517|464868686|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156023|NCT01791517|464868687|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156024|NCT01791517|464868688|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156025|NCT01791517|464868689|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156026|NCT01791517|464868690|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129156027|NCT01791517|464868679|FG000|Phase I: Period 2|Protocol Violation|0|||
129156028|NCT01791517|464868680|FG001|Phase I: Period 2|Protocol Violation|0|||
129156029|NCT01791517|464868681|FG002|Phase I: Period 2|Protocol Violation|0|||
129156030|NCT01791517|464868682|FG003|Phase I: Period 2|Protocol Violation|1|||
129156031|NCT01791517|464868683|FG004|Phase I: Period 2|Protocol Violation|0|||
129156032|NCT01791517|464868684|FG005|Phase I: Period 2|Protocol Violation|0|||
129156033|NCT01791517|464868685|FG006|Phase I: Period 2|Protocol Violation|0|||
129156034|NCT01791517|464868686|FG007|Phase I: Period 2|Protocol Violation|0|||
129156035|NCT01791517|464868687|FG008|Phase I: Period 2|Protocol Violation|0|||
129156036|NCT01791517|464868688|FG009|Phase I: Period 2|Protocol Violation|0|||
129156037|NCT01791517|464868689|FG010|Phase I: Period 2|Protocol Violation|0|||
129156038|NCT01791517|464868690|FG011|Phase I: Period 2|Protocol Violation|0|||
129156039|NCT01791517|464868679|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
129156040|NCT01791517|464868680|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
129156041|NCT01791517|464868681|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
129156042|NCT01791517|464868682|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
129156043|NCT01791517|464868683|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
129156044|NCT01791517|464868684|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
129156045|NCT01791517|464868685|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
129156046|NCT01791517|464868686|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
129156047|NCT01791517|464868687|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
129156048|NCT01791517|464868688|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
129156049|NCT01791517|464868689|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
129156050|NCT01791517|464868690|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
129156051|NCT01791517|464868679|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156052|NCT01791517|464868680|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156053|NCT01791517|464868681|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156054|NCT01791517|464868682|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156055|NCT01791517|464868683|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156056|NCT01791517|464868684|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156057|NCT01791517|464868685|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156058|NCT01791517|464868686|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156059|NCT01791517|464868687|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156060|NCT01791517|464868688|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156061|NCT01791517|464868689|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
129156062|NCT01791517|464868690|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129156063|NCT01791517|464868679|FG000|Phase I: Period 2|Lens Discomfort|0|||
129156064|NCT01791517|464868680|FG001|Phase I: Period 2|Lens Discomfort|0|||
129156065|NCT01791517|464868681|FG002|Phase I: Period 2|Lens Discomfort|0|||
129156066|NCT01791517|464868682|FG003|Phase I: Period 2|Lens Discomfort|0|||
129156067|NCT01791517|464868683|FG004|Phase I: Period 2|Lens Discomfort|0|||
129156068|NCT01791517|464868684|FG005|Phase I: Period 2|Lens Discomfort|1|||
129156069|NCT01791517|464868685|FG006|Phase I: Period 2|Lens Discomfort|0|||
129156070|NCT01791517|464868686|FG007|Phase I: Period 2|Lens Discomfort|0|||
129156071|NCT01791517|464868687|FG008|Phase I: Period 2|Lens Discomfort|0|||
129156072|NCT01791517|464868688|FG009|Phase I: Period 2|Lens Discomfort|0|||
129156073|NCT01791517|464868689|FG010|Phase I: Period 2|Lens Discomfort|0|||
129156074|NCT01791517|464868690|FG011|Phase I: Period 2|Lens Discomfort|0|||
129156075|NCT01791517|464868679|FG000|Phase I: Period 2|Lost to Follow-up|0|||
129156076|NCT01791517|464868680|FG001|Phase I: Period 2|Lost to Follow-up|3|||
129156077|NCT01791517|464868681|FG002|Phase I: Period 2|Lost to Follow-up|2|||
129156078|NCT01791517|464868682|FG003|Phase I: Period 2|Lost to Follow-up|0|||
129156079|NCT01791517|464868683|FG004|Phase I: Period 2|Lost to Follow-up|0|||
129156080|NCT01791517|464868684|FG005|Phase I: Period 2|Lost to Follow-up|0|||
129156081|NCT01791517|464868685|FG006|Phase I: Period 2|Lost to Follow-up|0|||
129156082|NCT01791517|464868686|FG007|Phase I: Period 2|Lost to Follow-up|0|||
129156083|NCT01791517|464868687|FG008|Phase I: Period 2|Lost to Follow-up|0|||
129156084|NCT01791517|464868688|FG009|Phase I: Period 2|Lost to Follow-up|0|||
129156085|NCT01791517|464868689|FG010|Phase I: Period 2|Lost to Follow-up|0|||
129156086|NCT01791517|464868690|FG011|Phase I: Period 2|Lost to Follow-up|0|||
129156087|NCT01791517|464868679|FG000|Phase I: Period 3|Lens Discomfort|0|||
129156088|NCT01791517|464868680|FG001|Phase I: Period 3|Lens Discomfort|0|||
129156089|NCT01791517|464868681|FG002|Phase I: Period 3|Lens Discomfort|0|||
129156090|NCT01791517|464868682|FG003|Phase I: Period 3|Lens Discomfort|0|||
129156091|NCT01791517|464868683|FG004|Phase I: Period 3|Lens Discomfort|0|||
129156092|NCT01791517|464868684|FG005|Phase I: Period 3|Lens Discomfort|0|||
129156093|NCT01791517|464868685|FG006|Phase I: Period 3|Lens Discomfort|0|||
129156094|NCT01791517|464868686|FG007|Phase I: Period 3|Lens Discomfort|0|||
129156095|NCT01791517|464868687|FG008|Phase I: Period 3|Lens Discomfort|0|||
129156096|NCT01791517|464868688|FG009|Phase I: Period 3|Lens Discomfort|0|||
129156097|NCT01791517|464868689|FG010|Phase I: Period 3|Lens Discomfort|0|||
129156098|NCT01791517|464868690|FG011|Phase I: Period 3|Lens Discomfort|1|||
129156099|NCT01791517|464868679|FG000|Phase I: Period 3|Lost to Follow-up|0|||
129156100|NCT01791517|464868680|FG001|Phase I: Period 3|Lost to Follow-up|1|||
129156101|NCT01791517|464868681|FG002|Phase I: Period 3|Lost to Follow-up|0|||
129156102|NCT01791517|464868682|FG003|Phase I: Period 3|Lost to Follow-up|0|||
129156103|NCT01791517|464868683|FG004|Phase I: Period 3|Lost to Follow-up|1|||
129156104|NCT01791517|464868684|FG005|Phase I: Period 3|Lost to Follow-up|0|||
129156105|NCT01791517|464868685|FG006|Phase I: Period 3|Lost to Follow-up|0|||
129156106|NCT01791517|464868686|FG007|Phase I: Period 3|Lost to Follow-up|0|||
129156107|NCT01791517|464868687|FG008|Phase I: Period 3|Lost to Follow-up|0|||
129156108|NCT01791517|464868688|FG009|Phase I: Period 3|Lost to Follow-up|0|||
129156109|NCT01791517|464868689|FG010|Phase I: Period 3|Lost to Follow-up|0|||
129156110|NCT01791517|464868690|FG011|Phase I: Period 3|Lost to Follow-up|0|||
129156111|NCT01791517|464868679|FG000|Phase I: Period 3|Adverse Event|0|||
129156112|NCT01791517|464868680|FG001|Phase I: Period 3|Adverse Event|0|||
129156113|NCT01791517|464868681|FG002|Phase I: Period 3|Adverse Event|0|||
129156114|NCT01791517|464868682|FG003|Phase I: Period 3|Adverse Event|1|||
129156115|NCT01791517|464868683|FG004|Phase I: Period 3|Adverse Event|0|||
129156116|NCT01791517|464868684|FG005|Phase I: Period 3|Adverse Event|0|||
129156117|NCT01791517|464868685|FG006|Phase I: Period 3|Adverse Event|0|||
129156118|NCT01791517|464868686|FG007|Phase I: Period 3|Adverse Event|0|||
128776867|NCT01782326|463472024|FG000|Double-blind Treatment|Lack of Efficacy|17|||
128776868|NCT01782326|463472025|FG001|Double-blind Treatment|Lack of Efficacy|22|||
128776869|NCT01782326|463472024|FG000|Double-blind Treatment|Physician Decision|13|||
128776870|NCT01782326|463472025|FG001|Double-blind Treatment|Physician Decision|16|||
128776871|NCT01782326|463472024|FG000|Double-blind Treatment|Protocol deviation|8|||
128776872|NCT01782326|463472025|FG001|Double-blind Treatment|Protocol deviation|7|||
129156119|NCT01791517|464868687|FG008|Phase I: Period 3|Adverse Event|0|||
129156120|NCT01791517|464868688|FG009|Phase I: Period 3|Adverse Event|0|||
129156121|NCT01791517|464868689|FG010|Phase I: Period 3|Adverse Event|0|||
129156122|NCT01791517|464868690|FG011|Phase I: Period 3|Adverse Event|0|||
129156123|NCT01791517|464868679|FG000|Phase II|Lost to Follow-up|1|||
129156124|NCT01791517|464868680|FG001|Phase II|Lost to Follow-up|0|||
129156125|NCT01791517|464868681|FG002|Phase II|Lost to Follow-up|1|||
129156126|NCT01791517|464868682|FG003|Phase II|Lost to Follow-up|0|||
129156127|NCT01791517|464868683|FG004|Phase II|Lost to Follow-up|1|||
129156128|NCT01791517|464868684|FG005|Phase II|Lost to Follow-up|2|||
128725689|NCT01714310|463292510|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
128725690|NCT01714310|463292511|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
128725691|NCT01714310|463292509|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
128725692|NCT01714310|463292510|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
128725693|NCT01714310|463292511|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
128725694|NCT01714310|463292509|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
128725695|NCT01714310|463292510|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
128725696|NCT01714310|463292511|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
128725697|NCT02487394|463292516|FG000|Phase 1|Withdrawal by Subject|0|||
128725698|NCT02487394|463292517|FG001|Phase 1|Withdrawal by Subject|1|||
128725699|NCT04164901|463292524|FG000|Overall Study|Withdrawal by Subject|4|||
128725700|NCT04164901|463292525|FG001|Overall Study|Withdrawal by Subject|4|||
128725701|NCT02046148|463292530|FG000|Overall Study|Lost to Follow-up|1|||
128725702|NCT02046148|463292531|FG001|Overall Study|Lost to Follow-up|1|||
128725703|NCT02046148|463292530|FG000|Overall Study|Withdrawal by Subject|0|||
128725704|NCT02046148|463292531|FG001|Overall Study|Withdrawal by Subject|2|||
128725705|NCT00314574|463292539|FG000|Overall Study|Death|3|||
128725706|NCT00314574|463292540|FG001|Overall Study|Death|0|||
128725707|NCT00314574|463292539|FG000|Overall Study|Adverse Event|11|||
128725708|NCT00314574|463292540|FG001|Overall Study|Adverse Event|16|||
128725709|NCT00314574|463292539|FG000|Overall Study|Lost to Follow-up|19|||
129156129|NCT01791517|464868685|FG006|Phase II|Lost to Follow-up|0|||
129156130|NCT01791517|464868686|FG007|Phase II|Lost to Follow-up|1|||
129156131|NCT01791517|464868687|FG008|Phase II|Lost to Follow-up|1|||
129156132|NCT01791517|464868688|FG009|Phase II|Lost to Follow-up|1|||
129156133|NCT01791517|464868689|FG010|Phase II|Lost to Follow-up|0|||
129156134|NCT01791517|464868690|FG011|Phase II|Lost to Follow-up|0|||
129156135|NCT01791517|464868679|FG000|Phase II|Withdrawal by Subject|1|||
129156136|NCT01791517|464868680|FG001|Phase II|Withdrawal by Subject|0|||
129156137|NCT01791517|464868681|FG002|Phase II|Withdrawal by Subject|0|||
129156138|NCT01791517|464868682|FG003|Phase II|Withdrawal by Subject|0|||
129156139|NCT01791517|464868683|FG004|Phase II|Withdrawal by Subject|0|||
129156140|NCT01791517|464868684|FG005|Phase II|Withdrawal by Subject|2|||
129156141|NCT01791517|464868685|FG006|Phase II|Withdrawal by Subject|0|||
129156142|NCT01791517|464868686|FG007|Phase II|Withdrawal by Subject|1|||
129156143|NCT01791517|464868687|FG008|Phase II|Withdrawal by Subject|0|||
129156144|NCT01791517|464868688|FG009|Phase II|Withdrawal by Subject|0|||
129156145|NCT01791517|464868689|FG010|Phase II|Withdrawal by Subject|1|||
129156146|NCT01791517|464868690|FG011|Phase II|Withdrawal by Subject|0|||
129156147|NCT01791517|464868679|FG000|Phase II|Lack of Efficacy|0|||
129156148|NCT01791517|464868680|FG001|Phase II|Lack of Efficacy|0|||
129156149|NCT01791517|464868681|FG002|Phase II|Lack of Efficacy|0|||
129156150|NCT01791517|464868682|FG003|Phase II|Lack of Efficacy|0|||
129156151|NCT01791517|464868683|FG004|Phase II|Lack of Efficacy|1|||
129156152|NCT01791517|464868684|FG005|Phase II|Lack of Efficacy|0|||
129156153|NCT01791517|464868685|FG006|Phase II|Lack of Efficacy|0|||
129156154|NCT01791517|464868686|FG007|Phase II|Lack of Efficacy|0|||
129156155|NCT01791517|464868687|FG008|Phase II|Lack of Efficacy|0|||
129156156|NCT01791517|464868688|FG009|Phase II|Lack of Efficacy|0|||
129156157|NCT01791517|464868689|FG010|Phase II|Lack of Efficacy|0|||
129156158|NCT01791517|464868690|FG011|Phase II|Lack of Efficacy|0|||
129156159|NCT01791517|464868679|FG000|Phase II|Adverse Event|0|||
129156160|NCT01791517|464868680|FG001|Phase II|Adverse Event|0|||
129156161|NCT01791517|464868681|FG002|Phase II|Adverse Event|0|||
129156162|NCT01791517|464868682|FG003|Phase II|Adverse Event|0|||
129156163|NCT01791517|464868683|FG004|Phase II|Adverse Event|0|||
129156164|NCT01791517|464868684|FG005|Phase II|Adverse Event|0|||
129156165|NCT01791517|464868685|FG006|Phase II|Adverse Event|2|||
129156166|NCT01791517|464868686|FG007|Phase II|Adverse Event|1|||
129156167|NCT01791517|464868687|FG008|Phase II|Adverse Event|0|||
129156168|NCT01791517|464868688|FG009|Phase II|Adverse Event|1|||
129156169|NCT01791517|464868689|FG010|Phase II|Adverse Event|0|||
129156170|NCT01791517|464868690|FG011|Phase II|Adverse Event|0|||
129156171|NCT01791517|464868679|FG000|Phase II|Lens Handling Difficulties|0|||
128725710|NCT00314574|463292540|FG001|Overall Study|Lost to Follow-up|25|||
129156172|NCT01791517|464868680|FG001|Phase II|Lens Handling Difficulties|0|||
129156173|NCT01791517|464868681|FG002|Phase II|Lens Handling Difficulties|0|||
129156174|NCT01791517|464868682|FG003|Phase II|Lens Handling Difficulties|0|||
129156175|NCT01791517|464868683|FG004|Phase II|Lens Handling Difficulties|0|||
128725711|NCT00314574|463292539|FG000|Overall Study|Withdrawal by Subject|33|||
129156176|NCT01791517|464868684|FG005|Phase II|Lens Handling Difficulties|0|||
129156177|NCT01791517|464868685|FG006|Phase II|Lens Handling Difficulties|0|||
129156178|NCT01791517|464868686|FG007|Phase II|Lens Handling Difficulties|0|||
129156179|NCT01791517|464868687|FG008|Phase II|Lens Handling Difficulties|1|||
129156180|NCT01791517|464868688|FG009|Phase II|Lens Handling Difficulties|0|||
129156181|NCT01791517|464868689|FG010|Phase II|Lens Handling Difficulties|0|||
129156182|NCT01791517|464868690|FG011|Phase II|Lens Handling Difficulties|0|||
129156183|NCT01791517|464868679|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
129156184|NCT01791517|464868680|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
129156185|NCT01791517|464868681|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
129156186|NCT01791517|464868682|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
129156187|NCT01791517|464868683|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
129156188|NCT01791517|464868684|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
129156189|NCT01791517|464868685|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
129156190|NCT01791517|464868686|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
129156191|NCT01791517|464868687|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
129156192|NCT01791517|464868688|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
128725712|NCT00314574|463292540|FG001|Overall Study|Withdrawal by Subject|22|||
129156193|NCT01791517|464868689|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
129156194|NCT01791517|464868690|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
129156195|NCT01791517|464868679|FG000|Phase II|Pre-Existing Ocular Issue|0|||
129156196|NCT01791517|464868680|FG001|Phase II|Pre-Existing Ocular Issue|0|||
129156197|NCT01791517|464868681|FG002|Phase II|Pre-Existing Ocular Issue|0|||
129156198|NCT01791517|464868682|FG003|Phase II|Pre-Existing Ocular Issue|0|||
129156199|NCT01791517|464868683|FG004|Phase II|Pre-Existing Ocular Issue|0|||
129156200|NCT01791517|464868684|FG005|Phase II|Pre-Existing Ocular Issue|0|||
129156201|NCT01791517|464868685|FG006|Phase II|Pre-Existing Ocular Issue|0|||
129156202|NCT01791517|464868686|FG007|Phase II|Pre-Existing Ocular Issue|0|||
129156203|NCT01791517|464868687|FG008|Phase II|Pre-Existing Ocular Issue|0|||
129156204|NCT01791517|464868688|FG009|Phase II|Pre-Existing Ocular Issue|0|||
129156205|NCT01791517|464868689|FG010|Phase II|Pre-Existing Ocular Issue|0|||
129156206|NCT01791517|464868690|FG011|Phase II|Pre-Existing Ocular Issue|1|||
129156207|NCT04011735|464868691|FG000|Overall Study|Withdrawal by Subject|1|||
129156208|NCT04011735|464868692|FG001|Overall Study|Withdrawal by Subject|0|||
129156209|NCT04011735|464868693|FG002|Overall Study|Withdrawal by Subject|1|||
129156210|NCT04011735|464868691|FG000|Overall Study|Met exclusion criteria after study entry|0|||
129156211|NCT04011735|464868692|FG001|Overall Study|Met exclusion criteria after study entry|1|||
129156212|NCT04011735|464868693|FG002|Overall Study|Met exclusion criteria after study entry|0|||
129156213|NCT02298868|464868694|FG000|Overall Study|Adverse Event|1|||
129156214|NCT02298868|464868694|FG000|Overall Study|Death|1|||
129156215|NCT02298868|464868694|FG000|Overall Study|Patient underwent transplant|1|||
129156216|NCT01000506|464868695|FG000|Overall Study|Adverse Event|6|||
129156217|NCT01000506|464868696|FG001|Overall Study|Adverse Event|5|||
129156218|NCT01000506|464868697|FG002|Overall Study|Adverse Event|8|||
129156219|NCT01000506|464868698|FG003|Overall Study|Adverse Event|9|||
129156220|NCT01000506|464868695|FG000|Overall Study|Lack of Efficacy|8|||
129156221|NCT01000506|464868696|FG001|Overall Study|Lack of Efficacy|6|||
129156222|NCT01000506|464868697|FG002|Overall Study|Lack of Efficacy|4|||
129156223|NCT01000506|464868698|FG003|Overall Study|Lack of Efficacy|4|||
129156224|NCT01000506|464868695|FG000|Overall Study|Protocol Violation|1|||
129156225|NCT01000506|464868696|FG001|Overall Study|Protocol Violation|1|||
129156226|NCT01000506|464868697|FG002|Overall Study|Protocol Violation|0|||
129156227|NCT01000506|464868698|FG003|Overall Study|Protocol Violation|0|||
129156228|NCT01000506|464868695|FG000|Overall Study|Lost to Follow-up|1|||
129156229|NCT01000506|464868696|FG001|Overall Study|Lost to Follow-up|1|||
129156230|NCT01000506|464868697|FG002|Overall Study|Lost to Follow-up|4|||
129156231|NCT01000506|464868698|FG003|Overall Study|Lost to Follow-up|0|||
129156232|NCT01000506|464868695|FG000|Overall Study|Physician Decision|1|||
129156233|NCT01000506|464868696|FG001|Overall Study|Physician Decision|3|||
129156234|NCT01000506|464868697|FG002|Overall Study|Physician Decision|3|||
128725713|NCT00314574|463292539|FG000|Overall Study|Physician Decision|22|||
128725714|NCT00314574|463292540|FG001|Overall Study|Physician Decision|15|||
129156235|NCT01000506|464868698|FG003|Overall Study|Physician Decision|3|||
129156236|NCT01000506|464868695|FG000|Overall Study|Withdrawal by Subject|11|||
129156237|NCT01000506|464868696|FG001|Overall Study|Withdrawal by Subject|8|||
129156238|NCT01000506|464868697|FG002|Overall Study|Withdrawal by Subject|2|||
129156239|NCT01000506|464868698|FG003|Overall Study|Withdrawal by Subject|7|||
129156240|NCT00739310|464868703|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
128725715|NCT00314574|463292539|FG000|Overall Study|Pregnancy|6|||
129156241|NCT00739310|464868703|FG000|Overall Study|Withdrawal by Subject|1|||
129156242|NCT00739310|464868703|FG000|Overall Study|Lost to Follow-up|2|||
129156243|NCT01071954|464868704|FG000|Overall Study|Noncompliance|4|||
129156244|NCT01071954|464868704|FG000|Overall Study|Adverse Event|1|||
128725716|NCT00314574|463292540|FG001|Overall Study|Pregnancy|4|||
128725717|NCT00314574|463292539|FG000|Overall Study|Data unknown at database lock|0|||
129156245|NCT01071954|464868704|FG000|Overall Study|Withdrawal by Subject|11|||
129156246|NCT01071954|464868704|FG000|Overall Study|Requirement for Alternative Therapy|5|||
129156247|NCT01071954|464868704|FG000|Overall Study|Administrative Decision|5|||
129156248|NCT01071954|464868704|FG000|Overall Study|Protocol Specified Criteria|1|||
129156249|NCT00590967|464868705|FG000|Overall Study|Withdrawal by Subject|1|||
129156250|NCT00590967|464868706|FG001|Overall Study|Withdrawal by Subject|1|||
129156251|NCT00590967|464868705|FG000|Overall Study|Ineligible|1|||
129156252|NCT00590967|464868706|FG001|Overall Study|Ineligible|0|||
129156253|NCT00590967|464868705|FG000|Overall Study|Poor performance status|0|||
128725718|NCT00314574|463292540|FG001|Overall Study|Data unknown at database lock|1|||
128725719|NCT00449956|463292541|FG000|Overall Study|Adverse Event|7|||
128725720|NCT00449956|463292542|FG001|Overall Study|Adverse Event|1|||
128725721|NCT00449956|463292543|FG002|Overall Study|Adverse Event|6|||
128725722|NCT00449956|463292541|FG000|Overall Study|Lack of Efficacy|0|||
128725723|NCT00449956|463292542|FG001|Overall Study|Lack of Efficacy|0|||
128725724|NCT00449956|463292543|FG002|Overall Study|Lack of Efficacy|1|||
128725725|NCT00449956|463292541|FG000|Overall Study|Protocol Violation|1|||
128725726|NCT00449956|463292542|FG001|Overall Study|Protocol Violation|1|||
128725727|NCT00449956|463292543|FG002|Overall Study|Protocol Violation|1|||
128725728|NCT00449956|463292541|FG000|Overall Study|Withdrawal by Subject|0|||
128725729|NCT00449956|463292542|FG001|Overall Study|Withdrawal by Subject|1|||
128725730|NCT00449956|463292543|FG002|Overall Study|Withdrawal by Subject|0|||
128725731|NCT00449956|463292541|FG000|Overall Study|Physician Decision|2|||
128725732|NCT00449956|463292542|FG001|Overall Study|Physician Decision|1|||
128725733|NCT00449956|463292543|FG002|Overall Study|Physician Decision|1|||
128725734|NCT01446965|463292544|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
128725735|NCT01446965|463292545|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
128725736|NCT01446965|463292544|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
128725737|NCT01446965|463292545|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
128725738|NCT02852265|463292546|FG000|3-month Follow-up|Lost to Follow-up|1|||
128725739|NCT02852265|463292547|FG001|3-month Follow-up|Lost to Follow-up|1|||
128725740|NCT02871375|463292550|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
128725741|NCT02871375|463292551|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
128725742|NCT01988571|463292554|FG000|Overall Study|Death|3|||
128725743|NCT01988571|463292555|FG001|Overall Study|Death|1|||
129156254|NCT00590967|464868706|FG001|Overall Study|Poor performance status|1|||
129156255|NCT00590967|464868705|FG000|Overall Study|Non-compliant|0|||
129156256|NCT00590967|464868706|FG001|Overall Study|Non-compliant|2|||
129156257|NCT00590967|464868705|FG000|Overall Study|Did not sign consent form|0|||
129156258|NCT00590967|464868706|FG001|Overall Study|Did not sign consent form|1|||
129156259|NCT00590967|464868705|FG000|Overall Study|Did not receive chemo per protocol|1|||
129156260|NCT00590967|464868706|FG001|Overall Study|Did not receive chemo per protocol|0|||
129156261|NCT01847755|464868707|FG000|Overall Study|Adverse Event|2|||
129156262|NCT01847755|464868707|FG000|Overall Study|Withdrawal by Subject|2|||
129156263|NCT01847755|464868707|FG000|Overall Study|Physician Decision|1|||
129156264|NCT00920556|464868708|FG000|Overall Study|Adverse Event|16|||
129156265|NCT00920556|464868708|FG000|Overall Study|Physician Decision|7|||
129156266|NCT00920556|464868708|FG000|Overall Study|Withdrawal by Subject|1|||
129156267|NCT00889707|464868712|FG000|Overall Study|Adverse Event|1|||
129156268|NCT00889707|464868713|FG001|Overall Study|Adverse Event|0|||
129156269|NCT00889707|464868712|FG000|Overall Study|Withdrawal by Subject|4|||
129156270|NCT00889707|464868713|FG001|Overall Study|Withdrawal by Subject|3|||
129156271|NCT00889707|464868712|FG000|Overall Study|Lost to Follow-up|0|||
129156272|NCT00889707|464868713|FG001|Overall Study|Lost to Follow-up|2|||
129156273|NCT00889707|464868712|FG000|Overall Study|Lack of Efficacy|2|||
129156274|NCT00889707|464868713|FG001|Overall Study|Lack of Efficacy|5|||
129156275|NCT02185534|464868714|FG000|First Period|Withdrawal by Subject|0|||
129156276|NCT02185534|464868715|FG001|First Period|Withdrawal by Subject|0|||
129156277|NCT02185534|464868716|FG002|First Period|Withdrawal by Subject|0|||
129156278|NCT02185534|464868717|FG003|First Period|Withdrawal by Subject|1|||
129156279|NCT02185534|464868718|FG004|First Period|Withdrawal by Subject|0|||
129156280|NCT02185534|464868719|FG005|First Period|Withdrawal by Subject|0|||
129156281|NCT02185534|464868714|FG000|First Washout Period|Withdrawal by Subject|1|||
129156282|NCT02185534|464868715|FG001|First Washout Period|Withdrawal by Subject|0|||
129156283|NCT02185534|464868716|FG002|First Washout Period|Withdrawal by Subject|0|||
129156284|NCT02185534|464868717|FG003|First Washout Period|Withdrawal by Subject|0|||
129156285|NCT02185534|464868718|FG004|First Washout Period|Withdrawal by Subject|1|||
129156286|NCT02185534|464868719|FG005|First Washout Period|Withdrawal by Subject|0|||
129156287|NCT02185534|464868714|FG000|First Washout Period|Protocol Violation|0|||
128725744|NCT01988571|463292554|FG000|Overall Study|Physician Decision|2|||
128725745|NCT01988571|463292555|FG001|Overall Study|Physician Decision|1|||
129156288|NCT02185534|464868715|FG001|First Washout Period|Protocol Violation|0|||
129156289|NCT02185534|464868716|FG002|First Washout Period|Protocol Violation|0|||
128725746|NCT01988571|463292554|FG000|Overall Study|Lost to Follow-up|3|||
128725747|NCT01988571|463292555|FG001|Overall Study|Lost to Follow-up|0|||
128725748|NCT01988571|463292554|FG000|Overall Study|Withdrawal by Subject|31|||
128725749|NCT01988571|463292555|FG001|Overall Study|Withdrawal by Subject|33|||
129156290|NCT02185534|464868717|FG003|First Washout Period|Protocol Violation|0|||
129156291|NCT02185534|464868718|FG004|First Washout Period|Protocol Violation|0|||
129156292|NCT02185534|464868719|FG005|First Washout Period|Protocol Violation|1|||
129156293|NCT02389465|464868723|FG000|Overall Study|Lost to Follow-up|1|||
128725750|NCT00004412|463292556|FG000|Randomized Period|Moved to Crossover Period|3|||
129156294|NCT02389465|464868724|FG001|Overall Study|Lost to Follow-up|3|||
129156295|NCT02389465|464868725|FG002|Overall Study|Lost to Follow-up|3|||
129156296|NCT02389465|464868726|FG003|Overall Study|Lost to Follow-up|0|||
129156297|NCT02389465|464868723|FG000|Overall Study|Physician Decision|0|||
129156298|NCT02389465|464868724|FG001|Overall Study|Physician Decision|0|||
129156299|NCT02389465|464868725|FG002|Overall Study|Physician Decision|0|||
129156300|NCT02389465|464868726|FG003|Overall Study|Physician Decision|1|||
129156301|NCT02389465|464868723|FG000|Overall Study|Withdrawal by Subject|0|||
129156302|NCT02389465|464868724|FG001|Overall Study|Withdrawal by Subject|1|||
129156303|NCT02389465|464868725|FG002|Overall Study|Withdrawal by Subject|2|||
129156304|NCT02389465|464868726|FG003|Overall Study|Withdrawal by Subject|2|||
129156305|NCT00846846|464868727|FG000|Overall Study|Death|56|||
129156306|NCT00846846|464868727|FG000|Overall Study|Withdrawal by Subject|19|||
129156307|NCT04179305|464868728|FG000|Overall Study|Death|1|||
129156308|NCT04179305|464868729|FG001|Overall Study|Death|1|||
129156309|NCT04179305|464868730|FG002|Overall Study|Death|0|||
129156310|NCT04179305|464868731|FG003|Overall Study|Death|0|||
129156311|NCT04179305|464868728|FG000|Overall Study|Lost to Follow-up|1|||
129156312|NCT04179305|464868729|FG001|Overall Study|Lost to Follow-up|1|||
129156313|NCT04179305|464868730|FG002|Overall Study|Lost to Follow-up|0|||
129156314|NCT04179305|464868731|FG003|Overall Study|Lost to Follow-up|0|||
129156315|NCT04179305|464868728|FG000|Overall Study|Withdrawal by Subject|0|||
129156316|NCT04179305|464868729|FG001|Overall Study|Withdrawal by Subject|1|||
129156317|NCT04179305|464868730|FG002|Overall Study|Withdrawal by Subject|0|||
129156318|NCT04179305|464868731|FG003|Overall Study|Withdrawal by Subject|0|||
129156319|NCT04179305|464868728|FG000|Overall Study|Did not have scan|1|||
129156320|NCT04179305|464868729|FG001|Overall Study|Did not have scan|0|||
129156321|NCT04179305|464868730|FG002|Overall Study|Did not have scan|0|||
129156322|NCT04179305|464868731|FG003|Overall Study|Did not have scan|0|||
129156323|NCT04179305|464868728|FG000|Overall Study|In hospice care|3|||
129156324|NCT04179305|464868729|FG001|Overall Study|In hospice care|0|||
129156325|NCT04179305|464868730|FG002|Overall Study|In hospice care|0|||
129156326|NCT04179305|464868731|FG003|Overall Study|In hospice care|0|||
129156327|NCT00503425|464868734|FG000|Overall Study|Participant files lost|6|||
129156328|NCT00503425|464868734|FG000|Overall Study|Adverse Event|5|||
129156329|NCT00503425|464868734|FG000|Overall Study|Lack of Efficacy|25|||
129156330|NCT00503425|464868734|FG000|Overall Study|Withdrawal by Subject|8|||
129156331|NCT00503425|464868734|FG000|Overall Study|Lost to Follow-up|3|||
129156332|NCT00503425|464868734|FG000|Overall Study|Death|3|||
129156333|NCT00503425|464868734|FG000|Overall Study|Missing Data/Unknown|4|||
129156334|NCT00326599|464868735|FG000|Overall Study|Withdrawal by Subject|1|||
129156335|NCT00326599|464868736|FG001|Overall Study|Withdrawal by Subject|0|||
129156336|NCT00326599|464868737|FG002|Overall Study|Withdrawal by Subject|5|||
129156337|NCT00326599|464868738|FG003|Overall Study|Withdrawal by Subject|2|||
129156338|NCT00326599|464868735|FG000|Overall Study|Adverse Event|1|||
129156339|NCT00326599|464868736|FG001|Overall Study|Adverse Event|0|||
129156340|NCT00326599|464868737|FG002|Overall Study|Adverse Event|32|||
129156341|NCT00326599|464868738|FG003|Overall Study|Adverse Event|3|||
129156342|NCT00326599|464868735|FG000|Overall Study|Disease Progression|3|||
129156343|NCT00326599|464868736|FG001|Overall Study|Disease Progression|1|||
129156344|NCT00326599|464868737|FG002|Overall Study|Disease Progression|13|||
129156345|NCT00326599|464868738|FG003|Overall Study|Disease Progression|11|||
129156346|NCT00326599|464868735|FG000|Overall Study|Alternate Treatment|1|||
129156347|NCT00326599|464868736|FG001|Overall Study|Alternate Treatment|0|||
129156348|NCT00326599|464868737|FG002|Overall Study|Alternate Treatment|0|||
129156349|NCT00326599|464868738|FG003|Overall Study|Alternate Treatment|0|||
129156350|NCT00326599|464868735|FG000|Overall Study|Death|0|||
129156351|NCT00326599|464868736|FG001|Overall Study|Death|0|||
129156352|NCT00326599|464868737|FG002|Overall Study|Death|1|||
129156353|NCT00326599|464868738|FG003|Overall Study|Death|2|||
129156354|NCT00326599|464868735|FG000|Overall Study|Other Unspecified Reason|0|||
129156355|NCT00326599|464868736|FG001|Overall Study|Other Unspecified Reason|0|||
129156356|NCT00326599|464868737|FG002|Overall Study|Other Unspecified Reason|2|||
129156357|NCT00326599|464868738|FG003|Overall Study|Other Unspecified Reason|1|||
129156358|NCT00437268|464868743|FG000|Overall Study|Adverse Event|1|||
129156359|NCT00437268|464868744|FG001|Overall Study|Adverse Event|1|||
129156360|NCT00437268|464868743|FG000|Overall Study|Withdrawal by Subject|2|||
129156361|NCT00437268|464868744|FG001|Overall Study|Withdrawal by Subject|2|||
129156362|NCT00437268|464868743|FG000|Overall Study|Progressive disease|9|||
129156363|NCT00437268|464868744|FG001|Overall Study|Progressive disease|9|||
129156364|NCT00437268|464868743|FG000|Overall Study|Physician Decision|1|||
129156365|NCT00437268|464868744|FG001|Overall Study|Physician Decision|0|||
129156366|NCT00437268|464868743|FG000|Overall Study|Death|0|||
129156367|NCT00437268|464868744|FG001|Overall Study|Death|1|||
129156368|NCT00444925|464868745|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
129156369|NCT00444925|464868746|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
129156370|NCT00444925|464868747|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
129156371|NCT00444925|464868745|FG000|Double-blind Treatment Period|Death|2|||
129156372|NCT00444925|464868746|FG001|Double-blind Treatment Period|Death|0|||
129156373|NCT00444925|464868747|FG002|Double-blind Treatment Period|Death|0|||
129156374|NCT00444925|464868745|FG000|Double-blind Treatment Period|Adverse Event|6|||
129156375|NCT00444925|464868746|FG001|Double-blind Treatment Period|Adverse Event|28|||
129156376|NCT00444925|464868747|FG002|Double-blind Treatment Period|Adverse Event|44|||
129156377|NCT00444925|464868745|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
129156378|NCT00444925|464868746|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
129156379|NCT00444925|464868747|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
129156380|NCT00444925|464868745|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
129156381|NCT00444925|464868746|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
129156382|NCT00444925|464868747|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
129156383|NCT00444925|464868745|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
129156384|NCT00444925|464868746|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
129156385|NCT00444925|464868747|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
129156386|NCT00444925|464868745|FG000|Double-blind Treatment Period|Other|7|||
129156387|NCT00444925|464868746|FG001|Double-blind Treatment Period|Other|7|||
129156388|NCT00444925|464868747|FG002|Double-blind Treatment Period|Other|12|||
129156389|NCT00714948|464868754|FG000|Overall Study|Adverse Event|2|||
129156390|NCT03382912|464868755|FG000|Overall Study|Physician Decision|0|||
129156391|NCT03382912|464868756|FG001|Overall Study|Physician Decision|1|||
129156392|NCT03382912|464868755|FG000|Overall Study|Sponsor Decision|6|||
129156393|NCT03382912|464868756|FG001|Overall Study|Sponsor Decision|6|||
129156394|NCT03382912|464868755|FG000|Overall Study|Withdrawal by Subject|0|||
129156395|NCT03382912|464868756|FG001|Overall Study|Withdrawal by Subject|5|||
129156396|NCT05588440|464868757|FG000|Overall Study|Sponsor Decision|2|||
129156397|NCT05588440|464868758|FG001|Overall Study|Sponsor Decision|0|||
129156398|NCT05588440|464868759|FG002|Overall Study|Sponsor Decision|1|||
129156399|NCT05588440|464868757|FG000|Overall Study|Death|1|||
129156400|NCT05588440|464868758|FG001|Overall Study|Death|1|||
129156401|NCT05588440|464868759|FG002|Overall Study|Death|1|||
129156402|NCT05588440|464868757|FG000|Overall Study|Screen Fail|0|||
129156403|NCT05588440|464868758|FG001|Overall Study|Screen Fail|1|||
129156404|NCT05588440|464868759|FG002|Overall Study|Screen Fail|1|||
129156405|NCT05588440|464868757|FG000|Overall Study|Withdrawal by Subject|0|||
129156406|NCT05588440|464868758|FG001|Overall Study|Withdrawal by Subject|0|||
129156407|NCT05588440|464868759|FG002|Overall Study|Withdrawal by Subject|1|||
129156408|NCT02137070|464868760|FG000|Overall Study|Adverse Event|12|||
129156409|NCT02137070|464868761|FG001|Overall Study|Adverse Event|3|||
129156410|NCT02137070|464868760|FG000|Overall Study|Death|2|||
129156411|NCT02137070|464868761|FG001|Overall Study|Death|0|||
129156412|NCT02137070|464868760|FG000|Overall Study|Lost to Follow-up|24|||
129156413|NCT02137070|464868761|FG001|Overall Study|Lost to Follow-up|9|||
129156414|NCT02137070|464868760|FG000|Overall Study|Physician Decision|0|||
129156415|NCT02137070|464868761|FG001|Overall Study|Physician Decision|1|||
129156416|NCT02137070|464868760|FG000|Overall Study|Protocol Violation|18|||
129156417|NCT02137070|464868761|FG001|Overall Study|Protocol Violation|4|||
129156418|NCT02137070|464868760|FG000|Overall Study|Withdrawal by Subject|18|||
129156419|NCT02137070|464868761|FG001|Overall Study|Withdrawal by Subject|1|||
129156420|NCT00342628|464870947|FG000|Overall Study|Withdrawal by Subject|19|||
129156421|NCT00342628|464870948|FG001|Overall Study|Withdrawal by Subject|19|||
129156422|NCT00342628|464870949|FG002|Overall Study|Withdrawal by Subject|18|||
129156423|NCT00342628|464870947|FG000|Overall Study|Death|1|||
129156424|NCT00342628|464870948|FG001|Overall Study|Death|1|||
129156425|NCT00342628|464870949|FG002|Overall Study|Death|0|||
129156426|NCT00342628|464870947|FG000|Overall Study|moved residence|0|||
129156427|NCT00342628|464870948|FG001|Overall Study|moved residence|1|||
129156428|NCT00342628|464870949|FG002|Overall Study|moved residence|1|||
129156429|NCT04971967|464870952|FG000|Overall Study|Lost to Follow-up|6|||
129156430|NCT04971967|464870953|FG001|Overall Study|Lost to Follow-up|7|||
129156431|NCT00682929|464870956|FG000|Overall Study|Adverse Event|4|||
129156432|NCT00682929|464870957|FG001|Overall Study|Adverse Event|1|||
129156433|NCT00682929|464870958|FG002|Overall Study|Adverse Event|1|||
129156434|NCT00682929|464870956|FG000|Overall Study|Withdrawal by Subject|1|||
129156435|NCT00682929|464870957|FG001|Overall Study|Withdrawal by Subject|2|||
129156436|NCT00682929|464870958|FG002|Overall Study|Withdrawal by Subject|1|||
129156437|NCT00682929|464870956|FG000|Overall Study|dosing compliance < 80%|0|||
129156438|NCT00682929|464870957|FG001|Overall Study|dosing compliance < 80%|2|||
129156439|NCT00682929|464870958|FG002|Overall Study|dosing compliance < 80%|0|||
129156440|NCT00682929|464870956|FG000|Overall Study|lag in DEA renewal|1|||
129156441|NCT00682929|464870957|FG001|Overall Study|lag in DEA renewal|0|||
129156442|NCT00682929|464870958|FG002|Overall Study|lag in DEA renewal|0|||
129156443|NCT01462929|464870959|FG000|Overall Study|Adverse Event|3|||
129156444|NCT01462929|464870960|FG001|Overall Study|Adverse Event|3|||
129156445|NCT01462929|464870961|FG002|Overall Study|Adverse Event|4|||
129156446|NCT01462929|464870959|FG000|Overall Study|Withdrawal by Subject|2|||
129156447|NCT01462929|464870960|FG001|Overall Study|Withdrawal by Subject|1|||
129156448|NCT01462929|464870961|FG002|Overall Study|Withdrawal by Subject|0|||
129156449|NCT01462929|464870959|FG000|Overall Study|Lack of Efficacy|0|||
129156450|NCT01462929|464870960|FG001|Overall Study|Lack of Efficacy|0|||
129156451|NCT01462929|464870961|FG002|Overall Study|Lack of Efficacy|1|||
129156452|NCT00399568|464870962|FG000|Overall Study|Adverse Event|1|||
129156453|NCT00399568|464870963|FG001|Overall Study|Adverse Event|2|||
129156454|NCT00399568|464870962|FG000|Overall Study|Withdrawal by Subject|7|||
129156455|NCT00399568|464870963|FG001|Overall Study|Withdrawal by Subject|3|||
129156456|NCT00399568|464870962|FG000|Overall Study|Protocol non-compliance|2|||
129156457|NCT00399568|464870963|FG001|Overall Study|Protocol non-compliance|2|||
129156458|NCT00399568|464870962|FG000|Overall Study|Lost to Follow-up|2|||
129156459|NCT00399568|464870963|FG001|Overall Study|Lost to Follow-up|2|||
129156460|NCT00506779|464870965|FG000|Overall Study|Withdrawal by Subject|1|||
129156461|NCT00506779|464870966|FG001|Overall Study|Withdrawal by Subject|0|||
129156462|NCT00506779|464870967|FG002|Overall Study|Withdrawal by Subject|1|||
129156463|NCT00506779|464870968|FG003|Overall Study|Withdrawal by Subject|0|||
129156464|NCT00506779|464870965|FG000|Overall Study|Adverse Event|0|||
129156465|NCT00506779|464870966|FG001|Overall Study|Adverse Event|1|||
129156466|NCT00506779|464870967|FG002|Overall Study|Adverse Event|1|||
129156467|NCT00506779|464870968|FG003|Overall Study|Adverse Event|1|||
129156468|NCT02639247|464870971|FG000|Overall Study|Lost to Follow-up|2|||
129156469|NCT02639247|464870972|FG001|Overall Study|Lost to Follow-up|1|||
129156470|NCT02639247|464870971|FG000|Overall Study|Death|2|||
129156471|NCT02639247|464870972|FG001|Overall Study|Death|0|||
129156472|NCT02639247|464870971|FG000|Overall Study|Withdrew Consent|0|||
129156473|NCT02639247|464870972|FG001|Overall Study|Withdrew Consent|1|||
129156474|NCT02639247|464870971|FG000|Overall Study|Protocol Violation|1|||
129156475|NCT02639247|464870972|FG001|Overall Study|Protocol Violation|0|||
129156476|NCT03462758|464870973|FG000|Overall Study|Chose no or other method of contraception|20|||
129156477|NCT03462758|464870974|FG001|Overall Study|Chose no or other method of contraception|23|||
129156478|NCT03462758|464870973|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
129156479|NCT03462758|464870974|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
129156480|NCT03462758|464870973|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
129156481|NCT03462758|464870974|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
129156482|NCT03462758|464870973|FG000|Overall Study|Medical contraindication|2|||
129156483|NCT03462758|464870974|FG001|Overall Study|Medical contraindication|2|||
129156484|NCT03462758|464870973|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
129156485|NCT03462758|464870974|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
129156486|NCT02820844|464870976|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
129156487|NCT02820844|464870977|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
129156488|NCT02820844|464870978|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129156489|NCT02820844|464870979|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129156490|NCT02820844|464870980|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129156491|NCT02820844|464870981|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129156492|NCT02820844|464870976|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
129156493|NCT02820844|464870977|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
129156494|NCT02820844|464870978|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129156495|NCT02820844|464870979|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129156496|NCT02820844|464870980|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129156497|NCT02820844|464870981|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129156498|NCT02820844|464870976|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129156499|NCT02820844|464870977|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
129156500|NCT02820844|464870978|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129156501|NCT02820844|464870979|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129156502|NCT02820844|464870980|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129156503|NCT02820844|464870981|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129156504|NCT02820844|464870976|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
129156505|NCT02820844|464870977|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
129156506|NCT02820844|464870978|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129156507|NCT02820844|464870979|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129156508|NCT02820844|464870980|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129156509|NCT02820844|464870981|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129156510|NCT02820844|464870976|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
128725751|NCT00004412|463292557|FG001|Randomized Period|Moved to Crossover Period|0|||
128725752|NCT00004412|463292558|FG002|Randomized Period|Moved to Crossover Period|0|||
128725753|NCT03144180|463292567|FG000|Overall Study|STAT Delivery|1|||
128725754|NCT03144180|463292568|FG001|Overall Study|STAT Delivery|1|||
128725755|NCT03144180|463292567|FG000|Overall Study|Provider forgot to fill out forms|1|||
129156511|NCT02820844|464870977|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129156512|NCT02820844|464870978|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129156513|NCT02820844|464870979|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129156514|NCT02820844|464870980|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129156515|NCT02820844|464870981|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129156516|NCT02820844|464870976|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129156517|NCT02820844|464870977|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129156518|NCT02820844|464870978|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
129156519|NCT02820844|464870979|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
129156520|NCT02820844|464870980|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129156521|NCT02820844|464870981|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129156522|NCT02820844|464870976|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129156523|NCT02820844|464870977|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129156524|NCT02820844|464870978|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
129156525|NCT02820844|464870979|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129156526|NCT02820844|464870980|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129156527|NCT02820844|464870981|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129156528|NCT02820844|464870976|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156529|NCT02820844|464870977|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156530|NCT02820844|464870978|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
129156531|NCT02820844|464870979|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
129156532|NCT02820844|464870980|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156533|NCT02820844|464870981|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156534|NCT02820844|464870976|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129156535|NCT02820844|464870977|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129156536|NCT02820844|464870978|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129156537|NCT02820844|464870979|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129156538|NCT02820844|464870980|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
129156539|NCT02820844|464870981|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129156540|NCT02820844|464870976|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156541|NCT02820844|464870977|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156542|NCT02820844|464870978|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156543|NCT02820844|464870979|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156544|NCT02820844|464870980|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129156545|NCT02820844|464870981|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
129156546|NCT02266147|464870982|FG000|PART 1: Dose Escalation|Physician Decision|0|||
129156547|NCT02266147|464870983|FG001|PART 1: Dose Escalation|Physician Decision|0|||
129156548|NCT02266147|464870984|FG002|PART 1: Dose Escalation|Physician Decision|1|||
129156549|NCT02266147|464870985|FG003|PART 1: Dose Escalation|Physician Decision|0|||
129156550|NCT02266147|464870982|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
129156551|NCT02266147|464870983|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
129156552|NCT02266147|464870984|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
129156553|NCT02266147|464870985|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
129156554|NCT02266147|464870982|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
129156555|NCT02266147|464870983|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
129156556|NCT02266147|464870984|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
129156557|NCT02266147|464870985|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
129156558|NCT02266147|464870982|FG000|PART 1: Dose Escalation|Other|1|||
129156559|NCT02266147|464870983|FG001|PART 1: Dose Escalation|Other|1|||
129156560|NCT02266147|464870984|FG002|PART 1: Dose Escalation|Other|0|||
129156561|NCT02266147|464870985|FG003|PART 1: Dose Escalation|Other|0|||
129156562|NCT02266147|464870982|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
129156563|NCT02266147|464870983|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
129156564|NCT02266147|464870984|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
129156565|NCT02266147|464870985|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
129156566|NCT02266147|464870982|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
129156567|NCT02266147|464870983|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
129156568|NCT02266147|464870984|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
129156569|NCT02266147|464870985|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
129156570|NCT01456130|464870986|FG000|Overall Study|Adverse Event|4|||
129156571|NCT01456130|464870986|FG000|Overall Study|Voluntary Withdrawal|1|||
129156572|NCT01456130|464870986|FG000|Overall Study|Lack of Efficacy|4|||
129156573|NCT01456130|464870986|FG000|Overall Study|Other|1|||
129156574|NCT00413660|464870989|FG000|Up To Week 12|Adverse Event|1|||
129156575|NCT00413660|464870990|FG001|Up To Week 12|Adverse Event|3|||
129156576|NCT00413660|464870991|FG002|Up To Week 12|Adverse Event|1|||
129156577|NCT00413660|464870992|FG003|Up To Week 12|Adverse Event|4|||
129156578|NCT00413660|464870993|FG004|Up To Week 12|Adverse Event|6|||
129156579|NCT00413660|464870994|FG005|Up To Week 12|Adverse Event|4|||
129156580|NCT00413660|464870995|FG006|Up To Week 12|Adverse Event|1|||
129156581|NCT00413660|464870996|FG007|Up To Week 12|Adverse Event|0|||
129156582|NCT00413660|464870997|FG008|Up To Week 12|Adverse Event|0|||
129156583|NCT00413660|464870998|FG009|Up To Week 12|Adverse Event|0|||
129156584|NCT00413660|464870999|FG010|Up To Week 12|Adverse Event|0|||
129156585|NCT00413660|464870989|FG000|Up To Week 12|Lack of Efficacy|2|||
129156586|NCT00413660|464870990|FG001|Up To Week 12|Lack of Efficacy|0|||
129156587|NCT00413660|464870991|FG002|Up To Week 12|Lack of Efficacy|0|||
129156588|NCT00413660|464870992|FG003|Up To Week 12|Lack of Efficacy|0|||
129156589|NCT00413660|464870993|FG004|Up To Week 12|Lack of Efficacy|0|||
129156590|NCT00413660|464870994|FG005|Up To Week 12|Lack of Efficacy|0|||
129156591|NCT00413660|464870995|FG006|Up To Week 12|Lack of Efficacy|5|||
129156592|NCT00413660|464870996|FG007|Up To Week 12|Lack of Efficacy|0|||
129156593|NCT00413660|464870997|FG008|Up To Week 12|Lack of Efficacy|0|||
129156594|NCT00413660|464870998|FG009|Up To Week 12|Lack of Efficacy|0|||
129156595|NCT00413660|464870999|FG010|Up To Week 12|Lack of Efficacy|0|||
129156596|NCT00413660|464870989|FG000|Up To Week 12|Lost to Follow-up|0|||
129156597|NCT00413660|464870990|FG001|Up To Week 12|Lost to Follow-up|1|||
129156598|NCT00413660|464870991|FG002|Up To Week 12|Lost to Follow-up|0|||
129156599|NCT00413660|464870992|FG003|Up To Week 12|Lost to Follow-up|0|||
129156600|NCT00413660|464870993|FG004|Up To Week 12|Lost to Follow-up|1|||
129156601|NCT00413660|464870994|FG005|Up To Week 12|Lost to Follow-up|0|||
129156602|NCT00413660|464870995|FG006|Up To Week 12|Lost to Follow-up|0|||
129156603|NCT00413660|464870996|FG007|Up To Week 12|Lost to Follow-up|0|||
129156604|NCT00413660|464870997|FG008|Up To Week 12|Lost to Follow-up|0|||
129156605|NCT00413660|464870998|FG009|Up To Week 12|Lost to Follow-up|0|||
129156606|NCT00413660|464870999|FG010|Up To Week 12|Lost to Follow-up|0|||
129156607|NCT00413660|464870989|FG000|Up To Week 12|Withdrawal by Subject|0|||
129156608|NCT00413660|464870990|FG001|Up To Week 12|Withdrawal by Subject|2|||
129156609|NCT00413660|464870991|FG002|Up To Week 12|Withdrawal by Subject|0|||
129156610|NCT00413660|464870992|FG003|Up To Week 12|Withdrawal by Subject|2|||
129156611|NCT00413660|464870993|FG004|Up To Week 12|Withdrawal by Subject|0|||
129156612|NCT00413660|464870994|FG005|Up To Week 12|Withdrawal by Subject|2|||
129156613|NCT00413660|464870995|FG006|Up To Week 12|Withdrawal by Subject|2|||
129156614|NCT00413660|464870996|FG007|Up To Week 12|Withdrawal by Subject|0|||
129156615|NCT00413660|464870997|FG008|Up To Week 12|Withdrawal by Subject|0|||
129156616|NCT00413660|464870998|FG009|Up To Week 12|Withdrawal by Subject|0|||
129156617|NCT00413660|464870999|FG010|Up To Week 12|Withdrawal by Subject|0|||
129156618|NCT00413660|464870989|FG000|Up To Week 12|Randomized, Not Treated|1|||
129156619|NCT00413660|464870990|FG001|Up To Week 12|Randomized, Not Treated|0|||
129156620|NCT00413660|464870991|FG002|Up To Week 12|Randomized, Not Treated|0|||
129156621|NCT00413660|464870992|FG003|Up To Week 12|Randomized, Not Treated|1|||
129156622|NCT00413660|464870993|FG004|Up To Week 12|Randomized, Not Treated|0|||
129156623|NCT00413660|464870994|FG005|Up To Week 12|Randomized, Not Treated|0|||
129156624|NCT00413660|464870995|FG006|Up To Week 12|Randomized, Not Treated|0|||
129156625|NCT00413660|464870996|FG007|Up To Week 12|Randomized, Not Treated|0|||
129156626|NCT00413660|464870997|FG008|Up To Week 12|Randomized, Not Treated|0|||
129156627|NCT00413660|464870998|FG009|Up To Week 12|Randomized, Not Treated|0|||
129156628|NCT00413660|464870999|FG010|Up To Week 12|Randomized, Not Treated|0|||
129156629|NCT00413660|464870989|FG000|Up To Week 12|Other|3|||
129156630|NCT00413660|464870990|FG001|Up To Week 12|Other|1|||
129156631|NCT00413660|464870991|FG002|Up To Week 12|Other|6|||
129156632|NCT00413660|464870992|FG003|Up To Week 12|Other|1|||
129156633|NCT00413660|464870993|FG004|Up To Week 12|Other|2|||
129156634|NCT00413660|464870994|FG005|Up To Week 12|Other|4|||
129156635|NCT00413660|464870995|FG006|Up To Week 12|Other|3|||
129156636|NCT00413660|464870996|FG007|Up To Week 12|Other|0|||
129156637|NCT00413660|464870997|FG008|Up To Week 12|Other|0|||
129156638|NCT00413660|464870998|FG009|Up To Week 12|Other|0|||
129156639|NCT00413660|464870999|FG010|Up To Week 12|Other|0|||
129156640|NCT00413660|464870989|FG000|Post Week 12|Adverse Event|2|||
129156641|NCT00413660|464870990|FG001|Post Week 12|Adverse Event|0|||
129156642|NCT00413660|464870991|FG002|Post Week 12|Adverse Event|2|||
129156643|NCT00413660|464870992|FG003|Post Week 12|Adverse Event|1|||
129156644|NCT00413660|464870993|FG004|Post Week 12|Adverse Event|4|||
129156645|NCT00413660|464870994|FG005|Post Week 12|Adverse Event|2|||
129156646|NCT00413660|464870995|FG006|Post Week 12|Adverse Event|2|||
129156647|NCT00413660|464870996|FG007|Post Week 12|Adverse Event|0|||
129156648|NCT00413660|464870997|FG008|Post Week 12|Adverse Event|0|||
129156649|NCT00413660|464870998|FG009|Post Week 12|Adverse Event|0|||
129156650|NCT00413660|464870999|FG010|Post Week 12|Adverse Event|0|||
129156651|NCT00413660|464870989|FG000|Post Week 12|Lack of Efficacy|0|||
129156652|NCT00413660|464870990|FG001|Post Week 12|Lack of Efficacy|0|||
129156653|NCT00413660|464870991|FG002|Post Week 12|Lack of Efficacy|1|||
129156654|NCT00413660|464870992|FG003|Post Week 12|Lack of Efficacy|0|||
129156655|NCT00413660|464870993|FG004|Post Week 12|Lack of Efficacy|0|||
129156656|NCT00413660|464870994|FG005|Post Week 12|Lack of Efficacy|0|||
129156657|NCT00413660|464870995|FG006|Post Week 12|Lack of Efficacy|0|||
129156658|NCT00413660|464870996|FG007|Post Week 12|Lack of Efficacy|0|||
129156659|NCT00413660|464870997|FG008|Post Week 12|Lack of Efficacy|0|||
129156660|NCT00413660|464870998|FG009|Post Week 12|Lack of Efficacy|1|||
129156661|NCT00413660|464870999|FG010|Post Week 12|Lack of Efficacy|0|||
129156662|NCT00413660|464870989|FG000|Post Week 12|Lost to Follow-up|0|||
129156663|NCT00413660|464870990|FG001|Post Week 12|Lost to Follow-up|1|||
129156664|NCT00413660|464870991|FG002|Post Week 12|Lost to Follow-up|1|||
129156665|NCT00413660|464870992|FG003|Post Week 12|Lost to Follow-up|0|||
129156666|NCT00413660|464870993|FG004|Post Week 12|Lost to Follow-up|0|||
129156667|NCT00413660|464870994|FG005|Post Week 12|Lost to Follow-up|0|||
129156668|NCT00413660|464870995|FG006|Post Week 12|Lost to Follow-up|0|||
129156669|NCT00413660|464870996|FG007|Post Week 12|Lost to Follow-up|0|||
129156670|NCT00413660|464870997|FG008|Post Week 12|Lost to Follow-up|0|||
129156671|NCT00413660|464870998|FG009|Post Week 12|Lost to Follow-up|0|||
129156672|NCT00413660|464870999|FG010|Post Week 12|Lost to Follow-up|0|||
129156673|NCT00413660|464870989|FG000|Post Week 12|Withdrawal by Subject|0|||
129156674|NCT00413660|464870990|FG001|Post Week 12|Withdrawal by Subject|1|||
129156675|NCT00413660|464870991|FG002|Post Week 12|Withdrawal by Subject|1|||
129156676|NCT00413660|464870992|FG003|Post Week 12|Withdrawal by Subject|0|||
129156677|NCT00413660|464870993|FG004|Post Week 12|Withdrawal by Subject|1|||
129156678|NCT00413660|464870994|FG005|Post Week 12|Withdrawal by Subject|0|||
129156679|NCT00413660|464870995|FG006|Post Week 12|Withdrawal by Subject|0|||
129156680|NCT00413660|464870996|FG007|Post Week 12|Withdrawal by Subject|0|||
129156681|NCT00413660|464870997|FG008|Post Week 12|Withdrawal by Subject|0|||
129156682|NCT00413660|464870998|FG009|Post Week 12|Withdrawal by Subject|0|||
129156683|NCT00413660|464870999|FG010|Post Week 12|Withdrawal by Subject|1|||
129156684|NCT00413660|464870989|FG000|Post Week 12|Other|1|||
129156685|NCT00413660|464870990|FG001|Post Week 12|Other|2|||
129156686|NCT00413660|464870991|FG002|Post Week 12|Other|3|||
129156687|NCT00413660|464870992|FG003|Post Week 12|Other|0|||
129156688|NCT00413660|464870993|FG004|Post Week 12|Other|1|||
129156689|NCT00413660|464870994|FG005|Post Week 12|Other|1|||
129156690|NCT00413660|464870995|FG006|Post Week 12|Other|1|||
129156691|NCT00413660|464870996|FG007|Post Week 12|Other|0|||
129156692|NCT00413660|464870997|FG008|Post Week 12|Other|0|||
129156693|NCT00413660|464870998|FG009|Post Week 12|Other|0|||
129156694|NCT00413660|464870999|FG010|Post Week 12|Other|0|||
129156695|NCT00400517|464871003|FG000|Overall Study|Withdrawal by Subject|1|||
129156696|NCT00400517|464871003|FG000|Overall Study|Physician Decision|1|||
129156697|NCT02831855|464871008|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
129156698|NCT02831855|464871009|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
129156699|NCT02831855|464871010|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
129156700|NCT02831855|464871008|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
129156701|NCT02831855|464871009|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
129156702|NCT02831855|464871010|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
129156703|NCT02831855|464871008|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
129156704|NCT02831855|464871009|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
129156705|NCT02831855|464871010|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
129156706|NCT02831855|464871008|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
129156707|NCT02831855|464871009|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
129156708|NCT02831855|464871010|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
129156709|NCT02831855|464871008|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
129156710|NCT02831855|464871009|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
129156711|NCT02831855|464871010|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
129156712|NCT02831855|464871008|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
129156713|NCT02831855|464871009|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
129156714|NCT02831855|464871010|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
129156715|NCT02831855|464871008|FG000|Open Label Phase (24 Weeks)|Other|4|||
129156716|NCT02831855|464871009|FG001|Open Label Phase (24 Weeks)|Other|0|||
129156717|NCT02831855|464871010|FG002|Open Label Phase (24 Weeks)|Other|0|||
129156718|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
129156719|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
129156720|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
129156721|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Death|0|||
129156722|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Death|0|||
129156723|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Death|2|||
129156724|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
129156725|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
129156726|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
129156727|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
129156728|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
129156729|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
129156730|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
129156731|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
129156732|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
129156733|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Other|0|||
129156734|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Other|2|||
129156735|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Other|5|||
129156736|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
128725756|NCT03144180|463292568|FG001|Overall Study|Provider forgot to fill out forms|3|||
128725757|NCT03144180|463292567|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
128725758|NCT03144180|463292568|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
128725759|NCT03144180|463292567|FG000|Overall Study|Scrub tech removed tube cap|0|||
129156737|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
129156738|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
129156739|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
129156740|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
129156741|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
129156742|NCT02831855|464871008|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
129156743|NCT02831855|464871009|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
129156744|NCT02831855|464871010|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
129156745|NCT01722994|464871011|FG000|Overall Study|Missing data|25|||
129156746|NCT01722994|464871012|FG001|Overall Study|Missing data|17|||
129156747|NCT01803880|464871016|FG000|Overall Study|Adverse Event|1|||
129156748|NCT01803880|464871017|FG001|Overall Study|Adverse Event|0|||
129156749|NCT01803880|464871018|FG002|Overall Study|Adverse Event|0|||
129156750|NCT01803880|464871016|FG000|Overall Study|Withdrawal by Subject|1|||
129156751|NCT01803880|464871017|FG001|Overall Study|Withdrawal by Subject|1|||
129156752|NCT01803880|464871018|FG002|Overall Study|Withdrawal by Subject|4|||
129156753|NCT01803880|464871016|FG000|Overall Study|Physician Decision|0|||
129156754|NCT01803880|464871017|FG001|Overall Study|Physician Decision|0|||
129156755|NCT01803880|464871018|FG002|Overall Study|Physician Decision|1|||
129156756|NCT01803880|464871016|FG000|Overall Study|Unable to return for follow-up visits|0|||
129156757|NCT01803880|464871017|FG001|Overall Study|Unable to return for follow-up visits|1|||
128725760|NCT03144180|463292568|FG001|Overall Study|Scrub tech removed tube cap|1|||
128725761|NCT02346136|463292573|FG000|Overall Study|Withdrawal by Subject|7|||
128725762|NCT02346136|463292574|FG001|Overall Study|Withdrawal by Subject|5|||
128725763|NCT02346136|463292573|FG000|Overall Study|Death|1|||
128725764|NCT02346136|463292574|FG001|Overall Study|Death|0|||
128725765|NCT02346136|463292573|FG000|Overall Study|Study termination|14|||
128725766|NCT02346136|463292574|FG001|Overall Study|Study termination|18|||
128725767|NCT03742141|463292588|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
128725768|NCT00850395|463292589|FG000|Overall Study|Death|1|||
128725769|NCT00850395|463292589|FG000|Overall Study|Adverse Event|1|||
128725770|NCT00850395|463292589|FG000|Overall Study|Insufficient clinical response|3|||
128725771|NCT00850395|463292589|FG000|Overall Study|Other|5|||
128725772|NCT02376166|463292590|FG000|Overall Study|Adverse Event|1|||
128725773|NCT02376166|463292590|FG000|Overall Study|Discontinued metformin early|2|||
128725774|NCT04180020|463292591|FG000|Overall Study|missed visit|18|||
128725775|NCT04180020|463292592|FG001|Overall Study|missed visit|16|||
128725776|NCT04180020|463292591|FG000|Overall Study|Death|2|||
128725777|NCT04180020|463292592|FG001|Overall Study|Death|3|||
128725778|NCT04180020|463292591|FG000|Overall Study|Withdrawal by Subject|1|||
128725779|NCT04180020|463292592|FG001|Overall Study|Withdrawal by Subject|5|||
128725780|NCT04180020|463292591|FG000|Overall Study|incarcerated|1|||
128725781|NCT04180020|463292592|FG001|Overall Study|incarcerated|1|||
128725782|NCT04180020|463292591|FG000|Overall Study|Physician Decision|0|||
128725783|NCT04180020|463292592|FG001|Overall Study|Physician Decision|2|||
128725784|NCT00842348|463292596|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
128725785|NCT00842348|463292597|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
128725786|NCT00842348|463292596|FG000|Study 729|Disease progression/death|19|||
128725787|NCT00842348|463292597|FG001|Study 729|Disease progression/death|30|||
128725788|NCT00842348|463292596|FG000|Study 729|Adverse Event|1|||
128725789|NCT00842348|463292597|FG001|Study 729|Adverse Event|1|||
128725790|NCT00842348|463292596|FG000|Study 729|Protocol Violation|1|||
128725791|NCT00842348|463292597|FG001|Study 729|Protocol Violation|1|||
128725792|NCT00842348|463292596|FG000|Study 729|Withdrawal by Subject|2|||
128725793|NCT00842348|463292597|FG001|Study 729|Withdrawal by Subject|4|||
128725794|NCT00842348|463292596|FG000|Study 729|Due to Sponsor stopping the study|1|||
128725795|NCT00842348|463292597|FG001|Study 729|Due to Sponsor stopping the study|1|||
128725796|NCT00842348|463292596|FG000|Study 729|Due to non-availability of IP|0|||
128725797|NCT00842348|463292597|FG001|Study 729|Due to non-availability of IP|1|||
128725798|NCT00842348|463292596|FG000|Study 729|Sponsor's decision|1|||
128725799|NCT00842348|463292597|FG001|Study 729|Sponsor's decision|0|||
128725800|NCT00842348|463292596|FG000|Study 729|Surgical resection|1|||
128725801|NCT00842348|463292597|FG001|Study 729|Surgical resection|0|||
128725802|NCT01524627|463292602|FG000|Overall Study|Physician Decision|0|||
128725803|NCT01524627|463292603|FG001|Overall Study|Physician Decision|1|||
128725804|NCT01524627|463292602|FG000|Overall Study|Lost to Follow-up|1|||
128725805|NCT01524627|463292603|FG001|Overall Study|Lost to Follow-up|1|||
128725806|NCT03323658|463292604|FG000|Overall Study|Adverse Event|0|||
128725807|NCT03323658|463292605|FG001|Overall Study|Adverse Event|1|||
129156758|NCT01803880|464871018|FG002|Overall Study|Unable to return for follow-up visits|2|||
129156759|NCT01803880|464871016|FG000|Overall Study|Lost to Follow-up|1|||
129156760|NCT01803880|464871017|FG001|Overall Study|Lost to Follow-up|2|||
128725808|NCT03323658|463292606|FG002|Overall Study|Adverse Event|0|||
128725809|NCT00717769|463292607|FG000|Overall Study|Adverse Event|9|||
128725810|NCT00717769|463292608|FG001|Overall Study|Adverse Event|6|||
129156761|NCT01803880|464871018|FG002|Overall Study|Lost to Follow-up|3|||
129156762|NCT01803880|464871016|FG000|Overall Study|Protocol Violation|1|||
129156763|NCT01803880|464871017|FG001|Overall Study|Protocol Violation|0|||
129156764|NCT01803880|464871018|FG002|Overall Study|Protocol Violation|0|||
129156765|NCT01803880|464871016|FG000|Overall Study|Early study termination|0|||
129156766|NCT01803880|464871017|FG001|Overall Study|Early study termination|6|||
129156767|NCT01803880|464871018|FG002|Overall Study|Early study termination|5|||
129156768|NCT01803880|464871016|FG000|Overall Study|Incomplete data entry by sites|2|||
129156769|NCT01803880|464871017|FG001|Overall Study|Incomplete data entry by sites|0|||
129156770|NCT01803880|464871018|FG002|Overall Study|Incomplete data entry by sites|0|||
129156771|NCT05384834|464871019|FG000|Overall Study|Lost to Follow-up|43|||
129156772|NCT05384834|464871019|FG000|Overall Study|Withdrawal by Subject|5|||
129156773|NCT02954887|464871020|FG000|Overall Study|Withdrawal by Subject|3|||
129156774|NCT02954887|464871020|FG000|Overall Study|Lack of Efficacy|3|||
129156775|NCT02954887|464871020|FG000|Overall Study|Other|1|||
129156776|NCT01459666|464871022|FG000|Overall Study|PI left institution|5|||
129156777|NCT01459666|464871023|FG001|Overall Study|PI left institution|4|||
129156778|NCT01881789|464871025|FG000|Overall Study|Withdrawal by Subject|0|||
129156779|NCT01881789|464871026|FG001|Overall Study|Withdrawal by Subject|2|||
129156780|NCT01881789|464871027|FG002|Overall Study|Withdrawal by Subject|1|||
129156781|NCT01881789|464871028|FG003|Overall Study|Withdrawal by Subject|0|||
129156782|NCT01881789|464871029|FG004|Overall Study|Withdrawal by Subject|1|||
129156783|NCT01881789|464871030|FG005|Overall Study|Withdrawal by Subject|1|||
129156784|NCT01881789|464871025|FG000|Overall Study|Study Terminated by Sponsor|0|||
129156785|NCT01881789|464871026|FG001|Overall Study|Study Terminated by Sponsor|0|||
129156786|NCT01881789|464871027|FG002|Overall Study|Study Terminated by Sponsor|0|||
129156787|NCT01881789|464871028|FG003|Overall Study|Study Terminated by Sponsor|0|||
129156788|NCT01881789|464871029|FG004|Overall Study|Study Terminated by Sponsor|0|||
129156789|NCT01881789|464871030|FG005|Overall Study|Study Terminated by Sponsor|1|||
129156790|NCT01881789|464871025|FG000|Overall Study|Other|3|||
129156791|NCT01881789|464871026|FG001|Overall Study|Other|5|||
129156792|NCT01881789|464871027|FG002|Overall Study|Other|2|||
129156793|NCT01881789|464871028|FG003|Overall Study|Other|3|||
129156794|NCT01881789|464871029|FG004|Overall Study|Other|1|||
129156795|NCT01881789|464871030|FG005|Overall Study|Other|1|||
129156796|NCT01299389|464871035|FG000|Double-blind|Adverse Event|45|||
129156797|NCT01299389|464871036|FG001|Double-blind|Adverse Event|27|||
129156798|NCT01299389|464871037|FG002|Double-blind|Adverse Event|0|||
129156799|NCT01299389|464871038|FG003|Double-blind|Adverse Event|0|||
129156800|NCT01299389|464871035|FG000|Double-blind|Lack of Efficacy|45|||
129156801|NCT01299389|464871036|FG001|Double-blind|Lack of Efficacy|21|||
129156802|NCT01299389|464871037|FG002|Double-blind|Lack of Efficacy|0|||
129156803|NCT01299389|464871038|FG003|Double-blind|Lack of Efficacy|0|||
129156804|NCT01299389|464871035|FG000|Double-blind|Lost to Follow-up|2|||
129156805|NCT01299389|464871036|FG001|Double-blind|Lost to Follow-up|1|||
129156806|NCT01299389|464871037|FG002|Double-blind|Lost to Follow-up|0|||
129156807|NCT01299389|464871038|FG003|Double-blind|Lost to Follow-up|0|||
129156808|NCT01299389|464871035|FG000|Double-blind|Withdrawal by Subject|16|||
129156809|NCT01299389|464871036|FG001|Double-blind|Withdrawal by Subject|13|||
129156810|NCT01299389|464871037|FG002|Double-blind|Withdrawal by Subject|0|||
128725811|NCT00717769|463292609|FG002|Overall Study|Adverse Event|1|||
128725812|NCT00717769|463292607|FG000|Overall Study|Lack of compliance|0|||
129156811|NCT01299389|464871038|FG003|Double-blind|Withdrawal by Subject|0|||
129156812|NCT01299389|464871035|FG000|Double-blind|Other|1|||
129156813|NCT01299389|464871036|FG001|Double-blind|Other|1|||
129156814|NCT01299389|464871037|FG002|Double-blind|Other|0|||
129156815|NCT01299389|464871038|FG003|Double-blind|Other|0|||
129156816|NCT01299389|464871035|FG000|Double-blind|"fail to meet study population criteria"|0|||
129156817|NCT01299389|464871036|FG001|Double-blind|"fail to meet study population criteria"|1|||
129156818|NCT01299389|464871037|FG002|Double-blind|"fail to meet study population criteria"|0|||
129156819|NCT01299389|464871038|FG003|Double-blind|"fail to meet study population criteria"|0|||
129156820|NCT01299389|464871035|FG000|Post-observational|Other|0|||
128725813|NCT00717769|463292608|FG001|Overall Study|Lack of compliance|2|||
128725814|NCT00717769|463292609|FG002|Overall Study|Lack of compliance|0|||
129156821|NCT01299389|464871036|FG001|Post-observational|Other|0|||
129156822|NCT01299389|464871037|FG002|Post-observational|Other|12|||
129156823|NCT01299389|464871038|FG003|Post-observational|Other|6|||
129156824|NCT04245709|464871039|FG000|Overall Study|Adverse Event|13|||
129156825|NCT04245709|464871039|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
129156826|NCT02948582|464871040|FG000|Washout Period 1|Adverse Event|0|||
129156827|NCT02948582|464871041|FG001|Washout Period 1|Adverse Event|2|||
129156828|NCT02948582|464871042|FG002|Washout Period 1|Adverse Event|0|||
129156829|NCT02948582|464871043|FG003|Washout Period 1|Adverse Event|0|||
129156830|NCT02948582|464871044|FG004|Washout Period 1|Adverse Event|0|||
129156831|NCT02948582|464871045|FG005|Washout Period 1|Adverse Event|0|||
129156832|NCT02948582|464871040|FG000|Washout Period 1|Protocol Violation|0|||
129156833|NCT02948582|464871041|FG001|Washout Period 1|Protocol Violation|0|||
129156834|NCT02948582|464871042|FG002|Washout Period 1|Protocol Violation|0|||
129156835|NCT02948582|464871043|FG003|Washout Period 1|Protocol Violation|0|||
129156836|NCT02948582|464871044|FG004|Washout Period 1|Protocol Violation|0|||
129156837|NCT02948582|464871045|FG005|Washout Period 1|Protocol Violation|1|||
129156838|NCT02948582|464871040|FG000|Washout Period 2|Adverse Event|0|||
129156839|NCT02948582|464871041|FG001|Washout Period 2|Adverse Event|1|||
129156840|NCT02948582|464871042|FG002|Washout Period 2|Adverse Event|0|||
129156841|NCT02948582|464871043|FG003|Washout Period 2|Adverse Event|0|||
129156842|NCT02948582|464871044|FG004|Washout Period 2|Adverse Event|0|||
129156843|NCT02948582|464871045|FG005|Washout Period 2|Adverse Event|0|||
129156844|NCT02948582|464871040|FG000|Washout Period 2|personal reasons|0|||
129156845|NCT02948582|464871041|FG001|Washout Period 2|personal reasons|0|||
129156846|NCT02948582|464871042|FG002|Washout Period 2|personal reasons|0|||
129156847|NCT02948582|464871043|FG003|Washout Period 2|personal reasons|1|||
129156848|NCT02948582|464871044|FG004|Washout Period 2|personal reasons|0|||
129156849|NCT02948582|464871045|FG005|Washout Period 2|personal reasons|0|||
129156850|NCT02948582|464871040|FG000|Washout Period 4|Adverse Event|1|||
129156851|NCT02948582|464871041|FG001|Washout Period 4|Adverse Event|0|||
129156852|NCT02948582|464871042|FG002|Washout Period 4|Adverse Event|1|||
129156853|NCT02948582|464871043|FG003|Washout Period 4|Adverse Event|0|||
129156854|NCT02948582|464871044|FG004|Washout Period 4|Adverse Event|0|||
129156855|NCT02948582|464871045|FG005|Washout Period 4|Adverse Event|0|||
129156856|NCT01151020|464871046|FG000|Overall Study|Death|25|||
129156857|NCT01151020|464871046|FG000|Overall Study|Conversion to open repair|1|||
129156858|NCT01151020|464871046|FG000|Overall Study|Lost to Follow-up|4|||
129156859|NCT01151020|464871046|FG000|Overall Study|Withdrawal by Subject|22|||
129156860|NCT01151020|464871046|FG000|Overall Study|Patients did not receive the device|2|||
128725815|NCT00717769|463292607|FG000|Overall Study|Lost to Follow-up|3|||
128725816|NCT00717769|463292608|FG001|Overall Study|Lost to Follow-up|4|||
128725817|NCT00717769|463292609|FG002|Overall Study|Lost to Follow-up|0|||
128725818|NCT00717769|463292607|FG000|Overall Study|Lack of Efficacy|1|||
129156861|NCT02041299|464871047|FG000|Overall Study|Adverse Event|9|||
129156862|NCT02041299|464871048|FG001|Overall Study|Adverse Event|3|||
129156863|NCT02041299|464871047|FG000|Overall Study|Lost to Follow-up|4|||
129156864|NCT02041299|464871048|FG001|Overall Study|Lost to Follow-up|1|||
129156865|NCT02041299|464871047|FG000|Overall Study|Physician Decision|1|||
129156866|NCT02041299|464871048|FG001|Overall Study|Physician Decision|1|||
129156867|NCT02041299|464871047|FG000|Overall Study|Withdrawal by Subject|13|||
129156868|NCT02041299|464871048|FG001|Overall Study|Withdrawal by Subject|7|||
128725819|NCT00717769|463292608|FG001|Overall Study|Lack of Efficacy|2|||
128725820|NCT00717769|463292609|FG002|Overall Study|Lack of Efficacy|0|||
128725821|NCT00717769|463292607|FG000|Overall Study|Protocol Violation|0|||
128725822|NCT00717769|463292608|FG001|Overall Study|Protocol Violation|2|||
128725823|NCT00717769|463292609|FG002|Overall Study|Protocol Violation|0|||
128725824|NCT00717769|463292607|FG000|Overall Study|Sponsor decision|1|||
128725825|NCT00717769|463292608|FG001|Overall Study|Sponsor decision|0|||
129156869|NCT02041299|464871047|FG000|Overall Study|Protocol Violation|11|||
128725826|NCT00717769|463292609|FG002|Overall Study|Sponsor decision|10|||
128725827|NCT00717769|463292607|FG000|Overall Study|Withdrew consent|2|||
128725828|NCT00717769|463292608|FG001|Overall Study|Withdrew consent|2|||
128725829|NCT00717769|463292609|FG002|Overall Study|Withdrew consent|0|||
128725830|NCT02849548|463292615|FG000|Overall Study|Lost to Follow-up|1|||
128725831|NCT02849548|463292616|FG001|Overall Study|Lost to Follow-up|2|||
128725832|NCT02849548|463292615|FG000|Overall Study|Protocol Violation|1|||
128725833|NCT02849548|463292616|FG001|Overall Study|Protocol Violation|0|||
128776873|NCT01782326|463472024|FG000|Double-blind Treatment|Technical problems|0|||
129156870|NCT02041299|464871048|FG001|Overall Study|Protocol Violation|4|||
129156871|NCT02041299|464871047|FG000|Overall Study|Termination of the study|7|||
129156872|NCT02041299|464871048|FG001|Overall Study|Termination of the study|3|||
129156873|NCT02041299|464871047|FG000|Overall Study|Required bone marrow transplant|0|||
129156874|NCT02041299|464871048|FG001|Overall Study|Required bone marrow transplant|1|||
129156875|NCT02041299|464871047|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
129156876|NCT02041299|464871048|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
129156877|NCT01635998|464871049|FG000|Overall Study|Death|1|||
129156878|NCT01635998|464871050|FG001|Overall Study|Death|1|||
129156879|NCT01635998|464871049|FG000|Overall Study|Lost to Follow-up|2|||
129156880|NCT01635998|464871050|FG001|Overall Study|Lost to Follow-up|1|||
129156881|NCT01635998|464871049|FG000|Overall Study|Withdrawal by Subject|1|||
129156882|NCT01635998|464871050|FG001|Overall Study|Withdrawal by Subject|5|||
129156883|NCT01220401|464871055|FG000|Overall Study|Withdrawal by Subject|2|||
129156884|NCT01220401|464871055|FG000|Overall Study|Protocol Violation|1|||
129156885|NCT01162473|464871059|FG000|Overall Study|Adverse Event|2|||
129156886|NCT01162473|464871060|FG001|Overall Study|Adverse Event|1|||
129156887|NCT01162473|464871059|FG000|Overall Study|Withdrawal by Subject|0|||
129156888|NCT01162473|464871060|FG001|Overall Study|Withdrawal by Subject|4|||
129156889|NCT00943761|464871071|FG000|Overall Study|Lost to Follow-up|2|||
129156890|NCT00943761|464871072|FG001|Overall Study|Lost to Follow-up|0|||
129156891|NCT00943761|464871071|FG000|Overall Study|Withdrawal by Subject|2|||
129156892|NCT00943761|464871072|FG001|Overall Study|Withdrawal by Subject|1|||
129156893|NCT02268383|464871073|FG000|Overall Study|Death|12|||
129156894|NCT02268383|464871073|FG000|Overall Study|Lost to Follow-up|2|||
129156895|NCT02268383|464871073|FG000|Overall Study|Withdrawal by Subject|9|||
129156896|NCT02268383|464871073|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
129156897|NCT02268383|464871073|FG000|Overall Study|Protocol deviation|3|||
129156898|NCT02268383|464871073|FG000|Overall Study|Sponsor decision|22|||
129156899|NCT02268383|464871073|FG000|Overall Study|Not reported|12|||
129156900|NCT02708680|464871074|FG000|Overall Study|Withdrawal by Subject|4|||
129156901|NCT02708680|464871075|FG001|Overall Study|Withdrawal by Subject|12|||
129156902|NCT02708680|464871076|FG002|Overall Study|Withdrawal by Subject|12|||
129156903|NCT02708680|464871074|FG000|Overall Study|Death|4|||
129156904|NCT02708680|464871075|FG001|Overall Study|Death|19|||
129156905|NCT02708680|464871076|FG002|Overall Study|Death|21|||
129156906|NCT02708680|464871074|FG000|Overall Study|Lost to Follow-up|0|||
129156907|NCT02708680|464871075|FG001|Overall Study|Lost to Follow-up|3|||
129156908|NCT02708680|464871076|FG002|Overall Study|Lost to Follow-up|3|||
129156909|NCT02708680|464871074|FG000|Overall Study|Study Terminated By Sponsor|0|||
129156910|NCT02708680|464871075|FG001|Overall Study|Study Terminated By Sponsor|5|||
129156911|NCT02708680|464871076|FG002|Overall Study|Study Terminated By Sponsor|4|||
129156912|NCT02708680|464871074|FG000|Overall Study|Other than Specified|0|||
129156913|NCT02708680|464871075|FG001|Overall Study|Other than Specified|0|||
129156914|NCT02708680|464871076|FG002|Overall Study|Other than Specified|1|||
129156915|NCT02708680|464871074|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
129156916|NCT02708680|464871075|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
129156917|NCT02708680|464871076|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
129156918|NCT01342926|464871077|FG000|Overall Study|Adverse Event|5|||
129156919|NCT01342926|464871078|FG001|Overall Study|Adverse Event|8|||
129156920|NCT01342926|464871079|FG002|Overall Study|Adverse Event|10|||
129156921|NCT01342926|464871080|FG003|Overall Study|Adverse Event|7|||
128725834|NCT00256698|463292617|FG000|Overall Study|Withdrawal by Subject|7|||
128725835|NCT00256698|463292618|FG001|Overall Study|Withdrawal by Subject|7|||
128725836|NCT00256698|463292617|FG000|Overall Study|Adverse Event|13|||
128725837|NCT00256698|463292618|FG001|Overall Study|Adverse Event|6|||
128725838|NCT00256698|463292617|FG000|Overall Study|Protocol Violation|6|||
128725839|NCT00256698|463292618|FG001|Overall Study|Protocol Violation|5|||
129156922|NCT01342926|464871077|FG000|Overall Study|Lost to Follow-up|0|||
129156923|NCT01342926|464871078|FG001|Overall Study|Lost to Follow-up|1|||
129156924|NCT01342926|464871079|FG002|Overall Study|Lost to Follow-up|1|||
128725840|NCT00256698|463292617|FG000|Overall Study|Lost to Follow-up|1|||
128725841|NCT00256698|463292618|FG001|Overall Study|Lost to Follow-up|3|||
128725842|NCT00256698|463292617|FG000|Overall Study|disease progression|97|||
128725843|NCT00256698|463292618|FG001|Overall Study|disease progression|105|||
128725844|NCT00256698|463292617|FG000|Overall Study|still ongoing at data cut-off|41|||
128725845|NCT00256698|463292618|FG001|Overall Study|still ongoing at data cut-off|46|||
128725846|NCT00256698|463292617|FG000|Overall Study|withdrawn due to osteoporosis|1|||
129156925|NCT01342926|464871080|FG003|Overall Study|Lost to Follow-up|0|||
129156926|NCT01342926|464871077|FG000|Overall Study|Investigator Discretion|2|||
129156927|NCT01342926|464871078|FG001|Overall Study|Investigator Discretion|2|||
129156928|NCT01342926|464871079|FG002|Overall Study|Investigator Discretion|0|||
128725847|NCT00256698|463292618|FG001|Overall Study|withdrawn due to osteoporosis|0|||
129156929|NCT01342926|464871080|FG003|Overall Study|Investigator Discretion|0|||
129156930|NCT01342926|464871077|FG000|Overall Study|Withdrawal by Subject|2|||
129156931|NCT01342926|464871078|FG001|Overall Study|Withdrawal by Subject|4|||
129156932|NCT01342926|464871079|FG002|Overall Study|Withdrawal by Subject|3|||
129156933|NCT01342926|464871080|FG003|Overall Study|Withdrawal by Subject|5|||
129156934|NCT04162470|464871081|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
129156935|NCT01544348|464871088|FG000|Overall Study|Lost to Follow-up|1|||
129156936|NCT01544348|464871089|FG001|Overall Study|Lost to Follow-up|0|||
129156937|NCT01544348|464871090|FG002|Overall Study|Lost to Follow-up|0|||
129156938|NCT01544348|464871091|FG003|Overall Study|Lost to Follow-up|0|||
129156939|NCT01544348|464871092|FG004|Overall Study|Lost to Follow-up|0|||
129156940|NCT01544348|464871093|FG005|Overall Study|Lost to Follow-up|0|||
129156941|NCT01544348|464871094|FG006|Overall Study|Lost to Follow-up|1|||
129156942|NCT01544348|464871095|FG007|Overall Study|Lost to Follow-up|0|||
129156943|NCT01544348|464871088|FG000|Overall Study|Withdrawal by Subject|1|||
129156944|NCT01544348|464871089|FG001|Overall Study|Withdrawal by Subject|0|||
129156945|NCT01544348|464871090|FG002|Overall Study|Withdrawal by Subject|0|||
129156946|NCT01544348|464871091|FG003|Overall Study|Withdrawal by Subject|0|||
129156947|NCT01544348|464871092|FG004|Overall Study|Withdrawal by Subject|1|||
129156948|NCT01544348|464871093|FG005|Overall Study|Withdrawal by Subject|2|||
129156949|NCT01544348|464871094|FG006|Overall Study|Withdrawal by Subject|1|||
129156950|NCT01544348|464871095|FG007|Overall Study|Withdrawal by Subject|0|||
129156951|NCT01544348|464871088|FG000|Overall Study|Physician Decision|0|||
129156952|NCT01544348|464871089|FG001|Overall Study|Physician Decision|0|||
129156953|NCT01544348|464871090|FG002|Overall Study|Physician Decision|0|||
129156954|NCT01544348|464871091|FG003|Overall Study|Physician Decision|0|||
129156955|NCT01544348|464871092|FG004|Overall Study|Physician Decision|0|||
129156956|NCT01544348|464871093|FG005|Overall Study|Physician Decision|1|||
129156957|NCT01544348|464871094|FG006|Overall Study|Physician Decision|0|||
129156958|NCT01544348|464871095|FG007|Overall Study|Physician Decision|0|||
129156959|NCT01445847|464871096|FG000|Overall Study|Protocol Violation|13|||
129156960|NCT01445847|464871097|FG001|Overall Study|Protocol Violation|14|||
129156961|NCT01445847|464871096|FG000|Overall Study|Missed Data|1|||
129156962|NCT01445847|464871097|FG001|Overall Study|Missed Data|0|||
129156963|NCT03008070|464871100|FG000|Overall Study|Adverse Event|3|||
129156964|NCT03008070|464871101|FG001|Overall Study|Adverse Event|3|||
129156965|NCT03008070|464871102|FG002|Overall Study|Adverse Event|3|||
129156966|NCT03008070|464871100|FG000|Overall Study|Lost to Follow-up|1|||
129156967|NCT03008070|464871101|FG001|Overall Study|Lost to Follow-up|1|||
129156968|NCT03008070|464871102|FG002|Overall Study|Lost to Follow-up|0|||
129156969|NCT03008070|464871100|FG000|Overall Study|Non compliance|0|||
129156970|NCT03008070|464871101|FG001|Overall Study|Non compliance|1|||
129156971|NCT03008070|464871102|FG002|Overall Study|Non compliance|1|||
129156972|NCT03008070|464871100|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
129156973|NCT03008070|464871101|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
129156974|NCT03008070|464871102|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
129156975|NCT03008070|464871100|FG000|Overall Study|Withdrawal by Subject|2|||
129156976|NCT03008070|464871101|FG001|Overall Study|Withdrawal by Subject|0|||
129156977|NCT03008070|464871102|FG002|Overall Study|Withdrawal by Subject|1|||
129156978|NCT03008070|464871100|FG000|Overall Study|Use of prohibited drug|0|||
129156979|NCT03008070|464871101|FG001|Overall Study|Use of prohibited drug|0|||
128725848|NCT00256698|463292617|FG000|Overall Study|Prematurely Discontinued|1|||
129156980|NCT03008070|464871102|FG002|Overall Study|Use of prohibited drug|2|||
129156981|NCT04409834|464871105|FG000|Overall Study|Death|55|||
129156982|NCT04409834|464871106|FG001|Overall Study|Death|62|||
129156983|NCT01365455|464871107|FG000|Induction Period|Adverse Event|5|||
129156984|NCT01365455|464871108|FG001|Induction Period|Adverse Event|3|||
129156985|NCT01365455|464871109|FG002|Induction Period|Adverse Event|4|||
129156986|NCT01365455|464871110|FG003|Induction Period|Adverse Event|0|||
129156987|NCT01365455|464871111|FG004|Induction Period|Adverse Event|0|||
129156988|NCT01365455|464871107|FG000|Induction Period|Lack of Efficacy|1|||
129156989|NCT01365455|464871108|FG001|Induction Period|Lack of Efficacy|1|||
129156990|NCT01365455|464871109|FG002|Induction Period|Lack of Efficacy|0|||
129156991|NCT01365455|464871110|FG003|Induction Period|Lack of Efficacy|0|||
128725849|NCT00256698|463292618|FG001|Overall Study|Prematurely Discontinued|0|||
128725850|NCT02917031|463292620|FG000|Overall Study|Reason not specified|7|||
129156992|NCT01365455|464871111|FG004|Induction Period|Lack of Efficacy|0|||
129156993|NCT01365455|464871107|FG000|Induction Period|Pregnancy|0|||
129156994|NCT01365455|464871108|FG001|Induction Period|Pregnancy|1|||
129156995|NCT01365455|464871109|FG002|Induction Period|Pregnancy|0|||
129156996|NCT01365455|464871110|FG003|Induction Period|Pregnancy|0|||
129156997|NCT01365455|464871111|FG004|Induction Period|Pregnancy|0|||
129156998|NCT01365455|464871107|FG000|Induction Period|Protocol deviation|0|||
129156999|NCT01365455|464871108|FG001|Induction Period|Protocol deviation|1|||
129157000|NCT01365455|464871109|FG002|Induction Period|Protocol deviation|1|||
129157001|NCT01365455|464871110|FG003|Induction Period|Protocol deviation|0|||
129157002|NCT01365455|464871111|FG004|Induction Period|Protocol deviation|0|||
129157003|NCT01365455|464871107|FG000|Induction Period|Subject/guardian decision|9|||
129157004|NCT01365455|464871108|FG001|Induction Period|Subject/guardian decision|1|||
129157005|NCT01365455|464871109|FG002|Induction Period|Subject/guardian decision|8|||
129157006|NCT01365455|464871110|FG003|Induction Period|Subject/guardian decision|0|||
129157007|NCT01365455|464871111|FG004|Induction Period|Subject/guardian decision|0|||
129157008|NCT01365455|464871107|FG000|Induction Period|Lost to Follow-up|0|||
129157009|NCT01365455|464871108|FG001|Induction Period|Lost to Follow-up|0|||
129157010|NCT01365455|464871109|FG002|Induction Period|Lost to Follow-up|3|||
129157011|NCT01365455|464871110|FG003|Induction Period|Lost to Follow-up|0|||
129157012|NCT01365455|464871111|FG004|Induction Period|Lost to Follow-up|0|||
129157013|NCT01365455|464871107|FG000|Maintenance Period|Adverse Event|12|||
129157014|NCT01365455|464871108|FG001|Maintenance Period|Adverse Event|5|||
129157015|NCT01365455|464871109|FG002|Maintenance Period|Adverse Event|1|||
129157016|NCT01365455|464871110|FG003|Maintenance Period|Adverse Event|2|||
129157017|NCT01365455|464871111|FG004|Maintenance Period|Adverse Event|4|||
129157018|NCT01365455|464871107|FG000|Maintenance Period|Lack of Efficacy|10|||
129157019|NCT01365455|464871108|FG001|Maintenance Period|Lack of Efficacy|2|||
129157020|NCT01365455|464871109|FG002|Maintenance Period|Lack of Efficacy|0|||
129157021|NCT01365455|464871110|FG003|Maintenance Period|Lack of Efficacy|2|||
129157022|NCT01365455|464871111|FG004|Maintenance Period|Lack of Efficacy|2|||
129157023|NCT01365455|464871107|FG000|Maintenance Period|Lost to Follow-up|2|||
129157024|NCT01365455|464871108|FG001|Maintenance Period|Lost to Follow-up|4|||
129157025|NCT01365455|464871109|FG002|Maintenance Period|Lost to Follow-up|0|||
129157026|NCT01365455|464871110|FG003|Maintenance Period|Lost to Follow-up|0|||
129157027|NCT01365455|464871111|FG004|Maintenance Period|Lost to Follow-up|3|||
129157028|NCT01365455|464871107|FG000|Maintenance Period|Non-compliance with study treatment|0|||
129157029|NCT01365455|464871108|FG001|Maintenance Period|Non-compliance with study treatment|0|||
129157030|NCT01365455|464871109|FG002|Maintenance Period|Non-compliance with study treatment|0|||
129157031|NCT01365455|464871110|FG003|Maintenance Period|Non-compliance with study treatment|1|||
129157032|NCT01365455|464871111|FG004|Maintenance Period|Non-compliance with study treatment|0|||
129157033|NCT01365455|464871107|FG000|Maintenance Period|Physician Decision|0|||
129157034|NCT01365455|464871108|FG001|Maintenance Period|Physician Decision|1|||
129157035|NCT01365455|464871109|FG002|Maintenance Period|Physician Decision|0|||
129157036|NCT01365455|464871110|FG003|Maintenance Period|Physician Decision|0|||
129157037|NCT01365455|464871111|FG004|Maintenance Period|Physician Decision|1|||
129157038|NCT01365455|464871107|FG000|Maintenance Period|Pregnancy|0|||
129157039|NCT01365455|464871108|FG001|Maintenance Period|Pregnancy|4|||
129157040|NCT01365455|464871109|FG002|Maintenance Period|Pregnancy|0|||
129157041|NCT01365455|464871110|FG003|Maintenance Period|Pregnancy|0|||
129157042|NCT01365455|464871111|FG004|Maintenance Period|Pregnancy|2|||
129157043|NCT01365455|464871107|FG000|Maintenance Period|Protocol deviation|1|||
129157044|NCT01365455|464871108|FG001|Maintenance Period|Protocol deviation|1|||
129157045|NCT01365455|464871109|FG002|Maintenance Period|Protocol deviation|0|||
129157046|NCT01365455|464871110|FG003|Maintenance Period|Protocol deviation|0|||
129157047|NCT01365455|464871111|FG004|Maintenance Period|Protocol deviation|0|||
129157048|NCT01365455|464871107|FG000|Maintenance Period|Subject/guardian decision|4|||
129157049|NCT01365455|464871108|FG001|Maintenance Period|Subject/guardian decision|6|||
129157050|NCT01365455|464871109|FG002|Maintenance Period|Subject/guardian decision|2|||
129157051|NCT01365455|464871110|FG003|Maintenance Period|Subject/guardian decision|4|||
129157052|NCT01365455|464871111|FG004|Maintenance Period|Subject/guardian decision|1|||
129157053|NCT00928187|464871112|FG000|Overall Study|Death|1|||
129157054|NCT00928187|464871113|FG001|Overall Study|Death|2|||
129157055|NCT00928187|464871114|FG002|Overall Study|Death|3|||
129157056|NCT00928187|464871112|FG000|Overall Study|Lost to Follow-up|1|||
129157057|NCT00928187|464871113|FG001|Overall Study|Lost to Follow-up|2|||
129157058|NCT00928187|464871114|FG002|Overall Study|Lost to Follow-up|1|||
129157059|NCT00928187|464871112|FG000|Overall Study|Withdrawal by Subject|0|||
129157060|NCT00928187|464871113|FG001|Overall Study|Withdrawal by Subject|1|||
129157061|NCT00928187|464871114|FG002|Overall Study|Withdrawal by Subject|1|||
129157062|NCT00928187|464871112|FG000|Overall Study|Protocol Violation|0|||
129157063|NCT00928187|464871113|FG001|Overall Study|Protocol Violation|1|||
129157064|NCT00928187|464871114|FG002|Overall Study|Protocol Violation|0|||
129157065|NCT04790279|464872440|FG000|Overall Study|Did not meet medication start criteria|27|||
129157066|NCT04790279|464872441|FG001|Overall Study|Did not meet medication start criteria|15|||
129157067|NCT04790279|464872440|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
129157068|NCT04790279|464872441|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
129157069|NCT04790279|464872440|FG000|Overall Study|Protocol Violation|8|||
129157070|NCT04790279|464872441|FG001|Overall Study|Protocol Violation|3|||
129157071|NCT04790279|464872440|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
129157072|NCT04790279|464872441|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
129157073|NCT00810277|464872454|FG000|Overall Study|Adverse Event|1|||
129157074|NCT00678288|464872461|FG000|Overall Study|Adverse Event|0|||
129157075|NCT00678288|464872462|FG001|Overall Study|Adverse Event|2|||
129157076|NCT00678288|464872461|FG000|Overall Study|Withdrawal by Subject|1|||
129157077|NCT00678288|464872462|FG001|Overall Study|Withdrawal by Subject|1|||
129157078|NCT00678288|464872461|FG000|Overall Study|Study terminated by the sponsor|2|||
129157079|NCT00678288|464872462|FG001|Overall Study|Study terminated by the sponsor|0|||
129157080|NCT00678288|464872461|FG000|Overall Study|Not compliant with study medication|0|||
129157081|NCT00678288|464872462|FG001|Overall Study|Not compliant with study medication|1|||
129157082|NCT00678288|464872461|FG000|Overall Study|Switch to commercial drug|0|||
129157083|NCT00678288|464872462|FG001|Overall Study|Switch to commercial drug|1|||
129157084|NCT00678288|464872461|FG000|Overall Study|Reason not reported|1|||
129157085|NCT00678288|464872462|FG001|Overall Study|Reason not reported|0|||
129157086|NCT00678288|464872461|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
129157087|NCT00678288|464872462|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
129157088|NCT02549989|464872463|FG000|Overall Study|Adverse Event|4|||
129157089|NCT02549989|464872463|FG000|Overall Study|Death|1|||
129157090|NCT02549989|464872463|FG000|Overall Study|Lack of Efficacy|19|||
129157091|NCT02549989|464872463|FG000|Overall Study|Withdrawal by Subject|3|||
129157092|NCT00972023|464872464|FG000|Overall Study|Withdrawal by Subject|1|||
129157093|NCT02628444|464872465|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
129157094|NCT02628444|464872466|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157095|NCT02628444|464872467|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157096|NCT02628444|464872468|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157097|NCT02628444|464872469|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157098|NCT02628444|464872470|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157099|NCT02628444|464872471|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157100|NCT02628444|464872472|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157101|NCT02628444|464872473|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129157102|NCT02628444|464872465|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129157103|NCT02628444|464872466|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
129157104|NCT02628444|464872467|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
129157105|NCT02628444|464872468|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129157106|NCT02628444|464872469|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129157107|NCT02628444|464872470|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129157108|NCT02628444|464872471|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129157109|NCT02628444|464872472|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129157110|NCT02628444|464872473|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129157111|NCT02628444|464872465|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
129157112|NCT02628444|464872466|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
129157113|NCT02628444|464872467|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
129157114|NCT02628444|464872468|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157115|NCT02628444|464872469|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157116|NCT02628444|464872470|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157117|NCT02628444|464872471|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157118|NCT02628444|464872472|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157119|NCT02628444|464872473|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157120|NCT02628444|464872465|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
129157121|NCT02628444|464872466|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
129157122|NCT02628444|464872467|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
128725851|NCT02917031|463292621|FG001|Overall Study|Reason not specified|5|||
128725852|NCT02917031|463292622|FG002|Overall Study|Reason not specified|6|||
129157123|NCT02628444|464872468|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129157124|NCT02628444|464872469|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129157125|NCT02628444|464872470|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129157126|NCT02628444|464872471|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129157127|NCT02628444|464872472|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129157128|NCT02628444|464872473|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129157129|NCT02628444|464872465|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
129157130|NCT02628444|464872466|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
129157131|NCT02628444|464872467|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
129157132|NCT02628444|464872468|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129157133|NCT02628444|464872469|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129157134|NCT02628444|464872470|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129157135|NCT02628444|464872471|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129157136|NCT02628444|464872472|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129157137|NCT02628444|464872473|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129157138|NCT02628444|464872465|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157139|NCT02628444|464872466|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157140|NCT02628444|464872467|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157141|NCT02628444|464872468|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
129157142|NCT02628444|464872469|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157143|NCT02628444|464872470|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157144|NCT02628444|464872471|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157145|NCT02628444|464872472|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157146|NCT02628444|464872473|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129157147|NCT02628444|464872465|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
129157148|NCT02628444|464872466|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
129157149|NCT02628444|464872467|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
129157150|NCT02628444|464872468|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
129157151|NCT02628444|464872469|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
129157152|NCT02628444|464872470|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
129157153|NCT02628444|464872471|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
129157154|NCT02628444|464872472|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
129157155|NCT02628444|464872473|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
129157156|NCT02628444|464872465|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157157|NCT02628444|464872466|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157158|NCT02628444|464872467|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
129157159|NCT02628444|464872468|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
129157160|NCT02628444|464872469|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
129157161|NCT02628444|464872470|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
129157162|NCT02628444|464872471|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
129157163|NCT02628444|464872472|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
129157164|NCT02628444|464872473|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
129157165|NCT02628444|464872465|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129157166|NCT02628444|464872466|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129157167|NCT02628444|464872467|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129157168|NCT02628444|464872468|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129157169|NCT02628444|464872469|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
129157170|NCT02628444|464872470|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129157171|NCT02628444|464872471|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129157172|NCT02628444|464872472|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
129157173|NCT02628444|464872473|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
129157174|NCT02628444|464872465|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
129157175|NCT02628444|464872466|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
129157176|NCT02628444|464872467|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
129157177|NCT02628444|464872468|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
129157178|NCT02628444|464872469|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
129157179|NCT02628444|464872470|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
129157180|NCT02628444|464872471|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
129157181|NCT02628444|464872472|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
129157182|NCT02628444|464872473|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
129157183|NCT00532129|464872474|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
129157184|NCT00532129|464872474|FG000|Treatment Period|Physician Decision|15|||
129157185|NCT00532129|464872474|FG000|Treatment Period|Disease progression|3|||
129157186|NCT00532129|464872474|FG000|Treatment Period|Protocol Violation|1|||
129157187|NCT00532129|464872474|FG000|Treatment Period|Other|5|||
129157188|NCT00532129|464872474|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
129157189|NCT00532129|464872474|FG000|Follow-up Period|Disease progression|57|||
129157190|NCT00532129|464872474|FG000|Follow-up Period|Lost to Follow-up|1|||
129157191|NCT00532129|464872474|FG000|Follow-up Period|Other|6|||
129157192|NCT00784368|464872477|FG000|Overall Study|Physician Decision|0|||
129157193|NCT00784368|464872478|FG001|Overall Study|Physician Decision|0|||
129157194|NCT00784368|464872479|FG002|Overall Study|Physician Decision|6|||
129157195|NCT00784368|464872477|FG000|Overall Study|Lack of Efficacy|2|||
129157196|NCT00784368|464872478|FG001|Overall Study|Lack of Efficacy|0|||
129157197|NCT00784368|464872479|FG002|Overall Study|Lack of Efficacy|1|||
129157198|NCT00784368|464872477|FG000|Overall Study|Adverse Event|6|||
129157199|NCT00784368|464872478|FG001|Overall Study|Adverse Event|9|||
129157200|NCT00784368|464872479|FG002|Overall Study|Adverse Event|2|||
129157201|NCT00784368|464872477|FG000|Overall Study|Diagnosis of fever|0|||
129157202|NCT00784368|464872478|FG001|Overall Study|Diagnosis of fever|0|||
129157203|NCT00784368|464872479|FG002|Overall Study|Diagnosis of fever|1|||
129157204|NCT00784368|464872477|FG000|Overall Study|Worsening of complications|0|||
129157205|NCT00784368|464872478|FG001|Overall Study|Worsening of complications|0|||
129157206|NCT00784368|464872479|FG002|Overall Study|Worsening of complications|1|||
129157207|NCT00784368|464872477|FG000|Overall Study|Worsening of symptoms|0|||
129157208|NCT00784368|464872478|FG001|Overall Study|Worsening of symptoms|1|||
129157209|NCT00784368|464872479|FG002|Overall Study|Worsening of symptoms|0|||
129157210|NCT00784368|464872477|FG000|Overall Study|Withdrawal of informed consent|0|||
129157211|NCT00784368|464872478|FG001|Overall Study|Withdrawal of informed consent|1|||
129157212|NCT00784368|464872479|FG002|Overall Study|Withdrawal of informed consent|0|||
129157213|NCT02079909|464872480|FG000|Overall Study|Adverse Event|23|||
129157214|NCT02079909|464872481|FG001|Overall Study|Adverse Event|23|||
129157215|NCT02079909|464872482|FG002|Overall Study|Adverse Event|7|||
129157216|NCT02079909|464872480|FG000|Overall Study|Withdrawal by Subject|9|||
129157217|NCT02079909|464872481|FG001|Overall Study|Withdrawal by Subject|17|||
129157218|NCT02079909|464872482|FG002|Overall Study|Withdrawal by Subject|4|||
129157219|NCT02079909|464872480|FG000|Overall Study|Lost to Follow-up|2|||
129157220|NCT02079909|464872481|FG001|Overall Study|Lost to Follow-up|3|||
129157221|NCT02079909|464872482|FG002|Overall Study|Lost to Follow-up|1|||
129157222|NCT02079909|464872480|FG000|Overall Study|Death|2|||
129157223|NCT02079909|464872481|FG001|Overall Study|Death|2|||
129157224|NCT02079909|464872482|FG002|Overall Study|Death|0|||
129157225|NCT02079909|464872480|FG000|Overall Study|Lack of Efficacy|0|||
129157226|NCT02079909|464872481|FG001|Overall Study|Lack of Efficacy|0|||
129157227|NCT02079909|464872482|FG002|Overall Study|Lack of Efficacy|1|||
129157228|NCT02079909|464872480|FG000|Overall Study|Protocol Violation|0|||
129157229|NCT02079909|464872481|FG001|Overall Study|Protocol Violation|1|||
129157230|NCT02079909|464872482|FG002|Overall Study|Protocol Violation|1|||
129157231|NCT02079909|464872480|FG000|Overall Study|Physician Decision|0|||
129157232|NCT02079909|464872481|FG001|Overall Study|Physician Decision|1|||
129157233|NCT02079909|464872482|FG002|Overall Study|Physician Decision|1|||
129157234|NCT02079909|464872480|FG000|Overall Study|Relocation etc.|2|||
129157235|NCT02079909|464872481|FG001|Overall Study|Relocation etc.|2|||
129157236|NCT02079909|464872482|FG002|Overall Study|Relocation etc.|3|||
129157237|NCT00720356|464872487|FG000|Registration to Study|Determined to have methylated MGMT|67|||
129157238|NCT00720356|464872487|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
129157239|NCT00720356|464872487|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
129157240|NCT00720356|464872487|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
129157241|NCT00720356|464872487|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
129157242|NCT00720356|464872487|FG000|Follow up Until Death|Withdrawal by Subject|1|||
129157243|NCT00720356|464872487|FG000|Follow up Until Death|Alive at last data collection|4|||
129157244|NCT02237001|464872490|FG000|Overall Study|Lost to Follow-up|2|||
129157245|NCT02237001|464872490|FG000|Overall Study|Withdrawal by Subject|1|||
129157246|NCT02237001|464872490|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
129157247|NCT02237001|464872490|FG000|Overall Study|Re-operation|4|||
129157248|NCT02237001|464872490|FG000|Overall Study|Incarceration|1|||
129157249|NCT01713582|464872491|FG000|Overall Study|Disease progression|3|||
129157250|NCT01713582|464872492|FG001|Overall Study|Disease progression|3|||
129157251|NCT01713582|464872493|FG002|Overall Study|Disease progression|3|||
129157252|NCT01713582|464872494|FG003|Overall Study|Disease progression|2|||
129157253|NCT01713582|464872495|FG004|Overall Study|Disease progression|3|||
129157254|NCT01713582|464872496|FG005|Overall Study|Disease progression|3|||
129157255|NCT01713582|464872497|FG006|Overall Study|Disease progression|3|||
129157256|NCT01713582|464872498|FG007|Overall Study|Disease progression|3|||
129157257|NCT01713582|464872499|FG008|Overall Study|Disease progression|3|||
129157258|NCT01713582|464872500|FG009|Overall Study|Disease progression|11|||
129157259|NCT01713582|464872501|FG010|Overall Study|Disease progression|10|||
129157260|NCT01713582|464872502|FG011|Overall Study|Disease progression|5|||
129157261|NCT01713582|464872503|FG012|Overall Study|Disease progression|3|||
129157262|NCT01713582|464872504|FG013|Overall Study|Disease progression|3|||
129157263|NCT01713582|464872505|FG014|Overall Study|Disease progression|6|||
129157264|NCT01713582|464872506|FG015|Overall Study|Disease progression|6|||
129157265|NCT01713582|464872507|FG016|Overall Study|Disease progression|5|||
129157266|NCT01713582|464872508|FG017|Overall Study|Disease progression|2|||
129157267|NCT01713582|464872509|FG018|Overall Study|Disease progression|3|||
129157268|NCT01713582|464872510|FG019|Overall Study|Disease progression|5|||
129157269|NCT01713582|464872511|FG020|Overall Study|Disease progression|15|||
129157270|NCT01713582|464872491|FG000|Overall Study|Death|0|||
129157271|NCT01713582|464872492|FG001|Overall Study|Death|0|||
129157272|NCT01713582|464872493|FG002|Overall Study|Death|0|||
129157273|NCT01713582|464872494|FG003|Overall Study|Death|1|||
129157274|NCT01713582|464872495|FG004|Overall Study|Death|1|||
129157275|NCT01713582|464872496|FG005|Overall Study|Death|3|||
129157276|NCT01713582|464872497|FG006|Overall Study|Death|3|||
129157277|NCT01713582|464872498|FG007|Overall Study|Death|2|||
129157278|NCT01713582|464872499|FG008|Overall Study|Death|3|||
129157279|NCT01713582|464872500|FG009|Overall Study|Death|4|||
129157280|NCT01713582|464872501|FG010|Overall Study|Death|3|||
129157281|NCT01713582|464872502|FG011|Overall Study|Death|0|||
129157282|NCT01713582|464872503|FG012|Overall Study|Death|0|||
129157283|NCT01713582|464872504|FG013|Overall Study|Death|0|||
129157284|NCT01713582|464872505|FG014|Overall Study|Death|0|||
129157285|NCT01713582|464872506|FG015|Overall Study|Death|0|||
129157286|NCT01713582|464872507|FG016|Overall Study|Death|0|||
129157287|NCT01713582|464872508|FG017|Overall Study|Death|0|||
129157288|NCT01713582|464872509|FG018|Overall Study|Death|0|||
129157289|NCT01713582|464872510|FG019|Overall Study|Death|0|||
129157290|NCT01713582|464872511|FG020|Overall Study|Death|0|||
129157291|NCT01713582|464872491|FG000|Overall Study|Adverse event-related|0|||
129157292|NCT01713582|464872492|FG001|Overall Study|Adverse event-related|0|||
129157293|NCT01713582|464872493|FG002|Overall Study|Adverse event-related|0|||
129157294|NCT01713582|464872494|FG003|Overall Study|Adverse event-related|0|||
129157295|NCT01713582|464872495|FG004|Overall Study|Adverse event-related|0|||
129157296|NCT01713582|464872496|FG005|Overall Study|Adverse event-related|0|||
129157297|NCT01713582|464872497|FG006|Overall Study|Adverse event-related|0|||
129157298|NCT01713582|464872498|FG007|Overall Study|Adverse event-related|0|||
129157299|NCT01713582|464872499|FG008|Overall Study|Adverse event-related|0|||
129157300|NCT01713582|464872500|FG009|Overall Study|Adverse event-related|1|||
129157301|NCT01713582|464872501|FG010|Overall Study|Adverse event-related|1|||
129157302|NCT01713582|464872502|FG011|Overall Study|Adverse event-related|0|||
129157303|NCT01713582|464872503|FG012|Overall Study|Adverse event-related|0|||
129157304|NCT01713582|464872504|FG013|Overall Study|Adverse event-related|0|||
129157305|NCT01713582|464872505|FG014|Overall Study|Adverse event-related|0|||
129157306|NCT01713582|464872506|FG015|Overall Study|Adverse event-related|0|||
129157307|NCT01713582|464872507|FG016|Overall Study|Adverse event-related|0|||
129157308|NCT01713582|464872508|FG017|Overall Study|Adverse event-related|0|||
129157309|NCT01713582|464872509|FG018|Overall Study|Adverse event-related|1|||
129157310|NCT01713582|464872510|FG019|Overall Study|Adverse event-related|0|||
129157311|NCT01713582|464872511|FG020|Overall Study|Adverse event-related|0|||
129157312|NCT01713582|464872491|FG000|Overall Study|Adverse event-unrelated|0|||
129157313|NCT01713582|464872492|FG001|Overall Study|Adverse event-unrelated|0|||
129157314|NCT01713582|464872493|FG002|Overall Study|Adverse event-unrelated|0|||
129157315|NCT01713582|464872494|FG003|Overall Study|Adverse event-unrelated|0|||
129157316|NCT01713582|464872495|FG004|Overall Study|Adverse event-unrelated|0|||
129157317|NCT01713582|464872496|FG005|Overall Study|Adverse event-unrelated|1|||
129157318|NCT01713582|464872497|FG006|Overall Study|Adverse event-unrelated|1|||
129157319|NCT01713582|464872498|FG007|Overall Study|Adverse event-unrelated|1|||
129157320|NCT01713582|464872499|FG008|Overall Study|Adverse event-unrelated|0|||
129157321|NCT01713582|464872500|FG009|Overall Study|Adverse event-unrelated|0|||
129157322|NCT01713582|464872501|FG010|Overall Study|Adverse event-unrelated|0|||
129157323|NCT01713582|464872502|FG011|Overall Study|Adverse event-unrelated|0|||
129157324|NCT01713582|464872503|FG012|Overall Study|Adverse event-unrelated|0|||
129157325|NCT01713582|464872504|FG013|Overall Study|Adverse event-unrelated|1|||
129157326|NCT01713582|464872505|FG014|Overall Study|Adverse event-unrelated|1|||
129157327|NCT01713582|464872506|FG015|Overall Study|Adverse event-unrelated|0|||
129157328|NCT01713582|464872507|FG016|Overall Study|Adverse event-unrelated|0|||
129157329|NCT01713582|464872508|FG017|Overall Study|Adverse event-unrelated|0|||
129157330|NCT01713582|464872509|FG018|Overall Study|Adverse event-unrelated|0|||
129157331|NCT01713582|464872510|FG019|Overall Study|Adverse event-unrelated|0|||
129157332|NCT01713582|464872511|FG020|Overall Study|Adverse event-unrelated|0|||
129157333|NCT01713582|464872491|FG000|Overall Study|Withdrawal of consent|0|||
129157334|NCT01713582|464872492|FG001|Overall Study|Withdrawal of consent|0|||
129157335|NCT01713582|464872493|FG002|Overall Study|Withdrawal of consent|1|||
129157336|NCT01713582|464872494|FG003|Overall Study|Withdrawal of consent|0|||
129157337|NCT01713582|464872495|FG004|Overall Study|Withdrawal of consent|0|||
129157338|NCT01713582|464872496|FG005|Overall Study|Withdrawal of consent|1|||
129157339|NCT01713582|464872497|FG006|Overall Study|Withdrawal of consent|0|||
129157340|NCT01713582|464872498|FG007|Overall Study|Withdrawal of consent|0|||
129157341|NCT01713582|464872499|FG008|Overall Study|Withdrawal of consent|0|||
129157342|NCT01713582|464872500|FG009|Overall Study|Withdrawal of consent|1|||
129157343|NCT01713582|464872501|FG010|Overall Study|Withdrawal of consent|0|||
129157344|NCT01713582|464872502|FG011|Overall Study|Withdrawal of consent|0|||
129157345|NCT01713582|464872503|FG012|Overall Study|Withdrawal of consent|0|||
129157346|NCT01713582|464872504|FG013|Overall Study|Withdrawal of consent|0|||
129157347|NCT01713582|464872505|FG014|Overall Study|Withdrawal of consent|0|||
129157348|NCT01713582|464872506|FG015|Overall Study|Withdrawal of consent|0|||
129157349|NCT01713582|464872507|FG016|Overall Study|Withdrawal of consent|0|||
129157350|NCT01713582|464872508|FG017|Overall Study|Withdrawal of consent|0|||
129157351|NCT01713582|464872509|FG018|Overall Study|Withdrawal of consent|1|||
129157352|NCT01713582|464872510|FG019|Overall Study|Withdrawal of consent|0|||
129157353|NCT01713582|464872511|FG020|Overall Study|Withdrawal of consent|0|||
129157354|NCT01713582|464872491|FG000|Overall Study|Lack of Efficacy|0|||
129157355|NCT01713582|464872492|FG001|Overall Study|Lack of Efficacy|0|||
129157356|NCT01713582|464872493|FG002|Overall Study|Lack of Efficacy|0|||
129157357|NCT01713582|464872494|FG003|Overall Study|Lack of Efficacy|0|||
129157358|NCT01713582|464872495|FG004|Overall Study|Lack of Efficacy|0|||
129157359|NCT01713582|464872496|FG005|Overall Study|Lack of Efficacy|0|||
129157360|NCT01713582|464872497|FG006|Overall Study|Lack of Efficacy|0|||
129157361|NCT01713582|464872498|FG007|Overall Study|Lack of Efficacy|0|||
129157362|NCT01713582|464872499|FG008|Overall Study|Lack of Efficacy|0|||
129157363|NCT01713582|464872500|FG009|Overall Study|Lack of Efficacy|1|||
129157364|NCT01713582|464872501|FG010|Overall Study|Lack of Efficacy|2|||
129157365|NCT01713582|464872502|FG011|Overall Study|Lack of Efficacy|0|||
129157366|NCT01713582|464872503|FG012|Overall Study|Lack of Efficacy|0|||
129157367|NCT01713582|464872504|FG013|Overall Study|Lack of Efficacy|0|||
129157368|NCT01713582|464872505|FG014|Overall Study|Lack of Efficacy|0|||
129157369|NCT01713582|464872506|FG015|Overall Study|Lack of Efficacy|0|||
129157370|NCT01713582|464872507|FG016|Overall Study|Lack of Efficacy|0|||
129157371|NCT01713582|464872508|FG017|Overall Study|Lack of Efficacy|0|||
129157372|NCT01713582|464872509|FG018|Overall Study|Lack of Efficacy|0|||
129157373|NCT01713582|464872510|FG019|Overall Study|Lack of Efficacy|0|||
129157374|NCT01713582|464872511|FG020|Overall Study|Lack of Efficacy|0|||
129157375|NCT01713582|464872491|FG000|Overall Study|Withdrawal by Subject|0|||
129157376|NCT01713582|464872492|FG001|Overall Study|Withdrawal by Subject|0|||
129157377|NCT01713582|464872493|FG002|Overall Study|Withdrawal by Subject|0|||
129157378|NCT01713582|464872494|FG003|Overall Study|Withdrawal by Subject|0|||
129157379|NCT01713582|464872495|FG004|Overall Study|Withdrawal by Subject|0|||
129157380|NCT01713582|464872496|FG005|Overall Study|Withdrawal by Subject|0|||
129157381|NCT01713582|464872497|FG006|Overall Study|Withdrawal by Subject|0|||
129157382|NCT01713582|464872498|FG007|Overall Study|Withdrawal by Subject|0|||
129157383|NCT01713582|464872499|FG008|Overall Study|Withdrawal by Subject|0|||
129157384|NCT01713582|464872500|FG009|Overall Study|Withdrawal by Subject|0|||
129157385|NCT01713582|464872501|FG010|Overall Study|Withdrawal by Subject|0|||
129157386|NCT01713582|464872502|FG011|Overall Study|Withdrawal by Subject|0|||
129157387|NCT01713582|464872503|FG012|Overall Study|Withdrawal by Subject|0|||
129157388|NCT01713582|464872504|FG013|Overall Study|Withdrawal by Subject|0|||
129157389|NCT01713582|464872505|FG014|Overall Study|Withdrawal by Subject|0|||
129157390|NCT01713582|464872506|FG015|Overall Study|Withdrawal by Subject|0|||
129157391|NCT01713582|464872507|FG016|Overall Study|Withdrawal by Subject|0|||
129157392|NCT01713582|464872508|FG017|Overall Study|Withdrawal by Subject|1|||
129157393|NCT01713582|464872509|FG018|Overall Study|Withdrawal by Subject|0|||
129157394|NCT01713582|464872510|FG019|Overall Study|Withdrawal by Subject|0|||
129157395|NCT01713582|464872511|FG020|Overall Study|Withdrawal by Subject|0|||
129157396|NCT01713582|464872491|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
129157397|NCT01713582|464872492|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
129157398|NCT01713582|464872493|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
129157399|NCT01713582|464872494|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
128725853|NCT02917031|463292620|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
129157400|NCT01713582|464872495|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
129157401|NCT01713582|464872496|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
129157402|NCT01713582|464872497|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
129157403|NCT01713582|464872498|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
129157404|NCT01713582|464872499|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
129157405|NCT01713582|464872500|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
128725854|NCT02917031|463292621|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
129157406|NCT01713582|464872501|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
129157407|NCT01713582|464872502|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
129157408|NCT01713582|464872503|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
129157409|NCT01713582|464872504|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
129157410|NCT01713582|464872505|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
129157411|NCT01713582|464872506|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
129157412|NCT01713582|464872507|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
129157413|NCT01713582|464872508|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
129157414|NCT01713582|464872509|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
129157415|NCT01713582|464872510|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
129157416|NCT01713582|464872511|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
129157417|NCT01713582|464872491|FG000|Overall Study|Disease progression and adverse event|0|||
129157418|NCT01713582|464872492|FG001|Overall Study|Disease progression and adverse event|0|||
129157419|NCT01713582|464872493|FG002|Overall Study|Disease progression and adverse event|0|||
129157420|NCT01713582|464872494|FG003|Overall Study|Disease progression and adverse event|0|||
129157421|NCT01713582|464872495|FG004|Overall Study|Disease progression and adverse event|0|||
129157422|NCT01713582|464872496|FG005|Overall Study|Disease progression and adverse event|0|||
129157423|NCT01713582|464872497|FG006|Overall Study|Disease progression and adverse event|0|||
129157424|NCT01713582|464872498|FG007|Overall Study|Disease progression and adverse event|0|||
129157425|NCT01713582|464872499|FG008|Overall Study|Disease progression and adverse event|0|||
129157426|NCT01713582|464872500|FG009|Overall Study|Disease progression and adverse event|0|||
129157427|NCT01713582|464872501|FG010|Overall Study|Disease progression and adverse event|0|||
129157428|NCT01713582|464872502|FG011|Overall Study|Disease progression and adverse event|0|||
129157429|NCT01713582|464872503|FG012|Overall Study|Disease progression and adverse event|0|||
129157430|NCT01713582|464872504|FG013|Overall Study|Disease progression and adverse event|0|||
129157431|NCT01713582|464872505|FG014|Overall Study|Disease progression and adverse event|0|||
129157432|NCT01713582|464872506|FG015|Overall Study|Disease progression and adverse event|0|||
129157433|NCT01713582|464872507|FG016|Overall Study|Disease progression and adverse event|1|||
129157434|NCT01713582|464872508|FG017|Overall Study|Disease progression and adverse event|0|||
129157435|NCT01713582|464872509|FG018|Overall Study|Disease progression and adverse event|0|||
129157436|NCT01713582|464872510|FG019|Overall Study|Disease progression and adverse event|0|||
129157437|NCT01713582|464872511|FG020|Overall Study|Disease progression and adverse event|0|||
129157438|NCT04551898|464872512|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
129157439|NCT04551898|464872513|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
129157440|NCT04551898|464872514|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
129157441|NCT04551898|464872515|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
129157442|NCT04551898|464872512|FG000|Overall Study|Withdrawal by Subject|5|||
129157443|NCT04551898|464872513|FG001|Overall Study|Withdrawal by Subject|1|||
129157444|NCT04551898|464872514|FG002|Overall Study|Withdrawal by Subject|2|||
129157445|NCT04551898|464872515|FG003|Overall Study|Withdrawal by Subject|2|||
129157446|NCT04551898|464872512|FG000|Overall Study|Lost to Follow-up|2|||
129157447|NCT04551898|464872513|FG001|Overall Study|Lost to Follow-up|1|||
129157448|NCT04551898|464872514|FG002|Overall Study|Lost to Follow-up|2|||
129157449|NCT04551898|464872515|FG003|Overall Study|Lost to Follow-up|2|||
129157450|NCT04551898|464872512|FG000|Overall Study|Death|1|||
129157451|NCT04551898|464872513|FG001|Overall Study|Death|0|||
129157452|NCT04551898|464872514|FG002|Overall Study|Death|0|||
129157453|NCT04551898|464872515|FG003|Overall Study|Death|0|||
129157454|NCT04551898|464872512|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
129157455|NCT04551898|464872513|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
129157456|NCT04551898|464872514|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
129157457|NCT04551898|464872515|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
129157458|NCT03427814|464872516|FG000|Overall Study|Withdrawal by Subject|4|||
129157459|NCT03427814|464872517|FG001|Overall Study|Withdrawal by Subject|4|||
129157460|NCT03427814|464872516|FG000|Overall Study|Lost to Follow-up|0|||
129157461|NCT03427814|464872517|FG001|Overall Study|Lost to Follow-up|2|||
129157462|NCT03427814|464872516|FG000|Overall Study|Death|42|||
129157463|NCT03427814|464872517|FG001|Overall Study|Death|31|||
129157464|NCT03427814|464872516|FG000|Overall Study|Sponsor's Decision|1|||
129157465|NCT03427814|464872517|FG001|Overall Study|Sponsor's Decision|0|||
129157466|NCT03427814|464872516|FG000|Overall Study|Investigator's Decision|1|||
129157467|NCT03427814|464872517|FG001|Overall Study|Investigator's Decision|2|||
129157468|NCT03427814|464872516|FG000|Overall Study|Disease progression|1|||
129157469|NCT03427814|464872517|FG001|Overall Study|Disease progression|0|||
129157470|NCT03427814|464872516|FG000|Overall Study|Treatment Completed|0|||
129157471|NCT03427814|464872517|FG001|Overall Study|Treatment Completed|1|||
129157472|NCT03427814|464872516|FG000|Overall Study|Sponsor's Decision to End study|21|||
129157473|NCT03427814|464872517|FG001|Overall Study|Sponsor's Decision to End study|25|||
129157474|NCT03427814|464872516|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
129157475|NCT03427814|464872517|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
129157476|NCT03145064|464872518|FG000|Overall Study|Death|24|||
129157477|NCT03145064|464872518|FG000|Overall Study|Lost to Follow-up|3|||
129157478|NCT03145064|464872518|FG000|Overall Study|Withdrawal by Subject|6|||
129157479|NCT03145064|464872518|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
129157480|NCT03145064|464872518|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
129157481|NCT03846427|464872519|FG000|Overall Study|Death|13|||
129157482|NCT03846427|464872519|FG000|Overall Study|Withdrawal by Subject|3|||
129157483|NCT03846427|464872519|FG000|Overall Study|Physician Decision|1|||
129157484|NCT01693250|464872520|FG000|Overall Study|Lost to Follow-up|2|||
129157485|NCT01693250|464872521|FG001|Overall Study|Lost to Follow-up|2|||
129157486|NCT01396187|464872522|FG000|Overall Study|Adverse Event|0|||
129157487|NCT01396187|464872523|FG001|Overall Study|Adverse Event|1|||
129157488|NCT01396187|464872524|FG002|Overall Study|Adverse Event|0|||
129157489|NCT01396187|464872525|FG003|Overall Study|Adverse Event|0|||
129157490|NCT01396187|464872526|FG004|Overall Study|Adverse Event|0|||
129157491|NCT01396187|464872522|FG000|Overall Study|Withdrawal by Subject|0|||
129157492|NCT01396187|464872523|FG001|Overall Study|Withdrawal by Subject|1|||
129157493|NCT01396187|464872524|FG002|Overall Study|Withdrawal by Subject|1|||
129157494|NCT01396187|464872525|FG003|Overall Study|Withdrawal by Subject|0|||
129157495|NCT01396187|464872526|FG004|Overall Study|Withdrawal by Subject|0|||
129157496|NCT01396187|464872522|FG000|Overall Study|Other|1|||
129157497|NCT01396187|464872523|FG001|Overall Study|Other|1|||
129157498|NCT01396187|464872524|FG002|Overall Study|Other|0|||
129157499|NCT01396187|464872525|FG003|Overall Study|Other|0|||
129157500|NCT01396187|464872526|FG004|Overall Study|Other|1|||
129157501|NCT01650831|464872529|FG000|Overall Study|Screen failure|1|||
129157502|NCT01048242|464872532|FG000|Overall Study|See study flow chart|4|||
129157503|NCT01048242|464872533|FG001|Overall Study|See study flow chart|2|||
129157504|NCT02964273|464872534|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
129157505|NCT02964273|464872535|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
129157506|NCT02964273|464872536|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
129157507|NCT02964273|464872537|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
129157508|NCT02964273|464872534|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
129157509|NCT02964273|464872535|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
129157510|NCT02964273|464872536|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
129157511|NCT02964273|464872537|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
129157512|NCT02964273|464872534|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
129157513|NCT02964273|464872535|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
129157514|NCT02964273|464872536|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
129157515|NCT02964273|464872537|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
129157516|NCT02964273|464872534|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
129157517|NCT02964273|464872535|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
129157518|NCT02964273|464872536|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
129157519|NCT02964273|464872537|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
129157520|NCT02964273|464872534|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
129157521|NCT02964273|464872535|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
129157522|NCT02964273|464872536|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
129157523|NCT02964273|464872537|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
129157524|NCT02964273|464872534|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
129157525|NCT02964273|464872535|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
129157526|NCT02964273|464872536|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
129157527|NCT02964273|464872537|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
129157528|NCT01453036|464872539|FG000|Overall Study|Lost to Follow-up|26|||
129157529|NCT01453036|464872540|FG001|Overall Study|Lost to Follow-up|115|||
129157530|NCT01453036|464872541|FG002|Overall Study|Lost to Follow-up|31|||
129157531|NCT00559104|464872542|FG000|Overall Study|Lack of Efficacy|9|||
129157532|NCT00559104|464872543|FG001|Overall Study|Lack of Efficacy|0|||
129157533|NCT03073525|464872544|FG000|Overall Study|Withdrawal by Subject|0|||
129157534|NCT03073525|464872545|FG001|Overall Study|Withdrawal by Subject|0|||
129157535|NCT03073525|464872546|FG002|Overall Study|Withdrawal by Subject|3|||
129157536|NCT01273038|464872547|FG000|Second Intervention (14 Days)|Adverse Event|0|||
129157537|NCT01273038|464872548|FG001|Second Intervention (14 Days)|Adverse Event|1|||
129157538|NCT01273038|464872547|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129157539|NCT01273038|464872548|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129157540|NCT01976299|464872549|FG000|Overall Study|Withdrawal by Subject|3|||
129157541|NCT01976299|464872550|FG001|Overall Study|Withdrawal by Subject|1|||
129157542|NCT01976299|464872549|FG000|Overall Study|Death|4|||
129157543|NCT01976299|464872550|FG001|Overall Study|Death|2|||
129157544|NCT01976299|464872549|FG000|Overall Study|Lost to Follow-up|7|||
129157545|NCT01976299|464872550|FG001|Overall Study|Lost to Follow-up|1|||
129157546|NCT01976299|464872549|FG000|Overall Study|See clarification above in comments|9|||
129157547|NCT01976299|464872550|FG001|Overall Study|See clarification above in comments|2|||
129157548|NCT01306643|464872551|FG000|Overall Study|Adverse Event|5|||
129157549|NCT01306643|464872551|FG000|Overall Study|Disease Progression|7|||
129157550|NCT01306643|464872551|FG000|Overall Study|Other: Change in Eligibility Status|1|||
129157551|NCT02071771|464872552|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
129157552|NCT02071771|464872553|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
129157553|NCT02071771|464872552|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
129157554|NCT02071771|464872553|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
129157555|NCT00355368|464872557|FG000|Overall Study|Protocol Violation|8|||
129157556|NCT00355368|464872558|FG001|Overall Study|Protocol Violation|7|||
129157557|NCT00355368|464872557|FG000|Overall Study|cardiac arrest prior to intubation|2|||
129157558|NCT00355368|464872558|FG001|Overall Study|cardiac arrest prior to intubation|2|||
129157559|NCT01152788|464872562|FG000|Overall Study|Withdrawal by Subject|0|||
129157560|NCT01152788|464872563|FG001|Overall Study|Withdrawal by Subject|3|||
129157561|NCT01152788|464872562|FG000|Overall Study|No treatment|0|||
129157562|NCT01152788|464872563|FG001|Overall Study|No treatment|1|||
129157563|NCT01282866|464872564|FG000|Overall Study|Adverse Event|1|||
129157564|NCT01964378|464872569|FG000|Overall Study|Disc. due to death before first dosing|0|||
129157565|NCT01964378|464872570|FG001|Overall Study|Disc. due to death before first dosing|1|||
129157566|NCT01964378|464872569|FG000|Overall Study|Disc. due to AE before first dosing|1|||
129157567|NCT01964378|464872570|FG001|Overall Study|Disc. due to AE before first dosing|0|||
129157568|NCT01964378|464872569|FG000|Overall Study|Death|3|||
129157569|NCT01964378|464872570|FG001|Overall Study|Death|2|||
129157570|NCT01964378|464872569|FG000|Overall Study|Adverse Event|12|||
129157571|NCT01964378|464872570|FG001|Overall Study|Adverse Event|5|||
129157572|NCT01964378|464872569|FG000|Overall Study|Lack of Efficacy|0|||
129157573|NCT01964378|464872570|FG001|Overall Study|Lack of Efficacy|1|||
129157574|NCT01964378|464872569|FG000|Overall Study|Protocol Violation|0|||
129157575|NCT01964378|464872570|FG001|Overall Study|Protocol Violation|1|||
129157576|NCT01964378|464872569|FG000|Overall Study|Lost to Follow-up|0|||
129157577|NCT01964378|464872570|FG001|Overall Study|Lost to Follow-up|1|||
129157578|NCT01964378|464872569|FG000|Overall Study|Withdrawal by Subject|7|||
129157579|NCT01964378|464872570|FG001|Overall Study|Withdrawal by Subject|5|||
129157580|NCT01964378|464872569|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
129157581|NCT01964378|464872570|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
129157582|NCT01964378|464872569|FG000|Overall Study|Other|1|||
129157583|NCT01964378|464872570|FG001|Overall Study|Other|2|||
129157584|NCT01928433|464872577|FG000|Overall Study|Adverse Event|5|||
129157585|NCT01928433|464872578|FG001|Overall Study|Adverse Event|2|||
129157586|NCT01928433|464872579|FG002|Overall Study|Adverse Event|5|||
129157587|NCT01928433|464872577|FG000|Overall Study|Protocol Violation|0|||
129157588|NCT01928433|464872578|FG001|Overall Study|Protocol Violation|0|||
129157589|NCT01928433|464872579|FG002|Overall Study|Protocol Violation|2|||
129157590|NCT01928433|464872577|FG000|Overall Study|Lack of Efficacy|5|||
129157591|NCT01928433|464872578|FG001|Overall Study|Lack of Efficacy|4|||
129157592|NCT01928433|464872579|FG002|Overall Study|Lack of Efficacy|4|||
129157593|NCT01928433|464872577|FG000|Overall Study|Withdrawal by Subject|0|||
129157594|NCT01928433|464872578|FG001|Overall Study|Withdrawal by Subject|4|||
129157595|NCT01928433|464872579|FG002|Overall Study|Withdrawal by Subject|0|||
129157596|NCT01928433|464872577|FG000|Overall Study|Negative screening urine culture|7|||
129157597|NCT01928433|464872578|FG001|Overall Study|Negative screening urine culture|6|||
129157598|NCT01928433|464872579|FG002|Overall Study|Negative screening urine culture|10|||
129157599|NCT01928433|464872577|FG000|Overall Study|Lost to Follow-up|0|||
129157600|NCT01928433|464872578|FG001|Overall Study|Lost to Follow-up|2|||
129157601|NCT01928433|464872579|FG002|Overall Study|Lost to Follow-up|3|||
129157602|NCT01928433|464872577|FG000|Overall Study|Other reasons|3|||
129157603|NCT01928433|464872578|FG001|Overall Study|Other reasons|3|||
129157604|NCT01928433|464872579|FG002|Overall Study|Other reasons|4|||
129157605|NCT01392573|464872580|FG000|Overall Study|Adverse Event|1|||
129157606|NCT01392573|464872581|FG001|Overall Study|Adverse Event|3|||
129157607|NCT01392573|464872580|FG000|Overall Study|Lack of Efficacy|1|||
129157608|NCT01392573|464872581|FG001|Overall Study|Lack of Efficacy|2|||
129157609|NCT01392573|464872580|FG000|Overall Study|Protocol Violation|0|||
129157610|NCT01392573|464872581|FG001|Overall Study|Protocol Violation|2|||
129157611|NCT01392573|464872580|FG000|Overall Study|Withdrawal Criteria|13|||
129157612|NCT01392573|464872581|FG001|Overall Study|Withdrawal Criteria|15|||
129157613|NCT01392573|464872580|FG000|Overall Study|Site closure|8|||
129157614|NCT01392573|464872581|FG001|Overall Study|Site closure|7|||
129157615|NCT01392573|464872580|FG000|Overall Study|Unclassified|9|||
129157616|NCT01392573|464872581|FG001|Overall Study|Unclassified|6|||
129157617|NCT00436436|464872582|FG000|Overall Study|Progression|4|||
129157618|NCT00436436|464872582|FG000|Overall Study|Adverse Event|2|||
129157619|NCT00436436|464872582|FG000|Overall Study|Death|6|||
129157620|NCT01102491|464872589|FG000|Overall Study|Protocol Violation|11|||
129157621|NCT01102491|464872590|FG001|Overall Study|Protocol Violation|12|||
129157622|NCT02151786|464872591|FG000|Overall Study|Unavailability of Case Report Form|26|||
129157623|NCT02151786|464872591|FG000|Overall Study|Outside the Contract Period|1|||
129157624|NCT02151786|464872591|FG000|Overall Study|Randomized, not Treated|1|||
129157625|NCT02151786|464872591|FG000|Overall Study|Unavailability of Information|8|||
129157626|NCT03533660|464872592|FG000|Overall Study|Withdrawal by Subject|2|||
129157627|NCT03533660|464872593|FG001|Overall Study|Withdrawal by Subject|2|||
129157628|NCT03533660|464872592|FG000|Overall Study|Death|2|||
129157629|NCT03533660|464872593|FG001|Overall Study|Death|4|||
129157630|NCT03533660|464872592|FG000|Overall Study|Adverse Event|0|||
129157631|NCT03533660|464872593|FG001|Overall Study|Adverse Event|2|||
129157632|NCT00996658|464872594|FG000|Overall Study|Adverse Event|2|||
129157633|NCT00996658|464872595|FG001|Overall Study|Adverse Event|5|||
129157634|NCT00996658|464872594|FG000|Overall Study|Protocol Violation|0|||
129157635|NCT00996658|464872595|FG001|Overall Study|Protocol Violation|1|||
129157636|NCT00996658|464872594|FG000|Overall Study|Lost to Follow-up|2|||
129157637|NCT00996658|464872595|FG001|Overall Study|Lost to Follow-up|5|||
129157638|NCT00996658|464872594|FG000|Overall Study|Non-compliance issues|3|||
129157639|NCT00996658|464872595|FG001|Overall Study|Non-compliance issues|3|||
129157640|NCT00996658|464872594|FG000|Overall Study|Other|9|||
129157641|NCT00996658|464872595|FG001|Overall Study|Other|7|||
129157642|NCT00628446|464874655|FG000|Overall Study|Lost to Follow-up|3|||
129157643|NCT00628446|464874655|FG000|Overall Study|Withdrawal by Subject|1|||
129157644|NCT00628446|464874655|FG000|Overall Study|Protocol Violation|3|||
129157645|NCT01898286|464874656|FG000|Overall Study|Withdrawal by Subject|1|||
129157646|NCT01898286|464874656|FG000|Overall Study|Protocol Violation|1|||
129157647|NCT01898286|464874656|FG000|Overall Study|Lost to Follow-up|1|||
129157648|NCT02257242|464874657|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
129157649|NCT02257242|464874658|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157650|NCT02257242|464874659|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157651|NCT02257242|464874660|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157652|NCT02257242|464874661|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157653|NCT02257242|464874662|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157654|NCT02257242|464874663|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157655|NCT02257242|464874664|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157656|NCT02257242|464874665|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129157657|NCT01336712|464874670|FG000|Overall Study|Death|2|||
129157658|NCT01336712|464874670|FG000|Overall Study|Lack of Efficacy|1|||
129157659|NCT00620373|464874672|FG000|Overall Study|Unverified cancer status|33|||
129157660|NCT03692403|464874673|FG000|Overall Study|Withdrawal by Subject|1|||
128725855|NCT02917031|463292622|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
128725856|NCT02917031|463292620|FG000|Overall Study|Withdrawal by Subject|3|||
128725857|NCT02917031|463292621|FG001|Overall Study|Withdrawal by Subject|3|||
128725858|NCT02917031|463292622|FG002|Overall Study|Withdrawal by Subject|0|||
128725859|NCT02917031|463292620|FG000|Overall Study|Physician Decision|1|||
128725860|NCT02917031|463292621|FG001|Overall Study|Physician Decision|0|||
128725861|NCT02917031|463292622|FG002|Overall Study|Physician Decision|0|||
128725862|NCT02917031|463292620|FG000|Overall Study|Adverse Event|4|||
128725863|NCT02917031|463292621|FG001|Overall Study|Adverse Event|1|||
128725864|NCT02917031|463292622|FG002|Overall Study|Adverse Event|5|||
129157661|NCT03692403|464874674|FG001|Overall Study|Withdrawal by Subject|0|||
128725865|NCT02917031|463292620|FG000|Overall Study|Death|2|||
128725866|NCT02917031|463292621|FG001|Overall Study|Death|3|||
128725867|NCT02917031|463292622|FG002|Overall Study|Death|4|||
128725868|NCT01852292|463294692|FG000|Overall Study|Untreated - did not receive study drug|3|||
128725869|NCT01852292|463294693|FG001|Overall Study|Untreated - did not receive study drug|1|||
128725870|NCT01852292|463294692|FG000|Overall Study|Death|9|||
128725871|NCT01852292|463294693|FG001|Overall Study|Death|8|||
128725872|NCT01852292|463294692|FG000|Overall Study|Patient/guardian decision|8|||
128725873|NCT01852292|463294693|FG001|Overall Study|Patient/guardian decision|4|||
128725874|NCT01852292|463294692|FG000|Overall Study|Adverse Event|8|||
128725875|NCT01852292|463294693|FG001|Overall Study|Adverse Event|11|||
128725876|NCT01852292|463294692|FG000|Overall Study|Physician Decision|6|||
128725877|NCT01852292|463294693|FG001|Overall Study|Physician Decision|2|||
128725878|NCT01852292|463294692|FG000|Overall Study|Protocol Violation|2|||
128725879|NCT01852292|463294693|FG001|Overall Study|Protocol Violation|0|||
128725880|NCT01852292|463294692|FG000|Overall Study|Non-compliance with study treatment|1|||
128725881|NCT01852292|463294693|FG001|Overall Study|Non-compliance with study treatment|0|||
128725882|NCT01852292|463294692|FG000|Overall Study|Study terminated by Sponsor|0|||
128725883|NCT01852292|463294693|FG001|Overall Study|Study terminated by Sponsor|1|||
128725884|NCT01852292|463294692|FG000|Overall Study|Progressive disease|42|||
128725885|NCT01852292|463294693|FG001|Overall Study|Progressive disease|52|||
128725886|NCT01914666|463294694|FG000|Treatment Period|Lack of Efficacy|0|||
128725887|NCT01914666|463294695|FG001|Treatment Period|Lack of Efficacy|0|||
128725888|NCT01914666|463294696|FG002|Treatment Period|Lack of Efficacy|2|||
128725889|NCT01914666|463294694|FG000|Treatment Period|Adverse Event|10|||
128725890|NCT01914666|463294695|FG001|Treatment Period|Adverse Event|4|||
128725891|NCT01914666|463294696|FG002|Treatment Period|Adverse Event|2|||
128725892|NCT01914666|463294694|FG000|Treatment Period|Withdrawal by Subject|3|||
128725893|NCT01914666|463294695|FG001|Treatment Period|Withdrawal by Subject|2|||
128725894|NCT01914666|463294696|FG002|Treatment Period|Withdrawal by Subject|2|||
128725895|NCT01914666|463294694|FG000|Treatment Period|Physician Decision|0|||
128725896|NCT01914666|463294695|FG001|Treatment Period|Physician Decision|0|||
128725897|NCT01914666|463294696|FG002|Treatment Period|Physician Decision|2|||
128725898|NCT01454726|463294697|FG000|Overall Study|Withdrawal by Subject|0|||
128725899|NCT01454726|463294698|FG001|Overall Study|Withdrawal by Subject|1|||
128725900|NCT02342704|463294699|FG000|Overall Study|Physician Decision|0|||
128725901|NCT02342704|463294700|FG001|Overall Study|Physician Decision|3|||
128725902|NCT02342704|463294699|FG000|Overall Study|Sponsor Termination|49|||
128725903|NCT02342704|463294700|FG001|Overall Study|Sponsor Termination|43|||
128725904|NCT02342704|463294699|FG000|Overall Study|Other|0|||
128725905|NCT02342704|463294700|FG001|Overall Study|Other|1|||
128725906|NCT02342704|463294699|FG000|Overall Study|Withdrawal by Subject|1|||
128725907|NCT02342704|463294700|FG001|Overall Study|Withdrawal by Subject|0|||
128725908|NCT02342704|463294699|FG000|Overall Study|Lost to Follow-up|2|||
128725909|NCT02342704|463294700|FG001|Overall Study|Lost to Follow-up|1|||
128725910|NCT02342704|463294699|FG000|Overall Study|Adverse Event|1|||
128725911|NCT02342704|463294700|FG001|Overall Study|Adverse Event|3|||
128725912|NCT02347527|463294701|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
128725913|NCT02347527|463294702|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
129157662|NCT03692403|464874675|FG002|Overall Study|Withdrawal by Subject|1|||
129157663|NCT03692403|464874676|FG003|Overall Study|Withdrawal by Subject|0|||
129157664|NCT03692403|464874673|FG000|Overall Study|Adverse Event|0|||
129157665|NCT03692403|464874674|FG001|Overall Study|Adverse Event|0|||
129157666|NCT03692403|464874675|FG002|Overall Study|Adverse Event|0|||
128725914|NCT02347527|463294703|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
128725915|NCT02347527|463294704|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
128725916|NCT02347527|463294701|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
128725917|NCT02347527|463294702|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
128725918|NCT02347527|463294703|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
128725919|NCT02347527|463294704|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
128725920|NCT02347527|463294701|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
128725921|NCT02347527|463294702|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
128725922|NCT02347527|463294703|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
128725923|NCT02347527|463294704|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
129157667|NCT03692403|464874676|FG003|Overall Study|Adverse Event|1|||
129157668|NCT03692403|464874673|FG000|Overall Study|Pregnancy|0|||
129157669|NCT03692403|464874674|FG001|Overall Study|Pregnancy|1|||
129157670|NCT03692403|464874675|FG002|Overall Study|Pregnancy|0|||
129157671|NCT03692403|464874676|FG003|Overall Study|Pregnancy|0|||
129157672|NCT03692403|464874673|FG000|Overall Study|Other|0|||
129157673|NCT03692403|464874674|FG001|Overall Study|Other|0|||
129157674|NCT03692403|464874675|FG002|Overall Study|Other|1|||
129157675|NCT03692403|464874676|FG003|Overall Study|Other|0|||
129157676|NCT01408277|464874682|FG000|Overall Study|Adverse Event|3|||
129157677|NCT01408277|464874683|FG001|Overall Study|Adverse Event|4|||
129157678|NCT01408277|464874682|FG000|Overall Study|Lost to Follow-up|1|||
129157679|NCT01408277|464874683|FG001|Overall Study|Lost to Follow-up|0|||
129157680|NCT01408277|464874682|FG000|Overall Study|Withdrawal by Subject|2|||
129157681|NCT01408277|464874683|FG001|Overall Study|Withdrawal by Subject|0|||
129157682|NCT01408277|464874682|FG000|Overall Study|Protocol Violation|2|||
129157683|NCT01408277|464874683|FG001|Overall Study|Protocol Violation|0|||
129157684|NCT01349673|464874684|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
129157685|NCT01349673|464874684|FG000|Overall Study|No Longer Qualified For Study|1|||
129157686|NCT01349673|464874684|FG000|Overall Study|Site Closure|10|||
129157687|NCT01349673|464874684|FG000|Overall Study|Withdrawal by Subject|21|||
129157688|NCT01349673|464874684|FG000|Overall Study|Lost to Follow-up|6|||
129157689|NCT01349673|464874684|FG000|Overall Study|Adverse Event|17|||
129157690|NCT01349673|464874684|FG000|Overall Study|Study Terminated By Sponsor|50|||
129157691|NCT01349673|464874684|FG000|Overall Study|Lack of Efficacy|8|||
129157692|NCT04263766|464874687|FG000|Overall Study|Withdrawal by Subject|6|||
129157693|NCT04263766|464874688|FG001|Overall Study|Withdrawal by Subject|4|||
129157694|NCT04263766|464874687|FG000|Overall Study|Lack of Efficacy|1|||
129157695|NCT04263766|464874688|FG001|Overall Study|Lack of Efficacy|3|||
129157696|NCT01891396|464874690|FG000|Overall Study|Withdrawal by Subject|4|||
129157697|NCT01891396|464874691|FG001|Overall Study|Withdrawal by Subject|4|||
129157698|NCT01891396|464874692|FG002|Overall Study|Withdrawal by Subject|3|||
129157699|NCT01891396|464874690|FG000|Overall Study|Lost to Follow-up|0|||
129157700|NCT01891396|464874691|FG001|Overall Study|Lost to Follow-up|1|||
129157701|NCT01891396|464874692|FG002|Overall Study|Lost to Follow-up|0|||
129157702|NCT00540592|464874693|FG000|Overall Study|Adverse Event|0|||
129157703|NCT00540592|464874694|FG001|Overall Study|Adverse Event|1|||
129157704|NCT00540592|464874695|FG002|Overall Study|Adverse Event|0|||
129157705|NCT00540592|464874696|FG003|Overall Study|Adverse Event|0|||
129157706|NCT00540592|464874697|FG004|Overall Study|Adverse Event|1|||
129157707|NCT00540592|464874698|FG005|Overall Study|Adverse Event|0|||
129157708|NCT00540592|464874699|FG006|Overall Study|Adverse Event|0|||
129157709|NCT00540592|464874700|FG007|Overall Study|Adverse Event|1|||
129157710|NCT00540592|464874701|FG008|Overall Study|Adverse Event|1|||
129157711|NCT00540592|464874702|FG009|Overall Study|Adverse Event|2|||
129157712|NCT00540592|464874693|FG000|Overall Study|Lost to Follow-up|2|||
129157713|NCT00540592|464874694|FG001|Overall Study|Lost to Follow-up|0|||
129157714|NCT00540592|464874695|FG002|Overall Study|Lost to Follow-up|0|||
129157715|NCT00540592|464874696|FG003|Overall Study|Lost to Follow-up|0|||
129157716|NCT00540592|464874697|FG004|Overall Study|Lost to Follow-up|0|||
129157717|NCT00540592|464874698|FG005|Overall Study|Lost to Follow-up|0|||
129157718|NCT00540592|464874699|FG006|Overall Study|Lost to Follow-up|0|||
129157719|NCT00540592|464874700|FG007|Overall Study|Lost to Follow-up|0|||
129157720|NCT00540592|464874701|FG008|Overall Study|Lost to Follow-up|0|||
129157721|NCT00540592|464874702|FG009|Overall Study|Lost to Follow-up|0|||
129157722|NCT00540592|464874693|FG000|Overall Study|Withdrawal by Subject|0|||
129157723|NCT00540592|464874694|FG001|Overall Study|Withdrawal by Subject|0|||
129157724|NCT00540592|464874695|FG002|Overall Study|Withdrawal by Subject|1|||
129157725|NCT00540592|464874696|FG003|Overall Study|Withdrawal by Subject|1|||
129157726|NCT00540592|464874697|FG004|Overall Study|Withdrawal by Subject|0|||
129157727|NCT00540592|464874698|FG005|Overall Study|Withdrawal by Subject|0|||
129157728|NCT00540592|464874699|FG006|Overall Study|Withdrawal by Subject|0|||
129157729|NCT00540592|464874700|FG007|Overall Study|Withdrawal by Subject|0|||
128725924|NCT02347527|463294701|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
129157730|NCT00540592|464874701|FG008|Overall Study|Withdrawal by Subject|0|||
129157731|NCT00540592|464874702|FG009|Overall Study|Withdrawal by Subject|0|||
129157732|NCT01766037|464874703|FG000|Overall Study|Adverse Event|1|||
129157733|NCT01766037|464874704|FG001|Overall Study|Adverse Event|0|||
129157734|NCT01766037|464874703|FG000|Overall Study|Lack of Efficacy|1|||
129157735|NCT01766037|464874704|FG001|Overall Study|Lack of Efficacy|0|||
129157736|NCT01766037|464874703|FG000|Overall Study|Lost to Follow-up|0|||
129157737|NCT01766037|464874704|FG001|Overall Study|Lost to Follow-up|10|||
129157738|NCT01766037|464874703|FG000|Overall Study|Physician Decision|0|||
129157739|NCT01766037|464874704|FG001|Overall Study|Physician Decision|1|||
129157740|NCT01766037|464874703|FG000|Overall Study|Withdrawal by Subject|18|||
129157741|NCT01766037|464874704|FG001|Overall Study|Withdrawal by Subject|16|||
129157742|NCT01766037|464874703|FG000|Overall Study|Moved from area|5|||
129157743|NCT01766037|464874704|FG001|Overall Study|Moved from area|0|||
129157744|NCT01766037|464874703|FG000|Overall Study|medical - unrelated|1|||
129157745|NCT01766037|464874704|FG001|Overall Study|medical - unrelated|2|||
129157746|NCT01766037|464874703|FG000|Overall Study|nausea / discomfort|3|||
129157747|NCT01766037|464874704|FG001|Overall Study|nausea / discomfort|0|||
129157748|NCT02413996|464874705|FG000|Overall Study|not comfortable with the intervention|9|||
129157749|NCT02413996|464874706|FG001|Overall Study|not comfortable with the intervention|2|||
129157750|NCT03810014|464874707|FG000|Overall Study|Pregnancy|2|||
129157751|NCT03810014|464874708|FG001|Overall Study|Pregnancy|2|||
129157752|NCT03810014|464874709|FG002|Overall Study|Pregnancy|0|||
129157753|NCT03810014|464874710|FG003|Overall Study|Pregnancy|2|||
129157754|NCT03606486|464874711|FG000|Overall Study|Unable to collect sample|5|||
129157755|NCT01853462|464874720|FG000|Overall Study|Withdrawal by Subject|1|||
129157756|NCT01853462|464874721|FG001|Overall Study|Withdrawal by Subject|1|||
129157757|NCT02148263|464874722|FG000|Overall Study|Withdrawal by Subject|3|||
129157758|NCT02148263|464874723|FG001|Overall Study|Withdrawal by Subject|2|||
129157759|NCT03386435|464874724|FG000|Overall Study|Protocol Violation|5|||
129157760|NCT03386435|464874725|FG001|Overall Study|Protocol Violation|7|||
129157761|NCT00625586|464874726|FG000|Overall Study|Adverse Event|1|||
129157762|NCT00625586|464874726|FG000|Overall Study|Progressive disease|1|||
129157763|NCT03083665|464874727|FG000|Double-Blind Period|Adverse Event|5|||
129157764|NCT03083665|464874728|FG001|Double-Blind Period|Adverse Event|4|||
129157765|NCT03083665|464874729|FG002|Double-Blind Period|Adverse Event|5|||
129157766|NCT03083665|464874730|FG003|Double-Blind Period|Adverse Event|0|||
129157767|NCT03083665|464874731|FG004|Double-Blind Period|Adverse Event|0|||
129157768|NCT03083665|464874732|FG005|Double-Blind Period|Adverse Event|0|||
129157769|NCT03083665|464874727|FG000|Double-Blind Period|Lack of Efficacy|0|||
129157770|NCT03083665|464874728|FG001|Double-Blind Period|Lack of Efficacy|0|||
129157771|NCT03083665|464874729|FG002|Double-Blind Period|Lack of Efficacy|1|||
129157772|NCT03083665|464874730|FG003|Double-Blind Period|Lack of Efficacy|0|||
129157773|NCT03083665|464874731|FG004|Double-Blind Period|Lack of Efficacy|0|||
129157774|NCT03083665|464874732|FG005|Double-Blind Period|Lack of Efficacy|0|||
129157775|NCT03083665|464874727|FG000|Double-Blind Period|Protocol Violation|1|||
129157776|NCT03083665|464874728|FG001|Double-Blind Period|Protocol Violation|0|||
129157777|NCT03083665|464874729|FG002|Double-Blind Period|Protocol Violation|1|||
129157778|NCT03083665|464874730|FG003|Double-Blind Period|Protocol Violation|0|||
129157779|NCT03083665|464874731|FG004|Double-Blind Period|Protocol Violation|0|||
129157780|NCT03083665|464874732|FG005|Double-Blind Period|Protocol Violation|0|||
129157781|NCT03083665|464874727|FG000|Double-Blind Period|Lost to Follow-up|1|||
129157782|NCT03083665|464874728|FG001|Double-Blind Period|Lost to Follow-up|0|||
129157783|NCT03083665|464874729|FG002|Double-Blind Period|Lost to Follow-up|1|||
129157784|NCT03083665|464874730|FG003|Double-Blind Period|Lost to Follow-up|0|||
129157785|NCT03083665|464874731|FG004|Double-Blind Period|Lost to Follow-up|0|||
129157786|NCT03083665|464874732|FG005|Double-Blind Period|Lost to Follow-up|0|||
129157787|NCT03083665|464874727|FG000|Double-Blind Period|Withdrawal by Subject|3|||
129157788|NCT03083665|464874728|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129157789|NCT03083665|464874729|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129157790|NCT03083665|464874730|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129157791|NCT03083665|464874731|FG004|Double-Blind Period|Withdrawal by Subject|0|||
129157792|NCT03083665|464874732|FG005|Double-Blind Period|Withdrawal by Subject|0|||
129157793|NCT03083665|464874727|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
129157794|NCT03083665|464874728|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129157795|NCT03083665|464874729|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129157796|NCT03083665|464874730|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129157797|NCT03083665|464874731|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129157798|NCT03083665|464874732|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129157799|NCT03083665|464874727|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
129157800|NCT03083665|464874728|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
129157801|NCT03083665|464874729|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
129157802|NCT03083665|464874730|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
129157803|NCT03083665|464874731|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
129157804|NCT03083665|464874732|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
129157805|NCT03083665|464874727|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129157806|NCT03083665|464874728|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129157807|NCT03083665|464874729|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129157808|NCT03083665|464874730|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
129157809|NCT03083665|464874731|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
128776874|NCT01782326|463472025|FG001|Double-blind Treatment|Technical problems|5|||
129157810|NCT03083665|464874732|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129157811|NCT03083665|464874727|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129157812|NCT03083665|464874728|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129157813|NCT03083665|464874729|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129157814|NCT03083665|464874730|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129157815|NCT03083665|464874731|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
128725925|NCT02347527|463294702|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
129157816|NCT03083665|464874732|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
129157817|NCT03083665|464874727|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
129157818|NCT03083665|464874728|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
129157819|NCT03083665|464874729|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
129157820|NCT03083665|464874730|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
129157821|NCT03083665|464874731|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
129157822|NCT03083665|464874732|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
129157823|NCT03083665|464874727|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129157824|NCT03083665|464874728|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129157825|NCT03083665|464874729|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129157826|NCT03083665|464874730|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129157827|NCT03083665|464874731|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129157828|NCT03083665|464874732|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
129157829|NCT03083665|464874727|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129157830|NCT03083665|464874728|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129157831|NCT03083665|464874729|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129157832|NCT03083665|464874730|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
129157833|NCT03083665|464874731|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129157834|NCT03083665|464874732|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129157835|NCT03083665|464874727|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129157836|NCT03083665|464874728|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129157837|NCT03083665|464874729|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129157838|NCT03083665|464874730|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129157839|NCT03083665|464874731|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129157840|NCT03083665|464874732|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
129157841|NCT03083665|464874727|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129157842|NCT03083665|464874728|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129157843|NCT03083665|464874729|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129157844|NCT03083665|464874730|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129157845|NCT03083665|464874731|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129157846|NCT03083665|464874732|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
129157847|NCT01467466|464874735|FG000|Overall Study|Withdrawal by Subject|15|||
129157848|NCT01467466|464874736|FG001|Overall Study|Withdrawal by Subject|18|||
129157849|NCT01467466|464874737|FG002|Overall Study|Withdrawal by Subject|13|||
129157850|NCT01467466|464874738|FG003|Overall Study|Withdrawal by Subject|11|||
129157851|NCT01467466|464874735|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
129157852|NCT01467466|464874736|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
129157853|NCT01467466|464874737|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
129157854|NCT01467466|464874738|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
129157855|NCT01467466|464874735|FG000|Overall Study|Procedure Cancelled|46|||
129157856|NCT01467466|464874736|FG001|Overall Study|Procedure Cancelled|45|||
129157857|NCT01467466|464874737|FG002|Overall Study|Procedure Cancelled|25|||
129157858|NCT01467466|464874738|FG003|Overall Study|Procedure Cancelled|29|||
129157859|NCT01467466|464874735|FG000|Overall Study|No Endpoint Blood Draw|38|||
129157860|NCT01467466|464874736|FG001|Overall Study|No Endpoint Blood Draw|32|||
129157861|NCT01467466|464874737|FG002|Overall Study|No Endpoint Blood Draw|51|||
129157862|NCT01467466|464874738|FG003|Overall Study|No Endpoint Blood Draw|43|||
129157863|NCT01144416|464874742|FG000|Intervention Period|Adverse Event|5|||
129157864|NCT01144416|464874743|FG001|Intervention Period|Adverse Event|6|||
129157865|NCT01144416|464874742|FG000|Intervention Period|Insufficient ovarian response|11|||
129157866|NCT01144416|464874743|FG001|Intervention Period|Insufficient ovarian response|17|||
129157867|NCT01144416|464874742|FG000|Intervention Period|Risk of OHSS|0|||
129157868|NCT01144416|464874743|FG001|Intervention Period|Risk of OHSS|1|||
129157869|NCT01144416|464874742|FG000|Intervention Period|Too high ovarian response|4|||
129157870|NCT01144416|464874743|FG001|Intervention Period|Too high ovarian response|2|||
129157871|NCT01144416|464874742|FG000|Intervention Period|No/too few/bad oocytes|7|||
129157872|NCT01144416|464874743|FG001|Intervention Period|No/too few/bad oocytes|5|||
129157873|NCT01144416|464874742|FG000|Intervention Period|No or abnormal fertilization|25|||
129157874|NCT01144416|464874743|FG001|Intervention Period|No or abnormal fertilization|10|||
129157875|NCT01144416|464874742|FG000|Intervention Period|No/too few/bad quality embryos|3|||
129157876|NCT01144416|464874743|FG001|Intervention Period|No/too few/bad quality embryos|3|||
128725926|NCT02347527|463294703|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
128725927|NCT02347527|463294704|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
129157877|NCT01144416|464874742|FG000|Intervention Period|Other|7|||
129157878|NCT01144416|464874743|FG001|Intervention Period|Other|5|||
129157879|NCT00124072|464874744|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
129157880|NCT00124072|464874745|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
129157881|NCT00124072|464874746|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
129157882|NCT00124072|464874747|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
129157883|NCT00124072|464874744|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
129157884|NCT00124072|464874745|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
129157885|NCT00124072|464874746|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
129157886|NCT00124072|464874747|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
129157887|NCT00124072|464874744|FG000|Overall Study|Death|499|||
129157888|NCT00124072|464874745|FG001|Overall Study|Death|484|||
129157889|NCT00124072|464874746|FG002|Overall Study|Death|471|||
129157890|NCT00124072|464874747|FG003|Overall Study|Death|480|||
129157891|NCT00886769|464874748|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129157892|NCT00886769|464874749|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
129157893|NCT03328832|464874750|FG000|Overall Study|Lost to Follow-up|0|||
129157894|NCT03328832|464874751|FG001|Overall Study|Lost to Follow-up|1|||
129157895|NCT00778336|464874752|FG000|Index Procedure-Discharge|Death|6|||
129157896|NCT00778336|464874753|FG001|Index Procedure-Discharge|Death|3|||
129157897|NCT00778336|464874754|FG002|Index Procedure-Discharge|Death|2|||
129157898|NCT00778336|464874755|FG003|Index Procedure-Discharge|Death|0|||
129157899|NCT00778336|464874752|FG000|3 Month Follow Up|Lost to Follow-up|15|||
129157900|NCT00778336|464874753|FG001|3 Month Follow Up|Lost to Follow-up|20|||
129157901|NCT00778336|464874754|FG002|3 Month Follow Up|Lost to Follow-up|3|||
129157902|NCT00778336|464874755|FG003|3 Month Follow Up|Lost to Follow-up|0|||
129157903|NCT00778336|464874752|FG000|3 Month Follow Up|Death|8|||
129157904|NCT00778336|464874753|FG001|3 Month Follow Up|Death|3|||
129157905|NCT00778336|464874754|FG002|3 Month Follow Up|Death|2|||
129157906|NCT00778336|464874755|FG003|3 Month Follow Up|Death|0|||
129157907|NCT00414076|464874758|FG000|Overall Study|Progression|1|||
129157908|NCT00414076|464874759|FG001|Overall Study|Progression|2|||
129157909|NCT00414076|464874758|FG000|Overall Study|Withdrawal by Subject|1|||
129157910|NCT00414076|464874759|FG001|Overall Study|Withdrawal by Subject|3|||
129157911|NCT00414076|464874758|FG000|Overall Study|Adverse Event|1|||
129157912|NCT00414076|464874759|FG001|Overall Study|Adverse Event|0|||
129157913|NCT03929913|464874760|FG000|Overall Study|Death|4|||
129157914|NCT03929913|464874760|FG000|Overall Study|Lost to Follow-up|1|||
129157915|NCT03929913|464874760|FG000|Overall Study|Failed Procedure|2|||
129157916|NCT02891226|464874761|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
129157917|NCT02891226|464874762|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
129157918|NCT02891226|464874763|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
129157919|NCT02891226|464874764|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157920|NCT02891226|464874765|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157921|NCT02891226|464874766|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157922|NCT02891226|464874767|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157923|NCT02891226|464874768|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157924|NCT02891226|464874769|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157925|NCT02891226|464874770|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157926|NCT02891226|464874771|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157927|NCT02891226|464874772|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157928|NCT02891226|464874773|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157929|NCT02891226|464874774|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157930|NCT02891226|464874775|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157931|NCT02891226|464874776|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129157932|NCT02891226|464874761|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
129157933|NCT02891226|464874762|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
129157934|NCT02891226|464874763|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157935|NCT02891226|464874764|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157936|NCT02891226|464874765|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157937|NCT02891226|464874766|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157938|NCT02891226|464874767|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157939|NCT02891226|464874768|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157940|NCT02891226|464874769|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157941|NCT02891226|464874770|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157942|NCT02891226|464874771|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157943|NCT02891226|464874772|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157944|NCT02891226|464874773|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157945|NCT02891226|464874774|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157946|NCT02891226|464874775|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157947|NCT02891226|464874776|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129157948|NCT02891226|464874761|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157949|NCT02891226|464874762|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157950|NCT02891226|464874763|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157951|NCT02891226|464874764|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
129157952|NCT02891226|464874765|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157953|NCT02891226|464874766|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157954|NCT02891226|464874767|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157955|NCT02891226|464874768|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157956|NCT02891226|464874769|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157957|NCT02891226|464874770|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157958|NCT02891226|464874771|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157959|NCT02891226|464874772|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157960|NCT02891226|464874773|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157961|NCT02891226|464874774|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157962|NCT02891226|464874775|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157963|NCT02891226|464874776|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129157964|NCT02891226|464874761|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157965|NCT02891226|464874762|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157966|NCT02891226|464874763|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
129157967|NCT02891226|464874764|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157968|NCT02891226|464874765|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157969|NCT02891226|464874766|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157970|NCT02891226|464874767|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157971|NCT02891226|464874768|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157972|NCT02891226|464874769|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157973|NCT02891226|464874770|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157974|NCT02891226|464874771|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157975|NCT02891226|464874772|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157976|NCT02891226|464874773|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157977|NCT02891226|464874774|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157978|NCT02891226|464874775|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157979|NCT02891226|464874776|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129157980|NCT02891226|464874761|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157981|NCT02891226|464874762|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157982|NCT02891226|464874763|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157983|NCT02891226|464874764|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
129157984|NCT02891226|464874765|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157985|NCT02891226|464874766|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157986|NCT02891226|464874767|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157987|NCT02891226|464874768|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157988|NCT02891226|464874769|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157989|NCT02891226|464874770|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157990|NCT02891226|464874771|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157991|NCT02891226|464874772|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157992|NCT02891226|464874773|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157993|NCT02891226|464874774|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157994|NCT02891226|464874775|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157995|NCT02891226|464874776|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129157996|NCT02891226|464874761|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129157997|NCT02891226|464874762|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129157998|NCT02891226|464874763|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129157999|NCT02891226|464874764|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
129158000|NCT02891226|464874765|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158001|NCT02891226|464874766|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158002|NCT02891226|464874767|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158003|NCT02891226|464874768|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158004|NCT02891226|464874769|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158005|NCT02891226|464874770|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158006|NCT02891226|464874771|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158007|NCT02891226|464874772|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158008|NCT02891226|464874773|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158009|NCT02891226|464874774|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158010|NCT02891226|464874775|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158011|NCT02891226|464874776|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129158012|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158013|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158014|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158015|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158016|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158017|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158018|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
129158019|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
129158020|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
129158021|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
129158022|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158023|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158024|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158025|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158026|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158027|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129158028|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158029|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158030|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158031|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158032|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158033|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
129158034|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158035|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158036|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158037|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
129158038|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158039|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158040|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158041|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158042|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158043|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129158044|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158045|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158046|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158047|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158048|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158049|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158050|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
129158051|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
129158052|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
129158053|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
129158054|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158055|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158056|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158057|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158058|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158059|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129158060|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158061|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158062|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158063|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158064|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
129158065|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158066|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158067|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158068|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158069|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158070|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158071|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158072|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158073|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158074|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158075|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129158076|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158077|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158078|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158079|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158080|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158081|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158082|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
129158083|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158084|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158085|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158086|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158087|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158088|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158089|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158090|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158091|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129158092|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158093|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158094|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
128725928|NCT02347527|463294701|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
128725929|NCT02347527|463294702|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
129158095|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158096|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158097|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158098|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158099|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
129158100|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
129158101|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
129158102|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158103|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158104|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158105|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158106|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158107|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129158108|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158109|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158110|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158111|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158112|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158113|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158114|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158115|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
129158116|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158117|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158118|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158119|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158120|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158121|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158122|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158123|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129158124|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158125|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158126|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158127|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158128|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158129|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158130|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158131|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158132|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
129158133|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158134|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158135|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158136|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158137|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158138|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158139|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129158140|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158141|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
128725930|NCT02347527|463294703|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
128725931|NCT02347527|463294704|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
128725932|NCT00302003|463294705|FG000|Overall Study|Lack of Efficacy|62|||
128725933|NCT00302003|463294705|FG000|Overall Study|Lost to Follow-up|1|||
128725934|NCT00302003|463294705|FG000|Overall Study|Physician Decision|2|||
128725935|NCT00302003|463294705|FG000|Overall Study|Withdrawal by Subject|5|||
128725936|NCT00302003|463294705|FG000|Overall Study|Ineligible|9|||
128776875|NCT01473420|463472026|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
128725937|NCT00302003|463294705|FG000|Overall Study|Protocol Violation|1|||
128725938|NCT02042924|463294706|FG000|Overall Study|Early Death|1|||
128725939|NCT01632891|463294707|FG000|Overall Study|Lost to Follow-up|0|||
128776876|NCT01473420|463472027|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
129158142|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158143|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158144|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158145|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158146|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158147|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158148|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158149|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
129158150|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158151|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158152|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158153|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158154|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158155|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129158156|NCT02891226|464874761|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158157|NCT02891226|464874762|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158158|NCT02891226|464874763|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158159|NCT02891226|464874764|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158160|NCT02891226|464874765|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158161|NCT02891226|464874766|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158162|NCT02891226|464874767|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158163|NCT02891226|464874768|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158164|NCT02891226|464874769|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158165|NCT02891226|464874770|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
129158166|NCT02891226|464874771|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158167|NCT02891226|464874772|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158168|NCT02891226|464874773|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158169|NCT02891226|464874774|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158170|NCT02891226|464874775|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158171|NCT02891226|464874776|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129158172|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158173|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158174|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158175|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158176|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158177|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158178|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158179|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158180|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158181|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158182|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
129158183|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158184|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158185|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158186|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158187|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129158188|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158189|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158190|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158191|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158192|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158193|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158194|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158195|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158196|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158197|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158198|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
129158199|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158200|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
128776877|NCT01473420|463472026|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
128776878|NCT01473420|463472027|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
128776879|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
129158201|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158202|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158203|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129158204|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158205|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158206|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158207|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158208|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158209|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158210|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158211|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158212|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158213|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158214|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
129158215|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158216|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158217|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158218|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158219|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129158220|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158221|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158222|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158223|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158224|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158225|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158226|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158227|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158228|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158229|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158230|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
129158231|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158232|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158233|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158234|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158235|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129158236|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158237|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158238|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158239|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158240|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158241|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158242|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158243|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158244|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158245|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158246|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
129158247|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158248|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158249|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158250|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158251|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129158252|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158253|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158254|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158255|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158256|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158257|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158258|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158259|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158260|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158261|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158262|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
128725940|NCT01632891|463294708|FG001|Overall Study|Lost to Follow-up|1|||
128725941|NCT01632891|463294707|FG000|Overall Study|Withdrawal by Subject|1|||
128725942|NCT01632891|463294708|FG001|Overall Study|Withdrawal by Subject|0|||
128725943|NCT02919670|463294709|FG000|Overall Study|Only 17 participants met compliance|43|||
128725944|NCT02919670|463294710|FG001|Overall Study|Only 17 participants met compliance|39|||
128725945|NCT01466270|463294711|FG000|Overall Study|Withdrawal by Subject|4|||
128725946|NCT01466270|463294712|FG001|Overall Study|Withdrawal by Subject|1|||
128725947|NCT01466270|463294711|FG000|Overall Study|Physician Decision|1|||
128725948|NCT01466270|463294712|FG001|Overall Study|Physician Decision|0|||
129158263|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158264|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158265|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158266|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158267|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129158268|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158269|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158270|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158271|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158272|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158273|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158274|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158275|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158276|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158277|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158278|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
129158279|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158280|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158281|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158282|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158283|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129158284|NCT02891226|464874761|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158285|NCT02891226|464874762|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158286|NCT02891226|464874763|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158287|NCT02891226|464874764|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158288|NCT02891226|464874765|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158289|NCT02891226|464874766|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158290|NCT02891226|464874767|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158291|NCT02891226|464874768|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158292|NCT02891226|464874769|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158293|NCT02891226|464874770|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158294|NCT02891226|464874771|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
129158295|NCT02891226|464874772|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158296|NCT02891226|464874773|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158297|NCT02891226|464874774|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
128725949|NCT01466270|463294711|FG000|Overall Study|Lost to Follow-up|1|||
128725950|NCT01466270|463294712|FG001|Overall Study|Lost to Follow-up|3|||
128725951|NCT01466270|463294711|FG000|Overall Study|Progression|1|||
129158298|NCT02891226|464874775|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158299|NCT02891226|464874776|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129158300|NCT02891226|464874761|FG000|Follow-up Period|Withdrawal by Subject|0|||
129158301|NCT02891226|464874762|FG001|Follow-up Period|Withdrawal by Subject|0|||
129158302|NCT02891226|464874763|FG002|Follow-up Period|Withdrawal by Subject|0|||
129158303|NCT02891226|464874764|FG003|Follow-up Period|Withdrawal by Subject|0|||
129158304|NCT02891226|464874765|FG004|Follow-up Period|Withdrawal by Subject|0|||
129158305|NCT02891226|464874766|FG005|Follow-up Period|Withdrawal by Subject|0|||
129158306|NCT02891226|464874767|FG006|Follow-up Period|Withdrawal by Subject|0|||
128725952|NCT01466270|463294712|FG001|Overall Study|Progression|0|||
128725953|NCT01466270|463294711|FG000|Overall Study|Toxicity|4|||
128725954|NCT01466270|463294712|FG001|Overall Study|Toxicity|1|||
128725955|NCT01466270|463294711|FG000|Overall Study|Multiple|1|||
128776880|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
128725956|NCT01466270|463294712|FG001|Overall Study|Multiple|1|||
128725957|NCT04206293|463294717|FG000|Overall Study|Consent withdrawal|1|||
128725958|NCT01454934|463294720|FG000|Overall Study|Clinical progression|28|||
128725959|NCT01454934|463294721|FG001|Overall Study|Clinical progression|25|||
128725960|NCT01454934|463294720|FG000|Overall Study|Other|6|||
128725961|NCT01454934|463294721|FG001|Overall Study|Other|17|||
129158307|NCT02891226|464874768|FG007|Follow-up Period|Withdrawal by Subject|0|||
129158308|NCT02891226|464874769|FG008|Follow-up Period|Withdrawal by Subject|0|||
129158309|NCT02891226|464874770|FG009|Follow-up Period|Withdrawal by Subject|0|||
129158310|NCT02891226|464874771|FG010|Follow-up Period|Withdrawal by Subject|0|||
129158311|NCT02891226|464874772|FG011|Follow-up Period|Withdrawal by Subject|1|||
129158312|NCT02891226|464874773|FG012|Follow-up Period|Withdrawal by Subject|0|||
129158313|NCT02891226|464874774|FG013|Follow-up Period|Withdrawal by Subject|0|||
129158314|NCT02891226|464874775|FG014|Follow-up Period|Withdrawal by Subject|1|||
129158315|NCT02891226|464874776|FG015|Follow-up Period|Withdrawal by Subject|1|||
129158316|NCT00145626|464874777|FG000|Overall Study|Did not have NK infusions|2|||
129158317|NCT00145626|464874777|FG000|Overall Study|Turned 2 years old before treatment|1|||
129158318|NCT00145626|464874777|FG000|Overall Study|Death|1|||
129158319|NCT00145626|464874777|FG000|Overall Study|Withdrawal by Subject|1|||
129158320|NCT03381287|464874778|FG000|Overall Study|Withdrawal by Subject|0|||
129158321|NCT03381287|464874779|FG001|Overall Study|Withdrawal by Subject|1|||
129158322|NCT03381287|464874780|FG002|Overall Study|Withdrawal by Subject|0|||
129158323|NCT03381287|464874781|FG003|Overall Study|Withdrawal by Subject|0|||
129158324|NCT03381287|464874778|FG000|Overall Study|Adverse Event|0|||
129158325|NCT03381287|464874779|FG001|Overall Study|Adverse Event|0|||
129158326|NCT03381287|464874780|FG002|Overall Study|Adverse Event|0|||
129158327|NCT03381287|464874781|FG003|Overall Study|Adverse Event|1|||
129158328|NCT03381287|464874778|FG000|Overall Study|Physician Decision|0|||
129158329|NCT03381287|464874779|FG001|Overall Study|Physician Decision|0|||
129158330|NCT03381287|464874780|FG002|Overall Study|Physician Decision|0|||
129158331|NCT03381287|464874781|FG003|Overall Study|Physician Decision|1|||
129158332|NCT03654274|464874782|FG000|Overall Study|Adverse Event|19|||
129158333|NCT03654274|464874783|FG001|Overall Study|Adverse Event|23|||
128725962|NCT01454934|463294720|FG000|Overall Study|Adverse Event|28|||
128725963|NCT01454934|463294721|FG001|Overall Study|Adverse Event|24|||
128725964|NCT01454934|463294720|FG000|Overall Study|Withdrawn consent|2|||
128725965|NCT01454934|463294721|FG001|Overall Study|Withdrawn consent|5|||
128725966|NCT01454934|463294720|FG000|Overall Study|Withdrawal by Subject|11|||
128725967|NCT01454934|463294721|FG001|Overall Study|Withdrawal by Subject|15|||
128725968|NCT01454934|463294720|FG000|Overall Study|Disease progression|194|||
128725969|NCT01454934|463294721|FG001|Overall Study|Disease progression|181|||
128725970|NCT01454934|463294720|FG000|Overall Study|Lost to Follow-up|0|||
128725971|NCT01454934|463294721|FG001|Overall Study|Lost to Follow-up|1|||
128725972|NCT01454934|463294720|FG000|Overall Study|Not treated|1|||
128725973|NCT01454934|463294721|FG001|Overall Study|Not treated|2|||
128725974|NCT00430092|463294724|FG000|Overall Study|Adverse Event|0|||
128725975|NCT00430092|463294725|FG001|Overall Study|Adverse Event|0|||
128725976|NCT00430092|463294726|FG002|Overall Study|Adverse Event|1|||
128725977|NCT00430092|463294724|FG000|Overall Study|Lack of Efficacy|5|||
128725978|NCT00430092|463294725|FG001|Overall Study|Lack of Efficacy|2|||
128725979|NCT00430092|463294726|FG002|Overall Study|Lack of Efficacy|54|||
128725980|NCT00430092|463294724|FG000|Overall Study|Lost to Follow-up|1|||
128725981|NCT00430092|463294725|FG001|Overall Study|Lost to Follow-up|0|||
128725982|NCT00430092|463294726|FG002|Overall Study|Lost to Follow-up|0|||
128725983|NCT00430092|463294724|FG000|Overall Study|Protocol Violation|0|||
128725984|NCT00430092|463294725|FG001|Overall Study|Protocol Violation|1|||
128725985|NCT00430092|463294726|FG002|Overall Study|Protocol Violation|1|||
128725986|NCT00430092|463294724|FG000|Overall Study|Withdrawal by Subject|0|||
128725987|NCT00430092|463294725|FG001|Overall Study|Withdrawal by Subject|1|||
128725988|NCT00430092|463294726|FG002|Overall Study|Withdrawal by Subject|1|||
129158334|NCT03654274|464874784|FG002|Overall Study|Adverse Event|24|||
129158335|NCT03654274|464874782|FG000|Overall Study|Protocol Deviation|0|||
129158336|NCT03654274|464874783|FG001|Overall Study|Protocol Deviation|2|||
129158337|NCT03654274|464874784|FG002|Overall Study|Protocol Deviation|0|||
129158338|NCT03654274|464874782|FG000|Overall Study|Lost to Follow-up|8|||
129158339|NCT03654274|464874783|FG001|Overall Study|Lost to Follow-up|6|||
129158340|NCT03654274|464874784|FG002|Overall Study|Lost to Follow-up|5|||
129158341|NCT03654274|464874782|FG000|Overall Study|Withdrawal by Subject|46|||
129158342|NCT03654274|464874783|FG001|Overall Study|Withdrawal by Subject|25|||
129158343|NCT03654274|464874784|FG002|Overall Study|Withdrawal by Subject|33|||
129158344|NCT03654274|464874782|FG000|Overall Study|Lack of Efficacy|4|||
129158345|NCT03654274|464874783|FG001|Overall Study|Lack of Efficacy|5|||
129158346|NCT03654274|464874784|FG002|Overall Study|Lack of Efficacy|7|||
129158347|NCT03654274|464874782|FG000|Overall Study|Pregnancy|2|||
128725989|NCT00706966|463294730|FG000|Overall Study|Adverse Event|1|||
128725990|NCT02884089|463294733|FG000|Period 1|Dosing error|2|||
128725991|NCT02884089|463294734|FG001|Period 1|Dosing error|2|||
128725992|NCT02884089|463294735|FG002|Period 1|Dosing error|0|||
128725993|NCT02884089|463294736|FG003|Period 1|Dosing error|0|||
128725994|NCT02884089|463294733|FG000|Washout Period 1|Lost to Follow-up|0|||
128725995|NCT02884089|463294734|FG001|Washout Period 1|Lost to Follow-up|1|||
128725996|NCT02884089|463294735|FG002|Washout Period 1|Lost to Follow-up|0|||
128725997|NCT02884089|463294736|FG003|Washout Period 1|Lost to Follow-up|1|||
129158348|NCT03654274|464874783|FG001|Overall Study|Pregnancy|2|||
129158349|NCT03654274|464874784|FG002|Overall Study|Pregnancy|1|||
129158350|NCT03654274|464874782|FG000|Overall Study|Other|27|||
129158351|NCT03654274|464874783|FG001|Overall Study|Other|29|||
129158352|NCT03654274|464874784|FG002|Overall Study|Other|32|||
129158353|NCT03654274|464874782|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
129158354|NCT03654274|464874783|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
129158355|NCT03654274|464874784|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
129158356|NCT01265992|464874785|FG000|Overall Study|Lost to Follow-up|1|||
129158357|NCT01265992|464874785|FG000|Overall Study|Withdrawal by Subject|1|||
129158358|NCT01265992|464874785|FG000|Overall Study|Adverse Event|1|||
128725998|NCT02884089|463294733|FG000|Washout Period 1|Withdrawal by Subject|0|||
128725999|NCT02884089|463294734|FG001|Washout Period 1|Withdrawal by Subject|1|||
128726000|NCT02884089|463294735|FG002|Washout Period 1|Withdrawal by Subject|0|||
128726001|NCT02884089|463294736|FG003|Washout Period 1|Withdrawal by Subject|0|||
128726002|NCT02884089|463294733|FG000|Period 2|Adverse Event|1|||
128726003|NCT02884089|463294734|FG001|Period 2|Adverse Event|0|||
128726004|NCT02884089|463294735|FG002|Period 2|Adverse Event|0|||
128726005|NCT02884089|463294736|FG003|Period 2|Adverse Event|0|||
128726006|NCT02884089|463294733|FG000|Period 3|Withdrawal by Subject|0|||
128726007|NCT02884089|463294734|FG001|Period 3|Withdrawal by Subject|0|||
128726008|NCT02884089|463294735|FG002|Period 3|Withdrawal by Subject|1|||
128726009|NCT02884089|463294736|FG003|Period 3|Withdrawal by Subject|0|||
128726010|NCT02884089|463294733|FG000|Washout Period 3|Withdrawal by Subject|0|||
128726011|NCT02884089|463294734|FG001|Washout Period 3|Withdrawal by Subject|0|||
128726012|NCT02884089|463294735|FG002|Washout Period 3|Withdrawal by Subject|1|||
128726013|NCT02884089|463294736|FG003|Washout Period 3|Withdrawal by Subject|0|||
129158359|NCT01265992|464874785|FG000|Overall Study|Administrative reasons|2|||
129158360|NCT01265992|464874785|FG000|Overall Study|Stopped treatment|3|||
129158361|NCT01265992|464874785|FG000|Overall Study|Did not receive treatment|1|||
129158362|NCT05005273|464874786|FG000|Overall Study|Study Terminated|1|||
129158363|NCT05005273|464874787|FG001|Overall Study|Study Terminated|0|||
129158364|NCT02685826|464874792|FG000|Overall Study|Adverse Event|2|||
129158365|NCT02685826|464874793|FG001|Overall Study|Adverse Event|0|||
129158366|NCT02685826|464874794|FG002|Overall Study|Adverse Event|1|||
129158367|NCT02685826|464874792|FG000|Overall Study|Progressive Disease|2|||
129158368|NCT02685826|464874793|FG001|Overall Study|Progressive Disease|1|||
129158369|NCT02685826|464874794|FG002|Overall Study|Progressive Disease|0|||
129158370|NCT02685826|464874792|FG000|Overall Study|Withdrawal by Subject|2|||
129158371|NCT02685826|464874793|FG001|Overall Study|Withdrawal by Subject|0|||
129158372|NCT02685826|464874794|FG002|Overall Study|Withdrawal by Subject|0|||
129158373|NCT02685826|464874792|FG000|Overall Study|Full Clinical Hold by FDA|19|||
129158374|NCT02685826|464874793|FG001|Overall Study|Full Clinical Hold by FDA|9|||
129158375|NCT02685826|464874794|FG002|Overall Study|Full Clinical Hold by FDA|20|||
129158376|NCT03154476|464874795|FG000|Overall Study|Lost to Follow-up|4|||
129158377|NCT03154476|464874796|FG001|Overall Study|Lost to Follow-up|4|||
129158378|NCT00200967|464874797|FG000|First Treatment Period|Withdrawal by Subject|5|||
129158379|NCT00200967|464874798|FG001|First Treatment Period|Withdrawal by Subject|1|||
129158380|NCT00200967|464874797|FG000|First Treatment Period|Pregnancy|1|||
129158381|NCT00200967|464874798|FG001|First Treatment Period|Pregnancy|0|||
129158382|NCT00200967|464874797|FG000|Wash-out Period|Lost to Follow-up|0|||
129158383|NCT00200967|464874798|FG001|Wash-out Period|Lost to Follow-up|1|||
129158384|NCT00200967|464874797|FG000|Second Treatment Period|Withdrawal by Subject|1|||
129158385|NCT00200967|464874798|FG001|Second Treatment Period|Withdrawal by Subject|2|||
129158386|NCT00200967|464874797|FG000|Run-out Period|Lost to Follow-up|1|||
129158387|NCT00200967|464874798|FG001|Run-out Period|Lost to Follow-up|0|||
129158388|NCT01444430|464874801|FG000|Overall Study|Withdrawal by Subject|53|||
129158389|NCT01444430|464874802|FG001|Overall Study|Withdrawal by Subject|72|||
129158390|NCT01444430|464874801|FG000|Overall Study|Death|6|||
129158391|NCT01444430|464874802|FG001|Overall Study|Death|8|||
129158392|NCT01444430|464874801|FG000|Overall Study|Lost to Follow-up|2|||
129158393|NCT01444430|464874802|FG001|Overall Study|Lost to Follow-up|0|||
129158394|NCT01444430|464874801|FG000|Overall Study|CRF termination module not completed.|0|||
129158395|NCT01444430|464874802|FG001|Overall Study|CRF termination module not completed.|1|||
129158396|NCT04245449|464875819|FG000|Overall Study|COVID shutdown|7|||
129158397|NCT02197572|464875824|FG000|Overall Study|Progressive Disease|28|||
129158398|NCT02197572|464875824|FG000|Overall Study|Withdrawal by Subject|9|||
129158399|NCT02197572|464875824|FG000|Overall Study|Adverse Event|3|||
129158400|NCT02197572|464875824|FG000|Overall Study|Reason Not Specified|4|||
128726014|NCT02884089|463294733|FG000|Washout Period 3|Lost to Follow-up|0|||
128726015|NCT02884089|463294734|FG001|Washout Period 3|Lost to Follow-up|0|||
128726016|NCT02884089|463294735|FG002|Washout Period 3|Lost to Follow-up|0|||
129158401|NCT01484496|464875829|FG000|Period 1|Protocol Violation|3|||
129158402|NCT01484496|464875830|FG001|Period 1|Protocol Violation|4|||
129158403|NCT01484496|464875831|FG002|Period 1|Protocol Violation|0|||
129158404|NCT01484496|464875832|FG003|Period 1|Protocol Violation|0|||
129158405|NCT01484496|464875829|FG000|Period 1|Physician Decision|5|||
129158406|NCT01484496|464875830|FG001|Period 1|Physician Decision|1|||
128726017|NCT02884089|463294736|FG003|Washout Period 3|Lost to Follow-up|1|||
128726018|NCT02884089|463294733|FG000|Period 4|Withdrawal by Subject|0|||
128726019|NCT02884089|463294734|FG001|Period 4|Withdrawal by Subject|1|||
129158407|NCT01484496|464875831|FG002|Period 1|Physician Decision|0|||
129158408|NCT01484496|464875832|FG003|Period 1|Physician Decision|0|||
129158409|NCT01484496|464875829|FG000|Period 1|Lack of Efficacy|10|||
129158410|NCT01484496|464875830|FG001|Period 1|Lack of Efficacy|15|||
129158411|NCT01484496|464875831|FG002|Period 1|Lack of Efficacy|0|||
129158412|NCT01484496|464875832|FG003|Period 1|Lack of Efficacy|0|||
129158413|NCT01484496|464875829|FG000|Period 1|Adverse Event|25|||
129158414|NCT01484496|464875830|FG001|Period 1|Adverse Event|40|||
128726020|NCT02884089|463294735|FG002|Period 4|Withdrawal by Subject|0|||
128726021|NCT02884089|463294736|FG003|Period 4|Withdrawal by Subject|0|||
128726022|NCT02884089|463294733|FG000|Period 4|Lost to Follow-up|1|||
128726023|NCT02884089|463294734|FG001|Period 4|Lost to Follow-up|0|||
128726024|NCT02884089|463294735|FG002|Period 4|Lost to Follow-up|0|||
128726025|NCT02884089|463294736|FG003|Period 4|Lost to Follow-up|0|||
128726026|NCT02884089|463294733|FG000|Follow-up Visit|Withdrawal by Subject|1|||
128726027|NCT02884089|463294734|FG001|Follow-up Visit|Withdrawal by Subject|0|||
128726028|NCT02884089|463294735|FG002|Follow-up Visit|Withdrawal by Subject|0|||
128726029|NCT02884089|463294736|FG003|Follow-up Visit|Withdrawal by Subject|1|||
128726030|NCT01631474|463294737|FG000|Overall Study|Lost to Follow-up|8|||
129158415|NCT01484496|464875831|FG002|Period 1|Adverse Event|0|||
129158416|NCT01484496|464875832|FG003|Period 1|Adverse Event|0|||
129158417|NCT01484496|464875829|FG000|Period 1|Withdrawal by Subject|15|||
129158418|NCT01484496|464875830|FG001|Period 1|Withdrawal by Subject|12|||
129158419|NCT01484496|464875831|FG002|Period 1|Withdrawal by Subject|0|||
129158420|NCT01484496|464875832|FG003|Period 1|Withdrawal by Subject|0|||
129158421|NCT01484496|464875829|FG000|Period 1|Lost to Follow-up|2|||
129158422|NCT01484496|464875830|FG001|Period 1|Lost to Follow-up|6|||
128726031|NCT01631474|463294738|FG001|Overall Study|Lost to Follow-up|5|||
128726032|NCT01631474|463294739|FG002|Overall Study|Lost to Follow-up|7|||
128726033|NCT01631474|463294740|FG003|Overall Study|Lost to Follow-up|5|||
128726034|NCT01631474|463294741|FG004|Overall Study|Lost to Follow-up|5|||
128726035|NCT01631474|463294737|FG000|Overall Study|Withdrawal by Subject|4|||
128726036|NCT01631474|463294738|FG001|Overall Study|Withdrawal by Subject|4|||
128726037|NCT01631474|463294739|FG002|Overall Study|Withdrawal by Subject|2|||
128726038|NCT01631474|463294740|FG003|Overall Study|Withdrawal by Subject|6|||
128726039|NCT01631474|463294741|FG004|Overall Study|Withdrawal by Subject|5|||
128726040|NCT01631474|463294737|FG000|Overall Study|Lack of Efficacy|2|||
128726041|NCT01631474|463294738|FG001|Overall Study|Lack of Efficacy|2|||
128726042|NCT01631474|463294739|FG002|Overall Study|Lack of Efficacy|0|||
128726043|NCT01631474|463294740|FG003|Overall Study|Lack of Efficacy|0|||
128726044|NCT01631474|463294741|FG004|Overall Study|Lack of Efficacy|2|||
128726045|NCT01631474|463294737|FG000|Overall Study|Noncompliance with Study Drug|0|||
128726046|NCT01631474|463294738|FG001|Overall Study|Noncompliance with Study Drug|0|||
128726047|NCT01631474|463294739|FG002|Overall Study|Noncompliance with Study Drug|0|||
128726048|NCT01631474|463294740|FG003|Overall Study|Noncompliance with Study Drug|0|||
128726049|NCT01631474|463294741|FG004|Overall Study|Noncompliance with Study Drug|1|||
128726050|NCT01631474|463294737|FG000|Overall Study|Adverse Event|0|||
128726051|NCT01631474|463294738|FG001|Overall Study|Adverse Event|1|||
128726052|NCT01631474|463294739|FG002|Overall Study|Adverse Event|0|||
128726053|NCT01631474|463294740|FG003|Overall Study|Adverse Event|0|||
128726054|NCT01631474|463294741|FG004|Overall Study|Adverse Event|0|||
128726055|NCT02624284|463294742|FG000|Overall Study|Withdrawal by Subject|3|||
128726056|NCT02624284|463294743|FG001|Overall Study|Withdrawal by Subject|6|||
129158423|NCT01484496|464875831|FG002|Period 1|Lost to Follow-up|0|||
129158424|NCT01484496|464875832|FG003|Period 1|Lost to Follow-up|0|||
129158425|NCT01484496|464875829|FG000|Period 1|Positive Pregnancy|1|||
129158426|NCT01484496|464875830|FG001|Period 1|Positive Pregnancy|6|||
129158427|NCT01484496|464875831|FG002|Period 1|Positive Pregnancy|0|||
129158428|NCT01484496|464875832|FG003|Period 1|Positive Pregnancy|0|||
129158429|NCT01484496|464875829|FG000|Period 1|Treatment Failure|3|||
128726057|NCT02624284|463294744|FG002|Overall Study|Withdrawal by Subject|3|||
128726058|NCT02624284|463294742|FG000|Overall Study|Protocol Violation|9|||
128726059|NCT02624284|463294743|FG001|Overall Study|Protocol Violation|10|||
128726060|NCT02624284|463294744|FG002|Overall Study|Protocol Violation|7|||
128726061|NCT02624284|463294742|FG000|Overall Study|Revealed exclusionary condition|2|||
128726062|NCT02624284|463294743|FG001|Overall Study|Revealed exclusionary condition|2|||
128726063|NCT02624284|463294744|FG002|Overall Study|Revealed exclusionary condition|0|||
128726064|NCT02624284|463294742|FG000|Overall Study|Adverse Event|0|||
128726065|NCT02624284|463294743|FG001|Overall Study|Adverse Event|0|||
128726066|NCT02624284|463294744|FG002|Overall Study|Adverse Event|1|||
129158430|NCT01484496|464875830|FG001|Period 1|Treatment Failure|6|||
129158431|NCT01484496|464875831|FG002|Period 1|Treatment Failure|0|||
129158432|NCT01484496|464875832|FG003|Period 1|Treatment Failure|0|||
128726067|NCT01641367|463294749|FG000|Cohorts|Death|18|||
128726068|NCT01641367|463294750|FG001|Cohorts|Death|1|||
129158433|NCT01484496|464875829|FG000|Period 1|Lack of Compliance|2|||
129158434|NCT01484496|464875830|FG001|Period 1|Lack of Compliance|1|||
129158435|NCT01484496|464875831|FG002|Period 1|Lack of Compliance|0|||
129158436|NCT01484496|464875832|FG003|Period 1|Lack of Compliance|0|||
129158437|NCT01484496|464875829|FG000|Period 1|Unable to Visit Site|0|||
129158438|NCT01484496|464875830|FG001|Period 1|Unable to Visit Site|2|||
129158439|NCT01484496|464875831|FG002|Period 1|Unable to Visit Site|0|||
129158440|NCT01484496|464875832|FG003|Period 1|Unable to Visit Site|0|||
129158441|NCT01484496|464875829|FG000|Period 2|Lack of Efficacy|0|||
129158442|NCT01484496|464875830|FG001|Period 2|Lack of Efficacy|0|||
129158443|NCT01484496|464875831|FG002|Period 2|Lack of Efficacy|1|||
129158444|NCT01484496|464875832|FG003|Period 2|Lack of Efficacy|3|||
129158445|NCT01484496|464875829|FG000|Period 2|Adverse Event|0|||
129158446|NCT01484496|464875830|FG001|Period 2|Adverse Event|0|||
129158447|NCT01484496|464875831|FG002|Period 2|Adverse Event|5|||
129158448|NCT01484496|464875832|FG003|Period 2|Adverse Event|13|||
129158449|NCT01484496|464875829|FG000|Period 2|Other|0|||
129158450|NCT01484496|464875830|FG001|Period 2|Other|0|||
129158451|NCT01484496|464875831|FG002|Period 2|Other|9|||
129158452|NCT01484496|464875832|FG003|Period 2|Other|6|||
129158453|NCT01645735|464875833|FG000|Overall Study|Physician Decision|2|||
129158454|NCT01645735|464875834|FG001|Overall Study|Physician Decision|0|||
129158455|NCT01645735|464875833|FG000|Overall Study|Withdrawal by Subject|1|||
129158456|NCT01645735|464875834|FG001|Overall Study|Withdrawal by Subject|0|||
129158457|NCT01645735|464875833|FG000|Overall Study|Protocol Violation|1|||
129158458|NCT01645735|464875834|FG001|Overall Study|Protocol Violation|0|||
129158459|NCT01645735|464875833|FG000|Overall Study|Adverse Event|0|||
129158460|NCT01645735|464875834|FG001|Overall Study|Adverse Event|1|||
129158461|NCT00573391|464875837|FG000|Overall Study|study stopped|2|||
129158462|NCT00573391|464875838|FG001|Overall Study|study stopped|2|||
129158463|NCT00573391|464875837|FG000|Overall Study|Death|1|||
129158464|NCT00573391|464875838|FG001|Overall Study|Death|0|||
129158465|NCT03369665|464875839|FG000|Overall Study|Adverse Event|3|||
129158466|NCT03369665|464875839|FG000|Overall Study|Lost to Follow-up|7|||
129158467|NCT03369665|464875839|FG000|Overall Study|Withdrawal by Subject|15|||
129158468|NCT03369665|464875839|FG000|Overall Study|Progression Disease|2|||
129158469|NCT03369665|464875839|FG000|Overall Study|Not classified|3|||
129158470|NCT02553928|464875840|FG000|Overall Study|Adverse Event|2|||
129158471|NCT02553928|464875841|FG001|Overall Study|Adverse Event|1|||
129158472|NCT02553928|464875840|FG000|Overall Study|Lost to Follow-up|0|||
129158473|NCT02553928|464875841|FG001|Overall Study|Lost to Follow-up|1|||
129158474|NCT02553928|464875840|FG000|Overall Study|Administrative reason(s)|0|||
129158475|NCT02553928|464875841|FG001|Overall Study|Administrative reason(s)|1|||
129158476|NCT01206140|464875847|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
129158477|NCT01206140|464875848|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
129158478|NCT02688192|464875849|FG000|Overall Study|Lost to Follow-up|11|||
129158479|NCT02688192|464875850|FG001|Overall Study|Lost to Follow-up|5|||
129158480|NCT02688192|464875849|FG000|Overall Study|Physician Decision|1|||
129158481|NCT02688192|464875850|FG001|Overall Study|Physician Decision|0|||
129158482|NCT00075764|464875851|FG000|Overall Study|Adverse Event|5|||
129158483|NCT00075764|464875852|FG001|Overall Study|Adverse Event|12|||
129158484|NCT00075764|464875851|FG000|Overall Study|Death|4|||
129158485|NCT00075764|464875852|FG001|Overall Study|Death|8|||
129158486|NCT00075764|464875851|FG000|Overall Study|Withdrawal by Subject|28|||
129158487|NCT00075764|464875852|FG001|Overall Study|Withdrawal by Subject|18|||
129158488|NCT00075764|464875851|FG000|Overall Study|Progression|269|||
129158489|NCT00075764|464875852|FG001|Overall Study|Progression|274|||
129158490|NCT00075764|464875851|FG000|Overall Study|Still on treatment|8|||
129158491|NCT00075764|464875852|FG001|Overall Study|Still on treatment|15|||
129158492|NCT00075764|464875851|FG000|Overall Study|Delinquent|4|||
129158493|NCT00075764|464875852|FG001|Overall Study|Delinquent|2|||
129158494|NCT00075764|464875851|FG000|Overall Study|Not protocol specified|27|||
129158495|NCT00075764|464875852|FG001|Overall Study|Not protocol specified|19|||
129158496|NCT00075764|464875851|FG000|Overall Study|Under review|0|||
129158497|NCT00075764|464875852|FG001|Overall Study|Under review|1|||
129158498|NCT02817594|464875853|FG000|Overall Study|Withdrawal by Subject|1|||
129158499|NCT02817594|464875853|FG000|Overall Study|Other|1|||
129158500|NCT02817594|464875853|FG000|Overall Study|Did Not Receive Treatment|1|||
129158501|NCT02010593|464875854|FG000|Overall Study|Lost to Follow-up|1|||
129158502|NCT02010593|464875855|FG001|Overall Study|Lost to Follow-up|0|||
129158503|NCT02010593|464875854|FG000|Overall Study|Physician Decision|1|||
129158504|NCT02010593|464875855|FG001|Overall Study|Physician Decision|0|||
129158505|NCT02010593|464875854|FG000|Overall Study|Unable to adhere to visit schedule|0|||
129158506|NCT02010593|464875855|FG001|Overall Study|Unable to adhere to visit schedule|2|||
129158507|NCT01773967|464875856|FG000|Overall Study|Lost to Follow-up|15|||
129158508|NCT01773967|464875857|FG001|Overall Study|Lost to Follow-up|13|||
129158509|NCT01135459|464875858|FG000|Overall Study|Adverse Event|8|||
129158510|NCT01135459|464875859|FG001|Overall Study|Adverse Event|10|||
129158511|NCT01135459|464875858|FG000|Overall Study|Lack of Efficacy|3|||
129158512|NCT01135459|464875859|FG001|Overall Study|Lack of Efficacy|1|||
129158513|NCT01135459|464875858|FG000|Overall Study|Withdrawal by Subject|2|||
129158514|NCT01135459|464875859|FG001|Overall Study|Withdrawal by Subject|3|||
129158515|NCT01135459|464875858|FG000|Overall Study|Protocol Violation|5|||
129158516|NCT01135459|464875859|FG001|Overall Study|Protocol Violation|3|||
129158517|NCT01135459|464875858|FG000|Overall Study|Lost to Follow-up|2|||
129158518|NCT01135459|464875859|FG001|Overall Study|Lost to Follow-up|1|||
129158519|NCT01135459|464875858|FG000|Overall Study|Non-compliance to study procedures|0|||
129158520|NCT01135459|464875859|FG001|Overall Study|Non-compliance to study procedures|1|||
129158521|NCT01135459|464875858|FG000|Overall Study|Other than specified|1|||
129158522|NCT01135459|464875859|FG001|Overall Study|Other than specified|1|||
129158523|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
129158524|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
129158525|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158526|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158527|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158528|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158529|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158530|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158531|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158532|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129158533|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
129158534|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
129158535|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158536|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158537|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158538|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158539|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158540|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158541|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158542|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129158543|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
129158544|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158545|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158546|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158547|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158548|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158549|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158550|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158551|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158552|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129158553|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
129158554|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
129158555|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158556|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158557|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158558|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158559|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158560|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158561|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158562|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129158563|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158564|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
129158565|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158566|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158567|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158568|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158569|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158570|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158571|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158572|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129158573|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
129158574|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
129158575|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158576|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158577|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158578|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158579|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158580|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158581|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158582|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129158583|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
129158584|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
129158585|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158586|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158587|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158588|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158589|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158590|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158591|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158592|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129158593|NCT01194219|464875860|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
129158594|NCT01194219|464875861|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
129158595|NCT01194219|464875862|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158596|NCT01194219|464875863|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158597|NCT01194219|464875864|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158598|NCT01194219|464875865|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158599|NCT01194219|464875866|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158600|NCT01194219|464875867|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158601|NCT01194219|464875868|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158602|NCT01194219|464875869|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129158603|NCT01194219|464875860|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158604|NCT01194219|464875861|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158605|NCT01194219|464875862|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
129158606|NCT01194219|464875863|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
129158607|NCT01194219|464875864|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158608|NCT01194219|464875865|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158609|NCT01194219|464875866|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158610|NCT01194219|464875867|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158611|NCT01194219|464875868|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158612|NCT01194219|464875869|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
129158613|NCT01194219|464875860|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158614|NCT01194219|464875861|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158615|NCT01194219|464875862|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
129158616|NCT01194219|464875863|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
129158617|NCT01194219|464875864|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158618|NCT01194219|464875865|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158619|NCT01194219|464875866|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158620|NCT01194219|464875867|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158621|NCT01194219|464875868|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158622|NCT01194219|464875869|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129158623|NCT01194219|464875860|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158624|NCT01194219|464875861|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158625|NCT01194219|464875862|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
129158626|NCT01194219|464875863|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
129158627|NCT01194219|464875864|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158628|NCT01194219|464875865|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158629|NCT01194219|464875866|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158630|NCT01194219|464875867|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158631|NCT01194219|464875868|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158632|NCT01194219|464875869|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129158633|NCT01194219|464875860|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158634|NCT01194219|464875861|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158635|NCT01194219|464875862|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
129158636|NCT01194219|464875863|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
129158637|NCT01194219|464875864|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158638|NCT01194219|464875865|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158639|NCT01194219|464875866|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158640|NCT01194219|464875867|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158641|NCT01194219|464875868|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158642|NCT01194219|464875869|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129158643|NCT01194219|464875860|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158644|NCT01194219|464875861|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158645|NCT01194219|464875862|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
129158646|NCT01194219|464875863|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158647|NCT01194219|464875864|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158648|NCT01194219|464875865|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158649|NCT01194219|464875866|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158650|NCT01194219|464875867|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158651|NCT01194219|464875868|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158652|NCT01194219|464875869|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129158653|NCT01194219|464875860|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158654|NCT01194219|464875861|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158655|NCT01194219|464875862|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158656|NCT01194219|464875863|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
129158657|NCT01194219|464875864|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158658|NCT01194219|464875865|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158659|NCT01194219|464875866|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158660|NCT01194219|464875867|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158661|NCT01194219|464875868|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158662|NCT01194219|464875869|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129158663|NCT01194219|464875860|FG000|Maintenance Phase Weeks16-32|Other|0|||
129158664|NCT01194219|464875861|FG001|Maintenance Phase Weeks16-32|Other|0|||
129158665|NCT01194219|464875862|FG002|Maintenance Phase Weeks16-32|Other|2|||
129158666|NCT01194219|464875863|FG003|Maintenance Phase Weeks16-32|Other|1|||
129158667|NCT01194219|464875864|FG004|Maintenance Phase Weeks16-32|Other|0|||
129158668|NCT01194219|464875865|FG005|Maintenance Phase Weeks16-32|Other|0|||
129158669|NCT01194219|464875866|FG006|Maintenance Phase Weeks16-32|Other|0|||
129158670|NCT01194219|464875867|FG007|Maintenance Phase Weeks16-32|Other|0|||
129158671|NCT01194219|464875868|FG008|Maintenance Phase Weeks16-32|Other|0|||
129158672|NCT01194219|464875869|FG009|Maintenance Phase Weeks16-32|Other|0|||
129158673|NCT01194219|464875860|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129158674|NCT01194219|464875861|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129158675|NCT01194219|464875862|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129158676|NCT01194219|464875863|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129158677|NCT01194219|464875864|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129158678|NCT01194219|464875865|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
129158679|NCT01194219|464875866|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
129158680|NCT01194219|464875867|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
129158681|NCT01194219|464875868|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129158682|NCT01194219|464875869|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129158683|NCT01194219|464875860|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129158684|NCT01194219|464875861|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129158685|NCT01194219|464875862|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129158686|NCT01194219|464875863|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129158687|NCT01194219|464875864|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
129158688|NCT01194219|464875865|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
129158689|NCT01194219|464875866|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
129158690|NCT01194219|464875867|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
129158691|NCT01194219|464875868|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129158692|NCT01194219|464875869|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129158693|NCT01194219|464875860|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158694|NCT01194219|464875861|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158695|NCT01194219|464875862|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158696|NCT01194219|464875863|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158697|NCT01194219|464875864|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
129158698|NCT01194219|464875865|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158699|NCT01194219|464875866|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
129158700|NCT01194219|464875867|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158701|NCT01194219|464875868|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158702|NCT01194219|464875869|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129158703|NCT01194219|464875860|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129158704|NCT01194219|464875861|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129158705|NCT01194219|464875862|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129158706|NCT01194219|464875863|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129158707|NCT01194219|464875864|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
129158708|NCT01194219|464875865|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129158709|NCT01194219|464875866|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
129158710|NCT01194219|464875867|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
129158711|NCT01194219|464875868|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129158712|NCT01194219|464875869|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129158713|NCT01194219|464875860|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129158714|NCT01194219|464875861|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129158715|NCT01194219|464875862|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129158716|NCT01194219|464875863|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129158717|NCT01194219|464875864|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
129158718|NCT01194219|464875865|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
129158719|NCT01194219|464875866|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
129158720|NCT01194219|464875867|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129158721|NCT01194219|464875868|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129158722|NCT01194219|464875869|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129158723|NCT01194219|464875860|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158724|NCT01194219|464875861|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158725|NCT01194219|464875862|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158726|NCT01194219|464875863|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158727|NCT01194219|464875864|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158728|NCT01194219|464875865|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158729|NCT01194219|464875866|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158730|NCT01194219|464875867|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
129158731|NCT01194219|464875868|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158732|NCT01194219|464875869|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129158733|NCT01194219|464875860|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158734|NCT01194219|464875861|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158735|NCT01194219|464875862|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158736|NCT01194219|464875863|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158737|NCT01194219|464875864|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158738|NCT01194219|464875865|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158739|NCT01194219|464875866|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
129158740|NCT01194219|464875867|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158741|NCT01194219|464875868|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158742|NCT01194219|464875869|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129158743|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158744|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158745|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158746|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158747|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158748|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158749|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158750|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129158751|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
129158752|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
129158753|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158754|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158755|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158756|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158757|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158758|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158759|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158760|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129158761|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
129158762|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
129158763|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158764|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158765|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158766|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158767|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158768|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158769|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158770|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129158771|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
129158772|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
129158773|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129158774|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129158775|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
128726069|NCT01641367|463294751|FG002|Cohorts|Death|2|||
129158776|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
128726070|NCT01641367|463294752|FG003|Cohorts|Death|0|||
128726071|NCT01641367|463294753|FG004|Cohorts|Death|1|||
128726072|NCT01641367|463294754|FG005|Cohorts|Death|1|||
128726073|NCT01641367|463294755|FG006|Cohorts|Death|0|||
128726074|NCT01641367|463294756|FG007|Cohorts|Death|0|||
129158777|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129158778|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129158779|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129158780|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129158781|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
129158782|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
129158783|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
129158784|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
129158785|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
129158786|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
129158787|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
129158788|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
129158789|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
129158790|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
129158791|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
129158792|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
129158793|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158794|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158795|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158796|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158797|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158798|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158799|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158800|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129158801|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
129158802|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
129158803|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158804|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158805|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158806|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158807|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158808|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158809|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158810|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158811|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
129158812|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129158813|NCT01194219|464875860|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158814|NCT01194219|464875861|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158815|NCT01194219|464875862|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158816|NCT01194219|464875863|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158817|NCT01194219|464875864|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158818|NCT01194219|464875865|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158819|NCT01194219|464875866|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158820|NCT01194219|464875867|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129158821|NCT01194219|464875868|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
129158822|NCT01194219|464875869|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
129158823|NCT00292045|464875870|FG000|Core Study (Through Week 13)|Adverse Event|1|||
129158824|NCT00292045|464875870|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
129158825|NCT04474197|464875871|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
129158826|NCT04474197|464875872|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
129158827|NCT04474197|464875873|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
129158828|NCT04474197|464875874|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
129158829|NCT01871545|464875875|FG000|Overall Study|Death|2|||
129158830|NCT01871545|464875876|FG001|Overall Study|Death|0|||
129158831|NCT01871545|464875875|FG000|Overall Study|Lack of Efficacy|11|||
129158832|NCT01871545|464875876|FG001|Overall Study|Lack of Efficacy|2|||
129158833|NCT01871545|464875875|FG000|Overall Study|Physician Decision|4|||
129158834|NCT01871545|464875876|FG001|Overall Study|Physician Decision|0|||
129158835|NCT01871545|464875875|FG000|Overall Study|Withdrawal by Subject|0|||
129158836|NCT01871545|464875876|FG001|Overall Study|Withdrawal by Subject|1|||
129158837|NCT04834726|464875879|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
129158838|NCT04834726|464875880|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
129158839|NCT04834726|464875881|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
129158840|NCT04834726|464875882|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
129158841|NCT04834726|464875883|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
129158842|NCT04834726|464875884|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
129158843|NCT04834726|464875885|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
129158844|NCT04834726|464875886|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
129158845|NCT04834726|464875887|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
129158846|NCT03943290|464875891|FG000|Overall Study|Sponsor Terminated Study|6|||
129158847|NCT03943290|464875892|FG001|Overall Study|Sponsor Terminated Study|1|||
129158848|NCT03943290|464875893|FG002|Overall Study|Sponsor Terminated Study|11|||
129158849|NCT03943290|464875894|FG003|Overall Study|Sponsor Terminated Study|6|||
129158850|NCT03943290|464875895|FG004|Overall Study|Sponsor Terminated Study|7|||
129158851|NCT03943290|464875896|FG005|Overall Study|Sponsor Terminated Study|6|||
129158852|NCT03943290|464875897|FG006|Overall Study|Sponsor Terminated Study|6|||
129158853|NCT03943290|464875898|FG007|Overall Study|Sponsor Terminated Study|7|||
129158854|NCT03943290|464875899|FG008|Overall Study|Sponsor Terminated Study|8|||
129158855|NCT03943290|464875891|FG000|Overall Study|Lost to Follow-up|1|||
129158856|NCT03943290|464875892|FG001|Overall Study|Lost to Follow-up|0|||
129158857|NCT03943290|464875893|FG002|Overall Study|Lost to Follow-up|1|||
129158858|NCT03943290|464875894|FG003|Overall Study|Lost to Follow-up|0|||
129158859|NCT03943290|464875895|FG004|Overall Study|Lost to Follow-up|0|||
129158860|NCT03943290|464875896|FG005|Overall Study|Lost to Follow-up|0|||
129158861|NCT03943290|464875897|FG006|Overall Study|Lost to Follow-up|0|||
129158862|NCT03943290|464875898|FG007|Overall Study|Lost to Follow-up|1|||
129158863|NCT03943290|464875899|FG008|Overall Study|Lost to Follow-up|0|||
129158864|NCT03943290|464875891|FG000|Overall Study|Withdrawal by Subject|0|||
129158865|NCT03943290|464875892|FG001|Overall Study|Withdrawal by Subject|0|||
129158866|NCT03943290|464875893|FG002|Overall Study|Withdrawal by Subject|1|||
129158867|NCT03943290|464875894|FG003|Overall Study|Withdrawal by Subject|0|||
129158868|NCT03943290|464875895|FG004|Overall Study|Withdrawal by Subject|0|||
129158869|NCT03943290|464875896|FG005|Overall Study|Withdrawal by Subject|0|||
129158870|NCT03943290|464875897|FG006|Overall Study|Withdrawal by Subject|0|||
129158871|NCT03943290|464875898|FG007|Overall Study|Withdrawal by Subject|0|||
129158872|NCT03943290|464875899|FG008|Overall Study|Withdrawal by Subject|0|||
129158873|NCT00955474|464875900|FG000|Overall Study|Physician Decision|7|||
129158874|NCT00955474|464875901|FG001|Overall Study|Physician Decision|5|||
129158875|NCT01737762|464875902|FG000|Overall Study|Adverse Event|2|||
129158876|NCT01737762|464875903|FG001|Overall Study|Adverse Event|2|||
129158877|NCT01737762|464875902|FG000|Overall Study|Lost to Follow-up|1|||
129158878|NCT01737762|464875903|FG001|Overall Study|Lost to Follow-up|0|||
129158879|NCT01737762|464875902|FG000|Overall Study|Withdrawal by Subject|2|||
129158880|NCT01737762|464875903|FG001|Overall Study|Withdrawal by Subject|2|||
129158881|NCT01737762|464875902|FG000|Overall Study|Progressive disease|1|||
129158882|NCT01737762|464875903|FG001|Overall Study|Progressive disease|2|||
129158883|NCT01737762|464875902|FG000|Overall Study|Physician Decision|1|||
129158884|NCT01737762|464875903|FG001|Overall Study|Physician Decision|1|||
129158885|NCT01737762|464875902|FG000|Overall Study|Moved from area|2|||
129158886|NCT01737762|464875903|FG001|Overall Study|Moved from area|1|||
129158887|NCT01737762|464875902|FG000|Overall Study|Trial termination|11|||
129158888|NCT01737762|464875903|FG001|Overall Study|Trial termination|9|||
129158889|NCT02534883|464875905|FG000|Overall Study|Early Termination|8|||
129158890|NCT02534883|464875906|FG001|Overall Study|Early Termination|3|||
129158891|NCT00049257|464875907|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
129158892|NCT00049257|464875907|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
129158893|NCT00049257|464875907|FG000|Carboplatin, Paclitaxel|Death|2|||
129158894|NCT00049257|464875907|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
129158895|NCT04721158|464875908|FG000|Overall Study|Lost to Follow-up|4|||
129158896|NCT04721158|464875908|FG000|Overall Study|Device did not connect|1|||
129158897|NCT00132301|464875909|FG000|Overall Study|Death|7|||
129158898|NCT00132301|464875910|FG001|Overall Study|Death|6|||
129158899|NCT00132301|464875909|FG000|Overall Study|Withdrawal by Subject|5|||
129158900|NCT00132301|464875910|FG001|Overall Study|Withdrawal by Subject|2|||
129158901|NCT00132301|464875909|FG000|Overall Study|Physician Decision|1|||
129158902|NCT00132301|464875910|FG001|Overall Study|Physician Decision|1|||
129158903|NCT00132301|464875909|FG000|Overall Study|Lost to Follow-up|5|||
129158904|NCT00132301|464875910|FG001|Overall Study|Lost to Follow-up|3|||
129158905|NCT00132301|464875909|FG000|Overall Study|Other|1|||
129158906|NCT00132301|464875910|FG001|Overall Study|Other|1|||
129158907|NCT00132301|464875909|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
129158908|NCT00132301|464875910|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
129158909|NCT02012218|464875911|FG000|Overall Study|Withdrawal by Subject|1|||
129158910|NCT02012218|464875912|FG001|Overall Study|Withdrawal by Subject|0|||
129158911|NCT02012218|464875913|FG002|Overall Study|Withdrawal by Subject|1|||
129158912|NCT02012218|464875914|FG003|Overall Study|Withdrawal by Subject|1|||
129158913|NCT02012218|464875915|FG004|Overall Study|Withdrawal by Subject|1|||
129158914|NCT02012218|464875911|FG000|Overall Study|Adverse Event|1|||
129158915|NCT02012218|464875912|FG001|Overall Study|Adverse Event|0|||
129158916|NCT02012218|464875913|FG002|Overall Study|Adverse Event|0|||
129158917|NCT02012218|464875914|FG003|Overall Study|Adverse Event|1|||
129158918|NCT02012218|464875915|FG004|Overall Study|Adverse Event|0|||
129158919|NCT02012218|464875911|FG000|Overall Study|Lost to Follow-up|0|||
129158920|NCT02012218|464875912|FG001|Overall Study|Lost to Follow-up|1|||
129158921|NCT02012218|464875913|FG002|Overall Study|Lost to Follow-up|1|||
129158922|NCT02012218|464875914|FG003|Overall Study|Lost to Follow-up|0|||
129158923|NCT02012218|464875915|FG004|Overall Study|Lost to Follow-up|0|||
129158924|NCT02012218|464875911|FG000|Overall Study|Protocol Specified|1|||
129158925|NCT02012218|464875912|FG001|Overall Study|Protocol Specified|0|||
129158926|NCT02012218|464875913|FG002|Overall Study|Protocol Specified|0|||
129158927|NCT02012218|464875914|FG003|Overall Study|Protocol Specified|0|||
129158928|NCT02012218|464875915|FG004|Overall Study|Protocol Specified|0|||
129158929|NCT02012218|464875911|FG000|Overall Study|Protocol Deviation|1|||
129158930|NCT02012218|464875912|FG001|Overall Study|Protocol Deviation|0|||
129158931|NCT02012218|464875913|FG002|Overall Study|Protocol Deviation|0|||
129158932|NCT02012218|464875914|FG003|Overall Study|Protocol Deviation|0|||
129158933|NCT02012218|464875915|FG004|Overall Study|Protocol Deviation|0|||
129158934|NCT04872569|464875917|FG000|Overall Study|Withdrawal by Subject|2|||
129158935|NCT02382991|464875923|FG000|Overall Study|Adverse Event|1|||
129158936|NCT02382991|464875924|FG001|Overall Study|Adverse Event|2|||
129158937|NCT02382991|464875923|FG000|Overall Study|Lost to Follow-up|1|||
129158938|NCT02382991|464875924|FG001|Overall Study|Lost to Follow-up|0|||
129158939|NCT02382991|464875923|FG000|Overall Study|Withdrawal by Subject|0|||
129158940|NCT02382991|464875924|FG001|Overall Study|Withdrawal by Subject|1|||
129158941|NCT01445613|464875926|FG000|30-day Follow-up|Withdrawal by Subject|6|||
129158942|NCT01445613|464875926|FG000|30-day Follow-up|Physician Decision|3|||
129158943|NCT01445613|464875926|FG000|30-day Follow-up|Missed visit|23|||
129158944|NCT01445613|464875926|FG000|30-day Follow-up|Death|3|||
129158945|NCT01445613|464875926|FG000|1-year Follow-up|Withdrawal by Subject|12|||
129158946|NCT01445613|464875926|FG000|1-year Follow-up|Missed visit|29|||
129158947|NCT01445613|464875926|FG000|1-year Follow-up|Lost to Follow-up|2|||
129158948|NCT01445613|464875926|FG000|1-year Follow-up|Death|30|||
129158949|NCT01445613|464875926|FG000|1-year Follow-up|Physician Decision|2|||
129158950|NCT01445613|464875926|FG000|1-year Follow-up|Received a non-study stent|2|||
129158951|NCT04466384|464875927|FG000|First Phase|Protocol Violation|1|||
129158952|NCT04466384|464875928|FG001|First Phase|Protocol Violation|0|||
129158953|NCT04466384|464875927|FG000|First Phase|Missing data|1|||
129158954|NCT04466384|464875928|FG001|First Phase|Missing data|0|||
129158955|NCT04466384|464875927|FG000|Cross Over Phase|Physician Decision|1|||
129158956|NCT04466384|464875928|FG001|Cross Over Phase|Physician Decision|0|||
129158957|NCT04466384|464875927|FG000|Cross Over Phase|Withdrawal by Subject|0|||
129158958|NCT04466384|464875928|FG001|Cross Over Phase|Withdrawal by Subject|1|||
129158959|NCT03666988|464875929|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
129158960|NCT03666988|464875930|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
129158961|NCT03666988|464875931|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
129158962|NCT03666988|464875932|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
129158963|NCT03666988|464875933|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
129158964|NCT03666988|464875934|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
128726075|NCT01641367|463294749|FG000|Cohorts|Lost to Follow-up|16|||
128726076|NCT01641367|463294750|FG001|Cohorts|Lost to Follow-up|0|||
128726077|NCT01641367|463294751|FG002|Cohorts|Lost to Follow-up|2|||
128726078|NCT01641367|463294752|FG003|Cohorts|Lost to Follow-up|0|||
128726079|NCT01641367|463294753|FG004|Cohorts|Lost to Follow-up|2|||
128726080|NCT01641367|463294754|FG005|Cohorts|Lost to Follow-up|0|||
129158965|NCT03666988|464875929|FG000|Part 1 (Up to 28 Months)|Other|0|||
129158966|NCT03666988|464875930|FG001|Part 1 (Up to 28 Months)|Other|1|||
128726081|NCT01641367|463294755|FG006|Cohorts|Lost to Follow-up|0|||
128726082|NCT01641367|463294756|FG007|Cohorts|Lost to Follow-up|0|||
128726083|NCT01641367|463294749|FG000|Randomized Adherence Intervention|Death|0|||
128726084|NCT01641367|463294750|FG001|Randomized Adherence Intervention|Death|0|||
129158967|NCT03666988|464875931|FG002|Part 1 (Up to 28 Months)|Other|1|||
129158968|NCT03666988|464875932|FG003|Part 1 (Up to 28 Months)|Other|0|||
129158969|NCT03666988|464875933|FG004|Part 1 (Up to 28 Months)|Other|0|||
129158970|NCT03666988|464875934|FG005|Part 1 (Up to 28 Months)|Other|0|||
129158971|NCT03666988|464875929|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
129158972|NCT03666988|464875930|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
128726085|NCT01641367|463294751|FG002|Randomized Adherence Intervention|Death|0|||
129158973|NCT03666988|464875931|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
129158974|NCT03666988|464875932|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
129158975|NCT03666988|464875933|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
129158976|NCT03666988|464875934|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
129158977|NCT03666988|464875929|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
129158978|NCT03666988|464875930|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
129158979|NCT03666988|464875931|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
129158980|NCT03666988|464875932|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
129158981|NCT03666988|464875933|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
128726086|NCT01641367|463294752|FG003|Randomized Adherence Intervention|Death|0|||
128726087|NCT01641367|463294753|FG004|Randomized Adherence Intervention|Death|0|||
128726088|NCT01641367|463294754|FG005|Randomized Adherence Intervention|Death|0|||
129158982|NCT03666988|464875934|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
129158983|NCT03666988|464875929|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
129158984|NCT03666988|464875930|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129158985|NCT03666988|464875931|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129158986|NCT03666988|464875932|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129158987|NCT03666988|464875933|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129158988|NCT03666988|464875934|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129158989|NCT03554018|464875939|FG000|Overall Study|Lost to Follow-up|3|||
129158990|NCT03554018|464875940|FG001|Overall Study|Lost to Follow-up|7|||
129158991|NCT01154452|464875941|FG000|Phase Ib|Not Treated|1|||
129158992|NCT01154452|464875942|FG001|Phase Ib|Not Treated|0|||
129158993|NCT01154452|464875943|FG002|Phase Ib|Not Treated|0|||
129158994|NCT01154452|464875944|FG003|Phase Ib|Not Treated|0|||
129158995|NCT01154452|464875941|FG000|Phase Ib|Adverse Event|2|||
129158996|NCT01154452|464875942|FG001|Phase Ib|Adverse Event|1|||
129158997|NCT01154452|464875943|FG002|Phase Ib|Adverse Event|0|||
129158998|NCT01154452|464875944|FG003|Phase Ib|Adverse Event|0|||
129158999|NCT01154452|464875941|FG000|Phase II|Withdrawal by Subject|0|||
129159000|NCT01154452|464875942|FG001|Phase II|Withdrawal by Subject|0|||
129159001|NCT01154452|464875943|FG002|Phase II|Withdrawal by Subject|1|||
129159002|NCT01154452|464875944|FG003|Phase II|Withdrawal by Subject|2|||
129159003|NCT01154452|464875941|FG000|Phase II|Adverse Event|0|||
129159004|NCT01154452|464875942|FG001|Phase II|Adverse Event|0|||
129159005|NCT01154452|464875943|FG002|Phase II|Adverse Event|4|||
129159006|NCT01154452|464875944|FG003|Phase II|Adverse Event|4|||
129159007|NCT01837680|464875947|FG000|Overall Study|Lost to Follow-up|2|||
129159008|NCT01837680|464875948|FG001|Overall Study|Lost to Follow-up|2|||
129159009|NCT01837680|464875947|FG000|Overall Study|lack of insurance|0|||
129159010|NCT01837680|464875948|FG001|Overall Study|lack of insurance|2|||
129159011|NCT01837680|464875947|FG000|Overall Study|allergic reaction|6|||
129159012|NCT01837680|464875948|FG001|Overall Study|allergic reaction|0|||
129159013|NCT01837680|464875947|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
129159014|NCT01837680|464875948|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
129159015|NCT02297815|464877548|FG000|Overall Study|Lost to Follow-up|236|||
129159016|NCT02297815|464877549|FG001|Overall Study|Lost to Follow-up|140|||
129159017|NCT00662831|464877550|FG000|Overall Study|Death|4|||
129159018|NCT00662831|464877551|FG001|Overall Study|Death|1|||
129159019|NCT00662831|464877550|FG000|Overall Study|Lack of Efficacy|6|||
129159020|NCT00662831|464877551|FG001|Overall Study|Lack of Efficacy|6|||
129159021|NCT00662831|464877550|FG000|Overall Study|Lost to Follow-up|1|||
129159022|NCT00662831|464877551|FG001|Overall Study|Lost to Follow-up|0|||
129159023|NCT00662831|464877550|FG000|Overall Study|Withdrawal by Subject|2|||
129159024|NCT00662831|464877551|FG001|Overall Study|Withdrawal by Subject|1|||
129159025|NCT00662831|464877550|FG000|Overall Study|Other|62|||
129159026|NCT00662831|464877551|FG001|Overall Study|Other|31|||
129159027|NCT00662831|464877550|FG000|Overall Study|Protocol Violation|8|||
129159028|NCT00662831|464877551|FG001|Overall Study|Protocol Violation|4|||
129159029|NCT00662831|464877550|FG000|Overall Study|Adverse Event|23|||
129159030|NCT00662831|464877551|FG001|Overall Study|Adverse Event|16|||
129159031|NCT01061723|464877554|FG000|Overall Study|Adverse Event|0|||
129159032|NCT01061723|464877555|FG001|Overall Study|Adverse Event|2|||
129159033|NCT01061723|464877556|FG002|Overall Study|Adverse Event|5|||
129159034|NCT01061723|464877557|FG003|Overall Study|Adverse Event|5|||
129159035|NCT01061723|464877558|FG004|Overall Study|Adverse Event|2|||
129159036|NCT01061723|464877559|FG005|Overall Study|Adverse Event|6|||
129159037|NCT01061723|464877554|FG000|Overall Study|Lack of Efficacy|2|||
129159038|NCT01061723|464877555|FG001|Overall Study|Lack of Efficacy|3|||
129159039|NCT01061723|464877556|FG002|Overall Study|Lack of Efficacy|4|||
129159040|NCT01061723|464877557|FG003|Overall Study|Lack of Efficacy|2|||
129159041|NCT01061723|464877558|FG004|Overall Study|Lack of Efficacy|1|||
129159042|NCT01061723|464877559|FG005|Overall Study|Lack of Efficacy|1|||
129159043|NCT01061723|464877554|FG000|Overall Study|Randomized but not treated|0|||
129159044|NCT01061723|464877555|FG001|Overall Study|Randomized but not treated|0|||
129159045|NCT01061723|464877556|FG002|Overall Study|Randomized but not treated|0|||
129159046|NCT01061723|464877557|FG003|Overall Study|Randomized but not treated|0|||
129159047|NCT01061723|464877558|FG004|Overall Study|Randomized but not treated|0|||
129159048|NCT01061723|464877559|FG005|Overall Study|Randomized but not treated|1|||
129159049|NCT01061723|464877554|FG000|Overall Study|Other than specified above|2|||
129159050|NCT01061723|464877555|FG001|Overall Study|Other than specified above|1|||
129159051|NCT01061723|464877556|FG002|Overall Study|Other than specified above|1|||
128726089|NCT01641367|463294755|FG006|Randomized Adherence Intervention|Death|11|||
129159052|NCT01061723|464877557|FG003|Overall Study|Other than specified above|1|||
129159053|NCT01061723|464877558|FG004|Overall Study|Other than specified above|0|||
129159054|NCT01061723|464877559|FG005|Overall Study|Other than specified above|1|||
129159055|NCT01147393|464877560|FG000|Dose Level 1|Dose limiting Toxicity|2|||
129159056|NCT01147393|464877560|FG000|Dose Level -1|Dose Limited Toxicity|1|||
129159057|NCT02840253|464877561|FG000|Overall Study|Unsuccessful block|4|||
129159058|NCT03783962|464877562|FG000|Overall Study|Lost to Follow-up|3|||
129159059|NCT03783962|464877563|FG001|Overall Study|Lost to Follow-up|6|||
129159060|NCT03783962|464877562|FG000|Overall Study|Protocol Violation|0|||
129159061|NCT03783962|464877563|FG001|Overall Study|Protocol Violation|1|||
129159062|NCT03458325|464877564|FG000|Overall Study|Withdrawal by Subject|1|||
129159063|NCT00460655|464877569|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
129159064|NCT00460655|464877570|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129159065|NCT00460655|464877571|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129159066|NCT00460655|464877572|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129159067|NCT00460655|464877569|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
129159068|NCT00460655|464877570|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129159069|NCT00460655|464877571|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129159070|NCT00460655|464877572|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129159071|NCT00460655|464877569|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
129159072|NCT00460655|464877570|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
129159073|NCT00460655|464877571|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
129159074|NCT00460655|464877572|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
129159075|NCT00460655|464877569|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129159076|NCT00460655|464877570|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129159077|NCT00460655|464877571|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
129159078|NCT00460655|464877572|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
129159079|NCT00460655|464877569|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129159080|NCT00460655|464877570|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129159081|NCT00460655|464877571|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
129159082|NCT00460655|464877572|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
129159083|NCT00460655|464877569|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
129159084|NCT00460655|464877570|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
129159085|NCT00460655|464877571|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
129159086|NCT00460655|464877572|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
129159087|NCT03801928|464877573|FG000|Overall Study|Adverse Event|1|||
129159088|NCT03801928|464877574|FG001|Overall Study|Adverse Event|0|||
129159089|NCT03801928|464877575|FG002|Overall Study|Adverse Event|1|||
129159090|NCT03801928|464877576|FG003|Overall Study|Adverse Event|2|||
129159091|NCT03801928|464877577|FG004|Overall Study|Adverse Event|0|||
129159092|NCT03801928|464877578|FG005|Overall Study|Adverse Event|2|||
129159093|NCT03801928|464877573|FG000|Overall Study|Lack of Efficacy|0|||
129159094|NCT03801928|464877574|FG001|Overall Study|Lack of Efficacy|0|||
129159095|NCT03801928|464877575|FG002|Overall Study|Lack of Efficacy|1|||
129159096|NCT03801928|464877576|FG003|Overall Study|Lack of Efficacy|0|||
129159097|NCT03801928|464877577|FG004|Overall Study|Lack of Efficacy|0|||
129159098|NCT03801928|464877578|FG005|Overall Study|Lack of Efficacy|0|||
129159099|NCT03801928|464877573|FG000|Overall Study|Lost to Follow-up|5|||
129159100|NCT03801928|464877574|FG001|Overall Study|Lost to Follow-up|1|||
129159101|NCT03801928|464877575|FG002|Overall Study|Lost to Follow-up|1|||
129159102|NCT03801928|464877576|FG003|Overall Study|Lost to Follow-up|4|||
129159103|NCT03801928|464877577|FG004|Overall Study|Lost to Follow-up|4|||
129159104|NCT03801928|464877578|FG005|Overall Study|Lost to Follow-up|2|||
129159105|NCT03801928|464877573|FG000|Overall Study|Withdrawal by Subject|0|||
129159106|NCT03801928|464877574|FG001|Overall Study|Withdrawal by Subject|0|||
129159107|NCT03801928|464877575|FG002|Overall Study|Withdrawal by Subject|2|||
129159108|NCT03801928|464877576|FG003|Overall Study|Withdrawal by Subject|1|||
129159109|NCT03801928|464877577|FG004|Overall Study|Withdrawal by Subject|0|||
129159110|NCT03801928|464877578|FG005|Overall Study|Withdrawal by Subject|0|||
129159111|NCT03801928|464877573|FG000|Overall Study|Other|0|||
129159112|NCT03801928|464877574|FG001|Overall Study|Other|2|||
129159113|NCT03801928|464877575|FG002|Overall Study|Other|0|||
129159114|NCT03801928|464877576|FG003|Overall Study|Other|1|||
129159115|NCT03801928|464877577|FG004|Overall Study|Other|0|||
129159116|NCT03801928|464877578|FG005|Overall Study|Other|1|||
129159117|NCT01724216|464877579|FG000|Overall Study|Scan was not completed|1|||
129159118|NCT00175916|464877580|FG000|Overall Study|Death|19|||
129159119|NCT00175916|464877580|FG000|Overall Study|Adverse Event|81|||
129159120|NCT00175916|464877580|FG000|Overall Study|Lack of Efficacy|354|||
129159121|NCT00175916|464877580|FG000|Overall Study|Lost to Follow-up|17|||
129159122|NCT00175916|464877580|FG000|Overall Study|Subject Choice|98|||
129159123|NCT00175916|464877580|FG000|Overall Study|Lack of compliance|8|||
129159124|NCT00175916|464877580|FG000|Overall Study|Patient cannot record seizures|1|||
129159125|NCT00175916|464877580|FG000|Overall Study|Sponsor decision|17|||
129159126|NCT00175916|464877580|FG000|Overall Study|Vigabatrin intake|1|||
129159127|NCT00175916|464877580|FG000|Overall Study|Suicidal behaviour|1|||
129159128|NCT00175916|464877580|FG000|Overall Study|Withdrawal by Subject|1|||
129159129|NCT00175916|464877580|FG000|Overall Study|Seizure - free|4|||
129159130|NCT00175916|464877580|FG000|Overall Study|Administrative reason|1|||
129159131|NCT00175916|464877580|FG000|Overall Study|Pregnancy|1|||
129159132|NCT00175916|464877580|FG000|Overall Study|Patient's request|2|||
129159133|NCT00175916|464877580|FG000|Overall Study|Treating physiciant's choice|1|||
129159134|NCT00175916|464877580|FG000|Overall Study|Moved overseas|1|||
129159135|NCT00175916|464877580|FG000|Overall Study|Loss of job and economic burden|1|||
129159136|NCT00175916|464877580|FG000|Overall Study|Site was closed|9|||
129159137|NCT00175916|464877580|FG000|Overall Study|Patient went to prison|1|||
129159138|NCT03650413|464877581|FG000|Overall Study|Adverse Event|1|||
129159139|NCT03650413|464877581|FG000|Overall Study|Lack of Efficacy|17|||
129159140|NCT03650413|464877581|FG000|Overall Study|Other|9|||
129159141|NCT03650413|464877581|FG000|Overall Study|Physician Decision|2|||
129159142|NCT03650413|464877581|FG000|Overall Study|Study Terminated By Sponsor|16|||
129159143|NCT03650413|464877581|FG000|Overall Study|Withdrawal by Subject|16|||
129159144|NCT01014767|464877582|FG000|Overall Study|PI left institution, data unavailable|12|||
129159145|NCT01014767|464877583|FG001|Overall Study|PI left institution, data unavailable|1|||
129159146|NCT01014767|464877584|FG002|Overall Study|PI left institution, data unavailable|4|||
129159147|NCT01014767|464877585|FG003|Overall Study|PI left institution, data unavailable|1|||
129159148|NCT00564733|464877586|FG000|Overall Study|Withdrawal by Subject|4|||
129159149|NCT00564733|464877586|FG000|Overall Study|Ineligible|5|||
129159150|NCT03654040|464877587|FG000|Overall Study|Death|1|||
129159151|NCT03654040|464877588|FG001|Overall Study|Death|0|||
129159152|NCT03654040|464877587|FG000|Overall Study|Withdrawal by Subject|1|||
129159153|NCT03654040|464877588|FG001|Overall Study|Withdrawal by Subject|0|||
129159154|NCT03654040|464877587|FG000|Overall Study|Study terminated by sponsor|8|||
129159155|NCT03654040|464877588|FG001|Overall Study|Study terminated by sponsor|2|||
129159156|NCT03654040|464877587|FG000|Overall Study|Failure to initiate study therapy|2|||
129159157|NCT03654040|464877588|FG001|Overall Study|Failure to initiate study therapy|0|||
129159158|NCT03654040|464877587|FG000|Overall Study|Transplanted at another center|2|||
129159159|NCT03654040|464877588|FG001|Overall Study|Transplanted at another center|0|||
129159160|NCT03654040|464877587|FG000|Overall Study|Failure to meet eligibility criteria|14|||
129159161|NCT03654040|464877588|FG001|Overall Study|Failure to meet eligibility criteria|2|||
129159162|NCT03654040|464877587|FG000|Overall Study|No longer transplant candidate|1|||
129159163|NCT03654040|464877588|FG001|Overall Study|No longer transplant candidate|0|||
129159164|NCT03654040|464877587|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
129159165|NCT03654040|464877588|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
129159166|NCT03654040|464877587|FG000|Overall Study|Recipient ineligible|0|||
129159167|NCT03654040|464877588|FG001|Overall Study|Recipient ineligible|2|||
129159168|NCT03654040|464877587|FG000|Overall Study|Received deceased liver|0|||
129159169|NCT03654040|464877588|FG001|Overall Study|Received deceased liver|1|||
129159170|NCT00310375|464877594|FG000|Primary Reporting Phase|Adverse Event|28|||
129159171|NCT00310375|464877595|FG001|Primary Reporting Phase|Adverse Event|22|||
129159172|NCT00310375|464877596|FG002|Primary Reporting Phase|Adverse Event|0|||
129159173|NCT00310375|464877594|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
129159174|NCT00310375|464877595|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
129159175|NCT00310375|464877596|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
129159176|NCT00310375|464877594|FG000|Primary Reporting Phase|Pregnancy|2|||
129159177|NCT00310375|464877595|FG001|Primary Reporting Phase|Pregnancy|2|||
129159178|NCT00310375|464877596|FG002|Primary Reporting Phase|Pregnancy|0|||
129159179|NCT00310375|464877594|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
129159180|NCT00310375|464877595|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
129159181|NCT00310375|464877596|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
129159182|NCT00310375|464877594|FG000|Primary Reporting Phase|Protocol Violation|8|||
129159183|NCT00310375|464877595|FG001|Primary Reporting Phase|Protocol Violation|5|||
129159184|NCT00310375|464877596|FG002|Primary Reporting Phase|Protocol Violation|0|||
129159185|NCT00310375|464877594|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
129159186|NCT00310375|464877595|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
129159187|NCT00310375|464877596|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
129159188|NCT00310375|464877594|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
129159189|NCT00310375|464877595|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
129159190|NCT00310375|464877596|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
129159191|NCT00310375|464877594|FG000|Primary Reporting Phase|Physician Decision|5|||
129159192|NCT00310375|464877595|FG001|Primary Reporting Phase|Physician Decision|3|||
129159193|NCT00310375|464877596|FG002|Primary Reporting Phase|Physician Decision|0|||
129159194|NCT00310375|464877594|FG000|Primary Reporting Phase|Request of the sponsor|2|||
129159195|NCT00310375|464877595|FG001|Primary Reporting Phase|Request of the sponsor|2|||
129159196|NCT00310375|464877596|FG002|Primary Reporting Phase|Request of the sponsor|0|||
129159197|NCT00310375|464877594|FG000|Primary Reporting Phase|Failed to return|1|||
129159198|NCT00310375|464877595|FG001|Primary Reporting Phase|Failed to return|3|||
129159199|NCT00310375|464877596|FG002|Primary Reporting Phase|Failed to return|0|||
129159200|NCT00310375|464877594|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
129159201|NCT00310375|464877595|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
129159202|NCT00310375|464877596|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
129159203|NCT00310375|464877594|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
129159204|NCT00310375|464877595|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
129159205|NCT00310375|464877596|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
129159206|NCT00310375|464877594|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
129159207|NCT00310375|464877595|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
129159208|NCT00310375|464877596|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
129159209|NCT00310375|464877594|FG000|Primary Reporting Phase|Site closure|3|||
128726090|NCT01641367|463294756|FG007|Randomized Adherence Intervention|Death|12|||
128726091|NCT01641367|463294749|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
128726092|NCT01641367|463294750|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
129159210|NCT00310375|464877595|FG001|Primary Reporting Phase|Site closure|0|||
129159211|NCT00310375|464877596|FG002|Primary Reporting Phase|Site closure|0|||
129159212|NCT00310375|464877594|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
129159213|NCT00310375|464877595|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
129159214|NCT00310375|464877596|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
129159215|NCT00310375|464877594|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
129159216|NCT00310375|464877595|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
129159217|NCT00310375|464877596|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
129159218|NCT00310375|464877594|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
129159219|NCT00310375|464877595|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
129159220|NCT00310375|464877596|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
129159221|NCT00310375|464877594|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
129159222|NCT00310375|464877595|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
129159223|NCT00310375|464877596|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
129159224|NCT00131352|464877597|FG000|Initial Treatment Period|Adverse Event|1|||
129159225|NCT00131352|464877598|FG001|Initial Treatment Period|Adverse Event|3|||
129159226|NCT00131352|464877597|FG000|Initial Treatment Period|Non-compliant|1|||
129159227|NCT00131352|464877598|FG001|Initial Treatment Period|Non-compliant|2|||
129159228|NCT00131352|464877597|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
129159229|NCT00131352|464877598|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
129159230|NCT00131352|464877597|FG000|Initial Treatment Period|Lack of Efficacy|6|||
129159231|NCT00131352|464877598|FG001|Initial Treatment Period|Lack of Efficacy|4|||
129159232|NCT00131352|464877597|FG000|Initial Treatment Period|Other|0|||
129159233|NCT00131352|464877598|FG001|Initial Treatment Period|Other|2|||
129159234|NCT00131352|464877597|FG000|Repeat Treatment Period|Adverse Event|1|||
129159235|NCT00131352|464877598|FG001|Repeat Treatment Period|Adverse Event|0|||
129159236|NCT00131352|464877597|FG000|Repeat Treatment Period|Other|1|||
129159237|NCT00131352|464877598|FG001|Repeat Treatment Period|Other|0|||
129159238|NCT03230318|464877599|FG000|Overall Study|Radiographic disease progression|72|||
129159239|NCT03230318|464877600|FG001|Overall Study|Radiographic disease progression|19|||
129159240|NCT03230318|464877599|FG000|Overall Study|Clinical progression|17|||
129159241|NCT03230318|464877600|FG001|Overall Study|Clinical progression|7|||
129159242|NCT03230318|464877599|FG000|Overall Study|Adverse Event|5|||
129159243|NCT03230318|464877600|FG001|Overall Study|Adverse Event|3|||
129159244|NCT03230318|464877599|FG000|Overall Study|Physician Decision|2|||
129159245|NCT03230318|464877600|FG001|Overall Study|Physician Decision|3|||
129159246|NCT03230318|464877599|FG000|Overall Study|Death|3|||
129159247|NCT03230318|464877600|FG001|Overall Study|Death|2|||
129159248|NCT03230318|464877599|FG000|Overall Study|Lost to Follow-up|1|||
129159249|NCT03230318|464877600|FG001|Overall Study|Lost to Follow-up|0|||
129159250|NCT03230318|464877599|FG000|Overall Study|Withdrawal by Subject|1|||
129159251|NCT03230318|464877600|FG001|Overall Study|Withdrawal by Subject|3|||
129159252|NCT03230318|464877599|FG000|Overall Study|Other|3|||
129159253|NCT03230318|464877600|FG001|Overall Study|Other|7|||
129159254|NCT00211172|464877602|FG000|Overall Study|Died or lost health plan eligibility|39|||
129159255|NCT00211172|464877603|FG001|Overall Study|Died or lost health plan eligibility|32|||
129159256|NCT00770562|464877609|FG000|Overall Study|Did not take treatment|1|||
129159257|NCT00770562|464877610|FG001|Overall Study|Did not take treatment|1|||
129159258|NCT01643408|464877611|FG000|Overall Study|Adverse Event|12|||
129159259|NCT01643408|464877611|FG000|Overall Study|Other|2|||
129159260|NCT01057693|464877614|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
129159261|NCT01057693|464877615|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
129159262|NCT01057693|464877616|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
129159263|NCT01057693|464877614|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
129159264|NCT01057693|464877615|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
129159265|NCT01057693|464877616|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
129159266|NCT01057693|464877614|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
129159267|NCT01057693|464877615|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
129159268|NCT01057693|464877616|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
129159269|NCT01057693|464877614|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
129159270|NCT01057693|464877615|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
129159271|NCT01057693|464877616|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
129159272|NCT01057693|464877614|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
129159273|NCT01057693|464877615|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
129159274|NCT01057693|464877616|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
129159275|NCT01057693|464877614|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
129159276|NCT01057693|464877615|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
129159277|NCT01057693|464877616|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
129159278|NCT01057693|464877614|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
129159279|NCT01057693|464877615|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
129159280|NCT01057693|464877616|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
129159281|NCT01057693|464877614|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
129159282|NCT01057693|464877615|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
129159283|NCT01057693|464877616|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
129159284|NCT01057693|464877614|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
129159285|NCT01057693|464877615|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
129159286|NCT01057693|464877616|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
129159287|NCT01057693|464877614|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
129159288|NCT01057693|464877615|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
129159289|NCT01057693|464877616|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
129159290|NCT01057693|464877614|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
129159291|NCT01057693|464877615|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
129159292|NCT01057693|464877616|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
129159293|NCT01057693|464877614|FG000|Between Single-Blind and Double-Blind|Other|6|||
129159294|NCT01057693|464877615|FG001|Between Single-Blind and Double-Blind|Other|0|||
129159295|NCT01057693|464877616|FG002|Between Single-Blind and Double-Blind|Other|0|||
129159296|NCT01057693|464877614|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
129159297|NCT01057693|464877615|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
129159298|NCT01057693|464877616|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
129159299|NCT01057693|464877614|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
129159300|NCT01057693|464877615|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
129159301|NCT01057693|464877616|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
129159302|NCT01057693|464877614|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
129159303|NCT01057693|464877615|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
129159304|NCT01057693|464877616|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
129159305|NCT01057693|464877614|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
129159306|NCT01057693|464877615|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
129159307|NCT01057693|464877616|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
129159308|NCT01057693|464877614|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
129159309|NCT01057693|464877615|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
129159310|NCT01057693|464877616|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
129159311|NCT01057693|464877614|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
129159312|NCT01057693|464877615|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
129159313|NCT01057693|464877616|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
129159314|NCT01057693|464877614|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
129159315|NCT01057693|464877615|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
129159316|NCT01057693|464877616|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
129159317|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
129159318|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
129159319|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
129159320|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
129159321|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
129159322|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
129159323|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
129159324|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
129159325|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
129159326|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
129159327|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
129159328|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
129159329|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
129159330|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
129159331|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
129159332|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
129159333|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
129159334|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
129159335|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
129159336|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
129159337|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
129159338|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
129159339|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
129159340|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
129159341|NCT01672879|464877624|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
129159342|NCT01672879|464877625|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
128726093|NCT01641367|463294751|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
128726094|NCT01641367|463294752|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
128726095|NCT01641367|463294753|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
128726096|NCT01641367|463294754|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
128726097|NCT01641367|463294755|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
128726098|NCT01641367|463294756|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
128726099|NCT00782210|463294757|FG000|Overall Study|Adverse Event|21|||
128726100|NCT00782210|463294758|FG001|Overall Study|Adverse Event|17|||
128726101|NCT00782210|463294759|FG002|Overall Study|Adverse Event|16|||
128726102|NCT00782210|463294757|FG000|Overall Study|Lost to Follow-up|2|||
129159343|NCT01672879|464877626|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
129159344|NCT01672879|464877624|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
129159345|NCT01672879|464877625|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
129159346|NCT01672879|464877626|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
129159347|NCT01672879|464877624|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
129159348|NCT01672879|464877625|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
129159349|NCT01672879|464877626|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
129159350|NCT01672879|464877624|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
129159351|NCT01672879|464877625|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
129159352|NCT01672879|464877626|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
129159353|NCT01672879|464877624|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
129159354|NCT01672879|464877625|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
129159355|NCT01672879|464877626|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
129159356|NCT04860869|464877627|FG000|Overall Study|Withdrawal by Subject|1|||
129159357|NCT04860869|464877628|FG001|Overall Study|Withdrawal by Subject|0|||
129159358|NCT03951766|464877629|FG000|Treatment Phase|Lost to Follow-up|1|||
129159359|NCT03951766|464877629|FG000|Follow-up Phase|Lost to Follow-up|10|||
129159360|NCT00363142|464877631|FG000|Overall Study|Adverse Event|2|||
129159361|NCT00363142|464877632|FG001|Overall Study|Adverse Event|0|||
129159362|NCT00363142|464877631|FG000|Overall Study|Lack of Efficacy|0|||
129159363|NCT00363142|464877632|FG001|Overall Study|Lack of Efficacy|1|||
129159364|NCT00363142|464877631|FG000|Overall Study|Lost to Follow-up|1|||
129159365|NCT00363142|464877632|FG001|Overall Study|Lost to Follow-up|0|||
129159366|NCT00363142|464877631|FG000|Overall Study|Non-compliance|1|||
129159367|NCT00363142|464877632|FG001|Overall Study|Non-compliance|1|||
129159368|NCT00363142|464877631|FG000|Overall Study|Withdrawal by Subject|3|||
129159369|NCT00363142|464877632|FG001|Overall Study|Withdrawal by Subject|1|||
129159370|NCT01541865|464877633|FG000|Overall Study|Lost to Follow-up|11|||
129159371|NCT01541865|464877633|FG000|Overall Study|Withdrawal by Subject|9|||
129159372|NCT01541865|464877633|FG000|Overall Study|Adverse Event|1|||
129159373|NCT01541865|464877633|FG000|Overall Study|Protocol Violation|1|||
129159374|NCT00295646|464877638|FG000|Overall Study|Protocol Violation|18|||
129159375|NCT00295646|464877639|FG001|Overall Study|Protocol Violation|20|||
129159376|NCT00295646|464877640|FG002|Overall Study|Protocol Violation|20|||
129159377|NCT00295646|464877641|FG003|Overall Study|Protocol Violation|18|||
129159378|NCT00295646|464877638|FG000|Overall Study|Withdrawal by Subject|8|||
129159379|NCT00295646|464877639|FG001|Overall Study|Withdrawal by Subject|9|||
129159380|NCT00295646|464877640|FG002|Overall Study|Withdrawal by Subject|11|||
129159381|NCT00295646|464877641|FG003|Overall Study|Withdrawal by Subject|14|||
129159382|NCT00295646|464877638|FG000|Overall Study|Lost to Follow-up|0|||
129159383|NCT00295646|464877639|FG001|Overall Study|Lost to Follow-up|5|||
129159384|NCT00295646|464877640|FG002|Overall Study|Lost to Follow-up|1|||
129159385|NCT00295646|464877641|FG003|Overall Study|Lost to Follow-up|5|||
129159386|NCT00295646|464877638|FG000|Overall Study|Death|9|||
129159387|NCT00295646|464877639|FG001|Overall Study|Death|7|||
129159388|NCT00295646|464877640|FG002|Overall Study|Death|18|||
129159389|NCT00295646|464877641|FG003|Overall Study|Death|8|||
129159390|NCT02720523|464877650|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
129159391|NCT02720523|464877651|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
129159392|NCT02720523|464877652|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
129159393|NCT02720523|464877653|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
129159394|NCT02720523|464877654|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
129159395|NCT02720523|464877655|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
129159396|NCT02720523|464877656|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
129159397|NCT02720523|464877650|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
129159398|NCT02720523|464877651|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129159399|NCT02720523|464877652|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129159400|NCT02720523|464877653|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129159401|NCT02720523|464877654|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129159402|NCT02720523|464877655|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129159403|NCT02720523|464877656|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129159404|NCT02720523|464877650|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
129159405|NCT02720523|464877651|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129159406|NCT02720523|464877652|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129159407|NCT02720523|464877653|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129159408|NCT02720523|464877654|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129159409|NCT02720523|464877655|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129159410|NCT02720523|464877656|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129159411|NCT02720523|464877650|FG000|Period 1: Placebo-controlled Period|Other|0|||
129159412|NCT02720523|464877651|FG001|Period 1: Placebo-controlled Period|Other|0|||
129159413|NCT02720523|464877652|FG002|Period 1: Placebo-controlled Period|Other|1|||
129159414|NCT02720523|464877653|FG003|Period 1: Placebo-controlled Period|Other|1|||
129159415|NCT02720523|464877654|FG004|Period 1: Placebo-controlled Period|Other|0|||
129159416|NCT02720523|464877655|FG005|Period 1: Placebo-controlled Period|Other|0|||
129159417|NCT02720523|464877656|FG006|Period 1: Placebo-controlled Period|Other|0|||
129159418|NCT02720523|464877650|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
129159419|NCT02720523|464877651|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
129159420|NCT02720523|464877652|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
129159421|NCT02720523|464877653|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
129159422|NCT02720523|464877654|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
129159423|NCT02720523|464877655|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
129159424|NCT02720523|464877656|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
129159425|NCT02720523|464877650|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
129159426|NCT02720523|464877651|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
129159427|NCT02720523|464877652|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
129159428|NCT02720523|464877653|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
129159429|NCT02720523|464877654|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
129159430|NCT02720523|464877655|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
129159431|NCT02720523|464877656|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
129159432|NCT02720523|464877650|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129159433|NCT02720523|464877651|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129159434|NCT02720523|464877652|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129159435|NCT02720523|464877653|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129159436|NCT02720523|464877654|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
129159437|NCT02720523|464877655|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
129159438|NCT02720523|464877656|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
129159439|NCT02720523|464877650|FG000|Period 2: Long-term Extension Period|Other|0|||
129159440|NCT02720523|464877651|FG001|Period 2: Long-term Extension Period|Other|0|||
129159441|NCT02720523|464877652|FG002|Period 2: Long-term Extension Period|Other|0|||
129159442|NCT02720523|464877653|FG003|Period 2: Long-term Extension Period|Other|0|||
129159443|NCT02720523|464877654|FG004|Period 2: Long-term Extension Period|Other|2|||
129159444|NCT02720523|464877655|FG005|Period 2: Long-term Extension Period|Other|0|||
129159445|NCT02720523|464877656|FG006|Period 2: Long-term Extension Period|Other|3|||
129159446|NCT01890265|464877658|FG000|Overall Study|Other (Unspecified reason)|0|||
129159447|NCT01890265|464877659|FG001|Overall Study|Other (Unspecified reason)|1|||
129159448|NCT01890265|464877660|FG002|Overall Study|Other (Unspecified reason)|0|||
129159449|NCT01890265|464877661|FG003|Overall Study|Other (Unspecified reason)|0|||
129159450|NCT01890265|464877662|FG004|Overall Study|Other (Unspecified reason)|0|||
129159451|NCT01890265|464877663|FG005|Overall Study|Other (Unspecified reason)|0|||
129159452|NCT01890265|464877658|FG000|Overall Study|Progressive disease|6|||
129159453|NCT01890265|464877659|FG001|Overall Study|Progressive disease|6|||
129159454|NCT01890265|464877660|FG002|Overall Study|Progressive disease|0|||
129159455|NCT01890265|464877661|FG003|Overall Study|Progressive disease|0|||
129159456|NCT01890265|464877662|FG004|Overall Study|Progressive disease|0|||
129159457|NCT01890265|464877663|FG005|Overall Study|Progressive disease|0|||
129159458|NCT01890265|464877658|FG000|Overall Study|Adverse Event|2|||
129159459|NCT01890265|464877659|FG001|Overall Study|Adverse Event|1|||
129159460|NCT01890265|464877660|FG002|Overall Study|Adverse Event|0|||
129159461|NCT01890265|464877661|FG003|Overall Study|Adverse Event|0|||
129159462|NCT01890265|464877662|FG004|Overall Study|Adverse Event|0|||
129159463|NCT01890265|464877663|FG005|Overall Study|Adverse Event|0|||
129159464|NCT01890265|464877658|FG000|Overall Study|Death|2|||
129159465|NCT01890265|464877659|FG001|Overall Study|Death|3|||
129159466|NCT01890265|464877660|FG002|Overall Study|Death|1|||
129159467|NCT01890265|464877661|FG003|Overall Study|Death|0|||
129159468|NCT01890265|464877662|FG004|Overall Study|Death|0|||
129159469|NCT01890265|464877663|FG005|Overall Study|Death|0|||
129159470|NCT01890265|464877658|FG000|Overall Study|Withdrawal by Subject|0|||
129159471|NCT01890265|464877659|FG001|Overall Study|Withdrawal by Subject|2|||
129159472|NCT01890265|464877660|FG002|Overall Study|Withdrawal by Subject|3|||
129159473|NCT01890265|464877661|FG003|Overall Study|Withdrawal by Subject|0|||
129159474|NCT01890265|464877662|FG004|Overall Study|Withdrawal by Subject|2|||
129159475|NCT01890265|464877663|FG005|Overall Study|Withdrawal by Subject|0|||
128726103|NCT00782210|463294758|FG001|Overall Study|Lost to Follow-up|1|||
128726104|NCT00782210|463294759|FG002|Overall Study|Lost to Follow-up|2|||
128726105|NCT00782210|463294757|FG000|Overall Study|Withdrawal by Subject|11|||
128726106|NCT00782210|463294758|FG001|Overall Study|Withdrawal by Subject|8|||
128726107|NCT00782210|463294759|FG002|Overall Study|Withdrawal by Subject|11|||
128726108|NCT00782210|463294757|FG000|Overall Study|Non compliance with protocol|0|||
129159476|NCT01402869|464877668|FG000|Overall Study|Required Tooth Extraction|0|||
129159477|NCT01402869|464877669|FG001|Overall Study|Required Tooth Extraction|0|||
129159478|NCT01402869|464877670|FG002|Overall Study|Required Tooth Extraction|1|||
129159479|NCT01740687|464877674|FG000|Overall Study|Lost to Follow-up|11|||
129159480|NCT01740687|464877674|FG000|Overall Study|Withdrawal by Subject|2|||
129159481|NCT01740687|464877674|FG000|Overall Study|other reason|22|||
129159482|NCT01740687|464877674|FG000|Overall Study|treatment not received|2|||
129159483|NCT00326001|464877675|FG000|Overall Study|Adverse Event|4|||
129159484|NCT00326001|464877676|FG001|Overall Study|Adverse Event|5|||
129159485|NCT00326001|464877675|FG000|Overall Study|Physician Decision|3|||
129159486|NCT00326001|464877676|FG001|Overall Study|Physician Decision|3|||
129159487|NCT00104728|464877677|FG000|Overall Study|screen failures|19|||
129159488|NCT01963767|464877678|FG000|Overall Study|Withdrawal by Subject|4|||
129159489|NCT01963767|464877679|FG001|Overall Study|Withdrawal by Subject|2|||
129159490|NCT01963767|464877678|FG000|Overall Study|Adverse Event|2|||
129159491|NCT01963767|464877679|FG001|Overall Study|Adverse Event|0|||
129159492|NCT03960684|464877680|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
129159493|NCT03941483|464877681|FG000|Overall Study|Miscellaneous|2|||
129159494|NCT03941483|464877682|FG001|Overall Study|Miscellaneous|3|||
129159495|NCT03941483|464877683|FG002|Overall Study|Miscellaneous|0|||
129159496|NCT03941483|464877681|FG000|Overall Study|Study Terminated by Sponsor|1|||
129159497|NCT03941483|464877682|FG001|Overall Study|Study Terminated by Sponsor|0|||
129159498|NCT03941483|464877683|FG002|Overall Study|Study Terminated by Sponsor|0|||
129159499|NCT03941483|464877681|FG000|Overall Study|Withdrawal by Subject|1|||
129159500|NCT03941483|464877682|FG001|Overall Study|Withdrawal by Subject|4|||
129159501|NCT03941483|464877683|FG002|Overall Study|Withdrawal by Subject|1|||
129159502|NCT03941483|464877681|FG000|Overall Study|Lost to Follow-up|2|||
129159503|NCT03941483|464877682|FG001|Overall Study|Lost to Follow-up|1|||
129159504|NCT03941483|464877683|FG002|Overall Study|Lost to Follow-up|8|||
129159505|NCT03941483|464877681|FG000|Overall Study|Death|3|||
129159506|NCT03941483|464877682|FG001|Overall Study|Death|2|||
129159507|NCT03941483|464877683|FG002|Overall Study|Death|6|||
129159508|NCT01082081|464877684|FG000|Overall Study|Lost to Follow-up|0|||
129159509|NCT01082081|464877685|FG001|Overall Study|Lost to Follow-up|0|||
129159510|NCT01082081|464877686|FG002|Overall Study|Lost to Follow-up|1|||
129159511|NCT01082081|464877684|FG000|Overall Study|Withdrawal by Subject|0|||
129159512|NCT01082081|464877685|FG001|Overall Study|Withdrawal by Subject|0|||
129159513|NCT01082081|464877686|FG002|Overall Study|Withdrawal by Subject|1|||
129159514|NCT01082081|464877684|FG000|Overall Study|Other Reason|0|||
129159515|NCT01082081|464877685|FG001|Overall Study|Other Reason|1|||
129159516|NCT01082081|464877686|FG002|Overall Study|Other Reason|0|||
129159517|NCT00670930|464877689|FG000|Overall Study|Adminstrative Problem|0|||
129159518|NCT00670930|464877690|FG001|Overall Study|Adminstrative Problem|1|||
129159519|NCT00670930|464877689|FG000|Overall Study|Lost to Follow-up|1|||
129159520|NCT00670930|464877690|FG001|Overall Study|Lost to Follow-up|0|||
129159521|NCT03493451|464878812|FG000|Overall Study|Death|11|||
129159522|NCT03493451|464878813|FG001|Overall Study|Death|26|||
129159523|NCT03493451|464878814|FG002|Overall Study|Death|3|||
129159524|NCT03493451|464878812|FG000|Overall Study|Lost to Follow-up|1|||
129159525|NCT03493451|464878813|FG001|Overall Study|Lost to Follow-up|4|||
129159526|NCT03493451|464878814|FG002|Overall Study|Lost to Follow-up|1|||
129159527|NCT03493451|464878812|FG000|Overall Study|Withdrawal by Subject|1|||
129159528|NCT03493451|464878813|FG001|Overall Study|Withdrawal by Subject|1|||
129159529|NCT03493451|464878814|FG002|Overall Study|Withdrawal by Subject|2|||
129159530|NCT03493451|464878812|FG000|Overall Study|Progressive Disease|1|||
129159531|NCT03493451|464878813|FG001|Overall Study|Progressive Disease|0|||
129159532|NCT03493451|464878814|FG002|Overall Study|Progressive Disease|0|||
129159533|NCT03493451|464878812|FG000|Overall Study|Transferred to long term extension study|8|||
129159534|NCT03493451|464878813|FG001|Overall Study|Transferred to long term extension study|13|||
128726109|NCT00782210|463294758|FG001|Overall Study|Non compliance with protocol|3|||
129159535|NCT03493451|464878814|FG002|Overall Study|Transferred to long term extension study|5|||
129159536|NCT01238991|464878815|FG000|Overall Study|Adverse Event|1|||
129159537|NCT01238991|464878816|FG001|Overall Study|Adverse Event|0|||
129159538|NCT01238991|464878817|FG002|Overall Study|Adverse Event|3|||
129159539|NCT01238991|464878818|FG003|Overall Study|Adverse Event|1|||
129159540|NCT01238991|464878819|FG004|Overall Study|Adverse Event|1|||
129159541|NCT01238991|464878820|FG005|Overall Study|Adverse Event|0|||
129159542|NCT01238991|464878821|FG006|Overall Study|Adverse Event|1|||
129159543|NCT01238991|464878822|FG007|Overall Study|Adverse Event|1|||
129159544|NCT01238991|464878823|FG008|Overall Study|Adverse Event|0|||
129159545|NCT01238991|464878824|FG009|Overall Study|Adverse Event|0|||
129159546|NCT01238991|464878815|FG000|Overall Study|Death|0|||
129159547|NCT01238991|464878816|FG001|Overall Study|Death|0|||
129159548|NCT01238991|464878817|FG002|Overall Study|Death|0|||
129159549|NCT01238991|464878818|FG003|Overall Study|Death|1|||
129159550|NCT01238991|464878819|FG004|Overall Study|Death|0|||
129159551|NCT01238991|464878820|FG005|Overall Study|Death|0|||
129159552|NCT01238991|464878821|FG006|Overall Study|Death|0|||
129159553|NCT01238991|464878822|FG007|Overall Study|Death|0|||
129159554|NCT01238991|464878823|FG008|Overall Study|Death|0|||
129159555|NCT01238991|464878824|FG009|Overall Study|Death|0|||
129159556|NCT01238991|464878815|FG000|Overall Study|Lack of Efficacy|0|||
129159557|NCT01238991|464878816|FG001|Overall Study|Lack of Efficacy|0|||
129159558|NCT01238991|464878817|FG002|Overall Study|Lack of Efficacy|1|||
129159559|NCT01238991|464878818|FG003|Overall Study|Lack of Efficacy|0|||
129159560|NCT01238991|464878819|FG004|Overall Study|Lack of Efficacy|0|||
129159561|NCT01238991|464878820|FG005|Overall Study|Lack of Efficacy|0|||
129159562|NCT01238991|464878821|FG006|Overall Study|Lack of Efficacy|0|||
129159563|NCT01238991|464878822|FG007|Overall Study|Lack of Efficacy|0|||
129159564|NCT01238991|464878823|FG008|Overall Study|Lack of Efficacy|1|||
129159565|NCT01238991|464878824|FG009|Overall Study|Lack of Efficacy|0|||
129159566|NCT01238991|464878815|FG000|Overall Study|Withdrawal by Subject|0|||
129159567|NCT01238991|464878816|FG001|Overall Study|Withdrawal by Subject|0|||
129159568|NCT01238991|464878817|FG002|Overall Study|Withdrawal by Subject|1|||
129159569|NCT01238991|464878818|FG003|Overall Study|Withdrawal by Subject|0|||
129159570|NCT01238991|464878819|FG004|Overall Study|Withdrawal by Subject|0|||
129159571|NCT01238991|464878820|FG005|Overall Study|Withdrawal by Subject|0|||
129159572|NCT01238991|464878821|FG006|Overall Study|Withdrawal by Subject|0|||
129159573|NCT01238991|464878822|FG007|Overall Study|Withdrawal by Subject|0|||
129159574|NCT01238991|464878823|FG008|Overall Study|Withdrawal by Subject|0|||
129159575|NCT01238991|464878824|FG009|Overall Study|Withdrawal by Subject|0|||
129159576|NCT01238991|464878815|FG000|Overall Study|Study Terminated by Sponsor|0|||
129159577|NCT01238991|464878816|FG001|Overall Study|Study Terminated by Sponsor|0|||
129159578|NCT01238991|464878817|FG002|Overall Study|Study Terminated by Sponsor|0|||
129159579|NCT01238991|464878818|FG003|Overall Study|Study Terminated by Sponsor|0|||
129159580|NCT01238991|464878819|FG004|Overall Study|Study Terminated by Sponsor|1|||
129159581|NCT01238991|464878820|FG005|Overall Study|Study Terminated by Sponsor|0|||
129159582|NCT01238991|464878821|FG006|Overall Study|Study Terminated by Sponsor|7|||
129159583|NCT01238991|464878822|FG007|Overall Study|Study Terminated by Sponsor|4|||
129159584|NCT01238991|464878823|FG008|Overall Study|Study Terminated by Sponsor|2|||
129159585|NCT01238991|464878824|FG009|Overall Study|Study Terminated by Sponsor|2|||
129159586|NCT01238991|464878815|FG000|Overall Study|Caregiver's request|0|||
129159587|NCT01238991|464878816|FG001|Overall Study|Caregiver's request|0|||
129159588|NCT01238991|464878817|FG002|Overall Study|Caregiver's request|0|||
129159589|NCT01238991|464878818|FG003|Overall Study|Caregiver's request|0|||
128776881|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
129159590|NCT01238991|464878819|FG004|Overall Study|Caregiver's request|0|||
129159591|NCT01238991|464878820|FG005|Overall Study|Caregiver's request|0|||
129159592|NCT01238991|464878821|FG006|Overall Study|Caregiver's request|0|||
129159593|NCT01238991|464878822|FG007|Overall Study|Caregiver's request|0|||
129159594|NCT01238991|464878823|FG008|Overall Study|Caregiver's request|1|||
129159595|NCT01238991|464878824|FG009|Overall Study|Caregiver's request|0|||
129159596|NCT01238991|464878815|FG000|Overall Study|Admission to a nursing home|1|||
129159597|NCT01238991|464878816|FG001|Overall Study|Admission to a nursing home|0|||
129159598|NCT01238991|464878817|FG002|Overall Study|Admission to a nursing home|1|||
129159599|NCT01238991|464878818|FG003|Overall Study|Admission to a nursing home|0|||
129159600|NCT01238991|464878819|FG004|Overall Study|Admission to a nursing home|0|||
129159601|NCT01238991|464878820|FG005|Overall Study|Admission to a nursing home|0|||
129159602|NCT01238991|464878821|FG006|Overall Study|Admission to a nursing home|0|||
129159603|NCT01238991|464878822|FG007|Overall Study|Admission to a nursing home|0|||
129159604|NCT01238991|464878823|FG008|Overall Study|Admission to a nursing home|0|||
129159605|NCT01238991|464878824|FG009|Overall Study|Admission to a nursing home|0|||
129159606|NCT03370419|464878825|FG000|Overall Study|Lost to Follow-up|16|||
129159607|NCT00600106|464878835|FG000|Overall Study|Withdrawal by Subject|1|||
129159608|NCT00600106|464878836|FG001|Overall Study|Withdrawal by Subject|1|||
129159609|NCT01897727|464878837|FG000|Overall Study|Exclusion: central sleep apnea|0|||
129159610|NCT01897727|464878838|FG001|Overall Study|Exclusion: central sleep apnea|1|||
129159611|NCT03015363|464878839|FG000|Overall Study|Physician Decision|14|||
129159612|NCT03015363|464878839|FG000|Overall Study|Withdrawal by Subject|3|||
128776882|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
129159613|NCT00078806|464878840|FG000|Part 1A|Adverse Event|2|||
129159614|NCT00078806|464878841|FG001|Part 1A|Adverse Event|0|||
129159615|NCT00078806|464878842|FG002|Part 1A|Adverse Event|0|||
129159616|NCT00078806|464878843|FG003|Part 1A|Adverse Event|0|||
129159617|NCT00078806|464878840|FG000|Part 1A|Lack of Efficacy|7|||
129159618|NCT00078806|464878841|FG001|Part 1A|Lack of Efficacy|0|||
129159619|NCT00078806|464878842|FG002|Part 1A|Lack of Efficacy|0|||
129159620|NCT00078806|464878843|FG003|Part 1A|Lack of Efficacy|0|||
129159621|NCT00078806|464878840|FG000|Part 1A|Other|1|||
129159622|NCT00078806|464878841|FG001|Part 1A|Other|0|||
129159623|NCT00078806|464878842|FG002|Part 1A|Other|0|||
129159624|NCT00078806|464878843|FG003|Part 1A|Other|0|||
129159625|NCT00078806|464878840|FG000|Part 1B|Adverse Event|1|||
129159626|NCT00078806|464878841|FG001|Part 1B|Adverse Event|0|||
129159627|NCT00078806|464878842|FG002|Part 1B|Adverse Event|0|||
129159628|NCT00078806|464878843|FG003|Part 1B|Adverse Event|0|||
129159629|NCT00078806|464878840|FG000|Part 1B|Lack of Efficacy|7|||
129159630|NCT00078806|464878841|FG001|Part 1B|Lack of Efficacy|0|||
129159631|NCT00078806|464878842|FG002|Part 1B|Lack of Efficacy|0|||
129159632|NCT00078806|464878843|FG003|Part 1B|Lack of Efficacy|0|||
129159633|NCT00078806|464878840|FG000|Part 2|Adverse Event|0|||
129159634|NCT00078806|464878841|FG001|Part 2|Adverse Event|1|||
129159635|NCT00078806|464878842|FG002|Part 2|Adverse Event|0|||
129159636|NCT00078806|464878843|FG003|Part 2|Adverse Event|0|||
129159637|NCT01734785|464878846|FG000|Open-Label Period|Adverse Event|0|||
129159638|NCT01734785|464878847|FG001|Open-Label Period|Adverse Event|0|||
129159639|NCT01734785|464878848|FG002|Open-Label Period|Adverse Event|0|||
129159640|NCT01734785|464878849|FG003|Open-Label Period|Adverse Event|9|||
129159641|NCT01734785|464878846|FG000|Open-Label Period|Lack of Efficacy|0|||
129159642|NCT01734785|464878847|FG001|Open-Label Period|Lack of Efficacy|0|||
129159643|NCT01734785|464878848|FG002|Open-Label Period|Lack of Efficacy|0|||
129159644|NCT01734785|464878849|FG003|Open-Label Period|Lack of Efficacy|1|||
129159645|NCT01734785|464878846|FG000|Open-Label Period|Protocol Violation|0|||
129159646|NCT01734785|464878847|FG001|Open-Label Period|Protocol Violation|0|||
129159647|NCT01734785|464878848|FG002|Open-Label Period|Protocol Violation|0|||
129159648|NCT01734785|464878849|FG003|Open-Label Period|Protocol Violation|13|||
129159649|NCT01734785|464878846|FG000|Open-Label Period|Lost to Follow-up|0|||
129159650|NCT01734785|464878847|FG001|Open-Label Period|Lost to Follow-up|0|||
129159651|NCT01734785|464878848|FG002|Open-Label Period|Lost to Follow-up|0|||
129159652|NCT01734785|464878849|FG003|Open-Label Period|Lost to Follow-up|14|||
129159653|NCT01734785|464878846|FG000|Open-Label Period|Withdrawal by Subject|0|||
129159654|NCT01734785|464878847|FG001|Open-Label Period|Withdrawal by Subject|0|||
129159655|NCT01734785|464878848|FG002|Open-Label Period|Withdrawal by Subject|0|||
129159656|NCT01734785|464878849|FG003|Open-Label Period|Withdrawal by Subject|12|||
129159657|NCT01734785|464878846|FG000|Open-Label Period|Other Reasons|0|||
129159658|NCT01734785|464878847|FG001|Open-Label Period|Other Reasons|0|||
129159659|NCT01734785|464878848|FG002|Open-Label Period|Other Reasons|0|||
129159660|NCT01734785|464878849|FG003|Open-Label Period|Other Reasons|224|||
129159661|NCT01734785|464878846|FG000|Double-Blind Period|Adverse Event|0|||
129159662|NCT01734785|464878847|FG001|Double-Blind Period|Adverse Event|3|||
129159663|NCT01734785|464878848|FG002|Double-Blind Period|Adverse Event|2|||
129159664|NCT01734785|464878849|FG003|Double-Blind Period|Adverse Event|0|||
129159665|NCT01734785|464878846|FG000|Double-Blind Period|Lack of Efficacy|0|||
129159666|NCT01734785|464878847|FG001|Double-Blind Period|Lack of Efficacy|1|||
129159667|NCT01734785|464878848|FG002|Double-Blind Period|Lack of Efficacy|0|||
129159668|NCT01734785|464878849|FG003|Double-Blind Period|Lack of Efficacy|0|||
129159669|NCT01734785|464878846|FG000|Double-Blind Period|Protocol Violation|0|||
129159670|NCT01734785|464878847|FG001|Double-Blind Period|Protocol Violation|1|||
129159671|NCT01734785|464878848|FG002|Double-Blind Period|Protocol Violation|1|||
129159672|NCT01734785|464878849|FG003|Double-Blind Period|Protocol Violation|0|||
129159673|NCT01734785|464878846|FG000|Double-Blind Period|Lost to Follow-up|2|||
129159674|NCT01734785|464878847|FG001|Double-Blind Period|Lost to Follow-up|4|||
129159675|NCT01734785|464878848|FG002|Double-Blind Period|Lost to Follow-up|2|||
129159676|NCT01734785|464878849|FG003|Double-Blind Period|Lost to Follow-up|0|||
129159677|NCT01734785|464878846|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129159678|NCT01734785|464878847|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129159679|NCT01734785|464878848|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129159680|NCT01734785|464878849|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129159681|NCT01734785|464878846|FG000|Double-Blind Period|Not treated|1|||
129159682|NCT01734785|464878847|FG001|Double-Blind Period|Not treated|0|||
129159683|NCT01734785|464878848|FG002|Double-Blind Period|Not treated|0|||
129159684|NCT01734785|464878849|FG003|Double-Blind Period|Not treated|0|||
129159685|NCT00566982|464878850|FG000|Overall Study|Adverse Event|6|||
129159686|NCT00566982|464878851|FG001|Overall Study|Adverse Event|48|||
129159687|NCT00566982|464878850|FG000|Overall Study|Withdrawal by Subject|1|||
129159688|NCT00566982|464878851|FG001|Overall Study|Withdrawal by Subject|14|||
129159689|NCT00566982|464878850|FG000|Overall Study|Protocol Violation|1|||
129159690|NCT00566982|464878851|FG001|Overall Study|Protocol Violation|4|||
129159691|NCT00566982|464878850|FG000|Overall Study|Lost to Follow-up|0|||
129159692|NCT00566982|464878851|FG001|Overall Study|Lost to Follow-up|1|||
129159693|NCT00566982|464878850|FG000|Overall Study|Other-family problems & doctor's request|0|||
129159694|NCT00566982|464878851|FG001|Overall Study|Other-family problems & doctor's request|2|||
129159695|NCT02013778|464878857|FG000|Overall Study|Death|4|||
129159696|NCT02013778|464878857|FG000|Overall Study|Withdrawal by Subject|1|||
129159697|NCT02013778|464878857|FG000|Overall Study|Physician Decision|1|||
129159698|NCT02013778|464878857|FG000|Overall Study|Adverse Event|1|||
129159699|NCT00293813|464878858|FG000|Overall Study|Physician Decision|0|||
129159700|NCT00293813|464878859|FG001|Overall Study|Physician Decision|1|||
129159701|NCT00293813|464878860|FG002|Overall Study|Physician Decision|0|||
129159702|NCT00293813|464878858|FG000|Overall Study|Adverse Event|3|||
129159703|NCT00293813|464878859|FG001|Overall Study|Adverse Event|1|||
129159704|NCT00293813|464878860|FG002|Overall Study|Adverse Event|1|||
129159705|NCT00293813|464878858|FG000|Overall Study|Withdrawal by Subject|7|||
129159706|NCT00293813|464878859|FG001|Overall Study|Withdrawal by Subject|4|||
129159707|NCT00293813|464878860|FG002|Overall Study|Withdrawal by Subject|4|||
129159708|NCT00293813|464878858|FG000|Overall Study|Lost to Follow-up|3|||
129159709|NCT00293813|464878859|FG001|Overall Study|Lost to Follow-up|2|||
129159710|NCT00293813|464878860|FG002|Overall Study|Lost to Follow-up|3|||
129159711|NCT00293813|464878858|FG000|Overall Study|Noncompliance|0|||
129159712|NCT00293813|464878859|FG001|Overall Study|Noncompliance|1|||
129159713|NCT00293813|464878860|FG002|Overall Study|Noncompliance|0|||
129159714|NCT01465386|464878864|FG000|Overall Study|Lack of Efficacy|3|||
129159715|NCT01465386|464878864|FG000|Overall Study|Adverse Event|1|||
129159716|NCT00473889|464878865|FG000|Overall Study|Did not receive study medication|1|||
129159717|NCT00473889|464878866|FG001|Overall Study|Did not receive study medication|4|||
129159718|NCT00473889|464878865|FG000|Overall Study|Adverse Event|30|||
129159719|NCT00473889|464878866|FG001|Overall Study|Adverse Event|17|||
129159720|NCT00473889|464878865|FG000|Overall Study|Protocol Violation|4|||
129159721|NCT00473889|464878866|FG001|Overall Study|Protocol Violation|2|||
129159722|NCT00473889|464878865|FG000|Overall Study|Lack of Efficacy|28|||
129159723|NCT00473889|464878866|FG001|Overall Study|Lack of Efficacy|29|||
129159724|NCT00473889|464878865|FG000|Overall Study|Lost to Follow-up|2|||
129159725|NCT00473889|464878866|FG001|Overall Study|Lost to Follow-up|1|||
129159726|NCT00473889|464878865|FG000|Overall Study|Physician Decision|10|||
129159727|NCT00473889|464878866|FG001|Overall Study|Physician Decision|5|||
129159728|NCT00473889|464878865|FG000|Overall Study|Trial Terminated|3|||
129159729|NCT00473889|464878866|FG001|Overall Study|Trial Terminated|6|||
129159730|NCT00473889|464878865|FG000|Overall Study|Withdrawal by Subject|5|||
129159731|NCT00473889|464878866|FG001|Overall Study|Withdrawal by Subject|0|||
129159732|NCT02236572|464878867|FG000|Overall Study|Withdrawal by Subject|1|||
129159733|NCT02236572|464878867|FG000|Overall Study|Protocol Violation|1|||
129159734|NCT02236572|464878867|FG000|Overall Study|Lost to Follow-up|1|||
129159735|NCT02443337|464878868|FG000|Overall Study|Adverse Event|0|||
129159736|NCT02443337|464878869|FG001|Overall Study|Adverse Event|1|||
129159737|NCT02443337|464878868|FG000|Overall Study|Clinical Progressive Disease|3|||
129159738|NCT02443337|464878869|FG001|Overall Study|Clinical Progressive Disease|0|||
129159739|NCT02443337|464878868|FG000|Overall Study|Withdrawal by Subject|2|||
129159740|NCT02443337|464878869|FG001|Overall Study|Withdrawal by Subject|1|||
129159741|NCT00709319|464878870|FG000|Overall Study|Death|4|||
129159742|NCT00709319|464878870|FG000|Overall Study|Withdrawal by Subject|2|||
129159743|NCT00579553|464878871|FG000|Overall Study|Lost to Follow-up|16|||
129159744|NCT00579553|464878872|FG001|Overall Study|Lost to Follow-up|13|||
129159745|NCT00635349|464878873|FG000|Overall Study|Other|8|||
129159746|NCT00635349|464878874|FG001|Overall Study|Other|6|||
129159747|NCT00635349|464878873|FG000|Overall Study|Protocol Violation|18|||
129159748|NCT00635349|464878874|FG001|Overall Study|Protocol Violation|22|||
129159749|NCT00635349|464878873|FG000|Overall Study|Withdrawal by Subject|3|||
129159750|NCT00635349|464878874|FG001|Overall Study|Withdrawal by Subject|8|||
129159751|NCT00635349|464878873|FG000|Overall Study|Lost to Follow-up|4|||
129159752|NCT00635349|464878874|FG001|Overall Study|Lost to Follow-up|3|||
129159753|NCT00635349|464878873|FG000|Overall Study|Adverse Event|11|||
129159754|NCT00635349|464878874|FG001|Overall Study|Adverse Event|9|||
129159755|NCT00049322|464878876|FG000|Overall Study|disease burden|0|||
129159756|NCT00049322|464878877|FG001|Overall Study|disease burden|3|||
129159757|NCT00049322|464878876|FG000|Overall Study|Adverse Event|1|||
129159758|NCT00049322|464878877|FG001|Overall Study|Adverse Event|0|||
129159759|NCT00049322|464878876|FG000|Overall Study|refused angio|0|||
129159760|NCT00049322|464878877|FG001|Overall Study|refused angio|3|||
129159761|NCT03072043|464878878|FG000|Overall Study|Death|0|||
129159762|NCT03072043|464878879|FG001|Overall Study|Death|0|||
129159763|NCT03072043|464878880|FG002|Overall Study|Death|3|||
129159764|NCT03072043|464878878|FG000|Overall Study|Adverse Event|0|||
129159765|NCT03072043|464878879|FG001|Overall Study|Adverse Event|0|||
129159766|NCT03072043|464878880|FG002|Overall Study|Adverse Event|2|||
129159767|NCT03072043|464878878|FG000|Overall Study|Withdrawal by Subject|0|||
129159768|NCT03072043|464878879|FG001|Overall Study|Withdrawal by Subject|0|||
129159769|NCT03072043|464878880|FG002|Overall Study|Withdrawal by Subject|4|||
129159770|NCT01340664|464878881|FG000|Overall Study|Adverse Event|0|||
129159771|NCT01340664|464878882|FG001|Overall Study|Adverse Event|1|||
129159772|NCT01340664|464878883|FG002|Overall Study|Adverse Event|7|||
129159773|NCT01340664|464878881|FG000|Overall Study|Lost to Follow-up|2|||
129159774|NCT01340664|464878882|FG001|Overall Study|Lost to Follow-up|0|||
129159775|NCT01340664|464878883|FG002|Overall Study|Lost to Follow-up|2|||
129159776|NCT01340664|464878881|FG000|Overall Study|Withdrawal by Subject|2|||
129159777|NCT01340664|464878882|FG001|Overall Study|Withdrawal by Subject|4|||
129159778|NCT01340664|464878883|FG002|Overall Study|Withdrawal by Subject|0|||
129159779|NCT01340664|464878881|FG000|Overall Study|Glycemic withdrawal criteria|2|||
129159780|NCT01340664|464878882|FG001|Overall Study|Glycemic withdrawal criteria|0|||
129159781|NCT01340664|464878883|FG002|Overall Study|Glycemic withdrawal criteria|0|||
129159782|NCT01340664|464878881|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
129159783|NCT01340664|464878882|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
129159784|NCT01340664|464878883|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
129159785|NCT01340664|464878881|FG000|Overall Study|Other|1|||
129159786|NCT01340664|464878882|FG001|Overall Study|Other|2|||
129159787|NCT01340664|464878883|FG002|Overall Study|Other|2|||
129159788|NCT02997865|464878887|FG000|Overall Study|Death|2|||
129159789|NCT02997865|464878888|FG001|Overall Study|Death|1|||
129159790|NCT02997865|464878887|FG000|Overall Study|Lost to Follow-up|6|||
129159791|NCT02997865|464878888|FG001|Overall Study|Lost to Follow-up|3|||
129159792|NCT02997865|464878887|FG000|Overall Study|Withdrawal by Subject|5|||
129159793|NCT02997865|464878888|FG001|Overall Study|Withdrawal by Subject|0|||
129159794|NCT01926444|464878889|FG000|Overall Study|Colonoscopy not performed|0|||
129159795|NCT01926444|464878890|FG001|Overall Study|Colonoscopy not performed|0|||
129159796|NCT01926444|464878891|FG002|Overall Study|Colonoscopy not performed|4|||
129159797|NCT01926444|464878892|FG003|Overall Study|Colonoscopy not performed|2|||
129159798|NCT02441101|464878899|FG000|Overall Study|Withdrawal by Subject|1|||
129159799|NCT02441101|464878900|FG001|Overall Study|Withdrawal by Subject|0|||
129159800|NCT02441101|464878899|FG000|Overall Study|Lost to Follow-up|1|||
129159801|NCT02441101|464878900|FG001|Overall Study|Lost to Follow-up|0|||
129159802|NCT02441101|464878899|FG000|Overall Study|PI relocated and study terminated|1|||
129159803|NCT02441101|464878900|FG001|Overall Study|PI relocated and study terminated|0|||
129159804|NCT02528942|464878901|FG000|Overall Study|Did not meet imaging criteria|9|||
129159805|NCT02528942|464878901|FG000|Overall Study|Lost to Follow-up|25|||
129159806|NCT00881530|464878902|FG000|Overall Study|Adverse Event|5|||
129159807|NCT00881530|464878903|FG001|Overall Study|Adverse Event|1|||
129159808|NCT00881530|464878904|FG002|Overall Study|Adverse Event|1|||
129159809|NCT00881530|464878905|FG003|Overall Study|Adverse Event|4|||
129159810|NCT00881530|464878906|FG004|Overall Study|Adverse Event|10|||
129159811|NCT00881530|464878907|FG005|Overall Study|Adverse Event|2|||
129159812|NCT00881530|464878902|FG000|Overall Study|Lack of Efficacy|1|||
129159813|NCT00881530|464878903|FG001|Overall Study|Lack of Efficacy|0|||
129159814|NCT00881530|464878904|FG002|Overall Study|Lack of Efficacy|0|||
129159815|NCT00881530|464878905|FG003|Overall Study|Lack of Efficacy|0|||
129159816|NCT00881530|464878906|FG004|Overall Study|Lack of Efficacy|1|||
129159817|NCT00881530|464878907|FG005|Overall Study|Lack of Efficacy|1|||
129159818|NCT00881530|464878902|FG000|Overall Study|Not compliant with the protocol|0|||
129159819|NCT00881530|464878903|FG001|Overall Study|Not compliant with the protocol|0|||
129159820|NCT00881530|464878904|FG002|Overall Study|Not compliant with the protocol|0|||
129159821|NCT00881530|464878905|FG003|Overall Study|Not compliant with the protocol|0|||
129159822|NCT00881530|464878906|FG004|Overall Study|Not compliant with the protocol|2|||
129159823|NCT00881530|464878907|FG005|Overall Study|Not compliant with the protocol|0|||
129159824|NCT00881530|464878902|FG000|Overall Study|Lost to Follow-up|0|||
129159825|NCT00881530|464878903|FG001|Overall Study|Lost to Follow-up|1|||
129159826|NCT00881530|464878904|FG002|Overall Study|Lost to Follow-up|1|||
129159827|NCT00881530|464878905|FG003|Overall Study|Lost to Follow-up|3|||
129159828|NCT00881530|464878906|FG004|Overall Study|Lost to Follow-up|1|||
129159829|NCT00881530|464878907|FG005|Overall Study|Lost to Follow-up|0|||
129159830|NCT00881530|464878902|FG000|Overall Study|Refused to continue medication|7|||
129159831|NCT00881530|464878903|FG001|Overall Study|Refused to continue medication|2|||
129159832|NCT00881530|464878904|FG002|Overall Study|Refused to continue medication|1|||
129159833|NCT00881530|464878905|FG003|Overall Study|Refused to continue medication|2|||
129159834|NCT00881530|464878906|FG004|Overall Study|Refused to continue medication|0|||
129159835|NCT00881530|464878907|FG005|Overall Study|Refused to continue medication|0|||
129159836|NCT00881530|464878902|FG000|Overall Study|Other reason not defined above|1|||
129159837|NCT00881530|464878903|FG001|Overall Study|Other reason not defined above|1|||
129159838|NCT00881530|464878904|FG002|Overall Study|Other reason not defined above|2|||
129159839|NCT00881530|464878905|FG003|Overall Study|Other reason not defined above|0|||
129159840|NCT00881530|464878906|FG004|Overall Study|Other reason not defined above|0|||
129159841|NCT00881530|464878907|FG005|Overall Study|Other reason not defined above|2|||
129159842|NCT01509846|464878908|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
129159843|NCT01509846|464878909|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
129159844|NCT01509846|464878910|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
129159845|NCT01509846|464878911|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
129159846|NCT01509846|464878912|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
129159847|NCT01509846|464878908|FG000|Received Vaccination 2|Illness|0|||
129159848|NCT01509846|464878909|FG001|Received Vaccination 2|Illness|0|||
129159849|NCT01509846|464878910|FG002|Received Vaccination 2|Illness|0|||
129159850|NCT01509846|464878911|FG003|Received Vaccination 2|Illness|0|||
129159851|NCT01509846|464878912|FG004|Received Vaccination 2|Illness|1|||
129159852|NCT01509846|464878908|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
129159853|NCT01509846|464878909|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
129159854|NCT01509846|464878910|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
129159855|NCT01509846|464878911|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
129159856|NCT01509846|464878912|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
128726110|NCT00782210|463294759|FG002|Overall Study|Non compliance with protocol|2|||
128726111|NCT00782210|463294757|FG000|Overall Study|Lack of Efficacy|13|||
128726112|NCT00782210|463294758|FG001|Overall Study|Lack of Efficacy|4|||
128726113|NCT00782210|463294759|FG002|Overall Study|Lack of Efficacy|1|||
128726114|NCT00782210|463294757|FG000|Overall Study|Other reason not described above|3|||
128726115|NCT00782210|463294758|FG001|Overall Study|Other reason not described above|2|||
128726116|NCT00782210|463294759|FG002|Overall Study|Other reason not described above|3|||
128726117|NCT00654381|463294762|FG000|1st Stage|Adverse Event|3|||
128726118|NCT00654381|463294763|FG001|1st Stage|Adverse Event|3|||
128726119|NCT00654381|463294764|FG002|1st Stage|Adverse Event|3|||
128726120|NCT00654381|463294765|FG003|1st Stage|Adverse Event|3|||
128726121|NCT00654381|463294766|FG004|1st Stage|Adverse Event|2|||
128726122|NCT00654381|463294767|FG005|1st Stage|Adverse Event|1|||
128726123|NCT00654381|463294762|FG000|1st Stage|Withdrawal by Subject|0|||
128726124|NCT00654381|463294763|FG001|1st Stage|Withdrawal by Subject|0|||
128726125|NCT00654381|463294764|FG002|1st Stage|Withdrawal by Subject|0|||
128726126|NCT00654381|463294765|FG003|1st Stage|Withdrawal by Subject|1|||
128726127|NCT00654381|463294766|FG004|1st Stage|Withdrawal by Subject|0|||
128726128|NCT00654381|463294767|FG005|1st Stage|Withdrawal by Subject|1|||
128726129|NCT00654381|463294762|FG000|1st Stage|Investigator's decision|0|||
128726130|NCT00654381|463294763|FG001|1st Stage|Investigator's decision|0|||
128726131|NCT00654381|463294764|FG002|1st Stage|Investigator's decision|0|||
128726132|NCT00654381|463294765|FG003|1st Stage|Investigator's decision|1|||
128726133|NCT00654381|463294766|FG004|1st Stage|Investigator's decision|0|||
128726134|NCT00654381|463294767|FG005|1st Stage|Investigator's decision|0|||
128726135|NCT00654381|463294762|FG000|2nd Stage|Adverse Event|2|||
128726136|NCT00654381|463294763|FG001|2nd Stage|Adverse Event|0|||
128726137|NCT00654381|463294764|FG002|2nd Stage|Adverse Event|2|||
128726138|NCT00654381|463294765|FG003|2nd Stage|Adverse Event|3|||
128726139|NCT00654381|463294766|FG004|2nd Stage|Adverse Event|7|||
128726140|NCT00654381|463294767|FG005|2nd Stage|Adverse Event|2|||
128726141|NCT00654381|463294762|FG000|2nd Stage|Withdrawal by Subject|0|||
128726142|NCT00654381|463294763|FG001|2nd Stage|Withdrawal by Subject|0|||
128726143|NCT00654381|463294764|FG002|2nd Stage|Withdrawal by Subject|0|||
128726144|NCT00654381|463294765|FG003|2nd Stage|Withdrawal by Subject|0|||
128726145|NCT00654381|463294766|FG004|2nd Stage|Withdrawal by Subject|1|||
128726146|NCT00654381|463294767|FG005|2nd Stage|Withdrawal by Subject|1|||
128726147|NCT00654381|463294762|FG000|2nd Stage|Investigator's decision|0|||
128726148|NCT00654381|463294763|FG001|2nd Stage|Investigator's decision|0|||
128726149|NCT00654381|463294764|FG002|2nd Stage|Investigator's decision|1|||
128726150|NCT00654381|463294765|FG003|2nd Stage|Investigator's decision|1|||
129159857|NCT01509846|464878908|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
129159858|NCT01509846|464878909|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
129159859|NCT01509846|464878910|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
129159860|NCT01509846|464878911|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
129159861|NCT01509846|464878912|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
129159862|NCT01509846|464878908|FG000|Received Vaccination 3|Pregnancy|0|||
129159863|NCT01509846|464878909|FG001|Received Vaccination 3|Pregnancy|0|||
129159864|NCT01509846|464878910|FG002|Received Vaccination 3|Pregnancy|0|||
129159865|NCT01509846|464878911|FG003|Received Vaccination 3|Pregnancy|1|||
129159866|NCT01509846|464878912|FG004|Received Vaccination 3|Pregnancy|0|||
129159867|NCT01509846|464878908|FG000|Received Vaccination 3|Lost to Follow-up|0|||
129159868|NCT01509846|464878909|FG001|Received Vaccination 3|Lost to Follow-up|0|||
129159869|NCT01509846|464878910|FG002|Received Vaccination 3|Lost to Follow-up|1|||
129159870|NCT01509846|464878911|FG003|Received Vaccination 3|Lost to Follow-up|0|||
129159871|NCT01509846|464878912|FG004|Received Vaccination 3|Lost to Follow-up|0|||
129159872|NCT01637584|464878913|FG000|Overall Study|Withdrawal by Subject|1|||
129159873|NCT01637584|464878914|FG001|Overall Study|Withdrawal by Subject|3|||
129159874|NCT02969915|464878915|FG000|Overall Study|Death|104|||
129159875|NCT02969915|464878916|FG001|Overall Study|Death|125|||
129159876|NCT02969915|464878915|FG000|Overall Study|Lost to Follow-up|108|||
129159877|NCT02969915|464878916|FG001|Overall Study|Lost to Follow-up|112|||
129159878|NCT02969915|464878915|FG000|Overall Study|Censored due to COVID-19|481|||
129159879|NCT02969915|464878916|FG001|Overall Study|Censored due to COVID-19|471|||
128726151|NCT00654381|463294766|FG004|2nd Stage|Investigator's decision|0|||
128726152|NCT00654381|463294767|FG005|2nd Stage|Investigator's decision|0|||
128726153|NCT00654381|463294762|FG000|Extension Stage|Adverse Event|1|||
129159880|NCT01393899|464878917|FG000|Overall Study|Study terminated by sponsor|1|||
129159881|NCT01393899|464878918|FG001|Overall Study|Study terminated by sponsor|0|||
129159882|NCT01393899|464878919|FG002|Overall Study|Study terminated by sponsor|1|||
128726154|NCT00654381|463294763|FG001|Extension Stage|Adverse Event|2|||
128726155|NCT00654381|463294764|FG002|Extension Stage|Adverse Event|9|||
128726156|NCT00654381|463294765|FG003|Extension Stage|Adverse Event|7|||
128726157|NCT00654381|463294766|FG004|Extension Stage|Adverse Event|1|||
128726158|NCT00654381|463294767|FG005|Extension Stage|Adverse Event|1|||
128726159|NCT00654381|463294762|FG000|Extension Stage|Protocol Violation|0|||
128726160|NCT00654381|463294763|FG001|Extension Stage|Protocol Violation|0|||
128726161|NCT00654381|463294764|FG002|Extension Stage|Protocol Violation|0|||
128726162|NCT00654381|463294765|FG003|Extension Stage|Protocol Violation|1|||
129159883|NCT01393899|464878917|FG000|Overall Study|Other|1|||
128726163|NCT00654381|463294766|FG004|Extension Stage|Protocol Violation|0|||
128726164|NCT00654381|463294767|FG005|Extension Stage|Protocol Violation|0|||
128726165|NCT00654381|463294762|FG000|Extension Stage|Lack of Efficacy|0|||
128726166|NCT00654381|463294763|FG001|Extension Stage|Lack of Efficacy|0|||
128726167|NCT00654381|463294764|FG002|Extension Stage|Lack of Efficacy|1|||
128726168|NCT00654381|463294765|FG003|Extension Stage|Lack of Efficacy|0|||
128726169|NCT00654381|463294766|FG004|Extension Stage|Lack of Efficacy|0|||
128726170|NCT00654381|463294767|FG005|Extension Stage|Lack of Efficacy|0|||
128726171|NCT00654381|463294762|FG000|Extension Stage|Withdrawal by Subject|0|||
128726172|NCT00654381|463294763|FG001|Extension Stage|Withdrawal by Subject|0|||
128726173|NCT00654381|463294764|FG002|Extension Stage|Withdrawal by Subject|1|||
128726174|NCT00654381|463294765|FG003|Extension Stage|Withdrawal by Subject|1|||
128726175|NCT00654381|463294766|FG004|Extension Stage|Withdrawal by Subject|1|||
128726176|NCT00654381|463294767|FG005|Extension Stage|Withdrawal by Subject|1|||
128726177|NCT00654381|463294762|FG000|Extension Stage|Closure of the trial site|0|||
128726178|NCT00654381|463294763|FG001|Extension Stage|Closure of the trial site|0|||
128726179|NCT00654381|463294764|FG002|Extension Stage|Closure of the trial site|0|||
128726180|NCT00654381|463294765|FG003|Extension Stage|Closure of the trial site|0|||
128726181|NCT00654381|463294766|FG004|Extension Stage|Closure of the trial site|1|||
128726182|NCT00654381|463294767|FG005|Extension Stage|Closure of the trial site|1|||
128726183|NCT02586493|463294772|FG000|Overall Study|Adverse Event|4|||
128726184|NCT02586493|463294772|FG000|Overall Study|Protocol Violation|6|||
128726185|NCT02586493|463294772|FG000|Overall Study|Lost to Follow-up|1|||
128726186|NCT02586493|463294772|FG000|Overall Study|Withdrawal by Subject|1|||
128726187|NCT01675882|463294777|FG000|Overall Study|Adverse Event|0|||
128726188|NCT01675882|463294778|FG001|Overall Study|Adverse Event|2|||
128726189|NCT01675882|463294779|FG002|Overall Study|Adverse Event|1|||
128726190|NCT01675882|463294780|FG003|Overall Study|Adverse Event|0|||
128726191|NCT01675882|463294777|FG000|Overall Study|Participant unwilling to continue|2|||
128726192|NCT01675882|463294778|FG001|Overall Study|Participant unwilling to continue|4|||
128726193|NCT01675882|463294779|FG002|Overall Study|Participant unwilling to continue|2|||
128726194|NCT01675882|463294780|FG003|Overall Study|Participant unwilling to continue|1|||
128726195|NCT01675882|463294777|FG000|Overall Study|Lost to Follow-up|0|||
128726196|NCT01675882|463294778|FG001|Overall Study|Lost to Follow-up|1|||
128726197|NCT01675882|463294779|FG002|Overall Study|Lost to Follow-up|0|||
128726198|NCT01675882|463294780|FG003|Overall Study|Lost to Follow-up|0|||
129159884|NCT01393899|464878918|FG001|Overall Study|Other|0|||
129159885|NCT01393899|464878919|FG002|Overall Study|Other|0|||
129159886|NCT01393899|464878917|FG000|Overall Study|Withdrawal by Subject|2|||
129159887|NCT01393899|464878918|FG001|Overall Study|Withdrawal by Subject|2|||
129159888|NCT01393899|464878919|FG002|Overall Study|Withdrawal by Subject|1|||
129159889|NCT01393899|464878917|FG000|Overall Study|Lost to Follow-up|0|||
129159890|NCT01393899|464878918|FG001|Overall Study|Lost to Follow-up|0|||
129159891|NCT01393899|464878919|FG002|Overall Study|Lost to Follow-up|1|||
129159892|NCT01393899|464878917|FG000|Overall Study|Does not meet entrance criteria|1|||
129159893|NCT01393899|464878918|FG001|Overall Study|Does not meet entrance criteria|0|||
129159894|NCT01393899|464878919|FG002|Overall Study|Does not meet entrance criteria|1|||
129159895|NCT01393899|464878917|FG000|Overall Study|Lack of Efficacy|26|||
129159896|NCT01393899|464878918|FG001|Overall Study|Lack of Efficacy|21|||
129159897|NCT01393899|464878919|FG002|Overall Study|Lack of Efficacy|16|||
129159898|NCT01393899|464878917|FG000|Overall Study|Adverse Event|1|||
129159899|NCT01393899|464878918|FG001|Overall Study|Adverse Event|5|||
129159900|NCT01393899|464878919|FG002|Overall Study|Adverse Event|3|||
129159901|NCT02503085|464878922|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
129159902|NCT02503085|464878923|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
129159903|NCT02503085|464878924|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
129159904|NCT02503085|464878925|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
129159905|NCT00995436|464878926|FG000|Overall Study|Withdrawal by Subject|2|||
129159906|NCT00995436|464878927|FG001|Overall Study|Withdrawal by Subject|5|||
129159907|NCT00995436|464878928|FG002|Overall Study|Withdrawal by Subject|0|||
129159908|NCT01232127|464878929|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
129159909|NCT01232127|464878930|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
129159910|NCT01232127|464878931|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
129159911|NCT02131662|464878937|FG000|Overall Study|Protocol Violation|1|||
129159912|NCT02131662|464878938|FG001|Overall Study|Protocol Violation|0|||
129159913|NCT02131662|464878939|FG002|Overall Study|Protocol Violation|0|||
129159914|NCT02131662|464878940|FG003|Overall Study|Protocol Violation|0|||
129159915|NCT02131662|464878941|FG004|Overall Study|Protocol Violation|0|||
129159916|NCT02131662|464878937|FG000|Overall Study|Other|2|||
129159917|NCT02131662|464878938|FG001|Overall Study|Other|4|||
128726199|NCT01675882|463294777|FG000|Overall Study|Non-compliance|0|||
128726200|NCT01675882|463294778|FG001|Overall Study|Non-compliance|0|||
128726201|NCT01675882|463294779|FG002|Overall Study|Non-compliance|0|||
128726202|NCT01675882|463294780|FG003|Overall Study|Non-compliance|1|||
128726203|NCT00735371|463294784|FG000|Overall Study|Adverse Event|3|||
128776883|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
128726204|NCT00735371|463294785|FG001|Overall Study|Adverse Event|3|||
129159918|NCT02131662|464878939|FG002|Overall Study|Other|3|||
129159919|NCT02131662|464878940|FG003|Overall Study|Other|3|||
129159920|NCT02131662|464878941|FG004|Overall Study|Other|4|||
129159921|NCT02131662|464878937|FG000|Overall Study|Adverse Event|0|||
129159922|NCT02131662|464878938|FG001|Overall Study|Adverse Event|1|||
129159923|NCT02131662|464878939|FG002|Overall Study|Adverse Event|1|||
129159924|NCT02131662|464878940|FG003|Overall Study|Adverse Event|1|||
129159925|NCT02131662|464878941|FG004|Overall Study|Adverse Event|3|||
129159926|NCT02131662|464878937|FG000|Overall Study|Pregnancy|0|||
129159927|NCT02131662|464878938|FG001|Overall Study|Pregnancy|1|||
129159928|NCT02131662|464878939|FG002|Overall Study|Pregnancy|0|||
129159929|NCT02131662|464878940|FG003|Overall Study|Pregnancy|1|||
129159930|NCT02131662|464878941|FG004|Overall Study|Pregnancy|0|||
129159931|NCT02131662|464878937|FG000|Overall Study|Wish for pregnancy|0|||
129159932|NCT02131662|464878938|FG001|Overall Study|Wish for pregnancy|0|||
129159933|NCT02131662|464878939|FG002|Overall Study|Wish for pregnancy|0|||
129159934|NCT02131662|464878940|FG003|Overall Study|Wish for pregnancy|0|||
129159935|NCT02131662|464878941|FG004|Overall Study|Wish for pregnancy|1|||
129159936|NCT02131662|464878937|FG000|Overall Study|Lack of Efficacy|1|||
129159937|NCT02131662|464878938|FG001|Overall Study|Lack of Efficacy|0|||
129159938|NCT02131662|464878939|FG002|Overall Study|Lack of Efficacy|0|||
129159939|NCT02131662|464878940|FG003|Overall Study|Lack of Efficacy|0|||
129159940|NCT02131662|464878941|FG004|Overall Study|Lack of Efficacy|1|||
129159941|NCT02131662|464878937|FG000|Overall Study|Withdrawal by Subject|1|||
129159942|NCT02131662|464878938|FG001|Overall Study|Withdrawal by Subject|5|||
129159943|NCT02131662|464878939|FG002|Overall Study|Withdrawal by Subject|1|||
129159944|NCT02131662|464878940|FG003|Overall Study|Withdrawal by Subject|5|||
129159945|NCT02131662|464878941|FG004|Overall Study|Withdrawal by Subject|6|||
129159946|NCT02131662|464878937|FG000|Overall Study|Lost to Follow-up|1|||
129159947|NCT02131662|464878938|FG001|Overall Study|Lost to Follow-up|3|||
129159948|NCT02131662|464878939|FG002|Overall Study|Lost to Follow-up|0|||
129159949|NCT02131662|464878940|FG003|Overall Study|Lost to Follow-up|9|||
129159950|NCT02131662|464878941|FG004|Overall Study|Lost to Follow-up|0|||
129159951|NCT02131662|464878937|FG000|Overall Study|Not treated|2|||
129159952|NCT02131662|464878938|FG001|Overall Study|Not treated|0|||
129159953|NCT02131662|464878939|FG002|Overall Study|Not treated|2|||
129159954|NCT02131662|464878940|FG003|Overall Study|Not treated|2|||
129159955|NCT02131662|464878941|FG004|Overall Study|Not treated|3|||
129159956|NCT00809926|464878943|FG000|Overall Study|Adverse Event|18|||
129159957|NCT00809926|464878944|FG001|Overall Study|Adverse Event|10|||
129159958|NCT00809926|464878943|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129159959|NCT00809926|464878944|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129159960|NCT00809926|464878943|FG000|Overall Study|Patient withdrew consent|8|||
129159961|NCT00809926|464878944|FG001|Overall Study|Patient withdrew consent|6|||
129159962|NCT00809926|464878943|FG000|Overall Study|Lost to Follow-up|2|||
129159963|NCT00809926|464878944|FG001|Overall Study|Lost to Follow-up|1|||
129159964|NCT00809926|464878943|FG000|Overall Study|Administrative Problems|0|||
129159965|NCT00809926|464878944|FG001|Overall Study|Administrative Problems|1|||
129159966|NCT00809926|464878943|FG000|Overall Study|Protocol deviation|0|||
129159967|NCT00809926|464878944|FG001|Overall Study|Protocol deviation|2|||
129159968|NCT00130039|464878945|FG000|Overall Study|Withdrawal by Subject|15|||
129159969|NCT00130039|464878946|FG001|Overall Study|Withdrawal by Subject|11|||
129159970|NCT00130039|464878945|FG000|Overall Study|Lost to Follow-up|3|||
129159971|NCT00130039|464878946|FG001|Overall Study|Lost to Follow-up|1|||
129159972|NCT00130039|464878945|FG000|Overall Study|Adverse Event|4|||
129159973|NCT00130039|464878946|FG001|Overall Study|Adverse Event|2|||
129159974|NCT00130039|464878945|FG000|Overall Study|Physician Decision|3|||
129159975|NCT00130039|464878946|FG001|Overall Study|Physician Decision|0|||
129159976|NCT00130039|464878945|FG000|Overall Study|clinical events without follow up MRI|5|||
129159977|NCT00130039|464878946|FG001|Overall Study|clinical events without follow up MRI|4|||
129159978|NCT00100802|464878947|FG000|Overall Study|Adverse Event|9|||
129159979|NCT00100802|464878947|FG000|Overall Study|Death|1|||
129159980|NCT00100802|464878947|FG000|Overall Study|Lack of Efficacy|47|||
129159981|NCT00100802|464878947|FG000|Overall Study|Physician Decision|5|||
129159982|NCT00100802|464878947|FG000|Overall Study|Protocol Violation|1|||
129159983|NCT00100802|464878947|FG000|Overall Study|Withdrawal by Subject|5|||
129159984|NCT00100802|464878947|FG000|Overall Study|Ineligible|12|||
129159985|NCT02709720|464878949|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
129159986|NCT02709720|464878949|FG000|Overall Study|Protocol Violation|1|||
129159987|NCT02709720|464878949|FG000|Overall Study|Not take study medication|1|||
129159988|NCT03265145|464878951|FG000|Overall Study|Protocol Violation|2|||
129159989|NCT03265145|464878952|FG001|Overall Study|Protocol Violation|0|||
129159990|NCT03265145|464878951|FG000|Overall Study|Adverse Event|1|||
129159991|NCT03265145|464878952|FG001|Overall Study|Adverse Event|0|||
129159992|NCT03265145|464878951|FG000|Overall Study|Withdrawal by Subject|23|||
129159993|NCT03265145|464878952|FG001|Overall Study|Withdrawal by Subject|19|||
129159994|NCT03265145|464878951|FG000|Overall Study|Death|12|||
129159995|NCT03265145|464878952|FG001|Overall Study|Death|12|||
129159996|NCT03265145|464878951|FG000|Overall Study|Lost to Follow-up|13|||
129159997|NCT03265145|464878952|FG001|Overall Study|Lost to Follow-up|9|||
129159998|NCT03265145|464878951|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
129159999|NCT03265145|464878952|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
129160000|NCT03265145|464878951|FG000|Overall Study|Switched back to previous medication|1|||
129160001|NCT03265145|464878952|FG001|Overall Study|Switched back to previous medication|0|||
129160002|NCT03265145|464878951|FG000|Overall Study|Did not want to take medication|1|||
128726205|NCT00735371|463294786|FG002|Overall Study|Adverse Event|4|||
128726206|NCT00735371|463294787|FG003|Overall Study|Adverse Event|1|||
128726207|NCT00735371|463294784|FG000|Overall Study|Protocol Violation|2|||
128726208|NCT00735371|463294785|FG001|Overall Study|Protocol Violation|2|||
128726209|NCT00735371|463294786|FG002|Overall Study|Protocol Violation|0|||
128726210|NCT00735371|463294787|FG003|Overall Study|Protocol Violation|3|||
128726211|NCT00735371|463294784|FG000|Overall Study|Withdrawal by Subject|0|||
128726212|NCT00735371|463294785|FG001|Overall Study|Withdrawal by Subject|2|||
128726213|NCT00735371|463294786|FG002|Overall Study|Withdrawal by Subject|2|||
128726214|NCT00735371|463294787|FG003|Overall Study|Withdrawal by Subject|0|||
128726215|NCT00735371|463294784|FG000|Overall Study|Lost to Follow-up|1|||
128726216|NCT00735371|463294785|FG001|Overall Study|Lost to Follow-up|1|||
128726217|NCT00735371|463294786|FG002|Overall Study|Lost to Follow-up|3|||
128726218|NCT00735371|463294787|FG003|Overall Study|Lost to Follow-up|1|||
128726219|NCT00735371|463294784|FG000|Overall Study|Lack of Efficacy|4|||
128726220|NCT00735371|463294785|FG001|Overall Study|Lack of Efficacy|2|||
128726221|NCT00735371|463294786|FG002|Overall Study|Lack of Efficacy|0|||
128726222|NCT00735371|463294787|FG003|Overall Study|Lack of Efficacy|4|||
129160003|NCT03265145|464878952|FG001|Overall Study|Did not want to take medication|0|||
129160004|NCT03265145|464878951|FG000|Overall Study|Subject could not afford medication|0|||
129160005|NCT03265145|464878952|FG001|Overall Study|Subject could not afford medication|1|||
129160006|NCT03265145|464878951|FG000|Overall Study|Site closed|2|||
129160007|NCT03265145|464878952|FG001|Overall Study|Site closed|3|||
129160008|NCT03265145|464878951|FG000|Overall Study|Incorrectly randomized|16|||
129160009|NCT03265145|464878952|FG001|Overall Study|Incorrectly randomized|6|||
129160010|NCT03265145|464878951|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
129160011|NCT03265145|464878952|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
129160012|NCT03265145|464878951|FG000|Overall Study|Physician Decision|0|||
129160013|NCT03265145|464878952|FG001|Overall Study|Physician Decision|3|||
129160014|NCT03265145|464878951|FG000|Overall Study|Subject transferred to another facility|0|||
129160015|NCT03265145|464878952|FG001|Overall Study|Subject transferred to another facility|1|||
129160016|NCT03276728|464880722|FG000|Overall Study|Lost to Follow-up|0|||
129160017|NCT03276728|464880723|FG001|Overall Study|Lost to Follow-up|0|||
129160018|NCT03276728|464880724|FG002|Overall Study|Lost to Follow-up|2|||
129160019|NCT03276728|464880725|FG003|Overall Study|Lost to Follow-up|2|||
129160020|NCT03276728|464880726|FG004|Overall Study|Lost to Follow-up|0|||
129160021|NCT03276728|464880727|FG005|Overall Study|Lost to Follow-up|0|||
129160022|NCT03276728|464880728|FG006|Overall Study|Lost to Follow-up|0|||
129160023|NCT03276728|464880729|FG007|Overall Study|Lost to Follow-up|0|||
129160024|NCT03276728|464880722|FG000|Overall Study|Withdrawal by Subject|0|||
129160025|NCT03276728|464880723|FG001|Overall Study|Withdrawal by Subject|0|||
129160026|NCT03276728|464880724|FG002|Overall Study|Withdrawal by Subject|0|||
129160027|NCT03276728|464880725|FG003|Overall Study|Withdrawal by Subject|3|||
129160028|NCT03276728|464880726|FG004|Overall Study|Withdrawal by Subject|0|||
129160029|NCT03276728|464880727|FG005|Overall Study|Withdrawal by Subject|0|||
129160030|NCT03276728|464880728|FG006|Overall Study|Withdrawal by Subject|0|||
129160031|NCT03276728|464880729|FG007|Overall Study|Withdrawal by Subject|0|||
129160032|NCT03276728|464880722|FG000|Overall Study|Decision by sponsor|0|||
129160033|NCT03276728|464880723|FG001|Overall Study|Decision by sponsor|0|||
129160034|NCT03276728|464880724|FG002|Overall Study|Decision by sponsor|0|||
129160035|NCT03276728|464880725|FG003|Overall Study|Decision by sponsor|0|||
129160036|NCT03276728|464880726|FG004|Overall Study|Decision by sponsor|1|||
129160037|NCT03276728|464880727|FG005|Overall Study|Decision by sponsor|0|||
129160038|NCT03276728|464880728|FG006|Overall Study|Decision by sponsor|2|||
129160039|NCT03276728|464880729|FG007|Overall Study|Decision by sponsor|1|||
129160040|NCT01234480|464880736|FG000|Overall Study|Pregnancy|88|||
129160041|NCT01234480|464880736|FG000|Overall Study|>36/Normal History|50|||
129160042|NCT01234480|464880736|FG000|Overall Study|Age|3|||
129160043|NCT01234480|464880736|FG000|Overall Study|HPV Vaccine History|28|||
129160044|NCT01234480|464880736|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
129160045|NCT01234480|464880736|FG000|Overall Study|Hysterectomy|2|||
129160046|NCT01234480|464880736|FG000|Overall Study|Hysterectomy post enrollment|1|||
129160047|NCT01234480|464880736|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
129160048|NCT01234480|464880736|FG000|Overall Study|Informed Consent Form Violation|30|||
129160049|NCT01234480|464880736|FG000|Overall Study|Incorrect Visit|3|||
129160050|NCT01234480|464880736|FG000|Overall Study|No Florida Lab License|20|||
129160051|NCT01234480|464880736|FG000|Overall Study|Out of Window|42|||
129160052|NCT01234480|464880736|FG000|Overall Study|Sample Processing/Storage|92|||
129160053|NCT01234480|464880736|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
128726223|NCT00735371|463294784|FG000|Overall Study|Sponsor Decision|3|||
129160054|NCT01234480|464880736|FG000|Overall Study|Site/Subject non-compliance|44|||
129160055|NCT01234480|464880736|FG000|Overall Study|Missing Sample|9|||
129160056|NCT02974140|464880737|FG000|Overall Study|Adverse Event|2|||
129160057|NCT02974140|464880737|FG000|Overall Study|Lost to Follow-up|1|||
129160058|NCT02974140|464880737|FG000|Overall Study|Study Terminated by Sponsor|36|||
129160059|NCT00617084|464880738|FG000|Overall Study|Withdrawal by Subject|5|||
129160060|NCT00617084|464880739|FG001|Overall Study|Withdrawal by Subject|7|||
129160061|NCT00617084|464880738|FG000|Overall Study|Missed 12 Months visit|16|||
129160062|NCT00617084|464880739|FG001|Overall Study|Missed 12 Months visit|19|||
129160063|NCT02522429|464880740|FG000|Overall Study|Lost to Follow-up|8|||
129160064|NCT02522429|464880740|FG000|Overall Study|Adverse Event|2|||
129160065|NCT02522429|464880740|FG000|Overall Study|Death|1|||
129160066|NCT02522429|464880740|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
129160067|NCT01521923|464880746|FG000|Overall Study|AE, serious fatal|1|||
129160068|NCT01521923|464880747|FG001|Overall Study|AE, serious fatal|0|||
129160069|NCT01521923|464880748|FG002|Overall Study|AE, serious fatal|0|||
129160070|NCT01521923|464880749|FG003|Overall Study|AE, serious fatal|0|||
129160071|NCT01521923|464880746|FG000|Overall Study|SAE, non-fatal|0|||
129160072|NCT01521923|464880747|FG001|Overall Study|SAE, non-fatal|2|||
129160073|NCT01521923|464880748|FG002|Overall Study|SAE, non-fatal|2|||
129160074|NCT01521923|464880749|FG003|Overall Study|SAE, non-fatal|0|||
129160075|NCT01521923|464880746|FG000|Overall Study|AE, non-serious, non-fatal|1|||
129160076|NCT01521923|464880747|FG001|Overall Study|AE, non-serious, non-fatal|3|||
129160077|NCT01521923|464880748|FG002|Overall Study|AE, non-serious, non-fatal|6|||
129160078|NCT01521923|464880749|FG003|Overall Study|AE, non-serious, non-fatal|2|||
129160079|NCT01521923|464880746|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
129160080|NCT01521923|464880747|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
129160081|NCT01521923|464880748|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
129160082|NCT01521923|464880749|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
129160083|NCT01521923|464880746|FG000|Overall Study|Lack of Efficacy|1|||
129160084|NCT01521923|464880747|FG001|Overall Study|Lack of Efficacy|1|||
129160085|NCT01521923|464880748|FG002|Overall Study|Lack of Efficacy|0|||
129160086|NCT01521923|464880749|FG003|Overall Study|Lack of Efficacy|0|||
129160087|NCT01521923|464880746|FG000|Overall Study|Protocol Violation|0|||
129160088|NCT01521923|464880747|FG001|Overall Study|Protocol Violation|0|||
129160089|NCT01521923|464880748|FG002|Overall Study|Protocol Violation|1|||
129160090|NCT01521923|464880749|FG003|Overall Study|Protocol Violation|0|||
129160091|NCT01521923|464880746|FG000|Overall Study|Lost to Follow-up|1|||
129160092|NCT01521923|464880747|FG001|Overall Study|Lost to Follow-up|0|||
129160093|NCT01521923|464880748|FG002|Overall Study|Lost to Follow-up|2|||
129160094|NCT01521923|464880749|FG003|Overall Study|Lost to Follow-up|1|||
129160095|NCT01521923|464880746|FG000|Overall Study|Withdrawal by Subject|1|||
129160096|NCT01521923|464880747|FG001|Overall Study|Withdrawal by Subject|1|||
129160097|NCT01521923|464880748|FG002|Overall Study|Withdrawal by Subject|1|||
129160098|NCT01521923|464880749|FG003|Overall Study|Withdrawal by Subject|2|||
129160099|NCT01521923|464880746|FG000|Overall Study|Other|2|||
129160100|NCT01521923|464880747|FG001|Overall Study|Other|1|||
129160101|NCT01521923|464880748|FG002|Overall Study|Other|3|||
128776884|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
128776885|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
128776886|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
128776887|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
128776888|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
128776889|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
128776890|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
128776891|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
128776892|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
128776893|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
128776894|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
129160102|NCT01521923|464880749|FG003|Overall Study|Other|6|||
129160103|NCT01521923|464880746|FG000|Overall Study|AE, captured in Period 1|0|||
129160104|NCT01521923|464880747|FG001|Overall Study|AE, captured in Period 1|1|||
129160105|NCT01521923|464880748|FG002|Overall Study|AE, captured in Period 1|0|||
128776895|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
129160106|NCT01521923|464880749|FG003|Overall Study|AE, captured in Period 1|1|||
129160107|NCT01279044|464880750|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
129160108|NCT01279044|464880751|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
129160109|NCT01279044|464880752|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
129160110|NCT01279044|464880750|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
129160111|NCT01279044|464880751|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
129160112|NCT01279044|464880752|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
129160113|NCT01279044|464880750|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
129160114|NCT01279044|464880751|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
129160115|NCT01279044|464880752|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
129160116|NCT01582009|464880753|FG000|Overall Study|Withdrawal by Subject|1|||
129160117|NCT01582009|464880753|FG000|Overall Study|Physician Decision|1|||
129160118|NCT00833469|464880754|FG000|Overall Study|Withdrawal by Subject|1|||
129160119|NCT00833469|464880754|FG000|Overall Study|Lost to Follow-up|1|||
129160120|NCT03592771|464880755|FG000|Overall Study|Adverse Event|2|||
129160121|NCT03592771|464880756|FG001|Overall Study|Adverse Event|0|||
129160122|NCT03592771|464880757|FG002|Overall Study|Adverse Event|1|||
129160123|NCT03592771|464880755|FG000|Overall Study|Death|0|||
129160124|NCT03592771|464880756|FG001|Overall Study|Death|1|||
129160125|NCT03592771|464880757|FG002|Overall Study|Death|1|||
129160126|NCT03592771|464880755|FG000|Overall Study|Lost to Follow-up|5|||
129160127|NCT03592771|464880756|FG001|Overall Study|Lost to Follow-up|11|||
129160128|NCT03592771|464880757|FG002|Overall Study|Lost to Follow-up|15|||
129160129|NCT03592771|464880755|FG000|Overall Study|Withdrawal by Subject|0|||
129160130|NCT03592771|464880756|FG001|Overall Study|Withdrawal by Subject|2|||
129160131|NCT03592771|464880757|FG002|Overall Study|Withdrawal by Subject|0|||
129160132|NCT01665911|464880758|FG000|Overall Study|Protocol Violation|4|||
129160133|NCT01665911|464880758|FG000|Overall Study|Withdrawal by Subject|1|||
129160134|NCT01665911|464880758|FG000|Overall Study|Adverse Event|1|||
129160135|NCT00735553|464880759|FG000|Overall Study|Study prematurely terminated|77|||
129160136|NCT04830215|464880760|FG000|Overall Study|Adverse Event|6|||
129160137|NCT04830215|464880760|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
129160138|NCT04830215|464880760|FG000|Overall Study|Withdrawal by Subject|3|||
129160139|NCT04830215|464880760|FG000|Overall Study|Protocol Deviation|1|||
129160140|NCT03726658|464880766|FG000|Overall Study|Lost to Follow-up|0|||
129160141|NCT03726658|464880767|FG001|Overall Study|Lost to Follow-up|0|||
129160142|NCT03726658|464880768|FG002|Overall Study|Lost to Follow-up|2|||
129160143|NCT03726658|464880769|FG003|Overall Study|Lost to Follow-up|0|||
129160144|NCT03726658|464880770|FG004|Overall Study|Lost to Follow-up|0|||
129160145|NCT03726658|464880771|FG005|Overall Study|Lost to Follow-up|1|||
129160146|NCT03726658|464880772|FG006|Overall Study|Lost to Follow-up|1|||
129160147|NCT03726658|464880766|FG000|Overall Study|Withdrawal by Subject|1|||
129160148|NCT03726658|464880767|FG001|Overall Study|Withdrawal by Subject|0|||
129160149|NCT03726658|464880768|FG002|Overall Study|Withdrawal by Subject|0|||
129160150|NCT03726658|464880769|FG003|Overall Study|Withdrawal by Subject|0|||
129160151|NCT03726658|464880770|FG004|Overall Study|Withdrawal by Subject|6|||
129160152|NCT03726658|464880771|FG005|Overall Study|Withdrawal by Subject|4|||
129160153|NCT03726658|464880772|FG006|Overall Study|Withdrawal by Subject|2|||
129160154|NCT03726658|464880766|FG000|Overall Study|Pregnancy|0|||
129160155|NCT03726658|464880767|FG001|Overall Study|Pregnancy|0|||
129160156|NCT03726658|464880768|FG002|Overall Study|Pregnancy|0|||
129160157|NCT03726658|464880769|FG003|Overall Study|Pregnancy|0|||
129160158|NCT03726658|464880770|FG004|Overall Study|Pregnancy|0|||
129160159|NCT03726658|464880771|FG005|Overall Study|Pregnancy|0|||
129160160|NCT03726658|464880772|FG006|Overall Study|Pregnancy|1|||
129160161|NCT03726658|464880766|FG000|Overall Study|Not Reported|0|||
129160162|NCT03726658|464880767|FG001|Overall Study|Not Reported|0|||
129160163|NCT03726658|464880768|FG002|Overall Study|Not Reported|0|||
129160164|NCT03726658|464880769|FG003|Overall Study|Not Reported|0|||
129160165|NCT03726658|464880770|FG004|Overall Study|Not Reported|0|||
129160166|NCT03726658|464880771|FG005|Overall Study|Not Reported|0|||
129160167|NCT03726658|464880772|FG006|Overall Study|Not Reported|1|||
129160168|NCT00090779|464880773|FG000|Step 1|Withdrawal by Subject|4|||
129160169|NCT00090779|464880774|FG001|Step 1|Withdrawal by Subject|2|||
129160170|NCT00090779|464880773|FG000|Step 1|Lost to Follow-up|3|||
129160171|NCT00090779|464880774|FG001|Step 1|Lost to Follow-up|2|||
129160172|NCT00090779|464880773|FG000|Step 1|Death|0|||
129160173|NCT00090779|464880774|FG001|Step 1|Death|2|||
129160174|NCT00090779|464880773|FG000|Step 1|Physician Decision|1|||
129160175|NCT00090779|464880774|FG001|Step 1|Physician Decision|0|||
129160176|NCT00090779|464880773|FG000|Step 1|Pregnancy|1|||
129160177|NCT00090779|464880774|FG001|Step 1|Pregnancy|0|||
129160178|NCT00090779|464880773|FG000|Step 1|Non-compliance to study requirements|0|||
129160179|NCT00090779|464880774|FG001|Step 1|Non-compliance to study requirements|1|||
129160180|NCT00090779|464880773|FG000|Step 1|Subject relocated|2|||
129160181|NCT00090779|464880774|FG001|Step 1|Subject relocated|8|||
129160182|NCT00090779|464880773|FG000|Step 2|Off study per study closure|6|||
129160183|NCT00090779|464880774|FG001|Step 2|Off study per study closure|16|||
129160184|NCT00090779|464880773|FG000|Step 2|Subject relocated|0|||
129160185|NCT00090779|464880774|FG001|Step 2|Subject relocated|1|||
129160186|NCT00090779|464880773|FG000|Step 2|Non-compliance to study requirements|0|||
129160187|NCT00090779|464880774|FG001|Step 2|Non-compliance to study requirements|1|||
129160188|NCT00090779|464880773|FG000|Step 3|Initiation of ART and off extended study|3|||
129160189|NCT00090779|464880774|FG001|Step 3|Initiation of ART and off extended study|2|||
129160190|NCT00090779|464880773|FG000|Step 3|Off extended study due to study closure|4|||
129160191|NCT00090779|464880774|FG001|Step 3|Off extended study due to study closure|3|||
129160192|NCT01318135|464880775|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
129160193|NCT01318135|464880776|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129160194|NCT01318135|464880777|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129160195|NCT01318135|464880778|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129160196|NCT01318135|464880779|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129160197|NCT01318135|464880780|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129160198|NCT01318135|464880781|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129160199|NCT01318135|464880782|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129160200|NCT01318135|464880775|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
129160201|NCT01318135|464880776|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129160202|NCT01318135|464880777|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129160203|NCT01318135|464880778|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129160204|NCT01318135|464880779|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129160205|NCT01318135|464880780|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129160206|NCT01318135|464880781|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129160207|NCT01318135|464880782|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129160208|NCT01318135|464880775|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
129160209|NCT01318135|464880776|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
129160210|NCT01318135|464880777|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
129160211|NCT01318135|464880778|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
129160212|NCT01318135|464880779|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
129160213|NCT01318135|464880780|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
129160214|NCT01318135|464880781|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
129160215|NCT01318135|464880782|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
129160216|NCT01318135|464880775|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
129160217|NCT01318135|464880776|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
129160218|NCT01318135|464880777|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
129160219|NCT01318135|464880778|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
129160220|NCT01318135|464880779|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
129160221|NCT01318135|464880780|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
129160222|NCT01318135|464880781|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
129160223|NCT01318135|464880782|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
129160224|NCT01318135|464880775|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129160225|NCT01318135|464880776|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129160226|NCT01318135|464880777|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129160227|NCT01318135|464880778|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129160228|NCT01318135|464880779|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129160229|NCT01318135|464880780|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129160230|NCT01318135|464880781|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129160231|NCT01318135|464880782|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129160232|NCT01318135|464880775|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
129160233|NCT01318135|464880776|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
129160234|NCT01318135|464880777|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
129160235|NCT01318135|464880778|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
129160236|NCT01318135|464880779|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
129160237|NCT01318135|464880780|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
129160238|NCT01318135|464880781|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129160239|NCT01318135|464880782|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129160240|NCT01318135|464880775|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129160241|NCT01318135|464880776|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129160242|NCT01318135|464880777|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129160243|NCT01318135|464880778|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129160244|NCT01318135|464880779|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129160245|NCT01318135|464880780|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129160246|NCT01318135|464880781|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129160247|NCT01318135|464880782|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
129160248|NCT01775553|464880787|FG000|Overall Study|Adverse Event|1|||
129160249|NCT01775553|464880787|FG000|Overall Study|Disease Progression|12|||
129160250|NCT00988052|464880788|FG000|Overall Study|Missing|1|||
129160251|NCT00988052|464880789|FG001|Overall Study|Missing|0|||
129160252|NCT00988052|464880788|FG000|Overall Study|Teva requested subject withdrawal|3|||
129160253|NCT00988052|464880789|FG001|Overall Study|Teva requested subject withdrawal|1|||
129160254|NCT00988052|464880788|FG000|Overall Study|Death|1|||
129160255|NCT00988052|464880789|FG001|Overall Study|Death|3|||
129160256|NCT00988052|464880788|FG000|Overall Study|Protocol Violation|6|||
129160257|NCT00988052|464880789|FG001|Overall Study|Protocol Violation|5|||
129160258|NCT00988052|464880788|FG000|Overall Study|Pregnancy|6|||
129160259|NCT00988052|464880789|FG001|Overall Study|Pregnancy|6|||
129160260|NCT00988052|464880788|FG000|Overall Study|Lack of Efficacy|8|||
129160261|NCT00988052|464880789|FG001|Overall Study|Lack of Efficacy|7|||
129160262|NCT00988052|464880788|FG000|Overall Study|Lost to Follow-up|6|||
129160263|NCT00988052|464880789|FG001|Overall Study|Lost to Follow-up|11|||
129160264|NCT00988052|464880788|FG000|Overall Study|Physician Decision|27|||
129160265|NCT00988052|464880789|FG001|Overall Study|Physician Decision|28|||
129160266|NCT00988052|464880788|FG000|Overall Study|Adverse Event|35|||
129160267|NCT00988052|464880789|FG001|Overall Study|Adverse Event|28|||
129160268|NCT00988052|464880788|FG000|Overall Study|Withdrawal by Subject|90|||
129160269|NCT00988052|464880789|FG001|Overall Study|Withdrawal by Subject|91|||
129160270|NCT00988052|464880788|FG000|Overall Study|Study terminated by sponsor|240|||
129160271|NCT00988052|464880789|FG001|Overall Study|Study terminated by sponsor|236|||
129160272|NCT01523743|464880790|FG000|Period 1|Adverse Event|1|||
129160273|NCT01523743|464880791|FG001|Period 1|Adverse Event|0|||
129160274|NCT01523743|464880790|FG000|Period 1|Withdrawal by Subject|6|||
129160275|NCT01523743|464880791|FG001|Period 1|Withdrawal by Subject|2|||
129160276|NCT01523743|464880790|FG000|Period 1|Lost to Follow-up|1|||
129160277|NCT01523743|464880791|FG001|Period 1|Lost to Follow-up|0|||
129160278|NCT01523743|464880790|FG000|Period 1|Lack of Efficacy|1|||
129160279|NCT01523743|464880791|FG001|Period 1|Lack of Efficacy|0|||
129160280|NCT01523743|464880790|FG000|Period 1|Felt unable to empty bladder|1|||
129160281|NCT01523743|464880791|FG001|Period 1|Felt unable to empty bladder|0|||
129160282|NCT01523743|464880790|FG000|Period 2|Withdrawal by Subject|0|||
129160283|NCT01523743|464880791|FG001|Period 2|Withdrawal by Subject|2|||
129160284|NCT01523743|464880790|FG000|Period 2|Adverse Event|1|||
129160285|NCT01523743|464880791|FG001|Period 2|Adverse Event|0|||
129160286|NCT02569476|464880792|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
129160287|NCT02569476|464880792|FG000|Overall Study|Death|33|||
129160288|NCT02569476|464880792|FG000|Overall Study|Withdrawal by Subject|9|||
129160289|NCT02569476|464880792|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
129160290|NCT02569476|464880792|FG000|Overall Study|Palliative care|1|||
129160291|NCT02569476|464880792|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
129160292|NCT02569476|464880792|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
129160293|NCT03782064|464880793|FG000|Overall Study|Lack of Efficacy|2|||
129160294|NCT03782064|464880793|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
129160295|NCT02446769|464880796|FG000|Screening Period|Screen Failure|11|||
129160296|NCT02446769|464880797|FG001|Screening Period|Screen Failure|0|||
129160297|NCT02446769|464880798|FG002|Screening Period|Screen Failure|0|||
129160298|NCT02446769|464880796|FG000|Study Period|Randomized in Error|0|||
129160299|NCT02446769|464880797|FG001|Study Period|Randomized in Error|2|||
129160300|NCT02446769|464880798|FG002|Study Period|Randomized in Error|0|||
129160301|NCT00703963|464880799|FG000|Overall Study|Withdrawal by Subject|7|||
129160302|NCT00703963|464880800|FG001|Overall Study|Withdrawal by Subject|13|||
129160303|NCT00703963|464880799|FG000|Overall Study|Physician Decision|0|||
129160304|NCT00703963|464880800|FG001|Overall Study|Physician Decision|1|||
129160305|NCT00645840|464880801|FG000|Overall Study|Protocol Violation|3|||
129160306|NCT00402324|464880802|FG000|Overall Study|Lost to Follow-up|11|||
129160307|NCT00402324|464880803|FG001|Overall Study|Lost to Follow-up|11|||
129160308|NCT00402324|464880802|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
129160309|NCT00402324|464880803|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
129160310|NCT00402324|464880802|FG000|Overall Study|Protocol Violation|8|||
129160311|NCT00402324|464880803|FG001|Overall Study|Protocol Violation|7|||
129160312|NCT00402324|464880802|FG000|Overall Study|Withdrawal by Subject|5|||
129160313|NCT00402324|464880803|FG001|Overall Study|Withdrawal by Subject|2|||
129160314|NCT00402324|464880802|FG000|Overall Study|Physician Decision|2|||
129160315|NCT00402324|464880803|FG001|Overall Study|Physician Decision|4|||
129160316|NCT00402324|464880802|FG000|Overall Study|Sponsor Decision|4|||
129160317|NCT00402324|464880803|FG001|Overall Study|Sponsor Decision|5|||
129160318|NCT00402324|464880802|FG000|Overall Study|Lack of Efficacy|1|||
129160319|NCT00402324|464880803|FG001|Overall Study|Lack of Efficacy|4|||
129160320|NCT00402324|464880802|FG000|Overall Study|Adverse Event|6|||
129160321|NCT00402324|464880803|FG001|Overall Study|Adverse Event|4|||
129160322|NCT00402324|464880802|FG000|Overall Study|Death|1|||
129160323|NCT00402324|464880803|FG001|Overall Study|Death|0|||
129160324|NCT03994211|464880804|FG000|Core Phase|Adverse Event|0|||
129160325|NCT03994211|464880805|FG001|Core Phase|Adverse Event|1|||
129160326|NCT03994211|464880806|FG002|Core Phase|Adverse Event|0|||
129160327|NCT03994211|464880804|FG000|Extension Phase|Adverse Event|0|||
129160328|NCT03994211|464880805|FG001|Extension Phase|Adverse Event|0|||
129160329|NCT03994211|464880806|FG002|Extension Phase|Adverse Event|1|||
129160330|NCT03994211|464880804|FG000|Extension Phase|Physician Decision|0|||
128776896|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
129160331|NCT03994211|464880805|FG001|Extension Phase|Physician Decision|0|||
129160332|NCT03994211|464880806|FG002|Extension Phase|Physician Decision|1|||
129160333|NCT03994211|464880804|FG000|Extension Phase|Progressive Disease|0|||
129160334|NCT03994211|464880805|FG001|Extension Phase|Progressive Disease|0|||
129160335|NCT03994211|464880806|FG002|Extension Phase|Progressive Disease|20|||
129160336|NCT03994211|464880804|FG000|Extension Phase|Withdrawal by Subject|0|||
129160337|NCT03994211|464880805|FG001|Extension Phase|Withdrawal by Subject|0|||
128776897|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
128776898|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
128776899|NCT01473420|463472026|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
129160338|NCT03994211|464880806|FG002|Extension Phase|Withdrawal by Subject|2|||
129160339|NCT02625220|464880807|FG000|Overall Study|Adverse Event|2|||
129160340|NCT02625220|464880807|FG000|Overall Study|Lost to Follow-up|2|||
129160341|NCT02625220|464880807|FG000|Overall Study|Protocol Violation|1|||
129160342|NCT02625220|464880807|FG000|Overall Study|Study discontinued at site|2|||
129160343|NCT01140867|464880808|FG000|Overall Study|Adverse Event|22|||
129160344|NCT01140867|464880808|FG000|Overall Study|Lack of Efficacy|3|||
129160345|NCT01140867|464880808|FG000|Overall Study|Lost to Follow-up|2|||
129160346|NCT01140867|464880808|FG000|Overall Study|Withdrawal by Subject|1|||
129160347|NCT01140867|464880808|FG000|Overall Study|Protocol Violation|1|||
129160348|NCT01140867|464880808|FG000|Overall Study|Uncooperative patient|2|||
129160349|NCT01140867|464880808|FG000|Overall Study|Medication Noncompliance|2|||
129160350|NCT04599803|464880812|FG000|Overall Study|Withdrawal by Subject|5|||
129160351|NCT04599803|464880812|FG000|Overall Study|Lost to Follow-up|26|||
129160352|NCT02484443|464880814|FG000|Overall Study|Lack of Efficacy|28|||
129160353|NCT02484443|464880814|FG000|Overall Study|Physician Decision|2|||
129160354|NCT02484443|464880814|FG000|Overall Study|Ineligible|2|||
129160355|NCT04677543|464880815|FG000|Overall Study|Withdrawal by Subject|4|||
129160356|NCT04677543|464880816|FG001|Overall Study|Withdrawal by Subject|1|||
129160357|NCT04677543|464880815|FG000|Overall Study|Physician Decision|0|||
129160358|NCT04677543|464880816|FG001|Overall Study|Physician Decision|1|||
129160359|NCT04677543|464880815|FG000|Overall Study|Adverse Event|0|||
129160360|NCT04677543|464880816|FG001|Overall Study|Adverse Event|1|||
129160361|NCT03799952|464880817|FG000|Overall Study|Program was too easy, discontinued|1|||
129160362|NCT03799952|464880818|FG001|Overall Study|Program was too easy, discontinued|0|||
129160363|NCT03799952|464880817|FG000|Overall Study|Lost to Follow-up|0|||
129160364|NCT03799952|464880818|FG001|Overall Study|Lost to Follow-up|2|||
129160365|NCT02595866|464880819|FG000|Overall Study|Adverse Event|2|||
129160366|NCT02595866|464880820|FG001|Overall Study|Adverse Event|5|||
129160367|NCT02595866|464880819|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
129160368|NCT02595866|464880820|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
129160369|NCT02595866|464880819|FG000|Overall Study|Death|0|||
129160370|NCT02595866|464880820|FG001|Overall Study|Death|1|||
129160371|NCT02595866|464880819|FG000|Overall Study|Incarceration|1|||
129160372|NCT02595866|464880820|FG001|Overall Study|Incarceration|0|||
129160373|NCT02595866|464880819|FG000|Overall Study|Lack of Efficacy|17|||
129160374|NCT02595866|464880820|FG001|Overall Study|Lack of Efficacy|7|||
129160375|NCT02595866|464880819|FG000|Overall Study|Physician Decision|4|||
129160376|NCT02595866|464880820|FG001|Overall Study|Physician Decision|3|||
129160377|NCT02595866|464880819|FG000|Overall Study|Switched to Alternative Treatment|1|||
129160378|NCT02595866|464880820|FG001|Overall Study|Switched to Alternative Treatment|0|||
129160379|NCT02595866|464880819|FG000|Overall Study|Study Terminated|0|||
129160380|NCT02595866|464880820|FG001|Overall Study|Study Terminated|4|||
129160381|NCT02595866|464880819|FG000|Overall Study|Withdrawal by Subject|6|||
129160382|NCT02595866|464880820|FG001|Overall Study|Withdrawal by Subject|1|||
129160383|NCT02520388|464880821|FG000|Overall Study|Physician Decision|1|||
129160384|NCT02520388|464880822|FG001|Overall Study|Physician Decision|0|||
129160385|NCT02520388|464880821|FG000|Overall Study|Subject or parent/guardian request|0|||
129160386|NCT02520388|464880822|FG001|Overall Study|Subject or parent/guardian request|6|||
129160387|NCT02520388|464880821|FG000|Overall Study|Adverse Event|1|||
129160388|NCT02520388|464880822|FG001|Overall Study|Adverse Event|4|||
129160389|NCT02520388|464880821|FG000|Overall Study|Lost to Follow-up|3|||
129160390|NCT02520388|464880822|FG001|Overall Study|Lost to Follow-up|2|||
129160391|NCT02520388|464880821|FG000|Overall Study|Other (reason not defined)|4|||
129160392|NCT02520388|464880822|FG001|Overall Study|Other (reason not defined)|4|||
129160393|NCT03035864|464880826|FG000|Treatment Period|Adverse Event|1|||
129160394|NCT03035864|464880827|FG001|Treatment Period|Adverse Event|0|||
129160395|NCT03035864|464880826|FG000|Treatment Period|Other|3|||
129160396|NCT03035864|464880827|FG001|Treatment Period|Other|1|||
129160397|NCT03035864|464880826|FG000|Follow-up Period|Adverse Event|1|||
129160398|NCT03035864|464880827|FG001|Follow-up Period|Adverse Event|0|||
128776900|NCT01473420|463472027|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
129160399|NCT03035864|464880826|FG000|Follow-up Period|Lost to Follow-up|6|||
129160400|NCT03035864|464880827|FG001|Follow-up Period|Lost to Follow-up|2|||
129160401|NCT03035864|464880826|FG000|Follow-up Period|Physician Decision|1|||
129160402|NCT03035864|464880827|FG001|Follow-up Period|Physician Decision|0|||
129160403|NCT03035864|464880826|FG000|Follow-up Period|Other|3|||
128776901|NCT04172987|463472031|FG000|Lead In Period|Adverse Event|1|||
129160404|NCT03035864|464880827|FG001|Follow-up Period|Other|2|||
129160405|NCT02375373|464880828|FG000|Overall Study|Withdrawal by Subject|11|||
129160406|NCT00577707|464880829|FG000|Overall Study|Withdrawal by Subject|3|||
129160407|NCT03299244|464880830|FG000|Overall Study|Withdrawal by Subject|34|||
129160408|NCT03299244|464880831|FG001|Overall Study|Withdrawal by Subject|29|||
129160409|NCT03299244|464880830|FG000|Overall Study|Decision by Sponsor|4|||
129160410|NCT03299244|464880831|FG001|Overall Study|Decision by Sponsor|5|||
129160411|NCT03299244|464880830|FG000|Overall Study|Death|9|||
129160412|NCT03299244|464880831|FG001|Overall Study|Death|4|||
129160413|NCT00431444|464880832|FG000|Overall Study|Protocol Violation|1|||
129160414|NCT00431444|464880833|FG001|Overall Study|Protocol Violation|4|||
129160415|NCT00431444|464880832|FG000|Overall Study|Adverse Event|2|||
129160416|NCT00431444|464880833|FG001|Overall Study|Adverse Event|1|||
129160417|NCT00431444|464880832|FG000|Overall Study|Withdrawal by Subject|1|||
129160418|NCT00431444|464880833|FG001|Overall Study|Withdrawal by Subject|1|||
129160419|NCT00431444|464880832|FG000|Overall Study|Lost to Follow-up|1|||
129160420|NCT00431444|464880833|FG001|Overall Study|Lost to Follow-up|0|||
129160421|NCT00431444|464880832|FG000|Overall Study|Administrative Problems|0|||
129160422|NCT00431444|464880833|FG001|Overall Study|Administrative Problems|1|||
129160423|NCT01603043|464880834|FG000|Overall Study|Study Futility|7|||
129160424|NCT01603043|464880835|FG001|Overall Study|Study Futility|3|||
129160425|NCT00642707|464880850|FG000|Overall Study|Adverse Event|0|||
129160426|NCT00642707|464880851|FG001|Overall Study|Adverse Event|0|||
129160427|NCT00642707|464880852|FG002|Overall Study|Adverse Event|0|||
129160428|NCT00642707|464880853|FG003|Overall Study|Adverse Event|2|||
129160429|NCT00642707|464880850|FG000|Overall Study|Withdrawal by Subject|1|||
129160430|NCT00642707|464880851|FG001|Overall Study|Withdrawal by Subject|0|||
129160431|NCT00642707|464880852|FG002|Overall Study|Withdrawal by Subject|0|||
129160432|NCT00642707|464880853|FG003|Overall Study|Withdrawal by Subject|0|||
129160433|NCT02712996|464880869|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
129160434|NCT02712996|464880870|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
129160435|NCT01016132|464880871|FG000|Overall Study|Discomfort|1|||
129160436|NCT01451749|464880872|FG000|Overall Study|Protocol Violation|14|||
129160437|NCT01451749|464880873|FG001|Overall Study|Protocol Violation|7|||
129160438|NCT01451749|464880872|FG000|Overall Study|Lost to Follow-up|15|||
129160439|NCT01451749|464880873|FG001|Overall Study|Lost to Follow-up|5|||
129160440|NCT01451749|464880872|FG000|Overall Study|Meet the exclusion criteria,and|1|||
129160441|NCT01451749|464880873|FG001|Overall Study|Meet the exclusion criteria,and|1|||
129160442|NCT01451749|464880872|FG000|Overall Study|Adverse Event|2|||
129160443|NCT01451749|464880873|FG001|Overall Study|Adverse Event|0|||
129160444|NCT01451749|464880872|FG000|Overall Study|Withdrawal by Subject|0|||
129160445|NCT01451749|464880873|FG001|Overall Study|Withdrawal by Subject|1|||
129160446|NCT01198574|464880883|FG000|Overall Study|Resigned from schools|4|||
129160447|NCT01198574|464880884|FG001|Overall Study|Resigned from schools|1|||
129160448|NCT01198574|464880885|FG002|Overall Study|Resigned from schools|1|||
129160449|NCT01198574|464880886|FG003|Overall Study|Resigned from schools|4|||
129160450|NCT00556439|464880916|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
129160451|NCT00556439|464880917|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
129160452|NCT00556439|464880918|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
129160453|NCT00556439|464880919|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
129160454|NCT00556439|464880916|FG000|Study Entry to Week 12|Physician Decision|1|||
129160455|NCT00556439|464880917|FG001|Study Entry to Week 12|Physician Decision|0|||
129160456|NCT00556439|464880918|FG002|Study Entry to Week 12|Physician Decision|0|||
129160457|NCT00556439|464880919|FG003|Study Entry to Week 12|Physician Decision|0|||
129160458|NCT00556439|464880916|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
129160459|NCT00556439|464880917|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
129160460|NCT00556439|464880918|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
129160461|NCT00556439|464880919|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
129160462|NCT00556439|464880916|FG000|Study Entry to Week 12|Recurrent infection|1|||
129160463|NCT00556439|464880917|FG001|Study Entry to Week 12|Recurrent infection|0|||
129160464|NCT00556439|464880918|FG002|Study Entry to Week 12|Recurrent infection|0|||
129160465|NCT00556439|464880919|FG003|Study Entry to Week 12|Recurrent infection|0|||
129160466|NCT00556439|464880916|FG000|Study Entry to Week 12|Malignancy|0|||
129160467|NCT00556439|464880917|FG001|Study Entry to Week 12|Malignancy|0|||
129160468|NCT00556439|464880918|FG002|Study Entry to Week 12|Malignancy|1|||
129160469|NCT00556439|464880919|FG003|Study Entry to Week 12|Malignancy|0|||
129160470|NCT00556439|464880916|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
129160471|NCT00556439|464880917|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
129160472|NCT00556439|464880918|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
129160473|NCT00556439|464880919|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
129160474|NCT00556439|464880916|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
129160475|NCT00556439|464880917|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
129160476|NCT00556439|464880918|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
129160477|NCT00556439|464880919|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
129160478|NCT00556439|464880916|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
129160479|NCT00556439|464880917|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
129160480|NCT00556439|464880918|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
129160481|NCT00556439|464880919|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
129160482|NCT00556439|464880916|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
129160483|NCT00556439|464880917|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
129160484|NCT00556439|464880918|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
129160485|NCT00556439|464880919|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
129160486|NCT02100423|464880920|FG000|Overall Study|Death|1|||
129160487|NCT02100423|464880920|FG000|Overall Study|Withdrawal by Subject|3|||
129160488|NCT02100423|464880920|FG000|Overall Study|Adverse Event|1|||
129160489|NCT02100423|464880920|FG000|Overall Study|Physician Decision|1|||
129160490|NCT00325130|464880921|FG000|Overall Study|Lost to Follow-up|6|||
129160491|NCT00325130|464880922|FG001|Overall Study|Lost to Follow-up|14|||
129160492|NCT00325130|464880921|FG000|Overall Study|Withdrawal by Subject|12|||
129160493|NCT00325130|464880922|FG001|Overall Study|Withdrawal by Subject|14|||
129160494|NCT00325130|464880921|FG000|Overall Study|Protocol Deviation|0|||
129160495|NCT00325130|464880922|FG001|Overall Study|Protocol Deviation|1|||
129160496|NCT00325130|464880921|FG000|Overall Study|Moved|0|||
129160497|NCT00325130|464880922|FG001|Overall Study|Moved|1|||
129160498|NCT00325130|464880921|FG000|Overall Study|Patient Discontinued for Other|1|||
129160499|NCT00325130|464880922|FG001|Overall Study|Patient Discontinued for Other|0|||
129160500|NCT02454530|464880923|FG000|Overall Study|Other|8|||
129160501|NCT02454530|464880924|FG001|Overall Study|Other|13|||
129160502|NCT02454530|464880923|FG000|Overall Study|Missing information|56|||
129160503|NCT02454530|464880924|FG001|Overall Study|Missing information|69|||
129160504|NCT02454530|464880923|FG000|Overall Study|Death|2|||
129160505|NCT02454530|464880924|FG001|Overall Study|Death|41|||
129160506|NCT02454530|464880923|FG000|Overall Study|Lost to Follow-up|4|||
129160507|NCT02454530|464880924|FG001|Overall Study|Lost to Follow-up|4|||
129160508|NCT02949024|464880927|FG000|Overall Study|Withdrawal by Subject|0|||
129160509|NCT02949024|464880928|FG001|Overall Study|Withdrawal by Subject|1|||
129160510|NCT03159468|464880929|FG000|Overall Study|Withdrawal by Subject|0|||
129160511|NCT03159468|464880930|FG001|Overall Study|Withdrawal by Subject|0|||
129160512|NCT03159468|464880931|FG002|Overall Study|Withdrawal by Subject|3|||
129160513|NCT03159468|464880932|FG003|Overall Study|Withdrawal by Subject|0|||
129160514|NCT03159468|464880933|FG004|Overall Study|Withdrawal by Subject|0|||
129160515|NCT03159468|464880934|FG005|Overall Study|Withdrawal by Subject|0|||
129160516|NCT02524145|464880935|FG000|Overall Study|Withdrawal by Subject|2|||
129160517|NCT02524145|464880936|FG001|Overall Study|Withdrawal by Subject|2|||
129160518|NCT02524145|464880937|FG002|Overall Study|Withdrawal by Subject|3|||
129160519|NCT00283803|464882341|FG000|Overall Study|Physician Decision|9|||
128776902|NCT04172987|463472031|FG000|Lead In Period|Protocol Violation|1|||
129160520|NCT00283803|464882341|FG000|Overall Study|Withdrawal by Subject|4|||
129160521|NCT01127607|464882342|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
129160522|NCT01127607|464882343|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
129160523|NCT01127607|464882342|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
129160524|NCT01127607|464882343|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
129160525|NCT03640325|464882344|FG000|Overall Study|Withdrawal by Subject|4|||
129160526|NCT03640325|464882345|FG001|Overall Study|Withdrawal by Subject|1|||
129160527|NCT03640325|464882346|FG002|Overall Study|Withdrawal by Subject|0|||
129160528|NCT03640325|464882344|FG000|Overall Study|Lost to Follow-up|4|||
129160529|NCT03640325|464882345|FG001|Overall Study|Lost to Follow-up|5|||
129160530|NCT03640325|464882346|FG002|Overall Study|Lost to Follow-up|21|||
129160531|NCT03640325|464882344|FG000|Overall Study|Death|5|||
129160532|NCT03640325|464882345|FG001|Overall Study|Death|5|||
129160533|NCT03640325|464882346|FG002|Overall Study|Death|0|||
129160534|NCT01133756|464882350|FG000|Overall Study|Adverse Event|1|||
129160535|NCT01133756|464882351|FG001|Overall Study|Adverse Event|2|||
129160536|NCT01133756|464882352|FG002|Overall Study|Adverse Event|1|||
129160537|NCT01133756|464882350|FG000|Overall Study|Investigator Decision|1|||
129160538|NCT01133756|464882351|FG001|Overall Study|Investigator Decision|0|||
129160539|NCT01133756|464882352|FG002|Overall Study|Investigator Decision|0|||
129160540|NCT01133756|464882350|FG000|Overall Study|Withdrawal by Subject|0|||
129160541|NCT01133756|464882351|FG001|Overall Study|Withdrawal by Subject|1|||
129160542|NCT01133756|464882352|FG002|Overall Study|Withdrawal by Subject|0|||
129160543|NCT01133756|464882350|FG000|Overall Study|Progression of Disease|0|||
129160544|NCT01133756|464882351|FG001|Overall Study|Progression of Disease|0|||
128776903|NCT04172987|463472031|FG000|Period 1|Physician Decision|1|||
129160545|NCT01133756|464882352|FG002|Overall Study|Progression of Disease|1|||
129160546|NCT01566149|464882353|FG000|Overall Study|Adverse Event|0|||
129160547|NCT01566149|464882354|FG001|Overall Study|Adverse Event|1|||
129160548|NCT01566149|464882353|FG000|Overall Study|Non-compliance with study medication|2|||
129160549|NCT01566149|464882354|FG001|Overall Study|Non-compliance with study medication|0|||
129160550|NCT01566149|464882353|FG000|Overall Study|Protocol Violation|0|||
129160551|NCT01566149|464882354|FG001|Overall Study|Protocol Violation|1|||
129160552|NCT01566149|464882353|FG000|Overall Study|Withdrawal by Subject|1|||
129160553|NCT01566149|464882354|FG001|Overall Study|Withdrawal by Subject|0|||
129160554|NCT03941873|464882358|FG000|Overall Study|Death|0|||
128776904|NCT04172987|463472031|FG000|Period 2|Adverse Event|5|||
129160555|NCT03941873|464882359|FG001|Overall Study|Death|12|||
129160556|NCT03941873|464882360|FG002|Overall Study|Death|2|||
129160557|NCT03941873|464882361|FG003|Overall Study|Death|53|||
129160558|NCT03941873|464882358|FG000|Overall Study|Withdrawal by Subject|1|||
128726224|NCT00735371|463294785|FG001|Overall Study|Sponsor Decision|1|||
129160559|NCT03941873|464882359|FG001|Overall Study|Withdrawal by Subject|1|||
129160560|NCT03941873|464882360|FG002|Overall Study|Withdrawal by Subject|0|||
129160561|NCT03941873|464882361|FG003|Overall Study|Withdrawal by Subject|5|||
129160562|NCT03941873|464882358|FG000|Overall Study|Lost to Follow-up|1|||
129160563|NCT03941873|464882359|FG001|Overall Study|Lost to Follow-up|2|||
129160564|NCT03941873|464882360|FG002|Overall Study|Lost to Follow-up|0|||
129160565|NCT03941873|464882361|FG003|Overall Study|Lost to Follow-up|0|||
129160566|NCT03941873|464882358|FG000|Overall Study|Sponsor Decision|0|||
129160567|NCT03941873|464882359|FG001|Overall Study|Sponsor Decision|6|||
129160568|NCT03941873|464882360|FG002|Overall Study|Sponsor Decision|0|||
129160569|NCT03941873|464882361|FG003|Overall Study|Sponsor Decision|15|||
129160570|NCT02982772|464882364|FG000|Intervention|Lost to Follow-up|19|||
129160571|NCT02982772|464882365|FG001|Intervention|Lost to Follow-up|13|||
129160572|NCT02982772|464882364|FG000|1M Follow-Up|Lost to Follow-up|21|||
129160573|NCT02982772|464882365|FG001|1M Follow-Up|Lost to Follow-up|18|||
129160574|NCT02982772|464882364|FG000|3M Follow-Up|Lost to Follow-up|17|||
129160575|NCT02982772|464882365|FG001|3M Follow-Up|Lost to Follow-up|11|||
129160576|NCT02982772|464882364|FG000|6M Follow-Up|Lost to Follow-up|11|||
129160577|NCT02982772|464882365|FG001|6M Follow-Up|Lost to Follow-up|9|||
129160578|NCT02982772|464882364|FG000|12M Follow-Up|Lost to Follow-up|11|||
129160579|NCT02982772|464882365|FG001|12M Follow-Up|Lost to Follow-up|5|||
129160580|NCT00500357|464882370|FG000|Overall Study|Death|1|||
129160581|NCT00161616|464882371|FG000|Overall Study|Withdrawal by Subject|6|||
129160582|NCT00161616|464882372|FG001|Overall Study|Withdrawal by Subject|5|||
129160583|NCT00161616|464882371|FG000|Overall Study|Physician Decision|1|||
129160584|NCT00161616|464882372|FG001|Overall Study|Physician Decision|0|||
129160585|NCT00161616|464882371|FG000|Overall Study|Death|1|||
129160586|NCT00161616|464882372|FG001|Overall Study|Death|1|||
129160587|NCT00161616|464882371|FG000|Overall Study|Lost to Follow-up|17|||
129160588|NCT00161616|464882372|FG001|Overall Study|Lost to Follow-up|13|||
129160589|NCT00161616|464882371|FG000|Overall Study|Protocol deviation|1|||
129160590|NCT00161616|464882372|FG001|Overall Study|Protocol deviation|0|||
129160591|NCT00854724|464882373|FG000|First Intervention|Withdrawal by Subject|1|||
129160592|NCT00854724|464882374|FG001|First Intervention|Withdrawal by Subject|1|||
129160593|NCT00854724|464882373|FG000|Washout|Protocol Violation|1|||
129160594|NCT00854724|464882374|FG001|Washout|Protocol Violation|0|||
129160595|NCT00854724|464882373|FG000|Washout|Withdrawal by Subject|0|||
129160596|NCT00854724|464882374|FG001|Washout|Withdrawal by Subject|1|||
129160597|NCT00854724|464882373|FG000|Second Intervention|Protocol Violation|1|||
129160598|NCT00854724|464882374|FG001|Second Intervention|Protocol Violation|0|||
129160599|NCT00854724|464882373|FG000|Second Intervention|Physician Decision|0|||
129160600|NCT00854724|464882374|FG001|Second Intervention|Physician Decision|1|||
129160601|NCT02141633|464882375|FG000|Overall Study|Physician Decision|1|||
129160602|NCT02141633|464882376|FG001|Overall Study|Physician Decision|0|||
129160603|NCT02140970|464882383|FG000|Overall Study|Lost to Follow-up|1|||
129160604|NCT02140970|464882384|FG001|Overall Study|Lost to Follow-up|2|||
129160605|NCT02140970|464882383|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
129160606|NCT02140970|464882384|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
129160607|NCT02140970|464882383|FG000|Overall Study|Did not meet inclusion criteria|0|||
129160608|NCT02140970|464882384|FG001|Overall Study|Did not meet inclusion criteria|1|||
129160609|NCT01947283|464882388|FG000|Overall Study|Death|1|||
129160610|NCT01947283|464882389|FG001|Overall Study|Death|1|||
129160611|NCT01947283|464882390|FG002|Overall Study|Death|1|||
129160612|NCT01947283|464882391|FG003|Overall Study|Death|0|||
129160613|NCT01947283|464882392|FG004|Overall Study|Death|0|||
129160614|NCT01947283|464882393|FG005|Overall Study|Death|0|||
129160615|NCT01947283|464882394|FG006|Overall Study|Death|0|||
129160616|NCT01947283|464882388|FG000|Overall Study|Lost to Follow-up|4|||
129160617|NCT01947283|464882389|FG001|Overall Study|Lost to Follow-up|6|||
129160618|NCT01947283|464882390|FG002|Overall Study|Lost to Follow-up|5|||
129160619|NCT01947283|464882391|FG003|Overall Study|Lost to Follow-up|5|||
129160620|NCT01947283|464882392|FG004|Overall Study|Lost to Follow-up|0|||
129160621|NCT01947283|464882393|FG005|Overall Study|Lost to Follow-up|2|||
129160622|NCT01947283|464882394|FG006|Overall Study|Lost to Follow-up|5|||
129160623|NCT01947283|464882388|FG000|Overall Study|Withdrawal by Subject|10|||
128726225|NCT00735371|463294786|FG002|Overall Study|Sponsor Decision|0|||
129160624|NCT01947283|464882389|FG001|Overall Study|Withdrawal by Subject|8|||
129160625|NCT01947283|464882390|FG002|Overall Study|Withdrawal by Subject|4|||
129160626|NCT01947283|464882391|FG003|Overall Study|Withdrawal by Subject|1|||
129160627|NCT01947283|464882392|FG004|Overall Study|Withdrawal by Subject|0|||
129160628|NCT01947283|464882393|FG005|Overall Study|Withdrawal by Subject|0|||
129160629|NCT01947283|464882394|FG006|Overall Study|Withdrawal by Subject|2|||
129160630|NCT01947283|464882388|FG000|Overall Study|No Clinical Recording|12|||
129160631|NCT01947283|464882389|FG001|Overall Study|No Clinical Recording|6|||
129160632|NCT01947283|464882390|FG002|Overall Study|No Clinical Recording|8|||
129160633|NCT01947283|464882391|FG003|Overall Study|No Clinical Recording|10|||
129160634|NCT01947283|464882392|FG004|Overall Study|No Clinical Recording|0|||
129160635|NCT01947283|464882393|FG005|Overall Study|No Clinical Recording|0|||
129160636|NCT01947283|464882394|FG006|Overall Study|No Clinical Recording|0|||
129160637|NCT01947283|464882388|FG000|Overall Study|Non-coding Clinical Recording language|0|||
129160638|NCT01947283|464882389|FG001|Overall Study|Non-coding Clinical Recording language|0|||
129160639|NCT01947283|464882390|FG002|Overall Study|Non-coding Clinical Recording language|0|||
129160640|NCT01947283|464882391|FG003|Overall Study|Non-coding Clinical Recording language|1|||
129160641|NCT01947283|464882392|FG004|Overall Study|Non-coding Clinical Recording language|0|||
129160642|NCT01947283|464882393|FG005|Overall Study|Non-coding Clinical Recording language|0|||
129160643|NCT01947283|464882394|FG006|Overall Study|Non-coding Clinical Recording language|0|||
129160644|NCT01947283|464882388|FG000|Overall Study|Missing Follow-up Assessment|2|||
129160645|NCT01947283|464882389|FG001|Overall Study|Missing Follow-up Assessment|2|||
129160646|NCT01947283|464882390|FG002|Overall Study|Missing Follow-up Assessment|3|||
129160647|NCT01947283|464882391|FG003|Overall Study|Missing Follow-up Assessment|0|||
129160648|NCT01947283|464882392|FG004|Overall Study|Missing Follow-up Assessment|0|||
129160649|NCT01947283|464882393|FG005|Overall Study|Missing Follow-up Assessment|2|||
129160650|NCT01947283|464882394|FG006|Overall Study|Missing Follow-up Assessment|0|||
129160651|NCT01947283|464882388|FG000|Overall Study|No patients were enrolled in study|0|||
129160652|NCT01947283|464882389|FG001|Overall Study|No patients were enrolled in study|0|||
129160653|NCT01947283|464882390|FG002|Overall Study|No patients were enrolled in study|0|||
129160654|NCT01947283|464882391|FG003|Overall Study|No patients were enrolled in study|0|||
129160655|NCT01947283|464882392|FG004|Overall Study|No patients were enrolled in study|0|||
129160656|NCT01947283|464882393|FG005|Overall Study|No patients were enrolled in study|3|||
129160657|NCT01947283|464882394|FG006|Overall Study|No patients were enrolled in study|1|||
129160658|NCT00603941|464882395|FG000|Overall Study|Disease progression|6|||
129160659|NCT00603941|464882396|FG001|Overall Study|Disease progression|7|||
129160660|NCT00603941|464882397|FG002|Overall Study|Disease progression|1|||
129160661|NCT00603941|464882395|FG000|Overall Study|Adverse Event|1|||
129160662|NCT00603941|464882396|FG001|Overall Study|Adverse Event|0|||
129160663|NCT00603941|464882397|FG002|Overall Study|Adverse Event|1|||
129160664|NCT00603941|464882395|FG000|Overall Study|Physician Decision|0|||
129160665|NCT00603941|464882396|FG001|Overall Study|Physician Decision|1|||
129160666|NCT00603941|464882397|FG002|Overall Study|Physician Decision|0|||
129160667|NCT00603941|464882395|FG000|Overall Study|Withdrawal by Subject|0|||
129160668|NCT00603941|464882396|FG001|Overall Study|Withdrawal by Subject|2|||
129160669|NCT00603941|464882397|FG002|Overall Study|Withdrawal by Subject|0|||
129160670|NCT05069597|464882398|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129160671|NCT05069597|464882399|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
129160672|NCT02705105|464882400|FG000|Treatment|Objective Disease Progression|1|||
129160673|NCT02705105|464882401|FG001|Treatment|Objective Disease Progression|50|||
129160674|NCT02705105|464882400|FG000|Treatment|Withdrawal by Subject|3|||
129160675|NCT02705105|464882401|FG001|Treatment|Withdrawal by Subject|5|||
129160676|NCT02705105|464882400|FG000|Treatment|Adverse Event|0|||
129160677|NCT02705105|464882401|FG001|Treatment|Adverse Event|17|||
129160678|NCT02705105|464882400|FG000|Treatment|Clinical Disease Progression|0|||
129160679|NCT02705105|464882401|FG001|Treatment|Clinical Disease Progression|32|||
129160680|NCT02705105|464882400|FG000|Treatment|Physician Decision|0|||
129160681|NCT02705105|464882401|FG001|Treatment|Physician Decision|3|||
129160682|NCT02705105|464882400|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
129160683|NCT02705105|464882401|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
129160684|NCT02705105|464882400|FG000|Follow-Up|Death|3|||
129160685|NCT02705105|464882401|FG001|Follow-Up|Death|68|||
129160686|NCT02705105|464882400|FG000|Follow-Up|Withdrawal by Subject|1|||
129160687|NCT02705105|464882401|FG001|Follow-Up|Withdrawal by Subject|14|||
129160688|NCT02705105|464882400|FG000|Follow-Up|Study Terminated|0|||
129160689|NCT02705105|464882401|FG001|Follow-Up|Study Terminated|26|||
129160690|NCT02705105|464882400|FG000|Follow-Up|Discontinued per Amendment 3|0|||
129160691|NCT02705105|464882401|FG001|Follow-Up|Discontinued per Amendment 3|2|||
129160692|NCT01709110|464882402|FG000|Overall Study|Adverse Event|56|||
129160693|NCT01709110|464882403|FG001|Overall Study|Adverse Event|48|||
129160694|NCT01709110|464882402|FG000|Overall Study|Death|14|||
129160695|NCT01709110|464882403|FG001|Overall Study|Death|6|||
129160696|NCT01709110|464882402|FG000|Overall Study|Lost to Follow-up|7|||
129160697|NCT01709110|464882403|FG001|Overall Study|Lost to Follow-up|5|||
128726226|NCT00735371|463294787|FG003|Overall Study|Sponsor Decision|1|||
128726227|NCT00735371|463294784|FG000|Overall Study|Protocol Violation|0|||
128726228|NCT00735371|463294785|FG001|Overall Study|Protocol Violation|1|||
128726229|NCT00735371|463294786|FG002|Overall Study|Protocol Violation|2|||
128726230|NCT00735371|463294787|FG003|Overall Study|Protocol Violation|0|||
128726231|NCT00735371|463294784|FG000|Overall Study|Prior Vyvanse Exposure|1|||
128726232|NCT00735371|463294785|FG001|Overall Study|Prior Vyvanse Exposure|1|||
128726233|NCT00735371|463294786|FG002|Overall Study|Prior Vyvanse Exposure|0|||
128726234|NCT00735371|463294787|FG003|Overall Study|Prior Vyvanse Exposure|0|||
129160698|NCT01709110|464882402|FG000|Overall Study|Protocol Violation|4|||
129160699|NCT01709110|464882403|FG001|Overall Study|Protocol Violation|6|||
128726235|NCT00735371|463294784|FG000|Overall Study|Exclusion criteria|1|||
128726236|NCT00735371|463294785|FG001|Overall Study|Exclusion criteria|0|||
128726237|NCT00735371|463294786|FG002|Overall Study|Exclusion criteria|0|||
129160700|NCT01709110|464882402|FG000|Overall Study|Withdrawal by Subject|96|||
129160701|NCT01709110|464882403|FG001|Overall Study|Withdrawal by Subject|89|||
129160702|NCT01709110|464882402|FG000|Overall Study|Physician Decision|4|||
129160703|NCT01709110|464882403|FG001|Overall Study|Physician Decision|10|||
129160704|NCT01709110|464882402|FG000|Overall Study|Sponsor Decision|2|||
129160705|NCT01709110|464882403|FG001|Overall Study|Sponsor Decision|2|||
129160706|NCT01709110|464882402|FG000|Overall Study|Lack of Efficacy|1|||
129160707|NCT01709110|464882403|FG001|Overall Study|Lack of Efficacy|1|||
129160708|NCT01709110|464882402|FG000|Overall Study|Caregiver Decision|1|||
129160709|NCT01709110|464882403|FG001|Overall Study|Caregiver Decision|1|||
129160710|NCT04556591|464882404|FG000|Overall Study|Lost to Follow-up|1|||
129160711|NCT04556591|464882405|FG001|Overall Study|Lost to Follow-up|0|||
129160712|NCT04556591|464882404|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
129160713|NCT04556591|464882405|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
129160714|NCT03332173|464882406|FG000|Overall Study|Death|7|||
129160715|NCT03332173|464882406|FG000|Overall Study|Withdrawal by Subject|6|||
129160716|NCT03332173|464882406|FG000|Overall Study|Lost to Follow-up|2|||
129160717|NCT03332173|464882406|FG000|Overall Study|Transferred to long-term extension study|29|||
129160718|NCT02168101|464882407|FG000|Overall Study|Death|2|||
129160719|NCT02168101|464882408|FG001|Overall Study|Death|2|||
129160720|NCT02168101|464882409|FG002|Overall Study|Death|1|||
129160721|NCT05507567|464882410|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
129160722|NCT05507567|464882411|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
129160723|NCT05507567|464882412|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
129160724|NCT05507567|464882410|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
129160725|NCT05507567|464882411|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
129160726|NCT05507567|464882412|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
129160727|NCT05507567|464882410|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
129160728|NCT05507567|464882411|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
129160729|NCT05507567|464882412|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
129160730|NCT05507567|464882410|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
129160731|NCT05507567|464882411|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
129160732|NCT05507567|464882412|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
129160733|NCT00910910|464882413|FG000|Overall Study|Adverse Event|63|||
129160734|NCT00910910|464882414|FG001|Overall Study|Adverse Event|35|||
129160735|NCT00910910|464882413|FG000|Overall Study|PD without histologic change|27|||
129160736|NCT00910910|464882414|FG001|Overall Study|PD without histologic change|23|||
129160737|NCT00910910|464882413|FG000|Overall Study|PD with histologic change|0|||
129160738|NCT00910910|464882414|FG001|Overall Study|PD with histologic change|2|||
129160739|NCT00910910|464882413|FG000|Overall Study|Withdrawal by Subject|7|||
129160740|NCT00910910|464882414|FG001|Overall Study|Withdrawal by Subject|5|||
129160741|NCT00910910|464882413|FG000|Overall Study|Lost to Follow-up|2|||
129160742|NCT00910910|464882414|FG001|Overall Study|Lost to Follow-up|2|||
129160743|NCT00910910|464882413|FG000|Overall Study|Death|9|||
129160744|NCT00910910|464882414|FG001|Overall Study|Death|3|||
129160745|NCT00910910|464882413|FG000|Overall Study|Protocol Violation|2|||
129160746|NCT00910910|464882414|FG001|Overall Study|Protocol Violation|2|||
129160747|NCT00910910|464882413|FG000|Overall Study|Completed 13 cycles of treatment|0|||
129160748|NCT00910910|464882414|FG001|Overall Study|Completed 13 cycles of treatment|118|||
129160749|NCT00910910|464882413|FG000|Overall Study|Other|114|||
129160750|NCT00910910|464882414|FG001|Overall Study|Other|32|||
129160751|NCT00910910|464882413|FG000|Overall Study|Untreated before cycle 1|1|||
129160752|NCT00910910|464882414|FG001|Overall Study|Untreated before cycle 1|2|||
129160753|NCT01973231|464882415|FG000|Overall Study|Protocol Violation|1|||
129160754|NCT01973231|464882416|FG001|Overall Study|Protocol Violation|1|||
129160755|NCT01973231|464882415|FG000|Overall Study|Lost to Follow-up|1|||
129160756|NCT01973231|464882416|FG001|Overall Study|Lost to Follow-up|1|||
129160757|NCT01973231|464882415|FG000|Overall Study|unclassified|2|||
129160758|NCT01973231|464882416|FG001|Overall Study|unclassified|1|||
129160759|NCT01973231|464882415|FG000|Overall Study|Withdrawal by Subject|7|||
129160760|NCT01973231|464882416|FG001|Overall Study|Withdrawal by Subject|9|||
129160761|NCT01434654|464882419|FG000|Overall Study|Withdrawal by Subject|1|||
129160762|NCT01434654|464882420|FG001|Overall Study|Withdrawal by Subject|0|||
129160763|NCT01434654|464882419|FG000|Overall Study|Lost to Follow-up|1|||
129160764|NCT01434654|464882420|FG001|Overall Study|Lost to Follow-up|0|||
129160765|NCT01277822|464882423|FG000|Overall Study|Adverse Event|2|||
129160766|NCT01277822|464882424|FG001|Overall Study|Adverse Event|1|||
129160767|NCT01277822|464882423|FG000|Overall Study|Withdrawal by Subject|6|||
129160768|NCT01277822|464882424|FG001|Overall Study|Withdrawal by Subject|7|||
129160769|NCT01277822|464882423|FG000|Overall Study|Physician Decision|1|||
129160770|NCT01277822|464882424|FG001|Overall Study|Physician Decision|1|||
129160771|NCT01277822|464882423|FG000|Overall Study|Protocol Violation|1|||
129160772|NCT01277822|464882424|FG001|Overall Study|Protocol Violation|0|||
129160773|NCT01277822|464882423|FG000|Overall Study|Lost to Follow-up|2|||
129160774|NCT01277822|464882424|FG001|Overall Study|Lost to Follow-up|1|||
129160775|NCT01277822|464882423|FG000|Overall Study|Contraindicated medication used|2|||
129160776|NCT01277822|464882424|FG001|Overall Study|Contraindicated medication used|1|||
129160777|NCT01277822|464882423|FG000|Overall Study|Participant moved|1|||
129160778|NCT01277822|464882424|FG001|Overall Study|Participant moved|0|||
129160779|NCT02923531|464882425|FG000|Overall Study|Adverse Event|4|||
129160780|NCT02923531|464882425|FG000|Overall Study|Clinical Deterioration|1|||
129160781|NCT02923531|464882425|FG000|Overall Study|Disease Progression|3|||
129160782|NCT02923531|464882425|FG000|Overall Study|Study Termination|1|||
129160783|NCT00997984|464882426|FG000|Overall Study|Adverse Event|1|||
129160784|NCT00997984|464882427|FG001|Overall Study|Adverse Event|8|||
129160785|NCT00997984|464882428|FG002|Overall Study|Adverse Event|8|||
129160786|NCT00997984|464882426|FG000|Overall Study|Protocol Violation|1|||
129160787|NCT00997984|464882427|FG001|Overall Study|Protocol Violation|3|||
129160788|NCT00997984|464882428|FG002|Overall Study|Protocol Violation|0|||
129160789|NCT00997984|464882426|FG000|Overall Study|Withdrawal by Subject|6|||
129160790|NCT00997984|464882427|FG001|Overall Study|Withdrawal by Subject|9|||
129160791|NCT00997984|464882428|FG002|Overall Study|Withdrawal by Subject|5|||
129160792|NCT00997984|464882426|FG000|Overall Study|Lost to Follow-up|8|||
129160793|NCT00997984|464882427|FG001|Overall Study|Lost to Follow-up|5|||
129160794|NCT00997984|464882428|FG002|Overall Study|Lost to Follow-up|4|||
129160795|NCT00997984|464882426|FG000|Overall Study|Lack of Efficacy|20|||
129160796|NCT00997984|464882427|FG001|Overall Study|Lack of Efficacy|6|||
129160797|NCT00997984|464882428|FG002|Overall Study|Lack of Efficacy|3|||
129160798|NCT00997984|464882426|FG000|Overall Study|Met exclusion criteria|1|||
129160799|NCT00997984|464882427|FG001|Overall Study|Met exclusion criteria|0|||
129160800|NCT00997984|464882428|FG002|Overall Study|Met exclusion criteria|0|||
129160801|NCT00997984|464882426|FG000|Overall Study|non-compliance|0|||
129160802|NCT00997984|464882427|FG001|Overall Study|non-compliance|2|||
129160803|NCT00997984|464882428|FG002|Overall Study|non-compliance|3|||
129160804|NCT00997984|464882426|FG000|Overall Study|Wrong medication dispensed|0|||
129160805|NCT00997984|464882427|FG001|Overall Study|Wrong medication dispensed|1|||
129160806|NCT00997984|464882428|FG002|Overall Study|Wrong medication dispensed|0|||
129160807|NCT00997984|464882426|FG000|Overall Study|Suicidal ideation|0|||
129160808|NCT00997984|464882427|FG001|Overall Study|Suicidal ideation|0|||
129160809|NCT00997984|464882428|FG002|Overall Study|Suicidal ideation|1|||
129160810|NCT00997984|464882426|FG000|Overall Study|Work schedule|0|||
129160811|NCT00997984|464882427|FG001|Overall Study|Work schedule|0|||
129160812|NCT00997984|464882428|FG002|Overall Study|Work schedule|2|||
129160813|NCT01119066|464882430|FG000|Overall Study|Withdrawal by Subject|4|||
129160814|NCT01119066|464882431|FG001|Overall Study|Withdrawal by Subject|6|||
129160815|NCT01119066|464882432|FG002|Overall Study|Withdrawal by Subject|0|||
129160816|NCT01119066|464882433|FG003|Overall Study|Withdrawal by Subject|0|||
129160817|NCT01119066|464882430|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
129160818|NCT01119066|464882431|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
129160819|NCT01119066|464882432|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
129160820|NCT01119066|464882433|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
129160821|NCT01119066|464882430|FG000|Overall Study|Relapse identified before transplant|1|||
129160822|NCT01119066|464882431|FG001|Overall Study|Relapse identified before transplant|0|||
129160823|NCT01119066|464882432|FG002|Overall Study|Relapse identified before transplant|0|||
129160824|NCT01119066|464882433|FG003|Overall Study|Relapse identified before transplant|0|||
129160825|NCT01119066|464882430|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
129160826|NCT01119066|464882431|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
129160827|NCT01119066|464882432|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
129160828|NCT01119066|464882433|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
129160829|NCT01119066|464882430|FG000|Overall Study|Relapse identified before transplant|0|||
129160830|NCT01119066|464882431|FG001|Overall Study|Relapse identified before transplant|4|||
129160831|NCT01119066|464882432|FG002|Overall Study|Relapse identified before transplant|0|||
129160832|NCT01119066|464882433|FG003|Overall Study|Relapse identified before transplant|0|||
129160833|NCT00271856|464882436|FG000|Overall Study|Withdrawal by Subject|1|||
129160834|NCT00271856|464882437|FG001|Overall Study|Withdrawal by Subject|7|||
129160835|NCT00271856|464882436|FG000|Overall Study|Lost to Follow-up|10|||
129160836|NCT00271856|464882437|FG001|Overall Study|Lost to Follow-up|11|||
129160837|NCT02366923|464882438|FG000|Overall Study|Withdrawal by Subject|1|||
129160838|NCT02366923|464882438|FG000|Overall Study|Positive Slit Lamp Findings|2|||
129160839|NCT02366923|464882438|FG000|Overall Study|High Astigmatism|3|||
129160840|NCT01437111|464882443|FG000|Overall Study|Adverse Event|2|||
129160841|NCT01437111|464882443|FG000|Overall Study|Withdrawal by Subject|4|||
129160842|NCT01437111|464882443|FG000|Overall Study|Not reported|5|||
129160843|NCT01437111|464882443|FG000|Overall Study|Physician Decision|1|||
129160844|NCT01437111|464882443|FG000|Overall Study|Lost to Follow-up|5|||
129160845|NCT01437111|464882443|FG000|Overall Study|Protocol Violation|1|||
129160846|NCT03082677|464882445|FG000|Overall Study|Not Treated|2|||
129160847|NCT00771927|464882452|FG000|Overall Study|Adverse Event|100|||
129160848|NCT00771927|464882453|FG001|Overall Study|Adverse Event|105|||
129160849|NCT00771927|464882452|FG000|Overall Study|Lack of Efficacy|70|||
129160850|NCT00771927|464882453|FG001|Overall Study|Lack of Efficacy|42|||
129160851|NCT00771927|464882452|FG000|Overall Study|Lost to Follow-up|46|||
129160852|NCT00771927|464882453|FG001|Overall Study|Lost to Follow-up|46|||
129160853|NCT00771927|464882452|FG000|Overall Study|Withdrawal by Subject|16|||
128726238|NCT00735371|463294787|FG003|Overall Study|Exclusion criteria|0|||
128726239|NCT00994448|463294788|FG000|Overall Study|Adverse Event|1|||
128726240|NCT00994448|463294789|FG001|Overall Study|Adverse Event|0|||
128726241|NCT00994448|463294788|FG000|Overall Study|Lost to Follow-up|5|||
128726242|NCT00994448|463294789|FG001|Overall Study|Lost to Follow-up|1|||
129160854|NCT00771927|464882453|FG001|Overall Study|Withdrawal by Subject|17|||
129160855|NCT00771927|464882452|FG000|Overall Study|Other reason|23|||
129160856|NCT00771927|464882453|FG001|Overall Study|Other reason|27|||
129160857|NCT03711370|464882454|FG000|Overall Study|Lost to Follow-up|16|||
129160858|NCT03711370|464882455|FG001|Overall Study|Lost to Follow-up|10|||
129160859|NCT03711370|464882454|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
129160860|NCT03711370|464882455|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
129160861|NCT00407602|464882456|FG000|Overall Study|Death - unrelated to device|1|||
129160862|NCT00407602|464882456|FG000|Overall Study|Device explanted|5|||
129160863|NCT00407602|464882456|FG000|Overall Study|Withdrawal by Subject|1|||
129160864|NCT02063984|464882457|FG000|Overall Study|Lost to Follow-up|6|||
129160865|NCT02063984|464882458|FG001|Overall Study|Lost to Follow-up|5|||
129160866|NCT02195700|464882460|FG000|Overall Study|Protocol Violation|0|||
129160867|NCT02195700|464882461|FG001|Overall Study|Protocol Violation|2|||
129160868|NCT02195700|464882460|FG000|Overall Study|Noncompliance|1|||
129160869|NCT02195700|464882461|FG001|Overall Study|Noncompliance|0|||
129160870|NCT02195700|464882460|FG000|Overall Study|Adverse Event|1|||
129160871|NCT02195700|464882461|FG001|Overall Study|Adverse Event|2|||
129160872|NCT02195700|464882460|FG000|Overall Study|Withdrawal by Subject|3|||
129160873|NCT02195700|464882461|FG001|Overall Study|Withdrawal by Subject|2|||
129160874|NCT02195700|464882460|FG000|Overall Study|Lost to Follow-up|1|||
129160875|NCT02195700|464882461|FG001|Overall Study|Lost to Follow-up|1|||
129160876|NCT02931838|464882462|FG000|Overall Study|Reason not provided by investigator|1|||
129160877|NCT02931838|464882463|FG001|Overall Study|Reason not provided by investigator|0|||
129160878|NCT02931838|464882464|FG002|Overall Study|Reason not provided by investigator|1|||
129160879|NCT02931838|464882465|FG003|Overall Study|Reason not provided by investigator|0|||
129160880|NCT02931838|464882466|FG004|Overall Study|Reason not provided by investigator|0|||
129160881|NCT02931838|464882467|FG005|Overall Study|Reason not provided by investigator|0|||
129160882|NCT02931838|464882462|FG000|Overall Study|Poor/non-compliance|0|||
129160883|NCT02931838|464882463|FG001|Overall Study|Poor/non-compliance|0|||
129160884|NCT02931838|464882464|FG002|Overall Study|Poor/non-compliance|1|||
129160885|NCT02931838|464882465|FG003|Overall Study|Poor/non-compliance|0|||
129160886|NCT02931838|464882466|FG004|Overall Study|Poor/non-compliance|0|||
129160887|NCT02931838|464882467|FG005|Overall Study|Poor/non-compliance|0|||
129160888|NCT02931838|464882462|FG000|Overall Study|Lack of Efficacy|5|||
129160889|NCT02931838|464882463|FG001|Overall Study|Lack of Efficacy|4|||
129160890|NCT02931838|464882464|FG002|Overall Study|Lack of Efficacy|0|||
129160891|NCT02931838|464882465|FG003|Overall Study|Lack of Efficacy|0|||
129160892|NCT02931838|464882466|FG004|Overall Study|Lack of Efficacy|0|||
129160893|NCT02931838|464882467|FG005|Overall Study|Lack of Efficacy|1|||
129160894|NCT02931838|464882462|FG000|Overall Study|Lost to Follow-up|1|||
129160895|NCT02931838|464882463|FG001|Overall Study|Lost to Follow-up|0|||
129160896|NCT02931838|464882464|FG002|Overall Study|Lost to Follow-up|1|||
129160897|NCT02931838|464882465|FG003|Overall Study|Lost to Follow-up|1|||
129160898|NCT02931838|464882466|FG004|Overall Study|Lost to Follow-up|2|||
129160899|NCT02931838|464882467|FG005|Overall Study|Lost to Follow-up|0|||
129160900|NCT02931838|464882462|FG000|Overall Study|Subject request to discontinue treatment|4|||
129160901|NCT02931838|464882463|FG001|Overall Study|Subject request to discontinue treatment|3|||
129160902|NCT02931838|464882464|FG002|Overall Study|Subject request to discontinue treatment|3|||
129160903|NCT02931838|464882465|FG003|Overall Study|Subject request to discontinue treatment|0|||
129160904|NCT02931838|464882466|FG004|Overall Study|Subject request to discontinue treatment|1|||
129160905|NCT02931838|464882467|FG005|Overall Study|Subject request to discontinue treatment|0|||
129160906|NCT02931838|464882462|FG000|Overall Study|Withdrawal by Subject|1|||
129160907|NCT02931838|464882463|FG001|Overall Study|Withdrawal by Subject|2|||
129160908|NCT02931838|464882464|FG002|Overall Study|Withdrawal by Subject|0|||
129160909|NCT02931838|464882465|FG003|Overall Study|Withdrawal by Subject|1|||
129160910|NCT02931838|464882466|FG004|Overall Study|Withdrawal by Subject|0|||
129160911|NCT02931838|464882467|FG005|Overall Study|Withdrawal by Subject|0|||
129160912|NCT02931838|464882462|FG000|Overall Study|Adverse Event|2|||
129160913|NCT02931838|464882463|FG001|Overall Study|Adverse Event|1|||
129160914|NCT02931838|464882464|FG002|Overall Study|Adverse Event|2|||
129160915|NCT02931838|464882465|FG003|Overall Study|Adverse Event|1|||
129160916|NCT02931838|464882466|FG004|Overall Study|Adverse Event|3|||
128726243|NCT00994448|463294788|FG000|Overall Study|Withdrawal by Subject|1|||
129160917|NCT02931838|464882467|FG005|Overall Study|Adverse Event|1|||
129160918|NCT03110029|464882468|FG000|Overall Study|Withdrawal by Subject|1|||
129160919|NCT03110029|464882469|FG001|Overall Study|Withdrawal by Subject|1|||
129160920|NCT01042158|464882470|FG000|Overall Study|Physician Decision|1|||
129160921|NCT05823974|464884834|FG000|Overall Study|Lost to Follow-up|0|||
129160922|NCT05823974|464884835|FG001|Overall Study|Lost to Follow-up|3|||
129160923|NCT05823974|464884836|FG002|Overall Study|Lost to Follow-up|1|||
129160924|NCT05823974|464884837|FG003|Overall Study|Lost to Follow-up|0|||
129160925|NCT05823974|464884838|FG004|Overall Study|Lost to Follow-up|1|||
129160926|NCT05823974|464884839|FG005|Overall Study|Lost to Follow-up|0|||
129160927|NCT05823974|464884840|FG006|Overall Study|Lost to Follow-up|1|||
129160928|NCT05823974|464884841|FG007|Overall Study|Lost to Follow-up|0|||
129160929|NCT05823974|464884842|FG008|Overall Study|Lost to Follow-up|0|||
129160930|NCT05823974|464884843|FG009|Overall Study|Lost to Follow-up|1|||
129160931|NCT05823974|464884844|FG010|Overall Study|Lost to Follow-up|1|||
129160932|NCT05823974|464884845|FG011|Overall Study|Lost to Follow-up|0|||
129160933|NCT05823974|464884846|FG012|Overall Study|Lost to Follow-up|1|||
129160934|NCT05823974|464884847|FG013|Overall Study|Lost to Follow-up|2|||
129160935|NCT05823974|464884848|FG014|Overall Study|Lost to Follow-up|1|||
129160936|NCT05823974|464884849|FG015|Overall Study|Lost to Follow-up|1|||
129160937|NCT05823974|464884850|FG016|Overall Study|Lost to Follow-up|1|||
129160938|NCT05823974|464884851|FG017|Overall Study|Lost to Follow-up|0|||
129160939|NCT05823974|464884852|FG018|Overall Study|Lost to Follow-up|0|||
129160940|NCT05823974|464884853|FG019|Overall Study|Lost to Follow-up|2|||
129160941|NCT05823974|464884854|FG020|Overall Study|Lost to Follow-up|0|||
129160942|NCT05823974|464884834|FG000|Overall Study|Physician Decision|0|||
129160943|NCT05823974|464884835|FG001|Overall Study|Physician Decision|0|||
129160944|NCT05823974|464884836|FG002|Overall Study|Physician Decision|0|||
129160945|NCT05823974|464884837|FG003|Overall Study|Physician Decision|0|||
129160946|NCT05823974|464884838|FG004|Overall Study|Physician Decision|0|||
129160947|NCT05823974|464884839|FG005|Overall Study|Physician Decision|0|||
129160948|NCT05823974|464884840|FG006|Overall Study|Physician Decision|0|||
129160949|NCT05823974|464884841|FG007|Overall Study|Physician Decision|0|||
129160950|NCT05823974|464884842|FG008|Overall Study|Physician Decision|0|||
129160951|NCT05823974|464884843|FG009|Overall Study|Physician Decision|0|||
129160952|NCT05823974|464884844|FG010|Overall Study|Physician Decision|0|||
129160953|NCT05823974|464884845|FG011|Overall Study|Physician Decision|0|||
129160954|NCT05823974|464884846|FG012|Overall Study|Physician Decision|0|||
129160955|NCT05823974|464884847|FG013|Overall Study|Physician Decision|0|||
129160956|NCT05823974|464884848|FG014|Overall Study|Physician Decision|0|||
129160957|NCT05823974|464884849|FG015|Overall Study|Physician Decision|1|||
129160958|NCT05823974|464884850|FG016|Overall Study|Physician Decision|0|||
129160959|NCT05823974|464884851|FG017|Overall Study|Physician Decision|1|||
129160960|NCT05823974|464884852|FG018|Overall Study|Physician Decision|1|||
129160961|NCT05823974|464884853|FG019|Overall Study|Physician Decision|0|||
129160962|NCT05823974|464884854|FG020|Overall Study|Physician Decision|0|||
129160963|NCT05823974|464884834|FG000|Overall Study|Withdrawal by Subject|1|||
129160964|NCT05823974|464884835|FG001|Overall Study|Withdrawal by Subject|1|||
129160965|NCT05823974|464884836|FG002|Overall Study|Withdrawal by Subject|2|||
129160966|NCT05823974|464884837|FG003|Overall Study|Withdrawal by Subject|0|||
129160967|NCT05823974|464884838|FG004|Overall Study|Withdrawal by Subject|2|||
129160968|NCT05823974|464884839|FG005|Overall Study|Withdrawal by Subject|3|||
129160969|NCT05823974|464884840|FG006|Overall Study|Withdrawal by Subject|1|||
129160970|NCT05823974|464884841|FG007|Overall Study|Withdrawal by Subject|1|||
129160971|NCT05823974|464884842|FG008|Overall Study|Withdrawal by Subject|2|||
129160972|NCT05823974|464884843|FG009|Overall Study|Withdrawal by Subject|1|||
129160973|NCT05823974|464884844|FG010|Overall Study|Withdrawal by Subject|1|||
129160974|NCT05823974|464884845|FG011|Overall Study|Withdrawal by Subject|0|||
129160975|NCT05823974|464884846|FG012|Overall Study|Withdrawal by Subject|0|||
129160976|NCT05823974|464884847|FG013|Overall Study|Withdrawal by Subject|1|||
129160977|NCT05823974|464884848|FG014|Overall Study|Withdrawal by Subject|1|||
129160978|NCT05823974|464884849|FG015|Overall Study|Withdrawal by Subject|3|||
129160979|NCT05823974|464884850|FG016|Overall Study|Withdrawal by Subject|0|||
129160980|NCT05823974|464884851|FG017|Overall Study|Withdrawal by Subject|2|||
129160981|NCT05823974|464884852|FG018|Overall Study|Withdrawal by Subject|2|||
129160982|NCT05823974|464884853|FG019|Overall Study|Withdrawal by Subject|0|||
128776905|NCT04172987|463472031|FG000|Period 2|Dosing Termination by Sponsor|4|||
129160983|NCT05823974|464884854|FG020|Overall Study|Withdrawal by Subject|1|||
129160984|NCT05823974|464884834|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160985|NCT05823974|464884835|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160986|NCT05823974|464884836|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129160987|NCT05823974|464884837|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
128776906|NCT00738530|463472041|FG000|Overall Study|Death|220|||
129160988|NCT05823974|464884838|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160989|NCT05823974|464884839|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160990|NCT05823974|464884840|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160991|NCT05823974|464884841|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160992|NCT05823974|464884842|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160993|NCT05823974|464884843|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160994|NCT05823974|464884844|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160995|NCT05823974|464884845|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160996|NCT05823974|464884846|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160997|NCT05823974|464884847|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129160998|NCT05823974|464884848|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129160999|NCT05823974|464884849|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129161000|NCT05823974|464884850|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129161001|NCT05823974|464884851|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129161002|NCT05823974|464884852|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129161003|NCT05823974|464884853|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129161004|NCT05823974|464884854|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129161005|NCT05823974|464884834|FG000|Overall Study|Other|0|||
129161006|NCT05823974|464884835|FG001|Overall Study|Other|1|||
129161007|NCT05823974|464884836|FG002|Overall Study|Other|1|||
129161008|NCT05823974|464884837|FG003|Overall Study|Other|1|||
129161009|NCT05823974|464884838|FG004|Overall Study|Other|0|||
129161010|NCT05823974|464884839|FG005|Overall Study|Other|1|||
129161011|NCT05823974|464884840|FG006|Overall Study|Other|1|||
129161012|NCT05823974|464884841|FG007|Overall Study|Other|1|||
129161013|NCT05823974|464884842|FG008|Overall Study|Other|1|||
129161014|NCT05823974|464884843|FG009|Overall Study|Other|0|||
129161015|NCT05823974|464884844|FG010|Overall Study|Other|0|||
129161016|NCT05823974|464884845|FG011|Overall Study|Other|0|||
129161017|NCT05823974|464884846|FG012|Overall Study|Other|2|||
129161018|NCT05823974|464884847|FG013|Overall Study|Other|1|||
129161019|NCT05823974|464884848|FG014|Overall Study|Other|0|||
129161020|NCT05823974|464884849|FG015|Overall Study|Other|1|||
129161021|NCT05823974|464884850|FG016|Overall Study|Other|0|||
129161022|NCT05823974|464884851|FG017|Overall Study|Other|0|||
129161023|NCT05823974|464884852|FG018|Overall Study|Other|0|||
129161024|NCT05823974|464884853|FG019|Overall Study|Other|0|||
129161025|NCT05823974|464884854|FG020|Overall Study|Other|0|||
129161026|NCT00316706|464884855|FG000|Overall Study|Lost to Follow-up|38|||
129161027|NCT00316706|464884856|FG001|Overall Study|Lost to Follow-up|48|||
129161028|NCT02220855|464884857|FG000|Overall Study|Adverse Event|8|||
129161029|NCT02220855|464884857|FG000|Overall Study|Disease Progression|5|||
129161030|NCT02220855|464884857|FG000|Overall Study|Withdrawal by Subject|1|||
129161031|NCT03280303|464884858|FG000|Overall Study|Death|505|||
129161032|NCT03280303|464884858|FG000|Overall Study|Study terminated by sponsor|383|||
129161033|NCT03280303|464884858|FG000|Overall Study|Other|148|||
129161034|NCT03280303|464884858|FG000|Overall Study|No longer willing to participate in study|101|||
129161035|NCT03280303|464884858|FG000|Overall Study|Lost to follow up|39|||
129161036|NCT03280303|464884858|FG000|Overall Study|Adverse Event|20|||
129161037|NCT03419897|464884859|FG000|Overall Study|Death|180|||
129161038|NCT03419897|464884859|FG000|Overall Study|Lost to Follow-up|1|||
129161039|NCT03419897|464884859|FG000|Overall Study|Withdrawal by Subject|6|||
129161040|NCT03419897|464884859|FG000|Overall Study|Sponsor Decision|61|||
129161041|NCT03419897|464884859|FG000|Overall Study|Physician Decision|1|||
129161042|NCT02222688|464884872|FG000|Overall Study|Withdrawal by Subject|0|||
129161043|NCT02222688|464884873|FG001|Overall Study|Withdrawal by Subject|0|||
129161044|NCT02222688|464884874|FG002|Overall Study|Withdrawal by Subject|0|||
129161045|NCT02222688|464884875|FG003|Overall Study|Withdrawal by Subject|2|||
129161046|NCT02222688|464884876|FG004|Overall Study|Withdrawal by Subject|1|||
129161047|NCT02222688|464884877|FG005|Overall Study|Withdrawal by Subject|0|||
129161048|NCT02222688|464884878|FG006|Overall Study|Withdrawal by Subject|1|||
129161049|NCT02222688|464884872|FG000|Overall Study|Disease progression|1|||
129161050|NCT02222688|464884873|FG001|Overall Study|Disease progression|0|||
129161051|NCT02222688|464884874|FG002|Overall Study|Disease progression|0|||
129161052|NCT02222688|464884875|FG003|Overall Study|Disease progression|0|||
129161053|NCT02222688|464884876|FG004|Overall Study|Disease progression|0|||
129161054|NCT02222688|464884877|FG005|Overall Study|Disease progression|0|||
129161055|NCT02222688|464884878|FG006|Overall Study|Disease progression|0|||
129161056|NCT03107052|464884888|FG000|Overall Study|Adverse Event|6|||
129161057|NCT03107052|464884889|FG001|Overall Study|Adverse Event|1|||
129161058|NCT03107052|464884890|FG002|Overall Study|Adverse Event|2|||
129161059|NCT03107052|464884888|FG000|Overall Study|Withdrawal by Subject|9|||
129161060|NCT03107052|464884889|FG001|Overall Study|Withdrawal by Subject|5|||
129161061|NCT03107052|464884890|FG002|Overall Study|Withdrawal by Subject|8|||
129161062|NCT03107052|464884888|FG000|Overall Study|Protocol Violation|6|||
129161063|NCT03107052|464884889|FG001|Overall Study|Protocol Violation|0|||
129161064|NCT03107052|464884890|FG002|Overall Study|Protocol Violation|3|||
129161065|NCT03107052|464884888|FG000|Overall Study|Lost to Follow-up|4|||
129161066|NCT03107052|464884889|FG001|Overall Study|Lost to Follow-up|0|||
129161067|NCT03107052|464884890|FG002|Overall Study|Lost to Follow-up|1|||
129161068|NCT03107052|464884888|FG000|Overall Study|Lack of Efficacy|23|||
129161069|NCT03107052|464884889|FG001|Overall Study|Lack of Efficacy|7|||
128726244|NCT00994448|463294789|FG001|Overall Study|Withdrawal by Subject|1|||
128726245|NCT00994448|463294788|FG000|Overall Study|Physician Decision|1|||
129161070|NCT03107052|464884890|FG002|Overall Study|Lack of Efficacy|4|||
129161071|NCT03107052|464884888|FG000|Overall Study|Other than specified|4|||
129161072|NCT03107052|464884889|FG001|Overall Study|Other than specified|2|||
129161073|NCT03107052|464884890|FG002|Overall Study|Other than specified|0|||
129161074|NCT03107052|464884888|FG000|Overall Study|Study terminated due to futility|67|||
129161075|NCT03107052|464884889|FG001|Overall Study|Study terminated due to futility|31|||
129161076|NCT03107052|464884890|FG002|Overall Study|Study terminated due to futility|23|||
129161077|NCT00958360|464884891|FG000|Overall Study|Withdrawal by Subject|3|||
129161078|NCT00958360|464884892|FG001|Overall Study|Withdrawal by Subject|1|||
129161079|NCT00958360|464884891|FG000|Overall Study|Death|6|||
129161080|NCT00958360|464884892|FG001|Overall Study|Death|7|||
129161081|NCT00958360|464884891|FG000|Overall Study|Physician Decision|2|||
129161082|NCT00958360|464884892|FG001|Overall Study|Physician Decision|1|||
129161083|NCT00958360|464884891|FG000|Overall Study|Lost to Follow-up|0|||
129161084|NCT00958360|464884892|FG001|Overall Study|Lost to Follow-up|1|||
129161085|NCT02719691|464884894|FG000|Overall Study|Physician Decision|0|||
129161086|NCT02719691|464884895|FG001|Overall Study|Physician Decision|0|||
129161087|NCT02719691|464884896|FG002|Overall Study|Physician Decision|1|||
129161088|NCT02719691|464884897|FG003|Overall Study|Physician Decision|0|||
129161089|NCT02719691|464884898|FG004|Overall Study|Physician Decision|0|||
129161090|NCT02719691|464884899|FG005|Overall Study|Physician Decision|0|||
129161091|NCT02719691|464884900|FG006|Overall Study|Physician Decision|0|||
129161092|NCT02719691|464884894|FG000|Overall Study|Withdrawal by Subject|0|||
129161093|NCT02719691|464884895|FG001|Overall Study|Withdrawal by Subject|0|||
129161094|NCT02719691|464884896|FG002|Overall Study|Withdrawal by Subject|0|||
129161095|NCT02719691|464884897|FG003|Overall Study|Withdrawal by Subject|0|||
129161096|NCT02719691|464884898|FG004|Overall Study|Withdrawal by Subject|0|||
129161097|NCT02719691|464884899|FG005|Overall Study|Withdrawal by Subject|1|||
129161098|NCT02719691|464884900|FG006|Overall Study|Withdrawal by Subject|0|||
129161099|NCT00336284|464884903|FG000|Overall Study|Death|52|||
129161100|NCT00336284|464884904|FG001|Overall Study|Death|26|||
129161101|NCT00336284|464884903|FG000|Overall Study|Lost to Follow-up|82|||
129161102|NCT00336284|464884904|FG001|Overall Study|Lost to Follow-up|61|||
129161103|NCT00336284|464884903|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
129161104|NCT00336284|464884904|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
129161105|NCT00861757|464884907|FG000|Overall Study|Adverse Event|1|||
129161106|NCT00861757|464884908|FG001|Overall Study|Adverse Event|5|||
129161107|NCT00861757|464884909|FG002|Overall Study|Adverse Event|7|||
129161108|NCT00861757|464884910|FG003|Overall Study|Adverse Event|2|||
129161109|NCT00861757|464884907|FG000|Overall Study|Entry Criteria Not Met|1|||
129161110|NCT00861757|464884908|FG001|Overall Study|Entry Criteria Not Met|2|||
129161111|NCT00861757|464884909|FG002|Overall Study|Entry Criteria Not Met|1|||
129161112|NCT00861757|464884910|FG003|Overall Study|Entry Criteria Not Met|1|||
129161113|NCT00861757|464884907|FG000|Overall Study|Lack of Efficacy|3|||
129161114|NCT00861757|464884908|FG001|Overall Study|Lack of Efficacy|1|||
129161115|NCT00861757|464884909|FG002|Overall Study|Lack of Efficacy|0|||
129161116|NCT00861757|464884910|FG003|Overall Study|Lack of Efficacy|1|||
129161117|NCT00861757|464884907|FG000|Overall Study|Lost to Follow-up|1|||
129161118|NCT00861757|464884908|FG001|Overall Study|Lost to Follow-up|0|||
129161119|NCT00861757|464884909|FG002|Overall Study|Lost to Follow-up|1|||
129161120|NCT00861757|464884910|FG003|Overall Study|Lost to Follow-up|1|||
129161121|NCT00861757|464884907|FG000|Overall Study|Physician Decision|0|||
129161122|NCT00861757|464884908|FG001|Overall Study|Physician Decision|0|||
129161123|NCT00861757|464884909|FG002|Overall Study|Physician Decision|0|||
129161124|NCT00861757|464884910|FG003|Overall Study|Physician Decision|1|||
129161125|NCT00861757|464884907|FG000|Overall Study|Protocol Violation|2|||
129161126|NCT00861757|464884908|FG001|Overall Study|Protocol Violation|2|||
129161127|NCT00861757|464884909|FG002|Overall Study|Protocol Violation|4|||
129161128|NCT00861757|464884910|FG003|Overall Study|Protocol Violation|1|||
129161129|NCT00861757|464884907|FG000|Overall Study|Withdrawal by Subject|1|||
129161130|NCT00861757|464884908|FG001|Overall Study|Withdrawal by Subject|5|||
129161131|NCT00861757|464884909|FG002|Overall Study|Withdrawal by Subject|5|||
129161132|NCT00861757|464884910|FG003|Overall Study|Withdrawal by Subject|2|||
129161133|NCT03308968|464884911|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
129161134|NCT03308968|464884912|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
128726246|NCT00994448|463294789|FG001|Overall Study|Physician Decision|0|||
129161135|NCT03308968|464884913|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
129161136|NCT03308968|464884911|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
129161137|NCT03308968|464884912|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
129161138|NCT03308968|464884913|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
129161139|NCT03308968|464884911|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
129161140|NCT03308968|464884912|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
129161141|NCT03308968|464884913|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
129161142|NCT03308968|464884911|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
129161143|NCT03308968|464884912|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
129161144|NCT03308968|464884913|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
129161145|NCT03308968|464884911|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
129161146|NCT03308968|464884912|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
129161147|NCT03308968|464884913|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
129161148|NCT03308968|464884911|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
129161149|NCT03308968|464884912|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
129161150|NCT03308968|464884913|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
129161151|NCT03308968|464884911|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
129161152|NCT03308968|464884912|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
129161153|NCT03308968|464884913|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
129161154|NCT03308968|464884911|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
129161155|NCT03308968|464884912|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
129161156|NCT03308968|464884913|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
129161157|NCT03308968|464884911|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
129161158|NCT03308968|464884912|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
129161159|NCT03308968|464884913|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
129161160|NCT03308968|464884911|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
129161161|NCT03308968|464884912|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
129161162|NCT03308968|464884913|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
129161163|NCT03308968|464884911|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
129161164|NCT03308968|464884912|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
129161165|NCT03308968|464884913|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
129161166|NCT03308968|464884911|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
129161167|NCT03308968|464884912|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
129161168|NCT03308968|464884913|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
129161169|NCT03308968|464884911|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
129161170|NCT03308968|464884912|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
129161171|NCT03308968|464884913|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
129161172|NCT03308968|464884911|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
129161173|NCT03308968|464884912|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
129161174|NCT03308968|464884913|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
129161175|NCT01961297|464884919|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
129161176|NCT01961297|464884920|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
129161177|NCT02482298|464884921|FG000|Overall Study|Withdrawal by Subject|2|||
129161178|NCT02482298|464884922|FG001|Overall Study|Withdrawal by Subject|1|||
129161179|NCT02482298|464884923|FG002|Overall Study|Withdrawal by Subject|2|||
129161180|NCT02482298|464884921|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
129161181|NCT02482298|464884922|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
129161182|NCT02482298|464884923|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
129161183|NCT02482298|464884921|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
129161184|NCT02482298|464884922|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
129161185|NCT02482298|464884923|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
129161186|NCT02482298|464884921|FG000|Overall Study|Lost to Follow-up|0|||
129161187|NCT02482298|464884922|FG001|Overall Study|Lost to Follow-up|1|||
129161188|NCT02482298|464884923|FG002|Overall Study|Lost to Follow-up|0|||
129161189|NCT01188551|464884924|FG000|Overall Study|Pharmacy issues|1|||
129161190|NCT01188551|464884925|FG001|Overall Study|Pharmacy issues|0|||
129161191|NCT01188551|464884926|FG002|Overall Study|Pharmacy issues|0|||
129161192|NCT01188551|464884927|FG003|Overall Study|Pharmacy issues|0|||
129161193|NCT03782259|464884931|FG000|Overall Study|Lost to Follow-up|1|||
129161194|NCT03782259|464884932|FG001|Overall Study|Lost to Follow-up|1|||
129161195|NCT03782259|464884931|FG000|Overall Study|Moved out of state|0|||
129161196|NCT03782259|464884932|FG001|Overall Study|Moved out of state|2|||
129161197|NCT03782259|464884931|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
129161198|NCT03782259|464884932|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
128776907|NCT00738530|463472042|FG001|Overall Study|Death|224|||
128776908|NCT00738530|463472041|FG000|Overall Study|Lost to Follow-up|8|||
128776909|NCT00738530|463472042|FG001|Overall Study|Lost to Follow-up|6|||
129161199|NCT03782259|464884931|FG000|Overall Study|Subject discontinued intervention|1|||
129161200|NCT03782259|464884932|FG001|Overall Study|Subject discontinued intervention|0|||
129161201|NCT03012828|464884944|FG000|Overall Study|Lost to Follow-up|1|||
129161202|NCT03012828|464884945|FG001|Overall Study|Lost to Follow-up|0|||
129161203|NCT03012828|464884946|FG002|Overall Study|Lost to Follow-up|1|||
129161204|NCT03012828|464884947|FG003|Overall Study|Lost to Follow-up|0|||
129161205|NCT03012828|464884948|FG004|Overall Study|Lost to Follow-up|1|||
129161206|NCT03012828|464884949|FG005|Overall Study|Lost to Follow-up|0|||
129161207|NCT03012828|464884944|FG000|Overall Study|Withdrawal by Subject|0|||
129161208|NCT03012828|464884945|FG001|Overall Study|Withdrawal by Subject|0|||
129161209|NCT03012828|464884946|FG002|Overall Study|Withdrawal by Subject|1|||
129161210|NCT03012828|464884947|FG003|Overall Study|Withdrawal by Subject|0|||
129161211|NCT03012828|464884948|FG004|Overall Study|Withdrawal by Subject|0|||
129161212|NCT03012828|464884949|FG005|Overall Study|Withdrawal by Subject|1|||
129161213|NCT03012828|464884944|FG000|Overall Study|Non-compliance with protocol|0|||
129161214|NCT03012828|464884945|FG001|Overall Study|Non-compliance with protocol|0|||
129161215|NCT03012828|464884946|FG002|Overall Study|Non-compliance with protocol|0|||
129161216|NCT03012828|464884947|FG003|Overall Study|Non-compliance with protocol|0|||
129161217|NCT03012828|464884948|FG004|Overall Study|Non-compliance with protocol|1|||
129161218|NCT03012828|464884949|FG005|Overall Study|Non-compliance with protocol|0|||
129161219|NCT03012828|464884944|FG000|Overall Study|Delay to last visit would delay DBL|0|||
129161220|NCT03012828|464884945|FG001|Overall Study|Delay to last visit would delay DBL|0|||
129161221|NCT03012828|464884946|FG002|Overall Study|Delay to last visit would delay DBL|0|||
129161222|NCT03012828|464884947|FG003|Overall Study|Delay to last visit would delay DBL|0|||
129161223|NCT03012828|464884948|FG004|Overall Study|Delay to last visit would delay DBL|0|||
129161224|NCT03012828|464884949|FG005|Overall Study|Delay to last visit would delay DBL|1|||
129161225|NCT04396795|464884954|FG000|Month 1|Lost to Follow-up|2|||
129161226|NCT04396795|464884955|FG001|Month 1|Lost to Follow-up|3|||
129161227|NCT04396795|464884954|FG000|Month 3|Lost to Follow-up|1|||
129161228|NCT04396795|464884955|FG001|Month 3|Lost to Follow-up|3|||
129161229|NCT04396795|464884954|FG000|Month 6|Lost to Follow-up|3|||
129161230|NCT04396795|464884955|FG001|Month 6|Lost to Follow-up|3|||
129161231|NCT03902392|464884959|FG000|Overall Study|Lost to Follow-up|7|||
129161232|NCT03902392|464884960|FG001|Overall Study|Lost to Follow-up|7|||
129161233|NCT00244725|464884961|FG000|Overall Study|Lost to Follow-up|3|||
129161234|NCT00244725|464884962|FG001|Overall Study|Lost to Follow-up|4|||
129161235|NCT00244725|464884963|FG002|Overall Study|Lost to Follow-up|9|||
129161236|NCT00244725|464884964|FG003|Overall Study|Lost to Follow-up|2|||
129161237|NCT00244725|464884961|FG000|Overall Study|Withdrawal by Subject|9|||
129161238|NCT00244725|464884962|FG001|Overall Study|Withdrawal by Subject|7|||
129161239|NCT00244725|464884963|FG002|Overall Study|Withdrawal by Subject|7|||
129161240|NCT00244725|464884964|FG003|Overall Study|Withdrawal by Subject|8|||
129161241|NCT00244725|464884961|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
129161242|NCT00244725|464884962|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
129161243|NCT00244725|464884963|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
129161244|NCT00244725|464884964|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
129161245|NCT00244725|464884961|FG000|Overall Study|Physician Decision|3|||
129161246|NCT00244725|464884962|FG001|Overall Study|Physician Decision|0|||
129161247|NCT00244725|464884963|FG002|Overall Study|Physician Decision|1|||
129161248|NCT00244725|464884964|FG003|Overall Study|Physician Decision|2|||
129161249|NCT00244725|464884961|FG000|Overall Study|Adverse Events|3|||
129161250|NCT00244725|464884962|FG001|Overall Study|Adverse Events|1|||
129161251|NCT00244725|464884963|FG002|Overall Study|Adverse Events|4|||
129161252|NCT00244725|464884964|FG003|Overall Study|Adverse Events|4|||
129161253|NCT00244725|464884961|FG000|Overall Study|Withdrwal by participant|1|||
129161254|NCT00244725|464884962|FG001|Overall Study|Withdrwal by participant|0|||
129161255|NCT00244725|464884963|FG002|Overall Study|Withdrwal by participant|0|||
129161256|NCT00244725|464884964|FG003|Overall Study|Withdrwal by participant|1|||
129161257|NCT00244725|464884961|FG000|Overall Study|Liver function test abnormality|2|||
129161258|NCT00244725|464884962|FG001|Overall Study|Liver function test abnormality|0|||
129161259|NCT00244725|464884963|FG002|Overall Study|Liver function test abnormality|0|||
129161260|NCT00244725|464884964|FG003|Overall Study|Liver function test abnormality|1|||
129161261|NCT00244725|464884961|FG000|Overall Study|Sponsor withdrew the participant|1|||
129161262|NCT00244725|464884962|FG001|Overall Study|Sponsor withdrew the participant|0|||
129161263|NCT00244725|464884963|FG002|Overall Study|Sponsor withdrew the participant|0|||
129161264|NCT00244725|464884964|FG003|Overall Study|Sponsor withdrew the participant|1|||
129161265|NCT00244725|464884961|FG000|Overall Study|Mediciation Error|0|||
129161266|NCT00244725|464884962|FG001|Overall Study|Mediciation Error|1|||
129161267|NCT00244725|464884963|FG002|Overall Study|Mediciation Error|0|||
129161268|NCT00244725|464884964|FG003|Overall Study|Mediciation Error|0|||
129161269|NCT00244725|464884961|FG000|Overall Study|Rehab Refused to allow participantion|0|||
129161270|NCT00244725|464884962|FG001|Overall Study|Rehab Refused to allow participantion|1|||
129161271|NCT00244725|464884963|FG002|Overall Study|Rehab Refused to allow participantion|0|||
129161272|NCT00244725|464884964|FG003|Overall Study|Rehab Refused to allow participantion|0|||
129161273|NCT00244725|464884961|FG000|Overall Study|Headache|0|||
129161274|NCT00244725|464884962|FG001|Overall Study|Headache|1|||
129161275|NCT00244725|464884963|FG002|Overall Study|Headache|0|||
129161276|NCT00244725|464884964|FG003|Overall Study|Headache|0|||
128726247|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
129161277|NCT00244725|464884961|FG000|Overall Study|Received prohibited medication|0|||
129161278|NCT00244725|464884962|FG001|Overall Study|Received prohibited medication|1|||
129161279|NCT00244725|464884963|FG002|Overall Study|Received prohibited medication|0|||
129161280|NCT00244725|464884964|FG003|Overall Study|Received prohibited medication|1|||
129161281|NCT00244725|464884961|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
129161282|NCT00244725|464884962|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
128776910|NCT00738530|463472041|FG000|Overall Study|Withdrawal by Subject|6|||
129161283|NCT00244725|464884963|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
129161284|NCT00244725|464884964|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
129161285|NCT00244725|464884961|FG000|Overall Study|Administrative reason|0|||
129161286|NCT00244725|464884962|FG001|Overall Study|Administrative reason|0|||
129161287|NCT00244725|464884963|FG002|Overall Study|Administrative reason|1|||
129161288|NCT00244725|464884964|FG003|Overall Study|Administrative reason|0|||
129161289|NCT00244725|464884961|FG000|Overall Study|Vomit|0|||
129161290|NCT00244725|464884962|FG001|Overall Study|Vomit|0|||
129161291|NCT00244725|464884963|FG002|Overall Study|Vomit|1|||
129161292|NCT00244725|464884964|FG003|Overall Study|Vomit|0|||
129161293|NCT00244725|464884961|FG000|Overall Study|Failed to follow-up|0|||
129161294|NCT00244725|464884962|FG001|Overall Study|Failed to follow-up|0|||
129161295|NCT00244725|464884963|FG002|Overall Study|Failed to follow-up|1|||
129161296|NCT00244725|464884964|FG003|Overall Study|Failed to follow-up|1|||
129161297|NCT03472495|464884965|FG000|Overall Study|Treatment no longer indicated|1|||
129161298|NCT03472495|464884966|FG001|Overall Study|Treatment no longer indicated|2|||
129161299|NCT03472495|464884965|FG000|Overall Study|Physician Decision|0|||
129161300|NCT03472495|464884966|FG001|Overall Study|Physician Decision|2|||
129161301|NCT01107392|464884968|FG000|Overall Study|Adverse Event|2|||
129161302|NCT01107392|464884969|FG001|Overall Study|Adverse Event|0|||
129161303|NCT01107392|464884968|FG000|Overall Study|Personal Reasons|2|||
129161304|NCT01107392|464884969|FG001|Overall Study|Personal Reasons|3|||
129161305|NCT01107392|464884968|FG000|Overall Study|Administrative decision|1|||
129161306|NCT01107392|464884969|FG001|Overall Study|Administrative decision|0|||
129161307|NCT02998671|464884972|FG000|Period 1|Study Terminated By Sponsor|2|||
129161308|NCT02998671|464884973|FG001|Period 1|Study Terminated By Sponsor|1|||
129161309|NCT02998671|464884974|FG002|Period 1|Study Terminated By Sponsor|0|||
129161310|NCT02998671|464884975|FG003|Period 1|Study Terminated By Sponsor|0|||
129161311|NCT02998671|464884976|FG004|Period 1|Study Terminated By Sponsor|1|||
129161312|NCT02998671|464884972|FG000|Period 1|Withdrawal by Subject|1|||
129161313|NCT02998671|464884973|FG001|Period 1|Withdrawal by Subject|2|||
129161314|NCT02998671|464884974|FG002|Period 1|Withdrawal by Subject|0|||
129161315|NCT02998671|464884975|FG003|Period 1|Withdrawal by Subject|0|||
129161316|NCT02998671|464884976|FG004|Period 1|Withdrawal by Subject|2|||
129161317|NCT02998671|464884972|FG000|Period 1|Pregnancy|1|||
129161318|NCT02998671|464884973|FG001|Period 1|Pregnancy|0|||
129161319|NCT02998671|464884974|FG002|Period 1|Pregnancy|0|||
129161320|NCT02998671|464884975|FG003|Period 1|Pregnancy|0|||
129161321|NCT02998671|464884976|FG004|Period 1|Pregnancy|0|||
129161322|NCT02998671|464884972|FG000|Period 1|Adverse Event|0|||
129161323|NCT02998671|464884973|FG001|Period 1|Adverse Event|0|||
129161324|NCT02998671|464884974|FG002|Period 1|Adverse Event|0|||
129161325|NCT02998671|464884975|FG003|Period 1|Adverse Event|0|||
129161326|NCT02998671|464884976|FG004|Period 1|Adverse Event|1|||
129161327|NCT02998671|464884972|FG000|Period 2|Adverse Event|0|||
129161328|NCT02998671|464884973|FG001|Period 2|Adverse Event|1|||
129161329|NCT02998671|464884974|FG002|Period 2|Adverse Event|0|||
129161330|NCT02998671|464884975|FG003|Period 2|Adverse Event|0|||
129161331|NCT02998671|464884976|FG004|Period 2|Adverse Event|0|||
129161332|NCT02998671|464884972|FG000|Period 2|Study Terminated By Sponsor|3|||
129161333|NCT02998671|464884973|FG001|Period 2|Study Terminated By Sponsor|5|||
129161334|NCT02998671|464884974|FG002|Period 2|Study Terminated By Sponsor|1|||
129161335|NCT02998671|464884975|FG003|Period 2|Study Terminated By Sponsor|3|||
129161336|NCT02998671|464884976|FG004|Period 2|Study Terminated By Sponsor|0|||
129161337|NCT02998671|464884972|FG000|Period 2|Withdrawal by Subject|0|||
129161338|NCT02998671|464884973|FG001|Period 2|Withdrawal by Subject|1|||
129161339|NCT02998671|464884974|FG002|Period 2|Withdrawal by Subject|0|||
129161340|NCT02998671|464884975|FG003|Period 2|Withdrawal by Subject|0|||
129161341|NCT02998671|464884976|FG004|Period 2|Withdrawal by Subject|0|||
129161342|NCT02998671|464884972|FG000|Period 2|Lost to Follow-up|0|||
129161343|NCT02998671|464884973|FG001|Period 2|Lost to Follow-up|0|||
129161344|NCT02998671|464884974|FG002|Period 2|Lost to Follow-up|0|||
129161345|NCT02998671|464884975|FG003|Period 2|Lost to Follow-up|1|||
128776911|NCT00738530|463472042|FG001|Overall Study|Withdrawal by Subject|8|||
129161346|NCT02998671|464884976|FG004|Period 2|Lost to Follow-up|0|||
129161347|NCT02038946|464884978|FG000|Overall Study|Death|5|||
129161348|NCT02038946|464884978|FG000|Overall Study|Withdrawal by Subject|3|||
129161349|NCT02038946|464884978|FG000|Overall Study|Lost to Follow-up|2|||
129161350|NCT02038946|464884978|FG000|Overall Study|Other reasons|2|||
129161351|NCT02131311|464884979|FG000|Overall Study|Adverse Event|2|||
129161352|NCT02131311|464884979|FG000|Overall Study|Protocol Violation|1|||
129161353|NCT02131311|464884979|FG000|Overall Study|Lost to Follow-up|1|||
129161354|NCT02623205|464884981|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
129161355|NCT02623205|464884982|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
129161356|NCT03162796|464884983|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
129161357|NCT03162796|464884984|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
129161358|NCT03162796|464884985|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
129161359|NCT03162796|464884983|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
129161360|NCT03162796|464884984|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
129161361|NCT03162796|464884985|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
129161362|NCT03162796|464884983|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
129161363|NCT03162796|464884984|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
129161364|NCT03162796|464884985|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
129161365|NCT03162796|464884983|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
129161366|NCT03162796|464884984|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
129161367|NCT03162796|464884985|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
129161368|NCT03162796|464884983|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
129161369|NCT03162796|464884984|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
129161370|NCT03162796|464884985|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
129161371|NCT03162796|464884983|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
129161372|NCT03162796|464884984|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
129161373|NCT03162796|464884985|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
129161374|NCT03162796|464884983|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
129161375|NCT03162796|464884984|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
129161376|NCT03162796|464884985|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
129161377|NCT03162796|464884983|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
129161378|NCT03162796|464884984|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
129161379|NCT03162796|464884985|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
129161380|NCT03162796|464884983|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
129161381|NCT03162796|464884984|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
129161382|NCT03162796|464884985|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
129161383|NCT03162796|464884983|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
129161384|NCT03162796|464884984|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
129161385|NCT03162796|464884985|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
129161386|NCT03162796|464884983|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
129161387|NCT03162796|464884984|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
129161388|NCT03162796|464884985|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
129161389|NCT02342288|464884986|FG000|Overall Study|no protocol anesthesiologist available|3|||
129161390|NCT02342288|464884987|FG001|Overall Study|no protocol anesthesiologist available|2|||
129161391|NCT02342288|464884986|FG000|Overall Study|anesthesia leak in system|1|||
129161392|NCT02342288|464884987|FG001|Overall Study|anesthesia leak in system|0|||
129161393|NCT02342288|464884986|FG000|Overall Study|Withdrawal by Subject|1|||
129161394|NCT02342288|464884987|FG001|Overall Study|Withdrawal by Subject|0|||
129161395|NCT02342288|464884986|FG000|Overall Study|coordinator contaminated with blood|0|||
129161396|NCT02342288|464884987|FG001|Overall Study|coordinator contaminated with blood|1|||
129161397|NCT02342288|464884986|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
129161398|NCT02342288|464884987|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
129161399|NCT02342288|464884986|FG000|Overall Study|coordinator not available|0|||
129161400|NCT02342288|464884987|FG001|Overall Study|coordinator not available|2|||
129161401|NCT01916824|464884988|FG000|Overall Study|Lost to Follow-up|3|||
129161402|NCT01916824|464884989|FG001|Overall Study|Lost to Follow-up|6|||
129161403|NCT01916824|464884988|FG000|Overall Study|Physician Decision|2|||
129161404|NCT01916824|464884989|FG001|Overall Study|Physician Decision|0|||
129161405|NCT01916824|464884988|FG000|Overall Study|Withdrawal by Subject|2|||
129161406|NCT01916824|464884989|FG001|Overall Study|Withdrawal by Subject|3|||
129161407|NCT02467192|464884993|FG000|Overall Study|Death|1|||
129161408|NCT02467192|464884993|FG000|Overall Study|revealed to have pneumonia before|2|||
129161409|NCT03089047|464884994|FG000|Overall Study|Lost to Follow-up|1|||
129161410|NCT03089047|464884995|FG001|Overall Study|Lost to Follow-up|0|||
129161411|NCT03599518|464884996|FG000|Overall Study|Clinical progression|0|||
129161412|NCT03599518|464884997|FG001|Overall Study|Clinical progression|0|||
129161413|NCT03599518|464884998|FG002|Overall Study|Clinical progression|0|||
129161414|NCT03599518|464884999|FG003|Overall Study|Clinical progression|0|||
129161415|NCT03599518|464885000|FG004|Overall Study|Clinical progression|1|||
129161416|NCT03599518|464884996|FG000|Overall Study|Adverse Event|0|||
129161417|NCT03599518|464884997|FG001|Overall Study|Adverse Event|0|||
129161418|NCT03599518|464884998|FG002|Overall Study|Adverse Event|0|||
129161419|NCT03599518|464884999|FG003|Overall Study|Adverse Event|0|||
129161420|NCT03599518|464885000|FG004|Overall Study|Adverse Event|1|||
129161421|NCT03599518|464884996|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
129161422|NCT03599518|464884997|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
129161423|NCT03599518|464884998|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
129161424|NCT03599518|464884999|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
129161425|NCT03599518|464885000|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
129161426|NCT03599518|464884996|FG000|Overall Study|Participant withdrawal from study treatment|0|||
129161427|NCT03599518|464884997|FG001|Overall Study|Participant withdrawal from study treatment|0|||
129161428|NCT03599518|464884998|FG002|Overall Study|Participant withdrawal from study treatment|1|||
129161429|NCT03599518|464884999|FG003|Overall Study|Participant withdrawal from study treatment|0|||
129161430|NCT03599518|464885000|FG004|Overall Study|Participant withdrawal from study treatment|0|||
129161431|NCT02517398|464885001|FG000|Overall Study|Death|2|||
129161432|NCT02517398|464885002|FG001|Overall Study|Death|3|||
129161433|NCT02517398|464885003|FG002|Overall Study|Death|4|||
129161434|NCT02517398|464885004|FG003|Overall Study|Death|2|||
129161435|NCT02517398|464885005|FG004|Overall Study|Death|3|||
129161436|NCT02517398|464885006|FG005|Overall Study|Death|8|||
129161437|NCT02517398|464885007|FG006|Overall Study|Death|3|||
129161438|NCT02517398|464885008|FG007|Overall Study|Death|2|||
129161439|NCT02517398|464885009|FG008|Overall Study|Death|6|||
129161440|NCT02517398|464885010|FG009|Overall Study|Death|24|||
129161441|NCT02517398|464885011|FG010|Overall Study|Death|53|||
129161442|NCT02517398|464885012|FG011|Overall Study|Death|25|||
129161443|NCT02517398|464885013|FG012|Overall Study|Death|73|||
129161444|NCT02517398|464885014|FG013|Overall Study|Death|29|||
129161445|NCT02517398|464885015|FG014|Overall Study|Death|26|||
129161446|NCT02517398|464885016|FG015|Overall Study|Death|23|||
129161447|NCT02517398|464885017|FG016|Overall Study|Death|26|||
129161448|NCT02517398|464885018|FG017|Overall Study|Death|25|||
129161449|NCT02517398|464885019|FG018|Overall Study|Death|22|||
129161450|NCT02517398|464885020|FG019|Overall Study|Death|7|||
129161451|NCT02517398|464885021|FG020|Overall Study|Death|26|||
129161452|NCT02517398|464885022|FG021|Overall Study|Death|30|||
129161453|NCT02517398|464885023|FG022|Overall Study|Death|20|||
129161454|NCT02517398|464885001|FG000|Overall Study|Other|0|||
129161455|NCT02517398|464885002|FG001|Overall Study|Other|0|||
129161456|NCT02517398|464885003|FG002|Overall Study|Other|0|||
129161457|NCT02517398|464885004|FG003|Overall Study|Other|1|||
129161458|NCT02517398|464885005|FG004|Overall Study|Other|0|||
129161459|NCT02517398|464885006|FG005|Overall Study|Other|0|||
129161460|NCT02517398|464885007|FG006|Overall Study|Other|0|||
129161461|NCT02517398|464885008|FG007|Overall Study|Other|0|||
129161462|NCT02517398|464885009|FG008|Overall Study|Other|0|||
129161463|NCT02517398|464885010|FG009|Overall Study|Other|1|||
129161464|NCT02517398|464885011|FG010|Overall Study|Other|0|||
129161465|NCT02517398|464885012|FG011|Overall Study|Other|0|||
129161466|NCT02517398|464885013|FG012|Overall Study|Other|0|||
129161467|NCT02517398|464885014|FG013|Overall Study|Other|1|||
129161468|NCT02517398|464885015|FG014|Overall Study|Other|0|||
129161469|NCT02517398|464885016|FG015|Overall Study|Other|1|||
129161470|NCT02517398|464885017|FG016|Overall Study|Other|1|||
129161471|NCT02517398|464885018|FG017|Overall Study|Other|0|||
129161472|NCT02517398|464885019|FG018|Overall Study|Other|0|||
129161473|NCT02517398|464885020|FG019|Overall Study|Other|1|||
129161474|NCT02517398|464885021|FG020|Overall Study|Other|0|||
129161475|NCT02517398|464885022|FG021|Overall Study|Other|0|||
129161476|NCT02517398|464885023|FG022|Overall Study|Other|0|||
129161477|NCT02517398|464885001|FG000|Overall Study|Lost to Follow-up|0|||
129161478|NCT02517398|464885002|FG001|Overall Study|Lost to Follow-up|0|||
129161479|NCT02517398|464885003|FG002|Overall Study|Lost to Follow-up|0|||
129161480|NCT02517398|464885004|FG003|Overall Study|Lost to Follow-up|0|||
129161481|NCT02517398|464885005|FG004|Overall Study|Lost to Follow-up|0|||
129161482|NCT02517398|464885006|FG005|Overall Study|Lost to Follow-up|0|||
129161483|NCT02517398|464885007|FG006|Overall Study|Lost to Follow-up|0|||
129161484|NCT02517398|464885008|FG007|Overall Study|Lost to Follow-up|0|||
129161485|NCT02517398|464885009|FG008|Overall Study|Lost to Follow-up|0|||
129161486|NCT02517398|464885010|FG009|Overall Study|Lost to Follow-up|1|||
129161487|NCT02517398|464885011|FG010|Overall Study|Lost to Follow-up|0|||
129161488|NCT02517398|464885012|FG011|Overall Study|Lost to Follow-up|2|||
129161489|NCT02517398|464885013|FG012|Overall Study|Lost to Follow-up|2|||
129161490|NCT02517398|464885014|FG013|Overall Study|Lost to Follow-up|0|||
129161491|NCT02517398|464885015|FG014|Overall Study|Lost to Follow-up|1|||
129161492|NCT02517398|464885016|FG015|Overall Study|Lost to Follow-up|1|||
129161493|NCT02517398|464885017|FG016|Overall Study|Lost to Follow-up|0|||
129161494|NCT02517398|464885018|FG017|Overall Study|Lost to Follow-up|3|||
129161495|NCT02517398|464885019|FG018|Overall Study|Lost to Follow-up|1|||
129161496|NCT02517398|464885020|FG019|Overall Study|Lost to Follow-up|0|||
129161497|NCT02517398|464885021|FG020|Overall Study|Lost to Follow-up|1|||
129161498|NCT02517398|464885022|FG021|Overall Study|Lost to Follow-up|0|||
129161499|NCT02517398|464885023|FG022|Overall Study|Lost to Follow-up|2|||
129161500|NCT02517398|464885001|FG000|Overall Study|Withdrew Consent|0|||
129161501|NCT02517398|464885002|FG001|Overall Study|Withdrew Consent|0|||
129161502|NCT02517398|464885003|FG002|Overall Study|Withdrew Consent|0|||
129161503|NCT02517398|464885004|FG003|Overall Study|Withdrew Consent|0|||
129161504|NCT02517398|464885005|FG004|Overall Study|Withdrew Consent|0|||
129161505|NCT02517398|464885006|FG005|Overall Study|Withdrew Consent|0|||
129161506|NCT02517398|464885007|FG006|Overall Study|Withdrew Consent|1|||
129161507|NCT02517398|464885008|FG007|Overall Study|Withdrew Consent|0|||
129161508|NCT02517398|464885009|FG008|Overall Study|Withdrew Consent|0|||
129161509|NCT02517398|464885010|FG009|Overall Study|Withdrew Consent|2|||
129161510|NCT02517398|464885011|FG010|Overall Study|Withdrew Consent|7|||
129161511|NCT02517398|464885012|FG011|Overall Study|Withdrew Consent|1|||
129161512|NCT02517398|464885013|FG012|Overall Study|Withdrew Consent|5|||
129161513|NCT02517398|464885014|FG013|Overall Study|Withdrew Consent|4|||
129161514|NCT02517398|464885015|FG014|Overall Study|Withdrew Consent|2|||
129161515|NCT02517398|464885016|FG015|Overall Study|Withdrew Consent|5|||
129161516|NCT02517398|464885017|FG016|Overall Study|Withdrew Consent|4|||
129161517|NCT02517398|464885018|FG017|Overall Study|Withdrew Consent|2|||
129161518|NCT02517398|464885019|FG018|Overall Study|Withdrew Consent|3|||
129161519|NCT02517398|464885020|FG019|Overall Study|Withdrew Consent|2|||
129161520|NCT02517398|464885021|FG020|Overall Study|Withdrew Consent|9|||
129161521|NCT02517398|464885022|FG021|Overall Study|Withdrew Consent|3|||
129161522|NCT02517398|464885023|FG022|Overall Study|Withdrew Consent|1|||
129161523|NCT00005947|464885025|FG000|Overall Study|Death|54|||
129161524|NCT00005947|464885026|FG001|Overall Study|Death|40|||
129161525|NCT00005947|464885025|FG000|Overall Study|Patient Refused to Continue|2|||
129161526|NCT00005947|464885026|FG001|Overall Study|Patient Refused to Continue|1|||
129161527|NCT00005947|464885025|FG000|Overall Study|Site Closure|1|||
129161528|NCT00005947|464885026|FG001|Overall Study|Site Closure|0|||
129161529|NCT00429182|464885027|FG000|Overall Study|Not evaluable, Disease Progression|2|||
129161530|NCT00429182|464885027|FG000|Overall Study|Not eligible|5|||
129161531|NCT00790582|464885028|FG000|Overall Study|Death|14|||
129161532|NCT00790582|464885029|FG001|Overall Study|Death|32|||
129161533|NCT00790582|464885028|FG000|Overall Study|Physician Decision|7|||
129161534|NCT00790582|464885029|FG001|Overall Study|Physician Decision|1|||
129161535|NCT00790582|464885028|FG000|Overall Study|Lost to Follow-up|3|||
129161536|NCT00790582|464885029|FG001|Overall Study|Lost to Follow-up|3|||
129161537|NCT00790582|464885028|FG000|Overall Study|Withdrawal by Subject|7|||
129161538|NCT00790582|464885029|FG001|Overall Study|Withdrawal by Subject|51|||
129161539|NCT02701764|464885031|FG000|Overall Study|Lost to Follow-up|0|||
129161540|NCT02701764|464885032|FG001|Overall Study|Lost to Follow-up|1|||
129161541|NCT01027650|464885033|FG000|Overall Study|Personal Reasons|0|||
129161542|NCT01027650|464885034|FG001|Overall Study|Personal Reasons|0|||
129161543|NCT01027650|464885035|FG002|Overall Study|Personal Reasons|0|||
129161544|NCT01027650|464885036|FG003|Overall Study|Personal Reasons|0|||
129161545|NCT01027650|464885037|FG004|Overall Study|Personal Reasons|2|||
129161546|NCT01027650|464885038|FG005|Overall Study|Personal Reasons|1|||
129161547|NCT01027650|464885039|FG006|Overall Study|Personal Reasons|0|||
129161548|NCT01027650|464885040|FG007|Overall Study|Personal Reasons|0|||
129161549|NCT01027650|464885033|FG000|Overall Study|Lost to Follow-up|0|||
129161550|NCT01027650|464885034|FG001|Overall Study|Lost to Follow-up|0|||
129161551|NCT01027650|464885035|FG002|Overall Study|Lost to Follow-up|0|||
129161552|NCT01027650|464885036|FG003|Overall Study|Lost to Follow-up|0|||
129161553|NCT01027650|464885037|FG004|Overall Study|Lost to Follow-up|0|||
129161554|NCT01027650|464885038|FG005|Overall Study|Lost to Follow-up|0|||
129161555|NCT01027650|464885039|FG006|Overall Study|Lost to Follow-up|1|||
129161556|NCT01027650|464885040|FG007|Overall Study|Lost to Follow-up|0|||
129161557|NCT01027650|464885033|FG000|Overall Study|Lack of Efficacy|0|||
129161558|NCT01027650|464885034|FG001|Overall Study|Lack of Efficacy|0|||
129161559|NCT01027650|464885035|FG002|Overall Study|Lack of Efficacy|0|||
129161560|NCT01027650|464885036|FG003|Overall Study|Lack of Efficacy|0|||
129161561|NCT01027650|464885037|FG004|Overall Study|Lack of Efficacy|0|||
129161562|NCT01027650|464885038|FG005|Overall Study|Lack of Efficacy|1|||
129161563|NCT01027650|464885039|FG006|Overall Study|Lack of Efficacy|0|||
129161564|NCT01027650|464885040|FG007|Overall Study|Lack of Efficacy|0|||
129161565|NCT00912782|464885041|FG000|Overall Study|Death|2|||
129161566|NCT00912782|464885042|FG001|Overall Study|Death|1|||
129161567|NCT00912782|464885041|FG000|Overall Study|Lost to Follow-up|0|||
129161568|NCT00912782|464885042|FG001|Overall Study|Lost to Follow-up|1|||
129161569|NCT00912782|464885041|FG000|Overall Study|Did not receive vascular access type|1|||
129161570|NCT00912782|464885042|FG001|Overall Study|Did not receive vascular access type|2|||
129161571|NCT00912782|464885041|FG000|Overall Study|Relocated before study completion|0|||
129161572|NCT00912782|464885042|FG001|Overall Study|Relocated before study completion|1|||
129161573|NCT00391053|464886877|FG000|Overall Study|Serious Adverse Events|1|||
129161574|NCT00391053|464886878|FG001|Overall Study|Serious Adverse Events|0|||
129161575|NCT00391053|464886879|FG002|Overall Study|Serious Adverse Events|1|||
129161576|NCT00391053|464886880|FG003|Overall Study|Serious Adverse Events|4|||
129161577|NCT00391053|464886877|FG000|Overall Study|Protocol Violation|2|||
129161578|NCT00391053|464886878|FG001|Overall Study|Protocol Violation|0|||
129161579|NCT00391053|464886879|FG002|Overall Study|Protocol Violation|0|||
129161580|NCT00391053|464886880|FG003|Overall Study|Protocol Violation|0|||
129161581|NCT00391053|464886877|FG000|Overall Study|Lost to Follow-up|1|||
129161582|NCT00391053|464886878|FG001|Overall Study|Lost to Follow-up|0|||
129161583|NCT00391053|464886879|FG002|Overall Study|Lost to Follow-up|0|||
129161584|NCT00391053|464886880|FG003|Overall Study|Lost to Follow-up|5|||
129161585|NCT00391053|464886877|FG000|Overall Study|Withdrawal by Subject|5|||
129161586|NCT00391053|464886878|FG001|Overall Study|Withdrawal by Subject|1|||
129161587|NCT00391053|464886879|FG002|Overall Study|Withdrawal by Subject|1|||
129161588|NCT00391053|464886880|FG003|Overall Study|Withdrawal by Subject|1|||
129161589|NCT05002985|464886881|FG000|Overall Study|Withdrawal by Subject|1|||
129161590|NCT02943070|464886882|FG000|Overall Study|Physician Decision|1|||
129161591|NCT02943070|464886882|FG000|Overall Study|Adverse Event|2|||
129161592|NCT02943070|464886882|FG000|Overall Study|Death|2|||
129161593|NCT02943070|464886882|FG000|Overall Study|Withdrawal by Subject|3|||
129161594|NCT02943070|464886882|FG000|Overall Study|Lost to Follow-up|4|||
129161595|NCT02943070|464886882|FG000|Overall Study|Retreatment or TURP|13|||
129161596|NCT02943070|464886882|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
129161597|NCT04123093|464886883|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
129161598|NCT04123093|464886884|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
129161599|NCT04123093|464886883|FG000|Phase 2|Physician Decision|0|||
129161600|NCT04123093|464886884|FG001|Phase 2|Physician Decision|1|||
129161601|NCT04123093|464886883|FG000|Phase 2|Withdrawal by Subject|0|||
129161602|NCT04123093|464886884|FG001|Phase 2|Withdrawal by Subject|1|||
129161603|NCT01485796|464886886|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
129161604|NCT01485796|464886886|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
129161605|NCT01485796|464886886|FG000|Period 2: Epoch 2|Adverse Event|3|||
129161606|NCT01485796|464886886|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
129161607|NCT01485796|464886886|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
129161608|NCT01485796|464886886|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
129161609|NCT01485796|464886886|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
129161610|NCT01485796|464886886|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
129161611|NCT00606411|464886896|FG000|Overall Study|Adverse Event|1|||
129161612|NCT00606411|464886897|FG001|Overall Study|Adverse Event|2|||
129161613|NCT00606411|464886896|FG000|Overall Study|Lack of Adherence|1|||
129161614|NCT00606411|464886897|FG001|Overall Study|Lack of Adherence|1|||
129161615|NCT00606411|464886896|FG000|Overall Study|Lack of Efficacy|1|||
129161616|NCT00606411|464886897|FG001|Overall Study|Lack of Efficacy|1|||
129161617|NCT00606411|464886896|FG000|Overall Study|Withdrawal by Subject|2|||
129161618|NCT00606411|464886897|FG001|Overall Study|Withdrawal by Subject|0|||
129161619|NCT00606411|464886896|FG000|Overall Study|Lost to Follow-up|1|||
129161620|NCT00606411|464886897|FG001|Overall Study|Lost to Follow-up|2|||
129161621|NCT00606411|464886896|FG000|Overall Study|Move out of state|0|||
129161622|NCT00606411|464886897|FG001|Overall Study|Move out of state|1|||
129161623|NCT02526212|464886898|FG000|Overall Study|Incarceration|1|||
129161624|NCT02526212|464886899|FG001|Overall Study|Incarceration|0|||
129161625|NCT02526212|464886898|FG000|Overall Study|Lost to Follow-up|1|||
129161626|NCT02526212|464886899|FG001|Overall Study|Lost to Follow-up|0|||
129161627|NCT02526212|464886898|FG000|Overall Study|Death|0|||
129161628|NCT02526212|464886899|FG001|Overall Study|Death|1|||
129161629|NCT01390298|464886900|FG000|Overall Study|Death|1|||
129161630|NCT01390298|464886900|FG000|Overall Study|long term ICU admission|1|||
129161631|NCT01390298|464886900|FG000|Overall Study|Withdrawal by Subject|14|||
129161632|NCT01390298|464886900|FG000|Overall Study|Lost to Follow-up|7|||
129161633|NCT01390298|464886900|FG000|Overall Study|Surgery cancelled|1|||
129161634|NCT00040742|464886907|FG000|Overall Study|Death|0|||
129161635|NCT00040742|464886908|FG001|Overall Study|Death|0|||
129161636|NCT00040742|464886909|FG002|Overall Study|Death|1|||
129161637|NCT00040742|464886910|FG003|Overall Study|Death|0|||
129161638|NCT00040742|464886907|FG000|Overall Study|Adverse Event|15|||
129161639|NCT00040742|464886908|FG001|Overall Study|Adverse Event|16|||
129161640|NCT00040742|464886909|FG002|Overall Study|Adverse Event|21|||
129161641|NCT00040742|464886910|FG003|Overall Study|Adverse Event|9|||
129161642|NCT00040742|464886907|FG000|Overall Study|Withdrawal by Subject|7|||
129161643|NCT00040742|464886908|FG001|Overall Study|Withdrawal by Subject|15|||
129161644|NCT00040742|464886909|FG002|Overall Study|Withdrawal by Subject|10|||
129161645|NCT00040742|464886910|FG003|Overall Study|Withdrawal by Subject|13|||
129161646|NCT00040742|464886907|FG000|Overall Study|Chemotoxicity|4|||
129161647|NCT00040742|464886908|FG001|Overall Study|Chemotoxicity|3|||
129161648|NCT00040742|464886909|FG002|Overall Study|Chemotoxicity|5|||
129161649|NCT00040742|464886910|FG003|Overall Study|Chemotoxicity|2|||
129161650|NCT00040742|464886907|FG000|Overall Study|Incomplete Forms|6|||
129161651|NCT00040742|464886908|FG001|Overall Study|Incomplete Forms|10|||
129161652|NCT00040742|464886909|FG002|Overall Study|Incomplete Forms|4|||
129161653|NCT00040742|464886910|FG003|Overall Study|Incomplete Forms|5|||
129161654|NCT00040742|464886907|FG000|Overall Study|Other medical|7|||
129161655|NCT00040742|464886908|FG001|Overall Study|Other medical|5|||
129161656|NCT00040742|464886909|FG002|Overall Study|Other medical|5|||
129161657|NCT00040742|464886910|FG003|Overall Study|Other medical|5|||
129161658|NCT03520920|464886913|FG000|Overall Study|Death|13|||
129161659|NCT03520920|464886914|FG001|Overall Study|Death|1|||
129161660|NCT03520920|464886915|FG002|Overall Study|Death|0|||
129161661|NCT03520920|464886913|FG000|Overall Study|Withdrawal by Subject|2|||
129161662|NCT03520920|464886914|FG001|Overall Study|Withdrawal by Subject|1|||
129161663|NCT03520920|464886915|FG002|Overall Study|Withdrawal by Subject|0|||
129161664|NCT03520920|464886913|FG000|Overall Study|Study Terminated by the Sponsor|5|||
129161665|NCT03520920|464886914|FG001|Overall Study|Study Terminated by the Sponsor|14|||
129161666|NCT03520920|464886915|FG002|Overall Study|Study Terminated by the Sponsor|5|||
129161667|NCT00405392|464886916|FG000|Overall Study|Adverse Event|15|||
129161668|NCT00405392|464886917|FG001|Overall Study|Adverse Event|14|||
129161669|NCT00405392|464886916|FG000|Overall Study|Did not meet Eligibility criteria|7|||
129161670|NCT00405392|464886917|FG001|Overall Study|Did not meet Eligibility criteria|2|||
129161671|NCT00405392|464886916|FG000|Overall Study|Withdrawal by Subject|4|||
129161672|NCT00405392|464886917|FG001|Overall Study|Withdrawal by Subject|3|||
129161673|NCT00405392|464886916|FG000|Overall Study|Lost to Follow-up|1|||
129161674|NCT00405392|464886917|FG001|Overall Study|Lost to Follow-up|2|||
129161675|NCT00405392|464886916|FG000|Overall Study|Data missing|2|||
129161676|NCT00405392|464886917|FG001|Overall Study|Data missing|0|||
129161677|NCT00405392|464886916|FG000|Overall Study|Non-compliance|0|||
129161678|NCT00405392|464886917|FG001|Overall Study|Non-compliance|1|||
129161679|NCT00405392|464886916|FG000|Overall Study|Other|1|||
129161680|NCT00405392|464886917|FG001|Overall Study|Other|5|||
129161681|NCT00412958|464886918|FG000|Overall Study|Withdrawal by Subject|3|||
129161682|NCT00412958|464886919|FG001|Overall Study|Withdrawal by Subject|0|||
129161683|NCT00412958|464886920|FG002|Overall Study|Withdrawal by Subject|0|||
129161684|NCT00412958|464886921|FG003|Overall Study|Withdrawal by Subject|1|||
129161685|NCT00412958|464886918|FG000|Overall Study|Adverse Event|0|||
129161686|NCT00412958|464886919|FG001|Overall Study|Adverse Event|1|||
129161687|NCT00412958|464886920|FG002|Overall Study|Adverse Event|0|||
129161688|NCT00412958|464886921|FG003|Overall Study|Adverse Event|0|||
129161689|NCT00412958|464886918|FG000|Overall Study|Lost to Follow-up|0|||
129161690|NCT00412958|464886919|FG001|Overall Study|Lost to Follow-up|1|||
129161691|NCT00412958|464886920|FG002|Overall Study|Lost to Follow-up|0|||
129161692|NCT00412958|464886921|FG003|Overall Study|Lost to Follow-up|0|||
129161693|NCT00412958|464886918|FG000|Overall Study|Death|0|||
129161694|NCT00412958|464886919|FG001|Overall Study|Death|1|||
129161695|NCT00412958|464886920|FG002|Overall Study|Death|0|||
129161696|NCT00412958|464886921|FG003|Overall Study|Death|0|||
129161697|NCT00412958|464886918|FG000|Overall Study|Transport issue|0|||
129161698|NCT00412958|464886919|FG001|Overall Study|Transport issue|1|||
129161699|NCT00412958|464886920|FG002|Overall Study|Transport issue|0|||
129161700|NCT00412958|464886921|FG003|Overall Study|Transport issue|0|||
129161701|NCT02819297|464886935|FG000|Overall Study|Withdrawal by Subject|25|||
129161702|NCT02819297|464886936|FG001|Overall Study|Withdrawal by Subject|13|||
129161703|NCT02819297|464886935|FG000|Overall Study|Lost to Follow-up|12|||
129161704|NCT02819297|464886936|FG001|Overall Study|Lost to Follow-up|14|||
129161705|NCT02819297|464886935|FG000|Overall Study|Adverse Event|12|||
129161706|NCT02819297|464886936|FG001|Overall Study|Adverse Event|10|||
129161707|NCT02819297|464886935|FG000|Overall Study|Physician Decision|5|||
129161708|NCT02819297|464886936|FG001|Overall Study|Physician Decision|5|||
129161709|NCT02819297|464886935|FG000|Overall Study|Lack of Efficacy|5|||
129161710|NCT02819297|464886936|FG001|Overall Study|Lack of Efficacy|8|||
129161711|NCT02819297|464886935|FG000|Overall Study|Protocol Violation|1|||
129161712|NCT02819297|464886936|FG001|Overall Study|Protocol Violation|2|||
129161713|NCT02858440|464886937|FG000|Overall Study|Lost to Follow-up|3|||
129161714|NCT02858440|464886937|FG000|Overall Study|Protocol Violation|2|||
129161715|NCT02858440|464886937|FG000|Overall Study|Consent withdrawal|3|||
129161716|NCT02858440|464886937|FG000|Overall Study|Migrated/moved from study area|4|||
129161717|NCT01670279|464886938|FG000|Overall Study|Adverse Event|0|||
129161718|NCT01670279|464886939|FG001|Overall Study|Adverse Event|1|||
129161719|NCT01670279|464886940|FG002|Overall Study|Adverse Event|0|||
129161720|NCT01670279|464886941|FG003|Overall Study|Adverse Event|0|||
129161721|NCT01670279|464886938|FG000|Overall Study|Physician Decision|0|||
129161722|NCT01670279|464886939|FG001|Overall Study|Physician Decision|1|||
129161723|NCT01670279|464886940|FG002|Overall Study|Physician Decision|0|||
129161724|NCT01670279|464886941|FG003|Overall Study|Physician Decision|0|||
129161725|NCT01670279|464886938|FG000|Overall Study|Participant met withdrawal criteria|0|||
129161726|NCT01670279|464886939|FG001|Overall Study|Participant met withdrawal criteria|0|||
129161727|NCT01670279|464886940|FG002|Overall Study|Participant met withdrawal criteria|0|||
129161728|NCT01670279|464886941|FG003|Overall Study|Participant met withdrawal criteria|1|||
129161729|NCT01901614|464886942|FG000|Overall Study|Adverse Event|0|||
129161730|NCT01901614|464886943|FG001|Overall Study|Adverse Event|1|||
129161731|NCT01901614|464886942|FG000|Overall Study|Lost to Follow-up|1|||
129161732|NCT01901614|464886943|FG001|Overall Study|Lost to Follow-up|0|||
129161733|NCT01901614|464886942|FG000|Overall Study|Screen Fail|1|||
129161734|NCT01901614|464886943|FG001|Overall Study|Screen Fail|0|||
129161735|NCT01823198|464886945|FG000|Overall Study|Physician Decision|0|||
129161736|NCT01823198|464886946|FG001|Overall Study|Physician Decision|1|||
129161737|NCT01823198|464886947|FG002|Overall Study|Physician Decision|0|||
129161738|NCT01823198|464886948|FG003|Overall Study|Physician Decision|0|||
129161739|NCT01823198|464886949|FG004|Overall Study|Physician Decision|0|||
129161740|NCT01823198|464886950|FG005|Overall Study|Physician Decision|3|||
129161741|NCT01823198|464886951|FG006|Overall Study|Physician Decision|3|||
129161742|NCT01262638|464886952|FG000|Overall Study|Adverse Event|3|||
129161743|NCT01262638|464886953|FG001|Overall Study|Adverse Event|4|||
129161744|NCT01262638|464886954|FG002|Overall Study|Adverse Event|3|||
129161745|NCT01262638|464886955|FG003|Overall Study|Adverse Event|4|||
129161746|NCT01262638|464886952|FG000|Overall Study|Protocol Violation|1|||
129161747|NCT01262638|464886953|FG001|Overall Study|Protocol Violation|0|||
129161748|NCT01262638|464886954|FG002|Overall Study|Protocol Violation|0|||
129161749|NCT01262638|464886955|FG003|Overall Study|Protocol Violation|1|||
129161750|NCT01262638|464886952|FG000|Overall Study|Withdrawal by Subject|2|||
129161751|NCT01262638|464886953|FG001|Overall Study|Withdrawal by Subject|1|||
129161752|NCT01262638|464886954|FG002|Overall Study|Withdrawal by Subject|0|||
129161753|NCT01262638|464886955|FG003|Overall Study|Withdrawal by Subject|1|||
129161754|NCT01262638|464886952|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
129161755|NCT01262638|464886953|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
129161756|NCT01262638|464886954|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
129161757|NCT01262638|464886955|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
129161758|NCT01262638|464886952|FG000|Overall Study|Lost to Follow-up|1|||
129161759|NCT01262638|464886953|FG001|Overall Study|Lost to Follow-up|1|||
129161760|NCT01262638|464886954|FG002|Overall Study|Lost to Follow-up|1|||
129161761|NCT01262638|464886955|FG003|Overall Study|Lost to Follow-up|1|||
129161762|NCT01262638|464886952|FG000|Overall Study|Participant Went Out of Town|0|||
129161763|NCT01262638|464886953|FG001|Overall Study|Participant Went Out of Town|0|||
129161764|NCT01262638|464886954|FG002|Overall Study|Participant Went Out of Town|1|||
129161765|NCT01262638|464886955|FG003|Overall Study|Participant Went Out of Town|0|||
129161766|NCT02243371|464886960|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
129161767|NCT02243371|464886961|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
129161768|NCT02243371|464886960|FG000|Overall Study|Death (unrelated)|2|||
129161769|NCT02243371|464886961|FG001|Overall Study|Death (unrelated)|4|||
129161770|NCT02243371|464886960|FG000|Overall Study|Adverse Event (unrelated)|0|||
129161771|NCT02243371|464886961|FG001|Overall Study|Adverse Event (unrelated)|1|||
129161772|NCT02243371|464886960|FG000|Overall Study|Lack of Clinical Benefit|0|||
129161773|NCT02243371|464886961|FG001|Overall Study|Lack of Clinical Benefit|1|||
129161774|NCT02243371|464886960|FG000|Overall Study|Withdrawal by Subject|0|||
129161775|NCT02243371|464886961|FG001|Overall Study|Withdrawal by Subject|2|||
129161776|NCT01369199|464886962|FG000|Overall Study|Withdrawal by Subject|1|||
129161777|NCT01369199|464886962|FG000|Overall Study|Lost to Follow-up|2|||
129161778|NCT01071252|464886963|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
129161779|NCT01071252|464886964|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
129161780|NCT01071252|464886965|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
129161781|NCT01071252|464886966|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
129161782|NCT01071252|464886967|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
129161783|NCT01071252|464886963|FG000|Overall Study|Withdrawal by Subject|8|||
129161784|NCT01071252|464886964|FG001|Overall Study|Withdrawal by Subject|2|||
129161785|NCT01071252|464886965|FG002|Overall Study|Withdrawal by Subject|1|||
129161786|NCT01071252|464886966|FG003|Overall Study|Withdrawal by Subject|2|||
129161787|NCT01071252|464886967|FG004|Overall Study|Withdrawal by Subject|3|||
129161788|NCT01071252|464886963|FG000|Overall Study|administrative problems|1|||
129161789|NCT01071252|464886964|FG001|Overall Study|administrative problems|1|||
129161790|NCT01071252|464886965|FG002|Overall Study|administrative problems|0|||
129161791|NCT01071252|464886966|FG003|Overall Study|administrative problems|2|||
129161792|NCT01071252|464886967|FG004|Overall Study|administrative problems|1|||
129161793|NCT01071252|464886963|FG000|Overall Study|Lost to Follow-up|1|||
129161794|NCT01071252|464886964|FG001|Overall Study|Lost to Follow-up|0|||
129161795|NCT01071252|464886965|FG002|Overall Study|Lost to Follow-up|1|||
129161796|NCT01071252|464886966|FG003|Overall Study|Lost to Follow-up|2|||
129161797|NCT01071252|464886967|FG004|Overall Study|Lost to Follow-up|0|||
129161798|NCT01071252|464886963|FG000|Overall Study|Adverse Event|1|||
129161799|NCT01071252|464886964|FG001|Overall Study|Adverse Event|1|||
129161800|NCT01071252|464886965|FG002|Overall Study|Adverse Event|0|||
129161801|NCT01071252|464886966|FG003|Overall Study|Adverse Event|1|||
129161802|NCT01071252|464886967|FG004|Overall Study|Adverse Event|0|||
129161803|NCT01071252|464886963|FG000|Overall Study|Death|0|||
129161804|NCT01071252|464886964|FG001|Overall Study|Death|0|||
129161805|NCT01071252|464886965|FG002|Overall Study|Death|0|||
129161806|NCT01071252|464886966|FG003|Overall Study|Death|0|||
129161807|NCT01071252|464886967|FG004|Overall Study|Death|1|||
129161808|NCT03928418|464886968|FG000|Overall Study|Lost to Follow-up|5|||
129161809|NCT03928418|464886969|FG001|Overall Study|Lost to Follow-up|3|||
129161810|NCT03928418|464886970|FG002|Overall Study|Lost to Follow-up|5|||
129161811|NCT03928418|464886968|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
129161812|NCT03928418|464886969|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
129161813|NCT03928418|464886970|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
129161814|NCT00470262|464886971|FG000|Overall Study|Withdrawal by Subject|2|||
129161815|NCT00470262|464886972|FG001|Overall Study|Withdrawal by Subject|0|||
129161816|NCT03900728|464886973|FG000|Overall Study|No text responses|0|||
129161817|NCT03900728|464886974|FG001|Overall Study|No text responses|0|||
129161818|NCT03900728|464886975|FG002|Overall Study|No text responses|4|||
129161819|NCT00763256|464886976|FG000|Overall Study|Didn't return for appointments|7|||
129161820|NCT00763256|464886977|FG001|Overall Study|Didn't return for appointments|10|||
129161821|NCT02544750|464886978|FG000|Overall Study|Physician Decision|3|||
129161822|NCT02544750|464886979|FG001|Overall Study|Physician Decision|1|||
129161823|NCT02544750|464886978|FG000|Overall Study|Other reasons|69|||
129161824|NCT02544750|464886979|FG001|Overall Study|Other reasons|39|||
129161825|NCT02544750|464886978|FG000|Overall Study|Met withdrawal criteria|2|||
129161826|NCT02544750|464886979|FG001|Overall Study|Met withdrawal criteria|2|||
129161827|NCT02544750|464886978|FG000|Overall Study|Transition To Commercial Product|1|||
129161828|NCT02544750|464886979|FG001|Overall Study|Transition To Commercial Product|0|||
129161829|NCT02544750|464886978|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
129161830|NCT02544750|464886979|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
129161831|NCT02544750|464886978|FG000|Overall Study|Adverse Event|8|||
129161832|NCT02544750|464886979|FG001|Overall Study|Adverse Event|10|||
129161833|NCT02544750|464886978|FG000|Overall Study|Withdrawal by Subject|10|||
129161834|NCT02544750|464886979|FG001|Overall Study|Withdrawal by Subject|4|||
129161835|NCT02544750|464886978|FG000|Overall Study|Lost to Follow-up|1|||
129161836|NCT02544750|464886979|FG001|Overall Study|Lost to Follow-up|0|||
129161837|NCT03248167|464886982|FG000|Overall Study|Withdrawal by Subject|2|||
129161838|NCT03248167|464886983|FG001|Overall Study|Withdrawal by Subject|2|||
129161839|NCT03248167|464886982|FG000|Overall Study|Physician Decision|0|||
129161840|NCT03248167|464886983|FG001|Overall Study|Physician Decision|1|||
129161841|NCT03248167|464886982|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
129161842|NCT03248167|464886983|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
129161843|NCT03248167|464886982|FG000|Overall Study|Lost to Follow-up|1|||
129161844|NCT03248167|464886983|FG001|Overall Study|Lost to Follow-up|0|||
129161845|NCT02122146|464886984|FG000|Part 1: Dose Escalation|Death|0|||
129161846|NCT02122146|464886985|FG001|Part 1: Dose Escalation|Death|1|||
129161847|NCT02122146|464886986|FG002|Part 1: Dose Escalation|Death|1|||
129161848|NCT02122146|464886987|FG003|Part 1: Dose Escalation|Death|0|||
129161849|NCT02122146|464886988|FG004|Part 1: Dose Escalation|Death|0|||
129161850|NCT02122146|464886989|FG005|Part 1: Dose Escalation|Death|0|||
129161851|NCT02122146|464886990|FG006|Part 1: Dose Escalation|Death|0|||
129161852|NCT02122146|464886991|FG007|Part 1: Dose Escalation|Death|0|||
129161853|NCT02122146|464886984|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
129161854|NCT02122146|464886985|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
129161855|NCT02122146|464886986|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
129161856|NCT02122146|464886987|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
129161857|NCT02122146|464886988|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
129161858|NCT02122146|464886989|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
129161859|NCT02122146|464886990|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
129161860|NCT02122146|464886991|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
129161861|NCT02122146|464886984|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129161862|NCT02122146|464886985|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129161863|NCT02122146|464886986|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129161864|NCT02122146|464886987|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
129161865|NCT02122146|464886988|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129161866|NCT02122146|464886989|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129161867|NCT02122146|464886990|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129161868|NCT02122146|464886991|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129161869|NCT02122146|464886984|FG000|Part 1: Dose Escalation|Other|1|||
129161870|NCT02122146|464886985|FG001|Part 1: Dose Escalation|Other|0|||
129161871|NCT02122146|464886986|FG002|Part 1: Dose Escalation|Other|0|||
129161872|NCT02122146|464886987|FG003|Part 1: Dose Escalation|Other|0|||
129161873|NCT02122146|464886988|FG004|Part 1: Dose Escalation|Other|0|||
129161874|NCT02122146|464886989|FG005|Part 1: Dose Escalation|Other|1|||
129161875|NCT02122146|464886990|FG006|Part 1: Dose Escalation|Other|1|||
129161876|NCT02122146|464886991|FG007|Part 1: Dose Escalation|Other|2|||
129161877|NCT02473471|464886992|FG000|Overall Study|poor oral hygiene|2|||
129161878|NCT02473471|464886992|FG000|Overall Study|Lost to Follow-up|1|||
129161879|NCT02725476|464886995|FG000|Overall Study|Physician Decision|2|||
129161880|NCT02725476|464886996|FG001|Overall Study|Physician Decision|0|||
129161881|NCT02725476|464886995|FG000|Overall Study|Adverse Event|1|||
129161882|NCT02725476|464886996|FG001|Overall Study|Adverse Event|1|||
129161883|NCT00553436|464886998|FG000|Overall Study|Conversion to another procedure|1|||
129161884|NCT04188834|464886999|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
129161885|NCT01030952|464887000|FG000|Overall Study|Protocol Violation|0|||
129161886|NCT01030952|464887001|FG001|Overall Study|Protocol Violation|1|||
129161887|NCT01030952|464887000|FG000|Overall Study|Informed consent withdrawal|1|||
129161888|NCT01030952|464887001|FG001|Overall Study|Informed consent withdrawal|0|||
129161889|NCT01030952|464887000|FG000|Overall Study|Lost to Follow-up|0|||
129161890|NCT01030952|464887001|FG001|Overall Study|Lost to Follow-up|1|||
129161891|NCT01030952|464887000|FG000|Overall Study|Unexplained|1|||
129161892|NCT01030952|464887001|FG001|Overall Study|Unexplained|1|||
129161893|NCT02455336|464887002|FG000|Overall Study|Withdrawal by Subject|0|||
129161894|NCT02455336|464887003|FG001|Overall Study|Withdrawal by Subject|2|||
129161895|NCT02455336|464887002|FG000|Overall Study|Adverse Event|3|||
129161896|NCT02455336|464887003|FG001|Overall Study|Adverse Event|0|||
129161897|NCT02455336|464887002|FG000|Overall Study|Non-responder to treatment|2|||
129161898|NCT02455336|464887003|FG001|Overall Study|Non-responder to treatment|0|||
129161899|NCT00391430|464887004|FG000|Overall Study|Withdrawal by Subject|3|||
129161900|NCT00391430|464887005|FG001|Overall Study|Withdrawal by Subject|0|||
129161901|NCT00391430|464887006|FG002|Overall Study|Withdrawal by Subject|12|||
129161902|NCT01814046|464887010|FG000|Drug Administration|Death due to complications of RSV|1|||
129161903|NCT01814046|464887011|FG001|Drug Administration|Death due to complications of RSV|0|||
129161904|NCT01814046|464887012|FG002|Drug Administration|Death due to complications of RSV|0|||
129161905|NCT00958347|464887013|FG000|Overall Study|Death|43|||
129161906|NCT00958347|464887013|FG000|Overall Study|Withdrawal by Subject|23|||
129161907|NCT00958347|464887013|FG000|Overall Study|Lost to Follow-up|15|||
129161908|NCT00958347|464887013|FG000|Overall Study|revision/removal|10|||
128726248|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
129161909|NCT00958347|464887013|FG000|Overall Study|study termination|135|||
129161910|NCT03146663|464887016|FG000|Overall Study|Did not receive study treatment|1|||
129161911|NCT03146663|464887017|FG001|Overall Study|Did not receive study treatment|1|||
129161912|NCT02311881|464887043|FG000|Overall Study|Did not meet the study criteria|2|||
129161913|NCT02311881|464887044|FG001|Overall Study|Did not meet the study criteria|2|||
129161914|NCT02311881|464887045|FG002|Overall Study|Did not meet the study criteria|0|||
129161915|NCT02311881|464887043|FG000|Overall Study|Adverse Event|7|||
129161916|NCT02311881|464887044|FG001|Overall Study|Adverse Event|15|||
129161917|NCT02311881|464887045|FG002|Overall Study|Adverse Event|8|||
129161918|NCT02311881|464887043|FG000|Overall Study|Lost to Follow-up|3|||
129161919|NCT02311881|464887044|FG001|Overall Study|Lost to Follow-up|3|||
129161920|NCT02311881|464887045|FG002|Overall Study|Lost to Follow-up|2|||
129161921|NCT02311881|464887043|FG000|Overall Study|Protocol Violation|1|||
129161922|NCT02311881|464887044|FG001|Overall Study|Protocol Violation|2|||
129161923|NCT02311881|464887045|FG002|Overall Study|Protocol Violation|3|||
129161924|NCT02311881|464887043|FG000|Overall Study|Withdrawal of consent|14|||
129161925|NCT02311881|464887044|FG001|Overall Study|Withdrawal of consent|16|||
129161926|NCT02311881|464887045|FG002|Overall Study|Withdrawal of consent|17|||
129161927|NCT02311881|464887043|FG000|Overall Study|Other|0|||
129161928|NCT02311881|464887044|FG001|Overall Study|Other|0|||
129161929|NCT02311881|464887045|FG002|Overall Study|Other|1|||
129161930|NCT02311881|464887043|FG000|Overall Study|Lack of Efficacy|1|||
129161931|NCT02311881|464887044|FG001|Overall Study|Lack of Efficacy|2|||
129161932|NCT02311881|464887045|FG002|Overall Study|Lack of Efficacy|0|||
129161933|NCT02311881|464887043|FG000|Overall Study|Subject has border line pregnancy test|1|||
129161934|NCT02311881|464887044|FG001|Overall Study|Subject has border line pregnancy test|0|||
129161935|NCT02311881|464887045|FG002|Overall Study|Subject has border line pregnancy test|0|||
129161936|NCT02311881|464887043|FG000|Overall Study|Withdrawal by Subject|3|||
129161937|NCT02311881|464887044|FG001|Overall Study|Withdrawal by Subject|1|||
129161938|NCT02311881|464887045|FG002|Overall Study|Withdrawal by Subject|4|||
129161939|NCT02311881|464887043|FG000|Overall Study|Sponsor Decision|1|||
129161940|NCT02311881|464887044|FG001|Overall Study|Sponsor Decision|1|||
128726249|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
128726250|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
128726251|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
128726252|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
128726253|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
128726254|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
128726255|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
128726256|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
128726257|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
128726258|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
128726259|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
128726260|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
128726261|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
128726262|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Death|5|||
128726263|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Death|0|||
128726264|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Death|2|||
128726265|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Death|0|||
128726266|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Death|4|||
128776912|NCT01628510|463472043|FG000|Overall Study|Withdrawal by Subject|0|||
128776913|NCT01628510|463472044|FG001|Overall Study|Withdrawal by Subject|4|||
128776914|NCT01628510|463472043|FG000|Overall Study|Death|3|||
128776915|NCT01628510|463472044|FG001|Overall Study|Death|1|||
129161941|NCT02311881|464887045|FG002|Overall Study|Sponsor Decision|1|||
129161942|NCT02311881|464887043|FG000|Overall Study|Protocol Deviation|1|||
129161943|NCT02311881|464887044|FG001|Overall Study|Protocol Deviation|0|||
129161944|NCT02311881|464887045|FG002|Overall Study|Protocol Deviation|0|||
129161945|NCT02311881|464887043|FG000|Overall Study|Non-Compliance|1|||
129161946|NCT02311881|464887044|FG001|Overall Study|Non-Compliance|0|||
129161947|NCT02311881|464887045|FG002|Overall Study|Non-Compliance|2|||
129161948|NCT02311881|464887043|FG000|Overall Study|Physician Decision|0|||
129161949|NCT02311881|464887044|FG001|Overall Study|Physician Decision|0|||
129161950|NCT02311881|464887045|FG002|Overall Study|Physician Decision|1|||
129161951|NCT02311881|464887043|FG000|Overall Study|Medical Monitor Discretion|0|||
129161952|NCT02311881|464887044|FG001|Overall Study|Medical Monitor Discretion|0|||
129161953|NCT02311881|464887045|FG002|Overall Study|Medical Monitor Discretion|1|||
129161954|NCT02311881|464887043|FG000|Overall Study|Participant taking another medication|0|||
129161955|NCT02311881|464887044|FG001|Overall Study|Participant taking another medication|0|||
129161956|NCT02311881|464887045|FG002|Overall Study|Participant taking another medication|1|||
129161957|NCT02311881|464887043|FG000|Overall Study|Serious Adverse Event|0|||
129161958|NCT02311881|464887044|FG001|Overall Study|Serious Adverse Event|1|||
129161959|NCT02311881|464887045|FG002|Overall Study|Serious Adverse Event|0|||
129161960|NCT00819156|464887046|FG000|Overall Study|Adverse Event|1|||
129161961|NCT00819156|464887047|FG001|Overall Study|Adverse Event|4|||
129161962|NCT00819156|464887048|FG002|Overall Study|Adverse Event|2|||
129161963|NCT00819156|464887049|FG003|Overall Study|Adverse Event|1|||
129161964|NCT00819156|464887050|FG004|Overall Study|Adverse Event|2|||
129161965|NCT00819156|464887051|FG005|Overall Study|Adverse Event|3|||
129161966|NCT00819156|464887046|FG000|Overall Study|Withdrawal by Subject|0|||
129161967|NCT00819156|464887047|FG001|Overall Study|Withdrawal by Subject|3|||
129161968|NCT00819156|464887048|FG002|Overall Study|Withdrawal by Subject|2|||
129161969|NCT00819156|464887049|FG003|Overall Study|Withdrawal by Subject|0|||
129161970|NCT00819156|464887050|FG004|Overall Study|Withdrawal by Subject|1|||
129161971|NCT00819156|464887051|FG005|Overall Study|Withdrawal by Subject|0|||
129161972|NCT00819156|464887046|FG000|Overall Study|Protocol Violation|1|||
129161973|NCT00819156|464887047|FG001|Overall Study|Protocol Violation|0|||
129161974|NCT00819156|464887048|FG002|Overall Study|Protocol Violation|1|||
129161975|NCT00819156|464887049|FG003|Overall Study|Protocol Violation|0|||
129161976|NCT00819156|464887050|FG004|Overall Study|Protocol Violation|0|||
129161977|NCT00819156|464887051|FG005|Overall Study|Protocol Violation|1|||
129161978|NCT00819156|464887046|FG000|Overall Study|Lost to Follow-up|0|||
129161979|NCT00819156|464887047|FG001|Overall Study|Lost to Follow-up|1|||
129161980|NCT00819156|464887048|FG002|Overall Study|Lost to Follow-up|0|||
129161981|NCT00819156|464887049|FG003|Overall Study|Lost to Follow-up|0|||
129161982|NCT00819156|464887050|FG004|Overall Study|Lost to Follow-up|0|||
129161983|NCT00819156|464887051|FG005|Overall Study|Lost to Follow-up|2|||
129161984|NCT00819156|464887046|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
129161985|NCT00819156|464887047|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
129161986|NCT00819156|464887048|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
129161987|NCT00819156|464887049|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
129161988|NCT00819156|464887050|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
129161989|NCT00819156|464887051|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
129161990|NCT00819156|464887046|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
129161991|NCT00819156|464887047|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129161992|NCT00819156|464887048|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129161993|NCT00819156|464887049|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129161994|NCT00819156|464887050|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
129161995|NCT00819156|464887051|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129161996|NCT00819156|464887046|FG000|Overall Study|Prostate-specific antigen progression|0|||
129161997|NCT00819156|464887047|FG001|Overall Study|Prostate-specific antigen progression|0|||
129161998|NCT00819156|464887048|FG002|Overall Study|Prostate-specific antigen progression|0|||
129161999|NCT00819156|464887049|FG003|Overall Study|Prostate-specific antigen progression|0|||
129162000|NCT00819156|464887050|FG004|Overall Study|Prostate-specific antigen progression|1|||
129162001|NCT00819156|464887051|FG005|Overall Study|Prostate-specific antigen progression|0|||
129162002|NCT00803595|464887052|FG000|Overall Study|Adverse Event|3|||
129162003|NCT00803595|464887053|FG001|Overall Study|Adverse Event|4|||
129162004|NCT00803595|464887054|FG002|Overall Study|Adverse Event|1|||
129162005|NCT00803595|464887052|FG000|Overall Study|Protocol Violation|7|||
129162006|NCT00803595|464887053|FG001|Overall Study|Protocol Violation|2|||
128726267|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
128726268|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
128726269|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
128726270|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
128726271|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
128726272|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
129162007|NCT00803595|464887054|FG002|Overall Study|Protocol Violation|12|||
129162008|NCT00803595|464887052|FG000|Overall Study|Withdrawal by Subject|5|||
129162009|NCT00803595|464887053|FG001|Overall Study|Withdrawal by Subject|2|||
129162010|NCT00803595|464887054|FG002|Overall Study|Withdrawal by Subject|3|||
129162011|NCT01575808|464887057|FG000|Overall Study|Death|2|||
129162012|NCT01575808|464887058|FG001|Overall Study|Death|0|||
129162013|NCT01575808|464887057|FG000|Overall Study|Withdrawal by Subject|1|||
129162014|NCT01575808|464887058|FG001|Overall Study|Withdrawal by Subject|0|||
129162015|NCT00294671|464888838|FG000|Overall Study|Lack of Efficacy|11|||
129162016|NCT00294671|464888839|FG001|Overall Study|Lack of Efficacy|23|||
129162017|NCT00294671|464888838|FG000|Overall Study|Liver transplant|7|||
129162018|NCT00294671|464888839|FG001|Overall Study|Liver transplant|9|||
129162019|NCT00294671|464888838|FG000|Overall Study|Drug related adverse event (AE)|4|||
129162020|NCT00294671|464888839|FG001|Overall Study|Drug related adverse event (AE)|2|||
129162021|NCT00294671|464888838|FG000|Overall Study|Non-drug related AE|3|||
129162022|NCT00294671|464888839|FG001|Overall Study|Non-drug related AE|2|||
129162023|NCT00294671|464888838|FG000|Overall Study|Lost to Follow-up|1|||
129162024|NCT00294671|464888839|FG001|Overall Study|Lost to Follow-up|3|||
129162025|NCT00294671|464888838|FG000|Overall Study|Non-compliance|1|||
129162026|NCT00294671|464888839|FG001|Overall Study|Non-compliance|0|||
129162027|NCT00294671|464888838|FG000|Overall Study|Death|0|||
129162028|NCT00294671|464888839|FG001|Overall Study|Death|1|||
129162029|NCT02263326|464888846|FG000|Overall Study|Lost to Follow-up|1|||
129162030|NCT02263326|464888847|FG001|Overall Study|Lost to Follow-up|1|||
129162031|NCT01893411|464888848|FG000|Overall Study|Protocol Violation|1|||
129162032|NCT01893411|464888849|FG001|Overall Study|Protocol Violation|0|||
129162033|NCT01893411|464888850|FG002|Overall Study|Protocol Violation|0|||
129162034|NCT01893411|464888848|FG000|Overall Study|Physician Decision|1|||
129162035|NCT01893411|464888849|FG001|Overall Study|Physician Decision|1|||
129162036|NCT01893411|464888850|FG002|Overall Study|Physician Decision|2|||
129162037|NCT01893411|464888848|FG000|Overall Study|Lack of Efficacy|2|||
129162038|NCT01893411|464888849|FG001|Overall Study|Lack of Efficacy|1|||
129162039|NCT01893411|464888850|FG002|Overall Study|Lack of Efficacy|0|||
129162040|NCT01893411|464888848|FG000|Overall Study|Other|3|||
129162041|NCT01893411|464888849|FG001|Overall Study|Other|1|||
129162042|NCT01893411|464888850|FG002|Overall Study|Other|3|||
129162043|NCT01893411|464888848|FG000|Overall Study|Adverse Event|1|||
129162044|NCT01893411|464888849|FG001|Overall Study|Adverse Event|0|||
129162045|NCT01893411|464888850|FG002|Overall Study|Adverse Event|0|||
129162046|NCT01893411|464888848|FG000|Overall Study|Withdrawal by Subject|7|||
129162047|NCT01893411|464888849|FG001|Overall Study|Withdrawal by Subject|4|||
129162048|NCT01893411|464888850|FG002|Overall Study|Withdrawal by Subject|3|||
129162049|NCT01893411|464888848|FG000|Overall Study|Lost to Follow-up|2|||
129162050|NCT01893411|464888849|FG001|Overall Study|Lost to Follow-up|0|||
129162051|NCT01893411|464888850|FG002|Overall Study|Lost to Follow-up|1|||
129162052|NCT02397915|464888851|FG000|Period 1|Protocol Violation|0|||
129162053|NCT02397915|464888852|FG001|Period 1|Protocol Violation|1|||
129162054|NCT02397915|464888853|FG002|Period 1|Protocol Violation|0|||
129162055|NCT02397915|464888854|FG003|Period 1|Protocol Violation|0|||
129162056|NCT02397915|464888851|FG000|Period 1|Physician Decision|1|||
129162057|NCT02397915|464888852|FG001|Period 1|Physician Decision|0|||
129162058|NCT02397915|464888853|FG002|Period 1|Physician Decision|0|||
129162059|NCT02397915|464888854|FG003|Period 1|Physician Decision|0|||
129162060|NCT03292874|464888855|FG000|Overall Study|Due to pandemic|5|||
129162061|NCT00933608|464888856|FG000|Overall Study|Adverse Event|4|||
129162062|NCT00933608|464888857|FG001|Overall Study|Adverse Event|2|||
129162063|NCT00933608|464888856|FG000|Overall Study|Physician Decision|1|||
129162064|NCT00933608|464888857|FG001|Overall Study|Physician Decision|0|||
129162065|NCT03053440|464888860|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
129162066|NCT03053440|464888861|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
129162067|NCT03053440|464888860|FG000|Overall Study|Death|18|||
129162068|NCT03053440|464888861|FG001|Overall Study|Death|14|||
129162069|NCT03053440|464888860|FG000|Overall Study|Withdrawal by Subject|9|||
129162070|NCT03053440|464888861|FG001|Overall Study|Withdrawal by Subject|8|||
129162071|NCT03053440|464888860|FG000|Overall Study|Lost to Follow-up|1|||
129162072|NCT03053440|464888861|FG001|Overall Study|Lost to Follow-up|0|||
129162073|NCT03053440|464888860|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
129162074|NCT03053440|464888861|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
129162075|NCT03053440|464888860|FG000|Overall Study|Physician Decision|2|||
129162076|NCT03053440|464888861|FG001|Overall Study|Physician Decision|1|||
129162077|NCT03053440|464888860|FG000|Overall Study|Participant Randomized but died before dosing|1|||
129162078|NCT03053440|464888861|FG001|Overall Study|Participant Randomized but died before dosing|0|||
128776916|NCT04179461|463472045|FG000|Overall Study|Lost to Follow-up|4|||
129162079|NCT04908384|464888862|FG000|Overall Study|Lost to Follow-up|4|||
129162080|NCT04908384|464888863|FG001|Overall Study|Lost to Follow-up|4|||
129162081|NCT04908384|464888864|FG002|Overall Study|Lost to Follow-up|0|||
129162082|NCT04908384|464888865|FG003|Overall Study|Lost to Follow-up|0|||
129162083|NCT00430989|464888866|FG000|Overall Study|Lost to Follow-up|2|||
129162084|NCT00430989|464888867|FG001|Overall Study|Lost to Follow-up|3|||
129162085|NCT00430989|464888866|FG000|Overall Study|Withdrawal by Subject|15|||
129162086|NCT00430989|464888867|FG001|Overall Study|Withdrawal by Subject|14|||
129162087|NCT00430989|464888866|FG000|Overall Study|Protocol Violation|30|||
129162088|NCT00430989|464888867|FG001|Overall Study|Protocol Violation|37|||
129162089|NCT00430989|464888866|FG000|Overall Study|Not eligible|13|||
129162090|NCT00430989|464888867|FG001|Overall Study|Not eligible|6|||
129162091|NCT01642901|464888868|FG000|12-month Follow-up|Withdrawal by Subject|1|||
129162092|NCT01642901|464888869|FG001|12-month Follow-up|Withdrawal by Subject|0|||
129162093|NCT00485758|464888876|FG000|Overall Study|Adverse Event|102|||
129162094|NCT00485758|464888877|FG001|Overall Study|Adverse Event|31|||
129162095|NCT00485758|464888876|FG000|Overall Study|Death|0|||
129162096|NCT00485758|464888877|FG001|Overall Study|Death|1|||
129162097|NCT00485758|464888876|FG000|Overall Study|Lost to Follow-up|5|||
128776917|NCT01653847|463472046|FG000|Overall Study|Withdrawal by Subject|1|||
128776918|NCT01653847|463472047|FG001|Overall Study|Withdrawal by Subject|0|||
128776919|NCT04707391|463472048|FG000|Overall Study|Adverse Event|5|||
128776920|NCT04707391|463472049|FG001|Overall Study|Adverse Event|8|||
128776921|NCT04707391|463472048|FG000|Overall Study|Lost to Follow-up|44|||
129162098|NCT00485758|464888877|FG001|Overall Study|Lost to Follow-up|1|||
129162099|NCT00485758|464888876|FG000|Overall Study|Physician Decision|3|||
129162100|NCT00485758|464888877|FG001|Overall Study|Physician Decision|3|||
129162101|NCT00485758|464888876|FG000|Overall Study|Protocol Violation|11|||
129162102|NCT00485758|464888877|FG001|Overall Study|Protocol Violation|2|||
129162103|NCT00485758|464888876|FG000|Overall Study|Withdrawal by Subject|32|||
129162104|NCT00485758|464888877|FG001|Overall Study|Withdrawal by Subject|27|||
129162105|NCT00485758|464888876|FG000|Overall Study|Study Terminated by Sponsor|3|||
129162106|NCT00485758|464888877|FG001|Overall Study|Study Terminated by Sponsor|0|||
129162107|NCT04551963|464888878|FG000|Overall Study|Physician Decision|1|||
129162108|NCT04551963|464888879|FG001|Overall Study|Physician Decision|1|||
129162109|NCT04551963|464888878|FG000|Overall Study|Death|1|||
129162110|NCT04551963|464888879|FG001|Overall Study|Death|0|||
129162111|NCT03379259|464888880|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
129162112|NCT03379259|464888881|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
129162113|NCT03379259|464888882|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
129162114|NCT03379259|464888883|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
129162115|NCT03379259|464888884|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
129162116|NCT03379259|464888885|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
129162117|NCT03379259|464888880|FG000|Overall Study|Death|0|||
129162118|NCT03379259|464888881|FG001|Overall Study|Death|1|||
129162119|NCT03379259|464888882|FG002|Overall Study|Death|2|||
129162120|NCT03379259|464888883|FG003|Overall Study|Death|1|||
129162121|NCT03379259|464888884|FG004|Overall Study|Death|4|||
129162122|NCT03379259|464888885|FG005|Overall Study|Death|2|||
129162123|NCT03379259|464888880|FG000|Overall Study|Withdrawal by Subject|0|||
129162124|NCT03379259|464888881|FG001|Overall Study|Withdrawal by Subject|0|||
129162125|NCT03379259|464888882|FG002|Overall Study|Withdrawal by Subject|1|||
129162126|NCT03379259|464888883|FG003|Overall Study|Withdrawal by Subject|0|||
129162127|NCT03379259|464888884|FG004|Overall Study|Withdrawal by Subject|2|||
129162128|NCT03379259|464888885|FG005|Overall Study|Withdrawal by Subject|0|||
129162129|NCT03379259|464888880|FG000|Overall Study|Study terminated by sponsor|0|||
129162130|NCT03379259|464888881|FG001|Overall Study|Study terminated by sponsor|0|||
129162131|NCT03379259|464888882|FG002|Overall Study|Study terminated by sponsor|0|||
129162132|NCT03379259|464888883|FG003|Overall Study|Study terminated by sponsor|1|||
129162133|NCT03379259|464888884|FG004|Overall Study|Study terminated by sponsor|1|||
129162134|NCT03379259|464888885|FG005|Overall Study|Study terminated by sponsor|4|||
129162135|NCT03379259|464888880|FG000|Overall Study|Disease progression|0|||
129162136|NCT03379259|464888881|FG001|Overall Study|Disease progression|0|||
129162137|NCT03379259|464888882|FG002|Overall Study|Disease progression|0|||
129162138|NCT03379259|464888883|FG003|Overall Study|Disease progression|1|||
129162139|NCT03379259|464888884|FG004|Overall Study|Disease progression|0|||
129162140|NCT03379259|464888885|FG005|Overall Study|Disease progression|1|||
129162141|NCT03379259|464888880|FG000|Overall Study|Lost to Follow-up|0|||
129162142|NCT03379259|464888881|FG001|Overall Study|Lost to Follow-up|0|||
129162143|NCT03379259|464888882|FG002|Overall Study|Lost to Follow-up|0|||
129162144|NCT03379259|464888883|FG003|Overall Study|Lost to Follow-up|0|||
129162145|NCT03379259|464888884|FG004|Overall Study|Lost to Follow-up|1|||
129162146|NCT03379259|464888885|FG005|Overall Study|Lost to Follow-up|0|||
129162147|NCT03379259|464888880|FG000|Overall Study|Deteriorating condition|0|||
129162148|NCT03379259|464888881|FG001|Overall Study|Deteriorating condition|0|||
129162149|NCT03379259|464888882|FG002|Overall Study|Deteriorating condition|0|||
129162150|NCT03379259|464888883|FG003|Overall Study|Deteriorating condition|0|||
128776922|NCT04707391|463472049|FG001|Overall Study|Lost to Follow-up|31|||
128776923|NCT04707391|463472048|FG000|Overall Study|Protocol Violation|1|||
128776924|NCT04707391|463472049|FG001|Overall Study|Protocol Violation|5|||
129162151|NCT03379259|464888884|FG004|Overall Study|Deteriorating condition|1|||
129162152|NCT03379259|464888885|FG005|Overall Study|Deteriorating condition|0|||
129162153|NCT00700622|464888886|FG000|Overall Study|Adverse Event|4|||
129162154|NCT00700622|464888887|FG001|Overall Study|Adverse Event|0|||
129162155|NCT00700622|464888886|FG000|Overall Study|Lost to Follow-up|0|||
129162156|NCT00700622|464888887|FG001|Overall Study|Lost to Follow-up|1|||
129162157|NCT00700622|464888886|FG000|Overall Study|Physician Decision|2|||
129162158|NCT00700622|464888887|FG001|Overall Study|Physician Decision|1|||
129162159|NCT00700622|464888886|FG000|Overall Study|Protocol Violation|0|||
129162160|NCT00700622|464888887|FG001|Overall Study|Protocol Violation|1|||
129162161|NCT00700622|464888886|FG000|Overall Study|Withdrawal by Subject|4|||
129162162|NCT00700622|464888887|FG001|Overall Study|Withdrawal by Subject|1|||
129162163|NCT00700622|464888886|FG000|Overall Study|Other|3|||
129162164|NCT00700622|464888887|FG001|Overall Study|Other|1|||
129162165|NCT00383331|464888888|FG000|Overall Study|Protocol Violation|0|||
129162166|NCT00383331|464888889|FG001|Overall Study|Protocol Violation|1|||
129162167|NCT00375427|464888890|FG000|Overall Study|Adverse Event|21|||
129162168|NCT00375427|464888891|FG001|Overall Study|Adverse Event|27|||
129162169|NCT00375427|464888890|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129162170|NCT00375427|464888891|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129162171|NCT00375427|464888890|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129162172|NCT00375427|464888891|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129162173|NCT00375427|464888890|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129162174|NCT00375427|464888891|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129162175|NCT00375427|464888890|FG000|Overall Study|Patient no longer requires study drug|3|||
129162176|NCT00375427|464888891|FG001|Overall Study|Patient no longer requires study drug|7|||
129162177|NCT00375427|464888890|FG000|Overall Study|Protocol Violation|10|||
129162178|NCT00375427|464888891|FG001|Overall Study|Protocol Violation|8|||
129162179|NCT00375427|464888890|FG000|Overall Study|Withdrawal by Subject|9|||
129162180|NCT00375427|464888891|FG001|Overall Study|Withdrawal by Subject|13|||
129162181|NCT00375427|464888890|FG000|Overall Study|Lost to Follow-up|1|||
129162182|NCT00375427|464888891|FG001|Overall Study|Lost to Follow-up|1|||
129162183|NCT00375427|464888890|FG000|Overall Study|Administrative reasons|0|||
129162184|NCT00375427|464888891|FG001|Overall Study|Administrative reasons|1|||
129162185|NCT00375427|464888890|FG000|Overall Study|Death|11|||
129162186|NCT00375427|464888891|FG001|Overall Study|Death|10|||
129162187|NCT03850093|464888892|FG000|Overall Study|Withdrawal by Subject|1|||
129162188|NCT03850093|464888893|FG001|Overall Study|Withdrawal by Subject|0|||
129162189|NCT03850093|464888894|FG002|Overall Study|Withdrawal by Subject|2|||
129162190|NCT03226249|464888900|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
129162191|NCT03226249|464888900|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
129162192|NCT03226249|464888900|FG000|Survival Follow-up|Patients still in follow-up.|30|||
129162193|NCT01532921|464888901|FG000|Overall Study|Death|3|||
129162194|NCT01532921|464888901|FG000|Overall Study|Withdrawal by Subject|2|||
129162195|NCT01532921|464888901|FG000|Overall Study|Lost to Follow-up|3|||
129162196|NCT01532921|464888901|FG000|Overall Study|Physician Decision|7|||
129162197|NCT01532921|464888901|FG000|Overall Study|Device was explanted during procedure|1|||
129162198|NCT00070109|464888902|FG000|Overall Study|Death|1|||
129162199|NCT00070109|464888903|FG001|Overall Study|Death|1|||
129162200|NCT00070109|464888904|FG002|Overall Study|Death|0|||
129162201|NCT00070109|464888905|FG003|Overall Study|Death|0|||
129162202|NCT00070109|464888906|FG004|Overall Study|Death|1|||
129162203|NCT00070109|464888902|FG000|Overall Study|Lack of Efficacy|6|||
129162204|NCT00070109|464888903|FG001|Overall Study|Lack of Efficacy|4|||
129162205|NCT00070109|464888904|FG002|Overall Study|Lack of Efficacy|5|||
129162206|NCT00070109|464888905|FG003|Overall Study|Lack of Efficacy|15|||
129162207|NCT00070109|464888906|FG004|Overall Study|Lack of Efficacy|5|||
129162208|NCT00070109|464888902|FG000|Overall Study|Physician Decision|1|||
129162209|NCT00070109|464888903|FG001|Overall Study|Physician Decision|0|||
129162210|NCT00070109|464888904|FG002|Overall Study|Physician Decision|0|||
129162211|NCT00070109|464888905|FG003|Overall Study|Physician Decision|0|||
129162212|NCT00070109|464888906|FG004|Overall Study|Physician Decision|0|||
129162213|NCT00070109|464888902|FG000|Overall Study|Withdrawal by Subject|0|||
129162214|NCT00070109|464888903|FG001|Overall Study|Withdrawal by Subject|1|||
129162215|NCT00070109|464888904|FG002|Overall Study|Withdrawal by Subject|1|||
129162216|NCT00070109|464888905|FG003|Overall Study|Withdrawal by Subject|0|||
129162217|NCT00070109|464888906|FG004|Overall Study|Withdrawal by Subject|0|||
129162218|NCT00070109|464888902|FG000|Overall Study|Adverse Event|0|||
129162219|NCT00070109|464888903|FG001|Overall Study|Adverse Event|0|||
129162220|NCT00070109|464888904|FG002|Overall Study|Adverse Event|2|||
129162221|NCT00070109|464888905|FG003|Overall Study|Adverse Event|4|||
129162222|NCT00070109|464888906|FG004|Overall Study|Adverse Event|2|||
129162223|NCT00070109|464888902|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
129162224|NCT00070109|464888903|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
129162225|NCT00070109|464888904|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
129162226|NCT00070109|464888905|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
129162227|NCT00070109|464888906|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
129162228|NCT00624468|464888909|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
129162229|NCT00624468|464888910|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
129162230|NCT00624468|464888911|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
129162231|NCT00624468|464888912|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
129162232|NCT00624468|464888909|FG000|Double-blind Period|Withdrew Prematurely|1|||
129162233|NCT00624468|464888910|FG001|Double-blind Period|Withdrew Prematurely|1|||
129162234|NCT00624468|464888911|FG002|Double-blind Period|Withdrew Prematurely|0|||
129162235|NCT00624468|464888912|FG003|Double-blind Period|Withdrew Prematurely|0|||
129162236|NCT00624468|464888909|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
129162237|NCT00624468|464888910|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
129162238|NCT00624468|464888911|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
129162239|NCT00624468|464888912|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
129162240|NCT00624468|464888909|FG000|Safety Follow-up (SFU) Period|Other|0|||
129162241|NCT00624468|464888910|FG001|Safety Follow-up (SFU) Period|Other|0|||
129162242|NCT00624468|464888911|FG002|Safety Follow-up (SFU) Period|Other|1|||
129162243|NCT00624468|464888912|FG003|Safety Follow-up (SFU) Period|Other|1|||
129162244|NCT01703091|464888915|FG000|Overall Study|Adverse Event|5|||
129162245|NCT01703091|464888916|FG001|Overall Study|Adverse Event|3|||
129162246|NCT01703091|464888915|FG000|Overall Study|Physician Decision|2|||
129162247|NCT01703091|464888916|FG001|Overall Study|Physician Decision|1|||
129162248|NCT01703091|464888915|FG000|Overall Study|Withdrawal by Subject|1|||
129162249|NCT01703091|464888916|FG001|Overall Study|Withdrawal by Subject|0|||
129162250|NCT01703091|464888915|FG000|Overall Study|Sponsor Decision|1|||
129162251|NCT01703091|464888916|FG001|Overall Study|Sponsor Decision|0|||
129162252|NCT02550288|464888917|FG000|Overall Study|Adverse Event|0|||
129162253|NCT02550288|464888918|FG001|Overall Study|Adverse Event|1|||
129162254|NCT02550288|464888919|FG002|Overall Study|Adverse Event|0|||
129162255|NCT02550288|464888920|FG003|Overall Study|Adverse Event|0|||
129162256|NCT02550288|464888921|FG004|Overall Study|Adverse Event|0|||
129162257|NCT02550288|464888917|FG000|Overall Study|Physician Decision|0|||
129162258|NCT02550288|464888918|FG001|Overall Study|Physician Decision|0|||
129162259|NCT02550288|464888919|FG002|Overall Study|Physician Decision|0|||
129162260|NCT02550288|464888920|FG003|Overall Study|Physician Decision|1|||
129162261|NCT02550288|464888921|FG004|Overall Study|Physician Decision|0|||
129162262|NCT02550288|464888917|FG000|Overall Study|Protocol Violation|2|||
129162263|NCT02550288|464888918|FG001|Overall Study|Protocol Violation|2|||
129162264|NCT02550288|464888919|FG002|Overall Study|Protocol Violation|1|||
129162265|NCT02550288|464888920|FG003|Overall Study|Protocol Violation|0|||
129162266|NCT02550288|464888921|FG004|Overall Study|Protocol Violation|3|||
129162267|NCT02550288|464888917|FG000|Overall Study|Participant moved|0|||
129162268|NCT02550288|464888918|FG001|Overall Study|Participant moved|0|||
129162269|NCT02550288|464888919|FG002|Overall Study|Participant moved|0|||
129162270|NCT02550288|464888920|FG003|Overall Study|Participant moved|1|||
129162271|NCT02550288|464888921|FG004|Overall Study|Participant moved|0|||
129162272|NCT02550288|464888917|FG000|Overall Study|Withdrawal by Subject|0|||
129162273|NCT02550288|464888918|FG001|Overall Study|Withdrawal by Subject|0|||
129162274|NCT02550288|464888919|FG002|Overall Study|Withdrawal by Subject|0|||
129162275|NCT02550288|464888920|FG003|Overall Study|Withdrawal by Subject|1|||
129162276|NCT02550288|464888921|FG004|Overall Study|Withdrawal by Subject|0|||
129162277|NCT00803361|464888923|FG000|Overall Study|Adverse Event|13|||
129162278|NCT00803361|464888924|FG001|Overall Study|Adverse Event|3|||
129162279|NCT00803361|464888923|FG000|Overall Study|Lack of Efficacy|4|||
129162280|NCT00803361|464888924|FG001|Overall Study|Lack of Efficacy|13|||
129162281|NCT00803361|464888923|FG000|Overall Study|Lost to Follow-up|1|||
129162282|NCT00803361|464888924|FG001|Overall Study|Lost to Follow-up|2|||
129162283|NCT00803361|464888923|FG000|Overall Study|Physician Decision|1|||
129162284|NCT00803361|464888924|FG001|Overall Study|Physician Decision|0|||
129162285|NCT00803361|464888923|FG000|Overall Study|Protocol Violation|2|||
129162286|NCT00803361|464888924|FG001|Overall Study|Protocol Violation|4|||
129162287|NCT00803361|464888923|FG000|Overall Study|Withdrawal by Subject|5|||
129162288|NCT00803361|464888924|FG001|Overall Study|Withdrawal by Subject|6|||
129162289|NCT03629223|464888925|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
129162290|NCT03629223|464888926|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
129162291|NCT03629223|464888927|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
129162292|NCT03629223|464888928|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
129162293|NCT03629223|464888929|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
129162294|NCT03629223|464888930|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
129162295|NCT03629223|464888925|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129162296|NCT03629223|464888926|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129162297|NCT03629223|464888927|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129162298|NCT03629223|464888928|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
129162299|NCT03629223|464888929|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129162300|NCT03629223|464888930|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129162301|NCT03629223|464888925|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129162302|NCT03629223|464888926|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
129162303|NCT03629223|464888927|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129162304|NCT03629223|464888928|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129162305|NCT03629223|464888929|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129162306|NCT03629223|464888930|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129162307|NCT03629223|464888925|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129162308|NCT03629223|464888926|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
129162309|NCT03629223|464888927|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129162310|NCT03629223|464888928|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129162311|NCT03629223|464888929|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129162312|NCT03629223|464888930|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129162313|NCT03629223|464888925|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
129162314|NCT03629223|464888926|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129162315|NCT03629223|464888927|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129162316|NCT03629223|464888928|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129162317|NCT03629223|464888929|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129162318|NCT03629223|464888930|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129162319|NCT01534351|464888931|FG000|Overall Study|Study Terminated Early|1|||
129162320|NCT01534351|464888932|FG001|Overall Study|Study Terminated Early|0|||
129162321|NCT01534351|464888933|FG002|Overall Study|Study Terminated Early|0|||
129162322|NCT02702609|464888934|FG000|Overall Study|Lost to Follow-up|8|||
129162323|NCT02702609|464888935|FG001|Overall Study|Lost to Follow-up|4|||
129162324|NCT02702609|464888934|FG000|Overall Study|Physician Decision|1|||
129162325|NCT02702609|464888935|FG001|Overall Study|Physician Decision|0|||
129162326|NCT02674464|464888936|FG000|Overall Study|Death|10|||
129162327|NCT02674464|464888937|FG001|Overall Study|Death|21|||
129162328|NCT02674464|464888936|FG000|Overall Study|Withdrawal by Subject|24|||
129162329|NCT02674464|464888937|FG001|Overall Study|Withdrawal by Subject|44|||
129162330|NCT02674464|464888936|FG000|Overall Study|Lost to Follow-up|97|||
129162331|NCT02674464|464888937|FG001|Overall Study|Lost to Follow-up|92|||
129162332|NCT02674464|464888936|FG000|Overall Study|Outside survey window|6|||
129162333|NCT02674464|464888937|FG001|Overall Study|Outside survey window|3|||
129162334|NCT00783835|464888938|FG000|Overall Study|Adverse Event|3|||
129162335|NCT00783835|464888938|FG000|Overall Study|Medical Criteria|1|||
129162336|NCT00783835|464888938|FG000|Overall Study|Withdrawal by Subject|2|||
129162337|NCT00783835|464888938|FG000|Overall Study|Lost to Follow-up|1|||
129162338|NCT00783835|464888938|FG000|Overall Study|Participant not Adherent|3|||
129162339|NCT03835481|464888939|FG000|Double-blind Period|Other not stated below|0|||
129162340|NCT03835481|464888940|FG001|Double-blind Period|Other not stated below|0|||
129162341|NCT03835481|464888941|FG002|Double-blind Period|Other not stated below|0|||
129162342|NCT03835481|464888942|FG003|Double-blind Period|Other not stated below|1|||
129162343|NCT03835481|464888943|FG004|Double-blind Period|Other not stated below|1|||
129162344|NCT03835481|464888939|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
129162345|NCT03835481|464888940|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
129162346|NCT03835481|464888941|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
129162347|NCT03835481|464888942|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
129162348|NCT03835481|464888943|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
129162349|NCT03835481|464888939|FG000|Double-blind Period|Withdrawal by Subject|0|||
129162350|NCT03835481|464888940|FG001|Double-blind Period|Withdrawal by Subject|0|||
129162351|NCT03835481|464888941|FG002|Double-blind Period|Withdrawal by Subject|1|||
129162352|NCT03835481|464888942|FG003|Double-blind Period|Withdrawal by Subject|0|||
129162353|NCT03835481|464888943|FG004|Double-blind Period|Withdrawal by Subject|5|||
129162354|NCT03835481|464888939|FG000|Double-blind Period|Lost to Follow-up|0|||
129162355|NCT03835481|464888940|FG001|Double-blind Period|Lost to Follow-up|0|||
129162356|NCT03835481|464888941|FG002|Double-blind Period|Lost to Follow-up|0|||
129162357|NCT03835481|464888942|FG003|Double-blind Period|Lost to Follow-up|1|||
129162358|NCT03835481|464888943|FG004|Double-blind Period|Lost to Follow-up|0|||
129162359|NCT03835481|464888939|FG000|Double-blind Period|Protocol Violation|0|||
129162360|NCT03835481|464888940|FG001|Double-blind Period|Protocol Violation|2|||
129162361|NCT03835481|464888941|FG002|Double-blind Period|Protocol Violation|0|||
129162362|NCT03835481|464888942|FG003|Double-blind Period|Protocol Violation|1|||
129162363|NCT03835481|464888943|FG004|Double-blind Period|Protocol Violation|0|||
129162364|NCT03835481|464888939|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
129162365|NCT03835481|464888940|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
129162366|NCT03835481|464888941|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
129162367|NCT03835481|464888942|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
129162368|NCT03835481|464888943|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
129162369|NCT03835481|464888939|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
129162370|NCT03835481|464888940|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
129162371|NCT03835481|464888941|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
129162372|NCT03835481|464888942|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
129162373|NCT03835481|464888943|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
129162374|NCT03835481|464888939|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
129162375|NCT03835481|464888940|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
129162376|NCT03835481|464888941|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
129162377|NCT03835481|464888942|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
129162378|NCT03835481|464888943|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
129162379|NCT03835481|464888939|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
129162380|NCT03835481|464888940|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
129162381|NCT03835481|464888941|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
129162382|NCT03835481|464888942|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
129162383|NCT03835481|464888943|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
129162384|NCT03835481|464888939|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129162385|NCT03835481|464888940|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129162386|NCT03835481|464888941|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129162387|NCT03835481|464888942|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
129162388|NCT03835481|464888943|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129162389|NCT03835481|464888939|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
129162390|NCT03835481|464888940|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
129162391|NCT03835481|464888941|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
129162392|NCT03835481|464888942|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
129162393|NCT03835481|464888943|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
129162394|NCT00255723|464888946|FG000|Overall Study|Adverse Event|1|||
129162395|NCT00255723|464888947|FG001|Overall Study|Adverse Event|1|||
129162396|NCT00255723|464888946|FG000|Overall Study|Death|0|||
129162397|NCT00255723|464888947|FG001|Overall Study|Death|1|||
129162398|NCT00255723|464888946|FG000|Overall Study|Response Data Not Available|1|||
129162399|NCT00255723|464888947|FG001|Overall Study|Response Data Not Available|0|||
129162400|NCT00191945|464888948|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
129162401|NCT00191945|464888949|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
129162402|NCT00191945|464888948|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
129162403|NCT00191945|464888949|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
129162404|NCT00191945|464888948|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
129162405|NCT00191945|464888949|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
129162406|NCT00191945|464888948|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
129162407|NCT00191945|464888949|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
129162408|NCT01169701|464888963|FG000|Overall Study|Lost to Follow-up|1|||
129162409|NCT01169701|464888964|FG001|Overall Study|Lost to Follow-up|1|||
129162410|NCT01169701|464888963|FG000|Overall Study|Withdrawal by Subject|1|||
129162411|NCT01169701|464888964|FG001|Overall Study|Withdrawal by Subject|3|||
129162412|NCT01169701|464888963|FG000|Overall Study|Adverse Event|1|||
129162413|NCT01169701|464888964|FG001|Overall Study|Adverse Event|2|||
129162414|NCT01169701|464888963|FG000|Overall Study|Exclusion criteria|2|||
129162415|NCT01169701|464888964|FG001|Overall Study|Exclusion criteria|0|||
129162416|NCT01169701|464888963|FG000|Overall Study|Death|0|||
129162417|NCT01169701|464888964|FG001|Overall Study|Death|1|||
129162418|NCT01169701|464888963|FG000|Overall Study|Administrative problems|0|||
129162419|NCT01169701|464888964|FG001|Overall Study|Administrative problems|1|||
129162420|NCT01169701|464888963|FG000|Overall Study|Serious adverse event|0|||
129162421|NCT01169701|464888964|FG001|Overall Study|Serious adverse event|1|||
129162422|NCT01169701|464888963|FG000|Overall Study|Sponsor decision|0|||
129162423|NCT01169701|464888964|FG001|Overall Study|Sponsor decision|1|||
129162424|NCT00564902|464888969|FG000|Overall Study|Withdrawal by Subject|0|||
129162425|NCT00564902|464888970|FG001|Overall Study|Withdrawal by Subject|3|||
129162426|NCT00564902|464888971|FG002|Overall Study|Withdrawal by Subject|4|||
129162427|NCT00564902|464888969|FG000|Overall Study|Death|1|||
129162428|NCT00564902|464888970|FG001|Overall Study|Death|1|||
129162429|NCT00564902|464888971|FG002|Overall Study|Death|0|||
129162430|NCT03583359|464888974|FG000|Overall Study|Withdrawal by Subject|15|||
129162431|NCT03583359|464888975|FG001|Overall Study|Withdrawal by Subject|6|||
129162432|NCT03583359|464888974|FG000|Overall Study|Lost to Follow-up|12|||
129162433|NCT03583359|464888975|FG001|Overall Study|Lost to Follow-up|3|||
129162434|NCT03583359|464888974|FG000|Overall Study|Adverse Event|0|||
129162435|NCT03583359|464888975|FG001|Overall Study|Adverse Event|1|||
129162436|NCT03583359|464888974|FG000|Overall Study|Protocol Violation|0|||
129162437|NCT03583359|464888975|FG001|Overall Study|Protocol Violation|1|||
129162438|NCT03583359|464888974|FG000|Overall Study|Other|2|||
129162439|NCT03583359|464888975|FG001|Overall Study|Other|1|||
129162440|NCT00375505|464888976|FG000|Overall Study|Adverse Event|1|||
129162441|NCT00375505|464888977|FG001|Overall Study|Adverse Event|2|||
129162442|NCT01831466|464888978|FG000|Overall Study|Protocol Violation|1|||
129162443|NCT01831466|464888979|FG001|Overall Study|Protocol Violation|1|||
129162444|NCT01831466|464888980|FG002|Overall Study|Protocol Violation|2|||
129162445|NCT01831466|464888981|FG003|Overall Study|Protocol Violation|0|||
129162446|NCT01831466|464888982|FG004|Overall Study|Protocol Violation|0|||
129162447|NCT01831466|464888983|FG005|Overall Study|Protocol Violation|1|||
129162448|NCT01831466|464888984|FG006|Overall Study|Protocol Violation|0|||
129162449|NCT01831466|464888985|FG007|Overall Study|Protocol Violation|0|||
129162450|NCT01831466|464888986|FG008|Overall Study|Protocol Violation|0|||
129162451|NCT01831466|464888987|FG009|Overall Study|Protocol Violation|0|||
129162452|NCT01831466|464888988|FG010|Overall Study|Protocol Violation|0|||
129162453|NCT01831466|464888989|FG011|Overall Study|Protocol Violation|0|||
129162454|NCT01831466|464888978|FG000|Overall Study|Other|2|||
129162455|NCT01831466|464888979|FG001|Overall Study|Other|3|||
129162456|NCT01831466|464888980|FG002|Overall Study|Other|2|||
129162457|NCT01831466|464888981|FG003|Overall Study|Other|2|||
129162458|NCT01831466|464888982|FG004|Overall Study|Other|2|||
129162459|NCT01831466|464888983|FG005|Overall Study|Other|1|||
129162460|NCT01831466|464888984|FG006|Overall Study|Other|0|||
129162461|NCT01831466|464888985|FG007|Overall Study|Other|0|||
129162462|NCT01831466|464888986|FG008|Overall Study|Other|0|||
129162463|NCT01831466|464888987|FG009|Overall Study|Other|0|||
129162464|NCT01831466|464888988|FG010|Overall Study|Other|0|||
128726273|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
128726274|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
128726275|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
128726276|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
128726277|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
128726278|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
128726279|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
128726280|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
128726281|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
128726282|NCT01604343|463294790|FG000|Prior to W52 Administration(Through W52)|Other|15|||
128726283|NCT01604343|463294791|FG001|Prior to W52 Administration(Through W52)|Other|0|||
128726284|NCT01604343|463294792|FG002|Prior to W52 Administration(Through W52)|Other|10|||
128726285|NCT01604343|463294793|FG003|Prior to W52 Administration(Through W52)|Other|0|||
128726286|NCT01604343|463294794|FG004|Prior to W52 Administration(Through W52)|Other|6|||
128726287|NCT01604343|463294790|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
128726288|NCT01604343|463294791|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
128726289|NCT01604343|463294792|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
128726290|NCT01604343|463294793|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
128726291|NCT01604343|463294794|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
128726292|NCT01604343|463294790|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
128726293|NCT01604343|463294791|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
128726294|NCT01604343|463294792|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
128726295|NCT01604343|463294793|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
128726296|NCT01604343|463294794|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
128726297|NCT01604343|463294790|FG000|Week 52 to Week 104|Adverse Event|0|||
128726298|NCT01604343|463294791|FG001|Week 52 to Week 104|Adverse Event|12|||
128726299|NCT01604343|463294792|FG002|Week 52 to Week 104|Adverse Event|26|||
128726300|NCT01604343|463294793|FG003|Week 52 to Week 104|Adverse Event|21|||
128726301|NCT01604343|463294794|FG004|Week 52 to Week 104|Adverse Event|27|||
128726302|NCT01604343|463294790|FG000|Week 52 to Week 104|Death|0|||
128726303|NCT01604343|463294791|FG001|Week 52 to Week 104|Death|4|||
128726304|NCT01604343|463294792|FG002|Week 52 to Week 104|Death|2|||
129162465|NCT01831466|464888989|FG011|Overall Study|Other|0|||
129162466|NCT01831466|464888978|FG000|Overall Study|Non-compliance with study treatment|2|||
129162467|NCT01831466|464888979|FG001|Overall Study|Non-compliance with study treatment|1|||
129162468|NCT01831466|464888980|FG002|Overall Study|Non-compliance with study treatment|1|||
129162469|NCT01831466|464888981|FG003|Overall Study|Non-compliance with study treatment|0|||
129162470|NCT01831466|464888982|FG004|Overall Study|Non-compliance with study treatment|0|||
129162471|NCT01831466|464888983|FG005|Overall Study|Non-compliance with study treatment|1|||
129162472|NCT01831466|464888984|FG006|Overall Study|Non-compliance with study treatment|0|||
129162473|NCT01831466|464888985|FG007|Overall Study|Non-compliance with study treatment|0|||
129162474|NCT01831466|464888986|FG008|Overall Study|Non-compliance with study treatment|0|||
129162475|NCT01831466|464888987|FG009|Overall Study|Non-compliance with study treatment|0|||
129162476|NCT01831466|464888988|FG010|Overall Study|Non-compliance with study treatment|0|||
129162477|NCT01831466|464888989|FG011|Overall Study|Non-compliance with study treatment|0|||
129162478|NCT01831466|464888978|FG000|Overall Study|Death|0|||
129162479|NCT01831466|464888979|FG001|Overall Study|Death|1|||
129162480|NCT01831466|464888980|FG002|Overall Study|Death|0|||
129162481|NCT01831466|464888981|FG003|Overall Study|Death|0|||
129162482|NCT01831466|464888982|FG004|Overall Study|Death|0|||
129162483|NCT01831466|464888983|FG005|Overall Study|Death|0|||
129162484|NCT01831466|464888984|FG006|Overall Study|Death|0|||
129162485|NCT01831466|464888985|FG007|Overall Study|Death|0|||
129162486|NCT01831466|464888986|FG008|Overall Study|Death|0|||
128726305|NCT01604343|463294793|FG003|Week 52 to Week 104|Death|5|||
128726306|NCT01604343|463294794|FG004|Week 52 to Week 104|Death|0|||
128726307|NCT01604343|463294790|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
129162487|NCT01831466|464888987|FG009|Overall Study|Death|0|||
129162488|NCT01831466|464888988|FG010|Overall Study|Death|0|||
129162489|NCT01831466|464888989|FG011|Overall Study|Death|0|||
129162490|NCT01831466|464888978|FG000|Overall Study|Withdrawal by Subject|6|||
128726308|NCT01604343|463294791|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
128726309|NCT01604343|463294792|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
129162491|NCT01831466|464888979|FG001|Overall Study|Withdrawal by Subject|3|||
129162492|NCT01831466|464888980|FG002|Overall Study|Withdrawal by Subject|3|||
129162493|NCT01831466|464888981|FG003|Overall Study|Withdrawal by Subject|3|||
129162494|NCT01831466|464888982|FG004|Overall Study|Withdrawal by Subject|3|||
128726310|NCT01604343|463294793|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
128726311|NCT01604343|463294794|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
129162495|NCT01831466|464888983|FG005|Overall Study|Withdrawal by Subject|5|||
129162496|NCT01831466|464888984|FG006|Overall Study|Withdrawal by Subject|0|||
129162497|NCT01831466|464888985|FG007|Overall Study|Withdrawal by Subject|0|||
129162498|NCT01831466|464888986|FG008|Overall Study|Withdrawal by Subject|0|||
129162499|NCT01831466|464888987|FG009|Overall Study|Withdrawal by Subject|1|||
129162500|NCT01831466|464888988|FG010|Overall Study|Withdrawal by Subject|0|||
129162501|NCT01831466|464888989|FG011|Overall Study|Withdrawal by Subject|1|||
129162502|NCT01831466|464888978|FG000|Overall Study|Lost to Follow-up|0|||
129162503|NCT01831466|464888979|FG001|Overall Study|Lost to Follow-up|1|||
129162504|NCT01831466|464888980|FG002|Overall Study|Lost to Follow-up|4|||
129162505|NCT01831466|464888981|FG003|Overall Study|Lost to Follow-up|2|||
129162506|NCT01831466|464888982|FG004|Overall Study|Lost to Follow-up|0|||
129162507|NCT01831466|464888983|FG005|Overall Study|Lost to Follow-up|3|||
129162508|NCT01831466|464888984|FG006|Overall Study|Lost to Follow-up|0|||
129162509|NCT01831466|464888985|FG007|Overall Study|Lost to Follow-up|0|||
129162510|NCT01831466|464888986|FG008|Overall Study|Lost to Follow-up|0|||
129162511|NCT01831466|464888987|FG009|Overall Study|Lost to Follow-up|1|||
129162512|NCT01831466|464888988|FG010|Overall Study|Lost to Follow-up|0|||
129162513|NCT01831466|464888989|FG011|Overall Study|Lost to Follow-up|1|||
129162514|NCT01831466|464888978|FG000|Overall Study|Lack of Efficacy|5|||
129162515|NCT01831466|464888979|FG001|Overall Study|Lack of Efficacy|8|||
129162516|NCT01831466|464888980|FG002|Overall Study|Lack of Efficacy|7|||
129162517|NCT01831466|464888981|FG003|Overall Study|Lack of Efficacy|6|||
129162518|NCT01831466|464888982|FG004|Overall Study|Lack of Efficacy|9|||
129162519|NCT01831466|464888983|FG005|Overall Study|Lack of Efficacy|8|||
129162520|NCT01831466|464888984|FG006|Overall Study|Lack of Efficacy|1|||
129162521|NCT01831466|464888985|FG007|Overall Study|Lack of Efficacy|1|||
129162522|NCT01831466|464888986|FG008|Overall Study|Lack of Efficacy|2|||
129162523|NCT01831466|464888987|FG009|Overall Study|Lack of Efficacy|2|||
129162524|NCT01831466|464888988|FG010|Overall Study|Lack of Efficacy|2|||
129162525|NCT01831466|464888989|FG011|Overall Study|Lack of Efficacy|0|||
129162526|NCT01831466|464888978|FG000|Overall Study|Adverse Event|0|||
129162527|NCT01831466|464888979|FG001|Overall Study|Adverse Event|0|||
129162528|NCT01831466|464888980|FG002|Overall Study|Adverse Event|4|||
129162529|NCT01831466|464888981|FG003|Overall Study|Adverse Event|6|||
129162530|NCT01831466|464888982|FG004|Overall Study|Adverse Event|3|||
129162531|NCT01831466|464888983|FG005|Overall Study|Adverse Event|7|||
129162532|NCT01831466|464888984|FG006|Overall Study|Adverse Event|0|||
129162533|NCT01831466|464888985|FG007|Overall Study|Adverse Event|1|||
129162534|NCT01831466|464888986|FG008|Overall Study|Adverse Event|1|||
129162535|NCT01831466|464888987|FG009|Overall Study|Adverse Event|1|||
129162536|NCT01831466|464888988|FG010|Overall Study|Adverse Event|0|||
129162537|NCT01831466|464888989|FG011|Overall Study|Adverse Event|2|||
129162538|NCT02470585|464888990|FG000|Overall Study|Death|224|||
129162539|NCT02470585|464888991|FG001|Overall Study|Death|227|||
129162540|NCT02470585|464888992|FG002|Overall Study|Death|199|||
129162541|NCT02470585|464888990|FG000|Overall Study|Withdrew consent|21|||
129162542|NCT02470585|464888991|FG001|Overall Study|Withdrew consent|22|||
129162543|NCT02470585|464888992|FG002|Overall Study|Withdrew consent|31|||
129162544|NCT02470585|464888990|FG000|Overall Study|Lost to Follow-up|8|||
129162545|NCT02470585|464888991|FG001|Overall Study|Lost to Follow-up|15|||
129162546|NCT02470585|464888992|FG002|Overall Study|Lost to Follow-up|13|||
129162547|NCT02470585|464888990|FG000|Overall Study|Sponsor discontinued study|117|||
129162548|NCT02470585|464888991|FG001|Overall Study|Sponsor discontinued study|110|||
129162549|NCT02470585|464888992|FG002|Overall Study|Sponsor discontinued study|122|||
129162550|NCT02470585|464888990|FG000|Overall Study|Other, not specified|5|||
129162551|NCT02470585|464888991|FG001|Overall Study|Other, not specified|7|||
129162552|NCT02470585|464888992|FG002|Overall Study|Other, not specified|14|||
129162553|NCT02470585|464888990|FG000|Overall Study|Missing due to site non-compliance|0|||
129162554|NCT02470585|464888991|FG001|Overall Study|Missing due to site non-compliance|2|||
129162555|NCT02470585|464888992|FG002|Overall Study|Missing due to site non-compliance|3|||
129162556|NCT03497039|464888993|FG000|Overall Study|Withdrawal by Subject|1|||
129162557|NCT03497039|464888994|FG001|Overall Study|Withdrawal by Subject|0|||
129162558|NCT03497039|464888993|FG000|Overall Study|Protocol Violation|0|||
129162559|NCT03497039|464888994|FG001|Overall Study|Protocol Violation|1|||
129162560|NCT02146131|464888995|FG000|Overall Study|Physician Decision|61|||
129162561|NCT02146131|464888996|FG001|Overall Study|Physician Decision|56|||
129162562|NCT00465972|464888999|FG000|Overall Study|Withdrawal by Subject|2|||
129162563|NCT00465972|464889000|FG001|Overall Study|Withdrawal by Subject|1|||
129162564|NCT00861692|464889001|FG000|Overall Study|Death|6|||
129162565|NCT03292640|464889002|FG000|Overall Study|Withdrawal by Subject|17|||
129162566|NCT03292640|464889003|FG001|Overall Study|Withdrawal by Subject|16|||
129162567|NCT03292640|464889002|FG000|Overall Study|Adverse Event|20|||
129162568|NCT03292640|464889003|FG001|Overall Study|Adverse Event|2|||
129162569|NCT03292640|464889002|FG000|Overall Study|Lost to Follow-up|24|||
129162570|NCT03292640|464889003|FG001|Overall Study|Lost to Follow-up|24|||
129162571|NCT02218697|464889004|FG000|Overall Study|Adverse Event|0|||
129162572|NCT02218697|464889005|FG001|Overall Study|Adverse Event|2|||
129162573|NCT02218697|464889004|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
129162574|NCT02218697|464889005|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
129162575|NCT02218697|464889004|FG000|Overall Study|Withdrawal by Subject|2|||
129162576|NCT02218697|464889005|FG001|Overall Study|Withdrawal by Subject|3|||
129162577|NCT04380753|464889006|FG000|Overall Study|Participants continuing study|4|||
129162578|NCT04380753|464889006|FG000|Overall Study|Death|2|||
129162579|NCT03306433|464889009|FG000|Overall Study|Lost to Follow-up|3|||
129162580|NCT03306433|464889009|FG000|Overall Study|Patient did not have teeth extracted|1|||
129162581|NCT03306433|464889009|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
129162582|NCT02403817|464890701|FG000|Overall Study|Withdrawal by Subject|5|||
129162583|NCT02403817|464890702|FG001|Overall Study|Withdrawal by Subject|0|||
129162584|NCT03050450|464890703|FG000|Overall Study|Physician Decision|1|||
129162585|NCT03050450|464890704|FG001|Overall Study|Physician Decision|0|||
129162586|NCT03050450|464890705|FG002|Overall Study|Physician Decision|0|||
129162587|NCT03050450|464890706|FG003|Overall Study|Physician Decision|0|||
129162588|NCT03050450|464890707|FG004|Overall Study|Physician Decision|0|||
129162589|NCT01701362|464890708|FG000|Overall Study|Adverse events not related to study drug|1|||
129162590|NCT01701362|464890709|FG001|Overall Study|Adverse events not related to study drug|6|||
129162591|NCT01701362|464890708|FG000|Overall Study|Adverse events related to study drug|12|||
129162592|NCT01701362|464890709|FG001|Overall Study|Adverse events related to study drug|10|||
129162593|NCT01701362|464890708|FG000|Overall Study|Protocol Violation|5|||
129162594|NCT01701362|464890709|FG001|Overall Study|Protocol Violation|3|||
129162595|NCT01701362|464890708|FG000|Overall Study|No longer willing to participate|8|||
129162596|NCT01701362|464890709|FG001|Overall Study|No longer willing to participate|14|||
129162597|NCT01701362|464890708|FG000|Overall Study|Lost to Follow-up|6|||
129162598|NCT01701362|464890709|FG001|Overall Study|Lost to Follow-up|9|||
129162599|NCT01701362|464890708|FG000|Overall Study|Insufficient clinical response|6|||
129162600|NCT01701362|464890709|FG001|Overall Study|Insufficient clinical response|6|||
129162601|NCT01701362|464890708|FG000|Overall Study|Death|0|||
129162602|NCT01701362|464890709|FG001|Overall Study|Death|1|||
129162603|NCT01701362|464890708|FG000|Overall Study|Randomized but not treated|1|||
129162604|NCT01701362|464890709|FG001|Overall Study|Randomized but not treated|2|||
129162605|NCT01701362|464890708|FG000|Overall Study|Reasons other than those mentioned above|3|||
129162606|NCT01701362|464890709|FG001|Overall Study|Reasons other than those mentioned above|5|||
129162607|NCT00570778|464890710|FG000|Overall Study|Protocol deviation|2|||
129162608|NCT00570778|464890711|FG001|Overall Study|Protocol deviation|1|||
129162609|NCT00570778|464890712|FG002|Overall Study|Protocol deviation|2|||
129162610|NCT00570778|464890713|FG003|Overall Study|Protocol deviation|2|||
129162611|NCT00570778|464890710|FG000|Overall Study|Adverse Event|0|||
129162612|NCT00570778|464890711|FG001|Overall Study|Adverse Event|1|||
129162613|NCT00570778|464890712|FG002|Overall Study|Adverse Event|4|||
129162614|NCT00570778|464890713|FG003|Overall Study|Adverse Event|1|||
129162615|NCT00570778|464890710|FG000|Overall Study|Subject withdrew consent|0|||
129162616|NCT00570778|464890711|FG001|Overall Study|Subject withdrew consent|1|||
129162617|NCT00570778|464890712|FG002|Overall Study|Subject withdrew consent|0|||
129162618|NCT00570778|464890713|FG003|Overall Study|Subject withdrew consent|1|||
129162619|NCT00570778|464890710|FG000|Overall Study|Abnormal test procedure|1|||
129162620|NCT00570778|464890711|FG001|Overall Study|Abnormal test procedure|0|||
129162621|NCT00570778|464890712|FG002|Overall Study|Abnormal test procedure|0|||
129162622|NCT00570778|464890713|FG003|Overall Study|Abnormal test procedure|0|||
129162623|NCT00570778|464890710|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129162624|NCT00570778|464890711|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129162625|NCT00570778|464890712|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129162626|NCT00570778|464890713|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129162627|NCT00570778|464890710|FG000|Overall Study|Lost to Follow-up|0|||
129162628|NCT00570778|464890711|FG001|Overall Study|Lost to Follow-up|0|||
129162629|NCT00570778|464890712|FG002|Overall Study|Lost to Follow-up|1|||
129162630|NCT00570778|464890713|FG003|Overall Study|Lost to Follow-up|0|||
129162631|NCT00570778|464890710|FG000|Overall Study|Subject no longer requires study drug|0|||
129162632|NCT00570778|464890711|FG001|Overall Study|Subject no longer requires study drug|1|||
129162633|NCT00570778|464890712|FG002|Overall Study|Subject no longer requires study drug|0|||
129162634|NCT00570778|464890713|FG003|Overall Study|Subject no longer requires study drug|0|||
129162635|NCT00711594|464890714|FG000|Overall Study|Progressive disease|2|||
129162636|NCT00711594|464890715|FG001|Overall Study|Progressive disease|2|||
129162637|NCT00711594|464890716|FG002|Overall Study|Progressive disease|6|||
129162638|NCT00711594|464890717|FG003|Overall Study|Progressive disease|44|||
129162639|NCT00711594|464890714|FG000|Overall Study|Other Adverse Event|1|||
129162640|NCT00711594|464890715|FG001|Overall Study|Other Adverse Event|0|||
129162641|NCT00711594|464890716|FG002|Overall Study|Other Adverse Event|0|||
129162642|NCT00711594|464890717|FG003|Overall Study|Other Adverse Event|16|||
129162643|NCT00711594|464890714|FG000|Overall Study|Withdrawal by Subject|0|||
129162644|NCT00711594|464890715|FG001|Overall Study|Withdrawal by Subject|1|||
129162645|NCT00711594|464890716|FG002|Overall Study|Withdrawal by Subject|0|||
129162646|NCT00711594|464890717|FG003|Overall Study|Withdrawal by Subject|2|||
129162647|NCT00443872|464890718|FG000|Overall Study|Protocol Violation|7|||
129162648|NCT00443872|464890718|FG000|Overall Study|Lost to Follow-up|2|||
129162649|NCT00443872|464890718|FG000|Overall Study|Adverse Event|8|||
129162650|NCT02120781|464890723|FG000|Overall Study|Physician Decision|2|||
129162651|NCT02120781|464890724|FG001|Overall Study|Physician Decision|0|||
129162652|NCT02120781|464890723|FG000|Overall Study|Completion not documented|2|||
129162653|NCT02120781|464890724|FG001|Overall Study|Completion not documented|1|||
129162654|NCT00654745|464890727|FG000|Overall Study|Adverse Event|12|||
129162655|NCT00654745|464890727|FG000|Overall Study|Lost to Follow-up|7|||
129162656|NCT00654745|464890727|FG000|Overall Study|Protocol Violation|11|||
129162657|NCT00654745|464890727|FG000|Overall Study|Withdrawal by Subject|10|||
129162658|NCT00654745|464890727|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
129162659|NCT00984165|464890728|FG000|Overall Study|Death on study|2|||
129162660|NCT00984165|464890729|FG001|Overall Study|Death on study|0|||
129162661|NCT00984165|464890730|FG002|Overall Study|Death on study|0|||
129162662|NCT00984165|464890731|FG003|Overall Study|Death on study|0|||
129162663|NCT00984165|464890728|FG000|Overall Study|Disease progression on study|5|||
128726312|NCT01604343|463294790|FG000|Week 52 to Week 104|Physician Decision|0|||
128726313|NCT01604343|463294791|FG001|Week 52 to Week 104|Physician Decision|1|||
128726314|NCT01604343|463294792|FG002|Week 52 to Week 104|Physician Decision|0|||
128726315|NCT01604343|463294793|FG003|Week 52 to Week 104|Physician Decision|0|||
128726316|NCT01604343|463294794|FG004|Week 52 to Week 104|Physician Decision|2|||
128726317|NCT01604343|463294790|FG000|Week 52 to Week 104|Pregnancy|0|||
128726318|NCT01604343|463294791|FG001|Week 52 to Week 104|Pregnancy|0|||
128726319|NCT01604343|463294792|FG002|Week 52 to Week 104|Pregnancy|1|||
128726320|NCT01604343|463294793|FG003|Week 52 to Week 104|Pregnancy|2|||
128726321|NCT01604343|463294794|FG004|Week 52 to Week 104|Pregnancy|1|||
128726322|NCT01604343|463294790|FG000|Week 52 to Week 104|Other|0|||
128726323|NCT01604343|463294791|FG001|Week 52 to Week 104|Other|11|||
128726324|NCT01604343|463294792|FG002|Week 52 to Week 104|Other|11|||
128726325|NCT01604343|463294793|FG003|Week 52 to Week 104|Other|6|||
128726326|NCT01604343|463294794|FG004|Week 52 to Week 104|Other|3|||
128726327|NCT01604343|463294790|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
128726328|NCT01604343|463294791|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
128726329|NCT01604343|463294792|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
128726330|NCT01604343|463294793|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
128726331|NCT01604343|463294794|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
128726332|NCT01604343|463294790|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
128726333|NCT01604343|463294791|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
128726334|NCT01604343|463294792|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
128726335|NCT01604343|463294793|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
128726336|NCT01604343|463294794|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
128726337|NCT01604343|463294790|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
128726338|NCT01604343|463294791|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
128726339|NCT01604343|463294792|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
128726340|NCT01604343|463294793|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
128726341|NCT01604343|463294794|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
128726342|NCT00436748|463294799|FG000|Overall Study|Ineligibility Determined|1|||
128726343|NCT00436748|463294800|FG001|Overall Study|Ineligibility Determined|1|||
128726344|NCT00436748|463294799|FG000|Overall Study|Adverse Event|0|||
128726345|NCT00436748|463294800|FG001|Overall Study|Adverse Event|2|||
128726346|NCT00436748|463294799|FG000|Overall Study|Consent Withdrawn|1|||
128726347|NCT00436748|463294800|FG001|Overall Study|Consent Withdrawn|4|||
129162664|NCT00984165|464890729|FG001|Overall Study|Disease progression on study|1|||
129162665|NCT00984165|464890730|FG002|Overall Study|Disease progression on study|0|||
129162666|NCT00984165|464890731|FG003|Overall Study|Disease progression on study|0|||
129162667|NCT00984165|464890728|FG000|Overall Study|Death of recipient|0|||
129162668|NCT00984165|464890729|FG001|Overall Study|Death of recipient|0|||
129162669|NCT00984165|464890730|FG002|Overall Study|Death of recipient|0|||
129162670|NCT00984165|464890731|FG003|Overall Study|Death of recipient|1|||
129162671|NCT00984165|464890728|FG000|Overall Study|New protocol|0|||
129162672|NCT00984165|464890729|FG001|Overall Study|New protocol|0|||
129162673|NCT00984165|464890730|FG002|Overall Study|New protocol|0|||
129162674|NCT00984165|464890731|FG003|Overall Study|New protocol|1|||
128726348|NCT00436748|463294799|FG000|Overall Study|Administrative Decision|1|||
128726349|NCT00436748|463294800|FG001|Overall Study|Administrative Decision|0|||
128726350|NCT00436748|463294799|FG000|Overall Study|Lost to Follow-up|0|||
129162675|NCT00984165|464890728|FG000|Overall Study|P+/donor pair removed from protocol|0|||
128726351|NCT00436748|463294800|FG001|Overall Study|Lost to Follow-up|1|||
128726352|NCT00436748|463294799|FG000|Overall Study|Protocol-specified Criteria|5|||
128726353|NCT00436748|463294800|FG001|Overall Study|Protocol-specified Criteria|4|||
128726354|NCT00436748|463294799|FG000|Overall Study|Other|3|||
128726355|NCT00436748|463294800|FG001|Overall Study|Other|0|||
129162676|NCT00984165|464890729|FG001|Overall Study|P+/donor pair removed from protocol|0|||
129162677|NCT00984165|464890730|FG002|Overall Study|P+/donor pair removed from protocol|0|||
129162678|NCT00984165|464890731|FG003|Overall Study|P+/donor pair removed from protocol|1|||
128726356|NCT01610791|463294801|FG000|Overall Study|Lost to Follow-up|7|||
128726357|NCT01610791|463294801|FG000|Overall Study|Adverse Event|6|||
128726358|NCT01610791|463294801|FG000|Overall Study|Physician Decision|1|||
129162679|NCT00984165|464890728|FG000|Overall Study|removed with a pair recipient|0|||
129162680|NCT00984165|464890729|FG001|Overall Study|removed with a pair recipient|0|||
129162681|NCT00984165|464890730|FG002|Overall Study|removed with a pair recipient|0|||
129162682|NCT00984165|464890731|FG003|Overall Study|removed with a pair recipient|1|||
129162683|NCT00466947|464890732|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
129162684|NCT00466947|464890733|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
129162685|NCT00466947|464890732|FG000|Study End Analysis Period|Adverse Event|35|||
129162686|NCT00466947|464890733|FG001|Study End Analysis Period|Adverse Event|43|||
129162687|NCT00466947|464890732|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
129162688|NCT00466947|464890733|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
129162689|NCT00466947|464890732|FG000|Study End Analysis Period|Physician Decision|29|||
129162690|NCT00466947|464890733|FG001|Study End Analysis Period|Physician Decision|29|||
129162691|NCT00466947|464890732|FG000|Study End Analysis Period|Protocol Violation|9|||
129162692|NCT00466947|464890733|FG001|Study End Analysis Period|Protocol Violation|17|||
129162693|NCT00466947|464890732|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
129162694|NCT00466947|464890733|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
129162695|NCT00466947|464890732|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
129162696|NCT00466947|464890733|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
129162697|NCT00466947|464890732|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
129162698|NCT00466947|464890733|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
129162699|NCT00466947|464890732|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
129162700|NCT00466947|464890733|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
129162701|NCT01995526|464890734|FG000|Overall Study|Physician Decision|1|||
129162702|NCT02229825|464890740|FG000|Overall Study|Personal Reasons|0|||
129162703|NCT02229825|464890741|FG001|Overall Study|Personal Reasons|1|||
129162704|NCT02229825|464890740|FG000|Overall Study|Refused continuing medication|7|||
129162705|NCT02229825|464890741|FG001|Overall Study|Refused continuing medication|6|||
129162706|NCT02229825|464890740|FG000|Overall Study|Lost to Follow-up|1|||
129162707|NCT02229825|464890741|FG001|Overall Study|Lost to Follow-up|2|||
129162708|NCT02229825|464890740|FG000|Overall Study|Protocol Violation|1|||
129162709|NCT02229825|464890741|FG001|Overall Study|Protocol Violation|1|||
129162710|NCT02229825|464890740|FG000|Overall Study|Lack of Efficacy|4|||
129162711|NCT02229825|464890741|FG001|Overall Study|Lack of Efficacy|10|||
129162712|NCT02229825|464890740|FG000|Overall Study|Adverse Event|11|||
129162713|NCT02229825|464890741|FG001|Overall Study|Adverse Event|9|||
129162714|NCT02229825|464890740|FG000|Overall Study|Not treated|0|||
129162715|NCT02229825|464890741|FG001|Overall Study|Not treated|1|||
129162716|NCT00104416|464890742|FG000|Double-Blind Phase|Adverse Event|2|||
129162717|NCT00104416|464890743|FG001|Double-Blind Phase|Adverse Event|1|||
129162718|NCT00104416|464890744|FG002|Double-Blind Phase|Adverse Event|0|||
129162719|NCT00104416|464890745|FG003|Double-Blind Phase|Adverse Event|0|||
129162720|NCT00104416|464890746|FG004|Double-Blind Phase|Adverse Event|0|||
129162721|NCT00104416|464890742|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129162722|NCT00104416|464890743|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129162723|NCT00104416|464890744|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129162724|NCT00104416|464890745|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129162725|NCT00104416|464890746|FG004|Double-Blind Phase|Lost to Follow-up|0|||
129162726|NCT00104416|464890742|FG000|Double-Blind Phase|Protocol Violation|0|||
129162727|NCT00104416|464890743|FG001|Double-Blind Phase|Protocol Violation|1|||
129162728|NCT00104416|464890744|FG002|Double-Blind Phase|Protocol Violation|0|||
129162729|NCT00104416|464890745|FG003|Double-Blind Phase|Protocol Violation|0|||
129162730|NCT00104416|464890746|FG004|Double-Blind Phase|Protocol Violation|0|||
129162731|NCT00104416|464890742|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129162732|NCT00104416|464890743|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
129162733|NCT00104416|464890744|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129162734|NCT00104416|464890745|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129162735|NCT00104416|464890746|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129162736|NCT00104416|464890742|FG000|Double-Blind Phase|Pregnancy|1|||
129162737|NCT00104416|464890743|FG001|Double-Blind Phase|Pregnancy|0|||
129162738|NCT00104416|464890744|FG002|Double-Blind Phase|Pregnancy|0|||
129162739|NCT00104416|464890745|FG003|Double-Blind Phase|Pregnancy|0|||
129162740|NCT00104416|464890746|FG004|Double-Blind Phase|Pregnancy|0|||
129162741|NCT00104416|464890742|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
129162742|NCT00104416|464890743|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
129162743|NCT00104416|464890744|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
129162744|NCT00104416|464890745|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
129162745|NCT00104416|464890746|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
129162746|NCT00104416|464890742|FG000|Continuation Phase|Adverse Event|0|||
129162747|NCT00104416|464890743|FG001|Continuation Phase|Adverse Event|0|||
129162748|NCT00104416|464890744|FG002|Continuation Phase|Adverse Event|2|||
129162749|NCT00104416|464890745|FG003|Continuation Phase|Adverse Event|0|||
129162750|NCT00104416|464890746|FG004|Continuation Phase|Adverse Event|2|||
129162751|NCT00104416|464890742|FG000|Continuation Phase|Lost to Follow-up|0|||
129162752|NCT00104416|464890743|FG001|Continuation Phase|Lost to Follow-up|0|||
129162753|NCT00104416|464890744|FG002|Continuation Phase|Lost to Follow-up|1|||
129162754|NCT00104416|464890745|FG003|Continuation Phase|Lost to Follow-up|0|||
129162755|NCT00104416|464890746|FG004|Continuation Phase|Lost to Follow-up|1|||
129162756|NCT00104416|464890742|FG000|Continuation Phase|Withdrawal by Subject|0|||
129162757|NCT00104416|464890743|FG001|Continuation Phase|Withdrawal by Subject|0|||
129162758|NCT00104416|464890744|FG002|Continuation Phase|Withdrawal by Subject|2|||
129162759|NCT00104416|464890745|FG003|Continuation Phase|Withdrawal by Subject|1|||
129162760|NCT00104416|464890746|FG004|Continuation Phase|Withdrawal by Subject|1|||
129162761|NCT00104416|464890742|FG000|Continuation Phase|Pregnancy|0|||
129162762|NCT00104416|464890743|FG001|Continuation Phase|Pregnancy|0|||
129162763|NCT00104416|464890744|FG002|Continuation Phase|Pregnancy|1|||
129162764|NCT00104416|464890745|FG003|Continuation Phase|Pregnancy|1|||
129162765|NCT00104416|464890746|FG004|Continuation Phase|Pregnancy|0|||
129162766|NCT00104416|464890742|FG000|Continuation Phase|Non-compliance|0|||
129162767|NCT00104416|464890743|FG001|Continuation Phase|Non-compliance|0|||
129162768|NCT00104416|464890744|FG002|Continuation Phase|Non-compliance|0|||
129162769|NCT00104416|464890745|FG003|Continuation Phase|Non-compliance|0|||
129162770|NCT00104416|464890746|FG004|Continuation Phase|Non-compliance|1|||
129162771|NCT01309997|464890747|FG000|Overall Study|Adverse Event|1|||
129162772|NCT01309997|464890748|FG001|Overall Study|Adverse Event|0|||
129162773|NCT01309997|464890747|FG000|Overall Study|Death|1|||
129162774|NCT01309997|464890748|FG001|Overall Study|Death|3|||
129162775|NCT01309997|464890747|FG000|Overall Study|Lack of Efficacy|2|||
129162776|NCT01309997|464890748|FG001|Overall Study|Lack of Efficacy|2|||
129162777|NCT01309997|464890747|FG000|Overall Study|Withdrawal by Subject|1|||
129162778|NCT01309997|464890748|FG001|Overall Study|Withdrawal by Subject|1|||
129162779|NCT03462641|464890751|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
129162780|NCT03462641|464890752|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
129162781|NCT03462641|464890751|FG000|Visit 2|Withdrawal by Subject|0|||
129162782|NCT03462641|464890752|FG001|Visit 2|Withdrawal by Subject|1|||
129162783|NCT02096952|464890756|FG000|Overall Study|Adverse Event|1|||
129162784|NCT02684617|464890757|FG000|Overall Study|Adverse Event|1|||
129162785|NCT02684617|464890758|FG001|Overall Study|Adverse Event|0|||
129162786|NCT02684617|464890759|FG002|Overall Study|Adverse Event|1|||
129162787|NCT02684617|464890757|FG000|Overall Study|Death|8|||
129162788|NCT02684617|464890758|FG001|Overall Study|Death|16|||
129162789|NCT02684617|464890759|FG002|Overall Study|Death|28|||
129162790|NCT02684617|464890757|FG000|Overall Study|Withdrawal by Subject|2|||
129162791|NCT02684617|464890758|FG001|Overall Study|Withdrawal by Subject|0|||
129162792|NCT02684617|464890759|FG002|Overall Study|Withdrawal by Subject|4|||
129162793|NCT02684617|464890757|FG000|Overall Study|Screen Failure|1|||
129162794|NCT02684617|464890758|FG001|Overall Study|Screen Failure|0|||
129162795|NCT02684617|464890759|FG002|Overall Study|Screen Failure|2|||
129162796|NCT02684617|464890757|FG000|Overall Study|Study Terminated by Sponsor|6|||
129162797|NCT02684617|464890758|FG001|Overall Study|Study Terminated by Sponsor|1|||
129162798|NCT02684617|464890759|FG002|Overall Study|Study Terminated by Sponsor|5|||
129162799|NCT04482439|464890768|FG000|Overall Study|Lost to Follow-up|1|||
129162800|NCT04482439|464890768|FG000|Overall Study|Unrelated illness|1|||
129162801|NCT02318368|464890769|FG000|Overall Study|Withdrawal by Subject|2|||
129162802|NCT02318368|464890770|FG001|Overall Study|Withdrawal by Subject|0|||
129162803|NCT02318368|464890769|FG000|Overall Study|Study terminated by the sponsor|5|||
129162804|NCT02318368|464890770|FG001|Overall Study|Study terminated by the sponsor|2|||
129162805|NCT02318368|464890769|FG000|Overall Study|Death|0|||
129162806|NCT02318368|464890770|FG001|Overall Study|Death|1|||
129162807|NCT02201329|464890771|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
129162808|NCT02201329|464890771|FG000|Overall Study|Withdrawal by Subject|2|||
129162809|NCT01945996|464890772|FG000|Overall Study|Lost to Follow-up|3|||
129162810|NCT01945996|464890773|FG001|Overall Study|Lost to Follow-up|5|||
129162811|NCT01066104|464890774|FG000|Overall Study|Adverse Event|1|||
129162812|NCT01066104|464890775|FG001|Overall Study|Adverse Event|1|||
129162813|NCT01066104|464890774|FG000|Overall Study|Protocol Violation|1|||
129162814|NCT01066104|464890775|FG001|Overall Study|Protocol Violation|0|||
129162815|NCT04660552|464890776|FG000|Overall Study|Withdrawal by Subject|3|||
129162816|NCT04660552|464890777|FG001|Overall Study|Withdrawal by Subject|1|||
129162817|NCT02091362|464890785|FG000|Period 1|Protocol Violation|1|||
129162818|NCT02091362|464890786|FG001|Period 1|Protocol Violation|0|||
129162819|NCT02091362|464890785|FG000|Period 1|Withdrawal by Subject|2|||
129162820|NCT02091362|464890786|FG001|Period 1|Withdrawal by Subject|3|||
129162821|NCT02091362|464890785|FG000|Period 1|Lost to Follow-up|0|||
129162822|NCT02091362|464890786|FG001|Period 1|Lost to Follow-up|1|||
129162823|NCT02091362|464890785|FG000|Period 1|Adverse Event|2|||
129162824|NCT02091362|464890786|FG001|Period 1|Adverse Event|0|||
129162825|NCT02091362|464890785|FG000|Wash-out|Lost to Follow-up|1|||
129162826|NCT02091362|464890786|FG001|Wash-out|Lost to Follow-up|1|||
129162827|NCT02091362|464890785|FG000|Wash-out|Withdrawal by Subject|0|||
129162828|NCT02091362|464890786|FG001|Wash-out|Withdrawal by Subject|2|||
129162829|NCT02091362|464890785|FG000|Period 2|Adverse Event|1|||
129162830|NCT02091362|464890786|FG001|Period 2|Adverse Event|0|||
129162831|NCT02091362|464890785|FG000|Period 2|Lost to Follow-up|0|||
129162832|NCT02091362|464890786|FG001|Period 2|Lost to Follow-up|1|||
129162833|NCT02091362|464890785|FG000|Period 2|Withdrawal by Subject|1|||
129162834|NCT02091362|464890786|FG001|Period 2|Withdrawal by Subject|1|||
129162835|NCT00690430|464890787|FG000|Core Phase|Abnormal Laboratory value|0|||
129162836|NCT00690430|464890788|FG001|Core Phase|Abnormal Laboratory value|1|||
129162837|NCT00690430|464890789|FG002|Core Phase|Abnormal Laboratory value|0|||
129162838|NCT00690430|464890787|FG000|Core Phase|Adverse Event|5|||
129162839|NCT00690430|464890788|FG001|Core Phase|Adverse Event|1|||
129162840|NCT00690430|464890789|FG002|Core Phase|Adverse Event|0|||
129162841|NCT00690430|464890787|FG000|Core Phase|Death|0|||
129162842|NCT00690430|464890788|FG001|Core Phase|Death|2|||
129162843|NCT00690430|464890789|FG002|Core Phase|Death|0|||
129162844|NCT00690430|464890787|FG000|Core Phase|Protocol Violation|1|||
129162845|NCT00690430|464890788|FG001|Core Phase|Protocol Violation|0|||
129162846|NCT00690430|464890789|FG002|Core Phase|Protocol Violation|0|||
129162847|NCT00690430|464890787|FG000|Core Phase|Withdrawal by Subject|3|||
129162848|NCT00690430|464890788|FG001|Core Phase|Withdrawal by Subject|3|||
129162849|NCT00690430|464890789|FG002|Core Phase|Withdrawal by Subject|0|||
129162850|NCT00690430|464890787|FG000|Core Phase|Subject no longer requires study drug|1|||
129162851|NCT00690430|464890788|FG001|Core Phase|Subject no longer requires study drug|0|||
129162852|NCT00690430|464890789|FG002|Core Phase|Subject no longer requires study drug|0|||
129162853|NCT00690430|464890787|FG000|Core Phase|Lack of Efficacy|8|||
129162854|NCT00690430|464890788|FG001|Core Phase|Lack of Efficacy|10|||
129162855|NCT00690430|464890789|FG002|Core Phase|Lack of Efficacy|0|||
129162856|NCT00690430|464890787|FG000|Core Phase|Administrative Problems|0|||
129162857|NCT00690430|464890788|FG001|Core Phase|Administrative Problems|1|||
129162858|NCT00690430|464890789|FG002|Core Phase|Administrative Problems|0|||
129162859|NCT00690430|464890787|FG000|Core Phase|Early Termination|0|||
129162860|NCT00690430|464890788|FG001|Core Phase|Early Termination|5|||
129162861|NCT00690430|464890789|FG002|Core Phase|Early Termination|0|||
129162862|NCT00690430|464890787|FG000|Extension Phase|Lack of Efficacy|3|||
129162863|NCT00690430|464890788|FG001|Extension Phase|Lack of Efficacy|1|||
129162864|NCT00690430|464890789|FG002|Extension Phase|Lack of Efficacy|4|||
129162865|NCT00690430|464890787|FG000|Extension Phase|Abnormal Lab Values|1|||
129162866|NCT00690430|464890788|FG001|Extension Phase|Abnormal Lab Values|0|||
129162867|NCT00690430|464890789|FG002|Extension Phase|Abnormal Lab Values|0|||
129162868|NCT00690430|464890787|FG000|Extension Phase|Abnormal test procedure results|1|||
129162869|NCT00690430|464890788|FG001|Extension Phase|Abnormal test procedure results|0|||
129162870|NCT00690430|464890789|FG002|Extension Phase|Abnormal test procedure results|0|||
129162871|NCT00690430|464890787|FG000|Extension Phase|Administrative Problems|0|||
129162872|NCT00690430|464890788|FG001|Extension Phase|Administrative Problems|1|||
129162873|NCT00690430|464890789|FG002|Extension Phase|Administrative Problems|1|||
129162874|NCT00690430|464890787|FG000|Extension Phase|Adverse Event|2|||
129162875|NCT00690430|464890788|FG001|Extension Phase|Adverse Event|1|||
129162876|NCT00690430|464890789|FG002|Extension Phase|Adverse Event|2|||
129162877|NCT00690430|464890787|FG000|Extension Phase|Death|1|||
129162878|NCT00690430|464890788|FG001|Extension Phase|Death|1|||
128726359|NCT01610791|463294801|FG000|Overall Study|Adverse event and Investigator decision|1|||
128726360|NCT01610791|463294801|FG000|Overall Study|Death|1|||
128726361|NCT01610791|463294801|FG000|Overall Study|Not determined|5|||
128726362|NCT00850200|463294803|FG000|Overall Study|Physician Decision|2|||
128726363|NCT00850200|463294803|FG000|Overall Study|Did not recieve treatment|2|||
128726364|NCT00850200|463294803|FG000|Overall Study|Withdrawal by Subject|1|||
129162879|NCT00690430|464890789|FG002|Extension Phase|Death|1|||
129162880|NCT00690430|464890787|FG000|Extension Phase|Withdrawal by Subject|0|||
129162881|NCT00690430|464890788|FG001|Extension Phase|Withdrawal by Subject|0|||
129162882|NCT00690430|464890789|FG002|Extension Phase|Withdrawal by Subject|2|||
129162883|NCT00690430|464890787|FG000|Extension Phase|Early Termination|10|||
129162884|NCT00690430|464890788|FG001|Extension Phase|Early Termination|1|||
128726365|NCT02711800|463294804|FG000|Overall Study|Lost to Follow-up|1|||
128726366|NCT02711800|463294804|FG000|Overall Study|Withdrawal by Subject|1|||
128726367|NCT05040152|463294809|FG000|Overall Study|Withdrawal by Subject|5|||
128726368|NCT05040152|463294810|FG001|Overall Study|Withdrawal by Subject|0|||
129162885|NCT00690430|464890789|FG002|Extension Phase|Early Termination|3|||
129162886|NCT02125838|464890798|FG000|Overall Study|Lost to Follow-up|4|||
129162887|NCT02125838|464890799|FG001|Overall Study|Lost to Follow-up|4|||
129162888|NCT00787839|464890800|FG000|Overall Study|Failure to have the OGTT was most common|404|||
129162889|NCT01970241|464890805|FG000|Overall Study|Withdrawal by Subject|2|||
129162890|NCT01970241|464890806|FG001|Overall Study|Withdrawal by Subject|0|||
129162891|NCT01970241|464890805|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
129162892|NCT01970241|464890806|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
129162893|NCT01001767|464890809|FG000|Overall Study|no baseline study performed|1|||
129162894|NCT01001767|464890810|FG001|Overall Study|no baseline study performed|0|||
129162895|NCT01001767|464890809|FG000|Overall Study|Protocol Violation|1|||
129162896|NCT01001767|464890810|FG001|Overall Study|Protocol Violation|0|||
129162897|NCT01001767|464890809|FG000|Overall Study|Lost to Follow-up|1|||
129162898|NCT01001767|464890810|FG001|Overall Study|Lost to Follow-up|0|||
129162899|NCT01001767|464890809|FG000|Overall Study|Physician Decision|1|||
129162900|NCT01001767|464890810|FG001|Overall Study|Physician Decision|0|||
129162901|NCT01667133|464890812|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
129162902|NCT01667133|464890813|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
129162903|NCT01667133|464890814|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
129162904|NCT01667133|464890815|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
129162905|NCT01667133|464890816|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
129162906|NCT01667133|464890817|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
128726369|NCT05040152|463294809|FG000|Overall Study|Lost to Follow-up|0|||
128726370|NCT05040152|463294810|FG001|Overall Study|Lost to Follow-up|2|||
129162907|NCT01667133|464890818|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
129162908|NCT01667133|464890819|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
129162909|NCT01667133|464890820|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
129162910|NCT01667133|464890821|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
129162911|NCT01667133|464890822|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
129162912|NCT01667133|464890823|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
129162913|NCT01667133|464890812|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162914|NCT01667133|464890813|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162915|NCT01667133|464890814|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
129162916|NCT01667133|464890815|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162917|NCT01667133|464890816|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162918|NCT01667133|464890817|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162919|NCT01667133|464890818|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162920|NCT01667133|464890819|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162921|NCT01667133|464890820|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162922|NCT01667133|464890821|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162923|NCT01667133|464890822|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162924|NCT01667133|464890823|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129162925|NCT01667133|464890812|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
129162926|NCT01667133|464890813|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
129162927|NCT01667133|464890814|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
129162928|NCT01667133|464890815|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
129162929|NCT01667133|464890816|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
129162930|NCT01667133|464890817|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
129162931|NCT01667133|464890818|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
129162932|NCT01667133|464890819|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
129162933|NCT01667133|464890820|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
129162934|NCT01667133|464890821|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
129162935|NCT01667133|464890822|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
129162936|NCT01667133|464890823|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
129162937|NCT01667133|464890812|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162938|NCT01667133|464890813|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162939|NCT01667133|464890814|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162940|NCT01667133|464890815|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
129162941|NCT01667133|464890816|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162942|NCT01667133|464890817|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162943|NCT01667133|464890818|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162944|NCT01667133|464890819|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162945|NCT01667133|464890820|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162946|NCT01667133|464890821|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162947|NCT01667133|464890822|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162948|NCT01667133|464890823|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129162949|NCT01667133|464890812|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
129162950|NCT01667133|464890813|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
129162951|NCT01667133|464890814|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
129162952|NCT01667133|464890815|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
129162953|NCT01667133|464890816|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
129162954|NCT01667133|464890817|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
129162955|NCT01667133|464890818|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
129162956|NCT01667133|464890819|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
129162957|NCT01667133|464890820|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
129162958|NCT01667133|464890821|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
129162959|NCT01667133|464890822|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
129162960|NCT01667133|464890823|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
129162961|NCT01667133|464890812|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162962|NCT01667133|464890813|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162963|NCT01667133|464890814|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
128726371|NCT02086110|463294816|FG000|Overall Study|Withdrawal by Subject|1|||
129162964|NCT01667133|464890815|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162965|NCT01667133|464890816|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162966|NCT01667133|464890817|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162967|NCT01667133|464890818|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162968|NCT01667133|464890819|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162969|NCT01667133|464890820|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162970|NCT01667133|464890821|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
129162971|NCT01667133|464890822|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162972|NCT01667133|464890823|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129162973|NCT01667133|464890812|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
129162974|NCT01667133|464890813|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
129162975|NCT01667133|464890814|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
129162976|NCT01667133|464890815|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
129162977|NCT01667133|464890816|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
129162978|NCT01667133|464890817|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
129162979|NCT01667133|464890818|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
129162980|NCT01667133|464890819|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
129162981|NCT01667133|464890820|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
129162982|NCT01667133|464890821|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
129162983|NCT01667133|464890822|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
129162984|NCT01667133|464890823|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
129162985|NCT01667133|464890812|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162986|NCT01667133|464890813|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162987|NCT01667133|464890814|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162988|NCT01667133|464890815|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162989|NCT01667133|464890816|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162990|NCT01667133|464890817|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162991|NCT01667133|464890818|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162992|NCT01667133|464890819|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162993|NCT01667133|464890820|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162994|NCT01667133|464890821|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
129162995|NCT01667133|464890822|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162996|NCT01667133|464890823|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129162997|NCT01667133|464890812|FG000|Phase 2: Dose-expansion|Death|0|||
129162998|NCT01667133|464890813|FG001|Phase 2: Dose-expansion|Death|0|||
129162999|NCT01667133|464890814|FG002|Phase 2: Dose-expansion|Death|0|||
129163000|NCT01667133|464890815|FG003|Phase 2: Dose-expansion|Death|0|||
129163001|NCT01667133|464890816|FG004|Phase 2: Dose-expansion|Death|0|||
129163002|NCT01667133|464890817|FG005|Phase 2: Dose-expansion|Death|0|||
129163003|NCT01667133|464890818|FG006|Phase 2: Dose-expansion|Death|0|||
129163004|NCT01667133|464890819|FG007|Phase 2: Dose-expansion|Death|0|||
129163005|NCT01667133|464890820|FG008|Phase 2: Dose-expansion|Death|0|||
129163006|NCT01667133|464890821|FG009|Phase 2: Dose-expansion|Death|1|||
129163007|NCT01667133|464890822|FG010|Phase 2: Dose-expansion|Death|0|||
129163008|NCT01667133|464890823|FG011|Phase 2: Dose-expansion|Death|0|||
129163009|NCT01667133|464890812|FG000|Phase 2: Dose-expansion|Other|0|||
129163010|NCT01667133|464890813|FG001|Phase 2: Dose-expansion|Other|0|||
129163011|NCT01667133|464890814|FG002|Phase 2: Dose-expansion|Other|0|||
129163012|NCT01667133|464890815|FG003|Phase 2: Dose-expansion|Other|0|||
129163013|NCT01667133|464890816|FG004|Phase 2: Dose-expansion|Other|0|||
129163014|NCT01667133|464890817|FG005|Phase 2: Dose-expansion|Other|0|||
129163015|NCT01667133|464890818|FG006|Phase 2: Dose-expansion|Other|0|||
129163016|NCT01667133|464890819|FG007|Phase 2: Dose-expansion|Other|0|||
129163017|NCT01667133|464890820|FG008|Phase 2: Dose-expansion|Other|0|||
129163018|NCT01667133|464890821|FG009|Phase 2: Dose-expansion|Other|0|||
129163019|NCT01667133|464890822|FG010|Phase 2: Dose-expansion|Other|0|||
129163020|NCT01667133|464890823|FG011|Phase 2: Dose-expansion|Other|1|||
129163021|NCT00289289|464890828|FG000|Overall Study|Withdrawal by Subject|5|||
129163022|NCT00289289|464890829|FG001|Overall Study|Withdrawal by Subject|3|||
129163023|NCT00289289|464890830|FG002|Overall Study|Withdrawal by Subject|15|||
129163024|NCT00289289|464890828|FG000|Overall Study|Lost to Follow-up|1|||
129163025|NCT00289289|464890829|FG001|Overall Study|Lost to Follow-up|0|||
129163026|NCT00289289|464890830|FG002|Overall Study|Lost to Follow-up|1|||
129163027|NCT00289289|464890828|FG000|Overall Study|Death|4|||
129163028|NCT00289289|464890829|FG001|Overall Study|Death|2|||
129163029|NCT00289289|464890830|FG002|Overall Study|Death|5|||
128726372|NCT02086110|463294817|FG001|Overall Study|Withdrawal by Subject|1|||
128726373|NCT02308735|463294822|FG000|Overall Study|Physician Decision|2|||
128726374|NCT02308735|463294823|FG001|Overall Study|Physician Decision|0|||
128726375|NCT02308735|463294824|FG002|Overall Study|Physician Decision|0|||
128726376|NCT02308735|463294825|FG003|Overall Study|Physician Decision|2|||
128726377|NCT00606892|463294831|FG000|First Intervention|Protocol Violation|1|||
128726378|NCT00606892|463294832|FG001|First Intervention|Protocol Violation|4|||
128726379|NCT04960228|463294840|FG000|Overall Study|Withdrawal by Subject|216|||
128726380|NCT04960228|463294841|FG001|Overall Study|Withdrawal by Subject|35|||
128726381|NCT04960228|463294840|FG000|Overall Study|Failed attention check|69|||
128726382|NCT04960228|463294841|FG001|Overall Study|Failed attention check|148|||
128726383|NCT04960228|463294840|FG000|Overall Study|Flagged for response quality by Dynata|3|||
128726384|NCT04960228|463294841|FG001|Overall Study|Flagged for response quality by Dynata|3|||
128726385|NCT00794196|463294843|FG000|Overall Study|Lost to Follow-up|5|||
128726386|NCT00794196|463294844|FG001|Overall Study|Lost to Follow-up|23|||
128726387|NCT02129803|463294847|FG000|Overall Study|Protocol Violation|4|||
128726388|NCT02129803|463294848|FG001|Overall Study|Protocol Violation|0|||
128726389|NCT02129803|463294847|FG000|Overall Study|Physician Decision|0|||
128726390|NCT02129803|463294848|FG001|Overall Study|Physician Decision|1|||
128726391|NCT02129803|463294847|FG000|Overall Study|Difficulty sleeping|1|||
128726392|NCT02129803|463294848|FG001|Overall Study|Difficulty sleeping|0|||
128726393|NCT02129803|463294847|FG000|Overall Study|Morning headache|0|||
128726394|NCT02129803|463294848|FG001|Overall Study|Morning headache|1|||
128726395|NCT02129803|463294847|FG000|Overall Study|Withdrawal by Subject|1|||
128726396|NCT02129803|463294848|FG001|Overall Study|Withdrawal by Subject|1|||
128726397|NCT03274986|463294851|FG000|Overall Study|Withdrawal by Subject|0|||
128726398|NCT03274986|463294852|FG001|Overall Study|Withdrawal by Subject|1|||
128726399|NCT03274986|463294851|FG000|Overall Study|Lost to Follow-up|0|||
128726400|NCT03274986|463294852|FG001|Overall Study|Lost to Follow-up|1|||
128726401|NCT00603746|463294853|FG000|Overall Study|Adverse Event|2|||
128726402|NCT00603746|463294854|FG001|Overall Study|Adverse Event|3|||
128726403|NCT00603746|463294855|FG002|Overall Study|Adverse Event|0|||
128726404|NCT00603746|463294856|FG003|Overall Study|Adverse Event|1|||
128726405|NCT00603746|463294857|FG004|Overall Study|Adverse Event|0|||
128726406|NCT00603746|463294858|FG005|Overall Study|Adverse Event|4|||
128726407|NCT00603746|463294853|FG000|Overall Study|Lack of Efficacy|34|||
128726408|NCT00603746|463294854|FG001|Overall Study|Lack of Efficacy|11|||
128726409|NCT00603746|463294855|FG002|Overall Study|Lack of Efficacy|6|||
128726410|NCT00603746|463294856|FG003|Overall Study|Lack of Efficacy|11|||
129163030|NCT00289289|464890828|FG000|Overall Study|No implant attempted|0|||
129163031|NCT00289289|464890829|FG001|Overall Study|No implant attempted|0|||
129163032|NCT00289289|464890830|FG002|Overall Study|No implant attempted|1|||
129163033|NCT00289289|464890828|FG000|Overall Study|Physician Decision|1|||
129163034|NCT00289289|464890829|FG001|Overall Study|Physician Decision|0|||
129163035|NCT00289289|464890830|FG002|Overall Study|Physician Decision|6|||
129163036|NCT00289289|464890828|FG000|Overall Study|Non-study device implanted|2|||
129163037|NCT00289289|464890829|FG001|Overall Study|Non-study device implanted|1|||
129163038|NCT00289289|464890830|FG002|Overall Study|Non-study device implanted|3|||
129163039|NCT00289289|464890828|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
129163040|NCT00289289|464890829|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
129163041|NCT00289289|464890830|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
129163042|NCT00289289|464890828|FG000|Overall Study|Other Exit Reason|6|||
129163043|NCT00289289|464890829|FG001|Overall Study|Other Exit Reason|4|||
129163044|NCT00289289|464890830|FG002|Overall Study|Other Exit Reason|12|||
129163045|NCT02567799|464890831|FG000|Concurrent Chemoradiotherapy|Death|1|||
129163046|NCT02567799|464890832|FG001|Concurrent Chemoradiotherapy|Death|0|||
129163047|NCT02567799|464890833|FG002|Concurrent Chemoradiotherapy|Death|0|||
129163048|NCT02567799|464890831|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
129163049|NCT02567799|464890832|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
129163050|NCT02567799|464890833|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
129163051|NCT02567799|464890831|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
129163052|NCT02567799|464890832|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
129163053|NCT02567799|464890833|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
129163054|NCT02567799|464890831|FG000|Follow-up|Death|1|||
129163055|NCT02567799|464890832|FG001|Follow-up|Death|0|||
128726411|NCT00603746|463294857|FG004|Overall Study|Lack of Efficacy|12|||
128726412|NCT00603746|463294858|FG005|Overall Study|Lack of Efficacy|8|||
128726413|NCT00603746|463294853|FG000|Overall Study|Protocol Violation|0|||
129163056|NCT02567799|464890833|FG002|Follow-up|Death|1|||
129163057|NCT02567799|464890831|FG000|Follow-up|Progressive Disease|1|||
129163058|NCT02567799|464890832|FG001|Follow-up|Progressive Disease|1|||
128726414|NCT00603746|463294854|FG001|Overall Study|Protocol Violation|3|||
128726415|NCT00603746|463294855|FG002|Overall Study|Protocol Violation|1|||
128726416|NCT00603746|463294856|FG003|Overall Study|Protocol Violation|0|||
128726417|NCT00603746|463294857|FG004|Overall Study|Protocol Violation|1|||
128726418|NCT00603746|463294858|FG005|Overall Study|Protocol Violation|0|||
129163059|NCT02567799|464890833|FG002|Follow-up|Progressive Disease|3|||
129163060|NCT00349349|464890835|FG000|Overall Study|Adverse Event|5|||
128726419|NCT00603746|463294853|FG000|Overall Study|Lost to Follow-up|0|||
128726420|NCT00603746|463294854|FG001|Overall Study|Lost to Follow-up|1|||
128726421|NCT00603746|463294855|FG002|Overall Study|Lost to Follow-up|1|||
128726422|NCT00603746|463294856|FG003|Overall Study|Lost to Follow-up|0|||
128726423|NCT00603746|463294857|FG004|Overall Study|Lost to Follow-up|0|||
128726424|NCT00603746|463294858|FG005|Overall Study|Lost to Follow-up|0|||
128726425|NCT00603746|463294853|FG000|Overall Study|Physician Decision|1|||
128726426|NCT00603746|463294854|FG001|Overall Study|Physician Decision|0|||
128726427|NCT00603746|463294855|FG002|Overall Study|Physician Decision|0|||
128726428|NCT00603746|463294856|FG003|Overall Study|Physician Decision|0|||
128726429|NCT00603746|463294857|FG004|Overall Study|Physician Decision|1|||
128726430|NCT00603746|463294858|FG005|Overall Study|Physician Decision|0|||
128726431|NCT00603746|463294853|FG000|Overall Study|Withdrawal by Subject|1|||
128726432|NCT00603746|463294854|FG001|Overall Study|Withdrawal by Subject|0|||
128726433|NCT00603746|463294855|FG002|Overall Study|Withdrawal by Subject|0|||
128726434|NCT00603746|463294856|FG003|Overall Study|Withdrawal by Subject|1|||
128726435|NCT00603746|463294857|FG004|Overall Study|Withdrawal by Subject|3|||
128726436|NCT00603746|463294858|FG005|Overall Study|Withdrawal by Subject|1|||
128726437|NCT02586012|463296944|FG000|Overall Study|Withdrawal by Subject|1|||
128726438|NCT02586012|463296945|FG001|Overall Study|Withdrawal by Subject|1|||
128726439|NCT02586012|463296946|FG002|Overall Study|Withdrawal by Subject|0|||
128726440|NCT02586012|463296947|FG003|Overall Study|Withdrawal by Subject|1|||
129163061|NCT00349349|464890836|FG001|Overall Study|Adverse Event|6|||
129163062|NCT00349349|464890837|FG002|Overall Study|Adverse Event|2|||
129163063|NCT00349349|464890835|FG000|Overall Study|Withdrawal by Subject|5|||
129163064|NCT00349349|464890836|FG001|Overall Study|Withdrawal by Subject|2|||
129163065|NCT00349349|464890837|FG002|Overall Study|Withdrawal by Subject|1|||
129163066|NCT00349349|464890835|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
129163067|NCT00349349|464890836|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
129163068|NCT00349349|464890837|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
129163069|NCT00349349|464890835|FG000|Overall Study|Death|13|||
129163070|NCT00349349|464890836|FG001|Overall Study|Death|10|||
129163071|NCT00349349|464890837|FG002|Overall Study|Death|1|||
129163072|NCT00349349|464890835|FG000|Overall Study|Other Treatment Selected|2|||
129163073|NCT00349349|464890836|FG001|Overall Study|Other Treatment Selected|0|||
129163074|NCT00349349|464890837|FG002|Overall Study|Other Treatment Selected|0|||
129163075|NCT00349349|464890835|FG000|Overall Study|Participant Reduced General Condition|0|||
129163076|NCT00349349|464890836|FG001|Overall Study|Participant Reduced General Condition|1|||
129163077|NCT00349349|464890837|FG002|Overall Study|Participant Reduced General Condition|0|||
129163078|NCT00349349|464890835|FG000|Overall Study|Physician Decision|1|||
129163079|NCT00349349|464890836|FG001|Overall Study|Physician Decision|2|||
129163080|NCT00349349|464890837|FG002|Overall Study|Physician Decision|1|||
129163081|NCT00349349|464890835|FG000|Overall Study|No Response|0|||
129163082|NCT00349349|464890836|FG001|Overall Study|No Response|3|||
129163083|NCT00349349|464890837|FG002|Overall Study|No Response|0|||
129163084|NCT00349349|464890835|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
129163085|NCT00349349|464890836|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
129163086|NCT00349349|464890837|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
129163087|NCT01854775|464890842|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
129163088|NCT01854775|464890843|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
129163089|NCT01854775|464890844|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
129163090|NCT01854775|464890842|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
129163091|NCT01854775|464890843|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
129163092|NCT01854775|464890844|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
129163093|NCT01854775|464890842|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
129163094|NCT01854775|464890843|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
129163095|NCT01854775|464890844|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
129163096|NCT01854775|464890842|FG000|Extension Phase|Pregnancy|3|||
128726441|NCT02586012|463296948|FG004|Overall Study|Withdrawal by Subject|0|||
128726442|NCT02586012|463296949|FG005|Overall Study|Withdrawal by Subject|2|||
128726443|NCT02586012|463296944|FG000|Overall Study|Protocol Violation|0|||
128726444|NCT02586012|463296945|FG001|Overall Study|Protocol Violation|0|||
128726445|NCT02586012|463296946|FG002|Overall Study|Protocol Violation|0|||
128726446|NCT02586012|463296947|FG003|Overall Study|Protocol Violation|0|||
128726447|NCT02586012|463296948|FG004|Overall Study|Protocol Violation|0|||
128726448|NCT02586012|463296949|FG005|Overall Study|Protocol Violation|1|||
129163097|NCT01854775|464890843|FG001|Extension Phase|Pregnancy|0|||
129163098|NCT01854775|464890844|FG002|Extension Phase|Pregnancy|0|||
129163099|NCT01854775|464890842|FG000|Extension Phase|Investigator's Discretion|1|||
128726449|NCT02586012|463296944|FG000|Overall Study|study terminated|0|||
129163100|NCT01854775|464890843|FG001|Extension Phase|Investigator's Discretion|0|||
129163101|NCT01854775|464890844|FG002|Extension Phase|Investigator's Discretion|0|||
129163102|NCT01854775|464890842|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
129163103|NCT01854775|464890843|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
129163104|NCT01854775|464890844|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
128726450|NCT02586012|463296945|FG001|Overall Study|study terminated|2|||
128776925|NCT04707391|463472048|FG000|Overall Study|Withdrawal by Subject|27|||
128776926|NCT04707391|463472049|FG001|Overall Study|Withdrawal by Subject|25|||
128776927|NCT04707391|463472048|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
128776928|NCT04707391|463472049|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
128776929|NCT04707391|463472048|FG000|Overall Study|Other|0|||
128776930|NCT04707391|463472049|FG001|Overall Study|Other|2|||
128776931|NCT03246672|463472050|FG000|Overall Study|Lost to Follow-up|2|||
128776932|NCT01347645|463472051|FG000|Overall Study|Death|1|||
128776933|NCT01347645|463472052|FG001|Overall Study|Death|5|||
128776934|NCT01347645|463472053|FG002|Overall Study|Death|2|||
128776935|NCT01347645|463472054|FG003|Overall Study|Death|7|||
128776936|NCT01347645|463472055|FG004|Overall Study|Death|7|||
129163105|NCT01854775|464890842|FG000|Extension Phase|Lost to Follow-up|2|||
129163106|NCT01854775|464890843|FG001|Extension Phase|Lost to Follow-up|0|||
129163107|NCT01854775|464890844|FG002|Extension Phase|Lost to Follow-up|0|||
129163108|NCT01854775|464890842|FG000|Extension Phase|Still on Study|32|||
129163109|NCT01854775|464890843|FG001|Extension Phase|Still on Study|47|||
129163110|NCT01854775|464890844|FG002|Extension Phase|Still on Study|18|||
129163111|NCT05111002|464890845|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
129163112|NCT05111002|464890846|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
129163113|NCT05111002|464890845|FG000|Secondary Outcome|Lost to Follow-up|1|||
129163114|NCT05111002|464890846|FG001|Secondary Outcome|Lost to Follow-up|0|||
129163115|NCT04776720|464890849|FG000|Overall Study|COVID Related|4|||
129163116|NCT04776720|464890850|FG001|Overall Study|COVID Related|2|||
129163117|NCT04776720|464890849|FG000|Overall Study|Adverse Event|2|||
129163118|NCT04776720|464890850|FG001|Overall Study|Adverse Event|0|||
129163119|NCT04776720|464890849|FG000|Overall Study|Serious Adverse Event|0|||
129163120|NCT04776720|464890850|FG001|Overall Study|Serious Adverse Event|1|||
129163121|NCT04776720|464890849|FG000|Overall Study|Too Busy|3|||
129163122|NCT04776720|464890850|FG001|Overall Study|Too Busy|1|||
129163123|NCT04776720|464890849|FG000|Overall Study|Lost to Follow-up|1|||
129163124|NCT04776720|464890850|FG001|Overall Study|Lost to Follow-up|2|||
129163125|NCT04776720|464890849|FG000|Overall Study|Family|2|||
129163126|NCT04776720|464890850|FG001|Overall Study|Family|2|||
129163127|NCT04776720|464890849|FG000|Overall Study|No remote technology access|0|||
129163128|NCT04776720|464890850|FG001|Overall Study|No remote technology access|1|||
129163129|NCT04776720|464890849|FG000|Overall Study|Withdrawal by Subject|1|||
129163130|NCT04776720|464890850|FG001|Overall Study|Withdrawal by Subject|0|||
129163131|NCT04776720|464890849|FG000|Overall Study|Cannot tolerate intervention|1|||
129163132|NCT04776720|464890850|FG001|Overall Study|Cannot tolerate intervention|0|||
129163133|NCT04776720|464890849|FG000|Overall Study|Incomplete outcome data|6|||
129163134|NCT04776720|464890850|FG001|Overall Study|Incomplete outcome data|1|||
129163135|NCT05356910|464890851|FG000|Overall Study|Lost to Follow-up|10|||
129163136|NCT05356910|464890852|FG001|Overall Study|Lost to Follow-up|19|||
129163137|NCT05356910|464890853|FG002|Overall Study|Lost to Follow-up|0|||
129163138|NCT05356910|464890854|FG003|Overall Study|Lost to Follow-up|0|||
129163139|NCT05356910|464890851|FG000|Overall Study|Withdrawal by Subject|4|||
129163140|NCT05356910|464890852|FG001|Overall Study|Withdrawal by Subject|2|||
129163141|NCT05356910|464890853|FG002|Overall Study|Withdrawal by Subject|0|||
129163142|NCT05356910|464890854|FG003|Overall Study|Withdrawal by Subject|0|||
129163143|NCT03122145|464890856|FG000|Overall Study|Concurrent respiratory disease|3|||
129163144|NCT03122145|464890857|FG001|Overall Study|Concurrent respiratory disease|0|||
129163145|NCT01597908|464890858|FG000|Randomized Phase|Death|217|||
129163146|NCT01597908|464890859|FG001|Randomized Phase|Death|238|||
129163147|NCT01597908|464890860|FG002|Randomized Phase|Death|0|||
129163148|NCT01597908|464890858|FG000|Randomized Phase|Sponsor Decision|93|||
129163149|NCT01597908|464890859|FG001|Randomized Phase|Sponsor Decision|39|||
129163150|NCT01597908|464890860|FG002|Randomized Phase|Sponsor Decision|0|||
129163151|NCT01597908|464890858|FG000|Randomized Phase|Lost to Follow-up|9|||
128776937|NCT01347645|463472051|FG000|Overall Study|Lost to Follow-up|1|||
128776938|NCT01347645|463472052|FG001|Overall Study|Lost to Follow-up|1|||
128776939|NCT01347645|463472053|FG002|Overall Study|Lost to Follow-up|0|||
129163152|NCT01597908|464890859|FG001|Randomized Phase|Lost to Follow-up|16|||
128982110|NCT01190839|464219094|FG001|Overall Study|Trial stopped by Sponsor|68|||
128982111|NCT01190839|464219093|FG000|Overall Study|Undefined|35|||
128982112|NCT01190839|464219094|FG001|Overall Study|Undefined|31|||
128982113|NCT01190839|464219093|FG000|Overall Study|Randomized but not treated|2|||
128982114|NCT01190839|464219094|FG001|Overall Study|Randomized but not treated|4|||
128982115|NCT02993731|464219098|FG000|Overall Study|Study Termination|101|||
128982116|NCT02993731|464219099|FG001|Overall Study|Study Termination|105|||
128982117|NCT02545504|464219103|FG000|Overall Study|Death|174|||
128982118|NCT02545504|464219104|FG001|Overall Study|Death|168|||
129163153|NCT01597908|464890860|FG002|Randomized Phase|Lost to Follow-up|0|||
129163154|NCT01597908|464890858|FG000|Randomized Phase|Physician Decision|6|||
129163155|NCT01597908|464890859|FG001|Randomized Phase|Physician Decision|3|||
129163156|NCT01597908|464890860|FG002|Randomized Phase|Physician Decision|0|||
129163157|NCT01597908|464890858|FG000|Randomized Phase|Withdrawal by Subject|26|||
128776940|NCT01347645|463472054|FG003|Overall Study|Lost to Follow-up|1|||
128776941|NCT01347645|463472055|FG004|Overall Study|Lost to Follow-up|1|||
129163158|NCT01597908|464890859|FG001|Randomized Phase|Withdrawal by Subject|22|||
129163159|NCT01597908|464890860|FG002|Randomized Phase|Withdrawal by Subject|0|||
129163160|NCT01597908|464890858|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
129163161|NCT01597908|464890859|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
129163162|NCT01597908|464890860|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
129163163|NCT01597908|464890858|FG000|Crossover Phase|Death|0|||
129163164|NCT01597908|464890859|FG001|Crossover Phase|Death|0|||
129163165|NCT01597908|464890860|FG002|Crossover Phase|Death|11|||
129163166|NCT01597908|464890858|FG000|Crossover Phase|Withdrawal by Subject|0|||
129163167|NCT01597908|464890859|FG001|Crossover Phase|Withdrawal by Subject|0|||
129163168|NCT01597908|464890860|FG002|Crossover Phase|Withdrawal by Subject|3|||
129163169|NCT01597908|464890858|FG000|Crossover Phase|Sponsor Decision|0|||
129163170|NCT01597908|464890859|FG001|Crossover Phase|Sponsor Decision|0|||
129163171|NCT01597908|464890860|FG002|Crossover Phase|Sponsor Decision|20|||
129163172|NCT00837161|464890861|FG000|Overall Study|refused hysterectomy|2|||
129163173|NCT01659996|464890864|FG000|Overall Study|Protocol Violation|3|||
129163174|NCT01659996|464890865|FG001|Overall Study|Protocol Violation|3|||
129163175|NCT01659996|464890866|FG002|Overall Study|Protocol Violation|3|||
129163176|NCT01659996|464890864|FG000|Overall Study|Lost to Follow-up|1|||
129163177|NCT01659996|464890865|FG001|Overall Study|Lost to Follow-up|3|||
129163178|NCT01659996|464890866|FG002|Overall Study|Lost to Follow-up|2|||
129163179|NCT01659996|464890864|FG000|Overall Study|Adverse Event|0|||
129163180|NCT01659996|464890865|FG001|Overall Study|Adverse Event|0|||
129163181|NCT01659996|464890866|FG002|Overall Study|Adverse Event|1|||
129163182|NCT01659996|464890864|FG000|Overall Study|Withdrawal by Subject|4|||
129163183|NCT01659996|464890865|FG001|Overall Study|Withdrawal by Subject|1|||
129163184|NCT01659996|464890866|FG002|Overall Study|Withdrawal by Subject|5|||
129163185|NCT02709577|464890867|FG000|Overall Study|non-accommodating anatomy|0|||
129163186|NCT02709577|464890868|FG001|Overall Study|non-accommodating anatomy|1|||
129163187|NCT02709577|464890869|FG002|Overall Study|non-accommodating anatomy|0|||
129163188|NCT02709577|464890870|FG003|Overall Study|non-accommodating anatomy|0|||
129163189|NCT02709577|464890867|FG000|Overall Study|procedural complication|0|||
129163190|NCT02709577|464890868|FG001|Overall Study|procedural complication|1|||
129163191|NCT02709577|464890869|FG002|Overall Study|procedural complication|0|||
129163192|NCT02709577|464890870|FG003|Overall Study|procedural complication|0|||
129163193|NCT02709577|464890867|FG000|Overall Study|Withdrawal by Subject|2|||
129163194|NCT02709577|464890868|FG001|Overall Study|Withdrawal by Subject|3|||
129163195|NCT02709577|464890869|FG002|Overall Study|Withdrawal by Subject|2|||
129163196|NCT02709577|464890870|FG003|Overall Study|Withdrawal by Subject|0|||
129163197|NCT03744910|464893424|FG000|Overall Study|Withdrew Consent|1|||
129163198|NCT03744910|464893425|FG001|Overall Study|Withdrew Consent|8|||
129163199|NCT03744910|464893424|FG000|Overall Study|Physician Decision|5|||
129163200|NCT03744910|464893425|FG001|Overall Study|Physician Decision|4|||
129163201|NCT03744910|464893424|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
129163202|NCT03744910|464893425|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
129163203|NCT03744910|464893424|FG000|Overall Study|Lost to Follow-up|0|||
129163204|NCT03744910|464893425|FG001|Overall Study|Lost to Follow-up|1|||
129163205|NCT03744910|464893424|FG000|Overall Study|Other-unspecified|4|||
129163206|NCT03744910|464893425|FG001|Overall Study|Other-unspecified|1|||
129163207|NCT00064259|464893426|FG000|Overall Study|Adverse Event|1|||
129163208|NCT00064259|464893427|FG001|Overall Study|Adverse Event|0|||
129163209|NCT00064259|464893428|FG002|Overall Study|Adverse Event|0|||
129163210|NCT00064259|464893429|FG003|Overall Study|Adverse Event|1|||
129163211|NCT01132651|464893432|FG000|Overall Study|Lost to Follow-up|1|||
129163212|NCT01132651|464893433|FG001|Overall Study|Lost to Follow-up|1|||
129163213|NCT00948857|464893434|FG000|Overall Study|Lost to Follow-up|1|||
129163214|NCT00948857|464893435|FG001|Overall Study|Lost to Follow-up|0|||
129163215|NCT03430843|464893438|FG000|Overall Study|Death|233|||
129163216|NCT03430843|464893439|FG001|Overall Study|Death|233|||
129163217|NCT03430843|464893438|FG000|Overall Study|Sponsor Decision|17|||
129163218|NCT03430843|464893439|FG001|Overall Study|Sponsor Decision|6|||
129163219|NCT03430843|464893438|FG000|Overall Study|Withdrawal by Subject|5|||
129163220|NCT03430843|464893439|FG001|Overall Study|Withdrawal by Subject|14|||
128726451|NCT02586012|463296946|FG002|Overall Study|study terminated|1|||
128726452|NCT02586012|463296947|FG003|Overall Study|study terminated|1|||
128726453|NCT02586012|463296948|FG004|Overall Study|study terminated|1|||
128726454|NCT02586012|463296949|FG005|Overall Study|study terminated|0|||
128726455|NCT02388737|463296950|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
128726456|NCT02388737|463296951|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
128726457|NCT02388737|463296952|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
128726458|NCT02388737|463296950|FG000|Overall Study|Major Protocol Deviation|18|||
129163221|NCT03430843|464893438|FG000|Overall Study|Lost to Follow-up|1|||
129163222|NCT03430843|464893439|FG001|Overall Study|Lost to Follow-up|3|||
129163223|NCT01905943|464893446|FG000|Overall Study|Withdrawal of consent|90|||
129163224|NCT01905943|464893446|FG000|Overall Study|Lost to Follow-up|16|||
129163225|NCT01905943|464893446|FG000|Overall Study|Investigator discretion|7|||
129163226|NCT01905943|464893446|FG000|Overall Study|Death|186|||
129163227|NCT01905943|464893446|FG000|Overall Study|Adverse Event|3|||
129163228|NCT01905943|464893446|FG000|Overall Study|Other|12|||
129163229|NCT02574078|464893447|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163230|NCT02574078|464893448|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163231|NCT02574078|464893449|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163232|NCT02574078|464893450|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163233|NCT02574078|464893451|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163234|NCT02574078|464893452|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129163235|NCT02574078|464893453|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
129163236|NCT02574078|464893454|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163237|NCT02574078|464893455|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129163238|NCT02574078|464893456|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163239|NCT02574078|464893457|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163240|NCT02574078|464893458|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163241|NCT02574078|464893459|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129163242|NCT02574078|464893447|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
129163243|NCT02574078|464893448|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129163244|NCT02574078|464893449|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
129163245|NCT02574078|464893450|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
129163246|NCT02574078|464893451|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
129163247|NCT02574078|464893452|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
129163248|NCT02574078|464893453|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
129163249|NCT02574078|464893454|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
129163250|NCT02574078|464893455|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
129163251|NCT02574078|464893456|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
129163252|NCT02574078|464893457|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
129163253|NCT02574078|464893458|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
129163254|NCT02574078|464893459|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
129163255|NCT02574078|464893447|FG000|Pre-Treatment Period|Other reasons|0|||
129163256|NCT02574078|464893448|FG001|Pre-Treatment Period|Other reasons|0|||
129163257|NCT02574078|464893449|FG002|Pre-Treatment Period|Other reasons|0|||
129163258|NCT02574078|464893450|FG003|Pre-Treatment Period|Other reasons|0|||
129163259|NCT02574078|464893451|FG004|Pre-Treatment Period|Other reasons|0|||
129163260|NCT02574078|464893452|FG005|Pre-Treatment Period|Other reasons|0|||
129163261|NCT02574078|464893453|FG006|Pre-Treatment Period|Other reasons|2|||
129163262|NCT02574078|464893454|FG007|Pre-Treatment Period|Other reasons|0|||
129163263|NCT02574078|464893455|FG008|Pre-Treatment Period|Other reasons|0|||
129163264|NCT02574078|464893456|FG009|Pre-Treatment Period|Other reasons|0|||
129163265|NCT02574078|464893457|FG010|Pre-Treatment Period|Other reasons|2|||
129163266|NCT02574078|464893458|FG011|Pre-Treatment Period|Other reasons|0|||
129163267|NCT02574078|464893459|FG012|Pre-Treatment Period|Other reasons|0|||
129163268|NCT02574078|464893447|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
129163269|NCT02574078|464893448|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
129163270|NCT02574078|464893449|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
129163271|NCT02574078|464893450|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
129163272|NCT02574078|464893451|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
129163273|NCT02574078|464893452|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
129163274|NCT02574078|464893453|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
129163275|NCT02574078|464893454|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
129163276|NCT02574078|464893455|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
129163277|NCT02574078|464893456|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
128726459|NCT02388737|463296951|FG001|Overall Study|Major Protocol Deviation|25|||
128726460|NCT02388737|463296952|FG002|Overall Study|Major Protocol Deviation|22|||
129163278|NCT02574078|464893457|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
129163279|NCT02574078|464893458|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
129163280|NCT02574078|464893459|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
129163281|NCT02574078|464893447|FG000|Treatment Period|Disease progression|6|||
129163282|NCT02574078|464893448|FG001|Treatment Period|Disease progression|4|||
129163283|NCT02574078|464893449|FG002|Treatment Period|Disease progression|7|||
129163284|NCT02574078|464893450|FG003|Treatment Period|Disease progression|18|||
128726461|NCT02388737|463296950|FG000|Overall Study|Lost to Follow-up|5|||
129163285|NCT02574078|464893451|FG004|Treatment Period|Disease progression|16|||
128726462|NCT02388737|463296951|FG001|Overall Study|Lost to Follow-up|1|||
128726463|NCT02388737|463296952|FG002|Overall Study|Lost to Follow-up|4|||
129163286|NCT02574078|464893452|FG005|Treatment Period|Disease progression|26|||
129163287|NCT02574078|464893453|FG006|Treatment Period|Disease progression|5|||
129163288|NCT02574078|464893454|FG007|Treatment Period|Disease progression|9|||
129163289|NCT02574078|464893455|FG008|Treatment Period|Disease progression|8|||
129163290|NCT02574078|464893456|FG009|Treatment Period|Disease progression|5|||
129163291|NCT02574078|464893457|FG010|Treatment Period|Disease progression|20|||
129163292|NCT02574078|464893458|FG011|Treatment Period|Disease progression|29|||
129163293|NCT02574078|464893459|FG012|Treatment Period|Disease progression|2|||
129163294|NCT02574078|464893447|FG000|Treatment Period|Study drug toxicity|1|||
129163295|NCT02574078|464893448|FG001|Treatment Period|Study drug toxicity|1|||
129163296|NCT02574078|464893449|FG002|Treatment Period|Study drug toxicity|0|||
129163297|NCT02574078|464893450|FG003|Treatment Period|Study drug toxicity|5|||
129163298|NCT02574078|464893451|FG004|Treatment Period|Study drug toxicity|3|||
129163299|NCT02574078|464893452|FG005|Treatment Period|Study drug toxicity|1|||
129163300|NCT02574078|464893453|FG006|Treatment Period|Study drug toxicity|2|||
129163301|NCT02574078|464893454|FG007|Treatment Period|Study drug toxicity|0|||
129163302|NCT02574078|464893455|FG008|Treatment Period|Study drug toxicity|2|||
129163303|NCT02574078|464893456|FG009|Treatment Period|Study drug toxicity|1|||
129163304|NCT02574078|464893457|FG010|Treatment Period|Study drug toxicity|16|||
129163305|NCT02574078|464893458|FG011|Treatment Period|Study drug toxicity|2|||
129163306|NCT02574078|464893459|FG012|Treatment Period|Study drug toxicity|4|||
129163307|NCT02574078|464893447|FG000|Treatment Period|Death|2|||
129163308|NCT02574078|464893448|FG001|Treatment Period|Death|0|||
129163309|NCT02574078|464893449|FG002|Treatment Period|Death|0|||
129163310|NCT02574078|464893450|FG003|Treatment Period|Death|0|||
129163311|NCT02574078|464893451|FG004|Treatment Period|Death|1|||
129163312|NCT02574078|464893452|FG005|Treatment Period|Death|1|||
129163313|NCT02574078|464893453|FG006|Treatment Period|Death|1|||
129163314|NCT02574078|464893454|FG007|Treatment Period|Death|1|||
129163315|NCT02574078|464893455|FG008|Treatment Period|Death|7|||
129163316|NCT02574078|464893456|FG009|Treatment Period|Death|1|||
129163317|NCT02574078|464893457|FG010|Treatment Period|Death|0|||
129163318|NCT02574078|464893458|FG011|Treatment Period|Death|2|||
129163319|NCT02574078|464893459|FG012|Treatment Period|Death|1|||
129163320|NCT02574078|464893447|FG000|Treatment Period|Adverse event unrelated to drug|0|||
129163321|NCT02574078|464893448|FG001|Treatment Period|Adverse event unrelated to drug|0|||
129163322|NCT02574078|464893449|FG002|Treatment Period|Adverse event unrelated to drug|1|||
129163323|NCT02574078|464893450|FG003|Treatment Period|Adverse event unrelated to drug|0|||
129163324|NCT02574078|464893451|FG004|Treatment Period|Adverse event unrelated to drug|2|||
129163325|NCT02574078|464893452|FG005|Treatment Period|Adverse event unrelated to drug|3|||
129163326|NCT02574078|464893453|FG006|Treatment Period|Adverse event unrelated to drug|0|||
129163327|NCT02574078|464893454|FG007|Treatment Period|Adverse event unrelated to drug|0|||
129163328|NCT02574078|464893455|FG008|Treatment Period|Adverse event unrelated to drug|1|||
129163329|NCT02574078|464893456|FG009|Treatment Period|Adverse event unrelated to drug|2|||
129163330|NCT02574078|464893457|FG010|Treatment Period|Adverse event unrelated to drug|4|||
129163331|NCT02574078|464893458|FG011|Treatment Period|Adverse event unrelated to drug|1|||
129163332|NCT02574078|464893459|FG012|Treatment Period|Adverse event unrelated to drug|0|||
129163333|NCT02574078|464893447|FG000|Treatment Period|Administrative reason by Sponsor|0|||
129163334|NCT02574078|464893448|FG001|Treatment Period|Administrative reason by Sponsor|1|||
129163335|NCT02574078|464893449|FG002|Treatment Period|Administrative reason by Sponsor|0|||
129163336|NCT02574078|464893450|FG003|Treatment Period|Administrative reason by Sponsor|0|||
129163337|NCT02574078|464893451|FG004|Treatment Period|Administrative reason by Sponsor|0|||
129163338|NCT02574078|464893452|FG005|Treatment Period|Administrative reason by Sponsor|0|||
129163339|NCT02574078|464893453|FG006|Treatment Period|Administrative reason by Sponsor|1|||
129163340|NCT02574078|464893454|FG007|Treatment Period|Administrative reason by Sponsor|0|||
129163341|NCT02574078|464893455|FG008|Treatment Period|Administrative reason by Sponsor|0|||
129163342|NCT02574078|464893456|FG009|Treatment Period|Administrative reason by Sponsor|0|||
129163343|NCT02574078|464893457|FG010|Treatment Period|Administrative reason by Sponsor|0|||
129163344|NCT02574078|464893458|FG011|Treatment Period|Administrative reason by Sponsor|0|||
129163345|NCT02574078|464893459|FG012|Treatment Period|Administrative reason by Sponsor|3|||
129163346|NCT02574078|464893447|FG000|Treatment Period|Other reasons|1|||
129163347|NCT02574078|464893448|FG001|Treatment Period|Other reasons|0|||
129163348|NCT02574078|464893449|FG002|Treatment Period|Other reasons|1|||
129163349|NCT02574078|464893450|FG003|Treatment Period|Other reasons|3|||
129163350|NCT02574078|464893451|FG004|Treatment Period|Other reasons|3|||
129163351|NCT02574078|464893452|FG005|Treatment Period|Other reasons|1|||
128726464|NCT02388737|463296950|FG000|Overall Study|Voluntary Withdrawal|10|||
128726465|NCT02388737|463296951|FG001|Overall Study|Voluntary Withdrawal|18|||
129163352|NCT02574078|464893453|FG006|Treatment Period|Other reasons|2|||
129163353|NCT02574078|464893454|FG007|Treatment Period|Other reasons|1|||
129163354|NCT02574078|464893455|FG008|Treatment Period|Other reasons|3|||
129163355|NCT02574078|464893456|FG009|Treatment Period|Other reasons|1|||
129163356|NCT02574078|464893457|FG010|Treatment Period|Other reasons|1|||
129163357|NCT02574078|464893458|FG011|Treatment Period|Other reasons|3|||
129163358|NCT02574078|464893459|FG012|Treatment Period|Other reasons|1|||
129163359|NCT02574078|464893447|FG000|Treatment Period|Participant request to stop drug|0|||
129163360|NCT02574078|464893448|FG001|Treatment Period|Participant request to stop drug|0|||
129163361|NCT02574078|464893449|FG002|Treatment Period|Participant request to stop drug|0|||
129163362|NCT02574078|464893450|FG003|Treatment Period|Participant request to stop drug|2|||
128982119|NCT02545504|464219103|FG000|Overall Study|Unknown reason|30|||
129163363|NCT02574078|464893451|FG004|Treatment Period|Participant request to stop drug|4|||
129163364|NCT02574078|464893452|FG005|Treatment Period|Participant request to stop drug|0|||
129163365|NCT02574078|464893453|FG006|Treatment Period|Participant request to stop drug|1|||
129163366|NCT02574078|464893454|FG007|Treatment Period|Participant request to stop drug|0|||
129163367|NCT02574078|464893455|FG008|Treatment Period|Participant request to stop drug|3|||
129163368|NCT02574078|464893456|FG009|Treatment Period|Participant request to stop drug|2|||
129163369|NCT02574078|464893457|FG010|Treatment Period|Participant request to stop drug|2|||
129163370|NCT02574078|464893458|FG011|Treatment Period|Participant request to stop drug|4|||
129163371|NCT02574078|464893459|FG012|Treatment Period|Participant request to stop drug|1|||
129163372|NCT02574078|464893447|FG000|Treatment Period|Participant withdrew consent|0|||
129163373|NCT02574078|464893448|FG001|Treatment Period|Participant withdrew consent|0|||
129163374|NCT02574078|464893449|FG002|Treatment Period|Participant withdrew consent|0|||
129163375|NCT02574078|464893450|FG003|Treatment Period|Participant withdrew consent|0|||
129163376|NCT02574078|464893451|FG004|Treatment Period|Participant withdrew consent|1|||
129163377|NCT02574078|464893452|FG005|Treatment Period|Participant withdrew consent|1|||
129163378|NCT02574078|464893453|FG006|Treatment Period|Participant withdrew consent|0|||
129163379|NCT02574078|464893454|FG007|Treatment Period|Participant withdrew consent|1|||
129163380|NCT02574078|464893455|FG008|Treatment Period|Participant withdrew consent|0|||
129163381|NCT02574078|464893456|FG009|Treatment Period|Participant withdrew consent|2|||
129163382|NCT02574078|464893457|FG010|Treatment Period|Participant withdrew consent|1|||
129163383|NCT02574078|464893458|FG011|Treatment Period|Participant withdrew consent|4|||
128726466|NCT02388737|463296952|FG002|Overall Study|Voluntary Withdrawal|17|||
129163384|NCT02574078|464893459|FG012|Treatment Period|Participant withdrew consent|1|||
128726467|NCT02388737|463296950|FG000|Overall Study|Lack of Efficacy|3|||
128726468|NCT02388737|463296951|FG001|Overall Study|Lack of Efficacy|0|||
128726469|NCT02388737|463296952|FG002|Overall Study|Lack of Efficacy|3|||
128726470|NCT02388737|463296950|FG000|Overall Study|Reason Not Specified|5|||
128726471|NCT02388737|463296951|FG001|Overall Study|Reason Not Specified|5|||
128726472|NCT02388737|463296952|FG002|Overall Study|Reason Not Specified|4|||
128726473|NCT03252522|463296953|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
128726474|NCT03252522|463296954|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
128726475|NCT03252522|463296955|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
128726476|NCT03252522|463296953|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
128726477|NCT03252522|463296954|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
128726478|NCT03252522|463296955|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
128726479|NCT03252522|463296953|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
129163385|NCT02574078|464893447|FG000|Treatment Period|Participant no longer meets criteria|0|||
129163386|NCT02574078|464893448|FG001|Treatment Period|Participant no longer meets criteria|0|||
129163387|NCT02574078|464893449|FG002|Treatment Period|Participant no longer meets criteria|0|||
129163388|NCT02574078|464893450|FG003|Treatment Period|Participant no longer meets criteria|0|||
128726480|NCT03252522|463296954|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
128726481|NCT03252522|463296955|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
128726482|NCT03252522|463296953|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
129163389|NCT02574078|464893451|FG004|Treatment Period|Participant no longer meets criteria|1|||
129163390|NCT02574078|464893452|FG005|Treatment Period|Participant no longer meets criteria|0|||
129163391|NCT02574078|464893453|FG006|Treatment Period|Participant no longer meets criteria|0|||
129163392|NCT02574078|464893454|FG007|Treatment Period|Participant no longer meets criteria|0|||
129163393|NCT02574078|464893455|FG008|Treatment Period|Participant no longer meets criteria|0|||
129163394|NCT02574078|464893456|FG009|Treatment Period|Participant no longer meets criteria|1|||
129163395|NCT02574078|464893457|FG010|Treatment Period|Participant no longer meets criteria|1|||
129163396|NCT02574078|464893458|FG011|Treatment Period|Participant no longer meets criteria|1|||
129163397|NCT02574078|464893459|FG012|Treatment Period|Participant no longer meets criteria|0|||
129163398|NCT02574078|464893447|FG000|Treatment Period|Lost to Follow-up|0|||
129163399|NCT02574078|464893448|FG001|Treatment Period|Lost to Follow-up|0|||
129163400|NCT02574078|464893449|FG002|Treatment Period|Lost to Follow-up|0|||
129163401|NCT02574078|464893450|FG003|Treatment Period|Lost to Follow-up|0|||
129163402|NCT02574078|464893451|FG004|Treatment Period|Lost to Follow-up|0|||
128726483|NCT03252522|463296954|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
129163403|NCT02574078|464893452|FG005|Treatment Period|Lost to Follow-up|0|||
129163404|NCT02574078|464893453|FG006|Treatment Period|Lost to Follow-up|0|||
129163405|NCT02574078|464893454|FG007|Treatment Period|Lost to Follow-up|0|||
129163406|NCT02574078|464893455|FG008|Treatment Period|Lost to Follow-up|0|||
128726484|NCT03252522|463296955|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
128726485|NCT03252522|463296953|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
128726486|NCT03252522|463296954|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
128726487|NCT03252522|463296955|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
128726488|NCT03252522|463296953|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
129163407|NCT02574078|464893456|FG009|Treatment Period|Lost to Follow-up|1|||
129163408|NCT02574078|464893457|FG010|Treatment Period|Lost to Follow-up|0|||
129163409|NCT02574078|464893458|FG011|Treatment Period|Lost to Follow-up|1|||
129163410|NCT02574078|464893459|FG012|Treatment Period|Lost to Follow-up|0|||
129163411|NCT02574078|464893447|FG000|Treatment Period|Maximum clinical benefit|0|||
129163412|NCT02574078|464893448|FG001|Treatment Period|Maximum clinical benefit|0|||
129163413|NCT02574078|464893449|FG002|Treatment Period|Maximum clinical benefit|0|||
129163414|NCT02574078|464893450|FG003|Treatment Period|Maximum clinical benefit|0|||
129163415|NCT02574078|464893451|FG004|Treatment Period|Maximum clinical benefit|0|||
128726489|NCT03252522|463296954|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
128726490|NCT03252522|463296955|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
128726491|NCT03252522|463296953|FG000|Phase 2: Open Label|Adverse Event|0|||
128726492|NCT03252522|463296954|FG001|Phase 2: Open Label|Adverse Event|0|||
128726493|NCT03252522|463296955|FG002|Phase 2: Open Label|Adverse Event|2|||
128726494|NCT03252522|463296953|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
129163416|NCT02574078|464893452|FG005|Treatment Period|Maximum clinical benefit|0|||
129163417|NCT02574078|464893453|FG006|Treatment Period|Maximum clinical benefit|0|||
129163418|NCT02574078|464893454|FG007|Treatment Period|Maximum clinical benefit|0|||
129163419|NCT02574078|464893455|FG008|Treatment Period|Maximum clinical benefit|0|||
129163420|NCT02574078|464893456|FG009|Treatment Period|Maximum clinical benefit|1|||
129163421|NCT02574078|464893457|FG010|Treatment Period|Maximum clinical benefit|0|||
129163422|NCT02574078|464893458|FG011|Treatment Period|Maximum clinical benefit|0|||
129163423|NCT02574078|464893459|FG012|Treatment Period|Maximum clinical benefit|0|||
129163424|NCT03037476|464893460|FG000|Overall Study|Lost to Follow-up|63|||
129163425|NCT03037476|464893461|FG001|Overall Study|Lost to Follow-up|46|||
129163426|NCT00135330|464893462|FG000|Overall Study|Adverse Event|2|||
129163427|NCT00135330|464893463|FG001|Overall Study|Adverse Event|5|||
129163428|NCT00135330|464893464|FG002|Overall Study|Adverse Event|1|||
129163429|NCT00135330|464893462|FG000|Overall Study|Lost to Follow-up|0|||
129163430|NCT00135330|464893463|FG001|Overall Study|Lost to Follow-up|2|||
129163431|NCT00135330|464893464|FG002|Overall Study|Lost to Follow-up|3|||
129163432|NCT00135330|464893462|FG000|Overall Study|Physician Decision|1|||
129163433|NCT00135330|464893463|FG001|Overall Study|Physician Decision|1|||
129163434|NCT00135330|464893464|FG002|Overall Study|Physician Decision|0|||
129163435|NCT00135330|464893462|FG000|Overall Study|Protocol Violation|4|||
129163436|NCT00135330|464893463|FG001|Overall Study|Protocol Violation|3|||
129163437|NCT00135330|464893464|FG002|Overall Study|Protocol Violation|3|||
129163438|NCT00135330|464893462|FG000|Overall Study|Patient Decision|5|||
129163439|NCT00135330|464893463|FG001|Overall Study|Patient Decision|1|||
129163440|NCT00135330|464893464|FG002|Overall Study|Patient Decision|4|||
129163441|NCT00135330|464893462|FG000|Overall Study|Sponsor Decision|0|||
129163442|NCT00135330|464893463|FG001|Overall Study|Sponsor Decision|1|||
129163443|NCT00135330|464893464|FG002|Overall Study|Sponsor Decision|0|||
129163444|NCT00372619|464893465|FG000|Overall Study|Ineligible|0|||
129163445|NCT00372619|464893466|FG001|Overall Study|Ineligible|0|||
129163446|NCT00372619|464893467|FG002|Overall Study|Ineligible|0|||
129163447|NCT00372619|464893468|FG003|Overall Study|Ineligible|0|||
129163448|NCT00372619|464893469|FG004|Overall Study|Ineligible|0|||
129163449|NCT00372619|464893470|FG005|Overall Study|Ineligible|2|||
129163450|NCT00372619|464893471|FG006|Overall Study|Ineligible|0|||
129163451|NCT00372619|464893465|FG000|Overall Study|Inevaluable|0|||
129163452|NCT00372619|464893466|FG001|Overall Study|Inevaluable|0|||
129163453|NCT00372619|464893467|FG002|Overall Study|Inevaluable|0|||
129163454|NCT00372619|464893468|FG003|Overall Study|Inevaluable|0|||
129163455|NCT00372619|464893469|FG004|Overall Study|Inevaluable|0|||
129163456|NCT00372619|464893470|FG005|Overall Study|Inevaluable|1|||
129163457|NCT00372619|464893471|FG006|Overall Study|Inevaluable|0|||
129163458|NCT00066222|464893472|FG000|Overall Study|No protocol treatment received|1|||
129163459|NCT01524224|464893479|FG000|Overall Study|Progressive Disease|1|||
129163460|NCT01524224|464893480|FG001|Overall Study|Progressive Disease|0|||
129163461|NCT01524224|464893481|FG002|Overall Study|Progressive Disease|2|||
129163462|NCT01524224|464893482|FG003|Overall Study|Progressive Disease|1|||
129163463|NCT01524224|464893483|FG004|Overall Study|Progressive Disease|2|||
129163464|NCT01524224|464893484|FG005|Overall Study|Progressive Disease|1|||
129163465|NCT01524224|464893485|FG006|Overall Study|Progressive Disease|1|||
129163466|NCT01524224|464893486|FG007|Overall Study|Progressive Disease|5|||
129163467|NCT01524224|464893479|FG000|Overall Study|Withdrawal by Subject|2|||
129163468|NCT01524224|464893480|FG001|Overall Study|Withdrawal by Subject|0|||
129163469|NCT01524224|464893481|FG002|Overall Study|Withdrawal by Subject|0|||
129163470|NCT01524224|464893482|FG003|Overall Study|Withdrawal by Subject|0|||
129163471|NCT01524224|464893483|FG004|Overall Study|Withdrawal by Subject|0|||
129163472|NCT01524224|464893484|FG005|Overall Study|Withdrawal by Subject|0|||
129163473|NCT01524224|464893485|FG006|Overall Study|Withdrawal by Subject|2|||
128726495|NCT03252522|463296954|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
128726496|NCT03252522|463296955|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
129163474|NCT01524224|464893486|FG007|Overall Study|Withdrawal by Subject|0|||
129163475|NCT01524224|464893479|FG000|Overall Study|Adverse Event|0|||
129163476|NCT01524224|464893480|FG001|Overall Study|Adverse Event|1|||
129163477|NCT01524224|464893481|FG002|Overall Study|Adverse Event|0|||
129163478|NCT01524224|464893482|FG003|Overall Study|Adverse Event|0|||
129163479|NCT01524224|464893483|FG004|Overall Study|Adverse Event|0|||
129163480|NCT01524224|464893484|FG005|Overall Study|Adverse Event|1|||
129163481|NCT01524224|464893485|FG006|Overall Study|Adverse Event|0|||
129163482|NCT01524224|464893486|FG007|Overall Study|Adverse Event|0|||
129163483|NCT01524224|464893479|FG000|Overall Study|Physician Decision|0|||
129163484|NCT01524224|464893480|FG001|Overall Study|Physician Decision|0|||
129163485|NCT01524224|464893481|FG002|Overall Study|Physician Decision|0|||
129163486|NCT01524224|464893482|FG003|Overall Study|Physician Decision|1|||
129163487|NCT01524224|464893483|FG004|Overall Study|Physician Decision|1|||
129163488|NCT01524224|464893484|FG005|Overall Study|Physician Decision|0|||
129163489|NCT01524224|464893485|FG006|Overall Study|Physician Decision|0|||
129163490|NCT01524224|464893486|FG007|Overall Study|Physician Decision|1|||
129163491|NCT01524224|464893479|FG000|Overall Study|Sponsor Decision|0|||
129163492|NCT01524224|464893480|FG001|Overall Study|Sponsor Decision|0|||
129163493|NCT01524224|464893481|FG002|Overall Study|Sponsor Decision|0|||
129163494|NCT01524224|464893482|FG003|Overall Study|Sponsor Decision|0|||
129163495|NCT01524224|464893483|FG004|Overall Study|Sponsor Decision|1|||
129163496|NCT01524224|464893484|FG005|Overall Study|Sponsor Decision|0|||
129163497|NCT01524224|464893485|FG006|Overall Study|Sponsor Decision|0|||
129163498|NCT01524224|464893486|FG007|Overall Study|Sponsor Decision|0|||
129163499|NCT00615719|464893488|FG000|Overall Study|Physician Decision|5|||
129163500|NCT03517371|464893489|FG000|Overall Study|Adverse Event|8|||
129163501|NCT03517371|464893490|FG001|Overall Study|Adverse Event|9|||
129163502|NCT03517371|464893489|FG000|Overall Study|Lost to Follow-up|1|||
129163503|NCT03517371|464893490|FG001|Overall Study|Lost to Follow-up|2|||
129163504|NCT03517371|464893489|FG000|Overall Study|Withdrawal by Subject|4|||
129163505|NCT03517371|464893490|FG001|Overall Study|Withdrawal by Subject|4|||
129163506|NCT03517371|464893489|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
129163507|NCT03517371|464893490|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
129163508|NCT03517371|464893489|FG000|Overall Study|COVID restrictions|2|||
129163509|NCT03517371|464893490|FG001|Overall Study|COVID restrictions|0|||
129163510|NCT03517371|464893489|FG000|Overall Study|Receiving DBS Surgery|0|||
129163511|NCT03517371|464893490|FG001|Overall Study|Receiving DBS Surgery|1|||
129163512|NCT05420961|464893491|FG000|Overall Study|Withdrawal by Subject|2|||
129163513|NCT05420961|464893492|FG001|Overall Study|Withdrawal by Subject|1|||
129163514|NCT05420961|464893493|FG002|Overall Study|Withdrawal by Subject|1|||
129163515|NCT05420961|464893494|FG003|Overall Study|Withdrawal by Subject|0|||
129163516|NCT05420961|464893495|FG004|Overall Study|Withdrawal by Subject|0|||
129163517|NCT05420961|464893491|FG000|Overall Study|Lost to Follow-up|0|||
129163518|NCT05420961|464893492|FG001|Overall Study|Lost to Follow-up|0|||
129163519|NCT05420961|464893493|FG002|Overall Study|Lost to Follow-up|1|||
129163520|NCT05420961|464893494|FG003|Overall Study|Lost to Follow-up|0|||
129163521|NCT05420961|464893495|FG004|Overall Study|Lost to Follow-up|0|||
129163522|NCT05420961|464893491|FG000|Overall Study|Randomized by mistake without study treatment|0|||
129163523|NCT05420961|464893492|FG001|Overall Study|Randomized by mistake without study treatment|0|||
129163524|NCT05420961|464893493|FG002|Overall Study|Randomized by mistake without study treatment|1|||
129163525|NCT05420961|464893494|FG003|Overall Study|Randomized by mistake without study treatment|0|||
129163526|NCT05420961|464893495|FG004|Overall Study|Randomized by mistake without study treatment|1|||
129163527|NCT04283656|464893496|FG000|Overall Study|Adverse Event|1|||
129163528|NCT04283656|464893497|FG001|Overall Study|Adverse Event|0|||
129163529|NCT04283656|464893496|FG000|Overall Study|Lost to Follow-up|0|||
129163530|NCT04283656|464893497|FG001|Overall Study|Lost to Follow-up|1|||
129163531|NCT00935493|464893502|FG000|Overall Study|Lost to Follow-up|1|||
129163532|NCT00935493|464893503|FG001|Overall Study|Lost to Follow-up|1|||
129163533|NCT00935493|464893504|FG002|Overall Study|Lost to Follow-up|1|||
129163534|NCT00935493|464893502|FG000|Overall Study|Treatment Discontinued|0|||
129163535|NCT00935493|464893503|FG001|Overall Study|Treatment Discontinued|1|||
129163536|NCT00935493|464893504|FG002|Overall Study|Treatment Discontinued|0|||
129163537|NCT01555073|464893505|FG000|Overall Study|Lost to Follow-up|1|||
129163538|NCT01555073|464893506|FG001|Overall Study|Lost to Follow-up|2|||
129163539|NCT01555073|464893507|FG002|Overall Study|Lost to Follow-up|0|||
129163540|NCT01555073|464893508|FG003|Overall Study|Lost to Follow-up|5|||
129163541|NCT02565147|464893512|FG000|Overall Study|Withdrawal by Subject|5|||
129163542|NCT02565147|464893513|FG001|Overall Study|Withdrawal by Subject|1|||
129163543|NCT02565147|464893512|FG000|Overall Study|Lost to Follow-up|0|||
129163544|NCT02565147|464893513|FG001|Overall Study|Lost to Follow-up|1|||
129163545|NCT02565147|464893512|FG000|Overall Study|Death|1|||
129163546|NCT02565147|464893513|FG001|Overall Study|Death|1|||
129163547|NCT00335738|464893514|FG000|Overall Study|Physician Decision|6|||
129163548|NCT00335738|464893515|FG001|Overall Study|Physician Decision|0|||
129163549|NCT00335738|464893514|FG000|Overall Study|Withdrawal by Subject|2|||
129163550|NCT00335738|464893515|FG001|Overall Study|Withdrawal by Subject|0|||
129163551|NCT00335738|464893514|FG000|Overall Study|Ineligible|3|||
129163552|NCT00335738|464893515|FG001|Overall Study|Ineligible|4|||
129163553|NCT00992056|464893522|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
129163554|NCT00992056|464893523|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
129163555|NCT00992056|464893522|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
129163556|NCT00992056|464893523|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
129163557|NCT00902850|464893524|FG000|Overall Study|Physician Decision|2|||
129163558|NCT00902850|464893525|FG001|Overall Study|Physician Decision|2|||
128726497|NCT03299842|463296957|FG000|Overall Study|Caregiver withdrew consent|2|||
128726498|NCT03299842|463296957|FG000|Overall Study|Child would not keep the watch on|3|||
128726499|NCT01816139|463296958|FG000|Overall Study|Adverse Event|6|||
129163559|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
129163560|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
129163561|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
129163562|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129163563|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129163564|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129163565|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129163566|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129163567|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129163568|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129163569|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129163570|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129163571|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129163572|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129163573|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
129163574|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
129163575|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
129163576|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129163577|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129163578|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129163579|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129163580|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
129163581|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
129163582|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129163583|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129163584|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129163585|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129163586|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129163587|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
129163588|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129163589|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129163590|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129163591|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129163592|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129163593|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129163594|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129163595|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
129163596|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129163597|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129163598|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129163599|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129163600|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129163601|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
129163602|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
129163603|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
129163604|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129163605|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129163606|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129163607|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129163608|NCT03745638|464893526|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
129163609|NCT03745638|464893527|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
129163610|NCT03745638|464893528|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129163611|NCT03745638|464893529|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129163612|NCT03745638|464893530|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129163613|NCT03745638|464893531|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129163614|NCT03745638|464893532|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129163615|NCT03745638|464893526|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129163616|NCT03745638|464893527|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129163617|NCT03745638|464893528|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129163618|NCT03745638|464893529|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
128726500|NCT01816139|463296959|FG001|Overall Study|Adverse Event|8|||
129163619|NCT03745638|464893530|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129163620|NCT03745638|464893531|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
129163621|NCT03745638|464893532|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
129163622|NCT03745638|464893526|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129163623|NCT03745638|464893527|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129163624|NCT03745638|464893528|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129163625|NCT03745638|464893529|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
129163626|NCT03745638|464893530|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129163627|NCT03745638|464893531|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
129163628|NCT03745638|464893532|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
129163629|NCT03745638|464893526|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129163630|NCT03745638|464893527|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129163631|NCT03745638|464893528|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129163632|NCT03745638|464893529|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
129163633|NCT03745638|464893530|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
129163634|NCT03745638|464893531|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
129163635|NCT03745638|464893532|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
129163636|NCT03745638|464893526|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129163637|NCT03745638|464893527|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129163638|NCT03745638|464893528|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129163639|NCT03745638|464893529|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129163640|NCT03745638|464893530|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
129163641|NCT03745638|464893531|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
129163642|NCT03745638|464893532|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129163643|NCT03745638|464893526|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129163644|NCT03745638|464893527|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129163645|NCT03745638|464893528|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129163646|NCT03745638|464893529|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129163647|NCT03745638|464893530|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129163648|NCT03745638|464893531|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
129163649|NCT03745638|464893532|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129163650|NCT03745638|464893526|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129163651|NCT03745638|464893527|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129163652|NCT03745638|464893528|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129163653|NCT03745638|464893529|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
129163654|NCT03745638|464893530|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
129163655|NCT03745638|464893531|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
129163656|NCT03745638|464893532|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
129163657|NCT03745638|464893526|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129163658|NCT03745638|464893527|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129163659|NCT03745638|464893528|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129163660|NCT03745638|464893529|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129163661|NCT03745638|464893530|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129163662|NCT03745638|464893531|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
129163663|NCT03745638|464893532|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
129163664|NCT04470050|464893533|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129163665|NCT04470050|464893534|FG001|Double-blind Treatment Phase|Adverse Event|0|||
129163666|NCT04470050|464893535|FG002|Double-blind Treatment Phase|Adverse Event|0|||
129163667|NCT04470050|464893536|FG003|Double-blind Treatment Phase|Adverse Event|1|||
129163668|NCT04470050|464893537|FG004|Double-blind Treatment Phase|Adverse Event|0|||
129163669|NCT04470050|464893538|FG005|Double-blind Treatment Phase|Adverse Event|0|||
129163670|NCT04470050|464893539|FG006|Double-blind Treatment Phase|Adverse Event|0|||
129163671|NCT04470050|464893533|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129163672|NCT04470050|464893534|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
129163673|NCT04470050|464893535|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
129163674|NCT04470050|464893536|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
129163675|NCT04470050|464893537|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
129163676|NCT04470050|464893538|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
129163677|NCT04470050|464893539|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
129163678|NCT04470050|464893533|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
129163679|NCT04470050|464893534|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
129163680|NCT04470050|464893535|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
129163681|NCT04470050|464893536|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
129163682|NCT04470050|464893537|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
129163683|NCT04470050|464893538|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
129163684|NCT04470050|464893539|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
129163685|NCT03604172|464893541|FG000|Overall Study|Lost to Follow-up|1|||
129163686|NCT03604172|464893542|FG001|Overall Study|Lost to Follow-up|2|||
129163687|NCT02676895|464893543|FG000|Overall Study|Administrative reason|1|||
129163688|NCT02676895|464893544|FG001|Overall Study|Administrative reason|0|||
129163689|NCT02676895|464893545|FG002|Overall Study|Administrative reason|0|||
129163690|NCT02676895|464893543|FG000|Overall Study|Protocol Violation|1|||
129163691|NCT02676895|464893544|FG001|Overall Study|Protocol Violation|0|||
129163692|NCT02676895|464893545|FG002|Overall Study|Protocol Violation|0|||
129163693|NCT02676895|464893543|FG000|Overall Study|Adverse Event|0|||
129163694|NCT02676895|464893544|FG001|Overall Study|Adverse Event|3|||
129163695|NCT02676895|464893545|FG002|Overall Study|Adverse Event|1|||
129163696|NCT02676895|464893543|FG000|Overall Study|Lost to Follow-up|0|||
129163697|NCT02676895|464893544|FG001|Overall Study|Lost to Follow-up|0|||
129163698|NCT02676895|464893545|FG002|Overall Study|Lost to Follow-up|1|||
129163699|NCT02676895|464893543|FG000|Overall Study|Withdrawal by Subject|0|||
129163700|NCT02676895|464893544|FG001|Overall Study|Withdrawal by Subject|0|||
129163701|NCT02676895|464893545|FG002|Overall Study|Withdrawal by Subject|1|||
129163702|NCT00976716|464893551|FG000|Overall Study|Adverse Event|1|||
129163703|NCT03028129|464893554|FG000|Overall Study|Adverse Event|13|||
129163704|NCT03028129|464893555|FG001|Overall Study|Adverse Event|2|||
129163705|NCT03028129|464893554|FG000|Overall Study|Lost to Follow-up|50|||
129163706|NCT03028129|464893555|FG001|Overall Study|Lost to Follow-up|38|||
129163707|NCT03028129|464893554|FG000|Overall Study|Physician Decision|0|||
129163708|NCT03028129|464893555|FG001|Overall Study|Physician Decision|1|||
129163709|NCT03028129|464893554|FG000|Overall Study|Protocol Violation|1|||
129163710|NCT03028129|464893555|FG001|Overall Study|Protocol Violation|1|||
129163711|NCT03028129|464893554|FG000|Overall Study|Withdrawal by Subject|62|||
129163712|NCT03028129|464893555|FG001|Overall Study|Withdrawal by Subject|45|||
129163713|NCT04222699|464893559|FG000|Overall Study|Lost to Follow-up|2|||
129163714|NCT00923351|464893560|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
129163715|NCT00923351|464893561|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
129163716|NCT00923351|464893562|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
129163717|NCT01536561|464893567|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
129163718|NCT01536561|464893567|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
129163719|NCT01536561|464893567|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
129163720|NCT01536561|464893567|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
129163721|NCT01536561|464893567|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
129163722|NCT01536561|464893567|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
129163723|NCT00972517|464893570|FG000|Overall Study|Adverse Event|0|||
129163724|NCT00972517|464893571|FG001|Overall Study|Adverse Event|0|||
129163725|NCT00972517|464893572|FG002|Overall Study|Adverse Event|0|||
129163726|NCT00972517|464893573|FG003|Overall Study|Adverse Event|1|||
129163727|NCT00972517|464893574|FG004|Overall Study|Adverse Event|0|||
129163728|NCT00972517|464893575|FG005|Overall Study|Adverse Event|0|||
129163729|NCT00972517|464893570|FG000|Overall Study|Withdrawal by Subject|0|||
129163730|NCT00972517|464893571|FG001|Overall Study|Withdrawal by Subject|1|||
129163731|NCT00972517|464893572|FG002|Overall Study|Withdrawal by Subject|0|||
129163732|NCT00972517|464893573|FG003|Overall Study|Withdrawal by Subject|2|||
129163733|NCT00972517|464893574|FG004|Overall Study|Withdrawal by Subject|1|||
129163734|NCT00972517|464893575|FG005|Overall Study|Withdrawal by Subject|0|||
129163735|NCT00984594|464893576|FG000|Overall Study|Lost to Follow-up|1|||
129163736|NCT00984594|464893577|FG001|Overall Study|Lost to Follow-up|0|||
129163737|NCT00984594|464893576|FG000|Overall Study|Withdrawal by Subject|0|||
129163738|NCT00984594|464893577|FG001|Overall Study|Withdrawal by Subject|1|||
129163739|NCT00851890|464893578|FG000|Overall Study|Lost to Follow-up|0|||
129163740|NCT00851890|464893579|FG001|Overall Study|Lost to Follow-up|1|||
129163741|NCT00851890|464893580|FG002|Overall Study|Lost to Follow-up|0|||
129163742|NCT00851890|464893581|FG003|Overall Study|Lost to Follow-up|1|||
129163743|NCT03135431|464893582|FG000|Overall Study|Study Surgeon not available|2|||
129163744|NCT03135431|464893583|FG001|Overall Study|Study Surgeon not available|0|||
129163745|NCT00281099|464893586|FG000|Overall Study|Death|46|||
129163746|NCT00281099|464893587|FG001|Overall Study|Death|57|||
129163747|NCT00281099|464893586|FG000|Overall Study|Lost to Follow-up|10|||
129163748|NCT00281099|464893587|FG001|Overall Study|Lost to Follow-up|19|||
129163749|NCT00281099|464893586|FG000|Overall Study|Withdrawal by Subject|65|||
129163750|NCT00281099|464893587|FG001|Overall Study|Withdrawal by Subject|70|||
129163751|NCT00281099|464893586|FG000|Overall Study|Physician Decision|79|||
129163752|NCT00281099|464893587|FG001|Overall Study|Physician Decision|72|||
129163753|NCT00281099|464893586|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
129163754|NCT00281099|464893587|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
129163755|NCT01059864|464893594|FG000|Open-Label Run-In Phase|Adverse Event|7|||
129163756|NCT01059864|464893595|FG001|Open-Label Run-In Phase|Adverse Event|0|||
129163757|NCT01059864|464893596|FG002|Open-Label Run-In Phase|Adverse Event|0|||
129163758|NCT01059864|464893594|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
129163759|NCT01059864|464893595|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
129163760|NCT01059864|464893596|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
129163761|NCT01059864|464893594|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
129163762|NCT01059864|464893595|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
129163763|NCT01059864|464893596|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
129163764|NCT01059864|464893594|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
129163765|NCT01059864|464893595|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
129163766|NCT01059864|464893596|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
129163767|NCT01059864|464893594|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
129163768|NCT01059864|464893595|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
129163769|NCT01059864|464893596|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
129163770|NCT01059864|464893594|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129163771|NCT01059864|464893595|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
129163772|NCT01059864|464893596|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
129163773|NCT00451958|464893597|FG000|CS21A (NCT00451958)|Adverse Event|21|||
129163774|NCT00451958|464893598|FG001|CS21A (NCT00451958)|Adverse Event|34|||
129163775|NCT00451958|464893599|FG002|CS21A (NCT00451958)|Adverse Event|14|||
129163776|NCT00451958|464893600|FG003|CS21A (NCT00451958)|Adverse Event|17|||
129163777|NCT00451958|464893601|FG004|CS21A (NCT00451958)|Adverse Event|0|||
129163778|NCT00451958|464893597|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
129163779|NCT00451958|464893598|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
129163780|NCT00451958|464893599|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
129163781|NCT00451958|464893600|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
129163782|NCT00451958|464893601|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
129163783|NCT00451958|464893597|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
129163784|NCT00451958|464893598|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
129163785|NCT00451958|464893599|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
129163786|NCT00451958|464893600|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
129163787|NCT00451958|464893601|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
129163788|NCT00451958|464893597|FG000|CS21A (NCT00451958)|Physician Decision|2|||
129163789|NCT00451958|464893598|FG001|CS21A (NCT00451958)|Physician Decision|4|||
129163790|NCT00451958|464893599|FG002|CS21A (NCT00451958)|Physician Decision|4|||
129163791|NCT00451958|464893600|FG003|CS21A (NCT00451958)|Physician Decision|4|||
129163792|NCT00451958|464893601|FG004|CS21A (NCT00451958)|Physician Decision|0|||
129163793|NCT00451958|464893597|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
129163794|NCT00451958|464893598|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
129163795|NCT00451958|464893599|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
129163796|NCT00451958|464893600|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
129163797|NCT00451958|464893601|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
129163798|NCT00451958|464893597|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
129163799|NCT00451958|464893598|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
129163800|NCT00451958|464893599|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
129163801|NCT00451958|464893600|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
129163802|NCT00451958|464893601|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
129163803|NCT03108521|464893605|FG000|Overall Study|Lost to Follow-up|3|||
129163804|NCT03108521|464893606|FG001|Overall Study|Lost to Follow-up|0|||
129163805|NCT03108521|464893605|FG000|Overall Study|Lack of Efficacy|2|||
129163806|NCT03108521|464893606|FG001|Overall Study|Lack of Efficacy|0|||
129163807|NCT03108521|464893605|FG000|Overall Study|Physician Decision|4|||
129163808|NCT03108521|464893606|FG001|Overall Study|Physician Decision|0|||
129163809|NCT03108521|464893605|FG000|Overall Study|Adverse Event|3|||
129163810|NCT03108521|464893606|FG001|Overall Study|Adverse Event|0|||
129163811|NCT06899737|464893611|FG000|Overall Study|Lost to Follow-up|19|||
128776942|NCT01347645|463472051|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
128776943|NCT01347645|463472052|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
128776944|NCT01347645|463472053|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
128776945|NCT01347645|463472054|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
128776946|NCT01347645|463472055|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
128776947|NCT01347645|463472051|FG000|Overall Study|Other|1|||
128776948|NCT01347645|463472052|FG001|Overall Study|Other|0|||
128776949|NCT01347645|463472053|FG002|Overall Study|Other|0|||
128776950|NCT01347645|463472054|FG003|Overall Study|Other|0|||
128776951|NCT01347645|463472055|FG004|Overall Study|Other|1|||
128776952|NCT01347645|463472051|FG000|Overall Study|Withdrawal by Subject|0|||
128776953|NCT01347645|463472052|FG001|Overall Study|Withdrawal by Subject|0|||
128776954|NCT01347645|463472053|FG002|Overall Study|Withdrawal by Subject|0|||
128776955|NCT01347645|463472054|FG003|Overall Study|Withdrawal by Subject|3|||
128776956|NCT01347645|463472055|FG004|Overall Study|Withdrawal by Subject|3|||
128776957|NCT01347645|463472051|FG000|Overall Study|Physician Decision|0|||
128776958|NCT01347645|463472052|FG001|Overall Study|Physician Decision|0|||
128776959|NCT01347645|463472053|FG002|Overall Study|Physician Decision|0|||
129163812|NCT06899737|464893612|FG001|Overall Study|Lost to Follow-up|7|||
129163813|NCT03281629|464893614|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
128726501|NCT01816139|463296958|FG000|Overall Study|Lack of Efficacy|1|||
128726502|NCT01816139|463296959|FG001|Overall Study|Lack of Efficacy|2|||
128726503|NCT01816139|463296958|FG000|Overall Study|Lost to Follow-up|5|||
128726504|NCT01816139|463296959|FG001|Overall Study|Lost to Follow-up|3|||
129163814|NCT03281629|464893615|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
129163815|NCT03281629|464893614|FG000|Overall Study|Death|0|||
129163816|NCT03281629|464893615|FG001|Overall Study|Death|1|||
129163817|NCT03281629|464893614|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
129163818|NCT03281629|464893615|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
129163819|NCT02175277|464893617|FG000|Overall Study|Protocol-specified Criteria|1|||
129163820|NCT00375674|464893622|FG000|Overall Study|Other|26|||
129163821|NCT00375674|464893623|FG001|Overall Study|Other|18|||
129163822|NCT00375674|464893622|FG000|Overall Study|Death|67|||
129163823|NCT00375674|464893623|FG001|Overall Study|Death|76|||
129163824|NCT00375674|464893622|FG000|Overall Study|Participants refused further follow-up|31|||
129163825|NCT00375674|464893623|FG001|Overall Study|Participants refused further follow-up|30|||
129163826|NCT00375674|464893622|FG000|Overall Study|Lost to Follow-up|17|||
129163827|NCT00375674|464893623|FG001|Overall Study|Lost to Follow-up|15|||
129163828|NCT00375674|464893622|FG000|Overall Study|Enrolled but not treated|3|||
129163829|NCT00375674|464893623|FG001|Overall Study|Enrolled but not treated|2|||
129163830|NCT01498692|464895425|FG000|Overall Study|Death|4|||
129163831|NCT01498692|464895425|FG000|Overall Study|Withdrawal by Subject|1|||
129163832|NCT01498692|464895425|FG000|Overall Study|Missed 12-month visit|3|||
129163833|NCT00590122|464895426|FG000|Overall Study|swallowed oral dissolving dose|1|||
129163834|NCT00590122|464895427|FG001|Overall Study|swallowed oral dissolving dose|0|||
129163835|NCT01208324|464895428|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
129163836|NCT01208324|464895429|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
129163837|NCT01208324|464895430|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
129163838|NCT01208324|464895431|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
129163839|NCT02707965|464895432|FG000|Overall Study|Withdrawal by Subject|0|||
129163840|NCT02707965|464895433|FG001|Overall Study|Withdrawal by Subject|0|||
129163841|NCT02707965|464895434|FG002|Overall Study|Withdrawal by Subject|1|||
129163842|NCT02707965|464895435|FG003|Overall Study|Withdrawal by Subject|0|||
129163843|NCT02707965|464895436|FG004|Overall Study|Withdrawal by Subject|0|||
129163844|NCT02707965|464895437|FG005|Overall Study|Withdrawal by Subject|0|||
129163845|NCT02707965|464895438|FG006|Overall Study|Withdrawal by Subject|0|||
129163846|NCT02707965|464895439|FG007|Overall Study|Withdrawal by Subject|2|||
129163847|NCT02707965|464895440|FG008|Overall Study|Withdrawal by Subject|0|||
129163848|NCT02707965|464895441|FG009|Overall Study|Withdrawal by Subject|0|||
129163849|NCT02707965|464895442|FG010|Overall Study|Withdrawal by Subject|0|||
129163850|NCT02707965|464895443|FG011|Overall Study|Withdrawal by Subject|0|||
129163851|NCT02707965|464895444|FG012|Overall Study|Withdrawal by Subject|0|||
129163852|NCT02707965|464895445|FG013|Overall Study|Withdrawal by Subject|0|||
129163853|NCT02707965|464895446|FG014|Overall Study|Withdrawal by Subject|0|||
129163854|NCT02707965|464895447|FG015|Overall Study|Withdrawal by Subject|0|||
129163855|NCT02707965|464895432|FG000|Overall Study|PI decisions|0|||
129163856|NCT02707965|464895433|FG001|Overall Study|PI decisions|0|||
129163857|NCT02707965|464895434|FG002|Overall Study|PI decisions|0|||
129163858|NCT02707965|464895435|FG003|Overall Study|PI decisions|0|||
129163859|NCT02707965|464895436|FG004|Overall Study|PI decisions|0|||
129163860|NCT02707965|464895437|FG005|Overall Study|PI decisions|0|||
129163861|NCT02707965|464895438|FG006|Overall Study|PI decisions|0|||
129163862|NCT02707965|464895439|FG007|Overall Study|PI decisions|0|||
129163863|NCT02707965|464895440|FG008|Overall Study|PI decisions|0|||
129163864|NCT02707965|464895441|FG009|Overall Study|PI decisions|0|||
129163865|NCT02707965|464895442|FG010|Overall Study|PI decisions|0|||
129163866|NCT02707965|464895443|FG011|Overall Study|PI decisions|0|||
129163867|NCT02707965|464895444|FG012|Overall Study|PI decisions|0|||
129163868|NCT02707965|464895445|FG013|Overall Study|PI decisions|0|||
129163869|NCT02707965|464895446|FG014|Overall Study|PI decisions|2|||
129163870|NCT02707965|464895447|FG015|Overall Study|PI decisions|0|||
129163871|NCT02707965|464895432|FG000|Overall Study|Protocol deviation|1|||
129163872|NCT02707965|464895433|FG001|Overall Study|Protocol deviation|1|||
129163873|NCT02707965|464895434|FG002|Overall Study|Protocol deviation|0|||
129163874|NCT02707965|464895435|FG003|Overall Study|Protocol deviation|0|||
129163875|NCT02707965|464895436|FG004|Overall Study|Protocol deviation|0|||
129163876|NCT02707965|464895437|FG005|Overall Study|Protocol deviation|0|||
129163877|NCT02707965|464895438|FG006|Overall Study|Protocol deviation|0|||
129163878|NCT02707965|464895439|FG007|Overall Study|Protocol deviation|1|||
129163879|NCT02707965|464895440|FG008|Overall Study|Protocol deviation|0|||
129163880|NCT02707965|464895441|FG009|Overall Study|Protocol deviation|0|||
129163881|NCT02707965|464895442|FG010|Overall Study|Protocol deviation|0|||
129163882|NCT02707965|464895443|FG011|Overall Study|Protocol deviation|0|||
129163883|NCT02707965|464895444|FG012|Overall Study|Protocol deviation|0|||
129163884|NCT02707965|464895445|FG013|Overall Study|Protocol deviation|0|||
129163885|NCT02707965|464895446|FG014|Overall Study|Protocol deviation|0|||
129163886|NCT02707965|464895447|FG015|Overall Study|Protocol deviation|0|||
128726505|NCT01816139|463296958|FG000|Overall Study|Withdrew Consent|6|||
128726506|NCT01816139|463296959|FG001|Overall Study|Withdrew Consent|4|||
128726507|NCT01816139|463296958|FG000|Overall Study|Protocol Violation|6|||
129163887|NCT00249808|464895448|FG000|Overall Study|Other|27|||
129163888|NCT00249808|464895448|FG000|Overall Study|Protocol Violation|3|||
129163889|NCT00249808|464895448|FG000|Overall Study|Lost to Follow-up|8|||
129163890|NCT00249808|464895448|FG000|Overall Study|Adverse Event|81|||
129163891|NCT00249808|464895448|FG000|Overall Study|Lack of Efficacy|52|||
129163892|NCT00249808|464895448|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
129163893|NCT02789345|464895449|FG000|Overall Study|Adverse Event|0|||
129163894|NCT02789345|464895450|FG001|Overall Study|Adverse Event|0|||
129163895|NCT02789345|464895451|FG002|Overall Study|Adverse Event|1|||
129163896|NCT02789345|464895449|FG000|Overall Study|Death|0|||
129163897|NCT02789345|464895450|FG001|Overall Study|Death|0|||
129163898|NCT02789345|464895451|FG002|Overall Study|Death|1|||
129163899|NCT02789345|464895449|FG000|Overall Study|Physician Decision|2|||
129163900|NCT02789345|464895450|FG001|Overall Study|Physician Decision|0|||
129163901|NCT02789345|464895451|FG002|Overall Study|Physician Decision|1|||
129163902|NCT02789345|464895449|FG000|Overall Study|Progressive Disease|1|||
129163903|NCT02789345|464895450|FG001|Overall Study|Progressive Disease|3|||
129163904|NCT02789345|464895451|FG002|Overall Study|Progressive Disease|14|||
129163905|NCT00748618|464895453|FG000|Overall Study|Adverse Event|1|||
129163906|NCT00748618|464895454|FG001|Overall Study|Adverse Event|0|||
129163907|NCT02854436|464895458|FG000|Overall Study|Adverse Event|1|||
129163908|NCT02854436|464895458|FG000|Overall Study|Death|208|||
129163909|NCT02854436|464895458|FG000|Overall Study|Lost to Follow-up|5|||
129163910|NCT02854436|464895458|FG000|Overall Study|Withdrawal by Subject|24|||
129163911|NCT02854436|464895458|FG000|Overall Study|Other|45|||
129163912|NCT02854436|464895458|FG000|Overall Study|Physician Decision|6|||
129163913|NCT01977729|464895459|FG000|Overall Study|Study terminated|1|||
129163914|NCT01268046|464895460|FG000|Overall Study|Withdrawal by Subject|1|||
129163915|NCT01268046|464895461|FG001|Overall Study|Withdrawal by Subject|0|||
129163916|NCT01268046|464895462|FG002|Overall Study|Withdrawal by Subject|0|||
129163917|NCT01268046|464895463|FG003|Overall Study|Withdrawal by Subject|1|||
129163918|NCT01268046|464895460|FG000|Overall Study|Lost to Follow-up|0|||
129163919|NCT01268046|464895461|FG001|Overall Study|Lost to Follow-up|0|||
129163920|NCT01268046|464895462|FG002|Overall Study|Lost to Follow-up|1|||
129163921|NCT01268046|464895463|FG003|Overall Study|Lost to Follow-up|0|||
129163922|NCT01147250|464895466|FG000|Overall Study|Lost to Follow-up|14|||
129163923|NCT01147250|464895467|FG001|Overall Study|Lost to Follow-up|11|||
129163924|NCT01147250|464895466|FG000|Overall Study|Withdrawal by Subject|83|||
129163925|NCT01147250|464895467|FG001|Overall Study|Withdrawal by Subject|88|||
129163926|NCT01147250|464895466|FG000|Overall Study|Site termination by sponsor|13|||
129163927|NCT01147250|464895467|FG001|Overall Study|Site termination by sponsor|5|||
129163928|NCT01147250|464895466|FG000|Overall Study|Other than specified|0|||
129163929|NCT01147250|464895467|FG001|Overall Study|Other than specified|1|||
129163930|NCT00338286|464895469|FG000|Overall Study|Withdrawal by Subject|50|||
129163931|NCT00338286|464895470|FG001|Overall Study|Withdrawal by Subject|54|||
129163932|NCT00338286|464895469|FG000|Overall Study|Lost to Follow-up|80|||
129163933|NCT00338286|464895470|FG001|Overall Study|Lost to Follow-up|66|||
129163934|NCT00338286|464895469|FG000|Overall Study|Other|103|||
129163935|NCT00338286|464895470|FG001|Overall Study|Other|93|||
129163936|NCT00022763|464895474|FG000|Overall Study|Adverse Event|1|||
129163937|NCT00022763|464895475|FG001|Overall Study|Adverse Event|2|||
129163938|NCT00022763|464895474|FG000|Overall Study|Injection Site Reactions|0|||
129163939|NCT00022763|464895475|FG001|Overall Study|Injection Site Reactions|2|||
129163940|NCT00022763|464895474|FG000|Overall Study|Death|0|||
129163941|NCT00022763|464895475|FG001|Overall Study|Death|1|||
129163942|NCT00022763|464895474|FG000|Overall Study|Lost to Follow-up|0|||
129163943|NCT00022763|464895475|FG001|Overall Study|Lost to Follow-up|3|||
129163944|NCT00022763|464895474|FG000|Overall Study|Withdrawal by Subject|4|||
129163945|NCT00022763|464895475|FG001|Overall Study|Withdrawal by Subject|7|||
129163946|NCT00022763|464895474|FG000|Overall Study|Insufficient Therapy|1|||
128726508|NCT01816139|463296959|FG001|Overall Study|Protocol Violation|3|||
129163947|NCT00022763|464895475|FG001|Overall Study|Insufficient Therapy|0|||
129163948|NCT00022763|464895474|FG000|Overall Study|Admin|3|||
129163949|NCT00022763|464895475|FG001|Overall Study|Admin|2|||
129163950|NCT00716482|464895476|FG000|Overall Study|Lost to Follow-up|6|||
129163951|NCT00716482|464895476|FG000|Overall Study|Inadequate acquisition or analysis|50|||
129163952|NCT00716482|464895476|FG000|Overall Study|no pathology obtained|10|||
129163953|NCT00716482|464895476|FG000|Overall Study|technical/machine error|28|||
129163954|NCT00716482|464895476|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
129163955|NCT03248531|464895477|FG000|Overall Study|Adverse Event|0|||
129163956|NCT03248531|464895478|FG001|Overall Study|Adverse Event|0|||
129163957|NCT03248531|464895479|FG002|Overall Study|Adverse Event|1|||
128726509|NCT01816139|463296958|FG000|Overall Study|Reason not Specified|4|||
129163958|NCT03248531|464895477|FG000|Overall Study|Lost to Follow-up|1|||
129163959|NCT03248531|464895478|FG001|Overall Study|Lost to Follow-up|0|||
128726510|NCT01816139|463296959|FG001|Overall Study|Reason not Specified|2|||
128726511|NCT03240575|463296962|FG000|Overall Study|Adverse Event|0|||
128726512|NCT03240575|463296963|FG001|Overall Study|Adverse Event|2|||
128726513|NCT03240575|463296964|FG002|Overall Study|Adverse Event|0|||
128726514|NCT03240575|463296965|FG003|Overall Study|Adverse Event|1|||
128726515|NCT03240575|463296962|FG000|Overall Study|Withdrawal by Subject|2|||
128726516|NCT03240575|463296963|FG001|Overall Study|Withdrawal by Subject|11|||
128726517|NCT03240575|463296964|FG002|Overall Study|Withdrawal by Subject|0|||
128726518|NCT03240575|463296965|FG003|Overall Study|Withdrawal by Subject|1|||
128726519|NCT03240575|463296962|FG000|Overall Study|Other|0|||
128726520|NCT03240575|463296963|FG001|Overall Study|Other|1|||
128726521|NCT03240575|463296964|FG002|Overall Study|Other|0|||
128726522|NCT03240575|463296965|FG003|Overall Study|Other|0|||
128726523|NCT03643562|463296966|FG000|Overall Study|Adverse Event|1|||
128726524|NCT03643562|463296967|FG001|Overall Study|Adverse Event|0|||
128726525|NCT03643562|463296966|FG000|Overall Study|Lack of Efficacy|0|||
128726526|NCT03643562|463296967|FG001|Overall Study|Lack of Efficacy|1|||
128726527|NCT03643562|463296966|FG000|Overall Study|Physician Decision|0|||
128726528|NCT03643562|463296967|FG001|Overall Study|Physician Decision|1|||
128726529|NCT03643562|463296966|FG000|Overall Study|Study Terminated by Sponsor|2|||
128726530|NCT03643562|463296967|FG001|Overall Study|Study Terminated by Sponsor|10|||
128726531|NCT03643562|463296966|FG000|Overall Study|Withdrawal by Subject|2|||
128726532|NCT03643562|463296967|FG001|Overall Study|Withdrawal by Subject|2|||
128726533|NCT03643562|463296966|FG000|Overall Study|Other than specified|3|||
128726534|NCT03643562|463296967|FG001|Overall Study|Other than specified|2|||
128726535|NCT01982253|463296970|FG000|Overall Study|Withdrawal by Subject|1|||
128726536|NCT01982253|463296971|FG001|Overall Study|Withdrawal by Subject|0|||
128726537|NCT01982253|463296972|FG002|Overall Study|Withdrawal by Subject|0|||
128726538|NCT01982253|463296970|FG000|Overall Study|Study terminated by sponsor|1|||
128726539|NCT01982253|463296971|FG001|Overall Study|Study terminated by sponsor|4|||
128726540|NCT01982253|463296972|FG002|Overall Study|Study terminated by sponsor|4|||
128726541|NCT00913744|463296973|FG000|Overall Study|Adverse Event|2|||
128726542|NCT00913744|463296974|FG001|Overall Study|Adverse Event|0|||
128726543|NCT00913744|463296973|FG000|Overall Study|Withdrawal by Subject|2|||
128726544|NCT00913744|463296974|FG001|Overall Study|Withdrawal by Subject|1|||
128726545|NCT00913744|463296973|FG000|Overall Study|Death|1|||
128726546|NCT00913744|463296974|FG001|Overall Study|Death|0|||
128726547|NCT02945410|463296975|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
128726548|NCT02945410|463296976|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
128726549|NCT02945410|463296977|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
128726550|NCT02945410|463296978|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
128726551|NCT02945410|463296979|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
128726552|NCT02945410|463296980|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
128726553|NCT02945410|463296975|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
128726554|NCT02945410|463296976|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
128726555|NCT02945410|463296977|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
128726556|NCT02945410|463296978|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
128726557|NCT02945410|463296979|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
128726558|NCT02945410|463296980|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
128726559|NCT02945410|463296975|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
128726560|NCT02945410|463296976|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
128726561|NCT02945410|463296977|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
128726562|NCT02945410|463296978|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
128726563|NCT02945410|463296979|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
128726564|NCT02945410|463296980|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129163960|NCT03248531|464895479|FG002|Overall Study|Lost to Follow-up|5|||
128726565|NCT01344369|463296983|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
128776960|NCT01347645|463472054|FG003|Overall Study|Physician Decision|0|||
128776961|NCT01347645|463472055|FG004|Overall Study|Physician Decision|1|||
129163961|NCT03248531|464895477|FG000|Overall Study|Withdrawal by Subject|3|||
129163962|NCT03248531|464895478|FG001|Overall Study|Withdrawal by Subject|3|||
128726566|NCT01344369|463296984|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
128726567|NCT01344369|463296983|FG000|Washout of 28 Days|Physician Decision|0|||
128726568|NCT01344369|463296984|FG001|Washout of 28 Days|Physician Decision|1|||
128726569|NCT01344369|463296983|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
128726570|NCT01344369|463296984|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
128726571|NCT01886833|463296987|FG000|Overall Study|IgA not available from both periods|204|||
128776962|NCT01347645|463472051|FG000|Overall Study|Adverse Event|0|||
128776963|NCT01347645|463472052|FG001|Overall Study|Adverse Event|0|||
128776964|NCT01347645|463472053|FG002|Overall Study|Adverse Event|0|||
128726572|NCT03848845|463296988|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
128726573|NCT03848845|463296989|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
128726574|NCT03848845|463296990|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
128726575|NCT03848845|463296991|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
128726576|NCT03848845|463296988|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
128776965|NCT01347645|463472054|FG003|Overall Study|Adverse Event|1|||
129163963|NCT03248531|464895479|FG002|Overall Study|Withdrawal by Subject|2|||
129163964|NCT03248531|464895477|FG000|Overall Study|Sponsor Request|0|||
129163965|NCT03248531|464895478|FG001|Overall Study|Sponsor Request|2|||
129163966|NCT03248531|464895479|FG002|Overall Study|Sponsor Request|0|||
129163967|NCT04075513|464895480|FG000|Overall Study|Withdrawal by Subject|2|||
129163968|NCT04075513|464895481|FG001|Overall Study|Withdrawal by Subject|2|||
129163969|NCT04075513|464895480|FG000|Overall Study|Lack of Efficacy|1|||
129163970|NCT04075513|464895481|FG001|Overall Study|Lack of Efficacy|0|||
129163971|NCT04075513|464895480|FG000|Overall Study|Lost to Follow-up|4|||
129163972|NCT04075513|464895481|FG001|Overall Study|Lost to Follow-up|2|||
129163973|NCT04075513|464895480|FG000|Overall Study|Switch to insulin pump|1|||
129163974|NCT04075513|464895481|FG001|Overall Study|Switch to insulin pump|0|||
129163975|NCT03748706|464895483|FG000|Overall Study|Lost to Follow-up|1|||
129163976|NCT04153981|464895486|FG000|Overall Study|Death|1|||
129163977|NCT04153981|464895486|FG000|Overall Study|Withdrawal by Subject|24|||
129163978|NCT04153981|464895486|FG000|Overall Study|Lost to Follow-up|1|||
129163979|NCT04153981|464895486|FG000|Overall Study|Physician Decision|1|||
129163980|NCT04153981|464895486|FG000|Overall Study|Due to Unavailable Glucometer|1|||
129163981|NCT04153981|464895486|FG000|Overall Study|Covid 19|52|||
129163982|NCT04153981|464895486|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
129163983|NCT04153981|464895486|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
129163984|NCT01355679|464895487|FG000|Overall Study|benign tumor types found at biopsy|2|||
129163985|NCT03490292|464895488|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
129163986|NCT03490292|464895489|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
129163987|NCT03490292|464895488|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
129163988|NCT03490292|464895489|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
129163989|NCT03490292|464895488|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
129163990|NCT03490292|464895489|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
129163991|NCT03490292|464895488|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
129163992|NCT03490292|464895489|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
129163993|NCT03490292|464895488|FG000|1 Year Follow Up Post Last Dose|Death|1|||
129163994|NCT03490292|464895489|FG001|1 Year Follow Up Post Last Dose|Death|1|||
129163995|NCT00964002|464895492|FG000|Overall Study|Protocol Violation|8|||
129163996|NCT00904670|464895493|FG000|Open Label Phase|Withdrawal by Subject|2|||
129163997|NCT00904670|464895494|FG001|Open Label Phase|Withdrawal by Subject|0|||
129163998|NCT00904670|464895493|FG000|Open Label Phase|Adverse Event|2|||
129163999|NCT00904670|464895494|FG001|Open Label Phase|Adverse Event|0|||
129164000|NCT00904670|464895493|FG000|Open Label Phase|Lack of Efficacy|1|||
129164001|NCT00904670|464895494|FG001|Open Label Phase|Lack of Efficacy|0|||
129164002|NCT00904670|464895493|FG000|Open Label Phase|Lost to Follow-up|1|||
129164003|NCT00904670|464895494|FG001|Open Label Phase|Lost to Follow-up|0|||
129164004|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
129164005|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
129164006|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
129164007|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
129164008|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Death|58|||
129164009|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Death|65|||
129164010|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Adverse Event|28|||
129164011|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Adverse Event|40|||
129164012|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Disease Progression|22|||
129164013|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Disease Progression|35|||
129164014|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Other|25|||
129164015|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Other|33|||
129164016|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
129164017|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
129164018|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Noncompliance|8|||
129164019|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Noncompliance|8|||
129164020|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
129164021|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
129164022|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
129164023|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
129164024|NCT00286091|464895503|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
129164025|NCT00286091|464895504|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
129164026|NCT00286091|464895503|FG000|Open-label Treatment Phase|Physician Decision|24|||
129164027|NCT00286091|464895504|FG001|Open-label Treatment Phase|Physician Decision|21|||
129164028|NCT00286091|464895503|FG000|Open-label Treatment Phase|Adverse Event|5|||
129164029|NCT00286091|464895504|FG001|Open-label Treatment Phase|Adverse Event|16|||
129164030|NCT00286091|464895503|FG000|Open-label Treatment Phase|Other|11|||
129164031|NCT00286091|464895504|FG001|Open-label Treatment Phase|Other|11|||
129164032|NCT00286091|464895503|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
129164033|NCT00286091|464895504|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
129164034|NCT00286091|464895503|FG000|Open-label Treatment Phase|Death|10|||
129164035|NCT00286091|464895504|FG001|Open-label Treatment Phase|Death|7|||
129164036|NCT00286091|464895503|FG000|Open-label Treatment Phase|Disease Progression|9|||
129164037|NCT00286091|464895504|FG001|Open-label Treatment Phase|Disease Progression|3|||
129164038|NCT00286091|464895503|FG000|Open-label Treatment Phase|Noncompliance|3|||
129164039|NCT00286091|464895504|FG001|Open-label Treatment Phase|Noncompliance|1|||
129164040|NCT00286091|464895503|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
129164041|NCT00286091|464895504|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
129164042|NCT00286091|464895503|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
129164043|NCT00286091|464895504|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
129164044|NCT00286091|464895503|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
129164045|NCT00286091|464895504|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
129164046|NCT02936869|464895505|FG000|Overall Study|Lost to Follow-up|1|||
129164047|NCT02936869|464895506|FG001|Overall Study|Lost to Follow-up|3|||
129164048|NCT02936869|464895505|FG000|Overall Study|Death|0|||
129164049|NCT02936869|464895506|FG001|Overall Study|Death|1|||
129164050|NCT02936869|464895505|FG000|Overall Study|Legal Case|0|||
129164051|NCT02936869|464895506|FG001|Overall Study|Legal Case|1|||
129164052|NCT02936869|464895505|FG000|Overall Study|Protocol Violation|1|||
129164053|NCT02936869|464895506|FG001|Overall Study|Protocol Violation|0|||
129164054|NCT04004221|464895507|FG000|Overall Study|Death|89|||
129164055|NCT04004221|464895507|FG000|Overall Study|Withdrawal by Subject|5|||
129164056|NCT04004221|464895507|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
129164057|NCT04004221|464895507|FG000|Overall Study|Sponsor Decision|9|||
129164058|NCT04004221|464895507|FG000|Overall Study|Participant refused to enter LTE|1|||
129164059|NCT03423238|464895508|FG000|Overall Study|Lost to Follow-up|1|||
129164060|NCT03423238|464895509|FG001|Overall Study|Lost to Follow-up|0|||
129164061|NCT03423238|464895508|FG000|Overall Study|Withdrawal by Subject|1|||
129164062|NCT03423238|464895509|FG001|Overall Study|Withdrawal by Subject|0|||
129164063|NCT02036580|464895510|FG000|Overall Study|Withdrawal by Subject|0|||
129164064|NCT02036580|464895511|FG001|Overall Study|Withdrawal by Subject|1|||
129164065|NCT02036580|464895512|FG002|Overall Study|Withdrawal by Subject|0|||
129164066|NCT02036580|464895510|FG000|Overall Study|Adverse Event|1|||
129164067|NCT02036580|464895511|FG001|Overall Study|Adverse Event|0|||
129164068|NCT02036580|464895512|FG002|Overall Study|Adverse Event|0|||
129164069|NCT00506454|464895513|FG000|Overall Study|Withdrawal by Subject|1|||
129164070|NCT00506454|464895514|FG001|Overall Study|Withdrawal by Subject|1|||
129164071|NCT02584452|464895517|FG000|Overall Study|Physician Decision|1|||
129164072|NCT02584452|464895518|FG001|Overall Study|Physician Decision|1|||
129164073|NCT02584452|464895517|FG000|Overall Study|Lost to Follow-up|1|||
129164074|NCT02584452|464895518|FG001|Overall Study|Lost to Follow-up|1|||
129164075|NCT02689206|464895519|FG000|Overall Study|Adverse Event|0|||
129164076|NCT02689206|464895520|FG001|Overall Study|Adverse Event|0|||
129164077|NCT02689206|464895521|FG002|Overall Study|Adverse Event|1|||
129164078|NCT02689206|464895522|FG003|Overall Study|Adverse Event|0|||
129164079|NCT02689206|464895523|FG004|Overall Study|Adverse Event|2|||
129164080|NCT02689206|464895519|FG000|Overall Study|Protocol Violation|1|||
129164081|NCT02689206|464895520|FG001|Overall Study|Protocol Violation|0|||
129164082|NCT02689206|464895521|FG002|Overall Study|Protocol Violation|0|||
129164083|NCT02689206|464895522|FG003|Overall Study|Protocol Violation|1|||
129164084|NCT02689206|464895523|FG004|Overall Study|Protocol Violation|2|||
129164085|NCT02689206|464895519|FG000|Overall Study|Other: Reached stopping criteria|0|||
129164086|NCT02689206|464895520|FG001|Overall Study|Other: Reached stopping criteria|1|||
129164087|NCT02689206|464895521|FG002|Overall Study|Other: Reached stopping criteria|2|||
129164088|NCT02689206|464895522|FG003|Overall Study|Other: Reached stopping criteria|3|||
129164089|NCT02689206|464895523|FG004|Overall Study|Other: Reached stopping criteria|4|||
129164090|NCT02689206|464895519|FG000|Overall Study|Physician Decision|1|||
129164091|NCT02689206|464895520|FG001|Overall Study|Physician Decision|0|||
129164092|NCT02689206|464895521|FG002|Overall Study|Physician Decision|0|||
129164093|NCT02689206|464895522|FG003|Overall Study|Physician Decision|0|||
129164094|NCT02689206|464895523|FG004|Overall Study|Physician Decision|0|||
129164095|NCT02689206|464895519|FG000|Overall Study|Withdrawal by Subject|1|||
129164096|NCT02689206|464895520|FG001|Overall Study|Withdrawal by Subject|0|||
129164097|NCT02689206|464895521|FG002|Overall Study|Withdrawal by Subject|1|||
129164098|NCT02689206|464895522|FG003|Overall Study|Withdrawal by Subject|0|||
129164099|NCT02689206|464895523|FG004|Overall Study|Withdrawal by Subject|0|||
129164100|NCT01558596|464895524|FG000|Overall Study|Withdrawal by Subject|1|||
129164101|NCT01558596|464895525|FG001|Overall Study|Withdrawal by Subject|0|||
129164102|NCT01558596|464895524|FG000|Overall Study|surgery elsewhere or cancelled|1|||
129164103|NCT01558596|464895525|FG001|Overall Study|surgery elsewhere or cancelled|1|||
128726577|NCT03848845|463296989|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
128726578|NCT03848845|463296990|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
129164104|NCT01558596|464895524|FG000|Overall Study|Protocol Violation|1|||
129164105|NCT01558596|464895525|FG001|Overall Study|Protocol Violation|0|||
129164106|NCT01479764|464895529|FG000|Randomized|Adverse Event|1|||
129164107|NCT01479764|464895530|FG001|Randomized|Adverse Event|1|||
129164108|NCT01479764|464895529|FG000|Randomized|Withdrawal by Subject|1|||
128776966|NCT01347645|463472055|FG004|Overall Study|Adverse Event|1|||
128776967|NCT00388362|463472056|FG000|Enrolled|Ineligible|1|||
129164109|NCT01479764|464895530|FG001|Randomized|Withdrawal by Subject|0|||
129164110|NCT01479764|464895529|FG000|Treated|Lost to Follow-up|0|||
129164111|NCT01479764|464895530|FG001|Treated|Lost to Follow-up|2|||
129164112|NCT00260832|464895532|FG000|Overall Study|Adverse Event|26|||
129164113|NCT00260832|464895533|FG001|Overall Study|Adverse Event|19|||
129164114|NCT00260832|464895532|FG000|Overall Study|Progression|116|||
129164115|NCT00260832|464895533|FG001|Overall Study|Progression|96|||
129164116|NCT00260832|464895532|FG000|Overall Study|Withdrawal by Subject|15|||
129164117|NCT00260832|464895533|FG001|Overall Study|Withdrawal by Subject|17|||
129164118|NCT00260832|464895532|FG000|Overall Study|Physician Decision|15|||
129164119|NCT00260832|464895533|FG001|Overall Study|Physician Decision|9|||
129164120|NCT00260832|464895532|FG000|Overall Study|Death|43|||
129164121|NCT00260832|464895533|FG001|Overall Study|Death|62|||
129164122|NCT00260832|464895532|FG000|Overall Study|Other|10|||
129164123|NCT00260832|464895533|FG001|Overall Study|Other|7|||
129164124|NCT00260832|464895532|FG000|Overall Study|Protocol Violation|3|||
129164125|NCT00260832|464895533|FG001|Overall Study|Protocol Violation|1|||
129164126|NCT03098433|464895536|FG000|Overall Study|Withdrawal by Subject|10|||
129164127|NCT01104545|464895537|FG000|Overall Study|Adverse Event|0|||
129164128|NCT01104545|464895538|FG001|Overall Study|Adverse Event|1|||
129164129|NCT01104545|464895539|FG002|Overall Study|Adverse Event|2|||
129164130|NCT03585764|464895542|FG000|Overall Study|Death|3|||
129164131|NCT03585764|464895543|FG001|Overall Study|Death|2|||
129164132|NCT03585764|464895544|FG002|Overall Study|Death|3|||
129164133|NCT03585764|464895545|FG003|Overall Study|Death|0|||
129164134|NCT03585764|464895542|FG000|Overall Study|Lost to Follow-up|0|||
129164135|NCT03585764|464895543|FG001|Overall Study|Lost to Follow-up|1|||
129164136|NCT03585764|464895544|FG002|Overall Study|Lost to Follow-up|0|||
129164137|NCT03585764|464895545|FG003|Overall Study|Lost to Follow-up|0|||
129164138|NCT03585764|464895542|FG000|Overall Study|Physician Decision|0|||
129164139|NCT03585764|464895543|FG001|Overall Study|Physician Decision|0|||
129164140|NCT03585764|464895544|FG002|Overall Study|Physician Decision|2|||
129164141|NCT03585764|464895545|FG003|Overall Study|Physician Decision|0|||
129164142|NCT03640507|464895546|FG000|Overall Study|Withdrawal by Subject|0|||
129164143|NCT03640507|464895547|FG001|Overall Study|Withdrawal by Subject|0|||
129164144|NCT03640507|464895548|FG002|Overall Study|Withdrawal by Subject|1|||
129164145|NCT02993822|464895549|FG000|Overall Study|Lack of Efficacy|1|||
129164146|NCT02993822|464895550|FG001|Overall Study|Lack of Efficacy|1|||
129164147|NCT02993822|464895551|FG002|Overall Study|Lack of Efficacy|0|||
129164148|NCT02993822|464895552|FG003|Overall Study|Lack of Efficacy|0|||
129164149|NCT02993822|464895549|FG000|Overall Study|Protocol Violation|1|||
129164150|NCT02993822|464895550|FG001|Overall Study|Protocol Violation|0|||
129164151|NCT02993822|464895551|FG002|Overall Study|Protocol Violation|0|||
129164152|NCT02993822|464895552|FG003|Overall Study|Protocol Violation|0|||
129164153|NCT02993822|464895549|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
129164154|NCT02993822|464895550|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
129164155|NCT02993822|464895551|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
129164156|NCT02993822|464895552|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
129164157|NCT02993822|464895549|FG000|Overall Study|Adverse Event|3|||
129164158|NCT02993822|464895550|FG001|Overall Study|Adverse Event|1|||
129164159|NCT02993822|464895551|FG002|Overall Study|Adverse Event|7|||
129164160|NCT02993822|464895552|FG003|Overall Study|Adverse Event|0|||
129164161|NCT02993822|464895549|FG000|Overall Study|Withdrawal by Subject|4|||
129164162|NCT02993822|464895550|FG001|Overall Study|Withdrawal by Subject|2|||
129164163|NCT02993822|464895551|FG002|Overall Study|Withdrawal by Subject|2|||
129164164|NCT02993822|464895552|FG003|Overall Study|Withdrawal by Subject|3|||
129164165|NCT02993822|464895549|FG000|Overall Study|Lost to Follow-up|1|||
129164166|NCT02993822|464895550|FG001|Overall Study|Lost to Follow-up|0|||
129164167|NCT02993822|464895551|FG002|Overall Study|Lost to Follow-up|1|||
129164168|NCT02993822|464895552|FG003|Overall Study|Lost to Follow-up|0|||
129164169|NCT01221753|464895553|FG000|Overall Study|Adverse Event|1|||
129164170|NCT01939977|464895557|FG000|Overall Study|Adverse Event|4|||
129164171|NCT01939977|464895558|FG001|Overall Study|Adverse Event|3|||
129164172|NCT01939977|464895557|FG000|Overall Study|Lack of Efficacy|3|||
129164173|NCT01939977|464895558|FG001|Overall Study|Lack of Efficacy|0|||
129164174|NCT01939977|464895557|FG000|Overall Study|Physician Decision|1|||
129164175|NCT01939977|464895558|FG001|Overall Study|Physician Decision|1|||
129164176|NCT01939977|464895557|FG000|Overall Study|Withdrawal by Subject|0|||
129164177|NCT01939977|464895558|FG001|Overall Study|Withdrawal by Subject|2|||
129164178|NCT01939977|464895557|FG000|Overall Study|Did not meet inclusion criteria|1|||
129164179|NCT01939977|464895558|FG001|Overall Study|Did not meet inclusion criteria|0|||
129164180|NCT01939977|464895557|FG000|Overall Study|Did not receive study medication|0|||
129164181|NCT01939977|464895558|FG001|Overall Study|Did not receive study medication|1|||
128776968|NCT00388362|463472056|FG000|Enrolled|Adverse Event|9|||
129164182|NCT04552288|464895562|FG000|Overall Study|Death|3|||
129164183|NCT04552288|464895562|FG000|Overall Study|Lost to Follow-up|6|||
129164184|NCT04552288|464895562|FG000|Overall Study|Physician Decision|3|||
129164185|NCT04552288|464895562|FG000|Overall Study|Protocol Violation|9|||
128726579|NCT03848845|463296991|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
128726580|NCT03848845|463296988|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
128726581|NCT03848845|463296989|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
128726582|NCT03848845|463296990|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
128726583|NCT03848845|463296991|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
129164186|NCT04552288|464895562|FG000|Overall Study|Withdrawal by Subject|6|||
129164187|NCT04552288|464895562|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
129164188|NCT05285644|464895563|FG000|Overall Study|Adverse Event|3|||
129164189|NCT05285644|464895564|FG001|Overall Study|Adverse Event|3|||
129164190|NCT05285644|464895563|FG000|Overall Study|Withdrawal of Consent|2|||
129164191|NCT05285644|464895564|FG001|Overall Study|Withdrawal of Consent|5|||
129164192|NCT05285644|464895563|FG000|Overall Study|Noncompliance|0|||
129164193|NCT05285644|464895564|FG001|Overall Study|Noncompliance|4|||
129164194|NCT05285644|464895563|FG000|Overall Study|Lost to Follow-up|4|||
129164195|NCT05285644|464895564|FG001|Overall Study|Lost to Follow-up|6|||
129164196|NCT05285644|464895563|FG000|Overall Study|Disallowed Concurrent Medication|1|||
129164197|NCT05285644|464895564|FG001|Overall Study|Disallowed Concurrent Medication|1|||
129164198|NCT05285644|464895563|FG000|Overall Study|Investigator Decision|2|||
129164199|NCT05285644|464895564|FG001|Overall Study|Investigator Decision|0|||
129164200|NCT05285644|464895563|FG000|Overall Study|Protocol Deviation|1|||
129164201|NCT05285644|464895564|FG001|Overall Study|Protocol Deviation|0|||
129164202|NCT05285644|464895563|FG000|Overall Study|As specified in the Clinical Study Report|7|||
129164203|NCT05285644|464895564|FG001|Overall Study|As specified in the Clinical Study Report|3|||
129164204|NCT04532294|464895565|FG000|Overall Study|Withdrawal by Subject|0|||
129164205|NCT04532294|464895566|FG001|Overall Study|Withdrawal by Subject|0|||
129164206|NCT04532294|464895567|FG002|Overall Study|Withdrawal by Subject|1|||
129164207|NCT04532294|464895565|FG000|Overall Study|Participants Not Dosed|0|||
129164208|NCT04532294|464895566|FG001|Overall Study|Participants Not Dosed|0|||
129164209|NCT04532294|464895567|FG002|Overall Study|Participants Not Dosed|2|||
129164210|NCT04295759|464895568|FG000|Overall Study|Lack of Efficacy|9|||
129164211|NCT04295759|464895568|FG000|Overall Study|Death|1|||
129164212|NCT04295759|464895568|FG000|Overall Study|Withdrawal by Subject|2|||
129164213|NCT04295759|464895568|FG000|Overall Study|Deemed ineligible|1|||
129164214|NCT01696981|464895569|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
129164215|NCT01696981|464895570|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
129164216|NCT01696981|464895569|FG000|Overall Study|Died Before Randomization|3|||
129164217|NCT01696981|464895570|FG001|Overall Study|Died Before Randomization|8|||
129164218|NCT01696981|464895569|FG000|Overall Study|Died Before ASU (Control)|278|||
129164219|NCT01696981|464895570|FG001|Overall Study|Died Before ASU (Control)|0|||
129164220|NCT01696981|464895569|FG000|Overall Study|Refused ASU (Control)|920|||
129164221|NCT01696981|464895570|FG001|Overall Study|Refused ASU (Control)|0|||
129164222|NCT01696981|464895569|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
129164223|NCT01696981|464895570|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
129164224|NCT02798315|464895571|FG000|Overall Study|Failure to return|1|||
129164225|NCT03335150|464895573|FG000|Overall Study|Withdrawal by Subject|10|||
129164226|NCT03335150|464895574|FG001|Overall Study|Withdrawal by Subject|4|||
129164227|NCT03335150|464895573|FG000|Overall Study|Adverse Event|0|||
129164228|NCT03335150|464895574|FG001|Overall Study|Adverse Event|1|||
129164229|NCT02097719|464895575|FG000|Overall Study|Subject Withdrew Consent|1|||
129164230|NCT02097719|464895576|FG001|Overall Study|Subject Withdrew Consent|0|||
129164231|NCT02097719|464895575|FG000|Overall Study|Lost to Follow-up|0|||
129164232|NCT02097719|464895576|FG001|Overall Study|Lost to Follow-up|1|||
129164233|NCT02097719|464895575|FG000|Overall Study|Adverse Event|2|||
129164234|NCT02097719|464895576|FG001|Overall Study|Adverse Event|0|||
129164235|NCT04601532|464895577|FG000|Overall Study|Lost to Follow-up|1|||
129164236|NCT04601532|464895578|FG001|Overall Study|Lost to Follow-up|2|||
129164237|NCT04601532|464895577|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
129164238|NCT04601532|464895578|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
129164239|NCT02744612|464897725|FG000|Overall Study|Withdrawal by Subject|0|||
129164240|NCT02744612|464897726|FG001|Overall Study|Withdrawal by Subject|2|||
129164241|NCT02712983|464897728|FG000|Treatment Phase|Adverse Event|3|||
128726584|NCT03848845|463296988|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
129164242|NCT02712983|464897729|FG001|Treatment Phase|Adverse Event|1|||
129164243|NCT02712983|464897730|FG002|Treatment Phase|Adverse Event|1|||
129164244|NCT02712983|464897731|FG003|Treatment Phase|Adverse Event|4|||
129164245|NCT02712983|464897732|FG004|Treatment Phase|Adverse Event|3|||
129164246|NCT02712983|464897733|FG005|Treatment Phase|Adverse Event|0|||
129164247|NCT02712983|464897734|FG006|Treatment Phase|Adverse Event|6|||
129164248|NCT02712983|464897735|FG007|Treatment Phase|Adverse Event|6|||
129164249|NCT02712983|464897736|FG008|Treatment Phase|Adverse Event|1|||
128776969|NCT00388362|463472056|FG000|Enrolled|Death|1|||
129164250|NCT02712983|464897728|FG000|Treatment Phase|Protocol Deviation|0|||
129164251|NCT02712983|464897729|FG001|Treatment Phase|Protocol Deviation|0|||
129164252|NCT02712983|464897730|FG002|Treatment Phase|Protocol Deviation|0|||
128776970|NCT00388362|463472056|FG000|Enrolled|Loss insurance|1|||
128776971|NCT00388362|463472056|FG000|Enrolled|Withdrawal by Subject|1|||
128776972|NCT00388362|463472056|FG000|Remained on Study Median of 514 Days|Death|2|||
128776973|NCT01141660|463472057|FG000|Overall Study|Physician Decision|0|||
129164253|NCT02712983|464897731|FG003|Treatment Phase|Protocol Deviation|2|||
129164254|NCT02712983|464897732|FG004|Treatment Phase|Protocol Deviation|0|||
128776974|NCT01141660|463472058|FG001|Overall Study|Physician Decision|12|||
129164255|NCT02712983|464897733|FG005|Treatment Phase|Protocol Deviation|0|||
129164256|NCT02712983|464897734|FG006|Treatment Phase|Protocol Deviation|1|||
129164257|NCT02712983|464897735|FG007|Treatment Phase|Protocol Deviation|0|||
129164258|NCT02712983|464897736|FG008|Treatment Phase|Protocol Deviation|0|||
129164259|NCT02712983|464897728|FG000|Treatment Phase|Technical Problems|0|||
129164260|NCT02712983|464897729|FG001|Treatment Phase|Technical Problems|0|||
129164261|NCT02712983|464897730|FG002|Treatment Phase|Technical Problems|0|||
129164262|NCT02712983|464897731|FG003|Treatment Phase|Technical Problems|0|||
129164263|NCT02712983|464897732|FG004|Treatment Phase|Technical Problems|0|||
129164264|NCT02712983|464897733|FG005|Treatment Phase|Technical Problems|0|||
129164265|NCT02712983|464897734|FG006|Treatment Phase|Technical Problems|1|||
129164266|NCT02712983|464897735|FG007|Treatment Phase|Technical Problems|0|||
129164267|NCT02712983|464897736|FG008|Treatment Phase|Technical Problems|0|||
129164268|NCT02712983|464897728|FG000|Treatment Phase|Physician Decision|0|||
129164269|NCT02712983|464897729|FG001|Treatment Phase|Physician Decision|0|||
129164270|NCT02712983|464897730|FG002|Treatment Phase|Physician Decision|0|||
129164271|NCT02712983|464897731|FG003|Treatment Phase|Physician Decision|0|||
129164272|NCT02712983|464897732|FG004|Treatment Phase|Physician Decision|0|||
129164273|NCT02712983|464897733|FG005|Treatment Phase|Physician Decision|0|||
129164274|NCT02712983|464897734|FG006|Treatment Phase|Physician Decision|0|||
129164275|NCT02712983|464897735|FG007|Treatment Phase|Physician Decision|1|||
129164276|NCT02712983|464897736|FG008|Treatment Phase|Physician Decision|1|||
129164277|NCT02712983|464897728|FG000|Treatment Phase|Subject Decision|2|||
129164278|NCT02712983|464897729|FG001|Treatment Phase|Subject Decision|0|||
129164279|NCT02712983|464897730|FG002|Treatment Phase|Subject Decision|0|||
129164280|NCT02712983|464897731|FG003|Treatment Phase|Subject Decision|2|||
129164281|NCT02712983|464897732|FG004|Treatment Phase|Subject Decision|1|||
129164282|NCT02712983|464897733|FG005|Treatment Phase|Subject Decision|0|||
129164283|NCT02712983|464897734|FG006|Treatment Phase|Subject Decision|1|||
129164284|NCT02712983|464897735|FG007|Treatment Phase|Subject Decision|2|||
129164285|NCT02712983|464897736|FG008|Treatment Phase|Subject Decision|0|||
129164286|NCT02712983|464897728|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129164287|NCT02712983|464897729|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
129164288|NCT02712983|464897730|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129164289|NCT02712983|464897731|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129164290|NCT02712983|464897732|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129164291|NCT02712983|464897733|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129164292|NCT02712983|464897734|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
129164293|NCT02712983|464897735|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
129164294|NCT02712983|464897736|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129164295|NCT02712983|464897728|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164296|NCT02712983|464897729|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164297|NCT02712983|464897730|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164298|NCT02712983|464897731|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
129164299|NCT02712983|464897732|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164300|NCT02712983|464897733|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164301|NCT02712983|464897734|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164302|NCT02712983|464897735|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164303|NCT02712983|464897736|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129164304|NCT02712983|464897728|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129164305|NCT02712983|464897729|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
128776975|NCT00209027|463472060|FG000|Overall Study|study terminated|10|||
128776976|NCT00209027|463472061|FG001|Overall Study|study terminated|0|||
129164306|NCT02712983|464897730|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129164307|NCT02712983|464897731|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129164308|NCT02712983|464897732|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
129164309|NCT02712983|464897733|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
129164310|NCT02712983|464897734|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
129164311|NCT02712983|464897735|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
129164312|NCT02712983|464897736|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129164313|NCT01945216|464897737|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
129164314|NCT01945216|464897737|FG000|Overall Study|Protocol Violation|42|||
129164315|NCT01945216|464897737|FG000|Overall Study|CRF not assured by investigators|5|||
128776977|NCT01932996|463472062|FG000|Overall Study|Protocol Violation|2|||
129164316|NCT05360966|464897741|FG000|Overall Study|Adverse Event|5|||
129164317|NCT05360966|464897742|FG001|Overall Study|Adverse Event|5|||
129164318|NCT05360966|464897741|FG000|Overall Study|Withdrawal of Consent|5|||
129164319|NCT05360966|464897742|FG001|Overall Study|Withdrawal of Consent|3|||
129164320|NCT05360966|464897741|FG000|Overall Study|Noncompliance|2|||
129164321|NCT05360966|464897742|FG001|Overall Study|Noncompliance|1|||
129164322|NCT05360966|464897741|FG000|Overall Study|Lost to Follow-up|2|||
128726585|NCT03848845|463296989|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
128726586|NCT03848845|463296990|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
128726587|NCT03848845|463296991|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
129164323|NCT05360966|464897742|FG001|Overall Study|Lost to Follow-up|3|||
129164324|NCT05360966|464897741|FG000|Overall Study|Protocol Deviation|2|||
129164325|NCT05360966|464897742|FG001|Overall Study|Protocol Deviation|1|||
129164326|NCT05360966|464897741|FG000|Overall Study|As specified in the Clinical Study Report|1|||
129164327|NCT05360966|464897742|FG001|Overall Study|As specified in the Clinical Study Report|3|||
129164328|NCT05396014|464897743|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
129164329|NCT05396014|464897744|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164330|NCT05396014|464897745|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164331|NCT05396014|464897746|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164332|NCT05396014|464897747|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164333|NCT05396014|464897748|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164334|NCT05396014|464897749|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164335|NCT05396014|464897750|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164336|NCT05396014|464897751|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164337|NCT05396014|464897752|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164338|NCT05396014|464897753|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164339|NCT05396014|464897754|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164340|NCT05396014|464897755|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164341|NCT05396014|464897756|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
129164342|NCT05396014|464897757|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164343|NCT05396014|464897758|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164344|NCT05396014|464897759|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164345|NCT05396014|464897760|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164346|NCT05396014|464897761|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164347|NCT05396014|464897762|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164348|NCT05396014|464897763|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164349|NCT05396014|464897764|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164350|NCT05396014|464897765|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164351|NCT05396014|464897766|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164352|NCT05396014|464897767|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164353|NCT05396014|464897768|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164354|NCT05396014|464897769|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
129164355|NCT05396014|464897770|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164356|NCT05396014|464897771|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164357|NCT05396014|464897772|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164358|NCT05396014|464897773|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164359|NCT05396014|464897774|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164360|NCT05396014|464897775|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164361|NCT05396014|464897776|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164362|NCT05396014|464897777|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164363|NCT05396014|464897778|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164364|NCT05396014|464897779|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164365|NCT05396014|464897780|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164366|NCT05396014|464897781|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164367|NCT05396014|464897782|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
129164368|NCT05396014|464897783|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164369|NCT05396014|464897784|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164370|NCT05396014|464897785|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129164371|NCT05396014|464897743|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
129164372|NCT05396014|464897744|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164373|NCT05396014|464897745|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
128726588|NCT02223767|463296997|FG000|Overall Study|Withdrawal by Subject|4|||
128726589|NCT02223767|463296998|FG001|Overall Study|Withdrawal by Subject|4|||
129164374|NCT05396014|464897746|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164375|NCT05396014|464897747|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164376|NCT05396014|464897748|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164377|NCT05396014|464897749|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
128726590|NCT00283439|463297000|FG000|Overall Study|Adverse Event|0|||
128726591|NCT00283439|463297001|FG001|Overall Study|Adverse Event|0|||
128726592|NCT00283439|463297002|FG002|Overall Study|Adverse Event|0|||
128726593|NCT00283439|463297003|FG003|Overall Study|Adverse Event|1|||
128726594|NCT00283439|463297000|FG000|Overall Study|Death|0|||
128726595|NCT00283439|463297001|FG001|Overall Study|Death|0|||
128726596|NCT00283439|463297002|FG002|Overall Study|Death|1|||
128726597|NCT00283439|463297003|FG003|Overall Study|Death|0|||
128726598|NCT00283439|463297000|FG000|Overall Study|Disease progression|0|||
128726599|NCT00283439|463297001|FG001|Overall Study|Disease progression|1|||
128726600|NCT00283439|463297002|FG002|Overall Study|Disease progression|0|||
128776978|NCT01932996|463472063|FG001|Overall Study|Protocol Violation|0|||
128776979|NCT01848834|463472064|FG000|Overall Study|Adverse Event|3|||
128776980|NCT01848834|463472065|FG001|Overall Study|Adverse Event|11|||
128776981|NCT01848834|463472066|FG002|Overall Study|Adverse Event|3|||
128776982|NCT01848834|463472067|FG003|Overall Study|Adverse Event|5|||
128776983|NCT01848834|463472068|FG004|Overall Study|Adverse Event|9|||
128776984|NCT01848834|463472064|FG000|Overall Study|Death|2|||
128776985|NCT01848834|463472065|FG001|Overall Study|Death|11|||
128776986|NCT01848834|463472066|FG002|Overall Study|Death|1|||
128776987|NCT01848834|463472067|FG003|Overall Study|Death|8|||
128776988|NCT01848834|463472068|FG004|Overall Study|Death|27|||
128776989|NCT01848834|463472064|FG000|Overall Study|Excluded Medication|5|||
128776990|NCT01848834|463472065|FG001|Overall Study|Excluded Medication|4|||
128776991|NCT01848834|463472066|FG002|Overall Study|Excluded Medication|3|||
128776992|NCT01848834|463472067|FG003|Overall Study|Excluded Medication|6|||
128776993|NCT01848834|463472068|FG004|Overall Study|Excluded Medication|6|||
128776994|NCT01848834|463472064|FG000|Overall Study|Lost to Follow-up|5|||
128776995|NCT01848834|463472065|FG001|Overall Study|Lost to Follow-up|5|||
128776996|NCT01848834|463472066|FG002|Overall Study|Lost to Follow-up|3|||
128776997|NCT01848834|463472067|FG003|Overall Study|Lost to Follow-up|0|||
128776998|NCT01848834|463472068|FG004|Overall Study|Lost to Follow-up|3|||
128776999|NCT01848834|463472064|FG000|Overall Study|Physician Decision|1|||
128777000|NCT01848834|463472065|FG001|Overall Study|Physician Decision|3|||
128777001|NCT01848834|463472066|FG002|Overall Study|Physician Decision|4|||
129164378|NCT05396014|464897750|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164379|NCT05396014|464897751|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164380|NCT05396014|464897752|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164381|NCT05396014|464897753|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164382|NCT05396014|464897754|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164383|NCT05396014|464897755|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164384|NCT05396014|464897756|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
128726601|NCT00283439|463297003|FG003|Overall Study|Disease progression|0|||
129164385|NCT05396014|464897757|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164386|NCT05396014|464897758|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164387|NCT05396014|464897759|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164388|NCT05396014|464897760|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164389|NCT05396014|464897761|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164390|NCT05396014|464897762|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164391|NCT05396014|464897763|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164392|NCT05396014|464897764|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164393|NCT05396014|464897765|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164394|NCT05396014|464897766|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164395|NCT05396014|464897767|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164396|NCT05396014|464897768|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164397|NCT05396014|464897769|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
129164398|NCT05396014|464897770|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164399|NCT05396014|464897771|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
128777002|NCT01848834|463472067|FG003|Overall Study|Physician Decision|0|||
128777003|NCT01848834|463472068|FG004|Overall Study|Physician Decision|11|||
128777004|NCT01848834|463472064|FG000|Overall Study|Protocol Violation|0|||
128777005|NCT01848834|463472065|FG001|Overall Study|Protocol Violation|0|||
129164400|NCT05396014|464897772|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164401|NCT05396014|464897773|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164402|NCT05396014|464897774|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
128726602|NCT00283439|463297000|FG000|Overall Study|Requirement for alternative therapy|1|||
128777006|NCT01848834|463472066|FG002|Overall Study|Protocol Violation|0|||
128777007|NCT01848834|463472067|FG003|Overall Study|Protocol Violation|0|||
128777008|NCT01848834|463472068|FG004|Overall Study|Protocol Violation|1|||
128777009|NCT01848834|463472064|FG000|Overall Study|Sponsor Decision|1|||
128777010|NCT01848834|463472065|FG001|Overall Study|Sponsor Decision|1|||
128726603|NCT00283439|463297001|FG001|Overall Study|Requirement for alternative therapy|2|||
128777011|NCT01848834|463472066|FG002|Overall Study|Sponsor Decision|0|||
128777012|NCT01848834|463472067|FG003|Overall Study|Sponsor Decision|1|||
128777013|NCT01848834|463472068|FG004|Overall Study|Sponsor Decision|1|||
129164403|NCT05396014|464897775|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164404|NCT05396014|464897776|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164405|NCT05396014|464897777|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164406|NCT05396014|464897778|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164407|NCT05396014|464897779|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164408|NCT05396014|464897780|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164409|NCT05396014|464897781|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164410|NCT05396014|464897782|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
129164411|NCT05396014|464897783|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164412|NCT05396014|464897784|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164413|NCT05396014|464897785|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129164414|NCT05396014|464897743|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
129164415|NCT05396014|464897744|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164416|NCT05396014|464897745|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164417|NCT05396014|464897746|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164418|NCT05396014|464897747|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164419|NCT05396014|464897748|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164420|NCT05396014|464897749|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164421|NCT05396014|464897750|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164422|NCT05396014|464897751|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164423|NCT05396014|464897752|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
128726604|NCT00283439|463297002|FG002|Overall Study|Requirement for alternative therapy|5|||
128726605|NCT00283439|463297003|FG003|Overall Study|Requirement for alternative therapy|2|||
128726606|NCT00283439|463297000|FG000|Overall Study|Stem cell transplant|6|||
128726607|NCT00283439|463297001|FG001|Overall Study|Stem cell transplant|6|||
128726608|NCT00283439|463297002|FG002|Overall Study|Stem cell transplant|4|||
128726609|NCT00283439|463297003|FG003|Overall Study|Stem cell transplant|3|||
128726610|NCT00283439|463297000|FG000|Overall Study|Treatment discontinued|0|||
128726611|NCT00283439|463297001|FG001|Overall Study|Treatment discontinued|2|||
128726612|NCT00283439|463297002|FG002|Overall Study|Treatment discontinued|1|||
128726613|NCT00283439|463297003|FG003|Overall Study|Treatment discontinued|3|||
128726614|NCT00283439|463297000|FG000|Overall Study|Other|1|||
128726615|NCT00283439|463297001|FG001|Overall Study|Other|0|||
128726616|NCT00283439|463297002|FG002|Overall Study|Other|0|||
128726617|NCT00283439|463297003|FG003|Overall Study|Other|0|||
128726618|NCT02118428|463297004|FG000|Overall Study|Physician Decision|0|||
128726619|NCT02118428|463297005|FG001|Overall Study|Physician Decision|1|||
128726620|NCT02118428|463297006|FG002|Overall Study|Physician Decision|0|||
128726621|NCT02118428|463297004|FG000|Overall Study|Withdrawal by Subject|2|||
128726622|NCT02118428|463297005|FG001|Overall Study|Withdrawal by Subject|2|||
128726623|NCT02118428|463297006|FG002|Overall Study|Withdrawal by Subject|0|||
128726624|NCT02118428|463297004|FG000|Overall Study|Death|7|||
128726625|NCT02118428|463297005|FG001|Overall Study|Death|5|||
128726626|NCT02118428|463297006|FG002|Overall Study|Death|0|||
128726627|NCT02118428|463297004|FG000|Overall Study|Lost to Follow-up|3|||
128726628|NCT02118428|463297005|FG001|Overall Study|Lost to Follow-up|1|||
128726629|NCT02118428|463297006|FG002|Overall Study|Lost to Follow-up|0|||
128726630|NCT02118428|463297004|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
128726631|NCT02118428|463297005|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
128726632|NCT02118428|463297006|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
128726633|NCT03100825|463297021|FG000|Overall Study|Participant/Guardian Decision|7|||
128726634|NCT03100825|463297021|FG000|Overall Study|Physician Decision|1|||
128726635|NCT00826267|463297022|FG000|Overall Study|Other Adverse Event|1|||
128726636|NCT00826267|463297023|FG001|Overall Study|Other Adverse Event|0|||
128726637|NCT00826267|463297024|FG002|Overall Study|Other Adverse Event|0|||
128726638|NCT00048542|463297040|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
128726639|NCT00048542|463297041|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
128726640|NCT00048542|463297042|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
128726641|NCT00048542|463297043|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
128726642|NCT00048542|463297044|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
128726643|NCT00048542|463297045|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
129164424|NCT05396014|464897753|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164425|NCT05396014|464897754|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164426|NCT05396014|464897755|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
128726644|NCT00048542|463297046|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
128726645|NCT00048542|463297047|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
128726646|NCT00048542|463297040|FG000|Double-Blind Phase|Protocol Violation|0|||
128726647|NCT00048542|463297041|FG001|Double-Blind Phase|Protocol Violation|0|||
128726648|NCT00048542|463297042|FG002|Double-Blind Phase|Protocol Violation|1|||
128726649|NCT00048542|463297043|FG003|Double-Blind Phase|Protocol Violation|0|||
128726650|NCT00048542|463297044|FG004|Double-Blind Phase|Protocol Violation|0|||
128726651|NCT00048542|463297045|FG005|Double-Blind Phase|Protocol Violation|0|||
128726652|NCT00048542|463297046|FG006|Double-Blind Phase|Protocol Violation|0|||
128726653|NCT00048542|463297047|FG007|Double-Blind Phase|Protocol Violation|0|||
129164427|NCT05396014|464897756|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
129164428|NCT05396014|464897757|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164429|NCT05396014|464897758|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164430|NCT05396014|464897759|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164431|NCT05396014|464897760|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164432|NCT05396014|464897761|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164433|NCT05396014|464897762|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164434|NCT05396014|464897763|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164435|NCT05396014|464897764|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164436|NCT05396014|464897765|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164437|NCT05396014|464897766|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164438|NCT05396014|464897767|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164439|NCT05396014|464897768|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164440|NCT05396014|464897769|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
129164441|NCT05396014|464897770|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164442|NCT05396014|464897771|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164443|NCT05396014|464897772|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164444|NCT05396014|464897773|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164445|NCT05396014|464897774|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164446|NCT05396014|464897775|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164447|NCT05396014|464897776|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164448|NCT05396014|464897777|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164449|NCT05396014|464897778|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164450|NCT05396014|464897779|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164451|NCT05396014|464897780|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164452|NCT05396014|464897781|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164453|NCT05396014|464897782|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
129164454|NCT05396014|464897783|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164455|NCT05396014|464897784|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164456|NCT05396014|464897785|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129164457|NCT05396014|464897743|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164458|NCT05396014|464897744|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164459|NCT05396014|464897745|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164460|NCT05396014|464897746|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164461|NCT05396014|464897747|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164462|NCT05396014|464897748|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164463|NCT05396014|464897749|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164464|NCT05396014|464897750|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164465|NCT05396014|464897751|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164466|NCT05396014|464897752|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164467|NCT05396014|464897753|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164468|NCT05396014|464897754|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164469|NCT05396014|464897755|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164470|NCT05396014|464897756|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164471|NCT05396014|464897757|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164472|NCT05396014|464897758|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164473|NCT05396014|464897759|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164474|NCT05396014|464897760|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164475|NCT05396014|464897761|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164476|NCT05396014|464897762|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164477|NCT05396014|464897763|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164478|NCT05396014|464897764|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164479|NCT05396014|464897765|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164480|NCT05396014|464897766|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164481|NCT05396014|464897767|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164482|NCT05396014|464897768|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164483|NCT05396014|464897769|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
129164484|NCT05396014|464897770|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164485|NCT05396014|464897771|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164486|NCT05396014|464897772|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164487|NCT05396014|464897773|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164488|NCT05396014|464897774|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164489|NCT05396014|464897775|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164490|NCT05396014|464897776|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164491|NCT05396014|464897777|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164492|NCT05396014|464897778|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164493|NCT05396014|464897779|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164494|NCT05396014|464897780|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164495|NCT05396014|464897781|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164496|NCT05396014|464897782|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
129164497|NCT05396014|464897783|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164498|NCT05396014|464897784|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164499|NCT05396014|464897785|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129164500|NCT05396014|464897743|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164501|NCT05396014|464897744|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164502|NCT05396014|464897745|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164503|NCT05396014|464897746|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164504|NCT05396014|464897747|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164505|NCT05396014|464897748|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164506|NCT05396014|464897749|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164507|NCT05396014|464897750|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164508|NCT05396014|464897751|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164509|NCT05396014|464897752|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164510|NCT05396014|464897753|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164511|NCT05396014|464897754|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164512|NCT05396014|464897755|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164513|NCT05396014|464897756|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164514|NCT05396014|464897757|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164515|NCT05396014|464897758|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164516|NCT05396014|464897759|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164517|NCT05396014|464897760|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164518|NCT05396014|464897761|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164519|NCT05396014|464897762|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164520|NCT05396014|464897763|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164521|NCT05396014|464897764|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164522|NCT05396014|464897765|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164523|NCT05396014|464897766|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164524|NCT05396014|464897767|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164525|NCT05396014|464897768|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164526|NCT05396014|464897769|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
129164527|NCT05396014|464897770|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164528|NCT05396014|464897771|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164529|NCT05396014|464897772|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164530|NCT05396014|464897773|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164531|NCT05396014|464897774|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164532|NCT05396014|464897775|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164533|NCT05396014|464897776|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164534|NCT05396014|464897777|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164535|NCT05396014|464897778|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164536|NCT05396014|464897779|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164537|NCT05396014|464897780|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164538|NCT05396014|464897781|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164539|NCT05396014|464897782|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164540|NCT05396014|464897783|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164541|NCT05396014|464897784|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164542|NCT05396014|464897785|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129164543|NCT05396014|464897743|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164544|NCT05396014|464897744|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164545|NCT05396014|464897745|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164546|NCT05396014|464897746|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164547|NCT05396014|464897747|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164548|NCT05396014|464897748|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164549|NCT05396014|464897749|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164550|NCT05396014|464897750|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164551|NCT05396014|464897751|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164552|NCT05396014|464897752|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164553|NCT05396014|464897753|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164554|NCT05396014|464897754|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164555|NCT05396014|464897755|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
128726654|NCT00048542|463297040|FG000|Double-Blind Phase|Sponsor request or decision|2|||
128726655|NCT00048542|463297041|FG001|Double-Blind Phase|Sponsor request or decision|0|||
128726656|NCT00048542|463297042|FG002|Double-Blind Phase|Sponsor request or decision|0|||
129164556|NCT05396014|464897756|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
129164557|NCT05396014|464897757|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164558|NCT05396014|464897758|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164559|NCT05396014|464897759|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164560|NCT05396014|464897760|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164561|NCT05396014|464897761|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164562|NCT05396014|464897762|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164563|NCT05396014|464897763|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164564|NCT05396014|464897764|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164565|NCT05396014|464897765|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164566|NCT05396014|464897766|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164567|NCT05396014|464897767|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164568|NCT05396014|464897768|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164569|NCT05396014|464897769|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164570|NCT05396014|464897770|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164571|NCT05396014|464897771|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164572|NCT05396014|464897772|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164573|NCT05396014|464897773|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164574|NCT05396014|464897774|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164575|NCT05396014|464897775|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164576|NCT05396014|464897776|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164577|NCT05396014|464897777|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164578|NCT05396014|464897778|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164579|NCT05396014|464897779|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164580|NCT05396014|464897780|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164581|NCT05396014|464897781|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164582|NCT05396014|464897782|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164583|NCT05396014|464897783|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164584|NCT05396014|464897784|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164585|NCT05396014|464897785|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129164586|NCT05396014|464897743|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
129164587|NCT05396014|464897744|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164588|NCT05396014|464897745|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164589|NCT05396014|464897746|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164590|NCT05396014|464897747|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164591|NCT05396014|464897748|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164592|NCT05396014|464897749|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164593|NCT05396014|464897750|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164594|NCT05396014|464897751|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164595|NCT05396014|464897752|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164596|NCT05396014|464897753|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164597|NCT05396014|464897754|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164598|NCT05396014|464897755|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164599|NCT05396014|464897756|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
129164600|NCT05396014|464897757|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164601|NCT05396014|464897758|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164602|NCT05396014|464897759|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164603|NCT05396014|464897760|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164604|NCT05396014|464897761|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164605|NCT05396014|464897762|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164606|NCT05396014|464897763|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164607|NCT05396014|464897764|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164608|NCT05396014|464897765|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164609|NCT05396014|464897766|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164610|NCT05396014|464897767|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164611|NCT05396014|464897768|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164612|NCT05396014|464897769|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
128726657|NCT00048542|463297043|FG003|Double-Blind Phase|Sponsor request or decision|0|||
128726658|NCT00048542|463297044|FG004|Double-Blind Phase|Sponsor request or decision|0|||
128726659|NCT00048542|463297045|FG005|Double-Blind Phase|Sponsor request or decision|0|||
128726660|NCT00048542|463297046|FG006|Double-Blind Phase|Sponsor request or decision|0|||
128726661|NCT00048542|463297047|FG007|Double-Blind Phase|Sponsor request or decision|0|||
128726662|NCT00048542|463297040|FG000|Double-Blind Phase|Randomized in error|1|||
128982120|NCT02545504|464219104|FG001|Overall Study|Unknown reason|32|||
129164613|NCT05396014|464897770|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164614|NCT05396014|464897771|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164615|NCT05396014|464897772|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164616|NCT05396014|464897773|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164617|NCT05396014|464897774|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164618|NCT05396014|464897775|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164619|NCT05396014|464897776|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164620|NCT05396014|464897777|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164621|NCT05396014|464897778|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164622|NCT05396014|464897779|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
128777014|NCT01848834|463472064|FG000|Overall Study|Withdrawal by Subject|2|||
128777015|NCT01848834|463472065|FG001|Overall Study|Withdrawal by Subject|13|||
128777016|NCT01848834|463472066|FG002|Overall Study|Withdrawal by Subject|10|||
128777017|NCT01848834|463472067|FG003|Overall Study|Withdrawal by Subject|6|||
128777018|NCT01848834|463472068|FG004|Overall Study|Withdrawal by Subject|36|||
128777019|NCT02040090|463472071|FG000|Overall Study|Adverse Event|2|||
128777020|NCT02040090|463472072|FG001|Overall Study|Adverse Event|0|||
128777021|NCT02040090|463472071|FG000|Overall Study|Physician Decision|1|||
128777022|NCT02040090|463472072|FG001|Overall Study|Physician Decision|0|||
128777023|NCT02040090|463472071|FG000|Overall Study|Withdrawal by Subject|0|||
128777024|NCT02040090|463472072|FG001|Overall Study|Withdrawal by Subject|1|||
128777025|NCT02040090|463472071|FG000|Overall Study|Lost to Follow-up|0|||
128777026|NCT02040090|463472072|FG001|Overall Study|Lost to Follow-up|1|||
128777027|NCT03259373|463472079|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
128777028|NCT03259373|463472080|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
128777029|NCT03259373|463472079|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
128777030|NCT03259373|463472080|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
128777031|NCT03259373|463472079|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
128777032|NCT03259373|463472080|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
128777033|NCT03259373|463472079|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
128777034|NCT03259373|463472080|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
128777035|NCT03259373|463472079|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
128777036|NCT03259373|463472080|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
128777037|NCT03259373|463472079|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
128777038|NCT03259373|463472080|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
128777039|NCT04894903|463472081|FG000|Overall Study|Death|1|||
128777040|NCT04894903|463472082|FG001|Overall Study|Death|0|||
128777041|NCT04894903|463472081|FG000|Overall Study|Pregnancy|1|||
128777042|NCT04894903|463472082|FG001|Overall Study|Pregnancy|0|||
128777043|NCT04894903|463472081|FG000|Overall Study|Withdrawal by Subject|1|||
128777044|NCT04894903|463472082|FG001|Overall Study|Withdrawal by Subject|1|||
128777045|NCT04894903|463472081|FG000|Overall Study|moved or exited health system|1|||
128777046|NCT04894903|463472082|FG001|Overall Study|moved or exited health system|3|||
128777047|NCT00895843|463472083|FG000|Overall Study|Protocol Violation|12|||
128777048|NCT00895843|463472084|FG001|Overall Study|Protocol Violation|12|||
128777049|NCT04963062|463472092|FG000|Overall Study|withdrew by the study team|4|||
128777050|NCT04963062|463472093|FG001|Overall Study|withdrew by the study team|2|||
129164623|NCT05396014|464897780|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164624|NCT05396014|464897781|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164625|NCT05396014|464897782|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
129164626|NCT05396014|464897783|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164627|NCT05396014|464897784|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164628|NCT05396014|464897785|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129164629|NCT05396014|464897743|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
129164630|NCT05396014|464897744|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164631|NCT05396014|464897745|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164632|NCT05396014|464897746|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164633|NCT05396014|464897747|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164634|NCT05396014|464897748|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164635|NCT05396014|464897749|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164636|NCT05396014|464897750|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164637|NCT05396014|464897751|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164638|NCT05396014|464897752|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164639|NCT05396014|464897753|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
128777051|NCT01857323|463472094|FG000|Overall Study|Adverse Event|1|||
128777052|NCT01857323|463472094|FG000|Overall Study|Withdrawal by Subject|3|||
128777053|NCT01857323|463472094|FG000|Overall Study|Non-compliance|1|||
129164640|NCT05396014|464897754|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164641|NCT05396014|464897755|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164642|NCT05396014|464897756|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164643|NCT05396014|464897757|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164644|NCT05396014|464897758|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164645|NCT05396014|464897759|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164646|NCT05396014|464897760|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164647|NCT05396014|464897761|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164648|NCT05396014|464897762|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164649|NCT05396014|464897763|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164650|NCT05396014|464897764|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164651|NCT05396014|464897765|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164652|NCT05396014|464897766|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164653|NCT05396014|464897767|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164654|NCT05396014|464897768|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164655|NCT05396014|464897769|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
129164656|NCT05396014|464897770|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164657|NCT05396014|464897771|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164658|NCT05396014|464897772|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164659|NCT05396014|464897773|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164660|NCT05396014|464897774|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164661|NCT05396014|464897775|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164662|NCT05396014|464897776|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164663|NCT05396014|464897777|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164664|NCT05396014|464897778|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164665|NCT05396014|464897779|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164666|NCT05396014|464897780|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164667|NCT05396014|464897781|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164668|NCT05396014|464897782|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164669|NCT05396014|464897783|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164670|NCT05396014|464897784|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164671|NCT05396014|464897785|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129164672|NCT05396014|464897743|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164673|NCT05396014|464897744|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164674|NCT05396014|464897745|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164675|NCT05396014|464897746|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164676|NCT05396014|464897747|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164677|NCT05396014|464897748|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164678|NCT05396014|464897749|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164679|NCT05396014|464897750|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164680|NCT05396014|464897751|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164681|NCT05396014|464897752|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164682|NCT05396014|464897753|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164683|NCT05396014|464897754|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164684|NCT05396014|464897755|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164685|NCT05396014|464897756|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
129164686|NCT05396014|464897757|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164687|NCT05396014|464897758|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164688|NCT05396014|464897759|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164689|NCT05396014|464897760|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164690|NCT05396014|464897761|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164691|NCT05396014|464897762|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164692|NCT05396014|464897763|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164693|NCT05396014|464897764|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164694|NCT05396014|464897765|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164695|NCT05396014|464897766|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164696|NCT05396014|464897767|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164697|NCT05396014|464897768|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
128726663|NCT00048542|463297041|FG001|Double-Blind Phase|Randomized in error|0|||
128726664|NCT00048542|463297042|FG002|Double-Blind Phase|Randomized in error|0|||
128726665|NCT00048542|463297043|FG003|Double-Blind Phase|Randomized in error|0|||
129164698|NCT05396014|464897769|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164699|NCT05396014|464897770|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164700|NCT05396014|464897771|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164701|NCT05396014|464897772|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
128726666|NCT00048542|463297044|FG004|Double-Blind Phase|Randomized in error|0|||
129164702|NCT05396014|464897773|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164703|NCT05396014|464897774|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164704|NCT05396014|464897775|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164705|NCT05396014|464897776|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164706|NCT05396014|464897777|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164707|NCT05396014|464897778|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164708|NCT05396014|464897779|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164709|NCT05396014|464897780|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164710|NCT05396014|464897781|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164711|NCT05396014|464897782|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164712|NCT05396014|464897783|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164713|NCT05396014|464897784|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164714|NCT05396014|464897785|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129164715|NCT05396014|464897743|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164716|NCT05396014|464897744|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164717|NCT05396014|464897745|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164718|NCT05396014|464897746|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129164719|NCT05396014|464897747|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164720|NCT05396014|464897748|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164721|NCT05396014|464897749|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164722|NCT05396014|464897750|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164723|NCT05396014|464897751|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129164724|NCT05396014|464897752|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164725|NCT05396014|464897753|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164726|NCT05396014|464897754|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164727|NCT05396014|464897755|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164728|NCT05396014|464897756|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164729|NCT05396014|464897757|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164730|NCT05396014|464897758|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164731|NCT05396014|464897759|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164732|NCT05396014|464897760|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164733|NCT05396014|464897761|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164734|NCT05396014|464897762|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164735|NCT05396014|464897763|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164736|NCT05396014|464897764|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164737|NCT05396014|464897765|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164738|NCT05396014|464897766|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164739|NCT05396014|464897767|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164740|NCT05396014|464897768|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129164741|NCT05396014|464897769|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164742|NCT05396014|464897770|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164743|NCT05396014|464897771|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164744|NCT05396014|464897772|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164745|NCT05396014|464897773|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164746|NCT05396014|464897774|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164747|NCT05396014|464897775|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164748|NCT05396014|464897776|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164749|NCT05396014|464897777|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164750|NCT05396014|464897778|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
128726667|NCT00048542|463297045|FG005|Double-Blind Phase|Randomized in error|0|||
128726668|NCT00048542|463297046|FG006|Double-Blind Phase|Randomized in error|0|||
128726669|NCT00048542|463297047|FG007|Double-Blind Phase|Randomized in error|0|||
128726670|NCT00048542|463297040|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
128726671|NCT00048542|463297041|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129164751|NCT05396014|464897779|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
128726672|NCT00048542|463297042|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
128726673|NCT00048542|463297043|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
128726674|NCT00048542|463297044|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
128726675|NCT00048542|463297045|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
128726676|NCT00048542|463297046|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
128726677|NCT00048542|463297047|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
128726678|NCT00048542|463297040|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
128726679|NCT00048542|463297041|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
128726680|NCT00048542|463297042|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
128726681|NCT00048542|463297043|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
128726682|NCT00048542|463297044|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
128726683|NCT00048542|463297045|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
128726684|NCT00048542|463297046|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
129164752|NCT05396014|464897780|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164753|NCT05396014|464897781|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129164754|NCT05396014|464897782|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
128726685|NCT00048542|463297047|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
128777054|NCT01857323|463472094|FG000|Overall Study|Protocol Violation|6|||
129164755|NCT05396014|464897783|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
128777055|NCT01857323|463472094|FG000|Overall Study|Lost to Follow-up|1|||
129164756|NCT05396014|464897784|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129164757|NCT05396014|464897785|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129164758|NCT05396014|464897743|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164759|NCT05396014|464897744|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164760|NCT05396014|464897745|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164761|NCT05396014|464897746|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164762|NCT05396014|464897747|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164763|NCT05396014|464897748|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164764|NCT05396014|464897749|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164765|NCT05396014|464897750|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164766|NCT05396014|464897751|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
129164767|NCT05396014|464897752|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164768|NCT05396014|464897753|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164769|NCT05396014|464897754|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164770|NCT05396014|464897755|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
128777056|NCT01857323|463472094|FG000|Overall Study|Other|4|||
128777057|NCT01857323|463472094|FG000|Overall Study|Did not complete 180 doses|48|||
129164771|NCT05396014|464897756|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164772|NCT05396014|464897757|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164773|NCT05396014|464897758|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164774|NCT05396014|464897759|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164775|NCT05396014|464897760|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164776|NCT05396014|464897761|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164777|NCT05396014|464897762|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164778|NCT05396014|464897763|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164779|NCT05396014|464897764|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164780|NCT05396014|464897765|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
129164781|NCT05396014|464897766|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164782|NCT05396014|464897767|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164783|NCT05396014|464897768|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164784|NCT05396014|464897769|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164785|NCT05396014|464897770|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164786|NCT05396014|464897771|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164787|NCT05396014|464897772|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164788|NCT05396014|464897773|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164789|NCT05396014|464897774|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164790|NCT05396014|464897775|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164791|NCT05396014|464897776|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164792|NCT05396014|464897777|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164793|NCT05396014|464897778|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
129164794|NCT05396014|464897779|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164795|NCT05396014|464897780|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164796|NCT05396014|464897781|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164797|NCT05396014|464897782|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129164798|NCT05396014|464897783|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164799|NCT05396014|464897784|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
129164800|NCT05396014|464897785|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129164801|NCT05396014|464897743|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164802|NCT05396014|464897744|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164803|NCT05396014|464897745|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164804|NCT05396014|464897746|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164805|NCT05396014|464897747|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164806|NCT05396014|464897748|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164807|NCT05396014|464897749|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164808|NCT05396014|464897750|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164809|NCT05396014|464897751|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164810|NCT05396014|464897752|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164811|NCT05396014|464897753|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164812|NCT05396014|464897754|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164813|NCT05396014|464897755|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164814|NCT05396014|464897756|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129164815|NCT05396014|464897757|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164816|NCT05396014|464897758|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164817|NCT05396014|464897759|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164818|NCT05396014|464897760|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164819|NCT05396014|464897761|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164820|NCT05396014|464897762|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164821|NCT05396014|464897763|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164822|NCT05396014|464897764|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164823|NCT05396014|464897765|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164824|NCT05396014|464897766|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164825|NCT05396014|464897767|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164826|NCT05396014|464897768|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164827|NCT05396014|464897769|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129164828|NCT05396014|464897770|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164829|NCT05396014|464897771|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164830|NCT05396014|464897772|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164831|NCT05396014|464897773|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164832|NCT05396014|464897774|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164833|NCT05396014|464897775|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164834|NCT05396014|464897776|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
128726686|NCT00048542|463297040|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
128726687|NCT00048542|463297041|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
128726688|NCT00048542|463297042|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129164835|NCT05396014|464897777|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129164836|NCT05396014|464897778|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164837|NCT05396014|464897779|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164838|NCT05396014|464897780|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164839|NCT05396014|464897781|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164840|NCT05396014|464897782|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164841|NCT05396014|464897783|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164842|NCT05396014|464897784|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129164843|NCT05396014|464897785|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129164844|NCT05396014|464897743|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164845|NCT05396014|464897744|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164846|NCT05396014|464897745|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164847|NCT05396014|464897746|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164848|NCT05396014|464897747|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164849|NCT05396014|464897748|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164850|NCT05396014|464897749|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164851|NCT05396014|464897750|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164852|NCT05396014|464897751|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164853|NCT05396014|464897752|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164854|NCT05396014|464897753|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164855|NCT05396014|464897754|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164856|NCT05396014|464897755|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164857|NCT05396014|464897756|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164858|NCT05396014|464897757|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164859|NCT05396014|464897758|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164860|NCT05396014|464897759|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164861|NCT05396014|464897760|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164862|NCT05396014|464897761|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164863|NCT05396014|464897762|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164864|NCT05396014|464897763|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164865|NCT05396014|464897764|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164866|NCT05396014|464897765|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164867|NCT05396014|464897766|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164868|NCT05396014|464897767|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164869|NCT05396014|464897768|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164870|NCT05396014|464897769|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
129164871|NCT05396014|464897770|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164872|NCT05396014|464897771|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164873|NCT05396014|464897772|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164874|NCT05396014|464897773|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164875|NCT05396014|464897774|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164876|NCT05396014|464897775|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164877|NCT05396014|464897776|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164878|NCT05396014|464897777|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164879|NCT05396014|464897778|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164880|NCT05396014|464897779|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164881|NCT05396014|464897780|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164882|NCT05396014|464897781|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164883|NCT05396014|464897782|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164884|NCT05396014|464897783|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164885|NCT05396014|464897784|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164886|NCT05396014|464897785|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129164887|NCT03062280|464897786|FG000|Overall Study|Adverse Event|1|||
129164888|NCT03062280|464897786|FG000|Overall Study|Death|1|||
129164889|NCT03062280|464897786|FG000|Overall Study|Fertility Treatment|2|||
129164890|NCT03062280|464897786|FG000|Overall Study|Physician Decision|2|||
129164891|NCT03062280|464897786|FG000|Overall Study|Pregnancy|5|||
129164892|NCT03062280|464897786|FG000|Overall Study|Withdrawal by Subject|11|||
129164893|NCT04299308|464897788|FG000|Overall Study|Withdrawal by Subject|1|||
129164894|NCT04299308|464897789|FG001|Overall Study|Withdrawal by Subject|0|||
129164895|NCT04299308|464897788|FG000|Overall Study|issue with PET image (1)|1|||
129164896|NCT04299308|464897789|FG001|Overall Study|issue with PET image (1)|0|||
129164897|NCT05258890|464897790|FG000|Overall Study|Patient withdrawal|6|||
129164898|NCT05258890|464897791|FG001|Overall Study|Patient withdrawal|7|||
129164899|NCT05258890|464897790|FG000|Overall Study|Patient lost to follow-up|10|||
129164900|NCT05258890|464897791|FG001|Overall Study|Patient lost to follow-up|3|||
129164901|NCT05258890|464897790|FG000|Overall Study|Social network member withdrawal|1|||
128726689|NCT00048542|463297043|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129164902|NCT05258890|464897791|FG001|Overall Study|Social network member withdrawal|0|||
129164903|NCT05258890|464897790|FG000|Overall Study|Social network member lost to follow-up|5|||
129164904|NCT05258890|464897791|FG001|Overall Study|Social network member lost to follow-up|0|||
129164905|NCT04493424|464897792|FG000|Overall Study|Termination of the trial by the sponsor|89|||
129164906|NCT04493424|464897792|FG000|Overall Study|Withdrawal by Subject|9|||
129164907|NCT04493424|464897792|FG000|Overall Study|Lost to Follow-up|2|||
129164908|NCT04493424|464897792|FG000|Overall Study|Lack of Efficacy|3|||
129164909|NCT04493424|464897792|FG000|Overall Study|Adverse Event|5|||
129164910|NCT00516893|464897795|FG000|Overall Study|Lost to Follow-up|4|||
129164911|NCT00516893|464897795|FG000|Overall Study|Adverse Event|3|||
129164912|NCT00516893|464897795|FG000|Overall Study|Withdrawal by Subject|2|||
129164913|NCT00516893|464897795|FG000|Overall Study|Noncompliance|2|||
129164914|NCT00516893|464897795|FG000|Overall Study|Death|1|||
129164915|NCT00516893|464897795|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
129164916|NCT00516893|464897795|FG000|Overall Study|Relocated|1|||
129164917|NCT00516893|464897795|FG000|Overall Study|Pregnancy|1|||
129164918|NCT00516893|464897795|FG000|Overall Study|Received Medication From Another Study|1|||
129164919|NCT05924165|464897796|FG000|Overall Study|Physician Decision|2|||
129164920|NCT05924165|464897797|FG001|Overall Study|Physician Decision|3|||
129164921|NCT05959447|464897798|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
129164922|NCT05959447|464897799|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
129164923|NCT05959447|464897798|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
129164924|NCT05959447|464897799|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
129164925|NCT05959447|464897798|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
129164926|NCT05959447|464897799|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
129164927|NCT05959447|464897798|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
129164928|NCT05959447|464897799|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
129164929|NCT00301262|464897800|FG000|Double Blind Phase (DB)|Adverse Event|1|||
129164930|NCT00301262|464897801|FG001|Double Blind Phase (DB)|Adverse Event|0|||
129164931|NCT00301262|464897800|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
129164932|NCT00301262|464897801|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
129164933|NCT00301262|464897800|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
129164934|NCT00301262|464897801|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
129164935|NCT00301262|464897800|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
129164936|NCT00301262|464897801|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
129164937|NCT00301262|464897800|FG000|Double Blind Phase (DB)|Other|1|||
129164938|NCT00301262|464897801|FG001|Double Blind Phase (DB)|Other|4|||
129164939|NCT00301262|464897800|FG000|Open Label Phase (OL)|Adverse Event|1|||
129164940|NCT00301262|464897801|FG001|Open Label Phase (OL)|Adverse Event|0|||
129164941|NCT00301262|464897800|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
129164942|NCT00301262|464897801|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
129164943|NCT00301262|464897800|FG000|Open Label Phase (OL)|Other|2|||
129164944|NCT00301262|464897801|FG001|Open Label Phase (OL)|Other|0|||
129164945|NCT00368745|464897802|FG000|Double-blind Treatment Period|Adverse Event|6|||
129164946|NCT00368745|464897803|FG001|Double-blind Treatment Period|Adverse Event|6|||
129164947|NCT00368745|464897802|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
129164948|NCT00368745|464897803|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
129164949|NCT00368745|464897802|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
129164950|NCT00368745|464897803|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129164951|NCT00368745|464897802|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
129164952|NCT00368745|464897803|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
129164953|NCT00368745|464897802|FG000|Double-blind Treatment Period|Other|7|||
129164954|NCT00368745|464897803|FG001|Double-blind Treatment Period|Other|6|||
129164955|NCT01436656|464897804|FG000|Dose Escalation|Death|1|||
129164956|NCT01436656|464897805|FG001|Dose Escalation|Death|3|||
129164957|NCT01436656|464897806|FG002|Dose Escalation|Death|1|||
129164958|NCT01436656|464897807|FG003|Dose Escalation|Death|0|||
129164959|NCT01436656|464897808|FG004|Dose Escalation|Death|2|||
129164960|NCT01436656|464897809|FG005|Dose Escalation|Death|1|||
129164961|NCT01436656|464897810|FG006|Dose Escalation|Death|1|||
129164962|NCT01436656|464897811|FG007|Dose Escalation|Death|1|||
129164963|NCT01436656|464897812|FG008|Dose Escalation|Death|1|||
129164964|NCT01436656|464897813|FG009|Dose Escalation|Death|0|||
129164965|NCT01436656|464897814|FG010|Dose Escalation|Death|0|||
129164966|NCT01436656|464897815|FG011|Dose Escalation|Death|0|||
129164967|NCT01436656|464897816|FG012|Dose Escalation|Death|0|||
129164968|NCT01436656|464897817|FG013|Dose Escalation|Death|0|||
129164969|NCT01436656|464897818|FG014|Dose Escalation|Death|0|||
129164970|NCT01436656|464897819|FG015|Dose Escalation|Death|0|||
128777058|NCT03873246|463472095|FG000|Overall Study|Adverse Event|1|||
129164971|NCT01436656|464897820|FG016|Dose Escalation|Death|0|||
129164972|NCT01436656|464897821|FG017|Dose Escalation|Death|0|||
129164973|NCT01436656|464897804|FG000|Dose Escalation|Protocol Violation|0|||
129164974|NCT01436656|464897805|FG001|Dose Escalation|Protocol Violation|0|||
128777059|NCT03873246|463472096|FG001|Overall Study|Adverse Event|3|||
128777060|NCT03873246|463472097|FG002|Overall Study|Adverse Event|3|||
128777061|NCT03873246|463472095|FG000|Overall Study|Lost to Follow-up|4|||
129164975|NCT01436656|464897806|FG002|Dose Escalation|Protocol Violation|0|||
129164976|NCT01436656|464897807|FG003|Dose Escalation|Protocol Violation|0|||
129164977|NCT01436656|464897808|FG004|Dose Escalation|Protocol Violation|0|||
129164978|NCT01436656|464897809|FG005|Dose Escalation|Protocol Violation|1|||
129164979|NCT01436656|464897810|FG006|Dose Escalation|Protocol Violation|0|||
129164980|NCT01436656|464897811|FG007|Dose Escalation|Protocol Violation|0|||
129164981|NCT01436656|464897812|FG008|Dose Escalation|Protocol Violation|0|||
129164982|NCT01436656|464897813|FG009|Dose Escalation|Protocol Violation|0|||
129164983|NCT01436656|464897814|FG010|Dose Escalation|Protocol Violation|0|||
129164984|NCT01436656|464897815|FG011|Dose Escalation|Protocol Violation|0|||
129164985|NCT01436656|464897816|FG012|Dose Escalation|Protocol Violation|0|||
129164986|NCT01436656|464897817|FG013|Dose Escalation|Protocol Violation|0|||
129164987|NCT01436656|464897818|FG014|Dose Escalation|Protocol Violation|0|||
129164988|NCT01436656|464897819|FG015|Dose Escalation|Protocol Violation|0|||
129164989|NCT01436656|464897820|FG016|Dose Escalation|Protocol Violation|0|||
129164990|NCT01436656|464897821|FG017|Dose Escalation|Protocol Violation|0|||
129164991|NCT01436656|464897804|FG000|Dose Escalation|Withdrawal by Subject|0|||
129164992|NCT01436656|464897805|FG001|Dose Escalation|Withdrawal by Subject|0|||
129164993|NCT01436656|464897806|FG002|Dose Escalation|Withdrawal by Subject|0|||
129164994|NCT01436656|464897807|FG003|Dose Escalation|Withdrawal by Subject|0|||
129164995|NCT01436656|464897808|FG004|Dose Escalation|Withdrawal by Subject|1|||
129164996|NCT01436656|464897809|FG005|Dose Escalation|Withdrawal by Subject|0|||
129164997|NCT01436656|464897810|FG006|Dose Escalation|Withdrawal by Subject|0|||
129164998|NCT01436656|464897811|FG007|Dose Escalation|Withdrawal by Subject|2|||
129164999|NCT01436656|464897812|FG008|Dose Escalation|Withdrawal by Subject|0|||
129165000|NCT01436656|464897813|FG009|Dose Escalation|Withdrawal by Subject|1|||
129165001|NCT01436656|464897814|FG010|Dose Escalation|Withdrawal by Subject|1|||
129165002|NCT01436656|464897815|FG011|Dose Escalation|Withdrawal by Subject|0|||
129165003|NCT01436656|464897816|FG012|Dose Escalation|Withdrawal by Subject|0|||
129165004|NCT01436656|464897817|FG013|Dose Escalation|Withdrawal by Subject|0|||
129165005|NCT01436656|464897818|FG014|Dose Escalation|Withdrawal by Subject|0|||
129165006|NCT01436656|464897819|FG015|Dose Escalation|Withdrawal by Subject|0|||
129165007|NCT01436656|464897820|FG016|Dose Escalation|Withdrawal by Subject|0|||
129165008|NCT01436656|464897821|FG017|Dose Escalation|Withdrawal by Subject|0|||
129165009|NCT01436656|464897804|FG000|Dose Escalation|Administrative problems|0|||
129165010|NCT01436656|464897805|FG001|Dose Escalation|Administrative problems|1|||
129165011|NCT01436656|464897806|FG002|Dose Escalation|Administrative problems|0|||
129165012|NCT01436656|464897807|FG003|Dose Escalation|Administrative problems|0|||
129165013|NCT01436656|464897808|FG004|Dose Escalation|Administrative problems|0|||
129165014|NCT01436656|464897809|FG005|Dose Escalation|Administrative problems|0|||
129165015|NCT01436656|464897810|FG006|Dose Escalation|Administrative problems|0|||
129165016|NCT01436656|464897811|FG007|Dose Escalation|Administrative problems|0|||
129165017|NCT01436656|464897812|FG008|Dose Escalation|Administrative problems|0|||
129165018|NCT01436656|464897813|FG009|Dose Escalation|Administrative problems|0|||
129165019|NCT01436656|464897814|FG010|Dose Escalation|Administrative problems|0|||
129165020|NCT01436656|464897815|FG011|Dose Escalation|Administrative problems|0|||
129165021|NCT01436656|464897816|FG012|Dose Escalation|Administrative problems|0|||
129165022|NCT01436656|464897817|FG013|Dose Escalation|Administrative problems|0|||
129165023|NCT01436656|464897818|FG014|Dose Escalation|Administrative problems|0|||
129165024|NCT01436656|464897819|FG015|Dose Escalation|Administrative problems|0|||
129165025|NCT01436656|464897820|FG016|Dose Escalation|Administrative problems|0|||
129165026|NCT01436656|464897821|FG017|Dose Escalation|Administrative problems|0|||
128777062|NCT03873246|463472096|FG001|Overall Study|Lost to Follow-up|4|||
129165027|NCT01436656|464897804|FG000|Dose Escalation|Lost to Follow-up|1|||
129165028|NCT01436656|464897805|FG001|Dose Escalation|Lost to Follow-up|0|||
129165029|NCT01436656|464897806|FG002|Dose Escalation|Lost to Follow-up|0|||
129165030|NCT01436656|464897807|FG003|Dose Escalation|Lost to Follow-up|0|||
129165031|NCT01436656|464897808|FG004|Dose Escalation|Lost to Follow-up|1|||
129165032|NCT01436656|464897809|FG005|Dose Escalation|Lost to Follow-up|0|||
129165033|NCT01436656|464897810|FG006|Dose Escalation|Lost to Follow-up|0|||
129165034|NCT01436656|464897811|FG007|Dose Escalation|Lost to Follow-up|0|||
129165035|NCT01436656|464897812|FG008|Dose Escalation|Lost to Follow-up|0|||
129165036|NCT01436656|464897813|FG009|Dose Escalation|Lost to Follow-up|0|||
129165037|NCT01436656|464897814|FG010|Dose Escalation|Lost to Follow-up|0|||
129165038|NCT01436656|464897815|FG011|Dose Escalation|Lost to Follow-up|0|||
129165039|NCT01436656|464897816|FG012|Dose Escalation|Lost to Follow-up|0|||
129165040|NCT01436656|464897817|FG013|Dose Escalation|Lost to Follow-up|0|||
129165041|NCT01436656|464897818|FG014|Dose Escalation|Lost to Follow-up|0|||
129165042|NCT01436656|464897819|FG015|Dose Escalation|Lost to Follow-up|0|||
129165043|NCT01436656|464897820|FG016|Dose Escalation|Lost to Follow-up|0|||
129165044|NCT01436656|464897821|FG017|Dose Escalation|Lost to Follow-up|0|||
129165045|NCT01436656|464897804|FG000|Dose Escalation|New anti-cancer therapy|1|||
129165046|NCT01436656|464897805|FG001|Dose Escalation|New anti-cancer therapy|0|||
129165047|NCT01436656|464897806|FG002|Dose Escalation|New anti-cancer therapy|0|||
129165048|NCT01436656|464897807|FG003|Dose Escalation|New anti-cancer therapy|0|||
129165049|NCT01436656|464897808|FG004|Dose Escalation|New anti-cancer therapy|0|||
129165050|NCT01436656|464897809|FG005|Dose Escalation|New anti-cancer therapy|0|||
129165051|NCT01436656|464897810|FG006|Dose Escalation|New anti-cancer therapy|0|||
129165052|NCT01436656|464897811|FG007|Dose Escalation|New anti-cancer therapy|0|||
129165053|NCT01436656|464897812|FG008|Dose Escalation|New anti-cancer therapy|1|||
129165054|NCT01436656|464897813|FG009|Dose Escalation|New anti-cancer therapy|1|||
129165055|NCT01436656|464897814|FG010|Dose Escalation|New anti-cancer therapy|0|||
129165056|NCT01436656|464897815|FG011|Dose Escalation|New anti-cancer therapy|0|||
129165057|NCT01436656|464897816|FG012|Dose Escalation|New anti-cancer therapy|0|||
129165058|NCT01436656|464897817|FG013|Dose Escalation|New anti-cancer therapy|0|||
129165059|NCT01436656|464897818|FG014|Dose Escalation|New anti-cancer therapy|0|||
129165060|NCT01436656|464897819|FG015|Dose Escalation|New anti-cancer therapy|0|||
129165061|NCT01436656|464897820|FG016|Dose Escalation|New anti-cancer therapy|0|||
129165062|NCT01436656|464897821|FG017|Dose Escalation|New anti-cancer therapy|0|||
129165063|NCT01436656|464897804|FG000|Dose Expansion|Adverse Event|0|||
129165064|NCT01436656|464897805|FG001|Dose Expansion|Adverse Event|0|||
129165065|NCT01436656|464897806|FG002|Dose Expansion|Adverse Event|0|||
129165066|NCT01436656|464897807|FG003|Dose Expansion|Adverse Event|0|||
129165067|NCT01436656|464897808|FG004|Dose Expansion|Adverse Event|0|||
129165068|NCT01436656|464897809|FG005|Dose Expansion|Adverse Event|0|||
129165069|NCT01436656|464897810|FG006|Dose Expansion|Adverse Event|0|||
129165070|NCT01436656|464897811|FG007|Dose Expansion|Adverse Event|0|||
129165071|NCT01436656|464897812|FG008|Dose Expansion|Adverse Event|0|||
129165072|NCT01436656|464897813|FG009|Dose Expansion|Adverse Event|0|||
129165073|NCT01436656|464897814|FG010|Dose Expansion|Adverse Event|0|||
129165074|NCT01436656|464897815|FG011|Dose Expansion|Adverse Event|1|||
129165075|NCT01436656|464897816|FG012|Dose Expansion|Adverse Event|0|||
129165076|NCT01436656|464897817|FG013|Dose Expansion|Adverse Event|0|||
129165077|NCT01436656|464897818|FG014|Dose Expansion|Adverse Event|0|||
129165078|NCT01436656|464897819|FG015|Dose Expansion|Adverse Event|0|||
129165079|NCT01436656|464897820|FG016|Dose Expansion|Adverse Event|0|||
129165080|NCT01436656|464897821|FG017|Dose Expansion|Adverse Event|0|||
129165081|NCT01436656|464897804|FG000|Dose Expansion|Withdrawal by Subject|0|||
129165082|NCT01436656|464897805|FG001|Dose Expansion|Withdrawal by Subject|0|||
129165083|NCT01436656|464897806|FG002|Dose Expansion|Withdrawal by Subject|0|||
129165084|NCT01436656|464897807|FG003|Dose Expansion|Withdrawal by Subject|0|||
129165085|NCT01436656|464897808|FG004|Dose Expansion|Withdrawal by Subject|0|||
129165086|NCT01436656|464897809|FG005|Dose Expansion|Withdrawal by Subject|0|||
129165087|NCT01436656|464897810|FG006|Dose Expansion|Withdrawal by Subject|0|||
129165088|NCT01436656|464897811|FG007|Dose Expansion|Withdrawal by Subject|0|||
129165089|NCT01436656|464897812|FG008|Dose Expansion|Withdrawal by Subject|0|||
129165090|NCT01436656|464897813|FG009|Dose Expansion|Withdrawal by Subject|0|||
129165091|NCT01436656|464897814|FG010|Dose Expansion|Withdrawal by Subject|0|||
129165092|NCT01436656|464897815|FG011|Dose Expansion|Withdrawal by Subject|1|||
129165093|NCT01436656|464897816|FG012|Dose Expansion|Withdrawal by Subject|3|||
129165094|NCT01436656|464897817|FG013|Dose Expansion|Withdrawal by Subject|1|||
129165095|NCT01436656|464897818|FG014|Dose Expansion|Withdrawal by Subject|2|||
129165096|NCT01436656|464897819|FG015|Dose Expansion|Withdrawal by Subject|0|||
129165097|NCT01436656|464897820|FG016|Dose Expansion|Withdrawal by Subject|1|||
129165098|NCT01436656|464897821|FG017|Dose Expansion|Withdrawal by Subject|1|||
129165099|NCT01436656|464897804|FG000|Dose Expansion|Death|0|||
129165100|NCT01436656|464897805|FG001|Dose Expansion|Death|0|||
129165101|NCT01436656|464897806|FG002|Dose Expansion|Death|0|||
129165102|NCT01436656|464897807|FG003|Dose Expansion|Death|0|||
129165103|NCT01436656|464897808|FG004|Dose Expansion|Death|0|||
129165104|NCT01436656|464897809|FG005|Dose Expansion|Death|0|||
129165105|NCT01436656|464897810|FG006|Dose Expansion|Death|0|||
129165106|NCT01436656|464897811|FG007|Dose Expansion|Death|0|||
129165107|NCT01436656|464897812|FG008|Dose Expansion|Death|0|||
129165108|NCT01436656|464897813|FG009|Dose Expansion|Death|0|||
128777063|NCT03873246|463472097|FG002|Overall Study|Lost to Follow-up|5|||
129165109|NCT01436656|464897814|FG010|Dose Expansion|Death|0|||
129165110|NCT01436656|464897815|FG011|Dose Expansion|Death|0|||
129165111|NCT01436656|464897816|FG012|Dose Expansion|Death|1|||
128777064|NCT03873246|463472095|FG000|Overall Study|Protocol Violation|0|||
128777065|NCT03873246|463472096|FG001|Overall Study|Protocol Violation|1|||
128777066|NCT03873246|463472097|FG002|Overall Study|Protocol Violation|0|||
128777067|NCT03873246|463472095|FG000|Overall Study|Withdrawal by Subject|0|||
128777068|NCT03873246|463472096|FG001|Overall Study|Withdrawal by Subject|4|||
128777069|NCT03873246|463472097|FG002|Overall Study|Withdrawal by Subject|1|||
128777070|NCT03658811|463472098|FG000|Overall Study|Lost to Follow-up|3|||
128777071|NCT00946647|463472102|FG000|Phase 1 Part|Adverse Event|2|||
128777072|NCT00946647|463472103|FG001|Phase 1 Part|Adverse Event|5|||
128777073|NCT00946647|463472104|FG002|Phase 1 Part|Adverse Event|3|||
128777074|NCT00946647|463472105|FG003|Phase 1 Part|Adverse Event|0|||
128777075|NCT00946647|463472106|FG004|Phase 1 Part|Adverse Event|0|||
128777076|NCT00946647|463472102|FG000|Phase 1 Part|Disease progression|3|||
128777077|NCT00946647|463472103|FG001|Phase 1 Part|Disease progression|6|||
128777078|NCT00946647|463472104|FG002|Phase 1 Part|Disease progression|1|||
128777079|NCT00946647|463472105|FG003|Phase 1 Part|Disease progression|0|||
128777080|NCT00946647|463472106|FG004|Phase 1 Part|Disease progression|0|||
128777081|NCT00946647|463472102|FG000|Phase 1 Part|Withdrawal by Subject|1|||
128777082|NCT00946647|463472103|FG001|Phase 1 Part|Withdrawal by Subject|4|||
128777083|NCT00946647|463472104|FG002|Phase 1 Part|Withdrawal by Subject|3|||
128777084|NCT00946647|463472105|FG003|Phase 1 Part|Withdrawal by Subject|0|||
128777085|NCT00946647|463472106|FG004|Phase 1 Part|Withdrawal by Subject|0|||
128777086|NCT00946647|463472102|FG000|Phase 1 Part|Abnormal values|0|||
128777087|NCT00946647|463472103|FG001|Phase 1 Part|Abnormal values|2|||
128777088|NCT00946647|463472104|FG002|Phase 1 Part|Abnormal values|0|||
128777089|NCT00946647|463472105|FG003|Phase 1 Part|Abnormal values|0|||
128777090|NCT00946647|463472106|FG004|Phase 1 Part|Abnormal values|0|||
128777091|NCT00946647|463472102|FG000|Phase 1 Part|Reason missing|0|||
128777092|NCT00946647|463472103|FG001|Phase 1 Part|Reason missing|1|||
128777093|NCT00946647|463472104|FG002|Phase 1 Part|Reason missing|0|||
128777094|NCT00946647|463472105|FG003|Phase 1 Part|Reason missing|0|||
128777095|NCT00946647|463472106|FG004|Phase 1 Part|Reason missing|0|||
128777096|NCT00946647|463472102|FG000|Phase ll Part|Untreated|0|||
128777097|NCT00946647|463472103|FG001|Phase ll Part|Untreated|0|||
128777098|NCT00946647|463472104|FG002|Phase ll Part|Untreated|0|||
128777099|NCT00946647|463472105|FG003|Phase ll Part|Untreated|0|||
128777100|NCT00946647|463472106|FG004|Phase ll Part|Untreated|2|||
128777101|NCT00946647|463472102|FG000|Phase ll Part|Adverse Event|0|||
128777102|NCT00946647|463472103|FG001|Phase ll Part|Adverse Event|0|||
128777103|NCT00946647|463472104|FG002|Phase ll Part|Adverse Event|0|||
128777104|NCT00946647|463472105|FG003|Phase ll Part|Adverse Event|10|||
128777105|NCT00946647|463472106|FG004|Phase ll Part|Adverse Event|6|||
128777106|NCT00946647|463472102|FG000|Phase ll Part|Withdrawal by Subject|0|||
128777107|NCT00946647|463472103|FG001|Phase ll Part|Withdrawal by Subject|0|||
128777108|NCT00946647|463472104|FG002|Phase ll Part|Withdrawal by Subject|0|||
128777109|NCT00946647|463472105|FG003|Phase ll Part|Withdrawal by Subject|8|||
128777110|NCT00946647|463472106|FG004|Phase ll Part|Withdrawal by Subject|6|||
129165112|NCT01436656|464897817|FG013|Dose Expansion|Death|0|||
129165113|NCT01436656|464897818|FG014|Dose Expansion|Death|3|||
129165114|NCT01436656|464897819|FG015|Dose Expansion|Death|0|||
129165115|NCT01436656|464897820|FG016|Dose Expansion|Death|3|||
129165116|NCT01436656|464897821|FG017|Dose Expansion|Death|3|||
129165117|NCT01436656|464897804|FG000|Dose Expansion|Lost to Follow-up|0|||
129165118|NCT01436656|464897805|FG001|Dose Expansion|Lost to Follow-up|0|||
129165119|NCT01436656|464897806|FG002|Dose Expansion|Lost to Follow-up|0|||
129165120|NCT01436656|464897807|FG003|Dose Expansion|Lost to Follow-up|0|||
129165121|NCT01436656|464897808|FG004|Dose Expansion|Lost to Follow-up|0|||
129165122|NCT01436656|464897809|FG005|Dose Expansion|Lost to Follow-up|0|||
129165123|NCT01436656|464897810|FG006|Dose Expansion|Lost to Follow-up|0|||
129165124|NCT01436656|464897811|FG007|Dose Expansion|Lost to Follow-up|0|||
129165125|NCT01436656|464897812|FG008|Dose Expansion|Lost to Follow-up|0|||
129165126|NCT01436656|464897813|FG009|Dose Expansion|Lost to Follow-up|0|||
129165127|NCT01436656|464897814|FG010|Dose Expansion|Lost to Follow-up|0|||
128777111|NCT00946647|463472102|FG000|Phase ll Part|Administrative problems|0|||
128777112|NCT00946647|463472103|FG001|Phase ll Part|Administrative problems|0|||
128777113|NCT00946647|463472104|FG002|Phase ll Part|Administrative problems|0|||
128777114|NCT00946647|463472105|FG003|Phase ll Part|Administrative problems|3|||
128777115|NCT00946647|463472106|FG004|Phase ll Part|Administrative problems|8|||
128777116|NCT00946647|463472102|FG000|Phase ll Part|Death|0|||
128777117|NCT00946647|463472103|FG001|Phase ll Part|Death|0|||
128777118|NCT00946647|463472104|FG002|Phase ll Part|Death|0|||
128777119|NCT00946647|463472105|FG003|Phase ll Part|Death|7|||
129165128|NCT01436656|464897815|FG011|Dose Expansion|Lost to Follow-up|0|||
129165129|NCT01436656|464897816|FG012|Dose Expansion|Lost to Follow-up|0|||
129165130|NCT01436656|464897817|FG013|Dose Expansion|Lost to Follow-up|0|||
129165131|NCT01436656|464897818|FG014|Dose Expansion|Lost to Follow-up|0|||
129165132|NCT01436656|464897819|FG015|Dose Expansion|Lost to Follow-up|0|||
128777120|NCT00946647|463472106|FG004|Phase ll Part|Death|4|||
128777121|NCT00946647|463472102|FG000|Phase ll Part|Disease progression|0|||
128777122|NCT00946647|463472103|FG001|Phase ll Part|Disease progression|0|||
129165133|NCT01436656|464897820|FG016|Dose Expansion|Lost to Follow-up|0|||
129165134|NCT01436656|464897821|FG017|Dose Expansion|Lost to Follow-up|3|||
129165135|NCT01436656|464897804|FG000|Dose Expansion|Disease progression|0|||
129165136|NCT01436656|464897805|FG001|Dose Expansion|Disease progression|0|||
129165137|NCT01436656|464897806|FG002|Dose Expansion|Disease progression|0|||
129165138|NCT01436656|464897807|FG003|Dose Expansion|Disease progression|0|||
129165139|NCT01436656|464897808|FG004|Dose Expansion|Disease progression|0|||
129165140|NCT01436656|464897809|FG005|Dose Expansion|Disease progression|0|||
129165141|NCT01436656|464897810|FG006|Dose Expansion|Disease progression|0|||
129165142|NCT01436656|464897811|FG007|Dose Expansion|Disease progression|0|||
129165143|NCT01436656|464897812|FG008|Dose Expansion|Disease progression|0|||
129165144|NCT01436656|464897813|FG009|Dose Expansion|Disease progression|0|||
129165145|NCT01436656|464897814|FG010|Dose Expansion|Disease progression|0|||
129165146|NCT01436656|464897815|FG011|Dose Expansion|Disease progression|3|||
129165147|NCT01436656|464897816|FG012|Dose Expansion|Disease progression|1|||
129165148|NCT01436656|464897817|FG013|Dose Expansion|Disease progression|0|||
129165149|NCT01436656|464897818|FG014|Dose Expansion|Disease progression|1|||
129165150|NCT01436656|464897819|FG015|Dose Expansion|Disease progression|0|||
129165151|NCT01436656|464897820|FG016|Dose Expansion|Disease progression|0|||
129165152|NCT01436656|464897821|FG017|Dose Expansion|Disease progression|1|||
129165153|NCT01436656|464897804|FG000|Dose Expansion|New cancer therapy|0|||
129165154|NCT01436656|464897805|FG001|Dose Expansion|New cancer therapy|0|||
129165155|NCT01436656|464897806|FG002|Dose Expansion|New cancer therapy|0|||
129165156|NCT01436656|464897807|FG003|Dose Expansion|New cancer therapy|0|||
129165157|NCT01436656|464897808|FG004|Dose Expansion|New cancer therapy|0|||
129165158|NCT01436656|464897809|FG005|Dose Expansion|New cancer therapy|0|||
129165159|NCT01436656|464897810|FG006|Dose Expansion|New cancer therapy|0|||
129165160|NCT01436656|464897811|FG007|Dose Expansion|New cancer therapy|0|||
129165161|NCT01436656|464897812|FG008|Dose Expansion|New cancer therapy|0|||
129165162|NCT01436656|464897813|FG009|Dose Expansion|New cancer therapy|0|||
129165163|NCT01436656|464897814|FG010|Dose Expansion|New cancer therapy|0|||
129165164|NCT01436656|464897815|FG011|Dose Expansion|New cancer therapy|1|||
129165165|NCT01436656|464897816|FG012|Dose Expansion|New cancer therapy|1|||
129165166|NCT01436656|464897817|FG013|Dose Expansion|New cancer therapy|0|||
129165167|NCT01436656|464897818|FG014|Dose Expansion|New cancer therapy|2|||
129165168|NCT01436656|464897819|FG015|Dose Expansion|New cancer therapy|0|||
129165169|NCT01436656|464897820|FG016|Dose Expansion|New cancer therapy|0|||
129165170|NCT01436656|464897821|FG017|Dose Expansion|New cancer therapy|0|||
129165171|NCT04729972|464897822|FG000|Overall Study|Adverse Event|1|||
129165172|NCT00576628|464897824|FG000|Overall Study|Adverse Event|11|||
129165173|NCT00576628|464897824|FG000|Overall Study|Death|2|||
129165174|NCT00576628|464897824|FG000|Overall Study|Failure to return|1|||
129165175|NCT00576628|464897824|FG000|Overall Study|Refused Treatment|8|||
129165176|NCT00576628|464897824|FG000|Overall Study|Pregnancy|1|||
129165177|NCT00576628|464897824|FG000|Overall Study|RBC transfusion|1|||
129165178|NCT00576628|464897824|FG000|Overall Study|Progression of Kidney Disease|1|||
129165179|NCT00576628|464897824|FG000|Overall Study|Progression of Renal Failure|1|||
129165180|NCT00576628|464897824|FG000|Overall Study|The patient move into other town|1|||
129165181|NCT00576628|464897824|FG000|Overall Study|Transplantation|1|||
129165182|NCT00576628|464897824|FG000|Overall Study|Dialysis|15|||
129165183|NCT03206970|464897825|FG000|Overall Study|Death|21|||
129165184|NCT03206970|464897825|FG000|Overall Study|Withdrawal by Subject|13|||
129165185|NCT03206970|464897825|FG000|Overall Study|Lost to Follow-up|3|||
129165186|NCT03206970|464897825|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
129165187|NCT02516982|464897826|FG000|Overall Study|Called in to antenatal appointment|32|||
129165188|NCT02516982|464897827|FG001|Overall Study|Called in to antenatal appointment|35|||
129165189|NCT02516982|464897828|FG002|Overall Study|Called in to antenatal appointment|0|||
129165190|NCT02516982|464897829|FG003|Overall Study|Called in to antenatal appointment|0|||
129165191|NCT02516982|464897826|FG000|Overall Study|Withdrawal by Subject|0|||
129165192|NCT02516982|464897827|FG001|Overall Study|Withdrawal by Subject|0|||
129165193|NCT02516982|464897828|FG002|Overall Study|Withdrawal by Subject|1|||
129165194|NCT02516982|464897829|FG003|Overall Study|Withdrawal by Subject|2|||
129165195|NCT02516982|464897826|FG000|Overall Study|Protocol Violation|0|||
129165196|NCT02516982|464897827|FG001|Overall Study|Protocol Violation|0|||
129165197|NCT02516982|464897828|FG002|Overall Study|Protocol Violation|1|||
129165198|NCT02516982|464897829|FG003|Overall Study|Protocol Violation|1|||
129165199|NCT02516982|464897826|FG000|Overall Study|Did not install the app|0|||
128777123|NCT00946647|463472104|FG002|Phase ll Part|Disease progression|0|||
128777124|NCT00946647|463472105|FG003|Phase ll Part|Disease progression|6|||
128777125|NCT00946647|463472106|FG004|Phase ll Part|Disease progression|14|||
128777126|NCT00946647|463472102|FG000|Phase ll Part|Protocol Violation|0|||
128777127|NCT00946647|463472103|FG001|Phase ll Part|Protocol Violation|0|||
128777128|NCT00946647|463472104|FG002|Phase ll Part|Protocol Violation|0|||
128777129|NCT00946647|463472105|FG003|Phase ll Part|Protocol Violation|4|||
128777130|NCT00946647|463472106|FG004|Phase ll Part|Protocol Violation|2|||
128777131|NCT00946647|463472102|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
128777132|NCT00946647|463472103|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
128777133|NCT00946647|463472104|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
128777134|NCT00946647|463472105|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
128777135|NCT00946647|463472106|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
128777136|NCT00322868|463473646|FG000|Overall Study|disease progression|1|||
128777137|NCT02176928|463473647|FG000|Overall Study|Lost to Follow-up|2|||
128777138|NCT02176928|463473648|FG001|Overall Study|Lost to Follow-up|4|||
128777139|NCT01440049|463473652|FG000|Overall Study|Adverse Event|5|||
128777140|NCT03415022|463473654|FG000|Overall Study|Withdrawal by Subject|1|||
128777141|NCT03415022|463473655|FG001|Overall Study|Withdrawal by Subject|2|||
128777142|NCT03415022|463473654|FG000|Overall Study|COVID-19 Suspension|2|||
128777143|NCT03415022|463473655|FG001|Overall Study|COVID-19 Suspension|3|||
128777144|NCT03415022|463473654|FG000|Overall Study|Lost to Follow-up|2|||
128777145|NCT03415022|463473655|FG001|Overall Study|Lost to Follow-up|0|||
128777146|NCT04466618|463473656|FG000|Overall Study|Withdrawal by Subject|0|||
128777147|NCT04466618|463473657|FG001|Overall Study|Withdrawal by Subject|1|||
128777148|NCT00884286|463473662|FG000|Overall Study|Progressive disease|21|||
128777149|NCT00884286|463473663|FG001|Overall Study|Progressive disease|28|||
128777150|NCT00884286|463473662|FG000|Overall Study|Toxicity|4|||
128777151|NCT00884286|463473663|FG001|Overall Study|Toxicity|1|||
128777152|NCT00884286|463473662|FG000|Overall Study|Death|2|||
128777153|NCT00884286|463473663|FG001|Overall Study|Death|2|||
128777154|NCT00884286|463473662|FG000|Overall Study|Physician Decision|1|||
128777155|NCT00884286|463473663|FG001|Overall Study|Physician Decision|0|||
128777156|NCT00884286|463473662|FG000|Overall Study|Septic shock|1|||
129165200|NCT02516982|464897827|FG001|Overall Study|Did not install the app|0|||
129165201|NCT02516982|464897828|FG002|Overall Study|Did not install the app|46|||
129165202|NCT02516982|464897829|FG003|Overall Study|Did not install the app|47|||
129165203|NCT00962741|464897835|FG000|Overall Study|Failed to return|3|||
129165204|NCT00962741|464897835|FG000|Overall Study|Lost to Follow-up|2|||
129165205|NCT00962741|464897835|FG000|Overall Study|Withdrawal by Subject|1|||
129165206|NCT00962741|464897835|FG000|Overall Study|Lack of Efficacy|1|||
129165207|NCT00962741|464897835|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
129165208|NCT01814878|464897836|FG000|Overall Study|Adverse Event|16|||
129165209|NCT01814878|464897837|FG001|Overall Study|Adverse Event|5|||
129165210|NCT01814878|464897836|FG000|Overall Study|Withdrawal by Subject|20|||
129165211|NCT01814878|464897837|FG001|Overall Study|Withdrawal by Subject|16|||
129165212|NCT01814878|464897836|FG000|Overall Study|Protocol Violation|5|||
129165213|NCT01814878|464897837|FG001|Overall Study|Protocol Violation|5|||
129165214|NCT01814878|464897836|FG000|Overall Study|Physician Decision|3|||
129165215|NCT01814878|464897837|FG001|Overall Study|Physician Decision|1|||
129165216|NCT01814878|464897836|FG000|Overall Study|Screening failure (drop-out)|0|||
129165217|NCT01814878|464897837|FG001|Overall Study|Screening failure (drop-out)|3|||
129165218|NCT01814878|464897836|FG000|Overall Study|Other|2|||
129165219|NCT01814878|464897837|FG001|Overall Study|Other|0|||
129165220|NCT03645421|464897838|FG000|Overall Study|Adverse Event|0|||
129165221|NCT03645421|464897839|FG001|Overall Study|Adverse Event|0|||
129165222|NCT03645421|464897840|FG002|Overall Study|Adverse Event|4|||
129165223|NCT03645421|464897841|FG003|Overall Study|Adverse Event|1|||
129165224|NCT03645421|464897838|FG000|Overall Study|Withdrawal by patient|0|||
129165225|NCT03645421|464897839|FG001|Overall Study|Withdrawal by patient|0|||
129165226|NCT03645421|464897840|FG002|Overall Study|Withdrawal by patient|0|||
129165227|NCT03645421|464897841|FG003|Overall Study|Withdrawal by patient|3|||
129165228|NCT03645421|464897838|FG000|Overall Study|Study specific withdrawal criteria|0|||
129165229|NCT03645421|464897839|FG001|Overall Study|Study specific withdrawal criteria|0|||
129165230|NCT03645421|464897840|FG002|Overall Study|Study specific withdrawal criteria|1|||
128777157|NCT00884286|463473663|FG001|Overall Study|Septic shock|0|||
128777158|NCT00884286|463473662|FG000|Overall Study|Thrombus in right auricle|1|||
128777159|NCT00884286|463473663|FG001|Overall Study|Thrombus in right auricle|0|||
128777160|NCT00884286|463473662|FG000|Overall Study|Not treated|2|||
128777161|NCT00884286|463473663|FG001|Overall Study|Not treated|1|||
128777162|NCT00884286|463473662|FG000|Overall Study|Comprised lung carcinoma|0|||
128777163|NCT00884286|463473663|FG001|Overall Study|Comprised lung carcinoma|1|||
129165231|NCT03645421|464897841|FG003|Overall Study|Study specific withdrawal criteria|0|||
129165232|NCT02253433|464897845|FG000|Overall Study|Unable to Contact|9|||
128777164|NCT01720797|463473664|FG000|Overall Study|Withdrawal by Subject|3|||
129165233|NCT02253433|464897846|FG001|Overall Study|Unable to Contact|16|||
129165234|NCT02253433|464897845|FG000|Overall Study|Death|1|||
129165235|NCT02253433|464897846|FG001|Overall Study|Death|1|||
129165236|NCT02253433|464897845|FG000|Overall Study|No Longer Interested|3|||
129165237|NCT02253433|464897846|FG001|Overall Study|No Longer Interested|15|||
129165238|NCT02253433|464897845|FG000|Overall Study|Out of Study Area|2|||
129165239|NCT02253433|464897846|FG001|Overall Study|Out of Study Area|7|||
129165240|NCT02253433|464897845|FG000|Overall Study|Uncomfortable with home visitors|0|||
129165241|NCT02253433|464897846|FG001|Overall Study|Uncomfortable with home visitors|3|||
129165242|NCT02253433|464897845|FG000|Overall Study|Unstable Housing/Homeless|0|||
129165243|NCT02253433|464897846|FG001|Overall Study|Unstable Housing/Homeless|7|||
129165244|NCT02253433|464897845|FG000|Overall Study|Too Busy|0|||
129165245|NCT02253433|464897846|FG001|Overall Study|Too Busy|4|||
129165246|NCT02253433|464897845|FG000|Overall Study|Medical or Other Concerns|1|||
129165247|NCT02253433|464897846|FG001|Overall Study|Medical or Other Concerns|2|||
129165248|NCT02836717|464897852|FG000|Test Phase|Lack of Efficacy|14|||
129165249|NCT02836717|464897853|FG001|Test Phase|Lack of Efficacy|8|||
129165250|NCT02836717|464897854|FG002|Test Phase|Lack of Efficacy|0|||
129165251|NCT02836717|464897852|FG000|Study Phase|Adverse Event|2|||
129165252|NCT02836717|464897853|FG001|Study Phase|Adverse Event|0|||
129165253|NCT02836717|464897854|FG002|Study Phase|Adverse Event|0|||
129165254|NCT02836717|464897852|FG000|Study Phase|Lack of Efficacy|8|||
129165255|NCT02836717|464897853|FG001|Study Phase|Lack of Efficacy|6|||
129165256|NCT02836717|464897854|FG002|Study Phase|Lack of Efficacy|1|||
129165257|NCT02836717|464897852|FG000|Study Phase|Withdrawal by Subject|1|||
129165258|NCT02836717|464897853|FG001|Study Phase|Withdrawal by Subject|0|||
129165259|NCT02836717|464897854|FG002|Study Phase|Withdrawal by Subject|0|||
129165260|NCT02836717|464897852|FG000|Study Phase|Death|1|||
129165261|NCT02836717|464897853|FG001|Study Phase|Death|0|||
129165262|NCT02836717|464897854|FG002|Study Phase|Death|0|||
129165263|NCT02836717|464897852|FG000|Study Phase|abdominal surgeries|2|||
129165264|NCT02836717|464897853|FG001|Study Phase|abdominal surgeries|1|||
129165265|NCT02836717|464897854|FG002|Study Phase|abdominal surgeries|0|||
129165266|NCT00224120|464897855|FG000|Overall Study|Adverse Event|10|||
129165267|NCT00224120|464897856|FG001|Overall Study|Adverse Event|4|||
129165268|NCT00224120|464897855|FG000|Overall Study|Protocol Violation|1|||
129165269|NCT00224120|464897856|FG001|Overall Study|Protocol Violation|0|||
129165270|NCT00224120|464897855|FG000|Overall Study|Withdrawal by Subject|5|||
129165271|NCT00224120|464897856|FG001|Overall Study|Withdrawal by Subject|10|||
129165272|NCT00224120|464897855|FG000|Overall Study|Lack of Efficacy|0|||
129165273|NCT00224120|464897856|FG001|Overall Study|Lack of Efficacy|2|||
129165274|NCT00224120|464897855|FG000|Overall Study|Lost to Follow-up|2|||
129165275|NCT00224120|464897856|FG001|Overall Study|Lost to Follow-up|3|||
129165276|NCT00224120|464897855|FG000|Overall Study|Other|4|||
129165277|NCT00224120|464897856|FG001|Overall Study|Other|5|||
129165278|NCT00438360|464897857|FG000|Overall Study|Adverse Event|6|||
129165279|NCT00438360|464897858|FG001|Overall Study|Adverse Event|1|||
129165280|NCT00438360|464897857|FG000|Overall Study|Lack of Efficacy|42|||
129165281|NCT00438360|464897858|FG001|Overall Study|Lack of Efficacy|27|||
129165282|NCT00438360|464897857|FG000|Overall Study|Other|24|||
129165283|NCT00438360|464897858|FG001|Overall Study|Other|15|||
129165284|NCT00282087|464897859|FG000|Overall Study|Death|1|||
129165285|NCT01804049|464897862|FG000|Overall Study|Adverse Event|2|||
129165286|NCT01804049|464897863|FG001|Overall Study|Adverse Event|10|||
129165287|NCT01804049|464897862|FG000|Overall Study|Lost to Follow-up|2|||
129165288|NCT01804049|464897863|FG001|Overall Study|Lost to Follow-up|1|||
129165289|NCT01804049|464897862|FG000|Overall Study|Decreased interest/personal|4|||
129165290|NCT01804049|464897863|FG001|Overall Study|Decreased interest/personal|5|||
129165291|NCT01804049|464897862|FG000|Overall Study|Other health concerns|2|||
129165292|NCT01804049|464897863|FG001|Overall Study|Other health concerns|7|||
129165293|NCT01804049|464897862|FG000|Overall Study|Moved out of area|0|||
129165294|NCT01804049|464897863|FG001|Overall Study|Moved out of area|7|||
129165295|NCT01804049|464897862|FG000|Overall Study|other MD recommended|1|||
129165296|NCT01804049|464897863|FG001|Overall Study|other MD recommended|1|||
129165297|NCT01804049|464897862|FG000|Overall Study|Enrollment in dual studies|0|||
129165298|NCT01804049|464897863|FG001|Overall Study|Enrollment in dual studies|1|||
129165299|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129165300|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
129165301|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129165302|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129165303|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129165304|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129165305|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
129165306|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
129165307|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129165308|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129165309|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129165310|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129165311|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
129165312|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
129165313|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129165314|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129165315|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129165316|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129165317|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
129165318|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
129165319|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129165320|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129165321|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129165322|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129165323|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129165324|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
129165325|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129165326|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129165327|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129165328|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129165329|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
129165330|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
129165331|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129165332|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129165333|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129165334|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129165335|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129165336|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
129165337|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
128777165|NCT01720797|463473665|FG001|Overall Study|Withdrawal by Subject|0|||
128777166|NCT03541642|463473671|FG000|Overall Study|Withdrawal by Subject|1|||
128777167|NCT03541642|463473672|FG001|Overall Study|Withdrawal by Subject|2|||
128777168|NCT03541642|463473671|FG000|Overall Study|Lost to Follow-up|16|||
128777169|NCT03541642|463473672|FG001|Overall Study|Lost to Follow-up|12|||
129165338|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129165339|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129165340|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129165341|NCT03985943|464897868|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129165342|NCT03985943|464897869|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
129165343|NCT03985943|464897870|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129165344|NCT03985943|464897871|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129165345|NCT03985943|464897872|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129165346|NCT03985943|464897873|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129165347|NCT03985943|464897868|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129165348|NCT03985943|464897869|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129165349|NCT03985943|464897870|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
129165350|NCT03985943|464897871|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
129165351|NCT03985943|464897872|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
129165352|NCT03985943|464897873|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
129165353|NCT03985943|464897868|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129165354|NCT03985943|464897869|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
128777170|NCT03541642|463473671|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
129165355|NCT03985943|464897870|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
129165356|NCT03985943|464897871|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
129165357|NCT03985943|464897872|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
129165358|NCT03985943|464897873|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
129165359|NCT03985943|464897868|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
129165360|NCT03985943|464897869|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
129165361|NCT03985943|464897870|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
129165362|NCT03985943|464897871|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
129165363|NCT03985943|464897872|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
129165364|NCT03985943|464897873|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
129165365|NCT03985943|464897868|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129165366|NCT03985943|464897869|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129165367|NCT03985943|464897870|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129165368|NCT03985943|464897871|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129165369|NCT03985943|464897872|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129165370|NCT03985943|464897873|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129165371|NCT03985943|464897868|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129165372|NCT03985943|464897869|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129165373|NCT03985943|464897870|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
129165374|NCT03985943|464897871|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129165375|NCT03985943|464897872|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
129165376|NCT03985943|464897873|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129165377|NCT03985943|464897868|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
129165378|NCT03985943|464897869|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
129165379|NCT03985943|464897870|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
129165380|NCT03985943|464897871|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
129165381|NCT03985943|464897872|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
129165382|NCT03985943|464897873|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
129165383|NCT03985943|464897868|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
129165384|NCT03985943|464897869|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
129165385|NCT03985943|464897870|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
129165386|NCT03985943|464897871|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
129165387|NCT03985943|464897872|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
129165388|NCT03985943|464897873|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
129165389|NCT03249909|464897874|FG000|Overall Study|Withdrawal by Subject|3|||
129165390|NCT03249909|464897875|FG001|Overall Study|Withdrawal by Subject|0|||
129165391|NCT03249909|464897876|FG002|Overall Study|Withdrawal by Subject|0|||
129165392|NCT03249909|464897874|FG000|Overall Study|Adverse Event|3|||
129165393|NCT03249909|464897875|FG001|Overall Study|Adverse Event|0|||
129165394|NCT03249909|464897876|FG002|Overall Study|Adverse Event|0|||
129165395|NCT03249909|464897874|FG000|Overall Study|Lost to Follow-up|0|||
129165396|NCT03249909|464897875|FG001|Overall Study|Lost to Follow-up|1|||
129165397|NCT03249909|464897876|FG002|Overall Study|Lost to Follow-up|0|||
129165398|NCT05286658|464897877|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
129165399|NCT05286658|464897877|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
129165400|NCT01035463|464897878|FG000|Overall Study|Adverse Event|0|||
129165401|NCT01035463|464897879|FG001|Overall Study|Adverse Event|0|||
129165402|NCT01035463|464897880|FG002|Overall Study|Adverse Event|4|||
129165403|NCT01035463|464897881|FG003|Overall Study|Adverse Event|1|||
129165404|NCT01035463|464897882|FG004|Overall Study|Adverse Event|5|||
129165405|NCT01035463|464897883|FG005|Overall Study|Adverse Event|7|||
129165406|NCT01035463|464897878|FG000|Overall Study|Withdrawal by Subject|0|||
129165407|NCT01035463|464897879|FG001|Overall Study|Withdrawal by Subject|2|||
129165408|NCT01035463|464897880|FG002|Overall Study|Withdrawal by Subject|1|||
129165409|NCT01035463|464897881|FG003|Overall Study|Withdrawal by Subject|0|||
129165410|NCT01035463|464897882|FG004|Overall Study|Withdrawal by Subject|1|||
129165411|NCT01035463|464897883|FG005|Overall Study|Withdrawal by Subject|4|||
129165412|NCT01035463|464897878|FG000|Overall Study|Disease progression|0|||
129165413|NCT01035463|464897879|FG001|Overall Study|Disease progression|0|||
129165414|NCT01035463|464897880|FG002|Overall Study|Disease progression|0|||
129165415|NCT01035463|464897881|FG003|Overall Study|Disease progression|0|||
129165416|NCT01035463|464897882|FG004|Overall Study|Disease progression|0|||
129165417|NCT01035463|464897883|FG005|Overall Study|Disease progression|3|||
129165418|NCT01035463|464897878|FG000|Overall Study|Other Malignancy|0|||
129165419|NCT01035463|464897879|FG001|Overall Study|Other Malignancy|0|||
129165420|NCT01035463|464897880|FG002|Overall Study|Other Malignancy|0|||
129165421|NCT01035463|464897881|FG003|Overall Study|Other Malignancy|0|||
129165422|NCT01035463|464897882|FG004|Overall Study|Other Malignancy|0|||
129165423|NCT01035463|464897883|FG005|Overall Study|Other Malignancy|2|||
129165424|NCT01035463|464897878|FG000|Overall Study|Other|0|||
128982121|NCT02545504|464219103|FG000|Overall Study|Withdrew consent|9|||
129165425|NCT01035463|464897879|FG001|Overall Study|Other|0|||
129165426|NCT01035463|464897880|FG002|Overall Study|Other|0|||
129165427|NCT01035463|464897881|FG003|Overall Study|Other|1|||
129165428|NCT01035463|464897882|FG004|Overall Study|Other|0|||
129165429|NCT01035463|464897883|FG005|Overall Study|Other|2|||
129165430|NCT01092780|464897884|FG000|Washout Period 1|Adverse Event|0|||
129165431|NCT01092780|464897885|FG001|Washout Period 1|Adverse Event|1|||
129165432|NCT01092780|464897886|FG002|Washout Period 1|Adverse Event|0|||
129165433|NCT01092780|464897887|FG003|Washout Period 1|Adverse Event|0|||
129165434|NCT01092780|464897884|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
129165435|NCT01092780|464897885|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
129165436|NCT01092780|464897886|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
129165437|NCT01092780|464897887|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
129165438|NCT01092780|464897884|FG000|Washout Period 2|Adverse Event|0|||
129165439|NCT01092780|464897885|FG001|Washout Period 2|Adverse Event|1|||
129165440|NCT01092780|464897886|FG002|Washout Period 2|Adverse Event|1|||
129165441|NCT01092780|464897887|FG003|Washout Period 2|Adverse Event|0|||
129165442|NCT00851552|464897897|FG000|Overall Study|Death|2|||
129165443|NCT00851552|464897897|FG000|Overall Study|Adverse Event|1|||
129165444|NCT00851552|464897897|FG000|Overall Study|Disease Progression|4|||
129165445|NCT01270880|464897899|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
129165446|NCT00182078|464897900|FG000|Overall Study|Withdrawal by Subject|1|||
129165447|NCT00182078|464897901|FG001|Overall Study|Withdrawal by Subject|0|||
129165448|NCT01606176|464897902|FG000|Overall Study|Adverse Event|2|||
129165449|NCT01606176|464897903|FG001|Overall Study|Adverse Event|3|||
129165450|NCT01606176|464897902|FG000|Overall Study|Disease progression|1|||
129165451|NCT01606176|464897903|FG001|Overall Study|Disease progression|0|||
129165452|NCT01606176|464897902|FG000|Overall Study|Withdrawal by Subject|1|||
129165453|NCT01606176|464897903|FG001|Overall Study|Withdrawal by Subject|0|||
129165454|NCT01076205|464897905|FG000|Overall Study|Adverse Drug Reaction|299|||
129165455|NCT01076205|464897905|FG000|Overall Study|Lack of Effectiveness|1423|||
129165456|NCT01076205|464897905|FG000|Overall Study|Other Reason|1075|||
129165457|NCT01076205|464897905|FG000|Overall Study|Unknown Reason|71|||
129165458|NCT01076205|464897905|FG000|Overall Study|Lost to Follow-up|3151|||
129165459|NCT01832493|464897906|FG000|Overall Study|Physician Decision|2|||
129165460|NCT01832493|464897906|FG000|Overall Study|Protocol Violation|4|||
129165461|NCT01832493|464897906|FG000|Overall Study|Unable to place LV lead|2|||
129165462|NCT01732510|464897907|FG000|Overall Study|Adverse Event|0|||
129165463|NCT01732510|464897908|FG001|Overall Study|Adverse Event|1|||
129165464|NCT01732510|464897909|FG002|Overall Study|Adverse Event|1|||
129165465|NCT01732510|464897910|FG003|Overall Study|Adverse Event|0|||
129165466|NCT01732510|464897911|FG004|Overall Study|Adverse Event|0|||
129165467|NCT01732510|464897912|FG005|Overall Study|Adverse Event|0|||
129165468|NCT01732510|464897913|FG006|Overall Study|Adverse Event|1|||
129165469|NCT01732510|464897907|FG000|Overall Study|Protocol Violation|0|||
129165470|NCT01732510|464897908|FG001|Overall Study|Protocol Violation|0|||
129165471|NCT01732510|464897909|FG002|Overall Study|Protocol Violation|0|||
129165472|NCT01732510|464897910|FG003|Overall Study|Protocol Violation|1|||
129165473|NCT01732510|464897911|FG004|Overall Study|Protocol Violation|0|||
129165474|NCT01732510|464897912|FG005|Overall Study|Protocol Violation|0|||
129165475|NCT01732510|464897913|FG006|Overall Study|Protocol Violation|0|||
129165476|NCT01732510|464897907|FG000|Overall Study|Withdrawal by Subject|1|||
129165477|NCT01732510|464897908|FG001|Overall Study|Withdrawal by Subject|3|||
129165478|NCT01732510|464897909|FG002|Overall Study|Withdrawal by Subject|2|||
129165479|NCT01732510|464897910|FG003|Overall Study|Withdrawal by Subject|1|||
129165480|NCT01732510|464897911|FG004|Overall Study|Withdrawal by Subject|5|||
129165481|NCT01732510|464897912|FG005|Overall Study|Withdrawal by Subject|0|||
129165482|NCT01732510|464897913|FG006|Overall Study|Withdrawal by Subject|1|||
129165483|NCT01732510|464897907|FG000|Overall Study|Lost to Follow-up|0|||
129165484|NCT01732510|464897908|FG001|Overall Study|Lost to Follow-up|0|||
129165485|NCT01732510|464897909|FG002|Overall Study|Lost to Follow-up|1|||
129165486|NCT01732510|464897910|FG003|Overall Study|Lost to Follow-up|1|||
129165487|NCT01732510|464897911|FG004|Overall Study|Lost to Follow-up|0|||
129165488|NCT01732510|464897912|FG005|Overall Study|Lost to Follow-up|1|||
129165489|NCT01732510|464897913|FG006|Overall Study|Lost to Follow-up|0|||
129165490|NCT01732510|464897907|FG000|Overall Study|Physician Decision|0|||
129165491|NCT01732510|464897908|FG001|Overall Study|Physician Decision|1|||
129165492|NCT01732510|464897909|FG002|Overall Study|Physician Decision|0|||
129165493|NCT01732510|464897910|FG003|Overall Study|Physician Decision|0|||
129165494|NCT01732510|464897911|FG004|Overall Study|Physician Decision|0|||
129165495|NCT01732510|464897912|FG005|Overall Study|Physician Decision|0|||
129165496|NCT01732510|464897913|FG006|Overall Study|Physician Decision|0|||
129165497|NCT01732510|464897907|FG000|Overall Study|Pregnancy|0|||
129165498|NCT01732510|464897908|FG001|Overall Study|Pregnancy|0|||
129165499|NCT01732510|464897909|FG002|Overall Study|Pregnancy|0|||
129165500|NCT01732510|464897910|FG003|Overall Study|Pregnancy|1|||
129165501|NCT01732510|464897911|FG004|Overall Study|Pregnancy|0|||
129165502|NCT01732510|464897912|FG005|Overall Study|Pregnancy|0|||
129165503|NCT01732510|464897913|FG006|Overall Study|Pregnancy|0|||
129165504|NCT01732510|464897907|FG000|Overall Study|Study Terminated By Sponsor|0|||
129165505|NCT01732510|464897908|FG001|Overall Study|Study Terminated By Sponsor|0|||
129165506|NCT01732510|464897909|FG002|Overall Study|Study Terminated By Sponsor|0|||
129165507|NCT01732510|464897910|FG003|Overall Study|Study Terminated By Sponsor|1|||
129165508|NCT01732510|464897911|FG004|Overall Study|Study Terminated By Sponsor|0|||
129165509|NCT01732510|464897912|FG005|Overall Study|Study Terminated By Sponsor|12|||
129165510|NCT01732510|464897913|FG006|Overall Study|Study Terminated By Sponsor|6|||
129165511|NCT01262560|464897917|FG000|Overall Study|Protocol Violation|0|||
129165512|NCT01262560|464897918|FG001|Overall Study|Protocol Violation|1|||
129165513|NCT01262560|464897919|FG002|Overall Study|Protocol Violation|2|||
129165514|NCT03213938|464897920|FG000|Overall Study|Lost to Follow-up|4|||
129165515|NCT03213938|464897921|FG001|Overall Study|Lost to Follow-up|3|||
129165516|NCT03213938|464897920|FG000|Overall Study|Lack of Efficacy|1|||
129165517|NCT03213938|464897921|FG001|Overall Study|Lack of Efficacy|0|||
129165518|NCT03213938|464897920|FG000|Overall Study|Decline to participate|5|||
129165519|NCT03213938|464897921|FG001|Overall Study|Decline to participate|4|||
129165520|NCT03213938|464897920|FG000|Overall Study|Without reason|4|||
129165521|NCT03213938|464897921|FG001|Overall Study|Without reason|5|||
129165522|NCT04238481|464897922|FG000|Overall Study|Miscellaneous|0|||
129165523|NCT04238481|464897923|FG001|Overall Study|Miscellaneous|1|||
129165524|NCT04238481|464897924|FG002|Overall Study|Miscellaneous|0|||
129165525|NCT04238481|464897925|FG003|Overall Study|Miscellaneous|0|||
129165526|NCT00673231|464897926|FG000|Overall Study|Withdrawal by Subject|14|||
129165527|NCT00673231|464897927|FG001|Overall Study|Withdrawal by Subject|10|||
129165528|NCT00673231|464897928|FG002|Overall Study|Withdrawal by Subject|8|||
129165529|NCT00673231|464897929|FG003|Overall Study|Withdrawal by Subject|6|||
129165530|NCT00673231|464897926|FG000|Overall Study|Adverse Event|6|||
129165531|NCT00673231|464897927|FG001|Overall Study|Adverse Event|5|||
129165532|NCT00673231|464897928|FG002|Overall Study|Adverse Event|9|||
129165533|NCT00673231|464897929|FG003|Overall Study|Adverse Event|6|||
129165534|NCT00673231|464897926|FG000|Overall Study|Lost to Follow-up|1|||
129165535|NCT00673231|464897927|FG001|Overall Study|Lost to Follow-up|2|||
129165536|NCT00673231|464897928|FG002|Overall Study|Lost to Follow-up|1|||
129165537|NCT00673231|464897929|FG003|Overall Study|Lost to Follow-up|2|||
129165538|NCT00673231|464897926|FG000|Overall Study|Death|0|||
129165539|NCT00673231|464897927|FG001|Overall Study|Death|0|||
129165540|NCT00673231|464897928|FG002|Overall Study|Death|1|||
129165541|NCT00673231|464897929|FG003|Overall Study|Death|0|||
129165542|NCT00673231|464897926|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
129165543|NCT00673231|464897927|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
129165544|NCT00673231|464897928|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
129165545|NCT00673231|464897929|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
129165546|NCT02952313|464897930|FG000|Primary Endpoint|Lost to Follow-up|4|||
129165547|NCT02952313|464897930|FG000|Primary Endpoint|Withdrawal by Subject|1|||
129165548|NCT02952313|464897930|FG000|Primary Endpoint|Lack of Efficacy|1|||
129165549|NCT02952313|464897930|FG000|Primary Endpoint|Missed visit|1|||
129165550|NCT02952313|464897930|FG000|Long-term Follow-up|Lost to Follow-up|12|||
129165551|NCT02952313|464897930|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
129165552|NCT02952313|464897930|FG000|Long-term Follow-up|Lack of Efficacy|6|||
129165553|NCT02952313|464897930|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
129165554|NCT02952313|464897930|FG000|Long-term Follow-up|Physician Decision|1|||
129165555|NCT02952313|464897930|FG000|Long-term Follow-up|Death|1|||
129165556|NCT03594747|464897931|FG000|Overall Study|Death|78|||
128777171|NCT03541642|463473672|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
128777172|NCT01083160|463473677|FG000|Overall Study|Adverse Event|1|||
128777173|NCT00918749|463473680|FG000|Overall Study|Adverse Event|1|||
128777174|NCT00918749|463473681|FG001|Overall Study|Adverse Event|0|||
128777175|NCT00918749|463473682|FG002|Overall Study|Adverse Event|1|||
129165557|NCT03594747|464897932|FG001|Overall Study|Death|86|||
129165558|NCT03594747|464897933|FG002|Overall Study|Death|87|||
129165559|NCT03594747|464897931|FG000|Overall Study|Withdrawal by Subject|5|||
129165560|NCT03594747|464897932|FG001|Overall Study|Withdrawal by Subject|2|||
129165561|NCT03594747|464897933|FG002|Overall Study|Withdrawal by Subject|11|||
129165562|NCT03594747|464897931|FG000|Overall Study|Lost to Follow-up|4|||
129165563|NCT03594747|464897932|FG001|Overall Study|Lost to Follow-up|1|||
129165564|NCT03594747|464897933|FG002|Overall Study|Lost to Follow-up|1|||
129165565|NCT03594747|464897931|FG000|Overall Study|Physician Decision|0|||
129165566|NCT03594747|464897932|FG001|Overall Study|Physician Decision|1|||
129165567|NCT03594747|464897933|FG002|Overall Study|Physician Decision|0|||
129165568|NCT03594747|464897931|FG000|Overall Study|Sponsor decision|23|||
129165569|NCT03594747|464897932|FG001|Overall Study|Sponsor decision|17|||
129165570|NCT03594747|464897933|FG002|Overall Study|Sponsor decision|16|||
129165571|NCT03594747|464897931|FG000|Overall Study|Did not meet inclusion criteria|0|||
129165572|NCT03594747|464897932|FG001|Overall Study|Did not meet inclusion criteria|0|||
128777176|NCT00918749|463473680|FG000|Overall Study|Lost to Follow-up|0|||
128777177|NCT00918749|463473681|FG001|Overall Study|Lost to Follow-up|0|||
128777178|NCT00918749|463473682|FG002|Overall Study|Lost to Follow-up|1|||
129165573|NCT03594747|464897933|FG002|Overall Study|Did not meet inclusion criteria|1|||
129165574|NCT03594747|464897931|FG000|Overall Study|Transfer to long term extension study|10|||
128726690|NCT00048542|463297044|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
129165575|NCT03594747|464897932|FG001|Overall Study|Transfer to long term extension study|12|||
129165576|NCT03594747|464897933|FG002|Overall Study|Transfer to long term extension study|5|||
129165577|NCT02095873|464897934|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129165578|NCT02095873|464897935|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129165579|NCT02095873|464897934|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
129165580|NCT02095873|464897935|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129165581|NCT02095873|464897934|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
129165582|NCT02095873|464897935|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
129165583|NCT02015481|464897938|FG000|Overall Study|Death|1|||
129165584|NCT02485639|464897939|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
129165585|NCT02485639|464897939|FG000|Overall Study|Early termination|4|||
129165586|NCT02485639|464897939|FG000|Overall Study|Withdrawal by Subject|4|||
129165587|NCT01170273|464897940|FG000|Overall Study|Lost to Follow-up|6|||
129165588|NCT01170273|464897941|FG001|Overall Study|Lost to Follow-up|8|||
129165589|NCT01170273|464897940|FG000|Overall Study|Protocol Violation|1|||
129165590|NCT01170273|464897941|FG001|Overall Study|Protocol Violation|0|||
129165591|NCT01170273|464897940|FG000|Overall Study|Death|1|||
129165592|NCT01170273|464897941|FG001|Overall Study|Death|0|||
129165593|NCT01170273|464897940|FG000|Overall Study|Adverse Event|0|||
129165594|NCT01170273|464897941|FG001|Overall Study|Adverse Event|1|||
129165595|NCT00334737|464897942|FG000|Hospital Phase|Death|1|||
129165596|NCT00334737|464897943|FG001|Hospital Phase|Death|2|||
129165597|NCT00334737|464897944|FG002|Hospital Phase|Death|3|||
129165598|NCT00334737|464897942|FG000|Hospital Phase|Withdrawal by Subject|0|||
129165599|NCT00334737|464897943|FG001|Hospital Phase|Withdrawal by Subject|0|||
129165600|NCT00334737|464897944|FG002|Hospital Phase|Withdrawal by Subject|1|||
129165601|NCT00334737|464897942|FG000|Hospital Phase|Did not receive study drug|1|||
129165602|NCT00334737|464897943|FG001|Hospital Phase|Did not receive study drug|0|||
129165603|NCT00334737|464897944|FG002|Hospital Phase|Did not receive study drug|0|||
129165604|NCT00334737|464897942|FG000|Follow up Phase|Lost to Follow-up|5|||
129165605|NCT00334737|464897943|FG001|Follow up Phase|Lost to Follow-up|3|||
129165606|NCT00334737|464897944|FG002|Follow up Phase|Lost to Follow-up|6|||
129165607|NCT00583752|464897945|FG000|Overall Study|Lost to Follow-up|5|||
129165608|NCT00583752|464897946|FG001|Overall Study|Lost to Follow-up|5|||
129165609|NCT02316353|464897947|FG000|Overall Study|Pregnancy|1|||
129165610|NCT02316353|464897948|FG001|Overall Study|Pregnancy|3|||
129165611|NCT02316353|464897947|FG000|Overall Study|Adverse Event|1|||
129165612|NCT02316353|464897948|FG001|Overall Study|Adverse Event|3|||
129165613|NCT02316353|464897947|FG000|Overall Study|Withdrawal by Subject|6|||
129165614|NCT02316353|464897948|FG001|Overall Study|Withdrawal by Subject|2|||
129165615|NCT02147197|464897949|FG000|Overall Study|Adverse Event|1|||
129165616|NCT02147197|464897950|FG001|Overall Study|Adverse Event|0|||
129165617|NCT02147197|464897951|FG002|Overall Study|Adverse Event|0|||
129165618|NCT02147197|464897949|FG000|Overall Study|Withdrawal of Consent|4|||
129165619|NCT02147197|464897950|FG001|Overall Study|Withdrawal of Consent|3|||
129165620|NCT02147197|464897951|FG002|Overall Study|Withdrawal of Consent|2|||
129165621|NCT02147197|464897949|FG000|Overall Study|Lost to Follow-up|2|||
129165622|NCT02147197|464897950|FG001|Overall Study|Lost to Follow-up|3|||
129165623|NCT02147197|464897951|FG002|Overall Study|Lost to Follow-up|1|||
129165624|NCT02147197|464897949|FG000|Overall Study|Protocol Violation|1|||
129165625|NCT02147197|464897950|FG001|Overall Study|Protocol Violation|0|||
129165626|NCT02147197|464897951|FG002|Overall Study|Protocol Violation|3|||
129165627|NCT02147197|464897949|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129165628|NCT02147197|464897950|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129165629|NCT02147197|464897951|FG002|Overall Study|Other Miscellaneous Reasons|3|||
129165630|NCT03522246|464899756|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
129165631|NCT03522246|464899757|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
129165632|NCT03522246|464899758|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
129165633|NCT03522246|464899759|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
129165634|NCT03522246|464899760|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
128726691|NCT00048542|463297045|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
128726692|NCT00048542|463297046|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
128726693|NCT00048542|463297047|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
128726694|NCT00048542|463297040|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
128726695|NCT00048542|463297041|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
128726696|NCT00048542|463297042|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
128726697|NCT00048542|463297043|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
129165635|NCT04683029|464899761|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
129165636|NCT04683029|464899762|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
129165637|NCT04683029|464899763|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
129165638|NCT04683029|464899764|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
129165639|NCT04683029|464899761|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
129165640|NCT04683029|464899762|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
129165641|NCT04683029|464899763|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
129165642|NCT04683029|464899764|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
129165643|NCT04683029|464899761|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
129165644|NCT04683029|464899762|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
129165645|NCT04683029|464899763|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
129165646|NCT04683029|464899764|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
129165647|NCT00814580|464899765|FG000|Overall Study|Adverse Event|6|||
129165648|NCT00814580|464899766|FG001|Overall Study|Adverse Event|15|||
129165649|NCT00814580|464899765|FG000|Overall Study|Lack of Efficacy|18|||
129165650|NCT00814580|464899766|FG001|Overall Study|Lack of Efficacy|25|||
129165651|NCT00814580|464899765|FG000|Overall Study|Protocol Violation|2|||
129165652|NCT00814580|464899766|FG001|Overall Study|Protocol Violation|0|||
129165653|NCT00814580|464899765|FG000|Overall Study|Withdrawal by Subject|2|||
129165654|NCT00814580|464899766|FG001|Overall Study|Withdrawal by Subject|2|||
129165655|NCT00814580|464899765|FG000|Overall Study|Other|1|||
129165656|NCT00814580|464899766|FG001|Overall Study|Other|3|||
129165657|NCT00814580|464899765|FG000|Overall Study|Did Not Take Drug|2|||
129165658|NCT00814580|464899766|FG001|Overall Study|Did Not Take Drug|2|||
129165659|NCT02482428|464899767|FG000|Overall Study|Lost to Follow-up|4|||
129165660|NCT02482428|464899768|FG001|Overall Study|Lost to Follow-up|9|||
129165661|NCT02482428|464899769|FG002|Overall Study|Lost to Follow-up|1|||
129165662|NCT02482428|464899770|FG003|Overall Study|Lost to Follow-up|2|||
129165663|NCT02482428|464899771|FG004|Overall Study|Lost to Follow-up|4|||
129165664|NCT02482428|464899767|FG000|Overall Study|Physician Decision|0|||
129165665|NCT02482428|464899768|FG001|Overall Study|Physician Decision|0|||
129165666|NCT02482428|464899769|FG002|Overall Study|Physician Decision|0|||
129165667|NCT02482428|464899770|FG003|Overall Study|Physician Decision|0|||
129165668|NCT02482428|464899771|FG004|Overall Study|Physician Decision|1|||
129165669|NCT02482428|464899767|FG000|Overall Study|protocol deviation|1|||
129165670|NCT02482428|464899768|FG001|Overall Study|protocol deviation|1|||
129165671|NCT02482428|464899769|FG002|Overall Study|protocol deviation|0|||
129165672|NCT02482428|464899770|FG003|Overall Study|protocol deviation|0|||
129165673|NCT02482428|464899771|FG004|Overall Study|protocol deviation|0|||
129165674|NCT02482428|464899767|FG000|Overall Study|subject/guardian decision|4|||
129165675|NCT02482428|464899768|FG001|Overall Study|subject/guardian decision|2|||
129165676|NCT02482428|464899769|FG002|Overall Study|subject/guardian decision|0|||
129165677|NCT02482428|464899770|FG003|Overall Study|subject/guardian decision|0|||
129165678|NCT02482428|464899771|FG004|Overall Study|subject/guardian decision|2|||
129165679|NCT05935878|464899777|FG000|Overall Study|Death|1|||
129165680|NCT05935878|464899778|FG001|Overall Study|Death|2|||
129165681|NCT05935878|464899777|FG000|Overall Study|Withdrawal by Subject|5|||
129165682|NCT05935878|464899778|FG001|Overall Study|Withdrawal by Subject|5|||
129165683|NCT05935878|464899777|FG000|Overall Study|Revision of implant|1|||
129165684|NCT05935878|464899778|FG001|Overall Study|Revision of implant|1|||
129165685|NCT05935878|464899777|FG000|Overall Study|Mobile bearing dislocation|0|||
129165686|NCT05935878|464899778|FG001|Overall Study|Mobile bearing dislocation|1|||
128726698|NCT00048542|463297044|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
129165687|NCT00459875|464899781|FG000|Overall Study|Ineligible participant|1|||
128726699|NCT00048542|463297045|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
129165688|NCT00459875|464899781|FG000|Overall Study|Adverse Event|2|||
129165689|NCT01406938|464899784|FG000|Induction Period|Subject/guardian decision|6|||
129165690|NCT01406938|464899785|FG001|Induction Period|Subject/guardian decision|8|||
129165691|NCT01406938|464899786|FG002|Induction Period|Subject/guardian decision|0|||
129165692|NCT01406938|464899787|FG003|Induction Period|Subject/guardian decision|0|||
129165693|NCT01406938|464899788|FG004|Induction Period|Subject/guardian decision|0|||
129165694|NCT01406938|464899789|FG005|Induction Period|Subject/guardian decision|0|||
129165695|NCT01406938|464899784|FG000|Induction Period|Protocol deviation|1|||
129165696|NCT01406938|464899785|FG001|Induction Period|Protocol deviation|0|||
129165697|NCT01406938|464899786|FG002|Induction Period|Protocol deviation|0|||
129165698|NCT01406938|464899787|FG003|Induction Period|Protocol deviation|0|||
129165699|NCT01406938|464899788|FG004|Induction Period|Protocol deviation|0|||
129165700|NCT01406938|464899789|FG005|Induction Period|Protocol deviation|0|||
129165701|NCT01406938|464899784|FG000|Induction Period|Adverse Event|8|||
129165702|NCT01406938|464899785|FG001|Induction Period|Adverse Event|9|||
129165703|NCT01406938|464899786|FG002|Induction Period|Adverse Event|0|||
129165704|NCT01406938|464899787|FG003|Induction Period|Adverse Event|0|||
129165705|NCT01406938|464899788|FG004|Induction Period|Adverse Event|0|||
129165706|NCT01406938|464899789|FG005|Induction Period|Adverse Event|0|||
129165707|NCT01406938|464899784|FG000|Induction Period|Lack of Efficacy|1|||
129165708|NCT01406938|464899785|FG001|Induction Period|Lack of Efficacy|0|||
129165709|NCT01406938|464899786|FG002|Induction Period|Lack of Efficacy|0|||
129165710|NCT01406938|464899787|FG003|Induction Period|Lack of Efficacy|0|||
129165711|NCT01406938|464899788|FG004|Induction Period|Lack of Efficacy|0|||
129165712|NCT01406938|464899789|FG005|Induction Period|Lack of Efficacy|0|||
129165713|NCT01406938|464899784|FG000|Induction Period|Lost to Follow-up|2|||
129165714|NCT01406938|464899785|FG001|Induction Period|Lost to Follow-up|3|||
129165715|NCT01406938|464899786|FG002|Induction Period|Lost to Follow-up|0|||
129165716|NCT01406938|464899787|FG003|Induction Period|Lost to Follow-up|0|||
129165717|NCT01406938|464899788|FG004|Induction Period|Lost to Follow-up|0|||
129165718|NCT01406938|464899789|FG005|Induction Period|Lost to Follow-up|0|||
129165719|NCT01406938|464899784|FG000|Maintenance Period|Adverse Event|0|||
129165720|NCT01406938|464899785|FG001|Maintenance Period|Adverse Event|0|||
128726700|NCT00048542|463297046|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
128726701|NCT00048542|463297047|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
128726702|NCT00048542|463297040|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
128726703|NCT00048542|463297041|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
128726704|NCT00048542|463297042|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
128726705|NCT00048542|463297043|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
128726706|NCT00048542|463297044|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
128726707|NCT00048542|463297045|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
128726708|NCT00048542|463297046|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
128726709|NCT00048542|463297047|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
128726710|NCT00048542|463297040|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
128726711|NCT00048542|463297041|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
128726712|NCT00048542|463297042|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
128726713|NCT00048542|463297043|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
128726714|NCT00048542|463297044|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
128726715|NCT00048542|463297045|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
128726716|NCT00048542|463297046|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
128726717|NCT00048542|463297047|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
128726718|NCT00048542|463297040|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
128726719|NCT00048542|463297041|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
128726720|NCT00048542|463297042|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
128726721|NCT00048542|463297043|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
128726722|NCT00048542|463297044|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
128726723|NCT00048542|463297045|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
128726724|NCT00048542|463297046|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
128726725|NCT00048542|463297047|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
128726726|NCT00048542|463297040|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
128726727|NCT00048542|463297041|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
128726728|NCT00048542|463297042|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
128726729|NCT00048542|463297043|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
128726730|NCT00048542|463297044|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
128726731|NCT00048542|463297045|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
128726732|NCT00048542|463297046|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
128726733|NCT00048542|463297047|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
128726734|NCT00048542|463297040|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
128726735|NCT00048542|463297041|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
128726736|NCT00048542|463297042|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129165721|NCT01406938|464899786|FG002|Maintenance Period|Adverse Event|2|||
129165722|NCT01406938|464899787|FG003|Maintenance Period|Adverse Event|8|||
129165723|NCT01406938|464899788|FG004|Maintenance Period|Adverse Event|4|||
129165724|NCT01406938|464899789|FG005|Maintenance Period|Adverse Event|2|||
129165725|NCT01406938|464899784|FG000|Maintenance Period|Death|0|||
129165726|NCT01406938|464899785|FG001|Maintenance Period|Death|0|||
129165727|NCT01406938|464899786|FG002|Maintenance Period|Death|0|||
129165728|NCT01406938|464899787|FG003|Maintenance Period|Death|0|||
129165729|NCT01406938|464899788|FG004|Maintenance Period|Death|1|||
129165730|NCT01406938|464899789|FG005|Maintenance Period|Death|0|||
129165731|NCT01406938|464899784|FG000|Maintenance Period|Subject/guardian decision|0|||
129165732|NCT01406938|464899785|FG001|Maintenance Period|Subject/guardian decision|0|||
129165733|NCT01406938|464899786|FG002|Maintenance Period|Subject/guardian decision|11|||
129165734|NCT01406938|464899787|FG003|Maintenance Period|Subject/guardian decision|7|||
129165735|NCT01406938|464899788|FG004|Maintenance Period|Subject/guardian decision|10|||
129165736|NCT01406938|464899789|FG005|Maintenance Period|Subject/guardian decision|7|||
129165737|NCT01406938|464899784|FG000|Maintenance Period|Protocol Violation|0|||
129165738|NCT01406938|464899785|FG001|Maintenance Period|Protocol Violation|0|||
129165739|NCT01406938|464899786|FG002|Maintenance Period|Protocol Violation|2|||
129165740|NCT01406938|464899787|FG003|Maintenance Period|Protocol Violation|2|||
129165741|NCT01406938|464899788|FG004|Maintenance Period|Protocol Violation|2|||
129165742|NCT01406938|464899789|FG005|Maintenance Period|Protocol Violation|2|||
129165743|NCT01406938|464899784|FG000|Maintenance Period|Pregnancy|0|||
129165744|NCT01406938|464899785|FG001|Maintenance Period|Pregnancy|0|||
129165745|NCT01406938|464899786|FG002|Maintenance Period|Pregnancy|0|||
129165746|NCT01406938|464899787|FG003|Maintenance Period|Pregnancy|0|||
129165747|NCT01406938|464899788|FG004|Maintenance Period|Pregnancy|1|||
129165748|NCT01406938|464899789|FG005|Maintenance Period|Pregnancy|0|||
129165749|NCT01406938|464899784|FG000|Maintenance Period|Lost to Follow-up|0|||
129165750|NCT01406938|464899785|FG001|Maintenance Period|Lost to Follow-up|0|||
129165751|NCT01406938|464899786|FG002|Maintenance Period|Lost to Follow-up|0|||
129165752|NCT01406938|464899787|FG003|Maintenance Period|Lost to Follow-up|0|||
129165753|NCT01406938|464899788|FG004|Maintenance Period|Lost to Follow-up|4|||
129165754|NCT01406938|464899789|FG005|Maintenance Period|Lost to Follow-up|0|||
129165755|NCT01406938|464899784|FG000|Maintenance Period|Lack of Efficacy|0|||
129165756|NCT01406938|464899785|FG001|Maintenance Period|Lack of Efficacy|0|||
129165757|NCT01406938|464899786|FG002|Maintenance Period|Lack of Efficacy|2|||
129165758|NCT01406938|464899787|FG003|Maintenance Period|Lack of Efficacy|1|||
129165759|NCT01406938|464899788|FG004|Maintenance Period|Lack of Efficacy|3|||
129165760|NCT01406938|464899789|FG005|Maintenance Period|Lack of Efficacy|5|||
129165761|NCT01406938|464899784|FG000|Follow up|Lack of Efficacy|3|||
129165762|NCT01406938|464899785|FG001|Follow up|Lack of Efficacy|2|||
129165763|NCT01406938|464899786|FG002|Follow up|Lack of Efficacy|1|||
129165764|NCT01406938|464899787|FG003|Follow up|Lack of Efficacy|0|||
129165765|NCT01406938|464899788|FG004|Follow up|Lack of Efficacy|0|||
129165766|NCT01406938|464899789|FG005|Follow up|Lack of Efficacy|0|||
129165767|NCT01406938|464899784|FG000|Follow up|Patient/guardian decision|4|||
129165768|NCT01406938|464899785|FG001|Follow up|Patient/guardian decision|2|||
129165769|NCT01406938|464899786|FG002|Follow up|Patient/guardian decision|4|||
129165770|NCT01406938|464899787|FG003|Follow up|Patient/guardian decision|2|||
129165771|NCT01406938|464899788|FG004|Follow up|Patient/guardian decision|4|||
129165772|NCT01406938|464899789|FG005|Follow up|Patient/guardian decision|1|||
129165773|NCT01406938|464899784|FG000|Follow up|Protocol Violation|0|||
129165774|NCT01406938|464899785|FG001|Follow up|Protocol Violation|0|||
129165775|NCT01406938|464899786|FG002|Follow up|Protocol Violation|1|||
129165776|NCT01406938|464899787|FG003|Follow up|Protocol Violation|0|||
129165777|NCT01406938|464899788|FG004|Follow up|Protocol Violation|0|||
129165778|NCT01406938|464899789|FG005|Follow up|Protocol Violation|0|||
129165779|NCT01406938|464899784|FG000|Follow up|Physician Decision|0|||
129165780|NCT01406938|464899785|FG001|Follow up|Physician Decision|0|||
129165781|NCT01406938|464899786|FG002|Follow up|Physician Decision|2|||
129165782|NCT01406938|464899787|FG003|Follow up|Physician Decision|0|||
129165783|NCT01406938|464899788|FG004|Follow up|Physician Decision|3|||
129165784|NCT01406938|464899789|FG005|Follow up|Physician Decision|1|||
129165785|NCT01406938|464899784|FG000|Follow up|Lost to Follow-up|1|||
129165786|NCT01406938|464899785|FG001|Follow up|Lost to Follow-up|1|||
129165787|NCT01406938|464899786|FG002|Follow up|Lost to Follow-up|0|||
129165788|NCT01406938|464899787|FG003|Follow up|Lost to Follow-up|1|||
129165789|NCT01406938|464899788|FG004|Follow up|Lost to Follow-up|2|||
129165790|NCT01406938|464899789|FG005|Follow up|Lost to Follow-up|1|||
128726737|NCT00048542|463297043|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
128982122|NCT02545504|464219104|FG001|Overall Study|Withdrew consent|11|||
129165791|NCT01951586|464899797|FG000|Overall Study|Death|61|||
129165792|NCT01951586|464899798|FG001|Overall Study|Death|120|||
129165793|NCT01951586|464899797|FG000|Overall Study|Withdrawal by Subject|8|||
129165794|NCT01951586|464899798|FG001|Overall Study|Withdrawal by Subject|17|||
128777179|NCT00918749|463473680|FG000|Overall Study|Withdrawal by Subject|5|||
128777180|NCT00918749|463473681|FG001|Overall Study|Withdrawal by Subject|3|||
128777181|NCT00918749|463473682|FG002|Overall Study|Withdrawal by Subject|5|||
128777182|NCT00918749|463473680|FG000|Overall Study|No Study Medication Taken|1|||
128777183|NCT00918749|463473681|FG001|Overall Study|No Study Medication Taken|0|||
128777184|NCT00918749|463473682|FG002|Overall Study|No Study Medication Taken|0|||
128777185|NCT01951092|463473683|FG000|Overall Study|Lost to Follow-up|10|||
128777186|NCT01951092|463473683|FG000|Overall Study|Incarceration|1|||
128777187|NCT01951092|463473683|FG000|Overall Study|Transfer of Care|1|||
128777188|NCT01712789|463473684|FG000|Overall Study|Lack of Efficacy|2|||
128777189|NCT01712789|463473684|FG000|Overall Study|Lost to Follow-up|1|||
128777190|NCT01712789|463473684|FG000|Overall Study|Progressive Disease|504|||
128777191|NCT01712789|463473684|FG000|Overall Study|Death|57|||
128777192|NCT01712789|463473684|FG000|Overall Study|Adverse Event|52|||
128777193|NCT01712789|463473684|FG000|Overall Study|Miscellaneous|31|||
128777194|NCT01712789|463473684|FG000|Overall Study|Withdrawal by Subject|21|||
128777195|NCT01712789|463473684|FG000|Overall Study|Transition to Commercial Treatment|8|||
128777196|NCT01712789|463473684|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
128777197|NCT01708187|463473685|FG000|Overall Study|Lost to Follow-up|0|||
128777198|NCT01708187|463473686|FG001|Overall Study|Lost to Follow-up|1|||
128777199|NCT00873093|463473687|FG000|Overall Study|Adverse Event|0|||
128777200|NCT00873093|463473688|FG001|Overall Study|Adverse Event|2|||
128777201|NCT00873093|463473689|FG002|Overall Study|Adverse Event|0|||
128777202|NCT00873093|463473690|FG003|Overall Study|Adverse Event|0|||
128777203|NCT00873093|463473691|FG004|Overall Study|Adverse Event|0|||
128777204|NCT00873093|463473687|FG000|Overall Study|Death|0|||
128777205|NCT00873093|463473688|FG001|Overall Study|Death|3|||
128777206|NCT00873093|463473689|FG002|Overall Study|Death|2|||
128777207|NCT00873093|463473690|FG003|Overall Study|Death|0|||
128777208|NCT00873093|463473691|FG004|Overall Study|Death|0|||
128777209|NCT00873093|463473687|FG000|Overall Study|Physician Decision|0|||
128777210|NCT00873093|463473688|FG001|Overall Study|Physician Decision|17|||
128777211|NCT00873093|463473689|FG002|Overall Study|Physician Decision|10|||
128777212|NCT00873093|463473690|FG003|Overall Study|Physician Decision|10|||
128777213|NCT00873093|463473691|FG004|Overall Study|Physician Decision|2|||
128777214|NCT00873093|463473687|FG000|Overall Study|Withdrawal by Subject|1|||
128777215|NCT00873093|463473688|FG001|Overall Study|Withdrawal by Subject|4|||
128777216|NCT00873093|463473689|FG002|Overall Study|Withdrawal by Subject|4|||
128777217|NCT00873093|463473690|FG003|Overall Study|Withdrawal by Subject|0|||
128777218|NCT00873093|463473691|FG004|Overall Study|Withdrawal by Subject|0|||
128777219|NCT00873093|463473687|FG000|Overall Study|Ineligible|0|||
128777220|NCT00873093|463473688|FG001|Overall Study|Ineligible|1|||
128777221|NCT00873093|463473689|FG002|Overall Study|Ineligible|0|||
129165795|NCT01951586|464899797|FG000|Overall Study|Lost to Follow-up|0|||
129165796|NCT01951586|464899798|FG001|Overall Study|Lost to Follow-up|1|||
129165797|NCT01951586|464899797|FG000|Overall Study|Sponsor Decision|9|||
129165798|NCT01951586|464899798|FG001|Overall Study|Sponsor Decision|10|||
129165799|NCT00878254|464899800|FG000|Overall Study|Physician Decision|1|||
129165800|NCT00878254|464899800|FG000|Overall Study|Death|1|||
129165801|NCT00878254|464899800|FG000|Overall Study|Withdrawal by Subject|1|||
129165802|NCT04560816|464899802|FG000|Overall Study|Withdrawal by Subject|1|||
129165803|NCT04560816|464899803|FG001|Overall Study|Withdrawal by Subject|1|||
129165804|NCT04560816|464899804|FG002|Overall Study|Withdrawal by Subject|1|||
129165805|NCT04560816|464899805|FG003|Overall Study|Withdrawal by Subject|0|||
129165806|NCT04560816|464899806|FG004|Overall Study|Withdrawal by Subject|3|||
129165807|NCT04560816|464899807|FG005|Overall Study|Withdrawal by Subject|0|||
129165808|NCT04560816|464899802|FG000|Overall Study|Lost to Follow-up|1|||
129165809|NCT04560816|464899803|FG001|Overall Study|Lost to Follow-up|0|||
129165810|NCT04560816|464899804|FG002|Overall Study|Lost to Follow-up|0|||
129165811|NCT04560816|464899805|FG003|Overall Study|Lost to Follow-up|0|||
129165812|NCT04560816|464899806|FG004|Overall Study|Lost to Follow-up|0|||
129165813|NCT04560816|464899807|FG005|Overall Study|Lost to Follow-up|0|||
129165814|NCT04560816|464899802|FG000|Overall Study|Protocol Violation|1|||
129165815|NCT04560816|464899803|FG001|Overall Study|Protocol Violation|0|||
129165816|NCT04560816|464899804|FG002|Overall Study|Protocol Violation|0|||
128777222|NCT00873093|463473690|FG003|Overall Study|Ineligible|1|||
128777223|NCT00873093|463473691|FG004|Overall Study|Ineligible|0|||
128777224|NCT03055832|463473693|FG000|Week 2|Withdrawal by Subject|1|||
128777225|NCT03055832|463473694|FG001|Week 2|Withdrawal by Subject|0|||
128777226|NCT00136916|463473695|FG000|Overall Study|Never received study treatment|3|||
128777227|NCT00136916|463473696|FG001|Overall Study|Never received study treatment|5|||
128777228|NCT00136916|463473695|FG000|Overall Study|Death|1|||
128777229|NCT00136916|463473696|FG001|Overall Study|Death|3|||
128777230|NCT00136916|463473695|FG000|Overall Study|Adverse Event|27|||
128777231|NCT00136916|463473696|FG001|Overall Study|Adverse Event|8|||
128777232|NCT00136916|463473695|FG000|Overall Study|Laboratory abnormality|0|||
129165817|NCT04560816|464899805|FG003|Overall Study|Protocol Violation|0|||
129165818|NCT04560816|464899806|FG004|Overall Study|Protocol Violation|0|||
129165819|NCT04560816|464899807|FG005|Overall Study|Protocol Violation|0|||
129165820|NCT02277691|464899808|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
129165821|NCT02277691|464899808|FG000|Overall Study|Voluntary Withdrawal|7|||
129165822|NCT02277691|464899808|FG000|Overall Study|Lack of Efficacy|5|||
129165823|NCT02277691|464899808|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
129165824|NCT00441142|464899810|FG000|Overall Study|Adverse Event|2|||
129165825|NCT00441142|464899811|FG001|Overall Study|Adverse Event|3|||
129165826|NCT00441142|464899812|FG002|Overall Study|Adverse Event|3|||
129165827|NCT00441142|464899813|FG003|Overall Study|Adverse Event|22|||
129165828|NCT00441142|464899810|FG000|Overall Study|Lack of Efficacy|3|||
129165829|NCT00441142|464899811|FG001|Overall Study|Lack of Efficacy|3|||
129165830|NCT00441142|464899812|FG002|Overall Study|Lack of Efficacy|17|||
129165831|NCT00441142|464899813|FG003|Overall Study|Lack of Efficacy|32|||
129165832|NCT00441142|464899810|FG000|Overall Study|Withdrawal by Subject|0|||
129165833|NCT00441142|464899811|FG001|Overall Study|Withdrawal by Subject|0|||
129165834|NCT00441142|464899812|FG002|Overall Study|Withdrawal by Subject|2|||
129165835|NCT00441142|464899813|FG003|Overall Study|Withdrawal by Subject|10|||
129165836|NCT00441142|464899810|FG000|Overall Study|Patient still receiving active study tx|1|||
129165837|NCT00441142|464899811|FG001|Overall Study|Patient still receiving active study tx|0|||
129165838|NCT00441142|464899812|FG002|Overall Study|Patient still receiving active study tx|0|||
129165839|NCT00441142|464899813|FG003|Overall Study|Patient still receiving active study tx|2|||
129165840|NCT00441142|464899810|FG000|Overall Study|Physician Decision|0|||
129165841|NCT00441142|464899811|FG001|Overall Study|Physician Decision|1|||
129165842|NCT00441142|464899812|FG002|Overall Study|Physician Decision|0|||
129165843|NCT00441142|464899813|FG003|Overall Study|Physician Decision|1|||
129165844|NCT00441142|464899810|FG000|Overall Study|Death|0|||
129165845|NCT00441142|464899811|FG001|Overall Study|Death|0|||
129165846|NCT00441142|464899812|FG002|Overall Study|Death|0|||
129165847|NCT00441142|464899813|FG003|Overall Study|Death|1|||
129165848|NCT04952597|464899814|FG000|Overall Study|Death|12|||
129165849|NCT04952597|464899815|FG001|Overall Study|Death|13|||
129165850|NCT04952597|464899816|FG002|Overall Study|Death|14|||
129165851|NCT04952597|464899814|FG000|Overall Study|Withdrawal by Subject|1|||
129165852|NCT04952597|464899815|FG001|Overall Study|Withdrawal by Subject|0|||
129165853|NCT04952597|464899816|FG002|Overall Study|Withdrawal by Subject|3|||
129165854|NCT04952597|464899814|FG000|Overall Study|Lost to Follow-up|0|||
129165855|NCT04952597|464899815|FG001|Overall Study|Lost to Follow-up|1|||
129165856|NCT04952597|464899816|FG002|Overall Study|Lost to Follow-up|1|||
129165857|NCT01265563|464899817|FG000|Overall Study|Withdrawal by Subject|0|||
129165858|NCT01265563|464899818|FG001|Overall Study|Withdrawal by Subject|1|||
129165859|NCT01265563|464899819|FG002|Overall Study|Withdrawal by Subject|1|||
129165860|NCT01265563|464899820|FG003|Overall Study|Withdrawal by Subject|0|||
129165861|NCT01265563|464899821|FG004|Overall Study|Withdrawal by Subject|2|||
129165862|NCT04908865|464899826|FG000|Overall Study|Adverse Event|2|||
129165863|NCT04908865|464899826|FG000|Overall Study|Lack of Efficacy|5|||
129165864|NCT04908865|464899826|FG000|Overall Study|Lost to Follow-up|1|||
129165865|NCT02141399|464899827|FG000|Overall Study|Adverse Event|158|||
129165866|NCT02141399|464899827|FG000|Overall Study|Lack of Efficacy|62|||
129165867|NCT02141399|464899827|FG000|Overall Study|Lost to Follow-up|151|||
129165868|NCT02141399|464899827|FG000|Overall Study|Non-compliance with study drug|18|||
129165869|NCT02141399|464899827|FG000|Overall Study|Other|45|||
129165870|NCT02141399|464899827|FG000|Overall Study|Physician Decision|17|||
129165871|NCT02141399|464899827|FG000|Overall Study|Pregnancy|3|||
129165872|NCT02141399|464899827|FG000|Overall Study|Protocol Violation|38|||
129165873|NCT02141399|464899827|FG000|Overall Study|Withdrawal by Subject|238|||
129165874|NCT02141399|464899827|FG000|Overall Study|Failure to meet eligibility criteria|14|||
129165875|NCT05730335|464899830|FG000|Overall Study|Lost to Follow-up|8|||
129165876|NCT05730335|464899830|FG000|Overall Study|Withdrawal by Subject|6|||
129165877|NCT01296711|464899831|FG000|Overall Study|Adverse Event|3|||
129165878|NCT01296711|464899832|FG001|Overall Study|Adverse Event|1|||
129165879|NCT01296711|464899833|FG002|Overall Study|Adverse Event|4|||
129165880|NCT01296711|464899834|FG003|Overall Study|Adverse Event|3|||
129165881|NCT01296711|464899835|FG004|Overall Study|Adverse Event|1|||
129165882|NCT01296711|464899836|FG005|Overall Study|Adverse Event|6|||
129165883|NCT01296711|464899837|FG006|Overall Study|Adverse Event|11|||
129165884|NCT01296711|464899838|FG007|Overall Study|Adverse Event|3|||
129165885|NCT01296711|464899831|FG000|Overall Study|Lack of Efficacy|1|||
129165886|NCT01296711|464899832|FG001|Overall Study|Lack of Efficacy|4|||
129165887|NCT01296711|464899833|FG002|Overall Study|Lack of Efficacy|1|||
129165888|NCT01296711|464899834|FG003|Overall Study|Lack of Efficacy|1|||
129165889|NCT01296711|464899835|FG004|Overall Study|Lack of Efficacy|1|||
129165890|NCT01296711|464899836|FG005|Overall Study|Lack of Efficacy|0|||
129165891|NCT01296711|464899837|FG006|Overall Study|Lack of Efficacy|2|||
129165892|NCT01296711|464899838|FG007|Overall Study|Lack of Efficacy|3|||
129165893|NCT01296711|464899831|FG000|Overall Study|Lost to Follow-up|0|||
129165894|NCT01296711|464899832|FG001|Overall Study|Lost to Follow-up|0|||
129165895|NCT01296711|464899833|FG002|Overall Study|Lost to Follow-up|1|||
129165896|NCT01296711|464899834|FG003|Overall Study|Lost to Follow-up|1|||
129165897|NCT01296711|464899835|FG004|Overall Study|Lost to Follow-up|2|||
129165898|NCT01296711|464899836|FG005|Overall Study|Lost to Follow-up|0|||
128777233|NCT00136916|463473696|FG001|Overall Study|Laboratory abnormality|1|||
128777234|NCT00136916|463473695|FG000|Overall Study|Lack of Efficacy|13|||
128777235|NCT00136916|463473696|FG001|Overall Study|Lack of Efficacy|3|||
128777236|NCT00136916|463473695|FG000|Overall Study|Lost to Follow-up|12|||
128777237|NCT00136916|463473696|FG001|Overall Study|Lost to Follow-up|14|||
128777238|NCT00136916|463473695|FG000|Overall Study|Withdrawal by Subject|44|||
128777239|NCT00136916|463473696|FG001|Overall Study|Withdrawal by Subject|46|||
128777240|NCT00136916|463473695|FG000|Overall Study|Other|22|||
128777241|NCT00136916|463473696|FG001|Overall Study|Other|24|||
128777242|NCT00136916|463473695|FG000|Overall Study|Discontinued in follow up period|3|||
128777243|NCT00136916|463473696|FG001|Overall Study|Discontinued in follow up period|0|||
128777244|NCT01163149|463473706|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
128777245|NCT01163149|463473707|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
128777246|NCT01163149|463473708|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
128777247|NCT01163149|463473706|FG000|Extension Treatment Period|Adverse Event|0|||
128777248|NCT01163149|463473707|FG001|Extension Treatment Period|Adverse Event|1|||
128777249|NCT01163149|463473708|FG002|Extension Treatment Period|Adverse Event|0|||
128777250|NCT01163149|463473706|FG000|Extension Treatment Period|Noncompliance|0|||
128777251|NCT01163149|463473707|FG001|Extension Treatment Period|Noncompliance|0|||
128777252|NCT01163149|463473708|FG002|Extension Treatment Period|Noncompliance|1|||
128777253|NCT02806336|463473709|FG000|Overall Study|Physician Decision|1|||
128777254|NCT02806336|463473710|FG001|Overall Study|Physician Decision|0|||
128777255|NCT02806336|463473709|FG000|Overall Study|Withdrawal by Subject|2|||
128777256|NCT02806336|463473710|FG001|Overall Study|Withdrawal by Subject|4|||
128777257|NCT02806336|463473709|FG000|Overall Study|COVID-19 research shut down|3|||
128777258|NCT02806336|463473710|FG001|Overall Study|COVID-19 research shut down|4|||
128777259|NCT02806336|463473709|FG000|Overall Study|Lack of Efficacy|0|||
128777260|NCT02806336|463473710|FG001|Overall Study|Lack of Efficacy|1|||
128777261|NCT01923428|463473721|FG000|Overall Study|Adverse Event|8|||
128777262|NCT01923428|463473722|FG001|Overall Study|Adverse Event|6|||
128777263|NCT01923428|463473723|FG002|Overall Study|Adverse Event|3|||
128777264|NCT01923428|463473724|FG003|Overall Study|Adverse Event|3|||
128777265|NCT01923428|463473721|FG000|Overall Study|Withdrawal by Subject|5|||
128777266|NCT01923428|463473722|FG001|Overall Study|Withdrawal by Subject|3|||
128777267|NCT01923428|463473723|FG002|Overall Study|Withdrawal by Subject|0|||
128777268|NCT01923428|463473724|FG003|Overall Study|Withdrawal by Subject|4|||
128777269|NCT01923428|463473721|FG000|Overall Study|Lost to Follow-up|2|||
128777270|NCT01923428|463473722|FG001|Overall Study|Lost to Follow-up|1|||
128777271|NCT01923428|463473723|FG002|Overall Study|Lost to Follow-up|5|||
128777272|NCT01923428|463473724|FG003|Overall Study|Lost to Follow-up|0|||
128777273|NCT01923428|463473721|FG000|Overall Study|Protocol Violation|3|||
128777274|NCT01923428|463473722|FG001|Overall Study|Protocol Violation|0|||
128777275|NCT01923428|463473723|FG002|Overall Study|Protocol Violation|2|||
128777276|NCT01923428|463473724|FG003|Overall Study|Protocol Violation|1|||
128777277|NCT01923428|463473721|FG000|Overall Study|Non Compliance to treatment|1|||
128777278|NCT01923428|463473722|FG001|Overall Study|Non Compliance to treatment|2|||
128777279|NCT01923428|463473723|FG002|Overall Study|Non Compliance to treatment|0|||
129165899|NCT01296711|464899837|FG006|Overall Study|Lost to Follow-up|4|||
129165900|NCT01296711|464899838|FG007|Overall Study|Lost to Follow-up|2|||
129165901|NCT01296711|464899831|FG000|Overall Study|Protocol Violation|0|||
129165902|NCT01296711|464899832|FG001|Overall Study|Protocol Violation|0|||
129165903|NCT01296711|464899833|FG002|Overall Study|Protocol Violation|0|||
129165904|NCT01296711|464899834|FG003|Overall Study|Protocol Violation|1|||
129165905|NCT01296711|464899835|FG004|Overall Study|Protocol Violation|1|||
129165906|NCT01296711|464899836|FG005|Overall Study|Protocol Violation|0|||
129165907|NCT01296711|464899837|FG006|Overall Study|Protocol Violation|0|||
129165908|NCT01296711|464899838|FG007|Overall Study|Protocol Violation|0|||
129165909|NCT01296711|464899831|FG000|Overall Study|Withdrawal by Subject|4|||
129165910|NCT01296711|464899832|FG001|Overall Study|Withdrawal by Subject|2|||
129165911|NCT01296711|464899833|FG002|Overall Study|Withdrawal by Subject|2|||
129165912|NCT01296711|464899834|FG003|Overall Study|Withdrawal by Subject|1|||
129165913|NCT01296711|464899835|FG004|Overall Study|Withdrawal by Subject|1|||
129165914|NCT01296711|464899836|FG005|Overall Study|Withdrawal by Subject|1|||
129165915|NCT01296711|464899837|FG006|Overall Study|Withdrawal by Subject|2|||
128777280|NCT01923428|463473724|FG003|Overall Study|Non Compliance to treatment|1|||
128777281|NCT01923428|463473721|FG000|Overall Study|Lack of Efficacy|0|||
128777282|NCT01923428|463473722|FG001|Overall Study|Lack of Efficacy|0|||
128777283|NCT01923428|463473723|FG002|Overall Study|Lack of Efficacy|1|||
128777284|NCT01923428|463473724|FG003|Overall Study|Lack of Efficacy|1|||
128777285|NCT02550873|463473725|FG000|Randomized Double Blind|Adverse Event|3|||
128777286|NCT02550873|463473726|FG001|Randomized Double Blind|Adverse Event|1|||
128777287|NCT02550873|463473727|FG002|Randomized Double Blind|Adverse Event|0|||
128777288|NCT02550873|463473725|FG000|Randomized Double Blind|Disease progression|1|||
129165916|NCT01296711|464899838|FG007|Overall Study|Withdrawal by Subject|1|||
129165917|NCT01296711|464899831|FG000|Overall Study|Study termination|8|||
129165918|NCT01296711|464899832|FG001|Overall Study|Study termination|1|||
129165919|NCT01296711|464899833|FG002|Overall Study|Study termination|5|||
129165920|NCT01296711|464899834|FG003|Overall Study|Study termination|4|||
129165921|NCT01296711|464899835|FG004|Overall Study|Study termination|4|||
129165922|NCT01296711|464899836|FG005|Overall Study|Study termination|4|||
129165923|NCT01296711|464899837|FG006|Overall Study|Study termination|8|||
129165924|NCT01296711|464899838|FG007|Overall Study|Study termination|10|||
129165925|NCT01296711|464899831|FG000|Overall Study|Continued elevated liver enzymes|0|||
129165926|NCT01296711|464899832|FG001|Overall Study|Continued elevated liver enzymes|0|||
129165927|NCT01296711|464899833|FG002|Overall Study|Continued elevated liver enzymes|0|||
129165928|NCT01296711|464899834|FG003|Overall Study|Continued elevated liver enzymes|1|||
129165929|NCT01296711|464899835|FG004|Overall Study|Continued elevated liver enzymes|0|||
129165930|NCT01296711|464899836|FG005|Overall Study|Continued elevated liver enzymes|0|||
129165931|NCT01296711|464899837|FG006|Overall Study|Continued elevated liver enzymes|0|||
129165932|NCT01296711|464899838|FG007|Overall Study|Continued elevated liver enzymes|0|||
129165933|NCT01296711|464899831|FG000|Overall Study|Methotrexate discontinued|0|||
129165934|NCT01296711|464899832|FG001|Overall Study|Methotrexate discontinued|0|||
129165935|NCT01296711|464899833|FG002|Overall Study|Methotrexate discontinued|0|||
129165936|NCT01296711|464899834|FG003|Overall Study|Methotrexate discontinued|1|||
129165937|NCT01296711|464899835|FG004|Overall Study|Methotrexate discontinued|0|||
129165938|NCT01296711|464899836|FG005|Overall Study|Methotrexate discontinued|0|||
129165939|NCT01296711|464899837|FG006|Overall Study|Methotrexate discontinued|0|||
129165940|NCT01296711|464899838|FG007|Overall Study|Methotrexate discontinued|0|||
129165941|NCT01296711|464899831|FG000|Overall Study|Investigator discretion|0|||
129165942|NCT01296711|464899832|FG001|Overall Study|Investigator discretion|0|||
129165943|NCT01296711|464899833|FG002|Overall Study|Investigator discretion|0|||
129165944|NCT01296711|464899834|FG003|Overall Study|Investigator discretion|0|||
129165945|NCT01296711|464899835|FG004|Overall Study|Investigator discretion|0|||
129165946|NCT01296711|464899836|FG005|Overall Study|Investigator discretion|0|||
129165947|NCT01296711|464899837|FG006|Overall Study|Investigator discretion|1|||
129165948|NCT01296711|464899838|FG007|Overall Study|Investigator discretion|0|||
129165949|NCT01296711|464899831|FG000|Overall Study|Other|0|||
129165950|NCT01296711|464899832|FG001|Overall Study|Other|0|||
129165951|NCT01296711|464899833|FG002|Overall Study|Other|0|||
129165952|NCT01296711|464899834|FG003|Overall Study|Other|0|||
129165953|NCT01296711|464899835|FG004|Overall Study|Other|0|||
129165954|NCT01296711|464899836|FG005|Overall Study|Other|0|||
129165955|NCT01296711|464899837|FG006|Overall Study|Other|1|||
129165956|NCT01296711|464899838|FG007|Overall Study|Other|0|||
129165957|NCT01296711|464899831|FG000|Overall Study|Required restricted steroid injections|0|||
129165958|NCT01296711|464899832|FG001|Overall Study|Required restricted steroid injections|0|||
129165959|NCT01296711|464899833|FG002|Overall Study|Required restricted steroid injections|0|||
129165960|NCT01296711|464899834|FG003|Overall Study|Required restricted steroid injections|0|||
129165961|NCT01296711|464899835|FG004|Overall Study|Required restricted steroid injections|0|||
129165962|NCT01296711|464899836|FG005|Overall Study|Required restricted steroid injections|0|||
129165963|NCT01296711|464899837|FG006|Overall Study|Required restricted steroid injections|1|||
129165964|NCT01296711|464899838|FG007|Overall Study|Required restricted steroid injections|0|||
129165965|NCT01296711|464899831|FG000|Overall Study|Ongoing missed appointments|0|||
129165966|NCT01296711|464899832|FG001|Overall Study|Ongoing missed appointments|0|||
129165967|NCT01296711|464899833|FG002|Overall Study|Ongoing missed appointments|0|||
129165968|NCT01296711|464899834|FG003|Overall Study|Ongoing missed appointments|0|||
129165969|NCT01296711|464899835|FG004|Overall Study|Ongoing missed appointments|0|||
129165970|NCT01296711|464899836|FG005|Overall Study|Ongoing missed appointments|0|||
129165971|NCT01296711|464899837|FG006|Overall Study|Ongoing missed appointments|1|||
129165972|NCT01296711|464899838|FG007|Overall Study|Ongoing missed appointments|0|||
129165973|NCT01296711|464899831|FG000|Overall Study|Failure to comply with visits|0|||
129165974|NCT01296711|464899832|FG001|Overall Study|Failure to comply with visits|0|||
129165975|NCT01296711|464899833|FG002|Overall Study|Failure to comply with visits|0|||
129165976|NCT01296711|464899834|FG003|Overall Study|Failure to comply with visits|0|||
129165977|NCT01296711|464899835|FG004|Overall Study|Failure to comply with visits|0|||
129165978|NCT01296711|464899836|FG005|Overall Study|Failure to comply with visits|0|||
129165979|NCT01296711|464899837|FG006|Overall Study|Failure to comply with visits|0|||
129165980|NCT01296711|464899838|FG007|Overall Study|Failure to comply with visits|1|||
129165981|NCT01296711|464899831|FG000|Overall Study|Patient decision due to transport|0|||
129165982|NCT01296711|464899832|FG001|Overall Study|Patient decision due to transport|0|||
129165983|NCT01296711|464899833|FG002|Overall Study|Patient decision due to transport|0|||
129165984|NCT01296711|464899834|FG003|Overall Study|Patient decision due to transport|0|||
129165985|NCT01296711|464899835|FG004|Overall Study|Patient decision due to transport|0|||
129165986|NCT01296711|464899836|FG005|Overall Study|Patient decision due to transport|0|||
129165987|NCT01296711|464899837|FG006|Overall Study|Patient decision due to transport|0|||
129165988|NCT01296711|464899838|FG007|Overall Study|Patient decision due to transport|1|||
129165989|NCT05411822|464899844|FG000|Overall Study|Withdrawal by Subject|2|||
129165990|NCT05411822|464899845|FG001|Overall Study|Withdrawal by Subject|1|||
129165991|NCT01864148|464899847|FG000|Overall Study|Other|2|||
129165992|NCT01864148|464899848|FG001|Overall Study|Other|1|||
129165993|NCT01864148|464899849|FG002|Overall Study|Other|1|||
128726738|NCT00048542|463297044|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129165994|NCT01864148|464899850|FG003|Overall Study|Other|3|||
129165995|NCT01864148|464899851|FG004|Overall Study|Other|1|||
129165996|NCT01864148|464899847|FG000|Overall Study|Death|0|||
129165997|NCT01864148|464899848|FG001|Overall Study|Death|0|||
129165998|NCT01864148|464899849|FG002|Overall Study|Death|0|||
129165999|NCT01864148|464899850|FG003|Overall Study|Death|1|||
129166000|NCT01864148|464899851|FG004|Overall Study|Death|0|||
129166001|NCT01864148|464899847|FG000|Overall Study|Investigator Decision|5|||
129166002|NCT01864148|464899848|FG001|Overall Study|Investigator Decision|0|||
129166003|NCT01864148|464899849|FG002|Overall Study|Investigator Decision|0|||
129166004|NCT01864148|464899850|FG003|Overall Study|Investigator Decision|4|||
129166005|NCT01864148|464899851|FG004|Overall Study|Investigator Decision|6|||
129166006|NCT01864148|464899847|FG000|Overall Study|Withdrawal by Subject|9|||
129166007|NCT01864148|464899848|FG001|Overall Study|Withdrawal by Subject|2|||
129166008|NCT01864148|464899849|FG002|Overall Study|Withdrawal by Subject|6|||
128726739|NCT00048542|463297045|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
128726740|NCT00048542|463297046|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
128726741|NCT00048542|463297047|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
128726742|NCT00048542|463297040|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129166009|NCT01864148|464899850|FG003|Overall Study|Withdrawal by Subject|8|||
128726743|NCT00048542|463297041|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
128726744|NCT00048542|463297042|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
128726745|NCT00048542|463297043|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
128726746|NCT00048542|463297044|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
128726747|NCT00048542|463297045|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
128726748|NCT00048542|463297046|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
128726749|NCT00048542|463297047|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
129166010|NCT01864148|464899851|FG004|Overall Study|Withdrawal by Subject|8|||
129166011|NCT01864148|464899847|FG000|Overall Study|Lost to Follow-up|0|||
129166012|NCT01864148|464899848|FG001|Overall Study|Lost to Follow-up|0|||
129166013|NCT01864148|464899849|FG002|Overall Study|Lost to Follow-up|0|||
129166014|NCT01864148|464899850|FG003|Overall Study|Lost to Follow-up|2|||
128726750|NCT00048542|463297040|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
128726751|NCT00048542|463297041|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
128726752|NCT00048542|463297042|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
128726753|NCT00048542|463297043|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
128726754|NCT00048542|463297044|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
128726755|NCT00048542|463297045|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
128726756|NCT00048542|463297046|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
128726757|NCT00048542|463297047|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
128726758|NCT00578175|463297048|FG000|Overall Study|Adverse Event|0|||
128726759|NCT00578175|463297049|FG001|Overall Study|Adverse Event|1|||
128726760|NCT00578175|463297050|FG002|Overall Study|Adverse Event|1|||
128726761|NCT00578175|463297048|FG000|Overall Study|Other reasons|70|||
128726762|NCT00578175|463297049|FG001|Overall Study|Other reasons|42|||
128726763|NCT00578175|463297050|FG002|Overall Study|Other reasons|23|||
128726764|NCT01869192|463297051|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
128726765|NCT01869192|463297052|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
128726766|NCT01869192|463297051|FG000|Postoperative Chemotherapy|Physician Decision|0|||
128726767|NCT01869192|463297052|FG001|Postoperative Chemotherapy|Physician Decision|2|||
128726768|NCT00235872|463297056|FG000|Overall Study|Adverse Event|34|||
128726769|NCT00235872|463297056|FG000|Overall Study|Death|1|||
128726770|NCT00235872|463297056|FG000|Overall Study|Lost to Follow-up|1|||
128726771|NCT00235872|463297056|FG000|Overall Study|Withdrawal by Subject|50|||
128726772|NCT00235872|463297056|FG000|Overall Study|Administrative reason|61|||
128726773|NCT02272413|463297058|FG000|Randomized Through Treatment Start|Not treated|3|||
128726774|NCT02272413|463297059|FG001|Randomized Through Treatment Start|Not treated|5|||
128726775|NCT02272413|463297058|FG000|Pre-switch Period|Adverse Event|38|||
128726776|NCT02272413|463297059|FG001|Pre-switch Period|Adverse Event|37|||
128726777|NCT02272413|463297058|FG000|Pre-switch Period|Death|26|||
128726778|NCT02272413|463297059|FG001|Pre-switch Period|Death|26|||
128726779|NCT02272413|463297058|FG000|Pre-switch Period|Withdrawal by Subject|27|||
128726780|NCT02272413|463297059|FG001|Pre-switch Period|Withdrawal by Subject|15|||
128726781|NCT02272413|463297058|FG000|Pre-switch Period|Physician Decision|6|||
128726782|NCT02272413|463297059|FG001|Pre-switch Period|Physician Decision|18|||
128726783|NCT02272413|463297058|FG000|Pre-switch Period|Progressive disease|185|||
128726784|NCT02272413|463297059|FG001|Pre-switch Period|Progressive disease|173|||
128726785|NCT02272413|463297058|FG000|Pre-switch Period|Lost to Follow-up|0|||
128726786|NCT02272413|463297059|FG001|Pre-switch Period|Lost to Follow-up|2|||
128726787|NCT02272413|463297058|FG000|Pre-switch Period|Protocol Violation|1|||
128726788|NCT02272413|463297059|FG001|Pre-switch Period|Protocol Violation|0|||
128726789|NCT02272413|463297058|FG000|Pre-switch Period|Other than listed|10|||
128726790|NCT02272413|463297059|FG001|Pre-switch Period|Other than listed|11|||
128726791|NCT02272413|463297058|FG000|Post-switch Period|Adverse Event|4|||
128726792|NCT02272413|463297059|FG001|Post-switch Period|Adverse Event|4|||
128726793|NCT02272413|463297058|FG000|Post-switch Period|Death|3|||
128726794|NCT02272413|463297059|FG001|Post-switch Period|Death|2|||
128726795|NCT02272413|463297058|FG000|Post-switch Period|Withdrawal by Subject|1|||
128726796|NCT02272413|463297059|FG001|Post-switch Period|Withdrawal by Subject|2|||
128726797|NCT02272413|463297058|FG000|Post-switch Period|Physician Decision|1|||
128726798|NCT02272413|463297059|FG001|Post-switch Period|Physician Decision|1|||
128726799|NCT02272413|463297058|FG000|Post-switch Period|Progressive disease|21|||
128726800|NCT02272413|463297059|FG001|Post-switch Period|Progressive disease|21|||
128726801|NCT02272413|463297058|FG000|Post-switch Period|Study terminated by sponsor|8|||
128726802|NCT02272413|463297059|FG001|Post-switch Period|Study terminated by sponsor|11|||
128726803|NCT02272413|463297058|FG000|Post-switch Period|Other than listed|4|||
128726804|NCT02272413|463297059|FG001|Post-switch Period|Other than listed|5|||
128726805|NCT02126969|463297060|FG000|Overall Study|Withdrawal by Subject|1|||
128726806|NCT02126969|463297061|FG001|Overall Study|Withdrawal by Subject|2|||
128726807|NCT00423891|463297062|FG000|Enrolled|Withdrawal by Subject|0|||
128726808|NCT00423891|463297063|FG001|Enrolled|Withdrawal by Subject|0|||
128726809|NCT00423891|463297064|FG002|Enrolled|Withdrawal by Subject|1|||
128726810|NCT00423891|463297062|FG000|Enrolled|Lost to Follow-up|0|||
128726811|NCT00423891|463297063|FG001|Enrolled|Lost to Follow-up|0|||
128726812|NCT00423891|463297064|FG002|Enrolled|Lost to Follow-up|1|||
128726813|NCT00423891|463297062|FG000|Enrolled|No longer met criteria|11|||
128726814|NCT00423891|463297063|FG001|Enrolled|No longer met criteria|2|||
128726815|NCT00423891|463297064|FG002|Enrolled|No longer met criteria|1|||
128726816|NCT00423891|463297062|FG000|Treatment|Withdrawal by Subject|1|||
128726817|NCT00423891|463297063|FG001|Treatment|Withdrawal by Subject|0|||
129166015|NCT01864148|464899851|FG004|Overall Study|Lost to Follow-up|1|||
128726818|NCT00423891|463297064|FG002|Treatment|Withdrawal by Subject|0|||
128726819|NCT00423891|463297062|FG000|Treatment|Lost to Follow-up|1|||
128726820|NCT00423891|463297063|FG001|Treatment|Lost to Follow-up|0|||
128726821|NCT00423891|463297064|FG002|Treatment|Lost to Follow-up|0|||
128726822|NCT00423891|463297062|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
128726823|NCT00423891|463297063|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
128726824|NCT00423891|463297064|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
129166016|NCT01864148|464899847|FG000|Overall Study|Adverse Event|4|||
129166017|NCT01864148|464899848|FG001|Overall Study|Adverse Event|2|||
129166018|NCT01864148|464899849|FG002|Overall Study|Adverse Event|4|||
128777289|NCT02550873|463473726|FG001|Randomized Double Blind|Disease progression|1|||
128777290|NCT02550873|463473727|FG002|Randomized Double Blind|Disease progression|0|||
128777291|NCT02550873|463473725|FG000|Open Label Extension|Study ongoing|0|||
128777292|NCT02550873|463473726|FG001|Open Label Extension|Study ongoing|0|||
128777293|NCT02550873|463473727|FG002|Open Label Extension|Study ongoing|111|||
128777294|NCT01822353|463473728|FG000|Overall Study|Adverse Event|1|||
128777295|NCT01822353|463473729|FG001|Overall Study|Adverse Event|3|||
128777296|NCT01822353|463473730|FG002|Overall Study|Adverse Event|1|||
128777297|NCT01822353|463473728|FG000|Overall Study|Pregnancy|0|||
128777298|NCT01822353|463473729|FG001|Overall Study|Pregnancy|1|||
128777299|NCT01822353|463473730|FG002|Overall Study|Pregnancy|0|||
128777300|NCT01822353|463473728|FG000|Overall Study|Withdrawal by Subject|3|||
128777301|NCT01822353|463473729|FG001|Overall Study|Withdrawal by Subject|1|||
128777302|NCT01822353|463473730|FG002|Overall Study|Withdrawal by Subject|0|||
128777303|NCT00556374|463473735|FG000|Overall Study|Withdrawal by Subject|235|||
128777304|NCT00556374|463473736|FG001|Overall Study|Withdrawal by Subject|205|||
128777305|NCT00556374|463473735|FG000|Overall Study|Death|158|||
128777306|NCT00556374|463473736|FG001|Overall Study|Death|127|||
128777307|NCT00556374|463473735|FG000|Overall Study|Lost to Follow-up|24|||
128777308|NCT00556374|463473736|FG001|Overall Study|Lost to Follow-up|17|||
128777309|NCT00556374|463473735|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
128777310|NCT00556374|463473736|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
128777311|NCT04562779|463473737|FG000|Overall Study|Lost to Follow-up|7|||
128777312|NCT04562779|463473738|FG001|Overall Study|Lost to Follow-up|5|||
129166019|NCT01864148|464899850|FG003|Overall Study|Adverse Event|7|||
129166020|NCT01864148|464899851|FG004|Overall Study|Adverse Event|7|||
129166021|NCT01864148|464899847|FG000|Overall Study|Not Dosed|0|||
129166022|NCT01864148|464899848|FG001|Overall Study|Not Dosed|0|||
129166023|NCT01864148|464899849|FG002|Overall Study|Not Dosed|0|||
129166024|NCT01864148|464899850|FG003|Overall Study|Not Dosed|1|||
129166025|NCT01864148|464899851|FG004|Overall Study|Not Dosed|0|||
128726825|NCT00423891|463297062|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
128726826|NCT00423891|463297063|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
128726827|NCT00423891|463297064|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
128726828|NCT00414661|463297065|FG000|Overall Study|Death|2|||
128726829|NCT00414661|463297066|FG001|Overall Study|Death|5|||
128726830|NCT00414661|463297067|FG002|Overall Study|Death|0|||
128726831|NCT00414661|463297068|FG003|Overall Study|Death|0|||
128726832|NCT00414661|463297065|FG000|Overall Study|Lost to Follow-up|1|||
128726833|NCT00414661|463297066|FG001|Overall Study|Lost to Follow-up|4|||
128726834|NCT00414661|463297067|FG002|Overall Study|Lost to Follow-up|0|||
128726835|NCT00414661|463297068|FG003|Overall Study|Lost to Follow-up|1|||
128726836|NCT00414661|463297065|FG000|Overall Study|Withdrawal by Subject|5|||
128726837|NCT00414661|463297066|FG001|Overall Study|Withdrawal by Subject|2|||
128726838|NCT00414661|463297067|FG002|Overall Study|Withdrawal by Subject|2|||
128726839|NCT00414661|463297068|FG003|Overall Study|Withdrawal by Subject|2|||
128726840|NCT00414661|463297065|FG000|Overall Study|Other|6|||
128726841|NCT00414661|463297066|FG001|Overall Study|Other|3|||
128726842|NCT00414661|463297067|FG002|Overall Study|Other|0|||
128726843|NCT00414661|463297068|FG003|Overall Study|Other|0|||
128726844|NCT00357370|463297069|FG000|Cohort 2|Lack of Efficacy|0|||
128726845|NCT00357370|463297070|FG001|Cohort 2|Lack of Efficacy|2|||
128726846|NCT00357370|463297071|FG002|Cohort 2|Lack of Efficacy|1|||
128726847|NCT00357370|463297069|FG000|Cohort 2|Adverse Event|1|||
128726848|NCT00357370|463297070|FG001|Cohort 2|Adverse Event|1|||
128726849|NCT00357370|463297071|FG002|Cohort 2|Adverse Event|1|||
128726850|NCT00357370|463297069|FG000|Cohort 2|Lost to Follow-up|0|||
128726851|NCT00357370|463297070|FG001|Cohort 2|Lost to Follow-up|1|||
128726852|NCT00357370|463297071|FG002|Cohort 2|Lost to Follow-up|0|||
128726853|NCT00357370|463297069|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
128726854|NCT00357370|463297070|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
128777313|NCT04562779|463473739|FG002|Overall Study|Lost to Follow-up|10|||
128777314|NCT04562779|463473737|FG000|Overall Study|Protocol Violation|2|||
129166026|NCT02027311|464899852|FG000|Overall Study|Protocol Violation|3|||
129166027|NCT02027311|464899853|FG001|Overall Study|Protocol Violation|2|||
129166028|NCT02466425|464899856|FG000|Overall Study|Adverse Event|3|||
128726855|NCT00357370|463297071|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
128777315|NCT04562779|463473738|FG001|Overall Study|Protocol Violation|2|||
128777316|NCT04562779|463473739|FG002|Overall Study|Protocol Violation|0|||
128726856|NCT00357370|463297069|FG000|Cohort 2|Withdrawal by Subject|0|||
128726857|NCT00357370|463297070|FG001|Cohort 2|Withdrawal by Subject|2|||
128726858|NCT00357370|463297071|FG002|Cohort 2|Withdrawal by Subject|0|||
128726859|NCT01232296|463297072|FG000|Overall Study|Adverse Event|24|||
128726860|NCT01232296|463297073|FG001|Overall Study|Adverse Event|12|||
128726861|NCT01232296|463297072|FG000|Overall Study|Physician Decision|1|||
128726862|NCT01232296|463297073|FG001|Overall Study|Physician Decision|1|||
129166029|NCT02466425|464899857|FG001|Overall Study|Adverse Event|11|||
128777317|NCT04630756|463473740|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
128777318|NCT04630756|463473741|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
128777319|NCT04630756|463473742|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
128777320|NCT05593211|463473743|FG000|Overall Study|Withdrawal by Subject|1|||
128777321|NCT03077620|463473744|FG000|Overall Study|Unable to place lumbar catheter|1|||
128777322|NCT03077620|463473745|FG001|Overall Study|Unable to place lumbar catheter|0|||
128777323|NCT03077620|463473746|FG002|Overall Study|Unable to place lumbar catheter|1|||
128777324|NCT03077620|463473747|FG003|Overall Study|Unable to place lumbar catheter|0|||
128777325|NCT03077620|463473744|FG000|Overall Study|Withdrawal by Subject|0|||
128777326|NCT03077620|463473745|FG001|Overall Study|Withdrawal by Subject|1|||
128777327|NCT03077620|463473746|FG002|Overall Study|Withdrawal by Subject|0|||
128777328|NCT03077620|463473747|FG003|Overall Study|Withdrawal by Subject|0|||
128777329|NCT03077620|463473744|FG000|Overall Study|Physician Decision|0|||
129166030|NCT02466425|464899856|FG000|Overall Study|Lack of Efficacy|4|||
128777330|NCT03077620|463473745|FG001|Overall Study|Physician Decision|0|||
128777331|NCT03077620|463473746|FG002|Overall Study|Physician Decision|1|||
128777332|NCT03077620|463473747|FG003|Overall Study|Physician Decision|0|||
128777333|NCT03225846|463473748|FG000|Overall Study|Adverse Event|0|||
128777334|NCT03225846|463473749|FG001|Overall Study|Adverse Event|0|||
128777335|NCT03225846|463473750|FG002|Overall Study|Adverse Event|0|||
128777336|NCT03225846|463473751|FG003|Overall Study|Adverse Event|0|||
128777337|NCT03225846|463473752|FG004|Overall Study|Adverse Event|0|||
128777338|NCT03225846|463473753|FG005|Overall Study|Adverse Event|0|||
128777339|NCT03225846|463473754|FG006|Overall Study|Adverse Event|6|||
128777340|NCT03225846|463473748|FG000|Overall Study|Withdrawal by Subject|0|||
128777341|NCT03225846|463473749|FG001|Overall Study|Withdrawal by Subject|1|||
128777342|NCT03225846|463473750|FG002|Overall Study|Withdrawal by Subject|0|||
128777343|NCT03225846|463473751|FG003|Overall Study|Withdrawal by Subject|0|||
128777344|NCT03225846|463473752|FG004|Overall Study|Withdrawal by Subject|0|||
128777345|NCT03225846|463473753|FG005|Overall Study|Withdrawal by Subject|0|||
128777346|NCT03225846|463473754|FG006|Overall Study|Withdrawal by Subject|0|||
128777347|NCT03225846|463473748|FG000|Overall Study|Death|0|||
128777348|NCT03225846|463473749|FG001|Overall Study|Death|1|||
128777349|NCT03225846|463473750|FG002|Overall Study|Death|0|||
128777350|NCT03225846|463473751|FG003|Overall Study|Death|0|||
128777351|NCT03225846|463473752|FG004|Overall Study|Death|0|||
128777352|NCT03225846|463473753|FG005|Overall Study|Death|0|||
128777353|NCT03225846|463473754|FG006|Overall Study|Death|0|||
128777354|NCT03225846|463473748|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
128777355|NCT03225846|463473749|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
128777356|NCT03225846|463473750|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
128777357|NCT03225846|463473751|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
128777358|NCT03225846|463473752|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
128777359|NCT03225846|463473753|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
128777360|NCT03225846|463473754|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
128777361|NCT03225846|463473748|FG000|Overall Study|Patient decision|0|||
128777362|NCT03225846|463473749|FG001|Overall Study|Patient decision|0|||
128777363|NCT03225846|463473750|FG002|Overall Study|Patient decision|0|||
128777364|NCT03225846|463473751|FG003|Overall Study|Patient decision|0|||
128777365|NCT03225846|463473752|FG004|Overall Study|Patient decision|0|||
128777366|NCT03225846|463473753|FG005|Overall Study|Patient decision|0|||
128777367|NCT03225846|463473754|FG006|Overall Study|Patient decision|1|||
128777368|NCT00996580|463473755|FG000|Overall Study|Adverse Event|466|||
128777369|NCT00996580|463473755|FG000|Overall Study|Lost to Follow-up|480|||
128777370|NCT00996580|463473755|FG000|Overall Study|Noncompliance with the protocol|137|||
128777371|NCT00996580|463473755|FG000|Overall Study|Physician Decision|5|||
128777372|NCT00996580|463473755|FG000|Overall Study|Pregnancy|68|||
128777373|NCT00996580|463473755|FG000|Overall Study|Protocol Violation|16|||
128777374|NCT00996580|463473755|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
128777375|NCT00996580|463473755|FG000|Overall Study|Withdrawal by Subject|217|||
128777376|NCT00996580|463473755|FG000|Overall Study|Other|29|||
129166031|NCT02466425|464899857|FG001|Overall Study|Lack of Efficacy|1|||
128777377|NCT05708846|463473756|FG000|Overall Study|Death|5|||
128777378|NCT05708846|463473756|FG000|Overall Study|Withdrawal by Subject|20|||
129166032|NCT02466425|464899856|FG000|Overall Study|Lost to Follow-up|3|||
129166033|NCT02466425|464899857|FG001|Overall Study|Lost to Follow-up|0|||
128777379|NCT02036515|463473757|FG000|Overall Study|Adverse Event|1|||
128777380|NCT02036515|463473758|FG001|Overall Study|Adverse Event|1|||
128777381|NCT02036515|463473759|FG002|Overall Study|Adverse Event|2|||
128777382|NCT02036515|463473757|FG000|Overall Study|Lost to Follow-up|0|||
128777383|NCT02036515|463473758|FG001|Overall Study|Lost to Follow-up|2|||
128777384|NCT02036515|463473759|FG002|Overall Study|Lost to Follow-up|0|||
128777385|NCT02036515|463473757|FG000|Overall Study|Non-compliance with study drug|0|||
128777386|NCT02036515|463473758|FG001|Overall Study|Non-compliance with study drug|0|||
128777387|NCT02036515|463473759|FG002|Overall Study|Non-compliance with study drug|2|||
128777388|NCT02036515|463473757|FG000|Overall Study|Screen failure|0|||
129166034|NCT02466425|464899856|FG000|Overall Study|Protocol Violation|1|||
129166035|NCT02466425|464899857|FG001|Overall Study|Protocol Violation|0|||
129166036|NCT02466425|464899856|FG000|Overall Study|Withdrawal by Subject|0|||
129166037|NCT02466425|464899857|FG001|Overall Study|Withdrawal by Subject|1|||
129166038|NCT02466425|464899856|FG000|Overall Study|Other|1|||
129166039|NCT02466425|464899857|FG001|Overall Study|Other|3|||
129166040|NCT02466425|464899856|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129166041|NCT02466425|464899857|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129166042|NCT01721486|464899862|FG000|Overall Study|Protocol Violation|1|||
129166043|NCT01721486|464899863|FG001|Overall Study|Protocol Violation|0|||
129166044|NCT01721486|464899862|FG000|Overall Study|Physician Decision|0|||
129166045|NCT01721486|464899863|FG001|Overall Study|Physician Decision|1|||
129166046|NCT00582712|464899864|FG000|Overall Study|Adverse Event|1|||
129166047|NCT00582712|464899864|FG000|Overall Study|Lack of Efficacy|1|||
129166048|NCT00582712|464899864|FG000|Overall Study|Withdrawal by Subject|1|||
129166049|NCT00582712|464899864|FG000|Overall Study|Complicating disease requiring treatment|1|||
129166050|NCT01901289|464899866|FG000|Overall Study|Death|32|||
129166051|NCT01901289|464899866|FG000|Overall Study|Lost to Follow-up|16|||
129166052|NCT01901289|464899866|FG000|Overall Study|Withdrawal by Subject|35|||
129166053|NCT01901289|464899866|FG000|Overall Study|Other type of endpoint met|2|||
129166054|NCT01813058|464899867|FG000|Overall Study|Withdrawal by Subject|5|||
129166055|NCT01813058|464899868|FG001|Overall Study|Withdrawal by Subject|4|||
129166056|NCT03028415|464899880|FG000|Overall Study|Lost to Follow-up|6|||
129166057|NCT03028415|464899881|FG001|Overall Study|Lost to Follow-up|3|||
129166058|NCT03028415|464899880|FG000|Overall Study|Withdrawal by Subject|1|||
128726863|NCT01232296|463297072|FG000|Overall Study|Progressive disease|43|||
128726864|NCT01232296|463297073|FG001|Overall Study|Progressive disease|61|||
128726865|NCT01232296|463297072|FG000|Overall Study|Study terminated by sponsor|0|||
128726866|NCT01232296|463297073|FG001|Overall Study|Study terminated by sponsor|1|||
128726867|NCT01232296|463297072|FG000|Overall Study|Technical problems|3|||
128726868|NCT01232296|463297073|FG001|Overall Study|Technical problems|0|||
128726869|NCT01232296|463297072|FG000|Overall Study|Subject/guardian decision|10|||
128726870|NCT01232296|463297073|FG001|Overall Study|Subject/guardian decision|2|||
128726871|NCT01232296|463297072|FG000|Overall Study|Death|1|||
128726872|NCT01232296|463297073|FG001|Overall Study|Death|6|||
129166059|NCT03028415|464899881|FG001|Overall Study|Withdrawal by Subject|0|||
129166060|NCT03028415|464899880|FG000|Overall Study|Discontinued due to COVID-19|1|||
129166061|NCT03028415|464899881|FG001|Overall Study|Discontinued due to COVID-19|0|||
129166062|NCT02907216|464899882|FG000|Overall Study|No benefit to be obtained by continuing|0|||
129166063|NCT02907216|464899883|FG001|Overall Study|No benefit to be obtained by continuing|1|||
129166064|NCT02907216|464899882|FG000|Overall Study|Withdrawal by Subject|1|||
129166065|NCT02907216|464899883|FG001|Overall Study|Withdrawal by Subject|0|||
129166066|NCT02241733|464899886|FG000|Overall Study|Lost to Follow-up|9|||
129166067|NCT02241733|464899887|FG001|Overall Study|Lost to Follow-up|4|||
129166068|NCT02241733|464899886|FG000|Overall Study|Physician Decision|6|||
129166069|NCT02241733|464899887|FG001|Overall Study|Physician Decision|2|||
129166070|NCT02241733|464899886|FG000|Overall Study|Withdrawal by Subject|0|||
129166071|NCT02241733|464899887|FG001|Overall Study|Withdrawal by Subject|2|||
129166072|NCT02241733|464899886|FG000|Overall Study|Death|0|||
129166073|NCT02241733|464899887|FG001|Overall Study|Death|2|||
129166074|NCT00792740|464899898|FG000|Overall Study|Disease Worsening|3|||
129166075|NCT00792740|464899899|FG001|Overall Study|Disease Worsening|2|||
129166076|NCT00792740|464899898|FG000|Overall Study|Personal Reason|1|||
129166077|NCT00792740|464899899|FG001|Overall Study|Personal Reason|0|||
129166078|NCT00792740|464899898|FG000|Overall Study|Adverse Event|1|||
129166079|NCT00792740|464899899|FG001|Overall Study|Adverse Event|3|||
129166080|NCT00792740|464899898|FG000|Overall Study|Patient's withdrawal of consent|0|||
129166081|NCT00792740|464899899|FG001|Overall Study|Patient's withdrawal of consent|1|||
128726873|NCT00937547|463297074|FG000|Overall Study|misdiagnosis|1|||
128726874|NCT00937547|463297075|FG001|Overall Study|misdiagnosis|6|||
129166082|NCT00792740|464899898|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
129166083|NCT00792740|464899899|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
129166084|NCT00792740|464899898|FG000|Overall Study|Other reasons|0|||
128726875|NCT00937547|463297076|FG002|Overall Study|misdiagnosis|7|||
128726876|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
128777389|NCT02036515|463473758|FG001|Overall Study|Screen failure|2|||
128777390|NCT02036515|463473759|FG002|Overall Study|Screen failure|0|||
128777391|NCT02036515|463473757|FG000|Overall Study|Withdrawal by Subject|4|||
128777392|NCT02036515|463473758|FG001|Overall Study|Withdrawal by Subject|7|||
128777393|NCT02036515|463473759|FG002|Overall Study|Withdrawal by Subject|9|||
128777394|NCT02036515|463473757|FG000|Overall Study|Hyperglycemia|0|||
128777395|NCT02036515|463473758|FG001|Overall Study|Hyperglycemia|0|||
128777396|NCT02036515|463473759|FG002|Overall Study|Hyperglycemia|1|||
128777397|NCT00238420|463473760|FG000|Overall Study|Protocol Violation|1|||
128777398|NCT00238420|463473761|FG001|Overall Study|Protocol Violation|1|||
128777399|NCT00663962|463473762|FG000|Overall Study|somnolence|1|||
128777400|NCT00663962|463473763|FG001|Overall Study|somnolence|0|||
128777401|NCT04140890|463473764|FG000|Overall Study|Withdrawal by Subject|0|||
128777402|NCT04140890|463473765|FG001|Overall Study|Withdrawal by Subject|1|||
128777403|NCT02102464|463473766|FG000|Randomized Study|Withdrawal by Subject|0|||
128777404|NCT02102464|463473767|FG001|Randomized Study|Withdrawal by Subject|1|||
128777405|NCT02102464|463473768|FG002|Randomized Study|Withdrawal by Subject|0|||
128777406|NCT01700348|463473769|FG000|Overall Study|Withdrawal by Subject|22|||
128777407|NCT01700348|463473769|FG000|Overall Study|Lost to Follow-up|1|||
128777408|NCT03958630|463473770|FG000|Overall Study|Withdrawal by Subject|0|||
128777409|NCT03958630|463473771|FG001|Overall Study|Withdrawal by Subject|0|||
128777410|NCT03958630|463473772|FG002|Overall Study|Withdrawal by Subject|1|||
128777411|NCT03958630|463473770|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
128777412|NCT03958630|463473771|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
128777413|NCT03958630|463473772|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
128777414|NCT01824472|463473777|FG000|Overall Study|Lost to Follow-up|0|||
128777415|NCT01824472|463473778|FG001|Overall Study|Lost to Follow-up|0|||
128777416|NCT01824472|463473779|FG002|Overall Study|Lost to Follow-up|1|||
128777417|NCT01824472|463473777|FG000|Overall Study|Withdrawal by Subject|1|||
128777418|NCT01824472|463473778|FG001|Overall Study|Withdrawal by Subject|5|||
128777419|NCT01824472|463473779|FG002|Overall Study|Withdrawal by Subject|3|||
128777420|NCT01824472|463473777|FG000|Overall Study|Ineligible post randomization&screening|0|||
128777421|NCT01824472|463473778|FG001|Overall Study|Ineligible post randomization&screening|2|||
128777422|NCT01824472|463473779|FG002|Overall Study|Ineligible post randomization&screening|0|||
128777423|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
128777424|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
128777425|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
128777426|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
128777427|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
128777428|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
128777429|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
128777430|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
128777431|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
128777432|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
128777433|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
128777434|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
128777435|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
128777436|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
128777437|NCT01815736|463473780|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
128777438|NCT01815736|463473781|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
128777439|NCT01815736|463473780|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
128777440|NCT01815736|463473781|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
128777441|NCT01815736|463473780|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
129166085|NCT00792740|464899899|FG001|Overall Study|Other reasons|1|||
129166086|NCT01063062|464899900|FG000|Overall Study|Patient withdrew consent|0|||
129166087|NCT01063062|464899901|FG001|Overall Study|Patient withdrew consent|1|||
129166088|NCT01063062|464899900|FG000|Overall Study|Adverse Event|2|||
129166089|NCT01063062|464899901|FG001|Overall Study|Adverse Event|4|||
129166090|NCT01063062|464899900|FG000|Overall Study|Protocol Violation|5|||
129166091|NCT01063062|464899901|FG001|Overall Study|Protocol Violation|4|||
129166092|NCT01063062|464899900|FG000|Overall Study|Investigator's request|1|||
129166093|NCT01063062|464899901|FG001|Overall Study|Investigator's request|0|||
129166094|NCT01063062|464899900|FG000|Overall Study|Lost to Follow-up|0|||
129166095|NCT01063062|464899901|FG001|Overall Study|Lost to Follow-up|2|||
128777442|NCT01815736|463473781|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
128777443|NCT01815736|463473780|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
128777444|NCT01815736|463473781|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
128777445|NCT01815736|463473780|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
128777446|NCT01815736|463473781|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
128777447|NCT01815736|463473780|FG000|Extension Treatment Phase- After Week 96|Death|1|||
128777448|NCT01815736|463473781|FG001|Extension Treatment Phase- After Week 96|Death|0|||
128726877|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
128726878|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
128726879|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
129166096|NCT01063062|464899900|FG000|Overall Study|Miscellaneous reason|0|||
129166097|NCT01063062|464899901|FG001|Overall Study|Miscellaneous reason|1|||
129166098|NCT00703846|464899904|FG000|Overall Study|Adverse Event|8|||
129166099|NCT00703846|464899904|FG000|Overall Study|Lost to Follow-up|55|||
129166100|NCT00703846|464899904|FG000|Overall Study|Lack of Efficacy|15|||
129166101|NCT00703846|464899904|FG000|Overall Study|Noncompliance with Study Treatment|2|||
129166102|NCT00703846|464899904|FG000|Overall Study|Withdrawal by Subject|40|||
129166103|NCT00703846|464899904|FG000|Overall Study|Death|1|||
129166104|NCT00703846|464899904|FG000|Overall Study|Other|14|||
129166105|NCT00703846|464899904|FG000|Overall Study|Did Not Receive Study Drug|2|||
129166106|NCT02597452|464899905|FG000|Overall Study|testing incomplete|30|||
129166107|NCT02566785|464899912|FG000|Overall Study|Lost to Follow-up|0|||
129166108|NCT02566785|464899913|FG001|Overall Study|Lost to Follow-up|2|||
129166109|NCT02566785|464899912|FG000|Overall Study|Worsening condition|1|||
129166110|NCT02566785|464899913|FG001|Overall Study|Worsening condition|1|||
129166111|NCT04621240|464899916|FG000|Overall Study|Withdrawal by Subject|36|||
129166112|NCT03206918|464899917|FG000|Overall Study|Death|11|||
129166113|NCT03206918|464899917|FG000|Overall Study|Withdrawal by Subject|5|||
129166114|NCT03206918|464899917|FG000|Overall Study|Study terminated by sponsor|12|||
129166115|NCT03206918|464899917|FG000|Overall Study|Lost to Follow-up|3|||
129166116|NCT03206918|464899917|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
129166117|NCT03823287|464899918|FG000|Overall Study|Withdrawal by Subject|25|||
129166118|NCT03823287|464899919|FG001|Overall Study|Withdrawal by Subject|17|||
129166119|NCT03823287|464899918|FG000|Overall Study|Death|13|||
129166120|NCT03823287|464899919|FG001|Overall Study|Death|7|||
129166121|NCT03823287|464899918|FG000|Overall Study|Lost to Follow-up|7|||
129166122|NCT03823287|464899919|FG001|Overall Study|Lost to Follow-up|8|||
129166123|NCT03823287|464899918|FG000|Overall Study|Adverse Event|6|||
129166124|NCT03823287|464899919|FG001|Overall Study|Adverse Event|8|||
129166125|NCT03823287|464899918|FG000|Overall Study|Physician Decision|5|||
129166126|NCT03823287|464899919|FG001|Overall Study|Physician Decision|2|||
129166127|NCT03823287|464899918|FG000|Overall Study|Lack of Efficacy|2|||
129166128|NCT03823287|464899919|FG001|Overall Study|Lack of Efficacy|0|||
129166129|NCT03823287|464899918|FG000|Overall Study|Other|2|||
129166130|NCT03823287|464899919|FG001|Overall Study|Other|4|||
129166131|NCT02954406|464901134|FG000|Overall Study|Adverse Event|0|||
129166132|NCT02954406|464901135|FG001|Overall Study|Adverse Event|1|||
129166133|NCT02954406|464901136|FG002|Overall Study|Adverse Event|0|||
129166134|NCT02954406|464901137|FG003|Overall Study|Adverse Event|0|||
129166135|NCT02954406|464901138|FG004|Overall Study|Adverse Event|1|||
129166136|NCT02954406|464901139|FG005|Overall Study|Adverse Event|0|||
129166137|NCT02954406|464901140|FG006|Overall Study|Adverse Event|0|||
129166138|NCT02954406|464901141|FG007|Overall Study|Adverse Event|0|||
129166139|NCT02954406|464901142|FG008|Overall Study|Adverse Event|1|||
129166140|NCT02954406|464901143|FG009|Overall Study|Adverse Event|1|||
129166141|NCT02954406|464901144|FG010|Overall Study|Adverse Event|0|||
129166142|NCT02954406|464901134|FG000|Overall Study|Progressive Disease|3|||
129166143|NCT02954406|464901135|FG001|Overall Study|Progressive Disease|4|||
129166144|NCT02954406|464901136|FG002|Overall Study|Progressive Disease|3|||
129166145|NCT02954406|464901137|FG003|Overall Study|Progressive Disease|4|||
129166146|NCT02954406|464901138|FG004|Overall Study|Progressive Disease|3|||
129166147|NCT02954406|464901139|FG005|Overall Study|Progressive Disease|3|||
129166148|NCT02954406|464901140|FG006|Overall Study|Progressive Disease|2|||
129166149|NCT02954406|464901141|FG007|Overall Study|Progressive Disease|2|||
129166150|NCT02954406|464901142|FG008|Overall Study|Progressive Disease|1|||
129166151|NCT02954406|464901143|FG009|Overall Study|Progressive Disease|1|||
129166152|NCT02954406|464901144|FG010|Overall Study|Progressive Disease|0|||
129166153|NCT02954406|464901134|FG000|Overall Study|Symptomatic Deterioration|0|||
129166154|NCT02954406|464901135|FG001|Overall Study|Symptomatic Deterioration|1|||
129166155|NCT02954406|464901136|FG002|Overall Study|Symptomatic Deterioration|0|||
129166156|NCT02954406|464901137|FG003|Overall Study|Symptomatic Deterioration|0|||
129166157|NCT02954406|464901138|FG004|Overall Study|Symptomatic Deterioration|0|||
129166158|NCT02954406|464901139|FG005|Overall Study|Symptomatic Deterioration|0|||
129166159|NCT02954406|464901140|FG006|Overall Study|Symptomatic Deterioration|0|||
129166160|NCT02954406|464901141|FG007|Overall Study|Symptomatic Deterioration|0|||
128726880|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
129166161|NCT02954406|464901142|FG008|Overall Study|Symptomatic Deterioration|0|||
128726881|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
129166162|NCT02954406|464901143|FG009|Overall Study|Symptomatic Deterioration|0|||
129166163|NCT02954406|464901144|FG010|Overall Study|Symptomatic Deterioration|0|||
129166164|NCT02954406|464901134|FG000|Overall Study|Death|0|||
129166165|NCT02954406|464901135|FG001|Overall Study|Death|0|||
129166166|NCT02954406|464901136|FG002|Overall Study|Death|0|||
129166167|NCT02954406|464901137|FG003|Overall Study|Death|0|||
129166168|NCT02954406|464901138|FG004|Overall Study|Death|1|||
129166169|NCT02954406|464901139|FG005|Overall Study|Death|0|||
129166170|NCT02954406|464901140|FG006|Overall Study|Death|0|||
129166171|NCT02954406|464901141|FG007|Overall Study|Death|0|||
129166172|NCT02954406|464901142|FG008|Overall Study|Death|1|||
129166173|NCT02954406|464901143|FG009|Overall Study|Death|1|||
129166174|NCT02954406|464901144|FG010|Overall Study|Death|0|||
129166175|NCT02954406|464901134|FG000|Overall Study|Reason Not Specified|0|||
129166176|NCT02954406|464901135|FG001|Overall Study|Reason Not Specified|0|||
129166177|NCT02954406|464901136|FG002|Overall Study|Reason Not Specified|3|||
129166178|NCT02954406|464901137|FG003|Overall Study|Reason Not Specified|2|||
129166179|NCT02954406|464901138|FG004|Overall Study|Reason Not Specified|2|||
129166180|NCT02954406|464901139|FG005|Overall Study|Reason Not Specified|0|||
129166181|NCT02954406|464901140|FG006|Overall Study|Reason Not Specified|1|||
129166182|NCT02954406|464901141|FG007|Overall Study|Reason Not Specified|0|||
129166183|NCT02954406|464901142|FG008|Overall Study|Reason Not Specified|1|||
129166184|NCT02954406|464901143|FG009|Overall Study|Reason Not Specified|0|||
129166185|NCT02954406|464901144|FG010|Overall Study|Reason Not Specified|0|||
129166186|NCT00782171|464901145|FG000|Overall Study|Lost to Follow-up|2|||
129166187|NCT00782171|464901146|FG001|Overall Study|Lost to Follow-up|2|||
129166188|NCT00782171|464901145|FG000|Overall Study|Withdrawal by Subject|2|||
129166189|NCT00782171|464901146|FG001|Overall Study|Withdrawal by Subject|1|||
129166190|NCT00782171|464901145|FG000|Overall Study|complications|3|||
129166191|NCT00782171|464901146|FG001|Overall Study|complications|1|||
129166192|NCT00782171|464901145|FG000|Overall Study|others|7|||
129166193|NCT00782171|464901146|FG001|Overall Study|others|9|||
129166194|NCT00782171|464901145|FG000|Overall Study|not eligible|8|||
129166195|NCT00782171|464901146|FG001|Overall Study|not eligible|6|||
129166196|NCT04075292|464901152|FG000|Overall Study|Withdrawal by Subject|1|||
129166197|NCT04075292|464901153|FG001|Overall Study|Withdrawal by Subject|9|||
129166198|NCT04075292|464901152|FG000|Overall Study|Death|2|||
129166199|NCT04075292|464901153|FG001|Overall Study|Death|5|||
129166200|NCT04075292|464901152|FG000|Overall Study|Remained on study at time of DCO|74|||
129166201|NCT04075292|464901153|FG001|Overall Study|Remained on study at time of DCO|64|||
129166202|NCT04308239|464901154|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
129166203|NCT04308239|464901155|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
129166204|NCT04308239|464901154|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
129166205|NCT04308239|464901155|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
129166206|NCT04308239|464901154|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
129166207|NCT04308239|464901155|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
129166208|NCT04308239|464901154|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
129166209|NCT04308239|464901155|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
129166210|NCT01443364|464901156|FG000|Overall Study|Lack of Efficacy|14|||
129166211|NCT01443364|464901156|FG000|Overall Study|Lost to Follow-up|3|||
129166212|NCT01443364|464901156|FG000|Overall Study|Withdrawal by Subject|5|||
129166213|NCT01443364|464901156|FG000|Overall Study|Other Reason|4|||
129166214|NCT01443364|464901156|FG000|Overall Study|SAE, non-fatal|6|||
129166215|NCT01443364|464901156|FG000|Overall Study|AE, non-serious non-fatal|8|||
129166216|NCT01443364|464901156|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129166217|NCT00559845|464901159|FG000|Overall Study|Withdrew Consent|1|||
129166218|NCT00559845|464901159|FG000|Overall Study|Disease Progression|1|||
129166219|NCT00559845|464901159|FG000|Overall Study|Adverse Event|3|||
129166220|NCT00559845|464901159|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
129166221|NCT00559845|464901159|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
129166222|NCT03367403|464901162|FG000|Overall Study|Adverse Event|20|||
129166223|NCT03367403|464901163|FG001|Overall Study|Adverse Event|6|||
129166224|NCT03367403|464901164|FG002|Overall Study|Adverse Event|2|||
129166225|NCT03367403|464901162|FG000|Overall Study|Withdrawal by Subject|12|||
129166226|NCT03367403|464901163|FG001|Overall Study|Withdrawal by Subject|13|||
129166227|NCT03367403|464901164|FG002|Overall Study|Withdrawal by Subject|1|||
129166228|NCT03367403|464901162|FG000|Overall Study|Death|1|||
129166229|NCT03367403|464901163|FG001|Overall Study|Death|2|||
129166230|NCT03367403|464901164|FG002|Overall Study|Death|0|||
129166231|NCT03367403|464901162|FG000|Overall Study|Physician Decision|0|||
129166232|NCT03367403|464901163|FG001|Overall Study|Physician Decision|1|||
129166233|NCT03367403|464901164|FG002|Overall Study|Physician Decision|0|||
129166234|NCT03367403|464901162|FG000|Overall Study|Protocol Violation|1|||
129166235|NCT03367403|464901163|FG001|Overall Study|Protocol Violation|1|||
129166236|NCT03367403|464901164|FG002|Overall Study|Protocol Violation|0|||
129166237|NCT03367403|464901162|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
129166238|NCT03367403|464901163|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
129166239|NCT03367403|464901164|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
129166240|NCT03367403|464901162|FG000|Overall Study|COVID-19|3|||
129166241|NCT03367403|464901163|FG001|Overall Study|COVID-19|6|||
128726882|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
129166242|NCT03367403|464901164|FG002|Overall Study|COVID-19|0|||
129166243|NCT03367403|464901162|FG000|Overall Study|Abuse of Alcohol Intake|0|||
129166244|NCT03367403|464901163|FG001|Overall Study|Abuse of Alcohol Intake|1|||
128726883|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
129166245|NCT03367403|464901164|FG002|Overall Study|Abuse of Alcohol Intake|0|||
129166246|NCT03367403|464901162|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
129166247|NCT03367403|464901163|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
129166248|NCT03367403|464901164|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
129166249|NCT00194077|464901165|FG000|Overall Study|Lack of Efficacy|22|||
129166250|NCT00194077|464901166|FG001|Overall Study|Lack of Efficacy|29|||
129166251|NCT00194077|464901165|FG000|Overall Study|Study nonadherence|1|||
129166252|NCT00194077|464901166|FG001|Overall Study|Study nonadherence|0|||
129166253|NCT00194077|464901165|FG000|Overall Study|Withdrawal by Subject|1|||
129166254|NCT00194077|464901166|FG001|Overall Study|Withdrawal by Subject|1|||
129166255|NCT03470194|464901169|FG000|Overall Study|Lost to Follow-up|11|||
129166256|NCT03470194|464901170|FG001|Overall Study|Lost to Follow-up|17|||
129166257|NCT03286543|464901171|FG000|Consented|Screen failure before randomization|2|||
129166258|NCT03286543|464901172|FG001|Consented|Screen failure before randomization|0|||
129166259|NCT03286543|464901173|FG002|Consented|Screen failure before randomization|0|||
129166260|NCT03286543|464901171|FG000|Consented|Screen failure before enrollment|4|||
129166261|NCT03286543|464901172|FG001|Consented|Screen failure before enrollment|0|||
129166262|NCT03286543|464901173|FG002|Consented|Screen failure before enrollment|0|||
129166263|NCT03286543|464901171|FG000|Consented|TKA cancelled after enrollment|1|||
129166264|NCT03286543|464901172|FG001|Consented|TKA cancelled after enrollment|0|||
129166265|NCT03286543|464901173|FG002|Consented|TKA cancelled after enrollment|0|||
129166266|NCT03286543|464901171|FG000|Consented|Withdrawn from study|12|||
129166267|NCT03286543|464901172|FG001|Consented|Withdrawn from study|0|||
129166268|NCT03286543|464901173|FG002|Consented|Withdrawn from study|0|||
129166269|NCT03286543|464901171|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
129166270|NCT03286543|464901172|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
129166271|NCT03286543|464901173|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
129166272|NCT03286543|464901171|FG000|Study Enrollment|Withdrawn from study|0|||
129166273|NCT03286543|464901172|FG001|Study Enrollment|Withdrawn from study|6|||
129166274|NCT03286543|464901173|FG002|Study Enrollment|Withdrawn from study|6|||
129166275|NCT01822899|464901174|FG000|Overall Study|Adverse Event|6|||
129166276|NCT01822899|464901175|FG001|Overall Study|Adverse Event|5|||
129166277|NCT01822899|464901174|FG000|Overall Study|Lack of Efficacy|6|||
129166278|NCT01822899|464901175|FG001|Overall Study|Lack of Efficacy|3|||
129166279|NCT01822899|464901174|FG000|Overall Study|Protocol Violation|6|||
129166280|NCT01822899|464901175|FG001|Overall Study|Protocol Violation|3|||
129166281|NCT01822899|464901174|FG000|Overall Study|Lost to Follow-up|1|||
129166282|NCT01822899|464901175|FG001|Overall Study|Lost to Follow-up|0|||
129166283|NCT01822899|464901174|FG000|Overall Study|Withdrawal by Subject|5|||
129166284|NCT01822899|464901175|FG001|Overall Study|Withdrawal by Subject|7|||
129166285|NCT05332392|464901176|FG000|Overall Study|Did not meet inclusion criteria|25|||
129166286|NCT05332392|464901176|FG000|Overall Study|Principal Investigator's decision|17|||
129166287|NCT05332392|464901176|FG000|Overall Study|Adverse Event|1|||
129166288|NCT05332392|464901176|FG000|Overall Study|Subject's decision|1|||
129166289|NCT00759876|464901180|FG000|Overall Study|Sponsor terminated study early|36|||
129166290|NCT03636893|464901181|FG000|Overall Study|Death|0|||
129166291|NCT03636893|464901182|FG001|Overall Study|Death|1|||
129166292|NCT03636893|464901181|FG000|Overall Study|Protocol Violation|0|||
129166293|NCT03636893|464901182|FG001|Overall Study|Protocol Violation|3|||
129166294|NCT03636893|464901181|FG000|Overall Study|Withdrawal by Subject|1|||
129166295|NCT03636893|464901182|FG001|Overall Study|Withdrawal by Subject|2|||
129166296|NCT03636893|464901181|FG000|Overall Study|Refusal to surgery|4|||
129166297|NCT03636893|464901182|FG001|Overall Study|Refusal to surgery|3|||
129166298|NCT03636893|464901181|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
129166299|NCT03636893|464901182|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
129166300|NCT03636893|464901181|FG000|Overall Study|Adverse Event|1|||
129166301|NCT03636893|464901182|FG001|Overall Study|Adverse Event|1|||
129166302|NCT00758069|464901183|FG000|Overall Study|Lack of Efficacy|0|||
129166303|NCT00758069|464901184|FG001|Overall Study|Lack of Efficacy|0|||
129166304|NCT00758069|464901185|FG002|Overall Study|Lack of Efficacy|1|||
129166305|NCT00758069|464901183|FG000|Overall Study|Incorrect Study Drug|1|||
129166306|NCT00758069|464901184|FG001|Overall Study|Incorrect Study Drug|0|||
129166307|NCT00758069|464901185|FG002|Overall Study|Incorrect Study Drug|0|||
129166308|NCT03818607|464901187|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
129166309|NCT03818607|464901188|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
129166310|NCT03818607|464901187|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
129166311|NCT03818607|464901188|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
129166312|NCT03818607|464901187|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
129166313|NCT03818607|464901188|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
129166314|NCT00588237|464901189|FG000|Overall Study|Evaluable for toxicity only|3|||
129166315|NCT00588237|464901189|FG000|Overall Study|Patien not treated|1|||
129166316|NCT05059301|464901190|FG000|Overall Study|Adverse Event|0|||
129166317|NCT05059301|464901191|FG001|Overall Study|Adverse Event|2|||
129166318|NCT05059301|464901192|FG002|Overall Study|Adverse Event|2|||
129166319|NCT05059301|464901190|FG000|Overall Study|Lost to Follow-up|2|||
129166320|NCT05059301|464901191|FG001|Overall Study|Lost to Follow-up|3|||
128726884|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
128726885|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
128726886|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
128726887|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
129166321|NCT05059301|464901192|FG002|Overall Study|Lost to Follow-up|3|||
129166322|NCT01164891|464901196|FG000|Overall Study|Disease Progression|5|||
129166323|NCT01164891|464901196|FG000|Overall Study|Adverse Event|1|||
129166324|NCT00606034|464901199|FG000|Overall Study|incarceration|1|||
128726888|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
128726889|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
128726890|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
128726891|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
128726892|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
128726893|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
128726894|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Death|0|||
128726895|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Death|0|||
128726896|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Death|1|||
128726897|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Death|0|||
128726898|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Death|0|||
128726899|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Death|0|||
128726900|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Death|0|||
128726901|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Death|0|||
128726902|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Death|0|||
128726903|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
128726904|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
128726905|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
128726906|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
128726907|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
128726908|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
128726909|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
128726910|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
128726911|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
128726912|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
128726913|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
128726914|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
129166325|NCT01126268|464901202|FG000|Overall Study|Adverse Event|1|||
129166326|NCT01988662|464901203|FG000|Overall Study|Subject/guardian decision|1|||
129166327|NCT01988662|464901204|FG001|Overall Study|Subject/guardian decision|1|||
129166328|NCT01988662|464901203|FG000|Overall Study|Adverse Event|3|||
129166329|NCT01988662|464901204|FG001|Overall Study|Adverse Event|1|||
129166330|NCT00842153|464901208|FG000|Overall Study|Adverse Event|0|||
129166331|NCT00842153|464901209|FG001|Overall Study|Adverse Event|1|||
129166332|NCT00842153|464901208|FG000|Overall Study|Lost to Follow-up|1|||
129166333|NCT00842153|464901209|FG001|Overall Study|Lost to Follow-up|2|||
129166334|NCT00002540|464901210|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
129166335|NCT00002540|464901211|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
129166336|NCT00002540|464901210|FG000|Overall Study|Died Before Randomization|2|||
129166337|NCT00002540|464901211|FG001|Overall Study|Died Before Randomization|6|||
129166338|NCT00002540|464901210|FG000|Overall Study|Died Before ASU (Control)|202|||
129166339|NCT00002540|464901211|FG001|Overall Study|Died Before ASU (Control)|0|||
129166340|NCT00002540|464901210|FG000|Overall Study|Refused ASU (Control)|597|||
129166341|NCT00002540|464901211|FG001|Overall Study|Refused ASU (Control)|0|||
129166342|NCT00002540|464901210|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
129166343|NCT00002540|464901211|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
129166344|NCT05312697|464901212|FG000|Overall Study|Sponsor Terminated Trial|2|||
129166345|NCT04445519|464901213|FG000|Overall Study|Due to adaptive design|3|||
129166346|NCT04445519|464901214|FG001|Overall Study|Due to adaptive design|0|||
128726915|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
128777449|NCT03040687|463473783|FG000|Overall Study|Withdrawal by Subject|1|||
129166347|NCT04445519|464901215|FG002|Overall Study|Due to adaptive design|0|||
129166348|NCT04445519|464901213|FG000|Overall Study|Lost to Follow-up|0|||
129166349|NCT04445519|464901214|FG001|Overall Study|Lost to Follow-up|1|||
128726916|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
128726917|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
128726918|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129166350|NCT04445519|464901215|FG002|Overall Study|Lost to Follow-up|4|||
129166351|NCT04445519|464901213|FG000|Overall Study|Sponsor or IRB Decision|0|||
129166352|NCT04445519|464901214|FG001|Overall Study|Sponsor or IRB Decision|1|||
129166353|NCT04445519|464901215|FG002|Overall Study|Sponsor or IRB Decision|2|||
129166354|NCT04445519|464901213|FG000|Overall Study|Withdrawal by Subject|0|||
129166355|NCT04445519|464901214|FG001|Overall Study|Withdrawal by Subject|3|||
129166356|NCT04445519|464901215|FG002|Overall Study|Withdrawal by Subject|3|||
129166357|NCT04445519|464901213|FG000|Overall Study|Adverse Event|0|||
129166358|NCT04445519|464901214|FG001|Overall Study|Adverse Event|8|||
129166359|NCT04445519|464901215|FG002|Overall Study|Adverse Event|6|||
129166360|NCT04445519|464901213|FG000|Overall Study|Other Reason|0|||
129166361|NCT04445519|464901214|FG001|Overall Study|Other Reason|1|||
129166362|NCT04445519|464901215|FG002|Overall Study|Other Reason|1|||
129166363|NCT04445519|464901213|FG000|Overall Study|Protocol Violation|0|||
129166364|NCT04445519|464901214|FG001|Overall Study|Protocol Violation|0|||
129166365|NCT04445519|464901215|FG002|Overall Study|Protocol Violation|1|||
129166366|NCT01345929|464901216|FG000|Overall Study|Withdrawal by Subject|9|||
129166367|NCT01345929|464901217|FG001|Overall Study|Withdrawal by Subject|8|||
129166368|NCT01345929|464901216|FG000|Overall Study|Lost to Follow-up|9|||
129166369|NCT01345929|464901217|FG001|Overall Study|Lost to Follow-up|9|||
129166370|NCT01345929|464901216|FG000|Overall Study|Adverse Event|0|||
129166371|NCT01345929|464901217|FG001|Overall Study|Adverse Event|1|||
129166372|NCT01345929|464901216|FG000|Overall Study|Didn't meet eligibility criteria|2|||
129166373|NCT01345929|464901217|FG001|Overall Study|Didn't meet eligibility criteria|0|||
129166374|NCT01345929|464901216|FG000|Overall Study|40,000 CFU/ML|1|||
129166375|NCT01345929|464901217|FG001|Overall Study|40,000 CFU/ML|0|||
129166376|NCT01345929|464901216|FG000|Overall Study|Patient withdrawal|0|||
129166377|NCT01345929|464901217|FG001|Overall Study|Patient withdrawal|1|||
129166378|NCT02151903|464901218|FG000|Overall Study|Withdrawal by Subject|1|||
129166379|NCT02151903|464901219|FG001|Overall Study|Withdrawal by Subject|0|||
129166380|NCT02151903|464901218|FG000|Overall Study|Progressive disease|2|||
129166381|NCT02151903|464901219|FG001|Overall Study|Progressive disease|1|||
129166382|NCT05141175|464901220|FG000|Overall Study|Withdrawal by Subject|1|||
129166383|NCT00395486|464901221|FG000|Overall Study|Adverse Event|1|||
129166384|NCT00395486|464901222|FG001|Overall Study|Adverse Event|2|||
129166385|NCT00395486|464901221|FG000|Overall Study|Withdrawal by Subject|5|||
129166386|NCT00395486|464901222|FG001|Overall Study|Withdrawal by Subject|2|||
129166387|NCT00395486|464901221|FG000|Overall Study|Lost to Follow-up|0|||
129166388|NCT00395486|464901222|FG001|Overall Study|Lost to Follow-up|1|||
129166389|NCT00361231|464901227|FG000|Overall Study|Physician Decision|3|||
129166390|NCT00361231|464901227|FG000|Overall Study|Symptomatic deterioration|5|||
129166391|NCT00361231|464901227|FG000|Overall Study|Radiographic disease progression|16|||
129166392|NCT00361231|464901227|FG000|Overall Study|Withdrawal by Subject|4|||
129166393|NCT00361231|464901227|FG000|Overall Study|Adverse Event|6|||
129166394|NCT01814397|464901230|FG000|Overall Study|Adverse Event|7|||
129166395|NCT01814397|464901230|FG000|Overall Study|Withdrawal by Subject|7|||
129166396|NCT00313144|464901231|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
129166397|NCT00313144|464901231|FG000|Overall Study|Death|7|||
129166398|NCT00313144|464901231|FG000|Overall Study|Lost to Follow-up|5|||
129166399|NCT00313144|464901231|FG000|Overall Study|Withdrawal by Subject|4|||
129166400|NCT00313144|464901231|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
129166401|NCT00313144|464901231|FG000|Overall Study|Physician Decision|4|||
129166402|NCT00313144|464901231|FG000|Overall Study|Adverse event - transient|5|||
129166403|NCT00313144|464901231|FG000|Overall Study|Liver transplant|1|||
129166404|NCT00313144|464901231|FG000|Overall Study|Insurance (homecare provider) change|1|||
129166405|NCT00313144|464901231|FG000|Overall Study|Change to different product|1|||
129166406|NCT00313144|464901231|FG000|Overall Study|Due to termination of the study|66|||
129166407|NCT01932372|464901234|FG000|Overall Study|Not meeting eligibility criteria|33|||
129166408|NCT01932372|464901235|FG001|Overall Study|Not meeting eligibility criteria|179|||
129166409|NCT01917929|464901236|FG000|Overall Study|Death|8|||
129166410|NCT01917929|464901236|FG000|Overall Study|Lost to Follow-up|19|||
129166411|NCT01917929|464901236|FG000|Overall Study|Withdrawal by Subject|33|||
129166412|NCT01917929|464901236|FG000|Overall Study|Adverse Event|6|||
129166413|NCT01917929|464901236|FG000|Overall Study|Investigative Site Terminated|35|||
129166414|NCT01917929|464901236|FG000|Overall Study|Censored because study device not implanted|6|||
129166415|NCT01917929|464901236|FG000|Overall Study|Censored because surgery not performed|3|||
129166416|NCT01917929|464901236|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
129166417|NCT01917929|464901236|FG000|Overall Study|Sponsor terminated study|175|||
129166418|NCT03100539|464902939|FG000|Overall Study|Lost to Follow-up|60|||
129166419|NCT03100539|464902940|FG001|Overall Study|Lost to Follow-up|54|||
129166420|NCT03100539|464902941|FG002|Overall Study|Lost to Follow-up|17|||
129166421|NCT03100539|464902939|FG000|Overall Study|Uncollected|8|||
129166422|NCT03100539|464902940|FG001|Overall Study|Uncollected|8|||
129166423|NCT03100539|464902941|FG002|Overall Study|Uncollected|0|||
129166424|NCT03100539|464902939|FG000|Overall Study|Ally Health|0|||
129166425|NCT03100539|464902940|FG001|Overall Study|Ally Health|0|||
129166426|NCT03100539|464902941|FG002|Overall Study|Ally Health|3|||
129166427|NCT03100539|464902939|FG000|Overall Study|Disinterest|0|||
129166428|NCT03100539|464902940|FG001|Overall Study|Disinterest|0|||
128777450|NCT03040687|463473784|FG001|Overall Study|Withdrawal by Subject|0|||
128777451|NCT03040687|463473785|FG002|Overall Study|Withdrawal by Subject|0|||
128777452|NCT00810641|463473786|FG000|Overall Study|Withdrawal by Subject|0|||
128777453|NCT00810641|463473787|FG001|Overall Study|Withdrawal by Subject|1|||
128777454|NCT00810641|463473788|FG002|Overall Study|Withdrawal by Subject|2|||
128777455|NCT01556243|463473789|FG000|Overall Study|Ineligible|34|||
128777456|NCT01556243|463473789|FG000|Overall Study|Converted to mastectomy|14|||
128777457|NCT01556243|463473789|FG000|Overall Study|Unable to achieve negative margins|2|||
128777458|NCT01556243|463473789|FG000|Overall Study|Withdrawal by Subject|16|||
128777459|NCT02325713|463473792|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777460|NCT02325713|463473793|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777461|NCT02325713|463473794|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777462|NCT02325713|463473795|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777463|NCT02325713|463473796|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777464|NCT02325713|463473797|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777465|NCT02325713|463473798|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777466|NCT02325713|463473799|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777467|NCT02325713|463473800|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777468|NCT02325713|463473801|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777469|NCT02325713|463473802|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
128777470|NCT02325713|463473803|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777471|NCT02325713|463473804|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777472|NCT02325713|463473805|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777473|NCT02325713|463473806|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777474|NCT02325713|463473807|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
128777475|NCT02325713|463473792|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
128777476|NCT02325713|463473793|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777477|NCT02325713|463473794|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777478|NCT02325713|463473795|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777479|NCT02325713|463473796|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777480|NCT02325713|463473797|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777481|NCT02325713|463473798|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777482|NCT02325713|463473799|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777483|NCT02325713|463473800|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777484|NCT02325713|463473801|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777485|NCT02325713|463473802|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777486|NCT02325713|463473803|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777487|NCT02325713|463473804|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777488|NCT02325713|463473805|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777489|NCT02325713|463473806|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777490|NCT02325713|463473807|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
128777491|NCT02325713|463473792|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777492|NCT02325713|463473793|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777493|NCT02325713|463473794|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777494|NCT02325713|463473795|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777495|NCT02325713|463473796|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777496|NCT02325713|463473797|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777497|NCT02325713|463473798|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777498|NCT02325713|463473799|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777499|NCT02325713|463473800|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777500|NCT02325713|463473801|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
128777501|NCT02325713|463473802|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777502|NCT02325713|463473803|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777503|NCT02325713|463473804|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777504|NCT02325713|463473805|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777505|NCT02325713|463473806|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777506|NCT02325713|463473807|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
128777507|NCT02684903|463473808|FG000|Overall Study|COVID-19 shutdown of lab|4|||
128777508|NCT02684903|463473809|FG001|Overall Study|COVID-19 shutdown of lab|6|||
128777509|NCT02684903|463473808|FG000|Overall Study|Lost to Follow-up|31|||
128777510|NCT02684903|463473809|FG001|Overall Study|Lost to Follow-up|41|||
129166429|NCT03100539|464902941|FG002|Overall Study|Disinterest|22|||
128777511|NCT01155726|463475229|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
128777512|NCT01155726|463475230|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
129166430|NCT03100539|464902939|FG000|Overall Study|Veteran Health|0|||
129166431|NCT03100539|464902940|FG001|Overall Study|Veteran Health|0|||
129166432|NCT03100539|464902941|FG002|Overall Study|Veteran Health|8|||
129166433|NCT03100539|464902939|FG000|Overall Study|Moved|0|||
129166434|NCT03100539|464902940|FG001|Overall Study|Moved|0|||
128777513|NCT01155726|463475231|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
128777514|NCT01155726|463475232|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
128777515|NCT02459587|463475233|FG000|3-Month Follow-up Assessment|Death|0|||
128777516|NCT02459587|463475234|FG001|3-Month Follow-up Assessment|Death|2|||
128777517|NCT02459587|463475233|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
128777518|NCT02459587|463475234|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
128777519|NCT02459587|463475233|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
128777520|NCT02459587|463475234|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
128777521|NCT02459587|463475233|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
128777522|NCT02459587|463475234|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
128777523|NCT02459587|463475233|FG000|6-month Follow-up Assessment|Death|2|||
128777524|NCT02459587|463475234|FG001|6-month Follow-up Assessment|Death|1|||
128777525|NCT02459587|463475233|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
128777526|NCT02459587|463475234|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
128777527|NCT02459587|463475233|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
128777528|NCT02459587|463475234|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
128777529|NCT02459587|463475233|FG000|12-month Follow-up Assessment|Death|2|||
128777530|NCT02459587|463475234|FG001|12-month Follow-up Assessment|Death|0|||
128777531|NCT02459587|463475233|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
128777532|NCT02459587|463475234|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
128777533|NCT02459587|463475233|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
128777534|NCT02459587|463475234|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
128777535|NCT02459587|463475233|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
128777536|NCT02459587|463475234|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
128777537|NCT01152554|463475235|FG000|Overall Study|Withdrawal by Subject|73|||
128777538|NCT01152554|463475236|FG001|Overall Study|Withdrawal by Subject|28|||
128777539|NCT01152554|463475235|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
128777540|NCT01152554|463475236|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
128777541|NCT01152554|463475235|FG000|Overall Study|Adverse Event|67|||
128777542|NCT01152554|463475236|FG001|Overall Study|Adverse Event|14|||
128777543|NCT01152554|463475235|FG000|Overall Study|Severe non-compliance to protocol|36|||
128777544|NCT01152554|463475236|FG001|Overall Study|Severe non-compliance to protocol|14|||
128777545|NCT01152554|463475235|FG000|Overall Study|Condition under investigation worsened|5|||
128777546|NCT01152554|463475236|FG001|Overall Study|Condition under investigation worsened|2|||
128777547|NCT01152554|463475235|FG000|Overall Study|Lack of Efficacy|20|||
128777548|NCT01152554|463475236|FG001|Overall Study|Lack of Efficacy|3|||
128777549|NCT01152554|463475235|FG000|Overall Study|Study-specific withdrawal criteria|17|||
128777550|NCT01152554|463475236|FG001|Overall Study|Study-specific withdrawal criteria|8|||
128777551|NCT01152554|463475235|FG000|Overall Study|Lost to Follow-up|87|||
128777552|NCT01152554|463475236|FG001|Overall Study|Lost to Follow-up|32|||
128777553|NCT01152554|463475235|FG000|Overall Study|Other|28|||
128777554|NCT01152554|463475236|FG001|Overall Study|Other|8|||
128777555|NCT01152554|463475235|FG000|Overall Study|Death|1|||
128777556|NCT01152554|463475236|FG001|Overall Study|Death|1|||
128777557|NCT02117544|463475237|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
128777558|NCT02117544|463475238|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
128777559|NCT00184028|463475239|FG000|Overall Study|Death|1|||
128777560|NCT00184028|463475239|FG000|Overall Study|Lack of Efficacy|4|||
128777561|NCT00184028|463475239|FG000|Overall Study|Adverse Event|2|||
128777562|NCT00184028|463475239|FG000|Overall Study|Withdrawal by Subject|1|||
128777563|NCT00184028|463475239|FG000|Overall Study|Non-compliance|2|||
128777564|NCT01354938|463475242|FG000|Overall Study|Lost to Follow-up|1|||
128777565|NCT02335268|463475243|FG000|Overall Study|Physician Decision|5|||
128777566|NCT02335268|463475244|FG001|Overall Study|Physician Decision|1|||
128777567|NCT02335268|463475243|FG000|Overall Study|Lack of Efficacy|2|||
128777568|NCT02335268|463475244|FG001|Overall Study|Lack of Efficacy|1|||
129166435|NCT03100539|464902941|FG002|Overall Study|Moved|1|||
129166436|NCT03100539|464902939|FG000|Overall Study|Scheduling Conflicts|0|||
129166437|NCT03100539|464902940|FG001|Overall Study|Scheduling Conflicts|0|||
128777569|NCT02335268|463475243|FG000|Overall Study|Adverse Event|5|||
128777570|NCT02335268|463475244|FG001|Overall Study|Adverse Event|2|||
128777571|NCT02335268|463475243|FG000|Overall Study|increase blasts|2|||
128777572|NCT02335268|463475244|FG001|Overall Study|increase blasts|0|||
128777573|NCT02335268|463475243|FG000|Overall Study|Withdrawal by Subject|3|||
128777574|NCT02335268|463475244|FG001|Overall Study|Withdrawal by Subject|2|||
128777575|NCT01192295|463475248|FG000|Overall Study|Adverse Event|3|||
128777576|NCT01192295|463475249|FG001|Overall Study|Adverse Event|7|||
128777577|NCT01192295|463475248|FG000|Overall Study|Withdrawal by Subject|3|||
128777578|NCT01192295|463475249|FG001|Overall Study|Withdrawal by Subject|4|||
128777579|NCT01192295|463475248|FG000|Overall Study|Lost to Follow-up|0|||
128777580|NCT01192295|463475249|FG001|Overall Study|Lost to Follow-up|1|||
128777581|NCT01192295|463475248|FG000|Overall Study|Lack of Efficacy|0|||
128777582|NCT01192295|463475249|FG001|Overall Study|Lack of Efficacy|5|||
128777583|NCT01192295|463475248|FG000|Overall Study|Administrative|4|||
128777584|NCT01192295|463475249|FG001|Overall Study|Administrative|6|||
128777585|NCT03785340|463475252|FG000|Overall Study|Lost to Follow-up|2|||
128777586|NCT03785340|463475253|FG001|Overall Study|Lost to Follow-up|0|||
128777587|NCT03785340|463475252|FG000|Overall Study|Adverse Event|1|||
128777588|NCT03785340|463475253|FG001|Overall Study|Adverse Event|0|||
128777589|NCT04320615|463475256|FG000|Overall Study|Withdrawal by Subject|4|||
128777590|NCT04320615|463475257|FG001|Overall Study|Withdrawal by Subject|10|||
128777591|NCT04320615|463475256|FG000|Overall Study|Physician Decision|2|||
128777592|NCT04320615|463475257|FG001|Overall Study|Physician Decision|0|||
128777593|NCT04320615|463475256|FG000|Overall Study|Other|2|||
128777594|NCT04320615|463475257|FG001|Overall Study|Other|0|||
128777595|NCT04320615|463475256|FG000|Overall Study|Lost to Follow-up|5|||
128777596|NCT04320615|463475257|FG001|Overall Study|Lost to Follow-up|23|||
129166438|NCT03100539|464902941|FG002|Overall Study|Scheduling Conflicts|12|||
129166439|NCT00809835|464902944|FG000|Overall Study|Lost to Follow-up|7|||
129166440|NCT00809835|464902945|FG001|Overall Study|Lost to Follow-up|6|||
129166441|NCT00809835|464902946|FG002|Overall Study|Lost to Follow-up|10|||
129166442|NCT00809835|464902947|FG003|Overall Study|Lost to Follow-up|2|||
129166443|NCT00809835|464902944|FG000|Overall Study|Withdrawal by Subject|1|||
129166444|NCT00809835|464902945|FG001|Overall Study|Withdrawal by Subject|1|||
129166445|NCT00809835|464902946|FG002|Overall Study|Withdrawal by Subject|1|||
129166446|NCT00809835|464902947|FG003|Overall Study|Withdrawal by Subject|0|||
129166447|NCT05659719|464902948|FG000|Overall Study|At sponsor's request|0|||
129166448|NCT05659719|464902949|FG001|Overall Study|At sponsor's request|0|||
129166449|NCT05659719|464902950|FG002|Overall Study|At sponsor's request|0|||
129166450|NCT05659719|464902951|FG003|Overall Study|At sponsor's request|95|||
129166451|NCT05659719|464902948|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
129166452|NCT05659719|464902949|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
129166453|NCT05659719|464902950|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
129166454|NCT05659719|464902951|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
129166455|NCT05659719|464902948|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
129166456|NCT05659719|464902949|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
129166457|NCT05659719|464902950|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
129166458|NCT05659719|464902951|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
129166459|NCT05659719|464902948|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
129166460|NCT05659719|464902949|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
129166461|NCT05659719|464902950|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
129166462|NCT05659719|464902951|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
129166463|NCT05659719|464902948|FG000|Overall Study|Lost to Follow-up|0|||
129166464|NCT05659719|464902949|FG001|Overall Study|Lost to Follow-up|0|||
129166465|NCT05659719|464902950|FG002|Overall Study|Lost to Follow-up|0|||
129166466|NCT05659719|464902951|FG003|Overall Study|Lost to Follow-up|2|||
129166467|NCT05659719|464902948|FG000|Overall Study|Moved to another observational study|0|||
129166468|NCT05659719|464902949|FG001|Overall Study|Moved to another observational study|0|||
129166469|NCT05659719|464902950|FG002|Overall Study|Moved to another observational study|0|||
129166470|NCT05659719|464902951|FG003|Overall Study|Moved to another observational study|1|||
129166471|NCT05659719|464902948|FG000|Overall Study|The child was enrolled in an interventional study|0|||
129166472|NCT05659719|464902949|FG001|Overall Study|The child was enrolled in an interventional study|0|||
129166473|NCT05659719|464902950|FG002|Overall Study|The child was enrolled in an interventional study|0|||
129166474|NCT05659719|464902951|FG003|Overall Study|The child was enrolled in an interventional study|55|||
128777597|NCT04320615|463475256|FG000|Overall Study|Death|35|||
128777598|NCT04320615|463475257|FG001|Overall Study|Death|71|||
128777599|NCT01449721|463475258|FG000|Overall Study|Physician Decision|0|||
129166475|NCT05659719|464902948|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
129166476|NCT05659719|464902949|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
129166477|NCT05659719|464902950|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
129166478|NCT05659719|464902951|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
129166479|NCT05659719|464902948|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
128726919|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
128726920|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
128726921|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
128726922|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
128726923|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
128726924|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
128726925|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
128726926|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
128726927|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
128726928|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
128726929|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
128726930|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
128726931|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
128726932|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
128726933|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
128726934|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
128726935|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
128726936|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
128726937|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
128726938|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
128726939|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
128726940|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
128726941|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
128726942|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
128726943|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
128726944|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
128726945|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
128726946|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
128726947|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
128726948|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726949|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
128726950|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726951|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726952|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726953|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726954|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726955|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726956|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
128726957|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
128726958|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
128726959|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
128726960|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
128726961|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
128726962|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
128726963|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
128726964|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
128726965|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
128726966|NCT00404352|463297077|FG000|Double Blind (up to 24 Month)|Other|0|||
128726967|NCT00404352|463297078|FG001|Double Blind (up to 24 Month)|Other|1|||
128726968|NCT00404352|463297079|FG002|Double Blind (up to 24 Month)|Other|0|||
128726969|NCT00404352|463297080|FG003|Double Blind (up to 24 Month)|Other|0|||
128726970|NCT00404352|463297081|FG004|Double Blind (up to 24 Month)|Other|0|||
128726971|NCT00404352|463297082|FG005|Double Blind (up to 24 Month)|Other|0|||
128726972|NCT00404352|463297083|FG006|Double Blind (up to 24 Month)|Other|0|||
128726973|NCT00404352|463297084|FG007|Double Blind (up to 24 Month)|Other|0|||
128726974|NCT00404352|463297085|FG008|Double Blind (up to 24 Month)|Other|0|||
128726975|NCT00404352|463297077|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
128726976|NCT00404352|463297078|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
128777600|NCT01449721|463475259|FG001|Overall Study|Physician Decision|1|||
128777601|NCT01449721|463475258|FG000|Overall Study|Physician Decision|0|||
128726977|NCT00404352|463297079|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
128777602|NCT01449721|463475259|FG001|Overall Study|Physician Decision|1|||
129166480|NCT05659719|464902949|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
129166481|NCT05659719|464902950|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
129166482|NCT05659719|464902951|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
129166483|NCT01681186|464902952|FG000|Washout Period From Second Intervention|Adverse Event|0|||
129166484|NCT01681186|464902953|FG001|Washout Period From Second Intervention|Adverse Event|0|||
129166485|NCT01681186|464902954|FG002|Washout Period From Second Intervention|Adverse Event|0|||
129166486|NCT01681186|464902955|FG003|Washout Period From Second Intervention|Adverse Event|0|||
129166487|NCT01681186|464902956|FG004|Washout Period From Second Intervention|Adverse Event|0|||
129166488|NCT01681186|464902957|FG005|Washout Period From Second Intervention|Adverse Event|0|||
129166489|NCT01681186|464902958|FG006|Washout Period From Second Intervention|Adverse Event|1|||
129166490|NCT01681186|464902959|FG007|Washout Period From Second Intervention|Adverse Event|0|||
129166491|NCT01681186|464902952|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
129166492|NCT01681186|464902953|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
129166493|NCT01681186|464902954|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
129166494|NCT01681186|464902955|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
129166495|NCT01681186|464902956|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
129166496|NCT01681186|464902957|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
129166497|NCT01681186|464902958|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
129166498|NCT01681186|464902959|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
129166499|NCT01681186|464902952|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
129166500|NCT01681186|464902953|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
129166501|NCT01681186|464902954|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
129166502|NCT01681186|464902955|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
129166503|NCT01681186|464902956|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
129166504|NCT01681186|464902957|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
129166505|NCT01681186|464902958|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
129166506|NCT01681186|464902959|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
129166507|NCT01681186|464902952|FG000|Fourth Intervention|Protocol Violation|0|||
129166508|NCT01681186|464902953|FG001|Fourth Intervention|Protocol Violation|0|||
129166509|NCT01681186|464902954|FG002|Fourth Intervention|Protocol Violation|0|||
129166510|NCT01681186|464902955|FG003|Fourth Intervention|Protocol Violation|0|||
129166511|NCT01681186|464902956|FG004|Fourth Intervention|Protocol Violation|0|||
129166512|NCT01681186|464902957|FG005|Fourth Intervention|Protocol Violation|0|||
129166513|NCT01681186|464902958|FG006|Fourth Intervention|Protocol Violation|0|||
129166514|NCT01681186|464902959|FG007|Fourth Intervention|Protocol Violation|1|||
129166515|NCT05160415|464902960|FG000|Overall Study|Withdrawal by Subject|3|||
129166516|NCT02582814|464902961|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129166517|NCT02582814|464902962|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129166518|NCT02582814|464902961|FG000|Overall Study|Withdrawal by Subject|4|||
129166519|NCT02582814|464902962|FG001|Overall Study|Withdrawal by Subject|3|||
129166520|NCT02582814|464902961|FG000|Overall Study|Adverse Event|4|||
129166521|NCT02582814|464902962|FG001|Overall Study|Adverse Event|4|||
129166522|NCT03530995|464902963|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
129166523|NCT03530995|464902964|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
129166524|NCT03530995|464902963|FG000|Part 1 Period 3|Protocol Violation|1|||
129166525|NCT03530995|464902964|FG001|Part 1 Period 3|Protocol Violation|0|||
129166526|NCT03530995|464902963|FG000|Part 1 Period 4|Physician Decision|1|||
129166527|NCT03530995|464902964|FG001|Part 1 Period 4|Physician Decision|0|||
129166528|NCT03530995|464902963|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
129166529|NCT03530995|464902964|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
129166530|NCT01986231|464902968|FG000|Overall Study|Adverse Event|1|||
129166531|NCT00623233|464902969|FG000|Overall Study|Adverse Event|10|||
129166532|NCT00623233|464902969|FG000|Overall Study|Physician Decision|10|||
129166533|NCT00623233|464902969|FG000|Overall Study|Lost to Follow-up|1|||
129166534|NCT00623233|464902969|FG000|Overall Study|Withdrawal by Subject|3|||
129166535|NCT01751906|464902970|FG000|Overall Study|Lost to Follow-up|151|||
129166536|NCT01751906|464902971|FG001|Overall Study|Lost to Follow-up|68|||
129166537|NCT01751906|464902970|FG000|Overall Study|Withdrawal by Subject|22|||
129166538|NCT01751906|464902971|FG001|Overall Study|Withdrawal by Subject|18|||
129166539|NCT01751906|464902970|FG000|Overall Study|Physician Decision|5|||
129166540|NCT01751906|464902971|FG001|Overall Study|Physician Decision|2|||
129166541|NCT01751906|464902970|FG000|Overall Study|Death|84|||
129166542|NCT01751906|464902971|FG001|Overall Study|Death|43|||
129166543|NCT01751906|464902970|FG000|Overall Study|Denied on premises for follow-up by law|1|||
129166544|NCT01751906|464902971|FG001|Overall Study|Denied on premises for follow-up by law|0|||
129166545|NCT01110330|464902972|FG000|Overall Study|Adverse Event|0|||
129166546|NCT01110330|464902973|FG001|Overall Study|Adverse Event|4|||
129166547|NCT01110330|464902974|FG002|Overall Study|Adverse Event|3|||
129166548|NCT01110330|464902972|FG000|Overall Study|Lack of Efficacy|3|||
129166549|NCT01110330|464902973|FG001|Overall Study|Lack of Efficacy|1|||
129166550|NCT01110330|464902974|FG002|Overall Study|Lack of Efficacy|1|||
129166551|NCT01110330|464902972|FG000|Overall Study|Lost to Follow-up|9|||
129166552|NCT01110330|464902973|FG001|Overall Study|Lost to Follow-up|10|||
129166553|NCT01110330|464902974|FG002|Overall Study|Lost to Follow-up|15|||
129166554|NCT01110330|464902972|FG000|Overall Study|Physician Decision|0|||
129166555|NCT01110330|464902973|FG001|Overall Study|Physician Decision|1|||
129166556|NCT01110330|464902974|FG002|Overall Study|Physician Decision|0|||
129166557|NCT01110330|464902972|FG000|Overall Study|Protocol Violation|2|||
128726978|NCT00404352|463297080|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
128726979|NCT00404352|463297081|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
128726980|NCT00404352|463297082|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
128726981|NCT00404352|463297083|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
128726982|NCT00404352|463297084|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
128726983|NCT00404352|463297085|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
128726984|NCT00404352|463297077|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
128726985|NCT00404352|463297078|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
128726986|NCT00404352|463297079|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
128726987|NCT00404352|463297080|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
128726988|NCT00404352|463297081|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
128726989|NCT00404352|463297082|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
128726990|NCT00404352|463297083|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
128726991|NCT00404352|463297084|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
128726992|NCT00404352|463297085|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
128726993|NCT00404352|463297077|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128726994|NCT00404352|463297078|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128726995|NCT00404352|463297079|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128726996|NCT00404352|463297080|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128726997|NCT00404352|463297081|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
128726998|NCT00404352|463297082|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128726999|NCT00404352|463297083|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128727000|NCT00404352|463297084|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128727001|NCT00404352|463297085|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
128727002|NCT00404352|463297077|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727003|NCT00404352|463297078|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727004|NCT00404352|463297079|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727005|NCT00404352|463297080|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727006|NCT00404352|463297081|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727007|NCT00404352|463297082|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
128727008|NCT00404352|463297083|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727009|NCT00404352|463297084|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727010|NCT00404352|463297085|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
128727011|NCT00404352|463297077|FG000|Open Label (up to 24 Month)|Disease progression|0|||
128727012|NCT00404352|463297078|FG001|Open Label (up to 24 Month)|Disease progression|0|||
128727013|NCT00404352|463297079|FG002|Open Label (up to 24 Month)|Disease progression|0|||
128727014|NCT00404352|463297080|FG003|Open Label (up to 24 Month)|Disease progression|1|||
128777603|NCT00003509|463475260|FG000|Overall Study|Not evaluable|5|||
128777604|NCT03285711|463475261|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
128777605|NCT03285711|463475262|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
128777606|NCT03285711|463475263|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
128777607|NCT03285711|463475264|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
128777608|NCT03285711|463475261|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
128777609|NCT03285711|463475262|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
128777610|NCT03285711|463475263|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
128777611|NCT03285711|463475264|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
128777612|NCT03285711|463475261|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
128777613|NCT03285711|463475262|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
128777614|NCT03285711|463475263|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
128777615|NCT03285711|463475264|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
128777616|NCT03285711|463475261|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
128777617|NCT03285711|463475262|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
128777618|NCT03285711|463475263|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
128777619|NCT03285711|463475264|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
129166558|NCT01110330|464902973|FG001|Overall Study|Protocol Violation|0|||
129166559|NCT01110330|464902974|FG002|Overall Study|Protocol Violation|4|||
128727015|NCT00404352|463297081|FG004|Open Label (up to 24 Month)|Disease progression|0|||
128727016|NCT00404352|463297082|FG005|Open Label (up to 24 Month)|Disease progression|0|||
128727017|NCT00404352|463297083|FG006|Open Label (up to 24 Month)|Disease progression|0|||
128727018|NCT00404352|463297084|FG007|Open Label (up to 24 Month)|Disease progression|0|||
128777620|NCT02431533|463475265|FG000|Overall Study|Withdrawal by Subject|1|||
129166560|NCT01110330|464902972|FG000|Overall Study|Withdrawal by Subject|0|||
129166561|NCT01110330|464902973|FG001|Overall Study|Withdrawal by Subject|6|||
129166562|NCT01110330|464902974|FG002|Overall Study|Withdrawal by Subject|2|||
129166563|NCT01110330|464902972|FG000|Overall Study|Other|1|||
129166564|NCT01110330|464902973|FG001|Overall Study|Other|1|||
129166565|NCT01110330|464902974|FG002|Overall Study|Other|1|||
129166566|NCT02557100|464902975|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
129166567|NCT02557100|464902976|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
129166568|NCT02557100|464902977|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
129166569|NCT02557100|464902975|FG000|Single Blind Treatment Period|Death|0|||
129166570|NCT02557100|464902976|FG001|Single Blind Treatment Period|Death|1|||
129166571|NCT02557100|464902977|FG002|Single Blind Treatment Period|Death|0|||
129166572|NCT02557100|464902975|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
129166573|NCT02557100|464902976|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
129166574|NCT02557100|464902977|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
128727019|NCT00404352|463297085|FG008|Open Label (up to 24 Month)|Disease progression|0|||
128727020|NCT00404352|463297077|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
128727021|NCT00404352|463297078|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
128727022|NCT00404352|463297079|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
128727023|NCT00404352|463297080|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
128727024|NCT00404352|463297081|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
128727025|NCT00404352|463297082|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
128727026|NCT00404352|463297083|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
128727027|NCT00404352|463297084|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
128727028|NCT00404352|463297085|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
128727029|NCT00404352|463297077|FG000|Open Label Extension (up to 36 Months)|Other|0|||
128727030|NCT00404352|463297078|FG001|Open Label Extension (up to 36 Months)|Other|0|||
128727031|NCT00404352|463297079|FG002|Open Label Extension (up to 36 Months)|Other|0|||
128727032|NCT00404352|463297080|FG003|Open Label Extension (up to 36 Months)|Other|0|||
128727033|NCT00404352|463297081|FG004|Open Label Extension (up to 36 Months)|Other|0|||
128727034|NCT00404352|463297082|FG005|Open Label Extension (up to 36 Months)|Other|0|||
128727035|NCT00404352|463297083|FG006|Open Label Extension (up to 36 Months)|Other|0|||
128727036|NCT00404352|463297084|FG007|Open Label Extension (up to 36 Months)|Other|0|||
128727037|NCT00404352|463297085|FG008|Open Label Extension (up to 36 Months)|Other|2|||
128727038|NCT04370691|463297086|FG000|Overall Study|Pending visit|48|||
128727039|NCT04370691|463297086|FG000|Overall Study|Have Not Reached Lower Window|15|||
128727040|NCT04370691|463297086|FG000|Overall Study|Termination|14|||
128727041|NCT04370691|463297086|FG000|Overall Study|Missed or Overdue|10|||
128727042|NCT00696137|463297088|FG000|Overall Study|Withdrawal by Subject|2|||
128727043|NCT01640366|463297095|FG000|Overall Study|Withdrawal by Subject|1|||
128727044|NCT01640366|463297095|FG000|Overall Study|Protocol Violation|16|||
128727045|NCT01640366|463297095|FG000|Overall Study|Lost to Follow-up|5|||
128727046|NCT01116232|463297098|FG000|Overall Study|Progressive diease|4|||
128727047|NCT02357940|463297101|FG000|Overall Study|Adverse Event|0|||
128727048|NCT02357940|463297102|FG001|Overall Study|Adverse Event|1|||
128727049|NCT02357940|463297101|FG000|Overall Study|Investigator's judgement|0|||
128727050|NCT02357940|463297102|FG001|Overall Study|Investigator's judgement|1|||
128727051|NCT02275481|463297103|FG000|Overall Study|Death|2|||
128727052|NCT02275481|463297104|FG001|Overall Study|Death|1|||
128727053|NCT02275481|463297103|FG000|Overall Study|Lost to Follow-up|2|||
128727054|NCT02275481|463297104|FG001|Overall Study|Lost to Follow-up|0|||
128727055|NCT02275481|463297103|FG000|Overall Study|Withdrawal by Subject|3|||
128727056|NCT02275481|463297104|FG001|Overall Study|Withdrawal by Subject|0|||
128727057|NCT02275481|463297103|FG000|Overall Study|all other reasons combined|2|||
128727058|NCT02275481|463297104|FG001|Overall Study|all other reasons combined|1|||
128727059|NCT02275481|463297103|FG000|Overall Study|Physician Decision|0|||
128727060|NCT02275481|463297104|FG001|Overall Study|Physician Decision|1|||
128727061|NCT00291668|463297110|FG000|Overall Study|Lack of Efficacy|1|||
128727062|NCT00291668|463297111|FG001|Overall Study|Lack of Efficacy|0|||
128727063|NCT00291668|463297112|FG002|Overall Study|Lack of Efficacy|0|||
128727064|NCT00291668|463297110|FG000|Overall Study|SAE, non-fatal|1|||
128727065|NCT00291668|463297111|FG001|Overall Study|SAE, non-fatal|1|||
129166575|NCT02557100|464902975|FG000|Single Blind Treatment Period|Adverse Event|0|||
129166576|NCT02557100|464902976|FG001|Single Blind Treatment Period|Adverse Event|1|||
129166577|NCT02557100|464902977|FG002|Single Blind Treatment Period|Adverse Event|0|||
129166578|NCT02557100|464902975|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
129166579|NCT02557100|464902976|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
129166580|NCT02557100|464902977|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
129166581|NCT02557100|464902975|FG000|Cumulative Abatacept Period|Other Reasons|0|||
129166582|NCT02557100|464902976|FG001|Cumulative Abatacept Period|Other Reasons|0|||
129166583|NCT02557100|464902977|FG002|Cumulative Abatacept Period|Other Reasons|1|||
129166584|NCT02557100|464902975|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
128727066|NCT00291668|463297112|FG002|Overall Study|SAE, non-fatal|1|||
128727067|NCT00291668|463297110|FG000|Overall Study|AE, non-serious non-fatal|1|||
129166585|NCT02557100|464902976|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
128727068|NCT00291668|463297111|FG001|Overall Study|AE, non-serious non-fatal|0|||
128727069|NCT00291668|463297112|FG002|Overall Study|AE, non-serious non-fatal|0|||
128777621|NCT02431533|463475266|FG001|Overall Study|Withdrawal by Subject|3|||
128777622|NCT02431533|463475265|FG000|Overall Study|Developed Exclusionary criteria|1|||
128777623|NCT02431533|463475266|FG001|Overall Study|Developed Exclusionary criteria|0|||
128777624|NCT02107443|463475267|FG000|Overall Study|Death|42|||
128777625|NCT02107443|463475268|FG001|Overall Study|Death|30|||
128777626|NCT02107443|463475267|FG000|Overall Study|Study Protocol Violation|3|||
128777627|NCT02107443|463475268|FG001|Overall Study|Study Protocol Violation|1|||
129166586|NCT02557100|464902977|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
129166587|NCT02557100|464902975|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
129166588|NCT02557100|464902976|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
129166589|NCT02557100|464902977|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
129166590|NCT04644276|464902979|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
129166591|NCT04644276|464902980|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
129166592|NCT04644276|464902981|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
129166593|NCT01667224|464902985|FG000|Overall Study|Withdrawal by Subject|3|||
129166594|NCT01667224|464902986|FG001|Overall Study|Withdrawal by Subject|1|||
129166595|NCT01667224|464902985|FG000|Overall Study|Protocol Violation|1|||
129166596|NCT01667224|464902986|FG001|Overall Study|Protocol Violation|1|||
128727070|NCT00291668|463297110|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
128727071|NCT00291668|463297111|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
128727072|NCT00291668|463297112|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
128727073|NCT00313612|463297115|FG000|Overall Study|Patient never received treatment|0|||
128727074|NCT00313612|463297116|FG001|Overall Study|Patient never received treatment|1|||
128727075|NCT00451035|463297117|FG000|Overall Study|Disease progression|11|||
128727076|NCT00451035|463297117|FG000|Overall Study|Death|3|||
128727077|NCT00451035|463297117|FG000|Overall Study|New anti-neoplastic therapy|3|||
128727078|NCT03350503|463297121|FG000|Overall Study|Adverse Event|5|||
128727079|NCT03350503|463297121|FG000|Overall Study|Withdrawal by Subject|5|||
128727080|NCT03350503|463297121|FG000|Overall Study|Continuation impossible due to move|4|||
128727081|NCT03350503|463297121|FG000|Overall Study|Physician Decision|3|||
128727082|NCT04536727|463297122|FG000|Overall Study|Lost to Follow-up|1|||
128727083|NCT04536727|463297123|FG001|Overall Study|Lost to Follow-up|1|||
128727084|NCT04536727|463297122|FG000|Overall Study|Death|0|||
128727085|NCT04536727|463297123|FG001|Overall Study|Death|1|||
129166597|NCT02314156|464902992|FG000|Overall Study|Adverse Event|1|||
129166598|NCT02314156|464902993|FG001|Overall Study|Adverse Event|0|||
129166599|NCT02314156|464902992|FG000|Overall Study|Withdrawal by Subject|1|||
129166600|NCT02314156|464902993|FG001|Overall Study|Withdrawal by Subject|0|||
129166601|NCT02752633|464902994|FG000|Overall Study|Withdrawal by Subject|1|||
129166602|NCT02846389|464902995|FG000|Overall Study|Withdrawal by Subject|1|||
129166603|NCT02846389|464902996|FG001|Overall Study|Withdrawal by Subject|1|||
129166604|NCT00433966|464902999|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
129166605|NCT00433966|464903000|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
129166606|NCT00433966|464903001|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
129166607|NCT00433966|464903002|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
129166608|NCT00433966|464902999|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
129166609|NCT00433966|464903000|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
129166610|NCT00433966|464903001|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
129166611|NCT00433966|464903002|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
129166612|NCT00433966|464902999|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
129166613|NCT00433966|464903000|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
129166614|NCT00433966|464903001|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
129166615|NCT00433966|464903002|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
129166616|NCT00433966|464902999|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
129166617|NCT00433966|464903000|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
129166618|NCT00433966|464903001|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
129166619|NCT00433966|464903002|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
129166620|NCT00433966|464902999|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
129166621|NCT00433966|464903000|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
129166622|NCT00433966|464903001|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
129166623|NCT00433966|464903002|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
129166624|NCT00853242|464903004|FG000|Overall Study|Adverse Event|0|||
129166625|NCT00853242|464903005|FG001|Overall Study|Adverse Event|1|||
129166626|NCT00853242|464903006|FG002|Overall Study|Adverse Event|1|||
129166627|NCT00853242|464903007|FG003|Overall Study|Adverse Event|0|||
129166628|NCT00853242|464903008|FG004|Overall Study|Adverse Event|3|||
128727086|NCT01399593|463297124|FG000|Overall Study|Physician Decision|1|||
128727087|NCT01399593|463297125|FG001|Overall Study|Physician Decision|0|||
128727088|NCT01399593|463297124|FG000|Overall Study|Adverse Event|1|||
128777628|NCT02107443|463475267|FG000|Overall Study|Registered but Not Eligible|0|||
128777629|NCT02107443|463475268|FG001|Overall Study|Registered but Not Eligible|1|||
128777630|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
128777631|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
128777632|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
128777633|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
128777634|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Changed Mind|2|||
128777635|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Changed Mind|0|||
128777636|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
128777637|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
128777638|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
128777639|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
128777640|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
128777641|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
128777642|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
128777643|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
128777644|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Other Medical|9|||
128777645|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Other Medical|5|||
128777646|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Disease Progression|4|||
128777647|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Disease Progression|2|||
128777648|NCT02107443|463475267|FG000|Overall Study|Withdrawal: Personal Issues|0|||
128777649|NCT02107443|463475268|FG001|Overall Study|Withdrawal: Personal Issues|3|||
128777650|NCT00885495|463475269|FG000|Overall Study|Adverse Event|1|||
128777651|NCT00885495|463475270|FG001|Overall Study|Adverse Event|2|||
128777652|NCT00885495|463475269|FG000|Overall Study|Protocol Violation|0|||
128777653|NCT00885495|463475270|FG001|Overall Study|Protocol Violation|1|||
128777654|NCT00885495|463475269|FG000|Overall Study|Withdrawal by Subject|1|||
128777655|NCT00885495|463475270|FG001|Overall Study|Withdrawal by Subject|0|||
128777656|NCT01400893|463475271|FG000|Overall Study|Death|27|||
128777657|NCT01400893|463475272|FG001|Overall Study|Death|21|||
128777658|NCT01400893|463475271|FG000|Overall Study|Lost to Follow-up|0|||
128777659|NCT01400893|463475272|FG001|Overall Study|Lost to Follow-up|6|||
128777660|NCT01368211|463475273|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
128777661|NCT01368211|463475274|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
128777662|NCT01513967|463475285|FG000|Overall Study|Pregnancy|0|||
128777663|NCT01513967|463475286|FG001|Overall Study|Pregnancy|0|||
128777664|NCT01513967|463475287|FG002|Overall Study|Pregnancy|0|||
128777665|NCT01513967|463475288|FG003|Overall Study|Pregnancy|0|||
128777666|NCT01513967|463475289|FG004|Overall Study|Pregnancy|0|||
128777667|NCT01513967|463475290|FG005|Overall Study|Pregnancy|0|||
128777668|NCT01513967|463475291|FG006|Overall Study|Pregnancy|1|||
128777669|NCT01513967|463475292|FG007|Overall Study|Pregnancy|0|||
128777670|NCT01513967|463475285|FG000|Overall Study|missed a study visit|0|||
129166629|NCT00853242|464903009|FG005|Overall Study|Adverse Event|1|||
129166630|NCT00853242|464903010|FG006|Overall Study|Adverse Event|1|||
129166631|NCT00853242|464903004|FG000|Overall Study|Noncompliant|0|||
129166632|NCT00853242|464903005|FG001|Overall Study|Noncompliant|0|||
129166633|NCT00853242|464903006|FG002|Overall Study|Noncompliant|0|||
129166634|NCT00853242|464903007|FG003|Overall Study|Noncompliant|0|||
129166635|NCT00853242|464903008|FG004|Overall Study|Noncompliant|1|||
129166636|NCT00853242|464903009|FG005|Overall Study|Noncompliant|0|||
129166637|NCT00853242|464903010|FG006|Overall Study|Noncompliant|0|||
129166638|NCT00853242|464903004|FG000|Overall Study|Withdrawal by Subject|1|||
129166639|NCT00853242|464903005|FG001|Overall Study|Withdrawal by Subject|2|||
129166640|NCT00853242|464903006|FG002|Overall Study|Withdrawal by Subject|0|||
129166641|NCT00853242|464903007|FG003|Overall Study|Withdrawal by Subject|4|||
129166642|NCT00853242|464903008|FG004|Overall Study|Withdrawal by Subject|0|||
129166643|NCT00853242|464903009|FG005|Overall Study|Withdrawal by Subject|0|||
129166644|NCT00853242|464903010|FG006|Overall Study|Withdrawal by Subject|2|||
129166645|NCT00853242|464903004|FG000|Overall Study|Other|2|||
129166646|NCT00853242|464903005|FG001|Overall Study|Other|0|||
129166647|NCT00853242|464903006|FG002|Overall Study|Other|2|||
129166648|NCT00853242|464903007|FG003|Overall Study|Other|0|||
129166649|NCT00853242|464903008|FG004|Overall Study|Other|0|||
129166650|NCT00853242|464903009|FG005|Overall Study|Other|1|||
129166651|NCT00853242|464903010|FG006|Overall Study|Other|2|||
129166652|NCT03497975|464903011|FG000|Overall Study|Withdrew Consent|34|||
129166653|NCT03497975|464903012|FG001|Overall Study|Withdrew Consent|35|||
129166654|NCT03497975|464903011|FG000|Overall Study|Lost to Follow-up|7|||
129166655|NCT03497975|464903012|FG001|Overall Study|Lost to Follow-up|7|||
128777671|NCT01513967|463475286|FG001|Overall Study|missed a study visit|0|||
128777672|NCT01513967|463475287|FG002|Overall Study|missed a study visit|0|||
128777673|NCT01513967|463475288|FG003|Overall Study|missed a study visit|0|||
128777674|NCT01513967|463475289|FG004|Overall Study|missed a study visit|0|||
128777675|NCT01513967|463475290|FG005|Overall Study|missed a study visit|0|||
128777676|NCT01513967|463475291|FG006|Overall Study|missed a study visit|1|||
129166656|NCT03497975|464903011|FG000|Overall Study|Physician Decision|4|||
129166657|NCT03497975|464903012|FG001|Overall Study|Physician Decision|5|||
129166658|NCT03497975|464903011|FG000|Overall Study|Discontinued|42|||
128727089|NCT01399593|463297125|FG001|Overall Study|Adverse Event|0|||
128727090|NCT01399593|463297124|FG000|Overall Study|Death|1|||
128727091|NCT01399593|463297125|FG001|Overall Study|Death|1|||
128727092|NCT01399593|463297124|FG000|Overall Study|Transplantectomy|0|||
128727093|NCT01399593|463297125|FG001|Overall Study|Transplantectomy|1|||
128727094|NCT00344773|463297129|FG000|Overall Study|Adverse Event|2|||
128727095|NCT00344773|463297129|FG000|Overall Study|Objective Disease Progression|16|||
128727096|NCT00344773|463297129|FG000|Overall Study|Withdrawal by Subject|1|||
128727097|NCT00344773|463297129|FG000|Overall Study|Not Eligible for the study|2|||
128727098|NCT00714259|463297131|FG000|Overall Study|Death|2|||
128727099|NCT02141074|463297132|FG000|Pre-prophylaxis|Adverse Event|3|||
128727100|NCT02141074|463297133|FG001|Pre-prophylaxis|Adverse Event|0|||
128727101|NCT02141074|463297132|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
128727102|NCT02141074|463297133|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
128727103|NCT02141074|463297132|FG000|Prophylaxis|Adverse Event|0|||
128727104|NCT02141074|463297133|FG001|Prophylaxis|Adverse Event|4|||
128727105|NCT02141074|463297132|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
128727106|NCT02141074|463297133|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
128727107|NCT02141074|463297132|FG000|Prophylaxis|Withdrawal by Subject|0|||
128727108|NCT02141074|463297133|FG001|Prophylaxis|Withdrawal by Subject|1|||
128727109|NCT05627518|463297134|FG000|Treatment Period 1|Adverse Event|0|||
128727110|NCT05627518|463297135|FG001|Treatment Period 1|Adverse Event|0|||
128727111|NCT05627518|463297136|FG002|Treatment Period 1|Adverse Event|1|||
128727112|NCT05627518|463297137|FG003|Treatment Period 1|Adverse Event|0|||
128727113|NCT05627518|463297138|FG004|Treatment Period 1|Adverse Event|0|||
128727114|NCT05627518|463297139|FG005|Treatment Period 1|Adverse Event|0|||
128727115|NCT05627518|463297140|FG006|Treatment Period 1|Adverse Event|0|||
128727116|NCT05627518|463297141|FG007|Treatment Period 1|Adverse Event|1|||
128727117|NCT05627518|463297134|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128727118|NCT05627518|463297135|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128727119|NCT05627518|463297136|FG002|Treatment Period 1|Withdrawal by Subject|1|||
128727120|NCT05627518|463297137|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128727121|NCT05627518|463297138|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128727122|NCT05627518|463297139|FG005|Treatment Period 1|Withdrawal by Subject|1|||
128727123|NCT05627518|463297140|FG006|Treatment Period 1|Withdrawal by Subject|0|||
128727124|NCT05627518|463297141|FG007|Treatment Period 1|Withdrawal by Subject|0|||
128727125|NCT05627518|463297134|FG000|Treatment Period 1|Protocol Violation|0|||
128727126|NCT05627518|463297135|FG001|Treatment Period 1|Protocol Violation|0|||
128727127|NCT05627518|463297136|FG002|Treatment Period 1|Protocol Violation|0|||
128727128|NCT05627518|463297137|FG003|Treatment Period 1|Protocol Violation|0|||
128727129|NCT05627518|463297138|FG004|Treatment Period 1|Protocol Violation|0|||
128727130|NCT05627518|463297139|FG005|Treatment Period 1|Protocol Violation|0|||
128727131|NCT05627518|463297140|FG006|Treatment Period 1|Protocol Violation|6|||
128727132|NCT05627518|463297141|FG007|Treatment Period 1|Protocol Violation|6|||
128727133|NCT05627518|463297134|FG000|Treatment Period 2|Adverse Event|1|||
128727134|NCT05627518|463297135|FG001|Treatment Period 2|Adverse Event|0|||
128727135|NCT05627518|463297136|FG002|Treatment Period 2|Adverse Event|0|||
128727136|NCT05627518|463297137|FG003|Treatment Period 2|Adverse Event|0|||
128727137|NCT05627518|463297138|FG004|Treatment Period 2|Adverse Event|0|||
128727138|NCT05627518|463297139|FG005|Treatment Period 2|Adverse Event|0|||
128727139|NCT05627518|463297140|FG006|Treatment Period 2|Adverse Event|0|||
128727140|NCT05627518|463297141|FG007|Treatment Period 2|Adverse Event|0|||
128727141|NCT05627518|463297134|FG000|Treatment Period 2|Withdrawal by Subject|1|||
128727142|NCT05627518|463297135|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128727143|NCT05627518|463297136|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128727144|NCT05627518|463297137|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128727145|NCT05627518|463297138|FG004|Treatment Period 2|Withdrawal by Subject|0|||
128727146|NCT05627518|463297139|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128727147|NCT05627518|463297140|FG006|Treatment Period 2|Withdrawal by Subject|0|||
128727148|NCT05627518|463297141|FG007|Treatment Period 2|Withdrawal by Subject|0|||
128727149|NCT00403273|463298681|FG000|Overall Study|Lost to Follow-up|3|||
128727150|NCT00403273|463298682|FG001|Overall Study|Lost to Follow-up|2|||
128727151|NCT00403273|463298681|FG000|Overall Study|Physician Decision|0|||
128727152|NCT00403273|463298682|FG001|Overall Study|Physician Decision|1|||
128727153|NCT00403273|463298681|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
128727154|NCT00403273|463298682|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
128727155|NCT00574405|463298684|FG000|Overall Study|Withdrawal by Subject|3|||
128727156|NCT00574405|463298685|FG001|Overall Study|Withdrawal by Subject|2|||
128727157|NCT01336738|463298686|FG000|Overall Study|Adverse Event|0|||
128727158|NCT01336738|463298687|FG001|Overall Study|Adverse Event|3|||
128727159|NCT01336738|463298688|FG002|Overall Study|Adverse Event|2|||
128727160|NCT01336738|463298689|FG003|Overall Study|Adverse Event|1|||
128727161|NCT01336738|463298690|FG004|Overall Study|Adverse Event|3|||
128727162|NCT01336738|463298686|FG000|Overall Study|Lost to Follow-up|2|||
128727163|NCT01336738|463298687|FG001|Overall Study|Lost to Follow-up|1|||
128727164|NCT01336738|463298688|FG002|Overall Study|Lost to Follow-up|2|||
129166659|NCT03497975|464903012|FG001|Overall Study|Discontinued|39|||
129166660|NCT03497975|464903011|FG000|Overall Study|Reason Not Specified|15|||
129166661|NCT03497975|464903012|FG001|Overall Study|Reason Not Specified|14|||
129166662|NCT04026009|464903013|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129166663|NCT04026009|464903014|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129166664|NCT04026009|464903015|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129166665|NCT04026009|464903016|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129166666|NCT04026009|464903017|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129166667|NCT04026009|464903013|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
129166668|NCT04026009|464903014|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
129166669|NCT04026009|464903015|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
129166670|NCT04026009|464903016|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
129166671|NCT04026009|464903017|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
129166672|NCT01500252|464903021|FG000|Overall Study|Death|4|||
129166673|NCT01500252|464903022|FG001|Overall Study|Death|2|||
129166674|NCT01500252|464903021|FG000|Overall Study|Lost to Follow-up|5|||
129166675|NCT01500252|464903022|FG001|Overall Study|Lost to Follow-up|4|||
129166676|NCT05319600|464903024|FG000|Overall Study|Withdrawal by Subject|1|||
129166677|NCT05319600|464903025|FG001|Overall Study|Withdrawal by Subject|0|||
129166678|NCT05319600|464903024|FG000|Overall Study|Lost to Follow-up|0|||
129166679|NCT05319600|464903025|FG001|Overall Study|Lost to Follow-up|4|||
129166680|NCT03768089|464903029|FG000|Part A|Lost to Follow-up|0|||
129166681|NCT03768089|464903030|FG001|Part A|Lost to Follow-up|0|||
129166682|NCT03768089|464903031|FG002|Part A|Lost to Follow-up|0|||
129166683|NCT03768089|464903032|FG003|Part A|Lost to Follow-up|0|||
129166684|NCT03768089|464903033|FG004|Part A|Lost to Follow-up|1|||
129166685|NCT03768089|464903034|FG005|Part A|Lost to Follow-up|0|||
129166686|NCT03768089|464903035|FG006|Part A|Lost to Follow-up|0|||
129166687|NCT03768089|464903036|FG007|Part A|Lost to Follow-up|0|||
129166688|NCT03768089|464903037|FG008|Part A|Lost to Follow-up|0|||
129166689|NCT03768089|464903038|FG009|Part A|Lost to Follow-up|0|||
129166690|NCT03768089|464903039|FG010|Part A|Lost to Follow-up|0|||
129166691|NCT03768089|464903040|FG011|Part A|Lost to Follow-up|0|||
129166692|NCT03768089|464903041|FG012|Part A|Lost to Follow-up|0|||
129166693|NCT03768089|464903042|FG013|Part A|Lost to Follow-up|0|||
129166694|NCT03768089|464903043|FG014|Part A|Lost to Follow-up|0|||
129166695|NCT03768089|464903044|FG015|Part A|Lost to Follow-up|0|||
129166696|NCT03768089|464903045|FG016|Part A|Lost to Follow-up|0|||
129166697|NCT03768089|464903046|FG017|Part A|Lost to Follow-up|0|||
129166698|NCT03768089|464903029|FG000|Part C|Randomized, Never Dosed|0|||
129166699|NCT03768089|464903030|FG001|Part C|Randomized, Never Dosed|0|||
129166700|NCT03768089|464903031|FG002|Part C|Randomized, Never Dosed|0|||
129166701|NCT03768089|464903032|FG003|Part C|Randomized, Never Dosed|0|||
129166702|NCT03768089|464903033|FG004|Part C|Randomized, Never Dosed|0|||
129166703|NCT03768089|464903034|FG005|Part C|Randomized, Never Dosed|0|||
129166704|NCT03768089|464903035|FG006|Part C|Randomized, Never Dosed|0|||
129166705|NCT03768089|464903036|FG007|Part C|Randomized, Never Dosed|0|||
129166706|NCT03768089|464903037|FG008|Part C|Randomized, Never Dosed|0|||
129166707|NCT03768089|464903038|FG009|Part C|Randomized, Never Dosed|0|||
129166708|NCT03768089|464903039|FG010|Part C|Randomized, Never Dosed|0|||
129166709|NCT03768089|464903040|FG011|Part C|Randomized, Never Dosed|0|||
129166710|NCT03768089|464903041|FG012|Part C|Randomized, Never Dosed|0|||
129166711|NCT03768089|464903042|FG013|Part C|Randomized, Never Dosed|0|||
129166712|NCT03768089|464903043|FG014|Part C|Randomized, Never Dosed|1|||
129166713|NCT03768089|464903044|FG015|Part C|Randomized, Never Dosed|0|||
129166714|NCT03768089|464903045|FG016|Part C|Randomized, Never Dosed|0|||
129166715|NCT03768089|464903046|FG017|Part C|Randomized, Never Dosed|0|||
129166716|NCT02120300|464903051|FG000|Overall Study|Enrolled but Never Treated|2|||
129166717|NCT02120300|464903052|FG001|Overall Study|Enrolled but Never Treated|0|||
129166718|NCT02120300|464903053|FG002|Overall Study|Enrolled but Never Treated|0|||
129166719|NCT02120300|464903054|FG003|Overall Study|Enrolled but Never Treated|0|||
129166720|NCT02120300|464903051|FG000|Overall Study|Lack of Efficacy|0|||
129166721|NCT02120300|464903052|FG001|Overall Study|Lack of Efficacy|0|||
129166722|NCT02120300|464903053|FG002|Overall Study|Lack of Efficacy|0|||
129166723|NCT02120300|464903054|FG003|Overall Study|Lack of Efficacy|1|||
129166724|NCT02120300|464903051|FG000|Overall Study|Lost to Follow-up|1|||
129166725|NCT02120300|464903052|FG001|Overall Study|Lost to Follow-up|0|||
129166726|NCT02120300|464903053|FG002|Overall Study|Lost to Follow-up|0|||
129166727|NCT02120300|464903054|FG003|Overall Study|Lost to Follow-up|0|||
129166728|NCT00177294|464903055|FG000|Overall Study|Withdrawal by Subject|7|||
129166729|NCT00177294|464903056|FG001|Overall Study|Withdrawal by Subject|5|||
129166730|NCT02443116|464903060|FG000|Part 1|Adverse Event|2|||
129166731|NCT02443116|464903061|FG001|Part 1|Adverse Event|3|||
129166732|NCT02443116|464903062|FG002|Part 1|Adverse Event|0|||
129166733|NCT02443116|464903063|FG003|Part 1|Adverse Event|0|||
128777677|NCT01513967|463475292|FG007|Overall Study|missed a study visit|0|||
128777678|NCT01513967|463475285|FG000|Overall Study|excluded due to positive drug screen|0|||
128777679|NCT01513967|463475286|FG001|Overall Study|excluded due to positive drug screen|0|||
128777680|NCT01513967|463475287|FG002|Overall Study|excluded due to positive drug screen|0|||
128777681|NCT01513967|463475288|FG003|Overall Study|excluded due to positive drug screen|0|||
128777682|NCT01513967|463475289|FG004|Overall Study|excluded due to positive drug screen|0|||
128777683|NCT01513967|463475290|FG005|Overall Study|excluded due to positive drug screen|0|||
128777684|NCT01513967|463475291|FG006|Overall Study|excluded due to positive drug screen|0|||
128777685|NCT01513967|463475292|FG007|Overall Study|excluded due to positive drug screen|2|||
128777686|NCT01513967|463475285|FG000|Overall Study|Physician Decision|0|||
128777687|NCT01513967|463475286|FG001|Overall Study|Physician Decision|0|||
128777688|NCT01513967|463475287|FG002|Overall Study|Physician Decision|0|||
128777689|NCT01513967|463475288|FG003|Overall Study|Physician Decision|0|||
128777690|NCT01513967|463475289|FG004|Overall Study|Physician Decision|0|||
128777691|NCT01513967|463475290|FG005|Overall Study|Physician Decision|1|||
128777692|NCT01513967|463475291|FG006|Overall Study|Physician Decision|0|||
128777693|NCT01513967|463475292|FG007|Overall Study|Physician Decision|0|||
128777694|NCT02711826|463475293|FG000|Overall Study|Physician Decision|0|||
128777695|NCT02711826|463475294|FG001|Overall Study|Physician Decision|0|||
128777696|NCT02711826|463475295|FG002|Overall Study|Physician Decision|0|||
128777697|NCT02711826|463475296|FG003|Overall Study|Physician Decision|1|||
128777698|NCT02711826|463475297|FG004|Overall Study|Physician Decision|0|||
128777699|NCT02711826|463475293|FG000|Overall Study|Withdrawal by Subject|0|||
128777700|NCT02711826|463475294|FG001|Overall Study|Withdrawal by Subject|1|||
128777701|NCT02711826|463475295|FG002|Overall Study|Withdrawal by Subject|0|||
128777702|NCT02711826|463475296|FG003|Overall Study|Withdrawal by Subject|4|||
128777703|NCT02711826|463475297|FG004|Overall Study|Withdrawal by Subject|0|||
128777704|NCT02711826|463475293|FG000|Overall Study|Failure to manufacture cellular product|0|||
129166734|NCT02443116|464903064|FG004|Part 1|Adverse Event|0|||
129166735|NCT02443116|464903065|FG005|Part 1|Adverse Event|0|||
129166736|NCT02443116|464903066|FG006|Part 1|Adverse Event|0|||
129166737|NCT02443116|464903067|FG007|Part 1|Adverse Event|0|||
129166738|NCT02443116|464903068|FG008|Part 1|Adverse Event|0|||
129166739|NCT02443116|464903060|FG000|Part 1|Withdrew informed consent|0|||
129166740|NCT02443116|464903061|FG001|Part 1|Withdrew informed consent|1|||
129166741|NCT02443116|464903062|FG002|Part 1|Withdrew informed consent|0|||
129166742|NCT02443116|464903063|FG003|Part 1|Withdrew informed consent|0|||
129166743|NCT02443116|464903064|FG004|Part 1|Withdrew informed consent|0|||
129166744|NCT02443116|464903065|FG005|Part 1|Withdrew informed consent|0|||
129166745|NCT02443116|464903066|FG006|Part 1|Withdrew informed consent|0|||
129166746|NCT02443116|464903067|FG007|Part 1|Withdrew informed consent|0|||
129166747|NCT02443116|464903068|FG008|Part 1|Withdrew informed consent|0|||
129166748|NCT02443116|464903060|FG000|Part 1|Lost to Follow-up|0|||
129166749|NCT02443116|464903061|FG001|Part 1|Lost to Follow-up|0|||
129166750|NCT02443116|464903062|FG002|Part 1|Lost to Follow-up|2|||
129166751|NCT02443116|464903063|FG003|Part 1|Lost to Follow-up|0|||
129166752|NCT02443116|464903064|FG004|Part 1|Lost to Follow-up|0|||
129166753|NCT02443116|464903065|FG005|Part 1|Lost to Follow-up|0|||
129166754|NCT02443116|464903066|FG006|Part 1|Lost to Follow-up|0|||
129166755|NCT02443116|464903067|FG007|Part 1|Lost to Follow-up|0|||
129166756|NCT02443116|464903068|FG008|Part 1|Lost to Follow-up|0|||
129166757|NCT02443116|464903060|FG000|Part 1|Participant moved out of state|0|||
129166758|NCT02443116|464903061|FG001|Part 1|Participant moved out of state|0|||
129166759|NCT02443116|464903062|FG002|Part 1|Participant moved out of state|1|||
128777705|NCT02711826|463475294|FG001|Overall Study|Failure to manufacture cellular product|0|||
128777706|NCT02711826|463475295|FG002|Overall Study|Failure to manufacture cellular product|5|||
128777707|NCT02711826|463475296|FG003|Overall Study|Failure to manufacture cellular product|0|||
129166760|NCT02443116|464903063|FG003|Part 1|Participant moved out of state|0|||
129166761|NCT02443116|464903064|FG004|Part 1|Participant moved out of state|0|||
129166762|NCT02443116|464903065|FG005|Part 1|Participant moved out of state|0|||
129166763|NCT02443116|464903066|FG006|Part 1|Participant moved out of state|0|||
129166764|NCT02443116|464903067|FG007|Part 1|Participant moved out of state|0|||
129166765|NCT02443116|464903068|FG008|Part 1|Participant moved out of state|0|||
129166766|NCT02443116|464903060|FG000|Part 1|Participant enrolled in another clinical trial|0|||
129166767|NCT02443116|464903061|FG001|Part 1|Participant enrolled in another clinical trial|0|||
129166768|NCT02443116|464903062|FG002|Part 1|Participant enrolled in another clinical trial|1|||
129166769|NCT02443116|464903063|FG003|Part 1|Participant enrolled in another clinical trial|0|||
129166770|NCT02443116|464903064|FG004|Part 1|Participant enrolled in another clinical trial|0|||
129166771|NCT02443116|464903065|FG005|Part 1|Participant enrolled in another clinical trial|0|||
128777708|NCT02711826|463475297|FG004|Overall Study|Failure to manufacture cellular product|0|||
129166772|NCT02443116|464903066|FG006|Part 1|Participant enrolled in another clinical trial|0|||
129166773|NCT02443116|464903067|FG007|Part 1|Participant enrolled in another clinical trial|0|||
129166774|NCT02443116|464903068|FG008|Part 1|Participant enrolled in another clinical trial|0|||
129166775|NCT02443116|464903060|FG000|Part 2|Adverse Event|0|||
129166776|NCT02443116|464903061|FG001|Part 2|Adverse Event|0|||
129166777|NCT02443116|464903062|FG002|Part 2|Adverse Event|0|||
128727165|NCT01336738|463298689|FG003|Overall Study|Lost to Follow-up|2|||
128727166|NCT01336738|463298690|FG004|Overall Study|Lost to Follow-up|2|||
128727167|NCT01336738|463298686|FG000|Overall Study|Did not meet entrance criteria|0|||
128727168|NCT01336738|463298687|FG001|Overall Study|Did not meet entrance criteria|1|||
128727169|NCT01336738|463298688|FG002|Overall Study|Did not meet entrance criteria|0|||
128727170|NCT01336738|463298689|FG003|Overall Study|Did not meet entrance criteria|0|||
128727171|NCT01336738|463298690|FG004|Overall Study|Did not meet entrance criteria|0|||
128727172|NCT01336738|463298686|FG000|Overall Study|Protocol Violation|0|||
128727173|NCT01336738|463298687|FG001|Overall Study|Protocol Violation|1|||
128727174|NCT01336738|463298688|FG002|Overall Study|Protocol Violation|0|||
128727175|NCT01336738|463298689|FG003|Overall Study|Protocol Violation|0|||
128727176|NCT01336738|463298690|FG004|Overall Study|Protocol Violation|0|||
128727177|NCT01336738|463298686|FG000|Overall Study|Withdrawal by Subject|2|||
129166778|NCT02443116|464903063|FG003|Part 2|Adverse Event|0|||
129166779|NCT02443116|464903064|FG004|Part 2|Adverse Event|1|||
129166780|NCT02443116|464903065|FG005|Part 2|Adverse Event|1|||
129166781|NCT02443116|464903066|FG006|Part 2|Adverse Event|2|||
129166782|NCT02443116|464903067|FG007|Part 2|Adverse Event|0|||
129166783|NCT02443116|464903068|FG008|Part 2|Adverse Event|0|||
129166784|NCT02443116|464903060|FG000|Part 2|Withdrew informed consent|0|||
129166785|NCT02443116|464903061|FG001|Part 2|Withdrew informed consent|0|||
129166786|NCT02443116|464903062|FG002|Part 2|Withdrew informed consent|0|||
129166787|NCT02443116|464903063|FG003|Part 2|Withdrew informed consent|0|||
129166788|NCT02443116|464903064|FG004|Part 2|Withdrew informed consent|0|||
129166789|NCT02443116|464903065|FG005|Part 2|Withdrew informed consent|1|||
129166790|NCT02443116|464903066|FG006|Part 2|Withdrew informed consent|1|||
129166791|NCT02443116|464903067|FG007|Part 2|Withdrew informed consent|0|||
129166792|NCT02443116|464903068|FG008|Part 2|Withdrew informed consent|0|||
129166793|NCT02443116|464903060|FG000|Part 2|Inability to comply with protocol|0|||
129166794|NCT02443116|464903061|FG001|Part 2|Inability to comply with protocol|0|||
129166795|NCT02443116|464903062|FG002|Part 2|Inability to comply with protocol|0|||
129166796|NCT02443116|464903063|FG003|Part 2|Inability to comply with protocol|1|||
129166797|NCT02443116|464903064|FG004|Part 2|Inability to comply with protocol|0|||
129166798|NCT02443116|464903065|FG005|Part 2|Inability to comply with protocol|0|||
129166799|NCT02443116|464903066|FG006|Part 2|Inability to comply with protocol|0|||
129166800|NCT02443116|464903067|FG007|Part 2|Inability to comply with protocol|0|||
129166801|NCT02443116|464903068|FG008|Part 2|Inability to comply with protocol|0|||
129166802|NCT02443116|464903060|FG000|Part 2|Lost to Follow-up|0|||
129166803|NCT02443116|464903061|FG001|Part 2|Lost to Follow-up|0|||
129166804|NCT02443116|464903062|FG002|Part 2|Lost to Follow-up|0|||
129166805|NCT02443116|464903063|FG003|Part 2|Lost to Follow-up|1|||
129166806|NCT02443116|464903064|FG004|Part 2|Lost to Follow-up|0|||
129166807|NCT02443116|464903065|FG005|Part 2|Lost to Follow-up|0|||
129166808|NCT02443116|464903066|FG006|Part 2|Lost to Follow-up|0|||
129166809|NCT02443116|464903067|FG007|Part 2|Lost to Follow-up|0|||
129166810|NCT02443116|464903068|FG008|Part 2|Lost to Follow-up|0|||
129166811|NCT02443116|464903060|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166812|NCT02443116|464903061|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166813|NCT02443116|464903062|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166814|NCT02443116|464903063|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166815|NCT02443116|464903064|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166816|NCT02443116|464903065|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
129166817|NCT02443116|464903066|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166818|NCT02443116|464903067|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166819|NCT02443116|464903068|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129166820|NCT02443116|464903060|FG000|Part 3|Adverse Event|0|||
129166821|NCT02443116|464903061|FG001|Part 3|Adverse Event|0|||
129166822|NCT02443116|464903062|FG002|Part 3|Adverse Event|0|||
129166823|NCT02443116|464903063|FG003|Part 3|Adverse Event|0|||
129166824|NCT02443116|464903064|FG004|Part 3|Adverse Event|0|||
129166825|NCT02443116|464903065|FG005|Part 3|Adverse Event|0|||
129166826|NCT02443116|464903066|FG006|Part 3|Adverse Event|0|||
128727178|NCT01336738|463298687|FG001|Overall Study|Withdrawal by Subject|0|||
128727179|NCT01336738|463298688|FG002|Overall Study|Withdrawal by Subject|2|||
128727180|NCT01336738|463298689|FG003|Overall Study|Withdrawal by Subject|1|||
128727181|NCT01336738|463298690|FG004|Overall Study|Withdrawal by Subject|1|||
128727182|NCT01336738|463298686|FG000|Overall Study|Other|3|||
129166827|NCT02443116|464903067|FG007|Part 3|Adverse Event|0|||
129166828|NCT02443116|464903068|FG008|Part 3|Adverse Event|1|||
129166829|NCT02443116|464903060|FG000|Part 3|Withdrew informed consent|0|||
128777709|NCT02711826|463475293|FG000|Overall Study|Infusion canceled for active infection|0|||
128777710|NCT02711826|463475294|FG001|Overall Study|Infusion canceled for active infection|1|||
128777711|NCT02711826|463475295|FG002|Overall Study|Infusion canceled for active infection|0|||
128777712|NCT02711826|463475296|FG003|Overall Study|Infusion canceled for active infection|0|||
128777713|NCT02711826|463475297|FG004|Overall Study|Infusion canceled for active infection|0|||
128777714|NCT02711826|463475293|FG000|Overall Study|Screen failures|0|||
128777715|NCT02711826|463475294|FG001|Overall Study|Screen failures|0|||
128777716|NCT02711826|463475295|FG002|Overall Study|Screen failures|0|||
128777717|NCT02711826|463475296|FG003|Overall Study|Screen failures|4|||
128777718|NCT02711826|463475297|FG004|Overall Study|Screen failures|0|||
128777719|NCT02906202|463475298|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
128777720|NCT01960790|463475299|FG000|Overall Study|Survey forms could not be recovered|3|||
128777721|NCT01960790|463475299|FG000|Overall Study|Treat with Humira outside survey period|3|||
128777722|NCT01960790|463475299|FG000|Overall Study|Transferred to another hospital|4|||
128777723|NCT01960790|463475299|FG000|Overall Study|Unevaluable for safety|1|||
128777724|NCT01987830|463475300|FG000|Overall Study|Never received baseline scan|1|||
128777725|NCT03990363|463475301|FG000|Overall Study|Withdrawal by Subject|10|||
128777726|NCT03990363|463475302|FG001|Overall Study|Withdrawal by Subject|9|||
128777727|NCT03990363|463475303|FG002|Overall Study|Withdrawal by Subject|18|||
128777728|NCT03990363|463475304|FG003|Overall Study|Withdrawal by Subject|11|||
128777729|NCT03990363|463475305|FG004|Overall Study|Withdrawal by Subject|9|||
128777730|NCT03990363|463475301|FG000|Overall Study|Physician Decision|1|||
128777731|NCT03990363|463475302|FG001|Overall Study|Physician Decision|0|||
128777732|NCT03990363|463475303|FG002|Overall Study|Physician Decision|0|||
128777733|NCT03990363|463475304|FG003|Overall Study|Physician Decision|0|||
128777734|NCT03990363|463475305|FG004|Overall Study|Physician Decision|0|||
128777735|NCT03990363|463475301|FG000|Overall Study|Adverse Event|1|||
128777736|NCT03990363|463475302|FG001|Overall Study|Adverse Event|3|||
128777737|NCT03990363|463475303|FG002|Overall Study|Adverse Event|2|||
128777738|NCT03990363|463475304|FG003|Overall Study|Adverse Event|2|||
128777739|NCT03990363|463475305|FG004|Overall Study|Adverse Event|0|||
128777740|NCT03990363|463475301|FG000|Overall Study|Death|14|||
128777741|NCT03990363|463475302|FG001|Overall Study|Death|8|||
128777742|NCT03990363|463475303|FG002|Overall Study|Death|14|||
128777743|NCT03990363|463475304|FG003|Overall Study|Death|10|||
128777744|NCT03990363|463475305|FG004|Overall Study|Death|11|||
128777745|NCT03990363|463475301|FG000|Overall Study|Failure to meet randomization criteria|0|||
128777746|NCT03990363|463475302|FG001|Overall Study|Failure to meet randomization criteria|1|||
128777747|NCT03990363|463475303|FG002|Overall Study|Failure to meet randomization criteria|1|||
128777748|NCT03990363|463475304|FG003|Overall Study|Failure to meet randomization criteria|0|||
128777749|NCT03990363|463475305|FG004|Overall Study|Failure to meet randomization criteria|0|||
128777750|NCT03990363|463475301|FG000|Overall Study|Lost to Follow-up|0|||
128777751|NCT03990363|463475302|FG001|Overall Study|Lost to Follow-up|0|||
128777752|NCT03990363|463475303|FG002|Overall Study|Lost to Follow-up|0|||
128777753|NCT03990363|463475304|FG003|Overall Study|Lost to Follow-up|1|||
128777754|NCT03990363|463475305|FG004|Overall Study|Lost to Follow-up|2|||
128777755|NCT03990363|463475301|FG000|Overall Study|Non-compliance with study drug|2|||
128777756|NCT03990363|463475302|FG001|Overall Study|Non-compliance with study drug|1|||
128777757|NCT03990363|463475303|FG002|Overall Study|Non-compliance with study drug|2|||
128777758|NCT03990363|463475304|FG003|Overall Study|Non-compliance with study drug|0|||
128777759|NCT03990363|463475305|FG004|Overall Study|Non-compliance with study drug|0|||
128777760|NCT03990363|463475301|FG000|Overall Study|Study terminated by sponsor|0|||
128777761|NCT03990363|463475302|FG001|Overall Study|Study terminated by sponsor|1|||
128777762|NCT03990363|463475303|FG002|Overall Study|Study terminated by sponsor|0|||
128777763|NCT03990363|463475304|FG003|Overall Study|Study terminated by sponsor|0|||
128777764|NCT03990363|463475305|FG004|Overall Study|Study terminated by sponsor|0|||
128777765|NCT03990363|463475301|FG000|Overall Study|Site terminated by sponsor|2|||
128777766|NCT03990363|463475302|FG001|Overall Study|Site terminated by sponsor|1|||
128777767|NCT03990363|463475303|FG002|Overall Study|Site terminated by sponsor|2|||
128777768|NCT03990363|463475304|FG003|Overall Study|Site terminated by sponsor|0|||
128777769|NCT03990363|463475305|FG004|Overall Study|Site terminated by sponsor|2|||
128777770|NCT03990363|463475301|FG000|Overall Study|Not categorized|5|||
129166830|NCT02443116|464903061|FG001|Part 3|Withdrew informed consent|0|||
129166831|NCT02443116|464903062|FG002|Part 3|Withdrew informed consent|0|||
129166832|NCT02443116|464903063|FG003|Part 3|Withdrew informed consent|0|||
129166833|NCT02443116|464903064|FG004|Part 3|Withdrew informed consent|0|||
129166834|NCT02443116|464903065|FG005|Part 3|Withdrew informed consent|0|||
129166835|NCT02443116|464903066|FG006|Part 3|Withdrew informed consent|0|||
129166836|NCT02443116|464903067|FG007|Part 3|Withdrew informed consent|3|||
129166837|NCT02443116|464903068|FG008|Part 3|Withdrew informed consent|2|||
128777771|NCT03990363|463475302|FG001|Overall Study|Not categorized|5|||
128777772|NCT03990363|463475303|FG002|Overall Study|Not categorized|3|||
129166838|NCT02443116|464903060|FG000|Part 3|Lost to Follow-up|0|||
129166839|NCT02443116|464903061|FG001|Part 3|Lost to Follow-up|0|||
129166840|NCT02443116|464903062|FG002|Part 3|Lost to Follow-up|0|||
128777773|NCT03990363|463475304|FG003|Overall Study|Not categorized|2|||
128777774|NCT03990363|463475305|FG004|Overall Study|Not categorized|2|||
128777775|NCT01563978|463475315|FG000|Overall Study|Physician Decision|1|||
129166841|NCT02443116|464903063|FG003|Part 3|Lost to Follow-up|0|||
129166842|NCT02443116|464903064|FG004|Part 3|Lost to Follow-up|0|||
128777776|NCT01563978|463475316|FG001|Overall Study|Physician Decision|0|||
128777777|NCT01563978|463475315|FG000|Overall Study|Lost to Follow-up|1|||
128777778|NCT01563978|463475316|FG001|Overall Study|Lost to Follow-up|0|||
128777779|NCT01563978|463475315|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
128777780|NCT01563978|463475316|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
128777781|NCT01563978|463475315|FG000|Overall Study|Adverse Event|1|||
128777782|NCT01563978|463475316|FG001|Overall Study|Adverse Event|2|||
128777783|NCT05764239|463475317|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
128777784|NCT05764239|463475317|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
128777785|NCT05764239|463475317|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
128777786|NCT05764239|463475317|FG000|DEP (Part 1)|Adverse Event|1|||
128777787|NCT05764239|463475317|FG000|DEP (Part 1)|Lost to Follow-up|1|||
128777788|NCT05764239|463475317|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
128777789|NCT05764239|463475317|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
128777790|NCT05764239|463475317|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
128777791|NCT05764239|463475317|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
128777792|NCT00057811|463475318|FG000|Overall Study|Lack of Efficacy|1|||
128777793|NCT00057811|463475319|FG001|Overall Study|Lack of Efficacy|4|||
128777794|NCT00057811|463475318|FG000|Overall Study|Physician Decision|1|||
128777795|NCT00057811|463475319|FG001|Overall Study|Physician Decision|0|||
128777796|NCT00057811|463475318|FG000|Overall Study|Withdrawal by Subject|3|||
128777797|NCT00057811|463475319|FG001|Overall Study|Withdrawal by Subject|4|||
128777798|NCT00057811|463475318|FG000|Overall Study|Ineligible|4|||
128777799|NCT00057811|463475319|FG001|Overall Study|Ineligible|2|||
128777800|NCT00057811|463475318|FG000|Overall Study|Inevaluable|1|||
128777801|NCT00057811|463475319|FG001|Overall Study|Inevaluable|2|||
128777802|NCT02169219|463475320|FG000|Overall Study|Lack of Efficacy|6|||
128777803|NCT00333138|463475324|FG000|Core Study (6 Months)|Adverse Event|4|||
128777804|NCT00333138|463475325|FG001|Core Study (6 Months)|Adverse Event|5|||
128777805|NCT00333138|463475326|FG002|Core Study (6 Months)|Adverse Event|8|||
128777806|NCT00333138|463475324|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
128777807|NCT00333138|463475325|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
128777808|NCT00333138|463475326|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
128777809|NCT00333138|463475324|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
128777810|NCT00333138|463475325|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
128777811|NCT00333138|463475326|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
128777812|NCT00333138|463475324|FG000|Core Study (6 Months)|Protocol Violation|1|||
128777813|NCT00333138|463475325|FG001|Core Study (6 Months)|Protocol Violation|0|||
128777814|NCT00333138|463475326|FG002|Core Study (6 Months)|Protocol Violation|1|||
128777815|NCT00333138|463475324|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
128777816|NCT00333138|463475325|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
128777817|NCT00333138|463475326|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
128777818|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
128777819|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
128777820|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
128777821|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
128777822|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
129166843|NCT02443116|464903065|FG005|Part 3|Lost to Follow-up|0|||
129166844|NCT02443116|464903066|FG006|Part 3|Lost to Follow-up|0|||
129166845|NCT02443116|464903067|FG007|Part 3|Lost to Follow-up|1|||
129166846|NCT02443116|464903068|FG008|Part 3|Lost to Follow-up|2|||
129166847|NCT02059499|464903075|FG000|Upto Week 20|Lost to Follow-up|2|||
129166848|NCT02059499|464903076|FG001|Upto Week 20|Lost to Follow-up|6|||
129166849|NCT02059499|464903077|FG002|Upto Week 20|Lost to Follow-up|0|||
129166850|NCT02059499|464903075|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
128777823|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
129166851|NCT02059499|464903076|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
129166852|NCT02059499|464903077|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
129166853|NCT02059499|464903075|FG000|Upto Week 20|Withdrawal by Subject|1|||
129166854|NCT02059499|464903076|FG001|Upto Week 20|Withdrawal by Subject|1|||
129166855|NCT02059499|464903077|FG002|Upto Week 20|Withdrawal by Subject|0|||
128777824|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
128777825|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
128777826|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
128777827|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
128777828|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
128777829|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
128777830|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
129166856|NCT02059499|464903075|FG000|Upto Week 20|No treatment per protocol criteria|0|||
129166857|NCT02059499|464903076|FG001|Upto Week 20|No treatment per protocol criteria|0|||
129166858|NCT02059499|464903077|FG002|Upto Week 20|No treatment per protocol criteria|5|||
129166859|NCT02059499|464903075|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
129166860|NCT02059499|464903076|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
129166861|NCT02059499|464903077|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
129166862|NCT02059499|464903075|FG000|Post-week 20|Lost to Follow-up|0|||
129166863|NCT02059499|464903076|FG001|Post-week 20|Lost to Follow-up|2|||
129166864|NCT02059499|464903077|FG002|Post-week 20|Lost to Follow-up|0|||
129166865|NCT02059499|464903075|FG000|Post-week 20|Withdrawal by Subject|0|||
129166866|NCT02059499|464903076|FG001|Post-week 20|Withdrawal by Subject|1|||
129166867|NCT02059499|464903077|FG002|Post-week 20|Withdrawal by Subject|0|||
129166868|NCT02059499|464903075|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
129166869|NCT02059499|464903076|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
129166870|NCT02059499|464903077|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
129166871|NCT03989349|464903078|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
129166872|NCT03989349|464903079|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129166873|NCT03989349|464903080|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129166874|NCT03989349|464903081|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129166875|NCT03989349|464903082|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129166876|NCT03989349|464903083|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129166877|NCT03989349|464903078|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
129166878|NCT03989349|464903079|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
129166879|NCT03989349|464903080|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129166880|NCT03989349|464903081|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129166881|NCT03989349|464903082|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129166882|NCT03989349|464903083|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129166883|NCT03989349|464903078|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
129166884|NCT03989349|464903079|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
129166885|NCT03989349|464903080|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129166886|NCT03989349|464903081|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129166887|NCT03989349|464903082|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129166888|NCT03989349|464903083|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129166889|NCT03989349|464903078|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
129166890|NCT03989349|464903079|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
129166891|NCT03989349|464903080|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129166892|NCT03989349|464903081|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129166893|NCT03989349|464903082|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129166894|NCT03989349|464903083|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
128727183|NCT01336738|463298687|FG001|Overall Study|Other|3|||
128727184|NCT01336738|463298688|FG002|Overall Study|Other|2|||
128727185|NCT01336738|463298689|FG003|Overall Study|Other|3|||
128727186|NCT01336738|463298690|FG004|Overall Study|Other|4|||
128727187|NCT03003520|463298692|FG000|Overall Study|Adverse Event|9|||
128727188|NCT03003520|463298693|FG001|Overall Study|Adverse Event|0|||
128727189|NCT03003520|463298692|FG000|Overall Study|Death|1|||
128727190|NCT03003520|463298693|FG001|Overall Study|Death|0|||
128727191|NCT03003520|463298692|FG000|Overall Study|Other reasons|4|||
128727192|NCT03003520|463298693|FG001|Overall Study|Other reasons|0|||
128727193|NCT03003520|463298692|FG000|Overall Study|Withdrawal by Subject|6|||
128727194|NCT03003520|463298693|FG001|Overall Study|Withdrawal by Subject|0|||
128727195|NCT03003520|463298692|FG000|Overall Study|Progressive disease|9|||
128727196|NCT03003520|463298693|FG001|Overall Study|Progressive disease|1|||
128727197|NCT01332149|463298694|FG000|Overall Study|Adverse Event|11|||
128727198|NCT01332149|463298695|FG001|Overall Study|Adverse Event|9|||
128727199|NCT01332149|463298694|FG000|Overall Study|Other unspecified|5|||
128727200|NCT01332149|463298695|FG001|Overall Study|Other unspecified|7|||
128727201|NCT01332149|463298694|FG000|Overall Study|Protocol Violation|1|||
128727202|NCT01332149|463298695|FG001|Overall Study|Protocol Violation|3|||
128727203|NCT01332149|463298694|FG000|Overall Study|Withdrawal by Subject|4|||
128727204|NCT01332149|463298695|FG001|Overall Study|Withdrawal by Subject|5|||
128727205|NCT01332149|463298694|FG000|Overall Study|Lost to Follow-up|1|||
128727206|NCT01332149|463298695|FG001|Overall Study|Lost to Follow-up|1|||
128727207|NCT01332149|463298694|FG000|Overall Study|Insufficient clinical response|4|||
128727208|NCT01332149|463298695|FG001|Overall Study|Insufficient clinical response|7|||
129166895|NCT03989349|464903078|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
129166896|NCT03989349|464903079|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
129166897|NCT03989349|464903080|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
129166898|NCT03989349|464903081|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
128727209|NCT01332149|463298694|FG000|Overall Study|Did not meet entrance criteria|3|||
128727210|NCT01332149|463298695|FG001|Overall Study|Did not meet entrance criteria|4|||
128727211|NCT01332149|463298694|FG000|Overall Study|Randomized but not treated|1|||
128727212|NCT01332149|463298695|FG001|Overall Study|Randomized but not treated|2|||
128727213|NCT02565381|463298696|FG000|Overall Study|Lost to Follow-up|1|||
128727214|NCT02565381|463298697|FG001|Overall Study|Lost to Follow-up|0|||
128727215|NCT02565381|463298698|FG002|Overall Study|Lost to Follow-up|1|||
128727216|NCT04615949|463298701|FG000|Overall Study|Withdrawal by Subject|2|||
128727217|NCT04615949|463298702|FG001|Overall Study|Withdrawal by Subject|4|||
128727218|NCT04615949|463298701|FG000|Overall Study|Lost to Follow-up|2|||
128727219|NCT04615949|463298702|FG001|Overall Study|Lost to Follow-up|2|||
128727220|NCT04615949|463298701|FG000|Overall Study|Death|0|||
128727221|NCT04615949|463298702|FG001|Overall Study|Death|2|||
128727222|NCT05084053|463298703|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
128727223|NCT05084053|463298704|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
128727224|NCT05084053|463298705|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
128727225|NCT05084053|463298706|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
128727226|NCT05084053|463298703|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
128727227|NCT05084053|463298704|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
128727228|NCT05084053|463298705|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
128727229|NCT05084053|463298706|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
128727230|NCT05084053|463298703|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
128727231|NCT05084053|463298704|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
128727232|NCT05084053|463298705|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
128727233|NCT05084053|463298706|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
128727234|NCT01920932|463298708|FG000|Overall Study|Death|1|||
128727235|NCT01920932|463298708|FG000|Overall Study|Withdrawal of consent|1|||
128727236|NCT00071812|463298709|FG000|24-Week Double-Blind Period|Adverse Event|2|||
128727237|NCT00071812|463298710|FG001|24-Week Double-Blind Period|Adverse Event|3|||
128727238|NCT00071812|463298711|FG002|24-Week Double-Blind Period|Adverse Event|4|||
128727239|NCT00071812|463298712|FG003|24-Week Double-Blind Period|Adverse Event|4|||
128727240|NCT00071812|463298709|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
128727241|NCT00071812|463298710|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
128727242|NCT00071812|463298711|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
128727243|NCT00071812|463298712|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
128727244|NCT00071812|463298709|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
128727245|NCT00071812|463298710|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
128727246|NCT00071812|463298711|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
128727247|NCT00071812|463298712|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
128727248|NCT00071812|463298709|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
128727249|NCT00071812|463298710|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
128727250|NCT00071812|463298711|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
128727251|NCT00071812|463298712|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
128727252|NCT00071812|463298709|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
128727253|NCT00071812|463298710|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
128727254|NCT00071812|463298711|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
128727255|NCT00071812|463298712|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
128727256|NCT00071812|463298709|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
128727257|NCT00071812|463298710|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
128727258|NCT00071812|463298711|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
128727259|NCT00071812|463298712|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
128727260|NCT00071812|463298709|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
128777831|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
128777832|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
128777833|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
128777834|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
128777835|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
128777836|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
128777837|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
128777838|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
128777839|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
128777840|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
128777841|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
128777842|NCT00333138|463475324|FG000|Extension Study (Month6 to End of Study)|Death|0|||
128777843|NCT00333138|463475325|FG001|Extension Study (Month6 to End of Study)|Death|1|||
128777844|NCT00333138|463475326|FG002|Extension Study (Month6 to End of Study)|Death|0|||
128777845|NCT00847301|463475327|FG000|Overall Study|Adverse Event|35|||
128777846|NCT00847301|463475327|FG000|Overall Study|Switch to other anticoagulants|16|||
128777847|NCT00847301|463475327|FG000|Overall Study|Lost to Follow-up|1|||
128777848|NCT00847301|463475327|FG000|Overall Study|No prescription after hospital discharge|1|||
128777849|NCT00847301|463475327|FG000|Overall Study|Other reason not defined above|1|||
128777850|NCT04248465|463475331|FG000|Randomized-Controlled Period|Death|12|||
128777851|NCT04248465|463475332|FG001|Randomized-Controlled Period|Death|5|||
128777852|NCT04248465|463475331|FG000|Randomized-Controlled Period|Adverse Event|2|||
128777853|NCT04248465|463475332|FG001|Randomized-Controlled Period|Adverse Event|0|||
128777854|NCT04248465|463475331|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
128777855|NCT04248465|463475332|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
128777856|NCT04248465|463475331|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
128777857|NCT04248465|463475332|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
128777858|NCT04248465|463475331|FG000|Randomized-Controlled Period|Physician Decision|1|||
128777859|NCT04248465|463475332|FG001|Randomized-Controlled Period|Physician Decision|1|||
128777860|NCT04248465|463475331|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
128777861|NCT04248465|463475332|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
128777862|NCT04248465|463475331|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
128777863|NCT04248465|463475332|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
128777864|NCT04248465|463475331|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
128777865|NCT04248465|463475332|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
128777866|NCT03621982|463475333|FG000|Overall Study|Withdrawal by Subject|1|||
128777867|NCT03621982|463475334|FG001|Overall Study|Withdrawal by Subject|0|||
128777868|NCT03621982|463475335|FG002|Overall Study|Withdrawal by Subject|0|||
128777869|NCT03621982|463475336|FG003|Overall Study|Withdrawal by Subject|1|||
128777870|NCT03621982|463475337|FG004|Overall Study|Withdrawal by Subject|0|||
128777871|NCT03621982|463475338|FG005|Overall Study|Withdrawal by Subject|1|||
128777872|NCT03621982|463475339|FG006|Overall Study|Withdrawal by Subject|1|||
128777873|NCT03621982|463475340|FG007|Overall Study|Withdrawal by Subject|0|||
128777874|NCT03621982|463475341|FG008|Overall Study|Withdrawal by Subject|1|||
128777875|NCT03621982|463475342|FG009|Overall Study|Withdrawal by Subject|0|||
128777876|NCT03621982|463475343|FG010|Overall Study|Withdrawal by Subject|2|||
128777877|NCT03621982|463475344|FG011|Overall Study|Withdrawal by Subject|1|||
128777878|NCT03621982|463475345|FG012|Overall Study|Withdrawal by Subject|2|||
128777879|NCT03621982|463475346|FG013|Overall Study|Withdrawal by Subject|2|||
128777880|NCT03621982|463475333|FG000|Overall Study|Investigator/Sponsor decision|0|||
128777881|NCT03621982|463475334|FG001|Overall Study|Investigator/Sponsor decision|0|||
128777882|NCT03621982|463475335|FG002|Overall Study|Investigator/Sponsor decision|0|||
128777883|NCT03621982|463475336|FG003|Overall Study|Investigator/Sponsor decision|0|||
128777884|NCT03621982|463475337|FG004|Overall Study|Investigator/Sponsor decision|0|||
128777885|NCT03621982|463475338|FG005|Overall Study|Investigator/Sponsor decision|0|||
128777886|NCT03621982|463475339|FG006|Overall Study|Investigator/Sponsor decision|0|||
128777887|NCT03621982|463475340|FG007|Overall Study|Investigator/Sponsor decision|0|||
128777888|NCT03621982|463475341|FG008|Overall Study|Investigator/Sponsor decision|0|||
128777889|NCT03621982|463475342|FG009|Overall Study|Investigator/Sponsor decision|0|||
128777890|NCT03621982|463475343|FG010|Overall Study|Investigator/Sponsor decision|0|||
128777891|NCT03621982|463475344|FG011|Overall Study|Investigator/Sponsor decision|4|||
128777892|NCT03621982|463475345|FG012|Overall Study|Investigator/Sponsor decision|0|||
128777893|NCT03621982|463475346|FG013|Overall Study|Investigator/Sponsor decision|2|||
128777894|NCT03621982|463475333|FG000|Overall Study|Death|2|||
128777895|NCT03621982|463475334|FG001|Overall Study|Death|4|||
128777896|NCT03621982|463475335|FG002|Overall Study|Death|4|||
128777897|NCT03621982|463475336|FG003|Overall Study|Death|3|||
128777898|NCT03621982|463475337|FG004|Overall Study|Death|8|||
128777899|NCT03621982|463475338|FG005|Overall Study|Death|4|||
128777900|NCT03621982|463475339|FG006|Overall Study|Death|6|||
128777901|NCT03621982|463475340|FG007|Overall Study|Death|3|||
128777902|NCT03621982|463475341|FG008|Overall Study|Death|0|||
128777903|NCT03621982|463475342|FG009|Overall Study|Death|3|||
128777904|NCT03621982|463475343|FG010|Overall Study|Death|8|||
128777905|NCT03621982|463475344|FG011|Overall Study|Death|4|||
128777906|NCT03621982|463475345|FG012|Overall Study|Death|2|||
128777907|NCT03621982|463475346|FG013|Overall Study|Death|2|||
128777908|NCT03621982|463475333|FG000|Overall Study|Lost to Follow-up|0|||
128777909|NCT03621982|463475334|FG001|Overall Study|Lost to Follow-up|0|||
128777910|NCT03621982|463475335|FG002|Overall Study|Lost to Follow-up|1|||
128777911|NCT03621982|463475336|FG003|Overall Study|Lost to Follow-up|0|||
128777912|NCT03621982|463475337|FG004|Overall Study|Lost to Follow-up|0|||
128777913|NCT03621982|463475338|FG005|Overall Study|Lost to Follow-up|0|||
128777914|NCT03621982|463475339|FG006|Overall Study|Lost to Follow-up|1|||
128777915|NCT03621982|463475340|FG007|Overall Study|Lost to Follow-up|0|||
128777916|NCT03621982|463475341|FG008|Overall Study|Lost to Follow-up|0|||
128777917|NCT03621982|463475342|FG009|Overall Study|Lost to Follow-up|1|||
128777918|NCT03621982|463475343|FG010|Overall Study|Lost to Follow-up|0|||
128777919|NCT03621982|463475344|FG011|Overall Study|Lost to Follow-up|0|||
128777920|NCT03621982|463475345|FG012|Overall Study|Lost to Follow-up|0|||
128777921|NCT03621982|463475346|FG013|Overall Study|Lost to Follow-up|0|||
128727261|NCT00071812|463298710|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
128727262|NCT00071812|463298711|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
128727263|NCT00071812|463298712|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
128727264|NCT00071812|463298709|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
128727265|NCT00071812|463298710|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
128727266|NCT00071812|463298711|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
128727267|NCT00071812|463298712|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
128727268|NCT00071812|463298709|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128727269|NCT00071812|463298710|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128727270|NCT00071812|463298711|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128727271|NCT00071812|463298712|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
128727272|NCT00071812|463298709|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129166899|NCT03989349|464903082|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
129166900|NCT03989349|464903083|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
129166901|NCT03989349|464903078|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
129166902|NCT03989349|464903079|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129166903|NCT03989349|464903080|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129166904|NCT03989349|464903081|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129166905|NCT03989349|464903082|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129166906|NCT03989349|464903083|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129166907|NCT03989349|464903078|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
129166908|NCT03989349|464903079|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
129166909|NCT03989349|464903080|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129166910|NCT03989349|464903081|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129166911|NCT03989349|464903082|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129166912|NCT03989349|464903083|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129166913|NCT03989349|464903078|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129166914|NCT03989349|464903079|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129166915|NCT03989349|464903080|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
129166916|NCT03989349|464903081|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
129166917|NCT03989349|464903082|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
129166918|NCT03989349|464903083|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
129166919|NCT03989349|464903078|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129166920|NCT03989349|464903079|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129166921|NCT03989349|464903080|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
129166922|NCT03989349|464903081|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
129166923|NCT03989349|464903082|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
129166924|NCT03989349|464903083|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
129166925|NCT03989349|464903078|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129166926|NCT03989349|464903079|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129166927|NCT03989349|464903080|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
129166928|NCT03989349|464903081|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
129166929|NCT03989349|464903082|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
129166930|NCT03989349|464903083|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
129166931|NCT03989349|464903078|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129166932|NCT03989349|464903079|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129166933|NCT03989349|464903080|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129166934|NCT03989349|464903081|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129166935|NCT03989349|464903082|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
129166936|NCT03989349|464903083|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129166937|NCT03989349|464903078|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129166938|NCT03989349|464903079|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129166939|NCT03989349|464903080|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
129166940|NCT03989349|464903081|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
129166941|NCT03989349|464903082|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129166942|NCT03989349|464903083|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
129166943|NCT03989349|464903078|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
129166944|NCT03989349|464903079|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
129166945|NCT03989349|464903080|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
129166946|NCT03989349|464903081|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
129166947|NCT03989349|464903082|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
129166948|NCT03989349|464903083|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
129166949|NCT03989349|464903078|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
129166950|NCT03989349|464903079|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
129166951|NCT03989349|464903080|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
128727273|NCT00071812|463298710|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
128727274|NCT00071812|463298711|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
128727275|NCT00071812|463298712|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
128727276|NCT02554656|463298713|FG000|Overall Study|Protocol Violation|3|||
128727277|NCT00749463|463298718|FG000|Overall Study|Adverse Event|0|||
128727278|NCT00749463|463298719|FG001|Overall Study|Adverse Event|4|||
128727279|NCT00749463|463298720|FG002|Overall Study|Adverse Event|1|||
128727280|NCT00749463|463298718|FG000|Overall Study|Withdrawal by Subject|1|||
128727281|NCT00749463|463298719|FG001|Overall Study|Withdrawal by Subject|0|||
128727282|NCT00749463|463298720|FG002|Overall Study|Withdrawal by Subject|0|||
129166952|NCT03989349|464903081|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
129166953|NCT03989349|464903082|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
128727283|NCT00697346|463298725|FG000|Overall Study|Adverse Event|4|||
128727284|NCT00697346|463298726|FG001|Overall Study|Adverse Event|5|||
128727285|NCT00697346|463298727|FG002|Overall Study|Adverse Event|0|||
128727286|NCT00697346|463298725|FG000|Overall Study|Progressive Disease|19|||
128727287|NCT00697346|463298726|FG001|Overall Study|Progressive Disease|18|||
128727288|NCT00697346|463298727|FG002|Overall Study|Progressive Disease|0|||
128727289|NCT00697346|463298725|FG000|Overall Study|Symptomatic Deterioration|0|||
128727290|NCT00697346|463298726|FG001|Overall Study|Symptomatic Deterioration|1|||
128727291|NCT00697346|463298727|FG002|Overall Study|Symptomatic Deterioration|0|||
128727292|NCT00697346|463298725|FG000|Overall Study|Withdrawal by Subject|2|||
128727293|NCT00697346|463298726|FG001|Overall Study|Withdrawal by Subject|2|||
128727294|NCT00697346|463298727|FG002|Overall Study|Withdrawal by Subject|0|||
128727295|NCT00697346|463298725|FG000|Overall Study|Reason not Specified|3|||
128727296|NCT00697346|463298726|FG001|Overall Study|Reason not Specified|0|||
128727297|NCT00697346|463298727|FG002|Overall Study|Reason not Specified|1|||
128727298|NCT00805935|463298730|FG000|Overall Study|Stimulation Failure|1|||
128727299|NCT00805935|463298731|FG001|Overall Study|Stimulation Failure|5|||
128727300|NCT00805935|463298732|FG002|Overall Study|Stimulation Failure|2|||
128727301|NCT00805935|463298733|FG003|Overall Study|Stimulation Failure|2|||
128727302|NCT00805935|463298730|FG000|Overall Study|Cycle cancelled|0|||
128727303|NCT00805935|463298731|FG001|Overall Study|Cycle cancelled|0|||
128727304|NCT00805935|463298732|FG002|Overall Study|Cycle cancelled|2|||
128727305|NCT00805935|463298733|FG003|Overall Study|Cycle cancelled|0|||
128727306|NCT00805935|463298730|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
128727307|NCT00805935|463298731|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
128727308|NCT00805935|463298732|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
128727309|NCT00805935|463298733|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
128727310|NCT00805935|463298730|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
128727311|NCT00805935|463298731|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
128727312|NCT00805935|463298732|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
128727313|NCT00805935|463298733|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
128727314|NCT00805935|463298730|FG000|Overall Study|Lost to Follow-up|1|||
128727315|NCT00805935|463298731|FG001|Overall Study|Lost to Follow-up|0|||
128727316|NCT00805935|463298732|FG002|Overall Study|Lost to Follow-up|0|||
128727317|NCT00805935|463298733|FG003|Overall Study|Lost to Follow-up|0|||
128727318|NCT00805935|463298730|FG000|Overall Study|No positive serum pregnancy|8|||
128727319|NCT00805935|463298731|FG001|Overall Study|No positive serum pregnancy|7|||
128727320|NCT00805935|463298732|FG002|Overall Study|No positive serum pregnancy|6|||
128727321|NCT00805935|463298733|FG003|Overall Study|No positive serum pregnancy|5|||
128727322|NCT00805935|463298730|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
128727323|NCT00805935|463298731|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
128727324|NCT00805935|463298732|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
128727325|NCT00805935|463298733|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
128727326|NCT00805935|463298730|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
128727327|NCT00805935|463298731|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
128727328|NCT00805935|463298732|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
128727329|NCT00805935|463298733|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
128727330|NCT00805935|463298730|FG000|Overall Study|Biochemical pregnancy|0|||
128727331|NCT00805935|463298731|FG001|Overall Study|Biochemical pregnancy|1|||
128727332|NCT00805935|463298732|FG002|Overall Study|Biochemical pregnancy|0|||
128727333|NCT00805935|463298733|FG003|Overall Study|Biochemical pregnancy|0|||
128727334|NCT00805935|463298730|FG000|Overall Study|Chemical pregnancy|0|||
128727335|NCT00805935|463298731|FG001|Overall Study|Chemical pregnancy|5|||
128727336|NCT00805935|463298732|FG002|Overall Study|Chemical pregnancy|3|||
128727337|NCT00805935|463298733|FG003|Overall Study|Chemical pregnancy|2|||
128727338|NCT00805935|463298730|FG000|Overall Study|Ectopic pregnancy|0|||
128727339|NCT00805935|463298731|FG001|Overall Study|Ectopic pregnancy|0|||
128727340|NCT00805935|463298732|FG002|Overall Study|Ectopic pregnancy|1|||
128727341|NCT00805935|463298733|FG003|Overall Study|Ectopic pregnancy|0|||
128727342|NCT00805935|463298730|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
128727343|NCT00805935|463298731|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
128727344|NCT00805935|463298732|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
128727345|NCT00805935|463298733|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
128727346|NCT00240071|463298737|FG000|Overall Study|Withdrawal by Subject|3|||
128727347|NCT01143090|463298742|FG000|Overall Study|Lack of Efficacy|2|||
128727348|NCT01143090|463298742|FG000|Overall Study|Adverse Event|17|||
128727349|NCT01143090|463298742|FG000|Overall Study|Lost to Follow-up|9|||
128727350|NCT01143090|463298742|FG000|Overall Study|Protocol Violation|2|||
128727351|NCT01143090|463298742|FG000|Overall Study|Withdrawal by Subject|18|||
128727352|NCT01143090|463298742|FG000|Overall Study|Non-compliance with study drug|1|||
128727353|NCT01143090|463298742|FG000|Overall Study|Failure to meet eligibility criteria|1|||
128777922|NCT00442286|463475349|FG000|Overall Study|Death|2|||
128727354|NCT01143090|463298742|FG000|Overall Study|Administrative|1|||
129166954|NCT03989349|464903083|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
129166955|NCT01352221|464903084|FG000|Double-blind Phase|Adverse Event|6|||
129166956|NCT01352221|464903085|FG001|Double-blind Phase|Adverse Event|4|||
129166957|NCT01352221|464903086|FG002|Double-blind Phase|Adverse Event|0|||
129166958|NCT01352221|464903087|FG003|Double-blind Phase|Adverse Event|0|||
129166959|NCT01352221|464903084|FG000|Double-blind Phase|Withdrawal by Subject|3|||
129166960|NCT01352221|464903085|FG001|Double-blind Phase|Withdrawal by Subject|5|||
129166961|NCT01352221|464903086|FG002|Double-blind Phase|Withdrawal by Subject|0|||
129166962|NCT01352221|464903087|FG003|Double-blind Phase|Withdrawal by Subject|0|||
129166963|NCT01352221|464903084|FG000|Double-blind Phase|Lost to Follow-up|0|||
129166964|NCT01352221|464903085|FG001|Double-blind Phase|Lost to Follow-up|1|||
129166965|NCT01352221|464903086|FG002|Double-blind Phase|Lost to Follow-up|0|||
129166966|NCT01352221|464903087|FG003|Double-blind Phase|Lost to Follow-up|0|||
129166967|NCT01352221|464903084|FG000|Double-blind Phase|Protocol Violation|0|||
129166968|NCT01352221|464903085|FG001|Double-blind Phase|Protocol Violation|1|||
129166969|NCT01352221|464903086|FG002|Double-blind Phase|Protocol Violation|0|||
129166970|NCT01352221|464903087|FG003|Double-blind Phase|Protocol Violation|0|||
129166971|NCT01352221|464903084|FG000|Open-label Phase|Physician Decision|0|||
129166972|NCT01352221|464903085|FG001|Open-label Phase|Physician Decision|0|||
129166973|NCT01352221|464903086|FG002|Open-label Phase|Physician Decision|2|||
129166974|NCT01352221|464903087|FG003|Open-label Phase|Physician Decision|1|||
129166975|NCT01352221|464903084|FG000|Open-label Phase|Pregnancy|0|||
129166976|NCT01352221|464903085|FG001|Open-label Phase|Pregnancy|0|||
129166977|NCT01352221|464903086|FG002|Open-label Phase|Pregnancy|1|||
129166978|NCT01352221|464903087|FG003|Open-label Phase|Pregnancy|0|||
129166979|NCT01352221|464903084|FG000|Open-label Phase|Adverse Event|0|||
129166980|NCT01352221|464903085|FG001|Open-label Phase|Adverse Event|0|||
128727355|NCT01461096|463298745|FG000|Overall Study|Death|3|||
128727356|NCT01461096|463298746|FG001|Overall Study|Death|6|||
128727357|NCT01461096|463298745|FG000|Overall Study|Severe debilitation, unable to continue|1|||
128727358|NCT01461096|463298746|FG001|Overall Study|Severe debilitation, unable to continue|1|||
128727359|NCT01461096|463298745|FG000|Overall Study|Subj not able to get to clinic|15|||
128727360|NCT01461096|463298746|FG001|Overall Study|Subj not able to get to clinic|13|||
128727361|NCT01461096|463298745|FG000|Overall Study|Site is closing|27|||
128727362|NCT01461096|463298746|FG001|Overall Study|Site is closing|30|||
128727363|NCT01461096|463298745|FG000|Overall Study|Withdrawal by Subject|5|||
128727364|NCT01461096|463298746|FG001|Overall Study|Withdrawal by Subject|3|||
128727365|NCT01461096|463298745|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
128727366|NCT01461096|463298746|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
128727367|NCT01461096|463298745|FG000|Overall Study|Lost to Follow-up|8|||
128727368|NCT01461096|463298746|FG001|Overall Study|Lost to Follow-up|4|||
128727369|NCT01452412|463298752|FG000|Overall Study|Withdrawal by Subject|15|||
128727370|NCT01452412|463298753|FG001|Overall Study|Withdrawal by Subject|11|||
128727371|NCT01452412|463298752|FG000|Overall Study|Adverse Event|4|||
128727372|NCT01452412|463298753|FG001|Overall Study|Adverse Event|3|||
128727373|NCT01452412|463298752|FG000|Overall Study|Lost to Follow-up|5|||
128727374|NCT01452412|463298753|FG001|Overall Study|Lost to Follow-up|3|||
128727375|NCT01452412|463298752|FG000|Overall Study|Death|1|||
128727376|NCT01452412|463298753|FG001|Overall Study|Death|0|||
128727377|NCT01452412|463298752|FG000|Overall Study|Initiated dialysis|1|||
128727378|NCT01452412|463298753|FG001|Overall Study|Initiated dialysis|0|||
128727379|NCT01452412|463298752|FG000|Overall Study|Other|2|||
128727380|NCT01452412|463298753|FG001|Overall Study|Other|0|||
128727381|NCT03013543|463298757|FG000|Overall Study|Withdrawal by Subject|0|||
128727382|NCT03013543|463298758|FG001|Overall Study|Withdrawal by Subject|2|||
128727383|NCT03013543|463298759|FG002|Overall Study|Withdrawal by Subject|0|||
128727384|NCT03013543|463298760|FG003|Overall Study|Withdrawal by Subject|5|||
128727385|NCT03013543|463298761|FG004|Overall Study|Withdrawal by Subject|6|||
128727386|NCT03013543|463298762|FG005|Overall Study|Withdrawal by Subject|2|||
128727387|NCT03013543|463298763|FG006|Overall Study|Withdrawal by Subject|3|||
128727388|NCT03013543|463298764|FG007|Overall Study|Withdrawal by Subject|1|||
128727389|NCT03013543|463298765|FG008|Overall Study|Withdrawal by Subject|0|||
128727390|NCT03013543|463298766|FG009|Overall Study|Withdrawal by Subject|4|||
128727391|NCT03013543|463298757|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
128727392|NCT03013543|463298758|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
128727393|NCT03013543|463298759|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
129166981|NCT01352221|464903086|FG002|Open-label Phase|Adverse Event|8|||
128727394|NCT03013543|463298760|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
128727395|NCT03013543|463298761|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
128727396|NCT03013543|463298762|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
128727397|NCT03013543|463298763|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
128727398|NCT03013543|463298764|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
128777923|NCT00442286|463475350|FG001|Overall Study|Death|2|||
129166982|NCT01352221|464903087|FG003|Open-label Phase|Adverse Event|4|||
129166983|NCT01352221|464903084|FG000|Open-label Phase|Withdrawal by Subject|0|||
129166984|NCT01352221|464903085|FG001|Open-label Phase|Withdrawal by Subject|0|||
128777924|NCT00442286|463475349|FG000|Overall Study|Lost to Follow-up|1|||
128777925|NCT00442286|463475350|FG001|Overall Study|Lost to Follow-up|0|||
128777926|NCT00442286|463475349|FG000|Overall Study|Withdrawal by Subject|2|||
128777927|NCT00442286|463475350|FG001|Overall Study|Withdrawal by Subject|0|||
128777928|NCT00442286|463475349|FG000|Overall Study|System explanted|1|||
128777929|NCT00442286|463475350|FG001|Overall Study|System explanted|0|||
128777930|NCT00442286|463475349|FG000|Overall Study|Patient Injury|1|||
128777931|NCT00442286|463475350|FG001|Overall Study|Patient Injury|0|||
128777932|NCT01544582|463475351|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
128777933|NCT01544582|463475352|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
128777934|NCT01544582|463475353|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
128777935|NCT01544582|463475354|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
128777936|NCT01544582|463475351|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
128777937|NCT01544582|463475352|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
128777938|NCT01544582|463475353|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
128777939|NCT01544582|463475354|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
128777940|NCT01544582|463475351|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
128777941|NCT01544582|463475352|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
128777942|NCT01544582|463475353|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
128777943|NCT01544582|463475354|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
128777944|NCT01544582|463475351|FG000|Analysis Population|Physician Decision|0|||
128777945|NCT01544582|463475352|FG001|Analysis Population|Physician Decision|13|||
128777946|NCT01544582|463475353|FG002|Analysis Population|Physician Decision|10|||
128777947|NCT01544582|463475354|FG003|Analysis Population|Physician Decision|9|||
128777948|NCT01544582|463475351|FG000|Analysis Population|Safety Reason|0|||
128777949|NCT01544582|463475352|FG001|Analysis Population|Safety Reason|33|||
128777950|NCT01544582|463475353|FG002|Analysis Population|Safety Reason|31|||
128727399|NCT03013543|463298765|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
128727400|NCT03013543|463298766|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
128727401|NCT03013543|463298757|FG000|Overall Study|Other|0|||
128727402|NCT03013543|463298758|FG001|Overall Study|Other|0|||
128727403|NCT03013543|463298759|FG002|Overall Study|Other|2|||
128727404|NCT03013543|463298760|FG003|Overall Study|Other|0|||
128727405|NCT03013543|463298761|FG004|Overall Study|Other|2|||
128727406|NCT03013543|463298762|FG005|Overall Study|Other|0|||
128727407|NCT03013543|463298763|FG006|Overall Study|Other|0|||
128727408|NCT03013543|463298764|FG007|Overall Study|Other|0|||
128727409|NCT03013543|463298765|FG008|Overall Study|Other|1|||
128727410|NCT03013543|463298766|FG009|Overall Study|Other|0|||
128727411|NCT03013543|463298757|FG000|Overall Study|Adverse Event|0|||
128727412|NCT03013543|463298758|FG001|Overall Study|Adverse Event|0|||
128727413|NCT03013543|463298759|FG002|Overall Study|Adverse Event|0|||
128727414|NCT03013543|463298760|FG003|Overall Study|Adverse Event|3|||
128727415|NCT03013543|463298761|FG004|Overall Study|Adverse Event|2|||
128727416|NCT03013543|463298762|FG005|Overall Study|Adverse Event|1|||
128727417|NCT03013543|463298763|FG006|Overall Study|Adverse Event|3|||
128727418|NCT03013543|463298764|FG007|Overall Study|Adverse Event|8|||
128727419|NCT03013543|463298765|FG008|Overall Study|Adverse Event|0|||
128727420|NCT03013543|463298766|FG009|Overall Study|Adverse Event|2|||
128727421|NCT03013543|463298757|FG000|Overall Study|Death|0|||
128727422|NCT03013543|463298758|FG001|Overall Study|Death|0|||
128727423|NCT03013543|463298759|FG002|Overall Study|Death|0|||
128727424|NCT03013543|463298760|FG003|Overall Study|Death|1|||
128727425|NCT03013543|463298761|FG004|Overall Study|Death|0|||
128727426|NCT03013543|463298762|FG005|Overall Study|Death|0|||
128727427|NCT03013543|463298763|FG006|Overall Study|Death|0|||
128727428|NCT03013543|463298764|FG007|Overall Study|Death|0|||
128727429|NCT03013543|463298765|FG008|Overall Study|Death|0|||
128727430|NCT03013543|463298766|FG009|Overall Study|Death|0|||
128727431|NCT03013543|463298757|FG000|Overall Study|Lack of Efficacy|0|||
128727432|NCT03013543|463298758|FG001|Overall Study|Lack of Efficacy|0|||
128727433|NCT03013543|463298759|FG002|Overall Study|Lack of Efficacy|0|||
128727434|NCT03013543|463298760|FG003|Overall Study|Lack of Efficacy|1|||
128727435|NCT03013543|463298761|FG004|Overall Study|Lack of Efficacy|0|||
128727436|NCT03013543|463298762|FG005|Overall Study|Lack of Efficacy|0|||
128727437|NCT03013543|463298763|FG006|Overall Study|Lack of Efficacy|0|||
128727438|NCT03013543|463298764|FG007|Overall Study|Lack of Efficacy|0|||
128727439|NCT03013543|463298765|FG008|Overall Study|Lack of Efficacy|0|||
128727440|NCT03013543|463298766|FG009|Overall Study|Lack of Efficacy|0|||
128727441|NCT03013543|463298757|FG000|Overall Study|Lost to Follow-up|0|||
128727442|NCT03013543|463298758|FG001|Overall Study|Lost to Follow-up|0|||
128727443|NCT03013543|463298759|FG002|Overall Study|Lost to Follow-up|0|||
128727444|NCT03013543|463298760|FG003|Overall Study|Lost to Follow-up|1|||
128727445|NCT03013543|463298761|FG004|Overall Study|Lost to Follow-up|0|||
128727446|NCT03013543|463298762|FG005|Overall Study|Lost to Follow-up|0|||
128727447|NCT03013543|463298763|FG006|Overall Study|Lost to Follow-up|1|||
128727448|NCT03013543|463298764|FG007|Overall Study|Lost to Follow-up|0|||
128727449|NCT03013543|463298765|FG008|Overall Study|Lost to Follow-up|0|||
128727450|NCT03013543|463298766|FG009|Overall Study|Lost to Follow-up|2|||
128727451|NCT03013543|463298757|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128727452|NCT03013543|463298758|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128727453|NCT03013543|463298759|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128727454|NCT03013543|463298760|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128727455|NCT03013543|463298761|FG004|Overall Study|Non-Compliance With Study Drug|0|||
128727456|NCT03013543|463298762|FG005|Overall Study|Non-Compliance With Study Drug|0|||
128727457|NCT03013543|463298763|FG006|Overall Study|Non-Compliance With Study Drug|0|||
128727458|NCT03013543|463298764|FG007|Overall Study|Non-Compliance With Study Drug|0|||
128727459|NCT03013543|463298765|FG008|Overall Study|Non-Compliance With Study Drug|1|||
128727460|NCT03013543|463298766|FG009|Overall Study|Non-Compliance With Study Drug|0|||
128727461|NCT03013543|463298757|FG000|Overall Study|Physician Decision|0|||
128727462|NCT03013543|463298758|FG001|Overall Study|Physician Decision|0|||
128727463|NCT03013543|463298759|FG002|Overall Study|Physician Decision|0|||
128727464|NCT03013543|463298760|FG003|Overall Study|Physician Decision|0|||
128727465|NCT03013543|463298761|FG004|Overall Study|Physician Decision|1|||
128727466|NCT03013543|463298762|FG005|Overall Study|Physician Decision|0|||
128727467|NCT03013543|463298763|FG006|Overall Study|Physician Decision|0|||
128727468|NCT03013543|463298764|FG007|Overall Study|Physician Decision|0|||
128727469|NCT03013543|463298765|FG008|Overall Study|Physician Decision|0|||
128727470|NCT03013543|463298766|FG009|Overall Study|Physician Decision|0|||
128727471|NCT03013543|463298757|FG000|Overall Study|Protocol Violation|0|||
128727472|NCT03013543|463298758|FG001|Overall Study|Protocol Violation|0|||
128727473|NCT03013543|463298759|FG002|Overall Study|Protocol Violation|0|||
128727474|NCT03013543|463298760|FG003|Overall Study|Protocol Violation|0|||
128727475|NCT03013543|463298761|FG004|Overall Study|Protocol Violation|0|||
128727476|NCT03013543|463298762|FG005|Overall Study|Protocol Violation|0|||
128727477|NCT03013543|463298763|FG006|Overall Study|Protocol Violation|0|||
128727478|NCT03013543|463298764|FG007|Overall Study|Protocol Violation|0|||
128727479|NCT03013543|463298765|FG008|Overall Study|Protocol Violation|0|||
128727480|NCT03013543|463298766|FG009|Overall Study|Protocol Violation|1|||
128727481|NCT04225923|463298767|FG000|Overall Study|Protocol Violation|1|||
128727482|NCT04225923|463298768|FG001|Overall Study|Protocol Violation|0|||
128727483|NCT04225923|463298769|FG002|Overall Study|Protocol Violation|1|||
128727484|NCT04225923|463298767|FG000|Overall Study|Withdrawal by Subject|4|||
128727485|NCT04225923|463298768|FG001|Overall Study|Withdrawal by Subject|1|||
128777951|NCT01544582|463475354|FG003|Analysis Population|Safety Reason|8|||
128777952|NCT01544582|463475351|FG000|Analysis Population|Effectiveness Reason|0|||
128727486|NCT04225923|463298769|FG002|Overall Study|Withdrawal by Subject|3|||
128727487|NCT04225923|463298767|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
128727488|NCT04225923|463298768|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
128727489|NCT04225923|463298769|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
128727490|NCT00855309|463298770|FG000|Overall Study|patient never recieved drug|1|||
128727491|NCT00855309|463298771|FG001|Overall Study|patient never recieved drug|0|||
128727492|NCT01417481|463298772|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
128727493|NCT01417481|463298773|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
128727494|NCT00829296|463298774|FG000|Overall Study|Adverse Event|5|||
128727495|NCT00829296|463298775|FG001|Overall Study|Adverse Event|4|||
128727496|NCT03029624|463298776|FG000|Overall Study|Adverse Event|1|||
128727497|NCT03029624|463298776|FG000|Overall Study|Withdrawal by Subject|1|||
128727498|NCT03029624|463298776|FG000|Overall Study|Lack of Efficacy|1|||
128727499|NCT03029624|463298776|FG000|Overall Study|MRI need|2|||
128727500|NCT04116710|463298780|FG000|Overall Study|Death|4|||
128727501|NCT04116710|463298781|FG001|Overall Study|Death|6|||
128727502|NCT04116710|463298782|FG002|Overall Study|Death|3|||
128727503|NCT04116710|463298783|FG003|Overall Study|Death|1|||
128727504|NCT04116710|463298780|FG000|Overall Study|Withdrawal by Subject|0|||
128727505|NCT04116710|463298781|FG001|Overall Study|Withdrawal by Subject|0|||
128727506|NCT04116710|463298782|FG002|Overall Study|Withdrawal by Subject|0|||
128727507|NCT04116710|463298783|FG003|Overall Study|Withdrawal by Subject|1|||
128727508|NCT00582933|463298784|FG000|Overall Study|Physician Decision|3|||
128727509|NCT01077960|463298785|FG000|Overall Study|Adverse Event|6|||
128727510|NCT01077960|463298785|FG000|Overall Study|Protocol Violation|3|||
128727511|NCT01077960|463298785|FG000|Overall Study|Lost to Follow-up|5|||
128727512|NCT01077960|463298785|FG000|Overall Study|Subject decision|1|||
128727513|NCT01077960|463298785|FG000|Overall Study|Reason unspecified|1|||
128727514|NCT03837899|463298786|FG000|Overall Study|Death|6|||
128727515|NCT03837899|463298787|FG001|Overall Study|Death|8|||
128727516|NCT03837899|463298788|FG002|Overall Study|Death|3|||
128727517|NCT03837899|463298789|FG003|Overall Study|Death|7|||
128727518|NCT03837899|463298790|FG004|Overall Study|Death|8|||
128727519|NCT03837899|463298791|FG005|Overall Study|Death|7|||
128727520|NCT03837899|463298786|FG000|Overall Study|Moved to post-trial access program|0|||
128727521|NCT03837899|463298787|FG001|Overall Study|Moved to post-trial access program|1|||
128727522|NCT03837899|463298788|FG002|Overall Study|Moved to post-trial access program|0|||
128727523|NCT03837899|463298789|FG003|Overall Study|Moved to post-trial access program|0|||
128727524|NCT03837899|463298790|FG004|Overall Study|Moved to post-trial access program|0|||
128727525|NCT03837899|463298791|FG005|Overall Study|Moved to post-trial access program|0|||
128727526|NCT03837899|463298786|FG000|Overall Study|Other|0|||
128727527|NCT03837899|463298787|FG001|Overall Study|Other|0|||
128727528|NCT03837899|463298788|FG002|Overall Study|Other|0|||
128727529|NCT03837899|463298789|FG003|Overall Study|Other|0|||
128727530|NCT03837899|463298790|FG004|Overall Study|Other|0|||
128727531|NCT03837899|463298791|FG005|Overall Study|Other|2|||
128727532|NCT03837899|463298786|FG000|Overall Study|Lost to Follow-up|0|||
128727533|NCT03837899|463298787|FG001|Overall Study|Lost to Follow-up|1|||
128727534|NCT03837899|463298788|FG002|Overall Study|Lost to Follow-up|0|||
128777953|NCT01544582|463475352|FG001|Analysis Population|Effectiveness Reason|48|||
128727535|NCT03837899|463298789|FG003|Overall Study|Lost to Follow-up|0|||
128727536|NCT03837899|463298790|FG004|Overall Study|Lost to Follow-up|0|||
128727537|NCT03837899|463298791|FG005|Overall Study|Lost to Follow-up|0|||
128727538|NCT03837899|463298786|FG000|Overall Study|Withdrawal by Subject|0|||
128727539|NCT03837899|463298787|FG001|Overall Study|Withdrawal by Subject|0|||
128727540|NCT03837899|463298788|FG002|Overall Study|Withdrawal by Subject|0|||
128727541|NCT03837899|463298789|FG003|Overall Study|Withdrawal by Subject|1|||
128777954|NCT01544582|463475353|FG002|Analysis Population|Effectiveness Reason|29|||
128777955|NCT01544582|463475354|FG003|Analysis Population|Effectiveness Reason|12|||
128777956|NCT01544582|463475351|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
128777957|NCT01544582|463475352|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
128777958|NCT01544582|463475353|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
128777959|NCT01544582|463475354|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
129166985|NCT01352221|464903086|FG002|Open-label Phase|Withdrawal by Subject|1|||
129166986|NCT01352221|464903087|FG003|Open-label Phase|Withdrawal by Subject|6|||
128727542|NCT03837899|463298790|FG004|Overall Study|Withdrawal by Subject|0|||
128727543|NCT03837899|463298791|FG005|Overall Study|Withdrawal by Subject|0|||
128727544|NCT03837899|463298786|FG000|Overall Study|Study specific discontinuation criteria|0|||
128727545|NCT03837899|463298787|FG001|Overall Study|Study specific discontinuation criteria|1|||
128727546|NCT03837899|463298788|FG002|Overall Study|Study specific discontinuation criteria|0|||
128727547|NCT03837899|463298789|FG003|Overall Study|Study specific discontinuation criteria|0|||
128727548|NCT03837899|463298790|FG004|Overall Study|Study specific discontinuation criteria|3|||
129166987|NCT01352221|464903084|FG000|Open-label Phase|Worsening of IBD|0|||
128727549|NCT03837899|463298791|FG005|Overall Study|Study specific discontinuation criteria|1|||
128727550|NCT01371656|463298792|FG000|Overall Study|Death|7|||
128727551|NCT01371656|463298793|FG001|Overall Study|Death|4|||
128727552|NCT01371656|463298792|FG000|Overall Study|Physician Decision|46|||
128727553|NCT01371656|463298793|FG001|Overall Study|Physician Decision|7|||
128727554|NCT01371656|463298792|FG000|Overall Study|Withdrawal by Subject|7|||
128727555|NCT01371656|463298793|FG001|Overall Study|Withdrawal by Subject|0|||
128727556|NCT01371656|463298792|FG000|Overall Study|Ineligible|4|||
128727557|NCT01371656|463298793|FG001|Overall Study|Ineligible|3|||
128727558|NCT01465464|463298794|FG000|Overall Study|Adverse Event|96|||
128727559|NCT01465464|463298795|FG001|Overall Study|Adverse Event|49|||
128727560|NCT01465464|463298794|FG000|Overall Study|Lack of Efficacy|139|||
128727561|NCT01465464|463298795|FG001|Overall Study|Lack of Efficacy|190|||
128727562|NCT01465464|463298794|FG000|Overall Study|Physician Decision|13|||
128727563|NCT01465464|463298795|FG001|Overall Study|Physician Decision|5|||
128727564|NCT01465464|463298794|FG000|Overall Study|Protocol Violation|1|||
128727565|NCT01465464|463298795|FG001|Overall Study|Protocol Violation|1|||
128727566|NCT01465464|463298794|FG000|Overall Study|Withdrawal by Subject|46|||
128727567|NCT01465464|463298795|FG001|Overall Study|Withdrawal by Subject|30|||
128727568|NCT01465464|463298794|FG000|Overall Study|Other|9|||
128727569|NCT01465464|463298795|FG001|Overall Study|Other|3|||
128727570|NCT01465464|463298794|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
128727571|NCT01465464|463298795|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
128727572|NCT00785486|463298796|FG000|Midazolam Alone|Withdrawal by Subject|1|||
128727573|NCT01554618|463298797|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
128727574|NCT01554618|463298798|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
128727575|NCT01554618|463298797|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
128727576|NCT01554618|463298798|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
128727577|NCT01554618|463298797|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
128727578|NCT01554618|463298798|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
128727579|NCT01554618|463298797|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
128727580|NCT01554618|463298798|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
128727581|NCT01554618|463298797|FG000|Open-Label Extension Period|Physician Decision|0|||
128727582|NCT01554618|463298798|FG001|Open-Label Extension Period|Physician Decision|1|||
128727583|NCT01554618|463298797|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
128727584|NCT01554618|463298798|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
128727585|NCT01393405|463298800|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
128727586|NCT01393405|463298801|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
128727587|NCT01393405|463298802|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
128727588|NCT01393405|463298800|FG000|Induction Period (week1-16)|Adverse Event|16|||
128727589|NCT01393405|463298801|FG001|Induction Period (week1-16)|Adverse Event|0|||
128727590|NCT01393405|463298802|FG002|Induction Period (week1-16)|Adverse Event|0|||
128727591|NCT01393405|463298800|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
128727592|NCT01393405|463298801|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
128727593|NCT01393405|463298802|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
128727594|NCT01393405|463298800|FG000|Maintenance Period Week|Lack of Efficacy|0|||
129166988|NCT01352221|464903085|FG001|Open-label Phase|Worsening of IBD|0|||
129166989|NCT01352221|464903086|FG002|Open-label Phase|Worsening of IBD|1|||
129166990|NCT01352221|464903087|FG003|Open-label Phase|Worsening of IBD|0|||
129166991|NCT02016716|464903088|FG000|Overall Study|Withdrawal by Subject|5|||
128727595|NCT01393405|463298801|FG001|Maintenance Period Week|Lack of Efficacy|22|||
128727596|NCT01393405|463298802|FG002|Maintenance Period Week|Lack of Efficacy|22|||
128727597|NCT01393405|463298800|FG000|Maintenance Period Week|Adverse Event|0|||
128777960|NCT01544582|463475351|FG000|Analysis Population|Lost to Follow-up|0|||
128727598|NCT01393405|463298801|FG001|Maintenance Period Week|Adverse Event|5|||
128727599|NCT01393405|463298802|FG002|Maintenance Period Week|Adverse Event|2|||
128727600|NCT01393405|463298800|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
128727601|NCT01393405|463298801|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
129166992|NCT02016716|464903089|FG001|Overall Study|Withdrawal by Subject|5|||
129166993|NCT02016716|464903090|FG002|Overall Study|Withdrawal by Subject|5|||
128727602|NCT01393405|463298802|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
128727603|NCT01393405|463298800|FG000|Maintenance Period Week|Lost to Follow-up|0|||
128727604|NCT01393405|463298801|FG001|Maintenance Period Week|Lost to Follow-up|1|||
128727605|NCT01393405|463298802|FG002|Maintenance Period Week|Lost to Follow-up|0|||
128727606|NCT04365699|463298805|FG000|Overall Study|Death|2|||
128727607|NCT04365699|463298806|FG001|Overall Study|Death|5|||
128727608|NCT04365699|463298807|FG002|Overall Study|Death|15|||
128727609|NCT02540954|463298808|FG000|Overall Study|Physician Decision|3|||
128727610|NCT02540954|463298809|FG001|Overall Study|Physician Decision|1|||
128727611|NCT02540954|463298808|FG000|Overall Study|Withdrawal by Subject|6|||
128727612|NCT02540954|463298809|FG001|Overall Study|Withdrawal by Subject|5|||
128727613|NCT02540954|463298808|FG000|Overall Study|Lost to Follow-up|1|||
128727614|NCT02540954|463298809|FG001|Overall Study|Lost to Follow-up|1|||
128727615|NCT02540954|463298808|FG000|Overall Study|Adverse Event|4|||
128727616|NCT02540954|463298809|FG001|Overall Study|Adverse Event|2|||
128727617|NCT02540954|463298808|FG000|Overall Study|Death|0|||
128727618|NCT02540954|463298809|FG001|Overall Study|Death|3|||
128727619|NCT02540954|463298808|FG000|Overall Study|Treatment failure|1|||
128727620|NCT02540954|463298809|FG001|Overall Study|Treatment failure|0|||
128727621|NCT02540954|463298808|FG000|Overall Study|Other reason|4|||
128727622|NCT02540954|463298809|FG001|Overall Study|Other reason|2|||
128727623|NCT00834912|463298812|FG000|Treatment Period 1|Adverse Event|0|||
128727624|NCT00834912|463298813|FG001|Treatment Period 1|Adverse Event|1|||
128727625|NCT00834912|463298814|FG002|Treatment Period 1|Adverse Event|0|||
128727626|NCT00834912|463298815|FG003|Treatment Period 1|Adverse Event|1|||
128727627|NCT00834912|463298816|FG004|Treatment Period 1|Adverse Event|0|||
128727628|NCT00834912|463298817|FG005|Treatment Period 1|Adverse Event|0|||
128727629|NCT00834912|463298812|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128727630|NCT00834912|463298813|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128727631|NCT00834912|463298814|FG002|Treatment Period 2|Withdrawal by Subject|1|||
128727632|NCT00834912|463298815|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128727633|NCT00834912|463298816|FG004|Treatment Period 2|Withdrawal by Subject|1|||
128727634|NCT00834912|463298817|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128727635|NCT03829046|463298818|FG000|Overall Study|Withdrawal by Subject|1|||
128727636|NCT03829046|463298819|FG001|Overall Study|Withdrawal by Subject|0|||
128727637|NCT00244712|463298822|FG000|Overall Study|Adverse Event|20|||
128727638|NCT00244712|463298823|FG001|Overall Study|Adverse Event|21|||
128727639|NCT00244712|463298822|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
128727640|NCT00244712|463298823|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
128727641|NCT00244712|463298822|FG000|Overall Study|Lack of Compliance|10|||
128727642|NCT00244712|463298823|FG001|Overall Study|Lack of Compliance|11|||
128727643|NCT00244712|463298822|FG000|Overall Study|Lost to Follow-up|45|||
128727644|NCT00244712|463298823|FG001|Overall Study|Lost to Follow-up|52|||
128727645|NCT00244712|463298822|FG000|Overall Study|Withdrawal by Subject|13|||
128727646|NCT00244712|463298823|FG001|Overall Study|Withdrawal by Subject|23|||
128727647|NCT00244712|463298822|FG000|Overall Study|Protocol Violation, disease progression|13|||
128727648|NCT00244712|463298823|FG001|Overall Study|Protocol Violation, disease progression|11|||
128727649|NCT02970968|463300084|FG000|Overall Study|Withdrawal by Subject|3|||
128727650|NCT02970968|463300085|FG001|Overall Study|Withdrawal by Subject|3|||
128727651|NCT02970968|463300084|FG000|Overall Study|Adverse Event|1|||
128727652|NCT02970968|463300085|FG001|Overall Study|Adverse Event|2|||
128727653|NCT02970968|463300084|FG000|Overall Study|Lost to Follow-up|1|||
128727654|NCT02970968|463300085|FG001|Overall Study|Lost to Follow-up|1|||
128727655|NCT02970968|463300084|FG000|Overall Study|Non-Compliance|0|||
128727656|NCT02970968|463300085|FG001|Overall Study|Non-Compliance|1|||
128727657|NCT01945489|463300088|FG000|Cycle 1|Adverse Event|2|||
128727658|NCT01945489|463300089|FG001|Cycle 1|Adverse Event|0|||
128727659|NCT01945489|463300088|FG000|Cycle 1|Lost to Follow-up|4|||
128727660|NCT01945489|463300089|FG001|Cycle 1|Lost to Follow-up|0|||
128727661|NCT01945489|463300088|FG000|Cycle 1|Personal Reasons|4|||
128727662|NCT01945489|463300089|FG001|Cycle 1|Personal Reasons|2|||
128727663|NCT01945489|463300088|FG000|Cycle 1|Protocol Violation|0|||
128727664|NCT01945489|463300089|FG001|Cycle 1|Protocol Violation|1|||
129166994|NCT02016716|464903088|FG000|Overall Study|Protocol-specified Criteria|0|||
129166995|NCT02016716|464903089|FG001|Overall Study|Protocol-specified Criteria|1|||
129166996|NCT02016716|464903090|FG002|Overall Study|Protocol-specified Criteria|0|||
129166997|NCT02016716|464903088|FG000|Overall Study|Lost to Follow-up|1|||
129166998|NCT02016716|464903089|FG001|Overall Study|Lost to Follow-up|2|||
128727665|NCT01945489|463300088|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
128727666|NCT01945489|463300089|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
128777961|NCT01544582|463475352|FG001|Analysis Population|Lost to Follow-up|6|||
129166999|NCT02016716|464903090|FG002|Overall Study|Lost to Follow-up|1|||
129167000|NCT02248649|464903091|FG000|Overall Study|Death|7|||
128727667|NCT01945489|463300088|FG000|Cycle 2|Adverse Event|1|||
128727668|NCT01945489|463300089|FG001|Cycle 2|Adverse Event|0|||
128727669|NCT01945489|463300088|FG000|Cycle 2|Lost to Follow-up|0|||
128727670|NCT01945489|463300089|FG001|Cycle 2|Lost to Follow-up|1|||
128727671|NCT03569371|463300090|FG000|Overall Study|Lack of Efficacy|1|||
128727672|NCT03569371|463300090|FG000|Overall Study|Lost to Follow-up|1|||
128727673|NCT03569371|463300090|FG000|Overall Study|Adverse Event|1|||
129167001|NCT02248649|464903092|FG001|Overall Study|Death|11|||
129167002|NCT02248649|464903091|FG000|Overall Study|Lost to Follow-up|14|||
129167003|NCT02248649|464903092|FG001|Overall Study|Lost to Follow-up|10|||
129167004|NCT01439971|464903093|FG000|Overall Study|Required number in cohort dosed|0|||
129167005|NCT01439971|464903094|FG001|Overall Study|Required number in cohort dosed|1|||
128727674|NCT01236755|463300091|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
128727675|NCT01236755|463300091|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
128727676|NCT01236755|463300091|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
128727677|NCT01236755|463300091|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
128727678|NCT04904185|463300092|FG000|Overall Study|Expansion failure|1|||
128727679|NCT04904185|463300093|FG001|Overall Study|Expansion failure|0|||
128727680|NCT04904185|463300092|FG000|Overall Study|Late response on prior treatment|1|||
128727681|NCT04904185|463300093|FG001|Overall Study|Late response on prior treatment|0|||
128727682|NCT02433834|463300097|FG000|Overall Study|Protocol-specified criteria|7|||
128727683|NCT02433834|463300097|FG000|Overall Study|Protocol Violation|3|||
128727684|NCT02433834|463300097|FG000|Overall Study|Lost to Follow-up|6|||
128727685|NCT02433834|463300097|FG000|Overall Study|Withdrawal by Subject|14|||
128727686|NCT02433834|463300097|FG000|Overall Study|Adverse Event|6|||
128727687|NCT02433834|463300097|FG000|Overall Study|Physician Decision|1|||
128727688|NCT01539226|463300098|FG000|Overall Study|Withdrawal by Subject|24|||
128727689|NCT01539226|463300099|FG001|Overall Study|Withdrawal by Subject|54|||
128727690|NCT01539226|463300098|FG000|Overall Study|Lost to Follow-up|20|||
128727691|NCT01539226|463300099|FG001|Overall Study|Lost to Follow-up|54|||
128727692|NCT01539226|463300098|FG000|Overall Study|Death|1|||
128727693|NCT01539226|463300099|FG001|Overall Study|Death|2|||
128727694|NCT01539226|463300098|FG000|Overall Study|Adverse Event|2|||
128727695|NCT01539226|463300099|FG001|Overall Study|Adverse Event|0|||
128727696|NCT01539226|463300098|FG000|Overall Study|Pregnancy|13|||
128727697|NCT01539226|463300099|FG001|Overall Study|Pregnancy|29|||
128727698|NCT01539226|463300098|FG000|Overall Study|inappropriate enrollment|0|||
128727699|NCT01539226|463300099|FG001|Overall Study|inappropriate enrollment|1|||
128727700|NCT01539226|463300098|FG000|Overall Study|Multiple Reasons|3|||
128727701|NCT01539226|463300099|FG001|Overall Study|Multiple Reasons|1|||
128727702|NCT01539226|463300098|FG000|Overall Study|not HIV seroconversion-related|93|||
128727703|NCT01539226|463300099|FG001|Overall Study|not HIV seroconversion-related|176|||
128727704|NCT01539226|463300098|FG000|Overall Study|HIV seroconversion-related|55|||
128727705|NCT01539226|463300099|FG001|Overall Study|HIV seroconversion-related|80|||
128727706|NCT01539226|463300098|FG000|Overall Study|Non-compliance|6|||
128727707|NCT01539226|463300099|FG001|Overall Study|Non-compliance|8|||
128727708|NCT02643251|463300100|FG000|Overall Study|Adverse Event|3|||
128727709|NCT02643251|463300101|FG001|Overall Study|Adverse Event|1|||
128727710|NCT02643251|463300100|FG000|Overall Study|Withdrawal by Subject|2|||
128727711|NCT02643251|463300101|FG001|Overall Study|Withdrawal by Subject|0|||
128727712|NCT02643251|463300100|FG000|Overall Study|Lost to Follow-up|4|||
128727713|NCT02643251|463300101|FG001|Overall Study|Lost to Follow-up|1|||
129167006|NCT01439971|464903095|FG002|Overall Study|Required number in cohort dosed|2|||
129167007|NCT01439971|464903096|FG003|Overall Study|Required number in cohort dosed|0|||
129167008|NCT01439971|464903097|FG004|Overall Study|Required number in cohort dosed|1|||
129167009|NCT00661726|464903102|FG000|Overall Study|Adverse Event|1|||
129167010|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
129167011|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
129167012|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
129167013|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
129167014|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
129167015|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
129167016|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
129167017|NCT01673854|464903103|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
129167018|NCT01673854|464903103|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
129167019|NCT01673854|464903103|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
129167020|NCT01673854|464903103|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
129167021|NCT01673854|464903103|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
129167022|NCT00107900|464903104|FG000|Overall Study|Adverse Event|3|||
129167023|NCT00107900|464903105|FG001|Overall Study|Adverse Event|2|||
129167024|NCT00107900|464903106|FG002|Overall Study|Adverse Event|10|||
129167025|NCT00107900|464903107|FG003|Overall Study|Adverse Event|3|||
129167026|NCT00107900|464903108|FG004|Overall Study|Adverse Event|5|||
128727714|NCT02643251|463300100|FG000|Overall Study|Protocol Violation|1|||
128777962|NCT01544582|463475353|FG002|Analysis Population|Lost to Follow-up|6|||
129167027|NCT00107900|464903109|FG005|Overall Study|Adverse Event|3|||
129167028|NCT00107900|464903104|FG000|Overall Study|Death|0|||
128727715|NCT02643251|463300101|FG001|Overall Study|Protocol Violation|0|||
128727716|NCT02643251|463300100|FG000|Overall Study|PI Decision to terminate patient|1|||
128727717|NCT02643251|463300101|FG001|Overall Study|PI Decision to terminate patient|0|||
128727718|NCT00333229|463300104|FG000|Overall Study|Lack of Efficacy|0|||
128727719|NCT00333229|463300105|FG001|Overall Study|Lack of Efficacy|1|||
128727720|NCT00348556|463300106|FG000|Overall Study|Adverse Event|1|||
128727721|NCT01944059|463300107|FG000|Overall Study|Lost to Follow-up|1|||
128727722|NCT01944059|463300107|FG000|Overall Study|Physician Decision|3|||
128727723|NCT01944059|463300107|FG000|Overall Study|Withdrawal by Subject|1|||
128727724|NCT01944059|463300107|FG000|Overall Study|Adverse Event|2|||
128727725|NCT05923229|463300112|FG000|Overall Study|Withdrawal by Subject|3|||
128727726|NCT05923229|463300113|FG001|Overall Study|Withdrawal by Subject|0|||
128727727|NCT05923229|463300112|FG000|Overall Study|Health related|2|||
128727728|NCT05923229|463300113|FG001|Overall Study|Health related|1|||
128727729|NCT03064126|463300114|FG000|Overall Study|Death|40|||
128727730|NCT03064126|463300115|FG001|Overall Study|Death|16|||
128727731|NCT03064126|463300116|FG002|Overall Study|Death|4|||
128727732|NCT03064126|463300117|FG003|Overall Study|Death|2|||
128727733|NCT03064126|463300114|FG000|Overall Study|Withdrawal by Subject|17|||
128727734|NCT03064126|463300115|FG001|Overall Study|Withdrawal by Subject|9|||
128727735|NCT03064126|463300116|FG002|Overall Study|Withdrawal by Subject|0|||
128727736|NCT03064126|463300117|FG003|Overall Study|Withdrawal by Subject|2|||
128727737|NCT03064126|463300114|FG000|Overall Study|Lost to Follow-up|7|||
128727738|NCT03064126|463300115|FG001|Overall Study|Lost to Follow-up|3|||
128727739|NCT03064126|463300116|FG002|Overall Study|Lost to Follow-up|0|||
128727740|NCT03064126|463300117|FG003|Overall Study|Lost to Follow-up|0|||
128727741|NCT03064126|463300114|FG000|Overall Study|Adverse Event|2|||
128727742|NCT03064126|463300115|FG001|Overall Study|Adverse Event|0|||
128727743|NCT03064126|463300116|FG002|Overall Study|Adverse Event|0|||
128727744|NCT03064126|463300117|FG003|Overall Study|Adverse Event|0|||
128727745|NCT03064126|463300114|FG000|Overall Study|Physician Decision|3|||
128727746|NCT03064126|463300115|FG001|Overall Study|Physician Decision|0|||
128727747|NCT03064126|463300116|FG002|Overall Study|Physician Decision|0|||
128727748|NCT03064126|463300117|FG003|Overall Study|Physician Decision|0|||
128727749|NCT03064126|463300114|FG000|Overall Study|Other reason for early termination|3|||
128777963|NCT01544582|463475354|FG003|Analysis Population|Lost to Follow-up|5|||
129167029|NCT00107900|464903105|FG001|Overall Study|Death|0|||
129167030|NCT00107900|464903106|FG002|Overall Study|Death|0|||
129167031|NCT00107900|464903107|FG003|Overall Study|Death|0|||
129167032|NCT00107900|464903108|FG004|Overall Study|Death|1|||
129167033|NCT00107900|464903109|FG005|Overall Study|Death|0|||
129167034|NCT00107900|464903104|FG000|Overall Study|Lost to Follow-up|4|||
129167035|NCT00107900|464903105|FG001|Overall Study|Lost to Follow-up|1|||
129167036|NCT00107900|464903106|FG002|Overall Study|Lost to Follow-up|3|||
129167037|NCT00107900|464903107|FG003|Overall Study|Lost to Follow-up|2|||
129167038|NCT00107900|464903108|FG004|Overall Study|Lost to Follow-up|5|||
129167039|NCT00107900|464903109|FG005|Overall Study|Lost to Follow-up|5|||
129167040|NCT00107900|464903104|FG000|Overall Study|Protocol Violation|1|||
129167041|NCT00107900|464903105|FG001|Overall Study|Protocol Violation|0|||
129167042|NCT00107900|464903106|FG002|Overall Study|Protocol Violation|5|||
129167043|NCT00107900|464903107|FG003|Overall Study|Protocol Violation|5|||
129167044|NCT00107900|464903108|FG004|Overall Study|Protocol Violation|7|||
129167045|NCT00107900|464903109|FG005|Overall Study|Protocol Violation|0|||
129167046|NCT00107900|464903104|FG000|Overall Study|Withdrawal by Subject|1|||
129167047|NCT00107900|464903105|FG001|Overall Study|Withdrawal by Subject|0|||
129167048|NCT00107900|464903106|FG002|Overall Study|Withdrawal by Subject|5|||
129167049|NCT00107900|464903107|FG003|Overall Study|Withdrawal by Subject|0|||
129167050|NCT00107900|464903108|FG004|Overall Study|Withdrawal by Subject|1|||
129167051|NCT00107900|464903109|FG005|Overall Study|Withdrawal by Subject|1|||
129167052|NCT00107900|464903104|FG000|Overall Study|Administrative Reasons|1|||
129167053|NCT00107900|464903105|FG001|Overall Study|Administrative Reasons|0|||
129167054|NCT00107900|464903106|FG002|Overall Study|Administrative Reasons|2|||
129167055|NCT00107900|464903107|FG003|Overall Study|Administrative Reasons|2|||
129167056|NCT00107900|464903108|FG004|Overall Study|Administrative Reasons|2|||
129167057|NCT00107900|464903109|FG005|Overall Study|Administrative Reasons|0|||
129167058|NCT00830375|464903113|FG000|Overall Study|Lost to Follow-up|1|||
129167059|NCT01700959|464903114|FG000|Overall Study|Adverse Event|0|||
129167060|NCT01700959|464903115|FG001|Overall Study|Adverse Event|1|||
129167061|NCT01700959|464903116|FG002|Overall Study|Adverse Event|1|||
129167062|NCT01700959|464903117|FG003|Overall Study|Adverse Event|2|||
129167063|NCT01700959|464903118|FG004|Overall Study|Adverse Event|0|||
129167064|NCT01700959|464903119|FG005|Overall Study|Adverse Event|2|||
129167065|NCT01700959|464903114|FG000|Overall Study|Withdrawal by Subject|15|||
128727750|NCT03064126|463300115|FG001|Overall Study|Other reason for early termination|2|||
128727751|NCT03064126|463300116|FG002|Overall Study|Other reason for early termination|0|||
128727752|NCT03064126|463300117|FG003|Overall Study|Other reason for early termination|0|||
128727753|NCT03064126|463300114|FG000|Overall Study|Missed Visit|3|||
128727754|NCT03064126|463300115|FG001|Overall Study|Missed Visit|1|||
128727755|NCT03064126|463300116|FG002|Overall Study|Missed Visit|0|||
128727756|NCT03064126|463300117|FG003|Overall Study|Missed Visit|0|||
128777964|NCT01544582|463475351|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
128727757|NCT05288556|463300121|FG000|Overall Study|Protocol Violation|1|||
129167066|NCT01700959|464903115|FG001|Overall Study|Withdrawal by Subject|9|||
128727758|NCT05288556|463300121|FG000|Overall Study|Withdrawal by Subject|1|||
128727759|NCT02775344|463300123|FG000|Overall Study|No ovarian cyst identified|3|||
128727760|NCT02775344|463300124|FG001|Overall Study|No ovarian cyst identified|2|||
128727761|NCT04627064|463300125|FG000|Overall Study|Progressive disease|8|||
128727762|NCT04627064|463300126|FG001|Overall Study|Progressive disease|0|||
128727763|NCT04627064|463300125|FG000|Overall Study|Withdrawal by Subject|2|||
128727764|NCT04627064|463300126|FG001|Overall Study|Withdrawal by Subject|0|||
128727765|NCT04627064|463300125|FG000|Overall Study|Physician Decision|1|||
128727766|NCT04627064|463300126|FG001|Overall Study|Physician Decision|0|||
128727767|NCT01533246|463300127|FG000|Overall Study|Adverse Event|1|||
128727768|NCT01533246|463300127|FG000|Overall Study|Withdrawal by Subject|1|||
128727769|NCT03491150|463300128|FG000|Overall Study|Adverse Event|1|||
128727770|NCT03491150|463300129|FG001|Overall Study|Adverse Event|0|||
128727771|NCT03491150|463300128|FG000|Overall Study|Study Terminated by Sponsor|74|||
128727772|NCT03491150|463300129|FG001|Overall Study|Study Terminated by Sponsor|70|||
128777965|NCT01544582|463475352|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
128777966|NCT01544582|463475353|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
128777967|NCT01544582|463475354|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
128777968|NCT01544582|463475351|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
128777969|NCT01544582|463475352|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
128777970|NCT01544582|463475353|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
129167067|NCT01700959|464903116|FG002|Overall Study|Withdrawal by Subject|12|||
129167068|NCT01700959|464903117|FG003|Overall Study|Withdrawal by Subject|11|||
129167069|NCT01700959|464903118|FG004|Overall Study|Withdrawal by Subject|8|||
129167070|NCT01700959|464903119|FG005|Overall Study|Withdrawal by Subject|12|||
129167071|NCT01700959|464903114|FG000|Overall Study|Ineligible|2|||
129167072|NCT01700959|464903115|FG001|Overall Study|Ineligible|1|||
129167073|NCT01700959|464903116|FG002|Overall Study|Ineligible|2|||
129167074|NCT01700959|464903117|FG003|Overall Study|Ineligible|0|||
129167075|NCT01700959|464903118|FG004|Overall Study|Ineligible|0|||
129167076|NCT01700959|464903119|FG005|Overall Study|Ineligible|1|||
129167077|NCT01700959|464903114|FG000|Overall Study|Noncompliant|9|||
129167078|NCT01700959|464903115|FG001|Overall Study|Noncompliant|9|||
129167079|NCT01700959|464903116|FG002|Overall Study|Noncompliant|17|||
129167080|NCT01700959|464903117|FG003|Overall Study|Noncompliant|18|||
129167081|NCT01700959|464903118|FG004|Overall Study|Noncompliant|15|||
129167082|NCT01700959|464903119|FG005|Overall Study|Noncompliant|9|||
129167083|NCT01700959|464903114|FG000|Overall Study|Side effects|1|||
129167084|NCT01700959|464903115|FG001|Overall Study|Side effects|4|||
129167085|NCT01700959|464903116|FG002|Overall Study|Side effects|8|||
129167086|NCT01700959|464903117|FG003|Overall Study|Side effects|4|||
129167087|NCT01700959|464903118|FG004|Overall Study|Side effects|4|||
129167088|NCT01700959|464903119|FG005|Overall Study|Side effects|1|||
129167089|NCT00875485|464905785|FG000|Challenge Dose Epoch|Pregnancy|1|||
129167090|NCT00875485|464905786|FG001|Challenge Dose Epoch|Pregnancy|0|||
128777971|NCT01544582|463475354|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
129167091|NCT01271010|464905787|FG000|Overall Study|Reason not specified|11|||
129167092|NCT01271010|464905787|FG000|Overall Study|Start of new CLL therapy|1|||
129167093|NCT01271010|464905787|FG000|Overall Study|Protocol Violation|1|||
129167094|NCT01271010|464905787|FG000|Overall Study|Death|2|||
129167095|NCT01271010|464905787|FG000|Overall Study|Progression and relapse of disease|1|||
129167096|NCT01271010|464905787|FG000|Overall Study|Withdrawal by Subject|18|||
129167097|NCT01271010|464905787|FG000|Overall Study|Disease progression|27|||
129167098|NCT01631747|464905788|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
129167099|NCT01631747|464905789|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
129167100|NCT01631747|464905788|FG000|Live Birth|Pregnancy Termination|1|||
129167101|NCT01631747|464905789|FG001|Live Birth|Pregnancy Termination|0|||
129167102|NCT01631747|464905788|FG000|Live Birth|MIscarriage|2|||
129167103|NCT01631747|464905789|FG001|Live Birth|MIscarriage|0|||
129167104|NCT01631747|464905788|FG000|Live Birth|Stillbirth|1|||
129167105|NCT01631747|464905789|FG001|Live Birth|Stillbirth|1|||
129167106|NCT01631747|464905788|FG000|One Year Infant Outcomes|Patient Refused|13|||
129167107|NCT01631747|464905789|FG001|One Year Infant Outcomes|Patient Refused|9|||
129167108|NCT04848220|464905792|FG000|Overall Study|Unable to proceed to study procedure|0|||
129167109|NCT04848220|464905793|FG001|Overall Study|Unable to proceed to study procedure|1|||
129167110|NCT04848220|464905794|FG002|Overall Study|Unable to proceed to study procedure|0|||
129167111|NCT04848220|464905792|FG000|Overall Study|Fractional flow not significant|0|||
129167112|NCT04848220|464905793|FG001|Overall Study|Fractional flow not significant|1|||
129167113|NCT04848220|464905794|FG002|Overall Study|Fractional flow not significant|0|||
129167114|NCT02923830|464905795|FG000|Overall Study|Physician Decision|13|||
129167115|NCT02923830|464905796|FG001|Overall Study|Physician Decision|15|||
129167116|NCT00510718|464905797|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
129167117|NCT00510718|464905798|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
129167118|NCT00510718|464905797|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
129167119|NCT00510718|464905798|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
129167120|NCT00510718|464905797|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
129167121|NCT00510718|464905798|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
129167122|NCT00510718|464905797|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
129167123|NCT00510718|464905798|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
129167124|NCT00510718|464905797|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
129167125|NCT00510718|464905798|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
129167126|NCT00510718|464905797|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
129167127|NCT00510718|464905798|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
129167128|NCT02150057|464905807|FG000|Overall Study|Lost to Follow-up|6|||
129167129|NCT02150057|464905808|FG001|Overall Study|Lost to Follow-up|4|||
129167130|NCT00489424|464905809|FG000|Overall Study|Adverse Event|3|||
129167131|NCT00489424|464905810|FG001|Overall Study|Adverse Event|3|||
129167132|NCT00489424|464905811|FG002|Overall Study|Adverse Event|4|||
129167133|NCT00489424|464905809|FG000|Overall Study|Lack of Efficacy|1|||
128777972|NCT01544582|463475351|FG000|Analysis Population|Intolerance|0|||
129167134|NCT00489424|464905810|FG001|Overall Study|Lack of Efficacy|0|||
129167135|NCT00489424|464905811|FG002|Overall Study|Lack of Efficacy|0|||
129167136|NCT00489424|464905809|FG000|Overall Study|Administrative problems|0|||
129167137|NCT00489424|464905810|FG001|Overall Study|Administrative problems|2|||
128727773|NCT03491150|463300128|FG000|Overall Study|Other|0|||
128727774|NCT03491150|463300129|FG001|Overall Study|Other|1|||
128727775|NCT03491150|463300128|FG000|Overall Study|Withdrawal by Subject|1|||
128727776|NCT03491150|463300129|FG001|Overall Study|Withdrawal by Subject|2|||
128727777|NCT01800916|463300130|FG000|Test Period 1 (1 Week)|Convex product user|0|||
128727778|NCT01800916|463300131|FG001|Test Period 1 (1 Week)|Convex product user|0|||
128727779|NCT01800916|463300132|FG002|Test Period 1 (1 Week)|Convex product user|0|||
128727780|NCT01800916|463300133|FG003|Test Period 1 (1 Week)|Convex product user|1|||
128727781|NCT01800916|463300134|FG004|Test Period 1 (1 Week)|Convex product user|0|||
128727782|NCT01800916|463300135|FG005|Test Period 1 (1 Week)|Convex product user|0|||
128727783|NCT01800916|463300136|FG006|Test Period 1 (1 Week)|Convex product user|0|||
128727784|NCT01800916|463300137|FG007|Test Period 1 (1 Week)|Convex product user|0|||
128727785|NCT01800916|463300138|FG008|Test Period 1 (1 Week)|Convex product user|0|||
128727786|NCT01800916|463300130|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
128727787|NCT01800916|463300131|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
128727788|NCT01800916|463300132|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
128727789|NCT01800916|463300133|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
128727790|NCT01800916|463300134|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
128727791|NCT01800916|463300135|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
128727792|NCT01800916|463300136|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
128727793|NCT01800916|463300137|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
128727794|NCT01800916|463300138|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
128727795|NCT00727714|463300139|FG000|Overall Study|Lost to Follow-up|2|||
128727796|NCT00325234|463300142|FG000|Overall Study|Adverse Event|10|||
128727797|NCT00325234|463300143|FG001|Overall Study|Adverse Event|7|||
128727798|NCT00325234|463300142|FG000|Overall Study|Death due to Study Disease|1|||
128727799|NCT00325234|463300143|FG001|Overall Study|Death due to Study Disease|0|||
128727800|NCT00325234|463300142|FG000|Overall Study|Entry Criteria Not Met|1|||
128727801|NCT00325234|463300143|FG001|Overall Study|Entry Criteria Not Met|2|||
128727802|NCT00325234|463300142|FG000|Overall Study|Subject Decision|6|||
128727803|NCT00325234|463300143|FG001|Overall Study|Subject Decision|8|||
128727804|NCT00325234|463300142|FG000|Overall Study|Physician Decision|17|||
128727805|NCT00325234|463300143|FG001|Overall Study|Physician Decision|12|||
128727806|NCT00325234|463300142|FG000|Overall Study|Progressive Disease|34|||
128727807|NCT00325234|463300143|FG001|Overall Study|Progressive Disease|37|||
128727808|NCT01234467|463300144|FG000|Overall Study|Adverse Event|3|||
128727809|NCT01234467|463300144|FG000|Overall Study|Death|2|||
128727810|NCT01234467|463300144|FG000|Overall Study|Withdrawal by Subject|2|||
128727811|NCT01234467|463300144|FG000|Overall Study|Disease Progression|2|||
128727812|NCT01234467|463300144|FG000|Overall Study|Clinical deterioration|1|||
128727813|NCT01234467|463300144|FG000|Overall Study|Physician Decision|1|||
128727814|NCT01234467|463300144|FG000|Overall Study|Other complicating disease (stroke)|1|||
128727815|NCT00559962|463300147|FG000|Overall Study|Adverse Event|1|||
128727816|NCT00559962|463300148|FG001|Overall Study|Adverse Event|7|||
128727817|NCT00559962|463300149|FG002|Overall Study|Adverse Event|8|||
128727818|NCT00559962|463300150|FG003|Overall Study|Adverse Event|5|||
128727819|NCT00559962|463300151|FG004|Overall Study|Adverse Event|11|||
128727820|NCT00559962|463300152|FG005|Overall Study|Adverse Event|4|||
128727821|NCT00559962|463300153|FG006|Overall Study|Adverse Event|4|||
128727822|NCT00559962|463300154|FG007|Overall Study|Adverse Event|2|||
128727823|NCT00559962|463300147|FG000|Overall Study|Lost to Follow-up|0|||
128727824|NCT00559962|463300148|FG001|Overall Study|Lost to Follow-up|1|||
128727825|NCT00559962|463300149|FG002|Overall Study|Lost to Follow-up|0|||
128727826|NCT00559962|463300150|FG003|Overall Study|Lost to Follow-up|0|||
128727827|NCT00559962|463300151|FG004|Overall Study|Lost to Follow-up|0|||
128727828|NCT00559962|463300152|FG005|Overall Study|Lost to Follow-up|0|||
128727829|NCT00559962|463300153|FG006|Overall Study|Lost to Follow-up|0|||
128727830|NCT00559962|463300154|FG007|Overall Study|Lost to Follow-up|0|||
128727831|NCT00559962|463300147|FG000|Overall Study|Withdrawal by Subject|1|||
128727832|NCT00559962|463300148|FG001|Overall Study|Withdrawal by Subject|1|||
128727833|NCT00559962|463300149|FG002|Overall Study|Withdrawal by Subject|2|||
128727834|NCT00559962|463300150|FG003|Overall Study|Withdrawal by Subject|0|||
128727835|NCT00559962|463300151|FG004|Overall Study|Withdrawal by Subject|3|||
128727836|NCT00559962|463300152|FG005|Overall Study|Withdrawal by Subject|1|||
128727837|NCT00559962|463300153|FG006|Overall Study|Withdrawal by Subject|0|||
128727838|NCT00559962|463300154|FG007|Overall Study|Withdrawal by Subject|2|||
128727839|NCT00559962|463300147|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
128727840|NCT00559962|463300148|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
128727841|NCT00559962|463300149|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
128727842|NCT00559962|463300150|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
128727843|NCT00559962|463300151|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
128727844|NCT00559962|463300152|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
128727845|NCT00559962|463300153|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
128727846|NCT00559962|463300154|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
129167138|NCT00489424|464905811|FG002|Overall Study|Administrative problems|1|||
129167139|NCT00394251|464905812|FG000|Overall Study|Adverse Event|7|||
129167140|NCT00394251|464905813|FG001|Overall Study|Adverse Event|5|||
129167141|NCT00394251|464905812|FG000|Overall Study|Unacceptable Toxicity|20|||
129167142|NCT00394251|464905813|FG001|Overall Study|Unacceptable Toxicity|18|||
129167143|NCT00394251|464905812|FG000|Overall Study|Physician Decision|1|||
129167144|NCT00394251|464905813|FG001|Overall Study|Physician Decision|1|||
129167145|NCT00394251|464905812|FG000|Overall Study|Protocol Violation|0|||
129167146|NCT00394251|464905813|FG001|Overall Study|Protocol Violation|1|||
129167147|NCT00394251|464905812|FG000|Overall Study|Withdrawal by Subject|7|||
129167148|NCT00394251|464905813|FG001|Overall Study|Withdrawal by Subject|11|||
129167149|NCT00394251|464905812|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
129167150|NCT00394251|464905813|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
129167151|NCT05791565|464905814|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
129167152|NCT05791565|464905815|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
129167153|NCT01558115|464905816|FG000|Overall Study|Withdrawal by Subject|3|||
129167154|NCT01558115|464905816|FG000|Overall Study|Study closed due to poor enrollment|4|||
129167155|NCT01696994|464905817|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
129167156|NCT01696994|464905818|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
129167157|NCT01696994|464905817|FG000|Overall Study|Died Before Randomization|1|||
129167158|NCT01696994|464905818|FG001|Overall Study|Died Before Randomization|2|||
129167159|NCT01696994|464905817|FG000|Overall Study|Died Before ASU (Control)|73|||
129167160|NCT01696994|464905818|FG001|Overall Study|Died Before ASU (Control)|0|||
129167161|NCT01696994|464905817|FG000|Overall Study|No Ovaries at Baseline|4807|||
129167162|NCT01696994|464905818|FG001|Overall Study|No Ovaries at Baseline|4851|||
129167163|NCT01696994|464905817|FG000|Overall Study|Refused ASU (Control)|311|||
129167164|NCT01696994|464905818|FG001|Overall Study|Refused ASU (Control)|0|||
129167165|NCT01696994|464905817|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
129167166|NCT01696994|464905818|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
129167167|NCT02388165|464905819|FG000|Overall Study|Study terminated by sponsor|5|||
129167168|NCT02388165|464905820|FG001|Overall Study|Study terminated by sponsor|5|||
129167169|NCT02388165|464905819|FG000|Overall Study|Other|11|||
129167170|NCT02388165|464905820|FG001|Overall Study|Other|13|||
129167171|NCT02388165|464905819|FG000|Overall Study|No longer meet eligibility criteria|40|||
129167172|NCT02388165|464905820|FG001|Overall Study|No longer meet eligibility criteria|43|||
129167173|NCT02388165|464905819|FG000|Overall Study|Withdrawal of consent|31|||
129167174|NCT02388165|464905820|FG001|Overall Study|Withdrawal of consent|32|||
129167175|NCT02388165|464905819|FG000|Overall Study|Lost to Follow-up|19|||
129167176|NCT02388165|464905820|FG001|Overall Study|Lost to Follow-up|20|||
129167177|NCT02388165|464905819|FG000|Overall Study|Death|13|||
129167178|NCT02388165|464905820|FG001|Overall Study|Death|10|||
129167179|NCT02388165|464905819|FG000|Overall Study|Adverse Event|3|||
129167180|NCT02388165|464905820|FG001|Overall Study|Adverse Event|5|||
129167181|NCT02388165|464905819|FG000|Overall Study|Did not meet entrance criteria|5|||
129167182|NCT02388165|464905820|FG001|Overall Study|Did not meet entrance criteria|2|||
129167183|NCT00705250|464905821|FG000|Overall Study|Withdrawal by Subject|1|||
129167184|NCT00705250|464905821|FG000|Overall Study|Patient died in car accident|1|||
128727847|NCT01479621|463300155|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
128727848|NCT01479621|463300156|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128727849|NCT01479621|463300157|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128727850|NCT01479621|463300158|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128727851|NCT01479621|463300159|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128727852|NCT01479621|463300160|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128727853|NCT01479621|463300161|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
128727854|NCT01479621|463300155|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
128727855|NCT01479621|463300156|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128727856|NCT01479621|463300157|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129167185|NCT00880269|464905822|FG000|Overall Study|Protocol Violation|1|||
129167186|NCT00880269|464905823|FG001|Overall Study|Protocol Violation|0|||
129167187|NCT00880269|464905822|FG000|Overall Study|Disease Progression|13|||
129167188|NCT00880269|464905823|FG001|Overall Study|Disease Progression|11|||
129167189|NCT00880269|464905822|FG000|Overall Study|New Cancer Therapy|1|||
129167190|NCT00880269|464905823|FG001|Overall Study|New Cancer Therapy|0|||
129167191|NCT00880269|464905822|FG000|Overall Study|Death|4|||
129167192|NCT00880269|464905823|FG001|Overall Study|Death|2|||
129167193|NCT00880269|464905822|FG000|Overall Study|Lost to Follow-up|0|||
129167194|NCT00880269|464905823|FG001|Overall Study|Lost to Follow-up|1|||
129167195|NCT00880269|464905822|FG000|Overall Study|Withdrawal by Subject|3|||
129167196|NCT00880269|464905823|FG001|Overall Study|Withdrawal by Subject|4|||
129167197|NCT00880269|464905822|FG000|Overall Study|Adverse Event|10|||
128727857|NCT01479621|463300158|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128727858|NCT01479621|463300159|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128727859|NCT01479621|463300160|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128727860|NCT01479621|463300161|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
128727861|NCT01479621|463300155|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
128727862|NCT01479621|463300156|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128727863|NCT01479621|463300157|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128727864|NCT01479621|463300158|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128727865|NCT01479621|463300159|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128727866|NCT01479621|463300160|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128727867|NCT01479621|463300161|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
128727868|NCT01479621|463300155|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
128727869|NCT01479621|463300156|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128727870|NCT01479621|463300157|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128727871|NCT01479621|463300158|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128727872|NCT01479621|463300159|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128727873|NCT01479621|463300160|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128727874|NCT01479621|463300161|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
128727875|NCT01479621|463300155|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
128727876|NCT01479621|463300156|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128727877|NCT01479621|463300157|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128727878|NCT01479621|463300158|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128727879|NCT01479621|463300159|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128727880|NCT01479621|463300160|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128727881|NCT01479621|463300161|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
128727882|NCT01479621|463300155|FG000|Treatment Period|Adverse Event|0|||
128727883|NCT01479621|463300156|FG001|Treatment Period|Adverse Event|0|||
128727884|NCT01479621|463300157|FG002|Treatment Period|Adverse Event|0|||
128727885|NCT01479621|463300158|FG003|Treatment Period|Adverse Event|0|||
128727886|NCT01479621|463300159|FG004|Treatment Period|Adverse Event|1|||
128727887|NCT01479621|463300160|FG005|Treatment Period|Adverse Event|2|||
128727888|NCT01479621|463300161|FG006|Treatment Period|Adverse Event|2|||
128727889|NCT01479621|463300155|FG000|Treatment Period|Withdrawal by Subject|0|||
128727890|NCT01479621|463300156|FG001|Treatment Period|Withdrawal by Subject|4|||
128727891|NCT01479621|463300157|FG002|Treatment Period|Withdrawal by Subject|2|||
128727892|NCT01479621|463300158|FG003|Treatment Period|Withdrawal by Subject|2|||
128727893|NCT01479621|463300159|FG004|Treatment Period|Withdrawal by Subject|5|||
128727894|NCT01479621|463300160|FG005|Treatment Period|Withdrawal by Subject|5|||
128727895|NCT01479621|463300161|FG006|Treatment Period|Withdrawal by Subject|1|||
128727896|NCT01479621|463300155|FG000|Treatment Period|Physician Decision|0|||
128727897|NCT01479621|463300156|FG001|Treatment Period|Physician Decision|0|||
128727898|NCT01479621|463300157|FG002|Treatment Period|Physician Decision|0|||
128727899|NCT01479621|463300158|FG003|Treatment Period|Physician Decision|0|||
128727900|NCT01479621|463300159|FG004|Treatment Period|Physician Decision|1|||
128727901|NCT01479621|463300160|FG005|Treatment Period|Physician Decision|1|||
128727902|NCT01479621|463300161|FG006|Treatment Period|Physician Decision|0|||
128727903|NCT01479621|463300155|FG000|Treatment Period|Non-compliance to study drug|0|||
128727904|NCT01479621|463300156|FG001|Treatment Period|Non-compliance to study drug|1|||
128727905|NCT01479621|463300157|FG002|Treatment Period|Non-compliance to study drug|0|||
128727906|NCT01479621|463300158|FG003|Treatment Period|Non-compliance to study drug|0|||
128727907|NCT01479621|463300159|FG004|Treatment Period|Non-compliance to study drug|0|||
128727908|NCT01479621|463300160|FG005|Treatment Period|Non-compliance to study drug|0|||
128727909|NCT01479621|463300161|FG006|Treatment Period|Non-compliance to study drug|1|||
128727910|NCT01479621|463300155|FG000|Treatment Period|Protocol Violation|0|||
128727911|NCT01479621|463300156|FG001|Treatment Period|Protocol Violation|9|||
128727912|NCT01479621|463300157|FG002|Treatment Period|Protocol Violation|6|||
128727913|NCT01479621|463300158|FG003|Treatment Period|Protocol Violation|5|||
128727914|NCT01479621|463300159|FG004|Treatment Period|Protocol Violation|2|||
128727915|NCT01479621|463300160|FG005|Treatment Period|Protocol Violation|10|||
128727916|NCT01479621|463300161|FG006|Treatment Period|Protocol Violation|6|||
128727917|NCT01479621|463300155|FG000|Treatment Period|Pregnancy|0|||
129167198|NCT00880269|464905823|FG001|Overall Study|Adverse Event|9|||
129167199|NCT01576146|464905824|FG000|Extension Period 1|Adverse Event|2|||
128727918|NCT01479621|463300156|FG001|Treatment Period|Pregnancy|0|||
128727919|NCT01479621|463300157|FG002|Treatment Period|Pregnancy|2|||
128727920|NCT01479621|463300158|FG003|Treatment Period|Pregnancy|0|||
128727921|NCT01479621|463300159|FG004|Treatment Period|Pregnancy|0|||
128727922|NCT01479621|463300160|FG005|Treatment Period|Pregnancy|0|||
128727923|NCT01479621|463300161|FG006|Treatment Period|Pregnancy|0|||
128727924|NCT01479621|463300155|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
129167200|NCT01576146|464905824|FG000|Extension Period 1|Death|2|||
128727925|NCT01479621|463300156|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
128727926|NCT01479621|463300157|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
128727927|NCT01479621|463300158|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
128727928|NCT01479621|463300159|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
128727929|NCT01479621|463300160|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
128727930|NCT01479621|463300161|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
128727931|NCT01479621|463300155|FG000|Treatment Period|Lost to Follow-up|0|||
128727932|NCT01479621|463300156|FG001|Treatment Period|Lost to Follow-up|0|||
128727933|NCT01479621|463300157|FG002|Treatment Period|Lost to Follow-up|1|||
128727934|NCT01479621|463300158|FG003|Treatment Period|Lost to Follow-up|0|||
128727935|NCT01479621|463300159|FG004|Treatment Period|Lost to Follow-up|2|||
128727936|NCT01479621|463300160|FG005|Treatment Period|Lost to Follow-up|2|||
128727937|NCT01479621|463300161|FG006|Treatment Period|Lost to Follow-up|1|||
128727938|NCT01479621|463300155|FG000|Treatment Period|Met stopping criteria|0|||
128727939|NCT01479621|463300156|FG001|Treatment Period|Met stopping criteria|8|||
128727940|NCT01479621|463300157|FG002|Treatment Period|Met stopping criteria|7|||
128727941|NCT01479621|463300158|FG003|Treatment Period|Met stopping criteria|4|||
128727942|NCT01479621|463300159|FG004|Treatment Period|Met stopping criteria|9|||
128727943|NCT01479621|463300160|FG005|Treatment Period|Met stopping criteria|20|||
128727944|NCT01479621|463300161|FG006|Treatment Period|Met stopping criteria|6|||
128727945|NCT00486265|463300165|FG000|Overall Study|Adverse Event|1|||
128727946|NCT00486265|463300165|FG000|Overall Study|Lack of Efficacy|8|||
128727947|NCT03047135|463300166|FG000|Overall Study|Still being treated|3|||
128727948|NCT01537783|463300175|FG000|Overall Study|Lost to Follow-up|11|||
128727949|NCT01537783|463300176|FG001|Overall Study|Lost to Follow-up|2|||
128727950|NCT02244580|463300179|FG000|Overall Study|No cancer tissues available|241|||
128727951|NCT02722928|463300180|FG000|Overall Study|Standard CT was not as required per prot|5|||
128727952|NCT02722928|463300181|FG001|Overall Study|Standard CT was not as required per prot|13|||
128727953|NCT02722928|463300180|FG000|Overall Study|Required Intraoperative MRI|5|||
128727954|NCT02722928|463300181|FG001|Overall Study|Required Intraoperative MRI|7|||
128727955|NCT04011410|463300182|FG000|Overall Study|Withdrawal by Subject|1|||
128727956|NCT01838642|463300183|FG000|Overall Study|Died on study|1|||
128727957|NCT01398956|463300184|FG000|Overall Study|Withdrawal by Subject|4|||
128727958|NCT01398956|463300184|FG000|Overall Study|AE, non-serious non-fatal|4|||
128727959|NCT01398956|463300184|FG000|Overall Study|Withdrawal Criteria No.3|1|||
128727960|NCT01398956|463300184|FG000|Overall Study|Subject moved a long distance|1|||
128727961|NCT01557400|463300185|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
128727962|NCT01557400|463300185|FG000|Overall Study|Adverse Event|3|||
128727963|NCT01557400|463300185|FG000|Overall Study|Lost to Follow-up|5|||
128727964|NCT01557400|463300185|FG000|Overall Study|Withdrawal by Subject|9|||
128727965|NCT02281552|463300188|FG000|Overall Study|Medication error|1|||
128727966|NCT02281552|463300189|FG001|Overall Study|Medication error|0|||
128727967|NCT02281552|463300188|FG000|Overall Study|Insufficient clinical response|0|||
128727968|NCT02281552|463300189|FG001|Overall Study|Insufficient clinical response|1|||
128727969|NCT02281552|463300188|FG000|Overall Study|Adverse Event|3|||
128727970|NCT02281552|463300189|FG001|Overall Study|Adverse Event|9|||
128727971|NCT01224639|463300190|FG000|Overall Study|Withdrawal by Subject|0|||
128727972|NCT01224639|463300191|FG001|Overall Study|Withdrawal by Subject|0|||
128727973|NCT01224639|463300192|FG002|Overall Study|Withdrawal by Subject|0|||
128727974|NCT01224639|463300193|FG003|Overall Study|Withdrawal by Subject|0|||
128727975|NCT01224639|463300194|FG004|Overall Study|Withdrawal by Subject|2|||
128727976|NCT01224639|463300195|FG005|Overall Study|Withdrawal by Subject|0|||
128727977|NCT01224639|463300196|FG006|Overall Study|Withdrawal by Subject|1|||
128727978|NCT01224639|463300197|FG007|Overall Study|Withdrawal by Subject|1|||
128727979|NCT01224639|463300190|FG000|Overall Study|Adverse Event|0|||
128727980|NCT01224639|463300191|FG001|Overall Study|Adverse Event|0|||
128727981|NCT01224639|463300192|FG002|Overall Study|Adverse Event|0|||
128727982|NCT01224639|463300193|FG003|Overall Study|Adverse Event|0|||
128727983|NCT01224639|463300194|FG004|Overall Study|Adverse Event|0|||
128727984|NCT01224639|463300195|FG005|Overall Study|Adverse Event|0|||
128727985|NCT01224639|463300196|FG006|Overall Study|Adverse Event|0|||
128727986|NCT01224639|463300197|FG007|Overall Study|Adverse Event|1|||
128727987|NCT03465878|463300198|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
128727988|NCT03465878|463300199|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
128727989|NCT03465878|463300200|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
128727990|NCT03465878|463300201|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
128727991|NCT03465878|463300198|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
128727992|NCT03465878|463300199|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
128727993|NCT03465878|463300200|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
128727994|NCT03465878|463300201|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
128777973|NCT01544582|463475352|FG001|Analysis Population|Intolerance|1|||
128777974|NCT01544582|463475353|FG002|Analysis Population|Intolerance|0|||
128777975|NCT01544582|463475354|FG003|Analysis Population|Intolerance|0|||
128777976|NCT01544582|463475351|FG000|Analysis Population|Liver Transplantation|0|||
128727995|NCT03465878|463300198|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
128727996|NCT03465878|463300199|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
128727997|NCT03465878|463300200|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
128727998|NCT03465878|463300201|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
128727999|NCT04656132|463300202|FG000|Overall Study|Lost to Follow-up|4|||
128728000|NCT04656132|463300202|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
128728001|NCT00314366|463300203|FG000|Overall Study|not treated due to patient medical condi|1|||
128728002|NCT00314366|463300204|FG001|Overall Study|not treated due to patient medical condi|0|||
128728003|NCT00500370|463300213|FG000|Overall Study|Adverse Event|9|||
128728004|NCT00500370|463300214|FG001|Overall Study|Adverse Event|3|||
128728005|NCT00500370|463300213|FG000|Overall Study|Lost to Follow-up|10|||
128728006|NCT00500370|463300214|FG001|Overall Study|Lost to Follow-up|10|||
128728007|NCT00500370|463300213|FG000|Overall Study|Protocol Violation|2|||
128728008|NCT00500370|463300214|FG001|Overall Study|Protocol Violation|4|||
128728009|NCT00500370|463300213|FG000|Overall Study|Sponsor Decision|2|||
128728010|NCT00500370|463300214|FG001|Overall Study|Sponsor Decision|0|||
128728011|NCT00500370|463300213|FG000|Overall Study|Subject Decision|10|||
128728012|NCT00500370|463300214|FG001|Overall Study|Subject Decision|17|||
128728013|NCT01282424|463300215|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
128728014|NCT01282424|463300215|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
128728015|NCT01282424|463300215|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
128728016|NCT01282424|463300215|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
128728017|NCT01282424|463300215|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
128728018|NCT01282424|463300215|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
128728019|NCT01282424|463300215|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
128728020|NCT01282424|463300215|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
128728021|NCT04804813|463300216|FG000|Overall Study|Protocol Violation|2|||
128728022|NCT04804813|463300217|FG001|Overall Study|Protocol Violation|0|||
128728023|NCT04804813|463300216|FG000|Overall Study|Withdrawal by Subject|1|||
128728024|NCT04804813|463300217|FG001|Overall Study|Withdrawal by Subject|0|||
128728025|NCT02777125|463300222|FG000|Overall Study|Consent form violation|14|||
128728026|NCT02777125|463300223|FG001|Overall Study|Consent form violation|12|||
128728027|NCT02777125|463300222|FG000|Overall Study|Assent form violation|21|||
128728028|NCT02777125|463300223|FG001|Overall Study|Assent form violation|23|||
128728029|NCT02777125|463300222|FG000|Overall Study|Protocol Violation|8|||
128728030|NCT02777125|463300223|FG001|Overall Study|Protocol Violation|12|||
128728031|NCT06023394|463300225|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
128728032|NCT06023394|463300226|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
128728033|NCT06023394|463300225|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
128728034|NCT06023394|463300226|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
128728035|NCT06023394|463300225|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
128728036|NCT06023394|463300226|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
128728037|NCT06023394|463300225|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
128728038|NCT06023394|463300226|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
128728039|NCT02283788|463300227|FG000|Overall Study|Adverse Event|1|||
128728040|NCT02283788|463300228|FG001|Overall Study|Adverse Event|3|||
128728041|NCT02283788|463300229|FG002|Overall Study|Adverse Event|5|||
128728042|NCT02283788|463300230|FG003|Overall Study|Adverse Event|1|||
128728043|NCT02283788|463300227|FG000|Overall Study|Withdrawal by Subject|0|||
128728044|NCT02283788|463300228|FG001|Overall Study|Withdrawal by Subject|1|||
128728045|NCT02283788|463300229|FG002|Overall Study|Withdrawal by Subject|0|||
128728046|NCT02283788|463300230|FG003|Overall Study|Withdrawal by Subject|1|||
128728047|NCT01083433|463301726|FG000|Overall Study|Lost to Follow-up|2|||
128728048|NCT01083433|463301727|FG001|Overall Study|Lost to Follow-up|1|||
128728049|NCT01083433|463301728|FG002|Overall Study|Lost to Follow-up|1|||
128728050|NCT01083433|463301726|FG000|Overall Study|Withdrawal by Subject|0|||
128728051|NCT01083433|463301727|FG001|Overall Study|Withdrawal by Subject|5|||
128728052|NCT01083433|463301728|FG002|Overall Study|Withdrawal by Subject|3|||
128728053|NCT01083433|463301726|FG000|Overall Study|Pregnancy|0|||
128728054|NCT01083433|463301727|FG001|Overall Study|Pregnancy|0|||
128728055|NCT01083433|463301728|FG002|Overall Study|Pregnancy|1|||
128728056|NCT01581593|463301729|FG000|Overall Study|Withdrawal by Subject|1|||
128728057|NCT04982029|463301730|FG000|Overall Study|Lost to Follow-up|2|||
128728058|NCT04982029|463301731|FG001|Overall Study|Lost to Follow-up|3|||
128728059|NCT05458856|463301732|FG000|Overall Study|Withdrawal by Subject|5|||
128728060|NCT05458856|463301732|FG000|Overall Study|Death|4|||
128728061|NCT05458856|463301732|FG000|Overall Study|Protocol Deviation|3|||
128728062|NCT05458856|463301732|FG000|Overall Study|Physician Decision|1|||
128728063|NCT05168475|463301733|FG000|Period 1|Protocol Violation|1|||
128728064|NCT05168475|463301733|FG000|Period 1|IMP shortage|2|||
128728065|NCT05168475|463301733|FG000|Period 1|Not randomised|2|||
128728066|NCT05168475|463301733|FG000|Period 2|IMP shortage|1|||
128728067|NCT01589822|463301734|FG000|Overall Study|Withdrawal by Subject|1|||
128777977|NCT01544582|463475352|FG001|Analysis Population|Liver Transplantation|0|||
128777978|NCT01544582|463475353|FG002|Analysis Population|Liver Transplantation|1|||
128777979|NCT01544582|463475354|FG003|Analysis Population|Liver Transplantation|0|||
128777980|NCT01544582|463475351|FG000|Analysis Population|No Social Insurance|0|||
128777981|NCT01544582|463475352|FG001|Analysis Population|No Social Insurance|0|||
128777982|NCT01544582|463475353|FG002|Analysis Population|No Social Insurance|1|||
128777983|NCT01544582|463475354|FG003|Analysis Population|No Social Insurance|0|||
128777984|NCT01544582|463475351|FG000|Analysis Population|Poor Adherence|0|||
128777985|NCT01544582|463475352|FG001|Analysis Population|Poor Adherence|0|||
128777986|NCT01544582|463475353|FG002|Analysis Population|Poor Adherence|1|||
128777987|NCT01544582|463475354|FG003|Analysis Population|Poor Adherence|0|||
128777988|NCT01544582|463475351|FG000|Analysis Population|Poor Participant Compliance|0|||
128777989|NCT01544582|463475352|FG001|Analysis Population|Poor Participant Compliance|1|||
128777990|NCT01544582|463475353|FG002|Analysis Population|Poor Participant Compliance|0|||
128777991|NCT01544582|463475354|FG003|Analysis Population|Poor Participant Compliance|0|||
128777992|NCT01544582|463475351|FG000|Analysis Population|Programmed Surgery|0|||
128777993|NCT01544582|463475352|FG001|Analysis Population|Programmed Surgery|1|||
128777994|NCT01544582|463475353|FG002|Analysis Population|Programmed Surgery|0|||
128777995|NCT01544582|463475354|FG003|Analysis Population|Programmed Surgery|0|||
128777996|NCT01544582|463475351|FG000|Analysis Population|Participant in Jail|0|||
128777997|NCT01544582|463475352|FG001|Analysis Population|Participant in Jail|0|||
128777998|NCT01544582|463475353|FG002|Analysis Population|Participant in Jail|1|||
128777999|NCT01544582|463475354|FG003|Analysis Population|Participant in Jail|0|||
128778000|NCT03428815|463475355|FG000|Overall Study|Lost to Follow-up|2|||
128778001|NCT03428815|463475356|FG001|Overall Study|Lost to Follow-up|2|||
128778002|NCT03428815|463475355|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
128778003|NCT03428815|463475356|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
128778004|NCT03428815|463475355|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
129167201|NCT01576146|464905824|FG000|Extension Period 1|Physician Decision|2|||
129167202|NCT01576146|464905824|FG000|Extension Period 1|Withdrawal by Subject|1|||
129167203|NCT01576146|464905824|FG000|Extension Period 1|Lost to Follow-up|1|||
129167204|NCT01576146|464905824|FG000|Extension Period 1|Parathyroidectomy|1|||
129167205|NCT01576146|464905824|FG000|Extension Period 1|Renal Transplant|1|||
129167206|NCT01576146|464905824|FG000|Extension Period 2|Sponsor Decision|13|||
129167207|NCT01576146|464905824|FG000|Extension Period 2|Death|1|||
129167208|NCT01576146|464905824|FG000|Extension Period 2|Adverse Event|1|||
129167209|NCT01576146|464905824|FG000|Extension Period 2|Renal Transplant|1|||
129167210|NCT01576146|464905824|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
129167211|NCT00316225|464905825|FG000|Overall Study|Adverse Event|2|||
129167212|NCT00316225|464905825|FG000|Overall Study|Physician Decision|3|||
129167213|NCT00316225|464905825|FG000|Overall Study|Progressive Disease|15|||
129167214|NCT00316225|464905825|FG000|Overall Study|Withdrawal by Subject|3|||
129167215|NCT00316225|464905825|FG000|Overall Study|Death|2|||
129167216|NCT01811485|464905826|FG000|Overall Study|Adverse Event|1|||
129167217|NCT01811485|464905827|FG001|Overall Study|Adverse Event|3|||
129167218|NCT01811485|464905828|FG002|Overall Study|Adverse Event|2|||
129167219|NCT01811485|464905826|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129167220|NCT01811485|464905827|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129167221|NCT01811485|464905828|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
129167222|NCT01811485|464905826|FG000|Overall Study|Administrative problems|1|||
129167223|NCT01811485|464905827|FG001|Overall Study|Administrative problems|0|||
129167224|NCT01811485|464905828|FG002|Overall Study|Administrative problems|0|||
129167225|NCT01811485|464905826|FG000|Overall Study|Protocol Deviation|0|||
129167226|NCT01811485|464905827|FG001|Overall Study|Protocol Deviation|1|||
129167227|NCT01811485|464905828|FG002|Overall Study|Protocol Deviation|0|||
128778005|NCT03428815|463475356|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
129167228|NCT01545934|464905829|FG000|Overall Study|Withdrawal by Subject|4|||
129167229|NCT01545934|464905830|FG001|Overall Study|Withdrawal by Subject|3|||
129167230|NCT01545934|464905829|FG000|Overall Study|Lost to Follow-up|1|||
129167231|NCT01545934|464905830|FG001|Overall Study|Lost to Follow-up|0|||
129167232|NCT03654404|464905831|FG000|Overall Study|Death|1|||
129167233|NCT03654404|464905831|FG000|Overall Study|Lost to Follow-up|2|||
129167234|NCT03654404|464905831|FG000|Overall Study|Withdrawal by Subject|5|||
128778006|NCT00245011|463475361|FG000|Overall Study|Lack of Efficacy|1|||
128778007|NCT03317379|463475366|FG000|Overall Study|Lost to Follow-up|0|||
128778008|NCT03317379|463475367|FG001|Overall Study|Lost to Follow-up|3|||
129167235|NCT02003638|464905834|FG000|Overall Study|Withdrawal by Subject|1|||
129167236|NCT02003638|464905835|FG001|Overall Study|Withdrawal by Subject|0|||
129167237|NCT03215758|464905841|FG000|Overall Study|Technical Problems|1|||
128778009|NCT03317379|463475368|FG002|Overall Study|Lost to Follow-up|2|||
128778010|NCT00550173|463475369|FG000|Overall Study|Death|45|||
128778011|NCT00550173|463475370|FG001|Overall Study|Death|38|||
129167238|NCT03215758|464905842|FG001|Overall Study|Technical Problems|0|||
129167239|NCT03215758|464905841|FG000|Overall Study|Protocol deviation|0|||
129167240|NCT03215758|464905842|FG001|Overall Study|Protocol deviation|1|||
129167241|NCT03215758|464905841|FG000|Overall Study|Physician Decision|0|||
128778012|NCT00550173|463475371|FG002|Overall Study|Death|50|||
128778013|NCT00550173|463475369|FG000|Overall Study|Physician Decision|1|||
128778014|NCT00550173|463475370|FG001|Overall Study|Physician Decision|2|||
128778015|NCT00550173|463475371|FG002|Overall Study|Physician Decision|2|||
128778016|NCT00550173|463475369|FG000|Overall Study|Withdrawal by Subject|9|||
128778017|NCT00550173|463475370|FG001|Overall Study|Withdrawal by Subject|12|||
128778018|NCT00550173|463475371|FG002|Overall Study|Withdrawal by Subject|17|||
128778019|NCT00550173|463475369|FG000|Overall Study|Sponsor Decision|13|||
128778020|NCT00550173|463475370|FG001|Overall Study|Sponsor Decision|7|||
128778021|NCT00550173|463475371|FG002|Overall Study|Sponsor Decision|1|||
128778022|NCT00550173|463475369|FG000|Overall Study|Lost to Follow-up|4|||
128778023|NCT00550173|463475370|FG001|Overall Study|Lost to Follow-up|4|||
128778024|NCT00550173|463475371|FG002|Overall Study|Lost to Follow-up|3|||
128728068|NCT01589822|463301735|FG001|Overall Study|Withdrawal by Subject|2|||
128728069|NCT01589822|463301736|FG002|Overall Study|Withdrawal by Subject|0|||
128728070|NCT01589822|463301734|FG000|Overall Study|Death|1|||
128728071|NCT01589822|463301735|FG001|Overall Study|Death|0|||
128728072|NCT01589822|463301736|FG002|Overall Study|Death|0|||
128728073|NCT01589822|463301734|FG000|Overall Study|Missed 90 day visit|2|||
128728074|NCT01589822|463301735|FG001|Overall Study|Missed 90 day visit|1|||
128728075|NCT01589822|463301736|FG002|Overall Study|Missed 90 day visit|1|||
128728076|NCT01140477|463301739|FG000|Overall Study|Lost to Follow-up|4|||
128728077|NCT01140477|463301740|FG001|Overall Study|Lost to Follow-up|0|||
128728078|NCT01140477|463301739|FG000|Overall Study|Withdrawal by Subject|1|||
128728079|NCT01140477|463301740|FG001|Overall Study|Withdrawal by Subject|4|||
128728080|NCT01140477|463301739|FG000|Overall Study|Surgical complication preventing implant|2|||
128728081|NCT01140477|463301740|FG001|Overall Study|Surgical complication preventing implant|0|||
129167242|NCT03215758|464905842|FG001|Overall Study|Physician Decision|1|||
129167243|NCT03215758|464905841|FG000|Overall Study|Death|0|||
129167244|NCT03215758|464905842|FG001|Overall Study|Death|1|||
129167245|NCT03215758|464905841|FG000|Overall Study|Adverse Event|1|||
129167246|NCT03215758|464905842|FG001|Overall Study|Adverse Event|2|||
129167247|NCT03215758|464905841|FG000|Overall Study|Subject/Guardian Decision|3|||
129167248|NCT03215758|464905842|FG001|Overall Study|Subject/Guardian Decision|3|||
129167249|NCT00713349|464905843|FG000|Overall Study|Protocol Violation|1|||
129167250|NCT03764631|464905844|FG000|Overall Study|Personal Reasons|3|||
129167251|NCT03764631|464905845|FG001|Overall Study|Personal Reasons|2|||
129167252|NCT03764631|464905844|FG000|Overall Study|Switching Therapy|3|||
129167253|NCT03764631|464905845|FG001|Overall Study|Switching Therapy|3|||
129167254|NCT03764631|464905844|FG000|Overall Study|Adverse Event|0|||
129167255|NCT03764631|464905845|FG001|Overall Study|Adverse Event|1|||
129167256|NCT03764631|464905844|FG000|Overall Study|Lost to Follow-up|33|||
129167257|NCT03764631|464905845|FG001|Overall Study|Lost to Follow-up|41|||
129167258|NCT03764631|464905844|FG000|Overall Study|No data as study site was closed|2|||
129167259|NCT03764631|464905845|FG001|Overall Study|No data as study site was closed|6|||
129167260|NCT01200407|464905846|FG000|Overall Study|Lost to Follow-up|56|||
129167261|NCT01200407|464905846|FG000|Overall Study|Adverse Event|3|||
129167262|NCT01200407|464905846|FG000|Overall Study|Withdrawal by Subject|4|||
129167263|NCT01200407|464905846|FG000|Overall Study|Other|19|||
129167264|NCT03299881|464905847|FG000|Overall Study|Study Termination|17|||
128728082|NCT01140477|463301739|FG000|Overall Study|Death|1|||
128728083|NCT01140477|463301740|FG001|Overall Study|Death|1|||
128728084|NCT01140477|463301739|FG000|Overall Study|Subject explanted|0|||
128728085|NCT01140477|463301740|FG001|Overall Study|Subject explanted|1|||
128728086|NCT00773175|463301741|FG000|Overall Study|Adverse Event|2|||
128728087|NCT00773175|463301742|FG001|Overall Study|Adverse Event|0|||
128728088|NCT00773175|463301741|FG000|Overall Study|Consent Withdrawn|0|||
128728089|NCT00773175|463301742|FG001|Overall Study|Consent Withdrawn|2|||
128728090|NCT04127786|463301749|FG000|Primary Series|Adverse Event|1|||
128728091|NCT04127786|463301750|FG001|Primary Series|Adverse Event|0|||
128728092|NCT04127786|463301751|FG002|Primary Series|Adverse Event|0|||
128728093|NCT04127786|463301752|FG003|Primary Series|Adverse Event|1|||
128728094|NCT04127786|463301753|FG004|Primary Series|Adverse Event|0|||
128728095|NCT04127786|463301754|FG005|Primary Series|Adverse Event|1|||
128728096|NCT04127786|463301749|FG000|Primary Series|Protocol Violation|5|||
129167265|NCT03299881|464905848|FG001|Overall Study|Study Termination|13|||
129167266|NCT01257230|464905849|FG000|Overall Study|Not Treated|0|||
129167267|NCT01257230|464905850|FG001|Overall Study|Not Treated|0|||
129167268|NCT01257230|464905851|FG002|Overall Study|Not Treated|1|||
129167269|NCT01257230|464905849|FG000|Overall Study|Adverse Event|2|||
129167270|NCT01257230|464905850|FG001|Overall Study|Adverse Event|0|||
129167271|NCT01257230|464905851|FG002|Overall Study|Adverse Event|0|||
128728097|NCT04127786|463301750|FG001|Primary Series|Protocol Violation|3|||
128728098|NCT04127786|463301751|FG002|Primary Series|Protocol Violation|4|||
128728099|NCT04127786|463301752|FG003|Primary Series|Protocol Violation|3|||
128728100|NCT04127786|463301753|FG004|Primary Series|Protocol Violation|2|||
128728101|NCT04127786|463301754|FG005|Primary Series|Protocol Violation|0|||
128728102|NCT04127786|463301749|FG000|Primary Series|Withdrawal by Subject|0|||
128728103|NCT04127786|463301750|FG001|Primary Series|Withdrawal by Subject|0|||
129167272|NCT01257230|464905849|FG000|Overall Study|Lack of Efficacy|0|||
129167273|NCT01257230|464905850|FG001|Overall Study|Lack of Efficacy|1|||
128728104|NCT04127786|463301751|FG002|Primary Series|Withdrawal by Subject|0|||
128728105|NCT04127786|463301752|FG003|Primary Series|Withdrawal by Subject|1|||
128728106|NCT04127786|463301753|FG004|Primary Series|Withdrawal by Subject|0|||
128728107|NCT04127786|463301754|FG005|Primary Series|Withdrawal by Subject|0|||
128728108|NCT04127786|463301749|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
128728109|NCT04127786|463301750|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
128728110|NCT04127786|463301751|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
128728111|NCT04127786|463301752|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
128728112|NCT04127786|463301753|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
128728113|NCT04127786|463301754|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
128728114|NCT04127786|463301749|FG000|Booster Phase|Withdrawal by Subject|2|||
128728115|NCT04127786|463301750|FG001|Booster Phase|Withdrawal by Subject|0|||
128728116|NCT04127786|463301751|FG002|Booster Phase|Withdrawal by Subject|0|||
128728117|NCT04127786|463301752|FG003|Booster Phase|Withdrawal by Subject|0|||
128778025|NCT01388543|463475376|FG000|Day 14|Adverse Event|1|||
129167274|NCT01257230|464905851|FG002|Overall Study|Lack of Efficacy|0|||
129167275|NCT01257230|464905849|FG000|Overall Study|Protocol Violation|3|||
129167276|NCT01257230|464905850|FG001|Overall Study|Protocol Violation|0|||
129167277|NCT01257230|464905851|FG002|Overall Study|Protocol Violation|1|||
129167278|NCT01257230|464905849|FG000|Overall Study|Withdrawal by Subject|0|||
129167279|NCT01257230|464905850|FG001|Overall Study|Withdrawal by Subject|4|||
129167280|NCT01257230|464905851|FG002|Overall Study|Withdrawal by Subject|1|||
129167281|NCT01257230|464905849|FG000|Overall Study|Other reason not defined above|1|||
129167282|NCT01257230|464905850|FG001|Overall Study|Other reason not defined above|5|||
129167283|NCT01257230|464905851|FG002|Overall Study|Other reason not defined above|3|||
129167284|NCT01205061|464905854|FG000|Overall Study|Adverse Event|4|||
129167285|NCT01205061|464905854|FG000|Overall Study|Withdrawal by Subject|11|||
129167286|NCT01205061|464905854|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
129167287|NCT01205061|464905854|FG000|Overall Study|Lost to Follow-up|9|||
129167288|NCT01205061|464905854|FG000|Overall Study|Other|1|||
129167289|NCT00765037|464905855|FG000|Overall Study|Lost to Follow-up|5|||
129167290|NCT00765037|464905855|FG000|Overall Study|Adverse Event|1|||
129167291|NCT03070171|464905860|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
129167292|NCT03070171|464905861|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
129167293|NCT03070171|464905860|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
129167294|NCT03070171|464905861|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
129167295|NCT01471028|464905865|FG000|VTI-208|Adverse Event|39|||
129167296|NCT01471028|464905866|FG001|VTI-208|Adverse Event|41|||
129167297|NCT01471028|464905865|FG000|VTI-208|Withdrawal by Subject|0|||
129167298|NCT01471028|464905866|FG001|VTI-208|Withdrawal by Subject|2|||
129167299|NCT01471028|464905865|FG000|VTI-208|Lost to Follow-up|1|||
129167300|NCT01471028|464905866|FG001|VTI-208|Lost to Follow-up|1|||
129167301|NCT01471028|464905865|FG000|VTI-208E|Death|7|||
129167302|NCT01471028|464905866|FG001|VTI-208E|Death|10|||
129167303|NCT01471028|464905865|FG000|VTI-208E|Withdrawal by Subject|1|||
129167304|NCT01471028|464905866|FG001|VTI-208E|Withdrawal by Subject|0|||
129167305|NCT01471028|464905865|FG000|VTI-208E|Lost to Follow-up|0|||
129167306|NCT01471028|464905866|FG001|VTI-208E|Lost to Follow-up|2|||
129167307|NCT00610857|464905868|FG000|Overall Study|Not evaluable for response|2|||
129167308|NCT04826094|464905869|FG000|Overall Study|Lost to Follow-up|2|||
129167309|NCT04826094|464905870|FG001|Overall Study|Lost to Follow-up|1|||
129167310|NCT04826094|464905871|FG002|Overall Study|Lost to Follow-up|0|||
129167311|NCT04826094|464905872|FG003|Overall Study|Lost to Follow-up|0|||
129167312|NCT04826094|464905873|FG004|Overall Study|Lost to Follow-up|1|||
129167313|NCT04826094|464905874|FG005|Overall Study|Lost to Follow-up|3|||
129167314|NCT04826094|464905875|FG006|Overall Study|Lost to Follow-up|1|||
129167315|NCT04826094|464905876|FG007|Overall Study|Lost to Follow-up|1|||
129167316|NCT04826094|464905869|FG000|Overall Study|Participant withdrew consent|1|||
129167317|NCT04826094|464905870|FG001|Overall Study|Participant withdrew consent|0|||
129167318|NCT04826094|464905871|FG002|Overall Study|Participant withdrew consent|0|||
129167319|NCT04826094|464905872|FG003|Overall Study|Participant withdrew consent|1|||
129167320|NCT04826094|464905873|FG004|Overall Study|Participant withdrew consent|1|||
129167321|NCT04826094|464905874|FG005|Overall Study|Participant withdrew consent|1|||
129167322|NCT04826094|464905875|FG006|Overall Study|Participant withdrew consent|0|||
129167323|NCT04826094|464905876|FG007|Overall Study|Participant withdrew consent|1|||
128728118|NCT04127786|463301753|FG004|Booster Phase|Withdrawal by Subject|0|||
129167324|NCT04826094|464905869|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
129167325|NCT04826094|464905870|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
129167326|NCT04826094|464905871|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
129167327|NCT04826094|464905872|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
129167328|NCT04826094|464905873|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
129167329|NCT04826094|464905874|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
129167330|NCT04826094|464905875|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
129167331|NCT04826094|464905876|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
129167332|NCT04826094|464905869|FG000|Overall Study|Withdrawn by Investigator|0|||
129167333|NCT04826094|464905870|FG001|Overall Study|Withdrawn by Investigator|0|||
128728119|NCT04127786|463301754|FG005|Booster Phase|Withdrawal by Subject|0|||
128728120|NCT01904604|463301755|FG000|Overall Study|Withdrew before receiving dosing|0|||
128728121|NCT01904604|463301756|FG001|Overall Study|Withdrew before receiving dosing|1|||
128728122|NCT01904604|463301757|FG002|Overall Study|Withdrew before receiving dosing|0|||
128728123|NCT01904604|463301755|FG000|Overall Study|Non-compliance|1|||
128728124|NCT01904604|463301756|FG001|Overall Study|Non-compliance|0|||
128728125|NCT01904604|463301757|FG002|Overall Study|Non-compliance|0|||
128728126|NCT01904604|463301755|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
128728127|NCT01904604|463301756|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
128728128|NCT01904604|463301757|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
128728129|NCT01904604|463301755|FG000|Overall Study|Patch site reactions|1|||
128728130|NCT01904604|463301756|FG001|Overall Study|Patch site reactions|1|||
128728131|NCT01904604|463301757|FG002|Overall Study|Patch site reactions|0|||
128728132|NCT01904604|463301755|FG000|Overall Study|Increased syncope|0|||
128728133|NCT01904604|463301756|FG001|Overall Study|Increased syncope|1|||
128728134|NCT01904604|463301757|FG002|Overall Study|Increased syncope|0|||
128728135|NCT01904604|463301755|FG000|Overall Study|Unrelated illness|0|||
128728136|NCT01904604|463301756|FG001|Overall Study|Unrelated illness|1|||
128728137|NCT01904604|463301757|FG002|Overall Study|Unrelated illness|0|||
128728138|NCT01904604|463301755|FG000|Overall Study|Passed Week 52 OFC|1|||
128728139|NCT01904604|463301756|FG001|Overall Study|Passed Week 52 OFC|0|||
128728140|NCT01904604|463301757|FG002|Overall Study|Passed Week 52 OFC|0|||
128728141|NCT01904604|463301755|FG000|Overall Study|Withdrawal by Subject|1|||
128728142|NCT01904604|463301756|FG001|Overall Study|Withdrawal by Subject|2|||
128778026|NCT01388543|463475377|FG001|Day 14|Adverse Event|4|||
128778027|NCT01354106|463475379|FG000|Overall Study|Withdrawal by Subject|2|||
128778028|NCT00731042|463476944|FG000|Second Intervention|Did not meet inclusion criteria|0|||
128778029|NCT00731042|463476945|FG001|Second Intervention|Did not meet inclusion criteria|2|||
128778030|NCT02692235|463476946|FG000|Overall Study|Withdrawal by Subject|2|||
128778031|NCT02692235|463476947|FG001|Overall Study|Withdrawal by Subject|1|||
128778032|NCT02692235|463476946|FG000|Overall Study|Adverse Event|1|||
128778033|NCT02692235|463476947|FG001|Overall Study|Adverse Event|2|||
128778034|NCT00802841|463476948|FG000|Overall Study|Administrative problems|1|||
128778035|NCT00802841|463476949|FG001|Overall Study|Administrative problems|0|||
128778036|NCT00802841|463476948|FG000|Overall Study|Lost to Follow-up|2|||
128778037|NCT00802841|463476949|FG001|Overall Study|Lost to Follow-up|1|||
128778038|NCT00802841|463476948|FG000|Overall Study|Death|1|||
128778039|NCT00802841|463476949|FG001|Overall Study|Death|2|||
128778040|NCT00802841|463476948|FG000|Overall Study|Adverse Event|8|||
128778041|NCT00802841|463476949|FG001|Overall Study|Adverse Event|2|||
128778042|NCT00802841|463476948|FG000|Overall Study|Disease progression|7|||
128778043|NCT00802841|463476949|FG001|Overall Study|Disease progression|3|||
128778044|NCT00802841|463476948|FG000|Overall Study|Withdrawal by Subject|9|||
128778045|NCT00802841|463476949|FG001|Overall Study|Withdrawal by Subject|5|||
128778046|NCT00802841|463476948|FG000|Overall Study|Protocol deviation|2|||
128778047|NCT00802841|463476949|FG001|Overall Study|Protocol deviation|6|||
128778048|NCT00802841|463476948|FG000|Overall Study|Treatment duration completed|66|||
128778049|NCT00802841|463476949|FG001|Overall Study|Treatment duration completed|76|||
128778050|NCT00107380|463476952|FG000|Overall Study|Adverse Event|7|||
128778051|NCT00107380|463476952|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
128778052|NCT00107380|463476952|FG000|Overall Study|Progression/relapse|4|||
128778053|NCT00107380|463476952|FG000|Overall Study|Death|3|||
128778054|NCT00107380|463476952|FG000|Overall Study|Other - not protocol specified|7|||
128778055|NCT00107380|463476952|FG000|Overall Study|Ineligible|2|||
128778056|NCT03673098|463476953|FG000|Overall Study|Lost to Follow-up|2|||
128778057|NCT03673098|463476954|FG001|Overall Study|Lost to Follow-up|3|||
128778058|NCT03673098|463476953|FG000|Overall Study|Withdrawal by Subject|6|||
128778059|NCT03673098|463476954|FG001|Overall Study|Withdrawal by Subject|1|||
128778060|NCT03673098|463476953|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
128778061|NCT03673098|463476954|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
128778062|NCT01536262|463476956|FG000|Overall Study|Adverse Event|6|||
128778063|NCT01536262|463476957|FG001|Overall Study|Adverse Event|1|||
128778064|NCT01536262|463476958|FG002|Overall Study|Adverse Event|2|||
128778065|NCT01536262|463476956|FG000|Overall Study|Withdrawal by Subject|1|||
128778066|NCT01536262|463476957|FG001|Overall Study|Withdrawal by Subject|1|||
128778067|NCT01536262|463476958|FG002|Overall Study|Withdrawal by Subject|0|||
128778068|NCT01536262|463476956|FG000|Overall Study|Other than stated above|1|||
128778069|NCT01536262|463476957|FG001|Overall Study|Other than stated above|0|||
128778070|NCT01536262|463476958|FG002|Overall Study|Other than stated above|0|||
128778071|NCT01781611|463476962|FG000|Overall Study|Adverse Event|4|||
128778072|NCT01781611|463476963|FG001|Overall Study|Adverse Event|0|||
128778073|NCT03639675|463476964|FG000|Overall Study|Withdrawal by Subject|1|||
128778074|NCT02485353|463476965|FG000|Overall Study|Death|1|||
128778075|NCT02485353|463476965|FG000|Overall Study|Disease Progression|1|||
128778076|NCT03487666|463476966|FG000|Overall Study|Disease progression|4|||
128778077|NCT03487666|463476967|FG001|Overall Study|Disease progression|2|||
128778078|NCT03487666|463476968|FG002|Overall Study|Disease progression|0|||
128778079|NCT03487666|463476966|FG000|Overall Study|Adverse Event|0|||
128778080|NCT03487666|463476967|FG001|Overall Study|Adverse Event|0|||
128778081|NCT03487666|463476968|FG002|Overall Study|Adverse Event|1|||
128778082|NCT02264574|463476973|FG000|Overall Study|Death|21|||
128778083|NCT02264574|463476974|FG001|Overall Study|Death|21|||
128778084|NCT02264574|463476973|FG000|Overall Study|Withdrawal by Subject|8|||
128778085|NCT02264574|463476974|FG001|Overall Study|Withdrawal by Subject|6|||
128778086|NCT02264574|463476973|FG000|Overall Study|Other, Not Specified|0|||
128778087|NCT02264574|463476974|FG001|Overall Study|Other, Not Specified|3|||
129167334|NCT04826094|464905871|FG002|Overall Study|Withdrawn by Investigator|0|||
129167335|NCT04826094|464905872|FG003|Overall Study|Withdrawn by Investigator|0|||
129167336|NCT04826094|464905873|FG004|Overall Study|Withdrawn by Investigator|0|||
128778088|NCT01477749|463476975|FG000|Overall Study|Physician Decision|4|||
128778089|NCT02886728|463476976|FG000|Overall Study|Withdrew Consent|31|||
128778090|NCT02886728|463476977|FG001|Overall Study|Withdrew Consent|13|||
128778091|NCT02886728|463476978|FG002|Overall Study|Withdrew Consent|11|||
128778092|NCT02886728|463476979|FG003|Overall Study|Withdrew Consent|47|||
128778093|NCT02886728|463476976|FG000|Overall Study|Lost to Follow-up|12|||
128778094|NCT02886728|463476977|FG001|Overall Study|Lost to Follow-up|6|||
128778095|NCT02886728|463476978|FG002|Overall Study|Lost to Follow-up|13|||
128778096|NCT02886728|463476979|FG003|Overall Study|Lost to Follow-up|12|||
128778097|NCT02886728|463476976|FG000|Overall Study|Adverse Event|13|||
128778098|NCT02886728|463476977|FG001|Overall Study|Adverse Event|5|||
128778099|NCT02886728|463476978|FG002|Overall Study|Adverse Event|5|||
129167337|NCT04826094|464905874|FG005|Overall Study|Withdrawn by Investigator|1|||
129167338|NCT04826094|464905875|FG006|Overall Study|Withdrawn by Investigator|0|||
129167339|NCT04826094|464905876|FG007|Overall Study|Withdrawn by Investigator|1|||
129167340|NCT04826094|464905869|FG000|Overall Study|Other: Moved from area|1|||
129167341|NCT04826094|464905870|FG001|Overall Study|Other: Moved from area|1|||
129167342|NCT04826094|464905871|FG002|Overall Study|Other: Moved from area|1|||
129167343|NCT04826094|464905872|FG003|Overall Study|Other: Moved from area|0|||
129167344|NCT04826094|464905873|FG004|Overall Study|Other: Moved from area|0|||
129167345|NCT04826094|464905874|FG005|Overall Study|Other: Moved from area|0|||
129167346|NCT04826094|464905875|FG006|Overall Study|Other: Moved from area|0|||
129167347|NCT04826094|464905876|FG007|Overall Study|Other: Moved from area|0|||
129167348|NCT04826094|464905869|FG000|Overall Study|Other: Declined|0|||
129167349|NCT04826094|464905870|FG001|Overall Study|Other: Declined|0|||
129167350|NCT04826094|464905871|FG002|Overall Study|Other: Declined|0|||
129167351|NCT04826094|464905872|FG003|Overall Study|Other: Declined|0|||
129167352|NCT04826094|464905873|FG004|Overall Study|Other: Declined|1|||
129167353|NCT04826094|464905874|FG005|Overall Study|Other: Declined|0|||
129167354|NCT04826094|464905875|FG006|Overall Study|Other: Declined|0|||
129167355|NCT04826094|464905876|FG007|Overall Study|Other: Declined|0|||
129167356|NCT04826094|464905869|FG000|Overall Study|Other: Vaccine not administered|0|||
129167357|NCT04826094|464905870|FG001|Overall Study|Other: Vaccine not administered|0|||
129167358|NCT04826094|464905871|FG002|Overall Study|Other: Vaccine not administered|1|||
129167359|NCT04826094|464905872|FG003|Overall Study|Other: Vaccine not administered|0|||
129167360|NCT04826094|464905873|FG004|Overall Study|Other: Vaccine not administered|0|||
129167361|NCT04826094|464905874|FG005|Overall Study|Other: Vaccine not administered|1|||
129167362|NCT04826094|464905875|FG006|Overall Study|Other: Vaccine not administered|1|||
129167363|NCT04826094|464905876|FG007|Overall Study|Other: Vaccine not administered|3|||
129167364|NCT00700882|464905879|FG000|Overall Study|Never received treatment|6|||
129167365|NCT00700882|464905879|FG000|Overall Study|Ineligible|2|||
129167366|NCT00700882|464905879|FG000|Overall Study|No KIT mutation|51|||
129167367|NCT04154293|464905883|FG000|Overall Study|Withdrawal by Subject|2|||
129167368|NCT04154293|464905884|FG001|Overall Study|Withdrawal by Subject|3|||
129167369|NCT04154293|464905885|FG002|Overall Study|Withdrawal by Subject|1|||
129167370|NCT04154293|464905883|FG000|Overall Study|Physician Decision|0|||
129167371|NCT04154293|464905884|FG001|Overall Study|Physician Decision|0|||
129167372|NCT04154293|464905885|FG002|Overall Study|Physician Decision|1|||
129167373|NCT04731298|464905886|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
129167374|NCT04731298|464905887|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
129167375|NCT01208961|464905888|FG000|High-Fat Period III|Protocol Violation|1|||
129167376|NCT01208961|464905889|FG001|High-Fat Period III|Protocol Violation|0|||
129167377|NCT03403361|464905890|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
129167378|NCT02152371|464905891|FG000|Overall Study|Adverse Event|6|||
129167379|NCT02152371|464905892|FG001|Overall Study|Adverse Event|2|||
129167380|NCT02152371|464905891|FG000|Overall Study|Withdrawal by Subject|3|||
129167381|NCT02152371|464905892|FG001|Overall Study|Withdrawal by Subject|7|||
129167382|NCT02152371|464905891|FG000|Overall Study|Protocol Violation|2|||
129167383|NCT02152371|464905892|FG001|Overall Study|Protocol Violation|3|||
129167384|NCT02152371|464905891|FG000|Overall Study|Lost to Follow-up|1|||
129167385|NCT02152371|464905892|FG001|Overall Study|Lost to Follow-up|0|||
129167386|NCT02152371|464905891|FG000|Overall Study|Lack of Efficacy|0|||
129167387|NCT02152371|464905892|FG001|Overall Study|Lack of Efficacy|1|||
129167388|NCT02152371|464905891|FG000|Overall Study|Physician Decision|0|||
129167389|NCT02152371|464905892|FG001|Overall Study|Physician Decision|2|||
129167390|NCT02152371|464905891|FG000|Overall Study|Reason Not Given|0|||
129167391|NCT02152371|464905892|FG001|Overall Study|Reason Not Given|1|||
129167392|NCT04382586|464905898|FG000|Overall Study|Death|3|||
129167393|NCT04382586|464905899|FG001|Overall Study|Death|4|||
129167394|NCT04382586|464905898|FG000|Overall Study|Lost to Follow-up|11|||
129167395|NCT04382586|464905899|FG001|Overall Study|Lost to Follow-up|8|||
129167396|NCT04382586|464905898|FG000|Overall Study|Withdrawal by Subject|3|||
129167397|NCT04382586|464905899|FG001|Overall Study|Withdrawal by Subject|1|||
129167398|NCT04382586|464905898|FG000|Overall Study|Physician Decision|0|||
129167399|NCT04382586|464905899|FG001|Overall Study|Physician Decision|3|||
129167400|NCT06099223|464905905|FG000|Overall Study|Preoperative surveys missed|0|||
129167401|NCT06099223|464905906|FG001|Overall Study|Preoperative surveys missed|1|||
129167402|NCT00079391|464905907|FG000|Overall Study|Withdrawal by Subject|1|||
129167403|NCT02628600|464905911|FG000|Overall Study|Death|2|||
129167404|NCT02628600|464905912|FG001|Overall Study|Death|1|||
129167405|NCT02628600|464905911|FG000|Overall Study|Adverse Event|3|||
129167406|NCT02628600|464905912|FG001|Overall Study|Adverse Event|20|||
129167407|NCT02628600|464905911|FG000|Overall Study|Protocol Violation|0|||
129167408|NCT02628600|464905912|FG001|Overall Study|Protocol Violation|1|||
129167409|NCT02628600|464905911|FG000|Overall Study|Lack of Efficacy|2|||
129167410|NCT02628600|464905912|FG001|Overall Study|Lack of Efficacy|0|||
129167411|NCT02628600|464905911|FG000|Overall Study|Withdrawal by Subject|13|||
129167412|NCT02628600|464905912|FG001|Overall Study|Withdrawal by Subject|8|||
129167413|NCT02628600|464905911|FG000|Overall Study|Lost to Follow-up|1|||
129167414|NCT02628600|464905912|FG001|Overall Study|Lost to Follow-up|0|||
129167415|NCT02628600|464905911|FG000|Overall Study|Physician Decision|2|||
128778100|NCT02886728|463476979|FG003|Overall Study|Adverse Event|11|||
128778101|NCT02886728|463476976|FG000|Overall Study|Investigator's Discretion|11|||
128778102|NCT02886728|463476977|FG001|Overall Study|Investigator's Discretion|7|||
128778103|NCT02886728|463476978|FG002|Overall Study|Investigator's Discretion|5|||
128778104|NCT02886728|463476979|FG003|Overall Study|Investigator's Discretion|11|||
128778105|NCT02886728|463476976|FG000|Overall Study|Death|3|||
128778106|NCT02886728|463476977|FG001|Overall Study|Death|1|||
128778107|NCT02886728|463476978|FG002|Overall Study|Death|0|||
128778108|NCT02886728|463476979|FG003|Overall Study|Death|0|||
128778109|NCT02886728|463476976|FG000|Overall Study|Protocol Violation|0|||
128778110|NCT02886728|463476977|FG001|Overall Study|Protocol Violation|0|||
128778111|NCT02886728|463476978|FG002|Overall Study|Protocol Violation|0|||
128778112|NCT02886728|463476979|FG003|Overall Study|Protocol Violation|4|||
128778113|NCT02886728|463476976|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128778114|NCT02886728|463476977|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128778115|NCT02886728|463476978|FG002|Overall Study|Non-Compliance with Study Drug|1|||
128778116|NCT02886728|463476979|FG003|Overall Study|Non-Compliance with Study Drug|0|||
128778117|NCT02886728|463476976|FG000|Overall Study|Pregnancy|0|||
128778118|NCT02886728|463476977|FG001|Overall Study|Pregnancy|0|||
128778119|NCT02886728|463476978|FG002|Overall Study|Pregnancy|1|||
128778120|NCT02886728|463476979|FG003|Overall Study|Pregnancy|0|||
128778121|NCT02886728|463476976|FG000|Overall Study|Randomized but Not Dosed|1|||
128778122|NCT02886728|463476977|FG001|Overall Study|Randomized but Not Dosed|0|||
128778123|NCT02886728|463476978|FG002|Overall Study|Randomized but Not Dosed|0|||
128778124|NCT02886728|463476979|FG003|Overall Study|Randomized but Not Dosed|2|||
128778125|NCT04990440|463476982|FG000|Overall Study|Sponsor's Decision|0|||
128778126|NCT04990440|463476983|FG001|Overall Study|Sponsor's Decision|0|||
128778127|NCT04990440|463476984|FG002|Overall Study|Sponsor's Decision|1|||
128778128|NCT00724061|463476987|FG000|Dose Escalation Phase|Adverse Event|2|||
128778129|NCT00724061|463476987|FG000|Dose Escalation Phase|Disease Progression|3|||
128778130|NCT00688259|463476991|FG000|Overall Study|Lost to Follow-up|2|||
128778131|NCT00688259|463476992|FG001|Overall Study|Lost to Follow-up|4|||
128778132|NCT00688259|463476991|FG000|Overall Study|Physician Decision|1|||
128778133|NCT00688259|463476992|FG001|Overall Study|Physician Decision|0|||
128778134|NCT00688259|463476991|FG000|Overall Study|Withdrawal by Subject|2|||
128778135|NCT00688259|463476992|FG001|Overall Study|Withdrawal by Subject|0|||
128778136|NCT00688259|463476991|FG000|Overall Study|Declined Interview|2|||
128778137|NCT00688259|463476992|FG001|Overall Study|Declined Interview|3|||
128778138|NCT00688259|463476991|FG000|Overall Study|Hospitalized at Follow-up|0|||
128778139|NCT00688259|463476992|FG001|Overall Study|Hospitalized at Follow-up|1|||
128778140|NCT02118714|463476994|FG000|Overall Study|Lost to Follow-up|2|||
128778141|NCT02118714|463476994|FG000|Overall Study|Protocol Violation|1|||
128778142|NCT01310868|463476995|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
128778143|NCT02411591|463476996|FG000|Overall Study|Adverse Event|0|||
128778144|NCT02411591|463476997|FG001|Overall Study|Adverse Event|4|||
128778145|NCT02411591|463476998|FG002|Overall Study|Adverse Event|2|||
128778146|NCT02411591|463476996|FG000|Overall Study|Withdrawal by Subject|0|||
128778147|NCT02411591|463476997|FG001|Overall Study|Withdrawal by Subject|3|||
128778148|NCT02411591|463476998|FG002|Overall Study|Withdrawal by Subject|0|||
128778149|NCT02411591|463476996|FG000|Overall Study|Physician Decision|0|||
128778150|NCT02411591|463476997|FG001|Overall Study|Physician Decision|3|||
128778151|NCT02411591|463476998|FG002|Overall Study|Physician Decision|1|||
128778152|NCT02954575|463476999|FG000|Overall Study|Withdrawal by Subject|2|||
128778153|NCT02954575|463476999|FG000|Overall Study|Adverse Event|1|||
128778154|NCT02491892|463477001|FG000|Overall Study|Adverse Event|1|||
128778155|NCT02491892|463477002|FG001|Overall Study|Adverse Event|1|||
128778156|NCT02491892|463477001|FG000|Overall Study|Death|1|||
128778157|NCT02491892|463477002|FG001|Overall Study|Death|1|||
128778158|NCT02491892|463477001|FG000|Overall Study|Lack of Efficacy|37|||
128778159|NCT02491892|463477002|FG001|Overall Study|Lack of Efficacy|36|||
128778160|NCT02491892|463477001|FG000|Overall Study|Refused Treatment|1|||
128778161|NCT02491892|463477002|FG001|Overall Study|Refused Treatment|0|||
128778162|NCT02491892|463477001|FG000|Overall Study|Lost to Follow-up|1|||
128778163|NCT02491892|463477002|FG001|Overall Study|Lost to Follow-up|0|||
128778164|NCT04227340|463477003|FG000|Overall Study|Withdrawal by Subject|3|||
128778165|NCT01066156|463477004|FG000|Overall Study|ineligible|2|||
128778166|NCT01066156|463477004|FG000|Overall Study|Lost to Follow-up|7|||
128778167|NCT01066156|463477004|FG000|Overall Study|Withdrawal by Subject|1|||
128778168|NCT00661258|463477015|FG000|Overall Study|Death|1|||
128778169|NCT00661258|463477016|FG001|Overall Study|Death|0|||
128778170|NCT00661258|463477015|FG000|Overall Study|caught by police and in detox center|2|||
128778171|NCT00661258|463477016|FG001|Overall Study|caught by police and in detox center|1|||
128778172|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
128778173|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
129167416|NCT02628600|464905912|FG001|Overall Study|Physician Decision|2|||
128778174|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
128778175|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
128778176|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
129167417|NCT02628600|464905911|FG000|Overall Study|Other not specified|1|||
129167418|NCT02628600|464905912|FG001|Overall Study|Other not specified|0|||
129167419|NCT01221623|464905913|FG000|Overall Study|Withdrawal by Subject|19|||
129167420|NCT01221623|464905914|FG001|Overall Study|Withdrawal by Subject|8|||
129167421|NCT01221623|464905913|FG000|Overall Study|Lost to Follow-up|7|||
129167422|NCT01221623|464905914|FG001|Overall Study|Lost to Follow-up|1|||
129167423|NCT01221623|464905913|FG000|Overall Study|Adverse Event|6|||
129167424|NCT01221623|464905914|FG001|Overall Study|Adverse Event|3|||
129167425|NCT01221623|464905913|FG000|Overall Study|Death|1|||
129167426|NCT01221623|464905914|FG001|Overall Study|Death|0|||
129167427|NCT01221623|464905913|FG000|Overall Study|Other|5|||
129167428|NCT01221623|464905914|FG001|Overall Study|Other|2|||
129167429|NCT03479541|464905915|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
129167430|NCT03479541|464905916|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
129167431|NCT03479541|464905917|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
129167432|NCT03479541|464905918|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
128778177|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
129167433|NCT03479541|464905915|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
129167434|NCT03479541|464905916|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
129167435|NCT03479541|464905917|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
128778178|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
128778179|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
128778180|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
128778181|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
128778182|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
128778183|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
128778184|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
128778185|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
128778186|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
128778187|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
128778188|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
128778189|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
129167436|NCT03479541|464905918|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
129167437|NCT03479541|464905915|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
129167438|NCT03479541|464905916|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
129167439|NCT03479541|464905917|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
129167440|NCT03479541|464905918|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
129167441|NCT03479541|464905915|FG000|Home Monitoring|Lost to Follow-up|0|||
129167442|NCT03479541|464905916|FG001|Home Monitoring|Lost to Follow-up|0|||
129167443|NCT03479541|464905917|FG002|Home Monitoring|Lost to Follow-up|8|||
129167444|NCT03479541|464905918|FG003|Home Monitoring|Lost to Follow-up|12|||
129167445|NCT03479541|464905915|FG000|Home Monitoring|Withdrawal by Subject|0|||
129167446|NCT03479541|464905916|FG001|Home Monitoring|Withdrawal by Subject|0|||
129167447|NCT03479541|464905917|FG002|Home Monitoring|Withdrawal by Subject|17|||
129167448|NCT03479541|464905918|FG003|Home Monitoring|Withdrawal by Subject|30|||
129167449|NCT03479541|464905915|FG000|Home Monitoring|Early Termination - PI Decision|0|||
129167450|NCT03479541|464905916|FG001|Home Monitoring|Early Termination - PI Decision|0|||
129167451|NCT03479541|464905917|FG002|Home Monitoring|Early Termination - PI Decision|4|||
129167452|NCT03479541|464905918|FG003|Home Monitoring|Early Termination - PI Decision|6|||
129167453|NCT02461290|464905921|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
129167454|NCT02461290|464905921|FG000|Overall Study|Lost to Follow-up|3|||
129167455|NCT01456195|464907978|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129167456|NCT01456195|464907979|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
129167457|NCT01456195|464907980|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
129167458|NCT01456195|464907978|FG000|Overall Study|Lost to Follow-up|3|||
129167459|NCT01456195|464907979|FG001|Overall Study|Lost to Follow-up|1|||
129167460|NCT01456195|464907980|FG002|Overall Study|Lost to Follow-up|3|||
129167461|NCT01456195|464907978|FG000|Overall Study|Voluntary Withdrawal|5|||
129167462|NCT01456195|464907979|FG001|Overall Study|Voluntary Withdrawal|3|||
129167463|NCT01456195|464907980|FG002|Overall Study|Voluntary Withdrawal|7|||
129167464|NCT01456195|464907978|FG000|Overall Study|Lack of Efficacy|0|||
129167465|NCT01456195|464907979|FG001|Overall Study|Lack of Efficacy|1|||
129167466|NCT01456195|464907980|FG002|Overall Study|Lack of Efficacy|0|||
129167467|NCT01456195|464907978|FG000|Overall Study|Other Reasons|2|||
129167468|NCT01456195|464907979|FG001|Overall Study|Other Reasons|1|||
129167469|NCT01456195|464907980|FG002|Overall Study|Other Reasons|3|||
129167470|NCT02109432|464907981|FG000|Overall Study|Withdrawal by Subject|1|||
129167471|NCT02908685|464907982|FG000|Part 1 OLE|Withdrawal by Subject|0|||
129167472|NCT02908685|464907983|FG001|Part 1 OLE|Withdrawal by Subject|0|||
129167473|NCT02908685|464907984|FG002|Part 1 OLE|Withdrawal by Subject|0|||
129167474|NCT02908685|464907985|FG003|Part 1 OLE|Withdrawal by Subject|0|||
129167475|NCT02908685|464907986|FG004|Part 1 OLE|Withdrawal by Subject|0|||
129167476|NCT02908685|464907987|FG005|Part 1 OLE|Withdrawal by Subject|0|||
129167477|NCT02908685|464907988|FG006|Part 1 OLE|Withdrawal by Subject|0|||
129167478|NCT02908685|464907989|FG007|Part 1 OLE|Withdrawal by Subject|0|||
128778190|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
128778191|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
129167479|NCT02908685|464907990|FG008|Part 1 OLE|Withdrawal by Subject|0|||
129167480|NCT02908685|464907991|FG009|Part 1 OLE|Withdrawal by Subject|0|||
129167481|NCT02908685|464907992|FG010|Part 1 OLE|Withdrawal by Subject|2|||
129167482|NCT02908685|464907993|FG011|Part 1 OLE|Withdrawal by Subject|1|||
129167483|NCT02908685|464907994|FG012|Part 1 OLE|Withdrawal by Subject|0|||
129167484|NCT02908685|464907995|FG013|Part 1 OLE|Withdrawal by Subject|0|||
129167485|NCT02908685|464907982|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167486|NCT02908685|464907983|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167487|NCT02908685|464907984|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167488|NCT02908685|464907985|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
128778192|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
129167489|NCT02908685|464907986|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167490|NCT02908685|464907987|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167491|NCT02908685|464907988|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167492|NCT02908685|464907989|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167493|NCT02908685|464907990|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167494|NCT02908685|464907991|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167495|NCT02908685|464907992|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167496|NCT02908685|464907993|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129167497|NCT02908685|464907994|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
129167498|NCT02908685|464907995|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
129167499|NCT02908685|464907982|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167500|NCT02908685|464907983|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167501|NCT02908685|464907984|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167502|NCT02908685|464907985|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167503|NCT02908685|464907986|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167504|NCT02908685|464907987|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167505|NCT02908685|464907988|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167506|NCT02908685|464907989|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167507|NCT02908685|464907990|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167508|NCT02908685|464907991|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167509|NCT02908685|464907992|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167510|NCT02908685|464907993|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167511|NCT02908685|464907994|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
129167512|NCT02908685|464907995|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129167513|NCT02908685|464907982|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167514|NCT02908685|464907983|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167515|NCT02908685|464907984|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167516|NCT02908685|464907985|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167517|NCT02908685|464907986|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167518|NCT02908685|464907987|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167519|NCT02908685|464907988|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167520|NCT02908685|464907989|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167521|NCT02908685|464907990|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167522|NCT02908685|464907991|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167523|NCT02908685|464907992|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167524|NCT02908685|464907993|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167525|NCT02908685|464907994|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
129167526|NCT02908685|464907995|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129167527|NCT02908685|464907982|FG000|Part 2 OLE: > Month 24|Death|0|||
129167528|NCT02908685|464907983|FG001|Part 2 OLE: > Month 24|Death|0|||
129167529|NCT02908685|464907984|FG002|Part 2 OLE: > Month 24|Death|0|||
129167530|NCT02908685|464907985|FG003|Part 2 OLE: > Month 24|Death|0|||
129167531|NCT02908685|464907986|FG004|Part 2 OLE: > Month 24|Death|0|||
129167532|NCT02908685|464907987|FG005|Part 2 OLE: > Month 24|Death|0|||
129167533|NCT02908685|464907988|FG006|Part 2 OLE: > Month 24|Death|0|||
129167534|NCT02908685|464907989|FG007|Part 2 OLE: > Month 24|Death|0|||
129167535|NCT02908685|464907990|FG008|Part 2 OLE: > Month 24|Death|0|||
129167536|NCT02908685|464907991|FG009|Part 2 OLE: > Month 24|Death|0|||
129167537|NCT02908685|464907992|FG010|Part 2 OLE: > Month 24|Death|0|||
129167538|NCT02908685|464907993|FG011|Part 2 OLE: > Month 24|Death|0|||
129167539|NCT02908685|464907994|FG012|Part 2 OLE: > Month 24|Death|1|||
129167540|NCT02908685|464907995|FG013|Part 2 OLE: > Month 24|Death|0|||
129167541|NCT02908685|464907982|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
129167542|NCT02908685|464907983|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
129167543|NCT02908685|464907984|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
129167544|NCT02908685|464907985|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
129167545|NCT02908685|464907986|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
129167546|NCT02908685|464907987|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
129167547|NCT02908685|464907988|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
129167548|NCT02908685|464907989|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
129167549|NCT02908685|464907990|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
129167550|NCT02908685|464907991|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
129167551|NCT02908685|464907992|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
129167552|NCT02908685|464907993|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
129167553|NCT02908685|464907994|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
129167554|NCT02908685|464907995|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
129167555|NCT02908685|464907982|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167556|NCT02908685|464907983|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167557|NCT02908685|464907984|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167558|NCT02908685|464907985|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167559|NCT02908685|464907986|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167560|NCT02908685|464907987|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167561|NCT02908685|464907988|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167562|NCT02908685|464907989|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167563|NCT02908685|464907990|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167564|NCT02908685|464907991|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167565|NCT02908685|464907992|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167566|NCT02908685|464907993|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129167567|NCT02908685|464907994|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
129167568|NCT02908685|464907995|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
129167569|NCT01691014|464907996|FG000|Overall Study|Premature Termination|1|||
129167570|NCT01691014|464907997|FG001|Overall Study|Premature Termination|6|||
129167571|NCT01691014|464907998|FG002|Overall Study|Premature Termination|0|||
129167572|NCT01691014|464907999|FG003|Overall Study|Premature Termination|3|||
129167573|NCT01691014|464907996|FG000|Overall Study|Other|0|||
129167574|NCT01691014|464907997|FG001|Overall Study|Other|0|||
129167575|NCT01691014|464907998|FG002|Overall Study|Other|2|||
129167576|NCT01691014|464907999|FG003|Overall Study|Other|0|||
129167577|NCT01691014|464907996|FG000|Overall Study|Withdrawal by Subject|0|||
129167578|NCT01691014|464907997|FG001|Overall Study|Withdrawal by Subject|1|||
129167579|NCT01691014|464907998|FG002|Overall Study|Withdrawal by Subject|1|||
129167580|NCT01691014|464907999|FG003|Overall Study|Withdrawal by Subject|1|||
129167581|NCT01691014|464907996|FG000|Overall Study|Adverse Event|0|||
129167582|NCT01691014|464907997|FG001|Overall Study|Adverse Event|5|||
129167583|NCT01691014|464907998|FG002|Overall Study|Adverse Event|1|||
129167584|NCT01691014|464907999|FG003|Overall Study|Adverse Event|1|||
129167585|NCT01691014|464907996|FG000|Overall Study|Lack of Efficacy|2|||
129167586|NCT01691014|464907997|FG001|Overall Study|Lack of Efficacy|3|||
129167587|NCT01691014|464907998|FG002|Overall Study|Lack of Efficacy|7|||
129167588|NCT01691014|464907999|FG003|Overall Study|Lack of Efficacy|0|||
129167589|NCT02370537|464908000|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
129167590|NCT02370537|464908001|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
129167591|NCT02370537|464908002|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
129167592|NCT02370537|464908000|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
129167593|NCT02370537|464908001|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
129167594|NCT02370537|464908002|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
129167595|NCT02370537|464908000|FG000|Part B|Not randomised to receive treatment|1|||
129167596|NCT02370537|464908001|FG001|Part B|Not randomised to receive treatment|2|||
129167597|NCT02370537|464908002|FG002|Part B|Not randomised to receive treatment|259|||
129167598|NCT02370537|464908000|FG000|Part B|Withdrawal by Subject|0|||
129167599|NCT02370537|464908001|FG001|Part B|Withdrawal by Subject|1|||
129167600|NCT02370537|464908002|FG002|Part B|Withdrawal by Subject|0|||
129167601|NCT05897242|464908003|FG000|Overall Study|Lost to Follow-up|6|||
129167602|NCT05897242|464908004|FG001|Overall Study|Lost to Follow-up|1|||
129167603|NCT05897242|464908003|FG000|Overall Study|Incomplete|1|||
129167604|NCT05897242|464908004|FG001|Overall Study|Incomplete|0|||
129167605|NCT05897242|464908003|FG000|Overall Study|Withdrawal by Subject|1|||
129167606|NCT05897242|464908004|FG001|Overall Study|Withdrawal by Subject|0|||
129167607|NCT02920528|464908005|FG000|Overall Study|Incomplete Data|1|||
129167608|NCT02920528|464908006|FG001|Overall Study|Incomplete Data|1|||
129167609|NCT02920528|464908007|FG002|Overall Study|Incomplete Data|1|||
129167610|NCT02920528|464908005|FG000|Overall Study|Adverse Event|0|||
129167611|NCT02920528|464908006|FG001|Overall Study|Adverse Event|0|||
128728143|NCT01904604|463301757|FG002|Overall Study|Withdrawal by Subject|0|||
128728144|NCT01904604|463301755|FG000|Overall Study|Participant Relocated|1|||
128728145|NCT01904604|463301756|FG001|Overall Study|Participant Relocated|1|||
128728146|NCT01904604|463301757|FG002|Overall Study|Participant Relocated|1|||
128728147|NCT01904604|463301755|FG000|Overall Study|Lost to Follow-up|0|||
128728148|NCT01904604|463301756|FG001|Overall Study|Lost to Follow-up|0|||
128728149|NCT01904604|463301757|FG002|Overall Study|Lost to Follow-up|1|||
128728150|NCT03568942|463301760|FG000|Overall Study|Family emergency|1|||
128728151|NCT03568942|463301760|FG000|Overall Study|Lost to Follow-up|1|||
128728152|NCT00358527|463301762|FG000|Overall Study|Adverse Event|4|||
128728153|NCT00358527|463301763|FG001|Overall Study|Adverse Event|0|||
128728154|NCT00358527|463301762|FG000|Overall Study|Withdrawal by Subject|1|||
128728155|NCT00358527|463301763|FG001|Overall Study|Withdrawal by Subject|1|||
128728156|NCT00358527|463301762|FG000|Overall Study|Non-compliance with protocol|6|||
129167612|NCT02920528|464908007|FG002|Overall Study|Adverse Event|3|||
129167613|NCT02920528|464908005|FG000|Overall Study|Did not meet inclusion criteria|2|||
129167614|NCT02920528|464908006|FG001|Overall Study|Did not meet inclusion criteria|0|||
129167615|NCT02920528|464908007|FG002|Overall Study|Did not meet inclusion criteria|1|||
129167616|NCT02547038|464908008|FG000|Overall Study|Lost to Follow-up|3|||
129167617|NCT02547038|464908009|FG001|Overall Study|Lost to Follow-up|2|||
129167618|NCT01340625|464908010|FG000|First Intervention|Adverse Event|1|||
129167619|NCT01340625|464908011|FG001|First Intervention|Adverse Event|0|||
129167620|NCT01340625|464908010|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
129167621|NCT01340625|464908011|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
129167622|NCT00066703|464908012|FG000|Overall Study|Adverse Event|80|||
129167623|NCT00066703|464908013|FG001|Overall Study|Adverse Event|111|||
129167624|NCT00066703|464908012|FG000|Overall Study|Death|3|||
129167625|NCT00066703|464908013|FG001|Overall Study|Death|0|||
129167626|NCT00066703|464908012|FG000|Overall Study|Lack of Efficacy|114|||
129167627|NCT00066703|464908013|FG001|Overall Study|Lack of Efficacy|69|||
129167628|NCT00066703|464908012|FG000|Overall Study|Lost to Follow-up|31|||
129167629|NCT00066703|464908013|FG001|Overall Study|Lost to Follow-up|28|||
129167630|NCT00066703|464908012|FG000|Overall Study|Withdrawal by Subject|38|||
129167631|NCT00066703|464908013|FG001|Overall Study|Withdrawal by Subject|63|||
129167632|NCT00066703|464908012|FG000|Overall Study|Treatment ongoing|346|||
129167633|NCT00066703|464908013|FG001|Overall Study|Treatment ongoing|311|||
129167634|NCT01696968|464908014|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
129167635|NCT01696968|464908015|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
129167636|NCT01696968|464908014|FG000|Overall Study|Died Before Randomization|3|||
129167637|NCT01696968|464908015|FG001|Overall Study|Died Before Randomization|8|||
129167638|NCT01696968|464908014|FG000|Overall Study|Died Before ASU (Control)|278|||
129167639|NCT01696968|464908015|FG001|Overall Study|Died Before ASU (Control)|0|||
129167640|NCT01696968|464908014|FG000|Overall Study|Refused ASU (Control)|920|||
129167641|NCT01696968|464908015|FG001|Overall Study|Refused ASU (Control)|0|||
129167642|NCT01696968|464908014|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
129167643|NCT01696968|464908015|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
129167644|NCT04115748|464908041|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
129167645|NCT04115748|464908042|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
129167646|NCT04115748|464908043|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
129167647|NCT04115748|464908044|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
129167648|NCT04115748|464908045|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129167649|NCT04115748|464908046|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129167650|NCT04115748|464908047|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129167651|NCT04115748|464908048|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129167652|NCT04115748|464908049|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129167653|NCT04115748|464908050|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129167654|NCT04115748|464908041|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167655|NCT04115748|464908042|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167656|NCT04115748|464908043|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167657|NCT04115748|464908044|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
129167658|NCT04115748|464908045|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167659|NCT04115748|464908046|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167660|NCT04115748|464908047|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167661|NCT04115748|464908048|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167662|NCT04115748|464908049|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167663|NCT04115748|464908050|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129167664|NCT04115748|464908041|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129167665|NCT04115748|464908042|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129167666|NCT04115748|464908043|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129167667|NCT04115748|464908044|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129167668|NCT04115748|464908045|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
129167669|NCT04115748|464908046|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
129167670|NCT04115748|464908047|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
129167671|NCT04115748|464908048|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
129167672|NCT04115748|464908049|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
129167673|NCT04115748|464908050|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
129167674|NCT04115748|464908041|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167675|NCT04115748|464908042|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167676|NCT04115748|464908043|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167677|NCT04115748|464908044|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167678|NCT04115748|464908045|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167679|NCT04115748|464908046|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167680|NCT04115748|464908047|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167681|NCT04115748|464908048|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167682|NCT04115748|464908049|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
128728157|NCT00358527|463301763|FG001|Overall Study|Non-compliance with protocol|1|||
128728158|NCT00358527|463301762|FG000|Overall Study|Administrative|2|||
128728159|NCT00358527|463301763|FG001|Overall Study|Administrative|1|||
128728160|NCT04144166|463301764|FG000|Overall Study|Discharged before study start|1|||
128728161|NCT04144166|463301764|FG000|Overall Study|Pregnancy|1|||
128728162|NCT04144166|463301764|FG000|Overall Study|Nail polish could not be removed from finger|1|||
128728163|NCT04145895|463301766|FG000|Overall Study|Physician Decision|2|||
128728164|NCT04145895|463301767|FG001|Overall Study|Physician Decision|0|||
128728165|NCT04145895|463301766|FG000|Overall Study|Withdrawal by Subject|0|||
128728166|NCT04145895|463301767|FG001|Overall Study|Withdrawal by Subject|2|||
128728167|NCT01481116|463301768|FG000|Overall Study|Adverse Event|26|||
128728168|NCT01481116|463301769|FG001|Overall Study|Adverse Event|26|||
128728169|NCT01481116|463301770|FG002|Overall Study|Adverse Event|42|||
128728170|NCT01481116|463301768|FG000|Overall Study|Major Protocol Deviation|3|||
128728171|NCT01481116|463301769|FG001|Overall Study|Major Protocol Deviation|7|||
128728172|NCT01481116|463301770|FG002|Overall Study|Major Protocol Deviation|1|||
128728173|NCT01481116|463301768|FG000|Overall Study|Lost to Follow-up|8|||
128728174|NCT01481116|463301769|FG001|Overall Study|Lost to Follow-up|12|||
128728175|NCT01481116|463301770|FG002|Overall Study|Lost to Follow-up|11|||
128728176|NCT01481116|463301768|FG000|Overall Study|Withdrawal by Subject|37|||
128728177|NCT01481116|463301769|FG001|Overall Study|Withdrawal by Subject|33|||
128728178|NCT01481116|463301770|FG002|Overall Study|Withdrawal by Subject|37|||
129167683|NCT04115748|464908050|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129167684|NCT01549886|464908051|FG000|Overall Study|Sponsor's decision|2|||
129167685|NCT01549886|464908052|FG001|Overall Study|Sponsor's decision|3|||
129167686|NCT06004895|464908053|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
129167687|NCT06004895|464908053|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
129167688|NCT01450696|464908054|FG000|Overall Study|Never Treated|1|||
129167689|NCT01450696|464908055|FG001|Overall Study|Never Treated|1|||
129167690|NCT01450696|464908054|FG000|Overall Study|Death|77|||
129167691|NCT01450696|464908055|FG001|Overall Study|Death|84|||
129167692|NCT01450696|464908054|FG000|Overall Study|Lost to Follow-up|3|||
129167693|NCT01450696|464908055|FG001|Overall Study|Lost to Follow-up|3|||
129167694|NCT01450696|464908054|FG000|Overall Study|Non-Compliance|1|||
129167695|NCT01450696|464908055|FG001|Overall Study|Non-Compliance|0|||
129167696|NCT01450696|464908054|FG000|Overall Study|Withdrawal by Subject|13|||
129167697|NCT01450696|464908055|FG001|Overall Study|Withdrawal by Subject|2|||
129167698|NCT01450696|464908054|FG000|Overall Study|Study Terminated by Sponsor|53|||
129167699|NCT01450696|464908055|FG001|Overall Study|Study Terminated by Sponsor|58|||
129167700|NCT00967694|464908056|FG000|Overall Study|Withdrawal by Subject|6|||
129167701|NCT01843673|464908057|FG000|Overall Study|Lack of Efficacy|2|||
129167702|NCT01843673|464908057|FG000|Overall Study|Withdrawal by Subject|4|||
129167703|NCT02321319|464908058|FG000|Overall Study|Product discontinued|5|||
129167704|NCT02249091|464908059|FG000|Overall Study|Lack of Efficacy|8|||
129167705|NCT02249091|464908060|FG001|Overall Study|Lack of Efficacy|3|||
129167706|NCT02249091|464908059|FG000|Overall Study|Physician Decision|4|||
129167707|NCT02249091|464908060|FG001|Overall Study|Physician Decision|1|||
129167708|NCT02249091|464908059|FG000|Overall Study|Withdrawal by Subject|2|||
129167709|NCT02249091|464908060|FG001|Overall Study|Withdrawal by Subject|2|||
129167710|NCT02249091|464908059|FG000|Overall Study|Death|3|||
129167711|NCT02249091|464908060|FG001|Overall Study|Death|4|||
129167712|NCT02249091|464908059|FG000|Overall Study|Adverse Event|1|||
129167713|NCT02249091|464908060|FG001|Overall Study|Adverse Event|0|||
129167714|NCT02249091|464908059|FG000|Overall Study|Stable disease with following SCT|0|||
129167715|NCT02249091|464908060|FG001|Overall Study|Stable disease with following SCT|1|||
129167716|NCT02249091|464908059|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
129167717|NCT02249091|464908060|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
129167718|NCT02249091|464908059|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
129167719|NCT02249091|464908060|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
129167720|NCT02249091|464908059|FG000|Overall Study|Refractory AML|1|||
129167721|NCT02249091|464908060|FG001|Overall Study|Refractory AML|1|||
129167722|NCT02957747|464908061|FG000|Overall Study|Withdrawal by Subject|0|||
129167723|NCT02957747|464908062|FG001|Overall Study|Withdrawal by Subject|3|||
129167724|NCT02957747|464908061|FG000|Overall Study|Lost to Follow-up|10|||
129167725|NCT02957747|464908062|FG001|Overall Study|Lost to Follow-up|5|||
129167726|NCT00632827|464908065|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
129167727|NCT00632827|464908065|FG000|Overall Study|Death|2|||
129167728|NCT00632827|464908065|FG000|Overall Study|Adverse Event|5|||
129167729|NCT00632827|464908065|FG000|Overall Study|Lost to Follow-up|1|||
129167730|NCT01626118|464908068|FG000|Overall Study|Lack of Efficacy|1|||
129167731|NCT01626118|464908069|FG001|Overall Study|Lack of Efficacy|0|||
129167732|NCT01626118|464908070|FG002|Overall Study|Lack of Efficacy|1|||
129167733|NCT01626118|464908071|FG003|Overall Study|Lack of Efficacy|3|||
129167734|NCT01626118|464908068|FG000|Overall Study|Lost to Follow-up|1|||
129167735|NCT01626118|464908069|FG001|Overall Study|Lost to Follow-up|0|||
129167736|NCT01626118|464908070|FG002|Overall Study|Lost to Follow-up|0|||
129167737|NCT01626118|464908071|FG003|Overall Study|Lost to Follow-up|0|||
129167738|NCT01626118|464908068|FG000|Overall Study|Adverse Event|0|||
129167739|NCT01626118|464908069|FG001|Overall Study|Adverse Event|1|||
129167740|NCT01626118|464908070|FG002|Overall Study|Adverse Event|1|||
129167741|NCT01626118|464908071|FG003|Overall Study|Adverse Event|0|||
129167742|NCT01626118|464908068|FG000|Overall Study|Investigator Decision|0|||
129167743|NCT01626118|464908069|FG001|Overall Study|Investigator Decision|1|||
129167744|NCT01626118|464908070|FG002|Overall Study|Investigator Decision|0|||
129167745|NCT01626118|464908071|FG003|Overall Study|Investigator Decision|0|||
129167746|NCT03931382|464908072|FG000|Overall Study|Equipment malfunction|2|||
129167747|NCT03931382|464908073|FG001|Overall Study|Equipment malfunction|0|||
129167748|NCT03931382|464908074|FG002|Overall Study|Equipment malfunction|2|||
129167749|NCT03931382|464908072|FG000|Overall Study|Withdrawal by Subject|0|||
129167750|NCT03931382|464908073|FG001|Overall Study|Withdrawal by Subject|1|||
129167751|NCT03931382|464908074|FG002|Overall Study|Withdrawal by Subject|0|||
129167752|NCT00778375|464908080|FG000|Overall Study|Ineligible|3|||
129167753|NCT00939029|464908081|FG000|Overall Study|Withdrawal by Subject|3|||
129167754|NCT00939029|464908082|FG001|Overall Study|Withdrawal by Subject|7|||
129167755|NCT00939029|464908081|FG000|Overall Study|Lost to Follow-up|3|||
129167756|NCT00939029|464908082|FG001|Overall Study|Lost to Follow-up|4|||
129167757|NCT00939029|464908081|FG000|Overall Study|Adverse Event|0|||
129167758|NCT00939029|464908082|FG001|Overall Study|Adverse Event|1|||
129167759|NCT01421303|464908083|FG000|Overall Study|Lost to Follow-up|13|||
129167760|NCT01421303|464908083|FG000|Overall Study|Non compliance with study procedure|1|||
129167761|NCT01421303|464908083|FG000|Overall Study|Other|7|||
129167762|NCT01421303|464908083|FG000|Overall Study|Withdrawal by Subject|1|||
129167763|NCT06003777|464908084|FG000|Period 1|Adverse Event|0|||
129167764|NCT06003777|464908085|FG001|Period 1|Adverse Event|0|||
129167765|NCT06003777|464908086|FG002|Period 1|Adverse Event|1|||
129167766|NCT06003777|464908087|FG003|Period 1|Adverse Event|0|||
129167767|NCT06003777|464908088|FG004|Period 1|Adverse Event|0|||
129167768|NCT06003777|464908089|FG005|Period 1|Adverse Event|0|||
129167769|NCT06003777|464908090|FG006|Period 1|Adverse Event|0|||
129167770|NCT06003777|464908091|FG007|Period 1|Adverse Event|0|||
129167771|NCT06003777|464908092|FG008|Period 1|Adverse Event|0|||
129167772|NCT06003777|464908093|FG009|Period 1|Adverse Event|0|||
129167773|NCT06003777|464908094|FG010|Period 1|Adverse Event|0|||
129167774|NCT06003777|464908095|FG011|Period 1|Adverse Event|0|||
129167775|NCT06003777|464908084|FG000|Period 1|Withdrawal by Subject|0|||
129167776|NCT06003777|464908085|FG001|Period 1|Withdrawal by Subject|0|||
129167777|NCT06003777|464908086|FG002|Period 1|Withdrawal by Subject|0|||
129167778|NCT06003777|464908087|FG003|Period 1|Withdrawal by Subject|0|||
129167779|NCT06003777|464908088|FG004|Period 1|Withdrawal by Subject|1|||
129167780|NCT06003777|464908089|FG005|Period 1|Withdrawal by Subject|0|||
129167781|NCT06003777|464908090|FG006|Period 1|Withdrawal by Subject|0|||
129167782|NCT06003777|464908091|FG007|Period 1|Withdrawal by Subject|0|||
129167783|NCT06003777|464908092|FG008|Period 1|Withdrawal by Subject|0|||
129167784|NCT06003777|464908093|FG009|Period 1|Withdrawal by Subject|0|||
129167785|NCT06003777|464908094|FG010|Period 1|Withdrawal by Subject|0|||
129167786|NCT06003777|464908095|FG011|Period 1|Withdrawal by Subject|0|||
129167787|NCT06003777|464908084|FG000|Period 2|Withdrawal by Subject|0|||
129167788|NCT06003777|464908085|FG001|Period 2|Withdrawal by Subject|0|||
129167789|NCT06003777|464908086|FG002|Period 2|Withdrawal by Subject|0|||
129167790|NCT06003777|464908087|FG003|Period 2|Withdrawal by Subject|0|||
129167791|NCT06003777|464908088|FG004|Period 2|Withdrawal by Subject|0|||
129167792|NCT06003777|464908089|FG005|Period 2|Withdrawal by Subject|0|||
129167793|NCT06003777|464908090|FG006|Period 2|Withdrawal by Subject|0|||
129167794|NCT06003777|464908091|FG007|Period 2|Withdrawal by Subject|0|||
129167795|NCT06003777|464908092|FG008|Period 2|Withdrawal by Subject|1|||
129167796|NCT06003777|464908093|FG009|Period 2|Withdrawal by Subject|0|||
129167797|NCT06003777|464908094|FG010|Period 2|Withdrawal by Subject|0|||
129167798|NCT06003777|464908095|FG011|Period 2|Withdrawal by Subject|0|||
129167799|NCT06003777|464908084|FG000|Period 3|Adverse Event|0|||
129167800|NCT06003777|464908085|FG001|Period 3|Adverse Event|0|||
129167801|NCT06003777|464908086|FG002|Period 3|Adverse Event|0|||
129167802|NCT06003777|464908087|FG003|Period 3|Adverse Event|0|||
129167803|NCT06003777|464908088|FG004|Period 3|Adverse Event|0|||
129167804|NCT06003777|464908089|FG005|Period 3|Adverse Event|0|||
129167805|NCT06003777|464908090|FG006|Period 3|Adverse Event|1|||
129167806|NCT06003777|464908091|FG007|Period 3|Adverse Event|0|||
129167807|NCT06003777|464908092|FG008|Period 3|Adverse Event|0|||
129167808|NCT06003777|464908093|FG009|Period 3|Adverse Event|0|||
129167809|NCT06003777|464908094|FG010|Period 3|Adverse Event|0|||
129167810|NCT06003777|464908095|FG011|Period 3|Adverse Event|0|||
129167811|NCT06003777|464908084|FG000|Period 4|No longer met eligibility criteria|0|||
129167812|NCT06003777|464908085|FG001|Period 4|No longer met eligibility criteria|0|||
129167813|NCT06003777|464908086|FG002|Period 4|No longer met eligibility criteria|1|||
129167814|NCT06003777|464908087|FG003|Period 4|No longer met eligibility criteria|0|||
129167815|NCT06003777|464908088|FG004|Period 4|No longer met eligibility criteria|0|||
129167816|NCT06003777|464908089|FG005|Period 4|No longer met eligibility criteria|0|||
129167817|NCT06003777|464908090|FG006|Period 4|No longer met eligibility criteria|0|||
129167818|NCT06003777|464908091|FG007|Period 4|No longer met eligibility criteria|0|||
129167819|NCT06003777|464908092|FG008|Period 4|No longer met eligibility criteria|0|||
129167820|NCT06003777|464908093|FG009|Period 4|No longer met eligibility criteria|0|||
129167821|NCT06003777|464908094|FG010|Period 4|No longer met eligibility criteria|0|||
129167822|NCT06003777|464908095|FG011|Period 4|No longer met eligibility criteria|0|||
129167823|NCT06003777|464908084|FG000|Period 4|Withdrawal by Subject|0|||
129167824|NCT06003777|464908085|FG001|Period 4|Withdrawal by Subject|1|||
128728179|NCT01481116|463301768|FG000|Overall Study|Study Termination|730|||
128728180|NCT01481116|463301769|FG001|Overall Study|Study Termination|729|||
128728181|NCT01481116|463301770|FG002|Overall Study|Study Termination|713|||
128728182|NCT01481116|463301768|FG000|Overall Study|Pregnancy|0|||
128728183|NCT01481116|463301769|FG001|Overall Study|Pregnancy|0|||
128728184|NCT01481116|463301770|FG002|Overall Study|Pregnancy|1|||
128728185|NCT01481116|463301768|FG000|Overall Study|Lack of Efficacy|3|||
128728186|NCT01481116|463301769|FG001|Overall Study|Lack of Efficacy|3|||
128728187|NCT01481116|463301770|FG002|Overall Study|Lack of Efficacy|1|||
128728188|NCT01481116|463301768|FG000|Overall Study|Contraindications|1|||
128728189|NCT01481116|463301769|FG001|Overall Study|Contraindications|1|||
128728190|NCT01481116|463301770|FG002|Overall Study|Contraindications|0|||
128728191|NCT01481116|463301768|FG000|Overall Study|Other|1|||
128728192|NCT01481116|463301769|FG001|Overall Study|Other|1|||
129167825|NCT06003777|464908086|FG002|Period 4|Withdrawal by Subject|0|||
129167826|NCT06003777|464908087|FG003|Period 4|Withdrawal by Subject|0|||
128728193|NCT01481116|463301770|FG002|Overall Study|Other|0|||
129167827|NCT06003777|464908088|FG004|Period 4|Withdrawal by Subject|0|||
129167828|NCT06003777|464908089|FG005|Period 4|Withdrawal by Subject|0|||
128728194|NCT01481116|463301768|FG000|Overall Study|Participant Started Taking Glipizide|1|||
128728195|NCT01481116|463301769|FG001|Overall Study|Participant Started Taking Glipizide|0|||
129167829|NCT06003777|464908090|FG006|Period 4|Withdrawal by Subject|0|||
129167830|NCT06003777|464908091|FG007|Period 4|Withdrawal by Subject|0|||
129167831|NCT06003777|464908092|FG008|Period 4|Withdrawal by Subject|0|||
129167832|NCT06003777|464908093|FG009|Period 4|Withdrawal by Subject|0|||
129167833|NCT06003777|464908094|FG010|Period 4|Withdrawal by Subject|0|||
129167834|NCT06003777|464908095|FG011|Period 4|Withdrawal by Subject|0|||
129167835|NCT04154605|464908098|FG000|Overall Study|Procedure Canceled|1|||
129167836|NCT04154605|464908099|FG001|Overall Study|Procedure Canceled|1|||
129167837|NCT04154605|464908098|FG000|Overall Study|Missed follow up|1|||
129167838|NCT04154605|464908099|FG001|Overall Study|Missed follow up|1|||
129167839|NCT04154605|464908098|FG000|Overall Study|Withdrawal by Subject|1|||
129167840|NCT04154605|464908099|FG001|Overall Study|Withdrawal by Subject|0|||
129167841|NCT00675441|464908100|FG000|Overall Study|Withdrawal by Subject|2|||
129167842|NCT00675441|464908100|FG000|Overall Study|Death|1|||
129167843|NCT00344318|464908104|FG000|Overall Study|Adverse Event|0|||
129167844|NCT00344318|464908105|FG001|Overall Study|Adverse Event|3|||
129167845|NCT00344318|464908106|FG002|Overall Study|Adverse Event|0|||
129167846|NCT00344318|464908107|FG003|Overall Study|Adverse Event|1|||
129167847|NCT00344318|464908104|FG000|Overall Study|Withdrawal by Subject|2|||
129167848|NCT00344318|464908105|FG001|Overall Study|Withdrawal by Subject|2|||
129167849|NCT00344318|464908106|FG002|Overall Study|Withdrawal by Subject|0|||
129167850|NCT00344318|464908107|FG003|Overall Study|Withdrawal by Subject|2|||
129167851|NCT00344318|464908104|FG000|Overall Study|Lost to Follow-up|2|||
129167852|NCT00344318|464908105|FG001|Overall Study|Lost to Follow-up|0|||
129167853|NCT00344318|464908106|FG002|Overall Study|Lost to Follow-up|1|||
129167854|NCT00344318|464908107|FG003|Overall Study|Lost to Follow-up|0|||
129167855|NCT01923363|464908108|FG000|Overall Study|Protocol Violation|1|||
129167856|NCT00656058|464908109|FG000|Overall Study|Withdrawal by Subject|2|||
129167857|NCT00656058|464908109|FG000|Overall Study|Withdrawal by Subject|4|||
129167858|NCT06359028|464908110|FG000|Overall Study|Adverse Event|1|||
129167859|NCT06359028|464908111|FG001|Overall Study|Adverse Event|0|||
129167860|NCT06359028|464908110|FG000|Overall Study|Withdrawal by Subject|1|||
129167861|NCT06359028|464908111|FG001|Overall Study|Withdrawal by Subject|0|||
129167862|NCT03515551|464908112|FG000|Overall Study|Death|4|||
129167863|NCT03515551|464908113|FG001|Overall Study|Death|1|||
129167864|NCT03515551|464908114|FG002|Overall Study|Death|2|||
129167865|NCT03515551|464908115|FG003|Overall Study|Death|2|||
129167866|NCT03515551|464908116|FG004|Overall Study|Death|2|||
129167867|NCT03515551|464908117|FG005|Overall Study|Death|4|||
129167868|NCT03515551|464908118|FG006|Overall Study|Death|1|||
129167869|NCT03515551|464908112|FG000|Overall Study|Lost to Follow-up|0|||
129167870|NCT03515551|464908113|FG001|Overall Study|Lost to Follow-up|0|||
129167871|NCT03515551|464908114|FG002|Overall Study|Lost to Follow-up|1|||
129167872|NCT03515551|464908115|FG003|Overall Study|Lost to Follow-up|0|||
129167873|NCT03515551|464908116|FG004|Overall Study|Lost to Follow-up|0|||
129167874|NCT03515551|464908117|FG005|Overall Study|Lost to Follow-up|0|||
129167875|NCT03515551|464908118|FG006|Overall Study|Lost to Follow-up|0|||
129167876|NCT03515551|464908112|FG000|Overall Study|Withdrawal by Subject|0|||
129167877|NCT03515551|464908113|FG001|Overall Study|Withdrawal by Subject|1|||
129167878|NCT03515551|464908114|FG002|Overall Study|Withdrawal by Subject|0|||
129167879|NCT03515551|464908115|FG003|Overall Study|Withdrawal by Subject|0|||
129167880|NCT03515551|464908116|FG004|Overall Study|Withdrawal by Subject|0|||
129167881|NCT03515551|464908117|FG005|Overall Study|Withdrawal by Subject|0|||
129167882|NCT03515551|464908118|FG006|Overall Study|Withdrawal by Subject|1|||
129167883|NCT03515551|464908112|FG000|Overall Study|Study ended by sponsor|0|||
129167884|NCT03515551|464908113|FG001|Overall Study|Study ended by sponsor|0|||
129167885|NCT03515551|464908114|FG002|Overall Study|Study ended by sponsor|2|||
129167886|NCT03515551|464908115|FG003|Overall Study|Study ended by sponsor|1|||
129167887|NCT03515551|464908116|FG004|Overall Study|Study ended by sponsor|3|||
129167888|NCT03515551|464908117|FG005|Overall Study|Study ended by sponsor|0|||
129167889|NCT03515551|464908118|FG006|Overall Study|Study ended by sponsor|3|||
129167890|NCT03515551|464908112|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129167891|NCT03515551|464908113|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
129167892|NCT03515551|464908114|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129167893|NCT03515551|464908115|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129167894|NCT03515551|464908116|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129167895|NCT03515551|464908117|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129167896|NCT03515551|464908118|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129167897|NCT00920387|464908119|FG000|Stage 1|Adverse Event|1|||
129167898|NCT00920387|464908120|FG001|Stage 1|Adverse Event|0|||
129167899|NCT00920387|464908121|FG002|Stage 1|Adverse Event|0|||
129167900|NCT02265536|464908122|FG000|Overall Study|Adverse Event|1|||
129167901|NCT02265536|464908123|FG001|Overall Study|Adverse Event|0|||
129167902|NCT02265536|464908124|FG002|Overall Study|Adverse Event|0|||
129167903|NCT02265536|464908125|FG003|Overall Study|Adverse Event|0|||
129167904|NCT02265536|464908126|FG004|Overall Study|Adverse Event|1|||
129167905|NCT02265536|464908127|FG005|Overall Study|Adverse Event|0|||
128728196|NCT01481116|463301770|FG002|Overall Study|Participant Started Taking Glipizide|0|||
129167906|NCT02265536|464908122|FG000|Overall Study|Physician Decision|0|||
129167907|NCT02265536|464908123|FG001|Overall Study|Physician Decision|0|||
129167908|NCT02265536|464908124|FG002|Overall Study|Physician Decision|0|||
129167909|NCT02265536|464908125|FG003|Overall Study|Physician Decision|0|||
129167910|NCT02265536|464908126|FG004|Overall Study|Physician Decision|2|||
129167911|NCT02265536|464908127|FG005|Overall Study|Physician Decision|0|||
129167912|NCT02265536|464908122|FG000|Overall Study|Withdrawal by Subject|0|||
129167913|NCT02265536|464908123|FG001|Overall Study|Withdrawal by Subject|3|||
129167914|NCT02265536|464908124|FG002|Overall Study|Withdrawal by Subject|0|||
129167915|NCT02265536|464908125|FG003|Overall Study|Withdrawal by Subject|0|||
129167916|NCT02265536|464908126|FG004|Overall Study|Withdrawal by Subject|0|||
129167917|NCT02265536|464908127|FG005|Overall Study|Withdrawal by Subject|0|||
129167918|NCT01866111|464908128|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
129167919|NCT01866111|464908129|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
129167920|NCT01866111|464908130|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
129167921|NCT01866111|464908131|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
129167922|NCT01866111|464908128|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
129167923|NCT01866111|464908129|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
129167924|NCT01866111|464908130|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
129167925|NCT01866111|464908131|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
129167926|NCT01866111|464908128|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
129167927|NCT01866111|464908129|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
129167928|NCT01866111|464908130|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
129167929|NCT01866111|464908131|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
129167930|NCT01866111|464908128|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
129167931|NCT01866111|464908129|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
129167932|NCT01866111|464908130|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
129167933|NCT01866111|464908131|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
129167934|NCT01866111|464908128|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
128728197|NCT01481116|463301768|FG000|Overall Study|Participant Moved Out of Area|2|||
128728198|NCT01481116|463301769|FG001|Overall Study|Participant Moved Out of Area|0|||
128728199|NCT01481116|463301770|FG002|Overall Study|Participant Moved Out of Area|1|||
129167935|NCT01866111|464908129|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
129167936|NCT01866111|464908130|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
129167937|NCT01866111|464908131|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
128728200|NCT01481116|463301768|FG000|Overall Study|Participant Moved Out of Country|1|||
129167938|NCT01866111|464908128|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
129167939|NCT01866111|464908129|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
129167940|NCT01866111|464908130|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
129167941|NCT01866111|464908131|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
128728201|NCT01481116|463301769|FG001|Overall Study|Participant Moved Out of Country|0|||
128728202|NCT01481116|463301770|FG002|Overall Study|Participant Moved Out of Country|1|||
128728203|NCT01481116|463301768|FG000|Overall Study|Investigator Decision|3|||
129167942|NCT01866111|464908128|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
129167943|NCT01866111|464908129|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
129167944|NCT01866111|464908130|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
129167945|NCT01866111|464908131|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
129167946|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
129167947|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
129167948|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
129167949|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
129167950|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
129167951|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
129167952|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
129167953|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
129167954|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
129167955|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
129167956|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
129167957|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
129167958|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
129167959|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
129167960|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
129167961|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
129167962|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Death|1|||
129167963|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Death|1|||
129167964|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Death|3|||
129167965|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Death|2|||
129167966|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
129167967|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
129167968|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
129167969|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
129167970|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
129167971|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
129167972|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
129167973|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
129167974|NCT01866111|464908128|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
129167975|NCT01866111|464908129|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
129167976|NCT01866111|464908130|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
129167977|NCT01866111|464908131|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
129167978|NCT05596734|464908132|FG000|Substudy A|Withdrawal by Subject|1|||
129167979|NCT05596734|464908133|FG001|Substudy A|Withdrawal by Subject|0|||
129167980|NCT05596734|464908134|FG002|Substudy A|Withdrawal by Subject|0|||
129167981|NCT05596734|464908135|FG003|Substudy A|Withdrawal by Subject|0|||
129167982|NCT05596734|464908136|FG004|Substudy A|Withdrawal by Subject|0|||
129167983|NCT05596734|464908137|FG005|Substudy A|Withdrawal by Subject|0|||
129167984|NCT05596734|464908138|FG006|Substudy A|Withdrawal by Subject|1|||
129167985|NCT05596734|464908139|FG007|Substudy A|Withdrawal by Subject|0|||
129167986|NCT05596734|464908140|FG008|Substudy A|Withdrawal by Subject|0|||
129167987|NCT05596734|464908141|FG009|Substudy A|Withdrawal by Subject|0|||
129167988|NCT05596734|464908142|FG010|Substudy A|Withdrawal by Subject|0|||
129167989|NCT05596734|464908143|FG011|Substudy A|Withdrawal by Subject|0|||
129167990|NCT05596734|464908144|FG012|Substudy A|Withdrawal by Subject|0|||
129167991|NCT05596734|464908145|FG013|Substudy A|Withdrawal by Subject|0|||
129167992|NCT05596734|464908146|FG014|Substudy A|Withdrawal by Subject|0|||
129167993|NCT05596734|464908147|FG015|Substudy A|Withdrawal by Subject|0|||
129167994|NCT05596734|464908148|FG016|Substudy A|Withdrawal by Subject|0|||
129167995|NCT05596734|464908149|FG017|Substudy A|Withdrawal by Subject|0|||
129167996|NCT05596734|464908150|FG018|Substudy A|Withdrawal by Subject|0|||
129167997|NCT05596734|464908151|FG019|Substudy A|Withdrawal by Subject|0|||
129167998|NCT05596734|464908152|FG020|Substudy A|Withdrawal by Subject|0|||
129167999|NCT05596734|464908153|FG021|Substudy A|Withdrawal by Subject|0|||
129168000|NCT05596734|464908154|FG022|Substudy A|Withdrawal by Subject|0|||
129168001|NCT05596734|464908155|FG023|Substudy A|Withdrawal by Subject|0|||
129168002|NCT05596734|464908132|FG000|Substudy A|Lost to Follow-up|1|||
129168003|NCT05596734|464908133|FG001|Substudy A|Lost to Follow-up|0|||
129168004|NCT05596734|464908134|FG002|Substudy A|Lost to Follow-up|1|||
129168005|NCT05596734|464908135|FG003|Substudy A|Lost to Follow-up|0|||
129168006|NCT05596734|464908136|FG004|Substudy A|Lost to Follow-up|0|||
129168007|NCT05596734|464908137|FG005|Substudy A|Lost to Follow-up|0|||
129168008|NCT05596734|464908138|FG006|Substudy A|Lost to Follow-up|0|||
129168009|NCT05596734|464908139|FG007|Substudy A|Lost to Follow-up|0|||
129168010|NCT05596734|464908140|FG008|Substudy A|Lost to Follow-up|0|||
129168011|NCT05596734|464908141|FG009|Substudy A|Lost to Follow-up|0|||
129168012|NCT05596734|464908142|FG010|Substudy A|Lost to Follow-up|0|||
129168013|NCT05596734|464908143|FG011|Substudy A|Lost to Follow-up|0|||
129168014|NCT05596734|464908144|FG012|Substudy A|Lost to Follow-up|0|||
129168015|NCT05596734|464908145|FG013|Substudy A|Lost to Follow-up|0|||
129168016|NCT05596734|464908146|FG014|Substudy A|Lost to Follow-up|0|||
129168017|NCT05596734|464908147|FG015|Substudy A|Lost to Follow-up|0|||
129168018|NCT05596734|464908148|FG016|Substudy A|Lost to Follow-up|0|||
129168019|NCT05596734|464908149|FG017|Substudy A|Lost to Follow-up|0|||
129168020|NCT05596734|464908150|FG018|Substudy A|Lost to Follow-up|0|||
129168021|NCT05596734|464908151|FG019|Substudy A|Lost to Follow-up|0|||
129168022|NCT05596734|464908152|FG020|Substudy A|Lost to Follow-up|0|||
129168023|NCT05596734|464908153|FG021|Substudy A|Lost to Follow-up|0|||
129168024|NCT05596734|464908154|FG022|Substudy A|Lost to Follow-up|0|||
129168025|NCT05596734|464908155|FG023|Substudy A|Lost to Follow-up|0|||
129168026|NCT05596734|464908132|FG000|Substudy B|Withdrawal by Subject|0|||
129168027|NCT05596734|464908133|FG001|Substudy B|Withdrawal by Subject|0|||
129168028|NCT05596734|464908134|FG002|Substudy B|Withdrawal by Subject|0|||
129168029|NCT05596734|464908135|FG003|Substudy B|Withdrawal by Subject|0|||
129168030|NCT05596734|464908136|FG004|Substudy B|Withdrawal by Subject|0|||
129168031|NCT05596734|464908137|FG005|Substudy B|Withdrawal by Subject|0|||
129168032|NCT05596734|464908138|FG006|Substudy B|Withdrawal by Subject|0|||
129168033|NCT05596734|464908139|FG007|Substudy B|Withdrawal by Subject|0|||
129168034|NCT05596734|464908140|FG008|Substudy B|Withdrawal by Subject|0|||
129168035|NCT05596734|464908141|FG009|Substudy B|Withdrawal by Subject|0|||
129168036|NCT05596734|464908142|FG010|Substudy B|Withdrawal by Subject|0|||
129168037|NCT05596734|464908143|FG011|Substudy B|Withdrawal by Subject|0|||
129168038|NCT05596734|464908144|FG012|Substudy B|Withdrawal by Subject|1|||
129168039|NCT05596734|464908145|FG013|Substudy B|Withdrawal by Subject|0|||
129168040|NCT05596734|464908146|FG014|Substudy B|Withdrawal by Subject|1|||
129168041|NCT05596734|464908147|FG015|Substudy B|Withdrawal by Subject|2|||
129168042|NCT05596734|464908148|FG016|Substudy B|Withdrawal by Subject|2|||
129168043|NCT05596734|464908149|FG017|Substudy B|Withdrawal by Subject|1|||
129168044|NCT05596734|464908150|FG018|Substudy B|Withdrawal by Subject|2|||
129168045|NCT05596734|464908151|FG019|Substudy B|Withdrawal by Subject|0|||
129168046|NCT05596734|464908152|FG020|Substudy B|Withdrawal by Subject|0|||
129168047|NCT05596734|464908153|FG021|Substudy B|Withdrawal by Subject|0|||
129168048|NCT05596734|464908154|FG022|Substudy B|Withdrawal by Subject|0|||
129168049|NCT05596734|464908155|FG023|Substudy B|Withdrawal by Subject|1|||
129168050|NCT05596734|464908132|FG000|Substudy B|Physician Decision|0|||
129168051|NCT05596734|464908133|FG001|Substudy B|Physician Decision|0|||
129168052|NCT05596734|464908134|FG002|Substudy B|Physician Decision|0|||
129168053|NCT05596734|464908135|FG003|Substudy B|Physician Decision|0|||
129168054|NCT05596734|464908136|FG004|Substudy B|Physician Decision|0|||
129168055|NCT05596734|464908137|FG005|Substudy B|Physician Decision|0|||
129168056|NCT05596734|464908138|FG006|Substudy B|Physician Decision|0|||
129168057|NCT05596734|464908139|FG007|Substudy B|Physician Decision|0|||
129168058|NCT05596734|464908140|FG008|Substudy B|Physician Decision|0|||
129168059|NCT05596734|464908141|FG009|Substudy B|Physician Decision|0|||
129168060|NCT05596734|464908142|FG010|Substudy B|Physician Decision|0|||
129168061|NCT05596734|464908143|FG011|Substudy B|Physician Decision|0|||
129168062|NCT05596734|464908144|FG012|Substudy B|Physician Decision|0|||
129168063|NCT05596734|464908145|FG013|Substudy B|Physician Decision|0|||
129168064|NCT05596734|464908146|FG014|Substudy B|Physician Decision|0|||
129168065|NCT05596734|464908147|FG015|Substudy B|Physician Decision|1|||
129168066|NCT05596734|464908148|FG016|Substudy B|Physician Decision|0|||
129168067|NCT05596734|464908149|FG017|Substudy B|Physician Decision|0|||
129168068|NCT05596734|464908150|FG018|Substudy B|Physician Decision|0|||
129168069|NCT05596734|464908151|FG019|Substudy B|Physician Decision|0|||
128728204|NCT01481116|463301769|FG001|Overall Study|Investigator Decision|2|||
128728205|NCT01481116|463301770|FG002|Overall Study|Investigator Decision|1|||
129168070|NCT05596734|464908152|FG020|Substudy B|Physician Decision|0|||
129168071|NCT05596734|464908153|FG021|Substudy B|Physician Decision|0|||
129168072|NCT05596734|464908154|FG022|Substudy B|Physician Decision|0|||
129168073|NCT05596734|464908155|FG023|Substudy B|Physician Decision|0|||
129168074|NCT05596734|464908132|FG000|Substudy B|Lost to Follow-up|0|||
129168075|NCT05596734|464908133|FG001|Substudy B|Lost to Follow-up|0|||
129168076|NCT05596734|464908134|FG002|Substudy B|Lost to Follow-up|0|||
129168077|NCT05596734|464908135|FG003|Substudy B|Lost to Follow-up|0|||
129168078|NCT05596734|464908136|FG004|Substudy B|Lost to Follow-up|0|||
129168079|NCT05596734|464908137|FG005|Substudy B|Lost to Follow-up|0|||
129168080|NCT05596734|464908138|FG006|Substudy B|Lost to Follow-up|0|||
129168081|NCT05596734|464908139|FG007|Substudy B|Lost to Follow-up|0|||
129168082|NCT05596734|464908140|FG008|Substudy B|Lost to Follow-up|0|||
129168083|NCT05596734|464908141|FG009|Substudy B|Lost to Follow-up|0|||
129168084|NCT05596734|464908142|FG010|Substudy B|Lost to Follow-up|0|||
129168085|NCT05596734|464908143|FG011|Substudy B|Lost to Follow-up|0|||
129168086|NCT05596734|464908144|FG012|Substudy B|Lost to Follow-up|1|||
129168087|NCT05596734|464908145|FG013|Substudy B|Lost to Follow-up|0|||
129168088|NCT05596734|464908146|FG014|Substudy B|Lost to Follow-up|1|||
129168089|NCT05596734|464908147|FG015|Substudy B|Lost to Follow-up|1|||
128728206|NCT01481116|463301768|FG000|Overall Study|Sponsor Decision|0|||
128728207|NCT01481116|463301769|FG001|Overall Study|Sponsor Decision|1|||
128728208|NCT01481116|463301770|FG002|Overall Study|Sponsor Decision|3|||
128728209|NCT01481116|463301768|FG000|Overall Study|Non-Compliant With Study Drug|0|||
128728210|NCT01481116|463301769|FG001|Overall Study|Non-Compliant With Study Drug|1|||
128728211|NCT01481116|463301770|FG002|Overall Study|Non-Compliant With Study Drug|1|||
128728212|NCT01481116|463301768|FG000|Overall Study|Investigator's Discretion|2|||
128728213|NCT01481116|463301769|FG001|Overall Study|Investigator's Discretion|0|||
128728214|NCT01481116|463301770|FG002|Overall Study|Investigator's Discretion|0|||
128728215|NCT01481116|463301768|FG000|Overall Study|Death|2|||
128728216|NCT01481116|463301769|FG001|Overall Study|Death|1|||
128728217|NCT01481116|463301770|FG002|Overall Study|Death|0|||
128728218|NCT01481116|463301768|FG000|Overall Study|Hypoglycemic Event|4|||
128728219|NCT01481116|463301769|FG001|Overall Study|Hypoglycemic Event|0|||
128728220|NCT01481116|463301770|FG002|Overall Study|Hypoglycemic Event|0|||
128728221|NCT02365636|463301775|FG000|Overall Study|Adverse Event|3|||
128728222|NCT02365636|463301776|FG001|Overall Study|Adverse Event|3|||
128728223|NCT02365636|463301777|FG002|Overall Study|Adverse Event|2|||
128728224|NCT02365636|463301775|FG000|Overall Study|Protocol Violation|1|||
128728225|NCT02365636|463301776|FG001|Overall Study|Protocol Violation|4|||
128728226|NCT02365636|463301777|FG002|Overall Study|Protocol Violation|0|||
128728227|NCT02365636|463301775|FG000|Overall Study|Lost to Follow-up|0|||
128728228|NCT02365636|463301776|FG001|Overall Study|Lost to Follow-up|0|||
128728229|NCT02365636|463301777|FG002|Overall Study|Lost to Follow-up|1|||
128728230|NCT02365636|463301775|FG000|Overall Study|Other|2|||
128728231|NCT02365636|463301776|FG001|Overall Study|Other|0|||
128728232|NCT02365636|463301777|FG002|Overall Study|Other|0|||
128728233|NCT00463060|463301783|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
128728234|NCT00463060|463301783|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
128728235|NCT01782313|463301784|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
128728236|NCT01782313|463301784|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
128728237|NCT01782313|463301784|FG000|Treated Cycle 3|Progressive Disease|21|||
128728238|NCT01782313|463301784|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
128728239|NCT01782313|463301784|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
128728240|NCT01782313|463301784|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
128728241|NCT01782313|463301784|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
128728242|NCT01782313|463301784|FG000|Survival Follow up|Lost to Follow-up|1|||
128728243|NCT01802775|463301789|FG000|Overall Study|Death|0|||
128728244|NCT01802775|463301790|FG001|Overall Study|Death|3|||
128728245|NCT01802775|463301789|FG000|Overall Study|Reason not provided|0|||
128728246|NCT01802775|463301790|FG001|Overall Study|Reason not provided|1|||
128728247|NCT01802775|463301789|FG000|Overall Study|Physician Decision|1|||
128728248|NCT01802775|463301790|FG001|Overall Study|Physician Decision|0|||
128728249|NCT01802775|463301789|FG000|Overall Study|Adverse Event|1|||
128728250|NCT01802775|463301790|FG001|Overall Study|Adverse Event|1|||
128728251|NCT01802775|463301789|FG000|Overall Study|Withdrawal by Subject|3|||
128728252|NCT01802775|463301790|FG001|Overall Study|Withdrawal by Subject|5|||
128728253|NCT01802775|463301789|FG000|Overall Study|Lost to Follow-up|1|||
128728254|NCT01802775|463301790|FG001|Overall Study|Lost to Follow-up|2|||
128728255|NCT01067352|463301795|FG000|Overall Study|Withdrawal by Subject|1|||
128728256|NCT01067352|463301796|FG001|Overall Study|Withdrawal by Subject|2|||
128728257|NCT01067352|463301797|FG002|Overall Study|Withdrawal by Subject|1|||
128728258|NCT01067352|463301795|FG000|Overall Study|Physician Decision|0|||
128728259|NCT01067352|463301796|FG001|Overall Study|Physician Decision|1|||
128728260|NCT01067352|463301797|FG002|Overall Study|Physician Decision|0|||
128728261|NCT01096784|463301798|FG000|Overall Study|Withdrawal by Subject|2|||
128728262|NCT01096784|463301799|FG001|Overall Study|Withdrawal by Subject|1|||
128728263|NCT01096784|463301798|FG000|Overall Study|Adverse Event|11|||
128728264|NCT01096784|463301799|FG001|Overall Study|Adverse Event|9|||
128728265|NCT01096784|463301798|FG000|Overall Study|Protocol Deviation|2|||
128728266|NCT01096784|463301799|FG001|Overall Study|Protocol Deviation|2|||
129168090|NCT05596734|464908148|FG016|Substudy B|Lost to Follow-up|0|||
129168091|NCT05596734|464908149|FG017|Substudy B|Lost to Follow-up|0|||
129168092|NCT05596734|464908150|FG018|Substudy B|Lost to Follow-up|0|||
129168093|NCT05596734|464908151|FG019|Substudy B|Lost to Follow-up|0|||
129168094|NCT05596734|464908152|FG020|Substudy B|Lost to Follow-up|0|||
129168095|NCT05596734|464908153|FG021|Substudy B|Lost to Follow-up|0|||
129168096|NCT05596734|464908154|FG022|Substudy B|Lost to Follow-up|0|||
129168097|NCT05596734|464908155|FG023|Substudy B|Lost to Follow-up|0|||
129168098|NCT04113018|464908156|FG000|Overall Study|Death|2|||
129168099|NCT04113018|464908156|FG000|Overall Study|Lost to Follow-up|1|||
129168100|NCT04113018|464908156|FG000|Overall Study|Still On Study (on study treatment)|24|||
129168101|NCT04113018|464908156|FG000|Overall Study|Still On Study (in follow up)|12|||
129168102|NCT05005013|464908157|FG000|Overall Study|Withdrawal by Subject|5|||
129168103|NCT05005013|464908158|FG001|Overall Study|Withdrawal by Subject|1|||
129168104|NCT05005013|464908157|FG000|Overall Study|Lost to Follow-up|3|||
129168105|NCT05005013|464908158|FG001|Overall Study|Lost to Follow-up|1|||
129168106|NCT05005013|464908157|FG000|Overall Study|Ineligibility|1|||
129168107|NCT05005013|464908158|FG001|Overall Study|Ineligibility|1|||
129168108|NCT01802580|464908159|FG000|Overall Study|Physician Decision|1|||
129168109|NCT01802580|464908160|FG001|Overall Study|Physician Decision|0|||
129168110|NCT01802580|464908159|FG000|Overall Study|Protocol Violation|2|||
129168111|NCT01802580|464908160|FG001|Overall Study|Protocol Violation|0|||
129168112|NCT01802580|464908159|FG000|Overall Study|Withdrawal by Subject|5|||
129168113|NCT01802580|464908160|FG001|Overall Study|Withdrawal by Subject|6|||
129168114|NCT01802580|464908159|FG000|Overall Study|Other|1|||
129168115|NCT01802580|464908160|FG001|Overall Study|Other|3|||
129168116|NCT01802580|464908159|FG000|Overall Study|Lack of Efficacy|0|||
129168117|NCT01802580|464908160|FG001|Overall Study|Lack of Efficacy|2|||
129168118|NCT02791516|464908165|FG000|Overall Study|Withdrawal by Subject|1|||
129168119|NCT02791516|464908166|FG001|Overall Study|Withdrawal by Subject|1|||
129168120|NCT00211757|464908168|FG000|Overall Study|Withdrawal by Subject|1|||
129168121|NCT00211757|464908169|FG001|Overall Study|Withdrawal by Subject|1|||
129168122|NCT00211757|464908168|FG000|Overall Study|Lack of Efficacy|0|||
129168123|NCT00211757|464908169|FG001|Overall Study|Lack of Efficacy|1|||
129168124|NCT02644096|464908170|FG000|Overall Study|Withdrawal by Subject|28|||
129168125|NCT02644096|464908171|FG001|Overall Study|Withdrawal by Subject|25|||
129168126|NCT00526656|464908172|FG000|Overall Study|Death|1|||
129168127|NCT00526656|464908172|FG000|Overall Study|Refused surgery|1|||
129168128|NCT04091581|464908173|FG000|Overall Study|Lost to Follow-up|0|||
129168129|NCT04091581|464908174|FG001|Overall Study|Lost to Follow-up|1|||
129168130|NCT04439539|464910084|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
129168131|NCT04439539|464910085|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
129168132|NCT04439539|464910086|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
129168133|NCT04439539|464910084|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
129168134|NCT04439539|464910085|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
129168135|NCT04439539|464910086|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
129168136|NCT04439539|464910084|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
129168137|NCT04439539|464910085|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
129168138|NCT04439539|464910086|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
129168139|NCT00327015|464910090|FG000|Overall Study|Lack of Efficacy|18|||
129168140|NCT00327015|464910091|FG001|Overall Study|Lack of Efficacy|18|||
129168141|NCT00327015|464910092|FG002|Overall Study|Lack of Efficacy|35|||
129168142|NCT00327015|464910093|FG003|Overall Study|Lack of Efficacy|29|||
129168143|NCT00327015|464910090|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
129168144|NCT00327015|464910091|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
129168145|NCT00327015|464910092|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
129168146|NCT00327015|464910093|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
129168147|NCT00327015|464910090|FG000|Overall Study|Lost to Follow-up|22|||
129168148|NCT00327015|464910091|FG001|Overall Study|Lost to Follow-up|23|||
129168149|NCT00327015|464910092|FG002|Overall Study|Lost to Follow-up|29|||
129168150|NCT00327015|464910093|FG003|Overall Study|Lost to Follow-up|22|||
129168151|NCT00327015|464910090|FG000|Overall Study|Adverse Event|14|||
129168152|NCT00327015|464910091|FG001|Overall Study|Adverse Event|10|||
129168153|NCT00327015|464910092|FG002|Overall Study|Adverse Event|14|||
129168154|NCT00327015|464910093|FG003|Overall Study|Adverse Event|14|||
129168155|NCT00327015|464910090|FG000|Overall Study|Subject no longer meets study criteria|4|||
129168156|NCT00327015|464910091|FG001|Overall Study|Subject no longer meets study criteria|2|||
129168157|NCT00327015|464910092|FG002|Overall Study|Subject no longer meets study criteria|8|||
129168158|NCT00327015|464910093|FG003|Overall Study|Subject no longer meets study criteria|7|||
129168159|NCT00327015|464910090|FG000|Overall Study|Poor/Noncompliance|11|||
129168160|NCT00327015|464910091|FG001|Overall Study|Poor/Noncompliance|8|||
129168161|NCT00327015|464910092|FG002|Overall Study|Poor/Noncompliance|4|||
129168162|NCT00327015|464910093|FG003|Overall Study|Poor/Noncompliance|5|||
129168163|NCT00327015|464910090|FG000|Overall Study|Physician Decision|0|||
129168164|NCT00327015|464910091|FG001|Overall Study|Physician Decision|1|||
129168165|NCT00327015|464910092|FG002|Overall Study|Physician Decision|3|||
129168166|NCT00327015|464910093|FG003|Overall Study|Physician Decision|2|||
129168167|NCT00327015|464910090|FG000|Overall Study|Death|1|||
129168168|NCT00327015|464910091|FG001|Overall Study|Death|2|||
129168169|NCT00327015|464910092|FG002|Overall Study|Death|2|||
129168170|NCT00327015|464910093|FG003|Overall Study|Death|3|||
129168171|NCT00327015|464910090|FG000|Overall Study|Pregnancy|0|||
129168172|NCT00327015|464910091|FG001|Overall Study|Pregnancy|2|||
129168173|NCT00327015|464910092|FG002|Overall Study|Pregnancy|1|||
129168174|NCT00327015|464910093|FG003|Overall Study|Pregnancy|1|||
129168175|NCT00327015|464910090|FG000|Overall Study|Administrative Reason by Sponsor|1|||
129168176|NCT00327015|464910091|FG001|Overall Study|Administrative Reason by Sponsor|2|||
129168177|NCT00327015|464910092|FG002|Overall Study|Administrative Reason by Sponsor|2|||
128728267|NCT01096784|463301798|FG000|Overall Study|Administrative Decision|0|||
128728268|NCT01096784|463301799|FG001|Overall Study|Administrative Decision|1|||
128728269|NCT01096784|463301798|FG000|Overall Study|Other Unspecified|0|||
128728270|NCT01096784|463301799|FG001|Overall Study|Other Unspecified|1|||
128728271|NCT02465528|463301800|FG000|Overall Study|Progressive disease|0|||
128728272|NCT02465528|463301801|FG001|Overall Study|Progressive disease|2|||
128728273|NCT02465528|463301802|FG002|Overall Study|Progressive disease|9|||
128728274|NCT02465528|463301803|FG003|Overall Study|Progressive disease|4|||
128728275|NCT02465528|463301800|FG000|Overall Study|Study terminated by sponsor|1|||
128728276|NCT02465528|463301801|FG001|Overall Study|Study terminated by sponsor|2|||
128728277|NCT02465528|463301802|FG002|Overall Study|Study terminated by sponsor|0|||
128728278|NCT02465528|463301803|FG003|Overall Study|Study terminated by sponsor|0|||
128728279|NCT02465528|463301800|FG000|Overall Study|Withdrawal by Subject|0|||
128728280|NCT02465528|463301801|FG001|Overall Study|Withdrawal by Subject|0|||
128728281|NCT02465528|463301802|FG002|Overall Study|Withdrawal by Subject|2|||
128728282|NCT02465528|463301803|FG003|Overall Study|Withdrawal by Subject|0|||
128728283|NCT02465528|463301800|FG000|Overall Study|Adverse Event|0|||
128728284|NCT02465528|463301801|FG001|Overall Study|Adverse Event|0|||
128728285|NCT02465528|463301802|FG002|Overall Study|Adverse Event|0|||
128728286|NCT02465528|463301803|FG003|Overall Study|Adverse Event|1|||
128728287|NCT02465528|463301800|FG000|Overall Study|Physician Decision|0|||
128728288|NCT02465528|463301801|FG001|Overall Study|Physician Decision|0|||
128728289|NCT02465528|463301802|FG002|Overall Study|Physician Decision|1|||
128728290|NCT02465528|463301803|FG003|Overall Study|Physician Decision|0|||
128728291|NCT03795610|463301805|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
128728292|NCT03795610|463301805|FG000|Overall Study|Withdrawal by Subject|1|||
128728293|NCT03795610|463301805|FG000|Overall Study|Screen Failure (Unknown)|1|||
128728294|NCT00006489|463301807|FG000|Overall Study|Adverse Event|3|||
128728295|NCT00006489|463301808|FG001|Overall Study|Adverse Event|2|||
128728296|NCT00006489|463301809|FG002|Overall Study|Adverse Event|4|||
128728297|NCT00006489|463301810|FG003|Overall Study|Adverse Event|3|||
129168178|NCT00327015|464910093|FG003|Overall Study|Administrative Reason by Sponsor|1|||
129168179|NCT01519791|464910094|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
129168180|NCT01519791|464910095|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
129168181|NCT01519791|464910094|FG000|Overall Study|Protocol Violation|6|||
129168182|NCT01519791|464910095|FG001|Overall Study|Protocol Violation|19|||
129168183|NCT01519791|464910094|FG000|Overall Study|Other Reason|87|||
128728298|NCT00006489|463301807|FG000|Overall Study|Withdrawal by Subject|10|||
128728299|NCT00006489|463301808|FG001|Overall Study|Withdrawal by Subject|9|||
128728300|NCT00006489|463301809|FG002|Overall Study|Withdrawal by Subject|9|||
129168184|NCT01519791|464910095|FG001|Overall Study|Other Reason|222|||
129168185|NCT01519791|464910094|FG000|Overall Study|subjects randomized in error|2|||
128728301|NCT00006489|463301810|FG003|Overall Study|Withdrawal by Subject|6|||
128728302|NCT00006489|463301807|FG000|Overall Study|Scheduling Conflict|0|||
128728303|NCT00006489|463301808|FG001|Overall Study|Scheduling Conflict|3|||
128728304|NCT00006489|463301809|FG002|Overall Study|Scheduling Conflict|2|||
128728305|NCT00006489|463301810|FG003|Overall Study|Scheduling Conflict|1|||
128728306|NCT00006489|463301807|FG000|Overall Study|Death|0|||
128728307|NCT00006489|463301808|FG001|Overall Study|Death|0|||
128728308|NCT00006489|463301809|FG002|Overall Study|Death|0|||
128728309|NCT00006489|463301810|FG003|Overall Study|Death|1|||
128728310|NCT03571516|463301812|FG000|Overall Study|Severe diarrhea|1|||
128728311|NCT03571516|463301813|FG001|Overall Study|Severe diarrhea|0|||
128728312|NCT03571516|463301812|FG000|Overall Study|Withdrawal by Subject|0|||
128728313|NCT03571516|463301813|FG001|Overall Study|Withdrawal by Subject|1|||
128728314|NCT00677807|463301818|FG000|Overall Study|Adverse Event|4|||
128728315|NCT00677807|463301819|FG001|Overall Study|Adverse Event|1|||
128728316|NCT00677807|463301820|FG002|Overall Study|Adverse Event|6|||
128728317|NCT00677807|463301818|FG000|Overall Study|Lack of Efficacy|0|||
128728318|NCT00677807|463301819|FG001|Overall Study|Lack of Efficacy|0|||
128728319|NCT00677807|463301820|FG002|Overall Study|Lack of Efficacy|2|||
128728320|NCT00677807|463301818|FG000|Overall Study|Participant no longer needs study drug|0|||
128728321|NCT00677807|463301819|FG001|Overall Study|Participant no longer needs study drug|0|||
128728322|NCT00677807|463301820|FG002|Overall Study|Participant no longer needs study drug|1|||
128728323|NCT00677807|463301818|FG000|Overall Study|Withdrawal by Subject|10|||
128728324|NCT00677807|463301819|FG001|Overall Study|Withdrawal by Subject|3|||
128728325|NCT00677807|463301820|FG002|Overall Study|Withdrawal by Subject|6|||
128728326|NCT00677807|463301818|FG000|Overall Study|Lost to Follow-up|2|||
128728327|NCT00677807|463301819|FG001|Overall Study|Lost to Follow-up|2|||
128728328|NCT00677807|463301820|FG002|Overall Study|Lost to Follow-up|2|||
128728329|NCT00677807|463301818|FG000|Overall Study|Administrative problems|1|||
128728330|NCT00677807|463301819|FG001|Overall Study|Administrative problems|1|||
128728331|NCT00677807|463301820|FG002|Overall Study|Administrative problems|2|||
128728332|NCT00677807|463301818|FG000|Overall Study|Death|0|||
128728333|NCT00677807|463301819|FG001|Overall Study|Death|1|||
128728334|NCT00677807|463301820|FG002|Overall Study|Death|1|||
128728335|NCT00677807|463301818|FG000|Overall Study|Protocol Deviation|1|||
128728336|NCT00677807|463301819|FG001|Overall Study|Protocol Deviation|3|||
128728337|NCT00677807|463301820|FG002|Overall Study|Protocol Deviation|0|||
128728338|NCT04019041|463301821|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
128728339|NCT04019041|463301822|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
128728340|NCT04019041|463301823|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
128728341|NCT04019041|463301824|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
128728342|NCT04019041|463301825|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
128728343|NCT04019041|463301826|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
128728344|NCT04019041|463301821|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
128728345|NCT04019041|463301822|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
128728346|NCT04019041|463301823|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
128728347|NCT04019041|463301824|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
128728348|NCT04019041|463301825|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
128728349|NCT04019041|463301826|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
128728350|NCT04019041|463301821|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
128728351|NCT04019041|463301822|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
128728352|NCT04019041|463301823|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
128728353|NCT04019041|463301824|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
128728354|NCT04019041|463301825|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
128728355|NCT04019041|463301826|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
128728356|NCT04019041|463301821|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
128728357|NCT04019041|463301822|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
128728358|NCT04019041|463301823|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
128728359|NCT04019041|463301824|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
128728360|NCT04019041|463301825|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
128728361|NCT04019041|463301826|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
128728362|NCT04019041|463301821|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
128728363|NCT04019041|463301822|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
128728364|NCT04019041|463301823|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
128728365|NCT04019041|463301824|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
128728366|NCT04019041|463301825|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
128728367|NCT04019041|463301826|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
128728368|NCT04019041|463301821|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
128728369|NCT04019041|463301822|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129168186|NCT01519791|464910095|FG001|Overall Study|subjects randomized in error|0|||
129168187|NCT01519791|464910094|FG000|Overall Study|Lack of Efficacy|16|||
129168188|NCT01519791|464910095|FG001|Overall Study|Lack of Efficacy|20|||
129168189|NCT01519791|464910094|FG000|Overall Study|SAE, non-fatal|6|||
129168190|NCT01519791|464910095|FG001|Overall Study|SAE, non-fatal|22|||
129168191|NCT01519791|464910094|FG000|Overall Study|AE, serious fatal|0|||
129168192|NCT01519791|464910095|FG001|Overall Study|AE, serious fatal|1|||
129168193|NCT01519791|464910094|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
129168194|NCT01519791|464910095|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
129168195|NCT01519791|464910094|FG000|Overall Study|AE, non-serious non-fatal|12|||
129168196|NCT01519791|464910095|FG001|Overall Study|AE, non-serious non-fatal|31|||
129168197|NCT01519791|464910094|FG000|Overall Study|Withdrawal by Subject|15|||
129168198|NCT01519791|464910095|FG001|Overall Study|Withdrawal by Subject|37|||
129168199|NCT01519791|464910094|FG000|Overall Study|Lost to Follow-up|6|||
129168200|NCT01519791|464910095|FG001|Overall Study|Lost to Follow-up|14|||
129168201|NCT00837265|464910096|FG000|Pilot Phase|Withdrawal by Subject|0|||
129168202|NCT00837265|464910097|FG001|Pilot Phase|Withdrawal by Subject|2|||
129168203|NCT00837265|464910098|FG002|Pilot Phase|Withdrawal by Subject|3|||
129168204|NCT00837265|464910099|FG003|Pilot Phase|Withdrawal by Subject|2|||
129168205|NCT00837265|464910100|FG004|Pilot Phase|Withdrawal by Subject|0|||
129168206|NCT00837265|464910101|FG005|Pilot Phase|Withdrawal by Subject|0|||
129168207|NCT00837265|464910102|FG006|Pilot Phase|Withdrawal by Subject|0|||
129168208|NCT00837265|464910096|FG000|Pilot Phase|Decision of the investigator|2|||
129168209|NCT00837265|464910097|FG001|Pilot Phase|Decision of the investigator|1|||
129168210|NCT00837265|464910098|FG002|Pilot Phase|Decision of the investigator|0|||
129168211|NCT00837265|464910099|FG003|Pilot Phase|Decision of the investigator|0|||
129168212|NCT00837265|464910100|FG004|Pilot Phase|Decision of the investigator|0|||
129168213|NCT00837265|464910101|FG005|Pilot Phase|Decision of the investigator|0|||
129168214|NCT00837265|464910102|FG006|Pilot Phase|Decision of the investigator|0|||
129168215|NCT00837265|464910096|FG000|Pilot Phase|Adverse Event|1|||
129168216|NCT00837265|464910097|FG001|Pilot Phase|Adverse Event|0|||
129168217|NCT00837265|464910098|FG002|Pilot Phase|Adverse Event|0|||
129168218|NCT00837265|464910099|FG003|Pilot Phase|Adverse Event|0|||
129168219|NCT00837265|464910100|FG004|Pilot Phase|Adverse Event|0|||
129168220|NCT00837265|464910101|FG005|Pilot Phase|Adverse Event|0|||
129168221|NCT00837265|464910102|FG006|Pilot Phase|Adverse Event|0|||
129168222|NCT00837265|464910096|FG000|Pilot Phase|Disease progression|0|||
129168223|NCT00837265|464910097|FG001|Pilot Phase|Disease progression|0|||
129168224|NCT00837265|464910098|FG002|Pilot Phase|Disease progression|0|||
129168225|NCT00837265|464910099|FG003|Pilot Phase|Disease progression|1|||
129168226|NCT00837265|464910100|FG004|Pilot Phase|Disease progression|0|||
129168227|NCT00837265|464910101|FG005|Pilot Phase|Disease progression|0|||
129168228|NCT00837265|464910102|FG006|Pilot Phase|Disease progression|0|||
129168229|NCT00837265|464910096|FG000|Pilot Phase|Participant left the city|0|||
129168230|NCT00837265|464910097|FG001|Pilot Phase|Participant left the city|0|||
129168231|NCT00837265|464910098|FG002|Pilot Phase|Participant left the city|0|||
129168232|NCT00837265|464910099|FG003|Pilot Phase|Participant left the city|1|||
129168233|NCT00837265|464910100|FG004|Pilot Phase|Participant left the city|0|||
129168234|NCT00837265|464910101|FG005|Pilot Phase|Participant left the city|0|||
129168235|NCT00837265|464910102|FG006|Pilot Phase|Participant left the city|0|||
129168236|NCT00837265|464910096|FG000|Main Phase|Withdrawal by Subject|0|||
129168237|NCT00837265|464910097|FG001|Main Phase|Withdrawal by Subject|0|||
129168238|NCT00837265|464910098|FG002|Main Phase|Withdrawal by Subject|0|||
129168239|NCT00837265|464910099|FG003|Main Phase|Withdrawal by Subject|0|||
129168240|NCT00837265|464910100|FG004|Main Phase|Withdrawal by Subject|4|||
129168241|NCT00837265|464910101|FG005|Main Phase|Withdrawal by Subject|2|||
129168242|NCT00837265|464910102|FG006|Main Phase|Withdrawal by Subject|1|||
129168243|NCT00837265|464910096|FG000|Main Phase|Decision of the investigator|0|||
129168244|NCT00837265|464910097|FG001|Main Phase|Decision of the investigator|0|||
129168245|NCT00837265|464910098|FG002|Main Phase|Decision of the investigator|0|||
129168246|NCT00837265|464910099|FG003|Main Phase|Decision of the investigator|0|||
129168247|NCT00837265|464910100|FG004|Main Phase|Decision of the investigator|0|||
129168248|NCT00837265|464910101|FG005|Main Phase|Decision of the investigator|2|||
129168249|NCT00837265|464910102|FG006|Main Phase|Decision of the investigator|1|||
129168250|NCT00837265|464910096|FG000|Main Phase|Adverse Event|0|||
129168251|NCT00837265|464910097|FG001|Main Phase|Adverse Event|0|||
129168252|NCT00837265|464910098|FG002|Main Phase|Adverse Event|0|||
129168253|NCT00837265|464910099|FG003|Main Phase|Adverse Event|0|||
129168254|NCT00837265|464910100|FG004|Main Phase|Adverse Event|0|||
129168255|NCT00837265|464910101|FG005|Main Phase|Adverse Event|1|||
129168256|NCT00837265|464910102|FG006|Main Phase|Adverse Event|0|||
129168257|NCT00837265|464910096|FG000|Main Phase|Death|0|||
129168258|NCT00837265|464910097|FG001|Main Phase|Death|0|||
129168259|NCT00837265|464910098|FG002|Main Phase|Death|0|||
129168260|NCT00837265|464910099|FG003|Main Phase|Death|0|||
129168261|NCT00837265|464910100|FG004|Main Phase|Death|2|||
129168262|NCT00837265|464910101|FG005|Main Phase|Death|0|||
129168263|NCT00837265|464910102|FG006|Main Phase|Death|1|||
129168264|NCT00837265|464910096|FG000|Main Phase|Lost to Follow-up|0|||
129168265|NCT00837265|464910097|FG001|Main Phase|Lost to Follow-up|0|||
128778193|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
128778194|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
128778195|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
128778196|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
128778197|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
128778198|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
128778199|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
128778200|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
128778201|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
128778202|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
128778203|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
128778204|NCT03890120|463477017|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
128778205|NCT03890120|463477018|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
128778206|NCT03890120|463477019|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
128778207|NCT03890120|463477020|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
128778208|NCT03890120|463477017|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
128778209|NCT03890120|463477018|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
129168266|NCT00837265|464910098|FG002|Main Phase|Lost to Follow-up|0|||
129168267|NCT00837265|464910099|FG003|Main Phase|Lost to Follow-up|0|||
129168268|NCT00837265|464910100|FG004|Main Phase|Lost to Follow-up|1|||
129168269|NCT00837265|464910101|FG005|Main Phase|Lost to Follow-up|0|||
129168270|NCT00837265|464910102|FG006|Main Phase|Lost to Follow-up|0|||
129168271|NCT00837265|464910096|FG000|Main Phase|Principal investigator resignation|0|||
129168272|NCT00837265|464910097|FG001|Main Phase|Principal investigator resignation|0|||
129168273|NCT00837265|464910098|FG002|Main Phase|Principal investigator resignation|0|||
129168274|NCT00837265|464910099|FG003|Main Phase|Principal investigator resignation|0|||
129168275|NCT00837265|464910100|FG004|Main Phase|Principal investigator resignation|2|||
129168276|NCT00837265|464910101|FG005|Main Phase|Principal investigator resignation|0|||
129168277|NCT00837265|464910102|FG006|Main Phase|Principal investigator resignation|0|||
129168278|NCT00837265|464910096|FG000|Main Phase|Participant's personal reason|0|||
129168279|NCT00837265|464910097|FG001|Main Phase|Participant's personal reason|0|||
129168280|NCT00837265|464910098|FG002|Main Phase|Participant's personal reason|0|||
129168281|NCT00837265|464910099|FG003|Main Phase|Participant's personal reason|0|||
129168282|NCT00837265|464910100|FG004|Main Phase|Participant's personal reason|1|||
129168283|NCT00837265|464910101|FG005|Main Phase|Participant's personal reason|0|||
129168284|NCT00837265|464910102|FG006|Main Phase|Participant's personal reason|0|||
129168285|NCT01289353|464910106|FG000|Overall Study|Lost to Follow-up|2|||
129168286|NCT00473668|464910107|FG000|Overall Study|Withdrawal by Subject|0|||
129168287|NCT00473668|464910108|FG001|Overall Study|Withdrawal by Subject|2|||
129168288|NCT00473668|464910109|FG002|Overall Study|Withdrawal by Subject|0|||
129168289|NCT00473668|464910107|FG000|Overall Study|Migrated/moved from study area|3|||
129168290|NCT00473668|464910108|FG001|Overall Study|Migrated/moved from study area|2|||
129168291|NCT00473668|464910109|FG002|Overall Study|Migrated/moved from study area|0|||
129168292|NCT00473668|464910107|FG000|Overall Study|Lost to Follow-up|0|||
129168293|NCT00473668|464910108|FG001|Overall Study|Lost to Follow-up|4|||
129168294|NCT00473668|464910109|FG002|Overall Study|Lost to Follow-up|6|||
129168295|NCT00473668|464910107|FG000|Overall Study|Other|2|||
129168296|NCT00473668|464910108|FG001|Overall Study|Other|3|||
129168297|NCT00473668|464910109|FG002|Overall Study|Other|4|||
129168298|NCT02226562|464910110|FG000|Overall Study|Lost to Follow-up|0|||
129168299|NCT02226562|464910111|FG001|Overall Study|Lost to Follow-up|1|||
129168300|NCT01474772|464910113|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
129168301|NCT01474772|464910114|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
129168302|NCT01474772|464910113|FG000|Period 1|AE not Related to Study Drug|1|||
129168303|NCT01474772|464910114|FG001|Period 1|AE not Related to Study Drug|0|||
129168304|NCT01474772|464910113|FG000|Period 1|Withdrawal by Subject|3|||
129168305|NCT01474772|464910114|FG001|Period 1|Withdrawal by Subject|1|||
129168306|NCT01474772|464910113|FG000|Period 1|Lost to Follow-up|1|||
129168307|NCT01474772|464910114|FG001|Period 1|Lost to Follow-up|0|||
129168308|NCT01474772|464910113|FG000|Period 1|Reason not Specified|1|||
129168309|NCT01474772|464910114|FG001|Period 1|Reason not Specified|1|||
129168310|NCT01474772|464910113|FG000|Washout|AE not Related to Study Drug|2|||
129168311|NCT01474772|464910114|FG001|Washout|AE not Related to Study Drug|0|||
128778210|NCT03890120|463477019|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
129168312|NCT01474772|464910113|FG000|Washout|Withdrawal by Subject|1|||
129168313|NCT01474772|464910114|FG001|Washout|Withdrawal by Subject|0|||
129168314|NCT01474772|464910113|FG000|Washout|Lost to Follow-up|0|||
129168315|NCT01474772|464910114|FG001|Washout|Lost to Follow-up|1|||
129168316|NCT01474772|464910113|FG000|Washout|Reason not Specified|0|||
129168317|NCT01474772|464910114|FG001|Washout|Reason not Specified|1|||
129168318|NCT01474772|464910113|FG000|Period 2|Death|0|||
129168319|NCT01474772|464910114|FG001|Period 2|Death|1|||
129168320|NCT01474772|464910113|FG000|Period 2|AE Related to Study Drug|0|||
129168321|NCT01474772|464910114|FG001|Period 2|AE Related to Study Drug|1|||
128728370|NCT04019041|463301823|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
128728371|NCT04019041|463301824|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
128728372|NCT04019041|463301825|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
128728373|NCT04019041|463301826|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
128728374|NCT04019041|463301821|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
128728375|NCT04019041|463301822|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
128728376|NCT04019041|463301823|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
128728377|NCT04019041|463301824|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
128728378|NCT04019041|463301825|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
128728379|NCT04019041|463301826|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
128728380|NCT04019041|463301821|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
128728381|NCT04019041|463301822|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
128728382|NCT04019041|463301823|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
128728383|NCT04019041|463301824|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
128728384|NCT04019041|463301825|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
128728385|NCT04019041|463301826|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
128728386|NCT04019041|463301821|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
128728387|NCT04019041|463301822|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
128728388|NCT04019041|463301823|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
128728389|NCT04019041|463301824|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
128728390|NCT04019041|463301825|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
128728391|NCT04019041|463301826|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
128728392|NCT03925727|463301827|FG000|Overall Study|Adverse Event|4|||
128728393|NCT03925727|463301828|FG001|Overall Study|Adverse Event|0|||
128728394|NCT03925727|463301829|FG002|Overall Study|Adverse Event|3|||
128728395|NCT03925727|463301827|FG000|Overall Study|Protocol Violation|1|||
128728396|NCT03925727|463301828|FG001|Overall Study|Protocol Violation|2|||
128728397|NCT03925727|463301829|FG002|Overall Study|Protocol Violation|2|||
128728398|NCT03925727|463301827|FG000|Overall Study|Withdrawal by Subject|3|||
128728399|NCT03925727|463301828|FG001|Overall Study|Withdrawal by Subject|2|||
128728400|NCT03925727|463301829|FG002|Overall Study|Withdrawal by Subject|4|||
128728401|NCT03925727|463301827|FG000|Overall Study|Administrative Reasons|3|||
128728402|NCT03925727|463301828|FG001|Overall Study|Administrative Reasons|1|||
128728403|NCT03925727|463301829|FG002|Overall Study|Administrative Reasons|2|||
128728404|NCT03925727|463301827|FG000|Overall Study|Randomized in error or Disqualified|8|||
128728405|NCT03925727|463301828|FG001|Overall Study|Randomized in error or Disqualified|1|||
128728406|NCT03925727|463301829|FG002|Overall Study|Randomized in error or Disqualified|7|||
128728407|NCT01393743|463301830|FG000|Core Study|Adverse Event|5|||
128728408|NCT01393743|463301831|FG001|Core Study|Adverse Event|9|||
128728409|NCT01393743|463301832|FG002|Core Study|Adverse Event|0|||
128728410|NCT01393743|463301830|FG000|Core Study|Lost to Follow-up|1|||
128728411|NCT01393743|463301831|FG001|Core Study|Lost to Follow-up|1|||
128728412|NCT01393743|463301832|FG002|Core Study|Lost to Follow-up|0|||
128728413|NCT01393743|463301830|FG000|Core Study|Participant's Choice|2|||
128728414|NCT01393743|463301831|FG001|Core Study|Participant's Choice|3|||
128728415|NCT01393743|463301832|FG002|Core Study|Participant's Choice|0|||
128728416|NCT01393743|463301830|FG000|Core Study|Inadequate therapeutic effect|2|||
128728417|NCT01393743|463301831|FG001|Core Study|Inadequate therapeutic effect|0|||
128728418|NCT01393743|463301832|FG002|Core Study|Inadequate therapeutic effect|0|||
128728419|NCT01393743|463301830|FG000|Extension Phase|Adverse Event|0|||
128728420|NCT01393743|463301831|FG001|Extension Phase|Adverse Event|0|||
128728421|NCT01393743|463301832|FG002|Extension Phase|Adverse Event|12|||
128728422|NCT01393743|463301830|FG000|Extension Phase|Lost to Follow-up|0|||
128728423|NCT01393743|463301831|FG001|Extension Phase|Lost to Follow-up|0|||
128728424|NCT01393743|463301832|FG002|Extension Phase|Lost to Follow-up|2|||
128728425|NCT01393743|463301830|FG000|Extension Phase|Participant choice|0|||
128728426|NCT01393743|463301831|FG001|Extension Phase|Participant choice|0|||
128778211|NCT03890120|463477020|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
129168322|NCT01474772|464910113|FG000|Period 2|AE not Related to Study Drug|4|||
129168323|NCT01474772|464910114|FG001|Period 2|AE not Related to Study Drug|1|||
129168324|NCT01474772|464910113|FG000|Period 2|Lack of Efficacy|1|||
129168325|NCT01474772|464910114|FG001|Period 2|Lack of Efficacy|0|||
129168326|NCT01474772|464910113|FG000|Period 2|Withdrawal by Subject|3|||
129168327|NCT01474772|464910114|FG001|Period 2|Withdrawal by Subject|4|||
129168328|NCT01474772|464910113|FG000|Period 2|Lost to Follow-up|1|||
128728427|NCT01393743|463301832|FG002|Extension Phase|Participant choice|16|||
128728428|NCT01393743|463301830|FG000|Extension Phase|Inadequate therapeutic effect|0|||
128728429|NCT01393743|463301831|FG001|Extension Phase|Inadequate therapeutic effect|0|||
128728430|NCT01393743|463301832|FG002|Extension Phase|Inadequate therapeutic effect|7|||
128728431|NCT01393743|463301830|FG000|Extension Phase|Withdrawal by Subject|0|||
128728432|NCT01393743|463301831|FG001|Extension Phase|Withdrawal by Subject|0|||
128728433|NCT01393743|463301832|FG002|Extension Phase|Withdrawal by Subject|8|||
128728434|NCT01393743|463301830|FG000|Extension Phase|Pregnancy|0|||
129168329|NCT01474772|464910114|FG001|Period 2|Lost to Follow-up|1|||
129168330|NCT01474772|464910113|FG000|Period 2|Reason not Specified|0|||
129168331|NCT01474772|464910114|FG001|Period 2|Reason not Specified|2|||
129168332|NCT01474772|464910113|FG000|Follow-up|AE not Related to Study Drug|0|||
129168333|NCT01474772|464910114|FG001|Follow-up|AE not Related to Study Drug|1|||
129168334|NCT00223808|464910115|FG000|Overall Study|<5 hrs therapy before discharge|3|||
129168335|NCT00223808|464910116|FG001|Overall Study|<5 hrs therapy before discharge|5|||
129168336|NCT00223808|464910117|FG002|Overall Study|<5 hrs therapy before discharge|5|||
129168337|NCT03195660|464910118|FG000|Overall Study|The study was terminated|2|||
129168338|NCT05260073|464910120|FG000|Overall Study|Physician Decision|1|||
129168339|NCT05260073|464910120|FG000|Overall Study|Withdrawal by Subject|6|||
129168340|NCT05260073|464910120|FG000|Overall Study|Lost to Follow-up|14|||
129168341|NCT03458910|464910121|FG000|Overall Study|Withdrawal by Subject|7|||
129168342|NCT03458910|464910122|FG001|Overall Study|Withdrawal by Subject|8|||
129168343|NCT03458910|464910123|FG002|Overall Study|Withdrawal by Subject|6|||
129168344|NCT03458910|464910124|FG003|Overall Study|Withdrawal by Subject|4|||
129168345|NCT03458910|464910121|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
129168346|NCT03458910|464910122|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
129168347|NCT03458910|464910123|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
129168348|NCT03458910|464910124|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
129168349|NCT04484649|464910125|FG000|Overall Study|Lost to Follow-up|2|||
129168350|NCT04484649|464910126|FG001|Overall Study|Lost to Follow-up|1|||
129168351|NCT04484649|464910125|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
129168352|NCT04484649|464910126|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
129168353|NCT00152477|464910131|FG000|Chemotherapy Period|Adverse Event|9|||
129168354|NCT00152477|464910132|FG001|Chemotherapy Period|Adverse Event|4|||
129168355|NCT00152477|464910133|FG002|Chemotherapy Period|Adverse Event|5|||
129168356|NCT00152477|464910131|FG000|Chemotherapy Period|Death|1|||
129168357|NCT00152477|464910132|FG001|Chemotherapy Period|Death|3|||
129168358|NCT00152477|464910133|FG002|Chemotherapy Period|Death|3|||
129168359|NCT00152477|464910131|FG000|Chemotherapy Period|Lack of Efficacy|4|||
129168360|NCT00152477|464910132|FG001|Chemotherapy Period|Lack of Efficacy|5|||
129168361|NCT00152477|464910133|FG002|Chemotherapy Period|Lack of Efficacy|6|||
129168362|NCT00152477|464910131|FG000|Chemotherapy Period|Lost to Follow-up|1|||
129168363|NCT00152477|464910132|FG001|Chemotherapy Period|Lost to Follow-up|0|||
129168364|NCT00152477|464910133|FG002|Chemotherapy Period|Lost to Follow-up|1|||
129168365|NCT00152477|464910131|FG000|Chemotherapy Period|Protocol Violation|1|||
129168366|NCT00152477|464910132|FG001|Chemotherapy Period|Protocol Violation|1|||
129168367|NCT00152477|464910133|FG002|Chemotherapy Period|Protocol Violation|0|||
129168368|NCT00152477|464910131|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
129168369|NCT00152477|464910132|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
129168370|NCT00152477|464910133|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
129168371|NCT00152477|464910131|FG000|Chemotherapy Period|Progression of Disease|6|||
129168372|NCT00152477|464910132|FG001|Chemotherapy Period|Progression of Disease|8|||
129168373|NCT00152477|464910133|FG002|Chemotherapy Period|Progression of Disease|4|||
129168374|NCT00152477|464910131|FG000|Chemotherapy Period|Investigator decision|0|||
129168375|NCT00152477|464910132|FG001|Chemotherapy Period|Investigator decision|0|||
129168376|NCT00152477|464910133|FG002|Chemotherapy Period|Investigator decision|1|||
129168377|NCT00152477|464910131|FG000|Chemotherapy Period|Patient condition worsened|1|||
129168378|NCT00152477|464910132|FG001|Chemotherapy Period|Patient condition worsened|0|||
129168379|NCT00152477|464910133|FG002|Chemotherapy Period|Patient condition worsened|0|||
129168380|NCT00152477|464910131|FG000|Monotherapy Period|Adverse Event|1|||
129168381|NCT00152477|464910132|FG001|Monotherapy Period|Adverse Event|0|||
129168382|NCT00152477|464910133|FG002|Monotherapy Period|Adverse Event|5|||
129168383|NCT00152477|464910131|FG000|Monotherapy Period|Death|2|||
129168384|NCT00152477|464910132|FG001|Monotherapy Period|Death|0|||
129168385|NCT00152477|464910133|FG002|Monotherapy Period|Death|1|||
129168386|NCT00152477|464910131|FG000|Monotherapy Period|Lack of Efficacy|7|||
129168387|NCT00152477|464910132|FG001|Monotherapy Period|Lack of Efficacy|16|||
129168388|NCT00152477|464910133|FG002|Monotherapy Period|Lack of Efficacy|10|||
129168389|NCT00152477|464910131|FG000|Monotherapy Period|Protocol Violation|0|||
129168390|NCT00152477|464910132|FG001|Monotherapy Period|Protocol Violation|1|||
129168391|NCT00152477|464910133|FG002|Monotherapy Period|Protocol Violation|0|||
129168392|NCT00152477|464910131|FG000|Monotherapy Period|Withdrawal by Subject|0|||
129168393|NCT00152477|464910132|FG001|Monotherapy Period|Withdrawal by Subject|0|||
129168394|NCT00152477|464910133|FG002|Monotherapy Period|Withdrawal by Subject|4|||
129168395|NCT00152477|464910131|FG000|Monotherapy Period|Progression of Disease|5|||
129168396|NCT00152477|464910132|FG001|Monotherapy Period|Progression of Disease|11|||
129168397|NCT00152477|464910133|FG002|Monotherapy Period|Progression of Disease|12|||
129168398|NCT00152477|464910131|FG000|Monotherapy Period|Patient decision|0|||
129168399|NCT00152477|464910132|FG001|Monotherapy Period|Patient decision|1|||
129168400|NCT00152477|464910133|FG002|Monotherapy Period|Patient decision|1|||
129168401|NCT00152477|464910131|FG000|Monotherapy Period|Study personel decision|0|||
129168402|NCT00152477|464910132|FG001|Monotherapy Period|Study personel decision|0|||
129168403|NCT00152477|464910133|FG002|Monotherapy Period|Study personel decision|1|||
129168404|NCT02570152|464910134|FG000|Overall Study|Protocol Violation|2|||
128778212|NCT03890120|463477017|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
128778213|NCT03890120|463477018|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
128778214|NCT03890120|463477019|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
128778215|NCT03890120|463477020|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
128778216|NCT03890120|463477017|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
128778217|NCT03890120|463477018|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
129168405|NCT02570152|464910134|FG000|Overall Study|Migrated/moved from study area|13|||
129168406|NCT00923975|464910136|FG000|Overall Study|Did not meet inclusion criteria|1|||
129168407|NCT01328535|464910137|FG000|Overall Study|Ineligible|1|||
129168408|NCT01005316|464910138|FG000|Overall Study|Adverse Event|0|||
129168409|NCT01005316|464910139|FG001|Overall Study|Adverse Event|0|||
129168410|NCT01005316|464910140|FG002|Overall Study|Adverse Event|0|||
129168411|NCT01005316|464910141|FG003|Overall Study|Adverse Event|1|||
129168412|NCT01005316|464910138|FG000|Overall Study|Death|20|||
129168413|NCT01005316|464910139|FG001|Overall Study|Death|5|||
129168414|NCT01005316|464910140|FG002|Overall Study|Death|1|||
129168415|NCT01005316|464910141|FG003|Overall Study|Death|15|||
129168416|NCT01005316|464910138|FG000|Overall Study|Study Termination|5|||
129168417|NCT01005316|464910139|FG001|Overall Study|Study Termination|63|||
129168418|NCT01005316|464910140|FG002|Overall Study|Study Termination|9|||
129168419|NCT01005316|464910141|FG003|Overall Study|Study Termination|85|||
129168420|NCT01005316|464910138|FG000|Overall Study|Lost to Follow-up|1|||
129168421|NCT01005316|464910139|FG001|Overall Study|Lost to Follow-up|3|||
129168422|NCT01005316|464910140|FG002|Overall Study|Lost to Follow-up|0|||
129168423|NCT01005316|464910141|FG003|Overall Study|Lost to Follow-up|2|||
129168424|NCT01005316|464910138|FG000|Overall Study|Physician Decision|6|||
129168425|NCT01005316|464910139|FG001|Overall Study|Physician Decision|0|||
129168426|NCT01005316|464910140|FG002|Overall Study|Physician Decision|0|||
129168427|NCT01005316|464910141|FG003|Overall Study|Physician Decision|0|||
129168428|NCT01005316|464910138|FG000|Overall Study|Sponsor Decision|6|||
129168429|NCT01005316|464910139|FG001|Overall Study|Sponsor Decision|3|||
129168430|NCT01005316|464910140|FG002|Overall Study|Sponsor Decision|0|||
129168431|NCT01005316|464910141|FG003|Overall Study|Sponsor Decision|0|||
129168432|NCT01005316|464910138|FG000|Overall Study|Withdrawal by Subject|1|||
129168433|NCT01005316|464910139|FG001|Overall Study|Withdrawal by Subject|1|||
129168434|NCT01005316|464910140|FG002|Overall Study|Withdrawal by Subject|0|||
129168435|NCT01005316|464910141|FG003|Overall Study|Withdrawal by Subject|2|||
129168436|NCT01005316|464910138|FG000|Overall Study|Consented to Another Study|2|||
129168437|NCT01005316|464910139|FG001|Overall Study|Consented to Another Study|0|||
129168438|NCT01005316|464910140|FG002|Overall Study|Consented to Another Study|0|||
129168439|NCT01005316|464910141|FG003|Overall Study|Consented to Another Study|0|||
129168440|NCT01005316|464910138|FG000|Overall Study|Delisted|8|||
129168441|NCT01005316|464910139|FG001|Overall Study|Delisted|0|||
129168442|NCT01005316|464910140|FG002|Overall Study|Delisted|0|||
129168443|NCT01005316|464910141|FG003|Overall Study|Delisted|0|||
129168444|NCT01005316|464910138|FG000|Overall Study|Transferred Care|1|||
129168445|NCT01005316|464910139|FG001|Overall Study|Transferred Care|0|||
129168446|NCT01005316|464910140|FG002|Overall Study|Transferred Care|1|||
129168447|NCT01005316|464910141|FG003|Overall Study|Transferred Care|3|||
129168448|NCT01005316|464910138|FG000|Overall Study|Retransplanted|0|||
129168449|NCT01005316|464910139|FG001|Overall Study|Retransplanted|1|||
129168450|NCT01005316|464910140|FG002|Overall Study|Retransplanted|0|||
129168451|NCT01005316|464910141|FG003|Overall Study|Retransplanted|0|||
129168452|NCT00960011|464910142|FG000|Overall Study|Death|5|||
129168453|NCT00960011|464910143|FG001|Overall Study|Death|0|||
129168454|NCT00960011|464910142|FG000|Overall Study|Lost to Follow-up|6|||
129168455|NCT00960011|464910143|FG001|Overall Study|Lost to Follow-up|2|||
129168456|NCT04417218|464910144|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
129168457|NCT04417218|464910145|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
129168458|NCT01734395|464910148|FG000|Overall Study|Other|65|||
129168459|NCT01734395|464910148|FG000|Overall Study|Lost to Follow-up|287|||
129168460|NCT01734395|464910148|FG000|Overall Study|Lack of Efficacy|5|||
128778218|NCT03890120|463477019|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
128778219|NCT03890120|463477020|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
128778220|NCT03890120|463477017|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129168461|NCT01734395|464910148|FG000|Overall Study|Adverse Event|40|||
129168462|NCT01734395|464910148|FG000|Overall Study|Withdrawal by Subject|10|||
129168463|NCT01734395|464910148|FG000|Overall Study|Missing the reasons for not completed|3|||
129168464|NCT01032291|464910149|FG000|Safety Lead-in|Adverse Event|1|||
129168465|NCT01032291|464910150|FG001|Safety Lead-in|Adverse Event|0|||
129168466|NCT01032291|464910151|FG002|Safety Lead-in|Adverse Event|0|||
128778221|NCT03890120|463477018|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129168467|NCT01032291|464910149|FG000|Safety Lead-in|Death|1|||
129168468|NCT01032291|464910150|FG001|Safety Lead-in|Death|0|||
129168469|NCT01032291|464910151|FG002|Safety Lead-in|Death|0|||
129168470|NCT01032291|464910149|FG000|Proof of Concept|Adverse Event|0|||
129168471|NCT01032291|464910150|FG001|Proof of Concept|Adverse Event|5|||
129168472|NCT01032291|464910151|FG002|Proof of Concept|Adverse Event|1|||
129168473|NCT01032291|464910149|FG000|Proof of Concept|Death|0|||
129168474|NCT01032291|464910150|FG001|Proof of Concept|Death|1|||
129168475|NCT01032291|464910151|FG002|Proof of Concept|Death|2|||
129168476|NCT01032291|464910149|FG000|Proof of Concept|Lack of Efficacy|0|||
129168477|NCT01032291|464910150|FG001|Proof of Concept|Lack of Efficacy|1|||
129168478|NCT01032291|464910151|FG002|Proof of Concept|Lack of Efficacy|0|||
129168479|NCT01032291|464910149|FG000|Proof of Concept|Never Received Study Drug|0|||
129168480|NCT01032291|464910150|FG001|Proof of Concept|Never Received Study Drug|1|||
129168481|NCT01032291|464910151|FG002|Proof of Concept|Never Received Study Drug|0|||
129168482|NCT00313313|464910152|FG000|Overall Study|Lack of Efficacy|14|||
129168483|NCT00313313|464910153|FG001|Overall Study|Lack of Efficacy|9|||
129168484|NCT00313313|464910154|FG002|Overall Study|Lack of Efficacy|20|||
129168485|NCT00313313|464910152|FG000|Overall Study|Withdrawal of consent by subject|18|||
129168486|NCT00313313|464910153|FG001|Overall Study|Withdrawal of consent by subject|17|||
129168487|NCT00313313|464910154|FG002|Overall Study|Withdrawal of consent by subject|31|||
129168488|NCT00313313|464910152|FG000|Overall Study|Lost to Follow-up|10|||
129168489|NCT00313313|464910153|FG001|Overall Study|Lost to Follow-up|7|||
129168490|NCT00313313|464910154|FG002|Overall Study|Lost to Follow-up|9|||
129168491|NCT00313313|464910152|FG000|Overall Study|Adverse Event|15|||
129168492|NCT00313313|464910153|FG001|Overall Study|Adverse Event|16|||
129168493|NCT00313313|464910154|FG002|Overall Study|Adverse Event|12|||
128728435|NCT01393743|463301831|FG001|Extension Phase|Pregnancy|0|||
128728436|NCT01393743|463301832|FG002|Extension Phase|Pregnancy|1|||
129168494|NCT00313313|464910152|FG000|Overall Study|Physician Decision|2|||
129168495|NCT00313313|464910153|FG001|Overall Study|Physician Decision|6|||
128728437|NCT01393743|463301830|FG000|Extension Phase|Other|0|||
128728438|NCT01393743|463301831|FG001|Extension Phase|Other|0|||
128728439|NCT01393743|463301832|FG002|Extension Phase|Other|14|||
129168496|NCT00313313|464910154|FG002|Overall Study|Physician Decision|4|||
128778222|NCT03890120|463477019|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
128778223|NCT03890120|463477020|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
128778224|NCT01628874|463477021|FG000|Overall Study|Physician Decision|1|||
128778225|NCT01628874|463477022|FG001|Overall Study|Physician Decision|1|||
128778226|NCT01628874|463477021|FG000|Overall Study|Age >4 months|4|||
128778227|NCT01628874|463477022|FG001|Overall Study|Age >4 months|2|||
128778228|NCT00683449|463477023|FG000|Overall Study|Lost to Follow-up|0|||
128778229|NCT00683449|463477024|FG001|Overall Study|Lost to Follow-up|1|||
128778230|NCT00683449|463477025|FG002|Overall Study|Lost to Follow-up|0|||
128778231|NCT00683449|463477026|FG003|Overall Study|Lost to Follow-up|0|||
128778232|NCT00683449|463477027|FG004|Overall Study|Lost to Follow-up|0|||
128778233|NCT02559817|463477030|FG000|Treatment Period|Adverse Event|1|||
128778234|NCT02559817|463477031|FG001|Treatment Period|Adverse Event|0|||
128778235|NCT02559817|463477032|FG002|Treatment Period|Adverse Event|1|||
128778236|NCT02559817|463477033|FG003|Treatment Period|Adverse Event|0|||
128778237|NCT02559817|463477034|FG004|Treatment Period|Adverse Event|0|||
128778238|NCT02559817|463477030|FG000|Treatment Period|Lack of Efficacy|0|||
128778239|NCT02559817|463477031|FG001|Treatment Period|Lack of Efficacy|1|||
128778240|NCT02559817|463477032|FG002|Treatment Period|Lack of Efficacy|0|||
128778241|NCT02559817|463477033|FG003|Treatment Period|Lack of Efficacy|0|||
128778242|NCT02559817|463477034|FG004|Treatment Period|Lack of Efficacy|0|||
128778243|NCT02559817|463477030|FG000|Treatment Period|Lost to Follow-up|0|||
128778244|NCT02559817|463477031|FG001|Treatment Period|Lost to Follow-up|1|||
128778245|NCT02559817|463477032|FG002|Treatment Period|Lost to Follow-up|0|||
129168497|NCT00313313|464910152|FG000|Overall Study|Poor/Noncompliance|3|||
129168498|NCT00313313|464910153|FG001|Overall Study|Poor/Noncompliance|6|||
129168499|NCT00313313|464910154|FG002|Overall Study|Poor/Noncompliance|2|||
129168500|NCT00313313|464910152|FG000|Overall Study|Pregnancy|1|||
129168501|NCT00313313|464910153|FG001|Overall Study|Pregnancy|2|||
129168502|NCT00313313|464910154|FG002|Overall Study|Pregnancy|0|||
129168503|NCT00313313|464910152|FG000|Overall Study|Death|0|||
129168504|NCT00313313|464910153|FG001|Overall Study|Death|0|||
129168505|NCT00313313|464910154|FG002|Overall Study|Death|2|||
129168506|NCT00313313|464910152|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
129168507|NCT00313313|464910153|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
129168508|NCT00313313|464910154|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
129168509|NCT00758264|464910157|FG000|Active Phase|Withdrawal by Subject|0|||
129168510|NCT00758264|464910158|FG001|Active Phase|Withdrawal by Subject|0|||
129168511|NCT00758264|464910159|FG002|Active Phase|Withdrawal by Subject|1|||
129168512|NCT00758264|464910157|FG000|Active Phase|Lost to Follow-up|1|||
129168513|NCT00758264|464910158|FG001|Active Phase|Lost to Follow-up|0|||
129168514|NCT00758264|464910159|FG002|Active Phase|Lost to Follow-up|0|||
129168515|NCT00758264|464910157|FG000|Active Phase|Other|0|||
129168516|NCT00758264|464910158|FG001|Active Phase|Other|0|||
129168517|NCT00758264|464910159|FG002|Active Phase|Other|4|||
129168518|NCT03425006|464910160|FG000|Overall Study|Withdrawal by Subject|1|||
129168519|NCT03425006|464910160|FG000|Overall Study|Physician Decision|1|||
129168520|NCT03425006|464910160|FG000|Overall Study|Death|1|||
129168521|NCT01177553|464910161|FG000|Overall Study|babies not yet 6 months of age|1|||
129168522|NCT01177553|464910162|FG001|Overall Study|babies not yet 6 months of age|0|||
129168523|NCT00695955|464910169|FG000|Cohort 1|Adverse Event|26|||
129168524|NCT00695955|464910169|FG000|Cohort 1|Protocol Violation|2|||
129168525|NCT00695955|464910169|FG000|Cohort 1|Lost to Follow-up|30|||
129168526|NCT00695955|464910169|FG000|Cohort 1|Withdrawal by Subject|25|||
129168527|NCT00695955|464910169|FG000|Cohort 1|Lack of Efficacy|3|||
129168528|NCT00695955|464910169|FG000|Cohort 1|Other|16|||
129168529|NCT00695955|464910169|FG000|Cohort 2|Adverse Event|24|||
129168530|NCT00695955|464910169|FG000|Cohort 2|Protocol Violation|5|||
129168531|NCT00695955|464910169|FG000|Cohort 2|Lost to Follow-up|38|||
129168532|NCT00695955|464910169|FG000|Cohort 2|Withdrawal by Subject|28|||
129168533|NCT00695955|464910169|FG000|Cohort 2|Lack of Efficacy|4|||
129168534|NCT00695955|464910169|FG000|Cohort 2|Other|5|||
129168535|NCT00888329|464910170|FG000|Overall Study|Physician Decision|6|||
129168536|NCT00888329|464910171|FG001|Overall Study|Physician Decision|9|||
129168537|NCT01106651|464910173|FG000|Overall Study|Adverse Event|17|||
129168538|NCT01106651|464910174|FG001|Overall Study|Adverse Event|9|||
129168539|NCT01106651|464910175|FG002|Overall Study|Adverse Event|23|||
129168540|NCT01106651|464910173|FG000|Overall Study|Lost to Follow-up|8|||
129168541|NCT01106651|464910174|FG001|Overall Study|Lost to Follow-up|2|||
128778246|NCT02559817|463477033|FG003|Treatment Period|Lost to Follow-up|1|||
128778247|NCT02559817|463477034|FG004|Treatment Period|Lost to Follow-up|0|||
128778248|NCT02559817|463477030|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
128778249|NCT02559817|463477031|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
129168542|NCT01106651|464910175|FG002|Overall Study|Lost to Follow-up|6|||
129168543|NCT01106651|464910173|FG000|Overall Study|Physician Decision|4|||
129168544|NCT01106651|464910174|FG001|Overall Study|Physician Decision|3|||
129168545|NCT01106651|464910175|FG002|Overall Study|Physician Decision|1|||
129168546|NCT01106651|464910173|FG000|Overall Study|Protocol Violation|1|||
129168547|NCT01106651|464910174|FG001|Overall Study|Protocol Violation|2|||
128778250|NCT02559817|463477032|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
128778251|NCT02559817|463477033|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
128778252|NCT02559817|463477034|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
128778253|NCT02559817|463477030|FG000|Treatment Period|Protocol Violation|0|||
128778254|NCT02559817|463477031|FG001|Treatment Period|Protocol Violation|0|||
128778255|NCT02559817|463477032|FG002|Treatment Period|Protocol Violation|0|||
128778256|NCT02559817|463477033|FG003|Treatment Period|Protocol Violation|1|||
128778257|NCT02559817|463477034|FG004|Treatment Period|Protocol Violation|0|||
128778258|NCT00577720|463477036|FG000|Overall Study|Adverse Event|2|||
128778259|NCT00577720|463477037|FG001|Overall Study|Adverse Event|1|||
128778260|NCT00577720|463477038|FG002|Overall Study|Adverse Event|0|||
128778261|NCT00577720|463477039|FG003|Overall Study|Adverse Event|4|||
128778262|NCT00577720|463477036|FG000|Overall Study|Lost to Follow-up|0|||
128778263|NCT00577720|463477037|FG001|Overall Study|Lost to Follow-up|0|||
128778264|NCT00577720|463477038|FG002|Overall Study|Lost to Follow-up|1|||
128778265|NCT00577720|463477039|FG003|Overall Study|Lost to Follow-up|0|||
128778266|NCT00577720|463477036|FG000|Overall Study|Protocol Violation|0|||
128778267|NCT00577720|463477037|FG001|Overall Study|Protocol Violation|0|||
128778268|NCT00577720|463477038|FG002|Overall Study|Protocol Violation|0|||
128778269|NCT00577720|463477039|FG003|Overall Study|Protocol Violation|1|||
128778270|NCT00577720|463477036|FG000|Overall Study|Withdrawal by Subject|2|||
128778271|NCT00577720|463477037|FG001|Overall Study|Withdrawal by Subject|0|||
128728440|NCT02321462|463301836|FG000|Overall Study|Withdrawal by Subject|5|||
128728441|NCT02321462|463301837|FG001|Overall Study|Withdrawal by Subject|2|||
128728442|NCT02321462|463301836|FG000|Overall Study|Subject withdrawn before any treatment|1|||
128728443|NCT02321462|463301837|FG001|Overall Study|Subject withdrawn before any treatment|1|||
128728444|NCT03044197|463301846|FG000|Overall Study|Withdrawal by Subject|3|||
128728445|NCT03044197|463301847|FG001|Overall Study|Withdrawal by Subject|1|||
128728446|NCT00989833|463301856|FG000|Overall Study|Lost to Follow-up|0|||
128728447|NCT00989833|463301857|FG001|Overall Study|Lost to Follow-up|1|||
128728448|NCT00989833|463301858|FG002|Overall Study|Lost to Follow-up|0|||
128728449|NCT00989833|463301856|FG000|Overall Study|Protocol Violation|1|||
128728450|NCT00989833|463301857|FG001|Overall Study|Protocol Violation|2|||
128728451|NCT00989833|463301858|FG002|Overall Study|Protocol Violation|1|||
128728452|NCT00989833|463301856|FG000|Overall Study|Withdrawal by Subject|0|||
128728453|NCT00989833|463301857|FG001|Overall Study|Withdrawal by Subject|0|||
128728454|NCT00989833|463301858|FG002|Overall Study|Withdrawal by Subject|1|||
128728455|NCT00989833|463301856|FG000|Overall Study|Incorrectly randomized|1|||
128728456|NCT00989833|463301857|FG001|Overall Study|Incorrectly randomized|0|||
128728457|NCT00989833|463301858|FG002|Overall Study|Incorrectly randomized|0|||
128728458|NCT02469610|463301859|FG000|Overall Study|Death|1|||
128728459|NCT02469610|463301860|FG001|Overall Study|Death|0|||
128728460|NCT02469610|463301859|FG000|Overall Study|Lost to Follow-up|1|||
128728461|NCT02469610|463301860|FG001|Overall Study|Lost to Follow-up|0|||
128728462|NCT02469610|463301859|FG000|Overall Study|exclusion criteria|2|||
128728463|NCT02469610|463301860|FG001|Overall Study|exclusion criteria|1|||
128728464|NCT01806896|463301861|FG000|Overall Study|Adverse Event|2|||
128728465|NCT01806896|463301862|FG001|Overall Study|Adverse Event|0|||
128728466|NCT01806896|463301861|FG000|Overall Study|Other|1|||
128728467|NCT01806896|463301862|FG001|Overall Study|Other|0|||
128728468|NCT01574352|463301863|FG000|Overall Study|Withdrawal by Subject|6|||
128728469|NCT01574352|463301864|FG001|Overall Study|Withdrawal by Subject|13|||
128778272|NCT00577720|463477038|FG002|Overall Study|Withdrawal by Subject|0|||
128778273|NCT00577720|463477039|FG003|Overall Study|Withdrawal by Subject|2|||
128778274|NCT02839681|463477040|FG000|Overall Study|Death|2|||
128778275|NCT03100838|463477041|FG000|Overall Study|Adverse Event|1|||
128778276|NCT03100838|463477042|FG001|Overall Study|Adverse Event|0|||
128778277|NCT03100838|463477043|FG002|Overall Study|Adverse Event|0|||
128728470|NCT01574352|463301863|FG000|Overall Study|Injury in non-camp related sport|1|||
128728471|NCT01574352|463301864|FG001|Overall Study|Injury in non-camp related sport|0|||
128728472|NCT03316872|463301867|FG000|Overall Study|Death|1|||
128728473|NCT00910715|463303931|FG000|Overall Study|Lost to Follow-up|22|||
128728474|NCT00910715|463303932|FG001|Overall Study|Lost to Follow-up|26|||
128728475|NCT00910715|463303933|FG002|Overall Study|Lost to Follow-up|0|||
128728476|NCT01467076|463303934|FG000|Overall Study|Lost to Follow-up|1|||
128728477|NCT01467076|463303935|FG001|Overall Study|Lost to Follow-up|0|||
128728478|NCT01467076|463303936|FG002|Overall Study|Lost to Follow-up|0|||
128728479|NCT04649151|463303940|FG000|Overall Study|Pregnancy|0|||
128728480|NCT04649151|463303941|FG001|Overall Study|Pregnancy|0|||
128728481|NCT04649151|463303942|FG002|Overall Study|Pregnancy|0|||
128728482|NCT04649151|463303943|FG003|Overall Study|Pregnancy|0|||
128728483|NCT04649151|463303944|FG004|Overall Study|Pregnancy|3|||
128728484|NCT04649151|463303940|FG000|Overall Study|Physician Decision|10|||
128778278|NCT03100838|463477044|FG003|Overall Study|Adverse Event|0|||
128778279|NCT03100838|463477041|FG000|Overall Study|Physician Decision|1|||
128778280|NCT03100838|463477042|FG001|Overall Study|Physician Decision|1|||
128778281|NCT03100838|463477043|FG002|Overall Study|Physician Decision|1|||
129168548|NCT01106651|464910175|FG002|Overall Study|Protocol Violation|1|||
129168549|NCT01106651|464910173|FG000|Overall Study|Withdrawal by Subject|14|||
129168550|NCT01106651|464910174|FG001|Overall Study|Withdrawal by Subject|7|||
129168551|NCT01106651|464910175|FG002|Overall Study|Withdrawal by Subject|4|||
129168552|NCT01106651|464910173|FG000|Overall Study|Noncompliance with study drug|1|||
129168553|NCT01106651|464910174|FG001|Overall Study|Noncompliance with study drug|0|||
129168554|NCT01106651|464910175|FG002|Overall Study|Noncompliance with study drug|2|||
129168555|NCT01106651|464910173|FG000|Overall Study|Other|34|||
129168556|NCT01106651|464910174|FG001|Overall Study|Other|31|||
129168557|NCT01106651|464910175|FG002|Overall Study|Other|21|||
129168558|NCT01106651|464910173|FG000|Overall Study|Death|0|||
129168559|NCT01106651|464910174|FG001|Overall Study|Death|3|||
129168560|NCT01106651|464910175|FG002|Overall Study|Death|0|||
129168561|NCT04590404|464910176|FG000|Overall Study|Death|16|||
129168562|NCT04590404|464910177|FG001|Overall Study|Death|17|||
129168563|NCT04590404|464910176|FG000|Overall Study|Withdrawal by Subject|7|||
129168564|NCT04590404|464910177|FG001|Overall Study|Withdrawal by Subject|2|||
129168565|NCT01581021|464910179|FG000|Overall Study|Lost to Follow-up|4|||
129168566|NCT01581021|464910180|FG001|Overall Study|Lost to Follow-up|6|||
129168567|NCT01581021|464910179|FG000|Overall Study|More than 2 hooks in thoracic|3|||
129168568|NCT01581021|464910180|FG001|Overall Study|More than 2 hooks in thoracic|0|||
129168569|NCT01581021|464910179|FG000|Overall Study|Neuromuscular|2|||
129168570|NCT01581021|464910180|FG001|Overall Study|Neuromuscular|1|||
129168571|NCT01581021|464910179|FG000|Overall Study|Not Randomized|1|||
129168572|NCT01581021|464910180|FG001|Overall Study|Not Randomized|2|||
129168573|NCT01581021|464910179|FG000|Overall Study|Lenke 6 Classification|0|||
129168574|NCT01581021|464910180|FG001|Overall Study|Lenke 6 Classification|1|||
129168575|NCT01581021|464910179|FG000|Overall Study|Lack of Efficacy|0|||
129168576|NCT01581021|464910180|FG001|Overall Study|Lack of Efficacy|1|||
129168577|NCT00054327|464910183|FG000|Overall Study|Engraftment failure|1|||
129168578|NCT00054327|464910184|FG001|Overall Study|Engraftment failure|0|||
129168579|NCT00054327|464910185|FG002|Overall Study|Engraftment failure|0|||
129168580|NCT00054327|464910186|FG003|Overall Study|Engraftment failure|0|||
129168581|NCT00054327|464910187|FG004|Overall Study|Engraftment failure|0|||
129168582|NCT00054327|464910188|FG005|Overall Study|Engraftment failure|0|||
129168583|NCT00290771|464910197|FG000|Overall Study|Disease progression|95|||
129168584|NCT00290771|464910198|FG001|Overall Study|Disease progression|73|||
129168585|NCT00290771|464910197|FG000|Overall Study|Death|11|||
129168586|NCT00290771|464910198|FG001|Overall Study|Death|10|||
129168587|NCT00290771|464910197|FG000|Overall Study|Adverse Event|12|||
129168588|NCT00290771|464910198|FG001|Overall Study|Adverse Event|6|||
129168589|NCT00290771|464910197|FG000|Overall Study|Withdrawal by Subject|5|||
129168590|NCT00290771|464910198|FG001|Overall Study|Withdrawal by Subject|6|||
129168591|NCT00290771|464910197|FG000|Overall Study|Administrative problems|2|||
129168592|NCT00290771|464910198|FG001|Overall Study|Administrative problems|1|||
129168593|NCT00290771|464910197|FG000|Overall Study|Protocol Violation|2|||
129168594|NCT00290771|464910198|FG001|Overall Study|Protocol Violation|0|||
129168595|NCT00290771|464910197|FG000|Overall Study|Lost to Follow-up|0|||
129168596|NCT00290771|464910198|FG001|Overall Study|Lost to Follow-up|1|||
129168597|NCT00244933|464910201|FG000|Overall Study|Not response evaluable|2|||
129168598|NCT02487654|464910204|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
129168599|NCT02487654|464910205|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
129168600|NCT02487654|464910204|FG000|Overall Study|Withdrawal by Subject|3|||
129168601|NCT02487654|464910205|FG001|Overall Study|Withdrawal by Subject|7|||
129168602|NCT02247011|464910206|FG000|Overall Study|Poor quality of radiological results|125|||
129168603|NCT00616018|464910207|FG000|Overall Study|Protocol Violation|3|||
129168604|NCT04700540|464910208|FG000|Overall Study|Withdrawal by Subject|12|||
129168605|NCT04700540|464910209|FG001|Overall Study|Withdrawal by Subject|8|||
129168606|NCT04700540|464910208|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
129168607|NCT04700540|464910209|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
129168608|NCT01108731|464910228|FG000|Overall Study|Withdrawal by Subject|1|||
129168609|NCT01108731|464910229|FG001|Overall Study|Withdrawal by Subject|1|||
129168610|NCT01108731|464910228|FG000|Overall Study|Adverse Event|3|||
129168611|NCT01108731|464910229|FG001|Overall Study|Adverse Event|3|||
129168612|NCT04283994|464910232|FG000|Overall Study|Death|11|||
129168613|NCT04283994|464910233|FG001|Overall Study|Death|20|||
129168614|NCT04283994|464910234|FG002|Overall Study|Death|11|||
129168615|NCT04283994|464910235|FG003|Overall Study|Death|0|||
129168616|NCT04283994|464910236|FG004|Overall Study|Death|0|||
129168617|NCT04283994|464910237|FG005|Overall Study|Death|0|||
129168618|NCT04283994|464910238|FG006|Overall Study|Death|0|||
129168619|NCT04283994|464910232|FG000|Overall Study|Withdrawal by Subject|16|||
129168620|NCT04283994|464910233|FG001|Overall Study|Withdrawal by Subject|4|||
129168621|NCT04283994|464910234|FG002|Overall Study|Withdrawal by Subject|6|||
129168622|NCT04283994|464910235|FG003|Overall Study|Withdrawal by Subject|1|||
129168623|NCT04283994|464910236|FG004|Overall Study|Withdrawal by Subject|0|||
129168624|NCT04283994|464910237|FG005|Overall Study|Withdrawal by Subject|1|||
129168625|NCT04283994|464910238|FG006|Overall Study|Withdrawal by Subject|0|||
128728485|NCT04649151|463303941|FG001|Overall Study|Physician Decision|0|||
128728486|NCT04649151|463303942|FG002|Overall Study|Physician Decision|0|||
128728487|NCT04649151|463303943|FG003|Overall Study|Physician Decision|1|||
128728488|NCT04649151|463303944|FG004|Overall Study|Physician Decision|1|||
128728489|NCT04649151|463303940|FG000|Overall Study|Protocol Deviation|25|||
128728490|NCT04649151|463303941|FG001|Overall Study|Protocol Deviation|3|||
128728491|NCT04649151|463303942|FG002|Overall Study|Protocol Deviation|0|||
128728492|NCT04649151|463303943|FG003|Overall Study|Protocol Deviation|0|||
128728493|NCT04649151|463303944|FG004|Overall Study|Protocol Deviation|0|||
128728494|NCT04649151|463303940|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
128728495|NCT04649151|463303941|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
129168626|NCT00322452|464910239|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129168627|NCT00322452|464910240|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129168628|NCT00322452|464910239|FG000|Overall Study|Lost to Follow-up|5|||
129168629|NCT00322452|464910240|FG001|Overall Study|Lost to Follow-up|2|||
129168630|NCT00322452|464910239|FG000|Overall Study|Withdrawal by Subject|19|||
129168631|NCT00322452|464910240|FG001|Overall Study|Withdrawal by Subject|46|||
129168632|NCT00322452|464910239|FG000|Overall Study|Death|223|||
129168633|NCT00322452|464910240|FG001|Overall Study|Death|227|||
129168634|NCT01331837|464910241|FG000|Overall Study|Death|30|||
129168635|NCT01331837|464910242|FG001|Overall Study|Death|34|||
129168636|NCT01331837|464910241|FG000|Overall Study|Lost to Follow-up|3|||
129168637|NCT01331837|464910242|FG001|Overall Study|Lost to Follow-up|1|||
129168638|NCT01331837|464910241|FG000|Overall Study|Info not recorded|10|||
129168639|NCT01331837|464910242|FG001|Overall Study|Info not recorded|16|||
129168640|NCT01331837|464910241|FG000|Overall Study|Withdrawal by Subject|13|||
129168641|NCT01331837|464910242|FG001|Overall Study|Withdrawal by Subject|16|||
129168642|NCT03724981|464911932|FG000|First Device|Protocol Violation|1|||
129168643|NCT03724981|464911933|FG001|First Device|Protocol Violation|1|||
129168644|NCT00197145|464911935|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
129168645|NCT00197145|464911936|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
129168646|NCT00197145|464911935|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
129168647|NCT00197145|464911936|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
129168648|NCT00197145|464911935|FG000|Period 1: Randomized Treatment Phase|Other|2|||
129168649|NCT00197145|464911936|FG001|Period 1: Randomized Treatment Phase|Other|2|||
129168650|NCT00197145|464911935|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
129168651|NCT00197145|464911936|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
129168652|NCT00197145|464911935|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
129168653|NCT00197145|464911936|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
129168654|NCT00197145|464911935|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
129168655|NCT00197145|464911936|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
129168656|NCT00197145|464911935|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
129168657|NCT00197145|464911936|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
129168658|NCT00197145|464911935|FG000|Period 2 : Open Label Phase|Other|1|||
129168659|NCT00197145|464911936|FG001|Period 2 : Open Label Phase|Other|0|||
129168660|NCT03372551|464911937|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
129168661|NCT03372551|464911938|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
129168662|NCT02578680|464911941|FG000|Overall Study|Death|329|||
129168663|NCT02578680|464911942|FG001|Overall Study|Death|181|||
129168664|NCT02578680|464911941|FG000|Overall Study|Lost to Follow-up|3|||
129168665|NCT02578680|464911942|FG001|Overall Study|Lost to Follow-up|1|||
129168666|NCT02578680|464911941|FG000|Overall Study|Physician Decision|0|||
129168667|NCT02578680|464911942|FG001|Overall Study|Physician Decision|1|||
129168668|NCT02578680|464911941|FG000|Overall Study|Protocol Violation|1|||
129168669|NCT02578680|464911942|FG001|Overall Study|Protocol Violation|1|||
129168670|NCT02578680|464911941|FG000|Overall Study|Sponsor Decision|64|||
129168671|NCT02578680|464911942|FG001|Overall Study|Sponsor Decision|13|||
129168672|NCT02578680|464911941|FG000|Overall Study|Withdrawal by Subject|13|||
129168673|NCT02578680|464911942|FG001|Overall Study|Withdrawal by Subject|9|||
129168674|NCT03596047|464911943|FG000|Overall Study|Withdrawal by Subject|7|||
129168675|NCT03596047|464911944|FG001|Overall Study|Withdrawal by Subject|4|||
129168676|NCT03596047|464911943|FG000|Overall Study|Lost to Follow-up|0|||
128728496|NCT04649151|463303942|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
128728497|NCT04649151|463303943|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
128728498|NCT04649151|463303944|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
128728499|NCT04649151|463303940|FG000|Overall Study|Withdrawal by Subject|370|||
128728500|NCT04649151|463303941|FG001|Overall Study|Withdrawal by Subject|113|||
128728501|NCT04649151|463303942|FG002|Overall Study|Withdrawal by Subject|2|||
128728502|NCT04649151|463303943|FG003|Overall Study|Withdrawal by Subject|7|||
128728503|NCT04649151|463303944|FG004|Overall Study|Withdrawal by Subject|15|||
128728504|NCT04649151|463303940|FG000|Overall Study|Adverse Event|1|||
128728505|NCT04649151|463303941|FG001|Overall Study|Adverse Event|0|||
128728506|NCT04649151|463303942|FG002|Overall Study|Adverse Event|0|||
128728507|NCT04649151|463303943|FG003|Overall Study|Adverse Event|0|||
128728508|NCT04649151|463303944|FG004|Overall Study|Adverse Event|0|||
128728509|NCT04649151|463303940|FG000|Overall Study|Lost to Follow-up|256|||
128728510|NCT04649151|463303941|FG001|Overall Study|Lost to Follow-up|29|||
128728511|NCT04649151|463303942|FG002|Overall Study|Lost to Follow-up|10|||
128728512|NCT04649151|463303943|FG003|Overall Study|Lost to Follow-up|3|||
128728513|NCT04649151|463303944|FG004|Overall Study|Lost to Follow-up|6|||
128728514|NCT04649151|463303940|FG000|Overall Study|Other than specified|59|||
128728515|NCT04649151|463303941|FG001|Overall Study|Other than specified|294|||
128728516|NCT04649151|463303942|FG002|Overall Study|Other than specified|0|||
129168677|NCT03596047|464911944|FG001|Overall Study|Lost to Follow-up|2|||
129168678|NCT03727646|464911945|FG000|Overall Study|Adverse Event|1|||
129168679|NCT03727646|464911946|FG001|Overall Study|Adverse Event|0|||
129168680|NCT02290691|464911949|FG000|Overall Study|Noncompliance|0|||
128728517|NCT04649151|463303943|FG003|Overall Study|Other than specified|0|||
128728518|NCT04649151|463303944|FG004|Overall Study|Other than specified|4|||
128728519|NCT04649151|463303940|FG000|Overall Study|Death|0|||
129168681|NCT02290691|464911950|FG001|Overall Study|Noncompliance|1|||
129168682|NCT02290691|464911949|FG000|Overall Study|Withdrawal by Subject|1|||
129168683|NCT02290691|464911950|FG001|Overall Study|Withdrawal by Subject|1|||
129168684|NCT02290691|464911949|FG000|Overall Study|Lost to Follow-up|7|||
129168685|NCT02290691|464911950|FG001|Overall Study|Lost to Follow-up|7|||
129168686|NCT00734604|464911955|FG000|Overall Study|Adverse Event|0|||
129168687|NCT00734604|464911956|FG001|Overall Study|Adverse Event|2|||
129168688|NCT00734604|464911957|FG002|Overall Study|Adverse Event|0|||
129168689|NCT00734604|464911958|FG003|Overall Study|Adverse Event|2|||
129168690|NCT00734604|464911959|FG004|Overall Study|Adverse Event|1|||
129168691|NCT00734604|464911960|FG005|Overall Study|Adverse Event|1|||
129168692|NCT00734604|464911955|FG000|Overall Study|Serious Adverse Event|1|||
129168693|NCT00734604|464911956|FG001|Overall Study|Serious Adverse Event|0|||
129168694|NCT00734604|464911957|FG002|Overall Study|Serious Adverse Event|1|||
129168695|NCT00734604|464911958|FG003|Overall Study|Serious Adverse Event|2|||
129168696|NCT00734604|464911959|FG004|Overall Study|Serious Adverse Event|0|||
129168697|NCT00734604|464911960|FG005|Overall Study|Serious Adverse Event|1|||
129168698|NCT00734604|464911955|FG000|Overall Study|Lost to Follow-up|1|||
129168699|NCT00734604|464911956|FG001|Overall Study|Lost to Follow-up|2|||
129168700|NCT00734604|464911957|FG002|Overall Study|Lost to Follow-up|2|||
129168701|NCT00734604|464911958|FG003|Overall Study|Lost to Follow-up|4|||
129168702|NCT00734604|464911959|FG004|Overall Study|Lost to Follow-up|2|||
129168703|NCT00734604|464911960|FG005|Overall Study|Lost to Follow-up|3|||
129168704|NCT00734604|464911955|FG000|Overall Study|Physician Decision|0|||
129168705|NCT00734604|464911956|FG001|Overall Study|Physician Decision|1|||
129168706|NCT00734604|464911957|FG002|Overall Study|Physician Decision|1|||
129168707|NCT00734604|464911958|FG003|Overall Study|Physician Decision|0|||
129168708|NCT00734604|464911959|FG004|Overall Study|Physician Decision|0|||
128778282|NCT03100838|463477044|FG003|Overall Study|Physician Decision|1|||
128778283|NCT03100838|463477041|FG000|Overall Study|Pregnancy|0|||
128778284|NCT03100838|463477042|FG001|Overall Study|Pregnancy|1|||
128778285|NCT03100838|463477043|FG002|Overall Study|Pregnancy|0|||
128778286|NCT03100838|463477044|FG003|Overall Study|Pregnancy|0|||
128778287|NCT03100838|463477041|FG000|Overall Study|Lost to Follow-up|0|||
128778288|NCT03100838|463477042|FG001|Overall Study|Lost to Follow-up|0|||
128778289|NCT03100838|463477043|FG002|Overall Study|Lost to Follow-up|1|||
128778290|NCT03100838|463477044|FG003|Overall Study|Lost to Follow-up|0|||
128778291|NCT02554513|463477045|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
128778292|NCT02554513|463477046|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
128778293|NCT01670500|463477053|FG000|Overall Study|Withdrawal by Subject|1|||
128778294|NCT01670500|463477054|FG001|Overall Study|Withdrawal by Subject|0|||
128778295|NCT03473756|463477055|FG000|Overall Study|Withdrawal by Subject|1|||
128778296|NCT03473756|463477056|FG001|Overall Study|Withdrawal by Subject|4|||
128778297|NCT03473756|463477055|FG000|Overall Study|Adverse Event|6|||
128778298|NCT03473756|463477056|FG001|Overall Study|Adverse Event|7|||
128778299|NCT03473756|463477055|FG000|Overall Study|Lack of Efficacy|3|||
128778300|NCT03473756|463477056|FG001|Overall Study|Lack of Efficacy|10|||
128778301|NCT03473756|463477055|FG000|Overall Study|Physician Decision|0|||
128778302|NCT03473756|463477056|FG001|Overall Study|Physician Decision|2|||
128778303|NCT03473756|463477055|FG000|Overall Study|End of study treatment|0|||
129168709|NCT00734604|464911960|FG005|Overall Study|Physician Decision|0|||
129168710|NCT00734604|464911955|FG000|Overall Study|Protocol Violation|0|||
129168711|NCT00734604|464911956|FG001|Overall Study|Protocol Violation|2|||
129168712|NCT00734604|464911957|FG002|Overall Study|Protocol Violation|0|||
129168713|NCT00734604|464911958|FG003|Overall Study|Protocol Violation|0|||
129168714|NCT00734604|464911959|FG004|Overall Study|Protocol Violation|1|||
129168715|NCT00734604|464911960|FG005|Overall Study|Protocol Violation|0|||
129168716|NCT00734604|464911955|FG000|Overall Study|Sponsor Decision|1|||
129168717|NCT00734604|464911956|FG001|Overall Study|Sponsor Decision|2|||
129168718|NCT00734604|464911957|FG002|Overall Study|Sponsor Decision|1|||
129168719|NCT00734604|464911958|FG003|Overall Study|Sponsor Decision|0|||
129168720|NCT00734604|464911959|FG004|Overall Study|Sponsor Decision|2|||
129168721|NCT00734604|464911960|FG005|Overall Study|Sponsor Decision|0|||
129168722|NCT00734604|464911955|FG000|Overall Study|Withdrawal by Subject|0|||
129168723|NCT00734604|464911956|FG001|Overall Study|Withdrawal by Subject|2|||
129168724|NCT00734604|464911957|FG002|Overall Study|Withdrawal by Subject|0|||
129168725|NCT00734604|464911958|FG003|Overall Study|Withdrawal by Subject|1|||
129168726|NCT00734604|464911959|FG004|Overall Study|Withdrawal by Subject|2|||
129168727|NCT00734604|464911960|FG005|Overall Study|Withdrawal by Subject|1|||
129168728|NCT00734604|464911955|FG000|Overall Study|Lack of Efficacy|0|||
129168729|NCT00734604|464911956|FG001|Overall Study|Lack of Efficacy|1|||
129168730|NCT00734604|464911957|FG002|Overall Study|Lack of Efficacy|1|||
128778304|NCT03473756|463477056|FG001|Overall Study|End of study treatment|2|||
128778305|NCT03473756|463477055|FG000|Overall Study|Lost to Follow-up|0|||
128778306|NCT03473756|463477056|FG001|Overall Study|Lost to Follow-up|1|||
128778307|NCT02148718|463477057|FG000|Overall Study|Protocol Violation|26|||
128778308|NCT02148718|463477057|FG000|Overall Study|Discontinued Study Prematurely|5|||
128778309|NCT00333788|463477058|FG000|Overall Study|Adverse Event|44|||
129168731|NCT00734604|464911958|FG003|Overall Study|Lack of Efficacy|0|||
128778310|NCT00333788|463477058|FG000|Overall Study|Lack of Efficacy|80|||
128778311|NCT00333788|463477058|FG000|Overall Study|Lost to Follow-up|2|||
129168732|NCT00734604|464911959|FG004|Overall Study|Lack of Efficacy|0|||
129168733|NCT00734604|464911960|FG005|Overall Study|Lack of Efficacy|0|||
129168734|NCT02589665|464911961|FG000|Induction Period|Did not receive drug|0|||
129168735|NCT02589665|464911962|FG001|Induction Period|Did not receive drug|0|||
129168736|NCT02589665|464911963|FG002|Induction Period|Did not receive drug|0|||
129168737|NCT02589665|464911964|FG003|Induction Period|Did not receive drug|1|||
129168738|NCT02589665|464911965|FG004|Induction Period|Did not receive drug|0|||
129168739|NCT02589665|464911966|FG005|Induction Period|Did not receive drug|0|||
129168740|NCT02589665|464911967|FG006|Induction Period|Did not receive drug|0|||
129168741|NCT02589665|464911968|FG007|Induction Period|Did not receive drug|0|||
129168742|NCT02589665|464911969|FG008|Induction Period|Did not receive drug|0|||
129168743|NCT02589665|464911970|FG009|Induction Period|Did not receive drug|0|||
129168744|NCT02589665|464911961|FG000|Induction Period|Adverse Event|3|||
129168745|NCT02589665|464911962|FG001|Induction Period|Adverse Event|0|||
129168746|NCT02589665|464911963|FG002|Induction Period|Adverse Event|2|||
129168747|NCT02589665|464911964|FG003|Induction Period|Adverse Event|2|||
129168748|NCT02589665|464911965|FG004|Induction Period|Adverse Event|0|||
129168749|NCT02589665|464911966|FG005|Induction Period|Adverse Event|0|||
129168750|NCT02589665|464911967|FG006|Induction Period|Adverse Event|0|||
129168751|NCT02589665|464911968|FG007|Induction Period|Adverse Event|0|||
129168752|NCT02589665|464911969|FG008|Induction Period|Adverse Event|0|||
129168753|NCT02589665|464911970|FG009|Induction Period|Adverse Event|0|||
129168754|NCT02589665|464911961|FG000|Induction Period|Withdrawal by Subject|0|||
129168755|NCT02589665|464911962|FG001|Induction Period|Withdrawal by Subject|1|||
129168756|NCT02589665|464911963|FG002|Induction Period|Withdrawal by Subject|0|||
129168757|NCT02589665|464911964|FG003|Induction Period|Withdrawal by Subject|1|||
129168758|NCT02589665|464911965|FG004|Induction Period|Withdrawal by Subject|0|||
129168759|NCT02589665|464911966|FG005|Induction Period|Withdrawal by Subject|0|||
129168760|NCT02589665|464911967|FG006|Induction Period|Withdrawal by Subject|0|||
129168761|NCT02589665|464911968|FG007|Induction Period|Withdrawal by Subject|0|||
129168762|NCT02589665|464911969|FG008|Induction Period|Withdrawal by Subject|0|||
129168763|NCT02589665|464911970|FG009|Induction Period|Withdrawal by Subject|0|||
129168764|NCT02589665|464911961|FG000|Induction Period|Protocol Violation|0|||
129168765|NCT02589665|464911962|FG001|Induction Period|Protocol Violation|1|||
129168766|NCT02589665|464911963|FG002|Induction Period|Protocol Violation|0|||
129168767|NCT02589665|464911964|FG003|Induction Period|Protocol Violation|0|||
129168768|NCT02589665|464911965|FG004|Induction Period|Protocol Violation|0|||
129168769|NCT02589665|464911966|FG005|Induction Period|Protocol Violation|0|||
129168770|NCT02589665|464911967|FG006|Induction Period|Protocol Violation|0|||
129168771|NCT02589665|464911968|FG007|Induction Period|Protocol Violation|0|||
129168772|NCT02589665|464911969|FG008|Induction Period|Protocol Violation|0|||
129168773|NCT02589665|464911970|FG009|Induction Period|Protocol Violation|0|||
129168774|NCT02589665|464911961|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168775|NCT02589665|464911962|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168776|NCT02589665|464911963|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168777|NCT02589665|464911964|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168778|NCT02589665|464911965|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
129168779|NCT02589665|464911966|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
129168780|NCT02589665|464911967|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
129168781|NCT02589665|464911968|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168782|NCT02589665|464911969|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168783|NCT02589665|464911970|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168784|NCT02589665|464911961|FG000|Maintenance Period|Withdrawal by Subject|0|||
128778312|NCT00333788|463477058|FG000|Overall Study|Withdrawal by Subject|24|||
128778313|NCT00333788|463477058|FG000|Overall Study|Other: Non-compliance|2|||
128778314|NCT00333788|463477058|FG000|Overall Study|Other: Moved|2|||
128778315|NCT00333788|463477058|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
128778316|NCT00333788|463477058|FG000|Overall Study|Other: Investigator decision|1|||
128778317|NCT00333788|463477058|FG000|Overall Study|Other: Quality of life concern|1|||
128778318|NCT00333788|463477058|FG000|Overall Study|Other: Sponsor decision|1|||
128778319|NCT00333788|463477058|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
128778320|NCT00333788|463477058|FG000|Overall Study|Other: Medical monitor decision|1|||
128778321|NCT00333788|463477058|FG000|Overall Study|Other: Physician decision|1|||
128778322|NCT00333788|463477058|FG000|Overall Study|Other: Signed consent for another study|1|||
129168785|NCT02589665|464911962|FG001|Maintenance Period|Withdrawal by Subject|0|||
129168786|NCT02589665|464911963|FG002|Maintenance Period|Withdrawal by Subject|0|||
129168787|NCT02589665|464911964|FG003|Maintenance Period|Withdrawal by Subject|0|||
129168788|NCT02589665|464911965|FG004|Maintenance Period|Withdrawal by Subject|4|||
129168789|NCT02589665|464911966|FG005|Maintenance Period|Withdrawal by Subject|2|||
129168790|NCT02589665|464911967|FG006|Maintenance Period|Withdrawal by Subject|4|||
129168791|NCT02589665|464911968|FG007|Maintenance Period|Withdrawal by Subject|0|||
129168792|NCT02589665|464911969|FG008|Maintenance Period|Withdrawal by Subject|0|||
129168793|NCT02589665|464911970|FG009|Maintenance Period|Withdrawal by Subject|0|||
129168794|NCT02589665|464911961|FG000|Maintenance Period|Lack of Efficacy|0|||
129168795|NCT02589665|464911962|FG001|Maintenance Period|Lack of Efficacy|0|||
129168796|NCT02589665|464911963|FG002|Maintenance Period|Lack of Efficacy|0|||
129168797|NCT02589665|464911964|FG003|Maintenance Period|Lack of Efficacy|0|||
129168798|NCT02589665|464911965|FG004|Maintenance Period|Lack of Efficacy|2|||
129168799|NCT02589665|464911966|FG005|Maintenance Period|Lack of Efficacy|1|||
129168800|NCT02589665|464911967|FG006|Maintenance Period|Lack of Efficacy|0|||
129168801|NCT02589665|464911968|FG007|Maintenance Period|Lack of Efficacy|0|||
129168802|NCT02589665|464911969|FG008|Maintenance Period|Lack of Efficacy|0|||
129168803|NCT02589665|464911970|FG009|Maintenance Period|Lack of Efficacy|0|||
129168804|NCT02589665|464911961|FG000|Maintenance Period|Adverse Event|0|||
129168805|NCT02589665|464911962|FG001|Maintenance Period|Adverse Event|0|||
129168806|NCT02589665|464911963|FG002|Maintenance Period|Adverse Event|0|||
129168807|NCT02589665|464911964|FG003|Maintenance Period|Adverse Event|0|||
129168808|NCT02589665|464911965|FG004|Maintenance Period|Adverse Event|0|||
129168809|NCT02589665|464911966|FG005|Maintenance Period|Adverse Event|0|||
129168810|NCT02589665|464911967|FG006|Maintenance Period|Adverse Event|2|||
129168811|NCT02589665|464911968|FG007|Maintenance Period|Adverse Event|0|||
129168812|NCT02589665|464911969|FG008|Maintenance Period|Adverse Event|0|||
129168813|NCT02589665|464911970|FG009|Maintenance Period|Adverse Event|0|||
129168814|NCT02589665|464911961|FG000|Maintenance Period|Lost to Follow-up|0|||
129168815|NCT02589665|464911962|FG001|Maintenance Period|Lost to Follow-up|0|||
129168816|NCT02589665|464911963|FG002|Maintenance Period|Lost to Follow-up|0|||
129168817|NCT02589665|464911964|FG003|Maintenance Period|Lost to Follow-up|0|||
129168818|NCT02589665|464911965|FG004|Maintenance Period|Lost to Follow-up|0|||
129168819|NCT02589665|464911966|FG005|Maintenance Period|Lost to Follow-up|1|||
129168820|NCT02589665|464911967|FG006|Maintenance Period|Lost to Follow-up|0|||
129168821|NCT02589665|464911968|FG007|Maintenance Period|Lost to Follow-up|0|||
129168822|NCT02589665|464911969|FG008|Maintenance Period|Lost to Follow-up|0|||
129168823|NCT02589665|464911970|FG009|Maintenance Period|Lost to Follow-up|0|||
129168824|NCT02589665|464911961|FG000|Maintenance Period|Physician Decision|0|||
129168825|NCT02589665|464911962|FG001|Maintenance Period|Physician Decision|0|||
128728520|NCT04649151|463303941|FG001|Overall Study|Death|0|||
128728521|NCT04649151|463303942|FG002|Overall Study|Death|0|||
128728522|NCT04649151|463303943|FG003|Overall Study|Death|0|||
128728523|NCT04649151|463303944|FG004|Overall Study|Death|1|||
128728524|NCT03752619|463303945|FG000|Overall Study|Lost to Follow-up|2|||
128728525|NCT03752619|463303946|FG001|Overall Study|Lost to Follow-up|1|||
128728526|NCT03752619|463303945|FG000|Overall Study|Withdrawal by Subject|1|||
128728527|NCT03752619|463303946|FG001|Overall Study|Withdrawal by Subject|1|||
128728528|NCT03752619|463303945|FG000|Overall Study|Adverse Event|0|||
128728529|NCT03752619|463303946|FG001|Overall Study|Adverse Event|1|||
128728530|NCT03907683|463303947|FG000|Overall Study|Pregnancy|1|||
128728531|NCT03907683|463303947|FG000|Overall Study|Withdrawal by Subject|1|||
128728532|NCT03400332|463303948|FG000|Pre-Treatment|Other reasons|0|||
128728533|NCT03400332|463303949|FG001|Pre-Treatment|Other reasons|0|||
128728534|NCT03400332|463303950|FG002|Pre-Treatment|Other reasons|0|||
128728535|NCT03400332|463303951|FG003|Pre-Treatment|Other reasons|0|||
128728536|NCT03400332|463303952|FG004|Pre-Treatment|Other reasons|0|||
128728537|NCT03400332|463303953|FG005|Pre-Treatment|Other reasons|0|||
128728538|NCT03400332|463303954|FG006|Pre-Treatment|Other reasons|0|||
128728539|NCT03400332|463303955|FG007|Pre-Treatment|Other reasons|0|||
128728540|NCT03400332|463303956|FG008|Pre-Treatment|Other reasons|1|||
128728541|NCT03400332|463303948|FG000|Pre-Treatment|No longer met study criteria|0|||
128728542|NCT03400332|463303949|FG001|Pre-Treatment|No longer met study criteria|0|||
128728543|NCT03400332|463303950|FG002|Pre-Treatment|No longer met study criteria|0|||
128728544|NCT03400332|463303951|FG003|Pre-Treatment|No longer met study criteria|0|||
128728545|NCT03400332|463303952|FG004|Pre-Treatment|No longer met study criteria|0|||
128728546|NCT03400332|463303953|FG005|Pre-Treatment|No longer met study criteria|0|||
128728547|NCT03400332|463303954|FG006|Pre-Treatment|No longer met study criteria|0|||
128728548|NCT03400332|463303955|FG007|Pre-Treatment|No longer met study criteria|0|||
128728549|NCT03400332|463303956|FG008|Pre-Treatment|No longer met study criteria|1|||
128728550|NCT03400332|463303948|FG000|Pre-Treatment|Withdrawal by Subject|0|||
129168826|NCT02589665|464911963|FG002|Maintenance Period|Physician Decision|0|||
129168827|NCT02589665|464911964|FG003|Maintenance Period|Physician Decision|0|||
129168828|NCT02589665|464911965|FG004|Maintenance Period|Physician Decision|0|||
129168829|NCT02589665|464911966|FG005|Maintenance Period|Physician Decision|1|||
128728551|NCT03400332|463303949|FG001|Pre-Treatment|Withdrawal by Subject|0|||
128728552|NCT03400332|463303950|FG002|Pre-Treatment|Withdrawal by Subject|0|||
128728553|NCT03400332|463303951|FG003|Pre-Treatment|Withdrawal by Subject|0|||
129168830|NCT02589665|464911967|FG006|Maintenance Period|Physician Decision|0|||
128728554|NCT03400332|463303952|FG004|Pre-Treatment|Withdrawal by Subject|0|||
128728555|NCT03400332|463303953|FG005|Pre-Treatment|Withdrawal by Subject|0|||
128728556|NCT03400332|463303954|FG006|Pre-Treatment|Withdrawal by Subject|0|||
128728557|NCT03400332|463303955|FG007|Pre-Treatment|Withdrawal by Subject|0|||
128778323|NCT00729690|463477059|FG000|Overall Study|IT Catheter Malfunction|0|||
128778324|NCT00729690|463477060|FG001|Overall Study|IT Catheter Malfunction|2|||
128778325|NCT00729690|463477061|FG002|Overall Study|IT Catheter Malfunction|2|||
128778326|NCT02886936|463477067|FG000|Overall Study|Lost to Follow-up|4|||
128778327|NCT02886936|463477068|FG001|Overall Study|Lost to Follow-up|3|||
128778328|NCT02886936|463477069|FG002|Overall Study|Lost to Follow-up|0|||
128778329|NCT02320721|463477070|FG000|Overall Study|Adverse Event|6|||
128778330|NCT02320721|463477071|FG001|Overall Study|Adverse Event|6|||
128778331|NCT02320721|463477070|FG000|Overall Study|Lack of Efficacy|2|||
128778332|NCT02320721|463477071|FG001|Overall Study|Lack of Efficacy|0|||
128778333|NCT02320721|463477070|FG000|Overall Study|Poor compliance to protocol|3|||
128778334|NCT02320721|463477071|FG001|Overall Study|Poor compliance to protocol|7|||
128778335|NCT02320721|463477070|FG000|Overall Study|Randomized but not treated|0|||
128778336|NCT02320721|463477071|FG001|Overall Study|Randomized but not treated|1|||
128778337|NCT02320721|463477070|FG000|Overall Study|Hypoglycemia|1|||
128778338|NCT02320721|463477071|FG001|Overall Study|Hypoglycemia|0|||
128778339|NCT02320721|463477070|FG000|Overall Study|Other than specified above|15|||
128778340|NCT02320721|463477071|FG001|Overall Study|Other than specified above|20|||
128778341|NCT04131907|463477072|FG000|Overall Study|Adverse Event|2|||
128778342|NCT04131907|463477073|FG001|Overall Study|Adverse Event|0|||
128778343|NCT04131907|463477074|FG002|Overall Study|Adverse Event|0|||
128778344|NCT04131907|463477072|FG000|Overall Study|Physician Decision|4|||
128778345|NCT04131907|463477073|FG001|Overall Study|Physician Decision|22|||
128778346|NCT04131907|463477074|FG002|Overall Study|Physician Decision|0|||
128778347|NCT04131907|463477072|FG000|Overall Study|Withdrawal by Subject|2|||
128778348|NCT04131907|463477073|FG001|Overall Study|Withdrawal by Subject|0|||
128778349|NCT04131907|463477074|FG002|Overall Study|Withdrawal by Subject|1|||
128778350|NCT04131907|463477072|FG000|Overall Study|Treatment failure|2|||
128778351|NCT04131907|463477073|FG001|Overall Study|Treatment failure|0|||
128778352|NCT04131907|463477074|FG002|Overall Study|Treatment failure|1|||
128778353|NCT01778062|463477075|FG000|Overall Study|Adverse Event|1|||
128778354|NCT01778062|463477076|FG001|Overall Study|Adverse Event|3|||
128778355|NCT01778062|463477075|FG000|Overall Study|Consent Withdrawal|1|||
128778356|NCT01778062|463477076|FG001|Overall Study|Consent Withdrawal|5|||
128778357|NCT01778062|463477075|FG000|Overall Study|major protocol deviation|4|||
128778358|NCT01778062|463477076|FG001|Overall Study|major protocol deviation|3|||
128778359|NCT04445155|463477077|FG000|Overall Study|Lost to Follow-up|11|||
128778360|NCT04445155|463477078|FG001|Overall Study|Lost to Follow-up|2|||
128778361|NCT04445155|463477079|FG002|Overall Study|Lost to Follow-up|3|||
128778362|NCT04445155|463477080|FG003|Overall Study|Lost to Follow-up|0|||
128778363|NCT04445155|463477077|FG000|Overall Study|Withdrawal by Subject|8|||
128778364|NCT04445155|463477078|FG001|Overall Study|Withdrawal by Subject|0|||
128778365|NCT04445155|463477079|FG002|Overall Study|Withdrawal by Subject|0|||
128778366|NCT04445155|463477080|FG003|Overall Study|Withdrawal by Subject|0|||
128778367|NCT04445155|463477077|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
128778368|NCT04445155|463477078|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
128778369|NCT04445155|463477079|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
128778370|NCT04445155|463477080|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
128778371|NCT04445155|463477077|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
128778372|NCT04445155|463477078|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
128778373|NCT04445155|463477079|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
128778374|NCT04445155|463477080|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
128778375|NCT01213173|463477083|FG000|Overall Study|Protocol Violation|2|||
128778376|NCT01213173|463477084|FG001|Overall Study|Protocol Violation|0|||
128778377|NCT01213173|463477083|FG000|Overall Study|Adverse Event|4|||
128778378|NCT01213173|463477084|FG001|Overall Study|Adverse Event|8|||
128778379|NCT01213173|463477083|FG000|Overall Study|Withdrawal by Subject|5|||
128778380|NCT01213173|463477084|FG001|Overall Study|Withdrawal by Subject|5|||
128778381|NCT01213173|463477083|FG000|Overall Study|Incorrect Enrollment|1|||
128778382|NCT01213173|463477084|FG001|Overall Study|Incorrect Enrollment|3|||
128778383|NCT02353832|463477087|FG000|Overall Study|Ineligible after enrollment|1|||
128778384|NCT02353832|463477087|FG000|Overall Study|Lost to Follow-up|1|||
128778385|NCT04880161|463477088|FG000|Overall Study|Withdrawal by Subject|1|||
128778386|NCT04880161|463477089|FG001|Overall Study|Withdrawal by Subject|0|||
129168831|NCT02589665|464911968|FG007|Maintenance Period|Physician Decision|0|||
129168832|NCT02589665|464911969|FG008|Maintenance Period|Physician Decision|0|||
129168833|NCT02589665|464911970|FG009|Maintenance Period|Physician Decision|0|||
128778387|NCT04880161|463477088|FG000|Overall Study|Lack of Compliance|1|||
128778388|NCT04880161|463477089|FG001|Overall Study|Lack of Compliance|1|||
128778389|NCT04880161|463477088|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
128778390|NCT04880161|463477089|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
128778391|NCT04880161|463477088|FG000|Overall Study|Screen Failure|0|||
128778392|NCT04880161|463477089|FG001|Overall Study|Screen Failure|1|||
128778393|NCT04423393|463478708|FG000|Overall Study|Withdrawal by Subject|0|||
129168834|NCT02589665|464911961|FG000|Maintenance Period|Reason Not Collected|0|||
129168835|NCT02589665|464911962|FG001|Maintenance Period|Reason Not Collected|0|||
129168836|NCT02589665|464911963|FG002|Maintenance Period|Reason Not Collected|0|||
129168837|NCT02589665|464911964|FG003|Maintenance Period|Reason Not Collected|0|||
129168838|NCT02589665|464911965|FG004|Maintenance Period|Reason Not Collected|0|||
129168839|NCT02589665|464911966|FG005|Maintenance Period|Reason Not Collected|1|||
129168840|NCT02589665|464911967|FG006|Maintenance Period|Reason Not Collected|1|||
129168841|NCT02589665|464911968|FG007|Maintenance Period|Reason Not Collected|0|||
129168842|NCT02589665|464911969|FG008|Maintenance Period|Reason Not Collected|0|||
129168843|NCT02589665|464911970|FG009|Maintenance Period|Reason Not Collected|0|||
129168844|NCT02589665|464911961|FG000|Induction Extension Period|Adverse Event|0|||
129168845|NCT02589665|464911962|FG001|Induction Extension Period|Adverse Event|0|||
129168846|NCT02589665|464911963|FG002|Induction Extension Period|Adverse Event|0|||
129168847|NCT02589665|464911964|FG003|Induction Extension Period|Adverse Event|0|||
129168848|NCT02589665|464911965|FG004|Induction Extension Period|Adverse Event|0|||
129168849|NCT02589665|464911966|FG005|Induction Extension Period|Adverse Event|0|||
129168850|NCT02589665|464911967|FG006|Induction Extension Period|Adverse Event|0|||
129168851|NCT02589665|464911968|FG007|Induction Extension Period|Adverse Event|0|||
129168852|NCT02589665|464911969|FG008|Induction Extension Period|Adverse Event|4|||
129168853|NCT02589665|464911970|FG009|Induction Extension Period|Adverse Event|0|||
129168854|NCT02589665|464911961|FG000|Induction Extension Period|Lack of Efficacy|0|||
129168855|NCT02589665|464911962|FG001|Induction Extension Period|Lack of Efficacy|0|||
129168856|NCT02589665|464911963|FG002|Induction Extension Period|Lack of Efficacy|0|||
129168857|NCT02589665|464911964|FG003|Induction Extension Period|Lack of Efficacy|0|||
129168858|NCT02589665|464911965|FG004|Induction Extension Period|Lack of Efficacy|0|||
129168859|NCT02589665|464911966|FG005|Induction Extension Period|Lack of Efficacy|0|||
129168860|NCT02589665|464911967|FG006|Induction Extension Period|Lack of Efficacy|0|||
129168861|NCT02589665|464911968|FG007|Induction Extension Period|Lack of Efficacy|0|||
129168862|NCT02589665|464911969|FG008|Induction Extension Period|Lack of Efficacy|3|||
129168863|NCT02589665|464911970|FG009|Induction Extension Period|Lack of Efficacy|0|||
129168864|NCT02589665|464911961|FG000|Induction Extension Period|Withdrawal by Subject|0|||
129168865|NCT02589665|464911962|FG001|Induction Extension Period|Withdrawal by Subject|0|||
129168866|NCT02589665|464911963|FG002|Induction Extension Period|Withdrawal by Subject|0|||
129168867|NCT02589665|464911964|FG003|Induction Extension Period|Withdrawal by Subject|0|||
129168868|NCT02589665|464911965|FG004|Induction Extension Period|Withdrawal by Subject|0|||
129168869|NCT02589665|464911966|FG005|Induction Extension Period|Withdrawal by Subject|0|||
129168870|NCT02589665|464911967|FG006|Induction Extension Period|Withdrawal by Subject|0|||
129168871|NCT02589665|464911968|FG007|Induction Extension Period|Withdrawal by Subject|2|||
129168872|NCT02589665|464911969|FG008|Induction Extension Period|Withdrawal by Subject|3|||
129168873|NCT02589665|464911970|FG009|Induction Extension Period|Withdrawal by Subject|0|||
129168874|NCT02589665|464911961|FG000|Induction Extension Period|Physician Decision|0|||
129168875|NCT02589665|464911962|FG001|Induction Extension Period|Physician Decision|0|||
129168876|NCT02589665|464911963|FG002|Induction Extension Period|Physician Decision|0|||
129168877|NCT02589665|464911964|FG003|Induction Extension Period|Physician Decision|0|||
129168878|NCT02589665|464911965|FG004|Induction Extension Period|Physician Decision|0|||
129168879|NCT02589665|464911966|FG005|Induction Extension Period|Physician Decision|0|||
129168880|NCT02589665|464911967|FG006|Induction Extension Period|Physician Decision|0|||
129168881|NCT02589665|464911968|FG007|Induction Extension Period|Physician Decision|0|||
129168882|NCT02589665|464911969|FG008|Induction Extension Period|Physician Decision|1|||
129168883|NCT02589665|464911970|FG009|Induction Extension Period|Physician Decision|0|||
129168884|NCT02589665|464911961|FG000|Induction Extension Period|Reason Not Collected|0|||
129168885|NCT02589665|464911962|FG001|Induction Extension Period|Reason Not Collected|0|||
129168886|NCT02589665|464911963|FG002|Induction Extension Period|Reason Not Collected|0|||
129168887|NCT02589665|464911964|FG003|Induction Extension Period|Reason Not Collected|0|||
129168888|NCT02589665|464911965|FG004|Induction Extension Period|Reason Not Collected|0|||
129168889|NCT02589665|464911966|FG005|Induction Extension Period|Reason Not Collected|0|||
129168890|NCT02589665|464911967|FG006|Induction Extension Period|Reason Not Collected|0|||
129168891|NCT02589665|464911968|FG007|Induction Extension Period|Reason Not Collected|0|||
129168892|NCT02589665|464911969|FG008|Induction Extension Period|Reason Not Collected|1|||
129168893|NCT02589665|464911970|FG009|Induction Extension Period|Reason Not Collected|0|||
129168894|NCT02589665|464911961|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168895|NCT02589665|464911962|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168896|NCT02589665|464911963|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168897|NCT02589665|464911964|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168898|NCT02589665|464911965|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168899|NCT02589665|464911966|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168900|NCT02589665|464911967|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168901|NCT02589665|464911968|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168902|NCT02589665|464911969|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129168903|NCT02589665|464911970|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
129168904|NCT02589665|464911961|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
129168905|NCT02589665|464911962|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
129168906|NCT02589665|464911963|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
129168907|NCT02589665|464911964|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
129168908|NCT02589665|464911965|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
129168909|NCT02589665|464911966|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
129168910|NCT02589665|464911967|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
129168911|NCT02589665|464911968|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
129168912|NCT02589665|464911969|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
129168913|NCT02589665|464911970|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
129168914|NCT02589665|464911961|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
129168915|NCT02589665|464911962|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
129168916|NCT02589665|464911963|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
129168917|NCT02589665|464911964|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
129168918|NCT02589665|464911965|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
129168919|NCT02589665|464911966|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
129168920|NCT02589665|464911967|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
129168921|NCT02589665|464911968|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
129168922|NCT02589665|464911969|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
129168923|NCT02589665|464911970|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
129168924|NCT02589665|464911961|FG000|Maintenance Extension Period|Adverse Event|0|||
129168925|NCT02589665|464911962|FG001|Maintenance Extension Period|Adverse Event|0|||
129168926|NCT02589665|464911963|FG002|Maintenance Extension Period|Adverse Event|0|||
129168927|NCT02589665|464911964|FG003|Maintenance Extension Period|Adverse Event|0|||
129168928|NCT02589665|464911965|FG004|Maintenance Extension Period|Adverse Event|0|||
129168929|NCT02589665|464911966|FG005|Maintenance Extension Period|Adverse Event|0|||
129168930|NCT02589665|464911967|FG006|Maintenance Extension Period|Adverse Event|0|||
129168931|NCT02589665|464911968|FG007|Maintenance Extension Period|Adverse Event|0|||
129168932|NCT02589665|464911969|FG008|Maintenance Extension Period|Adverse Event|0|||
128728558|NCT03400332|463303956|FG008|Pre-Treatment|Withdrawal by Subject|1|||
128728559|NCT03400332|463303948|FG000|Treatment|Participant withdrew consent|2|||
128728560|NCT03400332|463303949|FG001|Treatment|Participant withdrew consent|2|||
128728561|NCT03400332|463303950|FG002|Treatment|Participant withdrew consent|0|||
128728562|NCT03400332|463303951|FG003|Treatment|Participant withdrew consent|0|||
128728563|NCT03400332|463303952|FG004|Treatment|Participant withdrew consent|3|||
128728564|NCT03400332|463303953|FG005|Treatment|Participant withdrew consent|3|||
128728565|NCT03400332|463303954|FG006|Treatment|Participant withdrew consent|1|||
128728566|NCT03400332|463303955|FG007|Treatment|Participant withdrew consent|1|||
128728567|NCT03400332|463303956|FG008|Treatment|Participant withdrew consent|1|||
128728568|NCT03400332|463303948|FG000|Treatment|Other reasons|0|||
128728569|NCT03400332|463303949|FG001|Treatment|Other reasons|1|||
128728570|NCT03400332|463303950|FG002|Treatment|Other reasons|1|||
128728571|NCT03400332|463303951|FG003|Treatment|Other reasons|0|||
128728572|NCT03400332|463303952|FG004|Treatment|Other reasons|3|||
128728573|NCT03400332|463303953|FG005|Treatment|Other reasons|1|||
128728574|NCT03400332|463303954|FG006|Treatment|Other reasons|2|||
128728575|NCT03400332|463303955|FG007|Treatment|Other reasons|0|||
128728576|NCT03400332|463303956|FG008|Treatment|Other reasons|1|||
128728577|NCT03400332|463303948|FG000|Treatment|Lost to Follow-up|0|||
128728578|NCT03400332|463303949|FG001|Treatment|Lost to Follow-up|1|||
128728579|NCT03400332|463303950|FG002|Treatment|Lost to Follow-up|0|||
128728580|NCT03400332|463303951|FG003|Treatment|Lost to Follow-up|0|||
128728581|NCT03400332|463303952|FG004|Treatment|Lost to Follow-up|0|||
128728582|NCT03400332|463303953|FG005|Treatment|Lost to Follow-up|0|||
128728583|NCT03400332|463303954|FG006|Treatment|Lost to Follow-up|0|||
128728584|NCT03400332|463303955|FG007|Treatment|Lost to Follow-up|0|||
128728585|NCT03400332|463303956|FG008|Treatment|Lost to Follow-up|0|||
128728586|NCT03400332|463303948|FG000|Treatment|Death|3|||
128728587|NCT03400332|463303949|FG001|Treatment|Death|1|||
128728588|NCT03400332|463303950|FG002|Treatment|Death|2|||
128728589|NCT03400332|463303951|FG003|Treatment|Death|3|||
129168933|NCT02589665|464911970|FG009|Maintenance Extension Period|Adverse Event|2|||
129168934|NCT02589665|464911961|FG000|Maintenance Extension Period|Non-responder|0|||
129168935|NCT02589665|464911962|FG001|Maintenance Extension Period|Non-responder|0|||
128728590|NCT03400332|463303952|FG004|Treatment|Death|6|||
128728591|NCT03400332|463303953|FG005|Treatment|Death|2|||
128728592|NCT03400332|463303954|FG006|Treatment|Death|1|||
128728593|NCT03400332|463303955|FG007|Treatment|Death|3|||
128728594|NCT03400332|463303956|FG008|Treatment|Death|6|||
128728595|NCT04476017|463303961|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
128728596|NCT04476017|463303962|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
128728597|NCT02704364|463303963|FG000|Overall Study|Adverse Event|1|||
128728598|NCT02704364|463303964|FG001|Overall Study|Adverse Event|1|||
128728599|NCT02704364|463303965|FG002|Overall Study|Adverse Event|0|||
128728600|NCT02704364|463303963|FG000|Overall Study|Noncompliance with study drug|1|||
129168936|NCT02589665|464911963|FG002|Maintenance Extension Period|Non-responder|0|||
129168937|NCT02589665|464911964|FG003|Maintenance Extension Period|Non-responder|0|||
129168938|NCT02589665|464911965|FG004|Maintenance Extension Period|Non-responder|0|||
129168939|NCT02589665|464911966|FG005|Maintenance Extension Period|Non-responder|0|||
129168940|NCT02589665|464911967|FG006|Maintenance Extension Period|Non-responder|0|||
129168941|NCT02589665|464911968|FG007|Maintenance Extension Period|Non-responder|0|||
128778394|NCT04423393|463478709|FG001|Overall Study|Withdrawal by Subject|0|||
128778395|NCT04423393|463478710|FG002|Overall Study|Withdrawal by Subject|0|||
128778396|NCT04423393|463478711|FG003|Overall Study|Withdrawal by Subject|0|||
128778397|NCT04423393|463478712|FG004|Overall Study|Withdrawal by Subject|0|||
128778398|NCT04423393|463478713|FG005|Overall Study|Withdrawal by Subject|1|||
128778399|NCT04423393|463478714|FG006|Overall Study|Withdrawal by Subject|0|||
128778400|NCT04423393|463478715|FG007|Overall Study|Withdrawal by Subject|0|||
128778401|NCT04423393|463478716|FG008|Overall Study|Withdrawal by Subject|0|||
129168942|NCT02589665|464911969|FG008|Maintenance Extension Period|Non-responder|0|||
129168943|NCT02589665|464911970|FG009|Maintenance Extension Period|Non-responder|1|||
129168944|NCT00978380|464911971|FG000|Overall Study|Protocol Violation|2|||
129168945|NCT00978380|464911971|FG000|Overall Study|Withdrawal criteria|9|||
129168946|NCT00978380|464911971|FG000|Overall Study|Unclassified|8|||
129168947|NCT00873041|464911981|FG000|Core Study|Adverse Event|2|||
129168948|NCT00873041|464911982|FG001|Core Study|Adverse Event|3|||
129168949|NCT00873041|464911983|FG002|Core Study|Adverse Event|1|||
129168950|NCT00873041|464911981|FG000|Core Study|Withdrawal by Subject|1|||
129168951|NCT00873041|464911982|FG001|Core Study|Withdrawal by Subject|2|||
129168952|NCT00873041|464911983|FG002|Core Study|Withdrawal by Subject|2|||
129168953|NCT00873041|464911981|FG000|Core Study|Lost to Follow-up|3|||
128778402|NCT04423393|463478717|FG009|Overall Study|Withdrawal by Subject|0|||
129168954|NCT00873041|464911982|FG001|Core Study|Lost to Follow-up|1|||
129168955|NCT00873041|464911983|FG002|Core Study|Lost to Follow-up|0|||
129168956|NCT00873041|464911981|FG000|Core Study|Abnormal laboratory value|0|||
129168957|NCT00873041|464911982|FG001|Core Study|Abnormal laboratory value|0|||
129168958|NCT00873041|464911983|FG002|Core Study|Abnormal laboratory value|1|||
129168959|NCT00873041|464911981|FG000|Core Study|Protocol deviation|1|||
129168960|NCT00873041|464911982|FG001|Core Study|Protocol deviation|0|||
129168961|NCT00873041|464911983|FG002|Core Study|Protocol deviation|1|||
129168962|NCT00873041|464911981|FG000|Extension Study|Adverse Event|1|||
129168963|NCT00873041|464911982|FG001|Extension Study|Adverse Event|0|||
129168964|NCT00873041|464911983|FG002|Extension Study|Adverse Event|1|||
129168965|NCT00873041|464911981|FG000|Extension Study|Administrative reasons|0|||
129168966|NCT00873041|464911982|FG001|Extension Study|Administrative reasons|0|||
129168967|NCT00873041|464911983|FG002|Extension Study|Administrative reasons|1|||
129168968|NCT03831191|464911984|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
129168969|NCT03831191|464911985|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
129168970|NCT03831191|464911986|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
129168971|NCT03831191|464911987|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
129168972|NCT03831191|464911988|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129168973|NCT03831191|464911989|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
129168974|NCT03831191|464911990|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
129168975|NCT03831191|464911991|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
129168976|NCT03831191|464911992|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
129168977|NCT03831191|464911993|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
129168978|NCT03831191|464911994|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
129168979|NCT03831191|464911995|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
129168980|NCT03831191|464911996|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
129168981|NCT03831191|464911997|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
129168982|NCT03831191|464911998|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
129168983|NCT03831191|464911984|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
129168984|NCT03831191|464911985|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
129168985|NCT03831191|464911986|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168986|NCT03831191|464911987|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168987|NCT03831191|464911988|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168988|NCT03831191|464911989|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168989|NCT03831191|464911990|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168990|NCT03831191|464911991|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168991|NCT03831191|464911992|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168992|NCT03831191|464911993|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168993|NCT03831191|464911994|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168994|NCT03831191|464911995|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168995|NCT03831191|464911996|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168996|NCT03831191|464911997|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168997|NCT03831191|464911998|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129168998|NCT03831191|464911984|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
129168999|NCT03831191|464911985|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
129169000|NCT03831191|464911986|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
129169001|NCT03831191|464911987|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
129169002|NCT03831191|464911988|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
129169003|NCT03831191|464911989|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
129169004|NCT03831191|464911990|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
129169005|NCT03831191|464911991|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
129169006|NCT03831191|464911992|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
129169007|NCT03831191|464911993|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
129169008|NCT03831191|464911994|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
129169009|NCT03831191|464911995|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
129169010|NCT03831191|464911996|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
129169011|NCT03831191|464911997|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
129169012|NCT03831191|464911998|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
129169013|NCT03831191|464911984|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
129169014|NCT03831191|464911985|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
129169015|NCT03831191|464911986|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
129169016|NCT03831191|464911987|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
129169017|NCT03831191|464911988|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
129169018|NCT03831191|464911989|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
129169019|NCT03831191|464911990|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
129169020|NCT03831191|464911991|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
129169021|NCT03831191|464911992|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
129169022|NCT03831191|464911993|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
129169023|NCT03831191|464911994|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
129169024|NCT03831191|464911995|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
129169025|NCT03831191|464911996|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
129169026|NCT03831191|464911997|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
129169027|NCT03831191|464911998|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
129169028|NCT03831191|464911984|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
129169029|NCT03831191|464911985|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
129169030|NCT03831191|464911986|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
129169031|NCT03831191|464911987|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
129169032|NCT03831191|464911988|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169033|NCT03831191|464911989|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169034|NCT03831191|464911990|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169035|NCT03831191|464911991|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169036|NCT03831191|464911992|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169037|NCT03831191|464911993|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169038|NCT03831191|464911994|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169039|NCT03831191|464911995|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169040|NCT03831191|464911996|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169041|NCT03831191|464911997|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129169042|NCT03831191|464911998|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128728601|NCT02704364|463303964|FG001|Overall Study|Noncompliance with study drug|1|||
128728602|NCT02704364|463303965|FG002|Overall Study|Noncompliance with study drug|0|||
128728603|NCT02704364|463303963|FG000|Overall Study|Other|0|||
128728604|NCT02704364|463303964|FG001|Overall Study|Other|1|||
128728605|NCT02704364|463303965|FG002|Overall Study|Other|1|||
128728606|NCT02975934|463303966|FG000|Treatment Phase|Never initiated study drug|0|||
128728607|NCT02975934|463303967|FG001|Treatment Phase|Never initiated study drug|5|||
128728608|NCT02975934|463303968|FG002|Treatment Phase|Never initiated study drug|0|||
128728609|NCT03362502|463303969|FG000|Overall Study|Death|0|||
128728610|NCT03362502|463303970|FG001|Overall Study|Death|0|||
128728611|NCT03362502|463303971|FG002|Overall Study|Death|1|||
128728612|NCT02075840|463303972|FG000|Overall Study|Withdrawal by Subject|13|||
128728613|NCT02075840|463303973|FG001|Overall Study|Withdrawal by Subject|22|||
128728614|NCT02075840|463303972|FG000|Overall Study|Reason not specified|1|||
128728615|NCT02075840|463303973|FG001|Overall Study|Reason not specified|0|||
128728616|NCT02075840|463303972|FG000|Overall Study|Adverse Event|0|||
128728617|NCT02075840|463303973|FG001|Overall Study|Adverse Event|2|||
128728618|NCT02075840|463303972|FG000|Overall Study|Death|35|||
128728619|NCT02075840|463303973|FG001|Overall Study|Death|40|||
128728620|NCT02075840|463303972|FG000|Overall Study|Lost to Follow-up|3|||
128728621|NCT02075840|463303973|FG001|Overall Study|Lost to Follow-up|2|||
128728622|NCT02075840|463303972|FG000|Overall Study|Physician Decision|1|||
128728623|NCT02075840|463303973|FG001|Overall Study|Physician Decision|3|||
128728624|NCT02075840|463303972|FG000|Overall Study|Ongoing at CCOD|99|||
128728625|NCT02075840|463303973|FG001|Overall Study|Ongoing at CCOD|82|||
128728626|NCT00846742|463303974|FG000|Overall Study|Withdrawal by Subject|1|||
128728627|NCT03909165|463303985|FG000|Overall Study|Physician Decision|0|||
128728628|NCT03909165|463303986|FG001|Overall Study|Physician Decision|1|||
128728629|NCT03909165|463303987|FG002|Overall Study|Physician Decision|0|||
128728630|NCT03909165|463303988|FG003|Overall Study|Physician Decision|0|||
128728631|NCT03909165|463303989|FG004|Overall Study|Physician Decision|0|||
128728632|NCT03909165|463303985|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128728633|NCT03909165|463303986|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129169043|NCT03831191|464911984|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
129169044|NCT03831191|464911985|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
129169045|NCT03831191|464911986|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
129169046|NCT03831191|464911987|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
129169047|NCT03831191|464911988|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169048|NCT03831191|464911989|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169049|NCT03831191|464911990|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169050|NCT03831191|464911991|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169051|NCT03831191|464911992|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169052|NCT03831191|464911993|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169053|NCT03831191|464911994|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169054|NCT03831191|464911995|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169055|NCT03831191|464911996|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169056|NCT03831191|464911997|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169057|NCT03831191|464911998|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129169058|NCT03831191|464911984|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169059|NCT03831191|464911985|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169060|NCT03831191|464911986|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169061|NCT03831191|464911987|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
129169062|NCT03831191|464911988|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169063|NCT03831191|464911989|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169064|NCT03831191|464911990|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169065|NCT03831191|464911991|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169066|NCT03831191|464911992|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169067|NCT03831191|464911993|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169068|NCT03831191|464911994|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169069|NCT03831191|464911995|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169070|NCT03831191|464911996|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169071|NCT03831191|464911997|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169072|NCT03831191|464911998|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
129169073|NCT03831191|464911984|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129169074|NCT03831191|464911985|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129169075|NCT03831191|464911986|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129169076|NCT03831191|464911987|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129169077|NCT03831191|464911988|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
129169078|NCT03831191|464911989|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
129169079|NCT03831191|464911990|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
129169080|NCT03831191|464911991|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
129169081|NCT03831191|464911992|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
129169082|NCT03831191|464911993|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
129169083|NCT03831191|464911994|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
129169084|NCT03831191|464911995|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
129169085|NCT03831191|464911996|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
129169086|NCT03831191|464911997|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
129169087|NCT03831191|464911998|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
129169088|NCT03831191|464911984|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169089|NCT03831191|464911985|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169090|NCT03831191|464911986|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169091|NCT03831191|464911987|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169092|NCT03831191|464911988|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169093|NCT03831191|464911989|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169094|NCT03831191|464911990|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169095|NCT03831191|464911991|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169096|NCT03831191|464911992|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169097|NCT03831191|464911993|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169098|NCT03831191|464911994|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169099|NCT03831191|464911995|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169100|NCT03831191|464911996|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169101|NCT03831191|464911997|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129169102|NCT03831191|464911998|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129169103|NCT03831191|464911984|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169104|NCT03831191|464911985|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169105|NCT03831191|464911986|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169106|NCT03831191|464911987|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169107|NCT03831191|464911988|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169108|NCT03831191|464911989|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169109|NCT03831191|464911990|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169110|NCT03831191|464911991|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
128728634|NCT03909165|463303987|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128728635|NCT03909165|463303988|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128728636|NCT03909165|463303989|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
128728637|NCT03909165|463303985|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
128728638|NCT03909165|463303986|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
128728639|NCT03909165|463303987|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
128728640|NCT03909165|463303988|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
128728641|NCT03909165|463303989|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
128728642|NCT03909165|463303985|FG000|Overall Study|Previous Drug Exposure|0|||
128728643|NCT03909165|463303986|FG001|Overall Study|Previous Drug Exposure|0|||
128728644|NCT03909165|463303987|FG002|Overall Study|Previous Drug Exposure|1|||
128728645|NCT03909165|463303988|FG003|Overall Study|Previous Drug Exposure|0|||
128728646|NCT03909165|463303989|FG004|Overall Study|Previous Drug Exposure|0|||
128728647|NCT03909165|463303985|FG000|Overall Study|Early Discharge|1|||
128728648|NCT03909165|463303986|FG001|Overall Study|Early Discharge|0|||
128728649|NCT03909165|463303987|FG002|Overall Study|Early Discharge|0|||
128728650|NCT03909165|463303988|FG003|Overall Study|Early Discharge|0|||
128728651|NCT03909165|463303989|FG004|Overall Study|Early Discharge|0|||
128728652|NCT02018458|463303991|FG000|Overall Study|Death|4|||
128728653|NCT04098458|463304016|FG000|Overall Study|Death|1|||
128728654|NCT04098458|463304016|FG000|Overall Study|did not meet study inclusion criteria|3|||
128728655|NCT04033159|463304017|FG000|Washout Period|Physician Decision|0|||
128728656|NCT04033159|463304018|FG001|Washout Period|Physician Decision|1|||
128728657|NCT04033159|463304019|FG002|Washout Period|Physician Decision|0|||
128728658|NCT04033159|463304017|FG000|Washout Period|Study terminated by Sponsor|0|||
128728659|NCT04033159|463304018|FG001|Washout Period|Study terminated by Sponsor|7|||
128728660|NCT04033159|463304019|FG002|Washout Period|Study terminated by Sponsor|0|||
128728661|NCT04033159|463304017|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
128728662|NCT04033159|463304018|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
128728663|NCT04033159|463304019|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
128728664|NCT02027844|463304022|FG000|Overall Study|Withdrawal by Subject|3|||
128728665|NCT02027844|463304023|FG001|Overall Study|Withdrawal by Subject|2|||
128728666|NCT02027844|463304024|FG002|Overall Study|Withdrawal by Subject|1|||
128728667|NCT02027844|463304022|FG000|Overall Study|Lost to Follow-up|0|||
128728668|NCT02027844|463304023|FG001|Overall Study|Lost to Follow-up|2|||
128728669|NCT02027844|463304024|FG002|Overall Study|Lost to Follow-up|1|||
128728670|NCT02027844|463304022|FG000|Overall Study|Protocol Violation|0|||
128728671|NCT02027844|463304023|FG001|Overall Study|Protocol Violation|2|||
128728672|NCT02027844|463304024|FG002|Overall Study|Protocol Violation|0|||
128728673|NCT02027844|463304022|FG000|Overall Study|Incomlete data|2|||
128728674|NCT02027844|463304023|FG001|Overall Study|Incomlete data|0|||
128728675|NCT02027844|463304024|FG002|Overall Study|Incomlete data|0|||
128728676|NCT00354172|463304027|FG000|Overall Study|Did not receive transplant|1|||
128728677|NCT04889625|463304035|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
128728678|NCT04889625|463304036|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
128728679|NCT04889625|463304035|FG000|Period 1|Subject out of window|0|||
128728680|NCT04889625|463304036|FG001|Period 1|Subject out of window|1|||
128728681|NCT04889625|463304035|FG000|Period 1|Wrong add power dispensed|0|||
128728682|NCT04889625|463304036|FG001|Period 1|Wrong add power dispensed|1|||
128728683|NCT04889625|463304035|FG000|Period 1|Discontinued due to fitting guide error|1|||
128728684|NCT04889625|463304036|FG001|Period 1|Discontinued due to fitting guide error|1|||
128728685|NCT04889625|463304035|FG000|Period 2|Test article no longer available|1|||
128728686|NCT04889625|463304036|FG001|Period 2|Test article no longer available|0|||
128728687|NCT04889625|463304035|FG000|Period 2|Incorrect lens dispensed|1|||
128728688|NCT04889625|463304036|FG001|Period 2|Incorrect lens dispensed|0|||
128728689|NCT04889625|463304035|FG000|Period 2|Wrong add power dispensed|0|||
128728690|NCT04889625|463304036|FG001|Period 2|Wrong add power dispensed|1|||
128728691|NCT03746522|463304046|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
128728692|NCT03746522|463304047|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
128728693|NCT03746522|463304048|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
128728694|NCT03746522|463304046|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
128728695|NCT03746522|463304047|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
128728696|NCT03746522|463304048|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
128728697|NCT03746522|463304046|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
128728698|NCT03746522|463304047|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
128728699|NCT03746522|463304048|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
128728700|NCT03746522|463304046|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
128728701|NCT03746522|463304047|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
128728702|NCT03746522|463304048|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
128728703|NCT03746522|463304046|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
128728704|NCT03746522|463304047|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
128778403|NCT04423393|463478718|FG010|Overall Study|Withdrawal by Subject|0|||
128778404|NCT04423393|463478719|FG011|Overall Study|Withdrawal by Subject|0|||
128778405|NCT04423393|463478720|FG012|Overall Study|Withdrawal by Subject|0|||
128778406|NCT04423393|463478721|FG013|Overall Study|Withdrawal by Subject|1|||
128778407|NCT04423393|463478722|FG014|Overall Study|Withdrawal by Subject|0|||
128778408|NCT04423393|463478723|FG015|Overall Study|Withdrawal by Subject|0|||
128778409|NCT04423393|463478724|FG016|Overall Study|Withdrawal by Subject|0|||
128778410|NCT04423393|463478725|FG017|Overall Study|Withdrawal by Subject|0|||
128778411|NCT04423393|463478708|FG000|Overall Study|Sponsor Decision|0|||
128778412|NCT04423393|463478709|FG001|Overall Study|Sponsor Decision|0|||
128778413|NCT04423393|463478710|FG002|Overall Study|Sponsor Decision|0|||
128778414|NCT04423393|463478711|FG003|Overall Study|Sponsor Decision|0|||
128778415|NCT04423393|463478712|FG004|Overall Study|Sponsor Decision|0|||
128778416|NCT04423393|463478713|FG005|Overall Study|Sponsor Decision|0|||
128778417|NCT04423393|463478714|FG006|Overall Study|Sponsor Decision|0|||
128778418|NCT04423393|463478715|FG007|Overall Study|Sponsor Decision|0|||
128778419|NCT04423393|463478716|FG008|Overall Study|Sponsor Decision|0|||
128778420|NCT04423393|463478717|FG009|Overall Study|Sponsor Decision|0|||
128778421|NCT04423393|463478718|FG010|Overall Study|Sponsor Decision|0|||
128778422|NCT04423393|463478719|FG011|Overall Study|Sponsor Decision|0|||
128778423|NCT04423393|463478720|FG012|Overall Study|Sponsor Decision|0|||
128778424|NCT04423393|463478721|FG013|Overall Study|Sponsor Decision|1|||
128778425|NCT04423393|463478722|FG014|Overall Study|Sponsor Decision|0|||
128778426|NCT04423393|463478723|FG015|Overall Study|Sponsor Decision|0|||
128778427|NCT04423393|463478724|FG016|Overall Study|Sponsor Decision|0|||
128778428|NCT04423393|463478725|FG017|Overall Study|Sponsor Decision|0|||
128778429|NCT02711995|463478726|FG000|Washout (90 Days)|Conflicting medication|1|||
128778430|NCT02819479|463478731|FG000|Overall Study|Adverse Event|2|||
128778431|NCT03531905|463478732|FG000|Overall Study|Withdrawal by Subject|3|||
128778432|NCT03531905|463478733|FG001|Overall Study|Withdrawal by Subject|3|||
128778433|NCT03531905|463478734|FG002|Overall Study|Withdrawal by Subject|2|||
128778434|NCT03531905|463478732|FG000|Overall Study|Lost to Follow-up|2|||
128778435|NCT03531905|463478733|FG001|Overall Study|Lost to Follow-up|2|||
128778436|NCT03531905|463478734|FG002|Overall Study|Lost to Follow-up|1|||
128778437|NCT03531905|463478732|FG000|Overall Study|Participant was out of town|1|||
128778438|NCT03531905|463478733|FG001|Overall Study|Participant was out of town|0|||
128778439|NCT03531905|463478734|FG002|Overall Study|Participant was out of town|0|||
128778440|NCT03531905|463478732|FG000|Overall Study|Could not speak with the participant|1|||
128778441|NCT03531905|463478733|FG001|Overall Study|Could not speak with the participant|0|||
128778442|NCT03531905|463478734|FG002|Overall Study|Could not speak with the participant|0|||
128778443|NCT01646320|463478742|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
128778444|NCT01646320|463478743|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
129169111|NCT03831191|464911992|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169112|NCT03831191|464911993|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169113|NCT03831191|464911994|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169114|NCT03831191|464911995|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169115|NCT03831191|464911996|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169116|NCT03831191|464911997|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129169117|NCT03831191|464911998|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
129169118|NCT02300558|464911999|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
128728705|NCT03746522|463304048|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
128728706|NCT00323414|463304051|FG000|Overall Study|Withdrawal by Subject|0|||
128728707|NCT00323414|463304052|FG001|Overall Study|Withdrawal by Subject|1|||
128728708|NCT02552316|463304054|FG000|Overall Study|Withdrawal by Subject|1|||
128728709|NCT02552316|463304054|FG000|Overall Study|Withdrawal due to non-compliance|1|||
128728710|NCT02659020|463304055|FG000|Overall Study|Adverse Event|0|||
128728711|NCT02659020|463304056|FG001|Overall Study|Adverse Event|0|||
128728712|NCT02659020|463304057|FG002|Overall Study|Adverse Event|0|||
128728713|NCT02659020|463304058|FG003|Overall Study|Adverse Event|2|||
128728714|NCT02659020|463304059|FG004|Overall Study|Adverse Event|0|||
128728715|NCT02659020|463304060|FG005|Overall Study|Adverse Event|0|||
128728716|NCT02659020|463304061|FG006|Overall Study|Adverse Event|2|||
128728717|NCT02659020|463304055|FG000|Overall Study|Lost to Follow-up|1|||
128728718|NCT02659020|463304056|FG001|Overall Study|Lost to Follow-up|2|||
128728719|NCT02659020|463304057|FG002|Overall Study|Lost to Follow-up|1|||
128728720|NCT02659020|463304058|FG003|Overall Study|Lost to Follow-up|6|||
128778445|NCT01646320|463478742|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
128778446|NCT01646320|463478743|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
128778447|NCT01646320|463478742|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
128778448|NCT01646320|463478743|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
128778449|NCT01646320|463478742|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
128778450|NCT01646320|463478743|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
128778451|NCT01646320|463478742|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
128728721|NCT02659020|463304059|FG004|Overall Study|Lost to Follow-up|1|||
128728722|NCT02659020|463304060|FG005|Overall Study|Lost to Follow-up|5|||
129169119|NCT02300558|464911999|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
129169120|NCT02300558|464911999|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
129169121|NCT02300558|464911999|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
129169122|NCT01054560|464912002|FG000|Overall Study|Death|10|||
129169123|NCT01054560|464912003|FG001|Overall Study|Death|21|||
129169124|NCT01054560|464912002|FG000|Overall Study|Lost to Follow-up|2|||
129169125|NCT01054560|464912003|FG001|Overall Study|Lost to Follow-up|5|||
129169126|NCT01054560|464912002|FG000|Overall Study|Withdrawal by Subject|0|||
129169127|NCT01054560|464912003|FG001|Overall Study|Withdrawal by Subject|2|||
129169128|NCT01054560|464912002|FG000|Overall Study|Physician Decision|1|||
129169129|NCT01054560|464912003|FG001|Overall Study|Physician Decision|0|||
129169130|NCT02135029|464912007|FG000|Overall Study|Adverse Event|2|||
129169131|NCT02135029|464912008|FG001|Overall Study|Adverse Event|2|||
129169132|NCT02135029|464912009|FG002|Overall Study|Adverse Event|2|||
129169133|NCT02135029|464912007|FG000|Overall Study|Lost to Follow-up|0|||
129169134|NCT02135029|464912008|FG001|Overall Study|Lost to Follow-up|1|||
129169135|NCT02135029|464912009|FG002|Overall Study|Lost to Follow-up|0|||
129169136|NCT02135029|464912007|FG000|Overall Study|Withdrawal by Subject|2|||
129169137|NCT02135029|464912008|FG001|Overall Study|Withdrawal by Subject|0|||
129169138|NCT02135029|464912009|FG002|Overall Study|Withdrawal by Subject|1|||
129169139|NCT02135029|464912007|FG000|Overall Study|Other|0|||
129169140|NCT02135029|464912008|FG001|Overall Study|Other|1|||
129169141|NCT02135029|464912009|FG002|Overall Study|Other|0|||
129169142|NCT02135029|464912007|FG000|Overall Study|Death|0|||
129169143|NCT02135029|464912008|FG001|Overall Study|Death|1|||
129169144|NCT02135029|464912009|FG002|Overall Study|Death|0|||
129169145|NCT00712725|464912010|FG000|Overall Study|Adverse Event|1|||
129169146|NCT00712725|464912011|FG001|Overall Study|Adverse Event|0|||
129169147|NCT00712725|464912012|FG002|Overall Study|Adverse Event|0|||
129169148|NCT00712725|464912013|FG003|Overall Study|Adverse Event|1|||
129169149|NCT00712725|464912014|FG004|Overall Study|Adverse Event|0|||
129169150|NCT00712725|464912015|FG005|Overall Study|Adverse Event|0|||
129169151|NCT00712725|464912016|FG006|Overall Study|Adverse Event|0|||
129169152|NCT00712725|464912017|FG007|Overall Study|Adverse Event|0|||
129169153|NCT00712725|464912010|FG000|Overall Study|Lost to Follow-up|3|||
129169154|NCT00712725|464912011|FG001|Overall Study|Lost to Follow-up|2|||
129169155|NCT00712725|464912012|FG002|Overall Study|Lost to Follow-up|1|||
129169156|NCT00712725|464912013|FG003|Overall Study|Lost to Follow-up|1|||
129169157|NCT00712725|464912014|FG004|Overall Study|Lost to Follow-up|2|||
129169158|NCT00712725|464912015|FG005|Overall Study|Lost to Follow-up|2|||
129169159|NCT00712725|464912016|FG006|Overall Study|Lost to Follow-up|3|||
129169160|NCT00712725|464912017|FG007|Overall Study|Lost to Follow-up|1|||
129169161|NCT00712725|464912010|FG000|Overall Study|Physician Decision|2|||
129169162|NCT00712725|464912011|FG001|Overall Study|Physician Decision|0|||
129169163|NCT00712725|464912012|FG002|Overall Study|Physician Decision|0|||
129169164|NCT00712725|464912013|FG003|Overall Study|Physician Decision|0|||
129169165|NCT00712725|464912014|FG004|Overall Study|Physician Decision|1|||
129169166|NCT00712725|464912015|FG005|Overall Study|Physician Decision|0|||
129169167|NCT00712725|464912016|FG006|Overall Study|Physician Decision|2|||
129169168|NCT00712725|464912017|FG007|Overall Study|Physician Decision|0|||
129169169|NCT00712725|464912010|FG000|Overall Study|Pregnancy|0|||
129169170|NCT00712725|464912011|FG001|Overall Study|Pregnancy|1|||
129169171|NCT00712725|464912012|FG002|Overall Study|Pregnancy|0|||
129169172|NCT00712725|464912013|FG003|Overall Study|Pregnancy|0|||
129169173|NCT00712725|464912014|FG004|Overall Study|Pregnancy|1|||
128778452|NCT01646320|463478743|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
128778453|NCT01646320|463478742|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
128778454|NCT01646320|463478743|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
128778455|NCT01646320|463478742|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
128778456|NCT01646320|463478743|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
128778457|NCT01646320|463478742|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
128778458|NCT01646320|463478743|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
128778459|NCT01646320|463478742|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
128778460|NCT01646320|463478743|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
128778461|NCT01646320|463478742|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
128778462|NCT01646320|463478743|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
128778463|NCT01646320|463478742|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
128778464|NCT01646320|463478743|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
128778465|NCT01489020|463478744|FG000|Overall Study|Withdrawal by Subject|1|||
128778466|NCT01489020|463478745|FG001|Overall Study|Withdrawal by Subject|0|||
128778467|NCT01489020|463478746|FG002|Overall Study|Withdrawal by Subject|0|||
128778468|NCT01489020|463478747|FG003|Overall Study|Withdrawal by Subject|0|||
128778469|NCT01489020|463478748|FG004|Overall Study|Withdrawal by Subject|0|||
128778470|NCT01489020|463478749|FG005|Overall Study|Withdrawal by Subject|0|||
128778471|NCT01489020|463478744|FG000|Overall Study|Adverse Event|0|||
128778472|NCT01489020|463478745|FG001|Overall Study|Adverse Event|0|||
128778473|NCT01489020|463478746|FG002|Overall Study|Adverse Event|3|||
128778474|NCT01489020|463478747|FG003|Overall Study|Adverse Event|0|||
128778475|NCT01489020|463478748|FG004|Overall Study|Adverse Event|3|||
128778476|NCT01489020|463478749|FG005|Overall Study|Adverse Event|0|||
128778477|NCT01489020|463478744|FG000|Overall Study|Concomitant disease|0|||
128778478|NCT01489020|463478745|FG001|Overall Study|Concomitant disease|0|||
128778479|NCT01489020|463478746|FG002|Overall Study|Concomitant disease|0|||
128778480|NCT01489020|463478747|FG003|Overall Study|Concomitant disease|0|||
128778481|NCT01489020|463478748|FG004|Overall Study|Concomitant disease|3|||
128778482|NCT01489020|463478749|FG005|Overall Study|Concomitant disease|0|||
128778483|NCT01174550|463478750|FG000|Overall Study|Death|75|||
128778484|NCT01174550|463478751|FG001|Overall Study|Death|74|||
128778485|NCT01174550|463478750|FG000|Overall Study|Lost to Follow-up|652|||
128778486|NCT01174550|463478751|FG001|Overall Study|Lost to Follow-up|510|||
128778487|NCT01174550|463478750|FG000|Overall Study|Withdrawal by Subject|543|||
128778488|NCT01174550|463478751|FG001|Overall Study|Withdrawal by Subject|289|||
128778489|NCT05257837|463478752|FG000|Overall Study|Excluded (did not find the guns)|4|||
128778490|NCT05257837|463478753|FG001|Overall Study|Excluded (did not find the guns)|2|||
128778491|NCT05257837|463478754|FG002|Overall Study|Excluded (did not find the guns)|4|||
128778492|NCT05257837|463478755|FG003|Overall Study|Excluded (did not find the guns)|0|||
128778493|NCT01625338|463478756|FG000|Overall Study|Enrolled but not Treated|0|||
128778494|NCT01625338|463478757|FG001|Overall Study|Enrolled but not Treated|0|||
128778495|NCT01625338|463478758|FG002|Overall Study|Enrolled but not Treated|1|||
128778496|NCT01625338|463478756|FG000|Overall Study|Efficacy Failure|27|||
128778497|NCT01625338|463478757|FG001|Overall Study|Efficacy Failure|39|||
128778498|NCT01625338|463478758|FG002|Overall Study|Efficacy Failure|31|||
128778499|NCT01625338|463478756|FG000|Overall Study|Lost to Follow-up|3|||
128778500|NCT01625338|463478757|FG001|Overall Study|Lost to Follow-up|3|||
129169174|NCT00712725|464912015|FG005|Overall Study|Pregnancy|0|||
129169175|NCT00712725|464912016|FG006|Overall Study|Pregnancy|2|||
129169176|NCT00712725|464912017|FG007|Overall Study|Pregnancy|0|||
129169177|NCT00712725|464912010|FG000|Overall Study|Protocol Violation|2|||
129169178|NCT00712725|464912011|FG001|Overall Study|Protocol Violation|0|||
129169179|NCT00712725|464912012|FG002|Overall Study|Protocol Violation|1|||
129169180|NCT00712725|464912013|FG003|Overall Study|Protocol Violation|3|||
129169181|NCT00712725|464912014|FG004|Overall Study|Protocol Violation|2|||
129169182|NCT00712725|464912015|FG005|Overall Study|Protocol Violation|0|||
129169183|NCT00712725|464912016|FG006|Overall Study|Protocol Violation|1|||
128778501|NCT01625338|463478758|FG002|Overall Study|Lost to Follow-up|2|||
128778502|NCT01625338|463478756|FG000|Overall Study|Investigator Decision|0|||
128778503|NCT01625338|463478757|FG001|Overall Study|Investigator Decision|2|||
128778504|NCT01625338|463478758|FG002|Overall Study|Investigator Decision|1|||
128778505|NCT01625338|463478756|FG000|Overall Study|Subject Withdrew Consent|1|||
128778506|NCT01625338|463478757|FG001|Overall Study|Subject Withdrew Consent|0|||
128778507|NCT01625338|463478758|FG002|Overall Study|Subject Withdrew Consent|2|||
128778508|NCT01625338|463478756|FG000|Overall Study|Adverse Event|1|||
128778509|NCT01625338|463478757|FG001|Overall Study|Adverse Event|0|||
128778510|NCT01625338|463478758|FG002|Overall Study|Adverse Event|1|||
128778511|NCT01625338|463478756|FG000|Overall Study|Study Discontinued by Sponsor|0|||
129169184|NCT00712725|464912017|FG007|Overall Study|Protocol Violation|1|||
128778512|NCT01625338|463478757|FG001|Overall Study|Study Discontinued by Sponsor|0|||
129169185|NCT00712725|464912010|FG000|Overall Study|Withdrawal by Subject|2|||
128778513|NCT01625338|463478758|FG002|Overall Study|Study Discontinued by Sponsor|1|||
128778514|NCT01021332|463478759|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
128778515|NCT01021332|463478759|FG000|Overall Study|Adverse Event|43|||
128778516|NCT01021332|463478759|FG000|Overall Study|Lack of Efficacy|19|||
128778517|NCT01021332|463478759|FG000|Overall Study|Withdrawal of Consent|23|||
128778518|NCT01021332|463478759|FG000|Overall Study|Lost to Follow-up|4|||
128778519|NCT01021332|463478759|FG000|Overall Study|Protocol Violation|9|||
128778520|NCT01021332|463478759|FG000|Overall Study|Miscellaneous|3|||
128778521|NCT05343455|463478764|FG000|Overall Study|Withdrawal by Subject|4|||
128778522|NCT05343455|463478765|FG001|Overall Study|Withdrawal by Subject|9|||
128778523|NCT05343455|463478766|FG002|Overall Study|Withdrawal by Subject|7|||
128778524|NCT05343455|463478764|FG000|Overall Study|Adverse Event|2|||
128778525|NCT05343455|463478765|FG001|Overall Study|Adverse Event|1|||
128778526|NCT05343455|463478766|FG002|Overall Study|Adverse Event|2|||
128778527|NCT05343455|463478764|FG000|Overall Study|Lost to Follow-up|1|||
128778528|NCT05343455|463478765|FG001|Overall Study|Lost to Follow-up|1|||
128778529|NCT05343455|463478766|FG002|Overall Study|Lost to Follow-up|3|||
128778530|NCT05343455|463478764|FG000|Overall Study|Pregnancy|1|||
128778531|NCT05343455|463478765|FG001|Overall Study|Pregnancy|0|||
128778532|NCT05343455|463478766|FG002|Overall Study|Pregnancy|0|||
128778533|NCT05343455|463478764|FG000|Overall Study|Physician Decision|0|||
128778534|NCT05343455|463478765|FG001|Overall Study|Physician Decision|0|||
129169186|NCT00712725|464912011|FG001|Overall Study|Withdrawal by Subject|1|||
129169187|NCT00712725|464912012|FG002|Overall Study|Withdrawal by Subject|1|||
129169188|NCT00712725|464912013|FG003|Overall Study|Withdrawal by Subject|2|||
129169189|NCT00712725|464912014|FG004|Overall Study|Withdrawal by Subject|1|||
129169190|NCT00712725|464912015|FG005|Overall Study|Withdrawal by Subject|1|||
129169191|NCT00712725|464912016|FG006|Overall Study|Withdrawal by Subject|1|||
129169192|NCT00712725|464912017|FG007|Overall Study|Withdrawal by Subject|2|||
129169193|NCT00712725|464912010|FG000|Overall Study|Lack of Qualifying Event|16|||
129169194|NCT00712725|464912011|FG001|Overall Study|Lack of Qualifying Event|2|||
129169195|NCT00712725|464912012|FG002|Overall Study|Lack of Qualifying Event|6|||
129169196|NCT00712725|464912013|FG003|Overall Study|Lack of Qualifying Event|8|||
129169197|NCT00712725|464912014|FG004|Overall Study|Lack of Qualifying Event|11|||
129169198|NCT00712725|464912015|FG005|Overall Study|Lack of Qualifying Event|13|||
129169199|NCT00712725|464912016|FG006|Overall Study|Lack of Qualifying Event|11|||
129169200|NCT00712725|464912017|FG007|Overall Study|Lack of Qualifying Event|6|||
129169201|NCT00712725|464912010|FG000|Overall Study|Protocol Specified Criteria|3|||
129169202|NCT00712725|464912011|FG001|Overall Study|Protocol Specified Criteria|0|||
129169203|NCT00712725|464912012|FG002|Overall Study|Protocol Specified Criteria|1|||
129169204|NCT00712725|464912013|FG003|Overall Study|Protocol Specified Criteria|2|||
129169205|NCT00712725|464912014|FG004|Overall Study|Protocol Specified Criteria|1|||
129169206|NCT00712725|464912015|FG005|Overall Study|Protocol Specified Criteria|0|||
129169207|NCT00712725|464912016|FG006|Overall Study|Protocol Specified Criteria|2|||
129169208|NCT00712725|464912017|FG007|Overall Study|Protocol Specified Criteria|1|||
129169209|NCT03466099|464912018|FG000|Overall Study|Adverse Event|1|||
129169210|NCT03466099|464912019|FG001|Overall Study|Adverse Event|1|||
129169211|NCT03466099|464912020|FG002|Overall Study|Adverse Event|1|||
129169212|NCT03466099|464912018|FG000|Overall Study|Withdrawal by Subject|2|||
129169213|NCT03466099|464912019|FG001|Overall Study|Withdrawal by Subject|3|||
129169214|NCT03466099|464912020|FG002|Overall Study|Withdrawal by Subject|1|||
129169215|NCT03466099|464912018|FG000|Overall Study|Use of rescue medication|8|||
129169216|NCT03466099|464912019|FG001|Overall Study|Use of rescue medication|9|||
129169217|NCT03466099|464912020|FG002|Overall Study|Use of rescue medication|13|||
129169218|NCT03466099|464912018|FG000|Overall Study|Rescued without meeting criteria|4|||
129169219|NCT03466099|464912019|FG001|Overall Study|Rescued without meeting criteria|1|||
129169220|NCT03466099|464912020|FG002|Overall Study|Rescued without meeting criteria|1|||
129169221|NCT03466099|464912018|FG000|Overall Study|Subject compliance|2|||
129169222|NCT03466099|464912019|FG001|Overall Study|Subject compliance|0|||
129169223|NCT03466099|464912020|FG002|Overall Study|Subject compliance|0|||
129169224|NCT03466099|464912018|FG000|Overall Study|Worsening disease|0|||
129169225|NCT03466099|464912019|FG001|Overall Study|Worsening disease|0|||
129169226|NCT03466099|464912020|FG002|Overall Study|Worsening disease|1|||
129169227|NCT00613327|464912023|FG000|Overall Study|Adverse Event|38|||
129169228|NCT00613327|464912023|FG000|Overall Study|Lost to Follow-up|8|||
129169229|NCT00613327|464912023|FG000|Overall Study|Withdrawal by Subject|6|||
128778535|NCT05343455|463478766|FG002|Overall Study|Physician Decision|1|||
128778536|NCT05343455|463478764|FG000|Overall Study|Protocol Violation|0|||
128778537|NCT05343455|463478765|FG001|Overall Study|Protocol Violation|1|||
128778538|NCT05343455|463478766|FG002|Overall Study|Protocol Violation|1|||
128778539|NCT02748512|463478767|FG000|Overall Study|Lost to Follow-up|1|||
128778540|NCT02748512|463478768|FG001|Overall Study|Lost to Follow-up|1|||
128778541|NCT03930186|463478770|FG000|Weeks 0 to 16|Adverse Event|6|||
128778542|NCT03930186|463478770|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
129169230|NCT00613327|464912023|FG000|Overall Study|Protocol Violation|2|||
129169231|NCT00613327|464912023|FG000|Overall Study|Other|47|||
129169232|NCT03832322|464912026|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
129169233|NCT03832322|464912027|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
129169234|NCT03718884|464912028|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
129169235|NCT03718884|464912029|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
129169236|NCT03718884|464912028|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
129169237|NCT03718884|464912029|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
129169238|NCT01453205|464912030|FG000|Overall Study|Lost to Follow-up|3|||
129169239|NCT01453205|464912031|FG001|Overall Study|Lost to Follow-up|0|||
129169240|NCT01453205|464912032|FG002|Overall Study|Lost to Follow-up|1|||
129169241|NCT01453205|464912030|FG000|Overall Study|Withdrawal by Subject|8|||
129169242|NCT01453205|464912031|FG001|Overall Study|Withdrawal by Subject|3|||
129169243|NCT01453205|464912032|FG002|Overall Study|Withdrawal by Subject|0|||
129169244|NCT01453205|464912030|FG000|Overall Study|Death|24|||
129169245|NCT01453205|464912031|FG001|Overall Study|Death|22|||
129169246|NCT01453205|464912032|FG002|Overall Study|Death|18|||
129169247|NCT01453205|464912030|FG000|Overall Study|Other|45|||
129169248|NCT01453205|464912031|FG001|Overall Study|Other|27|||
129169249|NCT01453205|464912032|FG002|Overall Study|Other|35|||
129169250|NCT02602275|464912036|FG000|Day 1|Physician Decision|0|||
129169251|NCT02602275|464912037|FG001|Day 1|Physician Decision|1|||
129169252|NCT03802630|464912038|FG000|Overall Study|Study terminated by sponsor|130|||
129169253|NCT03802630|464912039|FG001|Overall Study|Study terminated by sponsor|134|||
129169254|NCT03802630|464912038|FG000|Overall Study|Subject decision|16|||
129169255|NCT03802630|464912039|FG001|Overall Study|Subject decision|9|||
129169256|NCT03802630|464912038|FG000|Overall Study|Adverse Event|3|||
129169257|NCT03802630|464912039|FG001|Overall Study|Adverse Event|1|||
129169258|NCT03802630|464912038|FG000|Overall Study|Lost to Follow-up|2|||
129169259|NCT03802630|464912039|FG001|Overall Study|Lost to Follow-up|2|||
129169260|NCT03802630|464912038|FG000|Overall Study|Physician Decision|2|||
129169261|NCT03802630|464912039|FG001|Overall Study|Physician Decision|0|||
129169262|NCT03802630|464912038|FG000|Overall Study|Death|0|||
129169263|NCT03802630|464912039|FG001|Overall Study|Death|2|||
129169264|NCT00157196|464912040|FG000|Overall Study|Ongoing at data cut-off|9|||
129169265|NCT04210245|464912041|FG000|Overall Study|Adverse Event|0|||
129169266|NCT04210245|464912042|FG001|Overall Study|Adverse Event|3|||
129169267|NCT04210245|464912043|FG002|Overall Study|Adverse Event|6|||
129169268|NCT04210245|464912044|FG003|Overall Study|Adverse Event|0|||
129169269|NCT04210245|464912041|FG000|Overall Study|Withdrawal by Subject|0|||
129169270|NCT04210245|464912042|FG001|Overall Study|Withdrawal by Subject|1|||
129169271|NCT04210245|464912043|FG002|Overall Study|Withdrawal by Subject|4|||
129169272|NCT04210245|464912044|FG003|Overall Study|Withdrawal by Subject|4|||
129169273|NCT04210245|464912041|FG000|Overall Study|Lost to Follow-up|0|||
129169274|NCT04210245|464912042|FG001|Overall Study|Lost to Follow-up|1|||
129169275|NCT04210245|464912043|FG002|Overall Study|Lost to Follow-up|1|||
129169276|NCT04210245|464912044|FG003|Overall Study|Lost to Follow-up|1|||
129169277|NCT04210245|464912041|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
129169278|NCT04210245|464912042|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
129169279|NCT04210245|464912043|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
129169280|NCT04210245|464912044|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
129169281|NCT01892722|464912045|FG000|Overall Study|Protocol deviation|0|||
129169282|NCT01892722|464912046|FG001|Overall Study|Protocol deviation|1|||
129169283|NCT01892722|464912045|FG000|Overall Study|Administrative problems|0|||
129169284|NCT01892722|464912046|FG001|Overall Study|Administrative problems|1|||
129169285|NCT01892722|464912045|FG000|Overall Study|Patient/guardian decision|0|||
129169286|NCT01892722|464912046|FG001|Overall Study|Patient/guardian decision|2|||
129169287|NCT01892722|464912045|FG000|Overall Study|Physician Decision|1|||
129169288|NCT01892722|464912046|FG001|Overall Study|Physician Decision|2|||
129169289|NCT01892722|464912045|FG000|Overall Study|Adverse Event|3|||
129169290|NCT01892722|464912046|FG001|Overall Study|Adverse Event|2|||
129169291|NCT01892722|464912045|FG000|Overall Study|Lack of Efficacy|0|||
129169292|NCT01892722|464912046|FG001|Overall Study|Lack of Efficacy|7|||
129169293|NCT01892722|464912045|FG000|Overall Study|Withdrawal by Subject|3|||
129169294|NCT01892722|464912046|FG001|Overall Study|Withdrawal by Subject|5|||
129169295|NCT01252186|464912047|FG000|Overall Study|Adverse Event|9|||
129169296|NCT01252186|464912048|FG001|Overall Study|Adverse Event|6|||
129169297|NCT01252186|464912049|FG002|Overall Study|Adverse Event|8|||
129169298|NCT01252186|464912047|FG000|Overall Study|Withdrawal by Subject|2|||
129169299|NCT01252186|464912048|FG001|Overall Study|Withdrawal by Subject|5|||
129169300|NCT01252186|464912049|FG002|Overall Study|Withdrawal by Subject|2|||
129169301|NCT01252186|464912047|FG000|Overall Study|Physician Decision|0|||
129169302|NCT01252186|464912048|FG001|Overall Study|Physician Decision|0|||
129169303|NCT01252186|464912049|FG002|Overall Study|Physician Decision|1|||
129169304|NCT01252186|464912047|FG000|Overall Study|Non-compliance|0|||
129169305|NCT01252186|464912048|FG001|Overall Study|Non-compliance|3|||
129169306|NCT01252186|464912049|FG002|Overall Study|Non-compliance|4|||
129169307|NCT01252186|464912047|FG000|Overall Study|Protocol Violation|0|||
129169308|NCT01252186|464912048|FG001|Overall Study|Protocol Violation|0|||
129169309|NCT01252186|464912049|FG002|Overall Study|Protocol Violation|1|||
128778543|NCT03930186|463478770|FG000|Weeks 16 to 32|Adverse Event|1|||
128778544|NCT03930186|463478770|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
128778545|NCT03712098|463478782|FG000|Overall Study|Lost to Follow-up|3|||
128778546|NCT03712098|463478783|FG001|Overall Study|Lost to Follow-up|7|||
128778547|NCT03712098|463478782|FG000|Overall Study|Withdrawal by Subject|9|||
128778548|NCT03712098|463478783|FG001|Overall Study|Withdrawal by Subject|4|||
128778549|NCT03712098|463478782|FG000|Overall Study|Protocol Violation|2|||
128778550|NCT03712098|463478783|FG001|Overall Study|Protocol Violation|1|||
128778551|NCT00953160|463478786|FG000|Overall Study|Lost to Follow-up|23|||
128778552|NCT00953160|463478786|FG000|Overall Study|Withdrawal by Subject|4|||
128778553|NCT02724020|463478789|FG000|Overall Study|Death|16|||
128778554|NCT02724020|463478790|FG001|Overall Study|Death|18|||
128778555|NCT02724020|463478791|FG002|Overall Study|Death|19|||
128778556|NCT02724020|463478789|FG000|Overall Study|Lost to Follow-up|0|||
128778557|NCT02724020|463478790|FG001|Overall Study|Lost to Follow-up|3|||
128778558|NCT02724020|463478791|FG002|Overall Study|Lost to Follow-up|0|||
128778559|NCT02724020|463478789|FG000|Overall Study|Site Terminated by Sponsor|15|||
128778560|NCT02724020|463478790|FG001|Overall Study|Site Terminated by Sponsor|8|||
128778561|NCT02724020|463478791|FG002|Overall Study|Site Terminated by Sponsor|8|||
128778562|NCT02724020|463478789|FG000|Overall Study|Withdrawal by Subject|1|||
128778563|NCT02724020|463478790|FG001|Overall Study|Withdrawal by Subject|3|||
128778564|NCT02724020|463478791|FG002|Overall Study|Withdrawal by Subject|5|||
128778565|NCT00425503|463478792|FG000|Overall Study|Adverse Event|2|||
128778566|NCT00425503|463478792|FG000|Overall Study|Protocol Violation|1|||
128778567|NCT00479674|463478795|FG000|Overall Study|Adverse Event|18|||
128778568|NCT00479674|463478795|FG000|Overall Study|Withdrawal by Subject|6|||
128778569|NCT00479674|463478795|FG000|Overall Study|Physician Decision|14|||
128778570|NCT00479674|463478795|FG000|Overall Study|none provided|3|||
128778571|NCT02059161|463478798|FG000|Overall Study|Pregnancy|0|||
128778572|NCT02059161|463478799|FG001|Overall Study|Pregnancy|2|||
128778573|NCT02059161|463478798|FG000|Overall Study|Adverse Event|2|||
128778574|NCT02059161|463478799|FG001|Overall Study|Adverse Event|6|||
128778575|NCT02059161|463478798|FG000|Overall Study|Lost to Follow-up|20|||
128778576|NCT02059161|463478799|FG001|Overall Study|Lost to Follow-up|12|||
128778577|NCT02059161|463478798|FG000|Overall Study|Physician Decision|4|||
128778578|NCT02059161|463478799|FG001|Overall Study|Physician Decision|4|||
128778579|NCT02059161|463478798|FG000|Overall Study|Protocol Violation|1|||
128778580|NCT02059161|463478799|FG001|Overall Study|Protocol Violation|1|||
129169310|NCT01252186|464912047|FG000|Overall Study|Pregnancy|2|||
129169311|NCT01252186|464912048|FG001|Overall Study|Pregnancy|2|||
129169312|NCT01252186|464912049|FG002|Overall Study|Pregnancy|0|||
129169313|NCT01252186|464912047|FG000|Overall Study|Sponsor Request|2|||
129169314|NCT01252186|464912048|FG001|Overall Study|Sponsor Request|1|||
129169315|NCT01252186|464912049|FG002|Overall Study|Sponsor Request|0|||
129169316|NCT01252186|464912047|FG000|Overall Study|Lost to Follow-up|10|||
129169317|NCT01252186|464912048|FG001|Overall Study|Lost to Follow-up|10|||
129169318|NCT01252186|464912049|FG002|Overall Study|Lost to Follow-up|11|||
129169319|NCT01252186|464912047|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
129169320|NCT01252186|464912048|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
129169321|NCT01252186|464912049|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
129169322|NCT02524275|464912050|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
129169323|NCT03763656|464912057|FG000|Overall Study|Physician Decision|1|||
129169324|NCT03763656|464912057|FG000|Overall Study|Protocol Violation|1|||
129169325|NCT03763656|464912057|FG000|Overall Study|Withdrawal by Subject|7|||
129169326|NCT00487942|464912058|FG000|Overall Study|Adverse Event|1|||
129169327|NCT00487942|464912059|FG001|Overall Study|Adverse Event|1|||
129169328|NCT00487942|464912060|FG002|Overall Study|Adverse Event|1|||
129169329|NCT00487942|464912061|FG003|Overall Study|Adverse Event|1|||
129169330|NCT00487942|464912058|FG000|Overall Study|Lost to Follow-up|1|||
129169331|NCT00487942|464912059|FG001|Overall Study|Lost to Follow-up|0|||
129169332|NCT00487942|464912060|FG002|Overall Study|Lost to Follow-up|0|||
129169333|NCT00487942|464912061|FG003|Overall Study|Lost to Follow-up|1|||
129169334|NCT00487942|464912058|FG000|Overall Study|Protocol Violation|1|||
129169335|NCT00487942|464912059|FG001|Overall Study|Protocol Violation|1|||
129169336|NCT00487942|464912060|FG002|Overall Study|Protocol Violation|0|||
129169337|NCT00487942|464912061|FG003|Overall Study|Protocol Violation|0|||
129169338|NCT00487942|464912058|FG000|Overall Study|Withdrawal by Subject|0|||
129169339|NCT00487942|464912059|FG001|Overall Study|Withdrawal by Subject|1|||
129169340|NCT00487942|464912060|FG002|Overall Study|Withdrawal by Subject|2|||
128778581|NCT02059161|463478798|FG000|Overall Study|Withdrawal by Subject|16|||
128778582|NCT02059161|463478799|FG001|Overall Study|Withdrawal by Subject|13|||
128778583|NCT02059161|463478798|FG000|Overall Study|Randomized in error, no study drug|0|||
128778584|NCT02059161|463478799|FG001|Overall Study|Randomized in error, no study drug|1|||
129169341|NCT00487942|464912061|FG003|Overall Study|Withdrawal by Subject|0|||
129169342|NCT00082368|464912064|FG000|Overall Study|Not treated-pt had poor IV access|1|||
128778585|NCT02059161|463478798|FG000|Overall Study|Non-compliance with study drug|6|||
128778586|NCT02059161|463478799|FG001|Overall Study|Non-compliance with study drug|2|||
129169343|NCT03319953|464912067|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
129169344|NCT03319953|464912068|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
129169345|NCT03319953|464912069|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
129169346|NCT03319953|464912070|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
129169347|NCT03319953|464912067|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
129169348|NCT03319953|464912068|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
129169349|NCT03319953|464912069|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
129169350|NCT03319953|464912070|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
129169351|NCT01795495|464912071|FG000|Overall Study|Protocol Violation|1|||
129169352|NCT01795495|464912072|FG001|Overall Study|Protocol Violation|0|||
129169353|NCT01795495|464912073|FG002|Overall Study|Protocol Violation|1|||
129169354|NCT01795495|464912071|FG000|Overall Study|Physician Decision|0|||
129169355|NCT01795495|464912072|FG001|Overall Study|Physician Decision|0|||
129169356|NCT01795495|464912073|FG002|Overall Study|Physician Decision|1|||
129169357|NCT01380535|464913545|FG000|Overall Study|Adverse Event|3|||
129169358|NCT01380535|464913546|FG001|Overall Study|Adverse Event|3|||
129169359|NCT01380535|464913545|FG000|Overall Study|Death|3|||
129169360|NCT01380535|464913546|FG001|Overall Study|Death|0|||
129169361|NCT01380535|464913545|FG000|Overall Study|Study site closed|0|||
129169362|NCT01380535|464913546|FG001|Overall Study|Study site closed|5|||
129169363|NCT01380535|464913545|FG000|Overall Study|Withdrawal by Subject|1|||
129169364|NCT01380535|464913546|FG001|Overall Study|Withdrawal by Subject|2|||
129169365|NCT01380535|464913545|FG000|Overall Study|Protocol Violation|0|||
129169366|NCT01380535|464913546|FG001|Overall Study|Protocol Violation|2|||
129169367|NCT01380535|464913545|FG000|Overall Study|Lack of Efficacy|0|||
128778587|NCT01723826|463478804|FG000|Overall Study|Adverse Event|4|||
129169368|NCT01380535|464913546|FG001|Overall Study|Lack of Efficacy|3|||
129169369|NCT00420004|464913556|FG000|Overall Study|Adverse Event|4|||
129169370|NCT00420004|464913557|FG001|Overall Study|Adverse Event|1|||
129169371|NCT00420004|464913558|FG002|Overall Study|Adverse Event|1|||
129169372|NCT00420004|464913556|FG000|Overall Study|Lack of Efficacy|5|||
129169373|NCT00420004|464913557|FG001|Overall Study|Lack of Efficacy|4|||
129169374|NCT00420004|464913558|FG002|Overall Study|Lack of Efficacy|1|||
129169375|NCT00420004|464913556|FG000|Overall Study|Lost to Follow-up|31|||
129169376|NCT00420004|464913557|FG001|Overall Study|Lost to Follow-up|12|||
129169377|NCT00420004|464913558|FG002|Overall Study|Lost to Follow-up|10|||
129169378|NCT00420004|464913556|FG000|Overall Study|Entry Criteria Not Met|0|||
129169379|NCT00420004|464913557|FG001|Overall Study|Entry Criteria Not Met|1|||
129169380|NCT00420004|464913558|FG002|Overall Study|Entry Criteria Not Met|0|||
129169381|NCT00420004|464913556|FG000|Overall Study|Physician Decision|14|||
129169382|NCT00420004|464913557|FG001|Overall Study|Physician Decision|4|||
129169383|NCT00420004|464913558|FG002|Overall Study|Physician Decision|2|||
129169384|NCT00420004|464913556|FG000|Overall Study|Protocol Violation|5|||
129169385|NCT00420004|464913557|FG001|Overall Study|Protocol Violation|4|||
129169386|NCT00420004|464913558|FG002|Overall Study|Protocol Violation|3|||
129169387|NCT00420004|464913556|FG000|Overall Study|Withdrawal by Subject|67|||
129169388|NCT00420004|464913557|FG001|Overall Study|Withdrawal by Subject|42|||
129169389|NCT00420004|464913558|FG002|Overall Study|Withdrawal by Subject|14|||
129169390|NCT00420004|464913556|FG000|Overall Study|Sponsor Decision|3|||
129169391|NCT00420004|464913557|FG001|Overall Study|Sponsor Decision|3|||
129169392|NCT00420004|464913558|FG002|Overall Study|Sponsor Decision|1|||
129169393|NCT00591149|464913559|FG000|Overall Study|Adverse Event|4|||
129169394|NCT00591149|464913559|FG000|Overall Study|Withdrawal by Subject|1|||
129169395|NCT00470093|464913560|FG000|Overall Study|Adverse Event|2|||
129169396|NCT00664560|464913561|FG000|Overall Study|Adverse Event|19|||
129169397|NCT00664560|464913562|FG001|Overall Study|Adverse Event|16|||
129169398|NCT00664560|464913563|FG002|Overall Study|Adverse Event|7|||
129169399|NCT00664560|464913561|FG000|Overall Study|Withdrawal by Subject|9|||
129169400|NCT00664560|464913562|FG001|Overall Study|Withdrawal by Subject|13|||
129169401|NCT00664560|464913563|FG002|Overall Study|Withdrawal by Subject|7|||
129169402|NCT00664560|464913561|FG000|Overall Study|Lost to Follow-up|0|||
129169403|NCT00664560|464913562|FG001|Overall Study|Lost to Follow-up|2|||
129169404|NCT00664560|464913563|FG002|Overall Study|Lost to Follow-up|0|||
129169405|NCT00664560|464913561|FG000|Overall Study|Other|11|||
129169406|NCT00664560|464913562|FG001|Overall Study|Other|4|||
129169407|NCT00664560|464913563|FG002|Overall Study|Other|5|||
129169408|NCT02456636|464913564|FG000|Overall Study|Death|0|||
129169409|NCT02456636|464913565|FG001|Overall Study|Death|3|||
129169410|NCT02456636|464913566|FG002|Overall Study|Death|0|||
129169411|NCT02456636|464913564|FG000|Overall Study|Pregnancy|1|||
129169412|NCT02456636|464913565|FG001|Overall Study|Pregnancy|3|||
129169413|NCT02456636|464913566|FG002|Overall Study|Pregnancy|5|||
129169414|NCT02456636|464913564|FG000|Overall Study|Physician Decision|4|||
129169415|NCT02456636|464913565|FG001|Overall Study|Physician Decision|5|||
129169416|NCT02456636|464913566|FG002|Overall Study|Physician Decision|4|||
129169417|NCT02456636|464913564|FG000|Overall Study|Withdrawal by Subject|13|||
129169418|NCT02456636|464913565|FG001|Overall Study|Withdrawal by Subject|14|||
129169419|NCT02456636|464913566|FG002|Overall Study|Withdrawal by Subject|16|||
129169420|NCT02456636|464913564|FG000|Overall Study|Lost to Follow-up|50|||
129169421|NCT02456636|464913565|FG001|Overall Study|Lost to Follow-up|44|||
129169422|NCT02456636|464913566|FG002|Overall Study|Lost to Follow-up|50|||
129169423|NCT03350035|464913567|FG000|Overall Study|Lack of Efficacy|2|||
129169424|NCT03350035|464913568|FG001|Overall Study|Lack of Efficacy|0|||
129169425|NCT03350035|464913569|FG002|Overall Study|Lack of Efficacy|0|||
129169426|NCT03350035|464913567|FG000|Overall Study|Subject discharged to hospice|0|||
128728723|NCT02659020|463304061|FG006|Overall Study|Lost to Follow-up|0|||
128728724|NCT02659020|463304055|FG000|Overall Study|Physician Decision|0|||
128728725|NCT02659020|463304056|FG001|Overall Study|Physician Decision|0|||
128728726|NCT02659020|463304057|FG002|Overall Study|Physician Decision|0|||
128728727|NCT02659020|463304058|FG003|Overall Study|Physician Decision|1|||
128728728|NCT02659020|463304059|FG004|Overall Study|Physician Decision|1|||
128728729|NCT02659020|463304060|FG005|Overall Study|Physician Decision|0|||
128728730|NCT02659020|463304061|FG006|Overall Study|Physician Decision|1|||
128728731|NCT02659020|463304055|FG000|Overall Study|Withdrawal by Subject|2|||
128728732|NCT02659020|463304056|FG001|Overall Study|Withdrawal by Subject|1|||
128728733|NCT02659020|463304057|FG002|Overall Study|Withdrawal by Subject|0|||
128728734|NCT02659020|463304058|FG003|Overall Study|Withdrawal by Subject|3|||
128728735|NCT02659020|463304059|FG004|Overall Study|Withdrawal by Subject|3|||
128728736|NCT02659020|463304060|FG005|Overall Study|Withdrawal by Subject|6|||
128728737|NCT02659020|463304061|FG006|Overall Study|Withdrawal by Subject|3|||
129169427|NCT03350035|464913568|FG001|Overall Study|Subject discharged to hospice|0|||
129169428|NCT03350035|464913569|FG002|Overall Study|Subject discharged to hospice|1|||
129169429|NCT01610557|464913570|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129169430|NCT01610557|464913571|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
129169431|NCT01610557|464913572|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129169432|NCT01610557|464913573|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129169433|NCT01610557|464913574|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129169434|NCT01610557|464913570|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129169435|NCT01610557|464913571|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129169436|NCT01610557|464913572|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129169437|NCT01610557|464913573|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129169438|NCT01610557|464913574|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
129169439|NCT02039219|464913575|FG000|Treatment|Withdrawal by Subject|1|||
129169440|NCT02039219|464913576|FG001|Treatment|Withdrawal by Subject|0|||
129169441|NCT02039219|464913575|FG000|Treatment|Adverse Event|0|||
129169442|NCT02039219|464913576|FG001|Treatment|Adverse Event|1|||
129169443|NCT02039219|464913575|FG000|Treatment|Physician Decision|1|||
129169444|NCT02039219|464913576|FG001|Treatment|Physician Decision|0|||
129169445|NCT02039219|464913575|FG000|Treatment|Lost to Follow-up|0|||
129169446|NCT02039219|464913576|FG001|Treatment|Lost to Follow-up|1|||
129169447|NCT02039219|464913575|FG000|Treatment|Protocol Violation|1|||
129169448|NCT02039219|464913576|FG001|Treatment|Protocol Violation|0|||
128728738|NCT02659020|463304055|FG000|Overall Study|Progressive Disease|0|||
128728739|NCT02659020|463304056|FG001|Overall Study|Progressive Disease|0|||
128728740|NCT02659020|463304057|FG002|Overall Study|Progressive Disease|0|||
128728741|NCT02659020|463304058|FG003|Overall Study|Progressive Disease|4|||
128728742|NCT02659020|463304059|FG004|Overall Study|Progressive Disease|1|||
129169449|NCT02039219|464913575|FG000|Treatment|Death|1|||
129169450|NCT02039219|464913576|FG001|Treatment|Death|0|||
129169451|NCT02039219|464913575|FG000|Follow up|Adverse Event|0|||
129169452|NCT02039219|464913576|FG001|Follow up|Adverse Event|1|||
129169453|NCT02974855|464913577|FG000|Overall Study|Adverse Event|0|||
129169454|NCT02974855|464913578|FG001|Overall Study|Adverse Event|1|||
129169455|NCT02974855|464913579|FG002|Overall Study|Adverse Event|0|||
129169456|NCT02974855|464913580|FG003|Overall Study|Adverse Event|1|||
129169457|NCT03576066|464913581|FG000|Overall Study|Noncompliance with study drug|0|||
129169458|NCT03576066|464913582|FG001|Overall Study|Noncompliance with study drug|1|||
129169459|NCT00129701|464913583|FG000|Overall Study|Withdrawal by Subject|33|||
129169460|NCT02750345|464913584|FG000|Intervention 1|Adverse Event|0|||
129169461|NCT02750345|464913585|FG001|Intervention 1|Adverse Event|0|||
129169462|NCT02750345|464913586|FG002|Intervention 1|Adverse Event|0|||
129169463|NCT02750345|464913587|FG003|Intervention 1|Adverse Event|0|||
129169464|NCT02750345|464913588|FG004|Intervention 1|Adverse Event|1|||
129169465|NCT02750345|464913589|FG005|Intervention 1|Adverse Event|0|||
129169466|NCT00006164|464913590|FG000|Overall Study|Withdrew or lost to follow-up|70|||
129169467|NCT00006164|464913591|FG001|Overall Study|Withdrew or lost to follow-up|81|||
129169468|NCT00633074|464913594|FG000|Overall Study|Adverse Event|1|||
129169469|NCT00633074|464913595|FG001|Overall Study|Adverse Event|0|||
129169470|NCT00365105|464913596|FG000|Overall Study|Protocol Violation|5|||
129169471|NCT00365105|464913597|FG001|Overall Study|Protocol Violation|8|||
129169472|NCT00608023|464913598|FG000|Overall Study|Withdrawal by Subject|8|||
129169473|NCT00608023|464913599|FG001|Overall Study|Withdrawal by Subject|10|||
129169474|NCT00608023|464913600|FG002|Overall Study|Withdrawal by Subject|7|||
129169475|NCT00608023|464913598|FG000|Overall Study|Adverse Event|1|||
129169476|NCT00608023|464913599|FG001|Overall Study|Adverse Event|4|||
129169477|NCT00608023|464913600|FG002|Overall Study|Adverse Event|5|||
129169478|NCT00608023|464913598|FG000|Overall Study|Lost to Follow-up|2|||
129169479|NCT00608023|464913599|FG001|Overall Study|Lost to Follow-up|2|||
129169480|NCT00608023|464913600|FG002|Overall Study|Lost to Follow-up|1|||
129169481|NCT00608023|464913598|FG000|Overall Study|Protocol Violation|1|||
129169482|NCT00608023|464913599|FG001|Overall Study|Protocol Violation|3|||
129169483|NCT00608023|464913600|FG002|Overall Study|Protocol Violation|1|||
129169484|NCT00608023|464913598|FG000|Overall Study|Unknown reason|0|||
129169485|NCT00608023|464913599|FG001|Overall Study|Unknown reason|3|||
129169486|NCT00608023|464913600|FG002|Overall Study|Unknown reason|0|||
129169487|NCT06422364|464913601|FG000|Overall Study|Withdrawn due to study closure|0|||
129169488|NCT06422364|464913602|FG001|Overall Study|Withdrawn due to study closure|2|||
129169489|NCT01681069|464913607|FG000|Overall Study|Withdrawal by Subject|4|||
129169490|NCT01681069|464913608|FG001|Overall Study|Withdrawal by Subject|5|||
129169491|NCT01681069|464913607|FG000|Overall Study|Protocol Violation|1|||
129169492|NCT01681069|464913608|FG001|Overall Study|Protocol Violation|1|||
129169493|NCT01681069|464913607|FG000|Overall Study|Adverse Event|0|||
129169494|NCT01681069|464913608|FG001|Overall Study|Adverse Event|1|||
129169495|NCT01463696|464913609|FG000|Overall Study|Adverse Event|0|||
129169496|NCT01463696|464913610|FG001|Overall Study|Adverse Event|1|||
129169497|NCT01463696|464913611|FG002|Overall Study|Adverse Event|0|||
129169498|NCT01463696|464913612|FG003|Overall Study|Adverse Event|2|||
129169499|NCT01463696|464913613|FG004|Overall Study|Adverse Event|0|||
129169500|NCT01463696|464913614|FG005|Overall Study|Adverse Event|1|||
129169501|NCT01463696|464913615|FG006|Overall Study|Adverse Event|3|||
129169502|NCT01463696|464913616|FG007|Overall Study|Adverse Event|2|||
129169503|NCT01463696|464913609|FG000|Overall Study|Lost to Follow-up|0|||
129169504|NCT01463696|464913610|FG001|Overall Study|Lost to Follow-up|0|||
129169505|NCT01463696|464913611|FG002|Overall Study|Lost to Follow-up|1|||
129169506|NCT01463696|464913612|FG003|Overall Study|Lost to Follow-up|0|||
129169507|NCT01463696|464913613|FG004|Overall Study|Lost to Follow-up|0|||
129169508|NCT01463696|464913614|FG005|Overall Study|Lost to Follow-up|0|||
129169509|NCT01463696|464913615|FG006|Overall Study|Lost to Follow-up|0|||
129169510|NCT01463696|464913616|FG007|Overall Study|Lost to Follow-up|0|||
129169511|NCT01463696|464913609|FG000|Overall Study|Progressive Disease|0|||
129169512|NCT01463696|464913610|FG001|Overall Study|Progressive Disease|1|||
129169513|NCT01463696|464913611|FG002|Overall Study|Progressive Disease|0|||
129169514|NCT01463696|464913612|FG003|Overall Study|Progressive Disease|1|||
129169515|NCT01463696|464913613|FG004|Overall Study|Progressive Disease|0|||
129169516|NCT01463696|464913614|FG005|Overall Study|Progressive Disease|1|||
129169517|NCT01463696|464913615|FG006|Overall Study|Progressive Disease|4|||
129169518|NCT01463696|464913616|FG007|Overall Study|Progressive Disease|2|||
129169519|NCT01463696|464913609|FG000|Overall Study|Withdrawal by Subject|0|||
129169520|NCT01463696|464913610|FG001|Overall Study|Withdrawal by Subject|0|||
129169521|NCT01463696|464913611|FG002|Overall Study|Withdrawal by Subject|0|||
129169522|NCT01463696|464913612|FG003|Overall Study|Withdrawal by Subject|1|||
129169523|NCT01463696|464913613|FG004|Overall Study|Withdrawal by Subject|1|||
129169524|NCT01463696|464913614|FG005|Overall Study|Withdrawal by Subject|1|||
129169525|NCT01463696|464913615|FG006|Overall Study|Withdrawal by Subject|2|||
129169526|NCT01463696|464913616|FG007|Overall Study|Withdrawal by Subject|0|||
129169527|NCT01463696|464913609|FG000|Overall Study|Not Treated|0|||
129169528|NCT01463696|464913610|FG001|Overall Study|Not Treated|0|||
129169529|NCT01463696|464913611|FG002|Overall Study|Not Treated|0|||
129169530|NCT01463696|464913612|FG003|Overall Study|Not Treated|0|||
129169531|NCT01463696|464913613|FG004|Overall Study|Not Treated|0|||
129169532|NCT01463696|464913614|FG005|Overall Study|Not Treated|0|||
129169533|NCT01463696|464913615|FG006|Overall Study|Not Treated|1|||
129169534|NCT01463696|464913616|FG007|Overall Study|Not Treated|0|||
129169535|NCT03883165|464913617|FG000|Overall Study|Withdrawal by Subject|4|||
128778588|NCT01723826|463478805|FG001|Overall Study|Adverse Event|1|||
128778589|NCT01723826|463478806|FG002|Overall Study|Adverse Event|4|||
128778590|NCT01723826|463478807|FG003|Overall Study|Adverse Event|5|||
128778591|NCT01723826|463478804|FG000|Overall Study|Death according to AE eCRF|2|||
128778592|NCT01723826|463478805|FG001|Overall Study|Death according to AE eCRF|3|||
128778593|NCT01723826|463478806|FG002|Overall Study|Death according to AE eCRF|3|||
128778594|NCT01723826|463478807|FG003|Overall Study|Death according to AE eCRF|7|||
128778595|NCT01723826|463478804|FG000|Overall Study|Lost to Follow-up|1|||
128778596|NCT01723826|463478805|FG001|Overall Study|Lost to Follow-up|3|||
128778597|NCT01723826|463478806|FG002|Overall Study|Lost to Follow-up|1|||
128778598|NCT01723826|463478807|FG003|Overall Study|Lost to Follow-up|1|||
128778599|NCT01723826|463478804|FG000|Overall Study|Non-compliance|0|||
128778600|NCT01723826|463478805|FG001|Overall Study|Non-compliance|1|||
128778601|NCT01723826|463478806|FG002|Overall Study|Non-compliance|3|||
128778602|NCT01723826|463478807|FG003|Overall Study|Non-compliance|3|||
128778603|NCT01723826|463478804|FG000|Overall Study|Non-compliance With Study Drug|0|||
128778604|NCT01723826|463478805|FG001|Overall Study|Non-compliance With Study Drug|1|||
128778605|NCT01723826|463478806|FG002|Overall Study|Non-compliance With Study Drug|0|||
128778606|NCT01723826|463478807|FG003|Overall Study|Non-compliance With Study Drug|0|||
128778607|NCT01723826|463478804|FG000|Overall Study|Other Reason|8|||
128778608|NCT01723826|463478805|FG001|Overall Study|Other Reason|6|||
129169536|NCT03883165|464913618|FG001|Overall Study|Withdrawal by Subject|3|||
129169537|NCT00245050|464913622|FG000|Overall Study|Adverse Event|3|||
129169538|NCT00245050|464913623|FG001|Overall Study|Adverse Event|2|||
129169539|NCT00425698|464913624|FG000|Overall Study|Adverse Event|3|||
129169540|NCT00425698|464913625|FG001|Overall Study|Adverse Event|1|||
129169541|NCT00425698|464913624|FG000|Overall Study|Withdrawal by Subject|0|||
129169542|NCT00425698|464913625|FG001|Overall Study|Withdrawal by Subject|1|||
129169543|NCT03275246|464913632|FG000|Overall Study|Protocol Violation|5|||
129169544|NCT03275246|464913632|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
129169545|NCT03905265|464913636|FG000|Overall Study|Withdrawal by Subject|1|||
129169546|NCT03905265|464913637|FG001|Overall Study|Withdrawal by Subject|1|||
129169547|NCT03905265|464913638|FG002|Overall Study|Withdrawal by Subject|0|||
128778609|NCT01723826|463478806|FG002|Overall Study|Other Reason|12|||
128778610|NCT01723826|463478807|FG003|Overall Study|Other Reason|14|||
129169548|NCT03905265|464913639|FG003|Overall Study|Withdrawal by Subject|0|||
129169549|NCT02516098|464913644|FG000|Period 1|Protocol Violation|1|||
129169550|NCT02516098|464913645|FG001|Period 1|Protocol Violation|0|||
129169551|NCT02516098|464913644|FG000|Washout After Period 1|Adverse Event|0|||
129169552|NCT02516098|464913645|FG001|Washout After Period 1|Adverse Event|1|||
129169553|NCT02516098|464913644|FG000|Period 2|Withdrawal by Subject|0|||
129169554|NCT02516098|464913645|FG001|Period 2|Withdrawal by Subject|1|||
129169555|NCT01973387|464913646|FG000|Overall Study|Adverse Event|14|||
129169556|NCT01973387|464913647|FG001|Overall Study|Adverse Event|4|||
129169557|NCT01973387|464913646|FG000|Overall Study|Withdrawal by Subject|7|||
129169558|NCT01973387|464913647|FG001|Overall Study|Withdrawal by Subject|4|||
129169559|NCT01973387|464913646|FG000|Overall Study|Study terminated by sponsor|63|||
129169560|NCT01973387|464913647|FG001|Overall Study|Study terminated by sponsor|0|||
129169561|NCT01973387|464913646|FG000|Overall Study|Progressive disease or relapse|16|||
129169562|NCT01973387|464913647|FG001|Overall Study|Progressive disease or relapse|5|||
129169563|NCT01973387|464913646|FG000|Overall Study|Death|4|||
129169564|NCT01973387|464913647|FG001|Overall Study|Death|3|||
129169565|NCT01973387|464913646|FG000|Overall Study|Randomized, not treated|2|||
129169566|NCT01973387|464913647|FG001|Overall Study|Randomized, not treated|2|||
129169567|NCT03888235|464913656|FG000|Overall Study|Lost to Follow-up|1|||
129169568|NCT03888235|464913657|FG001|Overall Study|Lost to Follow-up|1|||
129169569|NCT03888235|464913658|FG002|Overall Study|Lost to Follow-up|0|||
129169570|NCT03703817|464913665|FG000|Overall Study|Not meeting eligibility criteria|7|||
129169571|NCT03703817|464913666|FG001|Overall Study|Not meeting eligibility criteria|4|||
129169572|NCT00404755|464913668|FG000|Phase I (Bupropion)|Adverse Event|3|||
129169573|NCT00404755|464913668|FG000|Phase I (Bupropion)|Other|1|||
129169574|NCT00404755|464913668|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
129169575|NCT00350870|464913669|FG000|Overall Study|Withdrawal by Subject|21|||
129169576|NCT00350870|464913670|FG001|Overall Study|Withdrawal by Subject|17|||
129169577|NCT00350870|464913671|FG002|Overall Study|Withdrawal by Subject|15|||
129169578|NCT00350870|464913672|FG003|Overall Study|Withdrawal by Subject|14|||
128778611|NCT01723826|463478804|FG000|Overall Study|Physician Decision|1|||
128778612|NCT01723826|463478805|FG001|Overall Study|Physician Decision|3|||
128778613|NCT01723826|463478806|FG002|Overall Study|Physician Decision|4|||
128778614|NCT01723826|463478807|FG003|Overall Study|Physician Decision|11|||
129169579|NCT00350870|464913669|FG000|Overall Study|Physician Decision|1|||
129169580|NCT00350870|464913670|FG001|Overall Study|Physician Decision|0|||
129169581|NCT00350870|464913671|FG002|Overall Study|Physician Decision|1|||
129169582|NCT00350870|464913672|FG003|Overall Study|Physician Decision|1|||
129169583|NCT00349921|464913673|FG000|First Spinal Injection|Physician Decision|1|||
129169584|NCT00349921|464913674|FG001|First Spinal Injection|Physician Decision|0|||
129169585|NCT00349921|464913675|FG002|First Spinal Injection|Physician Decision|0|||
129169586|NCT00349921|464913676|FG003|First Spinal Injection|Physician Decision|0|||
129169587|NCT00349921|464913673|FG000|First Spinal Injection|Adverse Event|0|||
129169588|NCT00349921|464913674|FG001|First Spinal Injection|Adverse Event|0|||
129169589|NCT00349921|464913675|FG002|First Spinal Injection|Adverse Event|1|||
129169590|NCT00349921|464913676|FG003|First Spinal Injection|Adverse Event|0|||
129169591|NCT03194568|464913677|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
129169592|NCT05248997|464913678|FG000|Overall Study|Lost to Follow-up|1|||
129169593|NCT05248997|464913679|FG001|Overall Study|Lost to Follow-up|1|||
129169594|NCT05248997|464913678|FG000|Overall Study|Randomized but not treated|32|||
129169595|NCT05248997|464913679|FG001|Overall Study|Randomized but not treated|25|||
129169596|NCT04262882|464913681|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
129169597|NCT04262882|464913682|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
129169598|NCT04262882|464913681|FG000|Overall Study|Lost to Follow-up|1|||
129169599|NCT04262882|464913682|FG001|Overall Study|Lost to Follow-up|0|||
129169600|NCT01301066|464913683|FG000|Overall Study|Lost to Follow-up|5|||
129169601|NCT01301066|464913684|FG001|Overall Study|Lost to Follow-up|11|||
129169602|NCT01301066|464913683|FG000|Overall Study|Protocol Violation|8|||
129169603|NCT01301066|464913684|FG001|Overall Study|Protocol Violation|7|||
129169604|NCT01301066|464913683|FG000|Overall Study|Withdrawal by Subject|4|||
129169605|NCT01301066|464913684|FG001|Overall Study|Withdrawal by Subject|9|||
129169606|NCT01301066|464913683|FG000|Overall Study|Adverse Event|6|||
129169607|NCT01301066|464913684|FG001|Overall Study|Adverse Event|6|||
129169608|NCT01301066|464913683|FG000|Overall Study|Sponsor Decision|2|||
129169609|NCT01301066|464913684|FG001|Overall Study|Sponsor Decision|1|||
129169610|NCT01301066|464913683|FG000|Overall Study|Physician Decision|0|||
129169611|NCT01301066|464913684|FG001|Overall Study|Physician Decision|1|||
129169612|NCT01301066|464913683|FG000|Overall Study|Other|2|||
129169613|NCT01301066|464913684|FG001|Overall Study|Other|0|||
129169614|NCT03268954|464913689|FG000|Overall Study|Ongoing|23|||
129169615|NCT03268954|464913690|FG001|Overall Study|Ongoing|31|||
129169616|NCT03268954|464913689|FG000|Overall Study|Adverse Event|53|||
129169617|NCT03268954|464913690|FG001|Overall Study|Adverse Event|62|||
129169618|NCT03268954|464913689|FG000|Overall Study|Withdrawal by Subject|25|||
129169619|NCT03268954|464913690|FG001|Overall Study|Withdrawal by Subject|16|||
129169620|NCT03268954|464913689|FG000|Overall Study|Progressive Disease|61|||
129169621|NCT03268954|464913690|FG001|Overall Study|Progressive Disease|48|||
129169622|NCT03268954|464913689|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
129169623|NCT03268954|464913690|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
129169624|NCT03268954|464913689|FG000|Overall Study|Reason not Specified|40|||
129169625|NCT03268954|464913690|FG001|Overall Study|Reason not Specified|40|||
129169626|NCT00778258|464913691|FG000|Overall Study|Adverse Event|1|||
129169627|NCT00778258|464913692|FG001|Overall Study|Adverse Event|0|||
129169628|NCT00778258|464913693|FG002|Overall Study|Adverse Event|0|||
129169629|NCT00778258|464913694|FG003|Overall Study|Adverse Event|0|||
129169630|NCT00778258|464913695|FG004|Overall Study|Adverse Event|0|||
129169631|NCT00778258|464913696|FG005|Overall Study|Adverse Event|1|||
129169632|NCT00778258|464913697|FG006|Overall Study|Adverse Event|0|||
129169633|NCT00778258|464913698|FG007|Overall Study|Adverse Event|0|||
129169634|NCT00778258|464913699|FG008|Overall Study|Adverse Event|0|||
129169635|NCT00778258|464913691|FG000|Overall Study|Lost to Follow-up|0|||
129169636|NCT00778258|464913692|FG001|Overall Study|Lost to Follow-up|0|||
129169637|NCT00778258|464913693|FG002|Overall Study|Lost to Follow-up|2|||
129169638|NCT00778258|464913694|FG003|Overall Study|Lost to Follow-up|0|||
129169639|NCT00778258|464913695|FG004|Overall Study|Lost to Follow-up|0|||
129169640|NCT00778258|464913696|FG005|Overall Study|Lost to Follow-up|3|||
129169641|NCT00778258|464913697|FG006|Overall Study|Lost to Follow-up|2|||
129169642|NCT00778258|464913698|FG007|Overall Study|Lost to Follow-up|2|||
129169643|NCT00778258|464913699|FG008|Overall Study|Lost to Follow-up|0|||
129169644|NCT00778258|464913691|FG000|Overall Study|Withdrawal by Subject|6|||
129169645|NCT00778258|464913692|FG001|Overall Study|Withdrawal by Subject|2|||
129169646|NCT00778258|464913693|FG002|Overall Study|Withdrawal by Subject|8|||
129169647|NCT00778258|464913694|FG003|Overall Study|Withdrawal by Subject|2|||
129169648|NCT00778258|464913695|FG004|Overall Study|Withdrawal by Subject|0|||
128728743|NCT02659020|463304060|FG005|Overall Study|Progressive Disease|0|||
129169649|NCT00778258|464913696|FG005|Overall Study|Withdrawal by Subject|6|||
129169650|NCT00778258|464913697|FG006|Overall Study|Withdrawal by Subject|12|||
129169651|NCT00778258|464913698|FG007|Overall Study|Withdrawal by Subject|12|||
129169652|NCT00778258|464913699|FG008|Overall Study|Withdrawal by Subject|4|||
128728744|NCT02659020|463304061|FG006|Overall Study|Progressive Disease|2|||
129169653|NCT00778258|464913691|FG000|Overall Study|New Contraindication|0|||
129169654|NCT00778258|464913692|FG001|Overall Study|New Contraindication|0|||
129169655|NCT00778258|464913693|FG002|Overall Study|New Contraindication|0|||
129169656|NCT00778258|464913694|FG003|Overall Study|New Contraindication|0|||
129169657|NCT00778258|464913695|FG004|Overall Study|New Contraindication|0|||
129169658|NCT00778258|464913696|FG005|Overall Study|New Contraindication|0|||
129169659|NCT00778258|464913697|FG006|Overall Study|New Contraindication|0|||
129169660|NCT00778258|464913698|FG007|Overall Study|New Contraindication|1|||
129169661|NCT00778258|464913699|FG008|Overall Study|New Contraindication|0|||
129169662|NCT00778258|464913691|FG000|Overall Study|Non-compliance|0|||
129169663|NCT00778258|464913692|FG001|Overall Study|Non-compliance|0|||
129169664|NCT00778258|464913693|FG002|Overall Study|Non-compliance|0|||
129169665|NCT00778258|464913694|FG003|Overall Study|Non-compliance|1|||
129169666|NCT00778258|464913695|FG004|Overall Study|Non-compliance|0|||
129169667|NCT00778258|464913696|FG005|Overall Study|Non-compliance|0|||
129169668|NCT00778258|464913697|FG006|Overall Study|Non-compliance|0|||
129169669|NCT00778258|464913698|FG007|Overall Study|Non-compliance|0|||
129169670|NCT00778258|464913699|FG008|Overall Study|Non-compliance|0|||
129169671|NCT00778258|464913691|FG000|Overall Study|Other|0|||
129169672|NCT00778258|464913692|FG001|Overall Study|Other|0|||
129169673|NCT00778258|464913693|FG002|Overall Study|Other|0|||
129169674|NCT00778258|464913694|FG003|Overall Study|Other|0|||
129169675|NCT00778258|464913695|FG004|Overall Study|Other|0|||
129169676|NCT00778258|464913696|FG005|Overall Study|Other|0|||
129169677|NCT00778258|464913697|FG006|Overall Study|Other|1|||
129169678|NCT00778258|464913698|FG007|Overall Study|Other|0|||
129169679|NCT00778258|464913699|FG008|Overall Study|Other|0|||
129169680|NCT00790868|464915773|FG000|Overall Study|Withdrawal by Subject|4|||
129169681|NCT00790868|464915774|FG001|Overall Study|Withdrawal by Subject|5|||
129169682|NCT00790868|464915773|FG000|Overall Study|Lost to Follow-up|2|||
129169683|NCT00790868|464915774|FG001|Overall Study|Lost to Follow-up|12|||
129169684|NCT03285958|464915782|FG000|Overall Study|Lost to Follow-up|1|||
129169685|NCT03285958|464915783|FG001|Overall Study|Lost to Follow-up|1|||
129169686|NCT03285958|464915782|FG000|Overall Study|Withdrawal by Subject|1|||
129169687|NCT03285958|464915783|FG001|Overall Study|Withdrawal by Subject|0|||
129169688|NCT03285958|464915782|FG000|Overall Study|Not able to attend required orientation|3|||
129169689|NCT03285958|464915783|FG001|Overall Study|Not able to attend required orientation|0|||
129169690|NCT03116828|464915784|FG000|Overall Study|Adverse Event|1|||
129169691|NCT03116828|464915785|FG001|Overall Study|Adverse Event|10|||
129169692|NCT03116828|464915784|FG000|Overall Study|Withdrawal by Subject|4|||
129169693|NCT03116828|464915785|FG001|Overall Study|Withdrawal by Subject|8|||
129169694|NCT03116828|464915784|FG000|Overall Study|OTHER|3|||
129169695|NCT03116828|464915785|FG001|Overall Study|OTHER|3|||
129169696|NCT00882583|464915786|FG000|Overall Study|Physician Decision|1|||
129169697|NCT00882583|464915787|FG001|Overall Study|Physician Decision|0|||
129169698|NCT00882583|464915786|FG000|Overall Study|Adverse Event|0|||
129169699|NCT00882583|464915787|FG001|Overall Study|Adverse Event|1|||
129169700|NCT04753658|464915796|FG000|Overall Study|Progressive disease|7|||
129169701|NCT04753658|464915796|FG000|Overall Study|Other|7|||
129169702|NCT04753658|464915796|FG000|Overall Study|Adverse Event|1|||
129169703|NCT00306293|464915797|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
129169704|NCT00306293|464915798|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
128728745|NCT04382911|463304062|FG000|Overall Study|unable to be imaged prior to surgery|2|||
128728746|NCT01585766|463304063|FG000|Overall Study|Withdrawal by Subject|0|||
128728747|NCT01585766|463304064|FG001|Overall Study|Withdrawal by Subject|1|||
128728748|NCT01585766|463304065|FG002|Overall Study|Withdrawal by Subject|1|||
128728749|NCT01585766|463304066|FG003|Overall Study|Withdrawal by Subject|0|||
128728750|NCT01585766|463304067|FG004|Overall Study|Withdrawal by Subject|0|||
128728751|NCT01585766|463304068|FG005|Overall Study|Withdrawal by Subject|0|||
128728752|NCT01585766|463304063|FG000|Overall Study|Death|0|||
128728753|NCT01585766|463304064|FG001|Overall Study|Death|1|||
128728754|NCT01585766|463304065|FG002|Overall Study|Death|0|||
128728755|NCT01585766|463304066|FG003|Overall Study|Death|0|||
128728756|NCT01585766|463304067|FG004|Overall Study|Death|0|||
128728757|NCT01585766|463304068|FG005|Overall Study|Death|0|||
128778615|NCT01723826|463478804|FG000|Overall Study|Protocol Violation|1|||
128778616|NCT01723826|463478805|FG001|Overall Study|Protocol Violation|1|||
128778617|NCT01723826|463478806|FG002|Overall Study|Protocol Violation|3|||
129169705|NCT00306293|464915797|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
129169706|NCT00306293|464915798|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
129169707|NCT00306293|464915797|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
129169708|NCT00306293|464915798|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
129169709|NCT00306293|464915797|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
129169710|NCT00306293|464915798|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
129169711|NCT00306293|464915797|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
129169712|NCT00306293|464915798|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
129169713|NCT00306293|464915797|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
129169714|NCT00306293|464915798|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
129169715|NCT00306293|464915797|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
129169716|NCT00306293|464915798|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
129169717|NCT00306293|464915797|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
128728758|NCT01585766|463304063|FG000|Overall Study|Physician Decision|0|||
128728759|NCT01585766|463304064|FG001|Overall Study|Physician Decision|0|||
128778618|NCT01723826|463478807|FG003|Overall Study|Protocol Violation|1|||
129169718|NCT00306293|464915798|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
129169719|NCT00218634|464915799|FG000|Overall Study|Lost to Follow-up|8|||
129169720|NCT00218634|464915800|FG001|Overall Study|Lost to Follow-up|15|||
129169721|NCT05243745|464915801|FG000|Overall Study|Withdrawal by Subject|0|||
129169722|NCT05243745|464915802|FG001|Overall Study|Withdrawal by Subject|0|||
129169723|NCT05243745|464915803|FG002|Overall Study|Withdrawal by Subject|0|||
129169724|NCT05243745|464915804|FG003|Overall Study|Withdrawal by Subject|1|||
129169725|NCT05243745|464915801|FG000|Overall Study|Unable to Attend Visit 6|0|||
129169726|NCT05243745|464915802|FG001|Overall Study|Unable to Attend Visit 6|0|||
129169727|NCT05243745|464915803|FG002|Overall Study|Unable to Attend Visit 6|1|||
129169728|NCT05243745|464915804|FG003|Overall Study|Unable to Attend Visit 6|0|||
129169729|NCT00176488|464915817|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
129169730|NCT01044745|464915818|FG000|Overall Study|Ineiligible|2|||
129169731|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Adverse Event|76|||
129169732|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Adverse Event|0|||
129169733|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Adverse Event|0|||
129169734|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Death|3|||
129169735|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Death|0|||
129169736|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Death|0|||
129169737|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
129169738|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
129169739|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
129169740|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Physician Decision|9|||
129169741|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Physician Decision|0|||
129169742|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Physician Decision|0|||
129169743|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
129169744|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
129169745|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
129169746|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Disease progression|45|||
129169747|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Disease progression|0|||
129169748|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Disease progression|0|||
129169749|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
129169750|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
129169751|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
129169752|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
129169753|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
129169754|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
129169755|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
129169756|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
129169757|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
129169758|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
129169759|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
129169760|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
129169761|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
129169762|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
129169763|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
129169764|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
129169765|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
129169766|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
129169767|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
129169768|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
129169769|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
129169770|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
129169771|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
129169772|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
129169773|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
129169774|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
129169775|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
129169776|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Promotor request|1|||
129169777|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Promotor request|0|||
129169778|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Promotor request|0|||
129169779|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
129169780|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
129169781|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
129169782|NCT01461928|464915823|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
129169783|NCT01461928|464915824|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
129169784|NCT01461928|464915825|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
129169785|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Death|3|||
128728760|NCT01585766|463304065|FG002|Overall Study|Physician Decision|1|||
128728761|NCT01585766|463304066|FG003|Overall Study|Physician Decision|0|||
128728762|NCT01585766|463304067|FG004|Overall Study|Physician Decision|0|||
128728763|NCT01585766|463304068|FG005|Overall Study|Physician Decision|0|||
128728764|NCT01120210|463304069|FG000|MAIN INFUSION|Adverse Event|1|||
128728765|NCT01120210|463304070|FG001|MAIN INFUSION|Adverse Event|0|||
128728766|NCT01120210|463304069|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
128728767|NCT01120210|463304070|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
128728768|NCT02043015|463304081|FG000|Overall Study|Lost to Follow-up|4|||
128728769|NCT02043015|463304081|FG000|Overall Study|Withdrawal by Subject|4|||
128728770|NCT02043015|463304081|FG000|Overall Study|Removed once target enrollment reached|15|||
128728771|NCT02043015|463304081|FG000|Overall Study|Participant moved away from study city|4|||
128728772|NCT02043015|463304081|FG000|Overall Study|Incarceration|1|||
128728773|NCT02385799|463304083|FG000|Overall Study|Lost to Follow-up|1|||
128728774|NCT02385799|463304084|FG001|Overall Study|Lost to Follow-up|2|||
128728775|NCT02385799|463304083|FG000|Overall Study|Adverse Event|4|||
128728776|NCT02385799|463304084|FG001|Overall Study|Adverse Event|2|||
128728777|NCT02385799|463304083|FG000|Overall Study|Withdrawal by Subject|0|||
128728778|NCT02385799|463304084|FG001|Overall Study|Withdrawal by Subject|4|||
128728779|NCT02130765|463304085|FG000|Overall Study|Did not receive treatment|4|||
128728780|NCT02130765|463304086|FG001|Overall Study|Did not receive treatment|0|||
128728781|NCT02130765|463304087|FG002|Overall Study|Did not receive treatment|0|||
128728782|NCT02130765|463304088|FG003|Overall Study|Did not receive treatment|0|||
128728783|NCT00477672|463304091|FG000|Overall Study|Adverse Event|3|||
128728784|NCT00477672|463304092|FG001|Overall Study|Adverse Event|5|||
128728785|NCT00477672|463304093|FG002|Overall Study|Adverse Event|6|||
128728786|NCT00477672|463304091|FG000|Overall Study|Death|0|||
128728787|NCT00477672|463304092|FG001|Overall Study|Death|1|||
128728788|NCT00477672|463304093|FG002|Overall Study|Death|0|||
128728789|NCT00477672|463304091|FG000|Overall Study|Disease progression|0|||
128728790|NCT00477672|463304092|FG001|Overall Study|Disease progression|1|||
128728791|NCT00477672|463304093|FG002|Overall Study|Disease progression|0|||
128728792|NCT00477672|463304091|FG000|Overall Study|Physician Decision|1|||
128728793|NCT00477672|463304092|FG001|Overall Study|Physician Decision|0|||
128728794|NCT00477672|463304093|FG002|Overall Study|Physician Decision|0|||
128728795|NCT00477672|463304091|FG000|Overall Study|Protocol noncompliance|0|||
128728796|NCT00477672|463304092|FG001|Overall Study|Protocol noncompliance|2|||
128728797|NCT00477672|463304093|FG002|Overall Study|Protocol noncompliance|0|||
128728798|NCT00477672|463304091|FG000|Overall Study|Consent withdrawn|2|||
128728799|NCT00477672|463304092|FG001|Overall Study|Consent withdrawn|5|||
128728800|NCT00477672|463304093|FG002|Overall Study|Consent withdrawn|10|||
128728801|NCT00477672|463304091|FG000|Overall Study|Discretion of Sponsor|1|||
128728802|NCT00477672|463304092|FG001|Overall Study|Discretion of Sponsor|2|||
128728803|NCT00477672|463304093|FG002|Overall Study|Discretion of Sponsor|0|||
128728804|NCT01455012|463304097|FG000|Overall Study|Adverse Event|0|||
129169786|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Death|0|||
129169787|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Death|0|||
129169788|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
129169789|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
129169790|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
129169791|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
129169792|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
129169793|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
129169794|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Diseases progression|91|||
129169795|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Diseases progression|0|||
129169796|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Diseases progression|0|||
129169797|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Adverse Event|70|||
129169798|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Adverse Event|0|||
129169799|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Adverse Event|0|||
129169800|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Physician Decision|9|||
129169801|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Physician Decision|0|||
128728805|NCT01455012|463304098|FG001|Overall Study|Adverse Event|2|||
128728806|NCT01455012|463304097|FG000|Overall Study|Lack of Efficacy|6|||
129169802|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Physician Decision|0|||
128728807|NCT01455012|463304098|FG001|Overall Study|Lack of Efficacy|1|||
128728808|NCT01455012|463304097|FG000|Overall Study|Withdrawal by Subject|3|||
128728809|NCT01455012|463304098|FG001|Overall Study|Withdrawal by Subject|1|||
128728810|NCT01455012|463304097|FG000|Overall Study|Unknown reason|2|||
128728811|NCT01455012|463304098|FG001|Overall Study|Unknown reason|0|||
128728812|NCT01215227|463304099|FG000|Overall Study|Adverse Event|11|||
128728813|NCT01215227|463304100|FG001|Overall Study|Adverse Event|11|||
129169803|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
128728814|NCT01215227|463304101|FG002|Overall Study|Adverse Event|4|||
128728815|NCT01215227|463304102|FG003|Overall Study|Adverse Event|8|||
129169804|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
129169805|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
129169806|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
129169807|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
129169808|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
129169809|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
129169810|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
129169811|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
129169812|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Not compliant|1|||
129169813|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Not compliant|0|||
129169814|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Not compliant|0|||
129169815|NCT01461928|464915823|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
129169816|NCT01461928|464915824|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
129169817|NCT01461928|464915825|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
129169818|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Adverse Event|0|||
129169819|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Adverse Event|2|||
129169820|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Adverse Event|0|||
129169821|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Death|0|||
129169822|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Death|10|||
129169823|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Death|8|||
129169824|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Physician Decision|0|||
129169825|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Physician Decision|0|||
129169826|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Physician Decision|4|||
129169827|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
129169828|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
129169829|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
129169830|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Moved to another town|0|||
129169831|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Moved to another town|1|||
129169832|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Moved to another town|0|||
129169833|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Disease progression|0|||
129169834|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Disease progression|0|||
129169835|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Disease progression|3|||
129169836|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
129169837|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
129169838|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
129169839|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
129169840|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
129169841|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
129169842|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
129169843|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
129169844|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
129169845|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
129169846|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
129169847|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
129169848|NCT01461928|464915823|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
129169849|NCT01461928|464915824|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
129169850|NCT01461928|464915825|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
129169851|NCT01159171|464915826|FG000|Overall Study|Adverse Event|11|||
129169852|NCT01159171|464915826|FG000|Overall Study|Progression of Disease|28|||
129169853|NCT01159171|464915826|FG000|Overall Study|Protocol Violation|1|||
129169854|NCT01159171|464915826|FG000|Overall Study|Need for Surgery|5|||
129169855|NCT01159171|464915826|FG000|Overall Study|Medical Decision|4|||
128728816|NCT01215227|463304103|FG004|Overall Study|Adverse Event|7|||
128728817|NCT01215227|463304104|FG005|Overall Study|Adverse Event|6|||
128728818|NCT01215227|463304099|FG000|Overall Study|Treatment Failure|8|||
129169856|NCT01159171|464915826|FG000|Overall Study|Death|1|||
129169857|NCT02242435|464915837|FG000|Overall Study|Lost to Follow-up|3|||
128728819|NCT01215227|463304100|FG001|Overall Study|Treatment Failure|4|||
128728820|NCT01215227|463304101|FG002|Overall Study|Treatment Failure|1|||
129169858|NCT02242435|464915838|FG001|Overall Study|Lost to Follow-up|4|||
129169859|NCT02242435|464915837|FG000|Overall Study|Adverse Event|3|||
129169860|NCT02242435|464915838|FG001|Overall Study|Adverse Event|2|||
129169861|NCT02242435|464915837|FG000|Overall Study|Withdrawal by Subject|13|||
128728821|NCT01215227|463304102|FG003|Overall Study|Treatment Failure|5|||
128728822|NCT01215227|463304103|FG004|Overall Study|Treatment Failure|1|||
128728823|NCT01215227|463304104|FG005|Overall Study|Treatment Failure|1|||
128728824|NCT01215227|463304099|FG000|Overall Study|Lost to Follow-up|1|||
128728825|NCT01215227|463304100|FG001|Overall Study|Lost to Follow-up|4|||
128728826|NCT01215227|463304101|FG002|Overall Study|Lost to Follow-up|1|||
128728827|NCT01215227|463304102|FG003|Overall Study|Lost to Follow-up|1|||
128728828|NCT01215227|463304103|FG004|Overall Study|Lost to Follow-up|1|||
128728829|NCT01215227|463304104|FG005|Overall Study|Lost to Follow-up|2|||
128728830|NCT01215227|463304099|FG000|Overall Study|Subject Withdrew Consent|16|||
128728831|NCT01215227|463304100|FG001|Overall Study|Subject Withdrew Consent|20|||
128728832|NCT01215227|463304101|FG002|Overall Study|Subject Withdrew Consent|7|||
128728833|NCT01215227|463304102|FG003|Overall Study|Subject Withdrew Consent|10|||
128728834|NCT01215227|463304103|FG004|Overall Study|Subject Withdrew Consent|11|||
128728835|NCT01215227|463304104|FG005|Overall Study|Subject Withdrew Consent|8|||
128728836|NCT01215227|463304099|FG000|Overall Study|Non-Compliance With Protocol|2|||
128728837|NCT01215227|463304100|FG001|Overall Study|Non-Compliance With Protocol|6|||
128728838|NCT01215227|463304101|FG002|Overall Study|Non-Compliance With Protocol|1|||
128728839|NCT01215227|463304102|FG003|Overall Study|Non-Compliance With Protocol|0|||
128728840|NCT01215227|463304103|FG004|Overall Study|Non-Compliance With Protocol|0|||
128728841|NCT01215227|463304104|FG005|Overall Study|Non-Compliance With Protocol|0|||
128728842|NCT01215227|463304099|FG000|Overall Study|Administrative|83|||
128728843|NCT01215227|463304100|FG001|Overall Study|Administrative|73|||
128728844|NCT01215227|463304101|FG002|Overall Study|Administrative|42|||
128728845|NCT01215227|463304102|FG003|Overall Study|Administrative|24|||
128728846|NCT01215227|463304103|FG004|Overall Study|Administrative|28|||
128728847|NCT01215227|463304104|FG005|Overall Study|Administrative|40|||
128728848|NCT01215227|463304099|FG000|Overall Study|Missing Status|0|||
128728849|NCT01215227|463304100|FG001|Overall Study|Missing Status|1|||
128728850|NCT01215227|463304101|FG002|Overall Study|Missing Status|0|||
128728851|NCT01215227|463304102|FG003|Overall Study|Missing Status|0|||
128728852|NCT01215227|463304103|FG004|Overall Study|Missing Status|0|||
128728853|NCT01215227|463304104|FG005|Overall Study|Missing Status|0|||
128728854|NCT01215227|463304099|FG000|Overall Study|Randomized but not treated|0|||
128728855|NCT01215227|463304100|FG001|Overall Study|Randomized but not treated|0|||
128728856|NCT01215227|463304101|FG002|Overall Study|Randomized but not treated|1|||
128728857|NCT01215227|463304102|FG003|Overall Study|Randomized but not treated|1|||
128728858|NCT01215227|463304103|FG004|Overall Study|Randomized but not treated|0|||
128728859|NCT01215227|463304104|FG005|Overall Study|Randomized but not treated|1|||
128728860|NCT02253810|463304105|FG000|Overall Study|Withdrawal by Subject|2|||
128728861|NCT02253810|463304106|FG001|Overall Study|Withdrawal by Subject|1|||
128728862|NCT02253810|463304105|FG000|Overall Study|Unknown concomitant procedure|3|||
128728863|NCT02253810|463304106|FG001|Overall Study|Unknown concomitant procedure|2|||
128728864|NCT01434290|463304113|FG000|Overall Study|Protocol Violation|6|||
128728865|NCT01434290|463304114|FG001|Overall Study|Protocol Violation|3|||
128728866|NCT01434290|463304113|FG000|Overall Study|No protocol treatment|2|||
128728867|NCT01434290|463304114|FG001|Overall Study|No protocol treatment|4|||
128728868|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
128728869|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
128728870|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
128728871|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
128728872|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
128728873|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
128728874|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
128728875|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
128728876|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
128728877|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
128728878|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
128728879|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
128728880|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
128728881|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
128728882|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
128728883|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
128728884|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
128728885|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
128728886|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
128728887|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
128728888|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Other|3|||
128728889|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Other|0|||
128728890|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Other|2|||
128728891|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Other|2|||
128728892|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Other|7|||
128728893|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
128728894|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
128728895|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
128728896|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
128728897|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
128778619|NCT01723826|463478804|FG000|Overall Study|Withdrawal by Subject|10|||
128778620|NCT01723826|463478805|FG001|Overall Study|Withdrawal by Subject|17|||
129169862|NCT02242435|464915838|FG001|Overall Study|Withdrawal by Subject|8|||
129169863|NCT02242435|464915837|FG000|Overall Study|Death|0|||
129169864|NCT02242435|464915838|FG001|Overall Study|Death|1|||
129169865|NCT02242435|464915837|FG000|Overall Study|Protocol Violation|1|||
129169866|NCT02242435|464915838|FG001|Overall Study|Protocol Violation|0|||
129169867|NCT02242435|464915837|FG000|Overall Study|Physician Decision|0|||
129169868|NCT02242435|464915838|FG001|Overall Study|Physician Decision|1|||
129169869|NCT03895086|464915839|FG000|Overall Study|Early termination study|1|||
129169870|NCT03895086|464915840|FG001|Overall Study|Early termination study|0|||
129169871|NCT01089413|464915846|FG000|Overall Study|Lost to Follow-up|1|||
129169872|NCT01089413|464915846|FG000|Overall Study|Progressive Disease|93|||
129169873|NCT01089413|464915846|FG000|Overall Study|Participant Withdrew Consent|1|||
129169874|NCT01089413|464915846|FG000|Overall Study|Unacceptable Toxicity|12|||
129169875|NCT01089413|464915846|FG000|Overall Study|Death|10|||
129169876|NCT01089413|464915846|FG000|Overall Study|Metastasectomy|13|||
129169877|NCT01089413|464915846|FG000|Overall Study|Other|71|||
129169878|NCT02513485|464915847|FG000|Overall Study|Adverse Event|1|||
129169879|NCT02513485|464915848|FG001|Overall Study|Adverse Event|0|||
129169880|NCT02526524|464915856|FG000|Overall Study|Withdrawal by Subject|3|||
129169881|NCT02526524|464915857|FG001|Overall Study|Withdrawal by Subject|3|||
129169882|NCT02526524|464915858|FG002|Overall Study|Withdrawal by Subject|6|||
129169883|NCT02526524|464915859|FG003|Overall Study|Withdrawal by Subject|1|||
128778621|NCT01723826|463478806|FG002|Overall Study|Withdrawal by Subject|27|||
129169884|NCT02526524|464915860|FG004|Overall Study|Withdrawal by Subject|9|||
129169885|NCT02526524|464915861|FG005|Overall Study|Withdrawal by Subject|5|||
128778622|NCT01723826|463478807|FG003|Overall Study|Withdrawal by Subject|48|||
128778623|NCT01272011|463478808|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
128778624|NCT01272011|463478809|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
128778625|NCT01272011|463478810|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
128778626|NCT02013687|463478811|FG000|Overall Study|Lost to Follow-up|0|||
128778627|NCT02013687|463478812|FG001|Overall Study|Lost to Follow-up|0|||
128778628|NCT02013687|463478813|FG002|Overall Study|Lost to Follow-up|1|||
128778629|NCT02013687|463478814|FG003|Overall Study|Lost to Follow-up|0|||
128778630|NCT02013687|463478811|FG000|Overall Study|Protocol Violation|0|||
128778631|NCT02013687|463478812|FG001|Overall Study|Protocol Violation|0|||
128778632|NCT02013687|463478813|FG002|Overall Study|Protocol Violation|0|||
128778633|NCT02013687|463478814|FG003|Overall Study|Protocol Violation|1|||
128778634|NCT02013687|463478811|FG000|Overall Study|Withdrawal by Subject|0|||
128778635|NCT02013687|463478812|FG001|Overall Study|Withdrawal by Subject|0|||
128778636|NCT02013687|463478813|FG002|Overall Study|Withdrawal by Subject|0|||
128778637|NCT02013687|463478814|FG003|Overall Study|Withdrawal by Subject|1|||
128778638|NCT02013687|463478811|FG000|Overall Study|Missed visits due to patient travel|0|||
128778639|NCT02013687|463478812|FG001|Overall Study|Missed visits due to patient travel|0|||
128778640|NCT02013687|463478813|FG002|Overall Study|Missed visits due to patient travel|1|||
128778641|NCT02013687|463478814|FG003|Overall Study|Missed visits due to patient travel|0|||
128778642|NCT01627340|463478815|FG000|Overall Study|Adverse Event|1|||
128778643|NCT01627340|463478816|FG001|Overall Study|Adverse Event|0|||
128778644|NCT01627340|463478815|FG000|Overall Study|Lost to Follow-up|8|||
128778645|NCT01627340|463478816|FG001|Overall Study|Lost to Follow-up|4|||
128778646|NCT01627340|463478815|FG000|Overall Study|Pregnancy|1|||
128778647|NCT01627340|463478816|FG001|Overall Study|Pregnancy|0|||
128778648|NCT01627340|463478815|FG000|Overall Study|Withdrawal by Subject|2|||
128778649|NCT01627340|463478816|FG001|Overall Study|Withdrawal by Subject|0|||
128778650|NCT01657032|463478817|FG000|Overall Study|Lost to Follow-up|0|||
128778651|NCT01657032|463478818|FG001|Overall Study|Lost to Follow-up|7|||
128778652|NCT03633903|463478819|FG000|Overall Study|Withdrawal by Subject|1|||
128778653|NCT03633903|463478820|FG001|Overall Study|Withdrawal by Subject|2|||
128778654|NCT03633903|463478819|FG000|Overall Study|Lost to Follow-up|5|||
128778655|NCT03633903|463478820|FG001|Overall Study|Lost to Follow-up|5|||
128778656|NCT05968482|463478821|FG000|First Crossover Period|Withdrawal by Subject|0|||
128778657|NCT05968482|463478822|FG001|First Crossover Period|Withdrawal by Subject|0|||
128778658|NCT05968482|463478823|FG002|First Crossover Period|Withdrawal by Subject|1|||
128778659|NCT05968482|463478824|FG003|First Crossover Period|Withdrawal by Subject|0|||
128778660|NCT05968482|463478825|FG004|First Crossover Period|Withdrawal by Subject|0|||
128778661|NCT05968482|463478826|FG005|First Crossover Period|Withdrawal by Subject|0|||
128778662|NCT05968482|463478821|FG000|First Crossover Period|Adverse Event|0|||
128778663|NCT05968482|463478822|FG001|First Crossover Period|Adverse Event|0|||
128778664|NCT05968482|463478823|FG002|First Crossover Period|Adverse Event|0|||
128778665|NCT05968482|463478824|FG003|First Crossover Period|Adverse Event|0|||
128778666|NCT05968482|463478825|FG004|First Crossover Period|Adverse Event|0|||
128778667|NCT05968482|463478826|FG005|First Crossover Period|Adverse Event|1|||
128778668|NCT05968482|463478821|FG000|Second Crossover Period|Withdrawal by Subject|0|||
128778669|NCT05968482|463478822|FG001|Second Crossover Period|Withdrawal by Subject|0|||
128728898|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728899|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728900|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728901|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728902|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
128728903|NCT00213148|463304116|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
128728904|NCT00213148|463304117|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
128728905|NCT00213148|463304118|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
128728906|NCT00213148|463304119|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
128728907|NCT00213148|463304120|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
128728908|NCT00213148|463304116|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
128728909|NCT00213148|463304117|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
128728910|NCT00213148|463304118|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
128728911|NCT00213148|463304119|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
128728912|NCT00213148|463304120|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
128728913|NCT00213148|463304116|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
128728914|NCT00213148|463304117|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
128728915|NCT00213148|463304118|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
128778670|NCT05968482|463478823|FG002|Second Crossover Period|Withdrawal by Subject|0|||
128778671|NCT05968482|463478824|FG003|Second Crossover Period|Withdrawal by Subject|0|||
128728916|NCT00213148|463304119|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
128728917|NCT00213148|463304120|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
128778672|NCT05968482|463478825|FG004|Second Crossover Period|Withdrawal by Subject|1|||
128778673|NCT05968482|463478826|FG005|Second Crossover Period|Withdrawal by Subject|0|||
128778674|NCT05968482|463478821|FG000|Third Crossover Period|Adverse Event|0|||
128778675|NCT05968482|463478822|FG001|Third Crossover Period|Adverse Event|0|||
129169886|NCT02526524|464915856|FG000|Overall Study|Adverse Event|3|||
129169887|NCT02526524|464915857|FG001|Overall Study|Adverse Event|2|||
129169888|NCT02526524|464915858|FG002|Overall Study|Adverse Event|4|||
129169889|NCT02526524|464915859|FG003|Overall Study|Adverse Event|2|||
129169890|NCT02526524|464915860|FG004|Overall Study|Adverse Event|6|||
129169891|NCT02526524|464915861|FG005|Overall Study|Adverse Event|8|||
129169892|NCT02526524|464915856|FG000|Overall Study|Lost to Follow-up|2|||
129169893|NCT02526524|464915857|FG001|Overall Study|Lost to Follow-up|3|||
128728918|NCT00213148|463304116|FG000|Cycle 2 (1 Month)|Other|2|||
128728919|NCT00213148|463304117|FG001|Cycle 2 (1 Month)|Other|1|||
128728920|NCT00213148|463304118|FG002|Cycle 2 (1 Month)|Other|2|||
128728921|NCT00213148|463304119|FG003|Cycle 2 (1 Month)|Other|8|||
128728922|NCT00213148|463304120|FG004|Cycle 2 (1 Month)|Other|7|||
129169894|NCT02526524|464915858|FG002|Overall Study|Lost to Follow-up|8|||
128728923|NCT00213148|463304116|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129169895|NCT02526524|464915859|FG003|Overall Study|Lost to Follow-up|1|||
129169896|NCT02526524|464915860|FG004|Overall Study|Lost to Follow-up|2|||
129169897|NCT02526524|464915861|FG005|Overall Study|Lost to Follow-up|5|||
129169898|NCT02526524|464915856|FG000|Overall Study|Protocol Violation|3|||
128778676|NCT05968482|463478823|FG002|Third Crossover Period|Adverse Event|0|||
128778677|NCT05968482|463478824|FG003|Third Crossover Period|Adverse Event|0|||
129169899|NCT02526524|464915857|FG001|Overall Study|Protocol Violation|1|||
129169900|NCT02526524|464915858|FG002|Overall Study|Protocol Violation|5|||
129169901|NCT02526524|464915859|FG003|Overall Study|Protocol Violation|3|||
129169902|NCT02526524|464915860|FG004|Overall Study|Protocol Violation|4|||
129169903|NCT02526524|464915861|FG005|Overall Study|Protocol Violation|3|||
129169904|NCT02526524|464915856|FG000|Overall Study|Loss of Glucose Control|0|||
129169905|NCT02526524|464915857|FG001|Overall Study|Loss of Glucose Control|0|||
129169906|NCT02526524|464915858|FG002|Overall Study|Loss of Glucose Control|3|||
129169907|NCT02526524|464915859|FG003|Overall Study|Loss of Glucose Control|0|||
129169908|NCT02526524|464915860|FG004|Overall Study|Loss of Glucose Control|2|||
129169909|NCT02526524|464915861|FG005|Overall Study|Loss of Glucose Control|0|||
128778678|NCT05968482|463478825|FG004|Third Crossover Period|Adverse Event|1|||
129169910|NCT02526524|464915856|FG000|Overall Study|Physician Decision|0|||
128778679|NCT05968482|463478826|FG005|Third Crossover Period|Adverse Event|0|||
128778680|NCT05968482|463478821|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
128778681|NCT05968482|463478822|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
128778682|NCT05968482|463478823|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
128778683|NCT05968482|463478824|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
128778684|NCT05968482|463478825|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
128778685|NCT05968482|463478826|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
128778686|NCT01925170|463478828|FG000|Overall Study|Unverified cancer status|53|||
128778687|NCT00761774|463478829|FG000|Overall Study|Adverse Event|17|||
128778688|NCT00761774|463478829|FG000|Overall Study|Lack of Efficacy|37|||
128778689|NCT00761774|463478829|FG000|Overall Study|Lost to Follow-up|2|||
128778690|NCT00761774|463478829|FG000|Overall Study|Withdrawal by Subject|9|||
128778691|NCT00761774|463478829|FG000|Overall Study|Non-compliance|4|||
128778692|NCT00761774|463478829|FG000|Overall Study|End of study|2|||
128778693|NCT00761774|463478829|FG000|Overall Study|Reclassification of seizures|1|||
128778694|NCT00761774|463478829|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
128778695|NCT00761774|463478829|FG000|Overall Study|Sponsor decision|1|||
128778696|NCT00761774|463478829|FG000|Overall Study|Investigator clinical judgement|1|||
128778697|NCT00761774|463478829|FG000|Overall Study|Patient moved out of study area|1|||
128778698|NCT00761774|463478829|FG000|Overall Study|Coordinator leaving site|1|||
128778699|NCT00761774|463478829|FG000|Overall Study|Subject IP non-compliance|1|||
128778700|NCT00761774|463478829|FG000|Overall Study|IP stopped by hospital physician|1|||
128778701|NCT01077024|463478832|FG000|Overall Study|Lost to Follow-up|20|||
128778702|NCT01077024|463478833|FG001|Overall Study|Lost to Follow-up|14|||
128778703|NCT01077024|463478832|FG000|Overall Study|Withdrawal by Subject|0|||
128778704|NCT01077024|463478833|FG001|Overall Study|Withdrawal by Subject|2|||
128778705|NCT01077024|463478832|FG000|Overall Study|Incarcerated|7|||
128778706|NCT01077024|463478833|FG001|Overall Study|Incarcerated|8|||
128778707|NCT01077024|463478832|FG000|Overall Study|Other|4|||
128778708|NCT01077024|463478833|FG001|Overall Study|Other|4|||
128778709|NCT03379233|463478834|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
128778710|NCT03379233|463478835|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
129169911|NCT02526524|464915857|FG001|Overall Study|Physician Decision|0|||
128778711|NCT01603121|463478836|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
128778712|NCT01603121|463478837|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
128778713|NCT02300311|463478840|FG000|Overall Study|Other than the reason specified|1|||
129169912|NCT02526524|464915858|FG002|Overall Study|Physician Decision|0|||
129169913|NCT02526524|464915859|FG003|Overall Study|Physician Decision|0|||
128778714|NCT02300311|463478841|FG001|Overall Study|Other than the reason specified|0|||
129169914|NCT02526524|464915860|FG004|Overall Study|Physician Decision|1|||
129169915|NCT02526524|464915861|FG005|Overall Study|Physician Decision|0|||
128778715|NCT02300311|463478840|FG000|Overall Study|Refused to continue taking medication|18|||
128778716|NCT02300311|463478841|FG001|Overall Study|Refused to continue taking medication|0|||
128778717|NCT00419003|463478842|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
128778718|NCT00419003|463478843|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
128778719|NCT00419003|463478842|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
128778720|NCT00419003|463478843|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
128778721|NCT01656759|463478844|FG000|Overall Study|Protocol Violation|2|||
128778722|NCT01656759|463478845|FG001|Overall Study|Protocol Violation|3|||
128778723|NCT02687919|463478846|FG000|Overall Study|Withdrawal by Subject|6|||
128778724|NCT02687919|463478847|FG001|Overall Study|Withdrawal by Subject|6|||
128778725|NCT02687919|463478846|FG000|Overall Study|Protocol Violation|2|||
128778726|NCT02687919|463478847|FG001|Overall Study|Protocol Violation|0|||
128778727|NCT02531438|463478848|FG000|Overall Study|Adverse Event|7|||
128778728|NCT02531438|463478849|FG001|Overall Study|Adverse Event|9|||
128778729|NCT02531438|463478848|FG000|Overall Study|Lost to Follow-up|0|||
128778730|NCT02531438|463478849|FG001|Overall Study|Lost to Follow-up|3|||
128778731|NCT02531438|463478848|FG000|Overall Study|Withdrawal by Subject|7|||
128778732|NCT02531438|463478849|FG001|Overall Study|Withdrawal by Subject|8|||
128778733|NCT02531438|463478848|FG000|Overall Study|Physician Decision|0|||
128778734|NCT02531438|463478849|FG001|Overall Study|Physician Decision|1|||
128778735|NCT02531438|463478848|FG000|Overall Study|Death|6|||
128778736|NCT02531438|463478849|FG001|Overall Study|Death|3|||
128778737|NCT02531438|463478848|FG000|Overall Study|Randomized, but Not Treated|4|||
128778738|NCT02531438|463478849|FG001|Overall Study|Randomized, but Not Treated|0|||
128778739|NCT02531438|463478848|FG000|Overall Study|Missed EOT/PTE Visit|5|||
128778740|NCT02531438|463478849|FG001|Overall Study|Missed EOT/PTE Visit|2|||
128778741|NCT02531438|463478848|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
128778742|NCT02531438|463478849|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
128778743|NCT00772928|463478850|FG000|Overall Study|Lost to Follow-up|9|||
128778744|NCT00772928|463478851|FG001|Overall Study|Lost to Follow-up|6|||
128778745|NCT00772928|463478850|FG000|Overall Study|Protocol Violation|10|||
128778746|NCT00772928|463478851|FG001|Overall Study|Protocol Violation|12|||
128778747|NCT00772928|463478850|FG000|Overall Study|Withdrawal by Subject|25|||
128778748|NCT00772928|463478851|FG001|Overall Study|Withdrawal by Subject|22|||
128778749|NCT00772928|463478850|FG000|Overall Study|Did not receive vaccine|0|||
128778750|NCT00772928|463478851|FG001|Overall Study|Did not receive vaccine|1|||
128778751|NCT00801242|463478858|FG000|Overall Study|Adverse Event|10|||
128778752|NCT00801242|463478858|FG000|Overall Study|Withdrawal by Subject|13|||
128778753|NCT00801242|463478858|FG000|Overall Study|Protocol Violation|5|||
128778754|NCT00801242|463478858|FG000|Overall Study|Physician Decision|3|||
128778755|NCT00801242|463478858|FG000|Overall Study|Lost to Follow-up|1|||
128778756|NCT00801242|463478858|FG000|Overall Study|Miscellaneous reasons|20|||
128778757|NCT02015195|463478860|FG000|Overall Study|Adverse Event|0|||
128778758|NCT02015195|463478861|FG001|Overall Study|Adverse Event|0|||
128778759|NCT02015195|463478862|FG002|Overall Study|Adverse Event|0|||
128778760|NCT02015195|463478863|FG003|Overall Study|Adverse Event|1|||
128778761|NCT02015195|463478864|FG004|Overall Study|Adverse Event|0|||
128778762|NCT02015195|463478865|FG005|Overall Study|Adverse Event|0|||
128778763|NCT02015195|463478866|FG006|Overall Study|Adverse Event|0|||
128778764|NCT01318811|463478867|FG000|Overall Study|Physician Decision|1|||
128778765|NCT01318811|463478868|FG001|Overall Study|Physician Decision|1|||
128778766|NCT01318811|463478867|FG000|Overall Study|CRRT stopped for head CT|0|||
128778767|NCT01318811|463478868|FG001|Overall Study|CRRT stopped for head CT|1|||
128778768|NCT01318811|463478867|FG000|Overall Study|Death|0|||
129169916|NCT02526524|464915856|FG000|Overall Study|Sponsor Decision|1|||
129169917|NCT02526524|464915857|FG001|Overall Study|Sponsor Decision|0|||
129169918|NCT02526524|464915858|FG002|Overall Study|Sponsor Decision|0|||
129169919|NCT02526524|464915859|FG003|Overall Study|Sponsor Decision|0|||
129169920|NCT02526524|464915860|FG004|Overall Study|Sponsor Decision|0|||
129169921|NCT02526524|464915861|FG005|Overall Study|Sponsor Decision|0|||
129169922|NCT05312632|464915862|FG000|Overall Study|Adverse Event|12|||
129169923|NCT05312632|464915862|FG000|Overall Study|Withdrawal by Subject|10|||
129169924|NCT05312632|464915862|FG000|Overall Study|Lack of Efficacy|4|||
128778769|NCT01318811|463478868|FG001|Overall Study|Death|1|||
128778770|NCT01318811|463478867|FG000|Overall Study|CRRT stopped for head MRI|0|||
128778771|NCT01318811|463478868|FG001|Overall Study|CRRT stopped for head MRI|1|||
128778772|NCT00811187|463478869|FG000|Overall Study|Unable to place device / procedure abort|3|||
128778773|NCT00811187|463478870|FG001|Overall Study|Unable to place device / procedure abort|3|||
128778774|NCT00131911|463478871|FG000|Overall Study|Withdrawal by Subject|1|||
128778775|NCT00131911|463478872|FG001|Overall Study|Withdrawal by Subject|0|||
128778776|NCT00329303|463478873|FG000|Overall Study|Lack of Efficacy|1|||
128778777|NCT00329303|463478874|FG001|Overall Study|Lack of Efficacy|0|||
128778778|NCT00329303|463478873|FG000|Overall Study|Decision of the sponsor|0|||
128778779|NCT00329303|463478874|FG001|Overall Study|Decision of the sponsor|1|||
129169925|NCT05312632|464915862|FG000|Overall Study|Non-compliance with study procedures|9|||
129169926|NCT05312632|464915862|FG000|Overall Study|Other|4|||
129169927|NCT02379221|464915863|FG000|Overall Study|Lost to Follow-up|1|||
128778780|NCT00329303|463478873|FG000|Overall Study|Patient no longer available|1|||
128778781|NCT00329303|463478874|FG001|Overall Study|Patient no longer available|0|||
128778782|NCT00329303|463478873|FG000|Overall Study|Patient relocated|0|||
128778783|NCT00329303|463478874|FG001|Overall Study|Patient relocated|1|||
128778784|NCT04951479|463478878|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
128778785|NCT00394095|463480389|FG000|Screening|Withdrawal by Subject|1|||
128778786|NCT00394095|463480390|FG001|Screening|Withdrawal by Subject|0|||
128778787|NCT00394095|463480389|FG000|Randomized|Withdrawal by Subject|5|||
128778788|NCT00394095|463480390|FG001|Randomized|Withdrawal by Subject|1|||
128778789|NCT00394095|463480389|FG000|Randomized|Adverse Event|1|||
128778790|NCT00394095|463480390|FG001|Randomized|Adverse Event|1|||
128778791|NCT00394095|463480389|FG000|Randomized|Overdose|1|||
128778792|NCT00394095|463480390|FG001|Randomized|Overdose|0|||
128778793|NCT00394095|463480389|FG000|Randomized|Lost to Follow-up|1|||
128778794|NCT00394095|463480390|FG001|Randomized|Lost to Follow-up|2|||
128778795|NCT04213846|463480391|FG000|Overall Study|Withdrawal by Subject|7|||
128778796|NCT04213846|463480392|FG001|Overall Study|Withdrawal by Subject|6|||
128778797|NCT04213846|463480391|FG000|Overall Study|Lost to Follow-up|15|||
128778798|NCT04213846|463480392|FG001|Overall Study|Lost to Follow-up|21|||
128778799|NCT01115998|463480395|FG000|Overall Study|Lost to Follow-up|6|||
128778800|NCT01115998|463480396|FG001|Overall Study|Lost to Follow-up|6|||
128778801|NCT01268059|463480397|FG000|Overall Study|Lost to Follow-up|0|||
128778802|NCT01268059|463480398|FG001|Overall Study|Lost to Follow-up|1|||
128778803|NCT01268059|463480399|FG002|Overall Study|Lost to Follow-up|0|||
128778804|NCT01268059|463480400|FG003|Overall Study|Lost to Follow-up|0|||
128778805|NCT01268059|463480397|FG000|Overall Study|Withdrawal by Subject|7|||
128778806|NCT01268059|463480398|FG001|Overall Study|Withdrawal by Subject|4|||
128778807|NCT01268059|463480399|FG002|Overall Study|Withdrawal by Subject|0|||
128778808|NCT01268059|463480400|FG003|Overall Study|Withdrawal by Subject|0|||
128778809|NCT01268059|463480397|FG000|Overall Study|Death|20|||
128778810|NCT01268059|463480398|FG001|Overall Study|Death|30|||
128778811|NCT01268059|463480399|FG002|Overall Study|Death|3|||
128778812|NCT01268059|463480400|FG003|Overall Study|Death|5|||
128778813|NCT01268059|463480397|FG000|Overall Study|Progression of disease|1|||
128778814|NCT01268059|463480398|FG001|Overall Study|Progression of disease|0|||
128778815|NCT01268059|463480399|FG002|Overall Study|Progression of disease|0|||
128778816|NCT01268059|463480400|FG003|Overall Study|Progression of disease|0|||
128778817|NCT03850444|463480401|FG000|Overall Study|Adverse Event|16|||
128778818|NCT03850444|463480402|FG001|Overall Study|Adverse Event|10|||
128778819|NCT03850444|463480401|FG000|Overall Study|Death|87|||
128778820|NCT03850444|463480402|FG001|Overall Study|Death|107|||
128778821|NCT03850444|463480401|FG000|Overall Study|Lost to Follow-up|1|||
128778822|NCT03850444|463480402|FG001|Overall Study|Lost to Follow-up|1|||
128778823|NCT03850444|463480401|FG000|Overall Study|Withdrawal by Subject|1|||
128778824|NCT03850444|463480402|FG001|Overall Study|Withdrawal by Subject|5|||
128778825|NCT03850444|463480401|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
128778826|NCT03850444|463480402|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
128778827|NCT04096365|463480403|FG000|Overall Study|Adverse Event|1|||
128778828|NCT05310084|463480404|FG000|Overall Study|Withdrawal by Subject|2|||
128778829|NCT05310084|463480405|FG001|Overall Study|Withdrawal by Subject|3|||
128778830|NCT05310084|463480404|FG000|Overall Study|Participant availability|0|||
128778831|NCT05310084|463480405|FG001|Overall Study|Participant availability|4|||
128778832|NCT05310084|463480404|FG000|Overall Study|Lost to Follow-up|1|||
128778833|NCT05310084|463480405|FG001|Overall Study|Lost to Follow-up|1|||
128778834|NCT05310084|463480404|FG000|Overall Study|Adverse Event|1|||
128778835|NCT05310084|463480405|FG001|Overall Study|Adverse Event|1|||
128778836|NCT05310084|463480404|FG000|Overall Study|Randomized but not vaccinated|4|||
128778837|NCT05310084|463480405|FG001|Overall Study|Randomized but not vaccinated|2|||
129169928|NCT00519376|464915864|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169929|NCT00519376|464915865|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169930|NCT00519376|464915866|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169931|NCT00519376|464915867|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169932|NCT00519376|464915868|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169933|NCT00519376|464915869|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169934|NCT00519376|464915870|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169935|NCT00519376|464915871|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
128778838|NCT01598987|463480407|FG000|Baseline to Month 12|Administrative problems|2|||
128778839|NCT01598987|463480407|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
128778840|NCT01598987|463480407|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
128778841|NCT01598987|463480407|FG000|Baseline to 24 Month|Administrative problems|2|||
128778842|NCT01598987|463480407|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
128778843|NCT02107274|463480408|FG000|Treatment vs. Placebo|Adverse Event|3|||
128778844|NCT02107274|463480409|FG001|Treatment vs. Placebo|Adverse Event|0|||
128778845|NCT02107274|463480408|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
128778846|NCT02107274|463480409|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
128778847|NCT02107274|463480408|FG000|Control Phase|Lost to Follow-up|1|||
128778848|NCT02107274|463480409|FG001|Control Phase|Lost to Follow-up|1|||
128778849|NCT02107274|463480408|FG000|Control Phase|Death|2|||
128778850|NCT02107274|463480409|FG001|Control Phase|Death|0|||
128778851|NCT02107274|463480408|FG000|Control Phase|Adverse Event|0|||
128778852|NCT02107274|463480409|FG001|Control Phase|Adverse Event|1|||
128778853|NCT01036087|463480411|FG000|Overall Study|Adverse Event|2|||
128778854|NCT01036087|463480411|FG000|Overall Study|Lack of Efficacy|1|||
128778855|NCT02424344|463480415|FG000|Overall Study|Lack of Efficacy|0|||
128778856|NCT02424344|463480416|FG001|Overall Study|Lack of Efficacy|1|||
128778857|NCT02424344|463480415|FG000|Overall Study|Withdrawal by Subject|2|||
128778858|NCT02424344|463480416|FG001|Overall Study|Withdrawal by Subject|1|||
128778859|NCT02424344|463480415|FG000|Overall Study|Lost to Follow-up|1|||
128778860|NCT02424344|463480416|FG001|Overall Study|Lost to Follow-up|0|||
128778861|NCT02424344|463480415|FG000|Overall Study|Adverse Event|4|||
128778862|NCT02424344|463480416|FG001|Overall Study|Adverse Event|8|||
128778863|NCT00765362|463480426|FG000|Overall Study|Death|9|||
128778864|NCT00765362|463480426|FG000|Overall Study|Adverse Event|2|||
128778865|NCT00765362|463480426|FG000|Overall Study|Protocol Violation|18|||
128778866|NCT00765362|463480426|FG000|Overall Study|Withdrawal by Subject|13|||
128778867|NCT00765362|463480426|FG000|Overall Study|Lost to Follow-up|95|||
128778868|NCT00557505|463480430|FG000|Overall Study|Death|0|||
128778869|NCT00557505|463480431|FG001|Overall Study|Death|0|||
128778870|NCT00557505|463480432|FG002|Overall Study|Death|0|||
128778871|NCT00557505|463480433|FG003|Overall Study|Death|0|||
128778872|NCT00557505|463480434|FG004|Overall Study|Death|0|||
128778873|NCT00557505|463480435|FG005|Overall Study|Death|0|||
129169936|NCT00519376|464915872|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169937|NCT00519376|464915873|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169938|NCT00519376|464915874|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169939|NCT00519376|464915875|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169940|NCT00519376|464915876|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
129169941|NCT00519376|464915877|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169942|NCT00519376|464915878|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169943|NCT00519376|464915879|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129169944|NCT00519376|464915864|FG000|Treatment Period 4|Lost to Follow-up|0|||
129169945|NCT00519376|464915865|FG001|Treatment Period 4|Lost to Follow-up|0|||
129169946|NCT00519376|464915866|FG002|Treatment Period 4|Lost to Follow-up|1|||
129169947|NCT00519376|464915867|FG003|Treatment Period 4|Lost to Follow-up|0|||
129169948|NCT00519376|464915868|FG004|Treatment Period 4|Lost to Follow-up|0|||
129169949|NCT00519376|464915869|FG005|Treatment Period 4|Lost to Follow-up|0|||
129169950|NCT00519376|464915870|FG006|Treatment Period 4|Lost to Follow-up|0|||
129169951|NCT00519376|464915871|FG007|Treatment Period 4|Lost to Follow-up|0|||
129169952|NCT00519376|464915872|FG008|Treatment Period 4|Lost to Follow-up|0|||
129169953|NCT00519376|464915873|FG009|Treatment Period 4|Lost to Follow-up|0|||
129169954|NCT00519376|464915874|FG010|Treatment Period 4|Lost to Follow-up|0|||
129169955|NCT00519376|464915875|FG011|Treatment Period 4|Lost to Follow-up|0|||
129169956|NCT00519376|464915876|FG012|Treatment Period 4|Lost to Follow-up|0|||
129169957|NCT00519376|464915877|FG013|Treatment Period 4|Lost to Follow-up|0|||
129169958|NCT00519376|464915878|FG014|Treatment Period 4|Lost to Follow-up|0|||
129169959|NCT00519376|464915879|FG015|Treatment Period 4|Lost to Follow-up|0|||
129169960|NCT02650128|464915882|FG000|Overall Study|Death|2|||
129169961|NCT01801436|464915896|FG000|Overall Study|Withdrawal by Subject|3|||
129169962|NCT01801436|464915896|FG000|Overall Study|Adverse Event|2|||
129169963|NCT01801436|464915896|FG000|Overall Study|Progressive disease|4|||
129169964|NCT01885208|464915897|FG000|Overall Study|Unclassified|32|||
129169965|NCT01885208|464915898|FG001|Overall Study|Unclassified|38|||
129169966|NCT01498575|464915902|FG000|Overall Sample|Withdrawal by Subject|60|||
129169967|NCT01498575|464915903|FG001|Overall Sample|Withdrawal by Subject|14|||
129169968|NCT01498575|464915902|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
129169969|NCT01498575|464915903|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
129169970|NCT01498575|464915902|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
129169971|NCT01498575|464915903|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
129169972|NCT01126437|464915909|FG000|Overall Study|Not treated|11|||
129169973|NCT01126437|464915910|FG001|Overall Study|Not treated|18|||
128778874|NCT00557505|463480436|FG006|Overall Study|Death|0|||
128778875|NCT00557505|463480437|FG007|Overall Study|Death|0|||
128778876|NCT00557505|463480438|FG008|Overall Study|Death|1|||
128778877|NCT00557505|463480430|FG000|Overall Study|Adverse Event|0|||
128778878|NCT00557505|463480431|FG001|Overall Study|Adverse Event|0|||
129169974|NCT01126437|464915911|FG002|Overall Study|Not treated|19|||
129169975|NCT01126437|464915909|FG000|Overall Study|Sites with data irregularities/fraud|6|||
129169976|NCT01126437|464915910|FG001|Overall Study|Sites with data irregularities/fraud|6|||
129169977|NCT01126437|464915911|FG002|Overall Study|Sites with data irregularities/fraud|7|||
129169978|NCT01126437|464915909|FG000|Overall Study|Adverse Event|602|||
128778879|NCT00557505|463480432|FG002|Overall Study|Adverse Event|1|||
129169979|NCT01126437|464915910|FG001|Overall Study|Adverse Event|606|||
129169980|NCT01126437|464915911|FG002|Overall Study|Adverse Event|635|||
129169981|NCT01126437|464915909|FG000|Overall Study|Lack of Efficacy|65|||
129169982|NCT01126437|464915910|FG001|Overall Study|Lack of Efficacy|60|||
129169983|NCT01126437|464915911|FG002|Overall Study|Lack of Efficacy|59|||
129169984|NCT01126437|464915909|FG000|Overall Study|Protocol Violation|64|||
129169985|NCT01126437|464915910|FG001|Overall Study|Protocol Violation|66|||
129169986|NCT01126437|464915911|FG002|Overall Study|Protocol Violation|41|||
128728924|NCT00213148|463304117|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
128728925|NCT00213148|463304118|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
128728926|NCT00213148|463304119|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
128728927|NCT00213148|463304120|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
128728928|NCT00213148|463304116|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
128728929|NCT00213148|463304117|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728930|NCT00213148|463304118|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728931|NCT00213148|463304119|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728932|NCT00213148|463304120|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
128728933|NCT00213148|463304116|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
128728934|NCT00213148|463304117|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
128728935|NCT00213148|463304118|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
128728936|NCT00213148|463304119|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
128728937|NCT00213148|463304120|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
128728938|NCT00213148|463304116|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
128728939|NCT00213148|463304117|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
128728940|NCT00213148|463304118|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
128728941|NCT00213148|463304119|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
128728942|NCT00213148|463304120|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
128728943|NCT00213148|463304116|FG000|Cycle 3 (1 Month)|Other|0|||
128728944|NCT00213148|463304117|FG001|Cycle 3 (1 Month)|Other|0|||
128728945|NCT00213148|463304118|FG002|Cycle 3 (1 Month)|Other|1|||
128728946|NCT00213148|463304119|FG003|Cycle 3 (1 Month)|Other|1|||
128728947|NCT00213148|463304120|FG004|Cycle 3 (1 Month)|Other|0|||
128728948|NCT00558103|463304121|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
128728949|NCT00558103|463304122|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
128728950|NCT00558103|463304123|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
128728951|NCT00558103|463304124|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
128728952|NCT00558103|463304125|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
128728953|NCT00558103|463304126|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
128728954|NCT00558103|463304121|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
128728955|NCT00558103|463304122|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
128728956|NCT00558103|463304123|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
128728957|NCT00558103|463304124|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
128728958|NCT00558103|463304125|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
128728959|NCT00558103|463304126|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
128728960|NCT00558103|463304121|FG000|Randomized Treatment Phase|Disease Progression|1|||
128728961|NCT00558103|463304122|FG001|Randomized Treatment Phase|Disease Progression|0|||
128728962|NCT00558103|463304123|FG002|Randomized Treatment Phase|Disease Progression|1|||
128728963|NCT00558103|463304124|FG003|Randomized Treatment Phase|Disease Progression|0|||
128728964|NCT00558103|463304125|FG004|Randomized Treatment Phase|Disease Progression|0|||
128728965|NCT00558103|463304126|FG005|Randomized Treatment Phase|Disease Progression|0|||
128728966|NCT00558103|463304121|FG000|Randomized Treatment Phase|Adverse Event|0|||
128728967|NCT00558103|463304122|FG001|Randomized Treatment Phase|Adverse Event|0|||
128728968|NCT00558103|463304123|FG002|Randomized Treatment Phase|Adverse Event|0|||
128728969|NCT00558103|463304124|FG003|Randomized Treatment Phase|Adverse Event|1|||
128728970|NCT00558103|463304125|FG004|Randomized Treatment Phase|Adverse Event|1|||
128728971|NCT00558103|463304126|FG005|Randomized Treatment Phase|Adverse Event|0|||
128728972|NCT00558103|463304121|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
128728973|NCT00558103|463304122|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
128728974|NCT00558103|463304123|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
128728975|NCT00558103|463304124|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
128728976|NCT00558103|463304125|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
128728977|NCT00558103|463304126|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
128728978|NCT00558103|463304121|FG000|Monotherapy Extension Phase|Disease Progression|0|||
128728979|NCT00558103|463304122|FG001|Monotherapy Extension Phase|Disease Progression|0|||
128728980|NCT00558103|463304123|FG002|Monotherapy Extension Phase|Disease Progression|0|||
129169987|NCT01126437|464915909|FG000|Overall Study|Lost to Follow-up|52|||
128728981|NCT00558103|463304124|FG003|Monotherapy Extension Phase|Disease Progression|0|||
128728982|NCT00558103|463304125|FG004|Monotherapy Extension Phase|Disease Progression|0|||
128728983|NCT00558103|463304126|FG005|Monotherapy Extension Phase|Disease Progression|8|||
128728984|NCT02434770|463304129|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
128728985|NCT02434770|463304130|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
129169988|NCT01126437|464915910|FG001|Overall Study|Lost to Follow-up|63|||
129169989|NCT01126437|464915911|FG002|Overall Study|Lost to Follow-up|55|||
128778880|NCT00557505|463480433|FG003|Overall Study|Adverse Event|0|||
128778881|NCT00557505|463480434|FG004|Overall Study|Adverse Event|0|||
128778882|NCT00557505|463480435|FG005|Overall Study|Adverse Event|0|||
128778883|NCT00557505|463480436|FG006|Overall Study|Adverse Event|1|||
128778884|NCT00557505|463480437|FG007|Overall Study|Adverse Event|0|||
128778885|NCT00557505|463480438|FG008|Overall Study|Adverse Event|0|||
128778886|NCT00557505|463480430|FG000|Overall Study|Global deterioration of health|1|||
128778887|NCT00557505|463480431|FG001|Overall Study|Global deterioration of health|0|||
128778888|NCT00557505|463480432|FG002|Overall Study|Global deterioration of health|0|||
129169990|NCT01126437|464915909|FG000|Overall Study|Withdrawal by Subject|331|||
129169991|NCT01126437|464915910|FG001|Overall Study|Withdrawal by Subject|335|||
129169992|NCT01126437|464915911|FG002|Overall Study|Withdrawal by Subject|319|||
129169993|NCT01126437|464915909|FG000|Overall Study|Other reason not specified|210|||
129169994|NCT01126437|464915910|FG001|Overall Study|Other reason not specified|176|||
129169995|NCT01126437|464915911|FG002|Overall Study|Other reason not specified|178|||
129169996|NCT01972308|464915918|FG000|Overall Study|Withdrawal by Subject|0|||
129169997|NCT01972308|464915919|FG001|Overall Study|Withdrawal by Subject|1|||
129169998|NCT01972308|464915918|FG000|Overall Study|Lost to Follow-up|4|||
128778889|NCT00557505|463480433|FG003|Overall Study|Global deterioration of health|0|||
128778890|NCT00557505|463480434|FG004|Overall Study|Global deterioration of health|0|||
129169999|NCT01972308|464915919|FG001|Overall Study|Lost to Follow-up|6|||
129170000|NCT01972308|464915918|FG000|Overall Study|Death|4|||
129170001|NCT01972308|464915919|FG001|Overall Study|Death|1|||
128778891|NCT00557505|463480435|FG005|Overall Study|Global deterioration of health|0|||
128778892|NCT00557505|463480436|FG006|Overall Study|Global deterioration of health|0|||
128778893|NCT00557505|463480437|FG007|Overall Study|Global deterioration of health|0|||
128778894|NCT00557505|463480438|FG008|Overall Study|Global deterioration of health|0|||
128778895|NCT00557505|463480430|FG000|Overall Study|Objective progression or relapse|2|||
128778896|NCT00557505|463480431|FG001|Overall Study|Objective progression or relapse|3|||
128778897|NCT00557505|463480432|FG002|Overall Study|Objective progression or relapse|3|||
128778898|NCT00557505|463480433|FG003|Overall Study|Objective progression or relapse|2|||
128778899|NCT00557505|463480434|FG004|Overall Study|Objective progression or relapse|2|||
128778900|NCT00557505|463480435|FG005|Overall Study|Objective progression or relapse|3|||
128778901|NCT00557505|463480436|FG006|Overall Study|Objective progression or relapse|2|||
128778902|NCT00557505|463480437|FG007|Overall Study|Objective progression or relapse|5|||
128778903|NCT00557505|463480438|FG008|Overall Study|Objective progression or relapse|15|||
128778904|NCT00557505|463480430|FG000|Overall Study|Withdrawal by Subject|0|||
128778905|NCT00557505|463480431|FG001|Overall Study|Withdrawal by Subject|0|||
128778906|NCT00557505|463480432|FG002|Overall Study|Withdrawal by Subject|0|||
128778907|NCT00557505|463480433|FG003|Overall Study|Withdrawal by Subject|1|||
128778908|NCT00557505|463480434|FG004|Overall Study|Withdrawal by Subject|0|||
128778909|NCT00557505|463480435|FG005|Overall Study|Withdrawal by Subject|0|||
128778910|NCT00557505|463480436|FG006|Overall Study|Withdrawal by Subject|0|||
128778911|NCT00557505|463480437|FG007|Overall Study|Withdrawal by Subject|0|||
128778912|NCT00557505|463480438|FG008|Overall Study|Withdrawal by Subject|1|||
128778913|NCT01636362|463480439|FG000|Overall Study|Physician Decision|6|||
128778914|NCT01636362|463480439|FG000|Overall Study|Subject healed, not returning|1|||
128778915|NCT01636362|463480439|FG000|Overall Study|Withdrawal by Subject|1|||
128778916|NCT00519779|463480440|FG000|Overall Study|Withdrawal by Subject|0|||
129170002|NCT01846663|464915920|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
129170003|NCT01846663|464915921|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
129170004|NCT01846663|464915920|FG000|Overall Study|Withdrawal by Subject|1|||
129170005|NCT01846663|464915921|FG001|Overall Study|Withdrawal by Subject|0|||
129170006|NCT01846663|464915920|FG000|Overall Study|Adverse Event|1|||
129170007|NCT01846663|464915921|FG001|Overall Study|Adverse Event|2|||
129170008|NCT01562314|464915926|FG000|Overall Study|Adverse Event|10|||
129170009|NCT01562314|464915927|FG001|Overall Study|Adverse Event|5|||
129170010|NCT01562314|464915926|FG000|Overall Study|Met Withdrawal Criteria|3|||
129170011|NCT01562314|464915927|FG001|Overall Study|Met Withdrawal Criteria|2|||
129170012|NCT01562314|464915926|FG000|Overall Study|Withdrawal by Subject|0|||
129170013|NCT01562314|464915927|FG001|Overall Study|Withdrawal by Subject|1|||
129170014|NCT02851797|464915928|FG000|Overall Study|Withdrawal by Subject|4|||
129170015|NCT02851797|464915929|FG001|Overall Study|Withdrawal by Subject|2|||
129170016|NCT02851797|464915928|FG000|Overall Study|Adverse Event|3|||
128778917|NCT00519779|463480441|FG001|Overall Study|Withdrawal by Subject|1|||
128778918|NCT01561079|463480442|FG000|Overall Study|Physician Decision|17|||
128778919|NCT01561079|463480442|FG000|Overall Study|Withdrawal by Subject|59|||
128778920|NCT01561079|463480442|FG000|Overall Study|Protocol Violation|2|||
128778921|NCT03330119|463480443|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
129170017|NCT02851797|464915929|FG001|Overall Study|Adverse Event|0|||
129170018|NCT03655054|464915930|FG000|Overall Study|Lost to Follow-up|1|||
129170019|NCT00813865|464915934|FG000|Overall Study|Failure to Respond|3|||
129170020|NCT00813865|464915934|FG000|Overall Study|Lost to Follow-up|3|||
129170021|NCT00813865|464915934|FG000|Overall Study|Withdrawal by Subject|1|||
128778922|NCT03330119|463480444|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
128778923|NCT00664521|463480456|FG000|Overall Study|Adverse Event|4|||
128778924|NCT00664521|463480457|FG001|Overall Study|Adverse Event|1|||
128778925|NCT00664521|463480456|FG000|Overall Study|Lost to Follow-up|1|||
128778926|NCT00664521|463480457|FG001|Overall Study|Lost to Follow-up|0|||
128778927|NCT00664521|463480456|FG000|Overall Study|Other|1|||
128778928|NCT00664521|463480457|FG001|Overall Study|Other|0|||
128778929|NCT02459964|463480458|FG000|Overall Study|Withdrawal by Subject|0|||
128778930|NCT02459964|463480459|FG001|Overall Study|Withdrawal by Subject|0|||
128778931|NCT02459964|463480460|FG002|Overall Study|Withdrawal by Subject|1|||
128778932|NCT02459964|463480458|FG000|Overall Study|Abnormal EKG changes|0|||
128778933|NCT02459964|463480459|FG001|Overall Study|Abnormal EKG changes|0|||
128778934|NCT02459964|463480460|FG002|Overall Study|Abnormal EKG changes|1|||
128778935|NCT00550732|463480461|FG000|Overall Study|Death|4|||
128778936|NCT00550732|463480461|FG000|Overall Study|Withdrawal by Subject|2|||
128778937|NCT00550732|463480461|FG000|Overall Study|Physician Decision|2|||
128778938|NCT00550732|463480461|FG000|Overall Study|Lost to Follow-up|1|||
128778939|NCT00550732|463480461|FG000|Overall Study|Palliative care|1|||
128778940|NCT00550732|463480461|FG000|Overall Study|Adverse Event|1|||
128778941|NCT03302910|463480462|FG000|Overall Study|Protocol Violation|1|||
128778942|NCT03302910|463480463|FG001|Overall Study|Protocol Violation|0|||
128778943|NCT04004208|463480467|FG000|Overall Study|Withdrawal by parent/guardian|1|||
128778944|NCT04004208|463480468|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128778945|NCT04004208|463480467|FG000|Overall Study|Death|3|||
128778946|NCT04004208|463480468|FG001|Overall Study|Death|0|||
128778947|NCT04004208|463480467|FG000|Overall Study|COVID-19 pandemic|1|||
128778948|NCT04004208|463480468|FG001|Overall Study|COVID-19 pandemic|0|||
128778949|NCT04004208|463480467|FG000|Overall Study|Physician Decision|1|||
128778950|NCT04004208|463480468|FG001|Overall Study|Physician Decision|0|||
128778951|NCT04004208|463480467|FG000|Overall Study|Adverse Event|1|||
128778952|NCT04004208|463480468|FG001|Overall Study|Adverse Event|1|||
128778953|NCT01734382|463480477|FG000|Part 1|Adverse Event|2|||
128778954|NCT01734382|463480478|FG001|Part 1|Adverse Event|0|||
128778955|NCT01734382|463480479|FG002|Part 1|Adverse Event|0|||
128778956|NCT01734382|463480477|FG000|Part 2|Adverse Event|0|||
128778957|NCT01734382|463480478|FG001|Part 2|Adverse Event|0|||
128778958|NCT01734382|463480479|FG002|Part 2|Adverse Event|1|||
128778959|NCT01734382|463480477|FG000|Part 2|Lack of Efficacy|0|||
128778960|NCT01734382|463480478|FG001|Part 2|Lack of Efficacy|1|||
128778961|NCT01734382|463480479|FG002|Part 2|Lack of Efficacy|1|||
129170022|NCT02256384|464915939|FG000|Overall Study|Withdrawal by Subject|12|||
129170023|NCT02256384|464915939|FG000|Overall Study|Equipment not capturing data|2|||
129170024|NCT00543803|464915949|FG000|Overall Study|Adverse Event|14|||
129170025|NCT00543803|464915949|FG000|Overall Study|Lack of Efficacy|22|||
129170026|NCT00543803|464915949|FG000|Overall Study|Lost to Follow-up|20|||
129170027|NCT00543803|464915949|FG000|Overall Study|Other|86|||
129170028|NCT04295681|464915953|FG000|Overall Study|Eligibility error|1|||
129170029|NCT04295681|464915954|FG001|Overall Study|Eligibility error|3|||
129170030|NCT03525600|464915961|FG000|Overall Study|Adverse Event|9|||
129170031|NCT03525600|464915962|FG001|Overall Study|Adverse Event|6|||
129170032|NCT03525600|464915963|FG002|Overall Study|Adverse Event|5|||
129170033|NCT03525600|464915964|FG003|Overall Study|Adverse Event|3|||
129170034|NCT03525600|464915961|FG000|Overall Study|Lost to Follow-up|2|||
128778962|NCT01734382|463480477|FG000|Part 2|Other|0|||
128778963|NCT01734382|463480478|FG001|Part 2|Other|0|||
128778964|NCT01734382|463480479|FG002|Part 2|Other|1|||
128778965|NCT01734382|463480477|FG000|Part 2|Physician Decision|0|||
128778966|NCT01734382|463480478|FG001|Part 2|Physician Decision|0|||
128778967|NCT01734382|463480479|FG002|Part 2|Physician Decision|3|||
128778968|NCT01734382|463480477|FG000|Part 2|Protocol Violation|0|||
128778969|NCT01734382|463480478|FG001|Part 2|Protocol Violation|1|||
128778970|NCT01734382|463480479|FG002|Part 2|Protocol Violation|0|||
128778971|NCT01734382|463480477|FG000|Part 2|Withdrawal by Subject|0|||
129170035|NCT03525600|464915962|FG001|Overall Study|Lost to Follow-up|4|||
129170036|NCT03525600|464915963|FG002|Overall Study|Lost to Follow-up|4|||
129170037|NCT03525600|464915964|FG003|Overall Study|Lost to Follow-up|0|||
129170038|NCT03525600|464915961|FG000|Overall Study|Physician Decision|1|||
129170039|NCT03525600|464915962|FG001|Overall Study|Physician Decision|0|||
129170040|NCT03525600|464915963|FG002|Overall Study|Physician Decision|2|||
129170041|NCT03525600|464915964|FG003|Overall Study|Physician Decision|0|||
129170042|NCT03525600|464915961|FG000|Overall Study|Consent withdrawal|36|||
129170043|NCT03525600|464915962|FG001|Overall Study|Consent withdrawal|20|||
129170044|NCT03525600|464915963|FG002|Overall Study|Consent withdrawal|6|||
129170045|NCT03525600|464915964|FG003|Overall Study|Consent withdrawal|13|||
129170046|NCT03525600|464915961|FG000|Overall Study|Death|7|||
129170047|NCT03525600|464915962|FG001|Overall Study|Death|6|||
129170048|NCT03525600|464915963|FG002|Overall Study|Death|4|||
129170049|NCT03525600|464915964|FG003|Overall Study|Death|3|||
129170050|NCT03525600|464915961|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
129170051|NCT03525600|464915962|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
129170052|NCT03525600|464915963|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
129170053|NCT03525600|464915964|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
129170054|NCT03525600|464915961|FG000|Overall Study|Other|0|||
129170055|NCT03525600|464915962|FG001|Overall Study|Other|1|||
128728986|NCT02434770|463304131|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
128728987|NCT02434770|463304129|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
128728988|NCT02434770|463304130|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
128728989|NCT02434770|463304131|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
128728990|NCT02434770|463304129|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
128728991|NCT02434770|463304130|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
128728992|NCT02434770|463304131|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
128728993|NCT02434770|463304129|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
128728994|NCT02434770|463304130|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
128728995|NCT02434770|463304131|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
128728996|NCT02434770|463304129|FG000|Week 1 to Week 18|Death|1|||
128728997|NCT02434770|463304130|FG001|Week 1 to Week 18|Death|0|||
128728998|NCT02434770|463304131|FG002|Week 1 to Week 18|Death|0|||
128728999|NCT02434770|463304129|FG000|Week 18 to Week|Lost to Follow-up|2|||
128729000|NCT02434770|463304130|FG001|Week 18 to Week|Lost to Follow-up|2|||
128729001|NCT02434770|463304131|FG002|Week 18 to Week|Lost to Follow-up|1|||
128729002|NCT02434770|463304129|FG000|Week 18 to Week|Withdrawal by Subject|0|||
128729003|NCT02434770|463304130|FG001|Week 18 to Week|Withdrawal by Subject|0|||
128729004|NCT02434770|463304131|FG002|Week 18 to Week|Withdrawal by Subject|2|||
128729005|NCT02434770|463304129|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
128729006|NCT02434770|463304130|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
128729007|NCT02434770|463304131|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
128729008|NCT00245765|463304132|FG000|Overall Study|Adverse Event|1|||
128729009|NCT00245765|463304133|FG001|Overall Study|Adverse Event|1|||
128729010|NCT00245765|463304134|FG002|Overall Study|Adverse Event|0|||
128729011|NCT00245765|463304132|FG000|Overall Study|Lack of Efficacy|14|||
128729012|NCT00245765|463304133|FG001|Overall Study|Lack of Efficacy|7|||
128729013|NCT00245765|463304134|FG002|Overall Study|Lack of Efficacy|0|||
128729014|NCT00245765|463304132|FG000|Overall Study|Lost to Follow-up|1|||
128729015|NCT00245765|463304133|FG001|Overall Study|Lost to Follow-up|2|||
128729016|NCT00245765|463304134|FG002|Overall Study|Lost to Follow-up|0|||
128729017|NCT00245765|463304132|FG000|Overall Study|Withdrawal by Subject|1|||
128729018|NCT00245765|463304133|FG001|Overall Study|Withdrawal by Subject|0|||
128729019|NCT00245765|463304134|FG002|Overall Study|Withdrawal by Subject|3|||
128729020|NCT00245765|463304132|FG000|Overall Study|Other reason|2|||
128729021|NCT00245765|463304133|FG001|Overall Study|Other reason|0|||
128729022|NCT00245765|463304134|FG002|Overall Study|Other reason|1|||
128729023|NCT00245765|463304132|FG000|Overall Study|Other|13|||
128729024|NCT00245765|463304133|FG001|Overall Study|Other|4|||
128729025|NCT00245765|463304134|FG002|Overall Study|Other|4|||
128729026|NCT00660348|463304135|FG000|Overall Study|Withdrawal by Subject|1|||
128729027|NCT00660348|463304136|FG001|Overall Study|Withdrawal by Subject|0|||
128729028|NCT04074317|463304142|FG000|Third Period|Withdrawal by Subject|0|||
128729029|NCT04074317|463304143|FG001|Third Period|Withdrawal by Subject|0|||
128729030|NCT04074317|463304144|FG002|Third Period|Withdrawal by Subject|0|||
128729031|NCT04074317|463304145|FG003|Third Period|Withdrawal by Subject|1|||
129170056|NCT03525600|464915963|FG002|Overall Study|Other|0|||
128729032|NCT04074317|463304146|FG004|Third Period|Withdrawal by Subject|0|||
128729033|NCT04074317|463304147|FG005|Third Period|Withdrawal by Subject|0|||
128729034|NCT03548584|463306544|FG000|Overall Study|Lost to Follow-up|0|||
128729035|NCT03548584|463306545|FG001|Overall Study|Lost to Follow-up|0|||
128729036|NCT03548584|463306546|FG002|Overall Study|Lost to Follow-up|1|||
128729037|NCT03548584|463306544|FG000|Overall Study|Adverse Event|1|||
128729038|NCT03548584|463306545|FG001|Overall Study|Adverse Event|11|||
128729039|NCT03548584|463306546|FG002|Overall Study|Adverse Event|5|||
128729040|NCT03548584|463306544|FG000|Overall Study|Site Terminated by Sponsor|1|||
129170057|NCT03525600|464915964|FG003|Overall Study|Other|0|||
129170058|NCT03255967|464915974|FG000|Overall Study|Adverse Event|26|||
129170059|NCT03255967|464915975|FG001|Overall Study|Adverse Event|30|||
128729041|NCT03548584|463306545|FG001|Overall Study|Site Terminated by Sponsor|3|||
128729042|NCT03548584|463306546|FG002|Overall Study|Site Terminated by Sponsor|2|||
128729043|NCT03548584|463306544|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
128729044|NCT03548584|463306545|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
128729045|NCT03548584|463306546|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
128729046|NCT03548584|463306544|FG000|Overall Study|Lack of Efficacy|0|||
128729047|NCT03548584|463306545|FG001|Overall Study|Lack of Efficacy|1|||
128729048|NCT03548584|463306546|FG002|Overall Study|Lack of Efficacy|0|||
128729049|NCT03548584|463306544|FG000|Overall Study|Non-compliance with Study Drug|0|||
128729050|NCT03548584|463306545|FG001|Overall Study|Non-compliance with Study Drug|1|||
128729051|NCT03548584|463306546|FG002|Overall Study|Non-compliance with Study Drug|0|||
128729052|NCT03548584|463306544|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
128729053|NCT03548584|463306545|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
128729054|NCT03548584|463306546|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
128729055|NCT00653224|463306549|FG000|Overall Study|Adverse Event|2|||
128729056|NCT00653224|463306550|FG001|Overall Study|Adverse Event|1|||
128729057|NCT00653224|463306549|FG000|Overall Study|Lack of Efficacy|1|||
128729058|NCT00653224|463306550|FG001|Overall Study|Lack of Efficacy|2|||
128729059|NCT00653224|463306549|FG000|Overall Study|Loss of efficacy|1|||
128729060|NCT00653224|463306550|FG001|Overall Study|Loss of efficacy|0|||
128729061|NCT00653224|463306549|FG000|Overall Study|Lost to Follow-up|1|||
128729062|NCT00653224|463306550|FG001|Overall Study|Lost to Follow-up|0|||
128729063|NCT00653224|463306549|FG000|Overall Study|Other|2|||
128729064|NCT00653224|463306550|FG001|Overall Study|Other|4|||
128729065|NCT05308901|463306551|FG000|Overall Study|Death|6|||
128729066|NCT04482179|463306552|FG000|Overall Study|Death|1|||
128729067|NCT04482179|463306553|FG001|Overall Study|Death|0|||
128729068|NCT04482179|463306552|FG000|Overall Study|Withdrawal by Subject|1|||
128729069|NCT04482179|463306553|FG001|Overall Study|Withdrawal by Subject|0|||
128729070|NCT00640510|463306554|FG000|Overall Study|Lack of Efficacy|0|||
128729071|NCT00640510|463306555|FG001|Overall Study|Lack of Efficacy|1|||
128729072|NCT00640510|463306554|FG000|Overall Study|Protocol Violation|1|||
128729073|NCT00640510|463306555|FG001|Overall Study|Protocol Violation|0|||
128729074|NCT00640510|463306554|FG000|Overall Study|Physician Decision|0|||
128729075|NCT00640510|463306555|FG001|Overall Study|Physician Decision|1|||
128729076|NCT00355238|463306557|FG000|Overall Study|Adverse event unrelated to study drug|2|||
128729077|NCT00355238|463306558|FG001|Overall Study|Adverse event unrelated to study drug|2|||
128729078|NCT00355238|463306559|FG002|Overall Study|Adverse event unrelated to study drug|0|||
128729079|NCT00355238|463306560|FG003|Overall Study|Adverse event unrelated to study drug|1|||
128729080|NCT00355238|463306557|FG000|Overall Study|Death|1|||
128729081|NCT00355238|463306558|FG001|Overall Study|Death|0|||
128729082|NCT00355238|463306559|FG002|Overall Study|Death|0|||
128729083|NCT00355238|463306560|FG003|Overall Study|Death|0|||
128729084|NCT00355238|463306557|FG000|Overall Study|Disease progression|37|||
128729085|NCT00355238|463306558|FG001|Overall Study|Disease progression|36|||
128729086|NCT00355238|463306559|FG002|Overall Study|Disease progression|16|||
128729087|NCT00355238|463306560|FG003|Overall Study|Disease progression|11|||
128729088|NCT00355238|463306557|FG000|Overall Study|Study drug toxicity|11|||
128729089|NCT00355238|463306558|FG001|Overall Study|Study drug toxicity|7|||
128729090|NCT00355238|463306559|FG002|Overall Study|Study drug toxicity|5|||
128729091|NCT00355238|463306560|FG003|Overall Study|Study drug toxicity|2|||
128729092|NCT00355238|463306557|FG000|Overall Study|Participant withdrew consent|3|||
128729093|NCT00355238|463306558|FG001|Overall Study|Participant withdrew consent|1|||
128729094|NCT00355238|463306559|FG002|Overall Study|Participant withdrew consent|0|||
128729095|NCT00355238|463306560|FG003|Overall Study|Participant withdrew consent|0|||
128729096|NCT00355238|463306557|FG000|Overall Study|Participant request to discontinue study treatment|1|||
128729097|NCT00355238|463306558|FG001|Overall Study|Participant request to discontinue study treatment|0|||
128729098|NCT00355238|463306559|FG002|Overall Study|Participant request to discontinue study treatment|1|||
128729099|NCT00355238|463306560|FG003|Overall Study|Participant request to discontinue study treatment|0|||
129170060|NCT03255967|464915974|FG000|Overall Study|Withdrawal by Subject|6|||
129170061|NCT03255967|464915975|FG001|Overall Study|Withdrawal by Subject|6|||
129170062|NCT03255967|464915974|FG000|Overall Study|Schedule conflict|6|||
129170063|NCT03255967|464915975|FG001|Overall Study|Schedule conflict|4|||
128729100|NCT01956110|463306561|FG000|Overall Study|Protocol Violation|25|||
128729101|NCT01956110|463306562|FG001|Overall Study|Protocol Violation|11|||
128729102|NCT01956110|463306561|FG000|Overall Study|Adverse Event|9|||
128729103|NCT01956110|463306562|FG001|Overall Study|Adverse Event|10|||
128729104|NCT01956110|463306561|FG000|Overall Study|Personal reasons|1|||
128729105|NCT01956110|463306562|FG001|Overall Study|Personal reasons|1|||
128729106|NCT02506816|463306565|FG000|Overall Study|Adverse Event|3|||
128729107|NCT00418691|463306566|FG000|Overall Study|Lost to Follow-up|1|||
128729108|NCT00418691|463306567|FG001|Overall Study|Lost to Follow-up|2|||
128729109|NCT00418691|463306568|FG002|Overall Study|Lost to Follow-up|3|||
129170064|NCT03255967|464915974|FG000|Overall Study|POA did not sign consent form|2|||
128729110|NCT00418691|463306566|FG000|Overall Study|Started new medication voiding entry|0|||
129170065|NCT03255967|464915975|FG001|Overall Study|POA did not sign consent form|0|||
129170066|NCT01202188|464915978|FG000|Overall Study|Protocol deviation|14|||
129170067|NCT01202188|464915979|FG001|Overall Study|Protocol deviation|8|||
129170068|NCT01202188|464915980|FG002|Overall Study|Protocol deviation|12|||
129170069|NCT01202188|464915981|FG003|Overall Study|Protocol deviation|10|||
129170070|NCT01202188|464915982|FG004|Overall Study|Protocol deviation|11|||
129170071|NCT01202188|464915978|FG000|Overall Study|Subject withdrew consent|12|||
129170072|NCT01202188|464915979|FG001|Overall Study|Subject withdrew consent|13|||
129170073|NCT01202188|464915980|FG002|Overall Study|Subject withdrew consent|22|||
129170074|NCT01202188|464915981|FG003|Overall Study|Subject withdrew consent|11|||
129170075|NCT01202188|464915982|FG004|Overall Study|Subject withdrew consent|13|||
129170076|NCT01202188|464915978|FG000|Overall Study|Adverse Event|5|||
129170077|NCT01202188|464915979|FG001|Overall Study|Adverse Event|23|||
129170078|NCT01202188|464915980|FG002|Overall Study|Adverse Event|13|||
129170079|NCT01202188|464915981|FG003|Overall Study|Adverse Event|10|||
129170080|NCT01202188|464915982|FG004|Overall Study|Adverse Event|10|||
129170081|NCT01202188|464915978|FG000|Overall Study|Administrative problems|3|||
129170082|NCT01202188|464915979|FG001|Overall Study|Administrative problems|2|||
129170083|NCT01202188|464915980|FG002|Overall Study|Administrative problems|1|||
129170084|NCT01202188|464915981|FG003|Overall Study|Administrative problems|1|||
129170085|NCT01202188|464915982|FG004|Overall Study|Administrative problems|2|||
129170086|NCT01202188|464915978|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129170087|NCT01202188|464915979|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129170088|NCT01202188|464915980|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129170089|NCT01202188|464915981|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
129170090|NCT01202188|464915982|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
129170091|NCT01202188|464915978|FG000|Overall Study|Lost to Follow-up|1|||
129170092|NCT01202188|464915979|FG001|Overall Study|Lost to Follow-up|1|||
129170093|NCT01202188|464915980|FG002|Overall Study|Lost to Follow-up|0|||
129170094|NCT01202188|464915981|FG003|Overall Study|Lost to Follow-up|4|||
129170095|NCT01202188|464915982|FG004|Overall Study|Lost to Follow-up|1|||
129170096|NCT01202188|464915978|FG000|Overall Study|Death|1|||
129170097|NCT01202188|464915979|FG001|Overall Study|Death|1|||
129170098|NCT01202188|464915980|FG002|Overall Study|Death|1|||
129170099|NCT01202188|464915981|FG003|Overall Study|Death|1|||
129170100|NCT01202188|464915982|FG004|Overall Study|Death|0|||
129170101|NCT01202188|464915978|FG000|Overall Study|Abnormal test procedure result (s)|0|||
129170102|NCT01202188|464915979|FG001|Overall Study|Abnormal test procedure result (s)|0|||
129170103|NCT01202188|464915980|FG002|Overall Study|Abnormal test procedure result (s)|2|||
129170104|NCT01202188|464915981|FG003|Overall Study|Abnormal test procedure result (s)|0|||
129170105|NCT01202188|464915982|FG004|Overall Study|Abnormal test procedure result (s)|0|||
129170106|NCT00780143|464915984|FG000|Overall Study|Progressive disease|1|||
129170107|NCT00780143|464915984|FG000|Overall Study|Toxicity|1|||
129170108|NCT00780143|464915984|FG000|Overall Study|Adverse Event|1|||
129170109|NCT02438384|464915985|FG000|Overall Study|Lost to Follow-up|8|||
129170110|NCT02438384|464915986|FG001|Overall Study|Lost to Follow-up|6|||
129170111|NCT02438384|464915987|FG002|Overall Study|Lost to Follow-up|4|||
129170112|NCT03315793|464915988|FG000|Overall Study|Adverse Event|4|||
129170113|NCT03315793|464915989|FG001|Overall Study|Adverse Event|2|||
129170114|NCT03315793|464915988|FG000|Overall Study|Protocol Deviation|1|||
129170115|NCT03315793|464915989|FG001|Overall Study|Protocol Deviation|0|||
129170116|NCT03315793|464915988|FG000|Overall Study|Difficult for regular visit|0|||
129170117|NCT03315793|464915989|FG001|Overall Study|Difficult for regular visit|1|||
129170118|NCT02640625|464918039|FG000|Overall Study|Adverse Event|1|||
129170119|NCT00511433|464918040|FG000|Overall Study|Adverse Event|5|||
129170120|NCT00511433|464918041|FG001|Overall Study|Adverse Event|0|||
129170121|NCT00511433|464918040|FG000|Overall Study|Other Reason|1|||
129170122|NCT00511433|464918041|FG001|Overall Study|Other Reason|1|||
129170123|NCT01740089|464918042|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
129170124|NCT01740089|464918043|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
129170125|NCT01740089|464918044|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
129170126|NCT01740089|464918042|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
129170127|NCT01740089|464918043|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
129170128|NCT01740089|464918044|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
129170129|NCT01740089|464918042|FG000|After 12 Weeks|Lack of Efficacy|3|||
129170130|NCT01740089|464918043|FG001|After 12 Weeks|Lack of Efficacy|1|||
129170131|NCT01740089|464918044|FG002|After 12 Weeks|Lack of Efficacy|4|||
129170132|NCT01740089|464918042|FG000|After 12 Weeks|Adverse Event|2|||
128729111|NCT00418691|463306567|FG001|Overall Study|Started new medication voiding entry|0|||
128729112|NCT00418691|463306568|FG002|Overall Study|Started new medication voiding entry|1|||
128729113|NCT00418691|463306566|FG000|Overall Study|Progressive Disease|1|||
128729114|NCT00418691|463306567|FG001|Overall Study|Progressive Disease|0|||
128729115|NCT00418691|463306568|FG002|Overall Study|Progressive Disease|1|||
128729116|NCT03761628|463306569|FG000|Overall Study|Withdrawal by Subject|3|||
128729117|NCT03761628|463306569|FG000|Overall Study|Physician Decision|1|||
128729118|NCT03761628|463306569|FG000|Overall Study|Pregnancy|1|||
128729119|NCT03761628|463306569|FG000|Overall Study|Lost to Follow-up|1|||
128729120|NCT05358821|463306570|FG000|Overall Study|Withdrawal by Subject|0|||
128729121|NCT05358821|463306571|FG001|Overall Study|Withdrawal by Subject|1|||
128729122|NCT05358821|463306572|FG002|Overall Study|Withdrawal by Subject|0|||
129170133|NCT01740089|464918043|FG001|After 12 Weeks|Adverse Event|0|||
129170134|NCT01740089|464918044|FG002|After 12 Weeks|Adverse Event|5|||
129170135|NCT01740089|464918042|FG000|After 12 Weeks|Protocol Violation|1|||
129170136|NCT01740089|464918043|FG001|After 12 Weeks|Protocol Violation|1|||
129170137|NCT01740089|464918044|FG002|After 12 Weeks|Protocol Violation|1|||
129170138|NCT01740089|464918042|FG000|After 12 Weeks|Withdrawal by Subject|1|||
129170139|NCT01740089|464918043|FG001|After 12 Weeks|Withdrawal by Subject|1|||
129170140|NCT01740089|464918044|FG002|After 12 Weeks|Withdrawal by Subject|1|||
129170141|NCT01579565|464918047|FG000|Randomized|Adverse Event|1|||
129170142|NCT01579565|464918048|FG001|Randomized|Adverse Event|3|||
129170143|NCT01579565|464918047|FG000|Randomized|Withdrawal by Subject|3|||
129170144|NCT01579565|464918048|FG001|Randomized|Withdrawal by Subject|0|||
129170145|NCT01579565|464918047|FG000|Randomized|inadequate preoperative pupil dilation|0|||
129170146|NCT01579565|464918048|FG001|Randomized|inadequate preoperative pupil dilation|1|||
128729123|NCT05358821|463306570|FG000|Overall Study|Withdrawal of Consent|0|||
128729124|NCT05358821|463306571|FG001|Overall Study|Withdrawal of Consent|0|||
128729125|NCT05358821|463306572|FG002|Overall Study|Withdrawal of Consent|1|||
128729126|NCT03901963|463306573|FG000|Overall Study|Lost to Follow-up|1|||
128729127|NCT03901963|463306574|FG001|Overall Study|Lost to Follow-up|1|||
128729128|NCT03901963|463306573|FG000|Overall Study|Physician Decision|1|||
128729129|NCT03901963|463306574|FG001|Overall Study|Physician Decision|2|||
128729130|NCT03901963|463306573|FG000|Overall Study|Protocol Violation|1|||
129170147|NCT01579565|464918047|FG000|Randomized|prohibited preoperative eating|1|||
129170148|NCT01579565|464918048|FG001|Randomized|prohibited preoperative eating|0|||
129170149|NCT01579565|464918047|FG000|Randomized|prohibited preoperative medication|0|||
129170150|NCT01579565|464918048|FG001|Randomized|prohibited preoperative medication|1|||
129170151|NCT01579565|464918047|FG000|Treated|Physician Decision|0|||
129170152|NCT01579565|464918048|FG001|Treated|Physician Decision|1|||
129170153|NCT01579565|464918047|FG000|Treated|Lost to Follow-up|2|||
129170154|NCT01579565|464918048|FG001|Treated|Lost to Follow-up|1|||
129170155|NCT01579565|464918047|FG000|Treated|declined to return for final visit|0|||
129170156|NCT01579565|464918048|FG001|Treated|declined to return for final visit|1|||
129170157|NCT02867813|464918049|FG000|Overall Study|Withdrawal by Subject|57|||
129170158|NCT02867813|464918050|FG001|Overall Study|Withdrawal by Subject|56|||
129170159|NCT02867813|464918049|FG000|Overall Study|Decision by Sponsor|7|||
129170160|NCT02867813|464918050|FG001|Overall Study|Decision by Sponsor|7|||
129170161|NCT02867813|464918049|FG000|Overall Study|Lost to Follow-up|91|||
129170162|NCT02867813|464918050|FG001|Overall Study|Lost to Follow-up|78|||
129170163|NCT02867813|464918049|FG000|Overall Study|Missing|2|||
129170164|NCT02867813|464918050|FG001|Overall Study|Missing|1|||
129170165|NCT02867813|464918049|FG000|Overall Study|Death|294|||
129170166|NCT02867813|464918050|FG001|Overall Study|Death|268|||
129170167|NCT01952665|464918051|FG000|Overall Study|Physician Decision|3|||
129170168|NCT01952665|464918052|FG001|Overall Study|Physician Decision|2|||
129170169|NCT01952665|464918051|FG000|Overall Study|Lost to Follow-up|1|||
129170170|NCT01952665|464918052|FG001|Overall Study|Lost to Follow-up|2|||
129170171|NCT01952665|464918051|FG000|Overall Study|Adverse Event|2|||
129170172|NCT01952665|464918052|FG001|Overall Study|Adverse Event|1|||
129170173|NCT01952665|464918051|FG000|Overall Study|Protocol Violation|0|||
129170174|NCT01952665|464918052|FG001|Overall Study|Protocol Violation|1|||
129170175|NCT01537081|464918054|FG000|Overall Study|Adverse Event|5|||
129170176|NCT01537081|464918055|FG001|Overall Study|Adverse Event|2|||
129170177|NCT01537081|464918056|FG002|Overall Study|Adverse Event|2|||
129170178|NCT01537081|464918054|FG000|Overall Study|Lack of Efficacy|2|||
129170179|NCT01537081|464918055|FG001|Overall Study|Lack of Efficacy|1|||
129170180|NCT01537081|464918056|FG002|Overall Study|Lack of Efficacy|0|||
129170181|NCT01537081|464918054|FG000|Overall Study|Lost to Follow-up|17|||
129170182|NCT01537081|464918055|FG001|Overall Study|Lost to Follow-up|15|||
129170183|NCT01537081|464918056|FG002|Overall Study|Lost to Follow-up|9|||
129170184|NCT01537081|464918054|FG000|Overall Study|Protocol Violation|3|||
129170185|NCT01537081|464918055|FG001|Overall Study|Protocol Violation|2|||
129170186|NCT01537081|464918056|FG002|Overall Study|Protocol Violation|2|||
129170187|NCT01537081|464918054|FG000|Overall Study|Withdrawal by Subject|6|||
129170188|NCT01537081|464918055|FG001|Overall Study|Withdrawal by Subject|11|||
129170189|NCT01537081|464918056|FG002|Overall Study|Withdrawal by Subject|3|||
129170190|NCT01537081|464918054|FG000|Overall Study|Physician Decision|5|||
129170191|NCT01537081|464918055|FG001|Overall Study|Physician Decision|6|||
129170192|NCT01537081|464918056|FG002|Overall Study|Physician Decision|0|||
129170193|NCT01537081|464918054|FG000|Overall Study|Sponsor decision|0|||
129170194|NCT01537081|464918055|FG001|Overall Study|Sponsor decision|1|||
129170195|NCT01537081|464918056|FG002|Overall Study|Sponsor decision|0|||
129170196|NCT01537081|464918054|FG000|Overall Study|Assigned but never dosed|1|||
129170197|NCT01537081|464918055|FG001|Overall Study|Assigned but never dosed|0|||
129170198|NCT01537081|464918056|FG002|Overall Study|Assigned but never dosed|0|||
129170199|NCT01463111|464918059|FG000|Overall Study|Withdrawal by Subject|2|||
129170200|NCT01463111|464918059|FG000|Overall Study|Lost to Follow-up|5|||
129170201|NCT01463111|464918059|FG000|Overall Study|Physician Decision|2|||
129170202|NCT02596958|464918063|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
129170203|NCT02596958|464918063|FG000|Overall Study|Cancer Progression|441|||
129170204|NCT02596958|464918063|FG000|Overall Study|Death From Cancer|112|||
129170205|NCT02596958|464918063|FG000|Overall Study|Death From Other Cause|33|||
129170206|NCT02596958|464918063|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
128778972|NCT01734382|463480478|FG001|Part 2|Withdrawal by Subject|0|||
128778973|NCT01734382|463480479|FG002|Part 2|Withdrawal by Subject|1|||
128778974|NCT02400307|463480480|FG000|Overall Study|Enrolled and Never Dosed|1|||
128778975|NCT02400307|463480481|FG001|Overall Study|Enrolled and Never Dosed|0|||
128778976|NCT01052662|463480482|FG000|Overall Study|Lost to Follow-up|15|||
128778977|NCT01052662|463480483|FG001|Overall Study|Lost to Follow-up|13|||
128778978|NCT01052662|463480484|FG002|Overall Study|Lost to Follow-up|18|||
128778979|NCT01052662|463480482|FG000|Overall Study|Withdrawal by Subject|3|||
128778980|NCT01052662|463480483|FG001|Overall Study|Withdrawal by Subject|2|||
128778981|NCT01052662|463480484|FG002|Overall Study|Withdrawal by Subject|1|||
128778982|NCT01052662|463480482|FG000|Overall Study|Pharmacy issue|1|||
128778983|NCT01052662|463480483|FG001|Overall Study|Pharmacy issue|3|||
128778984|NCT01052662|463480484|FG002|Overall Study|Pharmacy issue|3|||
128778985|NCT01052662|463480482|FG000|Overall Study|Adverse Event|1|||
128778986|NCT01052662|463480483|FG001|Overall Study|Adverse Event|1|||
128778987|NCT01052662|463480484|FG002|Overall Study|Adverse Event|0|||
128778988|NCT01052662|463480482|FG000|Overall Study|Legal Problem|2|||
128778989|NCT01052662|463480483|FG001|Overall Study|Legal Problem|0|||
128778990|NCT01052662|463480484|FG002|Overall Study|Legal Problem|0|||
129170207|NCT02596958|464918063|FG000|Overall Study|Administrative Reasons/Other|231|||
129170208|NCT02596958|464918063|FG000|Overall Study|Lost to Follow-up|33|||
129170209|NCT02596958|464918063|FG000|Overall Study|Missing|32|||
129170210|NCT02596958|464918063|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
129170211|NCT01559259|464918064|FG000|Overall Study|Withdrawal by Subject|0|||
129170212|NCT01559259|464918065|FG001|Overall Study|Withdrawal by Subject|0|||
129170213|NCT01559259|464918066|FG002|Overall Study|Withdrawal by Subject|0|||
129170214|NCT01559259|464918067|FG003|Overall Study|Withdrawal by Subject|1|||
129170215|NCT01559259|464918068|FG004|Overall Study|Withdrawal by Subject|0|||
129170216|NCT01559259|464918064|FG000|Overall Study|Adverse Event|0|||
129170217|NCT01559259|464918065|FG001|Overall Study|Adverse Event|1|||
129170218|NCT01559259|464918066|FG002|Overall Study|Adverse Event|1|||
129170219|NCT01559259|464918067|FG003|Overall Study|Adverse Event|0|||
129170220|NCT01559259|464918068|FG004|Overall Study|Adverse Event|0|||
129170221|NCT00185380|464918069|FG000|Overall Study|Adverse Event|41|||
129170222|NCT00185380|464918070|FG001|Overall Study|Adverse Event|43|||
129170223|NCT00185380|464918071|FG002|Overall Study|Adverse Event|48|||
129170224|NCT00185380|464918069|FG000|Overall Study|Lost to Follow-up|0|||
129170225|NCT00185380|464918070|FG001|Overall Study|Lost to Follow-up|4|||
129170226|NCT00185380|464918071|FG002|Overall Study|Lost to Follow-up|3|||
129170227|NCT00185380|464918069|FG000|Overall Study|Pregnancy|1|||
129170228|NCT00185380|464918070|FG001|Overall Study|Pregnancy|4|||
129170229|NCT00185380|464918071|FG002|Overall Study|Pregnancy|0|||
129170230|NCT00185380|464918069|FG000|Overall Study|Protocol Violation|2|||
129170231|NCT00185380|464918070|FG001|Overall Study|Protocol Violation|2|||
129170232|NCT00185380|464918071|FG002|Overall Study|Protocol Violation|1|||
129170233|NCT00185380|464918069|FG000|Overall Study|Withdrawal by Subject|1|||
129170234|NCT00185380|464918070|FG001|Overall Study|Withdrawal by Subject|2|||
129170235|NCT00185380|464918071|FG002|Overall Study|Withdrawal by Subject|0|||
129170236|NCT00185380|464918069|FG000|Overall Study|Failed insertion|1|||
129170237|NCT00185380|464918070|FG001|Overall Study|Failed insertion|1|||
129170238|NCT00185380|464918071|FG002|Overall Study|Failed insertion|2|||
128729131|NCT03901963|463306574|FG001|Overall Study|Protocol Violation|1|||
128729132|NCT03901963|463306573|FG000|Overall Study|Withdrawal by Subject|4|||
128729133|NCT03901963|463306574|FG001|Overall Study|Withdrawal by Subject|11|||
128729134|NCT03901963|463306573|FG000|Overall Study|Ongoing|84|||
128729135|NCT03901963|463306574|FG001|Overall Study|Ongoing|73|||
128729136|NCT03901963|463306573|FG000|Overall Study|Randomized but not treated|3|||
128729137|NCT03901963|463306574|FG001|Overall Study|Randomized but not treated|3|||
128729138|NCT00433654|463306575|FG000|Overall Study|Death|4|||
128729139|NCT00433654|463306576|FG001|Overall Study|Death|0|||
128729140|NCT00433654|463306575|FG000|Overall Study|Missed visit|6|||
128729141|NCT00433654|463306576|FG001|Overall Study|Missed visit|3|||
128729142|NCT00433654|463306575|FG000|Overall Study|Subject not yet due for visit|4|||
128729143|NCT00433654|463306576|FG001|Overall Study|Subject not yet due for visit|0|||
128729144|NCT00433654|463306575|FG000|Overall Study|Withdrawal by Subject|1|||
128729145|NCT00433654|463306576|FG001|Overall Study|Withdrawal by Subject|2|||
128729146|NCT03762083|463306577|FG000|Overall Study|Withdrawal by Subject|2|||
128729147|NCT03762083|463306577|FG000|Overall Study|Physician Decision|1|||
128729148|NCT00116558|463306578|FG000|Overall Study|Death|11|||
128729149|NCT00116558|463306579|FG001|Overall Study|Death|5|||
128729150|NCT00116558|463306580|FG002|Overall Study|Death|3|||
128729151|NCT00116558|463306578|FG000|Overall Study|Withdrawal by Subject|17|||
128729152|NCT00116558|463306579|FG001|Overall Study|Withdrawal by Subject|3|||
128778991|NCT01052662|463480482|FG000|Overall Study|Administrative|0|||
128778992|NCT01052662|463480483|FG001|Overall Study|Administrative|3|||
129170239|NCT00185380|464918069|FG000|Overall Study|Planned pregnancy|9|||
128778993|NCT01052662|463480484|FG002|Overall Study|Administrative|0|||
128778994|NCT02015663|463480486|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
128778995|NCT02015663|463480487|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
128778996|NCT02015663|463480486|FG000|Overall Study|Withdrawal by Subject|1|||
128778997|NCT02015663|463480487|FG001|Overall Study|Withdrawal by Subject|0|||
128778998|NCT02015663|463480486|FG000|Overall Study|Protocol Violation|0|||
128778999|NCT02015663|463480487|FG001|Overall Study|Protocol Violation|1|||
128779000|NCT02015663|463480486|FG000|Overall Study|Adverse Event|3|||
128779001|NCT02015663|463480487|FG001|Overall Study|Adverse Event|0|||
128779002|NCT02015663|463480486|FG000|Overall Study|Administrative problems|10|||
128779003|NCT02015663|463480487|FG001|Overall Study|Administrative problems|11|||
128779004|NCT00146640|463480491|FG000|Overall Study|Adverse Event|12|||
128779005|NCT00146640|463480492|FG001|Overall Study|Adverse Event|10|||
128779006|NCT00146640|463480491|FG000|Overall Study|Medical Reasons|3|||
128779007|NCT00146640|463480492|FG001|Overall Study|Medical Reasons|0|||
128779008|NCT00146640|463480491|FG000|Overall Study|Non-Medical Reasons|8|||
128779009|NCT00146640|463480492|FG001|Overall Study|Non-Medical Reasons|4|||
128779010|NCT03293485|463480493|FG000|Overall Study|Death|1|||
128779011|NCT03293485|463480493|FG000|Overall Study|Screen Failure|2|||
128779012|NCT03293485|463480493|FG000|Overall Study|Withdrawal by Subject|2|||
128779013|NCT02408549|463480496|FG000|Overall Study|Adverse Event|15|||
128779014|NCT02408549|463480496|FG000|Overall Study|Death|4|||
128779015|NCT02408549|463480496|FG000|Overall Study|Lack of Efficacy|17|||
128779016|NCT02408549|463480496|FG000|Overall Study|Protocol Violation|4|||
128779017|NCT02408549|463480496|FG000|Overall Study|Lost to Follow-up|6|||
128779018|NCT02408549|463480496|FG000|Overall Study|Consent withdrawn|30|||
128779019|NCT02408549|463480496|FG000|Overall Study|Neurology research program closing at site|1|||
128779020|NCT02408549|463480496|FG000|Overall Study|Site closure|1|||
128779021|NCT02408549|463480496|FG000|Overall Study|Pregnancy|1|||
128779022|NCT02408549|463480496|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
128779023|NCT02408549|463480496|FG000|Overall Study|Subject moved to another place, far from site|1|||
128779024|NCT02408549|463480496|FG000|Overall Study|Study terminated at site|1|||
129170240|NCT00185380|464918070|FG001|Overall Study|Planned pregnancy|12|||
128729153|NCT00116558|463306580|FG002|Overall Study|Withdrawal by Subject|12|||
128729154|NCT00116558|463306578|FG000|Overall Study|disease progression|3|||
128729155|NCT00116558|463306579|FG001|Overall Study|disease progression|7|||
128729156|NCT00116558|463306580|FG002|Overall Study|disease progression|18|||
128729157|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
128729158|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
128729159|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Graft loss|1|||
128729160|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Graft loss|2|||
128729161|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Death|5|||
128729162|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Death|3|||
128729163|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
128729164|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
128729165|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
128729166|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
128729167|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
128729168|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
128729169|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
128729170|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
128729171|NCT00378014|463306581|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
128729172|NCT00378014|463306582|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
128729173|NCT00378014|463306581|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
128729174|NCT00378014|463306582|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
128729175|NCT00378014|463306581|FG000|Extension (Month 12 to Month 59)|Death|1|||
128729176|NCT00378014|463306582|FG001|Extension (Month 12 to Month 59)|Death|2|||
128729177|NCT00378014|463306581|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
128729178|NCT00378014|463306582|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
128729179|NCT00378014|463306581|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
128729180|NCT00378014|463306582|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
128779025|NCT00994279|463480499|FG000|Overall Study|Withdrawal by Subject|2|||
129170241|NCT00185380|464918071|FG002|Overall Study|Planned pregnancy|12|||
129170242|NCT00185380|464918069|FG000|Overall Study|No need for contraception|3|||
129170243|NCT00185380|464918070|FG001|Overall Study|No need for contraception|3|||
129170244|NCT00185380|464918071|FG002|Overall Study|No need for contraception|3|||
128729181|NCT00378014|463306581|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
128729182|NCT00378014|463306582|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
128779026|NCT00994279|463480500|FG001|Overall Study|Withdrawal by Subject|2|||
128779027|NCT00994279|463480499|FG000|Overall Study|Toxicity|1|||
128779028|NCT00994279|463480500|FG001|Overall Study|Toxicity|0|||
128779029|NCT00994279|463480499|FG000|Overall Study|Multiple reasons|1|||
128779030|NCT00994279|463480500|FG001|Overall Study|Multiple reasons|3|||
128779031|NCT01606189|463480501|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
128779032|NCT01606189|463480502|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
128779033|NCT01606189|463480503|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
128779034|NCT01606189|463480504|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
128779035|NCT01606189|463480505|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
128779036|NCT01606189|463480506|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
128779037|NCT01606189|463480501|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
128779038|NCT01606189|463480502|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
128779039|NCT01606189|463480503|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
128779040|NCT01606189|463480504|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
128779041|NCT01606189|463480505|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
128779042|NCT01606189|463480506|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
128779043|NCT00162942|463480507|FG000|Overall Study|Adverse Event|10|||
128779044|NCT00162942|463480508|FG001|Overall Study|Adverse Event|6|||
128779045|NCT00162942|463480507|FG000|Overall Study|Death|1|||
128779046|NCT00162942|463480508|FG001|Overall Study|Death|0|||
128779047|NCT00162942|463480507|FG000|Overall Study|Withdrawal by Subject|3|||
128779048|NCT00162942|463480508|FG001|Overall Study|Withdrawal by Subject|6|||
128779049|NCT00162942|463480507|FG000|Overall Study|Physician Decision|1|||
128779050|NCT00162942|463480508|FG001|Overall Study|Physician Decision|0|||
128779051|NCT00162942|463480507|FG000|Overall Study|Enter Open-Label Study|76|||
128779052|NCT00162942|463480508|FG001|Overall Study|Enter Open-Label Study|35|||
128779053|NCT00162942|463480507|FG000|Overall Study|Alternate Therapy|6|||
128779054|NCT00162942|463480508|FG001|Overall Study|Alternate Therapy|2|||
128779055|NCT00162942|463480507|FG000|Overall Study|Lack of Efficacy|1|||
129170245|NCT00185380|464918069|FG000|Overall Study|Could not attend visits|2|||
129170246|NCT00185380|464918070|FG001|Overall Study|Could not attend visits|0|||
129170247|NCT00185380|464918071|FG002|Overall Study|Could not attend visits|4|||
129170248|NCT00185380|464918069|FG000|Overall Study|personal reason|6|||
129170249|NCT00185380|464918070|FG001|Overall Study|personal reason|1|||
129170250|NCT00185380|464918071|FG002|Overall Study|personal reason|1|||
129170251|NCT02199314|464918072|FG000|Overall Study|Withdrawal by Subject|6|||
129170252|NCT02199314|464918072|FG000|Overall Study|Physician Decision|10|||
129170253|NCT03842969|464918073|FG000|Overall Study|Participant declined follow-up visit|0|||
129170254|NCT03842969|464918074|FG001|Overall Study|Participant declined follow-up visit|1|||
129170255|NCT03842969|464918075|FG002|Overall Study|Participant declined follow-up visit|0|||
129170256|NCT03842969|464918073|FG000|Overall Study|Sponsor's decision|12|||
129170257|NCT03842969|464918074|FG001|Overall Study|Sponsor's decision|99|||
129170258|NCT03842969|464918075|FG002|Overall Study|Sponsor's decision|61|||
129170259|NCT03842969|464918073|FG000|Overall Study|Pregnancy|0|||
129170260|NCT03842969|464918074|FG001|Overall Study|Pregnancy|0|||
129170261|NCT03842969|464918075|FG002|Overall Study|Pregnancy|1|||
129170262|NCT03842969|464918073|FG000|Overall Study|Death|1|||
129170263|NCT03842969|464918074|FG001|Overall Study|Death|0|||
129170264|NCT03842969|464918075|FG002|Overall Study|Death|1|||
129170265|NCT03842969|464918073|FG000|Overall Study|Withdrawal by Subject|3|||
129170266|NCT03842969|464918074|FG001|Overall Study|Withdrawal by Subject|30|||
129170267|NCT03842969|464918075|FG002|Overall Study|Withdrawal by Subject|18|||
129170268|NCT03842969|464918073|FG000|Overall Study|Protocol Violation|1|||
129170269|NCT03842969|464918074|FG001|Overall Study|Protocol Violation|1|||
129170270|NCT03842969|464918075|FG002|Overall Study|Protocol Violation|0|||
129170271|NCT03842969|464918073|FG000|Overall Study|Physician Decision|0|||
129170272|NCT03842969|464918074|FG001|Overall Study|Physician Decision|3|||
129170273|NCT03842969|464918075|FG002|Overall Study|Physician Decision|0|||
129170274|NCT03842969|464918073|FG000|Overall Study|Lost to Follow-up|0|||
129170275|NCT03842969|464918074|FG001|Overall Study|Lost to Follow-up|2|||
129170276|NCT03842969|464918075|FG002|Overall Study|Lost to Follow-up|0|||
129170277|NCT03842969|464918073|FG000|Overall Study|Adverse Event|0|||
129170278|NCT03842969|464918074|FG001|Overall Study|Adverse Event|2|||
128779056|NCT00162942|463480508|FG001|Overall Study|Lack of Efficacy|0|||
128779057|NCT00162942|463480507|FG000|Overall Study|Flare During Active Treatment|7|||
129170279|NCT03842969|464918075|FG002|Overall Study|Adverse Event|0|||
129170280|NCT01892436|464918076|FG000|Overall Study|Withdrawal by Subject|8|||
129170281|NCT01892436|464918077|FG001|Overall Study|Withdrawal by Subject|15|||
129170282|NCT01892436|464918078|FG002|Overall Study|Withdrawal by Subject|4|||
129170283|NCT01892436|464918079|FG003|Overall Study|Withdrawal by Subject|4|||
128779058|NCT00162942|463480508|FG001|Overall Study|Flare During Active Treatment|3|||
128779059|NCT00162942|463480507|FG000|Overall Study|2 or more consecutive treatments missed|1|||
129170284|NCT01892436|464918076|FG000|Overall Study|Death|1|||
129170285|NCT01892436|464918077|FG001|Overall Study|Death|1|||
129170286|NCT01892436|464918078|FG002|Overall Study|Death|0|||
129170287|NCT01892436|464918079|FG003|Overall Study|Death|0|||
129170288|NCT01892436|464918076|FG000|Overall Study|Physician Decision|2|||
129170289|NCT01892436|464918077|FG001|Overall Study|Physician Decision|1|||
129170290|NCT01892436|464918078|FG002|Overall Study|Physician Decision|0|||
129170291|NCT01892436|464918079|FG003|Overall Study|Physician Decision|1|||
129170292|NCT01892436|464918076|FG000|Overall Study|Pregnancy|0|||
129170293|NCT01892436|464918077|FG001|Overall Study|Pregnancy|2|||
129170294|NCT01892436|464918078|FG002|Overall Study|Pregnancy|1|||
129170295|NCT01892436|464918079|FG003|Overall Study|Pregnancy|0|||
129170296|NCT01892436|464918076|FG000|Overall Study|Technical problems|2|||
128729183|NCT00378014|463306581|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
128729184|NCT00378014|463306582|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
128729185|NCT02287896|463306589|FG000|Second Injection Visit|Withdrawal by Subject|0|||
128729186|NCT02287896|463306590|FG001|Second Injection Visit|Withdrawal by Subject|1|||
128729187|NCT05179421|463306591|FG000|First Infusion Day|Adverse Event|1|||
128729188|NCT05179421|463306592|FG001|First Infusion Day|Adverse Event|0|||
128729189|NCT01639040|463306594|FG000|Overall Study|Adverse Event|1|||
128729190|NCT01639040|463306595|FG001|Overall Study|Adverse Event|0|||
128729191|NCT03473743|463306596|FG000|Overall Study|Withdrawal by Subject|0|||
128729192|NCT03473743|463306597|FG001|Overall Study|Withdrawal by Subject|0|||
128729193|NCT03473743|463306598|FG002|Overall Study|Withdrawal by Subject|0|||
128729194|NCT03473743|463306599|FG003|Overall Study|Withdrawal by Subject|0|||
128729195|NCT03473743|463306600|FG004|Overall Study|Withdrawal by Subject|0|||
128729196|NCT03473743|463306601|FG005|Overall Study|Withdrawal by Subject|0|||
128729197|NCT03473743|463306602|FG006|Overall Study|Withdrawal by Subject|0|||
128729198|NCT03473743|463306603|FG007|Overall Study|Withdrawal by Subject|3|||
128729199|NCT03473743|463306596|FG000|Overall Study|Other|0|||
128729200|NCT03473743|463306597|FG001|Overall Study|Other|0|||
128729201|NCT03473743|463306598|FG002|Overall Study|Other|0|||
128729202|NCT03473743|463306599|FG003|Overall Study|Other|1|||
128729203|NCT03473743|463306600|FG004|Overall Study|Other|0|||
128729204|NCT03473743|463306601|FG005|Overall Study|Other|0|||
128729205|NCT03473743|463306602|FG006|Overall Study|Other|0|||
128729206|NCT03473743|463306603|FG007|Overall Study|Other|0|||
128729207|NCT03473743|463306596|FG000|Overall Study|Ongoing|0|||
128729208|NCT03473743|463306597|FG001|Overall Study|Ongoing|0|||
129170297|NCT01892436|464918077|FG001|Overall Study|Technical problems|1|||
129170298|NCT01892436|464918078|FG002|Overall Study|Technical problems|1|||
129170299|NCT01892436|464918079|FG003|Overall Study|Technical problems|1|||
129170300|NCT01892436|464918076|FG000|Overall Study|Lack of Efficacy|1|||
129170301|NCT01892436|464918077|FG001|Overall Study|Lack of Efficacy|2|||
129170302|NCT01892436|464918078|FG002|Overall Study|Lack of Efficacy|2|||
129170303|NCT01892436|464918079|FG003|Overall Study|Lack of Efficacy|2|||
129170304|NCT01892436|464918076|FG000|Overall Study|Lost to Follow-up|1|||
129170305|NCT01892436|464918077|FG001|Overall Study|Lost to Follow-up|1|||
129170306|NCT01892436|464918078|FG002|Overall Study|Lost to Follow-up|1|||
129170307|NCT01892436|464918079|FG003|Overall Study|Lost to Follow-up|3|||
129170308|NCT01892436|464918076|FG000|Overall Study|non-compliance with treatment|1|||
129170309|NCT01892436|464918077|FG001|Overall Study|non-compliance with treatment|0|||
129170310|NCT01892436|464918078|FG002|Overall Study|non-compliance with treatment|0|||
129170311|NCT01892436|464918079|FG003|Overall Study|non-compliance with treatment|0|||
129170312|NCT01892436|464918076|FG000|Overall Study|Adverse Event|7|||
129170313|NCT01892436|464918077|FG001|Overall Study|Adverse Event|6|||
129170314|NCT01892436|464918078|FG002|Overall Study|Adverse Event|2|||
129170315|NCT01892436|464918079|FG003|Overall Study|Adverse Event|3|||
129170316|NCT00733291|464918081|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
129170317|NCT00733291|464918082|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
129170318|NCT00733291|464918083|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
129170319|NCT00733291|464918084|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
129170320|NCT02759107|464918087|FG000|Overall Study|Adverse Event|0|||
129170321|NCT02759107|464918088|FG001|Overall Study|Adverse Event|0|||
129170322|NCT02759107|464918089|FG002|Overall Study|Adverse Event|0|||
129170323|NCT02759107|464918090|FG003|Overall Study|Adverse Event|0|||
129170324|NCT02759107|464918091|FG004|Overall Study|Adverse Event|0|||
129170325|NCT02759107|464918092|FG005|Overall Study|Adverse Event|0|||
129170326|NCT02759107|464918093|FG006|Overall Study|Adverse Event|0|||
128729209|NCT03473743|463306598|FG002|Overall Study|Ongoing|6|||
128729210|NCT03473743|463306599|FG003|Overall Study|Ongoing|8|||
129170327|NCT02759107|464918094|FG007|Overall Study|Adverse Event|0|||
129170328|NCT02759107|464918095|FG008|Overall Study|Adverse Event|0|||
129170329|NCT02759107|464918096|FG009|Overall Study|Adverse Event|0|||
129170330|NCT02759107|464918097|FG010|Overall Study|Adverse Event|0|||
128729211|NCT03473743|463306600|FG004|Overall Study|Ongoing|1|||
128729212|NCT03473743|463306601|FG005|Overall Study|Ongoing|1|||
129170331|NCT02759107|464918098|FG011|Overall Study|Adverse Event|0|||
129170332|NCT02759107|464918099|FG012|Overall Study|Adverse Event|2|||
129170333|NCT02759107|464918100|FG013|Overall Study|Adverse Event|0|||
129170334|NCT02759107|464918101|FG014|Overall Study|Adverse Event|0|||
129170335|NCT02759107|464918102|FG015|Overall Study|Adverse Event|1|||
129170336|NCT02759107|464918103|FG016|Overall Study|Adverse Event|0|||
129170337|NCT02759107|464918104|FG017|Overall Study|Adverse Event|2|||
129170338|NCT02759107|464918087|FG000|Overall Study|Scheduling Conflict|0|||
129170339|NCT02759107|464918088|FG001|Overall Study|Scheduling Conflict|0|||
129170340|NCT02759107|464918089|FG002|Overall Study|Scheduling Conflict|0|||
129170341|NCT02759107|464918090|FG003|Overall Study|Scheduling Conflict|0|||
129170342|NCT02759107|464918091|FG004|Overall Study|Scheduling Conflict|0|||
129170343|NCT02759107|464918092|FG005|Overall Study|Scheduling Conflict|0|||
129170344|NCT02759107|464918093|FG006|Overall Study|Scheduling Conflict|0|||
129170345|NCT02759107|464918094|FG007|Overall Study|Scheduling Conflict|0|||
129170346|NCT02759107|464918095|FG008|Overall Study|Scheduling Conflict|0|||
129170347|NCT02759107|464918096|FG009|Overall Study|Scheduling Conflict|1|||
129170348|NCT02759107|464918097|FG010|Overall Study|Scheduling Conflict|0|||
129170349|NCT02759107|464918098|FG011|Overall Study|Scheduling Conflict|0|||
129170350|NCT02759107|464918099|FG012|Overall Study|Scheduling Conflict|0|||
129170351|NCT02759107|464918100|FG013|Overall Study|Scheduling Conflict|0|||
129170352|NCT02759107|464918101|FG014|Overall Study|Scheduling Conflict|0|||
129170353|NCT02759107|464918102|FG015|Overall Study|Scheduling Conflict|0|||
129170354|NCT02759107|464918103|FG016|Overall Study|Scheduling Conflict|0|||
129170355|NCT02759107|464918104|FG017|Overall Study|Scheduling Conflict|0|||
129170356|NCT02019108|464918109|FG000|Overall Study|Lost to Follow-up|5|||
129170357|NCT02019108|464918110|FG001|Overall Study|Lost to Follow-up|7|||
129170358|NCT04569136|464918116|FG000|Overall Study|Lost to Follow-up|2|||
129170359|NCT04569136|464918117|FG001|Overall Study|Lost to Follow-up|0|||
129170360|NCT04569136|464918118|FG002|Overall Study|Lost to Follow-up|1|||
129170361|NCT01466660|464918123|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
129170362|NCT01466660|464918124|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
129170363|NCT01466660|464918123|FG000|Overall Study|Worsening of underlying cancer disease|5|||
129170364|NCT01466660|464918124|FG001|Overall Study|Worsening of underlying cancer disease|2|||
129170365|NCT01466660|464918123|FG000|Overall Study|Other adverse event|19|||
129170366|NCT01466660|464918124|FG001|Overall Study|Other adverse event|18|||
129170367|NCT01466660|464918123|FG000|Overall Study|Protocol Violation|2|||
129170368|NCT01466660|464918124|FG001|Overall Study|Protocol Violation|1|||
129170369|NCT01466660|464918123|FG000|Overall Study|Refused continuation of trial medication|4|||
129170370|NCT01466660|464918124|FG001|Overall Study|Refused continuation of trial medication|3|||
129170371|NCT01466660|464918123|FG000|Overall Study|Other reason not defined above|10|||
129170372|NCT01466660|464918124|FG001|Overall Study|Other reason not defined above|8|||
129170373|NCT00191724|464918125|FG000|Overall Study|Adverse Event|0|||
129170374|NCT00191724|464918126|FG001|Overall Study|Adverse Event|0|||
129170375|NCT00191724|464918127|FG002|Overall Study|Adverse Event|1|||
129170376|NCT00191724|464918128|FG003|Overall Study|Adverse Event|0|||
129170377|NCT00191724|464918129|FG004|Overall Study|Adverse Event|0|||
129170378|NCT00191724|464918125|FG000|Overall Study|Lost to Follow-up|1|||
129170379|NCT00191724|464918126|FG001|Overall Study|Lost to Follow-up|1|||
129170380|NCT00191724|464918127|FG002|Overall Study|Lost to Follow-up|0|||
129170381|NCT00191724|464918128|FG003|Overall Study|Lost to Follow-up|2|||
129170382|NCT00191724|464918129|FG004|Overall Study|Lost to Follow-up|3|||
129170383|NCT00191724|464918125|FG000|Overall Study|Withdrawal by Subject|0|||
129170384|NCT00191724|464918126|FG001|Overall Study|Withdrawal by Subject|0|||
129170385|NCT00191724|464918127|FG002|Overall Study|Withdrawal by Subject|0|||
129170386|NCT00191724|464918128|FG003|Overall Study|Withdrawal by Subject|1|||
129170387|NCT00191724|464918129|FG004|Overall Study|Withdrawal by Subject|0|||
129170388|NCT02301546|464918132|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
129170389|NCT02301546|464918133|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
129170390|NCT02301546|464918132|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
129170391|NCT02301546|464918133|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
129170392|NCT02301546|464918132|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
129170393|NCT02301546|464918133|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
129170394|NCT02301546|464918132|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
129170395|NCT02301546|464918133|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
129170396|NCT02301546|464918132|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
129170397|NCT02301546|464918133|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
129170398|NCT02301546|464918132|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
129170399|NCT02301546|464918133|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
129170400|NCT02301546|464918132|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
129170401|NCT02301546|464918133|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
129170402|NCT02447250|464918138|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
129170403|NCT02447250|464918138|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
129170404|NCT02447250|464918138|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
129170405|NCT03632993|464918139|FG000|Overall Study|Withdrawal by Subject|1|||
129170406|NCT03632993|464918140|FG001|Overall Study|Withdrawal by Subject|0|||
128779060|NCT00162942|463480508|FG001|Overall Study|2 or more consecutive treatments missed|0|||
128779061|NCT02162732|463480509|FG000|Overall Study|Biopsy not performed.|18|||
128779062|NCT01167023|463480510|FG000|Overall Study|Lost to Follow-up|0|||
128779063|NCT01167023|463480511|FG001|Overall Study|Lost to Follow-up|1|||
128779064|NCT01167023|463480512|FG002|Overall Study|Lost to Follow-up|1|||
128779065|NCT01167023|463480510|FG000|Overall Study|Screen Failure|0|||
128779066|NCT01167023|463480511|FG001|Overall Study|Screen Failure|1|||
128779067|NCT01167023|463480512|FG002|Overall Study|Screen Failure|0|||
129170407|NCT03632993|464918141|FG002|Overall Study|Withdrawal by Subject|0|||
129170408|NCT03632993|464918142|FG003|Overall Study|Withdrawal by Subject|0|||
129170409|NCT03632993|464918143|FG004|Overall Study|Withdrawal by Subject|0|||
129170410|NCT03632993|464918144|FG005|Overall Study|Withdrawal by Subject|0|||
129170411|NCT03632993|464918145|FG006|Overall Study|Withdrawal by Subject|0|||
129170412|NCT03632993|464918146|FG007|Overall Study|Withdrawal by Subject|0|||
129170413|NCT03632993|464918147|FG008|Overall Study|Withdrawal by Subject|0|||
129170414|NCT03632993|464918148|FG009|Overall Study|Withdrawal by Subject|1|||
129170415|NCT03632993|464918139|FG000|Overall Study|Protocol Non-compliance|0|||
129170416|NCT03632993|464918140|FG001|Overall Study|Protocol Non-compliance|1|||
129170417|NCT03632993|464918141|FG002|Overall Study|Protocol Non-compliance|0|||
129170418|NCT03632993|464918142|FG003|Overall Study|Protocol Non-compliance|0|||
129170419|NCT03632993|464918143|FG004|Overall Study|Protocol Non-compliance|0|||
129170420|NCT03632993|464918144|FG005|Overall Study|Protocol Non-compliance|0|||
129170421|NCT03632993|464918145|FG006|Overall Study|Protocol Non-compliance|0|||
129170422|NCT03632993|464918146|FG007|Overall Study|Protocol Non-compliance|0|||
129170423|NCT03632993|464918147|FG008|Overall Study|Protocol Non-compliance|0|||
129170424|NCT03632993|464918148|FG009|Overall Study|Protocol Non-compliance|0|||
129170425|NCT03632993|464918139|FG000|Overall Study|Lost to Follow-up|0|||
129170426|NCT03632993|464918140|FG001|Overall Study|Lost to Follow-up|0|||
129170427|NCT03632993|464918141|FG002|Overall Study|Lost to Follow-up|0|||
129170428|NCT03632993|464918142|FG003|Overall Study|Lost to Follow-up|0|||
129170429|NCT03632993|464918143|FG004|Overall Study|Lost to Follow-up|0|||
129170430|NCT03632993|464918144|FG005|Overall Study|Lost to Follow-up|1|||
129170431|NCT03632993|464918145|FG006|Overall Study|Lost to Follow-up|0|||
129170432|NCT03632993|464918146|FG007|Overall Study|Lost to Follow-up|1|||
129170433|NCT03632993|464918147|FG008|Overall Study|Lost to Follow-up|0|||
129170434|NCT03632993|464918148|FG009|Overall Study|Lost to Follow-up|0|||
129170435|NCT03632993|464918139|FG000|Overall Study|Adverse Event|0|||
129170436|NCT03632993|464918140|FG001|Overall Study|Adverse Event|0|||
129170437|NCT03632993|464918141|FG002|Overall Study|Adverse Event|0|||
129170438|NCT03632993|464918142|FG003|Overall Study|Adverse Event|0|||
129170439|NCT03632993|464918143|FG004|Overall Study|Adverse Event|0|||
129170440|NCT03632993|464918144|FG005|Overall Study|Adverse Event|1|||
129170441|NCT03632993|464918145|FG006|Overall Study|Adverse Event|0|||
129170442|NCT03632993|464918146|FG007|Overall Study|Adverse Event|1|||
129170443|NCT03632993|464918147|FG008|Overall Study|Adverse Event|0|||
129170444|NCT03632993|464918148|FG009|Overall Study|Adverse Event|0|||
129170445|NCT03224507|464918149|FG000|Overall Study|Death|3|||
129170446|NCT03224507|464918150|FG001|Overall Study|Death|0|||
129170447|NCT03224507|464918149|FG000|Overall Study|Lack of Efficacy|6|||
129170448|NCT03224507|464918150|FG001|Overall Study|Lack of Efficacy|0|||
129170449|NCT03224507|464918149|FG000|Overall Study|Withdrawal by Subject|6|||
129170450|NCT03224507|464918150|FG001|Overall Study|Withdrawal by Subject|0|||
129170451|NCT02186652|464918154|FG000|Overall Study|Lost to Follow-up|2|||
129170452|NCT02186652|464918155|FG001|Overall Study|Lost to Follow-up|0|||
129170453|NCT00744978|464918156|FG000|Period 1|Lost to Follow-up|1|||
129170454|NCT00744978|464918157|FG001|Period 1|Lost to Follow-up|0|||
129170455|NCT00744978|464918156|FG000|Period 1|Withdrawal by Subject|0|||
129170456|NCT00744978|464918157|FG001|Period 1|Withdrawal by Subject|2|||
129170457|NCT00744978|464918156|FG000|Period 1|Other|0|||
129170458|NCT00744978|464918157|FG001|Period 1|Other|2|||
129170459|NCT00744978|464918156|FG000|Period 1|Adverse Event|4|||
129170460|NCT00744978|464918157|FG001|Period 1|Adverse Event|0|||
129170461|NCT00744978|464918156|FG000|Period 1|Randomized but not Treated|1|||
129170462|NCT00744978|464918157|FG001|Period 1|Randomized but not Treated|1|||
129170463|NCT00744978|464918156|FG000|Period 2|Adverse Event|0|||
129170464|NCT00744978|464918157|FG001|Period 2|Adverse Event|1|||
129170465|NCT02099344|464918165|FG000|Overall Study|Physician Decision|1|||
129170466|NCT02099344|464918166|FG001|Overall Study|Physician Decision|0|||
129170467|NCT02839720|464918167|FG000|Overall Study|Adverse Event|2|||
129170468|NCT02839720|464918167|FG000|Overall Study|Non-compliance|2|||
129170469|NCT02839720|464918167|FG000|Overall Study|Intercurrent Illness|1|||
128779068|NCT01167023|463480510|FG000|Overall Study|Sponsor Decision|0|||
128779069|NCT01167023|463480511|FG001|Overall Study|Sponsor Decision|1|||
128779070|NCT01167023|463480512|FG002|Overall Study|Sponsor Decision|0|||
129170470|NCT02839720|464918167|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
129170471|NCT02649218|464918168|FG000|Overall Study|Adverse Event|8|||
129170472|NCT02649218|464918168|FG000|Overall Study|Lack of Efficacy|8|||
129170473|NCT02649218|464918168|FG000|Overall Study|Pregnancy|3|||
129170474|NCT02649218|464918168|FG000|Overall Study|Protocol Violation|3|||
129170475|NCT02649218|464918168|FG000|Overall Study|Physician Decision|1|||
128779071|NCT01167023|463480510|FG000|Overall Study|Withdrawal by Subject|0|||
128779072|NCT01167023|463480511|FG001|Overall Study|Withdrawal by Subject|0|||
128779073|NCT01167023|463480512|FG002|Overall Study|Withdrawal by Subject|1|||
128779074|NCT00410384|463480513|FG000|Overall Study|Withdrawal by Subject|28|||
128779075|NCT00410384|463480514|FG001|Overall Study|Withdrawal by Subject|17|||
128779076|NCT00410384|463480515|FG002|Overall Study|Withdrawal by Subject|20|||
128779077|NCT00410384|463480513|FG000|Overall Study|Adverse Event|23|||
128779078|NCT00410384|463480514|FG001|Overall Study|Adverse Event|18|||
128779079|NCT00410384|463480515|FG002|Overall Study|Adverse Event|23|||
128779080|NCT00410384|463480513|FG000|Overall Study|Lack of Efficacy|20|||
128779081|NCT00410384|463480514|FG001|Overall Study|Lack of Efficacy|12|||
128779082|NCT00410384|463480515|FG002|Overall Study|Lack of Efficacy|17|||
128779083|NCT00410384|463480513|FG000|Overall Study|Lack of Compliance|2|||
128779084|NCT00410384|463480514|FG001|Overall Study|Lack of Compliance|2|||
128779085|NCT00410384|463480515|FG002|Overall Study|Lack of Compliance|2|||
128779086|NCT00410384|463480513|FG000|Overall Study|Lost to Follow-up|4|||
128779087|NCT00410384|463480514|FG001|Overall Study|Lost to Follow-up|6|||
128779088|NCT00410384|463480515|FG002|Overall Study|Lost to Follow-up|6|||
128779089|NCT00410384|463480513|FG000|Overall Study|Protocol Violation|6|||
128779090|NCT00410384|463480514|FG001|Overall Study|Protocol Violation|6|||
128779091|NCT00410384|463480515|FG002|Overall Study|Protocol Violation|6|||
128779092|NCT00410384|463480513|FG000|Overall Study|Physician Decision|3|||
128779093|NCT00410384|463480514|FG001|Overall Study|Physician Decision|3|||
128779094|NCT00410384|463480515|FG002|Overall Study|Physician Decision|4|||
128779095|NCT00410384|463480513|FG000|Overall Study|Other|3|||
128779096|NCT00410384|463480514|FG001|Overall Study|Other|8|||
128779097|NCT00410384|463480515|FG002|Overall Study|Other|4|||
128779098|NCT01253200|463480518|FG000|Overall Study|Death|1|||
128779099|NCT01253200|463480519|FG001|Overall Study|Death|0|||
128779100|NCT01253200|463480520|FG002|Overall Study|Death|0|||
128779101|NCT01253200|463480521|FG003|Overall Study|Death|0|||
128779102|NCT01253200|463480522|FG004|Overall Study|Death|0|||
129170476|NCT02649218|464918168|FG000|Overall Study|Withdrawal by Subject|2|||
129170477|NCT00503581|464918169|FG000|Overall Study|Study closed|3|||
129170478|NCT00503581|464918170|FG001|Overall Study|Study closed|4|||
129170479|NCT00503581|464918171|FG002|Overall Study|Study closed|2|||
129170480|NCT06107803|464918178|FG000|Overall Study|Adverse Event|1|||
129170481|NCT06107803|464918178|FG000|Overall Study|Withdrawal by Subject|2|||
129170482|NCT06107803|464918178|FG000|Overall Study|Protocol Violation|1|||
129170483|NCT04730635|464918180|FG000|Overall Study|Lost to Follow-up|1|||
129170484|NCT04730635|464918181|FG001|Overall Study|Lost to Follow-up|0|||
129170485|NCT04730635|464918180|FG000|Overall Study|Withdrawal by Subject|0|||
129170486|NCT04730635|464918181|FG001|Overall Study|Withdrawal by Subject|1|||
129170487|NCT01096368|464918182|FG000|Overall Study|Death|0|||
129170488|NCT01096368|464918183|FG001|Overall Study|Death|1|||
129170489|NCT01096368|464918184|FG002|Overall Study|Death|0|||
129170490|NCT01096368|464918185|FG003|Overall Study|Death|0|||
129170491|NCT01096368|464918186|FG004|Overall Study|Death|0|||
129170492|NCT01096368|464918182|FG000|Overall Study|Physician Decision|0|||
129170493|NCT01096368|464918183|FG001|Overall Study|Physician Decision|13|||
129170494|NCT01096368|464918184|FG002|Overall Study|Physician Decision|2|||
129170495|NCT01096368|464918185|FG003|Overall Study|Physician Decision|4|||
129170496|NCT01096368|464918186|FG004|Overall Study|Physician Decision|6|||
129170497|NCT01096368|464918182|FG000|Overall Study|Withdrawal by Subject|0|||
129170498|NCT01096368|464918183|FG001|Overall Study|Withdrawal by Subject|52|||
129170499|NCT01096368|464918184|FG002|Overall Study|Withdrawal by Subject|0|||
129170500|NCT01096368|464918185|FG003|Overall Study|Withdrawal by Subject|10|||
129170501|NCT01096368|464918186|FG004|Overall Study|Withdrawal by Subject|14|||
129170502|NCT01096368|464918182|FG000|Overall Study|Ineligible|0|||
129170503|NCT01096368|464918183|FG001|Overall Study|Ineligible|3|||
129170504|NCT01096368|464918184|FG002|Overall Study|Ineligible|2|||
129170505|NCT01096368|464918185|FG003|Overall Study|Ineligible|0|||
128779103|NCT01253200|463480518|FG000|Overall Study|Lost to Follow-up|1|||
128779104|NCT01253200|463480519|FG001|Overall Study|Lost to Follow-up|1|||
129170506|NCT01096368|464918186|FG004|Overall Study|Ineligible|25|||
129170507|NCT01096368|464918182|FG000|Overall Study|Did not start treatment|0|||
129170508|NCT01096368|464918183|FG001|Overall Study|Did not start treatment|4|||
129170509|NCT01096368|464918184|FG002|Overall Study|Did not start treatment|4|||
129170510|NCT01096368|464918185|FG003|Overall Study|Did not start treatment|0|||
129170511|NCT01096368|464918186|FG004|Overall Study|Did not start treatment|0|||
128779105|NCT01253200|463480520|FG002|Overall Study|Lost to Follow-up|0|||
128779106|NCT01253200|463480521|FG003|Overall Study|Lost to Follow-up|0|||
128779107|NCT01253200|463480522|FG004|Overall Study|Lost to Follow-up|0|||
128779108|NCT01253200|463480518|FG000|Overall Study|Withdrawal by Subject|2|||
128779109|NCT01253200|463480519|FG001|Overall Study|Withdrawal by Subject|0|||
128779110|NCT01253200|463480520|FG002|Overall Study|Withdrawal by Subject|0|||
128779111|NCT01253200|463480521|FG003|Overall Study|Withdrawal by Subject|0|||
129170512|NCT01096368|464918182|FG000|Overall Study|Progressive disease|0|||
129170513|NCT01096368|464918183|FG001|Overall Study|Progressive disease|6|||
129170514|NCT01096368|464918184|FG002|Overall Study|Progressive disease|0|||
129170515|NCT01096368|464918185|FG003|Overall Study|Progressive disease|10|||
129170516|NCT01096368|464918186|FG004|Overall Study|Progressive disease|3|||
129170517|NCT01096368|464918182|FG000|Overall Study|Other|0|||
129170518|NCT01096368|464918183|FG001|Overall Study|Other|0|||
129170519|NCT01096368|464918184|FG002|Overall Study|Other|1|||
129170520|NCT01096368|464918185|FG003|Overall Study|Other|0|||
129170521|NCT01096368|464918186|FG004|Overall Study|Other|0|||
129170522|NCT01096368|464918182|FG000|Overall Study|Treated with institutional review|0|||
129170523|NCT01096368|464918183|FG001|Overall Study|Treated with institutional review|0|||
129170524|NCT01096368|464918184|FG002|Overall Study|Treated with institutional review|0|||
129170525|NCT01096368|464918185|FG003|Overall Study|Treated with institutional review|0|||
129170526|NCT01096368|464918186|FG004|Overall Study|Treated with institutional review|1|||
129170527|NCT03070223|464918187|FG000|Overall Study|Lost to Follow-up|34|||
129170528|NCT03070223|464918188|FG001|Overall Study|Lost to Follow-up|27|||
129170529|NCT03070223|464918187|FG000|Overall Study|Withdrawal by Subject|12|||
128779112|NCT01253200|463480522|FG004|Overall Study|Withdrawal by Subject|0|||
129170530|NCT03070223|464918188|FG001|Overall Study|Withdrawal by Subject|22|||
128779113|NCT01253200|463480518|FG000|Overall Study|Protocol Violation|1|||
129170531|NCT03070223|464918187|FG000|Overall Study|Protocol Violation|0|||
129170532|NCT03070223|464918188|FG001|Overall Study|Protocol Violation|1|||
128779114|NCT01253200|463480519|FG001|Overall Study|Protocol Violation|4|||
129170533|NCT04934800|464918189|FG000|Overall Study|Other|1|||
129170534|NCT04934800|464918189|FG000|Overall Study|Withdrawal by Subject|5|||
129170535|NCT04934800|464918189|FG000|Overall Study|Lack of Efficacy|1|||
129170536|NCT04934800|464918189|FG000|Overall Study|Adverse Event|9|||
129170537|NCT04934800|464918189|FG000|Overall Study|Lost to Follow-up|5|||
129170538|NCT04934800|464918189|FG000|Overall Study|Enrolled but not treated|1|||
129170539|NCT00516906|464918190|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
129170540|NCT00516906|464918191|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
129170541|NCT01974206|464918194|FG000|Overall Study|Did Not Take Study Drug|0|||
129170542|NCT01974206|464918195|FG001|Overall Study|Did Not Take Study Drug|1|||
129170543|NCT01974206|464918194|FG000|Overall Study|Physician Decision|1|||
129170544|NCT01974206|464918195|FG001|Overall Study|Physician Decision|0|||
129170545|NCT01974206|464918194|FG000|Overall Study|Withdrawal by Subject|3|||
129170546|NCT01974206|464918195|FG001|Overall Study|Withdrawal by Subject|0|||
129170547|NCT01974206|464918194|FG000|Overall Study|Lost to Follow-up|1|||
129170548|NCT01974206|464918195|FG001|Overall Study|Lost to Follow-up|0|||
129170549|NCT01974206|464918194|FG000|Overall Study|Death|1|||
129170550|NCT01974206|464918195|FG001|Overall Study|Death|0|||
129170551|NCT02118766|464918200|FG000|Overall Study|Adverse Event|7|||
129170552|NCT02118766|464918201|FG001|Overall Study|Adverse Event|2|||
129170553|NCT02118766|464918200|FG000|Overall Study|Withdrawal by Subject|3|||
129170554|NCT02118766|464918201|FG001|Overall Study|Withdrawal by Subject|6|||
129170555|NCT02118766|464918200|FG000|Overall Study|Lost to Follow-up|5|||
129170556|NCT02118766|464918201|FG001|Overall Study|Lost to Follow-up|4|||
129170557|NCT02118766|464918200|FG000|Overall Study|Withdrawal by parent/guardian|12|||
129170558|NCT02118766|464918201|FG001|Overall Study|Withdrawal by parent/guardian|18|||
129170559|NCT02118766|464918200|FG000|Overall Study|Other|3|||
129170560|NCT02118766|464918201|FG001|Overall Study|Other|1|||
129170561|NCT03219034|464918205|FG000|Overall Study|Lost to Follow-up|9|||
129170562|NCT03219034|464918206|FG001|Overall Study|Lost to Follow-up|13|||
129170563|NCT03219034|464918205|FG000|Overall Study|Additional dental work needed|1|||
129170564|NCT03219034|464918206|FG001|Overall Study|Additional dental work needed|0|||
129170565|NCT03219034|464918205|FG000|Overall Study|UPPP Surgery|1|||
129170566|NCT03219034|464918206|FG001|Overall Study|UPPP Surgery|0|||
129170567|NCT03219034|464918205|FG000|Overall Study|Dental sensitivity|0|||
129170568|NCT03219034|464918206|FG001|Overall Study|Dental sensitivity|1|||
129170569|NCT03219034|464918205|FG000|Overall Study|Death in family|0|||
129170570|NCT03219034|464918206|FG001|Overall Study|Death in family|1|||
129170571|NCT02438683|464918207|FG000|Overall Study|Adverse Event|1|||
129170572|NCT02438683|464918208|FG001|Overall Study|Adverse Event|0|||
129170573|NCT02438683|464918209|FG002|Overall Study|Adverse Event|0|||
129170574|NCT02438683|464918210|FG003|Overall Study|Adverse Event|0|||
129170575|NCT02438683|464918211|FG004|Overall Study|Adverse Event|0|||
129170576|NCT02438683|464918212|FG005|Overall Study|Adverse Event|0|||
129170577|NCT04669262|464918223|FG000|Overall Study|Withdrawal by Subject|0|||
129170578|NCT04669262|464918224|FG001|Overall Study|Withdrawal by Subject|0|||
129170579|NCT04669262|464918225|FG002|Overall Study|Withdrawal by Subject|0|||
129170580|NCT04669262|464918226|FG003|Overall Study|Withdrawal by Subject|1|||
129170581|NCT04669262|464918223|FG000|Overall Study|Randomized but Not Treated|0|||
128729213|NCT03473743|463306602|FG006|Overall Study|Ongoing|22|||
128729214|NCT03473743|463306603|FG007|Overall Study|Ongoing|24|||
128729215|NCT03473743|463306596|FG000|Overall Study|Randomized but not treated|0|||
128729216|NCT03473743|463306597|FG001|Overall Study|Randomized but not treated|0|||
128729217|NCT03473743|463306598|FG002|Overall Study|Randomized but not treated|0|||
128729218|NCT03473743|463306599|FG003|Overall Study|Randomized but not treated|0|||
128729219|NCT03473743|463306600|FG004|Overall Study|Randomized but not treated|0|||
128729220|NCT03473743|463306601|FG005|Overall Study|Randomized but not treated|0|||
128729221|NCT03473743|463306602|FG006|Overall Study|Randomized but not treated|1|||
128729222|NCT03473743|463306603|FG007|Overall Study|Randomized but not treated|1|||
128729223|NCT02052739|463306609|FG000|Overall Study|Withdrew due to Adverse Event|3|||
128729224|NCT02052739|463306610|FG001|Overall Study|Withdrew due to Adverse Event|0|||
128729225|NCT02052739|463306609|FG000|Overall Study|Participant Died|2|||
128729226|NCT02052739|463306610|FG001|Overall Study|Participant Died|1|||
128729227|NCT05619692|463306611|FG000|Overall Study|Adverse Event|2|||
128729228|NCT05619692|463306612|FG001|Overall Study|Adverse Event|2|||
128729229|NCT05619692|463306611|FG000|Overall Study|Withdrawal by Participant|3|||
128729230|NCT05619692|463306612|FG001|Overall Study|Withdrawal by Participant|4|||
128729231|NCT05619692|463306611|FG000|Overall Study|Lost to Follow-up|2|||
128729232|NCT05619692|463306612|FG001|Overall Study|Lost to Follow-up|1|||
128729233|NCT05619692|463306611|FG000|Overall Study|Randomized but not treated|1|||
128729234|NCT05619692|463306612|FG001|Overall Study|Randomized but not treated|3|||
128729235|NCT05267054|463306614|FG000|Overall Study|Death|13|||
128729236|NCT05267054|463306615|FG001|Overall Study|Death|14|||
128729237|NCT05267054|463306614|FG000|Overall Study|Study Ended by Sponsor|9|||
128729238|NCT05267054|463306615|FG001|Overall Study|Study Ended by Sponsor|13|||
128729239|NCT05267054|463306614|FG000|Overall Study|Lost to Follow-up|1|||
128729240|NCT05267054|463306615|FG001|Overall Study|Lost to Follow-up|1|||
128729241|NCT05267054|463306614|FG000|Overall Study|Withdrawal by Subject|1|||
128729242|NCT05267054|463306615|FG001|Overall Study|Withdrawal by Subject|1|||
128729243|NCT04049760|463306616|FG000|Overall Study|Withdrawal by Subject|1|||
128729244|NCT02457598|463306617|FG000|Overall Study|Progressive Disease|2|||
128729245|NCT02457598|463306618|FG001|Overall Study|Progressive Disease|2|||
129170582|NCT04669262|464918224|FG001|Overall Study|Randomized but Not Treated|1|||
129170583|NCT04669262|464918225|FG002|Overall Study|Randomized but Not Treated|0|||
129170584|NCT04669262|464918226|FG003|Overall Study|Randomized but Not Treated|0|||
129170585|NCT01638013|464918227|FG000|Overall Study|Adverse Event|36|||
129170586|NCT01638013|464918228|FG001|Overall Study|Adverse Event|29|||
129170587|NCT01638013|464918229|FG002|Overall Study|Adverse Event|48|||
129170588|NCT01638013|464918227|FG000|Overall Study|Lack of Efficacy|39|||
129170589|NCT01638013|464918228|FG001|Overall Study|Lack of Efficacy|11|||
129170590|NCT01638013|464918229|FG002|Overall Study|Lack of Efficacy|14|||
128779115|NCT01253200|463480520|FG002|Overall Study|Protocol Violation|0|||
128779116|NCT01253200|463480521|FG003|Overall Study|Protocol Violation|0|||
129170591|NCT01638013|464918227|FG000|Overall Study|Protocol Violation|10|||
129170592|NCT01638013|464918228|FG001|Overall Study|Protocol Violation|7|||
129170593|NCT01638013|464918229|FG002|Overall Study|Protocol Violation|11|||
129170594|NCT01638013|464918227|FG000|Overall Study|Met discontinuation criteria|4|||
129170595|NCT01638013|464918228|FG001|Overall Study|Met discontinuation criteria|0|||
129170596|NCT01638013|464918229|FG002|Overall Study|Met discontinuation criteria|7|||
129170597|NCT01638013|464918227|FG000|Overall Study|Subject Lost to Follow up|1|||
129170598|NCT01638013|464918228|FG001|Overall Study|Subject Lost to Follow up|0|||
129170599|NCT01638013|464918229|FG002|Overall Study|Subject Lost to Follow up|1|||
129170600|NCT01638013|464918227|FG000|Overall Study|Miscellaneous|25|||
129170601|NCT01638013|464918228|FG001|Overall Study|Miscellaneous|19|||
129170602|NCT01638013|464918229|FG002|Overall Study|Miscellaneous|23|||
129170603|NCT01638013|464918227|FG000|Overall Study|Withdrawal of Consent|16|||
129170604|NCT01638013|464918228|FG001|Overall Study|Withdrawal of Consent|12|||
129170605|NCT01638013|464918229|FG002|Overall Study|Withdrawal of Consent|16|||
129170606|NCT01638013|464918227|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
129170607|NCT01638013|464918228|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
129170608|NCT01638013|464918229|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
129170609|NCT03559517|464918232|FG000|Overall Study|Withdrawal by Subject|1|||
129170610|NCT03559517|464918233|FG001|Overall Study|Withdrawal by Subject|0|||
129170611|NCT03559517|464918234|FG002|Overall Study|Withdrawal by Subject|0|||
129170612|NCT01846299|464918235|FG000|Overall Study|Physician Decision|4|||
129170613|NCT01846299|464918236|FG001|Overall Study|Physician Decision|2|||
129170614|NCT01846299|464918235|FG000|Overall Study|Protocol deviation|1|||
129170615|NCT01846299|464918236|FG001|Overall Study|Protocol deviation|0|||
129170616|NCT01846299|464918235|FG000|Overall Study|Death|1|||
129170617|NCT01846299|464918236|FG001|Overall Study|Death|2|||
129170618|NCT01846299|464918235|FG000|Overall Study|Lost to Follow-up|3|||
129170619|NCT01846299|464918236|FG001|Overall Study|Lost to Follow-up|0|||
129170620|NCT01846299|464918235|FG000|Overall Study|Withdrawal by Subject|1|||
129170621|NCT01846299|464918236|FG001|Overall Study|Withdrawal by Subject|6|||
129170622|NCT01846299|464918235|FG000|Overall Study|Adverse Event|2|||
129170623|NCT01846299|464918236|FG001|Overall Study|Adverse Event|0|||
129170624|NCT02013206|464920133|FG000|Overall Study|Progressive disease (PD)|14|||
129170625|NCT02013206|464920134|FG001|Overall Study|Progressive disease (PD)|17|||
129170626|NCT02013206|464920133|FG000|Overall Study|Symptomatic deterioration|3|||
129170627|NCT02013206|464920134|FG001|Overall Study|Symptomatic deterioration|1|||
129170628|NCT02013206|464920133|FG000|Overall Study|Adverse Event|1|||
129170629|NCT02013206|464920134|FG001|Overall Study|Adverse Event|0|||
129170630|NCT02013206|464920133|FG000|Overall Study|Patient refusal|2|||
129170631|NCT02013206|464920134|FG001|Overall Study|Patient refusal|0|||
129170632|NCT02013206|464920133|FG000|Overall Study|Patient non-compliance|1|||
129170633|NCT02013206|464920134|FG001|Overall Study|Patient non-compliance|0|||
129170634|NCT02013206|464920133|FG000|Overall Study|Death|1|||
129170635|NCT02013206|464920134|FG001|Overall Study|Death|2|||
129170636|NCT02013206|464920133|FG000|Overall Study|Other reasons off treatment|5|||
129170637|NCT02013206|464920134|FG001|Overall Study|Other reasons off treatment|2|||
129170638|NCT02791191|464920135|FG000|Overall Study|Adverse Event|2|||
129170639|NCT02791191|464920136|FG001|Overall Study|Adverse Event|4|||
129170640|NCT02791191|464920137|FG002|Overall Study|Adverse Event|5|||
129170641|NCT02791191|464920135|FG000|Overall Study|Lack of Efficacy|0|||
129170642|NCT02791191|464920136|FG001|Overall Study|Lack of Efficacy|1|||
128779117|NCT01253200|463480522|FG004|Overall Study|Protocol Violation|5|||
129170643|NCT02791191|464920137|FG002|Overall Study|Lack of Efficacy|0|||
128779118|NCT01253200|463480518|FG000|Overall Study|intents|10|||
128779119|NCT01253200|463480519|FG001|Overall Study|intents|10|||
128779120|NCT01253200|463480520|FG002|Overall Study|intents|1|||
128779121|NCT01253200|463480521|FG003|Overall Study|intents|3|||
128779122|NCT01253200|463480522|FG004|Overall Study|intents|0|||
128779123|NCT01253200|463480518|FG000|Overall Study|Attempts|6|||
128779124|NCT01253200|463480519|FG001|Overall Study|Attempts|4|||
128779125|NCT01253200|463480520|FG002|Overall Study|Attempts|1|||
128779126|NCT01253200|463480521|FG003|Overall Study|Attempts|2|||
128779127|NCT01253200|463480522|FG004|Overall Study|Attempts|0|||
128779128|NCT02049437|463480523|FG000|Period 1|Adverse Event|1|||
128779129|NCT02049437|463480524|FG001|Period 1|Adverse Event|1|||
128779130|NCT02049437|463480523|FG000|Period 1|Adverse Event|1|||
128779131|NCT02049437|463480524|FG001|Period 1|Adverse Event|0|||
128779132|NCT04529538|463480526|FG000|Overall Study|Lost to Follow-up|3|||
128779133|NCT04529538|463480527|FG001|Overall Study|Lost to Follow-up|2|||
128779134|NCT04529538|463480528|FG002|Overall Study|Lost to Follow-up|1|||
129170644|NCT02791191|464920135|FG000|Overall Study|Study Drug Non-Compliance|0|||
129170645|NCT02791191|464920136|FG001|Overall Study|Study Drug Non-Compliance|2|||
129170646|NCT02791191|464920137|FG002|Overall Study|Study Drug Non-Compliance|0|||
129170647|NCT02791191|464920135|FG000|Overall Study|Site Closed by Sponsor|1|||
129170648|NCT02791191|464920136|FG001|Overall Study|Site Closed by Sponsor|1|||
129170649|NCT02791191|464920137|FG002|Overall Study|Site Closed by Sponsor|3|||
129170650|NCT02791191|464920135|FG000|Overall Study|Progressive Disease|1|||
129170651|NCT02791191|464920136|FG001|Overall Study|Progressive Disease|0|||
129170652|NCT02791191|464920137|FG002|Overall Study|Progressive Disease|0|||
129170653|NCT02791191|464920135|FG000|Overall Study|Study Terminated by Sponsor|29|||
129170654|NCT02791191|464920136|FG001|Overall Study|Study Terminated by Sponsor|101|||
129170655|NCT02791191|464920137|FG002|Overall Study|Study Terminated by Sponsor|109|||
129170656|NCT02791191|464920135|FG000|Overall Study|Withdrawal by Subject|3|||
129170657|NCT02791191|464920136|FG001|Overall Study|Withdrawal by Subject|1|||
129170658|NCT02791191|464920137|FG002|Overall Study|Withdrawal by Subject|3|||
129170659|NCT02791191|464920135|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
129170660|NCT02791191|464920136|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
129170661|NCT02791191|464920137|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
129170662|NCT01448824|464920138|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129170663|NCT01448824|464920139|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129170664|NCT01448824|464920140|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129170665|NCT01448824|464920141|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129170666|NCT01448824|464920142|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129170667|NCT01448824|464920143|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129170668|NCT01448824|464920144|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
129170669|NCT01448824|464920145|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129170670|NCT01448824|464920138|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129170671|NCT01448824|464920139|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129170672|NCT01448824|464920140|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129170673|NCT01448824|464920141|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
129170674|NCT01448824|464920142|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
129170675|NCT01448824|464920143|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
129170676|NCT01448824|464920144|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129170677|NCT01448824|464920145|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129170678|NCT01448824|464920138|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129170679|NCT01448824|464920139|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129170680|NCT01448824|464920140|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129170681|NCT01448824|464920141|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129170682|NCT01448824|464920142|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129170683|NCT01448824|464920143|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
129170684|NCT01448824|464920144|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129170685|NCT01448824|464920145|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129170686|NCT01448824|464920138|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
128779135|NCT04529538|463480529|FG003|Overall Study|Lost to Follow-up|0|||
128779136|NCT04529538|463480530|FG004|Overall Study|Lost to Follow-up|1|||
128779137|NCT04529538|463480531|FG005|Overall Study|Lost to Follow-up|1|||
128779138|NCT04529538|463480532|FG006|Overall Study|Lost to Follow-up|2|||
128779139|NCT04529538|463480533|FG007|Overall Study|Lost to Follow-up|0|||
128779140|NCT04529538|463480526|FG000|Overall Study|Not eligible at enrollment|0|||
129170687|NCT01448824|464920139|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
129170688|NCT01448824|464920140|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
128779141|NCT04529538|463480527|FG001|Overall Study|Not eligible at enrollment|1|||
128779142|NCT04529538|463480528|FG002|Overall Study|Not eligible at enrollment|2|||
128779143|NCT04529538|463480529|FG003|Overall Study|Not eligible at enrollment|1|||
129170689|NCT01448824|464920141|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
129170690|NCT01448824|464920142|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
129170691|NCT01448824|464920143|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
129170692|NCT01448824|464920144|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
129170693|NCT01448824|464920145|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
129170694|NCT01448824|464920138|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129170695|NCT01448824|464920139|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129170696|NCT01448824|464920140|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129170697|NCT01448824|464920141|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129170698|NCT01448824|464920142|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129170699|NCT01448824|464920143|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129170700|NCT01448824|464920144|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129170701|NCT01448824|464920145|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
129170702|NCT01448824|464920138|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129170703|NCT01448824|464920139|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129170704|NCT01448824|464920140|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129170705|NCT01448824|464920141|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129170706|NCT01448824|464920142|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129170707|NCT01448824|464920143|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129170708|NCT01448824|464920144|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129170709|NCT01448824|464920145|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
129170710|NCT01448824|464920138|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129170711|NCT01448824|464920139|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129170712|NCT01448824|464920140|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129170713|NCT01448824|464920141|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129170714|NCT01448824|464920142|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129170715|NCT01448824|464920143|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129170716|NCT01448824|464920144|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129170717|NCT01448824|464920145|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
129170718|NCT01448824|464920138|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129170719|NCT01448824|464920139|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129170720|NCT01448824|464920140|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129170721|NCT01448824|464920141|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129170722|NCT01448824|464920142|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129170723|NCT01448824|464920143|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129170724|NCT01448824|464920144|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129170725|NCT01448824|464920145|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
129170726|NCT01995669|464920148|FG000|Overall Study|Progression|2|||
129170727|NCT01995669|464920149|FG001|Overall Study|Progression|1|||
129170728|NCT01995669|464920150|FG002|Overall Study|Progression|1|||
129170729|NCT01995669|464920151|FG003|Overall Study|Progression|13|||
129170730|NCT01995669|464920148|FG000|Overall Study|Adverse Event|0|||
129170731|NCT01995669|464920149|FG001|Overall Study|Adverse Event|0|||
129170732|NCT01995669|464920150|FG002|Overall Study|Adverse Event|0|||
129170733|NCT01995669|464920151|FG003|Overall Study|Adverse Event|3|||
129170734|NCT01995669|464920148|FG000|Overall Study|Death|0|||
129170735|NCT01995669|464920149|FG001|Overall Study|Death|0|||
129170736|NCT01995669|464920150|FG002|Overall Study|Death|0|||
129170737|NCT01995669|464920151|FG003|Overall Study|Death|6|||
129170738|NCT01995669|464920148|FG000|Overall Study|Withdrawal by Subject|0|||
129170739|NCT01995669|464920149|FG001|Overall Study|Withdrawal by Subject|0|||
129170740|NCT01995669|464920150|FG002|Overall Study|Withdrawal by Subject|0|||
129170741|NCT01995669|464920151|FG003|Overall Study|Withdrawal by Subject|6|||
129170742|NCT01995669|464920148|FG000|Overall Study|Insurance Expired|0|||
129170743|NCT01995669|464920149|FG001|Overall Study|Insurance Expired|0|||
128779144|NCT04529538|463480530|FG004|Overall Study|Not eligible at enrollment|0|||
128779145|NCT04529538|463480531|FG005|Overall Study|Not eligible at enrollment|0|||
128779146|NCT04529538|463480532|FG006|Overall Study|Not eligible at enrollment|0|||
128779147|NCT04529538|463480533|FG007|Overall Study|Not eligible at enrollment|1|||
128779148|NCT04529538|463480526|FG000|Overall Study|Withdrawal by Subject|0|||
128779149|NCT04529538|463480527|FG001|Overall Study|Withdrawal by Subject|1|||
128779150|NCT04529538|463480528|FG002|Overall Study|Withdrawal by Subject|1|||
129170744|NCT01995669|464920150|FG002|Overall Study|Insurance Expired|0|||
128779151|NCT04529538|463480529|FG003|Overall Study|Withdrawal by Subject|2|||
128779152|NCT04529538|463480530|FG004|Overall Study|Withdrawal by Subject|0|||
128779153|NCT04529538|463480531|FG005|Overall Study|Withdrawal by Subject|2|||
128779154|NCT04529538|463480532|FG006|Overall Study|Withdrawal by Subject|3|||
128779155|NCT04529538|463480533|FG007|Overall Study|Withdrawal by Subject|0|||
128779156|NCT04529538|463480526|FG000|Overall Study|Other|0|||
128779157|NCT04529538|463480527|FG001|Overall Study|Other|1|||
128779158|NCT04529538|463480528|FG002|Overall Study|Other|0|||
128779159|NCT04529538|463480529|FG003|Overall Study|Other|0|||
128779160|NCT04529538|463480530|FG004|Overall Study|Other|0|||
128779161|NCT04529538|463480531|FG005|Overall Study|Other|0|||
128779162|NCT04529538|463480532|FG006|Overall Study|Other|0|||
128779163|NCT04529538|463480533|FG007|Overall Study|Other|0|||
128779164|NCT04529538|463480526|FG000|Overall Study|Adverse Event|0|||
128779165|NCT04529538|463480527|FG001|Overall Study|Adverse Event|0|||
128779166|NCT04529538|463480528|FG002|Overall Study|Adverse Event|0|||
128779167|NCT04529538|463480529|FG003|Overall Study|Adverse Event|1|||
128779168|NCT04529538|463480530|FG004|Overall Study|Adverse Event|0|||
128779169|NCT04529538|463480531|FG005|Overall Study|Adverse Event|0|||
128779170|NCT04529538|463480532|FG006|Overall Study|Adverse Event|0|||
128779171|NCT04529538|463480533|FG007|Overall Study|Adverse Event|0|||
128779172|NCT04529538|463480526|FG000|Overall Study|Protocol Deviation|0|||
128779173|NCT04529538|463480527|FG001|Overall Study|Protocol Deviation|0|||
128779174|NCT04529538|463480528|FG002|Overall Study|Protocol Deviation|0|||
128779175|NCT04529538|463480529|FG003|Overall Study|Protocol Deviation|1|||
128779176|NCT04529538|463480530|FG004|Overall Study|Protocol Deviation|0|||
128779177|NCT04529538|463480531|FG005|Overall Study|Protocol Deviation|0|||
128779178|NCT04529538|463480532|FG006|Overall Study|Protocol Deviation|0|||
128779179|NCT04529538|463480533|FG007|Overall Study|Protocol Deviation|0|||
128779180|NCT04529538|463480526|FG000|Overall Study|Physician Decision|0|||
128779181|NCT04529538|463480527|FG001|Overall Study|Physician Decision|0|||
128779182|NCT04529538|463480528|FG002|Overall Study|Physician Decision|0|||
128779183|NCT04529538|463480529|FG003|Overall Study|Physician Decision|0|||
128779184|NCT04529538|463480530|FG004|Overall Study|Physician Decision|0|||
129170745|NCT01995669|464920151|FG003|Overall Study|Insurance Expired|1|||
129170746|NCT05425732|464920152|FG000|Overall Study|Death|4|||
129170747|NCT05425732|464920153|FG001|Overall Study|Death|2|||
129170748|NCT05425732|464920154|FG002|Overall Study|Death|0|||
129170749|NCT05425732|464920155|FG003|Overall Study|Death|0|||
129170750|NCT05425732|464920152|FG000|Overall Study|Lost to Follow-up|10|||
129170751|NCT05425732|464920153|FG001|Overall Study|Lost to Follow-up|15|||
129170752|NCT05425732|464920154|FG002|Overall Study|Lost to Follow-up|5|||
129170753|NCT05425732|464920155|FG003|Overall Study|Lost to Follow-up|3|||
129170754|NCT05425732|464920152|FG000|Overall Study|Physician Decision|0|||
129170755|NCT05425732|464920153|FG001|Overall Study|Physician Decision|2|||
129170756|NCT05425732|464920154|FG002|Overall Study|Physician Decision|0|||
129170757|NCT05425732|464920155|FG003|Overall Study|Physician Decision|0|||
129170758|NCT05425732|464920152|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129170759|NCT05425732|464920153|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
129170760|NCT05425732|464920154|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129170761|NCT05425732|464920155|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129170762|NCT05425732|464920152|FG000|Overall Study|Withdrawal by Subject|4|||
128779185|NCT04529538|463480531|FG005|Overall Study|Physician Decision|1|||
128779186|NCT04529538|463480532|FG006|Overall Study|Physician Decision|0|||
128779187|NCT04529538|463480533|FG007|Overall Study|Physician Decision|1|||
128779188|NCT00235495|463480536|FG000|Overall Study|Death|52|||
129170763|NCT05425732|464920153|FG001|Overall Study|Withdrawal by Subject|8|||
129170764|NCT05425732|464920154|FG002|Overall Study|Withdrawal by Subject|1|||
129170765|NCT05425732|464920155|FG003|Overall Study|Withdrawal by Subject|1|||
129170766|NCT05425732|464920152|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
129170767|NCT05425732|464920153|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
128779189|NCT00235495|463480537|FG001|Overall Study|Death|42|||
128779190|NCT00235495|463480536|FG000|Overall Study|Withdrawal by Subject|5|||
128779191|NCT00235495|463480537|FG001|Overall Study|Withdrawal by Subject|3|||
128779192|NCT00235495|463480536|FG000|Overall Study|Lost to Follow-up|11|||
128779193|NCT00235495|463480537|FG001|Overall Study|Lost to Follow-up|13|||
128779194|NCT00235495|463480536|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
129170768|NCT05425732|464920154|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
129170769|NCT05425732|464920155|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
129170770|NCT02998203|464920157|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
129170771|NCT02998203|464920158|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
129170772|NCT02998203|464920157|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
129170773|NCT02998203|464920158|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
129170774|NCT04187144|464920159|FG000|Overall Study|Lost to Follow-up|12|||
129170775|NCT04187144|464920160|FG001|Overall Study|Lost to Follow-up|11|||
129170776|NCT04187144|464920159|FG000|Overall Study|Withdrawal by Subject|20|||
129170777|NCT04187144|464920160|FG001|Overall Study|Withdrawal by Subject|18|||
129170778|NCT04187144|464920159|FG000|Overall Study|Adverse Event|19|||
129170779|NCT04187144|464920160|FG001|Overall Study|Adverse Event|4|||
129170780|NCT04187144|464920159|FG000|Overall Study|Physician Decision|5|||
129170781|NCT04187144|464920160|FG001|Overall Study|Physician Decision|3|||
129170782|NCT04187144|464920159|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
129170783|NCT04187144|464920160|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
129170784|NCT04187144|464920159|FG000|Overall Study|Protocol Deviation|1|||
129170785|NCT04187144|464920160|FG001|Overall Study|Protocol Deviation|4|||
129170786|NCT02650804|464920161|FG000|Overall Study|Adverse Event|3|||
129170787|NCT02650804|464920162|FG001|Overall Study|Adverse Event|2|||
129170788|NCT02650804|464920161|FG000|Overall Study|Death|1|||
129170789|NCT02650804|464920162|FG001|Overall Study|Death|2|||
129170790|NCT02650804|464920161|FG000|Overall Study|Progressive Disease|7|||
129170791|NCT02650804|464920162|FG001|Overall Study|Progressive Disease|10|||
129170792|NCT02650804|464920161|FG000|Overall Study|Physician Decision|0|||
129170793|NCT02650804|464920162|FG001|Overall Study|Physician Decision|2|||
129170794|NCT02650804|464920161|FG000|Overall Study|Withdrawal by Subject|1|||
129170795|NCT02650804|464920162|FG001|Overall Study|Withdrawal by Subject|4|||
129170796|NCT02650804|464920161|FG000|Overall Study|Symptomatic deterioration|5|||
129170797|NCT02650804|464920162|FG001|Overall Study|Symptomatic deterioration|7|||
129170798|NCT02650804|464920161|FG000|Overall Study|Protocol Violation|0|||
129170799|NCT02650804|464920162|FG001|Overall Study|Protocol Violation|1|||
129170800|NCT04085458|464920163|FG000|Overall Study|Other|1|||
129170801|NCT04085458|464920163|FG000|Overall Study|Withdrawal by Subject|2|||
129170802|NCT04085458|464920163|FG000|Overall Study|Adverse Event|2|||
129170803|NCT02743949|464920164|FG000|Overall Study|Adverse Event|0|||
129170804|NCT02743949|464920165|FG001|Overall Study|Adverse Event|0|||
129170805|NCT02743949|464920166|FG002|Overall Study|Adverse Event|2|||
129170806|NCT02743949|464920164|FG000|Overall Study|Significant Protocol Deviation|2|||
129170807|NCT02743949|464920165|FG001|Overall Study|Significant Protocol Deviation|0|||
129170808|NCT02743949|464920166|FG002|Overall Study|Significant Protocol Deviation|1|||
129170809|NCT02743949|464920164|FG000|Overall Study|Voluntary Withdrawal|2|||
129170810|NCT02743949|464920165|FG001|Overall Study|Voluntary Withdrawal|1|||
129170811|NCT02743949|464920166|FG002|Overall Study|Voluntary Withdrawal|0|||
129170812|NCT03389555|464920167|FG000|Overall Study|Protocol Violation|1|||
129170813|NCT03389555|464920168|FG001|Overall Study|Protocol Violation|3|||
129170814|NCT03389555|464920167|FG000|Overall Study|Death|1|||
129170815|NCT03389555|464920168|FG001|Overall Study|Death|0|||
129170816|NCT00920218|464920169|FG000|Overall Study|Serious Adverse Event|2|||
129170817|NCT00920218|464920170|FG001|Overall Study|Serious Adverse Event|0|||
129170818|NCT00920218|464920171|FG002|Overall Study|Serious Adverse Event|2|||
129170819|NCT00920218|464920172|FG003|Overall Study|Serious Adverse Event|1|||
129170820|NCT00920218|464920169|FG000|Overall Study|Withdrawal by Subject|0|||
129170821|NCT00920218|464920170|FG001|Overall Study|Withdrawal by Subject|3|||
129170822|NCT00920218|464920171|FG002|Overall Study|Withdrawal by Subject|2|||
129170823|NCT00920218|464920172|FG003|Overall Study|Withdrawal by Subject|0|||
129170824|NCT00920218|464920169|FG000|Overall Study|Migrated/moved from study area|0|||
129170825|NCT00920218|464920170|FG001|Overall Study|Migrated/moved from study area|0|||
129170826|NCT00920218|464920171|FG002|Overall Study|Migrated/moved from study area|1|||
129170827|NCT00920218|464920172|FG003|Overall Study|Migrated/moved from study area|0|||
129170828|NCT00920218|464920169|FG000|Overall Study|Lost to Follow-up|0|||
129170829|NCT00920218|464920170|FG001|Overall Study|Lost to Follow-up|1|||
129170830|NCT00920218|464920171|FG002|Overall Study|Lost to Follow-up|0|||
129170831|NCT00920218|464920172|FG003|Overall Study|Lost to Follow-up|3|||
129170832|NCT00920218|464920169|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
129170833|NCT00920218|464920170|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
129170834|NCT00920218|464920171|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
129170835|NCT00920218|464920172|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
129170836|NCT00920218|464920169|FG000|Overall Study|Other|0|||
129170837|NCT00920218|464920170|FG001|Overall Study|Other|0|||
129170838|NCT00920218|464920171|FG002|Overall Study|Other|1|||
129170839|NCT00920218|464920172|FG003|Overall Study|Other|0|||
129170840|NCT01007435|464920173|FG000|Overall Study|Adverse Event|16|||
129170841|NCT01007435|464920174|FG001|Overall Study|Adverse Event|25|||
129170842|NCT01007435|464920175|FG002|Overall Study|Adverse Event|47|||
129170843|NCT01007435|464920176|FG003|Overall Study|Adverse Event|31|||
128779195|NCT00235495|463480537|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
128779196|NCT02192359|463480541|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
128779197|NCT02192359|463480542|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
128779198|NCT02192359|463480543|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
128779199|NCT02192359|463480544|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
128779200|NCT02192359|463480541|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
128779201|NCT02192359|463480542|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
128779202|NCT02192359|463480543|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
128779203|NCT02192359|463480544|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
128779204|NCT02192359|463480541|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
128779205|NCT02192359|463480542|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
128779206|NCT02192359|463480543|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
128779207|NCT02192359|463480544|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
128779208|NCT03387514|463480545|FG000|Overall Study|Withdrawal by Subject|2|||
128779209|NCT03387514|463480545|FG000|Overall Study|Physician Decision|1|||
128779210|NCT03387514|463480545|FG000|Overall Study|Lost to Follow-up|2|||
128779211|NCT05567952|463482300|FG000|Overall Study|Lost to Follow-up|3|||
128779212|NCT05567952|463482301|FG001|Overall Study|Lost to Follow-up|2|||
128779213|NCT05567952|463482300|FG000|Overall Study|Withdrawal by Subject|6|||
128779214|NCT05567952|463482301|FG001|Overall Study|Withdrawal by Subject|3|||
128779215|NCT05567952|463482300|FG000|Overall Study|Other|3|||
128779216|NCT05567952|463482301|FG001|Overall Study|Other|1|||
128779217|NCT00777803|463482302|FG000|Overall Study|Lost to Follow-up|12|||
128779218|NCT00777803|463482303|FG001|Overall Study|Lost to Follow-up|5|||
128779219|NCT00777803|463482302|FG000|Overall Study|Adverse Event|1|||
128779220|NCT00777803|463482303|FG001|Overall Study|Adverse Event|0|||
128779221|NCT00777803|463482302|FG000|Overall Study|Non-compliance|2|||
128779222|NCT00777803|463482303|FG001|Overall Study|Non-compliance|2|||
128779223|NCT01021878|463482319|FG000|Overall Study|Lost to Follow-up|4|||
128779224|NCT01021878|463482320|FG001|Overall Study|Lost to Follow-up|3|||
128779225|NCT01021878|463482319|FG000|Overall Study|Death|0|||
128779226|NCT01021878|463482320|FG001|Overall Study|Death|1|||
128779227|NCT01021878|463482319|FG000|Overall Study|Adverse Event|6|||
128779228|NCT01021878|463482320|FG001|Overall Study|Adverse Event|5|||
128779229|NCT01021878|463482319|FG000|Overall Study|Transplantation|6|||
128779230|NCT01021878|463482320|FG001|Overall Study|Transplantation|1|||
128779231|NCT01460381|463482321|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
128779232|NCT01460381|463482322|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
128779233|NCT01333943|463482327|FG000|Overall Study|Known neuropathy|1|||
128779234|NCT01333943|463482328|FG001|Overall Study|Known neuropathy|0|||
128779235|NCT01511536|463482329|FG000|Phase 1|Other|0|||
128779236|NCT01511536|463482330|FG001|Phase 1|Other|1|||
128779237|NCT01511536|463482331|FG002|Phase 1|Other|0|||
128779238|NCT01511536|463482329|FG000|Phase 2|Other|0|||
128779239|NCT01511536|463482330|FG001|Phase 2|Other|0|||
128779240|NCT01511536|463482331|FG002|Phase 2|Other|9|||
128779241|NCT03019458|463482332|FG000|Overall Study|Death|0|||
128779242|NCT03019458|463482333|FG001|Overall Study|Death|1|||
128779243|NCT00031447|463482334|FG000|Overall Study|Lost to Follow-up|0|||
128779244|NCT00031447|463482335|FG001|Overall Study|Lost to Follow-up|1|||
128779245|NCT00031447|463482334|FG000|Overall Study|Non-compliant|1|||
128779246|NCT00031447|463482335|FG001|Overall Study|Non-compliant|1|||
128779247|NCT00031447|463482334|FG000|Overall Study|Re-activation of Disease|2|||
128779248|NCT00031447|463482335|FG001|Overall Study|Re-activation of Disease|1|||
128779249|NCT00031447|463482334|FG000|Overall Study|Disruption of blinded study drug supply|7|||
128779250|NCT00031447|463482335|FG001|Overall Study|Disruption of blinded study drug supply|4|||
128779251|NCT01244763|463482336|FG000|Overall Study|Adverse Event|1|||
128779252|NCT01244763|463482337|FG001|Overall Study|Adverse Event|0|||
128779253|NCT01244763|463482338|FG002|Overall Study|Adverse Event|0|||
128779254|NCT01244763|463482339|FG003|Overall Study|Adverse Event|0|||
128779255|NCT01244763|463482340|FG004|Overall Study|Adverse Event|0|||
128779256|NCT01244763|463482341|FG005|Overall Study|Adverse Event|1|||
128779257|NCT01244763|463482336|FG000|Overall Study|Death|1|||
128779258|NCT01244763|463482337|FG001|Overall Study|Death|0|||
128779259|NCT01244763|463482338|FG002|Overall Study|Death|1|||
128779260|NCT01244763|463482339|FG003|Overall Study|Death|0|||
128779261|NCT01244763|463482340|FG004|Overall Study|Death|2|||
128779262|NCT01244763|463482341|FG005|Overall Study|Death|0|||
128779263|NCT01244763|463482336|FG000|Overall Study|Physician Decision|0|||
128779264|NCT01244763|463482337|FG001|Overall Study|Physician Decision|0|||
128779265|NCT01244763|463482338|FG002|Overall Study|Physician Decision|1|||
129170844|NCT01007435|464920173|FG000|Overall Study|Death|2|||
129170845|NCT01007435|464920174|FG001|Overall Study|Death|4|||
129170846|NCT01007435|464920175|FG002|Overall Study|Death|2|||
129170847|NCT01007435|464920176|FG003|Overall Study|Death|1|||
129170848|NCT01007435|464920173|FG000|Overall Study|Insufficient Therapeutic Response|21|||
129170849|NCT01007435|464920174|FG001|Overall Study|Insufficient Therapeutic Response|7|||
129170850|NCT01007435|464920175|FG002|Overall Study|Insufficient Therapeutic Response|2|||
129170851|NCT01007435|464920176|FG003|Overall Study|Insufficient Therapeutic Response|9|||
129170852|NCT01007435|464920173|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
129170853|NCT01007435|464920174|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
129170854|NCT01007435|464920175|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
129170855|NCT01007435|464920176|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
129170856|NCT01007435|464920173|FG000|Overall Study|Other Protocol Violation|2|||
128729246|NCT02457598|463306619|FG002|Overall Study|Progressive Disease|1|||
129170857|NCT01007435|464920174|FG001|Overall Study|Other Protocol Violation|0|||
129170858|NCT01007435|464920175|FG002|Overall Study|Other Protocol Violation|1|||
128729247|NCT02457598|463306620|FG003|Overall Study|Progressive Disease|11|||
129170859|NCT01007435|464920176|FG003|Overall Study|Other Protocol Violation|0|||
128779266|NCT01244763|463482339|FG003|Overall Study|Physician Decision|0|||
128779267|NCT01244763|463482340|FG004|Overall Study|Physician Decision|0|||
128779268|NCT01244763|463482341|FG005|Overall Study|Physician Decision|0|||
128779269|NCT01244763|463482336|FG000|Overall Study|Withdrawal by Subject|1|||
128779270|NCT01244763|463482337|FG001|Overall Study|Withdrawal by Subject|2|||
128779271|NCT01244763|463482338|FG002|Overall Study|Withdrawal by Subject|0|||
128779272|NCT01244763|463482339|FG003|Overall Study|Withdrawal by Subject|1|||
128779273|NCT01244763|463482340|FG004|Overall Study|Withdrawal by Subject|1|||
128779274|NCT01244763|463482341|FG005|Overall Study|Withdrawal by Subject|2|||
128779275|NCT01244763|463482336|FG000|Overall Study|Lost to Follow-up|0|||
128779276|NCT01244763|463482337|FG001|Overall Study|Lost to Follow-up|1|||
128779277|NCT01244763|463482338|FG002|Overall Study|Lost to Follow-up|0|||
128779278|NCT01244763|463482339|FG003|Overall Study|Lost to Follow-up|0|||
128779279|NCT01244763|463482340|FG004|Overall Study|Lost to Follow-up|0|||
128779280|NCT01244763|463482341|FG005|Overall Study|Lost to Follow-up|0|||
128779281|NCT01244763|463482336|FG000|Overall Study|Enrolled into the Extension Study|0|||
128779282|NCT01244763|463482337|FG001|Overall Study|Enrolled into the Extension Study|0|||
128779283|NCT01244763|463482338|FG002|Overall Study|Enrolled into the Extension Study|0|||
128779284|NCT01244763|463482339|FG003|Overall Study|Enrolled into the Extension Study|0|||
128779285|NCT01244763|463482340|FG004|Overall Study|Enrolled into the Extension Study|0|||
128779286|NCT01244763|463482341|FG005|Overall Study|Enrolled into the Extension Study|1|||
128779287|NCT00367237|463482343|FG000|Overall Study|Adverse Event|7|||
128779288|NCT00367237|463482344|FG001|Overall Study|Adverse Event|2|||
128779289|NCT00367237|463482343|FG000|Overall Study|Lost to Follow-up|1|||
128779290|NCT00367237|463482344|FG001|Overall Study|Lost to Follow-up|0|||
128779291|NCT00367237|463482343|FG000|Overall Study|Withdrawal by Subject|0|||
128779292|NCT00367237|463482344|FG001|Overall Study|Withdrawal by Subject|4|||
128779293|NCT00367237|463482343|FG000|Overall Study|Protocol Violation|2|||
128779294|NCT00367237|463482344|FG001|Overall Study|Protocol Violation|5|||
128779295|NCT02800928|463482351|FG000|Overall Study|Withdrawal by Subject|1|||
129170860|NCT01007435|464920173|FG000|Overall Study|Refused Treatment|13|||
129170861|NCT01007435|464920174|FG001|Overall Study|Refused Treatment|13|||
129170862|NCT01007435|464920175|FG002|Overall Study|Refused Treatment|5|||
129170863|NCT01007435|464920176|FG003|Overall Study|Refused Treatment|8|||
129170864|NCT01007435|464920173|FG000|Overall Study|Failure to Return|5|||
129170865|NCT01007435|464920174|FG001|Overall Study|Failure to Return|4|||
129170866|NCT01007435|464920175|FG002|Overall Study|Failure to Return|3|||
129170867|NCT01007435|464920176|FG003|Overall Study|Failure to Return|6|||
129170868|NCT01007435|464920173|FG000|Overall Study|Reason not Specified|1|||
129170869|NCT01007435|464920174|FG001|Overall Study|Reason not Specified|1|||
129170870|NCT01007435|464920175|FG002|Overall Study|Reason not Specified|2|||
129170871|NCT01007435|464920176|FG003|Overall Study|Reason not Specified|1|||
129170872|NCT01345591|464920179|FG000|Overall Study|Lost to Follow-up|1|||
129170873|NCT00847665|464920186|FG000|Overall Study|Withdrawal by Subject|1|||
129170874|NCT00847665|464920187|FG001|Overall Study|Withdrawal by Subject|0|||
129170875|NCT00624585|464920188|FG000|Overall Study|Death|3|||
129170876|NCT00624585|464920188|FG000|Overall Study|Disease Progression|6|||
129170877|NCT00624585|464920188|FG000|Overall Study|Adverse Event|3|||
129170878|NCT00676520|464920190|FG000|Overall Study|Withdrawal by Subject|163|||
129170879|NCT00676520|464920190|FG000|Overall Study|Lost to Follow-up|162|||
129170880|NCT00676520|464920190|FG000|Overall Study|Death|159|||
129170881|NCT00676520|464920190|FG000|Overall Study|Physician Decision|20|||
129170882|NCT00676520|464920190|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
129170883|NCT00676520|464920190|FG000|Overall Study|Other Reason|18|||
129170884|NCT01425359|464920191|FG000|Overall Study|Randomized but Not Treated|2|||
129170885|NCT01425359|464920192|FG001|Overall Study|Randomized but Not Treated|3|||
129170886|NCT01425359|464920191|FG000|Overall Study|Adverse Event|9|||
129170887|NCT01425359|464920192|FG001|Overall Study|Adverse Event|8|||
129170888|NCT01425359|464920191|FG000|Overall Study|Revascularization|0|||
129170889|NCT01425359|464920192|FG001|Overall Study|Revascularization|1|||
129170890|NCT01425359|464920191|FG000|Overall Study|Death|0|||
129170891|NCT01425359|464920192|FG001|Overall Study|Death|1|||
129170892|NCT01425359|464920191|FG000|Overall Study|Unsatisfactory Response|1|||
129170893|NCT01425359|464920192|FG001|Overall Study|Unsatisfactory Response|0|||
129170894|NCT01425359|464920191|FG000|Overall Study|Protocol Violation|1|||
129170895|NCT01425359|464920192|FG001|Overall Study|Protocol Violation|2|||
129170896|NCT01425359|464920191|FG000|Overall Study|Subject Withdrew Consent|1|||
129170897|NCT01425359|464920192|FG001|Overall Study|Subject Withdrew Consent|2|||
128779296|NCT02800928|463482352|FG001|Overall Study|Withdrawal by Subject|1|||
128779297|NCT02800928|463482351|FG000|Overall Study|Protocol Violation|1|||
129170898|NCT01425359|464920191|FG000|Overall Study|Investigator's Discretion|2|||
129170899|NCT01425359|464920192|FG001|Overall Study|Investigator's Discretion|0|||
128779298|NCT02800928|463482352|FG001|Overall Study|Protocol Violation|1|||
128779299|NCT00570661|463482360|FG000|Overall Study|Disease worsening|5|||
128779300|NCT00570661|463482360|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
128779301|NCT00570661|463482360|FG000|Overall Study|Adverse Event|1|||
129170900|NCT01425359|464920191|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
129170901|NCT01425359|464920192|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
129170902|NCT03172325|464920203|FG000|Overall Study|Adverse Event|2|||
129170903|NCT03172325|464920204|FG001|Overall Study|Adverse Event|3|||
129170904|NCT03172325|464920203|FG000|Overall Study|Positive PPD|1|||
129170905|NCT03172325|464920204|FG001|Overall Study|Positive PPD|0|||
129170906|NCT03172325|464920203|FG000|Overall Study|Poor Compliance|1|||
129170907|NCT03172325|464920204|FG001|Overall Study|Poor Compliance|1|||
129170908|NCT03305419|464920210|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129170909|NCT03305419|464920211|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
129170910|NCT03305419|464920212|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129170911|NCT03305419|464920213|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129170912|NCT03305419|464920214|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129170913|NCT03305419|464920215|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129170914|NCT03305419|464920216|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129170915|NCT03305419|464920217|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129170916|NCT03305419|464920210|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
129170917|NCT03305419|464920211|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129170918|NCT03305419|464920212|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129170919|NCT03305419|464920213|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129170920|NCT03305419|464920214|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129170921|NCT03305419|464920215|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129170922|NCT03305419|464920216|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129170923|NCT03305419|464920217|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129170924|NCT03305419|464920210|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
129170925|NCT03305419|464920211|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129170926|NCT03305419|464920212|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129170927|NCT03305419|464920213|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129170928|NCT03305419|464920214|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129170929|NCT03305419|464920215|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129170930|NCT03305419|464920216|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129170931|NCT03305419|464920217|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129170932|NCT03305419|464920210|FG000|Part B (14 Days)|Adverse Event|0|||
129170933|NCT03305419|464920211|FG001|Part B (14 Days)|Adverse Event|0|||
129170934|NCT03305419|464920212|FG002|Part B (14 Days)|Adverse Event|0|||
129170935|NCT03305419|464920213|FG003|Part B (14 Days)|Adverse Event|0|||
129170936|NCT03305419|464920214|FG004|Part B (14 Days)|Adverse Event|1|||
129170937|NCT03305419|464920215|FG005|Part B (14 Days)|Adverse Event|2|||
129170938|NCT03305419|464920216|FG006|Part B (14 Days)|Adverse Event|4|||
129170939|NCT03305419|464920217|FG007|Part B (14 Days)|Adverse Event|0|||
129170940|NCT03305419|464920210|FG000|Part B (14 Days)|Physician Decision|0|||
129170941|NCT03305419|464920211|FG001|Part B (14 Days)|Physician Decision|0|||
129170942|NCT03305419|464920212|FG002|Part B (14 Days)|Physician Decision|0|||
129170943|NCT03305419|464920213|FG003|Part B (14 Days)|Physician Decision|0|||
129170944|NCT03305419|464920214|FG004|Part B (14 Days)|Physician Decision|2|||
129170945|NCT03305419|464920215|FG005|Part B (14 Days)|Physician Decision|8|||
129170946|NCT03305419|464920216|FG006|Part B (14 Days)|Physician Decision|1|||
129170947|NCT03305419|464920217|FG007|Part B (14 Days)|Physician Decision|0|||
129170948|NCT00075946|464920218|FG000|Overall Study|Path ineligible: undetermined histology|0|||
129170949|NCT00075946|464920219|FG001|Overall Study|Path ineligible: undetermined histology|0|||
129170950|NCT00075946|464920220|FG002|Overall Study|Path ineligible: undetermined histology|0|||
129170951|NCT00075946|464920221|FG003|Overall Study|Path ineligible: undetermined histology|0|||
129170952|NCT00075946|464920222|FG004|Overall Study|Path ineligible: undetermined histology|6|||
129170953|NCT00075946|464920218|FG000|Overall Study|Did not achieve response after induction|0|||
129170954|NCT00075946|464920219|FG001|Overall Study|Did not achieve response after induction|0|||
129170955|NCT00075946|464920220|FG002|Overall Study|Did not achieve response after induction|0|||
129170956|NCT00075946|464920221|FG003|Overall Study|Did not achieve response after induction|0|||
129170957|NCT00075946|464920222|FG004|Overall Study|Did not achieve response after induction|182|||
129170958|NCT00075946|464920218|FG000|Overall Study|Incorrectly randomized (no response)|5|||
129170959|NCT00075946|464920219|FG001|Overall Study|Incorrectly randomized (no response)|5|||
129170960|NCT00075946|464920220|FG002|Overall Study|Incorrectly randomized (no response)|5|||
129170961|NCT00075946|464920221|FG003|Overall Study|Incorrectly randomized (no response)|1|||
129170962|NCT00075946|464920222|FG004|Overall Study|Incorrectly randomized (no response)|0|||
129170963|NCT00075946|464920218|FG000|Overall Study|Adverse Event|2|||
129170964|NCT00075946|464920219|FG001|Overall Study|Adverse Event|10|||
129170965|NCT00075946|464920220|FG002|Overall Study|Adverse Event|0|||
129170966|NCT00075946|464920221|FG003|Overall Study|Adverse Event|2|||
129170967|NCT00075946|464920222|FG004|Overall Study|Adverse Event|0|||
129170968|NCT00075946|464920218|FG000|Overall Study|Death|0|||
129170969|NCT00075946|464920219|FG001|Overall Study|Death|1|||
129170970|NCT00075946|464920220|FG002|Overall Study|Death|0|||
129170971|NCT00075946|464920221|FG003|Overall Study|Death|0|||
129170972|NCT00075946|464920222|FG004|Overall Study|Death|0|||
129170973|NCT00075946|464920218|FG000|Overall Study|Withdrawal by Subject|23|||
129170974|NCT00075946|464920219|FG001|Overall Study|Withdrawal by Subject|58|||
129170975|NCT00075946|464920220|FG002|Overall Study|Withdrawal by Subject|4|||
129170976|NCT00075946|464920221|FG003|Overall Study|Withdrawal by Subject|9|||
129170977|NCT00075946|464920222|FG004|Overall Study|Withdrawal by Subject|0|||
129170978|NCT00075946|464920218|FG000|Overall Study|Alternative therapy|16|||
129170979|NCT00075946|464920219|FG001|Overall Study|Alternative therapy|2|||
129170980|NCT00075946|464920220|FG002|Overall Study|Alternative therapy|5|||
129170981|NCT00075946|464920221|FG003|Overall Study|Alternative therapy|0|||
129170982|NCT00075946|464920222|FG004|Overall Study|Alternative therapy|0|||
129170983|NCT00075946|464920218|FG000|Overall Study|Other complicating disease|7|||
129170984|NCT00075946|464920219|FG001|Overall Study|Other complicating disease|13|||
129170985|NCT00075946|464920220|FG002|Overall Study|Other complicating disease|1|||
129170986|NCT00075946|464920221|FG003|Overall Study|Other complicating disease|4|||
129170987|NCT00075946|464920222|FG004|Overall Study|Other complicating disease|0|||
129170988|NCT00075946|464920218|FG000|Overall Study|No response to retreatment|23|||
129170989|NCT00075946|464920219|FG001|Overall Study|No response to retreatment|0|||
129170990|NCT00075946|464920220|FG002|Overall Study|No response to retreatment|2|||
129170991|NCT00075946|464920221|FG003|Overall Study|No response to retreatment|0|||
129170992|NCT00075946|464920222|FG004|Overall Study|No response to retreatment|0|||
129170993|NCT00075946|464920218|FG000|Overall Study|Time to progression less than 6 months|15|||
129170994|NCT00075946|464920219|FG001|Overall Study|Time to progression less than 6 months|30|||
129170995|NCT00075946|464920220|FG002|Overall Study|Time to progression less than 6 months|8|||
129170996|NCT00075946|464920221|FG003|Overall Study|Time to progression less than 6 months|3|||
129170997|NCT00075946|464920222|FG004|Overall Study|Time to progression less than 6 months|0|||
129170998|NCT00075946|464920218|FG000|Overall Study|Other|57|||
129170999|NCT00075946|464920219|FG001|Overall Study|Other|32|||
129171000|NCT00075946|464920220|FG002|Overall Study|Other|3|||
129171001|NCT00075946|464920221|FG003|Overall Study|Other|11|||
129171002|NCT00075946|464920222|FG004|Overall Study|Other|0|||
129171003|NCT00889603|464920225|FG000|Overall Study|Adverse Event|7|||
129171004|NCT00889603|464920225|FG000|Overall Study|Death|3|||
129171005|NCT00889603|464920225|FG000|Overall Study|Lost to Follow-up|19|||
129171006|NCT00889603|464920225|FG000|Overall Study|No longer willing to participant in stud|4|||
129171007|NCT00889603|464920225|FG000|Overall Study|Other|4|||
129171008|NCT01229254|464920226|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
129171009|NCT01229254|464920227|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
129171010|NCT01229254|464920228|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
129171011|NCT01229254|464920226|FG000|Overall Study|Adverse Event|4|||
129171012|NCT01229254|464920227|FG001|Overall Study|Adverse Event|5|||
129171013|NCT01229254|464920228|FG002|Overall Study|Adverse Event|3|||
129171014|NCT01229254|464920226|FG000|Overall Study|Lost to Follow-up|3|||
129171015|NCT01229254|464920227|FG001|Overall Study|Lost to Follow-up|0|||
129171016|NCT01229254|464920228|FG002|Overall Study|Lost to Follow-up|1|||
129171017|NCT01229254|464920226|FG000|Overall Study|Physician Decision|0|||
129171018|NCT01229254|464920227|FG001|Overall Study|Physician Decision|3|||
129171019|NCT01229254|464920228|FG002|Overall Study|Physician Decision|0|||
129171020|NCT01229254|464920226|FG000|Overall Study|Protocol Violation|4|||
129171021|NCT01229254|464920227|FG001|Overall Study|Protocol Violation|6|||
129171022|NCT01229254|464920228|FG002|Overall Study|Protocol Violation|5|||
129171023|NCT01229254|464920226|FG000|Overall Study|Withdrawal by Subject|1|||
129171024|NCT01229254|464920227|FG001|Overall Study|Withdrawal by Subject|0|||
129171025|NCT01229254|464920228|FG002|Overall Study|Withdrawal by Subject|1|||
129171026|NCT01229254|464920226|FG000|Overall Study|Non-compliance with Study Drug|0|||
129171027|NCT01229254|464920227|FG001|Overall Study|Non-compliance with Study Drug|1|||
129171028|NCT01229254|464920228|FG002|Overall Study|Non-compliance with Study Drug|1|||
129171029|NCT02231892|464920229|FG000|Overall Study|Lost to Follow-up|1|||
129171030|NCT02231892|464920230|FG001|Overall Study|Lost to Follow-up|0|||
129171031|NCT02231892|464920231|FG002|Overall Study|Lost to Follow-up|3|||
129171032|NCT02231892|464920229|FG000|Overall Study|Withdrawal by Subject|4|||
129171033|NCT02231892|464920230|FG001|Overall Study|Withdrawal by Subject|3|||
129171034|NCT02231892|464920231|FG002|Overall Study|Withdrawal by Subject|15|||
129171035|NCT02231892|464920229|FG000|Overall Study|Physician Decision|0|||
129171036|NCT02231892|464920230|FG001|Overall Study|Physician Decision|2|||
129171037|NCT02231892|464920231|FG002|Overall Study|Physician Decision|4|||
129171038|NCT02231892|464920229|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
129171039|NCT02231892|464920230|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
129171040|NCT02231892|464920231|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
128729248|NCT02457598|463306621|FG004|Overall Study|Progressive Disease|7|||
129171041|NCT02231892|464920229|FG000|Overall Study|Participant motor threshold was >83%|0|||
128729249|NCT02457598|463306622|FG005|Overall Study|Progressive Disease|3|||
128729250|NCT02457598|463306623|FG006|Overall Study|Progressive Disease|2|||
129171042|NCT02231892|464920230|FG001|Overall Study|Participant motor threshold was >83%|0|||
129171043|NCT02231892|464920231|FG002|Overall Study|Participant motor threshold was >83%|9|||
129171044|NCT02231892|464920229|FG000|Overall Study|Could not find motor threshold|2|||
128729251|NCT02457598|463306624|FG007|Overall Study|Progressive Disease|1|||
128779302|NCT01113463|463482363|FG000|Overall Study|Physician Decision|5|||
128779303|NCT01237678|463482364|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
128779304|NCT01237678|463482365|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
128779305|NCT01237678|463482366|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
128779306|NCT01237678|463482364|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
128779307|NCT01237678|463482365|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
128779308|NCT01237678|463482366|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
128779309|NCT01237678|463482364|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
128779310|NCT01237678|463482365|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
128779311|NCT01237678|463482366|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
128779312|NCT01237678|463482364|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
128779313|NCT01237678|463482365|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
128779314|NCT01237678|463482366|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
128779315|NCT01237678|463482364|FG000|Phase II|Adverse Event|0|||
128779316|NCT01237678|463482365|FG001|Phase II|Adverse Event|39|||
128779317|NCT01237678|463482366|FG002|Phase II|Adverse Event|9|||
128779318|NCT01237678|463482364|FG000|Phase II|Death|0|||
129171045|NCT02231892|464920230|FG001|Overall Study|Could not find motor threshold|0|||
129171046|NCT02231892|464920231|FG002|Overall Study|Could not find motor threshold|1|||
129171047|NCT02231892|464920229|FG000|Overall Study|Could not find reliable motor hotspot|0|||
129171048|NCT02231892|464920230|FG001|Overall Study|Could not find reliable motor hotspot|0|||
129171049|NCT02231892|464920231|FG002|Overall Study|Could not find reliable motor hotspot|1|||
129171050|NCT02680041|464920233|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
128729252|NCT02457598|463306625|FG008|Overall Study|Progressive Disease|1|||
128729253|NCT02457598|463306626|FG009|Overall Study|Progressive Disease|2|||
128729254|NCT02457598|463306627|FG010|Overall Study|Progressive Disease|45|||
128729255|NCT02457598|463306628|FG011|Overall Study|Progressive Disease|6|||
128729256|NCT02457598|463306629|FG012|Overall Study|Progressive Disease|2|||
128729257|NCT02457598|463306630|FG013|Overall Study|Progressive Disease|2|||
128729258|NCT02457598|463306631|FG014|Overall Study|Progressive Disease|10|||
128729259|NCT02457598|463306632|FG015|Overall Study|Progressive Disease|1|||
128729260|NCT02457598|463306633|FG016|Overall Study|Progressive Disease|1|||
128729261|NCT02457598|463306617|FG000|Overall Study|Investigator's Discretion|0|||
128729262|NCT02457598|463306618|FG001|Overall Study|Investigator's Discretion|2|||
128729263|NCT02457598|463306619|FG002|Overall Study|Investigator's Discretion|2|||
128729264|NCT02457598|463306620|FG003|Overall Study|Investigator's Discretion|2|||
128729265|NCT02457598|463306621|FG004|Overall Study|Investigator's Discretion|0|||
128729266|NCT02457598|463306622|FG005|Overall Study|Investigator's Discretion|0|||
128729267|NCT02457598|463306623|FG006|Overall Study|Investigator's Discretion|0|||
128729268|NCT02457598|463306624|FG007|Overall Study|Investigator's Discretion|1|||
128729269|NCT02457598|463306625|FG008|Overall Study|Investigator's Discretion|2|||
128729270|NCT02457598|463306626|FG009|Overall Study|Investigator's Discretion|0|||
128729271|NCT02457598|463306627|FG010|Overall Study|Investigator's Discretion|10|||
128729272|NCT02457598|463306628|FG011|Overall Study|Investigator's Discretion|2|||
128729273|NCT02457598|463306629|FG012|Overall Study|Investigator's Discretion|2|||
128729274|NCT02457598|463306630|FG013|Overall Study|Investigator's Discretion|1|||
128729275|NCT02457598|463306631|FG014|Overall Study|Investigator's Discretion|5|||
128729276|NCT02457598|463306632|FG015|Overall Study|Investigator's Discretion|0|||
128729277|NCT02457598|463306633|FG016|Overall Study|Investigator's Discretion|0|||
128729278|NCT02457598|463306617|FG000|Overall Study|Study Terminated by Sponsor|0|||
128729279|NCT02457598|463306618|FG001|Overall Study|Study Terminated by Sponsor|1|||
128729280|NCT02457598|463306619|FG002|Overall Study|Study Terminated by Sponsor|0|||
128729281|NCT02457598|463306620|FG003|Overall Study|Study Terminated by Sponsor|4|||
128729282|NCT02457598|463306621|FG004|Overall Study|Study Terminated by Sponsor|1|||
128729283|NCT02457598|463306622|FG005|Overall Study|Study Terminated by Sponsor|0|||
128729284|NCT02457598|463306623|FG006|Overall Study|Study Terminated by Sponsor|1|||
128729285|NCT02457598|463306624|FG007|Overall Study|Study Terminated by Sponsor|0|||
128729286|NCT02457598|463306625|FG008|Overall Study|Study Terminated by Sponsor|0|||
128729287|NCT02457598|463306626|FG009|Overall Study|Study Terminated by Sponsor|0|||
128729288|NCT02457598|463306627|FG010|Overall Study|Study Terminated by Sponsor|4|||
128729289|NCT02457598|463306628|FG011|Overall Study|Study Terminated by Sponsor|0|||
128729290|NCT02457598|463306629|FG012|Overall Study|Study Terminated by Sponsor|1|||
128729291|NCT02457598|463306630|FG013|Overall Study|Study Terminated by Sponsor|0|||
128729292|NCT02457598|463306631|FG014|Overall Study|Study Terminated by Sponsor|8|||
128729293|NCT02457598|463306632|FG015|Overall Study|Study Terminated by Sponsor|1|||
128729294|NCT02457598|463306633|FG016|Overall Study|Study Terminated by Sponsor|0|||
128729295|NCT02457598|463306617|FG000|Overall Study|Adverse Event|0|||
128729296|NCT02457598|463306618|FG001|Overall Study|Adverse Event|1|||
128729297|NCT02457598|463306619|FG002|Overall Study|Adverse Event|1|||
128729298|NCT02457598|463306620|FG003|Overall Study|Adverse Event|4|||
128729299|NCT02457598|463306621|FG004|Overall Study|Adverse Event|1|||
128779319|NCT01237678|463482365|FG001|Phase II|Death|0|||
128779320|NCT01237678|463482366|FG002|Phase II|Death|2|||
128779321|NCT01237678|463482364|FG000|Phase II|Lack of Efficacy|0|||
129171051|NCT02680041|464920233|FG000|Overall Study|Lost to Follow-up|2|||
129171052|NCT00515294|464920237|FG000|Overall Study|Lost to Follow-up|3|||
129171053|NCT00515294|464920238|FG001|Overall Study|Lost to Follow-up|2|||
129171054|NCT00515294|464920239|FG002|Overall Study|Lost to Follow-up|3|||
129171055|NCT00515294|464920240|FG003|Overall Study|Lost to Follow-up|1|||
129171056|NCT00515294|464920237|FG000|Overall Study|Driver simulator problems|1|||
129171057|NCT00515294|464920238|FG001|Overall Study|Driver simulator problems|1|||
129171058|NCT00515294|464920239|FG002|Overall Study|Driver simulator problems|1|||
129171059|NCT00515294|464920240|FG003|Overall Study|Driver simulator problems|3|||
129171060|NCT00515294|464920237|FG000|Overall Study|Caffeine amount inaccurate|5|||
129171061|NCT00515294|464920238|FG001|Overall Study|Caffeine amount inaccurate|0|||
129171062|NCT00515294|464920239|FG002|Overall Study|Caffeine amount inaccurate|7|||
129171063|NCT00515294|464920240|FG003|Overall Study|Caffeine amount inaccurate|0|||
129171064|NCT03943550|464920245|FG000|Overall Study|Adverse Event|0|||
129171065|NCT03943550|464920246|FG001|Overall Study|Adverse Event|0|||
129171066|NCT03943550|464920247|FG002|Overall Study|Adverse Event|1|||
129171067|NCT03943550|464920245|FG000|Overall Study|Lost to Follow-up|0|||
129171068|NCT03943550|464920246|FG001|Overall Study|Lost to Follow-up|0|||
129171069|NCT03943550|464920247|FG002|Overall Study|Lost to Follow-up|1|||
129171070|NCT03943550|464920245|FG000|Overall Study|Progressive Disease|0|||
129171071|NCT03943550|464920246|FG001|Overall Study|Progressive Disease|0|||
129171072|NCT03943550|464920247|FG002|Overall Study|Progressive Disease|2|||
129171073|NCT03943550|464920245|FG000|Overall Study|Participant Moved Out of the Country|0|||
129171074|NCT03943550|464920246|FG001|Overall Study|Participant Moved Out of the Country|1|||
129171075|NCT03943550|464920247|FG002|Overall Study|Participant Moved Out of the Country|0|||
129171076|NCT03359785|464920248|FG000|Overall Study|Protocol Violation|0|||
129171077|NCT03359785|464920249|FG001|Overall Study|Protocol Violation|1|||
129171078|NCT03359785|464920250|FG002|Overall Study|Protocol Violation|0|||
129171079|NCT03359785|464920251|FG003|Overall Study|Protocol Violation|0|||
129171080|NCT03359785|464920248|FG000|Overall Study|Early study termination due to study pause|0|||
129171081|NCT03359785|464920249|FG001|Overall Study|Early study termination due to study pause|0|||
129171082|NCT03359785|464920250|FG002|Overall Study|Early study termination due to study pause|2|||
129171083|NCT03359785|464920251|FG003|Overall Study|Early study termination due to study pause|0|||
129171084|NCT03359785|464920248|FG000|Overall Study|Withdrawal by Subject|2|||
129171085|NCT03359785|464920249|FG001|Overall Study|Withdrawal by Subject|2|||
129171086|NCT03359785|464920250|FG002|Overall Study|Withdrawal by Subject|0|||
129171087|NCT03359785|464920251|FG003|Overall Study|Withdrawal by Subject|0|||
129171088|NCT01895543|464920252|FG000|Overall Study|Withdrawal by Subject|43|||
128779322|NCT01237678|463482365|FG001|Phase II|Lack of Efficacy|25|||
129171089|NCT01895543|464920252|FG000|Overall Study|Lost to Follow-up|25|||
129171090|NCT01895543|464920252|FG000|Overall Study|Adverse Event|28|||
129171091|NCT01895543|464920252|FG000|Overall Study|Subject's substantial non-compliance|6|||
129171092|NCT01895543|464920252|FG000|Overall Study|Protocol Violation|1|||
129171093|NCT01895543|464920252|FG000|Overall Study|Physician Decision|2|||
128779323|NCT01237678|463482366|FG002|Phase II|Lack of Efficacy|3|||
128779324|NCT01237678|463482364|FG000|Phase II|Withdrawal by Subject|0|||
128779325|NCT01237678|463482365|FG001|Phase II|Withdrawal by Subject|1|||
128779326|NCT01237678|463482366|FG002|Phase II|Withdrawal by Subject|5|||
128779327|NCT01237678|463482364|FG000|Phase II|Completed Cycles 4-6|0|||
128779328|NCT01237678|463482365|FG001|Phase II|Completed Cycles 4-6|11|||
128779329|NCT01237678|463482366|FG002|Phase II|Completed Cycles 4-6|21|||
128779330|NCT01237678|463482364|FG000|Phase II|Sponsor Decision/Study Closed|0|||
128779331|NCT01237678|463482365|FG001|Phase II|Sponsor Decision/Study Closed|18|||
128779332|NCT01237678|463482366|FG002|Phase II|Sponsor Decision/Study Closed|7|||
128779333|NCT01237678|463482364|FG000|Phase II|Randomized but were not treated|0|||
128779334|NCT01237678|463482365|FG001|Phase II|Randomized but were not treated|4|||
128779335|NCT01237678|463482366|FG002|Phase II|Randomized but were not treated|3|||
128779336|NCT03023332|463482367|FG000|Overall Study|Withdrawal by Subject|10|||
128779337|NCT03023332|463482368|FG001|Overall Study|Withdrawal by Subject|5|||
128779338|NCT03023332|463482369|FG002|Overall Study|Withdrawal by Subject|4|||
128779339|NCT03023332|463482370|FG003|Overall Study|Withdrawal by Subject|7|||
128779340|NCT03023332|463482367|FG000|Overall Study|Lost to Follow-up|13|||
128779341|NCT03023332|463482368|FG001|Overall Study|Lost to Follow-up|16|||
128779342|NCT03023332|463482369|FG002|Overall Study|Lost to Follow-up|8|||
128779343|NCT03023332|463482370|FG003|Overall Study|Lost to Follow-up|13|||
128779344|NCT03023332|463482367|FG000|Overall Study|Death|1|||
128779345|NCT03023332|463482368|FG001|Overall Study|Death|0|||
128779346|NCT03023332|463482369|FG002|Overall Study|Death|0|||
128779347|NCT03023332|463482370|FG003|Overall Study|Death|0|||
128779348|NCT01818700|463482371|FG000|Overall Study|Adverse Event|67|||
128779349|NCT01818700|463482371|FG000|Overall Study|Lack of Efficacy|2|||
128779350|NCT01818700|463482371|FG000|Overall Study|Lost to Follow-up|5|||
128779351|NCT01818700|463482371|FG000|Overall Study|Withdrawal by Subject|27|||
128779352|NCT01818700|463482371|FG000|Overall Study|Protocol Violation|2|||
128779353|NCT01818700|463482371|FG000|Overall Study|Other|1|||
128779354|NCT01657682|463482372|FG000|Overall Study|Lost to Follow-up|1|||
128779355|NCT01657682|463482373|FG001|Overall Study|Lost to Follow-up|0|||
128779356|NCT01657682|463482374|FG002|Overall Study|Lost to Follow-up|0|||
128779357|NCT01657682|463482372|FG000|Overall Study|Withdrawal by Subject|0|||
128779358|NCT01657682|463482373|FG001|Overall Study|Withdrawal by Subject|1|||
128779359|NCT01657682|463482374|FG002|Overall Study|Withdrawal by Subject|1|||
128779360|NCT01657682|463482372|FG000|Overall Study|Adverse Event|0|||
128779361|NCT01657682|463482373|FG001|Overall Study|Adverse Event|1|||
128779362|NCT01657682|463482374|FG002|Overall Study|Adverse Event|0|||
128779363|NCT01719861|463482375|FG000|Cycle 1|Death|4|||
128779364|NCT01719861|463482375|FG000|Cycle 2|Death|1|||
128779365|NCT00087490|463482376|FG000|Overall Study|Death|6|||
128779366|NCT00087490|463482377|FG001|Overall Study|Death|4|||
128779367|NCT00087490|463482376|FG000|Overall Study|Adverse Event|3|||
128779368|NCT00087490|463482377|FG001|Overall Study|Adverse Event|8|||
128779369|NCT00087490|463482376|FG000|Overall Study|Lack of Efficacy|0|||
128779370|NCT00087490|463482377|FG001|Overall Study|Lack of Efficacy|2|||
128779371|NCT00087490|463482376|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
128779372|NCT00087490|463482377|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
128779373|NCT00087490|463482376|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
128779374|NCT00087490|463482377|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
128779375|NCT00087490|463482376|FG000|Overall Study|Randomized but not treated|7|||
128779376|NCT00087490|463482377|FG001|Overall Study|Randomized but not treated|18|||
128779377|NCT02034435|463482378|FG000|Overall Study|Withdrawal by Subject|1|||
128779378|NCT02034435|463482379|FG001|Overall Study|Withdrawal by Subject|0|||
128779379|NCT02034435|463482380|FG002|Overall Study|Withdrawal by Subject|0|||
128779380|NCT02034435|463482381|FG003|Overall Study|Withdrawal by Subject|0|||
128779381|NCT02034435|463482378|FG000|Overall Study|Illness|0|||
128779382|NCT02034435|463482379|FG001|Overall Study|Illness|2|||
128779383|NCT02034435|463482380|FG002|Overall Study|Illness|0|||
128779384|NCT02034435|463482381|FG003|Overall Study|Illness|0|||
128779385|NCT02034435|463482378|FG000|Overall Study|Inadequate IV access|1|||
128779386|NCT02034435|463482379|FG001|Overall Study|Inadequate IV access|0|||
128779387|NCT02034435|463482380|FG002|Overall Study|Inadequate IV access|0|||
128779388|NCT02034435|463482381|FG003|Overall Study|Inadequate IV access|1|||
128779389|NCT00630539|463482382|FG000|Overall Study|Adverse Event|1|||
128779390|NCT00630539|463482383|FG001|Overall Study|Adverse Event|3|||
128779391|NCT00630539|463482384|FG002|Overall Study|Adverse Event|1|||
128779392|NCT00630539|463482385|FG003|Overall Study|Adverse Event|2|||
128779393|NCT00630539|463482382|FG000|Overall Study|Withdrawal by Subject|0|||
128779394|NCT00630539|463482383|FG001|Overall Study|Withdrawal by Subject|1|||
128779395|NCT00630539|463482384|FG002|Overall Study|Withdrawal by Subject|0|||
128779396|NCT00630539|463482385|FG003|Overall Study|Withdrawal by Subject|1|||
128779397|NCT01700530|463482386|FG000|Overall Study|Withdrawal by Subject|0|||
128779398|NCT01700530|463482387|FG001|Overall Study|Withdrawal by Subject|3|||
128779399|NCT01700530|463482388|FG002|Overall Study|Withdrawal by Subject|1|||
128779400|NCT04833855|463482399|FG000|Overall Study|Decision by sponsor|0|||
129171094|NCT01895543|464920252|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
129171095|NCT04659174|464920257|FG000|Overall Study|Sponsor decision to discontinue study|0|||
129171096|NCT04659174|464920258|FG001|Overall Study|Sponsor decision to discontinue study|2|||
129171097|NCT04659174|464920257|FG000|Overall Study|Lost to Follow-up|9|||
129171098|NCT04659174|464920258|FG001|Overall Study|Lost to Follow-up|11|||
129171099|NCT04659174|464920257|FG000|Overall Study|Adverse Event|8|||
129171100|NCT04659174|464920258|FG001|Overall Study|Adverse Event|5|||
129171101|NCT04659174|464920257|FG000|Overall Study|Withdrawal by Subject|17|||
129171102|NCT04659174|464920258|FG001|Overall Study|Withdrawal by Subject|33|||
129171103|NCT04659174|464920257|FG000|Overall Study|Progressive disease|0|||
129171104|NCT04659174|464920258|FG001|Overall Study|Progressive disease|2|||
129171105|NCT04659174|464920257|FG000|Overall Study|Other reasons|0|||
129171106|NCT04659174|464920258|FG001|Overall Study|Other reasons|2|||
129171107|NCT04659174|464920257|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
129171108|NCT04659174|464920258|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
129171109|NCT04659174|464920257|FG000|Overall Study|Alcohol or illegal drug use|0|||
129171110|NCT04659174|464920258|FG001|Overall Study|Alcohol or illegal drug use|3|||
129171111|NCT04659174|464920257|FG000|Overall Study|Violation of entry criteria|1|||
129171112|NCT04659174|464920258|FG001|Overall Study|Violation of entry criteria|0|||
129171113|NCT04659174|464920257|FG000|Overall Study|Death|0|||
129171114|NCT04659174|464920258|FG001|Overall Study|Death|1|||
129171115|NCT05129449|464920259|FG000|Overall Study|Protocol Violation|1|||
129171116|NCT03650803|464920261|FG000|Overall Study|Lost to Follow-up|6|||
129171117|NCT02901054|464920262|FG000|Overall Study|Physician Decision|1|||
129171118|NCT02901054|464920262|FG000|Overall Study|Withdrawal by Subject|3|||
129171119|NCT01534260|464920263|FG000|Overall Study|Adverse Event|1|||
129171120|NCT01534260|464920264|FG001|Overall Study|Adverse Event|8|||
129171121|NCT01534260|464920263|FG000|Overall Study|Death|2|||
129171122|NCT01534260|464920264|FG001|Overall Study|Death|0|||
129171123|NCT01534260|464920263|FG000|Overall Study|Lack of Efficacy|1|||
129171124|NCT01534260|464920264|FG001|Overall Study|Lack of Efficacy|1|||
129171125|NCT01534260|464920263|FG000|Overall Study|Withdrawal by Subject|1|||
129171126|NCT01534260|464920264|FG001|Overall Study|Withdrawal by Subject|3|||
129171127|NCT01534260|464920263|FG000|Overall Study|Disease Progression|8|||
129171128|NCT01534260|464920264|FG001|Overall Study|Disease Progression|6|||
129171129|NCT01534260|464920263|FG000|Overall Study|Physician Decision|3|||
129171130|NCT01534260|464920264|FG001|Overall Study|Physician Decision|1|||
129171131|NCT01534260|464920263|FG000|Overall Study|No treatment, per protocol|0|||
129171132|NCT01534260|464920264|FG001|Overall Study|No treatment, per protocol|1|||
129171133|NCT01818258|464920267|FG000|Overall Study|Death|3|||
129171134|NCT01818258|464920268|FG001|Overall Study|Death|0|||
129171135|NCT01818258|464920267|FG000|Overall Study|Withdrawal by Subject|0|||
129171136|NCT01818258|464920268|FG001|Overall Study|Withdrawal by Subject|1|||
129171137|NCT01818258|464920267|FG000|Overall Study|Lost to Follow-up|0|||
129171138|NCT01818258|464920268|FG001|Overall Study|Lost to Follow-up|1|||
129171139|NCT01818258|464920267|FG000|Overall Study|Unable to Travel to Clinic|0|||
129171140|NCT01818258|464920268|FG001|Overall Study|Unable to Travel to Clinic|1|||
129171141|NCT01639339|464920273|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
129171142|NCT01639339|464920274|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
129171143|NCT01639339|464920273|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
129171144|NCT01639339|464920274|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
129171145|NCT01639339|464920273|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
128729300|NCT02457598|463306622|FG005|Overall Study|Adverse Event|0|||
128729301|NCT02457598|463306623|FG006|Overall Study|Adverse Event|0|||
128729302|NCT02457598|463306624|FG007|Overall Study|Adverse Event|1|||
128729303|NCT02457598|463306625|FG008|Overall Study|Adverse Event|0|||
128729304|NCT02457598|463306626|FG009|Overall Study|Adverse Event|1|||
128729305|NCT02457598|463306627|FG010|Overall Study|Adverse Event|6|||
128729306|NCT02457598|463306628|FG011|Overall Study|Adverse Event|0|||
128729307|NCT02457598|463306629|FG012|Overall Study|Adverse Event|0|||
128729308|NCT02457598|463306630|FG013|Overall Study|Adverse Event|1|||
128729309|NCT02457598|463306631|FG014|Overall Study|Adverse Event|2|||
128729310|NCT02457598|463306632|FG015|Overall Study|Adverse Event|0|||
128729311|NCT02457598|463306633|FG016|Overall Study|Adverse Event|0|||
128729312|NCT02457598|463306617|FG000|Overall Study|Death|0|||
128729313|NCT02457598|463306618|FG001|Overall Study|Death|0|||
128729314|NCT02457598|463306619|FG002|Overall Study|Death|0|||
128729315|NCT02457598|463306620|FG003|Overall Study|Death|3|||
128729316|NCT02457598|463306621|FG004|Overall Study|Death|0|||
129171146|NCT01639339|464920274|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
129171147|NCT01639339|464920273|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
129171148|NCT01639339|464920274|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
129171149|NCT01639339|464920273|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
129171150|NCT01639339|464920274|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
128729317|NCT02457598|463306622|FG005|Overall Study|Death|1|||
128729318|NCT02457598|463306623|FG006|Overall Study|Death|0|||
129171151|NCT01639339|464920273|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
129171152|NCT01639339|464920274|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
129171153|NCT01639339|464920273|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
129171154|NCT01639339|464920274|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
129171155|NCT01639339|464920273|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
129171156|NCT01639339|464920274|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
129171157|NCT01639339|464920273|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
129171158|NCT01639339|464920274|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
129171159|NCT01639339|464920273|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
129171160|NCT01639339|464920274|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
129171161|NCT05145322|464920278|FG000|Overall Study|Lost to Follow-up|4|||
129171162|NCT05145322|464920279|FG001|Overall Study|Lost to Follow-up|5|||
129171163|NCT03022097|464920280|FG000|Overall Study|Adverse Event|3|||
129171164|NCT03022097|464920281|FG001|Overall Study|Adverse Event|4|||
129171165|NCT03022097|464920282|FG002|Overall Study|Adverse Event|1|||
129171166|NCT03022097|464920283|FG003|Overall Study|Adverse Event|3|||
129171167|NCT03022097|464920280|FG000|Overall Study|Progressive Disease|2|||
129171168|NCT03022097|464920281|FG001|Overall Study|Progressive Disease|0|||
129171169|NCT03022097|464920282|FG002|Overall Study|Progressive Disease|5|||
129171170|NCT03022097|464920283|FG003|Overall Study|Progressive Disease|2|||
129171171|NCT03022097|464920280|FG000|Overall Study|Lack of Efficacy|0|||
128729319|NCT02457598|463306624|FG007|Overall Study|Death|0|||
128729320|NCT02457598|463306625|FG008|Overall Study|Death|0|||
128729321|NCT02457598|463306626|FG009|Overall Study|Death|0|||
128729322|NCT02457598|463306627|FG010|Overall Study|Death|3|||
128729323|NCT02457598|463306628|FG011|Overall Study|Death|0|||
128729324|NCT02457598|463306629|FG012|Overall Study|Death|0|||
129171172|NCT03022097|464920281|FG001|Overall Study|Lack of Efficacy|0|||
129171173|NCT03022097|464920282|FG002|Overall Study|Lack of Efficacy|3|||
129171174|NCT03022097|464920283|FG003|Overall Study|Lack of Efficacy|3|||
129171175|NCT03022097|464920280|FG000|Overall Study|Protocol Violation|1|||
129171176|NCT03022097|464920281|FG001|Overall Study|Protocol Violation|0|||
129171177|NCT03022097|464920282|FG002|Overall Study|Protocol Violation|1|||
129171178|NCT03022097|464920283|FG003|Overall Study|Protocol Violation|0|||
129171179|NCT03022097|464920280|FG000|Overall Study|Withdrawal by Subject|11|||
129171180|NCT03022097|464920281|FG001|Overall Study|Withdrawal by Subject|13|||
129171181|NCT03022097|464920282|FG002|Overall Study|Withdrawal by Subject|15|||
129171182|NCT03022097|464920283|FG003|Overall Study|Withdrawal by Subject|21|||
129171183|NCT03022097|464920280|FG000|Overall Study|Lost to Follow-up|0|||
129171184|NCT03022097|464920281|FG001|Overall Study|Lost to Follow-up|0|||
129171185|NCT03022097|464920282|FG002|Overall Study|Lost to Follow-up|1|||
129171186|NCT03022097|464920283|FG003|Overall Study|Lost to Follow-up|1|||
129171187|NCT03022097|464920280|FG000|Overall Study|Other|4|||
129171188|NCT03022097|464920281|FG001|Overall Study|Other|1|||
129171189|NCT03022097|464920282|FG002|Overall Study|Other|6|||
129171190|NCT03022097|464920283|FG003|Overall Study|Other|4|||
129171191|NCT03022097|464920280|FG000|Overall Study|Due to COVID-19 pandemic|0|||
129171192|NCT03022097|464920281|FG001|Overall Study|Due to COVID-19 pandemic|1|||
129171193|NCT03022097|464920282|FG002|Overall Study|Due to COVID-19 pandemic|0|||
129171194|NCT03022097|464920283|FG003|Overall Study|Due to COVID-19 pandemic|0|||
129171195|NCT01349322|464920286|FG000|Overall Study|Protocol Violation|45|||
129171196|NCT01349322|464920287|FG001|Overall Study|Protocol Violation|47|||
129171197|NCT05593913|464920292|FG000|Overall Study|Insufficient image quality|39|||
129171198|NCT04470908|464920293|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
129171199|NCT04376684|464920294|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
129171200|NCT04376684|464920295|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
129171201|NCT04376684|464920296|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
129171202|NCT04376684|464920297|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
129171203|NCT04376684|464920294|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
129171204|NCT04376684|464920295|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
129171205|NCT04376684|464920296|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
129171206|NCT04376684|464920297|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
129171207|NCT04376684|464920294|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
129171208|NCT04376684|464920295|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
129171209|NCT04376684|464920296|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
129171210|NCT04376684|464920297|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
129171211|NCT04376684|464920294|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
128729325|NCT02457598|463306630|FG013|Overall Study|Death|1|||
128729326|NCT02457598|463306631|FG014|Overall Study|Death|2|||
128729327|NCT02457598|463306632|FG015|Overall Study|Death|0|||
128729328|NCT02457598|463306633|FG016|Overall Study|Death|1|||
128729329|NCT02457598|463306617|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
129171212|NCT04376684|464920295|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
129171213|NCT04376684|464920296|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
129171214|NCT04376684|464920297|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
129171215|NCT04376684|464920294|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
128729330|NCT02457598|463306618|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
128729331|NCT02457598|463306619|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729332|NCT02457598|463306620|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
128729333|NCT02457598|463306621|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729334|NCT02457598|463306622|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729335|NCT02457598|463306623|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729336|NCT02457598|463306624|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
128729337|NCT02457598|463306625|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729338|NCT02457598|463306626|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729339|NCT02457598|463306627|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
128729340|NCT02457598|463306628|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729341|NCT02457598|463306629|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729342|NCT02457598|463306630|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
128729343|NCT02457598|463306631|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
128729344|NCT02457598|463306632|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
128729345|NCT02457598|463306633|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
128779401|NCT04833855|463482400|FG001|Overall Study|Decision by sponsor|1|||
128779402|NCT04833855|463482401|FG002|Overall Study|Decision by sponsor|0|||
128779403|NCT04833855|463482402|FG003|Overall Study|Decision by sponsor|0|||
128779404|NCT04833855|463482399|FG000|Overall Study|Withdrawal by Subject|4|||
128779405|NCT04833855|463482400|FG001|Overall Study|Withdrawal by Subject|1|||
128779406|NCT04833855|463482401|FG002|Overall Study|Withdrawal by Subject|3|||
128779407|NCT04833855|463482402|FG003|Overall Study|Withdrawal by Subject|1|||
128779408|NCT04833855|463482399|FG000|Overall Study|Lost to Follow-up|1|||
128779409|NCT04833855|463482400|FG001|Overall Study|Lost to Follow-up|0|||
129171216|NCT04376684|464920295|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
129171217|NCT04376684|464920296|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
129171218|NCT04376684|464920297|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
129171219|NCT04376684|464920294|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
129171220|NCT04376684|464920295|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
129171221|NCT04376684|464920296|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
129171222|NCT04376684|464920297|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
129171223|NCT04376684|464920294|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
129171224|NCT04376684|464920295|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
129171225|NCT04376684|464920296|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
129171226|NCT04376684|464920297|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
129171227|NCT02136680|464920298|FG000|Overall Study|No Longer Interested|1|||
129171228|NCT02136680|464920299|FG001|Overall Study|No Longer Interested|1|||
129171229|NCT02136680|464920298|FG000|Overall Study|No longer receiving care at clinic|3|||
129171230|NCT02136680|464920299|FG001|Overall Study|No longer receiving care at clinic|5|||
129171231|NCT02136680|464920298|FG000|Overall Study|Moved away|5|||
129171232|NCT02136680|464920299|FG001|Overall Study|Moved away|4|||
129171233|NCT02136680|464920298|FG000|Overall Study|Unable to schedule|17|||
129171234|NCT02136680|464920299|FG001|Overall Study|Unable to schedule|16|||
129171235|NCT02136680|464920298|FG000|Overall Study|Study ended before interview due|6|||
129171236|NCT02136680|464920299|FG001|Overall Study|Study ended before interview due|3|||
129171237|NCT05151445|464920300|FG000|Overall Study|Withdrawal by Subject|3|||
129171238|NCT01457014|464920301|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
129171239|NCT01457014|464920302|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
129171240|NCT01457014|464920303|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
129171241|NCT01457014|464920304|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
129171242|NCT01457014|464920301|FG000|First Night|Withdrawal by Subject|3|||
129171243|NCT01457014|464920302|FG001|First Night|Withdrawal by Subject|0|||
129171244|NCT01457014|464920303|FG002|First Night|Withdrawal by Subject|0|||
129171245|NCT01457014|464920304|FG003|First Night|Withdrawal by Subject|0|||
129171246|NCT05463744|464920305|FG000|Treatment Period|Withdrawal by Subject|19|||
129171247|NCT05463744|464920306|FG001|Treatment Period|Withdrawal by Subject|16|||
129171248|NCT05463744|464920305|FG000|Treatment Period|Adverse Event|4|||
129171249|NCT05463744|464920306|FG001|Treatment Period|Adverse Event|4|||
129171250|NCT05463744|464920305|FG000|Treatment Period|Pregnancy|0|||
129171251|NCT05463744|464920306|FG001|Treatment Period|Pregnancy|3|||
129171252|NCT05463744|464920305|FG000|Treatment Period|Lost to Follow-up|1|||
129171253|NCT05463744|464920306|FG001|Treatment Period|Lost to Follow-up|3|||
129171254|NCT05463744|464920305|FG000|Treatment Period|Inadvertent enrollment|2|||
129171255|NCT05463744|464920306|FG001|Treatment Period|Inadvertent enrollment|1|||
129171256|NCT05463744|464920305|FG000|Treatment Period|Death|0|||
129171257|NCT05463744|464920306|FG001|Treatment Period|Death|1|||
129171258|NCT05463744|464920305|FG000|Treatment Period|Non-compliance with Study Drug|1|||
129171259|NCT05463744|464920306|FG001|Treatment Period|Non-compliance with Study Drug|0|||
129171260|NCT05463744|464920305|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
129171261|NCT05463744|464920306|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
128729346|NCT02457598|463306617|FG000|Overall Study|Withdrew Consent|0|||
128729347|NCT02457598|463306618|FG001|Overall Study|Withdrew Consent|0|||
128779410|NCT04833855|463482401|FG002|Overall Study|Lost to Follow-up|2|||
129171262|NCT05463744|464920305|FG000|Treatment Period|Physician Decision|0|||
129171263|NCT05463744|464920306|FG001|Treatment Period|Physician Decision|1|||
129171264|NCT05463744|464920305|FG000|Follow-Up Period|Withdrawal by Subject|3|||
129171265|NCT05463744|464920306|FG001|Follow-Up Period|Withdrawal by Subject|1|||
129171266|NCT05463744|464920305|FG000|Follow-Up Period|Lost to Follow-up|1|||
129171267|NCT05463744|464920306|FG001|Follow-Up Period|Lost to Follow-up|1|||
129171268|NCT01357161|464920307|FG000|Part 1 (Open Label Run-in)|Death|5|||
129171269|NCT01357161|464920308|FG001|Part 1 (Open Label Run-in)|Death|0|||
129171270|NCT01357161|464920309|FG002|Part 1 (Open Label Run-in)|Death|0|||
129171271|NCT01357161|464920307|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
129171272|NCT01357161|464920308|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
129171273|NCT01357161|464920309|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
129171274|NCT01357161|464920307|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
129171275|NCT01357161|464920308|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
129171276|NCT01357161|464920309|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
129171277|NCT01357161|464920307|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
129171278|NCT01357161|464920308|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
129171279|NCT01357161|464920309|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
129171280|NCT01357161|464920307|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
129171281|NCT01357161|464920308|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
129171282|NCT01357161|464920309|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
129171283|NCT01357161|464920307|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
129171284|NCT01357161|464920308|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
129171285|NCT01357161|464920309|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
129171286|NCT01357161|464920307|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
129171287|NCT01357161|464920308|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
129171288|NCT01357161|464920309|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
129171289|NCT01357161|464920307|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
129171290|NCT01357161|464920308|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
129171291|NCT01357161|464920309|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
129171292|NCT01357161|464920307|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
129171293|NCT01357161|464920308|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
129171294|NCT01357161|464920309|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
129171295|NCT01357161|464920307|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
129171296|NCT01357161|464920308|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
129171297|NCT01357161|464920309|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
129171298|NCT01357161|464920307|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
129171299|NCT01357161|464920308|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
129171300|NCT01357161|464920309|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
129171301|NCT02825420|464920311|FG000|Overall Study|Death|30|||
129171302|NCT02825420|464920312|FG001|Overall Study|Death|12|||
129171303|NCT02825420|464920311|FG000|Overall Study|Progressive disease|6|||
129171304|NCT02825420|464920312|FG001|Overall Study|Progressive disease|1|||
129171305|NCT02825420|464920311|FG000|Overall Study|Lost to Follow-up|2|||
129171306|NCT02825420|464920312|FG001|Overall Study|Lost to Follow-up|2|||
129171307|NCT02825420|464920311|FG000|Overall Study|Withdrawal by Subject|1|||
129171308|NCT02825420|464920312|FG001|Overall Study|Withdrawal by Subject|1|||
129171309|NCT02825420|464920311|FG000|Overall Study|Protocol amendment not signed|1|||
129171310|NCT02825420|464920312|FG001|Overall Study|Protocol amendment not signed|1|||
129171311|NCT02825420|464920311|FG000|Overall Study|Physician Decision|1|||
129171312|NCT02825420|464920312|FG001|Overall Study|Physician Decision|0|||
129171313|NCT02825420|464920311|FG000|Overall Study|Did not receive PLD|2|||
129171314|NCT02825420|464920312|FG001|Overall Study|Did not receive PLD|0|||
129171315|NCT04027049|464920313|FG000|Overall Study|Withdrawn by family|1|||
129171316|NCT04027049|464920314|FG001|Overall Study|Withdrawn by family|0|||
129171317|NCT04027049|464920313|FG000|Overall Study|Participant safety|1|||
129171318|NCT04027049|464920314|FG001|Overall Study|Participant safety|0|||
129171319|NCT00789581|464921968|FG000|AC Therapy|Adverse Event|2|||
129171320|NCT00789581|464921969|FG001|AC Therapy|Adverse Event|3|||
129171321|NCT00789581|464921968|FG000|AC Therapy|Withdrawal by Subject|4|||
129171322|NCT00789581|464921969|FG001|AC Therapy|Withdrawal by Subject|7|||
129171323|NCT00789581|464921968|FG000|AC Therapy|Disease recurrence|3|||
129171324|NCT00789581|464921969|FG001|AC Therapy|Disease recurrence|1|||
129171325|NCT00789581|464921968|FG000|AC Therapy|Intercurrent Illness|1|||
129171326|NCT00789581|464921969|FG001|AC Therapy|Intercurrent Illness|0|||
129171327|NCT00789581|464921968|FG000|AC Therapy|Never Treated|1|||
129171328|NCT00789581|464921969|FG001|AC Therapy|Never Treated|4|||
129171329|NCT00789581|464921968|FG000|AC Therapy|Other|0|||
129171330|NCT00789581|464921969|FG001|AC Therapy|Other|2|||
129171331|NCT00789581|464921968|FG000|Adjuvant Therapy|Never treated|2|||
129171332|NCT00789581|464921969|FG001|Adjuvant Therapy|Never treated|2|||
129171333|NCT00789581|464921968|FG000|Adjuvant Therapy|Adverse Event|20|||
129171334|NCT00789581|464921969|FG001|Adjuvant Therapy|Adverse Event|44|||
129171335|NCT00789581|464921968|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
129171336|NCT00789581|464921969|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
128779411|NCT04833855|463482402|FG003|Overall Study|Lost to Follow-up|2|||
128779412|NCT04833855|463482399|FG000|Overall Study|Protocol specified criteria|0|||
128779413|NCT04833855|463482400|FG001|Overall Study|Protocol specified criteria|0|||
128779414|NCT04833855|463482401|FG002|Overall Study|Protocol specified criteria|2|||
128779415|NCT04833855|463482402|FG003|Overall Study|Protocol specified criteria|1|||
128779416|NCT03682536|463482404|FG000|Randomization|Withdrawal by Subject|0|||
128779417|NCT03682536|463482405|FG001|Randomization|Withdrawal by Subject|2|||
128779418|NCT03682536|463482404|FG000|Treatment|Other Reasons|8|||
128779419|NCT03682536|463482405|FG001|Treatment|Other Reasons|7|||
128779420|NCT03682536|463482404|FG000|Treatment|Physician Decision|5|||
128779421|NCT03682536|463482405|FG001|Treatment|Physician Decision|5|||
128779422|NCT03682536|463482404|FG000|Treatment|Protocol Violation|1|||
128779423|NCT03682536|463482405|FG001|Treatment|Protocol Violation|0|||
128779424|NCT03682536|463482404|FG000|Treatment|Study Terminated by Sponsor|1|||
128779425|NCT03682536|463482405|FG001|Treatment|Study Terminated by Sponsor|2|||
128779426|NCT03682536|463482404|FG000|Treatment|Lost to Follow-up|0|||
128779427|NCT03682536|463482405|FG001|Treatment|Lost to Follow-up|1|||
128779428|NCT03682536|463482404|FG000|Treatment|Withdrawal by Subject|16|||
128779429|NCT03682536|463482405|FG001|Treatment|Withdrawal by Subject|18|||
128779430|NCT03682536|463482404|FG000|Treatment|Lack of Efficacy|41|||
128779431|NCT03682536|463482405|FG001|Treatment|Lack of Efficacy|68|||
128779432|NCT03682536|463482404|FG000|Treatment|Disease Progression|9|||
128779433|NCT03682536|463482405|FG001|Treatment|Disease Progression|7|||
128779434|NCT03682536|463482404|FG000|Treatment|Adverse Event|9|||
128779435|NCT03682536|463482405|FG001|Treatment|Adverse Event|5|||
128779436|NCT03682536|463482404|FG000|Treatment|Death|14|||
128779437|NCT03682536|463482405|FG001|Treatment|Death|13|||
128779438|NCT03008122|463482406|FG000|Overall Study|Physician Decision|3|||
128779439|NCT03008122|463482407|FG001|Overall Study|Physician Decision|2|||
128779440|NCT03008122|463482408|FG002|Overall Study|Physician Decision|0|||
128779441|NCT03008122|463482406|FG000|Overall Study|Withdrawal by Subject|1|||
128779442|NCT03008122|463482407|FG001|Overall Study|Withdrawal by Subject|3|||
129171337|NCT00789581|464921968|FG000|Adjuvant Therapy|Disease recurrence|2|||
129171338|NCT00789581|464921969|FG001|Adjuvant Therapy|Disease recurrence|1|||
129171339|NCT00789581|464921968|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
129171340|NCT00789581|464921969|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
129171341|NCT00789581|464921968|FG000|Adjuvant Therapy|Protocol Violation|1|||
129171342|NCT00789581|464921969|FG001|Adjuvant Therapy|Protocol Violation|1|||
129171343|NCT00789581|464921968|FG000|Adjuvant Therapy|Other|0|||
129171344|NCT00789581|464921969|FG001|Adjuvant Therapy|Other|1|||
129171345|NCT01468207|464921970|FG000|Treatment Period 1|Adverse Event|1|||
129171346|NCT01468207|464921971|FG001|Treatment Period 1|Adverse Event|0|||
129171347|NCT01468207|464921972|FG002|Treatment Period 1|Adverse Event|0|||
129171348|NCT01468207|464921973|FG003|Treatment Period 1|Adverse Event|0|||
129171349|NCT01468207|464921974|FG004|Treatment Period 1|Adverse Event|0|||
129171350|NCT01468207|464921975|FG005|Treatment Period 1|Adverse Event|0|||
129171351|NCT01468207|464921970|FG000|Treatment Period 1|Protocol Violation|1|||
129171352|NCT01468207|464921971|FG001|Treatment Period 1|Protocol Violation|1|||
129171353|NCT01468207|464921972|FG002|Treatment Period 1|Protocol Violation|0|||
129171354|NCT01468207|464921973|FG003|Treatment Period 1|Protocol Violation|0|||
129171355|NCT01468207|464921974|FG004|Treatment Period 1|Protocol Violation|0|||
129171356|NCT01468207|464921975|FG005|Treatment Period 1|Protocol Violation|0|||
129171357|NCT01468207|464921970|FG000|Treatment Period 1|Withdrawal by Subject|5|||
129171358|NCT01468207|464921971|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129171359|NCT01468207|464921972|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129171360|NCT01468207|464921973|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129171361|NCT01468207|464921974|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129171362|NCT01468207|464921975|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129171363|NCT01468207|464921970|FG000|Treatment Period 1|Lost to Follow-up|2|||
129171364|NCT01468207|464921971|FG001|Treatment Period 1|Lost to Follow-up|1|||
129171365|NCT01468207|464921972|FG002|Treatment Period 1|Lost to Follow-up|0|||
129171366|NCT01468207|464921973|FG003|Treatment Period 1|Lost to Follow-up|0|||
129171367|NCT01468207|464921974|FG004|Treatment Period 1|Lost to Follow-up|0|||
129171368|NCT01468207|464921975|FG005|Treatment Period 1|Lost to Follow-up|0|||
129171369|NCT01468207|464921970|FG000|Treatment Period 1|Other|0|||
129171370|NCT01468207|464921971|FG001|Treatment Period 1|Other|2|||
129171371|NCT01468207|464921972|FG002|Treatment Period 1|Other|0|||
129171372|NCT01468207|464921973|FG003|Treatment Period 1|Other|0|||
129171373|NCT01468207|464921974|FG004|Treatment Period 1|Other|0|||
129171374|NCT01468207|464921975|FG005|Treatment Period 1|Other|0|||
129171375|NCT01468207|464921970|FG000|Treatment Period 2|Adverse Event|0|||
129171376|NCT01468207|464921971|FG001|Treatment Period 2|Adverse Event|0|||
129171377|NCT01468207|464921972|FG002|Treatment Period 2|Adverse Event|6|||
129171378|NCT01468207|464921973|FG003|Treatment Period 2|Adverse Event|1|||
129171379|NCT01468207|464921974|FG004|Treatment Period 2|Adverse Event|2|||
129171380|NCT01468207|464921975|FG005|Treatment Period 2|Adverse Event|1|||
129171381|NCT01468207|464921970|FG000|Treatment Period 2|Lack of Efficacy|0|||
129171382|NCT01468207|464921971|FG001|Treatment Period 2|Lack of Efficacy|0|||
129171383|NCT01468207|464921972|FG002|Treatment Period 2|Lack of Efficacy|1|||
128779443|NCT03008122|463482408|FG002|Overall Study|Withdrawal by Subject|0|||
129171384|NCT01468207|464921973|FG003|Treatment Period 2|Lack of Efficacy|1|||
128779444|NCT03008122|463482406|FG000|Overall Study|Lost to Follow-up|4|||
128779445|NCT03008122|463482407|FG001|Overall Study|Lost to Follow-up|8|||
129171385|NCT01468207|464921974|FG004|Treatment Period 2|Lack of Efficacy|0|||
129171386|NCT01468207|464921975|FG005|Treatment Period 2|Lack of Efficacy|2|||
129171387|NCT01468207|464921970|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129171388|NCT01468207|464921971|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129171389|NCT01468207|464921972|FG002|Treatment Period 2|Withdrawal by Subject|5|||
129171390|NCT01468207|464921973|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129171391|NCT01468207|464921974|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129171392|NCT01468207|464921975|FG005|Treatment Period 2|Withdrawal by Subject|2|||
129171393|NCT01468207|464921970|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
129171394|NCT01468207|464921971|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
129171395|NCT01468207|464921972|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
129171396|NCT01468207|464921973|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
129171397|NCT01468207|464921974|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
129171398|NCT01468207|464921975|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
129171399|NCT01468207|464921970|FG000|Treatment Period 2|Lost to Follow-up|0|||
129171400|NCT01468207|464921971|FG001|Treatment Period 2|Lost to Follow-up|0|||
129171401|NCT01468207|464921972|FG002|Treatment Period 2|Lost to Follow-up|5|||
129171402|NCT01468207|464921973|FG003|Treatment Period 2|Lost to Follow-up|1|||
129171403|NCT01468207|464921974|FG004|Treatment Period 2|Lost to Follow-up|0|||
129171404|NCT01468207|464921975|FG005|Treatment Period 2|Lost to Follow-up|0|||
129171405|NCT01468207|464921970|FG000|Treatment Period 2|Other|0|||
129171406|NCT01468207|464921971|FG001|Treatment Period 2|Other|0|||
129171407|NCT01468207|464921972|FG002|Treatment Period 2|Other|5|||
129171408|NCT01468207|464921973|FG003|Treatment Period 2|Other|1|||
129171409|NCT01468207|464921974|FG004|Treatment Period 2|Other|1|||
129171410|NCT01468207|464921975|FG005|Treatment Period 2|Other|2|||
129171411|NCT00539513|464921978|FG000|Overall Study|Withdrawal by Subject|2|||
129171412|NCT00539513|464921979|FG001|Overall Study|Withdrawal by Subject|1|||
129171413|NCT00539513|464921978|FG000|Overall Study|Lost to Follow-up|0|||
129171414|NCT00539513|464921979|FG001|Overall Study|Lost to Follow-up|1|||
129171415|NCT01328041|464921980|FG000|Overall Study|Adverse Event|7|||
129171416|NCT01328041|464921980|FG000|Overall Study|Lack of Efficacy|27|||
129171417|NCT01328041|464921980|FG000|Overall Study|Protocol Violation|7|||
129171418|NCT01328041|464921980|FG000|Overall Study|Lost to Follow-up|7|||
129171419|NCT01328041|464921980|FG000|Overall Study|Physician Decision|2|||
129171420|NCT01328041|464921980|FG000|Overall Study|Withdrawal by Subject|7|||
129171421|NCT02688088|464921984|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129171422|NCT02688088|464921985|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
129171423|NCT02688088|464921986|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129171424|NCT02688088|464921987|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129171425|NCT02688088|464921988|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129171426|NCT02688088|464921984|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129171427|NCT02688088|464921985|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
129171428|NCT02688088|464921986|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129171429|NCT02688088|464921987|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129171430|NCT02688088|464921988|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129171431|NCT02688088|464921984|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129171432|NCT02688088|464921985|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
129171433|NCT02688088|464921986|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129171434|NCT02688088|464921987|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129171435|NCT02688088|464921988|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129171436|NCT02688088|464921984|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129171437|NCT02688088|464921985|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
129171438|NCT02688088|464921986|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129171439|NCT02688088|464921987|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129171440|NCT02688088|464921988|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129171441|NCT02688088|464921984|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129171442|NCT02688088|464921985|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129171443|NCT02688088|464921986|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
129171444|NCT02688088|464921987|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129171445|NCT02688088|464921988|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129171446|NCT02688088|464921984|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129171447|NCT02688088|464921985|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129171448|NCT02688088|464921986|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
129171449|NCT02688088|464921987|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129171450|NCT02688088|464921988|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129171451|NCT02688088|464921984|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
129171452|NCT02688088|464921985|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
128729348|NCT02457598|463306619|FG002|Overall Study|Withdrew Consent|0|||
128729349|NCT02457598|463306620|FG003|Overall Study|Withdrew Consent|0|||
128729350|NCT02457598|463306621|FG004|Overall Study|Withdrew Consent|0|||
129171453|NCT02688088|464921986|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
129171454|NCT02688088|464921987|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
129171455|NCT02688088|464921988|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
129171456|NCT02688088|464921984|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129171457|NCT02688088|464921985|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129171458|NCT02688088|464921986|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129171459|NCT02688088|464921987|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
129171460|NCT02688088|464921988|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129171461|NCT02688088|464921984|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129171462|NCT02688088|464921985|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129171463|NCT02688088|464921986|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129171464|NCT02688088|464921987|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129171465|NCT02688088|464921988|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
129171466|NCT04021524|464921991|FG000|Overall Study|Change in surgical intervention|0|||
129171467|NCT04021524|464921992|FG001|Overall Study|Change in surgical intervention|1|||
129171468|NCT05275010|464921993|FG000|Overall Study|Reason Not Specified|4|||
129171469|NCT05275010|464921994|FG001|Overall Study|Reason Not Specified|1|||
129171470|NCT05275010|464921993|FG000|Overall Study|Withdrawal by Subject|1|||
129171471|NCT05275010|464921994|FG001|Overall Study|Withdrawal by Subject|0|||
129171472|NCT05275010|464921993|FG000|Overall Study|Lost to Follow-up|0|||
129171473|NCT05275010|464921994|FG001|Overall Study|Lost to Follow-up|1|||
129171474|NCT00730041|464921995|FG000|Overall Study|Lost to Follow-up|0|||
129171475|NCT00730041|464921996|FG001|Overall Study|Lost to Follow-up|2|||
129171476|NCT05526781|464921997|FG000|Overall Study|Lost to Follow-up|1|||
129171477|NCT01921218|464921998|FG000|Overall Study|Death|2|||
129171478|NCT01921218|464921999|FG001|Overall Study|Death|1|||
129171479|NCT01921218|464921998|FG000|Overall Study|Withdrawal by Subject|0|||
129171480|NCT01921218|464921999|FG001|Overall Study|Withdrawal by Subject|2|||
129171481|NCT01921218|464921998|FG000|Overall Study|Kidney transplant|1|||
129171482|NCT01921218|464921999|FG001|Overall Study|Kidney transplant|1|||
129171483|NCT02449889|464922000|FG000|Overall Study|Adverse Event|1|||
129171484|NCT02449889|464922001|FG001|Overall Study|Adverse Event|2|||
129171485|NCT02449889|464922002|FG002|Overall Study|Adverse Event|0|||
129171486|NCT02449889|464922000|FG000|Overall Study|Protocol Violation|0|||
129171487|NCT02449889|464922001|FG001|Overall Study|Protocol Violation|4|||
129171488|NCT02449889|464922002|FG002|Overall Study|Protocol Violation|1|||
129171489|NCT03327220|464922003|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
129171490|NCT03327220|464922004|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
129171491|NCT03327220|464922003|FG000|Overall Study|Investigator Decision|2|||
129171492|NCT03327220|464922004|FG001|Overall Study|Investigator Decision|0|||
129171493|NCT03327220|464922003|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
129171494|NCT03327220|464922004|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
129171495|NCT03327220|464922003|FG000|Overall Study|Fungal infection|1|||
129171496|NCT03327220|464922004|FG001|Overall Study|Fungal infection|0|||
129171497|NCT03327220|464922003|FG000|Overall Study|Discharged to Rehabilitation|0|||
129171498|NCT03327220|464922004|FG001|Overall Study|Discharged to Rehabilitation|1|||
129171499|NCT03327220|464922003|FG000|Overall Study|Missing|1|||
129171500|NCT03327220|464922004|FG001|Overall Study|Missing|0|||
129171501|NCT00368836|464922007|FG000|Phase II|Screen Failure|1|||
129171502|NCT00368836|464922007|FG000|Phase II|Withdrawal by Subject|1|||
129171503|NCT00368836|464922007|FG000|Phase II|unable to collect blood and/or breath|17|||
129171504|NCT00368836|464922007|FG000|Phase II|Protocol Violation|2|||
129171505|NCT01082874|464922008|FG000|Overall Study|Lost to Follow-up|10|||
129171506|NCT01082874|464922009|FG001|Overall Study|Lost to Follow-up|10|||
129171507|NCT01082874|464922010|FG002|Overall Study|Lost to Follow-up|6|||
129171508|NCT01082874|464922011|FG003|Overall Study|Lost to Follow-up|10|||
129171509|NCT01082874|464922008|FG000|Overall Study|Withdrawal by Subject|1|||
129171510|NCT01082874|464922009|FG001|Overall Study|Withdrawal by Subject|2|||
129171511|NCT01082874|464922010|FG002|Overall Study|Withdrawal by Subject|5|||
129171512|NCT01082874|464922011|FG003|Overall Study|Withdrawal by Subject|3|||
129171513|NCT00090142|464922013|FG000|Treatment Period I|Lost to Follow-up|1|||
129171514|NCT00090142|464922014|FG001|Treatment Period I|Lost to Follow-up|2|||
129171515|NCT00090142|464922013|FG000|Treatment Period I|Protocol Violation|2|||
129171516|NCT00090142|464922014|FG001|Treatment Period I|Protocol Violation|0|||
129171517|NCT00090142|464922013|FG000|Treatment Period I|Withdrawal by Subject|2|||
129171518|NCT00090142|464922014|FG001|Treatment Period I|Withdrawal by Subject|0|||
129171519|NCT00090142|464922013|FG000|Treatment Period I|Other|0|||
129171520|NCT00090142|464922014|FG001|Treatment Period I|Other|1|||
129171521|NCT00090142|464922013|FG000|Treatment Period II|Other|1|||
129171522|NCT00090142|464922014|FG001|Treatment Period II|Other|0|||
129171523|NCT02442310|464922015|FG000|Overall Study|Adverse Event|2|||
129171524|NCT02442310|464922015|FG000|Overall Study|Withdrawal by Subject|1|||
129171525|NCT00688324|464922016|FG000|Overall Study|Withdrawal by Subject|2|||
129171526|NCT00688324|464922016|FG000|Overall Study|Physician Decision|5|||
129171527|NCT00688324|464922016|FG000|Overall Study|Lost to Follow-up|1|||
129171528|NCT00006046|464922017|FG000|Overall Study|Adverse Event|3|||
129171529|NCT00006046|464922018|FG001|Overall Study|Adverse Event|0|||
129171530|NCT00006046|464922019|FG002|Overall Study|Adverse Event|0|||
129171531|NCT00006046|464922020|FG003|Overall Study|Adverse Event|0|||
129171532|NCT00006046|464922021|FG004|Overall Study|Adverse Event|0|||
129171533|NCT00006046|464922017|FG000|Overall Study|Disease Progression|2|||
129171534|NCT00006046|464922018|FG001|Overall Study|Disease Progression|0|||
129171535|NCT00006046|464922019|FG002|Overall Study|Disease Progression|0|||
129171536|NCT00006046|464922020|FG003|Overall Study|Disease Progression|0|||
129171537|NCT00006046|464922021|FG004|Overall Study|Disease Progression|0|||
129171538|NCT03176472|464922022|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
129171539|NCT03176472|464922023|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
129171540|NCT03176472|464922022|FG000|Double Blind Treatment Period|Adverse Event|0|||
129171541|NCT03176472|464922023|FG001|Double Blind Treatment Period|Adverse Event|5|||
129171542|NCT03176472|464922022|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
129171543|NCT03176472|464922023|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
129171544|NCT03176472|464922022|FG000|Double Blind Treatment Period|Physician Decision|0|||
129171545|NCT03176472|464922023|FG001|Double Blind Treatment Period|Physician Decision|1|||
129171546|NCT03176472|464922022|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129171547|NCT03176472|464922023|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129171548|NCT03176472|464922022|FG000|Double Blind Treatment Period|Not Provided|1|||
129171549|NCT03176472|464922023|FG001|Double Blind Treatment Period|Not Provided|0|||
129171550|NCT03176472|464922022|FG000|Open Label Extension|Withdrawal by Subject|3|||
129171551|NCT03176472|464922023|FG001|Open Label Extension|Withdrawal by Subject|4|||
129171552|NCT03176472|464922022|FG000|Open Label Extension|Adverse Event|2|||
129171553|NCT03176472|464922023|FG001|Open Label Extension|Adverse Event|4|||
129171554|NCT03176472|464922022|FG000|Open Label Extension|Lost to Follow-up|1|||
129171555|NCT03176472|464922023|FG001|Open Label Extension|Lost to Follow-up|2|||
129171556|NCT03176472|464922022|FG000|Open Label Extension|Protocol Violation|0|||
129171557|NCT03176472|464922023|FG001|Open Label Extension|Protocol Violation|1|||
129171558|NCT03176472|464922022|FG000|Open Label Extension|Not Provided|2|||
129171559|NCT03176472|464922023|FG001|Open Label Extension|Not Provided|1|||
129171560|NCT00596154|464922024|FG000|Overall Study|Not Evaluable|2|||
129171561|NCT00642369|464922025|FG000|Overall Study|Adverse Event|2|||
129171562|NCT00642369|464922026|FG001|Overall Study|Adverse Event|3|||
129171563|NCT00642369|464922025|FG000|Overall Study|Withdrawal by Subject|1|||
129171564|NCT00642369|464922026|FG001|Overall Study|Withdrawal by Subject|0|||
129171565|NCT00642369|464922025|FG000|Overall Study|misdiagnosis|0|||
129171566|NCT00642369|464922026|FG001|Overall Study|misdiagnosis|1|||
129171567|NCT00642369|464922025|FG000|Overall Study|Lack of Efficacy|2|||
129171568|NCT00642369|464922026|FG001|Overall Study|Lack of Efficacy|2|||
129171569|NCT03077438|464922033|FG000|Overall Study|Protocol Violation|3|||
129171570|NCT03077438|464922034|FG001|Overall Study|Protocol Violation|5|||
129171571|NCT03077438|464922033|FG000|Overall Study|Withdrawal by Subject|3|||
129171572|NCT03077438|464922034|FG001|Overall Study|Withdrawal by Subject|6|||
129171573|NCT03077438|464922033|FG000|Overall Study|Lost to Follow-up|6|||
129171574|NCT03077438|464922034|FG001|Overall Study|Lost to Follow-up|3|||
129171575|NCT01190475|464922035|FG000|Overall Study|Withdrawal by Subject|0|||
129171576|NCT01190475|464922036|FG001|Overall Study|Withdrawal by Subject|0|||
129171577|NCT01190475|464922037|FG002|Overall Study|Withdrawal by Subject|1|||
129171578|NCT04154345|464922040|FG000|Overall Study|Covid-19 pandemic|4|||
129171579|NCT03622112|464922042|FG000|Overall Study|Withdrawal by Subject|6|||
129171580|NCT03622112|464922043|FG001|Overall Study|Withdrawal by Subject|2|||
129171581|NCT03622112|464922044|FG002|Overall Study|Withdrawal by Subject|4|||
129171582|NCT03622112|464922045|FG003|Overall Study|Withdrawal by Subject|2|||
129171583|NCT03622112|464922046|FG004|Overall Study|Withdrawal by Subject|1|||
129171584|NCT03622112|464922047|FG005|Overall Study|Withdrawal by Subject|2|||
129171585|NCT03622112|464922048|FG006|Overall Study|Withdrawal by Subject|2|||
129171586|NCT03622112|464922042|FG000|Overall Study|Death|0|||
129171587|NCT03622112|464922043|FG001|Overall Study|Death|0|||
129171588|NCT03622112|464922044|FG002|Overall Study|Death|0|||
129171589|NCT03622112|464922045|FG003|Overall Study|Death|1|||
129171590|NCT03622112|464922046|FG004|Overall Study|Death|0|||
129171591|NCT03622112|464922047|FG005|Overall Study|Death|0|||
129171592|NCT03622112|464922048|FG006|Overall Study|Death|0|||
129171593|NCT03622112|464922042|FG000|Overall Study|Lost to Follow-up|1|||
128779446|NCT03008122|463482408|FG002|Overall Study|Lost to Follow-up|3|||
129171594|NCT03622112|464922043|FG001|Overall Study|Lost to Follow-up|1|||
129171595|NCT03622112|464922044|FG002|Overall Study|Lost to Follow-up|0|||
129171596|NCT03622112|464922045|FG003|Overall Study|Lost to Follow-up|0|||
129171597|NCT03622112|464922046|FG004|Overall Study|Lost to Follow-up|0|||
129171598|NCT03622112|464922047|FG005|Overall Study|Lost to Follow-up|0|||
129171599|NCT03622112|464922048|FG006|Overall Study|Lost to Follow-up|0|||
129171600|NCT03622112|464922042|FG000|Overall Study|Study-specific withdrawal criteria|10|||
129171601|NCT03622112|464922043|FG001|Overall Study|Study-specific withdrawal criteria|8|||
129171602|NCT03622112|464922044|FG002|Overall Study|Study-specific withdrawal criteria|7|||
129171603|NCT03622112|464922045|FG003|Overall Study|Study-specific withdrawal criteria|6|||
129171604|NCT03622112|464922046|FG004|Overall Study|Study-specific withdrawal criteria|4|||
129171605|NCT03622112|464922047|FG005|Overall Study|Study-specific withdrawal criteria|18|||
129171606|NCT03622112|464922048|FG006|Overall Study|Study-specific withdrawal criteria|4|||
128729351|NCT02457598|463306622|FG005|Overall Study|Withdrew Consent|0|||
128729352|NCT02457598|463306623|FG006|Overall Study|Withdrew Consent|0|||
128729353|NCT02457598|463306624|FG007|Overall Study|Withdrew Consent|2|||
128729354|NCT02457598|463306625|FG008|Overall Study|Withdrew Consent|0|||
128729355|NCT02457598|463306626|FG009|Overall Study|Withdrew Consent|0|||
128729356|NCT02457598|463306627|FG010|Overall Study|Withdrew Consent|3|||
128729357|NCT02457598|463306628|FG011|Overall Study|Withdrew Consent|0|||
128729358|NCT02457598|463306629|FG012|Overall Study|Withdrew Consent|0|||
128729359|NCT02457598|463306630|FG013|Overall Study|Withdrew Consent|1|||
128729360|NCT02457598|463306631|FG014|Overall Study|Withdrew Consent|0|||
128729361|NCT02457598|463306632|FG015|Overall Study|Withdrew Consent|0|||
128729362|NCT02457598|463306633|FG016|Overall Study|Withdrew Consent|0|||
128729363|NCT02457598|463306617|FG000|Overall Study|Unacceptable Toxicity|0|||
128729364|NCT02457598|463306618|FG001|Overall Study|Unacceptable Toxicity|0|||
128729365|NCT02457598|463306619|FG002|Overall Study|Unacceptable Toxicity|0|||
128729366|NCT02457598|463306620|FG003|Overall Study|Unacceptable Toxicity|0|||
128729367|NCT02457598|463306621|FG004|Overall Study|Unacceptable Toxicity|0|||
128729368|NCT02457598|463306622|FG005|Overall Study|Unacceptable Toxicity|0|||
128729369|NCT02457598|463306623|FG006|Overall Study|Unacceptable Toxicity|0|||
128729370|NCT02457598|463306624|FG007|Overall Study|Unacceptable Toxicity|0|||
128729371|NCT02457598|463306625|FG008|Overall Study|Unacceptable Toxicity|0|||
128729372|NCT02457598|463306626|FG009|Overall Study|Unacceptable Toxicity|0|||
128729373|NCT02457598|463306627|FG010|Overall Study|Unacceptable Toxicity|1|||
128729374|NCT02457598|463306628|FG011|Overall Study|Unacceptable Toxicity|0|||
128729375|NCT02457598|463306629|FG012|Overall Study|Unacceptable Toxicity|1|||
128729376|NCT02457598|463306630|FG013|Overall Study|Unacceptable Toxicity|1|||
128729377|NCT02457598|463306631|FG014|Overall Study|Unacceptable Toxicity|1|||
128729378|NCT02457598|463306632|FG015|Overall Study|Unacceptable Toxicity|0|||
128729379|NCT02457598|463306633|FG016|Overall Study|Unacceptable Toxicity|0|||
128729380|NCT02457598|463306617|FG000|Overall Study|Intercurrent Illness|0|||
128729381|NCT02457598|463306618|FG001|Overall Study|Intercurrent Illness|0|||
128729382|NCT02457598|463306619|FG002|Overall Study|Intercurrent Illness|0|||
128729383|NCT02457598|463306620|FG003|Overall Study|Intercurrent Illness|0|||
128729384|NCT02457598|463306621|FG004|Overall Study|Intercurrent Illness|0|||
128729385|NCT02457598|463306622|FG005|Overall Study|Intercurrent Illness|0|||
128729386|NCT02457598|463306623|FG006|Overall Study|Intercurrent Illness|0|||
128729387|NCT02457598|463306624|FG007|Overall Study|Intercurrent Illness|0|||
128729388|NCT02457598|463306625|FG008|Overall Study|Intercurrent Illness|0|||
128729389|NCT02457598|463306626|FG009|Overall Study|Intercurrent Illness|0|||
128729390|NCT02457598|463306627|FG010|Overall Study|Intercurrent Illness|1|||
128729391|NCT02457598|463306628|FG011|Overall Study|Intercurrent Illness|0|||
128729392|NCT02457598|463306629|FG012|Overall Study|Intercurrent Illness|0|||
128729393|NCT02457598|463306630|FG013|Overall Study|Intercurrent Illness|0|||
128729394|NCT02457598|463306631|FG014|Overall Study|Intercurrent Illness|0|||
128729395|NCT02457598|463306632|FG015|Overall Study|Intercurrent Illness|0|||
128729396|NCT02457598|463306633|FG016|Overall Study|Intercurrent Illness|0|||
128729397|NCT02457598|463306617|FG000|Overall Study|Protocol Violation|0|||
128729398|NCT02457598|463306618|FG001|Overall Study|Protocol Violation|0|||
128729399|NCT02457598|463306619|FG002|Overall Study|Protocol Violation|0|||
128729400|NCT02457598|463306620|FG003|Overall Study|Protocol Violation|0|||
128729401|NCT02457598|463306621|FG004|Overall Study|Protocol Violation|0|||
128729402|NCT02457598|463306622|FG005|Overall Study|Protocol Violation|0|||
128729403|NCT02457598|463306623|FG006|Overall Study|Protocol Violation|0|||
128729404|NCT02457598|463306624|FG007|Overall Study|Protocol Violation|0|||
128729405|NCT02457598|463306625|FG008|Overall Study|Protocol Violation|0|||
128729406|NCT02457598|463306626|FG009|Overall Study|Protocol Violation|0|||
128729407|NCT02457598|463306627|FG010|Overall Study|Protocol Violation|1|||
128729408|NCT02457598|463306628|FG011|Overall Study|Protocol Violation|0|||
128729409|NCT02457598|463306629|FG012|Overall Study|Protocol Violation|0|||
128729410|NCT02457598|463306630|FG013|Overall Study|Protocol Violation|0|||
128729411|NCT02457598|463306631|FG014|Overall Study|Protocol Violation|0|||
128729412|NCT02457598|463306632|FG015|Overall Study|Protocol Violation|0|||
128729413|NCT02457598|463306633|FG016|Overall Study|Protocol Violation|0|||
128729414|NCT01403974|463306634|FG000|Overall Study|Progressive disease according to RECIST|3|||
128729415|NCT01403974|463306635|FG001|Overall Study|Progressive disease according to RECIST|3|||
129171607|NCT03622112|464922042|FG000|Overall Study|Protocol Violation|2|||
129171608|NCT03622112|464922043|FG001|Overall Study|Protocol Violation|0|||
128729416|NCT01403974|463306636|FG002|Overall Study|Progressive disease according to RECIST|2|||
128729417|NCT01403974|463306637|FG003|Overall Study|Progressive disease according to RECIST|3|||
128779447|NCT03008122|463482406|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
128779448|NCT03008122|463482407|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
128779449|NCT03008122|463482408|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
128779450|NCT03008122|463482406|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
128779451|NCT03008122|463482407|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
128779452|NCT03008122|463482408|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
128779453|NCT03008122|463482406|FG000|Overall Study|Death|0|||
128779454|NCT03008122|463482407|FG001|Overall Study|Death|0|||
128779455|NCT03008122|463482408|FG002|Overall Study|Death|1|||
128779456|NCT02338609|463482409|FG000|Overall Study|Physician Decision|1|||
128779457|NCT02338609|463482409|FG000|Overall Study|Death|1|||
128779458|NCT02223182|463482412|FG000|Double-Blind Period|Adverse Event|0|||
128779459|NCT02223182|463482413|FG001|Double-Blind Period|Adverse Event|2|||
128779460|NCT02223182|463482414|FG002|Double-Blind Period|Adverse Event|1|||
128779461|NCT02223182|463482415|FG003|Double-Blind Period|Adverse Event|0|||
128779462|NCT02223182|463482412|FG000|Double-Blind Period|Withdrawal by Subject|1|||
128779463|NCT02223182|463482413|FG001|Double-Blind Period|Withdrawal by Subject|1|||
128779464|NCT02223182|463482414|FG002|Double-Blind Period|Withdrawal by Subject|1|||
128779465|NCT02223182|463482415|FG003|Double-Blind Period|Withdrawal by Subject|0|||
128779466|NCT02223182|463482412|FG000|Double-Blind Period|Lost to Follow-up|0|||
128779467|NCT02223182|463482413|FG001|Double-Blind Period|Lost to Follow-up|1|||
128779468|NCT02223182|463482414|FG002|Double-Blind Period|Lost to Follow-up|0|||
128779469|NCT02223182|463482415|FG003|Double-Blind Period|Lost to Follow-up|0|||
128779470|NCT02223182|463482412|FG000|Double-Blind Period|Non Compliance|0|||
128779471|NCT02223182|463482413|FG001|Double-Blind Period|Non Compliance|0|||
128779472|NCT02223182|463482414|FG002|Double-Blind Period|Non Compliance|0|||
128779473|NCT02223182|463482415|FG003|Double-Blind Period|Non Compliance|1|||
128779474|NCT02223182|463482412|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
128779475|NCT02223182|463482413|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
128779476|NCT02223182|463482414|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
128779477|NCT02223182|463482415|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
128779478|NCT02223182|463482412|FG000|Open-Label 500 Period|Adverse Event|1|||
128779479|NCT02223182|463482413|FG001|Open-Label 500 Period|Adverse Event|0|||
129171609|NCT03622112|464922044|FG002|Overall Study|Protocol Violation|1|||
129171610|NCT03622112|464922045|FG003|Overall Study|Protocol Violation|1|||
129171611|NCT03622112|464922046|FG004|Overall Study|Protocol Violation|0|||
129171612|NCT03622112|464922047|FG005|Overall Study|Protocol Violation|0|||
129171613|NCT03622112|464922048|FG006|Overall Study|Protocol Violation|0|||
129171614|NCT03622112|464922042|FG000|Overall Study|Adverse Event|6|||
129171615|NCT03622112|464922043|FG001|Overall Study|Adverse Event|8|||
129171616|NCT03622112|464922044|FG002|Overall Study|Adverse Event|4|||
129171617|NCT03622112|464922045|FG003|Overall Study|Adverse Event|11|||
129171618|NCT03622112|464922046|FG004|Overall Study|Adverse Event|4|||
129171619|NCT03622112|464922047|FG005|Overall Study|Adverse Event|20|||
129171620|NCT03622112|464922048|FG006|Overall Study|Adverse Event|2|||
129171621|NCT03622112|464922042|FG000|Overall Study|Reason not specified|0|||
129171622|NCT03622112|464922043|FG001|Overall Study|Reason not specified|1|||
129171623|NCT03622112|464922044|FG002|Overall Study|Reason not specified|0|||
129171624|NCT03622112|464922045|FG003|Overall Study|Reason not specified|1|||
129171625|NCT03622112|464922046|FG004|Overall Study|Reason not specified|1|||
129171626|NCT03622112|464922047|FG005|Overall Study|Reason not specified|2|||
129171627|NCT03622112|464922048|FG006|Overall Study|Reason not specified|1|||
129171628|NCT01694121|464922050|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
129171629|NCT01694121|464922051|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
129171630|NCT00521599|464922052|FG000|Overall Study|Adverse Event|5|||
129171631|NCT00521599|464922053|FG001|Overall Study|Adverse Event|7|||
129171632|NCT00521599|464922054|FG002|Overall Study|Adverse Event|6|||
129171633|NCT00521599|464922052|FG000|Overall Study|Treatment Failure|8|||
129171634|NCT00521599|464922053|FG001|Overall Study|Treatment Failure|9|||
129171635|NCT00521599|464922054|FG002|Overall Study|Treatment Failure|22|||
129171636|NCT00521599|464922052|FG000|Overall Study|Lost to Follow-up|2|||
129171637|NCT00521599|464922053|FG001|Overall Study|Lost to Follow-up|1|||
129171638|NCT00521599|464922054|FG002|Overall Study|Lost to Follow-up|2|||
129171639|NCT00521599|464922052|FG000|Overall Study|Withdrawal by Subject|3|||
129171640|NCT00521599|464922053|FG001|Overall Study|Withdrawal by Subject|5|||
129171641|NCT00521599|464922054|FG002|Overall Study|Withdrawal by Subject|1|||
129171642|NCT00521599|464922052|FG000|Overall Study|Withdrawal by subject treatment related|3|||
129171643|NCT00521599|464922053|FG001|Overall Study|Withdrawal by subject treatment related|1|||
129171644|NCT00521599|464922054|FG002|Overall Study|Withdrawal by subject treatment related|2|||
129171645|NCT00521599|464922052|FG000|Overall Study|Protocol Violation|2|||
129171646|NCT00521599|464922053|FG001|Overall Study|Protocol Violation|4|||
129171647|NCT00521599|464922054|FG002|Overall Study|Protocol Violation|2|||
129171648|NCT00521599|464922052|FG000|Overall Study|Did not meet protocol eligibility|2|||
129171649|NCT00521599|464922053|FG001|Overall Study|Did not meet protocol eligibility|2|||
129171650|NCT00521599|464922054|FG002|Overall Study|Did not meet protocol eligibility|1|||
129171651|NCT00866047|464922055|FG000|Treatment Period|Progressive disease|13|||
129171652|NCT00866047|464922055|FG000|Treatment Period|Adverse Event|16|||
129171653|NCT00866047|464922055|FG000|Treatment Period|Physician Decision|14|||
129171654|NCT00866047|464922055|FG000|Treatment Period|Withdrawal by Subject|5|||
129171655|NCT00866047|464922055|FG000|Follow-up Period|Lost to Follow-up|5|||
129171656|NCT02928029|464922056|FG000|Overall Study|Withdrawal by Subject|0|||
129171657|NCT02928029|464922057|FG001|Overall Study|Withdrawal by Subject|1|||
129171658|NCT02928029|464922056|FG000|Overall Study|Radiological progression|1|||
129171659|NCT02928029|464922057|FG001|Overall Study|Radiological progression|0|||
129171660|NCT02928029|464922056|FG000|Overall Study|Clinical progression|1|||
129171661|NCT02928029|464922057|FG001|Overall Study|Clinical progression|2|||
129171662|NCT02928029|464922056|FG000|Overall Study|AE not related to clinical progression|1|||
129171663|NCT02928029|464922057|FG001|Overall Study|AE not related to clinical progression|1|||
129171664|NCT01610713|464922058|FG000|Overall Study|Adverse Event|3|||
129171665|NCT01610713|464922059|FG001|Overall Study|Adverse Event|0|||
129171666|NCT01610713|464922058|FG000|Overall Study|Lack of Efficacy|1|||
129171667|NCT01610713|464922059|FG001|Overall Study|Lack of Efficacy|0|||
129171668|NCT01610713|464922058|FG000|Overall Study|low mood and poor motivation|1|||
129171669|NCT01610713|464922059|FG001|Overall Study|low mood and poor motivation|0|||
129171670|NCT01610713|464922058|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
129171671|NCT01610713|464922059|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
129171672|NCT01610713|464922058|FG000|Overall Study|Lost to Follow-up|0|||
129171673|NCT01610713|464922059|FG001|Overall Study|Lost to Follow-up|1|||
129171674|NCT02778555|464922061|FG000|Overall Study|Withdrawal by Subject|55|||
129171675|NCT02778555|464922062|FG001|Overall Study|Withdrawal by Subject|32|||
129171676|NCT02778555|464922063|FG002|Overall Study|Withdrawal by Subject|107|||
129171677|NCT01451931|464922065|FG000|Overall Study|Lost to Follow-up|17|||
129171678|NCT01451931|464922066|FG001|Overall Study|Lost to Follow-up|36|||
129171679|NCT01451931|464922067|FG002|Overall Study|Lost to Follow-up|21|||
129171680|NCT01451931|464922065|FG000|Overall Study|Withdrawal by Subject|16|||
129171681|NCT01451931|464922066|FG001|Overall Study|Withdrawal by Subject|22|||
129171682|NCT01451931|464922067|FG002|Overall Study|Withdrawal by Subject|22|||
129171683|NCT02979093|464922070|FG000|First Scan Session|Scanning data problems|1|||
129171684|NCT02979093|464922071|FG001|First Scan Session|Scanning data problems|2|||
129171685|NCT02979093|464922072|FG002|First Scan Session|Scanning data problems|2|||
129171686|NCT02979093|464922073|FG003|First Scan Session|Scanning data problems|0|||
129171687|NCT02979093|464922070|FG000|Second Scan Session|Scanning data problems|3|||
129171688|NCT02979093|464922071|FG001|Second Scan Session|Scanning data problems|0|||
129171689|NCT02979093|464922072|FG002|Second Scan Session|Scanning data problems|1|||
129171690|NCT02979093|464922073|FG003|Second Scan Session|Scanning data problems|3|||
129171691|NCT03099174|464922074|FG000|Overall Study|Withdrawal by Subject|0|||
129171692|NCT03099174|464922075|FG001|Overall Study|Withdrawal by Subject|0|||
129171693|NCT03099174|464922076|FG002|Overall Study|Withdrawal by Subject|1|||
129171694|NCT03099174|464922077|FG003|Overall Study|Withdrawal by Subject|0|||
129171695|NCT03099174|464922078|FG004|Overall Study|Withdrawal by Subject|2|||
129171696|NCT03099174|464922079|FG005|Overall Study|Withdrawal by Subject|2|||
129171697|NCT03099174|464922080|FG006|Overall Study|Withdrawal by Subject|1|||
129171698|NCT03099174|464922081|FG007|Overall Study|Withdrawal by Subject|4|||
129171699|NCT03099174|464922074|FG000|Overall Study|Adverse Event|0|||
129171700|NCT03099174|464922075|FG001|Overall Study|Adverse Event|1|||
129171701|NCT03099174|464922076|FG002|Overall Study|Adverse Event|1|||
129171702|NCT03099174|464922077|FG003|Overall Study|Adverse Event|2|||
129171703|NCT03099174|464922078|FG004|Overall Study|Adverse Event|5|||
129171704|NCT03099174|464922079|FG005|Overall Study|Adverse Event|3|||
129171705|NCT03099174|464922080|FG006|Overall Study|Adverse Event|6|||
129171706|NCT03099174|464922081|FG007|Overall Study|Adverse Event|4|||
129171707|NCT03099174|464922074|FG000|Overall Study|Other than listed|6|||
129171708|NCT03099174|464922075|FG001|Overall Study|Other than listed|6|||
129171709|NCT03099174|464922076|FG002|Overall Study|Other than listed|5|||
129171710|NCT03099174|464922077|FG003|Overall Study|Other than listed|6|||
129171711|NCT03099174|464922078|FG004|Overall Study|Other than listed|19|||
129171712|NCT03099174|464922079|FG005|Overall Study|Other than listed|10|||
129171713|NCT03099174|464922080|FG006|Overall Study|Other than listed|26|||
129171714|NCT03099174|464922081|FG007|Overall Study|Other than listed|23|||
129171715|NCT02378298|464922082|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
129171716|NCT02378298|464922083|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
129171717|NCT02378298|464922084|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
129171718|NCT02378298|464922082|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
129171719|NCT02378298|464922083|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
129171720|NCT02378298|464922084|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
129171721|NCT02378298|464922082|FG000|Surveillance (19-68 Weeks)|Death|1|||
129171722|NCT02378298|464922083|FG001|Surveillance (19-68 Weeks)|Death|0|||
129171723|NCT02378298|464922084|FG002|Surveillance (19-68 Weeks)|Death|0|||
129171724|NCT04173260|464922085|FG000|Overall Study|Early termination|4|||
128779480|NCT02223182|463482414|FG002|Open-Label 500 Period|Adverse Event|2|||
128779481|NCT02223182|463482415|FG003|Open-Label 500 Period|Adverse Event|1|||
128779482|NCT02223182|463482412|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
128779483|NCT02223182|463482413|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
128779484|NCT02223182|463482414|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
128779485|NCT02223182|463482415|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
128779486|NCT02223182|463482412|FG000|Open-Label 500 Period|Physician Decision|0|||
128779487|NCT02223182|463482413|FG001|Open-Label 500 Period|Physician Decision|0|||
128779488|NCT02223182|463482414|FG002|Open-Label 500 Period|Physician Decision|0|||
128779489|NCT02223182|463482415|FG003|Open-Label 500 Period|Physician Decision|1|||
128779490|NCT02223182|463482412|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
128779491|NCT02223182|463482413|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
128779492|NCT02223182|463482414|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
128779493|NCT02223182|463482415|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
128779494|NCT02223182|463482412|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
128779495|NCT02223182|463482413|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
128779496|NCT02223182|463482414|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
128779497|NCT02223182|463482415|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
128779498|NCT02223182|463482412|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
128779499|NCT02223182|463482413|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
128779500|NCT02223182|463482414|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
128779501|NCT02223182|463482415|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
128779502|NCT02223182|463482412|FG000|Open-Label 300 Period|Non Compliance|0|||
128779503|NCT02223182|463482413|FG001|Open-Label 300 Period|Non Compliance|2|||
128779504|NCT02223182|463482414|FG002|Open-Label 300 Period|Non Compliance|1|||
128779505|NCT02223182|463482415|FG003|Open-Label 300 Period|Non Compliance|0|||
128779506|NCT03714022|463482416|FG000|Overall Study|Adverse Event|1|||
128779507|NCT03714022|463482417|FG001|Overall Study|Adverse Event|0|||
128779508|NCT03714022|463482416|FG000|Overall Study|Consent withdrawal|0|||
128779509|NCT03714022|463482417|FG001|Overall Study|Consent withdrawal|1|||
128779510|NCT03714022|463482416|FG000|Overall Study|Lost to Follow-up|3|||
128779511|NCT03714022|463482417|FG001|Overall Study|Lost to Follow-up|2|||
128779512|NCT02234310|463482426|FG000|Overall Study|Physician Decision|1|||
128779513|NCT02234310|463482426|FG000|Overall Study|Adverse Event|1|||
128779514|NCT02234310|463482426|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
128779515|NCT02234310|463482426|FG000|Overall Study|Withdrawal by Subject|2|||
128779516|NCT03289455|463482427|FG000|Overall Study|Death|1|||
128779517|NCT03289455|463482428|FG001|Overall Study|Death|0|||
128779518|NCT03289455|463482429|FG002|Overall Study|Death|0|||
128779519|NCT03289455|463482427|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
128779520|NCT03289455|463482428|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
128779521|NCT03289455|463482429|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
128779522|NCT03289455|463482427|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
128779523|NCT03289455|463482428|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
128779524|NCT03289455|463482429|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
128779525|NCT03289455|463482427|FG000|Overall Study|Progressive disease|3|||
128779526|NCT03289455|463482428|FG001|Overall Study|Progressive disease|4|||
128779527|NCT03289455|463482429|FG002|Overall Study|Progressive disease|5|||
128779528|NCT00114959|463482430|FG000|Overall Study|Lack of Efficacy|6|||
128779529|NCT00114959|463482430|FG000|Overall Study|Physician Decision|1|||
128779530|NCT00114959|463482430|FG000|Overall Study|Death|1|||
129171725|NCT02308163|464922086|FG000|Overall Study|Not fulfill eligible criteria|1|||
129171726|NCT02308163|464922087|FG001|Overall Study|Not fulfill eligible criteria|2|||
129171727|NCT02308163|464922088|FG002|Overall Study|Not fulfill eligible criteria|0|||
129171728|NCT02308163|464922089|FG003|Overall Study|Not fulfill eligible criteria|1|||
129171729|NCT02308163|464922090|FG004|Overall Study|Not fulfill eligible criteria|1|||
129171730|NCT02308163|464922086|FG000|Overall Study|Adverse Event|9|||
129171731|NCT02308163|464922087|FG001|Overall Study|Adverse Event|5|||
129171732|NCT02308163|464922088|FG002|Overall Study|Adverse Event|2|||
129171733|NCT02308163|464922089|FG003|Overall Study|Adverse Event|2|||
129171734|NCT02308163|464922090|FG004|Overall Study|Adverse Event|11|||
129171735|NCT02308163|464922086|FG000|Overall Study|Lack of Efficacy|11|||
129171736|NCT02308163|464922087|FG001|Overall Study|Lack of Efficacy|3|||
129171737|NCT02308163|464922088|FG002|Overall Study|Lack of Efficacy|8|||
129171738|NCT02308163|464922089|FG003|Overall Study|Lack of Efficacy|4|||
129171739|NCT02308163|464922090|FG004|Overall Study|Lack of Efficacy|6|||
129171740|NCT02308163|464922086|FG000|Overall Study|Withdrawal of consent|2|||
128779531|NCT04482855|463482435|FG000|Overall Study|Lost to Follow-up|1|||
128779532|NCT04482855|463482436|FG001|Overall Study|Lost to Follow-up|0|||
128779533|NCT04482855|463482435|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
129171741|NCT02308163|464922087|FG001|Overall Study|Withdrawal of consent|3|||
129171742|NCT02308163|464922088|FG002|Overall Study|Withdrawal of consent|0|||
128779534|NCT04482855|463482436|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
128779535|NCT04482855|463482435|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
128779536|NCT04482855|463482436|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
128779537|NCT02753530|463482437|FG000|Overall Study|Adverse Event|7|||
128779538|NCT02753530|463482438|FG001|Overall Study|Adverse Event|1|||
128779539|NCT02753530|463482437|FG000|Overall Study|Death|0|||
128779540|NCT02753530|463482438|FG001|Overall Study|Death|1|||
128779541|NCT02753530|463482437|FG000|Overall Study|Physician Decision|0|||
128779542|NCT02753530|463482438|FG001|Overall Study|Physician Decision|1|||
128779543|NCT02753530|463482437|FG000|Overall Study|Protocol Violation|1|||
128779544|NCT02753530|463482438|FG001|Overall Study|Protocol Violation|0|||
128779545|NCT02753530|463482437|FG000|Overall Study|Withdrawal by Subject|4|||
128779546|NCT02753530|463482438|FG001|Overall Study|Withdrawal by Subject|3|||
128779547|NCT00429793|463482443|FG000|Overall Study|Improper pre-protocol treatment|3|||
128779548|NCT00429793|463482443|FG000|Overall Study|Required test not done|1|||
128779549|NCT00429793|463482443|FG000|Overall Study|Never treated|1|||
128779550|NCT00429793|463482443|FG000|Overall Study|Non-measurable|1|||
128779551|NCT01641861|463482444|FG000|Overall Study|Lost to Follow-up|21|||
128779552|NCT01641861|463482445|FG001|Overall Study|Lost to Follow-up|16|||
128779553|NCT01641861|463482444|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
128779554|NCT01641861|463482445|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
128779555|NCT01641861|463482444|FG000|Overall Study|Died due to drowning|0|||
128779556|NCT01641861|463482445|FG001|Overall Study|Died due to drowning|1|||
128779557|NCT00432159|463484498|FG000|Overall Study|Death|0|||
128779558|NCT00432159|463484499|FG001|Overall Study|Death|1|||
128779559|NCT00432159|463484500|FG002|Overall Study|Death|0|||
128779560|NCT00432159|463484501|FG003|Overall Study|Death|0|||
128779561|NCT00432159|463484502|FG004|Overall Study|Death|0|||
128779562|NCT00432159|463484498|FG000|Overall Study|Failure|9|||
128779563|NCT00432159|463484499|FG001|Overall Study|Failure|5|||
128779564|NCT00432159|463484500|FG002|Overall Study|Failure|3|||
128779565|NCT00432159|463484501|FG003|Overall Study|Failure|2|||
128779566|NCT00432159|463484502|FG004|Overall Study|Failure|3|||
128779567|NCT00432159|463484498|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
128779568|NCT00432159|463484499|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
128779569|NCT00432159|463484500|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
128779570|NCT00432159|463484501|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
128779571|NCT00432159|463484502|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
128779572|NCT01852162|463484503|FG000|Overall Study|Adverse Event|1|||
128779573|NCT01852162|463484504|FG001|Overall Study|Adverse Event|0|||
128779574|NCT01852162|463484503|FG000|Overall Study|Withdrawal by Subject|3|||
128779575|NCT01852162|463484504|FG001|Overall Study|Withdrawal by Subject|1|||
128779576|NCT05305040|463484508|FG000|Overall Study|Not Dosed|37|||
128779577|NCT05305040|463484509|FG001|Overall Study|Not Dosed|37|||
128779578|NCT05305040|463484508|FG000|Overall Study|Study Closure|34|||
128779579|NCT05305040|463484509|FG001|Overall Study|Study Closure|46|||
128779580|NCT05305040|463484508|FG000|Overall Study|Death|14|||
128779581|NCT05305040|463484509|FG001|Overall Study|Death|13|||
128779582|NCT05305040|463484508|FG000|Overall Study|Withdrawal by Subject|15|||
128779583|NCT05305040|463484509|FG001|Overall Study|Withdrawal by Subject|10|||
128779584|NCT05305040|463484508|FG000|Overall Study|Other|13|||
128779585|NCT05305040|463484509|FG001|Overall Study|Other|10|||
128779586|NCT05305040|463484508|FG000|Overall Study|Primary Malignancy Relapse|3|||
128779587|NCT05305040|463484509|FG001|Overall Study|Primary Malignancy Relapse|4|||
128779588|NCT05305040|463484508|FG000|Overall Study|Adverse Event|3|||
128779589|NCT05305040|463484509|FG001|Overall Study|Adverse Event|3|||
128779590|NCT05305040|463484508|FG000|Overall Study|Lost to Follow-up|2|||
128779591|NCT05305040|463484509|FG001|Overall Study|Lost to Follow-up|1|||
128779592|NCT05305040|463484508|FG000|Overall Study|Graft versus host disease|2|||
128779593|NCT05305040|463484509|FG001|Overall Study|Graft versus host disease|0|||
128779594|NCT05305040|463484508|FG000|Overall Study|Investigator's Decision|1|||
128779595|NCT05305040|463484509|FG001|Overall Study|Investigator's Decision|1|||
128779596|NCT05305040|463484508|FG000|Overall Study|COVID-19 Reasons|1|||
128779597|NCT05305040|463484509|FG001|Overall Study|COVID-19 Reasons|0|||
128779598|NCT02123966|463484510|FG000|Overall Study|Intercurrent Illness|1|||
128779599|NCT00465361|463484511|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
128779600|NCT05406791|463484512|FG000|Overall Study|Lost to Follow-up|13|||
128779601|NCT05406791|463484513|FG001|Overall Study|Lost to Follow-up|10|||
128779602|NCT02652130|463484514|FG000|Overall Study|Death|1|||
128779603|NCT00354029|463484515|FG000|Overall Study|Protocol Violation|4|||
128779604|NCT00354029|463484516|FG001|Overall Study|Protocol Violation|2|||
128779605|NCT00826280|463484517|FG000|Overall Study|Randomized but drug not received|1|||
128779606|NCT00826280|463484518|FG001|Overall Study|Randomized but drug not received|0|||
128779607|NCT00826280|463484519|FG002|Overall Study|Randomized but drug not received|1|||
128779608|NCT00826280|463484517|FG000|Overall Study|Adverse Event|1|||
128779609|NCT00826280|463484518|FG001|Overall Study|Adverse Event|3|||
128779610|NCT00826280|463484519|FG002|Overall Study|Adverse Event|0|||
128779611|NCT00826280|463484517|FG000|Overall Study|Lost to Follow-up|0|||
128779612|NCT00826280|463484518|FG001|Overall Study|Lost to Follow-up|1|||
128779613|NCT00826280|463484519|FG002|Overall Study|Lost to Follow-up|0|||
128779614|NCT00826280|463484517|FG000|Overall Study|Sponsor discontinued subject or study|1|||
128779615|NCT00826280|463484518|FG001|Overall Study|Sponsor discontinued subject or study|0|||
128779616|NCT00826280|463484519|FG002|Overall Study|Sponsor discontinued subject or study|0|||
128779617|NCT00826280|463484517|FG000|Overall Study|Reversible ischemic defect not present|43|||
128779618|NCT00826280|463484518|FG001|Overall Study|Reversible ischemic defect not present|40|||
128779619|NCT00826280|463484519|FG002|Overall Study|Reversible ischemic defect not present|44|||
128779620|NCT00826280|463484517|FG000|Overall Study|Interpretation Failure|1|||
128779621|NCT00826280|463484518|FG001|Overall Study|Interpretation Failure|0|||
128779622|NCT00826280|463484519|FG002|Overall Study|Interpretation Failure|0|||
128779623|NCT00826280|463484517|FG000|Overall Study|Machine Failure|1|||
128779624|NCT00826280|463484518|FG001|Overall Study|Machine Failure|1|||
128779625|NCT00826280|463484519|FG002|Overall Study|Machine Failure|0|||
128779626|NCT00826280|463484517|FG000|Overall Study|One or more non-interpretable scan|0|||
128779627|NCT00826280|463484518|FG001|Overall Study|One or more non-interpretable scan|1|||
128779628|NCT00826280|463484519|FG002|Overall Study|One or more non-interpretable scan|1|||
128779629|NCT03201757|463484520|FG000|Overall Study|Withdrawal by Subject|133|||
128779630|NCT03201757|463484520|FG000|Overall Study|Adverse Event|44|||
128779631|NCT03201757|463484520|FG000|Overall Study|Lost to Follow-up|37|||
128779632|NCT03201757|463484520|FG000|Overall Study|Pregnancy|2|||
128779633|NCT03201757|463484520|FG000|Overall Study|Lack of Efficacy|1|||
128779634|NCT03201757|463484520|FG000|Overall Study|Protocol Violation|20|||
128779635|NCT03201757|463484520|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
128779636|NCT03201757|463484520|FG000|Overall Study|Not Yet Determined|5|||
128779637|NCT03201757|463484520|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
128779638|NCT03201757|463484520|FG000|Overall Study|Other|20|||
128779639|NCT02297503|463484521|FG000|Overall Study|Withdrawal by Subject|1|||
128779640|NCT02297503|463484522|FG001|Overall Study|Withdrawal by Subject|1|||
128779641|NCT02297503|463484521|FG000|Overall Study|Protocol Violation|1|||
128779642|NCT02297503|463484522|FG001|Overall Study|Protocol Violation|0|||
128779643|NCT02297503|463484521|FG000|Overall Study|Pregnancy|0|||
128779644|NCT02297503|463484522|FG001|Overall Study|Pregnancy|1|||
129171743|NCT02308163|464922089|FG003|Overall Study|Withdrawal of consent|2|||
129171744|NCT02308163|464922090|FG004|Overall Study|Withdrawal of consent|6|||
129171745|NCT02308163|464922086|FG000|Overall Study|Protocol Violation|3|||
129171746|NCT02308163|464922087|FG001|Overall Study|Protocol Violation|3|||
129171747|NCT02308163|464922088|FG002|Overall Study|Protocol Violation|3|||
129171748|NCT02308163|464922089|FG003|Overall Study|Protocol Violation|2|||
129171749|NCT02308163|464922090|FG004|Overall Study|Protocol Violation|5|||
129171750|NCT02308163|464922086|FG000|Overall Study|Lab data met discontinuation criteria|3|||
129171751|NCT02308163|464922087|FG001|Overall Study|Lab data met discontinuation criteria|0|||
129171752|NCT02308163|464922088|FG002|Overall Study|Lab data met discontinuation criteria|0|||
129171753|NCT02308163|464922089|FG003|Overall Study|Lab data met discontinuation criteria|2|||
129171754|NCT02308163|464922090|FG004|Overall Study|Lab data met discontinuation criteria|0|||
129171755|NCT02308163|464922086|FG000|Overall Study|Miscellaneous|2|||
129171756|NCT02308163|464922087|FG001|Overall Study|Miscellaneous|2|||
129171757|NCT02308163|464922088|FG002|Overall Study|Miscellaneous|1|||
129171758|NCT02308163|464922089|FG003|Overall Study|Miscellaneous|0|||
129171759|NCT02308163|464922090|FG004|Overall Study|Miscellaneous|5|||
129171760|NCT02684058|464922095|FG000|Treatment Period|Progressive disease|4|||
129171761|NCT02684058|464922096|FG001|Treatment Period|Progressive disease|10|||
129171762|NCT02684058|464922097|FG002|Treatment Period|Progressive disease|19|||
129171763|NCT02684058|464922095|FG000|Treatment Period|Adverse Event|3|||
129171764|NCT02684058|464922096|FG001|Treatment Period|Adverse Event|8|||
129171765|NCT02684058|464922097|FG002|Treatment Period|Adverse Event|1|||
129171766|NCT02684058|464922095|FG000|Treatment Period|Physician Decision|5|||
129171767|NCT02684058|464922096|FG001|Treatment Period|Physician Decision|1|||
129171768|NCT02684058|464922097|FG002|Treatment Period|Physician Decision|2|||
129171769|NCT02684058|464922095|FG000|Treatment Period|New therapy for study indication|1|||
129171770|NCT02684058|464922096|FG001|Treatment Period|New therapy for study indication|0|||
129171771|NCT02684058|464922097|FG002|Treatment Period|New therapy for study indication|0|||
128779645|NCT02297503|463484521|FG000|Overall Study|Lost to Follow-up|0|||
128779646|NCT02297503|463484522|FG001|Overall Study|Lost to Follow-up|1|||
128779647|NCT02297503|463484521|FG000|Overall Study|Medical reason|0|||
128779648|NCT02297503|463484522|FG001|Overall Study|Medical reason|1|||
128779649|NCT02263885|463484524|FG000|Overall Study|Withdrawal by Subject|7|||
129171772|NCT02684058|464922095|FG000|Treatment Period|Protocol deviation|0|||
129171773|NCT02684058|464922096|FG001|Treatment Period|Protocol deviation|1|||
129171774|NCT02684058|464922097|FG002|Treatment Period|Protocol deviation|0|||
129171775|NCT02684058|464922095|FG000|Treatment Period|Subject/guardian decision|4|||
129171776|NCT02684058|464922096|FG001|Treatment Period|Subject/guardian decision|3|||
128779650|NCT02263885|463484524|FG000|Overall Study|Alternative Treatment|3|||
128779651|NCT04337489|463484531|FG000|Overall Study|Withdrawal by Subject|1|||
128779652|NCT02412761|463484532|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128779653|NCT02412761|463484533|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
128779654|NCT02412761|463484534|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
128779655|NCT02412761|463484535|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128779656|NCT02412761|463484536|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128779657|NCT02412761|463484537|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
128779658|NCT02240680|463484538|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
128779659|NCT02240680|463484539|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
128779660|NCT02240680|463484540|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
128779661|NCT02240680|463484541|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
128779662|NCT02240680|463484538|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
128779663|NCT02240680|463484539|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
128779664|NCT02240680|463484540|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
128779665|NCT02240680|463484541|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
128779666|NCT02240680|463484538|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
128779667|NCT02240680|463484539|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
128779668|NCT02240680|463484540|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
128779669|NCT02240680|463484541|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
128779670|NCT02240680|463484538|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
129171777|NCT02684058|464922097|FG002|Treatment Period|Subject/guardian decision|0|||
128779671|NCT02240680|463484539|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
128779672|NCT02240680|463484540|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
128779673|NCT02240680|463484541|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
128779674|NCT02240680|463484538|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
128779675|NCT02240680|463484539|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
128779676|NCT02240680|463484540|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
128779677|NCT02240680|463484541|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
128779678|NCT02240680|463484538|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
128779679|NCT02240680|463484539|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
128779680|NCT02240680|463484540|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
128779681|NCT02240680|463484541|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
128779682|NCT02240680|463484538|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
128779683|NCT02240680|463484539|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
128779684|NCT02240680|463484540|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
128779685|NCT02240680|463484541|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
128779686|NCT02240680|463484538|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
128779687|NCT02240680|463484539|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
128779688|NCT02240680|463484540|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
128779689|NCT02240680|463484541|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
128779690|NCT00562965|463484542|FG000|Overall Study|Withdrawal by Subject|0|||
128779691|NCT00562965|463484543|FG001|Overall Study|Withdrawal by Subject|1|||
128779692|NCT00562965|463484542|FG000|Overall Study|Death|2|||
128779693|NCT00562965|463484543|FG001|Overall Study|Death|4|||
128779694|NCT00562965|463484542|FG000|Overall Study|Lost to Follow-up|1|||
128779695|NCT00562965|463484543|FG001|Overall Study|Lost to Follow-up|0|||
128779696|NCT00562965|463484542|FG000|Overall Study|Other|0|||
128779697|NCT00562965|463484543|FG001|Overall Study|Other|1|||
128779698|NCT00965484|463484547|FG000|Overall Study|Protocol Violation|1|||
128779699|NCT00965484|463484547|FG000|Overall Study|Withdrawal by Subject|1|||
128779700|NCT00848211|463484548|FG000|Overall Study|Protocol Violation|0|||
128779701|NCT00848211|463484549|FG001|Overall Study|Protocol Violation|1|||
128779702|NCT00848211|463484550|FG002|Overall Study|Protocol Violation|1|||
128779703|NCT00848211|463484551|FG003|Overall Study|Protocol Violation|0|||
128779704|NCT00848211|463484548|FG000|Overall Study|Adverse Event|0|||
128779705|NCT00848211|463484549|FG001|Overall Study|Adverse Event|0|||
128779706|NCT00848211|463484550|FG002|Overall Study|Adverse Event|0|||
128779707|NCT00848211|463484551|FG003|Overall Study|Adverse Event|0|||
128779708|NCT01124617|463484552|FG000|Overall Study|Adverse Event|5|||
128779709|NCT01124617|463484553|FG001|Overall Study|Adverse Event|2|||
128779710|NCT01124617|463484552|FG000|Overall Study|Lack of Efficacy|2|||
128779711|NCT01124617|463484553|FG001|Overall Study|Lack of Efficacy|1|||
128779712|NCT01124617|463484552|FG000|Overall Study|Protocol Violation|1|||
128779713|NCT01124617|463484553|FG001|Overall Study|Protocol Violation|1|||
128779714|NCT01124617|463484552|FG000|Overall Study|Withdrawal by Subject|9|||
128779715|NCT01124617|463484553|FG001|Overall Study|Withdrawal by Subject|1|||
128779716|NCT01124617|463484552|FG000|Overall Study|Other|2|||
128779717|NCT01124617|463484553|FG001|Overall Study|Other|1|||
128779718|NCT00945477|463484554|FG000|Overall Study|Adverse Event|3|||
128779719|NCT00945477|463484554|FG000|Overall Study|Lack of Efficacy|2|||
128779720|NCT00945477|463484554|FG000|Overall Study|Withdrawal by Subject|1|||
129171778|NCT02684058|464922095|FG000|Treatment Period|Death|0|||
129171779|NCT02684058|464922096|FG001|Treatment Period|Death|0|||
128779721|NCT00619151|463484555|FG000|Overall Study|Study terminated prior to followup|1|||
128779722|NCT00619151|463484556|FG001|Overall Study|Study terminated prior to followup|0|||
128779723|NCT02825043|463484557|FG000|Overall Study|Lost to Follow-up|4|||
128779724|NCT03582137|463484560|FG000|Overall Study|Adverse Event|1|||
128779725|NCT03582137|463484561|FG001|Overall Study|Adverse Event|0|||
128779726|NCT01982760|463484562|FG000|Overall Study|Physician Decision|1|||
128779727|NCT01982760|463484563|FG001|Overall Study|Physician Decision|0|||
128779728|NCT03704298|463484565|FG000|Overall Study|Death|3|||
128779729|NCT03704298|463484566|FG001|Overall Study|Death|1|||
128779730|NCT03704298|463484567|FG002|Overall Study|Death|1|||
128779731|NCT03704298|463484568|FG003|Overall Study|Death|0|||
128779732|NCT03704298|463484565|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
128779733|NCT03704298|463484566|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
128779734|NCT03704298|463484567|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
128779735|NCT03704298|463484568|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
128779736|NCT03704298|463484565|FG000|Overall Study|Withdrawal by Subject|1|||
128779737|NCT03704298|463484566|FG001|Overall Study|Withdrawal by Subject|0|||
128779738|NCT03704298|463484567|FG002|Overall Study|Withdrawal by Subject|0|||
128779739|NCT03704298|463484568|FG003|Overall Study|Withdrawal by Subject|0|||
128779740|NCT03704298|463484565|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
128779741|NCT03704298|463484566|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
128779742|NCT03704298|463484567|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
128779743|NCT03704298|463484568|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
128779744|NCT02303574|463484571|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779745|NCT02303574|463484572|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779746|NCT02303574|463484573|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
128779747|NCT02303574|463484574|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779748|NCT02303574|463484575|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779749|NCT02303574|463484576|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779750|NCT02303574|463484577|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779751|NCT02303574|463484578|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779752|NCT02303574|463484579|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779753|NCT02303574|463484580|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
128779754|NCT02303574|463484571|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779755|NCT02303574|463484572|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779756|NCT02303574|463484573|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779757|NCT02303574|463484574|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779758|NCT02303574|463484575|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779759|NCT02303574|463484576|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779760|NCT02303574|463484577|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779761|NCT02303574|463484578|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
128779762|NCT02303574|463484579|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779763|NCT02303574|463484580|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
128779764|NCT00859014|463484581|FG000|Overall Study|Death|4|||
128779765|NCT00859014|463484581|FG000|Overall Study|Lost to Follow-up|1|||
128779766|NCT04796935|463484582|FG000|Overall Study|Withdrawal by Subject|0|||
128779767|NCT04796935|463484583|FG001|Overall Study|Withdrawal by Subject|1|||
128779768|NCT04796935|463484582|FG000|Overall Study|Physician Decision|0|||
128779769|NCT04796935|463484583|FG001|Overall Study|Physician Decision|1|||
128779770|NCT04796935|463484582|FG000|Overall Study|Device not available|1|||
128779771|NCT04796935|463484583|FG001|Overall Study|Device not available|0|||
128779772|NCT04796935|463484582|FG000|Overall Study|Trained provider not available|1|||
128779773|NCT04796935|463484583|FG001|Overall Study|Trained provider not available|0|||
128779774|NCT00783718|463484584|FG000|Induction Phase|Adverse Event|4|||
128779775|NCT00783718|463484585|FG001|Induction Phase|Adverse Event|0|||
128779776|NCT00783718|463484586|FG002|Induction Phase|Adverse Event|7|||
128779777|NCT00783718|463484587|FG003|Induction Phase|Adverse Event|0|||
128779778|NCT00783718|463484588|FG004|Induction Phase|Adverse Event|0|||
128779779|NCT00783718|463484589|FG005|Induction Phase|Adverse Event|0|||
128779780|NCT00783718|463484590|FG006|Induction Phase|Adverse Event|0|||
128779781|NCT00783718|463484584|FG000|Induction Phase|Protocol Violation|1|||
128779782|NCT00783718|463484585|FG001|Induction Phase|Protocol Violation|1|||
128779783|NCT00783718|463484586|FG002|Induction Phase|Protocol Violation|6|||
128779784|NCT00783718|463484587|FG003|Induction Phase|Protocol Violation|0|||
128779785|NCT00783718|463484588|FG004|Induction Phase|Protocol Violation|0|||
128779786|NCT00783718|463484589|FG005|Induction Phase|Protocol Violation|0|||
128779787|NCT00783718|463484590|FG006|Induction Phase|Protocol Violation|0|||
128779788|NCT00783718|463484584|FG000|Induction Phase|Lack of Efficacy|5|||
128779789|NCT00783718|463484585|FG001|Induction Phase|Lack of Efficacy|2|||
129171780|NCT02684058|464922097|FG002|Treatment Period|Death|2|||
129171781|NCT02684058|464922095|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
128779790|NCT00783718|463484586|FG002|Induction Phase|Lack of Efficacy|14|||
129171782|NCT02684058|464922096|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129171783|NCT02684058|464922097|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129171784|NCT02684058|464922095|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
129171785|NCT02684058|464922096|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129171786|NCT02684058|464922097|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
129171787|NCT02684058|464922095|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129171788|NCT02684058|464922096|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129171789|NCT02684058|464922097|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129171790|NCT02684058|464922095|FG000|Post-treatment Efficacy Follow-up|Death|0|||
129171791|NCT02684058|464922096|FG001|Post-treatment Efficacy Follow-up|Death|0|||
129171792|NCT02684058|464922097|FG002|Post-treatment Efficacy Follow-up|Death|3|||
129171793|NCT02684058|464922095|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
129171794|NCT02684058|464922096|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
129171795|NCT02684058|464922097|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
129171796|NCT02684058|464922095|FG000|Post-treatment Survival Follow-up|Death|0|||
129171797|NCT02684058|464922096|FG001|Post-treatment Survival Follow-up|Death|0|||
129171798|NCT02684058|464922097|FG002|Post-treatment Survival Follow-up|Death|7|||
129171799|NCT02684058|464922095|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
129171800|NCT02684058|464922096|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
129171801|NCT02684058|464922097|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
129171802|NCT02684058|464922095|FG000|Crossover Treatment Period|Progressive disease|0|||
129171803|NCT02684058|464922096|FG001|Crossover Treatment Period|Progressive disease|1|||
129171804|NCT02684058|464922097|FG002|Crossover Treatment Period|Progressive disease|0|||
129171805|NCT01330628|464922102|FG000|Overall Study|Death|2|||
129171806|NCT01330628|464922103|FG001|Overall Study|Death|3|||
129171807|NCT01330628|464922102|FG000|Overall Study|Lost to Follow-up|5|||
129171808|NCT01330628|464922103|FG001|Overall Study|Lost to Follow-up|6|||
129171809|NCT01330628|464922102|FG000|Overall Study|Adverse Event|44|||
129171810|NCT01330628|464922103|FG001|Overall Study|Adverse Event|25|||
129171811|NCT01330628|464922102|FG000|Overall Study|Withdrawn|18|||
129171812|NCT01330628|464922103|FG001|Overall Study|Withdrawn|6|||
129171813|NCT01330628|464922102|FG000|Overall Study|Didn't receive study treatment|1|||
129171814|NCT01330628|464922103|FG001|Overall Study|Didn't receive study treatment|0|||
129171815|NCT01730339|464923630|FG000|Overall Study|Withdrawal by Subject|3|||
129171816|NCT01730339|464923631|FG001|Overall Study|Withdrawal by Subject|2|||
129171817|NCT01730339|464923630|FG000|Overall Study|Lost to Follow-up|1|||
129171818|NCT01730339|464923631|FG001|Overall Study|Lost to Follow-up|1|||
129171819|NCT01730339|464923630|FG000|Overall Study|Un-specified|1|||
129171820|NCT01730339|464923631|FG001|Overall Study|Un-specified|0|||
129171821|NCT03095027|464923632|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
129171822|NCT03095027|464923633|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
129171823|NCT04143217|464923634|FG000|Overall Study|Withdrawal by Subject|42|||
129171824|NCT04143217|464923634|FG000|Overall Study|Adverse Event|29|||
129171825|NCT04143217|464923634|FG000|Overall Study|Lost to Follow-up|29|||
129171826|NCT04143217|464923634|FG000|Overall Study|Lack of Efficacy|15|||
129171827|NCT04143217|464923634|FG000|Overall Study|Physician Decision|1|||
129171828|NCT04143217|464923634|FG000|Overall Study|Non-Compliance With Study Drug|6|||
129171829|NCT04143217|464923634|FG000|Overall Study|Other, Multiple Categories|11|||
129171830|NCT02264665|464923637|FG000|Overall Study|Other|0|||
129171831|NCT02264665|464923638|FG001|Overall Study|Other|0|||
128729418|NCT01403974|463306638|FG004|Overall Study|Progressive disease according to RECIST|3|||
128729419|NCT01403974|463306639|FG005|Overall Study|Progressive disease according to RECIST|2|||
128729420|NCT01403974|463306640|FG006|Overall Study|Progressive disease according to RECIST|3|||
128729421|NCT01403974|463306641|FG007|Overall Study|Progressive disease according to RECIST|2|||
128729422|NCT01403974|463306642|FG008|Overall Study|Progressive disease according to RECIST|6|||
128729423|NCT01403974|463306643|FG009|Overall Study|Progressive disease according to RECIST|2|||
128729424|NCT01403974|463306644|FG010|Overall Study|Progressive disease according to RECIST|3|||
128729425|NCT01403974|463306645|FG011|Overall Study|Progressive disease according to RECIST|2|||
128729426|NCT01403974|463306646|FG012|Overall Study|Progressive disease according to RECIST|2|||
128729427|NCT01403974|463306647|FG013|Overall Study|Progressive disease according to RECIST|3|||
128729428|NCT01403974|463306648|FG014|Overall Study|Progressive disease according to RECIST|1|||
128729429|NCT01403974|463306649|FG015|Overall Study|Progressive disease according to RECIST|8|||
128729430|NCT01403974|463306634|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
128729431|NCT01403974|463306635|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
128729432|NCT01403974|463306636|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
128729433|NCT01403974|463306637|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
128729434|NCT01403974|463306638|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
128729435|NCT01403974|463306639|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
128729436|NCT01403974|463306640|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
128729437|NCT01403974|463306641|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
128729438|NCT01403974|463306642|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
128779791|NCT00783718|463484587|FG003|Induction Phase|Lack of Efficacy|0|||
128779792|NCT00783718|463484588|FG004|Induction Phase|Lack of Efficacy|0|||
128779793|NCT00783718|463484589|FG005|Induction Phase|Lack of Efficacy|0|||
128779794|NCT00783718|463484590|FG006|Induction Phase|Lack of Efficacy|0|||
128779795|NCT00783718|463484584|FG000|Induction Phase|Withdrawal by Subject|3|||
128779796|NCT00783718|463484585|FG001|Induction Phase|Withdrawal by Subject|4|||
128779797|NCT00783718|463484586|FG002|Induction Phase|Withdrawal by Subject|8|||
128779798|NCT00783718|463484587|FG003|Induction Phase|Withdrawal by Subject|0|||
128779799|NCT00783718|463484588|FG004|Induction Phase|Withdrawal by Subject|0|||
128779800|NCT00783718|463484589|FG005|Induction Phase|Withdrawal by Subject|0|||
128779801|NCT00783718|463484590|FG006|Induction Phase|Withdrawal by Subject|0|||
128779802|NCT00783718|463484584|FG000|Induction Phase|Lost to Follow-up|1|||
128779803|NCT00783718|463484585|FG001|Induction Phase|Lost to Follow-up|0|||
128779804|NCT00783718|463484586|FG002|Induction Phase|Lost to Follow-up|1|||
128779805|NCT00783718|463484587|FG003|Induction Phase|Lost to Follow-up|0|||
128779806|NCT00783718|463484588|FG004|Induction Phase|Lost to Follow-up|0|||
128779807|NCT00783718|463484589|FG005|Induction Phase|Lost to Follow-up|0|||
128779808|NCT00783718|463484590|FG006|Induction Phase|Lost to Follow-up|0|||
129171832|NCT02264665|464923639|FG002|Overall Study|Other|3|||
129171833|NCT02264665|464923640|FG003|Overall Study|Other|0|||
128729439|NCT01403974|463306643|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
128729440|NCT01403974|463306644|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
128729441|NCT01403974|463306645|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
128729442|NCT01403974|463306646|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
128729443|NCT01403974|463306647|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
128729444|NCT01403974|463306648|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
128729445|NCT01403974|463306649|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
128729446|NCT01403974|463306634|FG000|Overall Study|Refused to continue study medication|0|||
128729447|NCT01403974|463306635|FG001|Overall Study|Refused to continue study medication|0|||
128729448|NCT01403974|463306636|FG002|Overall Study|Refused to continue study medication|0|||
128729449|NCT01403974|463306637|FG003|Overall Study|Refused to continue study medication|0|||
129171834|NCT02264665|464923641|FG004|Overall Study|Other|0|||
129171835|NCT02264665|464923642|FG005|Overall Study|Other|0|||
129171836|NCT02264665|464923643|FG006|Overall Study|Other|0|||
129171837|NCT02264665|464923637|FG000|Overall Study|Death|9|||
129171838|NCT02264665|464923638|FG001|Overall Study|Death|8|||
129171839|NCT02264665|464923639|FG002|Overall Study|Death|13|||
129171840|NCT02264665|464923640|FG003|Overall Study|Death|5|||
128729450|NCT01403974|463306638|FG004|Overall Study|Refused to continue study medication|0|||
128729451|NCT01403974|463306639|FG005|Overall Study|Refused to continue study medication|1|||
128729452|NCT01403974|463306640|FG006|Overall Study|Refused to continue study medication|0|||
128729453|NCT01403974|463306641|FG007|Overall Study|Refused to continue study medication|0|||
128729454|NCT01403974|463306642|FG008|Overall Study|Refused to continue study medication|1|||
128729455|NCT01403974|463306643|FG009|Overall Study|Refused to continue study medication|0|||
128729456|NCT01403974|463306644|FG010|Overall Study|Refused to continue study medication|1|||
128729457|NCT01403974|463306645|FG011|Overall Study|Refused to continue study medication|0|||
128729458|NCT01403974|463306646|FG012|Overall Study|Refused to continue study medication|0|||
128729459|NCT01403974|463306647|FG013|Overall Study|Refused to continue study medication|0|||
128729460|NCT01403974|463306648|FG014|Overall Study|Refused to continue study medication|0|||
128729461|NCT01403974|463306649|FG015|Overall Study|Refused to continue study medication|4|||
128729462|NCT01403974|463306634|FG000|Overall Study|Adverse Event|0|||
128729463|NCT01403974|463306635|FG001|Overall Study|Adverse Event|0|||
128729464|NCT01403974|463306636|FG002|Overall Study|Adverse Event|1|||
128729465|NCT01403974|463306637|FG003|Overall Study|Adverse Event|0|||
129171841|NCT02264665|464923641|FG004|Overall Study|Death|0|||
129171842|NCT02264665|464923642|FG005|Overall Study|Death|0|||
129171843|NCT02264665|464923643|FG006|Overall Study|Death|1|||
129171844|NCT02264665|464923637|FG000|Overall Study|Lost to Follow-up|1|||
129171845|NCT02264665|464923638|FG001|Overall Study|Lost to Follow-up|0|||
129171846|NCT02264665|464923639|FG002|Overall Study|Lost to Follow-up|2|||
129171847|NCT02264665|464923640|FG003|Overall Study|Lost to Follow-up|1|||
129171848|NCT02264665|464923641|FG004|Overall Study|Lost to Follow-up|0|||
128729466|NCT01403974|463306638|FG004|Overall Study|Adverse Event|0|||
128729467|NCT01403974|463306639|FG005|Overall Study|Adverse Event|0|||
128729468|NCT01403974|463306640|FG006|Overall Study|Adverse Event|0|||
128779809|NCT00783718|463484584|FG000|Maintenance Phase|Adverse Event|12|||
128779810|NCT00783718|463484585|FG001|Maintenance Phase|Adverse Event|0|||
128779811|NCT00783718|463484586|FG002|Maintenance Phase|Adverse Event|0|||
129171849|NCT02264665|464923642|FG005|Overall Study|Lost to Follow-up|0|||
129171850|NCT02264665|464923643|FG006|Overall Study|Lost to Follow-up|0|||
129171851|NCT02264665|464923637|FG000|Overall Study|Participant decision|0|||
128729469|NCT01403974|463306641|FG007|Overall Study|Adverse Event|1|||
128729470|NCT01403974|463306642|FG008|Overall Study|Adverse Event|0|||
128779812|NCT00783718|463484587|FG003|Maintenance Phase|Adverse Event|15|||
128779813|NCT00783718|463484588|FG004|Maintenance Phase|Adverse Event|7|||
129171852|NCT02264665|464923638|FG001|Overall Study|Participant decision|0|||
128779814|NCT00783718|463484589|FG005|Maintenance Phase|Adverse Event|6|||
128779815|NCT00783718|463484590|FG006|Maintenance Phase|Adverse Event|16|||
128779816|NCT00783718|463484584|FG000|Maintenance Phase|Protocol Violation|1|||
128779817|NCT00783718|463484585|FG001|Maintenance Phase|Protocol Violation|0|||
128779818|NCT00783718|463484586|FG002|Maintenance Phase|Protocol Violation|0|||
128779819|NCT00783718|463484587|FG003|Maintenance Phase|Protocol Violation|0|||
128779820|NCT00783718|463484588|FG004|Maintenance Phase|Protocol Violation|0|||
128779821|NCT00783718|463484589|FG005|Maintenance Phase|Protocol Violation|0|||
128779822|NCT00783718|463484590|FG006|Maintenance Phase|Protocol Violation|2|||
128779823|NCT00783718|463484584|FG000|Maintenance Phase|Lack of Efficacy|83|||
128779824|NCT00783718|463484585|FG001|Maintenance Phase|Lack of Efficacy|0|||
128779825|NCT00783718|463484586|FG002|Maintenance Phase|Lack of Efficacy|0|||
129171853|NCT02264665|464923639|FG002|Overall Study|Participant decision|0|||
129171854|NCT02264665|464923640|FG003|Overall Study|Participant decision|1|||
129171855|NCT02264665|464923641|FG004|Overall Study|Participant decision|0|||
129171856|NCT02264665|464923642|FG005|Overall Study|Participant decision|0|||
129171857|NCT02264665|464923643|FG006|Overall Study|Participant decision|0|||
129171858|NCT02264665|464923637|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
129171859|NCT02264665|464923638|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
129171860|NCT02264665|464923639|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
129171861|NCT02264665|464923640|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
129171862|NCT02264665|464923641|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
129171863|NCT02264665|464923642|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
129171864|NCT02264665|464923643|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
129171865|NCT02264665|464923637|FG000|Overall Study|Data Missing|0|||
129171866|NCT02264665|464923638|FG001|Overall Study|Data Missing|0|||
129171867|NCT02264665|464923639|FG002|Overall Study|Data Missing|1|||
129171868|NCT02264665|464923640|FG003|Overall Study|Data Missing|0|||
129171869|NCT02264665|464923641|FG004|Overall Study|Data Missing|0|||
129171870|NCT02264665|464923642|FG005|Overall Study|Data Missing|0|||
129171871|NCT02264665|464923643|FG006|Overall Study|Data Missing|0|||
129171872|NCT01962987|464923644|FG000|Overall Study|Adverse Event|4|||
129171873|NCT01962987|464923645|FG001|Overall Study|Adverse Event|4|||
129171874|NCT01962987|464923646|FG002|Overall Study|Adverse Event|0|||
129171875|NCT01962987|464923644|FG000|Overall Study|Lost to Follow-up|0|||
129171876|NCT01962987|464923645|FG001|Overall Study|Lost to Follow-up|0|||
129171877|NCT01962987|464923646|FG002|Overall Study|Lost to Follow-up|1|||
129171878|NCT01962987|464923644|FG000|Overall Study|Non compliance with dosing requirements|4|||
129171879|NCT01962987|464923645|FG001|Overall Study|Non compliance with dosing requirements|2|||
129171880|NCT01962987|464923646|FG002|Overall Study|Non compliance with dosing requirements|0|||
129171881|NCT01962987|464923644|FG000|Overall Study|Miscellaneous|1|||
129171882|NCT01962987|464923645|FG001|Overall Study|Miscellaneous|9|||
129171883|NCT01962987|464923646|FG002|Overall Study|Miscellaneous|2|||
129171884|NCT01962987|464923644|FG000|Overall Study|Restricted medication|5|||
129171885|NCT01962987|464923645|FG001|Overall Study|Restricted medication|1|||
129171886|NCT01962987|464923646|FG002|Overall Study|Restricted medication|1|||
129171887|NCT01962987|464923644|FG000|Overall Study|Serious Adverse Event|1|||
129171888|NCT01962987|464923645|FG001|Overall Study|Serious Adverse Event|0|||
129171889|NCT01962987|464923646|FG002|Overall Study|Serious Adverse Event|0|||
129171890|NCT01962987|464923644|FG000|Overall Study|Withdrawal by Subject|11|||
129171891|NCT01962987|464923645|FG001|Overall Study|Withdrawal by Subject|10|||
129171892|NCT01962987|464923646|FG002|Overall Study|Withdrawal by Subject|6|||
129171893|NCT01962987|464923644|FG000|Overall Study|Randomized in Error|4|||
129171894|NCT01962987|464923645|FG001|Overall Study|Randomized in Error|2|||
129171895|NCT01962987|464923646|FG002|Overall Study|Randomized in Error|2|||
129171896|NCT00585546|464923647|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
129171897|NCT00585546|464923647|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
129171898|NCT00113399|464923656|FG000|Overall Study|Death|1|||
129171899|NCT00113399|464923657|FG001|Overall Study|Death|1|||
129171900|NCT00113399|464923656|FG000|Overall Study|Withdrawal by Subject|1|||
129171901|NCT00113399|464923657|FG001|Overall Study|Withdrawal by Subject|2|||
129171902|NCT00113399|464923656|FG000|Overall Study|Complete Response|0|||
129171903|NCT00113399|464923657|FG001|Overall Study|Complete Response|1|||
129171904|NCT00113399|464923656|FG000|Overall Study|Other|0|||
129171905|NCT00113399|464923657|FG001|Overall Study|Other|1|||
129171906|NCT01779856|464923659|FG000|Overall Study|Withdrawal by Subject|15|||
129171907|NCT01779856|464923659|FG000|Overall Study|Death|3|||
129171908|NCT01779856|464923659|FG000|Overall Study|Physician Decision|1|||
129171909|NCT01779856|464923659|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
128779826|NCT00783718|463484587|FG003|Maintenance Phase|Lack of Efficacy|61|||
128779827|NCT00783718|463484588|FG004|Maintenance Phase|Lack of Efficacy|31|||
128779828|NCT00783718|463484589|FG005|Maintenance Phase|Lack of Efficacy|33|||
128779829|NCT00783718|463484590|FG006|Maintenance Phase|Lack of Efficacy|155|||
128779830|NCT00783718|463484584|FG000|Maintenance Phase|Withdrawal by Subject|6|||
128779831|NCT00783718|463484585|FG001|Maintenance Phase|Withdrawal by Subject|0|||
128779832|NCT00783718|463484586|FG002|Maintenance Phase|Withdrawal by Subject|0|||
128779833|NCT00783718|463484587|FG003|Maintenance Phase|Withdrawal by Subject|2|||
128779834|NCT00783718|463484588|FG004|Maintenance Phase|Withdrawal by Subject|5|||
128779835|NCT00783718|463484589|FG005|Maintenance Phase|Withdrawal by Subject|2|||
128779836|NCT00783718|463484590|FG006|Maintenance Phase|Withdrawal by Subject|20|||
128779837|NCT00783718|463484584|FG000|Maintenance Phase|Lost to Follow-up|3|||
128779838|NCT00783718|463484585|FG001|Maintenance Phase|Lost to Follow-up|0|||
128779839|NCT00783718|463484586|FG002|Maintenance Phase|Lost to Follow-up|0|||
128779840|NCT00783718|463484587|FG003|Maintenance Phase|Lost to Follow-up|0|||
128779841|NCT00783718|463484588|FG004|Maintenance Phase|Lost to Follow-up|2|||
128779842|NCT00783718|463484589|FG005|Maintenance Phase|Lost to Follow-up|0|||
128779843|NCT00783718|463484590|FG006|Maintenance Phase|Lost to Follow-up|2|||
128779844|NCT01027871|463484592|FG000|Overall Study|Physician Decision|1|||
128779845|NCT01027871|463484593|FG001|Overall Study|Physician Decision|5|||
128779846|NCT01027871|463484594|FG002|Overall Study|Physician Decision|0|||
128779847|NCT01027871|463484592|FG000|Overall Study|Protocol Violation|0|||
128779848|NCT01027871|463484593|FG001|Overall Study|Protocol Violation|2|||
128779849|NCT01027871|463484594|FG002|Overall Study|Protocol Violation|2|||
128779850|NCT01027871|463484592|FG000|Overall Study|Withdrawal by Subject|1|||
128779851|NCT01027871|463484593|FG001|Overall Study|Withdrawal by Subject|2|||
128779852|NCT01027871|463484594|FG002|Overall Study|Withdrawal by Subject|2|||
128779853|NCT01027871|463484592|FG000|Overall Study|Adverse Event|0|||
128779854|NCT01027871|463484593|FG001|Overall Study|Adverse Event|2|||
128779855|NCT01027871|463484594|FG002|Overall Study|Adverse Event|2|||
128779856|NCT01027871|463484592|FG000|Overall Study|Sponsor Decision|0|||
128779857|NCT01027871|463484593|FG001|Overall Study|Sponsor Decision|2|||
128779858|NCT01027871|463484594|FG002|Overall Study|Sponsor Decision|0|||
128779859|NCT01027871|463484592|FG000|Overall Study|Discontinued Prior to Treatment|0|||
128779860|NCT01027871|463484593|FG001|Overall Study|Discontinued Prior to Treatment|0|||
128779861|NCT01027871|463484594|FG002|Overall Study|Discontinued Prior to Treatment|1|||
128779862|NCT04159896|463484600|FG000|Overall Study|Lack of Efficacy|7|||
128779863|NCT04159896|463484600|FG000|Overall Study|Withdrawal by Subject|1|||
128779864|NCT04159896|463484600|FG000|Overall Study|Adverse Event|1|||
128779865|NCT04159896|463484600|FG000|Overall Study|A transient ischaemic attack|1|||
128779866|NCT05705167|463484601|FG000|Overall Study|Randomised but not Treated|0|||
128779867|NCT05705167|463484602|FG001|Overall Study|Randomised but not Treated|2|||
128779868|NCT05705167|463484603|FG002|Overall Study|Randomised but not Treated|0|||
128779869|NCT05705167|463484604|FG003|Overall Study|Randomised but not Treated|7|||
128779870|NCT05705167|463484605|FG004|Overall Study|Randomised but not Treated|0|||
128779871|NCT05705167|463484606|FG005|Overall Study|Randomised but not Treated|0|||
128779872|NCT05705167|463484607|FG006|Overall Study|Randomised but not Treated|0|||
128779873|NCT05705167|463484601|FG000|Overall Study|Death|0|||
128779874|NCT05705167|463484602|FG001|Overall Study|Death|0|||
128779875|NCT05705167|463484603|FG002|Overall Study|Death|3|||
128779876|NCT05705167|463484604|FG003|Overall Study|Death|0|||
128779877|NCT05705167|463484605|FG004|Overall Study|Death|1|||
128779878|NCT05705167|463484606|FG005|Overall Study|Death|1|||
128779879|NCT05705167|463484607|FG006|Overall Study|Death|1|||
128779880|NCT05705167|463484601|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
128779881|NCT05705167|463484602|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
128779882|NCT05705167|463484603|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
128779883|NCT05705167|463484604|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
128779884|NCT05705167|463484605|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
128779885|NCT05705167|463484606|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
128779886|NCT05705167|463484607|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
128779887|NCT02099539|463484608|FG000|Overall Study|Progressive Disease|3|||
128779888|NCT02099539|463484609|FG001|Overall Study|Progressive Disease|2|||
128779889|NCT02099539|463484610|FG002|Overall Study|Progressive Disease|2|||
128779890|NCT02099539|463484611|FG003|Overall Study|Progressive Disease|1|||
128779891|NCT02099539|463484612|FG004|Overall Study|Progressive Disease|4|||
128779892|NCT02099539|463484613|FG005|Overall Study|Progressive Disease|2|||
128779893|NCT02099539|463484614|FG006|Overall Study|Progressive Disease|0|||
128779894|NCT02099539|463484608|FG000|Overall Study|Adverse Event|0|||
129171910|NCT01779856|464923659|FG000|Overall Study|Delays in scheduling implant|1|||
129171911|NCT01779856|464923659|FG000|Overall Study|Subject ineligible for Implant|2|||
129171912|NCT01535599|464923661|FG000|Overall Study|Adverse Event|6|||
128779895|NCT02099539|463484609|FG001|Overall Study|Adverse Event|0|||
128779896|NCT02099539|463484610|FG002|Overall Study|Adverse Event|1|||
128779897|NCT02099539|463484611|FG003|Overall Study|Adverse Event|1|||
128779898|NCT02099539|463484612|FG004|Overall Study|Adverse Event|0|||
128779899|NCT02099539|463484613|FG005|Overall Study|Adverse Event|0|||
128779900|NCT02099539|463484614|FG006|Overall Study|Adverse Event|0|||
128779901|NCT02099539|463484608|FG000|Overall Study|Physician Decision|0|||
129171913|NCT01535599|464923662|FG001|Overall Study|Adverse Event|15|||
128729471|NCT01403974|463306643|FG009|Overall Study|Adverse Event|0|||
128729472|NCT01403974|463306644|FG010|Overall Study|Adverse Event|0|||
128729473|NCT01403974|463306645|FG011|Overall Study|Adverse Event|0|||
128729474|NCT01403974|463306646|FG012|Overall Study|Adverse Event|1|||
128729475|NCT01403974|463306647|FG013|Overall Study|Adverse Event|0|||
128729476|NCT01403974|463306648|FG014|Overall Study|Adverse Event|0|||
128729477|NCT01403974|463306649|FG015|Overall Study|Adverse Event|0|||
128729478|NCT01403974|463306634|FG000|Overall Study|Other than specified|0|||
128729479|NCT01403974|463306635|FG001|Overall Study|Other than specified|0|||
128729480|NCT01403974|463306636|FG002|Overall Study|Other than specified|0|||
128729481|NCT01403974|463306637|FG003|Overall Study|Other than specified|0|||
128729482|NCT01403974|463306638|FG004|Overall Study|Other than specified|0|||
128729483|NCT01403974|463306639|FG005|Overall Study|Other than specified|0|||
128729484|NCT01403974|463306640|FG006|Overall Study|Other than specified|0|||
128729485|NCT01403974|463306641|FG007|Overall Study|Other than specified|0|||
128729486|NCT01403974|463306642|FG008|Overall Study|Other than specified|0|||
128729487|NCT01403974|463306643|FG009|Overall Study|Other than specified|1|||
128729488|NCT01403974|463306644|FG010|Overall Study|Other than specified|0|||
128729489|NCT01403974|463306645|FG011|Overall Study|Other than specified|1|||
128729490|NCT01403974|463306646|FG012|Overall Study|Other than specified|0|||
128729491|NCT01403974|463306647|FG013|Overall Study|Other than specified|0|||
128729492|NCT01403974|463306648|FG014|Overall Study|Other than specified|0|||
128729493|NCT01403974|463306649|FG015|Overall Study|Other than specified|0|||
128729494|NCT01526889|463306650|FG000|Treatment Period|Adverse Event|2|||
128729495|NCT01526889|463306651|FG001|Treatment Period|Adverse Event|0|||
128729496|NCT01526889|463306650|FG000|Treatment Extension Period|Administrative problems|1|||
128729497|NCT01526889|463306651|FG001|Treatment Extension Period|Administrative problems|0|||
128729498|NCT00974571|463306654|FG000|Overall Study|Adverse Event|31|||
128729499|NCT00974571|463306655|FG001|Overall Study|Adverse Event|4|||
128729500|NCT00974571|463306656|FG002|Overall Study|Adverse Event|27|||
128729501|NCT00974571|463306654|FG000|Overall Study|Lack of Efficacy|3|||
128729502|NCT00974571|463306655|FG001|Overall Study|Lack of Efficacy|2|||
128729503|NCT00974571|463306656|FG002|Overall Study|Lack of Efficacy|9|||
128729504|NCT00974571|463306654|FG000|Overall Study|Lost to Follow-up|2|||
128729505|NCT00974571|463306655|FG001|Overall Study|Lost to Follow-up|1|||
128729506|NCT00974571|463306656|FG002|Overall Study|Lost to Follow-up|2|||
128729507|NCT00974571|463306654|FG000|Overall Study|Protocol Violation|13|||
128729508|NCT00974571|463306655|FG001|Overall Study|Protocol Violation|4|||
128729509|NCT00974571|463306656|FG002|Overall Study|Protocol Violation|18|||
128729510|NCT00974571|463306654|FG000|Overall Study|Withdrawal by Subject|14|||
128729511|NCT00974571|463306655|FG001|Overall Study|Withdrawal by Subject|5|||
128729512|NCT00974571|463306656|FG002|Overall Study|Withdrawal by Subject|16|||
128729513|NCT00974571|463306654|FG000|Overall Study|Patient Moved|1|||
128729514|NCT00974571|463306655|FG001|Overall Study|Patient Moved|0|||
128729515|NCT00974571|463306656|FG002|Overall Study|Patient Moved|1|||
128729516|NCT00974571|463306654|FG000|Overall Study|Other|4|||
128729517|NCT00974571|463306655|FG001|Overall Study|Other|0|||
128729518|NCT00974571|463306656|FG002|Overall Study|Other|10|||
128729519|NCT01494610|463306673|FG000|Period 1|Withdrawal by Subject|1|||
128729520|NCT01494610|463306674|FG001|Period 1|Withdrawal by Subject|1|||
128729521|NCT01494610|463306673|FG000|Period 3|Adverse Event|1|||
128729522|NCT01494610|463306674|FG001|Period 3|Adverse Event|0|||
128729523|NCT01494610|463306673|FG000|Period 3|Withdrawal by Subject|1|||
128729524|NCT01494610|463306674|FG001|Period 3|Withdrawal by Subject|0|||
128729525|NCT01494610|463306673|FG000|Period 4|Protocol Violation|1|||
128729526|NCT01494610|463306674|FG001|Period 4|Protocol Violation|0|||
128729527|NCT04334460|463306675|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
128729528|NCT04334460|463306676|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
128729529|NCT04334460|463306675|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
128729530|NCT04334460|463306676|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
128729531|NCT00547703|463306679|FG000|Overall Study|Lost to Follow-up|1|||
128729532|NCT00547703|463306680|FG001|Overall Study|Lost to Follow-up|0|||
128729533|NCT03995953|463306683|FG000|Overall Study|Death|3|||
128729534|NCT03995953|463306684|FG001|Overall Study|Death|0|||
128729535|NCT03995953|463306685|FG002|Overall Study|Death|3|||
128729536|NCT03995953|463306686|FG003|Overall Study|Death|0|||
128729537|NCT03995953|463306687|FG004|Overall Study|Death|3|||
128729538|NCT03995953|463306688|FG005|Overall Study|Death|0|||
128729539|NCT03995953|463306689|FG006|Overall Study|Death|0|||
128729540|NCT03995953|463306690|FG007|Overall Study|Death|0|||
128729541|NCT03995953|463306691|FG008|Overall Study|Death|1|||
128729542|NCT03995953|463306692|FG009|Overall Study|Death|0|||
128729543|NCT03995953|463306693|FG010|Overall Study|Death|0|||
128729544|NCT03995953|463306694|FG011|Overall Study|Death|0|||
128729545|NCT03995953|463306683|FG000|Overall Study|Lost to Follow-up|6|||
129171914|NCT01535599|464923661|FG000|Overall Study|Lost to Follow-up|3|||
129171915|NCT01535599|464923662|FG001|Overall Study|Lost to Follow-up|4|||
129171916|NCT01535599|464923661|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
129171917|NCT01535599|464923662|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
129171918|NCT01535599|464923661|FG000|Overall Study|Treatment Failure|33|||
129171919|NCT01535599|464923662|FG001|Overall Study|Treatment Failure|66|||
129171920|NCT01535599|464923661|FG000|Overall Study|BL Culture + for Group A Strep|0|||
129171921|NCT01535599|464923662|FG001|Overall Study|BL Culture + for Group A Strep|1|||
129171922|NCT01535599|464923661|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
129171923|NCT01535599|464923662|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
129171924|NCT01535599|464923661|FG000|Overall Study|Randomized in Error|2|||
129171925|NCT01535599|464923662|FG001|Overall Study|Randomized in Error|4|||
129171926|NCT01535599|464923661|FG000|Overall Study|Did not use product|1|||
129171927|NCT01535599|464923662|FG001|Overall Study|Did not use product|0|||
129171928|NCT01535599|464923661|FG000|Overall Study|Other|1|||
129171929|NCT01535599|464923662|FG001|Overall Study|Other|0|||
129171930|NCT01535599|464923661|FG000|Overall Study|Stopped medication|0|||
129171931|NCT01535599|464923662|FG001|Overall Study|Stopped medication|1|||
129171932|NCT01535599|464923661|FG000|Overall Study|Noncompliance|0|||
129171933|NCT01535599|464923662|FG001|Overall Study|Noncompliance|1|||
129171934|NCT04043234|464923663|FG000|Overall Study|Lost to Follow-up|1|||
129171935|NCT04043234|464923663|FG000|Overall Study|Withdrawal by Subject|1|||
129171936|NCT01165320|464923664|FG000|Overall Study|Clinical adverse experience|2|||
129171937|NCT01165320|464923665|FG001|Overall Study|Clinical adverse experience|1|||
129171938|NCT01165320|464923666|FG002|Overall Study|Clinical adverse experience|0|||
129171939|NCT01165320|464923664|FG000|Overall Study|Laboratory adverse experience|1|||
129171940|NCT01165320|464923665|FG001|Overall Study|Laboratory adverse experience|0|||
129171941|NCT01165320|464923666|FG002|Overall Study|Laboratory adverse experience|0|||
129171942|NCT01165320|464923664|FG000|Overall Study|Lack of Efficacy|0|||
129171943|NCT01165320|464923665|FG001|Overall Study|Lack of Efficacy|2|||
129171944|NCT01165320|464923666|FG002|Overall Study|Lack of Efficacy|0|||
129171945|NCT01165320|464923664|FG000|Overall Study|Reason unknown|0|||
129171946|NCT01165320|464923665|FG001|Overall Study|Reason unknown|1|||
129171947|NCT01165320|464923666|FG002|Overall Study|Reason unknown|0|||
129171948|NCT00385944|464923667|FG000|1st Maintenance Dose Period|Physician Decision|1|||
129171949|NCT00385944|464923668|FG001|1st Maintenance Dose Period|Physician Decision|0|||
129171950|NCT00385944|464923669|FG002|1st Maintenance Dose Period|Physician Decision|0|||
129171951|NCT00385944|464923667|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
129171952|NCT00385944|464923668|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
129171953|NCT00385944|464923669|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
129171954|NCT00385944|464923667|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
129171955|NCT00385944|464923668|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
129171956|NCT00385944|464923669|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
129171957|NCT00385944|464923667|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
129171958|NCT00385944|464923668|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
129171959|NCT00385944|464923669|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
129171960|NCT00590824|464923673|FG000|Overall Study|Disease could not be resected|0|||
129171961|NCT00590824|464923674|FG001|Overall Study|Disease could not be resected|2|||
129171962|NCT00590824|464923675|FG002|Overall Study|Disease could not be resected|1|||
129171963|NCT00590824|464923676|FG003|Overall Study|Disease could not be resected|0|||
129171964|NCT00590824|464923673|FG000|Overall Study|Adverse Event|0|||
129171965|NCT00590824|464923674|FG001|Overall Study|Adverse Event|0|||
129171966|NCT00590824|464923675|FG002|Overall Study|Adverse Event|0|||
129171967|NCT00590824|464923676|FG003|Overall Study|Adverse Event|1|||
129171968|NCT01155466|464923677|FG000|Overall Study|Adverse Event|13|||
129171969|NCT01155466|464923678|FG001|Overall Study|Adverse Event|15|||
129171970|NCT01155466|464923679|FG002|Overall Study|Adverse Event|6|||
129171971|NCT01155466|464923680|FG003|Overall Study|Adverse Event|17|||
129171972|NCT01155466|464923681|FG004|Overall Study|Adverse Event|18|||
129171973|NCT01155466|464923677|FG000|Overall Study|Lost to Follow-up|0|||
129171974|NCT01155466|464923678|FG001|Overall Study|Lost to Follow-up|0|||
129171975|NCT01155466|464923679|FG002|Overall Study|Lost to Follow-up|0|||
129171976|NCT01155466|464923680|FG003|Overall Study|Lost to Follow-up|0|||
129171977|NCT01155466|464923681|FG004|Overall Study|Lost to Follow-up|2|||
129171978|NCT01155466|464923677|FG000|Overall Study|Withdrawal by Subject|7|||
129171979|NCT01155466|464923678|FG001|Overall Study|Withdrawal by Subject|5|||
129171980|NCT01155466|464923679|FG002|Overall Study|Withdrawal by Subject|9|||
129171981|NCT01155466|464923680|FG003|Overall Study|Withdrawal by Subject|4|||
129171982|NCT01155466|464923681|FG004|Overall Study|Withdrawal by Subject|4|||
129171983|NCT01155466|464923677|FG000|Overall Study|Protocol Violation|0|||
129171984|NCT01155466|464923678|FG001|Overall Study|Protocol Violation|0|||
129171985|NCT01155466|464923679|FG002|Overall Study|Protocol Violation|2|||
129171986|NCT01155466|464923680|FG003|Overall Study|Protocol Violation|0|||
129171987|NCT01155466|464923681|FG004|Overall Study|Protocol Violation|1|||
129171988|NCT01155466|464923677|FG000|Overall Study|Administrative|0|||
129171989|NCT01155466|464923678|FG001|Overall Study|Administrative|3|||
129171990|NCT01155466|464923679|FG002|Overall Study|Administrative|0|||
129171991|NCT01155466|464923680|FG003|Overall Study|Administrative|0|||
129171992|NCT01155466|464923681|FG004|Overall Study|Administrative|0|||
129171993|NCT01155466|464923677|FG000|Overall Study|Randomized not treated|2|||
129171994|NCT01155466|464923678|FG001|Overall Study|Randomized not treated|2|||
129171995|NCT01155466|464923679|FG002|Overall Study|Randomized not treated|3|||
129171996|NCT01155466|464923680|FG003|Overall Study|Randomized not treated|0|||
129171997|NCT01155466|464923681|FG004|Overall Study|Randomized not treated|2|||
129171998|NCT02210689|464923682|FG000|Overall Study|Withdrawal by Subject|7|||
129171999|NCT02210689|464923683|FG001|Overall Study|Withdrawal by Subject|4|||
129172000|NCT02210689|464923684|FG002|Overall Study|Withdrawal by Subject|2|||
129172001|NCT02210689|464923682|FG000|Overall Study|Adverse Event|0|||
129172002|NCT02210689|464923683|FG001|Overall Study|Adverse Event|1|||
129172003|NCT02210689|464923684|FG002|Overall Study|Adverse Event|0|||
129172004|NCT02210689|464923682|FG000|Overall Study|Protocol Violation|1|||
129172005|NCT02210689|464923683|FG001|Overall Study|Protocol Violation|0|||
129172006|NCT02210689|464923684|FG002|Overall Study|Protocol Violation|0|||
129172007|NCT02210689|464923682|FG000|Overall Study|Lost to Follow-up|11|||
129172008|NCT02210689|464923683|FG001|Overall Study|Lost to Follow-up|9|||
129172009|NCT02210689|464923684|FG002|Overall Study|Lost to Follow-up|5|||
129172010|NCT02210689|464923682|FG000|Overall Study|Pregnancy|0|||
129172011|NCT02210689|464923683|FG001|Overall Study|Pregnancy|1|||
129172012|NCT02210689|464923684|FG002|Overall Study|Pregnancy|0|||
129172013|NCT02210689|464923682|FG000|Overall Study|Lack of Efficacy|0|||
129172014|NCT02210689|464923683|FG001|Overall Study|Lack of Efficacy|1|||
129172015|NCT02210689|464923684|FG002|Overall Study|Lack of Efficacy|5|||
129172016|NCT02210689|464923682|FG000|Overall Study|Prohibited medication|2|||
129172017|NCT02210689|464923683|FG001|Overall Study|Prohibited medication|8|||
129172018|NCT02210689|464923684|FG002|Overall Study|Prohibited medication|1|||
129172019|NCT02210689|464923682|FG000|Overall Study|Negative Nugent score at baseline|6|||
129172020|NCT02210689|464923683|FG001|Overall Study|Negative Nugent score at baseline|2|||
129172021|NCT02210689|464923684|FG002|Overall Study|Negative Nugent score at baseline|2|||
129172022|NCT02210689|464923682|FG000|Overall Study|Other|25|||
128779902|NCT02099539|463484609|FG001|Overall Study|Physician Decision|0|||
128779903|NCT02099539|463484610|FG002|Overall Study|Physician Decision|0|||
129172023|NCT02210689|464923683|FG001|Overall Study|Other|21|||
129172024|NCT02210689|464923684|FG002|Overall Study|Other|8|||
129172025|NCT00791479|464923690|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129172026|NCT00791479|464923691|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129172027|NCT00791479|464923692|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129172028|NCT00791479|464923693|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129172029|NCT00791479|464923694|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
129172030|NCT00791479|464923695|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129172031|NCT00791479|464923690|FG000|Overall Study|Adverse Event|0|||
129172032|NCT00791479|464923691|FG001|Overall Study|Adverse Event|1|||
129172033|NCT00791479|464923692|FG002|Overall Study|Adverse Event|0|||
129172034|NCT00791479|464923693|FG003|Overall Study|Adverse Event|2|||
129172035|NCT00791479|464923694|FG004|Overall Study|Adverse Event|0|||
128729546|NCT03995953|463306684|FG001|Overall Study|Lost to Follow-up|54|||
128729547|NCT03995953|463306685|FG002|Overall Study|Lost to Follow-up|3|||
128729548|NCT03995953|463306686|FG003|Overall Study|Lost to Follow-up|32|||
128729549|NCT03995953|463306687|FG004|Overall Study|Lost to Follow-up|5|||
128729550|NCT03995953|463306688|FG005|Overall Study|Lost to Follow-up|44|||
128729551|NCT03995953|463306689|FG006|Overall Study|Lost to Follow-up|0|||
128729552|NCT03995953|463306690|FG007|Overall Study|Lost to Follow-up|31|||
128729553|NCT03995953|463306691|FG008|Overall Study|Lost to Follow-up|8|||
128729554|NCT03995953|463306692|FG009|Overall Study|Lost to Follow-up|36|||
128729555|NCT03995953|463306693|FG010|Overall Study|Lost to Follow-up|5|||
128729556|NCT03995953|463306694|FG011|Overall Study|Lost to Follow-up|41|||
128729557|NCT03995953|463306683|FG000|Overall Study|Withdrawal by Subject|4|||
128729558|NCT03995953|463306684|FG001|Overall Study|Withdrawal by Subject|0|||
128729559|NCT03995953|463306685|FG002|Overall Study|Withdrawal by Subject|1|||
128729560|NCT03995953|463306686|FG003|Overall Study|Withdrawal by Subject|0|||
128729561|NCT03995953|463306687|FG004|Overall Study|Withdrawal by Subject|1|||
128729562|NCT03995953|463306688|FG005|Overall Study|Withdrawal by Subject|0|||
128729563|NCT03995953|463306689|FG006|Overall Study|Withdrawal by Subject|1|||
128729564|NCT03995953|463306690|FG007|Overall Study|Withdrawal by Subject|0|||
128729565|NCT03995953|463306691|FG008|Overall Study|Withdrawal by Subject|3|||
128729566|NCT03995953|463306692|FG009|Overall Study|Withdrawal by Subject|0|||
128729567|NCT03995953|463306693|FG010|Overall Study|Withdrawal by Subject|3|||
128729568|NCT03995953|463306694|FG011|Overall Study|Withdrawal by Subject|0|||
128729569|NCT03995953|463306683|FG000|Overall Study|Health Issues|0|||
128729570|NCT03995953|463306684|FG001|Overall Study|Health Issues|0|||
128729571|NCT03995953|463306685|FG002|Overall Study|Health Issues|0|||
128729572|NCT03995953|463306686|FG003|Overall Study|Health Issues|0|||
128729573|NCT03995953|463306687|FG004|Overall Study|Health Issues|1|||
128729574|NCT03995953|463306688|FG005|Overall Study|Health Issues|0|||
128729575|NCT03995953|463306689|FG006|Overall Study|Health Issues|0|||
128729576|NCT03995953|463306690|FG007|Overall Study|Health Issues|0|||
128729577|NCT03995953|463306691|FG008|Overall Study|Health Issues|4|||
128729578|NCT03995953|463306692|FG009|Overall Study|Health Issues|0|||
128729579|NCT03995953|463306693|FG010|Overall Study|Health Issues|0|||
128729580|NCT03995953|463306694|FG011|Overall Study|Health Issues|0|||
128729581|NCT03995953|463306683|FG000|Overall Study|Relocated|11|||
128729582|NCT03995953|463306684|FG001|Overall Study|Relocated|0|||
128729583|NCT03995953|463306685|FG002|Overall Study|Relocated|16|||
128729584|NCT03995953|463306686|FG003|Overall Study|Relocated|0|||
128729585|NCT03995953|463306687|FG004|Overall Study|Relocated|14|||
128729586|NCT03995953|463306688|FG005|Overall Study|Relocated|0|||
128729587|NCT03995953|463306689|FG006|Overall Study|Relocated|16|||
128729588|NCT03995953|463306690|FG007|Overall Study|Relocated|0|||
128729589|NCT03995953|463306691|FG008|Overall Study|Relocated|14|||
128729590|NCT03995953|463306692|FG009|Overall Study|Relocated|0|||
128729591|NCT03995953|463306693|FG010|Overall Study|Relocated|15|||
128729592|NCT03995953|463306694|FG011|Overall Study|Relocated|0|||
128729593|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
128729594|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
128729595|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
128729596|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
128729597|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
128729598|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
128729599|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
128729600|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
128729601|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
128729602|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
129172036|NCT00791479|464923695|FG005|Overall Study|Adverse Event|1|||
129172037|NCT00791479|464923690|FG000|Overall Study|Lost to Follow-up|0|||
129172038|NCT00791479|464923691|FG001|Overall Study|Lost to Follow-up|1|||
128729603|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
128729604|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
128729605|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
128729606|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
128729607|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
128729608|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
128729609|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
128729610|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
128729611|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129172039|NCT00791479|464923692|FG002|Overall Study|Lost to Follow-up|0|||
128729612|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
128729613|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
128729614|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
128729615|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
128729616|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
128779904|NCT02099539|463484611|FG003|Overall Study|Physician Decision|0|||
129172040|NCT00791479|464923693|FG003|Overall Study|Lost to Follow-up|0|||
128729617|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
128729618|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
128729619|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
128729620|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
128729621|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129172041|NCT00791479|464923694|FG004|Overall Study|Lost to Follow-up|0|||
129172042|NCT00791479|464923695|FG005|Overall Study|Lost to Follow-up|1|||
129172043|NCT00791479|464923690|FG000|Overall Study|Protocol Violation|2|||
129172044|NCT00791479|464923691|FG001|Overall Study|Protocol Violation|1|||
129172045|NCT00791479|464923692|FG002|Overall Study|Protocol Violation|0|||
129172046|NCT00791479|464923693|FG003|Overall Study|Protocol Violation|1|||
129172047|NCT00791479|464923694|FG004|Overall Study|Protocol Violation|0|||
129172048|NCT00791479|464923695|FG005|Overall Study|Protocol Violation|0|||
129172049|NCT00791479|464923690|FG000|Overall Study|Withdrawal by Subject|0|||
129172050|NCT00791479|464923691|FG001|Overall Study|Withdrawal by Subject|0|||
129172051|NCT00791479|464923692|FG002|Overall Study|Withdrawal by Subject|0|||
129172052|NCT00791479|464923693|FG003|Overall Study|Withdrawal by Subject|1|||
129172053|NCT00791479|464923694|FG004|Overall Study|Withdrawal by Subject|0|||
129172054|NCT00791479|464923695|FG005|Overall Study|Withdrawal by Subject|1|||
129172055|NCT01778049|464923696|FG000|Open Label Treatment Period|Adverse Event|5|||
129172056|NCT01778049|464923697|FG001|Open Label Treatment Period|Adverse Event|15|||
129172057|NCT01778049|464923698|FG002|Open Label Treatment Period|Adverse Event|0|||
129172058|NCT01778049|464923699|FG003|Open Label Treatment Period|Adverse Event|0|||
129172059|NCT01778049|464923700|FG004|Open Label Treatment Period|Adverse Event|0|||
129172060|NCT01778049|464923701|FG005|Open Label Treatment Period|Adverse Event|0|||
129172061|NCT01778049|464923696|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
129172062|NCT01778049|464923697|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
129172063|NCT01778049|464923698|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
129172064|NCT01778049|464923699|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
129172065|NCT01778049|464923700|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
129172066|NCT01778049|464923701|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
129172067|NCT01778049|464923696|FG000|Open Label Treatment Period|Protocol Violation|5|||
129172068|NCT01778049|464923697|FG001|Open Label Treatment Period|Protocol Violation|5|||
129172069|NCT01778049|464923698|FG002|Open Label Treatment Period|Protocol Violation|0|||
129172070|NCT01778049|464923699|FG003|Open Label Treatment Period|Protocol Violation|0|||
129172071|NCT01778049|464923700|FG004|Open Label Treatment Period|Protocol Violation|0|||
129172072|NCT01778049|464923701|FG005|Open Label Treatment Period|Protocol Violation|0|||
129172073|NCT01778049|464923696|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
129172074|NCT01778049|464923697|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
129172075|NCT01778049|464923698|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
129172076|NCT01778049|464923699|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
129172077|NCT01778049|464923700|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
129172078|NCT01778049|464923701|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
129172079|NCT01778049|464923696|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
129172080|NCT01778049|464923697|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
129172081|NCT01778049|464923698|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
129172082|NCT01778049|464923699|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
129172083|NCT01778049|464923700|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
129172084|NCT01778049|464923701|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
129172085|NCT01778049|464923696|FG000|Open Label Treatment Period|Not treated|2|||
129172086|NCT01778049|464923697|FG001|Open Label Treatment Period|Not treated|1|||
129172087|NCT01778049|464923698|FG002|Open Label Treatment Period|Not treated|0|||
129172088|NCT01778049|464923699|FG003|Open Label Treatment Period|Not treated|0|||
129172089|NCT01778049|464923700|FG004|Open Label Treatment Period|Not treated|0|||
129172090|NCT01778049|464923701|FG005|Open Label Treatment Period|Not treated|0|||
129172091|NCT01778049|464923696|FG000|Open Label Treatment Period|Other reason not defined above|77|||
129172092|NCT01778049|464923697|FG001|Open Label Treatment Period|Other reason not defined above|94|||
129172093|NCT01778049|464923698|FG002|Open Label Treatment Period|Other reason not defined above|0|||
129172094|NCT01778049|464923699|FG003|Open Label Treatment Period|Other reason not defined above|0|||
129172095|NCT01778049|464923700|FG004|Open Label Treatment Period|Other reason not defined above|0|||
129172096|NCT01778049|464923701|FG005|Open Label Treatment Period|Other reason not defined above|0|||
129172097|NCT01778049|464923696|FG000|Double Blind Treatment Period|Adverse Event|0|||
129172098|NCT01778049|464923697|FG001|Double Blind Treatment Period|Adverse Event|0|||
128729622|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
128729623|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
129172099|NCT01778049|464923698|FG002|Double Blind Treatment Period|Adverse Event|4|||
129172100|NCT01778049|464923699|FG003|Double Blind Treatment Period|Adverse Event|5|||
129172101|NCT01778049|464923700|FG004|Double Blind Treatment Period|Adverse Event|3|||
129172102|NCT01778049|464923701|FG005|Double Blind Treatment Period|Adverse Event|2|||
129172103|NCT01778049|464923696|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
128729624|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
128729625|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
128729626|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
128729627|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
128729628|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
128729629|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
128729630|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
128729631|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
128729632|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
128729633|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
128729634|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
128729635|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
128729636|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
128729637|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
128729638|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
128729639|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
128729640|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
128729641|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
128729642|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
128729643|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
128729644|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
128729645|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
128729646|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
128729647|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
128729648|NCT04951622|463306704|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
128729649|NCT04951622|463306705|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
128729650|NCT04951622|463306706|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
128729651|NCT04951622|463306707|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
128729652|NCT04951622|463306708|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129172104|NCT01778049|464923697|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
128729653|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
129172105|NCT01778049|464923698|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
129172106|NCT01778049|464923699|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
129172107|NCT01778049|464923700|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
129172108|NCT01778049|464923701|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
129172109|NCT01778049|464923696|FG000|Double Blind Treatment Period|Protocol Violation|0|||
129172110|NCT01778049|464923697|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129172111|NCT01778049|464923698|FG002|Double Blind Treatment Period|Protocol Violation|2|||
129172112|NCT01778049|464923699|FG003|Double Blind Treatment Period|Protocol Violation|0|||
129172113|NCT01778049|464923700|FG004|Double Blind Treatment Period|Protocol Violation|0|||
129172114|NCT01778049|464923701|FG005|Double Blind Treatment Period|Protocol Violation|0|||
129172115|NCT01778049|464923696|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
129172116|NCT01778049|464923697|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
129172117|NCT01778049|464923698|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
129172118|NCT01778049|464923699|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
129172119|NCT01778049|464923700|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
129172120|NCT01778049|464923701|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
129172121|NCT01778049|464923696|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
129172122|NCT01778049|464923697|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
129172123|NCT01778049|464923698|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
129172124|NCT01778049|464923699|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
128729654|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
128729655|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
128729656|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
128729657|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
128729658|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
128729659|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
128729660|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
128729661|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
128729662|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
128729663|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
128729664|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
128729665|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
128729666|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
129172125|NCT01778049|464923700|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
128779905|NCT02099539|463484612|FG004|Overall Study|Physician Decision|0|||
128779906|NCT02099539|463484613|FG005|Overall Study|Physician Decision|1|||
128779907|NCT02099539|463484614|FG006|Overall Study|Physician Decision|0|||
128779908|NCT03251378|463484618|FG000|Overall Study|Death|3|||
128779909|NCT03251378|463484619|FG001|Overall Study|Death|2|||
128779910|NCT03251378|463484620|FG002|Overall Study|Death|3|||
128779911|NCT03251378|463484621|FG003|Overall Study|Death|30|||
128779912|NCT03251378|463484622|FG004|Overall Study|Death|24|||
128779913|NCT03251378|463484623|FG005|Overall Study|Death|12|||
128779914|NCT03251378|463484624|FG006|Overall Study|Death|12|||
128779915|NCT03251378|463484618|FG000|Overall Study|Lost to Follow-up|0|||
128779916|NCT03251378|463484619|FG001|Overall Study|Lost to Follow-up|0|||
128779917|NCT03251378|463484620|FG002|Overall Study|Lost to Follow-up|1|||
128779918|NCT03251378|463484621|FG003|Overall Study|Lost to Follow-up|3|||
128779919|NCT03251378|463484622|FG004|Overall Study|Lost to Follow-up|0|||
128779920|NCT03251378|463484623|FG005|Overall Study|Lost to Follow-up|0|||
128779921|NCT03251378|463484624|FG006|Overall Study|Lost to Follow-up|0|||
128779922|NCT03251378|463484618|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
128779923|NCT03251378|463484619|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
128779924|NCT03251378|463484620|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
128779925|NCT03251378|463484621|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
128779926|NCT03251378|463484622|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
128779927|NCT03251378|463484623|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
128779928|NCT03251378|463484624|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
128779929|NCT03251378|463484618|FG000|Overall Study|Progressive disease|2|||
128779930|NCT03251378|463484619|FG001|Overall Study|Progressive disease|0|||
128779931|NCT03251378|463484620|FG002|Overall Study|Progressive disease|0|||
128779932|NCT03251378|463484621|FG003|Overall Study|Progressive disease|1|||
128779933|NCT03251378|463484622|FG004|Overall Study|Progressive disease|0|||
128779934|NCT03251378|463484623|FG005|Overall Study|Progressive disease|0|||
128779935|NCT03251378|463484624|FG006|Overall Study|Progressive disease|0|||
128779936|NCT03251378|463484618|FG000|Overall Study|Physician Decision|0|||
128779937|NCT03251378|463484619|FG001|Overall Study|Physician Decision|2|||
128779938|NCT03251378|463484620|FG002|Overall Study|Physician Decision|0|||
128779939|NCT03251378|463484621|FG003|Overall Study|Physician Decision|0|||
128779940|NCT03251378|463484622|FG004|Overall Study|Physician Decision|0|||
128779941|NCT03251378|463484623|FG005|Overall Study|Physician Decision|0|||
128779942|NCT03251378|463484624|FG006|Overall Study|Physician Decision|0|||
128779943|NCT03251378|463484618|FG000|Overall Study|Other|2|||
128779944|NCT03251378|463484619|FG001|Overall Study|Other|3|||
128779945|NCT03251378|463484620|FG002|Overall Study|Other|2|||
128779946|NCT03251378|463484621|FG003|Overall Study|Other|0|||
128779947|NCT03251378|463484622|FG004|Overall Study|Other|1|||
128779948|NCT03251378|463484623|FG005|Overall Study|Other|1|||
128779949|NCT03251378|463484624|FG006|Overall Study|Other|1|||
128779950|NCT03251378|463484618|FG000|Overall Study|Other|0|||
128779951|NCT03251378|463484619|FG001|Overall Study|Other|0|||
128779952|NCT03251378|463484620|FG002|Overall Study|Other|0|||
128779953|NCT03251378|463484621|FG003|Overall Study|Other|4|||
128779954|NCT03251378|463484622|FG004|Overall Study|Other|13|||
128779955|NCT03251378|463484623|FG005|Overall Study|Other|0|||
128779956|NCT03251378|463484624|FG006|Overall Study|Other|0|||
128779957|NCT04060680|463484626|FG000|Overall Study|Unsuccessful implant|17|||
128779958|NCT04060680|463484627|FG001|Overall Study|Unsuccessful implant|2|||
128779959|NCT04060680|463484626|FG000|Overall Study|Adverse Event|3|||
128779960|NCT04060680|463484627|FG001|Overall Study|Adverse Event|0|||
128779961|NCT04060680|463484626|FG000|Overall Study|Death|2|||
128779962|NCT04060680|463484627|FG001|Overall Study|Death|0|||
128779963|NCT04060680|463484626|FG000|Overall Study|Study product no longer in use|1|||
128779964|NCT04060680|463484627|FG001|Overall Study|Study product no longer in use|0|||
128779965|NCT04060680|463484626|FG000|Overall Study|Withdrawal by Subject|1|||
128779966|NCT04060680|463484627|FG001|Overall Study|Withdrawal by Subject|0|||
128779967|NCT02322775|463484631|FG000|Overall Study|Adverse Event|1|||
128779968|NCT02322775|463484632|FG001|Overall Study|Adverse Event|0|||
128779969|NCT02322775|463484631|FG000|Overall Study|Lost to Follow-up|0|||
128779970|NCT02322775|463484632|FG001|Overall Study|Lost to Follow-up|1|||
128779971|NCT02322775|463484631|FG000|Overall Study|Protocol Violation|1|||
128729667|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
128729668|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
128729669|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
128729670|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
128729671|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
128729672|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
128729673|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
128729674|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
128729675|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
128729676|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
128729677|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
128729678|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
128729679|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
128729680|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
128729681|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
128729682|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
128779972|NCT02322775|463484632|FG001|Overall Study|Protocol Violation|0|||
128779973|NCT02322775|463484631|FG000|Overall Study|Withdrawal by Subject|3|||
128779974|NCT02322775|463484632|FG001|Overall Study|Withdrawal by Subject|4|||
128779975|NCT02322775|463484631|FG000|Overall Study|Not willing to perform all FU visits|0|||
128779976|NCT02322775|463484632|FG001|Overall Study|Not willing to perform all FU visits|1|||
128779977|NCT04739423|463484637|FG000|Overall Study|Protocol Violation|0|||
128779978|NCT04739423|463484638|FG001|Overall Study|Protocol Violation|1|||
128779979|NCT04739423|463484639|FG002|Overall Study|Protocol Violation|0|||
128779980|NCT04739423|463484640|FG003|Overall Study|Protocol Violation|0|||
128779981|NCT04739423|463484641|FG004|Overall Study|Protocol Violation|0|||
128779982|NCT04739423|463484642|FG005|Overall Study|Protocol Violation|0|||
128779983|NCT04739423|463484637|FG000|Overall Study|Adverse Event|0|||
128779984|NCT04739423|463484638|FG001|Overall Study|Adverse Event|0|||
128779985|NCT04739423|463484639|FG002|Overall Study|Adverse Event|1|||
128779986|NCT04739423|463484640|FG003|Overall Study|Adverse Event|0|||
128779987|NCT04739423|463484641|FG004|Overall Study|Adverse Event|1|||
128779988|NCT04739423|463484642|FG005|Overall Study|Adverse Event|0|||
128779989|NCT04739423|463484637|FG000|Overall Study|Withdrawal by Subject|0|||
128779990|NCT04739423|463484638|FG001|Overall Study|Withdrawal by Subject|0|||
128779991|NCT04739423|463484639|FG002|Overall Study|Withdrawal by Subject|0|||
128779992|NCT04739423|463484640|FG003|Overall Study|Withdrawal by Subject|0|||
128779993|NCT04739423|463484641|FG004|Overall Study|Withdrawal by Subject|0|||
128779994|NCT04739423|463484642|FG005|Overall Study|Withdrawal by Subject|1|||
128779995|NCT01007552|463484646|FG000|Overall Study|Withdrawal by Subject|1|||
128779996|NCT03212365|463484652|FG000|Overall Study|Discharged prior to Xa level|12|||
128779997|NCT03212365|463484653|FG001|Overall Study|Discharged prior to Xa level|8|||
128779998|NCT03212365|463484652|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
128779999|NCT03212365|463484653|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
128780000|NCT03212365|463484652|FG000|Overall Study|Refused study medication|3|||
128780001|NCT03212365|463484653|FG001|Overall Study|Refused study medication|0|||
128780002|NCT03212365|463484652|FG000|Overall Study|Initiated heparin infusion on floor|1|||
128780003|NCT03212365|463484653|FG001|Overall Study|Initiated heparin infusion on floor|1|||
128780004|NCT03212365|463484652|FG000|Overall Study|Unexpected return to OR|1|||
128780005|NCT03212365|463484653|FG001|Overall Study|Unexpected return to OR|1|||
128780006|NCT03212365|463484652|FG000|Overall Study|Medication distribution error|1|||
128780007|NCT03212365|463484653|FG001|Overall Study|Medication distribution error|0|||
128780008|NCT03212365|463484652|FG000|Overall Study|Required epidural placement|1|||
128780009|NCT03212365|463484653|FG001|Overall Study|Required epidural placement|0|||
128780010|NCT03212365|463484652|FG000|Overall Study|Withdrawal by Subject|0|||
128780011|NCT03212365|463484653|FG001|Overall Study|Withdrawal by Subject|1|||
128780012|NCT03212365|463484652|FG000|Overall Study|developed acute renal failure|0|||
128780013|NCT03212365|463484653|FG001|Overall Study|developed acute renal failure|1|||
128780014|NCT02507219|463484654|FG000|Overall Study|Physician Decision|1|||
128780015|NCT02507219|463484655|FG001|Overall Study|Physician Decision|0|||
128780016|NCT02507219|463484656|FG002|Overall Study|Physician Decision|0|||
128780017|NCT02507219|463484657|FG003|Overall Study|Physician Decision|0|||
128780018|NCT02507219|463484658|FG004|Overall Study|Physician Decision|0|||
128780019|NCT02507219|463484659|FG005|Overall Study|Physician Decision|0|||
128780020|NCT02507219|463484654|FG000|Overall Study|Withdrawal by Subject|0|||
128780021|NCT02507219|463484655|FG001|Overall Study|Withdrawal by Subject|0|||
128780022|NCT02507219|463484656|FG002|Overall Study|Withdrawal by Subject|0|||
128780023|NCT02507219|463484657|FG003|Overall Study|Withdrawal by Subject|0|||
128780024|NCT02507219|463484658|FG004|Overall Study|Withdrawal by Subject|1|||
128780025|NCT02507219|463484659|FG005|Overall Study|Withdrawal by Subject|0|||
128780026|NCT05174065|463484664|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
128780027|NCT05174065|463484665|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
128780028|NCT05174065|463484666|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
128780029|NCT05174065|463484664|FG000|Placebo-controlled Period|Other|0|||
128780030|NCT05174065|463484665|FG001|Placebo-controlled Period|Other|1|||
128780031|NCT05174065|463484666|FG002|Placebo-controlled Period|Other|0|||
129172126|NCT01778049|464923701|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
129172127|NCT01778049|464923696|FG000|Double Blind Treatment Period|Not treated|0|||
129172128|NCT01778049|464923697|FG001|Double Blind Treatment Period|Not treated|0|||
128780032|NCT05174065|463484664|FG000|Placebo-controlled Period|Adverse Event|1|||
128780033|NCT05174065|463484665|FG001|Placebo-controlled Period|Adverse Event|1|||
128780034|NCT05174065|463484666|FG002|Placebo-controlled Period|Adverse Event|0|||
128780035|NCT05174065|463484664|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
128780036|NCT05174065|463484665|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
128780037|NCT05174065|463484666|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
128780038|NCT05174065|463484664|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
128780039|NCT05174065|463484665|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
128780040|NCT05174065|463484666|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
128780041|NCT05174065|463484664|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
128780042|NCT05174065|463484665|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
128729683|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
129172129|NCT01778049|464923698|FG002|Double Blind Treatment Period|Not treated|0|||
129172130|NCT01778049|464923699|FG003|Double Blind Treatment Period|Not treated|2|||
129172131|NCT01778049|464923700|FG004|Double Blind Treatment Period|Not treated|2|||
129172132|NCT01778049|464923701|FG005|Double Blind Treatment Period|Not treated|0|||
129172133|NCT01778049|464923696|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
129172134|NCT01778049|464923697|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
129172135|NCT01778049|464923698|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
129172136|NCT01778049|464923699|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
129172137|NCT01778049|464923700|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
129172138|NCT01778049|464923701|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
129172139|NCT03773133|464923702|FG000|Overall Study|Screen Failure|8|||
129172140|NCT03770728|464923706|FG000|Overall Study|Adverse Event|1|||
129172141|NCT03770728|464923707|FG001|Overall Study|Adverse Event|0|||
129172142|NCT03770728|464923708|FG002|Overall Study|Adverse Event|1|||
129172143|NCT03770728|464923709|FG003|Overall Study|Adverse Event|0|||
129172144|NCT03770728|464923706|FG000|Overall Study|Poor compliance to protocol|0|||
129172145|NCT03770728|464923707|FG001|Overall Study|Poor compliance to protocol|0|||
129172146|NCT03770728|464923708|FG002|Overall Study|Poor compliance to protocol|1|||
129172147|NCT03770728|464923709|FG003|Overall Study|Poor compliance to protocol|0|||
129172148|NCT03770728|464923706|FG000|Overall Study|Withdrawal by Subject|13|||
129172149|NCT03770728|464923707|FG001|Overall Study|Withdrawal by Subject|8|||
129172150|NCT03770728|464923708|FG002|Overall Study|Withdrawal by Subject|9|||
129172151|NCT03770728|464923709|FG003|Overall Study|Withdrawal by Subject|13|||
129172152|NCT03770728|464923706|FG000|Overall Study|Other than specified|24|||
129172153|NCT03770728|464923707|FG001|Overall Study|Other than specified|23|||
129172154|NCT03770728|464923708|FG002|Overall Study|Other than specified|21|||
129172155|NCT03770728|464923709|FG003|Overall Study|Other than specified|22|||
129172156|NCT00503776|464923710|FG000|Overall Study|Withdrawal by Subject|1|||
129172157|NCT00503776|464923711|FG001|Overall Study|Withdrawal by Subject|0|||
129172158|NCT00503776|464923712|FG002|Overall Study|Withdrawal by Subject|1|||
129172159|NCT00503776|464923713|FG003|Overall Study|Withdrawal by Subject|1|||
129172160|NCT00503776|464923710|FG000|Overall Study|Physician Decision|0|||
129172161|NCT00503776|464923711|FG001|Overall Study|Physician Decision|0|||
129172162|NCT00503776|464923712|FG002|Overall Study|Physician Decision|1|||
129172163|NCT00503776|464923713|FG003|Overall Study|Physician Decision|1|||
129172164|NCT02379988|464923714|FG000|Overall Study|Not eligible|1|||
129172165|NCT00107315|464923715|FG000|Overall Study|Disease Progression|9|||
129172166|NCT00107315|464923715|FG000|Overall Study|Adverse Event|4|||
129172167|NCT00107315|464923715|FG000|Overall Study|Withdrawal by Subject|2|||
129172168|NCT02509039|464923718|FG000|Overall Study|Adverse Event|0|||
129172169|NCT02509039|464923719|FG001|Overall Study|Adverse Event|1|||
129172170|NCT02509039|464923720|FG002|Overall Study|Adverse Event|1|||
129172171|NCT02509039|464923721|FG003|Overall Study|Adverse Event|1|||
129172172|NCT02509039|464923718|FG000|Overall Study|Withdrawal by Subject|0|||
129172173|NCT02509039|464923719|FG001|Overall Study|Withdrawal by Subject|0|||
129172174|NCT02509039|464923720|FG002|Overall Study|Withdrawal by Subject|1|||
129172175|NCT02509039|464923721|FG003|Overall Study|Withdrawal by Subject|0|||
129172176|NCT02509039|464923718|FG000|Overall Study|Progressive disease|2|||
129172177|NCT02509039|464923719|FG001|Overall Study|Progressive disease|2|||
129172178|NCT02509039|464923720|FG002|Overall Study|Progressive disease|1|||
129172179|NCT02509039|464923721|FG003|Overall Study|Progressive disease|5|||
129172180|NCT02509039|464923718|FG000|Overall Study|Study terminated by Sponsor|1|||
129172181|NCT02509039|464923719|FG001|Overall Study|Study terminated by Sponsor|0|||
129172182|NCT02509039|464923720|FG002|Overall Study|Study terminated by Sponsor|0|||
129172183|NCT02509039|464923721|FG003|Overall Study|Study terminated by Sponsor|0|||
129172184|NCT05427539|464923726|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
129172185|NCT05427539|464923727|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
129172186|NCT05427539|464923726|FG000|Period 1|Withdrawal by Subject|1|||
129172187|NCT05427539|464923727|FG001|Period 1|Withdrawal by Subject|0|||
129172188|NCT00223977|464923728|FG000|Overall Study|Adverse Event|7|||
129172189|NCT00223977|464923729|FG001|Overall Study|Adverse Event|10|||
129172190|NCT00223977|464923730|FG002|Overall Study|Adverse Event|0|||
129172191|NCT00223977|464923728|FG000|Overall Study|Protocol Violation|0|||
129172192|NCT00223977|464923729|FG001|Overall Study|Protocol Violation|0|||
129172193|NCT00223977|464923730|FG002|Overall Study|Protocol Violation|1|||
129172194|NCT00223977|464923728|FG000|Overall Study|Withdrawal by Subject|1|||
129172195|NCT00223977|464923729|FG001|Overall Study|Withdrawal by Subject|1|||
129172196|NCT00223977|464923730|FG002|Overall Study|Withdrawal by Subject|2|||
129172197|NCT00223977|464923728|FG000|Overall Study|Other|1|||
129172198|NCT00223977|464923729|FG001|Overall Study|Other|0|||
129172199|NCT00223977|464923730|FG002|Overall Study|Other|0|||
129172200|NCT00543296|464923731|FG000|Overall Study|Physician Decision|7|||
128780043|NCT05174065|463484666|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
129172201|NCT03136497|464923732|FG000|Overall Study|Screen Failure|1|||
129172202|NCT03136497|464923733|FG001|Overall Study|Screen Failure|0|||
128729684|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
128729685|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
128729686|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
128729687|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
128729688|NCT04951622|463306704|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
128729689|NCT04951622|463306705|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
128780044|NCT01342887|463484672|FG000|Overall Study|Death|2|||
128780045|NCT00209274|463484673|FG000|Overall Study|Missed visit|3|||
128780046|NCT00209274|463484674|FG001|Overall Study|Missed visit|2|||
128780047|NCT00209274|463484673|FG000|Overall Study|Death|32|||
128780048|NCT00209274|463484674|FG001|Overall Study|Death|15|||
128780049|NCT00209274|463484673|FG000|Overall Study|Withdrawal by Subject|30|||
128780050|NCT00209274|463484674|FG001|Overall Study|Withdrawal by Subject|15|||
128780051|NCT00209274|463484673|FG000|Overall Study|Randomized not treated (RNT)|6|||
128780052|NCT00209274|463484674|FG001|Overall Study|Randomized not treated (RNT)|15|||
128780053|NCT00097370|463484679|FG000|Stage 1|Adverse Event|3|||
128780054|NCT00097370|463484679|FG000|Stage 1|Withdrawal by Subject|1|||
128780055|NCT00097370|463484679|FG000|Stage 1|Lack of Efficacy|2|||
128780056|NCT00097370|463484679|FG000|Stage 2|Adverse Event|5|||
128780057|NCT00097370|463484679|FG000|Stage 2|Withdrawal by Subject|1|||
128780058|NCT00097370|463484679|FG000|Stage 2|Lack of Efficacy|3|||
128780059|NCT00097370|463484679|FG000|Stage 2|Pregnancy|1|||
128780060|NCT00097370|463484679|FG000|Stage 2|Sponsor Terminated Study|2|||
128780061|NCT00097370|463484679|FG000|Stage 2|Lost to Follow-up|1|||
128780062|NCT00097370|463484679|FG000|Stage 3|Adverse Event|2|||
128780063|NCT00097370|463484679|FG000|Stage 3|Withdrawal by Subject|3|||
128780064|NCT00097370|463484679|FG000|Stage 3|Lack of Efficacy|1|||
128780065|NCT00097370|463484679|FG000|Stage 3|Sponsor Terminated Study|52|||
128780066|NCT00097370|463484679|FG000|Stage 3|Lost to Follow-up|1|||
128780067|NCT02337361|463484680|FG000|3-month Follow-up|Lost to Follow-up|19|||
128780068|NCT02337361|463484681|FG001|3-month Follow-up|Lost to Follow-up|14|||
128780069|NCT02337361|463484680|FG000|6-month Follow-up|Lost to Follow-up|2|||
128780070|NCT02337361|463484681|FG001|6-month Follow-up|Lost to Follow-up|4|||
128780071|NCT02419755|463484682|FG000|Overall Study|Death|1|||
128780072|NCT02419755|463484683|FG001|Overall Study|Death|3|||
128780073|NCT02419755|463484682|FG000|Overall Study|Relapse|0|||
128780074|NCT02419755|463484683|FG001|Overall Study|Relapse|1|||
128780075|NCT02419755|463484682|FG000|Overall Study|Ineligible|1|||
128780076|NCT02419755|463484683|FG001|Overall Study|Ineligible|0|||
128780077|NCT02419755|463484682|FG000|Overall Study|Withdrawal by Subject|1|||
128780078|NCT02419755|463484683|FG001|Overall Study|Withdrawal by Subject|0|||
128780079|NCT02427646|463484685|FG000|Overall Study|Lack of Efficacy|2|||
128780080|NCT02427646|463484686|FG001|Overall Study|Lack of Efficacy|3|||
128780081|NCT02427646|463484685|FG000|Overall Study|Physician Decision|1|||
128780082|NCT02427646|463484686|FG001|Overall Study|Physician Decision|4|||
128780083|NCT02427646|463484685|FG000|Overall Study|Protocol Violation|3|||
128780084|NCT02427646|463484686|FG001|Overall Study|Protocol Violation|3|||
128780085|NCT02427646|463484685|FG000|Overall Study|Bothersome hand weakness|2|||
128780086|NCT02427646|463484686|FG001|Overall Study|Bothersome hand weakness|4|||
128780087|NCT01101542|463484687|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
128780088|NCT01101542|463484687|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
128780089|NCT01101542|463484687|FG000|Year 4 Surveillance Period|Other|287|||
128780090|NCT01101542|463484687|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
128780091|NCT01101542|463484687|FG000|Year 5 Surveillance Period|Pregnancy|1|||
128780092|NCT01101542|463484687|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
128780093|NCT01101542|463484687|FG000|Year 6 Surveillance Period|Pregnancy|1|||
128780094|NCT01101542|463484687|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
128780095|NCT00901485|463484688|FG000|Overall Study|Lack of Efficacy|0|||
128780096|NCT00901485|463484689|FG001|Overall Study|Lack of Efficacy|2|||
128780097|NCT00901485|463484688|FG000|Overall Study|Withdrawal by Subject|1|||
128780098|NCT00901485|463484689|FG001|Overall Study|Withdrawal by Subject|2|||
128780099|NCT01929993|463486408|FG000|Overall Study|Protocol Violation|4|||
128780100|NCT01929993|463486409|FG001|Overall Study|Protocol Violation|6|||
128780101|NCT01929993|463486408|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
128780102|NCT01929993|463486409|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
128780103|NCT01256476|463486410|FG000|Overall Study|Adverse Event|2|||
128780104|NCT01256476|463486411|FG001|Overall Study|Adverse Event|1|||
128780105|NCT01256476|463486410|FG000|Overall Study|Withdrawal by Subject|2|||
128780106|NCT01256476|463486411|FG001|Overall Study|Withdrawal by Subject|1|||
128780107|NCT01256476|463486410|FG000|Overall Study|Lost to Follow-up|1|||
128780108|NCT01256476|463486411|FG001|Overall Study|Lost to Follow-up|2|||
128780109|NCT01256476|463486410|FG000|Overall Study|Persistent ALT or AST elevation|1|||
128780110|NCT01256476|463486411|FG001|Overall Study|Persistent ALT or AST elevation|0|||
128780111|NCT01256476|463486410|FG000|Overall Study|Physician Decision|0|||
128780112|NCT01256476|463486411|FG001|Overall Study|Physician Decision|1|||
128780113|NCT01256476|463486410|FG000|Overall Study|Subject non-compliance|0|||
128780114|NCT01256476|463486411|FG001|Overall Study|Subject non-compliance|1|||
128780115|NCT01256476|463486410|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
128780116|NCT01256476|463486411|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
128780117|NCT00163215|463486412|FG000|Overall Study|Lack of Efficacy|3|||
128780118|NCT00163215|463486412|FG000|Overall Study|Withdrawal by Subject|5|||
128780119|NCT00163215|463486412|FG000|Overall Study|Other|7|||
128780120|NCT03660943|463486413|FG000|Overall Study|Adverse Event|5|||
128780121|NCT03660943|463486414|FG001|Overall Study|Adverse Event|3|||
128780122|NCT03660943|463486413|FG000|Overall Study|Death|0|||
128780123|NCT03660943|463486414|FG001|Overall Study|Death|2|||
129172203|NCT03136497|464923734|FG002|Overall Study|Screen Failure|0|||
129172204|NCT00934947|464923735|FG000|Overall Study|Adverse Event|0|||
129172205|NCT00934947|464923736|FG001|Overall Study|Adverse Event|2|||
129172206|NCT00557310|464923741|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
129172207|NCT00557310|464923741|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
129172208|NCT00557310|464923741|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
129172209|NCT00557310|464923741|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
129172210|NCT00557310|464923741|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
129172211|NCT00557310|464923741|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
129172212|NCT03276026|464923744|FG000|Overall Study|Protocol Violation|1|||
129172213|NCT03276026|464923745|FG001|Overall Study|Protocol Violation|0|||
129172214|NCT04049266|464923749|FG000|Overall Study|Adverse Event|16|||
129172215|NCT04049266|464923750|FG001|Overall Study|Adverse Event|9|||
129172216|NCT04049266|464923749|FG000|Overall Study|Non-compliance with study drug|0|||
129172217|NCT04049266|464923750|FG001|Overall Study|Non-compliance with study drug|3|||
129172218|NCT04049266|464923749|FG000|Overall Study|Withdrawal by Subject|6|||
129172219|NCT04049266|464923750|FG001|Overall Study|Withdrawal by Subject|10|||
129172220|NCT04049266|464923749|FG000|Overall Study|Lost to Follow-up|2|||
129172221|NCT04049266|464923750|FG001|Overall Study|Lost to Follow-up|2|||
129172222|NCT04049266|464923749|FG000|Overall Study|Progressive disease|11|||
129172223|NCT04049266|464923750|FG001|Overall Study|Progressive disease|2|||
129172224|NCT04049266|464923749|FG000|Overall Study|Physician Decision|1|||
129172225|NCT04049266|464923750|FG001|Overall Study|Physician Decision|0|||
129172226|NCT04049266|464923749|FG000|Overall Study|Patient moved out of state|1|||
129172227|NCT04049266|464923750|FG001|Overall Study|Patient moved out of state|0|||
129172228|NCT01703208|464923751|FG000|Overall Study|Death|61|||
129172229|NCT01703208|464923752|FG001|Overall Study|Death|48|||
129172230|NCT01703208|464923751|FG000|Overall Study|Lack of Efficacy|1|||
129172231|NCT01703208|464923752|FG001|Overall Study|Lack of Efficacy|2|||
129172232|NCT01703208|464923751|FG000|Overall Study|Lost to Follow-up|68|||
129172233|NCT01703208|464923752|FG001|Overall Study|Lost to Follow-up|62|||
129172234|NCT01703208|464923751|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129172235|NCT01703208|464923752|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129172236|NCT01703208|464923751|FG000|Overall Study|Excluded Medication|1|||
129172237|NCT01703208|464923752|FG001|Overall Study|Excluded Medication|2|||
129172238|NCT01703208|464923751|FG000|Overall Study|Site Discontinued Study Participation|23|||
129172239|NCT01703208|464923752|FG001|Overall Study|Site Discontinued Study Participation|27|||
129172240|NCT01703208|464923751|FG000|Overall Study|Physician Decision|11|||
129172241|NCT01703208|464923752|FG001|Overall Study|Physician Decision|13|||
129172242|NCT01703208|464923751|FG000|Overall Study|Progressive disease|2|||
129172243|NCT01703208|464923752|FG001|Overall Study|Progressive disease|2|||
129172244|NCT01703208|464923751|FG000|Overall Study|Protocol Violation|1|||
129172245|NCT01703208|464923752|FG001|Overall Study|Protocol Violation|1|||
129172246|NCT01703208|464923751|FG000|Overall Study|Study Terminated by Sponsor|1710|||
129172247|NCT01703208|464923752|FG001|Overall Study|Study Terminated by Sponsor|1716|||
129172248|NCT01703208|464923751|FG000|Overall Study|Withdrawal by Subject|205|||
129172249|NCT01703208|464923752|FG001|Overall Study|Withdrawal by Subject|209|||
129172250|NCT01703208|464923751|FG000|Overall Study|Adverse Event|14|||
129172251|NCT01703208|464923752|FG001|Overall Study|Adverse Event|19|||
129172252|NCT01703208|464923751|FG000|Overall Study|Technical Problems|0|||
129172253|NCT01703208|464923752|FG001|Overall Study|Technical Problems|1|||
129172254|NCT01703208|464923751|FG000|Overall Study|Protocol Deviation|2|||
129172255|NCT01703208|464923752|FG001|Overall Study|Protocol Deviation|0|||
129172256|NCT00367744|464923756|FG000|Overall Study|Lost to Follow-up|4|||
129172257|NCT00367744|464923757|FG001|Overall Study|Lost to Follow-up|5|||
129172258|NCT04003207|464923759|FG000|Overall Study|Protocol Violation|1|||
129172259|NCT03941964|464923762|FG000|Overall Study|Adverse Event|1|||
129172260|NCT03941964|464923763|FG001|Overall Study|Adverse Event|8|||
129172261|NCT03941964|464923762|FG000|Overall Study|Progressive disease|7|||
129172262|NCT03941964|464923763|FG001|Overall Study|Progressive disease|3|||
129172263|NCT03941964|464923762|FG000|Overall Study|Lack of Efficacy|0|||
129172264|NCT03941964|464923763|FG001|Overall Study|Lack of Efficacy|1|||
129172265|NCT03941964|464923762|FG000|Overall Study|Death|3|||
129172266|NCT03941964|464923763|FG001|Overall Study|Death|1|||
129172267|NCT03941964|464923762|FG000|Overall Study|Withdrew consent|1|||
129172268|NCT03941964|464923763|FG001|Overall Study|Withdrew consent|3|||
129172269|NCT03941964|464923762|FG000|Overall Study|Physician Decision|9|||
129172270|NCT03941964|464923763|FG001|Overall Study|Physician Decision|2|||
129172271|NCT03941964|464923762|FG000|Overall Study|Other, not specified|2|||
129172272|NCT03941964|464923763|FG001|Overall Study|Other, not specified|1|||
129172273|NCT02298179|464923764|FG000|Overall Study|Lost to Follow-up|0|||
129172274|NCT02298179|464923765|FG001|Overall Study|Lost to Follow-up|0|||
129172275|NCT02298179|464923766|FG002|Overall Study|Lost to Follow-up|1|||
129172276|NCT02298179|464923767|FG003|Overall Study|Lost to Follow-up|0|||
129172277|NCT02298179|464923768|FG004|Overall Study|Lost to Follow-up|0|||
129172278|NCT02298179|464923769|FG005|Overall Study|Lost to Follow-up|0|||
129172279|NCT02298179|464923770|FG006|Overall Study|Lost to Follow-up|0|||
129172280|NCT02298179|464923771|FG007|Overall Study|Lost to Follow-up|1|||
129172281|NCT02298179|464923772|FG008|Overall Study|Lost to Follow-up|0|||
129172282|NCT02298179|464923773|FG009|Overall Study|Lost to Follow-up|0|||
129172283|NCT02298179|464923774|FG010|Overall Study|Lost to Follow-up|0|||
129172284|NCT02298179|464923775|FG011|Overall Study|Lost to Follow-up|0|||
129172285|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
129172286|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
129172287|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Death|0|||
129172288|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Death|0|||
129172289|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
129172290|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
129172291|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
129172292|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
129172293|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
128729690|NCT04951622|463306706|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
128729691|NCT04951622|463306707|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
128729692|NCT04951622|463306708|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
128729693|NCT04108208|463306709|FG000|Overall Study|Withdrawal by Subject|2|||
128729694|NCT04108208|463306710|FG001|Overall Study|Withdrawal by Subject|6|||
128729695|NCT04108208|463306709|FG000|Overall Study|other-ongoing|20|||
128729696|NCT04108208|463306710|FG001|Overall Study|other-ongoing|40|||
128729697|NCT04108208|463306709|FG000|Overall Study|Death|1|||
128729698|NCT04108208|463306710|FG001|Overall Study|Death|4|||
128729699|NCT04108208|463306709|FG000|Overall Study|Lost to Follow-up|2|||
128729700|NCT04108208|463306710|FG001|Overall Study|Lost to Follow-up|0|||
128729701|NCT02948842|463306712|FG000|Overall Study|Withdrawal by Subject|4|||
128729702|NCT02350309|463306714|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
128729703|NCT02350309|463306715|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
128729704|NCT02350309|463306716|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
128729705|NCT02350309|463306717|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
128729706|NCT02350309|463306718|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
128729707|NCT02350309|463306719|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
128729708|NCT02350309|463306714|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
128729709|NCT02350309|463306715|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
128729710|NCT02350309|463306716|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
128729711|NCT02350309|463306717|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
128729712|NCT02350309|463306718|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
128729713|NCT02350309|463306719|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
128729714|NCT00058825|463306720|FG000|Overall Study|Relapse|9|||
128729715|NCT00058825|463306720|FG000|Overall Study|Progressive Disease|5|||
128729716|NCT00058825|463306720|FG000|Overall Study|Graft Failure|5|||
128729717|NCT00058825|463306720|FG000|Overall Study|Death|3|||
128729718|NCT04399161|463306721|FG000|Overall Study|Withdrawal by Subject|1|||
128729719|NCT04399161|463306722|FG001|Overall Study|Withdrawal by Subject|0|||
128729720|NCT04399161|463306723|FG002|Overall Study|Withdrawal by Subject|2|||
128729721|NCT04399161|463306721|FG000|Overall Study|Protocol Violation|1|||
128729722|NCT04399161|463306722|FG001|Overall Study|Protocol Violation|2|||
128729723|NCT04399161|463306723|FG002|Overall Study|Protocol Violation|0|||
128729724|NCT01736696|463306724|FG000|Overall Study|Withdrawal by Subject|0|||
128729725|NCT01736696|463306725|FG001|Overall Study|Withdrawal by Subject|0|||
128729726|NCT01736696|463306726|FG002|Overall Study|Withdrawal by Subject|1|||
128729727|NCT01736696|463306727|FG003|Overall Study|Withdrawal by Subject|0|||
128729728|NCT01736696|463306728|FG004|Overall Study|Withdrawal by Subject|0|||
128729729|NCT01736696|463306729|FG005|Overall Study|Withdrawal by Subject|0|||
128729730|NCT01736696|463306730|FG006|Overall Study|Withdrawal by Subject|0|||
128729731|NCT00838565|463306731|FG000|Overall Study|Withdrawal by Subject|0|||
128729732|NCT00838565|463306732|FG001|Overall Study|Withdrawal by Subject|0|||
128729733|NCT00838565|463306733|FG002|Overall Study|Withdrawal by Subject|1|||
128729734|NCT00838565|463306734|FG003|Overall Study|Withdrawal by Subject|0|||
128729735|NCT00838565|463306735|FG004|Overall Study|Withdrawal by Subject|0|||
128729736|NCT00838565|463306736|FG005|Overall Study|Withdrawal by Subject|2|||
128729737|NCT00838565|463306731|FG000|Overall Study|Other|0|||
128729738|NCT00838565|463306732|FG001|Overall Study|Other|2|||
128729739|NCT00838565|463306733|FG002|Overall Study|Other|0|||
128729740|NCT00838565|463306734|FG003|Overall Study|Other|0|||
128729741|NCT00838565|463306735|FG004|Overall Study|Other|0|||
128729742|NCT00838565|463306736|FG005|Overall Study|Other|0|||
128729743|NCT00838565|463306731|FG000|Overall Study|Randomized but not Treated|0|||
128729744|NCT00838565|463306732|FG001|Overall Study|Randomized but not Treated|1|||
128729745|NCT00838565|463306733|FG002|Overall Study|Randomized but not Treated|0|||
128729746|NCT00838565|463306734|FG003|Overall Study|Randomized but not Treated|0|||
128729747|NCT00838565|463306735|FG004|Overall Study|Randomized but not Treated|0|||
129172294|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
129172295|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
128780124|NCT03660943|463486413|FG000|Overall Study|Lost to Follow-up|7|||
129172296|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
129172297|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
129172298|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
128729748|NCT00838565|463306736|FG005|Overall Study|Randomized but not Treated|0|||
128729749|NCT02741115|463306743|FG000|Overall Study|Adverse Event|1|||
128729750|NCT02741115|463306744|FG001|Overall Study|Adverse Event|0|||
129172299|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
129172300|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
129172301|NCT00433160|464923782|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
129172302|NCT00433160|464923783|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
129172303|NCT00433160|464923782|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
129172304|NCT00433160|464923783|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
129172305|NCT00433160|464923782|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
129172306|NCT00433160|464923783|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
129172307|NCT00433160|464923782|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
129172308|NCT00433160|464923783|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
128729751|NCT02741115|463306743|FG000|Overall Study|Lost to Follow-up|7|||
128729752|NCT02741115|463306744|FG001|Overall Study|Lost to Follow-up|4|||
128729753|NCT02741115|463306743|FG000|Overall Study|Withdrawal by Subject|4|||
128729754|NCT02741115|463306744|FG001|Overall Study|Withdrawal by Subject|2|||
128729755|NCT01101841|463308213|FG000|Overall Study|Adverse Event|15|||
128729756|NCT01101841|463308214|FG001|Overall Study|Adverse Event|15|||
128729757|NCT01101841|463308213|FG000|Overall Study|Lost to Follow-up|9|||
128729758|NCT01101841|463308214|FG001|Overall Study|Lost to Follow-up|3|||
128729759|NCT01101841|463308213|FG000|Overall Study|Withdrawal by Subject|21|||
128729760|NCT01101841|463308214|FG001|Overall Study|Withdrawal by Subject|40|||
128729761|NCT01101841|463308213|FG000|Overall Study|Protocol Violation|1|||
128729762|NCT01101841|463308214|FG001|Overall Study|Protocol Violation|1|||
128729763|NCT01101841|463308213|FG000|Overall Study|Physician Decision|0|||
128729764|NCT01101841|463308214|FG001|Overall Study|Physician Decision|2|||
128729765|NCT01101841|463308213|FG000|Overall Study|Lack of Efficacy|0|||
128729766|NCT01101841|463308214|FG001|Overall Study|Lack of Efficacy|2|||
128729767|NCT01101841|463308213|FG000|Overall Study|Other|0|||
128729768|NCT01101841|463308214|FG001|Overall Study|Other|1|||
128729769|NCT01101841|463308213|FG000|Overall Study|Suicidality Tracking Scale|3|||
128729770|NCT01101841|463308214|FG001|Overall Study|Suicidality Tracking Scale|1|||
128729771|NCT01101841|463308213|FG000|Overall Study|Eligibility Criteria|1|||
128729772|NCT01101841|463308214|FG001|Overall Study|Eligibility Criteria|2|||
128729773|NCT03633396|463308219|FG000|Overall Study|Withdrawal by Subject|4|||
128729774|NCT03633396|463308220|FG001|Overall Study|Withdrawal by Subject|4|||
128729775|NCT03633396|463308219|FG000|Overall Study|Adverse Event|1|||
128729776|NCT03633396|463308220|FG001|Overall Study|Adverse Event|1|||
128729777|NCT03633396|463308219|FG000|Overall Study|Lack of Efficacy|1|||
128729778|NCT03633396|463308220|FG001|Overall Study|Lack of Efficacy|0|||
128729779|NCT03633396|463308219|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
128729780|NCT03633396|463308220|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
128729781|NCT01012817|463308221|FG000|Overall Study|Withdrawal by Subject|0|||
128729782|NCT01012817|463308222|FG001|Overall Study|Withdrawal by Subject|0|||
128729783|NCT01012817|463308223|FG002|Overall Study|Withdrawal by Subject|0|||
128729784|NCT01012817|463308224|FG003|Overall Study|Withdrawal by Subject|1|||
128729785|NCT01012817|463308225|FG004|Overall Study|Withdrawal by Subject|0|||
128729786|NCT01012817|463308226|FG005|Overall Study|Withdrawal by Subject|0|||
128729787|NCT01012817|463308227|FG006|Overall Study|Withdrawal by Subject|0|||
128729788|NCT01012817|463308228|FG007|Overall Study|Withdrawal by Subject|1|||
128729789|NCT01012817|463308229|FG008|Overall Study|Withdrawal by Subject|0|||
128729790|NCT01012817|463308230|FG009|Overall Study|Withdrawal by Subject|0|||
128729791|NCT01012817|463308231|FG010|Overall Study|Withdrawal by Subject|1|||
128729792|NCT01012817|463308232|FG011|Overall Study|Withdrawal by Subject|1|||
128729793|NCT01012817|463308233|FG012|Overall Study|Withdrawal by Subject|0|||
128729794|NCT01012817|463308234|FG013|Overall Study|Withdrawal by Subject|1|||
128729795|NCT01012817|463308221|FG000|Overall Study|Adverse Event|0|||
128729796|NCT01012817|463308222|FG001|Overall Study|Adverse Event|0|||
128729797|NCT01012817|463308223|FG002|Overall Study|Adverse Event|0|||
128729798|NCT01012817|463308224|FG003|Overall Study|Adverse Event|0|||
128729799|NCT01012817|463308225|FG004|Overall Study|Adverse Event|0|||
128729800|NCT01012817|463308226|FG005|Overall Study|Adverse Event|1|||
128729801|NCT01012817|463308227|FG006|Overall Study|Adverse Event|0|||
128729802|NCT01012817|463308228|FG007|Overall Study|Adverse Event|0|||
128729803|NCT01012817|463308229|FG008|Overall Study|Adverse Event|0|||
128729804|NCT01012817|463308230|FG009|Overall Study|Adverse Event|0|||
128729805|NCT01012817|463308231|FG010|Overall Study|Adverse Event|1|||
128729806|NCT01012817|463308232|FG011|Overall Study|Adverse Event|0|||
128729807|NCT01012817|463308233|FG012|Overall Study|Adverse Event|0|||
128729808|NCT01012817|463308234|FG013|Overall Study|Adverse Event|1|||
128729809|NCT03756558|463308235|FG000|Overall Study|Death|1|||
128729810|NCT03756558|463308235|FG000|Overall Study|Lost to Follow-up|2|||
128780125|NCT03660943|463486414|FG001|Overall Study|Lost to Follow-up|3|||
129172309|NCT00433160|464923782|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
129172310|NCT00433160|464923783|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
129172311|NCT00433160|464923782|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
129172312|NCT00433160|464923783|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
129172313|NCT00433160|464923782|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
129172314|NCT00433160|464923783|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
129172315|NCT00433160|464923782|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
129172316|NCT00433160|464923783|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
129172317|NCT02226198|464925377|FG000|Lead-in Phase|Protocol Violation|1|||
129172318|NCT02226198|464925378|FG001|Lead-in Phase|Protocol Violation|0|||
129172319|NCT02226198|464925379|FG002|Lead-in Phase|Protocol Violation|0|||
129172320|NCT02226198|464925377|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
129172321|NCT02226198|464925378|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
129172322|NCT02226198|464925379|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
129172323|NCT01440517|464925381|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
129172324|NCT01288612|464925383|FG000|Overall Study|Unable to contact|11|||
129172325|NCT01288612|464925384|FG001|Overall Study|Unable to contact|16|||
129172326|NCT01288612|464925385|FG002|Overall Study|Unable to contact|20|||
129172327|NCT01288612|464925383|FG000|Overall Study|Declined|78|||
129172328|NCT01288612|464925384|FG001|Overall Study|Declined|63|||
129172329|NCT01288612|464925385|FG002|Overall Study|Declined|62|||
129172330|NCT01288612|464925383|FG000|Overall Study|Unable to intubate|0|||
129172331|NCT01288612|464925384|FG001|Overall Study|Unable to intubate|3|||
129172332|NCT01288612|464925385|FG002|Overall Study|Unable to intubate|0|||
129172333|NCT05599451|464925386|FG000|Overall Study|Not randomized|11|||
129172334|NCT05599451|464925387|FG001|Overall Study|Not randomized|0|||
129172335|NCT05599451|464925388|FG002|Overall Study|Not randomized|0|||
129172336|NCT05599451|464925389|FG003|Overall Study|Not randomized|0|||
129172337|NCT05599451|464925390|FG004|Overall Study|Not randomized|0|||
129172338|NCT05599451|464925386|FG000|Overall Study|Physician Decision|0|||
129172339|NCT05599451|464925387|FG001|Overall Study|Physician Decision|0|||
129172340|NCT05599451|464925388|FG002|Overall Study|Physician Decision|0|||
129172341|NCT05599451|464925389|FG003|Overall Study|Physician Decision|1|||
129172342|NCT05599451|464925390|FG004|Overall Study|Physician Decision|0|||
129172343|NCT00496483|464925391|FG000|Overall Study|Not dosed|9|||
129172344|NCT00496483|464925391|FG000|Overall Study|Adverse Event|2|||
129172345|NCT00496483|464925391|FG000|Overall Study|Lack of Efficacy|1|||
129172346|NCT00983515|464925393|FG000|Ritonavir Alone|liver panel out of range|6|||
129172347|NCT00983515|464925393|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
129172348|NCT01145352|464925402|FG000|Overall Study|Found to have been registered twice|6|||
129172349|NCT01145352|464925402|FG000|Overall Study|Treated before marketing approval|4|||
129172350|NCT01145352|464925402|FG000|Overall Study|Syringe formulation was used|1|||
129172351|NCT01967823|464925403|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
129172352|NCT03392883|464925407|FG000|Overall Study|Lost to Follow-up|122|||
129172353|NCT03392883|464925408|FG001|Overall Study|Lost to Follow-up|13|||
129172354|NCT03392883|464925409|FG002|Overall Study|Lost to Follow-up|9|||
129172355|NCT03392883|464925407|FG000|Overall Study|Death|4|||
129172356|NCT03392883|464925408|FG001|Overall Study|Death|0|||
129172357|NCT03392883|464925409|FG002|Overall Study|Death|0|||
129172358|NCT03392883|464925407|FG000|Overall Study|Lack of Efficacy|29|||
129172359|NCT03392883|464925408|FG001|Overall Study|Lack of Efficacy|0|||
129172360|NCT03392883|464925409|FG002|Overall Study|Lack of Efficacy|0|||
129172361|NCT03392883|464925407|FG000|Overall Study|Withdrawal by Subject|180|||
129172362|NCT03392883|464925408|FG001|Overall Study|Withdrawal by Subject|0|||
129172363|NCT03392883|464925409|FG002|Overall Study|Withdrawal by Subject|0|||
129172364|NCT03392883|464925407|FG000|Overall Study|Adverse Event|1|||
129172365|NCT03392883|464925408|FG001|Overall Study|Adverse Event|0|||
129172366|NCT03392883|464925409|FG002|Overall Study|Adverse Event|0|||
129172367|NCT00132691|464925416|FG000|Overall Study|Lost to Follow-up|5|||
129172368|NCT00132691|464925417|FG001|Overall Study|Lost to Follow-up|8|||
129172369|NCT00132691|464925416|FG000|Overall Study|Missed 2-year visit|4|||
129172370|NCT00132691|464925417|FG001|Overall Study|Missed 2-year visit|4|||
129172371|NCT00132691|464925416|FG000|Overall Study|Death|2|||
129172372|NCT00132691|464925417|FG001|Overall Study|Death|0|||
129172373|NCT01739933|464925418|FG000|Overall Study|Death|89|||
129172374|NCT01739933|464925419|FG001|Overall Study|Death|86|||
128780126|NCT03660943|463486413|FG000|Overall Study|Protocol Violation|3|||
129172375|NCT01739933|464925418|FG000|Overall Study|Withdrawal by Subject|10|||
129172376|NCT01739933|464925419|FG001|Overall Study|Withdrawal by Subject|8|||
129172377|NCT01739933|464925418|FG000|Overall Study|Lost to Follow-up|3|||
129172378|NCT01739933|464925419|FG001|Overall Study|Lost to Follow-up|10|||
129172379|NCT01739933|464925418|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
129172380|NCT01739933|464925419|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
129172381|NCT04098367|464925420|FG000|Overall Study|Adverse Event|0|||
129172382|NCT04098367|464925421|FG001|Overall Study|Adverse Event|0|||
129172383|NCT04098367|464925422|FG002|Overall Study|Adverse Event|1|||
128729811|NCT03756558|463308235|FG000|Overall Study|Withdrawal by Subject|2|||
128729812|NCT00978731|463308236|FG000|Overall Study|Death|4|||
128729813|NCT00978731|463308237|FG001|Overall Study|Death|1|||
128729814|NCT00978731|463308238|FG002|Overall Study|Death|1|||
128729815|NCT00978731|463308239|FG003|Overall Study|Death|0|||
128729816|NCT00978731|463308236|FG000|Overall Study|Lost to Follow-up|0|||
128729817|NCT00978731|463308237|FG001|Overall Study|Lost to Follow-up|0|||
129172384|NCT04098367|464925420|FG000|Overall Study|Lost to Follow-up|1|||
129172385|NCT04098367|464925421|FG001|Overall Study|Lost to Follow-up|5|||
129172386|NCT04098367|464925422|FG002|Overall Study|Lost to Follow-up|2|||
129172387|NCT04098367|464925420|FG000|Overall Study|Withdrawal by Subject|0|||
129172388|NCT04098367|464925421|FG001|Overall Study|Withdrawal by Subject|0|||
129172389|NCT04098367|464925422|FG002|Overall Study|Withdrawal by Subject|1|||
129172390|NCT04098367|464925420|FG000|Overall Study|Sick . Could not attend visit|1|||
129172391|NCT04098367|464925421|FG001|Overall Study|Sick . Could not attend visit|0|||
129172392|NCT04098367|464925422|FG002|Overall Study|Sick . Could not attend visit|0|||
129172393|NCT00908115|464925427|FG000|Overall Study|Other|14|||
129172394|NCT01728077|464925428|FG000|Overall Study|Lack of Efficacy|3|||
128729818|NCT00978731|463308238|FG002|Overall Study|Lost to Follow-up|0|||
128729819|NCT00978731|463308239|FG003|Overall Study|Lost to Follow-up|1|||
128729820|NCT00978731|463308236|FG000|Overall Study|Adverse Event|5|||
129172395|NCT01728077|464925429|FG001|Overall Study|Lack of Efficacy|1|||
129172396|NCT01728077|464925428|FG000|Overall Study|Lost to Follow-up|1|||
129172397|NCT01728077|464925429|FG001|Overall Study|Lost to Follow-up|0|||
129172398|NCT01728077|464925428|FG000|Overall Study|Subject choice|2|||
129172399|NCT01728077|464925429|FG001|Overall Study|Subject choice|3|||
129172400|NCT01728077|464925428|FG000|Overall Study|Death|0|||
129172401|NCT01728077|464925429|FG001|Overall Study|Death|1|||
129172402|NCT01728077|464925428|FG000|Overall Study|Patient moving|1|||
129172403|NCT01728077|464925429|FG001|Overall Study|Patient moving|0|||
129172404|NCT01728077|464925428|FG000|Overall Study|Non compliance|1|||
129172405|NCT01728077|464925429|FG001|Overall Study|Non compliance|0|||
129172406|NCT00347438|464925435|FG000|Overall Study|Withdrawal by Subject|1|||
129172407|NCT00347438|464925435|FG000|Overall Study|Physician Decision|1|||
129172408|NCT00322023|464925436|FG000|Overall Study|various|0|||
129172409|NCT00322023|464925437|FG001|Overall Study|various|2|||
129172410|NCT00322023|464925438|FG002|Overall Study|various|6|||
129172411|NCT00523705|464925439|FG000|Overall Study|No time for study.|0|||
129172412|NCT00523705|464925440|FG001|Overall Study|No time for study.|1|||
129172413|NCT00693017|464925441|FG000|Overall Study|Sponsor Decision|2|||
129172414|NCT00693017|464925442|FG001|Overall Study|Sponsor Decision|1|||
129172415|NCT00693017|464925441|FG000|Overall Study|Death|0|||
129172416|NCT00693017|464925442|FG001|Overall Study|Death|1|||
129172417|NCT02359045|464925453|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
129172418|NCT02359045|464925454|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129172419|NCT02359045|464925453|FG000|Overall Study|Lost to Follow-up|1|||
129172420|NCT02359045|464925454|FG001|Overall Study|Lost to Follow-up|1|||
129172421|NCT02359045|464925453|FG000|Overall Study|Adverse Event|0|||
129172422|NCT02359045|464925454|FG001|Overall Study|Adverse Event|1|||
129172423|NCT01271712|464925462|FG000|Double Blind Treatment|Death|2|||
129172424|NCT01271712|464925463|FG001|Double Blind Treatment|Death|0|||
129172425|NCT01271712|464925462|FG000|Double Blind Treatment|Lack of Efficacy|1|||
129172426|NCT01271712|464925463|FG001|Double Blind Treatment|Lack of Efficacy|0|||
129172427|NCT01271712|464925462|FG000|Double Blind Treatment|Adverse Event|9|||
129172428|NCT01271712|464925463|FG001|Double Blind Treatment|Adverse Event|4|||
129172429|NCT01271712|464925462|FG000|Double Blind Treatment|Progressive disease|23|||
129172430|NCT01271712|464925463|FG001|Double Blind Treatment|Progressive disease|3|||
129172431|NCT01271712|464925462|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
129172432|NCT01271712|464925463|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
129172433|NCT01271712|464925462|FG000|Double Blind Treatment|Non compliance with study drug|2|||
129172434|NCT01271712|464925463|FG001|Double Blind Treatment|Non compliance with study drug|0|||
129172435|NCT01271712|464925462|FG000|Double Blind Treatment|receive no study drug|1|||
129172436|NCT01271712|464925463|FG001|Double Blind Treatment|receive no study drug|0|||
129172437|NCT01271712|464925462|FG000|Open Label Treatment|Death|6|||
129172438|NCT01271712|464925463|FG001|Open Label Treatment|Death|5|||
129172439|NCT01271712|464925462|FG000|Open Label Treatment|Withdrawal by Subject|6|||
129172440|NCT01271712|464925463|FG001|Open Label Treatment|Withdrawal by Subject|11|||
129172441|NCT01271712|464925462|FG000|Open Label Treatment|Physician Decision|2|||
129172442|NCT01271712|464925463|FG001|Open Label Treatment|Physician Decision|0|||
129172443|NCT01271712|464925462|FG000|Open Label Treatment|Adverse Event|14|||
129172444|NCT01271712|464925463|FG001|Open Label Treatment|Adverse Event|8|||
129172445|NCT01271712|464925462|FG000|Open Label Treatment|Progressive disease|59|||
129172446|NCT01271712|464925463|FG001|Open Label Treatment|Progressive disease|32|||
129172447|NCT01271712|464925462|FG000|Open Label Treatment|transferred to rollover study|1|||
129172448|NCT01271712|464925463|FG001|Open Label Treatment|transferred to rollover study|0|||
129172449|NCT01271712|464925462|FG000|Open Label Treatment|Non-compliance with study drug|1|||
129172450|NCT01271712|464925463|FG001|Open Label Treatment|Non-compliance with study drug|0|||
129172451|NCT01271712|464925462|FG000|Open Label Treatment|Protocol Violation|0|||
129172452|NCT01271712|464925463|FG001|Open Label Treatment|Protocol Violation|1|||
129172453|NCT01271712|464925462|FG000|Open Label Treatment|Switching to other therapy|2|||
129172454|NCT01271712|464925463|FG001|Open Label Treatment|Switching to other therapy|1|||
129172455|NCT01271712|464925462|FG000|Safety Follow-up|Death|11|||
129172456|NCT01271712|464925463|FG001|Safety Follow-up|Death|7|||
129172457|NCT01271712|464925462|FG000|Safety Follow-up|Withdrawal by Subject|4|||
129172458|NCT01271712|464925463|FG001|Safety Follow-up|Withdrawal by Subject|2|||
129172459|NCT01271712|464925462|FG000|Safety Follow-up|Protocol Violation|1|||
129172460|NCT01271712|464925463|FG001|Safety Follow-up|Protocol Violation|1|||
129172461|NCT01271712|464925462|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
129172462|NCT01271712|464925463|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
129172463|NCT01271712|464925462|FG000|Safety Follow-up|No follow-up|1|||
129172464|NCT01271712|464925463|FG001|Safety Follow-up|No follow-up|1|||
129172465|NCT01271712|464925462|FG000|Safety Follow-up|Progressive disease|1|||
129172466|NCT01271712|464925463|FG001|Safety Follow-up|Progressive disease|0|||
129172467|NCT01271712|464925462|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
129172468|NCT01271712|464925463|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
129172469|NCT00096226|464925466|FG000|Overall Study|Ineligible|2|||
129172470|NCT00096226|464925466|FG000|Overall Study|Protocol treatment not started|1|||
129172471|NCT01666119|464925467|FG000|Overall Study|Adverse Event|6|||
128780127|NCT03660943|463486414|FG001|Overall Study|Protocol Violation|5|||
128780128|NCT03660943|463486413|FG000|Overall Study|Withdrawal by Subject|8|||
128780129|NCT03660943|463486414|FG001|Overall Study|Withdrawal by Subject|15|||
128780130|NCT03660943|463486413|FG000|Overall Study|Lack of Efficacy|9|||
128780131|NCT03660943|463486414|FG001|Overall Study|Lack of Efficacy|12|||
128780132|NCT03660943|463486413|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
128780133|NCT03660943|463486414|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
128780134|NCT02892409|463486417|FG000|Overall Study|Adverse Event|1|||
129172472|NCT01666119|464925467|FG000|Overall Study|Withdrawal by Subject|16|||
129172473|NCT01666119|464925467|FG000|Overall Study|Lost to Follow-up|7|||
129172474|NCT01666119|464925467|FG000|Overall Study|non compliance with study medication, pa|18|||
129172475|NCT01666119|464925467|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
129172476|NCT05479097|464925473|FG000|Overall Study|Withdrawal by Subject|2|||
129172477|NCT03894969|464925479|FG000|Overall Study|Adverse Event|0|||
129172478|NCT03894969|464925480|FG001|Overall Study|Adverse Event|2|||
129172479|NCT03894969|464925481|FG002|Overall Study|Adverse Event|0|||
129172480|NCT03894969|464925482|FG003|Overall Study|Adverse Event|1|||
129172481|NCT03894969|464925483|FG004|Overall Study|Adverse Event|2|||
129172482|NCT03894969|464925479|FG000|Overall Study|Lost to Follow-up|3|||
129172483|NCT03894969|464925480|FG001|Overall Study|Lost to Follow-up|1|||
129172484|NCT03894969|464925481|FG002|Overall Study|Lost to Follow-up|1|||
129172485|NCT03894969|464925482|FG003|Overall Study|Lost to Follow-up|0|||
129172486|NCT03894969|464925483|FG004|Overall Study|Lost to Follow-up|0|||
129172487|NCT03894969|464925479|FG000|Overall Study|Withdrawal by Subject|2|||
129172488|NCT03894969|464925480|FG001|Overall Study|Withdrawal by Subject|1|||
129172489|NCT03894969|464925481|FG002|Overall Study|Withdrawal by Subject|3|||
129172490|NCT03894969|464925482|FG003|Overall Study|Withdrawal by Subject|4|||
129172491|NCT03894969|464925483|FG004|Overall Study|Withdrawal by Subject|8|||
129172492|NCT03894969|464925479|FG000|Overall Study|Other|0|||
129172493|NCT03894969|464925480|FG001|Overall Study|Other|0|||
129172494|NCT03894969|464925481|FG002|Overall Study|Other|0|||
129172495|NCT03894969|464925482|FG003|Overall Study|Other|0|||
129172496|NCT03894969|464925483|FG004|Overall Study|Other|3|||
129172497|NCT03894969|464925479|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
129172498|NCT03894969|464925480|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
129172499|NCT03894969|464925481|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
129172500|NCT03894969|464925482|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
128729821|NCT00978731|463308237|FG001|Overall Study|Adverse Event|2|||
128729822|NCT00978731|463308238|FG002|Overall Study|Adverse Event|0|||
128729823|NCT00978731|463308239|FG003|Overall Study|Adverse Event|0|||
128729824|NCT00978731|463308236|FG000|Overall Study|Participant's request|1|||
128729825|NCT00978731|463308237|FG001|Overall Study|Participant's request|0|||
128729826|NCT00978731|463308238|FG002|Overall Study|Participant's request|0|||
128729827|NCT00978731|463308239|FG003|Overall Study|Participant's request|0|||
128729828|NCT00978731|463308236|FG000|Overall Study|Administrative reason|3|||
128729829|NCT00978731|463308237|FG001|Overall Study|Administrative reason|3|||
128729830|NCT00978731|463308238|FG002|Overall Study|Administrative reason|1|||
128729831|NCT00978731|463308239|FG003|Overall Study|Administrative reason|0|||
128729832|NCT00978731|463308236|FG000|Overall Study|Deterioration without progression|0|||
128729833|NCT00978731|463308237|FG001|Overall Study|Deterioration without progression|1|||
128729834|NCT00978731|463308238|FG002|Overall Study|Deterioration without progression|0|||
128729835|NCT00978731|463308239|FG003|Overall Study|Deterioration without progression|0|||
128729836|NCT00978731|463308236|FG000|Overall Study|Disease progression/relapse|5|||
128729837|NCT00978731|463308237|FG001|Overall Study|Disease progression/relapse|4|||
128729838|NCT00978731|463308238|FG002|Overall Study|Disease progression/relapse|2|||
128729839|NCT00978731|463308239|FG003|Overall Study|Disease progression/relapse|2|||
128729840|NCT00978731|463308236|FG000|Overall Study|Study closure|3|||
128729841|NCT00978731|463308237|FG001|Overall Study|Study closure|4|||
128729842|NCT00978731|463308238|FG002|Overall Study|Study closure|1|||
128729843|NCT00978731|463308239|FG003|Overall Study|Study closure|1|||
128729844|NCT00978731|463308236|FG000|Overall Study|No response|1|||
128729845|NCT00978731|463308237|FG001|Overall Study|No response|0|||
128729846|NCT00978731|463308238|FG002|Overall Study|No response|0|||
128729847|NCT00978731|463308239|FG003|Overall Study|No response|0|||
128729848|NCT01896895|463308240|FG000|Double-blind MP|Physician Decision|0|||
128729849|NCT01896895|463308241|FG001|Double-blind MP|Physician Decision|0|||
128729850|NCT01896895|463308242|FG002|Double-blind MP|Physician Decision|1|||
128729851|NCT01896895|463308243|FG003|Double-blind MP|Physician Decision|0|||
128729852|NCT01896895|463308240|FG000|Double-blind MP|Withdrawal by Subject|0|||
128729853|NCT01896895|463308241|FG001|Double-blind MP|Withdrawal by Subject|2|||
128729854|NCT01896895|463308242|FG002|Double-blind MP|Withdrawal by Subject|1|||
128729855|NCT01896895|463308243|FG003|Double-blind MP|Withdrawal by Subject|0|||
128729856|NCT01896895|463308240|FG000|Double-blind MP|Lost to Follow-up|1|||
128729857|NCT01896895|463308241|FG001|Double-blind MP|Lost to Follow-up|0|||
128729858|NCT01896895|463308242|FG002|Double-blind MP|Lost to Follow-up|1|||
128729859|NCT01896895|463308243|FG003|Double-blind MP|Lost to Follow-up|0|||
128729860|NCT00293384|463308244|FG000|Overall Study|Non-compliance|2|||
128729861|NCT00293384|463308244|FG000|Overall Study|Missed dosage/study drug|1|||
128729862|NCT00293384|463308244|FG000|Overall Study|Ineligible|2|||
128729863|NCT04709237|463308245|FG000|Overall Study|Lost to Follow-up|1|||
128729864|NCT04709237|463308246|FG001|Overall Study|Lost to Follow-up|0|||
128729865|NCT04709237|463308247|FG002|Overall Study|Lost to Follow-up|0|||
128729866|NCT01302964|463308249|FG000|Overall Study|Adverse Event|1|||
128729867|NCT01302964|463308250|FG001|Overall Study|Adverse Event|0|||
128729868|NCT00145509|463308254|FG000|Overall Study|Adverse Event|10|||
128729869|NCT00145509|463308255|FG001|Overall Study|Adverse Event|3|||
128729870|NCT00145509|463308254|FG000|Overall Study|Lack of Efficacy|3|||
128729871|NCT00145509|463308255|FG001|Overall Study|Lack of Efficacy|1|||
128729872|NCT00145509|463308254|FG000|Overall Study|Lost to Follow-up|5|||
128729873|NCT00145509|463308255|FG001|Overall Study|Lost to Follow-up|9|||
128729874|NCT00145509|463308254|FG000|Overall Study|Withdrew Consent|2|||
128729875|NCT00145509|463308255|FG001|Overall Study|Withdrew Consent|7|||
128729876|NCT00145509|463308254|FG000|Overall Study|Reason not provided|2|||
128729877|NCT00145509|463308255|FG001|Overall Study|Reason not provided|1|||
128729878|NCT00419562|463308258|FG000|Overall Study|Lost to Follow-up|12|||
128729879|NCT00419562|463308259|FG001|Overall Study|Lost to Follow-up|13|||
128729880|NCT00419562|463308258|FG000|Overall Study|Withdrawal by Subject|20|||
128729881|NCT00419562|463308259|FG001|Overall Study|Withdrawal by Subject|18|||
128729882|NCT00419562|463308258|FG000|Overall Study|Participant Institutionalized|1|||
128729883|NCT00419562|463308259|FG001|Overall Study|Participant Institutionalized|0|||
128729884|NCT02789176|463308260|FG000|Overall Study|Death|0|||
128729885|NCT02789176|463308261|FG001|Overall Study|Death|0|||
128729886|NCT02789176|463308262|FG002|Overall Study|Death|3|||
128729887|NCT02789176|463308263|FG003|Overall Study|Death|0|||
128729888|NCT02789176|463308260|FG000|Overall Study|Withdrawal by Subject|0|||
128729889|NCT02789176|463308261|FG001|Overall Study|Withdrawal by Subject|0|||
128729890|NCT02789176|463308262|FG002|Overall Study|Withdrawal by Subject|1|||
128729891|NCT02789176|463308263|FG003|Overall Study|Withdrawal by Subject|0|||
128729892|NCT02789176|463308260|FG000|Overall Study|Lost to Follow-up|8|||
128729893|NCT02789176|463308261|FG001|Overall Study|Lost to Follow-up|2|||
128729894|NCT02789176|463308262|FG002|Overall Study|Lost to Follow-up|6|||
128729895|NCT02789176|463308263|FG003|Overall Study|Lost to Follow-up|1|||
128729896|NCT00596011|463308265|FG000|Overall Study|Withdrawal by Subject|2|||
128729897|NCT00596011|463308266|FG001|Overall Study|Withdrawal by Subject|3|||
128729898|NCT00596011|463308265|FG000|Overall Study|Adverse Event|11|||
128729899|NCT00596011|463308266|FG001|Overall Study|Adverse Event|7|||
128729900|NCT03325166|463308267|FG000|Overall Study|Adverse Event|1|||
128729901|NCT01400841|463308269|FG000|Initial Study Phase (6 Months)|Death|1|||
128729902|NCT01400841|463308269|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
128729903|NCT00770120|463308270|FG000|Overall Study|Progression|31|||
128729904|NCT00770120|463308270|FG000|Overall Study|Adverse Event|11|||
128729905|NCT00770120|463308270|FG000|Overall Study|Not Protocol Specified|11|||
128729906|NCT00770120|463308270|FG000|Overall Study|Death|3|||
128729907|NCT00770120|463308270|FG000|Overall Study|Withdrawal by Subject|2|||
128729908|NCT00770120|463308270|FG000|Overall Study|Ineligible|1|||
128729909|NCT00770120|463308270|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
128729910|NCT00770120|463308270|FG000|Overall Study|Reason under Review|1|||
128729911|NCT00958776|463308271|FG000|Overall Study|Adverse Event|0|||
128729912|NCT00958776|463308272|FG001|Overall Study|Adverse Event|1|||
128729913|NCT00958776|463308271|FG000|Overall Study|Physician Decision|1|||
128729914|NCT00958776|463308272|FG001|Overall Study|Physician Decision|0|||
128729915|NCT00958776|463308271|FG000|Overall Study|Lost to Follow-up|2|||
128729916|NCT00958776|463308272|FG001|Overall Study|Lost to Follow-up|6|||
128729917|NCT00958776|463308271|FG000|Overall Study|Withdrawal by Subject|7|||
128729918|NCT00958776|463308272|FG001|Overall Study|Withdrawal by Subject|16|||
128729919|NCT00958776|463308271|FG000|Overall Study|Protocol Violation|1|||
128729920|NCT00958776|463308272|FG001|Overall Study|Protocol Violation|1|||
128729921|NCT00958776|463308271|FG000|Overall Study|Death|2|||
128729922|NCT00958776|463308272|FG001|Overall Study|Death|1|||
128729923|NCT00958776|463308271|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
128729924|NCT00958776|463308272|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
128729925|NCT00958776|463308271|FG000|Overall Study|Missing|1|||
128729926|NCT00958776|463308272|FG001|Overall Study|Missing|1|||
128780135|NCT02892409|463486418|FG001|Overall Study|Adverse Event|0|||
128780136|NCT02892409|463486417|FG000|Overall Study|Withdrawal by Subject|2|||
128780137|NCT02892409|463486418|FG001|Overall Study|Withdrawal by Subject|1|||
128780138|NCT01033643|463486423|FG000|Overall Study|Withdrew Consent|0|||
128780139|NCT01033643|463486424|FG001|Overall Study|Withdrew Consent|3|||
128780140|NCT01033643|463486425|FG002|Overall Study|Withdrew Consent|0|||
128780141|NCT01033643|463486426|FG003|Overall Study|Withdrew Consent|0|||
128780142|NCT01033643|463486427|FG004|Overall Study|Withdrew Consent|0|||
128780143|NCT01033643|463486428|FG005|Overall Study|Withdrew Consent|1|||
128780144|NCT01789203|463486429|FG000|Overall Study|Adverse Event|2|||
128780145|NCT01789203|463486430|FG001|Overall Study|Adverse Event|2|||
128780146|NCT01789203|463486429|FG000|Overall Study|Withdrawal by Subject|1|||
128780147|NCT01789203|463486430|FG001|Overall Study|Withdrawal by Subject|0|||
128780148|NCT01789203|463486429|FG000|Overall Study|Death|1|||
128780149|NCT01789203|463486430|FG001|Overall Study|Death|0|||
128780150|NCT01789203|463486429|FG000|Overall Study|Protocol Violation|2|||
128780151|NCT01789203|463486430|FG001|Overall Study|Protocol Violation|1|||
128780152|NCT01789203|463486429|FG000|Overall Study|Other|1|||
128780153|NCT01789203|463486430|FG001|Overall Study|Other|1|||
128780154|NCT01789203|463486429|FG000|Overall Study|patient non-adherent|2|||
128780155|NCT01789203|463486430|FG001|Overall Study|patient non-adherent|0|||
128780156|NCT02788656|463486433|FG000|Overall Study|Withdrawal by Subject|1|||
128780157|NCT02788656|463486434|FG001|Overall Study|Withdrawal by Subject|0|||
128780158|NCT01403987|463486444|FG000|Overall Study|Residents forgot their secret PIN|18|||
128780159|NCT01403987|463486445|FG001|Overall Study|Residents forgot their secret PIN|17|||
128780160|NCT01403987|463486446|FG002|Overall Study|Residents forgot their secret PIN|18|||
128780161|NCT00751790|463486448|FG000|Overall Study|Lost to Follow-up|1|||
128780162|NCT00751790|463486448|FG000|Overall Study|Death|3|||
128780163|NCT00751790|463486448|FG000|Overall Study|Withdrawal by Subject|1|||
128780164|NCT00180674|463486449|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
128780165|NCT00180674|463486449|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
128780166|NCT01106976|463486450|FG000|Overall Study|Lost to Follow-up|8|||
128780167|NCT03606460|463486454|FG000|Overall Study|Lost to Follow-up|1|||
128780168|NCT03606460|463486455|FG001|Overall Study|Lost to Follow-up|8|||
128780169|NCT04170023|463486456|FG000|LTE Period|Withdrawal by Subject|1|||
128780170|NCT04170023|463486457|FG001|LTE Period|Withdrawal by Subject|0|||
128780171|NCT04170023|463486458|FG002|LTE Period|Withdrawal by Subject|0|||
128780172|NCT04170023|463486456|FG000|LTE Period|Study Termination|11|||
128780173|NCT04170023|463486457|FG001|LTE Period|Study Termination|11|||
129172501|NCT03894969|464925483|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
129172502|NCT03894969|464925479|FG000|Overall Study|Solicited Adverse Event|0|||
129172503|NCT03894969|464925480|FG001|Overall Study|Solicited Adverse Event|1|||
129172504|NCT03894969|464925481|FG002|Overall Study|Solicited Adverse Event|0|||
129172505|NCT03894969|464925482|FG003|Overall Study|Solicited Adverse Event|0|||
129172506|NCT03894969|464925483|FG004|Overall Study|Solicited Adverse Event|0|||
129172507|NCT00468676|464925484|FG000|Overall Study|Lost to Follow-up|14|||
129172508|NCT00468676|464925485|FG001|Overall Study|Lost to Follow-up|11|||
129172509|NCT00468676|464925484|FG000|Overall Study|Death|2|||
129172510|NCT00468676|464925485|FG001|Overall Study|Death|1|||
129172511|NCT00118846|464925492|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
129172512|NCT00118846|464925493|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
129172513|NCT00118846|464925492|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
129172514|NCT00118846|464925493|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
129172515|NCT00118846|464925492|FG000|Overall Study|Physician Decision|1|||
129172516|NCT00118846|464925493|FG001|Overall Study|Physician Decision|0|||
129172517|NCT00118846|464925492|FG000|Overall Study|Medical condition|2|||
129172518|NCT00118846|464925493|FG001|Overall Study|Medical condition|2|||
128780174|NCT04170023|463486458|FG002|LTE Period|Study Termination|5|||
128780175|NCT03836664|463486459|FG000|Overall Study|Didn't complete forms and lost drug|3|||
128780176|NCT03836664|463486460|FG001|Overall Study|Didn't complete forms and lost drug|3|||
128780177|NCT01427907|463486461|FG000|Overall Study|Withdrawal by Subject|3|||
128780178|NCT01427907|463486462|FG001|Overall Study|Withdrawal by Subject|4|||
128780179|NCT02179918|463486463|FG000|Overall Study|Death|0|||
128780180|NCT02179918|463486464|FG001|Overall Study|Death|0|||
128780181|NCT02179918|463486465|FG002|Overall Study|Death|0|||
128780182|NCT02179918|463486466|FG003|Overall Study|Death|1|||
129172519|NCT00118846|464925492|FG000|Overall Study|Lost to Follow-up|0|||
128780183|NCT02179918|463486467|FG004|Overall Study|Death|0|||
128780184|NCT02179918|463486463|FG000|Overall Study|Lost to Follow-up|0|||
129172520|NCT00118846|464925493|FG001|Overall Study|Lost to Follow-up|2|||
128780185|NCT02179918|463486464|FG001|Overall Study|Lost to Follow-up|0|||
128780186|NCT02179918|463486465|FG002|Overall Study|Lost to Follow-up|1|||
129172521|NCT00118846|464925492|FG000|Overall Study|Personal reason|4|||
129172522|NCT00118846|464925493|FG001|Overall Study|Personal reason|5|||
129172523|NCT00443053|464925495|FG000|Overall Study|Adverse Event|2|||
129172524|NCT00443053|464925496|FG001|Overall Study|Adverse Event|1|||
129172525|NCT00443053|464925495|FG000|Overall Study|Withdrawal by Subject|9|||
128780187|NCT02179918|463486466|FG003|Overall Study|Lost to Follow-up|0|||
128780188|NCT02179918|463486467|FG004|Overall Study|Lost to Follow-up|0|||
128780189|NCT02179918|463486463|FG000|Overall Study|Progressive Disease|4|||
128780190|NCT02179918|463486464|FG001|Overall Study|Progressive Disease|1|||
128780191|NCT02179918|463486465|FG002|Overall Study|Progressive Disease|1|||
128780192|NCT02179918|463486466|FG003|Overall Study|Progressive Disease|2|||
128780193|NCT02179918|463486467|FG004|Overall Study|Progressive Disease|6|||
128780194|NCT02179918|463486463|FG000|Overall Study|Other|0|||
128780195|NCT02179918|463486464|FG001|Overall Study|Other|1|||
128780196|NCT02179918|463486465|FG002|Overall Study|Other|0|||
128780197|NCT02179918|463486466|FG003|Overall Study|Other|0|||
129172526|NCT00443053|464925496|FG001|Overall Study|Withdrawal by Subject|18|||
129172527|NCT00443053|464925495|FG000|Overall Study|Lost to Follow-up|4|||
129172528|NCT00443053|464925496|FG001|Overall Study|Lost to Follow-up|5|||
129172529|NCT00443053|464925495|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129172530|NCT00443053|464925496|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
129172531|NCT00443053|464925495|FG000|Overall Study|Noncompliance|2|||
129172532|NCT00443053|464925496|FG001|Overall Study|Noncompliance|1|||
129172533|NCT00443053|464925495|FG000|Overall Study|Other|3|||
129172534|NCT00443053|464925496|FG001|Overall Study|Other|4|||
129172535|NCT00443053|464925495|FG000|Overall Study|Physician Decision|0|||
129172536|NCT00443053|464925496|FG001|Overall Study|Physician Decision|4|||
129172537|NCT00541866|464925497|FG000|Overall Study|Adverse Event|3|||
129172538|NCT00541866|464925498|FG001|Overall Study|Adverse Event|0|||
129172539|NCT00541866|464925499|FG002|Overall Study|Adverse Event|0|||
129172540|NCT00541866|464925500|FG003|Overall Study|Adverse Event|0|||
129172541|NCT00541866|464925501|FG004|Overall Study|Adverse Event|0|||
129172542|NCT00541866|464925497|FG000|Overall Study|Death|1|||
129172543|NCT00541866|464925498|FG001|Overall Study|Death|0|||
128780198|NCT02179918|463486467|FG004|Overall Study|Other|1|||
129172544|NCT00541866|464925499|FG002|Overall Study|Death|0|||
129172545|NCT00541866|464925500|FG003|Overall Study|Death|0|||
129172546|NCT00541866|464925501|FG004|Overall Study|Death|0|||
129172547|NCT00541866|464925497|FG000|Overall Study|Lack of Efficacy|19|||
129172548|NCT00541866|464925498|FG001|Overall Study|Lack of Efficacy|15|||
129172549|NCT00541866|464925499|FG002|Overall Study|Lack of Efficacy|10|||
129172550|NCT00541866|464925500|FG003|Overall Study|Lack of Efficacy|12|||
129172551|NCT00541866|464925501|FG004|Overall Study|Lack of Efficacy|14|||
129172552|NCT00541866|464925497|FG000|Overall Study|Not Reported or Other|11|||
129172553|NCT00541866|464925498|FG001|Overall Study|Not Reported or Other|3|||
129172554|NCT00541866|464925499|FG002|Overall Study|Not Reported or Other|3|||
129172555|NCT00541866|464925500|FG003|Overall Study|Not Reported or Other|3|||
129172556|NCT00541866|464925501|FG004|Overall Study|Not Reported or Other|1|||
129172557|NCT00541866|464925497|FG000|Overall Study|Physician Decision|0|||
129172558|NCT00541866|464925498|FG001|Overall Study|Physician Decision|0|||
129172559|NCT00541866|464925499|FG002|Overall Study|Physician Decision|2|||
129172560|NCT00541866|464925500|FG003|Overall Study|Physician Decision|1|||
129172561|NCT00541866|464925501|FG004|Overall Study|Physician Decision|0|||
129172562|NCT01327053|464925502|FG000|Overall Study|Adverse Event|23|||
129172563|NCT01327053|464925503|FG001|Overall Study|Adverse Event|57|||
129172564|NCT01327053|464925502|FG000|Overall Study|Patient/guardian decision|11|||
129172565|NCT01327053|464925503|FG001|Overall Study|Patient/guardian decision|35|||
129172566|NCT01327053|464925502|FG000|Overall Study|Physician Decision|10|||
129172567|NCT01327053|464925503|FG001|Overall Study|Physician Decision|14|||
129172568|NCT01327053|464925502|FG000|Overall Study|Death|1|||
129172569|NCT01327053|464925503|FG001|Overall Study|Death|5|||
129172570|NCT01327053|464925502|FG000|Overall Study|Lost to Follow-up|2|||
129172571|NCT01327053|464925503|FG001|Overall Study|Lost to Follow-up|4|||
129172572|NCT01327053|464925502|FG000|Overall Study|Non-compliance with study treatment|0|||
129172573|NCT01327053|464925503|FG001|Overall Study|Non-compliance with study treatment|5|||
129172574|NCT01327053|464925502|FG000|Overall Study|Study terminated by Sponsor|1|||
129172575|NCT01327053|464925503|FG001|Overall Study|Study terminated by Sponsor|3|||
129172576|NCT01327053|464925502|FG000|Overall Study|Progressive disease|31|||
129172577|NCT01327053|464925503|FG001|Overall Study|Progressive disease|26|||
129172578|NCT01327053|464925502|FG000|Overall Study|Protocol Violation|0|||
129172579|NCT01327053|464925503|FG001|Overall Study|Protocol Violation|1|||
129172580|NCT01327053|464925502|FG000|Overall Study|Untreated|0|||
129172581|NCT01327053|464925503|FG001|Overall Study|Untreated|1|||
129172582|NCT01574157|464925504|FG000|Overall Study|Withdrawal by Subject|4|||
129172583|NCT01574157|464925505|FG001|Overall Study|Withdrawal by Subject|5|||
129172584|NCT01574157|464925504|FG000|Overall Study|Lost to Follow-up|0|||
129172585|NCT01574157|464925505|FG001|Overall Study|Lost to Follow-up|3|||
129172586|NCT00721578|464925506|FG000|Overall Study|Death|1|||
129172587|NCT00721578|464925507|FG001|Overall Study|Death|1|||
129172588|NCT00721578|464925506|FG000|Overall Study|Withdrawal by Subject|1|||
129172589|NCT00721578|464925507|FG001|Overall Study|Withdrawal by Subject|1|||
129172590|NCT00350272|464925508|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
129172591|NCT00350272|464925509|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
129172592|NCT00350272|464925508|FG000|Blinded 12-Week Treatment|Death|1|||
129172593|NCT00350272|464925509|FG001|Blinded 12-Week Treatment|Death|0|||
129172594|NCT00350272|464925508|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
129172595|NCT00350272|464925509|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
129172596|NCT00350272|464925508|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
129172597|NCT00350272|464925509|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
129172598|NCT00350272|464925508|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
129172599|NCT00350272|464925509|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
129172600|NCT00350272|464925508|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
129172601|NCT00350272|464925509|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
129172602|NCT00350272|464925508|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
129172603|NCT00350272|464925509|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
129172604|NCT00350272|464925508|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
129172605|NCT00350272|464925509|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
129172606|NCT00350272|464925508|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
129172607|NCT00350272|464925509|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
129172608|NCT00350272|464925508|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
129172609|NCT00350272|464925509|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
129172610|NCT00350272|464925508|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
129172611|NCT00350272|464925509|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
129172612|NCT02910401|464925510|FG000|Overall Study|Study closure Study closure|0|||
129172613|NCT02910401|464925511|FG001|Overall Study|Study closure Study closure|0|||
129172614|NCT02910401|464925512|FG002|Overall Study|Study closure Study closure|2|||
129172615|NCT02910401|464925510|FG000|Overall Study|Physician Decision|1|||
129172616|NCT02910401|464925511|FG001|Overall Study|Physician Decision|0|||
129172617|NCT02910401|464925512|FG002|Overall Study|Physician Decision|0|||
129172618|NCT03300024|464925513|FG000|Overall Study|Physician Decision|4|||
129172619|NCT03300024|464925514|FG001|Overall Study|Physician Decision|6|||
129172620|NCT03222973|464925515|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
129172621|NCT03222973|464925516|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
129172622|NCT03222973|464925517|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
129172623|NCT03222973|464925518|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
129172624|NCT03222973|464925515|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
129172625|NCT03222973|464925516|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
129172626|NCT03222973|464925517|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
129172627|NCT03222973|464925518|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
129172628|NCT03222973|464925515|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
129172629|NCT03222973|464925516|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
129172630|NCT03222973|464925517|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
129172631|NCT03222973|464925518|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
129172632|NCT03222973|464925515|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
129172633|NCT03222973|464925516|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
128780199|NCT02179918|463486463|FG000|Overall Study|Subject refused further follow-up|0|||
128729927|NCT02583256|463308273|FG000|Overall Study|Withdrawal by Subject|0|||
128729928|NCT02583256|463308274|FG001|Overall Study|Withdrawal by Subject|1|||
128729929|NCT02583256|463308275|FG002|Overall Study|Withdrawal by Subject|1|||
128729930|NCT02583256|463308276|FG003|Overall Study|Withdrawal by Subject|0|||
128729931|NCT02583256|463308273|FG000|Overall Study|Lost to Follow-up|1|||
128729932|NCT02583256|463308274|FG001|Overall Study|Lost to Follow-up|1|||
128729933|NCT02583256|463308275|FG002|Overall Study|Lost to Follow-up|0|||
128729934|NCT02583256|463308276|FG003|Overall Study|Lost to Follow-up|1|||
128729935|NCT02583256|463308273|FG000|Overall Study|Administrative/Other|2|||
129172634|NCT03222973|464925517|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
129172635|NCT03222973|464925518|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
129172636|NCT03222973|464925515|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
129172637|NCT03222973|464925516|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
129172638|NCT03222973|464925517|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
129172639|NCT03222973|464925518|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
129172640|NCT03222973|464925515|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
129172641|NCT03222973|464925516|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
129172642|NCT03222973|464925517|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
129172643|NCT03222973|464925518|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
129172644|NCT03222973|464925515|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
129172645|NCT03222973|464925516|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
129172646|NCT03222973|464925517|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
129172647|NCT03222973|464925518|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
129172648|NCT03222973|464925515|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
129172649|NCT03222973|464925516|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
129172650|NCT03222973|464925517|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
129172651|NCT03222973|464925518|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
129172652|NCT03222973|464925515|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
129172653|NCT03222973|464925516|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
129172654|NCT03222973|464925517|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
129172655|NCT03222973|464925518|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
129172656|NCT03222973|464925515|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
129172657|NCT03222973|464925516|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
129172658|NCT03222973|464925517|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
129172659|NCT03222973|464925518|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
129172660|NCT03222973|464925515|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
129172661|NCT03222973|464925516|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
129172662|NCT03222973|464925517|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
129172663|NCT03222973|464925518|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
129172664|NCT03222973|464925515|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
129172665|NCT03222973|464925516|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
129172666|NCT03222973|464925517|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
129172667|NCT03222973|464925518|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
129172668|NCT02080481|464925519|FG000|Overall Study|Never received a block.|1|||
129172669|NCT02080481|464925520|FG001|Overall Study|Never received a block.|0|||
129172670|NCT00840060|464927529|FG000|Overall Study|Withdrawal by Subject|1|||
129172671|NCT00840060|464927530|FG001|Overall Study|Withdrawal by Subject|0|||
129172672|NCT00840060|464927529|FG000|Overall Study|Change in emotional/behavioral status|0|||
129172673|NCT00840060|464927530|FG001|Overall Study|Change in emotional/behavioral status|1|||
129172674|NCT00871923|464927531|FG000|Overall Study|Death|1|||
129172675|NCT00871923|464927531|FG000|Overall Study|Withdrawal by Subject|1|||
129172676|NCT01263015|464927536|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
129172677|NCT01263015|464927537|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
129172678|NCT01263015|464927536|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
129172679|NCT01263015|464927537|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
129172680|NCT01263015|464927536|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
129172681|NCT01263015|464927537|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
129172682|NCT01263015|464927536|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
129172683|NCT01263015|464927537|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
129172684|NCT01263015|464927536|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
129172685|NCT01263015|464927537|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
129172686|NCT01263015|464927536|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
129172687|NCT01263015|464927537|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
129172688|NCT01263015|464927536|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
129172689|NCT01263015|464927537|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
129172690|NCT01263015|464927536|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
129172691|NCT01263015|464927537|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
129172692|NCT01263015|464927536|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
129172693|NCT01263015|464927537|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
129172694|NCT01263015|464927536|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
129172695|NCT01263015|464927537|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
129172696|NCT01263015|464927536|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
129172697|NCT01263015|464927537|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
129172698|NCT01263015|464927536|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
129172699|NCT01263015|464927537|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
129172700|NCT02723006|464927538|FG000|Overall Study|Withdrawal by Subject|0|||
129172701|NCT02723006|464927539|FG001|Overall Study|Withdrawal by Subject|1|||
128729936|NCT02583256|463308274|FG001|Overall Study|Administrative/Other|0|||
128729937|NCT02583256|463308275|FG002|Overall Study|Administrative/Other|1|||
129172702|NCT02723006|464927540|FG002|Overall Study|Withdrawal by Subject|1|||
129172703|NCT02723006|464927538|FG000|Overall Study|Study Terminated by Sponsor|1|||
129172704|NCT02723006|464927539|FG001|Overall Study|Study Terminated by Sponsor|6|||
129172705|NCT02723006|464927540|FG002|Overall Study|Study Terminated by Sponsor|6|||
129172706|NCT00303446|464927541|FG000|Overall Study|Withdrawal by Subject|2|||
129172707|NCT00303446|464927542|FG001|Overall Study|Withdrawal by Subject|2|||
129172708|NCT00303446|464927541|FG000|Overall Study|Death|0|||
129172709|NCT00303446|464927542|FG001|Overall Study|Death|1|||
129172710|NCT00303446|464927541|FG000|Overall Study|Physician Decision|0|||
129172711|NCT00303446|464927542|FG001|Overall Study|Physician Decision|1|||
129172712|NCT04258995|464927543|FG000|Overall Study|Lost to Follow-up|1|||
129172713|NCT04258995|464927544|FG001|Overall Study|Lost to Follow-up|1|||
129172714|NCT00642174|464927546|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
129172715|NCT00642174|464927547|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
129172716|NCT00896363|464927548|FG000|Overall Study|Adverse Event|3|||
129172717|NCT00896363|464927549|FG001|Overall Study|Adverse Event|4|||
129172718|NCT00896363|464927550|FG002|Overall Study|Adverse Event|2|||
129172719|NCT00896363|464927548|FG000|Overall Study|Lack of Efficacy|0|||
129172720|NCT00896363|464927549|FG001|Overall Study|Lack of Efficacy|2|||
129172721|NCT00896363|464927550|FG002|Overall Study|Lack of Efficacy|1|||
129172722|NCT00896363|464927548|FG000|Overall Study|Withdrawal by Subject|3|||
129172723|NCT00896363|464927549|FG001|Overall Study|Withdrawal by Subject|5|||
129172724|NCT00896363|464927550|FG002|Overall Study|Withdrawal by Subject|5|||
129172725|NCT00316693|464927555|FG000|Overall Study|Adverse Event|6|||
129172726|NCT00316693|464927556|FG001|Overall Study|Adverse Event|1|||
129172727|NCT00316693|464927555|FG000|Overall Study|Protocol Violation|1|||
129172728|NCT00316693|464927556|FG001|Overall Study|Protocol Violation|0|||
129172729|NCT00316693|464927555|FG000|Overall Study|Withdrawal by Subject|6|||
129172730|NCT00316693|464927556|FG001|Overall Study|Withdrawal by Subject|6|||
129172731|NCT00316693|464927555|FG000|Overall Study|Lost to Follow-up|26|||
129172732|NCT00316693|464927556|FG001|Overall Study|Lost to Follow-up|34|||
129172733|NCT00316693|464927555|FG000|Overall Study|Other|38|||
129172734|NCT00316693|464927556|FG001|Overall Study|Other|44|||
129172735|NCT03002818|464927559|FG000|Overall Study|Decision of the investigator|1|||
129172736|NCT00711113|464927561|FG000|Overall Study|Lost to Follow-up|9|||
129172737|NCT00711113|464927561|FG000|Overall Study|Implant lost|2|||
129172738|NCT01606787|464927568|FG000|Overall Study|Withdrawal by Subject|4|||
129172739|NCT01606787|464927569|FG001|Overall Study|Withdrawal by Subject|5|||
129172740|NCT01606787|464927568|FG000|Overall Study|Surgery canceled|0|||
129172741|NCT01606787|464927569|FG001|Overall Study|Surgery canceled|2|||
129172742|NCT04225676|464927570|FG000|Overall Study|Physician Decision|1|||
129172743|NCT04225676|464927570|FG000|Overall Study|Lack of Efficacy|1|||
129172744|NCT04225676|464927570|FG000|Overall Study|Study terminated by sponsor|3|||
129172745|NCT03245736|464927571|FG000|Overall Study|Adverse Event|1|||
129172746|NCT03245736|464927571|FG000|Overall Study|Progressive Disease|4|||
129172747|NCT05289271|464927574|FG000|Overall Study|Mistakenly allocated, untreated|1|||
129172748|NCT05289271|464927575|FG001|Overall Study|Mistakenly allocated, untreated|0|||
129172749|NCT01257568|464927577|FG000|Overall Study|Lost to Follow-up|2|||
129172750|NCT01257568|464927577|FG000|Overall Study|Withdrawal by Subject|6|||
129172751|NCT01257568|464927577|FG000|Overall Study|Terminated|1|||
129172752|NCT01257568|464927577|FG000|Overall Study|Component Revision|24|||
129172753|NCT01231321|464927583|FG000|Overall Study|Adverse Event|3|||
129172754|NCT01231321|464927583|FG000|Overall Study|Lack of Efficacy|2|||
129172755|NCT00354107|464927587|FG000|Overall Study|Adverse Event|2|||
128729938|NCT02583256|463308276|FG003|Overall Study|Administrative/Other|2|||
128729939|NCT03364049|463308285|FG000|Overall Study|Death|6|||
129172756|NCT00354107|464927587|FG000|Overall Study|Physician Decision|2|||
129172757|NCT00354107|464927587|FG000|Overall Study|Withdrawal by Subject|1|||
129172758|NCT01685801|464927590|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
129172759|NCT01685801|464927591|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
129172760|NCT01685801|464927592|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
128729940|NCT03364049|463308286|FG001|Overall Study|Death|4|||
128729941|NCT03364049|463308287|FG002|Overall Study|Death|5|||
128729942|NCT03364049|463308288|FG003|Overall Study|Death|14|||
128729943|NCT03364049|463308285|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
128729944|NCT03364049|463308286|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
128729945|NCT03364049|463308287|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
128729946|NCT03364049|463308288|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
128729947|NCT03364049|463308285|FG000|Overall Study|Withdrawal by Subject|0|||
128729948|NCT03364049|463308286|FG001|Overall Study|Withdrawal by Subject|1|||
128729949|NCT03364049|463308287|FG002|Overall Study|Withdrawal by Subject|1|||
128729950|NCT03364049|463308288|FG003|Overall Study|Withdrawal by Subject|1|||
128729951|NCT02953821|463308289|FG000|Overall Study|Adverse Event|0|||
128729952|NCT02953821|463308290|FG001|Overall Study|Adverse Event|4|||
128729953|NCT02953821|463308289|FG000|Overall Study|Death|1|||
128729954|NCT02953821|463308290|FG001|Overall Study|Death|0|||
128729955|NCT02953821|463308289|FG000|Overall Study|Progressive Disease|5|||
128729956|NCT02953821|463308290|FG001|Overall Study|Progressive Disease|1|||
128729957|NCT02953821|463308289|FG000|Overall Study|Lost to Follow-up|2|||
128729958|NCT02953821|463308290|FG001|Overall Study|Lost to Follow-up|0|||
128729959|NCT02953821|463308289|FG000|Overall Study|Physician Decision|1|||
128729960|NCT02953821|463308290|FG001|Overall Study|Physician Decision|1|||
128729961|NCT02953821|463308289|FG000|Overall Study|Withdrawal by Subject|3|||
128729962|NCT02953821|463308290|FG001|Overall Study|Withdrawal by Subject|3|||
128729963|NCT02953821|463308289|FG000|Overall Study|Change of address|0|||
128729964|NCT02953821|463308290|FG001|Overall Study|Change of address|1|||
128729965|NCT02953821|463308289|FG000|Overall Study|Lack of Efficacy|1|||
128729966|NCT02953821|463308290|FG001|Overall Study|Lack of Efficacy|0|||
128729967|NCT02953821|463308289|FG000|Overall Study|Out of state for indeterminate time|0|||
128729968|NCT02953821|463308290|FG001|Overall Study|Out of state for indeterminate time|1|||
128729969|NCT02953821|463308289|FG000|Overall Study|No improvement|0|||
128729970|NCT02953821|463308290|FG001|Overall Study|No improvement|1|||
129172761|NCT01685801|464927593|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
129172762|NCT01685801|464927590|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
129172763|NCT01685801|464927591|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
129172764|NCT01685801|464927592|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
129172765|NCT01685801|464927593|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
129172766|NCT00396136|464927594|FG000|Overall Study|Death|43|||
129172767|NCT00396136|464927594|FG000|Overall Study|Withdrawal by Subject|59|||
129172768|NCT00396136|464927594|FG000|Overall Study|Lost to Follow-up|15|||
129172769|NCT00396136|464927594|FG000|Overall Study|Study device explanted|8|||
129172770|NCT03960580|464927595|FG000|Overall Study|Adverse Event|2|||
129172771|NCT03960580|464927596|FG001|Overall Study|Adverse Event|1|||
129172772|NCT03960580|464927597|FG002|Overall Study|Adverse Event|1|||
129172773|NCT03960580|464927595|FG000|Overall Study|Lost to Follow-up|1|||
129172774|NCT03960580|464927596|FG001|Overall Study|Lost to Follow-up|0|||
129172775|NCT03960580|464927597|FG002|Overall Study|Lost to Follow-up|0|||
129172776|NCT03960580|464927595|FG000|Overall Study|Lack of Efficacy|2|||
129172777|NCT03960580|464927596|FG001|Overall Study|Lack of Efficacy|1|||
129172778|NCT03960580|464927597|FG002|Overall Study|Lack of Efficacy|0|||
129172779|NCT03960580|464927595|FG000|Overall Study|Protocol Violation|0|||
129172780|NCT03960580|464927596|FG001|Overall Study|Protocol Violation|0|||
129172781|NCT03960580|464927597|FG002|Overall Study|Protocol Violation|1|||
129172782|NCT03960580|464927595|FG000|Overall Study|Withdrawal by Subject|1|||
129172783|NCT03960580|464927596|FG001|Overall Study|Withdrawal by Subject|1|||
129172784|NCT03960580|464927597|FG002|Overall Study|Withdrawal by Subject|1|||
129172785|NCT03960580|464927595|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
129172786|NCT03960580|464927596|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
129172787|NCT03960580|464927597|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
129172788|NCT03447314|464927600|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
129172789|NCT03447314|464927601|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
129172790|NCT03447314|464927602|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
129172791|NCT03447314|464927603|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
129172792|NCT03447314|464927604|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
129172793|NCT03447314|464927605|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
129172794|NCT03447314|464927606|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
129172795|NCT03447314|464927607|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172796|NCT03447314|464927608|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172797|NCT03447314|464927609|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172798|NCT03447314|464927610|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
129172799|NCT03447314|464927611|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
129172800|NCT03447314|464927612|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172801|NCT03447314|464927613|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172802|NCT03447314|464927614|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172803|NCT03447314|464927615|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172804|NCT03447314|464927616|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172805|NCT03447314|464927617|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129172806|NCT03447314|464927600|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129172807|NCT03447314|464927601|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172808|NCT03447314|464927602|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129172809|NCT03447314|464927603|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172810|NCT03447314|464927604|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172811|NCT03447314|464927605|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129172812|NCT03447314|464927606|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129172813|NCT03447314|464927607|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172814|NCT03447314|464927608|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172815|NCT03447314|464927609|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172816|NCT03447314|464927610|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172817|NCT03447314|464927611|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172818|NCT03447314|464927612|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172819|NCT03447314|464927613|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172820|NCT03447314|464927614|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172821|NCT03447314|464927615|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172822|NCT03447314|464927616|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172823|NCT03447314|464927617|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129172824|NCT03447314|464927600|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172825|NCT03447314|464927601|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172826|NCT03447314|464927602|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
129172827|NCT03447314|464927603|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172828|NCT03447314|464927604|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172829|NCT03447314|464927605|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172830|NCT03447314|464927606|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172831|NCT03447314|464927607|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172832|NCT03447314|464927608|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172833|NCT03447314|464927609|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172834|NCT03447314|464927610|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172835|NCT03447314|464927611|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172836|NCT03447314|464927612|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
128780200|NCT02179918|463486464|FG001|Overall Study|Subject refused further follow-up|1|||
128780201|NCT02179918|463486465|FG002|Overall Study|Subject refused further follow-up|0|||
128780202|NCT02179918|463486466|FG003|Overall Study|Subject refused further follow-up|0|||
128780203|NCT02179918|463486467|FG004|Overall Study|Subject refused further follow-up|1|||
128780204|NCT00972543|463486472|FG000|Overall Study|Adverse Event|1|||
128780205|NCT00972543|463486473|FG001|Overall Study|Adverse Event|0|||
128780206|NCT00972543|463486472|FG000|Overall Study|Early study termination by sponsor|4|||
128780207|NCT00972543|463486473|FG001|Overall Study|Early study termination by sponsor|1|||
128780208|NCT04537949|463486476|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
128780209|NCT04537949|463486477|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
128780210|NCT04537949|463486478|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
128780211|NCT04537949|463486479|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
128780212|NCT04537949|463486480|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
128780213|NCT04537949|463486481|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
128780214|NCT04537949|463486482|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
128780215|NCT04537949|463486483|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
128780216|NCT04537949|463486476|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
128780217|NCT04537949|463486477|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
128780218|NCT04537949|463486478|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
128780219|NCT04537949|463486479|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
128780220|NCT04537949|463486480|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
128780221|NCT04537949|463486481|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
128780222|NCT04537949|463486482|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
128780223|NCT04537949|463486483|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
128780224|NCT04537949|463486476|FG000|Follow-up Phase|Lost to Follow-up|0|||
128780225|NCT04537949|463486477|FG001|Follow-up Phase|Lost to Follow-up|3|||
128780226|NCT04537949|463486478|FG002|Follow-up Phase|Lost to Follow-up|0|||
128780227|NCT04537949|463486479|FG003|Follow-up Phase|Lost to Follow-up|0|||
128780228|NCT04537949|463486480|FG004|Follow-up Phase|Lost to Follow-up|0|||
128780229|NCT04537949|463486481|FG005|Follow-up Phase|Lost to Follow-up|0|||
128780230|NCT04537949|463486482|FG006|Follow-up Phase|Lost to Follow-up|0|||
128780231|NCT04537949|463486483|FG007|Follow-up Phase|Lost to Follow-up|0|||
128780232|NCT04537949|463486476|FG000|Follow-up Phase|personal reasons|0|||
128780233|NCT04537949|463486477|FG001|Follow-up Phase|personal reasons|0|||
128780234|NCT04537949|463486478|FG002|Follow-up Phase|personal reasons|0|||
128780235|NCT04537949|463486479|FG003|Follow-up Phase|personal reasons|1|||
128780236|NCT04537949|463486480|FG004|Follow-up Phase|personal reasons|1|||
128780237|NCT04537949|463486481|FG005|Follow-up Phase|personal reasons|0|||
128780238|NCT04537949|463486482|FG006|Follow-up Phase|personal reasons|0|||
128780239|NCT04537949|463486483|FG007|Follow-up Phase|personal reasons|0|||
128780240|NCT04537949|463486476|FG000|Follow-up Phase|Withdrawal by Subject|0|||
128780241|NCT04537949|463486477|FG001|Follow-up Phase|Withdrawal by Subject|0|||
128780242|NCT04537949|463486478|FG002|Follow-up Phase|Withdrawal by Subject|0|||
128780243|NCT04537949|463486479|FG003|Follow-up Phase|Withdrawal by Subject|0|||
128780244|NCT04537949|463486480|FG004|Follow-up Phase|Withdrawal by Subject|1|||
128780245|NCT04537949|463486481|FG005|Follow-up Phase|Withdrawal by Subject|0|||
128780246|NCT04537949|463486482|FG006|Follow-up Phase|Withdrawal by Subject|0|||
128780247|NCT04537949|463486483|FG007|Follow-up Phase|Withdrawal by Subject|0|||
128780248|NCT04003974|463486485|FG000|Overall Study|Missing|1|||
128780249|NCT04003974|463486486|FG001|Overall Study|Missing|0|||
128780250|NCT04003974|463486485|FG000|Overall Study|Withdrawal by Subject|0|||
128780251|NCT04003974|463486486|FG001|Overall Study|Withdrawal by Subject|2|||
128780252|NCT04296942|463486487|FG000|Overall Study|Study closure by sponsor|1|||
128780253|NCT04296942|463486488|FG001|Overall Study|Study closure by sponsor|0|||
128780254|NCT04296942|463486489|FG002|Overall Study|Study closure by sponsor|0|||
128780255|NCT00335153|463486490|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
128780256|NCT00335153|463486490|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
128780257|NCT00335153|463486490|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
128780258|NCT00335153|463486490|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
128780259|NCT00335153|463486490|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
128780260|NCT00335153|463486490|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
128780261|NCT00335153|463486490|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
128780262|NCT00335153|463486490|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
128780263|NCT00335153|463486490|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
128780264|NCT00335153|463486490|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
128780265|NCT02478359|463486495|FG000|Overall Study|Disenrolled from health plan|106|||
128780266|NCT02478359|463486496|FG001|Overall Study|Disenrolled from health plan|65|||
128780267|NCT00372528|463486497|FG000|Overall Study|Lack of Efficacy|1|||
128780268|NCT00372528|463486497|FG000|Overall Study|Adverse Event|1|||
128780269|NCT00372528|463486497|FG000|Overall Study|Study Terminated by Sponsor|18|||
128780270|NCT00372528|463486497|FG000|Overall Study|Other|1|||
128780271|NCT01414166|463486506|FG000|Overall Study|Adverse Event|10|||
128780272|NCT01414166|463486507|FG001|Overall Study|Adverse Event|2|||
128780273|NCT01414166|463486506|FG000|Overall Study|Lost to Follow-up|4|||
128780274|NCT01414166|463486507|FG001|Overall Study|Lost to Follow-up|1|||
128780275|NCT01414166|463486506|FG000|Overall Study|Non-compliance with study drug|2|||
128780276|NCT01414166|463486507|FG001|Overall Study|Non-compliance with study drug|0|||
128780277|NCT01414166|463486506|FG000|Overall Study|Physician Decision|2|||
128780278|NCT01414166|463486507|FG001|Overall Study|Physician Decision|0|||
128780279|NCT01414166|463486506|FG000|Overall Study|Protocol Violation|2|||
128780280|NCT01414166|463486507|FG001|Overall Study|Protocol Violation|0|||
128780281|NCT01414166|463486506|FG000|Overall Study|Study terminated by Sponsor|68|||
128780282|NCT01414166|463486507|FG001|Overall Study|Study terminated by Sponsor|75|||
128780283|NCT01414166|463486506|FG000|Overall Study|Withdrawal by Subject|3|||
128780284|NCT01414166|463486507|FG001|Overall Study|Withdrawal by Subject|5|||
128780285|NCT03782727|463486508|FG000|Overall Study|Lost to Follow-up|32|||
128780286|NCT02084082|463486509|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
128780287|NCT02084082|463486510|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
128780288|NCT02084082|463486511|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
128780289|NCT02084082|463486512|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
128780290|NCT02084082|463486509|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
128780291|NCT02084082|463486510|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
128780292|NCT02084082|463486511|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
128780293|NCT02084082|463486512|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
128780294|NCT04736056|463486513|FG000|Overall Study|Death|0|||
128780295|NCT04736056|463486514|FG001|Overall Study|Death|0|||
128780296|NCT04736056|463486515|FG002|Overall Study|Death|0|||
128780297|NCT04736056|463486516|FG003|Overall Study|Death|1|||
128780298|NCT04736056|463486513|FG000|Overall Study|Lost to Follow-up|1|||
128780299|NCT04736056|463486514|FG001|Overall Study|Lost to Follow-up|0|||
128780300|NCT04736056|463486515|FG002|Overall Study|Lost to Follow-up|1|||
128780301|NCT04736056|463486516|FG003|Overall Study|Lost to Follow-up|1|||
128780302|NCT04736056|463486513|FG000|Overall Study|Withdrawal by Subject|2|||
128780303|NCT04736056|463486514|FG001|Overall Study|Withdrawal by Subject|0|||
128780304|NCT04736056|463486515|FG002|Overall Study|Withdrawal by Subject|0|||
128780305|NCT04736056|463486516|FG003|Overall Study|Withdrawal by Subject|0|||
128780306|NCT04736056|463486513|FG000|Overall Study|Physician Decision|1|||
128780307|NCT04736056|463486514|FG001|Overall Study|Physician Decision|0|||
128780308|NCT04736056|463486515|FG002|Overall Study|Physician Decision|1|||
128780309|NCT04736056|463486516|FG003|Overall Study|Physician Decision|0|||
128780310|NCT02956967|463486523|FG000|Overall Study|Adverse Event|3|||
128780311|NCT02956967|463486523|FG000|Overall Study|Reason non-related to neutropenia|10|||
128780312|NCT02956967|463486523|FG000|Overall Study|Lost to Follow-up|5|||
128780313|NCT02956967|463486523|FG000|Overall Study|Missing|1|||
128780314|NCT02956967|463486523|FG000|Overall Study|Termination of Nivestim administration|29|||
128780315|NCT00819234|463486524|FG000|Overall Study|Withdrawal by Subject|8|||
128780316|NCT00819234|463486525|FG001|Overall Study|Withdrawal by Subject|13|||
128780317|NCT00819234|463486526|FG002|Overall Study|Withdrawal by Subject|6|||
128780318|NCT00819234|463486527|FG003|Overall Study|Withdrawal by Subject|3|||
128780319|NCT00819234|463486528|FG004|Overall Study|Withdrawal by Subject|0|||
128780320|NCT00819234|463486529|FG005|Overall Study|Withdrawal by Subject|4|||
128780321|NCT00819234|463486530|FG006|Overall Study|Withdrawal by Subject|4|||
128780322|NCT00819234|463486531|FG007|Overall Study|Withdrawal by Subject|8|||
128780323|NCT00819234|463486532|FG008|Overall Study|Withdrawal by Subject|5|||
128780324|NCT00819234|463486533|FG009|Overall Study|Withdrawal by Subject|3|||
128780325|NCT00819234|463486524|FG000|Overall Study|Adverse Event|0|||
128780326|NCT00819234|463486525|FG001|Overall Study|Adverse Event|0|||
128780327|NCT00819234|463486526|FG002|Overall Study|Adverse Event|1|||
128780328|NCT00819234|463486527|FG003|Overall Study|Adverse Event|0|||
128780329|NCT00819234|463486528|FG004|Overall Study|Adverse Event|0|||
128780330|NCT00819234|463486529|FG005|Overall Study|Adverse Event|2|||
128780331|NCT00819234|463486530|FG006|Overall Study|Adverse Event|0|||
128780332|NCT00819234|463486531|FG007|Overall Study|Adverse Event|0|||
128780333|NCT00819234|463486532|FG008|Overall Study|Adverse Event|0|||
128780334|NCT00819234|463486533|FG009|Overall Study|Adverse Event|0|||
128780335|NCT00819234|463486524|FG000|Overall Study|Physician Decision|0|||
128780336|NCT00819234|463486525|FG001|Overall Study|Physician Decision|0|||
128780337|NCT00819234|463486526|FG002|Overall Study|Physician Decision|0|||
128780338|NCT00819234|463486527|FG003|Overall Study|Physician Decision|1|||
128780339|NCT00819234|463486528|FG004|Overall Study|Physician Decision|0|||
128780340|NCT00819234|463486529|FG005|Overall Study|Physician Decision|0|||
128780341|NCT00819234|463486530|FG006|Overall Study|Physician Decision|0|||
128780342|NCT00819234|463486531|FG007|Overall Study|Physician Decision|0|||
128780343|NCT00819234|463486532|FG008|Overall Study|Physician Decision|0|||
128780344|NCT00819234|463486533|FG009|Overall Study|Physician Decision|2|||
128780345|NCT00819234|463486524|FG000|Overall Study|Protocol Violation|0|||
128780346|NCT00819234|463486525|FG001|Overall Study|Protocol Violation|0|||
128780347|NCT00819234|463486526|FG002|Overall Study|Protocol Violation|1|||
128780348|NCT00819234|463486527|FG003|Overall Study|Protocol Violation|0|||
128780349|NCT00819234|463486528|FG004|Overall Study|Protocol Violation|0|||
128780350|NCT00819234|463486529|FG005|Overall Study|Protocol Violation|0|||
128780351|NCT00819234|463486530|FG006|Overall Study|Protocol Violation|0|||
128780352|NCT00819234|463486531|FG007|Overall Study|Protocol Violation|0|||
128780353|NCT00819234|463486532|FG008|Overall Study|Protocol Violation|0|||
128780354|NCT00819234|463486533|FG009|Overall Study|Protocol Violation|0|||
128780355|NCT00819234|463486524|FG000|Overall Study|Lost to Follow-up|2|||
128780356|NCT00819234|463486525|FG001|Overall Study|Lost to Follow-up|2|||
128780357|NCT00819234|463486526|FG002|Overall Study|Lost to Follow-up|0|||
128780358|NCT00819234|463486527|FG003|Overall Study|Lost to Follow-up|2|||
128780359|NCT00819234|463486528|FG004|Overall Study|Lost to Follow-up|1|||
128780360|NCT00819234|463486529|FG005|Overall Study|Lost to Follow-up|1|||
128780361|NCT00819234|463486530|FG006|Overall Study|Lost to Follow-up|1|||
128780362|NCT00819234|463486531|FG007|Overall Study|Lost to Follow-up|1|||
129172837|NCT03447314|464927613|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172838|NCT03447314|464927614|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172839|NCT03447314|464927615|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172840|NCT03447314|464927616|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172841|NCT03447314|464927617|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129172842|NCT03447314|464927600|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172843|NCT03447314|464927601|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172844|NCT03447314|464927602|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
129172845|NCT03447314|464927603|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172846|NCT03447314|464927604|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172847|NCT03447314|464927605|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172848|NCT03447314|464927606|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172849|NCT03447314|464927607|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172850|NCT03447314|464927608|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172851|NCT03447314|464927609|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172852|NCT03447314|464927610|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172853|NCT03447314|464927611|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172854|NCT03447314|464927612|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172855|NCT03447314|464927613|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172856|NCT03447314|464927614|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172857|NCT03447314|464927615|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172858|NCT03447314|464927616|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
128780363|NCT00819234|463486532|FG008|Overall Study|Lost to Follow-up|1|||
128780364|NCT00819234|463486533|FG009|Overall Study|Lost to Follow-up|2|||
128780365|NCT01823341|463486534|FG000|Overall Study|Failed run-in|7|||
128780366|NCT01823341|463486534|FG000|Overall Study|Withdrawal by Subject|7|||
128780367|NCT01823341|463486534|FG000|Overall Study|Adverse Event|1|||
128780368|NCT00924560|463486535|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
128780369|NCT00924560|463486536|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
128780370|NCT00924560|463486537|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
128780371|NCT00924560|463486535|FG000|Overall Study|Non Compliance with the Protocol|20|||
128780372|NCT00924560|463486536|FG001|Overall Study|Non Compliance with the Protocol|15|||
128780373|NCT00924560|463486537|FG002|Overall Study|Non Compliance with the Protocol|4|||
128780374|NCT00924560|463486535|FG000|Overall Study|Physician Decision|2|||
128780375|NCT00924560|463486536|FG001|Overall Study|Physician Decision|3|||
128780376|NCT00924560|463486537|FG002|Overall Study|Physician Decision|4|||
129172859|NCT03447314|464927617|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129172860|NCT03447314|464927600|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172861|NCT03447314|464927601|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172862|NCT03447314|464927602|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172863|NCT03447314|464927603|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172864|NCT03447314|464927604|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172865|NCT03447314|464927605|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172866|NCT03447314|464927606|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172867|NCT03447314|464927607|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172868|NCT03447314|464927608|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172869|NCT03447314|464927609|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172870|NCT03447314|464927610|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
129172871|NCT03447314|464927611|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172872|NCT03447314|464927612|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172873|NCT03447314|464927613|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172874|NCT03447314|464927614|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172875|NCT03447314|464927615|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172876|NCT03447314|464927616|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172877|NCT03447314|464927617|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129172878|NCT03447314|464927600|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172879|NCT03447314|464927601|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172880|NCT03447314|464927602|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172881|NCT03447314|464927603|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
129172882|NCT03447314|464927604|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172883|NCT03447314|464927605|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
129172884|NCT03447314|464927606|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172885|NCT03447314|464927607|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172886|NCT03447314|464927608|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172887|NCT03447314|464927609|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172888|NCT03447314|464927610|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172889|NCT03447314|464927611|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172890|NCT03447314|464927612|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172891|NCT03447314|464927613|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172892|NCT03447314|464927614|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172893|NCT03447314|464927615|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172894|NCT03447314|464927616|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
128729971|NCT02953821|463308289|FG000|Overall Study|Refused follow-up visit|2|||
129172895|NCT03447314|464927617|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129172896|NCT04600076|464927618|FG000|Overall Study|Lost to Follow-up|3|||
128729972|NCT02953821|463308290|FG001|Overall Study|Refused follow-up visit|1|||
128729973|NCT02103478|463308291|FG000|Overall Study|Adverse Event|0|||
128729974|NCT02103478|463308292|FG001|Overall Study|Adverse Event|0|||
128729975|NCT02103478|463308293|FG002|Overall Study|Adverse Event|1|||
128729976|NCT02103478|463308294|FG003|Overall Study|Adverse Event|1|||
128729977|NCT02103478|463308295|FG004|Overall Study|Adverse Event|2|||
128729978|NCT02103478|463308296|FG005|Overall Study|Adverse Event|1|||
128729979|NCT02103478|463308297|FG006|Overall Study|Adverse Event|0|||
128729980|NCT02103478|463308298|FG007|Overall Study|Adverse Event|0|||
128729981|NCT02103478|463308299|FG008|Overall Study|Adverse Event|0|||
128729982|NCT02103478|463308291|FG000|Overall Study|Death|2|||
128729983|NCT02103478|463308292|FG001|Overall Study|Death|2|||
128729984|NCT02103478|463308293|FG002|Overall Study|Death|1|||
128729985|NCT02103478|463308294|FG003|Overall Study|Death|1|||
128729986|NCT02103478|463308295|FG004|Overall Study|Death|5|||
128729987|NCT02103478|463308296|FG005|Overall Study|Death|15|||
128729988|NCT02103478|463308297|FG006|Overall Study|Death|14|||
128729989|NCT02103478|463308298|FG007|Overall Study|Death|10|||
128729990|NCT02103478|463308299|FG008|Overall Study|Death|11|||
128729991|NCT02103478|463308291|FG000|Overall Study|Progressive Disease|2|||
128729992|NCT02103478|463308292|FG001|Overall Study|Progressive Disease|1|||
128729993|NCT02103478|463308293|FG002|Overall Study|Progressive Disease|2|||
128729994|NCT02103478|463308294|FG003|Overall Study|Progressive Disease|0|||
129172897|NCT00957944|464927619|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
129172898|NCT00957944|464927620|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
129172899|NCT01482169|464927621|FG000|Overall Study|Physician Decision|2|||
129172900|NCT00522418|464927622|FG000|Overall Study|Local IRB Consent Violation|5|||
129172901|NCT00522418|464927623|FG001|Overall Study|Local IRB Consent Violation|5|||
129172902|NCT00522418|464927622|FG000|Overall Study|Early Study Termination|46|||
129172903|NCT00522418|464927623|FG001|Overall Study|Early Study Termination|47|||
129172904|NCT00522418|464927622|FG000|Overall Study|Noncompliance|2|||
129172905|NCT00522418|464927623|FG001|Overall Study|Noncompliance|2|||
129172906|NCT00522418|464927622|FG000|Overall Study|Reason Not Specified|3|||
129172907|NCT00522418|464927623|FG001|Overall Study|Reason Not Specified|1|||
129172908|NCT00522418|464927622|FG000|Overall Study|Consent Withdraw|1|||
129172909|NCT00522418|464927623|FG001|Overall Study|Consent Withdraw|2|||
129172910|NCT00522418|464927622|FG000|Overall Study|Lack of Efficacy|0|||
129172911|NCT00522418|464927623|FG001|Overall Study|Lack of Efficacy|1|||
129172912|NCT00578877|464927626|FG000|Overall Study|Lost to Follow-up|8|||
129172913|NCT00578877|464927627|FG001|Overall Study|Lost to Follow-up|10|||
129172914|NCT00578877|464927626|FG000|Overall Study|early discontinue|61|||
129172915|NCT00578877|464927627|FG001|Overall Study|early discontinue|101|||
129172916|NCT00578877|464927626|FG000|Overall Study|did not provide follow-up data|12|||
129172917|NCT00578877|464927627|FG001|Overall Study|did not provide follow-up data|17|||
129172918|NCT01944098|464927632|FG000|Overall Study|Physician Decision|1|||
129172919|NCT01944098|464927633|FG001|Overall Study|Physician Decision|0|||
129172920|NCT05032690|464927634|FG000|Period 1|Adverse Event|0|||
129172921|NCT05032690|464927635|FG001|Period 1|Adverse Event|1|||
129172922|NCT05032690|464927636|FG002|Period 1|Adverse Event|0|||
129172923|NCT05032690|464927637|FG003|Period 1|Adverse Event|0|||
129172924|NCT05032690|464927634|FG000|Period 1|Withdrawal by Subject|1|||
129172925|NCT05032690|464927635|FG001|Period 1|Withdrawal by Subject|0|||
129172926|NCT05032690|464927636|FG002|Period 1|Withdrawal by Subject|0|||
129172927|NCT05032690|464927637|FG003|Period 1|Withdrawal by Subject|0|||
129172928|NCT05032690|464927634|FG000|Period 1|No longer meets eligibility criteria|0|||
129172929|NCT05032690|464927635|FG001|Period 1|No longer meets eligibility criteria|1|||
129172930|NCT05032690|464927636|FG002|Period 1|No longer meets eligibility criteria|0|||
129172931|NCT05032690|464927637|FG003|Period 1|No longer meets eligibility criteria|0|||
129172932|NCT05032690|464927634|FG000|Period 2|Adverse Event|1|||
129172933|NCT05032690|464927635|FG001|Period 2|Adverse Event|0|||
129172934|NCT05032690|464927636|FG002|Period 2|Adverse Event|0|||
129172935|NCT05032690|464927637|FG003|Period 2|Adverse Event|0|||
129172936|NCT05032690|464927634|FG000|Period 2|Withdrawal by Subject|0|||
129172937|NCT05032690|464927635|FG001|Period 2|Withdrawal by Subject|1|||
129172938|NCT05032690|464927636|FG002|Period 2|Withdrawal by Subject|0|||
129172939|NCT05032690|464927637|FG003|Period 2|Withdrawal by Subject|0|||
129172940|NCT05032690|464927634|FG000|Period 2|No longer meets eligibility criteria|0|||
129172941|NCT05032690|464927635|FG001|Period 2|No longer meets eligibility criteria|1|||
129172942|NCT05032690|464927636|FG002|Period 2|No longer meets eligibility criteria|0|||
129172943|NCT05032690|464927637|FG003|Period 2|No longer meets eligibility criteria|0|||
129172944|NCT05032690|464927634|FG000|Period 3|Adverse Event|0|||
129172945|NCT05032690|464927635|FG001|Period 3|Adverse Event|1|||
129172946|NCT05032690|464927636|FG002|Period 3|Adverse Event|0|||
129172947|NCT05032690|464927637|FG003|Period 3|Adverse Event|0|||
129172948|NCT00737568|464927640|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
129172949|NCT00737568|464927641|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
129172950|NCT00737568|464927640|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
129172951|NCT00737568|464927641|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
129172952|NCT00737568|464927640|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
129172953|NCT00737568|464927641|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
129172954|NCT00737568|464927640|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
129172955|NCT00737568|464927641|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
129172956|NCT00737568|464927640|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
129172957|NCT00737568|464927641|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
129172958|NCT00737568|464927640|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
129172959|NCT00737568|464927641|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
129172960|NCT00737568|464927640|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
129172961|NCT00737568|464927641|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
129172962|NCT00737568|464927640|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
129172963|NCT00737568|464927641|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
129172964|NCT00737568|464927640|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
129172965|NCT00737568|464927641|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
129172966|NCT00855933|464927642|FG000|Overall Study|Withdrawal by Subject|0|||
129172967|NCT00855933|464927643|FG001|Overall Study|Withdrawal by Subject|1|||
129172968|NCT00951080|464927644|FG000|Overall Study|Adverse Event|3|||
129172969|NCT00951080|464927645|FG001|Overall Study|Adverse Event|3|||
129172970|NCT00951080|464927644|FG000|Overall Study|Lost to Follow-up|0|||
129172971|NCT00951080|464927645|FG001|Overall Study|Lost to Follow-up|1|||
129172972|NCT00951080|464927644|FG000|Overall Study|Physician Decision|4|||
129172973|NCT00951080|464927645|FG001|Overall Study|Physician Decision|1|||
129172974|NCT00951080|464927644|FG000|Overall Study|Other|19|||
129172975|NCT00951080|464927645|FG001|Overall Study|Other|22|||
129172976|NCT01960998|464927646|FG000|Overall Study|Lost to Follow-up|3|||
129172977|NCT01960998|464927647|FG001|Overall Study|Lost to Follow-up|7|||
129172978|NCT01960998|464927646|FG000|Overall Study|Death|0|||
129172979|NCT01960998|464927647|FG001|Overall Study|Death|1|||
129172980|NCT01960998|464927646|FG000|Overall Study|Withdrawal by Subject|8|||
129172981|NCT01960998|464927647|FG001|Overall Study|Withdrawal by Subject|2|||
129172982|NCT01960998|464927646|FG000|Overall Study|lost computer access|0|||
129172983|NCT01960998|464927647|FG001|Overall Study|lost computer access|1|||
129172984|NCT00759356|464927648|FG000|Overall Study|Adverse Event|0|||
129172985|NCT00759356|464927649|FG001|Overall Study|Adverse Event|1|||
129172986|NCT00759356|464927648|FG000|Overall Study|Withdrawal by Subject|0|||
129172987|NCT00759356|464927649|FG001|Overall Study|Withdrawal by Subject|2|||
129172988|NCT00759356|464927648|FG000|Overall Study|Subject was unable to return|1|||
129172989|NCT00759356|464927649|FG001|Overall Study|Subject was unable to return|0|||
129172990|NCT01713283|464927653|FG000|Overall Study|Lack of Efficacy|10|||
129172991|NCT01713283|464927654|FG001|Overall Study|Lack of Efficacy|2|||
129172992|NCT01713283|464927653|FG000|Overall Study|Lost to Follow-up|1|||
129172993|NCT01713283|464927654|FG001|Overall Study|Lost to Follow-up|1|||
129172994|NCT01904149|464927660|FG000|Overall Study|Adverse Event|3|||
129172995|NCT01904149|464927661|FG001|Overall Study|Adverse Event|4|||
129172996|NCT01904149|464927662|FG002|Overall Study|Adverse Event|0|||
129172997|NCT01904149|464927663|FG003|Overall Study|Adverse Event|1|||
129172998|NCT01904149|464927664|FG004|Overall Study|Adverse Event|1|||
129172999|NCT01904149|464927665|FG005|Overall Study|Adverse Event|2|||
129173000|NCT01904149|464927660|FG000|Overall Study|Lack of Efficacy|0|||
128780377|NCT00924560|463486535|FG000|Overall Study|Withdrawal by Subject|50|||
129173001|NCT01904149|464927661|FG001|Overall Study|Lack of Efficacy|3|||
129173002|NCT01904149|464927662|FG002|Overall Study|Lack of Efficacy|1|||
129173003|NCT01904149|464927663|FG003|Overall Study|Lack of Efficacy|3|||
129173004|NCT01904149|464927664|FG004|Overall Study|Lack of Efficacy|3|||
129173005|NCT01904149|464927665|FG005|Overall Study|Lack of Efficacy|1|||
129173006|NCT01904149|464927660|FG000|Overall Study|Withdrawal by Subject|1|||
129173007|NCT01904149|464927661|FG001|Overall Study|Withdrawal by Subject|3|||
129173008|NCT01904149|464927662|FG002|Overall Study|Withdrawal by Subject|1|||
129173009|NCT01904149|464927663|FG003|Overall Study|Withdrawal by Subject|0|||
129173010|NCT01904149|464927664|FG004|Overall Study|Withdrawal by Subject|1|||
129173011|NCT01904149|464927665|FG005|Overall Study|Withdrawal by Subject|0|||
129173012|NCT01904149|464927660|FG000|Overall Study|Protocol Violation|0|||
129173013|NCT01904149|464927661|FG001|Overall Study|Protocol Violation|1|||
129173014|NCT01904149|464927662|FG002|Overall Study|Protocol Violation|0|||
129173015|NCT01904149|464927663|FG003|Overall Study|Protocol Violation|0|||
129173016|NCT01904149|464927664|FG004|Overall Study|Protocol Violation|0|||
129173017|NCT01904149|464927665|FG005|Overall Study|Protocol Violation|0|||
129173018|NCT01904149|464927660|FG000|Overall Study|non compliance with study drug|1|||
129173019|NCT01904149|464927661|FG001|Overall Study|non compliance with study drug|0|||
129173020|NCT01904149|464927662|FG002|Overall Study|non compliance with study drug|0|||
129173021|NCT01904149|464927663|FG003|Overall Study|non compliance with study drug|0|||
129173022|NCT01904149|464927664|FG004|Overall Study|non compliance with study drug|0|||
129173023|NCT01904149|464927665|FG005|Overall Study|non compliance with study drug|0|||
129173024|NCT00812006|464927666|FG000|Overall Study|Lost to Follow-up|0|||
129173025|NCT00812006|464927667|FG001|Overall Study|Lost to Follow-up|0|||
129173026|NCT00812006|464927668|FG002|Overall Study|Lost to Follow-up|2|||
129173027|NCT00812006|464927666|FG000|Overall Study|Physician Decision|0|||
129173028|NCT00812006|464927667|FG001|Overall Study|Physician Decision|0|||
129173029|NCT00812006|464927668|FG002|Overall Study|Physician Decision|1|||
129173030|NCT00812006|464927666|FG000|Overall Study|Withdrawal by Subject|2|||
129173031|NCT00812006|464927667|FG001|Overall Study|Withdrawal by Subject|1|||
129173032|NCT00812006|464927668|FG002|Overall Study|Withdrawal by Subject|1|||
129173033|NCT00812006|464927666|FG000|Overall Study|Lack of Qualifying Event|4|||
129173034|NCT00812006|464927667|FG001|Overall Study|Lack of Qualifying Event|2|||
129173035|NCT00812006|464927668|FG002|Overall Study|Lack of Qualifying Event|2|||
129173036|NCT00235391|464927669|FG000|Overall Study|Adverse Event|4|||
129173037|NCT00235391|464927670|FG001|Overall Study|Adverse Event|5|||
129173038|NCT00235391|464927671|FG002|Overall Study|Adverse Event|10|||
129173039|NCT00235391|464927672|FG003|Overall Study|Adverse Event|72|||
129173040|NCT00235391|464927673|FG004|Overall Study|Adverse Event|5|||
129173041|NCT00235391|464927674|FG005|Overall Study|Adverse Event|2|||
129173042|NCT00235391|464927669|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129173043|NCT00235391|464927670|FG001|Overall Study|Abnormal laboratory value(s)|5|||
129173044|NCT00235391|464927671|FG002|Overall Study|Abnormal laboratory value(s)|4|||
129173045|NCT00235391|464927672|FG003|Overall Study|Abnormal laboratory value(s)|27|||
128780378|NCT00924560|463486536|FG001|Overall Study|Withdrawal by Subject|44|||
128780379|NCT00924560|463486537|FG002|Overall Study|Withdrawal by Subject|18|||
129173046|NCT00235391|464927673|FG004|Overall Study|Abnormal laboratory value(s)|1|||
129173047|NCT00235391|464927674|FG005|Overall Study|Abnormal laboratory value(s)|2|||
129173048|NCT00235391|464927669|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129173049|NCT00235391|464927670|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129173050|NCT00235391|464927671|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129173051|NCT00235391|464927672|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
129173052|NCT00235391|464927673|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
129173053|NCT00235391|464927674|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
129173054|NCT00235391|464927669|FG000|Overall Study|Condition no longer requires treatment|3|||
129173055|NCT00235391|464927670|FG001|Overall Study|Condition no longer requires treatment|0|||
129173056|NCT00235391|464927671|FG002|Overall Study|Condition no longer requires treatment|0|||
129173057|NCT00235391|464927672|FG003|Overall Study|Condition no longer requires treatment|11|||
129173058|NCT00235391|464927673|FG004|Overall Study|Condition no longer requires treatment|1|||
129173059|NCT00235391|464927674|FG005|Overall Study|Condition no longer requires treatment|0|||
128780380|NCT00924560|463486535|FG000|Overall Study|Adverse Event|39|||
128780381|NCT00924560|463486536|FG001|Overall Study|Adverse Event|33|||
128780382|NCT00924560|463486537|FG002|Overall Study|Adverse Event|0|||
128780383|NCT00924560|463486535|FG000|Overall Study|Pregnancy|5|||
128780384|NCT00924560|463486536|FG001|Overall Study|Pregnancy|7|||
128780385|NCT00924560|463486537|FG002|Overall Study|Pregnancy|1|||
128780386|NCT00924560|463486535|FG000|Overall Study|Lost to Follow-up|78|||
128780387|NCT00924560|463486536|FG001|Overall Study|Lost to Follow-up|94|||
128780388|NCT00924560|463486537|FG002|Overall Study|Lost to Follow-up|45|||
128780389|NCT00924560|463486535|FG000|Overall Study|Miscellaneous Reasons|13|||
128780390|NCT00924560|463486536|FG001|Overall Study|Miscellaneous Reasons|10|||
128780391|NCT00924560|463486537|FG002|Overall Study|Miscellaneous Reasons|10|||
128780392|NCT02696226|463486539|FG000|Overall Study|Study terminated - lack of enrollment|1|||
128780393|NCT02696226|463486540|FG001|Overall Study|Study terminated - lack of enrollment|0|||
128780394|NCT02696226|463486541|FG002|Overall Study|Study terminated - lack of enrollment|2|||
128780395|NCT02696226|463486542|FG003|Overall Study|Study terminated - lack of enrollment|0|||
128780396|NCT02909101|463486550|FG000|Overall Study|Lost to Follow-up|1|||
128780397|NCT02909101|463486551|FG001|Overall Study|Lost to Follow-up|1|||
128780398|NCT03073005|463486552|FG000|Overall Study|Death|6|||
129173060|NCT00235391|464927669|FG000|Overall Study|Protocol deviation|0|||
129173061|NCT00235391|464927670|FG001|Overall Study|Protocol deviation|0|||
129173062|NCT00235391|464927671|FG002|Overall Study|Protocol deviation|1|||
129173063|NCT00235391|464927672|FG003|Overall Study|Protocol deviation|11|||
129173064|NCT00235391|464927673|FG004|Overall Study|Protocol deviation|0|||
129173065|NCT00235391|464927674|FG005|Overall Study|Protocol deviation|0|||
129173066|NCT00235391|464927669|FG000|Overall Study|Withdrawal by Subject|2|||
129173067|NCT00235391|464927670|FG001|Overall Study|Withdrawal by Subject|3|||
129173068|NCT00235391|464927671|FG002|Overall Study|Withdrawal by Subject|3|||
129173069|NCT00235391|464927672|FG003|Overall Study|Withdrawal by Subject|61|||
129173070|NCT00235391|464927673|FG004|Overall Study|Withdrawal by Subject|5|||
129173071|NCT00235391|464927674|FG005|Overall Study|Withdrawal by Subject|0|||
129173072|NCT00235391|464927669|FG000|Overall Study|Lost to Follow-up|0|||
129173073|NCT00235391|464927670|FG001|Overall Study|Lost to Follow-up|3|||
129173074|NCT00235391|464927671|FG002|Overall Study|Lost to Follow-up|3|||
129173075|NCT00235391|464927672|FG003|Overall Study|Lost to Follow-up|16|||
129173076|NCT00235391|464927673|FG004|Overall Study|Lost to Follow-up|0|||
129173077|NCT00235391|464927674|FG005|Overall Study|Lost to Follow-up|0|||
129173078|NCT00235391|464927669|FG000|Overall Study|Administrative problems|0|||
129173079|NCT00235391|464927670|FG001|Overall Study|Administrative problems|0|||
129173080|NCT00235391|464927671|FG002|Overall Study|Administrative problems|0|||
129173081|NCT00235391|464927672|FG003|Overall Study|Administrative problems|1|||
129173082|NCT00235391|464927673|FG004|Overall Study|Administrative problems|0|||
129173083|NCT00235391|464927674|FG005|Overall Study|Administrative problems|0|||
129173084|NCT00235391|464927669|FG000|Overall Study|Death|0|||
129173085|NCT00235391|464927670|FG001|Overall Study|Death|0|||
129173086|NCT00235391|464927671|FG002|Overall Study|Death|1|||
129173087|NCT00235391|464927672|FG003|Overall Study|Death|4|||
129173088|NCT00235391|464927673|FG004|Overall Study|Death|0|||
129173089|NCT00235391|464927674|FG005|Overall Study|Death|0|||
129173090|NCT00098748|464927678|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
129173091|NCT00098748|464927679|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
129173092|NCT00098748|464927680|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
129173093|NCT00098748|464927678|FG000|Received Study Treatment|Death|2|||
128780399|NCT03073005|463486553|FG001|Overall Study|Death|0|||
128780400|NCT03073005|463486554|FG002|Overall Study|Death|7|||
128780401|NCT03073005|463486555|FG003|Overall Study|Death|0|||
128780402|NCT03073005|463486552|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
128780403|NCT03073005|463486553|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
129173094|NCT00098748|464927679|FG001|Received Study Treatment|Death|1|||
129173095|NCT00098748|464927680|FG002|Received Study Treatment|Death|2|||
129173096|NCT00098748|464927678|FG000|Received Study Treatment|Adverse Event|1|||
129173097|NCT00098748|464927679|FG001|Received Study Treatment|Adverse Event|2|||
129173098|NCT00098748|464927680|FG002|Received Study Treatment|Adverse Event|5|||
129173099|NCT00098748|464927678|FG000|Received Study Treatment|Lack of Efficacy|40|||
129173100|NCT00098748|464927679|FG001|Received Study Treatment|Lack of Efficacy|27|||
129173101|NCT00098748|464927680|FG002|Received Study Treatment|Lack of Efficacy|27|||
129173102|NCT00098748|464927678|FG000|Received Study Treatment|Other|2|||
129173103|NCT00098748|464927679|FG001|Received Study Treatment|Other|2|||
129173104|NCT00098748|464927680|FG002|Received Study Treatment|Other|6|||
129173105|NCT00098748|464927678|FG000|Received Study Treatment|Subject defaulted|3|||
129173106|NCT00098748|464927679|FG001|Received Study Treatment|Subject defaulted|4|||
129173107|NCT00098748|464927680|FG002|Received Study Treatment|Subject defaulted|4|||
129173108|NCT00098748|464927678|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
129173109|NCT00098748|464927679|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
129173110|NCT00098748|464927680|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
129173111|NCT00098748|464927678|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
129173112|NCT00098748|464927679|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
129173113|NCT00098748|464927680|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
129173114|NCT00098748|464927678|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
129173115|NCT00098748|464927679|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
129173116|NCT00098748|464927680|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
129173117|NCT00098748|464927678|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
129173118|NCT00098748|464927679|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
129173119|NCT00098748|464927680|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
129173120|NCT00098748|464927678|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
129173121|NCT00098748|464927679|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
129173122|NCT00098748|464927680|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
129173123|NCT00570037|464927681|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
129173124|NCT00570037|464927682|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
129173125|NCT01081301|464927685|FG000|Overall Study|Bereaved|3|||
129173126|NCT01081301|464927685|FG000|Overall Study|Too busy|5|||
129173127|NCT01081301|464927685|FG000|Overall Study|Patient too ill|2|||
129173128|NCT01081301|464927685|FG000|Overall Study|Lost to Follow-up|4|||
129173129|NCT03551665|464927686|FG000|Overall Study|Lost to Follow-up|11|||
129173130|NCT03551665|464927687|FG001|Overall Study|Lost to Follow-up|2|||
129173131|NCT00413894|464929584|FG000|Overall Study|Withdrawal by Subject|10|||
129173132|NCT00413894|464929584|FG000|Overall Study|Administrative Reasons|1|||
129173133|NCT00413894|464929584|FG000|Overall Study|Hb <10 grams/deciliter|12|||
129173134|NCT00413894|464929584|FG000|Overall Study|Adverse Event|28|||
129173135|NCT00413894|464929584|FG000|Overall Study|Protocol Violation|11|||
129173136|NCT00413894|464929584|FG000|Overall Study|Other|18|||
129173137|NCT01942161|464929585|FG000|Overall Study|Adverse Event|1|||
129173138|NCT01942161|464929586|FG001|Overall Study|Adverse Event|2|||
129173139|NCT01942161|464929587|FG002|Overall Study|Adverse Event|5|||
129173140|NCT01942161|464929585|FG000|Overall Study|Physician Decision|3|||
129173141|NCT01942161|464929586|FG001|Overall Study|Physician Decision|1|||
129173142|NCT01942161|464929587|FG002|Overall Study|Physician Decision|0|||
129173143|NCT01942161|464929585|FG000|Overall Study|Protocol Violation|1|||
129173144|NCT01942161|464929586|FG001|Overall Study|Protocol Violation|0|||
129173145|NCT01942161|464929587|FG002|Overall Study|Protocol Violation|0|||
129173146|NCT01942161|464929585|FG000|Overall Study|Withdrawal by Subject|3|||
129173147|NCT01942161|464929586|FG001|Overall Study|Withdrawal by Subject|3|||
129173148|NCT01942161|464929587|FG002|Overall Study|Withdrawal by Subject|1|||
129173149|NCT02251717|464929591|FG000|Overall Study|Adverse Event|0|||
129173150|NCT02251717|464929592|FG001|Overall Study|Adverse Event|1|||
129173151|NCT02251717|464929591|FG000|Overall Study|Withdrew Consent|1|||
129173152|NCT02251717|464929592|FG001|Overall Study|Withdrew Consent|0|||
129173153|NCT03356977|464929593|FG000|Overall Study|Lost to Follow-up|3|||
129173154|NCT03356977|464929593|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129173155|NCT00445939|464929597|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
129173156|NCT00445939|464929598|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
129173157|NCT00445939|464929599|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
129173158|NCT00445939|464929600|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
129173159|NCT00445939|464929597|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
129173160|NCT00445939|464929598|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
129173161|NCT00445939|464929599|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
129173162|NCT00445939|464929600|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
129173163|NCT00378599|464929605|FG000|Overall Study|Adverse Event|38|||
129173164|NCT00378599|464929605|FG000|Overall Study|Protocol Violation|2|||
128780404|NCT03073005|463486554|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
128780405|NCT03073005|463486555|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
128780406|NCT03073005|463486552|FG000|Overall Study|Lost to Follow-up|2|||
128780407|NCT03073005|463486553|FG001|Overall Study|Lost to Follow-up|2|||
128780408|NCT03073005|463486554|FG002|Overall Study|Lost to Follow-up|1|||
128780409|NCT03073005|463486555|FG003|Overall Study|Lost to Follow-up|2|||
128780410|NCT03073005|463486552|FG000|Overall Study|Withdrawal by Subject|0|||
128780411|NCT03073005|463486553|FG001|Overall Study|Withdrawal by Subject|4|||
128780412|NCT03073005|463486554|FG002|Overall Study|Withdrawal by Subject|4|||
128780413|NCT03073005|463486555|FG003|Overall Study|Withdrawal by Subject|4|||
128780414|NCT01290094|463486556|FG000|Overall Study|Withdrawal by Subject|1|||
128780415|NCT01290094|463486556|FG000|Overall Study|Lost to Follow-up|5|||
128780416|NCT04091672|463488497|FG000|Overall Study|Death|6|||
128780417|NCT04091672|463488498|FG001|Overall Study|Death|6|||
128780418|NCT04091672|463488497|FG000|Overall Study|Lost to Follow-up|7|||
128780419|NCT04091672|463488498|FG001|Overall Study|Lost to Follow-up|7|||
128780420|NCT04091672|463488497|FG000|Overall Study|Withdrawal by Subject|3|||
128780421|NCT04091672|463488498|FG001|Overall Study|Withdrawal by Subject|3|||
128780422|NCT04091672|463488497|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
128780423|NCT04091672|463488498|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
128780424|NCT05296629|463488499|FG000|Overall Study|Withdrawal by Subject|3|||
128780425|NCT05296629|463488500|FG001|Overall Study|Withdrawal by Subject|10|||
128780426|NCT05296629|463488501|FG002|Overall Study|Withdrawal by Subject|4|||
128780427|NCT05296629|463488499|FG000|Overall Study|Lost to Follow-up|2|||
128780428|NCT05296629|463488500|FG001|Overall Study|Lost to Follow-up|7|||
128780429|NCT05296629|463488501|FG002|Overall Study|Lost to Follow-up|1|||
128780430|NCT05296629|463488499|FG000|Overall Study|Adverse Event|0|||
128780431|NCT05296629|463488500|FG001|Overall Study|Adverse Event|4|||
128780432|NCT05296629|463488501|FG002|Overall Study|Adverse Event|2|||
128780433|NCT05296629|463488499|FG000|Overall Study|Protocol Violation|0|||
128780434|NCT05296629|463488500|FG001|Overall Study|Protocol Violation|2|||
128780435|NCT05296629|463488501|FG002|Overall Study|Protocol Violation|0|||
128780436|NCT02268396|463488505|FG000|Overall Study|Adverse Event|3|||
128780437|NCT02268396|463488505|FG000|Overall Study|Administrative|2|||
128780438|NCT02268396|463488505|FG000|Overall Study|Withdrawal by Subject|1|||
128780439|NCT02268396|463488505|FG000|Overall Study|Lost to Follow-up|2|||
128780440|NCT02268396|463488505|FG000|Overall Study|Protocol-Specified Criteria|2|||
128780441|NCT02268396|463488505|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
128780442|NCT00231179|463488506|FG000|Overall Study|Lost to Follow-up|21|||
128780443|NCT00231179|463488507|FG001|Overall Study|Lost to Follow-up|21|||
128780444|NCT00231179|463488506|FG000|Overall Study|Withdrawal by Subject|3|||
128780445|NCT00231179|463488507|FG001|Overall Study|Withdrawal by Subject|3|||
128780446|NCT02401529|463488508|FG000|Overall Study|Lost to Follow-up|2|||
128780447|NCT02401529|463488509|FG001|Overall Study|Lost to Follow-up|1|||
128780448|NCT02401529|463488508|FG000|Overall Study|Physician Decision|2|||
128780449|NCT02401529|463488509|FG001|Overall Study|Physician Decision|6|||
128780450|NCT02401529|463488508|FG000|Overall Study|Protocol Violation|5|||
128780451|NCT02401529|463488509|FG001|Overall Study|Protocol Violation|0|||
128780452|NCT02491411|463488510|FG000|Overall Study|Physician Decision|4|||
128780453|NCT04034238|463488511|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
128780454|NCT04034238|463488512|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
128780455|NCT04034238|463488513|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
128780456|NCT04034238|463488514|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
128780457|NCT04034238|463488511|FG000|Dose Escalation Phase|Screen failures|0|||
128780458|NCT04034238|463488512|FG001|Dose Escalation Phase|Screen failures|0|||
128780459|NCT04034238|463488513|FG002|Dose Escalation Phase|Screen failures|0|||
128780460|NCT04034238|463488514|FG003|Dose Escalation Phase|Screen failures|2|||
129173165|NCT00378599|464929605|FG000|Overall Study|Treatment failure|7|||
129173166|NCT00378599|464929605|FG000|Overall Study|Withdrawal by Subject|5|||
129173167|NCT00489736|464929606|FG000|Overall Study|Lack of Efficacy|53|||
129173168|NCT00489736|464929607|FG001|Overall Study|Lack of Efficacy|14|||
129173169|NCT00489736|464929606|FG000|Overall Study|Adverse Event|32|||
129173170|NCT00489736|464929607|FG001|Overall Study|Adverse Event|45|||
129173171|NCT00489736|464929606|FG000|Overall Study|Poor compliance|6|||
128780461|NCT04034238|463488511|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
128780462|NCT04034238|463488512|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
128780463|NCT04034238|463488513|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
128780464|NCT04034238|463488514|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
128780465|NCT04034238|463488511|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
128780466|NCT04034238|463488512|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
128780467|NCT04034238|463488513|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
128780468|NCT04034238|463488514|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
128780469|NCT01939158|463488515|FG000|Overall Study|Adverse Event|1|||
128780470|NCT01939158|463488516|FG001|Overall Study|Adverse Event|0|||
129173172|NCT00489736|464929607|FG001|Overall Study|Poor compliance|2|||
129173173|NCT00489736|464929606|FG000|Overall Study|Not coded/ Not pre-specified|5|||
129173174|NCT00489736|464929607|FG001|Overall Study|Not coded/ Not pre-specified|8|||
129173175|NCT03812185|464929611|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
129173176|NCT02576535|464929614|FG000|Overall Study|Withdrawal by Subject|2|||
129173177|NCT01529515|464929615|FG000|TRANSITION PHASE|Adverse Event|16|||
129173178|NCT01529515|464929616|FG001|TRANSITION PHASE|Adverse Event|0|||
129173179|NCT01529515|464929617|FG002|TRANSITION PHASE|Adverse Event|0|||
129173180|NCT01529515|464929618|FG003|TRANSITION PHASE|Adverse Event|0|||
129173181|NCT01529515|464929615|FG000|TRANSITION PHASE|Death|1|||
129173182|NCT01529515|464929616|FG001|TRANSITION PHASE|Death|0|||
129173183|NCT01529515|464929617|FG002|TRANSITION PHASE|Death|0|||
129173184|NCT01529515|464929618|FG003|TRANSITION PHASE|Death|0|||
129173185|NCT01529515|464929615|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
129173186|NCT01529515|464929616|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
129173187|NCT01529515|464929617|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
129173188|NCT01529515|464929618|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
129173189|NCT01529515|464929615|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
129173190|NCT01529515|464929616|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
129173191|NCT01529515|464929617|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
129173192|NCT01529515|464929618|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
129173193|NCT01529515|464929615|FG000|TRANSITION PHASE|Protocol Violation|4|||
129173194|NCT01529515|464929616|FG001|TRANSITION PHASE|Protocol Violation|0|||
129173195|NCT01529515|464929617|FG002|TRANSITION PHASE|Protocol Violation|0|||
129173196|NCT01529515|464929618|FG003|TRANSITION PHASE|Protocol Violation|0|||
129173197|NCT01529515|464929615|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
129173198|NCT01529515|464929616|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
129173199|NCT01529515|464929617|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
129173200|NCT01529515|464929618|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
129173201|NCT01529515|464929615|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
129173202|NCT01529515|464929616|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
129173203|NCT01529515|464929617|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
129173204|NCT01529515|464929618|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
129173205|NCT01529515|464929615|FG000|TRANSITION PHASE|Other|9|||
129173206|NCT01529515|464929616|FG001|TRANSITION PHASE|Other|0|||
129173207|NCT01529515|464929617|FG002|TRANSITION PHASE|Other|0|||
129173208|NCT01529515|464929618|FG003|TRANSITION PHASE|Other|0|||
129173209|NCT01529515|464929615|FG000|MAINTENANCE PHASE|Adverse Event|0|||
129173210|NCT01529515|464929616|FG001|MAINTENANCE PHASE|Adverse Event|10|||
129173211|NCT01529515|464929617|FG002|MAINTENANCE PHASE|Adverse Event|0|||
129173212|NCT01529515|464929618|FG003|MAINTENANCE PHASE|Adverse Event|0|||
129173213|NCT01529515|464929615|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
129173214|NCT01529515|464929616|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
129173215|NCT01529515|464929617|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
129173216|NCT01529515|464929618|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
129173217|NCT01529515|464929615|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
129173218|NCT01529515|464929616|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
129173219|NCT01529515|464929617|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
129173220|NCT01529515|464929618|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
129173221|NCT01529515|464929615|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
129173222|NCT01529515|464929616|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
129173223|NCT01529515|464929617|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
129173224|NCT01529515|464929618|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
129173225|NCT01529515|464929615|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
129173226|NCT01529515|464929616|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
129173227|NCT01529515|464929617|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
129173228|NCT01529515|464929618|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
129173229|NCT01529515|464929615|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
129173230|NCT01529515|464929616|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
129173231|NCT01529515|464929617|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
129173232|NCT01529515|464929618|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
129173233|NCT01529515|464929615|FG000|MAINTENANCE PHASE|Other|0|||
129173234|NCT01529515|464929616|FG001|MAINTENANCE PHASE|Other|10|||
129173235|NCT01529515|464929617|FG002|MAINTENANCE PHASE|Other|0|||
129173236|NCT01529515|464929618|FG003|MAINTENANCE PHASE|Other|0|||
129173237|NCT01529515|464929615|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
129173238|NCT01529515|464929616|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
129173239|NCT01529515|464929617|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
129173240|NCT01529515|464929618|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
129173241|NCT01529515|464929615|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
129173242|NCT01529515|464929616|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
129173243|NCT01529515|464929617|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
129173244|NCT01529515|464929618|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
129173245|NCT01529515|464929615|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
129173246|NCT01529515|464929616|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
129173247|NCT01529515|464929617|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
129173248|NCT01529515|464929618|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
129173249|NCT01529515|464929615|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
129173250|NCT01529515|464929616|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
129173251|NCT01529515|464929617|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
129173252|NCT01529515|464929618|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
129173253|NCT01529515|464929615|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
129173254|NCT01529515|464929616|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
129173255|NCT01529515|464929617|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
129173256|NCT01529515|464929618|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
129173257|NCT01529515|464929615|FG000|DOUBLE BLIND PHASE|Other|0|||
129173258|NCT01529515|464929616|FG001|DOUBLE BLIND PHASE|Other|0|||
129173259|NCT01529515|464929617|FG002|DOUBLE BLIND PHASE|Other|9|||
129173260|NCT01529515|464929618|FG003|DOUBLE BLIND PHASE|Other|2|||
129173261|NCT03334851|464929622|FG000|Overall Study|Other|0|||
129173262|NCT03334851|464929623|FG001|Overall Study|Other|0|||
129173263|NCT03334851|464929624|FG002|Overall Study|Other|0|||
129173264|NCT03334851|464929625|FG003|Overall Study|Other|0|||
129173265|NCT03334851|464929626|FG004|Overall Study|Other|0|||
129173266|NCT03334851|464929627|FG005|Overall Study|Other|0|||
129173267|NCT03334851|464929628|FG006|Overall Study|Other|0|||
129173268|NCT03334851|464929629|FG007|Overall Study|Other|1|||
129173269|NCT03334851|464929630|FG008|Overall Study|Other|0|||
129173270|NCT03334851|464929631|FG009|Overall Study|Other|0|||
129173271|NCT03334851|464929632|FG010|Overall Study|Other|0|||
129173272|NCT03334851|464929633|FG011|Overall Study|Other|0|||
129173273|NCT03334851|464929634|FG012|Overall Study|Other|0|||
129173274|NCT03334851|464929622|FG000|Overall Study|Adverse Event|0|||
129173275|NCT03334851|464929623|FG001|Overall Study|Adverse Event|0|||
129173276|NCT03334851|464929624|FG002|Overall Study|Adverse Event|0|||
129173277|NCT03334851|464929625|FG003|Overall Study|Adverse Event|0|||
129173278|NCT03334851|464929626|FG004|Overall Study|Adverse Event|0|||
129173279|NCT03334851|464929627|FG005|Overall Study|Adverse Event|0|||
129173280|NCT03334851|464929628|FG006|Overall Study|Adverse Event|0|||
129173281|NCT03334851|464929629|FG007|Overall Study|Adverse Event|1|||
129173282|NCT03334851|464929630|FG008|Overall Study|Adverse Event|0|||
129173283|NCT03334851|464929631|FG009|Overall Study|Adverse Event|0|||
129173284|NCT03334851|464929632|FG010|Overall Study|Adverse Event|0|||
129173285|NCT03334851|464929633|FG011|Overall Study|Adverse Event|0|||
129173286|NCT03334851|464929634|FG012|Overall Study|Adverse Event|0|||
129173287|NCT03334851|464929622|FG000|Overall Study|Withdrawal by Subject|0|||
129173288|NCT03334851|464929623|FG001|Overall Study|Withdrawal by Subject|0|||
129173289|NCT03334851|464929624|FG002|Overall Study|Withdrawal by Subject|0|||
129173290|NCT03334851|464929625|FG003|Overall Study|Withdrawal by Subject|0|||
129173291|NCT03334851|464929626|FG004|Overall Study|Withdrawal by Subject|0|||
129173292|NCT03334851|464929627|FG005|Overall Study|Withdrawal by Subject|0|||
129173293|NCT03334851|464929628|FG006|Overall Study|Withdrawal by Subject|0|||
129173294|NCT03334851|464929629|FG007|Overall Study|Withdrawal by Subject|0|||
129173295|NCT03334851|464929630|FG008|Overall Study|Withdrawal by Subject|0|||
129173296|NCT03334851|464929631|FG009|Overall Study|Withdrawal by Subject|0|||
129173297|NCT03334851|464929632|FG010|Overall Study|Withdrawal by Subject|1|||
129173298|NCT03334851|464929633|FG011|Overall Study|Withdrawal by Subject|0|||
129173299|NCT03334851|464929634|FG012|Overall Study|Withdrawal by Subject|1|||
129173300|NCT03334851|464929622|FG000|Overall Study|Lost to Follow-up|0|||
129173301|NCT03334851|464929623|FG001|Overall Study|Lost to Follow-up|0|||
129173302|NCT03334851|464929624|FG002|Overall Study|Lost to Follow-up|0|||
129173303|NCT03334851|464929625|FG003|Overall Study|Lost to Follow-up|0|||
129173304|NCT03334851|464929626|FG004|Overall Study|Lost to Follow-up|0|||
129173305|NCT03334851|464929627|FG005|Overall Study|Lost to Follow-up|0|||
129173306|NCT03334851|464929628|FG006|Overall Study|Lost to Follow-up|0|||
129173307|NCT03334851|464929629|FG007|Overall Study|Lost to Follow-up|0|||
129173308|NCT03334851|464929630|FG008|Overall Study|Lost to Follow-up|0|||
129173309|NCT03334851|464929631|FG009|Overall Study|Lost to Follow-up|0|||
129173310|NCT03334851|464929632|FG010|Overall Study|Lost to Follow-up|2|||
129173311|NCT03334851|464929633|FG011|Overall Study|Lost to Follow-up|1|||
129173312|NCT03334851|464929634|FG012|Overall Study|Lost to Follow-up|0|||
129173313|NCT03920293|464929635|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
129173314|NCT03920293|464929636|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
129173315|NCT03920293|464929635|FG000|Randomized-Controlled Period|Physician Decision|1|||
129173316|NCT03920293|464929636|FG001|Randomized-Controlled Period|Physician Decision|2|||
129173317|NCT03920293|464929635|FG000|Randomized-Controlled Period|Adverse Event|0|||
129173318|NCT03920293|464929636|FG001|Randomized-Controlled Period|Adverse Event|2|||
129173319|NCT03920293|464929635|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
129173320|NCT03920293|464929636|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
129173321|NCT03920293|464929635|FG000|Randomized-Controlled Period|Death|2|||
129173322|NCT03920293|464929636|FG001|Randomized-Controlled Period|Death|0|||
129173323|NCT03920293|464929635|FG000|Randomized-Controlled Period|Protocol Violation|1|||
129173324|NCT03920293|464929636|FG001|Randomized-Controlled Period|Protocol Violation|0|||
129173325|NCT03920293|464929635|FG000|Randomized-Controlled Period|Noncompliance|1|||
129173326|NCT03920293|464929636|FG001|Randomized-Controlled Period|Noncompliance|0|||
129173327|NCT03920293|464929635|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
129173328|NCT03920293|464929636|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
129173329|NCT03920293|464929635|FG000|Open- Label Extension Period|Death|3|||
129173330|NCT03920293|464929636|FG001|Open- Label Extension Period|Death|3|||
129173331|NCT03920293|464929635|FG000|Open- Label Extension Period|Physician Decision|5|||
129173332|NCT03920293|464929636|FG001|Open- Label Extension Period|Physician Decision|3|||
129173333|NCT03920293|464929635|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
129173334|NCT03920293|464929636|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
129173335|NCT01691885|464929638|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
129173336|NCT01691885|464929639|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
129173337|NCT01691885|464929638|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
129173338|NCT01691885|464929639|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
129173339|NCT03555981|464929640|FG000|Overall Study|Lost to Follow-up|0|||
129173340|NCT03555981|464929641|FG001|Overall Study|Lost to Follow-up|2|||
129173341|NCT03272828|464929644|FG000|Overall Study|Lost to Follow-up|7|||
129173342|NCT03272828|464929645|FG001|Overall Study|Lost to Follow-up|7|||
129173343|NCT03272828|464929644|FG000|Overall Study|Withdrawal by Subject|2|||
129173344|NCT03272828|464929645|FG001|Overall Study|Withdrawal by Subject|0|||
129173345|NCT03272828|464929644|FG000|Overall Study|Deceased|1|||
129173346|NCT03272828|464929645|FG001|Overall Study|Deceased|1|||
129173347|NCT03272828|464929644|FG000|Overall Study|Failed implant|1|||
129173348|NCT03272828|464929645|FG001|Overall Study|Failed implant|2|||
129173349|NCT03575065|464929649|FG000|Overall Study|Death|31|||
129173350|NCT03575065|464929650|FG001|Overall Study|Death|12|||
129173351|NCT03575065|464929649|FG000|Overall Study|Sponsor's Decision|28|||
129173352|NCT03575065|464929650|FG001|Overall Study|Sponsor's Decision|13|||
129173353|NCT03575065|464929649|FG000|Overall Study|Withdrawal by Subject|2|||
129173354|NCT03575065|464929650|FG001|Overall Study|Withdrawal by Subject|1|||
129173355|NCT03575065|464929649|FG000|Overall Study|Lost to Follow-up|1|||
129173356|NCT03575065|464929650|FG001|Overall Study|Lost to Follow-up|0|||
129173357|NCT02323126|464929655|FG000|Overall Study|Patient / guardian decision|0|||
129173358|NCT02323126|464929656|FG001|Overall Study|Patient / guardian decision|1|||
129173359|NCT02323126|464929657|FG002|Overall Study|Patient / guardian decision|2|||
129173360|NCT02323126|464929655|FG000|Overall Study|Progressive disease|14|||
129173361|NCT02323126|464929656|FG001|Overall Study|Progressive disease|8|||
129173362|NCT02323126|464929657|FG002|Overall Study|Progressive disease|14|||
129173363|NCT02323126|464929655|FG000|Overall Study|Physician Decision|0|||
129173364|NCT02323126|464929656|FG001|Overall Study|Physician Decision|1|||
129173365|NCT02323126|464929657|FG002|Overall Study|Physician Decision|3|||
129173366|NCT02323126|464929655|FG000|Overall Study|Death|1|||
129173367|NCT02323126|464929656|FG001|Overall Study|Death|1|||
129173368|NCT02323126|464929657|FG002|Overall Study|Death|4|||
129173369|NCT02323126|464929655|FG000|Overall Study|Adverse Event|3|||
129173370|NCT02323126|464929656|FG001|Overall Study|Adverse Event|5|||
129173371|NCT02323126|464929657|FG002|Overall Study|Adverse Event|7|||
129173372|NCT04686084|464929658|FG000|Overall Study|Lost to Follow-up|1|||
129173373|NCT03350256|464929659|FG000|Overall Study|Inclusion/exclusion violation|4|||
129173374|NCT03350256|464929659|FG000|Overall Study|Recommended for other therapies|2|||
129173375|NCT03350256|464929659|FG000|Overall Study|Protocol Violation|3|||
129173376|NCT03350256|464929659|FG000|Overall Study|Non compliance|2|||
129173377|NCT03350256|464929659|FG000|Overall Study|Denial by insurance|1|||
129173378|NCT03350256|464929659|FG000|Overall Study|Adverse Event|2|||
129173379|NCT03350256|464929659|FG000|Overall Study|Trial failure|12|||
129173380|NCT03350256|464929659|FG000|Overall Study|Did not proceed to permanent implant|3|||
129173381|NCT03350256|464929659|FG000|Overall Study|Withdrawal by Subject|3|||
129173382|NCT03350256|464929659|FG000|Overall Study|Subject moving out of state|1|||
129173383|NCT03350256|464929659|FG000|Overall Study|Lost to Follow-up|1|||
129173384|NCT03350256|464929659|FG000|Overall Study|Lack of Efficacy|2|||
129173385|NCT02891681|464929663|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
129173386|NCT02891681|464929664|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
129173387|NCT02891681|464929665|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
129173388|NCT02891681|464929663|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
129173389|NCT02891681|464929664|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
129173390|NCT02891681|464929665|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
129173391|NCT02891681|464929663|FG000|Overall Study|Taken off study after first imaging appointment|1|||
129173392|NCT02891681|464929664|FG001|Overall Study|Taken off study after first imaging appointment|0|||
129173393|NCT02891681|464929665|FG002|Overall Study|Taken off study after first imaging appointment|0|||
129173394|NCT03664674|464929668|FG000|Overall Study|Adverse Event|1|||
129173395|NCT03664674|464929669|FG001|Overall Study|Adverse Event|1|||
129173396|NCT03664674|464929668|FG000|Overall Study|Physician Decision|0|||
129173397|NCT03664674|464929669|FG001|Overall Study|Physician Decision|1|||
129173398|NCT03664674|464929668|FG000|Overall Study|Withdrawal by Subject|2|||
129173399|NCT03664674|464929669|FG001|Overall Study|Withdrawal by Subject|0|||
129173400|NCT02174523|464929670|FG000|Overall Study|Withdrawal by Subject|1|||
129173401|NCT02174523|464929671|FG001|Overall Study|Withdrawal by Subject|0|||
129173402|NCT00856206|464929672|FG000|Overall Study|Protocol Violation|6|||
129173403|NCT00856206|464929673|FG001|Overall Study|Protocol Violation|18|||
129173404|NCT00856206|464929672|FG000|Overall Study|Adverse Event|10|||
129173405|NCT00856206|464929673|FG001|Overall Study|Adverse Event|46|||
129173406|NCT00856206|464929672|FG000|Overall Study|Lack of Efficacy|1|||
129173407|NCT00856206|464929673|FG001|Overall Study|Lack of Efficacy|2|||
129173408|NCT00856206|464929672|FG000|Overall Study|Withdrawal by Subject|15|||
129173409|NCT00856206|464929673|FG001|Overall Study|Withdrawal by Subject|36|||
129173410|NCT00856206|464929672|FG000|Overall Study|Lost to Follow-up|13|||
129173411|NCT00856206|464929673|FG001|Overall Study|Lost to Follow-up|39|||
129173412|NCT00856206|464929672|FG000|Overall Study|Death|2|||
129173413|NCT00856206|464929673|FG001|Overall Study|Death|2|||
129173414|NCT00856206|464929672|FG000|Overall Study|Decision by the Sponsor|4|||
129173415|NCT00856206|464929673|FG001|Overall Study|Decision by the Sponsor|8|||
129173416|NCT00856206|464929672|FG000|Overall Study|Other than specified above|3|||
129173417|NCT00856206|464929673|FG001|Overall Study|Other than specified above|10|||
129173418|NCT02780856|464929678|FG000|Overall Study|Lost to Follow-up|1|||
129173419|NCT03006458|464929681|FG000|First Intervention|Unsatisfied Vision|0|||
129173420|NCT03006458|464929682|FG001|First Intervention|Unsatisfied Vision|3|||
129173421|NCT00457821|464929688|FG000|Part 2|Withdrawal by Subject|0|||
129173422|NCT00457821|464929689|FG001|Part 2|Withdrawal by Subject|0|||
129173423|NCT00457821|464929690|FG002|Part 2|Withdrawal by Subject|0|||
129173424|NCT00457821|464929691|FG003|Part 2|Withdrawal by Subject|0|||
129173425|NCT00457821|464929692|FG004|Part 2|Withdrawal by Subject|0|||
129173426|NCT00457821|464929693|FG005|Part 2|Withdrawal by Subject|0|||
129173427|NCT00457821|464929694|FG006|Part 2|Withdrawal by Subject|0|||
129173428|NCT00457821|464929695|FG007|Part 2|Withdrawal by Subject|1|||
129173429|NCT02437409|464929696|FG000|Overall Study|Withdrawal by Subject|3|||
129173430|NCT02437409|464929696|FG000|Overall Study|Screening failure|12|||
129173431|NCT01632241|464929697|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
129173432|NCT01632241|464929698|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
129173433|NCT01632241|464929697|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
129173434|NCT01632241|464929698|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
129173435|NCT01632241|464929697|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
129173436|NCT01632241|464929698|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
129173437|NCT01632241|464929697|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
129173438|NCT01632241|464929698|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
129173439|NCT01632241|464929697|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
129173440|NCT01632241|464929698|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
129173441|NCT01632241|464929697|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
129173442|NCT01632241|464929698|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
129173443|NCT01632241|464929697|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
129173444|NCT01632241|464929698|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
129173445|NCT01632241|464929697|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
129173446|NCT01632241|464929698|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
129173447|NCT01632241|464929697|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
129173448|NCT01632241|464929698|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
129173449|NCT01632241|464929697|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
129173450|NCT01632241|464929698|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
129173451|NCT01632241|464929697|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
129173452|NCT01632241|464929698|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
129173453|NCT01632241|464929697|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
128780471|NCT01939158|463488517|FG002|Overall Study|Adverse Event|0|||
128729995|NCT02103478|463308295|FG004|Overall Study|Progressive Disease|9|||
128729996|NCT02103478|463308296|FG005|Overall Study|Progressive Disease|1|||
128729997|NCT02103478|463308297|FG006|Overall Study|Progressive Disease|2|||
128729998|NCT02103478|463308298|FG007|Overall Study|Progressive Disease|0|||
128729999|NCT02103478|463308299|FG008|Overall Study|Progressive Disease|1|||
128730000|NCT02103478|463308291|FG000|Overall Study|Withdrawal by Subject|2|||
128730001|NCT02103478|463308292|FG001|Overall Study|Withdrawal by Subject|0|||
128730002|NCT02103478|463308293|FG002|Overall Study|Withdrawal by Subject|0|||
128730003|NCT02103478|463308294|FG003|Overall Study|Withdrawal by Subject|4|||
128730004|NCT02103478|463308295|FG004|Overall Study|Withdrawal by Subject|0|||
128730005|NCT02103478|463308296|FG005|Overall Study|Withdrawal by Subject|0|||
128730006|NCT02103478|463308297|FG006|Overall Study|Withdrawal by Subject|1|||
128730007|NCT02103478|463308298|FG007|Overall Study|Withdrawal by Subject|1|||
128730008|NCT02103478|463308299|FG008|Overall Study|Withdrawal by Subject|0|||
128730009|NCT02103478|463308291|FG000|Overall Study|Lost to Follow-up|0|||
128730010|NCT02103478|463308292|FG001|Overall Study|Lost to Follow-up|0|||
128730011|NCT02103478|463308293|FG002|Overall Study|Lost to Follow-up|0|||
128730012|NCT02103478|463308294|FG003|Overall Study|Lost to Follow-up|0|||
128730013|NCT02103478|463308295|FG004|Overall Study|Lost to Follow-up|0|||
128730014|NCT02103478|463308296|FG005|Overall Study|Lost to Follow-up|0|||
128730015|NCT02103478|463308297|FG006|Overall Study|Lost to Follow-up|0|||
128730016|NCT02103478|463308298|FG007|Overall Study|Lost to Follow-up|1|||
128730017|NCT02103478|463308299|FG008|Overall Study|Lost to Follow-up|0|||
128730018|NCT02103478|463308291|FG000|Overall Study|Other|1|||
128730019|NCT02103478|463308292|FG001|Overall Study|Other|3|||
128730020|NCT02103478|463308293|FG002|Overall Study|Other|2|||
128730021|NCT02103478|463308294|FG003|Overall Study|Other|0|||
128730022|NCT02103478|463308295|FG004|Overall Study|Other|3|||
128730023|NCT02103478|463308296|FG005|Overall Study|Other|8|||
128730024|NCT02103478|463308297|FG006|Overall Study|Other|8|||
128730025|NCT02103478|463308298|FG007|Overall Study|Other|4|||
128730026|NCT02103478|463308299|FG008|Overall Study|Other|2|||
128730027|NCT04182100|463308300|FG000|Overall Study|Adverse Event|1|||
128730028|NCT04182100|463308300|FG000|Overall Study|Withdrawal by Subject|1|||
128730029|NCT04988295|463308301|FG000|Overall Study|Withdrawal by Subject|9|||
128730030|NCT04988295|463308302|FG001|Overall Study|Withdrawal by Subject|29|||
128730031|NCT04988295|463308303|FG002|Overall Study|Withdrawal by Subject|6|||
128730032|NCT04988295|463308304|FG003|Overall Study|Withdrawal by Subject|0|||
128730033|NCT04988295|463308301|FG000|Overall Study|Lost to Follow-up|1|||
128730034|NCT04988295|463308302|FG001|Overall Study|Lost to Follow-up|0|||
128730035|NCT04988295|463308303|FG002|Overall Study|Lost to Follow-up|0|||
128730036|NCT04988295|463308304|FG003|Overall Study|Lost to Follow-up|0|||
128730037|NCT04988295|463308301|FG000|Overall Study|Study participation ongoing|186|||
128730038|NCT04988295|463308302|FG001|Overall Study|Study participation ongoing|169|||
128730039|NCT04988295|463308303|FG002|Overall Study|Study participation ongoing|99|||
128730040|NCT04988295|463308304|FG003|Overall Study|Study participation ongoing|119|||
128730041|NCT04083976|463308305|FG000|Overall Study|Lost to Follow-up|3|||
128730042|NCT04083976|463308306|FG001|Overall Study|Lost to Follow-up|0|||
128730043|NCT04083976|463308307|FG002|Overall Study|Lost to Follow-up|0|||
128730044|NCT04083976|463308308|FG003|Overall Study|Lost to Follow-up|1|||
128730045|NCT04083976|463308305|FG000|Overall Study|Withdrawal by Subject|16|||
128730046|NCT04083976|463308306|FG001|Overall Study|Withdrawal by Subject|1|||
128730047|NCT04083976|463308307|FG002|Overall Study|Withdrawal by Subject|9|||
128730048|NCT04083976|463308308|FG003|Overall Study|Withdrawal by Subject|0|||
128730049|NCT04083976|463308305|FG000|Overall Study|Sponsor Decision|14|||
128730050|NCT04083976|463308306|FG001|Overall Study|Sponsor Decision|0|||
128730051|NCT04083976|463308307|FG002|Overall Study|Sponsor Decision|0|||
128730052|NCT04083976|463308308|FG003|Overall Study|Sponsor Decision|7|||
128730053|NCT04083976|463308305|FG000|Overall Study|Other|1|||
128730054|NCT04083976|463308306|FG001|Overall Study|Other|0|||
128730055|NCT04083976|463308307|FG002|Overall Study|Other|1|||
128730056|NCT04083976|463308308|FG003|Overall Study|Other|0|||
128730057|NCT02504372|463308309|FG000|Overall Study|Death|136|||
128730058|NCT02504372|463308310|FG001|Overall Study|Death|154|||
128730059|NCT02504372|463308309|FG000|Overall Study|Lost to Follow-up|0|||
128730060|NCT02504372|463308310|FG001|Overall Study|Lost to Follow-up|2|||
128730061|NCT02504372|463308309|FG000|Overall Study|Withdrawal of consent|25|||
128730062|NCT02504372|463308310|FG001|Overall Study|Withdrawal of consent|16|||
128730063|NCT02504372|463308309|FG000|Overall Study|Participants ongoing|429|||
128730064|NCT02504372|463308310|FG001|Overall Study|Participants ongoing|415|||
128730065|NCT03748641|463308315|FG000|Overall Study|Ongoing|155|||
128730066|NCT03748641|463308316|FG001|Overall Study|Ongoing|148|||
128730067|NCT03748641|463308317|FG002|Overall Study|Ongoing|66|||
128730068|NCT03748641|463308318|FG003|Overall Study|Ongoing|79|||
128730069|NCT03748641|463308319|FG004|Overall Study|Ongoing|84|||
128730070|NCT03748641|463308315|FG000|Overall Study|Death|54|||
128730071|NCT03748641|463308316|FG001|Overall Study|Death|59|||
128730072|NCT03748641|463308317|FG002|Overall Study|Death|51|||
128730073|NCT03748641|463308318|FG003|Overall Study|Death|42|||
128780472|NCT01939158|463488518|FG003|Overall Study|Adverse Event|0|||
128780473|NCT01939158|463488515|FG000|Overall Study|Withdrawal by Subject|22|||
128780474|NCT01939158|463488516|FG001|Overall Study|Withdrawal by Subject|25|||
128780475|NCT01939158|463488517|FG002|Overall Study|Withdrawal by Subject|15|||
128780476|NCT01939158|463488518|FG003|Overall Study|Withdrawal by Subject|17|||
128780477|NCT01939158|463488515|FG000|Overall Study|Migrated/moved from study area|5|||
128780478|NCT01939158|463488516|FG001|Overall Study|Migrated/moved from study area|7|||
128780479|NCT01939158|463488517|FG002|Overall Study|Migrated/moved from study area|3|||
128780480|NCT01939158|463488518|FG003|Overall Study|Migrated/moved from study area|6|||
128780481|NCT01939158|463488515|FG000|Overall Study|Lost to Follow-up|18|||
128780482|NCT01939158|463488516|FG001|Overall Study|Lost to Follow-up|17|||
128780483|NCT01939158|463488517|FG002|Overall Study|Lost to Follow-up|17|||
128780484|NCT01939158|463488518|FG003|Overall Study|Lost to Follow-up|17|||
128780485|NCT01939158|463488515|FG000|Overall Study|Death|0|||
129173454|NCT01632241|464929698|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
129173455|NCT01632241|464929697|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
129173456|NCT01632241|464929698|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
129173457|NCT01632241|464929697|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
129173458|NCT01632241|464929698|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
129173459|NCT02851407|464929708|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129173460|NCT02851407|464929709|FG001|Overall Study|Withdrawal by parent/guardian|7|||
129173461|NCT02851407|464929708|FG000|Overall Study|Protocol deviation|0|||
129173462|NCT02851407|464929709|FG001|Overall Study|Protocol deviation|1|||
129173463|NCT02851407|464929708|FG000|Overall Study|Transferred to another hospital to continue|1|||
129173464|NCT02851407|464929709|FG001|Overall Study|Transferred to another hospital to continue|0|||
129173465|NCT02851407|464929708|FG000|Overall Study|Other Death|30|||
129173466|NCT02851407|464929709|FG001|Overall Study|Other Death|20|||
129173467|NCT02851407|464929708|FG000|Overall Study|Adverse event, serious fatal|6|||
129173468|NCT02851407|464929709|FG001|Overall Study|Adverse event, serious fatal|8|||
129173469|NCT02851407|464929708|FG000|Overall Study|Consent withdrawn by participant|5|||
129173470|NCT02851407|464929709|FG001|Overall Study|Consent withdrawn by participant|3|||
128780486|NCT01939158|463488516|FG001|Overall Study|Death|0|||
129173471|NCT02851407|464929708|FG000|Overall Study|Screen failure|2|||
128780487|NCT01939158|463488517|FG002|Overall Study|Death|1|||
128780488|NCT01939158|463488518|FG003|Overall Study|Death|1|||
129173472|NCT02851407|464929709|FG001|Overall Study|Screen failure|1|||
129173473|NCT02851407|464929708|FG000|Overall Study|Disease relapse|9|||
129173474|NCT02851407|464929709|FG001|Overall Study|Disease relapse|6|||
129173475|NCT02851407|464929708|FG000|Overall Study|Physician Decision|7|||
128780489|NCT01939158|463488515|FG000|Overall Study|No longer meets eligibility criteria|0|||
128780490|NCT01939158|463488516|FG001|Overall Study|No longer meets eligibility criteria|0|||
128780491|NCT01939158|463488517|FG002|Overall Study|No longer meets eligibility criteria|1|||
128780492|NCT01939158|463488518|FG003|Overall Study|No longer meets eligibility criteria|0|||
128780493|NCT01939158|463488515|FG000|Overall Study|Other|1|||
128780494|NCT01939158|463488516|FG001|Overall Study|Other|3|||
128780495|NCT01939158|463488517|FG002|Overall Study|Other|4|||
128780496|NCT01939158|463488518|FG003|Overall Study|Other|3|||
128780497|NCT02065245|463488519|FG000|Infusion 1|Lost to Follow-up|0|||
128780498|NCT02065245|463488520|FG001|Infusion 1|Lost to Follow-up|0|||
128780499|NCT02065245|463488521|FG002|Infusion 1|Lost to Follow-up|0|||
128780500|NCT02065245|463488522|FG003|Infusion 1|Lost to Follow-up|0|||
128780501|NCT02065245|463488523|FG004|Infusion 1|Lost to Follow-up|0|||
128780502|NCT02065245|463488524|FG005|Infusion 1|Lost to Follow-up|0|||
128780503|NCT02065245|463488525|FG006|Infusion 1|Lost to Follow-up|1|||
128780504|NCT02065245|463488519|FG000|Infusion 1|Death|0|||
128780505|NCT02065245|463488520|FG001|Infusion 1|Death|0|||
128780506|NCT02065245|463488521|FG002|Infusion 1|Death|1|||
128780507|NCT02065245|463488522|FG003|Infusion 1|Death|0|||
128780508|NCT02065245|463488523|FG004|Infusion 1|Death|1|||
128780509|NCT02065245|463488524|FG005|Infusion 1|Death|0|||
128780510|NCT02065245|463488525|FG006|Infusion 1|Death|0|||
128780511|NCT02065245|463488519|FG000|Infusion 2|Death|0|||
128780512|NCT02065245|463488520|FG001|Infusion 2|Death|0|||
128780513|NCT02065245|463488521|FG002|Infusion 2|Death|0|||
128780514|NCT02065245|463488522|FG003|Infusion 2|Death|0|||
128780515|NCT02065245|463488523|FG004|Infusion 2|Death|0|||
128780516|NCT02065245|463488524|FG005|Infusion 2|Death|0|||
128780517|NCT02065245|463488525|FG006|Infusion 2|Death|1|||
128780518|NCT02065245|463488519|FG000|Infusion 3|Lost to Follow-up|1|||
128780519|NCT02065245|463488520|FG001|Infusion 3|Lost to Follow-up|1|||
128780520|NCT02065245|463488521|FG002|Infusion 3|Lost to Follow-up|0|||
128780521|NCT02065245|463488522|FG003|Infusion 3|Lost to Follow-up|0|||
128780522|NCT02065245|463488523|FG004|Infusion 3|Lost to Follow-up|0|||
128780523|NCT02065245|463488524|FG005|Infusion 3|Lost to Follow-up|0|||
128780524|NCT02065245|463488525|FG006|Infusion 3|Lost to Follow-up|0|||
128780525|NCT01518257|463488526|FG000|Overall Study|Lost to Follow-up|1|||
128780526|NCT01518257|463488527|FG001|Overall Study|Lost to Follow-up|0|||
128780527|NCT01518257|463488526|FG000|Overall Study|Other Miscellaneous Reason|1|||
128780528|NCT01518257|463488527|FG001|Overall Study|Other Miscellaneous Reason|0|||
128780529|NCT01304706|463488528|FG000|Overall Study|Adverse Event|2|||
128780530|NCT01304706|463488528|FG000|Overall Study|Lack of Efficacy|1|||
128780531|NCT01304706|463488528|FG000|Overall Study|Death|3|||
128780532|NCT01304706|463488528|FG000|Overall Study|Withdrawal by Subject|3|||
128780533|NCT01304706|463488528|FG000|Overall Study|Lost to Follow-up|7|||
128780534|NCT01304706|463488528|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
128780535|NCT00924664|463488529|FG000|Overall Study|Adverse Event|23|||
128780536|NCT00924664|463488530|FG001|Overall Study|Adverse Event|39|||
128780537|NCT00924664|463488529|FG000|Overall Study|Lack of Efficacy|10|||
128780538|NCT00924664|463488530|FG001|Overall Study|Lack of Efficacy|15|||
128780539|NCT00924664|463488529|FG000|Overall Study|Lost to Follow-up|10|||
128780540|NCT00924664|463488530|FG001|Overall Study|Lost to Follow-up|12|||
128780541|NCT00924664|463488529|FG000|Overall Study|Withdrawal by Subject|47|||
128780542|NCT00924664|463488530|FG001|Overall Study|Withdrawal by Subject|71|||
128780543|NCT00924664|463488529|FG000|Overall Study|Protocol Violation|2|||
128780544|NCT00924664|463488530|FG001|Overall Study|Protocol Violation|5|||
128780545|NCT00924664|463488529|FG000|Overall Study|Pregnancy|1|||
128780546|NCT00924664|463488530|FG001|Overall Study|Pregnancy|1|||
128780547|NCT00924664|463488529|FG000|Overall Study|Death|0|||
128780548|NCT00924664|463488530|FG001|Overall Study|Death|2|||
128780549|NCT00924664|463488529|FG000|Overall Study|Study terminated by sponsor|199|||
128780550|NCT00924664|463488530|FG001|Overall Study|Study terminated by sponsor|330|||
128780551|NCT00924664|463488529|FG000|Overall Study|Other|29|||
128780552|NCT00924664|463488530|FG001|Overall Study|Other|52|||
128780553|NCT00924664|463488529|FG000|Overall Study|Randomized but not Treated|1|||
128780554|NCT00924664|463488530|FG001|Overall Study|Randomized but not Treated|0|||
128780555|NCT00093795|463488534|FG000|Overall Study|No follow up data|20|||
128780556|NCT00093795|463488535|FG001|Overall Study|No follow up data|16|||
128780557|NCT00093795|463488536|FG002|Overall Study|No follow up data|17|||
129173476|NCT02851407|464929709|FG001|Overall Study|Physician Decision|6|||
129173477|NCT02851407|464929708|FG000|Overall Study|Transferred to hospital closer to home|0|||
129173478|NCT02851407|464929709|FG001|Overall Study|Transferred to hospital closer to home|1|||
129173479|NCT02851407|464929708|FG000|Overall Study|Enrolled in an investigational study|0|||
129173480|NCT02851407|464929709|FG001|Overall Study|Enrolled in an investigational study|1|||
129173481|NCT02851407|464929708|FG000|Overall Study|Early recovery|1|||
129173482|NCT02851407|464929709|FG001|Overall Study|Early recovery|0|||
129173483|NCT02851407|464929708|FG000|Overall Study|Adverse event, non-fatal|7|||
129173484|NCT02851407|464929709|FG001|Overall Study|Adverse event, non-fatal|5|||
129173485|NCT02851407|464929708|FG000|Overall Study|Lost to Follow-up|0|||
129173486|NCT02851407|464929709|FG001|Overall Study|Lost to Follow-up|2|||
129173487|NCT02403635|464929710|FG000|Overall Study|Not eligible|9|||
129173488|NCT00835640|464929711|FG000|Second Intervention|Protocol Violation|1|||
129173489|NCT00835640|464929712|FG001|Second Intervention|Protocol Violation|0|||
129173490|NCT00068250|464929713|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
129173491|NCT00068250|464929714|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
129173492|NCT00068250|464929715|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
129173493|NCT00068250|464929716|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
129173494|NCT03349645|464929717|FG000|Overall Study|Sponsor Terminated Study|75|||
129173495|NCT03349645|464929717|FG000|Overall Study|Withdrawal by Subject|4|||
129173496|NCT03349645|464929717|FG000|Overall Study|Protocol Violation|1|||
129173497|NCT03349645|464929717|FG000|Overall Study|Other|2|||
129173498|NCT00580034|464929720|FG000|Overall Study|Toxicity|10|||
129173499|NCT00580034|464929721|FG001|Overall Study|Toxicity|0|||
129173500|NCT01939002|464929722|FG000|Overall Study|Adverse Event|13|||
129173501|NCT01939002|464929723|FG001|Overall Study|Adverse Event|13|||
129173502|NCT01939002|464929722|FG000|Overall Study|Withdrawal by Subject|5|||
129173503|NCT01939002|464929723|FG001|Overall Study|Withdrawal by Subject|3|||
129173504|NCT01939002|464929722|FG000|Overall Study|Other|1|||
129173505|NCT01939002|464929723|FG001|Overall Study|Other|2|||
129173506|NCT03372460|464929727|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
129173507|NCT03372460|464929728|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
129173508|NCT02499900|464929729|FG000|Core Study Period|Other|1|||
129173509|NCT02499900|464929730|FG001|Core Study Period|Other|4|||
129173510|NCT02499900|464929729|FG000|Core Study Period|Lost to Follow-up|1|||
129173511|NCT02499900|464929730|FG001|Core Study Period|Lost to Follow-up|2|||
129173512|NCT02499900|464929729|FG000|Core Study Period|Per sponsor request|0|||
129173513|NCT02499900|464929730|FG001|Core Study Period|Per sponsor request|1|||
129173514|NCT02499900|464929729|FG000|Core Study Period|Pregnancy|1|||
129173515|NCT02499900|464929730|FG001|Core Study Period|Pregnancy|0|||
129173516|NCT02499900|464929729|FG000|Core Study Period|Protocol Violation|3|||
129173517|NCT02499900|464929730|FG001|Core Study Period|Protocol Violation|0|||
129173518|NCT02499900|464929729|FG000|Core Study Period|Withdrawal by Subject|11|||
129173519|NCT02499900|464929730|FG001|Core Study Period|Withdrawal by Subject|10|||
129173520|NCT02499900|464929729|FG000|Core Study Period|Adverse Event|18|||
129173521|NCT02499900|464929730|FG001|Core Study Period|Adverse Event|14|||
129173522|NCT02499900|464929729|FG000|Core Study Period|Death|0|||
129173523|NCT02499900|464929730|FG001|Core Study Period|Death|1|||
129173524|NCT02499900|464929729|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
129173525|NCT02499900|464929730|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
129173526|NCT02499900|464929729|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
129173527|NCT02499900|464929730|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
129173528|NCT02499900|464929729|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
129173529|NCT02499900|464929730|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
129173530|NCT02499900|464929729|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
129173531|NCT02499900|464929730|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
129173532|NCT02499900|464929729|FG000|Extension Study Period|Adverse Event|2|||
129173533|NCT02499900|464929730|FG001|Extension Study Period|Adverse Event|4|||
129173534|NCT02499900|464929729|FG000|Extension Study Period|Withdrawal by Subject|5|||
129173535|NCT02499900|464929730|FG001|Extension Study Period|Withdrawal by Subject|2|||
129173536|NCT02499900|464929729|FG000|Extension Study Period|Physician Decision|2|||
129173537|NCT02499900|464929730|FG001|Extension Study Period|Physician Decision|5|||
129173538|NCT02499900|464929729|FG000|Extension Study Period|Pregnancy|1|||
129173539|NCT02499900|464929730|FG001|Extension Study Period|Pregnancy|2|||
129173540|NCT02499900|464929729|FG000|Extension Study Period|Lost to Follow-up|2|||
129173541|NCT02499900|464929730|FG001|Extension Study Period|Lost to Follow-up|5|||
129173542|NCT02499900|464929729|FG000|Extension Study Period|Other|0|||
129173543|NCT02499900|464929730|FG001|Extension Study Period|Other|2|||
129173544|NCT02439450|464929732|FG000|Overall Study|Adverse Event|4|||
129173545|NCT02439450|464929733|FG001|Overall Study|Adverse Event|1|||
129173546|NCT02439450|464929734|FG002|Overall Study|Adverse Event|0|||
129173547|NCT02439450|464929735|FG003|Overall Study|Adverse Event|0|||
129173548|NCT02439450|464929732|FG000|Overall Study|Withdrawal by Subject|1|||
129173549|NCT02439450|464929733|FG001|Overall Study|Withdrawal by Subject|2|||
129173550|NCT02439450|464929734|FG002|Overall Study|Withdrawal by Subject|0|||
129173551|NCT02439450|464929735|FG003|Overall Study|Withdrawal by Subject|0|||
129173552|NCT02439450|464929732|FG000|Overall Study|Death|3|||
129173553|NCT02439450|464929733|FG001|Overall Study|Death|0|||
129173554|NCT02439450|464929734|FG002|Overall Study|Death|0|||
129173555|NCT02439450|464929735|FG003|Overall Study|Death|1|||
129173556|NCT02439450|464929732|FG000|Overall Study|Progressive Disease|18|||
129173557|NCT02439450|464929733|FG001|Overall Study|Progressive Disease|41|||
129173558|NCT02439450|464929734|FG002|Overall Study|Progressive Disease|2|||
129173559|NCT02439450|464929735|FG003|Overall Study|Progressive Disease|3|||
129173560|NCT01170065|464929740|FG000|Overall Study|Adverse Event|17|||
129173561|NCT01170065|464929741|FG001|Overall Study|Adverse Event|50|||
129173562|NCT01170065|464929742|FG002|Overall Study|Adverse Event|10|||
129173563|NCT01170065|464929740|FG000|Overall Study|Lost to Follow-up|1|||
129173564|NCT01170065|464929741|FG001|Overall Study|Lost to Follow-up|4|||
129173565|NCT01170065|464929742|FG002|Overall Study|Lost to Follow-up|1|||
129173566|NCT01170065|464929740|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
129173567|NCT01170065|464929741|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
129173568|NCT01170065|464929742|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
129173569|NCT01170065|464929740|FG000|Overall Study|Reason other than specified|3|||
129173570|NCT01170065|464929741|FG001|Overall Study|Reason other than specified|8|||
129173571|NCT01170065|464929742|FG002|Overall Study|Reason other than specified|3|||
129173572|NCT01170065|464929740|FG000|Overall Study|Ongoing after planned observation time|5|||
129173573|NCT01170065|464929741|FG001|Overall Study|Ongoing after planned observation time|26|||
129173574|NCT01170065|464929742|FG002|Overall Study|Ongoing after planned observation time|10|||
129173575|NCT00428220|464931605|FG000|Overall Study|Participant died|8|||
129173576|NCT00428220|464931605|FG000|Overall Study|Global deterioration of health status|7|||
129173577|NCT00428220|464931605|FG000|Overall Study|Lost to Follow-up|4|||
129173578|NCT00428220|464931605|FG000|Overall Study|Objective progression or relapse|123|||
129173579|NCT00428220|464931605|FG000|Overall Study|Participant refused continued treatment|7|||
129173580|NCT00428220|464931605|FG000|Overall Study|Adverse Event|51|||
129173581|NCT00428220|464931605|FG000|Overall Study|Other|23|||
129173582|NCT00549900|464931606|FG000|Overall Study|Adverse Event|1|||
129173583|NCT02982018|464931607|FG000|Overall Study|Incorrect Lens Dispensed|1|||
129173584|NCT02982018|464931608|FG001|Overall Study|Incorrect Lens Dispensed|0|||
129173585|NCT02982018|464931607|FG000|Overall Study|Protocol Violation|1|||
129173586|NCT02982018|464931608|FG001|Overall Study|Protocol Violation|1|||
129173587|NCT02982018|464931607|FG000|Overall Study|Adverse Event|1|||
129173588|NCT02982018|464931608|FG001|Overall Study|Adverse Event|1|||
129173589|NCT02982018|464931607|FG000|Overall Study|Lens Discomfort|2|||
129173590|NCT02982018|464931608|FG001|Overall Study|Lens Discomfort|0|||
129173591|NCT02982018|464931607|FG000|Overall Study|Withdrawal by Subject|0|||
129173592|NCT02982018|464931608|FG001|Overall Study|Withdrawal by Subject|1|||
129173593|NCT03283098|464931609|FG000|Overall Study|Withdrawal by Subject|0|||
129173594|NCT03283098|464931610|FG001|Overall Study|Withdrawal by Subject|1|||
129173595|NCT00798317|464931611|FG000|Overall Study|Physician Decision|0|||
129173596|NCT00798317|464931612|FG001|Overall Study|Physician Decision|1|||
129173597|NCT00798317|464931611|FG000|Overall Study|Withdrawal by Subject|5|||
129173598|NCT00798317|464931612|FG001|Overall Study|Withdrawal by Subject|4|||
129173599|NCT00798317|464931611|FG000|Overall Study|Lost to Follow-up|2|||
129173600|NCT00798317|464931612|FG001|Overall Study|Lost to Follow-up|2|||
129173601|NCT00798317|464931611|FG000|Overall Study|Adverse Event|2|||
129173602|NCT00798317|464931612|FG001|Overall Study|Adverse Event|0|||
129173603|NCT00798317|464931611|FG000|Overall Study|Death|1|||
129173604|NCT00798317|464931612|FG001|Overall Study|Death|0|||
129173605|NCT00416715|464931613|FG000|Overall Study|Not evaluable for joint aches|7|||
129173606|NCT00416715|464931613|FG000|Overall Study|Vitamin D levels not evaluable|8|||
128730074|NCT03748641|463308319|FG004|Overall Study|Death|9|||
128730075|NCT03748641|463308315|FG000|Overall Study|Lost to Follow-up|0|||
128730076|NCT03748641|463308316|FG001|Overall Study|Lost to Follow-up|2|||
128730077|NCT03748641|463308317|FG002|Overall Study|Lost to Follow-up|1|||
129173607|NCT02545517|464931624|FG000|Overall Study|Death|2|||
129173608|NCT02545517|464931625|FG001|Overall Study|Death|2|||
129173609|NCT02545517|464931626|FG002|Overall Study|Death|1|||
129173610|NCT02545517|464931624|FG000|Overall Study|Lost to Follow-up|14|||
129173611|NCT02545517|464931625|FG001|Overall Study|Lost to Follow-up|13|||
129173612|NCT02545517|464931626|FG002|Overall Study|Lost to Follow-up|17|||
129173613|NCT02545517|464931624|FG000|Overall Study|Protocol Violation|0|||
129173614|NCT02545517|464931625|FG001|Overall Study|Protocol Violation|1|||
129173615|NCT02545517|464931626|FG002|Overall Study|Protocol Violation|1|||
129173616|NCT02545517|464931624|FG000|Overall Study|Withdrawal by Subject|5|||
128730078|NCT03748641|463308318|FG003|Overall Study|Lost to Follow-up|0|||
128730079|NCT03748641|463308319|FG004|Overall Study|Lost to Follow-up|0|||
128730080|NCT03748641|463308315|FG000|Overall Study|Withdrawal by Subject|3|||
129173617|NCT02545517|464931625|FG001|Overall Study|Withdrawal by Subject|8|||
129173618|NCT02545517|464931626|FG002|Overall Study|Withdrawal by Subject|9|||
129173619|NCT02545517|464931624|FG000|Overall Study|Administrative reason|5|||
129173620|NCT02545517|464931625|FG001|Overall Study|Administrative reason|6|||
129173621|NCT02545517|464931626|FG002|Overall Study|Administrative reason|10|||
129173622|NCT02545517|464931624|FG000|Overall Study|Other|2|||
129173623|NCT02545517|464931625|FG001|Overall Study|Other|4|||
129173624|NCT02545517|464931626|FG002|Overall Study|Other|3|||
129173625|NCT01069861|464931627|FG000|Overall Study|Death|1|||
129173626|NCT01069861|464931627|FG000|Overall Study|Adverse Event|1|||
129173627|NCT01069861|464931627|FG000|Overall Study|Did not meet entrance criteria|1|||
129173628|NCT04035564|464931628|FG000|Overall Study|Protocol Violation|1|||
129173629|NCT04035564|464931629|FG001|Overall Study|Protocol Violation|2|||
129173630|NCT04035564|464931628|FG000|Overall Study|No laboratory available|2|||
129173631|NCT04035564|464931629|FG001|Overall Study|No laboratory available|2|||
129173632|NCT04035564|464931628|FG000|Overall Study|Guardian declined consent|1|||
129173633|NCT04035564|464931629|FG001|Overall Study|Guardian declined consent|2|||
129173634|NCT00996281|464931631|FG000|Overall Study|Adverse Event|75|||
129173635|NCT00996281|464931632|FG001|Overall Study|Adverse Event|37|||
128780558|NCT01106287|463488537|FG000|Overall Study|Adverse Event|1|||
128780559|NCT01106287|463488538|FG001|Overall Study|Adverse Event|0|||
128780560|NCT01106287|463488539|FG002|Overall Study|Adverse Event|0|||
128780561|NCT01106287|463488540|FG003|Overall Study|Adverse Event|0|||
128780562|NCT00072475|463488541|FG000|Overall Study|Adverse Event|44|||
128780563|NCT00072475|463488541|FG000|Overall Study|Death|3|||
128780564|NCT00072475|463488541|FG000|Overall Study|Withdrawal by Subject|46|||
128780565|NCT00072475|463488541|FG000|Overall Study|Patient/Investigator Decision|4|||
129173636|NCT00996281|464931631|FG000|Overall Study|Major Protocol Deviation|6|||
129173637|NCT00996281|464931632|FG001|Overall Study|Major Protocol Deviation|7|||
129173638|NCT00996281|464931631|FG000|Overall Study|Lost to Follow-up|14|||
129173639|NCT00996281|464931632|FG001|Overall Study|Lost to Follow-up|16|||
129173640|NCT00996281|464931631|FG000|Overall Study|Withdrawal by Subject|31|||
129173641|NCT00996281|464931632|FG001|Overall Study|Withdrawal by Subject|20|||
129173642|NCT00996281|464931631|FG000|Overall Study|Lack of Efficacy|0|||
129173643|NCT00996281|464931632|FG001|Overall Study|Lack of Efficacy|2|||
129173644|NCT00996281|464931631|FG000|Overall Study|Other|5|||
129173645|NCT00996281|464931632|FG001|Overall Study|Other|7|||
129173646|NCT02754141|464931633|FG000|Overall Study|Disease progression|11|||
129173647|NCT02754141|464931634|FG001|Overall Study|Disease progression|7|||
129173648|NCT02754141|464931635|FG002|Overall Study|Disease progression|8|||
129173649|NCT02754141|464931636|FG003|Overall Study|Disease progression|5|||
129173650|NCT02754141|464931637|FG004|Overall Study|Disease progression|7|||
129173651|NCT02754141|464931638|FG005|Overall Study|Disease progression|7|||
129173652|NCT02754141|464931639|FG006|Overall Study|Disease progression|7|||
129173653|NCT02754141|464931640|FG007|Overall Study|Disease progression|6|||
129173654|NCT02754141|464931641|FG008|Overall Study|Disease progression|11|||
129173655|NCT02754141|464931642|FG009|Overall Study|Disease progression|16|||
129173656|NCT02754141|464931643|FG010|Overall Study|Disease progression|18|||
129173657|NCT02754141|464931644|FG011|Overall Study|Disease progression|13|||
129173658|NCT02754141|464931645|FG012|Overall Study|Disease progression|10|||
129173659|NCT02754141|464931646|FG013|Overall Study|Disease progression|12|||
129173660|NCT02754141|464931647|FG014|Overall Study|Disease progression|12|||
129173661|NCT02754141|464931648|FG015|Overall Study|Disease progression|14|||
129173662|NCT02754141|464931649|FG016|Overall Study|Disease progression|0|||
129173663|NCT02754141|464931650|FG017|Overall Study|Disease progression|1|||
128780566|NCT04730947|463488542|FG000|Overall Study|Withdrawal by Subject|0|||
128780567|NCT04730947|463488543|FG001|Overall Study|Withdrawal by Subject|1|||
128780568|NCT00940017|463488544|FG000|Overall Study|did not meet entrance criteria|3|||
129173664|NCT02754141|464931633|FG000|Overall Study|Study drug toxicity|1|||
129173665|NCT02754141|464931634|FG001|Overall Study|Study drug toxicity|1|||
128780569|NCT00940017|463488544|FG000|Overall Study|Adverse Event|1|||
128780570|NCT01450943|463488545|FG000|Overall Study|Screen failure, loss to follow-up|2|||
128780571|NCT01450943|463488546|FG001|Overall Study|Screen failure, loss to follow-up|7|||
128780572|NCT01450943|463488547|FG002|Overall Study|Screen failure, loss to follow-up|6|||
128780573|NCT02949271|463488550|FG000|Overall Study|Lack of Efficacy|5|||
128780574|NCT02949271|463488551|FG001|Overall Study|Lack of Efficacy|4|||
128780575|NCT02949271|463488550|FG000|Overall Study|Lost to Follow-up|3|||
128780576|NCT02949271|463488551|FG001|Overall Study|Lost to Follow-up|6|||
128780577|NCT02949271|463488550|FG000|Overall Study|Physician Decision|5|||
128780578|NCT02949271|463488551|FG001|Overall Study|Physician Decision|5|||
128780579|NCT02949271|463488550|FG000|Overall Study|Protocol Violation|6|||
128780580|NCT02949271|463488551|FG001|Overall Study|Protocol Violation|3|||
128780581|NCT02949271|463488550|FG000|Overall Study|Withdrawal by Subject|1|||
128780582|NCT02949271|463488551|FG001|Overall Study|Withdrawal by Subject|0|||
128780583|NCT02949271|463488550|FG000|Overall Study|Delivered prior to intervention|7|||
128780584|NCT02949271|463488551|FG001|Overall Study|Delivered prior to intervention|9|||
128780585|NCT02949271|463488550|FG000|Overall Study|Outside the window for cervical dilation|2|||
128780586|NCT02949271|463488551|FG001|Overall Study|Outside the window for cervical dilation|3|||
128780587|NCT01097655|463488552|FG000|Overall Study|Withdrawal by Subject|1|||
128780588|NCT01097655|463488552|FG000|Overall Study|Subject Documented Twice|1|||
128780589|NCT01097655|463488552|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
128780590|NCT01345292|463488553|FG000|Overall Study|Withdrawal by Subject|2|||
128780591|NCT01345292|463488554|FG001|Overall Study|Withdrawal by Subject|0|||
128780592|NCT01345292|463488555|FG002|Overall Study|Withdrawal by Subject|1|||
128780593|NCT05458102|463488557|FG000|Overall Study|Withdrew consent|2|||
128780594|NCT05458102|463488558|FG001|Overall Study|Withdrew consent|0|||
128780595|NCT05458102|463488557|FG000|Overall Study|Adverse Event|1|||
128780596|NCT05458102|463488558|FG001|Overall Study|Adverse Event|0|||
128780597|NCT05458102|463488557|FG000|Overall Study|Enrolled but never treated|1|||
128780598|NCT05458102|463488558|FG001|Overall Study|Enrolled but never treated|0|||
128780599|NCT05458102|463488557|FG000|Overall Study|Protocol Violation|1|||
128780600|NCT05458102|463488558|FG001|Overall Study|Protocol Violation|0|||
128780601|NCT03303105|463488559|FG000|Overall Study|Adverse Event|0|||
128780602|NCT03303105|463488560|FG001|Overall Study|Adverse Event|2|||
128780603|NCT03303105|463488559|FG000|Overall Study|Lack of Efficacy|1|||
128780604|NCT03303105|463488560|FG001|Overall Study|Lack of Efficacy|0|||
128780605|NCT03303105|463488559|FG000|Overall Study|Protocol Violation|1|||
128780606|NCT03303105|463488560|FG001|Overall Study|Protocol Violation|0|||
128780607|NCT03303105|463488559|FG000|Overall Study|Withdrawal by Subject|0|||
129173666|NCT02754141|464931635|FG002|Overall Study|Study drug toxicity|0|||
129173667|NCT02754141|464931636|FG003|Overall Study|Study drug toxicity|0|||
129173668|NCT02754141|464931637|FG004|Overall Study|Study drug toxicity|0|||
129173669|NCT02754141|464931638|FG005|Overall Study|Study drug toxicity|0|||
129173670|NCT02754141|464931639|FG006|Overall Study|Study drug toxicity|0|||
129173671|NCT02754141|464931640|FG007|Overall Study|Study drug toxicity|0|||
129173672|NCT02754141|464931641|FG008|Overall Study|Study drug toxicity|0|||
129173673|NCT02754141|464931642|FG009|Overall Study|Study drug toxicity|0|||
129173674|NCT02754141|464931643|FG010|Overall Study|Study drug toxicity|2|||
129173675|NCT02754141|464931644|FG011|Overall Study|Study drug toxicity|1|||
129173676|NCT02754141|464931645|FG012|Overall Study|Study drug toxicity|1|||
129173677|NCT02754141|464931646|FG013|Overall Study|Study drug toxicity|0|||
129173678|NCT02754141|464931647|FG014|Overall Study|Study drug toxicity|0|||
129173679|NCT02754141|464931648|FG015|Overall Study|Study drug toxicity|0|||
129173680|NCT02754141|464931649|FG016|Overall Study|Study drug toxicity|0|||
129173681|NCT02754141|464931650|FG017|Overall Study|Study drug toxicity|0|||
129173682|NCT02754141|464931633|FG000|Overall Study|AE unrelated to study drug|1|||
129173683|NCT02754141|464931634|FG001|Overall Study|AE unrelated to study drug|1|||
129173684|NCT02754141|464931635|FG002|Overall Study|AE unrelated to study drug|0|||
129173685|NCT02754141|464931636|FG003|Overall Study|AE unrelated to study drug|1|||
129173686|NCT02754141|464931637|FG004|Overall Study|AE unrelated to study drug|3|||
129173687|NCT02754141|464931638|FG005|Overall Study|AE unrelated to study drug|2|||
129173688|NCT02754141|464931639|FG006|Overall Study|AE unrelated to study drug|1|||
129173689|NCT02754141|464931640|FG007|Overall Study|AE unrelated to study drug|0|||
129173690|NCT02754141|464931641|FG008|Overall Study|AE unrelated to study drug|0|||
129173691|NCT02754141|464931642|FG009|Overall Study|AE unrelated to study drug|0|||
129173692|NCT02754141|464931643|FG010|Overall Study|AE unrelated to study drug|0|||
128780608|NCT03303105|463488560|FG001|Overall Study|Withdrawal by Subject|2|||
128780609|NCT04822298|463488561|FG000|Overall Study|Death|3|||
128780610|NCT00852475|463488570|FG000|Overall Study|Lost to Follow-up|3|||
128780611|NCT00852475|463488571|FG001|Overall Study|Lost to Follow-up|4|||
128780612|NCT00515086|463488572|FG000|Overall Study|Adverse Event|1|||
128780613|NCT00515086|463488573|FG001|Overall Study|Adverse Event|1|||
128780614|NCT00515086|463488574|FG002|Overall Study|Adverse Event|2|||
129173693|NCT02754141|464931644|FG011|Overall Study|AE unrelated to study drug|0|||
129173694|NCT02754141|464931645|FG012|Overall Study|AE unrelated to study drug|0|||
129173695|NCT02754141|464931646|FG013|Overall Study|AE unrelated to study drug|0|||
129173696|NCT02754141|464931647|FG014|Overall Study|AE unrelated to study drug|0|||
129173697|NCT02754141|464931648|FG015|Overall Study|AE unrelated to study drug|0|||
129173698|NCT02754141|464931649|FG016|Overall Study|AE unrelated to study drug|0|||
129173699|NCT02754141|464931650|FG017|Overall Study|AE unrelated to study drug|0|||
129173700|NCT02754141|464931633|FG000|Overall Study|Request to discontinue|0|||
129173701|NCT02754141|464931634|FG001|Overall Study|Request to discontinue|0|||
129173702|NCT02754141|464931635|FG002|Overall Study|Request to discontinue|0|||
129173703|NCT02754141|464931636|FG003|Overall Study|Request to discontinue|0|||
129173704|NCT02754141|464931637|FG004|Overall Study|Request to discontinue|0|||
129173705|NCT02754141|464931638|FG005|Overall Study|Request to discontinue|0|||
129173706|NCT02754141|464931639|FG006|Overall Study|Request to discontinue|0|||
129173707|NCT02754141|464931640|FG007|Overall Study|Request to discontinue|0|||
129173708|NCT02754141|464931641|FG008|Overall Study|Request to discontinue|1|||
129173709|NCT02754141|464931642|FG009|Overall Study|Request to discontinue|0|||
129173710|NCT02754141|464931643|FG010|Overall Study|Request to discontinue|0|||
129173711|NCT02754141|464931644|FG011|Overall Study|Request to discontinue|0|||
129173712|NCT02754141|464931645|FG012|Overall Study|Request to discontinue|0|||
129173713|NCT02754141|464931646|FG013|Overall Study|Request to discontinue|1|||
129173714|NCT02754141|464931647|FG014|Overall Study|Request to discontinue|1|||
129173715|NCT02754141|464931648|FG015|Overall Study|Request to discontinue|0|||
129173716|NCT02754141|464931649|FG016|Overall Study|Request to discontinue|0|||
129173717|NCT02754141|464931650|FG017|Overall Study|Request to discontinue|0|||
129173718|NCT02754141|464931633|FG000|Overall Study|Withdrew consent|0|||
129173719|NCT02754141|464931634|FG001|Overall Study|Withdrew consent|0|||
129173720|NCT02754141|464931635|FG002|Overall Study|Withdrew consent|0|||
129173721|NCT02754141|464931636|FG003|Overall Study|Withdrew consent|0|||
129173722|NCT02754141|464931637|FG004|Overall Study|Withdrew consent|0|||
129173723|NCT02754141|464931638|FG005|Overall Study|Withdrew consent|0|||
129173724|NCT02754141|464931639|FG006|Overall Study|Withdrew consent|0|||
129173725|NCT02754141|464931640|FG007|Overall Study|Withdrew consent|0|||
129173726|NCT02754141|464931641|FG008|Overall Study|Withdrew consent|0|||
129173727|NCT02754141|464931642|FG009|Overall Study|Withdrew consent|1|||
129173728|NCT02754141|464931643|FG010|Overall Study|Withdrew consent|0|||
129173729|NCT02754141|464931644|FG011|Overall Study|Withdrew consent|0|||
129173730|NCT02754141|464931645|FG012|Overall Study|Withdrew consent|0|||
129173731|NCT02754141|464931646|FG013|Overall Study|Withdrew consent|0|||
129173732|NCT02754141|464931647|FG014|Overall Study|Withdrew consent|0|||
129173733|NCT02754141|464931648|FG015|Overall Study|Withdrew consent|0|||
129173734|NCT02754141|464931649|FG016|Overall Study|Withdrew consent|0|||
129173735|NCT02754141|464931650|FG017|Overall Study|Withdrew consent|0|||
129173736|NCT02754141|464931633|FG000|Overall Study|Maximum clinical benefit|0|||
129173737|NCT02754141|464931634|FG001|Overall Study|Maximum clinical benefit|0|||
129173738|NCT02754141|464931635|FG002|Overall Study|Maximum clinical benefit|0|||
129173739|NCT02754141|464931636|FG003|Overall Study|Maximum clinical benefit|1|||
129173740|NCT02754141|464931637|FG004|Overall Study|Maximum clinical benefit|0|||
129173741|NCT02754141|464931638|FG005|Overall Study|Maximum clinical benefit|0|||
129173742|NCT02754141|464931639|FG006|Overall Study|Maximum clinical benefit|0|||
129173743|NCT02754141|464931640|FG007|Overall Study|Maximum clinical benefit|0|||
129173744|NCT02754141|464931641|FG008|Overall Study|Maximum clinical benefit|0|||
129173745|NCT02754141|464931642|FG009|Overall Study|Maximum clinical benefit|0|||
129173746|NCT02754141|464931643|FG010|Overall Study|Maximum clinical benefit|0|||
129173747|NCT02754141|464931644|FG011|Overall Study|Maximum clinical benefit|0|||
129173748|NCT02754141|464931645|FG012|Overall Study|Maximum clinical benefit|0|||
129173749|NCT02754141|464931646|FG013|Overall Study|Maximum clinical benefit|0|||
129173750|NCT02754141|464931647|FG014|Overall Study|Maximum clinical benefit|0|||
129173751|NCT02754141|464931648|FG015|Overall Study|Maximum clinical benefit|0|||
129173752|NCT02754141|464931649|FG016|Overall Study|Maximum clinical benefit|0|||
129173753|NCT02754141|464931650|FG017|Overall Study|Maximum clinical benefit|0|||
129173754|NCT02754141|464931633|FG000|Overall Study|No longer meets study criteria|0|||
129173755|NCT02754141|464931634|FG001|Overall Study|No longer meets study criteria|0|||
129173756|NCT02754141|464931635|FG002|Overall Study|No longer meets study criteria|0|||
129173757|NCT02754141|464931636|FG003|Overall Study|No longer meets study criteria|1|||
129173758|NCT02754141|464931637|FG004|Overall Study|No longer meets study criteria|0|||
129173759|NCT02754141|464931638|FG005|Overall Study|No longer meets study criteria|0|||
129173760|NCT02754141|464931639|FG006|Overall Study|No longer meets study criteria|0|||
129173761|NCT02754141|464931640|FG007|Overall Study|No longer meets study criteria|0|||
128730081|NCT03748641|463308316|FG001|Overall Study|Withdrawal by Subject|2|||
128730082|NCT03748641|463308317|FG002|Overall Study|Withdrawal by Subject|5|||
128730083|NCT03748641|463308318|FG003|Overall Study|Withdrawal by Subject|3|||
128730084|NCT03748641|463308319|FG004|Overall Study|Withdrawal by Subject|2|||
128730085|NCT04397263|463308320|FG000|Overall Study|Withdrawal by Subject|2|||
128730086|NCT01428193|463308321|FG000|Overall Study|Physician Decision|1|||
128730087|NCT01428193|463308321|FG000|Overall Study|Elevated screening liver enzymes|1|||
128730088|NCT02703636|463308322|FG000|Overall Study|Adverse Event|14|||
128730089|NCT02703636|463308322|FG000|Overall Study|Study stopped by sponsor|1|||
129173762|NCT02754141|464931641|FG008|Overall Study|No longer meets study criteria|0|||
129173763|NCT02754141|464931642|FG009|Overall Study|No longer meets study criteria|0|||
129173764|NCT02754141|464931643|FG010|Overall Study|No longer meets study criteria|0|||
129173765|NCT02754141|464931644|FG011|Overall Study|No longer meets study criteria|0|||
129173766|NCT02754141|464931645|FG012|Overall Study|No longer meets study criteria|0|||
129173767|NCT02754141|464931646|FG013|Overall Study|No longer meets study criteria|0|||
129173768|NCT02754141|464931647|FG014|Overall Study|No longer meets study criteria|0|||
129173769|NCT02754141|464931648|FG015|Overall Study|No longer meets study criteria|0|||
129173770|NCT02754141|464931649|FG016|Overall Study|No longer meets study criteria|0|||
129173771|NCT02754141|464931650|FG017|Overall Study|No longer meets study criteria|0|||
129173772|NCT02754141|464931633|FG000|Overall Study|Other reasons|0|||
128730090|NCT02703636|463308322|FG000|Overall Study|Withdrawal by Subject|1|||
128730091|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
128730092|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
129173773|NCT02754141|464931634|FG001|Overall Study|Other reasons|0|||
128730093|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
129173774|NCT02754141|464931635|FG002|Overall Study|Other reasons|0|||
129173775|NCT02754141|464931636|FG003|Overall Study|Other reasons|0|||
129173776|NCT02754141|464931637|FG004|Overall Study|Other reasons|0|||
129173777|NCT02754141|464931638|FG005|Overall Study|Other reasons|0|||
129173778|NCT02754141|464931639|FG006|Overall Study|Other reasons|0|||
129173779|NCT02754141|464931640|FG007|Overall Study|Other reasons|1|||
129173780|NCT02754141|464931641|FG008|Overall Study|Other reasons|0|||
129173781|NCT02754141|464931642|FG009|Overall Study|Other reasons|0|||
129173782|NCT02754141|464931643|FG010|Overall Study|Other reasons|0|||
129173783|NCT02754141|464931644|FG011|Overall Study|Other reasons|0|||
129173784|NCT02754141|464931645|FG012|Overall Study|Other reasons|2|||
129173785|NCT02754141|464931646|FG013|Overall Study|Other reasons|0|||
129173786|NCT02754141|464931647|FG014|Overall Study|Other reasons|0|||
129173787|NCT02754141|464931648|FG015|Overall Study|Other reasons|0|||
129173788|NCT02754141|464931649|FG016|Overall Study|Other reasons|0|||
129173789|NCT02754141|464931650|FG017|Overall Study|Other reasons|0|||
129173790|NCT02754141|464931633|FG000|Overall Study|Completed treatment as per protocol|0|||
129173791|NCT02754141|464931634|FG001|Overall Study|Completed treatment as per protocol|1|||
129173792|NCT02754141|464931635|FG002|Overall Study|Completed treatment as per protocol|0|||
129173793|NCT02754141|464931636|FG003|Overall Study|Completed treatment as per protocol|0|||
129173794|NCT02754141|464931637|FG004|Overall Study|Completed treatment as per protocol|0|||
129173795|NCT02754141|464931638|FG005|Overall Study|Completed treatment as per protocol|0|||
129173796|NCT02754141|464931639|FG006|Overall Study|Completed treatment as per protocol|0|||
129173797|NCT02754141|464931640|FG007|Overall Study|Completed treatment as per protocol|0|||
129173798|NCT02754141|464931641|FG008|Overall Study|Completed treatment as per protocol|0|||
129173799|NCT02754141|464931642|FG009|Overall Study|Completed treatment as per protocol|0|||
129173800|NCT02754141|464931643|FG010|Overall Study|Completed treatment as per protocol|0|||
129173801|NCT02754141|464931644|FG011|Overall Study|Completed treatment as per protocol|0|||
129173802|NCT02754141|464931645|FG012|Overall Study|Completed treatment as per protocol|1|||
129173803|NCT02754141|464931646|FG013|Overall Study|Completed treatment as per protocol|0|||
129173804|NCT02754141|464931647|FG014|Overall Study|Completed treatment as per protocol|0|||
129173805|NCT02754141|464931648|FG015|Overall Study|Completed treatment as per protocol|0|||
129173806|NCT02754141|464931649|FG016|Overall Study|Completed treatment as per protocol|0|||
129173807|NCT02754141|464931650|FG017|Overall Study|Completed treatment as per protocol|0|||
129173808|NCT02754141|464931633|FG000|Overall Study|Not completing monotherapy|0|||
129173809|NCT02754141|464931634|FG001|Overall Study|Not completing monotherapy|0|||
129173810|NCT02754141|464931635|FG002|Overall Study|Not completing monotherapy|0|||
129173811|NCT02754141|464931636|FG003|Overall Study|Not completing monotherapy|0|||
129173812|NCT02754141|464931637|FG004|Overall Study|Not completing monotherapy|0|||
129173813|NCT02754141|464931638|FG005|Overall Study|Not completing monotherapy|0|||
129173814|NCT02754141|464931639|FG006|Overall Study|Not completing monotherapy|0|||
129173815|NCT02754141|464931640|FG007|Overall Study|Not completing monotherapy|0|||
129173816|NCT02754141|464931641|FG008|Overall Study|Not completing monotherapy|0|||
129173817|NCT02754141|464931642|FG009|Overall Study|Not completing monotherapy|0|||
129173818|NCT02754141|464931643|FG010|Overall Study|Not completing monotherapy|0|||
129173819|NCT02754141|464931644|FG011|Overall Study|Not completing monotherapy|0|||
129173820|NCT02754141|464931645|FG012|Overall Study|Not completing monotherapy|0|||
129173821|NCT02754141|464931646|FG013|Overall Study|Not completing monotherapy|1|||
129173822|NCT02754141|464931647|FG014|Overall Study|Not completing monotherapy|0|||
129173823|NCT02754141|464931648|FG015|Overall Study|Not completing monotherapy|0|||
129173824|NCT02754141|464931649|FG016|Overall Study|Not completing monotherapy|0|||
129173825|NCT02754141|464931650|FG017|Overall Study|Not completing monotherapy|0|||
129173826|NCT03361189|464931651|FG000|Overall Study|Received heart transplant|1|||
129173827|NCT03361189|464931652|FG001|Overall Study|Received heart transplant|0|||
129173828|NCT03361189|464931651|FG000|Overall Study|Pacemake replacement|0|||
129173829|NCT03361189|464931652|FG001|Overall Study|Pacemake replacement|1|||
129173830|NCT03505788|464931653|FG000|Overall Study|Lost to Follow-up|2|||
129173831|NCT03505788|464931654|FG001|Overall Study|Lost to Follow-up|1|||
129173832|NCT03505788|464931653|FG000|Overall Study|Withdrawal by Subject|1|||
129173833|NCT03505788|464931654|FG001|Overall Study|Withdrawal by Subject|3|||
129173834|NCT03505788|464931653|FG000|Overall Study|Physician Decision|0|||
129173835|NCT03505788|464931654|FG001|Overall Study|Physician Decision|1|||
129173836|NCT03344549|464931655|FG000|Overall Study|Withdrawal by Subject|3|||
129173837|NCT03344549|464931656|FG001|Overall Study|Withdrawal by Subject|2|||
129173838|NCT03344549|464931655|FG000|Overall Study|Dialysis|2|||
129173839|NCT03344549|464931656|FG001|Overall Study|Dialysis|0|||
129173840|NCT03344549|464931655|FG000|Overall Study|Cancer|1|||
129173841|NCT03344549|464931656|FG001|Overall Study|Cancer|0|||
129173842|NCT03344549|464931655|FG000|Overall Study|Lack of electronic device|1|||
129173843|NCT03344549|464931656|FG001|Overall Study|Lack of electronic device|0|||
129173844|NCT03344549|464931655|FG000|Overall Study|Transportation difficulty|0|||
129173845|NCT03344549|464931656|FG001|Overall Study|Transportation difficulty|13|||
129173846|NCT03333252|464931657|FG000|Overall Study|Adverse Event|10|||
129173847|NCT03333252|464931658|FG001|Overall Study|Adverse Event|6|||
129173848|NCT03333252|464931659|FG002|Overall Study|Adverse Event|5|||
129173849|NCT03333252|464931660|FG003|Overall Study|Adverse Event|2|||
129173850|NCT03333252|464931657|FG000|Overall Study|Death|1|||
129173851|NCT03333252|464931658|FG001|Overall Study|Death|3|||
129173852|NCT03333252|464931659|FG002|Overall Study|Death|0|||
129173853|NCT03333252|464931660|FG003|Overall Study|Death|0|||
129173854|NCT03333252|464931657|FG000|Overall Study|Lack of Efficacy|8|||
129173855|NCT03333252|464931658|FG001|Overall Study|Lack of Efficacy|4|||
129173856|NCT03333252|464931659|FG002|Overall Study|Lack of Efficacy|0|||
129173857|NCT03333252|464931660|FG003|Overall Study|Lack of Efficacy|7|||
129173858|NCT03333252|464931657|FG000|Overall Study|Lost to Follow-up|0|||
129173859|NCT03333252|464931658|FG001|Overall Study|Lost to Follow-up|5|||
129173860|NCT03333252|464931659|FG002|Overall Study|Lost to Follow-up|9|||
129173861|NCT03333252|464931660|FG003|Overall Study|Lost to Follow-up|3|||
129173862|NCT03333252|464931657|FG000|Overall Study|Withdrawal by Subject|14|||
129173863|NCT03333252|464931658|FG001|Overall Study|Withdrawal by Subject|24|||
129173864|NCT03333252|464931659|FG002|Overall Study|Withdrawal by Subject|11|||
129173865|NCT03333252|464931660|FG003|Overall Study|Withdrawal by Subject|17|||
129173866|NCT00666588|464931664|FG000|Overall Study|ineligible|2|||
129173867|NCT00666588|464931665|FG001|Overall Study|ineligible|0|||
129173868|NCT00666588|464931666|FG002|Overall Study|ineligible|0|||
129173869|NCT00666588|464931667|FG003|Overall Study|ineligible|2|||
129173870|NCT00666588|464931664|FG000|Overall Study|inevaluable|2|||
129173871|NCT00666588|464931665|FG001|Overall Study|inevaluable|0|||
129173872|NCT00666588|464931666|FG002|Overall Study|inevaluable|0|||
129173873|NCT00666588|464931667|FG003|Overall Study|inevaluable|0|||
129173874|NCT02075047|464931672|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
129173875|NCT02075047|464931673|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
129173876|NCT02075047|464931672|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
129173877|NCT02075047|464931673|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
129173878|NCT02075047|464931672|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
129173879|NCT02075047|464931673|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
129173880|NCT02075047|464931672|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
129173881|NCT02075047|464931673|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
129173882|NCT02075047|464931672|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
129173883|NCT02075047|464931673|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
129173884|NCT02075047|464931672|FG000|Treatment Phase (4 Weeks)|Other|1|||
129173885|NCT02075047|464931673|FG001|Treatment Phase (4 Weeks)|Other|1|||
129173886|NCT02075047|464931672|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
129173887|NCT02075047|464931673|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
129173888|NCT02075047|464931672|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
129173889|NCT02075047|464931673|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
129173890|NCT02075047|464931672|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
129173891|NCT02075047|464931673|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
129173892|NCT02075047|464931672|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
129173893|NCT02075047|464931673|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
129173894|NCT02075047|464931672|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
129173895|NCT02075047|464931673|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
129173896|NCT02075047|464931672|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
129173897|NCT02075047|464931673|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
129173898|NCT02075047|464931672|FG000|Follow up Phase (5 Weeks)|Other|1|||
129173899|NCT02075047|464931673|FG001|Follow up Phase (5 Weeks)|Other|2|||
129173900|NCT02075047|464931672|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
129173901|NCT02075047|464931673|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
129173902|NCT01007123|464931674|FG000|Overall Study|Adverse Event|3|||
129173903|NCT01007123|464931675|FG001|Overall Study|Adverse Event|4|||
129173904|NCT01007123|464931676|FG002|Overall Study|Adverse Event|7|||
129173905|NCT01007123|464931677|FG003|Overall Study|Adverse Event|1|||
129173906|NCT01007123|464931674|FG000|Overall Study|Lack of Efficacy|1|||
129173907|NCT01007123|464931675|FG001|Overall Study|Lack of Efficacy|0|||
129173908|NCT01007123|464931676|FG002|Overall Study|Lack of Efficacy|1|||
129173909|NCT01007123|464931677|FG003|Overall Study|Lack of Efficacy|4|||
129173910|NCT01007123|464931674|FG000|Overall Study|Protocol Violation|1|||
129173911|NCT01007123|464931675|FG001|Overall Study|Protocol Violation|1|||
129173912|NCT01007123|464931676|FG002|Overall Study|Protocol Violation|2|||
129173913|NCT01007123|464931677|FG003|Overall Study|Protocol Violation|1|||
129173914|NCT01007123|464931674|FG000|Overall Study|Withdrawal by Subject|1|||
129173915|NCT01007123|464931675|FG001|Overall Study|Withdrawal by Subject|0|||
129173916|NCT01007123|464931676|FG002|Overall Study|Withdrawal by Subject|1|||
129173917|NCT01007123|464931677|FG003|Overall Study|Withdrawal by Subject|0|||
129173918|NCT01007123|464931674|FG000|Overall Study|Lost to Follow-up|0|||
129173919|NCT01007123|464931675|FG001|Overall Study|Lost to Follow-up|1|||
129173920|NCT01007123|464931676|FG002|Overall Study|Lost to Follow-up|0|||
129173921|NCT01007123|464931677|FG003|Overall Study|Lost to Follow-up|0|||
129173922|NCT02324205|464931682|FG000|Overall Study|Withdrawal by Subject|37|||
129173923|NCT04195438|464931687|FG000|Overall Study|Withdrawal by Subject|1|||
129173924|NCT01774097|464931688|FG000|Overall Study|Withdrawal by Subject|1|||
129173925|NCT01774097|464931689|FG001|Overall Study|Withdrawal by Subject|1|||
129173926|NCT01774097|464931688|FG000|Overall Study|Adverse Event|1|||
129173927|NCT01774097|464931689|FG001|Overall Study|Adverse Event|1|||
129173928|NCT00613925|464931690|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
129173929|NCT00613925|464931691|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
129173930|NCT01920568|464931699|FG000|Overall Study|Adverse Event|27|||
129173931|NCT01920568|464931700|FG001|Overall Study|Adverse Event|8|||
129173932|NCT01920568|464931699|FG000|Overall Study|Protocol Violation|5|||
129173933|NCT01920568|464931700|FG001|Overall Study|Protocol Violation|3|||
129173934|NCT01920568|464931699|FG000|Overall Study|Lost to Follow-up|2|||
129173935|NCT01920568|464931700|FG001|Overall Study|Lost to Follow-up|2|||
129173936|NCT01920568|464931699|FG000|Overall Study|Physician Decision|13|||
129173937|NCT01920568|464931700|FG001|Overall Study|Physician Decision|4|||
129173938|NCT01920568|464931699|FG000|Overall Study|Withdrawal by Subject|79|||
129173939|NCT01920568|464931700|FG001|Overall Study|Withdrawal by Subject|55|||
129173940|NCT01920568|464931699|FG000|Overall Study|Death due to disease progression|25|||
129173941|NCT01920568|464931700|FG001|Overall Study|Death due to disease progression|12|||
129173942|NCT00252694|464931705|FG000|Overall Study|Withdrawal by Subject|83|||
129173943|NCT00252694|464931706|FG001|Overall Study|Withdrawal by Subject|91|||
129173944|NCT00252694|464931705|FG000|Overall Study|Death|36|||
129173945|NCT00252694|464931706|FG001|Overall Study|Death|34|||
129173946|NCT00252694|464931705|FG000|Overall Study|Mostly Lost to Follow Up|8|||
129173947|NCT00252694|464931706|FG001|Overall Study|Mostly Lost to Follow Up|13|||
129173948|NCT00252694|464931705|FG000|Overall Study|Patient Moving|17|||
129173949|NCT00252694|464931706|FG001|Overall Study|Patient Moving|16|||
129173950|NCT00794365|464931707|FG000|Overall Study|Lost to Follow-up|38|||
129173951|NCT00794365|464931707|FG000|Overall Study|Other|17|||
129173952|NCT00794365|464931707|FG000|Overall Study|Poor Compliance|11|||
129173953|NCT00794365|464931707|FG000|Overall Study|Adverse Event|10|||
129173954|NCT00794365|464931707|FG000|Overall Study|Lack of Efficacy|3|||
129173955|NCT04584346|464931708|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
129173956|NCT04584346|464931709|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
129173957|NCT04239222|464931710|FG000|Baseline|Withdrawal by Subject|0|||
129173958|NCT04239222|464931711|FG001|Baseline|Withdrawal by Subject|0|||
129173959|NCT04239222|464931712|FG002|Baseline|Withdrawal by Subject|1|||
129173960|NCT04239222|464931713|FG003|Baseline|Withdrawal by Subject|1|||
129173961|NCT04239222|464931710|FG000|First Foot Assignment|Withdrawal by Subject|0|||
129173962|NCT04239222|464931711|FG001|First Foot Assignment|Withdrawal by Subject|0|||
129173963|NCT04239222|464931712|FG002|First Foot Assignment|Withdrawal by Subject|1|||
129173964|NCT04239222|464931713|FG003|First Foot Assignment|Withdrawal by Subject|0|||
129173965|NCT04239222|464931710|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
129173966|NCT04239222|464931711|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
129173967|NCT04239222|464931712|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
129173968|NCT04239222|464931713|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
129173969|NCT00230282|464931718|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
129173970|NCT00230282|464931718|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
129173971|NCT00230282|464931718|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
129173972|NCT00230282|464931718|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
129173973|NCT01468233|464931721|FG000|Treatment Period 1|Adverse Event|5|||
129173974|NCT01468233|464931722|FG001|Treatment Period 1|Adverse Event|3|||
129173975|NCT01468233|464931723|FG002|Treatment Period 1|Adverse Event|0|||
129173976|NCT01468233|464931724|FG003|Treatment Period 1|Adverse Event|0|||
129173977|NCT01468233|464931725|FG004|Treatment Period 1|Adverse Event|0|||
129173978|NCT01468233|464931726|FG005|Treatment Period 1|Adverse Event|0|||
129173979|NCT01468233|464931721|FG000|Treatment Period 1|Withdrawal by Subject|3|||
129173980|NCT01468233|464931722|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129173981|NCT01468233|464931723|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129173982|NCT01468233|464931724|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129173983|NCT01468233|464931725|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129173984|NCT01468233|464931726|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129173985|NCT01468233|464931721|FG000|Treatment Period 1|Lost to Follow-up|3|||
129173986|NCT01468233|464931722|FG001|Treatment Period 1|Lost to Follow-up|0|||
129173987|NCT01468233|464931723|FG002|Treatment Period 1|Lost to Follow-up|0|||
129173988|NCT01468233|464931724|FG003|Treatment Period 1|Lost to Follow-up|0|||
129173989|NCT01468233|464931725|FG004|Treatment Period 1|Lost to Follow-up|0|||
128780615|NCT00515086|463488575|FG003|Overall Study|Adverse Event|3|||
129173990|NCT01468233|464931726|FG005|Treatment Period 1|Lost to Follow-up|0|||
129173991|NCT01468233|464931721|FG000|Treatment Period 1|Other|1|||
129173992|NCT01468233|464931722|FG001|Treatment Period 1|Other|1|||
129173993|NCT01468233|464931723|FG002|Treatment Period 1|Other|0|||
129173994|NCT01468233|464931724|FG003|Treatment Period 1|Other|0|||
129173995|NCT01468233|464931725|FG004|Treatment Period 1|Other|0|||
129173996|NCT01468233|464931726|FG005|Treatment Period 1|Other|0|||
129173997|NCT01468233|464931721|FG000|Treatment Period 2|Adverse Event|0|||
129173998|NCT01468233|464931722|FG001|Treatment Period 2|Adverse Event|0|||
129173999|NCT01468233|464931723|FG002|Treatment Period 2|Adverse Event|3|||
129174000|NCT01468233|464931724|FG003|Treatment Period 2|Adverse Event|0|||
129174001|NCT01468233|464931725|FG004|Treatment Period 2|Adverse Event|2|||
129174002|NCT01468233|464931726|FG005|Treatment Period 2|Adverse Event|1|||
129174003|NCT01468233|464931721|FG000|Treatment Period 2|Lack of Efficacy|0|||
129174004|NCT01468233|464931722|FG001|Treatment Period 2|Lack of Efficacy|0|||
129174005|NCT01468233|464931723|FG002|Treatment Period 2|Lack of Efficacy|9|||
129174006|NCT01468233|464931724|FG003|Treatment Period 2|Lack of Efficacy|2|||
129174007|NCT01468233|464931725|FG004|Treatment Period 2|Lack of Efficacy|0|||
129174008|NCT01468233|464931726|FG005|Treatment Period 2|Lack of Efficacy|1|||
129174009|NCT01468233|464931721|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129174010|NCT01468233|464931722|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129174011|NCT01468233|464931723|FG002|Treatment Period 2|Withdrawal by Subject|9|||
129174012|NCT01468233|464931724|FG003|Treatment Period 2|Withdrawal by Subject|1|||
129174013|NCT01468233|464931725|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129174014|NCT01468233|464931726|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129174015|NCT01468233|464931721|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
129174016|NCT01468233|464931722|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
129174017|NCT01468233|464931723|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
129174018|NCT01468233|464931724|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
129174019|NCT01468233|464931725|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
129174020|NCT01468233|464931726|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
129174021|NCT01468233|464931721|FG000|Treatment Period 2|Lost to Follow-up|0|||
129174022|NCT01468233|464931722|FG001|Treatment Period 2|Lost to Follow-up|0|||
129174023|NCT01468233|464931723|FG002|Treatment Period 2|Lost to Follow-up|3|||
129174024|NCT01468233|464931724|FG003|Treatment Period 2|Lost to Follow-up|0|||
129174025|NCT01468233|464931725|FG004|Treatment Period 2|Lost to Follow-up|2|||
129174026|NCT01468233|464931726|FG005|Treatment Period 2|Lost to Follow-up|0|||
129174027|NCT01468233|464931721|FG000|Treatment Period 2|Other|0|||
129174028|NCT01468233|464931722|FG001|Treatment Period 2|Other|0|||
129174029|NCT01468233|464931723|FG002|Treatment Period 2|Other|3|||
129174030|NCT01468233|464931724|FG003|Treatment Period 2|Other|0|||
129174031|NCT01468233|464931725|FG004|Treatment Period 2|Other|1|||
129174032|NCT01468233|464931726|FG005|Treatment Period 2|Other|0|||
129174033|NCT02701777|464931734|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
129174034|NCT02701777|464931735|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
129174035|NCT02701777|464931736|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
129174036|NCT02701777|464931737|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
129174037|NCT02701777|464931734|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
129174038|NCT02701777|464931735|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
129174039|NCT02701777|464931736|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
129174040|NCT02701777|464931737|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
129174041|NCT00075725|464931738|FG000|Overall Study|Adverse Event|6|||
129174042|NCT00075725|464931739|FG001|Overall Study|Adverse Event|6|||
128780616|NCT00515086|463488572|FG000|Overall Study|Administrative|1|||
129174043|NCT00075725|464931740|FG002|Overall Study|Adverse Event|20|||
129174044|NCT00075725|464931741|FG003|Overall Study|Adverse Event|8|||
129174045|NCT00075725|464931742|FG004|Overall Study|Adverse Event|4|||
129174046|NCT00075725|464931743|FG005|Overall Study|Adverse Event|38|||
129174047|NCT00075725|464931744|FG006|Overall Study|Adverse Event|3|||
129174048|NCT00075725|464931745|FG007|Overall Study|Adverse Event|51|||
129174049|NCT00075725|464931746|FG008|Overall Study|Adverse Event|15|||
129174050|NCT00075725|464931747|FG009|Overall Study|Adverse Event|4|||
129174051|NCT00075725|464931748|FG010|Overall Study|Adverse Event|2|||
129174052|NCT00075725|464931749|FG011|Overall Study|Adverse Event|2|||
129174053|NCT00075725|464931738|FG000|Overall Study|Death|3|||
129174054|NCT00075725|464931739|FG001|Overall Study|Death|5|||
129174055|NCT00075725|464931740|FG002|Overall Study|Death|10|||
129174056|NCT00075725|464931741|FG003|Overall Study|Death|2|||
129174057|NCT00075725|464931742|FG004|Overall Study|Death|3|||
129174058|NCT00075725|464931743|FG005|Overall Study|Death|25|||
129174059|NCT00075725|464931744|FG006|Overall Study|Death|4|||
129174060|NCT00075725|464931745|FG007|Overall Study|Death|22|||
128780617|NCT00515086|463488573|FG001|Overall Study|Administrative|1|||
129174061|NCT00075725|464931746|FG008|Overall Study|Death|14|||
129174062|NCT00075725|464931747|FG009|Overall Study|Death|4|||
129174063|NCT00075725|464931748|FG010|Overall Study|Death|3|||
129174064|NCT00075725|464931749|FG011|Overall Study|Death|0|||
129174065|NCT00075725|464931738|FG000|Overall Study|Lost to Follow-up|1|||
129174066|NCT00075725|464931739|FG001|Overall Study|Lost to Follow-up|1|||
129174067|NCT00075725|464931740|FG002|Overall Study|Lost to Follow-up|4|||
129174068|NCT00075725|464931741|FG003|Overall Study|Lost to Follow-up|1|||
129174069|NCT00075725|464931742|FG004|Overall Study|Lost to Follow-up|0|||
129174070|NCT00075725|464931743|FG005|Overall Study|Lost to Follow-up|13|||
129174071|NCT00075725|464931744|FG006|Overall Study|Lost to Follow-up|2|||
129174072|NCT00075725|464931745|FG007|Overall Study|Lost to Follow-up|4|||
129174073|NCT00075725|464931746|FG008|Overall Study|Lost to Follow-up|1|||
129174074|NCT00075725|464931747|FG009|Overall Study|Lost to Follow-up|0|||
129174075|NCT00075725|464931748|FG010|Overall Study|Lost to Follow-up|0|||
128780618|NCT00515086|463488574|FG002|Overall Study|Administrative|0|||
128780619|NCT00515086|463488575|FG003|Overall Study|Administrative|0|||
128780620|NCT00515086|463488572|FG000|Overall Study|Withdrawal by Subject|1|||
128780621|NCT00515086|463488573|FG001|Overall Study|Withdrawal by Subject|0|||
128780622|NCT00515086|463488574|FG002|Overall Study|Withdrawal by Subject|0|||
128780623|NCT00515086|463488575|FG003|Overall Study|Withdrawal by Subject|1|||
128780624|NCT00515086|463488572|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
128780625|NCT00515086|463488573|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
128780626|NCT00515086|463488574|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
128780627|NCT00515086|463488575|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
128780628|NCT00515086|463488572|FG000|Overall Study|Lost to Follow-up|1|||
128780629|NCT00515086|463488573|FG001|Overall Study|Lost to Follow-up|0|||
128780630|NCT00515086|463488574|FG002|Overall Study|Lost to Follow-up|0|||
128780631|NCT00515086|463488575|FG003|Overall Study|Lost to Follow-up|0|||
128780632|NCT00515086|463488572|FG000|Overall Study|Study drug no longer required|0|||
128780633|NCT00515086|463488573|FG001|Overall Study|Study drug no longer required|1|||
128780634|NCT00515086|463488574|FG002|Overall Study|Study drug no longer required|0|||
128780635|NCT00515086|463488575|FG003|Overall Study|Study drug no longer required|0|||
128780636|NCT00515086|463488572|FG000|Overall Study|Death|2|||
128780637|NCT00515086|463488573|FG001|Overall Study|Death|0|||
128780638|NCT00515086|463488574|FG002|Overall Study|Death|0|||
128780639|NCT00515086|463488575|FG003|Overall Study|Death|0|||
128780640|NCT02028884|463488576|FG000|Double-blind Period|Adverse Event|5|||
128780641|NCT02028884|463488577|FG001|Double-blind Period|Adverse Event|3|||
128780642|NCT02028884|463488578|FG002|Double-blind Period|Adverse Event|0|||
128780643|NCT02028884|463488576|FG000|Double-blind Period|Eligibility Violation|1|||
128780644|NCT02028884|463488577|FG001|Double-blind Period|Eligibility Violation|0|||
128780645|NCT02028884|463488578|FG002|Double-blind Period|Eligibility Violation|0|||
128780646|NCT02028884|463488576|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
128780647|NCT02028884|463488577|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
128780648|NCT02028884|463488578|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
128780649|NCT02028884|463488576|FG000|Double-blind Period|Withdrawal by Subject|2|||
128780650|NCT02028884|463488577|FG001|Double-blind Period|Withdrawal by Subject|0|||
128780651|NCT02028884|463488578|FG002|Double-blind Period|Withdrawal by Subject|0|||
128780652|NCT02028884|463488576|FG000|Open-label Extension Period|Adverse Event|3|||
128780653|NCT02028884|463488577|FG001|Open-label Extension Period|Adverse Event|1|||
128780654|NCT02028884|463488578|FG002|Open-label Extension Period|Adverse Event|0|||
128780655|NCT02028884|463488576|FG000|Open-label Extension Period|Lack of Efficacy|3|||
128780656|NCT02028884|463488577|FG001|Open-label Extension Period|Lack of Efficacy|0|||
128780657|NCT02028884|463488578|FG002|Open-label Extension Period|Lack of Efficacy|0|||
128780658|NCT02028884|463488576|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
128780659|NCT02028884|463488577|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
128780660|NCT02028884|463488578|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
128780661|NCT02028884|463488576|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
128780662|NCT02028884|463488577|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
128780663|NCT02028884|463488578|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
128780664|NCT02028884|463488576|FG000|Open-label Extension Period|Switched to another treatment option|3|||
128780665|NCT02028884|463488577|FG001|Open-label Extension Period|Switched to another treatment option|0|||
128780666|NCT02028884|463488578|FG002|Open-label Extension Period|Switched to another treatment option|0|||
128780667|NCT02373813|463488579|FG000|Run-In Period|Other, Not Specified|5|||
128780668|NCT02373813|463488580|FG001|Run-In Period|Other, Not Specified|0|||
128780669|NCT02373813|463488581|FG002|Run-In Period|Other, Not Specified|0|||
128780670|NCT02373813|463488582|FG003|Run-In Period|Other, Not Specified|0|||
128780671|NCT02373813|463488579|FG000|Run-In Period|Withdrawal by Subject|16|||
128780672|NCT02373813|463488580|FG001|Run-In Period|Withdrawal by Subject|0|||
128780673|NCT02373813|463488581|FG002|Run-In Period|Withdrawal by Subject|0|||
128780674|NCT02373813|463488582|FG003|Run-In Period|Withdrawal by Subject|0|||
128780675|NCT02373813|463488579|FG000|Run-In Period|Decision by Sponsor|11|||
128780676|NCT02373813|463488580|FG001|Run-In Period|Decision by Sponsor|0|||
128780677|NCT02373813|463488581|FG002|Run-In Period|Decision by Sponsor|0|||
128780678|NCT02373813|463488582|FG003|Run-In Period|Decision by Sponsor|0|||
129174076|NCT00075725|464931749|FG011|Overall Study|Lost to Follow-up|0|||
129174077|NCT00075725|464931738|FG000|Overall Study|Physician Decision|2|||
129174078|NCT00075725|464931739|FG001|Overall Study|Physician Decision|6|||
129174079|NCT00075725|464931740|FG002|Overall Study|Physician Decision|5|||
129174080|NCT00075725|464931741|FG003|Overall Study|Physician Decision|8|||
129174081|NCT00075725|464931742|FG004|Overall Study|Physician Decision|4|||
129174082|NCT00075725|464931743|FG005|Overall Study|Physician Decision|19|||
129174083|NCT00075725|464931744|FG006|Overall Study|Physician Decision|3|||
129174084|NCT00075725|464931745|FG007|Overall Study|Physician Decision|17|||
129174085|NCT00075725|464931746|FG008|Overall Study|Physician Decision|5|||
129174086|NCT00075725|464931747|FG009|Overall Study|Physician Decision|0|||
129174087|NCT00075725|464931748|FG010|Overall Study|Physician Decision|1|||
129174088|NCT00075725|464931749|FG011|Overall Study|Physician Decision|0|||
129174089|NCT00075725|464931738|FG000|Overall Study|Pregnancy|0|||
129174090|NCT00075725|464931739|FG001|Overall Study|Pregnancy|0|||
129174091|NCT00075725|464931740|FG002|Overall Study|Pregnancy|0|||
129174092|NCT00075725|464931741|FG003|Overall Study|Pregnancy|0|||
129174093|NCT00075725|464931742|FG004|Overall Study|Pregnancy|0|||
129174094|NCT00075725|464931743|FG005|Overall Study|Pregnancy|1|||
129174095|NCT00075725|464931744|FG006|Overall Study|Pregnancy|0|||
129174096|NCT00075725|464931745|FG007|Overall Study|Pregnancy|1|||
129174097|NCT00075725|464931746|FG008|Overall Study|Pregnancy|0|||
129174098|NCT00075725|464931747|FG009|Overall Study|Pregnancy|0|||
129174099|NCT00075725|464931748|FG010|Overall Study|Pregnancy|0|||
129174100|NCT00075725|464931749|FG011|Overall Study|Pregnancy|0|||
129174101|NCT00075725|464931738|FG000|Overall Study|Protocol Violation|1|||
129174102|NCT00075725|464931739|FG001|Overall Study|Protocol Violation|1|||
129174103|NCT00075725|464931740|FG002|Overall Study|Protocol Violation|0|||
129174104|NCT00075725|464931741|FG003|Overall Study|Protocol Violation|3|||
129174105|NCT00075725|464931742|FG004|Overall Study|Protocol Violation|3|||
129174106|NCT00075725|464931743|FG005|Overall Study|Protocol Violation|2|||
129174107|NCT00075725|464931744|FG006|Overall Study|Protocol Violation|1|||
129174108|NCT00075725|464931745|FG007|Overall Study|Protocol Violation|2|||
129174109|NCT00075725|464931746|FG008|Overall Study|Protocol Violation|3|||
129174110|NCT00075725|464931747|FG009|Overall Study|Protocol Violation|0|||
129174111|NCT00075725|464931748|FG010|Overall Study|Protocol Violation|0|||
129174112|NCT00075725|464931749|FG011|Overall Study|Protocol Violation|1|||
129174113|NCT00075725|464931738|FG000|Overall Study|Withdrawal by Subject|12|||
129174114|NCT00075725|464931739|FG001|Overall Study|Withdrawal by Subject|3|||
129174115|NCT00075725|464931740|FG002|Overall Study|Withdrawal by Subject|6|||
128982123|NCT02545504|464219103|FG000|Overall Study|Investigator's discretion|3|||
128982124|NCT02545504|464219104|FG001|Overall Study|Investigator's discretion|1|||
128982125|NCT02545504|464219103|FG000|Overall Study|Lost to Follow-up|2|||
128982126|NCT02545504|464219104|FG001|Overall Study|Lost to Follow-up|2|||
128982127|NCT00508820|464219106|FG000|Overall Study|Adverse Event|6|||
128982128|NCT00508820|464219107|FG001|Overall Study|Adverse Event|10|||
129174116|NCT00075725|464931741|FG003|Overall Study|Withdrawal by Subject|10|||
129174117|NCT00075725|464931742|FG004|Overall Study|Withdrawal by Subject|6|||
129174118|NCT00075725|464931743|FG005|Overall Study|Withdrawal by Subject|27|||
129174119|NCT00075725|464931744|FG006|Overall Study|Withdrawal by Subject|7|||
129174120|NCT00075725|464931745|FG007|Overall Study|Withdrawal by Subject|31|||
129174121|NCT00075725|464931746|FG008|Overall Study|Withdrawal by Subject|10|||
129174122|NCT00075725|464931747|FG009|Overall Study|Withdrawal by Subject|2|||
129174123|NCT00075725|464931748|FG010|Overall Study|Withdrawal by Subject|0|||
129174124|NCT00075725|464931749|FG011|Overall Study|Withdrawal by Subject|0|||
129174125|NCT00075725|464931738|FG000|Overall Study|Disease Progression, all other reasons|17|||
129174126|NCT00075725|464931739|FG001|Overall Study|Disease Progression, all other reasons|5|||
129174127|NCT00075725|464931740|FG002|Overall Study|Disease Progression, all other reasons|33|||
129174128|NCT00075725|464931741|FG003|Overall Study|Disease Progression, all other reasons|6|||
129174129|NCT00075725|464931742|FG004|Overall Study|Disease Progression, all other reasons|21|||
129174130|NCT00075725|464931743|FG005|Overall Study|Disease Progression, all other reasons|59|||
129174131|NCT00075725|464931744|FG006|Overall Study|Disease Progression, all other reasons|20|||
129174132|NCT00075725|464931745|FG007|Overall Study|Disease Progression, all other reasons|46|||
129174133|NCT00075725|464931746|FG008|Overall Study|Disease Progression, all other reasons|21|||
129174134|NCT00075725|464931747|FG009|Overall Study|Disease Progression, all other reasons|4|||
129174135|NCT00075725|464931748|FG010|Overall Study|Disease Progression, all other reasons|0|||
129174136|NCT00075725|464931749|FG011|Overall Study|Disease Progression, all other reasons|5|||
129174137|NCT00075725|464931738|FG000|Overall Study|Patient off treatment|0|||
129174138|NCT00075725|464931739|FG001|Overall Study|Patient off treatment|0|||
129174139|NCT00075725|464931740|FG002|Overall Study|Patient off treatment|1|||
129174140|NCT00075725|464931741|FG003|Overall Study|Patient off treatment|2|||
129174141|NCT00075725|464931742|FG004|Overall Study|Patient off treatment|1|||
129174142|NCT00075725|464931743|FG005|Overall Study|Patient off treatment|0|||
129174143|NCT00075725|464931744|FG006|Overall Study|Patient off treatment|0|||
129174144|NCT00075725|464931745|FG007|Overall Study|Patient off treatment|2|||
129174145|NCT00075725|464931746|FG008|Overall Study|Patient off treatment|1|||
129174146|NCT00075725|464931747|FG009|Overall Study|Patient off treatment|0|||
128780679|NCT02373813|463488579|FG000|Run-In Period|Protocol Violation|75|||
128780680|NCT02373813|463488580|FG001|Run-In Period|Protocol Violation|0|||
128780681|NCT02373813|463488581|FG002|Run-In Period|Protocol Violation|0|||
128780682|NCT02373813|463488582|FG003|Run-In Period|Protocol Violation|0|||
128780683|NCT02373813|463488579|FG000|Run-In Period|Lost to Follow-up|2|||
128780684|NCT02373813|463488580|FG001|Run-In Period|Lost to Follow-up|0|||
128780685|NCT02373813|463488581|FG002|Run-In Period|Lost to Follow-up|0|||
129174147|NCT00075725|464931748|FG010|Overall Study|Patient off treatment|0|||
129174148|NCT00075725|464931749|FG011|Overall Study|Patient off treatment|0|||
129174149|NCT00075725|464931738|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
129174150|NCT00075725|464931739|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
129174151|NCT00075725|464931740|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
129174152|NCT00075725|464931741|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
129174153|NCT00075725|464931742|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
129174154|NCT00075725|464931743|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
129174155|NCT00075725|464931744|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
129174156|NCT00075725|464931745|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
129174157|NCT00075725|464931746|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
129174158|NCT00075725|464931747|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
129174159|NCT00075725|464931748|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
129174160|NCT00075725|464931749|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
129174161|NCT00075725|464931738|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
129174162|NCT00075725|464931739|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
129174163|NCT00075725|464931740|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
129174164|NCT00075725|464931741|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
129174165|NCT00075725|464931742|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
129174166|NCT00075725|464931743|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
129174167|NCT00075725|464931744|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
129174168|NCT00075725|464931745|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
129174169|NCT00075725|464931746|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
129174170|NCT00075725|464931747|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
129174171|NCT00075725|464931748|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
129174172|NCT00075725|464931749|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
129174173|NCT00075725|464931738|FG000|Overall Study|Pt non compliant with therapy|2|||
129174174|NCT00075725|464931739|FG001|Overall Study|Pt non compliant with therapy|1|||
129174175|NCT00075725|464931740|FG002|Overall Study|Pt non compliant with therapy|1|||
129174176|NCT00075725|464931741|FG003|Overall Study|Pt non compliant with therapy|0|||
129174177|NCT00075725|464931742|FG004|Overall Study|Pt non compliant with therapy|2|||
129174178|NCT00075725|464931743|FG005|Overall Study|Pt non compliant with therapy|14|||
129174179|NCT00075725|464931744|FG006|Overall Study|Pt non compliant with therapy|2|||
129174180|NCT00075725|464931745|FG007|Overall Study|Pt non compliant with therapy|5|||
129174181|NCT00075725|464931746|FG008|Overall Study|Pt non compliant with therapy|3|||
129174182|NCT00075725|464931747|FG009|Overall Study|Pt non compliant with therapy|0|||
129174183|NCT00075725|464931748|FG010|Overall Study|Pt non compliant with therapy|0|||
129174184|NCT00075725|464931749|FG011|Overall Study|Pt non compliant with therapy|0|||
129174185|NCT00075725|464931738|FG000|Overall Study|Pt age out of range for treatment|0|||
129174186|NCT00075725|464931739|FG001|Overall Study|Pt age out of range for treatment|1|||
129174187|NCT00075725|464931740|FG002|Overall Study|Pt age out of range for treatment|0|||
129174188|NCT00075725|464931741|FG003|Overall Study|Pt age out of range for treatment|0|||
129174189|NCT00075725|464931742|FG004|Overall Study|Pt age out of range for treatment|0|||
129174190|NCT00075725|464931743|FG005|Overall Study|Pt age out of range for treatment|1|||
129174191|NCT00075725|464931744|FG006|Overall Study|Pt age out of range for treatment|0|||
129174192|NCT00075725|464931745|FG007|Overall Study|Pt age out of range for treatment|1|||
129174193|NCT00075725|464931746|FG008|Overall Study|Pt age out of range for treatment|0|||
129174194|NCT00075725|464931747|FG009|Overall Study|Pt age out of range for treatment|0|||
129174195|NCT00075725|464931748|FG010|Overall Study|Pt age out of range for treatment|0|||
129174196|NCT00075725|464931749|FG011|Overall Study|Pt age out of range for treatment|0|||
129174197|NCT00075725|464931738|FG000|Overall Study|Insurance issues|0|||
129174198|NCT00075725|464931739|FG001|Overall Study|Insurance issues|1|||
129174199|NCT00075725|464931740|FG002|Overall Study|Insurance issues|0|||
129174200|NCT00075725|464931741|FG003|Overall Study|Insurance issues|1|||
129174201|NCT00075725|464931742|FG004|Overall Study|Insurance issues|1|||
129174202|NCT00075725|464931743|FG005|Overall Study|Insurance issues|1|||
129174203|NCT00075725|464931744|FG006|Overall Study|Insurance issues|0|||
129174204|NCT00075725|464931745|FG007|Overall Study|Insurance issues|1|||
129174205|NCT00075725|464931746|FG008|Overall Study|Insurance issues|0|||
129174206|NCT00075725|464931747|FG009|Overall Study|Insurance issues|0|||
129174207|NCT00075725|464931748|FG010|Overall Study|Insurance issues|0|||
129174208|NCT00075725|464931749|FG011|Overall Study|Insurance issues|0|||
129174209|NCT00075725|464931738|FG000|Overall Study|MRD positive after extended ind|0|||
129174210|NCT00075725|464931739|FG001|Overall Study|MRD positive after extended ind|1|||
129174211|NCT00075725|464931740|FG002|Overall Study|MRD positive after extended ind|1|||
129174212|NCT00075725|464931741|FG003|Overall Study|MRD positive after extended ind|0|||
129174213|NCT00075725|464931742|FG004|Overall Study|MRD positive after extended ind|1|||
129174214|NCT00075725|464931743|FG005|Overall Study|MRD positive after extended ind|2|||
129174215|NCT00075725|464931744|FG006|Overall Study|MRD positive after extended ind|0|||
129174216|NCT00075725|464931745|FG007|Overall Study|MRD positive after extended ind|1|||
129174217|NCT00075725|464931746|FG008|Overall Study|MRD positive after extended ind|0|||
129174218|NCT00075725|464931747|FG009|Overall Study|MRD positive after extended ind|0|||
129174219|NCT00075725|464931748|FG010|Overall Study|MRD positive after extended ind|0|||
129174220|NCT00075725|464931749|FG011|Overall Study|MRD positive after extended ind|0|||
129174221|NCT00075725|464931738|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
129174222|NCT00075725|464931739|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
129174223|NCT00075725|464931740|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
129174224|NCT00075725|464931741|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
129174225|NCT00075725|464931742|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
129174226|NCT00075725|464931743|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
129174227|NCT00075725|464931744|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
129174228|NCT00075725|464931745|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
129174229|NCT00075725|464931746|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
129174230|NCT00075725|464931747|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
129174231|NCT00075725|464931748|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
129174232|NCT00075725|464931749|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
129174233|NCT00075725|464931738|FG000|Overall Study|Inevaluable|1|||
129174234|NCT00075725|464931739|FG001|Overall Study|Inevaluable|1|||
129174235|NCT00075725|464931740|FG002|Overall Study|Inevaluable|4|||
129174236|NCT00075725|464931741|FG003|Overall Study|Inevaluable|2|||
129174237|NCT00075725|464931742|FG004|Overall Study|Inevaluable|2|||
129174238|NCT00075725|464931743|FG005|Overall Study|Inevaluable|9|||
129174239|NCT00075725|464931744|FG006|Overall Study|Inevaluable|1|||
129174240|NCT00075725|464931745|FG007|Overall Study|Inevaluable|11|||
129174241|NCT00075725|464931746|FG008|Overall Study|Inevaluable|2|||
129174242|NCT00075725|464931747|FG009|Overall Study|Inevaluable|0|||
129174243|NCT00075725|464931748|FG010|Overall Study|Inevaluable|1|||
129174244|NCT00075725|464931749|FG011|Overall Study|Inevaluable|0|||
129174245|NCT00075725|464931738|FG000|Overall Study|Other|4|||
129174246|NCT00075725|464931739|FG001|Overall Study|Other|2|||
129174247|NCT00075725|464931740|FG002|Overall Study|Other|1|||
129174248|NCT00075725|464931741|FG003|Overall Study|Other|1|||
129174249|NCT00075725|464931742|FG004|Overall Study|Other|1|||
129174250|NCT00075725|464931743|FG005|Overall Study|Other|4|||
129174251|NCT00075725|464931744|FG006|Overall Study|Other|2|||
129174252|NCT00075725|464931745|FG007|Overall Study|Other|9|||
129174253|NCT00075725|464931746|FG008|Overall Study|Other|2|||
129174254|NCT00075725|464931747|FG009|Overall Study|Other|1|||
129174255|NCT00075725|464931748|FG010|Overall Study|Other|0|||
129174256|NCT00075725|464931749|FG011|Overall Study|Other|3|||
129174257|NCT00075725|464931738|FG000|Overall Study|Pt trying to find a BM donor|0|||
129174258|NCT00075725|464931739|FG001|Overall Study|Pt trying to find a BM donor|1|||
129174259|NCT00075725|464931740|FG002|Overall Study|Pt trying to find a BM donor|0|||
129174260|NCT00075725|464931741|FG003|Overall Study|Pt trying to find a BM donor|0|||
129174261|NCT00075725|464931742|FG004|Overall Study|Pt trying to find a BM donor|0|||
129174262|NCT00075725|464931743|FG005|Overall Study|Pt trying to find a BM donor|0|||
129174263|NCT00075725|464931744|FG006|Overall Study|Pt trying to find a BM donor|0|||
129174264|NCT00075725|464931745|FG007|Overall Study|Pt trying to find a BM donor|0|||
129174265|NCT00075725|464931746|FG008|Overall Study|Pt trying to find a BM donor|0|||
129174266|NCT00075725|464931747|FG009|Overall Study|Pt trying to find a BM donor|0|||
129174267|NCT00075725|464931748|FG010|Overall Study|Pt trying to find a BM donor|0|||
129174268|NCT00075725|464931749|FG011|Overall Study|Pt trying to find a BM donor|0|||
129174269|NCT00075725|464931738|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
129174270|NCT00075725|464931739|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
129174271|NCT00075725|464931740|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
129174272|NCT00075725|464931741|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
129174273|NCT00075725|464931742|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
129174274|NCT00075725|464931743|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
129174275|NCT00075725|464931744|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
129174276|NCT00075725|464931745|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
129174277|NCT00075725|464931746|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
129174278|NCT00075725|464931747|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
129174279|NCT00075725|464931748|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
129174280|NCT00075725|464931749|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
129174281|NCT00075725|464931738|FG000|Overall Study|Unsuccessful institutional transfer|0|||
129174282|NCT00075725|464931739|FG001|Overall Study|Unsuccessful institutional transfer|0|||
129174283|NCT00075725|464931740|FG002|Overall Study|Unsuccessful institutional transfer|2|||
129174284|NCT00075725|464931741|FG003|Overall Study|Unsuccessful institutional transfer|0|||
129174285|NCT00075725|464931742|FG004|Overall Study|Unsuccessful institutional transfer|0|||
129174286|NCT00075725|464931743|FG005|Overall Study|Unsuccessful institutional transfer|0|||
129174287|NCT00075725|464931744|FG006|Overall Study|Unsuccessful institutional transfer|0|||
129174288|NCT00075725|464931745|FG007|Overall Study|Unsuccessful institutional transfer|0|||
129174289|NCT00075725|464931746|FG008|Overall Study|Unsuccessful institutional transfer|0|||
129174290|NCT00075725|464931747|FG009|Overall Study|Unsuccessful institutional transfer|1|||
129174291|NCT00075725|464931748|FG010|Overall Study|Unsuccessful institutional transfer|0|||
129174292|NCT00075725|464931749|FG011|Overall Study|Unsuccessful institutional transfer|0|||
129174293|NCT00075725|464931738|FG000|Overall Study|specimen(s) not submitted|0|||
129174294|NCT00075725|464931739|FG001|Overall Study|specimen(s) not submitted|0|||
129174295|NCT00075725|464931740|FG002|Overall Study|specimen(s) not submitted|2|||
129174296|NCT00075725|464931741|FG003|Overall Study|specimen(s) not submitted|0|||
129174297|NCT00075725|464931742|FG004|Overall Study|specimen(s) not submitted|0|||
129174298|NCT00075725|464931743|FG005|Overall Study|specimen(s) not submitted|0|||
129174299|NCT00075725|464931744|FG006|Overall Study|specimen(s) not submitted|0|||
128780686|NCT02373813|463488582|FG003|Run-In Period|Lost to Follow-up|0|||
128780687|NCT02373813|463488579|FG000|Run-In Period|Adverse Event|3|||
128780688|NCT02373813|463488580|FG001|Run-In Period|Adverse Event|0|||
128780689|NCT02373813|463488581|FG002|Run-In Period|Adverse Event|0|||
128780690|NCT02373813|463488582|FG003|Run-In Period|Adverse Event|0|||
128780691|NCT02373813|463488579|FG000|Run-In Period|Noncompliance|1|||
128780692|NCT02373813|463488580|FG001|Run-In Period|Noncompliance|0|||
128780693|NCT02373813|463488581|FG002|Run-In Period|Noncompliance|0|||
128780694|NCT02373813|463488582|FG003|Run-In Period|Noncompliance|0|||
128780695|NCT02373813|463488579|FG000|Run-In Period|Ineligibility Determined|3|||
128780696|NCT02373813|463488580|FG001|Run-In Period|Ineligibility Determined|0|||
128780697|NCT02373813|463488581|FG002|Run-In Period|Ineligibility Determined|0|||
128780698|NCT02373813|463488582|FG003|Run-In Period|Ineligibility Determined|0|||
128780699|NCT02373813|463488579|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
128780700|NCT02373813|463488580|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
128780701|NCT02373813|463488581|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
128780702|NCT02373813|463488582|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
128780703|NCT02373813|463488579|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
128780704|NCT02373813|463488580|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
128780705|NCT02373813|463488581|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
128780706|NCT02373813|463488582|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
128780707|NCT02373813|463488579|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128780708|NCT02373813|463488580|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
128780709|NCT02373813|463488581|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
128780710|NCT02373813|463488582|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
128780711|NCT02373813|463488579|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128780712|NCT02373813|463488580|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
128780713|NCT02373813|463488581|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
128780714|NCT02373813|463488582|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
128780715|NCT00723294|463488583|FG000|Overall Study|Lobular histology|2|||
128780716|NCT00723294|463488583|FG000|Overall Study|>25% intraductal component|1|||
128780717|NCT00723294|463488583|FG000|Overall Study|No MRI tumor enhancement|1|||
128780718|NCT00723294|463488583|FG000|Overall Study|1.0-Tesla MRI|1|||
128780719|NCT00723294|463488583|FG000|Overall Study|No cryoabalation|2|||
128780720|NCT00723294|463488583|FG000|Overall Study|Did not undergo surgery|1|||
128780721|NCT00723294|463488583|FG000|Overall Study|Treated prior to registration|1|||
128780722|NCT00723294|463488583|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
128780723|NCT00723294|463488583|FG000|Overall Study|Benign lesion|1|||
128780724|NCT00723294|463488583|FG000|Overall Study|Withdrawal by Subject|1|||
128780725|NCT00723294|463488583|FG000|Overall Study|No treatment due to probe failure|1|||
128780726|NCT02403674|463488584|FG000|Base Study|Death|1|||
128780727|NCT02403674|463488585|FG001|Base Study|Death|4|||
128780728|NCT02403674|463488584|FG000|Base Study|Adverse Event|11|||
128780729|NCT02403674|463488585|FG001|Base Study|Adverse Event|26|||
128780730|NCT02403674|463488584|FG000|Base Study|Lack of Efficacy|31|||
128780731|NCT02403674|463488585|FG001|Base Study|Lack of Efficacy|23|||
128780732|NCT02403674|463488584|FG000|Base Study|Lost to Follow-up|6|||
128780733|NCT02403674|463488585|FG001|Base Study|Lost to Follow-up|8|||
128780734|NCT02403674|463488584|FG000|Base Study|Withdrawal by Subject|10|||
128780735|NCT02403674|463488585|FG001|Base Study|Withdrawal by Subject|17|||
128780736|NCT02403674|463488584|FG000|Base Study|Physician Decision|2|||
128780737|NCT02403674|463488585|FG001|Base Study|Physician Decision|2|||
128780738|NCT02403674|463488584|FG000|Base Study|Pregnancy|2|||
128780739|NCT02403674|463488585|FG001|Base Study|Pregnancy|2|||
128780740|NCT02403674|463488584|FG000|Base Study|Protocol Violation|8|||
128780741|NCT02403674|463488585|FG001|Base Study|Protocol Violation|4|||
128780742|NCT02403674|463488584|FG000|Base Study|Non-Compliance with study drug|1|||
128780743|NCT02403674|463488585|FG001|Base Study|Non-Compliance with study drug|4|||
128780744|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
128780745|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
128780746|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
128780747|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
128780748|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
128780749|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
128780750|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
128780751|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
128780752|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
128780753|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
128780754|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
128780755|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
128780756|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Death|1|||
128780757|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Death|0|||
128780758|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
128780759|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
128780760|NCT02403674|463488584|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
128780761|NCT02403674|463488585|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
128780762|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
128780763|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
128780764|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
128780765|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
128780766|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
128780767|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
128780768|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
128780769|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
128780770|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
128780771|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
128780772|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Death|2|||
128780773|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Death|2|||
128780774|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
128780775|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
128780776|NCT02403674|463488584|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
128780777|NCT02403674|463488585|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
128780778|NCT02403674|463488584|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
128780779|NCT02403674|463488585|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
128780780|NCT02403674|463488584|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
128780781|NCT02403674|463488585|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
128780782|NCT02403674|463488584|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
128780783|NCT02403674|463488585|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
128780784|NCT02403674|463488584|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
128780785|NCT02403674|463488585|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
128780786|NCT02403674|463488584|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
128780787|NCT02403674|463488585|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
128780788|NCT01254305|463488590|FG000|Overall Study|Adverse Event|6|||
128780789|NCT01254305|463488591|FG001|Overall Study|Adverse Event|3|||
129174300|NCT00075725|464931745|FG007|Overall Study|specimen(s) not submitted|0|||
129174301|NCT00075725|464931746|FG008|Overall Study|specimen(s) not submitted|0|||
129174302|NCT00075725|464931747|FG009|Overall Study|specimen(s) not submitted|0|||
129174303|NCT00075725|464931748|FG010|Overall Study|specimen(s) not submitted|0|||
129174304|NCT00075725|464931749|FG011|Overall Study|specimen(s) not submitted|0|||
129174305|NCT00075725|464931738|FG000|Overall Study|Pt went to transplant|0|||
129174306|NCT00075725|464931739|FG001|Overall Study|Pt went to transplant|0|||
129174307|NCT00075725|464931740|FG002|Overall Study|Pt went to transplant|0|||
129174308|NCT00075725|464931741|FG003|Overall Study|Pt went to transplant|1|||
129174309|NCT00075725|464931742|FG004|Overall Study|Pt went to transplant|0|||
129174310|NCT00075725|464931743|FG005|Overall Study|Pt went to transplant|1|||
129174311|NCT00075725|464931744|FG006|Overall Study|Pt went to transplant|0|||
129174312|NCT00075725|464931745|FG007|Overall Study|Pt went to transplant|0|||
129174313|NCT00075725|464931746|FG008|Overall Study|Pt went to transplant|0|||
129174314|NCT00075725|464931747|FG009|Overall Study|Pt went to transplant|0|||
129174315|NCT00075725|464931748|FG010|Overall Study|Pt went to transplant|0|||
129174316|NCT00075725|464931749|FG011|Overall Study|Pt went to transplant|0|||
129174317|NCT00075725|464931738|FG000|Overall Study|Pt received additional steroids|0|||
129174318|NCT00075725|464931739|FG001|Overall Study|Pt received additional steroids|0|||
129174319|NCT00075725|464931740|FG002|Overall Study|Pt received additional steroids|0|||
129174320|NCT00075725|464931741|FG003|Overall Study|Pt received additional steroids|1|||
129174321|NCT00075725|464931742|FG004|Overall Study|Pt received additional steroids|0|||
129174322|NCT00075725|464931743|FG005|Overall Study|Pt received additional steroids|0|||
129174323|NCT00075725|464931744|FG006|Overall Study|Pt received additional steroids|0|||
129174324|NCT00075725|464931745|FG007|Overall Study|Pt received additional steroids|0|||
129174325|NCT00075725|464931746|FG008|Overall Study|Pt received additional steroids|0|||
129174326|NCT00075725|464931747|FG009|Overall Study|Pt received additional steroids|0|||
129174327|NCT00075725|464931748|FG010|Overall Study|Pt received additional steroids|0|||
129174328|NCT00075725|464931749|FG011|Overall Study|Pt received additional steroids|0|||
129174329|NCT00075725|464931738|FG000|Overall Study|Pt relocated|0|||
128780790|NCT01254305|463488592|FG002|Overall Study|Adverse Event|2|||
128780791|NCT01254305|463488590|FG000|Overall Study|Lack of Efficacy|1|||
128780792|NCT01254305|463488591|FG001|Overall Study|Lack of Efficacy|0|||
128780793|NCT01254305|463488592|FG002|Overall Study|Lack of Efficacy|1|||
129174330|NCT00075725|464931739|FG001|Overall Study|Pt relocated|0|||
129174331|NCT00075725|464931740|FG002|Overall Study|Pt relocated|0|||
129174332|NCT00075725|464931741|FG003|Overall Study|Pt relocated|2|||
129174333|NCT00075725|464931742|FG004|Overall Study|Pt relocated|0|||
128780794|NCT01254305|463488590|FG000|Overall Study|Protocol Violation|1|||
129174334|NCT00075725|464931743|FG005|Overall Study|Pt relocated|1|||
129174335|NCT00075725|464931744|FG006|Overall Study|Pt relocated|1|||
129174336|NCT00075725|464931745|FG007|Overall Study|Pt relocated|2|||
129174337|NCT00075725|464931746|FG008|Overall Study|Pt relocated|1|||
129174338|NCT00075725|464931747|FG009|Overall Study|Pt relocated|0|||
129174339|NCT00075725|464931748|FG010|Overall Study|Pt relocated|0|||
129174340|NCT00075725|464931749|FG011|Overall Study|Pt relocated|0|||
129174341|NCT00075725|464931738|FG000|Overall Study|Institution Terminated|0|||
129174342|NCT00075725|464931739|FG001|Overall Study|Institution Terminated|0|||
129174343|NCT00075725|464931740|FG002|Overall Study|Institution Terminated|0|||
129174344|NCT00075725|464931741|FG003|Overall Study|Institution Terminated|0|||
129174345|NCT00075725|464931742|FG004|Overall Study|Institution Terminated|1|||
129174346|NCT00075725|464931743|FG005|Overall Study|Institution Terminated|0|||
129174347|NCT00075725|464931744|FG006|Overall Study|Institution Terminated|0|||
129174348|NCT00075725|464931745|FG007|Overall Study|Institution Terminated|3|||
129174349|NCT00075725|464931746|FG008|Overall Study|Institution Terminated|0|||
129174350|NCT00075725|464931747|FG009|Overall Study|Institution Terminated|0|||
129174351|NCT00075725|464931748|FG010|Overall Study|Institution Terminated|0|||
129174352|NCT00075725|464931749|FG011|Overall Study|Institution Terminated|0|||
129174353|NCT00075725|464931738|FG000|Overall Study|Study Closure|1|||
129174354|NCT00075725|464931739|FG001|Overall Study|Study Closure|0|||
129174355|NCT00075725|464931740|FG002|Overall Study|Study Closure|0|||
129174356|NCT00075725|464931741|FG003|Overall Study|Study Closure|0|||
129174357|NCT00075725|464931742|FG004|Overall Study|Study Closure|1|||
129174358|NCT00075725|464931743|FG005|Overall Study|Study Closure|3|||
129174359|NCT00075725|464931744|FG006|Overall Study|Study Closure|0|||
129174360|NCT00075725|464931745|FG007|Overall Study|Study Closure|1|||
129174361|NCT00075725|464931746|FG008|Overall Study|Study Closure|0|||
129174362|NCT00075725|464931747|FG009|Overall Study|Study Closure|0|||
129174363|NCT00075725|464931748|FG010|Overall Study|Study Closure|0|||
129174364|NCT00075725|464931749|FG011|Overall Study|Study Closure|0|||
129174365|NCT00075725|464931738|FG000|Overall Study|Other complications|0|||
129174366|NCT00075725|464931739|FG001|Overall Study|Other complications|0|||
129174367|NCT00075725|464931740|FG002|Overall Study|Other complications|0|||
129174368|NCT00075725|464931741|FG003|Overall Study|Other complications|0|||
129174369|NCT00075725|464931742|FG004|Overall Study|Other complications|0|||
129174370|NCT00075725|464931743|FG005|Overall Study|Other complications|1|||
129174371|NCT00075725|464931744|FG006|Overall Study|Other complications|0|||
129174372|NCT00075725|464931745|FG007|Overall Study|Other complications|0|||
129174373|NCT00075725|464931746|FG008|Overall Study|Other complications|0|||
129174374|NCT00075725|464931747|FG009|Overall Study|Other complications|0|||
129174375|NCT00075725|464931748|FG010|Overall Study|Other complications|0|||
129174376|NCT00075725|464931749|FG011|Overall Study|Other complications|0|||
129174377|NCT00075725|464931738|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
129174378|NCT00075725|464931739|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
129174379|NCT00075725|464931740|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
129174380|NCT00075725|464931741|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
129174381|NCT00075725|464931742|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
129174382|NCT00075725|464931743|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
129174383|NCT00075725|464931744|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
129174384|NCT00075725|464931745|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
128730094|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
128730095|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
128730096|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
128730097|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
128730098|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
128730099|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
128730100|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
128730101|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
128730102|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
128730103|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
128730104|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
128730105|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
128730106|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
128730107|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
128730108|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
128730109|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
128730110|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
128780795|NCT01254305|463488591|FG001|Overall Study|Protocol Violation|7|||
129174385|NCT00075725|464931746|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
129174386|NCT00075725|464931747|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
129174387|NCT00075725|464931748|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
129174388|NCT00075725|464931749|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
129174389|NCT00075725|464931738|FG000|Overall Study|Pt incarcerated|0|||
129174390|NCT00075725|464931739|FG001|Overall Study|Pt incarcerated|0|||
129174391|NCT00075725|464931740|FG002|Overall Study|Pt incarcerated|0|||
129174392|NCT00075725|464931741|FG003|Overall Study|Pt incarcerated|0|||
129174393|NCT00075725|464931742|FG004|Overall Study|Pt incarcerated|0|||
129174394|NCT00075725|464931743|FG005|Overall Study|Pt incarcerated|0|||
129174395|NCT00075725|464931744|FG006|Overall Study|Pt incarcerated|0|||
129174396|NCT00075725|464931745|FG007|Overall Study|Pt incarcerated|1|||
129174397|NCT00075725|464931746|FG008|Overall Study|Pt incarcerated|0|||
129174398|NCT00075725|464931747|FG009|Overall Study|Pt incarcerated|0|||
129174399|NCT00075725|464931748|FG010|Overall Study|Pt incarcerated|0|||
129174400|NCT00075725|464931749|FG011|Overall Study|Pt incarcerated|0|||
129174401|NCT02240368|464931750|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
129174402|NCT02240368|464931751|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
129174403|NCT02240368|464931752|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
129174404|NCT02240368|464931750|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
129174405|NCT02240368|464931751|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
129174406|NCT02240368|464931752|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
129174407|NCT03385265|464931758|FG000|Overall Study|Withdrawal by Subject|5|||
129174408|NCT03385265|464931759|FG001|Overall Study|Withdrawal by Subject|2|||
129174409|NCT03385265|464931760|FG002|Overall Study|Withdrawal by Subject|5|||
129174410|NCT03385265|464931761|FG003|Overall Study|Withdrawal by Subject|2|||
129174411|NCT02752958|464931764|FG000|Overall Study|Adverse Event|3|||
129174412|NCT02752958|464931764|FG000|Overall Study|Lost to Follow-up|1|||
129174413|NCT02752958|464931764|FG000|Overall Study|Protocol Violation|1|||
129174414|NCT02752958|464931764|FG000|Overall Study|Withdrawal by Subject|2|||
129174415|NCT02752958|464931764|FG000|Overall Study|Other (Reason not specified)|2|||
129174416|NCT00853125|464931765|FG000|Overall Study|Study participant's donor was CMV +|1|||
129174417|NCT03746600|464931767|FG000|Overall Study|Withdrawal by Subject|3|||
129174418|NCT03746600|464931768|FG001|Overall Study|Withdrawal by Subject|3|||
129174419|NCT03746600|464931767|FG000|Overall Study|dismissed from study|1|||
129174420|NCT03746600|464931768|FG001|Overall Study|dismissed from study|0|||
129174421|NCT03746600|464931767|FG000|Overall Study|Lost to Follow-up|1|||
129174422|NCT03746600|464931768|FG001|Overall Study|Lost to Follow-up|0|||
129174423|NCT03023826|464931769|FG000|Period 1|Withdrawal by Subject|0|||
129174424|NCT03023826|464931770|FG001|Period 1|Withdrawal by Subject|0|||
129174425|NCT03023826|464931771|FG002|Period 1|Withdrawal by Subject|0|||
129174426|NCT03023826|464931772|FG003|Period 1|Withdrawal by Subject|0|||
129174427|NCT03023826|464931773|FG004|Period 1|Withdrawal by Subject|1|||
129174428|NCT03023826|464931774|FG005|Period 1|Withdrawal by Subject|0|||
129174429|NCT02182440|464931775|FG000|Overall Study|Adverse Event|0|||
129174430|NCT02182440|464931776|FG001|Overall Study|Adverse Event|1|||
129174431|NCT02182440|464931777|FG002|Overall Study|Adverse Event|0|||
129174432|NCT02182440|464931778|FG003|Overall Study|Adverse Event|0|||
129174433|NCT02182440|464931775|FG000|Overall Study|Death|31|||
129174434|NCT02182440|464931776|FG001|Overall Study|Death|8|||
129174435|NCT02182440|464931777|FG002|Overall Study|Death|5|||
129174436|NCT02182440|464931778|FG003|Overall Study|Death|16|||
129174437|NCT02182440|464931775|FG000|Overall Study|Protocol Violation|0|||
129174438|NCT02182440|464931776|FG001|Overall Study|Protocol Violation|1|||
129174439|NCT02182440|464931777|FG002|Overall Study|Protocol Violation|0|||
129174440|NCT02182440|464931778|FG003|Overall Study|Protocol Violation|0|||
129174441|NCT02182440|464931775|FG000|Overall Study|Physician Decision|1|||
129174442|NCT02182440|464931776|FG001|Overall Study|Physician Decision|0|||
129174443|NCT02182440|464931777|FG002|Overall Study|Physician Decision|0|||
129174444|NCT02182440|464931778|FG003|Overall Study|Physician Decision|0|||
129174445|NCT02182440|464931775|FG000|Overall Study|Withdrawal by Subject|1|||
129174446|NCT02182440|464931776|FG001|Overall Study|Withdrawal by Subject|1|||
129174447|NCT02182440|464931777|FG002|Overall Study|Withdrawal by Subject|3|||
129174448|NCT02182440|464931778|FG003|Overall Study|Withdrawal by Subject|4|||
129174449|NCT02182440|464931775|FG000|Overall Study|different, e.g adm other hospital|12|||
129174450|NCT02182440|464931776|FG001|Overall Study|different, e.g adm other hospital|3|||
129174451|NCT02182440|464931777|FG002|Overall Study|different, e.g adm other hospital|3|||
129174452|NCT02182440|464931778|FG003|Overall Study|different, e.g adm other hospital|10|||
129174453|NCT00072293|464931779|FG000|Overall Study|Lost to Follow-up|1|||
129174454|NCT00072293|464931780|FG001|Overall Study|Lost to Follow-up|1|||
129174455|NCT00072293|464931779|FG000|Overall Study|Withdrawal by Subject|0|||
129174456|NCT00072293|464931780|FG001|Overall Study|Withdrawal by Subject|1|||
129174457|NCT00953680|464931783|FG000|Period 1|Withdrawal by Subject|0|||
129174458|NCT00953680|464931784|FG001|Period 1|Withdrawal by Subject|1|||
129174459|NCT01187446|464933566|FG000|Overall Study|Patient started non-protocol therapy|0|||
129174460|NCT01187446|464933567|FG001|Overall Study|Patient started non-protocol therapy|1|||
129174461|NCT00149994|464933568|FG000|Overall Study|Administrative problems:|1|||
129174462|NCT00149994|464933569|FG001|Overall Study|Administrative problems:|0|||
129174463|NCT00149994|464933568|FG000|Overall Study|Protocol Violation|0|||
129174464|NCT00149994|464933569|FG001|Overall Study|Protocol Violation|1|||
129174465|NCT01342965|464933570|FG000|Overall Study|Death|58|||
129174466|NCT01342965|464933571|FG001|Overall Study|Death|57|||
128780796|NCT01254305|463488592|FG002|Overall Study|Protocol Violation|3|||
128780797|NCT01254305|463488590|FG000|Overall Study|Withdrawal by Subject|4|||
128780798|NCT01254305|463488591|FG001|Overall Study|Withdrawal by Subject|2|||
128780799|NCT01254305|463488592|FG002|Overall Study|Withdrawal by Subject|4|||
128780800|NCT01254305|463488590|FG000|Overall Study|Lost to Follow-up|10|||
128780801|NCT01254305|463488591|FG001|Overall Study|Lost to Follow-up|6|||
128780802|NCT01254305|463488592|FG002|Overall Study|Lost to Follow-up|5|||
128780803|NCT01254305|463488590|FG000|Overall Study|Other Reasons|0|||
128780804|NCT01254305|463488591|FG001|Overall Study|Other Reasons|0|||
128780805|NCT01254305|463488592|FG002|Overall Study|Other Reasons|2|||
128780806|NCT02703532|463488593|FG000|Overall Study|Withdrawal by Subject|0|||
128780807|NCT02703532|463488594|FG001|Overall Study|Withdrawal by Subject|1|||
128780808|NCT02703532|463488595|FG002|Overall Study|Withdrawal by Subject|0|||
128780809|NCT02703532|463488596|FG003|Overall Study|Withdrawal by Subject|1|||
128780810|NCT02703532|463488593|FG000|Overall Study|Lost to Follow-up|2|||
128780811|NCT02703532|463488594|FG001|Overall Study|Lost to Follow-up|0|||
128780812|NCT02703532|463488595|FG002|Overall Study|Lost to Follow-up|2|||
128780813|NCT02703532|463488596|FG003|Overall Study|Lost to Follow-up|0|||
128780814|NCT03738241|463488600|FG000|Overall Study|Withdrawal by Subject|0|||
128780815|NCT03738241|463488601|FG001|Overall Study|Withdrawal by Subject|0|||
128780816|NCT03738241|463488602|FG002|Overall Study|Withdrawal by Subject|0|||
128780817|NCT03738241|463488603|FG003|Overall Study|Withdrawal by Subject|0|||
128780818|NCT03738241|463488604|FG004|Overall Study|Withdrawal by Subject|0|||
128780819|NCT03738241|463488605|FG005|Overall Study|Withdrawal by Subject|0|||
128780820|NCT03738241|463488606|FG006|Overall Study|Withdrawal by Subject|0|||
128780821|NCT03738241|463488607|FG007|Overall Study|Withdrawal by Subject|0|||
128780822|NCT03738241|463488608|FG008|Overall Study|Withdrawal by Subject|0|||
128780823|NCT03738241|463488609|FG009|Overall Study|Withdrawal by Subject|1|||
128780824|NCT03738241|463488600|FG000|Overall Study|Physician Decision|0|||
128780825|NCT03738241|463488601|FG001|Overall Study|Physician Decision|0|||
128780826|NCT03738241|463488602|FG002|Overall Study|Physician Decision|0|||
128780827|NCT03738241|463488603|FG003|Overall Study|Physician Decision|0|||
128780828|NCT03738241|463488604|FG004|Overall Study|Physician Decision|0|||
128780829|NCT03738241|463488605|FG005|Overall Study|Physician Decision|0|||
128780830|NCT03738241|463488606|FG006|Overall Study|Physician Decision|0|||
128780831|NCT03738241|463488607|FG007|Overall Study|Physician Decision|0|||
129174467|NCT01342965|464933570|FG000|Overall Study|Lost to Follow-up|5|||
129174468|NCT01342965|464933571|FG001|Overall Study|Lost to Follow-up|3|||
129174469|NCT01342965|464933570|FG000|Overall Study|Other Reasons- Unspecified|44|||
129174470|NCT01342965|464933571|FG001|Overall Study|Other Reasons- Unspecified|38|||
129174471|NCT01342965|464933570|FG000|Overall Study|Withdrawal by Subject|2|||
129174472|NCT01342965|464933571|FG001|Overall Study|Withdrawal by Subject|9|||
129174473|NCT03538444|464933584|FG000|Overall Study|opioid withdrawal|1|||
129174474|NCT03538444|464933585|FG001|Overall Study|opioid withdrawal|0|||
129174475|NCT04422561|464933586|FG000|Overall Study|Lost to Follow-up|25|||
129174476|NCT04422561|464933587|FG001|Overall Study|Lost to Follow-up|11|||
129174477|NCT03640052|464933588|FG000|Overall Study|Lost to Follow-up|0|||
129174478|NCT03640052|464933589|FG001|Overall Study|Lost to Follow-up|1|||
129174479|NCT03640052|464933590|FG002|Overall Study|Lost to Follow-up|0|||
129174480|NCT03640052|464933591|FG003|Overall Study|Lost to Follow-up|0|||
129174481|NCT03640052|464933592|FG004|Overall Study|Lost to Follow-up|0|||
129174482|NCT00790647|464933595|FG000|Overall Study|Adverse Event|1|||
129174483|NCT04926831|464933596|FG000|Overall Study|Withdrawal by Subject|2|||
129174484|NCT04926831|464933596|FG000|Overall Study|Adverse Event|2|||
129174485|NCT03549871|464933599|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
129174486|NCT03549871|464933600|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
129174487|NCT03549871|464933599|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
129174488|NCT03549871|464933600|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
129174489|NCT03549871|464933599|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
129174490|NCT03549871|464933600|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
129174491|NCT03549871|464933599|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
129174492|NCT03549871|464933600|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
129174493|NCT03549871|464933599|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
128780832|NCT03738241|463488608|FG008|Overall Study|Physician Decision|1|||
128780833|NCT03738241|463488609|FG009|Overall Study|Physician Decision|0|||
128780834|NCT03738241|463488600|FG000|Overall Study|Adverse Event|1|||
128780835|NCT03738241|463488601|FG001|Overall Study|Adverse Event|0|||
128780836|NCT03738241|463488602|FG002|Overall Study|Adverse Event|0|||
128780837|NCT03738241|463488603|FG003|Overall Study|Adverse Event|0|||
128780838|NCT03738241|463488604|FG004|Overall Study|Adverse Event|0|||
129174494|NCT03549871|464933600|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
129174495|NCT03549871|464933599|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
129174496|NCT03549871|464933600|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
128780839|NCT03738241|463488605|FG005|Overall Study|Adverse Event|0|||
128780840|NCT03738241|463488606|FG006|Overall Study|Adverse Event|0|||
128780841|NCT03738241|463488607|FG007|Overall Study|Adverse Event|0|||
128780842|NCT03738241|463488608|FG008|Overall Study|Adverse Event|0|||
128780843|NCT03738241|463488609|FG009|Overall Study|Adverse Event|0|||
128780844|NCT03169361|463488610|FG000|Overall Study|Protocol Violation|32|||
128780845|NCT02271594|463488611|FG000|Overall Study|Study closed; recruiting failure|19|||
128780846|NCT02271594|463488612|FG001|Overall Study|Study closed; recruiting failure|12|||
128780847|NCT00088465|463488613|FG000|Overall Study|Withdrawal by Subject|290|||
128780848|NCT00088465|463488613|FG000|Overall Study|Adverse Event|77|||
128780849|NCT00088465|463488613|FG000|Overall Study|Lost to Follow-up|57|||
128780850|NCT00088465|463488613|FG000|Overall Study|Physician Decision|45|||
128780851|NCT00088465|463488613|FG000|Overall Study|Sponsor Decision|37|||
128780852|NCT00088465|463488613|FG000|Overall Study|Lack of Efficacy|27|||
129174497|NCT03549871|464933599|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
129174498|NCT03549871|464933600|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
129174499|NCT03549871|464933599|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
129174500|NCT03549871|464933600|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
129174501|NCT03549871|464933599|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
129174502|NCT03549871|464933600|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
129174503|NCT03549871|464933599|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
129174504|NCT03549871|464933600|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
129174505|NCT03549871|464933599|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
129174506|NCT03549871|464933600|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
129174507|NCT01133626|464933602|FG000|Overall Study|Adverse Event|0|||
129174508|NCT01133626|464933603|FG001|Overall Study|Adverse Event|1|||
129174509|NCT01133626|464933604|FG002|Overall Study|Adverse Event|0|||
129174510|NCT01133626|464933602|FG000|Overall Study|Withdrawal by Subject|1|||
129174511|NCT01133626|464933603|FG001|Overall Study|Withdrawal by Subject|2|||
129174512|NCT01133626|464933604|FG002|Overall Study|Withdrawal by Subject|2|||
129174513|NCT01133626|464933602|FG000|Overall Study|Other|0|||
129174514|NCT01133626|464933603|FG001|Overall Study|Other|2|||
129174515|NCT01133626|464933604|FG002|Overall Study|Other|0|||
129174516|NCT03298984|464933607|FG000|Overall Study|Physician Decision|1|||
129174517|NCT03298984|464933608|FG001|Overall Study|Physician Decision|0|||
129174518|NCT03298984|464933609|FG002|Overall Study|Physician Decision|0|||
129174519|NCT03298984|464933610|FG003|Overall Study|Physician Decision|6|||
128780853|NCT00088465|463488613|FG000|Overall Study|Protocol Violation|17|||
128780854|NCT00088465|463488613|FG000|Overall Study|Death|11|||
128780855|NCT00495469|463488614|FG000|Overall Study|Adverse Event|0|||
128780856|NCT00495469|463488615|FG001|Overall Study|Adverse Event|1|||
128780857|NCT00495469|463488616|FG002|Overall Study|Adverse Event|3|||
129174520|NCT03298984|464933607|FG000|Overall Study|Lack of Efficacy|0|||
129174521|NCT03298984|464933608|FG001|Overall Study|Lack of Efficacy|1|||
129174522|NCT03298984|464933609|FG002|Overall Study|Lack of Efficacy|1|||
129174523|NCT03298984|464933610|FG003|Overall Study|Lack of Efficacy|4|||
129174524|NCT03298984|464933607|FG000|Overall Study|Relapsed disease (following remission)|0|||
129174525|NCT03298984|464933608|FG001|Overall Study|Relapsed disease (following remission)|0|||
129174526|NCT03298984|464933609|FG002|Overall Study|Relapsed disease (following remission)|1|||
129174527|NCT03298984|464933610|FG003|Overall Study|Relapsed disease (following remission)|1|||
129174528|NCT03298984|464933607|FG000|Overall Study|Adverse Event|0|||
129174529|NCT03298984|464933608|FG001|Overall Study|Adverse Event|0|||
129174530|NCT03298984|464933609|FG002|Overall Study|Adverse Event|0|||
129174531|NCT03298984|464933610|FG003|Overall Study|Adverse Event|1|||
129174532|NCT03298984|464933607|FG000|Overall Study|Death|0|||
129174533|NCT03298984|464933608|FG001|Overall Study|Death|0|||
129174534|NCT03298984|464933609|FG002|Overall Study|Death|0|||
129174535|NCT03298984|464933610|FG003|Overall Study|Death|2|||
129174536|NCT03298984|464933607|FG000|Overall Study|Insurance Company Decision|0|||
129174537|NCT03298984|464933608|FG001|Overall Study|Insurance Company Decision|0|||
129174538|NCT03298984|464933609|FG002|Overall Study|Insurance Company Decision|0|||
129174539|NCT03298984|464933610|FG003|Overall Study|Insurance Company Decision|1|||
129174540|NCT00294645|464933611|FG000|Overall Study|Death|10|||
129174541|NCT00294645|464933612|FG001|Overall Study|Death|18|||
129174542|NCT00294645|464933611|FG000|Overall Study|Lost to Follow-up|1|||
129174543|NCT00294645|464933612|FG001|Overall Study|Lost to Follow-up|10|||
129174544|NCT00294645|464933611|FG000|Overall Study|Withdrawal by Subject|18|||
129174545|NCT00294645|464933612|FG001|Overall Study|Withdrawal by Subject|34|||
129174546|NCT00294645|464933611|FG000|Overall Study|Physician Decision|15|||
129174547|NCT00294645|464933612|FG001|Overall Study|Physician Decision|20|||
129174548|NCT00294645|464933611|FG000|Overall Study|Other|4|||
129174549|NCT00294645|464933612|FG001|Overall Study|Other|10|||
129174550|NCT03305081|464933617|FG000|Overall Study|Lost to Follow-up|10|||
129174551|NCT03305081|464933618|FG001|Overall Study|Lost to Follow-up|15|||
129174552|NCT01774253|464933625|FG000|Overall Study|Lack of Efficacy|4|||
129174553|NCT01774253|464933625|FG000|Overall Study|Physician Decision|2|||
129174554|NCT01774253|464933625|FG000|Overall Study|Withdrawal by Subject|2|||
129174555|NCT01774253|464933625|FG000|Overall Study|Death|1|||
129174556|NCT00772369|464933626|FG000|Overall Study|Did not return record release form|1|||
129174557|NCT00554619|464933627|FG000|Overall Study|Adverse Event|1|||
129174558|NCT00554619|464933627|FG000|Overall Study|Physician Decision|1|||
129174559|NCT00554619|464933627|FG000|Overall Study|Liver Function Test Abnormality|1|||
129174560|NCT01571284|464933630|FG000|Overall Study|Participant's decision|84|||
129174561|NCT01571284|464933630|FG000|Overall Study|Lost to Follow-up|3|||
129174562|NCT01571284|464933630|FG000|Overall Study|Enrolled but not treated|2|||
129174563|NCT01571284|464933630|FG000|Overall Study|Other than specified above|80|||
129174564|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Death|1|||
129174565|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Death|1|||
129174566|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Death|0|||
129174567|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Death|0|||
129174568|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Death|1|||
129174569|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Death|0|||
129174570|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Death|0|||
129174571|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Death|0|||
129174572|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Death|0|||
129174573|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Death|0|||
129174574|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
129174575|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
129174576|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
129174577|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
129174578|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
129174579|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
129174580|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
129174581|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
129174582|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
129174583|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
129174584|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174585|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174586|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174587|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174588|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
129174589|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174590|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174591|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174592|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174593|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129174594|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
129174595|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174596|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174597|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174598|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174599|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174600|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174601|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174602|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174603|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129174604|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
129174605|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129174606|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129174607|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
129174608|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
129174609|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129174610|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129174611|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129174612|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129174613|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129174614|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
129174615|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174616|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174617|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
129174618|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174619|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174620|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174621|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174622|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174623|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129174624|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
129174625|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
129174626|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
129174627|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
129174628|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
129174629|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129174630|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129174631|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129174632|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129174633|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129174634|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
129174635|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
129174636|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
129174637|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174638|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
129174639|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174640|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174641|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174642|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174643|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174644|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
129174645|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129174646|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129174647|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
129174648|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
129174649|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129174650|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129174651|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129174652|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129174653|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129174654|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129174655|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
128780858|NCT00495469|463488617|FG003|Overall Study|Adverse Event|0|||
128780859|NCT00495469|463488618|FG004|Overall Study|Adverse Event|1|||
128780860|NCT00495469|463488619|FG005|Overall Study|Adverse Event|1|||
128780861|NCT00495469|463488620|FG006|Overall Study|Adverse Event|1|||
128780862|NCT00495469|463488614|FG000|Overall Study|Lost to Follow-up|1|||
128780863|NCT00495469|463488615|FG001|Overall Study|Lost to Follow-up|1|||
128780864|NCT00495469|463488616|FG002|Overall Study|Lost to Follow-up|3|||
128780865|NCT00495469|463488617|FG003|Overall Study|Lost to Follow-up|1|||
128780866|NCT00495469|463488618|FG004|Overall Study|Lost to Follow-up|0|||
128780867|NCT00495469|463488619|FG005|Overall Study|Lost to Follow-up|0|||
128780868|NCT00495469|463488620|FG006|Overall Study|Lost to Follow-up|0|||
128780869|NCT00495469|463488614|FG000|Overall Study|Protocol Violation|0|||
128780870|NCT00495469|463488615|FG001|Overall Study|Protocol Violation|0|||
128780871|NCT00495469|463488616|FG002|Overall Study|Protocol Violation|0|||
128780872|NCT00495469|463488617|FG003|Overall Study|Protocol Violation|0|||
128780873|NCT00495469|463488618|FG004|Overall Study|Protocol Violation|1|||
128780874|NCT00495469|463488619|FG005|Overall Study|Protocol Violation|2|||
128780875|NCT00495469|463488620|FG006|Overall Study|Protocol Violation|0|||
128780876|NCT00495469|463488614|FG000|Overall Study|Withdrawal by Subject|5|||
128780877|NCT00495469|463488615|FG001|Overall Study|Withdrawal by Subject|3|||
128780878|NCT00495469|463488616|FG002|Overall Study|Withdrawal by Subject|1|||
128780879|NCT00495469|463488617|FG003|Overall Study|Withdrawal by Subject|3|||
128780880|NCT00495469|463488618|FG004|Overall Study|Withdrawal by Subject|3|||
128780881|NCT00495469|463488619|FG005|Overall Study|Withdrawal by Subject|2|||
128780882|NCT00495469|463488620|FG006|Overall Study|Withdrawal by Subject|3|||
128780883|NCT00495469|463488614|FG000|Overall Study|Lack of Efficacy|0|||
128780884|NCT00495469|463488615|FG001|Overall Study|Lack of Efficacy|0|||
128780885|NCT00495469|463488616|FG002|Overall Study|Lack of Efficacy|0|||
128780886|NCT00495469|463488617|FG003|Overall Study|Lack of Efficacy|0|||
128780887|NCT00495469|463488618|FG004|Overall Study|Lack of Efficacy|0|||
128780888|NCT00495469|463488619|FG005|Overall Study|Lack of Efficacy|0|||
128780889|NCT00495469|463488620|FG006|Overall Study|Lack of Efficacy|1|||
128780890|NCT00495469|463488614|FG000|Overall Study|Liver function test abnormality|0|||
128780891|NCT00495469|463488615|FG001|Overall Study|Liver function test abnormality|1|||
128780892|NCT00495469|463488616|FG002|Overall Study|Liver function test abnormality|0|||
128780893|NCT00495469|463488617|FG003|Overall Study|Liver function test abnormality|0|||
128780894|NCT00495469|463488618|FG004|Overall Study|Liver function test abnormality|0|||
128780895|NCT00495469|463488619|FG005|Overall Study|Liver function test abnormality|0|||
128780896|NCT00495469|463488620|FG006|Overall Study|Liver function test abnormality|0|||
128780897|NCT00495469|463488614|FG000|Overall Study|ST depression at randomisation in ECG|0|||
128780898|NCT00495469|463488615|FG001|Overall Study|ST depression at randomisation in ECG|1|||
128780899|NCT00495469|463488616|FG002|Overall Study|ST depression at randomisation in ECG|0|||
128780900|NCT00495469|463488617|FG003|Overall Study|ST depression at randomisation in ECG|0|||
129174656|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174657|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129174658|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129174659|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174660|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174661|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174662|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174663|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174664|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
128780901|NCT00495469|463488618|FG004|Overall Study|ST depression at randomisation in ECG|0|||
128780902|NCT00495469|463488619|FG005|Overall Study|ST depression at randomisation in ECG|0|||
128780903|NCT00495469|463488620|FG006|Overall Study|ST depression at randomisation in ECG|0|||
128780904|NCT00448864|463488623|FG000|Overall Study|Death|1|||
128780905|NCT00448864|463488624|FG001|Overall Study|Death|0|||
128780906|NCT00448864|463488625|FG002|Overall Study|Death|0|||
128780907|NCT00448864|463488623|FG000|Overall Study|Lost to Follow-up|3|||
128780908|NCT00448864|463488624|FG001|Overall Study|Lost to Follow-up|1|||
128780909|NCT00448864|463488625|FG002|Overall Study|Lost to Follow-up|0|||
128780910|NCT00448864|463488623|FG000|Overall Study|Physician Decision|1|||
128780911|NCT00448864|463488624|FG001|Overall Study|Physician Decision|0|||
128780912|NCT00448864|463488625|FG002|Overall Study|Physician Decision|1|||
128780913|NCT00448864|463488623|FG000|Overall Study|Withdrawal by Subject|0|||
128780914|NCT00448864|463488624|FG001|Overall Study|Withdrawal by Subject|2|||
129174665|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174666|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
129174667|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174668|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
129174669|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174670|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174671|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174672|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174673|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174674|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
129174675|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
129174676|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
129174677|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
129174678|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
129174679|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129174680|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129174681|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129174682|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129174683|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129174684|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174685|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174686|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174687|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
129174688|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
129174689|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174690|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174691|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174692|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174693|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174694|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129174695|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174696|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129174697|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129174698|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129174699|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174700|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174701|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174702|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174703|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174704|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
129174705|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174706|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174707|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174708|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
129174709|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174710|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174711|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174712|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129174713|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
128730111|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
128730112|NCT02161718|463308323|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
128730113|NCT02161718|463308324|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
128730114|NCT02161718|463308325|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
128730115|NCT02161718|463308323|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
129174714|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174715|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174716|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174717|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174718|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
129174719|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129204791|NCT02421172|465046943|FG002|Period 1|Patient/guardian decision|0|||
128730116|NCT02161718|463308324|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
128730117|NCT02161718|463308325|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
128730118|NCT02161718|463308323|FG000|Post- Randomization Period|Lost to Follow-up|0|||
128730119|NCT02161718|463308324|FG001|Post- Randomization Period|Lost to Follow-up|9|||
128730120|NCT02161718|463308325|FG002|Post- Randomization Period|Lost to Follow-up|15|||
128730121|NCT02161718|463308323|FG000|Post- Randomization Period|Adverse Event|0|||
128730122|NCT02161718|463308324|FG001|Post- Randomization Period|Adverse Event|9|||
128730123|NCT02161718|463308325|FG002|Post- Randomization Period|Adverse Event|10|||
128730124|NCT02161718|463308323|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
128730125|NCT02161718|463308324|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
128730126|NCT02161718|463308325|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
128730127|NCT02161718|463308323|FG000|Post- Randomization Period|Physician Decision|0|||
128730128|NCT02161718|463308324|FG001|Post- Randomization Period|Physician Decision|2|||
128730129|NCT02161718|463308325|FG002|Post- Randomization Period|Physician Decision|4|||
128730130|NCT02161718|463308323|FG000|Post- Randomization Period|Protocol Violation|0|||
128730131|NCT02161718|463308324|FG001|Post- Randomization Period|Protocol Violation|2|||
128730132|NCT02161718|463308325|FG002|Post- Randomization Period|Protocol Violation|3|||
128730133|NCT02161718|463308323|FG000|Post- Randomization Period|Lack of Efficacy|0|||
128730134|NCT02161718|463308324|FG001|Post- Randomization Period|Lack of Efficacy|0|||
128730135|NCT02161718|463308325|FG002|Post- Randomization Period|Lack of Efficacy|1|||
128730136|NCT02161718|463308323|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
128730137|NCT02161718|463308324|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
128730138|NCT02161718|463308325|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
128730139|NCT02161718|463308323|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
128730140|NCT02161718|463308324|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
128730141|NCT02161718|463308325|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
128730142|NCT02161718|463308323|FG000|Post- Randomization Period|Relocation|0|||
128730143|NCT02161718|463308324|FG001|Post- Randomization Period|Relocation|3|||
128730144|NCT02161718|463308325|FG002|Post- Randomization Period|Relocation|0|||
128730145|NCT00376168|463308329|FG000|Overall Study|Adverse Event|1|||
128730146|NCT00376168|463308330|FG001|Overall Study|Adverse Event|1|||
128730147|NCT00376168|463308329|FG000|Overall Study|Pregnancy|1|||
128730148|NCT00376168|463308330|FG001|Overall Study|Pregnancy|0|||
128730149|NCT01256710|463308331|FG000|Overall Study|Death|449|||
128730150|NCT01256710|463308331|FG000|Overall Study|System Explant|67|||
128730151|NCT01256710|463308331|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
128730152|NCT01256710|463308331|FG000|Overall Study|Lost to Follow-up|67|||
128730153|NCT01256710|463308331|FG000|Overall Study|Withdrawal by Subject|29|||
128730154|NCT01256710|463308331|FG000|Overall Study|Physician Decision|9|||
128730155|NCT01256710|463308331|FG000|Overall Study|Subject Noncompliance|2|||
128730156|NCT01256710|463308331|FG000|Overall Study|Study Terminated by Sponsor|273|||
128730157|NCT01205165|463308332|FG000|Overall Study|Lost to Follow-up|2|||
128730158|NCT02942017|463308333|FG000|Overall Study|Adverse Event|0|||
128730159|NCT02942017|463308334|FG001|Overall Study|Adverse Event|1|||
128730160|NCT02942017|463308333|FG000|Overall Study|Withdrawal by Subject|0|||
128730161|NCT02942017|463308334|FG001|Overall Study|Withdrawal by Subject|1|||
128730162|NCT02942017|463308333|FG000|Overall Study|Lost to Follow-up|1|||
128730163|NCT02942017|463308334|FG001|Overall Study|Lost to Follow-up|1|||
128730164|NCT02942017|463308333|FG000|Overall Study|Randomized but not dosed|1|||
128730165|NCT02942017|463308334|FG001|Overall Study|Randomized but not dosed|3|||
128730166|NCT02114879|463308337|FG000|Overall Study|Withdrawal by Subject|9|||
128730167|NCT02114879|463308338|FG001|Overall Study|Withdrawal by Subject|5|||
128730168|NCT02114879|463308337|FG000|Overall Study|Death|6|||
128730169|NCT02114879|463308338|FG001|Overall Study|Death|11|||
128730170|NCT02114879|463308337|FG000|Overall Study|Lost to Follow-up|4|||
128730171|NCT02114879|463308338|FG001|Overall Study|Lost to Follow-up|6|||
128730172|NCT02114879|463308337|FG000|Overall Study|Physician Decision|0|||
128730173|NCT02114879|463308338|FG001|Overall Study|Physician Decision|2|||
128730174|NCT00458484|463308339|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
128730175|NCT00458484|463308340|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
128730176|NCT00458484|463308341|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
128730177|NCT00458484|463308342|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
129174720|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174721|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174722|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174723|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174724|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174725|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
129174726|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174727|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174728|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
129174729|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174730|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174731|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174732|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174733|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129174734|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
129174735|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174736|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174737|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174738|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
129174739|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174740|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174741|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174742|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174743|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129174744|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
129174745|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129174746|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
129174747|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129174748|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
129174749|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129174750|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129174751|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129174752|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129174753|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129174754|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Other|5|||
129174755|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Other|1|||
129174756|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Other|0|||
129174757|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Other|3|||
129174758|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Other|0|||
129174759|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Other|0|||
129174760|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Other|0|||
129174761|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Other|0|||
129174762|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Other|0|||
129174763|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Other|0|||
129174764|NCT03352557|464933631|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174765|NCT03352557|464933632|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174766|NCT03352557|464933633|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174767|NCT03352557|464933634|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174768|NCT03352557|464933635|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
129174769|NCT03352557|464933636|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174770|NCT03352557|464933637|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174771|NCT03352557|464933638|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174772|NCT03352557|464933639|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174773|NCT03352557|464933640|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
129174774|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Death|0|||
129174775|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Death|0|||
129174776|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Death|0|||
129174777|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Death|0|||
129174778|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Death|0|||
129174779|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Death|1|||
129174780|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Death|0|||
129174781|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Death|1|||
129174782|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Death|1|||
129174783|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Death|1|||
128780915|NCT00448864|463488625|FG002|Overall Study|Withdrawal by Subject|0|||
128780916|NCT00448864|463488623|FG000|Overall Study|Protocol Violation|0|||
128780917|NCT00448864|463488624|FG001|Overall Study|Protocol Violation|2|||
128780918|NCT00448864|463488625|FG002|Overall Study|Protocol Violation|0|||
128780919|NCT01323660|463488626|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
128780920|NCT01323660|463488627|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129174784|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174785|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174786|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174787|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174788|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174789|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
129174790|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174791|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174792|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174793|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129174794|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174795|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174796|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174797|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174798|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174799|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174800|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174801|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174802|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
129174803|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129174804|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129174805|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129174806|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129174807|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129174808|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129174809|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
129174810|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
129174811|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
129174812|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
129174813|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
129174814|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174815|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174816|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174817|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174818|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174819|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
129174820|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129174821|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
129174822|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
129174823|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
129174824|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174825|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174826|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174827|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174828|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174829|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129174830|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174831|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129174832|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129174833|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129174834|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
128780921|NCT01323660|463488628|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129174835|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129174836|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129174837|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129174838|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129174839|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
129174840|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129174841|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
129174842|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
129174843|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
129174844|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174845|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174846|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174847|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174848|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174849|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174850|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174851|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129174852|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
129174853|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
129174854|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174855|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174856|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174857|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174858|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174859|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174860|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174861|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129174862|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174863|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129174864|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174865|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174866|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174867|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174868|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174869|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174870|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174871|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
129174872|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174873|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129174874|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174875|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174876|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174877|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174878|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174879|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174880|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174881|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
129174882|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
129174883|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129174884|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174885|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174886|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174887|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174888|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174889|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
129174890|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174891|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174892|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
129174893|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129174894|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174895|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174896|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174897|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174898|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174899|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174900|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174901|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174902|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129174903|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
129174904|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174905|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174906|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174907|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174908|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174909|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174910|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174911|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129174912|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
129174913|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
129174914|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174915|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174916|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174917|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174918|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174919|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174920|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174921|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
129174922|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
129174923|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129174924|NCT03352557|464933631|FG000|LTE Period: Week 80 to Week 173|Other|0|||
129174925|NCT03352557|464933632|FG001|LTE Period: Week 80 to Week 173|Other|0|||
129174926|NCT03352557|464933633|FG002|LTE Period: Week 80 to Week 173|Other|0|||
129174927|NCT03352557|464933634|FG003|LTE Period: Week 80 to Week 173|Other|0|||
129174928|NCT03352557|464933635|FG004|LTE Period: Week 80 to Week 173|Other|0|||
129174929|NCT03352557|464933636|FG005|LTE Period: Week 80 to Week 173|Other|0|||
129174930|NCT03352557|464933637|FG006|LTE Period: Week 80 to Week 173|Other|0|||
129174931|NCT03352557|464933638|FG007|LTE Period: Week 80 to Week 173|Other|1|||
129174932|NCT03352557|464933639|FG008|LTE Period: Week 80 to Week 173|Other|0|||
129174933|NCT03352557|464933640|FG009|LTE Period: Week 80 to Week 173|Other|0|||
129174934|NCT04065074|464933641|FG000|Overall Study|Adverse Event|1|||
129174935|NCT04065074|464933641|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
129174936|NCT00916058|464933642|FG000|Phase 1|Screen Failure|0|||
129174937|NCT00916058|464933643|FG001|Phase 1|Screen Failure|0|||
129174938|NCT00916058|464933644|FG002|Phase 1|Screen Failure|0|||
129174939|NCT00916058|464933645|FG003|Phase 1|Screen Failure|0|||
129174940|NCT00916058|464933646|FG004|Phase 1|Screen Failure|0|||
129174941|NCT00916058|464933647|FG005|Phase 1|Screen Failure|1|||
129174942|NCT00916058|464933648|FG006|Phase 1|Screen Failure|0|||
129174943|NCT00916058|464933642|FG000|Phase 2|Screen Failure|0|||
129174944|NCT00916058|464933643|FG001|Phase 2|Screen Failure|0|||
129174945|NCT00916058|464933644|FG002|Phase 2|Screen Failure|0|||
129174946|NCT00916058|464933645|FG003|Phase 2|Screen Failure|0|||
129174947|NCT00916058|464933646|FG004|Phase 2|Screen Failure|0|||
129174948|NCT00916058|464933647|FG005|Phase 2|Screen Failure|0|||
129174949|NCT00916058|464933648|FG006|Phase 2|Screen Failure|3|||
129174950|NCT00871117|464933649|FG000|Overall Study|Lost to Follow-up|5|||
129174951|NCT00871117|464933650|FG001|Overall Study|Lost to Follow-up|6|||
129174952|NCT00871117|464933649|FG000|Overall Study|Other|0|||
129174953|NCT00871117|464933650|FG001|Overall Study|Other|4|||
129174954|NCT03444766|464933651|FG000|Overall Study|Other Reasons|2|||
129174955|NCT03444766|464933651|FG000|Overall Study|Participant Withdrew Consent|5|||
129174956|NCT03444766|464933651|FG000|Overall Study|Lost to Follow-up|2|||
129174957|NCT03444766|464933651|FG000|Overall Study|Death|2|||
129174958|NCT03444766|464933651|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
129174959|NCT03444766|464933651|FG000|Overall Study|Disease Progression|49|||
129174960|NCT01767493|464933652|FG000|Overall Study|screen failures|3|||
129174961|NCT00977938|464933657|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
129174962|NCT00977938|464933658|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
129174963|NCT00977938|464933659|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
129174964|NCT00977938|464933660|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
129174965|NCT00977938|464933657|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
129174966|NCT00977938|464933658|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
129174967|NCT00977938|464933659|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
129174968|NCT00977938|464933660|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
129174969|NCT00977938|464933657|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
129174970|NCT00977938|464933658|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
129174971|NCT00977938|464933659|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
129174972|NCT00977938|464933660|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
129174973|NCT00977938|464933657|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
129174974|NCT00977938|464933658|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
129174975|NCT00977938|464933659|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
129174976|NCT00977938|464933660|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
129174977|NCT00977938|464933657|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
129174978|NCT00977938|464933658|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
129174979|NCT00977938|464933659|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
129174980|NCT00977938|464933660|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
129174981|NCT00977938|464933657|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
129174982|NCT00977938|464933658|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
129174983|NCT00977938|464933659|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
129174984|NCT00977938|464933660|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
129174985|NCT02142283|464933663|FG000|Overall Study|Death|20|||
129174986|NCT02142283|464933664|FG001|Overall Study|Death|18|||
129174987|NCT02142283|464933663|FG000|Overall Study|Withdrawal by Subject|1|||
129174988|NCT02142283|464933664|FG001|Overall Study|Withdrawal by Subject|3|||
129174989|NCT02460783|464933665|FG000|Overall Study|Withdrawal by Subject|1|||
129174990|NCT02460783|464933666|FG001|Overall Study|Withdrawal by Subject|3|||
129174991|NCT02460783|464933665|FG000|Overall Study|Lost to Follow-up|1|||
129174992|NCT02460783|464933666|FG001|Overall Study|Lost to Follow-up|1|||
129174993|NCT01646645|464933667|FG000|Overall Study|No Treated|1|||
129174994|NCT01646645|464933667|FG000|Overall Study|Inevaluable Donor|29|||
129174995|NCT02374814|464933673|FG000|Overall Study|Lost to Follow-up|1|||
129174996|NCT02374814|464933674|FG001|Overall Study|Lost to Follow-up|1|||
129174997|NCT02374814|464933675|FG002|Overall Study|Lost to Follow-up|0|||
129174998|NCT02374814|464933676|FG003|Overall Study|Lost to Follow-up|1|||
129174999|NCT02374814|464933677|FG004|Overall Study|Lost to Follow-up|0|||
129175000|NCT02374814|464933678|FG005|Overall Study|Lost to Follow-up|0|||
129175001|NCT02374814|464933673|FG000|Overall Study|Withdrawal by Subject|0|||
129175002|NCT02374814|464933674|FG001|Overall Study|Withdrawal by Subject|0|||
129175003|NCT02374814|464933675|FG002|Overall Study|Withdrawal by Subject|1|||
129175004|NCT02374814|464933676|FG003|Overall Study|Withdrawal by Subject|1|||
129175005|NCT02374814|464933677|FG004|Overall Study|Withdrawal by Subject|0|||
129175006|NCT02374814|464933678|FG005|Overall Study|Withdrawal by Subject|0|||
129175007|NCT00884039|464933682|FG000|Overall Study|Withdrawal by Subject|0|||
129175008|NCT00884039|464933683|FG001|Overall Study|Withdrawal by Subject|1|||
129175009|NCT00884039|464933682|FG000|Overall Study|Lack of Efficacy|2|||
129175010|NCT00884039|464933683|FG001|Overall Study|Lack of Efficacy|0|||
129175011|NCT00717522|464933684|FG000|Overall Study|Disease Progression|5|||
129175012|NCT00717522|464933684|FG000|Overall Study|Adverse Event|1|||
129175013|NCT00717522|464933684|FG000|Overall Study|Death|1|||
129175014|NCT01166958|464933687|FG000|Overall Study|Withdrawal by Subject|1|||
129175015|NCT01166958|464933688|FG001|Overall Study|Withdrawal by Subject|0|||
129175016|NCT04209114|464933689|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
129175017|NCT04209114|464933690|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
129175018|NCT04209114|464933691|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
129175019|NCT04209114|464933689|FG000|Pre-Treatment Phase|Other reasons|0|||
129175020|NCT04209114|464933690|FG001|Pre-Treatment Phase|Other reasons|0|||
129175021|NCT04209114|464933691|FG002|Pre-Treatment Phase|Other reasons|1|||
129175022|NCT04209114|464933689|FG000|Pre-Treatment Phase|Death|0|||
129175023|NCT04209114|464933690|FG001|Pre-Treatment Phase|Death|0|||
129175024|NCT04209114|464933691|FG002|Pre-Treatment Phase|Death|1|||
129175025|NCT04209114|464933689|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
129175026|NCT04209114|464933690|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
129175027|NCT04209114|464933691|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
129175028|NCT04209114|464933689|FG000|Treatment Phase|Other reasons|5|||
129175029|NCT04209114|464933690|FG001|Treatment Phase|Other reasons|3|||
129175030|NCT04209114|464933691|FG002|Treatment Phase|Other reasons|0|||
129175031|NCT04209114|464933689|FG000|Treatment Phase|Lost to Follow-up|1|||
129175032|NCT04209114|464933690|FG001|Treatment Phase|Lost to Follow-up|0|||
129175033|NCT04209114|464933691|FG002|Treatment Phase|Lost to Follow-up|0|||
129175034|NCT04209114|464933689|FG000|Treatment Phase|Participant withdrew consent|1|||
129175035|NCT04209114|464933690|FG001|Treatment Phase|Participant withdrew consent|0|||
129175036|NCT04209114|464933691|FG002|Treatment Phase|Participant withdrew consent|0|||
129175037|NCT04209114|464933689|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
129175038|NCT04209114|464933690|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
129175039|NCT04209114|464933691|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
129175040|NCT04209114|464933689|FG000|Treatment Phase|Death|4|||
129175041|NCT04209114|464933690|FG001|Treatment Phase|Death|1|||
129175042|NCT04209114|464933691|FG002|Treatment Phase|Death|0|||
129175043|NCT04209114|464933689|FG000|Treatment Phase|Study drug toxicity|4|||
129175044|NCT04209114|464933690|FG001|Treatment Phase|Study drug toxicity|6|||
129175045|NCT04209114|464933691|FG002|Treatment Phase|Study drug toxicity|0|||
129175046|NCT04209114|464933689|FG000|Treatment Phase|Disease progression|6|||
129175047|NCT04209114|464933690|FG001|Treatment Phase|Disease progression|9|||
129175048|NCT04209114|464933691|FG002|Treatment Phase|Disease progression|0|||
129175049|NCT00624819|464933694|FG000|Follow-up Period: Year 4|Parents decision|0|||
129175050|NCT00624819|464933695|FG001|Follow-up Period: Year 4|Parents decision|0|||
129175051|NCT00624819|464933696|FG002|Follow-up Period: Year 4|Parents decision|1|||
129175052|NCT00624819|464933697|FG003|Follow-up Period: Year 4|Parents decision|0|||
129175053|NCT00624819|464933694|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
129175054|NCT00624819|464933695|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
129175055|NCT00624819|464933696|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
129175056|NCT00624819|464933697|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
129175057|NCT00405964|464933702|FG000|Overall Study|Treatment Failure|17|||
129175058|NCT00405964|464933703|FG001|Overall Study|Treatment Failure|45|||
129175059|NCT00405964|464933702|FG000|Overall Study|Adverse Event|7|||
129175060|NCT00405964|464933703|FG001|Overall Study|Adverse Event|16|||
129175061|NCT00405964|464933702|FG000|Overall Study|Lost to Follow-up|5|||
129175062|NCT00405964|464933703|FG001|Overall Study|Lost to Follow-up|5|||
129175063|NCT00405964|464933702|FG000|Overall Study|Withdrawal by Subject|19|||
129175064|NCT00405964|464933703|FG001|Overall Study|Withdrawal by Subject|23|||
129175065|NCT00405964|464933702|FG000|Overall Study|Protocol Violation|11|||
129175066|NCT00405964|464933703|FG001|Overall Study|Protocol Violation|6|||
129175067|NCT02981407|464933712|FG000|Overall Study|Withdrawal by Subject|2|||
129175068|NCT02981407|464933713|FG001|Overall Study|Withdrawal by Subject|0|||
129175069|NCT01444027|464933714|FG000|Overall Study|Withdrawal by Subject|4|||
129175070|NCT01444027|464933715|FG001|Overall Study|Withdrawal by Subject|10|||
129175071|NCT01444027|464933716|FG002|Overall Study|Withdrawal by Subject|24|||
129175072|NCT01444027|464933714|FG000|Overall Study|Lost to Follow-up|26|||
129175073|NCT01444027|464933715|FG001|Overall Study|Lost to Follow-up|20|||
129175074|NCT01444027|464933716|FG002|Overall Study|Lost to Follow-up|14|||
129175075|NCT01416441|464933718|FG000|Overall Study|Lost to Follow-up|5|||
129175076|NCT01416441|464933718|FG000|Overall Study|Adverse Event|6|||
129175077|NCT01416441|464933718|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
129175078|NCT01416441|464933718|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
129175079|NCT01416441|464933718|FG000|Overall Study|Investigator Withdrew Subject|2|||
129175080|NCT01416441|464933718|FG000|Overall Study|Subject Withdrew Consent|12|||
129175081|NCT01416441|464933718|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
129175082|NCT02653495|464933723|FG000|Overall Study|Lost to Follow-up|2|||
129175083|NCT02653495|464933724|FG001|Overall Study|Lost to Follow-up|0|||
129175084|NCT02653495|464933723|FG000|Overall Study|Screening Failure|10|||
129175085|NCT02653495|464933724|FG001|Overall Study|Screening Failure|0|||
129175086|NCT01360398|464933725|FG000|Overall Study|Withdrawal by Subject|14|||
129175087|NCT01360398|464933725|FG000|Overall Study|Other|7|||
129175088|NCT01360398|464933725|FG000|Overall Study|Migrated/moved from study area|1|||
129175089|NCT00737711|464933726|FG000|Overall Study|Adverse Event|2|||
129175090|NCT00737711|464933726|FG000|Overall Study|Death|8|||
129175091|NCT00737711|464933726|FG000|Overall Study|Failure to return|4|||
129175092|NCT00737711|464933726|FG000|Overall Study|Protocol Violation|1|||
129175093|NCT00737711|464933726|FG000|Overall Study|Withdrawal by Subject|5|||
129175094|NCT00737711|464933726|FG000|Overall Study|Blood transfusion|6|||
129175095|NCT00737711|464933726|FG000|Overall Study|Other|5|||
129175096|NCT00624780|464933730|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
129175097|NCT00624780|464933731|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
129175098|NCT00624780|464933732|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
129175099|NCT00624780|464933733|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
129175100|NCT00624780|464933734|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
129175101|NCT00624780|464933735|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
129175102|NCT00624780|464933730|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
129175103|NCT00624780|464933731|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
129175104|NCT00624780|464933732|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
129175105|NCT00624780|464933733|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
129175106|NCT00624780|464933734|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
129175107|NCT00624780|464933735|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
129175108|NCT00624780|464933730|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
129175109|NCT00624780|464933731|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
129175110|NCT00624780|464933732|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
129175111|NCT00624780|464933733|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
129175112|NCT00624780|464933734|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
129175113|NCT00624780|464933735|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
129175114|NCT00624780|464933730|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
129175115|NCT00624780|464933731|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
129175116|NCT00624780|464933732|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
129175117|NCT00624780|464933733|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
129175118|NCT00624780|464933734|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
129175119|NCT00624780|464933735|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
129175120|NCT00624780|464933730|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
129175121|NCT00624780|464933731|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
129175122|NCT00624780|464933732|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
129175123|NCT00624780|464933733|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
129175124|NCT00624780|464933734|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
129175125|NCT00624780|464933735|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
129175126|NCT00624780|464933730|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
129175127|NCT00624780|464933731|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
129175128|NCT00624780|464933732|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
129175129|NCT00624780|464933733|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
129175130|NCT00624780|464933734|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
129175131|NCT00624780|464933735|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
129175132|NCT00624780|464933730|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
129175133|NCT00624780|464933731|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
129175134|NCT00624780|464933732|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
129175135|NCT00624780|464933733|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
129175136|NCT00624780|464933734|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
129175137|NCT00624780|464933735|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
129175138|NCT00624780|464933730|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129175139|NCT00624780|464933731|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
129175140|NCT00624780|464933732|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129175141|NCT00624780|464933733|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
129175142|NCT00624780|464933734|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129175143|NCT00624780|464933735|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129175144|NCT00624780|464933730|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
129175145|NCT00624780|464933731|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
129175146|NCT00624780|464933732|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
129175147|NCT00624780|464933733|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
129175148|NCT00624780|464933734|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
129175149|NCT00624780|464933735|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
129175150|NCT00624780|464933730|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
129175151|NCT00624780|464933731|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
129175152|NCT00624780|464933732|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
129175153|NCT00624780|464933733|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
129175154|NCT00624780|464933734|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
129175155|NCT00624780|464933735|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
129175156|NCT00624780|464933730|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
129175157|NCT00624780|464933731|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
129175158|NCT00624780|464933732|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
129175159|NCT00624780|464933733|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
129175160|NCT00624780|464933734|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
129175161|NCT00624780|464933735|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
129175162|NCT00624780|464933730|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
129175163|NCT00624780|464933731|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129175164|NCT00624780|464933732|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129175165|NCT00624780|464933733|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129175166|NCT00624780|464933734|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129175167|NCT00624780|464933735|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129175168|NCT00624780|464933730|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129175169|NCT00624780|464933731|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129175170|NCT00624780|464933732|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
129175171|NCT00624780|464933733|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129175172|NCT00624780|464933734|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129175173|NCT00624780|464933735|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129175174|NCT00624780|464933730|FG000|Follow-up (Week 26)|Death|0|||
129175175|NCT00624780|464933731|FG001|Follow-up (Week 26)|Death|0|||
129175176|NCT00624780|464933732|FG002|Follow-up (Week 26)|Death|1|||
129175177|NCT00624780|464933733|FG003|Follow-up (Week 26)|Death|0|||
129175178|NCT00624780|464933734|FG004|Follow-up (Week 26)|Death|0|||
129175179|NCT00624780|464933735|FG005|Follow-up (Week 26)|Death|0|||
129175180|NCT00624780|464933730|FG000|Follow-up (Week 26)|Adverse Event|0|||
129175181|NCT00624780|464933731|FG001|Follow-up (Week 26)|Adverse Event|0|||
129175182|NCT00624780|464933732|FG002|Follow-up (Week 26)|Adverse Event|0|||
129175183|NCT00624780|464933733|FG003|Follow-up (Week 26)|Adverse Event|0|||
129175184|NCT00624780|464933734|FG004|Follow-up (Week 26)|Adverse Event|1|||
129175185|NCT00624780|464933735|FG005|Follow-up (Week 26)|Adverse Event|0|||
129175186|NCT00624780|464933730|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
129175187|NCT00624780|464933731|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
129175188|NCT00624780|464933732|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
129175189|NCT00624780|464933733|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
129175190|NCT00624780|464933734|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
129175191|NCT00624780|464933735|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
129175192|NCT00624780|464933730|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
129175193|NCT00624780|464933731|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
129175194|NCT00624780|464933732|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
129175195|NCT00624780|464933733|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
129175196|NCT00624780|464933734|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
129175197|NCT00624780|464933735|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
129175198|NCT00624780|464933730|FG000|Follow-up (Week 26)|Other|1|||
129175199|NCT00624780|464933731|FG001|Follow-up (Week 26)|Other|1|||
129175200|NCT00624780|464933732|FG002|Follow-up (Week 26)|Other|0|||
129175201|NCT00624780|464933733|FG003|Follow-up (Week 26)|Other|0|||
129175202|NCT00624780|464933734|FG004|Follow-up (Week 26)|Other|0|||
129175203|NCT00624780|464933735|FG005|Follow-up (Week 26)|Other|0|||
129175204|NCT01514240|464935998|FG000|Overall Study|Adverse Event|4|||
129175205|NCT01514240|464935999|FG001|Overall Study|Adverse Event|4|||
129175206|NCT01514240|464935998|FG000|Overall Study|Subject Decision|2|||
129175207|NCT01514240|464935999|FG001|Overall Study|Subject Decision|7|||
129175208|NCT01103063|464936000|FG000|Overall Study|Adverse Event|3|||
129175209|NCT01103063|464936001|FG001|Overall Study|Adverse Event|1|||
129175210|NCT01103063|464936000|FG000|Overall Study|Lost to Follow-up|68|||
129175211|NCT01103063|464936001|FG001|Overall Study|Lost to Follow-up|51|||
129175212|NCT01103063|464936000|FG000|Overall Study|Withdrawal by Subject|60|||
129175213|NCT01103063|464936001|FG001|Overall Study|Withdrawal by Subject|15|||
129175214|NCT01103063|464936000|FG000|Overall Study|Other|16|||
129175215|NCT01103063|464936001|FG001|Overall Study|Other|11|||
129175216|NCT01103063|464936000|FG000|Overall Study|Protocol Violation|1|||
129175217|NCT01103063|464936001|FG001|Overall Study|Protocol Violation|0|||
129175218|NCT01103063|464936000|FG000|Overall Study|Study terminated by Sponsor|326|||
129175219|NCT01103063|464936001|FG001|Overall Study|Study terminated by Sponsor|342|||
129175220|NCT01103063|464936000|FG000|Overall Study|Death|3|||
129175221|NCT01103063|464936001|FG001|Overall Study|Death|1|||
129175222|NCT00496197|464936002|FG000|Overall Study|Discontinued study due to death|43|||
129175223|NCT00496197|464936002|FG000|Overall Study|Adverse Event|13|||
129175224|NCT00496197|464936002|FG000|Overall Study|Does not meet entrance criteria|5|||
129175225|NCT00496197|464936002|FG000|Overall Study|Insufficient clinical response|3|||
129175226|NCT00496197|464936002|FG000|Overall Study|Insufficient bacteriological response|10|||
129175227|NCT00496197|464936002|FG000|Overall Study|Lost to Follow-up|11|||
129175228|NCT00496197|464936002|FG000|Overall Study|Withdrawal by Subject|11|||
129175229|NCT00496197|464936002|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
129175230|NCT00496197|464936002|FG000|Overall Study|Other|14|||
129175231|NCT00496197|464936002|FG000|Overall Study|Protocol Violation|8|||
129175232|NCT01779869|464936007|FG000|Overall Study|Physician Decision|2|||
129175233|NCT00027378|464936008|FG000|Overall Study|Physician Decision|0|||
129175234|NCT00027378|464936009|FG001|Overall Study|Physician Decision|3|||
129175235|NCT05605691|464936010|FG000|Overall Study|Lost to Follow-up|1|||
129175236|NCT03263923|464936013|FG000|Overall Study|Withdrawal by Subject|10|||
129175237|NCT03263923|464936014|FG001|Overall Study|Withdrawal by Subject|8|||
129175238|NCT03263923|464936013|FG000|Overall Study|Lost to Follow-up|15|||
129175239|NCT03263923|464936014|FG001|Overall Study|Lost to Follow-up|13|||
129175240|NCT02098369|464936016|FG000|Overall Study|Withdrawal by Subject|1|||
129175241|NCT02098369|464936017|FG001|Overall Study|Withdrawal by Subject|5|||
129175242|NCT02098369|464936018|FG002|Overall Study|Withdrawal by Subject|0|||
129175243|NCT02098369|464936016|FG000|Overall Study|Lost to Follow-up|5|||
129175244|NCT02098369|464936017|FG001|Overall Study|Lost to Follow-up|1|||
129175245|NCT02098369|464936018|FG002|Overall Study|Lost to Follow-up|3|||
129175246|NCT02098369|464936016|FG000|Overall Study|Death|1|||
129175247|NCT02098369|464936017|FG001|Overall Study|Death|1|||
129175248|NCT02098369|464936018|FG002|Overall Study|Death|1|||
129175249|NCT02098369|464936016|FG000|Overall Study|Other|0|||
129175250|NCT02098369|464936017|FG001|Overall Study|Other|2|||
129175251|NCT02098369|464936018|FG002|Overall Study|Other|1|||
129175252|NCT02927925|464936031|FG000|Overall Study|Death|16|||
129175253|NCT02927925|464936031|FG000|Overall Study|Physician Decision|1|||
129175254|NCT02927925|464936031|FG000|Overall Study|Withdrawal by Subject|11|||
129175255|NCT02927925|464936031|FG000|Overall Study|Other|3|||
129175256|NCT02927925|464936031|FG000|Overall Study|Disease progression at clinical cutoff|1|||
129175257|NCT02229214|464936032|FG000|Overall Study|Adverse Event|2|||
129175258|NCT02229214|464936033|FG001|Overall Study|Adverse Event|0|||
129175259|NCT02229214|464936032|FG000|Overall Study|Withdrawal by Subject|4|||
129175260|NCT02229214|464936033|FG001|Overall Study|Withdrawal by Subject|0|||
129175261|NCT00246025|464936034|FG000|Overall Study|Adverse Event|7|||
129175262|NCT00246025|464936035|FG001|Overall Study|Adverse Event|9|||
129175263|NCT00246025|464936036|FG002|Overall Study|Adverse Event|9|||
129175264|NCT00246025|464936037|FG003|Overall Study|Adverse Event|10|||
129175265|NCT00246025|464936034|FG000|Overall Study|Withdrawal by Subject|3|||
129175266|NCT00246025|464936035|FG001|Overall Study|Withdrawal by Subject|0|||
129175267|NCT00246025|464936036|FG002|Overall Study|Withdrawal by Subject|1|||
129175268|NCT00246025|464936037|FG003|Overall Study|Withdrawal by Subject|2|||
129175269|NCT00246025|464936034|FG000|Overall Study|unsuitable medical history was found|0|||
129175270|NCT00246025|464936035|FG001|Overall Study|unsuitable medical history was found|0|||
129175271|NCT00246025|464936036|FG002|Overall Study|unsuitable medical history was found|0|||
129175272|NCT00246025|464936037|FG003|Overall Study|unsuitable medical history was found|1|||
129175273|NCT01238835|464936040|FG000|Overall Study|Death|124|||
129175274|NCT01238835|464936040|FG000|Overall Study|Withdrawal by Subject|9|||
129175275|NCT01238835|464936040|FG000|Overall Study|Lost to Follow-up|1|||
129175276|NCT01238835|464936040|FG000|Overall Study|Site early discontinuation|2|||
129175277|NCT00907803|464936042|FG000|Overall Study|Withdrawal of consent - long commute|1|||
129175278|NCT00907803|464936043|FG001|Overall Study|Withdrawal of consent - long commute|0|||
129175279|NCT00907803|464936044|FG002|Overall Study|Withdrawal of consent - long commute|0|||
129175280|NCT00907803|464936042|FG000|Overall Study|Adverse Event|2|||
129175281|NCT00907803|464936043|FG001|Overall Study|Adverse Event|0|||
129175282|NCT00907803|464936044|FG002|Overall Study|Adverse Event|0|||
129175283|NCT00907803|464936042|FG000|Overall Study|Withdrawal by Subject|0|||
129175284|NCT00907803|464936043|FG001|Overall Study|Withdrawal by Subject|1|||
129175285|NCT00907803|464936044|FG002|Overall Study|Withdrawal by Subject|0|||
129175286|NCT00907803|464936042|FG000|Overall Study|Lost to Follow-up|0|||
129175287|NCT00907803|464936043|FG001|Overall Study|Lost to Follow-up|1|||
129175288|NCT00907803|464936044|FG002|Overall Study|Lost to Follow-up|0|||
129175289|NCT00907803|464936042|FG000|Overall Study|Protocol Violation|0|||
129175290|NCT00907803|464936043|FG001|Overall Study|Protocol Violation|1|||
129175291|NCT00907803|464936044|FG002|Overall Study|Protocol Violation|0|||
129175292|NCT03510468|464936045|FG000|Overall Study|Lost to Follow-up|1|||
129175293|NCT03510468|464936045|FG000|Overall Study|Adverse Event|5|||
129175294|NCT03510468|464936045|FG000|Overall Study|Physician Decision|1|||
129175295|NCT03510468|464936045|FG000|Overall Study|non-compliant with treatment|2|||
129175296|NCT03510468|464936045|FG000|Overall Study|Missed visit|1|||
129175297|NCT04612842|464936046|FG000|Overall Study|Lost to Follow-up|20|||
129175298|NCT04612842|464936047|FG001|Overall Study|Lost to Follow-up|11|||
129175299|NCT04612842|464936046|FG000|Overall Study|Withdrawal by Subject|26|||
129175300|NCT04612842|464936047|FG001|Overall Study|Withdrawal by Subject|15|||
129175301|NCT04612842|464936046|FG000|Overall Study|Death|2|||
129175302|NCT04612842|464936047|FG001|Overall Study|Death|2|||
129175303|NCT05426031|464936048|FG000|Overall Study|Circulatory Arrest|3|||
129175304|NCT05426031|464936049|FG001|Overall Study|Circulatory Arrest|2|||
129175305|NCT02419131|464936050|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
129175306|NCT02419131|464936051|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
129175307|NCT02419131|464936052|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
129175308|NCT02419131|464936050|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
129175309|NCT02419131|464936051|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
129175310|NCT02419131|464936052|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
129175311|NCT04677660|464936053|FG000|Overall Study|Lost to Follow-up|0|||
129175312|NCT04677660|464936054|FG001|Overall Study|Lost to Follow-up|2|||
129175313|NCT04677660|464936053|FG000|Overall Study|Withdrawal by Subject|0|||
129175314|NCT04677660|464936054|FG001|Overall Study|Withdrawal by Subject|1|||
129175315|NCT04677660|464936053|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
129175316|NCT04677660|464936054|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
129175317|NCT02437305|464936058|FG000|Overall Study|Lost to Follow-up|18|||
129175318|NCT02437305|464936059|FG001|Overall Study|Lost to Follow-up|12|||
129175319|NCT01560637|464936076|FG000|Overall Study|Adverse Event|63|||
129175320|NCT01560637|464936076|FG000|Overall Study|Death|69|||
129175321|NCT01560637|464936076|FG000|Overall Study|Lost to Follow-up|8|||
129175322|NCT01560637|464936076|FG000|Overall Study|Protocol Violation|8|||
129175323|NCT01560637|464936076|FG000|Overall Study|Withdrawal by Subject|24|||
129175324|NCT01560637|464936076|FG000|Overall Study|Progressive Disease|20|||
129175325|NCT01560637|464936076|FG000|Overall Study|Other Reason Not Specified|6|||
129175326|NCT00413920|464936077|FG000|Overall Study|Adverse Event|9|||
129175327|NCT00413920|464936078|FG001|Overall Study|Adverse Event|11|||
129175328|NCT00413920|464936077|FG000|Overall Study|Lack of Efficacy|11|||
129175329|NCT00413920|464936078|FG001|Overall Study|Lack of Efficacy|9|||
129175330|NCT00413920|464936077|FG000|Overall Study|Death|3|||
129175331|NCT00413920|464936078|FG001|Overall Study|Death|5|||
129175332|NCT00413920|464936077|FG000|Overall Study|Graft Loss|5|||
129175333|NCT00413920|464936078|FG001|Overall Study|Graft Loss|3|||
129175334|NCT01071200|464936079|FG000|Overall Study|Lack of ovarian response|1|||
129175335|NCT01071200|464936080|FG001|Overall Study|Lack of ovarian response|1|||
129175336|NCT01071200|464936079|FG000|Overall Study|No fertilization|4|||
129175337|NCT01071200|464936080|FG001|Overall Study|No fertilization|0|||
129175338|NCT01071200|464936079|FG000|Overall Study|No oocytes retrieved|1|||
129175339|NCT01071200|464936080|FG001|Overall Study|No oocytes retrieved|1|||
129175340|NCT01071200|464936079|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
129175341|NCT01071200|464936080|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
129175342|NCT01071200|464936079|FG000|Overall Study|No viable embryos|0|||
129175343|NCT01071200|464936080|FG001|Overall Study|No viable embryos|1|||
129175344|NCT03730961|464936081|FG000|Overall Study|Adverse Event|0|||
129175345|NCT03730961|464936082|FG001|Overall Study|Adverse Event|1|||
129175346|NCT03762616|464936087|FG000|Overall Study|Protocol Violation|2|||
129175347|NCT04465877|464936089|FG000|Overall Study|Noncompliant with study requirements|0|||
129175348|NCT04465877|464936090|FG001|Overall Study|Noncompliant with study requirements|0|||
129175349|NCT04465877|464936091|FG002|Overall Study|Noncompliant with study requirements|1|||
129175350|NCT04465877|464936092|FG003|Overall Study|Noncompliant with study requirements|0|||
129175351|NCT02323204|464936095|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
129175352|NCT02323204|464936096|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
129175353|NCT02323204|464936097|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
129175354|NCT02323204|464936098|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
129175355|NCT02323204|464936095|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
129175356|NCT02323204|464936096|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
129175357|NCT02323204|464936097|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
129175358|NCT02323204|464936098|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
129175359|NCT02323204|464936095|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
129175360|NCT02323204|464936096|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
129175361|NCT02323204|464936097|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
129175362|NCT02323204|464936098|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
129175363|NCT02323204|464936095|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
129175364|NCT02323204|464936096|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
129175365|NCT02323204|464936097|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
129175366|NCT02323204|464936098|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
129175367|NCT02323204|464936095|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
129175368|NCT02323204|464936096|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
129175369|NCT02323204|464936097|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
129175370|NCT02323204|464936098|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
129175371|NCT02323204|464936095|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
129175372|NCT02323204|464936096|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
129175373|NCT02323204|464936097|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
129175374|NCT02323204|464936098|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
129175375|NCT02323204|464936095|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129175376|NCT02323204|464936096|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
129175377|NCT02323204|464936097|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129175378|NCT02323204|464936098|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
129175379|NCT02323204|464936095|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
129175380|NCT02323204|464936096|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
129175381|NCT02323204|464936097|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
129175382|NCT02323204|464936098|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
129175383|NCT02323204|464936095|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129175384|NCT02323204|464936096|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129175385|NCT02323204|464936097|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
128982129|NCT00508820|464219106|FG000|Overall Study|Death|6|||
129175386|NCT02323204|464936098|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
129175387|NCT03440918|464936104|FG000|Overall Study|Protocol Violation|0|||
129175388|NCT03440918|464936105|FG001|Overall Study|Protocol Violation|16|||
129175389|NCT01396265|464936117|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
129175390|NCT04962230|464936118|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
129175391|NCT04962230|464936118|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
129175392|NCT03576755|464936119|FG000|Overall Study|Withdrawal by Subject|1|||
129175393|NCT03576755|464936120|FG001|Overall Study|Withdrawal by Subject|0|||
129175394|NCT03576755|464936121|FG002|Overall Study|Withdrawal by Subject|0|||
129175395|NCT03576755|464936122|FG003|Overall Study|Withdrawal by Subject|0|||
129175396|NCT03958656|464936123|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
129175397|NCT03958656|464936124|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
129175398|NCT03958656|464936125|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
129175399|NCT03958656|464936126|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
129175400|NCT03958656|464936123|FG000|Overall Study|No longer meets eligibility criteria|0|||
129175401|NCT03958656|464936124|FG001|Overall Study|No longer meets eligibility criteria|0|||
129175402|NCT03958656|464936125|FG002|Overall Study|No longer meets eligibility criteria|1|||
129175403|NCT03958656|464936126|FG003|Overall Study|No longer meets eligibility criteria|0|||
129175404|NCT03958656|464936123|FG000|Overall Study|Started anti-cancer treatment|0|||
129175405|NCT03958656|464936124|FG001|Overall Study|Started anti-cancer treatment|0|||
129175406|NCT03958656|464936125|FG002|Overall Study|Started anti-cancer treatment|1|||
129175407|NCT03958656|464936126|FG003|Overall Study|Started anti-cancer treatment|0|||
129175408|NCT03831880|464936129|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
129175409|NCT03831880|464936130|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
129175410|NCT03831880|464936129|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
129175411|NCT03831880|464936130|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
129175412|NCT03158012|464936131|FG000|Overall Study|Withdrawal by Subject|0|||
129175413|NCT03158012|464936132|FG001|Overall Study|Withdrawal by Subject|1|||
129175414|NCT04346108|464936133|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
129175415|NCT04346108|464936134|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
129175416|NCT04346108|464936135|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
129175417|NCT04346108|464936133|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
129175418|NCT04346108|464936134|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
129175419|NCT04346108|464936135|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
129175420|NCT01598753|464936136|FG000|Overall Study|Adverse Event|1|||
129175421|NCT01598753|464936137|FG001|Overall Study|Adverse Event|9|||
129175422|NCT01598753|464936138|FG002|Overall Study|Adverse Event|1|||
129175423|NCT01598753|464936139|FG003|Overall Study|Adverse Event|7|||
129175424|NCT01598753|464936136|FG000|Overall Study|Lost to Follow-up|4|||
129175425|NCT01598753|464936137|FG001|Overall Study|Lost to Follow-up|3|||
129175426|NCT01598753|464936138|FG002|Overall Study|Lost to Follow-up|7|||
129175427|NCT01598753|464936139|FG003|Overall Study|Lost to Follow-up|5|||
129175428|NCT01598753|464936136|FG000|Overall Study|Physician Decision|0|||
129175429|NCT01598753|464936137|FG001|Overall Study|Physician Decision|1|||
129175430|NCT01598753|464936138|FG002|Overall Study|Physician Decision|0|||
129175431|NCT01598753|464936139|FG003|Overall Study|Physician Decision|2|||
129175432|NCT01598753|464936136|FG000|Overall Study|Withdrawal by Subject|7|||
129175433|NCT01598753|464936137|FG001|Overall Study|Withdrawal by Subject|2|||
129175434|NCT01598753|464936138|FG002|Overall Study|Withdrawal by Subject|0|||
129175435|NCT01598753|464936139|FG003|Overall Study|Withdrawal by Subject|1|||
129175436|NCT02788201|464936140|FG000|Overall Study|Death|1|||
129175437|NCT02788201|464936141|FG001|Overall Study|Death|1|||
129175438|NCT02788201|464936142|FG002|Overall Study|Death|1|||
129175439|NCT02788201|464936143|FG003|Overall Study|Death|1|||
129175440|NCT02788201|464936144|FG004|Overall Study|Death|0|||
129175441|NCT02788201|464936145|FG005|Overall Study|Death|1|||
129175442|NCT02788201|464936140|FG000|Overall Study|Ineligible|0|||
129175443|NCT02788201|464936141|FG001|Overall Study|Ineligible|0|||
128982130|NCT00508820|464219107|FG001|Overall Study|Death|8|||
129175444|NCT02788201|464936142|FG002|Overall Study|Ineligible|0|||
129175445|NCT02788201|464936143|FG003|Overall Study|Ineligible|0|||
129175446|NCT02788201|464936144|FG004|Overall Study|Ineligible|0|||
129175447|NCT02788201|464936145|FG005|Overall Study|Ineligible|1|||
129175448|NCT02788201|464936140|FG000|Overall Study|Withdrawal by Subject|0|||
129175449|NCT02788201|464936141|FG001|Overall Study|Withdrawal by Subject|0|||
128780922|NCT01323660|463488629|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
128780923|NCT01323660|463488630|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
128780924|NCT01323660|463488631|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
129175450|NCT02788201|464936142|FG002|Overall Study|Withdrawal by Subject|0|||
129175451|NCT02788201|464936143|FG003|Overall Study|Withdrawal by Subject|0|||
129175452|NCT02788201|464936144|FG004|Overall Study|Withdrawal by Subject|0|||
129175453|NCT02788201|464936145|FG005|Overall Study|Withdrawal by Subject|1|||
129175454|NCT01852825|464936146|FG000|Overall Study|Withdrawal by Subject|2|||
129175455|NCT01852825|464936147|FG001|Overall Study|Withdrawal by Subject|0|||
129175456|NCT01852825|464936148|FG002|Overall Study|Withdrawal by Subject|0|||
129175457|NCT02275117|464936151|FG000|Overall Study|Adverse Event|0|||
129175458|NCT02275117|464936152|FG001|Overall Study|Adverse Event|0|||
129175459|NCT02275117|464936153|FG002|Overall Study|Adverse Event|0|||
129175460|NCT02275117|464936154|FG003|Overall Study|Adverse Event|0|||
129175461|NCT02275117|464936155|FG004|Overall Study|Adverse Event|1|||
129175462|NCT02275117|464936151|FG000|Overall Study|Lack of Efficacy|6|||
129175463|NCT02275117|464936152|FG001|Overall Study|Lack of Efficacy|7|||
129175464|NCT02275117|464936153|FG002|Overall Study|Lack of Efficacy|5|||
129175465|NCT02275117|464936154|FG003|Overall Study|Lack of Efficacy|2|||
129175466|NCT02275117|464936155|FG004|Overall Study|Lack of Efficacy|10|||
129175467|NCT02275117|464936151|FG000|Overall Study|Lost to Follow-up|11|||
129175468|NCT02275117|464936152|FG001|Overall Study|Lost to Follow-up|16|||
129175469|NCT02275117|464936153|FG002|Overall Study|Lost to Follow-up|15|||
129175470|NCT02275117|464936154|FG003|Overall Study|Lost to Follow-up|16|||
129175471|NCT02275117|464936155|FG004|Overall Study|Lost to Follow-up|8|||
129175472|NCT02275117|464936151|FG000|Overall Study|Physician Decision|0|||
129175473|NCT02275117|464936152|FG001|Overall Study|Physician Decision|1|||
129175474|NCT02275117|464936153|FG002|Overall Study|Physician Decision|1|||
128780925|NCT01323660|463488626|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
129175475|NCT02275117|464936154|FG003|Overall Study|Physician Decision|0|||
129175476|NCT02275117|464936155|FG004|Overall Study|Physician Decision|1|||
129175477|NCT02275117|464936151|FG000|Overall Study|Protocol Violation|1|||
129175478|NCT02275117|464936152|FG001|Overall Study|Protocol Violation|0|||
129175479|NCT02275117|464936153|FG002|Overall Study|Protocol Violation|1|||
129175480|NCT02275117|464936154|FG003|Overall Study|Protocol Violation|1|||
129175481|NCT02275117|464936155|FG004|Overall Study|Protocol Violation|0|||
129175482|NCT02275117|464936151|FG000|Overall Study|Withdrawal by Subject|6|||
129175483|NCT02275117|464936152|FG001|Overall Study|Withdrawal by Subject|4|||
129175484|NCT02275117|464936153|FG002|Overall Study|Withdrawal by Subject|7|||
129175485|NCT02275117|464936154|FG003|Overall Study|Withdrawal by Subject|3|||
129175486|NCT02275117|464936155|FG004|Overall Study|Withdrawal by Subject|3|||
129175487|NCT02275117|464936151|FG000|Overall Study|Terminated by Sponsor|4|||
129175488|NCT02275117|464936152|FG001|Overall Study|Terminated by Sponsor|4|||
129175489|NCT02275117|464936153|FG002|Overall Study|Terminated by Sponsor|4|||
129175490|NCT02275117|464936154|FG003|Overall Study|Terminated by Sponsor|6|||
129175491|NCT02275117|464936155|FG004|Overall Study|Terminated by Sponsor|4|||
129175492|NCT02275117|464936151|FG000|Overall Study|Worsening of Study Indication|0|||
129175493|NCT02275117|464936152|FG001|Overall Study|Worsening of Study Indication|1|||
129175494|NCT02275117|464936153|FG002|Overall Study|Worsening of Study Indication|2|||
129175495|NCT02275117|464936154|FG003|Overall Study|Worsening of Study Indication|0|||
129175496|NCT02275117|464936155|FG004|Overall Study|Worsening of Study Indication|0|||
129175497|NCT02275117|464936151|FG000|Overall Study|Study Burden|5|||
129175498|NCT02275117|464936152|FG001|Overall Study|Study Burden|4|||
129175499|NCT02275117|464936153|FG002|Overall Study|Study Burden|7|||
129175500|NCT02275117|464936154|FG003|Overall Study|Study Burden|5|||
129175501|NCT02275117|464936155|FG004|Overall Study|Study Burden|7|||
129175502|NCT02275117|464936151|FG000|Overall Study|Other|1|||
129175503|NCT02275117|464936152|FG001|Overall Study|Other|0|||
129175504|NCT02275117|464936153|FG002|Overall Study|Other|0|||
129175505|NCT02275117|464936154|FG003|Overall Study|Other|0|||
129175506|NCT02275117|464936155|FG004|Overall Study|Other|2|||
129175507|NCT00724854|464936159|FG000|Overall Study|Lack of Efficacy|187|||
129175508|NCT00724854|464936160|FG001|Overall Study|Lack of Efficacy|13|||
129175509|NCT00724854|464936159|FG000|Overall Study|Lost to Follow-up|87|||
129175510|NCT00724854|464936160|FG001|Overall Study|Lost to Follow-up|10|||
129175511|NCT00724854|464936159|FG000|Overall Study|Adverse Event|62|||
129175512|NCT00724854|464936160|FG001|Overall Study|Adverse Event|4|||
129175513|NCT00724854|464936159|FG000|Overall Study|Other|42|||
129175514|NCT00724854|464936160|FG001|Overall Study|Other|3|||
129175515|NCT00724854|464936159|FG000|Overall Study|Death|11|||
129175516|NCT00724854|464936160|FG001|Overall Study|Death|0|||
129175517|NCT00724854|464936159|FG000|Overall Study|Change of treatment|7|||
129175518|NCT00724854|464936160|FG001|Overall Study|Change of treatment|0|||
129175519|NCT00724854|464936159|FG000|Overall Study|Withdrawal by Subject|5|||
129175520|NCT00724854|464936160|FG001|Overall Study|Withdrawal by Subject|0|||
129175521|NCT00724854|464936159|FG000|Overall Study|Adverse event + lack of efficacy|2|||
129175522|NCT00724854|464936160|FG001|Overall Study|Adverse event + lack of efficacy|1|||
129175523|NCT01095653|464936161|FG000|Overall Study|Lack of Efficacy|3|||
129175524|NCT01095653|464936162|FG001|Overall Study|Lack of Efficacy|0|||
129175525|NCT01095653|464936163|FG002|Overall Study|Lack of Efficacy|0|||
129175526|NCT01095653|464936161|FG000|Overall Study|Adverse Event|1|||
129175527|NCT01095653|464936162|FG001|Overall Study|Adverse Event|4|||
129175528|NCT01095653|464936163|FG002|Overall Study|Adverse Event|4|||
129175529|NCT01095653|464936161|FG000|Overall Study|Lost to Follow-up|1|||
129175530|NCT01095653|464936162|FG001|Overall Study|Lost to Follow-up|0|||
129175531|NCT01095653|464936163|FG002|Overall Study|Lost to Follow-up|4|||
129175532|NCT01095653|464936161|FG000|Overall Study|Withdrawal by Subject|4|||
129175533|NCT01095653|464936162|FG001|Overall Study|Withdrawal by Subject|5|||
129175534|NCT01095653|464936163|FG002|Overall Study|Withdrawal by Subject|3|||
129175535|NCT01095653|464936161|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
129175536|NCT01095653|464936162|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
129175537|NCT01095653|464936163|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
129175538|NCT02692040|464936164|FG000|Overall Study|Protocol Violation|0|||
129175539|NCT02692040|464936165|FG001|Overall Study|Protocol Violation|0|||
129175540|NCT02692040|464936166|FG002|Overall Study|Protocol Violation|0|||
129175541|NCT02692040|464936167|FG003|Overall Study|Protocol Violation|0|||
129175542|NCT02692040|464936168|FG004|Overall Study|Protocol Violation|0|||
129175543|NCT02692040|464936169|FG005|Overall Study|Protocol Violation|0|||
129175544|NCT02692040|464936170|FG006|Overall Study|Protocol Violation|0|||
129175545|NCT02692040|464936171|FG007|Overall Study|Protocol Violation|0|||
129175546|NCT02692040|464936172|FG008|Overall Study|Protocol Violation|0|||
129175547|NCT02692040|464936173|FG009|Overall Study|Protocol Violation|0|||
129175548|NCT02692040|464936174|FG010|Overall Study|Protocol Violation|0|||
129175549|NCT02692040|464936175|FG011|Overall Study|Protocol Violation|0|||
129175550|NCT02692040|464936176|FG012|Overall Study|Protocol Violation|1|||
129175551|NCT02692040|464936177|FG013|Overall Study|Protocol Violation|0|||
129175552|NCT02692040|464936178|FG014|Overall Study|Protocol Violation|0|||
129175553|NCT02692040|464936179|FG015|Overall Study|Protocol Violation|0|||
129175554|NCT02692040|464936180|FG016|Overall Study|Protocol Violation|0|||
128982131|NCT00508820|464219106|FG000|Overall Study|Lost to Follow-up|1|||
129175555|NCT02692040|464936164|FG000|Overall Study|Adverse Event|0|||
129175556|NCT02692040|464936165|FG001|Overall Study|Adverse Event|0|||
129175557|NCT02692040|464936166|FG002|Overall Study|Adverse Event|0|||
128730178|NCT00458484|463308343|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
129175558|NCT02692040|464936167|FG003|Overall Study|Adverse Event|0|||
129175559|NCT02692040|464936168|FG004|Overall Study|Adverse Event|0|||
129175560|NCT02692040|464936169|FG005|Overall Study|Adverse Event|0|||
129175561|NCT02692040|464936170|FG006|Overall Study|Adverse Event|0|||
129175562|NCT02692040|464936171|FG007|Overall Study|Adverse Event|0|||
129175563|NCT02692040|464936172|FG008|Overall Study|Adverse Event|0|||
129175564|NCT02692040|464936173|FG009|Overall Study|Adverse Event|0|||
129175565|NCT02692040|464936174|FG010|Overall Study|Adverse Event|0|||
129175566|NCT02692040|464936175|FG011|Overall Study|Adverse Event|0|||
129175567|NCT02692040|464936176|FG012|Overall Study|Adverse Event|0|||
129175568|NCT02692040|464936177|FG013|Overall Study|Adverse Event|3|||
129175569|NCT02692040|464936178|FG014|Overall Study|Adverse Event|1|||
129175570|NCT02692040|464936179|FG015|Overall Study|Adverse Event|1|||
129175571|NCT02692040|464936180|FG016|Overall Study|Adverse Event|0|||
129175572|NCT00171925|464936181|FG000|Overall Study|Adverse Event|10|||
129175573|NCT00171925|464936182|FG001|Overall Study|Adverse Event|6|||
129175574|NCT00171925|464936181|FG000|Overall Study|Protocol Violation|1|||
129175575|NCT00171925|464936182|FG001|Overall Study|Protocol Violation|1|||
129175576|NCT00171925|464936181|FG000|Overall Study|Withdrawal by Subject|6|||
129175577|NCT00171925|464936182|FG001|Overall Study|Withdrawal by Subject|9|||
129175578|NCT00171925|464936181|FG000|Overall Study|Lost to Follow-up|2|||
129175579|NCT00171925|464936182|FG001|Overall Study|Lost to Follow-up|2|||
129175580|NCT00171925|464936181|FG000|Overall Study|Administrative problems|10|||
129175581|NCT00171925|464936182|FG001|Overall Study|Administrative problems|11|||
129175582|NCT00171925|464936181|FG000|Overall Study|Death|1|||
129175583|NCT00171925|464936182|FG001|Overall Study|Death|2|||
129175584|NCT02826421|464936188|FG000|Overall Study|Adverse Event|1|||
129175585|NCT02826421|464936189|FG001|Overall Study|Adverse Event|0|||
129175586|NCT02826421|464936190|FG002|Overall Study|Adverse Event|0|||
129175587|NCT02826421|464936191|FG003|Overall Study|Adverse Event|1|||
129175588|NCT02826421|464936188|FG000|Overall Study|Withdrawal by Subject|1|||
129175589|NCT02826421|464936189|FG001|Overall Study|Withdrawal by Subject|3|||
129175590|NCT02826421|464936190|FG002|Overall Study|Withdrawal by Subject|1|||
129175591|NCT02826421|464936191|FG003|Overall Study|Withdrawal by Subject|1|||
129175592|NCT02826421|464936188|FG000|Overall Study|Reason not given|1|||
129175593|NCT02826421|464936189|FG001|Overall Study|Reason not given|0|||
129175594|NCT02826421|464936190|FG002|Overall Study|Reason not given|1|||
129175595|NCT02826421|464936191|FG003|Overall Study|Reason not given|0|||
129175596|NCT02210221|464936196|FG000|Overall Study|Lack of Efficacy|7|||
129175597|NCT02210221|464936196|FG000|Overall Study|Withdrawal by Subject|43|||
129175598|NCT02141490|464936197|FG000|Overall Study|Screening failures|4|||
129175599|NCT02141490|464936198|FG001|Overall Study|Screening failures|0|||
129175600|NCT02141490|464936199|FG002|Overall Study|Screening failures|0|||
129175601|NCT00355342|464936203|FG000|Overall Study|Adverse Event|13|||
129175602|NCT00355342|464936204|FG001|Overall Study|Adverse Event|15|||
129175603|NCT00355342|464936203|FG000|Overall Study|Lost to Follow-up|4|||
129175604|NCT00355342|464936204|FG001|Overall Study|Lost to Follow-up|2|||
129175605|NCT00355342|464936203|FG000|Overall Study|Withdrawal by Subject|14|||
129175606|NCT00355342|464936204|FG001|Overall Study|Withdrawal by Subject|11|||
129175607|NCT00355342|464936203|FG000|Overall Study|Sponsor terminated study|2|||
129175608|NCT00355342|464936204|FG001|Overall Study|Sponsor terminated study|2|||
129175609|NCT00355342|464936203|FG000|Overall Study|Overcompliant-PI discretion|1|||
129175610|NCT00355342|464936204|FG001|Overall Study|Overcompliant-PI discretion|0|||
129175611|NCT00355342|464936203|FG000|Overall Study|Use of prohibited medication|1|||
129175612|NCT00355342|464936204|FG001|Overall Study|Use of prohibited medication|0|||
129175613|NCT00355342|464936203|FG000|Overall Study|COPD exacerbation|1|||
129175614|NCT00355342|464936204|FG001|Overall Study|COPD exacerbation|1|||
129175615|NCT00355342|464936203|FG000|Overall Study|Dispensed wrong study drug kit|1|||
129175616|NCT00355342|464936204|FG001|Overall Study|Dispensed wrong study drug kit|0|||
129175617|NCT00355342|464936203|FG000|Overall Study|Non-compliance with Dexa scans|1|||
129175618|NCT00355342|464936204|FG001|Overall Study|Non-compliance with Dexa scans|0|||
129175619|NCT00355342|464936203|FG000|Overall Study|Withdrawal by participant and physician|1|||
129175620|NCT00355342|464936204|FG001|Overall Study|Withdrawal by participant and physician|0|||
129175621|NCT00355342|464936203|FG000|Overall Study|Participant relocated|0|||
129175622|NCT00355342|464936204|FG001|Overall Study|Participant relocated|1|||
129175623|NCT00355342|464936203|FG000|Overall Study|Participant discontinued study drug|0|||
129175624|NCT00355342|464936204|FG001|Overall Study|Participant discontinued study drug|1|||
129175625|NCT00355342|464936203|FG000|Overall Study|Study management|0|||
129175626|NCT00355342|464936204|FG001|Overall Study|Study management|1|||
129175627|NCT00355342|464936203|FG000|Overall Study|Protocol Violation|0|||
129175628|NCT00355342|464936204|FG001|Overall Study|Protocol Violation|1|||
129175629|NCT00355342|464936203|FG000|Overall Study|Use of protocol excluded medication|0|||
129175630|NCT00355342|464936204|FG001|Overall Study|Use of protocol excluded medication|1|||
129175631|NCT00434759|464936205|FG000|Overall Study|Lack of Efficacy|5|||
129175632|NCT00434759|464936206|FG001|Overall Study|Lack of Efficacy|4|||
129175633|NCT00434759|464936205|FG000|Overall Study|Withdrawal by Subject|17|||
129175634|NCT00434759|464936206|FG001|Overall Study|Withdrawal by Subject|1|||
129175635|NCT00434759|464936205|FG000|Overall Study|family affairs|2|||
129175636|NCT00434759|464936206|FG001|Overall Study|family affairs|0|||
129175637|NCT00969761|464936210|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129175638|NCT00969761|464936211|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175639|NCT00969761|464936212|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175640|NCT00969761|464936213|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129175641|NCT00969761|464936214|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175642|NCT00969761|464936215|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175643|NCT00969761|464936216|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175644|NCT00969761|464936217|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175645|NCT00969761|464936218|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129175646|NCT00969761|464936219|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129175647|NCT00969761|464936220|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175648|NCT00969761|464936221|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129175649|NCT00969761|464936210|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175650|NCT00969761|464936211|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175651|NCT00969761|464936212|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
129175652|NCT00969761|464936213|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175653|NCT00969761|464936214|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175654|NCT00969761|464936215|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175655|NCT00969761|464936216|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175656|NCT00969761|464936217|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175657|NCT00969761|464936218|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175658|NCT00969761|464936219|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175659|NCT00969761|464936220|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175660|NCT00969761|464936221|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129175661|NCT00969761|464936210|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175662|NCT00969761|464936211|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175663|NCT00969761|464936212|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
129175664|NCT00969761|464936213|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175665|NCT00969761|464936214|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175666|NCT00969761|464936215|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175667|NCT00969761|464936216|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175668|NCT00969761|464936217|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175669|NCT00969761|464936218|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175670|NCT00969761|464936219|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175671|NCT00969761|464936220|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175672|NCT00969761|464936221|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129175673|NCT00969761|464936210|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175674|NCT00969761|464936211|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175675|NCT00969761|464936212|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175676|NCT00969761|464936213|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175677|NCT00969761|464936214|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175678|NCT00969761|464936215|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175679|NCT00969761|464936216|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175680|NCT00969761|464936217|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175681|NCT00969761|464936218|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
129175682|NCT00969761|464936219|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175683|NCT00969761|464936220|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175684|NCT00969761|464936221|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129175685|NCT00969761|464936210|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
129175686|NCT00969761|464936211|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129175687|NCT00969761|464936212|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
129175688|NCT00969761|464936213|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129175689|NCT00969761|464936214|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
129175690|NCT00969761|464936215|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129175691|NCT00969761|464936216|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129175692|NCT00969761|464936217|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
129175693|NCT00969761|464936218|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
129175694|NCT00969761|464936219|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
129175695|NCT00969761|464936220|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129175696|NCT00969761|464936221|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129175697|NCT00969761|464936210|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175698|NCT00969761|464936211|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175699|NCT00969761|464936212|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175700|NCT00969761|464936213|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
129175701|NCT00969761|464936214|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
129175702|NCT00969761|464936215|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175703|NCT00969761|464936216|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175704|NCT00969761|464936217|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175705|NCT00969761|464936218|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
129175706|NCT00969761|464936219|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175707|NCT00969761|464936220|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175708|NCT00969761|464936221|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129175709|NCT00823212|464938709|FG000|Overall Study|Death|8|||
129175710|NCT00823212|464938710|FG001|Overall Study|Death|10|||
128982132|NCT00508820|464219107|FG001|Overall Study|Lost to Follow-up|1|||
129175711|NCT00823212|464938709|FG000|Overall Study|Withdrawal by Subject|6|||
129175712|NCT00823212|464938710|FG001|Overall Study|Withdrawal by Subject|1|||
129175713|NCT00823212|464938709|FG000|Overall Study|Incarcerated|0|||
129175714|NCT00823212|464938710|FG001|Overall Study|Incarcerated|1|||
129175715|NCT00823212|464938709|FG000|Overall Study|Missed 12-month visit|21|||
129175716|NCT00823212|464938710|FG001|Overall Study|Missed 12-month visit|21|||
129175717|NCT01344538|464938711|FG000|Overall Study|Adverse Event|1|||
129175718|NCT01344538|464938712|FG001|Overall Study|Adverse Event|1|||
129175719|NCT01344538|464938711|FG000|Overall Study|Lost to Follow-up|1|||
129175720|NCT01344538|464938712|FG001|Overall Study|Lost to Follow-up|0|||
129175721|NCT01655381|464938713|FG000|Overall Study|Investigator Decision|1|||
129175722|NCT01655381|464938713|FG000|Overall Study|Moved to Another City|1|||
129175723|NCT01655381|464938713|FG000|Overall Study|Insufficient Treatment Response|1|||
129175724|NCT00937404|464938725|FG000|Overall Study|Protocol Violation|1|||
129175725|NCT00937404|464938725|FG000|Overall Study|Withdrawal by Subject|1|||
129175726|NCT04644237|464938726|FG000|Overall Study|Death|3|||
129175727|NCT04644237|464938727|FG001|Overall Study|Death|2|||
129175728|NCT04644237|464938726|FG000|Overall Study|Adverse Event|15|||
129175729|NCT04644237|464938727|FG001|Overall Study|Adverse Event|12|||
129175730|NCT04644237|464938726|FG000|Overall Study|Progressive Disease|47|||
129175731|NCT04644237|464938727|FG001|Overall Study|Progressive Disease|19|||
129175732|NCT04644237|464938726|FG000|Overall Study|Clinical Progression|4|||
129175733|NCT04644237|464938727|FG001|Overall Study|Clinical Progression|1|||
129175734|NCT04644237|464938726|FG000|Overall Study|Withdrawal by Subject|1|||
129175735|NCT04644237|464938727|FG001|Overall Study|Withdrawal by Subject|2|||
129175736|NCT04644237|464938726|FG000|Overall Study|Physician Decision|3|||
129175737|NCT04644237|464938727|FG001|Overall Study|Physician Decision|0|||
129175738|NCT04644237|464938726|FG000|Overall Study|Other|1|||
129175739|NCT04644237|464938727|FG001|Overall Study|Other|0|||
129175740|NCT04644237|464938726|FG000|Overall Study|Randomized but not Treated|1|||
129175741|NCT04644237|464938727|FG001|Overall Study|Randomized but not Treated|0|||
129175742|NCT00090233|464938728|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
129175743|NCT00090233|464938729|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
129175744|NCT00090233|464938728|FG000|Overall Study|Adverse Event|214|||
129175745|NCT00090233|464938729|FG001|Overall Study|Adverse Event|198|||
129175746|NCT00090233|464938728|FG000|Overall Study|Lost to Follow-up|68|||
129175747|NCT00090233|464938729|FG001|Overall Study|Lost to Follow-up|95|||
129175748|NCT00090233|464938728|FG000|Overall Study|Protocol Violation|960|||
129175749|NCT00090233|464938729|FG001|Overall Study|Protocol Violation|1022|||
129175750|NCT00090233|464938728|FG000|Overall Study|Withdrawal by Subject|182|||
129175751|NCT00090233|464938729|FG001|Overall Study|Withdrawal by Subject|211|||
129175752|NCT00090233|464938728|FG000|Overall Study|Moved|203|||
129175753|NCT00090233|464938729|FG001|Overall Study|Moved|189|||
128730179|NCT00458484|463308344|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
128730180|NCT00458484|463308345|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
129175754|NCT00090233|464938728|FG000|Overall Study|Other|1211|||
129175755|NCT00090233|464938729|FG001|Overall Study|Other|1160|||
129175756|NCT00090233|464938728|FG000|Overall Study|Data not available at data cut-off point|1552|||
129175757|NCT00090233|464938729|FG001|Overall Study|Data not available at data cut-off point|1563|||
129175758|NCT04863248|464938730|FG000|Overall Study|Sponsor Terminated|4|||
129175759|NCT04863248|464938731|FG001|Overall Study|Sponsor Terminated|1|||
129175760|NCT04863248|464938730|FG000|Overall Study|Death|0|||
129175761|NCT04863248|464938731|FG001|Overall Study|Death|1|||
129175762|NCT04863248|464938730|FG000|Overall Study|Withdrawal by Subject|0|||
129175763|NCT04863248|464938731|FG001|Overall Study|Withdrawal by Subject|1|||
129175764|NCT02536300|464938732|FG000|Overall Study|Investigator's Discretion|17|||
129175765|NCT02536300|464938733|FG001|Overall Study|Investigator's Discretion|11|||
129175766|NCT02536300|464938734|FG002|Overall Study|Investigator's Discretion|2|||
129175767|NCT02536300|464938732|FG000|Overall Study|Progressive Disease|11|||
129175768|NCT02536300|464938733|FG001|Overall Study|Progressive Disease|7|||
129175769|NCT02536300|464938734|FG002|Overall Study|Progressive Disease|6|||
129175770|NCT02536300|464938732|FG000|Overall Study|Study Terminated by Sponsor|6|||
129175771|NCT02536300|464938733|FG001|Overall Study|Study Terminated by Sponsor|4|||
129175772|NCT02536300|464938734|FG002|Overall Study|Study Terminated by Sponsor|7|||
129175773|NCT02536300|464938732|FG000|Overall Study|Death|7|||
129175774|NCT02536300|464938733|FG001|Overall Study|Death|0|||
129175775|NCT02536300|464938734|FG002|Overall Study|Death|5|||
129175776|NCT02536300|464938732|FG000|Overall Study|Withdrew Consent|4|||
129175777|NCT02536300|464938733|FG001|Overall Study|Withdrew Consent|2|||
129175778|NCT02536300|464938734|FG002|Overall Study|Withdrew Consent|0|||
129175779|NCT02536300|464938732|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
129175780|NCT02536300|464938733|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
129175781|NCT02536300|464938734|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
129175782|NCT02536300|464938732|FG000|Overall Study|Enrolled but Never Treated|0|||
129175783|NCT02536300|464938733|FG001|Overall Study|Enrolled but Never Treated|0|||
129175784|NCT02536300|464938734|FG002|Overall Study|Enrolled but Never Treated|1|||
129175785|NCT02536300|464938732|FG000|Overall Study|Non-compliance With Study Drug|1|||
129175786|NCT02536300|464938733|FG001|Overall Study|Non-compliance With Study Drug|0|||
129175787|NCT02536300|464938734|FG002|Overall Study|Non-compliance With Study Drug|0|||
129175788|NCT02536300|464938732|FG000|Overall Study|Protocol Violation|0|||
129175789|NCT02536300|464938733|FG001|Overall Study|Protocol Violation|1|||
129175790|NCT02536300|464938734|FG002|Overall Study|Protocol Violation|0|||
129175791|NCT01691105|464938741|FG000|1 Month Follow-up|Lost to Follow-up|41|||
129175792|NCT01691105|464938742|FG001|1 Month Follow-up|Lost to Follow-up|38|||
129175793|NCT01691105|464938741|FG000|1 Month Follow-up|Death|2|||
129175794|NCT01691105|464938742|FG001|1 Month Follow-up|Death|3|||
129175795|NCT01691105|464938741|FG000|6 Month Follow-up|Lost to Follow-up|39|||
129175796|NCT01691105|464938742|FG001|6 Month Follow-up|Lost to Follow-up|58|||
129175797|NCT01691105|464938741|FG000|6 Month Follow-up|Death|13|||
129175798|NCT01691105|464938742|FG001|6 Month Follow-up|Death|13|||
129175799|NCT01691105|464938741|FG000|12 Month Follow-up|Lost to Follow-up|50|||
129175800|NCT01691105|464938742|FG001|12 Month Follow-up|Lost to Follow-up|71|||
129175801|NCT01691105|464938741|FG000|12 Month Follow-up|Death|22|||
129175802|NCT01691105|464938742|FG001|12 Month Follow-up|Death|30|||
129175803|NCT01691105|464938741|FG000|12 Month Biochemical Verification|Death|22|||
129175804|NCT01691105|464938742|FG001|12 Month Biochemical Verification|Death|30|||
129175805|NCT01691105|464938741|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
129175806|NCT01691105|464938742|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
129175807|NCT01691105|464938741|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
129175808|NCT01691105|464938742|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
129175809|NCT02233738|464938743|FG000|Overall Study|Lost to Follow-up|5|||
129175810|NCT02233738|464938744|FG001|Overall Study|Lost to Follow-up|12|||
129175811|NCT02233738|464938743|FG000|Overall Study|Death|0|||
129175812|NCT02233738|464938744|FG001|Overall Study|Death|1|||
129175813|NCT02233738|464938743|FG000|Overall Study|Withdrawal by Subject|0|||
129175814|NCT02233738|464938744|FG001|Overall Study|Withdrawal by Subject|1|||
129175815|NCT02233738|464938743|FG000|Overall Study|Did not return after Baseline|3|||
129175816|NCT02233738|464938744|FG001|Overall Study|Did not return after Baseline|2|||
129175817|NCT00096174|464938748|FG000|Overall Study|Lack of Efficacy|9|||
129175818|NCT00096174|464938748|FG000|Overall Study|Adverse Event|15|||
129175819|NCT00096174|464938748|FG000|Overall Study|Death|6|||
129175820|NCT00096174|464938748|FG000|Overall Study|Withdrawal by Subject|15|||
129175821|NCT00096174|464938748|FG000|Overall Study|Not started protocol therapy|3|||
129175822|NCT00096174|464938748|FG000|Overall Study|Ineligible|6|||
129175823|NCT00096174|464938748|FG000|Overall Study|other reason|8|||
129175824|NCT00445848|464938749|FG000|Overall Study|Adverse Event|14|||
129175825|NCT00445848|464938749|FG000|Overall Study|Withdrawal by Subject|4|||
129175826|NCT00445848|464938749|FG000|Overall Study|Progression|62|||
129175827|NCT00445848|464938749|FG000|Overall Study|Other-Not protocol specified|5|||
129175828|NCT04706273|464938750|FG000|Overall Study|Withdrawal by Subject|27|||
129175829|NCT04706273|464938750|FG000|Overall Study|Physician Decision|1|||
129175830|NCT04706273|464938750|FG000|Overall Study|Lost to Follow-up|42|||
129175831|NCT04706273|464938750|FG000|Overall Study|Death|85|||
129175832|NCT04706273|464938750|FG000|Overall Study|Amputation that removes study device|2|||
129175833|NCT04706273|464938750|FG000|Overall Study|Surgical bypass|3|||
129175834|NCT04706273|464938750|FG000|Overall Study|Changing hospital|23|||
129175835|NCT04706273|464938750|FG000|Overall Study|Unable to attend hospital|2|||
129175836|NCT03199053|464938753|FG000|ST Period|Withdrawal by Subject|2|||
129175837|NCT03199053|464938754|FG001|ST Period|Withdrawal by Subject|4|||
129175838|NCT03199053|464938755|FG002|ST Period|Withdrawal by Subject|6|||
128982133|NCT00508820|464219106|FG000|Overall Study|Physician Decision|8|||
129175839|NCT03199053|464938753|FG000|ST Period|Withdrawal by parent/guardian|1|||
129175840|NCT03199053|464938754|FG001|ST Period|Withdrawal by parent/guardian|1|||
129175841|NCT03199053|464938755|FG002|ST Period|Withdrawal by parent/guardian|1|||
129175842|NCT03199053|464938753|FG000|ST Period|Lost to Follow-up|2|||
129175843|NCT03199053|464938754|FG001|ST Period|Lost to Follow-up|0|||
129175844|NCT03199053|464938755|FG002|ST Period|Lost to Follow-up|1|||
129175845|NCT03199053|464938753|FG000|LT Period|Withdrawal by Subject|1|||
129175846|NCT03199053|464938754|FG001|LT Period|Withdrawal by Subject|3|||
129175847|NCT03199053|464938755|FG002|LT Period|Withdrawal by Subject|3|||
129175848|NCT03199053|464938753|FG000|LT Period|Withdrawal by parent/guardian|0|||
129175849|NCT03199053|464938754|FG001|LT Period|Withdrawal by parent/guardian|0|||
129175850|NCT03199053|464938755|FG002|LT Period|Withdrawal by parent/guardian|1|||
129175851|NCT03199053|464938753|FG000|LT Period|Lost to Follow-up|0|||
129175852|NCT03199053|464938754|FG001|LT Period|Lost to Follow-up|1|||
129175853|NCT03199053|464938755|FG002|LT Period|Lost to Follow-up|1|||
129175854|NCT03199053|464938753|FG000|LT Period|Miscellaneous|0|||
129175855|NCT03199053|464938754|FG001|LT Period|Miscellaneous|0|||
129175856|NCT03199053|464938755|FG002|LT Period|Miscellaneous|2|||
129175857|NCT03199053|464938753|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
129175858|NCT03199053|464938754|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
129175859|NCT03199053|464938755|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
129175860|NCT03199053|464938753|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
129175861|NCT03199053|464938754|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
129175862|NCT03199053|464938755|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
129175863|NCT03199053|464938753|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
129175864|NCT03199053|464938754|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
129175865|NCT03199053|464938755|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
129175866|NCT03199053|464938753|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
129175867|NCT03199053|464938754|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
129175868|NCT03199053|464938755|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
129175869|NCT02509052|464938758|FG000|Overall Study|Non compliance|0|||
129175870|NCT02509052|464938759|FG001|Overall Study|Non compliance|0|||
129175871|NCT02509052|464938760|FG002|Overall Study|Non compliance|1|||
129175872|NCT01824823|464938761|FG000|Overall Study|Lack of Efficacy|1|||
129175873|NCT01824823|464938762|FG001|Overall Study|Lack of Efficacy|1|||
129175874|NCT01824823|464938761|FG000|Overall Study|Off-treatment reason not submitted|1|||
129175875|NCT01824823|464938762|FG001|Overall Study|Off-treatment reason not submitted|0|||
129175876|NCT03362931|464938765|FG000|Overall Study|Adverse Event|1|||
129175877|NCT03362931|464938765|FG000|Overall Study|Death|2|||
129175878|NCT01323270|464938766|FG000|Overall Study|Withdrawal by Subject|19|||
129175879|NCT01323270|464938767|FG001|Overall Study|Withdrawal by Subject|10|||
129175880|NCT01323270|464938766|FG000|Overall Study|Protocol Violation|9|||
129175881|NCT01323270|464938767|FG001|Overall Study|Protocol Violation|7|||
129175882|NCT01323270|464938766|FG000|Overall Study|Lost to Follow-up|4|||
129175883|NCT01323270|464938767|FG001|Overall Study|Lost to Follow-up|6|||
129175884|NCT01323270|464938766|FG000|Overall Study|Adverse Event|8|||
129175885|NCT01323270|464938767|FG001|Overall Study|Adverse Event|0|||
129175886|NCT01323270|464938766|FG000|Overall Study|Other|0|||
129175887|NCT01323270|464938767|FG001|Overall Study|Other|3|||
129175888|NCT01323270|464938766|FG000|Overall Study|Physician Decision|0|||
129175889|NCT01323270|464938767|FG001|Overall Study|Physician Decision|2|||
129175890|NCT01323270|464938766|FG000|Overall Study|Not eligible|1|||
129175891|NCT01323270|464938767|FG001|Overall Study|Not eligible|1|||
129175892|NCT01323270|464938766|FG000|Overall Study|Death|1|||
129175893|NCT01323270|464938767|FG001|Overall Study|Death|0|||
129175894|NCT01323270|464938766|FG000|Overall Study|Randomized, but not vaccinated|1|||
129175895|NCT01323270|464938767|FG001|Overall Study|Randomized, but not vaccinated|0|||
129175896|NCT03761394|464938771|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
129175897|NCT03761394|464938772|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
129175898|NCT03761394|464938773|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
129175899|NCT03761394|464938774|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
129175900|NCT03761394|464938771|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
129175901|NCT03761394|464938772|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
129175902|NCT03761394|464938773|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
129175903|NCT03761394|464938774|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
129175904|NCT03761394|464938771|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
129175905|NCT03761394|464938772|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
129175906|NCT03761394|464938773|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
129175907|NCT03761394|464938774|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
129175908|NCT03761394|464938771|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
129175909|NCT03761394|464938772|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
129175910|NCT03761394|464938773|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
129175911|NCT03761394|464938774|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
129175912|NCT01080768|464938783|FG000|Overall Study|Protocol Deviation|2|||
129175913|NCT01080768|464938784|FG001|Overall Study|Protocol Deviation|1|||
129175914|NCT01643850|464938789|FG000|Overall Study|Withdrawal by Subject|0|||
129175915|NCT01643850|464938790|FG001|Overall Study|Withdrawal by Subject|0|||
129175916|NCT01643850|464938791|FG002|Overall Study|Withdrawal by Subject|0|||
129175917|NCT01643850|464938792|FG003|Overall Study|Withdrawal by Subject|0|||
129175918|NCT01643850|464938793|FG004|Overall Study|Withdrawal by Subject|1|||
129175919|NCT01643850|464938794|FG005|Overall Study|Withdrawal by Subject|0|||
129175920|NCT01643850|464938795|FG006|Overall Study|Withdrawal by Subject|0|||
129175921|NCT01643850|464938796|FG007|Overall Study|Withdrawal by Subject|0|||
129175922|NCT01643850|464938797|FG008|Overall Study|Withdrawal by Subject|0|||
129175923|NCT01643850|464938789|FG000|Overall Study|Lost to Follow-up|0|||
129175924|NCT01643850|464938790|FG001|Overall Study|Lost to Follow-up|0|||
129175925|NCT01643850|464938791|FG002|Overall Study|Lost to Follow-up|0|||
129175926|NCT01643850|464938792|FG003|Overall Study|Lost to Follow-up|0|||
129175927|NCT01643850|464938793|FG004|Overall Study|Lost to Follow-up|0|||
129175928|NCT01643850|464938794|FG005|Overall Study|Lost to Follow-up|0|||
129175929|NCT01643850|464938795|FG006|Overall Study|Lost to Follow-up|1|||
129175930|NCT01643850|464938796|FG007|Overall Study|Lost to Follow-up|0|||
129175931|NCT01643850|464938797|FG008|Overall Study|Lost to Follow-up|1|||
129175932|NCT01643850|464938789|FG000|Overall Study|Adverse Event|0|||
129175933|NCT01643850|464938790|FG001|Overall Study|Adverse Event|0|||
129175934|NCT01643850|464938791|FG002|Overall Study|Adverse Event|0|||
129175935|NCT01643850|464938792|FG003|Overall Study|Adverse Event|0|||
129175936|NCT01643850|464938793|FG004|Overall Study|Adverse Event|1|||
129175937|NCT01643850|464938794|FG005|Overall Study|Adverse Event|0|||
129175938|NCT01643850|464938795|FG006|Overall Study|Adverse Event|0|||
129175939|NCT01643850|464938796|FG007|Overall Study|Adverse Event|0|||
129175940|NCT01643850|464938797|FG008|Overall Study|Adverse Event|0|||
129175941|NCT01643850|464938789|FG000|Overall Study|Administrative Problems|0|||
129175942|NCT01643850|464938790|FG001|Overall Study|Administrative Problems|0|||
129175943|NCT01643850|464938791|FG002|Overall Study|Administrative Problems|1|||
129175944|NCT01643850|464938792|FG003|Overall Study|Administrative Problems|0|||
129175945|NCT01643850|464938793|FG004|Overall Study|Administrative Problems|1|||
129175946|NCT01643850|464938794|FG005|Overall Study|Administrative Problems|0|||
129175947|NCT01643850|464938795|FG006|Overall Study|Administrative Problems|0|||
129175948|NCT01643850|464938796|FG007|Overall Study|Administrative Problems|0|||
129175949|NCT01643850|464938797|FG008|Overall Study|Administrative Problems|0|||
129175950|NCT00931723|464938801|FG000|Overall Study|Withdrawal by Subject|11|||
129175951|NCT00931723|464938802|FG001|Overall Study|Withdrawal by Subject|13|||
129175952|NCT00931723|464938801|FG000|Overall Study|Adverse Event|6|||
129175953|NCT00931723|464938802|FG001|Overall Study|Adverse Event|13|||
129175954|NCT00931723|464938801|FG000|Overall Study|Lithium found in blood|0|||
129175955|NCT00931723|464938802|FG001|Overall Study|Lithium found in blood|1|||
129175956|NCT00931723|464938801|FG000|Overall Study|Condition under investigation worsened|1|||
129175957|NCT00931723|464938802|FG001|Overall Study|Condition under investigation worsened|2|||
129175958|NCT00931723|464938801|FG000|Overall Study|Lost to Follow-up|1|||
129175959|NCT00931723|464938802|FG001|Overall Study|Lost to Follow-up|2|||
129175960|NCT00931723|464938801|FG000|Overall Study|Study-specific discontinuation criteria|1|||
129175961|NCT00931723|464938802|FG001|Overall Study|Study-specific discontinuation criteria|1|||
129175962|NCT00931723|464938801|FG000|Overall Study|Severe non-compliance to protocol|2|||
129175963|NCT00931723|464938802|FG001|Overall Study|Severe non-compliance to protocol|0|||
129175964|NCT00931723|464938801|FG000|Overall Study|Safety reasons|0|||
129175965|NCT00931723|464938802|FG001|Overall Study|Safety reasons|1|||
129175966|NCT00931723|464938801|FG000|Overall Study|Took prohibited concomitant medication|0|||
129175967|NCT00931723|464938802|FG001|Overall Study|Took prohibited concomitant medication|1|||
129175968|NCT00931723|464938801|FG000|Overall Study|Lack or insufficient theraputic response|2|||
129175969|NCT00931723|464938802|FG001|Overall Study|Lack or insufficient theraputic response|5|||
128730181|NCT05059600|463308346|FG000|Overall Study|Enrolled but not Treated|10|||
129175970|NCT00931723|464938801|FG000|Overall Study|Sponsor decision|1|||
129175971|NCT00931723|464938802|FG001|Overall Study|Sponsor decision|0|||
129175972|NCT00931723|464938801|FG000|Overall Study|Late hospital discharge|1|||
129175973|NCT00931723|464938802|FG001|Overall Study|Late hospital discharge|0|||
129175974|NCT03054350|464938803|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
129175975|NCT03054350|464938804|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
129175976|NCT03054350|464938805|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
129175977|NCT03054350|464938806|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
129175978|NCT03054350|464938807|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
129175979|NCT03054350|464938808|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
129175980|NCT03054350|464938803|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129175981|NCT03054350|464938804|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129175982|NCT03054350|464938805|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
129175983|NCT03054350|464938806|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129175984|NCT03054350|464938807|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129175985|NCT03054350|464938808|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129175986|NCT03054350|464938803|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
129175987|NCT03054350|464938804|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129175988|NCT03054350|464938805|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129175989|NCT03054350|464938806|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
129175990|NCT03054350|464938807|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129175991|NCT03054350|464938808|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129175992|NCT03054350|464938803|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129175993|NCT03054350|464938804|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129175994|NCT03054350|464938805|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
129175995|NCT03054350|464938806|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129175996|NCT03054350|464938807|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129175997|NCT03054350|464938808|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129175998|NCT01133405|464938809|FG000|Period 1|Withdrawal by Subject|0|||
129175999|NCT01133405|464938810|FG001|Period 1|Withdrawal by Subject|1|||
129176000|NCT01133405|464938811|FG002|Period 1|Withdrawal by Subject|0|||
129176001|NCT01133405|464938812|FG003|Period 1|Withdrawal by Subject|1|||
129176002|NCT01133405|464938813|FG004|Period 1|Withdrawal by Subject|0|||
129176003|NCT01133405|464938814|FG005|Period 1|Withdrawal by Subject|1|||
129176004|NCT01133405|464938815|FG006|Period 1|Withdrawal by Subject|0|||
129176005|NCT01133405|464938816|FG007|Period 1|Withdrawal by Subject|0|||
129176006|NCT01133405|464938817|FG008|Period 1|Withdrawal by Subject|0|||
129176007|NCT01133405|464938818|FG009|Period 1|Withdrawal by Subject|0|||
129176008|NCT01133405|464938809|FG000|Period 1|Physician Decision|0|||
129176009|NCT01133405|464938810|FG001|Period 1|Physician Decision|0|||
129176010|NCT01133405|464938811|FG002|Period 1|Physician Decision|0|||
129176011|NCT01133405|464938812|FG003|Period 1|Physician Decision|1|||
129176012|NCT01133405|464938813|FG004|Period 1|Physician Decision|0|||
129176013|NCT01133405|464938814|FG005|Period 1|Physician Decision|0|||
129176014|NCT01133405|464938815|FG006|Period 1|Physician Decision|0|||
129176015|NCT01133405|464938816|FG007|Period 1|Physician Decision|0|||
129176016|NCT01133405|464938817|FG008|Period 1|Physician Decision|0|||
129176017|NCT01133405|464938818|FG009|Period 1|Physician Decision|0|||
129176018|NCT01133405|464938809|FG000|Period 1|Discontinued after randomization|1|||
129176019|NCT01133405|464938810|FG001|Period 1|Discontinued after randomization|0|||
129176020|NCT01133405|464938811|FG002|Period 1|Discontinued after randomization|0|||
129176021|NCT01133405|464938812|FG003|Period 1|Discontinued after randomization|0|||
129176022|NCT01133405|464938813|FG004|Period 1|Discontinued after randomization|0|||
129176023|NCT01133405|464938814|FG005|Period 1|Discontinued after randomization|0|||
129176024|NCT01133405|464938815|FG006|Period 1|Discontinued after randomization|1|||
129176025|NCT01133405|464938816|FG007|Period 1|Discontinued after randomization|0|||
129176026|NCT01133405|464938817|FG008|Period 1|Discontinued after randomization|0|||
129176027|NCT01133405|464938818|FG009|Period 1|Discontinued after randomization|0|||
129176028|NCT01133405|464938809|FG000|Period 1|Received drug only in period 2|0|||
129176029|NCT01133405|464938810|FG001|Period 1|Received drug only in period 2|1|||
129176030|NCT01133405|464938811|FG002|Period 1|Received drug only in period 2|0|||
129176031|NCT01133405|464938812|FG003|Period 1|Received drug only in period 2|2|||
129176032|NCT01133405|464938813|FG004|Period 1|Received drug only in period 2|0|||
129176033|NCT01133405|464938814|FG005|Period 1|Received drug only in period 2|1|||
129176034|NCT01133405|464938815|FG006|Period 1|Received drug only in period 2|0|||
129176035|NCT01133405|464938816|FG007|Period 1|Received drug only in period 2|0|||
129176036|NCT01133405|464938817|FG008|Period 1|Received drug only in period 2|0|||
129176037|NCT01133405|464938818|FG009|Period 1|Received drug only in period 2|0|||
129176038|NCT01133405|464938809|FG000|Period 1|Received drug only in period 3|0|||
129176039|NCT01133405|464938810|FG001|Period 1|Received drug only in period 3|1|||
129176040|NCT01133405|464938811|FG002|Period 1|Received drug only in period 3|1|||
129176041|NCT01133405|464938812|FG003|Period 1|Received drug only in period 3|0|||
129176042|NCT01133405|464938813|FG004|Period 1|Received drug only in period 3|0|||
129176043|NCT01133405|464938814|FG005|Period 1|Received drug only in period 3|0|||
129176044|NCT01133405|464938815|FG006|Period 1|Received drug only in period 3|0|||
129176045|NCT01133405|464938816|FG007|Period 1|Received drug only in period 3|0|||
129176046|NCT01133405|464938817|FG008|Period 1|Received drug only in period 3|0|||
129176047|NCT01133405|464938818|FG009|Period 1|Received drug only in period 3|0|||
129176048|NCT01133405|464938809|FG000|Period 2|Adverse Event|0|||
129176049|NCT01133405|464938810|FG001|Period 2|Adverse Event|0|||
128730182|NCT04538664|463308347|FG000|Overall Study|Withdrawal by Subject|5|||
128730183|NCT04538664|463308348|FG001|Overall Study|Withdrawal by Subject|9|||
128730184|NCT04538664|463308347|FG000|Overall Study|Lost to Follow-up|2|||
129176050|NCT01133405|464938811|FG002|Period 2|Adverse Event|1|||
129176051|NCT01133405|464938812|FG003|Period 2|Adverse Event|0|||
129176052|NCT01133405|464938813|FG004|Period 2|Adverse Event|0|||
129176053|NCT01133405|464938814|FG005|Period 2|Adverse Event|0|||
129176054|NCT01133405|464938815|FG006|Period 2|Adverse Event|0|||
129176055|NCT01133405|464938816|FG007|Period 2|Adverse Event|0|||
129176056|NCT01133405|464938817|FG008|Period 2|Adverse Event|0|||
129176057|NCT01133405|464938818|FG009|Period 2|Adverse Event|0|||
129176058|NCT01133405|464938809|FG000|Period 2|Withdrawal by Subject|0|||
129176059|NCT01133405|464938810|FG001|Period 2|Withdrawal by Subject|0|||
129176060|NCT01133405|464938811|FG002|Period 2|Withdrawal by Subject|0|||
129176061|NCT01133405|464938812|FG003|Period 2|Withdrawal by Subject|1|||
129176062|NCT01133405|464938813|FG004|Period 2|Withdrawal by Subject|0|||
129176063|NCT01133405|464938814|FG005|Period 2|Withdrawal by Subject|1|||
129176064|NCT01133405|464938815|FG006|Period 2|Withdrawal by Subject|0|||
129176065|NCT01133405|464938816|FG007|Period 2|Withdrawal by Subject|0|||
129176066|NCT01133405|464938817|FG008|Period 2|Withdrawal by Subject|0|||
129176067|NCT01133405|464938818|FG009|Period 2|Withdrawal by Subject|0|||
129176068|NCT01133405|464938809|FG000|Period 2|Entry Criteria Not Met|0|||
129176069|NCT01133405|464938810|FG001|Period 2|Entry Criteria Not Met|1|||
129176070|NCT01133405|464938811|FG002|Period 2|Entry Criteria Not Met|0|||
129176071|NCT01133405|464938812|FG003|Period 2|Entry Criteria Not Met|0|||
129176072|NCT01133405|464938813|FG004|Period 2|Entry Criteria Not Met|0|||
129176073|NCT01133405|464938814|FG005|Period 2|Entry Criteria Not Met|0|||
129176074|NCT01133405|464938815|FG006|Period 2|Entry Criteria Not Met|0|||
129176075|NCT01133405|464938816|FG007|Period 2|Entry Criteria Not Met|0|||
129176076|NCT01133405|464938817|FG008|Period 2|Entry Criteria Not Met|0|||
129176077|NCT01133405|464938818|FG009|Period 2|Entry Criteria Not Met|0|||
129176078|NCT01133405|464938809|FG000|Period 2|Physician Decision|0|||
129176079|NCT01133405|464938810|FG001|Period 2|Physician Decision|0|||
129176080|NCT01133405|464938811|FG002|Period 2|Physician Decision|0|||
129176081|NCT01133405|464938812|FG003|Period 2|Physician Decision|0|||
129176082|NCT01133405|464938813|FG004|Period 2|Physician Decision|0|||
129176083|NCT01133405|464938814|FG005|Period 2|Physician Decision|1|||
129176084|NCT01133405|464938815|FG006|Period 2|Physician Decision|0|||
129176085|NCT01133405|464938816|FG007|Period 2|Physician Decision|0|||
129176086|NCT01133405|464938817|FG008|Period 2|Physician Decision|0|||
129176087|NCT01133405|464938818|FG009|Period 2|Physician Decision|0|||
129176088|NCT03242772|464938819|FG000|Overall Study|Lost to Follow-up|2|||
129176089|NCT03242772|464938820|FG001|Overall Study|Lost to Follow-up|0|||
129176090|NCT03242772|464938819|FG000|Overall Study|Physician Decision|0|||
129176091|NCT03242772|464938820|FG001|Overall Study|Physician Decision|1|||
129176092|NCT03242772|464938819|FG000|Overall Study|Withdrawal by Subject|1|||
129176093|NCT03242772|464938820|FG001|Overall Study|Withdrawal by Subject|0|||
129176094|NCT00089986|464938821|FG000|Overall Study|Adverse Event|6|||
129176095|NCT00089986|464938822|FG001|Overall Study|Adverse Event|9|||
129176096|NCT00089986|464938823|FG002|Overall Study|Adverse Event|6|||
129176097|NCT00089986|464938821|FG000|Overall Study|Lost to Follow-up|3|||
129176098|NCT00089986|464938822|FG001|Overall Study|Lost to Follow-up|1|||
129176099|NCT00089986|464938823|FG002|Overall Study|Lost to Follow-up|1|||
129176100|NCT00089986|464938821|FG000|Overall Study|Protocol Violation|0|||
129176101|NCT00089986|464938822|FG001|Overall Study|Protocol Violation|1|||
129176102|NCT00089986|464938823|FG002|Overall Study|Protocol Violation|0|||
129176103|NCT00089986|464938821|FG000|Overall Study|Patient transferred to another hospital|2|||
129176104|NCT00089986|464938822|FG001|Overall Study|Patient transferred to another hospital|1|||
129176105|NCT00089986|464938823|FG002|Overall Study|Patient transferred to another hospital|0|||
129176106|NCT00089986|464938821|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
129176107|NCT00089986|464938822|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
129176108|NCT00089986|464938823|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
129176109|NCT00089986|464938821|FG000|Overall Study|Hemohlobin stopping rule|0|||
129176110|NCT00089986|464938822|FG001|Overall Study|Hemohlobin stopping rule|1|||
129176111|NCT00089986|464938823|FG002|Overall Study|Hemohlobin stopping rule|0|||
129176112|NCT00089986|464938821|FG000|Overall Study|Investigator decision to withdrew|0|||
129176113|NCT00089986|464938822|FG001|Overall Study|Investigator decision to withdrew|1|||
129176114|NCT00089986|464938823|FG002|Overall Study|Investigator decision to withdrew|0|||
129176115|NCT00089986|464938821|FG000|Overall Study|Enrollment in another study|0|||
129176116|NCT00089986|464938822|FG001|Overall Study|Enrollment in another study|1|||
129176117|NCT00089986|464938823|FG002|Overall Study|Enrollment in another study|0|||
129176118|NCT00089986|464938821|FG000|Overall Study|Family decision|0|||
129176119|NCT00089986|464938822|FG001|Overall Study|Family decision|1|||
129176120|NCT00089986|464938823|FG002|Overall Study|Family decision|0|||
129176121|NCT00089986|464938821|FG000|Overall Study|Do not resuscitate (DNR)|0|||
129176122|NCT00089986|464938822|FG001|Overall Study|Do not resuscitate (DNR)|0|||
129176123|NCT00089986|464938823|FG002|Overall Study|Do not resuscitate (DNR)|1|||
129176124|NCT00089986|464938821|FG000|Overall Study|Withdrawal by Subject|3|||
129176125|NCT00089986|464938822|FG001|Overall Study|Withdrawal by Subject|6|||
129176126|NCT00089986|464938823|FG002|Overall Study|Withdrawal by Subject|2|||
129176127|NCT02334683|464938830|FG000|First 12 Week Period|Lost to Follow-up|1|||
129176128|NCT02334683|464938831|FG001|First 12 Week Period|Lost to Follow-up|0|||
129176129|NCT02334683|464938830|FG000|Second 12 Week Period|Adverse Event|0|||
129176130|NCT02334683|464938831|FG001|Second 12 Week Period|Adverse Event|1|||
129176131|NCT01062841|464938832|FG000|Overall Study|Indwelling Device Removed|41|||
129176132|NCT01062841|464938833|FG001|Overall Study|Indwelling Device Removed|48|||
129176133|NCT01062841|464938832|FG000|Overall Study|Death|3|||
129176134|NCT01062841|464938833|FG001|Overall Study|Death|5|||
129176135|NCT01062841|464938832|FG000|Overall Study|Withdrawal by Subject|2|||
129176136|NCT01062841|464938833|FG001|Overall Study|Withdrawal by Subject|0|||
129176137|NCT01062841|464938832|FG000|Overall Study|Withdrawal by Study|3|||
129176138|NCT01062841|464938833|FG001|Overall Study|Withdrawal by Study|0|||
129176139|NCT01218100|464938834|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
129176140|NCT01218100|464938835|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
129176141|NCT01218100|464938836|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
129176142|NCT01218100|464938837|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
129176143|NCT01218100|464938834|FG000|Overall Study|Adverse Event|4|||
129176144|NCT01218100|464938835|FG001|Overall Study|Adverse Event|6|||
129176145|NCT01218100|464938836|FG002|Overall Study|Adverse Event|6|||
129176146|NCT01218100|464938837|FG003|Overall Study|Adverse Event|7|||
129176147|NCT01218100|464938834|FG000|Overall Study|Lack of Efficacy|9|||
129176148|NCT01218100|464938835|FG001|Overall Study|Lack of Efficacy|6|||
129176149|NCT01218100|464938836|FG002|Overall Study|Lack of Efficacy|5|||
129176150|NCT01218100|464938837|FG003|Overall Study|Lack of Efficacy|12|||
129176151|NCT01218100|464938834|FG000|Overall Study|Protocol Violation|0|||
129176152|NCT01218100|464938835|FG001|Overall Study|Protocol Violation|0|||
129176153|NCT01218100|464938836|FG002|Overall Study|Protocol Violation|1|||
129176154|NCT01218100|464938837|FG003|Overall Study|Protocol Violation|1|||
129176155|NCT01218100|464938834|FG000|Overall Study|Withdrawal by Subject|5|||
129176156|NCT01218100|464938835|FG001|Overall Study|Withdrawal by Subject|2|||
129176157|NCT01218100|464938836|FG002|Overall Study|Withdrawal by Subject|6|||
129176158|NCT01218100|464938837|FG003|Overall Study|Withdrawal by Subject|7|||
129176159|NCT01218100|464938834|FG000|Overall Study|Lost to Follow-up|3|||
129176160|NCT01218100|464938835|FG001|Overall Study|Lost to Follow-up|8|||
129176161|NCT01218100|464938836|FG002|Overall Study|Lost to Follow-up|2|||
129176162|NCT01218100|464938837|FG003|Overall Study|Lost to Follow-up|1|||
129176163|NCT01218100|464938834|FG000|Overall Study|Other Reason|2|||
129176164|NCT01218100|464938835|FG001|Overall Study|Other Reason|2|||
129176165|NCT01218100|464938836|FG002|Overall Study|Other Reason|6|||
129176166|NCT01218100|464938837|FG003|Overall Study|Other Reason|4|||
129176167|NCT02434354|464938844|FG000|Overall Study|screen fail|3|||
129176168|NCT01185964|464938846|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
129176169|NCT01185964|464938847|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
129176170|NCT01185964|464938848|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
129176171|NCT01185964|464938849|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
129176172|NCT01185964|464938846|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
129176173|NCT01185964|464938847|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
129176174|NCT01185964|464938848|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
129176175|NCT01185964|464938849|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
129176176|NCT01185964|464938846|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
129176177|NCT01185964|464938847|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
129176178|NCT01185964|464938848|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
129176179|NCT01185964|464938849|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
129176180|NCT01185964|464938846|FG000|Phase 1b and Phase 2|Adverse Event|1|||
129176181|NCT01185964|464938847|FG001|Phase 1b and Phase 2|Adverse Event|0|||
129176182|NCT01185964|464938848|FG002|Phase 1b and Phase 2|Adverse Event|2|||
129176183|NCT01185964|464938849|FG003|Phase 1b and Phase 2|Adverse Event|0|||
129176184|NCT01185964|464938846|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
129176185|NCT01185964|464938847|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
129176186|NCT01185964|464938848|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
129176187|NCT01185964|464938849|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
129176188|NCT01185964|464938846|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
129176189|NCT01185964|464938847|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
129176190|NCT01185964|464938848|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
129176191|NCT01185964|464938849|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
129176192|NCT01185964|464938846|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
129176193|NCT01185964|464938847|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
129176194|NCT01185964|464938848|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
129176195|NCT01185964|464938849|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
129176196|NCT01185964|464938846|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
129176197|NCT01185964|464938847|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
129176198|NCT01185964|464938848|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
129176199|NCT01185964|464938849|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
129176200|NCT01920893|464938850|FG000|Overall Study|Adverse Event|5|||
129176201|NCT01920893|464938851|FG001|Overall Study|Adverse Event|2|||
129176202|NCT01920893|464938850|FG000|Overall Study|Lack of Efficacy|2|||
129176203|NCT01920893|464938851|FG001|Overall Study|Lack of Efficacy|0|||
129176204|NCT02446418|464938854|FG000|Overall Study|Adverse Event|4|||
129176205|NCT02446418|464938855|FG001|Overall Study|Adverse Event|8|||
129176206|NCT02446418|464938854|FG000|Overall Study|Physician Decision|5|||
129176207|NCT02446418|464938855|FG001|Overall Study|Physician Decision|1|||
129176208|NCT02446418|464938854|FG000|Overall Study|Withdrawal by Subject|3|||
129176209|NCT02446418|464938855|FG001|Overall Study|Withdrawal by Subject|3|||
129176210|NCT02446418|464938854|FG000|Overall Study|Lost to Follow-up|2|||
129176211|NCT02446418|464938855|FG001|Overall Study|Lost to Follow-up|2|||
129176212|NCT02446418|464938854|FG000|Overall Study|Protocol Violation|1|||
129176213|NCT02446418|464938855|FG001|Overall Study|Protocol Violation|2|||
129176214|NCT02446418|464938854|FG000|Overall Study|Lack of Efficacy|2|||
129176215|NCT02446418|464938855|FG001|Overall Study|Lack of Efficacy|0|||
129176216|NCT02446418|464938854|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
129176217|NCT02446418|464938855|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
129176218|NCT04508751|464938856|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
129176219|NCT04508751|464938857|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
129176220|NCT04508751|464938858|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
129176221|NCT02014480|464938861|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129176222|NCT02014480|464938862|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129176223|NCT02014480|464938863|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
129176224|NCT02014480|464938864|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129176225|NCT02014480|464938865|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129176226|NCT02014480|464938866|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129176227|NCT02014480|464938861|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129176228|NCT02014480|464938862|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129176229|NCT02014480|464938863|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129176230|NCT02014480|464938864|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
129176231|NCT02014480|464938865|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129176232|NCT02014480|464938866|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129176233|NCT02014480|464938861|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129176234|NCT02014480|464938862|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129176235|NCT02014480|464938863|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
129176236|NCT02014480|464938864|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129176237|NCT02014480|464938865|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129176238|NCT02014480|464938866|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129176239|NCT02014480|464938861|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129176240|NCT02014480|464938862|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129176241|NCT02014480|464938863|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
129176242|NCT02014480|464938864|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129176243|NCT02014480|464938865|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129176244|NCT02014480|464938866|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129176245|NCT02014480|464938861|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129176246|NCT02014480|464938862|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
129176247|NCT02014480|464938863|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129176248|NCT02014480|464938864|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129176249|NCT02014480|464938865|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129176250|NCT02014480|464938866|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129176251|NCT02014480|464938861|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
129176252|NCT02014480|464938862|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
129176253|NCT02014480|464938863|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
129176254|NCT02014480|464938864|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
129176255|NCT02014480|464938865|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
129176256|NCT02014480|464938866|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
129176257|NCT02014480|464938861|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129176258|NCT02014480|464938862|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129176259|NCT02014480|464938863|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129176260|NCT02014480|464938864|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129176261|NCT02014480|464938865|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129176262|NCT02014480|464938866|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
129176263|NCT01865812|464938867|FG000|Primary Treatment Phase|Adverse Event|2|||
129176264|NCT01865812|464938868|FG001|Primary Treatment Phase|Adverse Event|0|||
129176265|NCT01865812|464938867|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
129176266|NCT01865812|464938868|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
129176267|NCT01865812|464938867|FG000|Long-term Safety Extension Phase|Pruritus|0|||
129176268|NCT01865812|464938868|FG001|Long-term Safety Extension Phase|Pruritus|3|||
129176269|NCT01865812|464938867|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
129176270|NCT01865812|464938868|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
129176271|NCT01865812|464938867|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
129176272|NCT01865812|464938868|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
129176273|NCT01338610|464938869|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
129176274|NCT01338610|464938870|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
129176275|NCT01338610|464938871|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
129176276|NCT01338610|464938869|FG000|Overall Study|Protocol Violation|1|||
129176277|NCT01338610|464938870|FG001|Overall Study|Protocol Violation|0|||
129176278|NCT01338610|464938871|FG002|Overall Study|Protocol Violation|1|||
129176279|NCT01338610|464938869|FG000|Overall Study|Adverse Event|3|||
129176280|NCT01338610|464938870|FG001|Overall Study|Adverse Event|0|||
129176281|NCT01338610|464938871|FG002|Overall Study|Adverse Event|0|||
129176282|NCT01414205|464938872|FG000|Overall Study|Death|5|||
129176283|NCT01414205|464938873|FG001|Overall Study|Death|1|||
129176284|NCT01414205|464938872|FG000|Overall Study|Lost to Follow-up|1|||
129176285|NCT01414205|464938873|FG001|Overall Study|Lost to Follow-up|4|||
129176286|NCT01414205|464938872|FG000|Overall Study|Physician Decision|0|||
129176287|NCT01414205|464938873|FG001|Overall Study|Physician Decision|1|||
129176288|NCT01414205|464938872|FG000|Overall Study|Randomized but not Treated|1|||
129176289|NCT01414205|464938873|FG001|Overall Study|Randomized but not Treated|1|||
129176290|NCT02046226|464938876|FG000|Overall Study|Lost to Follow-up|7|||
129176291|NCT02305849|464938883|FG000|Overall Study|Adverse Event|10|||
129176292|NCT02305849|464938884|FG001|Overall Study|Adverse Event|12|||
129176293|NCT02305849|464938885|FG002|Overall Study|Adverse Event|7|||
129176294|NCT02305849|464938886|FG003|Overall Study|Adverse Event|3|||
129176295|NCT02305849|464938883|FG000|Overall Study|Lack of Efficacy|10|||
129176296|NCT02305849|464938884|FG001|Overall Study|Lack of Efficacy|6|||
129176297|NCT02305849|464938885|FG002|Overall Study|Lack of Efficacy|3|||
129176298|NCT02305849|464938886|FG003|Overall Study|Lack of Efficacy|9|||
129176299|NCT02305849|464938883|FG000|Overall Study|Withdrawal by Subject|2|||
129176300|NCT02305849|464938884|FG001|Overall Study|Withdrawal by Subject|2|||
129176301|NCT02305849|464938885|FG002|Overall Study|Withdrawal by Subject|1|||
129176302|NCT02305849|464938886|FG003|Overall Study|Withdrawal by Subject|4|||
129176303|NCT02305849|464938883|FG000|Overall Study|Lost to Follow-up|0|||
129176304|NCT02305849|464938884|FG001|Overall Study|Lost to Follow-up|2|||
129176305|NCT02305849|464938885|FG002|Overall Study|Lost to Follow-up|0|||
129176306|NCT02305849|464938886|FG003|Overall Study|Lost to Follow-up|0|||
129176307|NCT02305849|464938883|FG000|Overall Study|Protocol Violation|3|||
129176308|NCT02305849|464938884|FG001|Overall Study|Protocol Violation|2|||
129176309|NCT02305849|464938885|FG002|Overall Study|Protocol Violation|1|||
129176310|NCT02305849|464938886|FG003|Overall Study|Protocol Violation|1|||
129176311|NCT02305849|464938883|FG000|Overall Study|Lab data met discontinuation criteria|0|||
129176312|NCT02305849|464938884|FG001|Overall Study|Lab data met discontinuation criteria|1|||
129176313|NCT02305849|464938885|FG002|Overall Study|Lab data met discontinuation criteria|2|||
129176314|NCT02305849|464938886|FG003|Overall Study|Lab data met discontinuation criteria|1|||
129176315|NCT02305849|464938883|FG000|Overall Study|Miscellaneous|1|||
129176316|NCT02305849|464938884|FG001|Overall Study|Miscellaneous|2|||
129176317|NCT02305849|464938885|FG002|Overall Study|Miscellaneous|4|||
129176318|NCT02305849|464938886|FG003|Overall Study|Miscellaneous|1|||
129176319|NCT02305849|464938883|FG000|Overall Study|Not fulfill eligibility criteria|1|||
129176320|NCT02305849|464938884|FG001|Overall Study|Not fulfill eligibility criteria|1|||
129176321|NCT02305849|464938885|FG002|Overall Study|Not fulfill eligibility criteria|0|||
129176322|NCT02305849|464938886|FG003|Overall Study|Not fulfill eligibility criteria|0|||
129176323|NCT00495521|464938892|FG000|Overall Study|Physician Decision|0|||
129176324|NCT00495521|464938893|FG001|Overall Study|Physician Decision|1|||
129176325|NCT01300819|464938894|FG000|Overall Study|Adverse Event|9|||
129176326|NCT01300819|464938895|FG001|Overall Study|Adverse Event|27|||
129176327|NCT01300819|464938894|FG000|Overall Study|Lack of Efficacy|2|||
129176328|NCT01300819|464938895|FG001|Overall Study|Lack of Efficacy|1|||
129176329|NCT01300819|464938894|FG000|Overall Study|Withdrawal by Subject|10|||
129176330|NCT01300819|464938895|FG001|Overall Study|Withdrawal by Subject|12|||
129176331|NCT01300819|464938894|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
129176332|NCT01300819|464938895|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
129176333|NCT01300819|464938894|FG000|Overall Study|Refusal to down titrate study drug|0|||
129176334|NCT01300819|464938895|FG001|Overall Study|Refusal to down titrate study drug|1|||
129176335|NCT01300819|464938894|FG000|Overall Study|Administrative reason|0|||
129176336|NCT01300819|464938895|FG001|Overall Study|Administrative reason|1|||
129176337|NCT01300819|464938894|FG000|Overall Study|Safety follow up not done by mistake|0|||
129176338|NCT01300819|464938895|FG001|Overall Study|Safety follow up not done by mistake|1|||
129176339|NCT01300819|464938894|FG000|Overall Study|Follow up call was not done|1|||
129176340|NCT01300819|464938895|FG001|Overall Study|Follow up call was not done|0|||
129176341|NCT01319721|464938896|FG000|Overall Study|Lost to Follow-up|1|||
129176342|NCT01319721|464938897|FG001|Overall Study|Lost to Follow-up|6|||
129176343|NCT00461305|464938899|FG000|Treatment|Adverse Event|26|||
129176344|NCT00461305|464938900|FG001|Treatment|Adverse Event|3|||
129176345|NCT00461305|464938899|FG000|Treatment|Lost to Follow-up|4|||
129176346|NCT00461305|464938900|FG001|Treatment|Lost to Follow-up|2|||
129176347|NCT00461305|464938899|FG000|Treatment|Protocol Violation|13|||
129176348|NCT00461305|464938900|FG001|Treatment|Protocol Violation|2|||
129176349|NCT00461305|464938899|FG000|Treatment|Withdrawal by Subject|48|||
129176350|NCT00461305|464938900|FG001|Treatment|Withdrawal by Subject|2|||
129176351|NCT00461305|464938899|FG000|Treatment|Never dispensed|5|||
129176352|NCT00461305|464938900|FG001|Treatment|Never dispensed|0|||
129176353|NCT00461305|464938899|FG000|Treatment|Study drug not taken|1|||
129176354|NCT00461305|464938900|FG001|Treatment|Study drug not taken|0|||
129176355|NCT00461305|464938899|FG000|Treatment|Partially missing diary|2|||
129176356|NCT00461305|464938900|FG001|Treatment|Partially missing diary|0|||
129176357|NCT00461305|464938899|FG000|Treatment|Other (missing drug etc)|2|||
129176358|NCT00461305|464938900|FG001|Treatment|Other (missing drug etc)|0|||
129176359|NCT00461305|464938899|FG000|Continued Treatment|Adverse Event|26|||
129176360|NCT00461305|464938900|FG001|Continued Treatment|Adverse Event|0|||
129176361|NCT00461305|464938899|FG000|Continued Treatment|Lost to Follow-up|4|||
129176362|NCT00461305|464938900|FG001|Continued Treatment|Lost to Follow-up|0|||
129176363|NCT00461305|464938899|FG000|Continued Treatment|Protocol Violation|13|||
129176364|NCT00461305|464938900|FG001|Continued Treatment|Protocol Violation|0|||
129176365|NCT00461305|464938899|FG000|Continued Treatment|Withdrawal by Subject|48|||
129176366|NCT00461305|464938900|FG001|Continued Treatment|Withdrawal by Subject|0|||
129176367|NCT00461305|464938899|FG000|Continued Treatment|Partially missing diary|2|||
129176368|NCT00461305|464938900|FG001|Continued Treatment|Partially missing diary|0|||
129176369|NCT00461305|464938899|FG000|Continued Treatment|Other (missing drug etc)|2|||
129176370|NCT00461305|464938900|FG001|Continued Treatment|Other (missing drug etc)|0|||
129176371|NCT00787930|464938905|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
129176372|NCT01896271|464938906|FG000|Overall Study|Physician Decision|10|||
129176373|NCT04030247|464941123|FG000|Overall Study|Withdrawal by Subject|4|||
129176374|NCT04030247|464941123|FG000|Overall Study|Lost to Follow-up|13|||
129176375|NCT00509093|464941124|FG000|Overall Study|Adverse Event|10|||
129176376|NCT00509093|464941124|FG000|Overall Study|Disease Progression|9|||
129176377|NCT00509093|464941124|FG000|Overall Study|Transformed into MDS|1|||
129176378|NCT00509093|464941124|FG000|Overall Study|Withdrawal by Subject|3|||
129176379|NCT00509093|464941124|FG000|Overall Study|Physician Decision|1|||
129176380|NCT03187834|464941125|FG000|Overall Study|Lost to Follow-up|0|||
129176381|NCT03187834|464941126|FG001|Overall Study|Lost to Follow-up|1|||
129176382|NCT03187834|464941127|FG002|Overall Study|Lost to Follow-up|2|||
129176383|NCT03187834|464941128|FG003|Overall Study|Lost to Follow-up|2|||
129176384|NCT03187834|464941125|FG000|Overall Study|Had invalid anthropometric measurements|5|||
129176385|NCT03187834|464941126|FG001|Overall Study|Had invalid anthropometric measurements|3|||
129176386|NCT03187834|464941127|FG002|Overall Study|Had invalid anthropometric measurements|4|||
129176387|NCT03187834|464941128|FG003|Overall Study|Had invalid anthropometric measurements|2|||
129176388|NCT00320255|464941129|FG000|Overall Study|Lack of Efficacy|1|||
129176389|NCT00320255|464941130|FG001|Overall Study|Lack of Efficacy|0|||
129176390|NCT00320255|464941131|FG002|Overall Study|Lack of Efficacy|0|||
129176391|NCT00320255|464941132|FG003|Overall Study|Lack of Efficacy|0|||
129176392|NCT00320255|464941133|FG004|Overall Study|Lack of Efficacy|0|||
129176393|NCT00320255|464941134|FG005|Overall Study|Lack of Efficacy|0|||
129176394|NCT00320255|464941129|FG000|Overall Study|Adverse Event|5|||
129176395|NCT00320255|464941130|FG001|Overall Study|Adverse Event|2|||
129176396|NCT00320255|464941131|FG002|Overall Study|Adverse Event|3|||
129176397|NCT00320255|464941132|FG003|Overall Study|Adverse Event|2|||
129176398|NCT00320255|464941133|FG004|Overall Study|Adverse Event|0|||
129176399|NCT00320255|464941134|FG005|Overall Study|Adverse Event|0|||
129176400|NCT00320255|464941129|FG000|Overall Study|Withdrawal by Subject|1|||
129176401|NCT00320255|464941130|FG001|Overall Study|Withdrawal by Subject|2|||
129176402|NCT00320255|464941131|FG002|Overall Study|Withdrawal by Subject|2|||
129176403|NCT00320255|464941132|FG003|Overall Study|Withdrawal by Subject|4|||
129176404|NCT00320255|464941133|FG004|Overall Study|Withdrawal by Subject|0|||
129176405|NCT00320255|464941134|FG005|Overall Study|Withdrawal by Subject|0|||
129176406|NCT00320255|464941129|FG000|Overall Study|Poor compliance/noncompliance|1|||
129176407|NCT00320255|464941130|FG001|Overall Study|Poor compliance/noncompliance|1|||
129176408|NCT00320255|464941131|FG002|Overall Study|Poor compliance/noncompliance|0|||
129176409|NCT00320255|464941132|FG003|Overall Study|Poor compliance/noncompliance|1|||
129176410|NCT00320255|464941133|FG004|Overall Study|Poor compliance/noncompliance|0|||
129176411|NCT00320255|464941134|FG005|Overall Study|Poor compliance/noncompliance|0|||
129176412|NCT00320255|464941129|FG000|Overall Study|No longer meets study criteria|0|||
129176413|NCT00320255|464941130|FG001|Overall Study|No longer meets study criteria|0|||
129176414|NCT00320255|464941131|FG002|Overall Study|No longer meets study criteria|0|||
129176415|NCT00320255|464941132|FG003|Overall Study|No longer meets study criteria|1|||
129176416|NCT00320255|464941133|FG004|Overall Study|No longer meets study criteria|0|||
129176417|NCT00320255|464941134|FG005|Overall Study|No longer meets study criteria|0|||
129176418|NCT00320255|464941129|FG000|Overall Study|Other|3|||
129176419|NCT00320255|464941130|FG001|Overall Study|Other|2|||
129176420|NCT00320255|464941131|FG002|Overall Study|Other|1|||
129176421|NCT00320255|464941132|FG003|Overall Study|Other|0|||
129176422|NCT00320255|464941133|FG004|Overall Study|Other|0|||
129176423|NCT00320255|464941134|FG005|Overall Study|Other|0|||
129176424|NCT04979897|464941135|FG000|Overall Study|Death|1|||
129176425|NCT04979897|464941136|FG001|Overall Study|Death|8|||
129176426|NCT04979897|464941135|FG000|Overall Study|Lost to Follow-up|111|||
129176427|NCT04979897|464941136|FG001|Overall Study|Lost to Follow-up|56|||
129176428|NCT04979897|464941135|FG000|Overall Study|Withdrawal by Subject|7|||
129176429|NCT04979897|464941136|FG001|Overall Study|Withdrawal by Subject|2|||
129176430|NCT03405935|464941137|FG000|Overall Study|Adverse Event|3|||
129176431|NCT03405935|464941137|FG000|Overall Study|Death|2|||
129176432|NCT03405935|464941137|FG000|Overall Study|Withdrawal by Subject|1|||
129176433|NCT03405935|464941137|FG000|Overall Study|Lost to Follow-up|2|||
129176434|NCT02781792|464941144|FG000|Overall Study|Adverse Event|1|||
129176435|NCT02781792|464941145|FG001|Overall Study|Adverse Event|2|||
129176436|NCT02781792|464941144|FG000|Overall Study|Withdrawal by Subject|3|||
129176437|NCT02781792|464941145|FG001|Overall Study|Withdrawal by Subject|1|||
129176438|NCT02781792|464941144|FG000|Overall Study|Lack of Efficacy|1|||
129176439|NCT02781792|464941145|FG001|Overall Study|Lack of Efficacy|1|||
129176440|NCT02781792|464941144|FG000|Overall Study|Hospice|0|||
129176441|NCT02781792|464941145|FG001|Overall Study|Hospice|1|||
129176442|NCT01703117|464941146|FG000|Overall Study|Adverse Event|4|||
129176443|NCT01703117|464941147|FG001|Overall Study|Adverse Event|3|||
129176444|NCT01703117|464941146|FG000|Overall Study|Withdrawal by Subject|0|||
129176445|NCT01703117|464941147|FG001|Overall Study|Withdrawal by Subject|1|||
129176446|NCT00683917|464941149|FG000|Overall Study|Study prematurely terminated|10|||
129176447|NCT01170598|464941156|FG000|Overall Study|Withdrawal by Subject|1|||
129176448|NCT01170598|464941156|FG000|Overall Study|Death|3|||
129176449|NCT01170598|464941156|FG000|Overall Study|Lost to Follow-up|1|||
129176450|NCT01170598|464941156|FG000|Overall Study|Refused|1|||
129176451|NCT02119156|464941157|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
129176452|NCT02119156|464941158|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
129176453|NCT02119156|464941159|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
129176454|NCT02119156|464941157|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
129176455|NCT02119156|464941158|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
129176456|NCT02119156|464941159|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
129176457|NCT02119156|464941157|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
129176458|NCT02119156|464941158|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
129176459|NCT02119156|464941159|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
129176460|NCT02119156|464941157|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
129176461|NCT02119156|464941158|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
129176462|NCT02119156|464941159|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
129176463|NCT02119156|464941157|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
129176464|NCT02119156|464941158|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
129176465|NCT02119156|464941159|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
129176466|NCT02469415|464941160|FG000|Overall Study|Withdrawal by Subject|1|||
129176467|NCT02469415|464941160|FG000|Overall Study|Investigational agent placed on hold|2|||
129176468|NCT00350623|464941163|FG000|Overall Study|Lost to Follow-up|8|||
129176469|NCT00350623|464941164|FG001|Overall Study|Lost to Follow-up|3|||
129176470|NCT00350623|464941165|FG002|Overall Study|Lost to Follow-up|4|||
129176471|NCT00350623|464941163|FG000|Overall Study|Withdrawal by Subject|0|||
129176472|NCT00350623|464941164|FG001|Overall Study|Withdrawal by Subject|1|||
129176473|NCT00350623|464941165|FG002|Overall Study|Withdrawal by Subject|1|||
129176474|NCT00350623|464941163|FG000|Overall Study|patient traveling outside the country|0|||
129176475|NCT00350623|464941164|FG001|Overall Study|patient traveling outside the country|0|||
129176476|NCT00350623|464941165|FG002|Overall Study|patient traveling outside the country|1|||
129176477|NCT02685748|464941166|FG000|Overall Study|Withdrawal by Subject|3|||
129176478|NCT02685748|464941167|FG001|Overall Study|Withdrawal by Subject|2|||
129176479|NCT04126564|464941168|FG000|Overall Study|Withdrawal by Subject|0|||
129176480|NCT04126564|464941169|FG001|Overall Study|Withdrawal by Subject|2|||
129176481|NCT04126564|464941168|FG000|Overall Study|Lost to Follow-up|0|||
129176482|NCT04126564|464941169|FG001|Overall Study|Lost to Follow-up|1|||
129176483|NCT03500172|464941170|FG000|Period 1: Baseline Randomization|Death|0|||
129176484|NCT03500172|464941171|FG001|Period 1: Baseline Randomization|Death|0|||
129176485|NCT03500172|464941172|FG002|Period 1: Baseline Randomization|Death|0|||
129176486|NCT03500172|464941173|FG003|Period 1: Baseline Randomization|Death|0|||
129176487|NCT03500172|464941174|FG004|Period 1: Baseline Randomization|Death|0|||
129176488|NCT03500172|464941175|FG005|Period 1: Baseline Randomization|Death|0|||
129176489|NCT03500172|464941176|FG006|Period 1: Baseline Randomization|Death|0|||
129176490|NCT03500172|464941177|FG007|Period 1: Baseline Randomization|Death|0|||
129176491|NCT03500172|464941178|FG008|Period 1: Baseline Randomization|Death|0|||
129176492|NCT03500172|464941179|FG009|Period 1: Baseline Randomization|Death|2|||
129176493|NCT03500172|464941180|FG010|Period 1: Baseline Randomization|Death|0|||
129176494|NCT03500172|464941170|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
129176495|NCT03500172|464941171|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
129176496|NCT03500172|464941172|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
129176497|NCT03500172|464941173|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
129176498|NCT03500172|464941174|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
129176499|NCT03500172|464941175|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
129176500|NCT03500172|464941176|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
129176501|NCT03500172|464941177|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
129176502|NCT03500172|464941178|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
129176503|NCT03500172|464941179|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
129176504|NCT03500172|464941180|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
129176505|NCT03500172|464941170|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
129176506|NCT03500172|464941171|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
129176507|NCT03500172|464941172|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
129176508|NCT03500172|464941173|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
129176509|NCT03500172|464941174|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
129176510|NCT03500172|464941175|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
129176511|NCT03500172|464941176|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
129176512|NCT03500172|464941177|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
129176513|NCT03500172|464941178|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
129176514|NCT03500172|464941179|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
129176515|NCT03500172|464941180|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
129176516|NCT03500172|464941170|FG000|Period 2: Re-Randomization|Death|0|||
129176517|NCT03500172|464941171|FG001|Period 2: Re-Randomization|Death|0|||
129176518|NCT03500172|464941172|FG002|Period 2: Re-Randomization|Death|0|||
129176519|NCT03500172|464941173|FG003|Period 2: Re-Randomization|Death|4|||
129176520|NCT03500172|464941174|FG004|Period 2: Re-Randomization|Death|2|||
129176521|NCT03500172|464941175|FG005|Period 2: Re-Randomization|Death|0|||
129176522|NCT03500172|464941176|FG006|Period 2: Re-Randomization|Death|5|||
129176523|NCT03500172|464941177|FG007|Period 2: Re-Randomization|Death|2|||
129176524|NCT03500172|464941178|FG008|Period 2: Re-Randomization|Death|0|||
129176525|NCT03500172|464941179|FG009|Period 2: Re-Randomization|Death|0|||
129176526|NCT03500172|464941180|FG010|Period 2: Re-Randomization|Death|0|||
129176527|NCT01974752|464941183|FG000|Overall Study|Death|33|||
129176528|NCT01974752|464941184|FG001|Overall Study|Death|11|||
129176529|NCT01974752|464941183|FG000|Overall Study|Lost to Follow-up|2|||
129176530|NCT01974752|464941184|FG001|Overall Study|Lost to Follow-up|0|||
129176531|NCT01974752|464941183|FG000|Overall Study|Withdrawal by Subject|2|||
129176532|NCT01974752|464941184|FG001|Overall Study|Withdrawal by Subject|3|||
129176533|NCT01974752|464941183|FG000|Overall Study|Other Eligibility Criteria|0|||
129176534|NCT01974752|464941184|FG001|Overall Study|Other Eligibility Criteria|1|||
129176535|NCT02435680|464941186|FG000|Overall Study|Physician Decision|3|||
129176536|NCT02435680|464941187|FG001|Overall Study|Physician Decision|0|||
129176537|NCT02435680|464941188|FG002|Overall Study|Physician Decision|0|||
129176538|NCT02435680|464941186|FG000|Overall Study|subject / guardian decision|0|||
129176539|NCT02435680|464941187|FG001|Overall Study|subject / guardian decision|3|||
129176540|NCT02435680|464941188|FG002|Overall Study|subject / guardian decision|2|||
129176541|NCT02435680|464941186|FG000|Overall Study|Adverse Event|8|||
129176542|NCT02435680|464941187|FG001|Overall Study|Adverse Event|3|||
129176543|NCT02435680|464941188|FG002|Overall Study|Adverse Event|2|||
129176544|NCT02435680|464941186|FG000|Overall Study|progressive disease|10|||
129176545|NCT02435680|464941187|FG001|Overall Study|progressive disease|7|||
129176546|NCT02435680|464941188|FG002|Overall Study|progressive disease|11|||
129176547|NCT02435680|464941186|FG000|Overall Study|not treated|0|||
129176548|NCT02435680|464941187|FG001|Overall Study|not treated|0|||
129176549|NCT02435680|464941188|FG002|Overall Study|not treated|1|||
129176550|NCT00330928|464941189|FG000|Overall Study|Lost to Follow-up|6|||
129176551|NCT00330928|464941189|FG000|Overall Study|Physician Decision|9|||
129176552|NCT00330928|464941189|FG000|Overall Study|Death|1|||
129176553|NCT00330928|464941189|FG000|Overall Study|IVUS could not be performed.|1|||
129176554|NCT03028480|464941192|FG000|Overall Study|No revisit after the first prescription date|2|||
129176555|NCT03028480|464941192|FG000|Overall Study|Did not use the drug|1|||
129176556|NCT03028480|464941192|FG000|Overall Study|Violation of the enrollment deadline|10|||
129176557|NCT03028480|464941192|FG000|Overall Study|Case report forms were not collected|21|||
129176558|NCT02279719|464941195|FG000|Overall Study|Patients randomized but never treated|0|||
129176559|NCT02279719|464941196|FG001|Overall Study|Patients randomized but never treated|0|||
129176560|NCT02279719|464941197|FG002|Overall Study|Patients randomized but never treated|0|||
129176561|NCT02279719|464941198|FG003|Overall Study|Patients randomized but never treated|0|||
129176562|NCT02279719|464941199|FG004|Overall Study|Patients randomized but never treated|3|||
129176563|NCT02279719|464941200|FG005|Overall Study|Patients randomized but never treated|0|||
129176564|NCT02279719|464941201|FG006|Overall Study|Patients randomized but never treated|3|||
129176565|NCT01369680|464941202|FG000|Overall Study|Lost to Follow-up|0|||
129176566|NCT01369680|464941203|FG001|Overall Study|Lost to Follow-up|0|||
129176567|NCT01369680|464941204|FG002|Overall Study|Lost to Follow-up|1|||
129176568|NCT01369680|464941205|FG003|Overall Study|Lost to Follow-up|2|||
129176569|NCT01118520|464941209|FG000|Overall Study|AAA repair|9|||
129176570|NCT01118520|464941210|FG001|Overall Study|AAA repair|7|||
129176571|NCT01118520|464941211|FG002|Overall Study|AAA repair|9|||
129176572|NCT01118520|464941209|FG000|Overall Study|Adverse Event|3|||
129176573|NCT01118520|464941210|FG001|Overall Study|Adverse Event|3|||
129176574|NCT01118520|464941211|FG002|Overall Study|Adverse Event|3|||
129176575|NCT01118520|464941209|FG000|Overall Study|Withdrawal by Subject|8|||
129176576|NCT01118520|464941210|FG001|Overall Study|Withdrawal by Subject|13|||
129176577|NCT01118520|464941211|FG002|Overall Study|Withdrawal by Subject|8|||
129176578|NCT01089023|464941212|FG000|Overall Study|Lost to Follow-up|3|||
129176579|NCT01089023|464941212|FG000|Overall Study|Adverse Event|1|||
129176580|NCT01089023|464941212|FG000|Overall Study|Withdrawal by Subject|1|||
129176581|NCT01089023|464941212|FG000|Overall Study|Protocol Violation|1|||
129176582|NCT01089023|464941212|FG000|Overall Study|Lack of Efficacy|1|||
129176583|NCT03421743|464941215|FG000|Overall Study|Lack of Efficacy|1|||
129176584|NCT03421743|464941216|FG001|Overall Study|Lack of Efficacy|0|||
129176585|NCT03421743|464941215|FG000|Overall Study|Adverse Event|2|||
129176586|NCT03421743|464941216|FG001|Overall Study|Adverse Event|1|||
129176587|NCT03421743|464941215|FG000|Overall Study|Withdrawal by Subject|0|||
129176588|NCT03421743|464941216|FG001|Overall Study|Withdrawal by Subject|1|||
129176589|NCT01166373|464941217|FG000|Overall Study|Lost to Follow-up|3|||
129176590|NCT01166373|464941218|FG001|Overall Study|Lost to Follow-up|2|||
129176591|NCT01166373|464941219|FG002|Overall Study|Lost to Follow-up|2|||
129176592|NCT01166373|464941220|FG003|Overall Study|Lost to Follow-up|2|||
129176593|NCT01166373|464941217|FG000|Overall Study|Withdrawal by Subject|1|||
129176594|NCT01166373|464941218|FG001|Overall Study|Withdrawal by Subject|2|||
129176595|NCT01166373|464941219|FG002|Overall Study|Withdrawal by Subject|2|||
129176596|NCT01166373|464941220|FG003|Overall Study|Withdrawal by Subject|3|||
129176597|NCT01166373|464941217|FG000|Overall Study|Physician Decision|1|||
129176598|NCT01166373|464941218|FG001|Overall Study|Physician Decision|0|||
129176599|NCT01166373|464941219|FG002|Overall Study|Physician Decision|0|||
129176600|NCT01166373|464941220|FG003|Overall Study|Physician Decision|0|||
129176601|NCT01819129|464941221|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
129176602|NCT01819129|464941222|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
129176603|NCT01819129|464941221|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
129176604|NCT01819129|464941222|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
129176605|NCT01819129|464941221|FG000|Overall Study|Other, Subject moved out of the country|0|||
129176606|NCT01819129|464941222|FG001|Overall Study|Other, Subject moved out of the country|1|||
129176607|NCT01819129|464941221|FG000|Overall Study|Withdrawal by Subject|15|||
129176608|NCT01819129|464941222|FG001|Overall Study|Withdrawal by Subject|15|||
129176609|NCT01819129|464941221|FG000|Overall Study|Lost to Follow-up|5|||
129176610|NCT01819129|464941222|FG001|Overall Study|Lost to Follow-up|2|||
129176611|NCT01819129|464941221|FG000|Overall Study|Lack of Efficacy|0|||
129176612|NCT01819129|464941222|FG001|Overall Study|Lack of Efficacy|1|||
129176613|NCT01819129|464941221|FG000|Overall Study|Adverse Event|1|||
129176614|NCT01819129|464941222|FG001|Overall Study|Adverse Event|4|||
129176615|NCT01819129|464941221|FG000|Overall Study|Death|1|||
129176616|NCT01819129|464941222|FG001|Overall Study|Death|1|||
129176617|NCT01819129|464941221|FG000|Overall Study|Withdrawal Criteria|20|||
129176618|NCT01819129|464941222|FG001|Overall Study|Withdrawal Criteria|15|||
129176619|NCT02836873|464941226|FG000|Overall Study|Protocol Violation|0|||
129176620|NCT02836873|464941227|FG001|Overall Study|Protocol Violation|1|||
129176621|NCT02836873|464941226|FG000|Overall Study|Adverse Event|1|||
129176622|NCT02836873|464941227|FG001|Overall Study|Adverse Event|4|||
129176623|NCT02836873|464941226|FG000|Overall Study|Withdrawal by Subject|2|||
129176624|NCT02836873|464941227|FG001|Overall Study|Withdrawal by Subject|2|||
129176625|NCT02836873|464941226|FG000|Overall Study|Lost to Follow-up|1|||
129176626|NCT02836873|464941227|FG001|Overall Study|Lost to Follow-up|3|||
129176627|NCT02836873|464941226|FG000|Overall Study|Physician Decision|0|||
129176628|NCT02836873|464941227|FG001|Overall Study|Physician Decision|1|||
129176629|NCT02836873|464941226|FG000|Overall Study|Other|1|||
129176630|NCT02836873|464941227|FG001|Overall Study|Other|0|||
129176631|NCT02914548|464941230|FG000|Overall Study|Adverse Event|15|||
129176632|NCT02914548|464941231|FG001|Overall Study|Adverse Event|7|||
129176633|NCT02914548|464941232|FG002|Overall Study|Adverse Event|15|||
129176634|NCT02914548|464941230|FG000|Overall Study|Physician Decision|2|||
129176635|NCT02914548|464941231|FG001|Overall Study|Physician Decision|2|||
129176636|NCT02914548|464941232|FG002|Overall Study|Physician Decision|0|||
129176637|NCT02914548|464941230|FG000|Overall Study|Protocol Violation|1|||
129176638|NCT02914548|464941231|FG001|Overall Study|Protocol Violation|0|||
129176639|NCT02914548|464941232|FG002|Overall Study|Protocol Violation|0|||
129176640|NCT02914548|464941230|FG000|Overall Study|Withdrawal by Subject|3|||
129176641|NCT02914548|464941231|FG001|Overall Study|Withdrawal by Subject|4|||
129176642|NCT02914548|464941232|FG002|Overall Study|Withdrawal by Subject|4|||
129176643|NCT02914548|464941230|FG000|Overall Study|>40% of body surface area|0|||
129176644|NCT02914548|464941231|FG001|Overall Study|>40% of body surface area|1|||
129176645|NCT02914548|464941232|FG002|Overall Study|>40% of body surface area|1|||
129176646|NCT02214225|464941233|FG000|Overall Study|Lost to Follow-up|46|||
129176647|NCT02214225|464941234|FG001|Overall Study|Lost to Follow-up|18|||
129176648|NCT02214225|464941235|FG002|Overall Study|Lost to Follow-up|18|||
129176649|NCT02214225|464941233|FG000|Overall Study|Withdrawal by Subject|2|||
129176650|NCT02214225|464941234|FG001|Overall Study|Withdrawal by Subject|0|||
129176651|NCT02214225|464941235|FG002|Overall Study|Withdrawal by Subject|2|||
129176652|NCT02214225|464941233|FG000|Overall Study|Death|5|||
129176653|NCT02214225|464941234|FG001|Overall Study|Death|0|||
129176654|NCT02214225|464941235|FG002|Overall Study|Death|1|||
129176655|NCT02214225|464941233|FG000|Overall Study|randomized in error, not vaccinated|2|||
129176656|NCT02214225|464941234|FG001|Overall Study|randomized in error, not vaccinated|1|||
129176657|NCT02214225|464941235|FG002|Overall Study|randomized in error, not vaccinated|1|||
129176658|NCT03754582|464941236|FG000|Treatment Phase|Adverse Event|0|||
129176659|NCT03754582|464941237|FG001|Treatment Phase|Adverse Event|1|||
129176660|NCT03754582|464941238|FG002|Treatment Phase|Adverse Event|0|||
129176661|NCT03754582|464941236|FG000|Follow-up Phase|Other|0|||
129176662|NCT03754582|464941237|FG001|Follow-up Phase|Other|0|||
129176663|NCT03754582|464941238|FG002|Follow-up Phase|Other|1|||
129176664|NCT02680574|464941239|FG000|Overall Study|Death|137|||
129176665|NCT02680574|464941240|FG001|Overall Study|Death|137|||
129176666|NCT02680574|464941239|FG000|Overall Study|Withdrawal by Subject|17|||
129176667|NCT02680574|464941240|FG001|Overall Study|Withdrawal by Subject|9|||
129176668|NCT02680574|464941239|FG000|Overall Study|Lost to Follow-up|4|||
129176669|NCT02680574|464941240|FG001|Overall Study|Lost to Follow-up|6|||
129176670|NCT02847858|464941241|FG000|Overall Study|Lost to Follow-up|401|||
129176671|NCT02847858|464941242|FG001|Overall Study|Lost to Follow-up|269|||
129176672|NCT00681564|464941245|FG000|Overall Study|Lost to Follow-up|6|||
129176673|NCT00681564|464941246|FG001|Overall Study|Lost to Follow-up|6|||
129176674|NCT00681564|464941245|FG000|Overall Study|Withdrawal by Subject|0|||
129176675|NCT00681564|464941246|FG001|Overall Study|Withdrawal by Subject|1|||
129176676|NCT00681564|464941245|FG000|Overall Study|Death|0|||
129176677|NCT00681564|464941246|FG001|Overall Study|Death|1|||
129176678|NCT01009346|464941249|FG000|Overall Study|Adverse Event|4|||
128780926|NCT01323660|463488627|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
128780927|NCT01323660|463488628|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
128780928|NCT01323660|463488629|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
128780929|NCT01323660|463488630|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
128780930|NCT01323660|463488631|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
129176679|NCT01253265|464941251|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
129176680|NCT01253265|464941252|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
129176681|NCT01253265|464941253|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
129176682|NCT01253265|464941254|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
129176683|NCT01253265|464941255|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
129176684|NCT01253265|464941251|FG000|Overall Study|Withdrawal by Subject|0|||
129176685|NCT01253265|464941252|FG001|Overall Study|Withdrawal by Subject|0|||
129176686|NCT01253265|464941253|FG002|Overall Study|Withdrawal by Subject|0|||
129176687|NCT01253265|464941254|FG003|Overall Study|Withdrawal by Subject|0|||
129176688|NCT01253265|464941255|FG004|Overall Study|Withdrawal by Subject|1|||
129176689|NCT00541099|464941256|FG000|Overall Study|Ineligible|3|||
129176690|NCT00066469|464941258|FG000|Overall Study|Death|3|||
129176691|NCT00066469|464941258|FG000|Overall Study|Lack of Efficacy|9|||
129176692|NCT00066469|464941258|FG000|Overall Study|Lost to Follow-up|1|||
129176693|NCT00066469|464941258|FG000|Overall Study|Physician Decision|1|||
129176694|NCT00066469|464941258|FG000|Overall Study|Withdrawal by Subject|1|||
129176695|NCT00066469|464941258|FG000|Overall Study|ineligible|1|||
129176696|NCT03271047|464941259|FG000|Phase 1b: Dose Finding Period|Death|8|||
129176697|NCT03271047|464941260|FG001|Phase 1b: Dose Finding Period|Death|8|||
129176698|NCT03271047|464941261|FG002|Phase 1b: Dose Finding Period|Death|0|||
129176699|NCT03271047|464941262|FG003|Phase 1b: Dose Finding Period|Death|0|||
129176700|NCT03271047|464941259|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
129176701|NCT03271047|464941260|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
129176702|NCT03271047|464941261|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
129176703|NCT03271047|464941262|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
129176704|NCT03271047|464941259|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
129176705|NCT03271047|464941260|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
129176706|NCT03271047|464941261|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
129176707|NCT03271047|464941262|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
129176708|NCT03271047|464941259|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
129176709|NCT03271047|464941260|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
129176710|NCT03271047|464941261|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
129176711|NCT03271047|464941262|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
129176712|NCT03271047|464941259|FG000|Randomized Phase 2 Period|Other|0|||
129176713|NCT03271047|464941260|FG001|Randomized Phase 2 Period|Other|0|||
129176714|NCT03271047|464941261|FG002|Randomized Phase 2 Period|Other|0|||
129176715|NCT03271047|464941262|FG003|Randomized Phase 2 Period|Other|1|||
129176716|NCT03271047|464941259|FG000|Randomized Phase 2 Period|Death|0|||
129176717|NCT03271047|464941260|FG001|Randomized Phase 2 Period|Death|0|||
129176718|NCT03271047|464941261|FG002|Randomized Phase 2 Period|Death|20|||
129176719|NCT03271047|464941262|FG003|Randomized Phase 2 Period|Death|21|||
129176720|NCT03271047|464941259|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
129176721|NCT03271047|464941260|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
129176722|NCT03271047|464941261|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
129176723|NCT03271047|464941262|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
129176724|NCT03271047|464941259|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
129176725|NCT03271047|464941260|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
129176726|NCT03271047|464941261|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
129176727|NCT03271047|464941262|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
129176728|NCT03271047|464941259|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
129176729|NCT03271047|464941260|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
129176730|NCT03271047|464941261|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
129176731|NCT03271047|464941262|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
129176732|NCT00711802|464941263|FG000|Overall Study|Not treated (no further detail)|2|||
129176733|NCT00711802|464941264|FG001|Overall Study|Not treated (no further detail)|1|||
129176734|NCT00711802|464941265|FG002|Overall Study|Not treated (no further detail)|2|||
129176735|NCT00711802|464941266|FG003|Overall Study|Not treated (no further detail)|0|||
129176736|NCT00711802|464941267|FG004|Overall Study|Not treated (no further detail)|2|||
129176737|NCT00711802|464941268|FG005|Overall Study|Not treated (no further detail)|0|||
129176738|NCT00711802|464941269|FG006|Overall Study|Not treated (no further detail)|0|||
129176739|NCT00711802|464941270|FG007|Overall Study|Not treated (no further detail)|0|||
129176740|NCT00711802|464941263|FG000|Overall Study|Adverse Event|0|||
129176741|NCT00711802|464941264|FG001|Overall Study|Adverse Event|0|||
129176742|NCT00711802|464941265|FG002|Overall Study|Adverse Event|0|||
129176743|NCT00711802|464941266|FG003|Overall Study|Adverse Event|0|||
129176744|NCT00711802|464941267|FG004|Overall Study|Adverse Event|1|||
129176745|NCT00711802|464941268|FG005|Overall Study|Adverse Event|1|||
129176746|NCT00711802|464941269|FG006|Overall Study|Adverse Event|0|||
129176747|NCT00711802|464941270|FG007|Overall Study|Adverse Event|0|||
129176748|NCT00711802|464941263|FG000|Overall Study|Microbiological failure|0|||
129176749|NCT00711802|464941264|FG001|Overall Study|Microbiological failure|1|||
129176750|NCT00711802|464941265|FG002|Overall Study|Microbiological failure|0|||
129176751|NCT00711802|464941266|FG003|Overall Study|Microbiological failure|0|||
129176752|NCT00711802|464941267|FG004|Overall Study|Microbiological failure|0|||
129176753|NCT00711802|464941268|FG005|Overall Study|Microbiological failure|1|||
129176754|NCT00711802|464941269|FG006|Overall Study|Microbiological failure|0|||
129176755|NCT00711802|464941270|FG007|Overall Study|Microbiological failure|0|||
129176756|NCT00711802|464941263|FG000|Overall Study|Protocol Violation|0|||
129176757|NCT00711802|464941264|FG001|Overall Study|Protocol Violation|0|||
129176758|NCT00711802|464941265|FG002|Overall Study|Protocol Violation|0|||
129176759|NCT00711802|464941266|FG003|Overall Study|Protocol Violation|1|||
129176760|NCT00711802|464941267|FG004|Overall Study|Protocol Violation|0|||
129176761|NCT00711802|464941268|FG005|Overall Study|Protocol Violation|0|||
129176762|NCT00711802|464941269|FG006|Overall Study|Protocol Violation|0|||
129176763|NCT00711802|464941270|FG007|Overall Study|Protocol Violation|0|||
129176764|NCT00711802|464941263|FG000|Overall Study|Physician Decision|0|||
129176765|NCT00711802|464941264|FG001|Overall Study|Physician Decision|2|||
129176766|NCT00711802|464941265|FG002|Overall Study|Physician Decision|0|||
129176767|NCT00711802|464941266|FG003|Overall Study|Physician Decision|0|||
129176768|NCT00711802|464941267|FG004|Overall Study|Physician Decision|0|||
129176769|NCT00711802|464941268|FG005|Overall Study|Physician Decision|0|||
129176770|NCT00711802|464941269|FG006|Overall Study|Physician Decision|0|||
129176771|NCT00711802|464941270|FG007|Overall Study|Physician Decision|0|||
129176772|NCT00711802|464941263|FG000|Overall Study|Withdrawal by Subject|0|||
129176773|NCT00711802|464941264|FG001|Overall Study|Withdrawal by Subject|1|||
129176774|NCT00711802|464941265|FG002|Overall Study|Withdrawal by Subject|0|||
129176775|NCT00711802|464941266|FG003|Overall Study|Withdrawal by Subject|1|||
129176776|NCT00711802|464941267|FG004|Overall Study|Withdrawal by Subject|0|||
129176777|NCT00711802|464941268|FG005|Overall Study|Withdrawal by Subject|0|||
129176778|NCT00711802|464941269|FG006|Overall Study|Withdrawal by Subject|0|||
129176779|NCT00711802|464941270|FG007|Overall Study|Withdrawal by Subject|0|||
129176780|NCT00711802|464941263|FG000|Overall Study|Lost to Follow-up|0|||
129176781|NCT00711802|464941264|FG001|Overall Study|Lost to Follow-up|0|||
129176782|NCT00711802|464941265|FG002|Overall Study|Lost to Follow-up|3|||
129176783|NCT00711802|464941266|FG003|Overall Study|Lost to Follow-up|1|||
129176784|NCT00711802|464941267|FG004|Overall Study|Lost to Follow-up|10|||
129176785|NCT00711802|464941268|FG005|Overall Study|Lost to Follow-up|6|||
129176786|NCT00711802|464941269|FG006|Overall Study|Lost to Follow-up|4|||
129176787|NCT00711802|464941270|FG007|Overall Study|Lost to Follow-up|2|||
129176788|NCT00711802|464941263|FG000|Overall Study|Reason not reported|0|||
129176789|NCT00711802|464941264|FG001|Overall Study|Reason not reported|1|||
129176790|NCT00711802|464941265|FG002|Overall Study|Reason not reported|1|||
129176791|NCT00711802|464941266|FG003|Overall Study|Reason not reported|0|||
129176792|NCT00711802|464941267|FG004|Overall Study|Reason not reported|1|||
129176793|NCT00711802|464941268|FG005|Overall Study|Reason not reported|0|||
129176794|NCT00711802|464941269|FG006|Overall Study|Reason not reported|1|||
129176795|NCT00711802|464941270|FG007|Overall Study|Reason not reported|0|||
129176796|NCT02410824|464941271|FG000|First Intervention (One Week)|Headache|0|||
129176797|NCT02410824|464941272|FG001|First Intervention (One Week)|Headache|1|||
129176798|NCT02436408|464941273|FG000|Overall Study|Death|1|||
129176799|NCT00392808|464941274|FG000|Overall Study|Lost to Follow-up|3|||
129176800|NCT00392808|464941275|FG001|Overall Study|Lost to Follow-up|2|||
129176801|NCT00392808|464941276|FG002|Overall Study|Lost to Follow-up|1|||
129176802|NCT00392808|464941277|FG003|Overall Study|Lost to Follow-up|2|||
129176803|NCT00392808|464941274|FG000|Overall Study|Unable to withdraw blood|3|||
129176804|NCT00392808|464941275|FG001|Overall Study|Unable to withdraw blood|1|||
129176805|NCT00392808|464941276|FG002|Overall Study|Unable to withdraw blood|1|||
129176806|NCT00392808|464941277|FG003|Overall Study|Unable to withdraw blood|2|||
129176807|NCT02649855|464941278|FG000|Overall Study|Refused further treatment|2|||
129176808|NCT02649855|464941279|FG001|Overall Study|Refused further treatment|1|||
129176809|NCT02649855|464941280|FG002|Overall Study|Refused further treatment|1|||
129176810|NCT02649855|464941278|FG000|Overall Study|Withdrew consent|0|||
129176811|NCT02649855|464941279|FG001|Overall Study|Withdrew consent|1|||
129176812|NCT02649855|464941280|FG002|Overall Study|Withdrew consent|0|||
129176813|NCT02649855|464941278|FG000|Overall Study|Switched to alternative treatment|0|||
129176814|NCT02649855|464941279|FG001|Overall Study|Switched to alternative treatment|1|||
129176815|NCT02649855|464941280|FG002|Overall Study|Switched to alternative treatment|1|||
129176816|NCT02649855|464941278|FG000|Overall Study|Principal investigator discretion|0|||
129176817|NCT02649855|464941279|FG001|Overall Study|Principal investigator discretion|1|||
129176818|NCT02649855|464941280|FG002|Overall Study|Principal investigator discretion|1|||
129176819|NCT02649855|464941278|FG000|Overall Study|No treatment, per protocol|1|||
129176820|NCT02649855|464941279|FG001|Overall Study|No treatment, per protocol|0|||
129176821|NCT02649855|464941280|FG002|Overall Study|No treatment, per protocol|0|||
129176822|NCT02649855|464941278|FG000|Overall Study|Initiate new treatment|1|||
129176823|NCT02649855|464941279|FG001|Overall Study|Initiate new treatment|0|||
129176824|NCT02649855|464941280|FG002|Overall Study|Initiate new treatment|0|||
129176825|NCT02782325|464941281|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
129176826|NCT02782325|464941282|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
129176827|NCT02782325|464941283|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
129176828|NCT02782325|464941281|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
129176829|NCT02782325|464941282|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
129176830|NCT02782325|464941283|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
129176831|NCT02818036|464941286|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
129176832|NCT02818036|464941287|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
129176833|NCT02818036|464941286|FG000|Overall Study|Withdrawal by Subject|1|||
129176834|NCT02818036|464941287|FG001|Overall Study|Withdrawal by Subject|0|||
129176835|NCT01038713|464941288|FG000|Overall Study|Patient to hospice|1|||
129176836|NCT01038713|464941289|FG001|Overall Study|Patient to hospice|1|||
129176837|NCT01038713|464941290|FG002|Overall Study|Patient to hospice|1|||
129176838|NCT01038713|464941288|FG000|Overall Study|Lost to Follow-up|3|||
129176839|NCT01038713|464941289|FG001|Overall Study|Lost to Follow-up|0|||
129176840|NCT01038713|464941290|FG002|Overall Study|Lost to Follow-up|0|||
129176841|NCT01038713|464941288|FG000|Overall Study|Neuroendocrine Tumor|0|||
129176842|NCT01038713|464941289|FG001|Overall Study|Neuroendocrine Tumor|1|||
129176843|NCT01038713|464941290|FG002|Overall Study|Neuroendocrine Tumor|0|||
129176844|NCT01038713|464941288|FG000|Overall Study|died from PEP|0|||
129176845|NCT01038713|464941289|FG001|Overall Study|died from PEP|1|||
129176846|NCT01038713|464941290|FG002|Overall Study|died from PEP|0|||
129176847|NCT01038713|464941288|FG000|Overall Study|Autoimmune Pancreatitis|1|||
129176848|NCT01038713|464941289|FG001|Overall Study|Autoimmune Pancreatitis|0|||
129176849|NCT01038713|464941290|FG002|Overall Study|Autoimmune Pancreatitis|0|||
129176850|NCT01154283|464941294|FG000|0-6 Weeks|Withdrawal by Subject|7|||
129176851|NCT01154283|464941295|FG001|0-6 Weeks|Withdrawal by Subject|2|||
129176852|NCT01154283|464941294|FG000|0-6 Weeks|Death|0|||
129176853|NCT01154283|464941295|FG001|0-6 Weeks|Death|1|||
129176854|NCT01154283|464941294|FG000|7-12 Weeks|Death|1|||
129176855|NCT01154283|464941295|FG001|7-12 Weeks|Death|0|||
129176856|NCT01154283|464941294|FG000|7-12 Weeks|Withdrawal by Subject|0|||
129176857|NCT01154283|464941295|FG001|7-12 Weeks|Withdrawal by Subject|1|||
129176858|NCT03777917|464941296|FG000|Overall Study|Withdrawal by Subject|1|||
129176859|NCT03777917|464941297|FG001|Overall Study|Withdrawal by Subject|0|||
129176860|NCT03777917|464941296|FG000|Overall Study|Physician Decision|1|||
129176861|NCT03777917|464941297|FG001|Overall Study|Physician Decision|0|||
129176862|NCT03777917|464941296|FG000|Overall Study|Lost to Follow-up|6|||
128730185|NCT04538664|463308348|FG001|Overall Study|Lost to Follow-up|1|||
129176863|NCT03777917|464941297|FG001|Overall Study|Lost to Follow-up|2|||
129176864|NCT03777917|464941296|FG000|Overall Study|Other|1|||
129176865|NCT03777917|464941297|FG001|Overall Study|Other|0|||
129176866|NCT00042432|464941298|FG000|Overall Study|Adverse Event|4|||
129176867|NCT00042432|464941299|FG001|Overall Study|Adverse Event|1|||
128730186|NCT04538664|463308347|FG000|Overall Study|Ongoing|106|||
129176868|NCT00042432|464941298|FG000|Overall Study|Withdrawal by Subject|1|||
129176869|NCT00042432|464941299|FG001|Overall Study|Withdrawal by Subject|3|||
129176870|NCT00042432|464941298|FG000|Overall Study|Death|0|||
129176871|NCT00042432|464941299|FG001|Overall Study|Death|2|||
129176872|NCT00042432|464941298|FG000|Overall Study|Ineligibility determined|1|||
129176873|NCT00042432|464941299|FG001|Overall Study|Ineligibility determined|0|||
129176874|NCT00042432|464941298|FG000|Overall Study|Initiation of maintenance dialysis|1|||
129176875|NCT00042432|464941299|FG001|Overall Study|Initiation of maintenance dialysis|1|||
129176876|NCT00042432|464941298|FG000|Overall Study|Other|2|||
129176877|NCT00042432|464941299|FG001|Overall Study|Other|0|||
129176878|NCT00657150|464941300|FG000|Overall Study|Adverse Event|19|||
129176879|NCT00657150|464941301|FG001|Overall Study|Adverse Event|10|||
129176880|NCT00657150|464941300|FG000|Overall Study|Non-compliant with protocol|5|||
129176881|NCT00657150|464941301|FG001|Overall Study|Non-compliant with protocol|9|||
129176882|NCT00657150|464941300|FG000|Overall Study|Lost to Follow-up|2|||
129176883|NCT00657150|464941301|FG001|Overall Study|Lost to Follow-up|0|||
129176884|NCT00657150|464941300|FG000|Overall Study|Withdrawal by Subject|51|||
129176885|NCT00657150|464941301|FG001|Overall Study|Withdrawal by Subject|36|||
129176886|NCT00657150|464941300|FG000|Overall Study|Other|38|||
129176887|NCT00657150|464941301|FG001|Overall Study|Other|38|||
129176888|NCT00657150|464941300|FG000|Treatment|Adverse Event|60|||
129176889|NCT00657150|464941301|FG001|Treatment|Adverse Event|53|||
129176890|NCT00657150|464941300|FG000|Treatment|Non-compliant with protocol|10|||
129176891|NCT00657150|464941301|FG001|Treatment|Non-compliant with protocol|9|||
129176892|NCT00657150|464941300|FG000|Treatment|Lost to Follow-up|1|||
129176893|NCT00657150|464941301|FG001|Treatment|Lost to Follow-up|0|||
129176894|NCT00657150|464941300|FG000|Treatment|Withdrawal by Subject|23|||
129176895|NCT00657150|464941301|FG001|Treatment|Withdrawal by Subject|20|||
129176896|NCT00657150|464941300|FG000|Treatment|Other|13|||
129176897|NCT00657150|464941301|FG001|Treatment|Other|15|||
129176898|NCT02966795|464941302|FG000|Overall Study|Patient Left the Country|0|||
129176899|NCT02966795|464941303|FG001|Overall Study|Patient Left the Country|1|||
129176900|NCT00432744|464941304|FG000|Months 0-6|Withdrawal by Subject|4|||
129176901|NCT00432744|464941305|FG001|Months 0-6|Withdrawal by Subject|4|||
129176902|NCT00432744|464941304|FG000|Months 0-6|Too disabled to score|1|||
129176903|NCT00432744|464941305|FG001|Months 0-6|Too disabled to score|0|||
129176904|NCT00432744|464941304|FG000|Months 7 - 12|Withdrawal by Subject|1|||
129176905|NCT00432744|464941305|FG001|Months 7 - 12|Withdrawal by Subject|0|||
129176906|NCT00432744|464941304|FG000|Months 7 - 12|Too disabled to score|0|||
129176907|NCT00432744|464941305|FG001|Months 7 - 12|Too disabled to score|1|||
129176908|NCT00468845|464941317|FG000|Overall Study|Adverse Event|9|||
129176909|NCT00468845|464941318|FG001|Overall Study|Adverse Event|14|||
129176910|NCT00468845|464941319|FG002|Overall Study|Adverse Event|11|||
129176911|NCT00468845|464941317|FG000|Overall Study|Lost to Follow-up|2|||
129176912|NCT00468845|464941318|FG001|Overall Study|Lost to Follow-up|1|||
129176913|NCT00468845|464941319|FG002|Overall Study|Lost to Follow-up|2|||
129176914|NCT00468845|464941317|FG000|Overall Study|Other|4|||
129176915|NCT00468845|464941318|FG001|Overall Study|Other|9|||
129176916|NCT00468845|464941319|FG002|Overall Study|Other|5|||
129176917|NCT00468845|464941317|FG000|Overall Study|No longer willing to participate|5|||
129176918|NCT00468845|464941318|FG001|Overall Study|No longer willing to participate|6|||
129176919|NCT00468845|464941319|FG002|Overall Study|No longer willing to participate|10|||
129176920|NCT00468845|464941317|FG000|Overall Study|Randomized, not treated|1|||
129176921|NCT00468845|464941318|FG001|Overall Study|Randomized, not treated|4|||
129176922|NCT00468845|464941319|FG002|Overall Study|Randomized, not treated|2|||
129176923|NCT02761694|464941324|FG000|Overall Study|Lack of Efficacy|0|||
129176924|NCT02761694|464941325|FG001|Overall Study|Lack of Efficacy|0|||
129176925|NCT02761694|464941326|FG002|Overall Study|Lack of Efficacy|0|||
129176926|NCT02761694|464941327|FG003|Overall Study|Lack of Efficacy|0|||
129176927|NCT02761694|464941328|FG004|Overall Study|Lack of Efficacy|0|||
129176928|NCT02761694|464941329|FG005|Overall Study|Lack of Efficacy|0|||
129176929|NCT02761694|464941330|FG006|Overall Study|Lack of Efficacy|6|||
129176930|NCT02761694|464941331|FG007|Overall Study|Lack of Efficacy|0|||
129176931|NCT02761694|464941332|FG008|Overall Study|Lack of Efficacy|0|||
129176932|NCT02761694|464941333|FG009|Overall Study|Lack of Efficacy|1|||
129176933|NCT02761694|464941334|FG010|Overall Study|Lack of Efficacy|1|||
129176934|NCT02761694|464941335|FG011|Overall Study|Lack of Efficacy|4|||
129176935|NCT02761694|464941324|FG000|Overall Study|Death|0|||
129176936|NCT02761694|464941325|FG001|Overall Study|Death|0|||
129176937|NCT02761694|464941326|FG002|Overall Study|Death|0|||
129176938|NCT02761694|464941327|FG003|Overall Study|Death|0|||
129176939|NCT02761694|464941328|FG004|Overall Study|Death|0|||
129176940|NCT02761694|464941329|FG005|Overall Study|Death|0|||
129176941|NCT02761694|464941330|FG006|Overall Study|Death|2|||
129176942|NCT02761694|464941331|FG007|Overall Study|Death|0|||
129176943|NCT02761694|464941332|FG008|Overall Study|Death|2|||
129176944|NCT02761694|464941333|FG009|Overall Study|Death|2|||
129176945|NCT02761694|464941334|FG010|Overall Study|Death|1|||
129176946|NCT02761694|464941335|FG011|Overall Study|Death|0|||
129176947|NCT02761694|464941324|FG000|Overall Study|Physician Decision|0|||
129176948|NCT02761694|464941325|FG001|Overall Study|Physician Decision|0|||
129176949|NCT02761694|464941326|FG002|Overall Study|Physician Decision|0|||
129176950|NCT02761694|464941327|FG003|Overall Study|Physician Decision|0|||
129176951|NCT02761694|464941328|FG004|Overall Study|Physician Decision|0|||
129176952|NCT02761694|464941329|FG005|Overall Study|Physician Decision|0|||
129176953|NCT02761694|464941330|FG006|Overall Study|Physician Decision|1|||
129176954|NCT02761694|464941331|FG007|Overall Study|Physician Decision|0|||
129176955|NCT02761694|464941332|FG008|Overall Study|Physician Decision|0|||
129176956|NCT02761694|464941333|FG009|Overall Study|Physician Decision|0|||
129176957|NCT02761694|464941334|FG010|Overall Study|Physician Decision|0|||
129176958|NCT02761694|464941335|FG011|Overall Study|Physician Decision|0|||
129176959|NCT02761694|464941324|FG000|Overall Study|Withdrawal by Subject|0|||
129176960|NCT02761694|464941325|FG001|Overall Study|Withdrawal by Subject|0|||
129176961|NCT02761694|464941326|FG002|Overall Study|Withdrawal by Subject|0|||
129176962|NCT02761694|464941327|FG003|Overall Study|Withdrawal by Subject|1|||
129176963|NCT02761694|464941328|FG004|Overall Study|Withdrawal by Subject|0|||
129176964|NCT02761694|464941329|FG005|Overall Study|Withdrawal by Subject|0|||
129176965|NCT02761694|464941330|FG006|Overall Study|Withdrawal by Subject|4|||
129176966|NCT02761694|464941331|FG007|Overall Study|Withdrawal by Subject|0|||
129176967|NCT02761694|464941332|FG008|Overall Study|Withdrawal by Subject|2|||
129176968|NCT02761694|464941333|FG009|Overall Study|Withdrawal by Subject|1|||
129176969|NCT02761694|464941334|FG010|Overall Study|Withdrawal by Subject|0|||
129176970|NCT02761694|464941335|FG011|Overall Study|Withdrawal by Subject|0|||
129176971|NCT02761694|464941324|FG000|Overall Study|Lost to Follow-up|0|||
129176972|NCT02761694|464941325|FG001|Overall Study|Lost to Follow-up|0|||
129176973|NCT02761694|464941326|FG002|Overall Study|Lost to Follow-up|0|||
129176974|NCT02761694|464941327|FG003|Overall Study|Lost to Follow-up|0|||
129176975|NCT02761694|464941328|FG004|Overall Study|Lost to Follow-up|0|||
129176976|NCT02761694|464941329|FG005|Overall Study|Lost to Follow-up|0|||
129176977|NCT02761694|464941330|FG006|Overall Study|Lost to Follow-up|1|||
129176978|NCT02761694|464941331|FG007|Overall Study|Lost to Follow-up|0|||
129176979|NCT02761694|464941332|FG008|Overall Study|Lost to Follow-up|0|||
129176980|NCT02761694|464941333|FG009|Overall Study|Lost to Follow-up|0|||
129176981|NCT02761694|464941334|FG010|Overall Study|Lost to Follow-up|0|||
129176982|NCT02761694|464941335|FG011|Overall Study|Lost to Follow-up|1|||
129176983|NCT02761694|464941324|FG000|Overall Study|Adverse Event|0|||
129176984|NCT02761694|464941325|FG001|Overall Study|Adverse Event|0|||
129176985|NCT02761694|464941326|FG002|Overall Study|Adverse Event|0|||
129176986|NCT02761694|464941327|FG003|Overall Study|Adverse Event|0|||
129176987|NCT02761694|464941328|FG004|Overall Study|Adverse Event|0|||
129176988|NCT02761694|464941329|FG005|Overall Study|Adverse Event|0|||
129176989|NCT02761694|464941330|FG006|Overall Study|Adverse Event|1|||
129176990|NCT02761694|464941331|FG007|Overall Study|Adverse Event|0|||
129176991|NCT02761694|464941332|FG008|Overall Study|Adverse Event|1|||
129176992|NCT02761694|464941333|FG009|Overall Study|Adverse Event|0|||
129176993|NCT02761694|464941334|FG010|Overall Study|Adverse Event|0|||
129176994|NCT02761694|464941335|FG011|Overall Study|Adverse Event|1|||
129176995|NCT02761694|464941324|FG000|Overall Study|Other|4|||
129176996|NCT02761694|464941325|FG001|Overall Study|Other|4|||
129176997|NCT02761694|464941326|FG002|Overall Study|Other|1|||
129176998|NCT02761694|464941327|FG003|Overall Study|Other|2|||
129176999|NCT02761694|464941328|FG004|Overall Study|Other|3|||
129177000|NCT02761694|464941329|FG005|Overall Study|Other|3|||
129177001|NCT02761694|464941330|FG006|Overall Study|Other|18|||
129177002|NCT02761694|464941331|FG007|Overall Study|Other|8|||
129177003|NCT02761694|464941332|FG008|Overall Study|Other|0|||
129177004|NCT02761694|464941333|FG009|Overall Study|Other|1|||
129177005|NCT02761694|464941334|FG010|Overall Study|Other|1|||
129177006|NCT02761694|464941335|FG011|Overall Study|Other|0|||
129177007|NCT02395055|464941336|FG000|Overall Study|Withdrawal by Subject|7|||
129177008|NCT02395055|464941337|FG001|Overall Study|Withdrawal by Subject|3|||
129177009|NCT03559699|464943159|FG000|Overall Study|Withdrawal by Subject|6|||
129177010|NCT03559699|464943159|FG000|Overall Study|Lost to Follow-up|1|||
129177011|NCT01930890|464943162|FG000|Overall Study|Study Termination|14|||
129177012|NCT01930890|464943163|FG001|Overall Study|Study Termination|28|||
129177013|NCT01930890|464943164|FG002|Overall Study|Study Termination|13|||
129177014|NCT01930890|464943165|FG003|Overall Study|Study Termination|25|||
129177015|NCT01930890|464943162|FG000|Overall Study|Death|0|||
129177016|NCT01930890|464943163|FG001|Overall Study|Death|0|||
129177017|NCT01930890|464943164|FG002|Overall Study|Death|0|||
129177018|NCT01930890|464943165|FG003|Overall Study|Death|1|||
129177019|NCT01930890|464943162|FG000|Overall Study|Investigator Decision|0|||
129177020|NCT01930890|464943163|FG001|Overall Study|Investigator Decision|1|||
128730187|NCT04538664|463308348|FG001|Overall Study|Ongoing|115|||
129177021|NCT01930890|464943164|FG002|Overall Study|Investigator Decision|0|||
129177022|NCT01930890|464943165|FG003|Overall Study|Investigator Decision|0|||
129177023|NCT01930890|464943162|FG000|Overall Study|Consent Withdrawn|0|||
129177024|NCT01930890|464943163|FG001|Overall Study|Consent Withdrawn|3|||
129177025|NCT01930890|464943164|FG002|Overall Study|Consent Withdrawn|0|||
129177026|NCT01930890|464943165|FG003|Overall Study|Consent Withdrawn|1|||
129177027|NCT01930890|464943162|FG000|Overall Study|Adverse Event|0|||
129177028|NCT01930890|464943163|FG001|Overall Study|Adverse Event|1|||
129177029|NCT01930890|464943164|FG002|Overall Study|Adverse Event|0|||
129177030|NCT01930890|464943165|FG003|Overall Study|Adverse Event|0|||
129177031|NCT02091284|464943166|FG000|Overall Study|Withdrawal by Subject|2|||
129177032|NCT02091284|464943167|FG001|Overall Study|Withdrawal by Subject|1|||
129177033|NCT02091284|464943166|FG000|Overall Study|unreliable data|1|||
129177034|NCT02091284|464943167|FG001|Overall Study|unreliable data|0|||
129177035|NCT01278407|464943168|FG000|Confirmatory Phase|Adverse Event|5|||
129177036|NCT01278407|464943169|FG001|Confirmatory Phase|Adverse Event|10|||
129177037|NCT01278407|464943170|FG002|Confirmatory Phase|Adverse Event|1|||
129177038|NCT01278407|464943171|FG003|Confirmatory Phase|Adverse Event|0|||
129177039|NCT01278407|464943172|FG004|Confirmatory Phase|Adverse Event|0|||
129177040|NCT01278407|464943168|FG000|Confirmatory Phase|Participant's Choice|3|||
129177041|NCT01278407|464943169|FG001|Confirmatory Phase|Participant's Choice|5|||
129177042|NCT01278407|464943170|FG002|Confirmatory Phase|Participant's Choice|3|||
129177043|NCT01278407|464943171|FG003|Confirmatory Phase|Participant's Choice|0|||
129177044|NCT01278407|464943172|FG004|Confirmatory Phase|Participant's Choice|0|||
129177045|NCT01278407|464943168|FG000|Confirmatory Phase|Other|1|||
129177046|NCT01278407|464943169|FG001|Confirmatory Phase|Other|1|||
129177047|NCT01278407|464943170|FG002|Confirmatory Phase|Other|2|||
129177048|NCT01278407|464943171|FG003|Confirmatory Phase|Other|0|||
129177049|NCT01278407|464943172|FG004|Confirmatory Phase|Other|0|||
129177050|NCT01278407|464943168|FG000|Extension Phase|Adverse Event|0|||
129177051|NCT01278407|464943169|FG001|Extension Phase|Adverse Event|0|||
129177052|NCT01278407|464943170|FG002|Extension Phase|Adverse Event|0|||
129177053|NCT01278407|464943171|FG003|Extension Phase|Adverse Event|7|||
129177054|NCT01278407|464943172|FG004|Extension Phase|Adverse Event|16|||
129177055|NCT01278407|464943168|FG000|Extension Phase|Participant's Choice|0|||
129177056|NCT01278407|464943169|FG001|Extension Phase|Participant's Choice|0|||
129177057|NCT01278407|464943170|FG002|Extension Phase|Participant's Choice|0|||
129177058|NCT01278407|464943171|FG003|Extension Phase|Participant's Choice|4|||
129177059|NCT01278407|464943172|FG004|Extension Phase|Participant's Choice|11|||
129177060|NCT01278407|464943168|FG000|Extension Phase|Other|0|||
129177061|NCT01278407|464943169|FG001|Extension Phase|Other|0|||
129177062|NCT01278407|464943170|FG002|Extension Phase|Other|0|||
129177063|NCT01278407|464943171|FG003|Extension Phase|Other|1|||
129177064|NCT01278407|464943172|FG004|Extension Phase|Other|3|||
129177065|NCT03383783|464943174|FG000|Overall Study|Withdrawal by Subject|2|||
129177066|NCT01224821|464943178|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
129177067|NCT01224821|464943178|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
129177068|NCT01224821|464943178|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
129177069|NCT01224821|464943178|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
129177070|NCT01224821|464943178|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
129177071|NCT01224821|464943178|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
129177072|NCT01224821|464943178|FG000|Long-Term Follow-Up|Death|2|||
129177073|NCT01224821|464943178|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
129177074|NCT01340937|464943179|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
129177075|NCT01340937|464943180|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
129177076|NCT01340937|464943181|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
129177077|NCT01340937|464943182|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
129177078|NCT01340937|464943179|FG000|Period 1: Infant Series|Adverse Event|0|||
129177079|NCT01340937|464943180|FG001|Period 1: Infant Series|Adverse Event|1|||
129177080|NCT01340937|464943181|FG002|Period 1: Infant Series|Adverse Event|4|||
129177081|NCT01340937|464943182|FG003|Period 1: Infant Series|Adverse Event|0|||
129177082|NCT01340937|464943179|FG000|Period 1: Infant Series|Death|2|||
129177083|NCT01340937|464943180|FG001|Period 1: Infant Series|Death|0|||
129177084|NCT01340937|464943181|FG002|Period 1: Infant Series|Death|2|||
129177085|NCT01340937|464943182|FG003|Period 1: Infant Series|Death|0|||
129177086|NCT01340937|464943179|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
129177087|NCT01340937|464943180|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
129177088|NCT01340937|464943181|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
129177089|NCT01340937|464943182|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
129177090|NCT01340937|464943179|FG000|Period 1: Infant Series|Physician Decision|2|||
129177091|NCT01340937|464943180|FG001|Period 1: Infant Series|Physician Decision|3|||
129177092|NCT01340937|464943181|FG002|Period 1: Infant Series|Physician Decision|1|||
129177093|NCT01340937|464943182|FG003|Period 1: Infant Series|Physician Decision|0|||
129177094|NCT01340937|464943179|FG000|Period 1: Infant Series|Protocol Violation|1|||
129177095|NCT01340937|464943180|FG001|Period 1: Infant Series|Protocol Violation|4|||
129177096|NCT01340937|464943181|FG002|Period 1: Infant Series|Protocol Violation|4|||
129177097|NCT01340937|464943182|FG003|Period 1: Infant Series|Protocol Violation|3|||
129177098|NCT01340937|464943179|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
129177099|NCT01340937|464943180|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
129177100|NCT01340937|464943181|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
129177101|NCT01340937|464943182|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
129177102|NCT01340937|464943179|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
129177103|NCT01340937|464943180|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
129177104|NCT01340937|464943181|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
129177105|NCT01340937|464943182|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
129177106|NCT01340937|464943179|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
129177107|NCT01340937|464943180|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
129177108|NCT01340937|464943181|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
129177109|NCT01340937|464943182|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
129177110|NCT01340937|464943179|FG000|Period 2: Interim Period|Adverse Event|1|||
128730188|NCT04552587|463308349|FG000|Overall Study|Lost to Follow-up|4|||
129177111|NCT01340937|464943180|FG001|Period 2: Interim Period|Adverse Event|0|||
129177112|NCT01340937|464943181|FG002|Period 2: Interim Period|Adverse Event|1|||
129177113|NCT01340937|464943182|FG003|Period 2: Interim Period|Adverse Event|0|||
129177114|NCT01340937|464943179|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
129177115|NCT01340937|464943180|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
129177116|NCT01340937|464943181|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
129177117|NCT01340937|464943182|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
129177118|NCT01340937|464943179|FG000|Period 2: Interim Period|Physician Decision|0|||
129177119|NCT01340937|464943180|FG001|Period 2: Interim Period|Physician Decision|1|||
129177120|NCT01340937|464943181|FG002|Period 2: Interim Period|Physician Decision|1|||
129177121|NCT01340937|464943182|FG003|Period 2: Interim Period|Physician Decision|0|||
129177122|NCT01340937|464943179|FG000|Period 2: Interim Period|Protocol Violation|5|||
129177123|NCT01340937|464943180|FG001|Period 2: Interim Period|Protocol Violation|3|||
129177124|NCT01340937|464943181|FG002|Period 2: Interim Period|Protocol Violation|6|||
129177125|NCT01340937|464943182|FG003|Period 2: Interim Period|Protocol Violation|3|||
129177126|NCT01340937|464943179|FG000|Period 2: Interim Period|Technical problems|4|||
129177127|NCT01340937|464943180|FG001|Period 2: Interim Period|Technical problems|4|||
129177128|NCT01340937|464943181|FG002|Period 2: Interim Period|Technical problems|6|||
129177129|NCT01340937|464943182|FG003|Period 2: Interim Period|Technical problems|3|||
129177130|NCT01340937|464943179|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
129177131|NCT01340937|464943180|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
129177132|NCT01340937|464943181|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
129177133|NCT01340937|464943182|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
129177134|NCT01340937|464943179|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
129177135|NCT01340937|464943180|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
129177136|NCT01340937|464943181|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
129177137|NCT01340937|464943182|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
129177138|NCT01340937|464943179|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129177139|NCT01340937|464943180|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129177140|NCT01340937|464943181|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129177141|NCT01340937|464943182|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
129177142|NCT01340937|464943179|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
129177143|NCT01340937|464943180|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
129177144|NCT01340937|464943181|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
129177145|NCT01340937|464943182|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
129177146|NCT00623545|464943183|FG000|Overall Study|Adverse Event|6|||
129177147|NCT00623545|464943183|FG000|Overall Study|Withdrawal by Subject|4|||
129177148|NCT03541187|464943186|FG000|Overall Study|Lost to Follow-up|2|||
129177149|NCT03541187|464943187|FG001|Overall Study|Lost to Follow-up|6|||
129177150|NCT03541187|464943186|FG000|Overall Study|Pregnancy|0|||
129177151|NCT03541187|464943187|FG001|Overall Study|Pregnancy|1|||
129177152|NCT03541187|464943186|FG000|Overall Study|Withdrawal by Subject|6|||
129177153|NCT03541187|464943187|FG001|Overall Study|Withdrawal by Subject|2|||
128780931|NCT01323660|463488626|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
128780932|NCT01323660|463488627|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
128780933|NCT01323660|463488628|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
128780934|NCT01323660|463488629|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129177154|NCT03541187|464943186|FG000|Overall Study|Moved out of town|1|||
129177155|NCT03541187|464943187|FG001|Overall Study|Moved out of town|0|||
129177156|NCT03541187|464943186|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
129177157|NCT03541187|464943187|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
129177158|NCT03541187|464943186|FG000|Overall Study|Did not meet randomization criteria|1|||
129177159|NCT03541187|464943187|FG001|Overall Study|Did not meet randomization criteria|1|||
129177160|NCT03541187|464943186|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
129177161|NCT03541187|464943187|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
129177162|NCT03541187|464943186|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
129177163|NCT03541187|464943187|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
129177164|NCT00585221|464943194|FG000|Overall Study|Protocol Violation|8|||
129177165|NCT02585830|464943195|FG000|Overall Study|Withdrawal by Subject|3|||
129177166|NCT03276052|464943200|FG000|Overall Study|Withdrawal by Subject|5|||
129177167|NCT03276052|464943200|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
129177168|NCT00435162|464943202|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
129177169|NCT00435162|464943203|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
129177170|NCT00435162|464943204|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
129177171|NCT00435162|464943205|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
129177172|NCT00435162|464943206|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
129177173|NCT00435162|464943207|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
129177174|NCT01765426|464943210|FG000|Overall Study|Lost to Follow-up|0|||
129177175|NCT01765426|464943211|FG001|Overall Study|Lost to Follow-up|1|||
129177176|NCT01765426|464943212|FG002|Overall Study|Lost to Follow-up|0|||
129177177|NCT01765426|464943213|FG003|Overall Study|Lost to Follow-up|0|||
129177178|NCT01510184|464943214|FG000|Overall Study|Sponsor discretion|28|||
129177179|NCT01510184|464943215|FG001|Overall Study|Sponsor discretion|28|||
129177180|NCT01510184|464943214|FG000|Overall Study|Death|1|||
129177181|NCT01510184|464943215|FG001|Overall Study|Death|2|||
129177182|NCT01510184|464943214|FG000|Overall Study|Withdrawal by Subject|1|||
129177183|NCT01510184|464943215|FG001|Overall Study|Withdrawal by Subject|4|||
129177184|NCT01510184|464943214|FG000|Overall Study|Other|0|||
129177185|NCT01510184|464943215|FG001|Overall Study|Other|1|||
129177186|NCT00694096|464943224|FG000|Overall Study|Withdrawal by Subject|5|||
129177187|NCT01484834|464943233|FG000|Overall Study|Lost to Follow-up|5|||
129177188|NCT01484834|464943234|FG001|Overall Study|Lost to Follow-up|8|||
129177189|NCT01484834|464943235|FG002|Overall Study|Lost to Follow-up|1|||
129177190|NCT01484834|464943236|FG003|Overall Study|Lost to Follow-up|4|||
129177191|NCT00747344|464943237|FG000|Controlled Period|Adverse Event|3|||
129177192|NCT00747344|464943238|FG001|Controlled Period|Adverse Event|0|||
129177193|NCT00747344|464943239|FG002|Controlled Period|Adverse Event|0|||
129177194|NCT00747344|464943240|FG003|Controlled Period|Adverse Event|0|||
129177195|NCT00747344|464943237|FG000|Controlled Period|Lack of Efficacy|2|||
129177196|NCT00747344|464943238|FG001|Controlled Period|Lack of Efficacy|1|||
129177197|NCT00747344|464943239|FG002|Controlled Period|Lack of Efficacy|0|||
129177198|NCT00747344|464943240|FG003|Controlled Period|Lack of Efficacy|0|||
129177199|NCT00747344|464943237|FG000|Controlled Period|Other|0|||
129177200|NCT00747344|464943238|FG001|Controlled Period|Other|3|||
129177201|NCT00747344|464943239|FG002|Controlled Period|Other|0|||
129177202|NCT00747344|464943240|FG003|Controlled Period|Other|0|||
129177203|NCT00747344|464943237|FG000|After Controlled Period|Adverse Event|0|||
129177204|NCT00747344|464943238|FG001|After Controlled Period|Adverse Event|0|||
129177205|NCT00747344|464943239|FG002|After Controlled Period|Adverse Event|0|||
129177206|NCT00747344|464943240|FG003|After Controlled Period|Adverse Event|1|||
129177207|NCT00765882|464943241|FG000|Overall Study|Adverse Event|10|||
129177208|NCT00765882|464943242|FG001|Overall Study|Adverse Event|21|||
129177209|NCT00765882|464943243|FG002|Overall Study|Adverse Event|20|||
129177210|NCT00765882|464943241|FG000|Overall Study|Lack of Efficacy|4|||
129177211|NCT00765882|464943242|FG001|Overall Study|Lack of Efficacy|0|||
129177212|NCT00765882|464943243|FG002|Overall Study|Lack of Efficacy|1|||
129177213|NCT00765882|464943241|FG000|Overall Study|Protocol Violation|4|||
129177214|NCT00765882|464943242|FG001|Overall Study|Protocol Violation|3|||
129177215|NCT00765882|464943243|FG002|Overall Study|Protocol Violation|1|||
129177216|NCT00765882|464943241|FG000|Overall Study|Withdrawal by Subject|2|||
129177217|NCT00765882|464943242|FG001|Overall Study|Withdrawal by Subject|6|||
129177218|NCT00765882|464943243|FG002|Overall Study|Withdrawal by Subject|6|||
129177219|NCT00765882|464943241|FG000|Overall Study|Lost to Follow-up|1|||
129177220|NCT00765882|464943242|FG001|Overall Study|Lost to Follow-up|9|||
129177221|NCT00765882|464943243|FG002|Overall Study|Lost to Follow-up|6|||
129177222|NCT00765882|464943241|FG000|Overall Study|Other Reason|3|||
129177223|NCT00765882|464943242|FG001|Overall Study|Other Reason|1|||
129177224|NCT00765882|464943243|FG002|Overall Study|Other Reason|2|||
129177225|NCT02231762|464943244|FG000|Combination Phase|Adverse Event|10|||
129177226|NCT02231762|464943245|FG001|Combination Phase|Adverse Event|0|||
129177227|NCT02231762|464943246|FG002|Combination Phase|Adverse Event|0|||
129177228|NCT02231762|464943247|FG003|Combination Phase|Adverse Event|0|||
129177229|NCT02231762|464943244|FG000|Combination Phase|Withdrawal by Subject|2|||
129177230|NCT02231762|464943245|FG001|Combination Phase|Withdrawal by Subject|0|||
129177231|NCT02231762|464943246|FG002|Combination Phase|Withdrawal by Subject|0|||
129177232|NCT02231762|464943247|FG003|Combination Phase|Withdrawal by Subject|0|||
129177233|NCT02231762|464943244|FG000|Combination Phase|Disease Progression|6|||
129177234|NCT02231762|464943245|FG001|Combination Phase|Disease Progression|0|||
129177235|NCT02231762|464943246|FG002|Combination Phase|Disease Progression|0|||
129177236|NCT02231762|464943247|FG003|Combination Phase|Disease Progression|0|||
129177237|NCT02231762|464943244|FG000|Combination Phase|Did not meet inclusion criteria|1|||
129177238|NCT02231762|464943245|FG001|Combination Phase|Did not meet inclusion criteria|0|||
129177239|NCT02231762|464943246|FG002|Combination Phase|Did not meet inclusion criteria|0|||
129177240|NCT02231762|464943247|FG003|Combination Phase|Did not meet inclusion criteria|0|||
129177241|NCT02231762|464943244|FG000|Combination Phase|Protocol Violation|1|||
129177242|NCT02231762|464943245|FG001|Combination Phase|Protocol Violation|0|||
129177243|NCT02231762|464943246|FG002|Combination Phase|Protocol Violation|0|||
129177244|NCT02231762|464943247|FG003|Combination Phase|Protocol Violation|0|||
129177245|NCT02231762|464943244|FG000|Maintenance Phase|Disease progression|0|||
129177246|NCT02231762|464943245|FG001|Maintenance Phase|Disease progression|3|||
129177247|NCT02231762|464943246|FG002|Maintenance Phase|Disease progression|4|||
129177248|NCT02231762|464943247|FG003|Maintenance Phase|Disease progression|3|||
129177249|NCT02231762|464943244|FG000|Maintenance Phase|Adverse Event|0|||
129177250|NCT02231762|464943245|FG001|Maintenance Phase|Adverse Event|0|||
129177251|NCT02231762|464943246|FG002|Maintenance Phase|Adverse Event|1|||
129177252|NCT02231762|464943247|FG003|Maintenance Phase|Adverse Event|2|||
129177253|NCT01799239|464943248|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
129177254|NCT01799239|464943249|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
129177255|NCT01799239|464943248|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
129177256|NCT01799239|464943249|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
129177257|NCT01799239|464943248|FG000|Period 1 (7 Days)|Protocol Violation|0|||
129177258|NCT01799239|464943249|FG001|Period 1 (7 Days)|Protocol Violation|1|||
129177259|NCT01799239|464943248|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
129177260|NCT01799239|464943249|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
129177261|NCT01799239|464943248|FG000|Period 2 (7 Days)|Protocol Violation|1|||
129177262|NCT01799239|464943249|FG001|Period 2 (7 Days)|Protocol Violation|0|||
129177263|NCT01286987|464943253|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
129177264|NCT01286987|464943254|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
129177265|NCT01286987|464943255|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
129177266|NCT01286987|464943256|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
129177267|NCT01286987|464943257|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
129177268|NCT01286987|464943258|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
129177269|NCT01286987|464943259|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
129177270|NCT01286987|464943260|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
129177271|NCT01286987|464943261|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
129177272|NCT01286987|464943262|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
129177273|NCT01286987|464943263|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
129177274|NCT01286987|464943264|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
129177275|NCT01286987|464943265|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
129177276|NCT01286987|464943266|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
129177277|NCT01286987|464943267|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
129177278|NCT01286987|464943253|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
129177279|NCT01286987|464943254|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
129177280|NCT01286987|464943255|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
129177281|NCT01286987|464943256|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
129177282|NCT01286987|464943257|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
129177283|NCT01286987|464943258|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
129177284|NCT01286987|464943259|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
129177285|NCT01286987|464943260|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
129177286|NCT01286987|464943261|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
129177287|NCT01286987|464943262|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
129177288|NCT01286987|464943263|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
129177289|NCT01286987|464943264|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
129177290|NCT01286987|464943265|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
129177291|NCT01286987|464943266|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
129177292|NCT01286987|464943267|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
129177293|NCT01286987|464943253|FG000|Part 1: Dose Escalation|Physician Decision|0|||
129177294|NCT01286987|464943254|FG001|Part 1: Dose Escalation|Physician Decision|0|||
129177295|NCT01286987|464943255|FG002|Part 1: Dose Escalation|Physician Decision|0|||
129177296|NCT01286987|464943256|FG003|Part 1: Dose Escalation|Physician Decision|0|||
129177297|NCT01286987|464943257|FG004|Part 1: Dose Escalation|Physician Decision|1|||
129177298|NCT01286987|464943258|FG005|Part 1: Dose Escalation|Physician Decision|0|||
129177299|NCT01286987|464943259|FG006|Part 1: Dose Escalation|Physician Decision|0|||
129177300|NCT01286987|464943260|FG007|Part 1: Dose Escalation|Physician Decision|0|||
129177301|NCT01286987|464943261|FG008|Part 1: Dose Escalation|Physician Decision|0|||
129177302|NCT01286987|464943262|FG009|Part 1: Dose Escalation|Physician Decision|0|||
129177303|NCT01286987|464943263|FG010|Part 1: Dose Escalation|Physician Decision|0|||
129177304|NCT01286987|464943264|FG011|Part 1: Dose Escalation|Physician Decision|0|||
129177305|NCT01286987|464943265|FG012|Part 1: Dose Escalation|Physician Decision|0|||
129177306|NCT01286987|464943266|FG013|Part 1: Dose Escalation|Physician Decision|0|||
129177307|NCT01286987|464943267|FG014|Part 1: Dose Escalation|Physician Decision|0|||
129177308|NCT01286987|464943253|FG000|Part 2: Dose Expansion|Death|0|||
129177309|NCT01286987|464943254|FG001|Part 2: Dose Expansion|Death|0|||
129177310|NCT01286987|464943255|FG002|Part 2: Dose Expansion|Death|0|||
129177311|NCT01286987|464943256|FG003|Part 2: Dose Expansion|Death|0|||
129177312|NCT01286987|464943257|FG004|Part 2: Dose Expansion|Death|0|||
129177313|NCT01286987|464943258|FG005|Part 2: Dose Expansion|Death|0|||
129177314|NCT01286987|464943259|FG006|Part 2: Dose Expansion|Death|0|||
129177315|NCT01286987|464943260|FG007|Part 2: Dose Expansion|Death|0|||
129177316|NCT01286987|464943261|FG008|Part 2: Dose Expansion|Death|0|||
129177317|NCT01286987|464943262|FG009|Part 2: Dose Expansion|Death|0|||
129177318|NCT01286987|464943263|FG010|Part 2: Dose Expansion|Death|0|||
129177319|NCT01286987|464943264|FG011|Part 2: Dose Expansion|Death|0|||
129177320|NCT01286987|464943265|FG012|Part 2: Dose Expansion|Death|1|||
129177321|NCT01286987|464943266|FG013|Part 2: Dose Expansion|Death|1|||
129177322|NCT01286987|464943267|FG014|Part 2: Dose Expansion|Death|0|||
129177323|NCT01286987|464943253|FG000|Part 2: Dose Expansion|Physician Decision|0|||
129177324|NCT01286987|464943254|FG001|Part 2: Dose Expansion|Physician Decision|0|||
129177325|NCT01286987|464943255|FG002|Part 2: Dose Expansion|Physician Decision|0|||
129177326|NCT01286987|464943256|FG003|Part 2: Dose Expansion|Physician Decision|0|||
129177327|NCT01286987|464943257|FG004|Part 2: Dose Expansion|Physician Decision|0|||
129177328|NCT01286987|464943258|FG005|Part 2: Dose Expansion|Physician Decision|0|||
129177329|NCT01286987|464943259|FG006|Part 2: Dose Expansion|Physician Decision|0|||
129177330|NCT01286987|464943260|FG007|Part 2: Dose Expansion|Physician Decision|0|||
129177331|NCT01286987|464943261|FG008|Part 2: Dose Expansion|Physician Decision|0|||
129177332|NCT01286987|464943262|FG009|Part 2: Dose Expansion|Physician Decision|0|||
129177333|NCT01286987|464943263|FG010|Part 2: Dose Expansion|Physician Decision|1|||
129177334|NCT01286987|464943264|FG011|Part 2: Dose Expansion|Physician Decision|1|||
129177335|NCT01286987|464943265|FG012|Part 2: Dose Expansion|Physician Decision|0|||
129177336|NCT01286987|464943266|FG013|Part 2: Dose Expansion|Physician Decision|1|||
129177337|NCT01286987|464943267|FG014|Part 2: Dose Expansion|Physician Decision|0|||
129177338|NCT01286987|464943253|FG000|Part 2: Dose Expansion|Other|0|||
129177339|NCT01286987|464943254|FG001|Part 2: Dose Expansion|Other|0|||
129177340|NCT01286987|464943255|FG002|Part 2: Dose Expansion|Other|0|||
129177341|NCT01286987|464943256|FG003|Part 2: Dose Expansion|Other|0|||
129177342|NCT01286987|464943257|FG004|Part 2: Dose Expansion|Other|0|||
129177343|NCT01286987|464943258|FG005|Part 2: Dose Expansion|Other|0|||
129177344|NCT01286987|464943259|FG006|Part 2: Dose Expansion|Other|0|||
129177345|NCT01286987|464943260|FG007|Part 2: Dose Expansion|Other|0|||
129177346|NCT01286987|464943261|FG008|Part 2: Dose Expansion|Other|0|||
129177347|NCT01286987|464943262|FG009|Part 2: Dose Expansion|Other|0|||
129177348|NCT01286987|464943263|FG010|Part 2: Dose Expansion|Other|0|||
129177349|NCT01286987|464943264|FG011|Part 2: Dose Expansion|Other|0|||
129177350|NCT01286987|464943265|FG012|Part 2: Dose Expansion|Other|0|||
129177351|NCT01286987|464943266|FG013|Part 2: Dose Expansion|Other|1|||
129177352|NCT01286987|464943267|FG014|Part 2: Dose Expansion|Other|0|||
129177353|NCT01286987|464943253|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
129177354|NCT01286987|464943254|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
129177355|NCT01286987|464943255|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
129177356|NCT01286987|464943256|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
129177357|NCT01286987|464943257|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
129177358|NCT01286987|464943258|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
129177359|NCT01286987|464943259|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
129177360|NCT01286987|464943260|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
129177361|NCT01286987|464943261|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
129177362|NCT01286987|464943262|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
129177363|NCT01286987|464943263|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
129177364|NCT01286987|464943264|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
129177365|NCT01286987|464943265|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
129177366|NCT01286987|464943266|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
129177367|NCT01286987|464943267|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
129177368|NCT01286987|464943253|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
129177369|NCT01286987|464943254|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
129177370|NCT01286987|464943255|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
129177371|NCT01286987|464943256|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
129177372|NCT01286987|464943257|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
129177373|NCT01286987|464943258|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
129177374|NCT01286987|464943259|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
129177375|NCT01286987|464943260|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
129177376|NCT01286987|464943261|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
129177377|NCT01286987|464943262|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
129177378|NCT01286987|464943263|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
129177379|NCT01286987|464943264|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
129177380|NCT01286987|464943265|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
129177381|NCT01286987|464943266|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
129177382|NCT01286987|464943267|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
129177383|NCT01286987|464943253|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177384|NCT01286987|464943254|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177385|NCT01286987|464943255|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177386|NCT01286987|464943256|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177387|NCT01286987|464943257|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177388|NCT01286987|464943258|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177389|NCT01286987|464943259|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177390|NCT01286987|464943260|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177391|NCT01286987|464943261|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177392|NCT01286987|464943262|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177393|NCT01286987|464943263|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
129177394|NCT01286987|464943264|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177395|NCT01286987|464943265|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177396|NCT01286987|464943266|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177397|NCT01286987|464943267|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129177398|NCT02594098|464943268|FG000|Overall Study|Lack of Efficacy|17|||
129177399|NCT02594098|464943269|FG001|Overall Study|Lack of Efficacy|6|||
129177400|NCT02594098|464943268|FG000|Overall Study|Withdrawal by Subject|1|||
129177401|NCT02594098|464943269|FG001|Overall Study|Withdrawal by Subject|3|||
129177402|NCT02594098|464943268|FG000|Overall Study|Terminated participation|6|||
129177403|NCT02594098|464943269|FG001|Overall Study|Terminated participation|2|||
129177404|NCT02594098|464943268|FG000|Overall Study|Seek alternative treatment|2|||
129177405|NCT02594098|464943269|FG001|Overall Study|Seek alternative treatment|1|||
129177406|NCT02594098|464943268|FG000|Overall Study|Other|0|||
129177407|NCT02594098|464943269|FG001|Overall Study|Other|1|||
129177408|NCT00033540|464943270|FG000|Overall Study|Adverse Event|14|||
129177409|NCT00033540|464943270|FG000|Overall Study|Death|1|||
129177410|NCT00033540|464943270|FG000|Overall Study|Progression|26|||
129177411|NCT00033540|464943270|FG000|Overall Study|Withdrawal by Subject|6|||
129177412|NCT00033540|464943270|FG000|Overall Study|Other|5|||
129177413|NCT00033540|464943270|FG000|Overall Study|Ineligible|3|||
129177414|NCT00033540|464943270|FG000|Overall Study|Never received treatment|2|||
129177415|NCT03366103|464943271|FG000|Overall Study|Disease Progression|3|||
129177416|NCT03366103|464943272|FG001|Overall Study|Disease Progression|1|||
129177417|NCT03366103|464943273|FG002|Overall Study|Disease Progression|0|||
129177418|NCT03366103|464943271|FG000|Overall Study|Adverse Event|0|||
129177419|NCT03366103|464943272|FG001|Overall Study|Adverse Event|1|||
129177420|NCT03366103|464943273|FG002|Overall Study|Adverse Event|0|||
129177421|NCT01036529|464943274|FG000|Overall Study|Adverse Event|0|||
129177422|NCT01036529|464943275|FG001|Overall Study|Adverse Event|1|||
129177423|NCT01036529|464943274|FG000|Overall Study|Lost to Follow-up|0|||
129177424|NCT01036529|464943275|FG001|Overall Study|Lost to Follow-up|1|||
129177425|NCT01036529|464943274|FG000|Overall Study|Physician Decision|1|||
129177426|NCT01036529|464943275|FG001|Overall Study|Physician Decision|0|||
129177427|NCT01036529|464943274|FG000|Overall Study|Withdrawal by Subject|1|||
129177428|NCT01036529|464943275|FG001|Overall Study|Withdrawal by Subject|1|||
129177429|NCT01036529|464943274|FG000|Overall Study|Sponsor study termination|11|||
129177430|NCT01036529|464943275|FG001|Overall Study|Sponsor study termination|12|||
129177431|NCT01853072|464943276|FG000|Overall Study|Adverse event prior to treatment|0|||
129177432|NCT01853072|464943277|FG001|Overall Study|Adverse event prior to treatment|1|||
129177433|NCT01853072|464943276|FG000|Overall Study|Adverse Event|0|||
129177434|NCT01853072|464943277|FG001|Overall Study|Adverse Event|3|||
129177435|NCT01853072|464943276|FG000|Overall Study|Death|1|||
129177436|NCT01853072|464943277|FG001|Overall Study|Death|4|||
129177437|NCT01853072|464943276|FG000|Overall Study|Lost to Follow-up|0|||
129177438|NCT01853072|464943277|FG001|Overall Study|Lost to Follow-up|3|||
129177439|NCT01853072|464943276|FG000|Overall Study|Non-compliance with study drug|0|||
128982134|NCT00508820|464219107|FG001|Overall Study|Physician Decision|2|||
129177440|NCT01853072|464943277|FG001|Overall Study|Non-compliance with study drug|1|||
129177441|NCT01853072|464943276|FG000|Overall Study|Physician Decision|1|||
129177442|NCT01853072|464943277|FG001|Overall Study|Physician Decision|1|||
129177443|NCT01853072|464943276|FG000|Overall Study|Withdrawal by Subject|1|||
129177444|NCT01853072|464943277|FG001|Overall Study|Withdrawal by Subject|2|||
129177445|NCT01853072|464943276|FG000|Overall Study|Reason not specified|9|||
129177446|NCT01853072|464943277|FG001|Overall Study|Reason not specified|6|||
129177447|NCT01816906|464943278|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
129177448|NCT01816906|464943279|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
129177449|NCT01816906|464943278|FG000|Six Months|Lost to Follow-up|14|||
129177450|NCT01816906|464943279|FG001|Six Months|Lost to Follow-up|16|||
129177451|NCT01816906|464943278|FG000|12 Months|Adverse Event|2|||
129177452|NCT01816906|464943279|FG001|12 Months|Adverse Event|2|||
129177453|NCT01816906|464943278|FG000|12 Months|Death|0|||
129177454|NCT01816906|464943279|FG001|12 Months|Death|2|||
129177455|NCT01816906|464943278|FG000|12 Months|Lost to Follow-up|2|||
129177456|NCT01816906|464943279|FG001|12 Months|Lost to Follow-up|1|||
129177457|NCT01527383|464943280|FG000|Overall Study|Adverse Event|5|||
129177458|NCT01527383|464943281|FG001|Overall Study|Adverse Event|0|||
129177459|NCT01527383|464943280|FG000|Overall Study|Lost to Follow-up|3|||
129177460|NCT01527383|464943281|FG001|Overall Study|Lost to Follow-up|0|||
129177461|NCT01527383|464943280|FG000|Overall Study|Physician Decision|2|||
129177462|NCT01527383|464943281|FG001|Overall Study|Physician Decision|0|||
129177463|NCT01527383|464943280|FG000|Overall Study|Pregnancy|1|||
129177464|NCT01527383|464943281|FG001|Overall Study|Pregnancy|0|||
129177465|NCT01527383|464943280|FG000|Overall Study|Protocol Violation|1|||
129177466|NCT01527383|464943281|FG001|Overall Study|Protocol Violation|0|||
129177467|NCT01527383|464943280|FG000|Overall Study|Screen failure|1|||
129177468|NCT01527383|464943281|FG001|Overall Study|Screen failure|0|||
129177469|NCT01527383|464943280|FG000|Overall Study|Participant moved|0|||
129177470|NCT01527383|464943281|FG001|Overall Study|Participant moved|1|||
129177471|NCT01527383|464943280|FG000|Overall Study|Withdrawal by Subject|2|||
129177472|NCT01527383|464943281|FG001|Overall Study|Withdrawal by Subject|3|||
129177473|NCT00746733|464943282|FG000|Second Intervention|Adverse Event|1|||
129177474|NCT00746733|464943283|FG001|Second Intervention|Adverse Event|0|||
129177475|NCT00746733|464943282|FG000|Third Intervention|Withdrawal by Subject|1|||
129177476|NCT00746733|464943283|FG001|Third Intervention|Withdrawal by Subject|1|||
129177477|NCT03412604|464943284|FG000|Overall Study|Withdrawal by Subject|1|||
129177478|NCT01287221|464943286|FG000|Overall Study|Lack of Perceived Benefit|1|||
129177479|NCT01287221|464943287|FG001|Overall Study|Lack of Perceived Benefit|1|||
129177480|NCT01287221|464943286|FG000|Overall Study|Adverse Event|3|||
129177481|NCT01287221|464943287|FG001|Overall Study|Adverse Event|3|||
129177482|NCT01287221|464943286|FG000|Overall Study|Withdrawal by Subject|0|||
129177483|NCT01287221|464943287|FG001|Overall Study|Withdrawal by Subject|1|||
129177484|NCT00930969|464943288|FG000|Overall Study|Death|5|||
129177485|NCT00930969|464943288|FG000|Overall Study|Lost to Follow-up|1|||
129177486|NCT00930969|464943288|FG000|Overall Study|Physician Decision|13|||
129177487|NCT00930969|464943288|FG000|Overall Study|Withdrawal by Subject|19|||
129177488|NCT00787137|464943290|FG000|Overall Study|Study Termination|0|||
129177489|NCT00787137|464943291|FG001|Overall Study|Study Termination|0|||
129177490|NCT00787137|464943292|FG002|Overall Study|Study Termination|1|||
129177491|NCT02513823|464943294|FG000|Overall Study|Lost to Follow-up|4|||
129177492|NCT02513823|464943294|FG000|Overall Study|Physician Decision|1|||
129177493|NCT02743780|464943299|FG000|Part 3 (7 Days)|Adverse Event|0|||
129177494|NCT02743780|464943300|FG001|Part 3 (7 Days)|Adverse Event|0|||
129177495|NCT02743780|464943301|FG002|Part 3 (7 Days)|Adverse Event|1|||
129177496|NCT02743780|464943302|FG003|Part 3 (7 Days)|Adverse Event|0|||
129177497|NCT02743780|464943303|FG004|Part 3 (7 Days)|Adverse Event|0|||
129177498|NCT01294462|464943304|FG000|Overall Study|Lost to Follow-up|1|||
129177499|NCT01294462|464943305|FG001|Overall Study|Lost to Follow-up|0|||
129177500|NCT01294462|464943304|FG000|Overall Study|Withdrawal by Subject|65|||
129177501|NCT01294462|464943305|FG001|Overall Study|Withdrawal by Subject|63|||
129177502|NCT04342689|464943313|FG000|Overall Study|Withdrawal by Subject|32|||
129177503|NCT04342689|464943314|FG001|Overall Study|Withdrawal by Subject|33|||
129177504|NCT04342689|464943313|FG000|Overall Study|Lost to Follow-up|10|||
129177505|NCT04342689|464943314|FG001|Overall Study|Lost to Follow-up|12|||
129177506|NCT01460407|464943317|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
129177507|NCT01460407|464943318|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
129177508|NCT04070326|464943319|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
129177509|NCT04070326|464943320|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
129177510|NCT01367704|464943324|FG000|Overall Study|Lost to Follow-up|47|||
129177511|NCT01367704|464943325|FG001|Overall Study|Lost to Follow-up|161|||
129177512|NCT00526110|464943326|FG000|Overall Study|Adverse Event|2|||
129177513|NCT00526110|464943327|FG001|Overall Study|Adverse Event|9|||
129177514|NCT00526110|464943326|FG000|Overall Study|Disease Progression|0|||
129177515|NCT00526110|464943327|FG001|Overall Study|Disease Progression|19|||
129177516|NCT00526110|464943326|FG000|Overall Study|Maximal Response|0|||
129177517|NCT00526110|464943327|FG001|Overall Study|Maximal Response|6|||
129177518|NCT00526110|464943326|FG000|Overall Study|Withdrawal by Subject|0|||
129177519|NCT00526110|464943327|FG001|Overall Study|Withdrawal by Subject|2|||
129177520|NCT00526110|464943326|FG000|Overall Study|Poor Tolerance|0|||
129177521|NCT00526110|464943327|FG001|Overall Study|Poor Tolerance|5|||
129177522|NCT01400243|464943328|FG000|Overall Study|Protocol Violation|8|||
129177523|NCT01400243|464943329|FG001|Overall Study|Protocol Violation|11|||
129177524|NCT02193087|464943331|FG000|Overall Study|Adverse Event|2|||
129177525|NCT02193087|464943332|FG001|Overall Study|Adverse Event|0|||
129177526|NCT02193087|464943333|FG002|Overall Study|Adverse Event|0|||
129177527|NCT02193087|464943334|FG003|Overall Study|Adverse Event|11|||
129177528|NCT02193087|464943331|FG000|Overall Study|Lost to Follow-up|14|||
129177529|NCT02193087|464943332|FG001|Overall Study|Lost to Follow-up|6|||
129177530|NCT02193087|464943333|FG002|Overall Study|Lost to Follow-up|4|||
129177531|NCT02193087|464943334|FG003|Overall Study|Lost to Follow-up|37|||
129177532|NCT02193087|464943331|FG000|Overall Study|Protocol Violation|2|||
129177533|NCT02193087|464943332|FG001|Overall Study|Protocol Violation|0|||
129177534|NCT02193087|464943333|FG002|Overall Study|Protocol Violation|1|||
129177535|NCT02193087|464943334|FG003|Overall Study|Protocol Violation|2|||
129177536|NCT02193087|464943331|FG000|Overall Study|Withdrawal by Subject|10|||
129177537|NCT02193087|464943332|FG001|Overall Study|Withdrawal by Subject|3|||
129177538|NCT02193087|464943333|FG002|Overall Study|Withdrawal by Subject|1|||
129177539|NCT02193087|464943334|FG003|Overall Study|Withdrawal by Subject|19|||
129177540|NCT02193087|464943331|FG000|Overall Study|Other Reason Not Specified|7|||
129177541|NCT02193087|464943332|FG001|Overall Study|Other Reason Not Specified|2|||
129177542|NCT02193087|464943333|FG002|Overall Study|Other Reason Not Specified|1|||
129177543|NCT02193087|464943334|FG003|Overall Study|Other Reason Not Specified|9|||
129177544|NCT02193087|464943331|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
129177545|NCT02193087|464943332|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
129177546|NCT02193087|464943333|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
129177547|NCT02193087|464943334|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
129177548|NCT04096820|464943335|FG000|Overall Study|Did not return for intervention|2|||
129177549|NCT04096820|464943335|FG000|Overall Study|Death|1|||
129177550|NCT00475865|464943336|FG000|Overall Study|Adverse Event|0|||
129177551|NCT00475865|464943337|FG001|Overall Study|Adverse Event|3|||
129177552|NCT00475865|464943338|FG002|Overall Study|Adverse Event|4|||
129177553|NCT00475865|464943336|FG000|Overall Study|Lack of Efficacy|1|||
129177554|NCT00475865|464943337|FG001|Overall Study|Lack of Efficacy|0|||
129177555|NCT00475865|464943338|FG002|Overall Study|Lack of Efficacy|0|||
129177556|NCT00475865|464943336|FG000|Overall Study|Progressive disease|0|||
129177557|NCT00475865|464943337|FG001|Overall Study|Progressive disease|1|||
129177558|NCT00475865|464943338|FG002|Overall Study|Progressive disease|2|||
129177559|NCT00475865|464943336|FG000|Overall Study|Participant did not wish to continue|1|||
129177560|NCT00475865|464943337|FG001|Overall Study|Participant did not wish to continue|0|||
129177561|NCT00475865|464943338|FG002|Overall Study|Participant did not wish to continue|0|||
129177562|NCT00475865|464943336|FG000|Overall Study|Other than above|0|||
129177563|NCT00475865|464943337|FG001|Overall Study|Other than above|1|||
129177564|NCT00475865|464943338|FG002|Overall Study|Other than above|0|||
129177565|NCT00946322|464943341|FG000|Pre-treatment|participant failure to follow up|1|||
129177566|NCT00946322|464943341|FG000|Post-treatment|participant failure to follow up|2|||
129177567|NCT01453946|464943342|FG000|Overall Study|Did not receive drug for the taper phase|1|||
129177568|NCT01453946|464943342|FG000|Overall Study|Protocol Violation|2|||
129177569|NCT01453946|464943342|FG000|Overall Study|Lack of Efficacy|3|||
129177570|NCT01453946|464943342|FG000|Overall Study|Adverse Event|3|||
129177571|NCT00846040|464943343|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
129177572|NCT00846040|464943344|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
129177573|NCT00846040|464943345|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
129177574|NCT00846040|464943343|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
129177575|NCT00846040|464943344|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
129177576|NCT00846040|464943345|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
129177577|NCT01048866|464943346|FG000|Overall Study|Adverse Event|1|||
129177578|NCT01048866|464943347|FG001|Overall Study|Adverse Event|0|||
129177579|NCT01048866|464943346|FG000|Overall Study|Protocol Violation|1|||
129177580|NCT01048866|464943347|FG001|Overall Study|Protocol Violation|0|||
129177581|NCT01048866|464943346|FG000|Overall Study|Physician Decision|1|||
129177582|NCT01048866|464943347|FG001|Overall Study|Physician Decision|0|||
129177583|NCT01048866|464943346|FG000|Overall Study|Withdrawal by Subject|0|||
129177584|NCT01048866|464943347|FG001|Overall Study|Withdrawal by Subject|2|||
129177585|NCT01048866|464943346|FG000|Overall Study|Lost to Follow-up|0|||
129177586|NCT01048866|464943347|FG001|Overall Study|Lost to Follow-up|2|||
129177587|NCT01048866|464943346|FG000|Overall Study|Other|1|||
129177588|NCT01048866|464943347|FG001|Overall Study|Other|1|||
129177589|NCT04068519|464943348|FG000|Dose Verification|Death|15|||
129177590|NCT04068519|464943348|FG000|Dose Verification|Withdrawal by Subject|1|||
129177591|NCT04068519|464943348|FG000|Pharmacokinetic Sub-study|Death|35|||
129177592|NCT04068519|464943348|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
129177593|NCT04068519|464943348|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
129177594|NCT04068519|464943348|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
129177595|NCT04068519|464943348|FG000|Indication Expansion|Death|152|||
129177596|NCT04068519|464943348|FG000|Indication Expansion|Withdrawal by Subject|10|||
129177597|NCT04068519|464943348|FG000|Indication Expansion|Lost to Follow-up|7|||
129177598|NCT03959982|464945186|FG000|Overall Study|Withdrawal by Subject|1|||
129177599|NCT03959982|464945187|FG001|Overall Study|Withdrawal by Subject|0|||
129177600|NCT03959982|464945186|FG000|Overall Study|Physician Decision|2|||
129177601|NCT03959982|464945187|FG001|Overall Study|Physician Decision|0|||
129177602|NCT03959982|464945186|FG000|Overall Study|Lost to Follow-up|1|||
129177603|NCT03959982|464945187|FG001|Overall Study|Lost to Follow-up|0|||
129177604|NCT00758589|464945188|FG000|Overall Study|Adverse Event|3|||
129177605|NCT00758589|464945189|FG001|Overall Study|Adverse Event|2|||
129177606|NCT00758589|464945190|FG002|Overall Study|Adverse Event|5|||
129177607|NCT00758589|464945191|FG003|Overall Study|Adverse Event|4|||
129177608|NCT00758589|464945188|FG000|Overall Study|Withdrawal by Subject|0|||
129177609|NCT00758589|464945189|FG001|Overall Study|Withdrawal by Subject|1|||
129177610|NCT00758589|464945190|FG002|Overall Study|Withdrawal by Subject|1|||
129177611|NCT00758589|464945191|FG003|Overall Study|Withdrawal by Subject|1|||
129177612|NCT00758589|464945188|FG000|Overall Study|Palm stopped to work|0|||
129177613|NCT00758589|464945189|FG001|Overall Study|Palm stopped to work|0|||
129177614|NCT00758589|464945190|FG002|Overall Study|Palm stopped to work|0|||
129177615|NCT00758589|464945191|FG003|Overall Study|Palm stopped to work|1|||
129177616|NCT05320393|464945192|FG000|Overall Study|Withdrawal by Subject|1|||
129177617|NCT05320393|464945193|FG001|Overall Study|Withdrawal by Subject|0|||
129177618|NCT05320393|464945194|FG002|Overall Study|Withdrawal by Subject|2|||
129177619|NCT05320393|464945192|FG000|Overall Study|Lost to Follow-up|1|||
129177620|NCT05320393|464945193|FG001|Overall Study|Lost to Follow-up|2|||
129177621|NCT05320393|464945194|FG002|Overall Study|Lost to Follow-up|1|||
129177622|NCT05320393|464945192|FG000|Overall Study|Moved; too much driving|0|||
129177623|NCT05320393|464945193|FG001|Overall Study|Moved; too much driving|0|||
129177624|NCT05320393|464945194|FG002|Overall Study|Moved; too much driving|2|||
129177625|NCT05320393|464945192|FG000|Overall Study|Did not receive treatment|0|||
129177626|NCT05320393|464945193|FG001|Overall Study|Did not receive treatment|0|||
129177627|NCT05320393|464945194|FG002|Overall Study|Did not receive treatment|1|||
129177628|NCT05438602|464945200|FG000|Treatment (15 Days)|Adverse Event|2|||
129177629|NCT05438602|464945201|FG001|Treatment (15 Days)|Adverse Event|1|||
129177630|NCT05438602|464945202|FG002|Treatment (15 Days)|Adverse Event|3|||
129177631|NCT05438602|464945200|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
129177632|NCT05438602|464945201|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
129177633|NCT05438602|464945202|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
129177634|NCT05438602|464945200|FG000|Treatment (15 Days)|Other|0|||
129177635|NCT05438602|464945201|FG001|Treatment (15 Days)|Other|0|||
129177636|NCT05438602|464945202|FG002|Treatment (15 Days)|Other|1|||
129177637|NCT05438602|464945200|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
129177638|NCT05438602|464945201|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
129177639|NCT05438602|464945202|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
129177640|NCT05438602|464945200|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
129177641|NCT05438602|464945201|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
129177642|NCT05438602|464945202|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
129177643|NCT05438602|464945200|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
129177644|NCT05438602|464945201|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
129177645|NCT05438602|464945202|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
129177646|NCT05438602|464945200|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
129177647|NCT05438602|464945201|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
129177648|NCT05438602|464945202|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
129177649|NCT05438602|464945200|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
129177650|NCT05438602|464945201|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
129177651|NCT05438602|464945202|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
129177652|NCT05438602|464945200|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
129177653|NCT05438602|464945201|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
129177654|NCT05438602|464945202|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
129177655|NCT05438602|464945200|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
129177656|NCT05438602|464945201|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
129177657|NCT05438602|464945202|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
129177658|NCT02534935|464945203|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
129177659|NCT02534935|464945204|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
129177660|NCT02534935|464945205|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
129177661|NCT02534935|464945203|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
129177662|NCT02534935|464945204|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
129177663|NCT02534935|464945205|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
129177664|NCT02534935|464945203|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
129177665|NCT02534935|464945204|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
129177666|NCT02534935|464945205|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
129177667|NCT02534935|464945203|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
129177668|NCT02534935|464945204|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
129177669|NCT02534935|464945205|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
129177670|NCT02534935|464945203|FG000|Stage 1: 24 Months|Adverse Event|0|||
129177671|NCT02534935|464945204|FG001|Stage 1: 24 Months|Adverse Event|2|||
129177672|NCT02534935|464945205|FG002|Stage 1: 24 Months|Adverse Event|0|||
129177673|NCT02534935|464945203|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
129177674|NCT02534935|464945204|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
129177675|NCT02534935|464945205|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
129177676|NCT02534935|464945203|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
129177677|NCT02534935|464945204|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
129177678|NCT02534935|464945205|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
129177679|NCT01460719|464945206|FG000|Overall Study|Adverse Event|1|||
129177680|NCT01460719|464945206|FG000|Overall Study|Withdrawal by Subject|1|||
129177681|NCT02838901|464945210|FG000|Overall Study|Withdrawal by Subject|1|||
129177682|NCT02838901|464945211|FG001|Overall Study|Withdrawal by Subject|1|||
129177683|NCT02838901|464945210|FG000|Overall Study|Lost to Follow-up|1|||
129177684|NCT02838901|464945211|FG001|Overall Study|Lost to Follow-up|1|||
129177685|NCT00076336|464945212|FG000|Overall Study|Death|13|||
129177686|NCT00076336|464945213|FG001|Overall Study|Death|17|||
129177687|NCT00076336|464945212|FG000|Overall Study|Adverse Event|4|||
129177688|NCT00076336|464945213|FG001|Overall Study|Adverse Event|4|||
129177689|NCT00076336|464945212|FG000|Overall Study|Lost to Follow-up|4|||
129177690|NCT00076336|464945213|FG001|Overall Study|Lost to Follow-up|4|||
129177691|NCT00076336|464945212|FG000|Overall Study|Non-Compliance|2|||
128730189|NCT03400033|463308352|FG000|Overall Study|Withdrawal by Subject|1|||
129177692|NCT00076336|464945213|FG001|Overall Study|Non-Compliance|0|||
129177693|NCT00076336|464945212|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
129177694|NCT00076336|464945213|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
129177695|NCT00076336|464945212|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
129177696|NCT00076336|464945213|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
129177697|NCT00076336|464945212|FG000|Overall Study|Liver Transplantation|3|||
129177698|NCT00076336|464945213|FG001|Overall Study|Liver Transplantation|3|||
129177699|NCT00076336|464945212|FG000|Overall Study|Virologic Breakthrough|14|||
129177700|NCT00076336|464945213|FG001|Overall Study|Virologic Breakthrough|16|||
129177701|NCT00076336|464945212|FG000|Overall Study|Treatment failure|4|||
129177702|NCT00076336|464945213|FG001|Overall Study|Treatment failure|5|||
129177703|NCT04431713|464945214|FG000|Overall Study|Withdrawal by Subject|2|||
129177704|NCT04431713|464945215|FG001|Overall Study|Withdrawal by Subject|0|||
129177705|NCT04431713|464945214|FG000|Overall Study|Death|2|||
129177706|NCT04431713|464945215|FG001|Overall Study|Death|2|||
129177707|NCT02285114|464945217|FG000|Main Phase|Investigator's Discretion|0|||
129177708|NCT02285114|464945218|FG001|Main Phase|Investigator's Discretion|2|||
129177709|NCT02285114|464945219|FG002|Main Phase|Investigator's Discretion|0|||
129177710|NCT02285114|464945220|FG003|Main Phase|Investigator's Discretion|0|||
129177711|NCT02285114|464945221|FG004|Main Phase|Investigator's Discretion|0|||
129177712|NCT02285114|464945222|FG005|Main Phase|Investigator's Discretion|0|||
129177713|NCT02285114|464945217|FG000|Main Phase|Enrolled but Never Treated|1|||
129177714|NCT02285114|464945218|FG001|Main Phase|Enrolled but Never Treated|0|||
129177715|NCT02285114|464945219|FG002|Main Phase|Enrolled but Never Treated|0|||
129177716|NCT02285114|464945220|FG003|Main Phase|Enrolled but Never Treated|0|||
129177717|NCT02285114|464945221|FG004|Main Phase|Enrolled but Never Treated|0|||
129177718|NCT02285114|464945222|FG005|Main Phase|Enrolled but Never Treated|0|||
129177719|NCT02285114|464945217|FG000|Main Phase|Withdrew Consent|0|||
129177720|NCT02285114|464945218|FG001|Main Phase|Withdrew Consent|0|||
129177721|NCT02285114|464945219|FG002|Main Phase|Withdrew Consent|1|||
129177722|NCT02285114|464945220|FG003|Main Phase|Withdrew Consent|0|||
129177723|NCT02285114|464945221|FG004|Main Phase|Withdrew Consent|0|||
129177724|NCT02285114|464945222|FG005|Main Phase|Withdrew Consent|0|||
129177725|NCT02285114|464945217|FG000|Extension Phase|Investigator's Discretion|0|||
129177726|NCT02285114|464945218|FG001|Extension Phase|Investigator's Discretion|0|||
129177727|NCT02285114|464945219|FG002|Extension Phase|Investigator's Discretion|0|||
129177728|NCT02285114|464945220|FG003|Extension Phase|Investigator's Discretion|14|||
129177729|NCT02285114|464945221|FG004|Extension Phase|Investigator's Discretion|1|||
129177730|NCT02285114|464945222|FG005|Extension Phase|Investigator's Discretion|0|||
129177731|NCT02285114|464945217|FG000|Extension Phase|Lost to Follow-up|0|||
129177732|NCT02285114|464945218|FG001|Extension Phase|Lost to Follow-up|0|||
129177733|NCT02285114|464945219|FG002|Extension Phase|Lost to Follow-up|0|||
129177734|NCT02285114|464945220|FG003|Extension Phase|Lost to Follow-up|1|||
129177735|NCT02285114|464945221|FG004|Extension Phase|Lost to Follow-up|1|||
129177736|NCT02285114|464945222|FG005|Extension Phase|Lost to Follow-up|0|||
129177737|NCT02285114|464945217|FG000|Extension Phase|Non-compliance with Study Drug|0|||
129177738|NCT02285114|464945218|FG001|Extension Phase|Non-compliance with Study Drug|0|||
129177739|NCT02285114|464945219|FG002|Extension Phase|Non-compliance with Study Drug|0|||
129177740|NCT02285114|464945220|FG003|Extension Phase|Non-compliance with Study Drug|2|||
129177741|NCT02285114|464945221|FG004|Extension Phase|Non-compliance with Study Drug|0|||
129177742|NCT02285114|464945222|FG005|Extension Phase|Non-compliance with Study Drug|0|||
129177743|NCT02285114|464945217|FG000|Extension Phase|Pregnancy|0|||
129177744|NCT02285114|464945218|FG001|Extension Phase|Pregnancy|0|||
129177745|NCT02285114|464945219|FG002|Extension Phase|Pregnancy|0|||
129177746|NCT02285114|464945220|FG003|Extension Phase|Pregnancy|1|||
129177747|NCT02285114|464945221|FG004|Extension Phase|Pregnancy|0|||
129177748|NCT02285114|464945222|FG005|Extension Phase|Pregnancy|0|||
129177749|NCT01156389|464945228|FG000|Overall Study|Elevated liver enzymes|4|||
129177750|NCT01156389|464945229|FG001|Overall Study|Elevated liver enzymes|0|||
129177751|NCT01156389|464945228|FG000|Overall Study|Vomiting|0|||
129177752|NCT01156389|464945229|FG001|Overall Study|Vomiting|1|||
129177753|NCT04599166|464945236|FG000|Overall Study|Technological failure connecting to study app|80|||
129177754|NCT01777542|464945237|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
129177755|NCT01777542|464945238|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
129177756|NCT00953524|464945240|FG000|Overall Study|Adverse Event|2|||
129177757|NCT00953524|464945241|FG001|Overall Study|Adverse Event|0|||
129177758|NCT00953524|464945242|FG002|Overall Study|Adverse Event|1|||
129177759|NCT00953524|464945243|FG003|Overall Study|Adverse Event|2|||
129177760|NCT00953524|464945240|FG000|Overall Study|Protocol Violation|18|||
129177761|NCT00953524|464945241|FG001|Overall Study|Protocol Violation|10|||
129177762|NCT00953524|464945242|FG002|Overall Study|Protocol Violation|11|||
129177763|NCT00953524|464945243|FG003|Overall Study|Protocol Violation|6|||
129177764|NCT00953524|464945240|FG000|Overall Study|Lost to Follow-up|0|||
129177765|NCT00953524|464945241|FG001|Overall Study|Lost to Follow-up|1|||
129177766|NCT00953524|464945242|FG002|Overall Study|Lost to Follow-up|1|||
129177767|NCT00953524|464945243|FG003|Overall Study|Lost to Follow-up|0|||
129177768|NCT00953524|464945240|FG000|Overall Study|Withdrawal by Subject|2|||
129177769|NCT00953524|464945241|FG001|Overall Study|Withdrawal by Subject|4|||
129177770|NCT00953524|464945242|FG002|Overall Study|Withdrawal by Subject|1|||
129177771|NCT00953524|464945243|FG003|Overall Study|Withdrawal by Subject|0|||
129177772|NCT00869050|464945251|FG000|Overall Study|Screen Failure|3|||
129177773|NCT03554772|464945255|FG000|Overall Study|Lost to Follow-up|0|||
129177774|NCT03554772|464945256|FG001|Overall Study|Lost to Follow-up|0|||
129177775|NCT03554772|464945257|FG002|Overall Study|Lost to Follow-up|0|||
129177776|NCT03554772|464945258|FG003|Overall Study|Lost to Follow-up|2|||
129177777|NCT05136898|464945260|FG000|Overall Study|Adverse Event|2|||
129177778|NCT01145053|464945261|FG000|Overall Study|Adverse Event|22|||
129177779|NCT01145053|464945261|FG000|Overall Study|Lost to Follow-up|28|||
129177780|NCT01145053|464945261|FG000|Overall Study|Withdrawal by Subject|25|||
129177781|NCT01145053|464945261|FG000|Overall Study|Other|18|||
129177782|NCT01994863|464945262|FG000|Period 1|Adverse Event|4|||
129177783|NCT01994863|464945263|FG001|Period 1|Adverse Event|0|||
129177784|NCT01994863|464945262|FG000|Period 1|Withdrawal by Subject|1|||
129177785|NCT01994863|464945263|FG001|Period 1|Withdrawal by Subject|0|||
129177786|NCT01994863|464945262|FG000|Period 1|Trial stopped by sponsor|1|||
129177787|NCT01994863|464945263|FG001|Period 1|Trial stopped by sponsor|3|||
129177788|NCT01994863|464945262|FG000|Period 1|Lack of Efficacy|1|||
129177789|NCT01994863|464945263|FG001|Period 1|Lack of Efficacy|0|||
129177790|NCT01994863|464945262|FG000|Period 2|Adverse Event|0|||
129177791|NCT01994863|464945263|FG001|Period 2|Adverse Event|1|||
129177792|NCT01994863|464945262|FG000|Period 2|Lack of Efficacy|0|||
129177793|NCT01994863|464945263|FG001|Period 2|Lack of Efficacy|2|||
129177794|NCT01994863|464945262|FG000|Period 2|Withdrawal by Subject|1|||
129177795|NCT01994863|464945263|FG001|Period 2|Withdrawal by Subject|1|||
129177796|NCT03060512|464945264|FG000|Overall Study|Adverse Event|4|||
129177797|NCT03060512|464945265|FG001|Overall Study|Adverse Event|6|||
129177798|NCT03060512|464945264|FG000|Overall Study|Lost to Follow-up|1|||
129177799|NCT03060512|464945265|FG001|Overall Study|Lost to Follow-up|1|||
129177800|NCT03060512|464945264|FG000|Overall Study|Withdrawal by Subject|1|||
129177801|NCT03060512|464945265|FG001|Overall Study|Withdrawal by Subject|0|||
129177802|NCT03060512|464945264|FG000|Overall Study|Non-compliance with study medication|1|||
129177803|NCT03060512|464945265|FG001|Overall Study|Non-compliance with study medication|2|||
129177804|NCT03946124|464945266|FG000|Overall Study|Withdrawal by Subject|19|||
129177805|NCT00241631|464945268|FG000|Run in (2 Weeks)|Physician Decision|3|||
129177806|NCT00241631|464945269|FG001|Run in (2 Weeks)|Physician Decision|3|||
129177807|NCT00241631|464945268|FG000|Phase 1 (4 Weeks)|sore throat|1|||
129177808|NCT00241631|464945269|FG001|Phase 1 (4 Weeks)|sore throat|0|||
129177809|NCT00241631|464945268|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
129177810|NCT00241631|464945269|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
129177811|NCT00241631|464945268|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
129177812|NCT00241631|464945269|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
129177813|NCT00241631|464945268|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
129177814|NCT00241631|464945269|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
129177815|NCT03220581|464945271|FG000|Overall Study|Withdrawal by Subject|0|||
129177816|NCT03220581|464945272|FG001|Overall Study|Withdrawal by Subject|1|||
129177817|NCT03220581|464945271|FG000|Overall Study|Lost to Follow-up|3|||
129177818|NCT03220581|464945272|FG001|Overall Study|Lost to Follow-up|6|||
129177819|NCT00919867|464945273|FG000|First Intervention|Withdrawal by Subject|0|||
129177820|NCT00919867|464945274|FG001|First Intervention|Withdrawal by Subject|0|||
129177821|NCT00919867|464945275|FG002|First Intervention|Withdrawal by Subject|1|||
129177822|NCT00919867|464945276|FG003|First Intervention|Withdrawal by Subject|0|||
129177823|NCT00919867|464945277|FG004|First Intervention|Withdrawal by Subject|0|||
129177824|NCT00919867|464945278|FG005|First Intervention|Withdrawal by Subject|0|||
129177825|NCT00919867|464945273|FG000|First Intervention|Physician Decision|0|||
129177826|NCT00919867|464945274|FG001|First Intervention|Physician Decision|0|||
129177827|NCT00919867|464945275|FG002|First Intervention|Physician Decision|0|||
129177828|NCT00919867|464945276|FG003|First Intervention|Physician Decision|0|||
129177829|NCT00919867|464945277|FG004|First Intervention|Physician Decision|0|||
129177830|NCT00919867|464945278|FG005|First Intervention|Physician Decision|1|||
129177831|NCT02813668|464945282|FG000|Overall Study|Death|4|||
129177832|NCT02813668|464945282|FG000|Overall Study|Lost to Follow-up|509|||
129177833|NCT02813668|464945282|FG000|Overall Study|Withdrawal by Subject|148|||
129177834|NCT02813668|464945282|FG000|Overall Study|No longer at worksite|85|||
129177835|NCT02813668|464945282|FG000|Overall Study|Medical reasons not related to the study|4|||
129177836|NCT02185014|464945283|FG000|Overall Study|Adverse Event|18|||
129177837|NCT02185014|464945283|FG000|Overall Study|Withdrew Consent|8|||
129177838|NCT02185014|464945283|FG000|Overall Study|Lost to Follow-up|4|||
129177839|NCT02185014|464945283|FG000|Overall Study|Lack of Efficacy|14|||
129177840|NCT02185014|464945283|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
129177841|NCT02185014|464945283|FG000|Overall Study|Subject Noncompliance|1|||
129177842|NCT02185014|464945283|FG000|Overall Study|Other|4|||
129177843|NCT02370641|464945288|FG000|Overall Study|dropped study|4|||
129177844|NCT02370641|464945289|FG001|Overall Study|dropped study|2|||
129177845|NCT02133664|464945293|FG000|Overall Study|Lost to Follow-up|2|||
129177846|NCT02133664|464945294|FG001|Overall Study|Lost to Follow-up|1|||
129177847|NCT02133664|464945293|FG000|Overall Study|Adverse Event|3|||
129177848|NCT02133664|464945294|FG001|Overall Study|Adverse Event|6|||
129177849|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
129177850|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
129177851|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
129177852|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
129177853|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
129177854|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
129177855|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
129177856|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
129177857|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
129177858|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
129177859|NCT03906656|464945297|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
129177860|NCT03906656|464945298|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
129177861|NCT03906656|464945297|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
129177862|NCT03906656|464945298|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
129177863|NCT03906656|464945297|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
129177864|NCT03906656|464945298|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
129177865|NCT03906656|464945297|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
129177866|NCT03906656|464945298|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
129177867|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
129177868|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
129177869|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
129177870|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
129177871|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
129177872|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
129177873|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
129177874|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
129177875|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
129177876|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
129177877|NCT03906656|464945297|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
129177878|NCT03906656|464945298|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
129177879|NCT03906656|464945297|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
129177880|NCT03906656|464945298|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
129177881|NCT03906656|464945297|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
129177882|NCT03906656|464945298|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
129177883|NCT03906656|464945297|FG000|Home Use 2 (3 Months)|Death|2|||
129177884|NCT03906656|464945298|FG001|Home Use 2 (3 Months)|Death|0|||
129177885|NCT03906656|464945297|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
129177886|NCT03906656|464945298|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
129177887|NCT03906656|464945297|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
129177888|NCT03906656|464945298|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
129177889|NCT01945775|464945299|FG000|Overall Study|Death|214|||
129177890|NCT01945775|464945300|FG001|Overall Study|Death|98|||
129177891|NCT01945775|464945299|FG000|Overall Study|Lost to Follow-up|12|||
129177892|NCT01945775|464945300|FG001|Overall Study|Lost to Follow-up|7|||
129177893|NCT01945775|464945299|FG000|Overall Study|Withdrawal by Subject|11|||
129177894|NCT01945775|464945300|FG001|Overall Study|Withdrawal by Subject|21|||
129177895|NCT01945775|464945299|FG000|Overall Study|Other|50|||
129177896|NCT01945775|464945300|FG001|Overall Study|Other|18|||
129177897|NCT02876328|464945301|FG000|Overall Study|Death|2|||
129177898|NCT02876328|464945302|FG001|Overall Study|Death|1|||
129177899|NCT02876328|464945303|FG002|Overall Study|Death|3|||
129177900|NCT02876328|464945304|FG003|Overall Study|Death|0|||
129177901|NCT02876328|464945305|FG004|Overall Study|Death|0|||
129177902|NCT02876328|464945306|FG005|Overall Study|Death|0|||
129177903|NCT02876328|464945307|FG006|Overall Study|Death|1|||
129177904|NCT02876328|464945308|FG007|Overall Study|Death|3|||
129177905|NCT02876328|464945309|FG008|Overall Study|Death|0|||
129177906|NCT02876328|464945310|FG009|Overall Study|Death|1|||
129177907|NCT02876328|464945311|FG010|Overall Study|Death|1|||
129177908|NCT02876328|464945312|FG011|Overall Study|Death|0|||
129177909|NCT02876328|464945313|FG012|Overall Study|Death|0|||
129177910|NCT02876328|464945314|FG013|Overall Study|Death|0|||
129177911|NCT02876328|464945315|FG014|Overall Study|Death|0|||
129177912|NCT02876328|464945316|FG015|Overall Study|Death|0|||
129177913|NCT02876328|464945317|FG016|Overall Study|Death|1|||
129177914|NCT02876328|464945318|FG017|Overall Study|Death|1|||
129177915|NCT02876328|464945319|FG018|Overall Study|Death|0|||
129177916|NCT02876328|464945320|FG019|Overall Study|Death|0|||
129177917|NCT02876328|464945321|FG020|Overall Study|Death|0|||
129177918|NCT02876328|464945322|FG021|Overall Study|Death|1|||
129177919|NCT02876328|464945323|FG022|Overall Study|Death|0|||
129177920|NCT02876328|464945324|FG023|Overall Study|Death|0|||
129177921|NCT02876328|464945301|FG000|Overall Study|Withdrawal by Subject|0|||
129177922|NCT02876328|464945302|FG001|Overall Study|Withdrawal by Subject|2|||
129177923|NCT02876328|464945303|FG002|Overall Study|Withdrawal by Subject|3|||
129177924|NCT02876328|464945304|FG003|Overall Study|Withdrawal by Subject|3|||
129177925|NCT02876328|464945305|FG004|Overall Study|Withdrawal by Subject|0|||
129177926|NCT02876328|464945306|FG005|Overall Study|Withdrawal by Subject|1|||
129177927|NCT02876328|464945307|FG006|Overall Study|Withdrawal by Subject|0|||
129177928|NCT02876328|464945308|FG007|Overall Study|Withdrawal by Subject|1|||
129177929|NCT02876328|464945309|FG008|Overall Study|Withdrawal by Subject|1|||
129177930|NCT02876328|464945310|FG009|Overall Study|Withdrawal by Subject|2|||
129177931|NCT02876328|464945311|FG010|Overall Study|Withdrawal by Subject|0|||
129177932|NCT02876328|464945312|FG011|Overall Study|Withdrawal by Subject|0|||
129177933|NCT02876328|464945313|FG012|Overall Study|Withdrawal by Subject|0|||
129177934|NCT02876328|464945314|FG013|Overall Study|Withdrawal by Subject|0|||
129177935|NCT02876328|464945315|FG014|Overall Study|Withdrawal by Subject|0|||
129177936|NCT02876328|464945316|FG015|Overall Study|Withdrawal by Subject|0|||
129177937|NCT02876328|464945317|FG016|Overall Study|Withdrawal by Subject|1|||
129177938|NCT02876328|464945318|FG017|Overall Study|Withdrawal by Subject|3|||
129177939|NCT02876328|464945319|FG018|Overall Study|Withdrawal by Subject|0|||
129177940|NCT02876328|464945320|FG019|Overall Study|Withdrawal by Subject|0|||
129177941|NCT02876328|464945321|FG020|Overall Study|Withdrawal by Subject|1|||
129177942|NCT02876328|464945322|FG021|Overall Study|Withdrawal by Subject|0|||
129177943|NCT02876328|464945323|FG022|Overall Study|Withdrawal by Subject|0|||
129177944|NCT02876328|464945324|FG023|Overall Study|Withdrawal by Subject|0|||
129177945|NCT02876328|464945301|FG000|Overall Study|Missed 12 Month Visit|15|||
129177946|NCT02876328|464945302|FG001|Overall Study|Missed 12 Month Visit|10|||
129177947|NCT02876328|464945303|FG002|Overall Study|Missed 12 Month Visit|11|||
129177948|NCT02876328|464945304|FG003|Overall Study|Missed 12 Month Visit|6|||
129177949|NCT02876328|464945305|FG004|Overall Study|Missed 12 Month Visit|10|||
129177950|NCT02876328|464945306|FG005|Overall Study|Missed 12 Month Visit|14|||
129177951|NCT02876328|464945307|FG006|Overall Study|Missed 12 Month Visit|3|||
129177952|NCT02876328|464945308|FG007|Overall Study|Missed 12 Month Visit|8|||
129177953|NCT02876328|464945309|FG008|Overall Study|Missed 12 Month Visit|9|||
129177954|NCT02876328|464945310|FG009|Overall Study|Missed 12 Month Visit|5|||
129177955|NCT02876328|464945311|FG010|Overall Study|Missed 12 Month Visit|4|||
129177956|NCT02876328|464945312|FG011|Overall Study|Missed 12 Month Visit|1|||
129177957|NCT02876328|464945313|FG012|Overall Study|Missed 12 Month Visit|5|||
128780935|NCT01323660|463488630|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
128780936|NCT01323660|463488631|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
128780937|NCT01323660|463488626|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129177958|NCT02876328|464945314|FG013|Overall Study|Missed 12 Month Visit|4|||
129177959|NCT02876328|464945315|FG014|Overall Study|Missed 12 Month Visit|4|||
129177960|NCT02876328|464945316|FG015|Overall Study|Missed 12 Month Visit|4|||
129177961|NCT02876328|464945317|FG016|Overall Study|Missed 12 Month Visit|3|||
129177962|NCT02876328|464945318|FG017|Overall Study|Missed 12 Month Visit|6|||
129177963|NCT02876328|464945319|FG018|Overall Study|Missed 12 Month Visit|2|||
129177964|NCT02876328|464945320|FG019|Overall Study|Missed 12 Month Visit|2|||
129177965|NCT02876328|464945321|FG020|Overall Study|Missed 12 Month Visit|11|||
129177966|NCT02876328|464945322|FG021|Overall Study|Missed 12 Month Visit|7|||
128780938|NCT01323660|463488627|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
128780939|NCT01323660|463488628|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129177967|NCT02876328|464945323|FG022|Overall Study|Missed 12 Month Visit|1|||
129177968|NCT02876328|464945324|FG023|Overall Study|Missed 12 Month Visit|0|||
129177969|NCT03515941|464945327|FG000|Overall Study|Adverse Event|1|||
129177970|NCT03515941|464945328|FG001|Overall Study|Adverse Event|0|||
129177971|NCT00334282|464945331|FG000|Overall Study|Lost to Follow-up|11|||
129177972|NCT00334282|464945332|FG001|Overall Study|Lost to Follow-up|5|||
129177973|NCT00334282|464945331|FG000|Overall Study|Withdrawal by Subject|17|||
129177974|NCT00334282|464945332|FG001|Overall Study|Withdrawal by Subject|3|||
129177975|NCT00334282|464945331|FG000|Overall Study|Death|194|||
129177976|NCT00334282|464945332|FG001|Overall Study|Death|100|||
129177977|NCT02759315|464945333|FG000|Overall Study|Adverse Event|0|||
129177978|NCT02759315|464945334|FG001|Overall Study|Adverse Event|0|||
129177979|NCT02759315|464945335|FG002|Overall Study|Adverse Event|0|||
128780940|NCT01323660|463488629|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129177980|NCT02759315|464945336|FG003|Overall Study|Adverse Event|1|||
129177981|NCT02759315|464945337|FG004|Overall Study|Adverse Event|0|||
129177982|NCT02759315|464945333|FG000|Overall Study|Death|0|||
129177983|NCT02759315|464945334|FG001|Overall Study|Death|0|||
129177984|NCT02759315|464945335|FG002|Overall Study|Death|1|||
129177985|NCT02759315|464945336|FG003|Overall Study|Death|0|||
129177986|NCT02759315|464945337|FG004|Overall Study|Death|0|||
129177987|NCT02759315|464945333|FG000|Overall Study|Lost to Follow-up|2|||
129177988|NCT02759315|464945334|FG001|Overall Study|Lost to Follow-up|0|||
129177989|NCT02759315|464945335|FG002|Overall Study|Lost to Follow-up|4|||
129177990|NCT02759315|464945336|FG003|Overall Study|Lost to Follow-up|0|||
129177991|NCT02759315|464945337|FG004|Overall Study|Lost to Follow-up|0|||
129177992|NCT02759315|464945333|FG000|Overall Study|Protocol Violation|0|||
129177993|NCT02759315|464945334|FG001|Overall Study|Protocol Violation|1|||
129177994|NCT02759315|464945335|FG002|Overall Study|Protocol Violation|0|||
129177995|NCT02759315|464945336|FG003|Overall Study|Protocol Violation|0|||
129177996|NCT02759315|464945337|FG004|Overall Study|Protocol Violation|0|||
129177997|NCT02759315|464945333|FG000|Overall Study|Study terminated prior to completion|2|||
129177998|NCT02759315|464945334|FG001|Overall Study|Study terminated prior to completion|0|||
129177999|NCT02759315|464945335|FG002|Overall Study|Study terminated prior to completion|5|||
129178000|NCT02759315|464945336|FG003|Overall Study|Study terminated prior to completion|0|||
129178001|NCT02759315|464945337|FG004|Overall Study|Study terminated prior to completion|1|||
129178002|NCT03464422|464945347|FG000|Overall Study|Lost to Follow-up|2|||
129178003|NCT03464422|464945347|FG000|Overall Study|Withdrawal by Subject|2|||
129178004|NCT01628367|464945352|FG000|Overall Study|Adverse Event|1|||
129178005|NCT01628367|464945353|FG001|Overall Study|Adverse Event|0|||
129178006|NCT03353922|464945354|FG000|Overall Study|Withdrawal by Subject|1|||
129178007|NCT03353922|464945355|FG001|Overall Study|Withdrawal by Subject|0|||
129178008|NCT03353922|464945356|FG002|Overall Study|Withdrawal by Subject|1|||
129178009|NCT03353922|464945357|FG003|Overall Study|Withdrawal by Subject|1|||
129178010|NCT03353922|464945358|FG004|Overall Study|Withdrawal by Subject|0|||
129178011|NCT03353922|464945359|FG005|Overall Study|Withdrawal by Subject|0|||
129178012|NCT03353922|464945354|FG000|Overall Study|Adverse Event|0|||
129178013|NCT03353922|464945355|FG001|Overall Study|Adverse Event|1|||
129178014|NCT03353922|464945356|FG002|Overall Study|Adverse Event|0|||
129178015|NCT03353922|464945357|FG003|Overall Study|Adverse Event|0|||
129178016|NCT03353922|464945358|FG004|Overall Study|Adverse Event|0|||
129178017|NCT03353922|464945359|FG005|Overall Study|Adverse Event|0|||
129178018|NCT00740714|464945360|FG000|Overall Study|Withdrawal by Subject|17|||
129178019|NCT00740714|464945361|FG001|Overall Study|Withdrawal by Subject|19|||
129178020|NCT00740714|464945362|FG002|Overall Study|Withdrawal by Subject|29|||
129178021|NCT03688555|464945363|FG000|Treatment Period|Adverse Event|0|||
129178022|NCT03688555|464945364|FG001|Treatment Period|Adverse Event|0|||
129178023|NCT03688555|464945365|FG002|Treatment Period|Adverse Event|1|||
129178024|NCT00886119|464945366|FG000|Period 1|Did not meet inclusion criteria|1|||
129178025|NCT00886119|464945367|FG001|Period 1|Did not meet inclusion criteria|0|||
129178026|NCT02153346|464945372|FG000|Overall Study|Lost to Follow-up|11|||
129178027|NCT03158272|464945376|FG000|Overall Study|Disease progression|3|||
129178028|NCT03158272|464945377|FG001|Overall Study|Disease progression|3|||
129178029|NCT03158272|464945378|FG002|Overall Study|Disease progression|4|||
129178030|NCT03158272|464945379|FG003|Overall Study|Disease progression|6|||
129178031|NCT03158272|464945376|FG000|Overall Study|Death|0|||
129178032|NCT03158272|464945377|FG001|Overall Study|Death|0|||
129178033|NCT03158272|464945378|FG002|Overall Study|Death|1|||
129178034|NCT03158272|464945379|FG003|Overall Study|Death|0|||
129178035|NCT03158272|464945376|FG000|Overall Study|Other reasons|0|||
129178036|NCT03158272|464945377|FG001|Overall Study|Other reasons|0|||
129178037|NCT03158272|464945378|FG002|Overall Study|Other reasons|1|||
129178038|NCT03158272|464945379|FG003|Overall Study|Other reasons|0|||
129178039|NCT03158272|464945376|FG000|Overall Study|Adverse event unrelated to the drug|0|||
129178040|NCT03158272|464945377|FG001|Overall Study|Adverse event unrelated to the drug|1|||
129178041|NCT03158272|464945378|FG002|Overall Study|Adverse event unrelated to the drug|0|||
129178042|NCT03158272|464945379|FG003|Overall Study|Adverse event unrelated to the drug|0|||
129178043|NCT01822535|464945380|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
129178044|NCT01822535|464945381|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
129178045|NCT01822535|464945380|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
129178046|NCT01822535|464945381|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
129178047|NCT01822535|464945380|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
129178048|NCT01822535|464945381|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
129178049|NCT02278614|464945384|FG000|Overall Study|Withdrawal by Subject|3|||
129178050|NCT02278614|464945385|FG001|Overall Study|Withdrawal by Subject|5|||
129178051|NCT02278614|464945384|FG000|Overall Study|Adverse Event|1|||
129178052|NCT02278614|464945385|FG001|Overall Study|Adverse Event|0|||
129178053|NCT02278614|464945384|FG000|Overall Study|left eye was not eligible|1|||
129178054|NCT02278614|464945385|FG001|Overall Study|left eye was not eligible|0|||
129178055|NCT02279498|464945388|FG000|Overall Study|Adverse Event|3|||
129178056|NCT02279498|464945389|FG001|Overall Study|Adverse Event|0|||
129178057|NCT02279498|464945388|FG000|Overall Study|Lack of Efficacy|4|||
129178058|NCT02279498|464945389|FG001|Overall Study|Lack of Efficacy|0|||
129178059|NCT02279498|464945388|FG000|Overall Study|Lost to Follow-up|0|||
129178060|NCT02279498|464945389|FG001|Overall Study|Lost to Follow-up|1|||
129178061|NCT02279498|464945388|FG000|Overall Study|Withdrawal by Subject|9|||
129178062|NCT02279498|464945389|FG001|Overall Study|Withdrawal by Subject|2|||
129178063|NCT02279498|464945388|FG000|Overall Study|Undefined|2|||
129178064|NCT02279498|464945389|FG001|Overall Study|Undefined|1|||
129178065|NCT03582813|464945390|FG000|Overall Study|Lost to Follow-up|18|||
129178066|NCT03582813|464945391|FG001|Overall Study|Lost to Follow-up|21|||
129178067|NCT03582813|464945390|FG000|Overall Study|Withdrawal by Subject|1|||
129178068|NCT03582813|464945391|FG001|Overall Study|Withdrawal by Subject|0|||
129178069|NCT02366767|464945394|FG000|Overall Study|left for home after 1 day at camp|1|||
129178070|NCT02366767|464945395|FG001|Overall Study|left for home after 1 day at camp|0|||
129178071|NCT02558400|464945398|FG000|Overall Study|Adverse Event|47|||
129178072|NCT02558400|464945399|FG001|Overall Study|Adverse Event|53|||
129178073|NCT02558400|464945400|FG002|Overall Study|Adverse Event|4|||
129178074|NCT02558400|464945398|FG000|Overall Study|Withdrawal by Subject|13|||
129178075|NCT02558400|464945399|FG001|Overall Study|Withdrawal by Subject|9|||
129178076|NCT02558400|464945400|FG002|Overall Study|Withdrawal by Subject|8|||
129178077|NCT02558400|464945398|FG000|Overall Study|Non-Compliant|0|||
129178078|NCT02558400|464945399|FG001|Overall Study|Non-Compliant|1|||
129178079|NCT02558400|464945400|FG002|Overall Study|Non-Compliant|3|||
129178080|NCT02558400|464945398|FG000|Overall Study|Lost to Follow-up|5|||
129178081|NCT02558400|464945399|FG001|Overall Study|Lost to Follow-up|5|||
129178082|NCT02558400|464945400|FG002|Overall Study|Lost to Follow-up|4|||
129178083|NCT02558400|464945398|FG000|Overall Study|Lack of Efficacy|0|||
129178084|NCT02558400|464945399|FG001|Overall Study|Lack of Efficacy|13|||
129178085|NCT02558400|464945400|FG002|Overall Study|Lack of Efficacy|1|||
129178086|NCT02558400|464945398|FG000|Overall Study|Disallowed Concurrent Medication|6|||
129178087|NCT02558400|464945399|FG001|Overall Study|Disallowed Concurrent Medication|7|||
129178088|NCT02558400|464945400|FG002|Overall Study|Disallowed Concurrent Medication|5|||
129178089|NCT02558400|464945398|FG000|Overall Study|Physician Decision|2|||
129178090|NCT02558400|464945399|FG001|Overall Study|Physician Decision|2|||
129178091|NCT02558400|464945400|FG002|Overall Study|Physician Decision|0|||
129178092|NCT02558400|464945398|FG000|Overall Study|Protocol Violation|6|||
129178093|NCT02558400|464945399|FG001|Overall Study|Protocol Violation|3|||
129178094|NCT02558400|464945400|FG002|Overall Study|Protocol Violation|8|||
129178095|NCT02558400|464945398|FG000|Overall Study|Death|0|||
129178096|NCT02558400|464945399|FG001|Overall Study|Death|1|||
129178097|NCT02558400|464945400|FG002|Overall Study|Death|0|||
129178098|NCT02558400|464945398|FG000|Overall Study|Ineligible for the study|0|||
129178099|NCT02558400|464945399|FG001|Overall Study|Ineligible for the study|2|||
129178100|NCT02558400|464945400|FG002|Overall Study|Ineligible for the study|0|||
129178101|NCT02230683|464945401|FG000|Overall Study|Adverse Event|1|||
129178102|NCT00260065|464945402|FG000|Overall Study|Progressive Disease|22|||
129178103|NCT00260065|464945402|FG000|Overall Study|Adverse Event|17|||
129178104|NCT00260065|464945402|FG000|Overall Study|Death|13|||
129178105|NCT00260065|464945402|FG000|Overall Study|Withdrawal by Subject|13|||
129178106|NCT00260065|464945402|FG000|Overall Study|Physician Decision|19|||
129178107|NCT00260065|464945402|FG000|Overall Study|Not otherwise specified|8|||
129178108|NCT00260065|464945402|FG000|Overall Study|Medication Noncompliance|1|||
129204792|NCT02421172|465046944|FG003|Period 1|Patient/guardian decision|0|||
129204793|NCT02421172|465046945|FG004|Period 1|Patient/guardian decision|0|||
129204794|NCT02421172|465046941|FG000|Period 2|Adverse Event|0|||
129204795|NCT02421172|465046942|FG001|Period 2|Adverse Event|0|||
129204796|NCT02421172|465046943|FG002|Period 2|Adverse Event|4|||
129204797|NCT02421172|465046944|FG003|Period 2|Adverse Event|0|||
129204798|NCT02421172|465046945|FG004|Period 2|Adverse Event|0|||
129204799|NCT02421172|465046941|FG000|Period 2|Lost to Follow-up|0|||
129204800|NCT02421172|465046942|FG001|Period 2|Lost to Follow-up|0|||
129204801|NCT02421172|465046943|FG002|Period 2|Lost to Follow-up|0|||
129204802|NCT02421172|465046944|FG003|Period 2|Lost to Follow-up|1|||
129204803|NCT02421172|465046945|FG004|Period 2|Lost to Follow-up|0|||
129204804|NCT02421172|465046941|FG000|Period 2|Patient/guardian decision|0|||
129204805|NCT02421172|465046942|FG001|Period 2|Patient/guardian decision|0|||
129204806|NCT02421172|465046943|FG002|Period 2|Patient/guardian decision|3|||
129204807|NCT02421172|465046944|FG003|Period 2|Patient/guardian decision|2|||
129204808|NCT02421172|465046945|FG004|Period 2|Patient/guardian decision|1|||
129204809|NCT00683878|465046948|FG000|Overall Study|Lack of Efficacy|3|||
129204810|NCT00683878|465046949|FG001|Overall Study|Lack of Efficacy|0|||
129204811|NCT00683878|465046950|FG002|Overall Study|Lack of Efficacy|1|||
129204812|NCT00683878|465046948|FG000|Overall Study|Adverse Event|4|||
129204813|NCT00683878|465046949|FG001|Overall Study|Adverse Event|3|||
129204814|NCT00683878|465046950|FG002|Overall Study|Adverse Event|3|||
129204815|NCT00683878|465046948|FG000|Overall Study|Withdrawal by Subject|9|||
129204816|NCT00683878|465046949|FG001|Overall Study|Withdrawal by Subject|8|||
129204817|NCT00683878|465046950|FG002|Overall Study|Withdrawal by Subject|6|||
129204818|NCT00683878|465046948|FG000|Overall Study|Death|0|||
129204819|NCT00683878|465046949|FG001|Overall Study|Death|1|||
129204820|NCT00683878|465046950|FG002|Overall Study|Death|0|||
129204821|NCT00683878|465046948|FG000|Overall Study|Lost to Follow-up|4|||
129204822|NCT00683878|465046949|FG001|Overall Study|Lost to Follow-up|2|||
129204823|NCT00683878|465046950|FG002|Overall Study|Lost to Follow-up|4|||
129204824|NCT00683878|465046948|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
129204825|NCT00683878|465046949|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
129204826|NCT00683878|465046950|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
129204827|NCT02869633|465046951|FG000|Overall Study|Death|2|||
129204828|NCT02869633|465046952|FG001|Overall Study|Death|1|||
129204829|NCT02869633|465046951|FG000|Overall Study|Patient refused follow-up|1|||
129204830|NCT02869633|465046952|FG001|Overall Study|Patient refused follow-up|0|||
129204831|NCT02869633|465046951|FG000|Overall Study|Provider discretion|1|||
129204832|NCT02869633|465046952|FG001|Overall Study|Provider discretion|0|||
129204833|NCT02869633|465046951|FG000|Overall Study|Investigator decision|1|||
129204834|NCT02869633|465046952|FG001|Overall Study|Investigator decision|0|||
129204835|NCT02869633|465046951|FG000|Overall Study|Lost to Follow-up|0|||
129204836|NCT02869633|465046952|FG001|Overall Study|Lost to Follow-up|1|||
129178109|NCT03654885|464946983|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
129178110|NCT03654885|464946984|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
129178111|NCT03654885|464946983|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
129178112|NCT03654885|464946984|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
129178113|NCT03654885|464946983|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
129178114|NCT03654885|464946984|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
129178115|NCT03654885|464946983|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
129178116|NCT03654885|464946984|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
129178117|NCT03654885|464946983|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
129178118|NCT03654885|464946984|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
129178119|NCT03654885|464946983|FG000|Overall Study|Adverse Event in Study Eye|3|||
129178120|NCT03654885|464946984|FG001|Overall Study|Adverse Event in Study Eye|0|||
129178121|NCT03654885|464946983|FG000|Overall Study|Consent Withdrawn|1|||
129178122|NCT03654885|464946984|FG001|Overall Study|Consent Withdrawn|0|||
129178123|NCT03654885|464946983|FG000|Overall Study|Death|3|||
129178124|NCT03654885|464946984|FG001|Overall Study|Death|1|||
129178125|NCT03654885|464946983|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
129178126|NCT03654885|464946984|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
129178127|NCT03654885|464946983|FG000|Overall Study|Lost to Follow-up|3|||
129178128|NCT03654885|464946984|FG001|Overall Study|Lost to Follow-up|3|||
129178129|NCT05275582|464946985|FG000|Overall Study|Lost to Follow-up|1|||
129178130|NCT05275582|464946986|FG001|Overall Study|Lost to Follow-up|0|||
129178131|NCT05275582|464946985|FG000|Overall Study|Withdrawal by Subject|0|||
129178132|NCT05275582|464946986|FG001|Overall Study|Withdrawal by Subject|2|||
129178133|NCT05275582|464946985|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
129178134|NCT05275582|464946986|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
129178135|NCT05275582|464946985|FG000|Overall Study|Death|1|||
129178136|NCT05275582|464946986|FG001|Overall Study|Death|0|||
129178137|NCT05275582|464946985|FG000|Overall Study|Protocol Violation|1|||
129178138|NCT05275582|464946986|FG001|Overall Study|Protocol Violation|0|||
129178139|NCT00031460|464946989|FG000|Overall Study|Lost to Follow-up|0|||
129178140|NCT00031460|464946990|FG001|Overall Study|Lost to Follow-up|1|||
129178141|NCT00031460|464946989|FG000|Overall Study|Withdrawal by Subject|1|||
129178142|NCT00031460|464946990|FG001|Overall Study|Withdrawal by Subject|1|||
129178143|NCT00031460|464946989|FG000|Overall Study|Non-Compliant|1|||
129178144|NCT00031460|464946990|FG001|Overall Study|Non-Compliant|1|||
129178145|NCT00031460|464946989|FG000|Overall Study|Death|0|||
129178146|NCT00031460|464946990|FG001|Overall Study|Death|1|||
129178147|NCT00031460|464946989|FG000|Overall Study|Reactivation of Disease|5|||
129178148|NCT00031460|464946990|FG001|Overall Study|Reactivation of Disease|9|||
129178149|NCT00031460|464946989|FG000|Overall Study|Disruption of blinded drug supply|2|||
129178150|NCT00031460|464946990|FG001|Overall Study|Disruption of blinded drug supply|0|||
129178151|NCT00031460|464946989|FG000|Overall Study|Confirmed unevaluable|0|||
129178152|NCT00031460|464946990|FG001|Overall Study|Confirmed unevaluable|1|||
129178153|NCT02210832|464946991|FG000|Overall Study|Pregnancy termination .|3|||
129178154|NCT02210832|464946992|FG001|Overall Study|Pregnancy termination .|4|||
129178155|NCT02210832|464946993|FG002|Overall Study|Pregnancy termination .|1|||
129178156|NCT02210832|464946991|FG000|Overall Study|Lost to Follow-up|26|||
129178157|NCT02210832|464946992|FG001|Overall Study|Lost to Follow-up|32|||
129178158|NCT02210832|464946993|FG002|Overall Study|Lost to Follow-up|17|||
129178159|NCT02080260|464946995|FG000|Overall Study|Death|18|||
129178160|NCT02080260|464946995|FG000|Overall Study|Withdrawal by Subject|1|||
129178161|NCT00471887|464947001|FG000|Overall Study|Adverse Event|9|||
129178162|NCT01030874|464947014|FG000|Overall Study|Withdrawal by Subject|1|||
129178163|NCT01030874|464947015|FG001|Overall Study|Withdrawal by Subject|0|||
129178164|NCT01030874|464947014|FG000|Overall Study|Discharged in first 2 weeks|17|||
129178165|NCT01030874|464947015|FG001|Overall Study|Discharged in first 2 weeks|16|||
129178166|NCT04639219|464947016|FG000|Overall Study|Withdrawal by Subject|8|||
129178167|NCT04639219|464947016|FG000|Overall Study|Lost to Follow-up|6|||
129178168|NCT04639219|464947016|FG000|Overall Study|Death|55|||
129178169|NCT01998893|464947017|FG000|Overall Study|Adverse Event|2|||
129178170|NCT01998893|464947017|FG000|Overall Study|Death|1|||
129178171|NCT01998893|464947017|FG000|Overall Study|Lost to Follow-up|8|||
129178172|NCT01998893|464947017|FG000|Overall Study|Physician Decision|2|||
129178173|NCT01998893|464947017|FG000|Overall Study|Protocol Violation|2|||
129178174|NCT01998893|464947017|FG000|Overall Study|Withdrawal by Subject|1|||
129178175|NCT01998893|464947017|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
129178176|NCT03784846|464947018|FG000|Pre-COVID Study|Lost to Follow-up|3|||
129178177|NCT03784846|464947019|FG001|Pre-COVID Study|Lost to Follow-up|3|||
129178178|NCT03784846|464947020|FG002|Pre-COVID Study|Lost to Follow-up|2|||
129178179|NCT03784846|464947018|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
129178180|NCT03784846|464947019|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
129204837|NCT02869633|465046951|FG000|Overall Study|Not eligible|6|||
129178181|NCT03784846|464947020|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
129178182|NCT03784846|464947018|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
129178183|NCT03784846|464947019|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
129178184|NCT03784846|464947020|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
129178185|NCT03784846|464947018|FG000|Post-COVID Study|Lost to Follow-up|3|||
129178186|NCT03784846|464947019|FG001|Post-COVID Study|Lost to Follow-up|5|||
129178187|NCT03784846|464947020|FG002|Post-COVID Study|Lost to Follow-up|1|||
129178188|NCT03784846|464947018|FG000|Post-COVID Study|Withdrawal by Subject|1|||
129178189|NCT03784846|464947019|FG001|Post-COVID Study|Withdrawal by Subject|2|||
129178190|NCT03784846|464947020|FG002|Post-COVID Study|Withdrawal by Subject|0|||
129178191|NCT00867087|464947021|FG000|Overall Study|Other|1|||
129178192|NCT00867087|464947021|FG000|Overall Study|Withdrawal by Subject|4|||
129178193|NCT00867087|464947021|FG000|Overall Study|Death|37|||
129178194|NCT03883113|464947023|FG000|Overall Study|Physician Decision|4|||
129178195|NCT03883113|464947024|FG001|Overall Study|Physician Decision|2|||
129178196|NCT03883113|464947023|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
129178197|NCT03883113|464947024|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
129178198|NCT03883113|464947023|FG000|Overall Study|Pregnancy|1|||
129178199|NCT03883113|464947024|FG001|Overall Study|Pregnancy|0|||
129178200|NCT03883113|464947023|FG000|Overall Study|Adverse Event|0|||
129178201|NCT03883113|464947024|FG001|Overall Study|Adverse Event|1|||
129178202|NCT03883113|464947023|FG000|Overall Study|Withdrawal by Subject|1|||
129178203|NCT03883113|464947024|FG001|Overall Study|Withdrawal by Subject|2|||
129178204|NCT03883113|464947023|FG000|Overall Study|Lost to Follow-up|1|||
129178205|NCT03883113|464947024|FG001|Overall Study|Lost to Follow-up|0|||
129178206|NCT01457950|464947025|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
129204838|NCT02869633|465046952|FG001|Overall Study|Not eligible|1|||
129204839|NCT02869633|465046951|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
129204840|NCT02869633|465046952|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
129204841|NCT02869633|465046951|FG000|Overall Study|Withdrawal by Subject|0|||
129204842|NCT02869633|465046952|FG001|Overall Study|Withdrawal by Subject|1|||
129204843|NCT04319198|465046955|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
129204844|NCT04319198|465046956|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
129204845|NCT04319198|465046957|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
129204846|NCT04319198|465046955|FG000|Overall Study|Death|0|||
129204847|NCT04319198|465046956|FG001|Overall Study|Death|3|||
129204848|NCT04319198|465046957|FG002|Overall Study|Death|3|||
129204849|NCT04319198|465046955|FG000|Overall Study|Reason Not Specified|0|||
129204850|NCT04319198|465046956|FG001|Overall Study|Reason Not Specified|2|||
129204851|NCT04319198|465046957|FG002|Overall Study|Reason Not Specified|4|||
129204852|NCT04319198|465046955|FG000|Overall Study|Withdrawal of Consent|0|||
129204853|NCT04319198|465046956|FG001|Overall Study|Withdrawal of Consent|0|||
129204854|NCT04319198|465046957|FG002|Overall Study|Withdrawal of Consent|5|||
129204855|NCT04319198|465046955|FG000|Overall Study|Site Terminated by Sponsor|0|||
129204856|NCT04319198|465046956|FG001|Overall Study|Site Terminated by Sponsor|1|||
129204857|NCT04319198|465046957|FG002|Overall Study|Site Terminated by Sponsor|0|||
129204858|NCT01693029|465046958|FG000|Overall Study|Withdrawal by Subject|15|||
129204859|NCT01693029|465046959|FG001|Overall Study|Withdrawal by Subject|22|||
129204860|NCT01693029|465046958|FG000|Overall Study|Kidney transplantation|7|||
129204861|NCT01693029|465046959|FG001|Overall Study|Kidney transplantation|7|||
129204862|NCT01693029|465046958|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
129204863|NCT01693029|465046959|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
129204864|NCT01693029|465046958|FG000|Overall Study|Protocol Violation|6|||
129204865|NCT01693029|465046959|FG001|Overall Study|Protocol Violation|7|||
129204866|NCT01693029|465046958|FG000|Overall Study|Change in dialysis modality|2|||
129204867|NCT01693029|465046959|FG001|Overall Study|Change in dialysis modality|1|||
129204868|NCT01693029|465046958|FG000|Overall Study|Physician Decision|0|||
129204869|NCT01693029|465046959|FG001|Overall Study|Physician Decision|2|||
129204870|NCT01693029|465046958|FG000|Overall Study|Lost to Follow-up|0|||
129204871|NCT01693029|465046959|FG001|Overall Study|Lost to Follow-up|1|||
129204872|NCT01693029|465046958|FG000|Overall Study|Adverse Event|1|||
129204873|NCT01693029|465046959|FG001|Overall Study|Adverse Event|6|||
129204874|NCT01693029|465046958|FG000|Overall Study|Death|5|||
129204875|NCT01693029|465046959|FG001|Overall Study|Death|8|||
129204876|NCT01693029|465046958|FG000|Overall Study|Non-compliance|2|||
129204877|NCT01693029|465046959|FG001|Overall Study|Non-compliance|1|||
129204878|NCT00657540|465046960|FG000|Overall Study|Lost to Follow-up|1|||
129204879|NCT00657540|465046961|FG001|Overall Study|Lost to Follow-up|4|||
129204880|NCT01169103|465046962|FG000|Overall Study|Lost to Follow-up|3|||
129204881|NCT01169103|465046963|FG001|Overall Study|Lost to Follow-up|3|||
129204882|NCT01169103|465046962|FG000|Overall Study|Withdrawal by Subject|3|||
129204883|NCT01169103|465046963|FG001|Overall Study|Withdrawal by Subject|1|||
129204884|NCT06039579|465046966|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129204885|NCT06039579|465046967|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129178207|NCT01457950|464947026|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
129178208|NCT01457950|464947027|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
129178209|NCT01457950|464947028|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
129178210|NCT01457950|464947025|FG000|Double-Blind Phase|Protocol Violation|2|||
129178211|NCT01457950|464947026|FG001|Double-Blind Phase|Protocol Violation|1|||
129178212|NCT01457950|464947027|FG002|Double-Blind Phase|Protocol Violation|0|||
129178213|NCT01457950|464947028|FG003|Double-Blind Phase|Protocol Violation|0|||
129178214|NCT01457950|464947025|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
129178215|NCT01457950|464947026|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
129178216|NCT01457950|464947027|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129178217|NCT01457950|464947028|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129178218|NCT01457950|464947025|FG000|Open-Label Phase|Adverse Event|0|||
129178219|NCT01457950|464947026|FG001|Open-Label Phase|Adverse Event|0|||
129178220|NCT01457950|464947027|FG002|Open-Label Phase|Adverse Event|0|||
129178221|NCT01457950|464947028|FG003|Open-Label Phase|Adverse Event|1|||
129178222|NCT01457950|464947025|FG000|Open-Label Phase|Protocol Violation|0|||
129178223|NCT01457950|464947026|FG001|Open-Label Phase|Protocol Violation|0|||
129178224|NCT01457950|464947027|FG002|Open-Label Phase|Protocol Violation|0|||
129178225|NCT01457950|464947028|FG003|Open-Label Phase|Protocol Violation|1|||
129178226|NCT01457950|464947025|FG000|Open-Label Phase|Withdrawal by Subject|0|||
129178227|NCT01457950|464947026|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129178228|NCT01457950|464947027|FG002|Open-Label Phase|Withdrawal by Subject|2|||
129178229|NCT01457950|464947028|FG003|Open-Label Phase|Withdrawal by Subject|0|||
129178230|NCT02498067|464947029|FG000|Overall Study|Lost to Follow-up|22|||
129178231|NCT02498067|464947029|FG000|Overall Study|Did not meet inclusion criteria|11|||
129178232|NCT01371643|464947034|FG000|Overall Study|Withdrawal by Subject|3|||
129178233|NCT01371643|464947035|FG001|Overall Study|Withdrawal by Subject|0|||
129178234|NCT03249935|464947036|FG000|Overall Study|Discharged from facility early|36|||
129178235|NCT03249935|464947036|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
129178236|NCT03249935|464947036|FG000|Overall Study|Protocol Violation|5|||
129178237|NCT03593681|464947037|FG000|Overall Study|Inadequate sample collected|12|||
129178238|NCT03593681|464947037|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
129178239|NCT03593681|464947037|FG000|Overall Study|Protocol Violation|3|||
129178240|NCT03593681|464947037|FG000|Overall Study|Withdrawal by Subject|3|||
129178241|NCT03593681|464947037|FG000|Overall Study|Procedure not attempted|3|||
129178242|NCT03593681|464947037|FG000|Overall Study|Adverse Event|2|||
129178243|NCT03593681|464947037|FG000|Overall Study|Physician Decision|1|||
129178244|NCT03987932|464947041|FG000|Overall Study|Lost to Follow-up|2|||
129178245|NCT03987932|464947042|FG001|Overall Study|Lost to Follow-up|1|||
129178246|NCT03987932|464947043|FG002|Overall Study|Lost to Follow-up|1|||
129178247|NCT03987932|464947041|FG000|Overall Study|Non-study related elective surgery|0|||
129178248|NCT03987932|464947042|FG001|Overall Study|Non-study related elective surgery|0|||
129178249|NCT03987932|464947043|FG002|Overall Study|Non-study related elective surgery|1|||
129178250|NCT01669421|464947047|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
129178251|NCT01669421|464947047|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
129178252|NCT01561755|464947053|FG000|Overall Study|Lost to Follow-up|0|||
129178253|NCT01561755|464947054|FG001|Overall Study|Lost to Follow-up|1|||
129178254|NCT04662073|464947056|FG000|Overall Study|Withdrawal by Subject|1|||
128730190|NCT03400033|463308353|FG001|Overall Study|Withdrawal by Subject|2|||
128730191|NCT02448875|463308354|FG000|Overall Study|Adverse Event|2|||
129178255|NCT04662073|464947057|FG001|Overall Study|Withdrawal by Subject|0|||
129178256|NCT00810901|464947058|FG000|Overall Study|Lost to Follow-up|88|||
129178257|NCT00810901|464947059|FG001|Overall Study|Lost to Follow-up|58|||
129178258|NCT00343915|464947066|FG000|Primary Study|Withdrawal by Subject|1|||
129178259|NCT00343915|464947067|FG001|Primary Study|Withdrawal by Subject|0|||
129178260|NCT00343915|464947066|FG000|Primary Study|Lost to Follow-up|2|||
129178261|NCT00343915|464947067|FG001|Primary Study|Lost to Follow-up|3|||
129178262|NCT00343915|464947066|FG000|Primary Study|Other|1|||
129178263|NCT00343915|464947067|FG001|Primary Study|Other|0|||
129178264|NCT00882908|464947068|FG000|Overall Study|Adverse Event|0|||
129178265|NCT00882908|464947069|FG001|Overall Study|Adverse Event|0|||
129178266|NCT00882908|464947070|FG002|Overall Study|Adverse Event|1|||
129178267|NCT00882908|464947071|FG003|Overall Study|Adverse Event|0|||
129178268|NCT00882908|464947072|FG004|Overall Study|Adverse Event|1|||
129178269|NCT00882908|464947068|FG000|Overall Study|Lost to Follow-up|3|||
129178270|NCT00882908|464947069|FG001|Overall Study|Lost to Follow-up|5|||
129178271|NCT00882908|464947070|FG002|Overall Study|Lost to Follow-up|3|||
129178272|NCT00882908|464947071|FG003|Overall Study|Lost to Follow-up|1|||
129178273|NCT00882908|464947072|FG004|Overall Study|Lost to Follow-up|2|||
129178274|NCT00882908|464947068|FG000|Overall Study|Protocol Violation|0|||
129178275|NCT00882908|464947069|FG001|Overall Study|Protocol Violation|1|||
129178276|NCT00882908|464947070|FG002|Overall Study|Protocol Violation|0|||
129178277|NCT00882908|464947071|FG003|Overall Study|Protocol Violation|0|||
129178278|NCT00882908|464947072|FG004|Overall Study|Protocol Violation|0|||
129178279|NCT00882908|464947068|FG000|Overall Study|Withdrawal by Subject|0|||
129178280|NCT00882908|464947069|FG001|Overall Study|Withdrawal by Subject|0|||
129178281|NCT00882908|464947070|FG002|Overall Study|Withdrawal by Subject|3|||
129178282|NCT00882908|464947071|FG003|Overall Study|Withdrawal by Subject|5|||
129178283|NCT00882908|464947072|FG004|Overall Study|Withdrawal by Subject|2|||
129178284|NCT00882908|464947068|FG000|Overall Study|Subject reached a virologic endpoint|0|||
129178285|NCT00882908|464947069|FG001|Overall Study|Subject reached a virologic endpoint|0|||
129178286|NCT00882908|464947070|FG002|Overall Study|Subject reached a virologic endpoint|0|||
129178287|NCT00882908|464947071|FG003|Overall Study|Subject reached a virologic endpoint|0|||
129178288|NCT00882908|464947072|FG004|Overall Study|Subject reached a virologic endpoint|1|||
129178289|NCT00882908|464947068|FG000|Overall Study|Study terminated in error|0|||
129178290|NCT00882908|464947069|FG001|Overall Study|Study terminated in error|0|||
129178291|NCT00882908|464947070|FG002|Overall Study|Study terminated in error|0|||
129178292|NCT00882908|464947071|FG003|Overall Study|Study terminated in error|1|||
129178293|NCT00882908|464947072|FG004|Overall Study|Study terminated in error|0|||
129178294|NCT05291936|464947073|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
129178295|NCT05291936|464947074|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
129178296|NCT05291936|464947073|FG000|Period 1|Withdrew Consent during study|1|||
129178297|NCT05291936|464947074|FG001|Period 1|Withdrew Consent during study|0|||
129178298|NCT05291936|464947073|FG000|Period 2|Adverse Event|0|||
129178299|NCT05291936|464947074|FG001|Period 2|Adverse Event|1|||
129178300|NCT05291936|464947073|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
129178301|NCT05291936|464947074|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129178302|NCT00581828|464947075|FG000|Overall Study|Protocol Violation|1|||
129178303|NCT02370095|464947076|FG000|Overall Study|Withdrawal by Subject|0|||
129178304|NCT02370095|464947077|FG001|Overall Study|Withdrawal by Subject|1|||
129178305|NCT01667562|464947078|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
129178306|NCT01667562|464947079|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
129178307|NCT01667562|464947078|FG000|Erlotinib Phase|Lost to Follow-up|0|||
129178308|NCT01667562|464947079|FG001|Erlotinib Phase|Lost to Follow-up|1|||
129178309|NCT01667562|464947078|FG000|Erlotinib Phase|Adverse Event|0|||
129178310|NCT01667562|464947079|FG001|Erlotinib Phase|Adverse Event|1|||
129178311|NCT01667562|464947078|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
129178312|NCT01667562|464947079|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
129178313|NCT02130986|464947083|FG000|Overall Study|Withdrawal by Subject|4|||
129178314|NCT02130986|464947084|FG001|Overall Study|Withdrawal by Subject|4|||
129178315|NCT02130986|464947083|FG000|Overall Study|Lost to Follow-up|151|||
129178316|NCT02130986|464947084|FG001|Overall Study|Lost to Follow-up|160|||
129178317|NCT01129882|464947085|FG000|Overall Study|Adverse Event|39|||
129178318|NCT01129882|464947085|FG000|Overall Study|Death|6|||
129178319|NCT01129882|464947085|FG000|Overall Study|Lack of Efficacy|5|||
129178320|NCT01129882|464947085|FG000|Overall Study|Lost to Follow-up|13|||
129178321|NCT01129882|464947085|FG000|Overall Study|Physician Decision|27|||
129178322|NCT01129882|464947085|FG000|Overall Study|Protocol Deviation|3|||
129178323|NCT01129882|464947085|FG000|Overall Study|Withdrawal Criteria Met|19|||
129178324|NCT01129882|464947085|FG000|Overall Study|Trial Termination by Sponsor|6|||
129178325|NCT01129882|464947085|FG000|Overall Study|Withdrawal by Subject|160|||
129178326|NCT05590000|464947086|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
129178327|NCT00762996|464947087|FG000|Period One|Protocol Violation|0|||
129178328|NCT00762996|464947088|FG001|Period One|Protocol Violation|0|||
129178329|NCT00762996|464947089|FG002|Period One|Protocol Violation|1|||
129178330|NCT00762996|464947090|FG003|Period One|Protocol Violation|0|||
129178331|NCT00762996|464947087|FG000|Period One|ineligible|0|||
129178332|NCT00762996|464947088|FG001|Period One|ineligible|0|||
129178333|NCT00762996|464947089|FG002|Period One|ineligible|1|||
129178334|NCT00762996|464947090|FG003|Period One|ineligible|1|||
129178335|NCT00762996|464947087|FG000|Period One|Adverse Event|0|||
129178336|NCT00762996|464947088|FG001|Period One|Adverse Event|0|||
129178337|NCT00762996|464947089|FG002|Period One|Adverse Event|1|||
129178338|NCT00762996|464947090|FG003|Period One|Adverse Event|0|||
129178339|NCT00762996|464947087|FG000|Period One|Withdrawal by Subject|0|||
129178340|NCT00762996|464947088|FG001|Period One|Withdrawal by Subject|0|||
129178341|NCT00762996|464947089|FG002|Period One|Withdrawal by Subject|1|||
129178342|NCT00762996|464947090|FG003|Period One|Withdrawal by Subject|0|||
129178343|NCT00536874|464947091|FG000|Overall Study|Adverse Event|1|||
129178344|NCT00536874|464947091|FG000|Overall Study|Death|2|||
129178345|NCT00536874|464947091|FG000|Overall Study|Withdrawal by Subject|1|||
129178346|NCT02689076|464947093|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
129178347|NCT02689076|464947094|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
129178348|NCT02689076|464947095|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
129178349|NCT02689076|464947093|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
129178350|NCT02689076|464947094|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
129178351|NCT02689076|464947095|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
129178352|NCT02689076|464947093|FG000|Overall Study|Did not have an HIE match|2|||
129178353|NCT02689076|464947094|FG001|Overall Study|Did not have an HIE match|0|||
129178354|NCT02689076|464947095|FG002|Overall Study|Did not have an HIE match|0|||
129178355|NCT02689076|464947093|FG000|Overall Study|Death during non-VA encounter|2|||
129178356|NCT02689076|464947094|FG001|Overall Study|Death during non-VA encounter|5|||
129178357|NCT02689076|464947095|FG002|Overall Study|Death during non-VA encounter|0|||
129178358|NCT02689076|464947093|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
129178359|NCT02689076|464947094|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
129178360|NCT02689076|464947095|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
129178361|NCT02689076|464947093|FG000|Overall Study|Participant no longer active in VA system|1|||
129178362|NCT02689076|464947094|FG001|Overall Study|Participant no longer active in VA system|0|||
129178363|NCT02689076|464947095|FG002|Overall Study|Participant no longer active in VA system|0|||
129178364|NCT02689076|464947093|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
129178365|NCT02689076|464947094|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
129178366|NCT02689076|464947095|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
129178367|NCT02084238|464947096|FG000|Overall Study|Lost to Follow-up|2|||
129178368|NCT01304329|464947097|FG000|Third Intervention (3 Days)|Adverse Event|0|||
129178369|NCT01304329|464947098|FG001|Third Intervention (3 Days)|Adverse Event|1|||
129178370|NCT01304329|464947099|FG002|Third Intervention (3 Days)|Adverse Event|0|||
129178371|NCT01304329|464947100|FG003|Third Intervention (3 Days)|Adverse Event|0|||
129178372|NCT01304329|464947101|FG004|Third Intervention (3 Days)|Adverse Event|0|||
129178373|NCT01304329|464947102|FG005|Third Intervention (3 Days)|Adverse Event|0|||
129178374|NCT00993499|464947109|FG000|Run-in Period (8 Days)|Adverse Event|0|||
129178375|NCT00993499|464947110|FG001|Run-in Period (8 Days)|Adverse Event|1|||
129178376|NCT00993499|464947111|FG002|Run-in Period (8 Days)|Adverse Event|0|||
129178377|NCT00993499|464947112|FG003|Run-in Period (8 Days)|Adverse Event|0|||
129178378|NCT00993499|464947113|FG004|Run-in Period (8 Days)|Adverse Event|0|||
129178379|NCT00993499|464947114|FG005|Run-in Period (8 Days)|Adverse Event|0|||
129178380|NCT00993499|464947109|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
129178381|NCT00993499|464947110|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129178382|NCT00993499|464947111|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129178383|NCT00993499|464947112|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129178384|NCT00993499|464947113|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129178385|NCT00993499|464947114|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129178386|NCT00993499|464947109|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
129178387|NCT00993499|464947110|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
129178388|NCT00993499|464947111|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
129178389|NCT00993499|464947112|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
129178390|NCT00993499|464947113|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
129178391|NCT00993499|464947114|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
129178392|NCT00993499|464947109|FG000|Run-in Period (8 Days)|Progressive disease|0|||
129178393|NCT00993499|464947110|FG001|Run-in Period (8 Days)|Progressive disease|1|||
129178394|NCT00993499|464947111|FG002|Run-in Period (8 Days)|Progressive disease|1|||
129178395|NCT00993499|464947112|FG003|Run-in Period (8 Days)|Progressive disease|0|||
129178396|NCT00993499|464947113|FG004|Run-in Period (8 Days)|Progressive disease|0|||
129178397|NCT00993499|464947114|FG005|Run-in Period (8 Days)|Progressive disease|0|||
129178398|NCT00993499|464947109|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
129178399|NCT00993499|464947110|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
129178400|NCT00993499|464947111|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
129178401|NCT00993499|464947112|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
129178402|NCT00993499|464947113|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
129178403|NCT00993499|464947114|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
129178404|NCT00993499|464947109|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
129178405|NCT00993499|464947110|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
129178406|NCT00993499|464947111|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129178407|NCT00993499|464947112|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129178408|NCT00993499|464947113|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129178409|NCT00993499|464947114|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129178410|NCT00993499|464947109|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129178411|NCT00993499|464947110|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129178412|NCT00993499|464947111|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
129178413|NCT00993499|464947112|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
129178414|NCT00993499|464947113|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129178415|NCT00993499|464947114|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129178416|NCT00993499|464947109|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129178417|NCT00993499|464947110|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129178418|NCT00993499|464947111|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
129178419|NCT00993499|464947112|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129178420|NCT00993499|464947113|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129178421|NCT00993499|464947114|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129178422|NCT00993499|464947109|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129178423|NCT00993499|464947110|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
129178424|NCT00993499|464947111|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129178425|NCT00993499|464947112|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129178426|NCT00993499|464947113|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129178427|NCT00993499|464947114|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129178428|NCT00993499|464947109|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
129178429|NCT00993499|464947110|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
129178430|NCT00993499|464947111|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
129178431|NCT00993499|464947112|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
129178432|NCT00993499|464947113|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
129178433|NCT00993499|464947114|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
129178434|NCT00993499|464947109|FG000|Discontinued After Starting Course 3|DLT|1|||
129178435|NCT00993499|464947110|FG001|Discontinued After Starting Course 3|DLT|0|||
129178436|NCT00993499|464947111|FG002|Discontinued After Starting Course 3|DLT|2|||
129178437|NCT00993499|464947112|FG003|Discontinued After Starting Course 3|DLT|1|||
129178438|NCT00993499|464947113|FG004|Discontinued After Starting Course 3|DLT|0|||
129178439|NCT00993499|464947114|FG005|Discontinued After Starting Course 3|DLT|0|||
129178440|NCT00993499|464947109|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
129178441|NCT00993499|464947110|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
129178442|NCT00993499|464947111|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
129178443|NCT00993499|464947112|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
129178444|NCT00993499|464947113|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
129178445|NCT00993499|464947114|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
129178446|NCT01406015|464947119|FG000|Overall Study|Withdrawal by Subject|3|||
129178447|NCT01406015|464947120|FG001|Overall Study|Withdrawal by Subject|3|||
129178448|NCT00844805|464947121|FG000|Treatment Phase|Adverse Event|5|||
129178449|NCT00844805|464947122|FG001|Treatment Phase|Adverse Event|1|||
129178450|NCT00844805|464947123|FG002|Treatment Phase|Adverse Event|0|||
129178451|NCT00844805|464947124|FG003|Treatment Phase|Adverse Event|0|||
129178452|NCT00844805|464947121|FG000|Treatment Phase|Withdrawal by Subject|3|||
129178453|NCT00844805|464947122|FG001|Treatment Phase|Withdrawal by Subject|4|||
129178454|NCT00844805|464947123|FG002|Treatment Phase|Withdrawal by Subject|0|||
129178455|NCT00844805|464947124|FG003|Treatment Phase|Withdrawal by Subject|0|||
129178456|NCT00844805|464947121|FG000|Treatment Phase|Noncompliance With Protocol|1|||
129178457|NCT00844805|464947122|FG001|Treatment Phase|Noncompliance With Protocol|0|||
129178458|NCT00844805|464947123|FG002|Treatment Phase|Noncompliance With Protocol|0|||
129178459|NCT00844805|464947124|FG003|Treatment Phase|Noncompliance With Protocol|0|||
129178460|NCT00844805|464947121|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
129178461|NCT00844805|464947122|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
129178462|NCT00844805|464947123|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
129178463|NCT00844805|464947124|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
129178464|NCT00844805|464947121|FG000|Follow-Up Phase|Adverse Event|0|||
129178465|NCT00844805|464947122|FG001|Follow-Up Phase|Adverse Event|0|||
129178466|NCT00844805|464947123|FG002|Follow-Up Phase|Adverse Event|1|||
129178467|NCT00844805|464947124|FG003|Follow-Up Phase|Adverse Event|0|||
129178468|NCT00844805|464947121|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
129178469|NCT00844805|464947122|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
129178470|NCT00844805|464947123|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
129178471|NCT00844805|464947124|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
129178472|NCT00844805|464947121|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
129178473|NCT00844805|464947122|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
129178474|NCT00844805|464947123|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
129178475|NCT00844805|464947124|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
129178476|NCT00844805|464947121|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
129178477|NCT00844805|464947122|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
129178478|NCT00844805|464947123|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
129178479|NCT00844805|464947124|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
129178480|NCT00844805|464947121|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
129178481|NCT00844805|464947122|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
129178482|NCT00844805|464947123|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
129178483|NCT00844805|464947124|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
129178484|NCT01352741|464947125|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
129178485|NCT01352741|464947126|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
129178486|NCT01352741|464947125|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
129178487|NCT01352741|464947126|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
129178488|NCT01352741|464947125|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
129178489|NCT01352741|464947126|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
129178490|NCT01352741|464947125|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
129178491|NCT01352741|464947126|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
129178492|NCT01352741|464947125|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
129178493|NCT01352741|464947126|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
129178494|NCT01352741|464947125|FG000|Open-label Tapentadol Titration Period|Other|4|||
129178495|NCT01352741|464947126|FG001|Open-label Tapentadol Titration Period|Other|0|||
129178496|NCT01352741|464947125|FG000|Double-blind Comparative Period|Protocol Violation|2|||
129178497|NCT01352741|464947126|FG001|Double-blind Comparative Period|Protocol Violation|0|||
129178498|NCT01352741|464947125|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
129178499|NCT01352741|464947126|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
129178500|NCT01352741|464947125|FG000|Double-blind Comparative Period|Adverse Event|16|||
129178501|NCT01352741|464947126|FG001|Double-blind Comparative Period|Adverse Event|17|||
129178502|NCT01352741|464947125|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
129178503|NCT01352741|464947126|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
129178504|NCT01352741|464947125|FG000|Double-blind Comparative Period|Death|0|||
129178505|NCT01352741|464947126|FG001|Double-blind Comparative Period|Death|1|||
129178506|NCT01352741|464947125|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
129178507|NCT01352741|464947126|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
129178508|NCT01352741|464947125|FG000|Double-blind Comparative Period|Other|1|||
129178509|NCT01352741|464947126|FG001|Double-blind Comparative Period|Other|2|||
129178510|NCT01352741|464947125|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
129178511|NCT01352741|464947126|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
129178512|NCT01352741|464947125|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
129178513|NCT01352741|464947126|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
129178514|NCT01352741|464947125|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
129178515|NCT01352741|464947126|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
129178516|NCT01352741|464947125|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
129178517|NCT01352741|464947126|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
129178518|NCT00259298|464947128|FG000|Overall Study|Withdrawal by Subject|1|||
129178519|NCT00259298|464947128|FG000|Overall Study|Physician Decision|2|||
129178520|NCT00645528|464947129|FG000|Overall Study|Did not show up for Visit 2|7|||
129178521|NCT01140568|464947130|FG000|Overall Study|disease progression|31|||
129178522|NCT01140568|464947130|FG000|Overall Study|Withdrawal by Subject|1|||
129178523|NCT01140568|464947130|FG000|Overall Study|Screen Fail|4|||
129178524|NCT03618628|464947131|FG000|Overall Study|Death|1|||
129178525|NCT03618628|464947131|FG000|Overall Study|Lost to Follow-up|1|||
129178526|NCT01741532|464947133|FG000|Overall Study|Adverse Event|4|||
129178527|NCT01741532|464947134|FG001|Overall Study|Adverse Event|0|||
129178528|NCT01741532|464947133|FG000|Overall Study|Withdrawal by Subject|1|||
129178529|NCT01741532|464947134|FG001|Overall Study|Withdrawal by Subject|1|||
129178530|NCT01741532|464947133|FG000|Overall Study|Protocol Violation|0|||
129178531|NCT01741532|464947134|FG001|Overall Study|Protocol Violation|1|||
129178532|NCT01741532|464947133|FG000|Overall Study|Worsening of the disease|3|||
129178533|NCT01741532|464947134|FG001|Overall Study|Worsening of the disease|1|||
129178534|NCT01741532|464947133|FG000|Overall Study|Sponsor decision|1|||
129178535|NCT01741532|464947134|FG001|Overall Study|Sponsor decision|0|||
129178536|NCT01741532|464947133|FG000|Overall Study|Medical event|1|||
129178537|NCT01741532|464947134|FG001|Overall Study|Medical event|0|||
129178538|NCT03081858|464948802|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
129178539|NCT03081858|464948803|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
129178540|NCT03081858|464948804|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
129178541|NCT03081858|464948805|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
129178542|NCT00262847|464948808|FG000|Overall Study|Disease Progression|309|||
129178543|NCT00262847|464948809|FG001|Overall Study|Disease Progression|274|||
129178544|NCT00262847|464948810|FG002|Overall Study|Disease Progression|195|||
129178545|NCT00262847|464948808|FG000|Overall Study|Patient Refusal|41|||
129178546|NCT00262847|464948809|FG001|Overall Study|Patient Refusal|52|||
129178547|NCT00262847|464948810|FG002|Overall Study|Patient Refusal|47|||
129178548|NCT00262847|464948808|FG000|Overall Study|Adverse Event|74|||
129178549|NCT00262847|464948809|FG001|Overall Study|Adverse Event|88|||
129178550|NCT00262847|464948810|FG002|Overall Study|Adverse Event|108|||
129178551|NCT00262847|464948808|FG000|Overall Study|Death|8|||
129178552|NCT00262847|464948809|FG001|Overall Study|Death|8|||
129178553|NCT00262847|464948810|FG002|Overall Study|Death|11|||
129178554|NCT00262847|464948808|FG000|Overall Study|Concomitant disease|3|||
129178555|NCT00262847|464948809|FG001|Overall Study|Concomitant disease|2|||
129178556|NCT00262847|464948810|FG002|Overall Study|Concomitant disease|4|||
129178557|NCT00262847|464948808|FG000|Overall Study|Other Reasons|79|||
129178558|NCT00262847|464948809|FG001|Overall Study|Other Reasons|88|||
129178559|NCT00262847|464948810|FG002|Overall Study|Other Reasons|27|||
129178560|NCT00262847|464948808|FG000|Overall Study|Did not receive study treatment|4|||
129178561|NCT00262847|464948809|FG001|Overall Study|Did not receive study treatment|1|||
129178562|NCT00262847|464948810|FG002|Overall Study|Did not receive study treatment|4|||
129178563|NCT03966885|464948811|FG000|Overall Study|Death|1|||
129178564|NCT03966885|464948812|FG001|Overall Study|Death|0|||
129178565|NCT03966885|464948811|FG000|Overall Study|Lost to Follow-up|1|||
129178566|NCT03966885|464948812|FG001|Overall Study|Lost to Follow-up|2|||
129178567|NCT03966885|464948811|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
129178568|NCT03966885|464948812|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
129178569|NCT03966885|464948811|FG000|Overall Study|Moved from study area.|0|||
129178570|NCT03966885|464948812|FG001|Overall Study|Moved from study area.|2|||
129178571|NCT01176565|464948829|FG000|Overall Study|Lost to Follow-up|12|||
129178572|NCT01176565|464948830|FG001|Overall Study|Lost to Follow-up|16|||
129178573|NCT01176565|464948829|FG000|Overall Study|Withdrawal by Subject|7|||
129178574|NCT01176565|464948830|FG001|Overall Study|Withdrawal by Subject|1|||
129178575|NCT01176565|464948829|FG000|Overall Study|Not Analyzed (any other reason)|1|||
129178576|NCT01176565|464948830|FG001|Overall Study|Not Analyzed (any other reason)|2|||
129178577|NCT03602885|464948831|FG000|Overall Study|Lost to Follow-up|3|||
129178578|NCT03602885|464948832|FG001|Overall Study|Lost to Follow-up|0|||
129178579|NCT02088073|464948835|FG000|Acute Phase|Withdrawal by Subject|5|||
129178580|NCT02088073|464948836|FG001|Acute Phase|Withdrawal by Subject|0|||
129178581|NCT02088073|464948837|FG002|Acute Phase|Withdrawal by Subject|0|||
129178582|NCT02088073|464948838|FG003|Acute Phase|Withdrawal by Subject|0|||
129178583|NCT02088073|464948839|FG004|Acute Phase|Withdrawal by Subject|0|||
129178584|NCT02088073|464948835|FG000|Acute Phase|Hyperkalemia|2|||
129178585|NCT02088073|464948836|FG001|Acute Phase|Hyperkalemia|0|||
128730192|NCT02448875|463308355|FG001|Overall Study|Adverse Event|1|||
129178586|NCT02088073|464948837|FG002|Acute Phase|Hyperkalemia|0|||
129178587|NCT02088073|464948838|FG003|Acute Phase|Hyperkalemia|0|||
129178588|NCT02088073|464948839|FG004|Acute Phase|Hyperkalemia|0|||
129178589|NCT02088073|464948835|FG000|Maintanance Phase|Withdrawal by Subject|0|||
129178590|NCT02088073|464948836|FG001|Maintanance Phase|Withdrawal by Subject|2|||
129178591|NCT02088073|464948837|FG002|Maintanance Phase|Withdrawal by Subject|0|||
129178592|NCT02088073|464948838|FG003|Maintanance Phase|Withdrawal by Subject|0|||
129178593|NCT02088073|464948839|FG004|Maintanance Phase|Withdrawal by Subject|0|||
129178594|NCT02088073|464948835|FG000|Maintanance Phase|Adverse Event|0|||
129178595|NCT02088073|464948836|FG001|Maintanance Phase|Adverse Event|0|||
129178596|NCT02088073|464948837|FG002|Maintanance Phase|Adverse Event|3|||
129178597|NCT02088073|464948838|FG003|Maintanance Phase|Adverse Event|0|||
129178598|NCT02088073|464948839|FG004|Maintanance Phase|Adverse Event|1|||
129178599|NCT02088073|464948835|FG000|Maintanance Phase|Physician Decision|0|||
129178600|NCT02088073|464948836|FG001|Maintanance Phase|Physician Decision|0|||
129178601|NCT02088073|464948837|FG002|Maintanance Phase|Physician Decision|0|||
129178602|NCT02088073|464948838|FG003|Maintanance Phase|Physician Decision|0|||
129178603|NCT02088073|464948839|FG004|Maintanance Phase|Physician Decision|1|||
129178604|NCT02088073|464948835|FG000|Maintanance Phase|Sponsor's decision|0|||
129178605|NCT02088073|464948836|FG001|Maintanance Phase|Sponsor's decision|2|||
129178606|NCT02088073|464948837|FG002|Maintanance Phase|Sponsor's decision|0|||
129178607|NCT02088073|464948838|FG003|Maintanance Phase|Sponsor's decision|2|||
129178608|NCT02088073|464948839|FG004|Maintanance Phase|Sponsor's decision|1|||
129178609|NCT02088073|464948835|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
129178610|NCT02088073|464948836|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
129178611|NCT02088073|464948837|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
129178612|NCT02088073|464948838|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
129178613|NCT02088073|464948839|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
129178614|NCT02088073|464948835|FG000|Maintanance Phase|Miscellaneous|0|||
129178615|NCT02088073|464948836|FG001|Maintanance Phase|Miscellaneous|2|||
128780941|NCT01323660|463488630|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
128780942|NCT01323660|463488631|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
128780943|NCT01323660|463488626|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128780944|NCT01323660|463488627|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128780945|NCT01323660|463488628|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128780946|NCT01323660|463488629|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128780947|NCT01323660|463488630|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
128780948|NCT01323660|463488631|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129178616|NCT02088073|464948837|FG002|Maintanance Phase|Miscellaneous|1|||
129178617|NCT02088073|464948838|FG003|Maintanance Phase|Miscellaneous|2|||
129178618|NCT02088073|464948839|FG004|Maintanance Phase|Miscellaneous|1|||
129178619|NCT02088073|464948835|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
129178620|NCT02088073|464948836|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
129178621|NCT02088073|464948837|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
129178622|NCT02088073|464948838|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
129178623|NCT02088073|464948839|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
129178624|NCT02088073|464948835|FG000|Maintanance Phase|Subject compliance|0|||
129178625|NCT02088073|464948836|FG001|Maintanance Phase|Subject compliance|1|||
129178626|NCT02088073|464948837|FG002|Maintanance Phase|Subject compliance|0|||
129178627|NCT02088073|464948838|FG003|Maintanance Phase|Subject compliance|0|||
129178628|NCT02088073|464948839|FG004|Maintanance Phase|Subject compliance|0|||
129178629|NCT02046174|464948840|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
129178630|NCT02046174|464948841|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
129178631|NCT02118597|464948842|FG000|Overall Study|Sponsor terminated the study|14|||
129178632|NCT02118597|464948842|FG000|Overall Study|Serious Adverse Event|1|||
129178633|NCT02118597|464948842|FG000|Overall Study|Investigator's decision|1|||
129178634|NCT00186537|464948846|FG000|Overall Study|Withdrawal by Subject|4|||
129178635|NCT00186537|464948847|FG001|Overall Study|Withdrawal by Subject|0|||
129178636|NCT00186537|464948848|FG002|Overall Study|Withdrawal by Subject|3|||
129178637|NCT00186537|464948846|FG000|Overall Study|ALT > 1.5 x ULN|3|||
129178638|NCT00186537|464948847|FG001|Overall Study|ALT > 1.5 x ULN|0|||
129178639|NCT00186537|464948848|FG002|Overall Study|ALT > 1.5 x ULN|0|||
129178640|NCT03294135|464948849|FG000|Overall Study|Serious Adverse Event|1|||
129178641|NCT03294135|464948850|FG001|Overall Study|Serious Adverse Event|0|||
129178642|NCT03294135|464948851|FG002|Overall Study|Serious Adverse Event|0|||
129178643|NCT03294135|464948849|FG000|Overall Study|Lost to Follow-up|1|||
129178644|NCT03294135|464948850|FG001|Overall Study|Lost to Follow-up|0|||
129178645|NCT03294135|464948851|FG002|Overall Study|Lost to Follow-up|1|||
129178646|NCT03294135|464948849|FG000|Overall Study|Withdrawal by Subject|0|||
129178647|NCT03294135|464948850|FG001|Overall Study|Withdrawal by Subject|0|||
128780949|NCT01323660|463488626|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
128982135|NCT00508820|464219106|FG000|Overall Study|Pregnancy|0|||
129178648|NCT03294135|464948851|FG002|Overall Study|Withdrawal by Subject|1|||
129178649|NCT03294135|464948849|FG000|Overall Study|Other|2|||
129178650|NCT03294135|464948850|FG001|Overall Study|Other|0|||
129178651|NCT03294135|464948851|FG002|Overall Study|Other|0|||
129178652|NCT02763254|464948852|FG000|Overall Study|Adverse Event|1|||
129178653|NCT03684304|464948853|FG000|Overall Study|Lost to Follow-up|19|||
129178654|NCT03684304|464948854|FG001|Overall Study|Lost to Follow-up|17|||
129178655|NCT01143051|464948855|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
129178656|NCT01143051|464948856|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
129178657|NCT01143051|464948857|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
129178658|NCT01143051|464948858|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
129178659|NCT01143051|464948859|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
129178660|NCT01143051|464948860|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
129178661|NCT01143051|464948855|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
129178662|NCT01143051|464948856|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
129178663|NCT01143051|464948857|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
129178664|NCT01143051|464948858|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
129178665|NCT01143051|464948859|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
129178666|NCT01143051|464948860|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
129178667|NCT00054691|464948861|FG000|Overall Study|Unmeasurable Disease|2|||
129178668|NCT00054691|464948861|FG000|Overall Study|Noncompliant|1|||
129178669|NCT03351114|464948862|FG000|Overall Study|Withdrawal by Subject|1|||
129178670|NCT01665430|464948866|FG000|Overall Study|Adverse Event|1|||
129178671|NCT01665430|464948866|FG000|Overall Study|Withdrawal by Subject|6|||
129178672|NCT01665430|464948866|FG000|Overall Study|Other Unspecified|2|||
129178673|NCT02310230|464948867|FG000|Overall Study|Physician Decision|1|||
129178674|NCT02310230|464948868|FG001|Overall Study|Physician Decision|3|||
129178675|NCT02310230|464948867|FG000|Overall Study|monitor baseline taken after induction|2|||
129178676|NCT02310230|464948868|FG001|Overall Study|monitor baseline taken after induction|7|||
129178677|NCT02310230|464948867|FG000|Overall Study|Poor signal quality|5|||
129178678|NCT02310230|464948868|FG001|Overall Study|Poor signal quality|8|||
129178679|NCT02310230|464948867|FG000|Overall Study|Case cancelled|1|||
129178680|NCT02310230|464948868|FG001|Overall Study|Case cancelled|0|||
129178681|NCT01605227|464948869|FG000|Overall Study|Did not receive study treatment|2|||
129178682|NCT01605227|464948870|FG001|Overall Study|Did not receive study treatment|3|||
129178683|NCT01605227|464948869|FG000|Overall Study|Adverse Event|228|||
129178684|NCT01605227|464948870|FG001|Overall Study|Adverse Event|42|||
129178685|NCT01605227|464948869|FG000|Overall Study|Progressive Disease|132|||
129178686|NCT01605227|464948870|FG001|Overall Study|Progressive Disease|128|||
129178687|NCT01605227|464948869|FG000|Overall Study|Clinical Deterioration|227|||
129178688|NCT01605227|464948870|FG001|Overall Study|Clinical Deterioration|133|||
129178689|NCT01605227|464948869|FG000|Overall Study|Lost to Follow-up|1|||
129178690|NCT01605227|464948870|FG001|Overall Study|Lost to Follow-up|0|||
129178691|NCT01605227|464948869|FG000|Overall Study|Protocol Violation|1|||
129178692|NCT01605227|464948870|FG001|Overall Study|Protocol Violation|0|||
129178693|NCT01605227|464948869|FG000|Overall Study|Physician Decision|9|||
129178694|NCT01605227|464948870|FG001|Overall Study|Physician Decision|7|||
129178695|NCT01605227|464948869|FG000|Overall Study|Withdrawal by Subject|18|||
129178696|NCT01605227|464948870|FG001|Overall Study|Withdrawal by Subject|14|||
129178697|NCT01605227|464948869|FG000|Overall Study|Sponsor Decision|2|||
129178698|NCT01605227|464948870|FG001|Overall Study|Sponsor Decision|0|||
129178699|NCT01605227|464948869|FG000|Overall Study|Started New Therapy|1|||
129178700|NCT01605227|464948870|FG001|Overall Study|Started New Therapy|0|||
129178701|NCT01605227|464948869|FG000|Overall Study|Subject Decision|0|||
129178702|NCT01605227|464948870|FG001|Overall Study|Subject Decision|1|||
129178703|NCT01605227|464948869|FG000|Overall Study|Dose Held >6 weeks|0|||
129178704|NCT01605227|464948870|FG001|Overall Study|Dose Held >6 weeks|1|||
129178705|NCT02961790|464948871|FG000|Overall Study|Canceled|4|||
129178706|NCT02961790|464948872|FG001|Overall Study|Canceled|5|||
129178707|NCT02961790|464948873|FG002|Overall Study|Canceled|1|||
129178708|NCT02961790|464948874|FG003|Overall Study|Canceled|4|||
129178709|NCT02961790|464948871|FG000|Overall Study|without baseline data|4|||
129178710|NCT02961790|464948872|FG001|Overall Study|without baseline data|0|||
129178711|NCT02961790|464948873|FG002|Overall Study|without baseline data|1|||
129178712|NCT02961790|464948874|FG003|Overall Study|without baseline data|0|||
129178713|NCT02961790|464948871|FG000|Overall Study|without post baseline data|7|||
129178714|NCT02961790|464948872|FG001|Overall Study|without post baseline data|6|||
129178715|NCT02961790|464948873|FG002|Overall Study|without post baseline data|4|||
129178716|NCT02961790|464948874|FG003|Overall Study|without post baseline data|1|||
129178717|NCT02078102|464948875|FG000|Overall Study|Adverse Event|1|||
129178718|NCT02078102|464948876|FG001|Overall Study|Adverse Event|0|||
128730193|NCT02448875|463308356|FG002|Overall Study|Adverse Event|0|||
129178719|NCT02078102|464948875|FG000|Overall Study|Withdrawal by Subject|1|||
129178720|NCT02078102|464948876|FG001|Overall Study|Withdrawal by Subject|0|||
129178721|NCT02078102|464948875|FG000|Overall Study|Physician Decision|0|||
129178722|NCT02078102|464948876|FG001|Overall Study|Physician Decision|1|||
129178723|NCT03093974|464948881|FG000|Overall Study|Withdrawal by Subject|32|||
129178724|NCT03093974|464948882|FG001|Overall Study|Withdrawal by Subject|27|||
129178725|NCT03093974|464948881|FG000|Overall Study|Adverse Event|17|||
129178726|NCT03093974|464948882|FG001|Overall Study|Adverse Event|24|||
129178727|NCT03093974|464948881|FG000|Overall Study|Death|0|||
129178728|NCT03093974|464948882|FG001|Overall Study|Death|1|||
129178729|NCT03093974|464948881|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129178730|NCT03093974|464948882|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129178731|NCT03093974|464948881|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
129178732|NCT03093974|464948882|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
129178733|NCT03093974|464948881|FG000|Overall Study|Lost to Follow-up|0|||
129178734|NCT03093974|464948882|FG001|Overall Study|Lost to Follow-up|1|||
129178735|NCT03093974|464948881|FG000|Overall Study|Other|1|||
129178736|NCT03093974|464948882|FG001|Overall Study|Other|2|||
129178737|NCT01866423|464948883|FG000|Overall Study|Lack of Efficacy|3|||
129178738|NCT01866423|464948883|FG000|Overall Study|Sponsor Decision|1|||
129178739|NCT01813721|464948884|FG000|Overall Study|Ineligibility determined|63|||
129178740|NCT01813721|464948884|FG000|Overall Study|Withdrawal by Subject|1|||
129178741|NCT02387164|464948885|FG000|Overall Study|Lost to Follow-up|2|||
129178742|NCT02387164|464948886|FG001|Overall Study|Lost to Follow-up|0|||
129178743|NCT02387164|464948885|FG000|Overall Study|Diagnosed|1|||
129178744|NCT02387164|464948886|FG001|Overall Study|Diagnosed|2|||
129178745|NCT01479595|464948889|FG000|Overall Study|Protocol deviation|0|||
129178746|NCT01479595|464948890|FG001|Overall Study|Protocol deviation|1|||
129178747|NCT01479595|464948889|FG000|Overall Study|Adverse Event|2|||
129178748|NCT01479595|464948890|FG001|Overall Study|Adverse Event|1|||
129178749|NCT02255565|464948892|FG000|Overall Study|Withdrawal by Subject|0|||
129178750|NCT02255565|464948893|FG001|Overall Study|Withdrawal by Subject|1|||
129178751|NCT02255565|464948894|FG002|Overall Study|Withdrawal by Subject|0|||
129178752|NCT02120365|464948895|FG000|Overall Study|Withdrawal by Subject|0|||
129178753|NCT02120365|464948896|FG001|Overall Study|Withdrawal by Subject|0|||
129178754|NCT02120365|464948897|FG002|Overall Study|Withdrawal by Subject|2|||
129178755|NCT02120365|464948898|FG003|Overall Study|Withdrawal by Subject|4|||
129178756|NCT02120365|464948899|FG004|Overall Study|Withdrawal by Subject|0|||
129178757|NCT02120365|464948900|FG005|Overall Study|Withdrawal by Subject|2|||
129178758|NCT01719003|464948903|FG000|Overall Study|Non compliant with protocol|1|||
129178759|NCT01719003|464948904|FG001|Overall Study|Non compliant with protocol|1|||
129178760|NCT01719003|464948905|FG002|Overall Study|Non compliant with protocol|0|||
129178761|NCT01719003|464948906|FG003|Overall Study|Non compliant with protocol|1|||
129178762|NCT01719003|464948907|FG004|Overall Study|Non compliant with protocol|2|||
129178763|NCT01719003|464948908|FG005|Overall Study|Non compliant with protocol|1|||
129178764|NCT01719003|464948909|FG006|Overall Study|Non compliant with protocol|2|||
129178765|NCT01719003|464948910|FG007|Overall Study|Non compliant with protocol|3|||
129178766|NCT01719003|464948911|FG008|Overall Study|Non compliant with protocol|0|||
129178767|NCT01719003|464948903|FG000|Overall Study|Adverse Event|6|||
129178768|NCT01719003|464948904|FG001|Overall Study|Adverse Event|5|||
129178769|NCT01719003|464948905|FG002|Overall Study|Adverse Event|4|||
129178770|NCT01719003|464948906|FG003|Overall Study|Adverse Event|3|||
129178771|NCT01719003|464948907|FG004|Overall Study|Adverse Event|4|||
129178772|NCT01719003|464948908|FG005|Overall Study|Adverse Event|3|||
129178773|NCT01719003|464948909|FG006|Overall Study|Adverse Event|6|||
129178774|NCT01719003|464948910|FG007|Overall Study|Adverse Event|5|||
129178775|NCT01719003|464948911|FG008|Overall Study|Adverse Event|0|||
129178776|NCT01719003|464948903|FG000|Overall Study|Lost to Follow-up|0|||
129178777|NCT01719003|464948904|FG001|Overall Study|Lost to Follow-up|6|||
129178778|NCT01719003|464948905|FG002|Overall Study|Lost to Follow-up|7|||
129178779|NCT01719003|464948906|FG003|Overall Study|Lost to Follow-up|2|||
129178780|NCT01719003|464948907|FG004|Overall Study|Lost to Follow-up|3|||
129178781|NCT01719003|464948908|FG005|Overall Study|Lost to Follow-up|4|||
129178782|NCT01719003|464948909|FG006|Overall Study|Lost to Follow-up|3|||
129178783|NCT01719003|464948910|FG007|Overall Study|Lost to Follow-up|2|||
129178784|NCT01719003|464948911|FG008|Overall Study|Lost to Follow-up|2|||
129178785|NCT01719003|464948903|FG000|Overall Study|Refusal to continue, not due to AE|2|||
128730194|NCT02448875|463308354|FG000|Overall Study|Lost to Follow-up|1|||
129178786|NCT01719003|464948904|FG001|Overall Study|Refusal to continue, not due to AE|5|||
129178787|NCT01719003|464948905|FG002|Overall Study|Refusal to continue, not due to AE|4|||
129178788|NCT01719003|464948906|FG003|Overall Study|Refusal to continue, not due to AE|4|||
129178789|NCT01719003|464948907|FG004|Overall Study|Refusal to continue, not due to AE|4|||
129178790|NCT01719003|464948908|FG005|Overall Study|Refusal to continue, not due to AE|3|||
129178791|NCT01719003|464948909|FG006|Overall Study|Refusal to continue, not due to AE|8|||
129178792|NCT01719003|464948910|FG007|Overall Study|Refusal to continue, not due to AE|7|||
129178793|NCT01719003|464948911|FG008|Overall Study|Refusal to continue, not due to AE|1|||
129178794|NCT01719003|464948903|FG000|Overall Study|Reason other than those specified|0|||
129178795|NCT01719003|464948904|FG001|Overall Study|Reason other than those specified|0|||
129178796|NCT01719003|464948905|FG002|Overall Study|Reason other than those specified|2|||
129178797|NCT01719003|464948906|FG003|Overall Study|Reason other than those specified|3|||
129178798|NCT01719003|464948907|FG004|Overall Study|Reason other than those specified|4|||
129178799|NCT01719003|464948908|FG005|Overall Study|Reason other than those specified|1|||
129178800|NCT01719003|464948909|FG006|Overall Study|Reason other than those specified|0|||
129178801|NCT01719003|464948910|FG007|Overall Study|Reason other than those specified|3|||
129178802|NCT01719003|464948911|FG008|Overall Study|Reason other than those specified|1|||
129178803|NCT01719003|464948903|FG000|Overall Study|Lack of Efficacy|0|||
129178804|NCT01719003|464948904|FG001|Overall Study|Lack of Efficacy|0|||
129178805|NCT01719003|464948905|FG002|Overall Study|Lack of Efficacy|0|||
129178806|NCT01719003|464948906|FG003|Overall Study|Lack of Efficacy|0|||
129178807|NCT01719003|464948907|FG004|Overall Study|Lack of Efficacy|0|||
129178808|NCT01719003|464948908|FG005|Overall Study|Lack of Efficacy|0|||
129178809|NCT01719003|464948909|FG006|Overall Study|Lack of Efficacy|1|||
129178810|NCT01719003|464948910|FG007|Overall Study|Lack of Efficacy|0|||
129178811|NCT01719003|464948911|FG008|Overall Study|Lack of Efficacy|0|||
129178812|NCT00900146|464948912|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
129178813|NCT00900146|464948913|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
129178814|NCT00900146|464948914|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
129178815|NCT00900146|464948915|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
129178816|NCT00900146|464948916|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
129178817|NCT00900146|464948912|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
129178818|NCT00900146|464948913|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
129178819|NCT00900146|464948914|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
129178820|NCT00900146|464948915|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
129178821|NCT00900146|464948916|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
129178822|NCT00900146|464948912|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
129178823|NCT00900146|464948913|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129178824|NCT00900146|464948914|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129178825|NCT00900146|464948915|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129178826|NCT00900146|464948916|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129178827|NCT00900146|464948912|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
129178828|NCT00900146|464948913|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
129178829|NCT00900146|464948914|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
129178830|NCT00900146|464948915|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
129178831|NCT00900146|464948916|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
129178832|NCT00900146|464948912|FG000|Intermediate: Period III|Lost to Follow-up|2|||
129178833|NCT00900146|464948913|FG001|Intermediate: Period III|Lost to Follow-up|0|||
129178834|NCT00900146|464948914|FG002|Intermediate: Period III|Lost to Follow-up|0|||
129178835|NCT00900146|464948915|FG003|Intermediate: Period III|Lost to Follow-up|0|||
129178836|NCT00900146|464948916|FG004|Intermediate: Period III|Lost to Follow-up|1|||
129178837|NCT00900146|464948912|FG000|Intermediate: Period III|Administrative problems|85|||
129178838|NCT00900146|464948913|FG001|Intermediate: Period III|Administrative problems|92|||
129178839|NCT00900146|464948914|FG002|Intermediate: Period III|Administrative problems|84|||
129178840|NCT00900146|464948915|FG003|Intermediate: Period III|Administrative problems|90|||
129178841|NCT00900146|464948916|FG004|Intermediate: Period III|Administrative problems|163|||
129178842|NCT01028716|464948921|FG000|Overall Study|Physician Decision|1|||
129178843|NCT01143896|464948926|FG000|Overall Study|Did not complete Baseline Interview|5|||
129178844|NCT01143896|464948927|FG001|Overall Study|Did not complete Baseline Interview|4|||
129178845|NCT01143896|464948926|FG000|Overall Study|Lost to Follow-up|18|||
129178846|NCT01143896|464948927|FG001|Overall Study|Lost to Follow-up|13|||
129178847|NCT01143896|464948926|FG000|Overall Study|Withdrawal by Subject|13|||
129178848|NCT01143896|464948927|FG001|Overall Study|Withdrawal by Subject|5|||
129178849|NCT01143896|464948926|FG000|Overall Study|Death|6|||
129178850|NCT01143896|464948927|FG001|Overall Study|Death|3|||
129178851|NCT00320372|464948928|FG000|Overall Study|Physician Decision|4|||
129178852|NCT00320372|464948929|FG001|Overall Study|Physician Decision|7|||
129178853|NCT00320372|464948928|FG000|Overall Study|Death|7|||
129178854|NCT00320372|464948929|FG001|Overall Study|Death|8|||
129178855|NCT00320372|464948928|FG000|Overall Study|Withdrawal by Subject|55|||
129178856|NCT00320372|464948929|FG001|Overall Study|Withdrawal by Subject|37|||
129178857|NCT00320372|464948928|FG000|Overall Study|Non-Compliance|40|||
129178858|NCT00320372|464948929|FG001|Overall Study|Non-Compliance|39|||
129178859|NCT00320372|464948928|FG000|Overall Study|Did not Meet (I/E)|3|||
129178860|NCT00320372|464948929|FG001|Overall Study|Did not Meet (I/E)|1|||
129178861|NCT00320372|464948928|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
129178862|NCT00320372|464948929|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
129178863|NCT02068118|464948931|FG000|18-month Comparative Study Period|Death|90|||
129178864|NCT02068118|464948932|FG001|18-month Comparative Study Period|Death|97|||
129178865|NCT02068118|464948931|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
129178866|NCT02068118|464948932|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
129178867|NCT02068118|464948931|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
129178868|NCT02068118|464948932|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
129178869|NCT02068118|464948931|FG000|18-month Comparative Study Period|Heart transplant|9|||
129178870|NCT02068118|464948932|FG001|18-month Comparative Study Period|Heart transplant|15|||
129178871|NCT02068118|464948931|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
129178872|NCT02068118|464948932|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
129178873|NCT02068118|464948931|FG000|18-month Comparative Study Period|Hemiplegia|0|||
129178874|NCT02068118|464948932|FG001|18-month Comparative Study Period|Hemiplegia|1|||
129178875|NCT02068118|464948931|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
129178876|NCT02068118|464948932|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
129178877|NCT02068118|464948931|FG000|18-month Comparative Study Period|Move|0|||
129178878|NCT02068118|464948932|FG001|18-month Comparative Study Period|Move|1|||
129178879|NCT02068118|464948931|FG000|18-month Comparative Study Period|Hearing loss|0|||
129178880|NCT02068118|464948932|FG001|18-month Comparative Study Period|Hearing loss|1|||
129178881|NCT02068118|464948931|FG000|Extension Period|Death|0|||
129178882|NCT02068118|464948932|FG001|Extension Period|Death|2|||
129178883|NCT02068118|464948931|FG000|Extension Period|Withdrawal by Subject|1|||
129178884|NCT02068118|464948932|FG001|Extension Period|Withdrawal by Subject|0|||
129178885|NCT02068118|464948931|FG000|Extension Period|Heart transplant|1|||
129178886|NCT02068118|464948932|FG001|Extension Period|Heart transplant|0|||
129178887|NCT02068118|464948931|FG000|Extension Period|Wrong device use|0|||
129178888|NCT02068118|464948932|FG001|Extension Period|Wrong device use|1|||
129178889|NCT00283868|464948933|FG000|Overall Study|Lost to Follow-up|7|||
129178890|NCT00283868|464948934|FG001|Overall Study|Lost to Follow-up|8|||
129178891|NCT01996592|464948940|FG000|Overall Study|no response to text/no diary entry|32|||
129178892|NCT01996592|464948940|FG000|Overall Study|change in surgical date|4|||
129178893|NCT01996592|464948940|FG000|Overall Study|Withdrawal by Subject|5|||
129178894|NCT01996592|464948940|FG000|Overall Study|change in mode of delivery|4|||
129178895|NCT00394901|464948941|FG000|Baseline Phase|Protocol Violation|0|||
129178896|NCT00394901|464948942|FG001|Baseline Phase|Protocol Violation|0|||
129178897|NCT00394901|464948943|FG002|Baseline Phase|Protocol Violation|1|||
129178898|NCT00394901|464948944|FG003|Baseline Phase|Protocol Violation|0|||
129178899|NCT00394901|464948941|FG000|Double-blind Phase|Adverse Event|5|||
129178900|NCT00394901|464948942|FG001|Double-blind Phase|Adverse Event|7|||
129178901|NCT00394901|464948943|FG002|Double-blind Phase|Adverse Event|16|||
129178902|NCT00394901|464948944|FG003|Double-blind Phase|Adverse Event|20|||
129178903|NCT00394901|464948941|FG000|Double-blind Phase|Lack of Efficacy|6|||
129178904|NCT00394901|464948942|FG001|Double-blind Phase|Lack of Efficacy|4|||
129178905|NCT00394901|464948943|FG002|Double-blind Phase|Lack of Efficacy|1|||
129178906|NCT00394901|464948944|FG003|Double-blind Phase|Lack of Efficacy|3|||
129178907|NCT00394901|464948941|FG000|Double-blind Phase|Withdrawal by Subject|2|||
129178908|NCT00394901|464948942|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129178909|NCT00394901|464948943|FG002|Double-blind Phase|Withdrawal by Subject|0|||
129178910|NCT00394901|464948944|FG003|Double-blind Phase|Withdrawal by Subject|0|||
129178911|NCT00394901|464948941|FG000|Double-blind Phase|Lost to Follow-up|0|||
129178912|NCT00394901|464948942|FG001|Double-blind Phase|Lost to Follow-up|0|||
129178913|NCT00394901|464948943|FG002|Double-blind Phase|Lost to Follow-up|0|||
129178914|NCT00394901|464948944|FG003|Double-blind Phase|Lost to Follow-up|1|||
129178915|NCT00394901|464948941|FG000|Double-blind Phase|Protocol Violation|0|||
129178916|NCT00394901|464948942|FG001|Double-blind Phase|Protocol Violation|0|||
129178917|NCT00394901|464948943|FG002|Double-blind Phase|Protocol Violation|0|||
129178918|NCT00394901|464948944|FG003|Double-blind Phase|Protocol Violation|1|||
129178919|NCT00394901|464948941|FG000|Double-blind Phase|Death|1|||
129178920|NCT00394901|464948942|FG001|Double-blind Phase|Death|0|||
129178921|NCT00394901|464948943|FG002|Double-blind Phase|Death|0|||
129178922|NCT00394901|464948944|FG003|Double-blind Phase|Death|0|||
129178923|NCT00394901|464948941|FG000|Double-blind Phase|Subject's Personal Reason|1|||
129178924|NCT00394901|464948942|FG001|Double-blind Phase|Subject's Personal Reason|0|||
129178925|NCT00394901|464948943|FG002|Double-blind Phase|Subject's Personal Reason|0|||
129178926|NCT00394901|464948944|FG003|Double-blind Phase|Subject's Personal Reason|1|||
129178927|NCT00394901|464948941|FG000|Double-blind Phase|Lack of Compliance|0|||
129178928|NCT00394901|464948942|FG001|Double-blind Phase|Lack of Compliance|3|||
129178929|NCT00394901|464948943|FG002|Double-blind Phase|Lack of Compliance|0|||
129178930|NCT00394901|464948944|FG003|Double-blind Phase|Lack of Compliance|0|||
129178931|NCT00394901|464948941|FG000|Double-blind Phase|Entry into another study was found|0|||
129178932|NCT00394901|464948942|FG001|Double-blind Phase|Entry into another study was found|0|||
129178933|NCT00394901|464948943|FG002|Double-blind Phase|Entry into another study was found|1|||
129178934|NCT00394901|464948944|FG003|Double-blind Phase|Entry into another study was found|0|||
129178935|NCT00394901|464948941|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
129178936|NCT00394901|464948942|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
129178937|NCT00394901|464948943|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
129178938|NCT00394901|464948944|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
129178939|NCT05028517|464948945|FG000|Overall Study|Lost to Follow-up|13|||
129178940|NCT05028517|464948946|FG001|Overall Study|Lost to Follow-up|20|||
129178941|NCT05028517|464948947|FG002|Overall Study|Lost to Follow-up|12|||
129178942|NCT05028517|464948945|FG000|Overall Study|Withdrawal by Subject|0|||
129178943|NCT05028517|464948946|FG001|Overall Study|Withdrawal by Subject|0|||
129178944|NCT05028517|464948947|FG002|Overall Study|Withdrawal by Subject|1|||
129178945|NCT01886690|464948950|FG000|Overall Study|Protocol Violation|0|||
129178946|NCT01886690|464948951|FG001|Overall Study|Protocol Violation|1|||
129178947|NCT01886690|464948950|FG000|Overall Study|Personal Reasons|0|||
129178948|NCT01886690|464948951|FG001|Overall Study|Personal Reasons|1|||
129178949|NCT02360293|464948952|FG000|Overall Study|Lost to Follow-up|73|||
129178950|NCT02360293|464948953|FG001|Overall Study|Lost to Follow-up|95|||
129178951|NCT02360293|464948952|FG000|Overall Study|Withdrawal by Subject|2|||
129178952|NCT02360293|464948953|FG001|Overall Study|Withdrawal by Subject|1|||
129178953|NCT02360293|464948952|FG000|Overall Study|Excluded|1|||
129178954|NCT02360293|464948953|FG001|Overall Study|Excluded|0|||
129178955|NCT04316741|464948954|FG000|Baseline Enrollment|Lost to Follow-up|1|||
129178956|NCT04316741|464948955|FG001|Baseline Enrollment|Lost to Follow-up|1|||
129178957|NCT04316741|464948954|FG000|Immediate Post-Test|Lost to Follow-up|5|||
129178958|NCT04316741|464948955|FG001|Immediate Post-Test|Lost to Follow-up|1|||
129178959|NCT04316741|464948954|FG000|1-month Post-test|Lost to Follow-up|7|||
129178960|NCT04316741|464948955|FG001|1-month Post-test|Lost to Follow-up|2|||
129178961|NCT04316741|464948954|FG000|3-month Follow-up|Lost to Follow-up|10|||
129178962|NCT04316741|464948955|FG001|3-month Follow-up|Lost to Follow-up|2|||
129178963|NCT01510145|464948956|FG000|Overall Study|Adverse Event|6|||
129178964|NCT01510145|464948956|FG000|Overall Study|Lost to Follow-up|5|||
129178965|NCT01510145|464948956|FG000|Overall Study|Withdrawal by Subject|6|||
129178966|NCT01510145|464948956|FG000|Overall Study|Relative reported subject withdrew|1|||
129178967|NCT01498185|464948958|FG000|Overall Study|Adverse Event|0|||
129178968|NCT01498185|464948959|FG001|Overall Study|Adverse Event|0|||
129178969|NCT01498185|464948960|FG002|Overall Study|Adverse Event|0|||
129178970|NCT01498185|464948961|FG003|Overall Study|Adverse Event|1|||
129178971|NCT01498185|464948962|FG004|Overall Study|Adverse Event|0|||
129178972|NCT01498185|464948958|FG000|Overall Study|Withdrawal by Subject|1|||
129178973|NCT01498185|464948959|FG001|Overall Study|Withdrawal by Subject|1|||
129178974|NCT01498185|464948960|FG002|Overall Study|Withdrawal by Subject|0|||
129178975|NCT01498185|464948961|FG003|Overall Study|Withdrawal by Subject|2|||
129178976|NCT01498185|464948962|FG004|Overall Study|Withdrawal by Subject|1|||
129178977|NCT01498185|464948958|FG000|Overall Study|No longer met criteria, etc|0|||
129178978|NCT01498185|464948959|FG001|Overall Study|No longer met criteria, etc|0|||
129178979|NCT01498185|464948960|FG002|Overall Study|No longer met criteria, etc|0|||
129178980|NCT01498185|464948961|FG003|Overall Study|No longer met criteria, etc|0|||
129178981|NCT01498185|464948962|FG004|Overall Study|No longer met criteria, etc|2|||
129178982|NCT01827332|464948963|FG000|Overall Study|Lost to Follow-up|2|||
129178983|NCT01827332|464948964|FG001|Overall Study|Lost to Follow-up|1|||
129178984|NCT02725593|464948965|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
129178985|NCT02725593|464948966|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
129178986|NCT02725593|464948965|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
129178987|NCT02725593|464948966|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
129178988|NCT02725593|464948965|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
129178989|NCT02725593|464948966|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
129178990|NCT02725593|464948965|FG000|Long Term Extension|Withdrawal by Subject|1|||
128730195|NCT02448875|463308355|FG001|Overall Study|Lost to Follow-up|0|||
129178991|NCT02725593|464948966|FG001|Long Term Extension|Withdrawal by Subject|3|||
129178992|NCT04411420|464950482|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
129178993|NCT04411420|464950483|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
129178994|NCT04411420|464950482|FG000|Survey Subset|Lost to Follow-up|134|||
129178995|NCT04411420|464950483|FG001|Survey Subset|Lost to Follow-up|120|||
129178996|NCT03899064|464950484|FG000|Overall Study|Lost to Follow-up|1|||
129178997|NCT03899064|464950484|FG000|Overall Study|Protocol Violation|2|||
129178998|NCT03899064|464950484|FG000|Overall Study|Withdrawal by Subject|2|||
129178999|NCT03899064|464950484|FG000|Overall Study|Other|2|||
129179000|NCT03710876|464950487|FG000|Overall Study|Death|0|||
129179001|NCT03710876|464950488|FG001|Overall Study|Death|2|||
128730196|NCT02448875|463308356|FG002|Overall Study|Lost to Follow-up|0|||
129179002|NCT03710876|464950487|FG000|Overall Study|Withdrawal by Subject|0|||
129179003|NCT03710876|464950488|FG001|Overall Study|Withdrawal by Subject|2|||
129179004|NCT03769311|464950489|FG000|Overall Study|Withdrawal by Subject|1|||
129179005|NCT00289198|464950500|FG000|Overall Study|Adverse Event|0|||
129179006|NCT00289198|464950501|FG001|Overall Study|Adverse Event|2|||
129179007|NCT00289198|464950500|FG000|Overall Study|Protocol Violation|2|||
129179008|NCT00289198|464950501|FG001|Overall Study|Protocol Violation|1|||
129179009|NCT00289198|464950500|FG000|Overall Study|Withdrawal by Subject|4|||
129179010|NCT00289198|464950501|FG001|Overall Study|Withdrawal by Subject|1|||
129179011|NCT00289198|464950500|FG000|Overall Study|Lack of Efficacy|2|||
129179012|NCT00289198|464950501|FG001|Overall Study|Lack of Efficacy|0|||
129179013|NCT00289198|464950500|FG000|Overall Study|Other: Low compliance|0|||
129179014|NCT00289198|464950501|FG001|Overall Study|Other: Low compliance|1|||
129179015|NCT00289198|464950500|FG000|Overall Study|Other: Physician's decision|0|||
129179016|NCT00289198|464950501|FG001|Overall Study|Other: Physician's decision|1|||
129179017|NCT00289198|464950500|FG000|Overall Study|Other: Unable to attend on schedule|2|||
129179018|NCT00289198|464950501|FG001|Overall Study|Other: Unable to attend on schedule|1|||
129179019|NCT00289198|464950500|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
129179020|NCT00289198|464950501|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
129179021|NCT00289198|464950500|FG000|Overall Study|Other: Impossible to come on visit|0|||
129179022|NCT00289198|464950501|FG001|Overall Study|Other: Impossible to come on visit|1|||
129179023|NCT01062061|464950502|FG000|Overall Study|Enrolled more than once|2|||
129179024|NCT01062061|464950502|FG000|Overall Study|Investigated before study start|13|||
129179025|NCT01062061|464950502|FG000|Overall Study|Outside chief indications|10|||
129179026|NCT01062061|464950502|FG000|Overall Study|Failed to meet inclusion criteria|2|||
129179027|NCT00524589|464950503|FG000|Overall Study|Withdrawal by Subject|2|||
129179028|NCT00524589|464950503|FG000|Overall Study|Disease Progression|16|||
129179029|NCT00440310|464950507|FG000|Overall Study|Lost to Follow-up|4|||
129179030|NCT00440310|464950508|FG001|Overall Study|Lost to Follow-up|5|||
129179031|NCT00440310|464950507|FG000|Overall Study|Protocol Violation|0|||
129179032|NCT00440310|464950508|FG001|Overall Study|Protocol Violation|1|||
129179033|NCT00440310|464950507|FG000|Overall Study|Withdrawal by Subject|15|||
129179034|NCT00440310|464950508|FG001|Overall Study|Withdrawal by Subject|14|||
129179035|NCT00440310|464950507|FG000|Overall Study|No Reply at EOS|7|||
129179036|NCT00440310|464950508|FG001|Overall Study|No Reply at EOS|7|||
129179037|NCT00440310|464950507|FG000|Overall Study|Other|1|||
129179038|NCT00440310|464950508|FG001|Overall Study|Other|0|||
129179039|NCT00440310|464950507|FG000|Overall Study|Status Unknown|1|||
129179040|NCT00440310|464950508|FG001|Overall Study|Status Unknown|3|||
129179041|NCT00799591|464950509|FG000|Overall Study|De-escalation of doses|20|||
129179042|NCT00799591|464950509|FG000|Overall Study|Death|14|||
129179043|NCT00799591|464950509|FG000|Overall Study|Technical failure|12|||
129179044|NCT00799591|464950509|FG000|Overall Study|Resistant germ|11|||
129179045|NCT00799591|464950509|FG000|Overall Study|New infection|4|||
129179046|NCT00799591|464950509|FG000|Overall Study|Resistance germ and technical failure|2|||
129179047|NCT00799591|464950509|FG000|Overall Study|Persistance of fever undetermined origin|1|||
129179048|NCT00799591|464950509|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
129179049|NCT00799591|464950509|FG000|Overall Study|Infectious origin not probable|1|||
129179050|NCT03106415|464950512|FG000|Phase 1|Withdrawal by Subject|1|||
129179051|NCT03106415|464950513|FG001|Phase 1|Withdrawal by Subject|0|||
129179052|NCT03106415|464950514|FG002|Phase 1|Withdrawal by Subject|0|||
129179053|NCT03106415|464950512|FG000|Phase 1|Adverse Event|1|||
129179054|NCT03106415|464950513|FG001|Phase 1|Adverse Event|1|||
129179055|NCT03106415|464950514|FG002|Phase 1|Adverse Event|0|||
129179056|NCT03106415|464950512|FG000|Phase 1|Protocol Violation|0|||
129179057|NCT03106415|464950513|FG001|Phase 1|Protocol Violation|1|||
129179058|NCT03106415|464950514|FG002|Phase 1|Protocol Violation|0|||
129179059|NCT00293709|464950515|FG000|Overall Study|Other|47|||
129179060|NCT01804582|464950516|FG000|Overall Study|Lost to Follow-up|47|||
129179061|NCT01804582|464950517|FG001|Overall Study|Lost to Follow-up|56|||
129179062|NCT01804582|464950516|FG000|Overall Study|Physician Decision|2|||
129179063|NCT01804582|464950517|FG001|Overall Study|Physician Decision|0|||
129179064|NCT01891344|464950518|FG000|Overall Study|Ongoing|6|||
129179065|NCT01891344|464950519|FG001|Overall Study|Ongoing|2|||
129179066|NCT01891344|464950520|FG002|Overall Study|Ongoing|0|||
129179067|NCT01891344|464950521|FG003|Overall Study|Ongoing|1|||
129179068|NCT01891344|464950522|FG004|Overall Study|Ongoing|4|||
129179069|NCT01891344|464950523|FG005|Overall Study|Ongoing|1|||
129179070|NCT01891344|464950524|FG006|Overall Study|Ongoing|0|||
129179071|NCT01891344|464950525|FG007|Overall Study|Ongoing|0|||
129179072|NCT02969590|464950526|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
129179073|NCT02969590|464950527|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
129179074|NCT02969590|464950528|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
129179075|NCT02590562|464950533|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
129179076|NCT00598078|464950539|FG000|Period 2 (Day 2)|Adverse Event|1|||
129179077|NCT00598078|464950540|FG001|Period 2 (Day 2)|Adverse Event|0|||
129179078|NCT02699450|464950544|FG000|Overall Study|Death|2|||
129179079|NCT02699450|464950545|FG001|Overall Study|Death|1|||
129179080|NCT02699450|464950546|FG002|Overall Study|Death|2|||
129179081|NCT02699450|464950544|FG000|Overall Study|Met Criteria for Study Exit|0|||
129179082|NCT02699450|464950545|FG001|Overall Study|Met Criteria for Study Exit|0|||
129179083|NCT02699450|464950546|FG002|Overall Study|Met Criteria for Study Exit|1|||
129179084|NCT02699450|464950544|FG000|Overall Study|Protocol Violation|4|||
129179085|NCT02699450|464950545|FG001|Overall Study|Protocol Violation|3|||
129179086|NCT02699450|464950546|FG002|Overall Study|Protocol Violation|5|||
129179087|NCT02699450|464950544|FG000|Overall Study|Lost to Follow-up|3|||
129179088|NCT02699450|464950545|FG001|Overall Study|Lost to Follow-up|0|||
129179089|NCT02699450|464950546|FG002|Overall Study|Lost to Follow-up|5|||
129179090|NCT02699450|464950544|FG000|Overall Study|Physician Decision|2|||
129179091|NCT02699450|464950545|FG001|Overall Study|Physician Decision|0|||
129179092|NCT02699450|464950546|FG002|Overall Study|Physician Decision|0|||
129179093|NCT02699450|464950544|FG000|Overall Study|Withdrawal by Subject|3|||
129179094|NCT02699450|464950545|FG001|Overall Study|Withdrawal by Subject|1|||
129179095|NCT02699450|464950546|FG002|Overall Study|Withdrawal by Subject|2|||
129179096|NCT02699450|464950544|FG000|Overall Study|Adverse Event|1|||
129179097|NCT02699450|464950545|FG001|Overall Study|Adverse Event|0|||
129179098|NCT02699450|464950546|FG002|Overall Study|Adverse Event|0|||
129179099|NCT01133275|464950549|FG000|Overall Study|Withdrawal by Subject|1|||
129179100|NCT01133275|464950549|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
129179101|NCT00700102|464950550|FG000|Overall Study|Died|394|||
129179102|NCT00700102|464950551|FG001|Overall Study|Died|385|||
129179103|NCT00700102|464950550|FG000|Overall Study|Lost to Follow-up|8|||
129179104|NCT00700102|464950551|FG001|Overall Study|Lost to Follow-up|10|||
129179105|NCT02525939|464950552|FG000|Overall Study|Lost to Follow-up|27|||
129179106|NCT02525939|464950553|FG001|Overall Study|Lost to Follow-up|24|||
129179107|NCT02525939|464950552|FG000|Overall Study|Physician Decision|0|||
129179108|NCT02525939|464950553|FG001|Overall Study|Physician Decision|1|||
129179109|NCT02525939|464950552|FG000|Overall Study|Withdrawal by Subject|24|||
129179110|NCT02525939|464950553|FG001|Overall Study|Withdrawal by Subject|39|||
129179111|NCT02525939|464950552|FG000|Overall Study|Death|180|||
129179112|NCT02525939|464950553|FG001|Overall Study|Death|179|||
129179113|NCT01635764|464950554|FG000|Overall Study|Adverse Event|46|||
129179114|NCT01635764|464950554|FG000|Overall Study|Lack of Efficacy|76|||
129179115|NCT01635764|464950554|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
129179116|NCT01635764|464950554|FG000|Overall Study|Protocol Deviation|1|||
129179117|NCT01635764|464950554|FG000|Overall Study|Withdrew Consent|67|||
129179118|NCT01635764|464950554|FG000|Overall Study|Lost to Follow-up|53|||
129179119|NCT01635764|464950554|FG000|Overall Study|Other|28|||
129179120|NCT01174004|464950555|FG000|Overall Study|Adverse Event|2|||
129179121|NCT01174004|464950556|FG001|Overall Study|Adverse Event|10|||
129179122|NCT01174004|464950555|FG000|Overall Study|Withdrawal by Subject|2|||
129179123|NCT01174004|464950556|FG001|Overall Study|Withdrawal by Subject|3|||
129179124|NCT01174004|464950555|FG000|Overall Study|At Discretion of Sponsor|2|||
129179125|NCT01174004|464950556|FG001|Overall Study|At Discretion of Sponsor|2|||
129179126|NCT01174004|464950555|FG000|Overall Study|Protocol Violation|0|||
129179127|NCT01174004|464950556|FG001|Overall Study|Protocol Violation|1|||
129179128|NCT01174004|464950555|FG000|Overall Study|Physician Decision|1|||
129179129|NCT01174004|464950556|FG001|Overall Study|Physician Decision|0|||
129179130|NCT00849875|464950559|FG000|Overall Study|Death|28|||
129179131|NCT00849875|464950559|FG000|Overall Study|Ongoing (unknown completion status)|11|||
129179132|NCT00849875|464950559|FG000|Overall Study|Others|6|||
129179133|NCT00849875|464950559|FG000|Overall Study|Lost to Follow-up|2|||
129179134|NCT00086502|464950560|FG000|Overall Study|Adverse Event|11|||
129179135|NCT00086502|464950561|FG001|Overall Study|Adverse Event|2|||
129179136|NCT00086502|464950560|FG000|Overall Study|Lack of Efficacy|0|||
129179137|NCT00086502|464950561|FG001|Overall Study|Lack of Efficacy|2|||
129179138|NCT00086502|464950560|FG000|Overall Study|Lost to Follow-up|3|||
129179139|NCT00086502|464950561|FG001|Overall Study|Lost to Follow-up|1|||
129179140|NCT00086502|464950560|FG000|Overall Study|Physician Decision|1|||
129179141|NCT00086502|464950561|FG001|Overall Study|Physician Decision|1|||
129179142|NCT00086502|464950560|FG000|Overall Study|Pregnancy|0|||
129179143|NCT00086502|464950561|FG001|Overall Study|Pregnancy|1|||
129179144|NCT00086502|464950560|FG000|Overall Study|Protocol Violation|3|||
129179145|NCT00086502|464950561|FG001|Overall Study|Protocol Violation|3|||
129179146|NCT00086502|464950560|FG000|Overall Study|Withdrawal by Subject|5|||
129179147|NCT00086502|464950561|FG001|Overall Study|Withdrawal by Subject|6|||
129179148|NCT00086502|464950560|FG000|Overall Study|Patient Moved|1|||
129179149|NCT00086502|464950561|FG001|Overall Study|Patient Moved|1|||
129179150|NCT00086502|464950560|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
129179151|NCT00086502|464950561|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
129179152|NCT00086502|464950560|FG000|Overall Study|Patient Accidentally Unblinded|1|||
129179153|NCT00086502|464950561|FG001|Overall Study|Patient Accidentally Unblinded|0|||
129179154|NCT01515475|464950567|FG000|Overall Study|Lost to Follow-up|20|||
129179155|NCT01515475|464950568|FG001|Overall Study|Lost to Follow-up|15|||
129179156|NCT01515475|464950569|FG002|Overall Study|Lost to Follow-up|12|||
129179157|NCT01515475|464950570|FG003|Overall Study|Lost to Follow-up|12|||
129179158|NCT01420627|464950571|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
129179159|NCT00837876|464950572|FG000|Overall Study|Death|2|||
129179160|NCT00837876|464950572|FG000|Overall Study|Adverse Event|7|||
129179161|NCT00837876|464950572|FG000|Overall Study|Physician Decision|1|||
129179162|NCT00837876|464950572|FG000|Overall Study|Withdrawal by Subject|3|||
129179163|NCT00837876|464950572|FG000|Overall Study|disease progression|24|||
129179164|NCT00453973|464950573|FG000|Overall Study|Adverse Event|4|||
129179165|NCT00453973|464950574|FG001|Overall Study|Adverse Event|9|||
129179166|NCT00453973|464950573|FG000|Overall Study|Withdrawal by Subject|7|||
129179167|NCT00453973|464950574|FG001|Overall Study|Withdrawal by Subject|6|||
129179168|NCT00453973|464950573|FG000|Overall Study|PI Decision|0|||
129179169|NCT00453973|464950574|FG001|Overall Study|PI Decision|2|||
129179170|NCT00453973|464950573|FG000|Overall Study|Relocation|1|||
129179171|NCT00453973|464950574|FG001|Overall Study|Relocation|0|||
129179172|NCT00453973|464950573|FG000|Overall Study|Renal transplant|1|||
129179173|NCT00453973|464950574|FG001|Overall Study|Renal transplant|1|||
129179174|NCT00453973|464950573|FG000|Overall Study|Site closed by sponsor|3|||
129179175|NCT00453973|464950574|FG001|Overall Study|Site closed by sponsor|0|||
129179176|NCT00453973|464950573|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
129179177|NCT00453973|464950574|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
129179178|NCT00276094|464950575|FG000|Overall Study|Adverse Event|15|||
129179179|NCT00276094|464950576|FG001|Overall Study|Adverse Event|13|||
129179180|NCT00276094|464950577|FG002|Overall Study|Adverse Event|11|||
129179181|NCT00276094|464950575|FG000|Overall Study|Withdrawal by Subject|14|||
129179182|NCT00276094|464950576|FG001|Overall Study|Withdrawal by Subject|14|||
129179183|NCT00276094|464950577|FG002|Overall Study|Withdrawal by Subject|12|||
129179184|NCT00276094|464950575|FG000|Overall Study|Protocol Violation|16|||
129179185|NCT00276094|464950576|FG001|Overall Study|Protocol Violation|7|||
129179186|NCT00276094|464950577|FG002|Overall Study|Protocol Violation|10|||
129179187|NCT00276094|464950575|FG000|Overall Study|Lost to Follow-up|8|||
129179188|NCT00276094|464950576|FG001|Overall Study|Lost to Follow-up|6|||
129179189|NCT00276094|464950577|FG002|Overall Study|Lost to Follow-up|4|||
129179190|NCT00276094|464950575|FG000|Overall Study|Other-Subject moved out of country|1|||
129179191|NCT00276094|464950576|FG001|Overall Study|Other-Subject moved out of country|0|||
129179192|NCT00276094|464950577|FG002|Overall Study|Other-Subject moved out of country|0|||
129179193|NCT00276094|464950575|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
129179194|NCT00276094|464950576|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
129179195|NCT00276094|464950577|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
129179196|NCT00276094|464950575|FG000|Overall Study|Other-Lack of efficacy|1|||
129179197|NCT00276094|464950576|FG001|Overall Study|Other-Lack of efficacy|0|||
129179198|NCT00276094|464950577|FG002|Overall Study|Other-Lack of efficacy|0|||
129179199|NCT00276094|464950575|FG000|Overall Study|Other-Refused follow-up visit|1|||
129179200|NCT00276094|464950576|FG001|Overall Study|Other-Refused follow-up visit|0|||
129179201|NCT00276094|464950577|FG002|Overall Study|Other-Refused follow-up visit|0|||
129179202|NCT00276094|464950575|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
129179203|NCT00276094|464950576|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
129179204|NCT00276094|464950577|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
129179205|NCT00276094|464950575|FG000|Overall Study|Other-Relocation|0|||
129179206|NCT00276094|464950576|FG001|Overall Study|Other-Relocation|1|||
129179207|NCT00276094|464950577|FG002|Overall Study|Other-Relocation|0|||
129179208|NCT00276094|464950575|FG000|Overall Study|Other-Study medication lost|0|||
129179209|NCT00276094|464950576|FG001|Overall Study|Other-Study medication lost|0|||
129179210|NCT00276094|464950577|FG002|Overall Study|Other-Study medication lost|1|||
129179211|NCT02075632|464950582|FG000|Overall Study|Adverse Event|1|||
129179212|NCT02075632|464950583|FG001|Overall Study|Adverse Event|1|||
129179213|NCT02075632|464950582|FG000|Overall Study|Lost to Follow-up|0|||
129179214|NCT02075632|464950583|FG001|Overall Study|Lost to Follow-up|3|||
129179215|NCT02075632|464950582|FG000|Overall Study|Withdrawal by Subject|0|||
129179216|NCT02075632|464950583|FG001|Overall Study|Withdrawal by Subject|1|||
129179217|NCT02256267|464950584|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
129179218|NCT02256267|464950584|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
129179219|NCT01969500|464950594|FG000|Overall Study|Death|0|||
129179220|NCT01969500|464950595|FG001|Overall Study|Death|1|||
129179221|NCT01969500|464950594|FG000|Overall Study|extended hospitalization|1|||
129179222|NCT01969500|464950595|FG001|Overall Study|extended hospitalization|1|||
129179223|NCT01873729|464950596|FG000|Overall Study|Withdrawal by Subject|1|||
129179224|NCT02463032|464950597|FG000|Overall Study|Lack of Efficacy|61|||
129179225|NCT02463032|464950598|FG001|Overall Study|Lack of Efficacy|50|||
129179226|NCT02463032|464950597|FG000|Overall Study|Death|8|||
129179227|NCT02463032|464950598|FG001|Overall Study|Death|8|||
129179228|NCT02463032|464950597|FG000|Overall Study|Adverse Event|2|||
129179229|NCT02463032|464950598|FG001|Overall Study|Adverse Event|6|||
129179230|NCT01066780|464950599|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
129179231|NCT01066780|464950600|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
129179232|NCT00613080|464950601|FG000|Overall Study|Ineligible / no protocol treatment|11|||
129179233|NCT03757130|464950602|FG000|Overall Study|Lost to Follow-up|0|||
129179234|NCT03757130|464950603|FG001|Overall Study|Lost to Follow-up|0|||
128982136|NCT00508820|464219107|FG001|Overall Study|Pregnancy|2|||
129179235|NCT03757130|464950604|FG002|Overall Study|Lost to Follow-up|0|||
129179236|NCT03757130|464950605|FG003|Overall Study|Lost to Follow-up|1|||
129179237|NCT03757130|464950606|FG004|Overall Study|Lost to Follow-up|0|||
129179238|NCT03757130|464950607|FG005|Overall Study|Lost to Follow-up|0|||
129179239|NCT03757130|464950608|FG006|Overall Study|Lost to Follow-up|0|||
129179240|NCT03757130|464950609|FG007|Overall Study|Lost to Follow-up|1|||
129179241|NCT03757130|464950602|FG000|Overall Study|Withdrawal by Subject|0|||
129179242|NCT03757130|464950603|FG001|Overall Study|Withdrawal by Subject|0|||
129179243|NCT03757130|464950604|FG002|Overall Study|Withdrawal by Subject|0|||
129179244|NCT03757130|464950605|FG003|Overall Study|Withdrawal by Subject|0|||
129179245|NCT03757130|464950606|FG004|Overall Study|Withdrawal by Subject|0|||
129179246|NCT03757130|464950607|FG005|Overall Study|Withdrawal by Subject|0|||
129179247|NCT03757130|464950608|FG006|Overall Study|Withdrawal by Subject|1|||
129179248|NCT03757130|464950609|FG007|Overall Study|Withdrawal by Subject|0|||
129179249|NCT02226549|464950610|FG000|Overall Study|Randomized but Never Treated|1|||
129179250|NCT02226549|464950611|FG001|Overall Study|Randomized but Never Treated|0|||
129179251|NCT02226549|464950610|FG000|Overall Study|Lost to Follow-up|0|||
129179252|NCT02226549|464950611|FG001|Overall Study|Lost to Follow-up|1|||
129179253|NCT02726880|464950613|FG000|Overall Study|Withdrawal by Subject|2|||
129179254|NCT02726880|464950614|FG001|Overall Study|Withdrawal by Subject|0|||
129179255|NCT02726880|464950613|FG000|Overall Study|Lost to Follow-up|1|||
129179256|NCT02726880|464950614|FG001|Overall Study|Lost to Follow-up|3|||
129179257|NCT02312219|464950615|FG000|Overall Study|Withdrawal by Subject|1|||
129179258|NCT02312219|464950616|FG001|Overall Study|Withdrawal by Subject|2|||
129179259|NCT02312219|464950615|FG000|Overall Study|could not schedule imaging in time|0|||
129179260|NCT02312219|464950616|FG001|Overall Study|could not schedule imaging in time|2|||
129179261|NCT02312219|464950615|FG000|Overall Study|Other|0|||
129179262|NCT02312219|464950616|FG001|Overall Study|Other|1|||
129179263|NCT02312219|464950615|FG000|Overall Study|Not randomized. Ineligible|0|||
129179264|NCT02312219|464950616|FG001|Overall Study|Not randomized. Ineligible|1|||
129179265|NCT01269385|464950617|FG000|Overall Study|Adverse Event|1|||
129179266|NCT01269385|464950618|FG001|Overall Study|Adverse Event|1|||
129179267|NCT01269385|464950619|FG002|Overall Study|Adverse Event|0|||
129179268|NCT01269385|464950620|FG003|Overall Study|Adverse Event|0|||
129179269|NCT00546260|464950621|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
129179270|NCT00546260|464950622|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
129179271|NCT03759041|464950623|FG000|Overall Study|Withdrawal by Subject|4|||
129179272|NCT03759041|464950624|FG001|Overall Study|Withdrawal by Subject|10|||
129179273|NCT03759041|464950625|FG002|Overall Study|Withdrawal by Subject|10|||
129179274|NCT03759041|464950623|FG000|Overall Study|Adverse Event|1|||
129179275|NCT03759041|464950624|FG001|Overall Study|Adverse Event|3|||
129179276|NCT03759041|464950625|FG002|Overall Study|Adverse Event|4|||
129179277|NCT03759041|464950623|FG000|Overall Study|Lack of Efficacy|0|||
129179278|NCT03759041|464950624|FG001|Overall Study|Lack of Efficacy|0|||
129179279|NCT03759041|464950625|FG002|Overall Study|Lack of Efficacy|1|||
129179280|NCT03759041|464950623|FG000|Overall Study|Study Terminated by Sponsor|15|||
129179281|NCT03759041|464950624|FG001|Overall Study|Study Terminated by Sponsor|16|||
129179282|NCT03759041|464950625|FG002|Overall Study|Study Terminated by Sponsor|10|||
129179283|NCT03759041|464950623|FG000|Overall Study|Other reason for discontinuation|0|||
129179284|NCT03759041|464950624|FG001|Overall Study|Other reason for discontinuation|2|||
129179285|NCT03759041|464950625|FG002|Overall Study|Other reason for discontinuation|1|||
129179286|NCT03759041|464950623|FG000|Overall Study|Lost to Follow-up|7|||
129179287|NCT03759041|464950624|FG001|Overall Study|Lost to Follow-up|2|||
129179288|NCT03759041|464950625|FG002|Overall Study|Lost to Follow-up|2|||
129179289|NCT03759041|464950623|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
129179290|NCT03759041|464950624|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
129179291|NCT03759041|464950625|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
129179292|NCT04384107|464950626|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
129179293|NCT04384107|464950627|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
129179294|NCT04384107|464950626|FG000|Overall Study|Lost to Follow-up|1|||
129179295|NCT04384107|464950627|FG001|Overall Study|Lost to Follow-up|0|||
129179296|NCT00276614|464950628|FG000|Overall Study|Progression of disease under study|3|||
129179297|NCT01522404|464950631|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
129179298|NCT01522404|464950632|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
129179299|NCT01522404|464950631|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
129179300|NCT01522404|464950632|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
129179301|NCT01522404|464950631|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
129179302|NCT01522404|464950632|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
129179303|NCT01591863|464950637|FG000|Overall Study|Adverse Event|3|||
129179304|NCT01591863|464950637|FG000|Overall Study|Withdrawal by Subject|1|||
129179305|NCT01591863|464950637|FG000|Overall Study|recurrence|9|||
129179306|NCT01591863|464950637|FG000|Overall Study|Lack of Efficacy|1|||
129179307|NCT00387647|464952220|FG000|Overall Study|Death|18|||
129179308|NCT01309269|464952223|FG000|Overall Study|Adverse Event|56|||
129179309|NCT01309269|464952223|FG000|Overall Study|Withdrawal by Subject|25|||
129179310|NCT01309269|464952223|FG000|Overall Study|Lack of Acceptance|15|||
129179311|NCT01309269|464952223|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
129179312|NCT01309269|464952223|FG000|Overall Study|Kidney Transplant|25|||
129179313|NCT01309269|464952223|FG000|Overall Study|Administrative Problems|141|||
129179314|NCT01309269|464952223|FG000|Overall Study|Other|256|||
129179315|NCT01309269|464952223|FG000|Overall Study|Other|1|||
129179316|NCT01309269|464952223|FG000|Overall Study|Study Completion Data Not Recorded|95|||
129179317|NCT01309269|464952223|FG000|Overall Study|Enrolled but not Treated|107|||
129179318|NCT03131596|464952226|FG000|Overall Study|Protocol Violation|3|||
129179319|NCT03131596|464952227|FG001|Overall Study|Protocol Violation|3|||
129179320|NCT03131596|464952226|FG000|Overall Study|Lost to Follow-up|3|||
129179321|NCT03131596|464952227|FG001|Overall Study|Lost to Follow-up|0|||
129179322|NCT05013424|464952230|FG000|Overall Study|Lost to Follow-up|1|||
129179323|NCT05013424|464952231|FG001|Overall Study|Lost to Follow-up|1|||
129179324|NCT05013424|464952232|FG002|Overall Study|Lost to Follow-up|1|||
129179325|NCT05013424|464952230|FG000|Overall Study|Withdrawal by Subject|0|||
129179326|NCT05013424|464952231|FG001|Overall Study|Withdrawal by Subject|1|||
129179327|NCT05013424|464952232|FG002|Overall Study|Withdrawal by Subject|0|||
129179328|NCT01596335|464952233|FG000|Overall Study|exacerbation of primary disease|5|||
129179329|NCT01596335|464952234|FG001|Overall Study|exacerbation of primary disease|9|||
129179330|NCT03627065|464952235|FG000|Overall Study|Study Terminated by sponsor|1|||
129179331|NCT03627065|464952235|FG000|Overall Study|Withdrawal by Subject|2|||
129179332|NCT04524455|464952236|FG000|Overall Study|Death|3|||
129179333|NCT04524455|464952237|FG001|Overall Study|Death|3|||
129179334|NCT04524455|464952236|FG000|Overall Study|Decision by Sponsor|0|||
129179335|NCT04524455|464952237|FG001|Overall Study|Decision by Sponsor|2|||
129179336|NCT04524455|464952236|FG000|Overall Study|Withdrawal of Consent From Study|1|||
129179337|NCT04524455|464952237|FG001|Overall Study|Withdrawal of Consent From Study|0|||
129179338|NCT04524455|464952236|FG000|Overall Study|Lost to Follow-up|0|||
129179339|NCT04524455|464952237|FG001|Overall Study|Lost to Follow-up|1|||
129179340|NCT00098722|464952238|FG000|Double Blind Phase|Adverse Event|7|||
129179341|NCT00098722|464952239|FG001|Double Blind Phase|Adverse Event|7|||
129179342|NCT00098722|464952240|FG002|Double Blind Phase|Adverse Event|3|||
129179343|NCT00098722|464952241|FG003|Double Blind Phase|Adverse Event|0|||
129179344|NCT00098722|464952242|FG004|Double Blind Phase|Adverse Event|0|||
129179345|NCT00098722|464952243|FG005|Double Blind Phase|Adverse Event|0|||
129179346|NCT00098722|464952244|FG006|Double Blind Phase|Adverse Event|0|||
129179347|NCT00098722|464952238|FG000|Double Blind Phase|Death|2|||
129179348|NCT00098722|464952239|FG001|Double Blind Phase|Death|5|||
129179349|NCT00098722|464952240|FG002|Double Blind Phase|Death|0|||
129179350|NCT00098722|464952241|FG003|Double Blind Phase|Death|0|||
129179351|NCT00098722|464952242|FG004|Double Blind Phase|Death|0|||
129179352|NCT00098722|464952243|FG005|Double Blind Phase|Death|0|||
129179353|NCT00098722|464952244|FG006|Double Blind Phase|Death|0|||
129179354|NCT00098722|464952238|FG000|Double Blind Phase|Lack of Efficacy|21|||
129179355|NCT00098722|464952239|FG001|Double Blind Phase|Lack of Efficacy|23|||
129179356|NCT00098722|464952240|FG002|Double Blind Phase|Lack of Efficacy|15|||
129179357|NCT00098722|464952241|FG003|Double Blind Phase|Lack of Efficacy|0|||
129179358|NCT00098722|464952242|FG004|Double Blind Phase|Lack of Efficacy|0|||
129179359|NCT00098722|464952243|FG005|Double Blind Phase|Lack of Efficacy|0|||
129179360|NCT00098722|464952244|FG006|Double Blind Phase|Lack of Efficacy|0|||
129179361|NCT00098722|464952238|FG000|Double Blind Phase|Participant defaulted|16|||
129179362|NCT00098722|464952239|FG001|Double Blind Phase|Participant defaulted|11|||
129179363|NCT00098722|464952240|FG002|Double Blind Phase|Participant defaulted|9|||
129179364|NCT00098722|464952241|FG003|Double Blind Phase|Participant defaulted|0|||
129179365|NCT00098722|464952242|FG004|Double Blind Phase|Participant defaulted|0|||
129179366|NCT00098722|464952243|FG005|Double Blind Phase|Participant defaulted|0|||
129179367|NCT00098722|464952244|FG006|Double Blind Phase|Participant defaulted|0|||
129179368|NCT00098722|464952238|FG000|Double Blind Phase|Pregnancy|1|||
129179369|NCT00098722|464952239|FG001|Double Blind Phase|Pregnancy|0|||
129179370|NCT00098722|464952240|FG002|Double Blind Phase|Pregnancy|0|||
129179371|NCT00098722|464952241|FG003|Double Blind Phase|Pregnancy|0|||
129179372|NCT00098722|464952242|FG004|Double Blind Phase|Pregnancy|0|||
129179373|NCT00098722|464952243|FG005|Double Blind Phase|Pregnancy|0|||
129179374|NCT00098722|464952244|FG006|Double Blind Phase|Pregnancy|0|||
129179375|NCT00098722|464952238|FG000|Double Blind Phase|Randomized, not treated|4|||
129179376|NCT00098722|464952239|FG001|Double Blind Phase|Randomized, not treated|3|||
129179377|NCT00098722|464952240|FG002|Double Blind Phase|Randomized, not treated|3|||
129179378|NCT00098722|464952241|FG003|Double Blind Phase|Randomized, not treated|0|||
129179379|NCT00098722|464952242|FG004|Double Blind Phase|Randomized, not treated|0|||
129179380|NCT00098722|464952243|FG005|Double Blind Phase|Randomized, not treated|0|||
129179381|NCT00098722|464952244|FG006|Double Blind Phase|Randomized, not treated|0|||
129179382|NCT00098722|464952238|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
129179383|NCT00098722|464952239|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
129179384|NCT00098722|464952240|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
129179385|NCT00098722|464952241|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
129179386|NCT00098722|464952242|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
129179387|NCT00098722|464952243|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
129179388|NCT00098722|464952244|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
129179389|NCT00098722|464952238|FG000|Double Blind Phase|Other|7|||
129179390|NCT00098722|464952239|FG001|Double Blind Phase|Other|8|||
129179391|NCT00098722|464952240|FG002|Double Blind Phase|Other|7|||
129179392|NCT00098722|464952241|FG003|Double Blind Phase|Other|0|||
129179393|NCT00098722|464952242|FG004|Double Blind Phase|Other|0|||
129179394|NCT00098722|464952243|FG005|Double Blind Phase|Other|0|||
129179395|NCT00098722|464952244|FG006|Double Blind Phase|Other|0|||
129179396|NCT00098722|464952238|FG000|Open Label Phase|Adverse Event|0|||
129179397|NCT00098722|464952239|FG001|Open Label Phase|Adverse Event|0|||
129179398|NCT00098722|464952240|FG002|Open Label Phase|Adverse Event|0|||
129179399|NCT00098722|464952241|FG003|Open Label Phase|Adverse Event|5|||
129179400|NCT00098722|464952242|FG004|Open Label Phase|Adverse Event|0|||
129179401|NCT00098722|464952243|FG005|Open Label Phase|Adverse Event|0|||
129179402|NCT00098722|464952244|FG006|Open Label Phase|Adverse Event|0|||
129179403|NCT00098722|464952238|FG000|Open Label Phase|Death|0|||
129179404|NCT00098722|464952239|FG001|Open Label Phase|Death|0|||
129179405|NCT00098722|464952240|FG002|Open Label Phase|Death|0|||
129179406|NCT00098722|464952241|FG003|Open Label Phase|Death|2|||
129179407|NCT00098722|464952242|FG004|Open Label Phase|Death|0|||
129179408|NCT00098722|464952243|FG005|Open Label Phase|Death|0|||
129179409|NCT00098722|464952244|FG006|Open Label Phase|Death|0|||
129179410|NCT00098722|464952238|FG000|Open Label Phase|Lack of Efficacy|0|||
129179411|NCT00098722|464952239|FG001|Open Label Phase|Lack of Efficacy|0|||
129179412|NCT00098722|464952240|FG002|Open Label Phase|Lack of Efficacy|0|||
129179413|NCT00098722|464952241|FG003|Open Label Phase|Lack of Efficacy|8|||
129179414|NCT00098722|464952242|FG004|Open Label Phase|Lack of Efficacy|0|||
129179415|NCT00098722|464952243|FG005|Open Label Phase|Lack of Efficacy|0|||
129179416|NCT00098722|464952244|FG006|Open Label Phase|Lack of Efficacy|0|||
129179417|NCT00098722|464952238|FG000|Open Label Phase|Pregnancy|0|||
129179418|NCT00098722|464952239|FG001|Open Label Phase|Pregnancy|0|||
129179419|NCT00098722|464952240|FG002|Open Label Phase|Pregnancy|0|||
129179420|NCT00098722|464952241|FG003|Open Label Phase|Pregnancy|1|||
129179421|NCT00098722|464952242|FG004|Open Label Phase|Pregnancy|0|||
129179422|NCT00098722|464952243|FG005|Open Label Phase|Pregnancy|0|||
129179423|NCT00098722|464952244|FG006|Open Label Phase|Pregnancy|0|||
129179424|NCT00098722|464952238|FG000|Open Label Phase|Participant defaulted|0|||
129179425|NCT00098722|464952239|FG001|Open Label Phase|Participant defaulted|0|||
129179426|NCT00098722|464952240|FG002|Open Label Phase|Participant defaulted|0|||
129179427|NCT00098722|464952241|FG003|Open Label Phase|Participant defaulted|18|||
129179428|NCT00098722|464952242|FG004|Open Label Phase|Participant defaulted|0|||
129179429|NCT00098722|464952243|FG005|Open Label Phase|Participant defaulted|0|||
129179430|NCT00098722|464952244|FG006|Open Label Phase|Participant defaulted|0|||
129179431|NCT00098722|464952238|FG000|Open Label Phase|Ongoing at cut-off date|0|||
129179432|NCT00098722|464952239|FG001|Open Label Phase|Ongoing at cut-off date|0|||
129179433|NCT00098722|464952240|FG002|Open Label Phase|Ongoing at cut-off date|0|||
129179434|NCT00098722|464952241|FG003|Open Label Phase|Ongoing at cut-off date|220|||
129179435|NCT00098722|464952242|FG004|Open Label Phase|Ongoing at cut-off date|50|||
129179436|NCT00098722|464952243|FG005|Open Label Phase|Ongoing at cut-off date|0|||
129179437|NCT00098722|464952244|FG006|Open Label Phase|Ongoing at cut-off date|0|||
129179438|NCT00098722|464952238|FG000|Open Label Phase|Other|0|||
129179439|NCT00098722|464952239|FG001|Open Label Phase|Other|0|||
129179440|NCT00098722|464952240|FG002|Open Label Phase|Other|0|||
129179441|NCT00098722|464952241|FG003|Open Label Phase|Other|18|||
129179442|NCT00098722|464952242|FG004|Open Label Phase|Other|0|||
129179443|NCT00098722|464952243|FG005|Open Label Phase|Other|0|||
129179444|NCT00098722|464952244|FG006|Open Label Phase|Other|0|||
129179445|NCT00098722|464952238|FG000|Observation Phase|Death|0|||
129179446|NCT00098722|464952239|FG001|Observation Phase|Death|0|||
129179447|NCT00098722|464952240|FG002|Observation Phase|Death|0|||
129179448|NCT00098722|464952241|FG003|Observation Phase|Death|0|||
129179449|NCT00098722|464952242|FG004|Observation Phase|Death|0|||
129179450|NCT00098722|464952243|FG005|Observation Phase|Death|5|||
129179451|NCT00098722|464952244|FG006|Observation Phase|Death|3|||
129179452|NCT00098722|464952238|FG000|Observation Phase|Lack of Efficacy|0|||
129179453|NCT00098722|464952239|FG001|Observation Phase|Lack of Efficacy|0|||
129179454|NCT00098722|464952240|FG002|Observation Phase|Lack of Efficacy|0|||
129179455|NCT00098722|464952241|FG003|Observation Phase|Lack of Efficacy|0|||
129179456|NCT00098722|464952242|FG004|Observation Phase|Lack of Efficacy|0|||
129179457|NCT00098722|464952243|FG005|Observation Phase|Lack of Efficacy|2|||
129179458|NCT00098722|464952244|FG006|Observation Phase|Lack of Efficacy|0|||
129179459|NCT00098722|464952238|FG000|Observation Phase|Participant defaulted|0|||
129179460|NCT00098722|464952239|FG001|Observation Phase|Participant defaulted|0|||
129179461|NCT00098722|464952240|FG002|Observation Phase|Participant defaulted|0|||
129179462|NCT00098722|464952241|FG003|Observation Phase|Participant defaulted|0|||
129179463|NCT00098722|464952242|FG004|Observation Phase|Participant defaulted|0|||
129179464|NCT00098722|464952243|FG005|Observation Phase|Participant defaulted|17|||
129179465|NCT00098722|464952244|FG006|Observation Phase|Participant defaulted|4|||
129179466|NCT00098722|464952238|FG000|Observation Phase|Other|0|||
129179467|NCT00098722|464952239|FG001|Observation Phase|Other|0|||
129179468|NCT00098722|464952240|FG002|Observation Phase|Other|0|||
129179469|NCT00098722|464952241|FG003|Observation Phase|Other|0|||
129179470|NCT00098722|464952242|FG004|Observation Phase|Other|0|||
129179471|NCT00098722|464952243|FG005|Observation Phase|Other|21|||
129179472|NCT00098722|464952244|FG006|Observation Phase|Other|10|||
129179473|NCT02351349|464952245|FG000|Overall Study|Withdrawal by Subject|2|||
129179474|NCT02351349|464952246|FG001|Overall Study|Withdrawal by Subject|3|||
129179475|NCT01519674|464952253|FG000|Overall Study|Adverse Event|3|||
129179476|NCT01519674|464952254|FG001|Overall Study|Adverse Event|3|||
129179477|NCT01519674|464952255|FG002|Overall Study|Adverse Event|0|||
129179478|NCT01519674|464952253|FG000|Overall Study|Lack of Efficacy|1|||
129179479|NCT01519674|464952254|FG001|Overall Study|Lack of Efficacy|1|||
129179480|NCT01519674|464952255|FG002|Overall Study|Lack of Efficacy|1|||
129179481|NCT01519674|464952253|FG000|Overall Study|Protocol Violation|0|||
129179482|NCT01519674|464952254|FG001|Overall Study|Protocol Violation|3|||
129179483|NCT01519674|464952255|FG002|Overall Study|Protocol Violation|1|||
129179484|NCT01519674|464952253|FG000|Overall Study|Withdrawal Criteria|7|||
129179485|NCT01519674|464952254|FG001|Overall Study|Withdrawal Criteria|2|||
129179486|NCT01519674|464952255|FG002|Overall Study|Withdrawal Criteria|7|||
129179487|NCT01519674|464952253|FG000|Overall Study|Unsclassified|10|||
129179488|NCT01519674|464952254|FG001|Overall Study|Unsclassified|4|||
129179489|NCT01519674|464952255|FG002|Overall Study|Unsclassified|3|||
129179490|NCT01610596|464952256|FG000|Overall Study|Lost to Follow-up|0|||
129179491|NCT01610596|464952257|FG001|Overall Study|Lost to Follow-up|1|||
129179492|NCT02317809|464952258|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
129179493|NCT02317809|464952259|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
129179494|NCT02317809|464952258|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
129179495|NCT02317809|464952259|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
129179496|NCT04912895|464952260|FG000|Overall Study|Unable to provide specimen|2|||
129179497|NCT04912895|464952261|FG001|Overall Study|Unable to provide specimen|0|||
129179498|NCT04912895|464952262|FG002|Overall Study|Unable to provide specimen|0|||
129179499|NCT00520013|464952263|FG000|Overall Study|Withdrawal by Subject|0|||
129179500|NCT00520013|464952264|FG001|Overall Study|Withdrawal by Subject|0|||
129179501|NCT00520013|464952265|FG002|Overall Study|Withdrawal by Subject|1|||
129179502|NCT00520013|464952263|FG000|Overall Study|Adverse Event|2|||
129179503|NCT00520013|464952264|FG001|Overall Study|Adverse Event|10|||
129179504|NCT00520013|464952265|FG002|Overall Study|Adverse Event|7|||
129179505|NCT00520013|464952263|FG000|Overall Study|Progressive Disease|7|||
129179506|NCT00520013|464952264|FG001|Overall Study|Progressive Disease|3|||
129179507|NCT00520013|464952265|FG002|Overall Study|Progressive Disease|0|||
129179508|NCT00520013|464952263|FG000|Overall Study|Clinical Progression|3|||
129179509|NCT00520013|464952264|FG001|Overall Study|Clinical Progression|1|||
129179510|NCT00520013|464952265|FG002|Overall Study|Clinical Progression|0|||
129179511|NCT00520013|464952263|FG000|Overall Study|Death|0|||
129179512|NCT00520013|464952264|FG001|Overall Study|Death|1|||
129179513|NCT00520013|464952265|FG002|Overall Study|Death|0|||
129179514|NCT00520013|464952263|FG000|Overall Study|Physician Decision|0|||
129179515|NCT00520013|464952264|FG001|Overall Study|Physician Decision|0|||
129179516|NCT00520013|464952265|FG002|Overall Study|Physician Decision|3|||
129179517|NCT02677844|464952266|FG000|Period 3|Withdrawal by Subject|0|||
129179518|NCT02677844|464952267|FG001|Period 3|Withdrawal by Subject|0|||
129179519|NCT02677844|464952268|FG002|Period 3|Withdrawal by Subject|0|||
129179520|NCT02677844|464952269|FG003|Period 3|Withdrawal by Subject|1|||
129179521|NCT02677844|464952270|FG004|Period 3|Withdrawal by Subject|0|||
129179522|NCT02677844|464952271|FG005|Period 3|Withdrawal by Subject|0|||
129179523|NCT02677844|464952272|FG006|Period 3|Withdrawal by Subject|0|||
129179524|NCT01149486|464952273|FG000|First Intervention|Adverse Event|0|||
129179525|NCT01149486|464952274|FG001|First Intervention|Adverse Event|1|||
129179526|NCT01135914|464952277|FG000|Overall Study|Withdrawal by Subject|1|||
129179527|NCT01135914|464952278|FG001|Overall Study|Withdrawal by Subject|3|||
129179528|NCT01135914|464952279|FG002|Overall Study|Withdrawal by Subject|6|||
129179529|NCT01135914|464952277|FG000|Overall Study|Lost to Follow-up|1|||
129179530|NCT01135914|464952278|FG001|Overall Study|Lost to Follow-up|0|||
129179531|NCT01135914|464952279|FG002|Overall Study|Lost to Follow-up|1|||
129179532|NCT01135914|464952277|FG000|Overall Study|Protocol Violation|0|||
129179533|NCT01135914|464952278|FG001|Overall Study|Protocol Violation|0|||
129179534|NCT01135914|464952279|FG002|Overall Study|Protocol Violation|3|||
129179535|NCT01135914|464952277|FG000|Overall Study|Lack of Efficacy|2|||
129179536|NCT01135914|464952278|FG001|Overall Study|Lack of Efficacy|1|||
129179537|NCT01135914|464952279|FG002|Overall Study|Lack of Efficacy|10|||
129179538|NCT01135914|464952277|FG000|Overall Study|Adverse Event|0|||
129179539|NCT01135914|464952278|FG001|Overall Study|Adverse Event|1|||
129179540|NCT01135914|464952279|FG002|Overall Study|Adverse Event|2|||
129179541|NCT03532932|464952281|FG000|Overall Study|Protocol Deviation|33|||
129179542|NCT03532932|464952282|FG001|Overall Study|Protocol Deviation|31|||
129179543|NCT03532932|464952281|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
129179544|NCT03532932|464952282|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
129179545|NCT03532932|464952281|FG000|Overall Study|Withdrawal by Subject|2|||
129179546|NCT03532932|464952282|FG001|Overall Study|Withdrawal by Subject|0|||
129179547|NCT03532932|464952281|FG000|Overall Study|Lost to Follow-up|15|||
129179548|NCT03532932|464952282|FG001|Overall Study|Lost to Follow-up|9|||
129179549|NCT03532932|464952281|FG000|Overall Study|Adverse Event|4|||
129179550|NCT03532932|464952282|FG001|Overall Study|Adverse Event|3|||
129179551|NCT03532932|464952281|FG000|Overall Study|Death|0|||
129179552|NCT03532932|464952282|FG001|Overall Study|Death|2|||
129179553|NCT03532932|464952281|FG000|Overall Study|Other|11|||
129179554|NCT03532932|464952282|FG001|Overall Study|Other|16|||
129179555|NCT01344629|464952287|FG000|Crossover Period 2|Withdrawal by Subject|0|||
129179556|NCT01344629|464952288|FG001|Crossover Period 2|Withdrawal by Subject|1|||
129179557|NCT00693472|464952290|FG000|Part 1|Adverse Event|1|||
129179558|NCT00693472|464952291|FG001|Part 1|Adverse Event|1|||
129179559|NCT00693472|464952292|FG002|Part 1|Adverse Event|0|||
129179560|NCT00693472|464952293|FG003|Part 1|Adverse Event|0|||
129179561|NCT00693472|464952290|FG000|Part 1|Lost to Follow-up|0|||
129179562|NCT00693472|464952291|FG001|Part 1|Lost to Follow-up|1|||
129179563|NCT00693472|464952292|FG002|Part 1|Lost to Follow-up|0|||
129179564|NCT00693472|464952293|FG003|Part 1|Lost to Follow-up|0|||
129179565|NCT00693472|464952290|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
129179566|NCT00693472|464952291|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
129179567|NCT00693472|464952292|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
129179568|NCT00693472|464952293|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
129179569|NCT00693472|464952290|FG000|Part 2|Adverse Event|0|||
129179570|NCT00693472|464952291|FG001|Part 2|Adverse Event|0|||
129179571|NCT00693472|464952292|FG002|Part 2|Adverse Event|1|||
129179572|NCT00693472|464952293|FG003|Part 2|Adverse Event|0|||
129179573|NCT00693472|464952290|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
129179574|NCT00693472|464952291|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
129179575|NCT00693472|464952292|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
129179576|NCT00693472|464952293|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
129179577|NCT04063787|464952294|FG000|Overall Study|Inadequate Doppler data|4|||
129179578|NCT04063787|464952294|FG000|Overall Study|Lost to Follow-up|2|||
129179579|NCT04063787|464952294|FG000|Overall Study|Death|3|||
129179580|NCT05545644|464952295|FG000|Overall Study|Lost to Follow-up|4|||
129179581|NCT05545644|464952296|FG001|Overall Study|Lost to Follow-up|3|||
129179582|NCT00554099|464952299|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
129179583|NCT00554099|464952300|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
129179584|NCT00554099|464952301|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
129179585|NCT00554099|464952299|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
129179586|NCT00554099|464952300|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
129179587|NCT00554099|464952301|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
129179588|NCT00554099|464952299|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129179589|NCT00554099|464952300|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129179590|NCT00554099|464952301|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
129179591|NCT00554099|464952299|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
129179592|NCT00554099|464952300|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
129179593|NCT00554099|464952301|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
129179594|NCT00554099|464952299|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
129179595|NCT00554099|464952300|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
129179596|NCT00554099|464952301|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
129179597|NCT00554099|464952299|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129179598|NCT00554099|464952300|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129179599|NCT00554099|464952301|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129179600|NCT00554099|464952299|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
129179601|NCT00554099|464952300|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
128780950|NCT01323660|463488627|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129179602|NCT00554099|464952301|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
129179603|NCT00554099|464952299|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
129179604|NCT00554099|464952300|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
129179605|NCT00554099|464952301|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
129179606|NCT00554099|464952299|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
129179607|NCT00554099|464952300|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
129179608|NCT00554099|464952301|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
129179609|NCT03002623|464952302|FG000|Overall Study|Lost to Follow-up|1|||
129179610|NCT03002623|464952303|FG001|Overall Study|Lost to Follow-up|0|||
129179611|NCT03002623|464952302|FG000|Overall Study|Physician Decision|1|||
129179612|NCT03002623|464952303|FG001|Overall Study|Physician Decision|1|||
129179613|NCT00493636|464952305|FG000|Overall Study|Withdrawal by Subject|1|||
129179614|NCT00493636|464952306|FG001|Overall Study|Withdrawal by Subject|0|||
129179615|NCT00493636|464952305|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
129179616|NCT00493636|464952306|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
129179617|NCT00493636|464952305|FG000|Overall Study|Mis-randomization|1|||
129179618|NCT00493636|464952306|FG001|Overall Study|Mis-randomization|1|||
129179619|NCT00612508|464952313|FG000|Overall Study|Withdrawal by Subject|3|||
129179620|NCT00612508|464952314|FG001|Overall Study|Withdrawal by Subject|4|||
129179621|NCT02012686|464952315|FG000|Overall Study|muscle contraction|0|||
129179622|NCT02012686|464952316|FG001|Overall Study|muscle contraction|1|||
129179623|NCT02012686|464952315|FG000|Overall Study|electrocardiography monitoring noise|0|||
129179624|NCT02012686|464952316|FG001|Overall Study|electrocardiography monitoring noise|1|||
129179625|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
129179626|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
129179627|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
129179628|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
129179629|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
129179630|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
129179631|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
129179632|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
129179633|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
129179634|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
129179635|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
129179636|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
129179637|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
129179638|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
129179639|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
129179640|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
129179641|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
129179642|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
129179643|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
129179644|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
129179645|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
129179646|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
129179647|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
129179648|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
129179649|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
129179650|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
129179651|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
129179652|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
129179653|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
129179654|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
129179655|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
129179656|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
129179657|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
129179658|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
129179659|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
129179660|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
129179661|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
129179662|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
129179663|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
129179664|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
129179665|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
129179666|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
129179667|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
129179668|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
129179669|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
129179670|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
129179671|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
129179672|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
129179673|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
129179674|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
129179675|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
129179676|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
129179677|NCT02008357|464952317|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
129179678|NCT02008357|464952318|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
129179679|NCT02008357|464952317|FG000|Open-label Extension Period|Adverse Event|8|||
129179680|NCT02008357|464952318|FG001|Open-label Extension Period|Adverse Event|7|||
129179681|NCT02008357|464952317|FG000|Open-label Extension Period|Death|7|||
129179682|NCT02008357|464952318|FG001|Open-label Extension Period|Death|4|||
129179683|NCT02008357|464952317|FG000|Open-label Extension Period|Lack of Efficacy|9|||
129179684|NCT02008357|464952318|FG001|Open-label Extension Period|Lack of Efficacy|5|||
129179685|NCT02008357|464952317|FG000|Open-label Extension Period|Lost to Follow-up|2|||
129179686|NCT02008357|464952318|FG001|Open-label Extension Period|Lost to Follow-up|2|||
129179687|NCT02008357|464952317|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
129179688|NCT02008357|464952318|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
129179689|NCT02008357|464952317|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
129179690|NCT02008357|464952318|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
129179691|NCT02008357|464952317|FG000|Open-label Extension Period|Safety Risk|2|||
129179692|NCT02008357|464952318|FG001|Open-label Extension Period|Safety Risk|1|||
129179693|NCT02008357|464952317|FG000|Open-label Extension Period|Non-Compliance|0|||
129179694|NCT02008357|464952318|FG001|Open-label Extension Period|Non-Compliance|1|||
129179695|NCT02008357|464952317|FG000|Open-label Extension Period|Investigator Recommendation|0|||
129179696|NCT02008357|464952318|FG001|Open-label Extension Period|Investigator Recommendation|1|||
129179697|NCT02008357|464952317|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
129179698|NCT02008357|464952318|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
129179699|NCT02008357|464952317|FG000|Open-label Extension Period|Coordinating Center Request|2|||
129179700|NCT02008357|464952318|FG001|Open-label Extension Period|Coordinating Center Request|4|||
128730197|NCT02448875|463308354|FG000|Overall Study|Investigator Decision|3|||
129179701|NCT02008357|464952317|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
129179702|NCT02008357|464952318|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
129179703|NCT02008357|464952317|FG000|Open-label Extension Period|Study Ended|20|||
129179704|NCT02008357|464952318|FG001|Open-label Extension Period|Study Ended|25|||
129179705|NCT02008357|464952317|FG000|Open-label Extension Period|Personal Reasons|0|||
129179706|NCT02008357|464952318|FG001|Open-label Extension Period|Personal Reasons|1|||
129179707|NCT02008357|464952317|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
129179708|NCT02008357|464952318|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
129179709|NCT02008357|464952317|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
129179710|NCT02008357|464952318|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
129179711|NCT02008357|464952317|FG000|Open-label Extension Period|Other|2|||
129179712|NCT02008357|464952318|FG001|Open-label Extension Period|Other|0|||
129179713|NCT01442064|464952319|FG000|Overall Study|Adverse Event|2|||
129179714|NCT01442064|464952320|FG001|Overall Study|Adverse Event|2|||
129179715|NCT01442064|464952321|FG002|Overall Study|Adverse Event|2|||
129179716|NCT01442064|464952322|FG003|Overall Study|Adverse Event|1|||
129179717|NCT01442064|464952323|FG004|Overall Study|Adverse Event|2|||
129179718|NCT01442064|464952324|FG005|Overall Study|Adverse Event|0|||
129179719|NCT01442064|464952319|FG000|Overall Study|Death|0|||
129179720|NCT01442064|464952320|FG001|Overall Study|Death|1|||
129179721|NCT01442064|464952321|FG002|Overall Study|Death|3|||
129179722|NCT01442064|464952322|FG003|Overall Study|Death|3|||
129179723|NCT01442064|464952323|FG004|Overall Study|Death|1|||
129179724|NCT01442064|464952324|FG005|Overall Study|Death|3|||
129179725|NCT01442064|464952319|FG000|Overall Study|Lost to Follow-up|5|||
129179726|NCT01442064|464952320|FG001|Overall Study|Lost to Follow-up|5|||
129179727|NCT01442064|464952321|FG002|Overall Study|Lost to Follow-up|1|||
129179728|NCT01442064|464952322|FG003|Overall Study|Lost to Follow-up|1|||
129179729|NCT01442064|464952323|FG004|Overall Study|Lost to Follow-up|3|||
129179730|NCT01442064|464952324|FG005|Overall Study|Lost to Follow-up|3|||
129179731|NCT01442064|464952319|FG000|Overall Study|Physician Decision|1|||
129179732|NCT01442064|464952320|FG001|Overall Study|Physician Decision|1|||
129179733|NCT01442064|464952321|FG002|Overall Study|Physician Decision|2|||
129179734|NCT01442064|464952322|FG003|Overall Study|Physician Decision|3|||
129179735|NCT01442064|464952323|FG004|Overall Study|Physician Decision|3|||
129179736|NCT01442064|464952324|FG005|Overall Study|Physician Decision|1|||
129179737|NCT01442064|464952319|FG000|Overall Study|Withdrawal by Subject|6|||
129179738|NCT01442064|464952320|FG001|Overall Study|Withdrawal by Subject|3|||
129179739|NCT01442064|464952321|FG002|Overall Study|Withdrawal by Subject|2|||
129179740|NCT01442064|464952322|FG003|Overall Study|Withdrawal by Subject|2|||
129179741|NCT01442064|464952323|FG004|Overall Study|Withdrawal by Subject|2|||
129179742|NCT01442064|464952324|FG005|Overall Study|Withdrawal by Subject|1|||
129179743|NCT01442064|464952319|FG000|Overall Study|Sponsor decision|82|||
129179744|NCT01442064|464952320|FG001|Overall Study|Sponsor decision|88|||
129179745|NCT01442064|464952321|FG002|Overall Study|Sponsor decision|92|||
129179746|NCT01442064|464952322|FG003|Overall Study|Sponsor decision|88|||
129179747|NCT01442064|464952323|FG004|Overall Study|Sponsor decision|95|||
129179748|NCT01442064|464952324|FG005|Overall Study|Sponsor decision|87|||
129179749|NCT01442064|464952319|FG000|Overall Study|Subject non-compliance|0|||
129179750|NCT01442064|464952320|FG001|Overall Study|Subject non-compliance|0|||
129179751|NCT01442064|464952321|FG002|Overall Study|Subject non-compliance|0|||
129179752|NCT01442064|464952322|FG003|Overall Study|Subject non-compliance|0|||
129179753|NCT01442064|464952323|FG004|Overall Study|Subject non-compliance|0|||
129179754|NCT01442064|464952324|FG005|Overall Study|Subject non-compliance|2|||
129179755|NCT01442064|464952319|FG000|Overall Study|Condition mandated other intervention|1|||
129179756|NCT01442064|464952320|FG001|Overall Study|Condition mandated other intervention|1|||
129179757|NCT01442064|464952321|FG002|Overall Study|Condition mandated other intervention|2|||
129179758|NCT01442064|464952322|FG003|Overall Study|Condition mandated other intervention|0|||
129179759|NCT01442064|464952323|FG004|Overall Study|Condition mandated other intervention|0|||
129179760|NCT01442064|464952324|FG005|Overall Study|Condition mandated other intervention|2|||
129179761|NCT03553498|464952327|FG000|Overall Study|Missing primary outcome|1|||
129179762|NCT03553498|464952328|FG001|Overall Study|Missing primary outcome|2|||
129179763|NCT04941807|464952329|FG000|Overall Study|Lost to Follow-up|1|||
129179764|NCT04941807|464952330|FG001|Overall Study|Lost to Follow-up|1|||
129179765|NCT01100567|464952331|FG000|Overall Study|Withdrawal by Subject|5|||
129179766|NCT01100567|464952332|FG001|Overall Study|Withdrawal by Subject|8|||
129179767|NCT01100567|464952331|FG000|Overall Study|Early Hospital Discharge|6|||
129179768|NCT01100567|464952332|FG001|Overall Study|Early Hospital Discharge|4|||
129179769|NCT01100567|464952331|FG000|Overall Study|Lost to Follow-up|1|||
129179770|NCT01100567|464952332|FG001|Overall Study|Lost to Follow-up|2|||
129179771|NCT01100567|464952331|FG000|Overall Study|Physician Decision|0|||
129179772|NCT01100567|464952332|FG001|Overall Study|Physician Decision|1|||
129179773|NCT01100567|464952331|FG000|Overall Study|Deemed ineligible after consent|0|||
128982137|NCT00508820|464219106|FG000|Overall Study|Protocol Violation|2|||
129179774|NCT01100567|464952332|FG001|Overall Study|Deemed ineligible after consent|1|||
129179775|NCT02741570|464952333|FG000|Pre-Treatment Period|Other reasons|0|||
129179776|NCT02741570|464952334|FG001|Pre-Treatment Period|Other reasons|3|||
129179777|NCT02741570|464952333|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
129179778|NCT02741570|464952334|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
129179779|NCT02741570|464952333|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
129179780|NCT02741570|464952334|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
129179781|NCT02741570|464952333|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
129179782|NCT02741570|464952334|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
129179783|NCT02741570|464952333|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
129179784|NCT02741570|464952334|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
129179785|NCT02741570|464952333|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129179786|NCT02741570|464952334|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
129179787|NCT02741570|464952333|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
129179788|NCT02741570|464952334|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129179789|NCT02741570|464952333|FG000|Pre-Treatment Period|Death|0|||
129179790|NCT02741570|464952334|FG001|Pre-Treatment Period|Death|1|||
129179791|NCT02741570|464952333|FG000|Pre-Treatment Period|Disease progression|0|||
129179792|NCT02741570|464952334|FG001|Pre-Treatment Period|Disease progression|1|||
129179793|NCT02741570|464952333|FG000|Treatment Period|Other reasons|47|||
129179794|NCT02741570|464952334|FG001|Treatment Period|Other reasons|12|||
129179795|NCT02741570|464952333|FG000|Treatment Period|Poor/non-compliance|0|||
129179796|NCT02741570|464952334|FG001|Treatment Period|Poor/non-compliance|2|||
129179797|NCT02741570|464952333|FG000|Treatment Period|Maximum clinical benefit|4|||
129179798|NCT02741570|464952334|FG001|Treatment Period|Maximum clinical benefit|6|||
129179799|NCT02741570|464952333|FG000|Treatment Period|Lost to Follow-up|1|||
129179800|NCT02741570|464952334|FG001|Treatment Period|Lost to Follow-up|3|||
129179801|NCT02741570|464952333|FG000|Treatment Period|Participant withdrew consent|9|||
129179802|NCT02741570|464952334|FG001|Treatment Period|Participant withdrew consent|13|||
129179803|NCT02741570|464952333|FG000|Treatment Period|Participant request to discontinue treatment|8|||
129179804|NCT02741570|464952334|FG001|Treatment Period|Participant request to discontinue treatment|23|||
129179805|NCT02741570|464952333|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
129179806|NCT02741570|464952334|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
129179807|NCT02741570|464952333|FG000|Treatment Period|Death|9|||
129179808|NCT02741570|464952334|FG001|Treatment Period|Death|7|||
129179809|NCT02741570|464952333|FG000|Treatment Period|Study drug toxicity|55|||
129179810|NCT02741570|464952334|FG001|Treatment Period|Study drug toxicity|47|||
129179811|NCT02741570|464952333|FG000|Treatment Period|Disease progression|294|||
129179812|NCT02741570|464952334|FG001|Treatment Period|Disease progression|301|||
129179813|NCT02741570|464952333|FG000|Treatment Period|Administrative reason by sponsor|0|||
129179814|NCT02741570|464952334|FG001|Treatment Period|Administrative reason by sponsor|1|||
129179815|NCT00160199|464952337|FG000|Overall Study|Adverse Event|5|||
129179816|NCT00160199|464952338|FG001|Overall Study|Adverse Event|14|||
129179817|NCT00160199|464952337|FG000|Overall Study|Lack of Efficacy|0|||
129179818|NCT00160199|464952338|FG001|Overall Study|Lack of Efficacy|1|||
129179819|NCT00160199|464952337|FG000|Overall Study|Lost to Follow-up|7|||
129179820|NCT00160199|464952338|FG001|Overall Study|Lost to Follow-up|7|||
129179821|NCT00160199|464952337|FG000|Overall Study|Withdrawal by Subject|4|||
129179822|NCT00160199|464952338|FG001|Overall Study|Withdrawal by Subject|6|||
129179823|NCT00160199|464952337|FG000|Overall Study|Administrative|0|||
129179824|NCT00160199|464952338|FG001|Overall Study|Administrative|1|||
129179825|NCT00160199|464952337|FG000|Overall Study|Protocol Violation|8|||
129179826|NCT00160199|464952338|FG001|Overall Study|Protocol Violation|8|||
129179827|NCT03352453|464952341|FG000|Overall Study|Miscellaneous Reasons|1|||
129179828|NCT03352453|464952342|FG001|Overall Study|Miscellaneous Reasons|2|||
129179829|NCT03352453|464952341|FG000|Overall Study|Lack of Efficacy|1|||
129179830|NCT03352453|464952342|FG001|Overall Study|Lack of Efficacy|0|||
129179831|NCT03352453|464952341|FG000|Overall Study|Withdrawal by Subject|8|||
129179832|NCT03352453|464952342|FG001|Overall Study|Withdrawal by Subject|14|||
129179833|NCT03352453|464952341|FG000|Overall Study|Study Terminated by Sponsor|2|||
129179834|NCT03352453|464952342|FG001|Overall Study|Study Terminated by Sponsor|1|||
129179835|NCT03352453|464952341|FG000|Overall Study|Protocol Deviation|1|||
129179836|NCT03352453|464952342|FG001|Overall Study|Protocol Deviation|0|||
129179837|NCT03352453|464952341|FG000|Overall Study|Lost to Follow-up|7|||
129179838|NCT03352453|464952342|FG001|Overall Study|Lost to Follow-up|6|||
129179839|NCT03352453|464952341|FG000|Overall Study|Adverse Event|2|||
129179840|NCT03352453|464952342|FG001|Overall Study|Adverse Event|9|||
129179841|NCT01241760|464952345|FG000|Overall Study|Adverse Event|1|||
129179842|NCT01241760|464952346|FG001|Overall Study|Adverse Event|0|||
128780951|NCT01323660|463488628|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129179843|NCT01241760|464952345|FG000|Overall Study|Lost to Follow-up|18|||
129179844|NCT01241760|464952346|FG001|Overall Study|Lost to Follow-up|22|||
129179845|NCT01241760|464952345|FG000|Overall Study|Withdrawal by Subject|13|||
129179846|NCT01241760|464952346|FG001|Overall Study|Withdrawal by Subject|13|||
129179847|NCT01241760|464952345|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
129179848|NCT01241760|464952346|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
129179849|NCT01241760|464952345|FG000|Overall Study|Other|1|||
129179850|NCT01241760|464952346|FG001|Overall Study|Other|1|||
129179851|NCT00514020|464952347|FG000|Overall Study|Adverse Event|6|||
129179852|NCT00514020|464952347|FG000|Overall Study|Withdrawal by Subject|3|||
129179853|NCT00514020|464952347|FG000|Overall Study|Physician Decision|1|||
129179854|NCT00514020|464952347|FG000|Overall Study|disease progression|9|||
129179855|NCT00514020|464952347|FG000|Overall Study|other complicating disease|2|||
129179856|NCT00514020|464952347|FG000|Overall Study|patient went to radiation treatment|1|||
129179857|NCT00514020|464952347|FG000|Overall Study|"patients moved to the no tx group"|6|||
129179858|NCT03089944|464952348|FG000|Overall Study|Lost to Follow-up|8|||
129179859|NCT03089944|464952348|FG000|Overall Study|Withdrew Consent|2|||
129179860|NCT03089944|464952348|FG000|Overall Study|Adverse Event|1|||
129179861|NCT03089944|464952348|FG000|Overall Study|Other|1|||
129179862|NCT03780959|464952352|FG000|Part 1|Adverse Event|1|||
129179863|NCT03780959|464952353|FG001|Part 1|Adverse Event|0|||
129179864|NCT03780959|464952354|FG002|Part 1|Adverse Event|0|||
129179865|NCT03780959|464952352|FG000|Part 1|Withdrawal by Subject|1|||
129179866|NCT03780959|464952353|FG001|Part 1|Withdrawal by Subject|0|||
129179867|NCT03780959|464952354|FG002|Part 1|Withdrawal by Subject|0|||
129179868|NCT03780959|464952352|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
129179869|NCT03780959|464952353|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
129179870|NCT03780959|464952354|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
129179871|NCT03780959|464952352|FG000|Part 1|Response Status|2|||
129179872|NCT03780959|464952353|FG001|Part 1|Response Status|0|||
129179873|NCT03780959|464952354|FG002|Part 1|Response Status|0|||
129179874|NCT03780959|464952352|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
129179875|NCT03780959|464952353|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
129179876|NCT03780959|464952354|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
129179877|NCT03780959|464952352|FG000|Part 2|Response Status|0|||
129179878|NCT03780959|464952353|FG001|Part 2|Response Status|18|||
129179879|NCT03780959|464952354|FG002|Part 2|Response Status|6|||
129179880|NCT01636713|464952355|FG000|Overall Study|Adverse Event|16|||
129179881|NCT01636713|464952356|FG001|Overall Study|Adverse Event|16|||
129179882|NCT01636713|464952357|FG002|Overall Study|Adverse Event|7|||
129179883|NCT01636713|464952355|FG000|Overall Study|Lack of Efficacy|6|||
129179884|NCT01636713|464952356|FG001|Overall Study|Lack of Efficacy|6|||
129179885|NCT01636713|464952357|FG002|Overall Study|Lack of Efficacy|2|||
129179886|NCT01636713|464952355|FG000|Overall Study|Protocol Violation|3|||
129179887|NCT01636713|464952356|FG001|Overall Study|Protocol Violation|0|||
129179888|NCT01636713|464952357|FG002|Overall Study|Protocol Violation|1|||
129179889|NCT01636713|464952355|FG000|Overall Study|Lost to Follow-up|0|||
129179890|NCT01636713|464952356|FG001|Overall Study|Lost to Follow-up|0|||
129179891|NCT01636713|464952357|FG002|Overall Study|Lost to Follow-up|1|||
129179892|NCT01636713|464952355|FG000|Overall Study|Withdrawal by Subject|5|||
129179893|NCT01636713|464952356|FG001|Overall Study|Withdrawal by Subject|4|||
129179894|NCT01636713|464952357|FG002|Overall Study|Withdrawal by Subject|8|||
129179895|NCT01636713|464952355|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
129179896|NCT01636713|464952356|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
129179897|NCT01636713|464952357|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
129179898|NCT03689244|464952359|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
129179899|NCT03689244|464952360|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
129179900|NCT03689244|464952361|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
129179901|NCT03689244|464952362|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
129179902|NCT03689244|464952359|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
129179903|NCT03689244|464952360|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
129179904|NCT03689244|464952361|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
129179905|NCT03689244|464952362|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
129179906|NCT03689244|464952359|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
129179907|NCT03689244|464952360|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
129179908|NCT03689244|464952361|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
129179909|NCT03689244|464952362|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
129179910|NCT03689244|464952359|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
129179911|NCT03689244|464952360|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
129179912|NCT03689244|464952361|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
129179913|NCT03689244|464952362|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
129179914|NCT03689244|464952359|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
129179915|NCT03689244|464952360|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
129179916|NCT03689244|464952361|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
129179917|NCT03689244|464952362|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
129179918|NCT03689244|464952359|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
129179919|NCT03689244|464952360|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
129179920|NCT03689244|464952361|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
129179921|NCT03689244|464952362|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
129179922|NCT03689244|464952359|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
129179923|NCT03689244|464952360|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
129179924|NCT03689244|464952361|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
129179925|NCT03689244|464952362|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
129179926|NCT03689244|464952359|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
129179927|NCT03689244|464952360|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
129179928|NCT03689244|464952361|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
129179929|NCT03689244|464952362|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
129179930|NCT03697993|464952373|FG000|Overall Study|Became Ineligible after Enrollment|1|||
129179931|NCT03697993|464952374|FG001|Overall Study|Became Ineligible after Enrollment|3|||
129179932|NCT03697993|464952373|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
129179933|NCT03697993|464952374|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
129179934|NCT03697993|464952373|FG000|Overall Study|Lost to Follow-up|3|||
129179935|NCT03697993|464952374|FG001|Overall Study|Lost to Follow-up|0|||
129179936|NCT03697993|464952373|FG000|Overall Study|Physician Decision|4|||
129179937|NCT03697993|464952374|FG001|Overall Study|Physician Decision|0|||
129179938|NCT03697993|464952373|FG000|Overall Study|Initial Urine Culture Negative|0|||
129179939|NCT03697993|464952374|FG001|Overall Study|Initial Urine Culture Negative|1|||
129179940|NCT01565564|464952375|FG000|Overall Study|Lost to Follow-up|5|||
129179941|NCT01565564|464952376|FG001|Overall Study|Lost to Follow-up|1|||
129179942|NCT02698371|464952377|FG000|All Participants Flow|Lost to Follow-up|3|||
129179943|NCT02698371|464952377|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
129179944|NCT02698371|464952377|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
129179945|NCT02698371|464952377|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
129179946|NCT02698371|464952377|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
129179947|NCT02698371|464952377|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
129179948|NCT02698371|464952377|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
129179949|NCT00459537|464952382|FG000|Overall Study|Adverse Event|1|||
129179950|NCT00459537|464952383|FG001|Overall Study|Adverse Event|6|||
129179951|NCT00459537|464952382|FG000|Overall Study|Lack of Efficacy|10|||
129179952|NCT00459537|464952383|FG001|Overall Study|Lack of Efficacy|11|||
129179953|NCT00459537|464952382|FG000|Overall Study|Withdrawal by Subject|20|||
129179954|NCT00459537|464952383|FG001|Overall Study|Withdrawal by Subject|26|||
129179955|NCT00459537|464952382|FG000|Overall Study|Lost to Follow-up|27|||
129179956|NCT00459537|464952383|FG001|Overall Study|Lost to Follow-up|30|||
129179957|NCT00459537|464952382|FG000|Overall Study|Administrative problems|3|||
129179958|NCT00459537|464952383|FG001|Overall Study|Administrative problems|0|||
129179959|NCT00459537|464952382|FG000|Overall Study|Protocol Violation|4|||
129179960|NCT00459537|464952383|FG001|Overall Study|Protocol Violation|3|||
129179961|NCT00459537|464952382|FG000|Overall Study|Missing|1|||
129179962|NCT00459537|464952383|FG001|Overall Study|Missing|0|||
129179963|NCT01999218|464952384|FG000|Overall Study|Hyperglycemia|18|||
129179964|NCT01999218|464952385|FG001|Overall Study|Hyperglycemia|17|||
129179965|NCT01999218|464952386|FG002|Overall Study|Hyperglycemia|17|||
129179966|NCT01999218|464952384|FG000|Overall Study|Lack of Efficacy|1|||
129179967|NCT01999218|464952385|FG001|Overall Study|Lack of Efficacy|0|||
129179968|NCT01999218|464952386|FG002|Overall Study|Lack of Efficacy|1|||
129179969|NCT01999218|464952384|FG000|Overall Study|Lost to Follow-up|22|||
129179970|NCT01999218|464952385|FG001|Overall Study|Lost to Follow-up|17|||
129179971|NCT01999218|464952386|FG002|Overall Study|Lost to Follow-up|18|||
129179972|NCT01999218|464952384|FG000|Overall Study|Non-Compliance With Study Drug|6|||
129179973|NCT01999218|464952385|FG001|Overall Study|Non-Compliance With Study Drug|4|||
129179974|NCT01999218|464952386|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129179975|NCT01999218|464952384|FG000|Overall Study|Physician Decision|1|||
129179976|NCT01999218|464952385|FG001|Overall Study|Physician Decision|4|||
129179977|NCT01999218|464952386|FG002|Overall Study|Physician Decision|6|||
129179978|NCT01999218|464952384|FG000|Overall Study|Protocol Violation|4|||
129179979|NCT01999218|464952385|FG001|Overall Study|Protocol Violation|5|||
129179980|NCT01999218|464952386|FG002|Overall Study|Protocol Violation|4|||
129179981|NCT01999218|464952384|FG000|Overall Study|Screen failure|0|||
129179982|NCT01999218|464952385|FG001|Overall Study|Screen failure|1|||
129179983|NCT01999218|464952386|FG002|Overall Study|Screen failure|0|||
129179984|NCT01999218|464952384|FG000|Overall Study|Study Terminated By Sponsor|7|||
129179985|NCT01999218|464952385|FG001|Overall Study|Study Terminated By Sponsor|5|||
129179986|NCT01999218|464952386|FG002|Overall Study|Study Terminated By Sponsor|12|||
129179987|NCT01999218|464952384|FG000|Overall Study|Participant moves|2|||
129179988|NCT01999218|464952385|FG001|Overall Study|Participant moves|5|||
129179989|NCT01999218|464952386|FG002|Overall Study|Participant moves|3|||
129179990|NCT01999218|464952384|FG000|Overall Study|Withdrawal by Subject|28|||
129179991|NCT01999218|464952385|FG001|Overall Study|Withdrawal by Subject|29|||
129179992|NCT01999218|464952386|FG002|Overall Study|Withdrawal by Subject|34|||
129179993|NCT01999218|464952384|FG000|Overall Study|Creatinine/eGFR|0|||
129179994|NCT01999218|464952385|FG001|Overall Study|Creatinine/eGFR|0|||
129179995|NCT01999218|464952386|FG002|Overall Study|Creatinine/eGFR|1|||
129179996|NCT01999218|464952384|FG000|Overall Study|Death|7|||
129179997|NCT01999218|464952385|FG001|Overall Study|Death|1|||
129179998|NCT01999218|464952386|FG002|Overall Study|Death|2|||
129179999|NCT01999218|464952384|FG000|Overall Study|Excluded Medication|1|||
129180000|NCT01999218|464952385|FG001|Overall Study|Excluded Medication|1|||
129180001|NCT01999218|464952386|FG002|Overall Study|Excluded Medication|2|||
129180002|NCT01999218|464952384|FG000|Overall Study|Adverse Event|9|||
129180003|NCT01999218|464952385|FG001|Overall Study|Adverse Event|7|||
129180004|NCT01999218|464952386|FG002|Overall Study|Adverse Event|7|||
129180005|NCT01999218|464952384|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
129180006|NCT01999218|464952385|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
129180007|NCT01999218|464952386|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
129180008|NCT00664326|464953827|FG000|Overall Study|Adverse Event|14|||
129180009|NCT00664326|464953827|FG000|Overall Study|Noncompliance with study medication|3|||
129180010|NCT00664326|464953827|FG000|Overall Study|Withdrawal by Subject|1|||
129180011|NCT00664326|464953827|FG000|Overall Study|Physician Decision|1|||
129180012|NCT00664326|464953827|FG000|Overall Study|Other Reasons|3|||
129180013|NCT00664326|464953827|FG000|Overall Study|Death|2|||
129180014|NCT00664326|464953827|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
129180015|NCT02032407|464953828|FG000|Overall Study|Lost to Follow-up|2|||
129180016|NCT02032407|464953828|FG000|Overall Study|Pregnancy|1|||
129180017|NCT02032407|464953828|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129180018|NCT02191605|464953829|FG000|Overall Study|Lost to Follow-up|9|||
129180019|NCT02191605|464953830|FG001|Overall Study|Lost to Follow-up|4|||
129180020|NCT02191605|464953831|FG002|Overall Study|Lost to Follow-up|7|||
129180021|NCT02191605|464953832|FG003|Overall Study|Lost to Follow-up|3|||
129180022|NCT02191605|464953833|FG004|Overall Study|Lost to Follow-up|4|||
128982138|NCT00508820|464219107|FG001|Overall Study|Protocol Violation|0|||
129180023|NCT03647267|464953837|FG000|Overall Study|Lost to Follow-up|1|||
129180024|NCT03647267|464953838|FG001|Overall Study|Lost to Follow-up|0|||
129180025|NCT01350115|464953839|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
129180026|NCT01350115|464953840|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
129180027|NCT01350115|464953839|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
129180028|NCT01350115|464953840|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
129180029|NCT01350115|464953839|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
129180030|NCT01350115|464953840|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
129180031|NCT05079477|464953841|FG000|Overall Study|Lost to Follow-up|2|||
129180032|NCT05079477|464953842|FG001|Overall Study|Lost to Follow-up|0|||
129180033|NCT05079477|464953841|FG000|Overall Study|Withdrawal by Subject|1|||
129180034|NCT05079477|464953842|FG001|Overall Study|Withdrawal by Subject|0|||
129180035|NCT05079477|464953841|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
129180036|NCT05079477|464953842|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
129180037|NCT05079477|464953841|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
129180038|NCT05079477|464953842|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
129180039|NCT00734071|464953843|FG000|Overall Study|Adverse Event|4|||
129180040|NCT00734071|464953844|FG001|Overall Study|Adverse Event|3|||
129180041|NCT00734071|464953843|FG000|Overall Study|Lack of Efficacy|3|||
129180042|NCT00734071|464953844|FG001|Overall Study|Lack of Efficacy|1|||
129180043|NCT00734071|464953843|FG000|Overall Study|Noncompliance|2|||
129180044|NCT00734071|464953844|FG001|Overall Study|Noncompliance|2|||
129180045|NCT00734071|464953843|FG000|Overall Study|Protocol Deviations|3|||
129180046|NCT00734071|464953844|FG001|Overall Study|Protocol Deviations|4|||
129180047|NCT00734071|464953843|FG000|Overall Study|Voluntary Withdrawal|9|||
129180048|NCT00734071|464953844|FG001|Overall Study|Voluntary Withdrawal|7|||
129180049|NCT00734071|464953843|FG000|Overall Study|Lost to Follow-up|16|||
129180050|NCT00734071|464953844|FG001|Overall Study|Lost to Follow-up|8|||
129180051|NCT00734071|464953843|FG000|Overall Study|Other|1|||
129180052|NCT00734071|464953844|FG001|Overall Study|Other|2|||
129180053|NCT00240110|464953848|FG000|Overall Study|Lost to Follow-up|6|||
129180054|NCT00240110|464953849|FG001|Overall Study|Lost to Follow-up|7|||
129180055|NCT00583791|464953850|FG000|Overall Study|Other|67|||
129180056|NCT00583791|464953850|FG000|Overall Study|Death|6|||
129180057|NCT03323736|464953851|FG000|Overall Study|Screen Failure|14|||
129180058|NCT03323736|464953852|FG001|Overall Study|Screen Failure|9|||
129180059|NCT03323736|464953853|FG002|Overall Study|Screen Failure|1|||
129180060|NCT03323736|464953851|FG000|Overall Study|Withdrawal Before Treatment|3|||
129180061|NCT03323736|464953852|FG001|Overall Study|Withdrawal Before Treatment|1|||
129180062|NCT03323736|464953853|FG002|Overall Study|Withdrawal Before Treatment|1|||
129180063|NCT03323736|464953851|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
129180064|NCT03323736|464953852|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
129180065|NCT03323736|464953853|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
129180066|NCT02654236|464953857|FG000|Overall Study|Withdrawal by Subject|0|||
129180067|NCT02654236|464953858|FG001|Overall Study|Withdrawal by Subject|0|||
129180068|NCT02654236|464953859|FG002|Overall Study|Withdrawal by Subject|2|||
129180069|NCT03204890|464953860|FG000|Overall Study|Withdrawal by Subject|1|||
129180070|NCT01549873|464953861|FG000|Overall Study|Physician Decision|0|||
129180071|NCT01549873|464953862|FG001|Overall Study|Physician Decision|1|||
129180072|NCT01688739|464953866|FG000|Overall Study|Administrative Decision|1|||
129180073|NCT01688739|464953867|FG001|Overall Study|Administrative Decision|0|||
129180074|NCT01688739|464953868|FG002|Overall Study|Administrative Decision|0|||
129180075|NCT01688739|464953869|FG003|Overall Study|Administrative Decision|0|||
129180076|NCT01688739|464953870|FG004|Overall Study|Administrative Decision|0|||
129180077|NCT01688739|464953871|FG005|Overall Study|Administrative Decision|0|||
129180078|NCT01688739|464953872|FG006|Overall Study|Administrative Decision|0|||
129180079|NCT01688739|464953873|FG007|Overall Study|Administrative Decision|0|||
129180080|NCT01688739|464953874|FG008|Overall Study|Administrative Decision|0|||
129180081|NCT01688739|464953875|FG009|Overall Study|Administrative Decision|0|||
129180082|NCT02559414|464953877|FG000|Overall Study|Lost to Follow-up|0|||
129180083|NCT02559414|464953878|FG001|Overall Study|Lost to Follow-up|1|||
129180084|NCT02559414|464953879|FG002|Overall Study|Lost to Follow-up|0|||
129180085|NCT02559414|464953877|FG000|Overall Study|Withdrawal by Subject|1|||
129180086|NCT02559414|464953878|FG001|Overall Study|Withdrawal by Subject|0|||
129180087|NCT02559414|464953879|FG002|Overall Study|Withdrawal by Subject|1|||
129180088|NCT02559414|464953877|FG000|Overall Study|Other|0|||
129180089|NCT02559414|464953878|FG001|Overall Study|Other|1|||
129180090|NCT02559414|464953879|FG002|Overall Study|Other|1|||
129180091|NCT03369431|464953880|FG000|Overall Study|Lost to Follow-up|1|||
129180092|NCT03369431|464953881|FG001|Overall Study|Lost to Follow-up|3|||
129180093|NCT03369431|464953880|FG000|Overall Study|Withdrawal by Subject|2|||
129180094|NCT03369431|464953881|FG001|Overall Study|Withdrawal by Subject|3|||
129180095|NCT03369431|464953880|FG000|Overall Study|Protocol Violation|1|||
129180096|NCT03369431|464953881|FG001|Overall Study|Protocol Violation|1|||
129180097|NCT01266317|464953886|FG000|Overall Study|Withdrawal by Subject|2|||
129180098|NCT00490776|464953887|FG000|Overall Study|Withdrawal by Subject|1|||
129180099|NCT00490776|464953887|FG000|Overall Study|Administrative Problems|1|||
129180100|NCT00490776|464953887|FG000|Overall Study|Death|1|||
129180101|NCT00490776|464953887|FG000|Overall Study|New Cancer Therapy|1|||
129180102|NCT00490776|464953887|FG000|Overall Study|Disease Progression|5|||
129180103|NCT00046930|464953895|FG000|Overall Study|Ineligible|12|||
129180104|NCT00046930|464953896|FG001|Overall Study|Ineligible|4|||
129180105|NCT01113580|464953897|FG000|Overall Study|Protocol Violation|1|||
129180106|NCT01113580|464953898|FG001|Overall Study|Protocol Violation|0|||
129180107|NCT02785458|464953906|FG000|1 Month|Withdrawal by Subject|2|||
129180108|NCT02785458|464953907|FG001|1 Month|Withdrawal by Subject|1|||
129180109|NCT02785458|464953906|FG000|1 Month|Lost to Follow-up|38|||
129180110|NCT02785458|464953907|FG001|1 Month|Lost to Follow-up|31|||
129180111|NCT02785458|464953906|FG000|1 Month|Deemed Ineligible|1|||
129180112|NCT02785458|464953907|FG001|1 Month|Deemed Ineligible|0|||
129180113|NCT02785458|464953906|FG000|1 Month|Completed Evaluation by Baseline|42|||
129180114|NCT02785458|464953907|FG001|1 Month|Completed Evaluation by Baseline|39|||
129180115|NCT02785458|464953906|FG000|1 Month|Partial Interview|0|||
129180116|NCT02785458|464953907|FG001|1 Month|Partial Interview|4|||
129180117|NCT02785458|464953906|FG000|3 Months|Withdrawal by Subject|3|||
129180118|NCT02785458|464953907|FG001|3 Months|Withdrawal by Subject|1|||
129180119|NCT02785458|464953906|FG000|3 Months|Lost to Follow-up|25|||
129180120|NCT02785458|464953907|FG001|3 Months|Lost to Follow-up|21|||
129180121|NCT02785458|464953906|FG000|3 Months|Completed Evaluation at 1 Month|100|||
129180122|NCT02785458|464953907|FG001|3 Months|Completed Evaluation at 1 Month|89|||
129180123|NCT00824005|464953909|FG000|Overall Study|Death|0|||
129180124|NCT00824005|464953910|FG001|Overall Study|Death|1|||
129180125|NCT00824005|464953909|FG000|Overall Study|Lost to Follow-up|0|||
129180126|NCT00824005|464953910|FG001|Overall Study|Lost to Follow-up|1|||
129180127|NCT03458702|464953911|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
129180128|NCT03458702|464953912|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
129180129|NCT03458702|464953911|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
129180130|NCT03458702|464953912|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
129180131|NCT01390779|464953913|FG000|Overall Study|Physician Decision|1|||
129180132|NCT01874275|464953914|FG000|Overall Study|Lost to Follow-up|1|||
129180133|NCT01874275|464953915|FG001|Overall Study|Lost to Follow-up|0|||
129180134|NCT01697462|464953916|FG000|Overall Study|Disease Progression|1|||
129180135|NCT01697462|464953916|FG000|Overall Study|Adverse Event|6|||
129180136|NCT01697462|464953916|FG000|Overall Study|Lost to Follow-up|21|||
129180137|NCT01697462|464953916|FG000|Overall Study|Withdrawal by Subject|12|||
129180138|NCT01697462|464953916|FG000|Overall Study|Investigator Decision|21|||
129180139|NCT01697462|464953916|FG000|Overall Study|Death|1|||
129180140|NCT01697462|464953916|FG000|Overall Study|Other|10|||
129180141|NCT01697462|464953916|FG000|Overall Study|Missing|5|||
129180142|NCT00168103|464953917|FG000|Overall Study|Withdrawal by Subject|1|||
129180143|NCT00168103|464953918|FG001|Overall Study|Withdrawal by Subject|2|||
129180144|NCT00168103|464953919|FG002|Overall Study|Withdrawal by Subject|1|||
129180145|NCT00168103|464953920|FG003|Overall Study|Withdrawal by Subject|0|||
129180146|NCT00168103|464953917|FG000|Overall Study|Lost to Follow-up|1|||
129180147|NCT00168103|464953918|FG001|Overall Study|Lost to Follow-up|3|||
129180148|NCT00168103|464953919|FG002|Overall Study|Lost to Follow-up|0|||
129180149|NCT00168103|464953920|FG003|Overall Study|Lost to Follow-up|0|||
129180150|NCT00989235|464953921|FG000|Overall Study|Death|0|||
129180151|NCT00989235|464953922|FG001|Overall Study|Death|1|||
129180152|NCT00989235|464953921|FG000|Overall Study|Adverse Event|0|||
129180153|NCT00989235|464953922|FG001|Overall Study|Adverse Event|1|||
129180154|NCT00989235|464953921|FG000|Overall Study|Lack of Efficacy|1|||
129180155|NCT00989235|464953922|FG001|Overall Study|Lack of Efficacy|0|||
129180156|NCT00989235|464953921|FG000|Overall Study|Withdrawal of Consent|1|||
129180157|NCT00989235|464953922|FG001|Overall Study|Withdrawal of Consent|1|||
129180158|NCT00989235|464953921|FG000|Overall Study|Desire to Become Pregnant|1|||
129180159|NCT00989235|464953922|FG001|Overall Study|Desire to Become Pregnant|0|||
129180160|NCT00989235|464953921|FG000|Overall Study|Randomized by Mistake|0|||
129180161|NCT00989235|464953922|FG001|Overall Study|Randomized by Mistake|2|||
129180162|NCT00989235|464953921|FG000|Overall Study|Lost to Follow-up|0|||
129180163|NCT00989235|464953922|FG001|Overall Study|Lost to Follow-up|1|||
129180164|NCT00545532|464953923|FG000|Overall Study|Withdrawal by Subject|1|||
129180165|NCT00545532|464953924|FG001|Overall Study|Withdrawal by Subject|3|||
129180166|NCT00545532|464953923|FG000|Overall Study|Lost to Follow-up|5|||
129180167|NCT00545532|464953924|FG001|Overall Study|Lost to Follow-up|6|||
129180168|NCT00545532|464953923|FG000|Overall Study|Death|0|||
129180169|NCT00545532|464953924|FG001|Overall Study|Death|1|||
129180170|NCT03630302|464953925|FG000|Surgery|hardware issue prevented LFP recordings|1|||
129180171|NCT03630302|464953925|FG000|3 Month Visit|Adverse Event|2|||
129180172|NCT03630302|464953925|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
129180173|NCT00931801|464953928|FG000|Overall Study|Adverse Event|0|||
129180174|NCT00931801|464953929|FG001|Overall Study|Adverse Event|0|||
129180175|NCT00931801|464953930|FG002|Overall Study|Adverse Event|1|||
129180176|NCT00931801|464953928|FG000|Overall Study|Lost to Follow-up|0|||
129180177|NCT00931801|464953929|FG001|Overall Study|Lost to Follow-up|1|||
129180178|NCT00931801|464953930|FG002|Overall Study|Lost to Follow-up|0|||
129180179|NCT00931801|464953928|FG000|Overall Study|Withdrawal by Subject|1|||
129180180|NCT00931801|464953929|FG001|Overall Study|Withdrawal by Subject|0|||
129180181|NCT00931801|464953930|FG002|Overall Study|Withdrawal by Subject|0|||
129180182|NCT00931801|464953928|FG000|Overall Study|Confirmed Virologic Failure|0|||
129180183|NCT00931801|464953929|FG001|Overall Study|Confirmed Virologic Failure|0|||
129180184|NCT00931801|464953930|FG002|Overall Study|Confirmed Virologic Failure|3|||
129180185|NCT00933244|464953931|FG000|Overall Study|Withdrawal by Subject|5|||
129180186|NCT00933244|464953932|FG001|Overall Study|Withdrawal by Subject|1|||
129180187|NCT00933244|464953933|FG002|Overall Study|Withdrawal by Subject|3|||
129180188|NCT02266875|464953934|FG000|Overall Study|Withdrawal by Subject|9|||
129180189|NCT02266875|464953935|FG001|Overall Study|Withdrawal by Subject|0|||
129180190|NCT02266875|464953934|FG000|Overall Study|Lost to Follow-up|2|||
129180191|NCT02266875|464953935|FG001|Overall Study|Lost to Follow-up|0|||
129180192|NCT00875056|464953939|FG000|Overall Study|Adverse Event|6|||
129180193|NCT00875056|464953940|FG001|Overall Study|Adverse Event|1|||
129180194|NCT00875056|464953941|FG002|Overall Study|Adverse Event|2|||
129180195|NCT00875056|464953939|FG000|Overall Study|Progressive Disease|14|||
129180196|NCT00875056|464953940|FG001|Overall Study|Progressive Disease|8|||
129180197|NCT00875056|464953941|FG002|Overall Study|Progressive Disease|3|||
129180198|NCT00875056|464953939|FG000|Overall Study|Withdrawal by Subject|3|||
129180199|NCT00875056|464953940|FG001|Overall Study|Withdrawal by Subject|0|||
129180200|NCT00875056|464953941|FG002|Overall Study|Withdrawal by Subject|1|||
129180201|NCT00391391|464953944|FG000|Overall Study|Adverse Event|0|||
129180202|NCT00391391|464953945|FG001|Overall Study|Adverse Event|0|||
129180203|NCT00391391|464953946|FG002|Overall Study|Adverse Event|0|||
129180204|NCT00391391|464953947|FG003|Overall Study|Adverse Event|1|||
129180205|NCT00391391|464953944|FG000|Overall Study|Lost to Follow-up|1|||
129180206|NCT00391391|464953945|FG001|Overall Study|Lost to Follow-up|3|||
129180207|NCT00391391|464953946|FG002|Overall Study|Lost to Follow-up|7|||
129180208|NCT00391391|464953947|FG003|Overall Study|Lost to Follow-up|4|||
129180209|NCT00391391|464953944|FG000|Overall Study|Protocol Violation|2|||
129180210|NCT00391391|464953945|FG001|Overall Study|Protocol Violation|3|||
129180211|NCT00391391|464953946|FG002|Overall Study|Protocol Violation|6|||
129180212|NCT00391391|464953947|FG003|Overall Study|Protocol Violation|7|||
129180213|NCT00391391|464953944|FG000|Overall Study|Withdrawal by Subject|6|||
129180214|NCT00391391|464953945|FG001|Overall Study|Withdrawal by Subject|4|||
129180215|NCT00391391|464953946|FG002|Overall Study|Withdrawal by Subject|10|||
129180216|NCT00391391|464953947|FG003|Overall Study|Withdrawal by Subject|7|||
129180217|NCT01920152|464953948|FG000|Overall Study|Withdrawal by Subject|1|||
129180218|NCT01920152|464953949|FG001|Overall Study|Withdrawal by Subject|2|||
129180219|NCT04375397|464953952|FG000|Overall Study|Death|1|||
129180220|NCT04375397|464953953|FG001|Overall Study|Death|1|||
129180221|NCT04375397|464953952|FG000|Overall Study|Withdrew consent|2|||
129180222|NCT04375397|464953953|FG001|Overall Study|Withdrew consent|0|||
129180223|NCT04375397|464953952|FG000|Overall Study|Lost to Follow-up|6|||
129180224|NCT04375397|464953953|FG001|Overall Study|Lost to Follow-up|4|||
129180225|NCT04375397|464953952|FG000|Overall Study|Other, not specified|0|||
129180226|NCT04375397|464953953|FG001|Overall Study|Other, not specified|1|||
129180227|NCT00610441|464953957|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
129180228|NCT00610441|464953958|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
129180229|NCT00610441|464953959|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
129180230|NCT00610441|464953960|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
129180231|NCT00610441|464953957|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
129180232|NCT00610441|464953958|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
129180233|NCT00610441|464953959|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
129180234|NCT00610441|464953960|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
129180235|NCT00610441|464953957|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
129180236|NCT00610441|464953958|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
129180237|NCT00610441|464953959|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
129180238|NCT00610441|464953960|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
129180239|NCT00610441|464953957|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
129180240|NCT00610441|464953958|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
129180241|NCT00610441|464953959|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
129180242|NCT00610441|464953960|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
129180243|NCT00610441|464953957|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
129180244|NCT00610441|464953958|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
129180245|NCT00610441|464953959|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
129180246|NCT00610441|464953960|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
129180247|NCT00610441|464953957|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129180248|NCT00610441|464953958|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
129180249|NCT00610441|464953959|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129180250|NCT00610441|464953960|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129180251|NCT00610441|464953957|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
129180252|NCT00610441|464953958|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
129180253|NCT00610441|464953959|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
129180254|NCT00610441|464953960|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
129180255|NCT00610441|464953957|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
129180256|NCT00610441|464953958|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
129180257|NCT00610441|464953959|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
129180258|NCT00610441|464953960|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
129180259|NCT00610441|464953957|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
129180260|NCT00610441|464953958|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
129180261|NCT00610441|464953959|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
129180262|NCT00610441|464953960|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
129180263|NCT01995552|464953961|FG000|Overall Study|Protocol Violation|1|||
129180264|NCT01995552|464953961|FG000|Overall Study|Lack of Efficacy|15|||
129180265|NCT01995552|464953961|FG000|Overall Study|Death|1|||
129180266|NCT01011933|464953963|FG000|Overall Study|Wrong cell type|1|||
129180267|NCT01011933|464953963|FG000|Overall Study|Improper pre-protocol Rx|1|||
129180268|NCT01011933|464953963|FG000|Overall Study|Inadequate pathology|1|||
129180269|NCT01011933|464953963|FG000|Overall Study|Never treated|1|||
129180270|NCT01439074|464953964|FG000|Overall Study|Lost to Follow-up|3|||
129180271|NCT01439074|464953965|FG001|Overall Study|Lost to Follow-up|4|||
129180272|NCT01439074|464953964|FG000|Overall Study|Subject shedding|1|||
129180273|NCT01439074|464953965|FG001|Overall Study|Subject shedding|0|||
129180274|NCT01439074|464953964|FG000|Overall Study|Withdrawal by Subject|1|||
129180275|NCT01439074|464953965|FG001|Overall Study|Withdrawal by Subject|5|||
129180276|NCT01439074|464953964|FG000|Overall Study|Other|4|||
129180277|NCT01439074|464953965|FG001|Overall Study|Other|4|||
129180278|NCT02639338|464953966|FG000|Overall Study|Lost to Follow-up|2|||
129180279|NCT02639338|464953967|FG001|Overall Study|Lost to Follow-up|2|||
129180280|NCT02639338|464953966|FG000|Overall Study|Withdrew Consent|1|||
129180281|NCT02639338|464953967|FG001|Overall Study|Withdrew Consent|2|||
129180282|NCT02639338|464953966|FG000|Overall Study|Death|1|||
129180283|NCT02639338|464953967|FG001|Overall Study|Death|0|||
129180284|NCT02639338|464953966|FG000|Overall Study|Randomized but Not Treated|0|||
129180285|NCT02639338|464953967|FG001|Overall Study|Randomized but Not Treated|1|||
129180286|NCT00787202|464953968|FG000|Overall Study|Adverse Event|3|||
129180287|NCT00787202|464953969|FG001|Overall Study|Adverse Event|2|||
129180288|NCT00787202|464953970|FG002|Overall Study|Adverse Event|0|||
129180289|NCT00787202|464953971|FG003|Overall Study|Adverse Event|0|||
129180290|NCT00787202|464953972|FG004|Overall Study|Adverse Event|2|||
129180291|NCT00787202|464953968|FG000|Overall Study|Lack of Efficacy|5|||
129180292|NCT00787202|464953969|FG001|Overall Study|Lack of Efficacy|6|||
129180293|NCT00787202|464953970|FG002|Overall Study|Lack of Efficacy|5|||
129180294|NCT00787202|464953971|FG003|Overall Study|Lack of Efficacy|2|||
129180295|NCT00787202|464953972|FG004|Overall Study|Lack of Efficacy|1|||
129180296|NCT00787202|464953968|FG000|Overall Study|Lost to Follow-up|1|||
129180297|NCT00787202|464953969|FG001|Overall Study|Lost to Follow-up|0|||
129180298|NCT00787202|464953970|FG002|Overall Study|Lost to Follow-up|0|||
129180299|NCT00787202|464953971|FG003|Overall Study|Lost to Follow-up|0|||
129180300|NCT00787202|464953972|FG004|Overall Study|Lost to Follow-up|0|||
129180301|NCT00787202|464953968|FG000|Overall Study|Withdrawal by Subject|2|||
129180302|NCT00787202|464953969|FG001|Overall Study|Withdrawal by Subject|2|||
129180303|NCT00787202|464953970|FG002|Overall Study|Withdrawal by Subject|2|||
129180304|NCT00787202|464953971|FG003|Overall Study|Withdrawal by Subject|0|||
129180305|NCT00787202|464953972|FG004|Overall Study|Withdrawal by Subject|0|||
129180306|NCT00787202|464953968|FG000|Overall Study|Protocol Violation|2|||
129180307|NCT00787202|464953969|FG001|Overall Study|Protocol Violation|1|||
129180308|NCT00787202|464953970|FG002|Overall Study|Protocol Violation|0|||
129180309|NCT00787202|464953971|FG003|Overall Study|Protocol Violation|0|||
129180310|NCT00787202|464953972|FG004|Overall Study|Protocol Violation|1|||
129180311|NCT00787202|464953968|FG000|Overall Study|Randomized, not treated|1|||
129180312|NCT00787202|464953969|FG001|Overall Study|Randomized, not treated|0|||
129180313|NCT00787202|464953970|FG002|Overall Study|Randomized, not treated|0|||
129180314|NCT00787202|464953971|FG003|Overall Study|Randomized, not treated|0|||
129180315|NCT00787202|464953972|FG004|Overall Study|Randomized, not treated|0|||
129180316|NCT03159104|464953973|FG000|Overall Study|Violation of inclusion criteria|1|||
129180317|NCT03159104|464953974|FG001|Overall Study|Violation of inclusion criteria|2|||
129180318|NCT00456599|464953975|FG000|Overall Study|Non-compliance|1|||
129180319|NCT00456599|464953975|FG000|Overall Study|Withdrawal by Subject|2|||
129180320|NCT04271475|464955547|FG000|DB Period: Day 1 up to EODBT|Death|1|||
129180321|NCT04271475|464955548|FG001|DB Period: Day 1 up to EODBT|Death|0|||
129180322|NCT04271475|464955549|FG002|DB Period: Day 1 up to EODBT|Death|0|||
129180323|NCT04271475|464955550|FG003|DB Period: Day 1 up to EODBT|Death|0|||
129180324|NCT04271475|464955547|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
129180325|NCT04271475|464955548|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
129180326|NCT04271475|464955549|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
129180327|NCT04271475|464955550|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
129180328|NCT04271475|464955547|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
129180329|NCT04271475|464955548|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
129180330|NCT04271475|464955549|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
129180331|NCT04271475|464955550|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
129180332|NCT04271475|464955547|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
129180333|NCT04271475|464955548|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
129180334|NCT04271475|464955549|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
129180335|NCT04271475|464955550|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
129180336|NCT04271475|464955547|FG000|DB Period: Day 1 up to EODBT|Other|8|||
129180337|NCT04271475|464955548|FG001|DB Period: Day 1 up to EODBT|Other|5|||
129180338|NCT04271475|464955549|FG002|DB Period: Day 1 up to EODBT|Other|0|||
129180339|NCT04271475|464955550|FG003|DB Period: Day 1 up to EODBT|Other|0|||
129180340|NCT04271475|464955547|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
129180341|NCT04271475|464955548|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
129180342|NCT04271475|464955549|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
129180343|NCT04271475|464955550|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
129180344|NCT04271475|464955547|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
129180345|NCT04271475|464955548|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
129180346|NCT04271475|464955549|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
129180347|NCT04271475|464955550|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
129180348|NCT00159913|464955552|FG000|Overall Study|Adverse Event|1|||
129180349|NCT00159913|464955553|FG001|Overall Study|Adverse Event|0|||
129180350|NCT00159913|464955554|FG002|Overall Study|Adverse Event|1|||
129180351|NCT00159913|464955555|FG003|Overall Study|Adverse Event|0|||
129180352|NCT00159913|464955552|FG000|Overall Study|Withdrawal by Subject|0|||
129180353|NCT00159913|464955553|FG001|Overall Study|Withdrawal by Subject|0|||
129180354|NCT00159913|464955554|FG002|Overall Study|Withdrawal by Subject|0|||
129180355|NCT00159913|464955555|FG003|Overall Study|Withdrawal by Subject|1|||
129180356|NCT00159913|464955552|FG000|Overall Study|Lost to Follow-up|0|||
129180357|NCT00159913|464955553|FG001|Overall Study|Lost to Follow-up|0|||
129180358|NCT00159913|464955554|FG002|Overall Study|Lost to Follow-up|0|||
129180359|NCT00159913|464955555|FG003|Overall Study|Lost to Follow-up|1|||
129180360|NCT00159913|464955552|FG000|Overall Study|Protocol Violation|1|||
129180361|NCT00159913|464955553|FG001|Overall Study|Protocol Violation|0|||
129180362|NCT00159913|464955554|FG002|Overall Study|Protocol Violation|1|||
129180363|NCT00159913|464955555|FG003|Overall Study|Protocol Violation|0|||
129180364|NCT01318070|464955560|FG000|Overall Study|Adverse Event|1|||
129180365|NCT01318070|464955561|FG001|Overall Study|Adverse Event|1|||
129180366|NCT01318070|464955562|FG002|Overall Study|Adverse Event|5|||
129180367|NCT01318070|464955560|FG000|Overall Study|Withdrawal by Subject|0|||
129180368|NCT01318070|464955561|FG001|Overall Study|Withdrawal by Subject|1|||
129180369|NCT01318070|464955562|FG002|Overall Study|Withdrawal by Subject|1|||
129180370|NCT01318070|464955560|FG000|Overall Study|Lack of Efficacy|0|||
129180371|NCT01318070|464955561|FG001|Overall Study|Lack of Efficacy|0|||
129180372|NCT01318070|464955562|FG002|Overall Study|Lack of Efficacy|1|||
129180373|NCT01318070|464955560|FG000|Overall Study|Principal Investigator Discretion|1|||
129180374|NCT01318070|464955561|FG001|Overall Study|Principal Investigator Discretion|0|||
129180375|NCT01318070|464955562|FG002|Overall Study|Principal Investigator Discretion|0|||
129180376|NCT02956850|464955563|FG000|Overall Study|Withdrawal by Subject|0|||
129180377|NCT02956850|464955564|FG001|Overall Study|Withdrawal by Subject|0|||
129180378|NCT02956850|464955565|FG002|Overall Study|Withdrawal by Subject|0|||
129180379|NCT02956850|464955566|FG003|Overall Study|Withdrawal by Subject|0|||
129180380|NCT02956850|464955567|FG004|Overall Study|Withdrawal by Subject|0|||
129180381|NCT02956850|464955568|FG005|Overall Study|Withdrawal by Subject|0|||
129180382|NCT02956850|464955569|FG006|Overall Study|Withdrawal by Subject|0|||
129180383|NCT02956850|464955570|FG007|Overall Study|Withdrawal by Subject|0|||
129180384|NCT02956850|464955571|FG008|Overall Study|Withdrawal by Subject|0|||
129180385|NCT02956850|464955572|FG009|Overall Study|Withdrawal by Subject|0|||
129180386|NCT02956850|464955573|FG010|Overall Study|Withdrawal by Subject|0|||
129180387|NCT02956850|464955574|FG011|Overall Study|Withdrawal by Subject|0|||
129180388|NCT02956850|464955575|FG012|Overall Study|Withdrawal by Subject|0|||
129180389|NCT02956850|464955576|FG013|Overall Study|Withdrawal by Subject|0|||
129180390|NCT02956850|464955577|FG014|Overall Study|Withdrawal by Subject|0|||
129180391|NCT02956850|464955578|FG015|Overall Study|Withdrawal by Subject|0|||
129180392|NCT02956850|464955579|FG016|Overall Study|Withdrawal by Subject|0|||
129180393|NCT02956850|464955580|FG017|Overall Study|Withdrawal by Subject|1|||
129180394|NCT01287195|464955585|FG000|Overall Study|Withdrawal by Subject|2|||
129180395|NCT00870194|464955589|FG000|Overall Study|Adverse Event|10|||
129180396|NCT00870194|464955590|FG001|Overall Study|Adverse Event|5|||
129180397|NCT00870194|464955589|FG000|Overall Study|Lack of Efficacy|0|||
129180398|NCT00870194|464955590|FG001|Overall Study|Lack of Efficacy|1|||
129180399|NCT00870194|464955589|FG000|Overall Study|Lost to Follow-up|2|||
129180400|NCT00870194|464955590|FG001|Overall Study|Lost to Follow-up|0|||
129180401|NCT00870194|464955589|FG000|Overall Study|Physician Decision|3|||
129180402|NCT00870194|464955590|FG001|Overall Study|Physician Decision|1|||
129180403|NCT00870194|464955589|FG000|Overall Study|Protocol Violation|3|||
129180404|NCT00870194|464955590|FG001|Overall Study|Protocol Violation|3|||
129180405|NCT00870194|464955589|FG000|Overall Study|Entry Criteria Not Met|1|||
129180406|NCT00870194|464955590|FG001|Overall Study|Entry Criteria Not Met|2|||
129180407|NCT00870194|464955589|FG000|Overall Study|Subject Decision|7|||
129180408|NCT00870194|464955590|FG001|Overall Study|Subject Decision|2|||
129180409|NCT02322190|464955591|FG000|Overall Study|Death on study|1|||
129180410|NCT02322190|464955592|FG001|Overall Study|Death on study|0|||
129180411|NCT01685983|464955596|FG000|Overall Study|Adverse Event|7|||
129180412|NCT01685983|464955596|FG000|Overall Study|Death|1|||
129180413|NCT01685983|464955596|FG000|Overall Study|Withdrawal by Subject|19|||
129180414|NCT01685983|464955596|FG000|Overall Study|Protocol Violation|2|||
129180415|NCT01685983|464955596|FG000|Overall Study|Physician Decision|13|||
129180416|NCT01685983|464955596|FG000|Overall Study|Other|7|||
129180417|NCT01685983|464955596|FG000|Overall Study|Progressive Disease|32|||
129180418|NCT01685983|464955596|FG000|Overall Study|Noncompliance with Study Drug|1|||
129180419|NCT01443130|464955597|FG000|Overall Study|Lost to Follow-up|44|||
129180420|NCT01443130|464955598|FG001|Overall Study|Lost to Follow-up|42|||
129180421|NCT01443130|464955599|FG002|Overall Study|Lost to Follow-up|50|||
129180422|NCT01443130|464955600|FG003|Overall Study|Lost to Follow-up|23|||
129180423|NCT01443130|464955601|FG004|Overall Study|Lost to Follow-up|25|||
129180424|NCT01443130|464955602|FG005|Overall Study|Lost to Follow-up|21|||
129180425|NCT01443130|464955597|FG000|Overall Study|Death|0|||
129180426|NCT01443130|464955598|FG001|Overall Study|Death|1|||
129180427|NCT01443130|464955599|FG002|Overall Study|Death|0|||
129180428|NCT01443130|464955600|FG003|Overall Study|Death|7|||
129180429|NCT01443130|464955601|FG004|Overall Study|Death|10|||
129180430|NCT01443130|464955602|FG005|Overall Study|Death|8|||
129180431|NCT01443130|464955597|FG000|Overall Study|Adverse Event|2|||
129180432|NCT01443130|464955598|FG001|Overall Study|Adverse Event|1|||
129180433|NCT01443130|464955599|FG002|Overall Study|Adverse Event|1|||
129180434|NCT01443130|464955600|FG003|Overall Study|Adverse Event|0|||
129180435|NCT01443130|464955601|FG004|Overall Study|Adverse Event|0|||
129180436|NCT01443130|464955602|FG005|Overall Study|Adverse Event|0|||
129180437|NCT01443130|464955597|FG000|Overall Study|Protocol Violation|2|||
129180438|NCT01443130|464955598|FG001|Overall Study|Protocol Violation|1|||
129180439|NCT01443130|464955599|FG002|Overall Study|Protocol Violation|3|||
129180440|NCT01443130|464955600|FG003|Overall Study|Protocol Violation|2|||
129180441|NCT01443130|464955601|FG004|Overall Study|Protocol Violation|2|||
129180442|NCT01443130|464955602|FG005|Overall Study|Protocol Violation|3|||
129180443|NCT01443130|464955597|FG000|Overall Study|Withdrawal by Subject|15|||
129180444|NCT01443130|464955598|FG001|Overall Study|Withdrawal by Subject|14|||
129180445|NCT01443130|464955599|FG002|Overall Study|Withdrawal by Subject|12|||
129180446|NCT01443130|464955600|FG003|Overall Study|Withdrawal by Subject|7|||
129180447|NCT01443130|464955601|FG004|Overall Study|Withdrawal by Subject|7|||
129180448|NCT01443130|464955602|FG005|Overall Study|Withdrawal by Subject|2|||
129180449|NCT01443130|464955597|FG000|Overall Study|Death of Subject's Infant|5|||
129180450|NCT01443130|464955598|FG001|Overall Study|Death of Subject's Infant|10|||
129180451|NCT01443130|464955599|FG002|Overall Study|Death of Subject's Infant|11|||
129180452|NCT01443130|464955600|FG003|Overall Study|Death of Subject's Infant|0|||
129180453|NCT01443130|464955601|FG004|Overall Study|Death of Subject's Infant|0|||
129180454|NCT01443130|464955602|FG005|Overall Study|Death of Subject's Infant|0|||
129180455|NCT01167907|464955604|FG000|Overall Study|Protocol Violation|1|||
129180456|NCT01167907|464955605|FG001|Overall Study|Protocol Violation|0|||
129180457|NCT01167907|464955604|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
129180458|NCT01167907|464955605|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
129180459|NCT03461406|464955606|FG000|Overall Study|Death|1|||
129180460|NCT03461406|464955607|FG001|Overall Study|Death|2|||
129180461|NCT03461406|464955606|FG000|Overall Study|Consent Withdrawn by Participant|0|||
129180462|NCT03461406|464955607|FG001|Overall Study|Consent Withdrawn by Participant|1|||
129180463|NCT03461406|464955606|FG000|Overall Study|Screen Failure|3|||
129180464|NCT03461406|464955607|FG001|Overall Study|Screen Failure|1|||
129180465|NCT03461406|464955606|FG000|Overall Study|Reason not Specified|1|||
129180466|NCT03461406|464955607|FG001|Overall Study|Reason not Specified|3|||
129180467|NCT03461406|464955606|FG000|Overall Study|Lost to Follow-up|3|||
129180468|NCT03461406|464955607|FG001|Overall Study|Lost to Follow-up|0|||
129180469|NCT03077698|464955608|FG000|Progestin Monotherapy|Stable Disease|8|||
129180470|NCT03077698|464955609|FG001|Progestin Monotherapy|Stable Disease|0|||
129180471|NCT03077698|464955608|FG000|Progestin Monotherapy|Adverse Event|1|||
129180472|NCT03077698|464955609|FG001|Progestin Monotherapy|Adverse Event|0|||
129180473|NCT03077698|464955608|FG000|Progestin Monotherapy|Death|1|||
129180474|NCT03077698|464955609|FG001|Progestin Monotherapy|Death|0|||
129180475|NCT03077698|464955608|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
129180476|NCT03077698|464955609|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
129180477|NCT03077698|464955608|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
129180478|NCT03077698|464955609|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
129180479|NCT03077698|464955608|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
129180480|NCT03077698|464955609|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
129180481|NCT03077698|464955608|FG000|Safety Follow Up|Withdrawal by Subject|2|||
129180482|NCT03077698|464955609|FG001|Safety Follow Up|Withdrawal by Subject|1|||
129180483|NCT03077698|464955608|FG000|Safety Follow Up|Transfer of care to hospice|1|||
129180484|NCT03077698|464955609|FG001|Safety Follow Up|Transfer of care to hospice|0|||
129180485|NCT00973102|464955614|FG000|Overall Study|Protocol Violation|1|||
129180486|NCT00973102|464955615|FG001|Overall Study|Protocol Violation|0|||
129180487|NCT00973102|464955614|FG000|Overall Study|Prisoner|0|||
129180488|NCT00973102|464955615|FG001|Overall Study|Prisoner|1|||
129180489|NCT01710527|464955618|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
129180490|NCT01710527|464955619|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
129180491|NCT02635347|464955622|FG000|Overall Study|Failed screening|20|||
129180492|NCT02635347|464955623|FG001|Overall Study|Failed screening|7|||
129180493|NCT02124772|464955625|FG000|Overall Study|Lack of Efficacy|2|||
129180494|NCT02124772|464955626|FG001|Overall Study|Lack of Efficacy|0|||
129180495|NCT02124772|464955627|FG002|Overall Study|Lack of Efficacy|0|||
129180496|NCT02124772|464955628|FG003|Overall Study|Lack of Efficacy|1|||
129180497|NCT02124772|464955629|FG004|Overall Study|Lack of Efficacy|2|||
129180498|NCT02124772|464955630|FG005|Overall Study|Lack of Efficacy|3|||
129180499|NCT02124772|464955631|FG006|Overall Study|Lack of Efficacy|0|||
129180500|NCT02124772|464955632|FG007|Overall Study|Lack of Efficacy|2|||
129180501|NCT02124772|464955633|FG008|Overall Study|Lack of Efficacy|0|||
129180502|NCT02124772|464955634|FG009|Overall Study|Lack of Efficacy|1|||
129180503|NCT02124772|464955635|FG010|Overall Study|Lack of Efficacy|0|||
129180504|NCT02124772|464955636|FG011|Overall Study|Lack of Efficacy|0|||
129180505|NCT02124772|464955637|FG012|Overall Study|Lack of Efficacy|1|||
129180506|NCT02124772|464955625|FG000|Overall Study|Adverse Event|1|||
129180507|NCT02124772|464955626|FG001|Overall Study|Adverse Event|4|||
129180508|NCT02124772|464955627|FG002|Overall Study|Adverse Event|1|||
129180509|NCT02124772|464955628|FG003|Overall Study|Adverse Event|5|||
129180510|NCT02124772|464955629|FG004|Overall Study|Adverse Event|2|||
129180511|NCT02124772|464955630|FG005|Overall Study|Adverse Event|1|||
129180512|NCT02124772|464955631|FG006|Overall Study|Adverse Event|1|||
129180513|NCT02124772|464955632|FG007|Overall Study|Adverse Event|5|||
129180514|NCT02124772|464955633|FG008|Overall Study|Adverse Event|0|||
129180515|NCT02124772|464955634|FG009|Overall Study|Adverse Event|3|||
129180516|NCT02124772|464955635|FG010|Overall Study|Adverse Event|1|||
129180517|NCT02124772|464955636|FG011|Overall Study|Adverse Event|3|||
129180518|NCT02124772|464955637|FG012|Overall Study|Adverse Event|1|||
129180519|NCT02124772|464955625|FG000|Overall Study|Withdrawal consent|0|||
129180520|NCT02124772|464955626|FG001|Overall Study|Withdrawal consent|1|||
129180521|NCT02124772|464955627|FG002|Overall Study|Withdrawal consent|1|||
129180522|NCT02124772|464955628|FG003|Overall Study|Withdrawal consent|1|||
129180523|NCT02124772|464955629|FG004|Overall Study|Withdrawal consent|0|||
129180524|NCT02124772|464955630|FG005|Overall Study|Withdrawal consent|1|||
129180525|NCT02124772|464955631|FG006|Overall Study|Withdrawal consent|1|||
129180526|NCT02124772|464955632|FG007|Overall Study|Withdrawal consent|0|||
129180527|NCT02124772|464955633|FG008|Overall Study|Withdrawal consent|0|||
129180528|NCT02124772|464955634|FG009|Overall Study|Withdrawal consent|1|||
129180529|NCT02124772|464955635|FG010|Overall Study|Withdrawal consent|0|||
129180530|NCT02124772|464955636|FG011|Overall Study|Withdrawal consent|1|||
129180531|NCT02124772|464955637|FG012|Overall Study|Withdrawal consent|0|||
129180532|NCT02124772|464955625|FG000|Overall Study|Investigator discretion|0|||
129180533|NCT02124772|464955626|FG001|Overall Study|Investigator discretion|2|||
129180534|NCT02124772|464955627|FG002|Overall Study|Investigator discretion|2|||
129180535|NCT02124772|464955628|FG003|Overall Study|Investigator discretion|1|||
129180536|NCT02124772|464955629|FG004|Overall Study|Investigator discretion|1|||
129180537|NCT02124772|464955630|FG005|Overall Study|Investigator discretion|0|||
129180538|NCT02124772|464955631|FG006|Overall Study|Investigator discretion|1|||
129180539|NCT02124772|464955632|FG007|Overall Study|Investigator discretion|0|||
129180540|NCT02124772|464955633|FG008|Overall Study|Investigator discretion|0|||
129180541|NCT02124772|464955634|FG009|Overall Study|Investigator discretion|1|||
129180542|NCT02124772|464955635|FG010|Overall Study|Investigator discretion|0|||
129180543|NCT02124772|464955636|FG011|Overall Study|Investigator discretion|1|||
129180544|NCT02124772|464955637|FG012|Overall Study|Investigator discretion|0|||
129180545|NCT02124772|464955625|FG000|Overall Study|Progressive disease|0|||
129180546|NCT02124772|464955626|FG001|Overall Study|Progressive disease|0|||
129180547|NCT02124772|464955627|FG002|Overall Study|Progressive disease|0|||
129180548|NCT02124772|464955628|FG003|Overall Study|Progressive disease|0|||
129180549|NCT02124772|464955629|FG004|Overall Study|Progressive disease|0|||
129180550|NCT02124772|464955630|FG005|Overall Study|Progressive disease|0|||
129180551|NCT02124772|464955631|FG006|Overall Study|Progressive disease|1|||
129180552|NCT02124772|464955632|FG007|Overall Study|Progressive disease|1|||
129180553|NCT02124772|464955633|FG008|Overall Study|Progressive disease|0|||
129180554|NCT02124772|464955634|FG009|Overall Study|Progressive disease|0|||
129180555|NCT02124772|464955635|FG010|Overall Study|Progressive disease|0|||
129180556|NCT02124772|464955636|FG011|Overall Study|Progressive disease|0|||
129180557|NCT02124772|464955637|FG012|Overall Study|Progressive disease|0|||
129180558|NCT02124772|464955625|FG000|Overall Study|Other|0|||
129180559|NCT02124772|464955626|FG001|Overall Study|Other|7|||
129180560|NCT02124772|464955627|FG002|Overall Study|Other|2|||
129180561|NCT02124772|464955628|FG003|Overall Study|Other|5|||
129180562|NCT02124772|464955629|FG004|Overall Study|Other|4|||
129180563|NCT02124772|464955630|FG005|Overall Study|Other|3|||
129180564|NCT02124772|464955631|FG006|Overall Study|Other|4|||
129180565|NCT02124772|464955632|FG007|Overall Study|Other|1|||
129180566|NCT02124772|464955633|FG008|Overall Study|Other|1|||
129180567|NCT02124772|464955634|FG009|Overall Study|Other|1|||
129180568|NCT02124772|464955635|FG010|Overall Study|Other|1|||
129180569|NCT02124772|464955636|FG011|Overall Study|Other|1|||
129180570|NCT02124772|464955637|FG012|Overall Study|Other|0|||
129180571|NCT00780273|464955638|FG000|Overall Study|Death|1|||
129180572|NCT00780273|464955638|FG000|Overall Study|Lost to Follow-up|1|||
129180573|NCT01688921|464955639|FG000|Overall Study|Lost to Follow-up|7|||
129180574|NCT01688921|464955640|FG001|Overall Study|Lost to Follow-up|13|||
129180575|NCT01688921|464955639|FG000|Overall Study|Physician Decision|6|||
129180576|NCT01688921|464955640|FG001|Overall Study|Physician Decision|1|||
129180577|NCT01688921|464955639|FG000|Overall Study|Protocol Violation|0|||
129180578|NCT01688921|464955640|FG001|Overall Study|Protocol Violation|1|||
129180579|NCT01688921|464955639|FG000|Overall Study|informed consent|3|||
129180580|NCT01688921|464955640|FG001|Overall Study|informed consent|0|||
129180581|NCT02358044|464955641|FG000|Overall Study|Adverse Event|0|||
129180582|NCT02358044|464955642|FG001|Overall Study|Adverse Event|1|||
129180583|NCT02358044|464955641|FG000|Overall Study|Lost to Follow-up|2|||
129180584|NCT02358044|464955642|FG001|Overall Study|Lost to Follow-up|1|||
129180585|NCT02358044|464955641|FG000|Overall Study|Physician Decision|0|||
129180586|NCT02358044|464955642|FG001|Overall Study|Physician Decision|1|||
129180587|NCT02358044|464955641|FG000|Overall Study|Withdrawal by Subject|0|||
129180588|NCT02358044|464955642|FG001|Overall Study|Withdrawal by Subject|4|||
129180589|NCT01739803|464955643|FG000|Overall Study|Lost to Follow-up|9|||
129180590|NCT01739803|464955644|FG001|Overall Study|Lost to Follow-up|6|||
129180591|NCT02525094|464955652|FG000|Overall Study|Lost to Follow-up|2|||
129180592|NCT02525094|464955653|FG001|Overall Study|Lost to Follow-up|1|||
129180593|NCT02525094|464955652|FG000|Overall Study|Withdrawal by Subject|5|||
129180594|NCT02525094|464955653|FG001|Overall Study|Withdrawal by Subject|6|||
129180595|NCT02525094|464955652|FG000|Overall Study|Not Treated|1|||
129180596|NCT02525094|464955653|FG001|Overall Study|Not Treated|1|||
129180597|NCT00969436|464955656|FG000|Overall Study|Protocol Violation|1|||
129180598|NCT00969436|464955657|FG001|Overall Study|Protocol Violation|3|||
129180599|NCT00969436|464955658|FG002|Overall Study|Protocol Violation|0|||
129180600|NCT00969436|464955656|FG000|Overall Study|Migrated/moved from study area|12|||
129180601|NCT00969436|464955657|FG001|Overall Study|Migrated/moved from study area|10|||
129180602|NCT00969436|464955658|FG002|Overall Study|Migrated/moved from study area|2|||
129180603|NCT00969436|464955656|FG000|Overall Study|Father - serious health problem|0|||
129180604|NCT00969436|464955657|FG001|Overall Study|Father - serious health problem|0|||
129180605|NCT00969436|464955658|FG002|Overall Study|Father - serious health problem|1|||
129180606|NCT00969436|464955656|FG000|Overall Study|Parents personal problem|0|||
129180607|NCT00969436|464955657|FG001|Overall Study|Parents personal problem|0|||
129180608|NCT00969436|464955658|FG002|Overall Study|Parents personal problem|1|||
129180609|NCT00969436|464955656|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
129180610|NCT00969436|464955657|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
129180611|NCT00969436|464955658|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
129180612|NCT00969436|464955656|FG000|Overall Study|Withdrawal by Subject|3|||
129180613|NCT00969436|464955657|FG001|Overall Study|Withdrawal by Subject|0|||
129180614|NCT00969436|464955658|FG002|Overall Study|Withdrawal by Subject|2|||
129180615|NCT00969436|464955656|FG000|Overall Study|Lost to Follow-up|8|||
129180616|NCT00969436|464955657|FG001|Overall Study|Lost to Follow-up|8|||
129180617|NCT00969436|464955658|FG002|Overall Study|Lost to Follow-up|5|||
129180618|NCT01751776|464955663|FG000|Overall Study|Adverse Event|0|||
129180619|NCT01751776|464955664|FG001|Overall Study|Adverse Event|0|||
129180620|NCT01751776|464955665|FG002|Overall Study|Adverse Event|0|||
129180621|NCT01751776|464955666|FG003|Overall Study|Adverse Event|0|||
129180622|NCT01751776|464955667|FG004|Overall Study|Adverse Event|0|||
129180623|NCT01751776|464955668|FG005|Overall Study|Adverse Event|0|||
129180624|NCT01751776|464955669|FG006|Overall Study|Adverse Event|4|||
129180625|NCT01751776|464955670|FG007|Overall Study|Adverse Event|2|||
129180626|NCT01751776|464955663|FG000|Overall Study|Consent withdrawn|0|||
129180627|NCT01751776|464955664|FG001|Overall Study|Consent withdrawn|0|||
129180628|NCT01751776|464955665|FG002|Overall Study|Consent withdrawn|0|||
129180629|NCT01751776|464955666|FG003|Overall Study|Consent withdrawn|0|||
129180630|NCT01751776|464955667|FG004|Overall Study|Consent withdrawn|0|||
129180631|NCT01751776|464955668|FG005|Overall Study|Consent withdrawn|0|||
129180632|NCT01751776|464955669|FG006|Overall Study|Consent withdrawn|0|||
129180633|NCT01751776|464955670|FG007|Overall Study|Consent withdrawn|1|||
129180634|NCT01751776|464955663|FG000|Overall Study|Other reason not specified above|0|||
129180635|NCT01751776|464955664|FG001|Overall Study|Other reason not specified above|0|||
129180636|NCT01751776|464955665|FG002|Overall Study|Other reason not specified above|0|||
129180637|NCT01751776|464955666|FG003|Overall Study|Other reason not specified above|0|||
129180638|NCT01751776|464955667|FG004|Overall Study|Other reason not specified above|0|||
129180639|NCT01751776|464955668|FG005|Overall Study|Other reason not specified above|0|||
129180640|NCT01751776|464955669|FG006|Overall Study|Other reason not specified above|0|||
129180641|NCT01751776|464955670|FG007|Overall Study|Other reason not specified above|1|||
129180642|NCT00831701|464955675|FG000|Overall Study|Withdrawal by Subject|2|||
129180643|NCT00831701|464955676|FG001|Overall Study|Withdrawal by Subject|0|||
129180644|NCT00831701|464955675|FG000|Overall Study|Stone expulsion before first medication|2|||
129180645|NCT00831701|464955676|FG001|Overall Study|Stone expulsion before first medication|2|||
129180646|NCT00831701|464955675|FG000|Overall Study|Lost to Follow-up|1|||
129180647|NCT00831701|464955676|FG001|Overall Study|Lost to Follow-up|3|||
129180648|NCT02210091|464955679|FG000|Overall Study|Physician Decision|0|||
129180649|NCT02210091|464955680|FG001|Overall Study|Physician Decision|1|||
129180650|NCT02210091|464955679|FG000|Overall Study|Withdrawal by Sponsor|0|||
129180651|NCT02210091|464955680|FG001|Overall Study|Withdrawal by Sponsor|1|||
129180652|NCT02290938|464955681|FG000|Overall Study|Lost to Follow-up|14|||
129180653|NCT02290938|464955682|FG001|Overall Study|Lost to Follow-up|43|||
129180654|NCT01831817|464955683|FG000|Overall Study|Lost to Follow-up|1|||
129180655|NCT01831817|464955684|FG001|Overall Study|Lost to Follow-up|0|||
129180656|NCT01831817|464955685|FG002|Overall Study|Lost to Follow-up|0|||
129180657|NCT01831817|464955686|FG003|Overall Study|Lost to Follow-up|0|||
129180658|NCT01831817|464955683|FG000|Overall Study|Withdrawl of Consent|3|||
129180659|NCT01831817|464955684|FG001|Overall Study|Withdrawl of Consent|0|||
129180660|NCT01831817|464955685|FG002|Overall Study|Withdrawl of Consent|0|||
129180661|NCT01831817|464955686|FG003|Overall Study|Withdrawl of Consent|0|||
129180662|NCT02198235|464955688|FG000|Overall Study|Lost to Follow-up|3|||
129180663|NCT02198235|464955689|FG001|Overall Study|Lost to Follow-up|2|||
129180664|NCT02198235|464955690|FG002|Overall Study|Lost to Follow-up|2|||
129180665|NCT00151372|464957312|FG000|Overall Study|Death|12|||
129180666|NCT00151372|464957313|FG001|Overall Study|Death|11|||
129180667|NCT00151372|464957312|FG000|Overall Study|Lost to Follow-up|5|||
129180668|NCT00151372|464957313|FG001|Overall Study|Lost to Follow-up|5|||
129180669|NCT00151372|464957312|FG000|Overall Study|Too sick medically to continue|5|||
129180670|NCT00151372|464957313|FG001|Overall Study|Too sick medically to continue|6|||
129180671|NCT00151372|464957312|FG000|Overall Study|Withdrawal by Subject|7|||
129180672|NCT00151372|464957313|FG001|Overall Study|Withdrawal by Subject|7|||
129180673|NCT00541346|464957314|FG000|Follow-up|Adverse Event|1|||
129180674|NCT04732949|464957315|FG000|Overall Study|Withdrawal by Subject|23|||
129180675|NCT04732949|464957316|FG001|Overall Study|Withdrawal by Subject|27|||
129180676|NCT04732949|464957315|FG000|Overall Study|Protocol Violation|0|||
129180677|NCT04732949|464957316|FG001|Overall Study|Protocol Violation|1|||
129180678|NCT04732949|464957315|FG000|Overall Study|Non-compliance|0|||
129180679|NCT04732949|464957316|FG001|Overall Study|Non-compliance|2|||
129180680|NCT04732949|464957315|FG000|Overall Study|Physician Decision|2|||
129180681|NCT04732949|464957316|FG001|Overall Study|Physician Decision|1|||
129180682|NCT04732949|464957315|FG000|Overall Study|Serious adverse event (Fatal)|16|||
129180683|NCT04732949|464957316|FG001|Overall Study|Serious adverse event (Fatal)|18|||
129180684|NCT04732949|464957315|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
129180685|NCT04732949|464957316|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
129180686|NCT04732949|464957315|FG000|Overall Study|Non-serious adverse event|1|||
129180687|NCT04732949|464957316|FG001|Overall Study|Non-serious adverse event|3|||
129180688|NCT04732949|464957315|FG000|Overall Study|Lost to Follow-up|26|||
129180689|NCT04732949|464957316|FG001|Overall Study|Lost to Follow-up|27|||
129180690|NCT04732949|464957315|FG000|Overall Study|Other|6|||
129180691|NCT04732949|464957316|FG001|Overall Study|Other|3|||
129180692|NCT02853435|464957317|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129180693|NCT02853435|464957318|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129180694|NCT02853435|464957319|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129180695|NCT02853435|464957320|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129180696|NCT02853435|464957321|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
129180697|NCT02853435|464957322|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129180698|NCT03747120|464957323|FG000|Overall Study|treatment related toxicity|3|||
129180699|NCT03747120|464957324|FG001|Overall Study|treatment related toxicity|0|||
129180700|NCT03747120|464957325|FG002|Overall Study|treatment related toxicity|0|||
129180701|NCT03747120|464957323|FG000|Overall Study|Withdrawal by Subject|0|||
129180702|NCT03747120|464957324|FG001|Overall Study|Withdrawal by Subject|1|||
129180703|NCT03747120|464957325|FG002|Overall Study|Withdrawal by Subject|2|||
129180704|NCT00996801|464957326|FG000|Overall Study|Adverse Event|6|||
129180705|NCT00996801|464957327|FG001|Overall Study|Adverse Event|4|||
129180706|NCT00996801|464957328|FG002|Overall Study|Adverse Event|12|||
129180707|NCT00996801|464957329|FG003|Overall Study|Adverse Event|17|||
129180708|NCT00996801|464957330|FG004|Overall Study|Adverse Event|31|||
129180709|NCT00996801|464957331|FG005|Overall Study|Adverse Event|3|||
129180710|NCT00996801|464957326|FG000|Overall Study|Lack of Efficacy|3|||
129180711|NCT00996801|464957327|FG001|Overall Study|Lack of Efficacy|0|||
129180712|NCT00996801|464957328|FG002|Overall Study|Lack of Efficacy|1|||
129180713|NCT00996801|464957329|FG003|Overall Study|Lack of Efficacy|3|||
129180714|NCT00996801|464957330|FG004|Overall Study|Lack of Efficacy|0|||
129180715|NCT00996801|464957331|FG005|Overall Study|Lack of Efficacy|1|||
129180716|NCT00996801|464957326|FG000|Overall Study|Lost to Follow-up|0|||
129180717|NCT00996801|464957327|FG001|Overall Study|Lost to Follow-up|0|||
129180718|NCT00996801|464957328|FG002|Overall Study|Lost to Follow-up|0|||
129180719|NCT00996801|464957329|FG003|Overall Study|Lost to Follow-up|3|||
129180720|NCT00996801|464957330|FG004|Overall Study|Lost to Follow-up|3|||
129180721|NCT00996801|464957331|FG005|Overall Study|Lost to Follow-up|2|||
129180722|NCT00996801|464957326|FG000|Overall Study|Physician Decision|0|||
129180723|NCT00996801|464957327|FG001|Overall Study|Physician Decision|0|||
129180724|NCT00996801|464957328|FG002|Overall Study|Physician Decision|0|||
129180725|NCT00996801|464957329|FG003|Overall Study|Physician Decision|1|||
129180726|NCT00996801|464957330|FG004|Overall Study|Physician Decision|0|||
129180727|NCT00996801|464957331|FG005|Overall Study|Physician Decision|0|||
129180728|NCT00996801|464957326|FG000|Overall Study|Progressive Disease|0|||
129180729|NCT00996801|464957327|FG001|Overall Study|Progressive Disease|1|||
129180730|NCT00996801|464957328|FG002|Overall Study|Progressive Disease|0|||
129180731|NCT00996801|464957329|FG003|Overall Study|Progressive Disease|0|||
129180732|NCT00996801|464957330|FG004|Overall Study|Progressive Disease|0|||
129180733|NCT00996801|464957331|FG005|Overall Study|Progressive Disease|0|||
129180734|NCT00996801|464957326|FG000|Overall Study|Protocol Violation|3|||
129180735|NCT00996801|464957327|FG001|Overall Study|Protocol Violation|4|||
129180736|NCT00996801|464957328|FG002|Overall Study|Protocol Violation|1|||
129180737|NCT00996801|464957329|FG003|Overall Study|Protocol Violation|2|||
129180738|NCT00996801|464957330|FG004|Overall Study|Protocol Violation|3|||
129180739|NCT00996801|464957331|FG005|Overall Study|Protocol Violation|4|||
129180740|NCT00996801|464957326|FG000|Overall Study|Study Terminated by Sponsor|0|||
129180741|NCT00996801|464957327|FG001|Overall Study|Study Terminated by Sponsor|1|||
129180742|NCT00996801|464957328|FG002|Overall Study|Study Terminated by Sponsor|0|||
129180743|NCT00996801|464957329|FG003|Overall Study|Study Terminated by Sponsor|0|||
129180744|NCT00996801|464957330|FG004|Overall Study|Study Terminated by Sponsor|46|||
129180745|NCT00996801|464957331|FG005|Overall Study|Study Terminated by Sponsor|0|||
129180746|NCT00996801|464957326|FG000|Overall Study|Withdrawal by Subject|8|||
129180747|NCT00996801|464957327|FG001|Overall Study|Withdrawal by Subject|6|||
129180748|NCT00996801|464957328|FG002|Overall Study|Withdrawal by Subject|9|||
129180749|NCT00996801|464957329|FG003|Overall Study|Withdrawal by Subject|5|||
129180750|NCT00996801|464957330|FG004|Overall Study|Withdrawal by Subject|5|||
129180751|NCT00996801|464957331|FG005|Overall Study|Withdrawal by Subject|9|||
129180752|NCT02804750|464957332|FG000|Period 1|Adverse Event|0|||
129180753|NCT02804750|464957333|FG001|Period 1|Adverse Event|2|||
129180754|NCT02804750|464957332|FG000|Period 1|Withdrawal by Subject|0|||
129180755|NCT02804750|464957333|FG001|Period 1|Withdrawal by Subject|1|||
129180756|NCT02804750|464957332|FG000|Period 2|Adverse Event|1|||
129180757|NCT02804750|464957333|FG001|Period 2|Adverse Event|0|||
129180758|NCT02804750|464957332|FG000|Period 3|Adverse Event|0|||
129180759|NCT02804750|464957333|FG001|Period 3|Adverse Event|2|||
129180760|NCT02804750|464957332|FG000|Period 4|Adverse Event|0|||
129180761|NCT02804750|464957333|FG001|Period 4|Adverse Event|5|||
129180762|NCT01657760|464957337|FG000|Overall Study|Withdrawal by Subject|0|||
129180763|NCT01657760|464957338|FG001|Overall Study|Withdrawal by Subject|0|||
129180764|NCT01657760|464957339|FG002|Overall Study|Withdrawal by Subject|0|||
129180765|NCT01657760|464957340|FG003|Overall Study|Withdrawal by Subject|1|||
129180766|NCT01657760|464957337|FG000|Overall Study|Physician Decision|1|||
129180767|NCT01657760|464957338|FG001|Overall Study|Physician Decision|1|||
129180768|NCT01657760|464957339|FG002|Overall Study|Physician Decision|1|||
129180769|NCT01657760|464957340|FG003|Overall Study|Physician Decision|2|||
129180770|NCT00940485|464957348|FG000|Overall Study|HBeAb positive at Baseline|3|||
129180771|NCT00940485|464957349|FG001|Overall Study|HBeAb positive at Baseline|2|||
129180772|NCT00940485|464957348|FG000|Overall Study|Lost to Follow-up|2|||
129180773|NCT00940485|464957349|FG001|Overall Study|Lost to Follow-up|3|||
129180774|NCT00940485|464957348|FG000|Overall Study|Adverse Event|8|||
129180775|NCT00940485|464957349|FG001|Overall Study|Adverse Event|0|||
129180776|NCT00940485|464957348|FG000|Overall Study|Withdrawal by Subject|1|||
129180777|NCT00940485|464957349|FG001|Overall Study|Withdrawal by Subject|1|||
129180778|NCT00940485|464957348|FG000|Overall Study|Others|1|||
129180779|NCT00940485|464957349|FG001|Overall Study|Others|1|||
129180780|NCT06250738|464957355|FG000|Overall Study|Lost to Follow-up|1|||
129180781|NCT02936284|464957357|FG000|Overall Study|Withdrawal by Subject|3|||
129180782|NCT02936284|464957358|FG001|Overall Study|Withdrawal by Subject|1|||
129180783|NCT02936284|464957357|FG000|Overall Study|Lost to Follow-up|7|||
129180784|NCT02936284|464957358|FG001|Overall Study|Lost to Follow-up|8|||
129180785|NCT01068249|464957361|FG000|Overall Study|Death|1|||
129180786|NCT01068249|464957361|FG000|Overall Study|Withdrawal by Subject|3|||
129180787|NCT03921554|464957364|FG000|Overall Study|Adverse Event|2|||
129180788|NCT03921554|464957364|FG000|Overall Study|Withdrawal by Subject|1|||
129180789|NCT03921554|464957364|FG000|Overall Study|Death|3|||
129180790|NCT01146652|464957365|FG000|Overall Study|Adverse Event|506|||
129180791|NCT01146652|464957366|FG001|Overall Study|Adverse Event|15|||
129180792|NCT01146652|464957365|FG000|Overall Study|Lack of Efficacy|91|||
129180793|NCT01146652|464957366|FG001|Overall Study|Lack of Efficacy|7|||
129180794|NCT01146652|464957365|FG000|Overall Study|Poor compliance to protocol|38|||
129180795|NCT01146652|464957366|FG001|Overall Study|Poor compliance to protocol|1|||
129180796|NCT01146652|464957365|FG000|Overall Study|Other unspecified reasons|314|||
129180797|NCT01146652|464957366|FG001|Overall Study|Other unspecified reasons|22|||
129180798|NCT01146652|464957365|FG000|Overall Study|Enrolled but not treated|2|||
129180799|NCT01146652|464957366|FG001|Overall Study|Enrolled but not treated|0|||
129180800|NCT00096018|464957377|FG000|Overall Study|Became Ineligible (not treated)|0|||
129180801|NCT00096018|464957378|FG001|Overall Study|Became Ineligible (not treated)|3|||
129180802|NCT00096018|464957377|FG000|Overall Study|Miscellaneous (not treated)|0|||
129180803|NCT00096018|464957378|FG001|Overall Study|Miscellaneous (not treated)|2|||
129180804|NCT00096018|464957377|FG000|Overall Study|Adverse Event|0|||
129180805|NCT00096018|464957378|FG001|Overall Study|Adverse Event|5|||
129180806|NCT00096018|464957377|FG000|Overall Study|Death|0|||
129180807|NCT00096018|464957378|FG001|Overall Study|Death|1|||
129180808|NCT00096018|464957377|FG000|Overall Study|Withdrawal by Subject|0|||
129180809|NCT00096018|464957378|FG001|Overall Study|Withdrawal by Subject|2|||
129180810|NCT00096018|464957377|FG000|Overall Study|Miscellaneous|2|||
129180811|NCT00096018|464957378|FG001|Overall Study|Miscellaneous|1|||
129180812|NCT03689712|464957379|FG000|Overall Study|Adverse Event|1|||
129180813|NCT03689712|464957380|FG001|Overall Study|Adverse Event|0|||
129180814|NCT03689712|464957379|FG000|Overall Study|Death|20|||
129180815|NCT03689712|464957380|FG001|Overall Study|Death|10|||
129180816|NCT03689712|464957379|FG000|Overall Study|Lost to Follow-up|6|||
129180817|NCT03689712|464957380|FG001|Overall Study|Lost to Follow-up|6|||
129180818|NCT03689712|464957379|FG000|Overall Study|Other|1|||
129180819|NCT03689712|464957380|FG001|Overall Study|Other|0|||
129180820|NCT03689712|464957379|FG000|Overall Study|Patient Non-Compliance|0|||
129180821|NCT03689712|464957380|FG001|Overall Study|Patient Non-Compliance|1|||
129180822|NCT03689712|464957379|FG000|Overall Study|Withdrawal by Subject|20|||
129180823|NCT03689712|464957380|FG001|Overall Study|Withdrawal by Subject|4|||
129180824|NCT03689712|464957379|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
129180825|NCT03689712|464957380|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
129180826|NCT03689712|464957379|FG000|Overall Study|Randomized but not Treated|13|||
129180827|NCT03689712|464957380|FG001|Overall Study|Randomized but not Treated|7|||
129180828|NCT03689712|464957379|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
129180829|NCT03689712|464957380|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
129180830|NCT03968159|464957381|FG000|Overall Study|Adverse Event|4|||
129180831|NCT03968159|464957382|FG001|Overall Study|Adverse Event|4|||
129180832|NCT03968159|464957381|FG000|Overall Study|Lost to Follow-up|1|||
129180833|NCT03968159|464957382|FG001|Overall Study|Lost to Follow-up|1|||
129180834|NCT03968159|464957381|FG000|Overall Study|Use of prohibited medication|0|||
129180835|NCT03968159|464957382|FG001|Overall Study|Use of prohibited medication|1|||
129180836|NCT03968159|464957381|FG000|Overall Study|Protocol Violation|2|||
129180837|NCT03968159|464957382|FG001|Overall Study|Protocol Violation|2|||
129180838|NCT03968159|464957381|FG000|Overall Study|Withdrawal by Subject|4|||
129180839|NCT03968159|464957382|FG001|Overall Study|Withdrawal by Subject|6|||
129180840|NCT03968159|464957381|FG000|Overall Study|Lack of Efficacy|0|||
129180841|NCT03968159|464957382|FG001|Overall Study|Lack of Efficacy|1|||
129180842|NCT03968159|464957381|FG000|Overall Study|Not further specified|2|||
129180843|NCT03968159|464957382|FG001|Overall Study|Not further specified|0|||
129180844|NCT03283150|464957383|FG000|Overall Study|Withdrawal by Subject|6|||
129180845|NCT03283150|464957384|FG001|Overall Study|Withdrawal by Subject|0|||
129180846|NCT03283150|464957385|FG002|Overall Study|Withdrawal by Subject|0|||
129180847|NCT00864851|464957386|FG000|Overall Study|Withdrawal by Subject|0|||
129180848|NCT00864851|464957387|FG001|Overall Study|Withdrawal by Subject|1|||
129180849|NCT00864851|464957388|FG002|Overall Study|Withdrawal by Subject|0|||
129180850|NCT00864851|464957386|FG000|Overall Study|Physician Decision|1|||
129180851|NCT00864851|464957387|FG001|Overall Study|Physician Decision|0|||
129180852|NCT00864851|464957388|FG002|Overall Study|Physician Decision|0|||
129180853|NCT00864851|464957386|FG000|Overall Study|Death|1|||
129180854|NCT00864851|464957387|FG001|Overall Study|Death|0|||
129180855|NCT00864851|464957388|FG002|Overall Study|Death|0|||
129180856|NCT00864851|464957386|FG000|Overall Study|Patient uncooperative|1|||
129180857|NCT00864851|464957387|FG001|Overall Study|Patient uncooperative|0|||
129180858|NCT00864851|464957388|FG002|Overall Study|Patient uncooperative|0|||
129180859|NCT01842581|464957392|FG000|Overall Study|Adverse Event|6|||
129180860|NCT01842581|464957393|FG001|Overall Study|Adverse Event|4|||
129180861|NCT01842581|464957392|FG000|Overall Study|HE breakthrough|26|||
129180862|NCT01842581|464957393|FG001|Overall Study|HE breakthrough|13|||
129180863|NCT01842581|464957392|FG000|Overall Study|Liver transplant|2|||
129180864|NCT01842581|464957393|FG001|Overall Study|Liver transplant|0|||
129180865|NCT01842581|464957392|FG000|Overall Study|Lost to Follow-up|2|||
129180866|NCT01842581|464957393|FG001|Overall Study|Lost to Follow-up|5|||
129180867|NCT01842581|464957392|FG000|Overall Study|Withdrawal by Subject|5|||
129180868|NCT01842581|464957393|FG001|Overall Study|Withdrawal by Subject|7|||
129180869|NCT01842581|464957392|FG000|Overall Study|Other than specified|3|||
129180870|NCT01842581|464957393|FG001|Overall Study|Other than specified|1|||
129180871|NCT00353873|464957394|FG000|Overall Study|Protocol Violation|1|||
129180872|NCT00353873|464957395|FG001|Overall Study|Protocol Violation|2|||
129180873|NCT00353873|464957394|FG000|Overall Study|Exacerbation|1|||
129180874|NCT00353873|464957395|FG001|Overall Study|Exacerbation|0|||
129180875|NCT00353873|464957394|FG000|Overall Study|Adverse Event|1|||
129180876|NCT00353873|464957395|FG001|Overall Study|Adverse Event|0|||
129180877|NCT00353873|464957394|FG000|Overall Study|Physician Decision|2|||
129180878|NCT00353873|464957395|FG001|Overall Study|Physician Decision|0|||
129180879|NCT00353873|464957394|FG000|Overall Study|Withdrawal by Subject|1|||
129180880|NCT00353873|464957395|FG001|Overall Study|Withdrawal by Subject|1|||
129180881|NCT02717130|464957396|FG000|Overall Study|Withdrawal by Subject|1|||
129180882|NCT02717130|464957396|FG000|Overall Study|Adverse Event|1|||
129180883|NCT02717130|464957396|FG000|Overall Study|Physician Decision|1|||
129180884|NCT02717130|464957396|FG000|Overall Study|Study Closure|4|||
129180885|NCT00106691|464957397|FG000|Overall Study|Adverse Event|60|||
129180886|NCT00106691|464957398|FG001|Overall Study|Adverse Event|64|||
129180887|NCT00106691|464957397|FG000|Overall Study|Lost to Follow-up|23|||
129180888|NCT00106691|464957398|FG001|Overall Study|Lost to Follow-up|18|||
129180889|NCT00106691|464957397|FG000|Overall Study|Physician Decision|18|||
129180890|NCT00106691|464957398|FG001|Overall Study|Physician Decision|21|||
129180891|NCT00106691|464957397|FG000|Overall Study|Protocol Violation|13|||
129180892|NCT00106691|464957398|FG001|Overall Study|Protocol Violation|18|||
129180893|NCT00106691|464957397|FG000|Overall Study|Withdrawal by Subject|75|||
129180894|NCT00106691|464957398|FG001|Overall Study|Withdrawal by Subject|70|||
129180895|NCT00106691|464957397|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
129180896|NCT00106691|464957398|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
129180897|NCT00106691|464957397|FG000|Overall Study|QTc>480|3|||
129180898|NCT00106691|464957398|FG001|Overall Study|QTc>480|1|||
129180899|NCT00106691|464957397|FG000|Overall Study|mililtary deployment|2|||
129180900|NCT00106691|464957398|FG001|Overall Study|mililtary deployment|0|||
129180901|NCT00106691|464957397|FG000|Overall Study|Study Site Closing/PI Moved|1|||
129180902|NCT00106691|464957398|FG001|Overall Study|Study Site Closing/PI Moved|2|||
129180903|NCT00106691|464957397|FG000|Overall Study|Cardiologist recommendation|1|||
129180904|NCT00106691|464957398|FG001|Overall Study|Cardiologist recommendation|0|||
129180905|NCT00106691|464957397|FG000|Overall Study|Pt. moved to another state|1|||
129180906|NCT00106691|464957398|FG001|Overall Study|Pt. moved to another state|0|||
129180907|NCT00106691|464957397|FG000|Overall Study|Taking exclusionary avodart|1|||
129180908|NCT00106691|464957398|FG001|Overall Study|Taking exclusionary avodart|0|||
129180909|NCT00106691|464957397|FG000|Overall Study|Not able to discontinue plavix|0|||
129180910|NCT00106691|464957398|FG001|Overall Study|Not able to discontinue plavix|1|||
129180911|NCT00530920|464957399|FG000|Overall Study|Randomized but not treated|0|||
129180912|NCT00530920|464957400|FG001|Overall Study|Randomized but not treated|2|||
129180913|NCT00530920|464957401|FG002|Overall Study|Randomized but not treated|0|||
129180914|NCT00530920|464957399|FG000|Overall Study|Adverse Event|0|||
129180915|NCT00530920|464957400|FG001|Overall Study|Adverse Event|0|||
129180916|NCT00530920|464957401|FG002|Overall Study|Adverse Event|3|||
129180917|NCT00530920|464957399|FG000|Overall Study|Withdrawal by Subject|0|||
129180918|NCT00530920|464957400|FG001|Overall Study|Withdrawal by Subject|0|||
129180919|NCT00530920|464957401|FG002|Overall Study|Withdrawal by Subject|1|||
129180920|NCT04957758|464957403|FG000|Overall Study|Adverse Event|1|||
129180921|NCT04957758|464957404|FG001|Overall Study|Adverse Event|0|||
129180922|NCT04957758|464957403|FG000|Overall Study|Lost to Follow-up|0|||
129180923|NCT04957758|464957404|FG001|Overall Study|Lost to Follow-up|2|||
129180924|NCT04957758|464957403|FG000|Overall Study|Withdrawal by Subject|4|||
129180925|NCT04957758|464957404|FG001|Overall Study|Withdrawal by Subject|2|||
129180926|NCT04957758|464957403|FG000|Overall Study|Protocol Violation|0|||
129180927|NCT04957758|464957404|FG001|Overall Study|Protocol Violation|1|||
129180928|NCT00707746|464957405|FG000|Treatment Period|Adverse Event|2|||
129180929|NCT00707746|464957406|FG001|Treatment Period|Adverse Event|4|||
129180930|NCT00707746|464957405|FG000|Treatment Period|Ineligibility|0|||
129180931|NCT00707746|464957406|FG001|Treatment Period|Ineligibility|1|||
129180932|NCT00685373|464957410|FG000|Overall Study|Adverse Event|3|||
129180933|NCT00685373|464957410|FG000|Overall Study|Withdrawal by Subject|5|||
129180934|NCT00685373|464957410|FG000|Overall Study|Lack of Efficacy|3|||
129180935|NCT00685373|464957410|FG000|Overall Study|Condition no longer requires study drug|1|||
129180936|NCT00685373|464957410|FG000|Overall Study|Lost to Follow-up|2|||
129180937|NCT00685373|464957410|FG000|Overall Study|Protocol Violation|1|||
129180938|NCT02642965|464957412|FG000|Overall Study|Lack of Efficacy|4|||
129180939|NCT02642965|464957412|FG000|Overall Study|Physician Decision|9|||
129180940|NCT03099148|464957415|FG000|Wash-out|scheduling conflict|0|||
129180941|NCT03099148|464957416|FG001|Wash-out|scheduling conflict|1|||
129180942|NCT03099148|464957417|FG002|Wash-out|scheduling conflict|0|||
129180943|NCT03099148|464957418|FG003|Wash-out|scheduling conflict|0|||
129180944|NCT03099148|464957415|FG000|Wash-out|Adverse Event|0|||
129180945|NCT03099148|464957416|FG001|Wash-out|Adverse Event|1|||
129180946|NCT03099148|464957417|FG002|Wash-out|Adverse Event|0|||
129180947|NCT03099148|464957418|FG003|Wash-out|Adverse Event|0|||
129180948|NCT00966719|464957419|FG000|Overall Study|Lost to Follow-up|6|||
129180949|NCT00966719|464957420|FG001|Overall Study|Lost to Follow-up|11|||
129180950|NCT01703065|464957421|FG000|Overall Study|Lack of Efficacy|1|||
129180951|NCT01703065|464957422|FG001|Overall Study|Lack of Efficacy|0|||
129180952|NCT01439126|464957423|FG000|Overall Study|Adverse Event|2|||
129180953|NCT01439126|464957424|FG001|Overall Study|Adverse Event|0|||
129180954|NCT01439126|464957423|FG000|Overall Study|Withdrawal by Subject|5|||
129180955|NCT01439126|464957424|FG001|Overall Study|Withdrawal by Subject|21|||
129180956|NCT01439126|464957423|FG000|Overall Study|Protocol Violation|6|||
129180957|NCT01439126|464957424|FG001|Overall Study|Protocol Violation|4|||
129180958|NCT01439126|464957423|FG000|Overall Study|Lost to Follow-up|6|||
129180959|NCT01439126|464957424|FG001|Overall Study|Lost to Follow-up|3|||
129180960|NCT01439126|464957423|FG000|Overall Study|Other-Use of prohibited treatment|0|||
129180961|NCT01439126|464957424|FG001|Overall Study|Other-Use of prohibited treatment|2|||
129180962|NCT01439126|464957423|FG000|Overall Study|Other-Miscellaneous|12|||
129180963|NCT01439126|464957424|FG001|Overall Study|Other-Miscellaneous|12|||
129180964|NCT01617447|464957425|FG000|Overall Study|Adverse Event|0|||
129180965|NCT01617447|464957426|FG001|Overall Study|Adverse Event|1|||
129180966|NCT01617447|464957425|FG000|Overall Study|Physician Decision|0|||
129180967|NCT01617447|464957426|FG001|Overall Study|Physician Decision|2|||
129180968|NCT02713529|464957428|FG000|Overall Study|Withdrawal by Subject|3|||
129180969|NCT02713529|464957429|FG001|Overall Study|Withdrawal by Subject|1|||
129180970|NCT02713529|464957430|FG002|Overall Study|Withdrawal by Subject|4|||
129180971|NCT02713529|464957431|FG003|Overall Study|Withdrawal by Subject|2|||
129180972|NCT02713529|464957432|FG004|Overall Study|Withdrawal by Subject|0|||
129180973|NCT02713529|464957433|FG005|Overall Study|Withdrawal by Subject|1|||
129180974|NCT02713529|464957434|FG006|Overall Study|Withdrawal by Subject|1|||
129180975|NCT02713529|464957428|FG000|Overall Study|Lost to Follow-up|1|||
129180976|NCT02713529|464957429|FG001|Overall Study|Lost to Follow-up|0|||
129180977|NCT02713529|464957430|FG002|Overall Study|Lost to Follow-up|1|||
129180978|NCT02713529|464957431|FG003|Overall Study|Lost to Follow-up|0|||
129180979|NCT02713529|464957432|FG004|Overall Study|Lost to Follow-up|0|||
129180980|NCT02713529|464957433|FG005|Overall Study|Lost to Follow-up|0|||
129180981|NCT02713529|464957434|FG006|Overall Study|Lost to Follow-up|0|||
129180982|NCT02713529|464957428|FG000|Overall Study|Death|3|||
129180983|NCT02713529|464957429|FG001|Overall Study|Death|3|||
129180984|NCT02713529|464957430|FG002|Overall Study|Death|26|||
129180985|NCT02713529|464957431|FG003|Overall Study|Death|27|||
129180986|NCT02713529|464957432|FG004|Overall Study|Death|3|||
129180987|NCT02713529|464957433|FG005|Overall Study|Death|13|||
129180988|NCT02713529|464957434|FG006|Overall Study|Death|3|||
129180989|NCT02827500|464957435|FG000|Overall Study|Death|7|||
129180990|NCT02827500|464957436|FG001|Overall Study|Death|3|||
129180991|NCT02827500|464957435|FG000|Overall Study|Lost to Follow-up|1|||
129180992|NCT02827500|464957436|FG001|Overall Study|Lost to Follow-up|1|||
129180993|NCT02827500|464957435|FG000|Overall Study|Withdrawal by Subject|3|||
129180994|NCT02827500|464957436|FG001|Overall Study|Withdrawal by Subject|1|||
129180995|NCT02827500|464957435|FG000|Overall Study|Missing primary endpoint data|3|||
129180996|NCT02827500|464957436|FG001|Overall Study|Missing primary endpoint data|1|||
129180997|NCT02827500|464957435|FG000|Overall Study|Other|5|||
129180998|NCT02827500|464957436|FG001|Overall Study|Other|1|||
129180999|NCT02308488|464957439|FG000|Overall Study|Withdrawal by Subject|2|||
129181000|NCT02242981|464957440|FG000|Overall Study|Withdrawal by Subject|1|||
129181001|NCT03474081|464957441|FG000|Overall Study|Adverse Event|6|||
129181002|NCT03474081|464957442|FG001|Overall Study|Adverse Event|3|||
129181003|NCT03474081|464957441|FG000|Overall Study|Lost to Follow-up|2|||
129181004|NCT03474081|464957442|FG001|Overall Study|Lost to Follow-up|1|||
129181005|NCT03474081|464957441|FG000|Overall Study|Physician Decision|3|||
129181006|NCT03474081|464957442|FG001|Overall Study|Physician Decision|2|||
129181007|NCT03474081|464957441|FG000|Overall Study|Withdrawal by Subject|5|||
129181008|NCT03474081|464957442|FG001|Overall Study|Withdrawal by Subject|7|||
129181009|NCT03474081|464957441|FG000|Overall Study|Investigator site closed|1|||
129181010|NCT03474081|464957442|FG001|Overall Study|Investigator site closed|0|||
129181011|NCT00897390|464957445|FG000|Overall Study|Adverse Event|2|||
129181012|NCT00897390|464957445|FG000|Overall Study|No Longer Met Study Criteria|1|||
129181013|NCT00897390|464957445|FG000|Overall Study|Personal Reasons|1|||
129181014|NCT00897390|464957445|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
129181015|NCT04573881|464957447|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
129181016|NCT02564978|464957450|FG000|Overall Study|Adverse Event|8|||
129181017|NCT02564978|464957450|FG000|Overall Study|Death|1|||
129181018|NCT02564978|464957450|FG000|Overall Study|Lost to Follow-up|1|||
129181019|NCT02564978|464957450|FG000|Overall Study|Withdrawal by Subject|15|||
129181020|NCT02564978|464957450|FG000|Overall Study|Early Study Closure|2|||
129181021|NCT02564978|464957450|FG000|Overall Study|Other Reason|5|||
129181022|NCT00203021|464958929|FG000|Overall Study|Death|4|||
129181023|NCT00203021|464958930|FG001|Overall Study|Death|1|||
129181024|NCT00203021|464958929|FG000|Overall Study|Adverse Event|10|||
129181025|NCT00203021|464958930|FG001|Overall Study|Adverse Event|5|||
129181026|NCT00203021|464958929|FG000|Overall Study|Withdrawal by Subject|45|||
129181027|NCT00203021|464958930|FG001|Overall Study|Withdrawal by Subject|48|||
129181028|NCT00203021|464958929|FG000|Overall Study|Lost to Follow-up|9|||
129181029|NCT00203021|464958930|FG001|Overall Study|Lost to Follow-up|7|||
129181030|NCT00203021|464958929|FG000|Overall Study|Other than specified|11|||
129181031|NCT00203021|464958930|FG001|Overall Study|Other than specified|16|||
129181032|NCT05160766|464958931|FG000|Overall Study|Adverse Event|0|||
129181033|NCT05160766|464958932|FG001|Overall Study|Adverse Event|1|||
129181034|NCT05160766|464958933|FG002|Overall Study|Adverse Event|0|||
129181035|NCT05160766|464958934|FG003|Overall Study|Adverse Event|0|||
129181036|NCT05160766|464958931|FG000|Overall Study|COVID-19 infection|0|||
129181037|NCT05160766|464958932|FG001|Overall Study|COVID-19 infection|1|||
129181038|NCT05160766|464958933|FG002|Overall Study|COVID-19 infection|0|||
129181039|NCT05160766|464958934|FG003|Overall Study|COVID-19 infection|0|||
129181040|NCT05160766|464958931|FG000|Overall Study|travel time|1|||
129181041|NCT05160766|464958932|FG001|Overall Study|travel time|0|||
129181042|NCT05160766|464958933|FG002|Overall Study|travel time|0|||
129181043|NCT05160766|464958934|FG003|Overall Study|travel time|1|||
129181044|NCT05160766|464958931|FG000|Overall Study|Withdrawal by Subject|3|||
129181045|NCT05160766|464958932|FG001|Overall Study|Withdrawal by Subject|5|||
129181046|NCT05160766|464958933|FG002|Overall Study|Withdrawal by Subject|4|||
129181047|NCT05160766|464958934|FG003|Overall Study|Withdrawal by Subject|2|||
129181048|NCT05160766|464958931|FG000|Overall Study|Death|0|||
129181049|NCT05160766|464958932|FG001|Overall Study|Death|0|||
129181050|NCT05160766|464958933|FG002|Overall Study|Death|2|||
129181051|NCT05160766|464958934|FG003|Overall Study|Death|5|||
129181052|NCT05160766|464958931|FG000|Overall Study|Lost to Follow-up|0|||
129181053|NCT05160766|464958932|FG001|Overall Study|Lost to Follow-up|0|||
129181054|NCT05160766|464958933|FG002|Overall Study|Lost to Follow-up|1|||
129181055|NCT05160766|464958934|FG003|Overall Study|Lost to Follow-up|2|||
129181056|NCT05160766|464958931|FG000|Overall Study|No show|0|||
129181057|NCT05160766|464958932|FG001|Overall Study|No show|0|||
129181058|NCT05160766|464958933|FG002|Overall Study|No show|1|||
129181059|NCT05160766|464958934|FG003|Overall Study|No show|1|||
129181060|NCT05160766|464958931|FG000|Overall Study|Physician Decision|0|||
129181061|NCT05160766|464958932|FG001|Overall Study|Physician Decision|0|||
129181062|NCT05160766|464958933|FG002|Overall Study|Physician Decision|0|||
129181063|NCT05160766|464958934|FG003|Overall Study|Physician Decision|1|||
129181064|NCT05160766|464958931|FG000|Overall Study|Protocol Violation|0|||
129181065|NCT05160766|464958932|FG001|Overall Study|Protocol Violation|0|||
129181066|NCT05160766|464958933|FG002|Overall Study|Protocol Violation|1|||
129181067|NCT05160766|464958934|FG003|Overall Study|Protocol Violation|0|||
129181068|NCT04284813|464958943|FG000|Overall Study|Withdrawal by Subject|1|||
129181069|NCT03455829|464958948|FG000|Overall Study|Death|2|||
129181070|NCT03455829|464958949|FG001|Overall Study|Death|3|||
129181071|NCT03455829|464958950|FG002|Overall Study|Death|2|||
129181072|NCT03455829|464958951|FG003|Overall Study|Death|4|||
129181073|NCT03455829|464958952|FG004|Overall Study|Death|2|||
129181074|NCT03455829|464958948|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
129181075|NCT03455829|464958949|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
129181076|NCT03455829|464958950|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
129181077|NCT03455829|464958951|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
129181078|NCT03455829|464958952|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
129181079|NCT03455829|464958948|FG000|Overall Study|Disease progression|0|||
129181080|NCT03455829|464958949|FG001|Overall Study|Disease progression|0|||
129181081|NCT03455829|464958950|FG002|Overall Study|Disease progression|0|||
129181082|NCT03455829|464958951|FG003|Overall Study|Disease progression|1|||
129181083|NCT03455829|464958952|FG004|Overall Study|Disease progression|1|||
129181084|NCT00689793|464958953|FG000|Overall Study|Lost to Follow-up|4|||
129181085|NCT00689793|464958954|FG001|Overall Study|Lost to Follow-up|5|||
129181086|NCT01100528|464958957|FG000|Overall Study|Death|1|||
129181087|NCT01100528|464958957|FG000|Overall Study|Withdrawal by Subject|2|||
129181088|NCT01299571|464958962|FG000|Overall Study|Protocol Violation|107|||
129181089|NCT02006069|464958963|FG000|Overall Study|MPP other programming|239|||
129181090|NCT02006069|464958964|FG001|Overall Study|MPP other programming|0|||
129181091|NCT02006069|464958963|FG000|Overall Study|RV only pacing|0|||
129181092|NCT02006069|464958964|FG001|Overall Study|RV only pacing|3|||
129181093|NCT02066129|464958965|FG000|Overall Study|Lost to Follow-up|13|||
128730198|NCT02448875|463308355|FG001|Overall Study|Investigator Decision|0|||
128730199|NCT02448875|463308356|FG002|Overall Study|Investigator Decision|1|||
129181094|NCT02066129|464958966|FG001|Overall Study|Lost to Follow-up|12|||
129181095|NCT02066129|464958965|FG000|Overall Study|Withdrawal by Subject|7|||
129181096|NCT02066129|464958966|FG001|Overall Study|Withdrawal by Subject|10|||
129181097|NCT02066129|464958965|FG000|Overall Study|Lack of Efficacy|8|||
129181098|NCT02066129|464958966|FG001|Overall Study|Lack of Efficacy|10|||
129181099|NCT02066129|464958965|FG000|Overall Study|Physician Decision|1|||
129181100|NCT02066129|464958966|FG001|Overall Study|Physician Decision|1|||
129181101|NCT00316888|464958970|FG000|Overall Study|Adverse Event|4|||
129181102|NCT00316888|464958971|FG001|Overall Study|Adverse Event|5|||
129181103|NCT00316888|464958970|FG000|Overall Study|Withdrawal by Subject|2|||
129181104|NCT00316888|464958971|FG001|Overall Study|Withdrawal by Subject|2|||
129181105|NCT00316888|464958970|FG000|Overall Study|Not start protocol therapy|0|||
129181106|NCT00316888|464958971|FG001|Overall Study|Not start protocol therapy|1|||
129181107|NCT00857948|464958972|FG000|Overall Study|Withdrawal by Subject|2|||
129181108|NCT00857948|464958973|FG001|Overall Study|Withdrawal by Subject|0|||
129181109|NCT00857948|464958974|FG002|Overall Study|Withdrawal by Subject|0|||
129181110|NCT00857948|464958975|FG003|Overall Study|Withdrawal by Subject|0|||
129181111|NCT00857948|464958972|FG000|Overall Study|Protocol Violation|1|||
129181112|NCT00857948|464958973|FG001|Overall Study|Protocol Violation|0|||
129181113|NCT00857948|464958974|FG002|Overall Study|Protocol Violation|1|||
129181114|NCT00857948|464958975|FG003|Overall Study|Protocol Violation|0|||
129181115|NCT00815191|464958976|FG000|Overall Study|Protocol Violation|1|||
129181116|NCT00815191|464958977|FG001|Overall Study|Protocol Violation|1|||
129181117|NCT01814670|464958980|FG000|Overall Study|Protocol Violation|12|||
129181118|NCT03443427|464958981|FG000|Overall Study|Adverse Event|2|||
129181119|NCT03443427|464958982|FG001|Overall Study|Adverse Event|3|||
129181120|NCT03443427|464958981|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
129181121|NCT03443427|464958982|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129181122|NCT03443427|464958981|FG000|Overall Study|Other|4|||
129181123|NCT03443427|464958982|FG001|Overall Study|Other|6|||
129181124|NCT02576860|464958983|FG000|Overall Study|Adverse Event|6|||
129181125|NCT02576860|464958984|FG001|Overall Study|Adverse Event|6|||
129181126|NCT02576860|464958983|FG000|Overall Study|Lost to Follow-up|5|||
129181127|NCT02576860|464958984|FG001|Overall Study|Lost to Follow-up|7|||
129181128|NCT02576860|464958983|FG000|Overall Study|Physician Decision|0|||
129181129|NCT02576860|464958984|FG001|Overall Study|Physician Decision|1|||
129181130|NCT02576860|464958983|FG000|Overall Study|Protocol Violation|0|||
129181131|NCT02576860|464958984|FG001|Overall Study|Protocol Violation|2|||
129181132|NCT02576860|464958983|FG000|Overall Study|Withdrawal by Subject|13|||
129181133|NCT02576860|464958984|FG001|Overall Study|Withdrawal by Subject|8|||
129181134|NCT02576860|464958983|FG000|Overall Study|Disallowed medication|1|||
129181135|NCT02576860|464958984|FG001|Overall Study|Disallowed medication|0|||
129181136|NCT01541917|464958985|FG000|Overall Study|Lost to Follow-up|2|||
129181137|NCT01541917|464958986|FG001|Overall Study|Lost to Follow-up|2|||
129181138|NCT01541917|464958985|FG000|Overall Study|Withdrawal by Subject|13|||
129181139|NCT01541917|464958986|FG001|Overall Study|Withdrawal by Subject|7|||
129181140|NCT00121641|464958987|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
129181141|NCT00121641|464958988|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
129181142|NCT00121641|464958989|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
129181143|NCT00121641|464958990|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
129181144|NCT00121641|464958991|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
129181145|NCT00121641|464958987|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
129181146|NCT00121641|464958988|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
129181147|NCT00121641|464958989|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
129181148|NCT00121641|464958990|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
129181149|NCT00121641|464958991|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
129181150|NCT00121641|464958987|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
129181151|NCT00121641|464958988|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
129181152|NCT00121641|464958989|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
129181153|NCT00121641|464958990|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
129181154|NCT00121641|464958991|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
129181155|NCT00121641|464958987|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
129181156|NCT00121641|464958988|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
129181157|NCT00121641|464958989|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
129181158|NCT00121641|464958990|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
129181159|NCT00121641|464958991|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
129181160|NCT00121641|464958987|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
129181161|NCT00121641|464958988|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
129181162|NCT00121641|464958989|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
129181163|NCT00121641|464958990|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
129181164|NCT00121641|464958991|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
129181165|NCT00121641|464958987|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
129181166|NCT00121641|464958988|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
129181167|NCT00121641|464958989|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
129181168|NCT00121641|464958990|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
129181169|NCT00121641|464958991|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
129181170|NCT00121641|464958987|FG000|24-week Short-term Treatment Period|Other Reason|1|||
129181171|NCT00121641|464958988|FG001|24-week Short-term Treatment Period|Other Reason|0|||
129181172|NCT00121641|464958989|FG002|24-week Short-term Treatment Period|Other Reason|0|||
129181173|NCT00121641|464958990|FG003|24-week Short-term Treatment Period|Other Reason|0|||
129181174|NCT00121641|464958991|FG004|24-week Short-term Treatment Period|Other Reason|0|||
129181175|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
129181176|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
129181177|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
129181178|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
129181179|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
129181180|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
129181181|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
129181182|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
129181183|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
129181184|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
129181185|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
128730200|NCT02448875|463308354|FG000|Overall Study|Withdrawal by Subject|1|||
129181186|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
129181187|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
129181188|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
129181189|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
129181190|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
129181191|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
129181192|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
129181193|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
129181194|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
129181195|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
129181196|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
129181197|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
129181198|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
129181199|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
129181200|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
129181201|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
129181202|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
129181203|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
129181204|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
129181205|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
129181206|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
129181207|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
129181208|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
129181209|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
129181210|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
129181211|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
129181212|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
129181213|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
129181214|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
129181215|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Death|0|||
129181216|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Death|0|||
129181217|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Death|0|||
129181218|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Death|1|||
129181219|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Death|0|||
129181220|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Missing|0|||
129181221|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Missing|0|||
129181222|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Missing|1|||
129181223|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Missing|0|||
129181224|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Missing|0|||
129181225|NCT00121641|464958987|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
129181226|NCT00121641|464958988|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
129181227|NCT00121641|464958989|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
129181228|NCT00121641|464958990|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
129181229|NCT00121641|464958991|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
129181230|NCT00094107|464958998|FG000|Overall Study|Lack of Efficacy|23|||
129181231|NCT00094107|464958998|FG000|Overall Study|Death|5|||
129181232|NCT00094107|464958998|FG000|Overall Study|Adverse Event|3|||
129181233|NCT00094107|464958998|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
129181234|NCT00525824|464959001|FG000|Overall Study|Adverse Event|7|||
129181235|NCT00525824|464959002|FG001|Overall Study|Adverse Event|11|||
129181236|NCT00525824|464959003|FG002|Overall Study|Adverse Event|6|||
129181237|NCT00525824|464959004|FG003|Overall Study|Adverse Event|7|||
129181238|NCT00525824|464959001|FG000|Overall Study|Withdrawal by Subject|5|||
129181239|NCT00525824|464959002|FG001|Overall Study|Withdrawal by Subject|9|||
129181240|NCT00525824|464959003|FG002|Overall Study|Withdrawal by Subject|3|||
129181241|NCT00525824|464959004|FG003|Overall Study|Withdrawal by Subject|4|||
129181242|NCT00525824|464959001|FG000|Overall Study|Lost to Follow-up|4|||
129181243|NCT00525824|464959002|FG001|Overall Study|Lost to Follow-up|2|||
129181244|NCT00525824|464959003|FG002|Overall Study|Lost to Follow-up|4|||
129181245|NCT00525824|464959004|FG003|Overall Study|Lost to Follow-up|0|||
129181246|NCT00525824|464959001|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
129181247|NCT00525824|464959002|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
129181248|NCT00525824|464959003|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
129181249|NCT00525824|464959004|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
129181250|NCT00525824|464959001|FG000|Overall Study|Severe non-compliance|0|||
128730201|NCT02448875|463308355|FG001|Overall Study|Withdrawal by Subject|0|||
129181251|NCT00525824|464959002|FG001|Overall Study|Severe non-compliance|1|||
129181252|NCT00525824|464959003|FG002|Overall Study|Severe non-compliance|1|||
129181253|NCT00525824|464959004|FG003|Overall Study|Severe non-compliance|1|||
129181254|NCT00525824|464959001|FG000|Overall Study|Safety reasons|1|||
129181255|NCT00525824|464959002|FG001|Overall Study|Safety reasons|0|||
129181256|NCT00525824|464959003|FG002|Overall Study|Safety reasons|1|||
129181257|NCT00525824|464959004|FG003|Overall Study|Safety reasons|0|||
129181258|NCT00525824|464959001|FG000|Overall Study|Other|1|||
129181259|NCT00525824|464959002|FG001|Overall Study|Other|3|||
129181260|NCT00525824|464959003|FG002|Overall Study|Other|3|||
129181261|NCT00525824|464959004|FG003|Overall Study|Other|1|||
129181262|NCT00806442|464959008|FG000|Overall Study|Lost to Follow-up|3|||
129181263|NCT00806442|464959009|FG001|Overall Study|Lost to Follow-up|2|||
129181264|NCT00806442|464959008|FG000|Overall Study|Withdrawal by Subject|1|||
129181265|NCT00806442|464959009|FG001|Overall Study|Withdrawal by Subject|5|||
129181266|NCT01264770|464959025|FG000|Overall Study|Not reported|0|||
129181267|NCT01264770|464959026|FG001|Overall Study|Not reported|0|||
129181268|NCT01264770|464959027|FG002|Overall Study|Not reported|1|||
129181269|NCT01264770|464959028|FG003|Overall Study|Not reported|0|||
129181270|NCT01264770|464959029|FG004|Overall Study|Not reported|0|||
129181271|NCT01264770|464959030|FG005|Overall Study|Not reported|0|||
129181272|NCT01264770|464959025|FG000|Overall Study|e.g., change in circumstances|8|||
129181273|NCT01264770|464959026|FG001|Overall Study|e.g., change in circumstances|3|||
129181274|NCT01264770|464959027|FG002|Overall Study|e.g., change in circumstances|3|||
129181275|NCT01264770|464959028|FG003|Overall Study|e.g., change in circumstances|3|||
129181276|NCT01264770|464959029|FG004|Overall Study|e.g., change in circumstances|4|||
129181277|NCT01264770|464959030|FG005|Overall Study|e.g., change in circumstances|4|||
129181278|NCT01264770|464959025|FG000|Overall Study|Severe non-compliance to protocol|0|||
129181279|NCT01264770|464959026|FG001|Overall Study|Severe non-compliance to protocol|0|||
129181280|NCT01264770|464959027|FG002|Overall Study|Severe non-compliance to protocol|1|||
129181281|NCT01264770|464959028|FG003|Overall Study|Severe non-compliance to protocol|1|||
129181282|NCT01264770|464959029|FG004|Overall Study|Severe non-compliance to protocol|0|||
129181283|NCT01264770|464959030|FG005|Overall Study|Severe non-compliance to protocol|0|||
129181284|NCT01264770|464959025|FG000|Overall Study|Lack of therapeutic response|1|||
129181285|NCT01264770|464959026|FG001|Overall Study|Lack of therapeutic response|0|||
129181286|NCT01264770|464959027|FG002|Overall Study|Lack of therapeutic response|2|||
129181287|NCT01264770|464959028|FG003|Overall Study|Lack of therapeutic response|1|||
129181288|NCT01264770|464959029|FG004|Overall Study|Lack of therapeutic response|1|||
129181289|NCT01264770|464959030|FG005|Overall Study|Lack of therapeutic response|0|||
129181290|NCT01264770|464959025|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
129181291|NCT01264770|464959026|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
129181292|NCT01264770|464959027|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
129181293|NCT01264770|464959028|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
129181294|NCT01264770|464959029|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
129181295|NCT01264770|464959030|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
129181296|NCT01264770|464959025|FG000|Overall Study|Lost to Follow-up|0|||
129181297|NCT01264770|464959026|FG001|Overall Study|Lost to Follow-up|0|||
129181298|NCT01264770|464959027|FG002|Overall Study|Lost to Follow-up|1|||
129181299|NCT01264770|464959028|FG003|Overall Study|Lost to Follow-up|1|||
129181300|NCT01264770|464959029|FG004|Overall Study|Lost to Follow-up|0|||
129181301|NCT01264770|464959030|FG005|Overall Study|Lost to Follow-up|0|||
129181302|NCT01264770|464959025|FG000|Overall Study|Adverse Event|7|||
129181303|NCT01264770|464959026|FG001|Overall Study|Adverse Event|7|||
129181304|NCT01264770|464959027|FG002|Overall Study|Adverse Event|8|||
129181305|NCT01264770|464959028|FG003|Overall Study|Adverse Event|0|||
129181306|NCT01264770|464959029|FG004|Overall Study|Adverse Event|2|||
129181307|NCT01264770|464959030|FG005|Overall Study|Adverse Event|1|||
129181308|NCT02356887|464959034|FG000|Overall Study|poor compliance|2|||
129181309|NCT01490294|464959035|FG000|Overall Study|Prematurely discontinuation|4|||
129181310|NCT01490294|464959036|FG001|Overall Study|Prematurely discontinuation|0|||
129181311|NCT01490294|464959037|FG002|Overall Study|Prematurely discontinuation|1|||
129181312|NCT01490294|464959038|FG003|Overall Study|Prematurely discontinuation|1|||
129181313|NCT01490294|464959035|FG000|Overall Study|Adverse Event|1|||
129181314|NCT01490294|464959036|FG001|Overall Study|Adverse Event|0|||
129181315|NCT01490294|464959037|FG002|Overall Study|Adverse Event|0|||
129181316|NCT01490294|464959038|FG003|Overall Study|Adverse Event|0|||
129181317|NCT00160654|464959043|FG000|Overall Study|Adverse Event|14|||
129181318|NCT00160654|464959043|FG000|Overall Study|Lack of Efficacy|4|||
129181319|NCT00160654|464959043|FG000|Overall Study|Lost to Follow-up|2|||
129181320|NCT00160654|464959043|FG000|Overall Study|Intake of expired drug|7|||
129181321|NCT00160654|464959043|FG000|Overall Study|Psychological trauma|1|||
129181322|NCT00160654|464959043|FG000|Overall Study|Sponsor decision|1|||
129181323|NCT00160654|464959043|FG000|Overall Study|Patient met exclusion criteria|1|||
129181324|NCT00160654|464959043|FG000|Overall Study|Patient decision|1|||
129181325|NCT00160654|464959043|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
129181326|NCT00160654|464959043|FG000|Overall Study|Met exclusion criteria|1|||
129181327|NCT02404649|464959044|FG000|Overall Study|Adverse Event|1|||
129181328|NCT02404649|464959045|FG001|Overall Study|Adverse Event|2|||
129181329|NCT00330668|464959049|FG000|BID Dosing Period|Adverse Event|1|||
129181330|NCT00330668|464959049|FG000|BID Dosing Period|Lost to Follow-up|7|||
129181331|NCT00330668|464959049|FG000|BID Dosing Period|Non-Compliance|5|||
129181332|NCT00330668|464959049|FG000|BID Dosing Period|Withdrawal by Subject|19|||
129181333|NCT00330668|464959049|FG000|BID Dosing Period|Sponsor's decision|1|||
129181334|NCT00330668|464959049|FG000|BID Dosing Period|Other|3|||
129181335|NCT00330668|464959049|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
129181336|NCT00330668|464959049|FG000|QD Dosing Period|Other|1|||
129181337|NCT00330668|464959049|FG000|QD Dosing Period|Withdrawal by Subject|1|||
129181338|NCT00330668|464959049|FG000|QD Dosing Period|Lost to Follow-up|2|||
129181339|NCT01839656|464959050|FG000|Overall Study|Withdrawal by Subject|1|||
129181340|NCT01839656|464959051|FG001|Overall Study|Withdrawal by Subject|1|||
129181341|NCT01839656|464959050|FG000|Overall Study|Adverse event, serious fatal|1|||
129181342|NCT01839656|464959051|FG001|Overall Study|Adverse event, serious fatal|4|||
129181343|NCT01839656|464959050|FG000|Overall Study|Early study closure|0|||
129181344|NCT01839656|464959051|FG001|Overall Study|Early study closure|11|||
129181345|NCT01839656|464959050|FG000|Overall Study|Adverse Event|1|||
129181346|NCT01839656|464959051|FG001|Overall Study|Adverse Event|0|||
129181347|NCT02644356|464959066|FG000|Overall Study|Withdrawal by Subject|2|||
129181348|NCT01825941|464960790|FG000|Overall Study|Lost to Follow-up|4|||
129181349|NCT01825941|464960791|FG001|Overall Study|Lost to Follow-up|1|||
129181350|NCT00528996|464960792|FG000|Overall Study|Other reasons than listing|6|||
129181351|NCT00528996|464960793|FG001|Overall Study|Other reasons than listing|7|||
129181352|NCT00528996|464960794|FG002|Overall Study|Other reasons than listing|14|||
129181353|NCT00528996|464960795|FG003|Overall Study|Other reasons than listing|11|||
129181354|NCT00528996|464960796|FG004|Overall Study|Other reasons than listing|5|||
129181355|NCT00528996|464960792|FG000|Overall Study|Refused continue medication|16|||
129181356|NCT00528996|464960793|FG001|Overall Study|Refused continue medication|0|||
129181357|NCT00528996|464960794|FG002|Overall Study|Refused continue medication|3|||
129181358|NCT00528996|464960795|FG003|Overall Study|Refused continue medication|3|||
129181359|NCT00528996|464960796|FG004|Overall Study|Refused continue medication|6|||
129181360|NCT00528996|464960792|FG000|Overall Study|Lost to Follow-up|2|||
129181361|NCT00528996|464960793|FG001|Overall Study|Lost to Follow-up|0|||
129181362|NCT00528996|464960794|FG002|Overall Study|Lost to Follow-up|4|||
129181363|NCT00528996|464960795|FG003|Overall Study|Lost to Follow-up|1|||
129181364|NCT00528996|464960796|FG004|Overall Study|Lost to Follow-up|3|||
129181365|NCT00528996|464960792|FG000|Overall Study|Protocol Violation|1|||
129181366|NCT00528996|464960793|FG001|Overall Study|Protocol Violation|2|||
129181367|NCT00528996|464960794|FG002|Overall Study|Protocol Violation|3|||
129181368|NCT00528996|464960795|FG003|Overall Study|Protocol Violation|3|||
129181369|NCT00528996|464960796|FG004|Overall Study|Protocol Violation|2|||
129181370|NCT00528996|464960792|FG000|Overall Study|Lack of Efficacy|7|||
129181371|NCT00528996|464960793|FG001|Overall Study|Lack of Efficacy|2|||
129181372|NCT00528996|464960794|FG002|Overall Study|Lack of Efficacy|1|||
129181373|NCT00528996|464960795|FG003|Overall Study|Lack of Efficacy|3|||
129181374|NCT00528996|464960796|FG004|Overall Study|Lack of Efficacy|3|||
129181375|NCT00528996|464960792|FG000|Overall Study|Adverse Event|32|||
129181376|NCT00528996|464960793|FG001|Overall Study|Adverse Event|13|||
129181377|NCT00528996|464960794|FG002|Overall Study|Adverse Event|18|||
129181378|NCT00528996|464960795|FG003|Overall Study|Adverse Event|29|||
129181379|NCT00528996|464960796|FG004|Overall Study|Adverse Event|18|||
129181380|NCT05565937|464960797|FG000|Overall Study|Adverse Event|0|||
129181381|NCT05565937|464960798|FG001|Overall Study|Adverse Event|1|||
129181382|NCT05565937|464960797|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
129181383|NCT05565937|464960798|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
129181384|NCT05565937|464960797|FG000|Overall Study|Lost to Follow-up|2|||
129181385|NCT05565937|464960798|FG001|Overall Study|Lost to Follow-up|0|||
129181386|NCT05565937|464960797|FG000|Overall Study|Pregnancy|0|||
129181387|NCT05565937|464960798|FG001|Overall Study|Pregnancy|2|||
129181388|NCT05565937|464960797|FG000|Overall Study|Anisometropia|0|||
129181389|NCT05565937|464960798|FG001|Overall Study|Anisometropia|1|||
129181390|NCT02943915|464960801|FG000|Overall Study|Withdrawal by Subject|2|||
129181391|NCT02943915|464960802|FG001|Overall Study|Withdrawal by Subject|1|||
129181392|NCT02943915|464960803|FG002|Overall Study|Withdrawal by Subject|0|||
129181393|NCT02943915|464960804|FG003|Overall Study|Withdrawal by Subject|0|||
129181394|NCT02943915|464960801|FG000|Overall Study|Lost to Follow-up|3|||
129181395|NCT02943915|464960802|FG001|Overall Study|Lost to Follow-up|1|||
129181396|NCT02943915|464960803|FG002|Overall Study|Lost to Follow-up|0|||
129181397|NCT02943915|464960804|FG003|Overall Study|Lost to Follow-up|0|||
129181398|NCT02943915|464960801|FG000|Overall Study|excluded|0|||
129181399|NCT02943915|464960802|FG001|Overall Study|excluded|1|||
129181400|NCT02943915|464960803|FG002|Overall Study|excluded|0|||
129181401|NCT02943915|464960804|FG003|Overall Study|excluded|0|||
129181402|NCT00004445|464960806|FG000|Overall Study|Physician Decision|2|||
129181403|NCT00004445|464960806|FG000|Overall Study|Withdrawal by Subject|1|||
129181404|NCT01818284|464960807|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
129181405|NCT01818284|464960808|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
129181406|NCT01818284|464960807|FG000|Overall Study|Death|0|||
129181407|NCT01818284|464960808|FG001|Overall Study|Death|2|||
129181408|NCT03681678|464960809|FG000|Overall Study|Lost to Follow-up|20|||
129181409|NCT01114360|464960812|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
129181410|NCT01114360|464960813|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
129181411|NCT03007745|464960814|FG000|Overall Study|Sleep test negative for OSA|53|||
129181412|NCT03007745|464960815|FG001|Overall Study|Sleep test negative for OSA|49|||
129181413|NCT03007745|464960814|FG000|Overall Study|Physician Decision|6|||
129181414|NCT03007745|464960815|FG001|Overall Study|Physician Decision|9|||
129181415|NCT03007745|464960814|FG000|Overall Study|Withdrawal by Subject|38|||
129181416|NCT03007745|464960815|FG001|Overall Study|Withdrawal by Subject|16|||
129181417|NCT03007745|464960814|FG000|Overall Study|Lost to Follow-up|19|||
129181418|NCT03007745|464960815|FG001|Overall Study|Lost to Follow-up|25|||
129181419|NCT03007745|464960814|FG000|Overall Study|Unable to login to website|17|||
129181420|NCT03007745|464960815|FG001|Overall Study|Unable to login to website|4|||
129181421|NCT01300351|464960816|FG000|Overall Study|Did not receive treatment|2|||
129181422|NCT01300351|464960817|FG001|Overall Study|Did not receive treatment|0|||
129181423|NCT01300351|464960816|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
129181424|NCT01300351|464960817|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
129181425|NCT01300351|464960816|FG000|Overall Study|Lost to Follow-up|0|||
129181426|NCT01300351|464960817|FG001|Overall Study|Lost to Follow-up|1|||
129181427|NCT01300351|464960816|FG000|Overall Study|Adverse Event|0|||
129181428|NCT01300351|464960817|FG001|Overall Study|Adverse Event|4|||
129181429|NCT01300351|464960816|FG000|Overall Study|Withdrawal by Subject|7|||
129181430|NCT01300351|464960817|FG001|Overall Study|Withdrawal by Subject|10|||
129181431|NCT00431951|464960819|FG000|Overall Study|Inability to follow study procedures|1|||
129181432|NCT00431951|464960820|FG001|Overall Study|Inability to follow study procedures|0|||
129181433|NCT00431951|464960821|FG002|Overall Study|Inability to follow study procedures|1|||
129181434|NCT00431951|464960822|FG003|Overall Study|Inability to follow study procedures|2|||
129181435|NCT00431951|464960819|FG000|Overall Study|Lost to Follow-up|0|||
129181436|NCT00431951|464960820|FG001|Overall Study|Lost to Follow-up|1|||
129181437|NCT00431951|464960821|FG002|Overall Study|Lost to Follow-up|0|||
129181438|NCT00431951|464960822|FG003|Overall Study|Lost to Follow-up|0|||
129181439|NCT00431951|464960819|FG000|Overall Study|Withdrawal by Subject|0|||
129181440|NCT00431951|464960820|FG001|Overall Study|Withdrawal by Subject|1|||
129181441|NCT00431951|464960821|FG002|Overall Study|Withdrawal by Subject|0|||
129181442|NCT00431951|464960822|FG003|Overall Study|Withdrawal by Subject|0|||
129181443|NCT00431951|464960819|FG000|Overall Study|Adverse Event|0|||
129181444|NCT00431951|464960820|FG001|Overall Study|Adverse Event|0|||
129181445|NCT00431951|464960821|FG002|Overall Study|Adverse Event|1|||
129181446|NCT00431951|464960822|FG003|Overall Study|Adverse Event|0|||
129181447|NCT01146288|464960823|FG000|First Intervention(1 Day)|Adverse Event|0|||
129181448|NCT01146288|464960824|FG001|First Intervention(1 Day)|Adverse Event|1|||
129181449|NCT00385723|464960825|FG000|Overall Study|Lost to Follow-up|1|||
129181450|NCT00385723|464960826|FG001|Overall Study|Lost to Follow-up|1|||
129181451|NCT00385723|464960827|FG002|Overall Study|Lost to Follow-up|0|||
129181452|NCT00385723|464960825|FG000|Overall Study|Withdrawal by Subject|1|||
129181453|NCT00385723|464960826|FG001|Overall Study|Withdrawal by Subject|0|||
129181454|NCT00385723|464960827|FG002|Overall Study|Withdrawal by Subject|2|||
129181455|NCT05824936|464960830|FG000|Overall Study|Lost to Follow-up|1|||
129181456|NCT00673881|464960831|FG000|Overall Study|Withdrawal by Subject|1|||
129181457|NCT00413010|464960832|FG000|Overall Study|Adverse Event|8|||
129181458|NCT00413010|464960833|FG001|Overall Study|Adverse Event|4|||
129181459|NCT00413010|464960832|FG000|Overall Study|Laboratory abnormality|0|||
129181460|NCT00413010|464960833|FG001|Overall Study|Laboratory abnormality|2|||
129181461|NCT00413010|464960832|FG000|Overall Study|Lack of Efficacy|0|||
129181462|NCT00413010|464960833|FG001|Overall Study|Lack of Efficacy|3|||
129181463|NCT00413010|464960832|FG000|Overall Study|Lost to Follow-up|3|||
129181464|NCT00413010|464960833|FG001|Overall Study|Lost to Follow-up|0|||
129181465|NCT00413010|464960832|FG000|Overall Study|Withdrawal by Subject|7|||
129181466|NCT00413010|464960833|FG001|Overall Study|Withdrawal by Subject|2|||
129181467|NCT00413010|464960832|FG000|Overall Study|Due to termination of the study|54|||
129181468|NCT00413010|464960833|FG001|Overall Study|Due to termination of the study|52|||
129181469|NCT00708734|464960836|FG000|Overall Study|scheduling conflict|2|||
129181470|NCT00708734|464960836|FG000|Overall Study|moved|1|||
129181471|NCT00708734|464960836|FG000|Overall Study|leg injury|1|||
129181472|NCT00708734|464960836|FG000|Overall Study|knee replacement|1|||
129181473|NCT00708734|464960836|FG000|Overall Study|vertigo|1|||
129181474|NCT00708734|464960836|FG000|Overall Study|leg fracture|1|||
129181475|NCT01533922|464960838|FG000|Overall Study|Adverse Event|5|||
129181476|NCT01533922|464960839|FG001|Overall Study|Adverse Event|8|||
129181477|NCT01533922|464960840|FG002|Overall Study|Adverse Event|6|||
129181478|NCT01533922|464960841|FG003|Overall Study|Adverse Event|3|||
129181479|NCT01533922|464960842|FG004|Overall Study|Adverse Event|4|||
129181480|NCT01533922|464960838|FG000|Overall Study|Lack of Efficacy|0|||
129181481|NCT01533922|464960839|FG001|Overall Study|Lack of Efficacy|0|||
129181482|NCT01533922|464960840|FG002|Overall Study|Lack of Efficacy|1|||
129181483|NCT01533922|464960841|FG003|Overall Study|Lack of Efficacy|0|||
129181484|NCT01533922|464960842|FG004|Overall Study|Lack of Efficacy|0|||
129181485|NCT01533922|464960838|FG000|Overall Study|Protocol Violation|0|||
129181486|NCT01533922|464960839|FG001|Overall Study|Protocol Violation|3|||
129181487|NCT01533922|464960840|FG002|Overall Study|Protocol Violation|0|||
129181488|NCT01533922|464960841|FG003|Overall Study|Protocol Violation|0|||
129181489|NCT01533922|464960842|FG004|Overall Study|Protocol Violation|1|||
129181490|NCT01533922|464960838|FG000|Overall Study|Withdrawal by Subject|3|||
129181491|NCT01533922|464960839|FG001|Overall Study|Withdrawal by Subject|1|||
129181492|NCT01533922|464960840|FG002|Overall Study|Withdrawal by Subject|2|||
129181493|NCT01533922|464960841|FG003|Overall Study|Withdrawal by Subject|2|||
129181494|NCT01533922|464960842|FG004|Overall Study|Withdrawal by Subject|1|||
129181495|NCT01533922|464960838|FG000|Overall Study|Other reason not defined above|2|||
129181496|NCT01533922|464960839|FG001|Overall Study|Other reason not defined above|0|||
129181497|NCT01533922|464960840|FG002|Overall Study|Other reason not defined above|1|||
129181498|NCT01533922|464960841|FG003|Overall Study|Other reason not defined above|0|||
129181499|NCT01533922|464960842|FG004|Overall Study|Other reason not defined above|0|||
129181500|NCT02634606|464960845|FG000|Overall Study|unable to obtain the drug at start|13|||
129181501|NCT01267175|464960846|FG000|Overall Study|Withdrawal by Subject|1|||
129181502|NCT01267175|464960846|FG000|Overall Study|Lost to Follow-up|1|||
129181503|NCT00286221|464960849|FG000|Overall Study|Protocol Violation|2|||
129181504|NCT00286221|464960850|FG001|Overall Study|Protocol Violation|1|||
129181505|NCT00286221|464960851|FG002|Overall Study|Protocol Violation|6|||
129181506|NCT00286221|464960852|FG003|Overall Study|Protocol Violation|4|||
129181507|NCT00286221|464960849|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
129181508|NCT00286221|464960850|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
129181509|NCT00286221|464960851|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
129181510|NCT00286221|464960852|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
129181511|NCT00286221|464960849|FG000|Overall Study|Inability to trigger PCA|2|||
129181512|NCT00286221|464960850|FG001|Overall Study|Inability to trigger PCA|0|||
129181513|NCT00286221|464960851|FG002|Overall Study|Inability to trigger PCA|0|||
129181514|NCT00286221|464960852|FG003|Overall Study|Inability to trigger PCA|0|||
129181515|NCT00286221|464960849|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
129181516|NCT00286221|464960850|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
129181517|NCT00286221|464960851|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
129181518|NCT00286221|464960852|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
129181519|NCT02553538|464960854|FG000|Overall Study|Could Not Reach by Telephone|133|||
129181520|NCT02553538|464960855|FG001|Overall Study|Could Not Reach by Telephone|0|||
129181521|NCT02553538|464960854|FG000|Overall Study|Died or Left Network|54|||
129181522|NCT02553538|464960855|FG001|Overall Study|Died or Left Network|56|||
129181523|NCT02690649|464960856|FG000|Overall Study|Withdrawal by Subject|1|||
129181524|NCT02690649|464960857|FG001|Overall Study|Withdrawal by Subject|1|||
129181525|NCT02690649|464960856|FG000|Overall Study|Protocol Violation|0|||
129181526|NCT02690649|464960857|FG001|Overall Study|Protocol Violation|3|||
129181527|NCT02276547|464960858|FG000|Overall Study|Death|2|||
129181528|NCT02276547|464960858|FG000|Overall Study|Explant|2|||
129181529|NCT01754194|464960859|FG000|Overall Study|Lost to Follow-up|39|||
129181530|NCT01754194|464960860|FG001|Overall Study|Lost to Follow-up|14|||
129181531|NCT01754194|464960859|FG000|Overall Study|Withdrawal by Subject|4|||
129181532|NCT01754194|464960860|FG001|Overall Study|Withdrawal by Subject|5|||
129181533|NCT01754194|464960859|FG000|Overall Study|Other|9|||
129181534|NCT01754194|464960860|FG001|Overall Study|Other|8|||
129181535|NCT00907296|464960861|FG000|Overall Study|Ineligibility Determined|1|||
129181536|NCT00907296|464960862|FG001|Overall Study|Ineligibility Determined|0|||
129181537|NCT00907296|464960863|FG002|Overall Study|Ineligibility Determined|0|||
129181538|NCT00907296|464960864|FG003|Overall Study|Ineligibility Determined|1|||
129181539|NCT00907296|464960865|FG004|Overall Study|Ineligibility Determined|0|||
129181540|NCT00907296|464960866|FG005|Overall Study|Ineligibility Determined|0|||
129181541|NCT00907296|464960867|FG006|Overall Study|Ineligibility Determined|0|||
129181542|NCT00907296|464960868|FG007|Overall Study|Ineligibility Determined|1|||
129181543|NCT00907296|464960869|FG008|Overall Study|Ineligibility Determined|0|||
129181544|NCT00907296|464960870|FG009|Overall Study|Ineligibility Determined|0|||
129181545|NCT00907296|464960861|FG000|Overall Study|Protocol Deviation|0|||
129181546|NCT00907296|464960862|FG001|Overall Study|Protocol Deviation|1|||
129181547|NCT00907296|464960863|FG002|Overall Study|Protocol Deviation|0|||
129181548|NCT00907296|464960864|FG003|Overall Study|Protocol Deviation|0|||
129181549|NCT00907296|464960865|FG004|Overall Study|Protocol Deviation|0|||
129181550|NCT00907296|464960866|FG005|Overall Study|Protocol Deviation|0|||
129181551|NCT00907296|464960867|FG006|Overall Study|Protocol Deviation|0|||
129181552|NCT00907296|464960868|FG007|Overall Study|Protocol Deviation|0|||
129181553|NCT00907296|464960869|FG008|Overall Study|Protocol Deviation|0|||
129181554|NCT00907296|464960870|FG009|Overall Study|Protocol Deviation|0|||
129181555|NCT00907296|464960861|FG000|Overall Study|Noncompliance|1|||
129181556|NCT00907296|464960862|FG001|Overall Study|Noncompliance|1|||
129181557|NCT00907296|464960863|FG002|Overall Study|Noncompliance|1|||
129181558|NCT00907296|464960864|FG003|Overall Study|Noncompliance|0|||
129181559|NCT00907296|464960865|FG004|Overall Study|Noncompliance|0|||
129181560|NCT00907296|464960866|FG005|Overall Study|Noncompliance|1|||
129181561|NCT00907296|464960867|FG006|Overall Study|Noncompliance|0|||
129181562|NCT00907296|464960868|FG007|Overall Study|Noncompliance|2|||
129181563|NCT00907296|464960869|FG008|Overall Study|Noncompliance|0|||
129181564|NCT00907296|464960870|FG009|Overall Study|Noncompliance|0|||
129181565|NCT00907296|464960861|FG000|Overall Study|Adverse Event|2|||
129181566|NCT00907296|464960862|FG001|Overall Study|Adverse Event|0|||
129181567|NCT00907296|464960863|FG002|Overall Study|Adverse Event|0|||
129181568|NCT00907296|464960864|FG003|Overall Study|Adverse Event|0|||
129181569|NCT00907296|464960865|FG004|Overall Study|Adverse Event|0|||
129181570|NCT00907296|464960866|FG005|Overall Study|Adverse Event|0|||
129181571|NCT00907296|464960867|FG006|Overall Study|Adverse Event|1|||
129181572|NCT00907296|464960868|FG007|Overall Study|Adverse Event|0|||
129181573|NCT00907296|464960869|FG008|Overall Study|Adverse Event|0|||
129181574|NCT00907296|464960870|FG009|Overall Study|Adverse Event|1|||
129181575|NCT00907296|464960861|FG000|Overall Study|Withdrawal by Subject|7|||
129181576|NCT00907296|464960862|FG001|Overall Study|Withdrawal by Subject|2|||
129181577|NCT00907296|464960863|FG002|Overall Study|Withdrawal by Subject|1|||
129181578|NCT00907296|464960864|FG003|Overall Study|Withdrawal by Subject|1|||
129181579|NCT00907296|464960865|FG004|Overall Study|Withdrawal by Subject|1|||
129181580|NCT00907296|464960866|FG005|Overall Study|Withdrawal by Subject|5|||
129181581|NCT00907296|464960867|FG006|Overall Study|Withdrawal by Subject|3|||
129181582|NCT00907296|464960868|FG007|Overall Study|Withdrawal by Subject|2|||
129181583|NCT00907296|464960869|FG008|Overall Study|Withdrawal by Subject|4|||
129181584|NCT00907296|464960870|FG009|Overall Study|Withdrawal by Subject|2|||
129181585|NCT00907296|464960861|FG000|Overall Study|Lost to Follow-up|9|||
129181586|NCT00907296|464960862|FG001|Overall Study|Lost to Follow-up|1|||
129181587|NCT00907296|464960863|FG002|Overall Study|Lost to Follow-up|0|||
129181588|NCT00907296|464960864|FG003|Overall Study|Lost to Follow-up|2|||
129181589|NCT00907296|464960865|FG004|Overall Study|Lost to Follow-up|0|||
129181590|NCT00907296|464960866|FG005|Overall Study|Lost to Follow-up|3|||
129181591|NCT00907296|464960867|FG006|Overall Study|Lost to Follow-up|2|||
129181592|NCT00907296|464960868|FG007|Overall Study|Lost to Follow-up|2|||
129181593|NCT00907296|464960869|FG008|Overall Study|Lost to Follow-up|0|||
129181594|NCT00907296|464960870|FG009|Overall Study|Lost to Follow-up|4|||
129181595|NCT00357656|464960874|FG000|Overall Study|Other, No surgery performed|0|||
129181596|NCT00357656|464960875|FG001|Overall Study|Other, No surgery performed|3|||
129181597|NCT02573246|464960876|FG000|Overall Study|Lost to Follow-up|2|||
129181598|NCT02573246|464960877|FG001|Overall Study|Lost to Follow-up|0|||
129181599|NCT02573246|464960878|FG002|Overall Study|Lost to Follow-up|0|||
129181600|NCT02573246|464960879|FG003|Overall Study|Lost to Follow-up|0|||
129181601|NCT02573246|464960880|FG004|Overall Study|Lost to Follow-up|1|||
129181602|NCT02573246|464960876|FG000|Overall Study|Withdrawal by Subject|0|||
129181603|NCT02573246|464960877|FG001|Overall Study|Withdrawal by Subject|0|||
129181604|NCT02573246|464960878|FG002|Overall Study|Withdrawal by Subject|0|||
129181605|NCT02573246|464960879|FG003|Overall Study|Withdrawal by Subject|0|||
129181606|NCT02573246|464960880|FG004|Overall Study|Withdrawal by Subject|1|||
129181607|NCT02573246|464960876|FG000|Overall Study|Physician Decision|1|||
129181608|NCT02573246|464960877|FG001|Overall Study|Physician Decision|1|||
129181609|NCT02573246|464960878|FG002|Overall Study|Physician Decision|3|||
129181610|NCT02573246|464960879|FG003|Overall Study|Physician Decision|2|||
129181611|NCT02573246|464960880|FG004|Overall Study|Physician Decision|2|||
129181612|NCT01219933|464960881|FG000|Overall Study|Adverse Event|8|||
129181613|NCT01219933|464960881|FG000|Overall Study|No LDA reached|5|||
129181614|NCT01219933|464960881|FG000|Overall Study|No LDA maintained|7|||
129181615|NCT01219933|464960881|FG000|Overall Study|Lost to Follow-up|3|||
129181616|NCT01219933|464960881|FG000|Overall Study|GC free|1|||
129181617|NCT01219933|464960881|FG000|Overall Study|Withdrawal by Subject|5|||
129181618|NCT01219933|464960881|FG000|Overall Study|Protocol Violation|8|||
129181619|NCT01219933|464960881|FG000|Overall Study|Lack of Efficacy|1|||
129181620|NCT03149003|464960882|FG000|Overall Study|Randomized but not treated|0|||
129181621|NCT03149003|464960883|FG001|Overall Study|Randomized but not treated|1|||
129181622|NCT03149003|464960884|FG002|Overall Study|Randomized but not treated|18|||
129181623|NCT02900170|464960886|FG000|Overall Study|Lost to Follow-up|8|||
129181624|NCT01565941|464960887|FG000|Overall Study|Withdrawn by parent/guardian|3|||
129181625|NCT01565941|464960888|FG001|Overall Study|Withdrawn by parent/guardian|2|||
129181626|NCT01565941|464960887|FG000|Overall Study|Randomized; did not receive intevention|8|||
129181627|NCT01565941|464960888|FG001|Overall Study|Randomized; did not receive intevention|2|||
129181628|NCT03262116|464960889|FG000|Overall Study|Physician Decision|0|||
129181629|NCT03262116|464960890|FG001|Overall Study|Physician Decision|2|||
129181630|NCT03262116|464960891|FG002|Overall Study|Physician Decision|1|||
129181631|NCT03262116|464960892|FG003|Overall Study|Physician Decision|1|||
129181632|NCT03262116|464960893|FG004|Overall Study|Physician Decision|1|||
129181633|NCT03262116|464960894|FG005|Overall Study|Physician Decision|2|||
129181634|NCT02365285|464960895|FG000|Overall Study|Physician Decision|0|||
129181635|NCT02365285|464960896|FG001|Overall Study|Physician Decision|1|||
129181636|NCT02365285|464960897|FG002|Overall Study|Physician Decision|1|||
129181637|NCT02365285|464960898|FG003|Overall Study|Physician Decision|0|||
129181638|NCT02365285|464960895|FG000|Overall Study|Adverse Event|0|||
129181639|NCT02365285|464960896|FG001|Overall Study|Adverse Event|0|||
129181640|NCT02365285|464960897|FG002|Overall Study|Adverse Event|0|||
129181641|NCT02365285|464960898|FG003|Overall Study|Adverse Event|2|||
129181642|NCT02608450|464960901|FG000|Overall Study|Lost to Follow-up|39|||
129181643|NCT02608450|464960902|FG001|Overall Study|Lost to Follow-up|32|||
129181644|NCT02608450|464960901|FG000|Overall Study|Withdrawal by Subject|21|||
129181645|NCT02608450|464960902|FG001|Overall Study|Withdrawal by Subject|15|||
129181646|NCT02608450|464960901|FG000|Overall Study|Adverse Event|3|||
129181647|NCT02608450|464960902|FG001|Overall Study|Adverse Event|6|||
129181648|NCT02608450|464960901|FG000|Overall Study|Withdrawal by parent|2|||
129181649|NCT02608450|464960902|FG001|Overall Study|Withdrawal by parent|3|||
129181650|NCT02608450|464960901|FG000|Overall Study|Lack of Efficacy|0|||
129181651|NCT02608450|464960902|FG001|Overall Study|Lack of Efficacy|3|||
129181652|NCT02608450|464960901|FG000|Overall Study|Noncompliance with study drug|0|||
129181653|NCT02608450|464960902|FG001|Overall Study|Noncompliance with study drug|2|||
129181654|NCT02608450|464960901|FG000|Overall Study|Physician Decision|0|||
129181655|NCT02608450|464960902|FG001|Overall Study|Physician Decision|1|||
129181656|NCT02608450|464960901|FG000|Overall Study|Pregnancy|0|||
129181657|NCT02608450|464960902|FG001|Overall Study|Pregnancy|1|||
129181658|NCT02608450|464960901|FG000|Overall Study|Progressive disease|1|||
129181659|NCT02608450|464960902|FG001|Overall Study|Progressive disease|0|||
129181660|NCT02608450|464960901|FG000|Overall Study|Multiple reasons|0|||
129181661|NCT02608450|464960902|FG001|Overall Study|Multiple reasons|2|||
129181662|NCT00249613|464960905|FG000|12 Month Follow-up|Death|1|||
129181663|NCT00249613|464960906|FG001|12 Month Follow-up|Death|1|||
129181664|NCT00249613|464960905|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
129181665|NCT00249613|464960906|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
129181666|NCT00249613|464960905|FG000|12 Month Follow-up|Lost to Follow-up|10|||
129181667|NCT00249613|464960906|FG001|12 Month Follow-up|Lost to Follow-up|8|||
129181668|NCT00424190|464960911|FG000|Overall Study|Withdrew consent|3|||
129181669|NCT00424190|464960912|FG001|Overall Study|Withdrew consent|4|||
129181670|NCT00424190|464960911|FG000|Overall Study|Death|3|||
129181671|NCT00424190|464960912|FG001|Overall Study|Death|0|||
129181672|NCT00424190|464960911|FG000|Overall Study|Noncompliance|1|||
129181673|NCT00424190|464960912|FG001|Overall Study|Noncompliance|2|||
129181674|NCT00424190|464960911|FG000|Overall Study|Request of sponsor or investigator|0|||
129181675|NCT00424190|464960912|FG001|Overall Study|Request of sponsor or investigator|2|||
129181676|NCT00424190|464960911|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
129181677|NCT00424190|464960912|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
129181678|NCT00424190|464960911|FG000|Overall Study|Other|15|||
129181679|NCT00424190|464960912|FG001|Overall Study|Other|21|||
129181680|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
129181681|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
129181682|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
129181683|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
129181684|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
129181685|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
129181686|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
129181687|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
129181688|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
129181689|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
129181690|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
129181691|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
129181692|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
129181693|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
129181694|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
129181695|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
129181696|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
129181697|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
129181698|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
128730202|NCT02448875|463308356|FG002|Overall Study|Withdrawal by Subject|0|||
129181699|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
129181700|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
129181701|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
129181702|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
129181703|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
129181704|NCT01672866|464960913|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
129181705|NCT01672866|464960914|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
129181706|NCT01672866|464960915|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
129181707|NCT01672866|464960913|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
129181708|NCT01672866|464960914|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
129181709|NCT01672866|464960915|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
129181710|NCT01672866|464960913|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
129181711|NCT01672866|464960914|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
129181712|NCT01672866|464960915|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
129181713|NCT01672866|464960913|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
129181714|NCT01672866|464960914|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
129181715|NCT01672866|464960915|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
129181716|NCT01672866|464960913|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
129181717|NCT01672866|464960914|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
129181718|NCT01672866|464960915|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
129181719|NCT01378429|464960918|FG000|Overall Study|Noncompliance with study drug|1|||
129181720|NCT01378429|464960919|FG001|Overall Study|Noncompliance with study drug|0|||
129181721|NCT02241187|464960920|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
129181722|NCT00199888|464960921|FG000|Overall Study|Lost to Follow-up|1|||
129181723|NCT05219669|464960924|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
129181724|NCT05219669|464960925|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
129181725|NCT05219669|464960926|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
129181726|NCT05219669|464960927|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
129181727|NCT05219669|464960928|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
129181728|NCT05219669|464960929|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
129181729|NCT02544373|464960931|FG000|Overall Study|Lost to Follow-up|5|||
129181730|NCT02544373|464960932|FG001|Overall Study|Lost to Follow-up|3|||
129181731|NCT02544373|464960931|FG000|Overall Study|Withdrawal by Subject|8|||
129181732|NCT02544373|464960932|FG001|Overall Study|Withdrawal by Subject|2|||
129181733|NCT02621073|464960933|FG000|Overall Study|Lost to Follow-up|0|||
129181734|NCT02621073|464960934|FG001|Overall Study|Lost to Follow-up|1|||
129181735|NCT02621073|464960933|FG000|Overall Study|Physician Decision|3|||
129181736|NCT02621073|464960934|FG001|Overall Study|Physician Decision|2|||
129181737|NCT01595581|464960935|FG000|Overall Study|Withdrawal by Subject|1|||
129181738|NCT01595581|464960936|FG001|Overall Study|Withdrawal by Subject|0|||
129181739|NCT01440881|464960937|FG000|Overall Study|Death|0|||
129181740|NCT01440881|464960938|FG001|Overall Study|Death|1|||
129181741|NCT02383433|464960941|FG000|Overall Study|Disease progression|2|||
129181742|NCT02535416|464960942|FG000|Overall Study|Family bereavement overseas|1|||
129181743|NCT02535416|464960943|FG001|Overall Study|Family bereavement overseas|0|||
129181744|NCT02535416|464960944|FG002|Overall Study|Family bereavement overseas|0|||
129181745|NCT02535416|464960945|FG003|Overall Study|Family bereavement overseas|0|||
129181746|NCT02535416|464960946|FG004|Overall Study|Family bereavement overseas|0|||
129181747|NCT02535416|464960947|FG005|Overall Study|Family bereavement overseas|0|||
129181748|NCT02535416|464960948|FG006|Overall Study|Family bereavement overseas|0|||
129181749|NCT02535416|464960949|FG007|Overall Study|Family bereavement overseas|0|||
129181750|NCT02535416|464960950|FG008|Overall Study|Family bereavement overseas|0|||
129181751|NCT02920957|464960951|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
129181752|NCT02920957|464960952|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
129181753|NCT02920957|464960951|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
129181754|NCT02920957|464960952|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
129181755|NCT02920957|464960951|FG000|First Intervention : 1 Month|Adverse Event|1|||
129181756|NCT02920957|464960952|FG001|First Intervention : 1 Month|Adverse Event|0|||
129181757|NCT02920957|464960951|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
129181758|NCT02920957|464960952|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
129181759|NCT02739321|464960958|FG000|Overall Study|Lack of Efficacy|1|||
129181760|NCT02739321|464960959|FG001|Overall Study|Lack of Efficacy|1|||
129181761|NCT02739321|464960958|FG000|Overall Study|Lost to Follow-up|1|||
129181762|NCT02739321|464960959|FG001|Overall Study|Lost to Follow-up|1|||
129181763|NCT02739321|464960958|FG000|Overall Study|Withdrawal by Subject|1|||
129181764|NCT02739321|464960959|FG001|Overall Study|Withdrawal by Subject|2|||
129181765|NCT01711866|464960960|FG000|Overall Study|Noncompliant|3|||
129181766|NCT01711866|464960960|FG000|Overall Study|Withdrawal by Subject|3|||
129181767|NCT01711866|464960960|FG000|Overall Study|Adverse Event|2|||
129181768|NCT01345682|464960961|FG000|Overall Study|Progressive disease per RECIST|226|||
129181769|NCT01345682|464960962|FG001|Overall Study|Progressive disease per RECIST|93|||
129181770|NCT01345682|464960961|FG000|Overall Study|Worsening of underlying cancer disease|23|||
129181771|NCT01345682|464960962|FG001|Overall Study|Worsening of underlying cancer disease|12|||
129181772|NCT01345682|464960961|FG000|Overall Study|Adverse Event|51|||
129181773|NCT01345682|464960962|FG001|Overall Study|Adverse Event|41|||
129181774|NCT01345682|464960961|FG000|Overall Study|Non-compliance with protocol|0|||
129181775|NCT01345682|464960962|FG001|Overall Study|Non-compliance with protocol|1|||
129181776|NCT01345682|464960961|FG000|Overall Study|Lost to Follow-up|0|||
129181777|NCT01345682|464960962|FG001|Overall Study|Lost to Follow-up|1|||
129181778|NCT01345682|464960961|FG000|Overall Study|Refused to continue trial medication|16|||
129181779|NCT01345682|464960962|FG001|Overall Study|Refused to continue trial medication|9|||
129181780|NCT01345682|464960961|FG000|Overall Study|Not treated|2|||
129181781|NCT01345682|464960962|FG001|Overall Study|Not treated|1|||
128780952|NCT01323660|463488629|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129181782|NCT01345682|464960961|FG000|Overall Study|Reason other than those specified above|4|||
129181783|NCT01345682|464960962|FG001|Overall Study|Reason other than those specified above|3|||
129181784|NCT00958217|464960965|FG000|Overall Study|Death|2|||
129181785|NCT00958217|464960966|FG001|Overall Study|Death|1|||
129181786|NCT00958217|464960965|FG000|Overall Study|Withdrawal by Subject|4|||
129181787|NCT00958217|464960966|FG001|Overall Study|Withdrawal by Subject|3|||
129181788|NCT00958217|464960965|FG000|Overall Study|Lost to Follow-up|17|||
129181789|NCT00958217|464960966|FG001|Overall Study|Lost to Follow-up|19|||
129181790|NCT00958217|464960965|FG000|Overall Study|Moved out of area|1|||
129181791|NCT00958217|464960966|FG001|Overall Study|Moved out of area|1|||
129181792|NCT00958217|464960965|FG000|Overall Study|Inpatient hospitalization|0|||
129181793|NCT00958217|464960966|FG001|Overall Study|Inpatient hospitalization|1|||
129181794|NCT01075984|464960969|FG000|Treatment Phase|Adverse Event|0|||
129181795|NCT01075984|464960970|FG001|Treatment Phase|Adverse Event|1|||
129181796|NCT01075984|464960971|FG002|Treatment Phase|Adverse Event|3|||
129181797|NCT01075984|464960972|FG003|Treatment Phase|Adverse Event|7|||
129181798|NCT01075984|464960973|FG004|Treatment Phase|Adverse Event|35|||
129181799|NCT01075984|464960969|FG000|Treatment Phase|Protocol Violation|0|||
129181800|NCT01075984|464960970|FG001|Treatment Phase|Protocol Violation|0|||
129181801|NCT01075984|464960971|FG002|Treatment Phase|Protocol Violation|1|||
129181802|NCT01075984|464960972|FG003|Treatment Phase|Protocol Violation|0|||
129181803|NCT01075984|464960973|FG004|Treatment Phase|Protocol Violation|3|||
129181804|NCT01075984|464960969|FG000|Treatment Phase|Withdrawal by Subject|0|||
129181805|NCT01075984|464960970|FG001|Treatment Phase|Withdrawal by Subject|0|||
129181806|NCT01075984|464960971|FG002|Treatment Phase|Withdrawal by Subject|2|||
129181807|NCT01075984|464960972|FG003|Treatment Phase|Withdrawal by Subject|0|||
129181808|NCT01075984|464960973|FG004|Treatment Phase|Withdrawal by Subject|15|||
129181809|NCT01075984|464960969|FG000|Treatment Phase|Treatment Failure|0|||
129181810|NCT01075984|464960970|FG001|Treatment Phase|Treatment Failure|0|||
129181811|NCT01075984|464960971|FG002|Treatment Phase|Treatment Failure|1|||
129181812|NCT01075984|464960972|FG003|Treatment Phase|Treatment Failure|0|||
129181813|NCT01075984|464960973|FG004|Treatment Phase|Treatment Failure|5|||
129181814|NCT01075984|464960969|FG000|Treatment Phase|Progression of disease|0|||
129181815|NCT01075984|464960970|FG001|Treatment Phase|Progression of disease|0|||
129181816|NCT01075984|464960971|FG002|Treatment Phase|Progression of disease|0|||
129181817|NCT01075984|464960972|FG003|Treatment Phase|Progression of disease|0|||
129181818|NCT01075984|464960973|FG004|Treatment Phase|Progression of disease|2|||
129181819|NCT01075984|464960969|FG000|Follow-up Phase|Protocol Violation|0|||
129181820|NCT01075984|464960970|FG001|Follow-up Phase|Protocol Violation|0|||
129181821|NCT01075984|464960971|FG002|Follow-up Phase|Protocol Violation|1|||
129181822|NCT01075984|464960972|FG003|Follow-up Phase|Protocol Violation|0|||
129181823|NCT01075984|464960973|FG004|Follow-up Phase|Protocol Violation|3|||
129181824|NCT01075984|464960969|FG000|Follow-up Phase|Adverse Event|0|||
129181825|NCT01075984|464960970|FG001|Follow-up Phase|Adverse Event|0|||
129181826|NCT01075984|464960971|FG002|Follow-up Phase|Adverse Event|0|||
129181827|NCT01075984|464960972|FG003|Follow-up Phase|Adverse Event|2|||
129181828|NCT01075984|464960973|FG004|Follow-up Phase|Adverse Event|27|||
129181829|NCT01075984|464960969|FG000|Follow-up Phase|Administrative|0|||
129181830|NCT01075984|464960970|FG001|Follow-up Phase|Administrative|0|||
129181831|NCT01075984|464960971|FG002|Follow-up Phase|Administrative|0|||
129181832|NCT01075984|464960972|FG003|Follow-up Phase|Administrative|0|||
129181833|NCT01075984|464960973|FG004|Follow-up Phase|Administrative|1|||
129181834|NCT01075984|464960969|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129181835|NCT01075984|464960970|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129181836|NCT01075984|464960971|FG002|Follow-up Phase|Withdrawal by Subject|0|||
129181837|NCT01075984|464960972|FG003|Follow-up Phase|Withdrawal by Subject|0|||
129181838|NCT01075984|464960973|FG004|Follow-up Phase|Withdrawal by Subject|10|||
129181839|NCT01075984|464960969|FG000|Follow-up Phase|Progression of disease|0|||
129181840|NCT01075984|464960970|FG001|Follow-up Phase|Progression of disease|0|||
129181841|NCT01075984|464960971|FG002|Follow-up Phase|Progression of disease|0|||
129181842|NCT01075984|464960972|FG003|Follow-up Phase|Progression of disease|0|||
129181843|NCT01075984|464960973|FG004|Follow-up Phase|Progression of disease|2|||
129181844|NCT01075984|464960969|FG000|Follow-up Phase|Treatment failure|0|||
129181845|NCT01075984|464960970|FG001|Follow-up Phase|Treatment failure|0|||
129181846|NCT01075984|464960971|FG002|Follow-up Phase|Treatment failure|0|||
129181847|NCT01075984|464960972|FG003|Follow-up Phase|Treatment failure|0|||
129181848|NCT01075984|464960973|FG004|Follow-up Phase|Treatment failure|4|||
129181849|NCT02440789|464960974|FG000|Overall Study|Withdrawal by Subject|3|||
129181850|NCT02440789|464960974|FG000|Overall Study|Not willing to adhere to reqs|1|||
129181851|NCT03684694|464960977|FG000|Phase 1|Withdrawal by Subject|1|||
129181852|NCT03684694|464960978|FG001|Phase 1|Withdrawal by Subject|0|||
129181853|NCT03684694|464960979|FG002|Phase 1|Withdrawal by Subject|0|||
129181854|NCT03684694|464960980|FG003|Phase 1|Withdrawal by Subject|0|||
129181855|NCT03684694|464960981|FG004|Phase 1|Withdrawal by Subject|0|||
129181856|NCT03684694|464960982|FG005|Phase 1|Withdrawal by Subject|0|||
129181857|NCT03684694|464960977|FG000|Phase 1|Investigator/Sponsor Decision|12|||
129181858|NCT03684694|464960978|FG001|Phase 1|Investigator/Sponsor Decision|2|||
129181859|NCT03684694|464960979|FG002|Phase 1|Investigator/Sponsor Decision|1|||
129181860|NCT03684694|464960980|FG003|Phase 1|Investigator/Sponsor Decision|0|||
129181861|NCT03684694|464960981|FG004|Phase 1|Investigator/Sponsor Decision|0|||
129181862|NCT03684694|464960982|FG005|Phase 1|Investigator/Sponsor Decision|0|||
129181863|NCT03684694|464960977|FG000|Phase 1|Death|24|||
129181864|NCT03684694|464960978|FG001|Phase 1|Death|0|||
129181865|NCT03684694|464960979|FG002|Phase 1|Death|3|||
129181866|NCT03684694|464960980|FG003|Phase 1|Death|0|||
129181867|NCT03684694|464960981|FG004|Phase 1|Death|0|||
129181868|NCT03684694|464960982|FG005|Phase 1|Death|0|||
129181869|NCT03684694|464960977|FG000|Phase 1|Lost to Follow-up|0|||
129181870|NCT03684694|464960978|FG001|Phase 1|Lost to Follow-up|0|||
129181871|NCT03684694|464960979|FG002|Phase 1|Lost to Follow-up|1|||
129181872|NCT03684694|464960980|FG003|Phase 1|Lost to Follow-up|0|||
129181873|NCT03684694|464960981|FG004|Phase 1|Lost to Follow-up|0|||
129181874|NCT03684694|464960982|FG005|Phase 1|Lost to Follow-up|0|||
129181875|NCT03684694|464960977|FG000|Phase 1|Miscellaneous|0|||
129181876|NCT03684694|464960978|FG001|Phase 1|Miscellaneous|1|||
129181877|NCT03684694|464960979|FG002|Phase 1|Miscellaneous|0|||
129181878|NCT03684694|464960980|FG003|Phase 1|Miscellaneous|0|||
129181879|NCT03684694|464960981|FG004|Phase 1|Miscellaneous|0|||
129181880|NCT03684694|464960982|FG005|Phase 1|Miscellaneous|0|||
129181881|NCT03684694|464960977|FG000|Phase 2|Withdrawal by Subject|0|||
129181882|NCT03684694|464960978|FG001|Phase 2|Withdrawal by Subject|0|||
129181883|NCT03684694|464960979|FG002|Phase 2|Withdrawal by Subject|0|||
129181884|NCT03684694|464960980|FG003|Phase 2|Withdrawal by Subject|0|||
129181885|NCT03684694|464960981|FG004|Phase 2|Withdrawal by Subject|0|||
129181886|NCT03684694|464960982|FG005|Phase 2|Withdrawal by Subject|1|||
129181887|NCT03684694|464960977|FG000|Phase 2|Investigator/Sponsor Decision|0|||
129181888|NCT03684694|464960978|FG001|Phase 2|Investigator/Sponsor Decision|0|||
129181889|NCT03684694|464960979|FG002|Phase 2|Investigator/Sponsor Decision|0|||
129181890|NCT03684694|464960980|FG003|Phase 2|Investigator/Sponsor Decision|17|||
129181891|NCT03684694|464960981|FG004|Phase 2|Investigator/Sponsor Decision|16|||
129181892|NCT03684694|464960982|FG005|Phase 2|Investigator/Sponsor Decision|6|||
129181893|NCT03684694|464960977|FG000|Phase 2|Death|0|||
129181894|NCT03684694|464960978|FG001|Phase 2|Death|0|||
129181895|NCT03684694|464960979|FG002|Phase 2|Death|0|||
129181896|NCT03684694|464960980|FG003|Phase 2|Death|28|||
129181897|NCT03684694|464960981|FG004|Phase 2|Death|14|||
129181898|NCT03684694|464960982|FG005|Phase 2|Death|3|||
129181899|NCT03684694|464960977|FG000|Phase 2|Lost to Follow-up|0|||
129181900|NCT03684694|464960978|FG001|Phase 2|Lost to Follow-up|0|||
129181901|NCT03684694|464960979|FG002|Phase 2|Lost to Follow-up|0|||
129181902|NCT03684694|464960980|FG003|Phase 2|Lost to Follow-up|1|||
129181903|NCT03684694|464960981|FG004|Phase 2|Lost to Follow-up|0|||
129181904|NCT03684694|464960982|FG005|Phase 2|Lost to Follow-up|0|||
129181905|NCT03684694|464960977|FG000|Phase 2|Miscellaneous|0|||
129181906|NCT03684694|464960978|FG001|Phase 2|Miscellaneous|0|||
129181907|NCT03684694|464960979|FG002|Phase 2|Miscellaneous|0|||
129181908|NCT03684694|464960980|FG003|Phase 2|Miscellaneous|3|||
129181909|NCT03684694|464960981|FG004|Phase 2|Miscellaneous|0|||
129181910|NCT03684694|464960982|FG005|Phase 2|Miscellaneous|0|||
129181911|NCT03172130|464962315|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
129181912|NCT03172130|464962316|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
129181913|NCT02831933|464962321|FG000|Overall Study|Physician Decision|11|||
129181914|NCT05065190|464962327|FG000|Overall Study|Other than listed|2|||
129181915|NCT05065190|464962328|FG001|Overall Study|Other than listed|12|||
129181916|NCT05065190|464962327|FG000|Overall Study|Lack of Efficacy|4|||
129181917|NCT05065190|464962328|FG001|Overall Study|Lack of Efficacy|0|||
129181918|NCT05065190|464962327|FG000|Overall Study|Adverse Event|1|||
129181919|NCT05065190|464962328|FG001|Overall Study|Adverse Event|10|||
129181920|NCT04544683|464962336|FG000|Overall Study|Lost to Follow-up|2|||
129181921|NCT04544683|464962336|FG000|Overall Study|Underwent cervical spine surgery|6|||
129181922|NCT01073930|464962337|FG000|Overall Study|Withdrawal by Subject|3|||
129181923|NCT01073930|464962338|FG001|Overall Study|Withdrawal by Subject|2|||
129181924|NCT01073930|464962337|FG000|Overall Study|Lost to Follow-up|0|||
129181925|NCT01073930|464962338|FG001|Overall Study|Lost to Follow-up|1|||
129181926|NCT01073930|464962337|FG000|Overall Study|Adverse Event|0|||
129181927|NCT01073930|464962338|FG001|Overall Study|Adverse Event|1|||
129181928|NCT01073930|464962337|FG000|Overall Study|Noncompliance with study drug|0|||
129181929|NCT01073930|464962338|FG001|Overall Study|Noncompliance with study drug|1|||
129181930|NCT01073930|464962337|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
129181931|NCT01073930|464962338|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
129181932|NCT01022424|464962339|FG000|Overall Study|Adverse Event|1|||
129181933|NCT01022424|464962339|FG000|Overall Study|Physician Decision|1|||
129181934|NCT01022424|464962339|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
129181935|NCT02783170|464962342|FG000|Overall Study|Randomized but not Vaccinated|1|||
129181936|NCT02783170|464962343|FG001|Overall Study|Randomized but not Vaccinated|0|||
129181937|NCT04938037|464962346|FG000|Overall Study|Lost to Follow-up|4|||
129181938|NCT04938037|464962347|FG001|Overall Study|Lost to Follow-up|3|||
129181939|NCT03320330|464962348|FG000|Overall Study|Lack of Efficacy|5|||
129181940|NCT03320330|464962349|FG001|Overall Study|Lack of Efficacy|5|||
129181941|NCT03320330|464962350|FG002|Overall Study|Lack of Efficacy|14|||
129181942|NCT03320330|464962348|FG000|Overall Study|Physician Decision|1|||
129181943|NCT03320330|464962349|FG001|Overall Study|Physician Decision|0|||
129181944|NCT03320330|464962350|FG002|Overall Study|Physician Decision|0|||
129181945|NCT01806064|464962351|FG000|Overall Study|Randomized Not Enrolled|0|||
129181946|NCT01806064|464962352|FG001|Overall Study|Randomized Not Enrolled|0|||
129181947|NCT01806064|464962353|FG002|Overall Study|Randomized Not Enrolled|0|||
129181948|NCT01806064|464962354|FG003|Overall Study|Randomized Not Enrolled|1|||
129181949|NCT01806064|464962355|FG004|Overall Study|Randomized Not Enrolled|2|||
129181950|NCT01282294|464962358|FG000|Overall Study|Lost to Follow-up|14|||
129181951|NCT01282294|464962358|FG000|Overall Study|Screening failure|1|||
129181952|NCT01282294|464962358|FG000|Overall Study|Adverse Event|1|||
129181953|NCT01282294|464962358|FG000|Overall Study|Patient non-compliance|2|||
129181954|NCT01282294|464962358|FG000|Overall Study|Physician Decision|1|||
129181955|NCT04692077|464962360|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
129181956|NCT02753127|464962370|FG000|Overall Study|Lost to Follow-up|13|||
129181957|NCT02753127|464962371|FG001|Overall Study|Lost to Follow-up|11|||
129181958|NCT02753127|464962370|FG000|Overall Study|Withdrawal by Subject|37|||
129181959|NCT02753127|464962371|FG001|Overall Study|Withdrawal by Subject|47|||
129181960|NCT02753127|464962370|FG000|Overall Study|Other|3|||
129181961|NCT02753127|464962371|FG001|Overall Study|Other|8|||
129181962|NCT02753127|464962370|FG000|Overall Study|Hospice|0|||
129181963|NCT02753127|464962371|FG001|Overall Study|Hospice|2|||
129181964|NCT03826342|464962372|FG000|Overall Study|Withdrawal by Subject|8|||
129181965|NCT03826342|464962373|FG001|Overall Study|Withdrawal by Subject|1|||
129181966|NCT03826342|464962372|FG000|Overall Study|Lost to Follow-up|7|||
129181967|NCT03826342|464962373|FG001|Overall Study|Lost to Follow-up|7|||
129181968|NCT03826342|464962372|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
129181969|NCT03826342|464962373|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
129181970|NCT02046070|464962380|FG000|Overall Study|Progressive Disease|18|||
129181971|NCT02046070|464962381|FG001|Overall Study|Progressive Disease|11|||
129181972|NCT02046070|464962382|FG002|Overall Study|Progressive Disease|40|||
129181973|NCT02046070|464962380|FG000|Overall Study|Adverse Event|8|||
129181974|NCT02046070|464962381|FG001|Overall Study|Adverse Event|10|||
129181975|NCT02046070|464962382|FG002|Overall Study|Adverse Event|17|||
129181976|NCT02046070|464962380|FG000|Overall Study|Withdrawal by Subject|1|||
129181977|NCT02046070|464962381|FG001|Overall Study|Withdrawal by Subject|2|||
129181978|NCT02046070|464962382|FG002|Overall Study|Withdrawal by Subject|6|||
129181979|NCT02046070|464962380|FG000|Overall Study|Study Terminated by Sponsor|1|||
129181980|NCT02046070|464962381|FG001|Overall Study|Study Terminated by Sponsor|1|||
129181981|NCT02046070|464962382|FG002|Overall Study|Study Terminated by Sponsor|1|||
129181982|NCT02046070|464962380|FG000|Overall Study|Reason not Specified|4|||
129181983|NCT02046070|464962381|FG001|Overall Study|Reason not Specified|4|||
129181984|NCT02046070|464962382|FG002|Overall Study|Reason not Specified|6|||
129181985|NCT04619004|464962383|FG000|Overall Study|Death|114|||
129181986|NCT04619004|464962384|FG001|Overall Study|Death|28|||
129181987|NCT04619004|464962383|FG000|Overall Study|Lost to Follow-up|1|||
129181988|NCT04619004|464962384|FG001|Overall Study|Lost to Follow-up|1|||
129181989|NCT04619004|464962383|FG000|Overall Study|Withdrawal by Subject|24|||
129181990|NCT04619004|464962384|FG001|Overall Study|Withdrawal by Subject|7|||
129181991|NCT04619004|464962383|FG000|Overall Study|Other - Not specified|0|||
129181992|NCT04619004|464962384|FG001|Overall Study|Other - Not specified|1|||
129181993|NCT04030962|464962385|FG000|Stage 2|Adverse Event|0|||
129181994|NCT04030962|464962386|FG001|Stage 2|Adverse Event|0|||
129181995|NCT04030962|464962387|FG002|Stage 2|Adverse Event|0|||
129181996|NCT04030962|464962388|FG003|Stage 2|Adverse Event|0|||
129181997|NCT04030962|464962389|FG004|Stage 2|Adverse Event|0|||
129181998|NCT04030962|464962390|FG005|Stage 2|Adverse Event|0|||
129181999|NCT04030962|464962391|FG006|Stage 2|Adverse Event|0|||
129182000|NCT04030962|464962392|FG007|Stage 2|Adverse Event|0|||
129182001|NCT04030962|464962393|FG008|Stage 2|Adverse Event|1|||
129182002|NCT04030962|464962394|FG009|Stage 2|Adverse Event|0|||
129182003|NCT04030962|464962395|FG010|Stage 2|Adverse Event|1|||
129182004|NCT04030962|464962396|FG011|Stage 2|Adverse Event|1|||
129182005|NCT04030962|464962397|FG012|Stage 2|Adverse Event|1|||
129182006|NCT04030962|464962385|FG000|Stage 2|Withdrawal by Subject|0|||
129182007|NCT04030962|464962386|FG001|Stage 2|Withdrawal by Subject|0|||
129182008|NCT04030962|464962387|FG002|Stage 2|Withdrawal by Subject|0|||
129182009|NCT04030962|464962388|FG003|Stage 2|Withdrawal by Subject|0|||
129182010|NCT04030962|464962389|FG004|Stage 2|Withdrawal by Subject|0|||
129182011|NCT04030962|464962390|FG005|Stage 2|Withdrawal by Subject|0|||
129182012|NCT04030962|464962391|FG006|Stage 2|Withdrawal by Subject|0|||
129182013|NCT04030962|464962392|FG007|Stage 2|Withdrawal by Subject|0|||
129182014|NCT04030962|464962393|FG008|Stage 2|Withdrawal by Subject|1|||
129182015|NCT04030962|464962394|FG009|Stage 2|Withdrawal by Subject|0|||
129182016|NCT04030962|464962395|FG010|Stage 2|Withdrawal by Subject|0|||
129182017|NCT04030962|464962396|FG011|Stage 2|Withdrawal by Subject|2|||
129182018|NCT04030962|464962397|FG012|Stage 2|Withdrawal by Subject|1|||
129182019|NCT04030962|464962385|FG000|Stage 2|Lost to Follow-up|0|||
129182020|NCT04030962|464962386|FG001|Stage 2|Lost to Follow-up|0|||
129182021|NCT04030962|464962387|FG002|Stage 2|Lost to Follow-up|0|||
128730203|NCT00689481|463308357|FG000|Overall Study|Adverse Event|7|||
128730204|NCT00689481|463308358|FG001|Overall Study|Adverse Event|1|||
128730205|NCT00689481|463308357|FG000|Overall Study|Lost to Follow-up|4|||
129182022|NCT04030962|464962388|FG003|Stage 2|Lost to Follow-up|0|||
129182023|NCT04030962|464962389|FG004|Stage 2|Lost to Follow-up|0|||
129182024|NCT04030962|464962390|FG005|Stage 2|Lost to Follow-up|0|||
129182025|NCT04030962|464962391|FG006|Stage 2|Lost to Follow-up|0|||
129182026|NCT04030962|464962392|FG007|Stage 2|Lost to Follow-up|0|||
129182027|NCT04030962|464962393|FG008|Stage 2|Lost to Follow-up|1|||
129182028|NCT04030962|464962394|FG009|Stage 2|Lost to Follow-up|0|||
128730206|NCT00689481|463308358|FG001|Overall Study|Lost to Follow-up|3|||
128730207|NCT00689481|463308357|FG000|Overall Study|Lack of Efficacy|4|||
128730208|NCT00689481|463308358|FG001|Overall Study|Lack of Efficacy|3|||
129182029|NCT04030962|464962395|FG010|Stage 2|Lost to Follow-up|0|||
129182030|NCT04030962|464962396|FG011|Stage 2|Lost to Follow-up|0|||
129182031|NCT04030962|464962397|FG012|Stage 2|Lost to Follow-up|0|||
129182032|NCT04030962|464962385|FG000|Stage 2|Technical Problems|0|||
129182033|NCT04030962|464962386|FG001|Stage 2|Technical Problems|0|||
129182034|NCT04030962|464962387|FG002|Stage 2|Technical Problems|0|||
129182035|NCT04030962|464962388|FG003|Stage 2|Technical Problems|0|||
129182036|NCT04030962|464962389|FG004|Stage 2|Technical Problems|0|||
129182037|NCT04030962|464962390|FG005|Stage 2|Technical Problems|0|||
128730209|NCT00689481|463308357|FG000|Overall Study|Non-compliance with study treatment|1|||
128730210|NCT00689481|463308358|FG001|Overall Study|Non-compliance with study treatment|1|||
129182038|NCT04030962|464962391|FG006|Stage 2|Technical Problems|0|||
129182039|NCT04030962|464962392|FG007|Stage 2|Technical Problems|0|||
129182040|NCT04030962|464962393|FG008|Stage 2|Technical Problems|0|||
129182041|NCT04030962|464962394|FG009|Stage 2|Technical Problems|0|||
129182042|NCT04030962|464962395|FG010|Stage 2|Technical Problems|0|||
129182043|NCT04030962|464962396|FG011|Stage 2|Technical Problems|1|||
129182044|NCT04030962|464962397|FG012|Stage 2|Technical Problems|0|||
129182045|NCT05601102|464962400|FG000|Overall Study|Death|1|||
129182046|NCT05601102|464962401|FG001|Overall Study|Death|2|||
129182047|NCT05601102|464962400|FG000|Overall Study|Withdrawal by Subject|1|||
129182048|NCT05601102|464962401|FG001|Overall Study|Withdrawal by Subject|1|||
129182049|NCT05601102|464962400|FG000|Overall Study|Lost to Follow-up|0|||
129182050|NCT05601102|464962401|FG001|Overall Study|Lost to Follow-up|2|||
129182051|NCT05288166|464962402|FG000|Overall Study|Adverse Event|1|||
129182052|NCT05288166|464962403|FG001|Overall Study|Adverse Event|0|||
129182053|NCT05288166|464962402|FG000|Overall Study|Lost to Follow-up|2|||
129182054|NCT05288166|464962403|FG001|Overall Study|Lost to Follow-up|0|||
129182055|NCT05288166|464962402|FG000|Overall Study|Physician Decision|0|||
129182056|NCT05288166|464962403|FG001|Overall Study|Physician Decision|2|||
129182057|NCT05288166|464962402|FG000|Overall Study|Screen Failure|1|||
129182058|NCT05288166|464962403|FG001|Overall Study|Screen Failure|1|||
129182059|NCT05288166|464962402|FG000|Overall Study|Withdrawal by Subject|4|||
129182060|NCT05288166|464962403|FG001|Overall Study|Withdrawal by Subject|2|||
129182061|NCT05288166|464962402|FG000|Overall Study|On Study Treatment|408|||
129182062|NCT05288166|464962403|FG001|Overall Study|On Study Treatment|418|||
129182063|NCT02981524|464962405|FG000|Overall Study|Progressive Disease|14|||
129182064|NCT02981524|464962405|FG000|Overall Study|Death (unrelated)|1|||
129182065|NCT02981524|464962405|FG000|Overall Study|Treatment Related Toxicity|1|||
129182066|NCT02981524|464962405|FG000|Overall Study|Withdrawal by Subject|1|||
129182067|NCT00895661|464962409|FG000|Overall Study|Death|1|||
129182068|NCT00895661|464962409|FG000|Overall Study|reason unknown|2|||
129182069|NCT04094584|464962410|FG000|Overall Study|No interest in study|88|||
129182070|NCT04094584|464962410|FG000|Overall Study|Unwilling to undergo screening tests|36|||
129182071|NCT04094584|464962410|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
129182072|NCT04094584|464962410|FG000|Overall Study|Opioid use|7|||
129182073|NCT04094584|464962410|FG000|Overall Study|Need for major surgery in study period|4|||
129182074|NCT04094584|464962410|FG000|Overall Study|eligible but declined enrollment|4|||
129182075|NCT04094584|464962410|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
129182076|NCT04094584|464962410|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
129182077|NCT04094584|464962410|FG000|Overall Study|Lost to Follow-up|3|||
129182078|NCT04094584|464962410|FG000|Overall Study|Withdrawal by Subject|2|||
129182079|NCT00791557|464962411|FG000|Overall Study|Adverse Event|1|||
129182080|NCT03344640|464962412|FG000|Overall Study|Adverse Event|1|||
129182081|NCT03344640|464962413|FG001|Overall Study|Adverse Event|0|||
129182082|NCT03344640|464962412|FG000|Overall Study|Physician Decision|1|||
129182083|NCT03344640|464962413|FG001|Overall Study|Physician Decision|1|||
129182084|NCT03344640|464962412|FG000|Overall Study|Withdrawal by Subject|1|||
129182085|NCT03344640|464962413|FG001|Overall Study|Withdrawal by Subject|2|||
129182086|NCT03344640|464962412|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
129182087|NCT03344640|464962413|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
129182088|NCT01902888|464962414|FG000|Overall Study|Study Terminated|3|||
129182089|NCT00582738|464962415|FG000|Overall Study|Administrative Problems|7|||
129182090|NCT00582738|464962416|FG001|Overall Study|Administrative Problems|8|||
129182091|NCT00582738|464962415|FG000|Overall Study|Adverse Event|0|||
129182092|NCT00582738|464962416|FG001|Overall Study|Adverse Event|5|||
129182093|NCT00582738|464962415|FG000|Overall Study|Graft Lost|0|||
129182094|NCT00582738|464962416|FG001|Overall Study|Graft Lost|1|||
129182095|NCT00582738|464962415|FG000|Overall Study|Other|1|||
129182096|NCT00582738|464962416|FG001|Overall Study|Other|0|||
129182097|NCT00582738|464962415|FG000|Overall Study|Protocol Violation|1|||
129182098|NCT00582738|464962416|FG001|Overall Study|Protocol Violation|1|||
129182099|NCT00582738|464962415|FG000|Overall Study|Withdrawal by Subject|0|||
129182100|NCT00582738|464962416|FG001|Overall Study|Withdrawal by Subject|3|||
129182101|NCT00652899|464962417|FG000|Overall Study|Death|1|||
129182102|NCT00652899|464962417|FG000|Overall Study|Treating physician decision|1|||
129182103|NCT04135859|464962419|FG000|Overall Study|Withdrawal by Subject|1|||
129182104|NCT04135859|464962420|FG001|Overall Study|Withdrawal by Subject|0|||
129182105|NCT04135859|464962419|FG000|Overall Study|Withdrawal due to screening failure|1|||
129182106|NCT04135859|464962420|FG001|Overall Study|Withdrawal due to screening failure|2|||
129182107|NCT04135859|464962419|FG000|Overall Study|Did not complete stress test|3|||
129182108|NCT04135859|464962420|FG001|Overall Study|Did not complete stress test|3|||
129182109|NCT04135859|464962419|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
129182110|NCT04135859|464962420|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
129182111|NCT00551291|464962421|FG000|Overall Study|Physician Decision|1|||
129182112|NCT01943552|464962422|FG000|Overall Study|Adverse Event|3|||
129182113|NCT01943552|464962423|FG001|Overall Study|Adverse Event|2|||
129182114|NCT01943552|464962422|FG000|Overall Study|Withdrawal by Subject|6|||
129182115|NCT01943552|464962423|FG001|Overall Study|Withdrawal by Subject|6|||
129182116|NCT01943552|464962422|FG000|Overall Study|Other Reasons|16|||
129182117|NCT01943552|464962423|FG001|Overall Study|Other Reasons|17|||
129182118|NCT01600053|464962424|FG000|Overall Study|Adverse Event|2|||
129182119|NCT01600053|464962424|FG000|Overall Study|trial will not meet the interim endpoint|9|||
129182120|NCT04047420|464962425|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
129182121|NCT04047420|464962425|FG000|Washout Period|Refused Participation|2|||
129182122|NCT02636946|464962427|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
129182123|NCT02636946|464962428|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
129182124|NCT02636946|464962427|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
129182125|NCT02636946|464962428|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
129182126|NCT02636946|464962427|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
129182127|NCT02636946|464962428|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
129182128|NCT02636946|464962427|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
129182129|NCT02636946|464962428|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
129182130|NCT02636946|464962427|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
129182131|NCT02636946|464962428|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
129182132|NCT02636946|464962427|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
129182133|NCT02636946|464962428|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
129182134|NCT00477269|464962429|FG000|Core Study|Adverse Event|6|||
129182135|NCT00477269|464962430|FG001|Core Study|Adverse Event|4|||
129182136|NCT00477269|464962431|FG002|Core Study|Adverse Event|0|||
129182137|NCT00477269|464962429|FG000|Core Study|Death|3|||
129182138|NCT00477269|464962430|FG001|Core Study|Death|3|||
129182139|NCT00477269|464962431|FG002|Core Study|Death|0|||
129182140|NCT00477269|464962429|FG000|Core Study|Withdrawn Consent|0|||
129182141|NCT00477269|464962430|FG001|Core Study|Withdrawn Consent|1|||
129182142|NCT00477269|464962431|FG002|Core Study|Withdrawn Consent|0|||
129182143|NCT00477269|464962429|FG000|Open Label Extension|Adverse Event|0|||
129182144|NCT00477269|464962430|FG001|Open Label Extension|Adverse Event|0|||
129182145|NCT00477269|464962431|FG002|Open Label Extension|Adverse Event|4|||
129182146|NCT00477269|464962429|FG000|Open Label Extension|Abnormal laboratory values|0|||
129182147|NCT00477269|464962430|FG001|Open Label Extension|Abnormal laboratory values|0|||
129182148|NCT00477269|464962431|FG002|Open Label Extension|Abnormal laboratory values|1|||
129182149|NCT00477269|464962429|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
129182150|NCT00477269|464962430|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
129182151|NCT00477269|464962431|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
129182152|NCT00477269|464962429|FG000|Open Label Extension|Adminiatrative problems|0|||
129182153|NCT00477269|464962430|FG001|Open Label Extension|Adminiatrative problems|0|||
129182154|NCT00477269|464962431|FG002|Open Label Extension|Adminiatrative problems|2|||
129182155|NCT00477269|464962429|FG000|Open Label Extension|Death|0|||
129182156|NCT00477269|464962430|FG001|Open Label Extension|Death|0|||
129182157|NCT00477269|464962431|FG002|Open Label Extension|Death|4|||
129182158|NCT01792518|464962434|FG000|Overall Study|Adverse Event|3|||
129182159|NCT01792518|464962435|FG001|Overall Study|Adverse Event|4|||
129182160|NCT01792518|464962434|FG000|Overall Study|Protocol Violation|0|||
129182161|NCT01792518|464962435|FG001|Overall Study|Protocol Violation|1|||
129182162|NCT01792518|464962434|FG000|Overall Study|Lost to Follow-up|3|||
129182163|NCT01792518|464962435|FG001|Overall Study|Lost to Follow-up|1|||
129182164|NCT01792518|464962434|FG000|Overall Study|Withdrawal by Subject|2|||
129182165|NCT01792518|464962435|FG001|Overall Study|Withdrawal by Subject|0|||
129182166|NCT01792518|464962434|FG000|Overall Study|Other Reason|0|||
129182167|NCT01792518|464962435|FG001|Overall Study|Other Reason|1|||
129182168|NCT01977690|464962464|FG000|Overall Study|Withdrawal by Subject|0|||
129182169|NCT01977690|464962465|FG001|Overall Study|Withdrawal by Subject|4|||
129182170|NCT00447122|464962466|FG000|Overall Study|worsening medical condition -came off|0|||
129182171|NCT00447122|464962467|FG001|Overall Study|worsening medical condition -came off|1|||
129182172|NCT00447122|464962468|FG002|Overall Study|worsening medical condition -came off|0|||
129182173|NCT00447122|464962469|FG003|Overall Study|worsening medical condition -came off|0|||
129182174|NCT01174173|464962472|FG000|Overall Study|drug-drug interaction|1|||
129182175|NCT02769962|464963708|FG000|Overall Study|Physician Decision|0|||
129182176|NCT02769962|464963709|FG001|Overall Study|Physician Decision|0|||
129182177|NCT02769962|464963710|FG002|Overall Study|Physician Decision|0|||
129182178|NCT02769962|464963711|FG003|Overall Study|Physician Decision|0|||
129182179|NCT02769962|464963712|FG004|Overall Study|Physician Decision|0|||
129182180|NCT02769962|464963713|FG005|Overall Study|Physician Decision|1|||
129182181|NCT02769962|464963714|FG006|Overall Study|Physician Decision|0|||
129182182|NCT02769962|464963715|FG007|Overall Study|Physician Decision|1|||
129182183|NCT02769962|464963708|FG000|Overall Study|Refused further treatment|0|||
129182184|NCT02769962|464963709|FG001|Overall Study|Refused further treatment|0|||
129182185|NCT02769962|464963710|FG002|Overall Study|Refused further treatment|0|||
129182186|NCT02769962|464963711|FG003|Overall Study|Refused further treatment|0|||
129182187|NCT02769962|464963712|FG004|Overall Study|Refused further treatment|0|||
129182188|NCT02769962|464963713|FG005|Overall Study|Refused further treatment|1|||
129182189|NCT02769962|464963714|FG006|Overall Study|Refused further treatment|1|||
129182190|NCT02769962|464963715|FG007|Overall Study|Refused further treatment|0|||
129182191|NCT01266590|464963716|FG000|Overall Study|Adverse Event|3|||
129182192|NCT01266590|464963716|FG000|Overall Study|Lost to Follow-up|1|||
129182193|NCT01266590|464963716|FG000|Overall Study|Withdrawal by Subject|1|||
129182194|NCT01266590|464963716|FG000|Overall Study|Physician Decision|1|||
129182195|NCT00720343|464963719|FG000|Overall Study|Lost to Follow-up|1|||
129182196|NCT00720343|464963720|FG001|Overall Study|Lost to Follow-up|0|||
129182197|NCT00720343|464963719|FG000|Overall Study|Protocol Violation|0|||
129182198|NCT00720343|464963720|FG001|Overall Study|Protocol Violation|2|||
129182199|NCT02008773|464963721|FG000|Overall Study|Adverse Event|3|||
129182200|NCT02008773|464963722|FG001|Overall Study|Adverse Event|3|||
129182201|NCT02008773|464963723|FG002|Overall Study|Adverse Event|1|||
129182202|NCT02008773|464963724|FG003|Overall Study|Adverse Event|2|||
129182203|NCT02008773|464963721|FG000|Overall Study|Medication Non-compliance|2|||
129182204|NCT02008773|464963722|FG001|Overall Study|Medication Non-compliance|1|||
129182205|NCT02008773|464963723|FG002|Overall Study|Medication Non-compliance|3|||
129182206|NCT02008773|464963724|FG003|Overall Study|Medication Non-compliance|2|||
129182207|NCT02008773|464963721|FG000|Overall Study|Withdrawal by Subject|8|||
129182208|NCT02008773|464963722|FG001|Overall Study|Withdrawal by Subject|4|||
129182209|NCT02008773|464963723|FG002|Overall Study|Withdrawal by Subject|7|||
129182210|NCT02008773|464963724|FG003|Overall Study|Withdrawal by Subject|6|||
129182211|NCT02008773|464963721|FG000|Overall Study|Lost to Follow-up|0|||
129182212|NCT02008773|464963722|FG001|Overall Study|Lost to Follow-up|1|||
129182213|NCT02008773|464963723|FG002|Overall Study|Lost to Follow-up|3|||
129182214|NCT02008773|464963724|FG003|Overall Study|Lost to Follow-up|2|||
129182215|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
129182216|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
129182217|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
129182218|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
129182219|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
129182220|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
129182221|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
129182222|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
129182223|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
129182224|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
129182225|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
129182226|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
129182227|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
129182228|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
129182229|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
129182230|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
129182231|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
129182232|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
129182233|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
129182234|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
129182235|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
129182236|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
129182237|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
129182238|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
129182239|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
129182240|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
129182241|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
129182242|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
129182243|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
129182244|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
129182245|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
129182246|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
129182247|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
129182248|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
129182249|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
129182250|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
129182251|NCT02198794|464963725|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
129182252|NCT02198794|464963726|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
129182253|NCT02198794|464963727|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
129182254|NCT02198794|464963728|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
129182255|NCT02198794|464963725|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
129182256|NCT02198794|464963726|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
129182257|NCT02198794|464963727|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
129182258|NCT02198794|464963728|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
129182259|NCT02198794|464963725|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
129182260|NCT02198794|464963726|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
129182261|NCT02198794|464963727|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
129182262|NCT02198794|464963728|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
129182263|NCT02198794|464963725|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
129182264|NCT02198794|464963726|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
129182265|NCT02198794|464963727|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
129182266|NCT02198794|464963728|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
129182267|NCT02198794|464963725|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
129182268|NCT02198794|464963726|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
129182269|NCT02198794|464963727|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
129182270|NCT02198794|464963728|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
129182271|NCT02198794|464963725|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
129182272|NCT02198794|464963726|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
129182273|NCT02198794|464963727|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
129182274|NCT02198794|464963728|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
129182275|NCT01918332|464963729|FG000|Overall Study|Adverse Event|0|||
129182276|NCT01918332|464963730|FG001|Overall Study|Adverse Event|0|||
129182277|NCT01918332|464963731|FG002|Overall Study|Adverse Event|0|||
129182278|NCT01918332|464963732|FG003|Overall Study|Adverse Event|1|||
129182279|NCT01918332|464963729|FG000|Overall Study|Withdrawal by Subject|2|||
129182280|NCT01918332|464963730|FG001|Overall Study|Withdrawal by Subject|3|||
129182281|NCT01918332|464963731|FG002|Overall Study|Withdrawal by Subject|2|||
129182282|NCT01918332|464963732|FG003|Overall Study|Withdrawal by Subject|3|||
129182283|NCT01918332|464963729|FG000|Overall Study|Protocol Violation|6|||
129182284|NCT01918332|464963730|FG001|Overall Study|Protocol Violation|2|||
129182285|NCT01918332|464963731|FG002|Overall Study|Protocol Violation|6|||
129182286|NCT01918332|464963732|FG003|Overall Study|Protocol Violation|3|||
129182287|NCT01918332|464963729|FG000|Overall Study|lipid result by central lab did not meet|0|||
129182288|NCT01918332|464963730|FG001|Overall Study|lipid result by central lab did not meet|0|||
129182289|NCT01918332|464963731|FG002|Overall Study|lipid result by central lab did not meet|1|||
129182290|NCT01918332|464963732|FG003|Overall Study|lipid result by central lab did not meet|0|||
129182291|NCT02408523|464963733|FG000|Overall Study|Adverse Event|4|||
129182292|NCT02408523|464963734|FG001|Overall Study|Adverse Event|10|||
129182293|NCT02408523|464963733|FG000|Overall Study|Lack of Efficacy|0|||
129182294|NCT02408523|464963734|FG001|Overall Study|Lack of Efficacy|1|||
129182295|NCT02408523|464963733|FG000|Overall Study|Protocol Violation|1|||
129182296|NCT02408523|464963734|FG001|Overall Study|Protocol Violation|2|||
129182297|NCT02408523|464963733|FG000|Overall Study|Lost to Follow-up|2|||
129182298|NCT02408523|464963734|FG001|Overall Study|Lost to Follow-up|3|||
129182299|NCT02408523|464963733|FG000|Overall Study|Withdrawal by Subject|3|||
129182300|NCT02408523|464963734|FG001|Overall Study|Withdrawal by Subject|1|||
129182301|NCT02408523|464963733|FG000|Overall Study|Sponsor request|1|||
129182302|NCT02408523|464963734|FG001|Overall Study|Sponsor request|0|||
129182303|NCT02408523|464963733|FG000|Overall Study|Did not satisfy extension conditions|0|||
129182304|NCT02408523|464963734|FG001|Overall Study|Did not satisfy extension conditions|1|||
129182305|NCT00701805|464963735|FG000|Overall Study|Withdrawal by Subject|3|||
129182306|NCT00701805|464963736|FG001|Overall Study|Withdrawal by Subject|1|||
129182307|NCT00701805|464963737|FG002|Overall Study|Withdrawal by Subject|4|||
129182308|NCT00701805|464963738|FG003|Overall Study|Withdrawal by Subject|3|||
129182309|NCT00701805|464963735|FG000|Overall Study|Adverse Event|0|||
129182310|NCT00701805|464963736|FG001|Overall Study|Adverse Event|1|||
129182311|NCT00701805|464963737|FG002|Overall Study|Adverse Event|1|||
129182312|NCT00701805|464963738|FG003|Overall Study|Adverse Event|0|||
129182313|NCT00701805|464963735|FG000|Overall Study|Missed 7 consecutive doses|0|||
129182314|NCT00701805|464963736|FG001|Overall Study|Missed 7 consecutive doses|1|||
129182315|NCT00701805|464963737|FG002|Overall Study|Missed 7 consecutive doses|0|||
129182316|NCT00701805|464963738|FG003|Overall Study|Missed 7 consecutive doses|0|||
129182317|NCT00701805|464963735|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
129182318|NCT00701805|464963736|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
129182319|NCT00701805|464963737|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
129182320|NCT00701805|464963738|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
129182321|NCT00701805|464963735|FG000|Overall Study|Physician decision, change of therapy|0|||
129182322|NCT00701805|464963736|FG001|Overall Study|Physician decision, change of therapy|0|||
129182323|NCT00701805|464963737|FG002|Overall Study|Physician decision, change of therapy|0|||
129182324|NCT00701805|464963738|FG003|Overall Study|Physician decision, change of therapy|1|||
129182325|NCT00701805|464963735|FG000|Overall Study|Difficult to travel to dialysis site|0|||
129182326|NCT00701805|464963736|FG001|Overall Study|Difficult to travel to dialysis site|0|||
129182327|NCT00701805|464963737|FG002|Overall Study|Difficult to travel to dialysis site|1|||
129182328|NCT00701805|464963738|FG003|Overall Study|Difficult to travel to dialysis site|0|||
129182329|NCT00701805|464963735|FG000|Overall Study|Resumption criteria were not met|0|||
129182330|NCT00701805|464963736|FG001|Overall Study|Resumption criteria were not met|1|||
129182331|NCT00701805|464963737|FG002|Overall Study|Resumption criteria were not met|0|||
129182332|NCT00701805|464963738|FG003|Overall Study|Resumption criteria were not met|0|||
129182333|NCT02252965|464963740|FG000|Overall Study|Adverse Event|9|||
129182334|NCT02252965|464963741|FG001|Overall Study|Adverse Event|14|||
129182335|NCT02252965|464963740|FG000|Overall Study|Lost to Follow-up|16|||
129182336|NCT02252965|464963741|FG001|Overall Study|Lost to Follow-up|8|||
129182337|NCT02252965|464963740|FG000|Overall Study|Protocol Violation|4|||
129182338|NCT02252965|464963741|FG001|Overall Study|Protocol Violation|5|||
129182339|NCT02252965|464963740|FG000|Overall Study|Lack of Efficacy|0|||
129182340|NCT02252965|464963741|FG001|Overall Study|Lack of Efficacy|2|||
129182341|NCT02252965|464963740|FG000|Overall Study|Withdrawal by Subject|7|||
129182342|NCT02252965|464963741|FG001|Overall Study|Withdrawal by Subject|9|||
129182343|NCT02252965|464963740|FG000|Overall Study|Other|4|||
129182344|NCT02252965|464963741|FG001|Overall Study|Other|5|||
129182345|NCT02797184|464963747|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
129182346|NCT02797184|464963748|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
129182347|NCT05149313|464963749|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
129182348|NCT05149313|464963750|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
129182349|NCT05149313|464963751|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
129182350|NCT05149313|464963752|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
129182351|NCT05149313|464963749|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
129182352|NCT05149313|464963750|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
129182353|NCT05149313|464963751|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
129182354|NCT05149313|464963752|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
129182355|NCT05149313|464963749|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
129182356|NCT05149313|464963750|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
128730211|NCT00689481|463308357|FG000|Overall Study|Withdrawal by Subject|8|||
128730212|NCT00689481|463308358|FG001|Overall Study|Withdrawal by Subject|4|||
128780953|NCT01323660|463488630|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
129182357|NCT05149313|464963751|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
129182358|NCT05149313|464963752|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
129182359|NCT05149313|464963749|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
129182360|NCT05149313|464963750|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
129182361|NCT05149313|464963751|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
129182362|NCT05149313|464963752|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
129182363|NCT05149313|464963749|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
129182364|NCT05149313|464963750|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
129182365|NCT05149313|464963751|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
129182366|NCT05149313|464963752|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
129182367|NCT05149313|464963749|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
129182368|NCT05149313|464963750|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
129182369|NCT05149313|464963751|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
129182370|NCT05149313|464963752|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
129182371|NCT05149313|464963749|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
129182372|NCT05149313|464963750|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
129182373|NCT05149313|464963751|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
129182374|NCT05149313|464963752|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
129182375|NCT05149313|464963749|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129182376|NCT05149313|464963750|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129182377|NCT05149313|464963751|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
129182378|NCT05149313|464963752|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
129182379|NCT05149313|464963749|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129182380|NCT05149313|464963750|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129182381|NCT05149313|464963751|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
129182382|NCT05149313|464963752|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
129182383|NCT05149313|464963749|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129182384|NCT05149313|464963750|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129182385|NCT05149313|464963751|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
129182386|NCT05149313|464963752|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129182387|NCT05149313|464963749|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
129182388|NCT05149313|464963750|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
129182389|NCT05149313|464963751|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
129182390|NCT05149313|464963752|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
129182391|NCT03199391|464963757|FG000|Overall Study|Death|1|||
129182392|NCT03199391|464963757|FG000|Overall Study|Lost to Follow-up|3|||
129182393|NCT03199391|464963757|FG000|Overall Study|Adverse Event|2|||
129182394|NCT03199391|464963757|FG000|Overall Study|Withdrawal by Subject|10|||
129182395|NCT01867086|464963758|FG000|Overall Study|Disease Progression|1|||
129182396|NCT00483041|464963760|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
129182397|NCT00483041|464963761|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
129182398|NCT02258529|464963763|FG000|Overall Study|Study Terminated by Sponsor|9|||
129182399|NCT02258529|464963763|FG000|Overall Study|Adverse Event|1|||
129182400|NCT00443781|464963764|FG000|Overall Study|Lost to Follow-up|10|||
129182401|NCT00443781|464963764|FG000|Overall Study|Physician Decision|2|||
129182402|NCT00443781|464963764|FG000|Overall Study|Protocol Violation|1|||
129182403|NCT00443781|464963764|FG000|Overall Study|Withdrawal by Subject|6|||
129182404|NCT00443781|464963764|FG000|Overall Study|Unable to comply with study follow up|2|||
129182405|NCT00443781|464963764|FG000|Overall Study|Investigator terminated participation|1|||
129182406|NCT00443781|464963764|FG000|Overall Study|Insurance not covered|2|||
129182407|NCT00443781|464963764|FG000|Overall Study|PD/FAD not done|1|||
129182408|NCT02066415|464963765|FG000|Overall Study|Decision by Sponsor|5|||
129182409|NCT02066415|464963766|FG001|Overall Study|Decision by Sponsor|4|||
129182410|NCT02066415|464963767|FG002|Overall Study|Decision by Sponsor|2|||
129182411|NCT02066415|464963765|FG000|Overall Study|Withdrawal by Subject|9|||
129182412|NCT02066415|464963766|FG001|Overall Study|Withdrawal by Subject|1|||
129182413|NCT02066415|464963767|FG002|Overall Study|Withdrawal by Subject|4|||
129182414|NCT02066415|464963765|FG000|Overall Study|Lost to Follow-up|7|||
129182415|NCT02066415|464963766|FG001|Overall Study|Lost to Follow-up|2|||
129182416|NCT02066415|464963767|FG002|Overall Study|Lost to Follow-up|2|||
129182417|NCT05432167|464963771|FG000|Overall Study|Adverse Event|0|||
129182418|NCT05432167|464963772|FG001|Overall Study|Adverse Event|2|||
129182419|NCT05432167|464963773|FG002|Overall Study|Adverse Event|1|||
129182420|NCT05432167|464963771|FG000|Overall Study|Lost to Follow-up|3|||
129182421|NCT05432167|464963772|FG001|Overall Study|Lost to Follow-up|3|||
129182422|NCT05432167|464963773|FG002|Overall Study|Lost to Follow-up|2|||
129182423|NCT05432167|464963771|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
129182424|NCT05432167|464963772|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
129182425|NCT05432167|464963773|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
129182426|NCT05432167|464963771|FG000|Overall Study|Physician Decision|1|||
129182427|NCT05432167|464963772|FG001|Overall Study|Physician Decision|0|||
129182428|NCT05432167|464963773|FG002|Overall Study|Physician Decision|0|||
129182429|NCT05432167|464963771|FG000|Overall Study|Withdrawal by Subject|7|||
129182430|NCT05432167|464963772|FG001|Overall Study|Withdrawal by Subject|4|||
129182431|NCT05432167|464963773|FG002|Overall Study|Withdrawal by Subject|11|||
129182432|NCT05432167|464963771|FG000|Overall Study|Other|0|||
129182433|NCT05432167|464963772|FG001|Overall Study|Other|0|||
129182434|NCT05432167|464963773|FG002|Overall Study|Other|1|||
129182435|NCT02616393|464963781|FG000|Overall Study|Death|5|||
129182436|NCT02616393|464963782|FG001|Overall Study|Death|12|||
129182437|NCT02616393|464963783|FG002|Overall Study|Death|1|||
129182438|NCT02616393|464963781|FG000|Overall Study|Termination by Sponsor|4|||
129182439|NCT02616393|464963782|FG001|Overall Study|Termination by Sponsor|5|||
129182440|NCT02616393|464963783|FG002|Overall Study|Termination by Sponsor|2|||
129182441|NCT02616393|464963781|FG000|Overall Study|Other|3|||
129182442|NCT02616393|464963782|FG001|Overall Study|Other|0|||
129182443|NCT02616393|464963783|FG002|Overall Study|Other|0|||
129182444|NCT02616393|464963781|FG000|Overall Study|Withdrawal by Subject|1|||
129182445|NCT02616393|464963782|FG001|Overall Study|Withdrawal by Subject|1|||
129182446|NCT02616393|464963783|FG002|Overall Study|Withdrawal by Subject|0|||
129182447|NCT02616393|464963781|FG000|Overall Study|Lost to Follow-up|0|||
129182448|NCT02616393|464963782|FG001|Overall Study|Lost to Follow-up|2|||
129182449|NCT02616393|464963783|FG002|Overall Study|Lost to Follow-up|0|||
129182450|NCT02758301|464963785|FG000|Overall Study|Death|12|||
129182451|NCT02758301|464963786|FG001|Overall Study|Death|0|||
129182452|NCT02758301|464963785|FG000|Overall Study|Physician Decision|10|||
129182453|NCT02758301|464963786|FG001|Overall Study|Physician Decision|1|||
129182454|NCT02758301|464963785|FG000|Overall Study|Withdrawal by Subject|5|||
129182455|NCT02758301|464963786|FG001|Overall Study|Withdrawal by Subject|6|||
129182456|NCT02758301|464963785|FG000|Overall Study|Lost to Follow-up|7|||
129182457|NCT02758301|464963786|FG001|Overall Study|Lost to Follow-up|0|||
129182458|NCT02758301|464963785|FG000|Overall Study|Protocol Violation|0|||
129182459|NCT02758301|464963786|FG001|Overall Study|Protocol Violation|1|||
129182460|NCT00364533|464963787|FG000|Overall Study|Adverse Event|8|||
129182461|NCT00364533|464963788|FG001|Overall Study|Adverse Event|7|||
129182462|NCT00364533|464963789|FG002|Overall Study|Adverse Event|15|||
129182463|NCT00364533|464963790|FG003|Overall Study|Adverse Event|5|||
129182464|NCT00364533|464963791|FG004|Overall Study|Adverse Event|2|||
129182465|NCT00364533|464963787|FG000|Overall Study|Withdrawal by Subject|4|||
129182466|NCT00364533|464963788|FG001|Overall Study|Withdrawal by Subject|8|||
129182467|NCT00364533|464963789|FG002|Overall Study|Withdrawal by Subject|6|||
129182468|NCT00364533|464963790|FG003|Overall Study|Withdrawal by Subject|6|||
129182469|NCT00364533|464963791|FG004|Overall Study|Withdrawal by Subject|6|||
129182470|NCT00364533|464963787|FG000|Overall Study|Lack of Efficacy|22|||
129182471|NCT00364533|464963788|FG001|Overall Study|Lack of Efficacy|22|||
129182472|NCT00364533|464963789|FG002|Overall Study|Lack of Efficacy|21|||
128730213|NCT00689481|463308357|FG000|Overall Study|Excluded medication started during study|0|||
129182473|NCT00364533|464963790|FG003|Overall Study|Lack of Efficacy|17|||
129182474|NCT00364533|464963791|FG004|Overall Study|Lack of Efficacy|42|||
129182475|NCT00364533|464963787|FG000|Overall Study|Subject discharged from hospital|4|||
129182476|NCT00364533|464963788|FG001|Overall Study|Subject discharged from hospital|1|||
129182477|NCT00364533|464963789|FG002|Overall Study|Subject discharged from hospital|2|||
129182478|NCT00364533|464963790|FG003|Overall Study|Subject discharged from hospital|3|||
129182479|NCT00364533|464963791|FG004|Overall Study|Subject discharged from hospital|1|||
129182480|NCT00364533|464963787|FG000|Overall Study|Variations in drug compliance|2|||
129182481|NCT00364533|464963788|FG001|Overall Study|Variations in drug compliance|1|||
129182482|NCT00364533|464963789|FG002|Overall Study|Variations in drug compliance|1|||
129182483|NCT00364533|464963790|FG003|Overall Study|Variations in drug compliance|0|||
129182484|NCT00364533|464963791|FG004|Overall Study|Variations in drug compliance|0|||
129182485|NCT00364533|464963787|FG000|Overall Study|Non-compliance|1|||
129182486|NCT00364533|464963788|FG001|Overall Study|Non-compliance|0|||
129182487|NCT00364533|464963789|FG002|Overall Study|Non-compliance|0|||
129182488|NCT00364533|464963790|FG003|Overall Study|Non-compliance|0|||
129182489|NCT00364533|464963791|FG004|Overall Study|Non-compliance|0|||
129182490|NCT00364533|464963787|FG000|Overall Study|Protocol Violation|1|||
129182491|NCT00364533|464963788|FG001|Overall Study|Protocol Violation|1|||
129182492|NCT00364533|464963789|FG002|Overall Study|Protocol Violation|0|||
129182493|NCT00364533|464963790|FG003|Overall Study|Protocol Violation|0|||
129182494|NCT00364533|464963791|FG004|Overall Study|Protocol Violation|0|||
129182495|NCT02445573|464963792|FG000|Overall Study|Withdrawal by Subject|1|||
129182496|NCT02445573|464963793|FG001|Overall Study|Withdrawal by Subject|1|||
129182497|NCT02445573|464963792|FG000|Overall Study|Lost to Follow-up|0|||
129182498|NCT02445573|464963793|FG001|Overall Study|Lost to Follow-up|1|||
129182499|NCT02855944|464963794|FG000|Period 1: Treatment|Ongoing|14|||
129182500|NCT02855944|464963795|FG001|Period 1: Treatment|Ongoing|0|||
129182501|NCT02855944|464963794|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
129182502|NCT02855944|464963795|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
129182503|NCT02855944|464963794|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
129182504|NCT02855944|464963795|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
129182505|NCT03242018|464963804|FG000|Overall Study|Adverse Event|7|||
129182506|NCT03242018|464963805|FG001|Overall Study|Adverse Event|7|||
129182507|NCT03242018|464963806|FG002|Overall Study|Adverse Event|6|||
129182508|NCT03242018|464963804|FG000|Overall Study|Lost to Follow-up|2|||
129182509|NCT03242018|464963805|FG001|Overall Study|Lost to Follow-up|2|||
129182510|NCT03242018|464963806|FG002|Overall Study|Lost to Follow-up|2|||
129182511|NCT03242018|464963804|FG000|Overall Study|At the Participant's Own Request|5|||
129182512|NCT03242018|464963805|FG001|Overall Study|At the Participant's Own Request|1|||
129182513|NCT03242018|464963806|FG002|Overall Study|At the Participant's Own Request|4|||
129182514|NCT03242018|464963804|FG000|Overall Study|Reason Not Specified|3|||
129182515|NCT03242018|464963805|FG001|Overall Study|Reason Not Specified|4|||
129182516|NCT03242018|464963806|FG002|Overall Study|Reason Not Specified|1|||
129182517|NCT03242018|464963804|FG000|Overall Study|Study Terminated by Sponsor|1|||
129182518|NCT03242018|464963805|FG001|Overall Study|Study Terminated by Sponsor|0|||
129182519|NCT03242018|464963806|FG002|Overall Study|Study Terminated by Sponsor|1|||
129182520|NCT01283542|464963808|FG000|Main Phase|Acute or progressive vision loss|1|||
129182521|NCT01283542|464963808|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
129182522|NCT01283542|464963808|FG000|Main Phase|abnormal laboratory values|5|||
129182523|NCT01283542|464963808|FG000|Extension Phase|Physician Decision|1|||
129182524|NCT01283542|464963808|FG000|Extension Phase|Adverse Event|1|||
129182525|NCT01283542|464963808|FG000|Extension Phase|Administrative problems|1|||
129182526|NCT00257660|464963809|FG000|Overall Study|Lack of Efficacy|5|||
129182527|NCT00257660|464963810|FG001|Overall Study|Lack of Efficacy|23|||
129182528|NCT00257660|464963809|FG000|Overall Study|Withdrawal by Subject|2|||
129182529|NCT00257660|464963810|FG001|Overall Study|Withdrawal by Subject|0|||
129182530|NCT00257660|464963809|FG000|Overall Study|Lost to Follow-up|1|||
129182531|NCT00257660|464963810|FG001|Overall Study|Lost to Follow-up|0|||
129182532|NCT00257660|464963809|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
129182533|NCT00257660|464963810|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
129182534|NCT00257660|464963809|FG000|Overall Study|No longer wanted to do blood draws|1|||
129182535|NCT00257660|464963810|FG001|Overall Study|No longer wanted to do blood draws|0|||
129182536|NCT02449018|464963815|FG000|Overall Study|Abnormal laboratory value|0|||
129182537|NCT02449018|464963816|FG001|Overall Study|Abnormal laboratory value|1|||
129182538|NCT02449018|464963815|FG000|Overall Study|Administrative problems|1|||
129182539|NCT02449018|464963816|FG001|Overall Study|Administrative problems|0|||
129182540|NCT02449018|464963815|FG000|Overall Study|Adverse Event|5|||
129182541|NCT02449018|464963816|FG001|Overall Study|Adverse Event|1|||
129182542|NCT02449018|464963815|FG000|Overall Study|Protocol deviation|4|||
129182543|NCT02449018|464963816|FG001|Overall Study|Protocol deviation|0|||
129182544|NCT02449018|464963815|FG000|Overall Study|Patient decision|2|||
129182545|NCT02449018|464963816|FG001|Overall Study|Patient decision|0|||
129182546|NCT03995355|464963817|FG000|Overall Study|Adverse Event|1|||
129182547|NCT03995355|464963818|FG001|Overall Study|Adverse Event|0|||
129182548|NCT03995355|464963817|FG000|Overall Study|Withdrawal by Subject|1|||
129182549|NCT03995355|464963818|FG001|Overall Study|Withdrawal by Subject|0|||
129182550|NCT03995355|464963817|FG000|Overall Study|Scheduling Issues|0|||
129182551|NCT03995355|464963818|FG001|Overall Study|Scheduling Issues|1|||
129182552|NCT03426631|464963819|FG000|Overall Study|Lost to Follow-up|0|||
129182553|NCT03426631|464963820|FG001|Overall Study|Lost to Follow-up|1|||
129182554|NCT00654004|464963821|FG000|Overall Study|Lost to Follow-up|1|||
129182555|NCT00654004|464963822|FG001|Overall Study|Lost to Follow-up|0|||
129182556|NCT00351273|464963828|FG000|Overall Study|Lost to Follow-up|1|||
129182557|NCT00351273|464963829|FG001|Overall Study|Lost to Follow-up|2|||
129182558|NCT00351273|464963830|FG002|Overall Study|Lost to Follow-up|5|||
129182559|NCT03442296|464963836|FG000|3 Month Follow-up|Death|3|||
129182560|NCT03442296|464963837|FG001|3 Month Follow-up|Death|1|||
129182561|NCT03442296|464963836|FG000|3 Month Follow-up|Lost to Follow-up|1|||
129182562|NCT03442296|464963837|FG001|3 Month Follow-up|Lost to Follow-up|1|||
129182563|NCT03442296|464963836|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
129182564|NCT03442296|464963837|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
129182565|NCT03442296|464963836|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
129182566|NCT03442296|464963837|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
129182567|NCT03442296|464963836|FG000|12 Month Follow-up|Incomplete measurement|1|||
129182568|NCT03442296|464963837|FG001|12 Month Follow-up|Incomplete measurement|1|||
129182569|NCT03938324|464965233|FG000|Overall Study|Lost to Follow-up|42|||
129182570|NCT03938324|464965234|FG001|Overall Study|Lost to Follow-up|21|||
129182571|NCT03938324|464965233|FG000|Overall Study|Withdrawal by Subject|6|||
129182572|NCT03938324|464965234|FG001|Overall Study|Withdrawal by Subject|1|||
129182573|NCT00837759|464965235|FG000|Overall Study|Protocol Violation|3|||
129182574|NCT00837759|464965235|FG000|Overall Study|Lost to Follow-up|1|||
129182575|NCT02081599|464965236|FG000|Period 1：Double-blind Period|Adverse Event|3|||
129182576|NCT02081599|464965237|FG001|Period 1：Double-blind Period|Adverse Event|0|||
129182577|NCT02081599|464965236|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
129182578|NCT02081599|464965237|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
129182579|NCT02081599|464965236|FG000|Period 1：Double-blind Period|Physician Decision|1|||
129182580|NCT02081599|464965237|FG001|Period 1：Double-blind Period|Physician Decision|0|||
129182581|NCT02081599|464965236|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
129182582|NCT02081599|464965237|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
129182583|NCT02081599|464965236|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
129182584|NCT02081599|464965237|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
129182585|NCT02081599|464965236|FG000|Period 1：Double-blind Period|stopping criteria|1|||
129182586|NCT02081599|464965237|FG001|Period 1：Double-blind Period|stopping criteria|0|||
129182587|NCT02081599|464965236|FG000|Period 2：Open-label Period|Adverse Event|1|||
129182588|NCT02081599|464965237|FG001|Period 2：Open-label Period|Adverse Event|0|||
129182589|NCT02081599|464965236|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
129182590|NCT02081599|464965237|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
129182591|NCT02081599|464965236|FG000|Period 2：Open-label Period|Physician Decision|1|||
129182592|NCT02081599|464965237|FG001|Period 2：Open-label Period|Physician Decision|0|||
129182593|NCT02081599|464965236|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
129182594|NCT02081599|464965237|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
129182595|NCT05063539|464965240|FG000|Overall Study|Adverse Event|1|||
129182596|NCT05063539|464965241|FG001|Overall Study|Adverse Event|2|||
128730214|NCT00689481|463308358|FG001|Overall Study|Excluded medication started during study|1|||
128730215|NCT00689481|463308357|FG000|Overall Study|Subject early term, left on vacation|0|||
129182597|NCT05063539|464965242|FG002|Overall Study|Adverse Event|1|||
129182598|NCT05063539|464965240|FG000|Overall Study|Death|0|||
129182599|NCT05063539|464965241|FG001|Overall Study|Death|1|||
129182600|NCT05063539|464965242|FG002|Overall Study|Death|1|||
129182601|NCT05063539|464965240|FG000|Overall Study|Lost to Follow-up|0|||
129182602|NCT05063539|464965241|FG001|Overall Study|Lost to Follow-up|1|||
129182603|NCT05063539|464965242|FG002|Overall Study|Lost to Follow-up|0|||
129182604|NCT05063539|464965240|FG000|Overall Study|Physician Decision|4|||
129182605|NCT05063539|464965241|FG001|Overall Study|Physician Decision|3|||
129182606|NCT05063539|464965242|FG002|Overall Study|Physician Decision|1|||
129182607|NCT05063539|464965240|FG000|Overall Study|Progressive Disease|0|||
129182608|NCT05063539|464965241|FG001|Overall Study|Progressive Disease|2|||
129182609|NCT05063539|464965242|FG002|Overall Study|Progressive Disease|0|||
129182610|NCT05063539|464965240|FG000|Overall Study|Withdrawal by Subject|17|||
129182611|NCT05063539|464965241|FG001|Overall Study|Withdrawal by Subject|26|||
129182612|NCT05063539|464965242|FG002|Overall Study|Withdrawal by Subject|14|||
129182613|NCT05063539|464965240|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
129182614|NCT05063539|464965241|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
129182615|NCT05063539|464965242|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
129182616|NCT05063539|464965240|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
129182617|NCT05063539|464965241|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
129182618|NCT05063539|464965242|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
129182619|NCT05063539|464965240|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
129182620|NCT05063539|464965241|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
129182621|NCT05063539|464965242|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
129182622|NCT05063539|464965240|FG000|Overall Study|Discontinued due to Common Close Design|0|||
129182623|NCT05063539|464965241|FG001|Overall Study|Discontinued due to Common Close Design|1|||
129182624|NCT05063539|464965242|FG002|Overall Study|Discontinued due to Common Close Design|0|||
129182625|NCT05063539|464965240|FG000|Overall Study|Participant not co-operative|0|||
129182626|NCT05063539|464965241|FG001|Overall Study|Participant not co-operative|1|||
129182627|NCT05063539|464965242|FG002|Overall Study|Participant not co-operative|0|||
129182628|NCT05063539|464965240|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
129182629|NCT05063539|464965241|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
129182630|NCT05063539|464965242|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
129182631|NCT05063539|464965240|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
129182632|NCT05063539|464965241|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
129182633|NCT05063539|464965242|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
129182634|NCT04256512|464965243|FG000|Overall Study|Withdrawal by Subject|1|||
129182635|NCT04435600|464965247|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182636|NCT04435600|464965248|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182637|NCT04435600|464965249|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
129182638|NCT04435600|464965250|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182639|NCT04435600|464965251|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182640|NCT04435600|464965252|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182641|NCT04435600|464965253|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182642|NCT04435600|464965254|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182643|NCT04435600|464965255|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182644|NCT04435600|464965256|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129182645|NCT04435600|464965247|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182646|NCT04435600|464965248|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182647|NCT04435600|464965249|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182648|NCT04435600|464965250|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182649|NCT04435600|464965251|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182650|NCT04435600|464965252|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182651|NCT04435600|464965253|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182652|NCT04435600|464965254|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182653|NCT04435600|464965255|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129182654|NCT04435600|464965256|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
129182655|NCT04435600|464965247|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182656|NCT04435600|464965248|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182657|NCT04435600|464965249|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182658|NCT04435600|464965250|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
128730216|NCT00689481|463308358|FG001|Overall Study|Subject early term, left on vacation|1|||
129182659|NCT04435600|464965251|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182660|NCT04435600|464965252|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182661|NCT04435600|464965253|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182662|NCT04435600|464965254|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182663|NCT04435600|464965255|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129182664|NCT04435600|464965256|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
129182665|NCT04435600|464965247|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182666|NCT04435600|464965248|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182667|NCT04435600|464965249|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182668|NCT04435600|464965250|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182669|NCT04435600|464965251|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182670|NCT04435600|464965252|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182671|NCT04435600|464965253|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182672|NCT04435600|464965254|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182673|NCT04435600|464965255|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
129182674|NCT04435600|464965256|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
129182675|NCT01751139|464965257|FG000|Overall Study|Other|135|||
129182676|NCT01751139|464965257|FG000|Overall Study|Sponsor study termination|1609|||
129182677|NCT01751139|464965257|FG000|Overall Study|Lost to Follow-up|240|||
129182678|NCT01751139|464965257|FG000|Overall Study|Withdrawal by Subject|251|||
129182679|NCT01751139|464965257|FG000|Overall Study|Adverse Event|1|||
129182680|NCT01751139|464965257|FG000|Overall Study|Death|31|||
129182681|NCT04736628|464965258|FG000|Overall Study|Not treated|0|||
129182682|NCT04736628|464965259|FG001|Overall Study|Not treated|0|||
129182683|NCT04736628|464965260|FG002|Overall Study|Not treated|0|||
129182684|NCT04736628|464965261|FG003|Overall Study|Not treated|2|||
129182685|NCT04736628|464965258|FG000|Overall Study|Other reason than listed|1|||
129182686|NCT04736628|464965259|FG001|Overall Study|Other reason than listed|2|||
129182687|NCT04736628|464965260|FG002|Overall Study|Other reason than listed|2|||
129182688|NCT04736628|464965261|FG003|Overall Study|Other reason than listed|3|||
129182689|NCT04736628|464965258|FG000|Overall Study|Protocol deviation|0|||
129182690|NCT04736628|464965259|FG001|Overall Study|Protocol deviation|0|||
129182691|NCT04736628|464965260|FG002|Overall Study|Protocol deviation|0|||
129182692|NCT04736628|464965261|FG003|Overall Study|Protocol deviation|1|||
129182693|NCT04736628|464965258|FG000|Overall Study|Burden of study procedures|1|||
129182694|NCT04736628|464965259|FG001|Overall Study|Burden of study procedures|0|||
129182695|NCT04736628|464965260|FG002|Overall Study|Burden of study procedures|0|||
129182696|NCT04736628|464965261|FG003|Overall Study|Burden of study procedures|1|||
129182697|NCT04736628|464965258|FG000|Overall Study|Change of residence|0|||
129182698|NCT04736628|464965259|FG001|Overall Study|Change of residence|1|||
129182699|NCT04736628|464965260|FG002|Overall Study|Change of residence|0|||
129182700|NCT04736628|464965261|FG003|Overall Study|Change of residence|0|||
129182701|NCT04736628|464965258|FG000|Overall Study|Perceived lack of efficacy|1|||
129182702|NCT04736628|464965259|FG001|Overall Study|Perceived lack of efficacy|0|||
129182703|NCT04736628|464965260|FG002|Overall Study|Perceived lack of efficacy|0|||
129182704|NCT04736628|464965261|FG003|Overall Study|Perceived lack of efficacy|1|||
129182705|NCT04736628|464965258|FG000|Overall Study|Adverse Event|3|||
129182706|NCT04736628|464965259|FG001|Overall Study|Adverse Event|2|||
129182707|NCT04736628|464965260|FG002|Overall Study|Adverse Event|4|||
129182708|NCT04736628|464965261|FG003|Overall Study|Adverse Event|3|||
129182709|NCT04279613|464965262|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129182710|NCT04279613|464965263|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129182711|NCT04279613|464965264|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129182712|NCT04279613|464965265|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129182713|NCT04279613|464965266|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
129182714|NCT04279613|464965262|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129182715|NCT04279613|464965263|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
129182716|NCT04279613|464965264|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129182717|NCT04279613|464965265|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129182718|NCT04279613|464965266|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129182719|NCT04279613|464965262|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129182720|NCT04279613|464965263|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129182721|NCT04279613|464965264|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
128730217|NCT06425458|463308359|FG000|Overall Study|Removed by study team|2|||
128730218|NCT06425458|463308359|FG000|Overall Study|Lost to Follow-up|5|||
129182722|NCT04279613|464965265|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129182723|NCT04279613|464965266|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129182724|NCT04279613|464965262|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129182725|NCT04279613|464965263|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129182726|NCT04279613|464965264|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129182727|NCT04279613|464965265|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129182728|NCT04279613|464965266|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
129182729|NCT04279613|464965262|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
128730219|NCT00445328|463308360|FG000|Overall Study|Death|0|||
128780954|NCT01323660|463488631|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
128780955|NCT01323660|463488626|FG000|Washout Period (14 Days)|Adverse Event|0|||
128780956|NCT01323660|463488627|FG001|Washout Period (14 Days)|Adverse Event|0|||
129182730|NCT04279613|464965263|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
129182731|NCT04279613|464965264|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
129182732|NCT04279613|464965265|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
129182733|NCT04279613|464965266|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
129182734|NCT04428151|464965267|FG000|Overall Study|Death|100|||
129182735|NCT04428151|464965268|FG001|Overall Study|Death|86|||
129182736|NCT04428151|464965269|FG002|Overall Study|Death|57|||
129182737|NCT04428151|464965267|FG000|Overall Study|Lost to Follow-up|1|||
129182738|NCT04428151|464965268|FG001|Overall Study|Lost to Follow-up|1|||
129182739|NCT04428151|464965269|FG002|Overall Study|Lost to Follow-up|0|||
129182740|NCT04428151|464965267|FG000|Overall Study|Withdrawal by Subject|2|||
129182741|NCT04428151|464965268|FG001|Overall Study|Withdrawal by Subject|2|||
129182742|NCT04428151|464965269|FG002|Overall Study|Withdrawal by Subject|3|||
129182743|NCT04428151|464965267|FG000|Overall Study|Participant Ongoing in Study|41|||
129182744|NCT04428151|464965268|FG001|Overall Study|Participant Ongoing in Study|53|||
129182745|NCT04428151|464965269|FG002|Overall Study|Participant Ongoing in Study|28|||
129182746|NCT02704689|464965270|FG000|Overall Study|Physician Decision|1|||
129182747|NCT02704689|464965270|FG000|Overall Study|Study device not implanted|2|||
129182748|NCT02212678|464965273|FG000|Overall Study|Adverse Event|1|||
129182749|NCT02337634|464965274|FG000|Overall Study|Protocol Violation|3|||
129182750|NCT02337634|464965275|FG001|Overall Study|Protocol Violation|1|||
129182751|NCT02337634|464965274|FG000|Overall Study|Lost to Follow-up|1|||
129182752|NCT02337634|464965275|FG001|Overall Study|Lost to Follow-up|0|||
129182753|NCT00527319|464965276|FG000|Overall Study|Withdrawal by Subject|5|||
129182754|NCT00527319|464965277|FG001|Overall Study|Withdrawal by Subject|0|||
129182755|NCT00527319|464965278|FG002|Overall Study|Withdrawal by Subject|1|||
129182756|NCT00527319|464965276|FG000|Overall Study|Lost to Follow-up|1|||
129182757|NCT00527319|464965277|FG001|Overall Study|Lost to Follow-up|0|||
129182758|NCT00527319|464965278|FG002|Overall Study|Lost to Follow-up|0|||
129182759|NCT00527319|464965276|FG000|Overall Study|Death|0|||
129182760|NCT00527319|464965277|FG001|Overall Study|Death|3|||
129182761|NCT00527319|464965278|FG002|Overall Study|Death|1|||
129182762|NCT00527319|464965276|FG000|Overall Study|Intercurrent Medical Illness|0|||
129182763|NCT00527319|464965277|FG001|Overall Study|Intercurrent Medical Illness|1|||
129182764|NCT00527319|464965278|FG002|Overall Study|Intercurrent Medical Illness|3|||
129182765|NCT00527319|464965276|FG000|Overall Study|Adverse Event|0|||
129182766|NCT00527319|464965277|FG001|Overall Study|Adverse Event|0|||
129182767|NCT00527319|464965278|FG002|Overall Study|Adverse Event|1|||
129182768|NCT03344172|464965279|FG000|Overall Study|Received <1 dose of treatment|1|||
129182769|NCT03344172|464965280|FG001|Overall Study|Received <1 dose of treatment|0|||
129182770|NCT00680368|464965283|FG000|Overall Study|not supervised, not eligible|15|||
129182771|NCT00430937|464965287|FG000|Overall Study|Adverse Event|3|||
129182772|NCT00430937|464965288|FG001|Overall Study|Adverse Event|8|||
129182773|NCT00430937|464965287|FG000|Overall Study|Death|0|||
129182774|NCT00430937|464965288|FG001|Overall Study|Death|1|||
129182775|NCT00430937|464965287|FG000|Overall Study|Lost to Follow-up|6|||
129182776|NCT00430937|464965288|FG001|Overall Study|Lost to Follow-up|6|||
129182777|NCT00430937|464965287|FG000|Overall Study|Withdrawal by Subject|5|||
129182778|NCT00430937|464965288|FG001|Overall Study|Withdrawal by Subject|2|||
129182779|NCT00430937|464965287|FG000|Overall Study|Protocol Violation|3|||
128730220|NCT00445328|463308361|FG001|Overall Study|Death|1|||
129182780|NCT00430937|464965288|FG001|Overall Study|Protocol Violation|2|||
129182781|NCT00430937|464965287|FG000|Overall Study|Lack of Efficacy|6|||
129182782|NCT00430937|464965288|FG001|Overall Study|Lack of Efficacy|5|||
129182783|NCT00430937|464965287|FG000|Overall Study|Inappropriate enrollment|2|||
129182784|NCT00430937|464965288|FG001|Overall Study|Inappropriate enrollment|1|||
129182785|NCT00430937|464965287|FG000|Overall Study|Administrative reasons|1|||
129182786|NCT00430937|464965288|FG001|Overall Study|Administrative reasons|0|||
129182787|NCT00430937|464965287|FG000|Overall Study|Protocol discontinuation criteria met|1|||
129182788|NCT00430937|464965288|FG001|Overall Study|Protocol discontinuation criteria met|2|||
129182789|NCT00430937|464965287|FG000|Overall Study|Unable to classify|0|||
129182790|NCT00430937|464965288|FG001|Overall Study|Unable to classify|1|||
129182791|NCT02392403|464965291|FG000|Overall Study|Adverse Event|1|||
129182792|NCT02392403|464965291|FG000|Overall Study|Death|1|||
129182793|NCT02392403|464965291|FG000|Overall Study|Withdrawal by Subject|1|||
129182794|NCT00657371|464965295|FG000|Overall Study|Poor bowel preparation|15|||
129182795|NCT00657371|464965295|FG000|Overall Study|Unable to intubate the cecum|5|||
129182796|NCT00657371|464965295|FG000|Overall Study|Protocol Violation|2|||
129182797|NCT00657371|464965295|FG000|Overall Study|Device- related reasons|13|||
129182798|NCT00657371|464965295|FG000|Overall Study|Pre-existing medical condition|4|||
129182799|NCT01639755|464965296|FG000|Overall Study|Study Ongoing|15|||
129182800|NCT01639755|464965296|FG000|Overall Study|Patient had device explantation|4|||
129182801|NCT03629912|464965297|FG000|Overall Study|Lost to Follow-up|19|||
129182802|NCT03629912|464965298|FG001|Overall Study|Lost to Follow-up|7|||
129182803|NCT03629912|464965299|FG002|Overall Study|Lost to Follow-up|5|||
129182804|NCT03629912|464965300|FG003|Overall Study|Lost to Follow-up|1|||
129182805|NCT03629912|464965297|FG000|Overall Study|Withdrawal by Subject|6|||
129182806|NCT03629912|464965298|FG001|Overall Study|Withdrawal by Subject|0|||
129182807|NCT03629912|464965299|FG002|Overall Study|Withdrawal by Subject|1|||
129182808|NCT03629912|464965300|FG003|Overall Study|Withdrawal by Subject|2|||
129182809|NCT03629912|464965297|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
129182810|NCT03629912|464965298|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
129182811|NCT03629912|464965299|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
129182812|NCT03629912|464965300|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
129182813|NCT03629912|464965297|FG000|Overall Study|Death|1|||
129182814|NCT03629912|464965298|FG001|Overall Study|Death|0|||
129182815|NCT03629912|464965299|FG002|Overall Study|Death|0|||
129182816|NCT03629912|464965300|FG003|Overall Study|Death|0|||
129182817|NCT01475162|464965301|FG000|Overall Study|Physician Decision|1|||
129182818|NCT01475162|464965301|FG000|Overall Study|Death|10|||
129182819|NCT01475162|464965301|FG000|Overall Study|Study closed for safety|3|||
129182820|NCT00490022|464965302|FG000|Overall Study|Adverse Event|0|||
129182821|NCT00490022|464965303|FG001|Overall Study|Adverse Event|2|||
129182822|NCT00490022|464965302|FG000|Overall Study|Withdrawal by Subject|1|||
129182823|NCT00490022|464965303|FG001|Overall Study|Withdrawal by Subject|0|||
129182824|NCT00490022|464965302|FG000|Overall Study|Subject failed to disclose concommitant|0|||
129182825|NCT00490022|464965303|FG001|Overall Study|Subject failed to disclose concommitant|1|||
129182826|NCT05059977|464965305|FG000|Overall Study|Withdrawal by Subject|0|||
129182827|NCT05059977|464965306|FG001|Overall Study|Withdrawal by Subject|0|||
129182828|NCT05059977|464965307|FG002|Overall Study|Withdrawal by Subject|1|||
129182829|NCT04405245|464965308|FG000|Overall Study|Adverse Event|0|||
129182830|NCT04405245|464965309|FG001|Overall Study|Adverse Event|1|||
129182831|NCT04405245|464965310|FG002|Overall Study|Adverse Event|0|||
129182832|NCT00576472|464965311|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182833|NCT00576472|464965312|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182834|NCT00576472|464965313|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182835|NCT00576472|464965314|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
129182836|NCT00576472|464965315|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182837|NCT00576472|464965316|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182838|NCT00576472|464965317|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182839|NCT00576472|464965318|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182840|NCT00576472|464965319|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182841|NCT00576472|464965320|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182842|NCT00576472|464965321|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182843|NCT00576472|464965322|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182844|NCT00576472|464965323|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182845|NCT00576472|464965324|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182846|NCT00576472|464965325|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
129182847|NCT00576472|464965311|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
129182848|NCT00576472|464965312|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
129182849|NCT00576472|464965313|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
129182850|NCT00576472|464965314|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
129182851|NCT00576472|464965315|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
129182852|NCT00576472|464965316|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
129182853|NCT00576472|464965317|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
129182854|NCT00576472|464965318|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
129182855|NCT00576472|464965319|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
129182856|NCT00576472|464965320|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
129182857|NCT00576472|464965321|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
129182858|NCT00576472|464965322|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
129182859|NCT00576472|464965323|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
129182860|NCT00576472|464965324|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
129182861|NCT00576472|464965325|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
129182862|NCT00576472|464965311|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182863|NCT00576472|464965312|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182864|NCT00576472|464965313|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182865|NCT00576472|464965314|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
129182866|NCT00576472|464965315|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182867|NCT00576472|464965316|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182868|NCT00576472|464965317|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182869|NCT00576472|464965318|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182870|NCT00576472|464965319|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182871|NCT00576472|464965320|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182872|NCT00576472|464965321|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182873|NCT00576472|464965322|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182874|NCT00576472|464965323|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182875|NCT00576472|464965324|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182876|NCT00576472|464965325|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129182877|NCT00576472|464965311|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
129182878|NCT00576472|464965312|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
129182879|NCT00576472|464965313|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
129182880|NCT00576472|464965314|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
129182881|NCT00576472|464965315|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
129182882|NCT00576472|464965316|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
129182883|NCT00576472|464965317|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
129182884|NCT00576472|464965318|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
129182885|NCT00576472|464965319|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
129182886|NCT00576472|464965320|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
129182887|NCT00576472|464965321|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
129182888|NCT00576472|464965322|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
129182889|NCT00576472|464965323|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
129182890|NCT00576472|464965324|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
129182891|NCT00576472|464965325|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
129182892|NCT00576472|464965311|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182893|NCT00576472|464965312|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182894|NCT00576472|464965313|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182895|NCT00576472|464965314|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
129182896|NCT00576472|464965315|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182897|NCT00576472|464965316|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182898|NCT00576472|464965317|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182899|NCT00576472|464965318|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182900|NCT00576472|464965319|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182901|NCT00576472|464965320|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182902|NCT00576472|464965321|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182903|NCT00576472|464965322|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182904|NCT00576472|464965323|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182905|NCT00576472|464965324|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182906|NCT00576472|464965325|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
129182907|NCT00576472|464965311|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182908|NCT00576472|464965312|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182909|NCT00576472|464965313|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182910|NCT00576472|464965314|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182911|NCT00576472|464965315|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182912|NCT00576472|464965316|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182913|NCT00576472|464965317|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
129182914|NCT00576472|464965318|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182915|NCT00576472|464965319|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182916|NCT00576472|464965320|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182917|NCT00576472|464965321|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182918|NCT00576472|464965322|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182919|NCT00576472|464965323|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182920|NCT00576472|464965324|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182921|NCT00576472|464965325|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
129182922|NCT00576472|464965311|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
129182923|NCT00576472|464965312|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
129182924|NCT00576472|464965313|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
129182925|NCT00576472|464965314|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
129182926|NCT00576472|464965315|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
129182927|NCT00576472|464965316|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
129182928|NCT00576472|464965317|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
129182929|NCT00576472|464965318|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
129182930|NCT00576472|464965319|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
129182931|NCT00576472|464965320|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
129182932|NCT00576472|464965321|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
129182933|NCT00576472|464965322|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
129182934|NCT00576472|464965323|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
129182935|NCT00576472|464965324|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
129182936|NCT00576472|464965325|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
129182937|NCT00576472|464965311|FG000|MPH Cross Over Phase|Physician Decision|0|||
129182938|NCT00576472|464965312|FG001|MPH Cross Over Phase|Physician Decision|0|||
129182939|NCT00576472|464965313|FG002|MPH Cross Over Phase|Physician Decision|0|||
129182940|NCT00576472|464965314|FG003|MPH Cross Over Phase|Physician Decision|0|||
129182941|NCT00576472|464965315|FG004|MPH Cross Over Phase|Physician Decision|0|||
129182942|NCT00576472|464965316|FG005|MPH Cross Over Phase|Physician Decision|0|||
129182943|NCT00576472|464965317|FG006|MPH Cross Over Phase|Physician Decision|4|||
129182944|NCT00576472|464965318|FG007|MPH Cross Over Phase|Physician Decision|0|||
129182945|NCT00576472|464965319|FG008|MPH Cross Over Phase|Physician Decision|0|||
129182946|NCT00576472|464965320|FG009|MPH Cross Over Phase|Physician Decision|0|||
129182947|NCT00576472|464965321|FG010|MPH Cross Over Phase|Physician Decision|0|||
129182948|NCT00576472|464965322|FG011|MPH Cross Over Phase|Physician Decision|0|||
129182949|NCT00576472|464965323|FG012|MPH Cross Over Phase|Physician Decision|0|||
129182950|NCT00576472|464965324|FG013|MPH Cross Over Phase|Physician Decision|0|||
129182951|NCT00576472|464965325|FG014|MPH Cross Over Phase|Physician Decision|0|||
129182952|NCT00576472|464965311|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182953|NCT00576472|464965312|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182954|NCT00576472|464965313|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182955|NCT00576472|464965314|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182956|NCT00576472|464965315|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182957|NCT00576472|464965316|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182958|NCT00576472|464965317|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182959|NCT00576472|464965318|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182960|NCT00576472|464965319|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
129182961|NCT00576472|464965320|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182962|NCT00576472|464965321|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
129182963|NCT00576472|464965322|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
129182964|NCT00576472|464965323|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182965|NCT00576472|464965324|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182966|NCT00576472|464965325|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
129182967|NCT00576472|464965311|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182968|NCT00576472|464965312|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182969|NCT00576472|464965313|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182970|NCT00576472|464965314|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182971|NCT00576472|464965315|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182972|NCT00576472|464965316|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182973|NCT00576472|464965317|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182974|NCT00576472|464965318|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182975|NCT00576472|464965319|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182976|NCT00576472|464965320|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182977|NCT00576472|464965321|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182978|NCT00576472|464965322|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182979|NCT00576472|464965323|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182980|NCT00576472|464965324|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
129182981|NCT00576472|464965325|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129182982|NCT00576472|464965311|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
129182983|NCT00576472|464965312|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
129182984|NCT00576472|464965313|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
129182985|NCT00576472|464965314|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
129182986|NCT00576472|464965315|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
129182987|NCT00576472|464965316|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
129182988|NCT00576472|464965317|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
129182989|NCT00576472|464965318|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
129182990|NCT00576472|464965319|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
129182991|NCT00576472|464965320|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
129182992|NCT00576472|464965321|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
129182993|NCT00576472|464965322|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
129182994|NCT00576472|464965323|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
129182995|NCT00576472|464965324|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
129182996|NCT00576472|464965325|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
129182997|NCT00576472|464965311|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
129182998|NCT00576472|464965312|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
129182999|NCT00576472|464965313|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
129183000|NCT00576472|464965314|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
129183001|NCT00576472|464965315|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
129183002|NCT00576472|464965316|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
129183003|NCT00576472|464965317|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
129183004|NCT00576472|464965318|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
129183005|NCT00576472|464965319|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
129183006|NCT00576472|464965320|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
129183007|NCT00576472|464965321|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
129183008|NCT00576472|464965322|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
129183009|NCT00576472|464965323|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
129183010|NCT00576472|464965324|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
129183011|NCT00576472|464965325|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
129183012|NCT00576472|464965311|FG000|MPH Home Maintenance Phase|Side effects|0|||
129183013|NCT00576472|464965312|FG001|MPH Home Maintenance Phase|Side effects|0|||
129183014|NCT00576472|464965313|FG002|MPH Home Maintenance Phase|Side effects|0|||
129183015|NCT00576472|464965314|FG003|MPH Home Maintenance Phase|Side effects|0|||
129183016|NCT00576472|464965315|FG004|MPH Home Maintenance Phase|Side effects|0|||
129183017|NCT00576472|464965316|FG005|MPH Home Maintenance Phase|Side effects|0|||
129183018|NCT00576472|464965317|FG006|MPH Home Maintenance Phase|Side effects|0|||
129183019|NCT00576472|464965318|FG007|MPH Home Maintenance Phase|Side effects|0|||
129183020|NCT00576472|464965319|FG008|MPH Home Maintenance Phase|Side effects|0|||
129183021|NCT00576472|464965320|FG009|MPH Home Maintenance Phase|Side effects|0|||
129183022|NCT00576472|464965321|FG010|MPH Home Maintenance Phase|Side effects|0|||
129183023|NCT00576472|464965322|FG011|MPH Home Maintenance Phase|Side effects|0|||
129183024|NCT00576472|464965323|FG012|MPH Home Maintenance Phase|Side effects|0|||
129183025|NCT00576472|464965324|FG013|MPH Home Maintenance Phase|Side effects|0|||
129183026|NCT00576472|464965325|FG014|MPH Home Maintenance Phase|Side effects|8|||
129183027|NCT00576472|464965311|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183028|NCT00576472|464965312|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183029|NCT00576472|464965313|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183030|NCT00576472|464965314|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183031|NCT00576472|464965315|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183032|NCT00576472|464965316|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183033|NCT00576472|464965317|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183034|NCT00576472|464965318|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183035|NCT00576472|464965319|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183036|NCT00576472|464965320|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183037|NCT00576472|464965321|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183038|NCT00576472|464965322|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183039|NCT00576472|464965323|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183040|NCT00576472|464965324|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129183041|NCT00576472|464965325|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
129183042|NCT00576472|464965311|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
129183043|NCT00576472|464965312|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
129183044|NCT00576472|464965313|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
129183045|NCT00576472|464965314|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
129183046|NCT00576472|464965315|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
129183047|NCT00576472|464965316|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
129183048|NCT00576472|464965317|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
129183049|NCT00576472|464965318|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
129183050|NCT00576472|464965319|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
129183051|NCT00576472|464965320|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
129183052|NCT00576472|464965321|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
129183053|NCT00576472|464965322|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
129183054|NCT00576472|464965323|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
129183055|NCT00576472|464965324|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
129183056|NCT00576472|464965325|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
129183057|NCT00576472|464965311|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183058|NCT00576472|464965312|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183059|NCT00576472|464965313|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183060|NCT00576472|464965314|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183061|NCT00576472|464965315|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183062|NCT00576472|464965316|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183063|NCT00576472|464965317|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183064|NCT00576472|464965318|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183065|NCT00576472|464965319|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183066|NCT00576472|464965320|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183067|NCT00576472|464965321|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183068|NCT00576472|464965322|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183069|NCT00576472|464965323|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183070|NCT00576472|464965324|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129183071|NCT00576472|464965325|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
129183072|NCT02391961|464965333|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
129183073|NCT02391961|464965334|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
129183074|NCT02391961|464965333|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129183075|NCT02391961|464965334|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
129183076|NCT02391961|464965333|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129183077|NCT02391961|464965334|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129183078|NCT03263780|464965337|FG000|Overall Study|Withdrawal by Subject|3|||
129183079|NCT03263780|464965337|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
129183080|NCT01504204|464965338|FG000|Overall Study|Lost to Follow-up|1|||
129183081|NCT01504204|464965339|FG001|Overall Study|Lost to Follow-up|1|||
129183082|NCT00903331|464965340|FG000|Overall Study|Death|4|||
129183083|NCT00903331|464965341|FG001|Overall Study|Death|8|||
129183084|NCT00903331|464965340|FG000|Overall Study|Withdrawal of consent|1|||
129183085|NCT00903331|464965341|FG001|Overall Study|Withdrawal of consent|8|||
129183086|NCT00903331|464965340|FG000|Overall Study|Lung transplant|0|||
129183087|NCT00903331|464965341|FG001|Overall Study|Lung transplant|2|||
129183088|NCT02723175|464965342|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
129183089|NCT02723175|464965343|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
129183090|NCT02723175|464965342|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
129183091|NCT02723175|464965343|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
129183092|NCT03691779|464965353|FG000|Part B (24 Weeks)|Adverse Event|0|||
129183093|NCT03691779|464965354|FG001|Part B (24 Weeks)|Adverse Event|1|||
129183094|NCT03691779|464965353|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
129183095|NCT03691779|464965354|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
129183096|NCT00267150|464965355|FG000|Overall Study|Adverse Event|1|||
129183097|NCT01561963|464965356|FG000|Overall Study|Adverse Event|1|||
129183098|NCT03134183|464965359|FG000|Overall Study|Withdrawal by Subject|1|||
129183099|NCT03134183|464965360|FG001|Overall Study|Withdrawal by Subject|1|||
129183100|NCT00162266|464965361|FG000|Double-Blind Period|Adverse Event|5|||
129183101|NCT00162266|464965362|FG001|Double-Blind Period|Adverse Event|9|||
129183102|NCT00162266|464965363|FG002|Double-Blind Period|Adverse Event|11|||
129183103|NCT00162266|464965364|FG003|Double-Blind Period|Adverse Event|0|||
129183104|NCT00162266|464965361|FG000|Double-Blind Period|Death|0|||
129183105|NCT00162266|464965362|FG001|Double-Blind Period|Death|1|||
129183106|NCT00162266|464965363|FG002|Double-Blind Period|Death|0|||
129183107|NCT00162266|464965364|FG003|Double-Blind Period|Death|0|||
129183108|NCT00162266|464965361|FG000|Double-Blind Period|Lost to Follow-up|1|||
129183109|NCT00162266|464965362|FG001|Double-Blind Period|Lost to Follow-up|2|||
129183110|NCT00162266|464965363|FG002|Double-Blind Period|Lost to Follow-up|0|||
129183111|NCT00162266|464965364|FG003|Double-Blind Period|Lost to Follow-up|0|||
129183112|NCT00162266|464965361|FG000|Double-Blind Period|Other Reason|1|||
129183113|NCT00162266|464965362|FG001|Double-Blind Period|Other Reason|0|||
129183114|NCT00162266|464965363|FG002|Double-Blind Period|Other Reason|1|||
129183115|NCT00162266|464965364|FG003|Double-Blind Period|Other Reason|0|||
129183116|NCT00162266|464965361|FG000|Double-Blind Period|Lack of Efficacy|13|||
129183117|NCT00162266|464965362|FG001|Double-Blind Period|Lack of Efficacy|17|||
129183118|NCT00162266|464965363|FG002|Double-Blind Period|Lack of Efficacy|30|||
129183119|NCT00162266|464965364|FG003|Double-Blind Period|Lack of Efficacy|0|||
129183120|NCT00162266|464965361|FG000|Double-Blind Period|Withdrawal by Subject|5|||
129183121|NCT00162266|464965362|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129183122|NCT00162266|464965363|FG002|Double-Blind Period|Withdrawal by Subject|6|||
129183123|NCT00162266|464965364|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129183124|NCT00162266|464965361|FG000|Open-Label Period|Death|0|||
129183125|NCT00162266|464965362|FG001|Open-Label Period|Death|0|||
129183126|NCT00162266|464965363|FG002|Open-Label Period|Death|0|||
129183127|NCT00162266|464965364|FG003|Open-Label Period|Death|7|||
129183128|NCT00162266|464965361|FG000|Open-Label Period|Adverse Event|0|||
129183129|NCT00162266|464965362|FG001|Open-Label Period|Adverse Event|0|||
129183130|NCT00162266|464965363|FG002|Open-Label Period|Adverse Event|0|||
129183131|NCT00162266|464965364|FG003|Open-Label Period|Adverse Event|46|||
129183132|NCT00162266|464965361|FG000|Open-Label Period|Lack of Efficacy|0|||
129183133|NCT00162266|464965362|FG001|Open-Label Period|Lack of Efficacy|0|||
129183134|NCT00162266|464965363|FG002|Open-Label Period|Lack of Efficacy|0|||
129183135|NCT00162266|464965364|FG003|Open-Label Period|Lack of Efficacy|26|||
129183136|NCT00162266|464965361|FG000|Open-Label Period|Lost to Follow-up|0|||
129183137|NCT00162266|464965362|FG001|Open-Label Period|Lost to Follow-up|0|||
129183138|NCT00162266|464965363|FG002|Open-Label Period|Lost to Follow-up|0|||
129183139|NCT00162266|464965364|FG003|Open-Label Period|Lost to Follow-up|3|||
129183140|NCT00162266|464965361|FG000|Open-Label Period|Withdrawal by Subject|0|||
129183141|NCT00162266|464965362|FG001|Open-Label Period|Withdrawal by Subject|0|||
129183142|NCT00162266|464965363|FG002|Open-Label Period|Withdrawal by Subject|0|||
129183143|NCT00162266|464965364|FG003|Open-Label Period|Withdrawal by Subject|31|||
129183144|NCT00162266|464965361|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
129183145|NCT00162266|464965362|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
129183146|NCT00162266|464965363|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
129183147|NCT00162266|464965364|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
129183148|NCT00162266|464965361|FG000|Open-Label Period|Other Reasons|0|||
129183149|NCT00162266|464965362|FG001|Open-Label Period|Other Reasons|0|||
129183150|NCT00162266|464965363|FG002|Open-Label Period|Other Reasons|0|||
129183151|NCT00162266|464965364|FG003|Open-Label Period|Other Reasons|15|||
129183152|NCT02299076|464965365|FG000|Overall Study|Fraudulent Entries|20|||
129183153|NCT02299076|464965366|FG001|Overall Study|Fraudulent Entries|14|||
129183154|NCT04208087|464965367|FG000|Overall Study|Adverse Event|1|||
129183155|NCT04208087|464965368|FG001|Overall Study|Adverse Event|0|||
129183156|NCT04208087|464965369|FG002|Overall Study|Adverse Event|0|||
129183157|NCT04208087|464965370|FG003|Overall Study|Adverse Event|0|||
129183158|NCT04208087|464965371|FG004|Overall Study|Adverse Event|0|||
129183159|NCT04208087|464965367|FG000|Overall Study|Withdrawal by Subject|0|||
129183160|NCT04208087|464965368|FG001|Overall Study|Withdrawal by Subject|0|||
129183161|NCT04208087|464965369|FG002|Overall Study|Withdrawal by Subject|1|||
128730221|NCT00445328|463308360|FG000|Overall Study|Adverse Event|0|||
129183162|NCT04208087|464965370|FG003|Overall Study|Withdrawal by Subject|0|||
129183163|NCT04208087|464965371|FG004|Overall Study|Withdrawal by Subject|0|||
129183164|NCT04208087|464965367|FG000|Overall Study|Other|0|||
129183165|NCT04208087|464965368|FG001|Overall Study|Other|0|||
129183166|NCT04208087|464965369|FG002|Overall Study|Other|0|||
129183167|NCT04208087|464965370|FG003|Overall Study|Other|0|||
129183168|NCT04208087|464965371|FG004|Overall Study|Other|1|||
129183169|NCT01969721|464965372|FG000|Overall Study|Adverse Event|3|||
129183170|NCT01969721|464965373|FG001|Overall Study|Adverse Event|8|||
129183171|NCT01969721|464965374|FG002|Overall Study|Adverse Event|3|||
129183172|NCT01969721|464965375|FG003|Overall Study|Adverse Event|2|||
129183173|NCT01969721|464965372|FG000|Overall Study|Lack of Efficacy|0|||
129183174|NCT01969721|464965373|FG001|Overall Study|Lack of Efficacy|0|||
129183175|NCT01969721|464965374|FG002|Overall Study|Lack of Efficacy|1|||
129183176|NCT01969721|464965375|FG003|Overall Study|Lack of Efficacy|0|||
129183177|NCT01969721|464965372|FG000|Overall Study|Non compliant with protocol|1|||
129183178|NCT01969721|464965373|FG001|Overall Study|Non compliant with protocol|1|||
129183179|NCT01969721|464965374|FG002|Overall Study|Non compliant with protocol|0|||
129183180|NCT01969721|464965375|FG003|Overall Study|Non compliant with protocol|2|||
129183181|NCT01969721|464965372|FG000|Overall Study|Other not defined above|0|||
129183182|NCT01969721|464965373|FG001|Overall Study|Other not defined above|2|||
129183183|NCT01969721|464965374|FG002|Overall Study|Other not defined above|0|||
129183184|NCT01969721|464965375|FG003|Overall Study|Other not defined above|0|||
129183185|NCT01969721|464965372|FG000|Overall Study|Discontinued during washout periods.|0|||
129183186|NCT01969721|464965373|FG001|Overall Study|Discontinued during washout periods.|1|||
129183187|NCT01969721|464965374|FG002|Overall Study|Discontinued during washout periods.|1|||
129183188|NCT01969721|464965375|FG003|Overall Study|Discontinued during washout periods.|2|||
129183189|NCT00495755|464965377|FG000|Overall Study|Adverse Event|3|||
129183190|NCT02117349|464965378|FG000|Overall Study|Withdrawal by Subject|1|||
129183191|NCT02117349|464965379|FG001|Overall Study|Withdrawal by Subject|0|||
129183192|NCT02117349|464965378|FG000|Overall Study|Lost to Follow-up|1|||
129183193|NCT02117349|464965379|FG001|Overall Study|Lost to Follow-up|1|||
129183194|NCT02117349|464965378|FG000|Overall Study|Death|1|||
129183195|NCT02117349|464965379|FG001|Overall Study|Death|0|||
129183196|NCT01012323|464965380|FG000|Overall Study|Investigator Judgment|1|||
129183197|NCT02265796|464965381|FG000|Overall Study|Death|1|||
129183198|NCT02265796|464965382|FG001|Overall Study|Death|0|||
129183199|NCT02265796|464965381|FG000|Overall Study|started on excluded medication|1|||
129183200|NCT02265796|464965382|FG001|Overall Study|started on excluded medication|0|||
129183201|NCT02265796|464965381|FG000|Overall Study|Withdrawal by Subject|1|||
129183202|NCT02265796|464965382|FG001|Overall Study|Withdrawal by Subject|1|||
129183203|NCT02477553|464965383|FG000|Overall Study|Screening up-to-date|12|||
129183204|NCT02477553|464965384|FG001|Overall Study|Screening up-to-date|13|||
129183205|NCT02477553|464965383|FG000|Overall Study|No MD visit|1|||
129183206|NCT02477553|464965384|FG001|Overall Study|No MD visit|1|||
129183207|NCT02477553|464965383|FG000|Overall Study|Workup consistent w/CRC|1|||
129183208|NCT02477553|464965384|FG001|Overall Study|Workup consistent w/CRC|1|||
129183209|NCT02477553|464965383|FG000|Overall Study|Technical issues with intervention|2|||
129183210|NCT02477553|464965384|FG001|Overall Study|Technical issues with intervention|0|||
129183211|NCT02477553|464965383|FG000|Overall Study|Elevated risk for CRC|2|||
129183212|NCT02477553|464965384|FG001|Overall Study|Elevated risk for CRC|2|||
129183213|NCT02477553|464965383|FG000|Overall Study|MD advised against screening|1|||
129183214|NCT02477553|464965384|FG001|Overall Study|MD advised against screening|3|||
129183215|NCT02477553|464965383|FG000|Overall Study|patient deceased|1|||
129183216|NCT02477553|464965384|FG001|Overall Study|patient deceased|0|||
129183217|NCT00637572|464965386|FG000|Overall Study|Adverse Event|1|||
129183218|NCT00637572|464965387|FG001|Overall Study|Adverse Event|2|||
129183219|NCT00637572|464965386|FG000|Overall Study|Death|0|||
129183220|NCT00637572|464965387|FG001|Overall Study|Death|1|||
129183221|NCT00637572|464965386|FG000|Overall Study|Lost to Follow-up|0|||
129183222|NCT00637572|464965387|FG001|Overall Study|Lost to Follow-up|1|||
129183223|NCT00637572|464965386|FG000|Overall Study|Physician Decision|1|||
129183224|NCT00637572|464965387|FG001|Overall Study|Physician Decision|1|||
129183225|NCT00637572|464965386|FG000|Overall Study|Withdrawal by Subject|0|||
129183226|NCT00637572|464965387|FG001|Overall Study|Withdrawal by Subject|2|||
129183227|NCT00637572|464965386|FG000|Overall Study|Illicit Drug Use|1|||
129183228|NCT00637572|464965387|FG001|Overall Study|Illicit Drug Use|0|||
129183229|NCT00896649|464965388|FG000|Overall Study|Physician Decision|1|||
129183230|NCT00896649|464965388|FG000|Overall Study|Pregnancy|1|||
129183231|NCT00896649|464965388|FG000|Overall Study|missing documentation|1|||
129183232|NCT00896649|464965388|FG000|Overall Study|technical difficulties|2|||
129183233|NCT03652675|464965391|FG000|Overall Study|Lost to Follow-up|4|||
129183234|NCT03652675|464965392|FG001|Overall Study|Lost to Follow-up|4|||
129183235|NCT01638559|464965393|FG000|Overall Study|Lost to Follow-up|1|||
129183236|NCT01638559|464965393|FG000|Overall Study|Withdrawal by Subject|1|||
129183237|NCT01638559|464965393|FG000|Overall Study|Subject declined to travel for biopsy|1|||
129183238|NCT00483002|464965396|FG000|Overall Study|Adverse Event|68|||
129183239|NCT00483002|464965396|FG000|Overall Study|Lack of Efficacy|555|||
129183240|NCT00483002|464965396|FG000|Overall Study|Lost to Follow-up|962|||
129183241|NCT00483002|464965396|FG000|Overall Study|Other|2|||
129183242|NCT00483002|464965396|FG000|Overall Study|Other|967|||
129183243|NCT01895309|464965397|FG000|Overall Study|Adverse Event|13|||
129183244|NCT01895309|464965398|FG001|Overall Study|Adverse Event|17|||
129183245|NCT01895309|464965397|FG000|Overall Study|Protocol Violation|1|||
129183246|NCT01895309|464965398|FG001|Overall Study|Protocol Violation|0|||
129183247|NCT01895309|464965397|FG000|Overall Study|Lack of Efficacy|1|||
129183248|NCT01895309|464965398|FG001|Overall Study|Lack of Efficacy|3|||
129183249|NCT01895309|464965397|FG000|Overall Study|Lost to Follow-up|1|||
129183250|NCT01895309|464965398|FG001|Overall Study|Lost to Follow-up|3|||
129183251|NCT01895309|464965397|FG000|Overall Study|Physician Decision|15|||
129183252|NCT01895309|464965398|FG001|Overall Study|Physician Decision|10|||
129183253|NCT01895309|464965397|FG000|Overall Study|Withdrawal by Subject|9|||
128780957|NCT01323660|463488628|FG002|Washout Period (14 Days)|Adverse Event|0|||
128780958|NCT01323660|463488629|FG003|Washout Period (14 Days)|Adverse Event|0|||
128780959|NCT01323660|463488630|FG004|Washout Period (14 Days)|Adverse Event|1|||
128780960|NCT01323660|463488631|FG005|Washout Period (14 Days)|Adverse Event|0|||
129183254|NCT01895309|464965398|FG001|Overall Study|Withdrawal by Subject|18|||
129183255|NCT04268745|464965399|FG000|Overall Study|Lost to Follow-up|2|||
129183256|NCT04268745|464965400|FG001|Overall Study|Lost to Follow-up|3|||
129183257|NCT04268745|464965399|FG000|Overall Study|Withdrawal by Subject|4|||
129183258|NCT04268745|464965400|FG001|Overall Study|Withdrawal by Subject|2|||
129183259|NCT04268745|464965399|FG000|Overall Study|Death in the family|1|||
129183260|NCT04268745|464965400|FG001|Overall Study|Death in the family|0|||
129183261|NCT01286077|464966803|FG000|Overall Study|Adverse Event|2|||
129183262|NCT01286077|464966804|FG001|Overall Study|Adverse Event|0|||
129183263|NCT01286077|464966803|FG000|Overall Study|Death|1|||
129183264|NCT01286077|464966804|FG001|Overall Study|Death|0|||
129183265|NCT01286077|464966803|FG000|Overall Study|Protocol Violation|1|||
129183266|NCT01286077|464966804|FG001|Overall Study|Protocol Violation|1|||
129183267|NCT01286077|464966803|FG000|Overall Study|Withdrawal by Subject|0|||
129183268|NCT01286077|464966804|FG001|Overall Study|Withdrawal by Subject|2|||
129183269|NCT01286077|464966803|FG000|Overall Study|Intercurrent illness|1|||
129183270|NCT01286077|464966804|FG001|Overall Study|Intercurrent illness|0|||
129183271|NCT01286077|464966803|FG000|Overall Study|Non-compliance|1|||
129183272|NCT01286077|464966804|FG001|Overall Study|Non-compliance|0|||
129183273|NCT01286077|464966803|FG000|Overall Study|The subject starts with alternative MMY|0|||
129183274|NCT01286077|464966804|FG001|Overall Study|The subject starts with alternative MMY|3|||
129183275|NCT01286077|464966803|FG000|Overall Study|Patient's decision to stop treatment|3|||
129183276|NCT01286077|464966804|FG001|Overall Study|Patient's decision to stop treatment|0|||
129183277|NCT01286077|464966803|FG000|Overall Study|Progression of disease|0|||
129183278|NCT01286077|464966804|FG001|Overall Study|Progression of disease|1|||
129183279|NCT01286077|464966803|FG000|Overall Study|refill medication not received in time|1|||
129183280|NCT01286077|464966804|FG001|Overall Study|refill medication not received in time|0|||
129183281|NCT04068610|464966805|FG000|Overall Study|Death|4|||
129183282|NCT04068610|464966806|FG001|Overall Study|Death|8|||
129183283|NCT04068610|464966807|FG002|Overall Study|Death|13|||
129183284|NCT04068610|464966805|FG000|Overall Study|Lost to Follow-up|0|||
129183285|NCT04068610|464966806|FG001|Overall Study|Lost to Follow-up|2|||
129183286|NCT04068610|464966807|FG002|Overall Study|Lost to Follow-up|0|||
129183287|NCT04068610|464966805|FG000|Overall Study|Withdrawal by Subject|0|||
129183288|NCT04068610|464966806|FG001|Overall Study|Withdrawal by Subject|4|||
129183289|NCT04068610|464966807|FG002|Overall Study|Withdrawal by Subject|2|||
129183290|NCT04068610|464966805|FG000|Overall Study|Other|3|||
129183291|NCT04068610|464966806|FG001|Overall Study|Other|12|||
129183292|NCT04068610|464966807|FG002|Overall Study|Other|11|||
129183293|NCT02428205|464966808|FG000|Overall Study|Lack of Efficacy|1|||
129183294|NCT02428205|464966809|FG001|Overall Study|Lack of Efficacy|0|||
129183295|NCT02428205|464966808|FG000|Overall Study|Lost to Follow-up|1|||
129183296|NCT02428205|464966809|FG001|Overall Study|Lost to Follow-up|1|||
129183297|NCT02428205|464966808|FG000|Overall Study|Worse behavior|0|||
129183298|NCT02428205|464966809|FG001|Overall Study|Worse behavior|1|||
129183299|NCT01646203|464966812|FG000|Overall Study|Adverse Event|2|||
129183300|NCT01646203|464966813|FG001|Overall Study|Adverse Event|0|||
129183301|NCT01646203|464966814|FG002|Overall Study|Adverse Event|1|||
129183302|NCT01646203|464966812|FG000|Overall Study|Withdrawal by Subject|0|||
129183303|NCT01646203|464966813|FG001|Overall Study|Withdrawal by Subject|1|||
129183304|NCT01646203|464966814|FG002|Overall Study|Withdrawal by Subject|0|||
129183305|NCT01646203|464966812|FG000|Overall Study|Physician's Decision|0|||
129183306|NCT01646203|464966813|FG001|Overall Study|Physician's Decision|1|||
129183307|NCT01646203|464966814|FG002|Overall Study|Physician's Decision|0|||
129183308|NCT03242252|464966816|FG000|Overall Study|At the Participant's own Request|18|||
129183309|NCT03242252|464966817|FG001|Overall Study|At the Participant's own Request|10|||
129183310|NCT03242252|464966818|FG002|Overall Study|At the Participant's own Request|15|||
129183311|NCT03242252|464966816|FG000|Overall Study|Adverse Event|8|||
129183312|NCT03242252|464966817|FG001|Overall Study|Adverse Event|6|||
129183313|NCT03242252|464966818|FG002|Overall Study|Adverse Event|9|||
129183314|NCT03242252|464966816|FG000|Overall Study|Poor Compliance to Protocol|0|||
129183315|NCT03242252|464966817|FG001|Overall Study|Poor Compliance to Protocol|2|||
129183316|NCT03242252|464966818|FG002|Overall Study|Poor Compliance to Protocol|3|||
129183317|NCT03242252|464966816|FG000|Overall Study|Study Terminated by Sponsor|1|||
129183318|NCT03242252|464966817|FG001|Overall Study|Study Terminated by Sponsor|0|||
129183319|NCT03242252|464966818|FG002|Overall Study|Study Terminated by Sponsor|0|||
129183320|NCT03242252|464966816|FG000|Overall Study|Reason not Specified|4|||
129183321|NCT03242252|464966817|FG001|Overall Study|Reason not Specified|4|||
129183322|NCT03242252|464966818|FG002|Overall Study|Reason not Specified|1|||
129183323|NCT03242252|464966816|FG000|Overall Study|Lost to Follow-up|5|||
129183324|NCT03242252|464966817|FG001|Overall Study|Lost to Follow-up|1|||
129183325|NCT03242252|464966818|FG002|Overall Study|Lost to Follow-up|4|||
129183326|NCT01659255|464966819|FG000|Overall Study|Adverse Event|0|||
128730222|NCT00445328|463308361|FG001|Overall Study|Adverse Event|3|||
128730223|NCT00445328|463308360|FG000|Overall Study|Other|0|||
128730224|NCT00445328|463308361|FG001|Overall Study|Other|2|||
128730225|NCT00445328|463308360|FG000|Overall Study|Withdrawal by Subject|2|||
128730226|NCT00445328|463308361|FG001|Overall Study|Withdrawal by Subject|0|||
128730227|NCT00445328|463308360|FG000|Overall Study|Protocol Violation|1|||
128730228|NCT00445328|463308361|FG001|Overall Study|Protocol Violation|0|||
128730229|NCT00316199|463308364|FG000|Overall Study|Adverse Event|2|||
129183327|NCT01659255|464966820|FG001|Overall Study|Adverse Event|0|||
129183328|NCT01659255|464966821|FG002|Overall Study|Adverse Event|0|||
129183329|NCT01659255|464966822|FG003|Overall Study|Adverse Event|0|||
129183330|NCT01659255|464966823|FG004|Overall Study|Adverse Event|0|||
129183331|NCT01659255|464966824|FG005|Overall Study|Adverse Event|1|||
129183332|NCT01659255|464966825|FG006|Overall Study|Adverse Event|1|||
129183333|NCT01659255|464966826|FG007|Overall Study|Adverse Event|0|||
129183334|NCT01659255|464966827|FG008|Overall Study|Adverse Event|0|||
129183335|NCT01659255|464966828|FG009|Overall Study|Adverse Event|1|||
129183336|NCT01659255|464966829|FG010|Overall Study|Adverse Event|0|||
129183337|NCT01659255|464966830|FG011|Overall Study|Adverse Event|1|||
129183338|NCT01659255|464966831|FG012|Overall Study|Adverse Event|0|||
129183339|NCT01659255|464966832|FG013|Overall Study|Adverse Event|2|||
129183340|NCT01659255|464966833|FG014|Overall Study|Adverse Event|0|||
129183341|NCT01659255|464966834|FG015|Overall Study|Adverse Event|1|||
129183342|NCT01659255|464966835|FG016|Overall Study|Adverse Event|0|||
129183343|NCT01659255|464966819|FG000|Overall Study|Death|0|||
129183344|NCT01659255|464966820|FG001|Overall Study|Death|1|||
129183345|NCT01659255|464966821|FG002|Overall Study|Death|0|||
129183346|NCT01659255|464966822|FG003|Overall Study|Death|0|||
129183347|NCT01659255|464966823|FG004|Overall Study|Death|0|||
129183348|NCT01659255|464966824|FG005|Overall Study|Death|0|||
129183349|NCT01659255|464966825|FG006|Overall Study|Death|0|||
129183350|NCT01659255|464966826|FG007|Overall Study|Death|1|||
129183351|NCT01659255|464966827|FG008|Overall Study|Death|1|||
129183352|NCT01659255|464966828|FG009|Overall Study|Death|0|||
129183353|NCT01659255|464966829|FG010|Overall Study|Death|0|||
129183354|NCT01659255|464966830|FG011|Overall Study|Death|0|||
129183355|NCT01659255|464966831|FG012|Overall Study|Death|1|||
129183356|NCT01659255|464966832|FG013|Overall Study|Death|1|||
129183357|NCT01659255|464966833|FG014|Overall Study|Death|2|||
129183358|NCT01659255|464966834|FG015|Overall Study|Death|1|||
129183359|NCT01659255|464966835|FG016|Overall Study|Death|0|||
129183360|NCT01659255|464966819|FG000|Overall Study|Progressive Disease|2|||
129183361|NCT01659255|464966820|FG001|Overall Study|Progressive Disease|0|||
129183362|NCT01659255|464966821|FG002|Overall Study|Progressive Disease|0|||
129183363|NCT01659255|464966822|FG003|Overall Study|Progressive Disease|0|||
129183364|NCT01659255|464966823|FG004|Overall Study|Progressive Disease|0|||
129183365|NCT01659255|464966824|FG005|Overall Study|Progressive Disease|0|||
129183366|NCT01659255|464966825|FG006|Overall Study|Progressive Disease|0|||
129183367|NCT01659255|464966826|FG007|Overall Study|Progressive Disease|1|||
129183368|NCT01659255|464966827|FG008|Overall Study|Progressive Disease|0|||
129183369|NCT01659255|464966828|FG009|Overall Study|Progressive Disease|2|||
129183370|NCT01659255|464966829|FG010|Overall Study|Progressive Disease|2|||
129183371|NCT01659255|464966830|FG011|Overall Study|Progressive Disease|3|||
129183372|NCT01659255|464966831|FG012|Overall Study|Progressive Disease|5|||
129183373|NCT01659255|464966832|FG013|Overall Study|Progressive Disease|13|||
129183374|NCT01659255|464966833|FG014|Overall Study|Progressive Disease|6|||
129183375|NCT01659255|464966834|FG015|Overall Study|Progressive Disease|2|||
129183376|NCT01659255|464966835|FG016|Overall Study|Progressive Disease|3|||
129183377|NCT01659255|464966819|FG000|Overall Study|Withdrew Consent|0|||
129183378|NCT01659255|464966820|FG001|Overall Study|Withdrew Consent|0|||
129183379|NCT01659255|464966821|FG002|Overall Study|Withdrew Consent|0|||
129183380|NCT01659255|464966822|FG003|Overall Study|Withdrew Consent|0|||
129183381|NCT01659255|464966823|FG004|Overall Study|Withdrew Consent|0|||
129183382|NCT01659255|464966824|FG005|Overall Study|Withdrew Consent|0|||
129183383|NCT01659255|464966825|FG006|Overall Study|Withdrew Consent|0|||
129183384|NCT01659255|464966826|FG007|Overall Study|Withdrew Consent|0|||
129183385|NCT01659255|464966827|FG008|Overall Study|Withdrew Consent|0|||
129183386|NCT01659255|464966828|FG009|Overall Study|Withdrew Consent|0|||
129183387|NCT01659255|464966829|FG010|Overall Study|Withdrew Consent|1|||
129183388|NCT01659255|464966830|FG011|Overall Study|Withdrew Consent|0|||
129183389|NCT01659255|464966831|FG012|Overall Study|Withdrew Consent|0|||
129183390|NCT01659255|464966832|FG013|Overall Study|Withdrew Consent|1|||
129183391|NCT01659255|464966833|FG014|Overall Study|Withdrew Consent|0|||
129183392|NCT01659255|464966834|FG015|Overall Study|Withdrew Consent|0|||
129183393|NCT01659255|464966835|FG016|Overall Study|Withdrew Consent|0|||
129183394|NCT01659255|464966819|FG000|Overall Study|Investigator Decision|0|||
129183395|NCT01659255|464966820|FG001|Overall Study|Investigator Decision|0|||
129183396|NCT01659255|464966821|FG002|Overall Study|Investigator Decision|0|||
129183397|NCT01659255|464966822|FG003|Overall Study|Investigator Decision|0|||
129183398|NCT01659255|464966823|FG004|Overall Study|Investigator Decision|0|||
129183399|NCT01659255|464966824|FG005|Overall Study|Investigator Decision|0|||
129183400|NCT01659255|464966825|FG006|Overall Study|Investigator Decision|0|||
129183401|NCT01659255|464966826|FG007|Overall Study|Investigator Decision|0|||
129183402|NCT01659255|464966827|FG008|Overall Study|Investigator Decision|0|||
129183403|NCT01659255|464966828|FG009|Overall Study|Investigator Decision|0|||
129183404|NCT01659255|464966829|FG010|Overall Study|Investigator Decision|0|||
129183405|NCT01659255|464966830|FG011|Overall Study|Investigator Decision|0|||
129183406|NCT01659255|464966831|FG012|Overall Study|Investigator Decision|1|||
129183407|NCT01659255|464966832|FG013|Overall Study|Investigator Decision|1|||
129183408|NCT01659255|464966833|FG014|Overall Study|Investigator Decision|0|||
129183409|NCT01659255|464966834|FG015|Overall Study|Investigator Decision|0|||
129183410|NCT01659255|464966835|FG016|Overall Study|Investigator Decision|0|||
129183411|NCT01659255|464966819|FG000|Overall Study|Sponsor's Decision|0|||
129183412|NCT01659255|464966820|FG001|Overall Study|Sponsor's Decision|0|||
129183413|NCT01659255|464966821|FG002|Overall Study|Sponsor's Decision|0|||
129183414|NCT01659255|464966822|FG003|Overall Study|Sponsor's Decision|0|||
129183415|NCT01659255|464966823|FG004|Overall Study|Sponsor's Decision|0|||
129183416|NCT01659255|464966824|FG005|Overall Study|Sponsor's Decision|0|||
129183417|NCT01659255|464966825|FG006|Overall Study|Sponsor's Decision|1|||
129183418|NCT01659255|464966826|FG007|Overall Study|Sponsor's Decision|0|||
129183419|NCT01659255|464966827|FG008|Overall Study|Sponsor's Decision|0|||
129183420|NCT01659255|464966828|FG009|Overall Study|Sponsor's Decision|0|||
129183421|NCT01659255|464966829|FG010|Overall Study|Sponsor's Decision|0|||
129183422|NCT01659255|464966830|FG011|Overall Study|Sponsor's Decision|0|||
129183423|NCT01659255|464966831|FG012|Overall Study|Sponsor's Decision|0|||
129183424|NCT01659255|464966832|FG013|Overall Study|Sponsor's Decision|0|||
129183425|NCT01659255|464966833|FG014|Overall Study|Sponsor's Decision|0|||
129183426|NCT01659255|464966834|FG015|Overall Study|Sponsor's Decision|0|||
129183427|NCT01659255|464966835|FG016|Overall Study|Sponsor's Decision|0|||
129183428|NCT01659255|464966819|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183429|NCT01659255|464966820|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183430|NCT01659255|464966821|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183431|NCT01659255|464966822|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183432|NCT01659255|464966823|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183433|NCT01659255|464966824|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183434|NCT01659255|464966825|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183435|NCT01659255|464966826|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183436|NCT01659255|464966827|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183437|NCT01659255|464966828|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183438|NCT01659255|464966829|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183439|NCT01659255|464966830|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183440|NCT01659255|464966831|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183441|NCT01659255|464966832|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183442|NCT01659255|464966833|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183443|NCT01659255|464966834|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
129183444|NCT01659255|464966835|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129183445|NCT01659255|464966819|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
129183446|NCT01659255|464966820|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
129183447|NCT01659255|464966821|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
129183448|NCT01659255|464966822|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
129183449|NCT01659255|464966823|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
129183450|NCT01659255|464966824|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
129183451|NCT01659255|464966825|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
129183452|NCT01659255|464966826|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
129183453|NCT01659255|464966827|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
129183454|NCT01659255|464966828|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
129183455|NCT01659255|464966829|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
129183456|NCT01659255|464966830|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
129183457|NCT01659255|464966831|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
129183458|NCT01659255|464966832|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
129183459|NCT01659255|464966833|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
129183460|NCT01659255|464966834|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
129183461|NCT01659255|464966835|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
129183462|NCT01116427|464966836|FG000|Core Phase|Adverse Event|0|||
129183463|NCT01116427|464966837|FG001|Core Phase|Adverse Event|1|||
129183464|NCT01116427|464966836|FG000|Core Phase|Lost to Follow-up|1|||
129183465|NCT01116427|464966837|FG001|Core Phase|Lost to Follow-up|0|||
129183466|NCT01116427|464966836|FG000|Core Phase|Withdrawal by Subject|3|||
129183467|NCT01116427|464966837|FG001|Core Phase|Withdrawal by Subject|0|||
129183468|NCT01116427|464966836|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
129183469|NCT01116427|464966837|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
129183470|NCT01116427|464966836|FG000|Extension Phase|Adverse Event|1|||
129183471|NCT01116427|464966837|FG001|Extension Phase|Adverse Event|1|||
129183472|NCT01116427|464966836|FG000|Extension Phase|Lost to Follow-up|2|||
129183473|NCT01116427|464966837|FG001|Extension Phase|Lost to Follow-up|0|||
129183474|NCT01116427|464966836|FG000|Extension Phase|Withdrawal by Subject|5|||
129183475|NCT01116427|464966837|FG001|Extension Phase|Withdrawal by Subject|1|||
129183476|NCT01116427|464966836|FG000|Extension Phase|Not using appropriate birth control|1|||
129183477|NCT01116427|464966837|FG001|Extension Phase|Not using appropriate birth control|0|||
129183478|NCT02989805|464966838|FG000|Overall Study|invalid consent|6|||
129183479|NCT02989805|464966839|FG001|Overall Study|invalid consent|4|||
129183480|NCT02648217|464966840|FG000|Overall Study|Adverse Event|0|||
129183481|NCT02648217|464966841|FG001|Overall Study|Adverse Event|1|||
129183482|NCT02648217|464966840|FG000|Overall Study|Lost to Follow-up|1|||
129183483|NCT02648217|464966841|FG001|Overall Study|Lost to Follow-up|1|||
129183484|NCT02648217|464966840|FG000|Overall Study|Withdrawal by Subject|4|||
129183485|NCT02648217|464966841|FG001|Overall Study|Withdrawal by Subject|3|||
129183486|NCT02648217|464966840|FG000|Overall Study|Unclassified|5|||
129183487|NCT02648217|464966841|FG001|Overall Study|Unclassified|0|||
129183488|NCT03316950|464966842|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
129183489|NCT03316950|464966843|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
129183490|NCT03316950|464966844|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
129183491|NCT03316950|464966845|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
129183492|NCT03316950|464966842|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
129183493|NCT03316950|464966843|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
129183494|NCT03316950|464966844|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
129183495|NCT03316950|464966845|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
129183496|NCT03316950|464966842|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
129183497|NCT03316950|464966843|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
129183498|NCT03316950|464966844|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
129183499|NCT03316950|464966845|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
129183500|NCT02335424|464966846|FG000|Overall Study|Withdrawal by Subject|19|||
129183501|NCT02335424|464966846|FG000|Overall Study|Adverse Event|25|||
129183502|NCT02335424|464966846|FG000|Overall Study|Death|273|||
129183503|NCT02335424|464966846|FG000|Overall Study|Lost to Follow-up|3|||
129183504|NCT02335424|464966846|FG000|Overall Study|Physician Decision|13|||
129183505|NCT02335424|464966846|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
129183506|NCT02335424|464966846|FG000|Overall Study|Protocol Violation|1|||
129183507|NCT02335424|464966846|FG000|Overall Study|Screen failure|1|||
129183508|NCT02776033|464966849|FG000|Overall Study|Withdrawal by Subject|0|||
129183509|NCT02776033|464966850|FG001|Overall Study|Withdrawal by Subject|0|||
129183510|NCT02776033|464966851|FG002|Overall Study|Withdrawal by Subject|2|||
129183511|NCT02776033|464966849|FG000|Overall Study|Physician Decision|2|||
129183512|NCT02776033|464966850|FG001|Overall Study|Physician Decision|0|||
129183513|NCT02776033|464966851|FG002|Overall Study|Physician Decision|0|||
129183514|NCT02776033|464966849|FG000|Overall Study|Lost to Follow-up|1|||
129183515|NCT02776033|464966850|FG001|Overall Study|Lost to Follow-up|0|||
129183516|NCT02776033|464966851|FG002|Overall Study|Lost to Follow-up|0|||
129183517|NCT02776033|464966849|FG000|Overall Study|Adverse Event|1|||
129183518|NCT02776033|464966850|FG001|Overall Study|Adverse Event|2|||
129183519|NCT02776033|464966851|FG002|Overall Study|Adverse Event|0|||
129183520|NCT02712424|464966852|FG000|Overall Study|Lost to Follow-up|34|||
129183521|NCT02712424|464966853|FG001|Overall Study|Lost to Follow-up|32|||
129183522|NCT02713867|464966859|FG000|Randomization|Other Reason|2|||
129183523|NCT02713867|464966860|FG001|Randomization|Other Reason|1|||
129183524|NCT02713867|464966859|FG000|Randomization|Participant Withdrew consent|0|||
129183525|NCT02713867|464966860|FG001|Randomization|Participant Withdrew consent|2|||
129183526|NCT02713867|464966859|FG000|Treatment Period|Other Reasons|22|||
129183527|NCT02713867|464966860|FG001|Treatment Period|Other Reasons|28|||
129183528|NCT02713867|464966859|FG000|Treatment Period|Administrative reason by sponsor|21|||
129183529|NCT02713867|464966860|FG001|Treatment Period|Administrative reason by sponsor|16|||
129183530|NCT02713867|464966859|FG000|Treatment Period|No longer meets study criteria|2|||
129183531|NCT02713867|464966860|FG001|Treatment Period|No longer meets study criteria|1|||
129183532|NCT02713867|464966859|FG000|Treatment Period|Poor/Non Compliance|1|||
129183533|NCT02713867|464966860|FG001|Treatment Period|Poor/Non Compliance|0|||
129183534|NCT02713867|464966859|FG000|Treatment Period|Maximum Clinical Benefit|5|||
129183535|NCT02713867|464966860|FG001|Treatment Period|Maximum Clinical Benefit|6|||
129183536|NCT02713867|464966859|FG000|Treatment Period|Withdrew consent|3|||
129183537|NCT02713867|464966860|FG001|Treatment Period|Withdrew consent|6|||
129183538|NCT02713867|464966859|FG000|Treatment Period|Requested to Discontinue|8|||
129183539|NCT02713867|464966860|FG001|Treatment Period|Requested to Discontinue|8|||
129183540|NCT02713867|464966859|FG000|Treatment Period|AE unrelated to Study Drug|11|||
129183541|NCT02713867|464966860|FG001|Treatment Period|AE unrelated to Study Drug|10|||
129183542|NCT02713867|464966859|FG000|Treatment Period|Death|7|||
129183543|NCT02713867|464966860|FG001|Treatment Period|Death|3|||
129183544|NCT02713867|464966859|FG000|Treatment Period|Study Drug Toxicity|16|||
129183545|NCT02713867|464966860|FG001|Treatment Period|Study Drug Toxicity|19|||
129183546|NCT02713867|464966859|FG000|Treatment Period|Disease Progression|82|||
129183547|NCT02713867|464966860|FG001|Treatment Period|Disease Progression|83|||
129183548|NCT02715726|464966864|FG000|Overall Study|Adverse Event|2|||
129183549|NCT02715726|464966865|FG001|Overall Study|Adverse Event|6|||
129183550|NCT02715726|464966864|FG000|Overall Study|Protocol Violation|1|||
129183551|NCT02715726|464966865|FG001|Overall Study|Protocol Violation|0|||
129183552|NCT02715726|464966864|FG000|Overall Study|Death|2|||
129183553|NCT02715726|464966865|FG001|Overall Study|Death|1|||
129183554|NCT02715726|464966864|FG000|Overall Study|Participant moved|1|||
129183555|NCT02715726|464966865|FG001|Overall Study|Participant moved|3|||
129183556|NCT02715726|464966864|FG000|Overall Study|Other than specified above|11|||
129183557|NCT02715726|464966865|FG001|Overall Study|Other than specified above|15|||
129183558|NCT02715726|464966864|FG000|Overall Study|Randomized but not treated|1|||
129183559|NCT02715726|464966865|FG001|Overall Study|Randomized but not treated|2|||
129183560|NCT03230292|464966866|FG000|Overall Study|Adverse Event|1|||
129183561|NCT03230292|464966866|FG000|Overall Study|Protocol Violation|1|||
129183562|NCT03230292|464966866|FG000|Overall Study|Lost to Follow-up|1|||
129183563|NCT03230292|464966866|FG000|Overall Study|Withdrawal by Subject|3|||
129183564|NCT04109976|464966867|FG000|Overall Study|Withdrawal by Subject|1|||
129183565|NCT04109976|464966868|FG001|Overall Study|Withdrawal by Subject|0|||
129183566|NCT00491608|464966869|FG000|Overall Study|Death|2|||
129183567|NCT00491608|464966869|FG000|Overall Study|Withdrawal by Subject|1|||
129183568|NCT00413374|464966870|FG000|Overall Study|Ineligible due to screening criteria.|3|||
129183569|NCT00413374|464966871|FG001|Overall Study|Ineligible due to screening criteria.|0|||
129183570|NCT00413374|464966870|FG000|Overall Study|Adverse Event|1|||
129183571|NCT00413374|464966871|FG001|Overall Study|Adverse Event|0|||
129183572|NCT00413374|464966870|FG000|Overall Study|Lost to Follow-up|1|||
129183573|NCT00413374|464966871|FG001|Overall Study|Lost to Follow-up|0|||
129183574|NCT00413374|464966870|FG000|Overall Study|Surgery|1|||
129183575|NCT00413374|464966871|FG001|Overall Study|Surgery|0|||
129183576|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
129183577|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
129183578|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
129183579|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
129183580|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
129183581|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
129183582|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129183583|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129183584|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129183585|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129183586|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129183587|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
129183588|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
129183589|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
129183590|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129183591|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
129183592|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
129183593|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129183594|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129183595|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129183596|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129183597|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129183598|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129183599|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
129183600|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
129183601|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
129183602|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
129183603|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
129183604|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129183605|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129183606|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129183607|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129183608|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129183609|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
129183610|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
129183611|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
129183612|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129183613|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
129183614|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
129183615|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129183616|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129183617|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129183618|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129183619|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129183620|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183621|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183622|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
129183623|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183624|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183625|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
129183626|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183627|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183628|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183629|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183630|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129183631|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
129183632|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183633|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183634|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183635|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183636|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183637|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183638|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183639|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183640|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183641|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129183642|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183643|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183644|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
129183645|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183646|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183647|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183648|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183649|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183650|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183651|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183652|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129183653|NCT02914561|464966877|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
129183654|NCT02914561|464966878|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129183655|NCT02914561|464966879|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129183656|NCT02914561|464966880|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129183657|NCT02914561|464966881|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129183658|NCT02914561|464966882|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129183659|NCT02914561|464966883|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129183660|NCT02914561|464966884|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129183661|NCT02914561|464966885|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129183662|NCT02914561|464966886|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129183663|NCT02914561|464966887|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129183664|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129183665|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129183666|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129183667|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129183668|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129183669|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129183670|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
129183671|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
129183672|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
129183673|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
129183674|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
129183675|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129183676|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129183677|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129183678|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129183679|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129183680|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129183681|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
129183682|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
129183683|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
129183684|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
129183685|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
129183686|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129183687|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129183688|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129183689|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129183690|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129183691|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129183692|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
128730230|NCT00316199|463308364|FG000|Overall Study|Death|8|||
129183693|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
129183694|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
129183695|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
129183696|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
129183697|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183698|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183699|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183700|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183701|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183702|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183703|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
129183704|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183705|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
129183706|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129183707|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
129183708|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129183709|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129183710|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129183711|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129183712|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129183713|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129183714|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
129183715|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129183716|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
129183717|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
129183718|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
129183719|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183720|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183721|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183722|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183723|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183724|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183725|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
129183726|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183727|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
129183728|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183729|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129183730|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183731|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183732|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183733|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183734|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183735|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183736|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183737|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183738|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
129183739|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183740|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129183741|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183742|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183743|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183744|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183745|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183746|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183747|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
129183748|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183749|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183750|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183751|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129183752|NCT02914561|464966877|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183753|NCT02914561|464966878|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183754|NCT02914561|464966879|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183755|NCT02914561|464966880|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183756|NCT02914561|464966881|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183757|NCT02914561|464966882|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183758|NCT02914561|464966883|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183759|NCT02914561|464966884|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129183760|NCT02914561|464966885|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
129183761|NCT02914561|464966886|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
129183762|NCT02914561|464966887|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
129183763|NCT01455220|464966890|FG000|Overall Study|screen fail|30|||
129183764|NCT00521222|464966892|FG000|Overall Study|Lost to Follow-up|0|||
129183765|NCT00521222|464966893|FG001|Overall Study|Lost to Follow-up|0|||
129183766|NCT00521222|464966894|FG002|Overall Study|Lost to Follow-up|1|||
129183767|NCT00521222|464966895|FG003|Overall Study|Lost to Follow-up|1|||
129183768|NCT00521222|464966892|FG000|Overall Study|Withdrawal by Subject|0|||
129183769|NCT00521222|464966893|FG001|Overall Study|Withdrawal by Subject|0|||
129183770|NCT00521222|464966894|FG002|Overall Study|Withdrawal by Subject|2|||
129183771|NCT00521222|464966895|FG003|Overall Study|Withdrawal by Subject|0|||
129183772|NCT00521222|464966892|FG000|Overall Study|Physician Decision|0|||
129183773|NCT00521222|464966893|FG001|Overall Study|Physician Decision|1|||
129183774|NCT00521222|464966894|FG002|Overall Study|Physician Decision|0|||
129183775|NCT00521222|464966895|FG003|Overall Study|Physician Decision|1|||
129183776|NCT03332160|464966896|FG000|Overall Study|Withdrawal by Subject|1|||
129183777|NCT03332160|464966897|FG001|Overall Study|Withdrawal by Subject|1|||
129183778|NCT03332160|464966896|FG000|Overall Study|Adverse Event|0|||
129183779|NCT03332160|464966897|FG001|Overall Study|Adverse Event|1|||
129183780|NCT03332160|464966896|FG000|Overall Study|Developed Exclusion Criteria|0|||
129183781|NCT03332160|464966897|FG001|Overall Study|Developed Exclusion Criteria|1|||
129183782|NCT03332160|464966896|FG000|Overall Study|Non-adherence to treatment|0|||
129183783|NCT03332160|464966897|FG001|Overall Study|Non-adherence to treatment|2|||
129183784|NCT03869333|464966898|FG000|Overall Study|Lost to Follow-up|1|||
129183785|NCT03869333|464966899|FG001|Overall Study|Lost to Follow-up|0|||
129183786|NCT03869333|464966900|FG002|Overall Study|Lost to Follow-up|0|||
129183787|NCT03869333|464966901|FG003|Overall Study|Lost to Follow-up|0|||
129183788|NCT03869333|464966898|FG000|Overall Study|Pregnancy|1|||
129183789|NCT03869333|464966899|FG001|Overall Study|Pregnancy|0|||
129183790|NCT03869333|464966900|FG002|Overall Study|Pregnancy|0|||
129183791|NCT03869333|464966901|FG003|Overall Study|Pregnancy|0|||
129183792|NCT03869333|464966898|FG000|Overall Study|Physician Decision|0|||
129183793|NCT03869333|464966899|FG001|Overall Study|Physician Decision|1|||
129183794|NCT03869333|464966900|FG002|Overall Study|Physician Decision|0|||
129183795|NCT03869333|464966901|FG003|Overall Study|Physician Decision|0|||
129183796|NCT01927055|464966902|FG000|Open-label|Adverse Event|6|||
129183797|NCT01927055|464966903|FG001|Open-label|Adverse Event|0|||
129183798|NCT01927055|464966904|FG002|Open-label|Adverse Event|0|||
129183799|NCT01927055|464966902|FG000|Open-label|Withdrawal by Subject|1|||
129183800|NCT01927055|464966903|FG001|Open-label|Withdrawal by Subject|0|||
129183801|NCT01927055|464966904|FG002|Open-label|Withdrawal by Subject|0|||
129183802|NCT01927055|464966902|FG000|Open-label|Study Stopped|4|||
129183803|NCT01927055|464966903|FG001|Open-label|Study Stopped|0|||
129183804|NCT01927055|464966904|FG002|Open-label|Study Stopped|0|||
129183805|NCT01927055|464966902|FG000|Open-label|Supine Hypertension|4|||
129183806|NCT01927055|464966903|FG001|Open-label|Supine Hypertension|0|||
129183807|NCT01927055|464966904|FG002|Open-label|Supine Hypertension|0|||
129183808|NCT01927055|464966902|FG000|Open-label|Difficulty attending study visits|1|||
129183809|NCT01927055|464966903|FG001|Open-label|Difficulty attending study visits|0|||
129183810|NCT01927055|464966904|FG002|Open-label|Difficulty attending study visits|0|||
129183811|NCT01927055|464966902|FG000|Double-Blind|Adverse Event|0|||
129183812|NCT01927055|464966903|FG001|Double-Blind|Adverse Event|1|||
129183813|NCT01927055|464966904|FG002|Double-Blind|Adverse Event|1|||
129183814|NCT01927055|464966902|FG000|Double-Blind|Protocol Violation|0|||
129183815|NCT01927055|464966903|FG001|Double-Blind|Protocol Violation|0|||
129183816|NCT01927055|464966904|FG002|Double-Blind|Protocol Violation|1|||
129183817|NCT01927055|464966902|FG000|Double-Blind|Withdrawal by Subject|0|||
129183818|NCT01927055|464966903|FG001|Double-Blind|Withdrawal by Subject|2|||
129183819|NCT01927055|464966904|FG002|Double-Blind|Withdrawal by Subject|3|||
129183820|NCT01927055|464966902|FG000|Double-Blind|Study Stopped|0|||
129183821|NCT01927055|464966903|FG001|Double-Blind|Study Stopped|7|||
129183822|NCT01927055|464966904|FG002|Double-Blind|Study Stopped|7|||
129183823|NCT01927055|464966902|FG000|Double-Blind|Supine Hypertension|0|||
129183824|NCT01927055|464966903|FG001|Double-Blind|Supine Hypertension|0|||
129183825|NCT01927055|464966904|FG002|Double-Blind|Supine Hypertension|1|||
129183826|NCT01927055|464966902|FG000|Double-Blind|Extended Vacation|0|||
129183827|NCT01927055|464966903|FG001|Double-Blind|Extended Vacation|1|||
129183828|NCT01927055|464966904|FG002|Double-Blind|Extended Vacation|0|||
129183829|NCT00952614|464966910|FG000|Overall Study|Death|3|||
129183830|NCT00952614|464966910|FG000|Overall Study|Lost to Follow-up|3|||
129183831|NCT00952614|464966910|FG000|Overall Study|other reason|1|||
129183832|NCT04023682|464966911|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
129183833|NCT01291277|464966912|FG000|Overall Study|Death|2|||
129183834|NCT01291277|464966913|FG001|Overall Study|Death|2|||
129183835|NCT01291277|464966912|FG000|Overall Study|Lost to Follow-up|3|||
129183836|NCT01291277|464966913|FG001|Overall Study|Lost to Follow-up|1|||
129183837|NCT02963701|464966914|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
129183838|NCT02963701|464966915|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
129183839|NCT03480009|464966916|FG000|Overall Study|Lost to Follow-up|4|||
129183840|NCT03480009|464966917|FG001|Overall Study|Lost to Follow-up|5|||
129183841|NCT03480009|464966918|FG002|Overall Study|Lost to Follow-up|4|||
129183842|NCT03480009|464966919|FG003|Overall Study|Lost to Follow-up|0|||
129183843|NCT01105377|464966922|FG000|Overall Study|Withdrawal by Subject|0|||
129183844|NCT01105377|464966923|FG001|Overall Study|Withdrawal by Subject|1|||
129183845|NCT01403116|464966929|FG000|Overall Study|Adverse Event|7|||
129183846|NCT01403116|464966930|FG001|Overall Study|Adverse Event|4|||
129183847|NCT01403116|464966929|FG000|Overall Study|Lost to Follow-up|7|||
129183848|NCT01403116|464966930|FG001|Overall Study|Lost to Follow-up|5|||
129183849|NCT01403116|464966929|FG000|Overall Study|Withdrawal by Subject|12|||
129183850|NCT01403116|464966930|FG001|Overall Study|Withdrawal by Subject|15|||
129183851|NCT01403116|464966929|FG000|Overall Study|Non-compliance of study drug|3|||
129183852|NCT01403116|464966930|FG001|Overall Study|Non-compliance of study drug|0|||
129183853|NCT01403116|464966929|FG000|Overall Study|Protocol Violation|0|||
129183854|NCT01403116|464966930|FG001|Overall Study|Protocol Violation|1|||
129183855|NCT01403116|464966929|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
129183856|NCT01403116|464966930|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
129183857|NCT01403116|464966929|FG000|Overall Study|Hct >54%|2|||
129183858|NCT01403116|464966930|FG001|Overall Study|Hct >54%|0|||
128780961|NCT01323660|463488626|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
128780962|NCT01323660|463488627|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
128780963|NCT01323660|463488628|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
128780964|NCT01323660|463488629|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
128780965|NCT01323660|463488630|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
128780966|NCT01323660|463488631|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
128780967|NCT01323660|463488626|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
128780968|NCT01323660|463488627|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
128780969|NCT01323660|463488628|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
128780970|NCT01323660|463488629|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
128780971|NCT01323660|463488630|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
128780972|NCT01323660|463488631|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
129183859|NCT01403116|464966929|FG000|Overall Study|unable to keep appointments|0|||
129183860|NCT01403116|464966930|FG001|Overall Study|unable to keep appointments|2|||
129183861|NCT02540291|464966931|FG000|Overall Study|Death|7|||
129183862|NCT02540291|464966932|FG001|Overall Study|Death|7|||
129183863|NCT02540291|464966933|FG002|Overall Study|Death|5|||
129183864|NCT02540291|464966934|FG003|Overall Study|Death|7|||
129183865|NCT02540291|464966931|FG000|Overall Study|Lost to Follow-up|0|||
129183866|NCT02540291|464966932|FG001|Overall Study|Lost to Follow-up|0|||
129183867|NCT02540291|464966933|FG002|Overall Study|Lost to Follow-up|1|||
129183868|NCT02540291|464966934|FG003|Overall Study|Lost to Follow-up|0|||
129183869|NCT02540291|464966931|FG000|Overall Study|Withdrawal Of Consent|0|||
129183870|NCT02540291|464966932|FG001|Overall Study|Withdrawal Of Consent|1|||
129183871|NCT02540291|464966933|FG002|Overall Study|Withdrawal Of Consent|0|||
129183872|NCT02540291|464966934|FG003|Overall Study|Withdrawal Of Consent|0|||
129183873|NCT02540291|464966931|FG000|Overall Study|Study Terminated By Sponsor|1|||
129183874|NCT02540291|464966932|FG001|Overall Study|Study Terminated By Sponsor|0|||
129183875|NCT02540291|464966933|FG002|Overall Study|Study Terminated By Sponsor|0|||
129183876|NCT02540291|464966934|FG003|Overall Study|Study Terminated By Sponsor|0|||
129183877|NCT02540291|464966931|FG000|Overall Study|Other|0|||
129183878|NCT02540291|464966932|FG001|Overall Study|Other|0|||
129183879|NCT02540291|464966933|FG002|Overall Study|Other|1|||
129183880|NCT02540291|464966934|FG003|Overall Study|Other|0|||
129183881|NCT04046250|464966948|FG000|Overall Study|Death|0|||
129183882|NCT04046250|464966949|FG001|Overall Study|Death|1|||
129183883|NCT04046250|464966948|FG000|Overall Study|Withdrawal by Subject|3|||
129183884|NCT04046250|464966949|FG001|Overall Study|Withdrawal by Subject|3|||
129183885|NCT04576897|464966950|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
129183886|NCT00527332|464966951|FG000|Overall Study|Protocol Violation|4|||
129183887|NCT00527332|464966952|FG001|Overall Study|Protocol Violation|8|||
129183888|NCT00527332|464966951|FG000|Overall Study|Withdrew consent|5|||
129183889|NCT00527332|464966952|FG001|Overall Study|Withdrew consent|1|||
129183890|NCT02666105|464966953|FG000|Overall Study|Death|1|||
129183891|NCT02100969|464968700|FG000|Overall Study|Did not pass screening phase|1|||
129183892|NCT01629953|464968701|FG000|Overall Study|Death|3|||
129183893|NCT01629953|464968702|FG001|Overall Study|Death|1|||
129183894|NCT01629953|464968701|FG000|Overall Study|Lost to Follow-up|10|||
129183895|NCT01629953|464968702|FG001|Overall Study|Lost to Follow-up|14|||
129183896|NCT04051827|464968704|FG000|Overall Study|Death|1|||
129183897|NCT04051827|464968704|FG000|Overall Study|Withdrawal by Subject|4|||
129183898|NCT04051827|464968704|FG000|Overall Study|Progressive disease|16|||
129183899|NCT04051827|464968704|FG000|Overall Study|Physician Decision|1|||
129183900|NCT04051827|464968704|FG000|Overall Study|Other|4|||
129183901|NCT01424566|464968705|FG000|Single-blind Treatment|Adverse Event|71|||
129183902|NCT01424566|464968706|FG001|Single-blind Treatment|Adverse Event|0|||
129183903|NCT01424566|464968707|FG002|Single-blind Treatment|Adverse Event|0|||
129183904|NCT01424566|464968705|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
129183905|NCT01424566|464968706|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
129183906|NCT01424566|464968707|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
129183907|NCT01424566|464968705|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
129183908|NCT01424566|464968706|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
129183909|NCT01424566|464968707|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
129183910|NCT01424566|464968705|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
129183911|NCT01424566|464968706|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
129183912|NCT01424566|464968707|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
129183913|NCT01424566|464968705|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
129183914|NCT01424566|464968706|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
129183915|NCT01424566|464968707|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
129183916|NCT01424566|464968705|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
129183917|NCT01424566|464968706|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
129183918|NCT01424566|464968707|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
129183919|NCT01424566|464968705|FG000|Double-blind Treatment|Adverse Event|0|||
129183920|NCT01424566|464968706|FG001|Double-blind Treatment|Adverse Event|21|||
129183921|NCT01424566|464968707|FG002|Double-blind Treatment|Adverse Event|13|||
129183922|NCT01424566|464968705|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
129183923|NCT01424566|464968706|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
129183924|NCT01424566|464968707|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
129183925|NCT01424566|464968705|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
129183926|NCT01424566|464968706|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
129183927|NCT01424566|464968707|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
129183928|NCT01424566|464968705|FG000|Double-blind Treatment|Lack of Efficacy|0|||
129183929|NCT01424566|464968706|FG001|Double-blind Treatment|Lack of Efficacy|1|||
129183930|NCT01424566|464968707|FG002|Double-blind Treatment|Lack of Efficacy|1|||
129183931|NCT03779503|464968712|FG000|First Intervention|Adverse Event|0|||
129183932|NCT03779503|464968713|FG001|First Intervention|Adverse Event|1|||
129183933|NCT03779503|464968712|FG000|First Intervention|Withdrawal by Subject|1|||
129183934|NCT03779503|464968713|FG001|First Intervention|Withdrawal by Subject|0|||
129183935|NCT02211313|464968716|FG000|Overall Study|Treatment Failure|5|||
129183936|NCT02211313|464968717|FG001|Overall Study|Treatment Failure|2|||
129183937|NCT02211313|464968716|FG000|Overall Study|No Follow up Questionnaires|1|||
129183938|NCT02211313|464968717|FG001|Overall Study|No Follow up Questionnaires|1|||
129183939|NCT03743064|464968718|FG000|Overall Study|Adverse Event|7|||
129183940|NCT03743064|464968719|FG001|Overall Study|Adverse Event|9|||
129183941|NCT03743064|464968718|FG000|Overall Study|Death|25|||
129183942|NCT03743064|464968719|FG001|Overall Study|Death|28|||
129183943|NCT03743064|464968718|FG000|Overall Study|Lost to Follow-up|3|||
129183944|NCT03743064|464968719|FG001|Overall Study|Lost to Follow-up|6|||
129183945|NCT03743064|464968718|FG000|Overall Study|Withdrawal by Subject|28|||
129183946|NCT03743064|464968719|FG001|Overall Study|Withdrawal by Subject|25|||
129183947|NCT03743064|464968718|FG000|Overall Study|Physician Decision|2|||
129183948|NCT03743064|464968719|FG001|Overall Study|Physician Decision|4|||
129183949|NCT03743064|464968718|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
129183950|NCT03743064|464968719|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
129183951|NCT02771626|464968720|FG000|Overall Study|Adverse Event|1|||
129183952|NCT02771626|464968721|FG001|Overall Study|Adverse Event|5|||
129183953|NCT02771626|464968722|FG002|Overall Study|Adverse Event|3|||
129183954|NCT02771626|464968723|FG003|Overall Study|Adverse Event|0|||
129183955|NCT02771626|464968724|FG004|Overall Study|Adverse Event|1|||
129183956|NCT02771626|464968725|FG005|Overall Study|Adverse Event|1|||
129183957|NCT02771626|464968720|FG000|Overall Study|Radiologic Disease Progression|6|||
129183958|NCT02771626|464968721|FG001|Overall Study|Radiologic Disease Progression|13|||
129183959|NCT02771626|464968722|FG002|Overall Study|Radiologic Disease Progression|10|||
129183960|NCT02771626|464968723|FG003|Overall Study|Radiologic Disease Progression|7|||
129183961|NCT02771626|464968724|FG004|Overall Study|Radiologic Disease Progression|28|||
129183962|NCT02771626|464968725|FG005|Overall Study|Radiologic Disease Progression|15|||
129183963|NCT02771626|464968720|FG000|Overall Study|Symptomatic Deterioration|0|||
129183964|NCT02771626|464968721|FG001|Overall Study|Symptomatic Deterioration|4|||
129183965|NCT02771626|464968722|FG002|Overall Study|Symptomatic Deterioration|2|||
129183966|NCT02771626|464968723|FG003|Overall Study|Symptomatic Deterioration|0|||
129183967|NCT02771626|464968724|FG004|Overall Study|Symptomatic Deterioration|5|||
129183968|NCT02771626|464968725|FG005|Overall Study|Symptomatic Deterioration|2|||
129183969|NCT02771626|464968720|FG000|Overall Study|Participant Request|0|||
129183970|NCT02771626|464968721|FG001|Overall Study|Participant Request|1|||
129183971|NCT02771626|464968722|FG002|Overall Study|Participant Request|0|||
129183972|NCT02771626|464968723|FG003|Overall Study|Participant Request|2|||
129183973|NCT02771626|464968724|FG004|Overall Study|Participant Request|0|||
129183974|NCT02771626|464968725|FG005|Overall Study|Participant Request|1|||
129183975|NCT02771626|464968720|FG000|Overall Study|Investigator Decision|0|||
129183976|NCT02771626|464968721|FG001|Overall Study|Investigator Decision|1|||
129183977|NCT02771626|464968722|FG002|Overall Study|Investigator Decision|0|||
129183978|NCT02771626|464968723|FG003|Overall Study|Investigator Decision|0|||
129183979|NCT02771626|464968724|FG004|Overall Study|Investigator Decision|1|||
129183980|NCT02771626|464968725|FG005|Overall Study|Investigator Decision|0|||
129183981|NCT02771626|464968720|FG000|Overall Study|Study Termination by Sponsor|0|||
129183982|NCT02771626|464968721|FG001|Overall Study|Study Termination by Sponsor|2|||
129183983|NCT02771626|464968722|FG002|Overall Study|Study Termination by Sponsor|1|||
129183984|NCT02771626|464968723|FG003|Overall Study|Study Termination by Sponsor|0|||
129183985|NCT02771626|464968724|FG004|Overall Study|Study Termination by Sponsor|1|||
129183986|NCT02771626|464968725|FG005|Overall Study|Study Termination by Sponsor|0|||
129183987|NCT02771626|464968720|FG000|Overall Study|Informed Consent Withdrawn|0|||
129183988|NCT02771626|464968721|FG001|Overall Study|Informed Consent Withdrawn|0|||
129183989|NCT02771626|464968722|FG002|Overall Study|Informed Consent Withdrawn|1|||
129183990|NCT02771626|464968723|FG003|Overall Study|Informed Consent Withdrawn|0|||
129183991|NCT02771626|464968724|FG004|Overall Study|Informed Consent Withdrawn|1|||
129183992|NCT02771626|464968725|FG005|Overall Study|Informed Consent Withdrawn|1|||
129183993|NCT02771626|464968720|FG000|Overall Study|Other, Not Specified|1|||
129183994|NCT02771626|464968721|FG001|Overall Study|Other, Not Specified|0|||
129183995|NCT02771626|464968722|FG002|Overall Study|Other, Not Specified|0|||
129183996|NCT02771626|464968723|FG003|Overall Study|Other, Not Specified|0|||
129183997|NCT02771626|464968724|FG004|Overall Study|Other, Not Specified|0|||
129183998|NCT02771626|464968725|FG005|Overall Study|Other, Not Specified|1|||
129183999|NCT01302054|464968726|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
129184000|NCT01302054|464968727|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
129184001|NCT01302054|464968728|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
129184002|NCT01302054|464968726|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
129184003|NCT01302054|464968727|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
129184004|NCT01302054|464968728|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
129184005|NCT01302054|464968726|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
129184006|NCT01302054|464968727|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
129184007|NCT01302054|464968728|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
129184008|NCT01302054|464968726|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
129184009|NCT01302054|464968727|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
129184010|NCT01302054|464968728|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
129184011|NCT01302054|464968726|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
129184012|NCT01302054|464968727|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
129184013|NCT01302054|464968728|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
129184014|NCT01302054|464968726|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
129184015|NCT01302054|464968727|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
129184016|NCT01302054|464968728|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
129184017|NCT01302054|464968726|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
129184018|NCT01302054|464968727|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
129184019|NCT01302054|464968728|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
129184020|NCT01302054|464968726|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
129184021|NCT01302054|464968727|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
129184022|NCT01302054|464968728|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
129184023|NCT01302054|464968726|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129184024|NCT01302054|464968727|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
129184025|NCT01302054|464968728|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
129184026|NCT01302054|464968726|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129184027|NCT01302054|464968727|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
129184028|NCT01302054|464968728|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129184029|NCT01302054|464968726|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129184030|NCT01302054|464968727|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
129184031|NCT01302054|464968728|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
129184032|NCT01302054|464968726|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
129184033|NCT01302054|464968727|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
129184034|NCT01302054|464968728|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
129184035|NCT01302054|464968726|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129184036|NCT01302054|464968727|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
129184037|NCT01302054|464968728|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
129184038|NCT01302054|464968726|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
129184039|NCT01302054|464968727|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
129184040|NCT01302054|464968728|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
129184041|NCT01302054|464968726|FG000|Double-Blind Treatment Phase|Other|0|||
129184042|NCT01302054|464968727|FG001|Double-Blind Treatment Phase|Other|4|||
129184043|NCT01302054|464968728|FG002|Double-Blind Treatment Phase|Other|9|||
129184044|NCT01177969|464968729|FG000|Overall Study|Protocol Violation|2|||
129184045|NCT01177969|464968730|FG001|Overall Study|Protocol Violation|1|||
129184046|NCT01177969|464968729|FG000|Overall Study|Withdrawal by Subject|1|||
129184047|NCT01177969|464968730|FG001|Overall Study|Withdrawal by Subject|2|||
129184048|NCT00687609|464968732|FG000|Overall Study|Physician Decision|1|||
129184049|NCT00687609|464968732|FG000|Overall Study|Withdrawal by Subject|2|||
129184050|NCT00908037|464968733|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184051|NCT00908037|464968734|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184052|NCT00908037|464968735|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184053|NCT00908037|464968736|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184054|NCT00908037|464968737|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
129184055|NCT00908037|464968738|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184056|NCT00908037|464968739|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
129184057|NCT00908037|464968740|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184058|NCT00908037|464968741|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
129184059|NCT00908037|464968742|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184060|NCT00908037|464968743|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184061|NCT00908037|464968744|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129184062|NCT00908037|464968733|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184063|NCT00908037|464968734|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184064|NCT00908037|464968735|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184065|NCT00908037|464968736|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184066|NCT00908037|464968737|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
129184067|NCT00908037|464968738|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184068|NCT00908037|464968739|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184069|NCT00908037|464968740|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184070|NCT00908037|464968741|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
129184071|NCT00908037|464968742|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184072|NCT00908037|464968743|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184073|NCT00908037|464968744|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129184074|NCT00908037|464968733|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184075|NCT00908037|464968734|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184076|NCT00908037|464968735|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184077|NCT00908037|464968736|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
129184078|NCT00908037|464968737|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184079|NCT00908037|464968738|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184080|NCT00908037|464968739|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
129184081|NCT00908037|464968740|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184082|NCT00908037|464968741|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184083|NCT00908037|464968742|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184084|NCT00908037|464968743|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184085|NCT00908037|464968744|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129184086|NCT00908037|464968733|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184087|NCT00908037|464968734|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184088|NCT00908037|464968735|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184089|NCT00908037|464968736|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184090|NCT00908037|464968737|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184091|NCT00908037|464968738|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184092|NCT00908037|464968739|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184093|NCT00908037|464968740|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184094|NCT00908037|464968741|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184095|NCT00908037|464968742|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184096|NCT00908037|464968743|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129184097|NCT00908037|464968744|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
129184098|NCT00908037|464968733|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184099|NCT00908037|464968734|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184100|NCT00908037|464968735|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184101|NCT00908037|464968736|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184102|NCT00908037|464968737|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184103|NCT00908037|464968738|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184104|NCT00908037|464968739|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184105|NCT00908037|464968740|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184106|NCT00908037|464968741|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184107|NCT00908037|464968742|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
129184108|NCT00908037|464968743|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129184109|NCT00908037|464968744|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
129184110|NCT00908037|464968733|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184111|NCT00908037|464968734|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184112|NCT00908037|464968735|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184113|NCT00908037|464968736|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184114|NCT00908037|464968737|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184115|NCT00908037|464968738|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184116|NCT00908037|464968739|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184117|NCT00908037|464968740|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184118|NCT00908037|464968741|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184119|NCT00908037|464968742|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
129184120|NCT00908037|464968743|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184121|NCT00908037|464968744|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129184122|NCT00908037|464968733|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184123|NCT00908037|464968734|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184124|NCT00908037|464968735|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184125|NCT00908037|464968736|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184126|NCT00908037|464968737|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184127|NCT00908037|464968738|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184128|NCT00908037|464968739|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184129|NCT00908037|464968740|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184130|NCT00908037|464968741|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184131|NCT00908037|464968742|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
128780973|NCT01323660|463488626|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
129184132|NCT00908037|464968743|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
129184133|NCT00908037|464968744|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129184134|NCT00908037|464968733|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184135|NCT00908037|464968734|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184136|NCT00908037|464968735|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184137|NCT00908037|464968736|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184138|NCT00908037|464968737|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184139|NCT00908037|464968738|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184140|NCT00908037|464968739|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184141|NCT00908037|464968740|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184142|NCT00908037|464968741|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184143|NCT00908037|464968742|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
129184144|NCT00908037|464968743|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184145|NCT00908037|464968744|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129184146|NCT00908037|464968733|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184147|NCT00908037|464968734|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184148|NCT00908037|464968735|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184149|NCT00908037|464968736|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184150|NCT00908037|464968737|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184151|NCT00908037|464968738|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184152|NCT00908037|464968739|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184153|NCT00908037|464968740|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184154|NCT00908037|464968741|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184155|NCT00908037|464968742|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184156|NCT00908037|464968743|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
129184157|NCT00908037|464968744|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129184158|NCT00635089|464968746|FG000|Overall Study|Adverse Event|7|||
129184159|NCT00635089|464968746|FG000|Overall Study|Lack of Efficacy|28|||
129184160|NCT00635089|464968746|FG000|Overall Study|Protocol Deviation|4|||
129184161|NCT00635089|464968746|FG000|Overall Study|Lost to Follow-up|8|||
129184162|NCT00635089|464968746|FG000|Overall Study|Other|31|||
129184163|NCT02565810|464968747|FG000|Overall Study|Withdrawal by Subject|1|||
129184164|NCT00581360|464968754|FG000|Overall Study|Withdrawal by Subject|1|||
129184165|NCT00552760|464968755|FG000|Overall Study|Adverse Event|3|||
129184166|NCT00552760|464968756|FG001|Overall Study|Adverse Event|5|||
129184167|NCT00552760|464968755|FG000|Overall Study|Relapsed- Depressed Event|10|||
129184168|NCT00552760|464968756|FG001|Overall Study|Relapsed- Depressed Event|16|||
129184169|NCT00552760|464968755|FG000|Overall Study|Relapse- Manic Event|3|||
129184170|NCT00552760|464968756|FG001|Overall Study|Relapse- Manic Event|3|||
129184171|NCT00552760|464968755|FG000|Overall Study|Relapsed- Mixed Event|3|||
129184172|NCT00552760|464968756|FG001|Overall Study|Relapsed- Mixed Event|5|||
129184173|NCT00552760|464968755|FG000|Overall Study|Protocol Violation|0|||
129184174|NCT00552760|464968756|FG001|Overall Study|Protocol Violation|1|||
129184175|NCT00552760|464968755|FG000|Overall Study|Lost to Follow-up|1|||
129184176|NCT00552760|464968756|FG001|Overall Study|Lost to Follow-up|1|||
129184177|NCT00552760|464968755|FG000|Overall Study|Non-compliance|1|||
129184178|NCT00552760|464968756|FG001|Overall Study|Non-compliance|1|||
129184179|NCT00552760|464968755|FG000|Overall Study|Medical Condition|1|||
129184180|NCT00552760|464968756|FG001|Overall Study|Medical Condition|1|||
129184181|NCT00552760|464968755|FG000|Overall Study|Withdrawal by Subject|3|||
129184182|NCT00552760|464968756|FG001|Overall Study|Withdrawal by Subject|0|||
129184183|NCT00552760|464968755|FG000|Overall Study|Medication Change|1|||
129184184|NCT00552760|464968756|FG001|Overall Study|Medication Change|0|||
129184185|NCT00924404|464968759|FG000|Overall Study|Lost to Follow-up|6|||
129184186|NCT00924404|464968760|FG001|Overall Study|Lost to Follow-up|4|||
129184187|NCT03831945|464968761|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
129184188|NCT03831945|464968762|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
129184189|NCT03831945|464968761|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
129184190|NCT03831945|464968762|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
129184191|NCT03831945|464968761|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
129184192|NCT03831945|464968762|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
129184193|NCT02613169|464968763|FG000|Overall Study|Withdrawal by Subject|4|||
129184194|NCT02613169|464968764|FG001|Overall Study|Withdrawal by Subject|1|||
129184195|NCT02613169|464968763|FG000|Overall Study|Lost to Follow-up|0|||
129184196|NCT02613169|464968764|FG001|Overall Study|Lost to Follow-up|5|||
129184197|NCT02613169|464968763|FG000|Overall Study|HIV|0|||
129184198|NCT02613169|464968764|FG001|Overall Study|HIV|2|||
129184199|NCT02613169|464968763|FG000|Overall Study|No TB infection endpoint|14|||
129184200|NCT02613169|464968764|FG001|Overall Study|No TB infection endpoint|9|||
129184201|NCT00343382|464968765|FG000|Overall Study|Adverse Event|2|||
129184202|NCT00343382|464968766|FG001|Overall Study|Adverse Event|10|||
129184203|NCT00343382|464968767|FG002|Overall Study|Adverse Event|7|||
129184204|NCT00343382|464968765|FG000|Overall Study|Withdrawal by Subject|1|||
129184205|NCT00343382|464968766|FG001|Overall Study|Withdrawal by Subject|2|||
129184206|NCT00343382|464968767|FG002|Overall Study|Withdrawal by Subject|6|||
129184207|NCT00343382|464968765|FG000|Overall Study|Other Reason Not Specified|1|||
129184208|NCT00343382|464968766|FG001|Overall Study|Other Reason Not Specified|2|||
129184209|NCT00343382|464968767|FG002|Overall Study|Other Reason Not Specified|4|||
129184210|NCT00710385|464968769|FG000|Overall Study|Did not qualify|1|||
129184211|NCT00710385|464968769|FG000|Overall Study|Withdrawal by Subject|1|||
129184212|NCT00710385|464968769|FG000|Overall Study|Undisclosed back pain|1|||
129184213|NCT00710385|464968769|FG000|Overall Study|Physician Decision|1|||
129184214|NCT00710385|464968769|FG000|Overall Study|Undisclosed excessive methadone use|1|||
129184215|NCT01985360|464968770|FG000|Overall Study|Withdrawal by Subject|4|||
129184216|NCT01985360|464968771|FG001|Overall Study|Withdrawal by Subject|0|||
129184217|NCT01985360|464968770|FG000|Overall Study|Lost to Follow-up|5|||
129184218|NCT01985360|464968771|FG001|Overall Study|Lost to Follow-up|3|||
129184219|NCT02976103|464968772|FG000|Overall Study|Withdrawal by Subject|1|||
129184220|NCT02976103|464968773|FG001|Overall Study|Withdrawal by Subject|0|||
129184221|NCT02976103|464968772|FG000|Overall Study|Lost to Follow-up|12|||
129184222|NCT02976103|464968773|FG001|Overall Study|Lost to Follow-up|8|||
129184223|NCT04881747|464968776|FG000|Period 2 Washout|Adverse Event|1|||
129184224|NCT04881747|464968777|FG001|Period 2 Washout|Adverse Event|0|||
129184225|NCT04881747|464968778|FG002|Period 2 Washout|Adverse Event|0|||
129184226|NCT04881747|464968779|FG003|Period 2 Washout|Adverse Event|0|||
129184227|NCT04881747|464968780|FG004|Period 2 Washout|Adverse Event|1|||
129184228|NCT04881747|464968781|FG005|Period 2 Washout|Adverse Event|0|||
129184229|NCT04881747|464968776|FG000|Period 2 Washout|Withdrawal by Subject|1|||
129184230|NCT04881747|464968777|FG001|Period 2 Washout|Withdrawal by Subject|0|||
129184231|NCT04881747|464968778|FG002|Period 2 Washout|Withdrawal by Subject|0|||
129184232|NCT04881747|464968779|FG003|Period 2 Washout|Withdrawal by Subject|1|||
129184233|NCT04881747|464968780|FG004|Period 2 Washout|Withdrawal by Subject|0|||
129184234|NCT04881747|464968781|FG005|Period 2 Washout|Withdrawal by Subject|0|||
129184235|NCT04598269|464968784|FG000|Overall Study|Adverse Event|0|||
129184236|NCT04598269|464968785|FG001|Overall Study|Adverse Event|3|||
129184237|NCT04598269|464968784|FG000|Overall Study|Withdrawal by Subject|1|||
129184238|NCT04598269|464968785|FG001|Overall Study|Withdrawal by Subject|4|||
129184239|NCT04598269|464968784|FG000|Overall Study|Lost to Follow-up|1|||
129184240|NCT04598269|464968785|FG001|Overall Study|Lost to Follow-up|0|||
129184241|NCT04598269|464968784|FG000|Overall Study|Not Treated|2|||
129184242|NCT04598269|464968785|FG001|Overall Study|Not Treated|0|||
129184243|NCT02598128|464968790|FG000|Period A: Days -7 to -1|Adverse Event|1|||
129184244|NCT02598128|464968791|FG001|Period A: Days -7 to -1|Adverse Event|0|||
129184245|NCT02598128|464968792|FG002|Period A: Days -7 to -1|Adverse Event|0|||
129184246|NCT02598128|464968793|FG003|Period A: Days -7 to -1|Adverse Event|0|||
129184247|NCT01459913|464968795|FG000|Overall Study|Adverse Event|0|||
129184248|NCT01459913|464968796|FG001|Overall Study|Adverse Event|0|||
129184249|NCT01459913|464968797|FG002|Overall Study|Adverse Event|0|||
129184250|NCT01459913|464968798|FG003|Overall Study|Adverse Event|3|||
129184251|NCT01459913|464968795|FG000|Overall Study|Withdrawal by Subject|4|||
129184252|NCT01459913|464968796|FG001|Overall Study|Withdrawal by Subject|0|||
129184253|NCT01459913|464968797|FG002|Overall Study|Withdrawal by Subject|0|||
129184254|NCT01459913|464968798|FG003|Overall Study|Withdrawal by Subject|5|||
129184255|NCT01459913|464968795|FG000|Overall Study|Lost to Follow-up|7|||
129184256|NCT01459913|464968796|FG001|Overall Study|Lost to Follow-up|4|||
129184257|NCT01459913|464968797|FG002|Overall Study|Lost to Follow-up|1|||
129184258|NCT01459913|464968798|FG003|Overall Study|Lost to Follow-up|8|||
129184259|NCT01459913|464968795|FG000|Overall Study|Death|0|||
129184260|NCT01459913|464968796|FG001|Overall Study|Death|0|||
129184261|NCT01459913|464968797|FG002|Overall Study|Death|0|||
129184262|NCT01459913|464968798|FG003|Overall Study|Death|1|||
129184263|NCT01459913|464968795|FG000|Overall Study|Non- Compliance|0|||
129184264|NCT01459913|464968796|FG001|Overall Study|Non- Compliance|0|||
129184265|NCT01459913|464968797|FG002|Overall Study|Non- Compliance|0|||
129184266|NCT01459913|464968798|FG003|Overall Study|Non- Compliance|3|||
129184267|NCT01459913|464968795|FG000|Overall Study|Physician Decision|0|||
129184268|NCT01459913|464968796|FG001|Overall Study|Physician Decision|1|||
129184269|NCT01459913|464968797|FG002|Overall Study|Physician Decision|0|||
129184270|NCT01459913|464968798|FG003|Overall Study|Physician Decision|0|||
129184271|NCT01459913|464968795|FG000|Overall Study|Study Terminated by Sponsor|30|||
129184272|NCT01459913|464968796|FG001|Overall Study|Study Terminated by Sponsor|15|||
129184273|NCT01459913|464968797|FG002|Overall Study|Study Terminated by Sponsor|9|||
129184274|NCT01459913|464968798|FG003|Overall Study|Study Terminated by Sponsor|11|||
129184275|NCT01459913|464968795|FG000|Overall Study|Other|0|||
129184276|NCT01459913|464968796|FG001|Overall Study|Other|0|||
129184277|NCT01459913|464968797|FG002|Overall Study|Other|3|||
129184278|NCT01459913|464968798|FG003|Overall Study|Other|1|||
129184279|NCT01459913|464968795|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
129184280|NCT01459913|464968796|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
129184281|NCT01459913|464968797|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
129184282|NCT01459913|464968798|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
129184283|NCT01064687|464968799|FG000|Overall Study|Adverse Event|9|||
129184284|NCT01064687|464968800|FG001|Overall Study|Adverse Event|4|||
129184285|NCT01064687|464968801|FG002|Overall Study|Adverse Event|10|||
129184286|NCT01064687|464968802|FG003|Overall Study|Adverse Event|3|||
129184287|NCT01064687|464968799|FG000|Overall Study|Death|1|||
129184288|NCT01064687|464968800|FG001|Overall Study|Death|1|||
129184289|NCT01064687|464968801|FG002|Overall Study|Death|0|||
129184290|NCT01064687|464968802|FG003|Overall Study|Death|0|||
129184291|NCT01064687|464968799|FG000|Overall Study|Entry Criteria Not Met|3|||
129184292|NCT01064687|464968800|FG001|Overall Study|Entry Criteria Not Met|0|||
129184293|NCT01064687|464968801|FG002|Overall Study|Entry Criteria Not Met|0|||
129184294|NCT01064687|464968802|FG003|Overall Study|Entry Criteria Not Met|0|||
129184295|NCT01064687|464968799|FG000|Overall Study|Lack of Efficacy|1|||
129184296|NCT01064687|464968800|FG001|Overall Study|Lack of Efficacy|0|||
129184297|NCT01064687|464968801|FG002|Overall Study|Lack of Efficacy|2|||
129184298|NCT01064687|464968802|FG003|Overall Study|Lack of Efficacy|3|||
129184299|NCT01064687|464968799|FG000|Overall Study|Lost to Follow-up|7|||
129184300|NCT01064687|464968800|FG001|Overall Study|Lost to Follow-up|10|||
129184301|NCT01064687|464968801|FG002|Overall Study|Lost to Follow-up|13|||
129184302|NCT01064687|464968802|FG003|Overall Study|Lost to Follow-up|5|||
129184303|NCT01064687|464968799|FG000|Overall Study|Physician Decision|2|||
129184304|NCT01064687|464968800|FG001|Overall Study|Physician Decision|2|||
129184305|NCT01064687|464968801|FG002|Overall Study|Physician Decision|0|||
129184306|NCT01064687|464968802|FG003|Overall Study|Physician Decision|0|||
129184307|NCT01064687|464968799|FG000|Overall Study|Protocol Violation|1|||
129184308|NCT01064687|464968800|FG001|Overall Study|Protocol Violation|1|||
129184309|NCT01064687|464968801|FG002|Overall Study|Protocol Violation|0|||
129184310|NCT01064687|464968802|FG003|Overall Study|Protocol Violation|1|||
129184311|NCT01064687|464968799|FG000|Overall Study|Sponsor Decision|0|||
129184312|NCT01064687|464968800|FG001|Overall Study|Sponsor Decision|0|||
129184313|NCT01064687|464968801|FG002|Overall Study|Sponsor Decision|3|||
129184314|NCT01064687|464968802|FG003|Overall Study|Sponsor Decision|0|||
129184315|NCT01064687|464968799|FG000|Overall Study|Withdrawal by Subject|9|||
129184316|NCT01064687|464968800|FG001|Overall Study|Withdrawal by Subject|7|||
129184317|NCT01064687|464968801|FG002|Overall Study|Withdrawal by Subject|12|||
129184318|NCT01064687|464968802|FG003|Overall Study|Withdrawal by Subject|5|||
129184319|NCT01064687|464968799|FG000|Overall Study|Treatment Noncompliance|1|||
129184320|NCT01064687|464968800|FG001|Overall Study|Treatment Noncompliance|1|||
129184321|NCT01064687|464968801|FG002|Overall Study|Treatment Noncompliance|1|||
129184322|NCT01064687|464968802|FG003|Overall Study|Treatment Noncompliance|0|||
129184323|NCT00619489|464968803|FG000|Overall Study|Adverse Event|0|||
129184324|NCT00619489|464968804|FG001|Overall Study|Adverse Event|7|||
129184325|NCT00619489|464968803|FG000|Overall Study|Withdrawal by Subject|1|||
129184326|NCT00619489|464968804|FG001|Overall Study|Withdrawal by Subject|1|||
129184327|NCT00619489|464968803|FG000|Overall Study|Lack of Efficacy|0|||
129184328|NCT00619489|464968804|FG001|Overall Study|Lack of Efficacy|11|||
129184329|NCT00619489|464968803|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
129184330|NCT00619489|464968804|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
129184331|NCT02966015|464968805|FG000|Inclusion Visit|did not answer questionnaire|8|||
129184332|NCT02966015|464968806|FG001|Inclusion Visit|did not answer questionnaire|3|||
129184333|NCT03040986|464968811|FG000|Overall Study|Hospice|1|||
129184334|NCT03040986|464968812|FG001|Overall Study|Hospice|0|||
129184335|NCT03040986|464968811|FG000|Overall Study|Adverse Event|2|||
129184336|NCT03040986|464968812|FG001|Overall Study|Adverse Event|1|||
129184337|NCT03040986|464968811|FG000|Overall Study|Disease progression on study|3|||
129184338|NCT03040986|464968812|FG001|Overall Study|Disease progression on study|1|||
129184339|NCT01183468|464968817|FG000|Overall Study|Lost to Follow-up|2|||
129184340|NCT01183468|464968818|FG001|Overall Study|Lost to Follow-up|1|||
129184341|NCT01183468|464968819|FG002|Overall Study|Lost to Follow-up|0|||
129184342|NCT01183468|464968820|FG003|Overall Study|Lost to Follow-up|0|||
129184343|NCT01183468|464968817|FG000|Overall Study|Physician Decision|1|||
129184344|NCT01183468|464968818|FG001|Overall Study|Physician Decision|0|||
129184345|NCT01183468|464968819|FG002|Overall Study|Physician Decision|0|||
129184346|NCT01183468|464968820|FG003|Overall Study|Physician Decision|0|||
129184347|NCT01183468|464968817|FG000|Overall Study|Withdrawal by Subject|0|||
129184348|NCT01183468|464968818|FG001|Overall Study|Withdrawal by Subject|1|||
129184349|NCT01183468|464968819|FG002|Overall Study|Withdrawal by Subject|0|||
129184350|NCT01183468|464968820|FG003|Overall Study|Withdrawal by Subject|0|||
129184351|NCT00845065|464968821|FG000|Overall Study|Adverse Event|3|||
129184352|NCT00845065|464968822|FG001|Overall Study|Adverse Event|23|||
129184353|NCT00845065|464968821|FG000|Overall Study|Lack of Efficacy|43|||
129184354|NCT00845065|464968822|FG001|Overall Study|Lack of Efficacy|21|||
129184355|NCT00845065|464968821|FG000|Overall Study|Non-Medical Reasons|1|||
129184356|NCT00845065|464968822|FG001|Overall Study|Non-Medical Reasons|11|||
129184357|NCT01198509|464968823|FG000|Overall Study|Withdrawal by Subject|1|||
129184358|NCT01198509|464968824|FG001|Overall Study|Withdrawal by Subject|0|||
129184359|NCT01198509|464968825|FG002|Overall Study|Withdrawal by Subject|0|||
129184360|NCT01198509|464968826|FG003|Overall Study|Withdrawal by Subject|0|||
129184361|NCT01198509|464968827|FG004|Overall Study|Withdrawal by Subject|0|||
129184362|NCT01198509|464968828|FG005|Overall Study|Withdrawal by Subject|0|||
129184363|NCT00499746|464968829|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
129184364|NCT00499746|464968829|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
129184365|NCT00499746|464968829|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
129184366|NCT00499746|464968829|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
129184367|NCT02273960|464968830|FG000|Short Term Period|Lost to Follow-up|1|||
129184368|NCT02273960|464968831|FG001|Short Term Period|Lost to Follow-up|0|||
129184369|NCT02273960|464968832|FG002|Short Term Period|Lost to Follow-up|0|||
129184370|NCT02273960|464968833|FG003|Short Term Period|Lost to Follow-up|0|||
129184371|NCT02273960|464968830|FG000|Short Term Period|Lack of Efficacy|0|||
129184372|NCT02273960|464968831|FG001|Short Term Period|Lack of Efficacy|0|||
129184373|NCT02273960|464968832|FG002|Short Term Period|Lack of Efficacy|0|||
129184374|NCT02273960|464968833|FG003|Short Term Period|Lack of Efficacy|1|||
129184375|NCT02273960|464968830|FG000|Short Term Period|ST complete, not entering LTE|4|||
129184376|NCT02273960|464968831|FG001|Short Term Period|ST complete, not entering LTE|6|||
129184377|NCT02273960|464968832|FG002|Short Term Period|ST complete, not entering LTE|4|||
129184378|NCT02273960|464968833|FG003|Short Term Period|ST complete, not entering LTE|5|||
129184379|NCT02273960|464968830|FG000|Long Term Extension|Death|0|||
129184380|NCT02273960|464968831|FG001|Long Term Extension|Death|0|||
129184381|NCT02273960|464968832|FG002|Long Term Extension|Death|0|||
129184382|NCT02273960|464968833|FG003|Long Term Extension|Death|1|||
129184383|NCT00558272|464968834|FG000|Overall Study|Adverse Event|10|||
129184384|NCT00558272|464968835|FG001|Overall Study|Adverse Event|0|||
129184385|NCT00558272|464968834|FG000|Overall Study|Death|1|||
129184386|NCT00558272|464968835|FG001|Overall Study|Death|0|||
129184387|NCT00558272|464968834|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
129184388|NCT00558272|464968835|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
129184389|NCT00558272|464968834|FG000|Overall Study|AZ study team decision|0|||
129184390|NCT00558272|464968835|FG001|Overall Study|AZ study team decision|1|||
129184391|NCT00558272|464968834|FG000|Overall Study|Incorrectly enrolled|1|||
129184392|NCT00558272|464968835|FG001|Overall Study|Incorrectly enrolled|0|||
129184393|NCT00558272|464968834|FG000|Overall Study|Withdrawal by Subject|0|||
129184394|NCT00558272|464968835|FG001|Overall Study|Withdrawal by Subject|1|||
129184395|NCT02745535|464968837|FG000|Overall Study|Death|1|||
129184396|NCT02745535|464968837|FG000|Overall Study|Adverse Event|3|||
129184397|NCT02745535|464968837|FG000|Overall Study|Lost to Follow-up|2|||
129184398|NCT00849108|464968838|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
129184399|NCT00849108|464968839|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
129184400|NCT00849108|464968838|FG000|Cohort 2 Efficacy|Adverse Event|0|||
129184401|NCT00849108|464968839|FG001|Cohort 2 Efficacy|Adverse Event|1|||
129184402|NCT00849108|464968838|FG000|Cohort 2 Efficacy|Other|0|||
129184403|NCT00849108|464968839|FG001|Cohort 2 Efficacy|Other|9|||
129184404|NCT01563172|464968840|FG000|Overall Study|Adverse Event|5|||
129184405|NCT01563172|464968840|FG000|Overall Study|Lost to Follow-up|2|||
129184406|NCT01563172|464968840|FG000|Overall Study|Other (Protocol deviation)|5|||
129184407|NCT01563172|464968840|FG000|Overall Study|Other (Not specified)|1|||
129184408|NCT02014584|464968843|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129184409|NCT02014584|464968844|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
129184410|NCT02014584|464968845|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129184411|NCT02014584|464968846|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129184412|NCT02014584|464968847|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129184413|NCT02014584|464968848|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129184414|NCT02014584|464968843|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
129184415|NCT02014584|464968844|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
129184416|NCT02014584|464968845|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129184417|NCT02014584|464968846|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129184418|NCT02014584|464968847|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129184419|NCT02014584|464968848|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129184420|NCT02014584|464968843|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129184421|NCT02014584|464968844|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129184422|NCT02014584|464968845|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
129184423|NCT02014584|464968846|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129184424|NCT02014584|464968847|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129184425|NCT02014584|464968848|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129184426|NCT02014584|464968843|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129184427|NCT02014584|464968844|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129184428|NCT02014584|464968845|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
129184429|NCT02014584|464968846|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
129184430|NCT02014584|464968847|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129184431|NCT02014584|464968848|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129184432|NCT02014584|464968843|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129184433|NCT02014584|464968844|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129184434|NCT02014584|464968845|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129184435|NCT02014584|464968846|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129184436|NCT02014584|464968847|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
129184437|NCT02014584|464968848|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129184438|NCT00772109|464968849|FG000|Overall Study|Serious adverse event|1|||
129184439|NCT00772109|464968850|FG001|Overall Study|Serious adverse event|0|||
129184440|NCT00772109|464968851|FG002|Overall Study|Serious adverse event|1|||
129184441|NCT00772109|464968852|FG003|Overall Study|Serious adverse event|0|||
129184442|NCT00772109|464968849|FG000|Overall Study|Protocol Violation|5|||
129184443|NCT00772109|464968850|FG001|Overall Study|Protocol Violation|8|||
129184444|NCT00772109|464968851|FG002|Overall Study|Protocol Violation|7|||
129184445|NCT00772109|464968852|FG003|Overall Study|Protocol Violation|6|||
129184446|NCT00772109|464968849|FG000|Overall Study|Lost to Follow-up|7|||
129184447|NCT00772109|464968850|FG001|Overall Study|Lost to Follow-up|3|||
129184448|NCT00772109|464968851|FG002|Overall Study|Lost to Follow-up|5|||
129184449|NCT00772109|464968852|FG003|Overall Study|Lost to Follow-up|9|||
129184450|NCT00772109|464968849|FG000|Overall Study|Withdrawal by Subject|8|||
129184451|NCT00772109|464968850|FG001|Overall Study|Withdrawal by Subject|8|||
129184452|NCT00772109|464968851|FG002|Overall Study|Withdrawal by Subject|6|||
129184453|NCT00772109|464968852|FG003|Overall Study|Withdrawal by Subject|16|||
129184454|NCT01624090|464968853|FG000|Overall Study|DLT, taken off therapy|0|||
129184455|NCT01624090|464968854|FG001|Overall Study|DLT, taken off therapy|1|||
129184456|NCT01624090|464968855|FG002|Overall Study|DLT, taken off therapy|0|||
129184457|NCT01624090|464968856|FG003|Overall Study|DLT, taken off therapy|0|||
129184458|NCT01624090|464968853|FG000|Overall Study|Withdrew prior to treatment|0|||
129184459|NCT01624090|464968854|FG001|Overall Study|Withdrew prior to treatment|1|||
129184460|NCT01624090|464968855|FG002|Overall Study|Withdrew prior to treatment|0|||
129184461|NCT01624090|464968856|FG003|Overall Study|Withdrew prior to treatment|0|||
129184462|NCT01624090|464968853|FG000|Overall Study|Died on study|0|||
129184463|NCT01624090|464968854|FG001|Overall Study|Died on study|0|||
129184464|NCT01624090|464968855|FG002|Overall Study|Died on study|2|||
129184465|NCT01624090|464968856|FG003|Overall Study|Died on study|0|||
129184466|NCT01624090|464968853|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
129184467|NCT01624090|464968854|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
129184468|NCT01624090|464968855|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
129184469|NCT01624090|464968856|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
129184470|NCT01624090|464968853|FG000|Overall Study|Dose escalated|0|||
129184471|NCT01624090|464968854|FG001|Overall Study|Dose escalated|0|||
129184472|NCT01624090|464968855|FG002|Overall Study|Dose escalated|3|||
129184473|NCT01624090|464968856|FG003|Overall Study|Dose escalated|0|||
129184474|NCT00752726|464968857|FG000|Overall Study|Lost to Follow-up|2|||
129184475|NCT00752726|464968858|FG001|Overall Study|Lost to Follow-up|1|||
129184476|NCT00752726|464968857|FG000|Overall Study|Adverse Event|3|||
129184477|NCT00752726|464968858|FG001|Overall Study|Adverse Event|0|||
129184478|NCT00752726|464968857|FG000|Overall Study|Withdrawal by Subject|5|||
129184479|NCT00752726|464968858|FG001|Overall Study|Withdrawal by Subject|10|||
129184480|NCT00752726|464968857|FG000|Overall Study|Other Reason|1|||
129184481|NCT00752726|464968858|FG001|Overall Study|Other Reason|2|||
129184482|NCT00042666|464968859|FG000|Overall Study|Adverse Event|2|||
129184483|NCT00042666|464968859|FG000|Overall Study|Death|4|||
129184484|NCT00042666|464968859|FG000|Overall Study|Protocol Violation|1|||
129184485|NCT00042666|464968859|FG000|Overall Study|Participant/Physician Perception|1|||
129184486|NCT00042666|464968859|FG000|Overall Study|Progressive Disease|41|||
129184487|NCT00042666|464968859|FG000|Overall Study|Other|1|||
129184488|NCT00042666|464968859|FG000|Overall Study|Other|4|||
129184489|NCT04232215|464968860|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129184490|NCT04232215|464968861|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129184491|NCT01555125|464968864|FG000|Induction Period|Lost to Follow-up|0|||
129184492|NCT01555125|464968865|FG001|Induction Period|Lost to Follow-up|2|||
129184493|NCT01555125|464968866|FG002|Induction Period|Lost to Follow-up|0|||
129184494|NCT01555125|464968867|FG003|Induction Period|Lost to Follow-up|0|||
129184495|NCT01555125|464968868|FG004|Induction Period|Lost to Follow-up|0|||
129184496|NCT01555125|464968864|FG000|Induction Period|Adverse Event|0|||
129184497|NCT01555125|464968865|FG001|Induction Period|Adverse Event|1|||
129184498|NCT01555125|464968866|FG002|Induction Period|Adverse Event|0|||
129184499|NCT01555125|464968867|FG003|Induction Period|Adverse Event|0|||
129184500|NCT01555125|464968868|FG004|Induction Period|Adverse Event|1|||
129184501|NCT01555125|464968864|FG000|Induction Period|Subject / guardian decision|0|||
129184502|NCT01555125|464968865|FG001|Induction Period|Subject / guardian decision|0|||
129184503|NCT01555125|464968866|FG002|Induction Period|Subject / guardian decision|0|||
129184504|NCT01555125|464968867|FG003|Induction Period|Subject / guardian decision|0|||
129184505|NCT01555125|464968868|FG004|Induction Period|Subject / guardian decision|2|||
129184506|NCT01555125|464968864|FG000|Induction Period|Death|1|||
129184507|NCT01555125|464968865|FG001|Induction Period|Death|0|||
129184508|NCT01555125|464968866|FG002|Induction Period|Death|0|||
129184509|NCT01555125|464968867|FG003|Induction Period|Death|0|||
129184510|NCT01555125|464968868|FG004|Induction Period|Death|0|||
129184511|NCT01555125|464968864|FG000|Maintenance Period|Adverse Event|1|||
129184512|NCT01555125|464968865|FG001|Maintenance Period|Adverse Event|1|||
129184513|NCT01555125|464968866|FG002|Maintenance Period|Adverse Event|0|||
129184514|NCT01555125|464968867|FG003|Maintenance Period|Adverse Event|0|||
129184515|NCT01555125|464968868|FG004|Maintenance Period|Adverse Event|0|||
129184516|NCT01555125|464968864|FG000|Maintenance Period|Subject / guardian decision|1|||
129184517|NCT01555125|464968865|FG001|Maintenance Period|Subject / guardian decision|2|||
129184518|NCT01555125|464968866|FG002|Maintenance Period|Subject / guardian decision|0|||
129184519|NCT01555125|464968867|FG003|Maintenance Period|Subject / guardian decision|0|||
129184520|NCT01555125|464968868|FG004|Maintenance Period|Subject / guardian decision|0|||
129184521|NCT01555125|464968864|FG000|Maintenance Period|Lost to Follow-up|2|||
129184522|NCT01555125|464968865|FG001|Maintenance Period|Lost to Follow-up|0|||
129184523|NCT01555125|464968866|FG002|Maintenance Period|Lost to Follow-up|0|||
129184524|NCT01555125|464968867|FG003|Maintenance Period|Lost to Follow-up|1|||
129184525|NCT01555125|464968868|FG004|Maintenance Period|Lost to Follow-up|0|||
129184526|NCT01555125|464968864|FG000|Maintenance Period|Lack of Efficacy|6|||
129184527|NCT01555125|464968865|FG001|Maintenance Period|Lack of Efficacy|1|||
129184528|NCT01555125|464968866|FG002|Maintenance Period|Lack of Efficacy|3|||
129184529|NCT01555125|464968867|FG003|Maintenance Period|Lack of Efficacy|0|||
129184530|NCT01555125|464968868|FG004|Maintenance Period|Lack of Efficacy|0|||
129184531|NCT01555125|464968864|FG000|Maintenance Period|Physician Decision|0|||
129184532|NCT01555125|464968865|FG001|Maintenance Period|Physician Decision|0|||
129184533|NCT01555125|464968866|FG002|Maintenance Period|Physician Decision|1|||
129184534|NCT01555125|464968867|FG003|Maintenance Period|Physician Decision|0|||
129184535|NCT01555125|464968868|FG004|Maintenance Period|Physician Decision|0|||
129184536|NCT01555125|464968864|FG000|Maintenance Period|Death|0|||
129184537|NCT01555125|464968865|FG001|Maintenance Period|Death|0|||
129184538|NCT01555125|464968866|FG002|Maintenance Period|Death|0|||
129184539|NCT01555125|464968867|FG003|Maintenance Period|Death|1|||
129184540|NCT01555125|464968868|FG004|Maintenance Period|Death|0|||
129184541|NCT01555125|464968864|FG000|Extension|Adverse Event|1|||
129184542|NCT01555125|464968865|FG001|Extension|Adverse Event|2|||
129184543|NCT01555125|464968866|FG002|Extension|Adverse Event|1|||
129184544|NCT01555125|464968867|FG003|Extension|Adverse Event|1|||
129184545|NCT01555125|464968868|FG004|Extension|Adverse Event|0|||
129184546|NCT01555125|464968864|FG000|Extension|Protocol deviation|1|||
129184547|NCT01555125|464968865|FG001|Extension|Protocol deviation|0|||
129184548|NCT01555125|464968866|FG002|Extension|Protocol deviation|0|||
129184549|NCT01555125|464968867|FG003|Extension|Protocol deviation|0|||
129184550|NCT01555125|464968868|FG004|Extension|Protocol deviation|0|||
129184551|NCT01555125|464968864|FG000|Extension|Lack of Efficacy|7|||
129184552|NCT01555125|464968865|FG001|Extension|Lack of Efficacy|6|||
129184553|NCT01555125|464968866|FG002|Extension|Lack of Efficacy|3|||
129184554|NCT01555125|464968867|FG003|Extension|Lack of Efficacy|0|||
129184555|NCT01555125|464968868|FG004|Extension|Lack of Efficacy|0|||
129184556|NCT01555125|464968864|FG000|Extension|Lost to Follow-up|2|||
129184557|NCT01555125|464968865|FG001|Extension|Lost to Follow-up|1|||
129184558|NCT01555125|464968866|FG002|Extension|Lost to Follow-up|2|||
129184559|NCT01555125|464968867|FG003|Extension|Lost to Follow-up|0|||
129184560|NCT01555125|464968868|FG004|Extension|Lost to Follow-up|0|||
129184561|NCT01555125|464968864|FG000|Extension|Study terminated by sponsor|32|||
129184562|NCT01555125|464968865|FG001|Extension|Study terminated by sponsor|33|||
129184563|NCT01555125|464968866|FG002|Extension|Study terminated by sponsor|16|||
129184564|NCT01555125|464968867|FG003|Extension|Study terminated by sponsor|20|||
129184565|NCT01555125|464968868|FG004|Extension|Study terminated by sponsor|0|||
129184566|NCT01555125|464968864|FG000|Extension|Subject/guardian decision|1|||
129184567|NCT01555125|464968865|FG001|Extension|Subject/guardian decision|9|||
129184568|NCT01555125|464968866|FG002|Extension|Subject/guardian decision|1|||
129184569|NCT01555125|464968867|FG003|Extension|Subject/guardian decision|0|||
129184570|NCT01555125|464968868|FG004|Extension|Subject/guardian decision|0|||
129184571|NCT01555125|464968864|FG000|Extension|Technical Problems|1|||
129184572|NCT01555125|464968865|FG001|Extension|Technical Problems|0|||
129184573|NCT01555125|464968866|FG002|Extension|Technical Problems|0|||
129184574|NCT01555125|464968867|FG003|Extension|Technical Problems|1|||
129184575|NCT01555125|464968868|FG004|Extension|Technical Problems|0|||
129184576|NCT01555125|464968864|FG000|Follow-Up Period|Lost to Follow-up|1|||
129184577|NCT01555125|464968865|FG001|Follow-Up Period|Lost to Follow-up|0|||
129184578|NCT01555125|464968866|FG002|Follow-Up Period|Lost to Follow-up|0|||
129184579|NCT01555125|464968867|FG003|Follow-Up Period|Lost to Follow-up|0|||
129184580|NCT01555125|464968868|FG004|Follow-Up Period|Lost to Follow-up|0|||
129184581|NCT01555125|464968864|FG000|Follow-Up Period|Subject / guardian decision|3|||
129184582|NCT01555125|464968865|FG001|Follow-Up Period|Subject / guardian decision|1|||
129184583|NCT01555125|464968866|FG002|Follow-Up Period|Subject / guardian decision|1|||
129184584|NCT01555125|464968867|FG003|Follow-Up Period|Subject / guardian decision|1|||
129184585|NCT01555125|464968868|FG004|Follow-Up Period|Subject / guardian decision|0|||
129184586|NCT02651220|464968869|FG000|Overall Study|Adverse Event|1|||
129184587|NCT02651220|464968870|FG001|Overall Study|Adverse Event|5|||
129184588|NCT02651220|464968871|FG002|Overall Study|Adverse Event|1|||
129184589|NCT02651220|464968869|FG000|Overall Study|Lost to Follow-up|8|||
129184590|NCT02651220|464968870|FG001|Overall Study|Lost to Follow-up|14|||
129184591|NCT02651220|464968871|FG002|Overall Study|Lost to Follow-up|14|||
129184592|NCT02651220|464968869|FG000|Overall Study|Non-Compliance with Study Drug|4|||
129184593|NCT02651220|464968870|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129184594|NCT02651220|464968871|FG002|Overall Study|Non-Compliance with Study Drug|1|||
129184595|NCT02651220|464968869|FG000|Overall Study|Pregnancy|1|||
129184596|NCT02651220|464968870|FG001|Overall Study|Pregnancy|0|||
129184597|NCT02651220|464968871|FG002|Overall Study|Pregnancy|1|||
129184598|NCT02651220|464968869|FG000|Overall Study|Protocol Violation|0|||
129184599|NCT02651220|464968870|FG001|Overall Study|Protocol Violation|0|||
129184600|NCT02651220|464968871|FG002|Overall Study|Protocol Violation|1|||
129184601|NCT02651220|464968869|FG000|Overall Study|Withdrawal by Subject|5|||
129184602|NCT02651220|464968870|FG001|Overall Study|Withdrawal by Subject|6|||
129184603|NCT02651220|464968871|FG002|Overall Study|Withdrawal by Subject|8|||
129184604|NCT02651220|464968869|FG000|Overall Study|Miscellaneous|4|||
129184605|NCT02651220|464968870|FG001|Overall Study|Miscellaneous|1|||
129184606|NCT02651220|464968871|FG002|Overall Study|Miscellaneous|2|||
129184607|NCT02651220|464968869|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129184608|NCT02651220|464968870|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129184609|NCT02651220|464968871|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
129184610|NCT01078168|464968880|FG000|Overall Study|Physician Decision|0|||
129184611|NCT01078168|464968881|FG001|Overall Study|Physician Decision|1|||
129184612|NCT00707954|464971383|FG000|Overall Study|Physician Decision|0|||
129184613|NCT00707954|464971384|FG001|Overall Study|Physician Decision|0|||
129184614|NCT00707954|464971385|FG002|Overall Study|Physician Decision|0|||
129184615|NCT00707954|464971386|FG003|Overall Study|Physician Decision|0|||
129184616|NCT00707954|464971387|FG004|Overall Study|Physician Decision|1|||
129184617|NCT04037254|464971388|FG000|Overall Study|Protocol Violation|1|||
129184618|NCT04037254|464971389|FG001|Overall Study|Protocol Violation|0|||
129184619|NCT04037254|464971390|FG002|Overall Study|Protocol Violation|0|||
129184620|NCT04037254|464971391|FG003|Overall Study|Protocol Violation|0|||
129184621|NCT04037254|464971392|FG004|Overall Study|Protocol Violation|0|||
129184622|NCT04037254|464971388|FG000|Overall Study|Withdrawal by Subject|0|||
129184623|NCT04037254|464971389|FG001|Overall Study|Withdrawal by Subject|0|||
129184624|NCT04037254|464971390|FG002|Overall Study|Withdrawal by Subject|1|||
129184625|NCT04037254|464971391|FG003|Overall Study|Withdrawal by Subject|0|||
129184626|NCT04037254|464971392|FG004|Overall Study|Withdrawal by Subject|0|||
129184627|NCT04037254|464971388|FG000|Overall Study|Delayed or incomplete treatment|0|||
129184628|NCT04037254|464971389|FG001|Overall Study|Delayed or incomplete treatment|2|||
129184629|NCT04037254|464971390|FG002|Overall Study|Delayed or incomplete treatment|1|||
129184630|NCT04037254|464971391|FG003|Overall Study|Delayed or incomplete treatment|0|||
129184631|NCT04037254|464971392|FG004|Overall Study|Delayed or incomplete treatment|0|||
129184632|NCT01306656|464971393|FG000|Overall Study|Lost to Follow-up|1|||
129184633|NCT01306656|464971394|FG001|Overall Study|Lost to Follow-up|0|||
129184634|NCT00477152|464971395|FG000|Overall Study|Parent withdrew consent|2|||
129184635|NCT00477152|464971395|FG000|Overall Study|Adverse Event|1|||
129184636|NCT02504580|464971396|FG000|Overall Study|Other|1|||
129184637|NCT02504580|464971397|FG001|Overall Study|Other|0|||
129184638|NCT02504580|464971398|FG002|Overall Study|Other|0|||
129184639|NCT02504580|464971399|FG003|Overall Study|Other|2|||
129184640|NCT02504580|464971400|FG004|Overall Study|Other|1|||
129184641|NCT02504580|464971401|FG005|Overall Study|Other|1|||
129184642|NCT02504580|464971402|FG006|Overall Study|Other|1|||
129184643|NCT02504580|464971403|FG007|Overall Study|Other|2|||
129184644|NCT02504580|464971404|FG008|Overall Study|Other|0|||
129184645|NCT02504580|464971405|FG009|Overall Study|Other|0|||
129184646|NCT02504580|464971406|FG010|Overall Study|Other|0|||
129184647|NCT02504580|464971407|FG011|Overall Study|Other|2|||
129184648|NCT02504580|464971396|FG000|Overall Study|Subject refusal to continue|0|||
129184649|NCT02504580|464971397|FG001|Overall Study|Subject refusal to continue|1|||
128780974|NCT01323660|463488627|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
128780975|NCT01323660|463488628|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
128780976|NCT01323660|463488629|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
128780977|NCT01323660|463488630|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129184650|NCT02504580|464971398|FG002|Overall Study|Subject refusal to continue|0|||
129184651|NCT02504580|464971399|FG003|Overall Study|Subject refusal to continue|0|||
129184652|NCT02504580|464971400|FG004|Overall Study|Subject refusal to continue|0|||
129184653|NCT02504580|464971401|FG005|Overall Study|Subject refusal to continue|0|||
129184654|NCT02504580|464971402|FG006|Overall Study|Subject refusal to continue|0|||
129184655|NCT02504580|464971403|FG007|Overall Study|Subject refusal to continue|0|||
129184656|NCT02504580|464971404|FG008|Overall Study|Subject refusal to continue|0|||
129184657|NCT02504580|464971405|FG009|Overall Study|Subject refusal to continue|0|||
129184658|NCT02504580|464971406|FG010|Overall Study|Subject refusal to continue|0|||
129184659|NCT02504580|464971407|FG011|Overall Study|Subject refusal to continue|0|||
129184660|NCT00448747|464971409|FG000|Overall Study|collapsed veins|1|||
129184661|NCT00448747|464971410|FG001|Overall Study|collapsed veins|0|||
129184662|NCT02905006|464971411|FG000|Overall Study|Adverse Event|1|||
129184663|NCT02905006|464971412|FG001|Overall Study|Adverse Event|1|||
129184664|NCT02905006|464971413|FG002|Overall Study|Adverse Event|1|||
129184665|NCT02905006|464971414|FG003|Overall Study|Adverse Event|1|||
129184666|NCT02905006|464971415|FG004|Overall Study|Adverse Event|0|||
129184667|NCT02905006|464971416|FG005|Overall Study|Adverse Event|1|||
129184668|NCT02905006|464971411|FG000|Overall Study|Lack of Efficacy|1|||
129184669|NCT02905006|464971412|FG001|Overall Study|Lack of Efficacy|0|||
129184670|NCT02905006|464971413|FG002|Overall Study|Lack of Efficacy|0|||
129184671|NCT02905006|464971414|FG003|Overall Study|Lack of Efficacy|0|||
129184672|NCT02905006|464971415|FG004|Overall Study|Lack of Efficacy|0|||
129184673|NCT02905006|464971416|FG005|Overall Study|Lack of Efficacy|0|||
129184674|NCT02905006|464971411|FG000|Overall Study|Protocol Violation|2|||
129184675|NCT02905006|464971412|FG001|Overall Study|Protocol Violation|0|||
129184676|NCT02905006|464971413|FG002|Overall Study|Protocol Violation|0|||
129184677|NCT02905006|464971414|FG003|Overall Study|Protocol Violation|0|||
129184678|NCT02905006|464971415|FG004|Overall Study|Protocol Violation|0|||
129184679|NCT02905006|464971416|FG005|Overall Study|Protocol Violation|0|||
129184680|NCT02905006|464971411|FG000|Overall Study|Lost to Follow-up|0|||
129184681|NCT02905006|464971412|FG001|Overall Study|Lost to Follow-up|0|||
129184682|NCT02905006|464971413|FG002|Overall Study|Lost to Follow-up|0|||
129184683|NCT02905006|464971414|FG003|Overall Study|Lost to Follow-up|1|||
129184684|NCT02905006|464971415|FG004|Overall Study|Lost to Follow-up|1|||
129184685|NCT02905006|464971416|FG005|Overall Study|Lost to Follow-up|0|||
129184686|NCT02905006|464971411|FG000|Overall Study|Withdrawal by Subject|0|||
129184687|NCT02905006|464971412|FG001|Overall Study|Withdrawal by Subject|0|||
129184688|NCT02905006|464971413|FG002|Overall Study|Withdrawal by Subject|1|||
129184689|NCT02905006|464971414|FG003|Overall Study|Withdrawal by Subject|1|||
129184690|NCT02905006|464971415|FG004|Overall Study|Withdrawal by Subject|0|||
129184691|NCT02905006|464971416|FG005|Overall Study|Withdrawal by Subject|1|||
129184692|NCT02905006|464971411|FG000|Overall Study|Screening exclusion criteria met|1|||
129184693|NCT02905006|464971412|FG001|Overall Study|Screening exclusion criteria met|0|||
129184694|NCT02905006|464971413|FG002|Overall Study|Screening exclusion criteria met|0|||
129184695|NCT02905006|464971414|FG003|Overall Study|Screening exclusion criteria met|0|||
129184696|NCT02905006|464971415|FG004|Overall Study|Screening exclusion criteria met|0|||
129184697|NCT02905006|464971416|FG005|Overall Study|Screening exclusion criteria met|0|||
129184698|NCT02905006|464971411|FG000|Overall Study|Lab withdrawal criterion met|0|||
129184699|NCT02905006|464971412|FG001|Overall Study|Lab withdrawal criterion met|1|||
129184700|NCT02905006|464971413|FG002|Overall Study|Lab withdrawal criterion met|2|||
129184701|NCT02905006|464971414|FG003|Overall Study|Lab withdrawal criterion met|2|||
129184702|NCT02905006|464971415|FG004|Overall Study|Lab withdrawal criterion met|2|||
129184703|NCT02905006|464971416|FG005|Overall Study|Lab withdrawal criterion met|1|||
129184704|NCT02905006|464971411|FG000|Overall Study|Positive for Tuberculosis|0|||
129184705|NCT02905006|464971412|FG001|Overall Study|Positive for Tuberculosis|1|||
129184706|NCT02905006|464971413|FG002|Overall Study|Positive for Tuberculosis|0|||
129184707|NCT02905006|464971414|FG003|Overall Study|Positive for Tuberculosis|0|||
129184708|NCT02905006|464971415|FG004|Overall Study|Positive for Tuberculosis|0|||
129184709|NCT02905006|464971416|FG005|Overall Study|Positive for Tuberculosis|0|||
129184710|NCT02905006|464971411|FG000|Overall Study|Subject positive for Hep B|0|||
129184711|NCT02905006|464971412|FG001|Overall Study|Subject positive for Hep B|0|||
129184712|NCT02905006|464971413|FG002|Overall Study|Subject positive for Hep B|1|||
129184713|NCT02905006|464971414|FG003|Overall Study|Subject positive for Hep B|0|||
129184714|NCT02905006|464971415|FG004|Overall Study|Subject positive for Hep B|0|||
129184715|NCT02905006|464971416|FG005|Overall Study|Subject positive for Hep B|0|||
129184716|NCT02905006|464971411|FG000|Overall Study|Patient moved abroad|0|||
129184717|NCT02905006|464971412|FG001|Overall Study|Patient moved abroad|0|||
129184718|NCT02905006|464971413|FG002|Overall Study|Patient moved abroad|0|||
129184719|NCT02905006|464971414|FG003|Overall Study|Patient moved abroad|1|||
129184720|NCT02905006|464971415|FG004|Overall Study|Patient moved abroad|0|||
129184721|NCT02905006|464971416|FG005|Overall Study|Patient moved abroad|0|||
129184722|NCT02905006|464971411|FG000|Overall Study|Patient randomized by mistake|0|||
129184723|NCT02905006|464971412|FG001|Overall Study|Patient randomized by mistake|0|||
129184724|NCT02905006|464971413|FG002|Overall Study|Patient randomized by mistake|0|||
129184725|NCT02905006|464971414|FG003|Overall Study|Patient randomized by mistake|0|||
129184726|NCT02905006|464971415|FG004|Overall Study|Patient randomized by mistake|0|||
129184727|NCT02905006|464971416|FG005|Overall Study|Patient randomized by mistake|1|||
129184728|NCT02429791|464971421|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
129184729|NCT02429791|464971422|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
129184730|NCT02429791|464971421|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
129184731|NCT02429791|464971422|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
129184732|NCT02429791|464971421|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
129184733|NCT02429791|464971422|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
129184734|NCT02429791|464971421|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
129184735|NCT02429791|464971422|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
129184736|NCT02429791|464971421|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
129184737|NCT02429791|464971422|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
129184738|NCT02429791|464971421|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
129184739|NCT02429791|464971422|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
129184740|NCT02429791|464971421|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
129184741|NCT02429791|464971422|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
129184742|NCT02429791|464971421|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
129184743|NCT02429791|464971422|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
129184744|NCT02429791|464971421|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
129184745|NCT02429791|464971422|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
129184746|NCT02429791|464971421|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
129184747|NCT02429791|464971422|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
129184748|NCT02429791|464971421|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
129184749|NCT02429791|464971422|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
129184750|NCT02429791|464971421|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
129184751|NCT02429791|464971422|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
129184752|NCT02429791|464971421|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
129184753|NCT02429791|464971422|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
129184754|NCT02429791|464971421|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
129184755|NCT02429791|464971422|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
129184756|NCT02429791|464971421|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
129184757|NCT02429791|464971422|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
129184758|NCT02429791|464971421|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
129184759|NCT02429791|464971422|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
129184760|NCT02429791|464971421|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
129184761|NCT02429791|464971422|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
129184762|NCT02429791|464971421|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
129184763|NCT02429791|464971422|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
129184764|NCT04201093|464971423|FG000|Overall Study|Adverse Event|6|||
129184765|NCT04201093|464971424|FG001|Overall Study|Adverse Event|29|||
129184766|NCT04201093|464971425|FG002|Overall Study|Adverse Event|35|||
129184767|NCT04201093|464971423|FG000|Overall Study|Death|2|||
129184768|NCT04201093|464971424|FG001|Overall Study|Death|1|||
129184769|NCT04201093|464971425|FG002|Overall Study|Death|0|||
129184770|NCT04201093|464971423|FG000|Overall Study|Lack of Efficacy|5|||
129184771|NCT04201093|464971424|FG001|Overall Study|Lack of Efficacy|1|||
129184772|NCT04201093|464971425|FG002|Overall Study|Lack of Efficacy|2|||
129184773|NCT04201093|464971423|FG000|Overall Study|Lost to Follow-up|0|||
129184774|NCT04201093|464971424|FG001|Overall Study|Lost to Follow-up|0|||
129184775|NCT04201093|464971425|FG002|Overall Study|Lost to Follow-up|1|||
129184776|NCT04201093|464971423|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
129184777|NCT04201093|464971424|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
129184778|NCT04201093|464971425|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
129184779|NCT04201093|464971423|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
129184780|NCT04201093|464971424|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
129184781|NCT04201093|464971425|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
129184782|NCT04201093|464971423|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
129184783|NCT04201093|464971424|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
129184784|NCT04201093|464971425|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
129184785|NCT04201093|464971423|FG000|Overall Study|Physician Decision|1|||
129184786|NCT04201093|464971424|FG001|Overall Study|Physician Decision|0|||
129184787|NCT04201093|464971425|FG002|Overall Study|Physician Decision|0|||
129184788|NCT04201093|464971423|FG000|Overall Study|Protocol Deviation|1|||
129184789|NCT04201093|464971424|FG001|Overall Study|Protocol Deviation|0|||
129184790|NCT04201093|464971425|FG002|Overall Study|Protocol Deviation|0|||
129184791|NCT04201093|464971423|FG000|Overall Study|Site Terminated by Sponsor|5|||
129184792|NCT04201093|464971424|FG001|Overall Study|Site Terminated by Sponsor|3|||
129184793|NCT04201093|464971425|FG002|Overall Study|Site Terminated by Sponsor|1|||
129184794|NCT04201093|464971423|FG000|Overall Study|Withdrawal by Subject|7|||
129184795|NCT04201093|464971424|FG001|Overall Study|Withdrawal by Subject|8|||
129184796|NCT04201093|464971425|FG002|Overall Study|Withdrawal by Subject|15|||
129184797|NCT04201093|464971423|FG000|Overall Study|Other|0|||
129184798|NCT04201093|464971424|FG001|Overall Study|Other|1|||
129184799|NCT04201093|464971425|FG002|Overall Study|Other|2|||
129184800|NCT00881504|464971426|FG000|Overall Study|Withdrawal by Subject|1|||
129184801|NCT00007020|464971427|FG000|Overall Study|Death|16|||
129184802|NCT00007020|464971427|FG000|Overall Study|Lost to Follow-up|13|||
129184803|NCT00007020|464971427|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
129184804|NCT00007020|464971427|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
129184805|NCT00007020|464971427|FG000|Overall Study|Pt cared for by outside physician|4|||
129184806|NCT00007020|464971427|FG000|Overall Study|No evidence of treatment|6|||
129184807|NCT01276223|464971428|FG000|Overall Study|Adverse Event|7|||
129184808|NCT01276223|464971429|FG001|Overall Study|Adverse Event|4|||
129184809|NCT01276223|464971430|FG002|Overall Study|Adverse Event|1|||
129184810|NCT01276223|464971428|FG000|Overall Study|Lost to Follow-up|0|||
129184811|NCT01276223|464971429|FG001|Overall Study|Lost to Follow-up|0|||
129184812|NCT01276223|464971430|FG002|Overall Study|Lost to Follow-up|1|||
129184813|NCT01276223|464971428|FG000|Overall Study|Other|0|||
129184814|NCT01276223|464971429|FG001|Overall Study|Other|0|||
129184815|NCT01276223|464971430|FG002|Overall Study|Other|1|||
129184816|NCT01276223|464971428|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
129184817|NCT01276223|464971429|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
129184818|NCT01276223|464971430|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
129184819|NCT01276223|464971428|FG000|Overall Study|Protocol Violation|1|||
129184820|NCT01276223|464971429|FG001|Overall Study|Protocol Violation|0|||
129184821|NCT01276223|464971430|FG002|Overall Study|Protocol Violation|0|||
129184822|NCT05856227|464971431|FG000|Overall Study|Adverse Event|0|||
129184823|NCT05856227|464971432|FG001|Overall Study|Adverse Event|1|||
129184824|NCT05856227|464971431|FG000|Overall Study|Due to Investigator absence|1|||
129184825|NCT05856227|464971432|FG001|Overall Study|Due to Investigator absence|0|||
128780978|NCT01323660|463488631|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
129184826|NCT05856227|464971431|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
129184827|NCT05856227|464971432|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
129184828|NCT01571232|464971434|FG000|Overall Study|Lost to Follow-up|0|||
129184829|NCT01571232|464971435|FG001|Overall Study|Lost to Follow-up|1|||
129184830|NCT01571232|464971434|FG000|Overall Study|Withdrawal by Subject|1|||
129184831|NCT01571232|464971435|FG001|Overall Study|Withdrawal by Subject|0|||
129184832|NCT00771615|464971436|FG000|Overall Study|Withdrawal by Subject|0|||
129184833|NCT00771615|464971437|FG001|Overall Study|Withdrawal by Subject|1|||
129184834|NCT00771615|464971438|FG002|Overall Study|Withdrawal by Subject|0|||
129184835|NCT00771615|464971439|FG003|Overall Study|Withdrawal by Subject|0|||
129184836|NCT00771615|464971440|FG004|Overall Study|Withdrawal by Subject|0|||
129184837|NCT00771615|464971441|FG005|Overall Study|Withdrawal by Subject|0|||
129184838|NCT00771615|464971442|FG006|Overall Study|Withdrawal by Subject|0|||
129184839|NCT00771615|464971443|FG007|Overall Study|Withdrawal by Subject|1|||
129184840|NCT00771615|464971444|FG008|Overall Study|Withdrawal by Subject|0|||
129184841|NCT00771615|464971436|FG000|Overall Study|Lost to Follow-up|1|||
129184842|NCT00771615|464971437|FG001|Overall Study|Lost to Follow-up|1|||
129184843|NCT00771615|464971438|FG002|Overall Study|Lost to Follow-up|1|||
129184844|NCT00771615|464971439|FG003|Overall Study|Lost to Follow-up|1|||
129184845|NCT00771615|464971440|FG004|Overall Study|Lost to Follow-up|0|||
129184846|NCT00771615|464971441|FG005|Overall Study|Lost to Follow-up|1|||
129184847|NCT00771615|464971442|FG006|Overall Study|Lost to Follow-up|1|||
129184848|NCT00771615|464971443|FG007|Overall Study|Lost to Follow-up|0|||
129184849|NCT00771615|464971444|FG008|Overall Study|Lost to Follow-up|0|||
129184850|NCT02455076|464971445|FG000|Inpatient|Withdrawal by Subject|1|||
129184851|NCT02455076|464971446|FG001|Inpatient|Withdrawal by Subject|0|||
129184852|NCT02455076|464971447|FG002|Inpatient|Withdrawal by Subject|0|||
129184853|NCT02455076|464971448|FG003|Inpatient|Withdrawal by Subject|0|||
129184854|NCT02455076|464971449|FG004|Inpatient|Withdrawal by Subject|0|||
129184855|NCT02455076|464971445|FG000|Inpatient|Discharged <24 h after admission|0|||
129184856|NCT02455076|464971446|FG001|Inpatient|Discharged <24 h after admission|1|||
129184857|NCT02455076|464971447|FG002|Inpatient|Discharged <24 h after admission|0|||
129184858|NCT02455076|464971448|FG003|Inpatient|Discharged <24 h after admission|0|||
129184859|NCT02455076|464971449|FG004|Inpatient|Discharged <24 h after admission|0|||
129184860|NCT02455076|464971445|FG000|Inpatient|Adverse Event|3|||
129184861|NCT02455076|464971446|FG001|Inpatient|Adverse Event|0|||
129184862|NCT02455076|464971447|FG002|Inpatient|Adverse Event|0|||
129184863|NCT02455076|464971448|FG003|Inpatient|Adverse Event|0|||
129184864|NCT02455076|464971449|FG004|Inpatient|Adverse Event|0|||
129184865|NCT02455076|464971445|FG000|Outpatient|Adverse Event|0|||
129184866|NCT02455076|464971446|FG001|Outpatient|Adverse Event|0|||
129184867|NCT02455076|464971447|FG002|Outpatient|Adverse Event|0|||
129184868|NCT02455076|464971448|FG003|Outpatient|Adverse Event|5|||
129184869|NCT02455076|464971449|FG004|Outpatient|Adverse Event|0|||
129184870|NCT02455076|464971445|FG000|Outpatient|Lost to Follow-up|0|||
129184871|NCT02455076|464971446|FG001|Outpatient|Lost to Follow-up|0|||
129184872|NCT02455076|464971447|FG002|Outpatient|Lost to Follow-up|0|||
129184873|NCT02455076|464971448|FG003|Outpatient|Lost to Follow-up|1|||
129184874|NCT02455076|464971449|FG004|Outpatient|Lost to Follow-up|12|||
129184875|NCT03517969|464971450|FG000|Overall Study|Never started protocol treatment|3|||
129184876|NCT03517969|464971451|FG001|Overall Study|Never started protocol treatment|5|||
129184877|NCT03517969|464971450|FG000|Overall Study|Disease progression|11|||
129184878|NCT03517969|464971451|FG001|Overall Study|Disease progression|16|||
129184879|NCT03517969|464971450|FG000|Overall Study|PSA progression|8|||
129184880|NCT03517969|464971451|FG001|Overall Study|PSA progression|1|||
129184881|NCT03517969|464971450|FG000|Overall Study|Clinical progression|4|||
129184882|NCT03517969|464971451|FG001|Overall Study|Clinical progression|2|||
129184883|NCT03517969|464971450|FG000|Overall Study|Adverse Event|5|||
129184884|NCT03517969|464971451|FG001|Overall Study|Adverse Event|4|||
129184885|NCT03517969|464971450|FG000|Overall Study|Intercurrent illness|1|||
129184886|NCT03517969|464971451|FG001|Overall Study|Intercurrent illness|2|||
129184887|NCT03517969|464971450|FG000|Overall Study|Death|1|||
129184888|NCT03517969|464971451|FG001|Overall Study|Death|1|||
129184889|NCT03517969|464971450|FG000|Overall Study|Withdrawal by Subject|1|||
129184890|NCT03517969|464971451|FG001|Overall Study|Withdrawal by Subject|2|||
129184891|NCT03517969|464971450|FG000|Overall Study|Physician Decision|1|||
129184892|NCT03517969|464971451|FG001|Overall Study|Physician Decision|1|||
129184893|NCT03517969|464971450|FG000|Overall Study|No clinical benefit|1|||
129184894|NCT03517969|464971451|FG001|Overall Study|No clinical benefit|0|||
128780979|NCT01323660|463488626|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129184895|NCT03517969|464971450|FG000|Overall Study|Delayed treatment for dental treatment|1|||
129184896|NCT03517969|464971451|FG001|Overall Study|Delayed treatment for dental treatment|0|||
129184897|NCT03517969|464971450|FG000|Overall Study|Difficult to maintain appointment|0|||
129184898|NCT03517969|464971451|FG001|Overall Study|Difficult to maintain appointment|1|||
129184899|NCT03517969|464971450|FG000|Overall Study|Protocol Violation|0|||
129184900|NCT03517969|464971451|FG001|Overall Study|Protocol Violation|1|||
129184901|NCT05779007|464971456|FG000|Overall Study|not meeting eligibility criteria|3517|||
129184902|NCT05779007|464971457|FG001|Overall Study|not meeting eligibility criteria|2009|||
129184903|NCT01638546|464971468|FG000|Overall Study|Adverse Event|1|||
129184904|NCT01638546|464971469|FG001|Overall Study|Adverse Event|3|||
129184905|NCT05147662|464971472|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129184906|NCT05147662|464971472|FG000|Overall Study|Assigned to treatment but never treated|1|||
129184907|NCT04676867|464971473|FG000|Overall Study|Screen failure|0|||
129184908|NCT04676867|464971474|FG001|Overall Study|Screen failure|0|||
129184909|NCT04676867|464971475|FG002|Overall Study|Screen failure|6|||
129184910|NCT04676867|464971476|FG003|Overall Study|Screen failure|2|||
129184911|NCT04676867|464971473|FG000|Overall Study|Death|0|||
129184912|NCT04676867|464971474|FG001|Overall Study|Death|0|||
129184913|NCT04676867|464971475|FG002|Overall Study|Death|1|||
129184914|NCT04676867|464971476|FG003|Overall Study|Death|0|||
129184915|NCT04676867|464971473|FG000|Overall Study|Withdrawal by Subject|2|||
129184916|NCT04676867|464971474|FG001|Overall Study|Withdrawal by Subject|2|||
129184917|NCT04676867|464971475|FG002|Overall Study|Withdrawal by Subject|4|||
129184918|NCT04676867|464971476|FG003|Overall Study|Withdrawal by Subject|4|||
129184919|NCT04676867|464971473|FG000|Overall Study|Lost to Follow-up|1|||
129184920|NCT04676867|464971474|FG001|Overall Study|Lost to Follow-up|0|||
129184921|NCT04676867|464971475|FG002|Overall Study|Lost to Follow-up|0|||
129184922|NCT04676867|464971476|FG003|Overall Study|Lost to Follow-up|0|||
129184923|NCT00549770|464971481|FG000|Overall Study|Protocol deviation|1|||
129184924|NCT00549770|464971482|FG001|Overall Study|Protocol deviation|1|||
129184925|NCT00549770|464971483|FG002|Overall Study|Protocol deviation|1|||
129184926|NCT00549770|464971484|FG003|Overall Study|Protocol deviation|2|||
129184927|NCT00549770|464971485|FG004|Overall Study|Protocol deviation|2|||
129184928|NCT00549770|464971486|FG005|Overall Study|Protocol deviation|2|||
129184929|NCT00549770|464971487|FG006|Overall Study|Protocol deviation|1|||
129184930|NCT00549770|464971488|FG007|Overall Study|Protocol deviation|2|||
129184931|NCT00549770|464971481|FG000|Overall Study|Administrative problems|0|||
129184932|NCT00549770|464971482|FG001|Overall Study|Administrative problems|1|||
129184933|NCT00549770|464971483|FG002|Overall Study|Administrative problems|0|||
129184934|NCT00549770|464971484|FG003|Overall Study|Administrative problems|0|||
129184935|NCT00549770|464971485|FG004|Overall Study|Administrative problems|0|||
129184936|NCT00549770|464971486|FG005|Overall Study|Administrative problems|0|||
129184937|NCT00549770|464971487|FG006|Overall Study|Administrative problems|0|||
129184938|NCT00549770|464971488|FG007|Overall Study|Administrative problems|1|||
129184939|NCT00549770|464971481|FG000|Overall Study|Lost to Follow-up|0|||
129184940|NCT00549770|464971482|FG001|Overall Study|Lost to Follow-up|0|||
129184941|NCT00549770|464971483|FG002|Overall Study|Lost to Follow-up|2|||
129184942|NCT00549770|464971484|FG003|Overall Study|Lost to Follow-up|2|||
129184943|NCT00549770|464971485|FG004|Overall Study|Lost to Follow-up|3|||
129184944|NCT00549770|464971486|FG005|Overall Study|Lost to Follow-up|2|||
129184945|NCT00549770|464971487|FG006|Overall Study|Lost to Follow-up|0|||
129184946|NCT00549770|464971488|FG007|Overall Study|Lost to Follow-up|0|||
129184947|NCT00549770|464971481|FG000|Overall Study|Withdrawal by Subject|4|||
129184948|NCT00549770|464971482|FG001|Overall Study|Withdrawal by Subject|6|||
129184949|NCT00549770|464971483|FG002|Overall Study|Withdrawal by Subject|4|||
129184950|NCT00549770|464971484|FG003|Overall Study|Withdrawal by Subject|5|||
129184951|NCT00549770|464971485|FG004|Overall Study|Withdrawal by Subject|6|||
129184952|NCT00549770|464971486|FG005|Overall Study|Withdrawal by Subject|6|||
129184953|NCT00549770|464971487|FG006|Overall Study|Withdrawal by Subject|4|||
129184954|NCT00549770|464971488|FG007|Overall Study|Withdrawal by Subject|9|||
129184955|NCT00549770|464971481|FG000|Overall Study|Lack of Efficacy|1|||
129184956|NCT00549770|464971482|FG001|Overall Study|Lack of Efficacy|0|||
129184957|NCT00549770|464971483|FG002|Overall Study|Lack of Efficacy|2|||
129184958|NCT00549770|464971484|FG003|Overall Study|Lack of Efficacy|3|||
129184959|NCT00549770|464971485|FG004|Overall Study|Lack of Efficacy|5|||
129184960|NCT00549770|464971486|FG005|Overall Study|Lack of Efficacy|1|||
129184961|NCT00549770|464971487|FG006|Overall Study|Lack of Efficacy|3|||
129184962|NCT00549770|464971488|FG007|Overall Study|Lack of Efficacy|8|||
129184963|NCT00549770|464971481|FG000|Overall Study|Abnormal test procedure results|0|||
129184964|NCT00549770|464971482|FG001|Overall Study|Abnormal test procedure results|0|||
129184965|NCT00549770|464971483|FG002|Overall Study|Abnormal test procedure results|0|||
129184966|NCT00549770|464971484|FG003|Overall Study|Abnormal test procedure results|2|||
129184967|NCT00549770|464971485|FG004|Overall Study|Abnormal test procedure results|0|||
129184968|NCT00549770|464971486|FG005|Overall Study|Abnormal test procedure results|1|||
129184969|NCT00549770|464971487|FG006|Overall Study|Abnormal test procedure results|1|||
129184970|NCT00549770|464971488|FG007|Overall Study|Abnormal test procedure results|1|||
129184971|NCT00549770|464971481|FG000|Overall Study|Abnormal laboratory values|0|||
129184972|NCT00549770|464971482|FG001|Overall Study|Abnormal laboratory values|0|||
129184973|NCT00549770|464971483|FG002|Overall Study|Abnormal laboratory values|0|||
129184974|NCT00549770|464971484|FG003|Overall Study|Abnormal laboratory values|0|||
129184975|NCT00549770|464971485|FG004|Overall Study|Abnormal laboratory values|0|||
129184976|NCT00549770|464971486|FG005|Overall Study|Abnormal laboratory values|1|||
129184977|NCT00549770|464971487|FG006|Overall Study|Abnormal laboratory values|0|||
129184978|NCT00549770|464971488|FG007|Overall Study|Abnormal laboratory values|0|||
129184979|NCT00549770|464971481|FG000|Overall Study|Adverse Event|1|||
129184980|NCT00549770|464971482|FG001|Overall Study|Adverse Event|3|||
129184981|NCT00549770|464971483|FG002|Overall Study|Adverse Event|1|||
129184982|NCT00549770|464971484|FG003|Overall Study|Adverse Event|2|||
129184983|NCT00549770|464971485|FG004|Overall Study|Adverse Event|1|||
129184984|NCT00549770|464971486|FG005|Overall Study|Adverse Event|0|||
129184985|NCT00549770|464971487|FG006|Overall Study|Adverse Event|5|||
129184986|NCT00549770|464971488|FG007|Overall Study|Adverse Event|4|||
129184987|NCT00548717|464971489|FG000|Overall Study|Death|5|||
129184988|NCT00548717|464971490|FG001|Overall Study|Death|2|||
129184989|NCT00548717|464971489|FG000|Overall Study|Relapse|3|||
129184990|NCT00548717|464971490|FG001|Overall Study|Relapse|0|||
129184991|NCT00548717|464971489|FG000|Overall Study|Alternative treatment for GVHD|1|||
129184992|NCT00548717|464971490|FG001|Overall Study|Alternative treatment for GVHD|0|||
129184993|NCT02809053|464971492|FG000|Overall Study|Death|0|||
129184994|NCT02809053|464971493|FG001|Overall Study|Death|1|||
129184995|NCT02809053|464971492|FG000|Overall Study|Lost to Follow-up|3|||
129184996|NCT02809053|464971493|FG001|Overall Study|Lost to Follow-up|1|||
129184997|NCT02809053|464971492|FG000|Overall Study|Withdrawal by Subject|2|||
129184998|NCT02809053|464971493|FG001|Overall Study|Withdrawal by Subject|3|||
129184999|NCT02809053|464971492|FG000|Overall Study|Disease Progression|2|||
129185000|NCT02809053|464971493|FG001|Overall Study|Disease Progression|1|||
129185001|NCT00869401|464971496|FG000|Overall Study|Withdrawal by Subject|0|||
129185002|NCT00869401|464971497|FG001|Overall Study|Withdrawal by Subject|0|||
129185003|NCT00869401|464971498|FG002|Overall Study|Withdrawal by Subject|0|||
129185004|NCT00869401|464971499|FG003|Overall Study|Withdrawal by Subject|5|||
129185005|NCT00869401|464971500|FG004|Overall Study|Withdrawal by Subject|3|||
129185006|NCT01147900|464971501|FG000|At Year 10|Lost to Follow-up|0|||
129185007|NCT01147900|464971502|FG001|At Year 10|Lost to Follow-up|1|||
129185008|NCT01147900|464971503|FG002|At Year 10|Lost to Follow-up|0|||
129185009|NCT01732913|464971504|FG000|Overall Study|Study Terminated by Sponsor|105|||
129185010|NCT01732913|464971505|FG001|Overall Study|Study Terminated by Sponsor|55|||
129185011|NCT01732913|464971504|FG000|Overall Study|Withdrawal by Subject|27|||
129185012|NCT01732913|464971505|FG001|Overall Study|Withdrawal by Subject|4|||
129185013|NCT01732913|464971504|FG000|Overall Study|Physician Decision|14|||
129185014|NCT01732913|464971505|FG001|Overall Study|Physician Decision|7|||
129185015|NCT01732913|464971504|FG000|Overall Study|Other|7|||
129185016|NCT01732913|464971505|FG001|Overall Study|Other|1|||
129185017|NCT01732913|464971504|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
129185018|NCT01732913|464971505|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
129185019|NCT00025155|464971506|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
129185020|NCT00025155|464971506|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
129185021|NCT03022981|464971507|FG000|Overall Study|Adverse Event|0|||
129185022|NCT03022981|464971508|FG001|Overall Study|Adverse Event|1|||
129185023|NCT03022981|464971509|FG002|Overall Study|Adverse Event|0|||
129185024|NCT03022981|464971507|FG000|Overall Study|Investigator's Discretion|0|||
129185025|NCT03022981|464971508|FG001|Overall Study|Investigator's Discretion|1|||
129185026|NCT03022981|464971509|FG002|Overall Study|Investigator's Discretion|2|||
129185027|NCT03022981|464971507|FG000|Overall Study|Lost to Follow-up|6|||
129185028|NCT03022981|464971508|FG001|Overall Study|Lost to Follow-up|2|||
129185029|NCT03022981|464971509|FG002|Overall Study|Lost to Follow-up|1|||
129185030|NCT03022981|464971507|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129185031|NCT03022981|464971508|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129185032|NCT03022981|464971509|FG002|Overall Study|Non-Compliance With Study Drug|2|||
129185033|NCT03022981|464971507|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
129185034|NCT03022981|464971508|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
129185035|NCT03022981|464971509|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
129185036|NCT00444067|464971510|FG000|Overall Study|Lost to Follow-up|0|||
129185037|NCT00444067|464971511|FG001|Overall Study|Lost to Follow-up|1|||
129185038|NCT03178669|464971512|FG000|Overall Study|Adverse Event|4|||
129185039|NCT03178669|464971513|FG001|Overall Study|Adverse Event|1|||
129185040|NCT03178669|464971514|FG002|Overall Study|Adverse Event|4|||
129185041|NCT03178669|464971515|FG003|Overall Study|Adverse Event|2|||
129185042|NCT03178669|464971516|FG004|Overall Study|Adverse Event|2|||
129185043|NCT03178669|464971512|FG000|Overall Study|Lack of Efficacy|0|||
129185044|NCT03178669|464971513|FG001|Overall Study|Lack of Efficacy|0|||
129185045|NCT03178669|464971514|FG002|Overall Study|Lack of Efficacy|2|||
129185046|NCT03178669|464971515|FG003|Overall Study|Lack of Efficacy|0|||
129185047|NCT03178669|464971516|FG004|Overall Study|Lack of Efficacy|1|||
129185048|NCT03178669|464971512|FG000|Overall Study|Physician Decision|0|||
129185049|NCT03178669|464971513|FG001|Overall Study|Physician Decision|0|||
129185050|NCT03178669|464971514|FG002|Overall Study|Physician Decision|0|||
129185051|NCT03178669|464971515|FG003|Overall Study|Physician Decision|0|||
129185052|NCT03178669|464971516|FG004|Overall Study|Physician Decision|1|||
129185053|NCT03178669|464971512|FG000|Overall Study|Withdrawal by Subject|1|||
129185054|NCT03178669|464971513|FG001|Overall Study|Withdrawal by Subject|0|||
129185055|NCT03178669|464971514|FG002|Overall Study|Withdrawal by Subject|1|||
129185056|NCT03178669|464971515|FG003|Overall Study|Withdrawal by Subject|1|||
129185057|NCT03178669|464971516|FG004|Overall Study|Withdrawal by Subject|0|||
129185058|NCT03178669|464971512|FG000|Overall Study|Lost to Follow-up|0|||
129185059|NCT03178669|464971513|FG001|Overall Study|Lost to Follow-up|0|||
129185060|NCT03178669|464971514|FG002|Overall Study|Lost to Follow-up|0|||
129185061|NCT03178669|464971515|FG003|Overall Study|Lost to Follow-up|1|||
128780980|NCT01323660|463488627|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129185062|NCT03178669|464971516|FG004|Overall Study|Lost to Follow-up|0|||
129185063|NCT01600092|464971517|FG000|Overall Study|Adverse Event|2|||
129185064|NCT01600092|464971518|FG001|Overall Study|Adverse Event|0|||
129185065|NCT01600092|464971517|FG000|Overall Study|Lost to Follow-up|4|||
129185066|NCT01600092|464971518|FG001|Overall Study|Lost to Follow-up|6|||
129185067|NCT01600092|464971517|FG000|Overall Study|Withdrawal by parent/guardian|8|||
129185068|NCT01600092|464971518|FG001|Overall Study|Withdrawal by parent/guardian|6|||
129185069|NCT01600092|464971517|FG000|Overall Study|Physician Decision|1|||
129185070|NCT01600092|464971518|FG001|Overall Study|Physician Decision|1|||
129185071|NCT01600092|464971517|FG000|Overall Study|Randomized but not vaccinated|3|||
129185072|NCT01600092|464971518|FG001|Overall Study|Randomized but not vaccinated|3|||
129185073|NCT00079677|464971519|FG000|Overall Study|Adverse Event|5|||
129185074|NCT00079677|464971520|FG001|Overall Study|Adverse Event|6|||
129185075|NCT00079677|464971519|FG000|Overall Study|Lack of Efficacy|1|||
128730231|NCT00316199|463308364|FG000|Overall Study|Lost to Follow-up|2|||
128730232|NCT00590954|463308365|FG000|Overall Study|Inevaluable|2|||
128730233|NCT02782949|463308367|FG000|Overall Study|Protocol Violation|1|||
129185076|NCT00079677|464971520|FG001|Overall Study|Lack of Efficacy|0|||
129185077|NCT00079677|464971519|FG000|Overall Study|Lost to Follow-up|2|||
128730234|NCT02782949|463308368|FG001|Overall Study|Protocol Violation|0|||
129185078|NCT00079677|464971520|FG001|Overall Study|Lost to Follow-up|2|||
129185079|NCT00079677|464971519|FG000|Overall Study|Physician Decision|3|||
129185080|NCT00079677|464971520|FG001|Overall Study|Physician Decision|0|||
129185081|NCT00079677|464971519|FG000|Overall Study|Protocol Violation|2|||
129185082|NCT00079677|464971520|FG001|Overall Study|Protocol Violation|3|||
129185083|NCT00079677|464971519|FG000|Overall Study|Withdrawal by Subject|5|||
129185084|NCT00079677|464971520|FG001|Overall Study|Withdrawal by Subject|3|||
129185085|NCT00079677|464971519|FG000|Overall Study|Miscellaneous|2|||
129185086|NCT00079677|464971520|FG001|Overall Study|Miscellaneous|0|||
129185087|NCT01300455|464971521|FG000|Washout|Withdrawal by Subject|1|||
129185088|NCT01300455|464971522|FG001|Washout|Withdrawal by Subject|0|||
129185089|NCT00084487|464971523|FG000|Overall Study|Death|1|||
128780981|NCT01323660|463488628|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129185090|NCT00565136|464971524|FG000|Overall Study|Lost to Follow-up|1|||
129185091|NCT00565136|464971524|FG000|Overall Study|Withdrawal by Subject|1|||
129185092|NCT00565136|464971524|FG000|Overall Study|Protocol Violation|1|||
129185093|NCT02528357|464971525|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185094|NCT02528357|464971526|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
129185095|NCT02528357|464971527|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185096|NCT02528357|464971528|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185097|NCT02528357|464971529|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185098|NCT02528357|464971530|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185099|NCT02528357|464971531|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185100|NCT02528357|464971532|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185101|NCT02528357|464971533|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185102|NCT02528357|464971534|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185103|NCT02528357|464971535|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185104|NCT02528357|464971536|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185105|NCT02528357|464971537|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185106|NCT02528357|464971538|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185107|NCT02528357|464971539|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185108|NCT02528357|464971540|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185109|NCT02528357|464971541|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185110|NCT02528357|464971542|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185111|NCT02528357|464971543|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129185112|NCT02528357|464971525|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185113|NCT02528357|464971526|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185114|NCT02528357|464971527|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185115|NCT02528357|464971528|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
129185116|NCT02528357|464971529|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185117|NCT02528357|464971530|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
129185118|NCT02528357|464971531|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185119|NCT02528357|464971532|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
129185120|NCT02528357|464971533|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185121|NCT02528357|464971534|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185122|NCT02528357|464971535|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185123|NCT02528357|464971536|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185124|NCT02528357|464971537|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185125|NCT02528357|464971538|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185126|NCT02528357|464971539|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185127|NCT02528357|464971540|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185128|NCT02528357|464971541|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185129|NCT02528357|464971542|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185130|NCT02528357|464971543|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129185131|NCT02528357|464971525|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185132|NCT02528357|464971526|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185133|NCT02528357|464971527|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
129185134|NCT02528357|464971528|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185135|NCT02528357|464971529|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
129185136|NCT02528357|464971530|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185137|NCT02528357|464971531|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
129185138|NCT02528357|464971532|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
129185139|NCT02528357|464971533|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185140|NCT02528357|464971534|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185141|NCT02528357|464971535|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185142|NCT02528357|464971536|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185143|NCT02528357|464971537|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185144|NCT02528357|464971538|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185145|NCT02528357|464971539|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185146|NCT02528357|464971540|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185147|NCT02528357|464971541|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185148|NCT02528357|464971542|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185149|NCT02528357|464971543|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129185150|NCT02528357|464971525|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185151|NCT02528357|464971526|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185152|NCT02528357|464971527|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185153|NCT02528357|464971528|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185154|NCT02528357|464971529|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129185155|NCT02528357|464971530|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185156|NCT02528357|464971531|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185157|NCT02528357|464971532|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185158|NCT02528357|464971533|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185159|NCT02528357|464971534|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185160|NCT02528357|464971535|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185161|NCT02528357|464971536|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185162|NCT02528357|464971537|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185163|NCT02528357|464971538|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185164|NCT02528357|464971539|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185165|NCT02528357|464971540|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185166|NCT02528357|464971541|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185167|NCT02528357|464971542|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185168|NCT02528357|464971543|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185169|NCT02528357|464971525|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185170|NCT02528357|464971526|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185171|NCT02528357|464971527|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185172|NCT02528357|464971528|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185173|NCT02528357|464971529|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185174|NCT02528357|464971530|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185175|NCT02528357|464971531|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185176|NCT02528357|464971532|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185177|NCT02528357|464971533|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185178|NCT02528357|464971534|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185179|NCT02528357|464971535|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185180|NCT02528357|464971536|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185181|NCT02528357|464971537|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185182|NCT02528357|464971538|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
129185183|NCT02528357|464971539|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
129185184|NCT02528357|464971540|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185185|NCT02528357|464971541|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185186|NCT02528357|464971542|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185187|NCT02528357|464971543|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129185188|NCT02528357|464971525|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185189|NCT02528357|464971526|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185190|NCT02528357|464971527|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185191|NCT02528357|464971528|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185192|NCT02528357|464971529|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185193|NCT02528357|464971530|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185194|NCT02528357|464971531|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185195|NCT02528357|464971532|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185196|NCT02528357|464971533|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185197|NCT02528357|464971534|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185198|NCT02528357|464971535|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185199|NCT02528357|464971536|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185200|NCT02528357|464971537|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185201|NCT02528357|464971538|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
129185202|NCT02528357|464971539|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185203|NCT02528357|464971540|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185204|NCT02528357|464971541|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185205|NCT02528357|464971542|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185206|NCT02528357|464971543|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129185207|NCT02528357|464971525|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185208|NCT02528357|464971526|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185209|NCT02528357|464971527|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185210|NCT02528357|464971528|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185211|NCT02528357|464971529|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185212|NCT02528357|464971530|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185213|NCT02528357|464971531|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185214|NCT02528357|464971532|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185215|NCT02528357|464971533|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185216|NCT02528357|464971534|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185217|NCT02528357|464971535|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
129185218|NCT02528357|464971536|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185219|NCT02528357|464971537|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
129185220|NCT02528357|464971538|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
129185221|NCT02528357|464971539|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
129185222|NCT02528357|464971540|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185223|NCT02528357|464971541|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185224|NCT02528357|464971542|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185225|NCT02528357|464971543|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129185226|NCT02528357|464971525|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185227|NCT02528357|464971526|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185228|NCT02528357|464971527|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185229|NCT02528357|464971528|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185230|NCT02528357|464971529|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185231|NCT02528357|464971530|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185232|NCT02528357|464971531|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185233|NCT02528357|464971532|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185234|NCT02528357|464971533|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129185235|NCT02528357|464971534|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129185236|NCT02528357|464971535|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185237|NCT02528357|464971536|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
129185238|NCT02528357|464971537|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
129185239|NCT02528357|464971538|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129185240|NCT02528357|464971539|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129185241|NCT02528357|464971540|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185242|NCT02528357|464971541|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185243|NCT02528357|464971542|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185244|NCT02528357|464971543|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185245|NCT02528357|464971525|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185246|NCT02528357|464971526|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185247|NCT02528357|464971527|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185248|NCT02528357|464971528|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185249|NCT02528357|464971529|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185250|NCT02528357|464971530|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185251|NCT02528357|464971531|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185252|NCT02528357|464971532|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185253|NCT02528357|464971533|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185254|NCT02528357|464971534|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185255|NCT02528357|464971535|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185256|NCT02528357|464971536|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185257|NCT02528357|464971537|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185258|NCT02528357|464971538|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185259|NCT02528357|464971539|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185260|NCT02528357|464971540|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185261|NCT02528357|464971541|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
129185262|NCT02528357|464971542|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185263|NCT02528357|464971543|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129185264|NCT02528357|464971525|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185265|NCT02528357|464971526|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185266|NCT02528357|464971527|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185267|NCT02528357|464971528|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185268|NCT02528357|464971529|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185269|NCT02528357|464971530|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185270|NCT02528357|464971531|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185271|NCT02528357|464971532|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185272|NCT02528357|464971533|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185273|NCT02528357|464971534|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185274|NCT02528357|464971535|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185275|NCT02528357|464971536|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185276|NCT02528357|464971537|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185277|NCT02528357|464971538|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185278|NCT02528357|464971539|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185279|NCT02528357|464971540|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129185280|NCT02528357|464971541|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129185281|NCT02528357|464971542|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
129185282|NCT02528357|464971543|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
129185283|NCT02438813|464971549|FG000|Overall Study|Patient Decision|59|||
129185284|NCT02438813|464971549|FG000|Overall Study|Patient Lost to Follow-Up|137|||
129185285|NCT02438813|464971549|FG000|Overall Study|Study Ended by Sponsor|80|||
129185286|NCT02438813|464971549|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
129185287|NCT02228096|464971560|FG000|Overall Study|Study terminated by Sponsor|24|||
129185288|NCT02228096|464971560|FG000|Overall Study|Lack of Efficacy|18|||
129185289|NCT02228096|464971560|FG000|Overall Study|Death|12|||
129185290|NCT02228096|464971560|FG000|Overall Study|Physician Decision|3|||
129185291|NCT02228096|464971560|FG000|Overall Study|Subject/guardian decision|2|||
129185292|NCT02228096|464971560|FG000|Overall Study|New therapy for study indication|1|||
129185293|NCT02228096|464971560|FG000|Overall Study|Enrolled, not infused|11|||
129185294|NCT00454649|464971561|FG000|Overall Study|Lack of Efficacy|2|||
129185295|NCT00454649|464971562|FG001|Overall Study|Lack of Efficacy|2|||
129185296|NCT00454649|464971563|FG002|Overall Study|Lack of Efficacy|10|||
129185297|NCT00454649|464971564|FG003|Overall Study|Lack of Efficacy|3|||
129185298|NCT00454649|464971565|FG004|Overall Study|Lack of Efficacy|0|||
129185299|NCT00454649|464971566|FG005|Overall Study|Lack of Efficacy|4|||
129185300|NCT00454649|464971567|FG006|Overall Study|Lack of Efficacy|5|||
129185301|NCT00454649|464971568|FG007|Overall Study|Lack of Efficacy|13|||
129185302|NCT00454649|464971569|FG008|Overall Study|Lack of Efficacy|10|||
129185303|NCT00454649|464971570|FG009|Overall Study|Lack of Efficacy|2|||
129185304|NCT00454649|464971561|FG000|Overall Study|Adverse Event|0|||
129185305|NCT00454649|464971562|FG001|Overall Study|Adverse Event|1|||
129185306|NCT00454649|464971563|FG002|Overall Study|Adverse Event|3|||
129185307|NCT00454649|464971564|FG003|Overall Study|Adverse Event|0|||
128730235|NCT02782949|463308367|FG000|Overall Study|Withdrawal by Subject|0|||
128730236|NCT02782949|463308368|FG001|Overall Study|Withdrawal by Subject|1|||
128730237|NCT01433263|463309925|FG000|Overall Study|Adverse Event|3|||
129185308|NCT00454649|464971565|FG004|Overall Study|Adverse Event|1|||
129185309|NCT00454649|464971566|FG005|Overall Study|Adverse Event|2|||
129185310|NCT00454649|464971567|FG006|Overall Study|Adverse Event|3|||
129185311|NCT00454649|464971568|FG007|Overall Study|Adverse Event|4|||
129185312|NCT00454649|464971569|FG008|Overall Study|Adverse Event|6|||
129185313|NCT00454649|464971570|FG009|Overall Study|Adverse Event|2|||
129185314|NCT00454649|464971561|FG000|Overall Study|Lost to Follow-up|0|||
129185315|NCT00454649|464971562|FG001|Overall Study|Lost to Follow-up|0|||
129185316|NCT00454649|464971563|FG002|Overall Study|Lost to Follow-up|1|||
129185317|NCT00454649|464971564|FG003|Overall Study|Lost to Follow-up|0|||
129185318|NCT00454649|464971565|FG004|Overall Study|Lost to Follow-up|0|||
129185319|NCT00454649|464971566|FG005|Overall Study|Lost to Follow-up|0|||
129185320|NCT00454649|464971567|FG006|Overall Study|Lost to Follow-up|1|||
129185321|NCT00454649|464971568|FG007|Overall Study|Lost to Follow-up|0|||
129185322|NCT00454649|464971569|FG008|Overall Study|Lost to Follow-up|0|||
129185323|NCT00454649|464971570|FG009|Overall Study|Lost to Follow-up|0|||
129185324|NCT00454649|464971561|FG000|Overall Study|Other|1|||
129185325|NCT00454649|464971562|FG001|Overall Study|Other|1|||
129185326|NCT00454649|464971563|FG002|Overall Study|Other|5|||
129185327|NCT00454649|464971564|FG003|Overall Study|Other|3|||
129185328|NCT00454649|464971565|FG004|Overall Study|Other|0|||
129185329|NCT00454649|464971566|FG005|Overall Study|Other|0|||
129185330|NCT00454649|464971567|FG006|Overall Study|Other|0|||
129185331|NCT00454649|464971568|FG007|Overall Study|Other|0|||
129185332|NCT00454649|464971569|FG008|Overall Study|Other|3|||
129185333|NCT00454649|464971570|FG009|Overall Study|Other|1|||
129185334|NCT00454649|464971561|FG000|Overall Study|Withdrawal by Subject|0|||
129185335|NCT00454649|464971562|FG001|Overall Study|Withdrawal by Subject|0|||
129185336|NCT00454649|464971563|FG002|Overall Study|Withdrawal by Subject|0|||
129185337|NCT00454649|464971564|FG003|Overall Study|Withdrawal by Subject|0|||
129185338|NCT00454649|464971565|FG004|Overall Study|Withdrawal by Subject|0|||
129185339|NCT00454649|464971566|FG005|Overall Study|Withdrawal by Subject|1|||
129185340|NCT00454649|464971567|FG006|Overall Study|Withdrawal by Subject|0|||
129185341|NCT00454649|464971568|FG007|Overall Study|Withdrawal by Subject|2|||
129185342|NCT00454649|464971569|FG008|Overall Study|Withdrawal by Subject|1|||
129185343|NCT00454649|464971570|FG009|Overall Study|Withdrawal by Subject|0|||
129185344|NCT01789606|464971571|FG000|Overall Study|Participant not Purchased the Product|0|||
129185345|NCT01789606|464971572|FG001|Overall Study|Participant not Purchased the Product|20|||
129185346|NCT01789606|464971571|FG000|Overall Study|Withdrawal by Subject|0|||
129185347|NCT01789606|464971572|FG001|Overall Study|Withdrawal by Subject|1|||
129185348|NCT01789606|464971571|FG000|Overall Study|Ineligible|6|||
129185349|NCT01789606|464971572|FG001|Overall Study|Ineligible|2|||
129185350|NCT01789606|464971571|FG000|Overall Study|Administrative Reasons|17|||
129185351|NCT01789606|464971572|FG001|Overall Study|Administrative Reasons|6|||
129185352|NCT01789606|464971571|FG000|Overall Study|No Study Medication Taken|0|||
129185353|NCT01789606|464971572|FG001|Overall Study|No Study Medication Taken|1|||
129185354|NCT01789606|464971571|FG000|Overall Study|Protocol Violation|0|||
129185355|NCT01789606|464971572|FG001|Overall Study|Protocol Violation|55|||
129185356|NCT01789606|464971571|FG000|Overall Study|Adverse Event|0|||
129185357|NCT01789606|464971572|FG001|Overall Study|Adverse Event|3|||
129185358|NCT01789606|464971571|FG000|Overall Study|Lost to Follow-up|0|||
129185359|NCT01789606|464971572|FG001|Overall Study|Lost to Follow-up|14|||
129185360|NCT01789606|464971571|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
129185361|NCT01789606|464971572|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
129185362|NCT05327361|464971582|FG000|Overall Study|Lost to Follow-up|4|||
129185363|NCT01439373|464971587|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
129185364|NCT01439373|464971588|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
129185365|NCT01439373|464971587|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
129185366|NCT01439373|464971588|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
129185367|NCT01264419|464971589|FG000|Overall Study|Lost to Follow-up|3|||
129185368|NCT02720692|464973515|FG000|Overall Study|Withdrawal by Subject|3|||
129185369|NCT02720692|464973516|FG001|Overall Study|Withdrawal by Subject|0|||
129185370|NCT02720692|464973515|FG000|Overall Study|Physician Decision|1|||
129185371|NCT02720692|464973516|FG001|Overall Study|Physician Decision|0|||
128730238|NCT01433263|463309926|FG001|Overall Study|Adverse Event|1|||
129185372|NCT02720692|464973515|FG000|Overall Study|Lost to Follow-up|8|||
129185373|NCT02720692|464973516|FG001|Overall Study|Lost to Follow-up|3|||
129185374|NCT02720692|464973515|FG000|Overall Study|Subject unable to return for visit|1|||
129185375|NCT02720692|464973516|FG001|Overall Study|Subject unable to return for visit|0|||
129185376|NCT05011513|464973517|FG000|Overall Study|Death|0|||
129185377|NCT05011513|464973518|FG001|Overall Study|Death|1|||
129185378|NCT05011513|464973517|FG000|Overall Study|Lost to Follow-up|4|||
128730239|NCT01433263|463309925|FG000|Overall Study|Death|5|||
129185379|NCT05011513|464973518|FG001|Overall Study|Lost to Follow-up|0|||
129185380|NCT05011513|464973517|FG000|Overall Study|Withdrawal by Subject|18|||
129185381|NCT05011513|464973518|FG001|Overall Study|Withdrawal by Subject|17|||
129185382|NCT05011513|464973517|FG000|Overall Study|Other|4|||
129185383|NCT05011513|464973518|FG001|Overall Study|Other|2|||
129185384|NCT03878758|464973519|FG000|Overall Study|Withdrawal by Subject|1|||
129185385|NCT03878758|464973519|FG000|Overall Study|Protocol defined|2|||
129185386|NCT03878758|464973519|FG000|Overall Study|Improper consent documentation|1|||
129185387|NCT02315560|464973520|FG000|Overall Study|noncompliance by subjects|3|||
129185388|NCT00358436|464973522|FG000|Overall Study|Adverse Event|29|||
129185389|NCT00358436|464973523|FG001|Overall Study|Adverse Event|13|||
129185390|NCT00358436|464973522|FG000|Overall Study|Lack of Efficacy|34|||
129185391|NCT00358436|464973523|FG001|Overall Study|Lack of Efficacy|36|||
129185392|NCT00358436|464973522|FG000|Overall Study|Lost to Follow-up|11|||
129185393|NCT00358436|464973523|FG001|Overall Study|Lost to Follow-up|6|||
129185394|NCT00358436|464973522|FG000|Overall Study|Protocol Violation|8|||
129185395|NCT00358436|464973523|FG001|Overall Study|Protocol Violation|3|||
129185396|NCT00358436|464973522|FG000|Overall Study|Withdrawal by Subject|40|||
129185397|NCT00358436|464973523|FG001|Overall Study|Withdrawal by Subject|17|||
129185398|NCT00358436|464973522|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
129185399|NCT00358436|464973523|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
129185400|NCT00358436|464973522|FG000|Overall Study|COPD exacerbation|22|||
129185401|NCT00358436|464973523|FG001|Overall Study|COPD exacerbation|10|||
129185402|NCT00358436|464973522|FG000|Overall Study|Other|6|||
129185403|NCT00358436|464973523|FG001|Overall Study|Other|1|||
129185404|NCT00652951|464973526|FG000|Booster Phase|Adverse event, non-fatal|0|||
128730240|NCT01433263|463309926|FG001|Overall Study|Death|3|||
128730241|NCT01433263|463309925|FG000|Overall Study|Lost to Follow-up|0|||
128730242|NCT01433263|463309926|FG001|Overall Study|Lost to Follow-up|1|||
128730243|NCT01433263|463309925|FG000|Overall Study|Protocol Deviation|1|||
128730244|NCT01433263|463309926|FG001|Overall Study|Protocol Deviation|0|||
128730245|NCT01433263|463309925|FG000|Overall Study|Withdrawal by Subject|10|||
128730246|NCT01433263|463309926|FG001|Overall Study|Withdrawal by Subject|7|||
128730247|NCT02489318|463309927|FG000|Randomized|Withdrawal by Subject|0|||
129185405|NCT00652951|464973527|FG001|Booster Phase|Adverse event, non-fatal|1|||
129185406|NCT00652951|464973528|FG002|Booster Phase|Adverse event, non-fatal|0|||
129185407|NCT00652951|464973526|FG000|Booster Phase|Other|1|||
129185408|NCT00652951|464973527|FG001|Booster Phase|Other|0|||
129185409|NCT00652951|464973528|FG002|Booster Phase|Other|0|||
129185410|NCT01206582|464973529|FG000|Overall Study|Withdrew prior to study|1|||
129185411|NCT01206582|464973530|FG001|Overall Study|Withdrew prior to study|0|||
129185412|NCT01206582|464973529|FG000|Overall Study|Discontinued intervention before week 8|1|||
129185413|NCT01206582|464973530|FG001|Overall Study|Discontinued intervention before week 8|2|||
129185414|NCT06359080|464973531|FG000|Overall Study|Withdrawal by Subject|3|||
129185415|NCT00306527|464973534|FG000|Overall Study|Lost to Follow-up|3|||
129185416|NCT00306527|464973535|FG001|Overall Study|Lost to Follow-up|4|||
129185417|NCT00306527|464973536|FG002|Overall Study|Lost to Follow-up|3|||
129185418|NCT00306527|464973537|FG003|Overall Study|Lost to Follow-up|0|||
129185419|NCT00306527|464973534|FG000|Overall Study|Withdrawal by Subject|2|||
129185420|NCT00306527|464973535|FG001|Overall Study|Withdrawal by Subject|3|||
129185421|NCT00306527|464973536|FG002|Overall Study|Withdrawal by Subject|0|||
129185422|NCT00306527|464973537|FG003|Overall Study|Withdrawal by Subject|3|||
129185423|NCT00306527|464973534|FG000|Overall Study|Adverse Event|0|||
129185424|NCT00306527|464973535|FG001|Overall Study|Adverse Event|0|||
129185425|NCT00306527|464973536|FG002|Overall Study|Adverse Event|1|||
129185426|NCT00306527|464973537|FG003|Overall Study|Adverse Event|1|||
129185427|NCT00306527|464973534|FG000|Overall Study|Death|1|||
129185428|NCT00306527|464973535|FG001|Overall Study|Death|0|||
129185429|NCT00306527|464973536|FG002|Overall Study|Death|1|||
129185430|NCT00306527|464973537|FG003|Overall Study|Death|2|||
129185431|NCT02017522|464973555|FG000|Overall Study|Withdrawal by Subject|1|||
129185432|NCT02166463|464973556|FG000|Overall Study|Lost to Follow-up|0|||
129185433|NCT02166463|464973557|FG001|Overall Study|Lost to Follow-up|1|||
129185434|NCT02166463|464973556|FG000|Overall Study|Physician Decision|10|||
129185435|NCT02166463|464973557|FG001|Overall Study|Physician Decision|10|||
129185436|NCT02166463|464973556|FG000|Overall Study|Ineligible|11|||
129185437|NCT02166463|464973557|FG001|Overall Study|Ineligible|2|||
129185438|NCT02166463|464973556|FG000|Overall Study|Progressive Disease|9|||
129185439|NCT02166463|464973557|FG001|Overall Study|Progressive Disease|6|||
129185440|NCT02166463|464973556|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
129185441|NCT02166463|464973557|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
129185442|NCT02166463|464973556|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
129185443|NCT02166463|464973557|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
129185444|NCT02166463|464973556|FG000|Overall Study|Refusal of further protocol therapy|5|||
129185445|NCT02166463|464973557|FG001|Overall Study|Refusal of further protocol therapy|6|||
129185446|NCT02478164|464973558|FG000|Overall Study|Lack of Efficacy|13|||
129185447|NCT02478164|464973558|FG000|Overall Study|Adverse Event|1|||
129185448|NCT02478164|464973558|FG000|Overall Study|Withdrawal by Subject|1|||
129185449|NCT06151288|464973559|FG000|Overall Study|Lost to Follow-up|4|||
129185450|NCT06151288|464973560|FG001|Overall Study|Lost to Follow-up|2|||
129185451|NCT06151288|464973561|FG002|Overall Study|Lost to Follow-up|4|||
129185452|NCT06151288|464973562|FG003|Overall Study|Lost to Follow-up|3|||
129185453|NCT06151288|464973559|FG000|Overall Study|Withdrawal by Subject|4|||
129185454|NCT06151288|464973560|FG001|Overall Study|Withdrawal by Subject|5|||
129185455|NCT06151288|464973561|FG002|Overall Study|Withdrawal by Subject|1|||
129185456|NCT06151288|464973562|FG003|Overall Study|Withdrawal by Subject|1|||
129185457|NCT04588389|464973563|FG000|Overall Study|Issues with anesthesia during surgery|2|||
129185458|NCT04588389|464973564|FG001|Overall Study|Issues with anesthesia during surgery|0|||
129185459|NCT04588389|464973565|FG002|Overall Study|Issues with anesthesia during surgery|0|||
129185460|NCT02911142|464973566|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
129185461|NCT02911142|464973566|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
129185462|NCT02911142|464973566|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
129185463|NCT02911142|464973566|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
129185464|NCT00026312|464973567|FG000|Overall Study|Adverse Event|0|||
129185465|NCT00026312|464973568|FG001|Overall Study|Adverse Event|32|||
129185466|NCT00026312|464973567|FG000|Overall Study|Death|1|||
129185467|NCT00026312|464973568|FG001|Overall Study|Death|7|||
129185468|NCT00026312|464973567|FG000|Overall Study|Lack of Efficacy|19|||
129185469|NCT00026312|464973568|FG001|Overall Study|Lack of Efficacy|114|||
129185470|NCT00026312|464973567|FG000|Overall Study|Lost to Follow-up|0|||
129185471|NCT00026312|464973568|FG001|Overall Study|Lost to Follow-up|5|||
129185472|NCT00026312|464973567|FG000|Overall Study|Physician Decision|1|||
129185473|NCT00026312|464973568|FG001|Overall Study|Physician Decision|37|||
129185474|NCT00026312|464973567|FG000|Overall Study|Protocol Violation|0|||
129185475|NCT00026312|464973568|FG001|Overall Study|Protocol Violation|3|||
129185476|NCT00026312|464973567|FG000|Overall Study|Withdrawal by Subject|1|||
129185477|NCT00026312|464973568|FG001|Overall Study|Withdrawal by Subject|6|||
129185478|NCT00026312|464973567|FG000|Overall Study|Ineligible|4|||
129185479|NCT00026312|464973568|FG001|Overall Study|Ineligible|5|||
128730248|NCT02489318|463309928|FG001|Randomized|Withdrawal by Subject|1|||
128730249|NCT02489318|463309927|FG000|Treated|Adverse Event|19|||
129185480|NCT00026312|464973567|FG000|Overall Study|Entry onto another COG study|0|||
129185481|NCT00026312|464973568|FG001|Overall Study|Entry onto another COG study|1|||
129185482|NCT00026312|464973567|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
129185483|NCT00026312|464973568|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
129185484|NCT00231413|464973571|FG000|Overall Study|Non-serious AE|0|||
129185485|NCT00231413|464973572|FG001|Overall Study|Non-serious AE|0|||
129185486|NCT00231413|464973573|FG002|Overall Study|Non-serious AE|1|||
129185487|NCT00231413|464973574|FG003|Overall Study|Non-serious AE|0|||
129185488|NCT00231413|464973575|FG004|Overall Study|Non-serious AE|0|||
129185489|NCT00231413|464973576|FG005|Overall Study|Non-serious AE|0|||
129185490|NCT00231413|464973577|FG006|Overall Study|Non-serious AE|1|||
129185491|NCT00231413|464973571|FG000|Overall Study|Withdrawal by Subject|3|||
129185492|NCT00231413|464973572|FG001|Overall Study|Withdrawal by Subject|1|||
129185493|NCT00231413|464973573|FG002|Overall Study|Withdrawal by Subject|4|||
129185494|NCT00231413|464973574|FG003|Overall Study|Withdrawal by Subject|2|||
129185495|NCT00231413|464973575|FG004|Overall Study|Withdrawal by Subject|2|||
129185496|NCT00231413|464973576|FG005|Overall Study|Withdrawal by Subject|0|||
129185497|NCT00231413|464973577|FG006|Overall Study|Withdrawal by Subject|3|||
129185498|NCT00231413|464973571|FG000|Overall Study|Migrated/moved from study area|0|||
129185499|NCT00231413|464973572|FG001|Overall Study|Migrated/moved from study area|0|||
129185500|NCT00231413|464973573|FG002|Overall Study|Migrated/moved from study area|1|||
129185501|NCT00231413|464973574|FG003|Overall Study|Migrated/moved from study area|0|||
129185502|NCT00231413|464973575|FG004|Overall Study|Migrated/moved from study area|0|||
128730250|NCT02489318|463309928|FG001|Treated|Adverse Event|62|||
129185503|NCT00231413|464973576|FG005|Overall Study|Migrated/moved from study area|1|||
129185504|NCT00231413|464973577|FG006|Overall Study|Migrated/moved from study area|0|||
129185505|NCT00231413|464973571|FG000|Overall Study|Lost to Follow-up|4|||
129185506|NCT00231413|464973572|FG001|Overall Study|Lost to Follow-up|4|||
129185507|NCT00231413|464973573|FG002|Overall Study|Lost to Follow-up|1|||
129185508|NCT00231413|464973574|FG003|Overall Study|Lost to Follow-up|1|||
129185509|NCT00231413|464973575|FG004|Overall Study|Lost to Follow-up|1|||
129185510|NCT00231413|464973576|FG005|Overall Study|Lost to Follow-up|4|||
129185511|NCT00231413|464973577|FG006|Overall Study|Lost to Follow-up|0|||
129185512|NCT00231413|464973571|FG000|Overall Study|Pregnancy|1|||
129185513|NCT00231413|464973572|FG001|Overall Study|Pregnancy|0|||
129185514|NCT00231413|464973573|FG002|Overall Study|Pregnancy|0|||
129185515|NCT00231413|464973574|FG003|Overall Study|Pregnancy|0|||
129185516|NCT00231413|464973575|FG004|Overall Study|Pregnancy|0|||
129185517|NCT00231413|464973576|FG005|Overall Study|Pregnancy|0|||
129185518|NCT00231413|464973577|FG006|Overall Study|Pregnancy|0|||
129185519|NCT01079936|464973578|FG000|Phase I: MTD|First Remission Status|2|||
129185520|NCT01079936|464973579|FG001|Phase I: MTD|First Remission Status|0|||
129185521|NCT01079936|464973580|FG002|Phase I: MTD|First Remission Status|0|||
129185522|NCT01079936|464973581|FG003|Phase I: MTD|First Remission Status|0|||
129185523|NCT01079936|464973582|FG004|Phase I: MTD|First Remission Status|0|||
129185524|NCT01079936|464973578|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
129185525|NCT01079936|464973579|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
129185526|NCT01079936|464973580|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
129185527|NCT01079936|464973581|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
129185528|NCT01079936|464973582|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
129185529|NCT01079936|464973578|FG000|Phase II|Adverse Event|0|||
129185530|NCT01079936|464973579|FG001|Phase II|Adverse Event|0|||
129185531|NCT01079936|464973580|FG002|Phase II|Adverse Event|1|||
129185532|NCT01079936|464973581|FG003|Phase II|Adverse Event|0|||
129185533|NCT01079936|464973582|FG004|Phase II|Adverse Event|0|||
129185534|NCT01079936|464973578|FG000|Phase II|Insurance Issue|0|||
129185535|NCT01079936|464973579|FG001|Phase II|Insurance Issue|0|||
129185536|NCT01079936|464973580|FG002|Phase II|Insurance Issue|0|||
129185537|NCT01079936|464973581|FG003|Phase II|Insurance Issue|0|||
129185538|NCT01079936|464973582|FG004|Phase II|Insurance Issue|1|||
129185539|NCT02294734|464973583|FG000|Overall Study|Adverse Event|5|||
129185540|NCT02294734|464973584|FG001|Overall Study|Adverse Event|5|||
129185541|NCT02294734|464973583|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
129185542|NCT02294734|464973584|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
129185543|NCT02294734|464973583|FG000|Overall Study|Lost to Follow-up|2|||
129185544|NCT02294734|464973584|FG001|Overall Study|Lost to Follow-up|0|||
129185545|NCT02294734|464973583|FG000|Overall Study|Physician Decision|2|||
129185546|NCT02294734|464973584|FG001|Overall Study|Physician Decision|1|||
129185547|NCT02294734|464973583|FG000|Overall Study|Withdrawal by Subject|4|||
129185548|NCT02294734|464973584|FG001|Overall Study|Withdrawal by Subject|2|||
129185549|NCT03157583|464973585|FG000|Overall Study|Other (did not meet study criteria)|1|||
129185550|NCT00847015|464973588|FG000|Overall Study|Withdrawal by Subject|1|||
129185551|NCT00847015|464973588|FG000|Overall Study|declined any surgery|1|||
129185552|NCT00847015|464973588|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
129185553|NCT01141478|464973589|FG000|Overall Study|Withdrawal by Subject|1|||
129185554|NCT01141478|464973590|FG001|Overall Study|Withdrawal by Subject|1|||
129185555|NCT03847909|464973600|FG000|Overall Study|Withdrawal by Subject|1|||
129185556|NCT03847909|464973601|FG001|Overall Study|Withdrawal by Subject|1|||
129185557|NCT00975143|464973602|FG000|Overall Study|Adverse Event|19|||
129185558|NCT00975143|464973603|FG001|Overall Study|Adverse Event|15|||
129185559|NCT00975143|464973602|FG000|Overall Study|Withdrawal by Subject|15|||
129185560|NCT00975143|464973603|FG001|Overall Study|Withdrawal by Subject|15|||
129185561|NCT00975143|464973602|FG000|Overall Study|Lost to Follow-up|20|||
129185562|NCT00975143|464973603|FG001|Overall Study|Lost to Follow-up|16|||
129185563|NCT00975143|464973602|FG000|Overall Study|Non-compliance|5|||
129185564|NCT00975143|464973603|FG001|Overall Study|Non-compliance|8|||
129185565|NCT00975143|464973602|FG000|Overall Study|Physician Decision|1|||
129185566|NCT00975143|464973603|FG001|Overall Study|Physician Decision|2|||
129185567|NCT00975143|464973602|FG000|Overall Study|Details not available|10|||
129185568|NCT00975143|464973603|FG001|Overall Study|Details not available|4|||
129185569|NCT01375608|464973604|FG000|Overall Study|Withdrawal by Subject|2|||
129185570|NCT01953913|464973605|FG000|Overall Study|Disease Progression|349|||
129185571|NCT01953913|464973605|FG000|Overall Study|Worsening of underlying cancer|22|||
129185572|NCT01953913|464973605|FG000|Overall Study|Adverse Event|20|||
129185573|NCT01953913|464973605|FG000|Overall Study|Protocol Violation|6|||
129185574|NCT01953913|464973605|FG000|Overall Study|Lost to Follow-up|4|||
129185575|NCT01953913|464973605|FG000|Overall Study|Withdrawal by Subject|32|||
129185576|NCT01953913|464973605|FG000|Overall Study|Other than listed|108|||
129185577|NCT01953913|464973605|FG000|Overall Study|Not Treated|1|||
129185578|NCT00082381|464973608|FG000|Overall Study|Adverse Event|27|||
129185579|NCT00082381|464973609|FG001|Overall Study|Adverse Event|2|||
129185580|NCT00082381|464973608|FG000|Overall Study|Lost to Follow-up|5|||
129185581|NCT00082381|464973609|FG001|Overall Study|Lost to Follow-up|7|||
129185582|NCT00082381|464973608|FG000|Overall Study|Patient Decision|8|||
129185583|NCT00082381|464973609|FG001|Overall Study|Patient Decision|4|||
129185584|NCT00082381|464973608|FG000|Overall Study|Physician Decision|1|||
129185585|NCT00082381|464973609|FG001|Overall Study|Physician Decision|2|||
128730251|NCT02489318|463309927|FG000|Treated|Death|13|||
128730252|NCT02489318|463309928|FG001|Treated|Death|11|||
128730253|NCT02489318|463309927|FG000|Treated|Physician Decision|4|||
128730254|NCT02489318|463309928|FG001|Treated|Physician Decision|6|||
129185586|NCT00082381|464973608|FG000|Overall Study|Protocol Violation|10|||
129185587|NCT00082381|464973609|FG001|Overall Study|Protocol Violation|11|||
129185588|NCT00082381|464973608|FG000|Overall Study|Loss of Glucose Control|4|||
129185589|NCT00082381|464973609|FG001|Overall Study|Loss of Glucose Control|0|||
129185590|NCT02049138|464973610|FG000|Overall Study|Adverse Event|46|||
129185591|NCT02049138|464973611|FG001|Overall Study|Adverse Event|25|||
129185592|NCT02049138|464973612|FG002|Overall Study|Adverse Event|1|||
129185593|NCT02049138|464973610|FG000|Overall Study|Withdrawal by Subject|57|||
129185594|NCT02049138|464973611|FG001|Overall Study|Withdrawal by Subject|21|||
129185595|NCT02049138|464973612|FG002|Overall Study|Withdrawal by Subject|5|||
129185596|NCT02049138|464973610|FG000|Overall Study|Lost to Follow-up|18|||
129185597|NCT02049138|464973611|FG001|Overall Study|Lost to Follow-up|5|||
129185598|NCT02049138|464973612|FG002|Overall Study|Lost to Follow-up|1|||
129185599|NCT02049138|464973610|FG000|Overall Study|Lack of Efficacy|10|||
129185600|NCT02049138|464973611|FG001|Overall Study|Lack of Efficacy|26|||
129185601|NCT02049138|464973612|FG002|Overall Study|Lack of Efficacy|1|||
129185602|NCT02049138|464973610|FG000|Overall Study|Non-Compliance|15|||
129185603|NCT02049138|464973611|FG001|Overall Study|Non-Compliance|6|||
129185604|NCT02049138|464973612|FG002|Overall Study|Non-Compliance|0|||
129185605|NCT02049138|464973610|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
129185606|NCT02049138|464973611|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
129185607|NCT02049138|464973612|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
129185608|NCT02049138|464973610|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
129185609|NCT02049138|464973611|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
129185610|NCT02049138|464973612|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
129185611|NCT02049138|464973610|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129185612|NCT02049138|464973611|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
129185613|NCT02049138|464973612|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
129185614|NCT02049138|464973610|FG000|Overall Study|Other|15|||
129185615|NCT02049138|464973611|FG001|Overall Study|Other|13|||
129185616|NCT02049138|464973612|FG002|Overall Study|Other|0|||
129185617|NCT02049138|464973610|FG000|Overall Study|Missing|0|||
129185618|NCT02049138|464973611|FG001|Overall Study|Missing|1|||
129185619|NCT02049138|464973612|FG002|Overall Study|Missing|0|||
129185620|NCT02925741|464973613|FG000|Overall Study|Withdrawal by Subject|11|||
129185621|NCT02925741|464973614|FG001|Overall Study|Withdrawal by Subject|0|||
129185622|NCT05086510|464973615|FG000|Overall Study|Lost to Follow-up|0|||
129185623|NCT05086510|464973616|FG001|Overall Study|Lost to Follow-up|2|||
129185624|NCT05086510|464973615|FG000|Overall Study|Death|0|||
129185625|NCT05086510|464973616|FG001|Overall Study|Death|2|||
129185626|NCT00295932|464973617|FG000|Overall Study|Not Treated|0|||
129185627|NCT00295932|464973618|FG001|Overall Study|Not Treated|0|||
129185628|NCT00295932|464973619|FG002|Overall Study|Not Treated|0|||
129185629|NCT00295932|464973620|FG003|Overall Study|Not Treated|0|||
129185630|NCT00295932|464973621|FG004|Overall Study|Not Treated|0|||
129185631|NCT00295932|464973622|FG005|Overall Study|Not Treated|0|||
129185632|NCT00295932|464973623|FG006|Overall Study|Not Treated|0|||
129185633|NCT00295932|464973624|FG007|Overall Study|Not Treated|0|||
129185634|NCT00295932|464973625|FG008|Overall Study|Not Treated|0|||
129185635|NCT00295932|464973626|FG009|Overall Study|Not Treated|0|||
129185636|NCT00295932|464973627|FG010|Overall Study|Not Treated|1|||
129185637|NCT00109577|464973628|FG000|Overall Study|Withdrawal by Subject|3|||
129185638|NCT00109577|464973629|FG001|Overall Study|Withdrawal by Subject|3|||
129185639|NCT00884832|464973630|FG000|Overall Study|Withdrawal by Subject|0|||
129185640|NCT00884832|464973631|FG001|Overall Study|Withdrawal by Subject|1|||
129185641|NCT03322423|464973632|FG000|Period 1|Subject no longer eligible|0|||
129185642|NCT03322423|464973633|FG001|Period 1|Subject no longer eligible|1|||
129185643|NCT03322423|464973632|FG000|Period 1|Withdrawal by Subject|0|||
129185644|NCT03322423|464973633|FG001|Period 1|Withdrawal by Subject|1|||
129185645|NCT03322423|464973632|FG000|Period 1|Incorrect Lens Dispensed|1|||
129185646|NCT03322423|464973633|FG001|Period 1|Incorrect Lens Dispensed|0|||
129185647|NCT03322423|464973632|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
129185648|NCT03322423|464973633|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
129185649|NCT03322423|464973632|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
129185650|NCT03322423|464973633|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
129185651|NCT03322423|464973632|FG000|Period 2|Protocol Violation|1|||
129185652|NCT03322423|464973633|FG001|Period 2|Protocol Violation|0|||
129185653|NCT03322423|464973632|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
129185654|NCT03322423|464973633|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
129185655|NCT02096263|464973634|FG000|Overall Study|Adverse Event|1|||
129185656|NCT02096263|464973635|FG001|Overall Study|Adverse Event|0|||
129185657|NCT02096263|464973636|FG002|Overall Study|Adverse Event|1|||
129185658|NCT02096263|464973634|FG000|Overall Study|Lost to Follow-up|14|||
129185659|NCT02096263|464973635|FG001|Overall Study|Lost to Follow-up|18|||
129185660|NCT02096263|464973636|FG002|Overall Study|Lost to Follow-up|15|||
129185661|NCT02096263|464973634|FG000|Overall Study|Other|7|||
129185662|NCT02096263|464973635|FG001|Overall Study|Other|9|||
129185663|NCT02096263|464973636|FG002|Overall Study|Other|6|||
129185664|NCT02096263|464973634|FG000|Overall Study|Sponsor study termination|0|||
129185665|NCT02096263|464973635|FG001|Overall Study|Sponsor study termination|0|||
129185666|NCT02096263|464973636|FG002|Overall Study|Sponsor study termination|1|||
129185667|NCT02096263|464973634|FG000|Overall Study|Protocol Violation|7|||
129185668|NCT02096263|464973635|FG001|Overall Study|Protocol Violation|2|||
129185669|NCT02096263|464973636|FG002|Overall Study|Protocol Violation|8|||
129185670|NCT02096263|464973634|FG000|Overall Study|Withdrawal by Subject|5|||
129185671|NCT02096263|464973635|FG001|Overall Study|Withdrawal by Subject|7|||
129185672|NCT02096263|464973636|FG002|Overall Study|Withdrawal by Subject|8|||
129185673|NCT02337725|464973637|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
129185674|NCT02337725|464973638|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
129185675|NCT02337725|464973637|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
129185676|NCT02337725|464973638|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
129185677|NCT02337725|464973637|FG000|Overall Study|Major Protocol Deviation|0|||
129185678|NCT02337725|464973638|FG001|Overall Study|Major Protocol Deviation|1|||
129185679|NCT02337725|464973637|FG000|Overall Study|Voluntary Withdrawal|14|||
129185680|NCT02337725|464973638|FG001|Overall Study|Voluntary Withdrawal|3|||
129185681|NCT02337725|464973637|FG000|Overall Study|Lack of Efficacy|4|||
129185682|NCT02337725|464973638|FG001|Overall Study|Lack of Efficacy|0|||
129185683|NCT00500760|464973646|FG000|Overall Study|Death|32|||
129185684|NCT00500760|464973647|FG001|Overall Study|Death|15|||
129185685|NCT00500760|464973646|FG000|Overall Study|Withdrawal by Subject|5|||
129185686|NCT00500760|464973647|FG001|Overall Study|Withdrawal by Subject|7|||
129185687|NCT00500760|464973646|FG000|Overall Study|Administrative decision|2|||
129185688|NCT00500760|464973647|FG001|Overall Study|Administrative decision|0|||
129185689|NCT00500760|464973646|FG000|Overall Study|Lost to Follow-up|3|||
129185690|NCT00500760|464973647|FG001|Overall Study|Lost to Follow-up|0|||
129185691|NCT00500760|464973646|FG000|Overall Study|Other|1|||
129185692|NCT00500760|464973647|FG001|Overall Study|Other|2|||
129185693|NCT00279812|464973652|FG000|Overall Study|Protocol Violation|1|||
129185694|NCT00279812|464973653|FG001|Overall Study|Protocol Violation|1|||
129185695|NCT00279812|464973654|FG002|Overall Study|Protocol Violation|0|||
129185696|NCT00279812|464973655|FG003|Overall Study|Protocol Violation|0|||
129185697|NCT00279812|464973656|FG004|Overall Study|Protocol Violation|1|||
129185698|NCT00279812|464973657|FG005|Overall Study|Protocol Violation|0|||
129185699|NCT00279812|464973652|FG000|Overall Study|Withdrawal by Subject|0|||
129185700|NCT00279812|464973653|FG001|Overall Study|Withdrawal by Subject|4|||
129185701|NCT00279812|464973654|FG002|Overall Study|Withdrawal by Subject|2|||
129185702|NCT00279812|464973655|FG003|Overall Study|Withdrawal by Subject|0|||
129185703|NCT00279812|464973656|FG004|Overall Study|Withdrawal by Subject|0|||
129185704|NCT00279812|464973657|FG005|Overall Study|Withdrawal by Subject|0|||
129185705|NCT00279812|464973652|FG000|Overall Study|Adverse Event|0|||
129185706|NCT00279812|464973653|FG001|Overall Study|Adverse Event|1|||
129185707|NCT00279812|464973654|FG002|Overall Study|Adverse Event|1|||
129185708|NCT00279812|464973655|FG003|Overall Study|Adverse Event|0|||
129185709|NCT00279812|464973656|FG004|Overall Study|Adverse Event|2|||
129185710|NCT00279812|464973657|FG005|Overall Study|Adverse Event|1|||
129185711|NCT01879072|464973658|FG000|Overall Study|Withdrawal by Subject|121|||
129185712|NCT01879072|464973658|FG000|Overall Study|Not Transplanted|30|||
129185713|NCT03281304|464973664|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
129185714|NCT03281304|464973665|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
129185715|NCT03281304|464973664|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
129185716|NCT03281304|464973665|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
129185717|NCT03281304|464973664|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
129185718|NCT03281304|464973665|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
129185719|NCT03281304|464973664|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
129185720|NCT03281304|464973665|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
129185721|NCT03281304|464973664|FG000|Treatment Phase (up to 42 Months)|Death|0|||
129185722|NCT03281304|464973665|FG001|Treatment Phase (up to 42 Months)|Death|1|||
129185723|NCT03281304|464973664|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
129185724|NCT03281304|464973665|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
129185725|NCT03281304|464973664|FG000|Treatment Phase (up to 42 Months)|Other|0|||
129185726|NCT03281304|464973665|FG001|Treatment Phase (up to 42 Months)|Other|2|||
129185727|NCT03281304|464973664|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
129185728|NCT03281304|464973665|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
129185729|NCT00626405|464973666|FG000|Overall Study|Deemed Ineligible|1|||
129185730|NCT00626405|464973667|FG001|Overall Study|Deemed Ineligible|0|||
129185731|NCT00626405|464973666|FG000|Overall Study|Withdrawal by Subject|0|||
129185732|NCT00626405|464973667|FG001|Overall Study|Withdrawal by Subject|1|||
129185733|NCT03834220|464973668|FG000|Overall Study|Adverse Event|1|||
129185734|NCT03834220|464973669|FG001|Overall Study|Adverse Event|0|||
129185735|NCT03834220|464973670|FG002|Overall Study|Adverse Event|0|||
129185736|NCT03834220|464973668|FG000|Overall Study|Death|8|||
129185737|NCT03834220|464973669|FG001|Overall Study|Death|1|||
129185738|NCT03834220|464973670|FG002|Overall Study|Death|17|||
129185739|NCT03834220|464973668|FG000|Overall Study|Reason not Specified|9|||
129185740|NCT03834220|464973669|FG001|Overall Study|Reason not Specified|0|||
129185741|NCT03834220|464973670|FG002|Overall Study|Reason not Specified|6|||
129185742|NCT03834220|464973668|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
129185743|NCT03834220|464973669|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
129185744|NCT03834220|464973670|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
129185745|NCT03834220|464973668|FG000|Overall Study|Withdrawal of Consent|2|||
129185746|NCT03834220|464973669|FG001|Overall Study|Withdrawal of Consent|2|||
129185747|NCT03834220|464973670|FG002|Overall Study|Withdrawal of Consent|2|||
129185748|NCT02593318|464973671|FG000|Overall Study|Withdrawal by Subject|1|||
129185749|NCT02593318|464973672|FG001|Overall Study|Withdrawal by Subject|1|||
129185750|NCT01740401|464975603|FG000|Overall Study|Progression of disease|6|||
129185751|NCT01740401|464975603|FG000|Overall Study|Adverse Event|2|||
129185752|NCT01740401|464975603|FG000|Overall Study|Did not reach primary endpoint|2|||
129185753|NCT03667690|464975604|FG000|Overall Study|Adverse Event|0|||
129185754|NCT03667690|464975605|FG001|Overall Study|Adverse Event|3|||
129185755|NCT03667690|464975604|FG000|Overall Study|Death|22|||
129185756|NCT03667690|464975605|FG001|Overall Study|Death|21|||
129185757|NCT03667690|464975604|FG000|Overall Study|Lost to Follow-up|4|||
129185758|NCT03667690|464975605|FG001|Overall Study|Lost to Follow-up|5|||
129185759|NCT03667690|464975604|FG000|Overall Study|Withdrawal by Subject|7|||
129185760|NCT03667690|464975605|FG001|Overall Study|Withdrawal by Subject|8|||
129185761|NCT03667690|464975604|FG000|Overall Study|Subject could not return for additional investigational product|1|||
129185762|NCT03667690|464975605|FG001|Overall Study|Subject could not return for additional investigational product|0|||
129185763|NCT03667690|464975604|FG000|Overall Study|Subject discharged to hospice care|2|||
129185764|NCT03667690|464975605|FG001|Overall Study|Subject discharged to hospice care|0|||
129185765|NCT03667690|464975604|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
129185766|NCT03667690|464975605|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
129185767|NCT03667690|464975604|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
129185768|NCT03667690|464975605|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
129185769|NCT03667690|464975604|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
129185770|NCT03667690|464975605|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
129185771|NCT03667690|464975604|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
129185772|NCT03667690|464975605|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
129185773|NCT03667690|464975604|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
129185774|NCT03667690|464975605|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
129185775|NCT03495102|464975606|FG000|Overall Study|Adverse Event|5|||
129185776|NCT03495102|464975607|FG001|Overall Study|Adverse Event|7|||
129185777|NCT03495102|464975608|FG002|Overall Study|Adverse Event|10|||
129185778|NCT03495102|464975606|FG000|Overall Study|Death|3|||
129185779|NCT03495102|464975607|FG001|Overall Study|Death|4|||
129185780|NCT03495102|464975608|FG002|Overall Study|Death|4|||
129185781|NCT03495102|464975606|FG000|Overall Study|Lost to Follow-up|15|||
129185782|NCT03495102|464975607|FG001|Overall Study|Lost to Follow-up|16|||
129185783|NCT03495102|464975608|FG002|Overall Study|Lost to Follow-up|17|||
129185784|NCT03495102|464975606|FG000|Overall Study|Physician Decision|2|||
129185785|NCT03495102|464975607|FG001|Overall Study|Physician Decision|0|||
129185786|NCT03495102|464975608|FG002|Overall Study|Physician Decision|2|||
129185787|NCT03495102|464975606|FG000|Overall Study|Withdrawal by Subject|25|||
129185788|NCT03495102|464975607|FG001|Overall Study|Withdrawal by Subject|36|||
129185789|NCT03495102|464975608|FG002|Overall Study|Withdrawal by Subject|18|||
129185790|NCT03495102|464975606|FG000|Overall Study|Protocol Violation|1|||
129185791|NCT03495102|464975607|FG001|Overall Study|Protocol Violation|1|||
129185792|NCT03495102|464975608|FG002|Overall Study|Protocol Violation|0|||
129185793|NCT03495102|464975606|FG000|Overall Study|Site Closure|3|||
129185794|NCT03495102|464975607|FG001|Overall Study|Site Closure|1|||
129185795|NCT03495102|464975608|FG002|Overall Study|Site Closure|2|||
129185796|NCT03495102|464975606|FG000|Overall Study|Non-compliance|1|||
129185797|NCT03495102|464975607|FG001|Overall Study|Non-compliance|0|||
129185798|NCT03495102|464975608|FG002|Overall Study|Non-compliance|0|||
129185799|NCT03495102|464975606|FG000|Overall Study|Participant Duplicated at Another Site|0|||
129185800|NCT03495102|464975607|FG001|Overall Study|Participant Duplicated at Another Site|0|||
129185801|NCT03495102|464975608|FG002|Overall Study|Participant Duplicated at Another Site|1|||
129185802|NCT03495102|464975606|FG000|Overall Study|Primary Care Physician Recommendation|0|||
129185803|NCT03495102|464975607|FG001|Overall Study|Primary Care Physician Recommendation|1|||
129185804|NCT03495102|464975608|FG002|Overall Study|Primary Care Physician Recommendation|0|||
129185805|NCT03495102|464975606|FG000|Overall Study|Relocated to Another Country|0|||
129185806|NCT03495102|464975607|FG001|Overall Study|Relocated to Another Country|1|||
129185807|NCT03495102|464975608|FG002|Overall Study|Relocated to Another Country|0|||
129185808|NCT03495102|464975606|FG000|Overall Study|Participant was in Rehabilitation|1|||
129185809|NCT03495102|464975607|FG001|Overall Study|Participant was in Rehabilitation|0|||
129185810|NCT03495102|464975608|FG002|Overall Study|Participant was in Rehabilitation|0|||
129185811|NCT01161537|464975610|FG000|Part B|Withdrawal by Subject|2|||
129185812|NCT00321464|464975613|FG000|Overall Study|Death|169|||
129185813|NCT00321464|464975614|FG001|Overall Study|Death|174|||
129185814|NCT00321464|464975613|FG000|Overall Study|Disease progression|124|||
129185815|NCT00321464|464975614|FG001|Overall Study|Disease progression|124|||
129185816|NCT00321464|464975613|FG000|Overall Study|Withdrawal by Subject|117|||
129185817|NCT00321464|464975614|FG001|Overall Study|Withdrawal by Subject|118|||
129185818|NCT00321464|464975613|FG000|Overall Study|Participant request|57|||
129185819|NCT00321464|464975614|FG001|Overall Study|Participant request|61|||
129185820|NCT00321464|464975613|FG000|Overall Study|Adverse Event|43|||
129185821|NCT00321464|464975614|FG001|Overall Study|Adverse Event|28|||
129185822|NCT00321464|464975613|FG000|Overall Study|Physician Decision|15|||
129185823|NCT00321464|464975614|FG001|Overall Study|Physician Decision|14|||
129185824|NCT00321464|464975613|FG000|Overall Study|Noncompliance|4|||
129185825|NCT00321464|464975614|FG001|Overall Study|Noncompliance|10|||
129185826|NCT00321464|464975613|FG000|Overall Study|Lost to Follow-up|7|||
129185827|NCT00321464|464975614|FG001|Overall Study|Lost to Follow-up|8|||
129185828|NCT00321464|464975613|FG000|Overall Study|Protocol deviation|0|||
129185829|NCT00321464|464975614|FG001|Overall Study|Protocol deviation|2|||
129185830|NCT00321464|464975613|FG000|Overall Study|Ineligibility determined|2|||
129185831|NCT00321464|464975614|FG001|Overall Study|Ineligibility determined|1|||
129185832|NCT00321464|464975613|FG000|Overall Study|Other|21|||
129185833|NCT00321464|464975614|FG001|Overall Study|Other|18|||
129185834|NCT04327024|464975615|FG000|Overall Study|Death|1|||
129185835|NCT04327024|464975616|FG001|Overall Study|Death|2|||
129185836|NCT04327024|464975617|FG002|Overall Study|Death|1|||
129185837|NCT04327024|464975615|FG000|Overall Study|Non-compliance with study drug|0|||
129185838|NCT04327024|464975616|FG001|Overall Study|Non-compliance with study drug|1|||
129185839|NCT04327024|464975617|FG002|Overall Study|Non-compliance with study drug|0|||
129185840|NCT04327024|464975615|FG000|Overall Study|Withdrawal by Subject|1|||
129185841|NCT04327024|464975616|FG001|Overall Study|Withdrawal by Subject|1|||
129185842|NCT04327024|464975617|FG002|Overall Study|Withdrawal by Subject|2|||
129185843|NCT01192568|464975619|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
129185844|NCT01192568|464975620|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
129185845|NCT01192568|464975621|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
129185846|NCT01192568|464975622|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
129185847|NCT01192568|464975619|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
129185848|NCT01192568|464975620|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
129185849|NCT01192568|464975621|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
129185850|NCT01192568|464975622|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
129185851|NCT02593825|464975623|FG000|Intervention|Lost to Follow-up|10|||
129185852|NCT02593825|464975624|FG001|Intervention|Lost to Follow-up|12|||
129185853|NCT02522325|464975625|FG000|Overall Study|Adverse Event|0|||
129185854|NCT02522325|464975626|FG001|Overall Study|Adverse Event|1|||
129185855|NCT01209078|464975627|FG000|Overall Study|Adverse Event|5|||
129185856|NCT01209078|464975628|FG001|Overall Study|Adverse Event|0|||
129185857|NCT01209078|464975627|FG000|Overall Study|Lost to Follow-up|4|||
129185858|NCT01209078|464975628|FG001|Overall Study|Lost to Follow-up|0|||
129185859|NCT01209078|464975627|FG000|Overall Study|Physician Decision|5|||
129185860|NCT01209078|464975628|FG001|Overall Study|Physician Decision|2|||
129185861|NCT01209078|464975627|FG000|Overall Study|Withdrawal by Subject|2|||
129185862|NCT01209078|464975628|FG001|Overall Study|Withdrawal by Subject|1|||
129185863|NCT00924508|464975629|FG000|Overall Study|Withdrawal by Subject|3|||
129185864|NCT00511134|464975633|FG000|Overall Study|Withdrawal by Subject|0|||
129185865|NCT00511134|464975634|FG001|Overall Study|Withdrawal by Subject|2|||
129185866|NCT01949090|464975635|FG000|Overall Study|Serious Adverse Event|0|||
129185867|NCT01949090|464975636|FG001|Overall Study|Serious Adverse Event|1|||
129185868|NCT01949090|464975637|FG002|Overall Study|Serious Adverse Event|2|||
129185869|NCT01949090|464975638|FG003|Overall Study|Serious Adverse Event|0|||
129185870|NCT01949090|464975639|FG004|Overall Study|Serious Adverse Event|1|||
129185871|NCT01949090|464975635|FG000|Overall Study|Withdrawal by Subject|2|||
129185872|NCT01949090|464975636|FG001|Overall Study|Withdrawal by Subject|0|||
129185873|NCT01949090|464975637|FG002|Overall Study|Withdrawal by Subject|0|||
129185874|NCT01949090|464975638|FG003|Overall Study|Withdrawal by Subject|0|||
129185875|NCT01949090|464975639|FG004|Overall Study|Withdrawal by Subject|1|||
129185876|NCT01949090|464975635|FG000|Overall Study|Protocol non-compliance|0|||
129185877|NCT01949090|464975636|FG001|Overall Study|Protocol non-compliance|0|||
129185878|NCT01949090|464975637|FG002|Overall Study|Protocol non-compliance|0|||
129185879|NCT01949090|464975638|FG003|Overall Study|Protocol non-compliance|0|||
129185880|NCT01949090|464975639|FG004|Overall Study|Protocol non-compliance|1|||
129185881|NCT01949090|464975635|FG000|Overall Study|Lost to Follow-up|2|||
129185882|NCT01949090|464975636|FG001|Overall Study|Lost to Follow-up|1|||
129185883|NCT01949090|464975637|FG002|Overall Study|Lost to Follow-up|0|||
129185884|NCT01949090|464975638|FG003|Overall Study|Lost to Follow-up|1|||
129185885|NCT01949090|464975639|FG004|Overall Study|Lost to Follow-up|1|||
129185886|NCT03459365|464975640|FG000|Overall Study|Withdrawal by Subject|6|||
129185887|NCT03459365|464975640|FG000|Overall Study|Protocol Violation|8|||
129185888|NCT00785980|464975644|FG000|7 Day Washout Period|Protocol Violation|3|||
129185889|NCT03055013|464975645|FG000|Overall Study|Adverse Event|78|||
129185890|NCT03055013|464975646|FG001|Overall Study|Adverse Event|0|||
129185891|NCT03055013|464975645|FG000|Overall Study|Death|6|||
129185892|NCT03055013|464975646|FG001|Overall Study|Death|0|||
129185893|NCT03055013|464975645|FG000|Overall Study|Disease relapse|33|||
129185894|NCT03055013|464975646|FG001|Overall Study|Disease relapse|0|||
129185895|NCT03055013|464975645|FG000|Overall Study|Withdrawal by Subject|28|||
129185896|NCT03055013|464975646|FG001|Overall Study|Withdrawal by Subject|0|||
129185897|NCT03055013|464975645|FG000|Overall Study|Other complicating disease|5|||
129185898|NCT03055013|464975646|FG001|Overall Study|Other complicating disease|0|||
129185899|NCT03055013|464975645|FG000|Overall Study|Physician Decision|1|||
129185900|NCT03055013|464975646|FG001|Overall Study|Physician Decision|0|||
129185901|NCT03055013|464975645|FG000|Overall Study|Benign mass/non-RCC|4|||
129185902|NCT03055013|464975646|FG001|Overall Study|Benign mass/non-RCC|0|||
129185903|NCT03055013|464975645|FG000|Overall Study|Enrolled in another trial|1|||
129185904|NCT03055013|464975646|FG001|Overall Study|Enrolled in another trial|0|||
129185905|NCT03055013|464975645|FG000|Overall Study|Non-protocol therapy|1|||
129185906|NCT03055013|464975646|FG001|Overall Study|Non-protocol therapy|0|||
129185907|NCT03055013|464975645|FG000|Overall Study|Incompliance|1|||
129185908|NCT03055013|464975646|FG001|Overall Study|Incompliance|0|||
129185909|NCT03055013|464975645|FG000|Overall Study|Insurance issues|1|||
129185910|NCT03055013|464975646|FG001|Overall Study|Insurance issues|0|||
129185911|NCT03055013|464975645|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
129185912|NCT03055013|464975646|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
129185913|NCT03055013|464975645|FG000|Overall Study|Did not receive nivolumab|10|||
129185914|NCT03055013|464975646|FG001|Overall Study|Did not receive nivolumab|0|||
129185915|NCT03055013|464975645|FG000|Overall Study|Did not receive surgery|0|||
129185916|NCT03055013|464975646|FG001|Overall Study|Did not receive surgery|28|||
129185917|NCT00528801|464975647|FG000|Overall Study|Withdrawal by Subject|1|||
129185918|NCT00528801|464975648|FG001|Overall Study|Withdrawal by Subject|1|||
129185919|NCT00528801|464975647|FG000|Overall Study|Protocol Violation|11|||
129185920|NCT00528801|464975648|FG001|Overall Study|Protocol Violation|5|||
129185921|NCT00528801|464975647|FG000|Overall Study|Lost to Follow-up|15|||
129185922|NCT00528801|464975648|FG001|Overall Study|Lost to Follow-up|4|||
129185923|NCT00528801|464975647|FG000|Overall Study|Administrative Reasons|0|||
129185924|NCT00528801|464975648|FG001|Overall Study|Administrative Reasons|1|||
129185925|NCT00344500|464975649|FG000|Overall Study|Adverse Event|6|||
129185926|NCT00344500|464975650|FG001|Overall Study|Adverse Event|2|||
129185927|NCT00344500|464975651|FG002|Overall Study|Adverse Event|0|||
129185928|NCT00344500|464975649|FG000|Overall Study|Lost to Follow-up|5|||
129185929|NCT00344500|464975650|FG001|Overall Study|Lost to Follow-up|13|||
129185930|NCT00344500|464975651|FG002|Overall Study|Lost to Follow-up|1|||
129185931|NCT00344500|464975649|FG000|Overall Study|Withdrawal by Subject|7|||
129185932|NCT00344500|464975650|FG001|Overall Study|Withdrawal by Subject|10|||
129185933|NCT00344500|464975651|FG002|Overall Study|Withdrawal by Subject|0|||
128730255|NCT02489318|463309927|FG000|Treated|Protocol Violation|1|||
128730256|NCT02489318|463309928|FG001|Treated|Protocol Violation|2|||
128730257|NCT02489318|463309927|FG000|Treated|Withdrawal by Subject|37|||
128730258|NCT02489318|463309928|FG001|Treated|Withdrawal by Subject|36|||
128730259|NCT02489318|463309927|FG000|Treated|Other: Progressive Disease|245|||
129185934|NCT00344500|464975649|FG000|Overall Study|Protocol Violation|4|||
129185935|NCT00344500|464975650|FG001|Overall Study|Protocol Violation|7|||
129185936|NCT00344500|464975651|FG002|Overall Study|Protocol Violation|1|||
129185937|NCT00344500|464975649|FG000|Overall Study|Not Noted|1|||
129185938|NCT00344500|464975650|FG001|Overall Study|Not Noted|3|||
129185939|NCT00344500|464975651|FG002|Overall Study|Not Noted|0|||
129185940|NCT02207491|464975652|FG000|Overall Study|Adverse Event|20|||
129185941|NCT02207491|464975653|FG001|Overall Study|Adverse Event|4|||
129185942|NCT02207491|464975652|FG000|Overall Study|Withdrawal by Subject|3|||
129185943|NCT02207491|464975653|FG001|Overall Study|Withdrawal by Subject|2|||
129185944|NCT02207491|464975652|FG000|Overall Study|Non-compliant|0|||
129185945|NCT02207491|464975653|FG001|Overall Study|Non-compliant|1|||
129185946|NCT02207491|464975652|FG000|Overall Study|Lost to Follow-up|0|||
129185947|NCT02207491|464975653|FG001|Overall Study|Lost to Follow-up|1|||
129185948|NCT02207491|464975652|FG000|Overall Study|Lack of Efficacy|3|||
129185949|NCT02207491|464975653|FG001|Overall Study|Lack of Efficacy|0|||
128730260|NCT02489318|463309928|FG001|Treated|Other: Progressive Disease|138|||
128730261|NCT02489318|463309927|FG000|Treated|Other|0|||
128730262|NCT02489318|463309928|FG001|Treated|Other|2|||
128730263|NCT02489318|463309927|FG000|Treated|Ongoing|0|||
128730264|NCT02489318|463309928|FG001|Treated|Ongoing|267|||
128730265|NCT05723770|463309929|FG000|Overall Study|Lost to Follow-up|4|||
128730266|NCT05723770|463309929|FG000|Overall Study|Withdrawal by Subject|2|||
128780982|NCT01323660|463488629|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129185950|NCT02207491|464975652|FG000|Overall Study|Physician Decision|2|||
129185951|NCT02207491|464975653|FG001|Overall Study|Physician Decision|0|||
129185952|NCT02207491|464975652|FG000|Overall Study|Protocol Violation|3|||
128730267|NCT01171898|463309930|FG000|Overall Study|Death|0|||
128730268|NCT01171898|463309931|FG001|Overall Study|Death|0|||
128730269|NCT01171898|463309932|FG002|Overall Study|Death|2|||
128730270|NCT01171898|463309933|FG003|Overall Study|Death|0|||
128730271|NCT01171898|463309930|FG000|Overall Study|Lost to Follow-up|0|||
128730272|NCT01171898|463309931|FG001|Overall Study|Lost to Follow-up|1|||
128730273|NCT01171898|463309932|FG002|Overall Study|Lost to Follow-up|1|||
128730274|NCT01171898|463309933|FG003|Overall Study|Lost to Follow-up|1|||
128730275|NCT01171898|463309930|FG000|Overall Study|Withdrawal by Subject|1|||
128730276|NCT01171898|463309931|FG001|Overall Study|Withdrawal by Subject|4|||
129185953|NCT02207491|464975653|FG001|Overall Study|Protocol Violation|5|||
129185954|NCT00599755|464975654|FG000|Overall Study|Adverse Event|11|||
129185955|NCT00599755|464975654|FG000|Overall Study|Withdrawal by Subject|2|||
129185956|NCT00599755|464975654|FG000|Overall Study|Progression of Disease|3|||
129185957|NCT00599755|464975654|FG000|Overall Study|Other Reason|2|||
129185958|NCT00599755|464975654|FG000|Overall Study|No data available|1|||
129185959|NCT00417963|464975656|FG000|Overall Study|Lost to Follow-up|3|||
129185960|NCT00417963|464975656|FG000|Overall Study|Withdrawal by Subject|18|||
129185961|NCT00417963|464975656|FG000|Overall Study|Death|17|||
129185962|NCT00417963|464975656|FG000|Overall Study|Study device could not be deployed|3|||
129185963|NCT01023672|464975657|FG000|Overall Study|Worsening disease|2|||
128730277|NCT01171898|463309932|FG002|Overall Study|Withdrawal by Subject|6|||
128730278|NCT01171898|463309933|FG003|Overall Study|Withdrawal by Subject|3|||
128730279|NCT01171898|463309930|FG000|Overall Study|Terminated by Sponsor|1|||
128730280|NCT01171898|463309931|FG001|Overall Study|Terminated by Sponsor|0|||
128730281|NCT01171898|463309932|FG002|Overall Study|Terminated by Sponsor|0|||
128780983|NCT01323660|463488630|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
128780984|NCT01323660|463488631|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
129185964|NCT01023672|464975657|FG000|Overall Study|Death|1|||
129185965|NCT00387725|464975658|FG000|Overall Study|Adverse Event|0|||
129185966|NCT00387725|464975659|FG001|Overall Study|Adverse Event|0|||
129185967|NCT00387725|464975660|FG002|Overall Study|Adverse Event|0|||
129185968|NCT00387725|464975661|FG003|Overall Study|Adverse Event|1|||
129185969|NCT00387725|464975658|FG000|Overall Study|Protocol Violation|0|||
129185970|NCT00387725|464975659|FG001|Overall Study|Protocol Violation|1|||
129185971|NCT00387725|464975660|FG002|Overall Study|Protocol Violation|0|||
129185972|NCT00387725|464975661|FG003|Overall Study|Protocol Violation|0|||
129185973|NCT00387725|464975658|FG000|Overall Study|Withdrawal by Subject|1|||
129185974|NCT00387725|464975659|FG001|Overall Study|Withdrawal by Subject|0|||
129185975|NCT00387725|464975660|FG002|Overall Study|Withdrawal by Subject|1|||
129185976|NCT00387725|464975661|FG003|Overall Study|Withdrawal by Subject|0|||
129185977|NCT00387725|464975658|FG000|Overall Study|Parent/legal guardian request|0|||
129185978|NCT00387725|464975659|FG001|Overall Study|Parent/legal guardian request|0|||
129185979|NCT00387725|464975660|FG002|Overall Study|Parent/legal guardian request|1|||
129185980|NCT00387725|464975661|FG003|Overall Study|Parent/legal guardian request|1|||
129185981|NCT00859937|464975662|FG000|Overall Study|Protocol Violation|1|||
129185982|NCT00859937|464975663|FG001|Overall Study|Protocol Violation|0|||
129185983|NCT03908476|464975664|FG000|Overall Study|Death|3|||
129185984|NCT03908476|464975665|FG001|Overall Study|Death|0|||
129185985|NCT03908476|464975664|FG000|Overall Study|Lost to Follow-up|3|||
129185986|NCT03908476|464975665|FG001|Overall Study|Lost to Follow-up|1|||
129185987|NCT03908476|464975664|FG000|Overall Study|Withdrawal by Subject|7|||
129185988|NCT03908476|464975665|FG001|Overall Study|Withdrawal by Subject|1|||
129185989|NCT03908476|464975664|FG000|Overall Study|Physician Decision|2|||
129185990|NCT03908476|464975665|FG001|Overall Study|Physician Decision|0|||
129185991|NCT03908476|464975664|FG000|Overall Study|System Explanted and not Replaced|4|||
129185992|NCT03908476|464975665|FG001|Overall Study|System Explanted and not Replaced|0|||
129185993|NCT03908476|464975664|FG000|Overall Study|Intrathecal Pump|1|||
129185994|NCT03908476|464975665|FG001|Overall Study|Intrathecal Pump|0|||
129185995|NCT03908476|464975664|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
129185996|NCT03908476|464975665|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
129185997|NCT05194267|464975666|FG000|Overall Study|Withdrawal by Subject|2|||
129185998|NCT00802893|464975667|FG000|Overall Study|study terminated|3|||
129185999|NCT02868229|464975668|FG000|Overall Study|Adverse Event|1|||
129186000|NCT02868229|464975669|FG001|Overall Study|Adverse Event|0|||
129186001|NCT02868229|464975670|FG002|Overall Study|Adverse Event|0|||
129186002|NCT02868229|464975671|FG003|Overall Study|Adverse Event|1|||
129186003|NCT02868229|464975668|FG000|Overall Study|Death|0|||
129186004|NCT02868229|464975669|FG001|Overall Study|Death|0|||
129186005|NCT02868229|464975670|FG002|Overall Study|Death|1|||
129186006|NCT02868229|464975671|FG003|Overall Study|Death|1|||
129186007|NCT02868229|464975668|FG000|Overall Study|Missed dose|0|||
129186008|NCT02868229|464975669|FG001|Overall Study|Missed dose|0|||
129186009|NCT02868229|464975670|FG002|Overall Study|Missed dose|0|||
129186010|NCT02868229|464975671|FG003|Overall Study|Missed dose|3|||
129186011|NCT03194438|464975672|FG000|Overall Study|Withdrawal by Subject|2|||
129186012|NCT02250664|464975673|FG000|Overall Study|Lost to Follow-up|18|||
129186013|NCT02250664|464975674|FG001|Overall Study|Lost to Follow-up|28|||
129186014|NCT02250664|464975675|FG002|Overall Study|Lost to Follow-up|33|||
129186015|NCT02250664|464975673|FG000|Overall Study|Personal Reasons|7|||
129186016|NCT02250664|464975674|FG001|Overall Study|Personal Reasons|8|||
129186017|NCT02250664|464975675|FG002|Overall Study|Personal Reasons|14|||
129186018|NCT02250664|464975673|FG000|Overall Study|Adverse Event|6|||
129186019|NCT02250664|464975674|FG001|Overall Study|Adverse Event|3|||
129186020|NCT02250664|464975675|FG002|Overall Study|Adverse Event|8|||
129186021|NCT02250664|464975673|FG000|Overall Study|Incarcerated|2|||
129186022|NCT02250664|464975674|FG001|Overall Study|Incarcerated|1|||
129186023|NCT02250664|464975675|FG002|Overall Study|Incarcerated|2|||
128780985|NCT01323660|463488626|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
128780986|NCT01323660|463488627|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129186024|NCT02250664|464975673|FG000|Overall Study|Withdrawal by Subject|0|||
129186025|NCT02250664|464975674|FG001|Overall Study|Withdrawal by Subject|1|||
129186026|NCT02250664|464975675|FG002|Overall Study|Withdrawal by Subject|2|||
129186027|NCT02250664|464975673|FG000|Overall Study|Death|0|||
129186028|NCT02250664|464975674|FG001|Overall Study|Death|1|||
129186029|NCT02250664|464975675|FG002|Overall Study|Death|1|||
129186030|NCT02250664|464975673|FG000|Overall Study|Physician Decision|1|||
129186031|NCT02250664|464975674|FG001|Overall Study|Physician Decision|3|||
129186032|NCT02250664|464975675|FG002|Overall Study|Physician Decision|1|||
129186033|NCT02250664|464975673|FG000|Overall Study|Protocol Violation|1|||
129186034|NCT02250664|464975674|FG001|Overall Study|Protocol Violation|0|||
129186035|NCT02250664|464975675|FG002|Overall Study|Protocol Violation|1|||
129186036|NCT02250664|464975673|FG000|Overall Study|Reason unknown|1|||
129186037|NCT02250664|464975674|FG001|Overall Study|Reason unknown|0|||
129186038|NCT02250664|464975675|FG002|Overall Study|Reason unknown|0|||
128730282|NCT01171898|463309933|FG003|Overall Study|Terminated by Sponsor|0|||
129186039|NCT00117793|464975676|FG000|Overall Study|Withdrawal by Subject|12|||
129186040|NCT04268173|464975677|FG000|Overall Study|Lost to Follow-up|75|||
129186041|NCT04268173|464975678|FG001|Overall Study|Lost to Follow-up|108|||
129186042|NCT00545103|464975679|FG000|Overall Study|Lack of Efficacy|48|||
129186043|NCT00545103|464975680|FG001|Overall Study|Lack of Efficacy|45|||
129186044|NCT00545103|464975681|FG002|Overall Study|Lack of Efficacy|31|||
129186045|NCT00545103|464975682|FG003|Overall Study|Lack of Efficacy|27|||
129186046|NCT00545103|464975679|FG000|Overall Study|Withdrawal by Subject|6|||
129186047|NCT00545103|464975680|FG001|Overall Study|Withdrawal by Subject|10|||
129186048|NCT00545103|464975681|FG002|Overall Study|Withdrawal by Subject|18|||
129186049|NCT00545103|464975682|FG003|Overall Study|Withdrawal by Subject|22|||
129186050|NCT00545103|464975679|FG000|Overall Study|Adverse Event|11|||
129186051|NCT00545103|464975680|FG001|Overall Study|Adverse Event|12|||
129186052|NCT00545103|464975681|FG002|Overall Study|Adverse Event|17|||
129186053|NCT00545103|464975682|FG003|Overall Study|Adverse Event|10|||
129186054|NCT00545103|464975679|FG000|Overall Study|Lost to Follow-up|4|||
129186055|NCT00545103|464975680|FG001|Overall Study|Lost to Follow-up|6|||
129186056|NCT00545103|464975681|FG002|Overall Study|Lost to Follow-up|3|||
129186057|NCT00545103|464975682|FG003|Overall Study|Lost to Follow-up|4|||
129186058|NCT00545103|464975679|FG000|Overall Study|Protocol Violation|1|||
129186059|NCT00545103|464975680|FG001|Overall Study|Protocol Violation|2|||
129186060|NCT00545103|464975681|FG002|Overall Study|Protocol Violation|3|||
129186061|NCT00545103|464975682|FG003|Overall Study|Protocol Violation|0|||
129186062|NCT00545103|464975679|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
129186063|NCT00545103|464975680|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
129186064|NCT00545103|464975681|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
129186065|NCT00545103|464975682|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
129186066|NCT00545103|464975679|FG000|Overall Study|Difficult to open package|0|||
129186067|NCT00545103|464975680|FG001|Overall Study|Difficult to open package|0|||
129186068|NCT00545103|464975681|FG002|Overall Study|Difficult to open package|0|||
129186069|NCT00545103|464975682|FG003|Overall Study|Difficult to open package|1|||
129186070|NCT00545103|464975679|FG000|Overall Study|Investigational product not taken|1|||
129186071|NCT00545103|464975680|FG001|Overall Study|Investigational product not taken|0|||
129186072|NCT00545103|464975681|FG002|Overall Study|Investigational product not taken|0|||
129186073|NCT00545103|464975682|FG003|Overall Study|Investigational product not taken|1|||
129186074|NCT00545103|464975679|FG000|Overall Study|Wish to start a family|0|||
129186075|NCT00545103|464975680|FG001|Overall Study|Wish to start a family|0|||
129186076|NCT00545103|464975681|FG002|Overall Study|Wish to start a family|0|||
129186077|NCT00545103|464975682|FG003|Overall Study|Wish to start a family|1|||
129186078|NCT00545103|464975679|FG000|Overall Study|Diverticulitis crisis|0|||
129186079|NCT00545103|464975680|FG001|Overall Study|Diverticulitis crisis|0|||
129186080|NCT00545103|464975681|FG002|Overall Study|Diverticulitis crisis|0|||
129186081|NCT00545103|464975682|FG003|Overall Study|Diverticulitis crisis|1|||
129186082|NCT00545103|464975679|FG000|Overall Study|Personal reasons|1|||
129186083|NCT00545103|464975680|FG001|Overall Study|Personal reasons|0|||
129186084|NCT00545103|464975681|FG002|Overall Study|Personal reasons|0|||
129186085|NCT00545103|464975682|FG003|Overall Study|Personal reasons|0|||
129186086|NCT00545103|464975679|FG000|Overall Study|Subject's decision|1|||
129186087|NCT00545103|464975680|FG001|Overall Study|Subject's decision|0|||
129186088|NCT00545103|464975681|FG002|Overall Study|Subject's decision|0|||
129186089|NCT00545103|464975682|FG003|Overall Study|Subject's decision|0|||
129186090|NCT00545103|464975679|FG000|Overall Study|Noncompliance|0|||
129186091|NCT00545103|464975680|FG001|Overall Study|Noncompliance|1|||
129186092|NCT00545103|464975681|FG002|Overall Study|Noncompliance|0|||
129186093|NCT00545103|464975682|FG003|Overall Study|Noncompliance|0|||
129186094|NCT00545103|464975679|FG000|Overall Study|Investigator decision|0|||
129186095|NCT00545103|464975680|FG001|Overall Study|Investigator decision|0|||
129186096|NCT00545103|464975681|FG002|Overall Study|Investigator decision|1|||
129186097|NCT00545103|464975682|FG003|Overall Study|Investigator decision|0|||
129186098|NCT00545103|464975679|FG000|Overall Study|Subject moved|0|||
129186099|NCT00545103|464975680|FG001|Overall Study|Subject moved|1|||
129186100|NCT00545103|464975681|FG002|Overall Study|Subject moved|0|||
129186101|NCT00545103|464975682|FG003|Overall Study|Subject moved|0|||
129186102|NCT00545103|464975679|FG000|Overall Study|Use of prohibited medication|0|||
129186103|NCT00545103|464975680|FG001|Overall Study|Use of prohibited medication|0|||
129186104|NCT00545103|464975681|FG002|Overall Study|Use of prohibited medication|1|||
129186105|NCT00545103|464975682|FG003|Overall Study|Use of prohibited medication|0|||
129186106|NCT00545103|464975679|FG000|Overall Study|Does not want to take study drug anymore|1|||
129186107|NCT00545103|464975680|FG001|Overall Study|Does not want to take study drug anymore|0|||
129186108|NCT00545103|464975681|FG002|Overall Study|Does not want to take study drug anymore|1|||
129186109|NCT00545103|464975682|FG003|Overall Study|Does not want to take study drug anymore|0|||
129186110|NCT00545103|464975679|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
129186111|NCT00545103|464975680|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
129186112|NCT00545103|464975681|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
129186113|NCT00545103|464975682|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
129186114|NCT00545103|464975679|FG000|Overall Study|Death|0|||
129186115|NCT00545103|464975680|FG001|Overall Study|Death|1|||
129186116|NCT00545103|464975681|FG002|Overall Study|Death|0|||
129186117|NCT00545103|464975682|FG003|Overall Study|Death|0|||
129186118|NCT04891107|464975683|FG000|Overall Study|Physician Decision|1|||
129186119|NCT04891107|464975683|FG000|Overall Study|Withdrawal by Subject|1|||
129186120|NCT04891107|464975683|FG000|Overall Study|Screen failure after consent|1|||
129186121|NCT01571453|464975684|FG000|Overall Study|Adverse Event|14|||
129186122|NCT01571453|464975685|FG001|Overall Study|Adverse Event|32|||
129186123|NCT01571453|464975684|FG000|Overall Study|Lack of Efficacy|8|||
129186124|NCT01571453|464975685|FG001|Overall Study|Lack of Efficacy|3|||
129186125|NCT01571453|464975684|FG000|Overall Study|Non-compliance|2|||
129186126|NCT01571453|464975685|FG001|Overall Study|Non-compliance|4|||
129186127|NCT01571453|464975684|FG000|Overall Study|Protocol Violation|1|||
129186128|NCT01571453|464975685|FG001|Overall Study|Protocol Violation|5|||
129186129|NCT01571453|464975684|FG000|Overall Study|Withdrawal of consent|5|||
129186130|NCT01571453|464975685|FG001|Overall Study|Withdrawal of consent|13|||
129186131|NCT01571453|464975684|FG000|Overall Study|Lost to Follow-up|4|||
129186132|NCT01571453|464975685|FG001|Overall Study|Lost to Follow-up|2|||
129186133|NCT01571453|464975684|FG000|Overall Study|Administrative or other reason(s)|4|||
129186134|NCT01571453|464975685|FG001|Overall Study|Administrative or other reason(s)|3|||
129186135|NCT02453555|464975686|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
129186136|NCT02453555|464975687|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
129186137|NCT02453555|464975688|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
129186138|NCT02453555|464975689|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
129186139|NCT02453555|464975690|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
129186140|NCT02453555|464975691|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
129186141|NCT02453555|464975686|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
129186142|NCT02453555|464975687|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129186143|NCT02453555|464975688|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129186144|NCT02453555|464975689|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129186145|NCT02453555|464975690|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129186146|NCT02453555|464975691|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129186147|NCT02453555|464975686|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
129186148|NCT02453555|464975687|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
129186149|NCT02453555|464975688|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129186150|NCT02453555|464975689|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129186151|NCT02453555|464975690|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129186152|NCT02453555|464975691|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129186153|NCT02453555|464975686|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
129186154|NCT02453555|464975687|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
129186155|NCT02453555|464975688|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
129186156|NCT02453555|464975689|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
129186157|NCT02453555|464975690|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
129186158|NCT02453555|464975691|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
129186159|NCT02453555|464975686|FG000|Extension Period|Adverse Event|0|||
129186160|NCT02453555|464975687|FG001|Extension Period|Adverse Event|0|||
129186161|NCT02453555|464975688|FG002|Extension Period|Adverse Event|1|||
129186162|NCT02453555|464975689|FG003|Extension Period|Adverse Event|2|||
129186163|NCT02453555|464975690|FG004|Extension Period|Adverse Event|1|||
129186164|NCT02453555|464975691|FG005|Extension Period|Adverse Event|1|||
129186165|NCT02453555|464975686|FG000|Extension Period|Protocol Violation|0|||
129186166|NCT02453555|464975687|FG001|Extension Period|Protocol Violation|0|||
129186167|NCT02453555|464975688|FG002|Extension Period|Protocol Violation|1|||
129186168|NCT02453555|464975689|FG003|Extension Period|Protocol Violation|0|||
129186169|NCT02453555|464975690|FG004|Extension Period|Protocol Violation|0|||
129186170|NCT02453555|464975691|FG005|Extension Period|Protocol Violation|0|||
129186171|NCT02453555|464975686|FG000|Extension Period|Withdrawal by Subject|0|||
129186172|NCT02453555|464975687|FG001|Extension Period|Withdrawal by Subject|0|||
129186173|NCT02453555|464975688|FG002|Extension Period|Withdrawal by Subject|1|||
129186174|NCT02453555|464975689|FG003|Extension Period|Withdrawal by Subject|0|||
129186175|NCT02453555|464975690|FG004|Extension Period|Withdrawal by Subject|0|||
129186176|NCT02453555|464975691|FG005|Extension Period|Withdrawal by Subject|0|||
129186177|NCT04284774|464975692|FG000|Overall Study|Progressive disease|5|||
129186178|NCT02879578|464975693|FG000|Overall Study|Adverse Event|1|||
129186179|NCT02879578|464975694|FG001|Overall Study|Adverse Event|2|||
129186180|NCT02879578|464975695|FG002|Overall Study|Adverse Event|14|||
128730283|NCT01171898|463309930|FG000|Overall Study|Ongoing|1|||
129186181|NCT02879578|464975693|FG000|Overall Study|Protocol Violation|0|||
129186182|NCT02879578|464975694|FG001|Overall Study|Protocol Violation|1|||
129186183|NCT02879578|464975695|FG002|Overall Study|Protocol Violation|1|||
129186184|NCT02879578|464975693|FG000|Overall Study|Withdrawal by Subject|8|||
129186185|NCT02879578|464975694|FG001|Overall Study|Withdrawal by Subject|6|||
128730284|NCT01171898|463309931|FG001|Overall Study|Ongoing|9|||
128730285|NCT01171898|463309932|FG002|Overall Study|Ongoing|3|||
128730286|NCT01171898|463309933|FG003|Overall Study|Ongoing|0|||
128730287|NCT01171898|463309930|FG000|Overall Study|Other|1|||
128730288|NCT01171898|463309931|FG001|Overall Study|Other|5|||
128730289|NCT01171898|463309932|FG002|Overall Study|Other|0|||
128730290|NCT01171898|463309933|FG003|Overall Study|Other|2|||
129186186|NCT02879578|464975695|FG002|Overall Study|Withdrawal by Subject|9|||
129186187|NCT02879578|464975693|FG000|Overall Study|Lost to Follow-up|1|||
129186188|NCT02879578|464975694|FG001|Overall Study|Lost to Follow-up|0|||
129186189|NCT02879578|464975695|FG002|Overall Study|Lost to Follow-up|4|||
129186190|NCT02879578|464975693|FG000|Overall Study|Physician Decision|0|||
129186191|NCT02879578|464975694|FG001|Overall Study|Physician Decision|0|||
129186192|NCT02879578|464975695|FG002|Overall Study|Physician Decision|4|||
129186193|NCT03203291|464975701|FG000|Overall Study|Withdrawal by Subject|1|||
129186194|NCT02925728|464975702|FG000|Overall Study|Death|3|||
129186195|NCT02925728|464975703|FG001|Overall Study|Death|5|||
129186196|NCT02925728|464975702|FG000|Overall Study|Physician Decision|1|||
129186197|NCT02925728|464975703|FG001|Overall Study|Physician Decision|0|||
129186198|NCT02925728|464975702|FG000|Overall Study|Withdrawal by Subject|1|||
129186199|NCT02925728|464975703|FG001|Overall Study|Withdrawal by Subject|0|||
129186200|NCT05098509|464975704|FG000|Overall Study|Withdrawal by Subject|0|||
129186201|NCT05098509|464975705|FG001|Overall Study|Withdrawal by Subject|0|||
129186202|NCT05098509|464975706|FG002|Overall Study|Withdrawal by Subject|1|||
129186203|NCT05098509|464975707|FG003|Overall Study|Withdrawal by Subject|0|||
129186204|NCT05098509|464975704|FG000|Overall Study|Early study termination|1|||
129186205|NCT05098509|464975705|FG001|Overall Study|Early study termination|1|||
129186206|NCT05098509|464975706|FG002|Overall Study|Early study termination|1|||
129186207|NCT05098509|464975707|FG003|Overall Study|Early study termination|0|||
129186208|NCT04033068|464975708|FG000|Overall Study|Withdrawal by Subject|0|||
129186209|NCT04033068|464975709|FG001|Overall Study|Withdrawal by Subject|0|||
129186210|NCT04033068|464975710|FG002|Overall Study|Withdrawal by Subject|1|||
129186211|NCT04033068|464975711|FG003|Overall Study|Withdrawal by Subject|0|||
129186212|NCT04033068|464975708|FG000|Overall Study|Lost to Follow-up|0|||
129186213|NCT04033068|464975709|FG001|Overall Study|Lost to Follow-up|1|||
129186214|NCT04033068|464975710|FG002|Overall Study|Lost to Follow-up|0|||
129186215|NCT04033068|464975711|FG003|Overall Study|Lost to Follow-up|0|||
129186216|NCT04033068|464975708|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
129186217|NCT04033068|464975709|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
129186218|NCT04033068|464975710|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
129186219|NCT04033068|464975711|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
129186220|NCT02986854|464975713|FG000|Overall Study|Withdrawal by Subject|0|||
129186221|NCT02986854|464975714|FG001|Overall Study|Withdrawal by Subject|1|||
129186222|NCT02986854|464975715|FG002|Overall Study|Withdrawal by Subject|1|||
129186223|NCT02986854|464975713|FG000|Overall Study|Lost to Follow-up|3|||
129186224|NCT02986854|464975714|FG001|Overall Study|Lost to Follow-up|11|||
129186225|NCT02986854|464975715|FG002|Overall Study|Lost to Follow-up|2|||
129186226|NCT00324233|464975718|FG000|First Period|unable to insert catheter|1|||
129186227|NCT00324233|464975719|FG001|First Period|unable to insert catheter|0|||
129186228|NCT00324233|464975718|FG000|Second Period|unable to insert catheter|1|||
129186229|NCT00324233|464975719|FG001|Second Period|unable to insert catheter|1|||
129186230|NCT00324233|464975718|FG000|Second Period|Protocol Violation|4|||
129186231|NCT00324233|464975719|FG001|Second Period|Protocol Violation|6|||
129186232|NCT01972789|464975722|FG000|Overall Study|Adverse Event|11|||
129186233|NCT01972789|464975723|FG001|Overall Study|Adverse Event|4|||
129186234|NCT01972789|464975722|FG000|Overall Study|Subject withdrew consent|14|||
129186235|NCT01972789|464975723|FG001|Overall Study|Subject withdrew consent|12|||
129186236|NCT01972789|464975722|FG000|Overall Study|Lost to Follow-up|4|||
129186237|NCT01972789|464975723|FG001|Overall Study|Lost to Follow-up|7|||
129186238|NCT01972789|464975722|FG000|Overall Study|Death|7|||
129186239|NCT01972789|464975723|FG001|Overall Study|Death|5|||
129186240|NCT01972789|464975722|FG000|Overall Study|Protocol deviation|1|||
129186241|NCT01972789|464975723|FG001|Overall Study|Protocol deviation|0|||
129186242|NCT01972789|464975722|FG000|Overall Study|Physician Decision|3|||
129186243|NCT01972789|464975723|FG001|Overall Study|Physician Decision|2|||
129186244|NCT00086411|464975731|FG000|Overall Study|Lost to Follow-up|11|||
129186245|NCT00086411|464975732|FG001|Overall Study|Lost to Follow-up|11|||
129186246|NCT00086411|464975733|FG002|Overall Study|Lost to Follow-up|13|||
129186247|NCT00086411|464975734|FG003|Overall Study|Lost to Follow-up|12|||
129186248|NCT02039856|464975735|FG000|Overall Study|Death|5|||
129186249|NCT02039856|464975736|FG001|Overall Study|Death|3|||
129186250|NCT02039856|464975735|FG000|Overall Study|Partial survey completion|61|||
128730291|NCT01359592|463309934|FG000|Initial Registration|Adverse Event|1|||
129186251|NCT02039856|464975736|FG001|Overall Study|Partial survey completion|26|||
129186252|NCT02039856|464975735|FG000|Overall Study|Lost to Follow-up|388|||
129186253|NCT02039856|464975736|FG001|Overall Study|Lost to Follow-up|206|||
128730292|NCT01359592|463309935|FG001|Initial Registration|Adverse Event|0|||
128730293|NCT01359592|463309936|FG002|Initial Registration|Adverse Event|0|||
128730294|NCT01359592|463309937|FG003|Initial Registration|Adverse Event|0|||
128730295|NCT01359592|463309934|FG000|Initial Registration|Death|1|||
128730296|NCT01359592|463309935|FG001|Initial Registration|Death|0|||
128730297|NCT01359592|463309936|FG002|Initial Registration|Death|0|||
128730298|NCT01359592|463309937|FG003|Initial Registration|Death|0|||
128730299|NCT01359592|463309934|FG000|Initial Registration|Other reason not protocol specified|1|||
128730300|NCT01359592|463309935|FG001|Initial Registration|Other reason not protocol specified|0|||
128730301|NCT01359592|463309936|FG002|Initial Registration|Other reason not protocol specified|0|||
128730302|NCT01359592|463309937|FG003|Initial Registration|Other reason not protocol specified|0|||
128730303|NCT01359592|463309934|FG000|Initial Registration|Ineligible|26|||
128730304|NCT01359592|463309935|FG001|Initial Registration|Ineligible|0|||
129186254|NCT02039856|464975735|FG000|Overall Study|Withdrawal by Subject|1573|||
129186255|NCT02039856|464975736|FG001|Overall Study|Withdrawal by Subject|618|||
129186256|NCT02409342|464975737|FG000|Overall Study|Death|211|||
129186257|NCT02409342|464975738|FG001|Overall Study|Death|201|||
129186258|NCT02409342|464975737|FG000|Overall Study|Withdrawal by Subject|24|||
129186259|NCT02409342|464975738|FG001|Overall Study|Withdrawal by Subject|17|||
129186260|NCT02409342|464975737|FG000|Overall Study|Study Terminated By Sponsor|48|||
129186261|NCT02409342|464975738|FG001|Overall Study|Study Terminated By Sponsor|59|||
129186262|NCT02409342|464975737|FG000|Overall Study|Lost to Follow-up|3|||
129186263|NCT02409342|464975738|FG001|Overall Study|Lost to Follow-up|5|||
129186264|NCT02409342|464975737|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
129186265|NCT02409342|464975738|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
129186266|NCT02409342|464975737|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
129186267|NCT02409342|464975738|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
129186268|NCT02409342|464975737|FG000|Overall Study|Sponsor Decision|1|||
129186269|NCT02409342|464975738|FG001|Overall Study|Sponsor Decision|0|||
129186270|NCT03908970|464975739|FG000|Overall Study|Adverse Event|7|||
129186271|NCT03908970|464975740|FG001|Overall Study|Adverse Event|21|||
129186272|NCT03908970|464975739|FG000|Overall Study|Physician Decision|1|||
129186273|NCT03908970|464975740|FG001|Overall Study|Physician Decision|4|||
129186274|NCT03908970|464975739|FG000|Overall Study|Withdrawal by Subject|9|||
129186275|NCT03908970|464975740|FG001|Overall Study|Withdrawal by Subject|22|||
129186276|NCT01274429|464975746|FG000|Overall Study|Study closed do to lack of funding|5|||
129186277|NCT03268941|464977534|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129186278|NCT03268941|464977535|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129186279|NCT03268941|464977536|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129186280|NCT03268941|464977537|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
129186281|NCT03268941|464977538|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129186282|NCT03268941|464977539|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129186283|NCT03268941|464977540|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129186284|NCT03268941|464977534|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
129186285|NCT03268941|464977535|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
129186286|NCT03268941|464977536|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
129186287|NCT03268941|464977537|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
129186288|NCT03268941|464977538|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
129186289|NCT03268941|464977539|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
129186290|NCT03268941|464977540|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
129186291|NCT03268941|464977534|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
129186292|NCT03268941|464977535|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129186293|NCT03268941|464977536|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129186294|NCT03268941|464977537|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129186295|NCT03268941|464977538|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129186296|NCT03268941|464977539|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129186297|NCT03268941|464977540|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129186298|NCT03268941|464977534|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
129186299|NCT03268941|464977535|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
129186300|NCT03268941|464977536|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
129186301|NCT03268941|464977537|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
129186302|NCT03268941|464977538|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
129186303|NCT03268941|464977539|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
129186304|NCT03268941|464977540|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
129186305|NCT03268941|464977534|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129186306|NCT03268941|464977535|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129186307|NCT03268941|464977536|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129186308|NCT03268941|464977537|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129186309|NCT03268941|464977538|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129186310|NCT03268941|464977539|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129186311|NCT03268941|464977540|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
129186312|NCT01216683|464977541|FG000|Induction|Never started treatment|0|||
129186313|NCT01216683|464977542|FG001|Induction|Never started treatment|6|||
129186314|NCT01216683|464977543|FG002|Induction|Never started treatment|3|||
129186315|NCT01216683|464977541|FG000|Induction|Lack of Efficacy|4|||
129186316|NCT01216683|464977542|FG001|Induction|Lack of Efficacy|3|||
129186317|NCT01216683|464977543|FG002|Induction|Lack of Efficacy|7|||
129186318|NCT01216683|464977541|FG000|Induction|Adverse Event|0|||
129186319|NCT01216683|464977542|FG001|Induction|Adverse Event|5|||
129186320|NCT01216683|464977543|FG002|Induction|Adverse Event|5|||
129186321|NCT01216683|464977541|FG000|Induction|Death|0|||
129186322|NCT01216683|464977542|FG001|Induction|Death|0|||
129186323|NCT01216683|464977543|FG002|Induction|Death|2|||
129186324|NCT01216683|464977541|FG000|Induction|Withdrawal by Subject|0|||
129186325|NCT01216683|464977542|FG001|Induction|Withdrawal by Subject|4|||
129186326|NCT01216683|464977543|FG002|Induction|Withdrawal by Subject|2|||
129186327|NCT01216683|464977541|FG000|Induction|Other disease|0|||
129186328|NCT01216683|464977542|FG001|Induction|Other disease|1|||
128730305|NCT01359592|463309936|FG002|Initial Registration|Ineligible|0|||
128730306|NCT01359592|463309937|FG003|Initial Registration|Ineligible|0|||
128730307|NCT01359592|463309934|FG000|PET-Directed Therapy|Adverse Event|0|||
128730308|NCT01359592|463309935|FG001|PET-Directed Therapy|Adverse Event|0|||
128730309|NCT01359592|463309936|FG002|PET-Directed Therapy|Adverse Event|1|||
128730310|NCT01359592|463309937|FG003|PET-Directed Therapy|Adverse Event|0|||
128730311|NCT01359592|463309934|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
128730312|NCT01359592|463309935|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
129186329|NCT01216683|464977543|FG002|Induction|Other disease|2|||
129186330|NCT01216683|464977541|FG000|Continuation|Lack of Efficacy|3|||
129186331|NCT01216683|464977542|FG001|Continuation|Lack of Efficacy|2|||
129186332|NCT01216683|464977543|FG002|Continuation|Lack of Efficacy|7|||
129186333|NCT01216683|464977541|FG000|Continuation|Adverse Event|5|||
129186334|NCT01216683|464977542|FG001|Continuation|Adverse Event|3|||
129186335|NCT01216683|464977543|FG002|Continuation|Adverse Event|16|||
129186336|NCT01216683|464977541|FG000|Continuation|Death|1|||
129186337|NCT01216683|464977542|FG001|Continuation|Death|0|||
129186338|NCT01216683|464977543|FG002|Continuation|Death|2|||
129186339|NCT01216683|464977541|FG000|Continuation|Withdrawal by Subject|4|||
129186340|NCT01216683|464977542|FG001|Continuation|Withdrawal by Subject|5|||
129186341|NCT01216683|464977543|FG002|Continuation|Withdrawal by Subject|9|||
129186342|NCT01216683|464977541|FG000|Continuation|Other diseases|0|||
129186343|NCT01216683|464977542|FG001|Continuation|Other diseases|2|||
129186344|NCT01216683|464977543|FG002|Continuation|Other diseases|1|||
129186345|NCT01216683|464977541|FG000|Continuation|Physician Decision|1|||
129186346|NCT01216683|464977542|FG001|Continuation|Physician Decision|0|||
129186347|NCT01216683|464977543|FG002|Continuation|Physician Decision|1|||
129186348|NCT01216683|464977541|FG000|Continuation|Non-compliance|1|||
129186349|NCT01216683|464977542|FG001|Continuation|Non-compliance|0|||
129186350|NCT01216683|464977543|FG002|Continuation|Non-compliance|1|||
128730313|NCT01359592|463309936|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
128730314|NCT01359592|463309937|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
128730315|NCT01359592|463309934|FG000|PET-Directed Therapy|Ineligible|0|||
129186351|NCT01216683|464977541|FG000|Continuation|Insurance change|0|||
129186352|NCT01216683|464977542|FG001|Continuation|Insurance change|1|||
129186353|NCT01216683|464977543|FG002|Continuation|Insurance change|0|||
129186354|NCT01216683|464977541|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
129186355|NCT01216683|464977542|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
129186356|NCT01216683|464977543|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
129186357|NCT01216683|464977541|FG000|Continuation|Not reported|0|||
129186358|NCT01216683|464977542|FG001|Continuation|Not reported|0|||
129186359|NCT01216683|464977543|FG002|Continuation|Not reported|1|||
129186360|NCT01216683|464977541|FG000|Continuation|Never started treatment|0|||
129186361|NCT01216683|464977542|FG001|Continuation|Never started treatment|1|||
129186362|NCT01216683|464977543|FG002|Continuation|Never started treatment|5|||
129186363|NCT02503501|464977545|FG000|Overall Study|Physician Decision|1|||
129186364|NCT02503501|464977546|FG001|Overall Study|Physician Decision|0|||
129186365|NCT02503501|464977545|FG000|Overall Study|Protocol Violation|0|||
129186366|NCT02503501|464977546|FG001|Overall Study|Protocol Violation|1|||
129186367|NCT02503501|464977545|FG000|Overall Study|Withdrawal by Subject|0|||
129186368|NCT02503501|464977546|FG001|Overall Study|Withdrawal by Subject|2|||
129186369|NCT02806960|464977547|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129186370|NCT02806960|464977548|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129186371|NCT02806960|464977549|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129186372|NCT02806960|464977550|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129186373|NCT01041287|464977551|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
129186374|NCT01041287|464977552|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
129186375|NCT01041287|464977551|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
129186376|NCT01041287|464977552|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
129186377|NCT00495625|464977553|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
129186378|NCT01912339|464977554|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
129186379|NCT01912339|464977555|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
129186380|NCT01912339|464977556|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
129186381|NCT01912339|464977554|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
129186382|NCT01912339|464977555|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
129186383|NCT01912339|464977556|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
129186384|NCT01912339|464977554|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
129186385|NCT01912339|464977555|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
129186386|NCT01912339|464977556|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
129186387|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
129186388|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
129186389|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
129186390|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
129186391|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
129186392|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
129186393|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
129186394|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
129186395|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
129186396|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
129186397|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
129186398|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
129186399|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
129186400|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
129186401|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
129186402|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
129186403|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
129186404|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
129186405|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
129186406|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
129186407|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
129186408|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
129186409|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
129186410|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
129186411|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
129186412|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
129186413|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
129186414|NCT01912339|464977554|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
129186415|NCT01912339|464977555|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
129186416|NCT01912339|464977556|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
129186417|NCT03464019|464977557|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
129186418|NCT03464019|464977558|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
129186419|NCT03464019|464977559|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
129186420|NCT03464019|464977557|FG000|NODE-301 Part 1|Ablation|0|||
129186421|NCT03464019|464977558|FG001|NODE-301 Part 1|Ablation|0|||
129186422|NCT03464019|464977559|FG002|NODE-301 Part 1|Ablation|16|||
129186423|NCT03464019|464977557|FG000|NODE-301 Part 1|Test Dose Failure|0|||
129186424|NCT03464019|464977558|FG001|NODE-301 Part 1|Test Dose Failure|0|||
129186425|NCT03464019|464977559|FG002|NODE-301 Part 1|Test Dose Failure|8|||
129186426|NCT03464019|464977557|FG000|NODE-301 Part 1|Adverse Event|0|||
129186427|NCT03464019|464977558|FG001|NODE-301 Part 1|Adverse Event|0|||
129186428|NCT03464019|464977559|FG002|NODE-301 Part 1|Adverse Event|5|||
129186429|NCT03464019|464977557|FG000|NODE-301 Part 1|Physician Decision|0|||
129186430|NCT03464019|464977558|FG001|NODE-301 Part 1|Physician Decision|0|||
129186431|NCT03464019|464977559|FG002|NODE-301 Part 1|Physician Decision|4|||
129186432|NCT03464019|464977557|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
129186433|NCT03464019|464977558|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
129186434|NCT03464019|464977559|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
129186435|NCT03464019|464977557|FG000|NODE-301 Part 1|Protocol Violation|0|||
129186436|NCT03464019|464977558|FG001|NODE-301 Part 1|Protocol Violation|0|||
129186437|NCT03464019|464977559|FG002|NODE-301 Part 1|Protocol Violation|2|||
129186438|NCT03464019|464977557|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
129186439|NCT03464019|464977558|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
129186440|NCT03464019|464977559|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
129186441|NCT03464019|464977557|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
129186442|NCT03464019|464977558|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
129186443|NCT03464019|464977559|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
129186444|NCT03464019|464977557|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
129186445|NCT03464019|464977558|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
129186446|NCT03464019|464977559|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
129186447|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
129186448|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
129186449|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
129186450|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
129186451|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
129186452|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
129186453|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
129186454|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
129186455|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
129186456|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
129186457|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
129186458|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
129186459|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
129186460|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
129186461|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
129186462|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
129186463|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
129186464|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
129186465|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
129186466|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
129186467|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
129186468|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
129186469|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
129186470|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
129186471|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
129186472|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
129186473|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
129186474|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
129186475|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
129186476|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
129186477|NCT03464019|464977557|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
129186478|NCT03464019|464977558|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
129186479|NCT03464019|464977559|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
129186480|NCT00126776|464977560|FG000|Overall Study|follow up complete on all patients|0|||
129186481|NCT00126776|464977561|FG001|Overall Study|follow up complete on all patients|0|||
129186482|NCT03626545|464977565|FG000|Overall Study|Progressive disease|3|||
129186483|NCT03626545|464977566|FG001|Overall Study|Progressive disease|82|||
129186484|NCT03626545|464977567|FG002|Overall Study|Progressive disease|85|||
129186485|NCT03626545|464977565|FG000|Overall Study|Adverse Event|3|||
129186486|NCT03626545|464977566|FG001|Overall Study|Adverse Event|13|||
129186487|NCT03626545|464977567|FG002|Overall Study|Adverse Event|10|||
129186488|NCT03626545|464977565|FG000|Overall Study|Physician Decision|1|||
129186489|NCT03626545|464977566|FG001|Overall Study|Physician Decision|18|||
129186490|NCT03626545|464977567|FG002|Overall Study|Physician Decision|14|||
129186491|NCT03626545|464977565|FG000|Overall Study|Subject Decision|0|||
129186492|NCT03626545|464977566|FG001|Overall Study|Subject Decision|5|||
129186493|NCT03626545|464977567|FG002|Overall Study|Subject Decision|5|||
129186494|NCT03626545|464977565|FG000|Overall Study|Death|1|||
129186495|NCT03626545|464977566|FG001|Overall Study|Death|1|||
129186496|NCT03626545|464977567|FG002|Overall Study|Death|1|||
129186497|NCT03626545|464977565|FG000|Overall Study|Protocol Deviation|0|||
129186498|NCT03626545|464977566|FG001|Overall Study|Protocol Deviation|1|||
129186499|NCT03626545|464977567|FG002|Overall Study|Protocol Deviation|1|||
129186500|NCT03626545|464977565|FG000|Overall Study|Guardian Decision|0|||
129186501|NCT03626545|464977566|FG001|Overall Study|Guardian Decision|0|||
129186502|NCT03626545|464977567|FG002|Overall Study|Guardian Decision|1|||
129186503|NCT01939366|464977570|FG000|Overall Study|Adverse Event|8|||
129186504|NCT01939366|464977571|FG001|Overall Study|Adverse Event|17|||
129186505|NCT01939366|464977572|FG002|Overall Study|Adverse Event|30|||
129186506|NCT01939366|464977573|FG003|Overall Study|Adverse Event|8|||
129186507|NCT01939366|464977574|FG004|Overall Study|Adverse Event|5|||
129186508|NCT01939366|464977570|FG000|Overall Study|Lack of Efficacy|2|||
129186509|NCT01939366|464977571|FG001|Overall Study|Lack of Efficacy|1|||
129186510|NCT01939366|464977572|FG002|Overall Study|Lack of Efficacy|1|||
129186511|NCT01939366|464977573|FG003|Overall Study|Lack of Efficacy|1|||
129186512|NCT01939366|464977574|FG004|Overall Study|Lack of Efficacy|3|||
129186513|NCT01939366|464977570|FG000|Overall Study|Lost to Follow-up|1|||
129186514|NCT01939366|464977571|FG001|Overall Study|Lost to Follow-up|1|||
129186515|NCT01939366|464977572|FG002|Overall Study|Lost to Follow-up|0|||
129186516|NCT01939366|464977573|FG003|Overall Study|Lost to Follow-up|0|||
129186517|NCT01939366|464977574|FG004|Overall Study|Lost to Follow-up|0|||
129186518|NCT01939366|464977570|FG000|Overall Study|Withdrawal by Subject|1|||
129186519|NCT01939366|464977571|FG001|Overall Study|Withdrawal by Subject|0|||
129186520|NCT01939366|464977572|FG002|Overall Study|Withdrawal by Subject|2|||
129186521|NCT01939366|464977573|FG003|Overall Study|Withdrawal by Subject|2|||
129186522|NCT01939366|464977574|FG004|Overall Study|Withdrawal by Subject|3|||
129186523|NCT01939366|464977570|FG000|Overall Study|Inclusion criteria not met|0|||
129186524|NCT01939366|464977571|FG001|Overall Study|Inclusion criteria not met|1|||
129186525|NCT01939366|464977572|FG002|Overall Study|Inclusion criteria not met|1|||
129186526|NCT01939366|464977573|FG003|Overall Study|Inclusion criteria not met|0|||
129186527|NCT01939366|464977574|FG004|Overall Study|Inclusion criteria not met|1|||
129186528|NCT01939366|464977570|FG000|Overall Study|Other|0|||
129186529|NCT01939366|464977571|FG001|Overall Study|Other|0|||
129186530|NCT01939366|464977572|FG002|Overall Study|Other|2|||
129186531|NCT01939366|464977573|FG003|Overall Study|Other|2|||
129186532|NCT01939366|464977574|FG004|Overall Study|Other|1|||
129186533|NCT01939366|464977570|FG000|Overall Study|Protocol Violation|0|||
129186534|NCT01939366|464977571|FG001|Overall Study|Protocol Violation|0|||
129186535|NCT01939366|464977572|FG002|Overall Study|Protocol Violation|0|||
129186536|NCT01939366|464977573|FG003|Overall Study|Protocol Violation|1|||
129186537|NCT01939366|464977574|FG004|Overall Study|Protocol Violation|0|||
129186538|NCT01939366|464977570|FG000|Overall Study|Sponsor decision|0|||
129186539|NCT01939366|464977571|FG001|Overall Study|Sponsor decision|0|||
129186540|NCT01939366|464977572|FG002|Overall Study|Sponsor decision|0|||
129186541|NCT01939366|464977573|FG003|Overall Study|Sponsor decision|0|||
129186542|NCT01939366|464977574|FG004|Overall Study|Sponsor decision|2|||
129186543|NCT01939366|464977570|FG000|Overall Study|GCP non-compliance at site|2|||
129186544|NCT01939366|464977571|FG001|Overall Study|GCP non-compliance at site|3|||
129186545|NCT01939366|464977572|FG002|Overall Study|GCP non-compliance at site|2|||
129186546|NCT01939366|464977573|FG003|Overall Study|GCP non-compliance at site|3|||
129186547|NCT01939366|464977574|FG004|Overall Study|GCP non-compliance at site|3|||
129186548|NCT04680975|464977579|FG000|Overall Study|Adverse Event|3|||
129186549|NCT04680975|464977579|FG000|Overall Study|Death|1|||
129186550|NCT04680975|464977579|FG000|Overall Study|Progressive Disease|1|||
129186551|NCT04680975|464977579|FG000|Overall Study|Withdrawal by Subject|1|||
129186552|NCT03909152|464977580|FG000|Overall Study|Adverse Event|14|||
129186553|NCT03909152|464977581|FG001|Overall Study|Adverse Event|5|||
129186554|NCT03909152|464977582|FG002|Overall Study|Adverse Event|1|||
129186555|NCT03909152|464977583|FG003|Overall Study|Adverse Event|14|||
129186556|NCT02615691|464977584|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
129186557|NCT02615691|464977584|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
129186558|NCT02615691|464977584|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
129186559|NCT02615691|464977584|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
129186560|NCT02702414|464977585|FG000|Overall Study|Death|96|||
129186561|NCT02702414|464977586|FG001|Overall Study|Death|42|||
129186562|NCT02702414|464977585|FG000|Overall Study|Lost to Follow-up|0|||
129186563|NCT02702414|464977586|FG001|Overall Study|Lost to Follow-up|1|||
129186564|NCT02702414|464977585|FG000|Overall Study|Withdrawal by Subject|0|||
129186565|NCT02702414|464977586|FG001|Overall Study|Withdrawal by Subject|1|||
129186566|NCT02702414|464977585|FG000|Overall Study|Protocol Violation|1|||
129186567|NCT02702414|464977586|FG001|Overall Study|Protocol Violation|0|||
129186568|NCT02702414|464977585|FG000|Overall Study|Sponsor Decision|8|||
129186569|NCT02702414|464977586|FG001|Overall Study|Sponsor Decision|7|||
128730316|NCT01359592|463309935|FG001|PET-Directed Therapy|Ineligible|0|||
129186570|NCT02596230|464977587|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
129186571|NCT02596230|464977588|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
129186572|NCT02596230|464977589|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
129186573|NCT02596230|464977590|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
129186574|NCT02596230|464977591|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
129186575|NCT02596230|464977587|FG000|Objective 2, One Year|Lost to Follow-up|0|||
129186576|NCT02596230|464977588|FG001|Objective 2, One Year|Lost to Follow-up|41|||
129186577|NCT02596230|464977589|FG002|Objective 2, One Year|Lost to Follow-up|41|||
129186578|NCT02596230|464977590|FG003|Objective 2, One Year|Lost to Follow-up|32|||
129186579|NCT02596230|464977591|FG004|Objective 2, One Year|Lost to Follow-up|46|||
129186580|NCT02596230|464977587|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
129186581|NCT02596230|464977588|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
129186582|NCT02596230|464977589|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
129186583|NCT02596230|464977590|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
129186584|NCT02596230|464977591|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
129186585|NCT02596230|464977587|FG000|Objective 2, One Year|Adverse drug reaction|0|||
129186586|NCT02596230|464977588|FG001|Objective 2, One Year|Adverse drug reaction|1|||
129186587|NCT02596230|464977589|FG002|Objective 2, One Year|Adverse drug reaction|0|||
129186588|NCT02596230|464977590|FG003|Objective 2, One Year|Adverse drug reaction|0|||
129186589|NCT02596230|464977591|FG004|Objective 2, One Year|Adverse drug reaction|0|||
129186590|NCT02596230|464977587|FG000|Objective 2, One Year|Death|0|||
129186591|NCT02596230|464977588|FG001|Objective 2, One Year|Death|12|||
129186592|NCT02596230|464977589|FG002|Objective 2, One Year|Death|41|||
129186593|NCT02596230|464977590|FG003|Objective 2, One Year|Death|21|||
129186594|NCT02596230|464977591|FG004|Objective 2, One Year|Death|30|||
129186595|NCT02596230|464977587|FG000|Objective 2, One Year|Other|0|||
129186596|NCT02596230|464977588|FG001|Objective 2, One Year|Other|3|||
129186597|NCT02596230|464977589|FG002|Objective 2, One Year|Other|2|||
129186598|NCT02596230|464977590|FG003|Objective 2, One Year|Other|0|||
129186599|NCT02596230|464977591|FG004|Objective 2, One Year|Other|0|||
129186600|NCT01272869|464977592|FG000|Period 2 (14 Days)|Adverse Event|1|||
129186601|NCT01272869|464977593|FG001|Period 2 (14 Days)|Adverse Event|0|||
129186602|NCT02271945|464977594|FG000|Overall Study|Death|3|||
129186603|NCT02271945|464977595|FG001|Overall Study|Death|3|||
129186604|NCT02271945|464977594|FG000|Overall Study|Withdrawal by Subject|1|||
129186605|NCT02271945|464977595|FG001|Overall Study|Withdrawal by Subject|1|||
129186606|NCT02271945|464977594|FG000|Overall Study|Other|1|||
129186607|NCT02271945|464977595|FG001|Overall Study|Other|1|||
129186608|NCT00615030|464977597|FG000|Period I|Administrative problem|0|||
129186609|NCT00615030|464977598|FG001|Period I|Administrative problem|0|||
129186610|NCT00615030|464977599|FG002|Period I|Administrative problem|0|||
129186611|NCT00615030|464977600|FG003|Period I|Administrative problem|0|||
129186612|NCT00615030|464977601|FG004|Period I|Administrative problem|1|||
129186613|NCT00615030|464977602|FG005|Period I|Administrative problem|0|||
129186614|NCT00615030|464977603|FG006|Period I|Administrative problem|0|||
129186615|NCT00615030|464977604|FG007|Period I|Administrative problem|0|||
129186616|NCT00615030|464977605|FG008|Period I|Administrative problem|0|||
129186617|NCT00615030|464977606|FG009|Period I|Administrative problem|0|||
129186618|NCT00615030|464977607|FG010|Period I|Administrative problem|0|||
129186619|NCT00615030|464977608|FG011|Period I|Administrative problem|0|||
129186620|NCT00615030|464977597|FG000|Period I|Protocol deviation|1|||
129186621|NCT00615030|464977598|FG001|Period I|Protocol deviation|0|||
129186622|NCT00615030|464977599|FG002|Period I|Protocol deviation|0|||
129186623|NCT00615030|464977600|FG003|Period I|Protocol deviation|0|||
129186624|NCT00615030|464977601|FG004|Period I|Protocol deviation|0|||
129186625|NCT00615030|464977602|FG005|Period I|Protocol deviation|0|||
129186626|NCT00615030|464977603|FG006|Period I|Protocol deviation|0|||
129186627|NCT00615030|464977604|FG007|Period I|Protocol deviation|0|||
129186628|NCT00615030|464977605|FG008|Period I|Protocol deviation|0|||
129186629|NCT00615030|464977606|FG009|Period I|Protocol deviation|0|||
129186630|NCT00615030|464977607|FG010|Period I|Protocol deviation|0|||
129186631|NCT00615030|464977608|FG011|Period I|Protocol deviation|0|||
129186632|NCT00615030|464977597|FG000|Period I|Subject withdrew consent|0|||
129186633|NCT00615030|464977598|FG001|Period I|Subject withdrew consent|0|||
129186634|NCT00615030|464977599|FG002|Period I|Subject withdrew consent|0|||
129186635|NCT00615030|464977600|FG003|Period I|Subject withdrew consent|0|||
129186636|NCT00615030|464977601|FG004|Period I|Subject withdrew consent|0|||
129186637|NCT00615030|464977602|FG005|Period I|Subject withdrew consent|0|||
129186638|NCT00615030|464977603|FG006|Period I|Subject withdrew consent|0|||
129186639|NCT00615030|464977604|FG007|Period I|Subject withdrew consent|0|||
129186640|NCT00615030|464977605|FG008|Period I|Subject withdrew consent|1|||
129186641|NCT00615030|464977606|FG009|Period I|Subject withdrew consent|0|||
129186642|NCT00615030|464977607|FG010|Period I|Subject withdrew consent|1|||
129186643|NCT00615030|464977608|FG011|Period I|Subject withdrew consent|1|||
129186644|NCT00615030|464977597|FG000|Period I|Abnormal laboratory value(s)|0|||
129186645|NCT00615030|464977598|FG001|Period I|Abnormal laboratory value(s)|0|||
129186646|NCT00615030|464977599|FG002|Period I|Abnormal laboratory value(s)|0|||
129186647|NCT00615030|464977600|FG003|Period I|Abnormal laboratory value(s)|0|||
129186648|NCT00615030|464977601|FG004|Period I|Abnormal laboratory value(s)|0|||
129186649|NCT00615030|464977602|FG005|Period I|Abnormal laboratory value(s)|1|||
129186650|NCT00615030|464977603|FG006|Period I|Abnormal laboratory value(s)|0|||
129186651|NCT00615030|464977604|FG007|Period I|Abnormal laboratory value(s)|0|||
129186652|NCT00615030|464977605|FG008|Period I|Abnormal laboratory value(s)|0|||
129186653|NCT00615030|464977606|FG009|Period I|Abnormal laboratory value(s)|0|||
129186654|NCT00615030|464977607|FG010|Period I|Abnormal laboratory value(s)|0|||
129186655|NCT00615030|464977608|FG011|Period I|Abnormal laboratory value(s)|0|||
129186656|NCT00615030|464977597|FG000|Period II|Adverse Event|0|||
129186657|NCT00615030|464977598|FG001|Period II|Adverse Event|0|||
129186658|NCT00615030|464977599|FG002|Period II|Adverse Event|1|||
129186659|NCT00615030|464977600|FG003|Period II|Adverse Event|0|||
129186660|NCT00615030|464977601|FG004|Period II|Adverse Event|0|||
129186661|NCT00615030|464977602|FG005|Period II|Adverse Event|0|||
129186662|NCT00615030|464977603|FG006|Period II|Adverse Event|0|||
129186663|NCT00615030|464977604|FG007|Period II|Adverse Event|0|||
129186664|NCT00615030|464977605|FG008|Period II|Adverse Event|1|||
129186665|NCT00615030|464977606|FG009|Period II|Adverse Event|0|||
129186666|NCT00615030|464977607|FG010|Period II|Adverse Event|0|||
129186667|NCT00615030|464977608|FG011|Period II|Adverse Event|0|||
129186668|NCT00615030|464977597|FG000|Period II|Subject withdrew consent|0|||
129186669|NCT00615030|464977598|FG001|Period II|Subject withdrew consent|0|||
129186670|NCT00615030|464977599|FG002|Period II|Subject withdrew consent|0|||
129186671|NCT00615030|464977600|FG003|Period II|Subject withdrew consent|1|||
129186672|NCT00615030|464977601|FG004|Period II|Subject withdrew consent|0|||
129186673|NCT00615030|464977602|FG005|Period II|Subject withdrew consent|0|||
129186674|NCT00615030|464977603|FG006|Period II|Subject withdrew consent|1|||
129186675|NCT00615030|464977604|FG007|Period II|Subject withdrew consent|0|||
129186676|NCT00615030|464977605|FG008|Period II|Subject withdrew consent|0|||
129186677|NCT00615030|464977606|FG009|Period II|Subject withdrew consent|0|||
129186678|NCT00615030|464977607|FG010|Period II|Subject withdrew consent|0|||
129186679|NCT00615030|464977608|FG011|Period II|Subject withdrew consent|0|||
129186680|NCT00615030|464977597|FG000|Period III|Administrative problems|1|||
129186681|NCT00615030|464977598|FG001|Period III|Administrative problems|0|||
129186682|NCT00615030|464977599|FG002|Period III|Administrative problems|0|||
129186683|NCT00615030|464977600|FG003|Period III|Administrative problems|1|||
129186684|NCT00615030|464977601|FG004|Period III|Administrative problems|0|||
129186685|NCT00615030|464977602|FG005|Period III|Administrative problems|0|||
129186686|NCT00615030|464977603|FG006|Period III|Administrative problems|0|||
129186687|NCT00615030|464977604|FG007|Period III|Administrative problems|0|||
129186688|NCT00615030|464977605|FG008|Period III|Administrative problems|0|||
129186689|NCT00615030|464977606|FG009|Period III|Administrative problems|0|||
129186690|NCT00615030|464977607|FG010|Period III|Administrative problems|0|||
129186691|NCT00615030|464977608|FG011|Period III|Administrative problems|0|||
129186692|NCT00151476|464977609|FG000|FAP Identified Subjects|Protocol Violation|0|||
129186693|NCT00151476|464977610|FG001|FAP Identified Subjects|Protocol Violation|1|||
129186694|NCT00151476|464977609|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
129186695|NCT00151476|464977610|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
129186696|NCT00151476|464977609|FG000|FAP Analyzed Subjects|Other study participation|0|||
129186697|NCT00151476|464977610|FG001|FAP Analyzed Subjects|Other study participation|1|||
129186698|NCT03446456|464977611|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
129186699|NCT03446456|464977612|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
129186700|NCT03446456|464977611|FG000|Overall Study|Lost to Follow-up|1|||
129186701|NCT03446456|464977612|FG001|Overall Study|Lost to Follow-up|3|||
129186702|NCT03446456|464977611|FG000|Overall Study|Participant failed the toxicology test|1|||
129186703|NCT03446456|464977612|FG001|Overall Study|Participant failed the toxicology test|0|||
129186704|NCT03446456|464977611|FG000|Overall Study|Break down of the experimental equipment|1|||
129186705|NCT03446456|464977612|FG001|Overall Study|Break down of the experimental equipment|0|||
129186706|NCT04099511|464977619|FG000|Overall Study|Lost to Follow-up|2|||
129186707|NCT04099511|464977620|FG001|Overall Study|Lost to Follow-up|2|||
129186708|NCT04099511|464977619|FG000|Overall Study|Withdrawal by Subject|8|||
129186709|NCT04099511|464977620|FG001|Overall Study|Withdrawal by Subject|4|||
129186710|NCT03002311|464977625|FG000|Overall Study|Lost to Follow-up|13|||
129186711|NCT03002311|464977626|FG001|Overall Study|Lost to Follow-up|26|||
129186712|NCT03002311|464977625|FG000|Overall Study|Referral provider called to schedule app|3|||
129186713|NCT03002311|464977626|FG001|Overall Study|Referral provider called to schedule app|3|||
129186714|NCT03002311|464977625|FG000|Overall Study|Physician Decision|3|||
129186715|NCT03002311|464977626|FG001|Overall Study|Physician Decision|1|||
129186716|NCT00320424|464977627|FG000|Overall Study|Adverse Event|3|||
129186717|NCT00320424|464977627|FG000|Overall Study|Other|3|||
129186718|NCT00658814|464977628|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
129186719|NCT00658814|464977629|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
129186720|NCT00658814|464977628|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
129186721|NCT00658814|464977629|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
129186722|NCT00658814|464977628|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
129186723|NCT00658814|464977629|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
129186724|NCT00658814|464977628|FG000|Remission Induction Chemotherapy|Death|1|||
129186725|NCT00658814|464977629|FG001|Remission Induction Chemotherapy|Death|4|||
129186726|NCT00658814|464977628|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
129186727|NCT00658814|464977629|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
129186728|NCT00658814|464977628|FG000|Remission Induction Chemotherapy|Not eligible|1|||
129186729|NCT00658814|464977629|FG001|Remission Induction Chemotherapy|Not eligible|2|||
129186730|NCT00658814|464977628|FG000|Consolidation Therapy|Not protocol specified|0|||
129186731|NCT00658814|464977629|FG001|Consolidation Therapy|Not protocol specified|1|||
129186732|NCT00658814|464977628|FG000|Consolidation Therapy|Not eligible|2|||
129186733|NCT00658814|464977629|FG001|Consolidation Therapy|Not eligible|2|||
129186734|NCT00658814|464977628|FG000|Maintenance Therapy|Adverse Event|1|||
129186735|NCT00658814|464977629|FG001|Maintenance Therapy|Adverse Event|1|||
129186736|NCT00658814|464977628|FG000|Maintenance Therapy|Not protocol specified|1|||
129186737|NCT00658814|464977629|FG001|Maintenance Therapy|Not protocol specified|0|||
129186738|NCT00658814|464977628|FG000|Maintenance Therapy|Not eligible|1|||
129186739|NCT00658814|464977629|FG001|Maintenance Therapy|Not eligible|0|||
129186740|NCT03270891|464977630|FG000|Overall Study|Lost to Follow-up|3|||
129186741|NCT03270891|464977631|FG001|Overall Study|Lost to Follow-up|6|||
129186742|NCT03270891|464977632|FG002|Overall Study|Lost to Follow-up|0|||
129186743|NCT03270891|464977630|FG000|Overall Study|Withdrawal by Subject|1|||
129186744|NCT03270891|464977631|FG001|Overall Study|Withdrawal by Subject|0|||
129186745|NCT03270891|464977632|FG002|Overall Study|Withdrawal by Subject|0|||
129186746|NCT03270891|464977630|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
129186747|NCT03270891|464977631|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
129186748|NCT03270891|464977632|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
129186749|NCT02540668|464977633|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
129186750|NCT02540668|464977634|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
129186751|NCT02883062|464977636|FG000|Overall Study|Withdrawal by Subject|6|||
129186752|NCT02883062|464977637|FG001|Overall Study|Withdrawal by Subject|0|||
129186753|NCT02888743|464977638|FG000|Overall Study|Withdrawal by Subject|1|||
129186754|NCT02888743|464977639|FG001|Overall Study|Withdrawal by Subject|2|||
129186755|NCT02888743|464977640|FG002|Overall Study|Withdrawal by Subject|2|||
129186756|NCT02888743|464977641|FG003|Overall Study|Withdrawal by Subject|0|||
129186757|NCT02888743|464977642|FG004|Overall Study|Withdrawal by Subject|1|||
129186758|NCT02888743|464977638|FG000|Overall Study|Disease progression before treatment|2|||
129186759|NCT02888743|464977639|FG001|Overall Study|Disease progression before treatment|0|||
129186760|NCT02888743|464977640|FG002|Overall Study|Disease progression before treatment|2|||
129186761|NCT02888743|464977641|FG003|Overall Study|Disease progression before treatment|0|||
129186762|NCT02888743|464977642|FG004|Overall Study|Disease progression before treatment|0|||
129186763|NCT02888743|464977638|FG000|Overall Study|Patient ineligible|1|||
129186764|NCT02888743|464977639|FG001|Overall Study|Patient ineligible|2|||
129186765|NCT02888743|464977640|FG002|Overall Study|Patient ineligible|0|||
129186766|NCT02888743|464977641|FG003|Overall Study|Patient ineligible|0|||
129186767|NCT02888743|464977642|FG004|Overall Study|Patient ineligible|0|||
129186768|NCT04816721|464977647|FG000|Overall Study|Withdrawal by Subject|0|||
129186769|NCT04816721|464977648|FG001|Overall Study|Withdrawal by Subject|2|||
129186770|NCT04816721|464977649|FG002|Overall Study|Withdrawal by Subject|0|||
129186771|NCT04816721|464977650|FG003|Overall Study|Withdrawal by Subject|1|||
129186772|NCT04816721|464977651|FG004|Overall Study|Withdrawal by Subject|1|||
129186773|NCT04816721|464977652|FG005|Overall Study|Withdrawal by Subject|0|||
129186774|NCT04816721|464977653|FG006|Overall Study|Withdrawal by Subject|0|||
129186775|NCT04816721|464977654|FG007|Overall Study|Withdrawal by Subject|0|||
129186776|NCT04816721|464977647|FG000|Overall Study|Miscellaneous|0|||
129186777|NCT04816721|464977648|FG001|Overall Study|Miscellaneous|0|||
129186778|NCT04816721|464977649|FG002|Overall Study|Miscellaneous|0|||
129186779|NCT04816721|464977650|FG003|Overall Study|Miscellaneous|0|||
129186780|NCT04816721|464977651|FG004|Overall Study|Miscellaneous|0|||
129186781|NCT04816721|464977652|FG005|Overall Study|Miscellaneous|1|||
129186782|NCT04816721|464977653|FG006|Overall Study|Miscellaneous|0|||
129186783|NCT04816721|464977654|FG007|Overall Study|Miscellaneous|0|||
129186784|NCT04816721|464977647|FG000|Overall Study|Lost to Follow-up|0|||
129186785|NCT04816721|464977648|FG001|Overall Study|Lost to Follow-up|0|||
129186786|NCT04816721|464977649|FG002|Overall Study|Lost to Follow-up|0|||
129186787|NCT04816721|464977650|FG003|Overall Study|Lost to Follow-up|1|||
129186788|NCT04816721|464977651|FG004|Overall Study|Lost to Follow-up|0|||
129186789|NCT04816721|464977652|FG005|Overall Study|Lost to Follow-up|0|||
129186790|NCT04816721|464977653|FG006|Overall Study|Lost to Follow-up|0|||
129186791|NCT04816721|464977654|FG007|Overall Study|Lost to Follow-up|0|||
129186792|NCT02708485|464977655|FG000|Overall Study|Withdrawal by Subject|3|||
129186793|NCT02708485|464977656|FG001|Overall Study|Withdrawal by Subject|2|||
129186794|NCT03266172|464977657|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
129186795|NCT03266172|464977658|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
129186796|NCT03266172|464977659|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
129186797|NCT03266172|464977657|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
129186798|NCT03266172|464977658|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
129186799|NCT03266172|464977659|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
129186800|NCT03266172|464977657|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
129186801|NCT03266172|464977658|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
129186802|NCT03266172|464977659|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
129186803|NCT03266172|464977657|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
129186804|NCT03266172|464977658|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
129186805|NCT03266172|464977659|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
128780987|NCT01323660|463488628|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
128780988|NCT01323660|463488629|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
128780989|NCT01323660|463488630|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
128780990|NCT01323660|463488631|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
128780991|NCT01323660|463488626|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128780992|NCT01323660|463488627|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128780993|NCT01323660|463488628|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128780994|NCT01323660|463488629|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128780995|NCT01323660|463488630|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
128780996|NCT01323660|463488631|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128780997|NCT00278564|463488632|FG000|Overall Study|Lack of Efficacy|4|||
128780998|NCT00958009|463488641|FG000|Overall Study|Adverse Event|1|||
128780999|NCT00958009|463488641|FG000|Overall Study|Subject found device difficult to use|1|||
129186806|NCT03266172|464977657|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129186807|NCT03266172|464977658|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129186808|NCT03266172|464977659|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
129186809|NCT03266172|464977657|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129186810|NCT03266172|464977658|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129186811|NCT03266172|464977659|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
129186812|NCT01554514|464977662|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
129186813|NCT01554514|464977662|FG000|Overall Study|Physician Decision|1|||
129186814|NCT00290498|464977663|FG000|Overall Study|Death|2|||
129186815|NCT00290498|464977664|FG001|Overall Study|Death|0|||
129186816|NCT00290498|464977663|FG000|Overall Study|Physician Decision|1|||
129186817|NCT00290498|464977664|FG001|Overall Study|Physician Decision|0|||
129186818|NCT00290498|464977663|FG000|Overall Study|Withdrawal by Subject|1|||
129186819|NCT00290498|464977664|FG001|Overall Study|Withdrawal by Subject|0|||
129186820|NCT00290498|464977663|FG000|Overall Study|Ineligible|3|||
129186821|NCT00290498|464977664|FG001|Overall Study|Ineligible|0|||
129186822|NCT00290498|464977663|FG000|Overall Study|Non-Compliance|1|||
129186823|NCT00290498|464977664|FG001|Overall Study|Non-Compliance|0|||
129186824|NCT01716104|464977666|FG000|Overall Study|Do not meet inclusion criteria|6|||
129186825|NCT01716104|464977667|FG001|Overall Study|Do not meet inclusion criteria|7|||
129186826|NCT01753401|464977668|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
129186827|NCT01753401|464977669|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
129186828|NCT01753401|464977670|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
129186829|NCT01753401|464977671|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
129186830|NCT01753401|464977668|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
129186831|NCT01753401|464977669|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
128781000|NCT00558753|463488642|FG000|Overall Study|Lost to Follow-up|5|||
128781001|NCT00558753|463488643|FG001|Overall Study|Lost to Follow-up|7|||
128781002|NCT00578227|463488646|FG000|Overall Study|Lost to Follow-up|0|||
128781003|NCT00578227|463488647|FG001|Overall Study|Lost to Follow-up|1|||
129186832|NCT01753401|464977670|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
129186833|NCT01753401|464977671|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
129186834|NCT01753401|464977668|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
129186835|NCT01753401|464977669|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
129186836|NCT01753401|464977670|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
129186837|NCT01753401|464977671|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
129186838|NCT01753401|464977668|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
129186839|NCT01753401|464977669|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
129186840|NCT01753401|464977670|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
129186841|NCT01753401|464977671|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
129186842|NCT01753401|464977668|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
129186843|NCT01753401|464977669|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
129186844|NCT01753401|464977670|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
129186845|NCT01753401|464977671|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
129186846|NCT01753401|464977668|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
129186847|NCT01753401|464977669|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
129186848|NCT01753401|464977670|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
129186849|NCT01753401|464977671|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
129186850|NCT01753401|464977668|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
129186851|NCT01753401|464977669|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
129186852|NCT01753401|464977670|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
129186853|NCT01753401|464977671|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
129186854|NCT05026853|464977672|FG000|Overall Study|Cancelled appointment|1|||
129186855|NCT05026853|464977673|FG001|Overall Study|Cancelled appointment|0|||
129186856|NCT05026853|464977672|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
129186857|NCT05026853|464977673|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
129186858|NCT05026853|464977672|FG000|Overall Study|Did not complete 12-week survey|16|||
129186859|NCT05026853|464977673|FG001|Overall Study|Did not complete 12-week survey|16|||
129186860|NCT03615066|464977674|FG000|Main Study|Withdrew Consent|0|||
129186861|NCT03615066|464977675|FG001|Main Study|Withdrew Consent|1|||
129186862|NCT03615066|464977676|FG002|Main Study|Withdrew Consent|1|||
129186863|NCT03615066|464977674|FG000|Main Study|Lost to Follow-up|0|||
129186864|NCT03615066|464977675|FG001|Main Study|Lost to Follow-up|0|||
129186865|NCT03615066|464977676|FG002|Main Study|Lost to Follow-up|1|||
129186866|NCT03615066|464977674|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
129186867|NCT03615066|464977675|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
129186868|NCT03615066|464977676|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
129186869|NCT03615066|464977674|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
129186870|NCT03615066|464977675|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
129186871|NCT03615066|464977676|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
129186872|NCT03615066|464977674|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
129186873|NCT03615066|464977675|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
129186874|NCT03615066|464977676|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
129186875|NCT00129961|464977677|FG000|Overall Study|Adverse Event|1|||
129186876|NCT00129961|464977678|FG001|Overall Study|Adverse Event|0|||
129186877|NCT00129961|464977677|FG000|Overall Study|Death|1|||
129186878|NCT00129961|464977678|FG001|Overall Study|Death|1|||
129186879|NCT00129961|464977677|FG000|Overall Study|Withdrawal by Sponsor|14|||
129186880|NCT00129961|464977678|FG001|Overall Study|Withdrawal by Sponsor|20|||
129186881|NCT00129961|464977677|FG000|Overall Study|Physician Decision|1|||
129186882|NCT00129961|464977678|FG001|Overall Study|Physician Decision|0|||
129186883|NCT00129961|464977677|FG000|Overall Study|Withdrawal by Subject|2|||
129186884|NCT00129961|464977678|FG001|Overall Study|Withdrawal by Subject|1|||
129186885|NCT00129961|464977677|FG000|Overall Study|Missing Record|0|||
129186886|NCT00129961|464977678|FG001|Overall Study|Missing Record|1|||
129186887|NCT00694304|464977682|FG000|Overall Study|Adverse Event|42|||
129186888|NCT00694304|464977682|FG000|Overall Study|Lack of Efficacy|35|||
129186889|NCT00694304|464977682|FG000|Overall Study|Non-compliance With Study Product|16|||
129186890|NCT00694304|464977682|FG000|Overall Study|Protocol Violation|6|||
129186891|NCT00694304|464977682|FG000|Overall Study|Withdrawal of Consent|61|||
129186892|NCT00694304|464977682|FG000|Overall Study|Lost to Follow-up|15|||
129186893|NCT00694304|464977682|FG000|Overall Study|Administrative or Other Reasons|32|||
129186894|NCT01270256|464977683|FG000|Overall Study|Withdrawal by Subject|1|||
129186895|NCT01270256|464977684|FG001|Overall Study|Withdrawal by Subject|0|||
129186896|NCT04407234|464977693|FG000|Overall Study|Adverse Event|3|||
128730317|NCT01359592|463309936|FG002|PET-Directed Therapy|Ineligible|24|||
128730318|NCT01359592|463309937|FG003|PET-Directed Therapy|Ineligible|0|||
129186897|NCT04407234|464977694|FG001|Overall Study|Adverse Event|3|||
129186898|NCT00727558|464977695|FG000|Overall Study|Lens issue|0|||
129186899|NCT00727558|464977696|FG001|Overall Study|Lens issue|1|||
129186900|NCT00727558|464977695|FG000|Overall Study|Adverse Event|0|||
129186901|NCT00727558|464977696|FG001|Overall Study|Adverse Event|1|||
129186902|NCT00727558|464977695|FG000|Overall Study|Subject unable to return for follow-up|1|||
129186903|NCT00727558|464977696|FG001|Overall Study|Subject unable to return for follow-up|1|||
129186904|NCT00727558|464977695|FG000|Overall Study|Lost to Follow-up|1|||
129186905|NCT00727558|464977696|FG001|Overall Study|Lost to Follow-up|0|||
129186906|NCT00765063|464979353|FG000|Overall Study|Lack of Efficacy|5|||
129186907|NCT00765063|464979353|FG000|Overall Study|Withdrawal by Subject|1|||
129186908|NCT00765063|464979353|FG000|Overall Study|Other|16|||
129186909|NCT00765063|464979353|FG000|Overall Study|Protocol Violation|6|||
129186910|NCT00765063|464979353|FG000|Overall Study|Adverse Event|4|||
129186911|NCT03614325|464979356|FG000|Overall Study|Withdrawal by Subject|0|||
129186912|NCT03614325|464979357|FG001|Overall Study|Withdrawal by Subject|2|||
129186913|NCT03614325|464979356|FG000|Overall Study|Surgery Cancelled|2|||
129186914|NCT03614325|464979357|FG001|Overall Study|Surgery Cancelled|1|||
129186915|NCT03614325|464979356|FG000|Overall Study|Lost to Follow-up|2|||
129186916|NCT03614325|464979357|FG001|Overall Study|Lost to Follow-up|1|||
129186917|NCT03614325|464979356|FG000|Overall Study|Surgery never scheduled|1|||
129186918|NCT03614325|464979357|FG001|Overall Study|Surgery never scheduled|0|||
129186919|NCT02814175|464979358|FG000|Part 1|Adverse Event|2|||
129186920|NCT02814175|464979359|FG001|Part 1|Adverse Event|3|||
129186921|NCT02814175|464979360|FG002|Part 1|Adverse Event|0|||
129186922|NCT02814175|464979361|FG003|Part 1|Adverse Event|0|||
129186923|NCT02814175|464979362|FG004|Part 1|Adverse Event|0|||
129186924|NCT02814175|464979363|FG005|Part 1|Adverse Event|0|||
129186925|NCT02814175|464979358|FG000|Part 1|Withdrawal Consent|8|||
129186926|NCT02814175|464979359|FG001|Part 1|Withdrawal Consent|1|||
129186927|NCT02814175|464979360|FG002|Part 1|Withdrawal Consent|0|||
129186928|NCT02814175|464979361|FG003|Part 1|Withdrawal Consent|0|||
129186929|NCT02814175|464979362|FG004|Part 1|Withdrawal Consent|0|||
129186930|NCT02814175|464979363|FG005|Part 1|Withdrawal Consent|0|||
129186931|NCT02814175|464979358|FG000|Part 1|Lost to Follow-up|1|||
129186932|NCT02814175|464979359|FG001|Part 1|Lost to Follow-up|0|||
129186933|NCT02814175|464979360|FG002|Part 1|Lost to Follow-up|0|||
129186934|NCT02814175|464979361|FG003|Part 1|Lost to Follow-up|0|||
129186935|NCT02814175|464979362|FG004|Part 1|Lost to Follow-up|0|||
129186936|NCT02814175|464979363|FG005|Part 1|Lost to Follow-up|0|||
129186937|NCT02814175|464979358|FG000|Part 1|Lack of Efficacy|1|||
129186938|NCT02814175|464979359|FG001|Part 1|Lack of Efficacy|2|||
129186939|NCT02814175|464979360|FG002|Part 1|Lack of Efficacy|0|||
129186940|NCT02814175|464979361|FG003|Part 1|Lack of Efficacy|0|||
129186941|NCT02814175|464979362|FG004|Part 1|Lack of Efficacy|0|||
129186942|NCT02814175|464979363|FG005|Part 1|Lack of Efficacy|0|||
129186943|NCT02814175|464979358|FG000|Part 2|Adverse Event|0|||
129186944|NCT02814175|464979359|FG001|Part 2|Adverse Event|0|||
129186945|NCT02814175|464979360|FG002|Part 2|Adverse Event|0|||
129186946|NCT02814175|464979361|FG003|Part 2|Adverse Event|1|||
129186947|NCT02814175|464979362|FG004|Part 2|Adverse Event|1|||
129186948|NCT02814175|464979363|FG005|Part 2|Adverse Event|2|||
129186949|NCT02814175|464979358|FG000|Part 2|Withdrawal Consent|0|||
129186950|NCT02814175|464979359|FG001|Part 2|Withdrawal Consent|0|||
129186951|NCT02814175|464979360|FG002|Part 2|Withdrawal Consent|0|||
129186952|NCT02814175|464979361|FG003|Part 2|Withdrawal Consent|2|||
129186953|NCT02814175|464979362|FG004|Part 2|Withdrawal Consent|1|||
129186954|NCT02814175|464979363|FG005|Part 2|Withdrawal Consent|1|||
129186955|NCT02814175|464979358|FG000|Part 2|Lost to Follow-up|0|||
129186956|NCT02814175|464979359|FG001|Part 2|Lost to Follow-up|0|||
129186957|NCT02814175|464979360|FG002|Part 2|Lost to Follow-up|0|||
129186958|NCT02814175|464979361|FG003|Part 2|Lost to Follow-up|1|||
129186959|NCT02814175|464979362|FG004|Part 2|Lost to Follow-up|0|||
129186960|NCT02814175|464979363|FG005|Part 2|Lost to Follow-up|0|||
129186961|NCT02814175|464979358|FG000|Part 2|Lack of Efficacy|0|||
129186962|NCT02814175|464979359|FG001|Part 2|Lack of Efficacy|0|||
129186963|NCT02814175|464979360|FG002|Part 2|Lack of Efficacy|0|||
129186964|NCT02814175|464979361|FG003|Part 2|Lack of Efficacy|0|||
129186965|NCT02814175|464979362|FG004|Part 2|Lack of Efficacy|0|||
129186966|NCT02814175|464979363|FG005|Part 2|Lack of Efficacy|3|||
129186967|NCT01673620|464979369|FG000|Overall Study|Adverse Event|1|||
129186968|NCT01673620|464979370|FG001|Overall Study|Adverse Event|0|||
129186969|NCT01597635|464979371|FG000|Part A|Adverse Event|3|||
129186970|NCT01597635|464979372|FG001|Part A|Adverse Event|0|||
129186971|NCT01597635|464979373|FG002|Part A|Adverse Event|0|||
129186972|NCT01597635|464979371|FG000|Part B|Adverse Event|0|||
128730319|NCT00192075|463309944|FG000|Overall Study|Disease Progression|23|||
129186973|NCT01597635|464979372|FG001|Part B|Adverse Event|0|||
129186974|NCT01597635|464979373|FG002|Part B|Adverse Event|1|||
129186975|NCT01597635|464979371|FG000|Part B|Protocol Violation|0|||
129186976|NCT01597635|464979372|FG001|Part B|Protocol Violation|1|||
129186977|NCT01597635|464979373|FG002|Part B|Protocol Violation|0|||
129186978|NCT01597635|464979371|FG000|Part B|Protocol-defined stopping criteria|0|||
129186979|NCT01597635|464979372|FG001|Part B|Protocol-defined stopping criteria|4|||
129186980|NCT01597635|464979373|FG002|Part B|Protocol-defined stopping criteria|3|||
129186981|NCT01597635|464979371|FG000|Part B|Withdrawal by Subject|0|||
129186982|NCT01597635|464979372|FG001|Part B|Withdrawal by Subject|1|||
129186983|NCT01597635|464979373|FG002|Part B|Withdrawal by Subject|0|||
129186984|NCT01754493|464979374|FG000|Overall Study|Adverse Event|1|||
129186985|NCT01754493|464979374|FG000|Overall Study|Lost to Follow-up|3|||
129186986|NCT01754493|464979374|FG000|Overall Study|Withdrawal by Subject|1|||
129186987|NCT01754493|464979374|FG000|Overall Study|Moved out of town|1|||
129186988|NCT01754493|464979374|FG000|Overall Study|Scheduling conflict|1|||
129186989|NCT01543776|464979375|FG000|Overall Study|Withdrawal by Subject|2|||
129186990|NCT01543776|464979376|FG001|Overall Study|Withdrawal by Subject|2|||
129186991|NCT00568126|464979377|FG000|Overall Study|Adverse Event|3|||
129186992|NCT00568126|464979378|FG001|Overall Study|Adverse Event|0|||
129186993|NCT00568126|464979377|FG000|Overall Study|Withdrawal by Subject|2|||
129186994|NCT00568126|464979378|FG001|Overall Study|Withdrawal by Subject|3|||
129186995|NCT00568126|464979377|FG000|Overall Study|Lost to Follow-up|4|||
129186996|NCT00568126|464979378|FG001|Overall Study|Lost to Follow-up|3|||
129186997|NCT00568126|464979377|FG000|Overall Study|Lack of Efficacy|0|||
129186998|NCT00568126|464979378|FG001|Overall Study|Lack of Efficacy|1|||
129186999|NCT00568126|464979377|FG000|Overall Study|Physician Decision|2|||
129187000|NCT00568126|464979378|FG001|Overall Study|Physician Decision|2|||
129187001|NCT02421588|464979379|FG000|Overall Study|Non-treatment-related AE|8|||
129187002|NCT02421588|464979380|FG001|Overall Study|Non-treatment-related AE|8|||
129187003|NCT02421588|464979379|FG000|Overall Study|Progressive disease|152|||
129187004|NCT02421588|464979380|FG001|Overall Study|Progressive disease|135|||
129187005|NCT02421588|464979379|FG000|Overall Study|Death|11|||
129187006|NCT02421588|464979380|FG001|Overall Study|Death|3|||
129187007|NCT02421588|464979379|FG000|Overall Study|Physician Decision|8|||
129187008|NCT02421588|464979380|FG001|Overall Study|Physician Decision|17|||
129187009|NCT02421588|464979379|FG000|Overall Study|Other reason not specified|3|||
129187010|NCT02421588|464979380|FG001|Overall Study|Other reason not specified|1|||
129187011|NCT02421588|464979379|FG000|Overall Study|Symptomatic deterioration|13|||
129187012|NCT02421588|464979380|FG001|Overall Study|Symptomatic deterioration|19|||
129187013|NCT02421588|464979379|FG000|Overall Study|Treatment-related AE|10|||
129187014|NCT02421588|464979380|FG001|Overall Study|Treatment-related AE|14|||
129187015|NCT02421588|464979379|FG000|Overall Study|Withdrawal by Subject|14|||
129187016|NCT02421588|464979380|FG001|Overall Study|Withdrawal by Subject|16|||
129187017|NCT02421588|464979379|FG000|Overall Study|Not treated|2|||
129187018|NCT02421588|464979380|FG001|Overall Study|Not treated|8|||
129187019|NCT02649894|464979386|FG000|Overall Study|Adverse Event|1|||
129187020|NCT02649894|464979387|FG001|Overall Study|Adverse Event|0|||
129187021|NCT02649894|464979386|FG000|Overall Study|Physician Decision|0|||
129187022|NCT02649894|464979387|FG001|Overall Study|Physician Decision|1|||
129187023|NCT02649894|464979386|FG000|Overall Study|Withdrawal by Subject|5|||
129187024|NCT02649894|464979387|FG001|Overall Study|Withdrawal by Subject|2|||
129187025|NCT02649894|464979386|FG000|Overall Study|Lost to Follow-up|2|||
129187026|NCT02649894|464979387|FG001|Overall Study|Lost to Follow-up|1|||
129187027|NCT02649894|464979386|FG000|Overall Study|Death|30|||
129187028|NCT02649894|464979387|FG001|Overall Study|Death|7|||
129187029|NCT02649894|464979386|FG000|Overall Study|Other, not specified|6|||
129187030|NCT02649894|464979387|FG001|Overall Study|Other, not specified|0|||
129187031|NCT00719680|464979388|FG000|Overall Study|Adverse Event|1|||
129187032|NCT00719680|464979388|FG000|Overall Study|Lost to Follow-up|1|||
129187033|NCT00719680|464979388|FG000|Overall Study|Withdrawal by Subject|3|||
129187034|NCT01110382|464979390|FG000|Overall Study|Withdrawal by Subject|0|||
129187035|NCT01110382|464979391|FG001|Overall Study|Withdrawal by Subject|1|||
129187036|NCT01110382|464979390|FG000|Overall Study|Protocol Violation|0|||
129187037|NCT01110382|464979391|FG001|Overall Study|Protocol Violation|1|||
129187038|NCT05222555|464979392|FG000|Overall Study|Ongoing|2|||
129187039|NCT05222555|464979393|FG001|Overall Study|Ongoing|18|||
129187040|NCT05222555|464979392|FG000|Overall Study|Adverse Event|1|||
129187041|NCT05222555|464979393|FG001|Overall Study|Adverse Event|1|||
129187042|NCT05222555|464979392|FG000|Overall Study|Death|0|||
129187043|NCT05222555|464979393|FG001|Overall Study|Death|6|||
129187044|NCT05222555|464979392|FG000|Overall Study|Withdrawal by Subject|0|||
129187045|NCT05222555|464979393|FG001|Overall Study|Withdrawal by Subject|11|||
129187046|NCT00300365|464979394|FG000|Overall Study|Lost to Follow-up|1|||
129187047|NCT00300365|464979395|FG001|Overall Study|Lost to Follow-up|0|||
129187048|NCT00300365|464979394|FG000|Overall Study|Physician Decision|2|||
129187049|NCT00300365|464979395|FG001|Overall Study|Physician Decision|0|||
129187050|NCT00300365|464979394|FG000|Overall Study|Withdrawal by Subject|1|||
129187051|NCT00300365|464979395|FG001|Overall Study|Withdrawal by Subject|0|||
129187052|NCT00300365|464979394|FG000|Overall Study|Adverse Event|0|||
129187053|NCT00300365|464979395|FG001|Overall Study|Adverse Event|2|||
129187054|NCT01422824|464979396|FG000|Overall Study|Case record form not evaluated|1|||
129187055|NCT01422824|464979396|FG000|Overall Study|Lost to Follow-up|37|||
129187056|NCT00902174|464979397|FG000|Overall Study|Adverse Event|27|||
129187057|NCT00902174|464979398|FG001|Overall Study|Adverse Event|7|||
129187058|NCT00902174|464979397|FG000|Overall Study|Lack of Efficacy|1|||
129187059|NCT00902174|464979398|FG001|Overall Study|Lack of Efficacy|5|||
129187060|NCT00902174|464979397|FG000|Overall Study|Death|2|||
129187061|NCT00902174|464979398|FG001|Overall Study|Death|2|||
129187062|NCT00902174|464979397|FG000|Overall Study|Withdrawal by Subject|2|||
129187063|NCT00902174|464979398|FG001|Overall Study|Withdrawal by Subject|1|||
129187064|NCT00902174|464979397|FG000|Overall Study|Abnormal labs|1|||
129187065|NCT00902174|464979398|FG001|Overall Study|Abnormal labs|1|||
129187066|NCT00902174|464979397|FG000|Overall Study|Protocol Violation|1|||
129187067|NCT00902174|464979398|FG001|Overall Study|Protocol Violation|1|||
129187068|NCT00902174|464979397|FG000|Overall Study|Administration problem|0|||
129187069|NCT00902174|464979398|FG001|Overall Study|Administration problem|1|||
129187070|NCT01581619|464979399|FG000|Overall Study|Withdrawal by Subject|1|||
129187071|NCT01581619|464979399|FG000|Overall Study|Lost to Follow-up|1|||
129187072|NCT03129360|464979402|FG000|Overall Study|Did not meet entry criteria|0|||
129187073|NCT03129360|464979403|FG001|Overall Study|Did not meet entry criteria|2|||
129187074|NCT03129360|464979404|FG002|Overall Study|Did not meet entry criteria|1|||
129187075|NCT03129360|464979402|FG000|Overall Study|Excluded due to motion in scanner|1|||
128730320|NCT00192075|463309945|FG001|Overall Study|Disease Progression|6|||
128730321|NCT00192075|463309944|FG000|Overall Study|Adverse Event|1|||
129187076|NCT03129360|464979403|FG001|Overall Study|Excluded due to motion in scanner|0|||
129187077|NCT03129360|464979404|FG002|Overall Study|Excluded due to motion in scanner|0|||
129187078|NCT03006887|464979405|FG000|Overall Study|Adverse Event|1|||
129187079|NCT03836677|464979406|FG000|Period 1|Adverse Event|0|||
129187080|NCT03836677|464979407|FG001|Period 1|Adverse Event|1|||
129187081|NCT03836677|464979406|FG000|Period 2|Severe non-compliance to protocol|1|||
129187082|NCT03836677|464979407|FG001|Period 2|Severe non-compliance to protocol|0|||
129187083|NCT01353911|464979408|FG000|Overall Study|Lost to Follow-up|2|||
129187084|NCT01353911|464979409|FG001|Overall Study|Lost to Follow-up|6|||
129187085|NCT01353911|464979410|FG002|Overall Study|Lost to Follow-up|4|||
129187086|NCT01353911|464979411|FG003|Overall Study|Lost to Follow-up|0|||
129187087|NCT01353911|464979412|FG004|Overall Study|Lost to Follow-up|4|||
129187088|NCT01353911|464979413|FG005|Overall Study|Lost to Follow-up|4|||
129187089|NCT01353911|464979414|FG006|Overall Study|Lost to Follow-up|3|||
129187090|NCT01353911|464979415|FG007|Overall Study|Lost to Follow-up|6|||
129187091|NCT01353911|464979408|FG000|Overall Study|Withdrawal by Subject|2|||
129187092|NCT01353911|464979409|FG001|Overall Study|Withdrawal by Subject|3|||
129187093|NCT01353911|464979410|FG002|Overall Study|Withdrawal by Subject|4|||
129187094|NCT01353911|464979411|FG003|Overall Study|Withdrawal by Subject|2|||
129187095|NCT01353911|464979412|FG004|Overall Study|Withdrawal by Subject|2|||
129187096|NCT01353911|464979413|FG005|Overall Study|Withdrawal by Subject|3|||
129187097|NCT01353911|464979414|FG006|Overall Study|Withdrawal by Subject|3|||
129187098|NCT01353911|464979415|FG007|Overall Study|Withdrawal by Subject|9|||
129187099|NCT01353911|464979408|FG000|Overall Study|Status Not Recorded|4|||
129187100|NCT01353911|464979409|FG001|Overall Study|Status Not Recorded|0|||
129187101|NCT01353911|464979410|FG002|Overall Study|Status Not Recorded|1|||
129187102|NCT01353911|464979411|FG003|Overall Study|Status Not Recorded|0|||
129187103|NCT01353911|464979412|FG004|Overall Study|Status Not Recorded|0|||
129187104|NCT01353911|464979413|FG005|Overall Study|Status Not Recorded|0|||
129187105|NCT01353911|464979414|FG006|Overall Study|Status Not Recorded|0|||
129187106|NCT01353911|464979415|FG007|Overall Study|Status Not Recorded|0|||
129187107|NCT00462748|464979420|FG000|Overall Study|Adverse Event|7|||
129187108|NCT00462748|464979421|FG001|Overall Study|Adverse Event|5|||
129187109|NCT00462748|464979422|FG002|Overall Study|Adverse Event|9|||
129187110|NCT00462748|464979420|FG000|Overall Study|Protocol Violation|0|||
129187111|NCT00462748|464979421|FG001|Overall Study|Protocol Violation|2|||
129187112|NCT00462748|464979422|FG002|Overall Study|Protocol Violation|1|||
129187113|NCT00462748|464979420|FG000|Overall Study|Withdrew consent|3|||
129187114|NCT00462748|464979421|FG001|Overall Study|Withdrew consent|3|||
129187115|NCT00462748|464979422|FG002|Overall Study|Withdrew consent|0|||
129187116|NCT00462748|464979420|FG000|Overall Study|Lost to Follow-up|1|||
129187117|NCT00462748|464979421|FG001|Overall Study|Lost to Follow-up|1|||
129187118|NCT00462748|464979422|FG002|Overall Study|Lost to Follow-up|1|||
129187119|NCT00462748|464979420|FG000|Overall Study|Discontinued after 41 days Rx|1|||
129187120|NCT00462748|464979421|FG001|Overall Study|Discontinued after 41 days Rx|0|||
129187121|NCT00462748|464979422|FG002|Overall Study|Discontinued after 41 days Rx|0|||
129187122|NCT03233438|464979423|FG000|Overall Study|Lost to Follow-up|4|||
129187123|NCT03233438|464979424|FG001|Overall Study|Lost to Follow-up|9|||
129187124|NCT03233438|464979423|FG000|Overall Study|Withdrawal by Subject|2|||
129187125|NCT03233438|464979424|FG001|Overall Study|Withdrawal by Subject|1|||
129187126|NCT03233438|464979423|FG000|Overall Study|No recording of dalbavancin|0|||
129187127|NCT03233438|464979424|FG001|Overall Study|No recording of dalbavancin|1|||
129187128|NCT03429543|464979425|FG000|Overall Study|Adverse Event|1|||
129187129|NCT03429543|464979426|FG001|Overall Study|Adverse Event|1|||
129187130|NCT03429543|464979427|FG002|Overall Study|Adverse Event|0|||
129187131|NCT03429543|464979428|FG003|Overall Study|Adverse Event|0|||
129187132|NCT03429543|464979429|FG004|Overall Study|Adverse Event|0|||
129187133|NCT03429543|464979430|FG005|Overall Study|Adverse Event|2|||
129187134|NCT03429543|464979431|FG006|Overall Study|Adverse Event|0|||
129187135|NCT03429543|464979425|FG000|Overall Study|Lost to Follow-up|1|||
129187136|NCT03429543|464979426|FG001|Overall Study|Lost to Follow-up|0|||
129187137|NCT03429543|464979427|FG002|Overall Study|Lost to Follow-up|0|||
129187138|NCT03429543|464979428|FG003|Overall Study|Lost to Follow-up|0|||
129187139|NCT03429543|464979429|FG004|Overall Study|Lost to Follow-up|1|||
129187140|NCT03429543|464979430|FG005|Overall Study|Lost to Follow-up|0|||
128730322|NCT00192075|463309945|FG001|Overall Study|Adverse Event|3|||
129187141|NCT03429543|464979431|FG006|Overall Study|Lost to Follow-up|0|||
129187142|NCT03429543|464979425|FG000|Overall Study|Withdrawal by Subject|5|||
128730323|NCT00192075|463309944|FG000|Overall Study|Death|0|||
129187143|NCT03429543|464979426|FG001|Overall Study|Withdrawal by Subject|0|||
128730324|NCT00192075|463309945|FG001|Overall Study|Death|1|||
129187144|NCT03429543|464979427|FG002|Overall Study|Withdrawal by Subject|1|||
129187145|NCT03429543|464979428|FG003|Overall Study|Withdrawal by Subject|2|||
129187146|NCT03429543|464979429|FG004|Overall Study|Withdrawal by Subject|6|||
129187147|NCT03429543|464979430|FG005|Overall Study|Withdrawal by Subject|3|||
129187148|NCT03429543|464979431|FG006|Overall Study|Withdrawal by Subject|1|||
129187149|NCT03429543|464979425|FG000|Overall Study|Other reason than listed|0|||
129187150|NCT03429543|464979426|FG001|Overall Study|Other reason than listed|1|||
129187151|NCT03429543|464979427|FG002|Overall Study|Other reason than listed|0|||
129187152|NCT03429543|464979428|FG003|Overall Study|Other reason than listed|0|||
129187153|NCT03429543|464979429|FG004|Overall Study|Other reason than listed|4|||
129187154|NCT03429543|464979430|FG005|Overall Study|Other reason than listed|4|||
129187155|NCT03429543|464979431|FG006|Overall Study|Other reason than listed|0|||
129187156|NCT03429543|464979425|FG000|Overall Study|Not treated|0|||
129187157|NCT03429543|464979426|FG001|Overall Study|Not treated|0|||
129187158|NCT03429543|464979427|FG002|Overall Study|Not treated|0|||
129187159|NCT03429543|464979428|FG003|Overall Study|Not treated|0|||
129187160|NCT03429543|464979429|FG004|Overall Study|Not treated|1|||
129187161|NCT03429543|464979430|FG005|Overall Study|Not treated|0|||
129187162|NCT03429543|464979431|FG006|Overall Study|Not treated|0|||
129187163|NCT01818492|464979432|FG000|Overall Study|Adverse Event|2|||
129187164|NCT01818492|464979432|FG000|Overall Study|Death|3|||
129187165|NCT01818492|464979432|FG000|Overall Study|Withdrawal by Subject|1|||
129187166|NCT01818492|464979432|FG000|Overall Study|Additional therapy when not allowed PP|4|||
129187167|NCT01729208|464979433|FG000|Baseline|Physician Decision|5|||
129187168|NCT01729208|464979434|FG001|Baseline|Physician Decision|4|||
129187169|NCT01729208|464979433|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
129187170|NCT01729208|464979434|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
129187171|NCT01729208|464979433|FG000|12 Months Follow-up|Lost to Follow-up|3|||
129187172|NCT01729208|464979434|FG001|12 Months Follow-up|Lost to Follow-up|3|||
129187173|NCT01729208|464979433|FG000|24 Months Follow-up|Lost to Follow-up|3|||
129187174|NCT01729208|464979434|FG001|24 Months Follow-up|Lost to Follow-up|0|||
129187175|NCT01729208|464979433|FG000|36 Months Follow-up|Physician Decision|1|||
129187176|NCT01729208|464979434|FG001|36 Months Follow-up|Physician Decision|0|||
129187177|NCT01729208|464979433|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
129187178|NCT01729208|464979434|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
129187179|NCT02428413|464979436|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
129187180|NCT02428413|464979437|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
129187181|NCT02428413|464979436|FG000|Overall Study|Protocol Violation|1|||
129187182|NCT02428413|464979437|FG001|Overall Study|Protocol Violation|2|||
129187183|NCT02428413|464979436|FG000|Overall Study|Case Cancelled|2|||
129187184|NCT02428413|464979437|FG001|Overall Study|Case Cancelled|0|||
129187185|NCT02428413|464979436|FG000|Overall Study|Missed Cases|1|||
129187186|NCT02428413|464979437|FG001|Overall Study|Missed Cases|2|||
129187187|NCT02428413|464979436|FG000|Overall Study|Nurse Refusal|1|||
129187188|NCT02428413|464979437|FG001|Overall Study|Nurse Refusal|0|||
129187189|NCT02345330|464979440|FG000|Overall Study|Death|1|||
129187190|NCT02345330|464979440|FG000|Overall Study|Progressive Disease|2|||
129187191|NCT03688100|464979441|FG000|Overall Study|Lost to Follow-up|21|||
129187192|NCT03688100|464979442|FG001|Overall Study|Lost to Follow-up|15|||
129187193|NCT03688100|464979443|FG002|Overall Study|Lost to Follow-up|15|||
129187194|NCT03688100|464979444|FG003|Overall Study|Lost to Follow-up|18|||
129187195|NCT03688100|464979441|FG000|Overall Study|Withdrawal by Subject|19|||
129187196|NCT03688100|464979442|FG001|Overall Study|Withdrawal by Subject|16|||
129187197|NCT03688100|464979443|FG002|Overall Study|Withdrawal by Subject|0|||
129187198|NCT03688100|464979444|FG003|Overall Study|Withdrawal by Subject|0|||
129187199|NCT03688100|464979441|FG000|Overall Study|Death|36|||
129187200|NCT03688100|464979442|FG001|Overall Study|Death|27|||
129187201|NCT03688100|464979443|FG002|Overall Study|Death|0|||
129187202|NCT03688100|464979444|FG003|Overall Study|Death|0|||
129187203|NCT00494507|464979447|FG000|Double-Blind Phase|Adverse Event|2|||
129187204|NCT00494507|464979448|FG001|Double-Blind Phase|Adverse Event|0|||
129187205|NCT00494507|464979449|FG002|Double-Blind Phase|Adverse Event|1|||
129187206|NCT00494507|464979450|FG003|Double-Blind Phase|Adverse Event|0|||
129187207|NCT00494507|464979447|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
129187208|NCT00494507|464979448|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
129187209|NCT00494507|464979449|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129187210|NCT00494507|464979450|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
128982139|NCT00508820|464219106|FG000|Overall Study|Withdrawal by Subject|10|||
128982140|NCT00508820|464219107|FG001|Overall Study|Withdrawal by Subject|12|||
128982141|NCT00508820|464219106|FG000|Overall Study|Other|11|||
129187211|NCT00494507|464979447|FG000|Double-Blind Phase|Subject Non-compliance|0|||
129187212|NCT00494507|464979448|FG001|Double-Blind Phase|Subject Non-compliance|0|||
129187213|NCT00494507|464979449|FG002|Double-Blind Phase|Subject Non-compliance|1|||
129187214|NCT00494507|464979450|FG003|Double-Blind Phase|Subject Non-compliance|0|||
129187215|NCT00494507|464979447|FG000|Double-Blind Phase|Negative DNA test|0|||
129187216|NCT00494507|464979448|FG001|Double-Blind Phase|Negative DNA test|0|||
129187217|NCT00494507|464979449|FG002|Double-Blind Phase|Negative DNA test|0|||
129187218|NCT00494507|464979450|FG003|Double-Blind Phase|Negative DNA test|1|||
129187219|NCT00494507|464979447|FG000|Open-Label Phase|Adverse Event|0|||
129187220|NCT00494507|464979448|FG001|Open-Label Phase|Adverse Event|1|||
129187221|NCT00494507|464979449|FG002|Open-Label Phase|Adverse Event|5|||
129187222|NCT00494507|464979450|FG003|Open-Label Phase|Adverse Event|3|||
129187223|NCT00494507|464979447|FG000|Open-Label Phase|Worsening Disease|0|||
129187224|NCT00494507|464979448|FG001|Open-Label Phase|Worsening Disease|0|||
129187225|NCT00494507|464979449|FG002|Open-Label Phase|Worsening Disease|0|||
129187226|NCT00494507|464979450|FG003|Open-Label Phase|Worsening Disease|2|||
129187227|NCT02437084|464979452|FG000|Overall Study|Withdrawal by Subject|2|||
129187228|NCT02437084|464979452|FG000|Overall Study|Physician Decision|1|||
129187229|NCT00587847|464979453|FG000|Overall Study|Lack of Efficacy|5|||
129187230|NCT00587847|464979453|FG000|Overall Study|Adverse Event|2|||
129187231|NCT03729245|464979454|FG000|Overall Study|Lost to Follow-up|5|||
129187232|NCT03729245|464979455|FG001|Overall Study|Lost to Follow-up|6|||
129187233|NCT03729245|464979454|FG000|Overall Study|Withdrawal by Subject|16|||
129187234|NCT03729245|464979455|FG001|Overall Study|Withdrawal by Subject|19|||
129187235|NCT03729245|464979454|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
129187236|NCT03729245|464979455|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
129187237|NCT00989781|464979462|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
129187238|NCT00989781|464979463|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
129187239|NCT01805037|464979466|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
129187240|NCT01805037|464979467|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
129187241|NCT01805037|464979466|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
129187242|NCT01805037|464979467|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
129187243|NCT01805037|464979466|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
129187244|NCT01805037|464979467|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
129187245|NCT01805037|464979466|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
129187246|NCT01805037|464979467|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
129187247|NCT01805037|464979466|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
129187248|NCT01805037|464979467|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
129187249|NCT01805037|464979466|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
129187250|NCT01805037|464979467|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
129187251|NCT01805037|464979466|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
129187252|NCT01805037|464979467|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
129187253|NCT01805037|464979466|FG000|Follow Up (up to 3 Years)|Death|0|||
129187254|NCT01805037|464979467|FG001|Follow Up (up to 3 Years)|Death|2|||
129187255|NCT01805037|464979466|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
129187256|NCT01805037|464979467|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
129187257|NCT01805037|464979466|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
129187258|NCT01805037|464979467|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
129187259|NCT02177838|464979471|FG000|Overall Study|Withdrawal by Subject|1|||
129187260|NCT02177838|464979471|FG000|Overall Study|Physician Decision|1|||
129187261|NCT02177838|464979471|FG000|Overall Study|Death|1|||
129187262|NCT04566692|464979473|FG000|Overall Study|Adverse Event|2|||
129187263|NCT04566692|464979474|FG001|Overall Study|Adverse Event|0|||
129187264|NCT04566692|464979473|FG000|Overall Study|Withdrawal by Subject|1|||
129187265|NCT04566692|464979474|FG001|Overall Study|Withdrawal by Subject|1|||
129187266|NCT04311463|464979477|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
129187267|NCT04311463|464979478|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
129187268|NCT04311463|464979477|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
129187269|NCT04311463|464979478|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
129187270|NCT04311463|464979477|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
129187271|NCT04311463|464979478|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
129187272|NCT00737633|464979480|FG000|Overall Study|Study terminated by sponsor|44|||
129187273|NCT00737633|464979481|FG001|Overall Study|Study terminated by sponsor|55|||
129187274|NCT00737633|464979480|FG000|Overall Study|Lost to Follow-up|0|||
129187275|NCT00737633|464979481|FG001|Overall Study|Lost to Follow-up|1|||
129187276|NCT00737633|464979480|FG000|Overall Study|protocol non-compliance|0|||
129187277|NCT00737633|464979481|FG001|Overall Study|protocol non-compliance|1|||
129187278|NCT01300260|464979486|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
129187279|NCT01300260|464979487|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
129187280|NCT01300260|464979486|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
129187281|NCT01300260|464979487|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
128730325|NCT00192075|463309944|FG000|Overall Study|Lack of Efficacy|0|||
128730326|NCT00192075|463309945|FG001|Overall Study|Lack of Efficacy|0|||
129187282|NCT01300260|464979486|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
129187283|NCT01300260|464979487|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
129187284|NCT02540265|464979494|FG000|Overall Study|Lost to Follow-up|0|||
129187285|NCT02540265|464979495|FG001|Overall Study|Lost to Follow-up|0|||
129187286|NCT02540265|464979496|FG002|Overall Study|Lost to Follow-up|1|||
129187287|NCT03157037|464979499|FG000|Overall Study|Death|1|||
129187288|NCT02102399|464979503|FG000|Overall Study|Withdrawal by Subject|6|||
129187289|NCT02102399|464979504|FG001|Overall Study|Withdrawal by Subject|4|||
129187290|NCT03101085|464979505|FG000|Overall Study|Lost to Follow-up|0|||
129187291|NCT03101085|464979506|FG001|Overall Study|Lost to Follow-up|1|||
129187292|NCT00695864|464979507|FG000|Placebo|Withdrawal by Subject|1|||
129187293|NCT00695864|464979507|FG000|Placebo|Physician Decision|4|||
129187294|NCT00718770|464979508|FG000|Overall Study|Adverse Event|1|||
129187295|NCT00718770|464979508|FG000|Overall Study|Lack of Efficacy|1|||
129187296|NCT00718770|464979508|FG000|Overall Study|Lack of Efficacy|1|||
129187297|NCT00718770|464979508|FG000|Overall Study|Adverse Event|1|||
129187298|NCT00718770|464979508|FG000|Overall Study|Lack of Efficacy|1|||
129187299|NCT00718770|464979508|FG000|Overall Study|Adverse Event|1|||
129187300|NCT00718770|464979508|FG000|Overall Study|Lack of Efficacy|1|||
129187301|NCT00718770|464979508|FG000|Overall Study|Adverse Event|1|||
129187302|NCT01704456|464979509|FG000|Overall Study|Lost to Follow-up|8|||
129187303|NCT01704456|464979510|FG001|Overall Study|Lost to Follow-up|14|||
129187304|NCT00498355|464979511|FG000|Overall Study|Lost to Follow-up|1|||
129187305|NCT04583956|464979512|FG000|Overall Study|Death|9|||
129187306|NCT04583956|464979513|FG001|Overall Study|Death|11|||
129187307|NCT04583956|464979512|FG000|Overall Study|Lost to Follow-up|7|||
129187308|NCT04583956|464979513|FG001|Overall Study|Lost to Follow-up|9|||
129187309|NCT04583956|464979512|FG000|Overall Study|Protocol Violation|2|||
129187310|NCT04583956|464979513|FG001|Overall Study|Protocol Violation|0|||
129187311|NCT04583956|464979512|FG000|Overall Study|Withdrawal by Subject|0|||
129187312|NCT04583956|464979513|FG001|Overall Study|Withdrawal by Subject|2|||
129187313|NCT04583956|464979512|FG000|Overall Study|Randomized but not dosed|2|||
129187314|NCT04583956|464979513|FG001|Overall Study|Randomized but not dosed|3|||
129187315|NCT04583956|464979512|FG000|Overall Study|Withdrawal of consent before product administration|1|||
129187316|NCT04583956|464979513|FG001|Overall Study|Withdrawal of consent before product administration|0|||
129187317|NCT04599465|464981151|FG000|Overall Study|Physician Decision|1|||
129187318|NCT04599465|464981151|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
129187319|NCT03416127|464981152|FG000|Overall Study|Withdrawal by Subject|0|||
129187320|NCT03416127|464981153|FG001|Overall Study|Withdrawal by Subject|1|||
129187321|NCT03416127|464981154|FG002|Overall Study|Withdrawal by Subject|1|||
129187322|NCT01971008|464981155|FG000|Overall Study|Protocol Violation|2|||
129187323|NCT01971008|464981156|FG001|Overall Study|Protocol Violation|1|||
129187324|NCT02489942|464981159|FG000|Overall Study|Request by patient|602|||
129187325|NCT02489942|464981159|FG000|Overall Study|Improvement/remission|157|||
129187326|NCT02489942|464981159|FG000|Overall Study|No change/Progressive disease|263|||
129187327|NCT02489942|464981159|FG000|Overall Study|Adverse Event|522|||
129187328|NCT02489942|464981159|FG000|Overall Study|Other personal reasons|1218|||
129187329|NCT02489942|464981159|FG000|Overall Study|Lost to Follow-up|456|||
129187330|NCT02489942|464981159|FG000|Overall Study|Not continuously investigated|7|||
129187331|NCT02489942|464981159|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
129187332|NCT02489942|464981159|FG000|Overall Study|Multiple registration|1|||
129187333|NCT02489942|464981159|FG000|Overall Study|No patient visit after entry|100|||
129187334|NCT02489942|464981159|FG000|Overall Study|No treatment with Jardiance|2|||
129187335|NCT02489942|464981159|FG000|Overall Study|Patient received Jardiance before registration|1|||
129187336|NCT02489942|464981159|FG000|Overall Study|No CRF collected|86|||
129187337|NCT00858208|464981160|FG000|Overall Study|Adverse Event|3|||
129187338|NCT00858208|464981160|FG000|Overall Study|Lost to Follow-up|26|||
129187339|NCT00858208|464981160|FG000|Overall Study|Participant refused|40|||
129187340|NCT00858208|464981160|FG000|Overall Study|Other|10|||
129187341|NCT02702180|464981161|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129187342|NCT02702180|464981162|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129187343|NCT02702180|464981163|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129187344|NCT02702180|464981161|FG000|Double-blind Treatment Period|Adverse Event|0|||
129187345|NCT02702180|464981162|FG001|Double-blind Treatment Period|Adverse Event|0|||
129187346|NCT02702180|464981163|FG002|Double-blind Treatment Period|Adverse Event|1|||
129187347|NCT02702180|464981161|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
128730327|NCT00192075|463309944|FG000|Overall Study|Physician Decision|3|||
129187348|NCT02702180|464981162|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129187349|NCT02702180|464981163|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
129187350|NCT02702180|464981161|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129187351|NCT02702180|464981162|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129187352|NCT02702180|464981163|FG002|Double-blind Treatment Period|Protocol Violation|2|||
129187353|NCT02702180|464981161|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
129187354|NCT02702180|464981162|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
129187355|NCT02702180|464981163|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
129187356|NCT02702180|464981161|FG000|Open-label Treatment Period|Withdrawn in error|0|||
129187357|NCT02702180|464981162|FG001|Open-label Treatment Period|Withdrawn in error|0|||
129187358|NCT02702180|464981163|FG002|Open-label Treatment Period|Withdrawn in error|1|||
129187359|NCT00567359|464981164|FG000|Overall Study|Withdrawal by Subject|1|||
129187360|NCT00679172|464981165|FG000|Overall Study|Non-compliance|1|||
129187361|NCT00679172|464981166|FG001|Overall Study|Non-compliance|1|||
129187362|NCT00679172|464981167|FG002|Overall Study|Non-compliance|0|||
129187363|NCT00679172|464981168|FG003|Overall Study|Non-compliance|1|||
129187364|NCT00679172|464981169|FG004|Overall Study|Non-compliance|0|||
129187365|NCT00679172|464981165|FG000|Overall Study|Other not specified|0|||
129187366|NCT00679172|464981166|FG001|Overall Study|Other not specified|0|||
129187367|NCT00679172|464981167|FG002|Overall Study|Other not specified|1|||
129187368|NCT00679172|464981168|FG003|Overall Study|Other not specified|0|||
129187369|NCT00679172|464981169|FG004|Overall Study|Other not specified|0|||
129187370|NCT00793325|464981170|FG000|Overall Study|Protocol Violation|18|||
129187371|NCT00793325|464981170|FG000|Overall Study|Lost to Follow-up|1|||
129187372|NCT00372697|464981171|FG000|Overall Study|Protocol Violation|1|||
129187373|NCT00372697|464981172|FG001|Overall Study|Protocol Violation|1|||
129187374|NCT01815840|464981173|FG000|Overall Study|Missing|1|||
129187375|NCT01815840|464981174|FG001|Overall Study|Missing|0|||
129187376|NCT01815840|464981173|FG000|Overall Study|Withdrew Consent|31|||
129187377|NCT01815840|464981174|FG001|Overall Study|Withdrew Consent|30|||
129187378|NCT01815840|464981173|FG000|Overall Study|Administrative/Other|1|||
129187379|NCT01815840|464981174|FG001|Overall Study|Administrative/Other|3|||
129187380|NCT01815840|464981173|FG000|Overall Study|Adverse Event|10|||
129187381|NCT01815840|464981174|FG001|Overall Study|Adverse Event|16|||
129187382|NCT01815840|464981173|FG000|Overall Study|Death|2|||
129187383|NCT01815840|464981174|FG001|Overall Study|Death|2|||
129187384|NCT01815840|464981173|FG000|Overall Study|Disease progression|3|||
129187385|NCT01815840|464981174|FG001|Overall Study|Disease progression|2|||
129187386|NCT01815840|464981173|FG000|Overall Study|Investigators Decision|2|||
129187387|NCT01815840|464981174|FG001|Overall Study|Investigators Decision|3|||
129187388|NCT01815840|464981173|FG000|Overall Study|Lost to Follow-up|3|||
129187389|NCT01815840|464981174|FG001|Overall Study|Lost to Follow-up|6|||
129187390|NCT01815840|464981173|FG000|Overall Study|Refused Treatment|5|||
129187391|NCT01815840|464981174|FG001|Overall Study|Refused Treatment|1|||
129187392|NCT01815840|464981173|FG000|Overall Study|Sponsor Termination Treatment|1|||
129187393|NCT01815840|464981174|FG001|Overall Study|Sponsor Termination Treatment|0|||
129187394|NCT03221842|464981176|FG000|Period 1 (Open-label)|Adverse Event|4|||
129187395|NCT03221842|464981177|FG001|Period 1 (Open-label)|Adverse Event|0|||
129187396|NCT03221842|464981176|FG000|Period 1 (Open-label)|Physician Decision|2|||
129187397|NCT03221842|464981177|FG001|Period 1 (Open-label)|Physician Decision|0|||
129187398|NCT03221842|464981176|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
129187399|NCT03221842|464981177|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
129187400|NCT03221842|464981176|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
129187401|NCT03221842|464981177|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
129187402|NCT03221842|464981176|FG000|Period 1 (Open-label)|Other|2|||
129187403|NCT03221842|464981177|FG001|Period 1 (Open-label)|Other|0|||
129187404|NCT03221842|464981176|FG000|Period 2 (Randomized, Blinded)|Death|0|||
129187405|NCT03221842|464981177|FG001|Period 2 (Randomized, Blinded)|Death|1|||
129187406|NCT03221842|464981176|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
129187407|NCT03221842|464981177|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
129187408|NCT00704288|464981178|FG000|Overall Treatment Period|Adverse Event|11|||
129187409|NCT00704288|464981179|FG001|Overall Treatment Period|Adverse Event|8|||
129187410|NCT00704288|464981180|FG002|Overall Treatment Period|Adverse Event|22|||
129187411|NCT00704288|464981178|FG000|Overall Treatment Period|Death|0|||
129187412|NCT00704288|464981179|FG001|Overall Treatment Period|Death|0|||
129187413|NCT00704288|464981180|FG002|Overall Treatment Period|Death|1|||
129187414|NCT00704288|464981178|FG000|Overall Treatment Period|Physician Decision|0|||
129187415|NCT00704288|464981179|FG001|Overall Treatment Period|Physician Decision|2|||
129187416|NCT00704288|464981180|FG002|Overall Treatment Period|Physician Decision|0|||
129187417|NCT00704288|464981178|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
129187418|NCT00704288|464981179|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
129187419|NCT00704288|464981180|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
129187420|NCT00704288|464981178|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
129187421|NCT00704288|464981179|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
129187422|NCT00704288|464981180|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
129187423|NCT00704288|464981178|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
129187424|NCT00704288|464981179|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
129187425|NCT00704288|464981180|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
129187426|NCT00704288|464981178|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
129187427|NCT00704288|464981179|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
129187428|NCT00704288|464981180|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
129187429|NCT00704288|464981178|FG000|Overall Treatment Period|Roll-over to another study|1|||
129187430|NCT00704288|464981179|FG001|Overall Treatment Period|Roll-over to another study|0|||
129187431|NCT00704288|464981180|FG002|Overall Treatment Period|Roll-over to another study|4|||
129187432|NCT00704288|464981178|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
129187433|NCT00704288|464981179|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
129187434|NCT00704288|464981180|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
129187435|NCT00704288|464981178|FG000|Extended Post Treatment Follow Up Period|Death|41|||
129187436|NCT00704288|464981179|FG001|Extended Post Treatment Follow Up Period|Death|50|||
128781004|NCT00578227|463488648|FG002|Overall Study|Lost to Follow-up|1|||
129187437|NCT00704288|464981180|FG002|Extended Post Treatment Follow Up Period|Death|93|||
129187438|NCT00704288|464981178|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
129187439|NCT00704288|464981179|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
129187440|NCT00704288|464981180|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
129187441|NCT00704288|464981178|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
129187442|NCT00704288|464981179|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
129187443|NCT00704288|464981180|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
129187444|NCT00704288|464981178|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
129187445|NCT00704288|464981179|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
129187446|NCT00704288|464981180|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
129187447|NCT04395690|464981181|FG000|Overall Study|Lost to Follow-up|1|||
129187448|NCT04395690|464981182|FG001|Overall Study|Lost to Follow-up|1|||
129187449|NCT03387020|464981184|FG000|Overall Study|Adverse Event|0|||
129187450|NCT03387020|464981185|FG001|Overall Study|Adverse Event|2|||
129187451|NCT03387020|464981186|FG002|Overall Study|Adverse Event|0|||
129187452|NCT03387020|464981184|FG000|Overall Study|Withdrawal by Subject|2|||
129187453|NCT03387020|464981185|FG001|Overall Study|Withdrawal by Subject|0|||
129187454|NCT03387020|464981186|FG002|Overall Study|Withdrawal by Subject|0|||
129187455|NCT00434642|464981187|FG000|Blinded Treatment Phase|Adverse Event|12|||
129187456|NCT00434642|464981188|FG001|Blinded Treatment Phase|Adverse Event|58|||
129187457|NCT00434642|464981187|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
129187458|NCT00434642|464981188|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
129187459|NCT00434642|464981187|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
129187460|NCT00434642|464981188|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
129187461|NCT00434642|464981187|FG000|Blinded Treatment Phase|Physician Decision|19|||
129187462|NCT00434642|464981188|FG001|Blinded Treatment Phase|Physician Decision|27|||
129187463|NCT00434642|464981187|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
129187464|NCT00434642|464981188|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
129187465|NCT00434642|464981187|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
129187466|NCT00434642|464981188|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
129187467|NCT00434642|464981187|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
129187468|NCT00434642|464981188|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
129187469|NCT00434642|464981187|FG000|Open-label Treatment Phase|Adverse Event|0|||
129187470|NCT00434642|464981188|FG001|Open-label Treatment Phase|Adverse Event|5|||
129187471|NCT00434642|464981187|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
129187472|NCT00434642|464981188|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
129187473|NCT04512976|464981193|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129187474|NCT04512976|464981194|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129187475|NCT04512976|464981195|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129187476|NCT04512976|464981196|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129187477|NCT04512976|464981197|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129187478|NCT04512976|464981198|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
129187479|NCT00527982|464981199|FG000|Overall Study|Physician Decision|1|||
129187480|NCT00527982|464981200|FG001|Overall Study|Physician Decision|0|||
129187481|NCT00753454|464981207|FG000|Overall Study|Adverse Event|4|||
129187482|NCT00753454|464981207|FG000|Overall Study|Lack of Efficacy|1|||
129187483|NCT00753454|464981207|FG000|Overall Study|Lost to Follow-up|3|||
129187484|NCT00753454|464981207|FG000|Overall Study|Withdrawal by Subject|5|||
129187485|NCT00753454|464981207|FG000|Overall Study|Investigator Decision|1|||
129187486|NCT03927144|464981208|FG000|Core Phase|Adverse Event|9|||
129187487|NCT03927144|464981209|FG001|Core Phase|Adverse Event|5|||
129187488|NCT03927144|464981208|FG000|Core Phase|Lost to Follow-up|3|||
129187489|NCT03927144|464981209|FG001|Core Phase|Lost to Follow-up|2|||
129187490|NCT03927144|464981208|FG000|Core Phase|New Therapy for Study Indication|0|||
129187491|NCT03927144|464981209|FG001|Core Phase|New Therapy for Study Indication|1|||
129187492|NCT03927144|464981208|FG000|Core Phase|No Longer Clinically Benefiting|4|||
129187493|NCT03927144|464981209|FG001|Core Phase|No Longer Clinically Benefiting|4|||
129187494|NCT03927144|464981208|FG000|Core Phase|Physician Decision|2|||
129187495|NCT03927144|464981209|FG001|Core Phase|Physician Decision|8|||
129187496|NCT03927144|464981208|FG000|Core Phase|Protocol Violation|2|||
129187497|NCT03927144|464981209|FG001|Core Phase|Protocol Violation|2|||
129187498|NCT03927144|464981208|FG000|Core Phase|Withdrawal by Subject|16|||
129187499|NCT03927144|464981209|FG001|Core Phase|Withdrawal by Subject|40|||
129187500|NCT03927144|464981208|FG000|Extension Phase|Adverse Event|2|||
129187501|NCT03927144|464981209|FG001|Extension Phase|Adverse Event|1|||
129187502|NCT03927144|464981208|FG000|Extension Phase|No longer clinically benefiting|4|||
129187503|NCT03927144|464981209|FG001|Extension Phase|No longer clinically benefiting|5|||
129187504|NCT03927144|464981208|FG000|Extension Phase|Pregnancy|1|||
129187505|NCT03927144|464981209|FG001|Extension Phase|Pregnancy|0|||
129187506|NCT03927144|464981208|FG000|Extension Phase|Protocol Violation|0|||
129187507|NCT03927144|464981209|FG001|Extension Phase|Protocol Violation|1|||
129187508|NCT03927144|464981208|FG000|Extension Phase|Withdrawal by Subject|8|||
129187509|NCT03927144|464981209|FG001|Extension Phase|Withdrawal by Subject|3|||
129187510|NCT04541628|464981212|FG000|Overall Study|Study Terminated|1|||
129187511|NCT04541628|464981213|FG001|Overall Study|Study Terminated|1|||
129187512|NCT04541628|464981214|FG002|Overall Study|Study Terminated|1|||
129187513|NCT05011058|464981218|FG000|Overall Study|Sponsor Decision|2|||
129187514|NCT05011058|464981219|FG001|Overall Study|Sponsor Decision|0|||
129187515|NCT05011058|464981220|FG002|Overall Study|Sponsor Decision|14|||
129187516|NCT05011058|464981221|FG003|Overall Study|Sponsor Decision|0|||
129187517|NCT05011058|464981222|FG004|Overall Study|Sponsor Decision|0|||
129187518|NCT05011058|464981223|FG005|Overall Study|Sponsor Decision|1|||
128781005|NCT00578227|463488646|FG000|Overall Study|Withdrawal by Subject|5|||
129187519|NCT05011058|464981224|FG006|Overall Study|Sponsor Decision|0|||
129187520|NCT05011058|464981225|FG007|Overall Study|Sponsor Decision|5|||
129187521|NCT01452919|464981226|FG000|Open-Label Treatment|Adverse Event|5|||
129187522|NCT01452919|464981227|FG001|Open-Label Treatment|Adverse Event|0|||
129187523|NCT01452919|464981228|FG002|Open-Label Treatment|Adverse Event|0|||
129187524|NCT01452919|464981226|FG000|Open-Label Treatment|Lost to Follow-up|4|||
129187525|NCT01452919|464981227|FG001|Open-Label Treatment|Lost to Follow-up|0|||
129187526|NCT01452919|464981228|FG002|Open-Label Treatment|Lost to Follow-up|0|||
129187527|NCT01452919|464981226|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
129187528|NCT01452919|464981227|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
129187529|NCT01452919|464981228|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
129187530|NCT01452919|464981226|FG000|Open-Label Treatment|Protocol Violation|4|||
129187531|NCT01452919|464981227|FG001|Open-Label Treatment|Protocol Violation|0|||
129187532|NCT01452919|464981228|FG002|Open-Label Treatment|Protocol Violation|0|||
129187533|NCT01452919|464981226|FG000|Open-Label Treatment|Sponsor Decision|1|||
129187534|NCT01452919|464981227|FG001|Open-Label Treatment|Sponsor Decision|0|||
129187535|NCT01452919|464981228|FG002|Open-Label Treatment|Sponsor Decision|0|||
129187536|NCT01452919|464981226|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
129187537|NCT01452919|464981227|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129187538|NCT01452919|464981228|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
129187539|NCT01452919|464981226|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
129187540|NCT01452919|464981227|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
129187541|NCT01452919|464981228|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
129187542|NCT01452919|464981226|FG000|Randomization Treatment|Adverse Event|0|||
129187543|NCT01452919|464981227|FG001|Randomization Treatment|Adverse Event|0|||
129187544|NCT01452919|464981228|FG002|Randomization Treatment|Adverse Event|2|||
129187545|NCT01452919|464981226|FG000|Randomization Treatment|Sponsor Decision|0|||
129187546|NCT01452919|464981227|FG001|Randomization Treatment|Sponsor Decision|1|||
129187547|NCT01452919|464981228|FG002|Randomization Treatment|Sponsor Decision|0|||
129187548|NCT01452919|464981226|FG000|Randomization Treatment|Withdrawal by Subject|0|||
129187549|NCT01452919|464981227|FG001|Randomization Treatment|Withdrawal by Subject|1|||
129187550|NCT01452919|464981228|FG002|Randomization Treatment|Withdrawal by Subject|0|||
129187551|NCT01452919|464981226|FG000|Randomization Treatment|Subject is moving or has moved|0|||
129187552|NCT01452919|464981227|FG001|Randomization Treatment|Subject is moving or has moved|1|||
129187553|NCT01452919|464981228|FG002|Randomization Treatment|Subject is moving or has moved|0|||
129187554|NCT01192412|464981229|FG000|Overall Study|Lost to Follow-up|2|||
129187555|NCT01192412|464981230|FG001|Overall Study|Lost to Follow-up|1|||
129187556|NCT01192412|464981229|FG000|Overall Study|Withdrawal by Subject|2|||
129187557|NCT01192412|464981230|FG001|Overall Study|Withdrawal by Subject|1|||
129187558|NCT01359943|464981233|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
129187559|NCT01359943|464981234|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
129187560|NCT01359943|464981235|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
129187561|NCT01359943|464981233|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
129187562|NCT01359943|464981234|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
129187563|NCT01359943|464981235|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
129187564|NCT01359943|464981233|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
129187565|NCT01359943|464981234|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
129187566|NCT01359943|464981235|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
129187567|NCT01359943|464981233|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
129187568|NCT01359943|464981234|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
129187569|NCT01359943|464981235|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
129187570|NCT01359943|464981233|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
129187571|NCT01359943|464981234|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
129187572|NCT01359943|464981235|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
129187573|NCT01359943|464981233|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
129187574|NCT01359943|464981234|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
129187575|NCT01359943|464981235|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
129187576|NCT01359943|464981233|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
129187577|NCT01359943|464981234|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
129187578|NCT01359943|464981235|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
129187579|NCT01359943|464981233|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
129187580|NCT01359943|464981234|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
129187581|NCT01359943|464981235|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
129187582|NCT01359943|464981233|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
129187583|NCT01359943|464981234|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
129187584|NCT01359943|464981235|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
129187585|NCT01359943|464981233|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
129187586|NCT01359943|464981234|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
128781006|NCT00578227|463488647|FG001|Overall Study|Withdrawal by Subject|1|||
129187587|NCT01359943|464981235|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
129187588|NCT01359943|464981233|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
129187589|NCT01359943|464981234|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
129187590|NCT01359943|464981235|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
129187591|NCT01359943|464981233|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
129187592|NCT01359943|464981234|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
129187593|NCT01359943|464981235|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
129187594|NCT01359943|464981233|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
128730328|NCT00192075|463309945|FG001|Overall Study|Physician Decision|0|||
129187595|NCT01359943|464981234|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
129187596|NCT01359943|464981235|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
129187597|NCT01359943|464981233|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
129187598|NCT01359943|464981234|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
128730329|NCT00192075|463309944|FG000|Overall Study|Withdrawal by Subject|5|||
128730330|NCT00192075|463309945|FG001|Overall Study|Withdrawal by Subject|5|||
129187599|NCT01359943|464981235|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
129187600|NCT01359943|464981233|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
129187601|NCT01359943|464981234|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
129187602|NCT01359943|464981235|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
129187603|NCT00308074|464981239|FG000|Overall Study|Withdrawal by Subject|1|||
129187604|NCT03194646|464981248|FG000|Overall Study|Adverse Event|24|||
129187605|NCT03194646|464981249|FG001|Overall Study|Adverse Event|25|||
129187606|NCT03194646|464981250|FG002|Overall Study|Adverse Event|14|||
129187607|NCT03194646|464981251|FG003|Overall Study|Adverse Event|17|||
129187608|NCT03194646|464981248|FG000|Overall Study|Lack of Efficacy|4|||
129187609|NCT03194646|464981249|FG001|Overall Study|Lack of Efficacy|2|||
129187610|NCT03194646|464981250|FG002|Overall Study|Lack of Efficacy|2|||
129187611|NCT03194646|464981251|FG003|Overall Study|Lack of Efficacy|12|||
129187612|NCT03194646|464981248|FG000|Overall Study|Lost to Follow-up|30|||
129187613|NCT03194646|464981249|FG001|Overall Study|Lost to Follow-up|22|||
129187614|NCT03194646|464981250|FG002|Overall Study|Lost to Follow-up|12|||
129187615|NCT03194646|464981251|FG003|Overall Study|Lost to Follow-up|35|||
129187616|NCT03194646|464981248|FG000|Overall Study|Non-compliance with study drug|4|||
129187617|NCT03194646|464981249|FG001|Overall Study|Non-compliance with study drug|0|||
129187618|NCT03194646|464981250|FG002|Overall Study|Non-compliance with study drug|1|||
129187619|NCT03194646|464981251|FG003|Overall Study|Non-compliance with study drug|1|||
129187620|NCT03194646|464981248|FG000|Overall Study|Other|89|||
129187621|NCT03194646|464981249|FG001|Overall Study|Other|68|||
129187622|NCT03194646|464981250|FG002|Overall Study|Other|34|||
129187623|NCT03194646|464981251|FG003|Overall Study|Other|31|||
129187624|NCT03194646|464981248|FG000|Overall Study|Physician Decision|7|||
129187625|NCT03194646|464981249|FG001|Overall Study|Physician Decision|9|||
129187626|NCT03194646|464981250|FG002|Overall Study|Physician Decision|5|||
129187627|NCT03194646|464981251|FG003|Overall Study|Physician Decision|4|||
129187628|NCT03194646|464981248|FG000|Overall Study|Pregnancy|4|||
129187629|NCT03194646|464981249|FG001|Overall Study|Pregnancy|5|||
129187630|NCT03194646|464981250|FG002|Overall Study|Pregnancy|1|||
129187631|NCT03194646|464981251|FG003|Overall Study|Pregnancy|2|||
129187632|NCT03194646|464981248|FG000|Overall Study|Protocol Violation|4|||
129187633|NCT03194646|464981249|FG001|Overall Study|Protocol Violation|2|||
129187634|NCT03194646|464981250|FG002|Overall Study|Protocol Violation|1|||
129187635|NCT03194646|464981251|FG003|Overall Study|Protocol Violation|1|||
129187636|NCT03194646|464981248|FG000|Overall Study|Site terminated by sponsor|0|||
129187637|NCT03194646|464981249|FG001|Overall Study|Site terminated by sponsor|0|||
129187638|NCT03194646|464981250|FG002|Overall Study|Site terminated by sponsor|2|||
129187639|NCT03194646|464981251|FG003|Overall Study|Site terminated by sponsor|0|||
129187640|NCT03194646|464981248|FG000|Overall Study|Study terminated by sponsor|62|||
129187641|NCT03194646|464981249|FG001|Overall Study|Study terminated by sponsor|61|||
129187642|NCT03194646|464981250|FG002|Overall Study|Study terminated by sponsor|30|||
129187643|NCT03194646|464981251|FG003|Overall Study|Study terminated by sponsor|34|||
129187644|NCT03194646|464981248|FG000|Overall Study|Withdrawal by Subject|75|||
129187645|NCT03194646|464981249|FG001|Overall Study|Withdrawal by Subject|74|||
129187646|NCT03194646|464981250|FG002|Overall Study|Withdrawal by Subject|36|||
129187647|NCT03194646|464981251|FG003|Overall Study|Withdrawal by Subject|131|||
129187648|NCT03194646|464981248|FG000|Overall Study|Missing|1|||
129187649|NCT03194646|464981249|FG001|Overall Study|Missing|0|||
129187650|NCT03194646|464981250|FG002|Overall Study|Missing|1|||
129187651|NCT03194646|464981251|FG003|Overall Study|Missing|12|||
129187652|NCT02141360|464981252|FG000|Overall Study|Withdrawal by Subject|6|||
129187653|NCT02141360|464981253|FG001|Overall Study|Withdrawal by Subject|0|||
129187654|NCT02141360|464981254|FG002|Overall Study|Withdrawal by Subject|0|||
129187655|NCT02141360|464981252|FG000|Overall Study|Study Terminated before Visit|1|||
129187656|NCT02141360|464981253|FG001|Overall Study|Study Terminated before Visit|0|||
129187657|NCT02141360|464981254|FG002|Overall Study|Study Terminated before Visit|0|||
129187658|NCT04071158|464981255|FG000|Overall Study|Lost to Follow-up|1|||
129187659|NCT04071158|464981256|FG001|Overall Study|Lost to Follow-up|2|||
129187660|NCT04071158|464981257|FG002|Overall Study|Lost to Follow-up|3|||
129187661|NCT04071158|464981258|FG003|Overall Study|Lost to Follow-up|3|||
129187662|NCT04071158|464981259|FG004|Overall Study|Lost to Follow-up|5|||
129187663|NCT04071158|464981255|FG000|Overall Study|Randomized but not treated|2|||
129187664|NCT04071158|464981256|FG001|Overall Study|Randomized but not treated|2|||
129187665|NCT04071158|464981257|FG002|Overall Study|Randomized but not treated|0|||
129187666|NCT04071158|464981258|FG003|Overall Study|Randomized but not treated|0|||
129187667|NCT04071158|464981259|FG004|Overall Study|Randomized but not treated|0|||
129187668|NCT01178099|464981260|FG000|Overall Study|Physician Decision|0|||
129187669|NCT01178099|464981261|FG001|Overall Study|Physician Decision|1|||
129187670|NCT02516592|464981262|FG000|Overall Study|Patient withdrew consent|5|||
129187671|NCT02516592|464981263|FG001|Overall Study|Patient withdrew consent|2|||
129187672|NCT02516592|464981262|FG000|Overall Study|Protocol deviation|4|||
129187673|NCT02516592|464981263|FG001|Overall Study|Protocol deviation|4|||
129187674|NCT02516592|464981262|FG000|Overall Study|Lost to Follow-up|2|||
129187675|NCT02516592|464981263|FG001|Overall Study|Lost to Follow-up|3|||
128982142|NCT00508820|464219107|FG001|Overall Study|Other|2|||
129187676|NCT02516592|464981262|FG000|Overall Study|Patient/guardian decision|2|||
128730331|NCT00192075|463309944|FG000|Overall Study|Patient Non-Compliance|0|||
128730332|NCT00192075|463309945|FG001|Overall Study|Patient Non-Compliance|1|||
128730333|NCT00192075|463309944|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
128730334|NCT00192075|463309945|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
128730335|NCT00192075|463309944|FG000|Overall Study|Other|5|||
128730336|NCT00192075|463309945|FG001|Overall Study|Other|2|||
128730337|NCT00779675|463309946|FG000|Treatment Period|Adverse Event|87|||
128730338|NCT00779675|463309946|FG000|Treatment Period|Treatment Failure|80|||
129187677|NCT02516592|464981263|FG001|Overall Study|Patient/guardian decision|1|||
129187678|NCT02516592|464981262|FG000|Overall Study|Adverse Event|1|||
129187679|NCT02516592|464981263|FG001|Overall Study|Adverse Event|2|||
129187680|NCT02516592|464981262|FG000|Overall Study|Abnormal test procedure result|1|||
129187681|NCT02516592|464981263|FG001|Overall Study|Abnormal test procedure result|0|||
129187682|NCT02516592|464981262|FG000|Overall Study|Death|1|||
129187683|NCT02516592|464981263|FG001|Overall Study|Death|1|||
128730339|NCT00779675|463309946|FG000|Treatment Period|Transferred to Another Study|38|||
129187684|NCT01286740|464981264|FG000|Overall Study|Enrolled but not treated|1|||
129187685|NCT01286740|464981264|FG000|Overall Study|Protocol Violation|1|||
129187686|NCT04032080|464981266|FG000|Overall Study|Death|6|||
129187687|NCT01438177|464981272|FG000|Overall Study|Withdrawal by Subject|1|||
129187688|NCT01438177|464981272|FG000|Overall Study|Initiation of new therapy|1|||
129187689|NCT01727336|464981275|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129187690|NCT01727336|464981276|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
129187691|NCT01727336|464981277|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
129187692|NCT01727336|464981278|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129187693|NCT01727336|464981279|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129187694|NCT01727336|464981280|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129187695|NCT01727336|464981275|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
129187696|NCT01727336|464981276|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
129187697|NCT01727336|464981277|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
129187698|NCT01727336|464981278|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
129187699|NCT01727336|464981279|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
129187700|NCT01727336|464981280|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
129187701|NCT01727336|464981275|FG000|Part 2 Blinded|Death|0|||
129187702|NCT01727336|464981276|FG001|Part 2 Blinded|Death|0|||
129187703|NCT01727336|464981277|FG002|Part 2 Blinded|Death|0|||
129187704|NCT01727336|464981278|FG003|Part 2 Blinded|Death|0|||
129187705|NCT01727336|464981279|FG004|Part 2 Blinded|Death|20|||
129187706|NCT01727336|464981280|FG005|Part 2 Blinded|Death|16|||
129187707|NCT01727336|464981275|FG000|Part 2 Blinded|Lack of Efficacy|0|||
129187708|NCT01727336|464981276|FG001|Part 2 Blinded|Lack of Efficacy|0|||
129187709|NCT01727336|464981277|FG002|Part 2 Blinded|Lack of Efficacy|0|||
129187710|NCT01727336|464981278|FG003|Part 2 Blinded|Lack of Efficacy|0|||
129187711|NCT01727336|464981279|FG004|Part 2 Blinded|Lack of Efficacy|42|||
129187712|NCT01727336|464981280|FG005|Part 2 Blinded|Lack of Efficacy|44|||
129187713|NCT01727336|464981275|FG000|Part 2 Blinded|Lost to Follow-up|0|||
129187714|NCT01727336|464981276|FG001|Part 2 Blinded|Lost to Follow-up|0|||
129187715|NCT01727336|464981277|FG002|Part 2 Blinded|Lost to Follow-up|0|||
129187716|NCT01727336|464981278|FG003|Part 2 Blinded|Lost to Follow-up|0|||
129187717|NCT01727336|464981279|FG004|Part 2 Blinded|Lost to Follow-up|0|||
129187718|NCT01727336|464981280|FG005|Part 2 Blinded|Lost to Follow-up|1|||
129187719|NCT01727336|464981275|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
129187720|NCT01727336|464981276|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
129187721|NCT01727336|464981277|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
129187722|NCT01727336|464981278|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
129187723|NCT01727336|464981279|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
129187724|NCT01727336|464981280|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
129187725|NCT01727336|464981275|FG000|Part 2 Blinded|use of prohibited medications|0|||
129187726|NCT01727336|464981276|FG001|Part 2 Blinded|use of prohibited medications|0|||
129187727|NCT01727336|464981277|FG002|Part 2 Blinded|use of prohibited medications|0|||
129187728|NCT01727336|464981278|FG003|Part 2 Blinded|use of prohibited medications|0|||
129187729|NCT01727336|464981279|FG004|Part 2 Blinded|use of prohibited medications|1|||
129187730|NCT01727336|464981280|FG005|Part 2 Blinded|use of prohibited medications|3|||
129187731|NCT00576576|464981286|FG000|Overall Study|Lost to Follow-up|6|||
129187732|NCT00576576|464981286|FG000|Overall Study|Protocol Violation|1|||
129187733|NCT01424228|464981292|FG000|Overall Study|Withdrawal by Subject|27|||
129187734|NCT01424228|464981293|FG001|Overall Study|Withdrawal by Subject|11|||
129187735|NCT01424228|464981292|FG000|Overall Study|Adverse Event|10|||
129187736|NCT01424228|464981293|FG001|Overall Study|Adverse Event|14|||
129187737|NCT01424228|464981292|FG000|Overall Study|Sponsor's decision|9|||
129187738|NCT01424228|464981293|FG001|Overall Study|Sponsor's decision|12|||
129187739|NCT01424228|464981292|FG000|Overall Study|Lack of Efficacy|5|||
129187740|NCT01424228|464981293|FG001|Overall Study|Lack of Efficacy|7|||
129187741|NCT01424228|464981292|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
129187742|NCT01424228|464981293|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
129187743|NCT01424228|464981292|FG000|Overall Study|Non-compliance|2|||
129187744|NCT01424228|464981293|FG001|Overall Study|Non-compliance|0|||
129187745|NCT01424228|464981292|FG000|Overall Study|Worsening of symptoms|1|||
129187746|NCT01424228|464981293|FG001|Overall Study|Worsening of symptoms|0|||
129187747|NCT01424228|464981292|FG000|Overall Study|Unplanned journey|0|||
129187748|NCT01424228|464981293|FG001|Overall Study|Unplanned journey|1|||
129187749|NCT03517566|464981294|FG000|Overall Study|Adverse Event|5|||
129187750|NCT03517566|464981295|FG001|Overall Study|Adverse Event|2|||
129187751|NCT03517566|464981296|FG002|Overall Study|Adverse Event|2|||
129187752|NCT03517566|464981297|FG003|Overall Study|Adverse Event|8|||
129187753|NCT03517566|464981298|FG004|Overall Study|Adverse Event|7|||
129187754|NCT03517566|464981294|FG000|Overall Study|Lack of Efficacy|3|||
129187755|NCT03517566|464981295|FG001|Overall Study|Lack of Efficacy|2|||
129187756|NCT03517566|464981296|FG002|Overall Study|Lack of Efficacy|1|||
129187757|NCT03517566|464981297|FG003|Overall Study|Lack of Efficacy|1|||
129187758|NCT03517566|464981298|FG004|Overall Study|Lack of Efficacy|4|||
129187759|NCT03517566|464981294|FG000|Overall Study|Lost to Follow-up|3|||
129187760|NCT03517566|464981295|FG001|Overall Study|Lost to Follow-up|1|||
129187761|NCT03517566|464981296|FG002|Overall Study|Lost to Follow-up|1|||
129187762|NCT03517566|464981297|FG003|Overall Study|Lost to Follow-up|1|||
129187763|NCT03517566|464981298|FG004|Overall Study|Lost to Follow-up|0|||
129187764|NCT03517566|464981294|FG000|Overall Study|Physician Decision|1|||
129187765|NCT03517566|464981295|FG001|Overall Study|Physician Decision|1|||
129187766|NCT03517566|464981296|FG002|Overall Study|Physician Decision|0|||
129187767|NCT03517566|464981297|FG003|Overall Study|Physician Decision|1|||
129187768|NCT03517566|464981298|FG004|Overall Study|Physician Decision|0|||
129187769|NCT03517566|464981294|FG000|Overall Study|Pregnancy|0|||
129187770|NCT03517566|464981295|FG001|Overall Study|Pregnancy|1|||
129187771|NCT03517566|464981296|FG002|Overall Study|Pregnancy|0|||
129187772|NCT03517566|464981297|FG003|Overall Study|Pregnancy|0|||
129187773|NCT03517566|464981298|FG004|Overall Study|Pregnancy|0|||
129187774|NCT03517566|464981294|FG000|Overall Study|Protocol Deviation|0|||
129187775|NCT03517566|464981295|FG001|Overall Study|Protocol Deviation|1|||
129187776|NCT03517566|464981296|FG002|Overall Study|Protocol Deviation|0|||
129187777|NCT03517566|464981297|FG003|Overall Study|Protocol Deviation|1|||
129187778|NCT03517566|464981298|FG004|Overall Study|Protocol Deviation|1|||
129187779|NCT03517566|464981294|FG000|Overall Study|Study terminated by Sponsor|11|||
129187780|NCT03517566|464981295|FG001|Overall Study|Study terminated by Sponsor|5|||
129187781|NCT03517566|464981296|FG002|Overall Study|Study terminated by Sponsor|6|||
129187782|NCT03517566|464981297|FG003|Overall Study|Study terminated by Sponsor|14|||
129187783|NCT03517566|464981298|FG004|Overall Study|Study terminated by Sponsor|12|||
129187784|NCT03517566|464981294|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
129187785|NCT03517566|464981295|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
129187786|NCT03517566|464981296|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
129187787|NCT03517566|464981297|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
129187788|NCT03517566|464981298|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
129187789|NCT00671437|464981301|FG000|Overall Study|Progressive disease before C1 week 8|8|||
129187790|NCT00671437|464981301|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
129187791|NCT00671437|464981301|FG000|Overall Study|Adverse Event|3|||
129187792|NCT00671437|464981301|FG000|Overall Study|Ineligible post-hoc|1|||
129187793|NCT03927404|464981303|FG000|Overall Study|Withdrawal by Subject|1|||
129187794|NCT01229449|464981304|FG000|Overall Study|Withdrawal by Subject|0|||
129187795|NCT01229449|464981305|FG001|Overall Study|Withdrawal by Subject|3|||
129187796|NCT01229449|464981306|FG002|Overall Study|Withdrawal by Subject|0|||
129187797|NCT01229449|464981307|FG003|Overall Study|Withdrawal by Subject|1|||
129187798|NCT01229449|464981308|FG004|Overall Study|Withdrawal by Subject|1|||
129187799|NCT01229449|464981304|FG000|Overall Study|Lost to Follow-up|1|||
129187800|NCT01229449|464981305|FG001|Overall Study|Lost to Follow-up|1|||
129187801|NCT01229449|464981306|FG002|Overall Study|Lost to Follow-up|1|||
129187802|NCT01229449|464981307|FG003|Overall Study|Lost to Follow-up|0|||
129187803|NCT01229449|464981308|FG004|Overall Study|Lost to Follow-up|0|||
129187804|NCT01229449|464981304|FG000|Overall Study|Physician Decision|0|||
129187805|NCT01229449|464981305|FG001|Overall Study|Physician Decision|0|||
129187806|NCT01229449|464981306|FG002|Overall Study|Physician Decision|1|||
129187807|NCT01229449|464981307|FG003|Overall Study|Physician Decision|0|||
129187808|NCT01229449|464981308|FG004|Overall Study|Physician Decision|0|||
129187809|NCT00377364|464981309|FG000|Overall Study|Lost to Follow-up|1|||
129187810|NCT00377364|464981310|FG001|Overall Study|Lost to Follow-up|0|||
129187811|NCT00377364|464981309|FG000|Overall Study|Withdrawal by Subject|1|||
129187812|NCT00377364|464981310|FG001|Overall Study|Withdrawal by Subject|0|||
129187813|NCT00293020|464981314|FG000|Overall Study|Withdrawal by Subject|34|||
129187814|NCT00293020|464981314|FG000|Overall Study|Adverse Event|30|||
129187815|NCT00293020|464981314|FG000|Overall Study|Death|32|||
129187816|NCT00293020|464981314|FG000|Overall Study|Lack of Efficacy|12|||
129187817|NCT00293020|464981314|FG000|Overall Study|Lost to Follow-up|4|||
129187818|NCT00293020|464981314|FG000|Overall Study|Protocol Violation|6|||
129187819|NCT00293020|464981314|FG000|Overall Study|Physician Decision|21|||
129187820|NCT00293020|464981314|FG000|Overall Study|Other Reason|22|||
129187821|NCT00293020|464981314|FG000|Overall Study|No dose taken|1|||
129187822|NCT01147848|464981315|FG000|Run-in Period|Screen Failure|623|||
129187823|NCT01147848|464981316|FG001|Run-in Period|Screen Failure|0|||
129187824|NCT01147848|464981317|FG002|Run-in Period|Screen Failure|0|||
129187825|NCT01147848|464981315|FG000|Run-in Period|Run-in Failure|135|||
129187826|NCT01147848|464981316|FG001|Run-in Period|Run-in Failure|0|||
129187827|NCT01147848|464981317|FG002|Run-in Period|Run-in Failure|0|||
129187828|NCT01147848|464981315|FG000|Randomized Phase|Adverse Event|0|||
129187829|NCT01147848|464981316|FG001|Randomized Phase|Adverse Event|6|||
129187830|NCT01147848|464981317|FG002|Randomized Phase|Adverse Event|8|||
129187831|NCT01147848|464981315|FG000|Randomized Phase|Lack of Efficacy|0|||
129187832|NCT01147848|464981316|FG001|Randomized Phase|Lack of Efficacy|20|||
129187833|NCT01147848|464981317|FG002|Randomized Phase|Lack of Efficacy|11|||
129187834|NCT01147848|464981315|FG000|Randomized Phase|Protocol Violation|0|||
129187835|NCT01147848|464981316|FG001|Randomized Phase|Protocol Violation|7|||
129187836|NCT01147848|464981317|FG002|Randomized Phase|Protocol Violation|10|||
129187837|NCT01147848|464981315|FG000|Randomized Phase|Lost to Follow-up|0|||
129187838|NCT01147848|464981316|FG001|Randomized Phase|Lost to Follow-up|5|||
129187839|NCT01147848|464981317|FG002|Randomized Phase|Lost to Follow-up|7|||
129187840|NCT01147848|464981315|FG000|Randomized Phase|Physician Decision|0|||
129187841|NCT01147848|464981316|FG001|Randomized Phase|Physician Decision|0|||
129187842|NCT01147848|464981317|FG002|Randomized Phase|Physician Decision|1|||
129187843|NCT01147848|464981315|FG000|Randomized Phase|Withdrawal by Subject|0|||
129187844|NCT01147848|464981316|FG001|Randomized Phase|Withdrawal by Subject|7|||
129187845|NCT01147848|464981317|FG002|Randomized Phase|Withdrawal by Subject|9|||
129187846|NCT03180307|464981318|FG000|Overall Study|Lost to Follow-up|2|||
129187847|NCT03180307|464981319|FG001|Overall Study|Lost to Follow-up|0|||
129187848|NCT03180307|464981318|FG000|Overall Study|Death|1|||
129187849|NCT03180307|464981319|FG001|Overall Study|Death|0|||
129187850|NCT03180307|464981318|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
129187851|NCT03180307|464981319|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
129187852|NCT02100475|464983411|FG000|Overall Study|Unclassified|1|||
129187853|NCT02100475|464983412|FG001|Overall Study|Unclassified|2|||
129187854|NCT02100475|464983411|FG000|Overall Study|Withdrawal criteria|1|||
129187855|NCT02100475|464983412|FG001|Overall Study|Withdrawal criteria|0|||
129187856|NCT00649428|464983413|FG000|Overall Study|Adverse Event|2|||
129187857|NCT00649428|464983414|FG001|Overall Study|Adverse Event|2|||
129187858|NCT00649428|464983413|FG000|Overall Study|Withdrawal by Subject|6|||
129187859|NCT00649428|464983414|FG001|Overall Study|Withdrawal by Subject|6|||
129187860|NCT00649428|464983413|FG000|Overall Study|Lost to Follow-up|1|||
129187861|NCT00649428|464983414|FG001|Overall Study|Lost to Follow-up|3|||
129187862|NCT00649428|464983413|FG000|Overall Study|Insufficient manufacturing yield|5|||
129187863|NCT00649428|464983414|FG001|Overall Study|Insufficient manufacturing yield|1|||
129187864|NCT00649428|464983413|FG000|Overall Study|Protocol Violation|6|||
129187865|NCT00649428|464983414|FG001|Overall Study|Protocol Violation|2|||
129187866|NCT00649428|464983413|FG000|Overall Study|Physician Decision|0|||
129187867|NCT00649428|464983414|FG001|Overall Study|Physician Decision|1|||
129187868|NCT00742417|464983415|FG000|Randomized|Withdrawal by legal representative|0|||
129187869|NCT00742417|464983416|FG001|Randomized|Withdrawal by legal representative|1|||
129187870|NCT00742417|464983415|FG000|Randomized|Withdrawal by Subject|1|||
129187871|NCT00742417|464983416|FG001|Randomized|Withdrawal by Subject|0|||
129187872|NCT00742417|464983415|FG000|Randomized|Physician Decision|1|||
129187873|NCT00742417|464983416|FG001|Randomized|Physician Decision|0|||
129187874|NCT00742417|464983415|FG000|Intensive Period|Withdrawal by Subject|1|||
129187875|NCT00742417|464983416|FG001|Intensive Period|Withdrawal by Subject|1|||
129187876|NCT00742417|464983415|FG000|Intensive Period|Adverse Event|2|||
129187877|NCT00742417|464983416|FG001|Intensive Period|Adverse Event|0|||
129187878|NCT04566601|464983417|FG000|Overall Study|Other than listed|13|||
129187879|NCT04566601|464983418|FG001|Overall Study|Other than listed|4|||
129187880|NCT04566601|464983419|FG002|Overall Study|Other than listed|2|||
129187881|NCT04566601|464983420|FG003|Overall Study|Other than listed|1|||
129187882|NCT04566601|464983421|FG004|Overall Study|Other than listed|4|||
129187883|NCT04566601|464983417|FG000|Overall Study|Protocol deviation|3|||
129187884|NCT04566601|464983418|FG001|Overall Study|Protocol deviation|0|||
129187885|NCT04566601|464983419|FG002|Overall Study|Protocol deviation|1|||
129187886|NCT04566601|464983420|FG003|Overall Study|Protocol deviation|1|||
129187887|NCT04566601|464983421|FG004|Overall Study|Protocol deviation|1|||
129187888|NCT04566601|464983417|FG000|Overall Study|Technical problems|0|||
129187889|NCT04566601|464983418|FG001|Overall Study|Technical problems|0|||
129187890|NCT04566601|464983419|FG002|Overall Study|Technical problems|1|||
129187891|NCT04566601|464983420|FG003|Overall Study|Technical problems|0|||
129187892|NCT04566601|464983421|FG004|Overall Study|Technical problems|0|||
129187893|NCT04566601|464983417|FG000|Overall Study|No reason available|3|||
129187894|NCT04566601|464983418|FG001|Overall Study|No reason available|2|||
129187895|NCT04566601|464983419|FG002|Overall Study|No reason available|7|||
129187896|NCT04566601|464983420|FG003|Overall Study|No reason available|1|||
129187897|NCT04566601|464983421|FG004|Overall Study|No reason available|5|||
129187898|NCT04566601|464983417|FG000|Overall Study|Burden of study procedures|3|||
129187899|NCT04566601|464983418|FG001|Overall Study|Burden of study procedures|0|||
129187900|NCT04566601|464983419|FG002|Overall Study|Burden of study procedures|0|||
129187901|NCT04566601|464983420|FG003|Overall Study|Burden of study procedures|3|||
129187902|NCT04566601|464983421|FG004|Overall Study|Burden of study procedures|1|||
129187903|NCT04566601|464983417|FG000|Overall Study|Change of residence|2|||
129187904|NCT04566601|464983418|FG001|Overall Study|Change of residence|2|||
129187905|NCT04566601|464983419|FG002|Overall Study|Change of residence|0|||
129187906|NCT04566601|464983420|FG003|Overall Study|Change of residence|1|||
129187907|NCT04566601|464983421|FG004|Overall Study|Change of residence|2|||
129187908|NCT04566601|464983417|FG000|Overall Study|Perceived lack of efficacy|2|||
129187909|NCT04566601|464983418|FG001|Overall Study|Perceived lack of efficacy|0|||
129187910|NCT04566601|464983419|FG002|Overall Study|Perceived lack of efficacy|1|||
129187911|NCT04566601|464983420|FG003|Overall Study|Perceived lack of efficacy|1|||
129187912|NCT04566601|464983421|FG004|Overall Study|Perceived lack of efficacy|2|||
129187913|NCT04566601|464983417|FG000|Overall Study|Adverse Event|7|||
129187914|NCT04566601|464983418|FG001|Overall Study|Adverse Event|4|||
129187915|NCT04566601|464983419|FG002|Overall Study|Adverse Event|6|||
129187916|NCT04566601|464983420|FG003|Overall Study|Adverse Event|5|||
129187917|NCT04566601|464983421|FG004|Overall Study|Adverse Event|12|||
129187918|NCT01363661|464983423|FG000|Overall Study|Adverse Event|9|||
129187919|NCT01363661|464983424|FG001|Overall Study|Adverse Event|2|||
129187920|NCT01363661|464983423|FG000|Overall Study|Withdrawal by Subject|1|||
129187921|NCT01363661|464983424|FG001|Overall Study|Withdrawal by Subject|1|||
129187922|NCT01363661|464983423|FG000|Overall Study|Protocol Violation|1|||
129187923|NCT01363661|464983424|FG001|Overall Study|Protocol Violation|0|||
129187924|NCT01363661|464983423|FG000|Overall Study|Lost to Follow-up|3|||
129187925|NCT01363661|464983424|FG001|Overall Study|Lost to Follow-up|1|||
129187926|NCT03775512|464983425|FG000|Overall Study|Death|1|||
129187927|NCT03775512|464983426|FG001|Overall Study|Death|1|||
129187928|NCT03775512|464983425|FG000|Overall Study|Withdrawal by Subject|7|||
129187929|NCT03775512|464983426|FG001|Overall Study|Withdrawal by Subject|4|||
129187930|NCT03775512|464983425|FG000|Overall Study|Lost to Follow-up|5|||
129187931|NCT03775512|464983426|FG001|Overall Study|Lost to Follow-up|5|||
129187932|NCT03775512|464983425|FG000|Overall Study|Excluded before Catheter insertion|14|||
129187933|NCT03775512|464983426|FG001|Overall Study|Excluded before Catheter insertion|5|||
129187934|NCT03775512|464983425|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
129187935|NCT03775512|464983426|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
129187936|NCT03775512|464983425|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
129187937|NCT03775512|464983426|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
129187938|NCT01378325|464983429|FG000|Overall Study|Protocol Violation|0|||
129187939|NCT01378325|464983430|FG001|Overall Study|Protocol Violation|1|||
129187940|NCT00767806|464983431|FG000|Overall Study|Adverse Event|30|||
129187941|NCT00767806|464983432|FG001|Overall Study|Adverse Event|11|||
129187942|NCT00767806|464983431|FG000|Overall Study|Withdrawal by Subject|8|||
129187943|NCT00767806|464983432|FG001|Overall Study|Withdrawal by Subject|13|||
129187944|NCT00767806|464983431|FG000|Overall Study|Protocol Violation|6|||
129187945|NCT00767806|464983432|FG001|Overall Study|Protocol Violation|5|||
129187946|NCT00767806|464983431|FG000|Overall Study|Lack of Efficacy|1|||
129187947|NCT00767806|464983432|FG001|Overall Study|Lack of Efficacy|9|||
129187948|NCT00767806|464983431|FG000|Overall Study|Physician Decision|4|||
129187949|NCT00767806|464983432|FG001|Overall Study|Physician Decision|3|||
129187950|NCT00767806|464983431|FG000|Overall Study|Lost to Follow-up|1|||
129187951|NCT00767806|464983432|FG001|Overall Study|Lost to Follow-up|4|||
129187952|NCT00767806|464983431|FG000|Overall Study|Entry Criteria Not Met|1|||
129187953|NCT00767806|464983432|FG001|Overall Study|Entry Criteria Not Met|1|||
129187954|NCT00767806|464983431|FG000|Overall Study|Sponsor Decision|0|||
129187955|NCT00767806|464983432|FG001|Overall Study|Sponsor Decision|1|||
129187956|NCT01272635|464983433|FG000|Overall Study|Lost to Follow-up|31|||
129187957|NCT01272635|464983434|FG001|Overall Study|Lost to Follow-up|20|||
129187958|NCT01272635|464983435|FG002|Overall Study|Lost to Follow-up|31|||
129187959|NCT01272635|464983436|FG003|Overall Study|Lost to Follow-up|23|||
129187960|NCT02397057|464983439|FG000|Overall Study|Withdrawal by Subject|6|||
129187961|NCT02397057|464983440|FG001|Overall Study|Withdrawal by Subject|7|||
129187962|NCT02397057|464983439|FG000|Overall Study|Lost to Follow-up|4|||
129187963|NCT02397057|464983440|FG001|Overall Study|Lost to Follow-up|3|||
129187964|NCT02397057|464983439|FG000|Overall Study|Death|1|||
129187965|NCT02397057|464983440|FG001|Overall Study|Death|0|||
129187966|NCT02397057|464983439|FG000|Overall Study|Adverse Event|0|||
129187967|NCT02397057|464983440|FG001|Overall Study|Adverse Event|1|||
129187968|NCT02397057|464983439|FG000|Overall Study|Physician Decision|0|||
129187969|NCT02397057|464983440|FG001|Overall Study|Physician Decision|1|||
129187970|NCT02397057|464983439|FG000|Overall Study|Subject did not receive study drug|0|||
129187971|NCT02397057|464983440|FG001|Overall Study|Subject did not receive study drug|1|||
129187972|NCT01393639|464983441|FG000|Overall Study|Protocol Violation|0|||
129187973|NCT01393639|464983442|FG001|Overall Study|Protocol Violation|0|||
129187974|NCT01393639|464983443|FG002|Overall Study|Protocol Violation|0|||
129187975|NCT01393639|464983444|FG003|Overall Study|Protocol Violation|1|||
129187976|NCT01393639|464983445|FG004|Overall Study|Protocol Violation|0|||
129187977|NCT01393639|464983446|FG005|Overall Study|Protocol Violation|0|||
129187978|NCT01393639|464983447|FG006|Overall Study|Protocol Violation|0|||
129187979|NCT01393639|464983441|FG000|Overall Study|Other|0|||
129187980|NCT01393639|464983442|FG001|Overall Study|Other|2|||
129187981|NCT01393639|464983443|FG002|Overall Study|Other|0|||
129187982|NCT01393639|464983444|FG003|Overall Study|Other|2|||
129187983|NCT01393639|464983445|FG004|Overall Study|Other|1|||
129187984|NCT01393639|464983446|FG005|Overall Study|Other|0|||
129187985|NCT01393639|464983447|FG006|Overall Study|Other|1|||
129187986|NCT01393639|464983441|FG000|Overall Study|Withdrawal by Subject|1|||
129187987|NCT01393639|464983442|FG001|Overall Study|Withdrawal by Subject|1|||
129187988|NCT01393639|464983443|FG002|Overall Study|Withdrawal by Subject|0|||
129187989|NCT01393639|464983444|FG003|Overall Study|Withdrawal by Subject|0|||
129187990|NCT01393639|464983445|FG004|Overall Study|Withdrawal by Subject|0|||
129187991|NCT01393639|464983446|FG005|Overall Study|Withdrawal by Subject|0|||
129187992|NCT01393639|464983447|FG006|Overall Study|Withdrawal by Subject|1|||
129187993|NCT01393639|464983441|FG000|Overall Study|Medication error without associated AE|0|||
129187994|NCT01393639|464983442|FG001|Overall Study|Medication error without associated AE|0|||
129187995|NCT01393639|464983443|FG002|Overall Study|Medication error without associated AE|0|||
129187996|NCT01393639|464983444|FG003|Overall Study|Medication error without associated AE|0|||
129187997|NCT01393639|464983445|FG004|Overall Study|Medication error without associated AE|0|||
129187998|NCT01393639|464983446|FG005|Overall Study|Medication error without associated AE|0|||
129187999|NCT01393639|464983447|FG006|Overall Study|Medication error without associated AE|1|||
129188000|NCT01393639|464983441|FG000|Overall Study|Lost to Follow-up|0|||
129188001|NCT01393639|464983442|FG001|Overall Study|Lost to Follow-up|1|||
129188002|NCT01393639|464983443|FG002|Overall Study|Lost to Follow-up|0|||
129188003|NCT01393639|464983444|FG003|Overall Study|Lost to Follow-up|0|||
129188004|NCT01393639|464983445|FG004|Overall Study|Lost to Follow-up|0|||
129188005|NCT01393639|464983446|FG005|Overall Study|Lost to Follow-up|0|||
129188006|NCT01393639|464983447|FG006|Overall Study|Lost to Follow-up|1|||
129188007|NCT01393639|464983441|FG000|Overall Study|Lack of Efficacy|0|||
129188008|NCT01393639|464983442|FG001|Overall Study|Lack of Efficacy|0|||
129188009|NCT01393639|464983443|FG002|Overall Study|Lack of Efficacy|0|||
129188010|NCT01393639|464983444|FG003|Overall Study|Lack of Efficacy|0|||
129188011|NCT01393639|464983445|FG004|Overall Study|Lack of Efficacy|0|||
129188012|NCT01393639|464983446|FG005|Overall Study|Lack of Efficacy|0|||
129188013|NCT01393639|464983447|FG006|Overall Study|Lack of Efficacy|1|||
129188014|NCT01393639|464983441|FG000|Overall Study|Adverse Event|2|||
129188015|NCT01393639|464983442|FG001|Overall Study|Adverse Event|3|||
129188016|NCT01393639|464983443|FG002|Overall Study|Adverse Event|1|||
129188017|NCT01393639|464983444|FG003|Overall Study|Adverse Event|2|||
129188018|NCT01393639|464983445|FG004|Overall Study|Adverse Event|0|||
129188019|NCT01393639|464983446|FG005|Overall Study|Adverse Event|2|||
129188020|NCT01393639|464983447|FG006|Overall Study|Adverse Event|3|||
129188021|NCT02241343|464983450|FG000|Overall Study|Adverse Event|1|||
129188022|NCT01329939|464983453|FG000|Overall Study|Lost to Follow-up|3|||
129188023|NCT01329939|464983454|FG001|Overall Study|Lost to Follow-up|0|||
129188024|NCT01329939|464983455|FG002|Overall Study|Lost to Follow-up|1|||
129188025|NCT01329939|464983456|FG003|Overall Study|Lost to Follow-up|2|||
129188026|NCT01329939|464983453|FG000|Overall Study|Withdrawal by Subject|0|||
129188027|NCT01329939|464983454|FG001|Overall Study|Withdrawal by Subject|1|||
129188028|NCT01329939|464983455|FG002|Overall Study|Withdrawal by Subject|0|||
129188029|NCT01329939|464983456|FG003|Overall Study|Withdrawal by Subject|0|||
129188030|NCT01329939|464983453|FG000|Overall Study|Adverse Event|0|||
129188031|NCT01329939|464983454|FG001|Overall Study|Adverse Event|0|||
129188032|NCT01329939|464983455|FG002|Overall Study|Adverse Event|0|||
129188033|NCT01329939|464983456|FG003|Overall Study|Adverse Event|3|||
129188034|NCT03722524|464983457|FG000|Overall Study|Protocol Violation|86|||
129188035|NCT03722524|464983457|FG000|Overall Study|Adverse Event|7|||
129188036|NCT03722524|464983457|FG000|Overall Study|Lost to Follow-up|1|||
129188037|NCT03722524|464983457|FG000|Overall Study|Reason is not stated|1|||
129188038|NCT03722524|464983457|FG000|Overall Study|Physician Decision|1|||
129188039|NCT03722524|464983457|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
129188040|NCT02942485|464983458|FG000|Overall Study|Lost to Follow-up|1|||
129188041|NCT02942485|464983459|FG001|Overall Study|Lost to Follow-up|0|||
129188042|NCT04369950|464983461|FG000|Overall Study|Protocol Violation|2|||
129188043|NCT04369950|464983462|FG001|Overall Study|Protocol Violation|2|||
129188044|NCT00989963|464983463|FG000|Overall Study|Adverse Event|1|||
129188045|NCT00989963|464983464|FG001|Overall Study|Adverse Event|1|||
129188046|NCT00989963|464983465|FG002|Overall Study|Adverse Event|1|||
129188047|NCT01240200|464983466|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
129188048|NCT01240200|464983467|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
129188049|NCT01529034|464983470|FG000|Overall Study|Discontinued prior to study treatment|14|||
129188050|NCT01529034|464983470|FG000|Overall Study|Site closure|62|||
129188051|NCT01529034|464983470|FG000|Overall Study|Study termination|29|||
129188052|NCT01529034|464983470|FG000|Overall Study|Withdrawal by Subject|25|||
129188053|NCT01529034|464983470|FG000|Overall Study|No treated SCs within protocol window|13|||
129188054|NCT01529034|464983470|FG000|Overall Study|Noncompliance|8|||
129188055|NCT01529034|464983470|FG000|Overall Study|Caregiver no longer available|7|||
129188056|NCT01529034|464983470|FG000|Overall Study|Adverse Event|4|||
129188057|NCT01529034|464983470|FG000|Overall Study|Protocol Violation|4|||
129188058|NCT01529034|464983470|FG000|Overall Study|Lack of Efficacy|4|||
129188059|NCT01529034|464983470|FG000|Overall Study|Investigator no longer available|2|||
129188060|NCT01529034|464983470|FG000|Overall Study|Study drug not available|2|||
129188061|NCT00646399|464983472|FG000|Overall Study|Death|63|||
129188062|NCT00646399|464983473|FG001|Overall Study|Death|53|||
129188063|NCT00646399|464983472|FG000|Overall Study|Withdrawal by Subject|9|||
129188064|NCT00646399|464983473|FG001|Overall Study|Withdrawal by Subject|10|||
129188065|NCT00646399|464983472|FG000|Overall Study|Other Reason|11|||
129188066|NCT00646399|464983473|FG001|Overall Study|Other Reason|11|||
129188067|NCT02473367|464983476|FG000|Wait 1|Withdrawal by Subject|1|||
129188068|NCT02473367|464983476|FG000|Period 4|Lost to Follow-up|1|||
129188069|NCT00454584|464983477|FG000|Controlled Period|Adverse Event|5|||
129188070|NCT00454584|464983478|FG001|Controlled Period|Adverse Event|2|||
129188071|NCT00454584|464983479|FG002|Controlled Period|Adverse Event|1|||
129188072|NCT00454584|464983480|FG003|Controlled Period|Adverse Event|0|||
129188073|NCT00454584|464983481|FG004|Controlled Period|Adverse Event|0|||
129188074|NCT00454584|464983482|FG005|Controlled Period|Adverse Event|0|||
129188075|NCT00454584|464983477|FG000|Controlled Period|Lost to Follow-up|1|||
129188076|NCT00454584|464983478|FG001|Controlled Period|Lost to Follow-up|2|||
129188077|NCT00454584|464983479|FG002|Controlled Period|Lost to Follow-up|2|||
129188078|NCT00454584|464983480|FG003|Controlled Period|Lost to Follow-up|0|||
129188079|NCT00454584|464983481|FG004|Controlled Period|Lost to Follow-up|0|||
129188080|NCT00454584|464983482|FG005|Controlled Period|Lost to Follow-up|0|||
129188081|NCT00454584|464983477|FG000|Controlled Period|Other|5|||
129188082|NCT00454584|464983478|FG001|Controlled Period|Other|4|||
129188083|NCT00454584|464983479|FG002|Controlled Period|Other|2|||
129188084|NCT00454584|464983480|FG003|Controlled Period|Other|0|||
129188085|NCT00454584|464983481|FG004|Controlled Period|Other|0|||
129188086|NCT00454584|464983482|FG005|Controlled Period|Other|0|||
129188087|NCT00454584|464983477|FG000|After Controlled Period|Adverse Event|0|||
129188088|NCT00454584|464983478|FG001|After Controlled Period|Adverse Event|0|||
129188089|NCT00454584|464983479|FG002|After Controlled Period|Adverse Event|0|||
129188090|NCT00454584|464983480|FG003|After Controlled Period|Adverse Event|9|||
129188091|NCT00454584|464983481|FG004|After Controlled Period|Adverse Event|3|||
129188092|NCT00454584|464983482|FG005|After Controlled Period|Adverse Event|9|||
129188093|NCT00454584|464983477|FG000|After Controlled Period|Lack of Efficacy|0|||
129188094|NCT00454584|464983478|FG001|After Controlled Period|Lack of Efficacy|0|||
129188095|NCT00454584|464983479|FG002|After Controlled Period|Lack of Efficacy|0|||
129188096|NCT00454584|464983480|FG003|After Controlled Period|Lack of Efficacy|1|||
129188097|NCT00454584|464983481|FG004|After Controlled Period|Lack of Efficacy|0|||
129188098|NCT00454584|464983482|FG005|After Controlled Period|Lack of Efficacy|0|||
129188099|NCT00454584|464983477|FG000|After Controlled Period|Lost to Follow-up|0|||
129188100|NCT00454584|464983478|FG001|After Controlled Period|Lost to Follow-up|0|||
129188101|NCT00454584|464983479|FG002|After Controlled Period|Lost to Follow-up|0|||
129188102|NCT00454584|464983480|FG003|After Controlled Period|Lost to Follow-up|2|||
129188103|NCT00454584|464983481|FG004|After Controlled Period|Lost to Follow-up|4|||
129188104|NCT00454584|464983482|FG005|After Controlled Period|Lost to Follow-up|6|||
129188105|NCT00454584|464983477|FG000|After Controlled Period|Other|0|||
129188106|NCT00454584|464983478|FG001|After Controlled Period|Other|0|||
129188107|NCT00454584|464983479|FG002|After Controlled Period|Other|0|||
129188108|NCT00454584|464983480|FG003|After Controlled Period|Other|1|||
129188109|NCT00454584|464983481|FG004|After Controlled Period|Other|0|||
129188110|NCT00454584|464983482|FG005|After Controlled Period|Other|0|||
129188111|NCT00454584|464983477|FG000|After Controlled Period|Other|0|||
129188112|NCT00454584|464983478|FG001|After Controlled Period|Other|0|||
129188113|NCT00454584|464983479|FG002|After Controlled Period|Other|0|||
129188114|NCT00454584|464983480|FG003|After Controlled Period|Other|13|||
129188115|NCT00454584|464983481|FG004|After Controlled Period|Other|5|||
129188116|NCT00454584|464983482|FG005|After Controlled Period|Other|17|||
129188117|NCT00470418|464983483|FG000|Overall Study|Withdrawal by Subject|1|||
129188118|NCT00470418|464983484|FG001|Overall Study|Withdrawal by Subject|0|||
129188119|NCT00454181|464983486|FG000|Overall Study|Adverse Event|1|||
129188120|NCT00454181|464983487|FG001|Overall Study|Adverse Event|1|||
129188121|NCT00454181|464983486|FG000|Overall Study|Lost to Follow-up|11|||
129188122|NCT00454181|464983487|FG001|Overall Study|Lost to Follow-up|1|||
129188123|NCT00454181|464983486|FG000|Overall Study|Protocol Violation|1|||
129188124|NCT00454181|464983487|FG001|Overall Study|Protocol Violation|1|||
129188125|NCT00454181|464983486|FG000|Overall Study|Withdrawal by Subject|2|||
129188126|NCT00454181|464983487|FG001|Overall Study|Withdrawal by Subject|0|||
129188127|NCT03689855|464983494|FG000|Overall Study|Adverse Event|3|||
129188128|NCT03689855|464983494|FG000|Overall Study|Withdrawal by Subject|1|||
129188129|NCT02409719|464983495|FG000|Overall Study|Lost to Follow-up|3|||
129188130|NCT02409719|464983496|FG001|Overall Study|Lost to Follow-up|3|||
129188131|NCT02479139|464983497|FG000|Overall Study|Lost to Follow-up|2|||
129188132|NCT02479139|464983498|FG001|Overall Study|Lost to Follow-up|4|||
129188133|NCT02479139|464983499|FG002|Overall Study|Lost to Follow-up|4|||
129188134|NCT02479139|464983500|FG003|Overall Study|Lost to Follow-up|2|||
129188135|NCT02479139|464983501|FG004|Overall Study|Lost to Follow-up|3|||
129188136|NCT02479139|464983502|FG005|Overall Study|Lost to Follow-up|5|||
129188137|NCT02479139|464983497|FG000|Overall Study|Withdrew Consent|5|||
129188138|NCT02479139|464983498|FG001|Overall Study|Withdrew Consent|6|||
129188139|NCT02479139|464983499|FG002|Overall Study|Withdrew Consent|1|||
129188140|NCT02479139|464983500|FG003|Overall Study|Withdrew Consent|4|||
129188141|NCT02479139|464983501|FG004|Overall Study|Withdrew Consent|1|||
129188142|NCT02479139|464983502|FG005|Overall Study|Withdrew Consent|1|||
129188143|NCT02479139|464983497|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129188144|NCT02479139|464983498|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129188145|NCT02479139|464983499|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
129188146|NCT02479139|464983500|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129188147|NCT02479139|464983501|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129188148|NCT02479139|464983502|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129188149|NCT02479139|464983497|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129188150|NCT02479139|464983498|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129188151|NCT02479139|464983499|FG002|Overall Study|Other Miscellaneous Reasons|1|||
129188152|NCT02479139|464983500|FG003|Overall Study|Other Miscellaneous Reasons|1|||
129188153|NCT02479139|464983501|FG004|Overall Study|Other Miscellaneous Reasons|1|||
129188154|NCT02479139|464983502|FG005|Overall Study|Other Miscellaneous Reasons|0|||
129188155|NCT00764673|464983503|FG000|Overall Study|Death|1|||
129188156|NCT00764673|464983503|FG000|Overall Study|Lost to Follow-up|3|||
129188157|NCT00764673|464983503|FG000|Overall Study|Withdrawal by Subject|6|||
129188158|NCT00764673|464983503|FG000|Overall Study|Revision of Device|2|||
129188159|NCT00619099|464983504|FG000|Overall Study|Progressive Disease|7|||
129188160|NCT00619099|464983505|FG001|Overall Study|Progressive Disease|5|||
129188161|NCT00619099|464983504|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
129188162|NCT00619099|464983505|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
129188163|NCT00619099|464983504|FG000|Overall Study|Adverse Event|4|||
129188164|NCT00619099|464983505|FG001|Overall Study|Adverse Event|3|||
129188165|NCT00619099|464983504|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
129188166|NCT00619099|464983505|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
129188167|NCT00619099|464983504|FG000|Overall Study|Withdrawal by Subject|10|||
129188168|NCT00619099|464983505|FG001|Overall Study|Withdrawal by Subject|2|||
129188169|NCT00619099|464983504|FG000|Overall Study|Physician Decision|9|||
129188170|NCT00619099|464983505|FG001|Overall Study|Physician Decision|6|||
129188171|NCT00885482|464983506|FG000|Overall Study|Pregnancy|1|||
129188172|NCT00885482|464983506|FG000|Overall Study|Lack of Efficacy|1|||
129188173|NCT00885482|464983506|FG000|Overall Study|Death|1|||
129188174|NCT00885482|464983506|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
129188175|NCT00084656|464983507|FG000|Overall Study|Other reasons|0|||
129188176|NCT00084656|464983508|FG001|Overall Study|Other reasons|12|||
129188177|NCT00084656|464983509|FG002|Overall Study|Other reasons|11|||
129188178|NCT00084656|464983507|FG000|Overall Study|Withdrawal by Subject|15|||
129188179|NCT00084656|464983508|FG001|Overall Study|Withdrawal by Subject|4|||
129188180|NCT00084656|464983509|FG002|Overall Study|Withdrawal by Subject|4|||
129188181|NCT00084656|464983507|FG000|Overall Study|Disease relapse|0|||
129188182|NCT00084656|464983508|FG001|Overall Study|Disease relapse|9|||
129188183|NCT00084656|464983509|FG002|Overall Study|Disease relapse|10|||
129188184|NCT00084656|464983507|FG000|Overall Study|Disease progression|9|||
129188185|NCT00084656|464983508|FG001|Overall Study|Disease progression|0|||
129188186|NCT00084656|464983509|FG002|Overall Study|Disease progression|0|||
129188187|NCT00084656|464983507|FG000|Overall Study|Lost to Follow-up|1|||
129188188|NCT00084656|464983508|FG001|Overall Study|Lost to Follow-up|0|||
129188189|NCT00084656|464983509|FG002|Overall Study|Lost to Follow-up|1|||
129188190|NCT02772978|464983510|FG000|Overall Study|Withdrawal by Subject|1|||
129188191|NCT02772978|464983511|FG001|Overall Study|Withdrawal by Subject|1|||
129188192|NCT00129467|464983512|FG000|Received Intervention|Death|1|||
129188193|NCT00129467|464983513|FG001|Received Intervention|Death|1|||
129188194|NCT00129467|464983512|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
129188195|NCT00129467|464983513|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
129188196|NCT00129467|464983512|FG000|Received Intervention|Delirium|2|||
129188197|NCT00129467|464983513|FG001|Received Intervention|Delirium|0|||
129188198|NCT00129467|464983512|FG000|Received Intervention|Withdrawal by Subject|1|||
129188199|NCT00129467|464983513|FG001|Received Intervention|Withdrawal by Subject|0|||
129188200|NCT00129467|464983512|FG000|Received Intervention|Nausea|1|||
129188201|NCT00129467|464983513|FG001|Received Intervention|Nausea|0|||
129188202|NCT00129467|464983512|FG000|Received Intervention|Intolerance to citalopram|0|||
129188203|NCT00129467|464983513|FG001|Received Intervention|Intolerance to citalopram|1|||
129188204|NCT00129467|464983512|FG000|Received Intervention|Dizzyness, fatigue|0|||
129188205|NCT00129467|464983513|FG001|Received Intervention|Dizzyness, fatigue|1|||
129188206|NCT00129467|464983512|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
129188207|NCT00129467|464983513|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
129188208|NCT00129467|464983512|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
129188209|NCT00129467|464983513|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
129188210|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
129188211|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
129188212|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
129188213|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
129188214|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
128781007|NCT00578227|463488648|FG002|Overall Study|Withdrawal by Subject|3|||
129188215|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
129188216|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
129188217|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
129188218|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
129188219|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
129188220|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
129188221|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
129188222|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
129188223|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
129188224|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
129188225|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
129188226|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
129188227|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
129188228|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
129188229|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
129188230|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
129188231|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
129188232|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
129188233|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
129188234|NCT01532869|464983514|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
129188235|NCT01532869|464983515|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
129188236|NCT01532869|464983514|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
129188237|NCT01532869|464983515|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
129188238|NCT01532869|464983514|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
129188239|NCT01532869|464983515|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
129188240|NCT01532869|464983514|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
129188241|NCT01532869|464983515|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
129188242|NCT01532869|464983514|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
129188243|NCT01532869|464983515|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
129188244|NCT01331291|464983516|FG000|Overall Study|Lack of Efficacy|2|||
129188245|NCT01331291|464983517|FG001|Overall Study|Lack of Efficacy|8|||
129188246|NCT01331291|464983516|FG000|Overall Study|Death|0|||
129188247|NCT01331291|464983517|FG001|Overall Study|Death|1|||
129188248|NCT00778895|464983518|FG000|Active Phase|Adverse Event|3|||
129188249|NCT00778895|464983519|FG001|Active Phase|Adverse Event|1|||
129188250|NCT00778895|464983520|FG002|Active Phase|Adverse Event|0|||
129188251|NCT00778895|464983518|FG000|Active Phase|Withdrawal by Subject|1|||
129188252|NCT00778895|464983519|FG001|Active Phase|Withdrawal by Subject|4|||
129188253|NCT00778895|464983520|FG002|Active Phase|Withdrawal by Subject|0|||
129188254|NCT00778895|464983518|FG000|Active Phase|Lost to Follow-up|1|||
129188255|NCT00778895|464983519|FG001|Active Phase|Lost to Follow-up|1|||
129188256|NCT00778895|464983520|FG002|Active Phase|Lost to Follow-up|0|||
129188257|NCT00778895|464983518|FG000|Active Phase|Other|2|||
129188258|NCT00778895|464983519|FG001|Active Phase|Other|0|||
129188259|NCT00778895|464983520|FG002|Active Phase|Other|0|||
129188260|NCT00778895|464983518|FG000|ESFU Phase|Adverse Event|2|||
129188261|NCT00778895|464983519|FG001|ESFU Phase|Adverse Event|1|||
129188262|NCT00778895|464983520|FG002|ESFU Phase|Adverse Event|0|||
129188263|NCT00778895|464983518|FG000|ESFU Phase|Withdrawal by Subject|1|||
129188264|NCT00778895|464983519|FG001|ESFU Phase|Withdrawal by Subject|4|||
129188265|NCT00778895|464983520|FG002|ESFU Phase|Withdrawal by Subject|0|||
129188266|NCT00778895|464983518|FG000|ESFU Phase|Lost to Follow-up|6|||
129188267|NCT00778895|464983519|FG001|ESFU Phase|Lost to Follow-up|7|||
129188268|NCT00778895|464983520|FG002|ESFU Phase|Lost to Follow-up|2|||
129188269|NCT00778895|464983518|FG000|ESFU Phase|Other|2|||
129188270|NCT00778895|464983519|FG001|ESFU Phase|Other|0|||
129188271|NCT00778895|464983520|FG002|ESFU Phase|Other|0|||
129188272|NCT02540993|464983522|FG000|Overall Study|Lost to Follow-up|5|||
129188273|NCT02540993|464983523|FG001|Overall Study|Lost to Follow-up|3|||
129188274|NCT02540993|464983522|FG000|Overall Study|Withdrawal by Subject|4|||
129188275|NCT02540993|464983523|FG001|Overall Study|Withdrawal by Subject|6|||
129188276|NCT02540993|464983522|FG000|Overall Study|GCP violations|33|||
129188277|NCT02540993|464983523|FG001|Overall Study|GCP violations|27|||
128730340|NCT00779675|463309946|FG000|Treatment Period|Lost to Follow-up|23|||
128730341|NCT00779675|463309946|FG000|Treatment Period|Withdrawal by Subject|46|||
129188278|NCT00409344|464983524|FG000|Overall Study|no enrollment|0|||
129188279|NCT00409344|464983525|FG001|Overall Study|no enrollment|0|||
129188280|NCT01009086|464983526|FG000|Overall Study|Lack of Efficacy|16|||
129188281|NCT01009086|464983527|FG001|Overall Study|Lack of Efficacy|15|||
129188282|NCT01009086|464983528|FG002|Overall Study|Lack of Efficacy|9|||
129188283|NCT01009086|464983526|FG000|Overall Study|Lost to Follow-up|4|||
129188284|NCT01009086|464983527|FG001|Overall Study|Lost to Follow-up|5|||
129188285|NCT01009086|464983528|FG002|Overall Study|Lost to Follow-up|3|||
129188286|NCT01009086|464983526|FG000|Overall Study|Adverse Event|12|||
129188287|NCT01009086|464983527|FG001|Overall Study|Adverse Event|11|||
129188288|NCT01009086|464983528|FG002|Overall Study|Adverse Event|8|||
129188289|NCT01009086|464983526|FG000|Overall Study|Withdrawal by Subject|9|||
129188290|NCT01009086|464983527|FG001|Overall Study|Withdrawal by Subject|11|||
129188291|NCT01009086|464983528|FG002|Overall Study|Withdrawal by Subject|13|||
129188292|NCT01009086|464983526|FG000|Overall Study|Other|3|||
129188293|NCT01009086|464983527|FG001|Overall Study|Other|5|||
129188294|NCT01009086|464983528|FG002|Overall Study|Other|1|||
129188295|NCT00590577|464983530|FG000|Overall Study|Lack of Efficacy|31|||
129188296|NCT00590577|464983531|FG001|Overall Study|Lack of Efficacy|28|||
129188297|NCT00590577|464983532|FG002|Overall Study|Lack of Efficacy|23|||
129188298|NCT00590577|464983533|FG003|Overall Study|Lack of Efficacy|45|||
129188299|NCT00590577|464983530|FG000|Overall Study|Withdrawal by Subject|23|||
129188300|NCT00590577|464983531|FG001|Overall Study|Withdrawal by Subject|28|||
129188301|NCT00590577|464983532|FG002|Overall Study|Withdrawal by Subject|30|||
129188302|NCT00590577|464983533|FG003|Overall Study|Withdrawal by Subject|26|||
129188303|NCT00590577|464983530|FG000|Overall Study|Adverse Event|10|||
129188304|NCT00590577|464983531|FG001|Overall Study|Adverse Event|10|||
129188305|NCT00590577|464983532|FG002|Overall Study|Adverse Event|13|||
129188306|NCT00590577|464983533|FG003|Overall Study|Adverse Event|11|||
129188307|NCT00590577|464983530|FG000|Overall Study|Lost to Follow-up|12|||
129188308|NCT00590577|464983531|FG001|Overall Study|Lost to Follow-up|6|||
129188309|NCT00590577|464983532|FG002|Overall Study|Lost to Follow-up|6|||
129188310|NCT00590577|464983533|FG003|Overall Study|Lost to Follow-up|9|||
129188311|NCT00590577|464983530|FG000|Overall Study|Pregnancy|0|||
129188312|NCT00590577|464983531|FG001|Overall Study|Pregnancy|1|||
129188313|NCT00590577|464983532|FG002|Overall Study|Pregnancy|0|||
129188314|NCT00590577|464983533|FG003|Overall Study|Pregnancy|0|||
129188315|NCT00590577|464983530|FG000|Overall Study|Various reasons|1|||
129188316|NCT00590577|464983531|FG001|Overall Study|Various reasons|3|||
129188317|NCT00590577|464983532|FG002|Overall Study|Various reasons|1|||
129188318|NCT00590577|464983533|FG003|Overall Study|Various reasons|2|||
129188319|NCT04349033|464983534|FG000|Overall Study|Lost to Follow-up|3|||
129188320|NCT04349033|464983535|FG001|Overall Study|Lost to Follow-up|1|||
129188321|NCT04349033|464983536|FG002|Overall Study|Lost to Follow-up|1|||
129188322|NCT03596450|464983543|FG000|Overall Study|Death|9|||
129188323|NCT03596450|464983544|FG001|Overall Study|Death|9|||
129188324|NCT03596450|464983543|FG000|Overall Study|Protocol Violation|18|||
129188325|NCT03596450|464983544|FG001|Overall Study|Protocol Violation|26|||
129188326|NCT03596450|464983543|FG000|Overall Study|Lost to Follow-up|50|||
129188327|NCT03596450|464983544|FG001|Overall Study|Lost to Follow-up|56|||
129188328|NCT03596450|464983543|FG000|Overall Study|Adverse Event|14|||
129188329|NCT03596450|464983544|FG001|Overall Study|Adverse Event|7|||
129188330|NCT03596450|464983543|FG000|Overall Study|Withdrawal by Subject|38|||
129188331|NCT03596450|464983544|FG001|Overall Study|Withdrawal by Subject|36|||
129188332|NCT03596450|464983543|FG000|Overall Study|Accidentally Randomized|2|||
129188333|NCT03596450|464983544|FG001|Overall Study|Accidentally Randomized|0|||
129188334|NCT03596450|464983543|FG000|Overall Study|Other reasons|48|||
129188335|NCT03596450|464983544|FG001|Overall Study|Other reasons|53|||
129188336|NCT03596450|464983543|FG000|Overall Study|Pregnancy|2|||
129188337|NCT03596450|464983544|FG001|Overall Study|Pregnancy|0|||
129188338|NCT00410605|464983545|FG000|Overall Study|Adverse Event|12|||
129188339|NCT00410605|464983545|FG000|Overall Study|Physician Decision|3|||
129188340|NCT00410605|464983545|FG000|Overall Study|Withdrawal by Subject|5|||
129188341|NCT00410605|464983545|FG000|Overall Study|Started Non-Protocol Therapy|3|||
129188342|NCT00410605|464983545|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
129188343|NCT00410605|464983545|FG000|Overall Study|Transferred to another Institution|1|||
129188344|NCT04058886|464983548|FG000|Overall Study|Withdrawal by Subject|4|||
129188345|NCT04058886|464983548|FG000|Overall Study|Inadequate deafness interpreter service|1|||
129188346|NCT02332291|464983549|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
129188347|NCT02332291|464983550|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
129188348|NCT02332291|464983549|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
129188349|NCT02332291|464983550|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
129188350|NCT02332291|464983549|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
129188351|NCT02332291|464983550|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
129188352|NCT02332291|464983549|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
129188353|NCT02332291|464983550|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
129188354|NCT02332291|464983549|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
128730342|NCT00779675|463309946|FG000|Treatment Period|Protocol Violation|54|||
129188355|NCT02332291|464983550|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
129188356|NCT02332291|464983549|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
129188357|NCT02332291|464983550|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
129188358|NCT02220712|464983554|FG000|Overall Study|Adverse Event|1|||
129188359|NCT02220712|464983554|FG000|Overall Study|Withdrawal by Subject|2|||
129188360|NCT02220712|464983554|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
129188361|NCT00760838|464983555|FG000|Overall Study|Adverse Event|1|||
129188362|NCT00760838|464983556|FG001|Overall Study|Adverse Event|1|||
129188363|NCT00760838|464983555|FG000|Overall Study|Lack of Efficacy|1|||
129188364|NCT00760838|464983556|FG001|Overall Study|Lack of Efficacy|0|||
129188365|NCT00760838|464983555|FG000|Overall Study|Lost to Follow-up|2|||
129188366|NCT00760838|464983556|FG001|Overall Study|Lost to Follow-up|0|||
129188367|NCT00760838|464983555|FG000|Overall Study|Withdrawal by Subject|1|||
129188368|NCT00760838|464983556|FG001|Overall Study|Withdrawal by Subject|1|||
129188369|NCT03624127|464983557|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
129188370|NCT03624127|464983558|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
129188371|NCT03624127|464983559|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
129188372|NCT03624127|464983557|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
129188373|NCT03624127|464983558|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
129188374|NCT03624127|464983559|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
129188375|NCT03624127|464983557|FG000|Treatment Week 0 - Week 16|Death|0|||
129188376|NCT03624127|464983558|FG001|Treatment Week 0 - Week 16|Death|1|||
129188377|NCT03624127|464983559|FG002|Treatment Week 0 - Week 16|Death|0|||
129188378|NCT03624127|464983557|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
129188379|NCT03624127|464983558|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
129188380|NCT03624127|464983559|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
129188381|NCT03624127|464983557|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
129188382|NCT03624127|464983558|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
129188383|NCT03624127|464983559|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
129188384|NCT03624127|464983557|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
129188385|NCT03624127|464983558|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
129188386|NCT03624127|464983559|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
129188387|NCT03624127|464983557|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
129188388|NCT03624127|464983558|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
129188389|NCT03624127|464983559|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
129188390|NCT03624127|464983557|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
129188391|NCT03624127|464983558|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
129188392|NCT03624127|464983559|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
129188393|NCT03624127|464983557|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
129188394|NCT03624127|464983558|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
129188395|NCT03624127|464983559|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
129188396|NCT03624127|464983557|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
129188397|NCT03624127|464983558|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
129188398|NCT03624127|464983559|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
129188399|NCT03624127|464983557|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
129188400|NCT03624127|464983558|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
129188401|NCT03624127|464983559|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
129188402|NCT03624127|464983557|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
129188403|NCT03624127|464983558|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
129188404|NCT03624127|464983559|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
129188405|NCT03624127|464983557|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
129188406|NCT03624127|464983558|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
129188407|NCT03624127|464983559|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
129188408|NCT03624127|464983557|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
129188409|NCT03624127|464983558|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
129188410|NCT03624127|464983559|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
129188411|NCT03624127|464983557|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
129188412|NCT03624127|464983558|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
129188413|NCT03624127|464983559|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
129188414|NCT03624127|464983557|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
129188415|NCT03624127|464983558|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
129188416|NCT03624127|464983559|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
129188417|NCT03624127|464983557|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
129188418|NCT03624127|464983558|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
129188419|NCT03624127|464983559|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
129188420|NCT03624127|464983557|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
129188421|NCT03624127|464983558|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
129188422|NCT03624127|464983559|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
129188423|NCT03624127|464983557|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
129188424|NCT03624127|464983558|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
129188425|NCT03624127|464983559|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
129188426|NCT03624127|464983557|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
129188427|NCT03624127|464983558|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
129188428|NCT03624127|464983559|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
129188429|NCT03624127|464983557|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
129188430|NCT03624127|464983558|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
129188431|NCT03624127|464983559|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
129188432|NCT02607228|464983560|FG000|Overall Study|Progressive Disease|4|||
129188433|NCT02607228|464983561|FG001|Overall Study|Progressive Disease|3|||
129188434|NCT02607228|464983562|FG002|Overall Study|Progressive Disease|1|||
129188435|NCT02607228|464983563|FG003|Overall Study|Progressive Disease|5|||
129188436|NCT02607228|464983564|FG004|Overall Study|Progressive Disease|4|||
129188437|NCT02607228|464983565|FG005|Overall Study|Progressive Disease|3|||
129188438|NCT02607228|464983566|FG006|Overall Study|Progressive Disease|1|||
129188439|NCT02607228|464983560|FG000|Overall Study|Adverse Event|1|||
129188440|NCT02607228|464983561|FG001|Overall Study|Adverse Event|0|||
129188441|NCT02607228|464983562|FG002|Overall Study|Adverse Event|1|||
129188442|NCT02607228|464983563|FG003|Overall Study|Adverse Event|0|||
129188443|NCT02607228|464983564|FG004|Overall Study|Adverse Event|1|||
129188444|NCT02607228|464983565|FG005|Overall Study|Adverse Event|1|||
129188445|NCT02607228|464983566|FG006|Overall Study|Adverse Event|1|||
129188446|NCT02607228|464983560|FG000|Overall Study|Investigator's Discretion|0|||
129188447|NCT02607228|464983561|FG001|Overall Study|Investigator's Discretion|0|||
129188448|NCT02607228|464983562|FG002|Overall Study|Investigator's Discretion|1|||
129188449|NCT02607228|464983563|FG003|Overall Study|Investigator's Discretion|0|||
129188450|NCT02607228|464983564|FG004|Overall Study|Investigator's Discretion|0|||
129188451|NCT02607228|464983565|FG005|Overall Study|Investigator's Discretion|1|||
129188452|NCT02607228|464983566|FG006|Overall Study|Investigator's Discretion|0|||
129188453|NCT02607228|464983560|FG000|Overall Study|Withdrew Consent|0|||
129188454|NCT02607228|464983561|FG001|Overall Study|Withdrew Consent|1|||
129188455|NCT02607228|464983562|FG002|Overall Study|Withdrew Consent|0|||
129188456|NCT02607228|464983563|FG003|Overall Study|Withdrew Consent|0|||
129188457|NCT02607228|464983564|FG004|Overall Study|Withdrew Consent|0|||
129188458|NCT02607228|464983565|FG005|Overall Study|Withdrew Consent|1|||
129188459|NCT02607228|464983566|FG006|Overall Study|Withdrew Consent|0|||
129188460|NCT02607228|464983560|FG000|Overall Study|Study Terminated by Sponsor|0|||
129188461|NCT02607228|464983561|FG001|Overall Study|Study Terminated by Sponsor|0|||
129188462|NCT02607228|464983562|FG002|Overall Study|Study Terminated by Sponsor|0|||
129188463|NCT02607228|464983563|FG003|Overall Study|Study Terminated by Sponsor|1|||
129188464|NCT02607228|464983564|FG004|Overall Study|Study Terminated by Sponsor|0|||
129188465|NCT02607228|464983565|FG005|Overall Study|Study Terminated by Sponsor|0|||
129188466|NCT02607228|464983566|FG006|Overall Study|Study Terminated by Sponsor|0|||
128730343|NCT00779675|463309946|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
128730344|NCT00779675|463309946|FG000|Treatment Period|Administrative|3|||
129188467|NCT04356040|464983567|FG000|Overall Study|Death|2|||
129188468|NCT04356040|464983568|FG001|Overall Study|Death|0|||
129188469|NCT04356040|464983567|FG000|Overall Study|Lost to Follow-up|1|||
129188470|NCT04356040|464983568|FG001|Overall Study|Lost to Follow-up|0|||
129188471|NCT04356040|464983567|FG000|Overall Study|Physician Decision|0|||
129188472|NCT04356040|464983568|FG001|Overall Study|Physician Decision|1|||
129188473|NCT04356040|464983567|FG000|Overall Study|Withdrawal by Subject|13|||
129188474|NCT04356040|464983568|FG001|Overall Study|Withdrawal by Subject|1|||
129188475|NCT04356040|464983567|FG000|Overall Study|Enrollment Pause|10|||
129188476|NCT04356040|464983568|FG001|Overall Study|Enrollment Pause|0|||
129188477|NCT04356040|464983567|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
129188478|NCT04356040|464983568|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
129188479|NCT04356040|464983567|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
129188480|NCT04356040|464983568|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
129188481|NCT04356040|464983567|FG000|Overall Study|PI left institution|3|||
129188482|NCT04356040|464983568|FG001|Overall Study|PI left institution|0|||
129188483|NCT01990859|464983569|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
129188484|NCT01990859|464983569|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
129188485|NCT02262754|464983571|FG000|Overall Study|Adverse Event|3|||
129188486|NCT02262754|464983572|FG001|Overall Study|Adverse Event|4|||
129188487|NCT02262754|464983573|FG002|Overall Study|Adverse Event|0|||
129188488|NCT02262754|464983571|FG000|Overall Study|Lack of Efficacy|2|||
129188489|NCT02262754|464983572|FG001|Overall Study|Lack of Efficacy|0|||
129188490|NCT02262754|464983573|FG002|Overall Study|Lack of Efficacy|1|||
129188491|NCT02262754|464983571|FG000|Overall Study|Lost to Follow-up|0|||
129188492|NCT02262754|464983572|FG001|Overall Study|Lost to Follow-up|0|||
129188493|NCT02262754|464983573|FG002|Overall Study|Lost to Follow-up|1|||
129188494|NCT02262754|464983571|FG000|Overall Study|No longer meets eligibility criteria|0|||
129188495|NCT02262754|464983572|FG001|Overall Study|No longer meets eligibility criteria|1|||
129188496|NCT02262754|464983573|FG002|Overall Study|No longer meets eligibility criteria|0|||
129188497|NCT02262754|464983571|FG000|Overall Study|Study terminated by sponsor|5|||
129188498|NCT02262754|464983572|FG001|Overall Study|Study terminated by sponsor|4|||
129188499|NCT02262754|464983573|FG002|Overall Study|Study terminated by sponsor|4|||
129188500|NCT02262754|464983571|FG000|Overall Study|Protocol Violation|1|||
129188501|NCT02262754|464983572|FG001|Overall Study|Protocol Violation|0|||
129188502|NCT02262754|464983573|FG002|Overall Study|Protocol Violation|0|||
129188503|NCT02262754|464983571|FG000|Overall Study|Withdrawal by Subject|1|||
129188504|NCT02262754|464983572|FG001|Overall Study|Withdrawal by Subject|0|||
129188505|NCT02262754|464983573|FG002|Overall Study|Withdrawal by Subject|1|||
129188506|NCT02262754|464983571|FG000|Overall Study|Other|4|||
129188507|NCT02262754|464983572|FG001|Overall Study|Other|0|||
129188508|NCT02262754|464983573|FG002|Overall Study|Other|2|||
129188509|NCT02577016|464983578|FG000|Overall Study|Adverse Event|2|||
129188510|NCT02577016|464983579|FG001|Overall Study|Adverse Event|1|||
129188511|NCT02577016|464983578|FG000|Overall Study|Physician Decision|0|||
129188512|NCT02577016|464983579|FG001|Overall Study|Physician Decision|1|||
129188513|NCT02126839|464983580|FG000|Overall Study|Adverse Event|0|||
129188514|NCT02126839|464983581|FG001|Overall Study|Adverse Event|1|||
129188515|NCT02126839|464983580|FG000|Overall Study|Withdrawal by Subject|1|||
129188516|NCT02126839|464983581|FG001|Overall Study|Withdrawal by Subject|0|||
129188517|NCT02126839|464983580|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129188518|NCT02126839|464983581|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129188519|NCT02126839|464983580|FG000|Overall Study|Protocol Violation|2|||
129188520|NCT02126839|464983581|FG001|Overall Study|Protocol Violation|3|||
129188521|NCT02126839|464983580|FG000|Overall Study|Sponsor request|0|||
129188522|NCT02126839|464983581|FG001|Overall Study|Sponsor request|1|||
129188523|NCT02126839|464983580|FG000|Overall Study|Lost to Follow-up|1|||
129188524|NCT02126839|464983581|FG001|Overall Study|Lost to Follow-up|4|||
129188525|NCT02126839|464983580|FG000|Overall Study|Other|5|||
129188526|NCT02126839|464983581|FG001|Overall Study|Other|5|||
129188527|NCT00812565|464983584|FG000|Overall Study|Did Not Receive Study Medication|1|||
129188528|NCT00812565|464983585|FG001|Overall Study|Did Not Receive Study Medication|1|||
129188529|NCT00812565|464983586|FG002|Overall Study|Did Not Receive Study Medication|0|||
129188530|NCT00812565|464983587|FG003|Overall Study|Did Not Receive Study Medication|0|||
129188531|NCT00812565|464983588|FG004|Overall Study|Did Not Receive Study Medication|0|||
129188532|NCT00812565|464983589|FG005|Overall Study|Did Not Receive Study Medication|0|||
129188533|NCT00812565|464983590|FG006|Overall Study|Did Not Receive Study Medication|0|||
129188534|NCT00812565|464983591|FG007|Overall Study|Did Not Receive Study Medication|0|||
129188535|NCT00812565|464983584|FG000|Overall Study|Adverse Event|0|||
129188536|NCT00812565|464983585|FG001|Overall Study|Adverse Event|0|||
129188537|NCT00812565|464983586|FG002|Overall Study|Adverse Event|0|||
129188538|NCT00812565|464983587|FG003|Overall Study|Adverse Event|2|||
128781008|NCT00577629|463488649|FG000|Treatment Period|Death|1|||
129188539|NCT00812565|464983588|FG004|Overall Study|Adverse Event|0|||
129188540|NCT00812565|464983589|FG005|Overall Study|Adverse Event|0|||
129188541|NCT00812565|464983590|FG006|Overall Study|Adverse Event|0|||
129188542|NCT00812565|464983591|FG007|Overall Study|Adverse Event|1|||
129188543|NCT00812565|464983584|FG000|Overall Study|Did Not Come to Study Visit|1|||
129188544|NCT00812565|464983585|FG001|Overall Study|Did Not Come to Study Visit|0|||
129188545|NCT00812565|464983586|FG002|Overall Study|Did Not Come to Study Visit|0|||
129188546|NCT00812565|464983587|FG003|Overall Study|Did Not Come to Study Visit|0|||
129188547|NCT00812565|464983588|FG004|Overall Study|Did Not Come to Study Visit|0|||
129188548|NCT00812565|464983589|FG005|Overall Study|Did Not Come to Study Visit|0|||
129188549|NCT00812565|464983590|FG006|Overall Study|Did Not Come to Study Visit|0|||
129188550|NCT00812565|464983591|FG007|Overall Study|Did Not Come to Study Visit|0|||
129188551|NCT00812565|464983584|FG000|Overall Study|Withdrawal of Consent|1|||
129188552|NCT00812565|464983585|FG001|Overall Study|Withdrawal of Consent|0|||
129188553|NCT00812565|464983586|FG002|Overall Study|Withdrawal of Consent|0|||
129188554|NCT00812565|464983587|FG003|Overall Study|Withdrawal of Consent|0|||
129188555|NCT00812565|464983588|FG004|Overall Study|Withdrawal of Consent|1|||
129188556|NCT00812565|464983589|FG005|Overall Study|Withdrawal of Consent|0|||
129188557|NCT00812565|464983590|FG006|Overall Study|Withdrawal of Consent|0|||
129188558|NCT00812565|464983591|FG007|Overall Study|Withdrawal of Consent|0|||
129188559|NCT00812565|464983584|FG000|Overall Study|Reason Not Specified|0|||
129188560|NCT00812565|464983585|FG001|Overall Study|Reason Not Specified|0|||
129188561|NCT00812565|464983586|FG002|Overall Study|Reason Not Specified|0|||
129188562|NCT00812565|464983587|FG003|Overall Study|Reason Not Specified|0|||
129188563|NCT00812565|464983588|FG004|Overall Study|Reason Not Specified|0|||
129188564|NCT00812565|464983589|FG005|Overall Study|Reason Not Specified|1|||
129188565|NCT00812565|464983590|FG006|Overall Study|Reason Not Specified|0|||
129188566|NCT00812565|464983591|FG007|Overall Study|Reason Not Specified|0|||
129188567|NCT00422383|464983592|FG000|Overall Study|Adverse Event|5|||
129188568|NCT00422383|464983593|FG001|Overall Study|Adverse Event|3|||
129188569|NCT00422383|464983594|FG002|Overall Study|Adverse Event|1|||
129188570|NCT00422383|464983595|FG003|Overall Study|Adverse Event|1|||
129188571|NCT00422383|464983596|FG004|Overall Study|Adverse Event|0|||
129188572|NCT00422383|464983592|FG000|Overall Study|Lack of Efficacy|4|||
129188573|NCT00422383|464983593|FG001|Overall Study|Lack of Efficacy|4|||
129188574|NCT00422383|464983594|FG002|Overall Study|Lack of Efficacy|2|||
129188575|NCT00422383|464983595|FG003|Overall Study|Lack of Efficacy|1|||
129188576|NCT00422383|464983596|FG004|Overall Study|Lack of Efficacy|1|||
129188577|NCT00422383|464983592|FG000|Overall Study|Lost to Follow-up|0|||
129188578|NCT00422383|464983593|FG001|Overall Study|Lost to Follow-up|1|||
129188579|NCT00422383|464983594|FG002|Overall Study|Lost to Follow-up|0|||
129188580|NCT00422383|464983595|FG003|Overall Study|Lost to Follow-up|0|||
129188581|NCT00422383|464983596|FG004|Overall Study|Lost to Follow-up|1|||
129188582|NCT00422383|464983592|FG000|Overall Study|Protocol Violation|1|||
129188583|NCT00422383|464983593|FG001|Overall Study|Protocol Violation|1|||
129188584|NCT00422383|464983594|FG002|Overall Study|Protocol Violation|1|||
129188585|NCT00422383|464983595|FG003|Overall Study|Protocol Violation|0|||
129188586|NCT00422383|464983596|FG004|Overall Study|Protocol Violation|0|||
129188587|NCT00422383|464983592|FG000|Overall Study|Withdrawal by Subject|5|||
129188588|NCT00422383|464983593|FG001|Overall Study|Withdrawal by Subject|5|||
129188589|NCT00422383|464983594|FG002|Overall Study|Withdrawal by Subject|0|||
129188590|NCT00422383|464983595|FG003|Overall Study|Withdrawal by Subject|0|||
129188591|NCT00422383|464983596|FG004|Overall Study|Withdrawal by Subject|1|||
129188592|NCT05066165|464985552|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
129188593|NCT05066165|464985553|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
129188594|NCT05066165|464985552|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
129188595|NCT05066165|464985553|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
129188596|NCT03738618|464985554|FG000|Overall Study|Protocol deviation|23|||
129188597|NCT03738618|464985555|FG001|Overall Study|Protocol deviation|0|||
129188598|NCT03738618|464985554|FG000|Overall Study|Adverse Event|4|||
129188599|NCT03738618|464985555|FG001|Overall Study|Adverse Event|0|||
129188600|NCT03738618|464985554|FG000|Overall Study|Lost to Follow-up|2|||
129188601|NCT03738618|464985555|FG001|Overall Study|Lost to Follow-up|0|||
129188602|NCT03738618|464985554|FG000|Overall Study|Randomization failure|1|||
129188603|NCT03738618|464985555|FG001|Overall Study|Randomization failure|0|||
129188604|NCT03738618|464985554|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
129188605|NCT03738618|464985555|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
129188606|NCT03738618|464985554|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
129188607|NCT03738618|464985555|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
129188608|NCT01769196|464985556|FG000|Overall Study|Adverse Event|24|||
129188609|NCT01769196|464985557|FG001|Overall Study|Adverse Event|20|||
129188610|NCT01769196|464985556|FG000|Overall Study|Death|21|||
129188611|NCT01769196|464985557|FG001|Overall Study|Death|26|||
129188612|NCT01769196|464985556|FG000|Overall Study|Investigator Discretion|7|||
129188613|NCT01769196|464985557|FG001|Overall Study|Investigator Discretion|3|||
129188614|NCT01769196|464985556|FG000|Overall Study|Lack of Efficacy|3|||
129188615|NCT01769196|464985557|FG001|Overall Study|Lack of Efficacy|2|||
129188616|NCT01769196|464985556|FG000|Overall Study|Progressive disease|11|||
129188617|NCT01769196|464985557|FG001|Overall Study|Progressive disease|6|||
129188618|NCT01769196|464985556|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
128730345|NCT00779675|463309946|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
128730346|NCT00779675|463309946|FG000|Extended Treatment Period|Protocol Violation|13|||
128730347|NCT00779675|463309946|FG000|Extended Treatment Period|Adverse Event|6|||
128730348|NCT00779675|463309946|FG000|Extended Treatment Period|Treatment Failure|11|||
129188619|NCT01769196|464985557|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
129188620|NCT01769196|464985556|FG000|Overall Study|Protocol Violation|0|||
129188621|NCT01769196|464985557|FG001|Overall Study|Protocol Violation|3|||
129188622|NCT01769196|464985556|FG000|Overall Study|Study terminated by sponsor|160|||
129188623|NCT01769196|464985557|FG001|Overall Study|Study terminated by sponsor|161|||
129188624|NCT01769196|464985556|FG000|Overall Study|Participant never dosed with study drug|1|||
129188625|NCT01769196|464985557|FG001|Overall Study|Participant never dosed with study drug|0|||
129188626|NCT01769196|464985556|FG000|Overall Study|Withdrew consent|36|||
129188627|NCT01769196|464985557|FG001|Overall Study|Withdrew consent|40|||
129188628|NCT01450098|464985564|FG000|Period 3|Protocol Violation|0|||
129188629|NCT01450098|464985565|FG001|Period 3|Protocol Violation|1|||
129188630|NCT01450098|464985564|FG000|Period 3|Withdrawal by Subject|0|||
129188631|NCT01450098|464985565|FG001|Period 3|Withdrawal by Subject|2|||
129188632|NCT00655629|464985566|FG000|Overall Study|Adverse Event|4|||
129188633|NCT00655629|464985567|FG001|Overall Study|Adverse Event|1|||
129188634|NCT00655629|464985566|FG000|Overall Study|Lack of Efficacy|2|||
129188635|NCT00655629|464985567|FG001|Overall Study|Lack of Efficacy|12|||
129188636|NCT00655629|464985566|FG000|Overall Study|Lost to Follow-up|4|||
129188637|NCT00655629|464985567|FG001|Overall Study|Lost to Follow-up|3|||
129188638|NCT00655629|464985566|FG000|Overall Study|Protocol Violation|5|||
129188639|NCT00655629|464985567|FG001|Overall Study|Protocol Violation|3|||
129188640|NCT00655629|464985566|FG000|Overall Study|consent withdrawn|6|||
129188641|NCT00655629|464985567|FG001|Overall Study|consent withdrawn|4|||
129188642|NCT00705367|464985568|FG000|Long-term Extension Period|Adverse Event|2|||
129188643|NCT00705367|464985569|FG001|Long-term Extension Period|Adverse Event|0|||
129188644|NCT00705367|464985568|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
129188645|NCT00705367|464985569|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
129188646|NCT00705367|464985568|FG000|Long-term Extension Period|Lack of Efficacy|1|||
129188647|NCT00705367|464985569|FG001|Long-term Extension Period|Lack of Efficacy|0|||
129188648|NCT00705367|464985568|FG000|Long-term Extension Period|No longer met study criteria|1|||
129188649|NCT00705367|464985569|FG001|Long-term Extension Period|No longer met study criteria|0|||
129188650|NCT00705367|464985568|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
129188651|NCT00705367|464985569|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
129188652|NCT01832155|464985570|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
129188653|NCT01832155|464985571|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
129188654|NCT01832155|464985570|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
129188655|NCT01832155|464985571|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
129188656|NCT01055314|464985572|FG000|Overall Study|Adverse Event|7|||
129188657|NCT01055314|464985573|FG001|Overall Study|Adverse Event|4|||
129188658|NCT01055314|464985572|FG000|Overall Study|Death|2|||
129188659|NCT01055314|464985573|FG001|Overall Study|Death|1|||
129188660|NCT01055314|464985572|FG000|Overall Study|Lack of Efficacy|11|||
129188661|NCT01055314|464985573|FG001|Overall Study|Lack of Efficacy|19|||
129188662|NCT01055314|464985572|FG000|Overall Study|Physician Decision|10|||
129188663|NCT01055314|464985573|FG001|Overall Study|Physician Decision|5|||
129188664|NCT01055314|464985572|FG000|Overall Study|Withdrawal by Subject|1|||
129188665|NCT01055314|464985573|FG001|Overall Study|Withdrawal by Subject|0|||
129188666|NCT01055314|464985572|FG000|Overall Study|Ineligible|3|||
129188667|NCT01055314|464985573|FG001|Overall Study|Ineligible|5|||
129188668|NCT01055314|464985572|FG000|Overall Study|Refusal of further protocol therapy|10|||
129188669|NCT01055314|464985573|FG001|Overall Study|Refusal of further protocol therapy|4|||
129188670|NCT01055314|464985572|FG000|Overall Study|No treatment|1|||
129188671|NCT01055314|464985573|FG001|Overall Study|No treatment|0|||
129188672|NCT01279616|464985574|FG000|Overall Study|donor could not be located|5|||
129188673|NCT01279616|464985574|FG000|Overall Study|no signs of sickle cell disease|2|||
129188674|NCT02462720|464985575|FG000|Part 2|Withdrawal by Subject|1|||
129188675|NCT02462720|464985576|FG001|Part 2|Withdrawal by Subject|0|||
129188676|NCT02462720|464985575|FG000|Part 2|Protocol Violation|0|||
129188677|NCT02462720|464985576|FG001|Part 2|Protocol Violation|1|||
129188678|NCT00183625|464985579|FG000|Overall Study|Withdrawal by Subject|18|||
129188679|NCT00183625|464985580|FG001|Overall Study|Withdrawal by Subject|18|||
129188680|NCT00183625|464985581|FG002|Overall Study|Withdrawal by Subject|19|||
129188681|NCT00183625|464985582|FG003|Overall Study|Withdrawal by Subject|14|||
129188682|NCT05249569|464985585|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
129188683|NCT02678923|464985589|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
129188684|NCT02678923|464985590|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
129188685|NCT02678923|464985589|FG000|Overall Study|Withdrawal by Subject|3|||
129188686|NCT02678923|464985590|FG001|Overall Study|Withdrawal by Subject|2|||
129188687|NCT02678923|464985589|FG000|Overall Study|Lost to Follow-up|1|||
129188688|NCT02678923|464985590|FG001|Overall Study|Lost to Follow-up|0|||
129188689|NCT02678923|464985589|FG000|Overall Study|Did Not Return for Study Visits|1|||
129188690|NCT02678923|464985590|FG001|Overall Study|Did Not Return for Study Visits|0|||
129188691|NCT00455143|464985591|FG000|Overall Study|Physician Decision|1|||
129188692|NCT00455143|464985591|FG000|Overall Study|Withdrawal by Subject|1|||
129188693|NCT00455143|464985591|FG000|Overall Study|Staff was not avail to follow patient|2|||
129188694|NCT00455143|464985591|FG000|Overall Study|No longer met Inclusion Criteria|1|||
129188695|NCT00455143|464985591|FG000|Overall Study|Surgical time, staff not available|1|||
129188696|NCT00098306|464985594|FG000|Double Blind|Randomized, not treated|9|||
129188697|NCT00098306|464985595|FG001|Double Blind|Randomized, not treated|5|||
129188698|NCT00098306|464985596|FG002|Double Blind|Randomized, not treated|2|||
129188699|NCT00098306|464985597|FG003|Double Blind|Randomized, not treated|0|||
129188700|NCT00098306|464985598|FG004|Double Blind|Randomized, not treated|0|||
129188701|NCT00098306|464985599|FG005|Double Blind|Randomized, not treated|0|||
129188702|NCT00098306|464985600|FG006|Double Blind|Randomized, not treated|0|||
129188703|NCT00098306|464985594|FG000|Double Blind|Ongoing at cut-off date|151|||
129188704|NCT00098306|464985595|FG001|Double Blind|Ongoing at cut-off date|166|||
129188705|NCT00098306|464985596|FG002|Double Blind|Ongoing at cut-off date|72|||
129188706|NCT00098306|464985597|FG003|Double Blind|Ongoing at cut-off date|0|||
129188707|NCT00098306|464985598|FG004|Double Blind|Ongoing at cut-off date|0|||
129188708|NCT00098306|464985599|FG005|Double Blind|Ongoing at cut-off date|0|||
129188709|NCT00098306|464985600|FG006|Double Blind|Ongoing at cut-off date|0|||
129188710|NCT00098306|464985594|FG000|Double Blind|Adverse Event|11|||
129188711|NCT00098306|464985595|FG001|Double Blind|Adverse Event|10|||
129188712|NCT00098306|464985596|FG002|Double Blind|Adverse Event|6|||
129188713|NCT00098306|464985597|FG003|Double Blind|Adverse Event|0|||
129188714|NCT00098306|464985598|FG004|Double Blind|Adverse Event|0|||
129188715|NCT00098306|464985599|FG005|Double Blind|Adverse Event|0|||
129188716|NCT00098306|464985600|FG006|Double Blind|Adverse Event|0|||
129188717|NCT00098306|464985594|FG000|Double Blind|Lack of Efficacy|43|||
129188718|NCT00098306|464985595|FG001|Double Blind|Lack of Efficacy|34|||
129188719|NCT00098306|464985596|FG002|Double Blind|Lack of Efficacy|17|||
129188720|NCT00098306|464985597|FG003|Double Blind|Lack of Efficacy|0|||
129188721|NCT00098306|464985598|FG004|Double Blind|Lack of Efficacy|0|||
129188722|NCT00098306|464985599|FG005|Double Blind|Lack of Efficacy|0|||
129188723|NCT00098306|464985600|FG006|Double Blind|Lack of Efficacy|0|||
129188724|NCT00098306|464985594|FG000|Double Blind|Death|1|||
129188725|NCT00098306|464985595|FG001|Double Blind|Death|4|||
129188726|NCT00098306|464985596|FG002|Double Blind|Death|1|||
129188727|NCT00098306|464985597|FG003|Double Blind|Death|0|||
129188728|NCT00098306|464985598|FG004|Double Blind|Death|0|||
129188729|NCT00098306|464985599|FG005|Double Blind|Death|0|||
129188730|NCT00098306|464985600|FG006|Double Blind|Death|0|||
129188731|NCT00098306|464985594|FG000|Double Blind|Participant defaulted|19|||
129188732|NCT00098306|464985595|FG001|Double Blind|Participant defaulted|18|||
129188733|NCT00098306|464985596|FG002|Double Blind|Participant defaulted|11|||
129188734|NCT00098306|464985597|FG003|Double Blind|Participant defaulted|0|||
129188735|NCT00098306|464985598|FG004|Double Blind|Participant defaulted|0|||
129188736|NCT00098306|464985599|FG005|Double Blind|Participant defaulted|0|||
129188737|NCT00098306|464985600|FG006|Double Blind|Participant defaulted|0|||
129188738|NCT00098306|464985594|FG000|Double Blind|Un-specified|7|||
129188739|NCT00098306|464985595|FG001|Double Blind|Un-specified|3|||
129188740|NCT00098306|464985596|FG002|Double Blind|Un-specified|11|||
129188741|NCT00098306|464985597|FG003|Double Blind|Un-specified|0|||
129188742|NCT00098306|464985598|FG004|Double Blind|Un-specified|0|||
129188743|NCT00098306|464985599|FG005|Double Blind|Un-specified|0|||
129188744|NCT00098306|464985600|FG006|Double Blind|Un-specified|0|||
129188745|NCT00098306|464985594|FG000|Open Label|Lack of Efficacy|0|||
129188746|NCT00098306|464985595|FG001|Open Label|Lack of Efficacy|0|||
129188747|NCT00098306|464985596|FG002|Open Label|Lack of Efficacy|0|||
129188748|NCT00098306|464985597|FG003|Open Label|Lack of Efficacy|13|||
129188749|NCT00098306|464985598|FG004|Open Label|Lack of Efficacy|0|||
129188750|NCT00098306|464985599|FG005|Open Label|Lack of Efficacy|0|||
129188751|NCT00098306|464985600|FG006|Open Label|Lack of Efficacy|0|||
129188752|NCT00098306|464985594|FG000|Open Label|Adverse Event|0|||
129188753|NCT00098306|464985595|FG001|Open Label|Adverse Event|0|||
129188754|NCT00098306|464985596|FG002|Open Label|Adverse Event|0|||
129188755|NCT00098306|464985597|FG003|Open Label|Adverse Event|2|||
129188756|NCT00098306|464985598|FG004|Open Label|Adverse Event|0|||
129188757|NCT00098306|464985599|FG005|Open Label|Adverse Event|0|||
129188758|NCT00098306|464985600|FG006|Open Label|Adverse Event|0|||
129188759|NCT00098306|464985594|FG000|Open Label|Death|0|||
129188760|NCT00098306|464985595|FG001|Open Label|Death|0|||
129188761|NCT00098306|464985596|FG002|Open Label|Death|0|||
129188762|NCT00098306|464985597|FG003|Open Label|Death|4|||
129188763|NCT00098306|464985598|FG004|Open Label|Death|0|||
129188764|NCT00098306|464985599|FG005|Open Label|Death|0|||
129188765|NCT00098306|464985600|FG006|Open Label|Death|0|||
129188766|NCT00098306|464985594|FG000|Open Label|Participant defaulted|0|||
129188767|NCT00098306|464985595|FG001|Open Label|Participant defaulted|0|||
129188768|NCT00098306|464985596|FG002|Open Label|Participant defaulted|0|||
129188769|NCT00098306|464985597|FG003|Open Label|Participant defaulted|24|||
129188770|NCT00098306|464985598|FG004|Open Label|Participant defaulted|0|||
129188771|NCT00098306|464985599|FG005|Open Label|Participant defaulted|0|||
129188772|NCT00098306|464985600|FG006|Open Label|Participant defaulted|0|||
129188773|NCT00098306|464985594|FG000|Open Label|Un-specified|0|||
129188774|NCT00098306|464985595|FG001|Open Label|Un-specified|0|||
129188775|NCT00098306|464985596|FG002|Open Label|Un-specified|0|||
129188776|NCT00098306|464985597|FG003|Open Label|Un-specified|15|||
129188777|NCT00098306|464985598|FG004|Open Label|Un-specified|0|||
129188778|NCT00098306|464985599|FG005|Open Label|Un-specified|0|||
129188779|NCT00098306|464985600|FG006|Open Label|Un-specified|0|||
129188780|NCT00098306|464985594|FG000|Open Label|Ongoing at cut-off date|0|||
129188781|NCT00098306|464985595|FG001|Open Label|Ongoing at cut-off date|0|||
129188782|NCT00098306|464985596|FG002|Open Label|Ongoing at cut-off date|0|||
129188783|NCT00098306|464985597|FG003|Open Label|Ongoing at cut-off date|269|||
129188784|NCT00098306|464985598|FG004|Open Label|Ongoing at cut-off date|62|||
129188785|NCT00098306|464985599|FG005|Open Label|Ongoing at cut-off date|0|||
129188786|NCT00098306|464985600|FG006|Open Label|Ongoing at cut-off date|0|||
129188787|NCT00098306|464985594|FG000|Observational Phase|Death|0|||
129188788|NCT00098306|464985595|FG001|Observational Phase|Death|0|||
129188789|NCT00098306|464985596|FG002|Observational Phase|Death|0|||
129188790|NCT00098306|464985597|FG003|Observational Phase|Death|0|||
129188791|NCT00098306|464985598|FG004|Observational Phase|Death|0|||
129188792|NCT00098306|464985599|FG005|Observational Phase|Death|5|||
129188793|NCT00098306|464985600|FG006|Observational Phase|Death|4|||
129188794|NCT00098306|464985594|FG000|Observational Phase|Participant defaulted|0|||
129188795|NCT00098306|464985595|FG001|Observational Phase|Participant defaulted|0|||
129188796|NCT00098306|464985596|FG002|Observational Phase|Participant defaulted|0|||
129188797|NCT00098306|464985597|FG003|Observational Phase|Participant defaulted|0|||
129188798|NCT00098306|464985598|FG004|Observational Phase|Participant defaulted|0|||
129188799|NCT00098306|464985599|FG005|Observational Phase|Participant defaulted|34|||
129188800|NCT00098306|464985600|FG006|Observational Phase|Participant defaulted|18|||
129188801|NCT00098306|464985594|FG000|Observational Phase|Un-specified|0|||
129188802|NCT00098306|464985595|FG001|Observational Phase|Un-specified|0|||
129188803|NCT00098306|464985596|FG002|Observational Phase|Un-specified|0|||
129188804|NCT00098306|464985597|FG003|Observational Phase|Un-specified|0|||
129188805|NCT00098306|464985598|FG004|Observational Phase|Un-specified|0|||
129188806|NCT00098306|464985599|FG005|Observational Phase|Un-specified|7|||
129188807|NCT00098306|464985600|FG006|Observational Phase|Un-specified|4|||
129188808|NCT01423916|464985601|FG000|Overall Study|Adverse Event|5|||
129188809|NCT01423916|464985602|FG001|Overall Study|Adverse Event|9|||
129188810|NCT01423916|464985603|FG002|Overall Study|Adverse Event|2|||
129188811|NCT01423916|464985601|FG000|Overall Study|Met Withdrawal Criteria|1|||
129188812|NCT01423916|464985602|FG001|Overall Study|Met Withdrawal Criteria|1|||
129188813|NCT01423916|464985603|FG002|Overall Study|Met Withdrawal Criteria|1|||
129188814|NCT01423916|464985601|FG000|Overall Study|Physician Decision|1|||
129188815|NCT01423916|464985602|FG001|Overall Study|Physician Decision|0|||
129188816|NCT01423916|464985603|FG002|Overall Study|Physician Decision|1|||
129188817|NCT01423916|464985601|FG000|Overall Study|Withdrawal by Subject|3|||
129188818|NCT01423916|464985602|FG001|Overall Study|Withdrawal by Subject|10|||
129188819|NCT01423916|464985603|FG002|Overall Study|Withdrawal by Subject|3|||
129188820|NCT01423916|464985601|FG000|Overall Study|Protocol Deviation|1|||
129188821|NCT01423916|464985602|FG001|Overall Study|Protocol Deviation|0|||
129188822|NCT01423916|464985603|FG002|Overall Study|Protocol Deviation|0|||
129188823|NCT01966445|464985608|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129188824|NCT01966445|464985609|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129188825|NCT01966445|464985610|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129188826|NCT01966445|464985611|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
129188827|NCT01966445|464985612|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129188828|NCT01966445|464985613|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
129188829|NCT01966445|464985614|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129188830|NCT01966445|464985608|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129188831|NCT01966445|464985609|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
129188832|NCT01966445|464985610|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129188833|NCT01966445|464985611|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
129188834|NCT01966445|464985612|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
129188835|NCT01966445|464985613|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129188836|NCT01966445|464985614|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129188837|NCT01966445|464985608|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129188838|NCT01966445|464985609|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
128781009|NCT00577629|463488649|FG000|Long Term Follow-Up|Death|15|||
128781010|NCT00577629|463488649|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
128781011|NCT00577629|463488649|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
129188839|NCT01966445|464985610|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
129188840|NCT01966445|464985611|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129188841|NCT01966445|464985612|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
129188842|NCT01966445|464985613|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129188843|NCT01966445|464985614|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129188844|NCT01966445|464985608|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129188845|NCT01966445|464985609|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129188846|NCT01966445|464985610|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129188847|NCT01966445|464985611|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129188848|NCT01966445|464985612|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129188849|NCT01966445|464985613|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129188850|NCT01966445|464985614|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
129188851|NCT01966445|464985608|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129188852|NCT01966445|464985609|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129188853|NCT01966445|464985610|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129188854|NCT01966445|464985611|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129188855|NCT01966445|464985612|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129188856|NCT01966445|464985613|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129188857|NCT01966445|464985614|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
129188858|NCT01374178|464985615|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
129188859|NCT01374178|464985616|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
129188860|NCT01374178|464985615|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
129188861|NCT01374178|464985616|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
129188862|NCT04856904|464985619|FG000|Overall Study|Physician Decision|1|||
129188863|NCT04856904|464985620|FG001|Overall Study|Physician Decision|1|||
129188864|NCT04856904|464985619|FG000|Overall Study|Withdrawal by Subject|13|||
129188865|NCT04856904|464985620|FG001|Overall Study|Withdrawal by Subject|13|||
129188866|NCT04856904|464985619|FG000|Overall Study|Adverse Event|1|||
129188867|NCT04856904|464985620|FG001|Overall Study|Adverse Event|1|||
129188868|NCT04856904|464985619|FG000|Overall Study|Non-compliance with study drug|1|||
129188869|NCT04856904|464985620|FG001|Overall Study|Non-compliance with study drug|1|||
129188870|NCT04856904|464985619|FG000|Overall Study|Lost to Follow-up|4|||
129188871|NCT04856904|464985620|FG001|Overall Study|Lost to Follow-up|4|||
129188872|NCT04856904|464985619|FG000|Overall Study|Withdrawal by Subject|1|||
129188873|NCT04856904|464985620|FG001|Overall Study|Withdrawal by Subject|1|||
129188874|NCT04856904|464985619|FG000|Overall Study|Protocol Violation|1|||
129188875|NCT04856904|464985620|FG001|Overall Study|Protocol Violation|1|||
129188876|NCT00077649|464985621|FG000|Overall Study|Adverse Event|5|||
129188877|NCT00077649|464985622|FG001|Overall Study|Adverse Event|1|||
129188878|NCT00077649|464985623|FG002|Overall Study|Adverse Event|7|||
129188879|NCT00077649|464985624|FG003|Overall Study|Adverse Event|9|||
129188880|NCT00077649|464985621|FG000|Overall Study|Lack of Efficacy|5|||
129188881|NCT00077649|464985622|FG001|Overall Study|Lack of Efficacy|3|||
129188882|NCT00077649|464985623|FG002|Overall Study|Lack of Efficacy|3|||
129188883|NCT00077649|464985624|FG003|Overall Study|Lack of Efficacy|2|||
129188884|NCT00077649|464985621|FG000|Overall Study|Withdrawal by Subject|0|||
129188885|NCT00077649|464985622|FG001|Overall Study|Withdrawal by Subject|1|||
129188886|NCT00077649|464985623|FG002|Overall Study|Withdrawal by Subject|1|||
129188887|NCT00077649|464985624|FG003|Overall Study|Withdrawal by Subject|2|||
129188888|NCT00077649|464985621|FG000|Overall Study|Lost to Follow-up|2|||
129188889|NCT00077649|464985622|FG001|Overall Study|Lost to Follow-up|2|||
129188890|NCT00077649|464985623|FG002|Overall Study|Lost to Follow-up|3|||
129188891|NCT00077649|464985624|FG003|Overall Study|Lost to Follow-up|2|||
129188892|NCT00077649|464985621|FG000|Overall Study|Abnormality of Laboratory Test|1|||
129188893|NCT00077649|464985622|FG001|Overall Study|Abnormality of Laboratory Test|2|||
129188894|NCT00077649|464985623|FG002|Overall Study|Abnormality of Laboratory Test|1|||
129188895|NCT00077649|464985624|FG003|Overall Study|Abnormality of Laboratory Test|2|||
129188896|NCT00077649|464985621|FG000|Overall Study|Randomized but never dosed|1|||
129188897|NCT00077649|464985622|FG001|Overall Study|Randomized but never dosed|0|||
129188898|NCT00077649|464985623|FG002|Overall Study|Randomized but never dosed|0|||
129188899|NCT00077649|464985624|FG003|Overall Study|Randomized but never dosed|0|||
129188900|NCT01641822|464985625|FG000|Run-in Phase|Noncompliance with study drug|1|||
129188901|NCT01641822|464985626|FG001|Run-in Phase|Noncompliance with study drug|0|||
129188902|NCT01641822|464985627|FG002|Run-in Phase|Noncompliance with study drug|0|||
129188903|NCT01641822|464985625|FG000|Run-in Phase|Adverse Event|3|||
129188904|NCT01641822|464985626|FG001|Run-in Phase|Adverse Event|0|||
129188905|NCT01641822|464985627|FG002|Run-in Phase|Adverse Event|0|||
129188906|NCT01641822|464985625|FG000|Run-in Phase|Withdrew consent|1|||
129188907|NCT01641822|464985626|FG001|Run-in Phase|Withdrew consent|0|||
129188908|NCT01641822|464985627|FG002|Run-in Phase|Withdrew consent|0|||
129188909|NCT01641822|464985625|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
129188910|NCT01641822|464985626|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
129188911|NCT01641822|464985627|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
129188912|NCT01641822|464985625|FG000|Comparative Phase|Noncompliance with study drug|0|||
129188913|NCT01641822|464985626|FG001|Comparative Phase|Noncompliance with study drug|1|||
129188914|NCT01641822|464985627|FG002|Comparative Phase|Noncompliance with study drug|0|||
129188915|NCT01641822|464985625|FG000|Comparative Phase|Investigator's discretion|0|||
129188916|NCT01641822|464985626|FG001|Comparative Phase|Investigator's discretion|0|||
129188917|NCT01641822|464985627|FG002|Comparative Phase|Investigator's discretion|1|||
129188918|NCT01641822|464985625|FG000|Comparative Phase|Pregnancy|0|||
129188919|NCT01641822|464985626|FG001|Comparative Phase|Pregnancy|0|||
129188920|NCT01641822|464985627|FG002|Comparative Phase|Pregnancy|1|||
129188921|NCT01641822|464985625|FG000|Comparative Phase|Adverse event, serious fatal|0|||
129188922|NCT01641822|464985626|FG001|Comparative Phase|Adverse event, serious fatal|1|||
129188923|NCT01641822|464985627|FG002|Comparative Phase|Adverse event, serious fatal|0|||
129188924|NCT01641822|464985625|FG000|Comparative Phase|Withdrew consent|0|||
129188925|NCT01641822|464985626|FG001|Comparative Phase|Withdrew consent|3|||
129188926|NCT01641822|464985627|FG002|Comparative Phase|Withdrew consent|7|||
129188927|NCT01641822|464985625|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
129188928|NCT01641822|464985626|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
129188929|NCT01641822|464985627|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
129188930|NCT02421601|464985628|FG000|Overall Study|Adverse Event|4|||
129188931|NCT02421601|464985628|FG000|Overall Study|Lack of Efficacy|5|||
129188932|NCT02421601|464985628|FG000|Overall Study|Physician Decision|1|||
129188933|NCT02421601|464985628|FG000|Overall Study|Withdrawal by Subject|31|||
129188934|NCT02421601|464985628|FG000|Overall Study|Others|41|||
129188935|NCT00599638|464985629|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
129188936|NCT00599638|464985630|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
129188937|NCT00599638|464985631|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
129188938|NCT00599638|464985632|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
129188939|NCT00599638|464985629|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
129188940|NCT00599638|464985630|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
129188941|NCT00599638|464985631|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
129188942|NCT00599638|464985632|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
129188943|NCT00599638|464985629|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
129188944|NCT00599638|464985630|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
129188945|NCT00599638|464985631|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
129188946|NCT00599638|464985632|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
129188947|NCT00599638|464985629|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
129188948|NCT00599638|464985630|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
129188949|NCT00599638|464985631|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
129188950|NCT00599638|464985632|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
129188951|NCT00599638|464985629|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
129188952|NCT00599638|464985630|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
129188953|NCT00599638|464985631|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
129188954|NCT00599638|464985632|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
129188955|NCT00599638|464985629|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
129188956|NCT00599638|464985630|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
129188957|NCT00599638|464985631|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
129188958|NCT00599638|464985632|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
129188959|NCT00599638|464985629|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
129188960|NCT00599638|464985630|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
129188961|NCT00599638|464985631|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
129188962|NCT00599638|464985632|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
129188963|NCT00599638|464985629|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
129188964|NCT00599638|464985630|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
129188965|NCT00599638|464985631|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
129188966|NCT00599638|464985632|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
129188967|NCT00599638|464985629|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
129188968|NCT00599638|464985630|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
129188969|NCT00599638|464985631|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
129188970|NCT00599638|464985632|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
129188971|NCT02895945|464985635|FG000|Overall Study|Physician Decision|2|||
129188972|NCT02895945|464985636|FG001|Overall Study|Physician Decision|1|||
129188973|NCT01026220|464985640|FG000|Induction|Death|1|||
129188974|NCT01026220|464985641|FG001|Induction|Death|0|||
129188975|NCT01026220|464985642|FG002|Induction|Death|0|||
129188976|NCT01026220|464985640|FG000|Induction|Lack of Efficacy|2|||
129188977|NCT01026220|464985641|FG001|Induction|Lack of Efficacy|0|||
129188978|NCT01026220|464985642|FG002|Induction|Lack of Efficacy|0|||
129188979|NCT01026220|464985640|FG000|Induction|Physician Decision|12|||
129188980|NCT01026220|464985641|FG001|Induction|Physician Decision|0|||
129188981|NCT01026220|464985642|FG002|Induction|Physician Decision|0|||
129188982|NCT01026220|464985640|FG000|Induction|Withdrawal by Subject|9|||
129188983|NCT01026220|464985641|FG001|Induction|Withdrawal by Subject|0|||
129188984|NCT01026220|464985642|FG002|Induction|Withdrawal by Subject|0|||
129188985|NCT01026220|464985640|FG000|Induction|Ineligible|1|||
129188986|NCT01026220|464985641|FG001|Induction|Ineligible|0|||
129188987|NCT01026220|464985642|FG002|Induction|Ineligible|0|||
129188988|NCT01026220|464985640|FG000|Consolidation Maintenance|Death|0|||
129188989|NCT01026220|464985641|FG001|Consolidation Maintenance|Death|1|||
129188990|NCT01026220|464985642|FG002|Consolidation Maintenance|Death|0|||
128730349|NCT00779675|463309946|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
128730350|NCT00779675|463309946|FG000|Extended Treatment Period|Lost to Follow-up|6|||
128730351|NCT02821962|463309947|FG000|Overall Study|Lost to Follow-up|2|||
129188991|NCT01026220|464985640|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
129188992|NCT01026220|464985641|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
129188993|NCT01026220|464985642|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
129188994|NCT01026220|464985640|FG000|Consolidation Maintenance|Physician Decision|0|||
129188995|NCT01026220|464985641|FG001|Consolidation Maintenance|Physician Decision|2|||
129188996|NCT01026220|464985642|FG002|Consolidation Maintenance|Physician Decision|7|||
129188997|NCT01026220|464985640|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
129188998|NCT01026220|464985641|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
129188999|NCT01026220|464985642|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
129189000|NCT03550404|464985643|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
129189001|NCT03550404|464985644|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
129189002|NCT03550404|464985645|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
129189003|NCT03550404|464985643|FG000|Phase 2|Vacated position|1|||
129189004|NCT03550404|464985644|FG001|Phase 2|Vacated position|0|||
129189005|NCT03550404|464985645|FG002|Phase 2|Vacated position|0|||
129189006|NCT01389323|464985647|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
129189007|NCT01389323|464985647|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
129189008|NCT01389323|464985647|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
129189009|NCT01389323|464985647|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
129189010|NCT01389323|464985647|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
129189011|NCT01389323|464985647|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
129189012|NCT01389323|464985647|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
129189013|NCT01389323|464985647|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
129189014|NCT01389323|464985647|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
129189015|NCT01389323|464985647|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
129189016|NCT01389323|464985647|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
129189017|NCT05096312|464985648|FG000|Overall Study|Lost to Follow-up|2|||
129189018|NCT05096312|464985649|FG001|Overall Study|Lost to Follow-up|4|||
129189019|NCT05096312|464985648|FG000|Overall Study|Adverse Event|1|||
129189020|NCT05096312|464985649|FG001|Overall Study|Adverse Event|0|||
129189021|NCT03135210|464985650|FG000|Overall Study|Death|0|||
129189022|NCT03135210|464985651|FG001|Overall Study|Death|1|||
129189023|NCT00844558|464985653|FG000|Overall Study|Withdrawal by Subject|9|||
129189024|NCT00844558|464985654|FG001|Overall Study|Withdrawal by Subject|2|||
129189025|NCT00844558|464985653|FG000|Overall Study|Death|1|||
129189026|NCT00844558|464985654|FG001|Overall Study|Death|0|||
129189027|NCT00844558|464985653|FG000|Overall Study|Protocol Violation|1|||
129189028|NCT00844558|464985654|FG001|Overall Study|Protocol Violation|1|||
129189029|NCT00844558|464985653|FG000|Overall Study|Lost to Follow-up|0|||
129189030|NCT00844558|464985654|FG001|Overall Study|Lost to Follow-up|1|||
128730352|NCT02821962|463309948|FG001|Overall Study|Lost to Follow-up|0|||
129189031|NCT00844558|464985653|FG000|Overall Study|Physician Decision|1|||
129189032|NCT00844558|464985654|FG001|Overall Study|Physician Decision|0|||
129189033|NCT01894022|464985670|FG000|Overall Study|Death|1|||
129189034|NCT01894022|464985671|FG001|Overall Study|Death|0|||
129189035|NCT01894022|464985670|FG000|Overall Study|Adverse Event, non-fatal|1|||
129189036|NCT01894022|464985671|FG001|Overall Study|Adverse Event, non-fatal|0|||
129189037|NCT01894022|464985670|FG000|Overall Study|Study Closed/terminated|7|||
128730353|NCT00749775|463309953|FG000|Overall Study|Protocol Violation|24|||
128730354|NCT00749775|463309953|FG000|Overall Study|Lost to Follow-up|36|||
129189038|NCT01894022|464985671|FG001|Overall Study|Study Closed/terminated|10|||
129189039|NCT01887353|464985682|FG000|Overall Study|Study stopped early|4|||
129189040|NCT01887353|464985683|FG001|Overall Study|Study stopped early|3|||
129189041|NCT00699335|464985684|FG000|Overall Study|Combination of multiple reasons|176|||
129189042|NCT00699335|464985684|FG000|Overall Study|Missing data|52|||
129189043|NCT01069705|464985685|FG000|Overall Study|Adverse Event|1|||
129189044|NCT01069705|464985685|FG000|Overall Study|Withdrawal by Subject|2|||
129189045|NCT02999633|464985686|FG000|Overall Study|Adverse Event|2|||
129189046|NCT02999633|464985686|FG000|Overall Study|Progressive disease|12|||
129189047|NCT01545050|464985687|FG000|Overall Study|Lack of Efficacy|0|||
129189048|NCT01545050|464985688|FG001|Overall Study|Lack of Efficacy|0|||
129189049|NCT01545050|464985689|FG002|Overall Study|Lack of Efficacy|0|||
129189050|NCT01545050|464985690|FG003|Overall Study|Lack of Efficacy|3|||
129189051|NCT01545050|464985691|FG004|Overall Study|Lack of Efficacy|2|||
129189052|NCT01545050|464985687|FG000|Overall Study|Adverse Event|1|||
129189053|NCT01545050|464985688|FG001|Overall Study|Adverse Event|1|||
129189054|NCT01545050|464985689|FG002|Overall Study|Adverse Event|2|||
129189055|NCT01545050|464985690|FG003|Overall Study|Adverse Event|2|||
129189056|NCT01545050|464985691|FG004|Overall Study|Adverse Event|0|||
129189057|NCT01545050|464985687|FG000|Overall Study|Discontinued study treatment|1|||
129189058|NCT01545050|464985688|FG001|Overall Study|Discontinued study treatment|0|||
129189059|NCT01545050|464985689|FG002|Overall Study|Discontinued study treatment|0|||
129189060|NCT01545050|464985690|FG003|Overall Study|Discontinued study treatment|0|||
129189061|NCT01545050|464985691|FG004|Overall Study|Discontinued study treatment|0|||
129189062|NCT01545050|464985687|FG000|Overall Study|Withdrawal by Subject|1|||
129189063|NCT01545050|464985688|FG001|Overall Study|Withdrawal by Subject|0|||
129189064|NCT01545050|464985689|FG002|Overall Study|Withdrawal by Subject|0|||
129189065|NCT01545050|464985690|FG003|Overall Study|Withdrawal by Subject|2|||
129189066|NCT01545050|464985691|FG004|Overall Study|Withdrawal by Subject|1|||
129189067|NCT01545050|464985687|FG000|Overall Study|Participant no longer meets study criteria|0|||
129189068|NCT01545050|464985688|FG001|Overall Study|Participant no longer meets study criteria|2|||
129189069|NCT01545050|464985689|FG002|Overall Study|Participant no longer meets study criteria|0|||
129189070|NCT01545050|464985690|FG003|Overall Study|Participant no longer meets study criteria|0|||
129189071|NCT01545050|464985691|FG004|Overall Study|Participant no longer meets study criteria|1|||
129189072|NCT01545050|464985687|FG000|Overall Study|Administrative reason by sponsor|4|||
129189073|NCT01545050|464985688|FG001|Overall Study|Administrative reason by sponsor|2|||
129189074|NCT01545050|464985689|FG002|Overall Study|Administrative reason by sponsor|3|||
129189075|NCT01545050|464985690|FG003|Overall Study|Administrative reason by sponsor|5|||
129189076|NCT01545050|464985691|FG004|Overall Study|Administrative reason by sponsor|5|||
129189077|NCT03262441|464985692|FG000|Overall Study|Withdrawal by Subject|1|||
129189078|NCT03235089|464985693|FG000|Overall Study|Lost to Follow-up|1|||
129189079|NCT03235089|464985694|FG001|Overall Study|Lost to Follow-up|1|||
129189080|NCT03235089|464985693|FG000|Overall Study|Physician Decision|2|||
129189081|NCT03235089|464985694|FG001|Overall Study|Physician Decision|2|||
129189082|NCT03238924|464985697|FG000|Overall Study|Withdrawal by Subject|2|||
129189083|NCT03238924|464985698|FG001|Overall Study|Withdrawal by Subject|2|||
129189084|NCT03576716|464985700|FG000|Overall Study|Withdrawal by Subject|0|||
129189085|NCT03576716|464985701|FG001|Overall Study|Withdrawal by Subject|1|||
129189086|NCT00559988|464985702|FG000|Overall Study|Death|147|||
129189087|NCT00559988|464985703|FG001|Overall Study|Death|140|||
129189088|NCT00559988|464985702|FG000|Overall Study|Withdrawal by Subject|152|||
129189089|NCT00559988|464985703|FG001|Overall Study|Withdrawal by Subject|139|||
129189090|NCT00559988|464985702|FG000|Overall Study|Lost to Follow-up|42|||
129189091|NCT00559988|464985703|FG001|Overall Study|Lost to Follow-up|56|||
129189092|NCT00559988|464985702|FG000|Overall Study|ICD device explanted|10|||
129189093|NCT00559988|464985703|FG001|Overall Study|ICD device explanted|17|||
129189094|NCT01455194|464985704|FG000|Overall Study|Screen Failure|20|||
129189095|NCT01455194|464985705|FG001|Overall Study|Screen Failure|0|||
129189096|NCT01455194|464985706|FG002|Overall Study|Screen Failure|0|||
129189097|NCT01455194|464985707|FG003|Overall Study|Screen Failure|0|||
129189098|NCT01455194|464985704|FG000|Overall Study|Randomisation Failure|90|||
129189099|NCT01455194|464985705|FG001|Overall Study|Randomisation Failure|0|||
129189100|NCT01455194|464985706|FG002|Overall Study|Randomisation Failure|0|||
129189101|NCT01455194|464985707|FG003|Overall Study|Randomisation Failure|0|||
129189102|NCT01455194|464985704|FG000|Overall Study|Deterioration in asthma|12|||
129189103|NCT01455194|464985705|FG001|Overall Study|Deterioration in asthma|6|||
129189104|NCT01455194|464985706|FG002|Overall Study|Deterioration in asthma|14|||
129189105|NCT01455194|464985707|FG003|Overall Study|Deterioration in asthma|9|||
129189106|NCT01455194|464985704|FG000|Overall Study|Adverse Event|1|||
129189107|NCT01455194|464985705|FG001|Overall Study|Adverse Event|1|||
129189108|NCT01455194|464985706|FG002|Overall Study|Adverse Event|1|||
129189109|NCT01455194|464985707|FG003|Overall Study|Adverse Event|3|||
129189110|NCT01455194|464985704|FG000|Overall Study|Withdrawal by Subject|21|||
129189111|NCT01455194|464985705|FG001|Overall Study|Withdrawal by Subject|16|||
129189112|NCT01455194|464985706|FG002|Overall Study|Withdrawal by Subject|12|||
129189113|NCT01455194|464985707|FG003|Overall Study|Withdrawal by Subject|9|||
129189114|NCT01455194|464985704|FG000|Overall Study|Lost to Follow-up|2|||
129189115|NCT01455194|464985705|FG001|Overall Study|Lost to Follow-up|0|||
129189116|NCT01455194|464985706|FG002|Overall Study|Lost to Follow-up|1|||
129189117|NCT01455194|464985707|FG003|Overall Study|Lost to Follow-up|1|||
129189118|NCT01455194|464985704|FG000|Overall Study|Pregnancy|0|||
129189119|NCT01455194|464985705|FG001|Overall Study|Pregnancy|1|||
129189120|NCT01455194|464985706|FG002|Overall Study|Pregnancy|1|||
129189121|NCT01455194|464985707|FG003|Overall Study|Pregnancy|0|||
129189122|NCT01455194|464985704|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
129189123|NCT01455194|464985705|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
129189124|NCT01455194|464985706|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
129189125|NCT01455194|464985707|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
129189126|NCT01455194|464985704|FG000|Overall Study|Miscellaneous|4|||
129189127|NCT01455194|464985705|FG001|Overall Study|Miscellaneous|5|||
129189128|NCT01455194|464985706|FG002|Overall Study|Miscellaneous|1|||
129189129|NCT01455194|464985707|FG003|Overall Study|Miscellaneous|4|||
129189130|NCT02249182|464985708|FG000|Treatment Phase|Lost to Follow-up|4|||
129189131|NCT02249182|464985709|FG001|Treatment Phase|Lost to Follow-up|0|||
129189132|NCT02249182|464985710|FG002|Treatment Phase|Lost to Follow-up|0|||
129189133|NCT02249182|464985711|FG003|Treatment Phase|Lost to Follow-up|0|||
129189134|NCT02249182|464985712|FG004|Treatment Phase|Lost to Follow-up|0|||
129189135|NCT00788710|464985715|FG000|Overall Study|Adverse Event|1|||
129189136|NCT00788710|464985716|FG001|Overall Study|Adverse Event|3|||
129189137|NCT00788710|464985717|FG002|Overall Study|Adverse Event|4|||
129189138|NCT00788710|464985715|FG000|Overall Study|Lack of Efficacy|0|||
129189139|NCT00788710|464985716|FG001|Overall Study|Lack of Efficacy|0|||
129189140|NCT00788710|464985717|FG002|Overall Study|Lack of Efficacy|1|||
129189141|NCT00788710|464985715|FG000|Overall Study|Lost to Follow-up|0|||
129189142|NCT00788710|464985716|FG001|Overall Study|Lost to Follow-up|1|||
129189143|NCT00788710|464985717|FG002|Overall Study|Lost to Follow-up|0|||
129189144|NCT00788710|464985715|FG000|Overall Study|Physician Decision|2|||
129189145|NCT00788710|464985716|FG001|Overall Study|Physician Decision|1|||
129189146|NCT00788710|464985717|FG002|Overall Study|Physician Decision|0|||
129189147|NCT00788710|464985715|FG000|Overall Study|Protocol Violation|0|||
129189148|NCT00788710|464985716|FG001|Overall Study|Protocol Violation|1|||
129189149|NCT00788710|464985717|FG002|Overall Study|Protocol Violation|1|||
129189150|NCT00788710|464985715|FG000|Overall Study|Withdrawal by Subject|2|||
129189151|NCT00788710|464985716|FG001|Overall Study|Withdrawal by Subject|2|||
129189152|NCT00788710|464985717|FG002|Overall Study|Withdrawal by Subject|0|||
129189153|NCT01717326|464985718|FG000|Overall Study|Death|0|||
129189154|NCT01717326|464985719|FG001|Overall Study|Death|0|||
129189155|NCT01717326|464985720|FG002|Overall Study|Death|0|||
129189156|NCT01717326|464985721|FG003|Overall Study|Death|0|||
129189157|NCT01717326|464985722|FG004|Overall Study|Death|0|||
129189158|NCT01717326|464985723|FG005|Overall Study|Death|0|||
129189159|NCT01717326|464985724|FG006|Overall Study|Death|0|||
129189160|NCT01717326|464985725|FG007|Overall Study|Death|0|||
129189161|NCT01717326|464985726|FG008|Overall Study|Death|0|||
129189162|NCT01717326|464985727|FG009|Overall Study|Death|0|||
129189163|NCT01717326|464985728|FG010|Overall Study|Death|1|||
129189164|NCT01717326|464985729|FG011|Overall Study|Death|0|||
129189165|NCT01717326|464985730|FG012|Overall Study|Death|0|||
129189166|NCT01717326|464985731|FG013|Overall Study|Death|0|||
129189167|NCT01717326|464985732|FG014|Overall Study|Death|0|||
129189168|NCT01717326|464985733|FG015|Overall Study|Death|0|||
129189169|NCT01717326|464985734|FG016|Overall Study|Death|0|||
129189170|NCT01717326|464985735|FG017|Overall Study|Death|0|||
129189171|NCT01717326|464985736|FG018|Overall Study|Death|0|||
129189172|NCT01717326|464985737|FG019|Overall Study|Death|0|||
129189173|NCT01717326|464985718|FG000|Overall Study|Lost to Follow-up|3|||
129189174|NCT01717326|464985719|FG001|Overall Study|Lost to Follow-up|0|||
129189175|NCT01717326|464985720|FG002|Overall Study|Lost to Follow-up|0|||
129189176|NCT01717326|464985721|FG003|Overall Study|Lost to Follow-up|2|||
129189177|NCT01717326|464985722|FG004|Overall Study|Lost to Follow-up|1|||
129189178|NCT01717326|464985723|FG005|Overall Study|Lost to Follow-up|0|||
129189179|NCT01717326|464985724|FG006|Overall Study|Lost to Follow-up|1|||
129189180|NCT01717326|464985725|FG007|Overall Study|Lost to Follow-up|0|||
129189181|NCT01717326|464985726|FG008|Overall Study|Lost to Follow-up|0|||
129189182|NCT01717326|464985727|FG009|Overall Study|Lost to Follow-up|0|||
129189183|NCT01717326|464985728|FG010|Overall Study|Lost to Follow-up|1|||
129189184|NCT01717326|464985729|FG011|Overall Study|Lost to Follow-up|0|||
129189185|NCT01717326|464985730|FG012|Overall Study|Lost to Follow-up|0|||
129189186|NCT01717326|464985731|FG013|Overall Study|Lost to Follow-up|0|||
129189187|NCT01717326|464985732|FG014|Overall Study|Lost to Follow-up|0|||
129189188|NCT01717326|464985733|FG015|Overall Study|Lost to Follow-up|2|||
129189189|NCT01717326|464985734|FG016|Overall Study|Lost to Follow-up|1|||
129189190|NCT01717326|464985735|FG017|Overall Study|Lost to Follow-up|0|||
129189191|NCT01717326|464985736|FG018|Overall Study|Lost to Follow-up|2|||
129189192|NCT01717326|464985737|FG019|Overall Study|Lost to Follow-up|3|||
129189193|NCT01717326|464985718|FG000|Overall Study|Physician Decision|0|||
129189194|NCT01717326|464985719|FG001|Overall Study|Physician Decision|0|||
129189195|NCT01717326|464985720|FG002|Overall Study|Physician Decision|0|||
129189196|NCT01717326|464985721|FG003|Overall Study|Physician Decision|0|||
129189197|NCT01717326|464985722|FG004|Overall Study|Physician Decision|0|||
129189198|NCT01717326|464985723|FG005|Overall Study|Physician Decision|0|||
129189199|NCT01717326|464985724|FG006|Overall Study|Physician Decision|0|||
129189200|NCT01717326|464985725|FG007|Overall Study|Physician Decision|0|||
129189201|NCT01717326|464985726|FG008|Overall Study|Physician Decision|0|||
129189202|NCT01717326|464985727|FG009|Overall Study|Physician Decision|1|||
129189203|NCT01717326|464985728|FG010|Overall Study|Physician Decision|0|||
129189204|NCT01717326|464985729|FG011|Overall Study|Physician Decision|0|||
129189205|NCT01717326|464985730|FG012|Overall Study|Physician Decision|0|||
129189206|NCT01717326|464985731|FG013|Overall Study|Physician Decision|0|||
129189207|NCT01717326|464985732|FG014|Overall Study|Physician Decision|0|||
129189208|NCT01717326|464985733|FG015|Overall Study|Physician Decision|0|||
129189209|NCT01717326|464985734|FG016|Overall Study|Physician Decision|0|||
129189210|NCT01717326|464985735|FG017|Overall Study|Physician Decision|0|||
129189211|NCT01717326|464985736|FG018|Overall Study|Physician Decision|0|||
129189212|NCT01717326|464985737|FG019|Overall Study|Physician Decision|0|||
129189213|NCT01717326|464985718|FG000|Overall Study|Protocol Violation|0|||
129189214|NCT01717326|464985719|FG001|Overall Study|Protocol Violation|0|||
129189215|NCT01717326|464985720|FG002|Overall Study|Protocol Violation|0|||
129189216|NCT01717326|464985721|FG003|Overall Study|Protocol Violation|0|||
129189217|NCT01717326|464985722|FG004|Overall Study|Protocol Violation|1|||
129189218|NCT01717326|464985723|FG005|Overall Study|Protocol Violation|0|||
129189219|NCT01717326|464985724|FG006|Overall Study|Protocol Violation|0|||
129189220|NCT01717326|464985725|FG007|Overall Study|Protocol Violation|0|||
129189221|NCT01717326|464985726|FG008|Overall Study|Protocol Violation|0|||
129189222|NCT01717326|464985727|FG009|Overall Study|Protocol Violation|0|||
129189223|NCT01717326|464985728|FG010|Overall Study|Protocol Violation|0|||
129189224|NCT01717326|464985729|FG011|Overall Study|Protocol Violation|0|||
129189225|NCT01717326|464985730|FG012|Overall Study|Protocol Violation|0|||
129189226|NCT01717326|464985731|FG013|Overall Study|Protocol Violation|0|||
129189227|NCT01717326|464985732|FG014|Overall Study|Protocol Violation|0|||
129189228|NCT01717326|464985733|FG015|Overall Study|Protocol Violation|0|||
129189229|NCT01717326|464985734|FG016|Overall Study|Protocol Violation|0|||
129189230|NCT01717326|464985735|FG017|Overall Study|Protocol Violation|0|||
129189231|NCT01717326|464985736|FG018|Overall Study|Protocol Violation|0|||
129189232|NCT01717326|464985737|FG019|Overall Study|Protocol Violation|0|||
129189233|NCT01717326|464985718|FG000|Overall Study|Withdrawal by Subject|0|||
129189234|NCT01717326|464985719|FG001|Overall Study|Withdrawal by Subject|1|||
129189235|NCT01717326|464985720|FG002|Overall Study|Withdrawal by Subject|0|||
129189236|NCT01717326|464985721|FG003|Overall Study|Withdrawal by Subject|0|||
129189237|NCT01717326|464985722|FG004|Overall Study|Withdrawal by Subject|0|||
129189238|NCT01717326|464985723|FG005|Overall Study|Withdrawal by Subject|0|||
129189239|NCT01717326|464985724|FG006|Overall Study|Withdrawal by Subject|0|||
129189240|NCT01717326|464985725|FG007|Overall Study|Withdrawal by Subject|0|||
129189241|NCT01717326|464985726|FG008|Overall Study|Withdrawal by Subject|0|||
129189242|NCT01717326|464985727|FG009|Overall Study|Withdrawal by Subject|1|||
129189243|NCT01717326|464985728|FG010|Overall Study|Withdrawal by Subject|0|||
129189244|NCT01717326|464985729|FG011|Overall Study|Withdrawal by Subject|0|||
129189245|NCT01717326|464985730|FG012|Overall Study|Withdrawal by Subject|1|||
129189246|NCT01717326|464985731|FG013|Overall Study|Withdrawal by Subject|0|||
129189247|NCT01717326|464985732|FG014|Overall Study|Withdrawal by Subject|0|||
129189248|NCT01717326|464985733|FG015|Overall Study|Withdrawal by Subject|1|||
129189249|NCT01717326|464985734|FG016|Overall Study|Withdrawal by Subject|0|||
129189250|NCT01717326|464985735|FG017|Overall Study|Withdrawal by Subject|0|||
129189251|NCT01717326|464985736|FG018|Overall Study|Withdrawal by Subject|2|||
129189252|NCT01717326|464985737|FG019|Overall Study|Withdrawal by Subject|3|||
129189253|NCT00605345|464985738|FG000|Overall Study|Withdrawal by Subject|1|||
129189254|NCT00605345|464985739|FG001|Overall Study|Withdrawal by Subject|0|||
129189255|NCT00605345|464985738|FG000|Overall Study|Adverse Event|0|||
128730355|NCT00749775|463309953|FG000|Overall Study|No visit after first day of treatment|44|||
129189256|NCT00605345|464985739|FG001|Overall Study|Adverse Event|1|||
129189257|NCT00605345|464985738|FG000|Overall Study|Protocol Violation|0|||
129189258|NCT00605345|464985739|FG001|Overall Study|Protocol Violation|2|||
129189259|NCT02596945|464985740|FG000|Overall Study|No documentation of study drug dosing|3|||
129189260|NCT02596945|464985740|FG000|Overall Study|Other|32|||
129189261|NCT02596945|464985740|FG000|Overall Study|Change to hemodialysis|15|||
129189262|NCT02596945|464985740|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
129189263|NCT02596945|464985740|FG000|Overall Study|Withdrawal by Subject|1|||
129189264|NCT02596945|464985740|FG000|Overall Study|Missing|1|||
129189265|NCT00238238|464985741|FG000|Overall Study|Withdrawal by Subject|0|||
129189266|NCT00238238|464985742|FG001|Overall Study|Withdrawal by Subject|3|||
129189267|NCT00238238|464985743|FG002|Overall Study|Withdrawal by Subject|0|||
129189268|NCT01730586|464985745|FG000|Overall Study|Progressive Disease|2|||
128781012|NCT00577629|463488649|FG000|Long Term Follow-Up|Physician Decision|1|||
129189269|NCT01730586|464985745|FG000|Overall Study|Inadequate Trial|8|||
129189270|NCT01730586|464985745|FG000|Overall Study|Adverse Event|2|||
129189271|NCT01730586|464985745|FG000|Overall Study|Hospice|1|||
129189272|NCT00061633|464985746|FG000|Overall Study|Adverse Event|1|||
129189273|NCT00061633|464985747|FG001|Overall Study|Adverse Event|2|||
129189274|NCT00061633|464985746|FG000|Overall Study|Withdrawal by Subject|2|||
129189275|NCT00061633|464985747|FG001|Overall Study|Withdrawal by Subject|2|||
129189276|NCT00061633|464985746|FG000|Overall Study|Lost to Follow-up|1|||
129189277|NCT00061633|464985747|FG001|Overall Study|Lost to Follow-up|4|||
129189278|NCT00061633|464985746|FG000|Overall Study|Other|1|||
129189279|NCT00061633|464985747|FG001|Overall Study|Other|1|||
129189280|NCT00061633|464985746|FG000|Overall Study|Never received study treatment|0|||
129189281|NCT00061633|464985747|FG001|Overall Study|Never received study treatment|2|||
129189282|NCT01331109|464987834|FG000|Overall Study|Adverse Event|6|||
129189283|NCT01331109|464987834|FG000|Overall Study|Lack of Efficacy|2|||
129189284|NCT01331109|464987834|FG000|Overall Study|Protocol Violation|3|||
129189285|NCT01331109|464987834|FG000|Overall Study|Withdrawal by Subject|7|||
129189286|NCT01331109|464987834|FG000|Overall Study|Lost to Follow-up|1|||
129189287|NCT01331109|464987834|FG000|Overall Study|Study Terminated by Sponsor|38|||
129189288|NCT00479856|464987835|FG000|Overall Study|Adverse Event|1|||
129189289|NCT00479856|464987835|FG000|Overall Study|Withdrawal by Subject|1|||
129189290|NCT00479856|464987835|FG000|Overall Study|Physician Decision|1|||
129189291|NCT00661622|464987838|FG000|Overall Study|Protocol Violation|1|||
129189292|NCT00661622|464987839|FG001|Overall Study|Protocol Violation|0|||
129189293|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
129189294|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
129189295|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
129189296|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
129189297|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Death|2|||
129189298|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Death|2|||
129189299|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Death|0|||
129189300|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Death|0|||
129189301|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
129189302|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
129189303|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
129189304|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
129189305|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
129189306|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
129189307|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
129189308|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
129189309|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
129189310|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
129189311|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
129189312|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
129189313|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
129189314|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
129189315|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
129189316|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
129189317|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
129189318|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
129189319|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
129189320|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
129189321|NCT03068754|464987842|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
129189322|NCT03068754|464987843|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
129189323|NCT03068754|464987844|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
129189324|NCT03068754|464987845|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
129189325|NCT03068754|464987842|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
129189326|NCT03068754|464987843|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
129189327|NCT03068754|464987844|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
129189328|NCT03068754|464987845|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
129189329|NCT03068754|464987842|FG000|Open Label Extension Period (OLE)|Death|0|||
129189330|NCT03068754|464987843|FG001|Open Label Extension Period (OLE)|Death|0|||
129189331|NCT03068754|464987844|FG002|Open Label Extension Period (OLE)|Death|0|||
129189332|NCT03068754|464987845|FG003|Open Label Extension Period (OLE)|Death|1|||
129189333|NCT03068754|464987842|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
129189334|NCT03068754|464987843|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
129189335|NCT03068754|464987844|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
129189336|NCT03068754|464987845|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
129189337|NCT03068754|464987842|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
129189338|NCT03068754|464987843|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
129189339|NCT03068754|464987844|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
129189340|NCT03068754|464987845|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
129189341|NCT03068754|464987842|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
129189342|NCT03068754|464987843|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
129189343|NCT03068754|464987844|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
129189344|NCT03068754|464987845|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
129189345|NCT03068754|464987842|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
129189346|NCT03068754|464987843|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
129189347|NCT03068754|464987844|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
129189348|NCT03068754|464987845|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
129189349|NCT04496453|464987850|FG000|Overall Study|Lost to Follow-up|6|||
129189350|NCT03997825|464987851|FG000|Overall Study|Death|3|||
129189351|NCT03997825|464987851|FG000|Overall Study|Lost to Follow-up|10|||
129189352|NCT03997825|464987851|FG000|Overall Study|Withdrawal by Subject|3|||
129189353|NCT03997825|464987851|FG000|Overall Study|Refused participation|1|||
129189354|NCT00383162|464987852|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
129189355|NCT00383162|464987853|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
129189356|NCT00383162|464987852|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
129189357|NCT00383162|464987853|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
129189358|NCT00383162|464987852|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
129189359|NCT00383162|464987853|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
129189360|NCT00383162|464987852|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
129189361|NCT00383162|464987853|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
129189362|NCT00383162|464987852|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
129189363|NCT00383162|464987853|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
129189364|NCT00383162|464987852|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
129189365|NCT00383162|464987853|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
129189366|NCT00383162|464987852|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
129189367|NCT00383162|464987853|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
129189368|NCT00383162|464987852|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
129189369|NCT00383162|464987853|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
129189370|NCT00383162|464987852|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
129189371|NCT00383162|464987853|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
129189372|NCT00767819|464987854|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
129189373|NCT00767819|464987855|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
129189374|NCT00767819|464987856|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129189375|NCT00767819|464987854|FG000|Overall Study|Withdrawal by Subject|1|||
129189376|NCT00767819|464987855|FG001|Overall Study|Withdrawal by Subject|1|||
129189377|NCT00767819|464987856|FG002|Overall Study|Withdrawal by Subject|0|||
129189378|NCT00767819|464987854|FG000|Overall Study|Administrative problems|0|||
129189379|NCT00767819|464987855|FG001|Overall Study|Administrative problems|1|||
129189380|NCT00767819|464987856|FG002|Overall Study|Administrative problems|0|||
129189381|NCT00767819|464987854|FG000|Overall Study|Death|2|||
129189382|NCT00767819|464987855|FG001|Overall Study|Death|3|||
129189383|NCT00767819|464987856|FG002|Overall Study|Death|0|||
129189384|NCT00767819|464987854|FG000|Overall Study|Adverse Event|2|||
129189385|NCT00767819|464987855|FG001|Overall Study|Adverse Event|0|||
129189386|NCT00767819|464987856|FG002|Overall Study|Adverse Event|0|||
129189387|NCT00767819|464987854|FG000|Overall Study|Abnormal lab values|1|||
129189388|NCT00767819|464987855|FG001|Overall Study|Abnormal lab values|0|||
129189389|NCT00767819|464987856|FG002|Overall Study|Abnormal lab values|0|||
129189390|NCT00767819|464987854|FG000|Overall Study|Lost to Follow-up|1|||
129189391|NCT00767819|464987855|FG001|Overall Study|Lost to Follow-up|0|||
129189392|NCT00767819|464987856|FG002|Overall Study|Lost to Follow-up|0|||
129189393|NCT04294147|464987858|FG000|Overall Study|Protocol Violation|2|||
129189394|NCT04294147|464987859|FG001|Overall Study|Protocol Violation|0|||
129189395|NCT05392803|464987860|FG000|Overall Study|Lost to Follow-up|0|||
129189396|NCT05392803|464987861|FG001|Overall Study|Lost to Follow-up|2|||
129189397|NCT02726022|464987862|FG000|Overall Study|Adverse Event|14|||
129189398|NCT02726022|464987862|FG000|Overall Study|Treatment Failure|8|||
129189399|NCT02726022|464987862|FG000|Overall Study|Poor Compliance|13|||
129189400|NCT02726022|464987862|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
129189401|NCT00915551|464987863|FG000|Overall Study|Withdrawal by Subject|0|||
129189402|NCT00915551|464987864|FG001|Overall Study|Withdrawal by Subject|1|||
129189403|NCT00235716|464987865|FG000|Overall Study|Death|26|||
129189404|NCT00235716|464987866|FG001|Overall Study|Death|39|||
129189405|NCT00235716|464987867|FG002|Overall Study|Death|32|||
129189406|NCT00235716|464987868|FG003|Overall Study|Death|31|||
129189407|NCT00235716|464987865|FG000|Overall Study|Withdrawal by Subject|23|||
129189408|NCT00235716|464987866|FG001|Overall Study|Withdrawal by Subject|19|||
129189409|NCT00235716|464987867|FG002|Overall Study|Withdrawal by Subject|17|||
129189410|NCT00235716|464987868|FG003|Overall Study|Withdrawal by Subject|18|||
129189411|NCT00235716|464987865|FG000|Overall Study|Lost to Follow-up|12|||
129189412|NCT00235716|464987866|FG001|Overall Study|Lost to Follow-up|7|||
129189413|NCT00235716|464987867|FG002|Overall Study|Lost to Follow-up|14|||
129189414|NCT00235716|464987868|FG003|Overall Study|Lost to Follow-up|10|||
129189415|NCT00235716|464987865|FG000|Overall Study|Adverse Event|1|||
129189416|NCT00235716|464987866|FG001|Overall Study|Adverse Event|1|||
129189417|NCT00235716|464987867|FG002|Overall Study|Adverse Event|1|||
129189418|NCT00235716|464987868|FG003|Overall Study|Adverse Event|0|||
129189419|NCT00235716|464987865|FG000|Overall Study|Physician Decision|0|||
129189420|NCT00235716|464987866|FG001|Overall Study|Physician Decision|1|||
129189421|NCT00235716|464987867|FG002|Overall Study|Physician Decision|1|||
129189422|NCT00235716|464987868|FG003|Overall Study|Physician Decision|3|||
129189423|NCT04390841|464987869|FG000|Overall Study|Withdrawal by Subject|2|||
129189424|NCT02891382|464987880|FG000|Overall Study|Lost to Follow-up|3|||
129189425|NCT02891382|464987881|FG001|Overall Study|Lost to Follow-up|4|||
129189426|NCT02891382|464987882|FG002|Overall Study|Lost to Follow-up|5|||
129189427|NCT02891382|464987883|FG003|Overall Study|Lost to Follow-up|3|||
129189428|NCT02891382|464987884|FG004|Overall Study|Lost to Follow-up|4|||
129189429|NCT02188849|464987889|FG000|Overall Study|Lost to Follow-up|3|||
129189430|NCT02188849|464987890|FG001|Overall Study|Lost to Follow-up|8|||
129189431|NCT02516228|464987893|FG000|Overall Study|Lost to Follow-up|1|||
129189432|NCT02516228|464987893|FG000|Overall Study|Withdrawal by Subject|1|||
129189433|NCT02516228|464987893|FG000|Overall Study|Physician Decision|1|||
129189434|NCT03916484|464987894|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129189435|NCT03916484|464987895|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
129189436|NCT03916484|464987896|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129189437|NCT03916484|464987897|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129189438|NCT03916484|464987894|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
129189439|NCT03916484|464987895|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
129189440|NCT03916484|464987896|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
129189441|NCT03916484|464987897|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
129189442|NCT01196416|464987906|FG000|Overall Study|Withdrawal by Subject|2|||
129189443|NCT00504894|464987907|FG000|Overall Study|fMRI technical problems|1|||
129189444|NCT00504894|464987908|FG001|Overall Study|fMRI technical problems|1|||
129189445|NCT00504894|464987909|FG002|Overall Study|fMRI technical problems|0|||
129189446|NCT00504894|464987907|FG000|Overall Study|Withdrawal by Subject|0|||
129189447|NCT00504894|464987908|FG001|Overall Study|Withdrawal by Subject|1|||
129189448|NCT00504894|464987909|FG002|Overall Study|Withdrawal by Subject|0|||
129189449|NCT00504894|464987907|FG000|Overall Study|Infusion technical problems|0|||
129189450|NCT00504894|464987908|FG001|Overall Study|Infusion technical problems|1|||
129189451|NCT00504894|464987909|FG002|Overall Study|Infusion technical problems|0|||
129189452|NCT00504894|464987907|FG000|Overall Study|poor subject data|2|||
129189453|NCT00504894|464987908|FG001|Overall Study|poor subject data|0|||
129189454|NCT00504894|464987909|FG002|Overall Study|poor subject data|0|||
129189455|NCT05090852|464987910|FG000|Overall Study|Physician Decision|5|||
129189456|NCT00148941|464987912|FG000|Overall Study|Lost to Follow-up|17|||
129189457|NCT00148941|464987913|FG001|Overall Study|Lost to Follow-up|24|||
129189458|NCT00148941|464987914|FG002|Overall Study|Lost to Follow-up|18|||
129189459|NCT00148941|464987915|FG003|Overall Study|Lost to Follow-up|22|||
129189460|NCT00148941|464987912|FG000|Overall Study|Withdrawal by Subject|1|||
129189461|NCT00148941|464987913|FG001|Overall Study|Withdrawal by Subject|0|||
129189462|NCT00148941|464987914|FG002|Overall Study|Withdrawal by Subject|1|||
129189463|NCT00148941|464987915|FG003|Overall Study|Withdrawal by Subject|0|||
129189464|NCT00148941|464987912|FG000|Overall Study|Other|0|||
129189465|NCT00148941|464987913|FG001|Overall Study|Other|0|||
129189466|NCT00148941|464987914|FG002|Overall Study|Other|1|||
129189467|NCT00148941|464987915|FG003|Overall Study|Other|2|||
129189468|NCT02673684|464987916|FG000|Overall Study|Study not completed d/t loss of funding|9|||
129189469|NCT02673684|464987917|FG001|Overall Study|Study not completed d/t loss of funding|8|||
129189470|NCT01092663|464987918|FG000|Overall Study|Withdrawal by Subject|3|||
129189471|NCT01092663|464987919|FG001|Overall Study|Withdrawal by Subject|2|||
129189472|NCT01092663|464987918|FG000|Overall Study|Glucose >300mg/dL|1|||
129189473|NCT01092663|464987919|FG001|Overall Study|Glucose >300mg/dL|0|||
129189474|NCT01092663|464987918|FG000|Overall Study|High fasting triglyceride|2|||
129189475|NCT01092663|464987919|FG001|Overall Study|High fasting triglyceride|0|||
129189476|NCT01092663|464987918|FG000|Overall Study|Adverse Event|1|||
129189477|NCT01092663|464987919|FG001|Overall Study|Adverse Event|1|||
129189478|NCT01092663|464987918|FG000|Overall Study|Protocol Violation|0|||
129189479|NCT01092663|464987919|FG001|Overall Study|Protocol Violation|1|||
129189480|NCT03688620|464987920|FG000|Overall Study|Other|0|||
129189481|NCT03688620|464987921|FG001|Overall Study|Other|0|||
129189482|NCT03688620|464987922|FG002|Overall Study|Other|1|||
129189483|NCT03688620|464987920|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
129189484|NCT03688620|464987921|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
129189485|NCT03688620|464987922|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
129189486|NCT03688620|464987920|FG000|Overall Study|Lost to Follow-up|16|||
129189487|NCT03688620|464987921|FG001|Overall Study|Lost to Follow-up|0|||
129189488|NCT03688620|464987922|FG002|Overall Study|Lost to Follow-up|1|||
129189489|NCT03688620|464987920|FG000|Overall Study|Withdrawal by Subject|0|||
129189490|NCT03688620|464987921|FG001|Overall Study|Withdrawal by Subject|0|||
129189491|NCT03688620|464987922|FG002|Overall Study|Withdrawal by Subject|6|||
129189492|NCT01008904|464987923|FG000|Overall Study|Lost to Follow-up|1|||
129189493|NCT01008904|464987923|FG000|Overall Study|Adverse Event|2|||
129189494|NCT01008904|464987923|FG000|Overall Study|unexpected unrelated surgery|1|||
129189495|NCT01183065|464987924|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
129189496|NCT02456857|464987925|FG000|Overall Study|Disease Progression|4|||
129189497|NCT00781859|464987926|FG000|Overall Study|Adverse Event|2|||
129189498|NCT00781859|464987927|FG001|Overall Study|Adverse Event|2|||
129189499|NCT00781859|464987926|FG000|Overall Study|Withdrawal by Subject|8|||
129189500|NCT00781859|464987927|FG001|Overall Study|Withdrawal by Subject|4|||
129189501|NCT00781859|464987926|FG000|Overall Study|Lost to Follow-up|6|||
129189502|NCT00781859|464987927|FG001|Overall Study|Lost to Follow-up|3|||
129189503|NCT00781859|464987926|FG000|Overall Study|Death|3|||
129189504|NCT00781859|464987927|FG001|Overall Study|Death|0|||
129189505|NCT01983774|464987931|FG000|Overall Study|Lung Transplant|0|||
129189506|NCT01983774|464987932|FG001|Overall Study|Lung Transplant|1|||
129189507|NCT01983774|464987931|FG000|Overall Study|Lost to Follow-up|1|||
129189508|NCT01983774|464987932|FG001|Overall Study|Lost to Follow-up|0|||
129189509|NCT01008449|464987933|FG000|Overall Study|Lost to Follow-up|29|||
129189510|NCT01008449|464987934|FG001|Overall Study|Lost to Follow-up|19|||
129189511|NCT01220180|464987935|FG000|Overall Study|Lost to Follow-up|76|||
129189512|NCT01220180|464987935|FG000|Overall Study|Other|72|||
129189513|NCT01220180|464987935|FG000|Overall Study|Adverse Event|35|||
129189514|NCT01220180|464987935|FG000|Overall Study|Lack of Efficacy|22|||
129189515|NCT01220180|464987935|FG000|Overall Study|Death|1|||
129189516|NCT01220180|464987935|FG000|Overall Study|Randomized but not treated|1|||
129189517|NCT01067469|464987940|FG000|Overall Study|Withdrawal by Subject|0|||
129189518|NCT01067469|464987941|FG001|Overall Study|Withdrawal by Subject|1|||
129189519|NCT01067469|464987940|FG000|Overall Study|Disease Progression|0|||
129189520|NCT01067469|464987941|FG001|Overall Study|Disease Progression|1|||
129189521|NCT01299116|464987944|FG000|Overall Study|Lost to Follow-up|65|||
129189522|NCT01299116|464987945|FG001|Overall Study|Lost to Follow-up|9|||
129189523|NCT01299116|464987946|FG002|Overall Study|Lost to Follow-up|11|||
129189524|NCT01620944|464987948|FG000|Overall Study|Early termination of Study|2|||
129189525|NCT01620944|464987949|FG001|Overall Study|Early termination of Study|1|||
129189526|NCT01123707|464987950|FG000|Overall Study|Lost to Follow-up|3|||
129189527|NCT01123707|464987951|FG001|Overall Study|Lost to Follow-up|1|||
129189528|NCT01123707|464987952|FG002|Overall Study|Lost to Follow-up|3|||
129189529|NCT01123707|464987953|FG003|Overall Study|Lost to Follow-up|2|||
129189530|NCT01123707|464987950|FG000|Overall Study|Adverse Event|5|||
129189531|NCT01123707|464987951|FG001|Overall Study|Adverse Event|7|||
129189532|NCT01123707|464987952|FG002|Overall Study|Adverse Event|5|||
129189533|NCT01123707|464987953|FG003|Overall Study|Adverse Event|3|||
129189534|NCT01123707|464987950|FG000|Overall Study|Sponsor Discontinued Study|30|||
129189535|NCT01123707|464987951|FG001|Overall Study|Sponsor Discontinued Study|24|||
129189536|NCT01123707|464987952|FG002|Overall Study|Sponsor Discontinued Study|25|||
129189537|NCT01123707|464987953|FG003|Overall Study|Sponsor Discontinued Study|40|||
129189538|NCT01123707|464987950|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
129189539|NCT01123707|464987951|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
129189540|NCT01123707|464987952|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
129189541|NCT01123707|464987953|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
129189542|NCT01123707|464987950|FG000|Overall Study|Investigator Withdrew Participant|0|||
129189543|NCT01123707|464987951|FG001|Overall Study|Investigator Withdrew Participant|1|||
129189544|NCT01123707|464987952|FG002|Overall Study|Investigator Withdrew Participant|1|||
129189545|NCT01123707|464987953|FG003|Overall Study|Investigator Withdrew Participant|1|||
129189546|NCT01123707|464987950|FG000|Overall Study|Subject Withdrew Consent|4|||
129189547|NCT01123707|464987951|FG001|Overall Study|Subject Withdrew Consent|5|||
129189548|NCT01123707|464987952|FG002|Overall Study|Subject Withdrew Consent|1|||
129189549|NCT01123707|464987953|FG003|Overall Study|Subject Withdrew Consent|2|||
129189550|NCT01123707|464987950|FG000|Overall Study|Lack of Efficacy|1|||
129189551|NCT01123707|464987951|FG001|Overall Study|Lack of Efficacy|2|||
129189552|NCT01123707|464987952|FG002|Overall Study|Lack of Efficacy|1|||
129189553|NCT01123707|464987953|FG003|Overall Study|Lack of Efficacy|0|||
129189554|NCT01123707|464987950|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
129189555|NCT01123707|464987951|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
129189556|NCT01123707|464987952|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
129189557|NCT01123707|464987953|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
129189558|NCT04378114|464987954|FG000|Overall Study|Withdrawal by Subject|5|||
129189559|NCT01959243|464987959|FG000|Overall Study|Investigator Decision|3|||
129189560|NCT01959243|464987960|FG001|Overall Study|Investigator Decision|0|||
129189561|NCT01959243|464987959|FG000|Overall Study|Adverse Event|5|||
129189562|NCT01959243|464987960|FG001|Overall Study|Adverse Event|2|||
129189563|NCT01959243|464987959|FG000|Overall Study|Administrative reasons|2|||
129189564|NCT01959243|464987960|FG001|Overall Study|Administrative reasons|1|||
129189565|NCT01959243|464987959|FG000|Overall Study|Lost to Follow-up|3|||
129189566|NCT01959243|464987960|FG001|Overall Study|Lost to Follow-up|1|||
129189567|NCT00629798|464987961|FG000|Overall Study|Not Treated|4|||
129189568|NCT02554981|464987962|FG000|Overall Study|Adverse Event|1|||
129189569|NCT02554981|464987962|FG000|Overall Study|Administrative Reasons|1|||
129189570|NCT02554981|464987962|FG000|Overall Study|Other Miscellaneous Reasons|3|||
129189571|NCT01114438|464987963|FG000|Overall Study|Adverse Event|10|||
129189572|NCT01114438|464987963|FG000|Overall Study|concomitant medication|1|||
129189573|NCT01114438|464987963|FG000|Overall Study|Physician Decision|1|||
129189574|NCT01114438|464987963|FG000|Overall Study|Withdrawal by Subject|2|||
129189575|NCT00428844|464987964|FG000|Completed Study Drug Treatment|Adverse Event|2|||
129189576|NCT00428844|464987965|FG001|Completed Study Drug Treatment|Adverse Event|4|||
129189577|NCT00428844|464987966|FG002|Completed Study Drug Treatment|Adverse Event|4|||
129189578|NCT00428844|464987964|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
129189579|NCT00428844|464987965|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
129189580|NCT00428844|464987966|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
129189581|NCT00428844|464987964|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
129189582|NCT00428844|464987965|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
129189583|NCT00428844|464987966|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
129189584|NCT00428844|464987964|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
129189585|NCT00428844|464987965|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
129189586|NCT00428844|464987966|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
129189587|NCT00428844|464987964|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
129189588|NCT00428844|464987965|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
129189589|NCT00428844|464987966|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
129189590|NCT00428844|464987964|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
129189591|NCT00428844|464987965|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
129189592|NCT00428844|464987966|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
129189593|NCT00428844|464987964|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
129189594|NCT00428844|464987965|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
129189595|NCT00428844|464987966|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
129189596|NCT00428844|464987964|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
129189597|NCT00428844|464987965|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
129189598|NCT00428844|464987966|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
129189599|NCT00428844|464987964|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
129189600|NCT00428844|464987965|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
129189601|NCT00428844|464987966|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
129189602|NCT00488826|464987969|FG000|Overall Study|Withdrawal by Subject|40|||
129189603|NCT00488826|464987970|FG001|Overall Study|Withdrawal by Subject|35|||
129189604|NCT00488826|464987971|FG002|Overall Study|Withdrawal by Subject|19|||
129189605|NCT00488826|464987969|FG000|Overall Study|Protocol Violation|0|||
129189606|NCT00488826|464987970|FG001|Overall Study|Protocol Violation|0|||
129189607|NCT00488826|464987971|FG002|Overall Study|Protocol Violation|2|||
129189608|NCT00488826|464987969|FG000|Overall Study|Adverse Event|9|||
129189609|NCT00488826|464987970|FG001|Overall Study|Adverse Event|15|||
129189610|NCT00488826|464987971|FG002|Overall Study|Adverse Event|4|||
129189611|NCT00488826|464987969|FG000|Overall Study|Lost to Follow-up|5|||
129189612|NCT00488826|464987970|FG001|Overall Study|Lost to Follow-up|1|||
129189613|NCT00488826|464987971|FG002|Overall Study|Lost to Follow-up|0|||
129189614|NCT00488826|464987969|FG000|Overall Study|Protocol Deviations|2|||
129189615|NCT00488826|464987970|FG001|Overall Study|Protocol Deviations|1|||
129189616|NCT00488826|464987971|FG002|Overall Study|Protocol Deviations|1|||
129189617|NCT02292706|464987972|FG000|Overall Study|Lost to Follow-up|20|||
129189618|NCT02292706|464987973|FG001|Overall Study|Lost to Follow-up|44|||
129189619|NCT02292706|464987974|FG002|Overall Study|Lost to Follow-up|24|||
129189620|NCT02292706|464987975|FG003|Overall Study|Lost to Follow-up|61|||
129189621|NCT02292706|464987976|FG004|Overall Study|Lost to Follow-up|21|||
129189622|NCT02292706|464987977|FG005|Overall Study|Lost to Follow-up|52|||
129189623|NCT02292706|464987978|FG006|Overall Study|Lost to Follow-up|25|||
129189624|NCT02292706|464987979|FG007|Overall Study|Lost to Follow-up|0|||
129189625|NCT02292706|464987972|FG000|Overall Study|Withdrew consent|15|||
129189626|NCT02292706|464987973|FG001|Overall Study|Withdrew consent|56|||
129189627|NCT02292706|464987974|FG002|Overall Study|Withdrew consent|43|||
129189628|NCT02292706|464987975|FG003|Overall Study|Withdrew consent|36|||
129189629|NCT02292706|464987976|FG004|Overall Study|Withdrew consent|13|||
129189630|NCT02292706|464987977|FG005|Overall Study|Withdrew consent|51|||
129189631|NCT02292706|464987978|FG006|Overall Study|Withdrew consent|20|||
129189632|NCT02292706|464987979|FG007|Overall Study|Withdrew consent|0|||
129189633|NCT02292706|464987972|FG000|Overall Study|Death|3|||
129189634|NCT02292706|464987973|FG001|Overall Study|Death|11|||
129189635|NCT02292706|464987974|FG002|Overall Study|Death|16|||
129189636|NCT02292706|464987975|FG003|Overall Study|Death|22|||
129189637|NCT02292706|464987976|FG004|Overall Study|Death|8|||
129189638|NCT02292706|464987977|FG005|Overall Study|Death|17|||
129189639|NCT02292706|464987978|FG006|Overall Study|Death|3|||
129189640|NCT02292706|464987979|FG007|Overall Study|Death|0|||
129189641|NCT02292706|464987972|FG000|Overall Study|Study terminated by sponsor|0|||
129189642|NCT02292706|464987973|FG001|Overall Study|Study terminated by sponsor|9|||
129189643|NCT02292706|464987974|FG002|Overall Study|Study terminated by sponsor|4|||
129189644|NCT02292706|464987975|FG003|Overall Study|Study terminated by sponsor|21|||
129189645|NCT02292706|464987976|FG004|Overall Study|Study terminated by sponsor|11|||
129189646|NCT02292706|464987977|FG005|Overall Study|Study terminated by sponsor|13|||
129189647|NCT02292706|464987978|FG006|Overall Study|Study terminated by sponsor|3|||
129189648|NCT02292706|464987979|FG007|Overall Study|Study terminated by sponsor|0|||
129189649|NCT02292706|464987972|FG000|Overall Study|Investigator's discretion|4|||
129189650|NCT02292706|464987973|FG001|Overall Study|Investigator's discretion|9|||
129189651|NCT02292706|464987974|FG002|Overall Study|Investigator's discretion|7|||
129189652|NCT02292706|464987975|FG003|Overall Study|Investigator's discretion|11|||
129189653|NCT02292706|464987976|FG004|Overall Study|Investigator's discretion|4|||
129189654|NCT02292706|464987977|FG005|Overall Study|Investigator's discretion|10|||
129189655|NCT02292706|464987978|FG006|Overall Study|Investigator's discretion|1|||
129189656|NCT02292706|464987979|FG007|Overall Study|Investigator's discretion|0|||
129189657|NCT02292706|464987972|FG000|Overall Study|Liver transplant|1|||
129189658|NCT02292706|464987973|FG001|Overall Study|Liver transplant|1|||
129189659|NCT02292706|464987974|FG002|Overall Study|Liver transplant|11|||
129189660|NCT02292706|464987975|FG003|Overall Study|Liver transplant|16|||
129189661|NCT02292706|464987976|FG004|Overall Study|Liver transplant|5|||
129189662|NCT02292706|464987977|FG005|Overall Study|Liver transplant|6|||
129189663|NCT02292706|464987978|FG006|Overall Study|Liver transplant|5|||
129189664|NCT02292706|464987979|FG007|Overall Study|Liver transplant|0|||
129189665|NCT02292706|464987972|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
129189666|NCT02292706|464987973|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
129189667|NCT02292706|464987974|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
129189668|NCT02292706|464987975|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
129189669|NCT02292706|464987976|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
129189670|NCT02292706|464987977|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
129189671|NCT02292706|464987978|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
129189672|NCT02292706|464987979|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
129189673|NCT02292706|464987972|FG000|Overall Study|Subject terminated by sponsor|1|||
129189674|NCT02292706|464987973|FG001|Overall Study|Subject terminated by sponsor|0|||
129189675|NCT02292706|464987974|FG002|Overall Study|Subject terminated by sponsor|0|||
129189676|NCT02292706|464987975|FG003|Overall Study|Subject terminated by sponsor|2|||
129189677|NCT02292706|464987976|FG004|Overall Study|Subject terminated by sponsor|1|||
129189678|NCT02292706|464987977|FG005|Overall Study|Subject terminated by sponsor|0|||
129189679|NCT02292706|464987978|FG006|Overall Study|Subject terminated by sponsor|0|||
129189680|NCT02292706|464987979|FG007|Overall Study|Subject terminated by sponsor|0|||
129189681|NCT02292706|464987972|FG000|Overall Study|Missing|0|||
129189682|NCT02292706|464987973|FG001|Overall Study|Missing|0|||
129189683|NCT02292706|464987974|FG002|Overall Study|Missing|1|||
129189684|NCT02292706|464987975|FG003|Overall Study|Missing|1|||
129189685|NCT02292706|464987976|FG004|Overall Study|Missing|0|||
129189686|NCT02292706|464987977|FG005|Overall Study|Missing|1|||
129189687|NCT02292706|464987978|FG006|Overall Study|Missing|0|||
129189688|NCT02292706|464987979|FG007|Overall Study|Missing|0|||
129189689|NCT02292706|464987972|FG000|Overall Study|Virologic relapse or reinfection|1|||
129189690|NCT02292706|464987973|FG001|Overall Study|Virologic relapse or reinfection|0|||
129189691|NCT02292706|464987974|FG002|Overall Study|Virologic relapse or reinfection|0|||
129189692|NCT02292706|464987975|FG003|Overall Study|Virologic relapse or reinfection|1|||
129189693|NCT02292706|464987976|FG004|Overall Study|Virologic relapse or reinfection|0|||
129189694|NCT02292706|464987977|FG005|Overall Study|Virologic relapse or reinfection|1|||
129189695|NCT02292706|464987978|FG006|Overall Study|Virologic relapse or reinfection|0|||
129189696|NCT02292706|464987979|FG007|Overall Study|Virologic relapse or reinfection|0|||
129189697|NCT02725866|464987982|FG000|Overall Study|Failure to return|6|||
129189698|NCT02725866|464987982|FG000|Overall Study|Withdrew consent|3|||
129189699|NCT02725866|464987982|FG000|Overall Study|Insufficient virological response|1|||
129189700|NCT02725866|464987982|FG000|Overall Study|Other, not specified|4|||
129189701|NCT04667104|464987989|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
129189702|NCT04667104|464987990|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
129189703|NCT04667104|464987991|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
129189704|NCT03043651|464987992|FG000|Overall Study|Death|1|||
129189705|NCT03043651|464987992|FG000|Overall Study|Progressive Disease|2|||
129189706|NCT03043651|464987992|FG000|Overall Study|Adverse Event|2|||
129189707|NCT03043651|464987992|FG000|Overall Study|Withdrawal by Subject|4|||
129189708|NCT03043651|464987992|FG000|Overall Study|Study Terminated by Sponsor|39|||
129189709|NCT01630889|464987993|FG000|Overall Study|Death|2|||
129189710|NCT01630889|464987993|FG000|Overall Study|Withdrawal by Subject|1|||
129189711|NCT01630889|464987993|FG000|Overall Study|Other than Specified|2|||
129189712|NCT01630889|464987993|FG000|Overall Study|Lost to Follow-up|4|||
129189713|NCT01630889|464987993|FG000|Overall Study|Other|1|||
129189714|NCT03208088|464987998|FG000|Period 2|Withdrawal by Subject|0|||
129189715|NCT03208088|464987999|FG001|Period 2|Withdrawal by Subject|0|||
129189716|NCT03208088|464988000|FG002|Period 2|Withdrawal by Subject|0|||
129189717|NCT03208088|464988001|FG003|Period 2|Withdrawal by Subject|0|||
129189718|NCT03208088|464988002|FG004|Period 2|Withdrawal by Subject|0|||
129189719|NCT03208088|464988003|FG005|Period 2|Withdrawal by Subject|0|||
129189720|NCT03208088|464988004|FG006|Period 2|Withdrawal by Subject|0|||
129189721|NCT03208088|464988005|FG007|Period 2|Withdrawal by Subject|0|||
129189722|NCT03208088|464988006|FG008|Period 2|Withdrawal by Subject|1|||
129189723|NCT03208088|464988007|FG009|Period 2|Withdrawal by Subject|0|||
129189724|NCT03208088|464987998|FG000|Period 3|Unsatisfactory Test Article|0|||
129189725|NCT03208088|464987999|FG001|Period 3|Unsatisfactory Test Article|0|||
129189726|NCT03208088|464988000|FG002|Period 3|Unsatisfactory Test Article|0|||
129189727|NCT03208088|464988001|FG003|Period 3|Unsatisfactory Test Article|1|||
129189728|NCT03208088|464988002|FG004|Period 3|Unsatisfactory Test Article|0|||
129189729|NCT03208088|464988003|FG005|Period 3|Unsatisfactory Test Article|0|||
129189730|NCT03208088|464988004|FG006|Period 3|Unsatisfactory Test Article|0|||
129189731|NCT03208088|464988005|FG007|Period 3|Unsatisfactory Test Article|0|||
129189732|NCT03208088|464988006|FG008|Period 3|Unsatisfactory Test Article|0|||
129189733|NCT03208088|464988007|FG009|Period 3|Unsatisfactory Test Article|0|||
129189734|NCT03208088|464987998|FG000|Period 4|Unsatisfactory Test Article|0|||
129189735|NCT03208088|464987999|FG001|Period 4|Unsatisfactory Test Article|0|||
129189736|NCT03208088|464988000|FG002|Period 4|Unsatisfactory Test Article|0|||
129189737|NCT03208088|464988001|FG003|Period 4|Unsatisfactory Test Article|1|||
129189738|NCT03208088|464988002|FG004|Period 4|Unsatisfactory Test Article|0|||
129189739|NCT03208088|464988003|FG005|Period 4|Unsatisfactory Test Article|0|||
129189740|NCT03208088|464988004|FG006|Period 4|Unsatisfactory Test Article|0|||
129189741|NCT03208088|464988005|FG007|Period 4|Unsatisfactory Test Article|0|||
129189742|NCT03208088|464988006|FG008|Period 4|Unsatisfactory Test Article|0|||
129189743|NCT03208088|464988007|FG009|Period 4|Unsatisfactory Test Article|0|||
129189744|NCT03597061|464988008|FG000|Overall Study|Lost to Follow-up|1|||
129189745|NCT03597061|464988009|FG001|Overall Study|Lost to Follow-up|0|||
129189746|NCT03597061|464988008|FG000|Overall Study|Protocol Violation|0|||
129189747|NCT03597061|464988009|FG001|Overall Study|Protocol Violation|1|||
129189748|NCT00566254|464988010|FG000|Overall Study|Adverse Event|3|||
129189749|NCT00566254|464988011|FG001|Overall Study|Adverse Event|1|||
129189750|NCT00566254|464988010|FG000|Overall Study|Protocol Violation|1|||
129189751|NCT00566254|464988011|FG001|Overall Study|Protocol Violation|3|||
129189752|NCT00566254|464988010|FG000|Overall Study|Withdrawal by Subject|1|||
129189753|NCT00566254|464988011|FG001|Overall Study|Withdrawal by Subject|2|||
129189754|NCT00566254|464988010|FG000|Overall Study|Lack of Efficacy|5|||
129189755|NCT00566254|464988011|FG001|Overall Study|Lack of Efficacy|6|||
129189756|NCT00566254|464988010|FG000|Overall Study|Other|0|||
129189757|NCT00566254|464988011|FG001|Overall Study|Other|2|||
129189758|NCT01345669|464988012|FG000|Overall Study|Primary tumour recurrence|53|||
129189759|NCT01345669|464988013|FG001|Overall Study|Primary tumour recurrence|32|||
129189760|NCT01345669|464988012|FG000|Overall Study|Second primary tumour|4|||
129189761|NCT01345669|464988013|FG001|Overall Study|Second primary tumour|3|||
129189762|NCT01345669|464988012|FG000|Overall Study|Adverse Event|63|||
129189763|NCT01345669|464988013|FG001|Overall Study|Adverse Event|9|||
129189764|NCT01345669|464988012|FG000|Overall Study|Protocol Violation|3|||
129189765|NCT01345669|464988013|FG001|Overall Study|Protocol Violation|1|||
129189766|NCT01345669|464988012|FG000|Overall Study|Lost to Follow-up|1|||
129189767|NCT01345669|464988013|FG001|Overall Study|Lost to Follow-up|1|||
129189768|NCT01345669|464988012|FG000|Overall Study|Withdrawal by Subject|52|||
129189769|NCT01345669|464988013|FG001|Overall Study|Withdrawal by Subject|13|||
129189770|NCT01345669|464988012|FG000|Overall Study|Other Reasons|111|||
129189771|NCT01345669|464988013|FG001|Overall Study|Other Reasons|60|||
129189772|NCT01793883|464988014|FG000|Overall Study|Withdrawal by Subject|3|||
129189773|NCT01793883|464988015|FG001|Overall Study|Withdrawal by Subject|7|||
129189774|NCT01793883|464988016|FG002|Overall Study|Withdrawal by Subject|3|||
129189775|NCT01793883|464988014|FG000|Overall Study|Subject noncompliance|0|||
129189776|NCT01793883|464988015|FG001|Overall Study|Subject noncompliance|1|||
129189777|NCT01793883|464988016|FG002|Overall Study|Subject noncompliance|1|||
129189778|NCT01793883|464988014|FG000|Overall Study|Lost to Follow-up|5|||
129189779|NCT01793883|464988015|FG001|Overall Study|Lost to Follow-up|1|||
129189780|NCT01793883|464988016|FG002|Overall Study|Lost to Follow-up|3|||
129189781|NCT01793883|464988014|FG000|Overall Study|Randomized in error|1|||
129189782|NCT01793883|464988015|FG001|Overall Study|Randomized in error|0|||
129189783|NCT01793883|464988016|FG002|Overall Study|Randomized in error|0|||
129189784|NCT01793883|464988014|FG000|Overall Study|Unable to complete spriometry|1|||
129189785|NCT01793883|464988015|FG001|Overall Study|Unable to complete spriometry|0|||
129189786|NCT01793883|464988016|FG002|Overall Study|Unable to complete spriometry|0|||
129189787|NCT01793883|464988014|FG000|Overall Study|Unable to complete measurements|1|||
129189788|NCT01793883|464988015|FG001|Overall Study|Unable to complete measurements|0|||
129189789|NCT01793883|464988016|FG002|Overall Study|Unable to complete measurements|0|||
129189790|NCT01793883|464988014|FG000|Overall Study|Met exclusion criteria|1|||
129189791|NCT01793883|464988015|FG001|Overall Study|Met exclusion criteria|0|||
129189792|NCT01793883|464988016|FG002|Overall Study|Met exclusion criteria|0|||
129189793|NCT01793883|464988014|FG000|Overall Study|Dosing error|0|||
129189794|NCT01793883|464988015|FG001|Overall Study|Dosing error|1|||
129189795|NCT01793883|464988016|FG002|Overall Study|Dosing error|0|||
129189796|NCT01793883|464988014|FG000|Overall Study|Respiratory distress during spirometry|0|||
129189797|NCT01793883|464988015|FG001|Overall Study|Respiratory distress during spirometry|0|||
129189798|NCT01793883|464988016|FG002|Overall Study|Respiratory distress during spirometry|1|||
129189799|NCT02478255|464988017|FG000|Overall Study|Physician Decision|6|||
129189800|NCT02478255|464988018|FG001|Overall Study|Physician Decision|0|||
129189801|NCT02478255|464988017|FG000|Overall Study|Withdrawal by Subject|2|||
129189802|NCT02478255|464988018|FG001|Overall Study|Withdrawal by Subject|0|||
129189803|NCT00761527|464988019|FG000|Overall Study|Adverse Event|3|||
129189804|NCT00761527|464988019|FG000|Overall Study|Poor Compliance|8|||
129189805|NCT00761527|464988019|FG000|Overall Study|Lost to Follow-up|9|||
129189806|NCT00761527|464988019|FG000|Overall Study|Unknown reason|2|||
129189807|NCT01431963|464988020|FG000|Overall Study|Adverse Event|18|||
129189808|NCT01431963|464988020|FG000|Overall Study|Lack of Efficacy|7|||
129189809|NCT01431963|464988020|FG000|Overall Study|Protocol Violation|1|||
129189810|NCT01431963|464988020|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
129189811|NCT01431963|464988020|FG000|Overall Study|Physician Decision|4|||
129189812|NCT01431963|464988020|FG000|Overall Study|Withdrawal by Subject|3|||
129189813|NCT02921087|464988023|FG000|Overall Study|Withdrawal by Subject|0|||
129189814|NCT02921087|464988024|FG001|Overall Study|Withdrawal by Subject|1|||
129189815|NCT00687531|464988025|FG000|Overall Study|Did not meet protocol eligibility|104|||
129189816|NCT00687531|464988025|FG000|Overall Study|Adverse Event|5|||
129189817|NCT00687531|464988025|FG000|Overall Study|Lost to Follow-up|26|||
129189818|NCT03210961|464989866|FG000|Overall Study|Adverse Event|0|||
129189819|NCT03210961|464989867|FG001|Overall Study|Adverse Event|0|||
129189820|NCT03210961|464989868|FG002|Overall Study|Adverse Event|0|||
129189821|NCT03210961|464989869|FG003|Overall Study|Adverse Event|0|||
129189822|NCT03210961|464989870|FG004|Overall Study|Adverse Event|0|||
129189823|NCT03210961|464989871|FG005|Overall Study|Adverse Event|0|||
129189824|NCT03210961|464989872|FG006|Overall Study|Adverse Event|0|||
129189825|NCT03210961|464989873|FG007|Overall Study|Adverse Event|0|||
129189826|NCT03210961|464989874|FG008|Overall Study|Adverse Event|0|||
129189827|NCT03210961|464989875|FG009|Overall Study|Adverse Event|0|||
129189828|NCT03210961|464989876|FG010|Overall Study|Adverse Event|0|||
129189829|NCT03210961|464989877|FG011|Overall Study|Adverse Event|0|||
129189830|NCT03210961|464989878|FG012|Overall Study|Adverse Event|0|||
129189831|NCT03210961|464989879|FG013|Overall Study|Adverse Event|1|||
129189832|NCT03210961|464989880|FG014|Overall Study|Adverse Event|0|||
129189833|NCT03210961|464989866|FG000|Overall Study|Lost to Follow-up|0|||
129189834|NCT03210961|464989867|FG001|Overall Study|Lost to Follow-up|0|||
129189835|NCT03210961|464989868|FG002|Overall Study|Lost to Follow-up|0|||
129189836|NCT03210961|464989869|FG003|Overall Study|Lost to Follow-up|0|||
129189837|NCT03210961|464989870|FG004|Overall Study|Lost to Follow-up|0|||
129189838|NCT03210961|464989871|FG005|Overall Study|Lost to Follow-up|0|||
129189839|NCT03210961|464989872|FG006|Overall Study|Lost to Follow-up|0|||
129189840|NCT03210961|464989873|FG007|Overall Study|Lost to Follow-up|0|||
129189841|NCT03210961|464989874|FG008|Overall Study|Lost to Follow-up|0|||
129189842|NCT03210961|464989875|FG009|Overall Study|Lost to Follow-up|0|||
129189843|NCT03210961|464989876|FG010|Overall Study|Lost to Follow-up|0|||
129189844|NCT03210961|464989877|FG011|Overall Study|Lost to Follow-up|0|||
129189845|NCT03210961|464989878|FG012|Overall Study|Lost to Follow-up|0|||
129189846|NCT03210961|464989879|FG013|Overall Study|Lost to Follow-up|0|||
129189847|NCT03210961|464989880|FG014|Overall Study|Lost to Follow-up|1|||
129189848|NCT03210961|464989866|FG000|Overall Study|Withdrawal by Subject|0|||
129189849|NCT03210961|464989867|FG001|Overall Study|Withdrawal by Subject|0|||
129189850|NCT03210961|464989868|FG002|Overall Study|Withdrawal by Subject|0|||
129189851|NCT03210961|464989869|FG003|Overall Study|Withdrawal by Subject|0|||
129189852|NCT03210961|464989870|FG004|Overall Study|Withdrawal by Subject|0|||
129189853|NCT03210961|464989871|FG005|Overall Study|Withdrawal by Subject|0|||
129189854|NCT03210961|464989872|FG006|Overall Study|Withdrawal by Subject|0|||
129189855|NCT03210961|464989873|FG007|Overall Study|Withdrawal by Subject|0|||
129189856|NCT03210961|464989874|FG008|Overall Study|Withdrawal by Subject|0|||
129189857|NCT03210961|464989875|FG009|Overall Study|Withdrawal by Subject|0|||
129189858|NCT03210961|464989876|FG010|Overall Study|Withdrawal by Subject|0|||
129189859|NCT03210961|464989877|FG011|Overall Study|Withdrawal by Subject|0|||
129189860|NCT03210961|464989878|FG012|Overall Study|Withdrawal by Subject|0|||
129189861|NCT03210961|464989879|FG013|Overall Study|Withdrawal by Subject|0|||
129189862|NCT03210961|464989880|FG014|Overall Study|Withdrawal by Subject|1|||
129189863|NCT03210961|464989866|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189864|NCT03210961|464989867|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189865|NCT03210961|464989868|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189866|NCT03210961|464989869|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189867|NCT03210961|464989870|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189868|NCT03210961|464989871|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189869|NCT03210961|464989872|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189870|NCT03210961|464989873|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189871|NCT03210961|464989874|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189872|NCT03210961|464989875|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189873|NCT03210961|464989876|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189874|NCT03210961|464989877|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189875|NCT03210961|464989878|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189876|NCT03210961|464989879|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
129189877|NCT03210961|464989880|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
129189878|NCT03210961|464989866|FG000|Overall Study|Other|0|||
129189879|NCT03210961|464989867|FG001|Overall Study|Other|0|||
128730356|NCT00749775|463309953|FG000|Overall Study|No drug administration|3|||
128730357|NCT04300296|463309954|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
128730358|NCT04300296|463309955|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129189880|NCT03210961|464989868|FG002|Overall Study|Other|0|||
129189881|NCT03210961|464989869|FG003|Overall Study|Other|1|||
129189882|NCT03210961|464989870|FG004|Overall Study|Other|0|||
129189883|NCT03210961|464989871|FG005|Overall Study|Other|0|||
129189884|NCT03210961|464989872|FG006|Overall Study|Other|1|||
129189885|NCT03210961|464989873|FG007|Overall Study|Other|0|||
129189886|NCT03210961|464989874|FG008|Overall Study|Other|0|||
129189887|NCT03210961|464989875|FG009|Overall Study|Other|0|||
129189888|NCT03210961|464989876|FG010|Overall Study|Other|1|||
129189889|NCT03210961|464989877|FG011|Overall Study|Other|0|||
129189890|NCT03210961|464989878|FG012|Overall Study|Other|2|||
129189891|NCT03210961|464989879|FG013|Overall Study|Other|2|||
129189892|NCT03210961|464989880|FG014|Overall Study|Other|0|||
129189893|NCT00602420|464989881|FG000|Overall Study|Death|1|||
129189894|NCT00602420|464989882|FG001|Overall Study|Death|4|||
129189895|NCT00602420|464989881|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
129189896|NCT00602420|464989882|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
129189897|NCT00602420|464989881|FG000|Overall Study|Withdrawal by Subject|18|||
129189898|NCT00602420|464989882|FG001|Overall Study|Withdrawal by Subject|17|||
129189899|NCT00602420|464989881|FG000|Overall Study|Adverse Event|1|||
129189900|NCT00602420|464989882|FG001|Overall Study|Adverse Event|0|||
129189901|NCT00703924|464989889|FG000|Overall Study|Withdrawal by Subject|1|||
129189902|NCT00703924|464989890|FG001|Overall Study|Withdrawal by Subject|1|||
129189903|NCT03592368|464989891|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
129189904|NCT03592368|464989892|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
129189905|NCT03592368|464989893|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
129189906|NCT03592368|464989894|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
129189907|NCT03592368|464989891|FG000|Overall Study|Adverse Event|0|||
129189908|NCT03592368|464989892|FG001|Overall Study|Adverse Event|0|||
129189909|NCT03592368|464989893|FG002|Overall Study|Adverse Event|0|||
129189910|NCT03592368|464989894|FG003|Overall Study|Adverse Event|1|||
129189911|NCT03592368|464989891|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
129189912|NCT03592368|464989892|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
129189913|NCT03592368|464989893|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
129189914|NCT03592368|464989894|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
129189915|NCT02352753|464989897|FG000|6-Month Dosing Period|Decision by sponsor|2|||
129189916|NCT02352753|464989897|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
129189917|NCT02352753|464989897|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
129189918|NCT02352753|464989897|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
129189919|NCT02352753|464989897|FG000|3-Month Dosing Period|Decision by sponsor|14|||
129189920|NCT02352753|464989897|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
129189921|NCT00539305|464989898|FG000|Overall Study|Adverse Event|1|||
129189922|NCT00539305|464989899|FG001|Overall Study|Adverse Event|0|||
129189923|NCT00539305|464989898|FG000|Overall Study|Substance Use|0|||
129189924|NCT00539305|464989899|FG001|Overall Study|Substance Use|1|||
129189925|NCT00539305|464989898|FG000|Overall Study|Withdrawal by Subject|0|||
129189926|NCT00539305|464989899|FG001|Overall Study|Withdrawal by Subject|1|||
129189927|NCT00413036|464989905|FG000|Overall Study|Adverse Event|44|||
129189928|NCT00413036|464989905|FG000|Overall Study|Lack of Efficacy|129|||
129189929|NCT00413036|464989905|FG000|Overall Study|Withdrawal by Subject|7|||
129189930|NCT00413036|464989905|FG000|Overall Study|Death|9|||
129189931|NCT00413036|464989905|FG000|Overall Study|Other|26|||
129189932|NCT00413036|464989905|FG000|Overall Study|Missing|2|||
129189933|NCT01369641|464989906|FG000|Overall Study|Withdrawal by Subject|1|||
129189934|NCT00842543|464989907|FG000|Overall Study|Withdrawal by Subject|2|||
129189935|NCT00842543|464989908|FG001|Overall Study|Withdrawal by Subject|0|||
129189936|NCT00842543|464989909|FG002|Overall Study|Withdrawal by Subject|3|||
129189937|NCT00842543|464989910|FG003|Overall Study|Withdrawal by Subject|4|||
129189938|NCT01483183|464989915|FG000|Overall Study|Physician Decision|0|||
129189939|NCT01483183|464989916|FG001|Overall Study|Physician Decision|0|||
129189940|NCT01483183|464989917|FG002|Overall Study|Physician Decision|0|||
129189941|NCT01483183|464989918|FG003|Overall Study|Physician Decision|0|||
129189942|NCT01483183|464989919|FG004|Overall Study|Physician Decision|0|||
129189943|NCT01483183|464989920|FG005|Overall Study|Physician Decision|0|||
129189944|NCT01483183|464989921|FG006|Overall Study|Physician Decision|2|||
129189945|NCT01483183|464989922|FG007|Overall Study|Physician Decision|0|||
129189946|NCT01483183|464989923|FG008|Overall Study|Physician Decision|0|||
129189947|NCT01483183|464989924|FG009|Overall Study|Physician Decision|0|||
129189948|NCT01483183|464989915|FG000|Overall Study|Withdrawal by Subject|0|||
129189949|NCT01483183|464989916|FG001|Overall Study|Withdrawal by Subject|0|||
129189950|NCT01483183|464989917|FG002|Overall Study|Withdrawal by Subject|0|||
129189951|NCT01483183|464989918|FG003|Overall Study|Withdrawal by Subject|0|||
129189952|NCT01483183|464989919|FG004|Overall Study|Withdrawal by Subject|0|||
129189953|NCT01483183|464989920|FG005|Overall Study|Withdrawal by Subject|0|||
129189954|NCT01483183|464989921|FG006|Overall Study|Withdrawal by Subject|0|||
129189955|NCT01483183|464989922|FG007|Overall Study|Withdrawal by Subject|0|||
129189956|NCT01483183|464989923|FG008|Overall Study|Withdrawal by Subject|0|||
129189957|NCT01483183|464989924|FG009|Overall Study|Withdrawal by Subject|1|||
129189958|NCT00239928|464989925|FG000|Overall Study|Lack of Efficacy|1|||
129189959|NCT00239928|464989925|FG000|Overall Study|Adverse Event|4|||
129189960|NCT00239928|464989925|FG000|Overall Study|Not need to continue study|3|||
129189961|NCT00239928|464989925|FG000|Overall Study|Withdrawal by Subject|2|||
129189962|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129189963|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129189964|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
129189965|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
129189966|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
129189967|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129189968|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
129189969|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
129189970|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
129189971|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129189972|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129189973|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129189974|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129189975|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
129189976|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
129189977|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
129189978|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
129189979|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
129189980|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
129189981|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
129189982|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
129189983|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
129189984|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129189985|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129189986|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129189987|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129189988|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129189989|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129189990|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129189991|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129189992|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129189993|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129189994|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129189995|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129189996|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129189997|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129189998|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129189999|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129190000|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129190001|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190002|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129190003|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129190004|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190005|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190006|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190007|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129190008|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190009|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129190010|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190011|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190012|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190013|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129190014|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190015|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190016|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190017|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
129190018|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190019|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
128730359|NCT04300296|463309956|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
128730360|NCT04300296|463309957|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
128730361|NCT04300296|463309958|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
128730362|NCT04300296|463309959|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129190020|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190021|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
129190022|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190023|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190024|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190025|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190026|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129190027|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190028|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190029|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190030|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
129190031|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190032|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190033|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
129190034|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190035|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190036|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190037|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190038|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190039|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129190040|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190041|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
129190042|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190043|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190044|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190045|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190046|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190047|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190048|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190049|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190050|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190051|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190052|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129190053|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
129190054|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190055|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190056|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190057|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190058|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190059|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190060|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190061|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190062|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190063|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190064|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190065|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129190066|NCT03100058|464989927|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190067|NCT03100058|464989928|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190068|NCT03100058|464989929|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190069|NCT03100058|464989930|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190070|NCT03100058|464989931|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190071|NCT03100058|464989932|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190072|NCT03100058|464989933|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
129190073|NCT03100058|464989934|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190074|NCT03100058|464989935|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190075|NCT03100058|464989936|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190076|NCT03100058|464989937|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190077|NCT03100058|464989938|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190078|NCT03100058|464989939|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129190079|NCT03100058|464989927|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190080|NCT03100058|464989928|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190081|NCT03100058|464989929|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
128730363|NCT04300296|463309954|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129190082|NCT03100058|464989930|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190083|NCT03100058|464989931|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190084|NCT03100058|464989932|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190085|NCT03100058|464989933|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190086|NCT03100058|464989934|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190087|NCT03100058|464989935|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190088|NCT03100058|464989936|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129190089|NCT03100058|464989937|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
129190090|NCT03100058|464989938|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
129190091|NCT03100058|464989939|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
129190092|NCT03100058|464989927|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190093|NCT03100058|464989928|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190094|NCT03100058|464989929|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190095|NCT03100058|464989930|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190096|NCT03100058|464989931|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190097|NCT03100058|464989932|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190098|NCT03100058|464989933|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190099|NCT03100058|464989934|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190100|NCT03100058|464989935|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190101|NCT03100058|464989936|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190102|NCT03100058|464989937|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
129190103|NCT03100058|464989938|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
129190104|NCT03100058|464989939|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129190105|NCT03100058|464989927|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190106|NCT03100058|464989928|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190107|NCT03100058|464989929|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190108|NCT03100058|464989930|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190109|NCT03100058|464989931|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190110|NCT03100058|464989932|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190111|NCT03100058|464989933|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190112|NCT03100058|464989934|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190113|NCT03100058|464989935|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190114|NCT03100058|464989936|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
129190115|NCT03100058|464989937|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
129190116|NCT03100058|464989938|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129190117|NCT03100058|464989939|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
129190118|NCT03100058|464989927|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190119|NCT03100058|464989928|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190120|NCT03100058|464989929|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190121|NCT03100058|464989930|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190122|NCT03100058|464989931|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190123|NCT03100058|464989932|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190124|NCT03100058|464989933|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190125|NCT03100058|464989934|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190126|NCT03100058|464989935|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190127|NCT03100058|464989936|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190128|NCT03100058|464989937|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
129190129|NCT03100058|464989938|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190130|NCT03100058|464989939|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129190131|NCT03100058|464989927|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190132|NCT03100058|464989928|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190133|NCT03100058|464989929|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190134|NCT03100058|464989930|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190135|NCT03100058|464989931|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190136|NCT03100058|464989932|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190137|NCT03100058|464989933|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190138|NCT03100058|464989934|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190139|NCT03100058|464989935|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190140|NCT03100058|464989936|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190141|NCT03100058|464989937|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190142|NCT03100058|464989938|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129190143|NCT03100058|464989939|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
129190144|NCT03100058|464989927|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190145|NCT03100058|464989928|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190146|NCT03100058|464989929|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190147|NCT03100058|464989930|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190148|NCT03100058|464989931|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190149|NCT03100058|464989932|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190150|NCT03100058|464989933|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190151|NCT03100058|464989934|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190152|NCT03100058|464989935|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190153|NCT03100058|464989936|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
129190154|NCT03100058|464989937|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190155|NCT03100058|464989938|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190156|NCT03100058|464989939|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129190157|NCT00774800|464989943|FG000|Intervention 4|Withdrawal by Subject|1|||
129190158|NCT02760810|464989949|FG000|Overall Study|Protocol Violation|1|||
129190159|NCT00820222|464989950|FG000|Overall Study|Lost to Follow-up|10|||
129190160|NCT00820222|464989951|FG001|Overall Study|Lost to Follow-up|9|||
129190161|NCT00820222|464989950|FG000|Overall Study|Withdrawal by Subject|19|||
129190162|NCT00820222|464989951|FG001|Overall Study|Withdrawal by Subject|21|||
129190163|NCT00820222|464989950|FG000|Overall Study|Physician Decision|93|||
129190164|NCT00820222|464989951|FG001|Overall Study|Physician Decision|88|||
129190165|NCT00820222|464989950|FG000|Overall Study|Sponsor Terminated Study|43|||
129190166|NCT00820222|464989951|FG001|Overall Study|Sponsor Terminated Study|65|||
129190167|NCT00820222|464989950|FG000|Overall Study|Unkown|11|||
129190168|NCT00820222|464989951|FG001|Overall Study|Unkown|7|||
129190169|NCT00932165|464989952|FG000|Overall Study|Lost to Follow-up|1|||
129190170|NCT00588094|464989953|FG000|Overall Study|Adverse Event|3|||
129190171|NCT00588094|464989953|FG000|Overall Study|Progression of Disease|2|||
129190172|NCT01336023|464989954|FG000|Week 0 to Week 26|Adverse Event|8|||
129190173|NCT01336023|464989955|FG001|Week 0 to Week 26|Adverse Event|10|||
129190174|NCT01336023|464989956|FG002|Week 0 to Week 26|Adverse Event|24|||
129190175|NCT01336023|464989954|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
129190176|NCT01336023|464989955|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
129190177|NCT01336023|464989956|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
129190178|NCT01336023|464989954|FG000|Week 0 to Week 26|Protocol Violation|1|||
129190179|NCT01336023|464989955|FG001|Week 0 to Week 26|Protocol Violation|2|||
129190180|NCT01336023|464989956|FG002|Week 0 to Week 26|Protocol Violation|0|||
129190181|NCT01336023|464989954|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
129190182|NCT01336023|464989955|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
129190183|NCT01336023|464989956|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
129190184|NCT01336023|464989954|FG000|Week 0 to Week 26|Unclassified|5|||
129190185|NCT01336023|464989955|FG001|Week 0 to Week 26|Unclassified|16|||
129190186|NCT01336023|464989956|FG002|Week 0 to Week 26|Unclassified|9|||
129190187|NCT01336023|464989954|FG000|Week 27 to 52|Adverse Event|1|||
129190188|NCT01336023|464989955|FG001|Week 27 to 52|Adverse Event|5|||
129190189|NCT01336023|464989956|FG002|Week 27 to 52|Adverse Event|2|||
129190190|NCT01336023|464989954|FG000|Week 27 to 52|Protocol Violation|0|||
129190191|NCT01336023|464989955|FG001|Week 27 to 52|Protocol Violation|2|||
129190192|NCT01336023|464989956|FG002|Week 27 to 52|Protocol Violation|1|||
129190193|NCT01336023|464989954|FG000|Week 27 to 52|Withdrawal Criteria|14|||
129190194|NCT01336023|464989955|FG001|Week 27 to 52|Withdrawal Criteria|19|||
129190195|NCT01336023|464989956|FG002|Week 27 to 52|Withdrawal Criteria|16|||
129190196|NCT01336023|464989954|FG000|Week 27 to 52|Unclassified|13|||
129190197|NCT01336023|464989955|FG001|Week 27 to 52|Unclassified|18|||
129190198|NCT01336023|464989956|FG002|Week 27 to 52|Unclassified|9|||
129190199|NCT00666965|464989959|FG000|Overall Study|Adverse Event|0|||
129190200|NCT00666965|464989960|FG001|Overall Study|Adverse Event|2|||
129190201|NCT00666965|464989961|FG002|Overall Study|Adverse Event|1|||
129190202|NCT00666965|464989962|FG003|Overall Study|Adverse Event|9|||
129190203|NCT00666965|464989959|FG000|Overall Study|Lack of Efficacy|1|||
129190204|NCT00666965|464989960|FG001|Overall Study|Lack of Efficacy|1|||
129190205|NCT00666965|464989961|FG002|Overall Study|Lack of Efficacy|0|||
129190206|NCT00666965|464989962|FG003|Overall Study|Lack of Efficacy|0|||
129190207|NCT00666965|464989959|FG000|Overall Study|Protocol Violation|0|||
129190208|NCT00666965|464989960|FG001|Overall Study|Protocol Violation|0|||
129190209|NCT00666965|464989961|FG002|Overall Study|Protocol Violation|0|||
129190210|NCT00666965|464989962|FG003|Overall Study|Protocol Violation|2|||
129190211|NCT00666965|464989959|FG000|Overall Study|Discontinuation criteria|2|||
129190212|NCT00666965|464989960|FG001|Overall Study|Discontinuation criteria|1|||
129190213|NCT00666965|464989961|FG002|Overall Study|Discontinuation criteria|1|||
129190214|NCT00666965|464989962|FG003|Overall Study|Discontinuation criteria|2|||
129190215|NCT00666965|464989959|FG000|Overall Study|Withdrawal by Subject|0|||
129190216|NCT00666965|464989960|FG001|Overall Study|Withdrawal by Subject|0|||
129190217|NCT00666965|464989961|FG002|Overall Study|Withdrawal by Subject|0|||
129190218|NCT00666965|464989962|FG003|Overall Study|Withdrawal by Subject|2|||
129190219|NCT01853878|464989969|FG000|Overall Study|Recurrence|2|||
129190220|NCT01853878|464989970|FG001|Overall Study|Recurrence|0|||
129190221|NCT01853878|464989969|FG000|Overall Study|Adverse Event|2|||
129190222|NCT01853878|464989970|FG001|Overall Study|Adverse Event|0|||
129190223|NCT01853878|464989969|FG000|Overall Study|Withdrawal by Subject|3|||
129190224|NCT01853878|464989970|FG001|Overall Study|Withdrawal by Subject|1|||
129190225|NCT01853878|464989969|FG000|Overall Study|Migrated/moved from the study area|1|||
129190226|NCT01853878|464989970|FG001|Overall Study|Migrated/moved from the study area|0|||
129190227|NCT01853878|464989969|FG000|Overall Study|Other|55|||
129190228|NCT01853878|464989970|FG001|Overall Study|Other|43|||
129190229|NCT01361178|464989971|FG000|Overall Study|Death|13|||
129190230|NCT01361178|464989972|FG001|Overall Study|Death|0|||
129190231|NCT00391625|464989973|FG000|Month 14|Withdrawal by Subject|1|||
129190232|NCT00391625|464989973|FG000|Month 50|Physician Decision|1|||
129190233|NCT03916081|464989976|FG000|Overall Study|Adverse Event|1|||
129190234|NCT03916081|464989977|FG001|Overall Study|Adverse Event|0|||
129190235|NCT03916081|464989978|FG002|Overall Study|Adverse Event|0|||
129190236|NCT03916081|464989976|FG000|Overall Study|Physician Decision|0|||
129190237|NCT03916081|464989977|FG001|Overall Study|Physician Decision|0|||
129190238|NCT03916081|464989978|FG002|Overall Study|Physician Decision|1|||
129190239|NCT03916081|464989976|FG000|Overall Study|Lost to Follow-up|0|||
129190240|NCT03916081|464989977|FG001|Overall Study|Lost to Follow-up|1|||
129190241|NCT03916081|464989978|FG002|Overall Study|Lost to Follow-up|0|||
129190242|NCT03916081|464989976|FG000|Overall Study|Withdrawal by Subject|3|||
129190243|NCT03916081|464989977|FG001|Overall Study|Withdrawal by Subject|0|||
129190244|NCT03916081|464989978|FG002|Overall Study|Withdrawal by Subject|1|||
129190245|NCT03916081|464989976|FG000|Overall Study|Worsening of AD|0|||
129190246|NCT03916081|464989977|FG001|Overall Study|Worsening of AD|0|||
129190247|NCT03916081|464989978|FG002|Overall Study|Worsening of AD|1|||
129190248|NCT03244826|464989979|FG000|Overall Study|Withdrawal by Subject|2|||
129190249|NCT03244826|464989980|FG001|Overall Study|Withdrawal by Subject|0|||
129190250|NCT03244826|464989979|FG000|Overall Study|Transplant delayed or withdrawn|12|||
129190251|NCT03244826|464989980|FG001|Overall Study|Transplant delayed or withdrawn|10|||
129190252|NCT00416455|464989984|FG000|Overall Study|PET / CT not done|3|||
129190253|NCT00416455|464989985|FG001|Overall Study|PET / CT not done|5|||
129190254|NCT00416455|464989984|FG000|Overall Study|PET / CT poor quality|2|||
129190255|NCT00416455|464989985|FG001|Overall Study|PET / CT poor quality|1|||
129190256|NCT00416455|464989984|FG000|Overall Study|Inadequate pathology|11|||
129190257|NCT00416455|464989985|FG001|Overall Study|Inadequate pathology|2|||
129190258|NCT00622388|464989987|FG000|Overall Study|Disease Progression|47|||
129190259|NCT00622388|464989987|FG000|Overall Study|Adverse Event|6|||
129190260|NCT00622388|464989987|FG000|Overall Study|Protocol Violation|3|||
129190261|NCT00622388|464989987|FG000|Overall Study|Participant Refusal|1|||
129190262|NCT00622388|464989987|FG000|Overall Study|Death|3|||
129190263|NCT00622388|464989987|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
129190264|NCT00622388|464989987|FG000|Overall Study|Took Prohibited Medication|2|||
129190265|NCT00622388|464989987|FG000|Overall Study|Withdrew Consent|1|||
129190266|NCT00622388|464989987|FG000|Overall Study|Insurance Expired|1|||
129190267|NCT00348309|464989988|FG000|Overall Study|Adverse Event|56|||
129190268|NCT00348309|464989989|FG001|Overall Study|Adverse Event|28|||
129190269|NCT00348309|464989990|FG002|Overall Study|Adverse Event|63|||
129190270|NCT00348309|464989988|FG000|Overall Study|Lost to Follow-up|6|||
129190271|NCT00348309|464989989|FG001|Overall Study|Lost to Follow-up|7|||
129190272|NCT00348309|464989990|FG002|Overall Study|Lost to Follow-up|4|||
129190273|NCT00348309|464989988|FG000|Overall Study|Protocol Violation|7|||
129190274|NCT00348309|464989989|FG001|Overall Study|Protocol Violation|12|||
129190275|NCT00348309|464989990|FG002|Overall Study|Protocol Violation|7|||
129190276|NCT00348309|464989988|FG000|Overall Study|Withdrawal by Subject|33|||
129190277|NCT00348309|464989989|FG001|Overall Study|Withdrawal by Subject|37|||
129190278|NCT00348309|464989990|FG002|Overall Study|Withdrawal by Subject|40|||
129190279|NCT00348309|464989988|FG000|Overall Study|Non-compliance|8|||
129190280|NCT00348309|464989989|FG001|Overall Study|Non-compliance|6|||
129190281|NCT00348309|464989990|FG002|Overall Study|Non-compliance|8|||
129190282|NCT00348309|464989988|FG000|Overall Study|Death of caregiver|1|||
129190283|NCT00348309|464989989|FG001|Overall Study|Death of caregiver|0|||
129190284|NCT00348309|464989990|FG002|Overall Study|Death of caregiver|1|||
129190285|NCT00348309|464989988|FG000|Overall Study|Lack of insight, dementia|1|||
129190286|NCT00348309|464989989|FG001|Overall Study|Lack of insight, dementia|0|||
129190287|NCT00348309|464989990|FG002|Overall Study|Lack of insight, dementia|0|||
129190288|NCT00348309|464989988|FG000|Overall Study|Wrong bottle allocated|1|||
129190289|NCT00348309|464989989|FG001|Overall Study|Wrong bottle allocated|0|||
129190290|NCT00348309|464989990|FG002|Overall Study|Wrong bottle allocated|0|||
129190291|NCT00348309|464989988|FG000|Overall Study|Caregiver sick|1|||
129190292|NCT00348309|464989989|FG001|Overall Study|Caregiver sick|0|||
129190293|NCT00348309|464989990|FG002|Overall Study|Caregiver sick|0|||
129190294|NCT00348309|464989988|FG000|Overall Study|Use of prohibited medication|5|||
129190295|NCT00348309|464989989|FG001|Overall Study|Use of prohibited medication|2|||
129190296|NCT00348309|464989990|FG002|Overall Study|Use of prohibited medication|2|||
129190297|NCT00348309|464989988|FG000|Overall Study|Caregiver withdrawal|3|||
129190298|NCT00348309|464989989|FG001|Overall Study|Caregiver withdrawal|0|||
129190299|NCT00348309|464989990|FG002|Overall Study|Caregiver withdrawal|7|||
129190300|NCT00348309|464989988|FG000|Overall Study|Unable to complete ET visit|1|||
129190301|NCT00348309|464989989|FG001|Overall Study|Unable to complete ET visit|0|||
129190302|NCT00348309|464989990|FG002|Overall Study|Unable to complete ET visit|0|||
129190303|NCT00348309|464989988|FG000|Overall Study|PI closing medical practice|1|||
129190304|NCT00348309|464989989|FG001|Overall Study|PI closing medical practice|0|||
129190305|NCT00348309|464989990|FG002|Overall Study|PI closing medical practice|0|||
129190306|NCT00348309|464989988|FG000|Overall Study|Principal investigator's decision|1|||
129190307|NCT00348309|464989989|FG001|Overall Study|Principal investigator's decision|0|||
129190308|NCT00348309|464989990|FG002|Overall Study|Principal investigator's decision|0|||
129190309|NCT00348309|464989988|FG000|Overall Study|No disponibility of medication|1|||
129190310|NCT00348309|464989989|FG001|Overall Study|No disponibility of medication|0|||
129190311|NCT00348309|464989990|FG002|Overall Study|No disponibility of medication|0|||
129190312|NCT00348309|464989988|FG000|Overall Study|Worsened neurodegenerative disease|1|||
129190313|NCT00348309|464989989|FG001|Overall Study|Worsened neurodegenerative disease|0|||
129190314|NCT00348309|464989990|FG002|Overall Study|Worsened neurodegenerative disease|0|||
129190315|NCT00348309|464989988|FG000|Overall Study|Cognitive and behaviour worsening|2|||
129190316|NCT00348309|464989989|FG001|Overall Study|Cognitive and behaviour worsening|0|||
129190317|NCT00348309|464989990|FG002|Overall Study|Cognitive and behaviour worsening|0|||
129190318|NCT00348309|464989988|FG000|Overall Study|Worsening of alzheimer|1|||
129190319|NCT00348309|464989989|FG001|Overall Study|Worsening of alzheimer|0|||
129190320|NCT00348309|464989990|FG002|Overall Study|Worsening of alzheimer|1|||
129190321|NCT00348309|464989988|FG000|Overall Study|Did not appear in time for Visit 3|1|||
129190322|NCT00348309|464989989|FG001|Overall Study|Did not appear in time for Visit 3|0|||
129190323|NCT00348309|464989990|FG002|Overall Study|Did not appear in time for Visit 3|0|||
129190324|NCT00348309|464989988|FG000|Overall Study|Participant died|2|||
129190325|NCT00348309|464989989|FG001|Overall Study|Participant died|1|||
129190326|NCT00348309|464989990|FG002|Overall Study|Participant died|1|||
129190327|NCT00348309|464989988|FG000|Overall Study|Decision of sponsor|1|||
129190328|NCT00348309|464989989|FG001|Overall Study|Decision of sponsor|0|||
129190329|NCT00348309|464989990|FG002|Overall Study|Decision of sponsor|0|||
129190330|NCT00348309|464989988|FG000|Overall Study|Ineffectiveness of treatment|0|||
129190331|NCT00348309|464989989|FG001|Overall Study|Ineffectiveness of treatment|1|||
129190332|NCT00348309|464989990|FG002|Overall Study|Ineffectiveness of treatment|0|||
129190333|NCT00348309|464989988|FG000|Overall Study|A foul of exclusion criteria|0|||
129190334|NCT00348309|464989989|FG001|Overall Study|A foul of exclusion criteria|1|||
129190335|NCT00348309|464989990|FG002|Overall Study|A foul of exclusion criteria|0|||
129190336|NCT00348309|464989988|FG000|Overall Study|Participant was hospitalized|0|||
129190337|NCT00348309|464989989|FG001|Overall Study|Participant was hospitalized|1|||
129190338|NCT00348309|464989990|FG002|Overall Study|Participant was hospitalized|0|||
129190339|NCT00348309|464989988|FG000|Overall Study|Sponsor refuseal|0|||
129190340|NCT00348309|464989989|FG001|Overall Study|Sponsor refuseal|1|||
129190341|NCT00348309|464989990|FG002|Overall Study|Sponsor refuseal|1|||
129190342|NCT00348309|464989988|FG000|Overall Study|Forgot often medication|0|||
129190343|NCT00348309|464989989|FG001|Overall Study|Forgot often medication|1|||
129190344|NCT00348309|464989990|FG002|Overall Study|Forgot often medication|0|||
129190345|NCT00348309|464989988|FG000|Overall Study|Medical Monitor decision|0|||
129190346|NCT00348309|464989989|FG001|Overall Study|Medical Monitor decision|0|||
129190347|NCT00348309|464989990|FG002|Overall Study|Medical Monitor decision|1|||
129190348|NCT00348309|464989988|FG000|Overall Study|Increased dose of Aricept|0|||
129190349|NCT00348309|464989989|FG001|Overall Study|Increased dose of Aricept|0|||
129190350|NCT00348309|464989990|FG002|Overall Study|Increased dose of Aricept|1|||
129190351|NCT00348309|464989988|FG000|Overall Study|Site closure|0|||
129190352|NCT00348309|464989989|FG001|Overall Study|Site closure|0|||
129190353|NCT00348309|464989990|FG002|Overall Study|Site closure|1|||
129190354|NCT00348309|464989988|FG000|Overall Study|Adverse event not attended|0|||
129190355|NCT00348309|464989989|FG001|Overall Study|Adverse event not attended|0|||
129190356|NCT00348309|464989990|FG002|Overall Study|Adverse event not attended|1|||
129190357|NCT00348309|464989988|FG000|Overall Study|ECG abnormal|0|||
129190358|NCT00348309|464989989|FG001|Overall Study|ECG abnormal|0|||
129190359|NCT00348309|464989990|FG002|Overall Study|ECG abnormal|2|||
129190360|NCT00348309|464989988|FG000|Overall Study|Cardiologist recommendations|0|||
129190361|NCT00348309|464989989|FG001|Overall Study|Cardiologist recommendations|0|||
129190362|NCT00348309|464989990|FG002|Overall Study|Cardiologist recommendations|1|||
129190363|NCT00348309|464989988|FG000|Overall Study|HCV career|0|||
129190364|NCT00348309|464989989|FG001|Overall Study|HCV career|0|||
129190365|NCT00348309|464989990|FG002|Overall Study|HCV career|1|||
129190366|NCT00828750|464989991|FG000|Overall Study|Lack of Efficacy|3|||
129190367|NCT00828750|464989991|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
129190368|NCT04079114|464989992|FG000|Overall Study|Study prematuely terminated.|166|||
129190369|NCT01364389|464989993|FG000|Overall Study|Withdrawal by Subject|0|||
129190370|NCT01364389|464989994|FG001|Overall Study|Withdrawal by Subject|1|||
129190371|NCT01364389|464989995|FG002|Overall Study|Withdrawal by Subject|0|||
129190372|NCT01364389|464989993|FG000|Overall Study|Protocol deviation|0|||
129190373|NCT01364389|464989994|FG001|Overall Study|Protocol deviation|0|||
129190374|NCT01364389|464989995|FG002|Overall Study|Protocol deviation|1|||
129190375|NCT01364389|464989993|FG000|Overall Study|Administrative problems|1|||
129190376|NCT01364389|464989994|FG001|Overall Study|Administrative problems|0|||
129190377|NCT01364389|464989995|FG002|Overall Study|Administrative problems|0|||
129190378|NCT01364389|464989993|FG000|Overall Study|Adverse Event|1|||
129190379|NCT01364389|464989994|FG001|Overall Study|Adverse Event|0|||
129190380|NCT01364389|464989995|FG002|Overall Study|Adverse Event|0|||
129190381|NCT01068158|464990001|FG000|Overall Study|Withdrawal by Subject|1|||
129190382|NCT01068158|464990002|FG001|Overall Study|Withdrawal by Subject|2|||
129190383|NCT01068158|464990001|FG000|Overall Study|Lost to Follow-up|7|||
129190384|NCT01068158|464990002|FG001|Overall Study|Lost to Follow-up|0|||
129190385|NCT01068158|464990001|FG000|Overall Study|Protocol Violation|0|||
129190386|NCT01068158|464990002|FG001|Overall Study|Protocol Violation|2|||
129190387|NCT00991406|464990003|FG000|Overall Study|One participant did not respond to FES.|1|||
129190388|NCT01300572|464990004|FG000|Overall Study|HAMA + post dosimetry|1|||
129190389|NCT02160145|464990006|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
129190390|NCT02160145|464990007|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
129190391|NCT02160145|464990008|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
129190392|NCT02160145|464990006|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
129190393|NCT02160145|464990007|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
129190394|NCT02160145|464990008|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
129190395|NCT02160145|464990006|FG000|Randomized Double-blind Period|Subject decision|0|||
129190396|NCT02160145|464990007|FG001|Randomized Double-blind Period|Subject decision|21|||
129190397|NCT02160145|464990008|FG002|Randomized Double-blind Period|Subject decision|20|||
129190398|NCT02160145|464990006|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
129190399|NCT02160145|464990007|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
129190400|NCT02160145|464990008|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
129190401|NCT02160145|464990006|FG000|Randomized Double-blind Period|Physician Decision|0|||
129190402|NCT02160145|464990007|FG001|Randomized Double-blind Period|Physician Decision|7|||
129190403|NCT02160145|464990008|FG002|Randomized Double-blind Period|Physician Decision|5|||
129190404|NCT00375518|464990009|FG000|Overall Study|Withdrawal by Subject|2|||
129190405|NCT00375518|464990010|FG001|Overall Study|Withdrawal by Subject|10|||
129190406|NCT00375518|464990009|FG000|Overall Study|Patient Not Treated|6|||
129190407|NCT00375518|464990010|FG001|Overall Study|Patient Not Treated|6|||
129190408|NCT00375518|464990009|FG000|Overall Study|Death|0|||
129190409|NCT00375518|464990010|FG001|Overall Study|Death|1|||
129190410|NCT00411632|464990011|FG000|Overall Study|Death|1|||
129190411|NCT01108523|464990012|FG000|Overall Study|Protocol Violation|4|||
129190412|NCT03848949|464990018|FG000|Overall Study|Lost to Follow-up|5|||
129190413|NCT03848949|464990019|FG001|Overall Study|Lost to Follow-up|7|||
129190414|NCT02353728|464990022|FG000|Overall Study|Subject non-compliance|1|||
129190415|NCT02301624|464990023|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
129190416|NCT02301624|464990024|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
129190417|NCT02301624|464990023|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
129190418|NCT02301624|464990024|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
129190419|NCT02301624|464990023|FG000|Open-label Maintenance Phase|Adverse Event|2|||
129190420|NCT02301624|464990024|FG001|Open-label Maintenance Phase|Adverse Event|5|||
129190421|NCT02301624|464990023|FG000|Open-label Maintenance Phase|Physician Decision|3|||
129190422|NCT02301624|464990024|FG001|Open-label Maintenance Phase|Physician Decision|3|||
129190423|NCT02301624|464990023|FG000|Open-label Maintenance Phase|Death|2|||
129190424|NCT02301624|464990024|FG001|Open-label Maintenance Phase|Death|1|||
129190425|NCT02301624|464990023|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
129190426|NCT02301624|464990024|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
129190427|NCT00895310|464990025|FG000|Overall Study|Withdrawal by Subject|1|||
129190428|NCT00619307|464990026|FG000|Overall Study|Adverse Event|0|||
129190429|NCT00619307|464990027|FG001|Overall Study|Adverse Event|1|||
129190430|NCT00619307|464990026|FG000|Overall Study|Lost to Follow-up|0|||
129190431|NCT00619307|464990027|FG001|Overall Study|Lost to Follow-up|1|||
129190432|NCT00619307|464990026|FG000|Overall Study|Protocol Violation|3|||
129190433|NCT00619307|464990027|FG001|Overall Study|Protocol Violation|0|||
129190434|NCT00619307|464990026|FG000|Overall Study|Withdrew consent|1|||
129190435|NCT00619307|464990027|FG001|Overall Study|Withdrew consent|0|||
129190436|NCT00619307|464990026|FG000|Overall Study|Severe migraine|0|||
129190437|NCT00619307|464990027|FG001|Overall Study|Severe migraine|1|||
129190438|NCT00619307|464990026|FG000|Overall Study|MS attack plus steroids|0|||
129190439|NCT00619307|464990027|FG001|Overall Study|MS attack plus steroids|1|||
129190440|NCT00659230|464990028|FG000|Overall Study|Lost to Follow-up|2|||
129190441|NCT00659230|464990029|FG001|Overall Study|Lost to Follow-up|5|||
129190442|NCT00659230|464990028|FG000|Overall Study|Lost source documentation|5|||
129190443|NCT00659230|464990029|FG001|Overall Study|Lost source documentation|4|||
129190444|NCT00659230|464990028|FG000|Overall Study|Did not return post-randomization|2|||
129190445|NCT00659230|464990029|FG001|Overall Study|Did not return post-randomization|3|||
129190446|NCT00547521|464990030|FG000|Short Term Study (4 Months)|Adverse Event|1|||
129190447|NCT00547521|464990031|FG001|Short Term Study (4 Months)|Adverse Event|0|||
129190448|NCT00547521|464990030|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
129190449|NCT00547521|464990031|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
129190450|NCT00547521|464990030|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
129190451|NCT00547521|464990031|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
129190452|NCT00547521|464990030|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
129190453|NCT00547521|464990031|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
129190454|NCT00547521|464990030|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
129190455|NCT00547521|464990031|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
129190456|NCT00547521|464990030|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
129190457|NCT00547521|464990031|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
129190458|NCT00547521|464990030|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
129190459|NCT00547521|464990031|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
129190460|NCT00547521|464990030|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
129190461|NCT00547521|464990031|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
129190462|NCT00547521|464990030|FG000|Long Term Extension (LTE) Study|Other|0|||
129190463|NCT00547521|464990031|FG001|Long Term Extension (LTE) Study|Other|2|||
129190464|NCT00547521|464990030|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
129190465|NCT00547521|464990031|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
129190466|NCT03109184|464991841|FG000|Overall Study|Lost to Follow-up|6|||
129190467|NCT03109184|464991842|FG001|Overall Study|Lost to Follow-up|6|||
129190468|NCT03109184|464991841|FG000|Overall Study|Withdrawal by Subject|1|||
129190469|NCT03109184|464991842|FG001|Overall Study|Withdrawal by Subject|1|||
129190470|NCT03077919|464991845|FG000|Overall Study|Lost to Follow-up|4|||
129190471|NCT03077919|464991846|FG001|Overall Study|Lost to Follow-up|1|||
129190472|NCT01031979|464991849|FG000|Overall Study|Lost to Follow-up|5|||
129190473|NCT01031979|464991850|FG001|Overall Study|Lost to Follow-up|4|||
129190474|NCT03831100|464991852|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
129190475|NCT03831100|464991853|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
129190476|NCT02008227|464991857|FG000|Overall Study|Lost to Follow-up|7|||
129190477|NCT02008227|464991858|FG001|Overall Study|Lost to Follow-up|9|||
129190478|NCT02008227|464991857|FG000|Overall Study|Death|494|||
129190479|NCT02008227|464991858|FG001|Overall Study|Death|485|||
129190480|NCT02008227|464991857|FG000|Overall Study|Withdrawal by Subject|67|||
129190481|NCT02008227|464991858|FG001|Overall Study|Withdrawal by Subject|36|||
129190482|NCT02008227|464991857|FG000|Overall Study|Study Terminated By Sponsor|44|||
129190483|NCT02008227|464991858|FG001|Overall Study|Study Terminated By Sponsor|83|||
129190484|NCT01487265|464991861|FG000|Overall Study|Adverse Event|8|||
129190485|NCT01487265|464991861|FG000|Overall Study|Withdrawal by Subject|5|||
129190486|NCT01487265|464991861|FG000|Overall Study|Disease Progression|21|||
129190487|NCT01487265|464991861|FG000|Overall Study|Death|2|||
129190488|NCT01487265|464991861|FG000|Overall Study|Still on Treatment|1|||
129190489|NCT03499314|464991862|FG000|Overall Study|Time Commitment|1|||
129190490|NCT03499314|464991863|FG001|Overall Study|Time Commitment|2|||
129190491|NCT03499314|464991862|FG000|Overall Study|Medical issue unrelated to research study|1|||
129190492|NCT03499314|464991863|FG001|Overall Study|Medical issue unrelated to research study|1|||
129190493|NCT01618695|464991865|FG000|Core Phase|Adverse Event|4|||
129190494|NCT01618695|464991866|FG001|Core Phase|Adverse Event|5|||
129190495|NCT01618695|464991867|FG002|Core Phase|Adverse Event|15|||
129190496|NCT01618695|464991868|FG003|Core Phase|Adverse Event|20|||
129190497|NCT01618695|464991865|FG000|Core Phase|Lost to Follow-up|0|||
129190498|NCT01618695|464991866|FG001|Core Phase|Lost to Follow-up|0|||
129190499|NCT01618695|464991867|FG002|Core Phase|Lost to Follow-up|1|||
129190500|NCT01618695|464991868|FG003|Core Phase|Lost to Follow-up|0|||
129190501|NCT01618695|464991865|FG000|Core Phase|Withdrawal by Subject|16|||
129190502|NCT01618695|464991866|FG001|Core Phase|Withdrawal by Subject|11|||
129190503|NCT01618695|464991867|FG002|Core Phase|Withdrawal by Subject|9|||
129190504|NCT01618695|464991868|FG003|Core Phase|Withdrawal by Subject|13|||
129190505|NCT01618695|464991865|FG000|Core Phase|Pregnancy|2|||
129190506|NCT01618695|464991866|FG001|Core Phase|Pregnancy|0|||
129190507|NCT01618695|464991867|FG002|Core Phase|Pregnancy|0|||
129190508|NCT01618695|464991868|FG003|Core Phase|Pregnancy|0|||
129190509|NCT01618695|464991865|FG000|Core Phase|Lack of Efficacy|1|||
129190510|NCT01618695|464991866|FG001|Core Phase|Lack of Efficacy|2|||
129190511|NCT01618695|464991867|FG002|Core Phase|Lack of Efficacy|1|||
129190512|NCT01618695|464991868|FG003|Core Phase|Lack of Efficacy|1|||
129190513|NCT01618695|464991865|FG000|Core Phase|Other than specified|1|||
129190514|NCT01618695|464991866|FG001|Core Phase|Other than specified|2|||
129190515|NCT01618695|464991867|FG002|Core Phase|Other than specified|2|||
129190516|NCT01618695|464991868|FG003|Core Phase|Other than specified|2|||
129190517|NCT01618695|464991865|FG000|Core Phase|Not treated|1|||
129190518|NCT01618695|464991866|FG001|Core Phase|Not treated|0|||
129190519|NCT01618695|464991867|FG002|Core Phase|Not treated|2|||
129190520|NCT01618695|464991868|FG003|Core Phase|Not treated|0|||
129190521|NCT01618695|464991865|FG000|Extension Phase|Lack of Efficacy|17|||
129190522|NCT01618695|464991866|FG001|Extension Phase|Lack of Efficacy|33|||
129190523|NCT01618695|464991867|FG002|Extension Phase|Lack of Efficacy|26|||
129190524|NCT01618695|464991868|FG003|Extension Phase|Lack of Efficacy|24|||
129190525|NCT01618695|464991865|FG000|Extension Phase|Pregnancy|2|||
129190526|NCT01618695|464991866|FG001|Extension Phase|Pregnancy|0|||
129190527|NCT01618695|464991867|FG002|Extension Phase|Pregnancy|1|||
129190528|NCT01618695|464991868|FG003|Extension Phase|Pregnancy|1|||
129190529|NCT01618695|464991865|FG000|Extension Phase|Withdrawal by Subject|43|||
129190530|NCT01618695|464991866|FG001|Extension Phase|Withdrawal by Subject|48|||
129190531|NCT01618695|464991867|FG002|Extension Phase|Withdrawal by Subject|42|||
129190532|NCT01618695|464991868|FG003|Extension Phase|Withdrawal by Subject|33|||
129190533|NCT01618695|464991865|FG000|Extension Phase|Adverse Event|18|||
129190534|NCT01618695|464991866|FG001|Extension Phase|Adverse Event|16|||
129190535|NCT01618695|464991867|FG002|Extension Phase|Adverse Event|9|||
129190536|NCT01618695|464991868|FG003|Extension Phase|Adverse Event|20|||
129190537|NCT01618695|464991865|FG000|Extension Phase|Lost to Follow-up|2|||
129190538|NCT01618695|464991866|FG001|Extension Phase|Lost to Follow-up|1|||
129190539|NCT01618695|464991867|FG002|Extension Phase|Lost to Follow-up|1|||
129190540|NCT01618695|464991868|FG003|Extension Phase|Lost to Follow-up|1|||
129190541|NCT01618695|464991865|FG000|Extension Phase|Other than specified|13|||
129190542|NCT01618695|464991866|FG001|Extension Phase|Other than specified|18|||
129190543|NCT01618695|464991867|FG002|Extension Phase|Other than specified|13|||
129190544|NCT01618695|464991868|FG003|Extension Phase|Other than specified|18|||
129190545|NCT02454478|464991871|FG000|Overall Study|Incomplete DLT Evaluation|1|||
129190546|NCT00666224|464991872|FG000|Double-Blind|Adverse Event|15|||
129190547|NCT00666224|464991873|FG001|Double-Blind|Adverse Event|5|||
129190548|NCT00666224|464991872|FG000|Double-Blind|Lost to Follow-up|2|||
129190549|NCT00666224|464991873|FG001|Double-Blind|Lost to Follow-up|2|||
129190550|NCT00666224|464991872|FG000|Double-Blind|Withdrawal by Subject|18|||
129190551|NCT00666224|464991873|FG001|Double-Blind|Withdrawal by Subject|14|||
129190552|NCT00666224|464991872|FG000|Double-Blind|Physician Decision|0|||
129190553|NCT00666224|464991873|FG001|Double-Blind|Physician Decision|3|||
129190554|NCT00666224|464991872|FG000|Double-Blind|Sponsor decision|1|||
129190555|NCT00666224|464991873|FG001|Double-Blind|Sponsor decision|0|||
129190556|NCT00666224|464991872|FG000|Double-Blind|Pregnancy|3|||
129190557|NCT00666224|464991873|FG001|Double-Blind|Pregnancy|2|||
129190558|NCT00666224|464991872|FG000|Double-Blind|Noncompliance|1|||
129190559|NCT00666224|464991873|FG001|Double-Blind|Noncompliance|0|||
129190560|NCT00666224|464991872|FG000|Double-Blind|Death|1|||
129190561|NCT00666224|464991873|FG001|Double-Blind|Death|0|||
129190562|NCT00666224|464991872|FG000|Double-Blind|Undefined/Unknown|4|||
129190563|NCT00666224|464991873|FG001|Double-Blind|Undefined/Unknown|1|||
129190564|NCT00666224|464991872|FG000|Open-Label|Adverse Event|8|||
129190565|NCT00666224|464991873|FG001|Open-Label|Adverse Event|43|||
129190566|NCT00666224|464991872|FG000|Open-Label|Lost to Follow-up|4|||
129190567|NCT00666224|464991873|FG001|Open-Label|Lost to Follow-up|5|||
129190568|NCT00666224|464991872|FG000|Open-Label|Withdrawal by Subject|12|||
129190569|NCT00666224|464991873|FG001|Open-Label|Withdrawal by Subject|25|||
129190570|NCT00666224|464991872|FG000|Open-Label|Physician Decision|7|||
129190571|NCT00666224|464991873|FG001|Open-Label|Physician Decision|5|||
129190572|NCT00666224|464991872|FG000|Open-Label|Pregnancy|1|||
129190573|NCT00666224|464991873|FG001|Open-Label|Pregnancy|5|||
129190574|NCT00666224|464991872|FG000|Open-Label|Noncompliance|2|||
129190575|NCT00666224|464991873|FG001|Open-Label|Noncompliance|1|||
129190576|NCT00666224|464991872|FG000|Open-Label|Undefined/Unknown|1|||
129190577|NCT00666224|464991873|FG001|Open-Label|Undefined/Unknown|1|||
129190578|NCT01271725|464991879|FG000|Part A|Progressive disease according to RECIST|8|||
129190579|NCT01271725|464991880|FG001|Part A|Progressive disease according to RECIST|0|||
129190580|NCT01271725|464991879|FG000|Part A|Clinical signs/symptoms of progression|2|||
129190581|NCT01271725|464991880|FG001|Part A|Clinical signs/symptoms of progression|0|||
129190582|NCT01271725|464991879|FG000|Part A|Other Adverse Event|8|||
129190583|NCT01271725|464991880|FG001|Part A|Other Adverse Event|0|||
129190584|NCT01271725|464991879|FG000|Part A|Lost to Follow-up|1|||
129190585|NCT01271725|464991880|FG001|Part A|Lost to Follow-up|0|||
129190586|NCT01271725|464991879|FG000|Part A|Withdrawal by Subject|12|||
129190587|NCT01271725|464991880|FG001|Part A|Withdrawal by Subject|0|||
128982143|NCT00508820|464219106|FG000|Overall Study|Noncompliance|1|||
129190588|NCT01271725|464991879|FG000|Part A|Other than specified|3|||
129190589|NCT01271725|464991880|FG001|Part A|Other than specified|0|||
129190590|NCT01271725|464991879|FG000|Part A|Protocol Violation|1|||
129190591|NCT01271725|464991880|FG001|Part A|Protocol Violation|0|||
129190592|NCT01271725|464991879|FG000|Part B|Other than specified|0|||
129190593|NCT01271725|464991880|FG001|Part B|Other than specified|2|||
129190594|NCT01271725|464991879|FG000|Part B|Clinical signs/symptoms of progression|0|||
129190595|NCT01271725|464991880|FG001|Part B|Clinical signs/symptoms of progression|2|||
129190596|NCT01271725|464991879|FG000|Part B|Other Adverse Event|0|||
129190597|NCT01271725|464991880|FG001|Part B|Other Adverse Event|1|||
129190598|NCT01271725|464991879|FG000|Part B|Protocol Violation|0|||
129190599|NCT01271725|464991880|FG001|Part B|Protocol Violation|1|||
129190600|NCT01271725|464991879|FG000|Part B|Withdrawal by Subject|0|||
129190601|NCT01271725|464991880|FG001|Part B|Withdrawal by Subject|6|||
129190602|NCT01702025|464991881|FG000|Overall Study|Equipment failure|1|||
129190603|NCT01702025|464991882|FG001|Overall Study|Equipment failure|0|||
129190604|NCT01702025|464991883|FG002|Overall Study|Equipment failure|0|||
129190605|NCT01702025|464991884|FG003|Overall Study|Equipment failure|0|||
129190606|NCT01702025|464991881|FG000|Overall Study|Adverse Event|1|||
129190607|NCT01702025|464991882|FG001|Overall Study|Adverse Event|1|||
129190608|NCT01702025|464991883|FG002|Overall Study|Adverse Event|1|||
129190609|NCT01702025|464991884|FG003|Overall Study|Adverse Event|0|||
129190610|NCT03354273|464991885|FG000|Overall Study|Adverse Event|5|||
129190611|NCT03354273|464991885|FG000|Overall Study|Screen Failure|21|||
129190612|NCT03354273|464991885|FG000|Overall Study|Withdrawal by Subject|34|||
129190613|NCT03354273|464991885|FG000|Overall Study|Technical Problems|30|||
129190614|NCT03354273|464991885|FG000|Overall Study|Lost to Follow-up|4|||
129190615|NCT03354273|464991885|FG000|Overall Study|Investigator Decision|3|||
129190616|NCT03354273|464991885|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
129190617|NCT03354273|464991885|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
129190618|NCT03354273|464991885|FG000|Overall Study|COVID-19 Restrictions|9|||
129190619|NCT03354273|464991885|FG000|Overall Study|Other|5|||
129190620|NCT03229109|464991890|FG000|Overall Study|Withdrawal by Subject|0|||
129190621|NCT03229109|464991891|FG001|Overall Study|Withdrawal by Subject|0|||
129190622|NCT03229109|464991892|FG002|Overall Study|Withdrawal by Subject|0|||
129190623|NCT03229109|464991893|FG003|Overall Study|Withdrawal by Subject|1|||
129190624|NCT04207749|464991894|FG000|Overall Study|Lost to Follow-up|0|||
129190625|NCT04207749|464991895|FG001|Overall Study|Lost to Follow-up|2|||
129190626|NCT04207749|464991894|FG000|Overall Study|Protocol Violation|0|||
129190627|NCT04207749|464991895|FG001|Overall Study|Protocol Violation|1|||
129190628|NCT04207749|464991894|FG000|Overall Study|Withdrawal by Subject|3|||
129190629|NCT04207749|464991895|FG001|Overall Study|Withdrawal by Subject|0|||
129190630|NCT04207749|464991894|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
129190631|NCT04207749|464991895|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
129190632|NCT01835223|464991898|FG000|Overall Study|Adverse Event|1|||
129190633|NCT01835223|464991899|FG001|Overall Study|Adverse Event|0|||
129190634|NCT01835223|464991898|FG000|Overall Study|Withdrawal by Subject|2|||
129190635|NCT01835223|464991899|FG001|Overall Study|Withdrawal by Subject|0|||
129190636|NCT01835223|464991898|FG000|Overall Study|Disease progression|2|||
129190637|NCT01835223|464991899|FG001|Overall Study|Disease progression|1|||
129190638|NCT01835223|464991898|FG000|Overall Study|Became Inelligible|4|||
129190639|NCT01835223|464991899|FG001|Overall Study|Became Inelligible|0|||
129190640|NCT01504841|464991900|FG000|Overall Study|Withdrawal by Subject|1|||
129190641|NCT01504841|464991901|FG001|Overall Study|Withdrawal by Subject|1|||
129190642|NCT01504841|464991902|FG002|Overall Study|Withdrawal by Subject|0|||
129190643|NCT03149055|464991907|FG000|Overall Study|Not treated|4|||
129190644|NCT03679624|464991908|FG000|Overall Study|Adverse Event|1|||
129190645|NCT03679624|464991909|FG001|Overall Study|Adverse Event|0|||
129190646|NCT01610336|464991910|FG000|Overall Study|Progressive Disease|4|||
129190647|NCT01610336|464991911|FG001|Overall Study|Progressive Disease|6|||
129190648|NCT01610336|464991912|FG002|Overall Study|Progressive Disease|6|||
129190649|NCT01610336|464991913|FG003|Overall Study|Progressive Disease|5|||
129190650|NCT01610336|464991914|FG004|Overall Study|Progressive Disease|3|||
129190651|NCT01610336|464991915|FG005|Overall Study|Progressive Disease|10|||
129190652|NCT01610336|464991916|FG006|Overall Study|Progressive Disease|1|||
129190653|NCT01610336|464991917|FG007|Overall Study|Progressive Disease|6|||
129190654|NCT01610336|464991918|FG008|Overall Study|Progressive Disease|6|||
129190655|NCT01610336|464991919|FG009|Overall Study|Progressive Disease|40|||
129190656|NCT01610336|464991920|FG010|Overall Study|Progressive Disease|36|||
129190657|NCT01610336|464991910|FG000|Overall Study|Adverse Event|0|||
129190658|NCT01610336|464991911|FG001|Overall Study|Adverse Event|0|||
129190659|NCT01610336|464991912|FG002|Overall Study|Adverse Event|0|||
129190660|NCT01610336|464991913|FG003|Overall Study|Adverse Event|1|||
129190661|NCT01610336|464991914|FG004|Overall Study|Adverse Event|1|||
129190662|NCT01610336|464991915|FG005|Overall Study|Adverse Event|1|||
129190663|NCT01610336|464991916|FG006|Overall Study|Adverse Event|0|||
129190664|NCT01610336|464991917|FG007|Overall Study|Adverse Event|0|||
129190665|NCT01610336|464991918|FG008|Overall Study|Adverse Event|2|||
129190666|NCT01610336|464991919|FG009|Overall Study|Adverse Event|8|||
129190667|NCT01610336|464991920|FG010|Overall Study|Adverse Event|6|||
129190668|NCT01610336|464991910|FG000|Overall Study|Subject/Guardian decision|1|||
129190669|NCT01610336|464991911|FG001|Overall Study|Subject/Guardian decision|1|||
129190670|NCT01610336|464991912|FG002|Overall Study|Subject/Guardian decision|0|||
129190671|NCT01610336|464991913|FG003|Overall Study|Subject/Guardian decision|1|||
129190672|NCT01610336|464991914|FG004|Overall Study|Subject/Guardian decision|0|||
129190673|NCT01610336|464991915|FG005|Overall Study|Subject/Guardian decision|0|||
129190674|NCT01610336|464991916|FG006|Overall Study|Subject/Guardian decision|0|||
129190675|NCT01610336|464991917|FG007|Overall Study|Subject/Guardian decision|1|||
129190676|NCT01610336|464991918|FG008|Overall Study|Subject/Guardian decision|0|||
129190677|NCT01610336|464991919|FG009|Overall Study|Subject/Guardian decision|2|||
129190678|NCT01610336|464991920|FG010|Overall Study|Subject/Guardian decision|2|||
129190679|NCT01610336|464991910|FG000|Overall Study|Death|0|||
129190680|NCT01610336|464991911|FG001|Overall Study|Death|0|||
129190681|NCT01610336|464991912|FG002|Overall Study|Death|0|||
129190682|NCT01610336|464991913|FG003|Overall Study|Death|0|||
129190683|NCT01610336|464991914|FG004|Overall Study|Death|0|||
129190684|NCT01610336|464991915|FG005|Overall Study|Death|1|||
129190685|NCT01610336|464991916|FG006|Overall Study|Death|3|||
129190686|NCT01610336|464991917|FG007|Overall Study|Death|0|||
129190687|NCT01610336|464991918|FG008|Overall Study|Death|0|||
129190688|NCT01610336|464991919|FG009|Overall Study|Death|1|||
129190689|NCT01610336|464991920|FG010|Overall Study|Death|2|||
129190690|NCT01610336|464991910|FG000|Overall Study|Non-Compliance with study treatment|0|||
129190691|NCT01610336|464991911|FG001|Overall Study|Non-Compliance with study treatment|0|||
129190692|NCT01610336|464991912|FG002|Overall Study|Non-Compliance with study treatment|0|||
129190693|NCT01610336|464991913|FG003|Overall Study|Non-Compliance with study treatment|0|||
129190694|NCT01610336|464991914|FG004|Overall Study|Non-Compliance with study treatment|0|||
129190695|NCT01610336|464991915|FG005|Overall Study|Non-Compliance with study treatment|0|||
129190696|NCT01610336|464991916|FG006|Overall Study|Non-Compliance with study treatment|0|||
129190697|NCT01610336|464991917|FG007|Overall Study|Non-Compliance with study treatment|0|||
129190698|NCT01610336|464991918|FG008|Overall Study|Non-Compliance with study treatment|0|||
129190699|NCT01610336|464991919|FG009|Overall Study|Non-Compliance with study treatment|1|||
129190700|NCT01610336|464991920|FG010|Overall Study|Non-Compliance with study treatment|0|||
129190701|NCT01610336|464991910|FG000|Overall Study|Physician Decision|0|||
129190702|NCT01610336|464991911|FG001|Overall Study|Physician Decision|0|||
129190703|NCT01610336|464991912|FG002|Overall Study|Physician Decision|0|||
129190704|NCT01610336|464991913|FG003|Overall Study|Physician Decision|0|||
129190705|NCT01610336|464991914|FG004|Overall Study|Physician Decision|0|||
129190706|NCT01610336|464991915|FG005|Overall Study|Physician Decision|0|||
129190707|NCT01610336|464991916|FG006|Overall Study|Physician Decision|1|||
129190708|NCT01610336|464991917|FG007|Overall Study|Physician Decision|0|||
129190709|NCT01610336|464991918|FG008|Overall Study|Physician Decision|0|||
129190710|NCT01610336|464991919|FG009|Overall Study|Physician Decision|0|||
129190711|NCT01610336|464991920|FG010|Overall Study|Physician Decision|0|||
129190712|NCT01610336|464991910|FG000|Overall Study|Protocol Deviation|0|||
129190713|NCT01610336|464991911|FG001|Overall Study|Protocol Deviation|0|||
129190714|NCT01610336|464991912|FG002|Overall Study|Protocol Deviation|0|||
129190715|NCT01610336|464991913|FG003|Overall Study|Protocol Deviation|0|||
129190716|NCT01610336|464991914|FG004|Overall Study|Protocol Deviation|0|||
129190717|NCT01610336|464991915|FG005|Overall Study|Protocol Deviation|0|||
129190718|NCT01610336|464991916|FG006|Overall Study|Protocol Deviation|0|||
129190719|NCT01610336|464991917|FG007|Overall Study|Protocol Deviation|0|||
129190720|NCT01610336|464991918|FG008|Overall Study|Protocol Deviation|0|||
129190721|NCT01610336|464991919|FG009|Overall Study|Protocol Deviation|1|||
129190722|NCT01610336|464991920|FG010|Overall Study|Protocol Deviation|0|||
129190723|NCT01610336|464991910|FG000|Overall Study|Transfer to another trial|0|||
129190724|NCT01610336|464991911|FG001|Overall Study|Transfer to another trial|0|||
129190725|NCT01610336|464991912|FG002|Overall Study|Transfer to another trial|0|||
129190726|NCT01610336|464991913|FG003|Overall Study|Transfer to another trial|0|||
129190727|NCT01610336|464991914|FG004|Overall Study|Transfer to another trial|0|||
129190728|NCT01610336|464991915|FG005|Overall Study|Transfer to another trial|0|||
129190729|NCT01610336|464991916|FG006|Overall Study|Transfer to another trial|0|||
129190730|NCT01610336|464991917|FG007|Overall Study|Transfer to another trial|0|||
129190731|NCT01610336|464991918|FG008|Overall Study|Transfer to another trial|0|||
129190732|NCT01610336|464991919|FG009|Overall Study|Transfer to another trial|0|||
129190733|NCT01610336|464991920|FG010|Overall Study|Transfer to another trial|1|||
129190734|NCT04440813|464991921|FG000|Overall Study|Lost to Follow-up|5|||
129190735|NCT04440813|464991922|FG001|Overall Study|Lost to Follow-up|5|||
129190736|NCT02629822|464991923|FG000|Base Study|Lost to Follow-up|2|||
129190737|NCT02629822|464991923|FG000|Base Study|Non-Compliance With Study Drug|1|||
129190738|NCT02629822|464991923|FG000|Extension Study|Adverse Event|1|||
129190739|NCT02629822|464991923|FG000|Extension Study|Lost to Follow-up|1|||
129190740|NCT00741013|464991924|FG000|Overall Study|Adverse Event|1|||
129190741|NCT00741013|464991925|FG001|Overall Study|Adverse Event|0|||
129190742|NCT00741013|464991926|FG002|Overall Study|Adverse Event|0|||
129190743|NCT00741013|464991924|FG000|Overall Study|Withdrawal by Subject|0|||
129190744|NCT00741013|464991925|FG001|Overall Study|Withdrawal by Subject|0|||
129190745|NCT00741013|464991926|FG002|Overall Study|Withdrawal by Subject|1|||
129190746|NCT00741013|464991924|FG000|Overall Study|Discovered failed screen after enrolled|0|||
129190747|NCT00741013|464991925|FG001|Overall Study|Discovered failed screen after enrolled|2|||
129190748|NCT00741013|464991926|FG002|Overall Study|Discovered failed screen after enrolled|0|||
129190749|NCT01559675|464991930|FG000|Overall Study|Protocol Violation|1|||
129190750|NCT01559675|464991931|FG001|Overall Study|Protocol Violation|2|||
129190751|NCT01559675|464991930|FG000|Overall Study|2nd operation on same patient excluded|14|||
129190752|NCT01559675|464991931|FG001|Overall Study|2nd operation on same patient excluded|12|||
129190753|NCT00291018|464991932|FG000|Overall Study|Not Consented or Declined PAS|12|||
129190754|NCT00291018|464991933|FG001|Overall Study|Not Consented or Declined PAS|15|||
129190755|NCT00291018|464991934|FG002|Overall Study|Not Consented or Declined PAS|15|||
129190756|NCT00291018|464991932|FG000|Overall Study|Death|3|||
129190757|NCT00291018|464991933|FG001|Overall Study|Death|3|||
129190758|NCT00291018|464991934|FG002|Overall Study|Death|4|||
128730364|NCT04300296|463309955|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
128730365|NCT04300296|463309956|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
128730366|NCT04300296|463309957|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
128730367|NCT04300296|463309958|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
128730368|NCT04300296|463309959|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
128730369|NCT04300296|463309954|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
129190759|NCT00291018|464991932|FG000|Overall Study|Withdrawal by Subject|2|||
129190760|NCT00291018|464991933|FG001|Overall Study|Withdrawal by Subject|8|||
129190761|NCT00291018|464991934|FG002|Overall Study|Withdrawal by Subject|1|||
129190762|NCT00291018|464991932|FG000|Overall Study|Failures|5|||
129190763|NCT00291018|464991933|FG001|Overall Study|Failures|12|||
129190764|NCT00291018|464991934|FG002|Overall Study|Failures|5|||
129190765|NCT00291018|464991932|FG000|Overall Study|Lost to Follow-up|3|||
129190766|NCT00291018|464991933|FG001|Overall Study|Lost to Follow-up|4|||
129190767|NCT00291018|464991934|FG002|Overall Study|Lost to Follow-up|18|||
129190768|NCT01496469|464991935|FG000|Overall Study|Adverse Event|1|||
129190769|NCT01496469|464991936|FG001|Overall Study|Adverse Event|0|||
129190770|NCT01496469|464991935|FG000|Overall Study|Protocol Violation|2|||
129190771|NCT01496469|464991936|FG001|Overall Study|Protocol Violation|0|||
129190772|NCT01496469|464991935|FG000|Overall Study|Lost to Follow-up|1|||
129190773|NCT01496469|464991936|FG001|Overall Study|Lost to Follow-up|1|||
129190774|NCT01496469|464991935|FG000|Overall Study|Withdrawal by Subject|4|||
129190775|NCT01496469|464991936|FG001|Overall Study|Withdrawal by Subject|4|||
129190776|NCT01496469|464991935|FG000|Overall Study|BP exceeds protocol limits|1|||
129190777|NCT01496469|464991936|FG001|Overall Study|BP exceeds protocol limits|2|||
129190778|NCT01496469|464991935|FG000|Overall Study|Other|1|||
129190779|NCT01496469|464991936|FG001|Overall Study|Other|1|||
129190780|NCT00193180|464991937|FG000|Overall Study|Lack of Efficacy|1|||
129190781|NCT00193180|464991937|FG000|Overall Study|Adverse Event|8|||
129190782|NCT00193180|464991937|FG000|Overall Study|Protocol Violation|1|||
129190783|NCT01357551|464991938|FG000|Overall Study|Withdrawal by Subject|6|||
129190784|NCT01357551|464991939|FG001|Overall Study|Withdrawal by Subject|4|||
129190785|NCT01357551|464991938|FG000|Overall Study|Death|0|||
129190786|NCT01357551|464991939|FG001|Overall Study|Death|1|||
129190787|NCT01357551|464991938|FG000|Overall Study|Lost to Follow-up|16|||
129190788|NCT01357551|464991939|FG001|Overall Study|Lost to Follow-up|6|||
129190789|NCT01235234|464991940|FG000|Overall Study|Adverse Event|2|||
129190790|NCT01235234|464991941|FG001|Overall Study|Adverse Event|2|||
129190791|NCT01235234|464991942|FG002|Overall Study|Adverse Event|1|||
129190792|NCT04869358|464991943|FG000|Overall Study|Wish to have children.|1|||
129190793|NCT04869358|464991944|FG001|Overall Study|Wish to have children.|0|||
129190794|NCT04869358|464991945|FG002|Overall Study|Wish to have children.|0|||
129190795|NCT04869358|464991946|FG003|Overall Study|Wish to have children.|0|||
129190796|NCT04164732|464991947|FG000|Treatment run-in Period|Adverse Event|4|||
129190797|NCT04164732|464991948|FG001|Treatment run-in Period|Adverse Event|0|||
129190798|NCT04164732|464991949|FG002|Treatment run-in Period|Adverse Event|0|||
129190799|NCT04164732|464991947|FG000|Treatment run-in Period|Physician Decision|1|||
129190800|NCT04164732|464991948|FG001|Treatment run-in Period|Physician Decision|0|||
129190801|NCT04164732|464991949|FG002|Treatment run-in Period|Physician Decision|0|||
129190802|NCT04164732|464991947|FG000|Treatment run-in Period|Screen Failure|1|||
129190803|NCT04164732|464991948|FG001|Treatment run-in Period|Screen Failure|0|||
129190804|NCT04164732|464991949|FG002|Treatment run-in Period|Screen Failure|0|||
129190805|NCT04164732|464991947|FG000|Randomized Treatment Period|Adverse Event|0|||
128730370|NCT04300296|463309955|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
129190806|NCT04164732|464991948|FG001|Randomized Treatment Period|Adverse Event|1|||
129190807|NCT04164732|464991949|FG002|Randomized Treatment Period|Adverse Event|0|||
129190808|NCT04164732|464991947|FG000|Randomized Treatment Period|Protocol Deviation|0|||
128730371|NCT04300296|463309956|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129190809|NCT04164732|464991948|FG001|Randomized Treatment Period|Protocol Deviation|1|||
128982144|NCT00508820|464219107|FG001|Overall Study|Noncompliance|0|||
129190810|NCT04164732|464991949|FG002|Randomized Treatment Period|Protocol Deviation|1|||
129190811|NCT04164732|464991947|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
129190812|NCT04164732|464991948|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
129190813|NCT04164732|464991949|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
129190814|NCT04302545|464991950|FG000|Overall Study|Lost to Follow-up|3|||
129190815|NCT04302545|464991951|FG001|Overall Study|Lost to Follow-up|4|||
129190816|NCT02690714|464991955|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
129190817|NCT02690714|464991955|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
129190818|NCT02202538|464991956|FG000|Overall Study|Withdrawal by Subject|5|||
129190819|NCT02202538|464991956|FG000|Overall Study|Did not meet all inclusion criteria|2|||
129190820|NCT02202538|464991956|FG000|Overall Study|Investigator Decision|1|||
129190821|NCT01457846|464991957|FG000|Overall Study|Death before treatment|1|||
129190822|NCT01457846|464991958|FG001|Overall Study|Death before treatment|2|||
129190823|NCT01457846|464991957|FG000|Overall Study|Did not receive treatment|0|||
129190824|NCT01457846|464991958|FG001|Overall Study|Did not receive treatment|1|||
129190825|NCT01457846|464991957|FG000|Overall Study|Death|27|||
129190826|NCT01457846|464991958|FG001|Overall Study|Death|16|||
129190827|NCT01457846|464991957|FG000|Overall Study|Unclassified reason for not completed|11|||
129190828|NCT01457846|464991958|FG001|Overall Study|Unclassified reason for not completed|10|||
129190829|NCT01457846|464991957|FG000|Overall Study|Withdrawal by Subject|1|||
129190830|NCT01457846|464991958|FG001|Overall Study|Withdrawal by Subject|1|||
129190831|NCT01457846|464991957|FG000|Overall Study|Lost to Follow-up|1|||
129190832|NCT01457846|464991958|FG001|Overall Study|Lost to Follow-up|0|||
129190833|NCT02161757|464991959|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
129190834|NCT02161757|464991960|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
129190835|NCT02161757|464991961|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
129190836|NCT02161757|464991959|FG000|Treatment Through Study Completion|Adverse Event|1|||
129190837|NCT02161757|464991960|FG001|Treatment Through Study Completion|Adverse Event|1|||
129190838|NCT02161757|464991961|FG002|Treatment Through Study Completion|Adverse Event|0|||
129190839|NCT02161757|464991959|FG000|Treatment Through Study Completion|Protocol Violation|0|||
129190840|NCT02161757|464991960|FG001|Treatment Through Study Completion|Protocol Violation|1|||
129190841|NCT02161757|464991961|FG002|Treatment Through Study Completion|Protocol Violation|2|||
129190842|NCT02161757|464991959|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
129190843|NCT02161757|464991960|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
129190844|NCT02161757|464991961|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
129190845|NCT02161757|464991959|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
129190846|NCT02161757|464991960|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
129190847|NCT02161757|464991961|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
129190848|NCT02161757|464991959|FG000|Treatment Through Study Completion|Other|20|||
129190849|NCT02161757|464991960|FG001|Treatment Through Study Completion|Other|19|||
129190850|NCT02161757|464991961|FG002|Treatment Through Study Completion|Other|12|||
129190851|NCT02161757|464991959|FG000|Treatment Through Study Completion|Death|2|||
129190852|NCT02161757|464991960|FG001|Treatment Through Study Completion|Death|1|||
129190853|NCT02161757|464991961|FG002|Treatment Through Study Completion|Death|1|||
129190854|NCT00465647|464991964|FG000|Overall Study|Administrative|2|||
129190855|NCT00465647|464991965|FG001|Overall Study|Administrative|2|||
129190856|NCT00465647|464991966|FG002|Overall Study|Administrative|3|||
129190857|NCT00465647|464991967|FG003|Overall Study|Administrative|2|||
129190858|NCT00465647|464991964|FG000|Overall Study|Adverse Event|2|||
129190859|NCT00465647|464991965|FG001|Overall Study|Adverse Event|0|||
129190860|NCT00465647|464991966|FG002|Overall Study|Adverse Event|3|||
129190861|NCT00465647|464991967|FG003|Overall Study|Adverse Event|2|||
129190862|NCT00465647|464991964|FG000|Overall Study|Withdrawal by Subject|1|||
129190863|NCT00465647|464991965|FG001|Overall Study|Withdrawal by Subject|2|||
129190864|NCT00465647|464991966|FG002|Overall Study|Withdrawal by Subject|2|||
129190865|NCT00465647|464991967|FG003|Overall Study|Withdrawal by Subject|7|||
129190866|NCT00465647|464991964|FG000|Overall Study|"The other reasons included loss of IV"|8|||
129190867|NCT00465647|464991965|FG001|Overall Study|"The other reasons included loss of IV"|4|||
129190868|NCT00465647|464991966|FG002|Overall Study|"The other reasons included loss of IV"|3|||
129190869|NCT00465647|464991967|FG003|Overall Study|"The other reasons included loss of IV"|2|||
129190870|NCT01240135|464991970|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
129190871|NCT01240135|464991971|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
129190872|NCT01240135|464991970|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
129190873|NCT01240135|464991971|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
129190874|NCT01371305|464991972|FG000|Overall Study|Adverse Event|0|||
129190875|NCT01371305|464991973|FG001|Overall Study|Adverse Event|0|||
129190876|NCT01371305|464991974|FG002|Overall Study|Adverse Event|0|||
129190877|NCT01371305|464991975|FG003|Overall Study|Adverse Event|2|||
129190878|NCT01371305|464991976|FG004|Overall Study|Adverse Event|1|||
129190879|NCT01371305|464991977|FG005|Overall Study|Adverse Event|0|||
129190880|NCT01371305|464991972|FG000|Overall Study|Study terminated by sponsor|0|||
129190881|NCT01371305|464991973|FG001|Overall Study|Study terminated by sponsor|0|||
129190882|NCT01371305|464991974|FG002|Overall Study|Study terminated by sponsor|0|||
129190883|NCT01371305|464991975|FG003|Overall Study|Study terminated by sponsor|0|||
129190884|NCT01371305|464991976|FG004|Overall Study|Study terminated by sponsor|3|||
129190885|NCT01371305|464991977|FG005|Overall Study|Study terminated by sponsor|1|||
129190886|NCT01371305|464991972|FG000|Overall Study|Subject request|0|||
129190887|NCT01371305|464991973|FG001|Overall Study|Subject request|0|||
129190888|NCT01371305|464991974|FG002|Overall Study|Subject request|0|||
129190889|NCT01371305|464991975|FG003|Overall Study|Subject request|0|||
129190890|NCT01371305|464991976|FG004|Overall Study|Subject request|0|||
129190891|NCT01371305|464991977|FG005|Overall Study|Subject request|1|||
129190892|NCT02828020|464991980|FG000|Treatment Period|Adverse Event|3|||
129190893|NCT02828020|464991981|FG001|Treatment Period|Adverse Event|1|||
129190894|NCT02828020|464991982|FG002|Treatment Period|Adverse Event|1|||
129190895|NCT02828020|464991980|FG000|Treatment Period|Withdrawal of Consent|10|||
129190896|NCT02828020|464991981|FG001|Treatment Period|Withdrawal of Consent|14|||
128730372|NCT04300296|463309957|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
128730373|NCT04300296|463309958|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129190897|NCT02828020|464991982|FG002|Treatment Period|Withdrawal of Consent|9|||
129190898|NCT02828020|464991980|FG000|Treatment Period|Lost to Follow-up|21|||
129190899|NCT02828020|464991981|FG001|Treatment Period|Lost to Follow-up|24|||
129190900|NCT02828020|464991982|FG002|Treatment Period|Lost to Follow-up|18|||
129190901|NCT02828020|464991980|FG000|Treatment Period|Lack of Qualifying Event|44|||
129190902|NCT02828020|464991981|FG001|Treatment Period|Lack of Qualifying Event|53|||
129190903|NCT02828020|464991982|FG002|Treatment Period|Lack of Qualifying Event|43|||
129190904|NCT02828020|464991980|FG000|Treatment Period|Pregnancy|0|||
129190905|NCT02828020|464991981|FG001|Treatment Period|Pregnancy|2|||
129190906|NCT02828020|464991982|FG002|Treatment Period|Pregnancy|0|||
129190907|NCT02828020|464991980|FG000|Treatment Period|Protocol Violation|2|||
129190908|NCT02828020|464991981|FG001|Treatment Period|Protocol Violation|4|||
129190909|NCT02828020|464991982|FG002|Treatment Period|Protocol Violation|7|||
129190910|NCT02828020|464991980|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
129190911|NCT02828020|464991981|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
129190912|NCT02828020|464991982|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
129190913|NCT02828020|464991980|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
129190914|NCT02828020|464991981|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
129190915|NCT02828020|464991982|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
129190916|NCT02828020|464991980|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
129190917|NCT02828020|464991981|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
129190918|NCT02828020|464991982|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
129190919|NCT02828020|464991980|FG000|Safety Follow-up Period|Protocol Violation|0|||
129190920|NCT02828020|464991981|FG001|Safety Follow-up Period|Protocol Violation|2|||
129190921|NCT02828020|464991982|FG002|Safety Follow-up Period|Protocol Violation|1|||
129190922|NCT02828020|464991980|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
129190923|NCT02828020|464991981|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
129190924|NCT02828020|464991982|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
129190925|NCT01339897|464991983|FG000|Overall Study|Adverse Event|1|||
129190926|NCT01339897|464991984|FG001|Overall Study|Adverse Event|0|||
129190927|NCT01339897|464991985|FG002|Overall Study|Adverse Event|0|||
129190928|NCT01339897|464991986|FG003|Overall Study|Adverse Event|1|||
129190929|NCT01138501|464991987|FG000|Overall Study|Protocol Violation|2|||
129190930|NCT01138501|464991987|FG000|Overall Study|Withdrawal by Subject|3|||
129190931|NCT00847197|464991991|FG000|Overall Study|Adverse Event|21|||
129190932|NCT00847197|464991992|FG001|Overall Study|Adverse Event|3|||
129190933|NCT00847197|464991991|FG000|Overall Study|Protocol Violation|0|||
129190934|NCT00847197|464991992|FG001|Overall Study|Protocol Violation|1|||
129190935|NCT00847197|464991991|FG000|Overall Study|Withdrawal by Subject|3|||
129190936|NCT00847197|464991992|FG001|Overall Study|Withdrawal by Subject|1|||
129190937|NCT01894243|464991993|FG000|Overall Study|Adverse Event|0|||
129190938|NCT01894243|464991994|FG001|Overall Study|Adverse Event|1|||
129190939|NCT01894243|464991995|FG002|Overall Study|Adverse Event|2|||
129190940|NCT01894243|464991993|FG000|Overall Study|Death|0|||
129190941|NCT01894243|464991994|FG001|Overall Study|Death|0|||
129190942|NCT01894243|464991995|FG002|Overall Study|Death|3|||
129190943|NCT01894243|464991993|FG000|Overall Study|Lack of Efficacy|3|||
129190944|NCT01894243|464991994|FG001|Overall Study|Lack of Efficacy|3|||
129190945|NCT01894243|464991995|FG002|Overall Study|Lack of Efficacy|1|||
129190946|NCT01894243|464991993|FG000|Overall Study|Condition under investigation worsened|8|||
129190947|NCT01894243|464991994|FG001|Overall Study|Condition under investigation worsened|6|||
129190948|NCT01894243|464991995|FG002|Overall Study|Condition under investigation worsened|2|||
129190949|NCT01894243|464991993|FG000|Overall Study|Subject decision|1|||
129190950|NCT01894243|464991994|FG001|Overall Study|Subject decision|0|||
129190951|NCT01894243|464991995|FG002|Overall Study|Subject decision|0|||
129190952|NCT01894243|464991993|FG000|Overall Study|Other|1|||
129190953|NCT01894243|464991994|FG001|Overall Study|Other|0|||
129190954|NCT01894243|464991995|FG002|Overall Study|Other|0|||
129190955|NCT01743040|464991996|FG000|Overall Study|Death|1|||
129190956|NCT01743040|464991996|FG000|Overall Study|Lost to Follow-up|66|||
129190957|NCT01743040|464991996|FG000|Overall Study|Physician Decision|40|||
129190958|NCT01743040|464991996|FG000|Overall Study|Protocol Violation|1|||
129190959|NCT01743040|464991996|FG000|Overall Study|Withdrawal by Subject|121|||
129190960|NCT00830180|464992000|FG000|Overall Study|Adverse Event|6|||
129190961|NCT00830180|464992000|FG000|Overall Study|Death|11|||
129190962|NCT00830180|464992000|FG000|Overall Study|Insufficient clinical response|1|||
129190963|NCT00830180|464992000|FG000|Overall Study|Withdrawal by Subject|5|||
129190964|NCT00830180|464992000|FG000|Overall Study|Progressive disease|2|||
129190965|NCT00830180|464992000|FG000|Overall Study|Other - Unspecified|1|||
129190966|NCT01832532|464992001|FG000|Overall Study|Withdrawal by Subject|5|||
129190967|NCT01832532|464992002|FG001|Overall Study|Withdrawal by Subject|2|||
129190968|NCT02687581|464992004|FG000|Overall Study|Withdrawal by Subject|1|||
129190969|NCT02687581|464992005|FG001|Overall Study|Withdrawal by Subject|0|||
129190970|NCT02687581|464992006|FG002|Overall Study|Withdrawal by Subject|0|||
129190971|NCT02687581|464992007|FG003|Overall Study|Withdrawal by Subject|1|||
129190972|NCT02687581|464992004|FG000|Overall Study|Lost to Follow-up|2|||
129190973|NCT02687581|464992005|FG001|Overall Study|Lost to Follow-up|2|||
129190974|NCT02687581|464992006|FG002|Overall Study|Lost to Follow-up|0|||
129190975|NCT02687581|464992007|FG003|Overall Study|Lost to Follow-up|0|||
129190976|NCT02687581|464992004|FG000|Overall Study|the device is too small for the patient.|1|||
129190977|NCT02687581|464992005|FG001|Overall Study|the device is too small for the patient.|0|||
129190978|NCT02687581|464992006|FG002|Overall Study|the device is too small for the patient.|0|||
129190979|NCT02687581|464992007|FG003|Overall Study|the device is too small for the patient.|0|||
129190980|NCT01990612|464992010|FG000|Overall Study|Lost to Follow-up|2|||
129190981|NCT01990612|464992011|FG001|Overall Study|Lost to Follow-up|1|||
129190982|NCT01990612|464992010|FG000|Overall Study|Withdrawal by Subject|5|||
129190983|NCT01990612|464992011|FG001|Overall Study|Withdrawal by Subject|2|||
129190984|NCT02974842|464992012|FG000|Overall Study|Withdrawal by Subject|4|||
129190985|NCT02974842|464992012|FG000|Overall Study|Screen failures|4|||
129190986|NCT02467582|464994758|FG000|Allocation|Withdrawal by Subject|1|||
129190987|NCT02467582|464994759|FG001|Allocation|Withdrawal by Subject|0|||
129190988|NCT02467582|464994758|FG000|Follow-up|Death|5|||
129190989|NCT02467582|464994759|FG001|Follow-up|Death|4|||
129190990|NCT02467582|464994758|FG000|Follow-up|Lost to Follow-up|6|||
129190991|NCT02467582|464994759|FG001|Follow-up|Lost to Follow-up|5|||
129190992|NCT02291419|464994760|FG000|Overall Study|Early study termination|1|||
129190993|NCT02291419|464994761|FG001|Overall Study|Early study termination|5|||
129190994|NCT00965575|464994765|FG000|Overall Study|subject unwillingness to swallow study c|1|||
129190995|NCT00965575|464994766|FG001|Overall Study|subject unwillingness to swallow study c|0|||
129190996|NCT03047031|464994775|FG000|Overall Study|Other than listed|1|||
129190997|NCT03047031|464994776|FG001|Overall Study|Other than listed|0|||
129190998|NCT03047031|464994777|FG002|Overall Study|Other than listed|0|||
129190999|NCT03047031|464994775|FG000|Overall Study|Lost to Follow-up|4|||
129191000|NCT03047031|464994776|FG001|Overall Study|Lost to Follow-up|0|||
129191001|NCT03047031|464994777|FG002|Overall Study|Lost to Follow-up|0|||
129191002|NCT03047031|464994775|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
129191003|NCT03047031|464994776|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
129191004|NCT03047031|464994777|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
129191005|NCT03047031|464994775|FG000|Overall Study|Adverse Event|1|||
129191006|NCT03047031|464994776|FG001|Overall Study|Adverse Event|0|||
129191007|NCT03047031|464994777|FG002|Overall Study|Adverse Event|0|||
129191008|NCT03047031|464994775|FG000|Overall Study|Withdrawal by Subject|2|||
129191009|NCT03047031|464994776|FG001|Overall Study|Withdrawal by Subject|0|||
129191010|NCT03047031|464994777|FG002|Overall Study|Withdrawal by Subject|0|||
129191011|NCT03047031|464994775|FG000|Overall Study|Change to other medication|2|||
129191012|NCT03047031|464994776|FG001|Overall Study|Change to other medication|0|||
129191013|NCT03047031|464994777|FG002|Overall Study|Change to other medication|0|||
129191014|NCT03047031|464994775|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
129191015|NCT03047031|464994776|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
129191016|NCT03047031|464994777|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
129191017|NCT01959841|464994778|FG000|Overall Study|Adverse Event|1|||
129191018|NCT01959841|464994779|FG001|Overall Study|Adverse Event|3|||
129191019|NCT01959841|464994780|FG002|Overall Study|Adverse Event|2|||
129191020|NCT01959841|464994778|FG000|Overall Study|Lack of Efficacy|5|||
129191021|NCT01959841|464994779|FG001|Overall Study|Lack of Efficacy|0|||
129191022|NCT01959841|464994780|FG002|Overall Study|Lack of Efficacy|0|||
129191023|NCT01959841|464994778|FG000|Overall Study|Lost to Follow-up|1|||
129191024|NCT01959841|464994779|FG001|Overall Study|Lost to Follow-up|1|||
129191025|NCT01959841|464994780|FG002|Overall Study|Lost to Follow-up|0|||
129191026|NCT01959841|464994778|FG000|Overall Study|Physician Decision|0|||
129191027|NCT01959841|464994779|FG001|Overall Study|Physician Decision|2|||
129191028|NCT01959841|464994780|FG002|Overall Study|Physician Decision|3|||
129191029|NCT01959841|464994778|FG000|Overall Study|Protocol Violation|16|||
129191030|NCT01959841|464994779|FG001|Overall Study|Protocol Violation|23|||
129191031|NCT01959841|464994780|FG002|Overall Study|Protocol Violation|16|||
129191032|NCT01959841|464994778|FG000|Overall Study|Withdrawal by Subject|7|||
129191033|NCT01959841|464994779|FG001|Overall Study|Withdrawal by Subject|7|||
129191034|NCT01959841|464994780|FG002|Overall Study|Withdrawal by Subject|5|||
129191035|NCT01959841|464994778|FG000|Overall Study|Clinical laboratory value|2|||
129191036|NCT01959841|464994779|FG001|Overall Study|Clinical laboratory value|6|||
129191037|NCT01959841|464994780|FG002|Overall Study|Clinical laboratory value|6|||
129191038|NCT01959841|464994778|FG000|Overall Study|Platelet count below on day1 or 4|11|||
129191039|NCT01959841|464994779|FG001|Overall Study|Platelet count below on day1 or 4|15|||
129191040|NCT01959841|464994780|FG002|Overall Study|Platelet count below on day1 or 4|11|||
129191041|NCT00780416|464994781|FG000|Overall Study|Physician Decision|3|||
129191042|NCT00780416|464994782|FG001|Overall Study|Physician Decision|3|||
129191043|NCT00780416|464994781|FG000|Overall Study|Protocol Violation|1|||
129191044|NCT00780416|464994782|FG001|Overall Study|Protocol Violation|0|||
129191045|NCT00780416|464994781|FG000|Overall Study|Withdrawal by Subject|8|||
129191046|NCT00780416|464994782|FG001|Overall Study|Withdrawal by Subject|6|||
129191047|NCT03521141|464994785|FG000|Overall Study|Death|1|||
129191048|NCT03521141|464994786|FG001|Overall Study|Death|0|||
129191049|NCT03521141|464994787|FG002|Overall Study|Death|1|||
129191050|NCT01959139|464994804|FG000|Phase II|Disease progression|0|||
129191051|NCT01959139|464994805|FG001|Phase II|Disease progression|0|||
129191052|NCT01959139|464994806|FG002|Phase II|Disease progression|26|||
129191053|NCT01959139|464994807|FG003|Phase II|Disease progression|34|||
129191054|NCT01959139|464994804|FG000|Phase II|Adverse Event|0|||
129191055|NCT01959139|464994805|FG001|Phase II|Adverse Event|0|||
129191056|NCT01959139|464994806|FG002|Phase II|Adverse Event|10|||
129191057|NCT01959139|464994807|FG003|Phase II|Adverse Event|11|||
129191058|NCT01959139|464994804|FG000|Phase II|Patient Refusal|0|||
129191059|NCT01959139|464994805|FG001|Phase II|Patient Refusal|0|||
129191060|NCT01959139|464994806|FG002|Phase II|Patient Refusal|5|||
129191061|NCT01959139|464994807|FG003|Phase II|Patient Refusal|4|||
129191062|NCT01959139|464994804|FG000|Phase II|Death|0|||
129191063|NCT01959139|464994805|FG001|Phase II|Death|0|||
129191064|NCT01959139|464994806|FG002|Phase II|Death|3|||
129191065|NCT01959139|464994807|FG003|Phase II|Death|1|||
129191066|NCT01959139|464994804|FG000|Phase II|Other/Unknown|0|||
129191067|NCT01959139|464994805|FG001|Phase II|Other/Unknown|0|||
129191068|NCT01959139|464994806|FG002|Phase II|Other/Unknown|8|||
129191069|NCT01959139|464994807|FG003|Phase II|Other/Unknown|5|||
129191070|NCT01959139|464994804|FG000|Phase II|On treatment|0|||
129191071|NCT01959139|464994805|FG001|Phase II|On treatment|0|||
129191072|NCT01959139|464994806|FG002|Phase II|On treatment|4|||
129191073|NCT01959139|464994807|FG003|Phase II|On treatment|0|||
129191074|NCT00630344|464994810|FG000|Overall Study|Adverse Event|5|||
129191075|NCT00630344|464994810|FG000|Overall Study|Progressive Disease|19|||
129191076|NCT00630344|464994810|FG000|Overall Study|Physician Decision|9|||
129191077|NCT00630344|464994810|FG000|Overall Study|Withdrawal by Subject|1|||
129191078|NCT00630344|464994810|FG000|Overall Study|Intercurrent Illness|1|||
129191079|NCT00630344|464994810|FG000|Overall Study|Other|1|||
129191080|NCT05362058|464994811|FG000|Treatment Period|Adverse Event|3|||
129191081|NCT05362058|464994812|FG001|Treatment Period|Adverse Event|3|||
129191082|NCT05362058|464994811|FG000|Treatment Period|Assigned treatment by mistake|3|||
129191083|NCT05362058|464994812|FG001|Treatment Period|Assigned treatment by mistake|4|||
129191084|NCT05362058|464994811|FG000|Treatment Period|Death|1|||
129191085|NCT05362058|464994812|FG001|Treatment Period|Death|1|||
129191086|NCT05362058|464994811|FG000|Treatment Period|Lost to Follow-up|6|||
129191087|NCT05362058|464994812|FG001|Treatment Period|Lost to Follow-up|3|||
129191088|NCT05362058|464994811|FG000|Treatment Period|Non-compliance with study drug|0|||
129191089|NCT05362058|464994812|FG001|Treatment Period|Non-compliance with study drug|1|||
129191090|NCT05362058|464994811|FG000|Treatment Period|Physician Decision|1|||
129191091|NCT05362058|464994812|FG001|Treatment Period|Physician Decision|0|||
129191092|NCT05362058|464994811|FG000|Treatment Period|Protocol deviation|1|||
129191093|NCT05362058|464994812|FG001|Treatment Period|Protocol deviation|0|||
129191094|NCT05362058|464994811|FG000|Treatment Period|Withdrawal by Subject|10|||
129191095|NCT05362058|464994812|FG001|Treatment Period|Withdrawal by Subject|11|||
129191096|NCT05362058|464994811|FG000|Follow-Up Period|Death|1|||
129191097|NCT05362058|464994812|FG001|Follow-Up Period|Death|0|||
129191098|NCT05362058|464994811|FG000|Follow-Up Period|Lost to Follow-up|2|||
129191099|NCT05362058|464994812|FG001|Follow-Up Period|Lost to Follow-up|1|||
129191100|NCT05362058|464994811|FG000|Follow-Up Period|Protocol deviation|1|||
129191101|NCT05362058|464994812|FG001|Follow-Up Period|Protocol deviation|1|||
129191102|NCT05362058|464994811|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129191103|NCT05362058|464994812|FG001|Follow-Up Period|Withdrawal by Subject|3|||
129191104|NCT01964963|464994815|FG000|Overall Study|Case Report Forms Uncollected|888|||
129191105|NCT01964963|464994815|FG000|Overall Study|Protocol Deviation|50|||
129191106|NCT01964963|464994815|FG000|Overall Study|Data Reliability was not Assured|5|||
129191107|NCT00930553|464994816|FG000|Overall Study|Adverse Event|1|||
129191108|NCT00930553|464994816|FG000|Overall Study|Lack of Efficacy|7|||
129191109|NCT00930553|464994816|FG000|Overall Study|Physician Decision|39|||
129191110|NCT00930553|464994816|FG000|Overall Study|Protocol Violation|1|||
129191111|NCT00930553|464994816|FG000|Overall Study|Pregnancy|1|||
129191112|NCT00930553|464994816|FG000|Overall Study|Withdrawal by Subject|88|||
128781013|NCT03590743|463488652|FG000|Overall Study|Withdrawal by Subject|0|||
129191113|NCT00930553|464994816|FG000|Overall Study|Lost to Follow-up|25|||
129191114|NCT00930553|464994816|FG000|Overall Study|Death|9|||
129191115|NCT00930553|464994816|FG000|Overall Study|Study terminated by sponsor|24|||
129191116|NCT00930553|464994816|FG000|Overall Study|Other than specified above|28|||
129191117|NCT00856544|464994825|FG000|Overall Study|Randomized but not treated|3|||
129191118|NCT00856544|464994826|FG001|Overall Study|Randomized but not treated|0|||
129191119|NCT00856544|464994827|FG002|Overall Study|Randomized but not treated|0|||
129191120|NCT00856544|464994828|FG003|Overall Study|Randomized but not treated|0|||
129191121|NCT00856544|464994825|FG000|Overall Study|Death|0|||
129191122|NCT00856544|464994826|FG001|Overall Study|Death|2|||
129191123|NCT00856544|464994827|FG002|Overall Study|Death|0|||
129191124|NCT00856544|464994828|FG003|Overall Study|Death|0|||
129191125|NCT00856544|464994825|FG000|Overall Study|Adverse Event|20|||
129191126|NCT00856544|464994826|FG001|Overall Study|Adverse Event|29|||
129191127|NCT00856544|464994827|FG002|Overall Study|Adverse Event|2|||
129191128|NCT00856544|464994828|FG003|Overall Study|Adverse Event|3|||
129191129|NCT00856544|464994825|FG000|Overall Study|Lack of Efficacy|16|||
129191130|NCT00856544|464994826|FG001|Overall Study|Lack of Efficacy|12|||
129191131|NCT00856544|464994827|FG002|Overall Study|Lack of Efficacy|3|||
129191132|NCT00856544|464994828|FG003|Overall Study|Lack of Efficacy|3|||
129191133|NCT00856544|464994825|FG000|Overall Study|Other|9|||
129191134|NCT00856544|464994826|FG001|Overall Study|Other|16|||
129191135|NCT00856544|464994827|FG002|Overall Study|Other|1|||
129191136|NCT00856544|464994828|FG003|Overall Study|Other|6|||
129191137|NCT00856544|464994825|FG000|Overall Study|Lost to Follow-up|1|||
129191138|NCT00856544|464994826|FG001|Overall Study|Lost to Follow-up|2|||
129191139|NCT00856544|464994827|FG002|Overall Study|Lost to Follow-up|2|||
129191140|NCT00856544|464994828|FG003|Overall Study|Lost to Follow-up|0|||
129191141|NCT00856544|464994825|FG000|Overall Study|Withdrawal by Subject|8|||
129191142|NCT00856544|464994826|FG001|Overall Study|Withdrawal by Subject|5|||
129191143|NCT00856544|464994827|FG002|Overall Study|Withdrawal by Subject|0|||
129191144|NCT00856544|464994828|FG003|Overall Study|Withdrawal by Subject|1|||
129191145|NCT00787189|464994829|FG000|Overall Study|Lost to Follow-up|2|||
129191146|NCT00787189|464994830|FG001|Overall Study|Lost to Follow-up|2|||
129191147|NCT00286494|464994837|FG000|Overall Study|Hyperglycemic rescue|12|||
129191148|NCT00286494|464994838|FG001|Overall Study|Hyperglycemic rescue|19|||
129191149|NCT00286494|464994839|FG002|Overall Study|Hyperglycemic rescue|18|||
129191150|NCT00286494|464994837|FG000|Overall Study|Withdrawal by Subject|2|||
129191151|NCT00286494|464994838|FG001|Overall Study|Withdrawal by Subject|10|||
129191152|NCT00286494|464994839|FG002|Overall Study|Withdrawal by Subject|9|||
129191153|NCT00286494|464994837|FG000|Overall Study|Adverse Event|3|||
129191154|NCT00286494|464994838|FG001|Overall Study|Adverse Event|8|||
129191155|NCT00286494|464994839|FG002|Overall Study|Adverse Event|6|||
129191156|NCT00286494|464994837|FG000|Overall Study|Physician Decision|5|||
129191157|NCT00286494|464994838|FG001|Overall Study|Physician Decision|5|||
129191158|NCT00286494|464994839|FG002|Overall Study|Physician Decision|1|||
129191159|NCT00286494|464994837|FG000|Overall Study|Lost to Follow-up|3|||
129191160|NCT00286494|464994838|FG001|Overall Study|Lost to Follow-up|1|||
129191161|NCT00286494|464994839|FG002|Overall Study|Lost to Follow-up|3|||
129191162|NCT00286494|464994837|FG000|Overall Study|Protocol Violation|1|||
129191163|NCT00286494|464994838|FG001|Overall Study|Protocol Violation|1|||
129191164|NCT00286494|464994839|FG002|Overall Study|Protocol Violation|2|||
129191165|NCT04776317|464994840|FG000|Overall Study|Physician Decision|0|||
129191166|NCT04776317|464994841|FG001|Overall Study|Physician Decision|1|||
129191167|NCT04776317|464994842|FG002|Overall Study|Physician Decision|0|||
129191168|NCT04776317|464994843|FG003|Overall Study|Physician Decision|0|||
129191169|NCT04776317|464994844|FG004|Overall Study|Physician Decision|0|||
129191170|NCT04776317|464994845|FG005|Overall Study|Physician Decision|0|||
129191171|NCT04776317|464994846|FG006|Overall Study|Physician Decision|0|||
129191172|NCT04776317|464994847|FG007|Overall Study|Physician Decision|0|||
129191173|NCT04776317|464994848|FG008|Overall Study|Physician Decision|0|||
129191174|NCT04776317|464994849|FG009|Overall Study|Physician Decision|0|||
129191175|NCT04776317|464994850|FG010|Overall Study|Physician Decision|0|||
129191176|NCT04776317|464994851|FG011|Overall Study|Physician Decision|0|||
129191177|NCT04776317|464994852|FG012|Overall Study|Physician Decision|0|||
129191178|NCT04776317|464994853|FG013|Overall Study|Physician Decision|0|||
129191179|NCT04776317|464994854|FG014|Overall Study|Physician Decision|0|||
129191180|NCT04776317|464994840|FG000|Overall Study|Protocol Violation|0|||
129191181|NCT04776317|464994841|FG001|Overall Study|Protocol Violation|0|||
129191182|NCT04776317|464994842|FG002|Overall Study|Protocol Violation|1|||
129191183|NCT04776317|464994843|FG003|Overall Study|Protocol Violation|0|||
129191184|NCT04776317|464994844|FG004|Overall Study|Protocol Violation|0|||
129191185|NCT04776317|464994845|FG005|Overall Study|Protocol Violation|0|||
129191186|NCT04776317|464994846|FG006|Overall Study|Protocol Violation|0|||
129191187|NCT04776317|464994847|FG007|Overall Study|Protocol Violation|0|||
129191188|NCT04776317|464994848|FG008|Overall Study|Protocol Violation|0|||
129191189|NCT04776317|464994849|FG009|Overall Study|Protocol Violation|0|||
129191190|NCT04776317|464994850|FG010|Overall Study|Protocol Violation|0|||
129191191|NCT04776317|464994851|FG011|Overall Study|Protocol Violation|0|||
129191192|NCT04776317|464994852|FG012|Overall Study|Protocol Violation|0|||
129191193|NCT04776317|464994853|FG013|Overall Study|Protocol Violation|0|||
129191194|NCT04776317|464994854|FG014|Overall Study|Protocol Violation|0|||
129191195|NCT04776317|464994840|FG000|Overall Study|Withdrawal by Subject|0|||
129191196|NCT04776317|464994841|FG001|Overall Study|Withdrawal by Subject|0|||
129191197|NCT04776317|464994842|FG002|Overall Study|Withdrawal by Subject|0|||
129191198|NCT04776317|464994843|FG003|Overall Study|Withdrawal by Subject|0|||
129191199|NCT04776317|464994844|FG004|Overall Study|Withdrawal by Subject|1|||
129191200|NCT04776317|464994845|FG005|Overall Study|Withdrawal by Subject|0|||
129191201|NCT04776317|464994846|FG006|Overall Study|Withdrawal by Subject|0|||
129191202|NCT04776317|464994847|FG007|Overall Study|Withdrawal by Subject|0|||
129191203|NCT04776317|464994848|FG008|Overall Study|Withdrawal by Subject|0|||
129191204|NCT04776317|464994849|FG009|Overall Study|Withdrawal by Subject|0|||
129191205|NCT04776317|464994850|FG010|Overall Study|Withdrawal by Subject|0|||
129191206|NCT04776317|464994851|FG011|Overall Study|Withdrawal by Subject|0|||
129191207|NCT04776317|464994852|FG012|Overall Study|Withdrawal by Subject|0|||
129191208|NCT04776317|464994853|FG013|Overall Study|Withdrawal by Subject|0|||
129191209|NCT04776317|464994854|FG014|Overall Study|Withdrawal by Subject|0|||
129191210|NCT04207060|464994855|FG000|Overall Study|Lost to Follow-up|2|||
129191211|NCT04207060|464994856|FG001|Overall Study|Lost to Follow-up|0|||
129191212|NCT02524158|464994857|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
129191213|NCT02524158|464994858|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
129191214|NCT02524158|464994857|FG000|12-weeks Assessment|Lost to Follow-up|18|||
129191215|NCT02524158|464994858|FG001|12-weeks Assessment|Lost to Follow-up|12|||
129191216|NCT02524158|464994857|FG000|6-month Assessment|Withdrawal by Subject|1|||
129191217|NCT02524158|464994858|FG001|6-month Assessment|Withdrawal by Subject|1|||
129191218|NCT02524158|464994857|FG000|6-month Assessment|Lost to Follow-up|21|||
129191219|NCT02524158|464994858|FG001|6-month Assessment|Lost to Follow-up|20|||
129191220|NCT03671304|464994859|FG000|Overall Study|study terminated|7|||
129191221|NCT02718716|464994860|FG000|Overall Study|Lack of Efficacy|1|||
129191222|NCT02718716|464994861|FG001|Overall Study|Lack of Efficacy|0|||
129191223|NCT02718716|464994862|FG002|Overall Study|Lack of Efficacy|0|||
129191224|NCT02718716|464994863|FG003|Overall Study|Lack of Efficacy|0|||
129191225|NCT02718716|464994864|FG004|Overall Study|Lack of Efficacy|0|||
129191226|NCT00296140|464994865|FG000|Overall Study|Lost to Follow-up|1|||
129191227|NCT00296140|464994866|FG001|Overall Study|Lost to Follow-up|0|||
129191228|NCT00296140|464994865|FG000|Overall Study|Withdrawal by Subject|1|||
129191229|NCT00296140|464994866|FG001|Overall Study|Withdrawal by Subject|0|||
129191230|NCT00296140|464994865|FG000|Overall Study|Discharge to Nursing Home|1|||
129191231|NCT00296140|464994866|FG001|Overall Study|Discharge to Nursing Home|0|||
129191232|NCT01856582|464994870|FG000|Overall Study|Died prior to Boost infusion|1|||
129191233|NCT00596830|464994871|FG000|Overall Study|Death|258|||
129191234|NCT00596830|464994872|FG001|Overall Study|Death|247|||
129191235|NCT00596830|464994871|FG000|Overall Study|Lost to Follow-up|7|||
129191236|NCT00596830|464994872|FG001|Overall Study|Lost to Follow-up|11|||
129191237|NCT00596830|464994871|FG000|Overall Study|Withdrawal by Subject|22|||
129191238|NCT00596830|464994872|FG001|Overall Study|Withdrawal by Subject|12|||
129191239|NCT00596830|464994871|FG000|Overall Study|Study terminated by sponsor|51|||
129191240|NCT00596830|464994872|FG001|Overall Study|Study terminated by sponsor|62|||
129191241|NCT00596830|464994871|FG000|Overall Study|Follow-up was discontinued|1|||
129191242|NCT00596830|464994872|FG001|Overall Study|Follow-up was discontinued|0|||
129191243|NCT00596830|464994871|FG000|Overall Study|Randomized but not treated|3|||
129191244|NCT00596830|464994872|FG001|Overall Study|Randomized but not treated|7|||
129191245|NCT02097030|464994873|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
129191246|NCT02097030|464994874|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
129191247|NCT02097030|464994873|FG000|First Intervention (3 Days)|Visual Acuity|0|||
129191248|NCT02097030|464994874|FG001|First Intervention (3 Days)|Visual Acuity|1|||
129191249|NCT01919801|464994875|FG000|Overall Study|Withdrawal by Subject|1|||
129191250|NCT01919801|464994876|FG001|Overall Study|Withdrawal by Subject|0|||
129191251|NCT01919801|464994875|FG000|Overall Study|Physician Decision|0|||
129191252|NCT01919801|464994876|FG001|Overall Study|Physician Decision|1|||
129191253|NCT01919801|464994875|FG000|Overall Study|Lost to Follow-up|0|||
129191254|NCT01919801|464994876|FG001|Overall Study|Lost to Follow-up|1|||
129191255|NCT01919801|464994875|FG000|Overall Study|Other|0|||
129191256|NCT01919801|464994876|FG001|Overall Study|Other|1|||
129191257|NCT01843062|464994877|FG000|Overall Study|Protocol Violation|1|||
129191258|NCT01843062|464994878|FG001|Overall Study|Protocol Violation|0|||
129191259|NCT01843062|464994877|FG000|Overall Study|New treatment following progression|2|||
129191260|NCT01843062|464994878|FG001|Overall Study|New treatment following progression|0|||
129191261|NCT01843062|464994877|FG000|Overall Study|Pregnancy|1|||
129191262|NCT01843062|464994878|FG001|Overall Study|Pregnancy|0|||
129191263|NCT01843062|464994877|FG000|Overall Study|Adverse Event|2|||
129191264|NCT01843062|464994878|FG001|Overall Study|Adverse Event|0|||
129191265|NCT01843062|464994877|FG000|Overall Study|Incorrect randomisation|1|||
129191266|NCT01843062|464994878|FG001|Overall Study|Incorrect randomisation|0|||
129191267|NCT01843062|464994877|FG000|Overall Study|Withdrawal by Subject|12|||
129191268|NCT01843062|464994878|FG001|Overall Study|Withdrawal by Subject|3|||
129191269|NCT01843062|464994877|FG000|Overall Study|Death|1|||
129191270|NCT01843062|464994878|FG001|Overall Study|Death|2|||
129191271|NCT01843062|464994877|FG000|Overall Study|Lost to Follow-up|2|||
129191272|NCT01843062|464994878|FG001|Overall Study|Lost to Follow-up|4|||
129191273|NCT01677858|464994879|FG000|Overall Study|Adverse Event|0|||
129191274|NCT01677858|464994880|FG001|Overall Study|Adverse Event|0|||
129191275|NCT01677858|464994881|FG002|Overall Study|Adverse Event|2|||
129191276|NCT01677858|464994882|FG003|Overall Study|Adverse Event|3|||
129191277|NCT01677858|464994883|FG004|Overall Study|Adverse Event|13|||
129191278|NCT01677858|464994879|FG000|Overall Study|Death|0|||
129191279|NCT01677858|464994880|FG001|Overall Study|Death|0|||
129191280|NCT01677858|464994881|FG002|Overall Study|Death|0|||
129191281|NCT01677858|464994882|FG003|Overall Study|Death|0|||
129191282|NCT01677858|464994883|FG004|Overall Study|Death|1|||
129191283|NCT01677858|464994879|FG000|Overall Study|Physician Decision|1|||
129191284|NCT01677858|464994880|FG001|Overall Study|Physician Decision|0|||
129191285|NCT01677858|464994881|FG002|Overall Study|Physician Decision|2|||
129191286|NCT01677858|464994882|FG003|Overall Study|Physician Decision|0|||
129191287|NCT01677858|464994883|FG004|Overall Study|Physician Decision|12|||
129191288|NCT01677858|464994879|FG000|Overall Study|Progressive Disease|2|||
129191289|NCT01677858|464994880|FG001|Overall Study|Progressive Disease|1|||
129191290|NCT01677858|464994881|FG002|Overall Study|Progressive Disease|9|||
129191291|NCT01677858|464994882|FG003|Overall Study|Progressive Disease|3|||
129191292|NCT01677858|464994883|FG004|Overall Study|Progressive Disease|43|||
129191293|NCT01677858|464994879|FG000|Overall Study|Withdrawal by Subject|0|||
129191294|NCT01677858|464994880|FG001|Overall Study|Withdrawal by Subject|1|||
129191295|NCT01677858|464994881|FG002|Overall Study|Withdrawal by Subject|1|||
129191296|NCT01677858|464994882|FG003|Overall Study|Withdrawal by Subject|0|||
129191297|NCT01677858|464994883|FG004|Overall Study|Withdrawal by Subject|15|||
129191298|NCT01677858|464994879|FG000|Overall Study|Lost to Follow-up|0|||
129191299|NCT01677858|464994880|FG001|Overall Study|Lost to Follow-up|0|||
129191300|NCT01677858|464994881|FG002|Overall Study|Lost to Follow-up|0|||
129191301|NCT01677858|464994882|FG003|Overall Study|Lost to Follow-up|0|||
129191302|NCT01677858|464994883|FG004|Overall Study|Lost to Follow-up|1|||
129191303|NCT02669212|464994886|FG000|Overall Study|Lost to Follow-up|1|||
129191304|NCT02669212|464994887|FG001|Overall Study|Lost to Follow-up|0|||
129191305|NCT02669212|464994886|FG000|Overall Study|Medical Condition|3|||
129191306|NCT02669212|464994887|FG001|Overall Study|Medical Condition|4|||
129191307|NCT02669212|464994886|FG000|Overall Study|Withdrawal by Subject|0|||
129191308|NCT02669212|464994887|FG001|Overall Study|Withdrawal by Subject|2|||
129191309|NCT02669212|464994886|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
129191310|NCT02669212|464994887|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
129191311|NCT03549104|464994888|FG000|Overall Study|Withdrawal by Subject|5|||
129191312|NCT03549104|464994889|FG001|Overall Study|Withdrawal by Subject|2|||
129191313|NCT03549104|464994888|FG000|Overall Study|Covid shelter in place|1|||
129191314|NCT03549104|464994889|FG001|Overall Study|Covid shelter in place|2|||
129191315|NCT00391027|464994890|FG000|Overall Study|Adverse Event|8|||
129191316|NCT00391027|464994891|FG001|Overall Study|Adverse Event|8|||
129191317|NCT00391027|464994890|FG000|Overall Study|Lack of Efficacy|3|||
129191318|NCT00391027|464994891|FG001|Overall Study|Lack of Efficacy|0|||
129191319|NCT00391027|464994890|FG000|Overall Study|Withdrawal by Subject|10|||
129191320|NCT00391027|464994891|FG001|Overall Study|Withdrawal by Subject|1|||
129191321|NCT00391027|464994890|FG000|Overall Study|Other|4|||
129191322|NCT00391027|464994891|FG001|Overall Study|Other|3|||
129191323|NCT01628965|464994899|FG000|Overall Study|Adverse Event|30|||
129191324|NCT01628965|464994899|FG000|Overall Study|Lack of Efficacy|7|||
129191325|NCT01628965|464994899|FG000|Overall Study|Withdrawal by Subject|3|||
129191326|NCT01628965|464994899|FG000|Overall Study|Lost to Follow-up|1|||
129191327|NCT01628965|464994899|FG000|Overall Study|Discontinuation criteria|8|||
129191328|NCT03170193|464994901|FG000|Overall Study|Withdrawal by Subject|0|||
129191329|NCT03170193|464994902|FG001|Overall Study|Withdrawal by Subject|0|||
129191330|NCT03170193|464994903|FG002|Overall Study|Withdrawal by Subject|0|||
129191331|NCT03170193|464994904|FG003|Overall Study|Withdrawal by Subject|1|||
129191332|NCT03170193|464994905|FG004|Overall Study|Withdrawal by Subject|0|||
129191333|NCT03170193|464994906|FG005|Overall Study|Withdrawal by Subject|0|||
129191334|NCT03170193|464994907|FG006|Overall Study|Withdrawal by Subject|0|||
129191335|NCT03170193|464994901|FG000|Overall Study|Lost to Follow-up|1|||
129191336|NCT03170193|464994902|FG001|Overall Study|Lost to Follow-up|1|||
129191337|NCT03170193|464994903|FG002|Overall Study|Lost to Follow-up|0|||
129191338|NCT03170193|464994904|FG003|Overall Study|Lost to Follow-up|0|||
129191339|NCT03170193|464994905|FG004|Overall Study|Lost to Follow-up|0|||
129191340|NCT03170193|464994906|FG005|Overall Study|Lost to Follow-up|0|||
129191341|NCT03170193|464994907|FG006|Overall Study|Lost to Follow-up|0|||
129191342|NCT01368081|464994908|FG000|Overall Study|Adverse Event|4|||
129191343|NCT01368081|464994909|FG001|Overall Study|Adverse Event|4|||
129191344|NCT01368081|464994910|FG002|Overall Study|Adverse Event|3|||
129191345|NCT01368081|464994911|FG003|Overall Study|Adverse Event|2|||
129191346|NCT01368081|464994912|FG004|Overall Study|Adverse Event|2|||
129191347|NCT01368081|464994913|FG005|Overall Study|Adverse Event|5|||
129191348|NCT01368081|464994914|FG006|Overall Study|Adverse Event|6|||
129191349|NCT01368081|464994915|FG007|Overall Study|Adverse Event|2|||
129191350|NCT01368081|464994916|FG008|Overall Study|Adverse Event|3|||
129191351|NCT01368081|464994917|FG009|Overall Study|Adverse Event|5|||
129191352|NCT01368081|464994918|FG010|Overall Study|Adverse Event|6|||
129191353|NCT01368081|464994919|FG011|Overall Study|Adverse Event|1|||
129191354|NCT01368081|464994920|FG012|Overall Study|Adverse Event|3|||
129191355|NCT01368081|464994908|FG000|Overall Study|Lack of Efficacy|0|||
129191356|NCT01368081|464994909|FG001|Overall Study|Lack of Efficacy|1|||
129191357|NCT01368081|464994910|FG002|Overall Study|Lack of Efficacy|0|||
129191358|NCT01368081|464994911|FG003|Overall Study|Lack of Efficacy|1|||
129191359|NCT01368081|464994912|FG004|Overall Study|Lack of Efficacy|0|||
129191360|NCT01368081|464994913|FG005|Overall Study|Lack of Efficacy|0|||
129191361|NCT01368081|464994914|FG006|Overall Study|Lack of Efficacy|0|||
129191362|NCT01368081|464994915|FG007|Overall Study|Lack of Efficacy|2|||
129191363|NCT01368081|464994916|FG008|Overall Study|Lack of Efficacy|0|||
129191364|NCT01368081|464994917|FG009|Overall Study|Lack of Efficacy|0|||
129191365|NCT01368081|464994918|FG010|Overall Study|Lack of Efficacy|0|||
129191366|NCT01368081|464994919|FG011|Overall Study|Lack of Efficacy|0|||
129191367|NCT01368081|464994920|FG012|Overall Study|Lack of Efficacy|0|||
129191368|NCT01368081|464994908|FG000|Overall Study|Protocol Violation|0|||
129191369|NCT01368081|464994909|FG001|Overall Study|Protocol Violation|0|||
129191370|NCT01368081|464994910|FG002|Overall Study|Protocol Violation|0|||
129191371|NCT01368081|464994911|FG003|Overall Study|Protocol Violation|0|||
129191372|NCT01368081|464994912|FG004|Overall Study|Protocol Violation|0|||
129191373|NCT01368081|464994913|FG005|Overall Study|Protocol Violation|1|||
129191374|NCT01368081|464994914|FG006|Overall Study|Protocol Violation|0|||
129191375|NCT01368081|464994915|FG007|Overall Study|Protocol Violation|1|||
129191376|NCT01368081|464994916|FG008|Overall Study|Protocol Violation|0|||
129191377|NCT01368081|464994917|FG009|Overall Study|Protocol Violation|0|||
129191378|NCT01368081|464994918|FG010|Overall Study|Protocol Violation|0|||
129191379|NCT01368081|464994919|FG011|Overall Study|Protocol Violation|0|||
129191380|NCT01368081|464994920|FG012|Overall Study|Protocol Violation|0|||
129191381|NCT01368081|464994908|FG000|Overall Study|Lost to Follow-up|0|||
129191382|NCT01368081|464994909|FG001|Overall Study|Lost to Follow-up|0|||
129191383|NCT01368081|464994910|FG002|Overall Study|Lost to Follow-up|0|||
129191384|NCT01368081|464994911|FG003|Overall Study|Lost to Follow-up|0|||
129191385|NCT01368081|464994912|FG004|Overall Study|Lost to Follow-up|0|||
129191386|NCT01368081|464994913|FG005|Overall Study|Lost to Follow-up|0|||
129191387|NCT01368081|464994914|FG006|Overall Study|Lost to Follow-up|0|||
129191388|NCT01368081|464994915|FG007|Overall Study|Lost to Follow-up|0|||
129191389|NCT01368081|464994916|FG008|Overall Study|Lost to Follow-up|0|||
129191390|NCT01368081|464994917|FG009|Overall Study|Lost to Follow-up|0|||
129191391|NCT01368081|464994918|FG010|Overall Study|Lost to Follow-up|0|||
129191392|NCT01368081|464994919|FG011|Overall Study|Lost to Follow-up|0|||
129191393|NCT01368081|464994920|FG012|Overall Study|Lost to Follow-up|1|||
129191394|NCT01368081|464994908|FG000|Overall Study|Withdrawal by Subject|4|||
129191395|NCT01368081|464994909|FG001|Overall Study|Withdrawal by Subject|4|||
129191396|NCT01368081|464994910|FG002|Overall Study|Withdrawal by Subject|1|||
129191397|NCT01368081|464994911|FG003|Overall Study|Withdrawal by Subject|1|||
129191398|NCT01368081|464994912|FG004|Overall Study|Withdrawal by Subject|0|||
129191399|NCT01368081|464994913|FG005|Overall Study|Withdrawal by Subject|3|||
129191400|NCT01368081|464994914|FG006|Overall Study|Withdrawal by Subject|4|||
129191401|NCT01368081|464994915|FG007|Overall Study|Withdrawal by Subject|2|||
129191402|NCT01368081|464994916|FG008|Overall Study|Withdrawal by Subject|5|||
129191403|NCT01368081|464994917|FG009|Overall Study|Withdrawal by Subject|4|||
129191404|NCT01368081|464994918|FG010|Overall Study|Withdrawal by Subject|3|||
129191405|NCT01368081|464994919|FG011|Overall Study|Withdrawal by Subject|2|||
129191406|NCT01368081|464994920|FG012|Overall Study|Withdrawal by Subject|0|||
129191407|NCT01368081|464994908|FG000|Overall Study|Other reason not defined above|2|||
129191408|NCT01368081|464994909|FG001|Overall Study|Other reason not defined above|0|||
129191409|NCT01368081|464994910|FG002|Overall Study|Other reason not defined above|0|||
129191410|NCT01368081|464994911|FG003|Overall Study|Other reason not defined above|1|||
129191411|NCT01368081|464994912|FG004|Overall Study|Other reason not defined above|0|||
129191412|NCT01368081|464994913|FG005|Overall Study|Other reason not defined above|1|||
129191413|NCT01368081|464994914|FG006|Overall Study|Other reason not defined above|2|||
129191414|NCT01368081|464994915|FG007|Overall Study|Other reason not defined above|0|||
129191415|NCT01368081|464994916|FG008|Overall Study|Other reason not defined above|0|||
129191416|NCT01368081|464994917|FG009|Overall Study|Other reason not defined above|1|||
129191417|NCT01368081|464994918|FG010|Overall Study|Other reason not defined above|0|||
129191418|NCT01368081|464994919|FG011|Overall Study|Other reason not defined above|0|||
129191419|NCT01368081|464994920|FG012|Overall Study|Other reason not defined above|3|||
129191420|NCT03755661|464994923|FG000|Overall Study|Lost to Follow-up|1|||
129191421|NCT03755661|464994924|FG001|Overall Study|Lost to Follow-up|0|||
129191422|NCT02277119|464994925|FG000|Overall Study|Lack of Efficacy|1|||
129191423|NCT02277119|464994926|FG001|Overall Study|Lack of Efficacy|1|||
129191424|NCT02277119|464994927|FG002|Overall Study|Lack of Efficacy|1|||
129191425|NCT02277119|464994925|FG000|Overall Study|Protocol Violation|2|||
129191426|NCT02277119|464994926|FG001|Overall Study|Protocol Violation|3|||
129191427|NCT02277119|464994927|FG002|Overall Study|Protocol Violation|7|||
129191428|NCT04699461|464994928|FG000|Overall Study|Withdrawal by Subject|1|||
129191429|NCT04699461|464994929|FG001|Overall Study|Withdrawal by Subject|0|||
129191430|NCT04699461|464994928|FG000|Overall Study|Study termination by sponsor|2|||
129191431|NCT04699461|464994929|FG001|Overall Study|Study termination by sponsor|1|||
129191432|NCT04699461|464994928|FG000|Overall Study|Death|1|||
129191433|NCT04699461|464994929|FG001|Overall Study|Death|0|||
129191434|NCT04699461|464994928|FG000|Overall Study|Radiographic progression|0|||
129191435|NCT04699461|464994929|FG001|Overall Study|Radiographic progression|1|||
129191436|NCT03068767|464994930|FG000|Overall Study|Lost to Follow-up|7|||
129191437|NCT03068767|464994931|FG001|Overall Study|Lost to Follow-up|3|||
129191438|NCT03068767|464994930|FG000|Overall Study|Protocol Violation|3|||
129191439|NCT03068767|464994931|FG001|Overall Study|Protocol Violation|0|||
129191440|NCT04167137|464994934|FG000|Overall Study|Disease progression|1|||
129191441|NCT04167137|464994935|FG001|Overall Study|Disease progression|1|||
129191442|NCT04167137|464994936|FG002|Overall Study|Disease progression|3|||
129191443|NCT04167137|464994937|FG003|Overall Study|Disease progression|3|||
129191444|NCT04167137|464994938|FG004|Overall Study|Disease progression|2|||
129191445|NCT04167137|464994939|FG005|Overall Study|Disease progression|3|||
129191446|NCT04167137|464994940|FG006|Overall Study|Disease progression|2|||
129191447|NCT04167137|464994941|FG007|Overall Study|Disease progression|2|||
129191448|NCT04167137|464994934|FG000|Overall Study|Withdrawal by Subject|1|||
129191449|NCT04167137|464994935|FG001|Overall Study|Withdrawal by Subject|0|||
129191450|NCT04167137|464994936|FG002|Overall Study|Withdrawal by Subject|0|||
129191451|NCT04167137|464994937|FG003|Overall Study|Withdrawal by Subject|1|||
129191452|NCT04167137|464994938|FG004|Overall Study|Withdrawal by Subject|0|||
129191453|NCT04167137|464994939|FG005|Overall Study|Withdrawal by Subject|2|||
129191454|NCT04167137|464994940|FG006|Overall Study|Withdrawal by Subject|1|||
129191455|NCT04167137|464994941|FG007|Overall Study|Withdrawal by Subject|0|||
129191456|NCT04167137|464994934|FG000|Overall Study|Adverse Event|0|||
129191457|NCT04167137|464994935|FG001|Overall Study|Adverse Event|0|||
129191458|NCT04167137|464994936|FG002|Overall Study|Adverse Event|0|||
129191459|NCT04167137|464994937|FG003|Overall Study|Adverse Event|0|||
129191460|NCT04167137|464994938|FG004|Overall Study|Adverse Event|0|||
129191461|NCT04167137|464994939|FG005|Overall Study|Adverse Event|1|||
129191462|NCT04167137|464994940|FG006|Overall Study|Adverse Event|0|||
129191463|NCT04167137|464994941|FG007|Overall Study|Adverse Event|1|||
129191464|NCT04167137|464994934|FG000|Overall Study|Physician Decision|0|||
129191465|NCT04167137|464994935|FG001|Overall Study|Physician Decision|0|||
129191466|NCT04167137|464994936|FG002|Overall Study|Physician Decision|0|||
129191467|NCT04167137|464994937|FG003|Overall Study|Physician Decision|1|||
129191468|NCT04167137|464994938|FG004|Overall Study|Physician Decision|0|||
129191469|NCT04167137|464994939|FG005|Overall Study|Physician Decision|0|||
129191470|NCT04167137|464994940|FG006|Overall Study|Physician Decision|1|||
129191471|NCT04167137|464994941|FG007|Overall Study|Physician Decision|0|||
129191472|NCT04167137|464994934|FG000|Overall Study|Death|0|||
129191473|NCT04167137|464994935|FG001|Overall Study|Death|1|||
129191474|NCT04167137|464994936|FG002|Overall Study|Death|0|||
129191475|NCT04167137|464994937|FG003|Overall Study|Death|0|||
129191476|NCT04167137|464994938|FG004|Overall Study|Death|0|||
129191477|NCT04167137|464994939|FG005|Overall Study|Death|0|||
129191478|NCT04167137|464994940|FG006|Overall Study|Death|0|||
129191479|NCT04167137|464994941|FG007|Overall Study|Death|0|||
129191480|NCT04167137|464994934|FG000|Overall Study|Study terminated by Sponsor|0|||
129191481|NCT04167137|464994935|FG001|Overall Study|Study terminated by Sponsor|0|||
129191482|NCT04167137|464994936|FG002|Overall Study|Study terminated by Sponsor|0|||
129191483|NCT04167137|464994937|FG003|Overall Study|Study terminated by Sponsor|0|||
129191484|NCT04167137|464994938|FG004|Overall Study|Study terminated by Sponsor|0|||
129191485|NCT04167137|464994939|FG005|Overall Study|Study terminated by Sponsor|0|||
129191486|NCT04167137|464994940|FG006|Overall Study|Study terminated by Sponsor|0|||
129191487|NCT04167137|464994941|FG007|Overall Study|Study terminated by Sponsor|1|||
129191488|NCT01748825|464994944|FG000|Dose Escalation|Refused further treatment|2|||
129191489|NCT01748825|464994945|FG001|Dose Escalation|Refused further treatment|2|||
129191490|NCT01748825|464994946|FG002|Dose Escalation|Refused further treatment|0|||
129191491|NCT01748825|464994947|FG003|Dose Escalation|Refused further treatment|0|||
129191492|NCT01748825|464994948|FG004|Dose Escalation|Refused further treatment|1|||
129191493|NCT01748825|464994949|FG005|Dose Escalation|Refused further treatment|2|||
129191494|NCT01748825|464994950|FG006|Dose Escalation|Refused further treatment|0|||
129191495|NCT01748825|464994951|FG007|Dose Escalation|Refused further treatment|0|||
129191496|NCT01748825|464994952|FG008|Dose Escalation|Refused further treatment|0|||
129191497|NCT01748825|464994953|FG009|Dose Escalation|Refused further treatment|0|||
129191498|NCT01748825|464994944|FG000|Dose Escalation|Switched to alternative treatment|0|||
129191499|NCT01748825|464994945|FG001|Dose Escalation|Switched to alternative treatment|0|||
129191500|NCT01748825|464994946|FG002|Dose Escalation|Switched to alternative treatment|0|||
129191501|NCT01748825|464994947|FG003|Dose Escalation|Switched to alternative treatment|1|||
129191502|NCT01748825|464994948|FG004|Dose Escalation|Switched to alternative treatment|0|||
129191503|NCT01748825|464994949|FG005|Dose Escalation|Switched to alternative treatment|0|||
129191504|NCT01748825|464994950|FG006|Dose Escalation|Switched to alternative treatment|0|||
129191505|NCT01748825|464994951|FG007|Dose Escalation|Switched to alternative treatment|0|||
129191506|NCT01748825|464994952|FG008|Dose Escalation|Switched to alternative treatment|0|||
129191507|NCT01748825|464994953|FG009|Dose Escalation|Switched to alternative treatment|0|||
129191508|NCT01748825|464994944|FG000|Dose Escalation|Adverse Event|0|||
129191509|NCT01748825|464994945|FG001|Dose Escalation|Adverse Event|0|||
129191510|NCT01748825|464994946|FG002|Dose Escalation|Adverse Event|0|||
129191511|NCT01748825|464994947|FG003|Dose Escalation|Adverse Event|0|||
129191512|NCT01748825|464994948|FG004|Dose Escalation|Adverse Event|0|||
129191513|NCT01748825|464994949|FG005|Dose Escalation|Adverse Event|0|||
129191514|NCT01748825|464994950|FG006|Dose Escalation|Adverse Event|1|||
129191515|NCT01748825|464994951|FG007|Dose Escalation|Adverse Event|0|||
129191516|NCT01748825|464994952|FG008|Dose Escalation|Adverse Event|0|||
129191517|NCT01748825|464994953|FG009|Dose Escalation|Adverse Event|0|||
129191518|NCT01748825|464994944|FG000|Dose Expansion|Refused further treatment|0|||
129191519|NCT01748825|464994945|FG001|Dose Expansion|Refused further treatment|0|||
129191520|NCT01748825|464994946|FG002|Dose Expansion|Refused further treatment|0|||
129191521|NCT01748825|464994947|FG003|Dose Expansion|Refused further treatment|0|||
129191522|NCT01748825|464994948|FG004|Dose Expansion|Refused further treatment|0|||
129191523|NCT01748825|464994949|FG005|Dose Expansion|Refused further treatment|0|||
129191524|NCT01748825|464994950|FG006|Dose Expansion|Refused further treatment|0|||
129191525|NCT01748825|464994951|FG007|Dose Expansion|Refused further treatment|0|||
129191526|NCT01748825|464994952|FG008|Dose Expansion|Refused further treatment|1|||
129191527|NCT01748825|464994953|FG009|Dose Expansion|Refused further treatment|1|||
129191528|NCT01748825|464994944|FG000|Dose Expansion|Switched to alternative treatment|0|||
129191529|NCT01748825|464994945|FG001|Dose Expansion|Switched to alternative treatment|0|||
129191530|NCT01748825|464994946|FG002|Dose Expansion|Switched to alternative treatment|0|||
129191531|NCT01748825|464994947|FG003|Dose Expansion|Switched to alternative treatment|0|||
129191532|NCT01748825|464994948|FG004|Dose Expansion|Switched to alternative treatment|0|||
129191533|NCT01748825|464994949|FG005|Dose Expansion|Switched to alternative treatment|0|||
129191534|NCT01748825|464994950|FG006|Dose Expansion|Switched to alternative treatment|0|||
129191535|NCT01748825|464994951|FG007|Dose Expansion|Switched to alternative treatment|0|||
129191536|NCT01748825|464994952|FG008|Dose Expansion|Switched to alternative treatment|0|||
129191537|NCT01748825|464994953|FG009|Dose Expansion|Switched to alternative treatment|1|||
129191538|NCT01748825|464994944|FG000|Dose Expansion|Adverse Event|0|||
129191539|NCT01748825|464994945|FG001|Dose Expansion|Adverse Event|0|||
129191540|NCT01748825|464994946|FG002|Dose Expansion|Adverse Event|0|||
129191541|NCT01748825|464994947|FG003|Dose Expansion|Adverse Event|0|||
129191542|NCT01748825|464994948|FG004|Dose Expansion|Adverse Event|0|||
129191543|NCT01748825|464994949|FG005|Dose Expansion|Adverse Event|0|||
129191544|NCT01748825|464994950|FG006|Dose Expansion|Adverse Event|0|||
129191545|NCT01748825|464994951|FG007|Dose Expansion|Adverse Event|0|||
129191546|NCT01748825|464994952|FG008|Dose Expansion|Adverse Event|0|||
129191547|NCT01748825|464994953|FG009|Dose Expansion|Adverse Event|3|||
129191548|NCT01748825|464994944|FG000|Dose Expansion|Physician Decision|0|||
129191549|NCT01748825|464994945|FG001|Dose Expansion|Physician Decision|0|||
129191550|NCT01748825|464994946|FG002|Dose Expansion|Physician Decision|0|||
129191551|NCT01748825|464994947|FG003|Dose Expansion|Physician Decision|0|||
129191552|NCT01748825|464994948|FG004|Dose Expansion|Physician Decision|0|||
129191553|NCT01748825|464994949|FG005|Dose Expansion|Physician Decision|0|||
129191554|NCT01748825|464994950|FG006|Dose Expansion|Physician Decision|0|||
129191555|NCT01748825|464994951|FG007|Dose Expansion|Physician Decision|0|||
129191556|NCT01748825|464994952|FG008|Dose Expansion|Physician Decision|1|||
129191557|NCT01748825|464994953|FG009|Dose Expansion|Physician Decision|0|||
129191558|NCT04412707|464994957|FG000|Cycle 1|Death|0|||
129191559|NCT04412707|464994958|FG001|Cycle 1|Death|3|||
129191560|NCT04412707|464994957|FG000|Cycle 1|Disease progression|1|||
129191561|NCT04412707|464994958|FG001|Cycle 1|Disease progression|2|||
129191562|NCT04412707|464994957|FG000|Cycle 2|Death|0|||
129191563|NCT04412707|464994958|FG001|Cycle 2|Death|1|||
129191564|NCT04412707|464994957|FG000|Cycle 2|Disease progression|3|||
129191565|NCT04412707|464994958|FG001|Cycle 2|Disease progression|0|||
129191566|NCT04412707|464994957|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
129191567|NCT04412707|464994958|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
129191568|NCT04412707|464994957|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
129191569|NCT04412707|464994958|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
129191570|NCT04412707|464994957|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
129191571|NCT04412707|464994958|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
129191572|NCT04412707|464994957|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
129191573|NCT04412707|464994958|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
129191574|NCT01370265|464996444|FG000|First Intervention|Adverse Event|1|||
129191575|NCT01370265|464996445|FG001|First Intervention|Adverse Event|1|||
129191576|NCT01732770|464996447|FG000|Overall Study|Lost to Follow-up|2|||
129191577|NCT01732770|464996448|FG001|Overall Study|Lost to Follow-up|3|||
129191578|NCT01732770|464996447|FG000|Overall Study|Withdrawal by Subject|5|||
129191579|NCT01732770|464996448|FG001|Overall Study|Withdrawal by Subject|3|||
129191580|NCT01732770|464996447|FG000|Overall Study|Decision by Sponsor|2|||
129191581|NCT01732770|464996448|FG001|Overall Study|Decision by Sponsor|2|||
129191582|NCT01732770|464996447|FG000|Overall Study|Death|1|||
129191583|NCT01732770|464996448|FG001|Overall Study|Death|0|||
129191584|NCT00871338|464996452|FG000|Prior to Booster|Withdrawal by Subject|1|||
129191585|NCT00871338|464996453|FG001|Prior to Booster|Withdrawal by Subject|3|||
129191586|NCT00871338|464996452|FG000|Prior to Booster|Lost to Follow-up|1|||
129191587|NCT00871338|464996453|FG001|Prior to Booster|Lost to Follow-up|0|||
129191588|NCT02391363|464996454|FG000|Overall Study|Lost to Follow-up|5|||
129191589|NCT02391363|464996455|FG001|Overall Study|Lost to Follow-up|5|||
129191590|NCT02391363|464996454|FG000|Overall Study|Withdrawal by Subject|6|||
129191591|NCT02391363|464996455|FG001|Overall Study|Withdrawal by Subject|3|||
129191592|NCT04794270|464996456|FG000|Period 1|Non Compliance|1|||
129191593|NCT04794270|464996457|FG001|Period 1|Non Compliance|0|||
129191594|NCT04794270|464996456|FG000|Period 1|Adverse Event|1|||
129191595|NCT04794270|464996457|FG001|Period 1|Adverse Event|0|||
129191596|NCT04794270|464996456|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
129191597|NCT04794270|464996457|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
129191598|NCT00265317|464996460|FG000|Lead-In|Objective progression or relapse|6|||
129191599|NCT00265317|464996461|FG001|Lead-In|Objective progression or relapse|11|||
129191600|NCT00265317|464996462|FG002|Lead-In|Objective progression or relapse|0|||
129191601|NCT00265317|464996463|FG003|Lead-In|Objective progression or relapse|0|||
129191602|NCT00265317|464996460|FG000|Lead-In|Adverse Event|2|||
129191603|NCT00265317|464996461|FG001|Lead-In|Adverse Event|1|||
129191604|NCT00265317|464996462|FG002|Lead-In|Adverse Event|0|||
129191605|NCT00265317|464996463|FG003|Lead-In|Adverse Event|0|||
129191606|NCT00265317|464996460|FG000|Lead-In|Death|3|||
129191607|NCT00265317|464996461|FG001|Lead-In|Death|5|||
129191608|NCT00265317|464996462|FG002|Lead-In|Death|0|||
129191609|NCT00265317|464996463|FG003|Lead-In|Death|0|||
129191610|NCT00265317|464996460|FG000|Lead-In|Withdrawal/other than adverse event|1|||
129191611|NCT00265317|464996461|FG001|Lead-In|Withdrawal/other than adverse event|0|||
129191612|NCT00265317|464996462|FG002|Lead-In|Withdrawal/other than adverse event|0|||
129191613|NCT00265317|464996463|FG003|Lead-In|Withdrawal/other than adverse event|0|||
129191614|NCT00265317|464996460|FG000|Phase 2|Objective progression or relapse|0|||
129191615|NCT00265317|464996461|FG001|Phase 2|Objective progression or relapse|0|||
129191616|NCT00265317|464996462|FG002|Phase 2|Objective progression or relapse|37|||
129191617|NCT00265317|464996463|FG003|Phase 2|Objective progression or relapse|38|||
129191618|NCT00265317|464996460|FG000|Phase 2|Global deterioration of health status|0|||
129191619|NCT00265317|464996461|FG001|Phase 2|Global deterioration of health status|0|||
129191620|NCT00265317|464996462|FG002|Phase 2|Global deterioration of health status|3|||
129191621|NCT00265317|464996463|FG003|Phase 2|Global deterioration of health status|0|||
129191622|NCT00265317|464996460|FG000|Phase 2|Adverse Event|0|||
129191623|NCT00265317|464996461|FG001|Phase 2|Adverse Event|0|||
129191624|NCT00265317|464996462|FG002|Phase 2|Adverse Event|7|||
129191625|NCT00265317|464996463|FG003|Phase 2|Adverse Event|5|||
129191626|NCT00265317|464996460|FG000|Phase 2|Death|0|||
129191627|NCT00265317|464996461|FG001|Phase 2|Death|0|||
129191628|NCT00265317|464996462|FG002|Phase 2|Death|12|||
129191629|NCT00265317|464996463|FG003|Phase 2|Death|15|||
129191630|NCT00265317|464996460|FG000|Phase 2|Protocol Violation|0|||
129191631|NCT00265317|464996461|FG001|Phase 2|Protocol Violation|0|||
129191632|NCT00265317|464996462|FG002|Phase 2|Protocol Violation|1|||
129191633|NCT00265317|464996463|FG003|Phase 2|Protocol Violation|4|||
129191634|NCT00265317|464996460|FG000|Phase 2|Lost to Follow-up|0|||
129191635|NCT00265317|464996461|FG001|Phase 2|Lost to Follow-up|0|||
129191636|NCT00265317|464996462|FG002|Phase 2|Lost to Follow-up|0|||
129191637|NCT00265317|464996463|FG003|Phase 2|Lost to Follow-up|1|||
129191638|NCT00265317|464996460|FG000|Phase 2|Withdrawal/other than adverse event|0|||
129191639|NCT00265317|464996461|FG001|Phase 2|Withdrawal/other than adverse event|0|||
129191640|NCT00265317|464996462|FG002|Phase 2|Withdrawal/other than adverse event|2|||
129191641|NCT00265317|464996463|FG003|Phase 2|Withdrawal/other than adverse event|1|||
129191642|NCT00265317|464996460|FG000|Phase 2|Study terminated by sponsor|0|||
129191643|NCT00265317|464996461|FG001|Phase 2|Study terminated by sponsor|0|||
129191644|NCT00265317|464996462|FG002|Phase 2|Study terminated by sponsor|1|||
129191645|NCT00265317|464996463|FG003|Phase 2|Study terminated by sponsor|0|||
129191646|NCT00265317|464996460|FG000|Phase 2|Other|0|||
128730374|NCT04300296|463309959|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
128730375|NCT04300296|463309954|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
128730376|NCT04300296|463309955|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
128730377|NCT04300296|463309956|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
129191647|NCT00265317|464996461|FG001|Phase 2|Other|0|||
129191648|NCT00265317|464996462|FG002|Phase 2|Other|1|||
128730378|NCT04300296|463309957|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
128730379|NCT04300296|463309958|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
129191649|NCT00265317|464996463|FG003|Phase 2|Other|1|||
129191650|NCT02510001|464996464|FG000|Overall Study|Early disease progression|0|||
129191651|NCT02510001|464996465|FG001|Overall Study|Early disease progression|0|||
129191652|NCT02510001|464996466|FG002|Overall Study|Early disease progression|0|||
129191653|NCT02510001|464996467|FG003|Overall Study|Early disease progression|1|||
129191654|NCT02510001|464996468|FG004|Overall Study|Early disease progression|1|||
129191655|NCT02510001|464996469|FG005|Overall Study|Early disease progression|1|||
129191656|NCT02510001|464996470|FG006|Overall Study|Early disease progression|0|||
129191657|NCT02510001|464996471|FG007|Overall Study|Early disease progression|0|||
128730380|NCT04300296|463309959|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
129191658|NCT02510001|464996464|FG000|Overall Study|Adverse Event|0|||
129191659|NCT02510001|464996465|FG001|Overall Study|Adverse Event|0|||
129191660|NCT02510001|464996466|FG002|Overall Study|Adverse Event|0|||
129191661|NCT02510001|464996467|FG003|Overall Study|Adverse Event|1|||
129191662|NCT02510001|464996468|FG004|Overall Study|Adverse Event|2|||
128730381|NCT04300296|463309954|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
129191663|NCT02510001|464996469|FG005|Overall Study|Adverse Event|1|||
129191664|NCT02510001|464996470|FG006|Overall Study|Adverse Event|2|||
129191665|NCT02510001|464996471|FG007|Overall Study|Adverse Event|5|||
129191666|NCT02510001|464996464|FG000|Overall Study|Physician Decision|0|||
129191667|NCT02510001|464996465|FG001|Overall Study|Physician Decision|0|||
129191668|NCT02510001|464996466|FG002|Overall Study|Physician Decision|0|||
129191669|NCT02510001|464996467|FG003|Overall Study|Physician Decision|0|||
129191670|NCT02510001|464996468|FG004|Overall Study|Physician Decision|1|||
129191671|NCT02510001|464996469|FG005|Overall Study|Physician Decision|0|||
129191672|NCT02510001|464996470|FG006|Overall Study|Physician Decision|0|||
129191673|NCT02510001|464996471|FG007|Overall Study|Physician Decision|0|||
129191674|NCT02510001|464996464|FG000|Overall Study|Withdrawal by Subject|0|||
129191675|NCT02510001|464996465|FG001|Overall Study|Withdrawal by Subject|0|||
129191676|NCT02510001|464996466|FG002|Overall Study|Withdrawal by Subject|0|||
129191677|NCT02510001|464996467|FG003|Overall Study|Withdrawal by Subject|0|||
129191678|NCT02510001|464996468|FG004|Overall Study|Withdrawal by Subject|0|||
129191679|NCT02510001|464996469|FG005|Overall Study|Withdrawal by Subject|0|||
129191680|NCT02510001|464996470|FG006|Overall Study|Withdrawal by Subject|0|||
129191681|NCT02510001|464996471|FG007|Overall Study|Withdrawal by Subject|2|||
129191682|NCT02950480|464996476|FG000|Overall Study|Withdrawal by Subject|1|||
129191683|NCT02950480|464996477|FG001|Overall Study|Withdrawal by Subject|0|||
129191684|NCT01440816|464996485|FG000|Overall Study|Disease Progression|0|||
129191685|NCT01440816|464996486|FG001|Overall Study|Disease Progression|9|||
129191686|NCT01440816|464996485|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
129191687|NCT01440816|464996486|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
129191688|NCT01687101|464996487|FG000|Overall Study|Lost to Follow-up|7|||
129191689|NCT03920254|464996489|FG000|Overall Study|Adverse Event|1|||
129191690|NCT03920254|464996490|FG001|Overall Study|Adverse Event|0|||
129191691|NCT03920254|464996491|FG002|Overall Study|Adverse Event|0|||
129191692|NCT03920254|464996489|FG000|Overall Study|Physician Decision|0|||
129191693|NCT03920254|464996490|FG001|Overall Study|Physician Decision|1|||
129191694|NCT03920254|464996491|FG002|Overall Study|Physician Decision|2|||
129191695|NCT03920254|464996489|FG000|Overall Study|Study Terminated By Sponsor|12|||
129191696|NCT03920254|464996490|FG001|Overall Study|Study Terminated By Sponsor|17|||
129191697|NCT03920254|464996491|FG002|Overall Study|Study Terminated By Sponsor|12|||
129191698|NCT03920254|464996489|FG000|Overall Study|Withdrawal by Subject|0|||
129191699|NCT03920254|464996490|FG001|Overall Study|Withdrawal by Subject|0|||
129191700|NCT03920254|464996491|FG002|Overall Study|Withdrawal by Subject|1|||
129191701|NCT03250182|464996492|FG000|Overall Study|Withdrawal by Subject|1|||
129191702|NCT05274269|464996493|FG000|Overall Study|Adverse Event|0|||
129191703|NCT05274269|464996494|FG001|Overall Study|Adverse Event|3|||
129191704|NCT05274269|464996493|FG000|Overall Study|Death|0|||
129191705|NCT05274269|464996494|FG001|Overall Study|Death|1|||
129191706|NCT05274269|464996493|FG000|Overall Study|Other|0|||
129191707|NCT05274269|464996494|FG001|Overall Study|Other|2|||
129191708|NCT05274269|464996493|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129191709|NCT05274269|464996494|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129191710|NCT01858740|464996498|FG000|Overall Study|Death|4|||
129191711|NCT01068769|464996499|FG000|Overall Study|Ineligible|1|||
129191712|NCT00709618|464996500|FG000|Overall Study|Withdrawal by Subject|4|||
129191713|NCT00709618|464996500|FG000|Overall Study|Lost to Follow-up|1|||
129191714|NCT00709618|464996500|FG000|Overall Study|Study Closed/Terminated|25|||
129191715|NCT04042909|464996501|FG000|Overall Study|Withdrawal by Subject|1|||
129191716|NCT04042909|464996502|FG001|Overall Study|Withdrawal by Subject|0|||
129191717|NCT04042909|464996503|FG002|Overall Study|Withdrawal by Subject|0|||
129191718|NCT04042909|464996501|FG000|Overall Study|duplicate cases|2|||
129191719|NCT04042909|464996502|FG001|Overall Study|duplicate cases|0|||
129191720|NCT04042909|464996503|FG002|Overall Study|duplicate cases|0|||
129191721|NCT04042909|464996501|FG000|Overall Study|technical problem|0|||
129191722|NCT04042909|464996502|FG001|Overall Study|technical problem|1|||
129191723|NCT04042909|464996503|FG002|Overall Study|technical problem|0|||
129191724|NCT00894361|464996506|FG000|Overall Study|deaths and less than 2 years followup|24|||
129191725|NCT00894361|464996507|FG001|Overall Study|deaths and less than 2 years followup|64|||
129191726|NCT00887926|464996516|FG000|Overall Study|Withdrawal by Subject|0|||
129191727|NCT00887926|464996517|FG001|Overall Study|Withdrawal by Subject|1|||
129191728|NCT00887926|464996518|FG002|Overall Study|Withdrawal by Subject|0|||
129191729|NCT00887926|464996519|FG003|Overall Study|Withdrawal by Subject|0|||
129191730|NCT00880191|464996520|FG000|Overall Study|Refused further treatment|4|||
129191731|NCT00880191|464996521|FG001|Overall Study|Refused further treatment|1|||
129191732|NCT00880191|464996520|FG000|Overall Study|Adverse Event|8|||
128730382|NCT04300296|463309955|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
129191733|NCT00880191|464996521|FG001|Overall Study|Adverse Event|6|||
129191734|NCT00880191|464996520|FG000|Overall Study|Hospitalization/efficacy|1|||
129191735|NCT00880191|464996521|FG001|Overall Study|Hospitalization/efficacy|1|||
129191736|NCT00773747|464996522|FG000|Overall Study|Lack of Efficacy|112|||
129191737|NCT00773747|464996523|FG001|Overall Study|Lack of Efficacy|144|||
129191738|NCT00773747|464996522|FG000|Overall Study|Physician Decision|26|||
129191739|NCT00773747|464996523|FG001|Overall Study|Physician Decision|18|||
129191740|NCT00773747|464996522|FG000|Overall Study|Lost to Follow-up|0|||
129191741|NCT00773747|464996523|FG001|Overall Study|Lost to Follow-up|1|||
129191742|NCT00773747|464996522|FG000|Overall Study|Protocol Violation|2|||
129191743|NCT00773747|464996523|FG001|Overall Study|Protocol Violation|2|||
129191744|NCT00773747|464996522|FG000|Overall Study|Withdrawal by Subject|89|||
129191745|NCT00773747|464996523|FG001|Overall Study|Withdrawal by Subject|61|||
129191746|NCT00773747|464996522|FG000|Overall Study|Adverse Event|61|||
129191747|NCT00773747|464996523|FG001|Overall Study|Adverse Event|62|||
129191748|NCT00773747|464996522|FG000|Overall Study|Death|5|||
129191749|NCT00773747|464996523|FG001|Overall Study|Death|8|||
129191750|NCT00773747|464996522|FG000|Overall Study|Not Treated|2|||
129191751|NCT00773747|464996523|FG001|Overall Study|Not Treated|0|||
129191752|NCT03078855|464996524|FG000|Overall Study|Lack of Efficacy|62|||
129191753|NCT03078855|464996525|FG001|Overall Study|Lack of Efficacy|31|||
129191754|NCT03078855|464996524|FG000|Overall Study|Death|1|||
129191755|NCT03078855|464996525|FG001|Overall Study|Death|0|||
129191756|NCT03078855|464996524|FG000|Overall Study|Withdrawal by Subject|12|||
129191757|NCT03078855|464996525|FG001|Overall Study|Withdrawal by Subject|6|||
129191758|NCT03078855|464996524|FG000|Overall Study|Physician Decision|3|||
129191759|NCT03078855|464996525|FG001|Overall Study|Physician Decision|2|||
129191760|NCT03078855|464996524|FG000|Overall Study|Second Malignancy|4|||
129191761|NCT03078855|464996525|FG001|Overall Study|Second Malignancy|0|||
129191762|NCT03078855|464996524|FG000|Overall Study|Ineligible|2|||
129191763|NCT03078855|464996525|FG001|Overall Study|Ineligible|0|||
129191764|NCT03078855|464996524|FG000|Overall Study|Withdrew before day 1 treatment|2|||
129191765|NCT03078855|464996525|FG001|Overall Study|Withdrew before day 1 treatment|1|||
129191766|NCT04124705|464996526|FG000|Titration Period|Adverse Event|9|||
129191767|NCT04124705|464996527|FG001|Titration Period|Adverse Event|5|||
129191768|NCT04124705|464996526|FG000|Titration Period|Withdrawal by Subject|6|||
129191769|NCT04124705|464996527|FG001|Titration Period|Withdrawal by Subject|3|||
129191770|NCT04124705|464996526|FG000|Titration Period|Lost to Follow-up|0|||
129191771|NCT04124705|464996527|FG001|Titration Period|Lost to Follow-up|1|||
129191772|NCT04124705|464996526|FG000|Titration Period|Death|1|||
129191773|NCT04124705|464996527|FG001|Titration Period|Death|1|||
129191774|NCT04124705|464996526|FG000|Titration Period|Lack of Efficacy|2|||
129191775|NCT04124705|464996527|FG001|Titration Period|Lack of Efficacy|0|||
129191776|NCT04124705|464996526|FG000|Titration Period|Physician Decision|2|||
129191777|NCT04124705|464996527|FG001|Titration Period|Physician Decision|0|||
129191778|NCT04124705|464996526|FG000|Titration Period|Non-compliance with Study Drug|2|||
129191779|NCT04124705|464996527|FG001|Titration Period|Non-compliance with Study Drug|0|||
129191780|NCT04124705|464996526|FG000|Titration Period|Other|4|||
129191781|NCT04124705|464996527|FG001|Titration Period|Other|9|||
129191782|NCT04124705|464996526|FG000|Stabilization Period|Adverse Event|4|||
129191783|NCT04124705|464996527|FG001|Stabilization Period|Adverse Event|2|||
129191784|NCT04124705|464996526|FG000|Stabilization Period|Withdrawal by Subject|1|||
129191785|NCT04124705|464996527|FG001|Stabilization Period|Withdrawal by Subject|1|||
129191786|NCT04124705|464996526|FG000|Stabilization Period|Lost to Follow-up|0|||
129191787|NCT04124705|464996527|FG001|Stabilization Period|Lost to Follow-up|1|||
129191788|NCT04124705|464996526|FG000|Stabilization Period|Lack of Efficacy|4|||
129191789|NCT04124705|464996527|FG001|Stabilization Period|Lack of Efficacy|2|||
129191790|NCT04124705|464996526|FG000|Stabilization Period|Protocol Deviation|0|||
129191791|NCT04124705|464996527|FG001|Stabilization Period|Protocol Deviation|2|||
129191792|NCT04124705|464996526|FG000|Stabilization Period|Other|2|||
129191793|NCT04124705|464996527|FG001|Stabilization Period|Other|2|||
129191794|NCT01636986|464996528|FG000|Overall Study|Withdrawal by Subject|0|||
129191795|NCT01636986|464996529|FG001|Overall Study|Withdrawal by Subject|1|||
129191796|NCT01636986|464996528|FG000|Overall Study|Corneal Staining|0|||
129191797|NCT01636986|464996529|FG001|Overall Study|Corneal Staining|1|||
129191798|NCT01844778|464996535|FG000|Overall Study|Protocol deviation|0|||
129191799|NCT01844778|464996536|FG001|Overall Study|Protocol deviation|1|||
129191800|NCT01844778|464996537|FG002|Overall Study|Protocol deviation|2|||
129191801|NCT01844778|464996535|FG000|Overall Study|Withdrawal by Subject|2|||
129191802|NCT01844778|464996536|FG001|Overall Study|Withdrawal by Subject|0|||
129191803|NCT01844778|464996537|FG002|Overall Study|Withdrawal by Subject|0|||
129191804|NCT01844778|464996535|FG000|Overall Study|Adverse Event|0|||
129191805|NCT01844778|464996536|FG001|Overall Study|Adverse Event|2|||
129191806|NCT01844778|464996537|FG002|Overall Study|Adverse Event|2|||
129191807|NCT01846741|464996539|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
129191808|NCT01153698|464996540|FG000|Overall Study|Adverse Event|12|||
129191809|NCT01153698|464996540|FG000|Overall Study|Lost to Follow-up|4|||
129191810|NCT01153698|464996540|FG000|Overall Study|Withdrawal by Subject|2|||
128730383|NCT04300296|463309956|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
129191811|NCT01153698|464996540|FG000|Overall Study|Switch to other anticoagulants|4|||
129191812|NCT01153698|464996540|FG000|Overall Study|Other|2|||
129191813|NCT01153698|464996540|FG000|Overall Study|Not treated with Pradaxa|5|||
129191814|NCT01496846|464996541|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
129191815|NCT01496846|464996542|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
129191816|NCT01496846|464996543|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129191817|NCT01496846|464996544|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129191818|NCT01496846|464996545|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129191819|NCT01496846|464996546|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129191820|NCT01772576|464996547|FG000|Overall Study|Death|15|||
129191821|NCT01772576|464996547|FG000|Overall Study|Protocol Violation|1|||
129191822|NCT01772576|464996547|FG000|Overall Study|Lost to Follow-up|3|||
129191823|NCT01772576|464996547|FG000|Overall Study|Study device not used|3|||
129191824|NCT01772576|464996547|FG000|Overall Study|Adverse Event|6|||
129191825|NCT01772576|464996547|FG000|Overall Study|Withdrawal by Subject|6|||
129191826|NCT04356352|464996554|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
129191827|NCT04356352|464996555|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
129191828|NCT04356352|464996556|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
129191829|NCT04356352|464996554|FG000|Overall Study|Protocol Violation|0|||
129191830|NCT04356352|464996555|FG001|Overall Study|Protocol Violation|3|||
129191831|NCT04356352|464996556|FG002|Overall Study|Protocol Violation|1|||
129191832|NCT00379912|464996561|FG000|Overall Study|Lack of Efficacy|1|||
129191833|NCT00379912|464996562|FG001|Overall Study|Lack of Efficacy|0|||
129191834|NCT00621140|464996563|FG000|Overall Study|Adverse Event|4|||
129191835|NCT00621140|464996564|FG001|Overall Study|Adverse Event|5|||
129191836|NCT00621140|464996563|FG000|Overall Study|Lost to Follow-up|1|||
129191837|NCT00621140|464996564|FG001|Overall Study|Lost to Follow-up|2|||
129191838|NCT00621140|464996563|FG000|Overall Study|Withdrawal by Subject|4|||
129191839|NCT00621140|464996564|FG001|Overall Study|Withdrawal by Subject|6|||
129191840|NCT00621140|464996563|FG000|Overall Study|Other incl. lack of efficacy|6|||
129191841|NCT00621140|464996564|FG001|Overall Study|Other incl. lack of efficacy|5|||
129191842|NCT00360568|464996565|FG000|Overall Study|Adverse Event|1|||
129191843|NCT00360568|464996566|FG001|Overall Study|Adverse Event|2|||
129191844|NCT00360568|464996565|FG000|Overall Study|Lack of Efficacy|1|||
129191845|NCT00360568|464996566|FG001|Overall Study|Lack of Efficacy|0|||
129191846|NCT00360568|464996565|FG000|Overall Study|Withdrawal by Subject|0|||
129191847|NCT00360568|464996566|FG001|Overall Study|Withdrawal by Subject|3|||
129191848|NCT02873338|464996567|FG000|Overall Study|Adverse Event|0|||
129191849|NCT02873338|464996568|FG001|Overall Study|Adverse Event|2|||
129191850|NCT02873338|464996569|FG002|Overall Study|Adverse Event|1|||
129191851|NCT02873338|464996567|FG000|Overall Study|Death|2|||
129191852|NCT02873338|464996568|FG001|Overall Study|Death|1|||
129191853|NCT02873338|464996569|FG002|Overall Study|Death|1|||
129191854|NCT02873338|464996567|FG000|Overall Study|Withdrawal by Subject|2|||
129191855|NCT02873338|464996568|FG001|Overall Study|Withdrawal by Subject|1|||
129191856|NCT02873338|464996569|FG002|Overall Study|Withdrawal by Subject|3|||
129191857|NCT02873338|464996567|FG000|Overall Study|Lack of Efficacy|0|||
129191858|NCT02873338|464996568|FG001|Overall Study|Lack of Efficacy|2|||
129191859|NCT02873338|464996569|FG002|Overall Study|Lack of Efficacy|0|||
129191860|NCT02873338|464996567|FG000|Overall Study|Other or Missing|14|||
129191861|NCT02873338|464996568|FG001|Overall Study|Other or Missing|15|||
129191862|NCT02873338|464996569|FG002|Overall Study|Other or Missing|13|||
129191863|NCT03657095|464996570|FG000|Overall Study|Withdrawal by Subject|1|||
129191864|NCT03657095|464996571|FG001|Overall Study|Withdrawal by Subject|1|||
129191865|NCT03657095|464996570|FG000|Overall Study|Adverse Event|0|||
129191866|NCT03657095|464996571|FG001|Overall Study|Adverse Event|3|||
129191867|NCT03657095|464996570|FG000|Overall Study|Study Terminated by Sponsor|58|||
129191868|NCT03657095|464996571|FG001|Overall Study|Study Terminated by Sponsor|49|||
129191869|NCT04006392|464996572|FG000|Overall Study|Lost to Follow-up|0|||
128730384|NCT04300296|463309957|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
128730385|NCT04300296|463309958|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
128730386|NCT04300296|463309959|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
128730387|NCT04300296|463309954|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
128730388|NCT04300296|463309955|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
128730389|NCT04300296|463309956|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129191870|NCT04006392|464996573|FG001|Overall Study|Lost to Follow-up|1|||
129191871|NCT03824587|464996574|FG000|Run-in Period|Screen Failure|0|||
129191872|NCT03824587|464996575|FG001|Run-in Period|Screen Failure|275|||
129191873|NCT03824587|464996574|FG000|Treatment Period|Adverse Event|4|||
129191874|NCT03824587|464996575|FG001|Treatment Period|Adverse Event|1|||
129191875|NCT03824587|464996574|FG000|Treatment Period|Withdrawal by Subject|0|||
129191876|NCT03824587|464996575|FG001|Treatment Period|Withdrawal by Subject|1|||
129191877|NCT03824587|464996574|FG000|Treatment Period|Kidney Transplant|1|||
129191878|NCT03824587|464996575|FG001|Treatment Period|Kidney Transplant|1|||
129191879|NCT00986362|464996576|FG000|Overall Study|Death|2|||
129191880|NCT00986362|464996577|FG001|Overall Study|Death|0|||
129191881|NCT00986362|464996576|FG000|Overall Study|Lost to Follow-up|0|||
129191882|NCT00986362|464996577|FG001|Overall Study|Lost to Follow-up|1|||
129191883|NCT00384332|464996578|FG000|Overall Study|Lost to Follow-up|4|||
129191884|NCT00384332|464996579|FG001|Overall Study|Lost to Follow-up|0|||
129191885|NCT02006979|464996580|FG000|Overall Study|Withdrawal by Subject|1|||
129191886|NCT02006979|464996581|FG001|Overall Study|Withdrawal by Subject|1|||
129191887|NCT02006979|464996580|FG000|Overall Study|Protocol Violation|0|||
129191888|NCT02006979|464996581|FG001|Overall Study|Protocol Violation|1|||
129191889|NCT02560012|464996582|FG000|Overall Study|Study Terminated|2|||
129191890|NCT01007838|464996583|FG000|Overall Study|Withdrawal by Subject|1|||
129191891|NCT01007838|464996584|FG001|Overall Study|Withdrawal by Subject|0|||
129191892|NCT01007838|464996585|FG002|Overall Study|Withdrawal by Subject|0|||
129191893|NCT01007838|464996586|FG003|Overall Study|Withdrawal by Subject|0|||
129191894|NCT01007838|464996583|FG000|Overall Study|Physician Decision|1|||
129191895|NCT01007838|464996584|FG001|Overall Study|Physician Decision|0|||
129191896|NCT01007838|464996585|FG002|Overall Study|Physician Decision|0|||
129191897|NCT01007838|464996586|FG003|Overall Study|Physician Decision|0|||
129191898|NCT01007838|464996583|FG000|Overall Study|Started home haemodialysis|1|||
129191899|NCT01007838|464996584|FG001|Overall Study|Started home haemodialysis|0|||
129191900|NCT01007838|464996585|FG002|Overall Study|Started home haemodialysis|0|||
129191901|NCT01007838|464996586|FG003|Overall Study|Started home haemodialysis|0|||
129191902|NCT00852241|464996587|FG000|Overall Study|Physician Decision|18|||
129191903|NCT00118430|464996589|FG000|Overall Study|Withdrawal by Subject|6|||
129191904|NCT00118430|464996590|FG001|Overall Study|Withdrawal by Subject|2|||
129191905|NCT00118430|464996591|FG002|Overall Study|Withdrawal by Subject|0|||
129191906|NCT00118430|464996589|FG000|Overall Study|Lost to Follow-up|15|||
129191907|NCT00118430|464996590|FG001|Overall Study|Lost to Follow-up|22|||
129191908|NCT00118430|464996591|FG002|Overall Study|Lost to Follow-up|28|||
129191909|NCT02147288|464996592|FG000|Overall Study|post-operative hematoma|1|||
129191910|NCT02147288|464996593|FG001|Overall Study|post-operative hematoma|1|||
129191911|NCT02147288|464996594|FG002|Overall Study|post-operative hematoma|0|||
129191912|NCT02147288|464996595|FG003|Overall Study|post-operative hematoma|0|||
129191913|NCT02147288|464996596|FG004|Overall Study|post-operative hematoma|0|||
129191914|NCT02147288|464996597|FG005|Overall Study|post-operative hematoma|0|||
129191915|NCT02147288|464996598|FG006|Overall Study|post-operative hematoma|0|||
129191916|NCT02147288|464996599|FG007|Overall Study|post-operative hematoma|0|||
129191917|NCT02147288|464996600|FG008|Overall Study|post-operative hematoma|0|||
129191918|NCT02147288|464996601|FG009|Overall Study|post-operative hematoma|0|||
129191919|NCT02147288|464996592|FG000|Overall Study|complications from concurrent hernia rep|0|||
129191920|NCT02147288|464996593|FG001|Overall Study|complications from concurrent hernia rep|1|||
129191921|NCT02147288|464996594|FG002|Overall Study|complications from concurrent hernia rep|0|||
129191922|NCT02147288|464996595|FG003|Overall Study|complications from concurrent hernia rep|0|||
129191923|NCT02147288|464996596|FG004|Overall Study|complications from concurrent hernia rep|0|||
129191924|NCT02147288|464996597|FG005|Overall Study|complications from concurrent hernia rep|0|||
129191925|NCT02147288|464996598|FG006|Overall Study|complications from concurrent hernia rep|0|||
129191926|NCT02147288|464996599|FG007|Overall Study|complications from concurrent hernia rep|0|||
129191927|NCT02147288|464996600|FG008|Overall Study|complications from concurrent hernia rep|0|||
129191928|NCT02147288|464996601|FG009|Overall Study|complications from concurrent hernia rep|0|||
129191929|NCT02069392|464996604|FG000|Overall Study|Withdrawal by Subject|4|||
129191930|NCT02069392|464996605|FG001|Overall Study|Withdrawal by Subject|2|||
129191931|NCT00269633|464996606|FG000|Overall Study|Withdrawal by Subject|1|||
129191932|NCT00269633|464996607|FG001|Overall Study|Withdrawal by Subject|0|||
129191933|NCT02927938|464996608|FG000|Overall Study|Death|0|||
129191934|NCT02927938|464996609|FG001|Overall Study|Death|1|||
129191935|NCT02927938|464996610|FG002|Overall Study|Death|0|||
129191936|NCT02927938|464996611|FG003|Overall Study|Death|4|||
129191937|NCT02927938|464996608|FG000|Overall Study|Early Study Termination|1|||
129191938|NCT02927938|464996609|FG001|Overall Study|Early Study Termination|5|||
129191939|NCT02927938|464996610|FG002|Overall Study|Early Study Termination|4|||
129191940|NCT02927938|464996611|FG003|Overall Study|Early Study Termination|3|||
129191941|NCT02476006|464996612|FG000|Overall Study|Death|4|||
128730390|NCT04300296|463309957|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
128730391|NCT04300296|463309958|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
128730392|NCT04300296|463309959|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129191942|NCT02476006|464996612|FG000|Overall Study|Lack of treatment efficacy|2|||
129191943|NCT02476006|464996612|FG000|Overall Study|Pregnancy|1|||
129191944|NCT02476006|464996612|FG000|Overall Study|Participant did not wish to continue|39|||
129191945|NCT02476006|464996612|FG000|Overall Study|Adverse Event|41|||
129191946|NCT02476006|464996612|FG000|Overall Study|Poor compliance to study protocol|3|||
129191947|NCT02476006|464996612|FG000|Overall Study|Sponsor decision|6|||
129191948|NCT02476006|464996612|FG000|Overall Study|Lost to Follow-up|5|||
129191949|NCT02476006|464996612|FG000|Overall Study|Physician Decision|5|||
129191950|NCT02476006|464996612|FG000|Overall Study|Study ended treatment not available|4|||
129191951|NCT02476006|464996612|FG000|Overall Study|Switched to commercial drug|4|||
129191952|NCT02476006|464996612|FG000|Overall Study|Excluded from study|1|||
129191953|NCT02476006|464996612|FG000|Overall Study|Protocol Violation|1|||
129191954|NCT02476006|464996612|FG000|Overall Study|Enrolled but not treated|4|||
129191955|NCT02611817|464998777|FG000|Open-label Induction Phase|Reason not Specified|9|||
129191956|NCT02611817|464998778|FG001|Open-label Induction Phase|Reason not Specified|0|||
129191957|NCT02611817|464998779|FG002|Open-label Induction Phase|Reason not Specified|0|||
129191958|NCT02611817|464998777|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
129191959|NCT02611817|464998778|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
129191960|NCT02611817|464998779|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
129191961|NCT02611817|464998777|FG000|Open-label Induction Phase|Pregnancy|1|||
129191962|NCT02611817|464998778|FG001|Open-label Induction Phase|Pregnancy|0|||
129191963|NCT02611817|464998779|FG002|Open-label Induction Phase|Pregnancy|0|||
129191964|NCT02611817|464998777|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
129191965|NCT02611817|464998778|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
129191966|NCT02611817|464998779|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
129191967|NCT02611817|464998777|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
129191968|NCT02611817|464998778|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
129191969|NCT02611817|464998779|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
129191970|NCT02611817|464998777|FG000|Open-label Induction Phase|Protocol Violation|5|||
129191971|NCT02611817|464998778|FG001|Open-label Induction Phase|Protocol Violation|0|||
129191972|NCT02611817|464998779|FG002|Open-label Induction Phase|Protocol Violation|0|||
129191973|NCT02611817|464998777|FG000|Open-label Induction Phase|Adverse Event|16|||
129191974|NCT02611817|464998778|FG001|Open-label Induction Phase|Adverse Event|0|||
129191975|NCT02611817|464998779|FG002|Open-label Induction Phase|Adverse Event|0|||
129191976|NCT02611817|464998777|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
129191977|NCT02611817|464998778|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
129191978|NCT02611817|464998779|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
129191979|NCT02611817|464998777|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
129191980|NCT02611817|464998778|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
129191981|NCT02611817|464998779|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
129191982|NCT02611817|464998777|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
129191983|NCT02611817|464998778|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
129191984|NCT02611817|464998779|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
129191985|NCT02611817|464998777|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
129191986|NCT02611817|464998778|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
129191987|NCT02611817|464998779|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
129191988|NCT02611817|464998777|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
129191989|NCT02611817|464998778|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
129191990|NCT02611817|464998779|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
129191991|NCT02611817|464998777|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
129191992|NCT02611817|464998778|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
129191993|NCT02611817|464998779|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
129191994|NCT02611817|464998777|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
129191995|NCT02611817|464998778|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
129191996|NCT02611817|464998779|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
129191997|NCT00931606|464998780|FG000|Overall Study|Death|1|||
129191998|NCT00931606|464998781|FG001|Overall Study|Death|3|||
129191999|NCT00931606|464998782|FG002|Overall Study|Death|2|||
129192000|NCT00931606|464998783|FG003|Overall Study|Death|0|||
129192001|NCT00931606|464998780|FG000|Overall Study|Lost to Follow-up|0|||
129192002|NCT00931606|464998781|FG001|Overall Study|Lost to Follow-up|1|||
129192003|NCT00931606|464998782|FG002|Overall Study|Lost to Follow-up|0|||
129192004|NCT00931606|464998783|FG003|Overall Study|Lost to Follow-up|0|||
129192005|NCT00931606|464998780|FG000|Overall Study|Physician Decision|0|||
129192006|NCT00931606|464998781|FG001|Overall Study|Physician Decision|0|||
129192007|NCT00931606|464998782|FG002|Overall Study|Physician Decision|3|||
129192008|NCT00931606|464998783|FG003|Overall Study|Physician Decision|0|||
129192009|NCT00931606|464998780|FG000|Overall Study|Sponsor Decision|1|||
129192010|NCT00931606|464998781|FG001|Overall Study|Sponsor Decision|4|||
129192011|NCT00931606|464998782|FG002|Overall Study|Sponsor Decision|0|||
129192012|NCT00931606|464998783|FG003|Overall Study|Sponsor Decision|2|||
129192013|NCT00931606|464998780|FG000|Overall Study|Withdrawal by Subject|3|||
129192014|NCT00931606|464998781|FG001|Overall Study|Withdrawal by Subject|1|||
129192015|NCT00931606|464998782|FG002|Overall Study|Withdrawal by Subject|1|||
129192016|NCT00931606|464998783|FG003|Overall Study|Withdrawal by Subject|1|||
129192017|NCT03412812|464998791|FG000|Level 1|Death|3|||
128730393|NCT04300296|463309954|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
128730394|NCT04300296|463309955|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
128730395|NCT04300296|463309956|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
128730396|NCT04300296|463309957|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
129192018|NCT03412812|464998792|FG001|Level 1|Death|0|||
129192019|NCT03412812|464998791|FG000|Level 1|Adverse Event|0|||
129192020|NCT03412812|464998792|FG001|Level 1|Adverse Event|1|||
129192021|NCT03828617|464998796|FG000|Overall Study|Lost to Follow-up|22|||
129192022|NCT03828617|464998797|FG001|Overall Study|Lost to Follow-up|12|||
129192023|NCT03828617|464998798|FG002|Overall Study|Lost to Follow-up|23|||
129192024|NCT03828617|464998799|FG003|Overall Study|Lost to Follow-up|7|||
129192025|NCT03828617|464998796|FG000|Overall Study|No longer met eligibility criteria|0|||
129192026|NCT03828617|464998797|FG001|Overall Study|No longer met eligibility criteria|1|||
129192027|NCT03828617|464998798|FG002|Overall Study|No longer met eligibility criteria|1|||
129192028|NCT03828617|464998799|FG003|Overall Study|No longer met eligibility criteria|3|||
129192029|NCT03828617|464998796|FG000|Overall Study|Protocol Violation|0|||
129192030|NCT03828617|464998797|FG001|Overall Study|Protocol Violation|2|||
129192031|NCT03828617|464998798|FG002|Overall Study|Protocol Violation|0|||
129192032|NCT03828617|464998799|FG003|Overall Study|Protocol Violation|0|||
129192033|NCT03828617|464998796|FG000|Overall Study|Withdrawal by Subject|2|||
129192034|NCT03828617|464998797|FG001|Overall Study|Withdrawal by Subject|0|||
129192035|NCT03828617|464998798|FG002|Overall Study|Withdrawal by Subject|2|||
129192036|NCT03828617|464998799|FG003|Overall Study|Withdrawal by Subject|0|||
129192037|NCT03826186|464998800|FG000|Overall Study|Protocol Violation|2|||
129192038|NCT03826186|464998801|FG001|Overall Study|Protocol Violation|0|||
129192039|NCT03826186|464998800|FG000|Overall Study|Withdrawal by Subject|1|||
129192040|NCT03826186|464998801|FG001|Overall Study|Withdrawal by Subject|0|||
129192041|NCT00082407|464998804|FG000|Overall Study|Adverse Event|20|||
129192042|NCT00082407|464998805|FG001|Overall Study|Adverse Event|0|||
129192043|NCT00082407|464998804|FG000|Overall Study|Protocol Violation|14|||
129192044|NCT00082407|464998805|FG001|Overall Study|Protocol Violation|12|||
129192045|NCT00082407|464998804|FG000|Overall Study|Patient Decision|13|||
129192046|NCT00082407|464998805|FG001|Overall Study|Patient Decision|6|||
129192047|NCT00082407|464998804|FG000|Overall Study|Physician Decision|5|||
129192048|NCT00082407|464998805|FG001|Overall Study|Physician Decision|3|||
129192049|NCT00082407|464998804|FG000|Overall Study|Loss of Glucose Control|2|||
129192050|NCT00082407|464998805|FG001|Overall Study|Loss of Glucose Control|2|||
129192051|NCT00082407|464998804|FG000|Overall Study|Death|2|||
129192052|NCT00082407|464998805|FG001|Overall Study|Death|1|||
129192053|NCT00082407|464998804|FG000|Overall Study|Lost to Follow-up|0|||
129192054|NCT00082407|464998805|FG001|Overall Study|Lost to Follow-up|3|||
129192055|NCT00891228|464998807|FG000|Overall Study|Adverse Event|0|||
129192056|NCT00891228|464998808|FG001|Overall Study|Adverse Event|2|||
129192057|NCT00891228|464998809|FG002|Overall Study|Adverse Event|3|||
129192058|NCT00891228|464998807|FG000|Overall Study|Withdrawal by Subject|2|||
129192059|NCT00891228|464998808|FG001|Overall Study|Withdrawal by Subject|4|||
129192060|NCT00891228|464998809|FG002|Overall Study|Withdrawal by Subject|5|||
129192061|NCT00891228|464998807|FG000|Overall Study|Protocol Violation|3|||
129192062|NCT00891228|464998808|FG001|Overall Study|Protocol Violation|1|||
129192063|NCT00891228|464998809|FG002|Overall Study|Protocol Violation|2|||
129192064|NCT00891228|464998807|FG000|Overall Study|Physician Decision|2|||
129192065|NCT00891228|464998808|FG001|Overall Study|Physician Decision|1|||
129192066|NCT00891228|464998809|FG002|Overall Study|Physician Decision|0|||
129192067|NCT00891228|464998807|FG000|Overall Study|Lost to Follow-up|4|||
129192068|NCT00891228|464998808|FG001|Overall Study|Lost to Follow-up|4|||
129192069|NCT00891228|464998809|FG002|Overall Study|Lost to Follow-up|5|||
129192070|NCT00891228|464998807|FG000|Overall Study|Pregnancy|0|||
129192071|NCT00891228|464998808|FG001|Overall Study|Pregnancy|1|||
129192072|NCT00891228|464998809|FG002|Overall Study|Pregnancy|0|||
129192073|NCT02688985|464998812|FG000|Overall Study|Adverse Event|1|||
129192074|NCT02688985|464998813|FG001|Overall Study|Adverse Event|2|||
129192075|NCT02688985|464998814|FG002|Overall Study|Adverse Event|2|||
129192076|NCT02688985|464998815|FG003|Overall Study|Adverse Event|0|||
129192077|NCT02688985|464998816|FG004|Overall Study|Adverse Event|0|||
129192078|NCT02688985|464998812|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
129192079|NCT02688985|464998813|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
129192080|NCT02688985|464998814|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
129192081|NCT02688985|464998815|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
129192082|NCT02688985|464998816|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
129192083|NCT02688985|464998812|FG000|Overall Study|Death|0|||
129192084|NCT02688985|464998813|FG001|Overall Study|Death|0|||
129192085|NCT02688985|464998814|FG002|Overall Study|Death|0|||
129192086|NCT02688985|464998815|FG003|Overall Study|Death|0|||
129192087|NCT02688985|464998816|FG004|Overall Study|Death|1|||
129192088|NCT02688985|464998812|FG000|Overall Study|Lack of Efficacy|0|||
129192089|NCT02688985|464998813|FG001|Overall Study|Lack of Efficacy|0|||
129192090|NCT02688985|464998814|FG002|Overall Study|Lack of Efficacy|0|||
129192091|NCT02688985|464998815|FG003|Overall Study|Lack of Efficacy|0|||
129192092|NCT02688985|464998816|FG004|Overall Study|Lack of Efficacy|1|||
129192093|NCT02688985|464998812|FG000|Overall Study|Lost to Follow-up|2|||
129192094|NCT02688985|464998813|FG001|Overall Study|Lost to Follow-up|0|||
129192095|NCT02688985|464998814|FG002|Overall Study|Lost to Follow-up|1|||
129192096|NCT02688985|464998815|FG003|Overall Study|Lost to Follow-up|1|||
129192097|NCT02688985|464998816|FG004|Overall Study|Lost to Follow-up|1|||
129192098|NCT02688985|464998812|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129192099|NCT02688985|464998813|FG001|Overall Study|Non-Compliance With Study Drug|3|||
129192100|NCT02688985|464998814|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129192101|NCT02688985|464998815|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129192102|NCT02688985|464998816|FG004|Overall Study|Non-Compliance With Study Drug|1|||
129192103|NCT02688985|464998812|FG000|Overall Study|Other|3|||
129192104|NCT02688985|464998813|FG001|Overall Study|Other|4|||
129192105|NCT02688985|464998814|FG002|Overall Study|Other|1|||
129192106|NCT02688985|464998815|FG003|Overall Study|Other|0|||
129192107|NCT02688985|464998816|FG004|Overall Study|Other|0|||
129192108|NCT02688985|464998812|FG000|Overall Study|Physician Decision|2|||
129192109|NCT02688985|464998813|FG001|Overall Study|Physician Decision|2|||
129192110|NCT02688985|464998814|FG002|Overall Study|Physician Decision|0|||
129192111|NCT02688985|464998815|FG003|Overall Study|Physician Decision|0|||
129192112|NCT02688985|464998816|FG004|Overall Study|Physician Decision|1|||
129192113|NCT02688985|464998812|FG000|Overall Study|Pregnancy|0|||
129192114|NCT02688985|464998813|FG001|Overall Study|Pregnancy|0|||
129192115|NCT02688985|464998814|FG002|Overall Study|Pregnancy|2|||
129192116|NCT02688985|464998815|FG003|Overall Study|Pregnancy|1|||
129192117|NCT02688985|464998816|FG004|Overall Study|Pregnancy|0|||
129192118|NCT02688985|464998812|FG000|Overall Study|Study Terminated By Sponsor|0|||
129192119|NCT02688985|464998813|FG001|Overall Study|Study Terminated By Sponsor|0|||
129192120|NCT02688985|464998814|FG002|Overall Study|Study Terminated By Sponsor|0|||
129192121|NCT02688985|464998815|FG003|Overall Study|Study Terminated By Sponsor|1|||
129192122|NCT02688985|464998816|FG004|Overall Study|Study Terminated By Sponsor|0|||
129192123|NCT02688985|464998812|FG000|Overall Study|Withdrawal by Subject|2|||
129192124|NCT02688985|464998813|FG001|Overall Study|Withdrawal by Subject|8|||
129192125|NCT02688985|464998814|FG002|Overall Study|Withdrawal by Subject|7|||
129192126|NCT02688985|464998815|FG003|Overall Study|Withdrawal by Subject|1|||
129192127|NCT02688985|464998816|FG004|Overall Study|Withdrawal by Subject|4|||
129192128|NCT01726582|464998819|FG000|Overall Study|Physician Decision|99|||
129192129|NCT01726582|464998819|FG000|Overall Study|Death|85|||
129192130|NCT01363908|464998820|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
129192131|NCT01363908|464998821|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
129192132|NCT01363908|464998820|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
129192133|NCT01363908|464998821|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
129192134|NCT01363908|464998820|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
129192135|NCT01363908|464998821|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
129192136|NCT01363908|464998820|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
129192137|NCT01363908|464998821|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
129192138|NCT00711971|464998822|FG000|Overall Study|Lost to Follow-up|3|||
129192139|NCT00711971|464998823|FG001|Overall Study|Lost to Follow-up|4|||
129192140|NCT00711971|464998824|FG002|Overall Study|Lost to Follow-up|1|||
129192141|NCT02644343|464998825|FG000|Overall Study|Withdrawal by Subject|1|||
129192142|NCT03437577|464998826|FG000|Pre-Randomization|Withdrawal by Subject|0|||
129192143|NCT03437577|464998827|FG001|Pre-Randomization|Withdrawal by Subject|0|||
129192144|NCT03437577|464998828|FG002|Pre-Randomization|Withdrawal by Subject|10|||
129192145|NCT03437577|464998826|FG000|Post-Randomization|Physician Decision|0|||
129192146|NCT03437577|464998827|FG001|Post-Randomization|Physician Decision|2|||
129192147|NCT03437577|464998828|FG002|Post-Randomization|Physician Decision|0|||
129192148|NCT00536471|464998829|FG000|Overall Study|Lost to Follow-up|48|||
129192149|NCT00536471|464998830|FG001|Overall Study|Lost to Follow-up|23|||
129192150|NCT00536471|464998831|FG002|Overall Study|Lost to Follow-up|48|||
129192151|NCT00536471|464998832|FG003|Overall Study|Lost to Follow-up|22|||
129192152|NCT00536471|464998829|FG000|Overall Study|Adverse Event|32|||
129192153|NCT00536471|464998830|FG001|Overall Study|Adverse Event|16|||
129192154|NCT00536471|464998831|FG002|Overall Study|Adverse Event|28|||
129192155|NCT00536471|464998832|FG003|Overall Study|Adverse Event|13|||
129192156|NCT00536471|464998829|FG000|Overall Study|Withdrawal by Subject|40|||
129192157|NCT00536471|464998830|FG001|Overall Study|Withdrawal by Subject|24|||
129192158|NCT00536471|464998831|FG002|Overall Study|Withdrawal by Subject|43|||
129192159|NCT00536471|464998832|FG003|Overall Study|Withdrawal by Subject|21|||
129192160|NCT00536471|464998829|FG000|Overall Study|Lack of Efficacy|17|||
129192161|NCT00536471|464998830|FG001|Overall Study|Lack of Efficacy|18|||
129192162|NCT00536471|464998831|FG002|Overall Study|Lack of Efficacy|11|||
129192163|NCT00536471|464998832|FG003|Overall Study|Lack of Efficacy|9|||
129192164|NCT00536471|464998829|FG000|Overall Study|Protocol Violation|8|||
129192165|NCT00536471|464998830|FG001|Overall Study|Protocol Violation|1|||
129192166|NCT00536471|464998831|FG002|Overall Study|Protocol Violation|2|||
129192167|NCT00536471|464998832|FG003|Overall Study|Protocol Violation|3|||
129192168|NCT00536471|464998829|FG000|Overall Study|Physician Decision|11|||
129192169|NCT00536471|464998830|FG001|Overall Study|Physician Decision|1|||
129192170|NCT00536471|464998831|FG002|Overall Study|Physician Decision|3|||
129192171|NCT00536471|464998832|FG003|Overall Study|Physician Decision|2|||
129192172|NCT00536471|464998829|FG000|Overall Study|Death|0|||
129192173|NCT00536471|464998830|FG001|Overall Study|Death|0|||
129192174|NCT00536471|464998831|FG002|Overall Study|Death|1|||
128730397|NCT04300296|463309958|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
129192175|NCT00536471|464998832|FG003|Overall Study|Death|2|||
129192176|NCT00536471|464998829|FG000|Overall Study|Sponsor Decision|0|||
128730398|NCT04300296|463309959|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
128730399|NCT01633944|463309960|FG000|Open-label Titration Phase|Adverse Event|109|||
128730400|NCT01633944|463309961|FG001|Open-label Titration Phase|Adverse Event|0|||
128730401|NCT01633944|463309962|FG002|Open-label Titration Phase|Adverse Event|0|||
128730402|NCT01633944|463309960|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
128730403|NCT01633944|463309961|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
128730404|NCT01633944|463309962|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
128730405|NCT01633944|463309960|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
129192177|NCT00536471|464998830|FG001|Overall Study|Sponsor Decision|1|||
129192178|NCT00536471|464998831|FG002|Overall Study|Sponsor Decision|3|||
129192179|NCT00536471|464998832|FG003|Overall Study|Sponsor Decision|2|||
129192180|NCT03704688|464998833|FG000|Overall Study|Adverse Event|0|||
129192181|NCT03704688|464998834|FG001|Overall Study|Adverse Event|0|||
129192182|NCT03704688|464998835|FG002|Overall Study|Adverse Event|0|||
129192183|NCT03704688|464998836|FG003|Overall Study|Adverse Event|4|||
129192184|NCT03704688|464998837|FG004|Overall Study|Adverse Event|1|||
129192185|NCT03704688|464998838|FG005|Overall Study|Adverse Event|0|||
129192186|NCT03704688|464998833|FG000|Overall Study|Disease Progression|0|||
129192187|NCT03704688|464998834|FG001|Overall Study|Disease Progression|0|||
129192188|NCT03704688|464998835|FG002|Overall Study|Disease Progression|0|||
129192189|NCT03704688|464998836|FG003|Overall Study|Disease Progression|3|||
129192190|NCT03704688|464998837|FG004|Overall Study|Disease Progression|1|||
129192191|NCT03704688|464998838|FG005|Overall Study|Disease Progression|0|||
129192192|NCT03704688|464998833|FG000|Overall Study|Death|0|||
129192193|NCT03704688|464998834|FG001|Overall Study|Death|0|||
129192194|NCT03704688|464998835|FG002|Overall Study|Death|0|||
129192195|NCT03704688|464998836|FG003|Overall Study|Death|0|||
129192196|NCT03704688|464998837|FG004|Overall Study|Death|3|||
129192197|NCT03704688|464998838|FG005|Overall Study|Death|0|||
129192198|NCT00847886|464998845|FG000|Overall Study|Adverse Event|0|||
129192199|NCT00847886|464998846|FG001|Overall Study|Adverse Event|1|||
129192200|NCT01973998|464998847|FG000|Overall Study|Death|2|||
129192201|NCT01973998|464998848|FG001|Overall Study|Death|2|||
129192202|NCT02951429|464998854|FG000|Overall Study|Adverse Event|3|||
129192203|NCT02951429|464998855|FG001|Overall Study|Adverse Event|7|||
129192204|NCT02951429|464998854|FG000|Overall Study|Death|28|||
129192205|NCT02951429|464998855|FG001|Overall Study|Death|36|||
129192206|NCT02951429|464998854|FG000|Overall Study|Lack of Efficacy|0|||
129192207|NCT02951429|464998855|FG001|Overall Study|Lack of Efficacy|1|||
129192208|NCT02951429|464998854|FG000|Overall Study|Lost to Follow-up|0|||
129192209|NCT02951429|464998855|FG001|Overall Study|Lost to Follow-up|1|||
129192210|NCT02951429|464998854|FG000|Overall Study|Lung Transplantation|9|||
129192211|NCT02951429|464998855|FG001|Overall Study|Lung Transplantation|6|||
129192212|NCT02951429|464998854|FG000|Overall Study|Other|1|||
129192213|NCT02951429|464998855|FG001|Overall Study|Other|3|||
129192214|NCT02951429|464998854|FG000|Overall Study|Progressive Disease|1|||
129192215|NCT02951429|464998855|FG001|Overall Study|Progressive Disease|1|||
129192216|NCT02951429|464998854|FG000|Overall Study|Withdrawal by Subject|7|||
129192217|NCT02951429|464998855|FG001|Overall Study|Withdrawal by Subject|11|||
129192218|NCT02951429|464998854|FG000|Overall Study|Participant ongoing in the study|23|||
129192219|NCT02951429|464998855|FG001|Overall Study|Participant ongoing in the study|17|||
129192220|NCT01620528|464998856|FG000|Treatment Period|Did Not Receive Study Drug|0|||
129192221|NCT01620528|464998857|FG001|Treatment Period|Did Not Receive Study Drug|0|||
129192222|NCT01620528|464998858|FG002|Treatment Period|Did Not Receive Study Drug|1|||
129192223|NCT01620528|464998856|FG000|Treatment Period|Withdrawal by Subject|35|||
129192224|NCT01620528|464998857|FG001|Treatment Period|Withdrawal by Subject|21|||
129192225|NCT01620528|464998858|FG002|Treatment Period|Withdrawal by Subject|16|||
129192226|NCT01620528|464998856|FG000|Treatment Period|Adverse Event|17|||
129192227|NCT01620528|464998857|FG001|Treatment Period|Adverse Event|13|||
129192228|NCT01620528|464998858|FG002|Treatment Period|Adverse Event|21|||
129192229|NCT01620528|464998856|FG000|Treatment Period|Lost to Follow-up|16|||
129192230|NCT01620528|464998857|FG001|Treatment Period|Lost to Follow-up|8|||
129192231|NCT01620528|464998858|FG002|Treatment Period|Lost to Follow-up|14|||
129192232|NCT01620528|464998856|FG000|Treatment Period|Other|9|||
129192233|NCT01620528|464998857|FG001|Treatment Period|Other|5|||
129192234|NCT01620528|464998858|FG002|Treatment Period|Other|7|||
129192235|NCT01620528|464998856|FG000|Treatment Period|Subject Noncompliant|11|||
129192236|NCT01620528|464998857|FG001|Treatment Period|Subject Noncompliant|2|||
129192237|NCT01620528|464998858|FG002|Treatment Period|Subject Noncompliant|2|||
129192238|NCT01620528|464998856|FG000|Treatment Period|Pregnancy|7|||
129192239|NCT01620528|464998857|FG001|Treatment Period|Pregnancy|2|||
129192240|NCT01620528|464998858|FG002|Treatment Period|Pregnancy|2|||
129192241|NCT01620528|464998856|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
129192242|NCT01620528|464998857|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
129192243|NCT01620528|464998858|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
129192244|NCT01620528|464998856|FG000|Treatment Period|Exclusionary Medication Received|0|||
129192245|NCT01620528|464998857|FG001|Treatment Period|Exclusionary Medication Received|1|||
129192246|NCT01620528|464998858|FG002|Treatment Period|Exclusionary Medication Received|0|||
129192247|NCT01620528|464998856|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
129192248|NCT01620528|464998857|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
129192249|NCT01620528|464998858|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
129192250|NCT01620528|464998856|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129192251|NCT01620528|464998857|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129192252|NCT01620528|464998858|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
129192253|NCT01620528|464998856|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
129192254|NCT01620528|464998857|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
129192255|NCT01620528|464998858|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
129192256|NCT01620528|464998856|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
129192257|NCT01620528|464998857|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
129192258|NCT01620528|464998858|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
129192259|NCT01620528|464998856|FG000|Post-Treatment Follow-Up Period|Other|6|||
129192260|NCT01620528|464998857|FG001|Post-Treatment Follow-Up Period|Other|4|||
129192261|NCT01620528|464998858|FG002|Post-Treatment Follow-Up Period|Other|2|||
129192262|NCT03664765|464998859|FG000|Overall Study|Withdrawal by Subject|4|||
129192263|NCT03664765|464998860|FG001|Overall Study|Withdrawal by Subject|1|||
129192264|NCT03664765|464998859|FG000|Overall Study|Lost to Follow-up|0|||
129192265|NCT03664765|464998860|FG001|Overall Study|Lost to Follow-up|1|||
129192266|NCT01090063|464998861|FG000|Screen|Screen Failed|4|||
129192267|NCT01090063|464998861|FG000|Treatment|Withdrawal by Subject|4|||
129192268|NCT02106403|464998865|FG000|Follow-Up Visit 3|Other Reason|0|||
129192269|NCT02106403|464998866|FG001|Follow-Up Visit 3|Other Reason|0|||
129192270|NCT02106403|464998867|FG002|Follow-Up Visit 3|Other Reason|0|||
129192271|NCT02106403|464998868|FG003|Follow-Up Visit 3|Other Reason|0|||
129192272|NCT02106403|464998869|FG004|Follow-Up Visit 3|Other Reason|0|||
129192273|NCT02106403|464998870|FG005|Follow-Up Visit 3|Other Reason|1|||
129192274|NCT04038567|464998872|FG000|Overall Study|Lost to Follow-up|6|||
129192275|NCT04038567|464998873|FG001|Overall Study|Lost to Follow-up|4|||
129192276|NCT04038567|464998874|FG002|Overall Study|Lost to Follow-up|5|||
129192277|NCT04038567|464998875|FG003|Overall Study|Lost to Follow-up|4|||
129192278|NCT04038567|464998876|FG004|Overall Study|Lost to Follow-up|6|||
129192279|NCT04038567|464998877|FG005|Overall Study|Lost to Follow-up|4|||
129192280|NCT04038567|464998878|FG006|Overall Study|Lost to Follow-up|4|||
129192281|NCT04038567|464998879|FG007|Overall Study|Lost to Follow-up|1|||
129192282|NCT04038567|464998872|FG000|Overall Study|Withdrawal by Subject|2|||
129192283|NCT04038567|464998873|FG001|Overall Study|Withdrawal by Subject|1|||
129192284|NCT04038567|464998874|FG002|Overall Study|Withdrawal by Subject|1|||
129192285|NCT04038567|464998875|FG003|Overall Study|Withdrawal by Subject|1|||
129192286|NCT04038567|464998876|FG004|Overall Study|Withdrawal by Subject|4|||
129192287|NCT04038567|464998877|FG005|Overall Study|Withdrawal by Subject|1|||
129192288|NCT04038567|464998878|FG006|Overall Study|Withdrawal by Subject|1|||
129192289|NCT04038567|464998879|FG007|Overall Study|Withdrawal by Subject|1|||
129192290|NCT04038567|464998872|FG000|Overall Study|missed survey window|1|||
129192291|NCT04038567|464998873|FG001|Overall Study|missed survey window|2|||
129192292|NCT04038567|464998874|FG002|Overall Study|missed survey window|0|||
129192293|NCT04038567|464998875|FG003|Overall Study|missed survey window|0|||
129192294|NCT04038567|464998876|FG004|Overall Study|missed survey window|1|||
129192295|NCT04038567|464998877|FG005|Overall Study|missed survey window|1|||
129192296|NCT04038567|464998878|FG006|Overall Study|missed survey window|2|||
129192297|NCT04038567|464998879|FG007|Overall Study|missed survey window|2|||
129192298|NCT04038567|464998872|FG000|Overall Study|technical issues|0|||
129192299|NCT04038567|464998873|FG001|Overall Study|technical issues|0|||
129192300|NCT04038567|464998874|FG002|Overall Study|technical issues|0|||
129192301|NCT04038567|464998875|FG003|Overall Study|technical issues|0|||
129192302|NCT04038567|464998876|FG004|Overall Study|technical issues|0|||
129192303|NCT04038567|464998877|FG005|Overall Study|technical issues|0|||
129192304|NCT04038567|464998878|FG006|Overall Study|technical issues|1|||
129192305|NCT04038567|464998879|FG007|Overall Study|technical issues|0|||
129192306|NCT04038567|464998872|FG000|Overall Study|Medical issues (i.e., illness)|0|||
129192307|NCT04038567|464998873|FG001|Overall Study|Medical issues (i.e., illness)|1|||
129192308|NCT04038567|464998874|FG002|Overall Study|Medical issues (i.e., illness)|2|||
129192309|NCT04038567|464998875|FG003|Overall Study|Medical issues (i.e., illness)|1|||
129192310|NCT04038567|464998876|FG004|Overall Study|Medical issues (i.e., illness)|1|||
129192311|NCT04038567|464998877|FG005|Overall Study|Medical issues (i.e., illness)|1|||
129192312|NCT04038567|464998878|FG006|Overall Study|Medical issues (i.e., illness)|0|||
129192313|NCT04038567|464998879|FG007|Overall Study|Medical issues (i.e., illness)|0|||
129192314|NCT04038567|464998872|FG000|Overall Study|Death|0|||
129192315|NCT04038567|464998873|FG001|Overall Study|Death|0|||
129192316|NCT04038567|464998874|FG002|Overall Study|Death|0|||
129192317|NCT04038567|464998875|FG003|Overall Study|Death|1|||
129192318|NCT04038567|464998876|FG004|Overall Study|Death|1|||
129192319|NCT04038567|464998877|FG005|Overall Study|Death|0|||
129192320|NCT04038567|464998878|FG006|Overall Study|Death|0|||
129192321|NCT04038567|464998879|FG007|Overall Study|Death|1|||
129192322|NCT01817959|464998885|FG000|Overall Study|Graft loss|1|||
129192323|NCT01817959|464998886|FG001|Overall Study|Graft loss|1|||
129192324|NCT01817959|464998885|FG000|Overall Study|forbidden medication|1|||
129192325|NCT01817959|464998886|FG001|Overall Study|forbidden medication|1|||
129192326|NCT01817959|464998885|FG000|Overall Study|Adverse Event|1|||
129192327|NCT01817959|464998886|FG001|Overall Study|Adverse Event|0|||
129192328|NCT01817959|464998885|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
129192329|NCT01817959|464998886|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
129192330|NCT00923845|464998889|FG000|Induction Therapy|Poor performance status|0|||
129192331|NCT00923845|464998890|FG001|Induction Therapy|Poor performance status|2|||
129192332|NCT01128946|464998894|FG000|Period I|Protocol Violation|0|||
129192333|NCT01128946|464998895|FG001|Period I|Protocol Violation|1|||
129192334|NCT01128946|464998896|FG002|Period I|Protocol Violation|0|||
129192335|NCT01128946|464998897|FG003|Period I|Protocol Violation|0|||
129192336|NCT01128946|464998894|FG000|Period I|Withdrawal by Subject|0|||
129192337|NCT01128946|464998895|FG001|Period I|Withdrawal by Subject|0|||
129192338|NCT01128946|464998896|FG002|Period I|Withdrawal by Subject|1|||
129192339|NCT01128946|464998897|FG003|Period I|Withdrawal by Subject|1|||
129192340|NCT01128946|464998894|FG000|Period II|Protocol Violation|0|||
129192341|NCT01128946|464998895|FG001|Period II|Protocol Violation|1|||
129192342|NCT01128946|464998896|FG002|Period II|Protocol Violation|0|||
129192343|NCT01128946|464998897|FG003|Period II|Protocol Violation|0|||
129192344|NCT01128946|464998894|FG000|Period II|Withdrawal by Subject|0|||
129192345|NCT01128946|464998895|FG001|Period II|Withdrawal by Subject|0|||
129192346|NCT01128946|464998896|FG002|Period II|Withdrawal by Subject|0|||
129192347|NCT01128946|464998897|FG003|Period II|Withdrawal by Subject|1|||
129192348|NCT01128946|464998894|FG000|Period III|Protocol Violation|1|||
129192349|NCT01128946|464998895|FG001|Period III|Protocol Violation|0|||
129192350|NCT01128946|464998896|FG002|Period III|Protocol Violation|0|||
129192351|NCT01128946|464998897|FG003|Period III|Protocol Violation|0|||
129192352|NCT01371734|464998898|FG000|Overall Study|Other|2|||
129192353|NCT01371734|464998899|FG001|Overall Study|Other|1|||
129192354|NCT01371734|464998900|FG002|Overall Study|Other|2|||
129192355|NCT01371734|464998898|FG000|Overall Study|Withdrawal by Subject|3|||
129192356|NCT01371734|464998899|FG001|Overall Study|Withdrawal by Subject|4|||
129192357|NCT01371734|464998900|FG002|Overall Study|Withdrawal by Subject|9|||
129192358|NCT01371734|464998898|FG000|Overall Study|Lost to Follow-up|5|||
129192359|NCT01371734|464998899|FG001|Overall Study|Lost to Follow-up|3|||
129192360|NCT01371734|464998900|FG002|Overall Study|Lost to Follow-up|1|||
129192361|NCT01371734|464998898|FG000|Overall Study|Protocol Violation|3|||
129192362|NCT01371734|464998899|FG001|Overall Study|Protocol Violation|1|||
129192363|NCT01371734|464998900|FG002|Overall Study|Protocol Violation|2|||
129192364|NCT01371734|464998898|FG000|Overall Study|Adverse Event|8|||
129192365|NCT01371734|464998899|FG001|Overall Study|Adverse Event|8|||
129192366|NCT01371734|464998900|FG002|Overall Study|Adverse Event|3|||
129192367|NCT01371734|464998898|FG000|Overall Study|Lack of Efficacy|2|||
129192368|NCT01371734|464998899|FG001|Overall Study|Lack of Efficacy|2|||
129192369|NCT01371734|464998900|FG002|Overall Study|Lack of Efficacy|0|||
129192370|NCT03565237|464998901|FG000|Overall Study|Non-compliance of Investigational Product|1|||
129192371|NCT03565237|464998901|FG000|Overall Study|Physician Decision|1|||
129192372|NCT01140061|464998905|FG000|Part I|Adverse Event|1|||
129192373|NCT01140061|464998906|FG001|Part I|Adverse Event|0|||
129192374|NCT01140061|464998907|FG002|Part I|Adverse Event|0|||
129192375|NCT01140061|464998908|FG003|Part I|Adverse Event|0|||
129192376|NCT01140061|464998909|FG004|Part I|Adverse Event|0|||
129192377|NCT01140061|464998910|FG005|Part I|Adverse Event|0|||
129192378|NCT01140061|464998911|FG006|Part I|Adverse Event|0|||
129192379|NCT01140061|464998912|FG007|Part I|Adverse Event|0|||
129192380|NCT01140061|464998913|FG008|Part I|Adverse Event|0|||
129192381|NCT01140061|464998914|FG009|Part I|Adverse Event|0|||
129192382|NCT01140061|464998905|FG000|Extension|Laboratory Adverse Event|0|||
129192383|NCT01140061|464998906|FG001|Extension|Laboratory Adverse Event|0|||
129192384|NCT01140061|464998907|FG002|Extension|Laboratory Adverse Event|0|||
129192385|NCT01140061|464998908|FG003|Extension|Laboratory Adverse Event|0|||
129192386|NCT01140061|464998909|FG004|Extension|Laboratory Adverse Event|0|||
129192387|NCT01140061|464998910|FG005|Extension|Laboratory Adverse Event|0|||
129192388|NCT01140061|464998911|FG006|Extension|Laboratory Adverse Event|0|||
129192389|NCT01140061|464998912|FG007|Extension|Laboratory Adverse Event|0|||
129192390|NCT01140061|464998913|FG008|Extension|Laboratory Adverse Event|0|||
129192391|NCT01140061|464998914|FG009|Extension|Laboratory Adverse Event|1|||
129192392|NCT02669121|464998915|FG000|Overall Study|Adverse Event|4|||
129192393|NCT02669121|464998916|FG001|Overall Study|Adverse Event|5|||
129192394|NCT02669121|464998915|FG000|Overall Study|Lost to Follow-up|15|||
129192395|NCT02669121|464998916|FG001|Overall Study|Lost to Follow-up|27|||
128730406|NCT01633944|463309961|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
128730407|NCT01633944|463309962|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
128730408|NCT01633944|463309960|FG000|Open-label Titration Phase|Protocol Violation|24|||
128730409|NCT01633944|463309961|FG001|Open-label Titration Phase|Protocol Violation|0|||
129192396|NCT02669121|464998915|FG000|Overall Study|Withdrawal by Subject|132|||
129192397|NCT02669121|464998916|FG001|Overall Study|Withdrawal by Subject|140|||
129192398|NCT02669121|464998915|FG000|Overall Study|Pregnancy|0|||
129192399|NCT02669121|464998916|FG001|Overall Study|Pregnancy|1|||
129192400|NCT02669121|464998915|FG000|Overall Study|Discharged from US Military Active Service|117|||
129192401|NCT02669121|464998916|FG001|Overall Study|Discharged from US Military Active Service|91|||
129192402|NCT02669121|464998915|FG000|Overall Study|Reason not Specified|22|||
129192403|NCT02669121|464998916|FG001|Overall Study|Reason not Specified|18|||
129192404|NCT04384523|464998917|FG000|Overall Study|Lost to Follow-up|0|||
129192405|NCT04384523|464998918|FG001|Overall Study|Lost to Follow-up|0|||
129192406|NCT04384523|464998919|FG002|Overall Study|Lost to Follow-up|0|||
129192407|NCT04384523|464998920|FG003|Overall Study|Lost to Follow-up|0|||
129192408|NCT04384523|464998921|FG004|Overall Study|Lost to Follow-up|0|||
129192409|NCT04384523|464998922|FG005|Overall Study|Lost to Follow-up|1|||
129192410|NCT04384523|464998917|FG000|Overall Study|Protocol Violation|0|||
129192411|NCT04384523|464998918|FG001|Overall Study|Protocol Violation|1|||
129192412|NCT04384523|464998919|FG002|Overall Study|Protocol Violation|0|||
129192413|NCT04384523|464998920|FG003|Overall Study|Protocol Violation|0|||
129192414|NCT04384523|464998921|FG004|Overall Study|Protocol Violation|0|||
129192415|NCT04384523|464998922|FG005|Overall Study|Protocol Violation|0|||
129192416|NCT04384523|464998917|FG000|Overall Study|Withdrawal by Subject|1|||
129192417|NCT04384523|464998918|FG001|Overall Study|Withdrawal by Subject|0|||
129192418|NCT04384523|464998919|FG002|Overall Study|Withdrawal by Subject|0|||
129192419|NCT04384523|464998920|FG003|Overall Study|Withdrawal by Subject|0|||
129192420|NCT04384523|464998921|FG004|Overall Study|Withdrawal by Subject|0|||
129192421|NCT04384523|464998922|FG005|Overall Study|Withdrawal by Subject|0|||
129192422|NCT00835341|464998923|FG000|Overall Study|Lost to Follow-up|3|||
129192423|NCT00835341|464998924|FG001|Overall Study|Lost to Follow-up|12|||
129192424|NCT04405076|464998926|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
129192425|NCT04405076|464998927|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
129192426|NCT04405076|464998928|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
129192427|NCT04405076|464998929|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
129192428|NCT04405076|464998930|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
128730410|NCT01633944|463309962|FG002|Open-label Titration Phase|Protocol Violation|0|||
129192429|NCT04405076|464998931|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
129192430|NCT04405076|464998932|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
129192431|NCT04405076|464998933|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
129192432|NCT04405076|464998934|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
129192433|NCT04405076|464998926|FG000|Part A (Blinded Phase)|Physician Decision|1|||
128730411|NCT01633944|463309960|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
128730412|NCT01633944|463309961|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
129192434|NCT04405076|464998927|FG001|Part A (Blinded Phase)|Physician Decision|2|||
129192435|NCT04405076|464998928|FG002|Part A (Blinded Phase)|Physician Decision|0|||
128730413|NCT01633944|463309962|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
128730414|NCT01633944|463309960|FG000|Open-label Titration Phase|Other|68|||
128730415|NCT01633944|463309961|FG001|Open-label Titration Phase|Other|0|||
128730416|NCT01633944|463309962|FG002|Open-label Titration Phase|Other|0|||
128730417|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Adverse Event|0|||
128730418|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Adverse Event|13|||
128781014|NCT03590743|463488653|FG001|Overall Study|Withdrawal by Subject|1|||
129192436|NCT04405076|464998929|FG003|Part A (Blinded Phase)|Physician Decision|0|||
129192437|NCT04405076|464998930|FG004|Part A (Blinded Phase)|Physician Decision|0|||
129192438|NCT04405076|464998931|FG005|Part A (Blinded Phase)|Physician Decision|0|||
129192439|NCT04405076|464998932|FG006|Part A (Blinded Phase)|Physician Decision|0|||
129192440|NCT04405076|464998933|FG007|Part A (Blinded Phase)|Physician Decision|0|||
129192441|NCT04405076|464998934|FG008|Part A (Blinded Phase)|Physician Decision|0|||
129192442|NCT04405076|464998926|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
129192443|NCT04405076|464998927|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
129192444|NCT04405076|464998928|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
129192445|NCT04405076|464998929|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
129192446|NCT04405076|464998930|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
129192447|NCT04405076|464998931|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
129192448|NCT04405076|464998932|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
129192449|NCT04405076|464998933|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
129192450|NCT04405076|464998934|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
129192451|NCT04405076|464998926|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
129192452|NCT04405076|464998927|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192453|NCT04405076|464998928|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192454|NCT04405076|464998929|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192455|NCT04405076|464998930|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192456|NCT04405076|464998931|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192457|NCT04405076|464998932|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192458|NCT04405076|464998933|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192459|NCT04405076|464998934|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129192460|NCT04405076|464998926|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
129192461|NCT04405076|464998927|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
129192462|NCT04405076|464998928|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129192463|NCT04405076|464998929|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129192464|NCT04405076|464998930|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129192465|NCT04405076|464998931|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129192466|NCT04405076|464998932|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129192467|NCT04405076|464998933|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129192468|NCT04405076|464998934|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129192469|NCT04405076|464998926|FG000|Part A (Blinded Phase)|Other than Specified|0|||
129192470|NCT04405076|464998927|FG001|Part A (Blinded Phase)|Other than Specified|0|||
129192471|NCT04405076|464998928|FG002|Part A (Blinded Phase)|Other than Specified|3|||
129192472|NCT04405076|464998929|FG003|Part A (Blinded Phase)|Other than Specified|0|||
129192473|NCT04405076|464998930|FG004|Part A (Blinded Phase)|Other than Specified|0|||
129192474|NCT04405076|464998931|FG005|Part A (Blinded Phase)|Other than Specified|0|||
129192475|NCT04405076|464998932|FG006|Part A (Blinded Phase)|Other than Specified|0|||
129192476|NCT04405076|464998933|FG007|Part A (Blinded Phase)|Other than Specified|0|||
129192477|NCT04405076|464998934|FG008|Part A (Blinded Phase)|Other than Specified|0|||
129192478|NCT04405076|464998926|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129192479|NCT04405076|464998927|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129192480|NCT04405076|464998928|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129192481|NCT04405076|464998929|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
129192482|NCT04405076|464998930|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
129192483|NCT04405076|464998931|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
129192484|NCT04405076|464998932|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129192485|NCT04405076|464998933|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129192486|NCT04405076|464998934|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129192487|NCT04405076|464998926|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129192488|NCT04405076|464998927|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129192489|NCT04405076|464998928|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129192490|NCT04405076|464998929|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129192491|NCT04405076|464998930|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
129192492|NCT04405076|464998931|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129192493|NCT04405076|464998932|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
128781015|NCT00604786|463488654|FG000|Overall Study|Lost to Follow-up|2|||
128781016|NCT00604786|463488655|FG001|Overall Study|Lost to Follow-up|0|||
129192494|NCT04405076|464998933|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129192495|NCT04405076|464998934|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129192496|NCT04405076|464998926|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129192497|NCT04405076|464998927|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129192498|NCT04405076|464998928|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129192499|NCT04405076|464998929|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
129192500|NCT04405076|464998930|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
129192501|NCT04405076|464998931|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
129192502|NCT04405076|464998932|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129192503|NCT04405076|464998933|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129192504|NCT04405076|464998934|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129192505|NCT04405076|464998926|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129192506|NCT04405076|464998927|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129192507|NCT04405076|464998928|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129192508|NCT04405076|464998929|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129192509|NCT04405076|464998930|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129192510|NCT04405076|464998931|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129192511|NCT04405076|464998932|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129192512|NCT04405076|464998933|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
129192513|NCT04405076|464998934|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
129192514|NCT04405076|464998926|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192515|NCT04405076|464998927|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192516|NCT04405076|464998928|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192517|NCT04405076|464998929|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192518|NCT04405076|464998930|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192519|NCT04405076|464998931|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192520|NCT04405076|464998932|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
129192521|NCT04405076|464998933|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192522|NCT04405076|464998934|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129192523|NCT00392990|464998937|FG000|Treatment on Study|Adverse Event|3|||
129192524|NCT00392990|464998938|FG001|Treatment on Study|Adverse Event|1|||
129192525|NCT00392990|464998937|FG000|Follow up for 2 Years|Death|4|||
129192526|NCT00392990|464998938|FG001|Follow up for 2 Years|Death|0|||
129192527|NCT02980133|464998941|FG000|Overall Study|Other than specified|1|||
129192528|NCT02980133|464998942|FG001|Overall Study|Other than specified|1|||
129192529|NCT02980133|464998943|FG002|Overall Study|Other than specified|2|||
129192530|NCT02980133|464998944|FG003|Overall Study|Other than specified|2|||
129192531|NCT02980133|464998941|FG000|Overall Study|Lost to Follow-up|0|||
129192532|NCT02980133|464998942|FG001|Overall Study|Lost to Follow-up|0|||
129192533|NCT02980133|464998943|FG002|Overall Study|Lost to Follow-up|1|||
129192534|NCT02980133|464998944|FG003|Overall Study|Lost to Follow-up|3|||
129192535|NCT02980133|464998941|FG000|Overall Study|Protocol Violation|0|||
129192536|NCT02980133|464998942|FG001|Overall Study|Protocol Violation|1|||
129192537|NCT02980133|464998943|FG002|Overall Study|Protocol Violation|0|||
129192538|NCT02980133|464998944|FG003|Overall Study|Protocol Violation|0|||
129192539|NCT02980133|464998941|FG000|Overall Study|Withdrawal by parent/guardian|6|||
129192540|NCT02980133|464998942|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129192541|NCT02980133|464998943|FG002|Overall Study|Withdrawal by parent/guardian|3|||
129192542|NCT02980133|464998944|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129192543|NCT02980133|464998941|FG000|Overall Study|Withdrawal by Subject|0|||
129192544|NCT02980133|464998942|FG001|Overall Study|Withdrawal by Subject|0|||
129192545|NCT02980133|464998943|FG002|Overall Study|Withdrawal by Subject|1|||
129192546|NCT02980133|464998944|FG003|Overall Study|Withdrawal by Subject|0|||
129192547|NCT03052816|464998945|FG000|Overall Study|Withdrawal by Subject|1|||
129192548|NCT03052816|464998946|FG001|Overall Study|Withdrawal by Subject|0|||
129192549|NCT03052816|464998945|FG000|Overall Study|Desired opioids|2|||
129192550|NCT03052816|464998946|FG001|Overall Study|Desired opioids|0|||
129192551|NCT00895453|464998947|FG000|Overall Study|Lost to Follow-up|25|||
129192552|NCT00895453|464998948|FG001|Overall Study|Lost to Follow-up|25|||
129192553|NCT00895453|464998949|FG002|Overall Study|Lost to Follow-up|23|||
129192554|NCT01736618|464998956|FG000|Overall Study|Death|294|||
129192555|NCT01736618|464998956|FG000|Overall Study|Lost to Follow-up|193|||
129192556|NCT01736618|464998956|FG000|Overall Study|Withdrawal by Subject|54|||
129192557|NCT01736618|464998956|FG000|Overall Study|Subject unable to be followed at study location|223|||
129192558|NCT01736618|464998956|FG000|Overall Study|Physician Decision|33|||
129192559|NCT01736618|464998956|FG000|Overall Study|Transplant or removal of target organ|19|||
129192560|NCT01736618|464998956|FG000|Overall Study|Change in indication or condition|78|||
129192561|NCT01736618|464998956|FG000|Overall Study|Study device explant|103|||
128730419|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Adverse Event|7|||
128730420|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
128730421|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
128781017|NCT01221181|463488656|FG000|Overall Study|Lost to Follow-up|1|||
129192562|NCT01736618|464998956|FG000|Overall Study|Unable to complete implant|2|||
129192563|NCT00400569|464998961|FG000|Overall Study|Death|1|||
129192564|NCT00620113|464998964|FG000|Overall Study|Adverse Event|3|||
129192565|NCT00620113|464998965|FG001|Overall Study|Adverse Event|2|||
129192566|NCT00620113|464998966|FG002|Overall Study|Adverse Event|2|||
129192567|NCT00620113|464998967|FG003|Overall Study|Adverse Event|1|||
129192568|NCT00620113|464998964|FG000|Overall Study|Lack of Efficacy|2|||
129192569|NCT00620113|464998965|FG001|Overall Study|Lack of Efficacy|3|||
129192570|NCT00620113|464998966|FG002|Overall Study|Lack of Efficacy|0|||
129192571|NCT00620113|464998967|FG003|Overall Study|Lack of Efficacy|2|||
129192572|NCT00620113|464998964|FG000|Overall Study|Physician Decision|1|||
129192573|NCT00620113|464998965|FG001|Overall Study|Physician Decision|0|||
129192574|NCT00620113|464998966|FG002|Overall Study|Physician Decision|0|||
129192575|NCT00620113|464998967|FG003|Overall Study|Physician Decision|2|||
129192576|NCT00620113|464998964|FG000|Overall Study|Protocol Violation|2|||
129192577|NCT00620113|464998965|FG001|Overall Study|Protocol Violation|1|||
129192578|NCT00620113|464998966|FG002|Overall Study|Protocol Violation|0|||
129192579|NCT00620113|464998967|FG003|Overall Study|Protocol Violation|0|||
128730422|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
129192580|NCT00620113|464998964|FG000|Overall Study|Withdrawal by Subject|5|||
129192581|NCT00620113|464998965|FG001|Overall Study|Withdrawal by Subject|1|||
129192582|NCT00620113|464998966|FG002|Overall Study|Withdrawal by Subject|3|||
129192583|NCT00620113|464998967|FG003|Overall Study|Withdrawal by Subject|5|||
129192584|NCT02461745|464998972|FG000|Overall Study|Lack of Efficacy|9|||
129192585|NCT02461745|464998973|FG001|Overall Study|Lack of Efficacy|1|||
129192586|NCT02461745|464998972|FG000|Overall Study|Lost to Follow-up|2|||
129192587|NCT02461745|464998973|FG001|Overall Study|Lost to Follow-up|2|||
129192588|NCT02461745|464998972|FG000|Overall Study|Withdrawal by Subject|3|||
129192589|NCT02461745|464998973|FG001|Overall Study|Withdrawal by Subject|1|||
129192590|NCT00211887|464998974|FG000|Overall Study|Adverse Event|8|||
129192591|NCT00211887|464998975|FG001|Overall Study|Adverse Event|4|||
129192592|NCT00211887|464998976|FG002|Overall Study|Adverse Event|6|||
129192593|NCT00211887|464998974|FG000|Overall Study|Death|1|||
128730423|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
128730424|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
128730425|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
128730426|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
128730427|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
128730428|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
129192594|NCT00211887|464998975|FG001|Overall Study|Death|1|||
129192595|NCT00211887|464998976|FG002|Overall Study|Death|1|||
129192596|NCT00211887|464998974|FG000|Overall Study|Lost to Follow-up|28|||
129192597|NCT00211887|464998975|FG001|Overall Study|Lost to Follow-up|13|||
129192598|NCT00211887|464998976|FG002|Overall Study|Lost to Follow-up|9|||
129192599|NCT00211887|464998974|FG000|Overall Study|Non-medical reason|31|||
128730429|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
128730430|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
129192600|NCT00211887|464998975|FG001|Overall Study|Non-medical reason|14|||
129192601|NCT00211887|464998976|FG002|Overall Study|Non-medical reason|8|||
129192602|NCT00211887|464998974|FG000|Overall Study|Other medical reason|15|||
129192603|NCT00211887|464998975|FG001|Overall Study|Other medical reason|11|||
129192604|NCT00211887|464998976|FG002|Overall Study|Other medical reason|7|||
129192605|NCT00211887|464998974|FG000|Overall Study|Side effects|19|||
129192606|NCT00211887|464998975|FG001|Overall Study|Side effects|13|||
129192607|NCT00211887|464998976|FG002|Overall Study|Side effects|5|||
129192608|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Adverse Event|33|||
129192609|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
129192610|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
129192611|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
129192612|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Physician Decision|6|||
129192613|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
129192614|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
129192615|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
129192616|NCT00965419|464998980|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
129192617|NCT00965419|464998980|FG000|Follow-up Phase|Adverse Event|9|||
129192618|NCT00965419|464998980|FG000|Follow-up Phase|Protocol Violation|4|||
129192619|NCT00965419|464998980|FG000|Follow-up Phase|Withdrawal by Subject|8|||
129192620|NCT00965419|464998980|FG000|Follow-up Phase|Physician Decision|4|||
129192621|NCT00965419|464998980|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
129192622|NCT00965419|464998980|FG000|Follow-up Phase|Lack of Efficacy|28|||
129192623|NCT00826618|465000505|FG000|Overall Study|Withdrawal by Subject|1|||
129192624|NCT03712787|465000506|FG000|Overall Study|Adverse Event|2|||
129192625|NCT03712787|465000507|FG001|Overall Study|Adverse Event|3|||
129192626|NCT03712787|465000508|FG002|Overall Study|Adverse Event|0|||
129192627|NCT03712787|465000509|FG003|Overall Study|Adverse Event|4|||
129192628|NCT03712787|465000506|FG000|Overall Study|Withdrawal by Subject|4|||
129192629|NCT03712787|465000507|FG001|Overall Study|Withdrawal by Subject|14|||
129192630|NCT03712787|465000508|FG002|Overall Study|Withdrawal by Subject|12|||
129192631|NCT03712787|465000509|FG003|Overall Study|Withdrawal by Subject|8|||
129192632|NCT03712787|465000506|FG000|Overall Study|Lost to Follow-up|1|||
129192633|NCT03712787|465000507|FG001|Overall Study|Lost to Follow-up|1|||
129192634|NCT03712787|465000508|FG002|Overall Study|Lost to Follow-up|2|||
129192635|NCT03712787|465000509|FG003|Overall Study|Lost to Follow-up|1|||
129192636|NCT03712787|465000506|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129192637|NCT03712787|465000507|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
129192638|NCT03712787|465000508|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
129192639|NCT03712787|465000509|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
129192640|NCT03712787|465000506|FG000|Overall Study|COVID-19 Infection|0|||
129192641|NCT03712787|465000507|FG001|Overall Study|COVID-19 Infection|1|||
129192642|NCT03712787|465000508|FG002|Overall Study|COVID-19 Infection|0|||
129192643|NCT03712787|465000509|FG003|Overall Study|COVID-19 Infection|0|||
129192644|NCT03712787|465000506|FG000|Overall Study|Other, Not Specified|79|||
129192645|NCT03712787|465000507|FG001|Overall Study|Other, Not Specified|77|||
129192646|NCT03712787|465000508|FG002|Overall Study|Other, Not Specified|74|||
129192647|NCT03712787|465000509|FG003|Overall Study|Other, Not Specified|78|||
129192648|NCT00732875|465000510|FG000|Overall Study|Adverse Event|16|||
129192649|NCT00732875|465000510|FG000|Overall Study|Withdrawal by Subject|6|||
129192650|NCT00732875|465000510|FG000|Overall Study|Lack of Efficacy|13|||
129192651|NCT00303485|465000518|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
129192652|NCT00303485|465000519|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
129192653|NCT00303485|465000518|FG000|Overall Study|Failure to return|0|||
129192654|NCT00303485|465000519|FG001|Overall Study|Failure to return|1|||
129192655|NCT00303485|465000518|FG000|Overall Study|Withdrawal by Subject|1|||
129192656|NCT00303485|465000519|FG001|Overall Study|Withdrawal by Subject|0|||
129192657|NCT02219334|465000527|FG000|Overall Study|Withdrawal by Subject|1|||
129192658|NCT02219334|465000528|FG001|Overall Study|Withdrawal by Subject|0|||
129192659|NCT02219334|465000527|FG000|Overall Study|Protocol Violation|7|||
129192660|NCT02219334|465000528|FG001|Overall Study|Protocol Violation|3|||
129192661|NCT02630472|465000531|FG000|Overall Study|Physician Decision|10|||
129192662|NCT02630472|465000532|FG001|Overall Study|Physician Decision|0|||
129192663|NCT04878211|465000533|FG000|Overall Study|Lost to Follow-up|0|||
129192664|NCT04878211|465000534|FG001|Overall Study|Lost to Follow-up|0|||
129192665|NCT04878211|465000535|FG002|Overall Study|Lost to Follow-up|0|||
129192666|NCT04878211|465000536|FG003|Overall Study|Lost to Follow-up|1|||
129192667|NCT04878211|465000537|FG004|Overall Study|Lost to Follow-up|0|||
129192668|NCT04878211|465000538|FG005|Overall Study|Lost to Follow-up|1|||
129192669|NCT04878211|465000533|FG000|Overall Study|Protocol deviation|1|||
129192670|NCT04878211|465000534|FG001|Overall Study|Protocol deviation|0|||
129192671|NCT04878211|465000535|FG002|Overall Study|Protocol deviation|0|||
129192672|NCT04878211|465000536|FG003|Overall Study|Protocol deviation|0|||
129192673|NCT04878211|465000537|FG004|Overall Study|Protocol deviation|0|||
129192674|NCT04878211|465000538|FG005|Overall Study|Protocol deviation|0|||
129192675|NCT04878211|465000533|FG000|Overall Study|Study terminated by sponsor|0|||
129192676|NCT04878211|465000534|FG001|Overall Study|Study terminated by sponsor|0|||
129192677|NCT04878211|465000535|FG002|Overall Study|Study terminated by sponsor|0|||
129192678|NCT04878211|465000536|FG003|Overall Study|Study terminated by sponsor|0|||
129192679|NCT04878211|465000537|FG004|Overall Study|Study terminated by sponsor|9|||
129192680|NCT04878211|465000538|FG005|Overall Study|Study terminated by sponsor|4|||
129192681|NCT04878211|465000533|FG000|Overall Study|Subject decision|0|||
129192682|NCT04878211|465000534|FG001|Overall Study|Subject decision|0|||
129192683|NCT04878211|465000535|FG002|Overall Study|Subject decision|0|||
129192684|NCT04878211|465000536|FG003|Overall Study|Subject decision|0|||
129192685|NCT04878211|465000537|FG004|Overall Study|Subject decision|1|||
129192686|NCT04878211|465000538|FG005|Overall Study|Subject decision|0|||
129192687|NCT04774926|465000539|FG000|Overall Study|Adverse Event|15|||
129192688|NCT04774926|465000539|FG000|Overall Study|Lost to Follow-up|3|||
129192689|NCT04774926|465000539|FG000|Overall Study|Physician Decision|6|||
129192690|NCT04774926|465000539|FG000|Overall Study|Withdrawal by Subject|3|||
129192691|NCT04774926|465000539|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
129192692|NCT02783599|465000540|FG000|Overall Study|Progressive disease|23|||
129192693|NCT02783599|465000540|FG000|Overall Study|Surgical Resection|10|||
129192694|NCT02783599|465000540|FG000|Overall Study|Adverse Event|4|||
129192695|NCT02783599|465000540|FG000|Overall Study|Physician Decision|2|||
129192696|NCT02783599|465000540|FG000|Overall Study|Death|1|||
129192697|NCT05173012|465000544|FG000|Overall Study|Adverse Event|2|||
129192698|NCT05173012|465000545|FG001|Overall Study|Adverse Event|3|||
129192699|NCT05173012|465000546|FG002|Overall Study|Adverse Event|4|||
129192700|NCT05173012|465000547|FG003|Overall Study|Adverse Event|13|||
129192701|NCT05173012|465000548|FG004|Overall Study|Adverse Event|0|||
129192702|NCT05173012|465000549|FG005|Overall Study|Adverse Event|0|||
129192703|NCT05173012|465000550|FG006|Overall Study|Adverse Event|2|||
129192704|NCT05173012|465000551|FG007|Overall Study|Adverse Event|4|||
129192705|NCT05173012|465000544|FG000|Overall Study|Lost to Follow-up|0|||
129192706|NCT05173012|465000545|FG001|Overall Study|Lost to Follow-up|0|||
129192707|NCT05173012|465000546|FG002|Overall Study|Lost to Follow-up|0|||
129192708|NCT05173012|465000547|FG003|Overall Study|Lost to Follow-up|1|||
129192709|NCT05173012|465000548|FG004|Overall Study|Lost to Follow-up|0|||
129192710|NCT05173012|465000549|FG005|Overall Study|Lost to Follow-up|0|||
129192711|NCT05173012|465000550|FG006|Overall Study|Lost to Follow-up|0|||
129192712|NCT05173012|465000551|FG007|Overall Study|Lost to Follow-up|0|||
129192713|NCT05173012|465000544|FG000|Overall Study|Withdrawal by Subject|1|||
129192714|NCT05173012|465000545|FG001|Overall Study|Withdrawal by Subject|0|||
129192715|NCT05173012|465000546|FG002|Overall Study|Withdrawal by Subject|1|||
129192716|NCT05173012|465000547|FG003|Overall Study|Withdrawal by Subject|3|||
129192717|NCT05173012|465000548|FG004|Overall Study|Withdrawal by Subject|1|||
129192718|NCT05173012|465000549|FG005|Overall Study|Withdrawal by Subject|0|||
129192719|NCT05173012|465000550|FG006|Overall Study|Withdrawal by Subject|1|||
129192720|NCT05173012|465000551|FG007|Overall Study|Withdrawal by Subject|0|||
129192721|NCT05173012|465000544|FG000|Overall Study|Protocol Deviation|0|||
129192722|NCT05173012|465000545|FG001|Overall Study|Protocol Deviation|0|||
129192723|NCT05173012|465000546|FG002|Overall Study|Protocol Deviation|0|||
129192724|NCT05173012|465000547|FG003|Overall Study|Protocol Deviation|1|||
129192725|NCT05173012|465000548|FG004|Overall Study|Protocol Deviation|0|||
129192726|NCT05173012|465000549|FG005|Overall Study|Protocol Deviation|0|||
129192727|NCT05173012|465000550|FG006|Overall Study|Protocol Deviation|0|||
129192728|NCT05173012|465000551|FG007|Overall Study|Protocol Deviation|0|||
129192729|NCT05173012|465000544|FG000|Overall Study|Other|0|||
129192730|NCT05173012|465000545|FG001|Overall Study|Other|0|||
129192731|NCT05173012|465000546|FG002|Overall Study|Other|0|||
129192732|NCT05173012|465000547|FG003|Overall Study|Other|2|||
129192733|NCT05173012|465000548|FG004|Overall Study|Other|0|||
129192734|NCT05173012|465000549|FG005|Overall Study|Other|0|||
129192735|NCT05173012|465000550|FG006|Overall Study|Other|0|||
129192736|NCT05173012|465000551|FG007|Overall Study|Other|0|||
129192737|NCT03668613|465000552|FG000|Overall Study|Adverse Event|1|||
129192738|NCT03668613|465000553|FG001|Overall Study|Adverse Event|2|||
129192739|NCT03668613|465000552|FG000|Overall Study|Lack of Efficacy|5|||
129192740|NCT03668613|465000553|FG001|Overall Study|Lack of Efficacy|1|||
129192741|NCT03668613|465000552|FG000|Overall Study|Pregnancy|0|||
129192742|NCT03668613|465000553|FG001|Overall Study|Pregnancy|2|||
129192743|NCT03668613|465000552|FG000|Overall Study|Protocol Violation|1|||
129192744|NCT03668613|465000553|FG001|Overall Study|Protocol Violation|0|||
129192745|NCT03668613|465000552|FG000|Overall Study|Physician Decision|1|||
129192746|NCT03668613|465000553|FG001|Overall Study|Physician Decision|0|||
129192747|NCT03668613|465000552|FG000|Overall Study|Withdrawal by Subject|2|||
129192748|NCT03668613|465000553|FG001|Overall Study|Withdrawal by Subject|1|||
129192749|NCT03668613|465000552|FG000|Overall Study|Guardian decision|1|||
129192750|NCT03668613|465000553|FG001|Overall Study|Guardian decision|0|||
129192751|NCT01393821|465000554|FG000|Overall Study|Cancel|1|||
129192752|NCT01393821|465000555|FG001|Overall Study|Cancel|1|||
129192753|NCT01393821|465000554|FG000|Overall Study|not evaluable for primary endpoint|4|||
129192754|NCT01393821|465000555|FG001|Overall Study|not evaluable for primary endpoint|2|||
129192755|NCT01948063|465000556|FG000|Overall Study|Boston MCI halted research protocol|0|||
129192756|NCT01948063|465000557|FG001|Overall Study|Boston MCI halted research protocol|1|||
129192757|NCT01948063|465000556|FG000|Overall Study|Discovered an enrollment in other study|0|||
129192758|NCT01948063|465000557|FG001|Overall Study|Discovered an enrollment in other study|1|||
129192759|NCT01948063|465000556|FG000|Overall Study|Blood samples were accidentally thawed|1|||
129192760|NCT01948063|465000557|FG001|Overall Study|Blood samples were accidentally thawed|0|||
129192761|NCT01858766|465000558|FG000|Overall Study|Randomized but Never Treated|0|||
129192762|NCT01858766|465000559|FG001|Overall Study|Randomized but Never Treated|0|||
129192763|NCT01858766|465000560|FG002|Overall Study|Randomized but Never Treated|0|||
129192764|NCT01858766|465000561|FG003|Overall Study|Randomized but Never Treated|0|||
129192765|NCT01858766|465000562|FG004|Overall Study|Randomized but Never Treated|0|||
129192766|NCT01858766|465000563|FG005|Overall Study|Randomized but Never Treated|1|||
129192767|NCT01858766|465000564|FG006|Overall Study|Randomized but Never Treated|0|||
129192768|NCT01858766|465000565|FG007|Overall Study|Randomized but Never Treated|0|||
129192769|NCT01858766|465000566|FG008|Overall Study|Randomized but Never Treated|0|||
129192770|NCT01858766|465000567|FG009|Overall Study|Randomized but Never Treated|0|||
129192771|NCT01858766|465000568|FG010|Overall Study|Randomized but Never Treated|0|||
129192772|NCT01858766|465000569|FG011|Overall Study|Randomized but Never Treated|0|||
129192773|NCT01858766|465000570|FG012|Overall Study|Randomized but Never Treated|0|||
129192774|NCT01858766|465000571|FG013|Overall Study|Randomized but Never Treated|0|||
129192775|NCT01858766|465000572|FG014|Overall Study|Randomized but Never Treated|0|||
129192776|NCT01858766|465000573|FG015|Overall Study|Randomized but Never Treated|0|||
129192777|NCT01858766|465000574|FG016|Overall Study|Randomized but Never Treated|0|||
129192778|NCT01858766|465000575|FG017|Overall Study|Randomized but Never Treated|1|||
129192779|NCT01858766|465000576|FG018|Overall Study|Randomized but Never Treated|0|||
129192780|NCT01858766|465000558|FG000|Overall Study|Death|0|||
129192781|NCT01858766|465000559|FG001|Overall Study|Death|0|||
129192782|NCT01858766|465000560|FG002|Overall Study|Death|1|||
129192783|NCT01858766|465000561|FG003|Overall Study|Death|0|||
129192784|NCT01858766|465000562|FG004|Overall Study|Death|0|||
129192785|NCT01858766|465000563|FG005|Overall Study|Death|0|||
129192786|NCT01858766|465000564|FG006|Overall Study|Death|0|||
129192787|NCT01858766|465000565|FG007|Overall Study|Death|0|||
129192788|NCT01858766|465000566|FG008|Overall Study|Death|0|||
129192789|NCT01858766|465000567|FG009|Overall Study|Death|0|||
129192790|NCT01858766|465000568|FG010|Overall Study|Death|0|||
129192791|NCT01858766|465000569|FG011|Overall Study|Death|0|||
129192792|NCT01858766|465000570|FG012|Overall Study|Death|0|||
129192793|NCT01858766|465000571|FG013|Overall Study|Death|0|||
129192794|NCT01858766|465000572|FG014|Overall Study|Death|0|||
129192795|NCT01858766|465000573|FG015|Overall Study|Death|0|||
129192796|NCT01858766|465000574|FG016|Overall Study|Death|0|||
129192797|NCT01858766|465000575|FG017|Overall Study|Death|0|||
129192798|NCT01858766|465000576|FG018|Overall Study|Death|0|||
129192799|NCT01858766|465000558|FG000|Overall Study|Lack of Efficacy|1|||
129192800|NCT01858766|465000559|FG001|Overall Study|Lack of Efficacy|0|||
129192801|NCT01858766|465000560|FG002|Overall Study|Lack of Efficacy|0|||
129192802|NCT01858766|465000561|FG003|Overall Study|Lack of Efficacy|0|||
129192803|NCT01858766|465000562|FG004|Overall Study|Lack of Efficacy|1|||
129192804|NCT01858766|465000563|FG005|Overall Study|Lack of Efficacy|2|||
129192805|NCT01858766|465000564|FG006|Overall Study|Lack of Efficacy|0|||
129192806|NCT01858766|465000565|FG007|Overall Study|Lack of Efficacy|0|||
129192807|NCT01858766|465000566|FG008|Overall Study|Lack of Efficacy|0|||
129192808|NCT01858766|465000567|FG009|Overall Study|Lack of Efficacy|0|||
129192809|NCT01858766|465000568|FG010|Overall Study|Lack of Efficacy|0|||
129192810|NCT01858766|465000569|FG011|Overall Study|Lack of Efficacy|3|||
129192811|NCT01858766|465000570|FG012|Overall Study|Lack of Efficacy|5|||
129192812|NCT01858766|465000571|FG013|Overall Study|Lack of Efficacy|3|||
128781018|NCT02698436|463488657|FG000|Overall Study|Adverse Event|1|||
128781019|NCT02698436|463488658|FG001|Overall Study|Adverse Event|0|||
129192813|NCT01858766|465000572|FG014|Overall Study|Lack of Efficacy|5|||
129192814|NCT01858766|465000573|FG015|Overall Study|Lack of Efficacy|5|||
129192815|NCT01858766|465000574|FG016|Overall Study|Lack of Efficacy|2|||
129192816|NCT01858766|465000575|FG017|Overall Study|Lack of Efficacy|3|||
129192817|NCT01858766|465000576|FG018|Overall Study|Lack of Efficacy|3|||
129192818|NCT01858766|465000558|FG000|Overall Study|Lost to Follow-up|0|||
129192819|NCT01858766|465000559|FG001|Overall Study|Lost to Follow-up|0|||
129192820|NCT01858766|465000560|FG002|Overall Study|Lost to Follow-up|0|||
128781020|NCT02698436|463488657|FG000|Overall Study|Withdrawal by Subject|3|||
129192821|NCT01858766|465000561|FG003|Overall Study|Lost to Follow-up|0|||
129192822|NCT01858766|465000562|FG004|Overall Study|Lost to Follow-up|0|||
129192823|NCT01858766|465000563|FG005|Overall Study|Lost to Follow-up|1|||
129192824|NCT01858766|465000564|FG006|Overall Study|Lost to Follow-up|0|||
129192825|NCT01858766|465000565|FG007|Overall Study|Lost to Follow-up|2|||
129192826|NCT01858766|465000566|FG008|Overall Study|Lost to Follow-up|0|||
129192827|NCT01858766|465000567|FG009|Overall Study|Lost to Follow-up|0|||
129192828|NCT01858766|465000568|FG010|Overall Study|Lost to Follow-up|0|||
129192829|NCT01858766|465000569|FG011|Overall Study|Lost to Follow-up|1|||
129192830|NCT01858766|465000570|FG012|Overall Study|Lost to Follow-up|0|||
129192831|NCT01858766|465000571|FG013|Overall Study|Lost to Follow-up|0|||
129192832|NCT01858766|465000572|FG014|Overall Study|Lost to Follow-up|3|||
129192833|NCT01858766|465000573|FG015|Overall Study|Lost to Follow-up|1|||
129192834|NCT01858766|465000574|FG016|Overall Study|Lost to Follow-up|1|||
129192835|NCT01858766|465000575|FG017|Overall Study|Lost to Follow-up|0|||
129192836|NCT01858766|465000576|FG018|Overall Study|Lost to Follow-up|1|||
129192837|NCT01858766|465000558|FG000|Overall Study|Withdrew Consent|0|||
129192838|NCT01858766|465000559|FG001|Overall Study|Withdrew Consent|0|||
129192839|NCT01858766|465000560|FG002|Overall Study|Withdrew Consent|0|||
129192840|NCT01858766|465000561|FG003|Overall Study|Withdrew Consent|0|||
129192841|NCT01858766|465000562|FG004|Overall Study|Withdrew Consent|0|||
129192842|NCT01858766|465000563|FG005|Overall Study|Withdrew Consent|0|||
129192843|NCT01858766|465000564|FG006|Overall Study|Withdrew Consent|0|||
129192844|NCT01858766|465000565|FG007|Overall Study|Withdrew Consent|0|||
129192845|NCT01858766|465000566|FG008|Overall Study|Withdrew Consent|0|||
129192846|NCT01858766|465000567|FG009|Overall Study|Withdrew Consent|0|||
129192847|NCT01858766|465000568|FG010|Overall Study|Withdrew Consent|0|||
129192848|NCT01858766|465000569|FG011|Overall Study|Withdrew Consent|1|||
129192849|NCT01858766|465000570|FG012|Overall Study|Withdrew Consent|0|||
129192850|NCT01858766|465000571|FG013|Overall Study|Withdrew Consent|0|||
129192851|NCT01858766|465000572|FG014|Overall Study|Withdrew Consent|0|||
129192852|NCT01858766|465000573|FG015|Overall Study|Withdrew Consent|0|||
129192853|NCT01858766|465000574|FG016|Overall Study|Withdrew Consent|0|||
129192854|NCT01858766|465000575|FG017|Overall Study|Withdrew Consent|0|||
129192855|NCT01858766|465000576|FG018|Overall Study|Withdrew Consent|0|||
129192856|NCT03517228|465000579|FG000|Overall Study|Withdrawal by Subject|2|||
129192857|NCT03517228|465000579|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
129192858|NCT03517228|465000579|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
129192859|NCT03517228|465000579|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
129192860|NCT03517228|465000579|FG000|Overall Study|Canceled due to device being updated|1|||
129192861|NCT03517228|465000579|FG000|Overall Study|No V Cares in stock|1|||
129192862|NCT03517228|465000579|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
129192863|NCT03781414|465000590|FG000|Overall Study|Study terminated by sponsor|39|||
129192864|NCT03781414|465000591|FG001|Overall Study|Study terminated by sponsor|34|||
129192865|NCT03781414|465000592|FG002|Overall Study|Study terminated by sponsor|25|||
129192866|NCT03781414|465000590|FG000|Overall Study|Adverse Event|3|||
129192867|NCT03781414|465000591|FG001|Overall Study|Adverse Event|6|||
129192868|NCT03781414|465000592|FG002|Overall Study|Adverse Event|3|||
129192869|NCT03781414|465000590|FG000|Overall Study|Physician Decision|2|||
129192870|NCT03781414|465000591|FG001|Overall Study|Physician Decision|0|||
129192871|NCT03781414|465000592|FG002|Overall Study|Physician Decision|1|||
129192872|NCT03781414|465000590|FG000|Overall Study|Withdrawal by Subject|2|||
129192873|NCT03781414|465000591|FG001|Overall Study|Withdrawal by Subject|3|||
129192874|NCT03781414|465000592|FG002|Overall Study|Withdrawal by Subject|3|||
129192875|NCT03781414|465000590|FG000|Overall Study|Death|1|||
129192876|NCT03781414|465000591|FG001|Overall Study|Death|4|||
129192877|NCT03781414|465000592|FG002|Overall Study|Death|0|||
129192878|NCT03781414|465000590|FG000|Overall Study|Lost to Follow-up|1|||
129192879|NCT03781414|465000591|FG001|Overall Study|Lost to Follow-up|1|||
129192880|NCT03781414|465000592|FG002|Overall Study|Lost to Follow-up|0|||
129192881|NCT04752358|465000596|FG000|Overall Study|Death|2|||
129192882|NCT04752358|465000597|FG001|Overall Study|Death|1|||
129192883|NCT00719355|465000600|FG000|Overall Study|Death|0|||
129192884|NCT00719355|465000601|FG001|Overall Study|Death|1|||
129192885|NCT00719355|465000600|FG000|Overall Study|Medical|14|||
129192886|NCT00719355|465000601|FG001|Overall Study|Medical|5|||
129192887|NCT00719355|465000600|FG000|Overall Study|Compliance|4|||
129192888|NCT00719355|465000601|FG001|Overall Study|Compliance|6|||
129192889|NCT00719355|465000600|FG000|Overall Study|Moved|0|||
129192890|NCT00719355|465000601|FG001|Overall Study|Moved|1|||
129192891|NCT01835158|465000602|FG000|Overall Study|Withdrawal by Subject|1|||
129192892|NCT01835158|465000603|FG001|Overall Study|Withdrawal by Subject|6|||
129192893|NCT03364738|465000604|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
129192894|NCT03364738|465000604|FG000|Overall Study|Withdrawal by Subject|1|||
129192895|NCT03364738|465000604|FG000|Overall Study|Adverse Event|1|||
129192896|NCT03245398|465000609|FG000|Overall Study|Travelled to another island|1|||
129192897|NCT03245398|465000610|FG001|Overall Study|Travelled to another island|0|||
129192898|NCT00988091|465000620|FG000|Double-blind Period|Withdrawal by Subject|15|||
129192899|NCT00988091|465000621|FG001|Double-blind Period|Withdrawal by Subject|13|||
129192900|NCT00988091|465000620|FG000|Double-blind Period|Lost to Follow-up|12|||
128781021|NCT02698436|463488658|FG001|Overall Study|Withdrawal by Subject|3|||
129192901|NCT00988091|465000621|FG001|Double-blind Period|Lost to Follow-up|14|||
129192902|NCT00988091|465000620|FG000|Double-blind Period|Other|8|||
129192903|NCT00988091|465000621|FG001|Double-blind Period|Other|8|||
129192904|NCT00988091|465000620|FG000|Double-blind Period|Adverse Event|6|||
129192905|NCT00988091|465000621|FG001|Double-blind Period|Adverse Event|9|||
129192906|NCT00988091|465000620|FG000|Double-blind Period|Use of exclusionary medication|2|||
129192907|NCT00988091|465000621|FG001|Double-blind Period|Use of exclusionary medication|3|||
129192908|NCT00988091|465000620|FG000|Open-label Period|Adverse Event|4|||
129192909|NCT00988091|465000621|FG001|Open-label Period|Adverse Event|7|||
129192910|NCT00988091|465000620|FG000|Open-label Period|Use of exclusionary medication|1|||
129192911|NCT00988091|465000621|FG001|Open-label Period|Use of exclusionary medication|1|||
129192912|NCT00988091|465000620|FG000|Open-label Period|Protocol Violation|1|||
129192913|NCT00988091|465000621|FG001|Open-label Period|Protocol Violation|1|||
129192914|NCT00988091|465000620|FG000|Open-label Period|Withdrawal by Subject|10|||
129192915|NCT00988091|465000621|FG001|Open-label Period|Withdrawal by Subject|16|||
129192916|NCT00988091|465000620|FG000|Open-label Period|Lost to Follow-up|3|||
129192917|NCT00988091|465000621|FG001|Open-label Period|Lost to Follow-up|5|||
129192918|NCT00988091|465000620|FG000|Open-label Period|Other|2|||
129192919|NCT00988091|465000621|FG001|Open-label Period|Other|3|||
129192920|NCT00994422|465000622|FG000|Overall Study|Lost to Follow-up|7|||
129192921|NCT00994422|465000623|FG001|Overall Study|Lost to Follow-up|1|||
129192922|NCT00836186|465000628|FG000|Overall Study|Blood could not be drawn|1|||
129192923|NCT03422536|465000629|FG000|Randomized|Physician Decision|1|||
129192924|NCT03422536|465000630|FG001|Randomized|Physician Decision|1|||
129192925|NCT03422536|465000629|FG000|Allocation - Received Intervention|Disease progression|19|||
129192926|NCT03422536|465000630|FG001|Allocation - Received Intervention|Disease progression|25|||
129192927|NCT03422536|465000629|FG000|Allocation - Received Intervention|Death|1|||
129192928|NCT03422536|465000630|FG001|Allocation - Received Intervention|Death|3|||
129192929|NCT03422536|465000629|FG000|Allocation - Received Intervention|Adverse Event|1|||
129192930|NCT03422536|465000630|FG001|Allocation - Received Intervention|Adverse Event|0|||
129192931|NCT03422536|465000629|FG000|Allocation - Received Intervention|Physician Decision|1|||
129192932|NCT03422536|465000630|FG001|Allocation - Received Intervention|Physician Decision|1|||
129192933|NCT03422536|465000629|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
129192934|NCT03422536|465000630|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
129192935|NCT03422536|465000629|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
129192936|NCT03422536|465000630|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
129192937|NCT00532298|465000631|FG000|Overall Study|Adverse Event|1|||
129192938|NCT00532298|465000632|FG001|Overall Study|Adverse Event|0|||
129192939|NCT00532298|465000633|FG002|Overall Study|Adverse Event|0|||
129192940|NCT00532298|465000634|FG003|Overall Study|Adverse Event|0|||
129192941|NCT00532298|465000635|FG004|Overall Study|Adverse Event|1|||
129192942|NCT00532298|465000636|FG005|Overall Study|Adverse Event|1|||
129192943|NCT00532298|465000631|FG000|Overall Study|Lost to Follow-up|1|||
129192944|NCT00532298|465000632|FG001|Overall Study|Lost to Follow-up|1|||
129192945|NCT00532298|465000633|FG002|Overall Study|Lost to Follow-up|1|||
129192946|NCT00532298|465000634|FG003|Overall Study|Lost to Follow-up|0|||
129192947|NCT00532298|465000635|FG004|Overall Study|Lost to Follow-up|0|||
129192948|NCT00532298|465000636|FG005|Overall Study|Lost to Follow-up|1|||
129192949|NCT02023996|465000637|FG000|Overall Study|Protocol Violation|6|||
129192950|NCT00395850|465000646|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
129192951|NCT00395850|465000647|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
129192952|NCT00395850|465000648|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
129192953|NCT00395850|465000649|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
129192954|NCT00395850|465000646|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
129192955|NCT00395850|465000647|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
129192956|NCT00395850|465000648|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
129192957|NCT00395850|465000649|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
129192958|NCT00395850|465000646|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
129192959|NCT00395850|465000647|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
129192960|NCT00395850|465000648|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
129192961|NCT00395850|465000649|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
129192962|NCT00395850|465000646|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
129192963|NCT00395850|465000647|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
129192964|NCT00395850|465000648|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
129192965|NCT00395850|465000649|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
129192966|NCT00395850|465000646|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
129192967|NCT00395850|465000647|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
129192968|NCT00395850|465000648|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
129192969|NCT00395850|465000649|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
129192970|NCT00395850|465000646|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
128781022|NCT02698436|463488657|FG000|Overall Study|Lost to Follow-up|2|||
129192971|NCT00395850|465000647|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
129192972|NCT00395850|465000648|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
129192973|NCT00395850|465000649|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
129192974|NCT00395850|465000646|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
129192975|NCT00395850|465000647|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
129192976|NCT00395850|465000648|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
129192977|NCT00395850|465000649|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
129192978|NCT00330681|465000652|FG000|Overall Study|Adverse Event|3|||
129192979|NCT00330681|465000653|FG001|Overall Study|Adverse Event|6|||
129192980|NCT00330681|465000652|FG000|Overall Study|Protocol Violation|0|||
129192981|NCT00330681|465000653|FG001|Overall Study|Protocol Violation|1|||
129192982|NCT00330681|465000652|FG000|Overall Study|Withdrawal by Subject|5|||
129192983|NCT00330681|465000653|FG001|Overall Study|Withdrawal by Subject|5|||
129192984|NCT00330681|465000652|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
129192985|NCT00330681|465000653|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
129192986|NCT02578186|465000654|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
129192987|NCT02578186|465000655|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
129192988|NCT02578186|465000654|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
129192989|NCT02578186|465000655|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
129192990|NCT01534195|465000656|FG000|Overall Study|Withdrawal by Subject|1|||
129192991|NCT01534195|465000657|FG001|Overall Study|Withdrawal by Subject|1|||
129192992|NCT02708355|465000658|FG000|Overall Study|Adverse Event|1|||
129192993|NCT02708355|465000659|FG001|Overall Study|Adverse Event|0|||
129192994|NCT02708355|465000660|FG002|Overall Study|Adverse Event|0|||
129192995|NCT03216746|465000661|FG000|Overall Study|Lost to Follow-up|6|||
129192996|NCT03216746|465000662|FG001|Overall Study|Lost to Follow-up|8|||
129192997|NCT03216746|465000663|FG002|Overall Study|Lost to Follow-up|5|||
129192998|NCT03216746|465000664|FG003|Overall Study|Lost to Follow-up|6|||
129192999|NCT01320202|465000665|FG000|Overall Study|Adverse Event|5|||
129193000|NCT01320202|465000666|FG001|Overall Study|Adverse Event|5|||
129193001|NCT01320202|465000665|FG000|Overall Study|Death|5|||
129193002|NCT01320202|465000666|FG001|Overall Study|Death|3|||
129193003|NCT01320202|465000665|FG000|Overall Study|Lost to Follow-up|1|||
129193004|NCT01320202|465000666|FG001|Overall Study|Lost to Follow-up|0|||
129193005|NCT01320202|465000665|FG000|Overall Study|Physician Decision|3|||
129193006|NCT01320202|465000666|FG001|Overall Study|Physician Decision|1|||
129193007|NCT01320202|465000665|FG000|Overall Study|Protocol Violation|2|||
129193008|NCT01320202|465000666|FG001|Overall Study|Protocol Violation|1|||
129193009|NCT01320202|465000665|FG000|Overall Study|Withdrawal by Subject|10|||
129193010|NCT01320202|465000666|FG001|Overall Study|Withdrawal by Subject|3|||
129193011|NCT01320202|465000665|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
129193012|NCT01320202|465000666|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
129193013|NCT01320202|465000665|FG000|Overall Study|kidney transplant|1|||
129193014|NCT01320202|465000666|FG001|Overall Study|kidney transplant|2|||
129193015|NCT01320202|465000665|FG000|Overall Study|blood transfusion|1|||
129193016|NCT01320202|465000666|FG001|Overall Study|blood transfusion|7|||
129193017|NCT01320202|465000665|FG000|Overall Study|moved/changed dialysis|5|||
129193018|NCT01320202|465000666|FG001|Overall Study|moved/changed dialysis|2|||
129193019|NCT01320202|465000665|FG000|Overall Study|sponsor request|2|||
129193020|NCT01320202|465000666|FG001|Overall Study|sponsor request|0|||
129193021|NCT01320202|465000665|FG000|Overall Study|ineligible|3|||
129193022|NCT01320202|465000666|FG001|Overall Study|ineligible|0|||
129193023|NCT01320202|465000665|FG000|Overall Study|regained renal function|1|||
129193024|NCT01320202|465000666|FG001|Overall Study|regained renal function|0|||
129193025|NCT00635882|465000667|FG000|Overall Study|Protocol Violation|1|||
129193026|NCT00635882|465000668|FG001|Overall Study|Protocol Violation|0|||
129193027|NCT00635882|465000669|FG002|Overall Study|Protocol Violation|0|||
129193028|NCT00635882|465000670|FG003|Overall Study|Protocol Violation|0|||
129193029|NCT00635882|465000671|FG004|Overall Study|Protocol Violation|0|||
129193030|NCT00635882|465000672|FG005|Overall Study|Protocol Violation|0|||
129193031|NCT00825812|465000673|FG000|Overall Study|Never entered follow up|0|||
129193032|NCT00825812|465000674|FG001|Overall Study|Never entered follow up|0|||
129193033|NCT00825812|465000675|FG002|Overall Study|Never entered follow up|0|||
129193034|NCT00825812|465000676|FG003|Overall Study|Never entered follow up|1|||
129193035|NCT00825812|465000673|FG000|Overall Study|Adverse Event|0|||
129193036|NCT00825812|465000674|FG001|Overall Study|Adverse Event|0|||
129193037|NCT00825812|465000675|FG002|Overall Study|Adverse Event|0|||
129193038|NCT00825812|465000676|FG003|Overall Study|Adverse Event|1|||
129193039|NCT00825812|465000673|FG000|Overall Study|Subject withdrew consent|0|||
129193040|NCT00825812|465000674|FG001|Overall Study|Subject withdrew consent|0|||
129193041|NCT00825812|465000675|FG002|Overall Study|Subject withdrew consent|3|||
129193042|NCT00825812|465000676|FG003|Overall Study|Subject withdrew consent|2|||
129193043|NCT00825812|465000673|FG000|Overall Study|Non-compliance with protocol|0|||
129193044|NCT00825812|465000674|FG001|Overall Study|Non-compliance with protocol|0|||
129193045|NCT00825812|465000675|FG002|Overall Study|Non-compliance with protocol|0|||
129193046|NCT00825812|465000676|FG003|Overall Study|Non-compliance with protocol|1|||
129193047|NCT00825812|465000673|FG000|Overall Study|Administrative|0|||
129193048|NCT00825812|465000674|FG001|Overall Study|Administrative|1|||
129193049|NCT00825812|465000675|FG002|Overall Study|Administrative|3|||
129193050|NCT00825812|465000676|FG003|Overall Study|Administrative|5|||
129193051|NCT00408434|465000679|FG000|Overall Study|Adverse Event|0|||
129193052|NCT00408434|465000680|FG001|Overall Study|Adverse Event|0|||
129193053|NCT00408434|465000681|FG002|Overall Study|Adverse Event|1|||
129193054|NCT00408434|465000682|FG003|Overall Study|Adverse Event|0|||
129193055|NCT00408434|465000683|FG004|Overall Study|Adverse Event|0|||
129193056|NCT00408434|465000684|FG005|Overall Study|Adverse Event|0|||
129193057|NCT00408434|465000685|FG006|Overall Study|Adverse Event|0|||
129193058|NCT00408434|465000679|FG000|Overall Study|Progressive disease|6|||
129193059|NCT00408434|465000680|FG001|Overall Study|Progressive disease|3|||
129193060|NCT00408434|465000681|FG002|Overall Study|Progressive disease|4|||
129193061|NCT00408434|465000682|FG003|Overall Study|Progressive disease|3|||
129193062|NCT00408434|465000683|FG004|Overall Study|Progressive disease|3|||
129193063|NCT00408434|465000684|FG005|Overall Study|Progressive disease|1|||
129193064|NCT00408434|465000685|FG006|Overall Study|Progressive disease|4|||
129193065|NCT00408434|465000679|FG000|Overall Study|Other|0|||
129193066|NCT00408434|465000680|FG001|Overall Study|Other|0|||
129193067|NCT00408434|465000681|FG002|Overall Study|Other|1|||
129193068|NCT00408434|465000682|FG003|Overall Study|Other|0|||
129193069|NCT00408434|465000683|FG004|Overall Study|Other|2|||
129193070|NCT00408434|465000684|FG005|Overall Study|Other|1|||
129193071|NCT00408434|465000685|FG006|Overall Study|Other|0|||
129193072|NCT00408434|465000679|FG000|Overall Study|Terminated by Investigator|0|||
129193073|NCT00408434|465000680|FG001|Overall Study|Terminated by Investigator|0|||
129193074|NCT00408434|465000681|FG002|Overall Study|Terminated by Investigator|0|||
129193075|NCT00408434|465000682|FG003|Overall Study|Terminated by Investigator|0|||
129193076|NCT00408434|465000683|FG004|Overall Study|Terminated by Investigator|1|||
129193077|NCT00408434|465000684|FG005|Overall Study|Terminated by Investigator|1|||
129193078|NCT00408434|465000685|FG006|Overall Study|Terminated by Investigator|0|||
129193079|NCT01278797|465000686|FG000|Period 1|Adverse Event|0|||
129193080|NCT01278797|465000687|FG001|Period 1|Adverse Event|1|||
129193081|NCT01278797|465000686|FG000|Period 1|Protocol Violation|1|||
129193082|NCT01278797|465000687|FG001|Period 1|Protocol Violation|0|||
129193083|NCT00588354|465000688|FG000|Baseline to 2 Weeks|Adverse Event|1|||
129193084|NCT00588354|465000689|FG001|Baseline to 2 Weeks|Adverse Event|0|||
129193085|NCT00588354|465000688|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
129193086|NCT00588354|465000689|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
129193087|NCT00588354|465000688|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
129193088|NCT00588354|465000689|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
129193089|NCT04000581|465000690|FG000|Overall Study|Withdrawal by Subject|0|||
129193090|NCT04000581|465000691|FG001|Overall Study|Withdrawal by Subject|1|||
129193091|NCT02475278|465002889|FG000|Overall Study|Lost to Follow-up|1|||
129193092|NCT02475278|465002889|FG000|Overall Study|Reason Not Specified|1|||
129193093|NCT05111249|465002892|FG000|Overall Study|Lost to Follow-up|0|||
129193094|NCT05111249|465002893|FG001|Overall Study|Lost to Follow-up|2|||
129193095|NCT05111249|465002892|FG000|Overall Study|Physician Decision|0|||
129193096|NCT05111249|465002893|FG001|Overall Study|Physician Decision|1|||
129193097|NCT05111249|465002892|FG000|Overall Study|Participant decision|1|||
129193098|NCT05111249|465002893|FG001|Overall Study|Participant decision|5|||
129193099|NCT00872599|465002894|FG000|Second Washout Period|Adverse Event|1|||
129193100|NCT00872599|465002895|FG001|Second Washout Period|Adverse Event|1|||
129193101|NCT00801229|465002898|FG000|Signed Consent|Withdrawal by Subject|2|||
129193102|NCT00801229|465002899|FG001|Signed Consent|Withdrawal by Subject|2|||
129193103|NCT00801229|465002898|FG000|Signed Consent|Found Ineligible|1|||
129193104|NCT00801229|465002899|FG001|Signed Consent|Found Ineligible|1|||
129193105|NCT00801229|465002898|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
129193106|NCT00801229|465002899|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
129193107|NCT00801229|465002898|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
129193108|NCT00801229|465002899|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
129193109|NCT00801229|465002898|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
129193110|NCT00801229|465002899|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
129193111|NCT00801229|465002898|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
129193112|NCT00801229|465002899|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
129193113|NCT00801229|465002898|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
129193114|NCT00801229|465002899|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
129193115|NCT00801229|465002898|FG000|Received Study Drug/Placebo|Adverse Event|1|||
129193116|NCT00801229|465002899|FG001|Received Study Drug/Placebo|Adverse Event|1|||
129193117|NCT02610777|465002900|FG000|Overall Study|Lost to Follow-up|1|||
129193118|NCT02610777|465002901|FG001|Overall Study|Lost to Follow-up|0|||
129193119|NCT02610777|465002900|FG000|Overall Study|Site Terminated by Sponsor|9|||
129193120|NCT02610777|465002901|FG001|Overall Study|Site Terminated by Sponsor|8|||
129193121|NCT02610777|465002900|FG000|Overall Study|Withdrawal by Subject|2|||
129193122|NCT02610777|465002901|FG001|Overall Study|Withdrawal by Subject|2|||
129193123|NCT02610777|465002900|FG000|Overall Study|Reason not Specified|0|||
129193124|NCT02610777|465002901|FG001|Overall Study|Reason not Specified|1|||
129193125|NCT02610777|465002900|FG000|Overall Study|Death|50|||
129193126|NCT02610777|465002901|FG001|Overall Study|Death|47|||
129193127|NCT02300259|465002902|FG000|Period 1|Adverse Event|0|||
129193128|NCT02300259|465002903|FG001|Period 1|Adverse Event|0|||
129193129|NCT02300259|465002904|FG002|Period 1|Adverse Event|1|||
129193130|NCT02300259|465002902|FG000|Period 1|Withdrawal by Subject|0|||
129193131|NCT02300259|465002903|FG001|Period 1|Withdrawal by Subject|0|||
129193132|NCT02300259|465002904|FG002|Period 1|Withdrawal by Subject|1|||
129193133|NCT02300259|465002902|FG000|Period 2|Adverse Event|1|||
129193134|NCT02300259|465002903|FG001|Period 2|Adverse Event|0|||
129193135|NCT02300259|465002904|FG002|Period 2|Adverse Event|0|||
129193136|NCT02300259|465002902|FG000|Period 2|Withdrawal by Subject|0|||
129193137|NCT02300259|465002903|FG001|Period 2|Withdrawal by Subject|0|||
129193138|NCT02300259|465002904|FG002|Period 2|Withdrawal by Subject|1|||
129193139|NCT02737475|465002905|FG000|Overall Study|Other reasons|0|||
129193140|NCT02737475|465002906|FG001|Overall Study|Other reasons|0|||
129193141|NCT02737475|465002907|FG002|Overall Study|Other reasons|0|||
129193142|NCT02737475|465002908|FG003|Overall Study|Other reasons|0|||
129193143|NCT02737475|465002909|FG004|Overall Study|Other reasons|1|||
129193144|NCT02737475|465002910|FG005|Overall Study|Other reasons|1|||
129193145|NCT02737475|465002911|FG006|Overall Study|Other reasons|0|||
129193146|NCT02737475|465002912|FG007|Overall Study|Other reasons|0|||
129193147|NCT02737475|465002913|FG008|Overall Study|Other reasons|1|||
129193148|NCT02737475|465002914|FG009|Overall Study|Other reasons|0|||
129193149|NCT02737475|465002915|FG010|Overall Study|Other reasons|1|||
129193150|NCT02737475|465002916|FG011|Overall Study|Other reasons|0|||
129193151|NCT02737475|465002917|FG012|Overall Study|Other reasons|0|||
129193152|NCT02737475|465002918|FG013|Overall Study|Other reasons|0|||
129193153|NCT02737475|465002919|FG014|Overall Study|Other reasons|0|||
129193154|NCT02737475|465002920|FG015|Overall Study|Other reasons|0|||
129193155|NCT02737475|465002921|FG016|Overall Study|Other reasons|0|||
129193156|NCT02737475|465002922|FG017|Overall Study|Other reasons|0|||
129193157|NCT02737475|465002923|FG018|Overall Study|Other reasons|0|||
129193158|NCT02737475|465002924|FG019|Overall Study|Other reasons|0|||
129193159|NCT02737475|465002925|FG020|Overall Study|Other reasons|0|||
129193160|NCT02737475|465002926|FG021|Overall Study|Other reasons|1|||
129193161|NCT02737475|465002927|FG022|Overall Study|Other reasons|0|||
129193162|NCT02737475|465002928|FG023|Overall Study|Other reasons|1|||
129193163|NCT02737475|465002929|FG024|Overall Study|Other reasons|1|||
129193164|NCT02737475|465002930|FG025|Overall Study|Other reasons|1|||
129193165|NCT02737475|465002931|FG026|Overall Study|Other reasons|0|||
129193166|NCT02737475|465002905|FG000|Overall Study|Death|1|||
129193167|NCT02737475|465002906|FG001|Overall Study|Death|0|||
129193168|NCT02737475|465002907|FG002|Overall Study|Death|0|||
129193169|NCT02737475|465002908|FG003|Overall Study|Death|1|||
129193170|NCT02737475|465002909|FG004|Overall Study|Death|0|||
129193171|NCT02737475|465002910|FG005|Overall Study|Death|0|||
129193172|NCT02737475|465002911|FG006|Overall Study|Death|0|||
129193173|NCT02737475|465002912|FG007|Overall Study|Death|2|||
129193174|NCT02737475|465002913|FG008|Overall Study|Death|0|||
129193175|NCT02737475|465002914|FG009|Overall Study|Death|0|||
129193176|NCT02737475|465002915|FG010|Overall Study|Death|0|||
129193177|NCT02737475|465002916|FG011|Overall Study|Death|4|||
129193178|NCT02737475|465002917|FG012|Overall Study|Death|2|||
129193179|NCT02737475|465002918|FG013|Overall Study|Death|2|||
129193180|NCT02737475|465002919|FG014|Overall Study|Death|0|||
129193181|NCT02737475|465002920|FG015|Overall Study|Death|2|||
129193182|NCT02737475|465002921|FG016|Overall Study|Death|2|||
129193183|NCT02737475|465002922|FG017|Overall Study|Death|2|||
129193184|NCT02737475|465002923|FG018|Overall Study|Death|1|||
129193185|NCT02737475|465002924|FG019|Overall Study|Death|0|||
129193186|NCT02737475|465002925|FG020|Overall Study|Death|0|||
129193187|NCT02737475|465002926|FG021|Overall Study|Death|0|||
129193188|NCT02737475|465002927|FG022|Overall Study|Death|0|||
129193189|NCT02737475|465002928|FG023|Overall Study|Death|0|||
129193190|NCT02737475|465002929|FG024|Overall Study|Death|0|||
129193191|NCT02737475|465002930|FG025|Overall Study|Death|0|||
128781023|NCT02698436|463488658|FG001|Overall Study|Lost to Follow-up|4|||
129193192|NCT02737475|465002931|FG026|Overall Study|Death|0|||
129193193|NCT02737475|465002905|FG000|Overall Study|Participant withdrew consent|0|||
129193194|NCT02737475|465002906|FG001|Overall Study|Participant withdrew consent|0|||
129193195|NCT02737475|465002907|FG002|Overall Study|Participant withdrew consent|0|||
129193196|NCT02737475|465002908|FG003|Overall Study|Participant withdrew consent|0|||
129193197|NCT02737475|465002909|FG004|Overall Study|Participant withdrew consent|0|||
129193198|NCT02737475|465002910|FG005|Overall Study|Participant withdrew consent|2|||
129193199|NCT02737475|465002911|FG006|Overall Study|Participant withdrew consent|0|||
129193200|NCT02737475|465002912|FG007|Overall Study|Participant withdrew consent|0|||
129193201|NCT02737475|465002913|FG008|Overall Study|Participant withdrew consent|0|||
129193202|NCT02737475|465002914|FG009|Overall Study|Participant withdrew consent|0|||
129193203|NCT02737475|465002915|FG010|Overall Study|Participant withdrew consent|0|||
129193204|NCT02737475|465002916|FG011|Overall Study|Participant withdrew consent|0|||
129193205|NCT02737475|465002917|FG012|Overall Study|Participant withdrew consent|0|||
128781024|NCT02698436|463488657|FG000|Overall Study|Non-compliance with study regimen|1|||
129193206|NCT02737475|465002918|FG013|Overall Study|Participant withdrew consent|0|||
129193207|NCT02737475|465002919|FG014|Overall Study|Participant withdrew consent|1|||
129193208|NCT02737475|465002920|FG015|Overall Study|Participant withdrew consent|0|||
129193209|NCT02737475|465002921|FG016|Overall Study|Participant withdrew consent|0|||
129193210|NCT02737475|465002922|FG017|Overall Study|Participant withdrew consent|2|||
129193211|NCT02737475|465002923|FG018|Overall Study|Participant withdrew consent|1|||
129193212|NCT02737475|465002924|FG019|Overall Study|Participant withdrew consent|0|||
129193213|NCT02737475|465002925|FG020|Overall Study|Participant withdrew consent|2|||
129193214|NCT02737475|465002926|FG021|Overall Study|Participant withdrew consent|0|||
129193215|NCT02737475|465002927|FG022|Overall Study|Participant withdrew consent|0|||
129193216|NCT02737475|465002928|FG023|Overall Study|Participant withdrew consent|0|||
129193217|NCT02737475|465002929|FG024|Overall Study|Participant withdrew consent|0|||
129193218|NCT02737475|465002930|FG025|Overall Study|Participant withdrew consent|0|||
129193219|NCT02737475|465002931|FG026|Overall Study|Participant withdrew consent|0|||
129193220|NCT02737475|465002905|FG000|Overall Study|Lost to Follow-up|0|||
129193221|NCT02737475|465002906|FG001|Overall Study|Lost to Follow-up|0|||
129193222|NCT02737475|465002907|FG002|Overall Study|Lost to Follow-up|0|||
129193223|NCT02737475|465002908|FG003|Overall Study|Lost to Follow-up|0|||
129193224|NCT02737475|465002909|FG004|Overall Study|Lost to Follow-up|0|||
129193225|NCT02737475|465002910|FG005|Overall Study|Lost to Follow-up|0|||
129193226|NCT02737475|465002911|FG006|Overall Study|Lost to Follow-up|0|||
129193227|NCT02737475|465002912|FG007|Overall Study|Lost to Follow-up|0|||
129193228|NCT02737475|465002913|FG008|Overall Study|Lost to Follow-up|0|||
129193229|NCT02737475|465002914|FG009|Overall Study|Lost to Follow-up|0|||
129193230|NCT02737475|465002915|FG010|Overall Study|Lost to Follow-up|0|||
129193231|NCT02737475|465002916|FG011|Overall Study|Lost to Follow-up|0|||
129193232|NCT02737475|465002917|FG012|Overall Study|Lost to Follow-up|0|||
129193233|NCT02737475|465002918|FG013|Overall Study|Lost to Follow-up|0|||
129193234|NCT02737475|465002919|FG014|Overall Study|Lost to Follow-up|0|||
129193235|NCT02737475|465002920|FG015|Overall Study|Lost to Follow-up|1|||
129193236|NCT02737475|465002921|FG016|Overall Study|Lost to Follow-up|0|||
129193237|NCT02737475|465002922|FG017|Overall Study|Lost to Follow-up|0|||
129193238|NCT02737475|465002923|FG018|Overall Study|Lost to Follow-up|0|||
129193239|NCT02737475|465002924|FG019|Overall Study|Lost to Follow-up|0|||
129193240|NCT02737475|465002925|FG020|Overall Study|Lost to Follow-up|0|||
129193241|NCT02737475|465002926|FG021|Overall Study|Lost to Follow-up|0|||
129193242|NCT02737475|465002927|FG022|Overall Study|Lost to Follow-up|0|||
129193243|NCT02737475|465002928|FG023|Overall Study|Lost to Follow-up|0|||
129193244|NCT02737475|465002929|FG024|Overall Study|Lost to Follow-up|0|||
129193245|NCT02737475|465002930|FG025|Overall Study|Lost to Follow-up|0|||
129193246|NCT02737475|465002931|FG026|Overall Study|Lost to Follow-up|0|||
129193247|NCT02737475|465002905|FG000|Overall Study|Disease Progression|0|||
129193248|NCT02737475|465002906|FG001|Overall Study|Disease Progression|0|||
129193249|NCT02737475|465002907|FG002|Overall Study|Disease Progression|0|||
129193250|NCT02737475|465002908|FG003|Overall Study|Disease Progression|0|||
129193251|NCT02737475|465002909|FG004|Overall Study|Disease Progression|0|||
129193252|NCT02737475|465002910|FG005|Overall Study|Disease Progression|0|||
129193253|NCT02737475|465002911|FG006|Overall Study|Disease Progression|0|||
129193254|NCT02737475|465002912|FG007|Overall Study|Disease Progression|0|||
129193255|NCT02737475|465002913|FG008|Overall Study|Disease Progression|0|||
129193256|NCT02737475|465002914|FG009|Overall Study|Disease Progression|0|||
129193257|NCT02737475|465002915|FG010|Overall Study|Disease Progression|0|||
128730431|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
128730432|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
128730433|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
128730434|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
128730435|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
128730436|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
129193258|NCT02737475|465002916|FG011|Overall Study|Disease Progression|0|||
129193259|NCT02737475|465002917|FG012|Overall Study|Disease Progression|0|||
129193260|NCT02737475|465002918|FG013|Overall Study|Disease Progression|0|||
129193261|NCT02737475|465002919|FG014|Overall Study|Disease Progression|0|||
129193262|NCT02737475|465002920|FG015|Overall Study|Disease Progression|0|||
129193263|NCT02737475|465002921|FG016|Overall Study|Disease Progression|0|||
129193264|NCT02737475|465002922|FG017|Overall Study|Disease Progression|0|||
129193265|NCT02737475|465002923|FG018|Overall Study|Disease Progression|0|||
129193266|NCT02737475|465002924|FG019|Overall Study|Disease Progression|0|||
129193267|NCT02737475|465002925|FG020|Overall Study|Disease Progression|0|||
129193268|NCT02737475|465002926|FG021|Overall Study|Disease Progression|0|||
129193269|NCT02737475|465002927|FG022|Overall Study|Disease Progression|0|||
129193270|NCT02737475|465002928|FG023|Overall Study|Disease Progression|0|||
129193271|NCT02737475|465002929|FG024|Overall Study|Disease Progression|0|||
129193272|NCT02737475|465002930|FG025|Overall Study|Disease Progression|0|||
129193273|NCT02737475|465002931|FG026|Overall Study|Disease Progression|1|||
129193274|NCT03688074|465002932|FG000|Overall Study|Adverse Event|0|||
129193275|NCT03688074|465002933|FG001|Overall Study|Adverse Event|1|||
129193276|NCT03688074|465002932|FG000|Overall Study|Other|1|||
129193277|NCT03688074|465002933|FG001|Overall Study|Other|0|||
129193278|NCT01128244|465002940|FG000|Overall Study|Adverse Event|1|||
129193279|NCT01128244|465002940|FG000|Overall Study|Scheduling conflict|2|||
129193280|NCT03040674|465002946|FG000|Overall Study|Lost to Follow-up|225|||
129193281|NCT03040674|465002946|FG000|Overall Study|Death|23|||
129193282|NCT02206035|465002947|FG000|Overall Study|Physician Decision|10|||
129193283|NCT02206035|465002948|FG001|Overall Study|Physician Decision|0|||
129193284|NCT02206035|465002949|FG002|Overall Study|Physician Decision|175|||
129193285|NCT01934010|465002950|FG000|Overall Study|Adverse Event|1|||
129193286|NCT01934010|465002951|FG001|Overall Study|Adverse Event|1|||
129193287|NCT01934010|465002952|FG002|Overall Study|Adverse Event|0|||
129193288|NCT01934010|465002950|FG000|Overall Study|Withdrawal by Subject|15|||
129193289|NCT01934010|465002951|FG001|Overall Study|Withdrawal by Subject|6|||
129193290|NCT01934010|465002952|FG002|Overall Study|Withdrawal by Subject|2|||
129193291|NCT01934010|465002950|FG000|Overall Study|Lost to Follow-up|7|||
129193292|NCT01934010|465002951|FG001|Overall Study|Lost to Follow-up|4|||
129193293|NCT01934010|465002952|FG002|Overall Study|Lost to Follow-up|0|||
129193294|NCT02936843|465002953|FG000|Overall Study|Lost to Follow-up|3|||
129193295|NCT02936843|465002954|FG001|Overall Study|Lost to Follow-up|1|||
129193296|NCT02936843|465002953|FG000|Overall Study|Withdrawal by Subject|1|||
129193297|NCT02936843|465002954|FG001|Overall Study|Withdrawal by Subject|1|||
129193298|NCT03386487|465002955|FG000|Overall Study|Lost to Follow-up|5|||
129193299|NCT03386487|465002956|FG001|Overall Study|Lost to Follow-up|6|||
129193300|NCT03386487|465002955|FG000|Overall Study|Withdrawal by Subject|11|||
129193301|NCT03386487|465002956|FG001|Overall Study|Withdrawal by Subject|7|||
129193302|NCT03386487|465002955|FG000|Overall Study|Physician Decision|11|||
129193303|NCT03386487|465002956|FG001|Overall Study|Physician Decision|8|||
129193304|NCT02703324|465002957|FG000|Period Two|Withdrawal by Subject|0|||
129193305|NCT02703324|465002958|FG001|Period Two|Withdrawal by Subject|0|||
129193306|NCT02703324|465002959|FG002|Period Two|Withdrawal by Subject|1|||
129193307|NCT02703324|465002960|FG003|Period Two|Withdrawal by Subject|0|||
129193308|NCT02703324|465002961|FG004|Period Two|Withdrawal by Subject|0|||
129193309|NCT02703324|465002962|FG005|Period Two|Withdrawal by Subject|0|||
129193310|NCT04303572|465002963|FG000|Overall Study|Study closed due to poor enrollment|1|||
129193311|NCT06312592|465002964|FG000|Overall Study|Lost to Follow-up|29|||
129193312|NCT06312592|465002965|FG001|Overall Study|Lost to Follow-up|13|||
129193313|NCT04531241|465002968|FG000|Period 1|Withdrawal by Subject|2|||
129193314|NCT04531241|465002969|FG001|Period 1|Withdrawal by Subject|0|||
129193315|NCT04531241|465002968|FG000|Period 1|Dispesed incorrect lens power|1|||
129193316|NCT04531241|465002969|FG001|Period 1|Dispesed incorrect lens power|0|||
129193317|NCT04531241|465002968|FG000|Period 1|Protocol Violation|1|||
129193318|NCT04531241|465002969|FG001|Period 1|Protocol Violation|0|||
129193319|NCT04531241|465002968|FG000|Period 1|No longer eligible|0|||
129193320|NCT04531241|465002969|FG001|Period 1|No longer eligible|1|||
129193321|NCT04531241|465002968|FG000|Period 1|Lens Discomfort|0|||
129193322|NCT04531241|465002969|FG001|Period 1|Lens Discomfort|1|||
129193323|NCT04531241|465002968|FG000|Period 2|Covid-19 Related|1|||
129193324|NCT04531241|465002969|FG001|Period 2|Covid-19 Related|1|||
129193325|NCT04929249|465002970|FG000|Overall Study|Adverse Event|2|||
129193326|NCT04929249|465002971|FG001|Overall Study|Adverse Event|1|||
129193327|NCT04929249|465002970|FG000|Overall Study|Death|2|||
129193328|NCT04929249|465002971|FG001|Overall Study|Death|1|||
129193329|NCT04929249|465002970|FG000|Overall Study|Lost to Follow-up|3|||
129193330|NCT04929249|465002971|FG001|Overall Study|Lost to Follow-up|11|||
129193331|NCT04929249|465002970|FG000|Overall Study|Technical problems|0|||
129193332|NCT04929249|465002971|FG001|Overall Study|Technical problems|1|||
129193333|NCT04929249|465002970|FG000|Overall Study|Subject decision|6|||
129193334|NCT04929249|465002971|FG001|Overall Study|Subject decision|8|||
129193335|NCT04929249|465002970|FG000|Overall Study|Withdrew consent|0|||
129193336|NCT04929249|465002971|FG001|Overall Study|Withdrew consent|8|||
129193337|NCT01620762|465002978|FG000|Overall Study|Protocol Violation|1|||
129193338|NCT01620762|465002979|FG001|Overall Study|Protocol Violation|1|||
129193339|NCT01620762|465002980|FG002|Overall Study|Protocol Violation|1|||
129193340|NCT01620762|465002978|FG000|Overall Study|Adverse Event|9|||
129193341|NCT01620762|465002979|FG001|Overall Study|Adverse Event|5|||
129193342|NCT01620762|465002980|FG002|Overall Study|Adverse Event|2|||
129193343|NCT01620762|465002978|FG000|Overall Study|Withdrawal by Subject|23|||
129193344|NCT01620762|465002979|FG001|Overall Study|Withdrawal by Subject|26|||
129193345|NCT01620762|465002980|FG002|Overall Study|Withdrawal by Subject|27|||
129193346|NCT01620762|465002978|FG000|Overall Study|Lost to Follow-up|11|||
129193347|NCT01620762|465002979|FG001|Overall Study|Lost to Follow-up|17|||
129193348|NCT01620762|465002980|FG002|Overall Study|Lost to Follow-up|10|||
129193349|NCT01620762|465002978|FG000|Overall Study|Protocol deviation|1|||
129193350|NCT01620762|465002979|FG001|Overall Study|Protocol deviation|1|||
129193351|NCT01620762|465002980|FG002|Overall Study|Protocol deviation|6|||
129193352|NCT01620762|465002978|FG000|Overall Study|Subject deterioration|0|||
129193353|NCT01620762|465002979|FG001|Overall Study|Subject deterioration|1|||
129193354|NCT01620762|465002980|FG002|Overall Study|Subject deterioration|1|||
129193355|NCT01620762|465002978|FG000|Overall Study|Non-specified|3|||
129193356|NCT01620762|465002979|FG001|Overall Study|Non-specified|6|||
129193357|NCT01620762|465002980|FG002|Overall Study|Non-specified|5|||
129193358|NCT01620762|465002978|FG000|Overall Study|Use of prohibted therapies|0|||
129193359|NCT01620762|465002979|FG001|Overall Study|Use of prohibted therapies|1|||
129193360|NCT01620762|465002980|FG002|Overall Study|Use of prohibted therapies|1|||
129193361|NCT00705146|465002985|FG000|Overall Study|Lost to Follow-up|1|||
129193362|NCT00705146|465002986|FG001|Overall Study|Lost to Follow-up|1|||
129193363|NCT00095173|465002989|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
129193364|NCT00095173|465002990|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129193365|NCT00095173|465002991|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129193366|NCT00095173|465002992|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129193367|NCT00095173|465002993|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129193368|NCT00095173|465002994|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129193369|NCT00095173|465002989|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
128730437|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
129193370|NCT00095173|465002990|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129193371|NCT00095173|465002991|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129193372|NCT00095173|465002992|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129193373|NCT00095173|465002993|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129193374|NCT00095173|465002994|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129193375|NCT00095173|465002989|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
129193376|NCT00095173|465002990|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129193377|NCT00095173|465002991|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129193378|NCT00095173|465002992|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129193379|NCT00095173|465002993|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129193380|NCT00095173|465002994|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129193381|NCT00095173|465002989|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
129193382|NCT00095173|465002990|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
129193383|NCT00095173|465002991|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
129193384|NCT00095173|465002992|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
129193385|NCT00095173|465002993|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
129193386|NCT00095173|465002994|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
129193387|NCT00095173|465002989|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129193388|NCT00095173|465002990|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
129193389|NCT00095173|465002991|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
129193390|NCT00095173|465002992|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129193391|NCT00095173|465002993|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129193392|NCT00095173|465002994|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129193393|NCT00095173|465002989|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129193394|NCT00095173|465002990|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
129193395|NCT00095173|465002991|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129193396|NCT00095173|465002992|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129193397|NCT00095173|465002993|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129193398|NCT00095173|465002994|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129193399|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Death|0|||
129193400|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Death|0|||
129193401|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Death|0|||
129193402|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Death|0|||
129193403|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Death|0|||
129193404|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Death|1|||
129193405|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
129193406|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
129193407|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
129193408|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
129193409|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
129193410|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
129193411|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
129193412|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
129193413|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
129193414|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
129193415|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
129193416|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
129193417|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
129193418|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
129193419|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
129193420|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
129193421|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
129193422|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
129193423|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129193424|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129193425|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129193426|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
129193427|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
129193428|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129193429|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129193430|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129193431|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129193432|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129193433|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
129193434|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
129193435|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
129193436|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
128730438|NCT01633944|463309960|FG000|Double-blind Treatment Phase|Other|0|||
128730439|NCT01633944|463309961|FG001|Double-blind Treatment Phase|Other|7|||
128730440|NCT01633944|463309962|FG002|Double-blind Treatment Phase|Other|0|||
128730441|NCT00701129|463309963|FG000|Overall Study|Death|2|||
128730442|NCT02412631|463309964|FG000|Overall Study|Adverse Event|1|||
128730443|NCT02412631|463309965|FG001|Overall Study|Adverse Event|2|||
128730444|NCT02412631|463309964|FG000|Overall Study|Lost to Follow-up|5|||
129193437|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
129193438|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
129193439|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
129193440|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
129193441|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
129193442|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
129193443|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
129193444|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
129193445|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
129193446|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
129193447|NCT00095173|465002989|FG000|Open-Label Extension Phase (Period C)|Other|0|||
129193448|NCT00095173|465002990|FG001|Open-Label Extension Phase (Period C)|Other|0|||
129193449|NCT00095173|465002991|FG002|Open-Label Extension Phase (Period C)|Other|0|||
129193450|NCT00095173|465002992|FG003|Open-Label Extension Phase (Period C)|Other|4|||
129193451|NCT00095173|465002993|FG004|Open-Label Extension Phase (Period C)|Other|6|||
129193452|NCT00095173|465002994|FG005|Open-Label Extension Phase (Period C)|Other|8|||
129193453|NCT04698993|465002999|FG000|Overall Study|PCR results not accessible|2|||
129193454|NCT04698993|465003000|FG001|Overall Study|PCR results not accessible|7|||
129193455|NCT04698993|465002999|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
129193456|NCT04698993|465003000|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
129193457|NCT00527904|465003001|FG000|Overall Study|Adverse Event|45|||
129193458|NCT00527904|465003001|FG000|Overall Study|Withdrawal by Subject|21|||
129193459|NCT00527904|465003001|FG000|Overall Study|Lost to Follow-up|8|||
129193460|NCT00527904|465003001|FG000|Overall Study|misc|22|||
129193461|NCT00428389|465003003|FG000|Core Phase|Adverse Event|6|||
129193462|NCT00428389|465003004|FG001|Core Phase|Adverse Event|4|||
129193463|NCT00428389|465003003|FG000|Core Phase|Lack of Efficacy|2|||
129193464|NCT00428389|465003004|FG001|Core Phase|Lack of Efficacy|0|||
129193465|NCT00428389|465003003|FG000|Core Phase|Abnormal test procedure result(s)|0|||
129193466|NCT00428389|465003004|FG001|Core Phase|Abnormal test procedure result(s)|1|||
129193467|NCT00428389|465003003|FG000|Core Phase|Withdrawal by Subject|3|||
129193468|NCT00428389|465003004|FG001|Core Phase|Withdrawal by Subject|4|||
129193469|NCT00428389|465003003|FG000|Core Phase|Protocol deviation|0|||
129193470|NCT00428389|465003004|FG001|Core Phase|Protocol deviation|2|||
129193471|NCT00428389|465003003|FG000|Extension Phase|Adverse Event|17|||
129193472|NCT00428389|465003004|FG001|Extension Phase|Adverse Event|11|||
129193473|NCT00428389|465003003|FG000|Extension Phase|Lack of Efficacy|4|||
129193474|NCT00428389|465003004|FG001|Extension Phase|Lack of Efficacy|3|||
129193475|NCT00428389|465003003|FG000|Extension Phase|Withdrawal by Subject|6|||
129193476|NCT00428389|465003004|FG001|Extension Phase|Withdrawal by Subject|6|||
129193477|NCT00428389|465003003|FG000|Extension Phase|Lost to Follow-up|0|||
129193478|NCT00428389|465003004|FG001|Extension Phase|Lost to Follow-up|3|||
129193479|NCT00428389|465003003|FG000|Extension Phase|Death|1|||
129193480|NCT00428389|465003004|FG001|Extension Phase|Death|0|||
129193481|NCT00428389|465003003|FG000|Extension Phase|Protocol Violation|3|||
129193482|NCT00428389|465003004|FG001|Extension Phase|Protocol Violation|2|||
129193483|NCT00428389|465003003|FG000|Extension Phase|Administrative problems|1|||
129193484|NCT00428389|465003004|FG001|Extension Phase|Administrative problems|1|||
129193485|NCT00172042|465003008|FG000|Overall Study|Adverse Event|27|||
129193486|NCT00172042|465003009|FG001|Overall Study|Adverse Event|13|||
129193487|NCT00172042|465003008|FG000|Overall Study|Abnormal laboratory value(s)|5|||
129193488|NCT00172042|465003009|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129193489|NCT00172042|465003008|FG000|Overall Study|Abnormal test procedure(s)|0|||
129193490|NCT00172042|465003009|FG001|Overall Study|Abnormal test procedure(s)|3|||
129193491|NCT00172042|465003008|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
129193492|NCT00172042|465003009|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
129193493|NCT00172042|465003008|FG000|Overall Study|Patient no longer requires study drug|10|||
129193494|NCT00172042|465003009|FG001|Overall Study|Patient no longer requires study drug|8|||
129193495|NCT00172042|465003008|FG000|Overall Study|Protocol Violation|8|||
129193496|NCT00172042|465003009|FG001|Overall Study|Protocol Violation|7|||
129193497|NCT00172042|465003008|FG000|Overall Study|Withdrawal by Subject|37|||
128730445|NCT02412631|463309965|FG001|Overall Study|Lost to Follow-up|9|||
128730446|NCT02412631|463309964|FG000|Overall Study|Withdrawal by Subject|9|||
129193498|NCT00172042|465003009|FG001|Overall Study|Withdrawal by Subject|25|||
129193499|NCT00172042|465003008|FG000|Overall Study|Lost to Follow-up|3|||
129193500|NCT00172042|465003009|FG001|Overall Study|Lost to Follow-up|5|||
129193501|NCT00172042|465003008|FG000|Overall Study|Administrative problems|13|||
129193502|NCT00172042|465003009|FG001|Overall Study|Administrative problems|10|||
129193503|NCT00172042|465003008|FG000|Overall Study|Death|42|||
129193504|NCT00172042|465003009|FG001|Overall Study|Death|42|||
129193505|NCT01771250|465003010|FG000|Period 1|Met exclusion criteria|1|||
129193506|NCT01771250|465003011|FG001|Period 1|Met exclusion criteria|0|||
129193507|NCT00483938|465003012|FG000|Overall Study|Protocol Violation|0|||
129193508|NCT00483938|465003013|FG001|Overall Study|Protocol Violation|0|||
129193509|NCT00483938|465003014|FG002|Overall Study|Protocol Violation|0|||
129193510|NCT00483938|465003015|FG003|Overall Study|Protocol Violation|0|||
129193511|NCT00483938|465003016|FG004|Overall Study|Protocol Violation|0|||
129193512|NCT00483938|465003017|FG005|Overall Study|Protocol Violation|0|||
129193513|NCT00483938|465003018|FG006|Overall Study|Protocol Violation|3|||
129193514|NCT00483938|465003012|FG000|Overall Study|Withdrawal by Subject|1|||
129193515|NCT00483938|465003013|FG001|Overall Study|Withdrawal by Subject|6|||
129193516|NCT00483938|465003014|FG002|Overall Study|Withdrawal by Subject|0|||
129193517|NCT00483938|465003015|FG003|Overall Study|Withdrawal by Subject|0|||
129193518|NCT00483938|465003016|FG004|Overall Study|Withdrawal by Subject|1|||
129193519|NCT00483938|465003017|FG005|Overall Study|Withdrawal by Subject|3|||
129193520|NCT00483938|465003018|FG006|Overall Study|Withdrawal by Subject|2|||
129193521|NCT00483938|465003012|FG000|Overall Study|Lost to Follow-up|1|||
129193522|NCT00483938|465003013|FG001|Overall Study|Lost to Follow-up|2|||
129193523|NCT00483938|465003014|FG002|Overall Study|Lost to Follow-up|0|||
129193524|NCT00483938|465003015|FG003|Overall Study|Lost to Follow-up|2|||
129193525|NCT00483938|465003016|FG004|Overall Study|Lost to Follow-up|1|||
129193526|NCT00483938|465003017|FG005|Overall Study|Lost to Follow-up|1|||
129193527|NCT00483938|465003018|FG006|Overall Study|Lost to Follow-up|3|||
129193528|NCT00483938|465003012|FG000|Overall Study|Death|0|||
129193529|NCT00483938|465003013|FG001|Overall Study|Death|2|||
129193530|NCT00483938|465003014|FG002|Overall Study|Death|0|||
129193531|NCT00483938|465003015|FG003|Overall Study|Death|0|||
129193532|NCT00483938|465003016|FG004|Overall Study|Death|0|||
129193533|NCT00483938|465003017|FG005|Overall Study|Death|0|||
129193534|NCT00483938|465003018|FG006|Overall Study|Death|0|||
129193535|NCT00483938|465003012|FG000|Overall Study|Other|3|||
129193536|NCT00483938|465003013|FG001|Overall Study|Other|9|||
129193537|NCT00483938|465003014|FG002|Overall Study|Other|0|||
129193538|NCT00483938|465003015|FG003|Overall Study|Other|4|||
129193539|NCT00483938|465003016|FG004|Overall Study|Other|0|||
129193540|NCT00483938|465003017|FG005|Overall Study|Other|4|||
129193541|NCT00483938|465003018|FG006|Overall Study|Other|32|||
129193542|NCT02218008|465003019|FG000|Stage 1 (S1)|Adverse Event|6|||
129193543|NCT02218008|465003020|FG001|Stage 1 (S1)|Adverse Event|5|||
129193544|NCT02218008|465003021|FG002|Stage 1 (S1)|Adverse Event|11|||
129193545|NCT02218008|465003022|FG003|Stage 1 (S1)|Adverse Event|0|||
129193546|NCT02218008|465003023|FG004|Stage 1 (S1)|Adverse Event|0|||
128730447|NCT02412631|463309965|FG001|Overall Study|Withdrawal by Subject|3|||
129193547|NCT02218008|465003024|FG005|Stage 1 (S1)|Adverse Event|0|||
129193548|NCT02218008|465003019|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
129193549|NCT02218008|465003020|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
129193550|NCT02218008|465003021|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
129193551|NCT02218008|465003022|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
129193552|NCT02218008|465003023|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
129193553|NCT02218008|465003024|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
129193554|NCT02218008|465003019|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
129193555|NCT02218008|465003020|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
129193556|NCT02218008|465003021|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
129193557|NCT02218008|465003022|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
129193558|NCT02218008|465003023|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
129193559|NCT02218008|465003024|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
129193560|NCT02218008|465003019|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
129193561|NCT02218008|465003020|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
129193562|NCT02218008|465003021|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
129193563|NCT02218008|465003022|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
129193564|NCT02218008|465003023|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
129193565|NCT02218008|465003024|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
129193566|NCT02218008|465003019|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
129193567|NCT02218008|465003020|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
129193568|NCT02218008|465003021|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129193569|NCT02218008|465003022|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129193570|NCT02218008|465003023|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129193571|NCT02218008|465003024|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129193572|NCT02218008|465003019|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
129193573|NCT02218008|465003020|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
129193574|NCT02218008|465003021|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
129193575|NCT02218008|465003022|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
129193576|NCT02218008|465003023|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
129193577|NCT02218008|465003024|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
129193578|NCT02218008|465003019|FG000|Stage 1 (S1)|Pregnancy|0|||
129193579|NCT02218008|465003020|FG001|Stage 1 (S1)|Pregnancy|0|||
129193580|NCT02218008|465003021|FG002|Stage 1 (S1)|Pregnancy|1|||
129193581|NCT02218008|465003022|FG003|Stage 1 (S1)|Pregnancy|0|||
129193582|NCT02218008|465003023|FG004|Stage 1 (S1)|Pregnancy|0|||
129193583|NCT02218008|465003024|FG005|Stage 1 (S1)|Pregnancy|0|||
129193584|NCT02218008|465003019|FG000|Stage 1 (S1)|Protocol Violation|0|||
129193585|NCT02218008|465003020|FG001|Stage 1 (S1)|Protocol Violation|0|||
129193586|NCT02218008|465003021|FG002|Stage 1 (S1)|Protocol Violation|1|||
129193587|NCT02218008|465003022|FG003|Stage 1 (S1)|Protocol Violation|0|||
129193588|NCT02218008|465003023|FG004|Stage 1 (S1)|Protocol Violation|0|||
129193589|NCT02218008|465003024|FG005|Stage 1 (S1)|Protocol Violation|0|||
129193590|NCT02218008|465003019|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
129193591|NCT02218008|465003020|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129193592|NCT02218008|465003021|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129193593|NCT02218008|465003022|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129193594|NCT02218008|465003023|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129193595|NCT02218008|465003024|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129193596|NCT02218008|465003019|FG000|Stage 2 (S2)|Adverse Event|0|||
129193597|NCT02218008|465003020|FG001|Stage 2 (S2)|Adverse Event|0|||
129193598|NCT02218008|465003021|FG002|Stage 2 (S2)|Adverse Event|0|||
129193599|NCT02218008|465003022|FG003|Stage 2 (S2)|Adverse Event|2|||
129193600|NCT02218008|465003023|FG004|Stage 2 (S2)|Adverse Event|3|||
129193601|NCT02218008|465003024|FG005|Stage 2 (S2)|Adverse Event|3|||
129193602|NCT02218008|465003019|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
129193603|NCT02218008|465003020|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
129193604|NCT02218008|465003021|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
129193605|NCT02218008|465003022|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
129193606|NCT02218008|465003023|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
129193607|NCT02218008|465003024|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
129193608|NCT02218008|465003019|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
129193609|NCT02218008|465003020|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
129193610|NCT02218008|465003021|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
129193611|NCT02218008|465003022|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
129193612|NCT02218008|465003023|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
129193613|NCT02218008|465003024|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
129193614|NCT02218008|465003019|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129193615|NCT02218008|465003020|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129193616|NCT02218008|465003021|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129193617|NCT02218008|465003022|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
129193618|NCT02218008|465003023|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129193619|NCT02218008|465003024|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129193620|NCT02218008|465003019|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
129193621|NCT02218008|465003020|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
129193622|NCT02218008|465003021|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
129193623|NCT02218008|465003022|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
129193624|NCT02218008|465003023|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
129193625|NCT02218008|465003024|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
129193626|NCT00106353|465003025|FG000|Part 1|Disease progression|3|||
129193627|NCT00106353|465003026|FG001|Part 1|Disease progression|4|||
129193628|NCT00106353|465003027|FG002|Part 1|Disease progression|1|||
129193629|NCT00106353|465003028|FG003|Part 1|Disease progression|3|||
129193630|NCT00106353|465003029|FG004|Part 1|Disease progression|0|||
129193631|NCT00106353|465003030|FG005|Part 1|Disease progression|0|||
129193632|NCT00106353|465003031|FG006|Part 1|Disease progression|0|||
129193633|NCT00106353|465003025|FG000|Part 1|Withdrawal by Subject|0|||
129193634|NCT00106353|465003026|FG001|Part 1|Withdrawal by Subject|0|||
129193635|NCT00106353|465003027|FG002|Part 1|Withdrawal by Subject|1|||
129193636|NCT00106353|465003028|FG003|Part 1|Withdrawal by Subject|2|||
129193637|NCT00106353|465003029|FG004|Part 1|Withdrawal by Subject|0|||
129193638|NCT00106353|465003030|FG005|Part 1|Withdrawal by Subject|0|||
129193639|NCT00106353|465003031|FG006|Part 1|Withdrawal by Subject|0|||
129193640|NCT00106353|465003025|FG000|Part 1|Symptomatic deterioration|0|||
129193641|NCT00106353|465003026|FG001|Part 1|Symptomatic deterioration|0|||
129193642|NCT00106353|465003027|FG002|Part 1|Symptomatic deterioration|1|||
129193643|NCT00106353|465003028|FG003|Part 1|Symptomatic deterioration|0|||
129193644|NCT00106353|465003029|FG004|Part 1|Symptomatic deterioration|0|||
129193645|NCT00106353|465003030|FG005|Part 1|Symptomatic deterioration|0|||
129193646|NCT00106353|465003031|FG006|Part 1|Symptomatic deterioration|0|||
129193647|NCT00106353|465003025|FG000|Part 1|Entered follow-up phase|1|||
129193648|NCT00106353|465003026|FG001|Part 1|Entered follow-up phase|1|||
129193649|NCT00106353|465003027|FG002|Part 1|Entered follow-up phase|0|||
129193650|NCT00106353|465003028|FG003|Part 1|Entered follow-up phase|1|||
129193651|NCT00106353|465003029|FG004|Part 1|Entered follow-up phase|0|||
129193652|NCT00106353|465003030|FG005|Part 1|Entered follow-up phase|0|||
129193653|NCT00106353|465003031|FG006|Part 1|Entered follow-up phase|0|||
129193654|NCT00106353|465003025|FG000|Part 1|Adverse Event|0|||
129193655|NCT00106353|465003026|FG001|Part 1|Adverse Event|0|||
129193656|NCT00106353|465003027|FG002|Part 1|Adverse Event|0|||
129193657|NCT00106353|465003028|FG003|Part 1|Adverse Event|1|||
129193658|NCT00106353|465003029|FG004|Part 1|Adverse Event|0|||
129193659|NCT00106353|465003030|FG005|Part 1|Adverse Event|0|||
129193660|NCT00106353|465003031|FG006|Part 1|Adverse Event|0|||
129193661|NCT00106353|465003025|FG000|Part 2|Disease progression|0|||
129193662|NCT00106353|465003026|FG001|Part 2|Disease progression|0|||
129193663|NCT00106353|465003027|FG002|Part 2|Disease progression|0|||
129193664|NCT00106353|465003028|FG003|Part 2|Disease progression|0|||
129193665|NCT00106353|465003029|FG004|Part 2|Disease progression|8|||
129193666|NCT00106353|465003030|FG005|Part 2|Disease progression|14|||
129193667|NCT00106353|465003031|FG006|Part 2|Disease progression|13|||
129193668|NCT00106353|465003025|FG000|Part 2|Death|0|||
129193669|NCT00106353|465003026|FG001|Part 2|Death|0|||
129193670|NCT00106353|465003027|FG002|Part 2|Death|0|||
129193671|NCT00106353|465003028|FG003|Part 2|Death|0|||
129193672|NCT00106353|465003029|FG004|Part 2|Death|3|||
129193673|NCT00106353|465003030|FG005|Part 2|Death|0|||
129193674|NCT00106353|465003031|FG006|Part 2|Death|1|||
129193675|NCT00106353|465003025|FG000|Part 2|Symptomatic deterioration|0|||
129193676|NCT00106353|465003026|FG001|Part 2|Symptomatic deterioration|0|||
129193677|NCT00106353|465003027|FG002|Part 2|Symptomatic deterioration|0|||
129193678|NCT00106353|465003028|FG003|Part 2|Symptomatic deterioration|0|||
129193679|NCT00106353|465003029|FG004|Part 2|Symptomatic deterioration|3|||
129193680|NCT00106353|465003030|FG005|Part 2|Symptomatic deterioration|0|||
129193681|NCT00106353|465003031|FG006|Part 2|Symptomatic deterioration|0|||
129193682|NCT00106353|465003025|FG000|Part 2|Adverse Event|0|||
129193683|NCT00106353|465003026|FG001|Part 2|Adverse Event|0|||
129193684|NCT00106353|465003027|FG002|Part 2|Adverse Event|0|||
129193685|NCT00106353|465003028|FG003|Part 2|Adverse Event|0|||
129193686|NCT00106353|465003029|FG004|Part 2|Adverse Event|0|||
129193687|NCT00106353|465003030|FG005|Part 2|Adverse Event|2|||
129193688|NCT00106353|465003031|FG006|Part 2|Adverse Event|1|||
129193689|NCT00106353|465003025|FG000|Part 2|Other|0|||
129193690|NCT00106353|465003026|FG001|Part 2|Other|0|||
129193691|NCT00106353|465003027|FG002|Part 2|Other|0|||
129193692|NCT00106353|465003028|FG003|Part 2|Other|0|||
129193693|NCT00106353|465003029|FG004|Part 2|Other|1|||
129193694|NCT00106353|465003030|FG005|Part 2|Other|1|||
129193695|NCT00106353|465003031|FG006|Part 2|Other|1|||
129193696|NCT00106353|465003025|FG000|Part 2|Withdrawal by Subject|0|||
129193697|NCT00106353|465003026|FG001|Part 2|Withdrawal by Subject|0|||
129193698|NCT00106353|465003027|FG002|Part 2|Withdrawal by Subject|0|||
129193699|NCT00106353|465003028|FG003|Part 2|Withdrawal by Subject|0|||
129193700|NCT00106353|465003029|FG004|Part 2|Withdrawal by Subject|1|||
129193701|NCT00106353|465003030|FG005|Part 2|Withdrawal by Subject|0|||
129193702|NCT00106353|465003031|FG006|Part 2|Withdrawal by Subject|0|||
129193703|NCT00106353|465003025|FG000|Part 2|Physician Decision|0|||
129193704|NCT00106353|465003026|FG001|Part 2|Physician Decision|0|||
129193705|NCT00106353|465003027|FG002|Part 2|Physician Decision|0|||
129193706|NCT00106353|465003028|FG003|Part 2|Physician Decision|0|||
129193707|NCT00106353|465003029|FG004|Part 2|Physician Decision|0|||
129193708|NCT00106353|465003030|FG005|Part 2|Physician Decision|1|||
129193709|NCT00106353|465003031|FG006|Part 2|Physician Decision|0|||
128730448|NCT02412631|463309964|FG000|Overall Study|Early stop by FDA|5|||
128730449|NCT02412631|463309965|FG001|Overall Study|Early stop by FDA|2|||
128730450|NCT02412631|463309964|FG000|Overall Study|Unspecified reason|6|||
128730451|NCT02412631|463309965|FG001|Overall Study|Unspecified reason|8|||
128730452|NCT00480636|463309966|FG000|Overall Study|Death|12|||
128730453|NCT00480636|463309966|FG000|Overall Study|Lost to Follow-up|4|||
128730454|NCT00480636|463309966|FG000|Overall Study|Other|2|||
128730455|NCT00480636|463309966|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
128730456|NCT00326911|463309969|FG000|Overall Study|Hospitalization prior to treatment|0|||
128730457|NCT00326911|463309970|FG001|Overall Study|Hospitalization prior to treatment|1|||
128730458|NCT00326911|463309969|FG000|Overall Study|Physician decision prior to treatment|1|||
128730459|NCT00326911|463309970|FG001|Overall Study|Physician decision prior to treatment|0|||
128730460|NCT00326911|463309969|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
128730461|NCT00326911|463309970|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
128730462|NCT04537806|463309974|FG000|Overall Study|Randomized but not treated|1|||
128730463|NCT04537806|463309975|FG001|Overall Study|Randomized but not treated|0|||
128730464|NCT04537806|463309974|FG000|Overall Study|Adverse Event|1|||
128730465|NCT04537806|463309975|FG001|Overall Study|Adverse Event|1|||
128730466|NCT03019627|463309976|FG000|Overall Study|Adverse Event|8|||
128730467|NCT03019627|463309977|FG001|Overall Study|Adverse Event|0|||
128730468|NCT03019627|463309976|FG000|Overall Study|Unrelated to adverse event|1|||
128730469|NCT03019627|463309977|FG001|Overall Study|Unrelated to adverse event|3|||
128730470|NCT03019627|463309976|FG000|Overall Study|Lost to Follow-up|2|||
128730471|NCT03019627|463309977|FG001|Overall Study|Lost to Follow-up|1|||
128730472|NCT03019627|463309976|FG000|Overall Study|not compliance|2|||
128730473|NCT03019627|463309977|FG001|Overall Study|not compliance|2|||
128730474|NCT03019627|463309976|FG000|Overall Study|Other|2|||
128730475|NCT03019627|463309977|FG001|Overall Study|Other|2|||
128730476|NCT03219333|463309978|FG000|Overall Study|Withdrawal by Subject|9|||
129193710|NCT02038075|465003032|FG000|Overall Study|Withdrawal by Subject|3|||
129193711|NCT02038075|465003033|FG001|Overall Study|Withdrawal by Subject|0|||
129193712|NCT03477838|465003034|FG000|Overall Study|Lost to Follow-up|14|||
129193713|NCT02519595|465003038|FG000|Overall Study|Protocol Violation|8|||
129193714|NCT02519595|465003039|FG001|Overall Study|Protocol Violation|22|||
129193715|NCT02519595|465003040|FG002|Overall Study|Protocol Violation|16|||
129193716|NCT00850538|465003043|FG000|Overall Study|unable/unwilling to complete MRI|13|||
129193717|NCT00850538|465003043|FG000|Overall Study|specimen missed due to scheduling error|14|||
129193718|NCT00850538|465003043|FG000|Overall Study|specimen unusable|7|||
129193719|NCT00850538|465003043|FG000|Overall Study|Withdrawal by Subject|3|||
129193720|NCT00850538|465003043|FG000|Overall Study|radiology error|2|||
129193721|NCT00850538|465003043|FG000|Overall Study|Protocol Violation|2|||
129193722|NCT03188510|465003049|FG000|Overall Study|Inappropriate behavior with site staff|0|||
129193723|NCT03188510|465003050|FG001|Overall Study|Inappropriate behavior with site staff|1|||
129193724|NCT03188510|465003051|FG002|Overall Study|Inappropriate behavior with site staff|0|||
129193725|NCT03052049|465003053|FG000|Overall Study|Withdrawal by Subject|2|||
129193726|NCT00999518|465003057|FG000|Overall Study|Adverse Event|1|||
129193727|NCT00999518|465003058|FG001|Overall Study|Adverse Event|6|||
129193728|NCT00999518|465003059|FG002|Overall Study|Adverse Event|3|||
129193729|NCT00999518|465003060|FG003|Overall Study|Adverse Event|1|||
129193730|NCT00999518|465003061|FG004|Overall Study|Adverse Event|2|||
129193731|NCT00999518|465003057|FG000|Overall Study|Lack of Efficacy|2|||
129193732|NCT00999518|465003058|FG001|Overall Study|Lack of Efficacy|0|||
129193733|NCT00999518|465003059|FG002|Overall Study|Lack of Efficacy|0|||
129193734|NCT00999518|465003060|FG003|Overall Study|Lack of Efficacy|2|||
129193735|NCT00999518|465003061|FG004|Overall Study|Lack of Efficacy|2|||
129193736|NCT00999518|465003057|FG000|Overall Study|Lost to Follow-up|0|||
129193737|NCT00999518|465003058|FG001|Overall Study|Lost to Follow-up|0|||
129193738|NCT00999518|465003059|FG002|Overall Study|Lost to Follow-up|0|||
129193739|NCT00999518|465003060|FG003|Overall Study|Lost to Follow-up|4|||
129193740|NCT00999518|465003061|FG004|Overall Study|Lost to Follow-up|1|||
129193741|NCT00999518|465003057|FG000|Overall Study|Did not meet entrance criteria|0|||
129193742|NCT00999518|465003058|FG001|Overall Study|Did not meet entrance criteria|0|||
129193743|NCT00999518|465003059|FG002|Overall Study|Did not meet entrance criteria|0|||
129193744|NCT00999518|465003060|FG003|Overall Study|Did not meet entrance criteria|0|||
129193745|NCT00999518|465003061|FG004|Overall Study|Did not meet entrance criteria|1|||
129193746|NCT00999518|465003057|FG000|Overall Study|Study terminated by sponsor|10|||
129193747|NCT00999518|465003058|FG001|Overall Study|Study terminated by sponsor|6|||
129193748|NCT00999518|465003059|FG002|Overall Study|Study terminated by sponsor|5|||
129193749|NCT00999518|465003060|FG003|Overall Study|Study terminated by sponsor|5|||
129193750|NCT00999518|465003061|FG004|Overall Study|Study terminated by sponsor|9|||
129193751|NCT00999518|465003057|FG000|Overall Study|Pregnancy|0|||
129193752|NCT00999518|465003058|FG001|Overall Study|Pregnancy|0|||
129193753|NCT00999518|465003059|FG002|Overall Study|Pregnancy|1|||
129193754|NCT00999518|465003060|FG003|Overall Study|Pregnancy|0|||
129193755|NCT00999518|465003061|FG004|Overall Study|Pregnancy|0|||
129193756|NCT00999518|465003057|FG000|Overall Study|Protocol Violation|0|||
129193757|NCT00999518|465003058|FG001|Overall Study|Protocol Violation|1|||
129193758|NCT00999518|465003059|FG002|Overall Study|Protocol Violation|0|||
129193759|NCT00999518|465003060|FG003|Overall Study|Protocol Violation|0|||
129193760|NCT00999518|465003061|FG004|Overall Study|Protocol Violation|2|||
129193761|NCT00999518|465003057|FG000|Overall Study|Withdrawal by Subject|5|||
129193762|NCT00999518|465003058|FG001|Overall Study|Withdrawal by Subject|4|||
129193763|NCT00999518|465003059|FG002|Overall Study|Withdrawal by Subject|10|||
129193764|NCT00999518|465003060|FG003|Overall Study|Withdrawal by Subject|6|||
129193765|NCT00999518|465003061|FG004|Overall Study|Withdrawal by Subject|1|||
129193766|NCT00999518|465003057|FG000|Overall Study|Other|5|||
129193767|NCT00999518|465003058|FG001|Overall Study|Other|7|||
129193768|NCT00999518|465003059|FG002|Overall Study|Other|1|||
129193769|NCT00999518|465003060|FG003|Overall Study|Other|4|||
129193770|NCT00999518|465003061|FG004|Overall Study|Other|5|||
129193771|NCT00999518|465003057|FG000|Overall Study|Randomized but not Treated|1|||
129193772|NCT00999518|465003058|FG001|Overall Study|Randomized but not Treated|1|||
128730477|NCT03219333|463309979|FG001|Overall Study|Withdrawal by Subject|4|||
129193773|NCT00999518|465003059|FG002|Overall Study|Randomized but not Treated|2|||
129193774|NCT00999518|465003060|FG003|Overall Study|Randomized but not Treated|0|||
129193775|NCT00999518|465003061|FG004|Overall Study|Randomized but not Treated|1|||
129193776|NCT01088399|465003062|FG000|Overall Study|Adverse Event|211|||
129193777|NCT01088399|465003063|FG001|Overall Study|Adverse Event|16|||
129193778|NCT01088399|465003064|FG002|Overall Study|Adverse Event|0|||
129193779|NCT01088399|465003062|FG000|Overall Study|Death|204|||
129193780|NCT01088399|465003063|FG001|Overall Study|Death|45|||
129193781|NCT01088399|465003064|FG002|Overall Study|Death|0|||
129193782|NCT01088399|465003062|FG000|Overall Study|Lack of Efficacy|298|||
129193783|NCT01088399|465003063|FG001|Overall Study|Lack of Efficacy|7|||
129193784|NCT01088399|465003064|FG002|Overall Study|Lack of Efficacy|5|||
129193785|NCT01088399|465003062|FG000|Overall Study|Lost to Follow-up|1070|||
128730478|NCT03219333|463309978|FG000|Overall Study|Lost to Follow-up|1|||
128730479|NCT03219333|463309979|FG001|Overall Study|Lost to Follow-up|1|||
128730480|NCT03219333|463309978|FG000|Overall Study|Death|104|||
128730481|NCT03219333|463309979|FG001|Overall Study|Death|72|||
128730482|NCT03219333|463309978|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
128730483|NCT03219333|463309979|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
129193786|NCT01088399|465003063|FG001|Overall Study|Lost to Follow-up|278|||
129193787|NCT01088399|465003064|FG002|Overall Study|Lost to Follow-up|58|||
129193788|NCT01088399|465003062|FG000|Overall Study|Physician Decision|531|||
129193789|NCT01088399|465003063|FG001|Overall Study|Physician Decision|88|||
129193790|NCT01088399|465003064|FG002|Overall Study|Physician Decision|16|||
129193791|NCT01088399|465003062|FG000|Overall Study|Withdrawal by Subject|544|||
129193792|NCT01088399|465003063|FG001|Overall Study|Withdrawal by Subject|195|||
129193793|NCT01088399|465003064|FG002|Overall Study|Withdrawal by Subject|33|||
129193794|NCT01088399|465003062|FG000|Overall Study|Change to or start of somatropin therapy|234|||
129193795|NCT01088399|465003063|FG001|Overall Study|Change to or start of somatropin therapy|17|||
129193796|NCT01088399|465003064|FG002|Overall Study|Change to or start of somatropin therapy|12|||
129193797|NCT01088399|465003062|FG000|Overall Study|Sponsor decision|1573|||
129193798|NCT01088399|465003063|FG001|Overall Study|Sponsor decision|298|||
129193799|NCT01088399|465003064|FG002|Overall Study|Sponsor decision|7|||
129193800|NCT01088399|465003062|FG000|Overall Study|Protocol Violation|10|||
129193801|NCT01088399|465003063|FG001|Overall Study|Protocol Violation|1|||
129193802|NCT01088399|465003064|FG002|Overall Study|Protocol Violation|0|||
129193803|NCT01088399|465003062|FG000|Overall Study|Enrollment criteria not met|48|||
129193804|NCT01088399|465003063|FG001|Overall Study|Enrollment criteria not met|119|||
129193805|NCT01088399|465003064|FG002|Overall Study|Enrollment criteria not met|70|||
129193806|NCT01088399|465003062|FG000|Overall Study|Study summary visit not completed|2398|||
129193807|NCT01088399|465003063|FG001|Overall Study|Study summary visit not completed|283|||
129193808|NCT01088399|465003064|FG002|Overall Study|Study summary visit not completed|80|||
129193809|NCT00782483|465003065|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
129193810|NCT03343626|465004922|FG000|Overall Study|Lost to Follow-up|4|||
129193811|NCT03343626|465004923|FG001|Overall Study|Lost to Follow-up|3|||
129193812|NCT03343626|465004924|FG002|Overall Study|Lost to Follow-up|2|||
129193813|NCT03343626|465004925|FG003|Overall Study|Lost to Follow-up|5|||
129193814|NCT03343626|465004926|FG004|Overall Study|Lost to Follow-up|4|||
129193815|NCT03343626|465004927|FG005|Overall Study|Lost to Follow-up|4|||
129193816|NCT03343626|465004928|FG006|Overall Study|Lost to Follow-up|4|||
129193817|NCT03343626|465004929|FG007|Overall Study|Lost to Follow-up|7|||
129193818|NCT03343626|465004922|FG000|Overall Study|Withdrawal of Consent|2|||
129193819|NCT03343626|465004923|FG001|Overall Study|Withdrawal of Consent|1|||
129193820|NCT03343626|465004924|FG002|Overall Study|Withdrawal of Consent|0|||
129193821|NCT03343626|465004925|FG003|Overall Study|Withdrawal of Consent|3|||
129193822|NCT03343626|465004926|FG004|Overall Study|Withdrawal of Consent|3|||
129193823|NCT03343626|465004927|FG005|Overall Study|Withdrawal of Consent|1|||
129193824|NCT03343626|465004928|FG006|Overall Study|Withdrawal of Consent|1|||
129193825|NCT03343626|465004929|FG007|Overall Study|Withdrawal of Consent|2|||
129193826|NCT03343626|465004922|FG000|Overall Study|Reason not Specified|0|||
129193827|NCT03343626|465004923|FG001|Overall Study|Reason not Specified|1|||
129193828|NCT03343626|465004924|FG002|Overall Study|Reason not Specified|0|||
129193829|NCT03343626|465004925|FG003|Overall Study|Reason not Specified|0|||
129193830|NCT03343626|465004926|FG004|Overall Study|Reason not Specified|0|||
129193831|NCT03343626|465004927|FG005|Overall Study|Reason not Specified|0|||
129193832|NCT03343626|465004928|FG006|Overall Study|Reason not Specified|0|||
129193833|NCT03343626|465004929|FG007|Overall Study|Reason not Specified|1|||
129193834|NCT03343626|465004922|FG000|Overall Study|Data Entry Error|0|||
129193835|NCT03343626|465004923|FG001|Overall Study|Data Entry Error|0|||
129193836|NCT03343626|465004924|FG002|Overall Study|Data Entry Error|0|||
129193837|NCT03343626|465004925|FG003|Overall Study|Data Entry Error|0|||
129193838|NCT03343626|465004926|FG004|Overall Study|Data Entry Error|0|||
129193839|NCT03343626|465004927|FG005|Overall Study|Data Entry Error|0|||
129193840|NCT03343626|465004928|FG006|Overall Study|Data Entry Error|0|||
129193841|NCT03343626|465004929|FG007|Overall Study|Data Entry Error|1|||
129193842|NCT01865448|465004932|FG000|Overall Study|Adverse Event|1|||
129193843|NCT01865448|465004933|FG001|Overall Study|Adverse Event|1|||
129193844|NCT01865448|465004932|FG000|Overall Study|Pregnancy|0|||
129193845|NCT01865448|465004933|FG001|Overall Study|Pregnancy|1|||
129193846|NCT01865448|465004932|FG000|Overall Study|dropout unrelated to study|1|||
129193847|NCT01865448|465004933|FG001|Overall Study|dropout unrelated to study|1|||
129193848|NCT05128578|465004935|FG000|Overall Study|Withdrawal by Subject|9|||
129193849|NCT05128578|465004935|FG000|Overall Study|Lost to Follow-up|5|||
129193850|NCT01016600|465004939|FG000|Overall Study|Did not start treatment|1|||
129193851|NCT01016600|465004940|FG001|Overall Study|Did not start treatment|0|||
129193852|NCT01016600|465004941|FG002|Overall Study|Did not start treatment|0|||
129193853|NCT01016600|465004942|FG003|Overall Study|Did not start treatment|0|||
129193854|NCT02679755|465004943|FG000|Overall Study|Death|0|||
129193855|NCT02679755|465004944|FG001|Overall Study|Death|3|||
129193856|NCT02679755|465004943|FG000|Overall Study|Global deterioration of health status|1|||
129193857|NCT02679755|465004944|FG001|Overall Study|Global deterioration of health status|8|||
129193858|NCT02679755|465004943|FG000|Overall Study|Lost to Follow-up|1|||
129193859|NCT02679755|465004944|FG001|Overall Study|Lost to Follow-up|0|||
129193860|NCT02679755|465004943|FG000|Overall Study|Objective progression or relapse|24|||
129193861|NCT02679755|465004944|FG001|Overall Study|Objective progression or relapse|83|||
129193862|NCT02679755|465004943|FG000|Overall Study|Not defined|0|||
129193863|NCT02679755|465004944|FG001|Overall Study|Not defined|2|||
129193864|NCT02679755|465004943|FG000|Overall Study|Withdrawal by participant|6|||
129193865|NCT02679755|465004944|FG001|Overall Study|Withdrawal by participant|3|||
129193866|NCT02679755|465004943|FG000|Overall Study|Adverse Event|1|||
129193867|NCT02679755|465004944|FG001|Overall Study|Adverse Event|4|||
129193868|NCT02679755|465004943|FG000|Overall Study|Adverse events not related to study drug|1|||
129193869|NCT02679755|465004944|FG001|Overall Study|Adverse events not related to study drug|2|||
129193870|NCT02451917|465004947|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
129193871|NCT02451917|465004948|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
129193872|NCT02451917|465004947|FG000|First Intervention (24 Weeks)|Death|0|||
129193873|NCT02451917|465004948|FG001|First Intervention (24 Weeks)|Death|1|||
129193874|NCT02451917|465004947|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
129193875|NCT02451917|465004948|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
129193876|NCT04737278|465004953|FG000|Overall Study|Lost to Follow-up|1|||
129193877|NCT04737278|465004954|FG001|Overall Study|Lost to Follow-up|1|||
129193878|NCT04737278|465004953|FG000|Overall Study|Withdrawal by Subject|1|||
129193879|NCT04737278|465004954|FG001|Overall Study|Withdrawal by Subject|0|||
129193880|NCT04737278|465004953|FG000|Overall Study|Protocol Violation|1|||
129193881|NCT04737278|465004954|FG001|Overall Study|Protocol Violation|1|||
129193882|NCT04737278|465004953|FG000|Overall Study|failure to complete questionnaire|1|||
129193883|NCT04737278|465004954|FG001|Overall Study|failure to complete questionnaire|1|||
129193884|NCT00546000|465004955|FG000|Overall Study|Adverse Event|1|||
129193885|NCT00546000|465004955|FG000|Overall Study|Lost to Follow-up|1|||
129193886|NCT00546000|465004955|FG000|Overall Study|Baseline HPA Axis Supression|2|||
129193887|NCT00660179|465004957|FG000|Overall Study|Death|44|||
129193888|NCT00660179|465004958|FG001|Overall Study|Death|47|||
129193889|NCT00660179|465004959|FG002|Overall Study|Death|34|||
129193890|NCT00660179|465004957|FG000|Overall Study|Withdrawal of consent|4|||
129193891|NCT00660179|465004958|FG001|Overall Study|Withdrawal of consent|6|||
129193892|NCT00660179|465004959|FG002|Overall Study|Withdrawal of consent|4|||
129193893|NCT00660179|465004957|FG000|Overall Study|Lost to Follow-up|7|||
129193894|NCT00660179|465004958|FG001|Overall Study|Lost to Follow-up|5|||
129193895|NCT00660179|465004959|FG002|Overall Study|Lost to Follow-up|2|||
129193896|NCT00660179|465004957|FG000|Overall Study|Administrative reason|0|||
129193897|NCT00660179|465004958|FG001|Overall Study|Administrative reason|0|||
129193898|NCT00660179|465004959|FG002|Overall Study|Administrative reason|1|||
129193899|NCT00660179|465004957|FG000|Overall Study|Incorrect randomization|1|||
129193900|NCT00660179|465004958|FG001|Overall Study|Incorrect randomization|0|||
129193901|NCT00660179|465004959|FG002|Overall Study|Incorrect randomization|0|||
129193902|NCT02255461|465004960|FG000|Overall Study|Adverse Event|0|||
129193903|NCT02255461|465004961|FG001|Overall Study|Adverse Event|1|||
129193904|NCT02255461|465004962|FG002|Overall Study|Adverse Event|0|||
129193905|NCT02255461|465004963|FG003|Overall Study|Adverse Event|0|||
129193906|NCT02255461|465004964|FG004|Overall Study|Adverse Event|1|||
129193907|NCT02255461|465004960|FG000|Overall Study|Withdrawal by Subject|0|||
129193908|NCT02255461|465004961|FG001|Overall Study|Withdrawal by Subject|0|||
129193909|NCT02255461|465004962|FG002|Overall Study|Withdrawal by Subject|1|||
129193910|NCT02255461|465004963|FG003|Overall Study|Withdrawal by Subject|0|||
129193911|NCT02255461|465004964|FG004|Overall Study|Withdrawal by Subject|1|||
129193912|NCT02255461|465004960|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
129193913|NCT02255461|465004961|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
129193914|NCT02255461|465004962|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
129193915|NCT02255461|465004963|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
129193916|NCT02255461|465004964|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
129193917|NCT03056339|465004967|FG000|Overall Study|Failed Requirements|0|||
129193918|NCT03056339|465004968|FG001|Overall Study|Failed Requirements|2|||
129193919|NCT03056339|465004969|FG002|Overall Study|Failed Requirements|7|||
129193920|NCT03056339|465004970|FG003|Overall Study|Failed Requirements|1|||
129193921|NCT01504412|465004971|FG000|Overall Study|Adverse Event|1|||
129193922|NCT01504412|465004972|FG001|Overall Study|Adverse Event|8|||
129193923|NCT01504412|465004973|FG002|Overall Study|Adverse Event|1|||
129193924|NCT01504412|465004974|FG003|Overall Study|Adverse Event|7|||
129193925|NCT01504412|465004975|FG004|Overall Study|Adverse Event|10|||
129193926|NCT01504412|465004971|FG000|Overall Study|Withdrawal by Subject|2|||
129193927|NCT01504412|465004972|FG001|Overall Study|Withdrawal by Subject|1|||
129193928|NCT01504412|465004973|FG002|Overall Study|Withdrawal by Subject|1|||
129193929|NCT01504412|465004974|FG003|Overall Study|Withdrawal by Subject|5|||
129193930|NCT01504412|465004975|FG004|Overall Study|Withdrawal by Subject|1|||
128730484|NCT03219333|463309978|FG000|Overall Study|Other|2|||
128730485|NCT03219333|463309979|FG001|Overall Study|Other|2|||
128730486|NCT00976898|463309980|FG000|Overall Study|Protocol Violation|1|||
128730487|NCT00976898|463309980|FG000|Overall Study|Adverse Event|1|||
128730488|NCT00976898|463309980|FG000|Overall Study|Physician Decision|1|||
128730489|NCT00976898|463309980|FG000|Overall Study|Liver Transplant|1|||
128730490|NCT00976898|463309980|FG000|Overall Study|Progressive Disease|1|||
128730491|NCT05107128|463309981|FG000|Overall Study|Adverse Event|2|||
129193931|NCT01504412|465004971|FG000|Overall Study|Other|2|||
129193932|NCT01504412|465004972|FG001|Overall Study|Other|1|||
129193933|NCT01504412|465004973|FG002|Overall Study|Other|1|||
129193934|NCT01504412|465004974|FG003|Overall Study|Other|6|||
129193935|NCT01504412|465004975|FG004|Overall Study|Other|1|||
129193936|NCT01504412|465004971|FG000|Overall Study|Lost to Follow-up|0|||
129193937|NCT01504412|465004972|FG001|Overall Study|Lost to Follow-up|2|||
129193938|NCT01504412|465004973|FG002|Overall Study|Lost to Follow-up|0|||
129193939|NCT01504412|465004974|FG003|Overall Study|Lost to Follow-up|0|||
129193940|NCT01504412|465004975|FG004|Overall Study|Lost to Follow-up|0|||
129193941|NCT01504412|465004971|FG000|Overall Study|Lack of Efficacy|0|||
129193942|NCT01504412|465004972|FG001|Overall Study|Lack of Efficacy|0|||
129193943|NCT01504412|465004973|FG002|Overall Study|Lack of Efficacy|1|||
129193944|NCT01504412|465004974|FG003|Overall Study|Lack of Efficacy|0|||
129193945|NCT01504412|465004975|FG004|Overall Study|Lack of Efficacy|1|||
129193946|NCT01504412|465004971|FG000|Overall Study|Death|0|||
129193947|NCT01504412|465004972|FG001|Overall Study|Death|0|||
129193948|NCT01504412|465004973|FG002|Overall Study|Death|0|||
129193949|NCT01504412|465004974|FG003|Overall Study|Death|1|||
129193950|NCT01504412|465004975|FG004|Overall Study|Death|0|||
129193951|NCT04171219|465004976|FG000|Overall Study|Adverse Event|1|||
129193952|NCT04171219|465004977|FG001|Overall Study|Adverse Event|0|||
129193953|NCT04171219|465004976|FG000|Overall Study|Death|0|||
129193954|NCT04171219|465004977|FG001|Overall Study|Death|1|||
129193955|NCT04171219|465004976|FG000|Overall Study|Lack of Efficacy|9|||
129193956|NCT04171219|465004977|FG001|Overall Study|Lack of Efficacy|13|||
129193957|NCT04171219|465004976|FG000|Overall Study|Withdrawal by Subject|1|||
129193958|NCT04171219|465004977|FG001|Overall Study|Withdrawal by Subject|2|||
129193959|NCT04171219|465004976|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
129193960|NCT04171219|465004977|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
129193961|NCT04171219|465004976|FG000|Overall Study|Clinical PD/Patient choice|1|||
129193962|NCT04171219|465004977|FG001|Overall Study|Clinical PD/Patient choice|0|||
129193963|NCT04171219|465004976|FG000|Overall Study|Toxicity/ Patient choice|1|||
129193964|NCT04171219|465004977|FG001|Overall Study|Toxicity/ Patient choice|0|||
128730492|NCT05107128|463309982|FG001|Overall Study|Adverse Event|0|||
129193965|NCT04809285|465004978|FG000|Phase 1|Lost to Follow-up|6|||
129193966|NCT04809285|465004978|FG000|Phase 1|Protocol Violation|2|||
129193967|NCT04809285|465004978|FG000|Phase 1|Physician Decision|3|||
129193968|NCT04809285|465004978|FG000|Phase 1|Withdrawal by Subject|29|||
129193969|NCT04809285|465004978|FG000|Phase 2|Protocol Violation|3|||
129193970|NCT04809285|465004978|FG000|Phase 2|Withdrawal by Subject|4|||
129193971|NCT02974257|465004979|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
129193972|NCT02974257|465004980|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
129193973|NCT02974257|465004979|FG000|Overall Study|Clinical indication for thiamine|1|||
128730493|NCT05107128|463309981|FG000|Overall Study|Withdrawal by Subject|3|||
129193974|NCT02974257|465004980|FG001|Overall Study|Clinical indication for thiamine|0|||
128730494|NCT05107128|463309982|FG001|Overall Study|Withdrawal by Subject|3|||
129193975|NCT02974257|465004979|FG000|Overall Study|Already on thiamine|1|||
129193976|NCT02974257|465004980|FG001|Overall Study|Already on thiamine|0|||
129193977|NCT02974257|465004979|FG000|Overall Study|Extubated prior to study drug|0|||
129193978|NCT02974257|465004980|FG001|Overall Study|Extubated prior to study drug|1|||
129193979|NCT02974257|465004979|FG000|Overall Study|Death|0|||
129193980|NCT02974257|465004980|FG001|Overall Study|Death|1|||
129193981|NCT01449006|465004985|FG000|Overall Study|Lost to Follow-up|1|||
129193982|NCT01449006|465004986|FG001|Overall Study|Lost to Follow-up|0|||
129193983|NCT01449006|465004985|FG000|Overall Study|Withdrawal by Subject|1|||
129193984|NCT01449006|465004986|FG001|Overall Study|Withdrawal by Subject|0|||
129193985|NCT01449006|465004985|FG000|Overall Study|Protocol Violation|1|||
129193986|NCT01449006|465004986|FG001|Overall Study|Protocol Violation|0|||
129193987|NCT03350815|465004987|FG000|Period 1|Adverse Event|10|||
129193988|NCT03350815|465004988|FG001|Period 1|Adverse Event|0|||
129193989|NCT03350815|465004989|FG002|Period 1|Adverse Event|0|||
129193990|NCT03350815|465004990|FG003|Period 1|Adverse Event|0|||
129193991|NCT03350815|465004987|FG000|Period 1|Technical problems|1|||
128730495|NCT05107128|463309981|FG000|Overall Study|Withdrawal of Consent|0|||
128730496|NCT05107128|463309982|FG001|Overall Study|Withdrawal of Consent|1|||
128730497|NCT05107128|463309981|FG000|Overall Study|Reason Not Specified|2|||
128730498|NCT05107128|463309982|FG001|Overall Study|Reason Not Specified|0|||
128730499|NCT01470469|463309983|FG000|Overall Study|Withdrawal by Subject|4|||
128730500|NCT01470469|463309984|FG001|Overall Study|Withdrawal by Subject|6|||
128730501|NCT01470469|463309983|FG000|Overall Study|Lack of Efficacy|1|||
128730502|NCT01470469|463309984|FG001|Overall Study|Lack of Efficacy|7|||
128730503|NCT01470469|463309983|FG000|Overall Study|Adverse Event|0|||
128730504|NCT01470469|463309984|FG001|Overall Study|Adverse Event|7|||
128730505|NCT01470469|463309983|FG000|Overall Study|Lost to Follow-up|2|||
128730506|NCT01470469|463309984|FG001|Overall Study|Lost to Follow-up|2|||
128730507|NCT01470469|463309983|FG000|Overall Study|Protocol Violation|1|||
128730508|NCT01470469|463309984|FG001|Overall Study|Protocol Violation|1|||
128730509|NCT01470469|463309983|FG000|Overall Study|Other|2|||
128781025|NCT02698436|463488658|FG001|Overall Study|Non-compliance with study regimen|0|||
128730510|NCT01470469|463309984|FG001|Overall Study|Other|1|||
128730511|NCT05459129|463309985|FG000|Overall Study|Death|1|||
128730512|NCT05459129|463309986|FG001|Overall Study|Death|0|||
128730513|NCT05459129|463309985|FG000|Overall Study|Study Terminated By Sponsor|5|||
128730514|NCT05459129|463309986|FG001|Overall Study|Study Terminated By Sponsor|6|||
128730515|NCT04530552|463309991|FG000|Overall Study|Physician Decision|0|||
128730516|NCT04530552|463309992|FG001|Overall Study|Physician Decision|1|||
128730517|NCT04530552|463309991|FG000|Overall Study|Withdrawal by Subject|0|||
128730518|NCT04530552|463309992|FG001|Overall Study|Withdrawal by Subject|1|||
128730519|NCT04530552|463309991|FG000|Overall Study|Adverse Event|0|||
128730520|NCT04530552|463309992|FG001|Overall Study|Adverse Event|1|||
128730521|NCT04530552|463309991|FG000|Overall Study|No surgery|0|||
128730522|NCT04530552|463309992|FG001|Overall Study|No surgery|1|||
128730523|NCT06034496|463309993|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
128730524|NCT06034496|463309994|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
128730525|NCT06034496|463309993|FG000|Overall Study|Withdrawal by Subject|5|||
128730526|NCT06034496|463309994|FG001|Overall Study|Withdrawal by Subject|4|||
128730527|NCT03277261|463309997|FG000|Overall Study|Adverse Event|17|||
128730528|NCT03277261|463309998|FG001|Overall Study|Adverse Event|1|||
128730529|NCT03277261|463309997|FG000|Overall Study|Participant Withdrawal of Consent|6|||
128781026|NCT03158948|463490405|FG000|Overall Study|Death|1|||
128781027|NCT03158948|463490406|FG001|Overall Study|Death|1|||
128781028|NCT03158948|463490407|FG002|Overall Study|Death|3|||
129193992|NCT03350815|465004988|FG001|Period 1|Technical problems|0|||
129193993|NCT03350815|465004989|FG002|Period 1|Technical problems|0|||
129193994|NCT03350815|465004990|FG003|Period 1|Technical problems|0|||
129193995|NCT03350815|465004987|FG000|Period 1|Lost to Follow-up|3|||
129193996|NCT03350815|465004988|FG001|Period 1|Lost to Follow-up|0|||
129193997|NCT03350815|465004989|FG002|Period 1|Lost to Follow-up|0|||
129193998|NCT03350815|465004990|FG003|Period 1|Lost to Follow-up|0|||
129193999|NCT03350815|465004987|FG000|Period 1|Physician Decision|1|||
129194000|NCT03350815|465004988|FG001|Period 1|Physician Decision|0|||
129194001|NCT03350815|465004989|FG002|Period 1|Physician Decision|0|||
129194002|NCT03350815|465004990|FG003|Period 1|Physician Decision|0|||
129194003|NCT03350815|465004987|FG000|Period 1|Withdrawal by Subject|8|||
129194004|NCT03350815|465004988|FG001|Period 1|Withdrawal by Subject|0|||
129194005|NCT03350815|465004989|FG002|Period 1|Withdrawal by Subject|0|||
129194006|NCT03350815|465004990|FG003|Period 1|Withdrawal by Subject|0|||
129194007|NCT03350815|465004987|FG000|Period 1|Lack of Efficacy|15|||
129194008|NCT03350815|465004988|FG001|Period 1|Lack of Efficacy|0|||
129194009|NCT03350815|465004989|FG002|Period 1|Lack of Efficacy|0|||
129194010|NCT03350815|465004990|FG003|Period 1|Lack of Efficacy|0|||
129194011|NCT03350815|465004987|FG000|Period 1|Non-compliance with study treatment|2|||
129194012|NCT03350815|465004988|FG001|Period 1|Non-compliance with study treatment|0|||
129194013|NCT03350815|465004989|FG002|Period 1|Non-compliance with study treatment|0|||
129194014|NCT03350815|465004990|FG003|Period 1|Non-compliance with study treatment|0|||
129194015|NCT03350815|465004987|FG000|Period 1|Protocol Violation|3|||
129194016|NCT03350815|465004988|FG001|Period 1|Protocol Violation|0|||
129194017|NCT03350815|465004989|FG002|Period 1|Protocol Violation|0|||
129194018|NCT03350815|465004990|FG003|Period 1|Protocol Violation|0|||
129194019|NCT03350815|465004987|FG000|Period 2|Adverse Event|0|||
129194020|NCT03350815|465004988|FG001|Period 2|Adverse Event|3|||
129194021|NCT03350815|465004989|FG002|Period 2|Adverse Event|5|||
129194022|NCT03350815|465004990|FG003|Period 2|Adverse Event|0|||
129194023|NCT03350815|465004987|FG000|Period 2|Technical problem|0|||
129194024|NCT03350815|465004988|FG001|Period 2|Technical problem|1|||
129194025|NCT03350815|465004989|FG002|Period 2|Technical problem|0|||
129194026|NCT03350815|465004990|FG003|Period 2|Technical problem|0|||
129194027|NCT03350815|465004987|FG000|Period 2|Lost to Follow-up|0|||
129194028|NCT03350815|465004988|FG001|Period 2|Lost to Follow-up|3|||
129194029|NCT03350815|465004989|FG002|Period 2|Lost to Follow-up|3|||
129194030|NCT03350815|465004990|FG003|Period 2|Lost to Follow-up|0|||
129194031|NCT03350815|465004987|FG000|Period 2|Physician Decision|0|||
129194032|NCT03350815|465004988|FG001|Period 2|Physician Decision|0|||
129194033|NCT03350815|465004989|FG002|Period 2|Physician Decision|1|||
129194034|NCT03350815|465004990|FG003|Period 2|Physician Decision|0|||
129194035|NCT03350815|465004987|FG000|Period 2|Withdrawal by Subject|0|||
129194036|NCT03350815|465004988|FG001|Period 2|Withdrawal by Subject|3|||
129194037|NCT03350815|465004989|FG002|Period 2|Withdrawal by Subject|4|||
129194038|NCT03350815|465004990|FG003|Period 2|Withdrawal by Subject|0|||
129194039|NCT03350815|465004987|FG000|Period 2|Lack of Efficacy|0|||
129194040|NCT03350815|465004988|FG001|Period 2|Lack of Efficacy|6|||
129194041|NCT03350815|465004989|FG002|Period 2|Lack of Efficacy|2|||
129194042|NCT03350815|465004990|FG003|Period 2|Lack of Efficacy|0|||
129194043|NCT03350815|465004987|FG000|Period 2|Protocol Violation|0|||
129194044|NCT03350815|465004988|FG001|Period 2|Protocol Violation|0|||
129194045|NCT03350815|465004989|FG002|Period 2|Protocol Violation|1|||
129194046|NCT03350815|465004990|FG003|Period 2|Protocol Violation|0|||
129194047|NCT03350815|465004987|FG000|Period 2|New therapy for study indication|0|||
129194048|NCT03350815|465004988|FG001|Period 2|New therapy for study indication|0|||
129194049|NCT03350815|465004989|FG002|Period 2|New therapy for study indication|1|||
129194050|NCT03350815|465004990|FG003|Period 2|New therapy for study indication|0|||
129194051|NCT02837029|465004993|FG000|Screening|Failed to meet screening requirements.|7|||
129194052|NCT02837029|465004994|FG001|Screening|Failed to meet screening requirements.|3|||
129194053|NCT02837029|465004995|FG002|Screening|Failed to meet screening requirements.|0|||
129194054|NCT02837029|465004993|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
128781029|NCT03158948|463490408|FG003|Overall Study|Death|2|||
129194055|NCT02837029|465004994|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
129194056|NCT02837029|465004995|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
129194057|NCT02837029|465004993|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
129194058|NCT02837029|465004994|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
129194059|NCT02837029|465004995|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
129194060|NCT02837029|465004993|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
129194061|NCT02837029|465004994|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
129194062|NCT02837029|465004995|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
129194063|NCT02837029|465004993|FG000|Cycle 2 and Beyond|Adverse Event|1|||
129194064|NCT02837029|465004994|FG001|Cycle 2 and Beyond|Adverse Event|0|||
129194065|NCT02837029|465004995|FG002|Cycle 2 and Beyond|Adverse Event|0|||
129194066|NCT02837029|465004993|FG000|2 Year Follow-up|Death|6|||
129194067|NCT02837029|465004994|FG001|2 Year Follow-up|Death|7|||
129194068|NCT02837029|465004995|FG002|2 Year Follow-up|Death|0|||
129194069|NCT00398567|465004996|FG000|Overall Study|Disease Progression|3|||
128730530|NCT03277261|463309998|FG001|Overall Study|Participant Withdrawal of Consent|15|||
128730531|NCT03277261|463309997|FG000|Overall Study|Investigator / Sponsor Decision|4|||
128730532|NCT03277261|463309998|FG001|Overall Study|Investigator / Sponsor Decision|2|||
128730533|NCT03277261|463309997|FG000|Overall Study|Pregnancy|2|||
128730534|NCT03277261|463309998|FG001|Overall Study|Pregnancy|0|||
128730535|NCT03277261|463309997|FG000|Overall Study|Lost to Follow-up|2|||
128730536|NCT03277261|463309998|FG001|Overall Study|Lost to Follow-up|2|||
128730537|NCT03277261|463309997|FG000|Overall Study|Lack of Efficacy|2|||
128730538|NCT03277261|463309998|FG001|Overall Study|Lack of Efficacy|2|||
128781030|NCT03158948|463490405|FG000|Overall Study|Physician Decision|0|||
128781031|NCT03158948|463490406|FG001|Overall Study|Physician Decision|0|||
128730539|NCT03277261|463309997|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
128730540|NCT03277261|463309998|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
129194070|NCT00398567|465004997|FG001|Overall Study|Disease Progression|4|||
129194071|NCT00398567|465004998|FG002|Overall Study|Disease Progression|27|||
129194072|NCT00398567|465004996|FG000|Overall Study|Withdrawal by Subject|1|||
129194073|NCT00398567|465004997|FG001|Overall Study|Withdrawal by Subject|0|||
129194074|NCT00398567|465004998|FG002|Overall Study|Withdrawal by Subject|4|||
129194075|NCT00398567|465004996|FG000|Overall Study|Adverse Event|0|||
129194076|NCT00398567|465004997|FG001|Overall Study|Adverse Event|0|||
129194077|NCT00398567|465004998|FG002|Overall Study|Adverse Event|2|||
129194078|NCT00398567|465004996|FG000|Overall Study|Protocol Violation|0|||
129194079|NCT00398567|465004997|FG001|Overall Study|Protocol Violation|0|||
129194080|NCT00398567|465004998|FG002|Overall Study|Protocol Violation|1|||
129194081|NCT02034877|465004999|FG000|Overall Study|Lost to Follow-up|0|||
129194082|NCT02034877|465005000|FG001|Overall Study|Lost to Follow-up|3|||
129194083|NCT02034877|465004999|FG000|Overall Study|No Longer Willing to Participate|0|||
129194084|NCT02034877|465005000|FG001|Overall Study|No Longer Willing to Participate|3|||
129194085|NCT03906071|465005003|FG000|Overall Study|Death|180|||
129194086|NCT03906071|465005004|FG001|Overall Study|Death|185|||
129194087|NCT03906071|465005003|FG000|Overall Study|Lost to Follow-up|3|||
129194088|NCT03906071|465005004|FG001|Overall Study|Lost to Follow-up|3|||
129194089|NCT03906071|465005003|FG000|Overall Study|Withdrawal by Subject|15|||
129194090|NCT03906071|465005004|FG001|Overall Study|Withdrawal by Subject|27|||
129194091|NCT03906071|465005003|FG000|Overall Study|Other|2|||
129194092|NCT03906071|465005004|FG001|Overall Study|Other|1|||
129194093|NCT01564732|465005016|FG000|Overall Study|Early termination by the study sponsor|6|||
129194094|NCT01564732|465005017|FG001|Overall Study|Early termination by the study sponsor|5|||
129194095|NCT01979952|465005020|FG000|Overall Study|Adverse Event|4|||
129194096|NCT01979952|465005021|FG001|Overall Study|Adverse Event|5|||
129194097|NCT01979952|465005020|FG000|Overall Study|Protocol Violation|1|||
129194098|NCT01979952|465005021|FG001|Overall Study|Protocol Violation|0|||
129194099|NCT01979952|465005020|FG000|Overall Study|Withdrawal by Subject|2|||
129194100|NCT01979952|465005021|FG001|Overall Study|Withdrawal by Subject|1|||
129194101|NCT01979952|465005020|FG000|Overall Study|Other than specified above|1|||
129194102|NCT01979952|465005021|FG001|Overall Study|Other than specified above|0|||
129194103|NCT05438576|465005022|FG000|Overall Study|Death|1|||
129194104|NCT05438576|465005023|FG001|Overall Study|Death|1|||
129194105|NCT05438576|465005022|FG000|Overall Study|Withdrawal by Subject|4|||
129194106|NCT05438576|465005023|FG001|Overall Study|Withdrawal by Subject|2|||
129194107|NCT05438576|465005022|FG000|Overall Study|Not Eligible|2|||
129194108|NCT05438576|465005023|FG001|Overall Study|Not Eligible|1|||
129194109|NCT05438576|465005022|FG000|Overall Study|Did not complete baseline testing|22|||
129194110|NCT05438576|465005023|FG001|Overall Study|Did not complete baseline testing|4|||
129194111|NCT01067144|465005029|FG000|Treatment|Did not receive allocated intervention|4|||
129194112|NCT01067144|465005030|FG001|Treatment|Did not receive allocated intervention|7|||
129194113|NCT01067144|465005029|FG000|Follow-up|Lost to Follow-up|22|||
129194114|NCT01067144|465005030|FG001|Follow-up|Lost to Follow-up|12|||
129194115|NCT01067144|465005029|FG000|Follow-up|Censored owing to second surgery|19|||
129194116|NCT01067144|465005030|FG001|Follow-up|Censored owing to second surgery|28|||
129194117|NCT01067144|465005029|FG000|Follow-up|Withdrawal by Subject|18|||
129194118|NCT01067144|465005030|FG001|Follow-up|Withdrawal by Subject|14|||
129194119|NCT01067144|465005029|FG000|Follow-up|Surgery cancelled|0|||
129194120|NCT01067144|465005030|FG001|Follow-up|Surgery cancelled|1|||
129194121|NCT01067144|465005029|FG000|Follow-up|Death|0|||
129194122|NCT01067144|465005030|FG001|Follow-up|Death|1|||
129194123|NCT00475709|465005031|FG000|Overall Study|Did not meet eligibility criteria|8|||
129194124|NCT00475709|465005031|FG000|Overall Study|Death|41|||
129194125|NCT00475709|465005031|FG000|Overall Study|Device Explant|6|||
129194126|NCT00475709|465005031|FG000|Overall Study|Lost to Follow-up|21|||
129194127|NCT00555672|465005032|FG000|Overall Study|Death|0|||
129194128|NCT00555672|465005033|FG001|Overall Study|Death|2|||
129194129|NCT00555672|465005032|FG000|Overall Study|Adverse Event|8|||
129194130|NCT00555672|465005033|FG001|Overall Study|Adverse Event|2|||
129194131|NCT00555672|465005032|FG000|Overall Study|Objective progression or relapse|11|||
129194132|NCT00555672|465005033|FG001|Overall Study|Objective progression or relapse|5|||
129194133|NCT00555672|465005032|FG000|Overall Study|Other|3|||
129194134|NCT00555672|465005033|FG001|Overall Study|Other|1|||
129194135|NCT00555672|465005032|FG000|Overall Study|Participant refused|2|||
129194136|NCT00555672|465005033|FG001|Overall Study|Participant refused|0|||
129194137|NCT01415401|465005038|FG000|Overall Study|Adverse Event|5|||
129194138|NCT01415401|465005038|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
129194139|NCT01415401|465005038|FG000|Overall Study|Terminated by Sponsor|1|||
129194140|NCT04765202|465005052|FG000|Overall Study|Lost to Follow-up|1|||
129194141|NCT04765202|465005053|FG001|Overall Study|Lost to Follow-up|1|||
129194142|NCT04765202|465005054|FG002|Overall Study|Lost to Follow-up|2|||
128730541|NCT00499603|463310002|FG000|Overall Study|Adverse Event|0|||
128730542|NCT00499603|463310003|FG001|Overall Study|Adverse Event|1|||
128730543|NCT05132127|463310004|FG000|Overall Study|Adverse Event|1|||
128730544|NCT04697628|463310005|FG000|Overall Study|Withdrawal by Subject|17|||
128730545|NCT04697628|463310006|FG001|Overall Study|Withdrawal by Subject|23|||
128730546|NCT04697628|463310005|FG000|Overall Study|Lost to Follow-up|0|||
128730547|NCT04697628|463310006|FG001|Overall Study|Lost to Follow-up|4|||
128730548|NCT04697628|463310005|FG000|Overall Study|On-going in study|122|||
128730549|NCT04697628|463310006|FG001|Overall Study|On-going in study|91|||
128730550|NCT03604692|463310007|FG000|Overall Study|Investigator's Decision|0|||
128730551|NCT03604692|463310008|FG001|Overall Study|Investigator's Decision|0|||
128730552|NCT03604692|463310009|FG002|Overall Study|Investigator's Decision|0|||
129194143|NCT04765202|465005055|FG003|Overall Study|Lost to Follow-up|2|||
129194144|NCT04765202|465005052|FG000|Overall Study|Physician Decision|0|||
129194145|NCT04765202|465005053|FG001|Overall Study|Physician Decision|0|||
129194146|NCT04765202|465005054|FG002|Overall Study|Physician Decision|1|||
129194147|NCT04765202|465005055|FG003|Overall Study|Physician Decision|1|||
129194148|NCT02305238|465005057|FG000|Overall Study|Death|2|||
129194149|NCT02305238|465005058|FG001|Overall Study|Death|1|||
129194150|NCT02305238|465005059|FG002|Overall Study|Death|0|||
129194151|NCT02305238|465005057|FG000|Overall Study|Progressive disease|4|||
129194152|NCT02305238|465005058|FG001|Overall Study|Progressive disease|4|||
129194153|NCT02305238|465005059|FG002|Overall Study|Progressive disease|0|||
129194154|NCT02305238|465005057|FG000|Overall Study|Logistical difficulties|1|||
129194155|NCT02305238|465005058|FG001|Overall Study|Logistical difficulties|3|||
129194156|NCT02305238|465005059|FG002|Overall Study|Logistical difficulties|0|||
129194157|NCT02305238|465005057|FG000|Overall Study|Protocol Violation|0|||
129194158|NCT02305238|465005058|FG001|Overall Study|Protocol Violation|3|||
129194159|NCT02305238|465005059|FG002|Overall Study|Protocol Violation|0|||
129194160|NCT02305238|465005057|FG000|Overall Study|Physician Decision|2|||
129194161|NCT02305238|465005058|FG001|Overall Study|Physician Decision|1|||
129194162|NCT02305238|465005059|FG002|Overall Study|Physician Decision|0|||
129194163|NCT02305238|465005057|FG000|Overall Study|Adverse Event|4|||
129194164|NCT02305238|465005058|FG001|Overall Study|Adverse Event|2|||
129194165|NCT02305238|465005059|FG002|Overall Study|Adverse Event|0|||
129194166|NCT02305238|465005057|FG000|Overall Study|Withdrawal by Subject|3|||
129194167|NCT02305238|465005058|FG001|Overall Study|Withdrawal by Subject|4|||
129194168|NCT02305238|465005059|FG002|Overall Study|Withdrawal by Subject|0|||
129194169|NCT02305238|465005057|FG000|Overall Study|Randomized failure|0|||
129194170|NCT02305238|465005058|FG001|Overall Study|Randomized failure|0|||
129194171|NCT02305238|465005059|FG002|Overall Study|Randomized failure|8|||
129194172|NCT02305238|465005057|FG000|Overall Study|Required procedure failed|0|||
129194173|NCT02305238|465005058|FG001|Overall Study|Required procedure failed|1|||
129194174|NCT02305238|465005059|FG002|Overall Study|Required procedure failed|0|||
129194175|NCT01019369|465005060|FG000|Overall Study|Lost to Follow-up|10|||
129194176|NCT01019369|465005061|FG001|Overall Study|Lost to Follow-up|6|||
129194177|NCT01019369|465005060|FG000|Overall Study|Withdrawal by Subject|0|||
129194178|NCT01019369|465005061|FG001|Overall Study|Withdrawal by Subject|1|||
129194179|NCT02513472|465005062|FG000|Overall Study|Radiological Disease Progression|45|||
129194180|NCT02513472|465005063|FG001|Overall Study|Radiological Disease Progression|57|||
129194181|NCT02513472|465005062|FG000|Overall Study|Clinical Disease Progression|5|||
129194182|NCT02513472|465005063|FG001|Overall Study|Clinical Disease Progression|13|||
129194183|NCT02513472|465005062|FG000|Overall Study|Adverse Event|8|||
129194184|NCT02513472|465005063|FG001|Overall Study|Adverse Event|11|||
129194185|NCT02513472|465005062|FG000|Overall Study|Withdrawal by Subject|0|||
129194186|NCT02513472|465005063|FG001|Overall Study|Withdrawal by Subject|4|||
129194187|NCT02513472|465005062|FG000|Overall Study|Subject Choice|2|||
129194188|NCT02513472|465005063|FG001|Overall Study|Subject Choice|7|||
128730553|NCT03604692|463310010|FG003|Overall Study|Investigator's Decision|1|||
128730554|NCT03604692|463310011|FG004|Overall Study|Investigator's Decision|0|||
128730555|NCT03604692|463310012|FG005|Overall Study|Investigator's Decision|7|||
129194189|NCT02513472|465005062|FG000|Overall Study|Treatment Completed as per Protocol|3|||
129194190|NCT02513472|465005063|FG001|Overall Study|Treatment Completed as per Protocol|3|||
129194191|NCT02513472|465005062|FG000|Overall Study|Other|3|||
129194192|NCT02513472|465005063|FG001|Overall Study|Other|6|||
129194193|NCT01380834|465005064|FG000|Overall Study|Physician Decision|1|||
129194194|NCT01380834|465005065|FG001|Overall Study|Physician Decision|0|||
129194195|NCT04310566|465005066|FG000|Period 1|Study Termination due to COVID-19|15|||
129194196|NCT04310566|465005067|FG001|Period 1|Study Termination due to COVID-19|17|||
129194197|NCT04310566|465005066|FG000|Period 1|Protocol Violation|0|||
129194198|NCT04310566|465005067|FG001|Period 1|Protocol Violation|1|||
129194199|NCT04310566|465005066|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
129194200|NCT04310566|465005067|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
129194201|NCT04310566|465005066|FG000|Period 1|Lost to Follow-up|1|||
129194202|NCT04310566|465005067|FG001|Period 1|Lost to Follow-up|0|||
129194203|NCT04310566|465005066|FG000|Period 1|Withdrawal by Subject|0|||
128730556|NCT03604692|463310007|FG000|Overall Study|Withdrawal by Subject|0|||
128730557|NCT03604692|463310008|FG001|Overall Study|Withdrawal by Subject|0|||
128730558|NCT03604692|463310009|FG002|Overall Study|Withdrawal by Subject|0|||
128730559|NCT03604692|463310010|FG003|Overall Study|Withdrawal by Subject|0|||
128781032|NCT03158948|463490407|FG002|Overall Study|Physician Decision|0|||
128781033|NCT03158948|463490408|FG003|Overall Study|Physician Decision|1|||
128781034|NCT01876043|463490409|FG000|Overall Study|Death|1|||
128730560|NCT03604692|463310011|FG004|Overall Study|Withdrawal by Subject|0|||
128730561|NCT03604692|463310012|FG005|Overall Study|Withdrawal by Subject|2|||
128730562|NCT03604692|463310007|FG000|Overall Study|Progressive Disease|1|||
128730563|NCT03604692|463310008|FG001|Overall Study|Progressive Disease|0|||
128730564|NCT03604692|463310009|FG002|Overall Study|Progressive Disease|1|||
128730565|NCT03604692|463310010|FG003|Overall Study|Progressive Disease|0|||
128730566|NCT03604692|463310011|FG004|Overall Study|Progressive Disease|3|||
128730567|NCT03604692|463310012|FG005|Overall Study|Progressive Disease|4|||
128730568|NCT03604692|463310007|FG000|Overall Study|Difficulty Coming into Site|0|||
128730569|NCT03604692|463310008|FG001|Overall Study|Difficulty Coming into Site|0|||
128730570|NCT03604692|463310009|FG002|Overall Study|Difficulty Coming into Site|0|||
128730571|NCT03604692|463310010|FG003|Overall Study|Difficulty Coming into Site|0|||
128730572|NCT03604692|463310011|FG004|Overall Study|Difficulty Coming into Site|0|||
129194204|NCT04310566|465005067|FG001|Period 1|Withdrawal by Subject|1|||
129194205|NCT04310566|465005066|FG000|Period 2|Study Termination|7|||
129194206|NCT04310566|465005067|FG001|Period 2|Study Termination|5|||
129194207|NCT04565951|465005068|FG000|Overall Study|Lost to Follow-up|66|||
129194208|NCT04565951|465005069|FG001|Overall Study|Lost to Follow-up|38|||
129194209|NCT04565951|465005068|FG000|Overall Study|Withdrawal by Subject|14|||
129194210|NCT04565951|465005069|FG001|Overall Study|Withdrawal by Subject|7|||
129194211|NCT04565951|465005068|FG000|Overall Study|Death|0|||
129194212|NCT04565951|465005069|FG001|Overall Study|Death|1|||
129194213|NCT02328027|465005071|FG000|Overall Study|Withdrawal by Subject|0|||
129194214|NCT02328027|465005072|FG001|Overall Study|Withdrawal by Subject|1|||
129194215|NCT03319212|465005073|FG000|Overall Study|Discontinued as moving out of local area|0|||
129194216|NCT03319212|465005074|FG001|Overall Study|Discontinued as moving out of local area|1|||
129194217|NCT03319212|465005073|FG000|Overall Study|Adverse Event|2|||
129194218|NCT03319212|465005074|FG001|Overall Study|Adverse Event|2|||
129194219|NCT03319212|465005073|FG000|Overall Study|Withdrawal by Subject|0|||
129194220|NCT03319212|465005074|FG001|Overall Study|Withdrawal by Subject|1|||
129194221|NCT03319212|465005073|FG000|Overall Study|Lost to Follow-up|0|||
129194222|NCT03319212|465005074|FG001|Overall Study|Lost to Follow-up|1|||
129194223|NCT03319212|465005073|FG000|Overall Study|Physician Decision|1|||
129194224|NCT03319212|465005074|FG001|Overall Study|Physician Decision|0|||
129194225|NCT00250276|465005075|FG000|Overall Study|Serious Adverse Event|0|||
129194226|NCT00250276|465005076|FG001|Overall Study|Serious Adverse Event|0|||
129194227|NCT00250276|465005077|FG002|Overall Study|Serious Adverse Event|1|||
129194228|NCT00250276|465005078|FG003|Overall Study|Serious Adverse Event|0|||
129194229|NCT00250276|465005075|FG000|Overall Study|Non-serious Adverse Event|2|||
129194230|NCT00250276|465005076|FG001|Overall Study|Non-serious Adverse Event|0|||
129194231|NCT00250276|465005077|FG002|Overall Study|Non-serious Adverse Event|0|||
129194232|NCT00250276|465005078|FG003|Overall Study|Non-serious Adverse Event|2|||
129194233|NCT00250276|465005075|FG000|Overall Study|Protocol Violation|0|||
129194234|NCT00250276|465005076|FG001|Overall Study|Protocol Violation|1|||
129194235|NCT00250276|465005077|FG002|Overall Study|Protocol Violation|0|||
129194236|NCT00250276|465005078|FG003|Overall Study|Protocol Violation|0|||
129194237|NCT00250276|465005075|FG000|Overall Study|Withdrawal by Subject|1|||
129194238|NCT00250276|465005076|FG001|Overall Study|Withdrawal by Subject|2|||
129194239|NCT00250276|465005077|FG002|Overall Study|Withdrawal by Subject|3|||
129194240|NCT00250276|465005078|FG003|Overall Study|Withdrawal by Subject|2|||
129194241|NCT00250276|465005075|FG000|Overall Study|Migrated/moved from study area|3|||
129194242|NCT00250276|465005076|FG001|Overall Study|Migrated/moved from study area|0|||
129194243|NCT00250276|465005077|FG002|Overall Study|Migrated/moved from study area|2|||
129194244|NCT00250276|465005078|FG003|Overall Study|Migrated/moved from study area|7|||
129194245|NCT00250276|465005075|FG000|Overall Study|Lost to Follow-up|11|||
129194246|NCT00250276|465005076|FG001|Overall Study|Lost to Follow-up|18|||
129194247|NCT00250276|465005077|FG002|Overall Study|Lost to Follow-up|13|||
129194248|NCT00250276|465005078|FG003|Overall Study|Lost to Follow-up|8|||
129194249|NCT01811186|465005079|FG000|Overall Study|Adverse Event|54|||
129194250|NCT01811186|465005080|FG001|Overall Study|Adverse Event|38|||
129194251|NCT01811186|465005079|FG000|Overall Study|Protocol Violation|5|||
129194252|NCT01811186|465005080|FG001|Overall Study|Protocol Violation|6|||
129194253|NCT01811186|465005079|FG000|Overall Study|Withdrawal by Subject|5|||
129194254|NCT01811186|465005080|FG001|Overall Study|Withdrawal by Subject|10|||
129194255|NCT01811186|465005079|FG000|Overall Study|Lack of Efficacy|3|||
129194256|NCT01811186|465005080|FG001|Overall Study|Lack of Efficacy|6|||
129194257|NCT01811186|465005079|FG000|Overall Study|Lost to Follow-up|4|||
129194258|NCT01811186|465005080|FG001|Overall Study|Lost to Follow-up|2|||
129194259|NCT03369236|465005083|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
129194260|NCT03369236|465005084|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
129194261|NCT03369236|465005083|FG000|Open-label Extension Period|Lack of Efficacy|2|||
129194262|NCT03369236|465005084|FG001|Open-label Extension Period|Lack of Efficacy|1|||
129194263|NCT03369236|465005083|FG000|Open-label Extension Period|Adverse Event|0|||
129194264|NCT03369236|465005084|FG001|Open-label Extension Period|Adverse Event|1|||
129194265|NCT03369236|465005083|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
129194266|NCT03369236|465005084|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
128730573|NCT03604692|463310012|FG005|Overall Study|Difficulty Coming into Site|1|||
128730574|NCT03604692|463310007|FG000|Overall Study|Death|0|||
128730575|NCT03604692|463310008|FG001|Overall Study|Death|0|||
128730576|NCT03604692|463310009|FG002|Overall Study|Death|1|||
128730577|NCT03604692|463310010|FG003|Overall Study|Death|0|||
128730578|NCT03604692|463310011|FG004|Overall Study|Death|0|||
128730579|NCT03604692|463310012|FG005|Overall Study|Death|0|||
128730580|NCT03604692|463310007|FG000|Overall Study|Drug Intolerance|0|||
128730581|NCT03604692|463310008|FG001|Overall Study|Drug Intolerance|0|||
128730582|NCT03604692|463310009|FG002|Overall Study|Drug Intolerance|0|||
128730583|NCT03604692|463310010|FG003|Overall Study|Drug Intolerance|1|||
128730584|NCT03604692|463310011|FG004|Overall Study|Drug Intolerance|0|||
128730585|NCT03604692|463310012|FG005|Overall Study|Drug Intolerance|0|||
128730586|NCT03604692|463310007|FG000|Overall Study|Noncompliance with follow-up visit|0|||
128730587|NCT03604692|463310008|FG001|Overall Study|Noncompliance with follow-up visit|0|||
128730588|NCT03604692|463310009|FG002|Overall Study|Noncompliance with follow-up visit|0|||
128730589|NCT03604692|463310010|FG003|Overall Study|Noncompliance with follow-up visit|1|||
128730590|NCT03604692|463310011|FG004|Overall Study|Noncompliance with follow-up visit|0|||
128730591|NCT03604692|463310012|FG005|Overall Study|Noncompliance with follow-up visit|0|||
128730592|NCT03604692|463310007|FG000|Overall Study|Not Treated|0|||
128730593|NCT03604692|463310008|FG001|Overall Study|Not Treated|0|||
128730594|NCT03604692|463310009|FG002|Overall Study|Not Treated|0|||
128730595|NCT03604692|463310010|FG003|Overall Study|Not Treated|0|||
128730596|NCT03604692|463310011|FG004|Overall Study|Not Treated|1|||
128730597|NCT03604692|463310012|FG005|Overall Study|Not Treated|0|||
128730598|NCT01946204|463310013|FG000|Overall Study|Death|38|||
128730599|NCT01946204|463310014|FG001|Overall Study|Death|59|||
128730600|NCT01946204|463310013|FG000|Overall Study|Withdrawal by Subject|37|||
128730601|NCT01946204|463310014|FG001|Overall Study|Withdrawal by Subject|50|||
128730602|NCT01946204|463310013|FG000|Overall Study|Lost to Follow-up|3|||
128730603|NCT01946204|463310014|FG001|Overall Study|Lost to Follow-up|7|||
128730604|NCT01946204|463310013|FG000|Overall Study|Ongoing|316|||
128730605|NCT01946204|463310014|FG001|Overall Study|Ongoing|687|||
128730606|NCT01946204|463310013|FG000|Overall Study|Other|7|||
128730607|NCT01946204|463310014|FG001|Overall Study|Other|3|||
128730608|NCT03466411|463310015|FG000|Overall Study|Lost to Follow-up|0|||
128730609|NCT03466411|463310016|FG001|Overall Study|Lost to Follow-up|1|||
128730610|NCT03466411|463310017|FG002|Overall Study|Lost to Follow-up|1|||
128730611|NCT03466411|463310018|FG003|Overall Study|Lost to Follow-up|0|||
128730612|NCT03466411|463310019|FG004|Overall Study|Lost to Follow-up|0|||
128730613|NCT03466411|463310020|FG005|Overall Study|Lost to Follow-up|0|||
128730614|NCT03466411|463310021|FG006|Overall Study|Lost to Follow-up|1|||
128730615|NCT03466411|463310022|FG007|Overall Study|Lost to Follow-up|1|||
128730616|NCT03466411|463310023|FG008|Overall Study|Lost to Follow-up|0|||
128730617|NCT03466411|463310024|FG009|Overall Study|Lost to Follow-up|1|||
128730618|NCT03466411|463310025|FG010|Overall Study|Lost to Follow-up|1|||
128730619|NCT03466411|463310026|FG011|Overall Study|Lost to Follow-up|1|||
128730620|NCT03466411|463310027|FG012|Overall Study|Lost to Follow-up|0|||
128730621|NCT03466411|463310015|FG000|Overall Study|Withdrawal by Subject|14|||
128730622|NCT03466411|463310016|FG001|Overall Study|Withdrawal by Subject|7|||
128730623|NCT03466411|463310017|FG002|Overall Study|Withdrawal by Subject|8|||
128730624|NCT03466411|463310018|FG003|Overall Study|Withdrawal by Subject|4|||
128730625|NCT03466411|463310019|FG004|Overall Study|Withdrawal by Subject|6|||
128730626|NCT03466411|463310020|FG005|Overall Study|Withdrawal by Subject|3|||
128730627|NCT03466411|463310021|FG006|Overall Study|Withdrawal by Subject|6|||
128730628|NCT03466411|463310022|FG007|Overall Study|Withdrawal by Subject|9|||
128730629|NCT03466411|463310023|FG008|Overall Study|Withdrawal by Subject|6|||
128730630|NCT03466411|463310024|FG009|Overall Study|Withdrawal by Subject|11|||
128730631|NCT03466411|463310025|FG010|Overall Study|Withdrawal by Subject|14|||
128730632|NCT03466411|463310026|FG011|Overall Study|Withdrawal by Subject|12|||
128730633|NCT03466411|463310027|FG012|Overall Study|Withdrawal by Subject|7|||
128730634|NCT03466411|463310015|FG000|Overall Study|Other|1|||
128730635|NCT03466411|463310016|FG001|Overall Study|Other|1|||
128730636|NCT03466411|463310017|FG002|Overall Study|Other|0|||
128730637|NCT03466411|463310018|FG003|Overall Study|Other|1|||
128730638|NCT03466411|463310019|FG004|Overall Study|Other|2|||
128730639|NCT03466411|463310020|FG005|Overall Study|Other|0|||
128730640|NCT03466411|463310021|FG006|Overall Study|Other|0|||
128730641|NCT03466411|463310022|FG007|Overall Study|Other|0|||
128730642|NCT03466411|463310023|FG008|Overall Study|Other|0|||
128730643|NCT03466411|463310024|FG009|Overall Study|Other|1|||
128730644|NCT03466411|463310025|FG010|Overall Study|Other|2|||
128730645|NCT03466411|463310026|FG011|Overall Study|Other|0|||
128730646|NCT03466411|463310027|FG012|Overall Study|Other|0|||
128730647|NCT03466411|463310015|FG000|Overall Study|Randomized but not Treated|0|||
128730648|NCT03466411|463310016|FG001|Overall Study|Randomized but not Treated|0|||
128730649|NCT03466411|463310017|FG002|Overall Study|Randomized but not Treated|0|||
128730650|NCT03466411|463310018|FG003|Overall Study|Randomized but not Treated|0|||
128730651|NCT03466411|463310019|FG004|Overall Study|Randomized but not Treated|0|||
128730652|NCT03466411|463310020|FG005|Overall Study|Randomized but not Treated|0|||
128730653|NCT03466411|463310021|FG006|Overall Study|Randomized but not Treated|1|||
128730654|NCT03466411|463310022|FG007|Overall Study|Randomized but not Treated|0|||
128730655|NCT03466411|463310023|FG008|Overall Study|Randomized but not Treated|0|||
128730656|NCT03466411|463310024|FG009|Overall Study|Randomized but not Treated|0|||
128730657|NCT03466411|463310025|FG010|Overall Study|Randomized but not Treated|0|||
128730658|NCT03466411|463310026|FG011|Overall Study|Randomized but not Treated|0|||
128730659|NCT03466411|463310027|FG012|Overall Study|Randomized but not Treated|0|||
128730660|NCT00393939|463310028|FG000|Overall Study|Protocol Violation|1|||
128730661|NCT00393939|463310029|FG001|Overall Study|Protocol Violation|1|||
129194267|NCT01153724|465005089|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129194268|NCT01153724|465005089|FG000|Treatment Period 2|Adverse Event|1|||
129194269|NCT01153724|465005089|FG000|Treatment Period 2|Other reason not defined above|1|||
129194270|NCT02508428|465005096|FG000|Overall Study|Death|32|||
129194271|NCT02508428|465005097|FG001|Overall Study|Death|33|||
129194272|NCT02508428|465005096|FG000|Overall Study|Liner revised|3|||
129194273|NCT02508428|465005097|FG001|Overall Study|Liner revised|19|||
129194274|NCT02508428|465005096|FG000|Overall Study|Incomplete follow-up|17|||
129194275|NCT02508428|465005097|FG001|Overall Study|Incomplete follow-up|15|||
129194276|NCT00534976|465005102|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
129194277|NCT00534976|465005103|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
129194278|NCT00534976|465005102|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
129194279|NCT00534976|465005103|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
129194280|NCT00534976|465005102|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
129194281|NCT00534976|465005103|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
129194282|NCT02123576|465005104|FG000|Overall Study|Adverse Event|1|||
129194283|NCT02123576|465005105|FG001|Overall Study|Adverse Event|0|||
129194284|NCT00934128|465005106|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
129194285|NCT00934128|465005107|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
129194286|NCT00934128|465005106|FG000|First Intervention (2 Hours)|Adverse Event|4|||
129194287|NCT00934128|465005107|FG001|First Intervention (2 Hours)|Adverse Event|1|||
129194288|NCT00934128|465005106|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
129194289|NCT00934128|465005107|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
129194290|NCT00934128|465005106|FG000|Washout Period (1 Hour)|Patient preference|1|||
129194291|NCT00934128|465005107|FG001|Washout Period (1 Hour)|Patient preference|3|||
129194292|NCT00934128|465005106|FG000|Washout Period (1 Hour)|Pain|1|||
129194293|NCT00934128|465005107|FG001|Washout Period (1 Hour)|Pain|0|||
129194294|NCT00934128|465005106|FG000|Washout Period (1 Hour)|Too tired|1|||
129194295|NCT00934128|465005107|FG001|Washout Period (1 Hour)|Too tired|0|||
129194296|NCT00934128|465005106|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
129194297|NCT00934128|465005107|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
129194298|NCT00934128|465005106|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
129194299|NCT00934128|465005107|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
129194300|NCT02834247|465005108|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
129194301|NCT02834247|465005109|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
129194302|NCT02834247|465005110|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
129194303|NCT02834247|465005111|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
129194304|NCT02834247|465005108|FG000|Dose Escalation Phase|Death|5|||
129194305|NCT02834247|465005109|FG001|Dose Escalation Phase|Death|6|||
129194306|NCT02834247|465005110|FG002|Dose Escalation Phase|Death|5|||
129194307|NCT02834247|465005111|FG003|Dose Escalation Phase|Death|0|||
129194308|NCT02834247|465005108|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
129194309|NCT02834247|465005109|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
129194310|NCT02834247|465005110|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
129194311|NCT02834247|465005111|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
129194312|NCT02834247|465005108|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
129194313|NCT02834247|465005109|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
129194314|NCT02834247|465005110|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129194315|NCT02834247|465005111|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129194316|NCT02834247|465005108|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
129194317|NCT02834247|465005109|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
129194318|NCT02834247|465005110|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
129194319|NCT02834247|465005111|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
129194320|NCT02834247|465005108|FG000|Dose Expansion Phase|Death|0|||
129194321|NCT02834247|465005109|FG001|Dose Expansion Phase|Death|0|||
129194322|NCT02834247|465005110|FG002|Dose Expansion Phase|Death|0|||
129194323|NCT02834247|465005111|FG003|Dose Expansion Phase|Death|8|||
129194324|NCT02834247|465005108|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
129194325|NCT02834247|465005109|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
129194326|NCT02834247|465005110|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
129194327|NCT02834247|465005111|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
129194328|NCT02834247|465005108|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
129194329|NCT02834247|465005109|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
129194330|NCT02834247|465005110|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
129194331|NCT02834247|465005111|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
129194332|NCT00799266|465006774|FG000|Overall Study|Adverse Event|0|||
129194333|NCT00799266|465006775|FG001|Overall Study|Adverse Event|1|||
129194334|NCT00799266|465006774|FG000|Overall Study|Subject withdrew consent|3|||
129194335|NCT00799266|465006775|FG001|Overall Study|Subject withdrew consent|0|||
129194336|NCT01036321|465006777|FG000|Overall Study|Ineligible after randomization|0|||
129194337|NCT01036321|465006778|FG001|Overall Study|Ineligible after randomization|1|||
129194338|NCT01036321|465006777|FG000|Overall Study|Withdrawal by Subject|3|||
128730662|NCT00393939|463310028|FG000|Overall Study|Lost to Follow-up|2|||
128730663|NCT00393939|463310029|FG001|Overall Study|Lost to Follow-up|4|||
128730664|NCT00393939|463310028|FG000|Overall Study|Death|10|||
128730665|NCT00393939|463310029|FG001|Overall Study|Death|4|||
128730666|NCT00393939|463310028|FG000|Overall Study|Sponsor|5|||
128730667|NCT00393939|463310029|FG001|Overall Study|Sponsor|13|||
128730668|NCT00393939|463310028|FG000|Overall Study|Objective progression or relapse|239|||
128730669|NCT00393939|463310029|FG001|Overall Study|Objective progression or relapse|223|||
129194339|NCT01036321|465006778|FG001|Overall Study|Withdrawal by Subject|2|||
129194340|NCT01036321|465006777|FG000|Overall Study|Adverse Event|2|||
129194341|NCT01036321|465006778|FG001|Overall Study|Adverse Event|1|||
129194342|NCT00381693|465006781|FG000|Overall Study|Death|1|||
129194343|NCT00381693|465006781|FG000|Overall Study|Adverse Event|4|||
129194344|NCT00381693|465006781|FG000|Overall Study|Patient Choice|1|||
129194345|NCT00381693|465006781|FG000|Overall Study|Progression|2|||
129194346|NCT02598297|465006782|FG000|Overall Study|Study terminated by Sponsor|21|||
129194347|NCT02598297|465006783|FG001|Overall Study|Study terminated by Sponsor|23|||
129194348|NCT02598297|465006782|FG000|Overall Study|Adverse Event|1|||
129194349|NCT02598297|465006783|FG001|Overall Study|Adverse Event|1|||
129194350|NCT02598297|465006782|FG000|Overall Study|Physician Decision|1|||
129194351|NCT02598297|465006783|FG001|Overall Study|Physician Decision|0|||
129194352|NCT02598297|465006782|FG000|Overall Study|Subject/guardian decision|1|||
129194353|NCT02598297|465006783|FG001|Overall Study|Subject/guardian decision|0|||
129194354|NCT02598297|465006782|FG000|Overall Study|Followed for survival|1|||
129194355|NCT02598297|465006783|FG001|Overall Study|Followed for survival|0|||
129194356|NCT00394706|465006794|FG000|Overall Study|Withdrawal by Subject|2|||
129194357|NCT00394706|465006795|FG001|Overall Study|Withdrawal by Subject|0|||
129194358|NCT00394706|465006796|FG002|Overall Study|Withdrawal by Subject|1|||
129194359|NCT00394706|465006797|FG003|Overall Study|Withdrawal by Subject|0|||
129194360|NCT00394706|465006798|FG004|Overall Study|Withdrawal by Subject|0|||
129194361|NCT00394706|465006799|FG005|Overall Study|Withdrawal by Subject|2|||
129194362|NCT00394706|465006800|FG006|Overall Study|Withdrawal by Subject|1|||
129194363|NCT00394706|465006801|FG007|Overall Study|Withdrawal by Subject|0|||
129194364|NCT00394706|465006794|FG000|Overall Study|Lost to Follow-up|2|||
129194365|NCT00394706|465006795|FG001|Overall Study|Lost to Follow-up|2|||
129194366|NCT00394706|465006796|FG002|Overall Study|Lost to Follow-up|8|||
129194367|NCT00394706|465006797|FG003|Overall Study|Lost to Follow-up|1|||
129194368|NCT00394706|465006798|FG004|Overall Study|Lost to Follow-up|2|||
129194369|NCT00394706|465006799|FG005|Overall Study|Lost to Follow-up|5|||
129194370|NCT00394706|465006800|FG006|Overall Study|Lost to Follow-up|2|||
129194371|NCT00394706|465006801|FG007|Overall Study|Lost to Follow-up|0|||
129194372|NCT02003534|465006805|FG000|Overall Study|Lost to Follow-up|47|||
129194373|NCT02506192|465006808|FG000|Overall Study|Withdrawal by Subject|1|||
129194374|NCT02506192|465006809|FG001|Overall Study|Withdrawal by Subject|1|||
129194375|NCT05292131|465006812|FG000|Overall Study|Lost to Follow-up|1|||
129194376|NCT05292131|465006813|FG001|Overall Study|Lost to Follow-up|1|||
129194377|NCT05292131|465006812|FG000|Overall Study|Withdrawal by Subject|0|||
129194378|NCT05292131|465006813|FG001|Overall Study|Withdrawal by Subject|1|||
129194379|NCT06136897|465006814|FG000|Overall Study|Ineligible|3|||
129194380|NCT06136897|465006814|FG000|Overall Study|Mutation status not confirmed|7|||
129194381|NCT06136897|465006814|FG000|Overall Study|Adverse Event|2|||
129194382|NCT06136897|465006814|FG000|Overall Study|Death|1|||
129194383|NCT06136897|465006814|FG000|Overall Study|Disease progression|18|||
129194384|NCT06136897|465006814|FG000|Overall Study|Other complicating disease|1|||
129194385|NCT06136897|465006814|FG000|Overall Study|Withdrawal by Subject|1|||
129194386|NCT06136897|465006814|FG000|Overall Study|Still on treatment|1|||
129194387|NCT06136897|465006814|FG000|Overall Study|Lost to Follow-up|1|||
129194388|NCT03785405|465006815|FG000|Overall Study|Adverse Event|16|||
129194389|NCT03785405|465006816|FG001|Overall Study|Adverse Event|1|||
129194390|NCT03785405|465006815|FG000|Overall Study|Death|6|||
129194391|NCT03785405|465006816|FG001|Overall Study|Death|4|||
129194392|NCT03785405|465006815|FG000|Overall Study|Guardian decision|4|||
129194393|NCT03785405|465006816|FG001|Overall Study|Guardian decision|1|||
129194394|NCT03785405|465006815|FG000|Overall Study|Lost to Follow-up|1|||
129194395|NCT03785405|465006816|FG001|Overall Study|Lost to Follow-up|0|||
129194396|NCT03785405|465006815|FG000|Overall Study|Physician Decision|8|||
129194397|NCT03785405|465006816|FG001|Overall Study|Physician Decision|5|||
129194398|NCT03785405|465006815|FG000|Overall Study|Participant decision|2|||
129194399|NCT03785405|465006816|FG001|Overall Study|Participant decision|0|||
129194400|NCT03785405|465006815|FG000|Overall Study|Other|1|||
129194401|NCT03785405|465006816|FG001|Overall Study|Other|0|||
129194402|NCT03785405|465006815|FG000|Overall Study|No treatment was received|0|||
129194403|NCT03785405|465006816|FG001|Overall Study|No treatment was received|1|||
129194404|NCT03705559|465006817|FG000|Overall Study|COVID Shut down|1|||
129194405|NCT02881762|465006820|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129194406|NCT02881762|465006821|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
128730670|NCT00393939|463310028|FG000|Overall Study|Withdrawal by Subject|2|||
129194407|NCT00203424|465006825|FG000|Treatment Period|Withdrawal by Subject|4|||
129194408|NCT00203424|465006825|FG000|Treatment Period|Adverse Event|5|||
128781035|NCT01876043|463490409|FG000|Overall Study|Withdrawal by Subject|1|||
128781036|NCT00079937|463490410|FG000|Overall Study|Adverse Event|2|||
128781037|NCT00079937|463490411|FG001|Overall Study|Adverse Event|1|||
128730671|NCT00393939|463310029|FG001|Overall Study|Withdrawal by Subject|7|||
128730672|NCT00393939|463310028|FG000|Overall Study|Other|37|||
128730673|NCT00393939|463310029|FG001|Overall Study|Other|45|||
128730674|NCT03778931|463310030|FG000|Overall Study|Withdrawal by Subject|12|||
128730675|NCT03778931|463310031|FG001|Overall Study|Withdrawal by Subject|25|||
128730676|NCT03778931|463310030|FG000|Overall Study|Physician Decision|1|||
128730677|NCT03778931|463310031|FG001|Overall Study|Physician Decision|3|||
128730678|NCT03778931|463310030|FG000|Overall Study|Participant Noncompliance|1|||
128730679|NCT03778931|463310031|FG001|Overall Study|Participant Noncompliance|1|||
128730680|NCT03778931|463310030|FG000|Overall Study|Lost to Follow-up|4|||
128730681|NCT03778931|463310031|FG001|Overall Study|Lost to Follow-up|1|||
128730682|NCT03778931|463310030|FG000|Overall Study|Death|69|||
128730683|NCT03778931|463310031|FG001|Overall Study|Death|79|||
128730684|NCT00006184|463310032|FG000|Overall Study|Death|1|||
128730685|NCT00006184|463310033|FG001|Overall Study|Death|0|||
128730686|NCT04181827|463310040|FG000|Overall Study|Ongoing|124|||
128730687|NCT04181827|463310041|FG001|Overall Study|Ongoing|157|||
128730688|NCT04181827|463310040|FG000|Overall Study|Death|82|||
128730689|NCT04181827|463310041|FG001|Overall Study|Death|50|||
128730690|NCT04181827|463310040|FG000|Overall Study|Lost to Follow-up|0|||
128730691|NCT04181827|463310041|FG001|Overall Study|Lost to Follow-up|1|||
128730692|NCT04181827|463310040|FG000|Overall Study|Withdrawal by Subject|5|||
128730693|NCT04181827|463310041|FG001|Overall Study|Withdrawal by Subject|0|||
128730694|NCT01857063|463310042|FG000|Period 1 (7 Days)|Adverse Event|0|||
128730695|NCT01857063|463310043|FG001|Period 1 (7 Days)|Adverse Event|1|||
128730696|NCT01857063|463310042|FG000|Period 1 (7 Days)|Physician Decision|1|||
128730697|NCT01857063|463310043|FG001|Period 1 (7 Days)|Physician Decision|0|||
128730698|NCT01857063|463310042|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
128730699|NCT01857063|463310043|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
128730700|NCT01857063|463310042|FG000|Period 2 (7 Days)|Adverse Event|2|||
128730701|NCT01857063|463310043|FG001|Period 2 (7 Days)|Adverse Event|1|||
128730702|NCT01857063|463310042|FG000|Period 2 (7 Days)|Physician Decision|1|||
128730703|NCT01857063|463310043|FG001|Period 2 (7 Days)|Physician Decision|1|||
128730704|NCT01857063|463310042|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
128730705|NCT01857063|463310043|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
128730706|NCT04115358|463310046|FG000|Overall Study|exfoliation|0|||
128730707|NCT04115358|463310047|FG001|Overall Study|exfoliation|0|||
128730708|NCT04115358|463310048|FG002|Overall Study|exfoliation|1|||
128730709|NCT02681302|463310051|FG000|Overall Study|Withdrawal by Subject|1|||
128730710|NCT02681302|463310052|FG001|Overall Study|Withdrawal by Subject|1|||
128730711|NCT02681302|463310053|FG002|Overall Study|Withdrawal by Subject|0|||
128730712|NCT02681302|463310054|FG003|Overall Study|Withdrawal by Subject|0|||
128730713|NCT02681302|463310055|FG004|Overall Study|Withdrawal by Subject|1|||
128730714|NCT02681302|463310056|FG005|Overall Study|Withdrawal by Subject|0|||
128730715|NCT02681302|463310051|FG000|Overall Study|Screen Failure|2|||
128730716|NCT02681302|463310052|FG001|Overall Study|Screen Failure|4|||
128730717|NCT02681302|463310053|FG002|Overall Study|Screen Failure|2|||
128730718|NCT02681302|463310054|FG003|Overall Study|Screen Failure|0|||
129194409|NCT00203424|465006825|FG000|Treatment Period|progressive disease|2|||
129194410|NCT00203424|465006825|FG000|Follow-up Period|Withdrawal by Subject|1|||
129194411|NCT00203424|465006825|FG000|Follow-up Period|progressive disease|4|||
129194412|NCT00203424|465006825|FG000|Follow-up Period|Lost to Follow-up|1|||
129194413|NCT01053988|465006826|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
129194414|NCT01053988|465006827|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129194415|NCT01053988|465006828|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129194416|NCT01053988|465006829|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129194417|NCT01053988|465006830|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129194418|NCT01053988|465006831|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129194419|NCT01053988|465006826|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
129194420|NCT01053988|465006827|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129194421|NCT01053988|465006828|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129194422|NCT01053988|465006829|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129194423|NCT01053988|465006830|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129194424|NCT01053988|465006831|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129194425|NCT01053988|465006826|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
129194426|NCT01053988|465006827|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129194427|NCT01053988|465006828|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129194428|NCT01053988|465006829|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129194429|NCT01053988|465006830|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129194430|NCT01053988|465006831|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129194431|NCT01053988|465006826|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
129194432|NCT01053988|465006827|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
128730719|NCT02681302|463310055|FG004|Overall Study|Screen Failure|1|||
128730720|NCT02681302|463310056|FG005|Overall Study|Screen Failure|1|||
128730721|NCT02681302|463310051|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
128730722|NCT02681302|463310052|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
128730723|NCT02681302|463310053|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
128730724|NCT02681302|463310054|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
128730725|NCT02681302|463310055|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
128730726|NCT02681302|463310056|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
128730727|NCT02115282|463310057|FG000|Overall Study|Disease progression during treatment|216|||
128730728|NCT02115282|463310058|FG001|Overall Study|Disease progression during treatment|229|||
128730729|NCT02115282|463310057|FG000|Overall Study|Adverse Event|49|||
128730730|NCT02115282|463310058|FG001|Overall Study|Adverse Event|23|||
128730731|NCT02115282|463310057|FG000|Overall Study|Death|1|||
128730732|NCT02115282|463310058|FG001|Overall Study|Death|3|||
128730733|NCT02115282|463310057|FG000|Overall Study|Alternative therapy|1|||
128730734|NCT02115282|463310058|FG001|Overall Study|Alternative therapy|1|||
128730735|NCT02115282|463310057|FG000|Overall Study|Complicating disease|0|||
128730736|NCT02115282|463310058|FG001|Overall Study|Complicating disease|3|||
128730737|NCT02115282|463310057|FG000|Overall Study|Withdrawal by Subject|12|||
128730738|NCT02115282|463310058|FG001|Overall Study|Withdrawal by Subject|10|||
128730739|NCT02115282|463310057|FG000|Overall Study|Symptomatic progression/deterioration|7|||
128730740|NCT02115282|463310058|FG001|Overall Study|Symptomatic progression/deterioration|18|||
128730741|NCT02115282|463310057|FG000|Overall Study|Non-compliance|5|||
128730742|NCT02115282|463310058|FG001|Overall Study|Non-compliance|1|||
128730743|NCT02115282|463310057|FG000|Overall Study|Protocol Violation|2|||
128730744|NCT02115282|463310058|FG001|Overall Study|Protocol Violation|2|||
128730745|NCT02115282|463310057|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
128730746|NCT02115282|463310058|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
128730747|NCT02115282|463310057|FG000|Overall Study|Not start protocol therapy|9|||
128730748|NCT02115282|463310058|FG001|Overall Study|Not start protocol therapy|10|||
128730749|NCT02152995|463310059|FG000|Overall Study|Withdrawal by Subject|1|||
128730750|NCT02152995|463310060|FG001|Overall Study|Withdrawal by Subject|0|||
128730751|NCT04907032|463310062|FG000|Overall Study|Withdrawal by Subject|7|||
128730752|NCT04907032|463310063|FG001|Overall Study|Withdrawal by Subject|1|||
128730753|NCT00613509|463310064|FG000|Cycle 1|Adverse Event|2|||
128730754|NCT00613509|463310065|FG001|Cycle 1|Adverse Event|1|||
128730755|NCT00613509|463310064|FG000|Cycle 1|Disease Progression|2|||
128730756|NCT00613509|463310065|FG001|Cycle 1|Disease Progression|6|||
128730757|NCT00613509|463310064|FG000|Cycle 1|Unacceptable Toxicity|1|||
128730758|NCT00613509|463310065|FG001|Cycle 1|Unacceptable Toxicity|0|||
128730759|NCT00613509|463310064|FG000|Cycle 1|Other administrative reason|0|||
128730760|NCT00613509|463310065|FG001|Cycle 1|Other administrative reason|1|||
128730761|NCT01723228|463310072|FG000|Overall Study|Adverse Event|2|||
128730762|NCT01723228|463310073|FG001|Overall Study|Adverse Event|6|||
128730763|NCT01723228|463310072|FG000|Overall Study|Withdrawal by Subject|2|||
129194433|NCT01053988|465006828|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
129194434|NCT01053988|465006829|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
129194435|NCT01053988|465006830|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
129194436|NCT01053988|465006831|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
129194437|NCT01053988|465006826|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
129194438|NCT01053988|465006827|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
129194439|NCT01053988|465006828|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
129194440|NCT01053988|465006829|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
128730764|NCT01723228|463310073|FG001|Overall Study|Withdrawal by Subject|1|||
128730765|NCT01723228|463310072|FG000|Overall Study|Protocol Violation|0|||
128730766|NCT01723228|463310073|FG001|Overall Study|Protocol Violation|2|||
128730767|NCT01723228|463310072|FG000|Overall Study|Lost to Follow-up|2|||
128730768|NCT01723228|463310073|FG001|Overall Study|Lost to Follow-up|1|||
128730769|NCT01723228|463310072|FG000|Overall Study|Other|2|||
128781038|NCT00079937|463490410|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128781039|NCT00079937|463490411|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129194441|NCT01053988|465006830|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
129194442|NCT01053988|465006831|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
129194443|NCT01053988|465006826|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
128730770|NCT01723228|463310073|FG001|Overall Study|Other|1|||
128730771|NCT01451424|463310076|FG000|Overall Study|Withdrawal by Subject|1|||
128730772|NCT01451424|463310077|FG001|Overall Study|Withdrawal by Subject|1|||
128730773|NCT01451424|463310078|FG002|Overall Study|Withdrawal by Subject|0|||
128730774|NCT01451424|463310079|FG003|Overall Study|Withdrawal by Subject|2|||
128730775|NCT01451424|463310076|FG000|Overall Study|Lost to Follow-up|0|||
128730776|NCT01451424|463310077|FG001|Overall Study|Lost to Follow-up|1|||
128730777|NCT01451424|463310078|FG002|Overall Study|Lost to Follow-up|0|||
128730778|NCT01451424|463310079|FG003|Overall Study|Lost to Follow-up|1|||
128730779|NCT01451424|463310076|FG000|Overall Study|Physician Decision|0|||
128730780|NCT01451424|463310077|FG001|Overall Study|Physician Decision|0|||
128730781|NCT01451424|463310078|FG002|Overall Study|Physician Decision|1|||
129194444|NCT01053988|465006827|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129194445|NCT01053988|465006828|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129194446|NCT01053988|465006829|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129194447|NCT01053988|465006830|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129194448|NCT01053988|465006831|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129194449|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
129194450|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
129194451|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
129194452|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
129194453|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
129194454|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
129194455|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129194456|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
129194457|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
129194458|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
129194459|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
129194460|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129194461|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
129194462|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
129194463|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
129194464|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
129194465|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
129194466|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
129194467|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
129194468|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
129194469|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
129194470|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
129194471|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
129194472|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
129194473|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
129194474|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
129194475|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
129194476|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
129194477|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
129194478|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
129194479|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129194480|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
129194481|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129194482|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
129194483|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129194484|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
129194485|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
129194486|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
129194487|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
129194488|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
129194489|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
129194490|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
129194491|NCT01053988|465006826|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129194492|NCT01053988|465006827|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
129194493|NCT01053988|465006828|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129194494|NCT01053988|465006829|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
129194495|NCT01053988|465006830|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
129194496|NCT01053988|465006831|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129194497|NCT01922271|465006832|FG000|WASHOUT Period|Withdrawal by Subject|1|||
129194498|NCT01922271|465006833|FG001|WASHOUT Period|Withdrawal by Subject|0|||
129194499|NCT01824355|465006834|FG000|Overall Study|Adverse Event|2|||
129194500|NCT01824355|465006834|FG000|Overall Study|unevaluable reference method results per|1|||
129194501|NCT02576795|465006836|FG000|Overall Study|Lost to Follow-up|0|||
129194502|NCT02576795|465006837|FG001|Overall Study|Lost to Follow-up|0|||
129194503|NCT02576795|465006838|FG002|Overall Study|Lost to Follow-up|1|||
129194504|NCT02576795|465006839|FG003|Overall Study|Lost to Follow-up|0|||
129194505|NCT04427072|465006841|FG000|Randomized Treatment Phase|Progressive disease|9|||
129194506|NCT04427072|465006842|FG001|Randomized Treatment Phase|Progressive disease|4|||
129194507|NCT04427072|465006841|FG000|Randomized Treatment Phase|Adverse Event|3|||
129194508|NCT04427072|465006842|FG001|Randomized Treatment Phase|Adverse Event|1|||
129194509|NCT04427072|465006841|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
129194510|NCT04427072|465006842|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
129194511|NCT04427072|465006841|FG000|Randomized Treatment Phase|Death|0|||
129194512|NCT04427072|465006842|FG001|Randomized Treatment Phase|Death|1|||
129194513|NCT04427072|465006841|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
129194514|NCT04427072|465006842|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
129194515|NCT04427072|465006841|FG000|Extension Treatment Phase|Progressive disease|0|||
129194516|NCT04427072|465006842|FG001|Extension Treatment Phase|Progressive disease|5|||
129194517|NCT05232864|465006843|FG000|Overall Study|Adverse Event|0|||
129194518|NCT05232864|465006844|FG001|Overall Study|Adverse Event|1|||
129194519|NCT05232864|465006843|FG000|Overall Study|Study terminated by sponsor|16|||
129194520|NCT05232864|465006844|FG001|Overall Study|Study terminated by sponsor|14|||
129194521|NCT00465452|465006851|FG000|Overall Study|Adverse Event|1|||
129194522|NCT02104947|465006857|FG000|Overall Study|Withdrawal by Subject|10|||
129194523|NCT02104947|465006858|FG001|Overall Study|Withdrawal by Subject|3|||
129194524|NCT02104947|465006857|FG000|Overall Study|Lost to Follow-up|4|||
129194525|NCT02104947|465006858|FG001|Overall Study|Lost to Follow-up|4|||
129194526|NCT02104947|465006857|FG000|Overall Study|Protocol Violation|6|||
129194527|NCT02104947|465006858|FG001|Overall Study|Protocol Violation|8|||
129194528|NCT02104947|465006857|FG000|Overall Study|Adverse Event|57|||
129194529|NCT02104947|465006858|FG001|Overall Study|Adverse Event|38|||
129194530|NCT02104947|465006857|FG000|Overall Study|Other than stated above|2|||
129194531|NCT02104947|465006858|FG001|Overall Study|Other than stated above|3|||
129194532|NCT00145574|465006859|FG000|Double Blind|Adverse Event|0|||
129194533|NCT00145574|465006860|FG001|Double Blind|Adverse Event|3|||
129194534|NCT00145574|465006861|FG002|Double Blind|Adverse Event|1|||
129194535|NCT00145574|465006859|FG000|Double Blind|Withdrawal by Subject|1|||
129194536|NCT00145574|465006860|FG001|Double Blind|Withdrawal by Subject|1|||
129194537|NCT00145574|465006861|FG002|Double Blind|Withdrawal by Subject|1|||
129194538|NCT00145574|465006859|FG000|Double Blind|required restricted medicine|0|||
129194539|NCT00145574|465006860|FG001|Double Blind|required restricted medicine|1|||
129194540|NCT00145574|465006861|FG002|Double Blind|required restricted medicine|0|||
129194541|NCT00145574|465006859|FG000|Open Label Long-term Extension|Adverse Event|0|||
129194542|NCT00145574|465006860|FG001|Open Label Long-term Extension|Adverse Event|0|||
129194543|NCT00145574|465006861|FG002|Open Label Long-term Extension|Adverse Event|5|||
129194544|NCT00145574|465006859|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
129194545|NCT00145574|465006860|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
129194546|NCT00145574|465006861|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
129194547|NCT00145574|465006859|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
129194548|NCT00145574|465006860|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
129194549|NCT00145574|465006861|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
129194550|NCT00145574|465006859|FG000|Open Label Long-term Extension|required restricted medicine|0|||
129194551|NCT00145574|465006860|FG001|Open Label Long-term Extension|required restricted medicine|0|||
129194552|NCT00145574|465006861|FG002|Open Label Long-term Extension|required restricted medicine|1|||
129194553|NCT00858637|465006865|FG000|Active Comparison Phase|Adverse Event|14|||
129194554|NCT00858637|465006866|FG001|Active Comparison Phase|Adverse Event|0|||
129194555|NCT00858637|465006867|FG002|Active Comparison Phase|Adverse Event|0|||
129194556|NCT00858637|465006868|FG003|Active Comparison Phase|Adverse Event|9|||
129194557|NCT00858637|465006869|FG004|Active Comparison Phase|Adverse Event|0|||
129194558|NCT00858637|465006870|FG005|Active Comparison Phase|Adverse Event|0|||
129194559|NCT00858637|465006865|FG000|Active Comparison Phase|Death|1|||
129194560|NCT00858637|465006866|FG001|Active Comparison Phase|Death|0|||
129194561|NCT00858637|465006867|FG002|Active Comparison Phase|Death|0|||
129194562|NCT00858637|465006868|FG003|Active Comparison Phase|Death|1|||
129194563|NCT00858637|465006869|FG004|Active Comparison Phase|Death|0|||
129194564|NCT00858637|465006870|FG005|Active Comparison Phase|Death|0|||
129194565|NCT00858637|465006865|FG000|Active Comparison Phase|Physician Decision|1|||
129194566|NCT00858637|465006866|FG001|Active Comparison Phase|Physician Decision|0|||
129194567|NCT00858637|465006867|FG002|Active Comparison Phase|Physician Decision|0|||
129194568|NCT00858637|465006868|FG003|Active Comparison Phase|Physician Decision|1|||
129194569|NCT00858637|465006869|FG004|Active Comparison Phase|Physician Decision|0|||
129194570|NCT00858637|465006870|FG005|Active Comparison Phase|Physician Decision|0|||
129194571|NCT00858637|465006865|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
129194572|NCT00858637|465006866|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
129194573|NCT00858637|465006867|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
129194574|NCT00858637|465006868|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
129194575|NCT00858637|465006869|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
129194576|NCT00858637|465006870|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
129194577|NCT00858637|465006865|FG000|Active Comparison Phase|Other Reasons|1|||
129194578|NCT00858637|465006866|FG001|Active Comparison Phase|Other Reasons|0|||
129194579|NCT00858637|465006867|FG002|Active Comparison Phase|Other Reasons|0|||
129194580|NCT00858637|465006868|FG003|Active Comparison Phase|Other Reasons|1|||
129194581|NCT00858637|465006869|FG004|Active Comparison Phase|Other Reasons|0|||
129194582|NCT00858637|465006870|FG005|Active Comparison Phase|Other Reasons|0|||
129194583|NCT00858637|465006865|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
129194584|NCT00858637|465006866|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
129194585|NCT00858637|465006867|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
129194586|NCT00858637|465006868|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
129194587|NCT00858637|465006869|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
129194588|NCT00858637|465006870|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
129194589|NCT00858637|465006865|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129194590|NCT00858637|465006866|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129194591|NCT00858637|465006867|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129194592|NCT00858637|465006868|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129194593|NCT00858637|465006869|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129194594|NCT00858637|465006870|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
129194595|NCT04677504|465006874|FG000|Overall Study|Death|51|||
129194596|NCT04677504|465006875|FG001|Overall Study|Death|49|||
129194597|NCT04677504|465006874|FG000|Overall Study|Progressive Disease|1|||
129194598|NCT04677504|465006875|FG001|Overall Study|Progressive Disease|0|||
129194599|NCT04677504|465006874|FG000|Overall Study|Symptomatic Deterioration|1|||
129194600|NCT04677504|465006875|FG001|Overall Study|Symptomatic Deterioration|0|||
129194601|NCT04677504|465006874|FG000|Overall Study|Withdrawal by Subject|2|||
129194602|NCT04677504|465006875|FG001|Overall Study|Withdrawal by Subject|5|||
129194603|NCT04677504|465006874|FG000|Overall Study|Study Terminated By Sponsor|28|||
129194604|NCT04677504|465006875|FG001|Overall Study|Study Terminated By Sponsor|24|||
129194605|NCT04677504|465006874|FG000|Overall Study|Adverse Event|0|||
129194606|NCT04677504|465006875|FG001|Overall Study|Adverse Event|1|||
129194607|NCT03182907|465006876|FG000|Overall Study|Death|3|||
129194608|NCT03182907|465006877|FG001|Overall Study|Death|0|||
129194609|NCT03182907|465006876|FG000|Overall Study|Protocol Violation|4|||
129194610|NCT03182907|465006877|FG001|Overall Study|Protocol Violation|0|||
129194611|NCT03182907|465006876|FG000|Overall Study|Lost to Follow-up|1|||
129194612|NCT03182907|465006877|FG001|Overall Study|Lost to Follow-up|0|||
129194613|NCT03182907|465006876|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129194614|NCT03182907|465006877|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129194615|NCT00429169|465006885|FG000|Overall Study|Lost to Follow-up|0|||
129194616|NCT00429169|465006886|FG001|Overall Study|Lost to Follow-up|1|||
129194617|NCT00429169|465006885|FG000|Overall Study|Ineligibility discovered after entry|2|||
129194618|NCT00429169|465006886|FG001|Overall Study|Ineligibility discovered after entry|1|||
129194619|NCT01711645|465006889|FG000|Overall Study|Withdrawal by Subject|8|||
129194620|NCT01711645|465006889|FG000|Overall Study|Lost to Follow-up|6|||
129194621|NCT01711645|465006889|FG000|Overall Study|Physician Decision|5|||
129194622|NCT01746173|465006895|FG000|Overall Study|Disease Progression|2|||
129194623|NCT01371552|465006901|FG000|Part 1, First 3 Days|Inconvenience|0|||
129194624|NCT01371552|465006902|FG001|Part 1, First 3 Days|Inconvenience|0|||
129194625|NCT01371552|465006903|FG002|Part 1, First 3 Days|Inconvenience|1|||
129194626|NCT01371552|465006904|FG003|Part 1, First 3 Days|Inconvenience|0|||
129194627|NCT01371552|465006905|FG004|Part 1, First 3 Days|Inconvenience|0|||
129194628|NCT01371552|465006906|FG005|Part 1, First 3 Days|Inconvenience|0|||
129194629|NCT03304873|465006907|FG000|Overall Study|Lost to Follow-up|1|||
129194630|NCT03304873|465006908|FG001|Overall Study|Lost to Follow-up|8|||
129194631|NCT01546688|465006909|FG000|Overall Study|Adverse Event|0|||
129194632|NCT01546688|465006910|FG001|Overall Study|Adverse Event|4|||
129194633|NCT01546688|465006909|FG000|Overall Study|Withdrawal by Subject|2|||
129194634|NCT01546688|465006910|FG001|Overall Study|Withdrawal by Subject|1|||
129194635|NCT01546688|465006909|FG000|Overall Study|Lack of Efficacy|1|||
129194636|NCT01546688|465006910|FG001|Overall Study|Lack of Efficacy|0|||
129194637|NCT04230213|465006916|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
129194638|NCT04230213|465006917|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
129194639|NCT04230213|465006918|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
129194640|NCT04230213|465006916|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
129194641|NCT04230213|465006917|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
129194642|NCT04230213|465006918|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
129194643|NCT04230213|465006916|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
129194644|NCT04230213|465006917|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
129194645|NCT04230213|465006918|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
129194646|NCT04230213|465006916|FG000|TP2: Week 10 to Week 16|Other|0|||
129194647|NCT04230213|465006917|FG001|TP2: Week 10 to Week 16|Other|2|||
129194648|NCT04230213|465006918|FG002|TP2: Week 10 to Week 16|Other|1|||
129194649|NCT04230213|465006916|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
129194650|NCT04230213|465006917|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
129194651|NCT04230213|465006918|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
129194652|NCT04230213|465006916|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
129194653|NCT04230213|465006917|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
129194654|NCT04230213|465006918|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
129194655|NCT04230213|465006916|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
129194656|NCT04230213|465006917|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
129194657|NCT04230213|465006918|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
129194658|NCT04230213|465006916|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
129194659|NCT04230213|465006917|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
129194660|NCT04230213|465006918|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
129194661|NCT04230213|465006916|FG000|TP3: Week 16 to Week 22|Other|0|||
129194662|NCT04230213|465006917|FG001|TP3: Week 16 to Week 22|Other|1|||
129194663|NCT04230213|465006918|FG002|TP3: Week 16 to Week 22|Other|3|||
129194664|NCT04230213|465006916|FG000|TP4: Week 22 to Week 32|Other|0|||
129194665|NCT04230213|465006917|FG001|TP4: Week 22 to Week 32|Other|5|||
129194666|NCT04230213|465006918|FG002|TP4: Week 22 to Week 32|Other|5|||
129194667|NCT04230213|465006916|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
129194668|NCT04230213|465006917|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
129194669|NCT04230213|465006918|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
129194670|NCT04230213|465006916|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
129194671|NCT04230213|465006917|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
129194672|NCT04230213|465006918|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
129194673|NCT04230213|465006916|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
129194674|NCT04230213|465006917|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
129194675|NCT04230213|465006918|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
129194676|NCT04230213|465006916|FG000|Follow up: Week 32 to Week 36|Other|0|||
129194677|NCT04230213|465006917|FG001|Follow up: Week 32 to Week 36|Other|1|||
129194678|NCT04230213|465006918|FG002|Follow up: Week 32 to Week 36|Other|1|||
129194679|NCT01946152|465008637|FG000|Overall Study|Adverse Event|1|||
129194680|NCT01946152|465008638|FG001|Overall Study|Adverse Event|0|||
129194681|NCT01946152|465008639|FG002|Overall Study|Adverse Event|0|||
129194682|NCT01946152|465008640|FG003|Overall Study|Adverse Event|0|||
129194683|NCT01946152|465008637|FG000|Overall Study|Withdrawal by Subject|0|||
129194684|NCT01946152|465008638|FG001|Overall Study|Withdrawal by Subject|2|||
129194685|NCT01946152|465008639|FG002|Overall Study|Withdrawal by Subject|0|||
129194686|NCT01946152|465008640|FG003|Overall Study|Withdrawal by Subject|0|||
129194687|NCT01946152|465008637|FG000|Overall Study|Progression|0|||
129194688|NCT01946152|465008638|FG001|Overall Study|Progression|1|||
129194689|NCT01946152|465008639|FG002|Overall Study|Progression|4|||
129194690|NCT01946152|465008640|FG003|Overall Study|Progression|7|||
129194691|NCT01946152|465008637|FG000|Overall Study|Physician Decision|0|||
129194692|NCT01946152|465008638|FG001|Overall Study|Physician Decision|0|||
129194693|NCT01946152|465008639|FG002|Overall Study|Physician Decision|1|||
129194694|NCT01946152|465008640|FG003|Overall Study|Physician Decision|0|||
129194695|NCT01946152|465008637|FG000|Overall Study|Second malignancy|0|||
129194696|NCT01946152|465008638|FG001|Overall Study|Second malignancy|0|||
129194697|NCT01946152|465008639|FG002|Overall Study|Second malignancy|1|||
129194698|NCT01946152|465008640|FG003|Overall Study|Second malignancy|0|||
129194699|NCT01946152|465008637|FG000|Overall Study|Adverse Event|0|||
129194700|NCT01946152|465008638|FG001|Overall Study|Adverse Event|0|||
129194701|NCT01946152|465008639|FG002|Overall Study|Adverse Event|0|||
129194702|NCT01946152|465008640|FG003|Overall Study|Adverse Event|1|||
129194703|NCT01061359|465008646|FG000|Overall Study|Death|32|||
129194704|NCT01061359|465008646|FG000|Overall Study|Lost to Follow-up|1072|||
129194705|NCT01061359|465008646|FG000|Overall Study|Relapse|187|||
129194706|NCT01061359|465008646|FG000|Overall Study|Secondary neoplasm|11|||
129194707|NCT04273893|465008652|FG000|Overall Study|Withdrawal by Subject|0|||
129194708|NCT04273893|465008653|FG001|Overall Study|Withdrawal by Subject|2|||
129194709|NCT04273893|465008652|FG000|Overall Study|Treatment of Disease Progression|0|||
129194710|NCT04273893|465008653|FG001|Overall Study|Treatment of Disease Progression|2|||
129194711|NCT04273893|465008652|FG000|Overall Study|Death|1|||
129194712|NCT04273893|465008653|FG001|Overall Study|Death|2|||
129194713|NCT04273893|465008652|FG000|Overall Study|Lost to Follow-up|0|||
129194714|NCT04273893|465008653|FG001|Overall Study|Lost to Follow-up|2|||
129194715|NCT04273893|465008652|FG000|Overall Study|Physician Decision|1|||
129194716|NCT04273893|465008653|FG001|Overall Study|Physician Decision|0|||
129194717|NCT01957202|465008655|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194718|NCT01957202|465008656|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
129194719|NCT01957202|465008657|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194720|NCT01957202|465008658|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194721|NCT01957202|465008659|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194722|NCT01957202|465008660|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194723|NCT01957202|465008661|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194724|NCT01957202|465008662|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194725|NCT01957202|465008663|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194726|NCT01957202|465008664|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194727|NCT01957202|465008665|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
128730782|NCT01451424|463310079|FG003|Overall Study|Physician Decision|1|||
128730783|NCT01451424|463310076|FG000|Overall Study|Adverse Event|0|||
128730784|NCT01451424|463310077|FG001|Overall Study|Adverse Event|0|||
128730785|NCT01451424|463310078|FG002|Overall Study|Adverse Event|0|||
128730786|NCT01451424|463310079|FG003|Overall Study|Adverse Event|1|||
128730787|NCT00528528|463310080|FG000|Overall Study|Lost to Follow-up|0|||
128730788|NCT00528528|463310081|FG001|Overall Study|Lost to Follow-up|0|||
128730789|NCT00528528|463310082|FG002|Overall Study|Lost to Follow-up|1|||
128730790|NCT00528528|463310083|FG003|Overall Study|Lost to Follow-up|1|||
128730791|NCT00528528|463310080|FG000|Overall Study|Ineligible to continue the trial|0|||
128730792|NCT00528528|463310081|FG001|Overall Study|Ineligible to continue the trial|0|||
128730793|NCT00528528|463310082|FG002|Overall Study|Ineligible to continue the trial|0|||
128730794|NCT00528528|463310083|FG003|Overall Study|Ineligible to continue the trial|1|||
129194728|NCT01957202|465008666|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194729|NCT01957202|465008667|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194730|NCT01957202|465008668|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194731|NCT01957202|465008669|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194732|NCT01957202|465008670|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194733|NCT01957202|465008671|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
129194734|NCT01957202|465008672|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129194735|NCT01957202|465008655|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194736|NCT01957202|465008656|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194737|NCT01957202|465008657|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194738|NCT01957202|465008658|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194739|NCT01957202|465008659|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194740|NCT01957202|465008660|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194741|NCT01957202|465008661|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194742|NCT01957202|465008662|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194743|NCT01957202|465008663|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194744|NCT01957202|465008664|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194745|NCT01957202|465008665|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194746|NCT01957202|465008666|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194747|NCT01957202|465008667|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194748|NCT01957202|465008668|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194749|NCT01957202|465008669|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194750|NCT01957202|465008670|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194751|NCT01957202|465008671|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
129194752|NCT01957202|465008672|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
129194753|NCT02221674|465008678|FG000|Overall Study|Lost to Follow-up|1|||
129194754|NCT02221674|465008679|FG001|Overall Study|Lost to Follow-up|0|||
129194755|NCT02221674|465008680|FG002|Overall Study|Lost to Follow-up|0|||
129194756|NCT02557542|465008682|FG000|Overall Study|Poor recruitment|3|||
129194757|NCT02557542|465008683|FG001|Overall Study|Poor recruitment|0|||
129194758|NCT04390880|465008684|FG000|Overall Study|Withdrawal by Subject|1|||
129194759|NCT03724890|465008688|FG000|Overall Study|Death|2|||
129194760|NCT03724890|465008689|FG001|Overall Study|Death|6|||
129194761|NCT03724890|465008690|FG002|Overall Study|Death|3|||
129194762|NCT03724890|465008691|FG003|Overall Study|Death|5|||
129194763|NCT03724890|465008692|FG004|Overall Study|Death|2|||
129194764|NCT03724890|465008693|FG005|Overall Study|Death|0|||
129194765|NCT03724890|465008694|FG006|Overall Study|Death|2|||
129194766|NCT03724890|465008695|FG007|Overall Study|Death|3|||
129194767|NCT03724890|465008696|FG008|Overall Study|Death|4|||
129194768|NCT03724890|465008697|FG009|Overall Study|Death|2|||
129194769|NCT03724890|465008698|FG010|Overall Study|Death|2|||
129194770|NCT03724890|465008688|FG000|Overall Study|Lost to Follow-up|0|||
129194771|NCT03724890|465008689|FG001|Overall Study|Lost to Follow-up|3|||
129194772|NCT03724890|465008690|FG002|Overall Study|Lost to Follow-up|0|||
129194773|NCT03724890|465008691|FG003|Overall Study|Lost to Follow-up|1|||
129194774|NCT03724890|465008692|FG004|Overall Study|Lost to Follow-up|2|||
129194775|NCT03724890|465008693|FG005|Overall Study|Lost to Follow-up|2|||
129194776|NCT03724890|465008694|FG006|Overall Study|Lost to Follow-up|1|||
129194777|NCT03724890|465008695|FG007|Overall Study|Lost to Follow-up|0|||
129194778|NCT03724890|465008696|FG008|Overall Study|Lost to Follow-up|2|||
129194779|NCT03724890|465008697|FG009|Overall Study|Lost to Follow-up|0|||
129194780|NCT03724890|465008698|FG010|Overall Study|Lost to Follow-up|0|||
129194781|NCT03724890|465008688|FG000|Overall Study|Withdrawal by Subject|1|||
129194782|NCT03724890|465008689|FG001|Overall Study|Withdrawal by Subject|2|||
129194783|NCT03724890|465008690|FG002|Overall Study|Withdrawal by Subject|1|||
129194784|NCT03724890|465008691|FG003|Overall Study|Withdrawal by Subject|0|||
129194785|NCT03724890|465008692|FG004|Overall Study|Withdrawal by Subject|0|||
129194786|NCT03724890|465008693|FG005|Overall Study|Withdrawal by Subject|1|||
129194787|NCT03724890|465008694|FG006|Overall Study|Withdrawal by Subject|0|||
129194788|NCT03724890|465008695|FG007|Overall Study|Withdrawal by Subject|0|||
129194789|NCT03724890|465008696|FG008|Overall Study|Withdrawal by Subject|2|||
129194790|NCT03724890|465008697|FG009|Overall Study|Withdrawal by Subject|2|||
129194791|NCT03724890|465008698|FG010|Overall Study|Withdrawal by Subject|1|||
129194792|NCT03724890|465008688|FG000|Overall Study|Other|1|||
129194793|NCT03724890|465008689|FG001|Overall Study|Other|0|||
129194794|NCT03724890|465008690|FG002|Overall Study|Other|0|||
129194795|NCT03724890|465008691|FG003|Overall Study|Other|0|||
129194796|NCT03724890|465008692|FG004|Overall Study|Other|0|||
129194797|NCT03724890|465008693|FG005|Overall Study|Other|0|||
129194798|NCT03724890|465008694|FG006|Overall Study|Other|0|||
129194799|NCT03724890|465008695|FG007|Overall Study|Other|1|||
129194800|NCT03724890|465008696|FG008|Overall Study|Other|1|||
129194801|NCT03724890|465008697|FG009|Overall Study|Other|0|||
129194802|NCT03724890|465008698|FG010|Overall Study|Other|2|||
129194803|NCT02123823|465008699|FG000|Overall Study|Lack of Efficacy|0|||
129194804|NCT02123823|465008700|FG001|Overall Study|Lack of Efficacy|2|||
129194805|NCT02123823|465008701|FG002|Overall Study|Lack of Efficacy|8|||
129194806|NCT02123823|465008702|FG003|Overall Study|Lack of Efficacy|10|||
129194807|NCT02123823|465008699|FG000|Overall Study|Progressive disease|3|||
129194808|NCT02123823|465008700|FG001|Overall Study|Progressive disease|19|||
129194809|NCT02123823|465008701|FG002|Overall Study|Progressive disease|52|||
129194810|NCT02123823|465008702|FG003|Overall Study|Progressive disease|53|||
129194811|NCT02123823|465008699|FG000|Overall Study|Withdrawal by Subject|0|||
129194812|NCT02123823|465008700|FG001|Overall Study|Withdrawal by Subject|0|||
129194813|NCT02123823|465008701|FG002|Overall Study|Withdrawal by Subject|7|||
129194814|NCT02123823|465008702|FG003|Overall Study|Withdrawal by Subject|2|||
129194815|NCT02123823|465008699|FG000|Overall Study|Adverse Event|0|||
129194816|NCT02123823|465008700|FG001|Overall Study|Adverse Event|0|||
129194817|NCT02123823|465008701|FG002|Overall Study|Adverse Event|3|||
129194818|NCT02123823|465008702|FG003|Overall Study|Adverse Event|5|||
129194819|NCT01635855|465008703|FG000|Overall Study|Withdrawal by Subject|4|||
129194820|NCT05870865|465008706|FG000|Randomized|Did not receive study treatment|2|||
129194821|NCT05870865|465008707|FG001|Randomized|Did not receive study treatment|4|||
129194822|NCT05870865|465008708|FG002|Randomized|Did not receive study treatment|4|||
129194823|NCT05870865|465008709|FG003|Randomized|Did not receive study treatment|3|||
129194824|NCT05870865|465008706|FG000|Treatment Period|Adverse Event|1|||
129194825|NCT05870865|465008707|FG001|Treatment Period|Adverse Event|1|||
129194826|NCT05870865|465008708|FG002|Treatment Period|Adverse Event|1|||
129194827|NCT05870865|465008709|FG003|Treatment Period|Adverse Event|1|||
129194828|NCT05870865|465008706|FG000|Treatment Period|Lost to Follow-up|0|||
129194829|NCT05870865|465008707|FG001|Treatment Period|Lost to Follow-up|1|||
129194830|NCT05870865|465008708|FG002|Treatment Period|Lost to Follow-up|2|||
129194831|NCT05870865|465008709|FG003|Treatment Period|Lost to Follow-up|0|||
129194832|NCT05870865|465008706|FG000|Treatment Period|Protocol Violation|0|||
129194833|NCT05870865|465008707|FG001|Treatment Period|Protocol Violation|0|||
129194834|NCT05870865|465008708|FG002|Treatment Period|Protocol Violation|0|||
129194835|NCT05870865|465008709|FG003|Treatment Period|Protocol Violation|1|||
129194836|NCT05870865|465008706|FG000|Treatment Period|Withdrawal by Subject|0|||
129194837|NCT05870865|465008707|FG001|Treatment Period|Withdrawal by Subject|1|||
129194838|NCT05870865|465008708|FG002|Treatment Period|Withdrawal by Subject|1|||
129194839|NCT05870865|465008709|FG003|Treatment Period|Withdrawal by Subject|1|||
129194840|NCT03400176|465008710|FG000|Dose Escalation|Progressive disease|1|||
129194841|NCT03400176|465008711|FG001|Dose Escalation|Progressive disease|1|||
129194842|NCT03400176|465008712|FG002|Dose Escalation|Progressive disease|0|||
129194843|NCT03400176|465008713|FG003|Dose Escalation|Progressive disease|0|||
129194844|NCT03400176|465008714|FG004|Dose Escalation|Progressive disease|1|||
129194845|NCT03400176|465008710|FG000|Dose Escalation|Patient decision|0|||
129194846|NCT03400176|465008711|FG001|Dose Escalation|Patient decision|0|||
129194847|NCT03400176|465008712|FG002|Dose Escalation|Patient decision|0|||
129194848|NCT03400176|465008713|FG003|Dose Escalation|Patient decision|0|||
129194849|NCT03400176|465008714|FG004|Dose Escalation|Patient decision|1|||
129194850|NCT03400176|465008710|FG000|Dose Expansion|Patient decision|0|||
129194851|NCT03400176|465008711|FG001|Dose Expansion|Patient decision|0|||
129194852|NCT03400176|465008712|FG002|Dose Expansion|Patient decision|0|||
129194853|NCT03400176|465008713|FG003|Dose Expansion|Patient decision|1|||
129194854|NCT03400176|465008714|FG004|Dose Expansion|Patient decision|0|||
129194855|NCT03400176|465008710|FG000|Dose Expansion|Adverse Event|0|||
129194856|NCT03400176|465008711|FG001|Dose Expansion|Adverse Event|0|||
129194857|NCT03400176|465008712|FG002|Dose Expansion|Adverse Event|0|||
129194858|NCT03400176|465008713|FG003|Dose Expansion|Adverse Event|1|||
129194859|NCT03400176|465008714|FG004|Dose Expansion|Adverse Event|0|||
129194860|NCT03400176|465008710|FG000|Dose Expansion|Physician Decision|0|||
129194861|NCT03400176|465008711|FG001|Dose Expansion|Physician Decision|0|||
129194862|NCT03400176|465008712|FG002|Dose Expansion|Physician Decision|0|||
129194863|NCT03400176|465008713|FG003|Dose Expansion|Physician Decision|1|||
129194864|NCT03400176|465008714|FG004|Dose Expansion|Physician Decision|0|||
129194865|NCT03400176|465008710|FG000|Dose Expansion|Progressive disease|0|||
129194866|NCT03400176|465008711|FG001|Dose Expansion|Progressive disease|0|||
129194867|NCT03400176|465008712|FG002|Dose Expansion|Progressive disease|1|||
129194868|NCT03400176|465008713|FG003|Dose Expansion|Progressive disease|1|||
129194869|NCT03400176|465008714|FG004|Dose Expansion|Progressive disease|0|||
129194870|NCT00206440|465008715|FG000|Overall Study|Protocol Violation|1|||
129194871|NCT00206440|465008716|FG001|Overall Study|Protocol Violation|2|||
129194872|NCT00206440|465008715|FG000|Overall Study|Adverse Event|4|||
129194873|NCT00206440|465008716|FG001|Overall Study|Adverse Event|2|||
129194874|NCT01298765|465008717|FG000|Titration Period|Adverse Event|26|||
129194875|NCT01298765|465008717|FG000|Titration Period|Death|1|||
129194876|NCT01298765|465008717|FG000|Titration Period|Lack of Efficacy|21|||
129194877|NCT01298765|465008717|FG000|Titration Period|Lost to Follow-up|9|||
129194878|NCT01298765|465008717|FG000|Titration Period|Physician Decision|1|||
129194879|NCT01298765|465008717|FG000|Titration Period|Withdrawal by Subject|10|||
129194880|NCT01298765|465008717|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
129194881|NCT01298765|465008717|FG000|Long-Term Treatment Period|Adverse Event|19|||
129194882|NCT01298765|465008717|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
129194883|NCT01298765|465008717|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
129194884|NCT01298765|465008717|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
129194885|NCT01298765|465008717|FG000|Long-Term Treatment Period|Physician Decision|1|||
129194886|NCT01298765|465008717|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
129194887|NCT00766051|465008719|FG000|Overall Study|Withdrawal by Subject|2|||
129194888|NCT00766051|465008720|FG001|Overall Study|Withdrawal by Subject|0|||
129194889|NCT03302247|465008723|FG000|Overall Study|the study has closed prematurely|2|||
129194890|NCT03302247|465008723|FG000|Overall Study|Death|1|||
129194891|NCT04090242|465008724|FG000|Overall Study|Withdrawal by Subject|1|||
129194892|NCT04090242|465008725|FG001|Overall Study|Withdrawal by Subject|0|||
129194893|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
129194894|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
129194895|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
129194896|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Death|0|||
129194897|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Death|2|||
129194898|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Death|0|||
129194899|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
129194900|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
129194901|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
129194902|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
129194903|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
129194904|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
129194905|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
129194906|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
129194907|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
129194908|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
129194909|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
129194910|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
129194911|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
129194912|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
129194913|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
129194914|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Recovery|1|||
129194915|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Recovery|0|||
129194916|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Recovery|1|||
129194917|NCT00195663|465008726|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
129194918|NCT00195663|465008727|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
129194919|NCT00195663|465008728|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
129194920|NCT00195663|465008726|FG000|Open-Label Extension Period|Adverse Event|21|||
129194921|NCT00195663|465008727|FG001|Open-Label Extension Period|Adverse Event|32|||
129194922|NCT00195663|465008728|FG002|Open-Label Extension Period|Adverse Event|36|||
129194923|NCT00195663|465008726|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
129194924|NCT00195663|465008727|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
129194925|NCT00195663|465008728|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
129194926|NCT00195663|465008726|FG000|Open-Label Extension Period|Recovery|0|||
129194927|NCT00195663|465008727|FG001|Open-Label Extension Period|Recovery|2|||
129194928|NCT00195663|465008728|FG002|Open-Label Extension Period|Recovery|2|||
129194929|NCT00195663|465008726|FG000|Open-Label Extension Period|Protocol Violation|3|||
129194930|NCT00195663|465008727|FG001|Open-Label Extension Period|Protocol Violation|4|||
129194931|NCT00195663|465008728|FG002|Open-Label Extension Period|Protocol Violation|4|||
129194932|NCT00195663|465008726|FG000|Open-Label Extension Period|Death|2|||
129194933|NCT00195663|465008727|FG001|Open-Label Extension Period|Death|2|||
129194934|NCT00195663|465008728|FG002|Open-Label Extension Period|Death|2|||
129194935|NCT00195663|465008726|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
129194936|NCT00195663|465008727|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
129194937|NCT00195663|465008728|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
129194938|NCT00195663|465008726|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
129194939|NCT00195663|465008727|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
128730795|NCT00528528|463310080|FG000|Overall Study|Other|0|||
128730796|NCT00528528|463310081|FG001|Overall Study|Other|1|||
128730797|NCT00528528|463310082|FG002|Overall Study|Other|0|||
128730798|NCT00528528|463310083|FG003|Overall Study|Other|0|||
128730799|NCT00528528|463310080|FG000|Overall Study|Withdrawal by Subject|3|||
128730800|NCT00528528|463310081|FG001|Overall Study|Withdrawal by Subject|2|||
128730801|NCT00528528|463310082|FG002|Overall Study|Withdrawal by Subject|1|||
128730802|NCT00528528|463310083|FG003|Overall Study|Withdrawal by Subject|1|||
128730803|NCT00528528|463310080|FG000|Overall Study|Ongoing participant|0|||
128730804|NCT00528528|463310081|FG001|Overall Study|Ongoing participant|0|||
128730805|NCT00528528|463310082|FG002|Overall Study|Ongoing participant|1|||
128730806|NCT00528528|463310083|FG003|Overall Study|Ongoing participant|0|||
128730807|NCT04466891|463310084|FG000|Overall Study|Death|60|||
128730808|NCT04466891|463310085|FG001|Overall Study|Death|6|||
128730809|NCT04466891|463310084|FG000|Overall Study|Withdrawal by Subject|8|||
128730810|NCT04466891|463310085|FG001|Overall Study|Withdrawal by Subject|1|||
128730811|NCT04466891|463310084|FG000|Overall Study|Study terminated by sponsor|5|||
128730812|NCT04466891|463310085|FG001|Overall Study|Study terminated by sponsor|0|||
128730813|NCT04466891|463310084|FG000|Overall Study|Lost to Follow-up|2|||
128730814|NCT04466891|463310085|FG001|Overall Study|Lost to Follow-up|0|||
128730815|NCT04466891|463310084|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
128730816|NCT04466891|463310085|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
128730817|NCT03107988|463311335|FG000|Overall Study|Adverse Event|0|||
128730818|NCT03107988|463311336|FG001|Overall Study|Adverse Event|0|||
128730819|NCT03107988|463311337|FG002|Overall Study|Adverse Event|0|||
128730820|NCT03107988|463311338|FG003|Overall Study|Adverse Event|1|||
128730821|NCT03107988|463311339|FG004|Overall Study|Adverse Event|0|||
128730822|NCT03107988|463311340|FG005|Overall Study|Adverse Event|1|||
128730823|NCT03107988|463311341|FG006|Overall Study|Adverse Event|0|||
128730824|NCT03107988|463311342|FG007|Overall Study|Adverse Event|1|||
128730825|NCT03107988|463311343|FG008|Overall Study|Adverse Event|0|||
128730826|NCT03107988|463311344|FG009|Overall Study|Adverse Event|0|||
128730827|NCT03107988|463311345|FG010|Overall Study|Adverse Event|0|||
128730828|NCT03107988|463311346|FG011|Overall Study|Adverse Event|0|||
128730829|NCT03107988|463311347|FG012|Overall Study|Adverse Event|0|||
128730830|NCT03107988|463311335|FG000|Overall Study|Disease Progression or Relapse|1|||
128730831|NCT03107988|463311336|FG001|Overall Study|Disease Progression or Relapse|2|||
128730832|NCT03107988|463311337|FG002|Overall Study|Disease Progression or Relapse|2|||
128730833|NCT03107988|463311338|FG003|Overall Study|Disease Progression or Relapse|5|||
128730834|NCT03107988|463311339|FG004|Overall Study|Disease Progression or Relapse|1|||
128730835|NCT03107988|463311340|FG005|Overall Study|Disease Progression or Relapse|1|||
128730836|NCT03107988|463311341|FG006|Overall Study|Disease Progression or Relapse|0|||
128730837|NCT03107988|463311342|FG007|Overall Study|Disease Progression or Relapse|0|||
128730838|NCT03107988|463311343|FG008|Overall Study|Disease Progression or Relapse|0|||
128730839|NCT03107988|463311344|FG009|Overall Study|Disease Progression or Relapse|1|||
128730840|NCT03107988|463311345|FG010|Overall Study|Disease Progression or Relapse|4|||
128730841|NCT03107988|463311346|FG011|Overall Study|Disease Progression or Relapse|0|||
128730842|NCT03107988|463311347|FG012|Overall Study|Disease Progression or Relapse|0|||
128730843|NCT03107988|463311335|FG000|Overall Study|Ineligible|0|||
128730844|NCT03107988|463311336|FG001|Overall Study|Ineligible|0|||
128730845|NCT03107988|463311337|FG002|Overall Study|Ineligible|0|||
128730846|NCT03107988|463311338|FG003|Overall Study|Ineligible|0|||
128730847|NCT03107988|463311339|FG004|Overall Study|Ineligible|0|||
128730848|NCT03107988|463311340|FG005|Overall Study|Ineligible|0|||
128730849|NCT03107988|463311341|FG006|Overall Study|Ineligible|0|||
128730850|NCT03107988|463311342|FG007|Overall Study|Ineligible|0|||
128730851|NCT03107988|463311343|FG008|Overall Study|Ineligible|1|||
128730852|NCT03107988|463311344|FG009|Overall Study|Ineligible|0|||
128730853|NCT03107988|463311345|FG010|Overall Study|Ineligible|0|||
128730854|NCT03107988|463311346|FG011|Overall Study|Ineligible|0|||
128730855|NCT03107988|463311347|FG012|Overall Study|Ineligible|0|||
128730856|NCT02177266|463311348|FG000|Overall Study|Adverse Event|0|||
128730857|NCT02177266|463311349|FG001|Overall Study|Adverse Event|1|||
129194940|NCT00195663|465008728|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
128730858|NCT02177266|463311348|FG000|Overall Study|Withdrawal by Subject|1|||
128730859|NCT02177266|463311349|FG001|Overall Study|Withdrawal by Subject|0|||
128730860|NCT00546715|463311351|FG000|Overall Study|Withdrawal by Subject|0|||
128730861|NCT00546715|463311352|FG001|Overall Study|Withdrawal by Subject|1|||
128730862|NCT00546715|463311353|FG002|Overall Study|Withdrawal by Subject|0|||
128730863|NCT00546715|463311354|FG003|Overall Study|Withdrawal by Subject|0|||
128730864|NCT00723606|463311355|FG000|Overall Study|Adverse Event|2|||
128730865|NCT00723606|463311356|FG001|Overall Study|Adverse Event|5|||
128730866|NCT00723606|463311355|FG000|Overall Study|Other|2|||
128730867|NCT00723606|463311356|FG001|Overall Study|Other|0|||
128730868|NCT00723606|463311355|FG000|Overall Study|Withdrawal by Subject|0|||
128730869|NCT00723606|463311356|FG001|Overall Study|Withdrawal by Subject|2|||
128730870|NCT02365597|463311361|FG000|Overall Study|Lost to Follow-up|0|||
128730871|NCT02365597|463311362|FG001|Overall Study|Lost to Follow-up|1|||
128730872|NCT02365597|463311363|FG002|Overall Study|Lost to Follow-up|0|||
128730873|NCT02365597|463311364|FG003|Overall Study|Lost to Follow-up|1|||
128730874|NCT02365597|463311361|FG000|Overall Study|Withdrawal by Subject|1|||
128730875|NCT02365597|463311362|FG001|Overall Study|Withdrawal by Subject|8|||
128730876|NCT02365597|463311363|FG002|Overall Study|Withdrawal by Subject|5|||
128730877|NCT02365597|463311364|FG003|Overall Study|Withdrawal by Subject|1|||
128730878|NCT02365597|463311361|FG000|Overall Study|Sponsor's decision|1|||
128730879|NCT02365597|463311362|FG001|Overall Study|Sponsor's decision|3|||
128781040|NCT00079937|463490410|FG000|Overall Study|Subject no longer requires study drug|3|||
129194941|NCT00195663|465008726|FG000|Open-Label Extension Period|Administrative reasons|11|||
129194942|NCT00195663|465008727|FG001|Open-Label Extension Period|Administrative reasons|11|||
129194943|NCT00195663|465008728|FG002|Open-Label Extension Period|Administrative reasons|13|||
129194944|NCT00604695|465008729|FG000|Overall Study|Did not receive first bolus.|0|||
129194945|NCT00604695|465008730|FG001|Overall Study|Did not receive first bolus.|4|||
129194946|NCT03214406|465008731|FG000|Overall Study|did not meet enrollment criteria|9|||
129194947|NCT03214406|465008732|FG001|Overall Study|did not meet enrollment criteria|13|||
129194948|NCT03214406|465008731|FG000|Overall Study|Withdrawal by Subject|1|||
129194949|NCT03214406|465008732|FG001|Overall Study|Withdrawal by Subject|0|||
129194950|NCT03214406|465008731|FG000|Overall Study|Lost to Follow-up|0|||
129194951|NCT03214406|465008732|FG001|Overall Study|Lost to Follow-up|2|||
129194952|NCT01098305|465008735|FG000|Overall Study|Lost to Follow-up|31|||
129194953|NCT01098305|465008736|FG001|Overall Study|Lost to Follow-up|33|||
129194954|NCT01180296|465008741|FG000|Overall Study|Protocol Violation|1|||
129194955|NCT01180296|465008742|FG001|Overall Study|Protocol Violation|2|||
129194956|NCT03364309|465008745|FG000|Induction Period|Adverse Event|4|||
129194957|NCT03364309|465008746|FG001|Induction Period|Adverse Event|0|||
129194958|NCT03364309|465008747|FG002|Induction Period|Adverse Event|1|||
129194959|NCT03364309|465008748|FG003|Induction Period|Adverse Event|0|||
129194960|NCT03364309|465008749|FG004|Induction Period|Adverse Event|0|||
129194961|NCT03364309|465008750|FG005|Induction Period|Adverse Event|0|||
129194962|NCT03364309|465008751|FG006|Induction Period|Adverse Event|0|||
129194963|NCT03364309|465008752|FG007|Induction Period|Adverse Event|0|||
129194964|NCT03364309|465008753|FG008|Induction Period|Adverse Event|0|||
129194965|NCT03364309|465008754|FG009|Induction Period|Adverse Event|0|||
129194966|NCT03364309|465008755|FG010|Induction Period|Adverse Event|0|||
129194967|NCT03364309|465008756|FG011|Induction Period|Adverse Event|0|||
129194968|NCT03364309|465008757|FG012|Induction Period|Adverse Event|0|||
129194969|NCT03364309|465008758|FG013|Induction Period|Adverse Event|0|||
129194970|NCT03364309|465008759|FG014|Induction Period|Adverse Event|0|||
129194971|NCT03364309|465008760|FG015|Induction Period|Adverse Event|0|||
129194972|NCT03364309|465008761|FG016|Induction Period|Adverse Event|0|||
129194973|NCT03364309|465008762|FG017|Induction Period|Adverse Event|0|||
129194974|NCT03364309|465008763|FG018|Induction Period|Adverse Event|0|||
129194975|NCT03364309|465008745|FG000|Induction Period|Withdrawal by Subject|1|||
129194976|NCT03364309|465008746|FG001|Induction Period|Withdrawal by Subject|3|||
129194977|NCT03364309|465008747|FG002|Induction Period|Withdrawal by Subject|0|||
129194978|NCT03364309|465008748|FG003|Induction Period|Withdrawal by Subject|0|||
129194979|NCT03364309|465008749|FG004|Induction Period|Withdrawal by Subject|0|||
129194980|NCT03364309|465008750|FG005|Induction Period|Withdrawal by Subject|0|||
129194981|NCT03364309|465008751|FG006|Induction Period|Withdrawal by Subject|0|||
129194982|NCT03364309|465008752|FG007|Induction Period|Withdrawal by Subject|0|||
129194983|NCT03364309|465008753|FG008|Induction Period|Withdrawal by Subject|0|||
129194984|NCT03364309|465008754|FG009|Induction Period|Withdrawal by Subject|0|||
129194985|NCT03364309|465008755|FG010|Induction Period|Withdrawal by Subject|0|||
129194986|NCT03364309|465008756|FG011|Induction Period|Withdrawal by Subject|0|||
129194987|NCT03364309|465008757|FG012|Induction Period|Withdrawal by Subject|0|||
129194988|NCT03364309|465008758|FG013|Induction Period|Withdrawal by Subject|0|||
129194989|NCT03364309|465008759|FG014|Induction Period|Withdrawal by Subject|0|||
129194990|NCT03364309|465008760|FG015|Induction Period|Withdrawal by Subject|0|||
129194991|NCT03364309|465008761|FG016|Induction Period|Withdrawal by Subject|0|||
129194992|NCT03364309|465008762|FG017|Induction Period|Withdrawal by Subject|0|||
129194993|NCT03364309|465008763|FG018|Induction Period|Withdrawal by Subject|0|||
129194994|NCT03364309|465008745|FG000|Induction Period|Lost to Follow-up|1|||
129194995|NCT03364309|465008746|FG001|Induction Period|Lost to Follow-up|0|||
129194996|NCT03364309|465008747|FG002|Induction Period|Lost to Follow-up|0|||
129194997|NCT03364309|465008748|FG003|Induction Period|Lost to Follow-up|0|||
129194998|NCT03364309|465008749|FG004|Induction Period|Lost to Follow-up|0|||
129194999|NCT03364309|465008750|FG005|Induction Period|Lost to Follow-up|0|||
129195000|NCT03364309|465008751|FG006|Induction Period|Lost to Follow-up|0|||
129195001|NCT03364309|465008752|FG007|Induction Period|Lost to Follow-up|0|||
129195002|NCT03364309|465008753|FG008|Induction Period|Lost to Follow-up|0|||
128730880|NCT02365597|463311363|FG002|Overall Study|Sponsor's decision|13|||
128730881|NCT02365597|463311364|FG003|Overall Study|Sponsor's decision|0|||
128730882|NCT02365597|463311361|FG000|Overall Study|Other|0|||
128730883|NCT02365597|463311362|FG001|Overall Study|Other|4|||
128730884|NCT02365597|463311363|FG002|Overall Study|Other|0|||
128730885|NCT02365597|463311364|FG003|Overall Study|Other|0|||
128730886|NCT02365597|463311361|FG000|Overall Study|Enrolled but not treated|0|||
128730887|NCT02365597|463311362|FG001|Overall Study|Enrolled but not treated|1|||
128730888|NCT02365597|463311363|FG002|Overall Study|Enrolled but not treated|1|||
128730889|NCT02365597|463311364|FG003|Overall Study|Enrolled but not treated|0|||
128730890|NCT02365597|463311361|FG000|Overall Study|Ongoing|0|||
128730891|NCT02365597|463311362|FG001|Overall Study|Ongoing|0|||
128730892|NCT02365597|463311363|FG002|Overall Study|Ongoing|0|||
128730893|NCT02365597|463311364|FG003|Overall Study|Ongoing|17|||
128730894|NCT01552226|463311365|FG000|Overall Study|Withdrawal by Subject|4|||
128730895|NCT01552226|463311366|FG001|Overall Study|Withdrawal by Subject|4|||
128730896|NCT01110915|463311367|FG000|Overall Study|Death|2|||
128730897|NCT01110915|463311368|FG001|Overall Study|Death|1|||
128730898|NCT01110915|463311367|FG000|Overall Study|Lost to Follow-up|1|||
128730899|NCT01110915|463311368|FG001|Overall Study|Lost to Follow-up|0|||
128730900|NCT01110915|463311367|FG000|Overall Study|Withdrawal by Subject|7|||
128730901|NCT01110915|463311368|FG001|Overall Study|Withdrawal by Subject|1|||
128730902|NCT05091528|463311369|FG000|Overall Study|Study Termination by Sponsor|0|||
128730903|NCT05091528|463311370|FG001|Overall Study|Study Termination by Sponsor|1|||
128730904|NCT05091528|463311371|FG002|Overall Study|Study Termination by Sponsor|0|||
128730905|NCT05091528|463311372|FG003|Overall Study|Study Termination by Sponsor|1|||
128730906|NCT03306264|463311376|FG000|Overall Study|Death|33|||
128730907|NCT03306264|463311377|FG001|Overall Study|Death|25|||
128730908|NCT03306264|463311378|FG002|Overall Study|Death|34|||
128730909|NCT03306264|463311379|FG003|Overall Study|Death|34|||
128730910|NCT03306264|463311376|FG000|Overall Study|Complete Consent Withdrawal|4|||
128730911|NCT03306264|463311377|FG001|Overall Study|Complete Consent Withdrawal|4|||
128730912|NCT03306264|463311378|FG002|Overall Study|Complete Consent Withdrawal|1|||
128730913|NCT03306264|463311379|FG003|Overall Study|Complete Consent Withdrawal|8|||
128730914|NCT03306264|463311376|FG000|Overall Study|Lost to Follow-up|1|||
128730915|NCT03306264|463311377|FG001|Overall Study|Lost to Follow-up|0|||
128730916|NCT03306264|463311378|FG002|Overall Study|Lost to Follow-up|1|||
128730917|NCT03306264|463311379|FG003|Overall Study|Lost to Follow-up|0|||
128730918|NCT03306264|463311376|FG000|Overall Study|Rollover to ASTX727-06|10|||
128730919|NCT03306264|463311377|FG001|Overall Study|Rollover to ASTX727-06|18|||
128730920|NCT03306264|463311378|FG002|Overall Study|Rollover to ASTX727-06|4|||
128730921|NCT03306264|463311379|FG003|Overall Study|Rollover to ASTX727-06|2|||
128730922|NCT03306264|463311376|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
128730923|NCT03306264|463311377|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
128730924|NCT03306264|463311378|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
128730925|NCT03306264|463311379|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
128730926|NCT00480779|463311380|FG000|Overall Study|Other|2|||
128730927|NCT00480779|463311381|FG001|Overall Study|Other|0|||
128730928|NCT00480779|463311380|FG000|Overall Study|Job and Health-related|0|||
128730929|NCT00480779|463311381|FG001|Overall Study|Job and Health-related|3|||
128730930|NCT02257736|463311392|FG000|Overall Study|Progressive disease|365|||
128730931|NCT02257736|463311393|FG001|Overall Study|Progressive disease|327|||
128730932|NCT02257736|463311392|FG000|Overall Study|Adverse Event|45|||
128730933|NCT02257736|463311393|FG001|Overall Study|Adverse Event|56|||
128730934|NCT02257736|463311392|FG000|Overall Study|Withdrawal by Subject|21|||
128730935|NCT02257736|463311393|FG001|Overall Study|Withdrawal by Subject|38|||
128730936|NCT02257736|463311392|FG000|Overall Study|Death|11|||
128730937|NCT02257736|463311393|FG001|Overall Study|Death|6|||
129195003|NCT03364309|465008754|FG009|Induction Period|Lost to Follow-up|0|||
129195004|NCT03364309|465008755|FG010|Induction Period|Lost to Follow-up|0|||
129195005|NCT03364309|465008756|FG011|Induction Period|Lost to Follow-up|0|||
129195006|NCT03364309|465008757|FG012|Induction Period|Lost to Follow-up|0|||
128730938|NCT02257736|463311392|FG000|Overall Study|Physician Decision|5|||
128730939|NCT02257736|463311393|FG001|Overall Study|Physician Decision|9|||
128730940|NCT02257736|463311392|FG000|Overall Study|Non-Compliance with study drug|1|||
128730941|NCT02257736|463311393|FG001|Overall Study|Non-Compliance with study drug|2|||
128730942|NCT02257736|463311392|FG000|Overall Study|Protocol Violation|1|||
128730943|NCT02257736|463311393|FG001|Overall Study|Protocol Violation|0|||
128730944|NCT02257736|463311392|FG000|Overall Study|Other|1|||
128730945|NCT02257736|463311393|FG001|Overall Study|Other|7|||
128730946|NCT02257736|463311392|FG000|Overall Study|Randomized, not treated|1|||
128730947|NCT02257736|463311393|FG001|Overall Study|Randomized, not treated|2|||
128730948|NCT00308711|463311396|FG000|Overall Study|Withdrawal by Subject|1|||
128730949|NCT00308711|463311397|FG001|Overall Study|Withdrawal by Subject|0|||
128730950|NCT00308711|463311398|FG002|Overall Study|Withdrawal by Subject|1|||
128730951|NCT00308711|463311396|FG000|Overall Study|Protocol Violation|0|||
128730952|NCT00308711|463311397|FG001|Overall Study|Protocol Violation|1|||
128730953|NCT00308711|463311398|FG002|Overall Study|Protocol Violation|1|||
128730954|NCT00308711|463311396|FG000|Overall Study|Lost to Follow-up|0|||
128730955|NCT00308711|463311397|FG001|Overall Study|Lost to Follow-up|1|||
128730956|NCT00308711|463311398|FG002|Overall Study|Lost to Follow-up|0|||
128730957|NCT00308711|463311396|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
128730958|NCT00308711|463311397|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
128730959|NCT00308711|463311398|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
129195007|NCT03364309|465008758|FG013|Induction Period|Lost to Follow-up|0|||
129195008|NCT03364309|465008759|FG014|Induction Period|Lost to Follow-up|0|||
129195009|NCT03364309|465008760|FG015|Induction Period|Lost to Follow-up|0|||
129195010|NCT03364309|465008761|FG016|Induction Period|Lost to Follow-up|0|||
129195011|NCT03364309|465008762|FG017|Induction Period|Lost to Follow-up|0|||
129195012|NCT03364309|465008763|FG018|Induction Period|Lost to Follow-up|0|||
129195013|NCT03364309|465008745|FG000|Induction Period|Physician Decision|0|||
129195014|NCT03364309|465008746|FG001|Induction Period|Physician Decision|1|||
129195015|NCT03364309|465008747|FG002|Induction Period|Physician Decision|0|||
129195016|NCT03364309|465008748|FG003|Induction Period|Physician Decision|0|||
129195017|NCT03364309|465008749|FG004|Induction Period|Physician Decision|0|||
129195018|NCT03364309|465008750|FG005|Induction Period|Physician Decision|0|||
129195019|NCT03364309|465008751|FG006|Induction Period|Physician Decision|0|||
129195020|NCT03364309|465008752|FG007|Induction Period|Physician Decision|0|||
129195021|NCT03364309|465008753|FG008|Induction Period|Physician Decision|0|||
129195022|NCT03364309|465008754|FG009|Induction Period|Physician Decision|0|||
129195023|NCT03364309|465008755|FG010|Induction Period|Physician Decision|0|||
129195024|NCT03364309|465008756|FG011|Induction Period|Physician Decision|0|||
129195025|NCT03364309|465008757|FG012|Induction Period|Physician Decision|0|||
129195026|NCT03364309|465008758|FG013|Induction Period|Physician Decision|0|||
129195027|NCT03364309|465008759|FG014|Induction Period|Physician Decision|0|||
129195028|NCT03364309|465008760|FG015|Induction Period|Physician Decision|0|||
129195029|NCT03364309|465008761|FG016|Induction Period|Physician Decision|0|||
129195030|NCT03364309|465008762|FG017|Induction Period|Physician Decision|0|||
129195031|NCT03364309|465008763|FG018|Induction Period|Physician Decision|0|||
129195032|NCT03364309|465008745|FG000|Maintenance Period|Withdrawal by Subject|0|||
129195033|NCT03364309|465008746|FG001|Maintenance Period|Withdrawal by Subject|0|||
129195034|NCT03364309|465008747|FG002|Maintenance Period|Withdrawal by Subject|0|||
129195035|NCT03364309|465008748|FG003|Maintenance Period|Withdrawal by Subject|1|||
129195036|NCT03364309|465008749|FG004|Maintenance Period|Withdrawal by Subject|3|||
129195037|NCT03364309|465008750|FG005|Maintenance Period|Withdrawal by Subject|1|||
129195038|NCT03364309|465008751|FG006|Maintenance Period|Withdrawal by Subject|3|||
129195039|NCT03364309|465008752|FG007|Maintenance Period|Withdrawal by Subject|0|||
129195040|NCT03364309|465008753|FG008|Maintenance Period|Withdrawal by Subject|1|||
129195041|NCT03364309|465008754|FG009|Maintenance Period|Withdrawal by Subject|1|||
129195042|NCT03364309|465008755|FG010|Maintenance Period|Withdrawal by Subject|2|||
129195043|NCT03364309|465008756|FG011|Maintenance Period|Withdrawal by Subject|0|||
129195044|NCT03364309|465008757|FG012|Maintenance Period|Withdrawal by Subject|0|||
129195045|NCT03364309|465008758|FG013|Maintenance Period|Withdrawal by Subject|0|||
129195046|NCT03364309|465008759|FG014|Maintenance Period|Withdrawal by Subject|0|||
129195047|NCT03364309|465008760|FG015|Maintenance Period|Withdrawal by Subject|0|||
129195048|NCT03364309|465008761|FG016|Maintenance Period|Withdrawal by Subject|0|||
129195049|NCT03364309|465008762|FG017|Maintenance Period|Withdrawal by Subject|0|||
129195050|NCT03364309|465008763|FG018|Maintenance Period|Withdrawal by Subject|0|||
129195051|NCT03364309|465008745|FG000|Maintenance Period|Adverse Event|0|||
129195052|NCT03364309|465008746|FG001|Maintenance Period|Adverse Event|0|||
129195053|NCT03364309|465008747|FG002|Maintenance Period|Adverse Event|0|||
129195054|NCT03364309|465008748|FG003|Maintenance Period|Adverse Event|0|||
129195055|NCT03364309|465008749|FG004|Maintenance Period|Adverse Event|2|||
129195056|NCT03364309|465008750|FG005|Maintenance Period|Adverse Event|0|||
129195057|NCT03364309|465008751|FG006|Maintenance Period|Adverse Event|3|||
129195058|NCT03364309|465008752|FG007|Maintenance Period|Adverse Event|0|||
129195059|NCT03364309|465008753|FG008|Maintenance Period|Adverse Event|1|||
129195060|NCT03364309|465008754|FG009|Maintenance Period|Adverse Event|0|||
129195061|NCT03364309|465008755|FG010|Maintenance Period|Adverse Event|2|||
129195062|NCT03364309|465008756|FG011|Maintenance Period|Adverse Event|0|||
129195063|NCT03364309|465008757|FG012|Maintenance Period|Adverse Event|0|||
129195064|NCT03364309|465008758|FG013|Maintenance Period|Adverse Event|0|||
129195065|NCT03364309|465008759|FG014|Maintenance Period|Adverse Event|0|||
129195066|NCT03364309|465008760|FG015|Maintenance Period|Adverse Event|0|||
129195067|NCT03364309|465008761|FG016|Maintenance Period|Adverse Event|0|||
129195068|NCT03364309|465008762|FG017|Maintenance Period|Adverse Event|0|||
129195069|NCT03364309|465008763|FG018|Maintenance Period|Adverse Event|0|||
129195070|NCT03364309|465008745|FG000|Maintenance Period|Relapsed|0|||
129195071|NCT03364309|465008746|FG001|Maintenance Period|Relapsed|0|||
129195072|NCT03364309|465008747|FG002|Maintenance Period|Relapsed|0|||
129195073|NCT03364309|465008748|FG003|Maintenance Period|Relapsed|43|||
129195074|NCT03364309|465008749|FG004|Maintenance Period|Relapsed|7|||
129195075|NCT03364309|465008750|FG005|Maintenance Period|Relapsed|45|||
129195076|NCT03364309|465008751|FG006|Maintenance Period|Relapsed|10|||
129195077|NCT03364309|465008752|FG007|Maintenance Period|Relapsed|2|||
129195078|NCT03364309|465008753|FG008|Maintenance Period|Relapsed|0|||
129195079|NCT03364309|465008754|FG009|Maintenance Period|Relapsed|0|||
129195080|NCT03364309|465008755|FG010|Maintenance Period|Relapsed|0|||
129195081|NCT03364309|465008756|FG011|Maintenance Period|Relapsed|0|||
129195082|NCT03364309|465008757|FG012|Maintenance Period|Relapsed|0|||
129195083|NCT03364309|465008758|FG013|Maintenance Period|Relapsed|0|||
129195084|NCT03364309|465008759|FG014|Maintenance Period|Relapsed|0|||
129195085|NCT03364309|465008760|FG015|Maintenance Period|Relapsed|0|||
129195086|NCT03364309|465008761|FG016|Maintenance Period|Relapsed|0|||
129195087|NCT03364309|465008762|FG017|Maintenance Period|Relapsed|0|||
129195088|NCT03364309|465008763|FG018|Maintenance Period|Relapsed|0|||
129195089|NCT03364309|465008745|FG000|Maintenance Period|Lack of Efficacy|0|||
129195090|NCT03364309|465008746|FG001|Maintenance Period|Lack of Efficacy|0|||
129195091|NCT03364309|465008747|FG002|Maintenance Period|Lack of Efficacy|0|||
129195092|NCT03364309|465008748|FG003|Maintenance Period|Lack of Efficacy|0|||
129195093|NCT03364309|465008749|FG004|Maintenance Period|Lack of Efficacy|0|||
129195094|NCT03364309|465008750|FG005|Maintenance Period|Lack of Efficacy|0|||
129195095|NCT03364309|465008751|FG006|Maintenance Period|Lack of Efficacy|0|||
129195096|NCT03364309|465008752|FG007|Maintenance Period|Lack of Efficacy|0|||
129195097|NCT03364309|465008753|FG008|Maintenance Period|Lack of Efficacy|1|||
129195098|NCT03364309|465008754|FG009|Maintenance Period|Lack of Efficacy|3|||
129195099|NCT03364309|465008755|FG010|Maintenance Period|Lack of Efficacy|2|||
129195100|NCT03364309|465008756|FG011|Maintenance Period|Lack of Efficacy|0|||
129195101|NCT03364309|465008757|FG012|Maintenance Period|Lack of Efficacy|0|||
129195102|NCT03364309|465008758|FG013|Maintenance Period|Lack of Efficacy|0|||
129195103|NCT03364309|465008759|FG014|Maintenance Period|Lack of Efficacy|0|||
129195104|NCT03364309|465008760|FG015|Maintenance Period|Lack of Efficacy|0|||
129195105|NCT03364309|465008761|FG016|Maintenance Period|Lack of Efficacy|0|||
129195106|NCT03364309|465008762|FG017|Maintenance Period|Lack of Efficacy|0|||
129195107|NCT03364309|465008763|FG018|Maintenance Period|Lack of Efficacy|0|||
129195108|NCT03364309|465008745|FG000|Maintenance Period|Death|0|||
129195109|NCT03364309|465008746|FG001|Maintenance Period|Death|0|||
128730960|NCT00308711|463311396|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
128730961|NCT00308711|463311397|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
128730962|NCT00308711|463311398|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
128730963|NCT02167256|463311399|FG000|Overall Study|Adverse Event|13|||
128730964|NCT02167256|463311400|FG001|Overall Study|Adverse Event|6|||
128730965|NCT02167256|463311399|FG000|Overall Study|Withdrawal by Subject|4|||
128730966|NCT02167256|463311400|FG001|Overall Study|Withdrawal by Subject|4|||
128730967|NCT02167256|463311399|FG000|Overall Study|non-compliance|3|||
128730968|NCT02167256|463311400|FG001|Overall Study|non-compliance|0|||
128730969|NCT02167256|463311399|FG000|Overall Study|Study partner unable to participate|1|||
128730970|NCT02167256|463311400|FG001|Overall Study|Study partner unable to participate|0|||
128730971|NCT01420081|463311401|FG000|Overall Study|Death|1|||
128730972|NCT01420081|463311402|FG001|Overall Study|Death|0|||
128730973|NCT01420081|463311403|FG002|Overall Study|Death|8|||
128730974|NCT01420081|463311404|FG003|Overall Study|Death|0|||
128730975|NCT01420081|463311405|FG004|Overall Study|Death|7|||
128730976|NCT01420081|463311406|FG005|Overall Study|Death|12|||
128730977|NCT01420081|463311407|FG006|Overall Study|Death|0|||
129195110|NCT03364309|465008747|FG002|Maintenance Period|Death|0|||
129195111|NCT03364309|465008748|FG003|Maintenance Period|Death|0|||
129195112|NCT03364309|465008749|FG004|Maintenance Period|Death|0|||
129195113|NCT03364309|465008750|FG005|Maintenance Period|Death|0|||
129195114|NCT03364309|465008751|FG006|Maintenance Period|Death|0|||
129195115|NCT03364309|465008752|FG007|Maintenance Period|Death|0|||
129195116|NCT03364309|465008753|FG008|Maintenance Period|Death|1|||
128730978|NCT01420081|463311408|FG007|Overall Study|Death|1|||
128730979|NCT01420081|463311409|FG008|Overall Study|Death|1|||
129195117|NCT03364309|465008754|FG009|Maintenance Period|Death|0|||
129195118|NCT03364309|465008755|FG010|Maintenance Period|Death|0|||
129195119|NCT03364309|465008756|FG011|Maintenance Period|Death|0|||
129195120|NCT03364309|465008757|FG012|Maintenance Period|Death|0|||
129195121|NCT03364309|465008758|FG013|Maintenance Period|Death|0|||
129195122|NCT03364309|465008759|FG014|Maintenance Period|Death|0|||
129195123|NCT03364309|465008760|FG015|Maintenance Period|Death|0|||
129195124|NCT03364309|465008761|FG016|Maintenance Period|Death|0|||
129195125|NCT03364309|465008762|FG017|Maintenance Period|Death|0|||
129195126|NCT03364309|465008763|FG018|Maintenance Period|Death|0|||
129195127|NCT03364309|465008745|FG000|Maintenance Period|Lost to Follow-up|0|||
129195128|NCT03364309|465008746|FG001|Maintenance Period|Lost to Follow-up|0|||
129195129|NCT03364309|465008747|FG002|Maintenance Period|Lost to Follow-up|0|||
129195130|NCT03364309|465008748|FG003|Maintenance Period|Lost to Follow-up|0|||
129195131|NCT03364309|465008749|FG004|Maintenance Period|Lost to Follow-up|0|||
129195132|NCT03364309|465008750|FG005|Maintenance Period|Lost to Follow-up|0|||
129195133|NCT03364309|465008751|FG006|Maintenance Period|Lost to Follow-up|0|||
129195134|NCT03364309|465008752|FG007|Maintenance Period|Lost to Follow-up|0|||
129195135|NCT03364309|465008753|FG008|Maintenance Period|Lost to Follow-up|1|||
129195136|NCT03364309|465008754|FG009|Maintenance Period|Lost to Follow-up|0|||
129195137|NCT03364309|465008755|FG010|Maintenance Period|Lost to Follow-up|0|||
129195138|NCT03364309|465008756|FG011|Maintenance Period|Lost to Follow-up|0|||
129195139|NCT03364309|465008757|FG012|Maintenance Period|Lost to Follow-up|0|||
129195140|NCT03364309|465008758|FG013|Maintenance Period|Lost to Follow-up|0|||
129195141|NCT03364309|465008759|FG014|Maintenance Period|Lost to Follow-up|0|||
129195142|NCT03364309|465008760|FG015|Maintenance Period|Lost to Follow-up|0|||
129195143|NCT03364309|465008761|FG016|Maintenance Period|Lost to Follow-up|0|||
129195144|NCT03364309|465008762|FG017|Maintenance Period|Lost to Follow-up|0|||
129195145|NCT03364309|465008763|FG018|Maintenance Period|Lost to Follow-up|0|||
129195146|NCT03364309|465008745|FG000|Maintenance Period|Miscellaneous|0|||
129195147|NCT03364309|465008746|FG001|Maintenance Period|Miscellaneous|0|||
129195148|NCT03364309|465008747|FG002|Maintenance Period|Miscellaneous|0|||
129195149|NCT03364309|465008748|FG003|Maintenance Period|Miscellaneous|0|||
129195150|NCT03364309|465008749|FG004|Maintenance Period|Miscellaneous|0|||
129195151|NCT03364309|465008750|FG005|Maintenance Period|Miscellaneous|0|||
129195152|NCT03364309|465008751|FG006|Maintenance Period|Miscellaneous|0|||
129195153|NCT03364309|465008752|FG007|Maintenance Period|Miscellaneous|0|||
129195154|NCT03364309|465008753|FG008|Maintenance Period|Miscellaneous|1|||
129195155|NCT03364309|465008754|FG009|Maintenance Period|Miscellaneous|0|||
129195156|NCT03364309|465008755|FG010|Maintenance Period|Miscellaneous|0|||
129195157|NCT03364309|465008756|FG011|Maintenance Period|Miscellaneous|0|||
129195158|NCT03364309|465008757|FG012|Maintenance Period|Miscellaneous|0|||
129195159|NCT03364309|465008758|FG013|Maintenance Period|Miscellaneous|0|||
129195160|NCT03364309|465008759|FG014|Maintenance Period|Miscellaneous|0|||
129195161|NCT03364309|465008760|FG015|Maintenance Period|Miscellaneous|0|||
129195162|NCT03364309|465008761|FG016|Maintenance Period|Miscellaneous|0|||
129195163|NCT03364309|465008762|FG017|Maintenance Period|Miscellaneous|0|||
129195164|NCT03364309|465008763|FG018|Maintenance Period|Miscellaneous|0|||
129195165|NCT03364309|465008745|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195166|NCT03364309|465008746|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195167|NCT03364309|465008747|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195168|NCT03364309|465008748|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195169|NCT03364309|465008749|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195170|NCT03364309|465008750|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195171|NCT03364309|465008751|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195172|NCT03364309|465008752|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195173|NCT03364309|465008753|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195174|NCT03364309|465008754|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195175|NCT03364309|465008755|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195176|NCT03364309|465008756|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195177|NCT03364309|465008757|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195178|NCT03364309|465008758|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
129195179|NCT03364309|465008759|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
128730980|NCT01420081|463311401|FG000|Overall Study|Lost to Follow-up|0|||
129195180|NCT03364309|465008760|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
129195181|NCT03364309|465008761|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195182|NCT03364309|465008762|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129195183|NCT03364309|465008763|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
128730981|NCT01420081|463311402|FG001|Overall Study|Lost to Follow-up|0|||
128730982|NCT01420081|463311403|FG002|Overall Study|Lost to Follow-up|0|||
128730983|NCT01420081|463311404|FG003|Overall Study|Lost to Follow-up|0|||
128730984|NCT01420081|463311405|FG004|Overall Study|Lost to Follow-up|1|||
128730985|NCT01420081|463311406|FG005|Overall Study|Lost to Follow-up|1|||
128730986|NCT01420081|463311407|FG006|Overall Study|Lost to Follow-up|0|||
128730987|NCT01420081|463311408|FG007|Overall Study|Lost to Follow-up|0|||
128730988|NCT01420081|463311409|FG008|Overall Study|Lost to Follow-up|0|||
128730989|NCT01420081|463311401|FG000|Overall Study|Study Terminated by Sponsor|2|||
128730990|NCT01420081|463311402|FG001|Overall Study|Study Terminated by Sponsor|1|||
128730991|NCT01420081|463311403|FG002|Overall Study|Study Terminated by Sponsor|1|||
128730992|NCT01420081|463311404|FG003|Overall Study|Study Terminated by Sponsor|3|||
128730993|NCT01420081|463311405|FG004|Overall Study|Study Terminated by Sponsor|11|||
128730994|NCT01420081|463311406|FG005|Overall Study|Study Terminated by Sponsor|7|||
128730995|NCT01420081|463311407|FG006|Overall Study|Study Terminated by Sponsor|3|||
128730996|NCT01420081|463311408|FG007|Overall Study|Study Terminated by Sponsor|2|||
128730997|NCT01420081|463311409|FG008|Overall Study|Study Terminated by Sponsor|2|||
128730998|NCT01420081|463311401|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
128730999|NCT01420081|463311402|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
128731000|NCT01420081|463311403|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
128731001|NCT01420081|463311404|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
128731002|NCT01420081|463311405|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
128731003|NCT01420081|463311406|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
128731004|NCT01420081|463311407|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
128731005|NCT01420081|463311408|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
128731006|NCT01420081|463311409|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
128731007|NCT01420081|463311401|FG000|Overall Study|Other Reasons|0|||
128731008|NCT01420081|463311402|FG001|Overall Study|Other Reasons|0|||
128731009|NCT01420081|463311403|FG002|Overall Study|Other Reasons|1|||
128731010|NCT01420081|463311404|FG003|Overall Study|Other Reasons|0|||
128731011|NCT01420081|463311405|FG004|Overall Study|Other Reasons|0|||
128731012|NCT01420081|463311406|FG005|Overall Study|Other Reasons|0|||
128731013|NCT01420081|463311407|FG006|Overall Study|Other Reasons|0|||
128731014|NCT01420081|463311408|FG007|Overall Study|Other Reasons|0|||
128731015|NCT01420081|463311409|FG008|Overall Study|Other Reasons|0|||
128731016|NCT03431350|463311412|FG000|Overall Study|ONGOING|0|||
128731017|NCT03431350|463311413|FG001|Overall Study|ONGOING|0|||
128731018|NCT03431350|463311414|FG002|Overall Study|ONGOING|2|||
128731019|NCT03431350|463311415|FG003|Overall Study|ONGOING|0|||
128731020|NCT03431350|463311416|FG004|Overall Study|ONGOING|1|||
128731021|NCT03431350|463311417|FG005|Overall Study|ONGOING|3|||
128731022|NCT03431350|463311418|FG006|Overall Study|ONGOING|0|||
128731023|NCT03431350|463311419|FG007|Overall Study|ONGOING|1|||
128731024|NCT03431350|463311420|FG008|Overall Study|ONGOING|3|||
128731025|NCT03431350|463311421|FG009|Overall Study|ONGOING|4|||
128731026|NCT03431350|463311422|FG010|Overall Study|ONGOING|2|||
128731027|NCT03431350|463311423|FG011|Overall Study|ONGOING|1|||
128731028|NCT03431350|463311412|FG000|Overall Study|Death|6|||
128731029|NCT03431350|463311413|FG001|Overall Study|Death|5|||
128731030|NCT03431350|463311414|FG002|Overall Study|Death|18|||
128731031|NCT03431350|463311415|FG003|Overall Study|Death|7|||
128731032|NCT03431350|463311416|FG004|Overall Study|Death|4|||
128731033|NCT03431350|463311417|FG005|Overall Study|Death|3|||
128731034|NCT03431350|463311418|FG006|Overall Study|Death|2|||
128731035|NCT03431350|463311419|FG007|Overall Study|Death|0|||
128731036|NCT03431350|463311420|FG008|Overall Study|Death|0|||
128731037|NCT03431350|463311421|FG009|Overall Study|Death|0|||
128731038|NCT03431350|463311422|FG010|Overall Study|Death|4|||
128731039|NCT03431350|463311423|FG011|Overall Study|Death|0|||
128731040|NCT03431350|463311412|FG000|Overall Study|Lost to Follow-up|0|||
128731041|NCT03431350|463311413|FG001|Overall Study|Lost to Follow-up|1|||
128731042|NCT03431350|463311414|FG002|Overall Study|Lost to Follow-up|0|||
128731043|NCT03431350|463311415|FG003|Overall Study|Lost to Follow-up|0|||
128731044|NCT03431350|463311416|FG004|Overall Study|Lost to Follow-up|0|||
128731045|NCT03431350|463311417|FG005|Overall Study|Lost to Follow-up|0|||
128731046|NCT03431350|463311418|FG006|Overall Study|Lost to Follow-up|0|||
128731047|NCT03431350|463311419|FG007|Overall Study|Lost to Follow-up|0|||
128731048|NCT03431350|463311420|FG008|Overall Study|Lost to Follow-up|0|||
128731049|NCT03431350|463311421|FG009|Overall Study|Lost to Follow-up|0|||
128731050|NCT03431350|463311422|FG010|Overall Study|Lost to Follow-up|0|||
128731051|NCT03431350|463311423|FG011|Overall Study|Lost to Follow-up|0|||
128731052|NCT03431350|463311412|FG000|Overall Study|Withdrawal by Subject|0|||
128731053|NCT03431350|463311413|FG001|Overall Study|Withdrawal by Subject|0|||
128731054|NCT03431350|463311414|FG002|Overall Study|Withdrawal by Subject|0|||
128731055|NCT03431350|463311415|FG003|Overall Study|Withdrawal by Subject|1|||
128731056|NCT03431350|463311416|FG004|Overall Study|Withdrawal by Subject|1|||
128731057|NCT03431350|463311417|FG005|Overall Study|Withdrawal by Subject|1|||
128731058|NCT03431350|463311418|FG006|Overall Study|Withdrawal by Subject|0|||
128731059|NCT03431350|463311419|FG007|Overall Study|Withdrawal by Subject|0|||
128731060|NCT03431350|463311420|FG008|Overall Study|Withdrawal by Subject|0|||
128731061|NCT03431350|463311421|FG009|Overall Study|Withdrawal by Subject|2|||
128731062|NCT03431350|463311422|FG010|Overall Study|Withdrawal by Subject|0|||
128731063|NCT03431350|463311423|FG011|Overall Study|Withdrawal by Subject|1|||
128731064|NCT03431350|463311412|FG000|Overall Study|Other|0|||
128731065|NCT03431350|463311413|FG001|Overall Study|Other|0|||
128731066|NCT03431350|463311414|FG002|Overall Study|Other|1|||
128731067|NCT03431350|463311415|FG003|Overall Study|Other|3|||
128731068|NCT03431350|463311416|FG004|Overall Study|Other|2|||
128731069|NCT03431350|463311417|FG005|Overall Study|Other|2|||
128731070|NCT03431350|463311418|FG006|Overall Study|Other|4|||
128731071|NCT03431350|463311419|FG007|Overall Study|Other|0|||
128731072|NCT03431350|463311420|FG008|Overall Study|Other|14|||
128731073|NCT03431350|463311421|FG009|Overall Study|Other|11|||
128731074|NCT03431350|463311422|FG010|Overall Study|Other|11|||
128731075|NCT03431350|463311423|FG011|Overall Study|Other|15|||
128731076|NCT00414388|463311424|FG000|Overall Study|Adverse Event|1|||
128731077|NCT03591575|463311426|FG000|Overall Study|Adverse Event|2|||
128731078|NCT03591575|463311427|FG001|Overall Study|Adverse Event|0|||
128731079|NCT03591575|463311426|FG000|Overall Study|Withdrawal by Subject|4|||
128731080|NCT03591575|463311427|FG001|Overall Study|Withdrawal by Subject|1|||
128731081|NCT00218543|463311428|FG000|Overall Study|Lost to Follow-up|8|||
128731082|NCT00218543|463311428|FG000|Overall Study|relocated|1|||
128731083|NCT00218543|463311428|FG000|Overall Study|Withdrawal by Subject|1|||
128731084|NCT00218543|463311428|FG000|Overall Study|Physician Decision|3|||
128731085|NCT00218543|463311428|FG000|Overall Study|Adverse Event|2|||
128731086|NCT01864291|463311429|FG000|Overall Study|need for revision surgery|2|||
128731087|NCT04325828|463311431|FG000|Overall Study|Ongoing|26|||
128731088|NCT04602624|463311432|FG000|Overall Study|Protocol Deviation|1|||
128731089|NCT04602624|463311432|FG000|Overall Study|Withdrawal by Participant|1|||
128731090|NCT03508219|463311433|FG000|Overall Study|Death|2|||
128731091|NCT03508219|463311433|FG000|Overall Study|Withdrawal by Subject|1|||
128731092|NCT03508219|463311433|FG000|Overall Study|Lost to Follow-up|4|||
128731093|NCT03508219|463311433|FG000|Overall Study|Missed visit|2|||
129195184|NCT03364309|465008745|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195185|NCT03364309|465008746|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195186|NCT03364309|465008747|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195187|NCT03364309|465008748|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195188|NCT03364309|465008749|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195189|NCT03364309|465008750|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195190|NCT03364309|465008751|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195191|NCT03364309|465008752|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195192|NCT03364309|465008753|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195193|NCT03364309|465008754|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195194|NCT03364309|465008755|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195195|NCT03364309|465008756|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195196|NCT03364309|465008757|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195197|NCT03364309|465008758|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195198|NCT03364309|465008759|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
129195199|NCT03364309|465008760|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195200|NCT03364309|465008761|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195201|NCT03364309|465008762|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195202|NCT03364309|465008763|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
129195203|NCT03364309|465008745|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
129195204|NCT03364309|465008746|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
129195205|NCT03364309|465008747|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
129195206|NCT03364309|465008748|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
129195207|NCT03364309|465008749|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
129195208|NCT03364309|465008750|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
129195209|NCT03364309|465008751|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
129195210|NCT03364309|465008752|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
129195211|NCT03364309|465008753|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
129195212|NCT03364309|465008754|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
129195213|NCT03364309|465008755|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
129195214|NCT03364309|465008756|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
129195215|NCT03364309|465008757|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
129195216|NCT03364309|465008758|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
129195217|NCT03364309|465008759|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
129195218|NCT03364309|465008760|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
129195219|NCT03364309|465008761|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
129195220|NCT03364309|465008762|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
129195221|NCT03364309|465008763|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
129195222|NCT03364309|465008745|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195223|NCT03364309|465008746|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195224|NCT03364309|465008747|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195225|NCT03364309|465008748|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195226|NCT03364309|465008749|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195227|NCT03364309|465008750|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195228|NCT03364309|465008751|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195229|NCT03364309|465008752|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195230|NCT03364309|465008753|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195231|NCT03364309|465008754|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195232|NCT03364309|465008755|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195233|NCT03364309|465008756|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195234|NCT03364309|465008757|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195235|NCT03364309|465008758|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195236|NCT03364309|465008759|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195237|NCT03364309|465008760|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129195238|NCT03364309|465008761|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
129195239|NCT03364309|465008762|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
129195240|NCT03364309|465008763|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
129195241|NCT03364309|465008745|FG000|Post-Treatment Followup Period|Adverse Event|0|||
129195242|NCT03364309|465008746|FG001|Post-Treatment Followup Period|Adverse Event|0|||
129195243|NCT03364309|465008747|FG002|Post-Treatment Followup Period|Adverse Event|0|||
129195244|NCT03364309|465008748|FG003|Post-Treatment Followup Period|Adverse Event|0|||
128731094|NCT03945981|463311436|FG000|Overall Study|Lost to Follow-up|12|||
128731095|NCT03945981|463311436|FG000|Overall Study|Physician Decision|4|||
128731096|NCT03945981|463311436|FG000|Overall Study|Withdrawal by Subject|6|||
128731097|NCT03945981|463311436|FG000|Overall Study|Protocol Violation|1|||
128731098|NCT03665038|463311437|FG000|Overall Study|Lost to Follow-up|0|||
128731099|NCT03665038|463311438|FG001|Overall Study|Lost to Follow-up|0|||
128731100|NCT03665038|463311439|FG002|Overall Study|Lost to Follow-up|1|||
128731101|NCT04579679|463311440|FG000|Overall Study|New Antitumor Therapy|6|||
128731102|NCT04579679|463311441|FG001|Overall Study|New Antitumor Therapy|4|||
128731103|NCT04579679|463311442|FG002|Overall Study|New Antitumor Therapy|7|||
128731104|NCT04579679|463311443|FG003|Overall Study|New Antitumor Therapy|0|||
128731105|NCT04579679|463311440|FG000|Overall Study|Withdrawal of Consent|1|||
128731106|NCT04579679|463311441|FG001|Overall Study|Withdrawal of Consent|1|||
128731107|NCT04579679|463311442|FG002|Overall Study|Withdrawal of Consent|2|||
128731108|NCT04579679|463311443|FG003|Overall Study|Withdrawal of Consent|4|||
128731109|NCT04579679|463311440|FG000|Overall Study|Death|2|||
128731110|NCT04579679|463311441|FG001|Overall Study|Death|2|||
128731111|NCT04579679|463311442|FG002|Overall Study|Death|2|||
129195245|NCT03364309|465008749|FG004|Post-Treatment Followup Period|Adverse Event|0|||
129195246|NCT03364309|465008750|FG005|Post-Treatment Followup Period|Adverse Event|0|||
129195247|NCT03364309|465008751|FG006|Post-Treatment Followup Period|Adverse Event|0|||
129195248|NCT03364309|465008752|FG007|Post-Treatment Followup Period|Adverse Event|0|||
129195249|NCT03364309|465008753|FG008|Post-Treatment Followup Period|Adverse Event|0|||
129195250|NCT03364309|465008754|FG009|Post-Treatment Followup Period|Adverse Event|0|||
129195251|NCT03364309|465008755|FG010|Post-Treatment Followup Period|Adverse Event|0|||
129195252|NCT03364309|465008756|FG011|Post-Treatment Followup Period|Adverse Event|0|||
129195253|NCT03364309|465008757|FG012|Post-Treatment Followup Period|Adverse Event|0|||
129195254|NCT03364309|465008758|FG013|Post-Treatment Followup Period|Adverse Event|0|||
129195255|NCT03364309|465008759|FG014|Post-Treatment Followup Period|Adverse Event|0|||
129195256|NCT03364309|465008760|FG015|Post-Treatment Followup Period|Adverse Event|0|||
129195257|NCT03364309|465008761|FG016|Post-Treatment Followup Period|Adverse Event|2|||
129195258|NCT03364309|465008762|FG017|Post-Treatment Followup Period|Adverse Event|6|||
129195259|NCT03364309|465008763|FG018|Post-Treatment Followup Period|Adverse Event|1|||
129195260|NCT03364309|465008745|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195261|NCT03364309|465008746|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195262|NCT03364309|465008747|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195263|NCT03364309|465008748|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195264|NCT03364309|465008749|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195265|NCT03364309|465008750|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195266|NCT03364309|465008751|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195267|NCT03364309|465008752|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195268|NCT03364309|465008753|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195269|NCT03364309|465008754|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195270|NCT03364309|465008755|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195271|NCT03364309|465008756|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195272|NCT03364309|465008757|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195273|NCT03364309|465008758|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195274|NCT03364309|465008759|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195275|NCT03364309|465008760|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195276|NCT03364309|465008761|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195277|NCT03364309|465008762|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
129195278|NCT03364309|465008763|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
129195279|NCT03364309|465008745|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
129195280|NCT03364309|465008746|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
129195281|NCT03364309|465008747|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
129195282|NCT03364309|465008748|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
129195283|NCT03364309|465008749|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
129195284|NCT03364309|465008750|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
129195285|NCT03364309|465008751|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
129195286|NCT03364309|465008752|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
129195287|NCT03364309|465008753|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
129195288|NCT03364309|465008754|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
129195289|NCT03364309|465008755|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
129195290|NCT03364309|465008756|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
129195291|NCT03364309|465008757|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
129195292|NCT03364309|465008758|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
129195293|NCT03364309|465008759|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
129195294|NCT03364309|465008760|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
129195295|NCT03364309|465008761|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
129195296|NCT03364309|465008762|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
129195297|NCT03364309|465008763|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
129195298|NCT00167310|465008764|FG000|Overall Study|Protocol Violation|5|||
129195299|NCT00167310|465008765|FG001|Overall Study|Protocol Violation|3|||
129195300|NCT00167310|465008764|FG000|Overall Study|Withdrawal by Subject|3|||
129195301|NCT00167310|465008765|FG001|Overall Study|Withdrawal by Subject|7|||
129195302|NCT03543137|465008769|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
129195303|NCT03543137|465008770|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
129195304|NCT03543137|465008769|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
129195305|NCT03543137|465008770|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
129195306|NCT03543137|465008769|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
129195307|NCT03543137|465008770|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
128731112|NCT04579679|463311443|FG003|Overall Study|Death|0|||
128731113|NCT04579679|463311440|FG000|Overall Study|Adverse Event|0|||
129195308|NCT01052077|465008771|FG000|Phase A|Lost to Follow-up|22|||
129195309|NCT01052077|465008772|FG001|Phase A|Lost to Follow-up|0|||
129195310|NCT01052077|465008773|FG002|Phase A|Lost to Follow-up|0|||
129195311|NCT01052077|465008774|FG003|Phase A|Lost to Follow-up|0|||
129195312|NCT01052077|465008771|FG000|Phase A|Adverse Event|32|||
129195313|NCT01052077|465008772|FG001|Phase A|Adverse Event|0|||
128731114|NCT04579679|463311441|FG001|Overall Study|Adverse Event|4|||
128731115|NCT04579679|463311442|FG002|Overall Study|Adverse Event|0|||
128731116|NCT04579679|463311443|FG003|Overall Study|Adverse Event|0|||
128731117|NCT04579679|463311440|FG000|Overall Study|Disease Progression|9|||
128731118|NCT04579679|463311441|FG001|Overall Study|Disease Progression|13|||
128731119|NCT04579679|463311442|FG002|Overall Study|Disease Progression|7|||
128731120|NCT04579679|463311443|FG003|Overall Study|Disease Progression|0|||
128731121|NCT04579679|463311440|FG000|Overall Study|Physician Decision|0|||
128731122|NCT04579679|463311441|FG001|Overall Study|Physician Decision|0|||
128731123|NCT04579679|463311442|FG002|Overall Study|Physician Decision|1|||
129195314|NCT01052077|465008773|FG002|Phase A|Adverse Event|0|||
129195315|NCT01052077|465008774|FG003|Phase A|Adverse Event|0|||
129195316|NCT01052077|465008771|FG000|Phase A|Met Withdrawal Criteria|26|||
129195317|NCT01052077|465008772|FG001|Phase A|Met Withdrawal Criteria|0|||
129195318|NCT01052077|465008773|FG002|Phase A|Met Withdrawal Criteria|0|||
129195319|NCT01052077|465008774|FG003|Phase A|Met Withdrawal Criteria|0|||
129195320|NCT01052077|465008771|FG000|Phase A|Physician Decision|10|||
129195321|NCT01052077|465008772|FG001|Phase A|Physician Decision|0|||
129195322|NCT01052077|465008773|FG002|Phase A|Physician Decision|0|||
129195323|NCT01052077|465008774|FG003|Phase A|Physician Decision|0|||
129195324|NCT01052077|465008771|FG000|Phase A|Withdrawal by Subject|29|||
129195325|NCT01052077|465008772|FG001|Phase A|Withdrawal by Subject|0|||
129195326|NCT01052077|465008773|FG002|Phase A|Withdrawal by Subject|0|||
129195327|NCT01052077|465008774|FG003|Phase A|Withdrawal by Subject|0|||
129195328|NCT01052077|465008771|FG000|Phase A|Protocol Deviation|27|||
129195329|NCT01052077|465008772|FG001|Phase A|Protocol Deviation|0|||
129195330|NCT01052077|465008773|FG002|Phase A|Protocol Deviation|0|||
129195331|NCT01052077|465008774|FG003|Phase A|Protocol Deviation|0|||
129195332|NCT01052077|465008771|FG000|Phase B|Lost to Follow-up|0|||
129195333|NCT01052077|465008772|FG001|Phase B|Lost to Follow-up|2|||
129195334|NCT01052077|465008773|FG002|Phase B|Lost to Follow-up|3|||
129195335|NCT01052077|465008774|FG003|Phase B|Lost to Follow-up|0|||
129195336|NCT01052077|465008771|FG000|Phase B|Adverse Event|0|||
129195337|NCT01052077|465008772|FG001|Phase B|Adverse Event|9|||
129195338|NCT01052077|465008773|FG002|Phase B|Adverse Event|2|||
129195339|NCT01052077|465008774|FG003|Phase B|Adverse Event|0|||
129195340|NCT01052077|465008771|FG000|Phase B|Met Withdrawal Criteria|0|||
129195341|NCT01052077|465008772|FG001|Phase B|Met Withdrawal Criteria|2|||
129195342|NCT01052077|465008773|FG002|Phase B|Met Withdrawal Criteria|1|||
129195343|NCT01052077|465008774|FG003|Phase B|Met Withdrawal Criteria|0|||
129195344|NCT01052077|465008771|FG000|Phase B|Physician Decision|0|||
129195345|NCT01052077|465008772|FG001|Phase B|Physician Decision|1|||
129195346|NCT01052077|465008773|FG002|Phase B|Physician Decision|1|||
129195347|NCT01052077|465008774|FG003|Phase B|Physician Decision|0|||
129195348|NCT01052077|465008771|FG000|Phase B|Withdrawal by Subject|0|||
129195349|NCT01052077|465008772|FG001|Phase B|Withdrawal by Subject|0|||
129195350|NCT01052077|465008773|FG002|Phase B|Withdrawal by Subject|5|||
129195351|NCT01052077|465008774|FG003|Phase B|Withdrawal by Subject|0|||
129195352|NCT01052077|465008771|FG000|Phase B|Protocol Deviation|0|||
129195353|NCT01052077|465008772|FG001|Phase B|Protocol Deviation|3|||
129195354|NCT01052077|465008773|FG002|Phase B|Protocol Deviation|4|||
129195355|NCT01052077|465008774|FG003|Phase B|Protocol Deviation|0|||
129195356|NCT01052077|465008771|FG000|Phase B|Lack of Efficacy|0|||
129195357|NCT01052077|465008772|FG001|Phase B|Lack of Efficacy|1|||
129195358|NCT01052077|465008773|FG002|Phase B|Lack of Efficacy|0|||
129195359|NCT01052077|465008774|FG003|Phase B|Lack of Efficacy|0|||
129195360|NCT01052077|465008771|FG000|Phase A+|Lost to Follow-up|0|||
129195361|NCT01052077|465008772|FG001|Phase A+|Lost to Follow-up|0|||
129195362|NCT01052077|465008773|FG002|Phase A+|Lost to Follow-up|0|||
129195363|NCT01052077|465008774|FG003|Phase A+|Lost to Follow-up|8|||
129195364|NCT01052077|465008771|FG000|Phase A+|Adverse Event|0|||
128731124|NCT04579679|463311443|FG003|Overall Study|Physician Decision|0|||
129195365|NCT01052077|465008772|FG001|Phase A+|Adverse Event|0|||
129195366|NCT01052077|465008773|FG002|Phase A+|Adverse Event|0|||
129195367|NCT01052077|465008774|FG003|Phase A+|Adverse Event|4|||
129195368|NCT01052077|465008771|FG000|Phase A+|Met Withdrawal Criteria|0|||
129195369|NCT01052077|465008772|FG001|Phase A+|Met Withdrawal Criteria|0|||
128731125|NCT04579679|463311440|FG000|Overall Study|Study Terminated by Sponsor|2|||
128731126|NCT04579679|463311441|FG001|Overall Study|Study Terminated by Sponsor|7|||
128731127|NCT04579679|463311442|FG002|Overall Study|Study Terminated by Sponsor|1|||
128731128|NCT04579679|463311443|FG003|Overall Study|Study Terminated by Sponsor|0|||
128731129|NCT03091192|463311444|FG000|Overall Study|Study terminated by sponsor|21|||
129195370|NCT01052077|465008773|FG002|Phase A+|Met Withdrawal Criteria|0|||
129195371|NCT01052077|465008774|FG003|Phase A+|Met Withdrawal Criteria|2|||
129195372|NCT01052077|465008771|FG000|Phase A+|Withdrawal by Subject|0|||
129195373|NCT01052077|465008772|FG001|Phase A+|Withdrawal by Subject|0|||
129195374|NCT01052077|465008773|FG002|Phase A+|Withdrawal by Subject|0|||
129195375|NCT01052077|465008774|FG003|Phase A+|Withdrawal by Subject|7|||
129195376|NCT02465203|465008775|FG000|Overall Study|Protocol Violation|1|||
128731130|NCT03091192|463311445|FG001|Overall Study|Study terminated by sponsor|14|||
128731131|NCT03091192|463311444|FG000|Overall Study|Death|9|||
129195377|NCT02465203|465008776|FG001|Overall Study|Protocol Violation|1|||
129195378|NCT02465203|465008777|FG002|Overall Study|Protocol Violation|1|||
129195379|NCT02465203|465008775|FG000|Overall Study|Study terminated by sponsor|50|||
128731132|NCT03091192|463311445|FG001|Overall Study|Death|13|||
129195380|NCT02465203|465008776|FG001|Overall Study|Study terminated by sponsor|34|||
129195381|NCT02465203|465008777|FG002|Overall Study|Study terminated by sponsor|11|||
129195382|NCT02465203|465008775|FG000|Overall Study|New therapy for study indication|4|||
129195383|NCT02465203|465008776|FG001|Overall Study|New therapy for study indication|0|||
129195384|NCT02465203|465008777|FG002|Overall Study|New therapy for study indication|0|||
129195385|NCT02465203|465008775|FG000|Overall Study|Patient/guardian decision|1|||
129195386|NCT02465203|465008776|FG001|Overall Study|Patient/guardian decision|1|||
129195387|NCT02465203|465008777|FG002|Overall Study|Patient/guardian decision|1|||
129195388|NCT00042991|465008782|FG000|Overall Study|Adverse Event|1|||
129195389|NCT00042991|465008783|FG001|Overall Study|Adverse Event|4|||
129195390|NCT00042991|465008784|FG002|Overall Study|Adverse Event|2|||
129195391|NCT00042991|465008785|FG003|Overall Study|Adverse Event|0|||
129195392|NCT00042991|465008786|FG004|Overall Study|Adverse Event|0|||
129195393|NCT00042991|465008787|FG005|Overall Study|Adverse Event|1|||
129195394|NCT00042991|465008788|FG006|Overall Study|Adverse Event|0|||
129195395|NCT00042991|465008782|FG000|Overall Study|Withdrawal by Subject|0|||
129195396|NCT00042991|465008783|FG001|Overall Study|Withdrawal by Subject|7|||
129195397|NCT00042991|465008784|FG002|Overall Study|Withdrawal by Subject|2|||
129195398|NCT00042991|465008785|FG003|Overall Study|Withdrawal by Subject|0|||
129195399|NCT00042991|465008786|FG004|Overall Study|Withdrawal by Subject|1|||
129195400|NCT00042991|465008787|FG005|Overall Study|Withdrawal by Subject|0|||
129195401|NCT00042991|465008788|FG006|Overall Study|Withdrawal by Subject|0|||
129195402|NCT00042991|465008782|FG000|Overall Study|Disease Progression|5|||
129195403|NCT00042991|465008783|FG001|Overall Study|Disease Progression|29|||
129195404|NCT00042991|465008784|FG002|Overall Study|Disease Progression|2|||
129195405|NCT00042991|465008785|FG003|Overall Study|Disease Progression|2|||
129195406|NCT00042991|465008786|FG004|Overall Study|Disease Progression|1|||
129195407|NCT00042991|465008787|FG005|Overall Study|Disease Progression|4|||
129195408|NCT00042991|465008788|FG006|Overall Study|Disease Progression|2|||
129195409|NCT00042991|465008782|FG000|Overall Study|Alternative Therapy|0|||
129195410|NCT00042991|465008783|FG001|Overall Study|Alternative Therapy|0|||
129195411|NCT00042991|465008784|FG002|Overall Study|Alternative Therapy|0|||
129195412|NCT00042991|465008785|FG003|Overall Study|Alternative Therapy|0|||
129195413|NCT00042991|465008786|FG004|Overall Study|Alternative Therapy|1|||
129195414|NCT00042991|465008787|FG005|Overall Study|Alternative Therapy|0|||
129195415|NCT00042991|465008788|FG006|Overall Study|Alternative Therapy|0|||
129195416|NCT04072887|465008789|FG000|Overall Study|Withdrawal by Subject|3|||
129195417|NCT04072887|465008790|FG001|Overall Study|Withdrawal by Subject|8|||
129195418|NCT04072887|465008791|FG002|Overall Study|Withdrawal by Subject|1|||
129195419|NCT04072887|465008792|FG003|Overall Study|Withdrawal by Subject|3|||
129195420|NCT04072887|465008793|FG004|Overall Study|Withdrawal by Subject|3|||
129195421|NCT04072887|465008794|FG005|Overall Study|Withdrawal by Subject|13|||
129195422|NCT04072887|465008789|FG000|Overall Study|Adverse Event|2|||
129195423|NCT04072887|465008790|FG001|Overall Study|Adverse Event|4|||
129195424|NCT04072887|465008791|FG002|Overall Study|Adverse Event|1|||
129195425|NCT04072887|465008792|FG003|Overall Study|Adverse Event|4|||
129195426|NCT04072887|465008793|FG004|Overall Study|Adverse Event|0|||
129195427|NCT04072887|465008794|FG005|Overall Study|Adverse Event|1|||
129195428|NCT04072887|465008789|FG000|Overall Study|Physician Decision|2|||
129195429|NCT04072887|465008790|FG001|Overall Study|Physician Decision|0|||
129195430|NCT04072887|465008791|FG002|Overall Study|Physician Decision|0|||
129195431|NCT04072887|465008792|FG003|Overall Study|Physician Decision|0|||
129195432|NCT04072887|465008793|FG004|Overall Study|Physician Decision|0|||
129195433|NCT04072887|465008794|FG005|Overall Study|Physician Decision|1|||
129195434|NCT04072887|465008789|FG000|Overall Study|Lost to Follow-up|1|||
129195435|NCT04072887|465008790|FG001|Overall Study|Lost to Follow-up|3|||
129195436|NCT04072887|465008791|FG002|Overall Study|Lost to Follow-up|0|||
129195437|NCT04072887|465008792|FG003|Overall Study|Lost to Follow-up|0|||
129195438|NCT04072887|465008793|FG004|Overall Study|Lost to Follow-up|0|||
129195439|NCT04072887|465008794|FG005|Overall Study|Lost to Follow-up|0|||
129195440|NCT04072887|465008789|FG000|Overall Study|Death|0|||
129195441|NCT04072887|465008790|FG001|Overall Study|Death|2|||
129195442|NCT04072887|465008791|FG002|Overall Study|Death|0|||
129195443|NCT04072887|465008792|FG003|Overall Study|Death|2|||
129195444|NCT04072887|465008793|FG004|Overall Study|Death|3|||
129195445|NCT04072887|465008794|FG005|Overall Study|Death|0|||
129195446|NCT03193736|465008795|FG000|Overall Study|Death|2|||
129195447|NCT03193736|465008795|FG000|Overall Study|Withdrawal by Subject|1|||
128731133|NCT03091192|463311444|FG000|Overall Study|Withdrawal by Subject|2|||
129195448|NCT03193736|465008795|FG000|Overall Study|Lost to Follow-up|1|||
129195449|NCT03193736|465008795|FG000|Overall Study|implant not received|1|||
129195450|NCT00423449|465008796|FG000|Overall Study|Clinical Adverse Event|1|||
129195451|NCT00423449|465008797|FG001|Overall Study|Clinical Adverse Event|0|||
128731134|NCT03091192|463311445|FG001|Overall Study|Withdrawal by Subject|0|||
129195452|NCT00423449|465008798|FG002|Overall Study|Clinical Adverse Event|1|||
129195453|NCT00423449|465008799|FG003|Overall Study|Clinical Adverse Event|8|||
129195454|NCT00423449|465008800|FG004|Overall Study|Clinical Adverse Event|2|||
129195455|NCT00423449|465008796|FG000|Overall Study|Death|1|||
129195456|NCT00423449|465008797|FG001|Overall Study|Death|0|||
129195457|NCT00423449|465008798|FG002|Overall Study|Death|2|||
129195458|NCT00423449|465008799|FG003|Overall Study|Death|1|||
129195459|NCT00423449|465008800|FG004|Overall Study|Death|1|||
129195460|NCT00423449|465008796|FG000|Overall Study|Progressive Disease|1|||
129195461|NCT00423449|465008797|FG001|Overall Study|Progressive Disease|3|||
129195462|NCT00423449|465008798|FG002|Overall Study|Progressive Disease|8|||
129195463|NCT00423449|465008799|FG003|Overall Study|Progressive Disease|11|||
129195464|NCT00423449|465008800|FG004|Overall Study|Progressive Disease|4|||
129195465|NCT00423449|465008796|FG000|Overall Study|Laboratory Adverse Event|0|||
129195466|NCT00423449|465008797|FG001|Overall Study|Laboratory Adverse Event|1|||
129195467|NCT00423449|465008798|FG002|Overall Study|Laboratory Adverse Event|2|||
129195468|NCT00423449|465008799|FG003|Overall Study|Laboratory Adverse Event|0|||
129195469|NCT00423449|465008800|FG004|Overall Study|Laboratory Adverse Event|0|||
129195470|NCT00423449|465008796|FG000|Overall Study|Other|0|||
129195471|NCT00423449|465008797|FG001|Overall Study|Other|0|||
129195472|NCT00423449|465008798|FG002|Overall Study|Other|0|||
129195473|NCT00423449|465008799|FG003|Overall Study|Other|1|||
129195474|NCT00423449|465008800|FG004|Overall Study|Other|0|||
129195475|NCT00423449|465008796|FG000|Overall Study|Protocol Violation|0|||
129195476|NCT00423449|465008797|FG001|Overall Study|Protocol Violation|0|||
129195477|NCT00423449|465008798|FG002|Overall Study|Protocol Violation|2|||
129195478|NCT00423449|465008799|FG003|Overall Study|Protocol Violation|1|||
129195479|NCT00423449|465008800|FG004|Overall Study|Protocol Violation|0|||
129195480|NCT02697435|465008801|FG000|Overall Study|Withdrawal by Subject|1|||
129195481|NCT02697435|465008802|FG001|Overall Study|Withdrawal by Subject|0|||
129195482|NCT02697435|465008801|FG000|Overall Study|Physician Decision|0|||
129195483|NCT02697435|465008802|FG001|Overall Study|Physician Decision|4|||
129195484|NCT04371666|465008811|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
129195485|NCT04371666|465008812|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
129195486|NCT04371666|465008811|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
129195487|NCT04371666|465008812|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
129195488|NCT04371666|465008811|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
129195489|NCT04371666|465008812|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
129195490|NCT04371666|465008811|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
129195491|NCT04371666|465008812|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
129195492|NCT04371666|465008811|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
129195493|NCT04371666|465008812|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
129195494|NCT04371666|465008811|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
129195495|NCT04371666|465008812|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
129195496|NCT00861471|465008819|FG000|Overall Study|Withdrawal by Subject|1|||
129195497|NCT00861471|465008819|FG000|Overall Study|Adverse Event|2|||
129195498|NCT00861471|465008819|FG000|Overall Study|Lack of Efficacy|3|||
129195499|NCT00861471|465008819|FG000|Overall Study|treatment for lumbar laminectomy|1|||
129195500|NCT00861471|465008819|FG000|Overall Study|Physician Decision|2|||
129195501|NCT01445080|465008820|FG000|Overall Study|Adverse Event|5|||
129195502|NCT01445080|465008821|FG001|Overall Study|Adverse Event|3|||
129195503|NCT01445080|465008822|FG002|Overall Study|Adverse Event|11|||
129195504|NCT01445080|465008823|FG003|Overall Study|Adverse Event|6|||
129195505|NCT01445080|465008824|FG004|Overall Study|Adverse Event|2|||
129195506|NCT01445080|465008825|FG005|Overall Study|Adverse Event|3|||
129195507|NCT01445080|465008826|FG006|Overall Study|Adverse Event|0|||
129195508|NCT01445080|465008827|FG007|Overall Study|Adverse Event|3|||
129195509|NCT01445080|465008828|FG008|Overall Study|Adverse Event|10|||
129195510|NCT01445080|465008820|FG000|Overall Study|Physician Decision|0|||
129195511|NCT01445080|465008821|FG001|Overall Study|Physician Decision|0|||
129195512|NCT01445080|465008822|FG002|Overall Study|Physician Decision|1|||
129195513|NCT01445080|465008823|FG003|Overall Study|Physician Decision|0|||
129195514|NCT01445080|465008824|FG004|Overall Study|Physician Decision|0|||
129195515|NCT01445080|465008825|FG005|Overall Study|Physician Decision|3|||
129195516|NCT01445080|465008826|FG006|Overall Study|Physician Decision|2|||
129195517|NCT01445080|465008827|FG007|Overall Study|Physician Decision|2|||
129195518|NCT01445080|465008828|FG008|Overall Study|Physician Decision|0|||
129195519|NCT01445080|465008820|FG000|Overall Study|Withdrawal by Subject|1|||
129195520|NCT01445080|465008821|FG001|Overall Study|Withdrawal by Subject|0|||
129195521|NCT01445080|465008822|FG002|Overall Study|Withdrawal by Subject|0|||
129195522|NCT01445080|465008823|FG003|Overall Study|Withdrawal by Subject|1|||
129195523|NCT01445080|465008824|FG004|Overall Study|Withdrawal by Subject|0|||
129195524|NCT01445080|465008825|FG005|Overall Study|Withdrawal by Subject|0|||
129195525|NCT01445080|465008826|FG006|Overall Study|Withdrawal by Subject|0|||
129195526|NCT01445080|465008827|FG007|Overall Study|Withdrawal by Subject|0|||
129195527|NCT01445080|465008828|FG008|Overall Study|Withdrawal by Subject|2|||
129195528|NCT01445080|465008820|FG000|Overall Study|Ineligible/Inevaluable|1|||
129195529|NCT01445080|465008821|FG001|Overall Study|Ineligible/Inevaluable|2|||
129195530|NCT01445080|465008822|FG002|Overall Study|Ineligible/Inevaluable|0|||
129195531|NCT01445080|465008823|FG003|Overall Study|Ineligible/Inevaluable|1|||
128781041|NCT00079937|463490411|FG001|Overall Study|Subject no longer requires study drug|0|||
128781042|NCT00079937|463490410|FG000|Overall Study|Protocol Violation|8|||
128781043|NCT00079937|463490411|FG001|Overall Study|Protocol Violation|6|||
128781044|NCT00079937|463490410|FG000|Overall Study|Withdrawal by Subject|21|||
128781045|NCT00079937|463490411|FG001|Overall Study|Withdrawal by Subject|7|||
129195532|NCT01445080|465008824|FG004|Overall Study|Ineligible/Inevaluable|2|||
129195533|NCT01445080|465008825|FG005|Overall Study|Ineligible/Inevaluable|3|||
129195534|NCT01445080|465008826|FG006|Overall Study|Ineligible/Inevaluable|0|||
129195535|NCT01445080|465008827|FG007|Overall Study|Ineligible/Inevaluable|0|||
129195536|NCT01445080|465008828|FG008|Overall Study|Ineligible/Inevaluable|6|||
129195537|NCT00445770|465008829|FG000|Overall Study|Adverse Event|9|||
129195538|NCT00445770|465008830|FG001|Overall Study|Adverse Event|15|||
129195539|NCT00445770|465008831|FG002|Overall Study|Adverse Event|19|||
129195540|NCT00445770|465008829|FG000|Overall Study|Lack of Efficacy|38|||
129195541|NCT00445770|465008830|FG001|Overall Study|Lack of Efficacy|13|||
129195542|NCT00445770|465008831|FG002|Overall Study|Lack of Efficacy|6|||
129195543|NCT00445770|465008829|FG000|Overall Study|Lost to Follow-up|0|||
129195544|NCT00445770|465008830|FG001|Overall Study|Lost to Follow-up|2|||
129195545|NCT00445770|465008831|FG002|Overall Study|Lost to Follow-up|0|||
129195546|NCT00445770|465008829|FG000|Overall Study|Other|6|||
129195547|NCT00445770|465008830|FG001|Overall Study|Other|5|||
129195548|NCT00445770|465008831|FG002|Overall Study|Other|6|||
129195549|NCT03857542|465008832|FG000|Overall Study|Adverse Event|1|||
129195550|NCT03857542|465008833|FG001|Overall Study|Adverse Event|3|||
129195551|NCT03857542|465008832|FG000|Overall Study|Withdrawal by Subject|2|||
129195552|NCT03857542|465008833|FG001|Overall Study|Withdrawal by Subject|1|||
129195553|NCT03857542|465008832|FG000|Overall Study|Lost to Follow-up|2|||
129195554|NCT03857542|465008833|FG001|Overall Study|Lost to Follow-up|1|||
129195555|NCT03857542|465008832|FG000|Overall Study|Reason not Specified|1|||
129195556|NCT03857542|465008833|FG001|Overall Study|Reason not Specified|0|||
129195557|NCT03058692|465010818|FG000|Overall Study|Lost to Follow-up|2|||
129195558|NCT03058692|465010819|FG001|Overall Study|Lost to Follow-up|1|||
129195559|NCT03058692|465010818|FG000|Overall Study|Withdrawal by Subject|1|||
129195560|NCT03058692|465010819|FG001|Overall Study|Withdrawal by Subject|1|||
129195561|NCT01698814|465010822|FG000|Overall Study|Adverse Event|0|||
129195562|NCT01698814|465010823|FG001|Overall Study|Adverse Event|2|||
129195563|NCT01698814|465010822|FG000|Overall Study|Lost to Follow-up|0|||
129195564|NCT01698814|465010823|FG001|Overall Study|Lost to Follow-up|1|||
129195565|NCT01698814|465010822|FG000|Overall Study|Pregnancy|1|||
128781046|NCT00079937|463490410|FG000|Overall Study|Lost to Follow-up|12|||
129195566|NCT01698814|465010823|FG001|Overall Study|Pregnancy|0|||
129195567|NCT01698814|465010822|FG000|Overall Study|Randomized in error|1|||
129195568|NCT01698814|465010823|FG001|Overall Study|Randomized in error|0|||
129195569|NCT04014062|465010824|FG000|Period I: Dosing|Medical Grounds|4|||
128781047|NCT00079937|463490411|FG001|Overall Study|Lost to Follow-up|5|||
129195570|NCT04014062|465010825|FG001|Period I: Dosing|Medical Grounds|5|||
129195571|NCT04014062|465010824|FG000|Period I: Dosing|Withdrawal by Subject|3|||
129195572|NCT04014062|465010825|FG001|Period I: Dosing|Withdrawal by Subject|1|||
129195573|NCT03038126|465010827|FG000|Overall Study|Death|1|||
129195574|NCT03038126|465010828|FG001|Overall Study|Death|1|||
128781048|NCT00079937|463490410|FG000|Overall Study|Administrative problems|22|||
129195575|NCT03038126|465010827|FG000|Overall Study|Withdrawal by Subject|5|||
129195576|NCT03038126|465010828|FG001|Overall Study|Withdrawal by Subject|0|||
129195577|NCT03038126|465010827|FG000|Overall Study|Lost to Follow-up|0|||
129195578|NCT03038126|465010828|FG001|Overall Study|Lost to Follow-up|1|||
129195579|NCT03038126|465010827|FG000|Overall Study|Long Term Hospitalization|2|||
129195580|NCT03038126|465010828|FG001|Overall Study|Long Term Hospitalization|0|||
129195581|NCT03038126|465010827|FG000|Overall Study|Too Ill to Participate|1|||
129195582|NCT03038126|465010828|FG001|Overall Study|Too Ill to Participate|2|||
129195583|NCT01724866|465010829|FG000|Overall Study|Adverse Event|0|||
128731135|NCT03091192|463311444|FG000|Overall Study|Lost to Follow-up|1|||
128731136|NCT03091192|463311445|FG001|Overall Study|Lost to Follow-up|0|||
128731137|NCT04487080|463311448|FG000|Overall Study|Withdrawal by Subject|19|||
129195584|NCT01724866|465010830|FG001|Overall Study|Adverse Event|0|||
129195585|NCT01724866|465010831|FG002|Overall Study|Adverse Event|1|||
129195586|NCT01724866|465010832|FG003|Overall Study|Adverse Event|1|||
129195587|NCT01724866|465010829|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
129195588|NCT01724866|465010830|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
129195589|NCT01724866|465010831|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
129195590|NCT01724866|465010832|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
129195591|NCT01724866|465010829|FG000|Overall Study|Investigator's Discretion|0|||
129195592|NCT01724866|465010830|FG001|Overall Study|Investigator's Discretion|1|||
129195593|NCT01724866|465010831|FG002|Overall Study|Investigator's Discretion|1|||
129195594|NCT01724866|465010832|FG003|Overall Study|Investigator's Discretion|0|||
129195595|NCT01724866|465010829|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
129195596|NCT01724866|465010830|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
129195597|NCT01724866|465010831|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
129195598|NCT01724866|465010832|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
129195599|NCT01724866|465010829|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
129195600|NCT01724866|465010830|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
129195601|NCT01724866|465010831|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
129195602|NCT01724866|465010832|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
129195603|NCT01424501|465010833|FG000|Overall Study|Withdrawal by Subject|1|||
129195604|NCT01424501|465010834|FG001|Overall Study|Withdrawal by Subject|0|||
129195605|NCT01424501|465010835|FG002|Overall Study|Withdrawal by Subject|1|||
129195606|NCT01424501|465010836|FG003|Overall Study|Withdrawal by Subject|0|||
129195607|NCT01424501|465010837|FG004|Overall Study|Withdrawal by Subject|0|||
129195608|NCT01424501|465010838|FG005|Overall Study|Withdrawal by Subject|0|||
129195609|NCT01424501|465010833|FG000|Overall Study|Lost to Follow-up|0|||
129195610|NCT01424501|465010834|FG001|Overall Study|Lost to Follow-up|1|||
129195611|NCT01424501|465010835|FG002|Overall Study|Lost to Follow-up|1|||
129195612|NCT01424501|465010836|FG003|Overall Study|Lost to Follow-up|0|||
129195613|NCT01424501|465010837|FG004|Overall Study|Lost to Follow-up|0|||
129195614|NCT01424501|465010838|FG005|Overall Study|Lost to Follow-up|0|||
129195615|NCT01980095|465010839|FG000|Overall Study|Lost to Follow-up|6|||
129195616|NCT01980095|465010840|FG001|Overall Study|Lost to Follow-up|7|||
129195617|NCT01980095|465010839|FG000|Overall Study|Withdrawal by Subject|2|||
129195618|NCT01980095|465010840|FG001|Overall Study|Withdrawal by Subject|3|||
129195619|NCT01980095|465010839|FG000|Overall Study|Poor compliance|5|||
129195620|NCT01980095|465010840|FG001|Overall Study|Poor compliance|0|||
129195621|NCT01980095|465010839|FG000|Overall Study|Safety issue|0|||
129195622|NCT01980095|465010840|FG001|Overall Study|Safety issue|1|||
129195623|NCT01980095|465010839|FG000|Overall Study|Study drug discontinued|1|||
129195624|NCT01980095|465010840|FG001|Overall Study|Study drug discontinued|0|||
129195625|NCT01980095|465010839|FG000|Overall Study|Randomized by mistake|1|||
129195626|NCT01980095|465010840|FG001|Overall Study|Randomized by mistake|0|||
129195627|NCT01362608|465010847|FG000|Overall Study|Protocol Violation|0|||
129195628|NCT01362608|465010848|FG001|Overall Study|Protocol Violation|1|||
129195629|NCT01362608|465010847|FG000|Overall Study|Lost to Follow-up|3|||
129195630|NCT01362608|465010848|FG001|Overall Study|Lost to Follow-up|1|||
129195631|NCT01362608|465010847|FG000|Overall Study|Withdrawal by Subject|1|||
129195632|NCT01362608|465010848|FG001|Overall Study|Withdrawal by Subject|2|||
128731138|NCT04487080|463311449|FG001|Overall Study|Withdrawal by Subject|18|||
129195633|NCT01362608|465010847|FG000|Overall Study|Lack of Efficacy|0|||
129195634|NCT01362608|465010848|FG001|Overall Study|Lack of Efficacy|2|||
129195635|NCT01362608|465010847|FG000|Overall Study|Adverse Event|0|||
129195636|NCT01362608|465010848|FG001|Overall Study|Adverse Event|2|||
129195637|NCT04506502|465010854|FG000|Overall Study|Withdrawal by Subject|1|||
129195638|NCT04506502|465010854|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
129195639|NCT03526146|465010856|FG000|Overall Study|Lost to Follow-up|5|||
128731139|NCT04487080|463311450|FG002|Overall Study|Withdrawal by Subject|13|||
128731140|NCT04487080|463311448|FG000|Overall Study|Lost to Follow-up|3|||
128731141|NCT04487080|463311449|FG001|Overall Study|Lost to Follow-up|1|||
128731142|NCT04487080|463311450|FG002|Overall Study|Lost to Follow-up|0|||
128731143|NCT04487080|463311448|FG000|Overall Study|Ongoing|313|||
128731144|NCT04487080|463311449|FG001|Overall Study|Ongoing|297|||
129195640|NCT03526146|465010856|FG000|Overall Study|Withdrawal by Subject|6|||
129195641|NCT03526146|465010856|FG000|Overall Study|class canceled due to COVID-19|4|||
128731145|NCT04487080|463311450|FG002|Overall Study|Ongoing|149|||
128731146|NCT05645432|463311451|FG000|Overall Study|Withdrawal by Subject|1|||
129195642|NCT01136408|465010859|FG000|Overall Study|Adverse Event|4|||
129195643|NCT01136408|465010860|FG001|Overall Study|Adverse Event|8|||
129195644|NCT01136408|465010861|FG002|Overall Study|Adverse Event|4|||
129195645|NCT01136408|465010859|FG000|Overall Study|Protocol Violation|1|||
129195646|NCT01136408|465010860|FG001|Overall Study|Protocol Violation|1|||
129195647|NCT01136408|465010861|FG002|Overall Study|Protocol Violation|1|||
129195648|NCT02828436|465010862|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
129195649|NCT02828436|465010863|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
129195650|NCT02828436|465010862|FG000|Period 1|Lost to Follow-up|0|||
129195651|NCT02828436|465010863|FG001|Period 1|Lost to Follow-up|1|||
129195652|NCT02828436|465010862|FG000|Period 2|Withdrawal by Subject|4|||
129195653|NCT02828436|465010863|FG001|Period 2|Withdrawal by Subject|0|||
129195654|NCT02828436|465010862|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
129195655|NCT02828436|465010863|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
129195656|NCT02828436|465010862|FG000|Period 2|Lost to Follow-up|1|||
129195657|NCT02828436|465010863|FG001|Period 2|Lost to Follow-up|0|||
129195658|NCT04421482|465010866|FG000|Overall Study|Physician Decision|1|||
129195659|NCT03010319|465010869|FG000|Overall Study|Adverse Event|15|||
129195660|NCT03010319|465010870|FG001|Overall Study|Adverse Event|9|||
129195661|NCT03010319|465010869|FG000|Overall Study|Withdrawal by Subject|1|||
129195662|NCT03010319|465010870|FG001|Overall Study|Withdrawal by Subject|6|||
129195663|NCT03010319|465010869|FG000|Overall Study|Physician Decision|2|||
129195664|NCT03010319|465010870|FG001|Overall Study|Physician Decision|4|||
129195665|NCT03010319|465010869|FG000|Overall Study|Sponsor requested withdrawal|2|||
129195666|NCT03010319|465010870|FG001|Overall Study|Sponsor requested withdrawal|2|||
129195667|NCT03010319|465010869|FG000|Overall Study|Death|1|||
129195668|NCT03010319|465010870|FG001|Overall Study|Death|0|||
129195669|NCT03010319|465010869|FG000|Overall Study|Lost to Follow-up|0|||
129195670|NCT03010319|465010870|FG001|Overall Study|Lost to Follow-up|1|||
129195671|NCT03010319|465010869|FG000|Overall Study|Other Reason|5|||
129195672|NCT03010319|465010870|FG001|Overall Study|Other Reason|7|||
129195673|NCT02128724|465010871|FG000|Overall Study|Death|1|||
129195674|NCT02128724|465010872|FG001|Overall Study|Death|0|||
129195675|NCT02128724|465010873|FG002|Overall Study|Death|0|||
129195676|NCT02128724|465010874|FG003|Overall Study|Death|0|||
129195677|NCT02128724|465010871|FG000|Overall Study|Adverse Event|0|||
129195678|NCT02128724|465010872|FG001|Overall Study|Adverse Event|1|||
129195679|NCT02128724|465010873|FG002|Overall Study|Adverse Event|0|||
129195680|NCT02128724|465010874|FG003|Overall Study|Adverse Event|0|||
129195681|NCT02128724|465010871|FG000|Overall Study|Physician Decision|0|||
129195682|NCT02128724|465010872|FG001|Overall Study|Physician Decision|0|||
129195683|NCT02128724|465010873|FG002|Overall Study|Physician Decision|0|||
129195684|NCT02128724|465010874|FG003|Overall Study|Physician Decision|2|||
129195685|NCT02128724|465010871|FG000|Overall Study|Withdrawal by Subject|0|||
129195686|NCT02128724|465010872|FG001|Overall Study|Withdrawal by Subject|0|||
129195687|NCT02128724|465010873|FG002|Overall Study|Withdrawal by Subject|0|||
128781049|NCT00079937|463490411|FG001|Overall Study|Administrative problems|11|||
129195688|NCT02128724|465010874|FG003|Overall Study|Withdrawal by Subject|1|||
129195689|NCT03329092|465010875|FG000|Overall Study|Other|2|||
129195690|NCT03329092|465010876|FG001|Overall Study|Other|2|||
129195691|NCT03329092|465010875|FG000|Overall Study|Withdrawal by Subject|16|||
129195692|NCT03329092|465010876|FG001|Overall Study|Withdrawal by Subject|3|||
129195693|NCT03329092|465010875|FG000|Overall Study|Physician Decision|1|||
129195694|NCT03329092|465010876|FG001|Overall Study|Physician Decision|0|||
129195695|NCT03329092|465010875|FG000|Overall Study|Death|17|||
129195696|NCT03329092|465010876|FG001|Overall Study|Death|11|||
129195697|NCT03329092|465010875|FG000|Overall Study|Adverse Event|3|||
129195698|NCT03329092|465010876|FG001|Overall Study|Adverse Event|1|||
129195699|NCT03329092|465010875|FG000|Overall Study|Lost to Follow-up|1|||
129195700|NCT03329092|465010876|FG001|Overall Study|Lost to Follow-up|1|||
129195701|NCT05786508|465010877|FG000|Overall Study|Withdrawal by Subject|2|||
129195702|NCT05786508|465010878|FG001|Overall Study|Withdrawal by Subject|0|||
128731147|NCT03195478|463311452|FG000|Overall Study|Disease Progression|5|||
128731148|NCT03195478|463311453|FG001|Overall Study|Disease Progression|4|||
129195703|NCT04426318|465010879|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
129204886|NCT06039579|465046968|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129204887|NCT06039579|465046969|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129204888|NCT06039579|465046970|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129204889|NCT06039579|465046971|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129204890|NCT06039579|465046972|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
128731149|NCT03195478|463311454|FG002|Overall Study|Disease Progression|6|||
128731150|NCT03195478|463311455|FG003|Overall Study|Disease Progression|1|||
128731151|NCT03195478|463311452|FG000|Overall Study|Study Drug Toxicity|2|||
128731152|NCT03195478|463311453|FG001|Overall Study|Study Drug Toxicity|0|||
128731153|NCT03195478|463311454|FG002|Overall Study|Study Drug Toxicity|0|||
128731154|NCT03195478|463311455|FG003|Overall Study|Study Drug Toxicity|1|||
128731155|NCT03195478|463311452|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
128731156|NCT03195478|463311453|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
128731157|NCT03195478|463311454|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
128731158|NCT03195478|463311455|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
128731159|NCT03195478|463311452|FG000|Overall Study|Participant Withdrew Consent|1|||
128731160|NCT03195478|463311453|FG001|Overall Study|Participant Withdrew Consent|0|||
128731161|NCT03195478|463311454|FG002|Overall Study|Participant Withdrew Consent|0|||
128731162|NCT03195478|463311455|FG003|Overall Study|Participant Withdrew Consent|0|||
128731163|NCT03195478|463311452|FG000|Overall Study|Maximum Clinical benefit|0|||
128731164|NCT03195478|463311453|FG001|Overall Study|Maximum Clinical benefit|0|||
128731165|NCT03195478|463311454|FG002|Overall Study|Maximum Clinical benefit|1|||
128731166|NCT03195478|463311455|FG003|Overall Study|Maximum Clinical benefit|0|||
128731167|NCT03195478|463311452|FG000|Overall Study|Other Reasons|0|||
128731168|NCT03195478|463311453|FG001|Overall Study|Other Reasons|0|||
128731169|NCT03195478|463311454|FG002|Overall Study|Other Reasons|1|||
128731170|NCT03195478|463311455|FG003|Overall Study|Other Reasons|0|||
128731171|NCT03890367|463311456|FG000|Overall Study|Withdrawal by parent/guardian|1|||
128731172|NCT03890367|463311457|FG001|Overall Study|Withdrawal by parent/guardian|3|||
128731173|NCT03890367|463311458|FG002|Overall Study|Withdrawal by parent/guardian|0|||
128731174|NCT03890367|463311456|FG000|Overall Study|Protocol deviation|2|||
128731175|NCT03890367|463311457|FG001|Overall Study|Protocol deviation|2|||
128731176|NCT03890367|463311458|FG002|Overall Study|Protocol deviation|1|||
128731177|NCT03890367|463311456|FG000|Overall Study|Lost to Follow-up|1|||
128731178|NCT03890367|463311457|FG001|Overall Study|Lost to Follow-up|1|||
128731179|NCT03890367|463311458|FG002|Overall Study|Lost to Follow-up|0|||
128731180|NCT03370341|463312722|FG000|Overall Study|Lost to Follow-up|0|||
128731181|NCT03370341|463312723|FG001|Overall Study|Lost to Follow-up|1|||
128731182|NCT01707004|463312726|FG000|Overall Study|Physician Decision|3|||
128731183|NCT00533949|463312727|FG000|Overall Study|Protocol Violation|12|||
128731184|NCT00533949|463312728|FG001|Overall Study|Protocol Violation|12|||
128731185|NCT00533949|463312729|FG002|Overall Study|Protocol Violation|9|||
128731186|NCT00533949|463312730|FG003|Overall Study|Protocol Violation|9|||
128731187|NCT00533949|463312727|FG000|Overall Study|Withdrawal by Subject|3|||
128731188|NCT00533949|463312728|FG001|Overall Study|Withdrawal by Subject|2|||
128731189|NCT00533949|463312729|FG002|Overall Study|Withdrawal by Subject|1|||
128731190|NCT00533949|463312730|FG003|Overall Study|Withdrawal by Subject|1|||
128781050|NCT01616563|463490412|FG000|Overall Study|Lost to Follow-up|40|||
129195704|NCT04426318|465010880|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
129195705|NCT03574779|465010881|FG000|Overall Study|Screening failure|13|||
129195706|NCT03574779|465010882|FG001|Overall Study|Screening failure|83|||
129195707|NCT02588261|465010883|FG000|Overall Study|Study Terminated by Sponsor|157|||
129195708|NCT02588261|465010884|FG001|Overall Study|Study Terminated by Sponsor|142|||
129195709|NCT02588261|465010883|FG000|Overall Study|Protocol Deviation|1|||
129195710|NCT02588261|465010884|FG001|Overall Study|Protocol Deviation|0|||
129195711|NCT02588261|465010883|FG000|Overall Study|Death|1|||
129195712|NCT02588261|465010884|FG001|Overall Study|Death|2|||
129195713|NCT02588261|465010883|FG000|Overall Study|Withdrawal by Subject|12|||
129195714|NCT02588261|465010884|FG001|Overall Study|Withdrawal by Subject|8|||
129195715|NCT02588261|465010883|FG000|Overall Study|Noncompliance with Study Drug|0|||
129195716|NCT02588261|465010884|FG001|Overall Study|Noncompliance with Study Drug|1|||
129195717|NCT02588261|465010883|FG000|Overall Study|Miscellaneous|5|||
129195718|NCT02588261|465010884|FG001|Overall Study|Miscellaneous|4|||
128731191|NCT00727194|463312731|FG000|Screening Period|Low QMG scores|0|||
128731192|NCT00727194|463312732|FG001|Screening Period|Low QMG scores|0|||
128731193|NCT00727194|463312733|FG002|Screening Period|Low QMG scores|6|||
128731194|NCT00727194|463312731|FG000|Screening Period|Lacked AChR antibodies|0|||
128731195|NCT00727194|463312732|FG001|Screening Period|Lacked AChR antibodies|0|||
128731196|NCT00727194|463312733|FG002|Screening Period|Lacked AChR antibodies|5|||
128731197|NCT00727194|463312731|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
128731198|NCT00727194|463312732|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
128731199|NCT00727194|463312733|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
128731200|NCT00727194|463312731|FG000|Screening Period|Severe infections|0|||
128731201|NCT00727194|463312732|FG001|Screening Period|Severe infections|0|||
128731202|NCT00727194|463312733|FG002|Screening Period|Severe infections|2|||
128731203|NCT00727194|463312731|FG000|Screening Period|History of thymoma|0|||
128731204|NCT00727194|463312732|FG001|Screening Period|History of thymoma|0|||
128731205|NCT00727194|463312733|FG002|Screening Period|History of thymoma|1|||
128731206|NCT00727194|463312731|FG000|Treatment Period 2|Lack of Efficacy|0|||
129195719|NCT02588261|465010883|FG000|Overall Study|Progressive Disease|61|||
128731207|NCT00727194|463312732|FG001|Treatment Period 2|Lack of Efficacy|1|||
128731208|NCT00727194|463312733|FG002|Treatment Period 2|Lack of Efficacy|0|||
128731209|NCT04269161|463312739|FG000|Overall Study|Change of modality and no longer eligible|3|||
128731210|NCT04269161|463312740|FG001|Overall Study|Change of modality and no longer eligible|3|||
128731211|NCT04269161|463312739|FG000|Overall Study|Required procedure outside of NICU|1|||
128731212|NCT04269161|463312740|FG001|Overall Study|Required procedure outside of NICU|0|||
128731213|NCT04269161|463312739|FG000|Overall Study|Equipment issue|1|||
128731214|NCT04269161|463312740|FG001|Overall Study|Equipment issue|1|||
128731215|NCT01677195|463312741|FG000|Overall Study|Lost to Follow-up|14|||
128731216|NCT01677195|463312742|FG001|Overall Study|Lost to Follow-up|22|||
128731217|NCT01677195|463312743|FG002|Overall Study|Lost to Follow-up|22|||
128731218|NCT01677195|463312741|FG000|Overall Study|Withdrawal by Subject|1|||
128731219|NCT01677195|463312742|FG001|Overall Study|Withdrawal by Subject|0|||
128731220|NCT01677195|463312743|FG002|Overall Study|Withdrawal by Subject|1|||
128731221|NCT01677195|463312741|FG000|Overall Study|Adverse Event|6|||
128731222|NCT01677195|463312742|FG001|Overall Study|Adverse Event|4|||
128731223|NCT01677195|463312743|FG002|Overall Study|Adverse Event|1|||
128731224|NCT01677195|463312741|FG000|Overall Study|Physician Decision|1|||
128731225|NCT01677195|463312742|FG001|Overall Study|Physician Decision|2|||
128731226|NCT01677195|463312743|FG002|Overall Study|Physician Decision|2|||
128731227|NCT01677195|463312741|FG000|Overall Study|Pregnancy|0|||
128731228|NCT01677195|463312742|FG001|Overall Study|Pregnancy|1|||
128731229|NCT01677195|463312743|FG002|Overall Study|Pregnancy|0|||
128731230|NCT01677195|463312741|FG000|Overall Study|Protocol Violation|7|||
128731231|NCT01677195|463312742|FG001|Overall Study|Protocol Violation|3|||
128731232|NCT01677195|463312743|FG002|Overall Study|Protocol Violation|4|||
128731233|NCT04368429|463312744|FG000|Overall Study|Adverse Event|1|||
128731234|NCT04368429|463312745|FG001|Overall Study|Adverse Event|0|||
128731235|NCT02472756|463312747|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
128731236|NCT02472756|463312747|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
128731237|NCT02472756|463312747|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
128731238|NCT02472756|463312747|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
128731239|NCT02472756|463312747|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
128731240|NCT02143414|463312748|FG000|Induction|Adverse Event|1|||
128731241|NCT02143414|463312749|FG001|Induction|Adverse Event|2|||
128731242|NCT02143414|463312748|FG000|Induction|Death|1|||
128731243|NCT02143414|463312749|FG001|Induction|Death|2|||
128731244|NCT02143414|463312748|FG000|Induction|Patient refusal|1|||
128731245|NCT02143414|463312749|FG001|Induction|Patient refusal|1|||
128731246|NCT02143414|463312748|FG000|Induction|Refractory|1|||
128731247|NCT02143414|463312749|FG001|Induction|Refractory|0|||
128731248|NCT02143414|463312748|FG000|Induction|Began alternative treatment|1|||
128731249|NCT02143414|463312749|FG001|Induction|Began alternative treatment|0|||
128731250|NCT02143414|463312748|FG000|Induction|Ineligible for postremission|5|||
128731251|NCT02143414|463312749|FG001|Induction|Ineligible for postremission|1|||
128731252|NCT02143414|463312748|FG000|Post-remission|Adverse Event|0|||
128731253|NCT02143414|463312749|FG001|Post-remission|Adverse Event|2|||
128731254|NCT02143414|463312748|FG000|Post-remission|Disease progression/relapse|5|||
128731255|NCT02143414|463312749|FG001|Post-remission|Disease progression/relapse|0|||
128731256|NCT02143414|463312748|FG000|Maintenance|Adverse Event|4|||
128731257|NCT02143414|463312749|FG001|Maintenance|Adverse Event|6|||
128731258|NCT02143414|463312748|FG000|Maintenance|Disease progression/relapse|3|||
128731259|NCT02143414|463312749|FG001|Maintenance|Disease progression/relapse|2|||
128731260|NCT02143414|463312748|FG000|Maintenance|Patient refusal|2|||
128731261|NCT02143414|463312749|FG001|Maintenance|Patient refusal|1|||
128731262|NCT02143414|463312748|FG000|Maintenance|Physician Decision|1|||
128731263|NCT02143414|463312749|FG001|Maintenance|Physician Decision|0|||
128731264|NCT02143414|463312748|FG000|Maintenance|Death|0|||
128731265|NCT02143414|463312749|FG001|Maintenance|Death|1|||
129195720|NCT02588261|465010884|FG001|Overall Study|Progressive Disease|82|||
129195721|NCT02588261|465010883|FG000|Overall Study|Adverse Event|29|||
129195722|NCT02588261|465010884|FG001|Overall Study|Adverse Event|24|||
129195723|NCT02588261|465010883|FG000|Overall Study|Lost to Follow-up|1|||
129195724|NCT02588261|465010884|FG001|Overall Study|Lost to Follow-up|0|||
129195725|NCT02287467|465010886|FG000|Overall Study|Protocol Violation|12|||
129195726|NCT02287467|465010887|FG001|Overall Study|Protocol Violation|9|||
129195727|NCT03781778|465010888|FG000|Overall Study|Withdrawal by Subject|2|||
129195728|NCT03781778|465010889|FG001|Overall Study|Withdrawal by Subject|2|||
129195729|NCT01456169|465010890|FG000|Overall Study|Adverse Event|1|||
129195730|NCT01456169|465010891|FG001|Overall Study|Adverse Event|2|||
129195731|NCT01456169|465010892|FG002|Overall Study|Adverse Event|7|||
129195732|NCT01456169|465010890|FG000|Overall Study|Major Protocol Deviation|3|||
129195733|NCT01456169|465010891|FG001|Overall Study|Major Protocol Deviation|2|||
129195734|NCT01456169|465010892|FG002|Overall Study|Major Protocol Deviation|3|||
129195735|NCT01456169|465010890|FG000|Overall Study|Voluntary Withdrawal|3|||
129195736|NCT01456169|465010891|FG001|Overall Study|Voluntary Withdrawal|0|||
129195737|NCT01456169|465010892|FG002|Overall Study|Voluntary Withdrawal|2|||
129195738|NCT01456169|465010890|FG000|Overall Study|Lack of Efficacy|2|||
129195739|NCT01456169|465010891|FG001|Overall Study|Lack of Efficacy|0|||
129195740|NCT01456169|465010892|FG002|Overall Study|Lack of Efficacy|0|||
129195741|NCT01456169|465010890|FG000|Overall Study|Other|1|||
129195742|NCT01456169|465010891|FG001|Overall Study|Other|1|||
129195743|NCT01456169|465010892|FG002|Overall Study|Other|0|||
129195744|NCT02652156|465010894|FG000|Overall Study|Physician Decision|1|||
129195745|NCT02652156|465010895|FG001|Overall Study|Physician Decision|0|||
129195746|NCT02652156|465010896|FG002|Overall Study|Physician Decision|0|||
129195747|NCT02342223|465010897|FG000|Overall Study|Lost to Follow-up|1|||
129195748|NCT01200368|465010902|FG000|Infant Series|Adverse Event|2|||
129195749|NCT01200368|465010903|FG001|Infant Series|Adverse Event|2|||
129195750|NCT01200368|465010904|FG002|Infant Series|Adverse Event|3|||
129195751|NCT01200368|465010902|FG000|Infant Series|Withdrawal by Subject|0|||
129195752|NCT01200368|465010903|FG001|Infant Series|Withdrawal by Subject|2|||
129195753|NCT01200368|465010904|FG002|Infant Series|Withdrawal by Subject|2|||
129195754|NCT01200368|465010902|FG000|Infant Series|Did not meet entrance criteria|0|||
129195755|NCT01200368|465010903|FG001|Infant Series|Did not meet entrance criteria|1|||
129195756|NCT01200368|465010904|FG002|Infant Series|Did not meet entrance criteria|0|||
129195757|NCT01200368|465010902|FG000|Infant Series|Randomized, not vaccinated|0|||
129195758|NCT01200368|465010903|FG001|Infant Series|Randomized, not vaccinated|1|||
129195759|NCT01200368|465010904|FG002|Infant Series|Randomized, not vaccinated|1|||
129195760|NCT01200368|465010902|FG000|Infant Series|Other|1|||
129195761|NCT01200368|465010903|FG001|Infant Series|Other|0|||
129195762|NCT01200368|465010904|FG002|Infant Series|Other|0|||
129195763|NCT01200368|465010902|FG000|After Infant Series|Adverse Event|6|||
129195764|NCT01200368|465010903|FG001|After Infant Series|Adverse Event|6|||
129195765|NCT01200368|465010904|FG002|After Infant Series|Adverse Event|3|||
129195766|NCT01200368|465010902|FG000|After Infant Series|Withdrawal by Subject|10|||
129195767|NCT01200368|465010903|FG001|After Infant Series|Withdrawal by Subject|8|||
129195768|NCT01200368|465010904|FG002|After Infant Series|Withdrawal by Subject|4|||
129195769|NCT01200368|465010902|FG000|After Infant Series|Lost to Follow-up|1|||
129195770|NCT01200368|465010903|FG001|After Infant Series|Lost to Follow-up|0|||
129195771|NCT01200368|465010904|FG002|After Infant Series|Lost to Follow-up|0|||
129195772|NCT01200368|465010902|FG000|After Infant Series|Other|1|||
129195773|NCT01200368|465010903|FG001|After Infant Series|Other|2|||
129195774|NCT01200368|465010904|FG002|After Infant Series|Other|2|||
129195775|NCT01200368|465010902|FG000|Toddler Dose|Adverse Event|0|||
129195776|NCT01200368|465010903|FG001|Toddler Dose|Adverse Event|3|||
129195777|NCT01200368|465010904|FG002|Toddler Dose|Adverse Event|1|||
129195778|NCT00108862|465010905|FG000|Overall Study|Death|31|||
129195779|NCT00108862|465010906|FG001|Overall Study|Death|37|||
129195780|NCT00108862|465010905|FG000|Overall Study|Withdrawal by Subject|10|||
129195781|NCT00108862|465010906|FG001|Overall Study|Withdrawal by Subject|6|||
129195782|NCT00108862|465010905|FG000|Overall Study|Lost to Follow-up|27|||
129195783|NCT00108862|465010906|FG001|Overall Study|Lost to Follow-up|19|||
129195784|NCT03534141|465010907|FG000|Overall Study|Enrolled in other clinical trial|1|||
129195785|NCT03534141|465010908|FG001|Overall Study|Enrolled in other clinical trial|0|||
129195786|NCT03534141|465010907|FG000|Overall Study|Liver transplant aborted after randomization|0|||
129195787|NCT03534141|465010908|FG001|Overall Study|Liver transplant aborted after randomization|2|||
129195788|NCT03534141|465010907|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
129195789|NCT03534141|465010908|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
129195790|NCT00566852|465010911|FG000|Overall Study|Protocol Violation|22|||
129195791|NCT00566852|465010912|FG001|Overall Study|Protocol Violation|24|||
129195792|NCT00566852|465010911|FG000|Overall Study|Death|95|||
129195793|NCT00566852|465010912|FG001|Overall Study|Death|78|||
129195794|NCT00566852|465010911|FG000|Overall Study|Withdrawal by Subject|30|||
129195795|NCT00566852|465010912|FG001|Overall Study|Withdrawal by Subject|25|||
129195796|NCT00566852|465010911|FG000|Overall Study|Patient refusal|37|||
129195797|NCT00566852|465010912|FG001|Overall Study|Patient refusal|37|||
128731266|NCT02143414|463312748|FG000|Maintenance|On protocol treatment|0|||
128731267|NCT02143414|463312749|FG001|Maintenance|On protocol treatment|6|||
128731268|NCT00110266|463312754|FG000|Overall Study|Adverse Event|27|||
128731269|NCT00110266|463312754|FG000|Overall Study|Abnormal laboratory value|15|||
128731270|NCT00110266|463312754|FG000|Overall Study|Withdrawal by Subject|16|||
128731271|NCT00110266|463312754|FG000|Overall Study|Death|17|||
128731272|NCT00110266|463312754|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128731273|NCT00110266|463312754|FG000|Overall Study|Participant condition no longer requires study drug|1|||
128731274|NCT02896400|463312755|FG000|1 Month Follow-up|Lost to Follow-up|7|||
128731275|NCT02896400|463312756|FG001|1 Month Follow-up|Lost to Follow-up|7|||
128731276|NCT02896400|463312757|FG002|1 Month Follow-up|Lost to Follow-up|5|||
128731277|NCT02896400|463312758|FG003|1 Month Follow-up|Lost to Follow-up|8|||
128731278|NCT02896400|463312759|FG004|1 Month Follow-up|Lost to Follow-up|9|||
128731279|NCT02896400|463312760|FG005|1 Month Follow-up|Lost to Follow-up|6|||
128731280|NCT02896400|463312761|FG006|1 Month Follow-up|Lost to Follow-up|5|||
128731281|NCT02896400|463312762|FG007|1 Month Follow-up|Lost to Follow-up|6|||
128731282|NCT02896400|463312763|FG008|1 Month Follow-up|Lost to Follow-up|4|||
128731283|NCT02896400|463312764|FG009|1 Month Follow-up|Lost to Follow-up|7|||
128781051|NCT02206685|463490413|FG000|Overall Study|Surgery cancelled/changed|2|||
128781052|NCT02206685|463490414|FG001|Overall Study|Surgery cancelled/changed|3|||
128781053|NCT02206685|463490413|FG000|Overall Study|Withdrawal by Subject|1|||
128781054|NCT02206685|463490414|FG001|Overall Study|Withdrawal by Subject|2|||
128781055|NCT02206685|463490413|FG000|Overall Study|Protocol Violation|2|||
128781056|NCT02206685|463490414|FG001|Overall Study|Protocol Violation|2|||
128781057|NCT01195675|463490415|FG000|Overall Study|Adverse Event|1|||
128781058|NCT01195675|463490415|FG000|Overall Study|Withdrawal by Subject|2|||
128781059|NCT04454567|463490423|FG000|Overall Study|Study Terminated by Sponsor|1|||
128781060|NCT04454567|463490424|FG001|Overall Study|Study Terminated by Sponsor|1|||
128781061|NCT01175707|463490429|FG000|Overall Study|Adverse Event|4|||
128781062|NCT01175707|463490430|FG001|Overall Study|Adverse Event|6|||
128781063|NCT04531540|463490436|FG000|Overall Study|Adverse Event|1|||
128781064|NCT04531540|463490436|FG000|Overall Study|Protocol Violation|3|||
128781065|NCT04531540|463490436|FG000|Overall Study|Withdrawal by Subject|4|||
128781066|NCT04531540|463490436|FG000|Overall Study|Found to be Ineligible|1|||
128781067|NCT02688621|463490437|FG000|Overall Study|Pregnancy|1|||
128781068|NCT02688621|463490438|FG001|Overall Study|Pregnancy|3|||
128781069|NCT02688621|463490437|FG000|Overall Study|Lost to Follow-up|38|||
128781070|NCT02688621|463490438|FG001|Overall Study|Lost to Follow-up|15|||
128781071|NCT02688621|463490437|FG000|Overall Study|Withdrawal by Subject|1|||
128781072|NCT02688621|463490438|FG001|Overall Study|Withdrawal by Subject|0|||
128781073|NCT03239210|463490439|FG000|Overall Study|Lost to Follow-up|2|||
128781074|NCT03239210|463490440|FG001|Overall Study|Lost to Follow-up|2|||
128781075|NCT03239210|463490439|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
128781076|NCT03239210|463490440|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
128781077|NCT03239210|463490439|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
128781078|NCT03239210|463490440|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
128781079|NCT01575860|463490441|FG000|Overall Study|Withdrawal by Subject|1|||
128781080|NCT01575860|463490441|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
129195798|NCT00566852|465010911|FG000|Overall Study|Not tested due to disability|6|||
129195799|NCT00566852|465010912|FG001|Overall Study|Not tested due to disability|12|||
129195800|NCT00566852|465010911|FG000|Overall Study|Missing reason not specified|1|||
129195801|NCT00566852|465010912|FG001|Overall Study|Missing reason not specified|2|||
129195802|NCT00566852|465010911|FG000|Overall Study|Missing reason not reported|16|||
129195803|NCT00566852|465010912|FG001|Overall Study|Missing reason not reported|20|||
129195804|NCT04079816|465010913|FG000|Overall Study|Request of Subject|2|||
129195805|NCT04079816|465010913|FG000|Overall Study|Unable to draw samples|1|||
129195806|NCT04137731|465010914|FG000|Overall Study|Surgery Cancellation|1|||
129195807|NCT04137731|465010915|FG001|Overall Study|Surgery Cancellation|2|||
129195808|NCT04137731|465010914|FG000|Overall Study|Withdrawal by Subject|2|||
129195809|NCT04137731|465010915|FG001|Overall Study|Withdrawal by Subject|0|||
129195810|NCT04137731|465010914|FG000|Overall Study|Protocol Violation|0|||
129195811|NCT04137731|465010915|FG001|Overall Study|Protocol Violation|1|||
129195812|NCT00310817|465010916|FG000|Overall Study|AE or Death|3|||
129195813|NCT00310817|465010917|FG001|Overall Study|AE or Death|1|||
129195814|NCT00310817|465010918|FG002|Overall Study|AE or Death|0|||
129195815|NCT00310817|465010919|FG003|Overall Study|AE or Death|0|||
129195816|NCT00310817|465010916|FG000|Overall Study|Withdrawal by Subject|1|||
129195817|NCT00310817|465010917|FG001|Overall Study|Withdrawal by Subject|4|||
129195818|NCT00310817|465010918|FG002|Overall Study|Withdrawal by Subject|6|||
129195819|NCT00310817|465010919|FG003|Overall Study|Withdrawal by Subject|7|||
129195820|NCT00310817|465010916|FG000|Overall Study|Lost to Follow-up|2|||
129195821|NCT00310817|465010917|FG001|Overall Study|Lost to Follow-up|1|||
129195822|NCT00310817|465010918|FG002|Overall Study|Lost to Follow-up|0|||
128781081|NCT01094743|463490443|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
128781082|NCT02851511|463490444|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
129195823|NCT00310817|465010919|FG003|Overall Study|Lost to Follow-up|0|||
128781083|NCT02851511|463490445|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
128781084|NCT02851511|463490446|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
128781085|NCT02851511|463490447|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
129195824|NCT00310817|465010916|FG000|Overall Study|Inappropriate Enrollment|1|||
129195825|NCT00310817|465010917|FG001|Overall Study|Inappropriate Enrollment|0|||
129195826|NCT00310817|465010918|FG002|Overall Study|Inappropriate Enrollment|1|||
129195827|NCT00310817|465010919|FG003|Overall Study|Inappropriate Enrollment|0|||
128731284|NCT02896400|463312765|FG010|1 Month Follow-up|Lost to Follow-up|5|||
128731285|NCT02896400|463312766|FG011|1 Month Follow-up|Lost to Follow-up|5|||
128731286|NCT02896400|463312767|FG012|1 Month Follow-up|Lost to Follow-up|3|||
128731287|NCT02896400|463312768|FG013|1 Month Follow-up|Lost to Follow-up|4|||
128731288|NCT02896400|463312769|FG014|1 Month Follow-up|Lost to Follow-up|1|||
128731289|NCT02896400|463312770|FG015|1 Month Follow-up|Lost to Follow-up|2|||
128731290|NCT02896400|463312755|FG000|1 Month Follow-up|Death|0|||
128731291|NCT02896400|463312756|FG001|1 Month Follow-up|Death|0|||
128731292|NCT02896400|463312757|FG002|1 Month Follow-up|Death|0|||
128731293|NCT02896400|463312758|FG003|1 Month Follow-up|Death|0|||
128731294|NCT02896400|463312759|FG004|1 Month Follow-up|Death|0|||
128731295|NCT02896400|463312760|FG005|1 Month Follow-up|Death|0|||
128731296|NCT02896400|463312761|FG006|1 Month Follow-up|Death|0|||
128731297|NCT02896400|463312762|FG007|1 Month Follow-up|Death|0|||
128731298|NCT02896400|463312763|FG008|1 Month Follow-up|Death|0|||
128731299|NCT02896400|463312764|FG009|1 Month Follow-up|Death|0|||
128731300|NCT02896400|463312765|FG010|1 Month Follow-up|Death|0|||
128731301|NCT02896400|463312766|FG011|1 Month Follow-up|Death|0|||
128731302|NCT02896400|463312767|FG012|1 Month Follow-up|Death|0|||
128731303|NCT02896400|463312768|FG013|1 Month Follow-up|Death|0|||
128731304|NCT02896400|463312769|FG014|1 Month Follow-up|Death|0|||
129195828|NCT00310817|465010916|FG000|Overall Study|Protocol Violation|1|||
129195829|NCT00310817|465010917|FG001|Overall Study|Protocol Violation|1|||
129195830|NCT00310817|465010918|FG002|Overall Study|Protocol Violation|1|||
129195831|NCT00310817|465010919|FG003|Overall Study|Protocol Violation|1|||
129195832|NCT00310817|465010916|FG000|Overall Study|Unable to classify|3|||
129195833|NCT00310817|465010917|FG001|Overall Study|Unable to classify|1|||
129195834|NCT00310817|465010918|FG002|Overall Study|Unable to classify|0|||
129195835|NCT00310817|465010919|FG003|Overall Study|Unable to classify|0|||
129195836|NCT01702246|465010920|FG000|Overall Study|Lost to Follow-up|2|||
129195837|NCT01702246|465010920|FG000|Overall Study|Withdrawal by Subject|2|||
129195838|NCT01702246|465010920|FG000|Overall Study|Physician Decision|1|||
129195839|NCT01587040|465010921|FG000|Overall Study|Protocol Violation|0|||
129195840|NCT01587040|465010922|FG001|Overall Study|Protocol Violation|0|||
129195841|NCT01587040|465010923|FG002|Overall Study|Protocol Violation|1|||
129195842|NCT01587040|465010924|FG003|Overall Study|Protocol Violation|0|||
129195843|NCT01587040|465010921|FG000|Overall Study|Adverse Event|0|||
129195844|NCT01587040|465010922|FG001|Overall Study|Adverse Event|1|||
129195845|NCT01587040|465010923|FG002|Overall Study|Adverse Event|10|||
129195846|NCT01587040|465010924|FG003|Overall Study|Adverse Event|0|||
129195847|NCT01587040|465010921|FG000|Overall Study|Disease progression|12|||
129195848|NCT01587040|465010922|FG001|Overall Study|Disease progression|1|||
129195849|NCT01587040|465010923|FG002|Overall Study|Disease progression|15|||
129195850|NCT01587040|465010924|FG003|Overall Study|Disease progression|3|||
129195851|NCT01587040|465010921|FG000|Overall Study|Other than specified|5|||
129195852|NCT01587040|465010922|FG001|Overall Study|Other than specified|1|||
129195853|NCT01587040|465010923|FG002|Overall Study|Other than specified|11|||
129195854|NCT01587040|465010924|FG003|Overall Study|Other than specified|1|||
129195855|NCT04607837|465010929|FG000|Overall Study|Adverse Event|8|||
129195856|NCT04607837|465010930|FG001|Overall Study|Adverse Event|2|||
129195857|NCT04607837|465010929|FG000|Overall Study|Withdrawal by Subject|8|||
129195858|NCT04607837|465010930|FG001|Overall Study|Withdrawal by Subject|7|||
129195859|NCT04607837|465010929|FG000|Overall Study|Physician Decision|2|||
129195860|NCT04607837|465010930|FG001|Overall Study|Physician Decision|0|||
129195861|NCT04607837|465010929|FG000|Overall Study|Lack of Efficacy|2|||
129195862|NCT04607837|465010930|FG001|Overall Study|Lack of Efficacy|0|||
129195863|NCT04607837|465010929|FG000|Overall Study|Participant terminated by sponsor|1|||
129195864|NCT04607837|465010930|FG001|Overall Study|Participant terminated by sponsor|0|||
129195865|NCT04607837|465010929|FG000|Overall Study|Disease worsening|36|||
129195866|NCT04607837|465010930|FG001|Overall Study|Disease worsening|36|||
129195867|NCT04607837|465010929|FG000|Overall Study|Other|1|||
129195868|NCT04607837|465010930|FG001|Overall Study|Other|0|||
129195869|NCT04346654|465010932|FG000|Overall Study|Adverse Event|2|||
129195870|NCT04346654|465010933|FG001|Overall Study|Adverse Event|0|||
129195871|NCT04346654|465010932|FG000|Overall Study|Non-response|1|||
129195872|NCT04346654|465010933|FG001|Overall Study|Non-response|1|||
129195873|NCT04346654|465010932|FG000|Overall Study|Withdrawal by Subject|2|||
129195874|NCT04346654|465010933|FG001|Overall Study|Withdrawal by Subject|0|||
129195875|NCT04346654|465010932|FG000|Overall Study|Lost to Follow-up|0|||
129195876|NCT04346654|465010933|FG001|Overall Study|Lost to Follow-up|1|||
129195877|NCT04346654|465010932|FG000|Overall Study|Pregnancy|0|||
129195878|NCT04346654|465010933|FG001|Overall Study|Pregnancy|1|||
129195879|NCT03828019|465010937|FG000|Overall Study|Withdrawal by Subject|3|||
129195880|NCT03828019|465010938|FG001|Overall Study|Withdrawal by Subject|8|||
129195881|NCT03828019|465010937|FG000|Overall Study|Lost to Follow-up|1|||
129195882|NCT03828019|465010938|FG001|Overall Study|Lost to Follow-up|6|||
128731305|NCT02896400|463312770|FG015|1 Month Follow-up|Death|1|||
128731306|NCT02896400|463312755|FG000|3 Month Follow-up|Lost to Follow-up|6|||
128731307|NCT02896400|463312756|FG001|3 Month Follow-up|Lost to Follow-up|3|||
128731308|NCT02896400|463312757|FG002|3 Month Follow-up|Lost to Follow-up|6|||
128731309|NCT02896400|463312758|FG003|3 Month Follow-up|Lost to Follow-up|11|||
129195883|NCT03828019|465010937|FG000|Overall Study|Incarcerated|1|||
129195884|NCT03828019|465010938|FG001|Overall Study|Incarcerated|0|||
129195885|NCT03828019|465010937|FG000|Overall Study|Adverse Event|0|||
129195886|NCT03828019|465010938|FG001|Overall Study|Adverse Event|1|||
129195887|NCT05715242|465010939|FG000|Overall Study|Lost to Follow-up|0|||
129195888|NCT05715242|465010940|FG001|Overall Study|Lost to Follow-up|0|||
129195889|NCT05715242|465010941|FG002|Overall Study|Lost to Follow-up|1|||
129195890|NCT05715242|465010942|FG003|Overall Study|Lost to Follow-up|0|||
129195891|NCT05715242|465010943|FG004|Overall Study|Lost to Follow-up|0|||
129195892|NCT05715242|465010944|FG005|Overall Study|Lost to Follow-up|1|||
129195893|NCT05715242|465010945|FG006|Overall Study|Lost to Follow-up|0|||
129195894|NCT05715242|465010946|FG007|Overall Study|Lost to Follow-up|0|||
129195895|NCT05715242|465010947|FG008|Overall Study|Lost to Follow-up|0|||
129195896|NCT05715242|465010948|FG009|Overall Study|Lost to Follow-up|0|||
129195897|NCT05715242|465010949|FG010|Overall Study|Lost to Follow-up|0|||
129195898|NCT05715242|465010950|FG011|Overall Study|Lost to Follow-up|0|||
129195899|NCT05715242|465010951|FG012|Overall Study|Lost to Follow-up|0|||
129195900|NCT05715242|465010952|FG013|Overall Study|Lost to Follow-up|0|||
129195901|NCT05715242|465010953|FG014|Overall Study|Lost to Follow-up|0|||
129195902|NCT05715242|465010954|FG015|Overall Study|Lost to Follow-up|0|||
129195903|NCT02915978|465010955|FG000|Overall Study|Adverse Event|2|||
129195904|NCT02915978|465010956|FG001|Overall Study|Adverse Event|1|||
129195905|NCT02915978|465010957|FG002|Overall Study|Adverse Event|0|||
129195906|NCT02343406|465010963|FG000|Overall Study|Progressive disease|72|||
129195907|NCT02343406|465010964|FG001|Overall Study|Progressive disease|70|||
129195908|NCT02343406|465010965|FG002|Overall Study|Progressive disease|43|||
129195909|NCT02343406|465010966|FG003|Overall Study|Progressive disease|15|||
129195910|NCT02343406|465010967|FG004|Overall Study|Progressive disease|5|||
129195911|NCT02343406|465010963|FG000|Overall Study|Adverse Event|6|||
129195912|NCT02343406|465010964|FG001|Overall Study|Adverse Event|8|||
129195913|NCT02343406|465010965|FG002|Overall Study|Adverse Event|6|||
129195914|NCT02343406|465010966|FG003|Overall Study|Adverse Event|3|||
129195915|NCT02343406|465010967|FG004|Overall Study|Adverse Event|0|||
129195916|NCT02343406|465010963|FG000|Overall Study|Withdrawal by Subject|6|||
129195917|NCT02343406|465010964|FG001|Overall Study|Withdrawal by Subject|4|||
129195918|NCT02343406|465010965|FG002|Overall Study|Withdrawal by Subject|8|||
129195919|NCT02343406|465010966|FG003|Overall Study|Withdrawal by Subject|3|||
129195920|NCT02343406|465010967|FG004|Overall Study|Withdrawal by Subject|0|||
129195921|NCT02343406|465010963|FG000|Overall Study|Death|2|||
129195922|NCT02343406|465010964|FG001|Overall Study|Death|1|||
129195923|NCT02343406|465010965|FG002|Overall Study|Death|0|||
129195924|NCT02343406|465010966|FG003|Overall Study|Death|0|||
129195925|NCT02343406|465010967|FG004|Overall Study|Death|0|||
129195926|NCT02343406|465010963|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
129195927|NCT02343406|465010964|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
129195928|NCT02343406|465010965|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
129195929|NCT02343406|465010966|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
129195930|NCT02343406|465010967|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
129195931|NCT02343406|465010963|FG000|Overall Study|Other primary malignancy|0|||
129195932|NCT02343406|465010964|FG001|Overall Study|Other primary malignancy|1|||
129195933|NCT02343406|465010965|FG002|Overall Study|Other primary malignancy|0|||
129195934|NCT02343406|465010966|FG003|Overall Study|Other primary malignancy|0|||
129195935|NCT02343406|465010967|FG004|Overall Study|Other primary malignancy|0|||
129195936|NCT02343406|465010963|FG000|Overall Study|Other, not specified|2|||
129195937|NCT02343406|465010964|FG001|Overall Study|Other, not specified|1|||
129195938|NCT02343406|465010965|FG002|Overall Study|Other, not specified|1|||
129195939|NCT02343406|465010966|FG003|Overall Study|Other, not specified|4|||
129195940|NCT02343406|465010967|FG004|Overall Study|Other, not specified|0|||
129195941|NCT02451124|465010968|FG000|Overall Study|Withdrawal by Subject|1|||
129195942|NCT00958165|465010969|FG000|Overall Study|Lost to Follow-up|5|||
129195943|NCT00958165|465010969|FG000|Overall Study|Not eligible|9|||
129195944|NCT00166439|465010973|FG000|Overall Study|Ineligible|5|||
129195945|NCT00615992|465010974|FG000|Overall Study|Protocol Violation|67|||
129195946|NCT00856297|465010975|FG000|Overall Study|Unable to classify|2|||
129195947|NCT00856297|465010976|FG001|Overall Study|Unable to classify|0|||
129195948|NCT00856297|465010977|FG002|Overall Study|Unable to classify|0|||
129195949|NCT00856297|465010978|FG003|Overall Study|Unable to classify|0|||
129195950|NCT00856297|465010979|FG004|Overall Study|Unable to classify|0|||
129195951|NCT01392547|465012442|FG000|Overall Study|Adverse Event|2|||
129195952|NCT01392547|465012442|FG000|Overall Study|Non-compliance|2|||
129195953|NCT01392547|465012442|FG000|Overall Study|Withdrawal criteria|3|||
129195954|NCT01392547|465012442|FG000|Overall Study|Unclassified|1|||
129195955|NCT00615017|465012443|FG000|Overall Study|Adverse Event|0|||
129195956|NCT00615017|465012444|FG001|Overall Study|Adverse Event|1|||
129195957|NCT00615017|465012445|FG002|Overall Study|Adverse Event|2|||
129195958|NCT00615017|465012446|FG003|Overall Study|Adverse Event|0|||
129195959|NCT00615017|465012447|FG004|Overall Study|Adverse Event|0|||
129195960|NCT00615017|465012448|FG005|Overall Study|Adverse Event|1|||
129195961|NCT00615017|465012443|FG000|Overall Study|Death|0|||
129195962|NCT00615017|465012444|FG001|Overall Study|Death|0|||
129195963|NCT00615017|465012445|FG002|Overall Study|Death|2|||
129195964|NCT00615017|465012446|FG003|Overall Study|Death|0|||
129195965|NCT00615017|465012447|FG004|Overall Study|Death|1|||
129195966|NCT00615017|465012448|FG005|Overall Study|Death|1|||
129195967|NCT00615017|465012443|FG000|Overall Study|Sepsis resolved|0|||
129195968|NCT00615017|465012444|FG001|Overall Study|Sepsis resolved|0|||
129195969|NCT00615017|465012445|FG002|Overall Study|Sepsis resolved|1|||
129195970|NCT00615017|465012446|FG003|Overall Study|Sepsis resolved|0|||
129195971|NCT00615017|465012447|FG004|Overall Study|Sepsis resolved|0|||
129195972|NCT00615017|465012448|FG005|Overall Study|Sepsis resolved|0|||
129195973|NCT00615017|465012443|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
129195974|NCT00615017|465012444|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
129195975|NCT00615017|465012445|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
129195976|NCT00615017|465012446|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
129195977|NCT00615017|465012447|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
129195978|NCT00615017|465012448|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
129195979|NCT00615017|465012443|FG000|Overall Study|Physician discontinued drug|0|||
129195980|NCT00615017|465012444|FG001|Overall Study|Physician discontinued drug|0|||
129195981|NCT00615017|465012445|FG002|Overall Study|Physician discontinued drug|0|||
129195982|NCT00615017|465012446|FG003|Overall Study|Physician discontinued drug|0|||
129195983|NCT00615017|465012447|FG004|Overall Study|Physician discontinued drug|0|||
129195984|NCT00615017|465012448|FG005|Overall Study|Physician discontinued drug|1|||
129195985|NCT00806988|465012449|FG000|Overall Study|Death|15|||
129195986|NCT00806988|465012450|FG001|Overall Study|Death|16|||
129195987|NCT00806988|465012449|FG000|Overall Study|Withdrawal by Subject|8|||
129195988|NCT00806988|465012450|FG001|Overall Study|Withdrawal by Subject|8|||
129195989|NCT00806988|465012449|FG000|Overall Study|Lost to Follow-up|4|||
129195990|NCT00806988|465012450|FG001|Overall Study|Lost to Follow-up|19|||
129195991|NCT04775953|465012451|FG000|Overall Study|Lost to Follow-up|6|||
129195992|NCT04775953|465012452|FG001|Overall Study|Lost to Follow-up|11|||
129195993|NCT04775953|465012451|FG000|Overall Study|Death|5|||
129195994|NCT04775953|465012452|FG001|Overall Study|Death|4|||
129195995|NCT04775953|465012451|FG000|Overall Study|Withdrawal by Subject|3|||
129195996|NCT04775953|465012452|FG001|Overall Study|Withdrawal by Subject|3|||
129195997|NCT04775953|465012451|FG000|Overall Study|Protocol Violation|2|||
129195998|NCT04775953|465012452|FG001|Overall Study|Protocol Violation|0|||
129195999|NCT04775953|465012451|FG000|Overall Study|Participant non-compliance|0|||
129196000|NCT04775953|465012452|FG001|Overall Study|Participant non-compliance|1|||
129196001|NCT00855959|465012453|FG000|Overall Study|Adverse Event|2|||
129196002|NCT00855959|465012453|FG000|Overall Study|Lost to Follow-up|2|||
129196003|NCT00855959|465012453|FG000|Overall Study|Withdrawal by Subject|3|||
129196004|NCT00855959|465012453|FG000|Overall Study|Pregnancy|1|||
129196005|NCT00855959|465012453|FG000|Overall Study|Incorrect enrolment|1|||
129196006|NCT02813889|465012454|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
129196007|NCT02813889|465012455|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
129196008|NCT00368641|465012456|FG000|Overall Study|Adverse Event|2|||
129196009|NCT00368641|465012457|FG001|Overall Study|Adverse Event|1|||
129196010|NCT00368641|465012456|FG000|Overall Study|Death|1|||
129196011|NCT00368641|465012457|FG001|Overall Study|Death|0|||
129196012|NCT00368641|465012456|FG000|Overall Study|Withdrawal by Subject|1|||
129196013|NCT00368641|465012457|FG001|Overall Study|Withdrawal by Subject|0|||
129196014|NCT00368641|465012456|FG000|Overall Study|Sponsor decision to terminate study|2|||
129196015|NCT00368641|465012457|FG001|Overall Study|Sponsor decision to terminate study|5|||
129196016|NCT00699608|465012460|FG000|First Intervention|Withdrawal by Subject|0|||
129196017|NCT00699608|465012461|FG001|First Intervention|Withdrawal by Subject|0|||
129196018|NCT00699608|465012462|FG002|First Intervention|Withdrawal by Subject|1|||
129196019|NCT00699608|465012463|FG003|First Intervention|Withdrawal by Subject|0|||
129196020|NCT00699608|465012464|FG004|First Intervention|Withdrawal by Subject|0|||
129196021|NCT00699608|465012465|FG005|First Intervention|Withdrawal by Subject|0|||
129196022|NCT00699608|465012460|FG000|First Intervention|Protocol Violation|0|||
129196023|NCT00699608|465012461|FG001|First Intervention|Protocol Violation|0|||
129196024|NCT00699608|465012462|FG002|First Intervention|Protocol Violation|0|||
129196025|NCT00699608|465012463|FG003|First Intervention|Protocol Violation|0|||
129196026|NCT00699608|465012464|FG004|First Intervention|Protocol Violation|1|||
129196027|NCT00699608|465012465|FG005|First Intervention|Protocol Violation|0|||
129196028|NCT00699608|465012460|FG000|Second Intervention|Adverse Event|0|||
129196029|NCT00699608|465012461|FG001|Second Intervention|Adverse Event|0|||
129196030|NCT00699608|465012462|FG002|Second Intervention|Adverse Event|1|||
129196031|NCT00699608|465012463|FG003|Second Intervention|Adverse Event|0|||
129196032|NCT00699608|465012464|FG004|Second Intervention|Adverse Event|0|||
129196033|NCT00699608|465012465|FG005|Second Intervention|Adverse Event|0|||
129196034|NCT00699608|465012460|FG000|Second Intervention|Withdrawal by Subject|0|||
129196035|NCT00699608|465012461|FG001|Second Intervention|Withdrawal by Subject|0|||
129196036|NCT00699608|465012462|FG002|Second Intervention|Withdrawal by Subject|0|||
129196037|NCT00699608|465012463|FG003|Second Intervention|Withdrawal by Subject|1|||
129196038|NCT00699608|465012464|FG004|Second Intervention|Withdrawal by Subject|0|||
129196039|NCT00699608|465012465|FG005|Second Intervention|Withdrawal by Subject|0|||
129196040|NCT04720417|465012466|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
129196041|NCT00496080|465012472|FG000|Overall Study|Lost to Follow-up|9|||
129196042|NCT00496080|465012472|FG000|Overall Study|Surgical re-intervention|7|||
129196043|NCT00496080|465012472|FG000|Overall Study|Withdrawal by Subject|5|||
129196044|NCT00496080|465012472|FG000|Overall Study|Physician Decision|6|||
129196045|NCT00570310|465012473|FG000|Overall Study|Adverse Event|1|||
129196046|NCT00570310|465012474|FG001|Overall Study|Adverse Event|2|||
129196047|NCT00570310|465012473|FG000|Overall Study|Lack of Efficacy|1|||
129196048|NCT00570310|465012474|FG001|Overall Study|Lack of Efficacy|4|||
129196049|NCT00887549|465012475|FG000|Induction Therapy|Adverse Event|8|||
129196050|NCT00887549|465012475|FG000|Induction Therapy|Physician Decision|1|||
129196051|NCT00887549|465012475|FG000|Induction Therapy|Progressive Disease|13|||
129196052|NCT00887549|465012475|FG000|Induction Therapy|Death due to Study Disease|4|||
129196053|NCT00887549|465012475|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
129196054|NCT00887549|465012475|FG000|Maintenance Therapy|Adverse Event|16|||
129196055|NCT00887549|465012475|FG000|Maintenance Therapy|Physician Decision|1|||
129196056|NCT00887549|465012475|FG000|Maintenance Therapy|Progressive Disease|25|||
129196057|NCT00887549|465012475|FG000|Maintenance Therapy|Death due to adverse event|1|||
129196058|NCT03472950|465012479|FG000|Overall Study|Lost to Follow-up|0|||
129196059|NCT03472950|465012480|FG001|Overall Study|Lost to Follow-up|1|||
129196060|NCT03472950|465012479|FG000|Overall Study|Adverse Event|0|||
129196061|NCT03472950|465012480|FG001|Overall Study|Adverse Event|3|||
129196062|NCT00377858|465012486|FG000|Overall Study|Withdrawal by Subject|12|||
128731310|NCT02896400|463312759|FG004|3 Month Follow-up|Lost to Follow-up|12|||
128731311|NCT02896400|463312760|FG005|3 Month Follow-up|Lost to Follow-up|6|||
128731312|NCT02896400|463312761|FG006|3 Month Follow-up|Lost to Follow-up|4|||
128731313|NCT02896400|463312762|FG007|3 Month Follow-up|Lost to Follow-up|3|||
128731314|NCT02896400|463312763|FG008|3 Month Follow-up|Lost to Follow-up|6|||
128731315|NCT02896400|463312764|FG009|3 Month Follow-up|Lost to Follow-up|5|||
128731316|NCT02896400|463312765|FG010|3 Month Follow-up|Lost to Follow-up|6|||
128731317|NCT02896400|463312766|FG011|3 Month Follow-up|Lost to Follow-up|6|||
128731318|NCT02896400|463312767|FG012|3 Month Follow-up|Lost to Follow-up|3|||
128731319|NCT02896400|463312768|FG013|3 Month Follow-up|Lost to Follow-up|5|||
128731320|NCT02896400|463312769|FG014|3 Month Follow-up|Lost to Follow-up|3|||
128731321|NCT02896400|463312770|FG015|3 Month Follow-up|Lost to Follow-up|2|||
128731322|NCT02896400|463312755|FG000|3 Month Follow-up|Death|0|||
128731323|NCT02896400|463312756|FG001|3 Month Follow-up|Death|0|||
128731324|NCT02896400|463312757|FG002|3 Month Follow-up|Death|0|||
128731325|NCT02896400|463312758|FG003|3 Month Follow-up|Death|0|||
128731326|NCT02896400|463312759|FG004|3 Month Follow-up|Death|0|||
128731327|NCT02896400|463312760|FG005|3 Month Follow-up|Death|0|||
128731328|NCT02896400|463312761|FG006|3 Month Follow-up|Death|0|||
128731329|NCT02896400|463312762|FG007|3 Month Follow-up|Death|0|||
128731330|NCT02896400|463312763|FG008|3 Month Follow-up|Death|0|||
128731331|NCT02896400|463312764|FG009|3 Month Follow-up|Death|0|||
128731332|NCT02896400|463312765|FG010|3 Month Follow-up|Death|0|||
128731333|NCT02896400|463312766|FG011|3 Month Follow-up|Death|0|||
128731334|NCT02896400|463312767|FG012|3 Month Follow-up|Death|0|||
128731335|NCT02896400|463312768|FG013|3 Month Follow-up|Death|1|||
128731336|NCT02896400|463312769|FG014|3 Month Follow-up|Death|1|||
128731337|NCT02896400|463312770|FG015|3 Month Follow-up|Death|0|||
128731338|NCT02896400|463312755|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731339|NCT02896400|463312756|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
128731340|NCT02896400|463312757|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731341|NCT02896400|463312758|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731342|NCT02896400|463312759|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
128731343|NCT02896400|463312760|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731344|NCT02896400|463312761|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
128731345|NCT02896400|463312762|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
128731346|NCT02896400|463312763|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731347|NCT02896400|463312764|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731348|NCT02896400|463312765|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
128731349|NCT02896400|463312766|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129196063|NCT00377858|465012487|FG001|Overall Study|Withdrawal by Subject|11|||
129196064|NCT00377858|465012486|FG000|Overall Study|Lost to Follow-up|6|||
129196065|NCT00377858|465012487|FG001|Overall Study|Lost to Follow-up|1|||
129196066|NCT00377858|465012486|FG000|Overall Study|Physician Decision|5|||
129196067|NCT00377858|465012487|FG001|Overall Study|Physician Decision|5|||
129196068|NCT00377858|465012486|FG000|Overall Study|Protocol Violation|3|||
129196069|NCT00377858|465012487|FG001|Overall Study|Protocol Violation|4|||
128731350|NCT02896400|463312767|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731351|NCT02896400|463312768|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
128731352|NCT02896400|463312769|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
128731353|NCT02896400|463312770|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
128731354|NCT02896400|463312755|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
128731355|NCT02896400|463312756|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
128731356|NCT02896400|463312757|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
128731357|NCT02896400|463312758|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
128781086|NCT02851511|463490444|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
129196070|NCT00377858|465012486|FG000|Overall Study|Adverse Event|2|||
129196071|NCT00377858|465012487|FG001|Overall Study|Adverse Event|1|||
129196072|NCT00377858|465012486|FG000|Overall Study|Entry Criteria Not Met|2|||
129196073|NCT00377858|465012487|FG001|Overall Study|Entry Criteria Not Met|0|||
129196074|NCT00377858|465012486|FG000|Overall Study|Sponsor Decision|1|||
129196075|NCT00377858|465012487|FG001|Overall Study|Sponsor Decision|2|||
129196076|NCT00377858|465012486|FG000|Overall Study|Death|0|||
129196077|NCT00377858|465012487|FG001|Overall Study|Death|3|||
129196078|NCT00517361|465012488|FG000|Overall Study|Death|6|||
129196079|NCT00517361|465012488|FG000|Overall Study|The study was terminated|5|||
129196080|NCT01685697|465012489|FG000|Overall Study|Protocol Violation|3|||
129196081|NCT01685697|465012490|FG001|Overall Study|Protocol Violation|3|||
129196082|NCT00726232|465012491|FG000|Initial Phase (Dose-finding)|Death|0|||
129196083|NCT00726232|465012492|FG001|Initial Phase (Dose-finding)|Death|0|||
129196084|NCT00726232|465012493|FG002|Initial Phase (Dose-finding)|Death|0|||
129196085|NCT00726232|465012494|FG003|Initial Phase (Dose-finding)|Death|0|||
129196086|NCT00726232|465012495|FG004|Initial Phase (Dose-finding)|Death|1|||
129196087|NCT00726232|465012496|FG005|Initial Phase (Dose-finding)|Death|0|||
129196088|NCT00726232|465012497|FG006|Initial Phase (Dose-finding)|Death|0|||
129196089|NCT00726232|465012498|FG007|Initial Phase (Dose-finding)|Death|0|||
129196090|NCT00726232|465012491|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
129196091|NCT00726232|465012492|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
129196092|NCT00726232|465012493|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
129196093|NCT00726232|465012494|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
129196094|NCT00726232|465012495|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
129196095|NCT00726232|465012496|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
129196096|NCT00726232|465012497|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
129196097|NCT00726232|465012498|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
129196098|NCT00726232|465012491|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
129196099|NCT00726232|465012492|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129196100|NCT00726232|465012493|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129196101|NCT00726232|465012494|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
129196102|NCT00726232|465012495|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129196103|NCT00726232|465012496|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
129196104|NCT00726232|465012497|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129196105|NCT00726232|465012498|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129196106|NCT00726232|465012491|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
129196107|NCT00726232|465012492|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
129196108|NCT00726232|465012493|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
129196109|NCT00726232|465012494|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
129196110|NCT00726232|465012495|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
129196111|NCT00726232|465012496|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
129196112|NCT00726232|465012497|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
129196113|NCT00726232|465012498|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
129196114|NCT00726232|465012491|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
129196115|NCT00726232|465012492|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
129196116|NCT00726232|465012493|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
129196117|NCT00726232|465012494|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
129196118|NCT00726232|465012495|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
129196119|NCT00726232|465012496|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
129196120|NCT00726232|465012497|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
129196121|NCT00726232|465012498|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
129196122|NCT00726232|465012491|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
129196123|NCT00726232|465012492|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129196124|NCT00726232|465012493|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129196125|NCT00726232|465012494|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
129196126|NCT00726232|465012495|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
129196127|NCT00726232|465012496|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
129196128|NCT00726232|465012497|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129196129|NCT00726232|465012498|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129196130|NCT00726232|465012491|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
129196131|NCT00726232|465012492|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
129196132|NCT00726232|465012493|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
129196133|NCT00726232|465012494|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
129196134|NCT00726232|465012495|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
129196135|NCT00726232|465012496|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
129196136|NCT00726232|465012497|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
129196137|NCT00726232|465012498|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
129196138|NCT00726232|465012491|FG000|Expansion Phase|Death|0|||
129196139|NCT00726232|465012492|FG001|Expansion Phase|Death|0|||
129196140|NCT00726232|465012493|FG002|Expansion Phase|Death|0|||
129196141|NCT00726232|465012494|FG003|Expansion Phase|Death|0|||
129196142|NCT00726232|465012495|FG004|Expansion Phase|Death|0|||
129196143|NCT00726232|465012496|FG005|Expansion Phase|Death|0|||
129196144|NCT00726232|465012497|FG006|Expansion Phase|Death|0|||
129196145|NCT00726232|465012498|FG007|Expansion Phase|Death|1|||
129196146|NCT00726232|465012491|FG000|Expansion Phase|Adverse Event|0|||
129196147|NCT00726232|465012492|FG001|Expansion Phase|Adverse Event|0|||
129196148|NCT00726232|465012493|FG002|Expansion Phase|Adverse Event|0|||
129196149|NCT00726232|465012494|FG003|Expansion Phase|Adverse Event|0|||
129196150|NCT00726232|465012495|FG004|Expansion Phase|Adverse Event|0|||
129196151|NCT00726232|465012496|FG005|Expansion Phase|Adverse Event|0|||
129196152|NCT00726232|465012497|FG006|Expansion Phase|Adverse Event|6|||
129196153|NCT00726232|465012498|FG007|Expansion Phase|Adverse Event|11|||
129196154|NCT00726232|465012491|FG000|Expansion Phase|Withdrawal by Subject|0|||
129196155|NCT00726232|465012492|FG001|Expansion Phase|Withdrawal by Subject|0|||
129196156|NCT00726232|465012493|FG002|Expansion Phase|Withdrawal by Subject|0|||
129196157|NCT00726232|465012494|FG003|Expansion Phase|Withdrawal by Subject|0|||
129196158|NCT00726232|465012495|FG004|Expansion Phase|Withdrawal by Subject|0|||
129196159|NCT00726232|465012496|FG005|Expansion Phase|Withdrawal by Subject|0|||
129196160|NCT00726232|465012497|FG006|Expansion Phase|Withdrawal by Subject|2|||
129196161|NCT00726232|465012498|FG007|Expansion Phase|Withdrawal by Subject|3|||
129196162|NCT00726232|465012491|FG000|Expansion Phase|Disease progression|0|||
129196163|NCT00726232|465012492|FG001|Expansion Phase|Disease progression|0|||
129196164|NCT00726232|465012493|FG002|Expansion Phase|Disease progression|0|||
129196165|NCT00726232|465012494|FG003|Expansion Phase|Disease progression|0|||
129196166|NCT00726232|465012495|FG004|Expansion Phase|Disease progression|0|||
129196167|NCT00726232|465012496|FG005|Expansion Phase|Disease progression|0|||
129196168|NCT00726232|465012497|FG006|Expansion Phase|Disease progression|4|||
129196169|NCT00726232|465012498|FG007|Expansion Phase|Disease progression|0|||
129196170|NCT00726232|465012491|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
129196171|NCT00726232|465012492|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
129196172|NCT00726232|465012493|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
129196173|NCT00726232|465012494|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
129196174|NCT00726232|465012495|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
129196175|NCT00726232|465012496|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
129196176|NCT00726232|465012497|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
129196177|NCT00726232|465012498|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
129196178|NCT00726232|465012491|FG000|Expansion Phase|Per Investigator: lack of response|0|||
129196179|NCT00726232|465012492|FG001|Expansion Phase|Per Investigator: lack of response|0|||
129196180|NCT00726232|465012493|FG002|Expansion Phase|Per Investigator: lack of response|0|||
129196181|NCT00726232|465012494|FG003|Expansion Phase|Per Investigator: lack of response|0|||
129196182|NCT00726232|465012495|FG004|Expansion Phase|Per Investigator: lack of response|0|||
129196183|NCT00726232|465012496|FG005|Expansion Phase|Per Investigator: lack of response|0|||
129196184|NCT00726232|465012497|FG006|Expansion Phase|Per Investigator: lack of response|1|||
129196185|NCT00726232|465012498|FG007|Expansion Phase|Per Investigator: lack of response|7|||
129196186|NCT00726232|465012491|FG000|Expansion Phase|Unspecified reason|0|||
129196187|NCT00726232|465012492|FG001|Expansion Phase|Unspecified reason|0|||
129196188|NCT00726232|465012493|FG002|Expansion Phase|Unspecified reason|0|||
129196189|NCT00726232|465012494|FG003|Expansion Phase|Unspecified reason|0|||
129196190|NCT00726232|465012495|FG004|Expansion Phase|Unspecified reason|0|||
129196191|NCT00726232|465012496|FG005|Expansion Phase|Unspecified reason|0|||
129196192|NCT00726232|465012497|FG006|Expansion Phase|Unspecified reason|1|||
129196193|NCT00726232|465012498|FG007|Expansion Phase|Unspecified reason|0|||
129196194|NCT00195091|465012499|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
129196195|NCT04034004|465012504|FG000|Overall Study|Withdrawal by Subject|1|||
129196196|NCT04034004|465012505|FG001|Overall Study|Withdrawal by Subject|2|||
129196197|NCT04034004|465012506|FG002|Overall Study|Withdrawal by Subject|2|||
129196198|NCT04034004|465012507|FG003|Overall Study|Withdrawal by Subject|3|||
129196199|NCT04034004|465012504|FG000|Overall Study|could not find vein to administer IV|2|||
129196200|NCT04034004|465012505|FG001|Overall Study|could not find vein to administer IV|1|||
129196201|NCT04034004|465012506|FG002|Overall Study|could not find vein to administer IV|0|||
128731358|NCT02896400|463312759|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
128731359|NCT02896400|463312760|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
128731360|NCT02896400|463312761|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
128781087|NCT02851511|463490445|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
128731361|NCT02896400|463312762|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
128731362|NCT02896400|463312763|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
128731363|NCT02896400|463312764|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
128731364|NCT02896400|463312765|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
128731365|NCT02896400|463312766|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
128731366|NCT02896400|463312767|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
128731367|NCT02896400|463312768|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
128731368|NCT02896400|463312769|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
128731369|NCT02896400|463312770|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
128731370|NCT00634647|463312771|FG000|Overall Study|death on study|3|||
129196202|NCT04034004|465012507|FG003|Overall Study|could not find vein to administer IV|0|||
129196203|NCT04034004|465012504|FG000|Overall Study|nurse accidentally unblinded subject|0|||
129196204|NCT04034004|465012505|FG001|Overall Study|nurse accidentally unblinded subject|0|||
129196205|NCT04034004|465012506|FG002|Overall Study|nurse accidentally unblinded subject|0|||
129196206|NCT04034004|465012507|FG003|Overall Study|nurse accidentally unblinded subject|1|||
129196207|NCT00245037|465012513|FG000|Overall Study|Death|17|||
129196208|NCT04526145|465012516|FG000|Overall Study|Withdrawal by Subject|5|||
129196209|NCT01502228|465012519|FG000|Overall Study|Death|1|||
129196210|NCT06964165|465012524|FG000|Overall Study|Withdrawal by Subject|0|||
129196211|NCT06964165|465012525|FG001|Overall Study|Withdrawal by Subject|1|||
129196212|NCT06964165|465012524|FG000|Overall Study|Ongoing at the time of analysis|15|||
129196213|NCT06964165|465012525|FG001|Overall Study|Ongoing at the time of analysis|14|||
129196214|NCT06964165|465012524|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
129196215|NCT06964165|465012525|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
129196216|NCT06964165|465012524|FG000|Overall Study|Participant removed due to non-compliance|0|||
129196217|NCT06964165|465012525|FG001|Overall Study|Participant removed due to non-compliance|1|||
129196218|NCT01514201|465012540|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
129196219|NCT01514201|465012541|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129196220|NCT01514201|465012542|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129196221|NCT01514201|465012543|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129196222|NCT01514201|465012540|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129196223|NCT01514201|465012541|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
129196224|NCT01514201|465012542|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
129196225|NCT01514201|465012543|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129196226|NCT01514201|465012540|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
129196227|NCT01514201|465012541|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
129196228|NCT01514201|465012542|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
129196229|NCT01514201|465012543|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129196230|NCT01514201|465012540|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
129196231|NCT01514201|465012541|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
129196232|NCT01514201|465012542|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129196233|NCT01514201|465012543|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129196234|NCT01514201|465012540|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
129196235|NCT01514201|465012541|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
129196236|NCT01514201|465012542|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
129196237|NCT01514201|465012543|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
129196238|NCT01514201|465012540|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
129196239|NCT01514201|465012541|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
129196240|NCT01514201|465012542|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
129196241|NCT01514201|465012543|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
129196242|NCT01514201|465012540|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
129196243|NCT01514201|465012541|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
129196244|NCT01514201|465012542|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
129196245|NCT01514201|465012543|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
129196246|NCT01514201|465012540|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129196247|NCT01514201|465012541|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129196248|NCT01514201|465012542|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129196249|NCT01514201|465012543|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
129196250|NCT01514201|465012540|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
129196251|NCT01514201|465012541|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
129196252|NCT01514201|465012542|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
128781088|NCT02851511|463490446|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
128781089|NCT02851511|463490447|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
129196253|NCT01514201|465012543|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
129196254|NCT01514201|465012540|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129196255|NCT01514201|465012541|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129196256|NCT01514201|465012542|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129196257|NCT01514201|465012543|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
129196258|NCT01514201|465012540|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129196259|NCT01514201|465012541|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129196260|NCT01514201|465012542|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129196261|NCT01514201|465012543|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
129196262|NCT01514201|465012540|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129196263|NCT01514201|465012541|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129196264|NCT01514201|465012542|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129196265|NCT01514201|465012543|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
129196266|NCT05888181|465012544|FG000|Overall Study|Lost to Follow-up|1|||
129196267|NCT05888181|465012545|FG001|Overall Study|Lost to Follow-up|1|||
129196268|NCT05888181|465012546|FG002|Overall Study|Lost to Follow-up|0|||
129196269|NCT02534909|465012552|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
129196270|NCT01625000|465012555|FG000|Overall Study|Physician Decision|15|||
129196271|NCT01625000|465012556|FG001|Overall Study|Physician Decision|7|||
129196272|NCT01625000|465012557|FG002|Overall Study|Physician Decision|7|||
129196273|NCT01625000|465012558|FG003|Overall Study|Physician Decision|2|||
129196274|NCT01625000|465012559|FG004|Overall Study|Physician Decision|15|||
129196275|NCT01625000|465012555|FG000|Overall Study|Protocol Violation|3|||
129196276|NCT01625000|465012556|FG001|Overall Study|Protocol Violation|10|||
129196277|NCT01625000|465012557|FG002|Overall Study|Protocol Violation|4|||
129196278|NCT01625000|465012558|FG003|Overall Study|Protocol Violation|1|||
129196279|NCT01625000|465012559|FG004|Overall Study|Protocol Violation|2|||
129196280|NCT01625000|465012555|FG000|Overall Study|Withdrawal by Subject|19|||
129196281|NCT01625000|465012556|FG001|Overall Study|Withdrawal by Subject|16|||
129196282|NCT01625000|465012557|FG002|Overall Study|Withdrawal by Subject|11|||
129196283|NCT01625000|465012558|FG003|Overall Study|Withdrawal by Subject|9|||
129196284|NCT01625000|465012559|FG004|Overall Study|Withdrawal by Subject|17|||
129196285|NCT01625000|465012555|FG000|Overall Study|Adverse Event (including Death)|15|||
129196286|NCT01625000|465012556|FG001|Overall Study|Adverse Event (including Death)|19|||
129196287|NCT01625000|465012557|FG002|Overall Study|Adverse Event (including Death)|11|||
129196288|NCT01625000|465012558|FG003|Overall Study|Adverse Event (including Death)|7|||
129196289|NCT01625000|465012559|FG004|Overall Study|Adverse Event (including Death)|21|||
129196290|NCT00577824|465012562|FG000|Overall Study|Adverse Event|6|||
129196291|NCT00577824|465012563|FG001|Overall Study|Adverse Event|18|||
129196292|NCT00577824|465012564|FG002|Overall Study|Adverse Event|1|||
129196293|NCT00577824|465012562|FG000|Overall Study|Patient decision|0|||
129196294|NCT00577824|465012563|FG001|Overall Study|Patient decision|1|||
129196295|NCT00577824|465012564|FG002|Overall Study|Patient decision|1|||
129196296|NCT00577824|465012562|FG000|Overall Study|Protocol Violation|1|||
129196297|NCT00577824|465012563|FG001|Overall Study|Protocol Violation|1|||
129196298|NCT00577824|465012564|FG002|Overall Study|Protocol Violation|0|||
129196299|NCT00362648|465012565|FG000|Overall Study|Adverse Event|12|||
129196300|NCT00362648|465012566|FG001|Overall Study|Adverse Event|21|||
129196301|NCT00362648|465012567|FG002|Overall Study|Adverse Event|1|||
129196302|NCT00362648|465012568|FG003|Overall Study|Adverse Event|0|||
129196303|NCT00362648|465012565|FG000|Overall Study|Lost to Follow-up|62|||
129196304|NCT00362648|465012566|FG001|Overall Study|Lost to Follow-up|69|||
129196305|NCT00362648|465012567|FG002|Overall Study|Lost to Follow-up|4|||
129196306|NCT00362648|465012568|FG003|Overall Study|Lost to Follow-up|3|||
129196307|NCT00362648|465012565|FG000|Overall Study|Protocol Violation|4|||
129196308|NCT00362648|465012566|FG001|Overall Study|Protocol Violation|2|||
129196309|NCT00362648|465012567|FG002|Overall Study|Protocol Violation|2|||
129196310|NCT00362648|465012568|FG003|Overall Study|Protocol Violation|2|||
129196311|NCT00362648|465012565|FG000|Overall Study|Withdrawal by Subject|48|||
129196312|NCT00362648|465012566|FG001|Overall Study|Withdrawal by Subject|42|||
129196313|NCT00362648|465012567|FG002|Overall Study|Withdrawal by Subject|2|||
129196314|NCT00362648|465012568|FG003|Overall Study|Withdrawal by Subject|6|||
129196315|NCT03983304|465012569|FG000|Overall Study|Withdrawal by Subject|5|||
129196316|NCT03983304|465012569|FG000|Overall Study|Lost to Follow-up|2|||
129196317|NCT01518374|465012572|FG000|Overall Study|Withdrawal by Subject|2|||
129196318|NCT01518374|465012572|FG000|Overall Study|Protocol Violation|3|||
129196319|NCT01518374|465012572|FG000|Overall Study|Lost to Follow-up|2|||
129196320|NCT04300309|465012573|FG000|Overall Study|Lost to Follow-up|1|||
129196321|NCT04300309|465012574|FG001|Overall Study|Lost to Follow-up|0|||
129196322|NCT02362464|465012577|FG000|Overall Study|Switched to alternative therapy|1|||
129196323|NCT02362464|465012577|FG000|Overall Study|Refused further treatment|1|||
129196324|NCT02362464|465012577|FG000|Overall Study|Physician Decision|4|||
129196325|NCT04752332|465012578|FG000|Overall Study|Adverse Event|3|||
129196326|NCT04752332|465012579|FG001|Overall Study|Adverse Event|1|||
129196327|NCT04752332|465012578|FG000|Overall Study|Disease Relapse|1|||
128731371|NCT00634647|463312771|FG000|Overall Study|refused further treatment|3|||
128731372|NCT00634647|463312771|FG000|Overall Study|declined to participate before treatment|1|||
128731373|NCT02984020|463312772|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
128731374|NCT02984020|463312772|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
129196328|NCT04752332|465012579|FG001|Overall Study|Disease Relapse|0|||
129196329|NCT04752332|465012578|FG000|Overall Study|Non-compliance With Study Drug|2|||
129196330|NCT04752332|465012579|FG001|Overall Study|Non-compliance With Study Drug|0|||
129196331|NCT04752332|465012578|FG000|Overall Study|Physician Decision|2|||
129196332|NCT04752332|465012579|FG001|Overall Study|Physician Decision|1|||
129196333|NCT04752332|465012578|FG000|Overall Study|Protocol Violation|1|||
129196334|NCT04752332|465012579|FG001|Overall Study|Protocol Violation|1|||
129196335|NCT04752332|465012578|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
129196336|NCT04752332|465012579|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
129196337|NCT04752332|465012578|FG000|Overall Study|Study Terminated by Sponsor|10|||
129196338|NCT04752332|465012579|FG001|Overall Study|Study Terminated by Sponsor|48|||
129196339|NCT04752332|465012578|FG000|Overall Study|Withdrawal by Subject|11|||
129196340|NCT04752332|465012579|FG001|Overall Study|Withdrawal by Subject|3|||
129196341|NCT00048347|465012580|FG000|Overall Study|Screen failure|2|||
129196342|NCT02058563|465012581|FG000|Overall Study|Lost to Follow-up|26|||
129196343|NCT02058563|465012582|FG001|Overall Study|Lost to Follow-up|22|||
129196344|NCT02058563|465012581|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
129196345|NCT02058563|465012582|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
129196346|NCT02058563|465012581|FG000|Overall Study|Consent Withdrawal|1|||
129196347|NCT02058563|465012582|FG001|Overall Study|Consent Withdrawal|1|||
129196348|NCT02058563|465012581|FG000|Overall Study|Other (patient incarcerated)|0|||
129196349|NCT02058563|465012582|FG001|Overall Study|Other (patient incarcerated)|1|||
129196350|NCT04039217|465012583|FG000|Overall Study|Lost to Follow-up|1|||
129196351|NCT04522141|465012584|FG000|Overall Study|Withdrawal by Subject|1|||
129196352|NCT04522141|465012585|FG001|Overall Study|Withdrawal by Subject|0|||
129196353|NCT03508609|465012586|FG000|Overall Study|Withdrawal by Subject|1|||
129196354|NCT00555217|465012587|FG000|Overall Study|Withdrawal by Subject|35|||
129196355|NCT00555217|465012588|FG001|Overall Study|Withdrawal by Subject|31|||
129196356|NCT00555217|465012587|FG000|Overall Study|Lost to Follow-up|19|||
129196357|NCT00555217|465012588|FG001|Overall Study|Lost to Follow-up|20|||
129196358|NCT00555217|465012587|FG000|Overall Study|close out sites|21|||
129196359|NCT00555217|465012588|FG001|Overall Study|close out sites|17|||
129196360|NCT01868477|465012589|FG000|Overall Study|Adverse Event|2|||
129196361|NCT01868477|465012590|FG001|Overall Study|Adverse Event|4|||
129196362|NCT01868477|465012589|FG000|Overall Study|Disease progression|1|||
129196363|NCT01868477|465012590|FG001|Overall Study|Disease progression|1|||
129196364|NCT01868477|465012589|FG000|Overall Study|Withdrawal by Subject|1|||
129196365|NCT01868477|465012590|FG001|Overall Study|Withdrawal by Subject|0|||
129196366|NCT00367835|465012593|FG000|Overall Study|Adverse Event|14|||
129196367|NCT00367835|465012594|FG001|Overall Study|Adverse Event|1|||
129196368|NCT00367835|465012593|FG000|Overall Study|Protocol Violation|1|||
129196369|NCT00367835|465012594|FG001|Overall Study|Protocol Violation|7|||
129196370|NCT00367835|465012593|FG000|Overall Study|Withdrawal by Subject|7|||
129196371|NCT00367835|465012594|FG001|Overall Study|Withdrawal by Subject|6|||
129196372|NCT00367835|465012593|FG000|Overall Study|Lost to Follow-up|1|||
129196373|NCT00367835|465012594|FG001|Overall Study|Lost to Follow-up|4|||
129196374|NCT00367835|465012593|FG000|Overall Study|Lack of Efficacy|3|||
129196375|NCT00367835|465012594|FG001|Overall Study|Lack of Efficacy|12|||
129196376|NCT00367835|465012593|FG000|Overall Study|Subject in juvenile detention center|1|||
129196377|NCT00367835|465012594|FG001|Overall Study|Subject in juvenile detention center|0|||
129196378|NCT00367835|465012593|FG000|Overall Study|refused blood collection|1|||
129196379|NCT00367835|465012594|FG001|Overall Study|refused blood collection|0|||
129196380|NCT00367835|465012593|FG000|Overall Study|Did not respond to calls|1|||
129196381|NCT00367835|465012594|FG001|Overall Study|Did not respond to calls|0|||
129196382|NCT00367835|465012593|FG000|Overall Study|History of lead poisoning|0|||
129196383|NCT00367835|465012594|FG001|Overall Study|History of lead poisoning|1|||
129196384|NCT00811174|465012596|FG000|Overall Study|Protocol Violation|2|||
129196385|NCT00811174|465012596|FG000|Overall Study|Sponsors Decision|1|||
129196386|NCT02451943|465013772|FG000|Overall Study|Withdrawal by Subject|13|||
129196387|NCT02451943|465013773|FG001|Overall Study|Withdrawal by Subject|16|||
129196388|NCT02451943|465013772|FG000|Overall Study|Lost to Follow-up|3|||
129196389|NCT02451943|465013773|FG001|Overall Study|Lost to Follow-up|4|||
129196390|NCT02451943|465013772|FG000|Overall Study|Sponsor Decision|0|||
129196391|NCT02451943|465013773|FG001|Overall Study|Sponsor Decision|4|||
129196392|NCT01101035|465013775|FG000|Overall Study|Adverse Event|191|||
129196393|NCT01101035|465013776|FG001|Overall Study|Adverse Event|172|||
129196394|NCT01101035|465013775|FG000|Overall Study|Major Protocol Deviation|52|||
129196395|NCT01101035|465013776|FG001|Overall Study|Major Protocol Deviation|46|||
129196396|NCT01101035|465013775|FG000|Overall Study|Lost to Follow-up|226|||
129196397|NCT01101035|465013776|FG001|Overall Study|Lost to Follow-up|223|||
129196398|NCT01101035|465013775|FG000|Overall Study|Voluntary Withdrawal|595|||
129196399|NCT01101035|465013776|FG001|Overall Study|Voluntary Withdrawal|587|||
129196400|NCT01101035|465013775|FG000|Overall Study|Reason not Specified|333|||
129196401|NCT01101035|465013776|FG001|Overall Study|Reason not Specified|363|||
129196402|NCT00681629|465013779|FG000|Overall Study|Study termination|4|||
129196403|NCT00681629|465013780|FG001|Overall Study|Study termination|2|||
129196404|NCT00681629|465013779|FG000|Overall Study|Adverse Event|1|||
129196405|NCT00681629|465013780|FG001|Overall Study|Adverse Event|0|||
129196406|NCT02517541|465013790|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
129196407|NCT02517541|465013790|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
129196408|NCT02517541|465013790|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
129196409|NCT02517541|465013790|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
129196410|NCT02517541|465013790|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
129196411|NCT02517541|465013790|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
129196412|NCT01510158|465013791|FG000|Overall Study|Adverse Event|7|||
129196413|NCT01510158|465013792|FG001|Overall Study|Adverse Event|8|||
129196414|NCT01510158|465013793|FG002|Overall Study|Adverse Event|5|||
129196415|NCT01510158|465013791|FG000|Overall Study|Gout flare|1|||
129196416|NCT01510158|465013792|FG001|Overall Study|Gout flare|0|||
129196417|NCT01510158|465013793|FG002|Overall Study|Gout flare|0|||
129196418|NCT01510158|465013791|FG000|Overall Study|Protocol Violation|17|||
129196419|NCT01510158|465013792|FG001|Overall Study|Protocol Violation|16|||
129196420|NCT01510158|465013793|FG002|Overall Study|Protocol Violation|24|||
129196421|NCT01510158|465013791|FG000|Overall Study|Sponsor terminated study.|2|||
129196422|NCT01510158|465013792|FG001|Overall Study|Sponsor terminated study.|0|||
129196423|NCT01510158|465013793|FG002|Overall Study|Sponsor terminated study.|2|||
129196424|NCT01510158|465013791|FG000|Overall Study|Lost to Follow-up|13|||
129196425|NCT01510158|465013792|FG001|Overall Study|Lost to Follow-up|16|||
129196426|NCT01510158|465013793|FG002|Overall Study|Lost to Follow-up|9|||
129196427|NCT01510158|465013791|FG000|Overall Study|Withdrawal by Subject|10|||
129196428|NCT01510158|465013792|FG001|Overall Study|Withdrawal by Subject|13|||
129196429|NCT01510158|465013793|FG002|Overall Study|Withdrawal by Subject|10|||
129196430|NCT01510158|465013791|FG000|Overall Study|Death|1|||
129196431|NCT01510158|465013792|FG001|Overall Study|Death|0|||
129196432|NCT01510158|465013793|FG002|Overall Study|Death|0|||
129196433|NCT03078556|465013796|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
129196434|NCT03078556|465013797|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
129196435|NCT03078556|465013798|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
129196436|NCT03078556|465013799|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
129196437|NCT03078556|465013796|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
129196438|NCT03078556|465013797|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
129196439|NCT03078556|465013798|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
129196440|NCT03078556|465013799|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
129196441|NCT03078556|465013796|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
129196442|NCT03078556|465013797|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
129196443|NCT03078556|465013798|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
129196444|NCT03078556|465013799|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
129196445|NCT03078556|465013796|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
129196446|NCT03078556|465013797|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
129196447|NCT03078556|465013798|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
129196448|NCT03078556|465013799|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
129196449|NCT01442714|465013801|FG000|Overall Study|Death|11|||
129196450|NCT01442714|465013801|FG000|Overall Study|Withdrawal by Subject|1|||
129196451|NCT04306510|465013802|FG000|Overall Study|Voluntarily withdrawal|1|||
129196452|NCT04306510|465013802|FG000|Overall Study|Enrolled but Not Treated|1|||
129196453|NCT03314987|465013803|FG000|Overall Study|Lost to Follow-up|13|||
129196454|NCT03314987|465013804|FG001|Overall Study|Lost to Follow-up|13|||
129196455|NCT02751580|465013805|FG000|Overall Study|Lost to Follow-up|4|||
129196456|NCT02751580|465013805|FG000|Overall Study|Death|2|||
129196457|NCT04829916|465013809|FG000|Overall Study|Withdrawal by Subject|1|||
129196458|NCT04829916|465013810|FG001|Overall Study|Withdrawal by Subject|0|||
129196459|NCT02152761|465013817|FG000|Epoch: Treatment Epoch|Technical problems|0|||
129196460|NCT02152761|465013818|FG001|Epoch: Treatment Epoch|Technical problems|0|||
129196461|NCT02152761|465013819|FG002|Epoch: Treatment Epoch|Technical problems|0|||
129196462|NCT02152761|465013820|FG003|Epoch: Treatment Epoch|Technical problems|1|||
129196463|NCT02152761|465013817|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
129196464|NCT02152761|465013818|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
129196465|NCT02152761|465013819|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
129196466|NCT02152761|465013820|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
129196467|NCT02152761|465013817|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
129196468|NCT02152761|465013818|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
129196469|NCT02152761|465013819|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
129196470|NCT02152761|465013820|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
129196471|NCT02152761|465013817|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
129196472|NCT02152761|465013818|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
129196473|NCT02152761|465013819|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
129196474|NCT02152761|465013820|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
129196475|NCT02152761|465013817|FG000|Epoch: Treatment Epoch|Death|0|||
129196476|NCT02152761|465013818|FG001|Epoch: Treatment Epoch|Death|3|||
129196477|NCT02152761|465013819|FG002|Epoch: Treatment Epoch|Death|1|||
129196478|NCT02152761|465013820|FG003|Epoch: Treatment Epoch|Death|0|||
129196479|NCT02152761|465013817|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
129196480|NCT02152761|465013818|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
129196481|NCT02152761|465013819|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
129196482|NCT02152761|465013820|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
129196483|NCT02152761|465013817|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
129196484|NCT02152761|465013818|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
129196485|NCT02152761|465013819|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
129196486|NCT02152761|465013820|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
129196487|NCT02152761|465013817|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
129196488|NCT02152761|465013818|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
129196489|NCT02152761|465013819|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
129196490|NCT02152761|465013820|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
129196491|NCT02152761|465013817|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
129196492|NCT02152761|465013818|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
129196493|NCT02152761|465013819|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
129196494|NCT02152761|465013820|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
129196495|NCT02152761|465013817|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
129196496|NCT02152761|465013818|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
129196497|NCT02152761|465013819|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
129196498|NCT02152761|465013820|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
129196499|NCT04343755|465013821|FG000|Overall Study|Death|11|||
129196500|NCT04343755|465013821|FG000|Overall Study|Screen Failure|1|||
129196501|NCT03755882|465013822|FG000|Period 1|Protocol Violation|1|||
129196502|NCT03755882|465013823|FG001|Period 1|Protocol Violation|0|||
129196503|NCT03755882|465013822|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
129196504|NCT03755882|465013823|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
129196505|NCT02292446|465013824|FG000|Overall Study|Adverse Event|12|||
129196506|NCT02292446|465013824|FG000|Overall Study|Death|1|||
129196507|NCT02292446|465013824|FG000|Overall Study|Disease progression|2|||
129196508|NCT02292446|465013824|FG000|Overall Study|Subject/guardian decision|2|||
129196509|NCT02292446|465013824|FG000|Overall Study|Withdrawal by Subject|3|||
129196510|NCT01290757|465013827|FG000|Overall Study|Adverse Event|1|||
129196511|NCT01290757|465013828|FG001|Overall Study|Adverse Event|0|||
129196512|NCT01290757|465013827|FG000|Overall Study|Protocol Violation|1|||
129196513|NCT01290757|465013828|FG001|Overall Study|Protocol Violation|1|||
129196514|NCT01290757|465013827|FG000|Overall Study|Other|0|||
129196515|NCT01290757|465013828|FG001|Overall Study|Other|1|||
129196516|NCT00479336|465013830|FG000|Overall Study|Adverse Event|1|||
129196517|NCT00479336|465013831|FG001|Overall Study|Adverse Event|1|||
129196518|NCT00479336|465013832|FG002|Overall Study|Adverse Event|1|||
129196519|NCT00479336|465013833|FG003|Overall Study|Adverse Event|3|||
129196520|NCT00479336|465013830|FG000|Overall Study|Lack of Efficacy|1|||
129196521|NCT00479336|465013831|FG001|Overall Study|Lack of Efficacy|0|||
129196522|NCT00479336|465013832|FG002|Overall Study|Lack of Efficacy|0|||
129196523|NCT00479336|465013833|FG003|Overall Study|Lack of Efficacy|0|||
129196524|NCT00479336|465013830|FG000|Overall Study|Protocol Violation|0|||
129196525|NCT00479336|465013831|FG001|Overall Study|Protocol Violation|1|||
129196526|NCT00479336|465013832|FG002|Overall Study|Protocol Violation|0|||
129196527|NCT00479336|465013833|FG003|Overall Study|Protocol Violation|0|||
129196528|NCT00479336|465013830|FG000|Overall Study|Withdrawal by Subject|1|||
129196529|NCT00479336|465013831|FG001|Overall Study|Withdrawal by Subject|2|||
129196530|NCT00479336|465013832|FG002|Overall Study|Withdrawal by Subject|0|||
129196531|NCT00479336|465013833|FG003|Overall Study|Withdrawal by Subject|0|||
129196532|NCT00479336|465013830|FG000|Overall Study|Physician Decision|0|||
129196533|NCT00479336|465013831|FG001|Overall Study|Physician Decision|1|||
129196534|NCT00479336|465013832|FG002|Overall Study|Physician Decision|0|||
129196535|NCT00479336|465013833|FG003|Overall Study|Physician Decision|2|||
129196536|NCT00479336|465013830|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
129196537|NCT00479336|465013831|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
129196538|NCT00479336|465013832|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
129196539|NCT00479336|465013833|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
129196540|NCT03329846|465013834|FG000|Overall Study|Disease progression|4|||
129196541|NCT03329846|465013835|FG001|Overall Study|Disease progression|6|||
129196542|NCT03329846|465013834|FG000|Overall Study|Study drug toxicity|1|||
129196543|NCT03329846|465013835|FG001|Overall Study|Study drug toxicity|0|||
129196544|NCT03329846|465013834|FG000|Overall Study|Participant request to discontinue treatment|0|||
129196545|NCT03329846|465013835|FG001|Overall Study|Participant request to discontinue treatment|1|||
129196546|NCT03329846|465013834|FG000|Overall Study|Participant withdrew consent|1|||
129196547|NCT03329846|465013835|FG001|Overall Study|Participant withdrew consent|0|||
129196548|NCT03329846|465013834|FG000|Overall Study|Other reasons|2|||
129196549|NCT03329846|465013835|FG001|Overall Study|Other reasons|2|||
129196550|NCT03066193|465013836|FG000|Overall Study|Withdrawal by Subject|1|||
129196551|NCT02021643|465013837|FG000|Overall Study|Enrolled but Never Treated|1|||
129196552|NCT02021643|465013838|FG001|Overall Study|Enrolled but Never Treated|0|||
129196553|NCT02021643|465013839|FG002|Overall Study|Enrolled but Never Treated|0|||
129196554|NCT02021643|465013840|FG003|Overall Study|Enrolled but Never Treated|0|||
129196555|NCT02021643|465013837|FG000|Overall Study|Adverse Event|0|||
129196556|NCT02021643|465013838|FG001|Overall Study|Adverse Event|1|||
129196557|NCT02021643|465013839|FG002|Overall Study|Adverse Event|0|||
128731375|NCT02984020|463312772|FG000|Overall Study|Other significant protocol violation|2|||
128731376|NCT01700179|463312774|FG000|Overall Study|Physician Decision|2|||
128731377|NCT00679341|463312775|FG000|Overall Study|Disease progression|42|||
128731378|NCT00679341|463312776|FG001|Overall Study|Disease progression|36|||
128731379|NCT00679341|463312775|FG000|Overall Study|Adverse Event|5|||
128731380|NCT00679341|463312776|FG001|Overall Study|Adverse Event|6|||
129196558|NCT02021643|465013840|FG003|Overall Study|Adverse Event|0|||
129196559|NCT02021643|465013837|FG000|Overall Study|Death|0|||
129196560|NCT02021643|465013838|FG001|Overall Study|Death|1|||
129196561|NCT02021643|465013839|FG002|Overall Study|Death|0|||
129196562|NCT02021643|465013840|FG003|Overall Study|Death|0|||
129196563|NCT02021643|465013837|FG000|Overall Study|Investigator's Discretion|1|||
129196564|NCT02021643|465013838|FG001|Overall Study|Investigator's Discretion|0|||
129196565|NCT02021643|465013839|FG002|Overall Study|Investigator's Discretion|0|||
129196566|NCT02021643|465013840|FG003|Overall Study|Investigator's Discretion|0|||
129196567|NCT02021643|465013837|FG000|Overall Study|Lack of Efficacy|7|||
129196568|NCT02021643|465013838|FG001|Overall Study|Lack of Efficacy|6|||
129196569|NCT02021643|465013839|FG002|Overall Study|Lack of Efficacy|0|||
129196570|NCT02021643|465013840|FG003|Overall Study|Lack of Efficacy|12|||
129196571|NCT02021643|465013837|FG000|Overall Study|Lost to Follow-up|0|||
129196572|NCT02021643|465013838|FG001|Overall Study|Lost to Follow-up|1|||
129196573|NCT02021643|465013839|FG002|Overall Study|Lost to Follow-up|0|||
129196574|NCT02021643|465013840|FG003|Overall Study|Lost to Follow-up|0|||
129196575|NCT02021643|465013837|FG000|Overall Study|Withdrew Consent|0|||
129196576|NCT02021643|465013838|FG001|Overall Study|Withdrew Consent|1|||
129196577|NCT02021643|465013839|FG002|Overall Study|Withdrew Consent|0|||
129196578|NCT02021643|465013840|FG003|Overall Study|Withdrew Consent|0|||
129196579|NCT04854551|465013841|FG000|Overall Study|Withdrawal by Subject|1|||
129196580|NCT04854551|465013842|FG001|Overall Study|Withdrawal by Subject|1|||
129196581|NCT02631551|465013843|FG000|Overall Study|Adverse Event|1|||
129196582|NCT02631551|465013844|FG001|Overall Study|Adverse Event|2|||
129196583|NCT02631551|465013845|FG002|Overall Study|Adverse Event|4|||
129196584|NCT02631551|465013846|FG003|Overall Study|Adverse Event|0|||
129196585|NCT02631551|465013843|FG000|Overall Study|Lack of Efficacy|0|||
129196586|NCT02631551|465013844|FG001|Overall Study|Lack of Efficacy|0|||
129196587|NCT02631551|465013845|FG002|Overall Study|Lack of Efficacy|1|||
129196588|NCT02631551|465013846|FG003|Overall Study|Lack of Efficacy|0|||
129196589|NCT02631551|465013843|FG000|Overall Study|Lost to Follow-up|1|||
129196590|NCT02631551|465013844|FG001|Overall Study|Lost to Follow-up|2|||
129196591|NCT02631551|465013845|FG002|Overall Study|Lost to Follow-up|0|||
129196592|NCT02631551|465013846|FG003|Overall Study|Lost to Follow-up|3|||
129196593|NCT02631551|465013843|FG000|Overall Study|Withdrawal by Subject|2|||
129196594|NCT02631551|465013844|FG001|Overall Study|Withdrawal by Subject|2|||
129196595|NCT02631551|465013845|FG002|Overall Study|Withdrawal by Subject|0|||
129196596|NCT02631551|465013846|FG003|Overall Study|Withdrawal by Subject|5|||
129196597|NCT02631551|465013843|FG000|Overall Study|Protocol deviation|3|||
129196598|NCT02631551|465013844|FG001|Overall Study|Protocol deviation|6|||
129196599|NCT02631551|465013845|FG002|Overall Study|Protocol deviation|3|||
129196600|NCT02631551|465013846|FG003|Overall Study|Protocol deviation|0|||
129196601|NCT02631551|465013843|FG000|Overall Study|Non-compliance with study procedures|0|||
129196602|NCT02631551|465013844|FG001|Overall Study|Non-compliance with study procedures|0|||
129196603|NCT02631551|465013845|FG002|Overall Study|Non-compliance with study procedures|1|||
129196604|NCT02631551|465013846|FG003|Overall Study|Non-compliance with study procedures|1|||
129196605|NCT02631551|465013843|FG000|Overall Study|Non-compliance with study drug|1|||
129196606|NCT02631551|465013844|FG001|Overall Study|Non-compliance with study drug|0|||
129196607|NCT02631551|465013845|FG002|Overall Study|Non-compliance with study drug|0|||
129196608|NCT02631551|465013846|FG003|Overall Study|Non-compliance with study drug|0|||
129196609|NCT02631551|465013843|FG000|Overall Study|Other, specific reasons not collected|5|||
128731381|NCT00679341|463312775|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
129196610|NCT02631551|465013844|FG001|Overall Study|Other, specific reasons not collected|7|||
129196611|NCT02631551|465013845|FG002|Overall Study|Other, specific reasons not collected|2|||
129196612|NCT02631551|465013846|FG003|Overall Study|Other, specific reasons not collected|2|||
129196613|NCT04112303|465013847|FG000|Overall Study|Death|1|||
129196614|NCT05636852|465013855|FG000|Overall Study|Withdrawal by Subject|1|||
129196615|NCT05636852|465013855|FG000|Overall Study|Other than specified|1|||
129196616|NCT01076036|465013856|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
129196617|NCT03088917|465013857|FG000|Overall Study|In care/cured elsewhere|15|||
129196618|NCT03088917|465013857|FG000|Overall Study|Refuse re-evaluation|13|||
129196619|NCT03088917|465013857|FG000|Overall Study|Contact not established|13|||
129196620|NCT03088917|465013857|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
129196621|NCT03088917|465013857|FG000|Overall Study|Moved outside study region|50|||
129196622|NCT01221350|465013858|FG000|Overall Study|Discontinued intervention (GERD)|1|||
129196623|NCT01221350|465013859|FG001|Overall Study|Discontinued intervention (GERD)|0|||
129196624|NCT01221350|465013858|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
129196625|NCT01221350|465013859|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
129196626|NCT01221350|465013858|FG000|Overall Study|Withdrawal by Subject|4|||
129196627|NCT01221350|465013859|FG001|Overall Study|Withdrawal by Subject|2|||
129196628|NCT02735343|465013865|FG000|Overall Study|screen fail|0|||
129196629|NCT02735343|465013866|FG001|Overall Study|screen fail|2|||
129196630|NCT02204072|465013870|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
129196631|NCT02204072|465013871|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
129196632|NCT02204072|465013872|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
129196633|NCT02204072|465013873|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
129196634|NCT02204072|465013874|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
129196635|NCT02204072|465013870|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
129196636|NCT02204072|465013871|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
129196637|NCT02204072|465013872|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
129196638|NCT02204072|465013873|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
129196639|NCT02204072|465013874|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
129196640|NCT02204072|465013870|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
129196641|NCT02204072|465013871|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
129196642|NCT02204072|465013872|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
129196643|NCT02204072|465013873|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
129196644|NCT02204072|465013874|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
129196645|NCT02204072|465013870|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129196646|NCT02204072|465013871|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129196647|NCT02204072|465013872|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
129196648|NCT02204072|465013873|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129196649|NCT02204072|465013874|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129196650|NCT04209205|465013878|FG000|Overall Study|Adverse Event|2|||
129196651|NCT04209205|465013879|FG001|Overall Study|Adverse Event|3|||
129196652|NCT04209205|465013878|FG000|Overall Study|Lost to Follow-up|3|||
129196653|NCT04209205|465013879|FG001|Overall Study|Lost to Follow-up|1|||
129196654|NCT04209205|465013878|FG000|Overall Study|Physician Decision|1|||
129196655|NCT04209205|465013879|FG001|Overall Study|Physician Decision|1|||
129196656|NCT04209205|465013878|FG000|Overall Study|Subject decision|10|||
129196657|NCT04209205|465013879|FG001|Overall Study|Subject decision|10|||
129196658|NCT04209205|465013878|FG000|Overall Study|Progressive disease|1|||
129196659|NCT04209205|465013879|FG001|Overall Study|Progressive disease|0|||
129196660|NCT04209205|465013878|FG000|Overall Study|Protocol deviation|0|||
129196661|NCT04209205|465013879|FG001|Overall Study|Protocol deviation|1|||
129196662|NCT04209205|465013878|FG000|Overall Study|New therapy for study indication|1|||
129196663|NCT04209205|465013879|FG001|Overall Study|New therapy for study indication|0|||
129196664|NCT04209205|465013878|FG000|Overall Study|Adverse event - placebo not switched|0|||
129196665|NCT04209205|465013879|FG001|Overall Study|Adverse event - placebo not switched|1|||
129196666|NCT04209205|465013878|FG000|Overall Study|Subject decision - placebo not switched|0|||
129196667|NCT04209205|465013879|FG001|Overall Study|Subject decision - placebo not switched|5|||
129196668|NCT04209205|465013878|FG000|Overall Study|Death - placebo not switched|0|||
129196669|NCT04209205|465013879|FG001|Overall Study|Death - placebo not switched|1|||
129196670|NCT03761810|465013882|FG000|Overall Study|Adverse Event|12|||
129196671|NCT03761810|465013883|FG001|Overall Study|Adverse Event|0|||
129196672|NCT03761810|465013882|FG000|Overall Study|Lost to Follow-up|15|||
129196673|NCT03761810|465013883|FG001|Overall Study|Lost to Follow-up|7|||
129196674|NCT03761810|465013882|FG000|Overall Study|Pregnancy|1|||
129196675|NCT03761810|465013883|FG001|Overall Study|Pregnancy|0|||
129196676|NCT03761810|465013882|FG000|Overall Study|Withdrawal by Subject|14|||
129196677|NCT03761810|465013883|FG001|Overall Study|Withdrawal by Subject|5|||
129196678|NCT03761810|465013882|FG000|Overall Study|Physician Decision|1|||
128731382|NCT00679341|463312776|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
128731383|NCT00679341|463312775|FG000|Overall Study|Death|1|||
128731384|NCT00679341|463312776|FG001|Overall Study|Death|1|||
129196679|NCT03761810|465013883|FG001|Overall Study|Physician Decision|0|||
129196680|NCT03761810|465013882|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
129196681|NCT03761810|465013883|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129196682|NCT03761810|465013882|FG000|Overall Study|Other Than Specified|1|||
129196683|NCT03761810|465013883|FG001|Overall Study|Other Than Specified|0|||
129196684|NCT01574651|465013884|FG000|Overall Study|Lost to Follow-up|2|||
129196685|NCT01574651|465013885|FG001|Overall Study|Lost to Follow-up|4|||
129196686|NCT01574651|465013884|FG000|Overall Study|Administrative problems|0|||
129196687|NCT01574651|465013885|FG001|Overall Study|Administrative problems|1|||
129196688|NCT01574651|465013884|FG000|Overall Study|Death|3|||
129196689|NCT01574651|465013885|FG001|Overall Study|Death|3|||
129196690|NCT01574651|465013884|FG000|Overall Study|Patient's inability to use the device|0|||
129196691|NCT01574651|465013885|FG001|Overall Study|Patient's inability to use the device|1|||
129196692|NCT01574651|465013884|FG000|Overall Study|Adverse Event|36|||
129196693|NCT01574651|465013885|FG001|Overall Study|Adverse Event|27|||
129196694|NCT01574651|465013884|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129196695|NCT01574651|465013885|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129196696|NCT01574651|465013884|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129196697|NCT01574651|465013885|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129196698|NCT01574651|465013884|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129196699|NCT01574651|465013885|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129196700|NCT01574651|465013884|FG000|Overall Study|Protocol Violation|3|||
129196701|NCT01574651|465013885|FG001|Overall Study|Protocol Violation|5|||
129196702|NCT01574651|465013884|FG000|Overall Study|Withdrawal by Subject|9|||
129196703|NCT01574651|465013885|FG001|Overall Study|Withdrawal by Subject|10|||
129196704|NCT03887221|465013886|FG000|Overall Study|Protocol Violation|1|||
129196705|NCT03887221|465013887|FG001|Overall Study|Protocol Violation|0|||
129196706|NCT02487030|465013888|FG000|Overall Study|Lack of Efficacy|2|||
129196707|NCT02487030|465013889|FG001|Overall Study|Lack of Efficacy|4|||
129196708|NCT02487030|465013890|FG002|Overall Study|Lack of Efficacy|1|||
129196709|NCT02487030|465013891|FG003|Overall Study|Lack of Efficacy|0|||
129196710|NCT02487030|465013892|FG004|Overall Study|Lack of Efficacy|1|||
129196711|NCT02487030|465013893|FG005|Overall Study|Lack of Efficacy|0|||
129196712|NCT02487030|465013894|FG006|Overall Study|Lack of Efficacy|0|||
129196713|NCT02487030|465013888|FG000|Overall Study|Lost to Follow-up|0|||
129196714|NCT02487030|465013889|FG001|Overall Study|Lost to Follow-up|0|||
129196715|NCT02487030|465013890|FG002|Overall Study|Lost to Follow-up|1|||
129196716|NCT02487030|465013891|FG003|Overall Study|Lost to Follow-up|1|||
129196717|NCT02487030|465013892|FG004|Overall Study|Lost to Follow-up|0|||
129196718|NCT02487030|465013893|FG005|Overall Study|Lost to Follow-up|1|||
129196719|NCT02487030|465013894|FG006|Overall Study|Lost to Follow-up|0|||
129196720|NCT02487030|465013888|FG000|Overall Study|Adverse Event|0|||
129196721|NCT02487030|465013889|FG001|Overall Study|Adverse Event|0|||
129196722|NCT02487030|465013890|FG002|Overall Study|Adverse Event|0|||
129196723|NCT02487030|465013891|FG003|Overall Study|Adverse Event|1|||
129196724|NCT02487030|465013892|FG004|Overall Study|Adverse Event|0|||
129196725|NCT02487030|465013893|FG005|Overall Study|Adverse Event|0|||
129196726|NCT02487030|465013894|FG006|Overall Study|Adverse Event|0|||
129196727|NCT02487030|465013888|FG000|Overall Study|Death|0|||
129196728|NCT02487030|465013889|FG001|Overall Study|Death|0|||
129196729|NCT02487030|465013890|FG002|Overall Study|Death|0|||
129196730|NCT02487030|465013891|FG003|Overall Study|Death|0|||
129196731|NCT02487030|465013892|FG004|Overall Study|Death|1|||
129196732|NCT02487030|465013893|FG005|Overall Study|Death|0|||
129196733|NCT02487030|465013894|FG006|Overall Study|Death|0|||
129196734|NCT02092025|465013895|FG000|Overall Study|Case Report Forms Uncollected|44|||
129196735|NCT02092025|465013895|FG000|Overall Study|Protocol Deviation|24|||
129196736|NCT00264537|465013896|FG000|Overall Study|Death|0|||
129196737|NCT00264537|465013897|FG001|Overall Study|Death|3|||
129196738|NCT00264537|465013898|FG002|Overall Study|Death|3|||
129196739|NCT00264537|465013899|FG003|Overall Study|Death|2|||
129196740|NCT00264537|465013896|FG000|Overall Study|Lost to Follow-up|3|||
129196741|NCT00264537|465013897|FG001|Overall Study|Lost to Follow-up|4|||
129196742|NCT00264537|465013898|FG002|Overall Study|Lost to Follow-up|7|||
129196743|NCT00264537|465013899|FG003|Overall Study|Lost to Follow-up|6|||
129196744|NCT00264537|465013896|FG000|Overall Study|Adverse Event|21|||
129196745|NCT00264537|465013897|FG001|Overall Study|Adverse Event|32|||
129196746|NCT00264537|465013898|FG002|Overall Study|Adverse Event|24|||
129196747|NCT00264537|465013899|FG003|Overall Study|Adverse Event|34|||
129196748|NCT00264537|465013896|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129196749|NCT00264537|465013897|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129196750|NCT00264537|465013898|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
129196751|NCT00264537|465013899|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
129196752|NCT00264537|465013896|FG000|Overall Study|Other|21|||
129196753|NCT00264537|465013897|FG001|Overall Study|Other|11|||
129196754|NCT00264537|465013898|FG002|Overall Study|Other|10|||
129196755|NCT00264537|465013899|FG003|Overall Study|Other|11|||
129196756|NCT00264537|465013896|FG000|Overall Study|Not treated|0|||
129196757|NCT00264537|465013897|FG001|Overall Study|Not treated|2|||
129196758|NCT00264537|465013898|FG002|Overall Study|Not treated|1|||
129196759|NCT00264537|465013899|FG003|Overall Study|Not treated|0|||
129196760|NCT03228212|465013901|FG000|Period 1|Adverse Event|1|||
129196761|NCT03228212|465013902|FG001|Period 1|Adverse Event|0|||
129196762|NCT03228212|465013901|FG000|Period 1|no longer meets eligibility criteria|0|||
129196763|NCT03228212|465013902|FG001|Period 1|no longer meets eligibility criteria|1|||
129196764|NCT03228212|465013901|FG000|Period 2|Lost to Follow-up|1|||
129196765|NCT03228212|465013902|FG001|Period 2|Lost to Follow-up|0|||
129196766|NCT01807299|465013903|FG000|Overall Study|Protocol Violation|3|||
129196767|NCT01807299|465013904|FG001|Overall Study|Protocol Violation|1|||
129196768|NCT01807299|465013905|FG002|Overall Study|Protocol Violation|0|||
129196769|NCT01807299|465013906|FG003|Overall Study|Protocol Violation|2|||
129196770|NCT00999544|465015759|FG000|Overall Study|Withdrawal by Subject|1|||
129196771|NCT04864639|465015760|FG000|Overall Study|Death|1|||
129196772|NCT04864639|465015760|FG000|Overall Study|Lost to Follow-up|1|||
129196773|NCT01478971|465015769|FG000|Standard of Care Period|Adverse Event|1|||
129196774|NCT01478971|465015769|FG000|Standard of Care Period|Withdrawal by Subject|3|||
129196775|NCT01478971|465015769|FG000|Standard of Care Period|Death|8|||
129196776|NCT01478971|465015769|FG000|Standard of Care Period|Lost to Follow-up|9|||
129196777|NCT01478971|465015769|FG000|Standard of Care Period|Other|4|||
129196778|NCT01478971|465015769|FG000|Peginesatide Treatment Period|Adverse Event|1|||
129196779|NCT01478971|465015769|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
129196780|NCT01478971|465015769|FG000|Peginesatide Treatment Period|Death|4|||
129196781|NCT01478971|465015769|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
129196782|NCT01478971|465015769|FG000|Peginesatide Treatment Period|Other|4|||
129196783|NCT00584012|465015770|FG000|Overall Study|Withdrawal by Subject|1|||
129196784|NCT01525615|465015771|FG000|Overall Study|Adverse Event|11|||
129196785|NCT01525615|465015772|FG001|Overall Study|Adverse Event|7|||
129196786|NCT01525615|465015773|FG002|Overall Study|Adverse Event|5|||
129196787|NCT01525615|465015771|FG000|Overall Study|Lost to Follow-up|1|||
129196788|NCT01525615|465015772|FG001|Overall Study|Lost to Follow-up|0|||
129196789|NCT01525615|465015773|FG002|Overall Study|Lost to Follow-up|0|||
129196790|NCT01525615|465015771|FG000|Overall Study|Withdrawal by Subject|1|||
129196791|NCT01525615|465015772|FG001|Overall Study|Withdrawal by Subject|0|||
129196792|NCT01525615|465015773|FG002|Overall Study|Withdrawal by Subject|0|||
129196793|NCT01525615|465015771|FG000|Overall Study|Other reason not described above|1|||
129196794|NCT01525615|465015772|FG001|Overall Study|Other reason not described above|0|||
129196795|NCT01525615|465015773|FG002|Overall Study|Other reason not described above|1|||
129196796|NCT04050618|465015774|FG000|First Intervention|Withdrawal by Subject|2|||
129196797|NCT04050618|465015775|FG001|First Intervention|Withdrawal by Subject|0|||
129196798|NCT04050618|465015774|FG000|Second Intervention|Withdrawal by Subject|1|||
129196799|NCT04050618|465015775|FG001|Second Intervention|Withdrawal by Subject|0|||
129196800|NCT04404556|465015776|FG000|Intervention|Withdrawal by Subject|15|||
129196801|NCT04404556|465015777|FG001|Intervention|Withdrawal by Subject|3|||
129196802|NCT04404556|465015776|FG000|Intervention|Did not complete all intervention sessions|2|||
129196803|NCT04404556|465015777|FG001|Intervention|Did not complete all intervention sessions|1|||
129196804|NCT04404556|465015776|FG000|Post-Intervention|Missing Data|1|||
129196805|NCT04404556|465015777|FG001|Post-Intervention|Missing Data|2|||
129196806|NCT04404556|465015776|FG000|Follow-up 1|Withdrawal by Subject|5|||
129196807|NCT04404556|465015777|FG001|Follow-up 1|Withdrawal by Subject|1|||
129196808|NCT04404556|465015776|FG000|Follow-up 1|Missing Data|4|||
129196809|NCT04404556|465015777|FG001|Follow-up 1|Missing Data|7|||
129196810|NCT04404556|465015776|FG000|Follow-up 2|Withdrawal by Subject|1|||
129196811|NCT04404556|465015777|FG001|Follow-up 2|Withdrawal by Subject|1|||
129196812|NCT04404556|465015776|FG000|Follow-up 2|Missing Data|6|||
129196813|NCT04404556|465015777|FG001|Follow-up 2|Missing Data|5|||
129196814|NCT03777059|465015778|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
129196815|NCT03777059|465015779|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
129196816|NCT03777059|465015780|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
129196817|NCT03777059|465015781|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
129196818|NCT03777059|465015778|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
129196819|NCT03777059|465015779|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
129196820|NCT03777059|465015780|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
129196821|NCT03777059|465015781|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
129196822|NCT03777059|465015778|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
129196823|NCT03777059|465015779|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
129196824|NCT03777059|465015780|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
129196825|NCT03777059|465015781|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
129196826|NCT03777059|465015778|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
129196827|NCT03777059|465015779|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
129196828|NCT03777059|465015780|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
129196829|NCT03777059|465015781|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
128731385|NCT00679341|463312775|FG000|Overall Study|Other|1|||
129196830|NCT03777059|465015778|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
129196831|NCT03777059|465015779|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
129196832|NCT03777059|465015780|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
129196833|NCT03777059|465015781|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
129196834|NCT03777059|465015778|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
129196835|NCT03777059|465015779|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
129196836|NCT03777059|465015780|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
129196837|NCT03777059|465015781|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
129196838|NCT03777059|465015778|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
129196839|NCT03777059|465015779|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
129196840|NCT03777059|465015780|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
129196841|NCT03777059|465015781|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
129196842|NCT03777059|465015778|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
129196843|NCT03777059|465015779|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
129196844|NCT03777059|465015780|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
129196845|NCT03777059|465015781|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
129196846|NCT03777059|465015778|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
129196847|NCT03777059|465015779|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
129196848|NCT03777059|465015780|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
129196849|NCT03777059|465015781|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
129196850|NCT03777059|465015778|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
129196851|NCT03777059|465015779|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
129196852|NCT03777059|465015780|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
129196853|NCT03777059|465015781|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
129196854|NCT03777059|465015778|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
129196855|NCT03777059|465015779|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
129196856|NCT03777059|465015780|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
129196857|NCT03777059|465015781|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
129196858|NCT00763386|465015786|FG000|Overall Study|Adverse Event|43|||
129196859|NCT00763386|465015787|FG001|Overall Study|Adverse Event|33|||
129196860|NCT00763386|465015786|FG000|Overall Study|Death|1|||
129196861|NCT00763386|465015787|FG001|Overall Study|Death|2|||
129196862|NCT00763386|465015786|FG000|Overall Study|Lost to Follow-up|3|||
129196863|NCT00763386|465015787|FG001|Overall Study|Lost to Follow-up|3|||
129196864|NCT00763386|465015786|FG000|Overall Study|Withdrawal by Subject|0|||
129196865|NCT00763386|465015787|FG001|Overall Study|Withdrawal by Subject|1|||
129196866|NCT00763386|465015786|FG000|Overall Study|CRF missing|0|||
129196867|NCT00763386|465015787|FG001|Overall Study|CRF missing|1|||
129196868|NCT00763386|465015786|FG000|Overall Study|Study Prosthesis Removed|1|||
129196869|NCT00763386|465015787|FG001|Overall Study|Study Prosthesis Removed|0|||
129196870|NCT00411671|465015788|FG000|Overall Study|Adverse Event|15|||
129196871|NCT00411671|465015788|FG000|Overall Study|Death|2|||
129196872|NCT00411671|465015788|FG000|Overall Study|Lost to Follow-up|3|||
129196873|NCT01173601|465015790|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
129196874|NCT01173601|465015791|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129196875|NCT01173601|465015792|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129196876|NCT01173601|465015793|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129196877|NCT01173601|465015794|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129196878|NCT01173601|465015790|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
129196879|NCT01173601|465015791|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129196880|NCT01173601|465015792|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129196881|NCT01173601|465015793|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129196882|NCT01173601|465015794|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129196883|NCT01173601|465015790|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
129196884|NCT01173601|465015791|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129196885|NCT01173601|465015792|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129196886|NCT01173601|465015793|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129196887|NCT01173601|465015794|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129196888|NCT01173601|465015790|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
129196889|NCT01173601|465015791|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129196890|NCT01173601|465015792|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129196891|NCT01173601|465015793|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129196892|NCT01173601|465015794|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128731386|NCT00679341|463312776|FG001|Overall Study|Other|0|||
128731387|NCT00679341|463312775|FG000|Overall Study|Physician Decision|1|||
129196893|NCT01173601|465015790|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
129196894|NCT01173601|465015791|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129196895|NCT01173601|465015792|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129196896|NCT01173601|465015793|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128731388|NCT00679341|463312776|FG001|Overall Study|Physician Decision|0|||
128731389|NCT00679341|463312775|FG000|Overall Study|Not treated|0|||
128731390|NCT00679341|463312776|FG001|Overall Study|Not treated|2|||
128731391|NCT00679341|463312775|FG000|Overall Study|Physician/patient decision to withdraw|0|||
128731392|NCT00679341|463312776|FG001|Overall Study|Physician/patient decision to withdraw|6|||
128731393|NCT00667342|463312777|FG000|Overall Study|Protocol Violation|1|||
128731394|NCT00667342|463312778|FG001|Overall Study|Protocol Violation|0|||
128731395|NCT00667342|463312779|FG002|Overall Study|Protocol Violation|0|||
128731396|NCT00667342|463312777|FG000|Overall Study|Withdrawal by Subject|1|||
128731397|NCT00667342|463312778|FG001|Overall Study|Withdrawal by Subject|0|||
128731398|NCT00667342|463312779|FG002|Overall Study|Withdrawal by Subject|0|||
128731399|NCT00667342|463312777|FG000|Overall Study|Physician Decision|3|||
128731400|NCT00667342|463312778|FG001|Overall Study|Physician Decision|0|||
128731401|NCT00667342|463312779|FG002|Overall Study|Physician Decision|0|||
128731402|NCT00667342|463312777|FG000|Overall Study|Relapse or tumor progression|9|||
128731403|NCT00667342|463312778|FG001|Overall Study|Relapse or tumor progression|0|||
128731404|NCT00667342|463312779|FG002|Overall Study|Relapse or tumor progression|7|||
128731405|NCT00667342|463312777|FG000|Overall Study|Adverse Event|0|||
128731406|NCT00667342|463312778|FG001|Overall Study|Adverse Event|0|||
128731407|NCT00667342|463312779|FG002|Overall Study|Adverse Event|1|||
128731408|NCT00667342|463312777|FG000|Overall Study|Ineligible|0|||
128731409|NCT00667342|463312778|FG001|Overall Study|Ineligible|0|||
128731410|NCT00667342|463312779|FG002|Overall Study|Ineligible|1|||
129196897|NCT01173601|465015794|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129196898|NCT01173601|465015790|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
129196899|NCT01173601|465015791|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129196900|NCT01173601|465015792|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129196901|NCT01173601|465015793|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129196902|NCT01173601|465015794|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129196903|NCT01173601|465015790|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
129196904|NCT01173601|465015791|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129196905|NCT01173601|465015792|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129196906|NCT01173601|465015793|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129196907|NCT01173601|465015794|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129196908|NCT01173601|465015790|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
129196909|NCT01173601|465015791|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
129196910|NCT01173601|465015792|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
129196911|NCT01173601|465015793|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
129196912|NCT01173601|465015794|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
129196913|NCT01173601|465015790|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
129196914|NCT01173601|465015791|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
129196915|NCT01173601|465015792|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
129196916|NCT01173601|465015793|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
129196917|NCT01173601|465015794|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
129196918|NCT01173601|465015790|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
128731411|NCT01207778|463312780|FG000|Overall Study|Lost to Follow-up|0|||
128731412|NCT01207778|463312781|FG001|Overall Study|Lost to Follow-up|3|||
128731413|NCT01207778|463312782|FG002|Overall Study|Lost to Follow-up|3|||
128731414|NCT00646204|463312783|FG000|Overall Study|Adverse Event|3|||
128731415|NCT00646204|463312784|FG001|Overall Study|Adverse Event|0|||
128731416|NCT00646204|463312783|FG000|Overall Study|Withdrawal by Subject|1|||
128731417|NCT00646204|463312784|FG001|Overall Study|Withdrawal by Subject|0|||
129196919|NCT01173601|465015791|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
129196920|NCT01173601|465015792|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129196921|NCT01173601|465015793|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
129196922|NCT01173601|465015794|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
129196923|NCT01173601|465015790|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129196924|NCT01173601|465015791|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
129196925|NCT01173601|465015792|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129196926|NCT01173601|465015793|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
129196927|NCT01173601|465015794|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129196928|NCT01173601|465015790|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
129196929|NCT01173601|465015791|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
129196930|NCT01173601|465015792|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129196931|NCT01173601|465015793|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
129196932|NCT01173601|465015794|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129196933|NCT01173601|465015790|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
129196934|NCT01173601|465015791|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
129196935|NCT01173601|465015792|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
129196936|NCT01173601|465015793|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
129196937|NCT01173601|465015794|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
129196938|NCT01173601|465015790|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129196939|NCT01173601|465015791|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129196940|NCT01173601|465015792|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129196941|NCT01173601|465015793|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129196942|NCT01173601|465015794|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
129196943|NCT03951077|465015795|FG000|Overall Study|Adverse Event|1|||
129196944|NCT03951077|465015796|FG001|Overall Study|Adverse Event|0|||
129196945|NCT03951077|465015797|FG002|Overall Study|Adverse Event|0|||
129196946|NCT03951077|465015798|FG003|Overall Study|Adverse Event|0|||
129196947|NCT03951077|465015799|FG004|Overall Study|Adverse Event|0|||
129196948|NCT03951077|465015800|FG005|Overall Study|Adverse Event|0|||
129196949|NCT03951077|465015795|FG000|Overall Study|Withdrawal by Subject|3|||
129196950|NCT03951077|465015796|FG001|Overall Study|Withdrawal by Subject|3|||
129196951|NCT03951077|465015797|FG002|Overall Study|Withdrawal by Subject|0|||
129196952|NCT03951077|465015798|FG003|Overall Study|Withdrawal by Subject|3|||
129196953|NCT03951077|465015799|FG004|Overall Study|Withdrawal by Subject|3|||
129196954|NCT03951077|465015800|FG005|Overall Study|Withdrawal by Subject|2|||
129196955|NCT03951077|465015795|FG000|Overall Study|Lost to Follow-up|1|||
129196956|NCT03951077|465015796|FG001|Overall Study|Lost to Follow-up|1|||
129196957|NCT03951077|465015797|FG002|Overall Study|Lost to Follow-up|2|||
129196958|NCT03951077|465015798|FG003|Overall Study|Lost to Follow-up|3|||
129196959|NCT03951077|465015799|FG004|Overall Study|Lost to Follow-up|2|||
129196960|NCT03951077|465015800|FG005|Overall Study|Lost to Follow-up|3|||
129196961|NCT03951077|465015795|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
129196962|NCT03951077|465015796|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
129196963|NCT03951077|465015797|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
129196964|NCT03951077|465015798|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
129196965|NCT03951077|465015799|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
129196966|NCT03951077|465015800|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
129196967|NCT03951077|465015795|FG000|Overall Study|Other, Not Specified|12|||
129196968|NCT03951077|465015796|FG001|Overall Study|Other, Not Specified|10|||
129196969|NCT03951077|465015797|FG002|Overall Study|Other, Not Specified|10|||
129196970|NCT03951077|465015798|FG003|Overall Study|Other, Not Specified|5|||
129196971|NCT03951077|465015799|FG004|Overall Study|Other, Not Specified|9|||
129196972|NCT03951077|465015800|FG005|Overall Study|Other, Not Specified|6|||
128731418|NCT00326612|463312788|FG000|Overall Study|They did not have a seizure requiring tx|129|||
129196973|NCT03951077|465015795|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
129196974|NCT03951077|465015796|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
129196975|NCT03951077|465015797|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
129196976|NCT03951077|465015798|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
128781090|NCT02851511|463490444|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
128781091|NCT02851511|463490445|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
128781092|NCT02851511|463490446|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
128781093|NCT02851511|463490447|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
128781094|NCT02851511|463490444|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
128781095|NCT02851511|463490445|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
128781096|NCT02851511|463490446|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
128781097|NCT02851511|463490447|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
128781098|NCT02851511|463490444|FG000|Phase I|Physician Decision|0|||
128781099|NCT02851511|463490445|FG001|Phase I|Physician Decision|0|||
128781100|NCT02851511|463490446|FG002|Phase I|Physician Decision|0|||
128781101|NCT02851511|463490447|FG003|Phase I|Physician Decision|1|||
128781102|NCT02851511|463490444|FG000|Phase I|Withdrawal by Subject|2|||
128781103|NCT02851511|463490445|FG001|Phase I|Withdrawal by Subject|1|||
128781104|NCT02851511|463490446|FG002|Phase I|Withdrawal by Subject|0|||
128781105|NCT02851511|463490447|FG003|Phase I|Withdrawal by Subject|3|||
128781106|NCT02851511|463490444|FG000|Phase II|Physician Decision|18|||
128781107|NCT02851511|463490445|FG001|Phase II|Physician Decision|16|||
128781108|NCT02851511|463490446|FG002|Phase II|Physician Decision|0|||
128781109|NCT02851511|463490447|FG003|Phase II|Physician Decision|0|||
128781110|NCT02851511|463490444|FG000|Phase II|Withdrawal by Subject|18|||
128781111|NCT02851511|463490445|FG001|Phase II|Withdrawal by Subject|16|||
128781112|NCT02851511|463490446|FG002|Phase II|Withdrawal by Subject|0|||
129196977|NCT03951077|465015799|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
129196978|NCT03951077|465015800|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
129196979|NCT01395901|465015803|FG000|Overall Study|Lost to Follow-up|4|||
129196980|NCT01395901|465015804|FG001|Overall Study|Lost to Follow-up|0|||
129196981|NCT01395901|465015803|FG000|Overall Study|Randomized but not received study drug|5|||
129196982|NCT01395901|465015804|FG001|Overall Study|Randomized but not received study drug|4|||
129196983|NCT01395901|465015803|FG000|Overall Study|Adverse Event|0|||
129196984|NCT01395901|465015804|FG001|Overall Study|Adverse Event|1|||
129196985|NCT01395901|465015803|FG000|Overall Study|Withdrawal of consent|1|||
129196986|NCT01395901|465015804|FG001|Overall Study|Withdrawal of consent|0|||
129196987|NCT00713544|465015810|FG000|Overall Study|Adverse Event|5|||
129196988|NCT00713544|465015811|FG001|Overall Study|Adverse Event|3|||
129196989|NCT00713544|465015812|FG002|Overall Study|Adverse Event|7|||
129196990|NCT00713544|465015813|FG003|Overall Study|Adverse Event|7|||
129196991|NCT00713544|465015814|FG004|Overall Study|Adverse Event|3|||
129196992|NCT00713544|465015815|FG005|Overall Study|Adverse Event|5|||
129196993|NCT00713544|465015810|FG000|Overall Study|Withdrawal by Subject|2|||
129196994|NCT00713544|465015811|FG001|Overall Study|Withdrawal by Subject|0|||
129196995|NCT00713544|465015812|FG002|Overall Study|Withdrawal by Subject|3|||
129196996|NCT00713544|465015813|FG003|Overall Study|Withdrawal by Subject|2|||
129196997|NCT00713544|465015814|FG004|Overall Study|Withdrawal by Subject|3|||
129196998|NCT00713544|465015815|FG005|Overall Study|Withdrawal by Subject|1|||
129196999|NCT00713544|465015810|FG000|Overall Study|Protocol Violation|0|||
129197000|NCT00713544|465015811|FG001|Overall Study|Protocol Violation|0|||
129197001|NCT00713544|465015812|FG002|Overall Study|Protocol Violation|0|||
129197002|NCT00713544|465015813|FG003|Overall Study|Protocol Violation|0|||
129197003|NCT00713544|465015814|FG004|Overall Study|Protocol Violation|0|||
129197004|NCT00713544|465015815|FG005|Overall Study|Protocol Violation|1|||
129197005|NCT00713544|465015810|FG000|Overall Study|Physician Decision|0|||
129197006|NCT00713544|465015811|FG001|Overall Study|Physician Decision|0|||
129197007|NCT00713544|465015812|FG002|Overall Study|Physician Decision|0|||
128731419|NCT00326612|463312789|FG001|Overall Study|They did not have a seizure requiring tx|137|||
128731420|NCT00548808|463312791|FG000|Overall Study|Lost to Follow-up|9|||
128731421|NCT00548808|463312792|FG001|Overall Study|Lost to Follow-up|3|||
128731422|NCT00548808|463312791|FG000|Overall Study|Protocol Violation|8|||
129197008|NCT00713544|465015813|FG003|Overall Study|Physician Decision|0|||
129197009|NCT00713544|465015814|FG004|Overall Study|Physician Decision|0|||
129197010|NCT00713544|465015815|FG005|Overall Study|Physician Decision|2|||
129197011|NCT00713544|465015810|FG000|Overall Study|Lack of Efficacy|0|||
129197012|NCT00713544|465015811|FG001|Overall Study|Lack of Efficacy|1|||
129197013|NCT00713544|465015812|FG002|Overall Study|Lack of Efficacy|0|||
129197014|NCT00713544|465015813|FG003|Overall Study|Lack of Efficacy|1|||
129197015|NCT00713544|465015814|FG004|Overall Study|Lack of Efficacy|1|||
129197016|NCT00713544|465015815|FG005|Overall Study|Lack of Efficacy|0|||
129197017|NCT00713544|465015810|FG000|Overall Study|Lost to Follow-up|0|||
129197018|NCT00713544|465015811|FG001|Overall Study|Lost to Follow-up|0|||
129197019|NCT00713544|465015812|FG002|Overall Study|Lost to Follow-up|1|||
129197020|NCT00713544|465015813|FG003|Overall Study|Lost to Follow-up|0|||
129197021|NCT00713544|465015814|FG004|Overall Study|Lost to Follow-up|0|||
129197022|NCT00713544|465015815|FG005|Overall Study|Lost to Follow-up|0|||
129197023|NCT00713544|465015810|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129197024|NCT00713544|465015811|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
129197025|NCT00713544|465015812|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129197026|NCT00713544|465015813|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129197027|NCT00713544|465015814|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129197028|NCT00713544|465015815|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129197029|NCT00713544|465015810|FG000|Overall Study|Incorrect enrollment|0|||
129197030|NCT00713544|465015811|FG001|Overall Study|Incorrect enrollment|1|||
129197031|NCT00713544|465015812|FG002|Overall Study|Incorrect enrollment|0|||
129197032|NCT00713544|465015813|FG003|Overall Study|Incorrect enrollment|0|||
129197033|NCT00713544|465015814|FG004|Overall Study|Incorrect enrollment|0|||
129197034|NCT00713544|465015815|FG005|Overall Study|Incorrect enrollment|0|||
129197035|NCT00713544|465015810|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
129197036|NCT00713544|465015811|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
129197037|NCT00713544|465015812|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
129197038|NCT00713544|465015813|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
129197039|NCT00713544|465015814|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
129197040|NCT00713544|465015815|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
129197041|NCT02380287|465015816|FG000|Overall Study|Adverse Event|0|||
129197042|NCT02380287|465015817|FG001|Overall Study|Adverse Event|0|||
129197043|NCT02380287|465015818|FG002|Overall Study|Adverse Event|1|||
129197044|NCT02380287|465015819|FG003|Overall Study|Adverse Event|0|||
129197045|NCT02380287|465015820|FG004|Overall Study|Adverse Event|0|||
129197046|NCT02380287|465015821|FG005|Overall Study|Adverse Event|0|||
129197047|NCT02380287|465015822|FG006|Overall Study|Adverse Event|0|||
129197048|NCT02380287|465015823|FG007|Overall Study|Adverse Event|0|||
129197049|NCT01641601|465015824|FG000|Overall Study|Study discontinued.|3|||
129197050|NCT01641601|465015825|FG001|Overall Study|Study discontinued.|5|||
129197051|NCT00950846|465015828|FG000|Overall Study|Death|6|||
129197052|NCT00950846|465015828|FG000|Overall Study|Lost to Follow-up|3|||
129197053|NCT00950846|465015828|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
129197054|NCT01799226|465015829|FG000|Overall Study|Withdrawal by Subject|1|||
129197055|NCT01799226|465015830|FG001|Overall Study|Withdrawal by Subject|0|||
129197056|NCT01799226|465015829|FG000|Overall Study|Disqualified at Day 14|1|||
129197057|NCT01799226|465015830|FG001|Overall Study|Disqualified at Day 14|0|||
129197058|NCT02178995|465015831|FG000|Double Blind|Adverse Event|0|||
129197059|NCT02178995|465015832|FG001|Double Blind|Adverse Event|0|||
129197060|NCT02178995|465015833|FG002|Double Blind|Adverse Event|0|||
129197061|NCT02178995|465015834|FG003|Double Blind|Adverse Event|0|||
129197062|NCT02178995|465015835|FG004|Double Blind|Adverse Event|0|||
129197063|NCT02178995|465015836|FG005|Double Blind|Adverse Event|1|||
129197064|NCT02178995|465015837|FG006|Double Blind|Adverse Event|0|||
129197065|NCT02178995|465015838|FG007|Double Blind|Adverse Event|1|||
129197066|NCT02178995|465015839|FG008|Double Blind|Adverse Event|1|||
129197067|NCT02178995|465015831|FG000|Double Blind|Lost to Follow-up|0|||
129197068|NCT02178995|465015832|FG001|Double Blind|Lost to Follow-up|1|||
129197069|NCT02178995|465015833|FG002|Double Blind|Lost to Follow-up|0|||
129197070|NCT02178995|465015834|FG003|Double Blind|Lost to Follow-up|0|||
129197071|NCT02178995|465015835|FG004|Double Blind|Lost to Follow-up|0|||
129197072|NCT02178995|465015836|FG005|Double Blind|Lost to Follow-up|0|||
129197073|NCT02178995|465015837|FG006|Double Blind|Lost to Follow-up|0|||
129197074|NCT02178995|465015838|FG007|Double Blind|Lost to Follow-up|1|||
129197075|NCT02178995|465015839|FG008|Double Blind|Lost to Follow-up|0|||
129197076|NCT02178995|465015831|FG000|Open Label|Adverse Event|2|||
129197077|NCT02178995|465015832|FG001|Open Label|Adverse Event|0|||
129197078|NCT02178995|465015833|FG002|Open Label|Adverse Event|0|||
129197079|NCT02178995|465015834|FG003|Open Label|Adverse Event|0|||
129197080|NCT02178995|465015835|FG004|Open Label|Adverse Event|0|||
129197081|NCT02178995|465015836|FG005|Open Label|Adverse Event|0|||
129197082|NCT02178995|465015837|FG006|Open Label|Adverse Event|0|||
129197083|NCT02178995|465015838|FG007|Open Label|Adverse Event|0|||
129197084|NCT02178995|465015839|FG008|Open Label|Adverse Event|0|||
129197085|NCT02274792|465015840|FG000|Overall Study|Withdrawal by Subject|13|||
129197086|NCT02274792|465015840|FG000|Overall Study|Lost to Follow-up|8|||
129197087|NCT02274792|465015840|FG000|Overall Study|Protocol Specified Criteria|2|||
129197088|NCT02274792|465015840|FG000|Overall Study|Sponsor Decision|2|||
129197089|NCT05258149|465015841|FG000|Period 1|Protocol Deviation|1|||
129197090|NCT05258149|465015842|FG001|Period 1|Protocol Deviation|0|||
129197091|NCT05258149|465015841|FG000|Period 1|Adverse Event|0|||
129197092|NCT05258149|465015842|FG001|Period 1|Adverse Event|1|||
129197093|NCT05258149|465015841|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
129197094|NCT05258149|465015842|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129197095|NCT05258149|465015841|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
129197096|NCT05258149|465015842|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
129197097|NCT05258149|465015841|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
129197098|NCT05258149|465015842|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
129197099|NCT00832416|465015851|FG000|Overall Study|Lack of Efficacy|17|||
129197100|NCT00832416|465015852|FG001|Overall Study|Lack of Efficacy|15|||
129197101|NCT00832416|465015853|FG002|Overall Study|Lack of Efficacy|13|||
129197102|NCT00832416|465015854|FG003|Overall Study|Lack of Efficacy|52|||
129197103|NCT00832416|465015851|FG000|Overall Study|Withdrawal by Subject|5|||
129197104|NCT00832416|465015852|FG001|Overall Study|Withdrawal by Subject|7|||
129197105|NCT00832416|465015853|FG002|Overall Study|Withdrawal by Subject|2|||
129197106|NCT00832416|465015854|FG003|Overall Study|Withdrawal by Subject|10|||
129197107|NCT00832416|465015851|FG000|Overall Study|Physician Decision|2|||
129197108|NCT00832416|465015852|FG001|Overall Study|Physician Decision|12|||
129197109|NCT00832416|465015853|FG002|Overall Study|Physician Decision|5|||
129197110|NCT00832416|465015854|FG003|Overall Study|Physician Decision|10|||
129197111|NCT00832416|465015851|FG000|Overall Study|Administrative|0|||
129197112|NCT00832416|465015852|FG001|Overall Study|Administrative|0|||
129197113|NCT00832416|465015853|FG002|Overall Study|Administrative|0|||
129197114|NCT00832416|465015854|FG003|Overall Study|Administrative|1|||
129197115|NCT00832416|465015851|FG000|Overall Study|Adverse Event|21|||
129197116|NCT00832416|465015852|FG001|Overall Study|Adverse Event|19|||
129197117|NCT00832416|465015853|FG002|Overall Study|Adverse Event|41|||
129197118|NCT00832416|465015854|FG003|Overall Study|Adverse Event|10|||
129197119|NCT00832416|465015851|FG000|Overall Study|Death|1|||
129197120|NCT00832416|465015852|FG001|Overall Study|Death|0|||
129197121|NCT00832416|465015853|FG002|Overall Study|Death|0|||
129197122|NCT00832416|465015854|FG003|Overall Study|Death|0|||
129197123|NCT02741596|465015861|FG000|Overall Study|Adverse Event|1|||
129197124|NCT02741596|465015862|FG001|Overall Study|Adverse Event|5|||
129197125|NCT02741596|465015861|FG000|Overall Study|Lost to Follow-up|1|||
129197126|NCT02741596|465015862|FG001|Overall Study|Lost to Follow-up|1|||
129197127|NCT02741596|465015861|FG000|Overall Study|Physician Decision|2|||
129197128|NCT02741596|465015862|FG001|Overall Study|Physician Decision|1|||
129197129|NCT02741596|465015861|FG000|Overall Study|Pregnancy|3|||
129197130|NCT02741596|465015862|FG001|Overall Study|Pregnancy|1|||
129197131|NCT02741596|465015861|FG000|Overall Study|Other (Unspecified)|0|||
129197132|NCT02741596|465015862|FG001|Overall Study|Other (Unspecified)|3|||
129197133|NCT02741596|465015861|FG000|Overall Study|Subject withdrawn-Other|17|||
129197134|NCT02741596|465015862|FG001|Overall Study|Subject withdrawn-Other|4|||
129197135|NCT02741596|465015861|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
129197136|NCT02741596|465015862|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
129197137|NCT02859246|465015865|FG000|Overall Study|Screen fails|3|||
129197138|NCT02859246|465015865|FG000|Overall Study|Adverse Event|1|||
129197139|NCT02859246|465015865|FG000|Overall Study|Withdrawal by Subject|1|||
129197140|NCT00100789|465015866|FG000|Overall Study|Adverse Event|10|||
129197141|NCT00100789|465015866|FG000|Overall Study|Withdrawal by Subject|1|||
129197142|NCT00100789|465015866|FG000|Overall Study|Progression/relapse|42|||
129197143|NCT00100789|465015866|FG000|Overall Study|Death|2|||
129197144|NCT00100789|465015866|FG000|Overall Study|Not protocol specified|5|||
129197145|NCT00100789|465015866|FG000|Overall Study|Ineligible|3|||
129197146|NCT00100789|465015866|FG000|Overall Study|Never received treatment|1|||
129197147|NCT01746368|465015867|FG000|Overall Study|Lost to Follow-up|2|||
129197148|NCT01746368|465015868|FG001|Overall Study|Lost to Follow-up|0|||
129197149|NCT01746368|465015867|FG000|Overall Study|Withdrawal by Subject|0|||
129197150|NCT01746368|465015868|FG001|Overall Study|Withdrawal by Subject|1|||
129197151|NCT05280717|465015869|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
129197152|NCT05280717|465015870|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
129197153|NCT05280717|465015871|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
129197154|NCT05280717|465015872|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129197155|NCT05280717|465015873|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129197156|NCT05280717|465015874|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129197157|NCT05280717|465015875|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129197158|NCT05280717|465015869|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
129197159|NCT05280717|465015870|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129197160|NCT05280717|465015871|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129197161|NCT05280717|465015872|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129197162|NCT05280717|465015873|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129197163|NCT05280717|465015874|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129197164|NCT05280717|465015875|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129197165|NCT05280717|465015869|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129197166|NCT05280717|465015870|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
129197167|NCT05280717|465015871|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129197168|NCT05280717|465015872|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129197169|NCT05280717|465015873|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129197170|NCT05280717|465015874|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129197171|NCT05280717|465015875|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129197172|NCT05280717|465015869|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129197173|NCT05280717|465015870|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129197174|NCT05280717|465015871|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
129197175|NCT05280717|465015872|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129197176|NCT05280717|465015873|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129197177|NCT05280717|465015874|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129197178|NCT05280717|465015875|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129197179|NCT05280717|465015869|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129197180|NCT05280717|465015870|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129197181|NCT05280717|465015871|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129197182|NCT05280717|465015872|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129197183|NCT05280717|465015873|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129197184|NCT05280717|465015874|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
129197185|NCT05280717|465015875|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129197186|NCT05280717|465015869|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129197187|NCT05280717|465015870|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129197188|NCT05280717|465015871|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129197189|NCT05280717|465015872|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129197190|NCT05280717|465015873|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129197191|NCT05280717|465015874|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
129197192|NCT05280717|465015875|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129197193|NCT00080301|465015876|FG000|Overall Study|Randomized but Never Treated|5|||
129197194|NCT00080301|465015877|FG001|Overall Study|Randomized but Never Treated|10|||
129197195|NCT00080301|465015876|FG000|Overall Study|Still on Treatment as of CSR date|0|||
129197196|NCT00080301|465015877|FG001|Overall Study|Still on Treatment as of CSR date|1|||
129197197|NCT02518971|465015878|FG000|Overall Study|Lost to Follow-up|0|||
129197198|NCT02518971|465015879|FG001|Overall Study|Lost to Follow-up|1|||
129197199|NCT02518971|465015878|FG000|Overall Study|Physician Decision|6|||
129197200|NCT02518971|465015879|FG001|Overall Study|Physician Decision|6|||
129197201|NCT02518971|465015878|FG000|Overall Study|Protocol Violation|6|||
129197202|NCT02518971|465015879|FG001|Overall Study|Protocol Violation|4|||
129197203|NCT02518971|465015878|FG000|Overall Study|Withdrawal by Subject|4|||
129197204|NCT02518971|465015879|FG001|Overall Study|Withdrawal by Subject|5|||
129197205|NCT02518971|465015878|FG000|Overall Study|Side effects|1|||
129197206|NCT02518971|465015879|FG001|Overall Study|Side effects|0|||
129197207|NCT02518971|465015878|FG000|Overall Study|medication lost in mail|0|||
129197208|NCT02518971|465015879|FG001|Overall Study|medication lost in mail|1|||
128731423|NCT00548808|463312792|FG001|Overall Study|Protocol Violation|8|||
128731424|NCT00548808|463312791|FG000|Overall Study|Withdrawal by Subject|8|||
128731425|NCT00548808|463312792|FG001|Overall Study|Withdrawal by Subject|4|||
129197209|NCT02518971|465015878|FG000|Overall Study|eligibility criteria no longer met|6|||
128731426|NCT00548808|463312791|FG000|Overall Study|Physician Decision|6|||
128731427|NCT00548808|463312792|FG001|Overall Study|Physician Decision|3|||
128731428|NCT00548808|463312791|FG000|Overall Study|Adverse Event|4|||
128731429|NCT00548808|463312792|FG001|Overall Study|Adverse Event|5|||
128731430|NCT00548808|463312791|FG000|Overall Study|Death|2|||
128731431|NCT00548808|463312792|FG001|Overall Study|Death|0|||
128731432|NCT00548808|463312791|FG000|Overall Study|Entry Criteria Not Met|2|||
128731433|NCT00548808|463312792|FG001|Overall Study|Entry Criteria Not Met|2|||
128731434|NCT00548808|463312791|FG000|Overall Study|Lack of Efficacy|2|||
128731435|NCT00548808|463312792|FG001|Overall Study|Lack of Efficacy|0|||
128731436|NCT00548808|463312791|FG000|Overall Study|Sponsor Decision|1|||
128731437|NCT00548808|463312792|FG001|Overall Study|Sponsor Decision|1|||
128731438|NCT03912233|463312793|FG000|Overall Study|Adverse Event|1|||
128731439|NCT03912233|463312794|FG001|Overall Study|Adverse Event|0|||
128731440|NCT03912233|463312795|FG002|Overall Study|Adverse Event|0|||
128731441|NCT03912233|463312796|FG003|Overall Study|Adverse Event|0|||
128731442|NCT03912233|463312797|FG004|Overall Study|Adverse Event|0|||
128731443|NCT03912233|463312798|FG005|Overall Study|Adverse Event|0|||
128731444|NCT03912233|463312793|FG000|Overall Study|Physician Decision|1|||
128731445|NCT03912233|463312794|FG001|Overall Study|Physician Decision|0|||
128731446|NCT03912233|463312795|FG002|Overall Study|Physician Decision|0|||
128731447|NCT03912233|463312796|FG003|Overall Study|Physician Decision|0|||
128731448|NCT03912233|463312797|FG004|Overall Study|Physician Decision|0|||
128731449|NCT03912233|463312798|FG005|Overall Study|Physician Decision|0|||
128731450|NCT03912233|463312793|FG000|Overall Study|Other|0|||
128731451|NCT03912233|463312794|FG001|Overall Study|Other|0|||
128731452|NCT03912233|463312795|FG002|Overall Study|Other|0|||
128731453|NCT03912233|463312796|FG003|Overall Study|Other|0|||
128731454|NCT03912233|463312797|FG004|Overall Study|Other|7|||
128731455|NCT03912233|463312798|FG005|Overall Study|Other|12|||
128731456|NCT00953329|463312801|FG000|Overall Study|Lack of Efficacy|1|||
128731457|NCT02477020|463312804|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
128731458|NCT02477020|463312805|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
128731459|NCT02477020|463312804|FG000|Overall Study|Voluntary Withdrawal|7|||
128731460|NCT02477020|463312805|FG001|Overall Study|Voluntary Withdrawal|16|||
128731461|NCT02477020|463312804|FG000|Overall Study|Reason not Specified|3|||
128731462|NCT02477020|463312805|FG001|Overall Study|Reason not Specified|1|||
128731463|NCT02477020|463312804|FG000|Overall Study|Lack of Efficacy|14|||
128731464|NCT02477020|463312805|FG001|Overall Study|Lack of Efficacy|5|||
128781113|NCT02851511|463490447|FG003|Phase II|Withdrawal by Subject|0|||
128781114|NCT02851511|463490444|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
129197210|NCT02518971|465015879|FG001|Overall Study|eligibility criteria no longer met|3|||
129197211|NCT02336230|465015880|FG000|Overall Study|Adverse Event|1|||
129197212|NCT02336230|465015880|FG000|Overall Study|Withdrawal of consent|1|||
129197213|NCT02336230|465015880|FG000|Overall Study|Death|9|||
129197214|NCT02336230|465015880|FG000|Overall Study|Dose not received due to shipping delay|1|||
129197215|NCT02336230|465015880|FG000|Overall Study|Discontinuation of MSC infusion|1|||
129197216|NCT02524171|465015881|FG000|6-month Follow-up|Lost to Follow-up|53|||
129197217|NCT02524171|465015882|FG001|6-month Follow-up|Lost to Follow-up|45|||
129197218|NCT02524171|465015881|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
129197219|NCT02524171|465015882|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
129197220|NCT00757237|465015885|FG000|Overall Study|Lost to Follow-up|0|||
129197221|NCT00757237|465015886|FG001|Overall Study|Lost to Follow-up|1|||
129197222|NCT00757237|465015885|FG000|Overall Study|Protocol Violation|0|||
129197223|NCT00757237|465015886|FG001|Overall Study|Protocol Violation|2|||
129197224|NCT00757237|465015885|FG000|Overall Study|Physician Decision|2|||
129197225|NCT00757237|465015886|FG001|Overall Study|Physician Decision|3|||
129197226|NCT00757237|465015885|FG000|Overall Study|Withdrawal by Subject|8|||
129197227|NCT00757237|465015886|FG001|Overall Study|Withdrawal by Subject|12|||
129197228|NCT00757237|465015885|FG000|Overall Study|Safety or Tolerability|3|||
129197229|NCT00757237|465015886|FG001|Overall Study|Safety or Tolerability|5|||
128731465|NCT01340976|463312807|FG000|Overall Study|Physician Decision|2|||
128781115|NCT02851511|463490445|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
128781116|NCT02851511|463490446|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
128731466|NCT01340976|463312808|FG001|Overall Study|Physician Decision|0|||
128731467|NCT01340976|463312809|FG002|Overall Study|Physician Decision|1|||
128731468|NCT01340976|463312810|FG003|Overall Study|Physician Decision|1|||
128731469|NCT01340976|463312811|FG004|Overall Study|Physician Decision|1|||
128731470|NCT01340976|463312812|FG005|Overall Study|Physician Decision|0|||
128731471|NCT01340976|463312807|FG000|Overall Study|Death|0|||
128781117|NCT02851511|463490447|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
129197230|NCT00757237|465015885|FG000|Overall Study|Other|0|||
128731472|NCT01340976|463312808|FG001|Overall Study|Death|1|||
128731473|NCT01340976|463312809|FG002|Overall Study|Death|0|||
128731474|NCT01340976|463312810|FG003|Overall Study|Death|0|||
129197231|NCT00757237|465015886|FG001|Overall Study|Other|2|||
129197232|NCT01345188|465015887|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
129197233|NCT01345188|465015887|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
129197234|NCT05150990|465015888|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
129197235|NCT05150990|465015889|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
129197236|NCT05150990|465015888|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
129197237|NCT05150990|465015889|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
129197238|NCT05150990|465015888|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
129197239|NCT05150990|465015889|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
129197240|NCT05150990|465015888|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
129197241|NCT05150990|465015889|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
129197242|NCT05150990|465015888|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
129197243|NCT05150990|465015889|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
129197244|NCT05150990|465015888|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
129197245|NCT05150990|465015889|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
129197246|NCT05150990|465015888|FG000|Overall Study|Death (unrelated to the intervention)|1|||
129197247|NCT05150990|465015889|FG001|Overall Study|Death (unrelated to the intervention)|2|||
129197248|NCT00466921|465015890|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
129197249|NCT00466921|465015890|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
129197250|NCT00466921|465015890|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
129197251|NCT00466921|465015890|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
129197252|NCT00466921|465015890|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
129197253|NCT00466921|465015890|FG000|Follow up for a Minimum of 1 Year|Death|6|||
129197254|NCT05447663|465015892|FG000|Overall Study|Study terminated by Sponsor|5|||
129197255|NCT05447663|465015892|FG000|Overall Study|Death|2|||
129197256|NCT05447663|465015892|FG000|Overall Study|Withdrawal by Subject|1|||
129197257|NCT01397461|465015893|FG000|Overall Study|Withdrawal by Subject|2|||
129197258|NCT01397461|465015894|FG001|Overall Study|Withdrawal by Subject|1|||
129197259|NCT01397461|465015895|FG002|Overall Study|Withdrawal by Subject|0|||
129197260|NCT01397461|465015893|FG000|Overall Study|Lost to Follow-up|0|||
129197261|NCT01397461|465015894|FG001|Overall Study|Lost to Follow-up|2|||
129197262|NCT01397461|465015895|FG002|Overall Study|Lost to Follow-up|1|||
129197263|NCT01397461|465015893|FG000|Overall Study|Lack of Efficacy|0|||
129197264|NCT01397461|465015894|FG001|Overall Study|Lack of Efficacy|3|||
129197265|NCT01397461|465015895|FG002|Overall Study|Lack of Efficacy|0|||
129197266|NCT01397461|465015893|FG000|Overall Study|Not treated|0|||
129197267|NCT01397461|465015894|FG001|Overall Study|Not treated|0|||
129197268|NCT01397461|465015895|FG002|Overall Study|Not treated|1|||
129197269|NCT05729568|465015912|FG000|Overall Study|Still on Study|52|||
129197270|NCT05729568|465015913|FG001|Overall Study|Still on Study|26|||
129197271|NCT05729568|465015912|FG000|Overall Study|Randomized but Never Treated|3|||
129197272|NCT05729568|465015913|FG001|Overall Study|Randomized but Never Treated|0|||
129197273|NCT05729568|465015912|FG000|Overall Study|Adverse Event|0|||
129197274|NCT05729568|465015913|FG001|Overall Study|Adverse Event|1|||
129197275|NCT05729568|465015912|FG000|Overall Study|Investigator's Discretion|1|||
129197276|NCT05729568|465015913|FG001|Overall Study|Investigator's Discretion|0|||
129197277|NCT04181762|465015914|FG000|Overall Study|Adverse Event|1|||
129197278|NCT04181762|465015915|FG001|Overall Study|Adverse Event|3|||
129197279|NCT04181762|465015914|FG000|Overall Study|Lost to Follow-up|1|||
129197280|NCT04181762|465015915|FG001|Overall Study|Lost to Follow-up|1|||
129197281|NCT04181762|465015914|FG000|Overall Study|Physician Decision|1|||
129197282|NCT04181762|465015915|FG001|Overall Study|Physician Decision|3|||
129197283|NCT04181762|465015914|FG000|Overall Study|Pregnancy|0|||
129197284|NCT04181762|465015915|FG001|Overall Study|Pregnancy|1|||
129197285|NCT04181762|465015914|FG000|Overall Study|Lack of Efficacy|2|||
129197286|NCT04181762|465015915|FG001|Overall Study|Lack of Efficacy|2|||
129197287|NCT04181762|465015914|FG000|Overall Study|Study terminated by sponsor|95|||
129197288|NCT04181762|465015915|FG001|Overall Study|Study terminated by sponsor|97|||
129197289|NCT04181762|465015914|FG000|Overall Study|Subject decision|11|||
129197290|NCT04181762|465015915|FG001|Overall Study|Subject decision|4|||
129197291|NCT04181762|465015914|FG000|Overall Study|Death|1|||
129197292|NCT04181762|465015915|FG001|Overall Study|Death|1|||
129197293|NCT04181762|465015914|FG000|Overall Study|Protocol deviation|1|||
129197294|NCT04181762|465015915|FG001|Overall Study|Protocol deviation|0|||
129197295|NCT04181762|465015914|FG000|Overall Study|Withdrawal of informed consent|1|||
129197296|NCT04181762|465015915|FG001|Overall Study|Withdrawal of informed consent|3|||
129197297|NCT06041919|465015916|FG000|Overall Study|Lost to Follow-up|1|||
129197298|NCT06041919|465015917|FG001|Overall Study|Lost to Follow-up|0|||
129197299|NCT06041919|465015918|FG002|Overall Study|Lost to Follow-up|0|||
129197300|NCT06041919|465015919|FG003|Overall Study|Lost to Follow-up|0|||
129197301|NCT06041919|465015920|FG004|Overall Study|Lost to Follow-up|0|||
129197302|NCT06041919|465015916|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
129197303|NCT06041919|465015917|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
129197304|NCT06041919|465015918|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
129197305|NCT06041919|465015919|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
129197306|NCT06041919|465015920|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
129197307|NCT00637416|465015923|FG000|Overall Study|Lost to Follow-up|1|||
129197308|NCT00637416|465015924|FG001|Overall Study|Lost to Follow-up|1|||
129197309|NCT00637416|465015923|FG000|Overall Study|Unable to take study drug|0|||
129197310|NCT00637416|465015924|FG001|Overall Study|Unable to take study drug|1|||
129197311|NCT05236257|465015957|FG000|Overall Study|Ongoing with study treatment|29|||
129197312|NCT05236257|465015958|FG001|Overall Study|Ongoing with study treatment|1|||
129197313|NCT05236257|465015957|FG000|Overall Study|Discontinued study treatment|22|||
129197314|NCT05236257|465015958|FG001|Overall Study|Discontinued study treatment|41|||
129197315|NCT03197376|465015960|FG000|Primary and Booster Phase|Adverse Event|0|||
129197316|NCT03197376|465015961|FG001|Primary and Booster Phase|Adverse Event|0|||
129197317|NCT03197376|465015962|FG002|Primary and Booster Phase|Adverse Event|0|||
129197318|NCT03197376|465015963|FG003|Primary and Booster Phase|Adverse Event|1|||
129197319|NCT03197376|465015960|FG000|Primary and Booster Phase|Death|1|||
129197320|NCT03197376|465015961|FG001|Primary and Booster Phase|Death|0|||
129197321|NCT03197376|465015962|FG002|Primary and Booster Phase|Death|0|||
129197322|NCT03197376|465015963|FG003|Primary and Booster Phase|Death|2|||
129197323|NCT03197376|465015960|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
129197324|NCT03197376|465015961|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
129197325|NCT03197376|465015962|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
129197326|NCT03197376|465015963|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
129197327|NCT03197376|465015960|FG000|Primary and Booster Phase|Physician Decision|1|||
129197328|NCT03197376|465015961|FG001|Primary and Booster Phase|Physician Decision|0|||
129197329|NCT03197376|465015962|FG002|Primary and Booster Phase|Physician Decision|1|||
129197330|NCT03197376|465015963|FG003|Primary and Booster Phase|Physician Decision|3|||
129197331|NCT03197376|465015960|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
129197332|NCT03197376|465015961|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
129197333|NCT03197376|465015962|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
129197334|NCT03197376|465015963|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
129197335|NCT03197376|465015960|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
129197336|NCT03197376|465015961|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
129197337|NCT03197376|465015962|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
129197338|NCT03197376|465015963|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
129197339|NCT03197376|465015960|FG000|Primary and Booster Phase|Not vaccine related|1|||
129197340|NCT03197376|465015961|FG001|Primary and Booster Phase|Not vaccine related|2|||
129197341|NCT03197376|465015962|FG002|Primary and Booster Phase|Not vaccine related|0|||
129197342|NCT03197376|465015963|FG003|Primary and Booster Phase|Not vaccine related|6|||
129197343|NCT03197376|465015960|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
129197344|NCT03197376|465015961|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
129197345|NCT03197376|465015962|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
129197346|NCT03197376|465015963|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
129197347|NCT03197376|465015960|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
129197348|NCT03197376|465015961|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
129197349|NCT03197376|465015962|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
129197350|NCT03197376|465015963|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
129197351|NCT03197376|465015960|FG000|Immune Persistence Phase|Not vaccine related|1|||
129197352|NCT03197376|465015961|FG001|Immune Persistence Phase|Not vaccine related|0|||
129197353|NCT03197376|465015962|FG002|Immune Persistence Phase|Not vaccine related|1|||
129197354|NCT03197376|465015963|FG003|Immune Persistence Phase|Not vaccine related|1|||
129197355|NCT01123395|465015964|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
129197356|NCT01123395|465015965|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
129197357|NCT03691571|465015966|FG000|Overall Study|Withdrawal by Subject|9|||
129197358|NCT03691571|465015967|FG001|Overall Study|Withdrawal by Subject|2|||
129197359|NCT00186901|465015970|FG000|Overall Study|Pregnancy|6|||
129197360|NCT00186901|465015971|FG001|Overall Study|Pregnancy|3|||
129197361|NCT00186901|465015972|FG002|Overall Study|Pregnancy|0|||
129197362|NCT00186901|465015970|FG000|Overall Study|Lost to Follow-up|6|||
129197363|NCT00186901|465015971|FG001|Overall Study|Lost to Follow-up|3|||
129197364|NCT00186901|465015972|FG002|Overall Study|Lost to Follow-up|0|||
129197365|NCT00186901|465015970|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
129197366|NCT00186901|465015971|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
129197367|NCT00186901|465015972|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
129197368|NCT00186901|465015970|FG000|Overall Study|ALL relapse or second malignancy|1|||
129197369|NCT00186901|465015971|FG001|Overall Study|ALL relapse or second malignancy|2|||
129197370|NCT00186901|465015972|FG002|Overall Study|ALL relapse or second malignancy|0|||
129197371|NCT00186901|465015970|FG000|Overall Study|Withdrawal by Subject|4|||
129197372|NCT00186901|465015971|FG001|Overall Study|Withdrawal by Subject|5|||
129197373|NCT00186901|465015972|FG002|Overall Study|Withdrawal by Subject|0|||
129197374|NCT00186901|465015970|FG000|Overall Study|Open label|3|||
129197375|NCT00186901|465015971|FG001|Overall Study|Open label|2|||
129197376|NCT00186901|465015972|FG002|Overall Study|Open label|0|||
129197377|NCT00186901|465015970|FG000|Overall Study|Limited adherence to study requirements|20|||
129197378|NCT00186901|465015971|FG001|Overall Study|Limited adherence to study requirements|23|||
129197379|NCT00186901|465015972|FG002|Overall Study|Limited adherence to study requirements|0|||
129197380|NCT00186901|465015970|FG000|Overall Study|Bone Mineral Density > 0|0|||
129197381|NCT00186901|465015971|FG001|Overall Study|Bone Mineral Density > 0|0|||
129197382|NCT00186901|465015972|FG002|Overall Study|Bone Mineral Density > 0|149|||
129197383|NCT00291486|465015978|FG000|Overall Study|Adverse Event|0|||
129197384|NCT00291486|465015979|FG001|Overall Study|Adverse Event|3|||
129197385|NCT00291486|465015980|FG002|Overall Study|Adverse Event|0|||
129197386|NCT00291486|465015981|FG003|Overall Study|Adverse Event|1|||
129197387|NCT00291486|465015982|FG004|Overall Study|Adverse Event|0|||
129197388|NCT00291486|465015978|FG000|Overall Study|Withdrawal by Subject|0|||
129197389|NCT00291486|465015979|FG001|Overall Study|Withdrawal by Subject|0|||
129197390|NCT00291486|465015980|FG002|Overall Study|Withdrawal by Subject|0|||
129197391|NCT00291486|465015981|FG003|Overall Study|Withdrawal by Subject|0|||
129197392|NCT00291486|465015982|FG004|Overall Study|Withdrawal by Subject|1|||
129197393|NCT00291486|465015978|FG000|Overall Study|Disease progression|1|||
129197394|NCT00291486|465015979|FG001|Overall Study|Disease progression|0|||
129197395|NCT00291486|465015980|FG002|Overall Study|Disease progression|1|||
129197396|NCT00291486|465015981|FG003|Overall Study|Disease progression|0|||
129197397|NCT00291486|465015982|FG004|Overall Study|Disease progression|0|||
129197398|NCT01099397|465015983|FG000|Overall Study|Lost to Follow-up|4|||
129197399|NCT01099397|465015983|FG000|Overall Study|Protocol Violation|4|||
129197400|NCT01099397|465015983|FG000|Overall Study|Withdrawal by Subject|5|||
129197401|NCT00003199|465015988|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
129197402|NCT00003199|465015988|FG000|Overall Study|Lack of insurance clearance|2|||
129197403|NCT00003199|465015988|FG000|Overall Study|Screen fail|15|||
129197404|NCT02407223|465017499|FG000|Overall Study|Adverse Event|1|||
129197405|NCT02407223|465017500|FG001|Overall Study|Adverse Event|0|||
129197406|NCT02407223|465017501|FG002|Overall Study|Adverse Event|1|||
129197407|NCT02407223|465017499|FG000|Overall Study|Lack of Efficacy|6|||
129197408|NCT02407223|465017500|FG001|Overall Study|Lack of Efficacy|6|||
129197409|NCT02407223|465017501|FG002|Overall Study|Lack of Efficacy|4|||
129197410|NCT02407223|465017499|FG000|Overall Study|Lost to Follow-up|1|||
129197411|NCT02407223|465017500|FG001|Overall Study|Lost to Follow-up|0|||
128781118|NCT02851511|463490444|FG000|Phase II|Lost to Follow-up|0|||
129197412|NCT02407223|465017501|FG002|Overall Study|Lost to Follow-up|2|||
129197413|NCT02407223|465017499|FG000|Overall Study|Withdrawal by Subject|2|||
129197414|NCT02407223|465017500|FG001|Overall Study|Withdrawal by Subject|4|||
129197415|NCT02407223|465017501|FG002|Overall Study|Withdrawal by Subject|4|||
129197416|NCT02407223|465017499|FG000|Overall Study|Study Terminated by Sponsor|77|||
129197417|NCT02407223|465017500|FG001|Overall Study|Study Terminated by Sponsor|80|||
129197418|NCT02407223|465017501|FG002|Overall Study|Study Terminated by Sponsor|86|||
128731475|NCT01340976|463312811|FG004|Overall Study|Death|0|||
128731476|NCT01340976|463312812|FG005|Overall Study|Death|0|||
128731477|NCT01340976|463312807|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
128731478|NCT01340976|463312808|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129197419|NCT02407223|465017499|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
129197420|NCT02407223|465017500|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
129197421|NCT02407223|465017501|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
129197422|NCT02407223|465017499|FG000|Overall Study|Other|29|||
129197423|NCT02407223|465017500|FG001|Overall Study|Other|27|||
129197424|NCT02407223|465017501|FG002|Overall Study|Other|25|||
129197425|NCT00502671|465017502|FG000|Overall Study|Disease Progression|13|||
129197426|NCT00502671|465017502|FG000|Overall Study|Personal Reasons|22|||
129197427|NCT00502671|465017502|FG000|Overall Study|Lost to Follow-up|7|||
129197428|NCT00502671|465017502|FG000|Overall Study|Protocol Violation|16|||
129197429|NCT00502671|465017502|FG000|Overall Study|Adverse Event|19|||
129197430|NCT00412893|465017505|FG000|Overall Study|Adverse Event|31|||
129197431|NCT00412893|465017506|FG001|Overall Study|Adverse Event|53|||
129197432|NCT00412893|465017505|FG000|Overall Study|Death|17|||
129197433|NCT00412893|465017506|FG001|Overall Study|Death|21|||
129197434|NCT00412893|465017505|FG000|Overall Study|Insufficient Therapeutic Response|39|||
129197435|NCT00412893|465017506|FG001|Overall Study|Insufficient Therapeutic Response|23|||
129197436|NCT00412893|465017505|FG000|Overall Study|Lost to Follow-up|2|||
129197437|NCT00412893|465017506|FG001|Overall Study|Lost to Follow-up|1|||
129197438|NCT00412893|465017505|FG000|Overall Study|Violation of Selection at Entry|17|||
129197439|NCT00412893|465017506|FG001|Overall Study|Violation of Selection at Entry|10|||
129197440|NCT00412893|465017505|FG000|Overall Study|Other Protocol Violation|10|||
129197441|NCT00412893|465017506|FG001|Overall Study|Other Protocol Violation|6|||
129197442|NCT00412893|465017505|FG000|Overall Study|Did Not Cooperate|12|||
129197443|NCT00412893|465017506|FG001|Overall Study|Did Not Cooperate|9|||
129197444|NCT00412893|465017505|FG000|Overall Study|Administrative Reason|12|||
129197445|NCT00412893|465017506|FG001|Overall Study|Administrative Reason|15|||
129197446|NCT00412893|465017505|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
129197447|NCT00412893|465017506|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
129197448|NCT04473963|465017507|FG000|Overall Study|Withdrawal by Subject|1|||
129197449|NCT04473963|465017508|FG001|Overall Study|Withdrawal by Subject|1|||
129197450|NCT04473963|465017509|FG002|Overall Study|Withdrawal by Subject|0|||
129197451|NCT04473963|465017507|FG000|Overall Study|Not inducible in AF|0|||
129197452|NCT04473963|465017508|FG001|Overall Study|Not inducible in AF|0|||
129197453|NCT04473963|465017509|FG002|Overall Study|Not inducible in AF|2|||
129197454|NCT00587158|465017513|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
129197455|NCT00587158|465017514|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
129197456|NCT00587158|465017513|FG000|Overall Study|Physician Decision|0|||
129197457|NCT00587158|465017514|FG001|Overall Study|Physician Decision|1|||
129197458|NCT00587158|465017513|FG000|Overall Study|Lost to Follow-up|1|||
129197459|NCT00587158|465017514|FG001|Overall Study|Lost to Follow-up|2|||
129197460|NCT00587158|465017513|FG000|Overall Study|Death|0|||
129197461|NCT00587158|465017514|FG001|Overall Study|Death|1|||
129197462|NCT00587158|465017513|FG000|Overall Study|Subject did not want to take study med|0|||
129197463|NCT00587158|465017514|FG001|Overall Study|Subject did not want to take study med|1|||
129197464|NCT02114606|465017515|FG000|Overall Study|Unable to swallow Cytosponge|6|||
129197465|NCT00981461|465017516|FG000|Overall Study|Lost to Follow-up|5|||
129197466|NCT00981461|465017517|FG001|Overall Study|Lost to Follow-up|2|||
129197467|NCT03361293|465017526|FG000|Overall Study|Lost to Follow-up|0|||
129197468|NCT03361293|465017527|FG001|Overall Study|Lost to Follow-up|2|||
129197469|NCT03361293|465017526|FG000|Overall Study|Withdrawal by Subject|1|||
129197470|NCT03361293|465017527|FG001|Overall Study|Withdrawal by Subject|3|||
129197471|NCT01910402|465017530|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
129197472|NCT01910402|465017531|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
129197473|NCT01910402|465017532|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
129197474|NCT01910402|465017530|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
129197475|NCT01910402|465017531|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
129197476|NCT01910402|465017532|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
129197477|NCT01910402|465017530|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
129197478|NCT01910402|465017531|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
129197479|NCT01910402|465017532|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
129197480|NCT01910402|465017530|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
129197481|NCT01910402|465017531|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
129197482|NCT01910402|465017532|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
128731479|NCT01340976|463312809|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
128731480|NCT01340976|463312810|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129197483|NCT01910402|465017530|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
129197484|NCT01910402|465017531|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
129197485|NCT01910402|465017532|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
129204891|NCT06039579|465046973|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
128731481|NCT01340976|463312811|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
128731482|NCT01340976|463312812|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
128731483|NCT01340976|463312807|FG000|Overall Study|Withdrawal by Subject|0|||
128731484|NCT01340976|463312808|FG001|Overall Study|Withdrawal by Subject|0|||
128731485|NCT01340976|463312809|FG002|Overall Study|Withdrawal by Subject|0|||
128731486|NCT01340976|463312810|FG003|Overall Study|Withdrawal by Subject|1|||
128731487|NCT01340976|463312811|FG004|Overall Study|Withdrawal by Subject|1|||
128731488|NCT01340976|463312812|FG005|Overall Study|Withdrawal by Subject|0|||
129197486|NCT01910402|465017530|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
129197487|NCT01910402|465017531|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
129197488|NCT01910402|465017532|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
129197489|NCT01910402|465017530|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
129197490|NCT01910402|465017531|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
129197491|NCT01910402|465017532|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
129197492|NCT01910402|465017530|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
129197493|NCT01910402|465017531|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
129197494|NCT01910402|465017532|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
129197495|NCT01910402|465017530|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
129197496|NCT01910402|465017531|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
129197497|NCT01910402|465017532|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
129197498|NCT01910402|465017530|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
129197499|NCT01910402|465017531|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
129197500|NCT01910402|465017532|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
129197501|NCT01910402|465017530|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
129197502|NCT01910402|465017531|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
129197503|NCT01910402|465017532|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
129197504|NCT01910402|465017530|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
129197505|NCT01910402|465017531|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
129197506|NCT01910402|465017532|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
129197507|NCT01910402|465017530|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
129197508|NCT01910402|465017531|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
129197509|NCT01910402|465017532|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
129197510|NCT00571038|465017533|FG000|Overall Study|Lost to Follow-up|1|||
129197511|NCT00571038|465017534|FG001|Overall Study|Lost to Follow-up|4|||
129197512|NCT00571038|465017533|FG000|Overall Study|Death|7|||
129197513|NCT00571038|465017534|FG001|Overall Study|Death|5|||
129197514|NCT00571038|465017533|FG000|Overall Study|Withdrawal by Subject|1|||
129197515|NCT00571038|465017534|FG001|Overall Study|Withdrawal by Subject|3|||
129197516|NCT00571038|465017533|FG000|Overall Study|Moved out of state|2|||
129197517|NCT00571038|465017534|FG001|Overall Study|Moved out of state|2|||
129197518|NCT01550757|465017535|FG000|Overall Study|Lost to Follow-up|21|||
129197519|NCT01550757|465017536|FG001|Overall Study|Lost to Follow-up|14|||
129197520|NCT01550757|465017537|FG002|Overall Study|Lost to Follow-up|42|||
129197521|NCT01550757|465017538|FG003|Overall Study|Lost to Follow-up|53|||
129197522|NCT01550757|465017535|FG000|Overall Study|Withdrawal by Subject|2|||
129197523|NCT01550757|465017536|FG001|Overall Study|Withdrawal by Subject|0|||
129197524|NCT01550757|465017537|FG002|Overall Study|Withdrawal by Subject|3|||
129197525|NCT01550757|465017538|FG003|Overall Study|Withdrawal by Subject|1|||
129197526|NCT00740584|465017540|FG000|Overall Study|Withdrawal by Subject|1|||
129197527|NCT00413218|465017542|FG000|Overall Study|Randomized but didn't receive study drug|2|||
129197528|NCT00413218|465017543|FG001|Overall Study|Randomized but didn't receive study drug|8|||
128731489|NCT01340976|463312807|FG000|Overall Study|Other anemia treatment|1|||
128731490|NCT01340976|463312808|FG001|Overall Study|Other anemia treatment|0|||
128731491|NCT01340976|463312809|FG002|Overall Study|Other anemia treatment|2|||
129197529|NCT00413218|465017542|FG000|Overall Study|Death|57|||
129197530|NCT00413218|465017543|FG001|Overall Study|Death|56|||
129197531|NCT00413218|465017542|FG000|Overall Study|Lost to Follow-up|14|||
129197532|NCT00413218|465017543|FG001|Overall Study|Lost to Follow-up|17|||
129197533|NCT00413218|465017542|FG000|Overall Study|Admin|20|||
129197534|NCT00413218|465017543|FG001|Overall Study|Admin|14|||
129197535|NCT00413218|465017542|FG000|Overall Study|Missing|1|||
129197536|NCT00413218|465017543|FG001|Overall Study|Missing|0|||
129197537|NCT00413218|465017542|FG000|Overall Study|Withdrawal by Subject|9|||
129197538|NCT00413218|465017543|FG001|Overall Study|Withdrawal by Subject|1|||
129197539|NCT01196026|465017545|FG000|Overall Study|Withdrawal by Subject|1|||
129197540|NCT01196026|465017546|FG001|Overall Study|Withdrawal by Subject|4|||
129197541|NCT01196026|465017547|FG002|Overall Study|Withdrawal by Subject|0|||
129197542|NCT01196026|465017548|FG003|Overall Study|Withdrawal by Subject|0|||
129197543|NCT01196026|465017549|FG004|Overall Study|Withdrawal by Subject|0|||
129197544|NCT01196026|465017550|FG005|Overall Study|Withdrawal by Subject|0|||
129197545|NCT01196026|465017545|FG000|Overall Study|Lost to Follow-up|0|||
129197546|NCT01196026|465017546|FG001|Overall Study|Lost to Follow-up|3|||
129197547|NCT01196026|465017547|FG002|Overall Study|Lost to Follow-up|0|||
129197548|NCT01196026|465017548|FG003|Overall Study|Lost to Follow-up|0|||
129197549|NCT01196026|465017549|FG004|Overall Study|Lost to Follow-up|1|||
129197550|NCT01196026|465017550|FG005|Overall Study|Lost to Follow-up|0|||
129197551|NCT01196026|465017545|FG000|Overall Study|Other|0|||
129197552|NCT01196026|465017546|FG001|Overall Study|Other|1|||
129197553|NCT01196026|465017547|FG002|Overall Study|Other|0|||
129197554|NCT01196026|465017548|FG003|Overall Study|Other|0|||
129197555|NCT01196026|465017549|FG004|Overall Study|Other|0|||
129197556|NCT01196026|465017550|FG005|Overall Study|Other|0|||
129197557|NCT01687296|465017551|FG000|Overall Study|Lack of Efficacy|1|||
129197558|NCT01687296|465017552|FG001|Overall Study|Lack of Efficacy|1|||
129197559|NCT01687296|465017551|FG000|Overall Study|Protocol Violation|0|||
129197560|NCT01687296|465017552|FG001|Overall Study|Protocol Violation|1|||
129197561|NCT01687296|465017551|FG000|Overall Study|Withdrawal by Subject|6|||
129197562|NCT01687296|465017552|FG001|Overall Study|Withdrawal by Subject|3|||
129197563|NCT03672292|465017556|FG000|Overall Study|Adverse Event|3|||
129197564|NCT03672292|465017557|FG001|Overall Study|Adverse Event|1|||
129197565|NCT03672292|465017556|FG000|Overall Study|Physician Decision|0|||
129197566|NCT03672292|465017557|FG001|Overall Study|Physician Decision|1|||
129197567|NCT03672292|465017556|FG000|Overall Study|Withdrawal by Subject|1|||
129197568|NCT03672292|465017557|FG001|Overall Study|Withdrawal by Subject|2|||
129197569|NCT03797586|465017558|FG000|Overall Study|Lost to Follow-up|3|||
129197570|NCT03797586|465017559|FG001|Overall Study|Lost to Follow-up|6|||
129197571|NCT03797586|465017558|FG000|Overall Study|Death|1|||
129197572|NCT03797586|465017559|FG001|Overall Study|Death|1|||
129197573|NCT03797586|465017558|FG000|Overall Study|Adverse Event|0|||
129197574|NCT03797586|465017559|FG001|Overall Study|Adverse Event|2|||
129197575|NCT01147055|465017562|FG000|First Intervention Period|Lost to Follow-up|1|||
129197576|NCT01147055|465017563|FG001|First Intervention Period|Lost to Follow-up|0|||
129197577|NCT00132808|465017564|FG000|Stratum I|Adverse Event|2|||
129197578|NCT00132808|465017565|FG001|Stratum I|Adverse Event|1|||
129197579|NCT00132808|465017566|FG002|Stratum I|Adverse Event|0|||
129197580|NCT00132808|465017564|FG000|Stratum I|Lost to Follow-up|3|||
129197581|NCT00132808|465017565|FG001|Stratum I|Lost to Follow-up|4|||
129197582|NCT00132808|465017566|FG002|Stratum I|Lost to Follow-up|1|||
129197583|NCT00132808|465017564|FG000|Stratum I|Withdrawal by Subject|4|||
129197584|NCT00132808|465017565|FG001|Stratum I|Withdrawal by Subject|7|||
129197585|NCT00132808|465017566|FG002|Stratum I|Withdrawal by Subject|3|||
129197586|NCT00132808|465017564|FG000|Stratum I|Abnormal test procedure result (s)|0|||
129197587|NCT00132808|465017565|FG001|Stratum I|Abnormal test procedure result (s)|0|||
129197588|NCT00132808|465017566|FG002|Stratum I|Abnormal test procedure result (s)|1|||
129197589|NCT00132808|465017564|FG000|Stratum II|Adverse Event|1|||
129197590|NCT00132808|465017565|FG001|Stratum II|Adverse Event|2|||
128731492|NCT01340976|463312810|FG003|Overall Study|Other anemia treatment|1|||
128731493|NCT01340976|463312811|FG004|Overall Study|Other anemia treatment|0|||
128731494|NCT01340976|463312812|FG005|Overall Study|Other anemia treatment|1|||
129197591|NCT00132808|465017566|FG002|Stratum II|Adverse Event|1|||
129197592|NCT00132808|465017564|FG000|Stratum II|Death|1|||
129197593|NCT00132808|465017565|FG001|Stratum II|Death|0|||
129197594|NCT00132808|465017566|FG002|Stratum II|Death|0|||
129197595|NCT00132808|465017564|FG000|Stratum II|Lost to Follow-up|2|||
129197596|NCT00132808|465017565|FG001|Stratum II|Lost to Follow-up|2|||
129197597|NCT00132808|465017566|FG002|Stratum II|Lost to Follow-up|1|||
129197598|NCT00132808|465017564|FG000|Stratum II|Protocol Violation|0|||
129197599|NCT00132808|465017565|FG001|Stratum II|Protocol Violation|2|||
129197600|NCT00132808|465017566|FG002|Stratum II|Protocol Violation|1|||
129197601|NCT00132808|465017564|FG000|Stratum II|Withdrawal by Subject|4|||
129197602|NCT00132808|465017565|FG001|Stratum II|Withdrawal by Subject|9|||
129197603|NCT00132808|465017566|FG002|Stratum II|Withdrawal by Subject|6|||
129197604|NCT00924443|465017575|FG000|Overall Study|Physician Decision|2|||
129197605|NCT00924443|465017575|FG000|Overall Study|Protocol Violation|1|||
129197606|NCT00874848|465017577|FG000|Overall Study|Adverse Event|13|||
129197607|NCT00874848|465017578|FG001|Overall Study|Adverse Event|2|||
129197608|NCT00874848|465017577|FG000|Overall Study|Progressive neoplastic disease|38|||
129197609|NCT00874848|465017578|FG001|Overall Study|Progressive neoplastic disease|18|||
129197610|NCT00874848|465017577|FG000|Overall Study|Withdrawal by Subject|7|||
129197611|NCT00874848|465017578|FG001|Overall Study|Withdrawal by Subject|4|||
129197612|NCT00874848|465017577|FG000|Overall Study|Noncompliance|1|||
129197613|NCT00874848|465017578|FG001|Overall Study|Noncompliance|1|||
129197614|NCT00874848|465017577|FG000|Overall Study|Failure to comply with protocol|0|||
129197615|NCT00874848|465017578|FG001|Overall Study|Failure to comply with protocol|1|||
129197616|NCT00874848|465017577|FG000|Overall Study|Physician Decision|0|||
129197617|NCT00874848|465017578|FG001|Overall Study|Physician Decision|2|||
129197618|NCT00595478|465017585|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
129197619|NCT00595478|465017586|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
129197620|NCT00595478|465017585|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
129197621|NCT00595478|465017586|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
129197622|NCT03405818|465017589|FG000|Overall Study|Withdrawal by Subject|4|||
129197623|NCT03405818|465017589|FG000|Overall Study|Lost to Follow-up|4|||
129197624|NCT02713828|465017590|FG000|Overall Study|Death|2|||
129197625|NCT02713828|465017591|FG001|Overall Study|Death|0|||
129197626|NCT02713828|465017590|FG000|Overall Study|Withdrawal by Subject|1|||
129197627|NCT02713828|465017591|FG001|Overall Study|Withdrawal by Subject|0|||
129197628|NCT02713828|465017590|FG000|Overall Study|study terminated but patient allowed to|2|||
129197629|NCT02713828|465017591|FG001|Overall Study|study terminated but patient allowed to|0|||
129197630|NCT02363959|465017594|FG000|Overall Study|Medical instability|1|||
129197631|NCT02363959|465017595|FG001|Overall Study|Medical instability|0|||
129197632|NCT00950248|465017596|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
129197633|NCT00950248|465017597|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
129197634|NCT00950248|465017598|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
129197635|NCT00950248|465017596|FG000|Year 1: Baseline|worsening of symptoms|2|||
129197636|NCT00950248|465017597|FG001|Year 1: Baseline|worsening of symptoms|0|||
129197637|NCT00950248|465017598|FG002|Year 1: Baseline|worsening of symptoms|0|||
129197638|NCT00950248|465017596|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
129197639|NCT00950248|465017597|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
129197640|NCT00950248|465017598|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
129197641|NCT00950248|465017596|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
129197642|NCT00950248|465017597|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
129197643|NCT00950248|465017598|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
129197644|NCT00950248|465017596|FG000|Year 2&3 Treatment Randomization|Death|0|||
129197645|NCT00950248|465017597|FG001|Year 2&3 Treatment Randomization|Death|0|||
129197646|NCT00950248|465017598|FG002|Year 2&3 Treatment Randomization|Death|1|||
129197647|NCT00950248|465017596|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
128731495|NCT01340976|463312807|FG000|Overall Study|Adverse Event|0|||
129197648|NCT00950248|465017597|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
129197649|NCT00950248|465017598|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
129197650|NCT01900652|465017599|FG000|Overall Study|Progressive Disease|1|||
129197651|NCT01900652|465017600|FG001|Overall Study|Progressive Disease|0|||
129197652|NCT01900652|465017599|FG000|Overall Study|Consent withdrawn by subject|1|||
129197653|NCT01900652|465017600|FG001|Overall Study|Consent withdrawn by subject|1|||
129197654|NCT01900652|465017599|FG000|Overall Study|Death|3|||
129197655|NCT01900652|465017600|FG001|Overall Study|Death|0|||
129197656|NCT01900652|465017599|FG000|Overall Study|Adverse Event|2|||
129197657|NCT01900652|465017600|FG001|Overall Study|Adverse Event|1|||
129197658|NCT01900652|465017599|FG000|Overall Study|Physician Decision|1|||
129197659|NCT01900652|465017600|FG001|Overall Study|Physician Decision|1|||
129197660|NCT00869518|465017603|FG000|Overall Study|Lost to Follow-up|1|||
129197661|NCT00869518|465017604|FG001|Overall Study|Lost to Follow-up|1|||
128731496|NCT01340976|463312808|FG001|Overall Study|Adverse Event|1|||
128731497|NCT01340976|463312809|FG002|Overall Study|Adverse Event|0|||
128731498|NCT01340976|463312810|FG003|Overall Study|Adverse Event|0|||
128731499|NCT01340976|463312811|FG004|Overall Study|Adverse Event|0|||
128731500|NCT01340976|463312812|FG005|Overall Study|Adverse Event|0|||
128731501|NCT03670810|463312821|FG000|Main Study|Adverse Event|37|||
128731502|NCT03670810|463312822|FG001|Main Study|Adverse Event|38|||
128731503|NCT03670810|463312823|FG002|Main Study|Adverse Event|3|||
128731504|NCT03670810|463312824|FG003|Main Study|Adverse Event|4|||
128731505|NCT03670810|463312825|FG004|Main Study|Adverse Event|4|||
128731506|NCT03670810|463312826|FG005|Main Study|Adverse Event|5|||
128731507|NCT03670810|463312827|FG006|Main Study|Adverse Event|0|||
128731508|NCT03670810|463312828|FG007|Main Study|Adverse Event|0|||
129197662|NCT00947115|465017605|FG000|Overall Study|Missed reporting interval|3|||
129197663|NCT00947115|465017606|FG001|Overall Study|Missed reporting interval|4|||
129197664|NCT00947115|465017607|FG002|Overall Study|Missed reporting interval|2|||
129197665|NCT00947115|465017605|FG000|Overall Study|Physician Decision|0|||
129197666|NCT00947115|465017606|FG001|Overall Study|Physician Decision|2|||
129197667|NCT00947115|465017607|FG002|Overall Study|Physician Decision|0|||
129197668|NCT00947115|465017605|FG000|Overall Study|Death|0|||
129197669|NCT00947115|465017606|FG001|Overall Study|Death|1|||
129197670|NCT00947115|465017607|FG002|Overall Study|Death|1|||
129197671|NCT00947115|465017605|FG000|Overall Study|Migrated from study area|2|||
129197672|NCT00947115|465017606|FG001|Overall Study|Migrated from study area|0|||
129197673|NCT00947115|465017607|FG002|Overall Study|Migrated from study area|0|||
129197674|NCT00947115|465017605|FG000|Overall Study|Withdrawal by Subject|1|||
129197675|NCT00947115|465017606|FG001|Overall Study|Withdrawal by Subject|3|||
129197676|NCT00947115|465017607|FG002|Overall Study|Withdrawal by Subject|4|||
129197677|NCT00947115|465017605|FG000|Overall Study|Lost to Follow-up|11|||
129197678|NCT00947115|465017606|FG001|Overall Study|Lost to Follow-up|12|||
129197679|NCT00947115|465017607|FG002|Overall Study|Lost to Follow-up|8|||
129197680|NCT01223183|465017609|FG000|Imaging Day 1|Physician Decision|0|||
129197681|NCT01223183|465017610|FG001|Imaging Day 1|Physician Decision|1|||
129197682|NCT01223183|465017609|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
129197683|NCT01223183|465017610|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
129197684|NCT01223183|465017609|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
129197685|NCT01223183|465017610|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
129197686|NCT00900029|465017613|FG000|Overall Study|Lost to Follow-up|0|||
129197687|NCT00900029|465017614|FG001|Overall Study|Lost to Follow-up|2|||
129197688|NCT00900029|465017615|FG002|Overall Study|Lost to Follow-up|1|||
129197689|NCT00900029|465017616|FG003|Overall Study|Lost to Follow-up|4|||
129197690|NCT00900029|465017617|FG004|Overall Study|Lost to Follow-up|4|||
129197691|NCT00900029|465017613|FG000|Overall Study|Withdrawal by Subject|2|||
129197692|NCT00900029|465017614|FG001|Overall Study|Withdrawal by Subject|2|||
129197693|NCT00900029|465017615|FG002|Overall Study|Withdrawal by Subject|1|||
129197694|NCT00900029|465017616|FG003|Overall Study|Withdrawal by Subject|1|||
129197695|NCT00900029|465017617|FG004|Overall Study|Withdrawal by Subject|1|||
129197696|NCT00900029|465017613|FG000|Overall Study|Adverse Event|0|||
129197697|NCT00900029|465017614|FG001|Overall Study|Adverse Event|0|||
129197698|NCT00900029|465017615|FG002|Overall Study|Adverse Event|1|||
129197699|NCT00900029|465017616|FG003|Overall Study|Adverse Event|1|||
129197700|NCT00900029|465017617|FG004|Overall Study|Adverse Event|1|||
129197701|NCT00900029|465017613|FG000|Overall Study|Death|1|||
129197702|NCT00900029|465017614|FG001|Overall Study|Death|0|||
129197703|NCT00900029|465017615|FG002|Overall Study|Death|0|||
129197704|NCT00900029|465017616|FG003|Overall Study|Death|1|||
129197705|NCT00900029|465017617|FG004|Overall Study|Death|0|||
129197706|NCT00511238|465017620|FG000|Overall Study|Adverse Event|13|||
129197707|NCT00511238|465017621|FG001|Overall Study|Adverse Event|33|||
129197708|NCT00511238|465017620|FG000|Overall Study|Withdrawal by Subject|2|||
129197709|NCT00511238|465017621|FG001|Overall Study|Withdrawal by Subject|22|||
129197710|NCT00511238|465017620|FG000|Overall Study|Progressive Disease|23|||
129197711|NCT00511238|465017621|FG001|Overall Study|Progressive Disease|157|||
129197712|NCT00511238|465017620|FG000|Overall Study|various reasons|4|||
129197713|NCT00511238|465017621|FG001|Overall Study|various reasons|14|||
129197714|NCT03772665|465017622|FG000|Overall Study|Protocol Violation|1|||
129197715|NCT03772665|465017623|FG001|Overall Study|Protocol Violation|0|||
129197716|NCT00163020|465017624|FG000|Overall Study|Lost to Follow-up|0|||
129197717|NCT00163020|465017625|FG001|Overall Study|Lost to Follow-up|2|||
129197718|NCT02936635|465020425|FG000|Overall Study|Adverse Event|43|||
129197719|NCT02936635|465020426|FG001|Overall Study|Adverse Event|25|||
129197720|NCT02936635|465020425|FG000|Overall Study|Progressive Disease|10|||
129197721|NCT02936635|465020426|FG001|Overall Study|Progressive Disease|18|||
129197722|NCT02936635|465020425|FG000|Overall Study|Sponsor Discretion|10|||
129197723|NCT02936635|465020426|FG001|Overall Study|Sponsor Discretion|16|||
129197724|NCT02936635|465020425|FG000|Overall Study|Death|9|||
128781119|NCT02851511|463490445|FG001|Phase II|Lost to Follow-up|1|||
129197725|NCT02936635|465020426|FG001|Overall Study|Death|15|||
129197726|NCT02936635|465020425|FG000|Overall Study|Withdrawal by Subject|8|||
129197727|NCT02936635|465020426|FG001|Overall Study|Withdrawal by Subject|15|||
129197728|NCT02936635|465020425|FG000|Overall Study|Physician Decision|2|||
129197729|NCT02936635|465020426|FG001|Overall Study|Physician Decision|9|||
129197730|NCT02936635|465020425|FG000|Overall Study|Lost to Follow-up|1|||
129197731|NCT02936635|465020426|FG001|Overall Study|Lost to Follow-up|2|||
129197732|NCT02936635|465020425|FG000|Overall Study|Protocol Violation|1|||
129197733|NCT02936635|465020426|FG001|Overall Study|Protocol Violation|0|||
129197734|NCT02936635|465020425|FG000|Overall Study|Lack of effect/Entry into other study|31|||
129197735|NCT02936635|465020426|FG001|Overall Study|Lack of effect/Entry into other study|65|||
129197736|NCT03553758|465020427|FG000|Overall Study|Lost to Follow-up|1|||
129197737|NCT00447226|465020428|FG000|12-Week Open-label Phase|Adverse Event|0|||
129197738|NCT00447226|465020429|FG001|12-Week Open-label Phase|Adverse Event|3|||
129197739|NCT00447226|465020428|FG000|12-Week Open-label Phase|Protocol Violation|0|||
129197740|NCT00447226|465020429|FG001|12-Week Open-label Phase|Protocol Violation|1|||
129197741|NCT00447226|465020428|FG000|12-Week Open-label Phase|Disease Progression|0|||
129197742|NCT00447226|465020429|FG001|12-Week Open-label Phase|Disease Progression|20|||
129197743|NCT00447226|465020428|FG000|12-Week Open-label Phase|Physician Decision|0|||
129197744|NCT00447226|465020429|FG001|12-Week Open-label Phase|Physician Decision|1|||
129197745|NCT00447226|465020428|FG000|Double-blind Phase|Disease Progression|4|||
129197746|NCT00447226|465020429|FG001|Double-blind Phase|Disease Progression|3|||
129197747|NCT02871635|465020441|FG000|Overall Study|Primary lack of efficacy|4|||
129197748|NCT02871635|465020442|FG001|Overall Study|Primary lack of efficacy|4|||
129197749|NCT02871635|465020441|FG000|Overall Study|Protocol Violation|3|||
129197750|NCT02871635|465020442|FG001|Overall Study|Protocol Violation|1|||
129197751|NCT02871635|465020441|FG000|Overall Study|Lost to Follow-up|1|||
129197752|NCT02871635|465020442|FG001|Overall Study|Lost to Follow-up|2|||
129197753|NCT02871635|465020441|FG000|Overall Study|Pregnancy|0|||
129197754|NCT02871635|465020442|FG001|Overall Study|Pregnancy|2|||
129197755|NCT02871635|465020441|FG000|Overall Study|Physician Decision|1|||
129197756|NCT02871635|465020442|FG001|Overall Study|Physician Decision|1|||
129197757|NCT02871635|465020441|FG000|Overall Study|Withdrawal by Subject|3|||
129197758|NCT02871635|465020442|FG001|Overall Study|Withdrawal by Subject|4|||
129197759|NCT02871635|465020441|FG000|Overall Study|Adverse Event|4|||
129197760|NCT02871635|465020442|FG001|Overall Study|Adverse Event|4|||
129197761|NCT02871635|465020441|FG000|Overall Study|Secondary lack of efficacy|2|||
129197762|NCT02871635|465020442|FG001|Overall Study|Secondary lack of efficacy|1|||
129197763|NCT02420379|465020443|FG000|Overall Study|Withdrawal by Subject|0|||
129197764|NCT02420379|465020444|FG001|Overall Study|Withdrawal by Subject|3|||
129197765|NCT02420379|465020443|FG000|Overall Study|Unable to complete due to schooling|0|||
129197766|NCT02420379|465020444|FG001|Overall Study|Unable to complete due to schooling|1|||
129197767|NCT02420379|465020443|FG000|Overall Study|Transitioned to commercial drug|1|||
129197768|NCT02420379|465020444|FG001|Overall Study|Transitioned to commercial drug|0|||
129197769|NCT01217944|465020445|FG000|Overall Study|Protocol Violation|1|||
129197770|NCT01217944|465020446|FG001|Overall Study|Protocol Violation|1|||
129197771|NCT01217944|465020447|FG002|Overall Study|Protocol Violation|0|||
129197772|NCT01217944|465020445|FG000|Overall Study|Lost to Follow-up|3|||
129197773|NCT01217944|465020446|FG001|Overall Study|Lost to Follow-up|1|||
129197774|NCT01217944|465020447|FG002|Overall Study|Lost to Follow-up|0|||
129197775|NCT01217944|465020445|FG000|Overall Study|Withdrawal by Subject|1|||
129197776|NCT01217944|465020446|FG001|Overall Study|Withdrawal by Subject|2|||
129197777|NCT01217944|465020447|FG002|Overall Study|Withdrawal by Subject|0|||
129197778|NCT01217944|465020445|FG000|Overall Study|Lack of Efficacy|1|||
129197779|NCT01217944|465020446|FG001|Overall Study|Lack of Efficacy|0|||
129197780|NCT01217944|465020447|FG002|Overall Study|Lack of Efficacy|0|||
129197781|NCT00483405|465020448|FG000|Overall Study|Adverse Event|8|||
129197782|NCT00483405|465020448|FG000|Overall Study|Lack of Efficacy|14|||
129197783|NCT00483405|465020448|FG000|Overall Study|Death|3|||
129197784|NCT00483405|465020448|FG000|Overall Study|Withdrawal by Subject|2|||
129197785|NCT00483405|465020448|FG000|Overall Study|Other complicating disease|1|||
129197786|NCT04098809|465020449|FG000|Overall Study|Withdrawal by Subject|1|||
129197787|NCT04098809|465020450|FG001|Overall Study|Withdrawal by Subject|3|||
129197788|NCT04098809|465020449|FG000|Overall Study|Physician Decision|2|||
129197789|NCT04098809|465020450|FG001|Overall Study|Physician Decision|1|||
129197790|NCT00193206|465020451|FG000|Preoperative Therapy|Lack of Efficacy|2|||
129197791|NCT00193206|465020451|FG000|Preoperative Therapy|Adverse Event|2|||
129197792|NCT00193206|465020451|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
129197793|NCT00193206|465020451|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
129197794|NCT00193206|465020451|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
129197795|NCT00193206|465020451|FG000|Postoperative Therapy|Physician Decision|3|||
129197796|NCT00193206|465020451|FG000|Postoperative Therapy|Intercurrent Illness|2|||
129197797|NCT00193206|465020451|FG000|Postoperative Therapy|Lack of Efficacy|1|||
129197798|NCT00193206|465020451|FG000|Postoperative Therapy|Protocol Violation|1|||
129197799|NCT01426958|465020452|FG000|Overall Study|Adverse Event|2|||
129197800|NCT00991939|465020455|FG000|Overall Study|Lost to Follow-up|0|||
129197801|NCT00991939|465020456|FG001|Overall Study|Lost to Follow-up|1|||
129197802|NCT00991939|465020455|FG000|Overall Study|Withdrawal by Subject|1|||
129197803|NCT00991939|465020456|FG001|Overall Study|Withdrawal by Subject|0|||
129197804|NCT00991939|465020455|FG000|Overall Study|Entire study terminated|4|||
129197805|NCT00991939|465020456|FG001|Overall Study|Entire study terminated|1|||
129197806|NCT02073682|465020461|FG000|Overall Study|Low Creatinine Clearance|1|||
129197807|NCT02073682|465020462|FG001|Overall Study|Low Creatinine Clearance|2|||
129197808|NCT02073682|465020461|FG000|Overall Study|Death|86|||
129197809|NCT02073682|465020462|FG001|Overall Study|Death|100|||
129197810|NCT02073682|465020461|FG000|Overall Study|Cancer Cured|10|||
129197811|NCT02073682|465020462|FG001|Overall Study|Cancer Cured|15|||
129197812|NCT02073682|465020461|FG000|Overall Study|ID: Patient Noncompliance|1|||
129197813|NCT02073682|465020462|FG001|Overall Study|ID: Patient Noncompliance|2|||
129197814|NCT02073682|465020461|FG000|Overall Study|ID: Palliative Treatment Only|10|||
129197815|NCT02073682|465020462|FG001|Overall Study|ID: Palliative Treatment Only|7|||
129197816|NCT02073682|465020461|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
129197817|NCT02073682|465020462|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
129197818|NCT02073682|465020461|FG000|Overall Study|Platelet Count <50,000/mL|1|||
129197819|NCT02073682|465020462|FG001|Overall Study|Platelet Count <50,000/mL|2|||
129197820|NCT02073682|465020461|FG000|Overall Study|Surgery/Medical Procedure|3|||
129197821|NCT02073682|465020462|FG001|Overall Study|Surgery/Medical Procedure|1|||
129197822|NCT02073682|465020461|FG000|Overall Study|Withdrawal by Subject|6|||
129197823|NCT02073682|465020462|FG001|Overall Study|Withdrawal by Subject|8|||
129197824|NCT02073682|465020461|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
129197825|NCT02073682|465020462|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
129197826|NCT02073682|465020461|FG000|Overall Study|Cancer Progression|53|||
129197827|NCT02073682|465020462|FG001|Overall Study|Cancer Progression|33|||
129197828|NCT02073682|465020461|FG000|Overall Study|Protocol Violation|1|||
129197829|NCT02073682|465020462|FG001|Overall Study|Protocol Violation|0|||
129197830|NCT02073682|465020461|FG000|Overall Study|Adverse Event|79|||
129197831|NCT02073682|465020462|FG001|Overall Study|Adverse Event|62|||
129197832|NCT02073682|465020461|FG000|Overall Study|No reason provided|11|||
129197833|NCT02073682|465020462|FG001|Overall Study|No reason provided|9|||
129197834|NCT02073682|465020461|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
129197835|NCT02073682|465020462|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
129197836|NCT02073682|465020461|FG000|Overall Study|Lost to Follow-up|1|||
129197837|NCT02073682|465020462|FG001|Overall Study|Lost to Follow-up|1|||
129197838|NCT02073682|465020461|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
129197839|NCT02073682|465020462|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
129197840|NCT00181766|465020463|FG000|Overall Study|Lost to Follow-up|6|||
129197841|NCT00181766|465020463|FG000|Overall Study|Adverse Event|4|||
129197842|NCT00181766|465020463|FG000|Overall Study|non-compliance|2|||
129197843|NCT00855816|465020464|FG000|Overall Study|Withdrawal by Subject|22|||
129197844|NCT00855816|465020465|FG001|Overall Study|Withdrawal by Subject|15|||
129197845|NCT00855816|465020464|FG000|Overall Study|Lost to Follow-up|3|||
129197846|NCT00855816|465020465|FG001|Overall Study|Lost to Follow-up|5|||
129197847|NCT00855816|465020464|FG000|Overall Study|Death|1|||
129197848|NCT00855816|465020465|FG001|Overall Study|Death|0|||
129197849|NCT00855816|465020464|FG000|Overall Study|Became ineligible|0|||
129197850|NCT00855816|465020465|FG001|Overall Study|Became ineligible|1|||
129197851|NCT01965704|465020469|FG000|Overall Study|Withdrawal by Subject|2|||
129197852|NCT01965704|465020470|FG001|Overall Study|Withdrawal by Subject|2|||
129197853|NCT01965704|465020471|FG002|Overall Study|Withdrawal by Subject|1|||
129197854|NCT01965704|465020472|FG003|Overall Study|Withdrawal by Subject|1|||
129197855|NCT01965704|465020469|FG000|Overall Study|Delivered at home|1|||
129197856|NCT01965704|465020470|FG001|Overall Study|Delivered at home|1|||
129197857|NCT01965704|465020471|FG002|Overall Study|Delivered at home|0|||
129197858|NCT01965704|465020472|FG003|Overall Study|Delivered at home|0|||
129197859|NCT01965704|465020469|FG000|Overall Study|Experienced complications|0|||
129197860|NCT01965704|465020470|FG001|Overall Study|Experienced complications|0|||
129197861|NCT01965704|465020471|FG002|Overall Study|Experienced complications|2|||
129197862|NCT01965704|465020472|FG003|Overall Study|Experienced complications|2|||
129197863|NCT01965704|465020469|FG000|Overall Study|Adverse Event|0|||
129197864|NCT01965704|465020470|FG001|Overall Study|Adverse Event|0|||
129197865|NCT01965704|465020471|FG002|Overall Study|Adverse Event|1|||
129197866|NCT01965704|465020472|FG003|Overall Study|Adverse Event|1|||
129197867|NCT01965704|465020469|FG000|Overall Study|Did not meet inclusion criteria|0|||
129197868|NCT01965704|465020470|FG001|Overall Study|Did not meet inclusion criteria|0|||
129197869|NCT01965704|465020471|FG002|Overall Study|Did not meet inclusion criteria|1|||
129197870|NCT01965704|465020472|FG003|Overall Study|Did not meet inclusion criteria|1|||
129197871|NCT00687804|465020480|FG000|Core Study|Adverse Event|5|||
129197872|NCT00687804|465020481|FG001|Core Study|Adverse Event|3|||
129197873|NCT00687804|465020482|FG002|Core Study|Adverse Event|3|||
129197874|NCT00687804|465020480|FG000|Core Study|Abnormal laboratory value(s)|1|||
129197875|NCT00687804|465020481|FG001|Core Study|Abnormal laboratory value(s)|0|||
129197876|NCT00687804|465020482|FG002|Core Study|Abnormal laboratory value(s)|0|||
129197877|NCT00687804|465020480|FG000|Core Study|Lack of Efficacy|1|||
129197878|NCT00687804|465020481|FG001|Core Study|Lack of Efficacy|1|||
129197879|NCT00687804|465020482|FG002|Core Study|Lack of Efficacy|1|||
129197880|NCT00687804|465020480|FG000|Core Study|Withdrawal by Subject|4|||
129197881|NCT00687804|465020481|FG001|Core Study|Withdrawal by Subject|7|||
129197882|NCT00687804|465020482|FG002|Core Study|Withdrawal by Subject|7|||
129197883|NCT00687804|465020480|FG000|Core Study|Lost to Follow-up|0|||
129197884|NCT00687804|465020481|FG001|Core Study|Lost to Follow-up|1|||
129197885|NCT00687804|465020482|FG002|Core Study|Lost to Follow-up|0|||
129197886|NCT00687804|465020480|FG000|Core Study|Death|2|||
129197887|NCT00687804|465020481|FG001|Core Study|Death|2|||
129197888|NCT00687804|465020482|FG002|Core Study|Death|2|||
129197889|NCT00687804|465020480|FG000|Core Study|Protocol Violation|1|||
129197890|NCT00687804|465020481|FG001|Core Study|Protocol Violation|1|||
129197891|NCT00687804|465020482|FG002|Core Study|Protocol Violation|0|||
129197892|NCT00687804|465020480|FG000|Open-Label Extension Study|Adverse Event|2|||
129197893|NCT00687804|465020481|FG001|Open-Label Extension Study|Adverse Event|2|||
129197894|NCT00687804|465020482|FG002|Open-Label Extension Study|Adverse Event|2|||
129197895|NCT00687804|465020480|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
129197896|NCT00687804|465020481|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
129197897|NCT00687804|465020482|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
129197898|NCT00687804|465020480|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
129197899|NCT00687804|465020481|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
129197900|NCT00687804|465020482|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
129197901|NCT00687804|465020480|FG000|Open-Label Extension Study|Administrative problems|1|||
129197902|NCT00687804|465020481|FG001|Open-Label Extension Study|Administrative problems|1|||
129197903|NCT00687804|465020482|FG002|Open-Label Extension Study|Administrative problems|0|||
129197904|NCT00687804|465020480|FG000|Open-Label Extension Study|Death|2|||
129197905|NCT00687804|465020481|FG001|Open-Label Extension Study|Death|3|||
129197906|NCT00687804|465020482|FG002|Open-Label Extension Study|Death|3|||
129197907|NCT04390243|465020483|FG000|Overall Study|Death|1|||
129197908|NCT04390243|465020483|FG000|Overall Study|Disease Progression|4|||
129197909|NCT04390243|465020483|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
129197910|NCT00799903|465020486|FG000|Overall Study|Investigator Site Closed|25|||
129197911|NCT00799903|465020487|FG001|Overall Study|Investigator Site Closed|23|||
129197912|NCT00799903|465020486|FG000|Overall Study|Withdrawal by Subject|179|||
129197913|NCT00799903|465020487|FG001|Overall Study|Withdrawal by Subject|175|||
129197914|NCT00799903|465020486|FG000|Overall Study|Lost to Follow-up|69|||
129197915|NCT00799903|465020487|FG001|Overall Study|Lost to Follow-up|80|||
129197916|NCT00556998|465020492|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
129197917|NCT00556998|465020492|FG000|Voriconazole Intravenous (IV)|Other|4|||
129197918|NCT00556998|465020492|FG000|Voriconazole Oral|Adverse Event|1|||
129197919|NCT00556998|465020492|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
129197920|NCT00216671|465020495|FG000|Overall Study|Adverse Event|4|||
129197921|NCT00216671|465020496|FG001|Overall Study|Adverse Event|9|||
129197922|NCT00216671|465020495|FG000|Overall Study|Pregnancy|0|||
129197923|NCT00216671|465020496|FG001|Overall Study|Pregnancy|1|||
129197924|NCT00216671|465020495|FG000|Overall Study|Withdrawal by Subject|4|||
129197925|NCT00216671|465020496|FG001|Overall Study|Withdrawal by Subject|2|||
129197926|NCT00216671|465020495|FG000|Overall Study|Refused Injections|3|||
129197927|NCT00216671|465020496|FG001|Overall Study|Refused Injections|13|||
129197928|NCT00216671|465020495|FG000|Overall Study|No Need to Continue Medication|1|||
129197929|NCT00216671|465020496|FG001|Overall Study|No Need to Continue Medication|1|||
129197930|NCT00216671|465020495|FG000|Overall Study|Insufficient Response|9|||
129197931|NCT00216671|465020496|FG001|Overall Study|Insufficient Response|4|||
129197932|NCT00216671|465020495|FG000|Overall Study|Lost to Follow-up|3|||
129197933|NCT00216671|465020496|FG001|Overall Study|Lost to Follow-up|5|||
129197934|NCT00216671|465020495|FG000|Overall Study|Non compliant|2|||
129197935|NCT00216671|465020496|FG001|Overall Study|Non compliant|2|||
129197936|NCT00216671|465020495|FG000|Overall Study|Ineligible|0|||
129197937|NCT00216671|465020496|FG001|Overall Study|Ineligible|2|||
129197938|NCT00216671|465020495|FG000|Overall Study|Physician Decision|1|||
129197939|NCT00216671|465020496|FG001|Overall Study|Physician Decision|1|||
129197940|NCT00216671|465020495|FG000|Overall Study|Protocol Violation|3|||
129197941|NCT00216671|465020496|FG001|Overall Study|Protocol Violation|5|||
129197942|NCT00216671|465020495|FG000|Overall Study|Relapse|1|||
129197943|NCT00216671|465020496|FG001|Overall Study|Relapse|0|||
129197944|NCT00216671|465020495|FG000|Overall Study|Investigator Illness|0|||
129197945|NCT00216671|465020496|FG001|Overall Study|Investigator Illness|1|||
129197946|NCT00216671|465020495|FG000|Overall Study|Patient Moved|0|||
129197947|NCT00216671|465020496|FG001|Overall Study|Patient Moved|1|||
129197948|NCT00216671|465020495|FG000|Overall Study|Ineligible, no efficacy data|2|||
129197949|NCT00216671|465020496|FG001|Overall Study|Ineligible, no efficacy data|2|||
129197950|NCT00216671|465020495|FG000|Overall Study|Insufficient Response Adverse Event|2|||
129197951|NCT00216671|465020496|FG001|Overall Study|Insufficient Response Adverse Event|1|||
129197952|NCT04961541|465020497|FG000|Overall Study|Adverse Event|0|||
129197953|NCT04961541|465020498|FG001|Overall Study|Adverse Event|0|||
129197954|NCT04961541|465020499|FG002|Overall Study|Adverse Event|0|||
129197955|NCT04961541|465020500|FG003|Overall Study|Adverse Event|0|||
129197956|NCT04961541|465020501|FG004|Overall Study|Adverse Event|0|||
129197957|NCT04961541|465020502|FG005|Overall Study|Adverse Event|1|||
129197958|NCT04961541|465020503|FG006|Overall Study|Adverse Event|0|||
129197959|NCT04961541|465020504|FG007|Overall Study|Adverse Event|0|||
129197960|NCT04961541|465020505|FG008|Overall Study|Adverse Event|0|||
129197961|NCT04961541|465020506|FG009|Overall Study|Adverse Event|0|||
129197962|NCT04961541|465020507|FG010|Overall Study|Adverse Event|0|||
129197963|NCT04961541|465020508|FG011|Overall Study|Adverse Event|0|||
129197964|NCT04961541|465020509|FG012|Overall Study|Adverse Event|0|||
129197965|NCT04961541|465020510|FG013|Overall Study|Adverse Event|0|||
129197966|NCT04961541|465020497|FG000|Overall Study|Lost to Follow-up|0|||
129197967|NCT04961541|465020498|FG001|Overall Study|Lost to Follow-up|0|||
129197968|NCT04961541|465020499|FG002|Overall Study|Lost to Follow-up|3|||
129197969|NCT04961541|465020500|FG003|Overall Study|Lost to Follow-up|0|||
129197970|NCT04961541|465020501|FG004|Overall Study|Lost to Follow-up|0|||
129197971|NCT04961541|465020502|FG005|Overall Study|Lost to Follow-up|0|||
129197972|NCT04961541|465020503|FG006|Overall Study|Lost to Follow-up|1|||
129197973|NCT04961541|465020504|FG007|Overall Study|Lost to Follow-up|1|||
129197974|NCT04961541|465020505|FG008|Overall Study|Lost to Follow-up|0|||
129197975|NCT04961541|465020506|FG009|Overall Study|Lost to Follow-up|1|||
129197976|NCT04961541|465020507|FG010|Overall Study|Lost to Follow-up|0|||
129197977|NCT04961541|465020508|FG011|Overall Study|Lost to Follow-up|0|||
129197978|NCT04961541|465020509|FG012|Overall Study|Lost to Follow-up|1|||
129197979|NCT04961541|465020510|FG013|Overall Study|Lost to Follow-up|0|||
129197980|NCT04961541|465020497|FG000|Overall Study|Withdrawal by Subject|0|||
129197981|NCT04961541|465020498|FG001|Overall Study|Withdrawal by Subject|0|||
129197982|NCT04961541|465020499|FG002|Overall Study|Withdrawal by Subject|1|||
129197983|NCT04961541|465020500|FG003|Overall Study|Withdrawal by Subject|1|||
129197984|NCT04961541|465020501|FG004|Overall Study|Withdrawal by Subject|0|||
129197985|NCT04961541|465020502|FG005|Overall Study|Withdrawal by Subject|0|||
129197986|NCT04961541|465020503|FG006|Overall Study|Withdrawal by Subject|0|||
129197987|NCT04961541|465020504|FG007|Overall Study|Withdrawal by Subject|0|||
129197988|NCT04961541|465020505|FG008|Overall Study|Withdrawal by Subject|0|||
128731509|NCT03670810|463312829|FG008|Main Study|Adverse Event|0|||
129197989|NCT04961541|465020506|FG009|Overall Study|Withdrawal by Subject|1|||
129197990|NCT04961541|465020507|FG010|Overall Study|Withdrawal by Subject|0|||
129197991|NCT04961541|465020508|FG011|Overall Study|Withdrawal by Subject|0|||
129197992|NCT04961541|465020509|FG012|Overall Study|Withdrawal by Subject|0|||
129197993|NCT04961541|465020510|FG013|Overall Study|Withdrawal by Subject|0|||
129197994|NCT01100320|465020511|FG000|Period 1|Withdrawal by Subject|2|||
128731510|NCT03670810|463312821|FG000|Main Study|Lack of Efficacy|8|||
128731511|NCT03670810|463312822|FG001|Main Study|Lack of Efficacy|9|||
129197995|NCT01100320|465020512|FG001|Period 1|Withdrawal by Subject|4|||
129197996|NCT01100320|465020511|FG000|Period 1|Positive Drug Screen|1|||
129197997|NCT01100320|465020512|FG001|Period 1|Positive Drug Screen|1|||
129197998|NCT01100320|465020511|FG000|Period 1|Adverse Event|2|||
129197999|NCT01100320|465020512|FG001|Period 1|Adverse Event|2|||
129198000|NCT01100320|465020511|FG000|Period 2|Withdrawal by Subject|1|||
129198001|NCT01100320|465020512|FG001|Period 2|Withdrawal by Subject|1|||
129198002|NCT02864901|465020513|FG000|Overall Study|Withdrawal by Subject|1|||
129198003|NCT02864901|465020514|FG001|Overall Study|Withdrawal by Subject|0|||
129198004|NCT05730387|465020515|FG000|Overall Study|Stillbirth|0|||
129198005|NCT05730387|465020516|FG001|Overall Study|Stillbirth|262|||
129198006|NCT05730387|465020515|FG000|Overall Study|Died during or after delivery|2|||
129198007|NCT05730387|465020516|FG001|Overall Study|Died during or after delivery|85|||
129198008|NCT05730387|465020515|FG000|Overall Study|Died after being admitted|0|||
129198009|NCT05730387|465020516|FG001|Overall Study|Died after being admitted|44|||
129198010|NCT05730387|465020515|FG000|Overall Study|Lost to Follow-up|69|||
129198011|NCT05730387|465020516|FG001|Overall Study|Lost to Follow-up|77|||
129198012|NCT01219985|465020517|FG000|Overall Study|Physician Decision|20|||
129198013|NCT00596752|465020518|FG000|Overall Study|Other Reason|44|||
129198014|NCT00596752|465020519|FG001|Overall Study|Other Reason|49|||
129198015|NCT00596752|465020518|FG000|Overall Study|Adverse Event|34|||
129198016|NCT00596752|465020519|FG001|Overall Study|Adverse Event|34|||
129198017|NCT00596752|465020518|FG000|Overall Study|Lost to Follow-up|22|||
129198018|NCT00596752|465020519|FG001|Overall Study|Lost to Follow-up|38|||
129198019|NCT00596752|465020518|FG000|Overall Study|Withdrawal by Subject|12|||
129198020|NCT00596752|465020519|FG001|Overall Study|Withdrawal by Subject|9|||
129198021|NCT00596752|465020518|FG000|Overall Study|Unsatisfactory Compliance|9|||
129198022|NCT00596752|465020519|FG001|Overall Study|Unsatisfactory Compliance|6|||
129198023|NCT00596752|465020518|FG000|Overall Study|Lack of Efficacy|4|||
129198024|NCT00596752|465020519|FG001|Overall Study|Lack of Efficacy|7|||
129198025|NCT00596752|465020518|FG000|Overall Study|Protocol Violation|1|||
129198026|NCT00596752|465020519|FG001|Overall Study|Protocol Violation|0|||
129198027|NCT04797780|465020520|FG000|Overall Study|Lost to Follow-up|1|||
129198028|NCT04797780|465020521|FG001|Overall Study|Lost to Follow-up|1|||
129198029|NCT04797780|465020520|FG000|Overall Study|Withdrawal by Subject|14|||
129198030|NCT04797780|465020521|FG001|Overall Study|Withdrawal by Subject|9|||
129198031|NCT04797780|465020520|FG000|Overall Study|Death|49|||
129198032|NCT04797780|465020521|FG001|Overall Study|Death|20|||
129198033|NCT04669301|465020522|FG000|Overall Study|Lost to Follow-up|0|||
129198034|NCT04669301|465020523|FG001|Overall Study|Lost to Follow-up|1|||
129198035|NCT04669301|465020524|FG002|Overall Study|Lost to Follow-up|0|||
129198036|NCT04669301|465020522|FG000|Overall Study|Withdrawal by Subject|3|||
129198037|NCT04669301|465020523|FG001|Overall Study|Withdrawal by Subject|2|||
129198038|NCT04669301|465020524|FG002|Overall Study|Withdrawal by Subject|0|||
129198039|NCT02940496|465020525|FG000|Overall Study|Adverse Event|1|||
129198040|NCT02940496|465020526|FG001|Overall Study|Adverse Event|0|||
129198041|NCT02940496|465020525|FG000|Overall Study|Death|2|||
129198042|NCT02940496|465020526|FG001|Overall Study|Death|0|||
129198043|NCT02940496|465020525|FG000|Overall Study|Hospice Care|1|||
129198044|NCT02940496|465020526|FG001|Overall Study|Hospice Care|0|||
129198045|NCT02940496|465020525|FG000|Overall Study|No MRE Done|1|||
129198046|NCT02940496|465020526|FG001|Overall Study|No MRE Done|0|||
129198047|NCT02940496|465020525|FG000|Overall Study|MRE Failure|1|||
129198048|NCT02940496|465020526|FG001|Overall Study|MRE Failure|0|||
129198049|NCT05973006|465020527|FG000|Overall Study|Early termination|3|||
129198050|NCT05973006|465020528|FG001|Overall Study|Early termination|9|||
129198051|NCT00548145|465020538|FG000|Overall Study|Death|0|||
129198052|NCT00548145|465020539|FG001|Overall Study|Death|1|||
129198053|NCT00548145|465020538|FG000|Overall Study|Withdrawal by Subject|0|||
129198054|NCT00548145|465020539|FG001|Overall Study|Withdrawal by Subject|2|||
129198055|NCT00548145|465020538|FG000|Overall Study|Physician Decision|1|||
129198056|NCT00548145|465020539|FG001|Overall Study|Physician Decision|1|||
129198057|NCT02119663|465020541|FG000|Overall Study|Disease progression|26|||
129198058|NCT02119663|465020542|FG001|Overall Study|Disease progression|27|||
129198059|NCT02119663|465020541|FG000|Overall Study|Adverse Event|5|||
129198060|NCT02119663|465020542|FG001|Overall Study|Adverse Event|5|||
129198061|NCT02119663|465020541|FG000|Overall Study|Death|3|||
129198062|NCT02119663|465020542|FG001|Overall Study|Death|2|||
129198063|NCT02119663|465020541|FG000|Overall Study|Physician Decision|1|||
129198064|NCT02119663|465020542|FG001|Overall Study|Physician Decision|2|||
129198065|NCT02119663|465020541|FG000|Overall Study|Other unspecified|2|||
129198066|NCT02119663|465020542|FG001|Overall Study|Other unspecified|0|||
128781120|NCT02851511|463490446|FG002|Phase II|Lost to Follow-up|0|||
129198067|NCT02119663|465020541|FG000|Overall Study|Subject decision|0|||
129198068|NCT02119663|465020542|FG001|Overall Study|Subject decision|1|||
129198069|NCT02119663|465020541|FG000|Overall Study|Study Terminated by the Sponsor|3|||
129198070|NCT02119663|465020542|FG001|Overall Study|Study Terminated by the Sponsor|4|||
129198071|NCT02863328|465020543|FG000|Overall Study|Lost to Follow-up|4|||
129198072|NCT02863328|465020544|FG001|Overall Study|Lost to Follow-up|10|||
129198073|NCT02863328|465020543|FG000|Overall Study|Withdrawal by Subject|7|||
129198074|NCT02863328|465020544|FG001|Overall Study|Withdrawal by Subject|12|||
129198075|NCT02863328|465020543|FG000|Overall Study|Died|0|||
129198076|NCT02863328|465020544|FG001|Overall Study|Died|1|||
129198077|NCT00892775|465020545|FG000|Overall Study|Protocol Violation|1|||
129198078|NCT00892775|465020546|FG001|Overall Study|Protocol Violation|0|||
129198079|NCT00892775|465020545|FG000|Overall Study|Subject difficulties with blood drawing|1|||
129198080|NCT00892775|465020546|FG001|Overall Study|Subject difficulties with blood drawing|0|||
129198081|NCT00892775|465020545|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
129198082|NCT00892775|465020546|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
129198083|NCT00892775|465020545|FG000|Overall Study|Migrated/ moved from study area|1|||
129198084|NCT00892775|465020546|FG001|Overall Study|Migrated/ moved from study area|0|||
129198085|NCT00892775|465020545|FG000|Overall Study|Withdrawal by Subject|0|||
129198086|NCT00892775|465020546|FG001|Overall Study|Withdrawal by Subject|1|||
129198087|NCT00892775|465020545|FG000|Overall Study|Lost to Follow-up|1|||
129198088|NCT00892775|465020546|FG001|Overall Study|Lost to Follow-up|0|||
129198089|NCT00699660|465020547|FG000|Overall Study|Lost to Follow-up|4|||
129198090|NCT00699660|465020548|FG001|Overall Study|Lost to Follow-up|2|||
129198091|NCT00699660|465020547|FG000|Overall Study|missing reports and recording failures|10|||
129198092|NCT00699660|465020548|FG001|Overall Study|missing reports and recording failures|6|||
129198093|NCT00398320|465020549|FG000|Overall Study|Death|1|||
129198094|NCT00398320|465020549|FG000|Overall Study|Adverse Event|4|||
129198095|NCT00398320|465020549|FG000|Overall Study|Physician Decision|1|||
129198096|NCT00064792|465020550|FG000|Overall Study|Withdrawal by Subject|2|||
129198097|NCT00064792|465020551|FG001|Overall Study|Withdrawal by Subject|0|||
129198098|NCT00064792|465020550|FG000|Overall Study|Adverse Event|3|||
129198099|NCT00064792|465020551|FG001|Overall Study|Adverse Event|0|||
129198100|NCT01870726|465020552|FG000|Overall Study|Withdrawal of informed consent|0|||
129198101|NCT01870726|465020553|FG001|Overall Study|Withdrawal of informed consent|0|||
129198102|NCT01870726|465020554|FG002|Overall Study|Withdrawal of informed consent|0|||
129198103|NCT01870726|465020555|FG003|Overall Study|Withdrawal of informed consent|1|||
129198104|NCT01870726|465020556|FG004|Overall Study|Withdrawal of informed consent|0|||
129198105|NCT01870726|465020557|FG005|Overall Study|Withdrawal of informed consent|0|||
129198106|NCT01870726|465020558|FG006|Overall Study|Withdrawal of informed consent|0|||
129198107|NCT01870726|465020552|FG000|Overall Study|Withdrawal by Subject|0|||
129198108|NCT01870726|465020553|FG001|Overall Study|Withdrawal by Subject|1|||
129198109|NCT01870726|465020554|FG002|Overall Study|Withdrawal by Subject|0|||
129198110|NCT01870726|465020555|FG003|Overall Study|Withdrawal by Subject|0|||
129198111|NCT01870726|465020556|FG004|Overall Study|Withdrawal by Subject|0|||
129198112|NCT01870726|465020557|FG005|Overall Study|Withdrawal by Subject|0|||
129198113|NCT01870726|465020558|FG006|Overall Study|Withdrawal by Subject|0|||
129198114|NCT01870726|465020552|FG000|Overall Study|Adverse Event|0|||
129198115|NCT01870726|465020553|FG001|Overall Study|Adverse Event|0|||
129198116|NCT01870726|465020554|FG002|Overall Study|Adverse Event|0|||
129198117|NCT01870726|465020555|FG003|Overall Study|Adverse Event|0|||
129198118|NCT01870726|465020556|FG004|Overall Study|Adverse Event|1|||
129198119|NCT01870726|465020557|FG005|Overall Study|Adverse Event|1|||
129198120|NCT01870726|465020558|FG006|Overall Study|Adverse Event|0|||
129198121|NCT01870726|465020552|FG000|Overall Study|Progressive disease|5|||
129198122|NCT01870726|465020553|FG001|Overall Study|Progressive disease|5|||
129198123|NCT01870726|465020554|FG002|Overall Study|Progressive disease|4|||
129198124|NCT01870726|465020555|FG003|Overall Study|Progressive disease|5|||
129198125|NCT01870726|465020556|FG004|Overall Study|Progressive disease|6|||
129198126|NCT01870726|465020557|FG005|Overall Study|Progressive disease|4|||
129198127|NCT01870726|465020558|FG006|Overall Study|Progressive disease|10|||
129198128|NCT03301350|465020559|FG000|Overall Study|Withdrawal by Subject|4|||
129198129|NCT03301350|465020559|FG000|Overall Study|Adverse Event|1|||
129198130|NCT03301350|465020559|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
129198131|NCT03301350|465020559|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
129198132|NCT03301350|465020559|FG000|Overall Study|no detail provided|1|||
129198133|NCT01248949|465020562|FG000|Overall Study|Lost to Follow-up|2|||
129198134|NCT01248949|465020563|FG001|Overall Study|Lost to Follow-up|2|||
129198135|NCT01248949|465020564|FG002|Overall Study|Lost to Follow-up|2|||
129198136|NCT01248949|465020565|FG003|Overall Study|Lost to Follow-up|1|||
129198137|NCT01248949|465020566|FG004|Overall Study|Lost to Follow-up|0|||
129198138|NCT01248949|465020562|FG000|Overall Study|Withdrawal by Subject|5|||
129198139|NCT01248949|465020563|FG001|Overall Study|Withdrawal by Subject|3|||
129198140|NCT01248949|465020564|FG002|Overall Study|Withdrawal by Subject|11|||
128731512|NCT03670810|463312823|FG002|Main Study|Lack of Efficacy|3|||
129198141|NCT01248949|465020565|FG003|Overall Study|Withdrawal by Subject|3|||
129198142|NCT01248949|465020566|FG004|Overall Study|Withdrawal by Subject|1|||
129198143|NCT01248949|465020562|FG000|Overall Study|Death|22|||
129198144|NCT01248949|465020563|FG001|Overall Study|Death|7|||
129198145|NCT01248949|465020564|FG002|Overall Study|Death|21|||
129198146|NCT01248949|465020565|FG003|Overall Study|Death|6|||
129198147|NCT01248949|465020566|FG004|Overall Study|Death|2|||
129198148|NCT01248949|465020562|FG000|Overall Study|Alternative Therapy|1|||
129198149|NCT01248949|465020563|FG001|Overall Study|Alternative Therapy|0|||
129198150|NCT01248949|465020564|FG002|Overall Study|Alternative Therapy|0|||
129198151|NCT01248949|465020565|FG003|Overall Study|Alternative Therapy|0|||
129198152|NCT01248949|465020566|FG004|Overall Study|Alternative Therapy|0|||
129198153|NCT01248949|465020562|FG000|Overall Study|Alternative Therapy.|1|||
129198154|NCT01248949|465020563|FG001|Overall Study|Alternative Therapy.|0|||
129198155|NCT01248949|465020564|FG002|Overall Study|Alternative Therapy.|0|||
129198156|NCT01248949|465020565|FG003|Overall Study|Alternative Therapy.|0|||
129198157|NCT01248949|465020566|FG004|Overall Study|Alternative Therapy.|0|||
129198158|NCT01248949|465020562|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
129198159|NCT01248949|465020563|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
129198160|NCT01248949|465020564|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
129198161|NCT01248949|465020565|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
129198162|NCT01248949|465020566|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
129198163|NCT01248949|465020562|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
129198164|NCT01248949|465020563|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
129198165|NCT01248949|465020564|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
129198166|NCT01248949|465020565|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
129198167|NCT01248949|465020566|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
129198168|NCT01248949|465020562|FG000|Overall Study|Participant Went To Hospice|0|||
129198169|NCT01248949|465020563|FG001|Overall Study|Participant Went To Hospice|0|||
129198170|NCT01248949|465020564|FG002|Overall Study|Participant Went To Hospice|1|||
129198171|NCT01248949|465020565|FG003|Overall Study|Participant Went To Hospice|0|||
129198172|NCT01248949|465020566|FG004|Overall Study|Participant Went To Hospice|0|||
129198173|NCT01248949|465020562|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
129198174|NCT01248949|465020563|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129198175|NCT01248949|465020564|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129198176|NCT01248949|465020565|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129198177|NCT01248949|465020566|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129198178|NCT01248949|465020562|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
129198179|NCT01248949|465020563|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
129198180|NCT01248949|465020564|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
129198181|NCT01248949|465020565|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
129198182|NCT01248949|465020566|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
129198183|NCT01248949|465020562|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129198184|NCT01248949|465020563|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
129198185|NCT01248949|465020564|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129198186|NCT01248949|465020565|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129198187|NCT01248949|465020566|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129198188|NCT01248949|465020562|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129198189|NCT01248949|465020563|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129198190|NCT01248949|465020564|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
129198191|NCT01248949|465020565|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129198192|NCT01248949|465020566|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129198193|NCT00286429|465020567|FG000|Overall Study|Adverse Event|4|||
129198194|NCT00286429|465020568|FG001|Overall Study|Adverse Event|1|||
129198195|NCT00286429|465020569|FG002|Overall Study|Adverse Event|6|||
129198196|NCT00286429|465020567|FG000|Overall Study|Lack of Efficacy|52|||
129198197|NCT00286429|465020568|FG001|Overall Study|Lack of Efficacy|27|||
129198198|NCT00286429|465020569|FG002|Overall Study|Lack of Efficacy|25|||
129198199|NCT00286429|465020567|FG000|Overall Study|Lost to Follow-up|2|||
129198200|NCT00286429|465020568|FG001|Overall Study|Lost to Follow-up|4|||
129198201|NCT00286429|465020569|FG002|Overall Study|Lost to Follow-up|3|||
129198202|NCT00286429|465020567|FG000|Overall Study|Physician Decision|10|||
129198203|NCT00286429|465020568|FG001|Overall Study|Physician Decision|7|||
129198204|NCT00286429|465020569|FG002|Overall Study|Physician Decision|7|||
129198205|NCT00286429|465020567|FG000|Overall Study|Protocol Violation|3|||
129198206|NCT00286429|465020568|FG001|Overall Study|Protocol Violation|5|||
129198207|NCT00286429|465020569|FG002|Overall Study|Protocol Violation|4|||
129198208|NCT00286429|465020567|FG000|Overall Study|Withdrawal by Subject|3|||
129198209|NCT00286429|465020568|FG001|Overall Study|Withdrawal by Subject|2|||
129198210|NCT00286429|465020569|FG002|Overall Study|Withdrawal by Subject|6|||
129198211|NCT00286429|465020567|FG000|Overall Study|Administrative Error|1|||
129198212|NCT00286429|465020568|FG001|Overall Study|Administrative Error|1|||
129198213|NCT00286429|465020569|FG002|Overall Study|Administrative Error|1|||
129198214|NCT00286429|465020567|FG000|Overall Study|Administrative Decision|0|||
129198215|NCT00286429|465020568|FG001|Overall Study|Administrative Decision|1|||
129198216|NCT00286429|465020569|FG002|Overall Study|Administrative Decision|0|||
129198217|NCT01746225|465020572|FG000|Overall Study|Death|1|||
129198218|NCT01746225|465020573|FG001|Overall Study|Death|0|||
129198219|NCT01746225|465020574|FG002|Overall Study|Death|1|||
129198220|NCT01746225|465020572|FG000|Overall Study|Withdrawal by Subject|5|||
129198221|NCT01746225|465020573|FG001|Overall Study|Withdrawal by Subject|15|||
129198222|NCT01746225|465020574|FG002|Overall Study|Withdrawal by Subject|19|||
128731513|NCT03670810|463312824|FG003|Main Study|Lack of Efficacy|4|||
128731514|NCT03670810|463312825|FG004|Main Study|Lack of Efficacy|0|||
128731515|NCT03670810|463312826|FG005|Main Study|Lack of Efficacy|0|||
128731516|NCT03670810|463312827|FG006|Main Study|Lack of Efficacy|0|||
128731517|NCT03670810|463312828|FG007|Main Study|Lack of Efficacy|0|||
128731518|NCT03670810|463312829|FG008|Main Study|Lack of Efficacy|0|||
128731519|NCT03670810|463312821|FG000|Main Study|Lost to Follow-up|9|||
128731520|NCT03670810|463312822|FG001|Main Study|Lost to Follow-up|7|||
128731521|NCT03670810|463312823|FG002|Main Study|Lost to Follow-up|4|||
128731522|NCT03670810|463312824|FG003|Main Study|Lost to Follow-up|6|||
128731523|NCT03670810|463312825|FG004|Main Study|Lost to Follow-up|1|||
128731524|NCT03670810|463312826|FG005|Main Study|Lost to Follow-up|0|||
128731525|NCT03670810|463312827|FG006|Main Study|Lost to Follow-up|0|||
128731526|NCT03670810|463312828|FG007|Main Study|Lost to Follow-up|0|||
128731527|NCT03670810|463312829|FG008|Main Study|Lost to Follow-up|0|||
128731528|NCT03670810|463312821|FG000|Main Study|Non-compliance with Study Drug|0|||
128731529|NCT03670810|463312822|FG001|Main Study|Non-compliance with Study Drug|2|||
128731530|NCT03670810|463312823|FG002|Main Study|Non-compliance with Study Drug|3|||
128731531|NCT03670810|463312824|FG003|Main Study|Non-compliance with Study Drug|0|||
128731532|NCT03670810|463312825|FG004|Main Study|Non-compliance with Study Drug|0|||
128731533|NCT03670810|463312826|FG005|Main Study|Non-compliance with Study Drug|0|||
128731534|NCT03670810|463312827|FG006|Main Study|Non-compliance with Study Drug|0|||
128731535|NCT03670810|463312828|FG007|Main Study|Non-compliance with Study Drug|1|||
128731536|NCT03670810|463312829|FG008|Main Study|Non-compliance with Study Drug|0|||
128731537|NCT03670810|463312821|FG000|Main Study|Physician Decision|3|||
128731538|NCT03670810|463312822|FG001|Main Study|Physician Decision|0|||
128731539|NCT03670810|463312823|FG002|Main Study|Physician Decision|1|||
128731540|NCT03670810|463312824|FG003|Main Study|Physician Decision|0|||
128731541|NCT03670810|463312825|FG004|Main Study|Physician Decision|0|||
128731542|NCT03670810|463312826|FG005|Main Study|Physician Decision|0|||
128731543|NCT03670810|463312827|FG006|Main Study|Physician Decision|1|||
128731544|NCT03670810|463312828|FG007|Main Study|Physician Decision|1|||
128731545|NCT03670810|463312829|FG008|Main Study|Physician Decision|0|||
128731546|NCT03670810|463312821|FG000|Main Study|Pregnancy|1|||
128731547|NCT03670810|463312822|FG001|Main Study|Pregnancy|2|||
128731548|NCT03670810|463312823|FG002|Main Study|Pregnancy|0|||
128731549|NCT03670810|463312824|FG003|Main Study|Pregnancy|0|||
128731550|NCT03670810|463312825|FG004|Main Study|Pregnancy|0|||
128731551|NCT03670810|463312826|FG005|Main Study|Pregnancy|0|||
128731552|NCT03670810|463312827|FG006|Main Study|Pregnancy|0|||
128731553|NCT03670810|463312828|FG007|Main Study|Pregnancy|0|||
128731554|NCT03670810|463312829|FG008|Main Study|Pregnancy|0|||
128731555|NCT03670810|463312821|FG000|Main Study|Protocol Deviation|2|||
128731556|NCT03670810|463312822|FG001|Main Study|Protocol Deviation|12|||
128731557|NCT03670810|463312823|FG002|Main Study|Protocol Deviation|8|||
128731558|NCT03670810|463312824|FG003|Main Study|Protocol Deviation|4|||
128731559|NCT03670810|463312825|FG004|Main Study|Protocol Deviation|0|||
128731560|NCT03670810|463312826|FG005|Main Study|Protocol Deviation|0|||
128731561|NCT03670810|463312827|FG006|Main Study|Protocol Deviation|0|||
128731562|NCT03670810|463312828|FG007|Main Study|Protocol Deviation|0|||
128731563|NCT03670810|463312829|FG008|Main Study|Protocol Deviation|0|||
128731564|NCT03670810|463312821|FG000|Main Study|Withdrawal by Subject|21|||
128731565|NCT03670810|463312822|FG001|Main Study|Withdrawal by Subject|21|||
128731566|NCT03670810|463312823|FG002|Main Study|Withdrawal by Subject|8|||
128731567|NCT03670810|463312824|FG003|Main Study|Withdrawal by Subject|9|||
128781121|NCT02851511|463490447|FG003|Phase II|Lost to Follow-up|0|||
129198223|NCT01746225|465020572|FG000|Overall Study|Physician Decision|14|||
129198224|NCT01746225|465020573|FG001|Overall Study|Physician Decision|11|||
129198225|NCT01746225|465020574|FG002|Overall Study|Physician Decision|3|||
129198226|NCT01746225|465020572|FG000|Overall Study|Adverse Event|15|||
129198227|NCT01746225|465020573|FG001|Overall Study|Adverse Event|12|||
129198228|NCT01746225|465020574|FG002|Overall Study|Adverse Event|17|||
129198229|NCT01746225|465020572|FG000|Overall Study|Continuing Treatment|5|||
129198230|NCT01746225|465020573|FG001|Overall Study|Continuing Treatment|8|||
129198231|NCT01746225|465020574|FG002|Overall Study|Continuing Treatment|3|||
129198232|NCT03915470|465020575|FG000|Overall Study|Death|3|||
129198233|NCT03915470|465020576|FG001|Overall Study|Death|1|||
129198234|NCT03915470|465020575|FG000|Overall Study|Adverse Event|1|||
129198235|NCT03915470|465020576|FG001|Overall Study|Adverse Event|0|||
129198236|NCT03915470|465020575|FG000|Overall Study|Physician Decision|1|||
129198237|NCT03915470|465020576|FG001|Overall Study|Physician Decision|0|||
129198238|NCT03915470|465020575|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
129198239|NCT03915470|465020576|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
129198240|NCT03160898|465020577|FG000|Overall Study|Adverse Event|4|||
129198241|NCT03160898|465020578|FG001|Overall Study|Adverse Event|8|||
129198242|NCT03160898|465020579|FG002|Overall Study|Adverse Event|7|||
129198243|NCT03160898|465020580|FG003|Overall Study|Adverse Event|10|||
129198244|NCT03160898|465020577|FG000|Overall Study|Death|1|||
129198245|NCT03160898|465020578|FG001|Overall Study|Death|0|||
129198246|NCT03160898|465020579|FG002|Overall Study|Death|0|||
129198247|NCT03160898|465020580|FG003|Overall Study|Death|1|||
129198248|NCT03160898|465020577|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
129198249|NCT03160898|465020578|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
129198250|NCT03160898|465020579|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
129198251|NCT03160898|465020580|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
129198252|NCT03160898|465020577|FG000|Overall Study|Lost to Follow-up|1|||
129198253|NCT03160898|465020578|FG001|Overall Study|Lost to Follow-up|1|||
129198254|NCT03160898|465020579|FG002|Overall Study|Lost to Follow-up|1|||
129198255|NCT03160898|465020580|FG003|Overall Study|Lost to Follow-up|2|||
129198256|NCT03160898|465020577|FG000|Overall Study|Physician Decision|1|||
129198257|NCT03160898|465020578|FG001|Overall Study|Physician Decision|0|||
129198258|NCT03160898|465020579|FG002|Overall Study|Physician Decision|0|||
129198259|NCT03160898|465020580|FG003|Overall Study|Physician Decision|1|||
129198260|NCT03160898|465020577|FG000|Overall Study|Progressive Disease|4|||
129198261|NCT03160898|465020578|FG001|Overall Study|Progressive Disease|1|||
129198262|NCT03160898|465020579|FG002|Overall Study|Progressive Disease|2|||
129198263|NCT03160898|465020580|FG003|Overall Study|Progressive Disease|1|||
129198264|NCT03160898|465020577|FG000|Overall Study|Protocol Violation|1|||
129198265|NCT03160898|465020578|FG001|Overall Study|Protocol Violation|0|||
129198266|NCT03160898|465020579|FG002|Overall Study|Protocol Violation|2|||
129198267|NCT03160898|465020580|FG003|Overall Study|Protocol Violation|0|||
129198268|NCT03160898|465020577|FG000|Overall Study|Sponsor Discretion|2|||
129198269|NCT03160898|465020578|FG001|Overall Study|Sponsor Discretion|0|||
129198270|NCT03160898|465020579|FG002|Overall Study|Sponsor Discretion|0|||
129198271|NCT03160898|465020580|FG003|Overall Study|Sponsor Discretion|0|||
129198272|NCT03160898|465020577|FG000|Overall Study|Withdrawal by Subject|1|||
129198273|NCT03160898|465020578|FG001|Overall Study|Withdrawal by Subject|3|||
129198274|NCT03160898|465020579|FG002|Overall Study|Withdrawal by Subject|2|||
129198275|NCT03160898|465020580|FG003|Overall Study|Withdrawal by Subject|1|||
129198276|NCT03160898|465020577|FG000|Overall Study|Other|2|||
129198277|NCT03160898|465020578|FG001|Overall Study|Other|0|||
129198278|NCT03160898|465020579|FG002|Overall Study|Other|2|||
129198279|NCT03160898|465020580|FG003|Overall Study|Other|2|||
129198280|NCT03245775|465020581|FG000|Overall Study|Lost to Follow-up|25|||
129198281|NCT03245775|465020582|FG001|Overall Study|Lost to Follow-up|26|||
129198282|NCT03245775|465020583|FG002|Overall Study|Lost to Follow-up|16|||
129198283|NCT03245775|465020584|FG003|Overall Study|Lost to Follow-up|16|||
129198284|NCT02978833|465020591|FG000|Overall Study|Study terminated|1|||
129198285|NCT02978833|465020592|FG001|Overall Study|Study terminated|1|||
129198286|NCT00103740|465020593|FG000|Period 1 - Core|Adverse Event|1|||
129198287|NCT00103740|465020594|FG001|Period 1 - Core|Adverse Event|0|||
129198288|NCT00103740|465020593|FG000|Period 1 - Core|Protocol Violation|3|||
129198289|NCT00103740|465020594|FG001|Period 1 - Core|Protocol Violation|2|||
129198290|NCT00103740|465020593|FG000|Period 1 - Core|Patient withdrew consent|3|||
129198291|NCT00103740|465020594|FG001|Period 1 - Core|Patient withdrew consent|2|||
129198292|NCT00103740|465020593|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
129198293|NCT00103740|465020594|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
129198294|NCT00103740|465020593|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
129198295|NCT00103740|465020594|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
129198296|NCT00103740|465020593|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
129198297|NCT00103740|465020594|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
129198298|NCT00103740|465020593|FG000|Period 2 - Extended Observation Period|Death|6|||
129198299|NCT00103740|465020594|FG001|Period 2 - Extended Observation Period|Death|2|||
129198300|NCT00103740|465020593|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
129198301|NCT00103740|465020594|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
129198302|NCT02663622|465020601|FG000|Overall Study|Death|3|||
129198303|NCT02663622|465020602|FG001|Overall Study|Death|1|||
129198304|NCT02663622|465020603|FG002|Overall Study|Death|1|||
129198305|NCT02663622|465020604|FG003|Overall Study|Death|8|||
129198306|NCT02663622|465020601|FG000|Overall Study|Protocol Violation|0|||
129198307|NCT02663622|465020602|FG001|Overall Study|Protocol Violation|0|||
129198308|NCT02663622|465020603|FG002|Overall Study|Protocol Violation|0|||
129198309|NCT02663622|465020604|FG003|Overall Study|Protocol Violation|1|||
129198310|NCT02587819|465020605|FG000|Overall Study|Adverse Event|1|||
129198311|NCT02587819|465020605|FG000|Overall Study|Lost to Follow-up|1|||
129198312|NCT01594931|465021898|FG000|Overall Study|Adverse Event|3|||
129198313|NCT01594931|465021899|FG001|Overall Study|Adverse Event|1|||
129198314|NCT01594931|465021900|FG002|Overall Study|Adverse Event|1|||
129198315|NCT01594931|465021898|FG000|Overall Study|Withdrawal by Subject|2|||
129198316|NCT01594931|465021899|FG001|Overall Study|Withdrawal by Subject|1|||
129198317|NCT01594931|465021900|FG002|Overall Study|Withdrawal by Subject|1|||
129198318|NCT01594931|465021898|FG000|Overall Study|Lack of Efficacy|7|||
129198319|NCT01594931|465021899|FG001|Overall Study|Lack of Efficacy|2|||
129198320|NCT01594931|465021900|FG002|Overall Study|Lack of Efficacy|2|||
129198321|NCT01594931|465021898|FG000|Overall Study|Lost to Follow-up|4|||
129198322|NCT01594931|465021899|FG001|Overall Study|Lost to Follow-up|3|||
129198323|NCT01594931|465021900|FG002|Overall Study|Lost to Follow-up|3|||
129198324|NCT01594931|465021898|FG000|Overall Study|Protocol Violation|2|||
129198325|NCT01594931|465021899|FG001|Overall Study|Protocol Violation|1|||
129198326|NCT01594931|465021900|FG002|Overall Study|Protocol Violation|0|||
129198327|NCT01594931|465021898|FG000|Overall Study|No defiined|11|||
129198328|NCT01594931|465021899|FG001|Overall Study|No defiined|4|||
129198329|NCT01594931|465021900|FG002|Overall Study|No defiined|7|||
129198330|NCT01467505|465021902|FG000|Overall Study|Adverse Event|1|||
129198331|NCT01467505|465021903|FG001|Overall Study|Adverse Event|0|||
129198332|NCT01467505|465021902|FG000|Overall Study|Withdrawal by Subject|4|||
129198333|NCT01467505|465021903|FG001|Overall Study|Withdrawal by Subject|0|||
129198334|NCT01467505|465021902|FG000|Overall Study|Study Terminated by Sponsor|28|||
129198335|NCT01467505|465021903|FG001|Overall Study|Study Terminated by Sponsor|3|||
129198336|NCT03449758|465021904|FG000|Overall Study|Major protocol deviation|1|||
129198337|NCT03449758|465021904|FG000|Overall Study|Treatment inefficacy|5|||
129198338|NCT03449758|465021904|FG000|Overall Study|Adverse Event|9|||
129198339|NCT03449758|465021904|FG000|Overall Study|Consent withdrawal|1|||
129198340|NCT03449758|465021904|FG000|Overall Study|Other unspecified reason|3|||
129198341|NCT00922623|465021916|FG000|Overall Study|Other|4|||
129198342|NCT00922623|465021916|FG000|Overall Study|Lost to Follow-up|1|||
129198343|NCT01402817|465021917|FG000|Overall Study|Withdrawal by Subject|3|||
129198344|NCT01402817|465021917|FG000|Overall Study|Study Suspended by FDA|8|||
129198345|NCT01473732|465021919|FG000|Overall Study|Adverse Event|1|||
129198346|NCT01473732|465021920|FG001|Overall Study|Adverse Event|0|||
129198347|NCT01473732|465021919|FG000|Overall Study|Death|1|||
129198348|NCT01473732|465021920|FG001|Overall Study|Death|0|||
129198349|NCT03579940|465021924|FG000|Period 2|Withdrawal by Subject|0|||
129198350|NCT03579940|465021925|FG001|Period 2|Withdrawal by Subject|0|||
129198351|NCT03579940|465021926|FG002|Period 2|Withdrawal by Subject|1|||
129198352|NCT03579940|465021927|FG003|Period 2|Withdrawal by Subject|0|||
129198353|NCT03579940|465021928|FG004|Period 2|Withdrawal by Subject|0|||
129198354|NCT03579940|465021929|FG005|Period 2|Withdrawal by Subject|0|||
129198355|NCT03579940|465021930|FG006|Period 2|Withdrawal by Subject|0|||
129198356|NCT03579940|465021931|FG007|Period 2|Withdrawal by Subject|0|||
129198357|NCT03579940|465021932|FG008|Period 2|Withdrawal by Subject|0|||
129198358|NCT03579940|465021933|FG009|Period 2|Withdrawal by Subject|0|||
129198359|NCT03579940|465021934|FG010|Period 2|Withdrawal by Subject|0|||
129198360|NCT00671034|465021935|FG000|Overall Study|Adverse Event|5|||
129198361|NCT00671034|465021936|FG001|Overall Study|Adverse Event|7|||
129198362|NCT00671034|465021937|FG002|Overall Study|Adverse Event|1|||
129198363|NCT00671034|465021935|FG000|Overall Study|Death|3|||
129198364|NCT00671034|465021936|FG001|Overall Study|Death|2|||
129198365|NCT00671034|465021937|FG002|Overall Study|Death|1|||
129198366|NCT00671034|465021935|FG000|Overall Study|Physician Decision|12|||
129198367|NCT00671034|465021936|FG001|Overall Study|Physician Decision|4|||
129198368|NCT00671034|465021937|FG002|Overall Study|Physician Decision|5|||
129198369|NCT00671034|465021935|FG000|Overall Study|VHR ALL feature|8|||
129198370|NCT00671034|465021936|FG001|Overall Study|VHR ALL feature|3|||
129198371|NCT00671034|465021937|FG002|Overall Study|VHR ALL feature|5|||
129198372|NCT00671034|465021935|FG000|Overall Study|Refusal|5|||
129198373|NCT00671034|465021936|FG001|Overall Study|Refusal|3|||
129198374|NCT00671034|465021937|FG002|Overall Study|Refusal|5|||
129198375|NCT00671034|465021935|FG000|Overall Study|includes Alternative therapy, etc.|6|||
129198376|NCT00671034|465021936|FG001|Overall Study|includes Alternative therapy, etc.|1|||
129198377|NCT00671034|465021937|FG002|Overall Study|includes Alternative therapy, etc.|7|||
129198378|NCT00853151|465021938|FG000|Overall Study|Adverse Event|1|||
129198379|NCT00853151|465021939|FG001|Overall Study|Adverse Event|4|||
129198380|NCT00853151|465021940|FG002|Overall Study|Adverse Event|2|||
129198381|NCT00853151|465021941|FG003|Overall Study|Adverse Event|0|||
129198382|NCT00853151|465021938|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
129198383|NCT00853151|465021939|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129198384|NCT00853151|465021940|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129198385|NCT00853151|465021941|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129198386|NCT00853151|465021938|FG000|Overall Study|Lost to Follow-up|2|||
129198387|NCT00853151|465021939|FG001|Overall Study|Lost to Follow-up|0|||
129198388|NCT00853151|465021940|FG002|Overall Study|Lost to Follow-up|3|||
129198389|NCT00853151|465021941|FG003|Overall Study|Lost to Follow-up|0|||
129198390|NCT00853151|465021938|FG000|Overall Study|Death|1|||
129198391|NCT00853151|465021939|FG001|Overall Study|Death|0|||
129198392|NCT00853151|465021940|FG002|Overall Study|Death|0|||
129198393|NCT00853151|465021941|FG003|Overall Study|Death|1|||
129198394|NCT00853151|465021938|FG000|Overall Study|Protocol Violation|0|||
129198395|NCT00853151|465021939|FG001|Overall Study|Protocol Violation|0|||
129198396|NCT00853151|465021940|FG002|Overall Study|Protocol Violation|0|||
129198397|NCT00853151|465021941|FG003|Overall Study|Protocol Violation|1|||
129198398|NCT00853151|465021938|FG000|Overall Study|Withdrawal by Subject|5|||
129198399|NCT00853151|465021939|FG001|Overall Study|Withdrawal by Subject|4|||
129198400|NCT00853151|465021940|FG002|Overall Study|Withdrawal by Subject|2|||
129198401|NCT00853151|465021941|FG003|Overall Study|Withdrawal by Subject|1|||
129198402|NCT00853151|465021938|FG000|Overall Study|Physician Decision|0|||
129198403|NCT00853151|465021939|FG001|Overall Study|Physician Decision|2|||
129198404|NCT00853151|465021940|FG002|Overall Study|Physician Decision|1|||
129198405|NCT00853151|465021941|FG003|Overall Study|Physician Decision|0|||
129198406|NCT00853151|465021938|FG000|Overall Study|Sponsor Decision|0|||
129198407|NCT00853151|465021939|FG001|Overall Study|Sponsor Decision|3|||
129198408|NCT00853151|465021940|FG002|Overall Study|Sponsor Decision|0|||
129198409|NCT00853151|465021941|FG003|Overall Study|Sponsor Decision|0|||
129198410|NCT00269919|465021942|FG000|Overall Study|Other|26|||
129198411|NCT00269919|465021942|FG000|Overall Study|Started but not treated|1|||
129198412|NCT02471014|465021945|FG000|Overall Study|Lost to Follow-up|2|||
129198413|NCT02471014|465021946|FG001|Overall Study|Lost to Follow-up|2|||
129198414|NCT01751984|465021947|FG000|Overall Study|Adverse Event|5|||
129198415|NCT01751984|465021948|FG001|Overall Study|Adverse Event|3|||
129198416|NCT01751984|465021947|FG000|Overall Study|Withdrawal by Subject|0|||
129198417|NCT01751984|465021948|FG001|Overall Study|Withdrawal by Subject|1|||
129198418|NCT01751984|465021947|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
129198419|NCT01751984|465021948|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
128781122|NCT00051311|463490448|FG000|Overall Study|Starting new study|0|||
129198420|NCT01388907|465021949|FG000|Overall Study|Adverse Event|2|||
129198421|NCT01388907|465021950|FG001|Overall Study|Adverse Event|0|||
129198422|NCT03187132|465021951|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
129198423|NCT03187132|465021952|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
129198424|NCT03187132|465021951|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
129198425|NCT03187132|465021952|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
129198426|NCT03187132|465021951|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
129198427|NCT03187132|465021952|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
129198428|NCT03187132|465021951|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
129198429|NCT03187132|465021952|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
129198430|NCT03187132|465021951|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
129198431|NCT03187132|465021952|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
129198432|NCT03187132|465021951|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
129198433|NCT03187132|465021952|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
129198434|NCT03187132|465021951|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
129198435|NCT03187132|465021952|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
129198436|NCT03187132|465021951|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
129198437|NCT03187132|465021952|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
129198438|NCT03187132|465021951|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
129198439|NCT03187132|465021952|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
129198440|NCT03187132|465021951|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
129198441|NCT03187132|465021952|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
129198442|NCT03187132|465021951|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
129198443|NCT03187132|465021952|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
129198444|NCT02045095|465021953|FG000|Overall Study|Other|0|||
129198445|NCT02045095|465021954|FG001|Overall Study|Other|0|||
129198446|NCT02045095|465021955|FG002|Overall Study|Other|1|||
129198447|NCT02045095|465021956|FG003|Overall Study|Other|0|||
129198448|NCT02045095|465021957|FG004|Overall Study|Other|0|||
129198449|NCT02045095|465021958|FG005|Overall Study|Other|2|||
129198450|NCT02045095|465021959|FG006|Overall Study|Other|0|||
129198451|NCT02045095|465021953|FG000|Overall Study|Progressive Disease|3|||
129198452|NCT02045095|465021954|FG001|Overall Study|Progressive Disease|3|||
129198453|NCT02045095|465021955|FG002|Overall Study|Progressive Disease|2|||
129198454|NCT02045095|465021956|FG003|Overall Study|Progressive Disease|4|||
129198455|NCT02045095|465021957|FG004|Overall Study|Progressive Disease|2|||
129198456|NCT02045095|465021958|FG005|Overall Study|Progressive Disease|4|||
129198457|NCT02045095|465021959|FG006|Overall Study|Progressive Disease|1|||
129198458|NCT02045095|465021953|FG000|Overall Study|Withdrawal by Subject|0|||
129198459|NCT02045095|465021954|FG001|Overall Study|Withdrawal by Subject|0|||
129198460|NCT02045095|465021955|FG002|Overall Study|Withdrawal by Subject|0|||
129198461|NCT02045095|465021956|FG003|Overall Study|Withdrawal by Subject|0|||
129198462|NCT02045095|465021957|FG004|Overall Study|Withdrawal by Subject|3|||
129198463|NCT02045095|465021958|FG005|Overall Study|Withdrawal by Subject|0|||
129198464|NCT02045095|465021959|FG006|Overall Study|Withdrawal by Subject|0|||
129198465|NCT02045095|465021953|FG000|Overall Study|Adverse Event|0|||
129198466|NCT02045095|465021954|FG001|Overall Study|Adverse Event|1|||
129198467|NCT02045095|465021955|FG002|Overall Study|Adverse Event|1|||
129198468|NCT02045095|465021956|FG003|Overall Study|Adverse Event|0|||
129198469|NCT02045095|465021957|FG004|Overall Study|Adverse Event|0|||
129198470|NCT02045095|465021958|FG005|Overall Study|Adverse Event|2|||
129198471|NCT02045095|465021959|FG006|Overall Study|Adverse Event|0|||
129198472|NCT03594773|465021960|FG000|Overall Study|Withdrawal by Subject|3|||
129198473|NCT03594773|465021961|FG001|Overall Study|Withdrawal by Subject|2|||
129198474|NCT03594773|465021960|FG000|Overall Study|Lost to Follow-up|3|||
129198475|NCT03594773|465021961|FG001|Overall Study|Lost to Follow-up|4|||
129198476|NCT00714415|465021963|FG000|Overall Study|Lack of Efficacy|1|||
129198477|NCT00714415|465021964|FG001|Overall Study|Lack of Efficacy|0|||
129198478|NCT00714415|465021963|FG000|Overall Study|Death|1|||
129198479|NCT00714415|465021964|FG001|Overall Study|Death|0|||
129198480|NCT01461707|465021967|FG000|Overall Study|Withdrawal by Subject|1|||
129198481|NCT01461707|465021968|FG001|Overall Study|Withdrawal by Subject|0|||
129198482|NCT03461146|465021974|FG000|Overall Study|Adverse Event|2|||
129198483|NCT03461146|465021974|FG000|Overall Study|Physician Decision|1|||
129198484|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
129198485|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
129198486|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
129198487|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
129198488|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
129198489|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
129198490|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
129198491|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
129198492|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
129198493|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
129198494|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
129198495|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
129198496|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
128731568|NCT03670810|463312825|FG004|Main Study|Withdrawal by Subject|5|||
128731569|NCT03670810|463312826|FG005|Main Study|Withdrawal by Subject|2|||
128731570|NCT03670810|463312827|FG006|Main Study|Withdrawal by Subject|1|||
128731571|NCT03670810|463312828|FG007|Main Study|Withdrawal by Subject|1|||
128731572|NCT03670810|463312829|FG008|Main Study|Withdrawal by Subject|0|||
128731573|NCT03670810|463312821|FG000|Main Study|Participant did not want to take the three other treatments|1|||
128731574|NCT03670810|463312822|FG001|Main Study|Participant did not want to take the three other treatments|0|||
128731575|NCT03670810|463312823|FG002|Main Study|Participant did not want to take the three other treatments|0|||
128731576|NCT03670810|463312824|FG003|Main Study|Participant did not want to take the three other treatments|0|||
128731577|NCT03670810|463312825|FG004|Main Study|Participant did not want to take the three other treatments|0|||
128731578|NCT03670810|463312826|FG005|Main Study|Participant did not want to take the three other treatments|0|||
128731579|NCT03670810|463312827|FG006|Main Study|Participant did not want to take the three other treatments|0|||
128731580|NCT03670810|463312828|FG007|Main Study|Participant did not want to take the three other treatments|0|||
128731581|NCT03670810|463312829|FG008|Main Study|Participant did not want to take the three other treatments|0|||
128731582|NCT03670810|463312821|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731583|NCT03670810|463312822|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
128731584|NCT03670810|463312823|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731585|NCT03670810|463312824|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731586|NCT03670810|463312825|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731587|NCT03670810|463312826|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731588|NCT03670810|463312827|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731589|NCT03670810|463312828|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731590|NCT03670810|463312829|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
128731591|NCT03670810|463312821|FG000|Main Study|Travel and Coronavirus issues|0|||
128731592|NCT03670810|463312822|FG001|Main Study|Travel and Coronavirus issues|0|||
128731593|NCT03670810|463312823|FG002|Main Study|Travel and Coronavirus issues|0|||
128731594|NCT03670810|463312824|FG003|Main Study|Travel and Coronavirus issues|1|||
128731595|NCT03670810|463312825|FG004|Main Study|Travel and Coronavirus issues|0|||
128731596|NCT03670810|463312826|FG005|Main Study|Travel and Coronavirus issues|0|||
128731597|NCT03670810|463312827|FG006|Main Study|Travel and Coronavirus issues|0|||
128731598|NCT03670810|463312828|FG007|Main Study|Travel and Coronavirus issues|0|||
128731599|NCT03670810|463312829|FG008|Main Study|Travel and Coronavirus issues|0|||
128731600|NCT03670810|463312821|FG000|Open Label Extension|Protocol Deviation|0|||
128731601|NCT03670810|463312822|FG001|Open Label Extension|Protocol Deviation|0|||
128731602|NCT03670810|463312823|FG002|Open Label Extension|Protocol Deviation|0|||
128731603|NCT03670810|463312824|FG003|Open Label Extension|Protocol Deviation|0|||
129198497|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
129198498|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
129198499|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
129198500|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
129198501|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
129198502|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
129198503|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
129198504|NCT03573323|465021975|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
129198505|NCT03573323|465021976|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
129198506|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
129198507|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
129198508|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
129198509|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
129198510|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
129198511|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
129198512|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
128731604|NCT03670810|463312825|FG004|Open Label Extension|Protocol Deviation|0|||
128731605|NCT03670810|463312826|FG005|Open Label Extension|Protocol Deviation|0|||
128731606|NCT03670810|463312827|FG006|Open Label Extension|Protocol Deviation|0|||
128731607|NCT03670810|463312828|FG007|Open Label Extension|Protocol Deviation|0|||
128731608|NCT03670810|463312829|FG008|Open Label Extension|Protocol Deviation|5|||
128731609|NCT03670810|463312821|FG000|Open Label Extension|Death|0|||
128731610|NCT03670810|463312822|FG001|Open Label Extension|Death|0|||
128731611|NCT03670810|463312823|FG002|Open Label Extension|Death|0|||
128731612|NCT03670810|463312824|FG003|Open Label Extension|Death|0|||
128731613|NCT03670810|463312825|FG004|Open Label Extension|Death|0|||
128731614|NCT03670810|463312826|FG005|Open Label Extension|Death|0|||
128731615|NCT03670810|463312827|FG006|Open Label Extension|Death|0|||
128731616|NCT03670810|463312828|FG007|Open Label Extension|Death|0|||
128731617|NCT03670810|463312829|FG008|Open Label Extension|Death|1|||
128731618|NCT03670810|463312821|FG000|Open Label Extension|COVID-19|0|||
129198513|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
129198514|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
128781123|NCT00051311|463490449|FG001|Overall Study|Starting new study|1|||
128731619|NCT03670810|463312822|FG001|Open Label Extension|COVID-19|0|||
128731620|NCT03670810|463312823|FG002|Open Label Extension|COVID-19|0|||
128731621|NCT03670810|463312824|FG003|Open Label Extension|COVID-19|0|||
128731622|NCT03670810|463312825|FG004|Open Label Extension|COVID-19|0|||
128731623|NCT03670810|463312826|FG005|Open Label Extension|COVID-19|0|||
128731624|NCT03670810|463312827|FG006|Open Label Extension|COVID-19|0|||
129198515|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
129198516|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
129198517|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
129198518|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
129198519|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
129198520|NCT03573323|465021975|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
129198521|NCT03573323|465021976|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
129198522|NCT01338818|465021984|FG000|Overall Study|Adverse Event|8|||
129198523|NCT01338818|465021984|FG000|Overall Study|Lack of Efficacy|5|||
129198524|NCT01338818|465021984|FG000|Overall Study|no longer require study drug|1|||
129198525|NCT01338818|465021984|FG000|Overall Study|Withdrawal by Subject|11|||
129198526|NCT01338818|465021984|FG000|Overall Study|Lost to Follow-up|4|||
129198527|NCT01338818|465021984|FG000|Overall Study|Administrative problems|3|||
129198528|NCT01338818|465021984|FG000|Overall Study|Protocol Deviation|4|||
129198529|NCT01843023|465021992|FG000|Overall Study|Death|1|||
129198530|NCT01843023|465021993|FG001|Overall Study|Death|0|||
129198531|NCT01843023|465021992|FG000|Overall Study|Lost to Follow-up|24|||
129198532|NCT01843023|465021993|FG001|Overall Study|Lost to Follow-up|29|||
129198533|NCT01843023|465021992|FG000|Overall Study|Withdrawal by Subject|8|||
129198534|NCT01843023|465021993|FG001|Overall Study|Withdrawal by Subject|6|||
129198535|NCT03305770|465021994|FG000|Overall Study|Physician Decision - prior to dispense|0|||
129198536|NCT03305770|465021995|FG001|Overall Study|Physician Decision - prior to dispense|1|||
129198537|NCT03305770|465021994|FG000|Overall Study|Subject moved|1|||
128731625|NCT03670810|463312828|FG007|Open Label Extension|COVID-19|0|||
128731626|NCT03670810|463312829|FG008|Open Label Extension|COVID-19|1|||
128731627|NCT03670810|463312821|FG000|Open Label Extension|Lack of Efficacy|0|||
128731628|NCT03670810|463312822|FG001|Open Label Extension|Lack of Efficacy|0|||
128731629|NCT03670810|463312823|FG002|Open Label Extension|Lack of Efficacy|0|||
128731630|NCT03670810|463312824|FG003|Open Label Extension|Lack of Efficacy|0|||
128731631|NCT03670810|463312825|FG004|Open Label Extension|Lack of Efficacy|0|||
128731632|NCT03670810|463312826|FG005|Open Label Extension|Lack of Efficacy|0|||
128731633|NCT03670810|463312827|FG006|Open Label Extension|Lack of Efficacy|0|||
128731634|NCT03670810|463312828|FG007|Open Label Extension|Lack of Efficacy|0|||
128731635|NCT03670810|463312829|FG008|Open Label Extension|Lack of Efficacy|39|||
128731636|NCT03670810|463312821|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
128731637|NCT03670810|463312822|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
128731638|NCT03670810|463312823|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
128731639|NCT03670810|463312824|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
128731640|NCT03670810|463312825|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
128731641|NCT03670810|463312826|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
128731642|NCT03670810|463312827|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
128731643|NCT03670810|463312828|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
128731644|NCT03670810|463312829|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
128731645|NCT03670810|463312821|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129198538|NCT03305770|465021995|FG001|Overall Study|Subject moved|0|||
129198539|NCT03539601|465021996|FG000|Overall Study|Withdraw by parent/guardian|1|||
129198540|NCT03539601|465021997|FG001|Overall Study|Withdraw by parent/guardian|0|||
129198541|NCT03539601|465021998|FG002|Overall Study|Withdraw by parent/guardian|1|||
129198542|NCT03539601|465021999|FG003|Overall Study|Withdraw by parent/guardian|0|||
129198543|NCT03539601|465021996|FG000|Overall Study|Adverse Event|0|||
129198544|NCT03539601|465021997|FG001|Overall Study|Adverse Event|2|||
129198545|NCT03539601|465021998|FG002|Overall Study|Adverse Event|0|||
129198546|NCT03539601|465021999|FG003|Overall Study|Adverse Event|0|||
129198547|NCT03539601|465021996|FG000|Overall Study|Lost to Follow-up|2|||
128731646|NCT03670810|463312822|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129198548|NCT03539601|465021997|FG001|Overall Study|Lost to Follow-up|4|||
129198549|NCT03539601|465021998|FG002|Overall Study|Lost to Follow-up|5|||
129198550|NCT03539601|465021999|FG003|Overall Study|Lost to Follow-up|0|||
129198551|NCT03539601|465021996|FG000|Overall Study|Withdrawal by Subject|2|||
129198552|NCT03539601|465021997|FG001|Overall Study|Withdrawal by Subject|0|||
129198553|NCT03539601|465021998|FG002|Overall Study|Withdrawal by Subject|0|||
129198554|NCT03539601|465021999|FG003|Overall Study|Withdrawal by Subject|1|||
129198555|NCT03539601|465021996|FG000|Overall Study|Randomized but not treated|1|||
128731647|NCT03670810|463312823|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
128731648|NCT03670810|463312824|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
128781124|NCT00051311|463490448|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
129198556|NCT03539601|465021997|FG001|Overall Study|Randomized but not treated|1|||
129198557|NCT03539601|465021998|FG002|Overall Study|Randomized but not treated|0|||
129198558|NCT03539601|465021999|FG003|Overall Study|Randomized but not treated|0|||
129198559|NCT01970306|465022000|FG000|Overall Study|Not eligible|3|||
129198560|NCT01970306|465022000|FG000|Overall Study|Not able to be treated|9|||
128731649|NCT03670810|463312825|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
128731650|NCT03670810|463312826|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129198561|NCT00226811|465022001|FG000|Overall Study|Death|8|||
129198562|NCT00226811|465022001|FG000|Overall Study|Adverse Event|11|||
129198563|NCT00226811|465022001|FG000|Overall Study|Lack of Efficacy|55|||
129198564|NCT00226811|465022001|FG000|Overall Study|Withdrawal by Subject|2|||
129198565|NCT03081884|465022002|FG000|Overall Study|deferred prostate cancer treatment|1|||
129198566|NCT03081884|465022002|FG000|Overall Study|metastasis managed with systemic therapy|3|||
129198567|NCT03948334|465022004|FG000|Overall Study|Adverse Event|1|||
129198568|NCT03948334|465022005|FG001|Overall Study|Adverse Event|4|||
129198569|NCT03948334|465022004|FG000|Overall Study|Lack of Efficacy|2|||
129198570|NCT03948334|465022005|FG001|Overall Study|Lack of Efficacy|0|||
129198571|NCT03948334|465022004|FG000|Overall Study|Lost to Follow-up|1|||
129198572|NCT03948334|465022005|FG001|Overall Study|Lost to Follow-up|0|||
129198573|NCT03948334|465022004|FG000|Overall Study|Physician Decision|1|||
129198574|NCT03948334|465022005|FG001|Overall Study|Physician Decision|0|||
129198575|NCT03948334|465022004|FG000|Overall Study|Pregnancy|0|||
129198576|NCT03948334|465022005|FG001|Overall Study|Pregnancy|1|||
129198577|NCT03948334|465022004|FG000|Overall Study|Protocol Deviation|1|||
129198578|NCT03948334|465022005|FG001|Overall Study|Protocol Deviation|0|||
129198579|NCT03948334|465022004|FG000|Overall Study|Study terminated by Sponsor|50|||
129198580|NCT03948334|465022005|FG001|Overall Study|Study terminated by Sponsor|51|||
129198581|NCT03948334|465022004|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
129198582|NCT03948334|465022005|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
129198583|NCT00700713|465022006|FG000|Overall Study|Protocol Violation|1|||
129198584|NCT00700713|465022007|FG001|Overall Study|Protocol Violation|0|||
129198585|NCT00700713|465022008|FG002|Overall Study|Protocol Violation|1|||
129198586|NCT00700713|465022006|FG000|Overall Study|Withdrawal by Subject|0|||
129198587|NCT00700713|465022007|FG001|Overall Study|Withdrawal by Subject|0|||
129198588|NCT00700713|465022008|FG002|Overall Study|Withdrawal by Subject|1|||
129198589|NCT00550953|465022011|FG000|Overall Study|Adverse Event|4|||
129198590|NCT00550953|465022012|FG001|Overall Study|Adverse Event|3|||
129198591|NCT00550953|465022011|FG000|Overall Study|Not able to visit the site|2|||
129198592|NCT00550953|465022012|FG001|Overall Study|Not able to visit the site|3|||
129198593|NCT04980612|465022013|FG000|Overall Study|Withdrawal by Subject|7|||
129198594|NCT04980612|465022014|FG001|Overall Study|Withdrawal by Subject|5|||
129198595|NCT02446717|465022015|FG000|Overall Study|Adverse Event|0|||
129198596|NCT02446717|465022016|FG001|Overall Study|Adverse Event|0|||
129198597|NCT02446717|465022017|FG002|Overall Study|Adverse Event|1|||
129198598|NCT02446717|465022018|FG003|Overall Study|Adverse Event|0|||
129198599|NCT02446717|465022019|FG004|Overall Study|Adverse Event|0|||
129198600|NCT02446717|465022015|FG000|Overall Study|Lost to Follow-up|0|||
129198601|NCT02446717|465022016|FG001|Overall Study|Lost to Follow-up|1|||
129198602|NCT02446717|465022017|FG002|Overall Study|Lost to Follow-up|1|||
129198603|NCT02446717|465022018|FG003|Overall Study|Lost to Follow-up|0|||
129198604|NCT02446717|465022019|FG004|Overall Study|Lost to Follow-up|1|||
129198605|NCT02446717|465022015|FG000|Overall Study|Withdrew consent|0|||
129198606|NCT02446717|465022016|FG001|Overall Study|Withdrew consent|0|||
129198607|NCT02446717|465022017|FG002|Overall Study|Withdrew consent|0|||
129198608|NCT02446717|465022018|FG003|Overall Study|Withdrew consent|1|||
129198609|NCT02446717|465022019|FG004|Overall Study|Withdrew consent|0|||
129198610|NCT02680665|465022020|FG000|Overall Study|No visit after the first prescription|5|||
129198611|NCT01327599|465022021|FG000|Overall Study|Adverse Event|1|||
129198612|NCT01327599|465022021|FG000|Overall Study|Could Not Attend Visit|1|||
129198613|NCT01327599|465022021|FG000|Overall Study|Withdrawal of Consent|1|||
129198614|NCT00434109|465022022|FG000|Overall Study|Physician Decision|9|||
129198615|NCT00434109|465022022|FG000|Overall Study|Adverse Event|5|||
129198616|NCT00434109|465022022|FG000|Overall Study|Protocol Violation|1|||
129198617|NCT00434109|465022022|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
129198618|NCT00086047|465024331|FG000|Overall Study|Lost to Follow-up|7|||
129198619|NCT00086047|465024332|FG001|Overall Study|Lost to Follow-up|6|||
129198620|NCT00086047|465024331|FG000|Overall Study|Physician Decision|0|||
129198621|NCT00086047|465024332|FG001|Overall Study|Physician Decision|1|||
129198622|NCT01797263|465024336|FG000|Overall Study|Withdrawal by Subject|21|||
128731651|NCT03670810|463312827|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129198623|NCT01797263|465024337|FG001|Overall Study|Withdrawal by Subject|25|||
129198624|NCT01797263|465024336|FG000|Overall Study|Death|1|||
129198625|NCT01797263|465024337|FG001|Overall Study|Death|0|||
129198626|NCT01797263|465024336|FG000|Overall Study|Lost to Follow-up|15|||
129198627|NCT01797263|465024337|FG001|Overall Study|Lost to Follow-up|15|||
129198628|NCT01172535|465024338|FG000|Overall Study|Death|3|||
129198629|NCT01172535|465024338|FG000|Overall Study|Withdrawal by Subject|2|||
129198630|NCT01172535|465024338|FG000|Overall Study|Lost to Follow-up|1|||
129198631|NCT01172535|465024338|FG000|Overall Study|Ineligible at study entry|1|||
129198632|NCT01172535|465024338|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
129198633|NCT00988598|465024339|FG000|Overall Study|Withdrawal by Subject|2|||
129198634|NCT00988598|465024340|FG001|Overall Study|Withdrawal by Subject|0|||
129198635|NCT01450761|465024345|FG000|Randomization|Subject no longer meets study criteria|1|||
128731652|NCT03670810|463312828|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129198636|NCT01450761|465024346|FG001|Randomization|Subject no longer meets study criteria|2|||
129198637|NCT01450761|465024345|FG000|Randomization|Withdrawal by Subject|2|||
129198638|NCT01450761|465024346|FG001|Randomization|Withdrawal by Subject|0|||
129198639|NCT01450761|465024345|FG000|Randomization|Disease progression|0|||
129198640|NCT01450761|465024346|FG001|Randomization|Disease progression|2|||
129198641|NCT01450761|465024345|FG000|Randomization|Adverse Event unrelated to study drug|1|||
129198642|NCT01450761|465024346|FG001|Randomization|Adverse Event unrelated to study drug|0|||
129198643|NCT01450761|465024345|FG000|Randomization|Other|0|||
129198644|NCT01450761|465024346|FG001|Randomization|Other|1|||
129198645|NCT01450761|465024345|FG000|Lead-in Chemotherapy|Disease progression|33|||
129198646|NCT01450761|465024346|FG001|Lead-in Chemotherapy|Disease progression|32|||
129198647|NCT01450761|465024345|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
129198648|NCT01450761|465024346|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
129198649|NCT01450761|465024345|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
129198650|NCT01450761|465024346|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
129198651|NCT01450761|465024345|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
129198652|NCT01450761|465024346|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
129198653|NCT01450761|465024345|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
129198654|NCT01450761|465024346|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
129198655|NCT01450761|465024345|FG000|Lead-in Chemotherapy|Death|3|||
129198656|NCT01450761|465024346|FG001|Lead-in Chemotherapy|Death|3|||
129198657|NCT01450761|465024345|FG000|Lead-in Chemotherapy|Other|2|||
129198658|NCT01450761|465024346|FG001|Lead-in Chemotherapy|Other|2|||
129198659|NCT01450761|465024345|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
129198660|NCT01450761|465024346|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
129198661|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
129198662|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
129198663|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
129198664|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
129198665|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
129198666|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
129198667|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
129198668|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
129198669|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
129198670|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
129198671|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Death|5|||
129198672|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Death|6|||
129198673|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
129198674|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
129198675|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
129198676|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
128731653|NCT03670810|463312829|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
129198677|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
129198678|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
129198679|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
128731654|NCT03670810|463312821|FG000|Open Label Extension|Withdrawal by Subject|0|||
128731655|NCT03670810|463312822|FG001|Open Label Extension|Withdrawal by Subject|0|||
129198680|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
129198681|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
129198682|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
129198683|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
129198684|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
129198685|NCT01450761|465024345|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
129198686|NCT01450761|465024346|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
129198687|NCT03801174|465024359|FG000|Overall Study|Withdrawal by Subject|14|||
129198688|NCT03801174|465024360|FG001|Overall Study|Withdrawal by Subject|15|||
129198689|NCT03801174|465024359|FG000|Overall Study|Death|1|||
129198690|NCT03801174|465024360|FG001|Overall Study|Death|0|||
129198691|NCT03801174|465024359|FG000|Overall Study|Pregnancy|2|||
129198692|NCT03801174|465024360|FG001|Overall Study|Pregnancy|2|||
129198693|NCT03801174|465024359|FG000|Overall Study|Lost to Follow-up|19|||
129198694|NCT03801174|465024360|FG001|Overall Study|Lost to Follow-up|10|||
129198695|NCT03801174|465024359|FG000|Overall Study|Other|4|||
129198696|NCT03801174|465024360|FG001|Overall Study|Other|3|||
129198697|NCT03801174|465024359|FG000|Overall Study|Lack of Efficacy|4|||
129198698|NCT03801174|465024360|FG001|Overall Study|Lack of Efficacy|0|||
129198699|NCT03801174|465024359|FG000|Overall Study|Unwilling to complete activities|5|||
129198700|NCT03801174|465024360|FG001|Overall Study|Unwilling to complete activities|6|||
129198701|NCT03801174|465024359|FG000|Overall Study|Moved out of area|3|||
129198702|NCT03801174|465024360|FG001|Overall Study|Moved out of area|0|||
129198703|NCT00337207|465024361|FG000|Overall Study|Withdrawal by Subject|3|||
129198704|NCT00837213|465024365|FG000|Overall Study|Lost to Follow-up|3|||
129198705|NCT00837213|465024366|FG001|Overall Study|Lost to Follow-up|2|||
129198706|NCT00837213|465024365|FG000|Overall Study|Withdrawal by Subject|2|||
129198707|NCT00837213|465024366|FG001|Overall Study|Withdrawal by Subject|2|||
129198708|NCT00837213|465024365|FG000|Overall Study|not stated|1|||
129198709|NCT00837213|465024366|FG001|Overall Study|not stated|1|||
129198710|NCT02698826|465024368|FG000|Overall Study|Death|13|||
129198711|NCT02698826|465024368|FG000|Overall Study|Adverse Event|1|||
129198712|NCT04317040|465024369|FG000|Overall Study|Lost to Follow-up|2|||
129198713|NCT04317040|465024370|FG001|Overall Study|Lost to Follow-up|0|||
129198714|NCT04317040|465024369|FG000|Overall Study|Death|16|||
129198715|NCT04317040|465024370|FG001|Overall Study|Death|18|||
129198716|NCT04317040|465024369|FG000|Overall Study|Withdrawal by Subject|0|||
129198717|NCT04317040|465024370|FG001|Overall Study|Withdrawal by Subject|1|||
129198718|NCT04317040|465024369|FG000|Overall Study|Incomplete assessments|0|||
129198719|NCT04317040|465024370|FG001|Overall Study|Incomplete assessments|1|||
129198720|NCT03030417|465024375|FG000|Dose Expansion|Disease progression before treatment|0|||
129198721|NCT03030417|465024376|FG001|Dose Expansion|Disease progression before treatment|0|||
129198722|NCT03030417|465024377|FG002|Dose Expansion|Disease progression before treatment|0|||
129198723|NCT03030417|465024378|FG003|Dose Expansion|Disease progression before treatment|0|||
129198724|NCT03030417|465024379|FG004|Dose Expansion|Disease progression before treatment|0|||
129198725|NCT03030417|465024380|FG005|Dose Expansion|Disease progression before treatment|0|||
129198726|NCT03030417|465024381|FG006|Dose Expansion|Disease progression before treatment|0|||
129198727|NCT03030417|465024382|FG007|Dose Expansion|Disease progression before treatment|0|||
129198728|NCT03030417|465024383|FG008|Dose Expansion|Disease progression before treatment|0|||
129198729|NCT03030417|465024384|FG009|Dose Expansion|Disease progression before treatment|0|||
129198730|NCT03030417|465024385|FG010|Dose Expansion|Disease progression before treatment|0|||
129198731|NCT03030417|465024386|FG011|Dose Expansion|Disease progression before treatment|0|||
129198732|NCT03030417|465024387|FG012|Dose Expansion|Disease progression before treatment|1|||
129198733|NCT01076959|465024388|FG000|Overall Study|Adverse Event|767|||
129198734|NCT01076959|465024388|FG000|Overall Study|Lack of Efficacy|849|||
129198735|NCT01076959|465024388|FG000|Overall Study|Non-compliance|274|||
129198736|NCT01076959|465024388|FG000|Overall Study|Lost to Follow-up|241|||
129198737|NCT01076959|465024388|FG000|Overall Study|Other|119|||
129198738|NCT01078441|465024389|FG000|Overall Study|Withdrawal by Subject|1|||
129198739|NCT02868554|465024390|FG000|Overall Study|Lost to Follow-up|3|||
129198740|NCT02868554|465024391|FG001|Overall Study|Lost to Follow-up|0|||
129198741|NCT02868554|465024392|FG002|Overall Study|Lost to Follow-up|1|||
129198742|NCT02491983|465024393|FG000|Overall Study|Physician Decision|1|||
129198743|NCT02491983|465024394|FG001|Overall Study|Physician Decision|0|||
129198744|NCT02491983|465024393|FG000|Overall Study|Not meet selection criteria|1|||
129198745|NCT02491983|465024394|FG001|Overall Study|Not meet selection criteria|0|||
129198746|NCT02491983|465024393|FG000|Overall Study|Withdrawal by Subject|0|||
129198747|NCT02491983|465024394|FG001|Overall Study|Withdrawal by Subject|1|||
129198748|NCT02714569|465024395|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
129198749|NCT02714569|465024396|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
129198750|NCT02714569|465024397|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
129198751|NCT02714569|465024398|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
129198752|NCT02714569|465024399|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
129198753|NCT02714569|465024400|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
129198754|NCT02714569|465024401|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
129198755|NCT02714569|465024402|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
129198756|NCT02714569|465024403|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
129198757|NCT02714569|465024404|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
129198758|NCT02714569|465024405|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
129198759|NCT02714569|465024395|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198760|NCT02714569|465024396|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198761|NCT02714569|465024397|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198762|NCT02714569|465024398|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
129198763|NCT02714569|465024399|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198764|NCT02714569|465024400|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198765|NCT02714569|465024401|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198766|NCT02714569|465024402|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198767|NCT02714569|465024403|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198768|NCT02714569|465024404|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198769|NCT02714569|465024405|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129198770|NCT02714569|465024395|FG000|Part A Third Intervention|Adverse Event|0|||
129198771|NCT02714569|465024396|FG001|Part A Third Intervention|Adverse Event|0|||
129198772|NCT02714569|465024397|FG002|Part A Third Intervention|Adverse Event|1|||
129198773|NCT02714569|465024398|FG003|Part A Third Intervention|Adverse Event|0|||
129198774|NCT02714569|465024399|FG004|Part A Third Intervention|Adverse Event|0|||
129198775|NCT02714569|465024400|FG005|Part A Third Intervention|Adverse Event|0|||
129198776|NCT02714569|465024401|FG006|Part A Third Intervention|Adverse Event|0|||
129198777|NCT02714569|465024402|FG007|Part A Third Intervention|Adverse Event|0|||
129198778|NCT02714569|465024403|FG008|Part A Third Intervention|Adverse Event|0|||
129198779|NCT02714569|465024404|FG009|Part A Third Intervention|Adverse Event|0|||
129198780|NCT02714569|465024405|FG010|Part A Third Intervention|Adverse Event|0|||
129198781|NCT02714569|465024395|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
129198782|NCT02714569|465024396|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198783|NCT02714569|465024397|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198784|NCT02714569|465024398|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198785|NCT02714569|465024399|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198786|NCT02714569|465024400|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
129198787|NCT02714569|465024401|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198788|NCT02714569|465024402|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198789|NCT02714569|465024403|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198790|NCT02714569|465024404|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198791|NCT02714569|465024405|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129198792|NCT02714569|465024395|FG000|Part B (Overall)|Lost to Follow-up|0|||
129198793|NCT02714569|465024396|FG001|Part B (Overall)|Lost to Follow-up|0|||
129198794|NCT02714569|465024397|FG002|Part B (Overall)|Lost to Follow-up|0|||
129198795|NCT02714569|465024398|FG003|Part B (Overall)|Lost to Follow-up|0|||
129198796|NCT02714569|465024399|FG004|Part B (Overall)|Lost to Follow-up|0|||
129198797|NCT02714569|465024400|FG005|Part B (Overall)|Lost to Follow-up|0|||
129198798|NCT02714569|465024401|FG006|Part B (Overall)|Lost to Follow-up|1|||
129198799|NCT02714569|465024402|FG007|Part B (Overall)|Lost to Follow-up|0|||
129198800|NCT02714569|465024403|FG008|Part B (Overall)|Lost to Follow-up|0|||
129198801|NCT02714569|465024404|FG009|Part B (Overall)|Lost to Follow-up|0|||
129198802|NCT02714569|465024405|FG010|Part B (Overall)|Lost to Follow-up|0|||
129198803|NCT02714569|465024395|FG000|Part B (Overall)|Withdrawal by Subject|0|||
129198804|NCT02714569|465024396|FG001|Part B (Overall)|Withdrawal by Subject|0|||
129198805|NCT02714569|465024397|FG002|Part B (Overall)|Withdrawal by Subject|0|||
129198806|NCT02714569|465024398|FG003|Part B (Overall)|Withdrawal by Subject|0|||
129198807|NCT02714569|465024399|FG004|Part B (Overall)|Withdrawal by Subject|0|||
129198808|NCT02714569|465024400|FG005|Part B (Overall)|Withdrawal by Subject|0|||
129198809|NCT02714569|465024401|FG006|Part B (Overall)|Withdrawal by Subject|0|||
129198810|NCT02714569|465024402|FG007|Part B (Overall)|Withdrawal by Subject|1|||
129198811|NCT02714569|465024403|FG008|Part B (Overall)|Withdrawal by Subject|0|||
129198812|NCT02714569|465024404|FG009|Part B (Overall)|Withdrawal by Subject|1|||
129198813|NCT02714569|465024405|FG010|Part B (Overall)|Withdrawal by Subject|0|||
129198814|NCT02714569|465024395|FG000|Part B (Overall)|Adverse Event|0|||
129198815|NCT02714569|465024396|FG001|Part B (Overall)|Adverse Event|0|||
129198816|NCT02714569|465024397|FG002|Part B (Overall)|Adverse Event|0|||
129198817|NCT02714569|465024398|FG003|Part B (Overall)|Adverse Event|0|||
129198818|NCT02714569|465024399|FG004|Part B (Overall)|Adverse Event|0|||
129198819|NCT02714569|465024400|FG005|Part B (Overall)|Adverse Event|0|||
129198820|NCT02714569|465024401|FG006|Part B (Overall)|Adverse Event|0|||
128731656|NCT03670810|463312823|FG002|Open Label Extension|Withdrawal by Subject|0|||
128731657|NCT03670810|463312824|FG003|Open Label Extension|Withdrawal by Subject|0|||
128731658|NCT03670810|463312825|FG004|Open Label Extension|Withdrawal by Subject|0|||
128731659|NCT03670810|463312826|FG005|Open Label Extension|Withdrawal by Subject|0|||
128731660|NCT03670810|463312827|FG006|Open Label Extension|Withdrawal by Subject|0|||
128731661|NCT03670810|463312828|FG007|Open Label Extension|Withdrawal by Subject|0|||
128731662|NCT03670810|463312829|FG008|Open Label Extension|Withdrawal by Subject|46|||
128731663|NCT03670810|463312821|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731664|NCT03670810|463312822|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731665|NCT03670810|463312823|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731666|NCT03670810|463312824|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731667|NCT03670810|463312825|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731668|NCT03670810|463312826|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731669|NCT03670810|463312827|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731670|NCT03670810|463312828|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
128731671|NCT03670810|463312829|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
128731672|NCT03670810|463312821|FG000|Open Label Extension|Physician Decision|0|||
128731673|NCT03670810|463312822|FG001|Open Label Extension|Physician Decision|0|||
128731674|NCT03670810|463312823|FG002|Open Label Extension|Physician Decision|0|||
128731675|NCT03670810|463312824|FG003|Open Label Extension|Physician Decision|0|||
128731676|NCT03670810|463312825|FG004|Open Label Extension|Physician Decision|0|||
128731677|NCT03670810|463312826|FG005|Open Label Extension|Physician Decision|0|||
128731678|NCT03670810|463312827|FG006|Open Label Extension|Physician Decision|0|||
128731679|NCT03670810|463312828|FG007|Open Label Extension|Physician Decision|0|||
128731680|NCT03670810|463312829|FG008|Open Label Extension|Physician Decision|2|||
128731681|NCT03670810|463312821|FG000|Open Label Extension|Non-compliance with study drug|0|||
129198821|NCT02714569|465024402|FG007|Part B (Overall)|Adverse Event|0|||
129198822|NCT02714569|465024403|FG008|Part B (Overall)|Adverse Event|0|||
129198823|NCT02714569|465024404|FG009|Part B (Overall)|Adverse Event|1|||
129198824|NCT02714569|465024405|FG010|Part B (Overall)|Adverse Event|0|||
129198825|NCT01684202|465024406|FG000|Dose-escalation Period|Adverse Event|0|||
129198826|NCT01684202|465024407|FG001|Dose-escalation Period|Adverse Event|1|||
129198827|NCT01684202|465024408|FG002|Dose-escalation Period|Adverse Event|0|||
129198828|NCT01684202|465024409|FG003|Dose-escalation Period|Adverse Event|0|||
129198829|NCT01684202|465024406|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
129198830|NCT01684202|465024407|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
129198831|NCT01684202|465024408|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
129198832|NCT01684202|465024409|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
129198833|NCT01684202|465024406|FG000|Maintenance Period|Adverse Event|1|||
129198834|NCT01684202|465024407|FG001|Maintenance Period|Adverse Event|1|||
129198835|NCT01684202|465024408|FG002|Maintenance Period|Adverse Event|1|||
129198836|NCT01684202|465024409|FG003|Maintenance Period|Adverse Event|1|||
129198837|NCT01684202|465024406|FG000|Maintenance Period|Physician Decision|0|||
129198838|NCT01684202|465024407|FG001|Maintenance Period|Physician Decision|1|||
129198839|NCT01684202|465024408|FG002|Maintenance Period|Physician Decision|0|||
129198840|NCT01684202|465024409|FG003|Maintenance Period|Physician Decision|0|||
129198841|NCT01684202|465024406|FG000|Maintenance Period|Withdrawal by Subject|0|||
129198842|NCT01684202|465024407|FG001|Maintenance Period|Withdrawal by Subject|1|||
129198843|NCT01684202|465024408|FG002|Maintenance Period|Withdrawal by Subject|0|||
129198844|NCT01684202|465024409|FG003|Maintenance Period|Withdrawal by Subject|0|||
129198845|NCT00191308|465024410|FG000|Overall Study|Adverse Event|1|||
129198846|NCT00779025|465024411|FG000|Overall Study|Withdrawal by Subject|1|||
129198847|NCT03710642|465024415|FG000|Overall Study|Adverse Event|5|||
129198848|NCT03710642|465024416|FG001|Overall Study|Adverse Event|1|||
129198849|NCT03710642|465024415|FG000|Overall Study|non-site physician recommendation|1|||
129198850|NCT03710642|465024416|FG001|Overall Study|non-site physician recommendation|0|||
129198851|NCT03710642|465024415|FG000|Overall Study|Participant unwilling or unable to participate|1|||
129198852|NCT03710642|465024416|FG001|Overall Study|Participant unwilling or unable to participate|1|||
129198853|NCT03710642|465024415|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
129198854|NCT03710642|465024416|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
129198855|NCT03710642|465024415|FG000|Overall Study|NA-no code provided|1|||
129198856|NCT03710642|465024416|FG001|Overall Study|NA-no code provided|0|||
129198857|NCT03710642|465024415|FG000|Overall Study|Withdrawal by Subject|1|||
129198858|NCT03710642|465024416|FG001|Overall Study|Withdrawal by Subject|0|||
128731682|NCT03670810|463312822|FG001|Open Label Extension|Non-compliance with study drug|0|||
128731683|NCT03670810|463312823|FG002|Open Label Extension|Non-compliance with study drug|0|||
128731684|NCT03670810|463312824|FG003|Open Label Extension|Non-compliance with study drug|0|||
128731685|NCT03670810|463312825|FG004|Open Label Extension|Non-compliance with study drug|0|||
128731686|NCT03670810|463312826|FG005|Open Label Extension|Non-compliance with study drug|0|||
128731687|NCT03670810|463312827|FG006|Open Label Extension|Non-compliance with study drug|0|||
128731688|NCT03670810|463312828|FG007|Open Label Extension|Non-compliance with study drug|0|||
129198859|NCT02741635|465024419|FG000|Overall Study|Withdrawal by Subject|1|||
129198860|NCT01427933|465024423|FG000|Overall Study|Withdrawal by Subject|5|||
129198861|NCT01427933|465024424|FG001|Overall Study|Withdrawal by Subject|8|||
129198862|NCT01427933|465024423|FG000|Overall Study|Lost to Follow-up|1|||
129198863|NCT01427933|465024424|FG001|Overall Study|Lost to Follow-up|5|||
129198864|NCT01427933|465024423|FG000|Overall Study|Other|1|||
129198865|NCT01427933|465024424|FG001|Overall Study|Other|0|||
129198866|NCT01427933|465024423|FG000|Overall Study|Investigator's Decision|1|||
129198867|NCT01427933|465024424|FG001|Overall Study|Investigator's Decision|0|||
129198868|NCT01633541|465024425|FG000|Overall Study|Death|1|||
129198869|NCT01633541|465024426|FG001|Overall Study|Death|0|||
129198870|NCT03472326|465024429|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
129198871|NCT03472326|465024430|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
129198872|NCT03472326|465024431|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
129198873|NCT03472326|465024432|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
129198874|NCT03472326|465024429|FG000|Part 2: Combination Therapy|Pregnancy|0|||
129198875|NCT03472326|465024430|FG001|Part 2: Combination Therapy|Pregnancy|0|||
129198876|NCT03472326|465024431|FG002|Part 2: Combination Therapy|Pregnancy|0|||
129198877|NCT03472326|465024432|FG003|Part 2: Combination Therapy|Pregnancy|1|||
129198878|NCT01010971|465024433|FG000|Overall Study|Adverse Event|2|||
129198879|NCT01010971|465024434|FG001|Overall Study|Adverse Event|4|||
129198880|NCT01010971|465024435|FG002|Overall Study|Adverse Event|3|||
129198881|NCT01010971|465024433|FG000|Overall Study|Withdrawal by Subject|0|||
129198882|NCT01010971|465024434|FG001|Overall Study|Withdrawal by Subject|2|||
129198883|NCT01010971|465024435|FG002|Overall Study|Withdrawal by Subject|5|||
129198884|NCT01010971|465024433|FG000|Overall Study|Lost to Follow-up|0|||
129198885|NCT01010971|465024434|FG001|Overall Study|Lost to Follow-up|2|||
129198886|NCT01010971|465024435|FG002|Overall Study|Lost to Follow-up|3|||
129198887|NCT01010971|465024433|FG000|Overall Study|Other|1|||
129198888|NCT01010971|465024434|FG001|Overall Study|Other|0|||
129198889|NCT01010971|465024435|FG002|Overall Study|Other|2|||
129198890|NCT03386721|465024436|FG000|Overall Study|Death|12|||
129198891|NCT03386721|465024437|FG001|Overall Study|Death|21|||
129198892|NCT03386721|465024438|FG002|Overall Study|Death|2|||
129198893|NCT03386721|465024439|FG003|Overall Study|Death|5|||
129198894|NCT03386721|465024440|FG004|Overall Study|Death|1|||
129198895|NCT03386721|465024441|FG005|Overall Study|Death|12|||
129198896|NCT03386721|465024442|FG006|Overall Study|Death|1|||
129198897|NCT03386721|465024443|FG007|Overall Study|Death|1|||
129198898|NCT03386721|465024444|FG008|Overall Study|Death|12|||
129198899|NCT03386721|465024445|FG009|Overall Study|Death|20|||
129198900|NCT03386721|465024446|FG010|Overall Study|Death|21|||
129198901|NCT03386721|465024447|FG011|Overall Study|Death|21|||
129198902|NCT03386721|465024448|FG012|Overall Study|Death|14|||
129198903|NCT03386721|465024449|FG013|Overall Study|Death|2|||
129198904|NCT03386721|465024450|FG014|Overall Study|Death|1|||
129198905|NCT03386721|465024436|FG000|Overall Study|Lost to Follow-up|1|||
129198906|NCT03386721|465024437|FG001|Overall Study|Lost to Follow-up|3|||
129198907|NCT03386721|465024438|FG002|Overall Study|Lost to Follow-up|0|||
129198908|NCT03386721|465024439|FG003|Overall Study|Lost to Follow-up|0|||
129198909|NCT03386721|465024440|FG004|Overall Study|Lost to Follow-up|0|||
129198910|NCT03386721|465024441|FG005|Overall Study|Lost to Follow-up|2|||
129198911|NCT03386721|465024442|FG006|Overall Study|Lost to Follow-up|1|||
129198912|NCT03386721|465024443|FG007|Overall Study|Lost to Follow-up|0|||
129198913|NCT03386721|465024444|FG008|Overall Study|Lost to Follow-up|1|||
129198914|NCT03386721|465024445|FG009|Overall Study|Lost to Follow-up|2|||
129198915|NCT03386721|465024446|FG010|Overall Study|Lost to Follow-up|1|||
129198916|NCT03386721|465024447|FG011|Overall Study|Lost to Follow-up|0|||
129198917|NCT03386721|465024448|FG012|Overall Study|Lost to Follow-up|0|||
129198918|NCT03386721|465024449|FG013|Overall Study|Lost to Follow-up|0|||
129198919|NCT03386721|465024450|FG014|Overall Study|Lost to Follow-up|0|||
129198920|NCT03386721|465024436|FG000|Overall Study|Reason not specified|3|||
129198921|NCT03386721|465024437|FG001|Overall Study|Reason not specified|0|||
129198922|NCT03386721|465024438|FG002|Overall Study|Reason not specified|0|||
128731689|NCT03670810|463312829|FG008|Open Label Extension|Non-compliance with study drug|5|||
129198923|NCT03386721|465024439|FG003|Overall Study|Reason not specified|0|||
129198924|NCT03386721|465024440|FG004|Overall Study|Reason not specified|0|||
129198925|NCT03386721|465024441|FG005|Overall Study|Reason not specified|3|||
129198926|NCT03386721|465024442|FG006|Overall Study|Reason not specified|1|||
129198927|NCT03386721|465024443|FG007|Overall Study|Reason not specified|0|||
129198928|NCT03386721|465024444|FG008|Overall Study|Reason not specified|0|||
129198929|NCT03386721|465024445|FG009|Overall Study|Reason not specified|1|||
129198930|NCT03386721|465024446|FG010|Overall Study|Reason not specified|2|||
129198931|NCT03386721|465024447|FG011|Overall Study|Reason not specified|6|||
129198932|NCT03386721|465024448|FG012|Overall Study|Reason not specified|1|||
128731690|NCT03670810|463312821|FG000|Open Label Extension|Pregnancy|0|||
129198933|NCT03386721|465024449|FG013|Overall Study|Reason not specified|0|||
129198934|NCT03386721|465024450|FG014|Overall Study|Reason not specified|0|||
129198935|NCT03386721|465024436|FG000|Overall Study|Progressive Disease|0|||
129198936|NCT03386721|465024437|FG001|Overall Study|Progressive Disease|0|||
129198937|NCT03386721|465024438|FG002|Overall Study|Progressive Disease|1|||
129198938|NCT03386721|465024439|FG003|Overall Study|Progressive Disease|0|||
129198939|NCT03386721|465024440|FG004|Overall Study|Progressive Disease|0|||
129198940|NCT03386721|465024441|FG005|Overall Study|Progressive Disease|1|||
129198941|NCT03386721|465024442|FG006|Overall Study|Progressive Disease|0|||
129198942|NCT03386721|465024443|FG007|Overall Study|Progressive Disease|0|||
129198943|NCT03386721|465024444|FG008|Overall Study|Progressive Disease|2|||
129198944|NCT03386721|465024445|FG009|Overall Study|Progressive Disease|1|||
129198945|NCT03386721|465024446|FG010|Overall Study|Progressive Disease|1|||
129198946|NCT03386721|465024447|FG011|Overall Study|Progressive Disease|0|||
129198947|NCT03386721|465024448|FG012|Overall Study|Progressive Disease|1|||
129198948|NCT03386721|465024449|FG013|Overall Study|Progressive Disease|0|||
129198949|NCT03386721|465024450|FG014|Overall Study|Progressive Disease|0|||
129198950|NCT03386721|465024436|FG000|Overall Study|Site Terminated by Sponsor|5|||
129198951|NCT03386721|465024437|FG001|Overall Study|Site Terminated by Sponsor|5|||
129198952|NCT03386721|465024438|FG002|Overall Study|Site Terminated by Sponsor|0|||
129198953|NCT03386721|465024439|FG003|Overall Study|Site Terminated by Sponsor|0|||
129198954|NCT03386721|465024440|FG004|Overall Study|Site Terminated by Sponsor|1|||
129198955|NCT03386721|465024441|FG005|Overall Study|Site Terminated by Sponsor|3|||
129198956|NCT03386721|465024442|FG006|Overall Study|Site Terminated by Sponsor|0|||
129198957|NCT03386721|465024443|FG007|Overall Study|Site Terminated by Sponsor|1|||
129198958|NCT03386721|465024444|FG008|Overall Study|Site Terminated by Sponsor|4|||
129198959|NCT03386721|465024445|FG009|Overall Study|Site Terminated by Sponsor|5|||
129198960|NCT03386721|465024446|FG010|Overall Study|Site Terminated by Sponsor|3|||
129198961|NCT03386721|465024447|FG011|Overall Study|Site Terminated by Sponsor|11|||
129198962|NCT03386721|465024448|FG012|Overall Study|Site Terminated by Sponsor|6|||
129198963|NCT03386721|465024449|FG013|Overall Study|Site Terminated by Sponsor|0|||
129198964|NCT03386721|465024450|FG014|Overall Study|Site Terminated by Sponsor|0|||
129198965|NCT03386721|465024436|FG000|Overall Study|Symptomatic Deterioration|0|||
129198966|NCT03386721|465024437|FG001|Overall Study|Symptomatic Deterioration|0|||
129198967|NCT03386721|465024438|FG002|Overall Study|Symptomatic Deterioration|0|||
129198968|NCT03386721|465024439|FG003|Overall Study|Symptomatic Deterioration|0|||
129198969|NCT03386721|465024440|FG004|Overall Study|Symptomatic Deterioration|0|||
129198970|NCT03386721|465024441|FG005|Overall Study|Symptomatic Deterioration|0|||
129198971|NCT03386721|465024442|FG006|Overall Study|Symptomatic Deterioration|0|||
129198972|NCT03386721|465024443|FG007|Overall Study|Symptomatic Deterioration|0|||
129198973|NCT03386721|465024444|FG008|Overall Study|Symptomatic Deterioration|1|||
129198974|NCT03386721|465024445|FG009|Overall Study|Symptomatic Deterioration|0|||
129198975|NCT03386721|465024446|FG010|Overall Study|Symptomatic Deterioration|0|||
129198976|NCT03386721|465024447|FG011|Overall Study|Symptomatic Deterioration|1|||
129198977|NCT03386721|465024448|FG012|Overall Study|Symptomatic Deterioration|0|||
129198978|NCT03386721|465024449|FG013|Overall Study|Symptomatic Deterioration|0|||
129198979|NCT03386721|465024450|FG014|Overall Study|Symptomatic Deterioration|0|||
129198980|NCT03386721|465024436|FG000|Overall Study|Withdrawal by Subject|1|||
129198981|NCT03386721|465024437|FG001|Overall Study|Withdrawal by Subject|2|||
129198982|NCT03386721|465024438|FG002|Overall Study|Withdrawal by Subject|0|||
129198983|NCT03386721|465024439|FG003|Overall Study|Withdrawal by Subject|0|||
129198984|NCT03386721|465024440|FG004|Overall Study|Withdrawal by Subject|0|||
129198985|NCT03386721|465024441|FG005|Overall Study|Withdrawal by Subject|0|||
129198986|NCT03386721|465024442|FG006|Overall Study|Withdrawal by Subject|0|||
129198987|NCT03386721|465024443|FG007|Overall Study|Withdrawal by Subject|0|||
129198988|NCT03386721|465024444|FG008|Overall Study|Withdrawal by Subject|2|||
129198989|NCT03386721|465024445|FG009|Overall Study|Withdrawal by Subject|1|||
129198990|NCT03386721|465024446|FG010|Overall Study|Withdrawal by Subject|3|||
128731691|NCT03670810|463312822|FG001|Open Label Extension|Pregnancy|0|||
128731692|NCT03670810|463312823|FG002|Open Label Extension|Pregnancy|0|||
128731693|NCT03670810|463312824|FG003|Open Label Extension|Pregnancy|0|||
129198991|NCT03386721|465024447|FG011|Overall Study|Withdrawal by Subject|2|||
129198992|NCT03386721|465024448|FG012|Overall Study|Withdrawal by Subject|3|||
129198993|NCT03386721|465024449|FG013|Overall Study|Withdrawal by Subject|0|||
129198994|NCT03386721|465024450|FG014|Overall Study|Withdrawal by Subject|0|||
129198995|NCT05114473|465024451|FG000|Overall Study|Lost to Follow-up|2|||
128731694|NCT03670810|463312825|FG004|Open Label Extension|Pregnancy|0|||
128731695|NCT03670810|463312826|FG005|Open Label Extension|Pregnancy|0|||
128731696|NCT03670810|463312827|FG006|Open Label Extension|Pregnancy|0|||
128731697|NCT03670810|463312828|FG007|Open Label Extension|Pregnancy|0|||
128731698|NCT03670810|463312829|FG008|Open Label Extension|Pregnancy|3|||
128731699|NCT03670810|463312821|FG000|Open Label Extension|Adverse Event|0|||
128731700|NCT03670810|463312822|FG001|Open Label Extension|Adverse Event|0|||
128731701|NCT03670810|463312823|FG002|Open Label Extension|Adverse Event|0|||
128731702|NCT03670810|463312824|FG003|Open Label Extension|Adverse Event|0|||
128731703|NCT03670810|463312825|FG004|Open Label Extension|Adverse Event|0|||
128731704|NCT03670810|463312826|FG005|Open Label Extension|Adverse Event|0|||
128731705|NCT03670810|463312827|FG006|Open Label Extension|Adverse Event|0|||
128731706|NCT03670810|463312828|FG007|Open Label Extension|Adverse Event|0|||
128731707|NCT03670810|463312829|FG008|Open Label Extension|Adverse Event|24|||
128731708|NCT03670810|463312821|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
128731709|NCT03670810|463312822|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
128731710|NCT03670810|463312823|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
128731711|NCT03670810|463312824|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
128731712|NCT03670810|463312825|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
128731713|NCT03670810|463312826|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
128731714|NCT03670810|463312827|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
128731715|NCT03670810|463312828|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
128731716|NCT03670810|463312829|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
128731717|NCT03670810|463312821|FG000|Open Label Extension|Lost to Follow-up|0|||
128731718|NCT03670810|463312822|FG001|Open Label Extension|Lost to Follow-up|0|||
128731719|NCT03670810|463312823|FG002|Open Label Extension|Lost to Follow-up|0|||
128731720|NCT03670810|463312824|FG003|Open Label Extension|Lost to Follow-up|0|||
128731721|NCT03670810|463312825|FG004|Open Label Extension|Lost to Follow-up|0|||
128731722|NCT03670810|463312826|FG005|Open Label Extension|Lost to Follow-up|0|||
128731723|NCT03670810|463312827|FG006|Open Label Extension|Lost to Follow-up|0|||
128731724|NCT03670810|463312828|FG007|Open Label Extension|Lost to Follow-up|0|||
128731725|NCT03670810|463312829|FG008|Open Label Extension|Lost to Follow-up|23|||
128731726|NCT02644967|463312833|FG000|Overall Study|Death|26|||
128731727|NCT02644967|463312833|FG000|Overall Study|Physician Decision|1|||
128731728|NCT02644967|463312833|FG000|Overall Study|Withdrawal by Subject|2|||
128731729|NCT02644967|463312833|FG000|Overall Study|Protocol Violation|1|||
128731730|NCT02644967|463312833|FG000|Overall Study|Progressive Disease|1|||
128731731|NCT02644967|463312833|FG000|Overall Study|Study Terminated by Sponsor|4|||
128731732|NCT03323099|463312835|FG000|Overall Study|Withdrawal by Subject|6|||
128731733|NCT03323099|463312836|FG001|Overall Study|Withdrawal by Subject|12|||
128731734|NCT03323099|463312835|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
128731735|NCT03323099|463312836|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
128731736|NCT05220397|463312841|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
128731737|NCT05220397|463312842|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
128731738|NCT05220397|463312843|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
129198996|NCT05114473|465024452|FG001|Overall Study|Lost to Follow-up|2|||
129198997|NCT05114473|465024453|FG002|Overall Study|Lost to Follow-up|0|||
129198998|NCT01369784|465024456|FG000|Overall Study|Protocol Violation|12|||
129198999|NCT00782717|465024457|FG000|Overall Study|Adverse Event|2|||
129199000|NCT00782717|465024458|FG001|Overall Study|Adverse Event|5|||
129199001|NCT00782717|465024457|FG000|Overall Study|Patient decision unrelated to AE|6|||
129199002|NCT00782717|465024458|FG001|Overall Study|Patient decision unrelated to AE|3|||
129199003|NCT00782717|465024457|FG000|Overall Study|Noncompliance|2|||
129199004|NCT00782717|465024458|FG001|Overall Study|Noncompliance|1|||
129199005|NCT00782717|465024457|FG000|Overall Study|Treatment failure|3|||
129199006|NCT00782717|465024458|FG001|Overall Study|Treatment failure|14|||
129199007|NCT00782717|465024457|FG000|Overall Study|Enrollment close prior to surgery|1|||
129199008|NCT00782717|465024458|FG001|Overall Study|Enrollment close prior to surgery|0|||
129199009|NCT00782717|465024457|FG000|Overall Study|Did not meet entrance criteria|1|||
129199010|NCT00782717|465024458|FG001|Overall Study|Did not meet entrance criteria|3|||
129199011|NCT00782717|465024457|FG000|Overall Study|Exited in error|0|||
129199012|NCT00782717|465024458|FG001|Overall Study|Exited in error|2|||
129199013|NCT02905266|465024459|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
128731739|NCT05220397|463312844|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
128731740|NCT05220397|463312845|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
128731741|NCT01502644|463312846|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
128731742|NCT01502644|463312847|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
128731743|NCT01502644|463312848|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
128731744|NCT01502644|463312849|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
128731745|NCT01502644|463312846|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
129199014|NCT02905266|465024460|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
129199015|NCT02905266|465024459|FG000|Treatment Phase Part 1|Disease Progression|6|||
128731746|NCT01502644|463312847|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129199016|NCT02905266|465024460|FG001|Treatment Phase Part 1|Disease Progression|7|||
129199017|NCT02905266|465024459|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
129199018|NCT02905266|465024460|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
129199019|NCT02905266|465024459|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
129199020|NCT02905266|465024460|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
129199021|NCT02905266|465024459|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
129199022|NCT02905266|465024460|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
129199023|NCT02905266|465024459|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
129199024|NCT02905266|465024460|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
129199025|NCT02905266|465024459|FG000|Transition From Part 1 to Part 2|Death|0|||
129199026|NCT02905266|465024460|FG001|Transition From Part 1 to Part 2|Death|1|||
129199027|NCT02905266|465024459|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
129199028|NCT02905266|465024460|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
129199029|NCT02905266|465024459|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
129199030|NCT02905266|465024460|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
129199031|NCT02905266|465024459|FG000|Maintenance Phase Part 2|Disease Progression|9|||
129199032|NCT02905266|465024460|FG001|Maintenance Phase Part 2|Disease Progression|2|||
129199033|NCT02905266|465024459|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
129199034|NCT02905266|465024460|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
129199035|NCT02905266|465024459|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
128731747|NCT01502644|463312848|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
128731748|NCT01502644|463312849|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129199036|NCT02905266|465024460|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
129199037|NCT02292719|465024466|FG000|Overall Study|Withdrawal by Subject|0|||
129199038|NCT02292719|465024467|FG001|Overall Study|Withdrawal by Subject|0|||
129199039|NCT02292719|465024468|FG002|Overall Study|Withdrawal by Subject|0|||
129199040|NCT02292719|465024469|FG003|Overall Study|Withdrawal by Subject|1|||
129199041|NCT02292719|465024470|FG004|Overall Study|Withdrawal by Subject|1|||
129199042|NCT02292719|465024471|FG005|Overall Study|Withdrawal by Subject|0|||
129199043|NCT02292719|465024466|FG000|Overall Study|Subject enrolled in new study.|0|||
129199044|NCT02292719|465024467|FG001|Overall Study|Subject enrolled in new study.|0|||
129199045|NCT02292719|465024468|FG002|Overall Study|Subject enrolled in new study.|1|||
129199046|NCT02292719|465024469|FG003|Overall Study|Subject enrolled in new study.|0|||
129199047|NCT02292719|465024470|FG004|Overall Study|Subject enrolled in new study.|0|||
129199048|NCT02292719|465024471|FG005|Overall Study|Subject enrolled in new study.|0|||
129199049|NCT02586727|465024474|FG000|Overall Study|Lost to Follow-up|1|||
129199050|NCT02586727|465024475|FG001|Overall Study|Lost to Follow-up|0|||
129199051|NCT04378270|465024477|FG000|Overall Study|Lack of Efficacy|1|||
129199052|NCT04378270|465024477|FG000|Overall Study|Withdrawal by Subject|1|||
129199053|NCT04378270|465024477|FG000|Overall Study|Screen Failure|1|||
129199054|NCT04378270|465024477|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
129199055|NCT01132313|465024478|FG000|Overall Study|Lack of Efficacy|1|||
129199056|NCT01132313|465024479|FG001|Overall Study|Lack of Efficacy|0|||
129199057|NCT01132313|465024480|FG002|Overall Study|Lack of Efficacy|0|||
129199058|NCT01132313|465024481|FG003|Overall Study|Lack of Efficacy|0|||
129199059|NCT01132313|465024482|FG004|Overall Study|Lack of Efficacy|0|||
129199060|NCT01132313|465024483|FG005|Overall Study|Lack of Efficacy|0|||
129199061|NCT01132313|465024484|FG006|Overall Study|Lack of Efficacy|0|||
129199062|NCT01132313|465024485|FG007|Overall Study|Lack of Efficacy|3|||
129199063|NCT01132313|465024486|FG008|Overall Study|Lack of Efficacy|14|||
129199064|NCT01132313|465024487|FG009|Overall Study|Lack of Efficacy|16|||
129199065|NCT01132313|465024488|FG010|Overall Study|Lack of Efficacy|0|||
129199066|NCT01132313|465024489|FG011|Overall Study|Lack of Efficacy|0|||
129199067|NCT01132313|465024478|FG000|Overall Study|Not treated|2|||
129199068|NCT01132313|465024479|FG001|Overall Study|Not treated|0|||
129199069|NCT01132313|465024480|FG002|Overall Study|Not treated|0|||
129199070|NCT01132313|465024481|FG003|Overall Study|Not treated|0|||
129199071|NCT01132313|465024482|FG004|Overall Study|Not treated|2|||
129199072|NCT01132313|465024483|FG005|Overall Study|Not treated|1|||
129199073|NCT01132313|465024484|FG006|Overall Study|Not treated|3|||
129199074|NCT01132313|465024485|FG007|Overall Study|Not treated|0|||
129199075|NCT01132313|465024486|FG008|Overall Study|Not treated|0|||
129199076|NCT01132313|465024487|FG009|Overall Study|Not treated|0|||
129199077|NCT01132313|465024488|FG010|Overall Study|Not treated|0|||
129199078|NCT01132313|465024489|FG011|Overall Study|Not treated|0|||
129199079|NCT01132313|465024478|FG000|Overall Study|Adverse Event|0|||
129199080|NCT01132313|465024479|FG001|Overall Study|Adverse Event|0|||
129199081|NCT01132313|465024480|FG002|Overall Study|Adverse Event|4|||
129199082|NCT01132313|465024481|FG003|Overall Study|Adverse Event|10|||
129199083|NCT01132313|465024482|FG004|Overall Study|Adverse Event|19|||
129199084|NCT01132313|465024483|FG005|Overall Study|Adverse Event|6|||
129199085|NCT01132313|465024484|FG006|Overall Study|Adverse Event|5|||
129199086|NCT01132313|465024485|FG007|Overall Study|Adverse Event|3|||
129199087|NCT01132313|465024486|FG008|Overall Study|Adverse Event|7|||
129199088|NCT01132313|465024487|FG009|Overall Study|Adverse Event|2|||
129199089|NCT01132313|465024488|FG010|Overall Study|Adverse Event|0|||
129199090|NCT01132313|465024489|FG011|Overall Study|Adverse Event|0|||
129199091|NCT01132313|465024478|FG000|Overall Study|Protocol Violation|0|||
129199092|NCT01132313|465024479|FG001|Overall Study|Protocol Violation|0|||
129199093|NCT01132313|465024480|FG002|Overall Study|Protocol Violation|0|||
129199094|NCT01132313|465024481|FG003|Overall Study|Protocol Violation|1|||
129199095|NCT01132313|465024482|FG004|Overall Study|Protocol Violation|0|||
129199096|NCT01132313|465024483|FG005|Overall Study|Protocol Violation|0|||
129199097|NCT01132313|465024484|FG006|Overall Study|Protocol Violation|0|||
129199098|NCT01132313|465024485|FG007|Overall Study|Protocol Violation|0|||
129199099|NCT01132313|465024486|FG008|Overall Study|Protocol Violation|0|||
129199100|NCT01132313|465024487|FG009|Overall Study|Protocol Violation|0|||
129199101|NCT01132313|465024488|FG010|Overall Study|Protocol Violation|0|||
129199102|NCT01132313|465024489|FG011|Overall Study|Protocol Violation|0|||
129199103|NCT01132313|465024478|FG000|Overall Study|Lost to Follow-up|0|||
129199104|NCT01132313|465024479|FG001|Overall Study|Lost to Follow-up|0|||
129199105|NCT01132313|465024480|FG002|Overall Study|Lost to Follow-up|1|||
129199106|NCT01132313|465024481|FG003|Overall Study|Lost to Follow-up|0|||
129199107|NCT01132313|465024482|FG004|Overall Study|Lost to Follow-up|0|||
129199108|NCT01132313|465024483|FG005|Overall Study|Lost to Follow-up|0|||
129199109|NCT01132313|465024484|FG006|Overall Study|Lost to Follow-up|0|||
129199110|NCT01132313|465024485|FG007|Overall Study|Lost to Follow-up|1|||
129199111|NCT01132313|465024486|FG008|Overall Study|Lost to Follow-up|0|||
129199112|NCT01132313|465024487|FG009|Overall Study|Lost to Follow-up|0|||
129199113|NCT01132313|465024488|FG010|Overall Study|Lost to Follow-up|0|||
129199114|NCT01132313|465024489|FG011|Overall Study|Lost to Follow-up|0|||
129199115|NCT01132313|465024478|FG000|Overall Study|Withdrawal by Subject|0|||
129199116|NCT01132313|465024479|FG001|Overall Study|Withdrawal by Subject|0|||
128731749|NCT01502644|463312846|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
129199117|NCT01132313|465024480|FG002|Overall Study|Withdrawal by Subject|3|||
129199118|NCT01132313|465024481|FG003|Overall Study|Withdrawal by Subject|3|||
129199119|NCT01132313|465024482|FG004|Overall Study|Withdrawal by Subject|6|||
129199120|NCT01132313|465024483|FG005|Overall Study|Withdrawal by Subject|0|||
129199121|NCT01132313|465024484|FG006|Overall Study|Withdrawal by Subject|1|||
129199122|NCT01132313|465024485|FG007|Overall Study|Withdrawal by Subject|0|||
129199123|NCT01132313|465024486|FG008|Overall Study|Withdrawal by Subject|0|||
129199124|NCT01132313|465024487|FG009|Overall Study|Withdrawal by Subject|2|||
129199125|NCT01132313|465024488|FG010|Overall Study|Withdrawal by Subject|0|||
129199126|NCT01132313|465024489|FG011|Overall Study|Withdrawal by Subject|0|||
129199127|NCT01132313|465024478|FG000|Overall Study|Lack of antiviral response|0|||
129199128|NCT01132313|465024479|FG001|Overall Study|Lack of antiviral response|0|||
129199129|NCT01132313|465024480|FG002|Overall Study|Lack of antiviral response|12|||
129199130|NCT01132313|465024481|FG003|Overall Study|Lack of antiviral response|18|||
129199131|NCT01132313|465024482|FG004|Overall Study|Lack of antiviral response|18|||
129199132|NCT01132313|465024483|FG005|Overall Study|Lack of antiviral response|18|||
129199133|NCT01132313|465024484|FG006|Overall Study|Lack of antiviral response|21|||
129199134|NCT01132313|465024485|FG007|Overall Study|Lack of antiviral response|0|||
129199135|NCT01132313|465024486|FG008|Overall Study|Lack of antiviral response|0|||
129199136|NCT01132313|465024487|FG009|Overall Study|Lack of antiviral response|0|||
129199137|NCT01132313|465024488|FG010|Overall Study|Lack of antiviral response|1|||
129199138|NCT01132313|465024489|FG011|Overall Study|Lack of antiviral response|0|||
129199139|NCT01132313|465024478|FG000|Overall Study|Other reason not defined above|0|||
129199140|NCT01132313|465024479|FG001|Overall Study|Other reason not defined above|0|||
129199141|NCT01132313|465024480|FG002|Overall Study|Other reason not defined above|0|||
129199142|NCT01132313|465024481|FG003|Overall Study|Other reason not defined above|0|||
129199143|NCT01132313|465024482|FG004|Overall Study|Other reason not defined above|0|||
129199144|NCT01132313|465024483|FG005|Overall Study|Other reason not defined above|0|||
129199145|NCT01132313|465024484|FG006|Overall Study|Other reason not defined above|0|||
129199146|NCT01132313|465024485|FG007|Overall Study|Other reason not defined above|1|||
129199147|NCT01132313|465024486|FG008|Overall Study|Other reason not defined above|0|||
129199148|NCT01132313|465024487|FG009|Overall Study|Other reason not defined above|0|||
129199149|NCT01132313|465024488|FG010|Overall Study|Other reason not defined above|0|||
129199150|NCT01132313|465024489|FG011|Overall Study|Other reason not defined above|0|||
129199151|NCT02715609|465024491|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
129199152|NCT02715609|465024492|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
129199153|NCT02715609|465024493|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
129199154|NCT02715609|465024491|FG000|Overall Study|Withdrawal by Subject|0|||
129199155|NCT02715609|465024492|FG001|Overall Study|Withdrawal by Subject|0|||
129199156|NCT02715609|465024493|FG002|Overall Study|Withdrawal by Subject|1|||
129199157|NCT03201419|465024494|FG000|Overall Study|Adverse Event|3|||
129199158|NCT03201419|465024495|FG001|Overall Study|Adverse Event|1|||
129199159|NCT03201419|465024496|FG002|Overall Study|Adverse Event|0|||
129199160|NCT03201419|465024497|FG003|Overall Study|Adverse Event|0|||
129199161|NCT03201419|465024498|FG004|Overall Study|Adverse Event|1|||
129199162|NCT03201419|465024499|FG005|Overall Study|Adverse Event|1|||
129199163|NCT03201419|465024500|FG006|Overall Study|Adverse Event|5|||
129199164|NCT03201419|465024501|FG007|Overall Study|Adverse Event|0|||
129199165|NCT03201419|465024502|FG008|Overall Study|Adverse Event|0|||
129199166|NCT03201419|465024494|FG000|Overall Study|Lost to Follow-up|1|||
129199167|NCT03201419|465024495|FG001|Overall Study|Lost to Follow-up|0|||
129199168|NCT03201419|465024496|FG002|Overall Study|Lost to Follow-up|0|||
129199169|NCT03201419|465024497|FG003|Overall Study|Lost to Follow-up|0|||
129199170|NCT03201419|465024498|FG004|Overall Study|Lost to Follow-up|0|||
129199171|NCT03201419|465024499|FG005|Overall Study|Lost to Follow-up|0|||
129199172|NCT03201419|465024500|FG006|Overall Study|Lost to Follow-up|0|||
129199173|NCT03201419|465024501|FG007|Overall Study|Lost to Follow-up|0|||
129199174|NCT03201419|465024502|FG008|Overall Study|Lost to Follow-up|0|||
129199175|NCT03201419|465024494|FG000|Overall Study|Protocol Deviation|0|||
129199176|NCT03201419|465024495|FG001|Overall Study|Protocol Deviation|0|||
129199177|NCT03201419|465024496|FG002|Overall Study|Protocol Deviation|0|||
129199178|NCT03201419|465024497|FG003|Overall Study|Protocol Deviation|0|||
129199179|NCT03201419|465024498|FG004|Overall Study|Protocol Deviation|0|||
128731750|NCT01502644|463312847|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
129199180|NCT03201419|465024499|FG005|Overall Study|Protocol Deviation|0|||
129199181|NCT03201419|465024500|FG006|Overall Study|Protocol Deviation|1|||
129199182|NCT03201419|465024501|FG007|Overall Study|Protocol Deviation|0|||
129199183|NCT03201419|465024502|FG008|Overall Study|Protocol Deviation|0|||
129199184|NCT03201419|465024494|FG000|Overall Study|Withdrawal by Subject|4|||
129199185|NCT03201419|465024495|FG001|Overall Study|Withdrawal by Subject|2|||
129199186|NCT03201419|465024496|FG002|Overall Study|Withdrawal by Subject|1|||
129199187|NCT03201419|465024497|FG003|Overall Study|Withdrawal by Subject|0|||
129199188|NCT03201419|465024498|FG004|Overall Study|Withdrawal by Subject|0|||
129199189|NCT03201419|465024499|FG005|Overall Study|Withdrawal by Subject|0|||
128731751|NCT01502644|463312848|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
128731752|NCT01502644|463312849|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
128731753|NCT01502644|463312846|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
129199190|NCT03201419|465024500|FG006|Overall Study|Withdrawal by Subject|0|||
129199191|NCT03201419|465024501|FG007|Overall Study|Withdrawal by Subject|1|||
129199192|NCT03201419|465024502|FG008|Overall Study|Withdrawal by Subject|2|||
129199193|NCT03201419|465024494|FG000|Overall Study|Other|0|||
129199194|NCT03201419|465024495|FG001|Overall Study|Other|0|||
129199195|NCT03201419|465024496|FG002|Overall Study|Other|1|||
129199196|NCT03201419|465024497|FG003|Overall Study|Other|0|||
129199197|NCT03201419|465024498|FG004|Overall Study|Other|0|||
129199198|NCT03201419|465024499|FG005|Overall Study|Other|0|||
129199199|NCT03201419|465024500|FG006|Overall Study|Other|0|||
129199200|NCT03201419|465024501|FG007|Overall Study|Other|0|||
129199201|NCT03201419|465024502|FG008|Overall Study|Other|0|||
129199202|NCT05907395|465024505|FG000|Period 1|No longer met eligibility criteria|0|||
129199203|NCT05907395|465024506|FG001|Period 1|No longer met eligibility criteria|1|||
129199204|NCT05907395|465024507|FG002|Period 1|No longer met eligibility criteria|0|||
129199205|NCT05907395|465024508|FG003|Period 1|No longer met eligibility criteria|0|||
129199206|NCT05907395|465024509|FG004|Period 1|No longer met eligibility criteria|0|||
129199207|NCT05907395|465024510|FG005|Period 1|No longer met eligibility criteria|1|||
129199208|NCT05907395|465024511|FG006|Period 1|No longer met eligibility criteria|1|||
129199209|NCT05907395|465024512|FG007|Period 1|No longer met eligibility criteria|0|||
129199210|NCT05907395|465024513|FG008|Period 1|No longer met eligibility criteria|0|||
129199211|NCT05907395|465024514|FG009|Period 1|No longer met eligibility criteria|0|||
129199212|NCT05907395|465024515|FG010|Period 1|No longer met eligibility criteria|0|||
129199213|NCT05907395|465024516|FG011|Period 1|No longer met eligibility criteria|0|||
129199214|NCT05907395|465024505|FG000|Period 2|Adverse Event|0|||
129199215|NCT05907395|465024506|FG001|Period 2|Adverse Event|0|||
129199216|NCT05907395|465024507|FG002|Period 2|Adverse Event|0|||
129199217|NCT05907395|465024508|FG003|Period 2|Adverse Event|1|||
129199218|NCT05907395|465024509|FG004|Period 2|Adverse Event|0|||
129199219|NCT05907395|465024510|FG005|Period 2|Adverse Event|0|||
129199220|NCT05907395|465024511|FG006|Period 2|Adverse Event|0|||
129199221|NCT05907395|465024512|FG007|Period 2|Adverse Event|1|||
129199222|NCT05907395|465024513|FG008|Period 2|Adverse Event|0|||
129199223|NCT05907395|465024514|FG009|Period 2|Adverse Event|0|||
129199224|NCT05907395|465024515|FG010|Period 2|Adverse Event|0|||
129199225|NCT05907395|465024516|FG011|Period 2|Adverse Event|0|||
129199226|NCT05907395|465024505|FG000|Period 2|Personal reason|0|||
129199227|NCT05907395|465024506|FG001|Period 2|Personal reason|0|||
129199228|NCT05907395|465024507|FG002|Period 2|Personal reason|0|||
129199229|NCT05907395|465024508|FG003|Period 2|Personal reason|0|||
129199230|NCT05907395|465024509|FG004|Period 2|Personal reason|0|||
129199231|NCT05907395|465024510|FG005|Period 2|Personal reason|0|||
129199232|NCT05907395|465024511|FG006|Period 2|Personal reason|0|||
129199233|NCT05907395|465024512|FG007|Period 2|Personal reason|0|||
129199234|NCT05907395|465024513|FG008|Period 2|Personal reason|0|||
129199235|NCT05907395|465024514|FG009|Period 2|Personal reason|1|||
129199236|NCT05907395|465024515|FG010|Period 2|Personal reason|0|||
129199237|NCT05907395|465024516|FG011|Period 2|Personal reason|0|||
129199238|NCT05907395|465024505|FG000|Period 3|Adverse Event|0|||
129199239|NCT05907395|465024506|FG001|Period 3|Adverse Event|0|||
129199240|NCT05907395|465024507|FG002|Period 3|Adverse Event|0|||
129199241|NCT05907395|465024508|FG003|Period 3|Adverse Event|0|||
129199242|NCT05907395|465024509|FG004|Period 3|Adverse Event|1|||
129199243|NCT05907395|465024510|FG005|Period 3|Adverse Event|0|||
129199244|NCT05907395|465024511|FG006|Period 3|Adverse Event|0|||
129199245|NCT05907395|465024512|FG007|Period 3|Adverse Event|0|||
129199246|NCT05907395|465024513|FG008|Period 3|Adverse Event|0|||
129199247|NCT05907395|465024514|FG009|Period 3|Adverse Event|0|||
129199248|NCT05907395|465024515|FG010|Period 3|Adverse Event|0|||
129199249|NCT05907395|465024516|FG011|Period 3|Adverse Event|0|||
129199250|NCT04544956|465024517|FG000|Overall Study|Withdrawal by Subject|1|||
129199251|NCT01657292|465024519|FG000|Overall Study|Adverse Event|6|||
129199252|NCT01657292|465024519|FG000|Overall Study|Withdrawal by Subject|2|||
129199253|NCT01657292|465024519|FG000|Overall Study|Violation of eligibility criteria|1|||
129199254|NCT01657292|465024519|FG000|Overall Study|Change of therapy|1|||
129199255|NCT00650845|465024520|FG000|Overall Study|Withdrawal by Subject|5|||
129199256|NCT00650845|465024521|FG001|Overall Study|Withdrawal by Subject|0|||
129199257|NCT00650845|465024520|FG000|Overall Study|Protocol Violation|0|||
129199258|NCT00650845|465024521|FG001|Overall Study|Protocol Violation|13|||
129199259|NCT04178720|465024522|FG000|Overall Study|Withdrawal by Subject|2|||
129199260|NCT04178720|465024523|FG001|Overall Study|Withdrawal by Subject|0|||
129199261|NCT04178720|465024522|FG000|Overall Study|Relocation|0|||
129199262|NCT04178720|465024523|FG001|Overall Study|Relocation|1|||
129199263|NCT03922620|465024524|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
129199264|NCT03922620|465024525|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
129199265|NCT04177212|465024526|FG000|Overall Study|Withdrawal by Subject|9|||
129199266|NCT04177212|465024527|FG001|Overall Study|Withdrawal by Subject|7|||
129199267|NCT04177212|465024526|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
129199268|NCT04177212|465024527|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
129199269|NCT04177212|465024526|FG000|Overall Study|Physician Decision|1|||
129199270|NCT04177212|465024527|FG001|Overall Study|Physician Decision|0|||
129199271|NCT04177212|465024526|FG000|Overall Study|Lost to Follow-up|0|||
129199272|NCT04177212|465024527|FG001|Overall Study|Lost to Follow-up|3|||
129199273|NCT04177212|465024526|FG000|Overall Study|Adverse Event|0|||
129199274|NCT04177212|465024527|FG001|Overall Study|Adverse Event|1|||
129199275|NCT04177212|465024526|FG000|Overall Study|Other|1|||
129199276|NCT04177212|465024527|FG001|Overall Study|Other|2|||
129199277|NCT04725500|465024528|FG000|Screening|Screen Failure|26|||
129199278|NCT04725500|465024528|FG000|Screening|Withdrawal by Subject|1|||
129199279|NCT04725500|465024528|FG000|2 Week Take Home|Screen Fail|5|||
129199280|NCT01792115|465024529|FG000|Overall Study|Lost to Follow-up|0|||
129199281|NCT01792115|465024530|FG001|Overall Study|Lost to Follow-up|1|||
129199282|NCT01792115|465024531|FG002|Overall Study|Lost to Follow-up|0|||
129199283|NCT00930930|465024533|FG000|Overall Study|Death|1|||
129199284|NCT00930930|465024534|FG001|Overall Study|Death|0|||
129199285|NCT00930930|465024533|FG000|Overall Study|Physician Decision|1|||
129199286|NCT00930930|465024534|FG001|Overall Study|Physician Decision|0|||
129199287|NCT00930930|465024533|FG000|Overall Study|Adverse Event|13|||
129199288|NCT00930930|465024534|FG001|Overall Study|Adverse Event|3|||
129199289|NCT00930930|465024533|FG000|Overall Study|Withdrawal by Subject|3|||
129199290|NCT00930930|465024534|FG001|Overall Study|Withdrawal by Subject|1|||
128731754|NCT01502644|463312847|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
128731755|NCT01502644|463312848|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
128731756|NCT01502644|463312849|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
128731757|NCT01502644|463312846|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
128731758|NCT01502644|463312847|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
128731759|NCT01502644|463312848|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
128731760|NCT01502644|463312849|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
128731761|NCT00637195|463312852|FG000|Overall Study|Lost to Follow-up|1|||
128781125|NCT00051311|463490449|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
129199291|NCT00930930|465024533|FG000|Overall Study|Disease progression|2|||
129199292|NCT00930930|465024534|FG001|Overall Study|Disease progression|3|||
129199293|NCT00930930|465024533|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
129199294|NCT00930930|465024534|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
129199295|NCT00930930|465024533|FG000|Overall Study|patients not compliant|1|||
129199296|NCT00930930|465024534|FG001|Overall Study|patients not compliant|1|||
129199297|NCT04618744|465024535|FG000|Overall Study|Adverse Event|0|||
129199298|NCT04618744|465024536|FG001|Overall Study|Adverse Event|1|||
129199299|NCT04618744|465024535|FG000|Overall Study|Withdrawal by Subject|0|||
129199300|NCT04618744|465024536|FG001|Overall Study|Withdrawal by Subject|1|||
129199301|NCT01633788|465026660|FG000|Overall Study|Adverse Event|1|||
129199302|NCT01633788|465026661|FG001|Overall Study|Adverse Event|3|||
129199303|NCT01633788|465026662|FG002|Overall Study|Adverse Event|3|||
129199304|NCT01633788|465026663|FG003|Overall Study|Adverse Event|3|||
129199305|NCT01633788|465026660|FG000|Overall Study|Lost to Follow-up|2|||
129199306|NCT01633788|465026661|FG001|Overall Study|Lost to Follow-up|2|||
129199307|NCT01633788|465026662|FG002|Overall Study|Lost to Follow-up|2|||
129199308|NCT01633788|465026663|FG003|Overall Study|Lost to Follow-up|0|||
129199309|NCT01633788|465026660|FG000|Overall Study|Personal Reasons|3|||
129199310|NCT01633788|465026661|FG001|Overall Study|Personal Reasons|1|||
129199311|NCT01633788|465026662|FG002|Overall Study|Personal Reasons|1|||
129199312|NCT01633788|465026663|FG003|Overall Study|Personal Reasons|3|||
129199313|NCT01633788|465026660|FG000|Overall Study|Protocol Violation|1|||
129199314|NCT01633788|465026661|FG001|Overall Study|Protocol Violation|0|||
129199315|NCT01633788|465026662|FG002|Overall Study|Protocol Violation|1|||
129199316|NCT01633788|465026663|FG003|Overall Study|Protocol Violation|0|||
129199317|NCT01633788|465026660|FG000|Overall Study|Other Reasons|0|||
129199318|NCT01633788|465026661|FG001|Overall Study|Other Reasons|2|||
129199319|NCT01633788|465026662|FG002|Overall Study|Other Reasons|3|||
129199320|NCT01633788|465026663|FG003|Overall Study|Other Reasons|7|||
129199321|NCT01929226|465026664|FG000|Overall Study|Lost to Follow-up|4|||
129199322|NCT01929226|465026665|FG001|Overall Study|Lost to Follow-up|0|||
129199323|NCT01929226|465026664|FG000|Overall Study|Withdrawal by Subject|1|||
129199324|NCT01929226|465026665|FG001|Overall Study|Withdrawal by Subject|1|||
129199325|NCT00997035|465026670|FG000|3-week Followup Visit|Lost to Follow-up|9|||
129199326|NCT00997035|465026671|FG001|3-week Followup Visit|Lost to Follow-up|6|||
129199327|NCT00997035|465026670|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
129199328|NCT00997035|465026671|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
129199329|NCT02544503|465026672|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
129199330|NCT02544503|465026673|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
129199331|NCT02544503|465026672|FG000|Overall Study|Lost to Follow-up|9|||
129199332|NCT02544503|465026673|FG001|Overall Study|Lost to Follow-up|0|||
129199333|NCT02544503|465026672|FG000|Overall Study|Withdrawal by Subject|1|||
129199334|NCT02544503|465026673|FG001|Overall Study|Withdrawal by Subject|0|||
129199335|NCT03922581|465026679|FG000|Overall Study|Lost to Follow-up|20|||
129199336|NCT03922581|465026680|FG001|Overall Study|Lost to Follow-up|9|||
129199337|NCT03922581|465026679|FG000|Overall Study|Physician Decision|1|||
129199338|NCT03922581|465026680|FG001|Overall Study|Physician Decision|1|||
129199339|NCT03922581|465026679|FG000|Overall Study|Withdrawal by Subject|1|||
129199340|NCT03922581|465026680|FG001|Overall Study|Withdrawal by Subject|0|||
129199341|NCT04685798|465026683|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
129199342|NCT04640311|465026684|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
129199343|NCT04640311|465026685|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199344|NCT04640311|465026686|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199345|NCT04640311|465026687|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199346|NCT04640311|465026688|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199347|NCT04640311|465026689|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199348|NCT04640311|465026690|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199349|NCT04640311|465026691|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199350|NCT04640311|465026692|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199351|NCT04640311|465026693|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199352|NCT04640311|465026694|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199353|NCT04640311|465026695|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199354|NCT04640311|465026696|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199355|NCT04640311|465026684|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199356|NCT04640311|465026685|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
129199357|NCT04640311|465026686|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199358|NCT04640311|465026687|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199359|NCT04640311|465026688|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199360|NCT04640311|465026689|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199361|NCT04640311|465026690|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199362|NCT04640311|465026691|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
128731762|NCT00637195|463312853|FG001|Overall Study|Lost to Follow-up|0|||
128731763|NCT00637195|463312852|FG000|Overall Study|Other|2|||
128731764|NCT00637195|463312853|FG001|Overall Study|Other|0|||
128731765|NCT00637195|463312852|FG000|Overall Study|Withdrawal by Subject|0|||
128731766|NCT00637195|463312853|FG001|Overall Study|Withdrawal by Subject|1|||
128731767|NCT02388997|463312854|FG000|Overall Study|Adverse Event|1|||
128731768|NCT02388997|463312855|FG001|Overall Study|Adverse Event|2|||
128731769|NCT02388997|463312854|FG000|Overall Study|Withdrawal by Subject|2|||
128731770|NCT02388997|463312855|FG001|Overall Study|Withdrawal by Subject|1|||
128731771|NCT02388997|463312854|FG000|Overall Study|Lung function exclusion criteria|0|||
128731772|NCT02388997|463312855|FG001|Overall Study|Lung function exclusion criteria|2|||
128731773|NCT02388997|463312854|FG000|Overall Study|Tested positive for virus during run-in|0|||
128731774|NCT02388997|463312855|FG001|Overall Study|Tested positive for virus during run-in|1|||
128731775|NCT00207142|463312856|FG000|Induction Phase|Adverse Event|9|||
128731776|NCT00207142|463312857|FG001|Induction Phase|Adverse Event|0|||
128731777|NCT00207142|463312858|FG002|Induction Phase|Adverse Event|0|||
128731778|NCT00207142|463312859|FG003|Induction Phase|Adverse Event|0|||
128731779|NCT00207142|463312856|FG000|Induction Phase|Death|1|||
128731780|NCT00207142|463312857|FG001|Induction Phase|Death|0|||
128731781|NCT00207142|463312858|FG002|Induction Phase|Death|0|||
128731782|NCT00207142|463312859|FG003|Induction Phase|Death|0|||
128731783|NCT00207142|463312856|FG000|Induction Phase|Lack of Efficacy|1|||
128731784|NCT00207142|463312857|FG001|Induction Phase|Lack of Efficacy|0|||
128731785|NCT00207142|463312858|FG002|Induction Phase|Lack of Efficacy|0|||
128731786|NCT00207142|463312859|FG003|Induction Phase|Lack of Efficacy|0|||
128731787|NCT00207142|463312856|FG000|Induction Phase|Lost to Follow-up|5|||
128731788|NCT00207142|463312857|FG001|Induction Phase|Lost to Follow-up|0|||
128731789|NCT00207142|463312858|FG002|Induction Phase|Lost to Follow-up|0|||
128731790|NCT00207142|463312859|FG003|Induction Phase|Lost to Follow-up|0|||
128731791|NCT00207142|463312856|FG000|Induction Phase|Physician Decision|2|||
128731792|NCT00207142|463312857|FG001|Induction Phase|Physician Decision|0|||
128731793|NCT00207142|463312858|FG002|Induction Phase|Physician Decision|0|||
128731794|NCT00207142|463312859|FG003|Induction Phase|Physician Decision|0|||
128731795|NCT00207142|463312856|FG000|Induction Phase|Poor/noncompliance|2|||
128731796|NCT00207142|463312857|FG001|Induction Phase|Poor/noncompliance|0|||
128731797|NCT00207142|463312858|FG002|Induction Phase|Poor/noncompliance|0|||
128731798|NCT00207142|463312859|FG003|Induction Phase|Poor/noncompliance|0|||
128731799|NCT00207142|463312856|FG000|Induction Phase|Pregnancy|1|||
128731800|NCT00207142|463312857|FG001|Induction Phase|Pregnancy|0|||
128731801|NCT00207142|463312858|FG002|Induction Phase|Pregnancy|0|||
128731802|NCT00207142|463312859|FG003|Induction Phase|Pregnancy|0|||
128731803|NCT00207142|463312856|FG000|Induction Phase|Subject no longer meets study criteria|3|||
128731804|NCT00207142|463312857|FG001|Induction Phase|Subject no longer meets study criteria|0|||
128731805|NCT00207142|463312858|FG002|Induction Phase|Subject no longer meets study criteria|0|||
128731806|NCT00207142|463312859|FG003|Induction Phase|Subject no longer meets study criteria|0|||
128731807|NCT00207142|463312856|FG000|Induction Phase|Withdrawal by Subject|4|||
128731808|NCT00207142|463312857|FG001|Induction Phase|Withdrawal by Subject|0|||
128731809|NCT00207142|463312858|FG002|Induction Phase|Withdrawal by Subject|0|||
128731810|NCT00207142|463312859|FG003|Induction Phase|Withdrawal by Subject|0|||
128731811|NCT00207142|463312856|FG000|Induction Phase|Incarceration|1|||
128731812|NCT00207142|463312857|FG001|Induction Phase|Incarceration|0|||
128731813|NCT00207142|463312858|FG002|Induction Phase|Incarceration|0|||
128731814|NCT00207142|463312859|FG003|Induction Phase|Incarceration|0|||
128731815|NCT00207142|463312856|FG000|Induction Phase|Missing lab data|1|||
128731816|NCT00207142|463312857|FG001|Induction Phase|Missing lab data|0|||
128731817|NCT00207142|463312858|FG002|Induction Phase|Missing lab data|0|||
128731818|NCT00207142|463312859|FG003|Induction Phase|Missing lab data|0|||
128731819|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
128731820|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
128731821|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
128731822|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
128731823|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
129199363|NCT04640311|465026692|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199364|NCT04640311|465026693|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199365|NCT04640311|465026694|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199366|NCT04640311|465026695|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199367|NCT04640311|465026696|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129199368|NCT04640311|465026684|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199369|NCT04640311|465026685|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
129199370|NCT04640311|465026686|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199371|NCT04640311|465026687|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199372|NCT04640311|465026688|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199373|NCT04640311|465026689|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199374|NCT04640311|465026690|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199375|NCT04640311|465026691|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199376|NCT04640311|465026692|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199377|NCT04640311|465026693|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199378|NCT04640311|465026694|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199379|NCT04640311|465026695|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199380|NCT04640311|465026696|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199381|NCT04640311|465026684|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
129199382|NCT04640311|465026685|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
129199383|NCT04640311|465026686|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
129199384|NCT04640311|465026687|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199385|NCT04640311|465026688|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199386|NCT04640311|465026689|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199387|NCT04640311|465026690|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199388|NCT04640311|465026691|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199389|NCT04640311|465026692|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
128731824|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
128731825|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
128731826|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
128731827|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
128781126|NCT00051311|463490448|FG000|Overall Study|Death of recipient|8|||
129199390|NCT04640311|465026693|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
128731828|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
128731829|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
128731830|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
128731831|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
128731832|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
128731833|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
128731834|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
128731835|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
128731836|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
128731837|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
128731838|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
128731839|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
128731840|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
128731841|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
128731842|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
128731843|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
128731844|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
129199391|NCT04640311|465026694|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199392|NCT04640311|465026695|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199393|NCT04640311|465026696|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129199394|NCT04640311|465026684|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199395|NCT04640311|465026685|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199396|NCT04640311|465026686|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
129199397|NCT04640311|465026687|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199398|NCT04640311|465026688|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199399|NCT04640311|465026689|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199400|NCT04640311|465026690|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199401|NCT04640311|465026691|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199402|NCT04640311|465026692|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199403|NCT04640311|465026693|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199404|NCT04640311|465026694|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199405|NCT04640311|465026695|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199406|NCT04640311|465026696|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129199407|NCT04640311|465026684|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199408|NCT04640311|465026685|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199409|NCT04640311|465026686|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199410|NCT04640311|465026687|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
129199411|NCT04640311|465026688|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199412|NCT04640311|465026689|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199413|NCT04640311|465026690|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
129199414|NCT04640311|465026691|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199415|NCT04640311|465026692|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199416|NCT04640311|465026693|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199417|NCT04640311|465026694|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199418|NCT04640311|465026695|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199419|NCT04640311|465026696|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129199420|NCT04640311|465026684|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199421|NCT04640311|465026685|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199422|NCT04640311|465026686|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199423|NCT04640311|465026687|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199424|NCT04640311|465026688|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199425|NCT04640311|465026689|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
129199426|NCT04640311|465026690|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199427|NCT04640311|465026691|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199428|NCT04640311|465026692|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
129199429|NCT04640311|465026693|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199430|NCT04640311|465026694|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199431|NCT04640311|465026695|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129199432|NCT04640311|465026696|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
128731845|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
128731846|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
128731847|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Death|0|||
128731848|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Death|0|||
128731849|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Death|0|||
128731850|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Death|1|||
128731851|NCT00207142|463312856|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
128731852|NCT00207142|463312857|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
128731853|NCT00207142|463312858|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
128731854|NCT00207142|463312859|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
128731855|NCT02375672|463312860|FG000|Overall Study|remain on follow up|20|||
128731856|NCT02346240|463312863|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731857|NCT02346240|463312864|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
128731858|NCT02346240|463312865|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
128731859|NCT02346240|463312866|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
128781127|NCT00051311|463490449|FG001|Overall Study|Death of recipient|8|||
129199433|NCT04640311|465026684|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199434|NCT04640311|465026685|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199435|NCT04640311|465026686|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199436|NCT04640311|465026687|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199437|NCT04640311|465026688|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199438|NCT04640311|465026689|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199439|NCT04640311|465026690|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
129199440|NCT04640311|465026691|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199441|NCT04640311|465026692|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199442|NCT04640311|465026693|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199443|NCT04640311|465026694|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
129199444|NCT04640311|465026695|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199445|NCT04640311|465026696|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129199446|NCT04640311|465026684|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
128731860|NCT02346240|463312867|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731861|NCT02346240|463312868|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731862|NCT02346240|463312869|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731863|NCT02346240|463312870|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731864|NCT02346240|463312871|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731865|NCT02346240|463312872|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731866|NCT02346240|463312873|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731867|NCT02346240|463312874|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731868|NCT02346240|463312875|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731869|NCT02346240|463312876|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731870|NCT02346240|463312877|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731871|NCT02346240|463312878|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731872|NCT02346240|463312879|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731873|NCT02346240|463312880|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731874|NCT02346240|463312881|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731875|NCT02346240|463312882|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731876|NCT02346240|463312883|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731877|NCT02346240|463312884|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731878|NCT02346240|463312885|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731879|NCT02346240|463312886|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
128731880|NCT02346240|463312863|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731881|NCT02346240|463312864|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
128731882|NCT02346240|463312865|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731883|NCT02346240|463312866|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731884|NCT02346240|463312867|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731885|NCT02346240|463312868|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731886|NCT02346240|463312869|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731887|NCT02346240|463312870|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731888|NCT02346240|463312871|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731889|NCT02346240|463312872|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731890|NCT02346240|463312873|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731891|NCT02346240|463312874|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731892|NCT02346240|463312875|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731893|NCT02346240|463312876|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731894|NCT02346240|463312877|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731895|NCT02346240|463312878|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731896|NCT02346240|463312879|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731897|NCT02346240|463312880|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731898|NCT02346240|463312881|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129199447|NCT04640311|465026685|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199448|NCT04640311|465026686|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199449|NCT04640311|465026687|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199450|NCT04640311|465026688|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199451|NCT04640311|465026689|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199452|NCT04640311|465026690|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199453|NCT04640311|465026691|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199454|NCT04640311|465026692|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199455|NCT04640311|465026693|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199456|NCT04640311|465026694|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129199457|NCT04640311|465026695|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
129199458|NCT04640311|465026696|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
128731899|NCT02346240|463312882|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731900|NCT02346240|463312883|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129199459|NCT03956550|465026697|FG000|Overall Study|Sponsor decision|65|||
129199460|NCT03956550|465026698|FG001|Overall Study|Sponsor decision|66|||
129199461|NCT03956550|465026699|FG002|Overall Study|Sponsor decision|64|||
129199462|NCT03956550|465026697|FG000|Overall Study|Adverse Event|0|||
129199463|NCT03956550|465026698|FG001|Overall Study|Adverse Event|1|||
129199464|NCT03956550|465026699|FG002|Overall Study|Adverse Event|0|||
129199465|NCT03956550|465026697|FG000|Overall Study|Withdrawal by Subject|5|||
129199466|NCT03956550|465026698|FG001|Overall Study|Withdrawal by Subject|5|||
129199467|NCT03956550|465026699|FG002|Overall Study|Withdrawal by Subject|6|||
129199468|NCT00592904|465026702|FG000|Overall Study|Adverse Event|15|||
129199469|NCT00592904|465026703|FG001|Overall Study|Adverse Event|25|||
129199470|NCT00592904|465026704|FG002|Overall Study|Adverse Event|13|||
129199471|NCT00592904|465026705|FG003|Overall Study|Adverse Event|5|||
129199472|NCT00592904|465026702|FG000|Overall Study|Protocol Violation|1|||
129199473|NCT00592904|465026703|FG001|Overall Study|Protocol Violation|1|||
129199474|NCT00592904|465026704|FG002|Overall Study|Protocol Violation|0|||
129199475|NCT00592904|465026705|FG003|Overall Study|Protocol Violation|1|||
129199476|NCT00592904|465026702|FG000|Overall Study|Withdrawal by Subject|4|||
129199477|NCT00592904|465026703|FG001|Overall Study|Withdrawal by Subject|16|||
129199478|NCT00592904|465026704|FG002|Overall Study|Withdrawal by Subject|1|||
129199479|NCT00592904|465026705|FG003|Overall Study|Withdrawal by Subject|2|||
129199480|NCT00592904|465026702|FG000|Overall Study|Lack of Efficacy|2|||
129199481|NCT00592904|465026703|FG001|Overall Study|Lack of Efficacy|7|||
129199482|NCT00592904|465026704|FG002|Overall Study|Lack of Efficacy|2|||
129199483|NCT00592904|465026705|FG003|Overall Study|Lack of Efficacy|3|||
129199484|NCT00592904|465026702|FG000|Overall Study|Physician Decision|0|||
129199485|NCT00592904|465026703|FG001|Overall Study|Physician Decision|3|||
129199486|NCT00592904|465026704|FG002|Overall Study|Physician Decision|1|||
129199487|NCT00592904|465026705|FG003|Overall Study|Physician Decision|0|||
129199488|NCT00592904|465026702|FG000|Overall Study|Other|3|||
129199489|NCT00592904|465026703|FG001|Overall Study|Other|3|||
129199490|NCT00592904|465026704|FG002|Overall Study|Other|0|||
129199491|NCT00592904|465026705|FG003|Overall Study|Other|0|||
129199492|NCT03191630|465026706|FG000|Overall Study|Lost to Follow-up|7|||
129199493|NCT03191630|465026707|FG001|Overall Study|Lost to Follow-up|7|||
129199494|NCT03369418|465026712|FG000|Overall Study|Withdrawal by Subject|3|||
129199495|NCT03369418|465026713|FG001|Overall Study|Withdrawal by Subject|3|||
129199496|NCT01485094|465026714|FG000|Overall Study|Adverse Event|1|||
129199497|NCT01485094|465026715|FG001|Overall Study|Adverse Event|1|||
129199498|NCT01485094|465026716|FG002|Overall Study|Adverse Event|1|||
129199499|NCT01485094|465026714|FG000|Overall Study|Lost to Follow-up|1|||
129199500|NCT01485094|465026715|FG001|Overall Study|Lost to Follow-up|0|||
129199501|NCT01485094|465026716|FG002|Overall Study|Lost to Follow-up|0|||
129199502|NCT01485094|465026714|FG000|Overall Study|Withdrawal by Subject|1|||
129199503|NCT01485094|465026715|FG001|Overall Study|Withdrawal by Subject|1|||
129199504|NCT01485094|465026716|FG002|Overall Study|Withdrawal by Subject|0|||
129199505|NCT01367834|465026720|FG000|Overall Study|Withdrawal by Subject|2|||
129199506|NCT01367834|465026721|FG001|Overall Study|Withdrawal by Subject|2|||
129199507|NCT01367834|465026720|FG000|Overall Study|Study was ended.|0|||
129199508|NCT01367834|465026721|FG001|Overall Study|Study was ended.|1|||
129199509|NCT01818596|465026729|FG000|Overall Study|Enrolled but Not Treated|4|||
129199510|NCT01818596|465026730|FG001|Overall Study|Enrolled but Not Treated|0|||
129199511|NCT01818596|465026729|FG000|Overall Study|Adverse Event|7|||
129199512|NCT01818596|465026730|FG001|Overall Study|Adverse Event|0|||
129199513|NCT01818596|465026729|FG000|Overall Study|Death|3|||
129199514|NCT01818596|465026730|FG001|Overall Study|Death|0|||
129199515|NCT01818596|465026729|FG000|Overall Study|Investigator's Discretion|4|||
129199516|NCT01818596|465026730|FG001|Overall Study|Investigator's Discretion|0|||
129199517|NCT01818596|465026729|FG000|Overall Study|Protocol Violation|1|||
129199518|NCT01818596|465026730|FG001|Overall Study|Protocol Violation|0|||
129199519|NCT01818596|465026729|FG000|Overall Study|Withdrew Consent|5|||
129199520|NCT01818596|465026730|FG001|Overall Study|Withdrew Consent|0|||
129199521|NCT01818596|465026729|FG000|Overall Study|Lost to Follow-up|7|||
129199522|NCT01818596|465026730|FG001|Overall Study|Lost to Follow-up|0|||
129199523|NCT02915263|465026741|FG000|Overall Study|Covid|3|||
129199524|NCT02915263|465026742|FG001|Overall Study|Covid|2|||
129199525|NCT01879683|465026746|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
129199526|NCT01618669|465026747|FG000|Overall Study|Lost to Follow-up|1|||
129199527|NCT01618669|465026748|FG001|Overall Study|Lost to Follow-up|1|||
128731901|NCT02346240|463312884|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129199528|NCT01618669|465026747|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
129199529|NCT01618669|465026748|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
129199530|NCT01618669|465026747|FG000|Overall Study|Adverse Event|16|||
129199531|NCT01618669|465026748|FG001|Overall Study|Adverse Event|7|||
129199532|NCT01618669|465026747|FG000|Overall Study|Protocol Violation|5|||
129199533|NCT01618669|465026748|FG001|Overall Study|Protocol Violation|3|||
129199534|NCT01618669|465026747|FG000|Overall Study|Withdrawal by Subject|9|||
128731902|NCT02346240|463312885|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731903|NCT02346240|463312886|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
128731904|NCT02346240|463312863|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129199535|NCT01618669|465026748|FG001|Overall Study|Withdrawal by Subject|9|||
129199536|NCT01618669|465026747|FG000|Overall Study|Miscellaneous Reason|0|||
129199537|NCT01618669|465026748|FG001|Overall Study|Miscellaneous Reason|1|||
129199538|NCT01177007|465026751|FG000|Overall Study|Lost to Follow-up|2|||
129199539|NCT01177007|465026751|FG000|Overall Study|Death|4|||
129199540|NCT01177007|465026751|FG000|Overall Study|Entered hospice care|5|||
129199541|NCT01177007|465026751|FG000|Overall Study|Required additional Y90 treatment|6|||
129199542|NCT01177007|465026751|FG000|Overall Study|Change in treatment modality|21|||
129199543|NCT01702558|465026752|FG000|Overall Study|Withdrawal by Subject|0|||
129199544|NCT01702558|465026753|FG001|Overall Study|Withdrawal by Subject|0|||
129199545|NCT01702558|465026754|FG002|Overall Study|Withdrawal by Subject|0|||
129199546|NCT01702558|465026755|FG003|Overall Study|Withdrawal by Subject|12|||
129199547|NCT01702558|465026756|FG004|Overall Study|Withdrawal by Subject|4|||
129199548|NCT01702558|465026752|FG000|Overall Study|Lost to Follow-up|0|||
129199549|NCT01702558|465026753|FG001|Overall Study|Lost to Follow-up|0|||
129199550|NCT01702558|465026754|FG002|Overall Study|Lost to Follow-up|0|||
129199551|NCT01702558|465026755|FG003|Overall Study|Lost to Follow-up|3|||
129199552|NCT01702558|465026756|FG004|Overall Study|Lost to Follow-up|0|||
129199553|NCT01702558|465026752|FG000|Overall Study|Death|4|||
129199554|NCT01702558|465026753|FG001|Overall Study|Death|3|||
129199555|NCT01702558|465026754|FG002|Overall Study|Death|3|||
129199556|NCT01702558|465026755|FG003|Overall Study|Death|16|||
129199557|NCT01702558|465026756|FG004|Overall Study|Death|20|||
129199558|NCT01702558|465026752|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
129199559|NCT01702558|465026753|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
129199560|NCT01702558|465026754|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
129199561|NCT01702558|465026755|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
129199562|NCT01702558|465026756|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
129199563|NCT01702558|465026752|FG000|Overall Study|Study Terminated by Sponsor|0|||
129199564|NCT01702558|465026753|FG001|Overall Study|Study Terminated by Sponsor|1|||
129199565|NCT01702558|465026754|FG002|Overall Study|Study Terminated by Sponsor|0|||
129199566|NCT01702558|465026755|FG003|Overall Study|Study Terminated by Sponsor|0|||
129199567|NCT01702558|465026756|FG004|Overall Study|Study Terminated by Sponsor|1|||
129199568|NCT01702558|465026752|FG000|Overall Study|Other|0|||
129199569|NCT01702558|465026753|FG001|Overall Study|Other|0|||
129199570|NCT01702558|465026754|FG002|Overall Study|Other|0|||
129199571|NCT01702558|465026755|FG003|Overall Study|Other|16|||
129199572|NCT01702558|465026756|FG004|Overall Study|Other|17|||
129199573|NCT03259087|465026761|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129199574|NCT03259087|465026762|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129199575|NCT03259087|465026763|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129199576|NCT03259087|465026764|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129199577|NCT03259087|465026765|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
129199578|NCT03259087|465026761|FG000|Period 2 of Part 2|Adverse Event|0|||
129199579|NCT03259087|465026762|FG001|Period 2 of Part 2|Adverse Event|0|||
129199580|NCT03259087|465026763|FG002|Period 2 of Part 2|Adverse Event|0|||
129199581|NCT03259087|465026764|FG003|Period 2 of Part 2|Adverse Event|0|||
128731905|NCT02346240|463312864|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
129199582|NCT03259087|465026765|FG004|Period 2 of Part 2|Adverse Event|1|||
129199583|NCT04950465|465026766|FG000|Overall Study|Lost to Follow-up|1|||
129199584|NCT04950465|465026767|FG001|Overall Study|Lost to Follow-up|0|||
129199585|NCT04950465|465026768|FG002|Overall Study|Lost to Follow-up|0|||
129199586|NCT02366195|465026769|FG000|Overall Study|Protocol-specified criteria|3|||
129199587|NCT02366195|465026769|FG000|Overall Study|Withdrawal by Subject|9|||
129199588|NCT02366195|465026769|FG000|Overall Study|Lost to Follow-up|1|||
129199589|NCT02366195|465026769|FG000|Overall Study|Death|41|||
129199590|NCT01788566|465026770|FG000|Overall Study|Death|4|||
129199591|NCT01788566|465026770|FG000|Overall Study|Adverse Event|1|||
128731906|NCT02346240|463312865|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731907|NCT02346240|463312866|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731908|NCT02346240|463312867|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731909|NCT02346240|463312868|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731910|NCT02346240|463312869|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731911|NCT02346240|463312870|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731912|NCT02346240|463312871|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731913|NCT02346240|463312872|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731914|NCT02346240|463312873|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731915|NCT02346240|463312874|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731916|NCT02346240|463312875|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731917|NCT02346240|463312876|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731918|NCT02346240|463312877|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731919|NCT02346240|463312878|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731920|NCT02346240|463312879|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129199592|NCT01788566|465026770|FG000|Overall Study|Clinical Progressive Disease|3|||
129199593|NCT01620086|465026773|FG000|Overall Study|Withdrawal by Subject|3|||
129199594|NCT01620086|465026774|FG001|Overall Study|Withdrawal by Subject|3|||
129199595|NCT01620086|465026775|FG002|Overall Study|Withdrawal by Subject|0|||
129199596|NCT01620086|465026773|FG000|Overall Study|failed study criteria|1|||
129199597|NCT01620086|465026774|FG001|Overall Study|failed study criteria|4|||
129199598|NCT01620086|465026775|FG002|Overall Study|failed study criteria|0|||
129199599|NCT01620086|465026773|FG000|Overall Study|Physician Decision|1|||
129199600|NCT01620086|465026774|FG001|Overall Study|Physician Decision|0|||
129199601|NCT01620086|465026775|FG002|Overall Study|Physician Decision|0|||
129199602|NCT01695135|465026776|FG000|Double-blind Treatment Phase|Progressive disease|50|||
129199603|NCT01695135|465026777|FG001|Double-blind Treatment Phase|Progressive disease|110|||
129199604|NCT01695135|465026778|FG002|Double-blind Treatment Phase|Progressive disease|0|||
129199605|NCT01695135|465026779|FG003|Double-blind Treatment Phase|Progressive disease|0|||
129199606|NCT01695135|465026776|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
129199607|NCT01695135|465026777|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
129199608|NCT01695135|465026778|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129199609|NCT01695135|465026779|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129199610|NCT01695135|465026776|FG000|Double-blind Treatment Phase|Adverse Event|7|||
129199611|NCT01695135|465026777|FG001|Double-blind Treatment Phase|Adverse Event|7|||
129199612|NCT01695135|465026778|FG002|Double-blind Treatment Phase|Adverse Event|0|||
129199613|NCT01695135|465026779|FG003|Double-blind Treatment Phase|Adverse Event|0|||
129199614|NCT01695135|465026776|FG000|Double-blind Treatment Phase|Other|1|||
129199615|NCT01695135|465026777|FG001|Double-blind Treatment Phase|Other|3|||
129199616|NCT01695135|465026778|FG002|Double-blind Treatment Phase|Other|0|||
129199617|NCT01695135|465026779|FG003|Double-blind Treatment Phase|Other|0|||
129199618|NCT01695135|465026776|FG000|Double-blind Treatment Phase|Physician Decision|6|||
129199619|NCT01695135|465026777|FG001|Double-blind Treatment Phase|Physician Decision|3|||
129199620|NCT01695135|465026778|FG002|Double-blind Treatment Phase|Physician Decision|0|||
129199621|NCT01695135|465026779|FG003|Double-blind Treatment Phase|Physician Decision|0|||
129199622|NCT01695135|465026776|FG000|Double-blind Treatment Phase|Death|1|||
129199623|NCT01695135|465026777|FG001|Double-blind Treatment Phase|Death|1|||
129199624|NCT01695135|465026778|FG002|Double-blind Treatment Phase|Death|0|||
129199625|NCT01695135|465026779|FG003|Double-blind Treatment Phase|Death|0|||
129199626|NCT01695135|465026776|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
129199627|NCT01695135|465026777|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
129199628|NCT01695135|465026778|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
129199629|NCT01695135|465026779|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
129199630|NCT01695135|465026776|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
129199631|NCT01695135|465026777|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
129199632|NCT01695135|465026778|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
129199633|NCT01695135|465026779|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
129199634|NCT01695135|465026776|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
129199635|NCT01695135|465026777|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
129199636|NCT01695135|465026778|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
129199637|NCT01695135|465026779|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
129199638|NCT01695135|465026776|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
129199639|NCT01695135|465026777|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
129199640|NCT01695135|465026778|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
129199641|NCT01695135|465026779|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
129199642|NCT01695135|465026776|FG000|Open Label Extension Treatment Phase|Other|0|||
129199643|NCT01695135|465026777|FG001|Open Label Extension Treatment Phase|Other|0|||
129199644|NCT01695135|465026778|FG002|Open Label Extension Treatment Phase|Other|4|||
129199645|NCT01695135|465026779|FG003|Open Label Extension Treatment Phase|Other|7|||
129199646|NCT01695135|465026776|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
129199647|NCT01695135|465026777|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
128731921|NCT02346240|463312880|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128781128|NCT00051311|463490448|FG000|Overall Study|Recipient taken off study|4|||
129199648|NCT01695135|465026778|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
129199649|NCT01695135|465026779|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
129199650|NCT01695135|465026776|FG000|Open Label Extension Treatment Phase|Death|0|||
129199651|NCT01695135|465026777|FG001|Open Label Extension Treatment Phase|Death|0|||
129199652|NCT01695135|465026778|FG002|Open Label Extension Treatment Phase|Death|2|||
129199653|NCT01695135|465026779|FG003|Open Label Extension Treatment Phase|Death|7|||
129199654|NCT01695135|465026776|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
129199655|NCT01695135|465026777|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
129199656|NCT01695135|465026778|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
129199657|NCT01695135|465026779|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
129199658|NCT02562716|465026780|FG000|Overall Study|Adverse Event|7|||
129199659|NCT02562716|465026781|FG001|Overall Study|Adverse Event|14|||
129199660|NCT02562716|465026780|FG000|Overall Study|Withdrawal unrelated to AE|7|||
129199661|NCT02562716|465026781|FG001|Overall Study|Withdrawal unrelated to AE|1|||
129199662|NCT02562716|465026780|FG000|Overall Study|Progression|8|||
129199663|NCT02562716|465026781|FG001|Overall Study|Progression|10|||
129199664|NCT02562716|465026780|FG000|Overall Study|Death|2|||
129199665|NCT02562716|465026781|FG001|Overall Study|Death|1|||
129199666|NCT02562716|465026780|FG000|Overall Study|Not protocol specified|4|||
129199667|NCT02562716|465026781|FG001|Overall Study|Not protocol specified|2|||
129199668|NCT00684996|465026782|FG000|Overall Study|Adverse Event|1|||
129199669|NCT00684996|465026782|FG000|Overall Study|Refusal unrelated to adverse event|1|||
129199670|NCT00684996|465026782|FG000|Overall Study|Progression/relapse|2|||
129199671|NCT00684996|465026782|FG000|Overall Study|Other reasons not protocol specified|1|||
129199672|NCT01425801|465026785|FG000|Period 1|Withdrawal by Subject|0|||
129199673|NCT01425801|465026786|FG001|Period 1|Withdrawal by Subject|0|||
129199674|NCT01425801|465026787|FG002|Period 1|Withdrawal by Subject|0|||
129199675|NCT01425801|465026788|FG003|Period 1|Withdrawal by Subject|0|||
129199676|NCT01425801|465026789|FG004|Period 1|Withdrawal by Subject|1|||
129199677|NCT01425801|465026790|FG005|Period 1|Withdrawal by Subject|0|||
129199678|NCT01425801|465026785|FG000|Period 2|Withdrawal by Subject|0|||
129199679|NCT01425801|465026786|FG001|Period 2|Withdrawal by Subject|0|||
129199680|NCT01425801|465026787|FG002|Period 2|Withdrawal by Subject|0|||
129199681|NCT01425801|465026788|FG003|Period 2|Withdrawal by Subject|0|||
129199682|NCT01425801|465026789|FG004|Period 2|Withdrawal by Subject|1|||
129199683|NCT01425801|465026790|FG005|Period 2|Withdrawal by Subject|0|||
129199684|NCT01425801|465026785|FG000|Period 3|Stability criteria not fullfilled|0|||
129199685|NCT01425801|465026786|FG001|Period 3|Stability criteria not fullfilled|0|||
129199686|NCT01425801|465026787|FG002|Period 3|Stability criteria not fullfilled|1|||
129199687|NCT01425801|465026788|FG003|Period 3|Stability criteria not fullfilled|0|||
129199688|NCT01425801|465026789|FG004|Period 3|Stability criteria not fullfilled|0|||
129199689|NCT01425801|465026790|FG005|Period 3|Stability criteria not fullfilled|0|||
129199690|NCT01425801|465026785|FG000|Period 4|Not able to maintain visit schedule|0|||
129199691|NCT01425801|465026786|FG001|Period 4|Not able to maintain visit schedule|0|||
129199692|NCT01425801|465026787|FG002|Period 4|Not able to maintain visit schedule|1|||
129199693|NCT01425801|465026788|FG003|Period 4|Not able to maintain visit schedule|0|||
129199694|NCT01425801|465026789|FG004|Period 4|Not able to maintain visit schedule|0|||
129199695|NCT01425801|465026790|FG005|Period 4|Not able to maintain visit schedule|0|||
129199696|NCT02175017|465026791|FG000|Overall Study|Did not receive the investigational product|1|||
129199697|NCT02175017|465026792|FG001|Overall Study|Did not receive the investigational product|2|||
129199698|NCT02175017|465026791|FG000|Overall Study|Withdrawal by Subject|6|||
129199699|NCT02175017|465026792|FG001|Overall Study|Withdrawal by Subject|3|||
129199700|NCT02175017|465026791|FG000|Overall Study|Met an exclusion criteria|0|||
129199701|NCT02175017|465026792|FG001|Overall Study|Met an exclusion criteria|1|||
129199702|NCT02175017|465026791|FG000|Overall Study|Adverse Event|3|||
129199703|NCT02175017|465026792|FG001|Overall Study|Adverse Event|10|||
129199704|NCT02175017|465026791|FG000|Overall Study|Disease progression|20|||
129199705|NCT02175017|465026792|FG001|Overall Study|Disease progression|27|||
129199706|NCT02175017|465026791|FG000|Overall Study|Other than above reasons|3|||
129199707|NCT02175017|465026792|FG001|Overall Study|Other than above reasons|0|||
129199708|NCT04915729|465026793|FG000|Overall Study|Lost to Follow-up|20|||
129199709|NCT04915729|465026794|FG001|Overall Study|Lost to Follow-up|10|||
129199710|NCT04915729|465026793|FG000|Overall Study|Withdrawal by Subject|12|||
129199711|NCT04915729|465026794|FG001|Overall Study|Withdrawal by Subject|5|||
129199712|NCT04915729|465026793|FG000|Overall Study|Death|34|||
129199713|NCT04915729|465026794|FG001|Overall Study|Death|44|||
129199714|NCT04915729|465026793|FG000|Overall Study|not treated|3|||
129199715|NCT04915729|465026794|FG001|Overall Study|not treated|6|||
129199716|NCT04915729|465026793|FG000|Overall Study|Investigator removed subject|1|||
129199717|NCT04915729|465026794|FG001|Overall Study|Investigator removed subject|2|||
129199718|NCT04915729|465026793|FG000|Overall Study|questionnaire result not evaluated|1|||
129199719|NCT04915729|465026794|FG001|Overall Study|questionnaire result not evaluated|0|||
129199720|NCT04915729|465026793|FG000|Overall Study|refuse of hospital visit|1|||
129199721|NCT04915729|465026794|FG001|Overall Study|refuse of hospital visit|3|||
129199722|NCT04915729|465026793|FG000|Overall Study|Subject withdrew|1|||
129199723|NCT04915729|465026794|FG001|Overall Study|Subject withdrew|0|||
129199724|NCT02330055|465026795|FG000|Overall Study|technical issues|2|||
129199725|NCT02330055|465026796|FG001|Overall Study|technical issues|0|||
129199726|NCT02330055|465026795|FG000|Overall Study|participant forgot to wear device|5|||
129199727|NCT02330055|465026796|FG001|Overall Study|participant forgot to wear device|5|||
129199728|NCT02330055|465026795|FG000|Overall Study|data for less than 60 minutes|3|||
129199729|NCT02330055|465026796|FG001|Overall Study|data for less than 60 minutes|3|||
129199730|NCT02330055|465026795|FG000|Overall Study|participant did not sleep|0|||
129199731|NCT02330055|465026796|FG001|Overall Study|participant did not sleep|1|||
129199732|NCT00731679|465026803|FG000|Overall Study|Adverse Event|7|||
129199733|NCT00731679|465026804|FG001|Overall Study|Adverse Event|8|||
129199734|NCT00731679|465026803|FG000|Overall Study|Withdrawal by Subject|8|||
129199735|NCT00731679|465026804|FG001|Overall Study|Withdrawal by Subject|8|||
129199736|NCT00731679|465026803|FG000|Overall Study|Lost to Follow-up|7|||
129199737|NCT00731679|465026804|FG001|Overall Study|Lost to Follow-up|8|||
129199738|NCT00731679|465026803|FG000|Overall Study|Noncompliance|0|||
129199739|NCT00731679|465026804|FG001|Overall Study|Noncompliance|1|||
129199740|NCT00731679|465026803|FG000|Overall Study|Pregnancy|0|||
129199741|NCT00731679|465026804|FG001|Overall Study|Pregnancy|1|||
129199742|NCT02488005|465026805|FG000|Overall Study|Lost to Follow-up|2|||
129199743|NCT02326597|465026812|FG000|Overall Study|Lost to Follow-up|42|||
129199744|NCT02326597|465026813|FG001|Overall Study|Lost to Follow-up|32|||
129199745|NCT04089761|465026816|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
129199746|NCT04089761|465026816|FG000|"Run In Phase"|Lost to Follow-up|1|||
129199747|NCT04089761|465026816|FG000|"Treatment Phase"|No evaluable data|5|||
129199748|NCT04089761|465026816|FG000|"Treatment Phase"|Lost to Follow-up|1|||
129199749|NCT04739436|465026817|FG000|Overall Study|Lost to Follow-up|21|||
129199750|NCT04739436|465026818|FG001|Overall Study|Lost to Follow-up|23|||
129199751|NCT04739436|465026817|FG000|Overall Study|Withdrawal by Subject|4|||
129199752|NCT04739436|465026818|FG001|Overall Study|Withdrawal by Subject|6|||
129199753|NCT04739436|465026817|FG000|Overall Study|not randomized properly|1|||
129199754|NCT04739436|465026818|FG001|Overall Study|not randomized properly|0|||
129199755|NCT04628780|465026819|FG000|Overall Study|Death|0|||
129199756|NCT04628780|465026820|FG001|Overall Study|Death|1|||
129199757|NCT04628780|465026821|FG002|Overall Study|Death|0|||
129199758|NCT04628780|465026822|FG003|Overall Study|Death|0|||
129199759|NCT04628780|465026823|FG004|Overall Study|Death|1|||
129199760|NCT04628780|465026824|FG005|Overall Study|Death|0|||
129199761|NCT04628780|465026819|FG000|Overall Study|Physician Decision|2|||
129199762|NCT04628780|465026820|FG001|Overall Study|Physician Decision|0|||
129199763|NCT04628780|465026821|FG002|Overall Study|Physician Decision|0|||
129199764|NCT04628780|465026822|FG003|Overall Study|Physician Decision|0|||
129199765|NCT04628780|465026823|FG004|Overall Study|Physician Decision|2|||
129199766|NCT04628780|465026824|FG005|Overall Study|Physician Decision|0|||
129199767|NCT04628780|465026819|FG000|Overall Study|Progressive disease|2|||
129199768|NCT04628780|465026820|FG001|Overall Study|Progressive disease|2|||
129199769|NCT04628780|465026821|FG002|Overall Study|Progressive disease|2|||
129199770|NCT04628780|465026822|FG003|Overall Study|Progressive disease|3|||
129199771|NCT04628780|465026823|FG004|Overall Study|Progressive disease|9|||
129199772|NCT04628780|465026824|FG005|Overall Study|Progressive disease|4|||
129199773|NCT04628780|465026819|FG000|Overall Study|Withdrawal by Subject|0|||
129199774|NCT04628780|465026820|FG001|Overall Study|Withdrawal by Subject|1|||
129199775|NCT04628780|465026821|FG002|Overall Study|Withdrawal by Subject|2|||
129199776|NCT04628780|465026822|FG003|Overall Study|Withdrawal by Subject|0|||
129199777|NCT04628780|465026823|FG004|Overall Study|Withdrawal by Subject|3|||
129199778|NCT04628780|465026824|FG005|Overall Study|Withdrawal by Subject|1|||
129199779|NCT04628780|465026819|FG000|Overall Study|Global deterioration of health status|0|||
129199780|NCT04628780|465026820|FG001|Overall Study|Global deterioration of health status|0|||
129199781|NCT04628780|465026821|FG002|Overall Study|Global deterioration of health status|0|||
129199782|NCT04628780|465026822|FG003|Overall Study|Global deterioration of health status|0|||
129199783|NCT04628780|465026823|FG004|Overall Study|Global deterioration of health status|1|||
129199784|NCT04628780|465026824|FG005|Overall Study|Global deterioration of health status|1|||
129199785|NCT03622814|465026826|FG000|Overall Study|Lost to Follow-up|8|||
129199786|NCT03622814|465026827|FG001|Overall Study|Lost to Follow-up|14|||
129199787|NCT01156714|465026830|FG000|Overall Study|Withdrawal by Subject|9|||
129199788|NCT01156714|465026831|FG001|Overall Study|Withdrawal by Subject|4|||
128781129|NCT00051311|463490449|FG001|Overall Study|Recipient taken off study|4|||
129199789|NCT01156714|465026832|FG002|Overall Study|Withdrawal by Subject|3|||
129199790|NCT04896593|465026838|FG000|Overall Study|Withdrawal by Subject|2|||
129199791|NCT04896593|465026838|FG000|Overall Study|Lost to Follow-up|1|||
129199792|NCT04896593|465026838|FG000|Overall Study|Did not complete onboarding|2|||
129199793|NCT02777827|465026839|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
129199794|NCT02777827|465026840|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
129199795|NCT02777827|465026841|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
129199796|NCT02777827|465026842|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
129199797|NCT02777827|465026843|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
129199798|NCT02777827|465026844|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
129199799|NCT00176462|465026845|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
129199800|NCT00176462|465026846|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
129199801|NCT00176462|465026845|FG000|Induction (4 Weeks)|Death|1|||
129199802|NCT00176462|465026846|FG001|Induction (4 Weeks)|Death|2|||
129199803|NCT00176462|465026845|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
129199804|NCT00176462|465026846|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
129199805|NCT00176462|465026845|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
129199806|NCT00176462|465026846|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
129199807|NCT00176462|465026845|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
129199808|NCT00176462|465026846|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
129199809|NCT00176462|465026845|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
129199810|NCT00176462|465026846|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
129199811|NCT00176462|465026845|FG000|Consolidation (12 Weeks)|Not documented|0|||
129199812|NCT00176462|465026846|FG001|Consolidation (12 Weeks)|Not documented|1|||
129199813|NCT00176462|465026845|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
129199814|NCT00176462|465026846|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
129199815|NCT00176462|465026845|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
129199816|NCT00176462|465026846|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
129199817|NCT01408459|465026847|FG000|Overall Study|Withdrawal by Subject|1|||
129199818|NCT01408459|465026848|FG001|Overall Study|Withdrawal by Subject|1|||
129199819|NCT01301833|465026853|FG000|Overall Study|Adverse Event|7|||
129199820|NCT01301833|465026854|FG001|Overall Study|Adverse Event|5|||
129199821|NCT01301833|465026855|FG002|Overall Study|Adverse Event|5|||
129199822|NCT01301833|465026856|FG003|Overall Study|Adverse Event|5|||
129199823|NCT01301833|465026853|FG000|Overall Study|Lack of Efficacy|1|||
129199824|NCT01301833|465026854|FG001|Overall Study|Lack of Efficacy|1|||
129199825|NCT01301833|465026855|FG002|Overall Study|Lack of Efficacy|0|||
129199826|NCT01301833|465026856|FG003|Overall Study|Lack of Efficacy|0|||
129199827|NCT01301833|465026853|FG000|Overall Study|Physician Decision|3|||
129199828|NCT01301833|465026854|FG001|Overall Study|Physician Decision|1|||
129199829|NCT01301833|465026855|FG002|Overall Study|Physician Decision|1|||
129199830|NCT01301833|465026856|FG003|Overall Study|Physician Decision|0|||
129199831|NCT01301833|465026853|FG000|Overall Study|Withdrawal by Subject|3|||
129199832|NCT01301833|465026854|FG001|Overall Study|Withdrawal by Subject|1|||
129199833|NCT01301833|465026855|FG002|Overall Study|Withdrawal by Subject|1|||
129199834|NCT01301833|465026856|FG003|Overall Study|Withdrawal by Subject|2|||
129199835|NCT01301833|465026853|FG000|Overall Study|Personal matter|1|||
129199836|NCT01301833|465026854|FG001|Overall Study|Personal matter|0|||
129199837|NCT01301833|465026855|FG002|Overall Study|Personal matter|0|||
129199838|NCT01301833|465026856|FG003|Overall Study|Personal matter|0|||
129199839|NCT02709330|465026857|FG000|Overall Study|Death|5|||
129199840|NCT02709330|465026858|FG001|Overall Study|Death|0|||
129199841|NCT02709330|465026857|FG000|Overall Study|Lost to Follow-up|2|||
129199842|NCT02709330|465026858|FG001|Overall Study|Lost to Follow-up|0|||
129199843|NCT02709330|465026857|FG000|Overall Study|Physician Decision|2|||
129199844|NCT02709330|465026858|FG001|Overall Study|Physician Decision|0|||
129199845|NCT02709330|465026857|FG000|Overall Study|Withdrawal by Subject|4|||
129199846|NCT02709330|465026858|FG001|Overall Study|Withdrawal by Subject|0|||
129199847|NCT01279681|465026859|FG000|Overall Study|Disease Progression|9|||
129199848|NCT01279681|465026860|FG001|Overall Study|Disease Progression|6|||
129199849|NCT01279681|465026859|FG000|Overall Study|Withdrawal by Subject|3|||
129199850|NCT01279681|465026860|FG001|Overall Study|Withdrawal by Subject|4|||
129199851|NCT01279681|465026859|FG000|Overall Study|Adverse Event|2|||
129199852|NCT01279681|465026860|FG001|Overall Study|Adverse Event|3|||
129199853|NCT01279681|465026859|FG000|Overall Study|Death|0|||
129199854|NCT01279681|465026860|FG001|Overall Study|Death|1|||
129199855|NCT01279681|465026859|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
129199856|NCT01279681|465026860|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
129199857|NCT01279681|465026859|FG000|Overall Study|Physician Decision|1|||
129199858|NCT01279681|465026860|FG001|Overall Study|Physician Decision|0|||
129199859|NCT01279681|465026859|FG000|Overall Study|Other Reason|0|||
129199860|NCT01279681|465026860|FG001|Overall Study|Other Reason|2|||
129199861|NCT02807623|465028311|FG000|Overall Study|Lost to Follow-up|23|||
129199862|NCT02807623|465028312|FG001|Overall Study|Lost to Follow-up|18|||
129199863|NCT02807623|465028313|FG002|Overall Study|Lost to Follow-up|22|||
129199864|NCT02807623|465028311|FG000|Overall Study|Drug intolerance|0|||
129199865|NCT02807623|465028312|FG001|Overall Study|Drug intolerance|1|||
128731922|NCT02346240|463312881|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129199866|NCT02807623|465028313|FG002|Overall Study|Drug intolerance|0|||
129199867|NCT02807623|465028311|FG000|Overall Study|incomplete blood draw|0|||
129199868|NCT02807623|465028312|FG001|Overall Study|incomplete blood draw|2|||
129199869|NCT02807623|465028313|FG002|Overall Study|incomplete blood draw|1|||
129199870|NCT00859547|465028314|FG000|Overall Study|Lost to Follow-up|1|||
129199871|NCT00859547|465028314|FG000|Overall Study|Parent withdrew consent|1|||
128731923|NCT02346240|463312882|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129199872|NCT03310723|465028316|FG000|Overall Study|Withdrawal by Subject|0|||
129199873|NCT03310723|465028317|FG001|Overall Study|Withdrawal by Subject|1|||
129199874|NCT03310723|465028316|FG000|Overall Study|Protocol Violation|0|||
129199875|NCT03310723|465028317|FG001|Overall Study|Protocol Violation|2|||
129199876|NCT02098746|465028318|FG000|Overall Study|Changes of Investigator|2|||
129199877|NCT02098746|465028318|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129199878|NCT02098746|465028318|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
129199879|NCT02098746|465028318|FG000|Overall Study|Data Not Available After Treatment|1|||
129199880|NCT01410890|465028319|FG000|Overall Study|Withdrawal by Subject|0|||
129199881|NCT01410890|465028320|FG001|Overall Study|Withdrawal by Subject|1|||
129199882|NCT00217425|465028323|FG000|Overall Study|Never started treatment|2|||
129199883|NCT00217425|465028323|FG000|Overall Study|Patient ineligible|5|||
129199884|NCT00217425|465028323|FG000|Overall Study|Lack of Efficacy|13|||
129199885|NCT00217425|465028323|FG000|Overall Study|Adverse Event|8|||
129199886|NCT00217425|465028323|FG000|Overall Study|Withdrawal by Subject|4|||
129199887|NCT00217425|465028323|FG000|Overall Study|Other complicating disease|1|||
129199888|NCT00217425|465028323|FG000|Overall Study|Other|4|||
129199889|NCT01121146|465028324|FG000|Overall Study|Death|17|||
129199890|NCT01121146|465028325|FG001|Overall Study|Death|15|||
129199891|NCT01121146|465028324|FG000|Overall Study|Adverse Event|2|||
129199892|NCT01121146|465028325|FG001|Overall Study|Adverse Event|11|||
129199893|NCT01121146|465028324|FG000|Overall Study|Lost to Follow-up|7|||
129199894|NCT01121146|465028325|FG001|Overall Study|Lost to Follow-up|16|||
129199895|NCT00330759|465028326|FG000|Overall Study|Death|316|||
129199896|NCT00330759|465028327|FG001|Overall Study|Death|310|||
129199897|NCT00330759|465028326|FG000|Overall Study|Disease progression|104|||
129199898|NCT00330759|465028327|FG001|Overall Study|Disease progression|126|||
129199899|NCT00330759|465028326|FG000|Overall Study|Withdrawal by Subject|143|||
129199900|NCT00330759|465028327|FG001|Overall Study|Withdrawal by Subject|124|||
129199901|NCT00330759|465028326|FG000|Overall Study|Adverse Event|48|||
129199902|NCT00330759|465028327|FG001|Overall Study|Adverse Event|36|||
129199903|NCT00330759|465028326|FG000|Overall Study|Participant request|31|||
129199904|NCT00330759|465028327|FG001|Overall Study|Participant request|22|||
129199905|NCT00330759|465028326|FG000|Overall Study|Lost to Follow-up|16|||
129199906|NCT00330759|465028327|FG001|Overall Study|Lost to Follow-up|22|||
129199907|NCT00330759|465028326|FG000|Overall Study|Noncompliance|15|||
129199908|NCT00330759|465028327|FG001|Overall Study|Noncompliance|17|||
129199909|NCT00330759|465028326|FG000|Overall Study|Physician Decision|1|||
129199910|NCT00330759|465028327|FG001|Overall Study|Physician Decision|2|||
129199911|NCT00330759|465028326|FG000|Overall Study|Protocol deviation|0|||
129199912|NCT00330759|465028327|FG001|Overall Study|Protocol deviation|2|||
129199913|NCT00330759|465028326|FG000|Overall Study|Ineligibility determined|2|||
129199914|NCT00330759|465028327|FG001|Overall Study|Ineligibility determined|1|||
129199915|NCT00330759|465028326|FG000|Overall Study|Other|36|||
129199916|NCT00330759|465028327|FG001|Overall Study|Other|44|||
129199917|NCT03654690|465028332|FG000|Overall Study|Withdrawal by Subject|1|||
129199918|NCT03654690|465028333|FG001|Overall Study|Withdrawal by Subject|0|||
129199919|NCT03654690|465028334|FG002|Overall Study|Withdrawal by Subject|0|||
129199920|NCT00742183|465028337|FG000|Overall Study|Adverse Event|2|||
129199921|NCT00742183|465028338|FG001|Overall Study|Adverse Event|2|||
129199922|NCT00742183|465028337|FG000|Overall Study|Death|1|||
129199923|NCT00742183|465028338|FG001|Overall Study|Death|0|||
129199924|NCT00742183|465028337|FG000|Overall Study|Physician Decision|0|||
129199925|NCT00742183|465028338|FG001|Overall Study|Physician Decision|2|||
129199926|NCT00742183|465028337|FG000|Overall Study|Lost to Follow-up|4|||
129199927|NCT00742183|465028338|FG001|Overall Study|Lost to Follow-up|4|||
129199928|NCT00742183|465028337|FG000|Overall Study|Required skin-graft|1|||
129199929|NCT00742183|465028338|FG001|Overall Study|Required skin-graft|1|||
129199930|NCT00742183|465028337|FG000|Overall Study|Withdrawal by Subject|1|||
129199931|NCT00742183|465028338|FG001|Overall Study|Withdrawal by Subject|0|||
129199932|NCT00742183|465028337|FG000|Overall Study|Lack of Efficacy|0|||
129199933|NCT00742183|465028338|FG001|Overall Study|Lack of Efficacy|3|||
129199934|NCT00786799|465028342|FG000|Overall Study|Lost to Follow-up|1|||
129199935|NCT00786799|465028343|FG001|Overall Study|Lost to Follow-up|1|||
129199936|NCT02223715|465028347|FG000|Overall Study|Death|31|||
129199937|NCT02223715|465028347|FG000|Overall Study|Lost to Follow-up|73|||
129199938|NCT01745367|465028348|FG000|Overall Study|Death|1|||
129199939|NCT01745367|465028349|FG001|Overall Study|Death|0|||
129199940|NCT01745367|465028348|FG000|Overall Study|Withdrawal by Subject|1|||
129199941|NCT01745367|465028349|FG001|Overall Study|Withdrawal by Subject|2|||
129199942|NCT01745367|465028348|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
129199943|NCT01745367|465028349|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
129199944|NCT01745367|465028348|FG000|Overall Study|Other Reasons Unspecified|0|||
129199945|NCT01745367|465028349|FG001|Overall Study|Other Reasons Unspecified|2|||
129199946|NCT02640547|465028351|FG000|Overall Study|Failure to Return|1|||
129199947|NCT02640547|465028351|FG000|Overall Study|Withdrawal by Subject|1|||
129199948|NCT02640547|465028351|FG000|Overall Study|Death|6|||
129199949|NCT02640547|465028351|FG000|Overall Study|Miscellaneous|3|||
129199950|NCT02525588|465028352|FG000|Overall Study|Death|3|||
129199951|NCT02525588|465028353|FG001|Overall Study|Death|1|||
129199952|NCT02525588|465028352|FG000|Overall Study|Lost to Follow-up|2|||
129199953|NCT02525588|465028353|FG001|Overall Study|Lost to Follow-up|0|||
129199954|NCT02525588|465028352|FG000|Overall Study|Withdrawal by Subject|1|||
129199955|NCT02525588|465028353|FG001|Overall Study|Withdrawal by Subject|1|||
129199956|NCT02525588|465028352|FG000|Overall Study|Adverse Event|0|||
129199957|NCT02525588|465028353|FG001|Overall Study|Adverse Event|1|||
129199958|NCT01020786|465028358|FG000|Induction Period|Entry Criteria Not Met|2|||
129199959|NCT01020786|465028358|FG000|Induction Period|Adverse Event|10|||
129199960|NCT01020786|465028358|FG000|Induction Period|Progressive Disease|31|||
129199961|NCT01020786|465028358|FG000|Induction Period|Investigator Decision|3|||
129199962|NCT01020786|465028358|FG000|Induction Period|Withdrawal by Subject|3|||
129199963|NCT01020786|465028358|FG000|Maintenance Period|Adverse Event|8|||
129199964|NCT01020786|465028358|FG000|Maintenance Period|Progressive Disease|43|||
129199965|NCT01020786|465028358|FG000|Maintenance Period|Withdrawal by Subject|8|||
129199966|NCT01020786|465028358|FG000|Maintenance Period|Sponsor Decision|1|||
129199967|NCT01479868|465028373|FG000|Overall Study|Adverse Event|1|||
129199968|NCT01479868|465028373|FG000|Overall Study|Lost to Follow-up|4|||
129199969|NCT01479868|465028373|FG000|Overall Study|Protocol Violation|1|||
129199970|NCT01479868|465028373|FG000|Overall Study|Withdrawal by Subject|1|||
129199971|NCT01479868|465028373|FG000|Overall Study|Sponsor's Decision|1|||
129199972|NCT01479868|465028373|FG000|Overall Study|Initiation of new HCV Therapy|1|||
129199973|NCT01508169|465028377|FG000|Overall Study|Adverse Event|1|||
129199974|NCT01508169|465028378|FG001|Overall Study|Adverse Event|0|||
129199975|NCT01508169|465028377|FG000|Overall Study|Withdrawal by Subject|1|||
129199976|NCT01508169|465028378|FG001|Overall Study|Withdrawal by Subject|0|||
129199977|NCT01508169|465028377|FG000|Overall Study|Lost to Follow-up|1|||
129199978|NCT01508169|465028378|FG001|Overall Study|Lost to Follow-up|2|||
129199979|NCT02753946|465028383|FG000|Overall Study|Adverse Event|7|||
129199980|NCT02753946|465028384|FG001|Overall Study|Adverse Event|6|||
129199981|NCT02753946|465028383|FG000|Overall Study|Withdrawal by Subject|6|||
129199982|NCT02753946|465028384|FG001|Overall Study|Withdrawal by Subject|1|||
129199983|NCT02753946|465028383|FG000|Overall Study|Lack of Efficacy|1|||
129199984|NCT02753946|465028384|FG001|Overall Study|Lack of Efficacy|0|||
129199985|NCT02753946|465028383|FG000|Overall Study|Physician Decision|0|||
129199986|NCT02753946|465028384|FG001|Overall Study|Physician Decision|2|||
129199987|NCT02519439|465028385|FG000|Overall Study|Study Termination|19|||
129199988|NCT02519439|465028385|FG000|Overall Study|Withdrawal by Subject|1|||
129199989|NCT02519439|465028385|FG000|Overall Study|Adverse Event|1|||
129199990|NCT01539759|465028389|FG000|Overall Study|Lost to Follow-up|6|||
128781130|NCT00003377|463490450|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
129199991|NCT01539759|465028390|FG001|Overall Study|Lost to Follow-up|8|||
129199992|NCT03901144|465028391|FG000|Overall Study|Lost to Follow-up|1|||
129199993|NCT03901144|465028392|FG001|Overall Study|Lost to Follow-up|1|||
129199994|NCT03901144|465028393|FG002|Overall Study|Lost to Follow-up|1|||
129199995|NCT03901144|465028394|FG003|Overall Study|Lost to Follow-up|1|||
129199996|NCT03575403|465028395|FG000|Overall Study|Adverse Event|1|||
129199997|NCT03575403|465028396|FG001|Overall Study|Adverse Event|0|||
129199998|NCT03575403|465028397|FG002|Overall Study|Adverse Event|0|||
129199999|NCT03575403|465028395|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
129200000|NCT03575403|465028396|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
129200001|NCT03575403|465028397|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
129200002|NCT02728089|465028398|FG000|Overall Study|Physician Decision|2|||
129200003|NCT02728089|465028398|FG000|Overall Study|Withdrawal by Subject|1|||
129200004|NCT03359174|465028401|FG000|Overall Study|Adverse Event|1|||
129200005|NCT01332994|465028405|FG000|Overall Study|Adverse Event|34|||
129200006|NCT01332994|465028405|FG000|Overall Study|Death|1|||
129200007|NCT01332994|465028405|FG000|Overall Study|Lack of Efficacy|1|||
129200008|NCT01332994|465028405|FG000|Overall Study|Lost to Follow-up|4|||
129200009|NCT01332994|465028405|FG000|Overall Study|Protocol Violation|6|||
129200010|NCT01332994|465028405|FG000|Overall Study|Withdrawal by Subject|15|||
129200011|NCT01332994|465028405|FG000|Overall Study|Administrative Problem|2|||
128731924|NCT02346240|463312883|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731925|NCT02346240|463312884|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731926|NCT02346240|463312885|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731927|NCT02346240|463312886|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
128731928|NCT02346240|463312863|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
128731929|NCT02346240|463312864|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
128731930|NCT02346240|463312865|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
129200012|NCT01332994|465028405|FG000|Overall Study|Other|8|||
129200013|NCT02800863|465028406|FG000|Overall Study|Adverse Event|14|||
128731931|NCT02346240|463312866|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
128731932|NCT02346240|463312867|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731933|NCT02346240|463312868|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731934|NCT02346240|463312869|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731935|NCT02346240|463312870|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731936|NCT02346240|463312871|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731937|NCT02346240|463312872|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129200014|NCT02800863|465028406|FG000|Overall Study|Another Device Implanted|1|||
129200015|NCT02800863|465028406|FG000|Overall Study|Device Explanted|1|||
129200016|NCT02800863|465028406|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
129200017|NCT02800863|465028406|FG000|Overall Study|Health Issues|1|||
129200018|NCT02800863|465028406|FG000|Overall Study|Insurance Denial|8|||
129200019|NCT02800863|465028406|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
129200020|NCT02800863|465028406|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
129200021|NCT02800863|465028406|FG000|Overall Study|Screen Failure|1|||
129200022|NCT02800863|465028406|FG000|Overall Study|Sponsor Request|6|||
129200023|NCT02800863|465028406|FG000|Overall Study|Death|3|||
129200024|NCT02800863|465028406|FG000|Overall Study|Subject Implant at Another Facility|1|||
129200025|NCT02800863|465028406|FG000|Overall Study|Lost to Follow-up|26|||
129200026|NCT02800863|465028406|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
129200027|NCT02800863|465028406|FG000|Overall Study|Subject and/or Family Request|64|||
129200028|NCT02800863|465028406|FG000|Overall Study|Trial Failure|81|||
129200029|NCT02800863|465028406|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
129200030|NCT00279916|465028407|FG000|Overall Study|Withdrawal by Subject|4|||
129200031|NCT00279916|465028408|FG001|Overall Study|Withdrawal by Subject|3|||
129200032|NCT00279916|465028407|FG000|Overall Study|Lost to Follow-up|3|||
129200033|NCT00279916|465028408|FG001|Overall Study|Lost to Follow-up|2|||
129200034|NCT02717494|465028410|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
129200035|NCT02717494|465028411|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
129200036|NCT02717494|465028412|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
129200037|NCT02717494|465028410|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
129200038|NCT02717494|465028411|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
129200039|NCT02717494|465028412|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
129200040|NCT02717494|465028410|FG000|First Intervention (Step 1)|Death|0|||
129200041|NCT02717494|465028411|FG001|First Intervention (Step 1)|Death|0|||
129200042|NCT02717494|465028412|FG002|First Intervention (Step 1)|Death|1|||
129200043|NCT02717494|465028410|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
129200044|NCT02717494|465028411|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
129200045|NCT02717494|465028412|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
129200046|NCT00428948|465028415|FG000|Overall Study|Lost to Follow-up|15|||
129200047|NCT00428948|465028416|FG001|Overall Study|Lost to Follow-up|8|||
129200048|NCT00428948|465028415|FG000|Overall Study|Adverse Event|148|||
129200049|NCT00428948|465028416|FG001|Overall Study|Adverse Event|24|||
129200050|NCT00428948|465028415|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
129200051|NCT00428948|465028416|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
129200052|NCT00428948|465028415|FG000|Overall Study|Investigator Withdrew Subject|3|||
129200053|NCT00428948|465028416|FG001|Overall Study|Investigator Withdrew Subject|4|||
129200054|NCT00428948|465028415|FG000|Overall Study|Subject Withdrew Consent|50|||
129200055|NCT00428948|465028416|FG001|Overall Study|Subject Withdrew Consent|30|||
129200056|NCT00428948|465028415|FG000|Overall Study|Protocol Deviation|1|||
129200057|NCT00428948|465028416|FG001|Overall Study|Protocol Deviation|1|||
129200058|NCT04417361|465028418|FG000|Overall Study|Withdrawal by Subject|1|||
129200059|NCT04417361|465028419|FG001|Overall Study|Withdrawal by Subject|0|||
129200060|NCT04417361|465028418|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
129200061|NCT04417361|465028419|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
129200062|NCT01288989|465028420|FG000|Overall Study|Death|0|||
129200063|NCT01288989|465028421|FG001|Overall Study|Death|0|||
129200064|NCT01288989|465028422|FG002|Overall Study|Death|0|||
129200065|NCT01288989|465028423|FG003|Overall Study|Death|1|||
128731938|NCT02346240|463312873|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731939|NCT02346240|463312874|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731940|NCT02346240|463312875|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731941|NCT02346240|463312876|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731942|NCT02346240|463312877|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731943|NCT02346240|463312878|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731944|NCT02346240|463312879|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731945|NCT02346240|463312880|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129200066|NCT01288989|465028424|FG004|Overall Study|Death|0|||
129200067|NCT01288989|465028420|FG000|Overall Study|Dose limiting toxicity|1|||
129200068|NCT01288989|465028421|FG001|Overall Study|Dose limiting toxicity|0|||
129200069|NCT01288989|465028422|FG002|Overall Study|Dose limiting toxicity|0|||
129200070|NCT01288989|465028423|FG003|Overall Study|Dose limiting toxicity|0|||
129200071|NCT01288989|465028424|FG004|Overall Study|Dose limiting toxicity|0|||
129200072|NCT01288989|465028420|FG000|Overall Study|Adverse Event|0|||
129200073|NCT01288989|465028421|FG001|Overall Study|Adverse Event|0|||
129200074|NCT01288989|465028422|FG002|Overall Study|Adverse Event|0|||
129200075|NCT01288989|465028423|FG003|Overall Study|Adverse Event|0|||
129200076|NCT01288989|465028424|FG004|Overall Study|Adverse Event|2|||
129200077|NCT01288989|465028420|FG000|Overall Study|Physician Decision|0|||
129200078|NCT01288989|465028421|FG001|Overall Study|Physician Decision|0|||
129200079|NCT01288989|465028422|FG002|Overall Study|Physician Decision|0|||
129200080|NCT01288989|465028423|FG003|Overall Study|Physician Decision|0|||
129200081|NCT01288989|465028424|FG004|Overall Study|Physician Decision|1|||
129200082|NCT01288989|465028420|FG000|Overall Study|Withdrawal by Subject|0|||
129200083|NCT01288989|465028421|FG001|Overall Study|Withdrawal by Subject|0|||
129200084|NCT01288989|465028422|FG002|Overall Study|Withdrawal by Subject|0|||
129200085|NCT01288989|465028423|FG003|Overall Study|Withdrawal by Subject|0|||
129200086|NCT01288989|465028424|FG004|Overall Study|Withdrawal by Subject|3|||
129200087|NCT00165672|465028426|FG000|Overall Study|Adverse Event|0|||
129200088|NCT00165672|465028427|FG001|Overall Study|Adverse Event|1|||
129200089|NCT04965688|465028433|FG000|Overall Study|Withdrawal by Subject|2|||
129200090|NCT05864586|465028434|FG000|Overall Study|Ineligible|4|||
129200091|NCT05864586|465028435|FG001|Overall Study|Ineligible|12|||
129200092|NCT05864586|465028434|FG000|Overall Study|Pregnancy|0|||
129200093|NCT05864586|465028435|FG001|Overall Study|Pregnancy|1|||
129200094|NCT05864586|465028434|FG000|Overall Study|Withdrawal by Subject|0|||
129200095|NCT05864586|465028435|FG001|Overall Study|Withdrawal by Subject|1|||
129200096|NCT00369577|465028436|FG000|Overall Study|Withdrawal by Subject|0|||
129200097|NCT00369577|465028437|FG001|Overall Study|Withdrawal by Subject|0|||
129200098|NCT00369577|465028438|FG002|Overall Study|Withdrawal by Subject|1|||
129200099|NCT01059318|465028449|FG000|Core Study (26 Week)|Adverse Event|3|||
129200100|NCT01059318|465028449|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
129200101|NCT01059318|465028449|FG000|Extension (36 Week)|Adverse Event|3|||
129200102|NCT00983385|465028450|FG000|Observation Period|Not eligible to be dosed|20|||
129200103|NCT00983385|465028450|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
129200104|NCT01380769|465030008|FG000|Overall Study|Withdrawal by Subject|7|||
129200105|NCT01380769|465030009|FG001|Overall Study|Withdrawal by Subject|11|||
129200106|NCT01380769|465030008|FG000|Overall Study|Physician Decision|1|||
129200107|NCT01380769|465030009|FG001|Overall Study|Physician Decision|1|||
129200108|NCT01380769|465030008|FG000|Overall Study|Adverse Event|1|||
129200109|NCT01380769|465030009|FG001|Overall Study|Adverse Event|1|||
129200110|NCT01380769|465030008|FG000|Overall Study|Protocol Violation|0|||
129200111|NCT01380769|465030009|FG001|Overall Study|Protocol Violation|1|||
129200112|NCT01080807|465030010|FG000|Overall Study|Adverse Event|9|||
129200113|NCT01080807|465030011|FG001|Overall Study|Adverse Event|1|||
129200114|NCT01080807|465030010|FG000|Overall Study|Lack of Efficacy|0|||
129200115|NCT01080807|465030011|FG001|Overall Study|Lack of Efficacy|1|||
129200116|NCT01080807|465030010|FG000|Overall Study|Withdrawal by Subject|7|||
129200117|NCT01080807|465030011|FG001|Overall Study|Withdrawal by Subject|2|||
129200118|NCT01080807|465030010|FG000|Overall Study|Protocol Violation|7|||
129200119|NCT01080807|465030011|FG001|Overall Study|Protocol Violation|6|||
129200120|NCT01080807|465030010|FG000|Overall Study|Lost to Follow-up|6|||
129200121|NCT01080807|465030011|FG001|Overall Study|Lost to Follow-up|4|||
129200122|NCT01080807|465030010|FG000|Overall Study|Noncompliance with drug administration|1|||
129200123|NCT01080807|465030011|FG001|Overall Study|Noncompliance with drug administration|1|||
129200124|NCT01080807|465030010|FG000|Overall Study|Noncompliance to study procedures|1|||
129200125|NCT01080807|465030011|FG001|Overall Study|Noncompliance to study procedures|1|||
129200126|NCT01080807|465030010|FG000|Overall Study|Began working day shift|0|||
129200127|NCT01080807|465030011|FG001|Overall Study|Began working day shift|2|||
129200128|NCT01080807|465030010|FG000|Overall Study|Laid off or terminated from job|1|||
129200129|NCT01080807|465030011|FG001|Overall Study|Laid off or terminated from job|2|||
129200130|NCT01080807|465030010|FG000|Overall Study|Stopped working consistent night shifts|0|||
129200131|NCT01080807|465030011|FG001|Overall Study|Stopped working consistent night shifts|1|||
129200132|NCT01080807|465030010|FG000|Overall Study|Work schedule changing|1|||
129200133|NCT01080807|465030011|FG001|Overall Study|Work schedule changing|1|||
129200134|NCT01080807|465030010|FG000|Overall Study|Work schedule and travel|0|||
129200135|NCT01080807|465030011|FG001|Overall Study|Work schedule and travel|1|||
129200136|NCT01080807|465030010|FG000|Overall Study|Switched to first shift|1|||
129200137|NCT01080807|465030011|FG001|Overall Study|Switched to first shift|0|||
129200138|NCT01080807|465030010|FG000|Overall Study|Moved away without notifying center|1|||
129200139|NCT01080807|465030011|FG001|Overall Study|Moved away without notifying center|0|||
129200140|NCT00824473|465030012|FG000|Overall Study|Adverse Event|4|||
129200141|NCT00824473|465030013|FG001|Overall Study|Adverse Event|5|||
129200142|NCT00824473|465030012|FG000|Overall Study|Lack of Efficacy|2|||
129200143|NCT00824473|465030013|FG001|Overall Study|Lack of Efficacy|2|||
129200144|NCT00824473|465030012|FG000|Overall Study|Protocol Violation|2|||
129200145|NCT00824473|465030013|FG001|Overall Study|Protocol Violation|0|||
129200146|NCT00824473|465030012|FG000|Overall Study|Non-Compliance|4|||
129200147|NCT00824473|465030013|FG001|Overall Study|Non-Compliance|2|||
129200148|NCT00824473|465030012|FG000|Overall Study|Withdrawal by Subject|2|||
129200149|NCT00824473|465030013|FG001|Overall Study|Withdrawal by Subject|3|||
129200150|NCT00824473|465030012|FG000|Overall Study|Other|1|||
129200151|NCT00824473|465030013|FG001|Overall Study|Other|1|||
129200152|NCT01359904|465030014|FG000|Overall Study|Withdrawal by Subject|1|||
129200153|NCT01359904|465030015|FG001|Overall Study|Withdrawal by Subject|0|||
129200154|NCT03018691|465030019|FG000|Overall Study|Adverse Event|1|||
129200155|NCT03018691|465030020|FG001|Overall Study|Adverse Event|1|||
129200156|NCT03018691|465030021|FG002|Overall Study|Adverse Event|4|||
129200157|NCT03018691|465030019|FG000|Overall Study|Lack of Efficacy|0|||
129200158|NCT03018691|465030020|FG001|Overall Study|Lack of Efficacy|0|||
129200159|NCT03018691|465030021|FG002|Overall Study|Lack of Efficacy|1|||
129200160|NCT03018691|465030019|FG000|Overall Study|Withdrawal by Subject|0|||
129200161|NCT03018691|465030020|FG001|Overall Study|Withdrawal by Subject|0|||
129200162|NCT03018691|465030021|FG002|Overall Study|Withdrawal by Subject|1|||
129200163|NCT03018691|465030019|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129200164|NCT03018691|465030020|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129200165|NCT03018691|465030021|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129200166|NCT01521507|465030022|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
129200167|NCT01521507|465030023|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
129200168|NCT01521507|465030022|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
129200169|NCT01521507|465030023|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
129200170|NCT01521507|465030022|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
129200171|NCT01521507|465030023|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
129200172|NCT01521507|465030022|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
129200173|NCT01521507|465030023|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
129200174|NCT01521507|465030022|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
129200175|NCT01521507|465030023|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
129200176|NCT01521507|465030022|FG000|Stage 2: Observational Design|Physician Decision|1|||
129200177|NCT01521507|465030023|FG001|Stage 2: Observational Design|Physician Decision|0|||
129200178|NCT02478463|465030024|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
129200179|NCT02478463|465030024|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
129200180|NCT02478463|465030024|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
129200181|NCT01358825|465030025|FG000|Overall Study|Blood sample not drawn|0|||
129200182|NCT01358825|465030026|FG001|Overall Study|Blood sample not drawn|1|||
129200183|NCT01814527|465030028|FG000|Overall Study|RTP greater than 30 days|6|||
129200184|NCT01814527|465030029|FG001|Overall Study|RTP greater than 30 days|1|||
129200185|NCT04524858|465030032|FG000|Overall Study|Adverse Event|1|||
129200186|NCT01363700|465030035|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
128731946|NCT02346240|463312881|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731947|NCT02346240|463312882|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129200187|NCT01363700|465030036|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
129200188|NCT01363700|465030037|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
129200189|NCT01363700|465030038|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
129200190|NCT01363700|465030039|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
129200191|NCT00113841|465030044|FG000|Overall Study|Disease progression|0|||
129200192|NCT00113841|465030045|FG001|Overall Study|Disease progression|2|||
129200193|NCT00113841|465030044|FG000|Overall Study|Non-compliant|1|||
129200194|NCT00113841|465030045|FG001|Overall Study|Non-compliant|0|||
129200195|NCT00580723|465030050|FG000|Overall Study|Did not want to participate in extension|3|||
129200196|NCT00580723|465030050|FG000|Overall Study|Lost to Follow-up|5|||
129200197|NCT00148759|465030051|FG000|Overall Study|Withdrawal by Subject|1|||
129200198|NCT00148759|465030052|FG001|Overall Study|Withdrawal by Subject|1|||
129200199|NCT00148759|465030051|FG000|Overall Study|Lost to Follow-up|1|||
129200200|NCT00148759|465030052|FG001|Overall Study|Lost to Follow-up|0|||
129200201|NCT05202418|465030053|FG000|Overall Study|Withdrawal by Subject|2|||
129200202|NCT05202418|465030054|FG001|Overall Study|Withdrawal by Subject|1|||
129200203|NCT05202418|465030053|FG000|Overall Study|Lost to Follow-up|1|||
129200204|NCT05202418|465030054|FG001|Overall Study|Lost to Follow-up|1|||
129200205|NCT00104650|465030058|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
129200206|NCT00104650|465030059|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
129200207|NCT00104650|465030060|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
129200208|NCT00104650|465030058|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
129200209|NCT00104650|465030059|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
129200210|NCT00104650|465030060|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
129200211|NCT00104650|465030058|FG000|Treatment Period (25 Weeks)|Death|7|||
129200212|NCT00104650|465030059|FG001|Treatment Period (25 Weeks)|Death|5|||
129200213|NCT00104650|465030060|FG002|Treatment Period (25 Weeks)|Death|6|||
129200214|NCT00104650|465030058|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
129200215|NCT00104650|465030059|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
129200216|NCT00104650|465030060|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
129200217|NCT00104650|465030058|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
129200218|NCT00104650|465030059|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
129200219|NCT00104650|465030060|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
129200220|NCT00104650|465030058|FG000|Treatment Period (25 Weeks)|Other|1|||
129200221|NCT00104650|465030059|FG001|Treatment Period (25 Weeks)|Other|0|||
129200222|NCT00104650|465030060|FG002|Treatment Period (25 Weeks)|Other|0|||
129200223|NCT00104650|465030058|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
129200224|NCT00104650|465030059|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
129200225|NCT00104650|465030060|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
129200226|NCT00104650|465030058|FG000|Follow-up Period|Physician Decision|1|||
129200227|NCT00104650|465030059|FG001|Follow-up Period|Physician Decision|1|||
129200228|NCT00104650|465030060|FG002|Follow-up Period|Physician Decision|0|||
129200229|NCT00104650|465030058|FG000|Follow-up Period|Adverse Event|1|||
129200230|NCT00104650|465030059|FG001|Follow-up Period|Adverse Event|0|||
129200231|NCT00104650|465030060|FG002|Follow-up Period|Adverse Event|1|||
129200232|NCT00104650|465030058|FG000|Follow-up Period|Withdrawal by Subject|0|||
129200233|NCT00104650|465030059|FG001|Follow-up Period|Withdrawal by Subject|3|||
129200234|NCT00104650|465030060|FG002|Follow-up Period|Withdrawal by Subject|3|||
129200235|NCT00104650|465030058|FG000|Follow-up Period|Death|6|||
129200236|NCT00104650|465030059|FG001|Follow-up Period|Death|6|||
129200237|NCT00104650|465030060|FG002|Follow-up Period|Death|4|||
129200238|NCT00104650|465030058|FG000|Follow-up Period|Disease progression|3|||
129200239|NCT00104650|465030059|FG001|Follow-up Period|Disease progression|1|||
129200240|NCT00104650|465030060|FG002|Follow-up Period|Disease progression|0|||
129200241|NCT00104650|465030058|FG000|Follow-up Period|Lost to Follow-up|0|||
129200242|NCT00104650|465030059|FG001|Follow-up Period|Lost to Follow-up|1|||
129200243|NCT00104650|465030060|FG002|Follow-up Period|Lost to Follow-up|2|||
129200244|NCT00104650|465030058|FG000|Follow-up Period|Other|0|||
128731948|NCT02346240|463312883|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731949|NCT02346240|463312884|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
128731950|NCT02346240|463312885|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129200245|NCT00104650|465030059|FG001|Follow-up Period|Other|1|||
129200246|NCT00104650|465030060|FG002|Follow-up Period|Other|0|||
129200247|NCT02294058|465030061|FG000|Overall Study|Adverse Event|16|||
129200248|NCT02294058|465030062|FG001|Overall Study|Adverse Event|7|||
129200249|NCT02294058|465030063|FG002|Overall Study|Adverse Event|13|||
129200250|NCT02294058|465030061|FG000|Overall Study|Lack of Efficacy|3|||
129200251|NCT02294058|465030062|FG001|Overall Study|Lack of Efficacy|3|||
129200252|NCT02294058|465030063|FG002|Overall Study|Lack of Efficacy|0|||
129200253|NCT02294058|465030061|FG000|Overall Study|Lost to Follow-up|1|||
129200254|NCT02294058|465030062|FG001|Overall Study|Lost to Follow-up|0|||
129200255|NCT02294058|465030063|FG002|Overall Study|Lost to Follow-up|2|||
129200256|NCT02294058|465030061|FG000|Overall Study|Withdrawal by Subject|10|||
129200257|NCT02294058|465030062|FG001|Overall Study|Withdrawal by Subject|14|||
129200258|NCT02294058|465030063|FG002|Overall Study|Withdrawal by Subject|13|||
129200259|NCT02294058|465030061|FG000|Overall Study|Physician Decision|2|||
129200260|NCT02294058|465030062|FG001|Overall Study|Physician Decision|1|||
129200261|NCT02294058|465030063|FG002|Overall Study|Physician Decision|0|||
129200262|NCT02294058|465030061|FG000|Overall Study|Miscellaneous|4|||
129200263|NCT02294058|465030062|FG001|Overall Study|Miscellaneous|1|||
129200264|NCT02294058|465030063|FG002|Overall Study|Miscellaneous|1|||
129200265|NCT00773513|465030065|FG000|Overall Study|Renal Transplant|254|||
129200266|NCT00773513|465030066|FG001|Overall Study|Renal Transplant|263|||
129200267|NCT00773513|465030065|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
129200268|NCT00773513|465030066|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
129200269|NCT00773513|465030065|FG000|Overall Study|Withdrew Consent|68|||
129200270|NCT00773513|465030066|FG001|Overall Study|Withdrew Consent|69|||
129200271|NCT00773513|465030065|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
129200272|NCT00773513|465030066|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
129200273|NCT00773513|465030065|FG000|Overall Study|Failure to Return|22|||
129200274|NCT00773513|465030066|FG001|Overall Study|Failure to Return|8|||
129200275|NCT00773513|465030065|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129200276|NCT00773513|465030066|FG001|Overall Study|Insufficient Therapeutic Response|18|||
129200277|NCT00773513|465030065|FG000|Overall Study|Reason Not Specified|159|||
129200278|NCT00773513|465030066|FG001|Overall Study|Reason Not Specified|126|||
129200279|NCT00773513|465030065|FG000|Overall Study|Death|531|||
129200280|NCT00773513|465030066|FG001|Overall Study|Death|545|||
129200281|NCT01807598|465030067|FG000|Overall Study|Withdrawal by Subject|4|||
129200282|NCT01807598|465030067|FG000|Overall Study|Adverse Event|1|||
129200283|NCT01807598|465030067|FG000|Overall Study|Other Physician Decision|1|||
129200284|NCT03384940|465030074|FG000|Overall Study|Progressive disease|36|||
129200285|NCT03384940|465030075|FG001|Overall Study|Progressive disease|11|||
129200286|NCT03384940|465030076|FG002|Overall Study|Progressive disease|13|||
129200287|NCT03384940|465030074|FG000|Overall Study|Clinical progression|4|||
129200288|NCT03384940|465030075|FG001|Overall Study|Clinical progression|0|||
129200289|NCT03384940|465030076|FG002|Overall Study|Clinical progression|3|||
129200290|NCT03384940|465030074|FG000|Overall Study|Adverse Event|7|||
129200291|NCT03384940|465030075|FG001|Overall Study|Adverse Event|1|||
129200292|NCT03384940|465030076|FG002|Overall Study|Adverse Event|1|||
129200293|NCT03384940|465030074|FG000|Overall Study|Withdrawal by Subject|3|||
129200294|NCT03384940|465030075|FG001|Overall Study|Withdrawal by Subject|1|||
129200295|NCT03384940|465030076|FG002|Overall Study|Withdrawal by Subject|0|||
129200296|NCT03384940|465030074|FG000|Overall Study|Physician Decision|1|||
129200297|NCT03384940|465030075|FG001|Overall Study|Physician Decision|1|||
129200298|NCT03384940|465030076|FG002|Overall Study|Physician Decision|0|||
129200299|NCT03384940|465030074|FG000|Overall Study|Death|2|||
129200300|NCT03384940|465030075|FG001|Overall Study|Death|1|||
129200301|NCT03384940|465030076|FG002|Overall Study|Death|0|||
129200302|NCT03384940|465030074|FG000|Overall Study|Other|0|||
129200303|NCT03384940|465030075|FG001|Overall Study|Other|0|||
129200304|NCT03384940|465030076|FG002|Overall Study|Other|1|||
129200305|NCT03089580|465030082|FG000|Overall Study|Lost to Follow-up|2|||
129200306|NCT03087513|465030083|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
129200307|NCT04170543|465030084|FG000|Overall Study|Death|1|||
129200308|NCT04170543|465030085|FG001|Overall Study|Death|1|||
129200309|NCT04170543|465030086|FG002|Overall Study|Death|1|||
129200310|NCT04170543|465030087|FG003|Overall Study|Death|1|||
129200311|NCT04170543|465030088|FG004|Overall Study|Death|1|||
129200312|NCT04170543|465030084|FG000|Overall Study|Lost to Follow-up|3|||
129200313|NCT04170543|465030085|FG001|Overall Study|Lost to Follow-up|3|||
129200314|NCT04170543|465030086|FG002|Overall Study|Lost to Follow-up|0|||
129200315|NCT04170543|465030087|FG003|Overall Study|Lost to Follow-up|3|||
129200316|NCT04170543|465030088|FG004|Overall Study|Lost to Follow-up|1|||
129200317|NCT04170543|465030084|FG000|Overall Study|Withdrawal by Subject|13|||
129200318|NCT04170543|465030085|FG001|Overall Study|Withdrawal by Subject|6|||
129200319|NCT04170543|465030086|FG002|Overall Study|Withdrawal by Subject|5|||
129200320|NCT04170543|465030087|FG003|Overall Study|Withdrawal by Subject|4|||
129200321|NCT04170543|465030088|FG004|Overall Study|Withdrawal by Subject|9|||
129200322|NCT04170543|465030084|FG000|Overall Study|Not able to transition to phase 2b|8|||
129200323|NCT04170543|465030085|FG001|Overall Study|Not able to transition to phase 2b|0|||
129200324|NCT04170543|465030086|FG002|Overall Study|Not able to transition to phase 2b|10|||
129200325|NCT04170543|465030087|FG003|Overall Study|Not able to transition to phase 2b|0|||
129200326|NCT04170543|465030088|FG004|Overall Study|Not able to transition to phase 2b|6|||
129200327|NCT04170543|465030084|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
129200328|NCT04170543|465030085|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
129200329|NCT04170543|465030086|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
129200330|NCT04170543|465030087|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
129200331|NCT04170543|465030088|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
129200332|NCT04170543|465030084|FG000|Overall Study|Not Treated|0|||
129200333|NCT04170543|465030085|FG001|Overall Study|Not Treated|0|||
129200334|NCT04170543|465030086|FG002|Overall Study|Not Treated|0|||
129200335|NCT04170543|465030087|FG003|Overall Study|Not Treated|0|||
129200336|NCT04170543|465030088|FG004|Overall Study|Not Treated|2|||
129200337|NCT04170543|465030084|FG000|Overall Study|(CRF)|16|||
129200338|NCT04170543|465030085|FG001|Overall Study|(CRF)|15|||
129200339|NCT04170543|465030086|FG002|Overall Study|(CRF)|12|||
129200340|NCT04170543|465030087|FG003|Overall Study|(CRF)|17|||
129200341|NCT04170543|465030088|FG004|Overall Study|(CRF)|17|||
129200342|NCT04170543|465030084|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
129200343|NCT04170543|465030085|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
129200344|NCT04170543|465030086|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
128731951|NCT02346240|463312886|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129200345|NCT04170543|465030087|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
129200346|NCT04170543|465030088|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
129200347|NCT00770601|465030089|FG000|Overall Study|Withdrawal by Subject|1|||
129200348|NCT00801216|465030090|FG000|Overall Study|Screening Failure|2|||
129200349|NCT05481359|465030091|FG000|Overall Study|Lost to Follow-up|3|||
129200350|NCT05481359|465030091|FG000|Overall Study|Withdrawal by Subject|1|||
129200351|NCT00452790|465030093|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
129200352|NCT00452790|465030094|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
129200353|NCT00452790|465030093|FG000|Infant Series|Parent/legal guardian request|8|||
129200354|NCT00452790|465030094|FG001|Infant Series|Parent/legal guardian request|6|||
129200355|NCT00452790|465030093|FG000|Infant Series|Failed to return|4|||
129200356|NCT00452790|465030094|FG001|Infant Series|Failed to return|1|||
129200357|NCT00452790|465030093|FG000|Infant Series|Protocol Violation|1|||
129200358|NCT00452790|465030094|FG001|Infant Series|Protocol Violation|3|||
129200359|NCT00452790|465030093|FG000|Infant Series|Lost to Follow-up|2|||
129200360|NCT00452790|465030094|FG001|Infant Series|Lost to Follow-up|2|||
129200361|NCT00452790|465030093|FG000|Infant Series|Adverse Event|1|||
129200362|NCT00452790|465030094|FG001|Infant Series|Adverse Event|2|||
129200363|NCT00452790|465030093|FG000|Infant Series|Other reasons|1|||
129200364|NCT00452790|465030094|FG001|Infant Series|Other reasons|2|||
129200365|NCT00452790|465030093|FG000|Infant Series|Investigator request|0|||
129200366|NCT00452790|465030094|FG001|Infant Series|Investigator request|1|||
129200367|NCT00452790|465030093|FG000|Infant Series|Death|0|||
129200368|NCT00452790|465030094|FG001|Infant Series|Death|1|||
129200369|NCT00452790|465030093|FG000|After Infant Series|Investigator request|10|||
129200370|NCT00452790|465030094|FG001|After Infant Series|Investigator request|10|||
129200371|NCT00452790|465030093|FG000|After Infant Series|Adverse Event|4|||
129200372|NCT00452790|465030094|FG001|After Infant Series|Adverse Event|1|||
129200373|NCT00452790|465030093|FG000|After Infant Series|Parent/legal guardian request|1|||
129200374|NCT00452790|465030094|FG001|After Infant Series|Parent/legal guardian request|3|||
129200375|NCT00452790|465030093|FG000|After Infant Series|Lost to Follow-up|4|||
129200376|NCT00452790|465030094|FG001|After Infant Series|Lost to Follow-up|0|||
129200377|NCT00452790|465030093|FG000|After Infant Series|Failed to return|1|||
129200378|NCT00452790|465030094|FG001|After Infant Series|Failed to return|0|||
129200379|NCT00452790|465030093|FG000|After Infant Series|Other reasons|1|||
129200380|NCT00452790|465030094|FG001|After Infant Series|Other reasons|0|||
129200381|NCT00452790|465030093|FG000|Toddler Dose|Failed to return|0|||
129200382|NCT00452790|465030094|FG001|Toddler Dose|Failed to return|1|||
129200383|NCT00452790|465030093|FG000|Toddler Dose|Parent/legal guardian request|0|||
129200384|NCT00452790|465030094|FG001|Toddler Dose|Parent/legal guardian request|1|||
129200385|NCT00319254|465030110|FG000|Overall Study|Withdrawal by Subject|4|||
129200386|NCT00319254|465030110|FG000|Overall Study|Death|46|||
129200387|NCT00319254|465030110|FG000|Overall Study|Lost to Follow-up|2|||
129200388|NCT00319254|465030110|FG000|Overall Study|Enrolled, Not Treated|2|||
129200389|NCT01505374|465030111|FG000|Overall Study|Lost to Follow-up|1|||
129200390|NCT01505374|465030112|FG001|Overall Study|Lost to Follow-up|0|||
129200391|NCT02360228|465030113|FG000|Overall Study|Withdrawal by Subject|1|||
129200392|NCT02360228|465030114|FG001|Overall Study|Withdrawal by Subject|0|||
129200393|NCT02360228|465030115|FG002|Overall Study|Withdrawal by Subject|0|||
129200394|NCT02360228|465030113|FG000|Overall Study|Self-discontinued medication|0|||
129200395|NCT02360228|465030114|FG001|Overall Study|Self-discontinued medication|1|||
129200396|NCT02360228|465030115|FG002|Overall Study|Self-discontinued medication|0|||
129200397|NCT02360228|465030113|FG000|Overall Study|Unstable symptoms during screening|0|||
129200398|NCT02360228|465030114|FG001|Overall Study|Unstable symptoms during screening|0|||
129200399|NCT02360228|465030115|FG002|Overall Study|Unstable symptoms during screening|1|||
129200400|NCT01712204|465030116|FG000|Overall Study|Adverse Event|3|||
129200401|NCT01712204|465030117|FG001|Overall Study|Adverse Event|1|||
129200402|NCT01712204|465030116|FG000|Overall Study|Withdrawal by Subject|3|||
129200403|NCT01712204|465030117|FG001|Overall Study|Withdrawal by Subject|3|||
129200404|NCT01712204|465030116|FG000|Overall Study|Lost to Follow-up|1|||
129200405|NCT01712204|465030117|FG001|Overall Study|Lost to Follow-up|0|||
129200406|NCT01712204|465030116|FG000|Overall Study|Protocol Violation|1|||
129200407|NCT01712204|465030117|FG001|Overall Study|Protocol Violation|1|||
129200408|NCT02452424|465030120|FG000|Overall Study|Death|2|||
129200409|NCT02452424|465030121|FG001|Overall Study|Death|2|||
129200410|NCT02452424|465030122|FG002|Overall Study|Death|2|||
129200411|NCT02452424|465030123|FG003|Overall Study|Death|6|||
129200412|NCT02452424|465030124|FG004|Overall Study|Death|2|||
129200413|NCT02452424|465030125|FG005|Overall Study|Death|0|||
129200414|NCT02452424|465030126|FG006|Overall Study|Death|5|||
129200415|NCT02452424|465030127|FG007|Overall Study|Death|1|||
129200416|NCT02452424|465030128|FG008|Overall Study|Death|3|||
129200417|NCT02452424|465030129|FG009|Overall Study|Death|1|||
129200418|NCT02452424|465030130|FG010|Overall Study|Death|0|||
129200419|NCT02452424|465030120|FG000|Overall Study|Lost to Follow-up|0|||
129200420|NCT02452424|465030121|FG001|Overall Study|Lost to Follow-up|1|||
129200421|NCT02452424|465030122|FG002|Overall Study|Lost to Follow-up|1|||
129200422|NCT02452424|465030123|FG003|Overall Study|Lost to Follow-up|0|||
129200423|NCT02452424|465030124|FG004|Overall Study|Lost to Follow-up|0|||
129200424|NCT02452424|465030125|FG005|Overall Study|Lost to Follow-up|0|||
129200425|NCT02452424|465030126|FG006|Overall Study|Lost to Follow-up|0|||
129200426|NCT02452424|465030127|FG007|Overall Study|Lost to Follow-up|0|||
129200427|NCT02452424|465030128|FG008|Overall Study|Lost to Follow-up|0|||
129200428|NCT02452424|465030129|FG009|Overall Study|Lost to Follow-up|0|||
129200429|NCT02452424|465030130|FG010|Overall Study|Lost to Follow-up|0|||
129200430|NCT02452424|465030120|FG000|Overall Study|Withdrawal by Subject|0|||
129200431|NCT02452424|465030121|FG001|Overall Study|Withdrawal by Subject|0|||
129200432|NCT02452424|465030122|FG002|Overall Study|Withdrawal by Subject|3|||
129200433|NCT02452424|465030123|FG003|Overall Study|Withdrawal by Subject|2|||
129200434|NCT02452424|465030124|FG004|Overall Study|Withdrawal by Subject|0|||
129200435|NCT02452424|465030125|FG005|Overall Study|Withdrawal by Subject|0|||
129200436|NCT02452424|465030126|FG006|Overall Study|Withdrawal by Subject|1|||
129200437|NCT02452424|465030127|FG007|Overall Study|Withdrawal by Subject|0|||
129200438|NCT02452424|465030128|FG008|Overall Study|Withdrawal by Subject|1|||
129200439|NCT02452424|465030129|FG009|Overall Study|Withdrawal by Subject|1|||
129200440|NCT02452424|465030130|FG010|Overall Study|Withdrawal by Subject|0|||
129200441|NCT02452424|465030120|FG000|Overall Study|Other|0|||
129200442|NCT02452424|465030121|FG001|Overall Study|Other|0|||
129200443|NCT02452424|465030122|FG002|Overall Study|Other|1|||
129200444|NCT02452424|465030123|FG003|Overall Study|Other|0|||
129200445|NCT02452424|465030124|FG004|Overall Study|Other|0|||
129200446|NCT02452424|465030125|FG005|Overall Study|Other|1|||
129200447|NCT02452424|465030126|FG006|Overall Study|Other|4|||
129200448|NCT02452424|465030127|FG007|Overall Study|Other|3|||
129200449|NCT02452424|465030128|FG008|Overall Study|Other|0|||
129200450|NCT02452424|465030129|FG009|Overall Study|Other|0|||
129200451|NCT02452424|465030130|FG010|Overall Study|Other|1|||
129200452|NCT02452424|465030120|FG000|Overall Study|Progressive disease (per RECIST)|0|||
129200453|NCT02452424|465030121|FG001|Overall Study|Progressive disease (per RECIST)|0|||
129200454|NCT02452424|465030122|FG002|Overall Study|Progressive disease (per RECIST)|0|||
129200455|NCT02452424|465030123|FG003|Overall Study|Progressive disease (per RECIST)|0|||
129200456|NCT02452424|465030124|FG004|Overall Study|Progressive disease (per RECIST)|0|||
129200457|NCT02452424|465030125|FG005|Overall Study|Progressive disease (per RECIST)|0|||
129200458|NCT02452424|465030126|FG006|Overall Study|Progressive disease (per RECIST)|0|||
129200459|NCT02452424|465030127|FG007|Overall Study|Progressive disease (per RECIST)|0|||
129200460|NCT02452424|465030128|FG008|Overall Study|Progressive disease (per RECIST)|2|||
129200461|NCT02452424|465030129|FG009|Overall Study|Progressive disease (per RECIST)|0|||
129200462|NCT02452424|465030130|FG010|Overall Study|Progressive disease (per RECIST)|0|||
129200463|NCT02452424|465030120|FG000|Overall Study|Adverse Event|0|||
129200464|NCT02452424|465030121|FG001|Overall Study|Adverse Event|0|||
129200465|NCT02452424|465030122|FG002|Overall Study|Adverse Event|0|||
129200466|NCT02452424|465030123|FG003|Overall Study|Adverse Event|0|||
129200467|NCT02452424|465030124|FG004|Overall Study|Adverse Event|0|||
129200468|NCT02452424|465030125|FG005|Overall Study|Adverse Event|0|||
129200469|NCT02452424|465030126|FG006|Overall Study|Adverse Event|0|||
129200470|NCT02452424|465030127|FG007|Overall Study|Adverse Event|0|||
129200471|NCT02452424|465030128|FG008|Overall Study|Adverse Event|0|||
129200472|NCT02452424|465030129|FG009|Overall Study|Adverse Event|0|||
129200473|NCT02452424|465030130|FG010|Overall Study|Adverse Event|1|||
129200474|NCT01463306|465030131|FG000|Overall Study|Adverse Event|6|||
129200475|NCT01463306|465030132|FG001|Overall Study|Adverse Event|9|||
129200476|NCT01463306|465030133|FG002|Overall Study|Adverse Event|3|||
129200477|NCT01463306|465030131|FG000|Overall Study|Death|3|||
129200478|NCT01463306|465030132|FG001|Overall Study|Death|3|||
129200479|NCT01463306|465030133|FG002|Overall Study|Death|0|||
129200480|NCT01463306|465030131|FG000|Overall Study|Lack of Efficacy|22|||
129200481|NCT01463306|465030132|FG001|Overall Study|Lack of Efficacy|16|||
129200482|NCT01463306|465030133|FG002|Overall Study|Lack of Efficacy|1|||
129200483|NCT01463306|465030131|FG000|Overall Study|Lost to Follow-up|5|||
129200484|NCT01463306|465030132|FG001|Overall Study|Lost to Follow-up|2|||
129200485|NCT01463306|465030133|FG002|Overall Study|Lost to Follow-up|0|||
129200486|NCT01463306|465030131|FG000|Overall Study|Protocol Violation|4|||
129200487|NCT01463306|465030132|FG001|Overall Study|Protocol Violation|0|||
129200488|NCT01463306|465030133|FG002|Overall Study|Protocol Violation|0|||
129200489|NCT01463306|465030131|FG000|Overall Study|Withdrawal by Subject|19|||
129200490|NCT01463306|465030132|FG001|Overall Study|Withdrawal by Subject|9|||
129200491|NCT01463306|465030133|FG002|Overall Study|Withdrawal by Subject|1|||
129200492|NCT01463306|465030131|FG000|Overall Study|Other|26|||
129200493|NCT01463306|465030132|FG001|Overall Study|Other|13|||
129200494|NCT01463306|465030133|FG002|Overall Study|Other|0|||
129200495|NCT01463306|465030131|FG000|Overall Study|Approval expiry at site|1|||
129200496|NCT01463306|465030132|FG001|Overall Study|Approval expiry at site|0|||
129200497|NCT01463306|465030133|FG002|Overall Study|Approval expiry at site|0|||
129200498|NCT04186871|465030136|FG000|Overall Study|Lack of Efficacy|0|||
129200499|NCT04186871|465030137|FG001|Overall Study|Lack of Efficacy|1|||
129200500|NCT04186871|465030138|FG002|Overall Study|Lack of Efficacy|0|||
129200501|NCT04186871|465030139|FG003|Overall Study|Lack of Efficacy|0|||
129200502|NCT04186871|465030140|FG004|Overall Study|Lack of Efficacy|1|||
129200503|NCT04186871|465030141|FG005|Overall Study|Lack of Efficacy|1|||
129200504|NCT04186871|465030136|FG000|Overall Study|Adverse Event|1|||
129200505|NCT04186871|465030137|FG001|Overall Study|Adverse Event|1|||
129200506|NCT04186871|465030138|FG002|Overall Study|Adverse Event|0|||
129200507|NCT04186871|465030139|FG003|Overall Study|Adverse Event|0|||
129200508|NCT04186871|465030140|FG004|Overall Study|Adverse Event|0|||
129200509|NCT04186871|465030141|FG005|Overall Study|Adverse Event|2|||
129200510|NCT04186871|465030136|FG000|Overall Study|Study terminated by sponsor|1|||
129200511|NCT04186871|465030137|FG001|Overall Study|Study terminated by sponsor|2|||
129200512|NCT04186871|465030138|FG002|Overall Study|Study terminated by sponsor|0|||
129200513|NCT04186871|465030139|FG003|Overall Study|Study terminated by sponsor|1|||
129200514|NCT04186871|465030140|FG004|Overall Study|Study terminated by sponsor|0|||
129200515|NCT04186871|465030141|FG005|Overall Study|Study terminated by sponsor|0|||
129200516|NCT04186871|465030136|FG000|Overall Study|Other reasons|0|||
128731952|NCT02346240|463312863|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
128731953|NCT02346240|463312864|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
128731954|NCT02346240|463312865|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
128731955|NCT02346240|463312866|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
128731956|NCT02346240|463312867|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731957|NCT02346240|463312868|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731958|NCT02346240|463312869|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731959|NCT02346240|463312870|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731960|NCT02346240|463312871|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731961|NCT02346240|463312872|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731962|NCT02346240|463312873|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129200517|NCT04186871|465030137|FG001|Overall Study|Other reasons|0|||
129200518|NCT04186871|465030138|FG002|Overall Study|Other reasons|0|||
129200519|NCT04186871|465030139|FG003|Overall Study|Other reasons|0|||
129200520|NCT04186871|465030140|FG004|Overall Study|Other reasons|0|||
129200521|NCT04186871|465030141|FG005|Overall Study|Other reasons|1|||
129200522|NCT04186871|465030136|FG000|Overall Study|Withdrawal by Subject|0|||
129200523|NCT04186871|465030137|FG001|Overall Study|Withdrawal by Subject|0|||
129200524|NCT04186871|465030138|FG002|Overall Study|Withdrawal by Subject|0|||
129200525|NCT04186871|465030139|FG003|Overall Study|Withdrawal by Subject|0|||
129200526|NCT04186871|465030140|FG004|Overall Study|Withdrawal by Subject|0|||
129200527|NCT04186871|465030141|FG005|Overall Study|Withdrawal by Subject|1|||
129200528|NCT04186871|465030136|FG000|Overall Study|Lost to Follow-up|0|||
129200529|NCT04186871|465030137|FG001|Overall Study|Lost to Follow-up|0|||
129200530|NCT04186871|465030138|FG002|Overall Study|Lost to Follow-up|0|||
129200531|NCT04186871|465030139|FG003|Overall Study|Lost to Follow-up|0|||
129200532|NCT04186871|465030140|FG004|Overall Study|Lost to Follow-up|0|||
129200533|NCT04186871|465030141|FG005|Overall Study|Lost to Follow-up|1|||
129200534|NCT03790917|465030142|FG000|Overall Study|Death|1|||
129200535|NCT02464410|465030143|FG000|Overall Study|Death|3|||
129200536|NCT02464410|465030144|FG001|Overall Study|Death|4|||
129200537|NCT02464410|465030143|FG000|Overall Study|Lost to Follow-up|7|||
129200538|NCT02464410|465030144|FG001|Overall Study|Lost to Follow-up|9|||
129200539|NCT02464410|465030143|FG000|Overall Study|Withdrawal by Subject|12|||
129200540|NCT02464410|465030144|FG001|Overall Study|Withdrawal by Subject|3|||
129200541|NCT02679287|465030155|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
129200542|NCT02679287|465030156|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
129200543|NCT02679287|465030155|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
129200544|NCT02679287|465030156|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
129200545|NCT02679287|465030155|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
129200546|NCT02679287|465030156|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
129200547|NCT02679287|465030155|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
129200548|NCT02679287|465030156|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
129200549|NCT02679287|465030155|FG000|Period 2|Work/Scheduling Conflict|1|||
129200550|NCT02679287|465030156|FG001|Period 2|Work/Scheduling Conflict|0|||
129200551|NCT02679287|465030155|FG000|Period 2|Disliked Mobile System|2|||
129200552|NCT02679287|465030156|FG001|Period 2|Disliked Mobile System|0|||
129200553|NCT02679287|465030155|FG000|Period 3|Work/Scheduling Conflict|0|||
129200554|NCT02679287|465030156|FG001|Period 3|Work/Scheduling Conflict|1|||
129200555|NCT01150097|465030161|FG000|Months 24 to 36 Post-transplantation|Death|2|||
129200556|NCT01150097|465030162|FG001|Months 24 to 36 Post-transplantation|Death|0|||
129200557|NCT01150097|465030163|FG002|Months 24 to 36 Post-transplantation|Death|0|||
129200558|NCT01150097|465030161|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
129200559|NCT01150097|465030162|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
129200560|NCT01150097|465030163|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
129200561|NCT01150097|465030161|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
129200562|NCT01150097|465030162|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
129200563|NCT01150097|465030163|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
129200564|NCT01150097|465030161|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
129200565|NCT01150097|465030162|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
129200566|NCT01150097|465030163|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
129200567|NCT01150097|465030161|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
129200568|NCT01150097|465030162|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
129200569|NCT01150097|465030163|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
129200570|NCT01150097|465030161|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
129200571|NCT01150097|465030162|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
129200572|NCT01150097|465030163|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
128731963|NCT02346240|463312874|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129200573|NCT01150097|465030161|FG000|Months 24 to 48 Post-transplantation|Death|2|||
129200574|NCT01150097|465030162|FG001|Months 24 to 48 Post-transplantation|Death|0|||
129200575|NCT01150097|465030163|FG002|Months 24 to 48 Post-transplantation|Death|0|||
129200576|NCT00992459|465030167|FG000|Overall Study|Withdrawal by Subject|0|||
129200577|NCT00992459|465030168|FG001|Overall Study|Withdrawal by Subject|1|||
129200578|NCT00992459|465030167|FG000|Overall Study|Adverse Event|1|||
129200579|NCT00992459|465030168|FG001|Overall Study|Adverse Event|0|||
129200580|NCT00543387|465030169|FG000|Panel 1 + Panel 2|Adverse Event|0|||
129200581|NCT00543387|465030170|FG001|Panel 1 + Panel 2|Adverse Event|1|||
129200582|NCT00543387|465030171|FG002|Panel 1 + Panel 2|Adverse Event|0|||
129200583|NCT00543387|465030172|FG003|Panel 1 + Panel 2|Adverse Event|0|||
129200584|NCT00543387|465030173|FG004|Panel 1 + Panel 2|Adverse Event|0|||
129200585|NCT00543387|465030174|FG005|Panel 1 + Panel 2|Adverse Event|0|||
129200586|NCT00543387|465030175|FG006|Panel 1 + Panel 2|Adverse Event|0|||
129200587|NCT00543387|465030176|FG007|Panel 1 + Panel 2|Adverse Event|1|||
129200588|NCT00543387|465030177|FG008|Panel 1 + Panel 2|Adverse Event|1|||
129200589|NCT00543387|465030178|FG009|Panel 1 + Panel 2|Adverse Event|0|||
129200590|NCT00543387|465030179|FG010|Panel 1 + Panel 2|Adverse Event|0|||
129200591|NCT00543387|465030169|FG000|Panel 1 + Panel 2|Physician Decision|0|||
129200592|NCT00543387|465030170|FG001|Panel 1 + Panel 2|Physician Decision|0|||
129200593|NCT00543387|465030171|FG002|Panel 1 + Panel 2|Physician Decision|1|||
129200594|NCT00543387|465030172|FG003|Panel 1 + Panel 2|Physician Decision|0|||
129200595|NCT00543387|465030173|FG004|Panel 1 + Panel 2|Physician Decision|0|||
129200596|NCT00543387|465030174|FG005|Panel 1 + Panel 2|Physician Decision|0|||
129200597|NCT00543387|465030175|FG006|Panel 1 + Panel 2|Physician Decision|0|||
129200598|NCT00543387|465030176|FG007|Panel 1 + Panel 2|Physician Decision|1|||
129200599|NCT00543387|465030177|FG008|Panel 1 + Panel 2|Physician Decision|0|||
129200600|NCT00543387|465030178|FG009|Panel 1 + Panel 2|Physician Decision|0|||
129200601|NCT00543387|465030179|FG010|Panel 1 + Panel 2|Physician Decision|0|||
129200602|NCT00543387|465030169|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129200603|NCT00543387|465030170|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
129200604|NCT00543387|465030171|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
129200605|NCT00543387|465030172|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129200606|NCT00543387|465030173|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129200607|NCT00543387|465030174|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129200608|NCT00543387|465030175|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
129200609|NCT00543387|465030176|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
129200610|NCT00543387|465030177|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
129200611|NCT00543387|465030178|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
129200612|NCT00543387|465030179|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
129200613|NCT00543387|465030169|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200614|NCT00543387|465030170|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200615|NCT00543387|465030171|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
128731964|NCT02346240|463312875|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731965|NCT02346240|463312876|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731966|NCT02346240|463312877|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731967|NCT02346240|463312878|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731968|NCT02346240|463312879|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731969|NCT02346240|463312880|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731970|NCT02346240|463312881|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731971|NCT02346240|463312882|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731972|NCT02346240|463312883|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731973|NCT02346240|463312884|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731974|NCT02346240|463312885|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128731975|NCT02346240|463312886|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
128781131|NCT00003377|463490451|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
128781132|NCT00003377|463490452|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
129200616|NCT00543387|465030172|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200617|NCT00543387|465030173|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200618|NCT00543387|465030174|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200619|NCT00543387|465030175|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
129200620|NCT00543387|465030176|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200621|NCT00543387|465030177|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200622|NCT00543387|465030178|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200623|NCT00543387|465030179|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129200624|NCT00543387|465030169|FG000|Crossover Participants|Progressive Disease|0|||
129200625|NCT00543387|465030170|FG001|Crossover Participants|Progressive Disease|0|||
129200626|NCT00543387|465030171|FG002|Crossover Participants|Progressive Disease|0|||
129200627|NCT00543387|465030172|FG003|Crossover Participants|Progressive Disease|0|||
129200628|NCT00543387|465030173|FG004|Crossover Participants|Progressive Disease|0|||
129200629|NCT00543387|465030174|FG005|Crossover Participants|Progressive Disease|0|||
129200630|NCT00543387|465030175|FG006|Crossover Participants|Progressive Disease|0|||
129200631|NCT00543387|465030176|FG007|Crossover Participants|Progressive Disease|0|||
129200632|NCT00543387|465030177|FG008|Crossover Participants|Progressive Disease|0|||
129200633|NCT00543387|465030178|FG009|Crossover Participants|Progressive Disease|1|||
129200634|NCT00543387|465030179|FG010|Crossover Participants|Progressive Disease|2|||
129200635|NCT00543387|465030169|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
129200636|NCT00543387|465030170|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
129200637|NCT00543387|465030171|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
129200638|NCT00543387|465030172|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
129200639|NCT00543387|465030173|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
129200640|NCT00543387|465030174|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
129200641|NCT00543387|465030175|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
129200642|NCT00543387|465030176|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
129200643|NCT00543387|465030177|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
129200644|NCT00543387|465030178|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
129200645|NCT00543387|465030179|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
129200646|NCT01114828|465030180|FG000|Overall Study|Adverse Event|1|||
129200647|NCT01114828|465030181|FG001|Overall Study|Adverse Event|1|||
129200648|NCT01114828|465030180|FG000|Overall Study|Lack of Efficacy|0|||
129200649|NCT01114828|465030181|FG001|Overall Study|Lack of Efficacy|2|||
129200650|NCT01114828|465030180|FG000|Overall Study|Protocol Violation|2|||
129200651|NCT01114828|465030181|FG001|Overall Study|Protocol Violation|0|||
129200652|NCT01114828|465030180|FG000|Overall Study|Withdrawal by Subject|0|||
129200653|NCT01114828|465030181|FG001|Overall Study|Withdrawal by Subject|1|||
129200654|NCT00940498|465030182|FG000|Overall Study|Death|2|||
129200655|NCT00940498|465030183|FG001|Overall Study|Death|0|||
129200656|NCT00940498|465030184|FG002|Overall Study|Death|0|||
129200657|NCT00940498|465030185|FG003|Overall Study|Death|1|||
129200658|NCT00940498|465030186|FG004|Overall Study|Death|5|||
129200659|NCT00940498|465030187|FG005|Overall Study|Death|0|||
129200660|NCT00940498|465030188|FG006|Overall Study|Death|1|||
129200661|NCT00940498|465030189|FG007|Overall Study|Death|0|||
129200662|NCT00940498|465030182|FG000|Overall Study|Lost to Follow-up|1|||
129200663|NCT00940498|465030183|FG001|Overall Study|Lost to Follow-up|1|||
129200664|NCT00940498|465030184|FG002|Overall Study|Lost to Follow-up|2|||
129200665|NCT00940498|465030185|FG003|Overall Study|Lost to Follow-up|0|||
129200666|NCT00940498|465030186|FG004|Overall Study|Lost to Follow-up|1|||
129200667|NCT00940498|465030187|FG005|Overall Study|Lost to Follow-up|0|||
129200668|NCT00940498|465030188|FG006|Overall Study|Lost to Follow-up|0|||
129200669|NCT00940498|465030189|FG007|Overall Study|Lost to Follow-up|1|||
129200670|NCT00940498|465030182|FG000|Overall Study|Disease Progression|0|||
129200671|NCT00940498|465030183|FG001|Overall Study|Disease Progression|0|||
129200672|NCT00940498|465030184|FG002|Overall Study|Disease Progression|1|||
129200673|NCT00940498|465030185|FG003|Overall Study|Disease Progression|1|||
129200674|NCT00940498|465030186|FG004|Overall Study|Disease Progression|0|||
129200675|NCT00940498|465030187|FG005|Overall Study|Disease Progression|1|||
129200676|NCT00940498|465030188|FG006|Overall Study|Disease Progression|0|||
129200677|NCT00940498|465030189|FG007|Overall Study|Disease Progression|0|||
129200678|NCT00940498|465030182|FG000|Overall Study|Physician Decision|0|||
129200679|NCT00940498|465030183|FG001|Overall Study|Physician Decision|0|||
129200680|NCT00940498|465030184|FG002|Overall Study|Physician Decision|0|||
129200681|NCT00940498|465030185|FG003|Overall Study|Physician Decision|0|||
129200682|NCT00940498|465030186|FG004|Overall Study|Physician Decision|2|||
129200683|NCT00940498|465030187|FG005|Overall Study|Physician Decision|0|||
129200684|NCT00940498|465030188|FG006|Overall Study|Physician Decision|0|||
129200685|NCT00940498|465030189|FG007|Overall Study|Physician Decision|0|||
129200686|NCT00940498|465030182|FG000|Overall Study|Not treated due to disease related pain|0|||
129200687|NCT00940498|465030183|FG001|Overall Study|Not treated due to disease related pain|0|||
129200688|NCT00940498|465030184|FG002|Overall Study|Not treated due to disease related pain|0|||
128731976|NCT02346240|463312863|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731977|NCT02346240|463312864|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
128731978|NCT02346240|463312865|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731979|NCT02346240|463312866|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
128731980|NCT02346240|463312867|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731981|NCT02346240|463312868|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731982|NCT02346240|463312869|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731983|NCT02346240|463312870|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731984|NCT02346240|463312871|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731985|NCT02346240|463312872|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731986|NCT02346240|463312873|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731987|NCT02346240|463312874|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731988|NCT02346240|463312875|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731989|NCT02346240|463312876|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731990|NCT02346240|463312877|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731991|NCT02346240|463312878|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731992|NCT02346240|463312879|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731993|NCT02346240|463312880|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731994|NCT02346240|463312881|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731995|NCT02346240|463312882|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731996|NCT02346240|463312883|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731997|NCT02346240|463312884|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731998|NCT02346240|463312885|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128731999|NCT02346240|463312886|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
128732000|NCT02346240|463312863|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732001|NCT02346240|463312864|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732002|NCT02346240|463312865|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
128732003|NCT02346240|463312866|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128781133|NCT00003377|463490453|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
129200689|NCT00940498|465030185|FG003|Overall Study|Not treated due to disease related pain|0|||
129200690|NCT00940498|465030186|FG004|Overall Study|Not treated due to disease related pain|1|||
129200691|NCT00940498|465030187|FG005|Overall Study|Not treated due to disease related pain|0|||
129200692|NCT00940498|465030188|FG006|Overall Study|Not treated due to disease related pain|0|||
129200693|NCT00940498|465030189|FG007|Overall Study|Not treated due to disease related pain|0|||
129200694|NCT03932760|465030190|FG000|Overall Study|Became Ineligible|2|||
129200695|NCT03932760|465030191|FG001|Overall Study|Became Ineligible|5|||
129200696|NCT03932760|465030190|FG000|Overall Study|Withdrawal by Subject|6|||
129200697|NCT03932760|465030191|FG001|Overall Study|Withdrawal by Subject|6|||
129200698|NCT03566082|465030192|FG000|Overall Study|Death|7|||
129200699|NCT03566082|465030192|FG000|Overall Study|Failures (revision required)|2|||
129200700|NCT03566082|465030192|FG000|Overall Study|Lost to Follow-up|8|||
129200701|NCT00227721|465031483|FG000|Overall Study|On study, but never treated.|1|||
129200702|NCT01389882|465031489|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
129200703|NCT01389882|465031490|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
129200704|NCT01389882|465031489|FG000|Overall Study|Withdrawal by Subject|0|||
129200705|NCT01389882|465031490|FG001|Overall Study|Withdrawal by Subject|1|||
129200706|NCT00961181|465031491|FG000|Overall Study|Death|2|||
129200707|NCT00961181|465031491|FG000|Overall Study|Withdrawal by Subject|2|||
129200708|NCT00961181|465031491|FG000|Overall Study|Lost to Follow-up|1|||
129200709|NCT01276639|465031508|FG000|Week 0 to 16|Death|1|||
129200710|NCT01276639|465031509|FG001|Week 0 to 16|Death|0|||
129200711|NCT01276639|465031510|FG002|Week 0 to 16|Death|0|||
129200712|NCT01276639|465031511|FG003|Week 0 to 16|Death|0|||
129200713|NCT01276639|465031512|FG004|Week 0 to 16|Death|0|||
129200714|NCT01276639|465031508|FG000|Week 0 to 16|Adverse Event|11|||
129200715|NCT01276639|465031509|FG001|Week 0 to 16|Adverse Event|8|||
129200716|NCT01276639|465031510|FG002|Week 0 to 16|Adverse Event|11|||
129200717|NCT01276639|465031511|FG003|Week 0 to 16|Adverse Event|0|||
128732004|NCT02346240|463312867|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732005|NCT02346240|463312868|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732006|NCT02346240|463312869|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732007|NCT02346240|463312870|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732008|NCT02346240|463312871|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732009|NCT02346240|463312872|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732010|NCT02346240|463312873|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732011|NCT02346240|463312874|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732012|NCT02346240|463312875|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732013|NCT02346240|463312876|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732014|NCT02346240|463312877|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732015|NCT02346240|463312878|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732016|NCT02346240|463312879|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732017|NCT02346240|463312880|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732018|NCT02346240|463312881|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732019|NCT02346240|463312882|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732020|NCT02346240|463312883|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732021|NCT02346240|463312884|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732022|NCT02346240|463312885|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732023|NCT02346240|463312886|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
128732024|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732025|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732026|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732027|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732028|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128781134|NCT00003377|463490454|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
128781135|NCT00003377|463490450|FG000|Period II|Ureteral stent complications|0|||
128781136|NCT00003377|463490451|FG001|Period II|Ureteral stent complications|0|||
128781137|NCT00003377|463490452|FG002|Period II|Ureteral stent complications|0|||
128781138|NCT00003377|463490453|FG003|Period II|Ureteral stent complications|0|||
129200718|NCT01276639|465031512|FG004|Week 0 to 16|Adverse Event|0|||
129200719|NCT01276639|465031508|FG000|Week 0 to 16|Lack of Efficacy|20|||
129200720|NCT01276639|465031509|FG001|Week 0 to 16|Lack of Efficacy|15|||
129200721|NCT01276639|465031510|FG002|Week 0 to 16|Lack of Efficacy|25|||
129200722|NCT01276639|465031511|FG003|Week 0 to 16|Lack of Efficacy|0|||
129200723|NCT01276639|465031512|FG004|Week 0 to 16|Lack of Efficacy|0|||
129200724|NCT01276639|465031508|FG000|Week 0 to 16|Lost to Follow-up|3|||
129200725|NCT01276639|465031509|FG001|Week 0 to 16|Lost to Follow-up|5|||
129200726|NCT01276639|465031510|FG002|Week 0 to 16|Lost to Follow-up|3|||
129200727|NCT01276639|465031511|FG003|Week 0 to 16|Lost to Follow-up|0|||
129200728|NCT01276639|465031512|FG004|Week 0 to 16|Lost to Follow-up|0|||
129200729|NCT01276639|465031508|FG000|Week 0 to 16|Withdrawal by Subject|8|||
129200730|NCT01276639|465031509|FG001|Week 0 to 16|Withdrawal by Subject|5|||
129200731|NCT01276639|465031510|FG002|Week 0 to 16|Withdrawal by Subject|4|||
129200732|NCT01276639|465031511|FG003|Week 0 to 16|Withdrawal by Subject|0|||
129200733|NCT01276639|465031512|FG004|Week 0 to 16|Withdrawal by Subject|0|||
129200734|NCT01276639|465031508|FG000|Week 0 to 16|Other|7|||
129200735|NCT01276639|465031509|FG001|Week 0 to 16|Other|7|||
129200736|NCT01276639|465031510|FG002|Week 0 to 16|Other|2|||
129200737|NCT01276639|465031511|FG003|Week 0 to 16|Other|0|||
129200738|NCT01276639|465031512|FG004|Week 0 to 16|Other|0|||
129200739|NCT01276639|465031508|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
129200740|NCT01276639|465031509|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
128732029|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732030|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732031|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
128732032|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
128732033|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732034|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732035|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732036|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732037|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
128732038|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
128732039|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
128732040|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
128732041|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732042|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732043|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732044|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732045|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732046|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732047|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
128732048|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732049|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732050|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732051|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732052|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732053|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732054|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732055|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732056|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732057|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732058|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732059|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732060|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732061|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
128732062|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732063|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
128732064|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732065|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732066|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732067|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732068|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732069|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732070|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732071|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
128732072|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732073|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732074|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732075|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732076|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129200741|NCT01276639|465031510|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
129200742|NCT01276639|465031511|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
129200743|NCT01276639|465031512|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
129200744|NCT01276639|465031508|FG000|Week 16 to 52|Death|1|||
129200745|NCT01276639|465031509|FG001|Week 16 to 52|Death|0|||
129200746|NCT01276639|465031510|FG002|Week 16 to 52|Death|0|||
129200747|NCT01276639|465031511|FG003|Week 16 to 52|Death|0|||
129200748|NCT01276639|465031512|FG004|Week 16 to 52|Death|0|||
129200749|NCT01276639|465031508|FG000|Week 16 to 52|Adverse Event|10|||
129200750|NCT01276639|465031509|FG001|Week 16 to 52|Adverse Event|13|||
129200751|NCT01276639|465031510|FG002|Week 16 to 52|Adverse Event|0|||
129200752|NCT01276639|465031511|FG003|Week 16 to 52|Adverse Event|1|||
128732077|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732078|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732079|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732080|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129200753|NCT01276639|465031512|FG004|Week 16 to 52|Adverse Event|3|||
129200754|NCT01276639|465031508|FG000|Week 16 to 52|Lack of Efficacy|99|||
129200755|NCT01276639|465031509|FG001|Week 16 to 52|Lack of Efficacy|71|||
129200756|NCT01276639|465031510|FG002|Week 16 to 52|Lack of Efficacy|0|||
129200757|NCT01276639|465031511|FG003|Week 16 to 52|Lack of Efficacy|14|||
129200758|NCT01276639|465031512|FG004|Week 16 to 52|Lack of Efficacy|13|||
129200759|NCT01276639|465031508|FG000|Week 16 to 52|Lost to Follow-up|3|||
129200760|NCT01276639|465031509|FG001|Week 16 to 52|Lost to Follow-up|1|||
129200761|NCT01276639|465031510|FG002|Week 16 to 52|Lost to Follow-up|0|||
129200762|NCT01276639|465031511|FG003|Week 16 to 52|Lost to Follow-up|0|||
129200763|NCT01276639|465031512|FG004|Week 16 to 52|Lost to Follow-up|1|||
129200764|NCT01276639|465031508|FG000|Week 16 to 52|Withdrawal by Subject|4|||
129200765|NCT01276639|465031509|FG001|Week 16 to 52|Withdrawal by Subject|4|||
129200766|NCT01276639|465031510|FG002|Week 16 to 52|Withdrawal by Subject|0|||
129200767|NCT01276639|465031511|FG003|Week 16 to 52|Withdrawal by Subject|0|||
129200768|NCT01276639|465031512|FG004|Week 16 to 52|Withdrawal by Subject|1|||
129200769|NCT01276639|465031508|FG000|Week 16 to 52|Other|10|||
129200770|NCT01276639|465031509|FG001|Week 16 to 52|Other|12|||
129200771|NCT01276639|465031510|FG002|Week 16 to 52|Other|0|||
129200772|NCT01276639|465031511|FG003|Week 16 to 52|Other|1|||
129200773|NCT01276639|465031512|FG004|Week 16 to 52|Other|3|||
129200774|NCT00466440|465031517|FG000|Overall Study|Adverse Event|0|||
129200775|NCT00466440|465031518|FG001|Overall Study|Adverse Event|3|||
129200776|NCT00466440|465031519|FG002|Overall Study|Adverse Event|1|||
129200777|NCT00466440|465031517|FG000|Overall Study|Death|1|||
129200778|NCT00466440|465031518|FG001|Overall Study|Death|1|||
129200779|NCT00466440|465031519|FG002|Overall Study|Death|0|||
129200780|NCT00466440|465031517|FG000|Overall Study|Progressive disease|13|||
129200781|NCT00466440|465031518|FG001|Overall Study|Progressive disease|5|||
129200782|NCT00466440|465031519|FG002|Overall Study|Progressive disease|4|||
129200783|NCT00466440|465031517|FG000|Overall Study|Lost to Follow-up|0|||
128781139|NCT00003377|463490454|FG004|Period II|Ureteral stent complications|1|||
128781140|NCT02256969|463490456|FG000|Overall Study|Screenfailed or withdrew|2|||
129200784|NCT00466440|465031518|FG001|Overall Study|Lost to Follow-up|1|||
129200785|NCT00466440|465031519|FG002|Overall Study|Lost to Follow-up|0|||
129200786|NCT00466440|465031517|FG000|Overall Study|Physician Decision|0|||
129200787|NCT00466440|465031518|FG001|Overall Study|Physician Decision|1|||
128732081|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732082|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732083|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732084|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732085|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732086|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
128732087|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732088|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129200788|NCT00466440|465031519|FG002|Overall Study|Physician Decision|2|||
129200789|NCT00466440|465031517|FG000|Overall Study|Protocol entry criteria not met|0|||
129200790|NCT00466440|465031518|FG001|Overall Study|Protocol entry criteria not met|0|||
129200791|NCT00466440|465031519|FG002|Overall Study|Protocol entry criteria not met|4|||
129200792|NCT00466440|465031517|FG000|Overall Study|Withdrawal by Subject|0|||
129200793|NCT00466440|465031518|FG001|Overall Study|Withdrawal by Subject|1|||
129200794|NCT00466440|465031519|FG002|Overall Study|Withdrawal by Subject|0|||
129200795|NCT00466440|465031517|FG000|Overall Study|Sponsor decision|0|||
129200796|NCT00466440|465031518|FG001|Overall Study|Sponsor decision|0|||
129200797|NCT00466440|465031519|FG002|Overall Study|Sponsor decision|1|||
129200798|NCT00965081|465031520|FG000|Overall Study|Adverse Event|14|||
129200799|NCT00965081|465031521|FG001|Overall Study|Adverse Event|9|||
129200800|NCT00965081|465031520|FG000|Overall Study|Lack of Efficacy|2|||
129200801|NCT00965081|465031521|FG001|Overall Study|Lack of Efficacy|5|||
129200802|NCT00965081|465031520|FG000|Overall Study|Lost to Follow-up|4|||
129200803|NCT00965081|465031521|FG001|Overall Study|Lost to Follow-up|5|||
129200804|NCT00965081|465031520|FG000|Overall Study|Physician Decision|2|||
129200805|NCT00965081|465031521|FG001|Overall Study|Physician Decision|0|||
129200806|NCT00965081|465031520|FG000|Overall Study|Protocol Violation|2|||
129200807|NCT00965081|465031521|FG001|Overall Study|Protocol Violation|5|||
129200808|NCT00965081|465031520|FG000|Overall Study|Sponsor Decision|1|||
129200809|NCT00965081|465031521|FG001|Overall Study|Sponsor Decision|0|||
129200810|NCT00965081|465031520|FG000|Overall Study|Withdrawal by Subject|4|||
129200811|NCT00965081|465031521|FG001|Overall Study|Withdrawal by Subject|7|||
129200812|NCT00965081|465031520|FG000|Overall Study|Switched to Rescue Arm|5|||
129200813|NCT00965081|465031521|FG001|Overall Study|Switched to Rescue Arm|12|||
129200814|NCT00796666|465031524|FG000|Overall Study|Death|2|||
129200815|NCT00796666|465031525|FG001|Overall Study|Death|4|||
129200816|NCT00796666|465031524|FG000|Overall Study|Withdrawal by Subject|2|||
129200817|NCT00796666|465031525|FG001|Overall Study|Withdrawal by Subject|0|||
129200818|NCT00796666|465031524|FG000|Overall Study|Adverse Event|7|||
129200819|NCT00796666|465031525|FG001|Overall Study|Adverse Event|5|||
129200820|NCT00796666|465031524|FG000|Overall Study|Protocol Violation|1|||
129200821|NCT00796666|465031525|FG001|Overall Study|Protocol Violation|0|||
129200822|NCT00796666|465031524|FG000|Overall Study|Other|1|||
129200823|NCT00796666|465031525|FG001|Overall Study|Other|0|||
129200824|NCT00796666|465031524|FG000|Overall Study|Terminated by sponsor|53|||
129200825|NCT00796666|465031525|FG001|Overall Study|Terminated by sponsor|55|||
129200826|NCT00796666|465031524|FG000|Overall Study|Randomized and not treated|1|||
129200827|NCT00796666|465031525|FG001|Overall Study|Randomized and not treated|0|||
129200828|NCT00256724|465031528|FG000|Overall Study|Physician Decision|2|||
129200829|NCT00256724|465031529|FG001|Overall Study|Physician Decision|5|||
129200830|NCT00256724|465031528|FG000|Overall Study|Protocol Violation|3|||
129200831|NCT00256724|465031529|FG001|Overall Study|Protocol Violation|3|||
129200832|NCT01217463|465031530|FG000|Overall Study|Adverse Event|8|||
129200833|NCT01217463|465031531|FG001|Overall Study|Adverse Event|5|||
129200834|NCT01217463|465031530|FG000|Overall Study|Physician Decision|0|||
129200835|NCT01217463|465031531|FG001|Overall Study|Physician Decision|1|||
129200836|NCT01217463|465031530|FG000|Overall Study|Withdrawal by Subject|3|||
129200837|NCT01217463|465031531|FG001|Overall Study|Withdrawal by Subject|0|||
129200838|NCT01217463|465031530|FG000|Overall Study|Surgery on the Target Limb|0|||
129200839|NCT01217463|465031531|FG001|Overall Study|Surgery on the Target Limb|1|||
129200840|NCT01217463|465031530|FG000|Overall Study|Patient Non-compliant|1|||
129200841|NCT01217463|465031531|FG001|Overall Study|Patient Non-compliant|0|||
129200842|NCT01217463|465031530|FG000|Overall Study|Other|1|||
129200843|NCT01217463|465031531|FG001|Overall Study|Other|1|||
129200844|NCT01012258|465031532|FG000|Overall Study|Death|14|||
129200845|NCT01012258|465031532|FG000|Overall Study|Lost to Follow-up|1|||
129200846|NCT01012258|465031532|FG000|Overall Study|Adverse Event|1|||
129200847|NCT01012258|465031532|FG000|Overall Study|Progressive Disease (PD)|18|||
129200848|NCT01012258|465031532|FG000|Overall Study|Symptomatic Deterioration|1|||
129200849|NCT01012258|465031532|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
128732089|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129200850|NCT01012258|465031532|FG000|Overall Study|Another Tumor Discovered|1|||
129200851|NCT01012258|465031532|FG000|Overall Study|Ongoing|29|||
129200852|NCT03600740|465031533|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
129200853|NCT03571204|465031534|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
129200854|NCT03571204|465031535|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
128732090|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732091|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732092|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732093|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732094|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732095|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
128732096|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732097|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732098|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732099|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732100|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732101|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
128732102|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
128781141|NCT02256969|463490457|FG001|Overall Study|Screenfailed or withdrew|1|||
129200855|NCT03571204|465031536|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
129200856|NCT03571204|465031534|FG000|Overall Study|Physician Decision|0|||
129200857|NCT03571204|465031535|FG001|Overall Study|Physician Decision|1|||
129200858|NCT03571204|465031536|FG002|Overall Study|Physician Decision|0|||
129200859|NCT02396212|465031537|FG000|Overall Study|Adverse Event|1|||
129200860|NCT02396212|465031537|FG000|Overall Study|Lack of Efficacy|2|||
129200861|NCT01623115|465031538|FG000|Overall Study|Randomized but not treated|0|||
129200862|NCT01623115|465031539|FG001|Overall Study|Randomized but not treated|1|||
129200863|NCT01623115|465031538|FG000|Overall Study|Physician Decision|1|||
129200864|NCT01623115|465031539|FG001|Overall Study|Physician Decision|0|||
129200865|NCT01623115|465031538|FG000|Overall Study|Participants moved|1|||
129200866|NCT01623115|465031539|FG001|Overall Study|Participants moved|5|||
129200867|NCT01623115|465031538|FG000|Overall Study|Adverse Event|10|||
129200868|NCT01623115|465031539|FG001|Overall Study|Adverse Event|13|||
129200869|NCT01623115|465031538|FG000|Overall Study|Poor compliance to protocol|4|||
129200870|NCT01623115|465031539|FG001|Overall Study|Poor compliance to protocol|10|||
129200871|NCT01623115|465031538|FG000|Overall Study|Consent withdrawn by participant|2|||
129200872|NCT01623115|465031539|FG001|Overall Study|Consent withdrawn by participant|6|||
129200873|NCT01623115|465031538|FG000|Overall Study|Related to study drug administration|0|||
129200874|NCT01623115|465031539|FG001|Overall Study|Related to study drug administration|2|||
129200875|NCT01623115|465031538|FG000|Overall Study|Last visit outside protocol visit window|14|||
129200876|NCT01623115|465031539|FG001|Overall Study|Last visit outside protocol visit window|26|||
129200877|NCT01623115|465031538|FG000|Overall Study|Site closure|1|||
129200878|NCT01623115|465031539|FG001|Overall Study|Site closure|7|||
129200879|NCT01623115|465031538|FG000|Overall Study|Death|0|||
129200880|NCT01623115|465031539|FG001|Overall Study|Death|4|||
129200881|NCT01623115|465031538|FG000|Overall Study|Other than specified above|0|||
129200882|NCT01623115|465031539|FG001|Overall Study|Other than specified above|3|||
129200883|NCT01454596|465031542|FG000|Overall Study|Death|0|||
129200884|NCT01454596|465031543|FG001|Overall Study|Death|0|||
129200885|NCT01454596|465031544|FG002|Overall Study|Death|0|||
129200886|NCT01454596|465031545|FG003|Overall Study|Death|0|||
129200887|NCT01454596|465031546|FG004|Overall Study|Death|0|||
129200888|NCT01454596|465031547|FG005|Overall Study|Death|0|||
129200889|NCT01454596|465031548|FG006|Overall Study|Death|0|||
129200890|NCT01454596|465031549|FG007|Overall Study|Death|0|||
129200891|NCT01454596|465031550|FG008|Overall Study|Death|0|||
129200892|NCT01454596|465031551|FG009|Overall Study|Death|1|||
129200893|NCT01454596|465031552|FG010|Overall Study|Death|1|||
129200894|NCT01454596|465031553|FG011|Overall Study|Death|0|||
129200895|NCT02721875|465031555|FG000|Overall Study|Progressive disease/relapse|1|||
129200896|NCT02721875|465031556|FG001|Overall Study|Progressive disease/relapse|0|||
129200897|NCT00857285|465031557|FG000|Overall Study|Adverse Event|4|||
129200898|NCT00857285|465031558|FG001|Overall Study|Adverse Event|2|||
129200899|NCT00857285|465031557|FG000|Overall Study|Lack of Efficacy|0|||
129200900|NCT00857285|465031558|FG001|Overall Study|Lack of Efficacy|2|||
129200901|NCT00857285|465031557|FG000|Overall Study|Protocol Violation|3|||
129200902|NCT00857285|465031558|FG001|Overall Study|Protocol Violation|1|||
129200903|NCT00857285|465031557|FG000|Overall Study|Withdrawal by Subject|4|||
129200904|NCT00857285|465031558|FG001|Overall Study|Withdrawal by Subject|0|||
129200905|NCT00857285|465031557|FG000|Overall Study|Randomization criteria not met|1|||
129200906|NCT00857285|465031558|FG001|Overall Study|Randomization criteria not met|1|||
129200907|NCT00430716|465031561|FG000|Double Blind Phase|Death|1|||
129200908|NCT00430716|465031562|FG001|Double Blind Phase|Death|0|||
129200909|NCT00430716|465031563|FG002|Double Blind Phase|Death|0|||
129200910|NCT00430716|465031561|FG000|Double Blind Phase|No longer willing to participate|2|||
129200911|NCT00430716|465031562|FG001|Double Blind Phase|No longer willing to participate|1|||
129200912|NCT00430716|465031563|FG002|Double Blind Phase|No longer willing to participate|1|||
129200913|NCT00430716|465031561|FG000|Double Blind Phase|Other|0|||
129200914|NCT00430716|465031562|FG001|Double Blind Phase|Other|2|||
129200915|NCT00430716|465031563|FG002|Double Blind Phase|Other|0|||
129200916|NCT00430716|465031561|FG000|Double Blind Phase|Study terminated by sponsor|1|||
128732103|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
128732104|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
128732105|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732106|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129200917|NCT00430716|465031562|FG001|Double Blind Phase|Study terminated by sponsor|1|||
129200918|NCT00430716|465031563|FG002|Double Blind Phase|Study terminated by sponsor|2|||
129200919|NCT00430716|465031561|FG000|Double Blind Phase|Adverse Event|1|||
129200920|NCT00430716|465031562|FG001|Double Blind Phase|Adverse Event|1|||
129200921|NCT00430716|465031563|FG002|Double Blind Phase|Adverse Event|3|||
129200922|NCT00430716|465031561|FG000|Double Blind Phase|Not treated|1|||
129200923|NCT00430716|465031562|FG001|Double Blind Phase|Not treated|0|||
129200924|NCT00430716|465031563|FG002|Double Blind Phase|Not treated|0|||
129200925|NCT00430716|465031561|FG000|Open Label Phase|Lost to Follow-up|1|||
129200926|NCT00430716|465031562|FG001|Open Label Phase|Lost to Follow-up|0|||
129200927|NCT00430716|465031563|FG002|Open Label Phase|Lost to Follow-up|1|||
129200928|NCT00430716|465031561|FG000|Open Label Phase|No longer willing to participate|0|||
129200929|NCT00430716|465031562|FG001|Open Label Phase|No longer willing to participate|1|||
129200930|NCT00430716|465031563|FG002|Open Label Phase|No longer willing to participate|1|||
129200931|NCT00430716|465031561|FG000|Open Label Phase|Other|3|||
129200932|NCT00430716|465031562|FG001|Open Label Phase|Other|1|||
129200933|NCT00430716|465031563|FG002|Open Label Phase|Other|1|||
129200934|NCT00430716|465031561|FG000|Open Label Phase|Protocol Violation|1|||
129200935|NCT00430716|465031562|FG001|Open Label Phase|Protocol Violation|0|||
129200936|NCT00430716|465031563|FG002|Open Label Phase|Protocol Violation|0|||
129200937|NCT00430716|465031561|FG000|Open Label Phase|Study terminated by sponsor|4|||
129200938|NCT00430716|465031562|FG001|Open Label Phase|Study terminated by sponsor|5|||
129200939|NCT00430716|465031563|FG002|Open Label Phase|Study terminated by sponsor|4|||
129200940|NCT01329978|465031567|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
129200941|NCT01329978|465031568|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
129200942|NCT01329978|465031569|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
129200943|NCT01329978|465031570|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
129200944|NCT01329978|465031571|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
129200945|NCT01329978|465031567|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
129200946|NCT01329978|465031568|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
129200947|NCT01329978|465031569|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
129200948|NCT01329978|465031570|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
129200949|NCT01329978|465031571|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
129200950|NCT01329978|465031567|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
129200951|NCT01329978|465031568|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
129200952|NCT01329978|465031569|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
129200953|NCT01329978|465031570|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
129200954|NCT01329978|465031571|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
129200955|NCT01329978|465031567|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129200956|NCT01329978|465031568|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
129200957|NCT01329978|465031569|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129200958|NCT01329978|465031570|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129200959|NCT01329978|465031571|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129200960|NCT01329978|465031567|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129200961|NCT01329978|465031568|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
129200962|NCT01329978|465031569|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129200963|NCT01329978|465031570|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129200964|NCT01329978|465031571|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129200965|NCT01329978|465031567|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
129200966|NCT01329978|465031568|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
129200967|NCT01329978|465031569|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
129200968|NCT01329978|465031570|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
129200969|NCT01329978|465031571|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
129200970|NCT01329978|465031567|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129200971|NCT01329978|465031568|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129200972|NCT01329978|465031569|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129200973|NCT01329978|465031570|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129200974|NCT01329978|465031571|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
129200975|NCT01987102|465031576|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
129200976|NCT01987102|465031577|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
129200977|NCT01987102|465031576|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
129200978|NCT01987102|465031577|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
128732107|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
128732108|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732109|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
128732110|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
128732111|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
128732112|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
128732113|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732114|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732115|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732116|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732117|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732118|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732119|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
128732120|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732121|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732122|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732123|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732124|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732125|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732126|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732127|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732128|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732129|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732130|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732131|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732132|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732133|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
128732134|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
128732135|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
128732136|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
128732137|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732138|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732139|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732140|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732141|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732142|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129200979|NCT01987102|465031576|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
129200980|NCT01987102|465031577|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
129200981|NCT01987102|465031576|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
129200982|NCT01987102|465031577|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
129200983|NCT01987102|465031576|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
129200984|NCT01987102|465031577|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
129200985|NCT01987102|465031576|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
129200986|NCT01987102|465031577|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
129200987|NCT01236521|465031580|FG000|Overall Study|Withdrawal by Subject|12|||
129200988|NCT01236521|465031581|FG001|Overall Study|Withdrawal by Subject|17|||
129200989|NCT01236521|465031580|FG000|Overall Study|Death|2|||
129200990|NCT01236521|465031581|FG001|Overall Study|Death|1|||
129200991|NCT01236521|465031580|FG000|Overall Study|Lost to Follow-up|9|||
129200992|NCT01236521|465031581|FG001|Overall Study|Lost to Follow-up|7|||
129200993|NCT03116685|465031586|FG000|Overall Study|Physician Decision|0|||
129200994|NCT03116685|465031587|FG001|Overall Study|Physician Decision|1|||
129200995|NCT01045694|465031595|FG000|Overall Study|Withdrawal by Subject|2|||
129200996|NCT00549445|465031598|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
129200997|NCT00549445|465031599|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
129200998|NCT01943591|465031600|FG000|Overall Study|Lost to Follow-up|3|||
129200999|NCT01943591|465031601|FG001|Overall Study|Lost to Follow-up|4|||
129201000|NCT01943591|465031600|FG000|Overall Study|Death|2|||
129201001|NCT01943591|465031601|FG001|Overall Study|Death|7|||
129201002|NCT03790111|465032787|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
129201003|NCT02796677|465032794|FG000|Overall Study|Adverse Event|11|||
129201004|NCT02796677|465032795|FG001|Overall Study|Adverse Event|22|||
129201005|NCT02796677|465032796|FG002|Overall Study|Adverse Event|14|||
129201006|NCT02796677|465032797|FG003|Overall Study|Adverse Event|14|||
129201007|NCT02796677|465032794|FG000|Overall Study|Protocol Violation|7|||
129201008|NCT02796677|465032795|FG001|Overall Study|Protocol Violation|5|||
129201009|NCT02796677|465032796|FG002|Overall Study|Protocol Violation|4|||
129201010|NCT02796677|465032797|FG003|Overall Study|Protocol Violation|8|||
129201011|NCT02796677|465032794|FG000|Overall Study|Lost to Follow-up|1|||
129201012|NCT02796677|465032795|FG001|Overall Study|Lost to Follow-up|5|||
129201013|NCT02796677|465032796|FG002|Overall Study|Lost to Follow-up|2|||
129201014|NCT02796677|465032797|FG003|Overall Study|Lost to Follow-up|2|||
129201015|NCT02796677|465032794|FG000|Overall Study|Lack of Efficacy|7|||
129201016|NCT02796677|465032795|FG001|Overall Study|Lack of Efficacy|9|||
129201017|NCT02796677|465032796|FG002|Overall Study|Lack of Efficacy|14|||
129201018|NCT02796677|465032797|FG003|Overall Study|Lack of Efficacy|20|||
129201019|NCT02796677|465032794|FG000|Overall Study|Withdrawal by Subject|4|||
129201020|NCT02796677|465032795|FG001|Overall Study|Withdrawal by Subject|14|||
129201021|NCT02796677|465032796|FG002|Overall Study|Withdrawal by Subject|6|||
129201022|NCT02796677|465032797|FG003|Overall Study|Withdrawal by Subject|7|||
129201023|NCT02796677|465032794|FG000|Overall Study|Progressive disease|6|||
129201024|NCT02796677|465032795|FG001|Overall Study|Progressive disease|15|||
129201025|NCT02796677|465032796|FG002|Overall Study|Progressive disease|13|||
129201026|NCT02796677|465032797|FG003|Overall Study|Progressive disease|18|||
129201027|NCT02796677|465032794|FG000|Overall Study|Reason not mentioned|2|||
129201028|NCT02796677|465032795|FG001|Overall Study|Reason not mentioned|3|||
129201029|NCT02796677|465032796|FG002|Overall Study|Reason not mentioned|0|||
129201030|NCT02796677|465032797|FG003|Overall Study|Reason not mentioned|5|||
129201031|NCT03811340|465032800|FG000|Overall Study|subjects did not complete the survey.|90|||
129201032|NCT01045967|465032801|FG000|Second Intervention|Protocol Violation|0|||
129201033|NCT01045967|465032802|FG001|Second Intervention|Protocol Violation|1|||
129201034|NCT01777308|465032803|FG000|Overall Study|Withdrawal by Subject|5|||
129201035|NCT01777308|465032804|FG001|Overall Study|Withdrawal by Subject|1|||
129201036|NCT01777308|465032803|FG000|Overall Study|Migrated/moved from study area|1|||
129201037|NCT01777308|465032804|FG001|Overall Study|Migrated/moved from study area|0|||
129201038|NCT01777308|465032803|FG000|Overall Study|Lost to Follow-up|7|||
129201039|NCT01777308|465032804|FG001|Overall Study|Lost to Follow-up|2|||
129201040|NCT01777308|465032803|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
129201041|NCT01777308|465032804|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
129201042|NCT03212326|465032805|FG000|Overall Study|Physician Decision|4|||
129201043|NCT02219464|465032807|FG000|Overall Study|Withdrawal by Subject|1|||
129201044|NCT02219464|465032808|FG001|Overall Study|Withdrawal by Subject|0|||
129201045|NCT02219464|465032807|FG000|Overall Study|case cancelled|1|||
129201046|NCT02219464|465032808|FG001|Overall Study|case cancelled|0|||
129201047|NCT02219464|465032807|FG000|Overall Study|catheter malfunction|1|||
129201048|NCT02219464|465032808|FG001|Overall Study|catheter malfunction|0|||
129201049|NCT00280917|465032809|FG000|Overall Study|Adverse Event|1|||
129201050|NCT00280917|465032810|FG001|Overall Study|Adverse Event|1|||
129201051|NCT00280917|465032811|FG002|Overall Study|Adverse Event|4|||
129201052|NCT00280917|465032812|FG003|Overall Study|Adverse Event|1|||
129201053|NCT00280917|465032809|FG000|Overall Study|Change Therapy|1|||
129201054|NCT00280917|465032810|FG001|Overall Study|Change Therapy|2|||
129201055|NCT00280917|465032811|FG002|Overall Study|Change Therapy|0|||
129201056|NCT00280917|465032812|FG003|Overall Study|Change Therapy|0|||
129201057|NCT00280917|465032809|FG000|Overall Study|Withdrawal by Subject|0|||
129201058|NCT00280917|465032810|FG001|Overall Study|Withdrawal by Subject|2|||
129201059|NCT00280917|465032811|FG002|Overall Study|Withdrawal by Subject|0|||
129201060|NCT00280917|465032812|FG003|Overall Study|Withdrawal by Subject|1|||
129201061|NCT00280917|465032809|FG000|Overall Study|Noncompliance|0|||
129201062|NCT00280917|465032810|FG001|Overall Study|Noncompliance|1|||
129201063|NCT00280917|465032811|FG002|Overall Study|Noncompliance|2|||
129201064|NCT00280917|465032812|FG003|Overall Study|Noncompliance|0|||
129201065|NCT01544920|465032825|FG000|Overall Study|Adverse Event|0|||
129201066|NCT01544920|465032826|FG001|Overall Study|Adverse Event|3|||
129201067|NCT01544920|465032825|FG000|Overall Study|Death|0|||
129201068|NCT01544920|465032826|FG001|Overall Study|Death|1|||
129201069|NCT01544920|465032825|FG000|Overall Study|Lost to Follow-up|11|||
129201070|NCT01544920|465032826|FG001|Overall Study|Lost to Follow-up|12|||
129201071|NCT01544920|465032825|FG000|Overall Study|Protocol Violation|0|||
129201072|NCT01544920|465032826|FG001|Overall Study|Protocol Violation|2|||
129201073|NCT01544920|465032825|FG000|Overall Study|Physician Decision|4|||
129201074|NCT01544920|465032826|FG001|Overall Study|Physician Decision|1|||
129201075|NCT01544920|465032825|FG000|Overall Study|Withdrawal by Subject|4|||
129201076|NCT01544920|465032826|FG001|Overall Study|Withdrawal by Subject|4|||
129201077|NCT00474955|465032829|FG000|Overall Study|Adverse Event|2|||
129201078|NCT00474955|465032829|FG000|Overall Study|Drug unavailability|1|||
129201079|NCT00474955|465032829|FG000|Overall Study|Personal reasons|5|||
129201080|NCT01135134|465032830|FG000|Overall Study|Adverse Event|1|||
129201081|NCT01135134|465032831|FG001|Overall Study|Adverse Event|1|||
129201082|NCT01135134|465032830|FG000|Overall Study|Did not meet protocol eligibility|1|||
129201083|NCT01135134|465032831|FG001|Overall Study|Did not meet protocol eligibility|0|||
129201084|NCT02576639|465032832|FG000|Overall Study|Withdrawal by Subject|1|||
129201085|NCT02576639|465032833|FG001|Overall Study|Withdrawal by Subject|2|||
129201086|NCT02576639|465032834|FG002|Overall Study|Withdrawal by Subject|1|||
129201087|NCT02576639|465032835|FG003|Overall Study|Withdrawal by Subject|0|||
129201088|NCT02576639|465032836|FG004|Overall Study|Withdrawal by Subject|1|||
129201089|NCT02576639|465032832|FG000|Overall Study|Adverse Event|1|||
129201090|NCT02576639|465032833|FG001|Overall Study|Adverse Event|0|||
129201091|NCT02576639|465032834|FG002|Overall Study|Adverse Event|1|||
129201092|NCT02576639|465032835|FG003|Overall Study|Adverse Event|1|||
129201093|NCT02576639|465032836|FG004|Overall Study|Adverse Event|2|||
129201094|NCT02576639|465032832|FG000|Overall Study|Physician Decision|0|||
129201095|NCT02576639|465032833|FG001|Overall Study|Physician Decision|0|||
129201096|NCT02576639|465032834|FG002|Overall Study|Physician Decision|0|||
129201097|NCT02576639|465032835|FG003|Overall Study|Physician Decision|0|||
129201098|NCT02576639|465032836|FG004|Overall Study|Physician Decision|1|||
129201099|NCT00255190|465032837|FG000|Overall Study|Adverse Event|17|||
129201100|NCT00255190|465032838|FG001|Overall Study|Adverse Event|36|||
129201101|NCT00255190|465032837|FG000|Overall Study|Protocol Violation|2|||
129201102|NCT00255190|465032838|FG001|Overall Study|Protocol Violation|2|||
129201103|NCT00255190|465032837|FG000|Overall Study|Lost to Follow-up|10|||
129201104|NCT00255190|465032838|FG001|Overall Study|Lost to Follow-up|27|||
129201105|NCT00255190|465032837|FG000|Overall Study|Withdrew Consent|17|||
129201106|NCT00255190|465032838|FG001|Overall Study|Withdrew Consent|48|||
129201107|NCT00255190|465032837|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
129201108|NCT00255190|465032838|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
129201109|NCT00255190|465032837|FG000|Overall Study|Erosive esophagitis not healed|0|||
129201110|NCT00255190|465032838|FG001|Overall Study|Erosive esophagitis not healed|20|||
129201111|NCT00255190|465032837|FG000|Overall Study|Various|4|||
129201112|NCT00255190|465032838|FG001|Overall Study|Various|23|||
129201113|NCT01569841|465032841|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
129201114|NCT01569841|465032842|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
129201115|NCT00057863|465032846|FG000|Overall Study|Death|1|||
129201116|NCT00057863|465032846|FG000|Overall Study|Withdrawal by Subject|2|||
129201117|NCT02090426|465032847|FG000|Overall Study|Lost to Follow-up|12|||
129201118|NCT02090426|465032848|FG001|Overall Study|Lost to Follow-up|6|||
129201119|NCT02079038|465032849|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
129201120|NCT02079038|465032850|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
129201121|NCT02079038|465032849|FG000|Modified Intent to Treat Population|Death|1|||
129201122|NCT02079038|465032850|FG001|Modified Intent to Treat Population|Death|0|||
129201123|NCT02079038|465032849|FG000|Completed 6 Months|Lost to Follow-up|2|||
129201124|NCT02079038|465032850|FG001|Completed 6 Months|Lost to Follow-up|1|||
129201125|NCT01141712|465032851|FG000|Overall Study|Disease progression|3|||
129201126|NCT01308736|465032852|FG000|Overall Study|Did not attend a single session|6|||
129201127|NCT01308736|465032853|FG001|Overall Study|Did not attend a single session|5|||
129201128|NCT00985465|465032859|FG000|Overall Study|Withdrawal by Subject|1|||
129201129|NCT00985465|465032860|FG001|Overall Study|Withdrawal by Subject|2|||
129201130|NCT00985465|465032859|FG000|Overall Study|Considered to be part of the other group|0|||
129201131|NCT00985465|465032860|FG001|Overall Study|Considered to be part of the other group|1|||
129201132|NCT04701333|465032861|FG000|Overall Study|Lost to Follow-up|3|||
129201133|NCT04701333|465032862|FG001|Overall Study|Lost to Follow-up|7|||
129201134|NCT04701333|465032861|FG000|Overall Study|Withdrawal by Subject|0|||
129201135|NCT04701333|465032862|FG001|Overall Study|Withdrawal by Subject|1|||
129201136|NCT01292187|465032863|FG000|Overall Study|Adverse Event|10|||
129201137|NCT01292187|465032864|FG001|Overall Study|Adverse Event|5|||
129201138|NCT01292187|465032863|FG000|Overall Study|Withdrawal by Subject|6|||
129201139|NCT01292187|465032864|FG001|Overall Study|Withdrawal by Subject|5|||
129201140|NCT01292187|465032863|FG000|Overall Study|All other reasons|1|||
129201141|NCT01292187|465032864|FG001|Overall Study|All other reasons|3|||
129201142|NCT02888106|465032872|FG000|Overall Study|Withdrawal by Subject|1|||
129201143|NCT02888106|465032873|FG001|Overall Study|Withdrawal by Subject|2|||
129201144|NCT02888106|465032874|FG002|Overall Study|Withdrawal by Subject|0|||
129201145|NCT02888106|465032875|FG003|Overall Study|Withdrawal by Subject|1|||
129201146|NCT02888106|465032876|FG004|Overall Study|Withdrawal by Subject|0|||
129201147|NCT02888106|465032877|FG005|Overall Study|Withdrawal by Subject|0|||
129201148|NCT02888106|465032872|FG000|Overall Study|Lost to Follow-up|1|||
129201149|NCT02888106|465032873|FG001|Overall Study|Lost to Follow-up|0|||
129201150|NCT02888106|465032874|FG002|Overall Study|Lost to Follow-up|0|||
129201151|NCT02888106|465032875|FG003|Overall Study|Lost to Follow-up|1|||
129201152|NCT02888106|465032876|FG004|Overall Study|Lost to Follow-up|0|||
129201153|NCT02888106|465032877|FG005|Overall Study|Lost to Follow-up|1|||
129201154|NCT02888106|465032872|FG000|Overall Study|Adverse Event|2|||
129201155|NCT02888106|465032873|FG001|Overall Study|Adverse Event|0|||
129201156|NCT02888106|465032874|FG002|Overall Study|Adverse Event|0|||
129201157|NCT02888106|465032875|FG003|Overall Study|Adverse Event|0|||
129201158|NCT02888106|465032876|FG004|Overall Study|Adverse Event|0|||
129201159|NCT02888106|465032877|FG005|Overall Study|Adverse Event|0|||
129201160|NCT02888106|465032872|FG000|Overall Study|Withdrawal of consent|0|||
129201161|NCT02888106|465032873|FG001|Overall Study|Withdrawal of consent|0|||
129201162|NCT02888106|465032874|FG002|Overall Study|Withdrawal of consent|0|||
129201163|NCT02888106|465032875|FG003|Overall Study|Withdrawal of consent|0|||
129201164|NCT02888106|465032876|FG004|Overall Study|Withdrawal of consent|1|||
129201165|NCT02888106|465032877|FG005|Overall Study|Withdrawal of consent|0|||
129201166|NCT02888106|465032872|FG000|Overall Study|Pregnancy|1|||
129201167|NCT02888106|465032873|FG001|Overall Study|Pregnancy|0|||
129201168|NCT02888106|465032874|FG002|Overall Study|Pregnancy|0|||
129201169|NCT02888106|465032875|FG003|Overall Study|Pregnancy|0|||
129201170|NCT02888106|465032876|FG004|Overall Study|Pregnancy|0|||
129201171|NCT02888106|465032877|FG005|Overall Study|Pregnancy|0|||
129201172|NCT01188772|465032880|FG000|Overall Study|Randomized but Not Treated|0|||
129201173|NCT01188772|465032881|FG001|Overall Study|Randomized but Not Treated|1|||
129201174|NCT01188772|465032882|FG002|Overall Study|Randomized but Not Treated|0|||
129201175|NCT01188772|465032883|FG003|Overall Study|Randomized but Not Treated|0|||
129201176|NCT01188772|465032880|FG000|Overall Study|Adverse Event|0|||
129201177|NCT01188772|465032881|FG001|Overall Study|Adverse Event|1|||
129201178|NCT01188772|465032882|FG002|Overall Study|Adverse Event|2|||
129201179|NCT01188772|465032883|FG003|Overall Study|Adverse Event|0|||
129201180|NCT01188772|465032880|FG000|Overall Study|Lost to Follow-up|4|||
129201181|NCT01188772|465032881|FG001|Overall Study|Lost to Follow-up|1|||
129201182|NCT01188772|465032882|FG002|Overall Study|Lost to Follow-up|1|||
129201183|NCT01188772|465032883|FG003|Overall Study|Lost to Follow-up|1|||
129201184|NCT01188772|465032880|FG000|Overall Study|Non-responder|0|||
129201185|NCT01188772|465032881|FG001|Overall Study|Non-responder|0|||
129201186|NCT01188772|465032882|FG002|Overall Study|Non-responder|3|||
129201187|NCT01188772|465032883|FG003|Overall Study|Non-responder|0|||
129201188|NCT01188772|465032880|FG000|Overall Study|Physician Decision|0|||
129201189|NCT01188772|465032881|FG001|Overall Study|Physician Decision|0|||
129201190|NCT01188772|465032882|FG002|Overall Study|Physician Decision|1|||
129201191|NCT01188772|465032883|FG003|Overall Study|Physician Decision|0|||
129201192|NCT01188772|465032880|FG000|Overall Study|Terminated by Sponsor|0|||
129201193|NCT01188772|465032881|FG001|Overall Study|Terminated by Sponsor|0|||
129201194|NCT01188772|465032882|FG002|Overall Study|Terminated by Sponsor|1|||
129201195|NCT01188772|465032883|FG003|Overall Study|Terminated by Sponsor|0|||
129201196|NCT01188772|465032880|FG000|Overall Study|Treatment Failure|0|||
129201197|NCT01188772|465032881|FG001|Overall Study|Treatment Failure|0|||
129201198|NCT01188772|465032882|FG002|Overall Study|Treatment Failure|1|||
129201199|NCT01188772|465032883|FG003|Overall Study|Treatment Failure|0|||
129201200|NCT01188772|465032880|FG000|Overall Study|Virologic Failure|1|||
129201201|NCT01188772|465032881|FG001|Overall Study|Virologic Failure|0|||
129201202|NCT01188772|465032882|FG002|Overall Study|Virologic Failure|0|||
129201203|NCT01188772|465032883|FG003|Overall Study|Virologic Failure|0|||
129201204|NCT01188772|465032880|FG000|Overall Study|Withdrawal by Subject|0|||
129201205|NCT01188772|465032881|FG001|Overall Study|Withdrawal by Subject|0|||
129201206|NCT01188772|465032882|FG002|Overall Study|Withdrawal by Subject|2|||
129201207|NCT01188772|465032883|FG003|Overall Study|Withdrawal by Subject|0|||
129201208|NCT01433172|465032884|FG000|Overall Study|Withdrawal by Subject|0|||
129201209|NCT01433172|465032885|FG001|Overall Study|Withdrawal by Subject|1|||
129201210|NCT01433172|465032886|FG002|Overall Study|Withdrawal by Subject|0|||
129201211|NCT01433172|465032884|FG000|Overall Study|Disease Progression|0|||
129201212|NCT01433172|465032885|FG001|Overall Study|Disease Progression|0|||
129201213|NCT01433172|465032886|FG002|Overall Study|Disease Progression|1|||
129201214|NCT01433172|465032884|FG000|Overall Study|Death|0|||
129201215|NCT01433172|465032885|FG001|Overall Study|Death|2|||
129201216|NCT01433172|465032886|FG002|Overall Study|Death|0|||
129201217|NCT01894607|465032890|FG000|Overall Study|Ineligible|1|||
129201218|NCT04303559|465032891|FG000|Overall Study|Study closed due to poor enrollment.|1|||
129201219|NCT04037891|465032892|FG000|Open-label Period|Withdrawal by Subject|1|||
129201220|NCT04037891|465032893|FG001|Open-label Period|Withdrawal by Subject|0|||
129201221|NCT04037891|465032894|FG002|Open-label Period|Withdrawal by Subject|0|||
129201222|NCT04037891|465032892|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
129201223|NCT04037891|465032893|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
129201224|NCT04037891|465032894|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
129201225|NCT03446313|465032895|FG000|Overall Study|Lost to Follow-up|1|||
129201226|NCT03446313|465032896|FG001|Overall Study|Lost to Follow-up|2|||
129201227|NCT03446313|465032895|FG000|Overall Study|Failed primary screening|3|||
129201228|NCT03446313|465032896|FG001|Overall Study|Failed primary screening|0|||
129201229|NCT03446313|465032895|FG000|Overall Study|Diagnosed with terminal cancer|1|||
129201230|NCT03446313|465032896|FG001|Overall Study|Diagnosed with terminal cancer|0|||
129201231|NCT03446313|465032895|FG000|Overall Study|Excluded from analysis|1|||
129201232|NCT03446313|465032896|FG001|Overall Study|Excluded from analysis|1|||
129201233|NCT04491136|465032897|FG000|Overall Study|Patient withdraw informed consent|9|||
129201234|NCT04491136|465032897|FG000|Overall Study|Adverse Event|2|||
129201235|NCT04491136|465032897|FG000|Overall Study|Death|3|||
129201236|NCT04491136|465032897|FG000|Overall Study|Lost to Follow-up|3|||
129201237|NCT04491136|465032897|FG000|Overall Study|Physician Decision|45|||
129201238|NCT04491136|465032897|FG000|Overall Study|sponsor terminated the study early|16|||
129201239|NCT04491136|465032897|FG000|Overall Study|Patient/guardian's decision|1|||
129201240|NCT01611194|465032898|FG000|Overall Study|Lost to Follow-up|0|||
129201241|NCT01611194|465032899|FG001|Overall Study|Lost to Follow-up|1|||
129201242|NCT01611194|465032898|FG000|Overall Study|Withdrawal by Subject|0|||
129201243|NCT01611194|465032899|FG001|Overall Study|Withdrawal by Subject|1|||
129201244|NCT01611194|465032898|FG000|Overall Study|drug use|0|||
129201245|NCT01611194|465032899|FG001|Overall Study|drug use|1|||
129201246|NCT00348673|465032900|FG000|Stage 1|Randomized but not Treated|0|||
129201247|NCT00348673|465032901|FG001|Stage 1|Randomized but not Treated|0|||
129201248|NCT00348673|465032902|FG002|Stage 1|Randomized but not Treated|1|||
129201249|NCT00348673|465032903|FG003|Stage 1|Randomized but not Treated|0|||
129201250|NCT00348673|465032904|FG004|Stage 1|Randomized but not Treated|0|||
129201251|NCT00348673|465032905|FG005|Stage 1|Randomized but not Treated|0|||
129201252|NCT00348673|465032906|FG006|Stage 1|Randomized but not Treated|0|||
129201253|NCT00348673|465032907|FG007|Stage 1|Randomized but not Treated|0|||
129201254|NCT00348673|465032908|FG008|Stage 1|Randomized but not Treated|0|||
129201255|NCT02719171|465034849|FG000|Overall Study|Adverse Event|1|||
129201256|NCT02719171|465034850|FG001|Overall Study|Adverse Event|2|||
129201257|NCT02719171|465034851|FG002|Overall Study|Adverse Event|0|||
129201258|NCT02719171|465034852|FG003|Overall Study|Adverse Event|0|||
129201259|NCT02719171|465034853|FG004|Overall Study|Adverse Event|2|||
129201260|NCT02719171|465034849|FG000|Overall Study|Lost to Follow-up|0|||
129201261|NCT02719171|465034850|FG001|Overall Study|Lost to Follow-up|0|||
129201262|NCT02719171|465034851|FG002|Overall Study|Lost to Follow-up|1|||
129201263|NCT02719171|465034852|FG003|Overall Study|Lost to Follow-up|0|||
129201264|NCT02719171|465034853|FG004|Overall Study|Lost to Follow-up|0|||
129201265|NCT02719171|465034849|FG000|Overall Study|Subject Withdrawal|0|||
129201266|NCT02719171|465034850|FG001|Overall Study|Subject Withdrawal|2|||
129201267|NCT02719171|465034851|FG002|Overall Study|Subject Withdrawal|2|||
129201268|NCT02719171|465034852|FG003|Overall Study|Subject Withdrawal|1|||
129201269|NCT02719171|465034853|FG004|Overall Study|Subject Withdrawal|0|||
129201270|NCT02719171|465034849|FG000|Overall Study|Other|0|||
129201271|NCT02719171|465034850|FG001|Overall Study|Other|0|||
129201272|NCT02719171|465034851|FG002|Overall Study|Other|0|||
128732143|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
128732144|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732145|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732146|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129201273|NCT02719171|465034852|FG003|Overall Study|Other|1|||
129201274|NCT02719171|465034853|FG004|Overall Study|Other|0|||
129201275|NCT02614729|465034854|FG000|Overall Study|Withdrawal by Subject|1|||
129201276|NCT02614729|465034855|FG001|Overall Study|Withdrawal by Subject|0|||
129201277|NCT03798717|465034858|FG000|Overall Study|Failed Screening|0|||
129201278|NCT03798717|465034859|FG001|Overall Study|Failed Screening|0|||
129201279|NCT03798717|465034860|FG002|Overall Study|Failed Screening|0|||
129201280|NCT03798717|465034861|FG003|Overall Study|Failed Screening|0|||
129201281|NCT03798717|465034862|FG004|Overall Study|Failed Screening|0|||
129201282|NCT03798717|465034863|FG005|Overall Study|Failed Screening|1|||
129201283|NCT03798717|465034858|FG000|Overall Study|Physician Decision|1|||
129201284|NCT03798717|465034859|FG001|Overall Study|Physician Decision|0|||
129201285|NCT03798717|465034860|FG002|Overall Study|Physician Decision|1|||
129201286|NCT03798717|465034861|FG003|Overall Study|Physician Decision|0|||
129201287|NCT03798717|465034862|FG004|Overall Study|Physician Decision|0|||
129201288|NCT03798717|465034863|FG005|Overall Study|Physician Decision|0|||
129201289|NCT03798717|465034858|FG000|Overall Study|Withdrawal by Subject|0|||
129201290|NCT03798717|465034859|FG001|Overall Study|Withdrawal by Subject|0|||
129201291|NCT03798717|465034860|FG002|Overall Study|Withdrawal by Subject|0|||
129201292|NCT03798717|465034861|FG003|Overall Study|Withdrawal by Subject|1|||
129201293|NCT03798717|465034862|FG004|Overall Study|Withdrawal by Subject|0|||
129201294|NCT03798717|465034863|FG005|Overall Study|Withdrawal by Subject|0|||
129201295|NCT03798717|465034858|FG000|Overall Study|Lost to Follow-up|1|||
129201296|NCT03798717|465034859|FG001|Overall Study|Lost to Follow-up|0|||
129201297|NCT03798717|465034860|FG002|Overall Study|Lost to Follow-up|0|||
129201298|NCT03798717|465034861|FG003|Overall Study|Lost to Follow-up|1|||
129201299|NCT03798717|465034862|FG004|Overall Study|Lost to Follow-up|0|||
129201300|NCT03798717|465034863|FG005|Overall Study|Lost to Follow-up|0|||
128781142|NCT02256969|463490458|FG002|Overall Study|Screenfailed or withdrew|1|||
129201301|NCT03798717|465034858|FG000|Overall Study|Adverse Event|0|||
129201302|NCT03798717|465034859|FG001|Overall Study|Adverse Event|1|||
129201303|NCT03798717|465034860|FG002|Overall Study|Adverse Event|0|||
129201304|NCT03798717|465034861|FG003|Overall Study|Adverse Event|0|||
129201305|NCT03798717|465034862|FG004|Overall Study|Adverse Event|0|||
129201306|NCT03798717|465034863|FG005|Overall Study|Adverse Event|0|||
129201307|NCT03798717|465034858|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129201308|NCT03798717|465034859|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129201309|NCT03798717|465034860|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129201310|NCT03798717|465034861|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129201311|NCT03798717|465034862|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
129201312|NCT03798717|465034863|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129201313|NCT00985673|465034877|FG000|Overall Study|Lost to Follow-up|6|||
129201314|NCT00985673|465034878|FG001|Overall Study|Lost to Follow-up|7|||
129201315|NCT00985673|465034879|FG002|Overall Study|Lost to Follow-up|6|||
129201316|NCT00985673|465034880|FG003|Overall Study|Lost to Follow-up|10|||
129201317|NCT00985673|465034881|FG004|Overall Study|Lost to Follow-up|5|||
129201318|NCT00985673|465034882|FG005|Overall Study|Lost to Follow-up|3|||
129201319|NCT00985673|465034877|FG000|Overall Study|Withdrawal by Subject|0|||
129201320|NCT00985673|465034878|FG001|Overall Study|Withdrawal by Subject|4|||
129201321|NCT00985673|465034879|FG002|Overall Study|Withdrawal by Subject|5|||
129201322|NCT00985673|465034880|FG003|Overall Study|Withdrawal by Subject|2|||
129201323|NCT00985673|465034881|FG004|Overall Study|Withdrawal by Subject|2|||
129201324|NCT00985673|465034882|FG005|Overall Study|Withdrawal by Subject|3|||
129201325|NCT00985673|465034877|FG000|Overall Study|Other|1|||
129201326|NCT00985673|465034878|FG001|Overall Study|Other|0|||
129201327|NCT00985673|465034879|FG002|Overall Study|Other|1|||
129201328|NCT00985673|465034880|FG003|Overall Study|Other|0|||
129201329|NCT00985673|465034881|FG004|Overall Study|Other|1|||
129201330|NCT00985673|465034882|FG005|Overall Study|Other|0|||
129201331|NCT02252146|465034883|FG000|Overall Study|Lack of Efficacy|4|||
129201332|NCT02252146|465034883|FG000|Overall Study|Entered hospice care|1|||
129201333|NCT02252146|465034883|FG000|Overall Study|Inability to travel to study site|1|||
129201334|NCT00984256|465034886|FG000|Overall Study|Withdrawal by Subject|0|||
129201335|NCT00984256|465034887|FG001|Overall Study|Withdrawal by Subject|1|||
129201336|NCT03057496|465034888|FG000|Overall Study|Withdrawal by Subject|8|||
129201337|NCT03057496|465034888|FG000|Overall Study|Lost to Follow-up|5|||
129201338|NCT03057496|465034888|FG000|Overall Study|Did not use device during home trial|3|||
129201339|NCT03057496|465034888|FG000|Overall Study|Device failure|2|||
129201340|NCT03347123|465034893|FG000|Overall Study|Death|1|||
129201341|NCT03347123|465034894|FG001|Overall Study|Death|2|||
129201342|NCT03347123|465034895|FG002|Overall Study|Death|0|||
129201343|NCT03347123|465034896|FG003|Overall Study|Death|0|||
129201344|NCT03347123|465034897|FG004|Overall Study|Death|0|||
129201345|NCT03347123|465034898|FG005|Overall Study|Death|0|||
129201346|NCT03347123|465034899|FG006|Overall Study|Death|0|||
129201347|NCT03347123|465034893|FG000|Overall Study|Withdrawal by Subject|1|||
129201348|NCT03347123|465034894|FG001|Overall Study|Withdrawal by Subject|0|||
129201349|NCT03347123|465034895|FG002|Overall Study|Withdrawal by Subject|0|||
129201350|NCT03347123|465034896|FG003|Overall Study|Withdrawal by Subject|0|||
129201351|NCT03347123|465034897|FG004|Overall Study|Withdrawal by Subject|0|||
129201352|NCT03347123|465034898|FG005|Overall Study|Withdrawal by Subject|0|||
129201353|NCT03347123|465034899|FG006|Overall Study|Withdrawal by Subject|0|||
129201354|NCT03347123|465034893|FG000|Overall Study|Reason not Specified|3|||
129201355|NCT03347123|465034894|FG001|Overall Study|Reason not Specified|4|||
129201356|NCT03347123|465034895|FG002|Overall Study|Reason not Specified|0|||
129201357|NCT03347123|465034896|FG003|Overall Study|Reason not Specified|0|||
129201358|NCT03347123|465034897|FG004|Overall Study|Reason not Specified|0|||
129201359|NCT03347123|465034898|FG005|Overall Study|Reason not Specified|0|||
129201360|NCT03347123|465034899|FG006|Overall Study|Reason not Specified|0|||
129201361|NCT01132807|465034902|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
129201362|NCT01132807|465034903|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
129201363|NCT01132807|465034904|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
129201364|NCT01132807|465034902|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
129201365|NCT01132807|465034903|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
129201366|NCT01132807|465034904|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
129201367|NCT01731912|465034907|FG000|Overall Study|noncompliance|2|||
129201368|NCT02222558|465034908|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
129201369|NCT02222558|465034909|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
129201370|NCT02222558|465034910|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
129201371|NCT02222558|465034911|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
129201372|NCT02222558|465034912|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
129201373|NCT02222558|465034913|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
129201374|NCT02222558|465034908|FG000|Period 3|Withdrawal by Subject|0|||
129201375|NCT02222558|465034909|FG001|Period 3|Withdrawal by Subject|0|||
129201376|NCT02222558|465034910|FG002|Period 3|Withdrawal by Subject|0|||
129201377|NCT02222558|465034911|FG003|Period 3|Withdrawal by Subject|0|||
129201378|NCT02222558|465034912|FG004|Period 3|Withdrawal by Subject|0|||
129201379|NCT02222558|465034913|FG005|Period 3|Withdrawal by Subject|1|||
129201380|NCT00936702|465034914|FG000|Overall Study|Disease progression|34|||
129201381|NCT00936702|465034914|FG000|Overall Study|Adverse Event|8|||
129201382|NCT00936702|465034914|FG000|Overall Study|Withdrawal by Subject|2|||
129201383|NCT00936702|465034914|FG000|Overall Study|Alternative Treatment|1|||
129201384|NCT00936702|465034914|FG000|Overall Study|Other|1|||
129201385|NCT02532465|465034915|FG000|Overall Study|Protocol Violation|1|||
129201386|NCT02532465|465034916|FG001|Overall Study|Protocol Violation|0|||
129201387|NCT02532465|465034915|FG000|Overall Study|Lack of Efficacy|0|||
129201388|NCT02532465|465034916|FG001|Overall Study|Lack of Efficacy|1|||
129201389|NCT00354679|465034921|FG000|Overall Study|Patient Not Treated|1|||
129201390|NCT00622505|465034923|FG000|Overall Study|Adverse Event|9|||
129201391|NCT00622505|465034924|FG001|Overall Study|Adverse Event|7|||
129201392|NCT00622505|465034923|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
129201393|NCT00622505|465034924|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
129201394|NCT00622505|465034923|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
129201395|NCT00622505|465034924|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129201396|NCT00622505|465034923|FG000|Overall Study|Withdrawal by Subject|12|||
129201397|NCT00622505|465034924|FG001|Overall Study|Withdrawal by Subject|5|||
129201398|NCT00622505|465034923|FG000|Overall Study|Administrative Problems|2|||
129201399|NCT00622505|465034924|FG001|Overall Study|Administrative Problems|4|||
129201400|NCT00622505|465034923|FG000|Overall Study|Death|2|||
129201401|NCT00622505|465034924|FG001|Overall Study|Death|2|||
129201402|NCT02420093|465034927|FG000|Overall Study|Withdrawal by Subject|1|||
129201403|NCT02420093|465034928|FG001|Overall Study|Withdrawal by Subject|1|||
129201404|NCT03244917|465034931|FG000|Overall Study|Lost to Follow-up|2|||
129201405|NCT03244917|465034932|FG001|Overall Study|Lost to Follow-up|2|||
129201406|NCT02159066|465034935|FG000|Part I|Adverse Event|7|||
129201407|NCT02159066|465034936|FG001|Part I|Adverse Event|5|||
129201408|NCT02159066|465034937|FG002|Part I|Adverse Event|0|||
129201409|NCT02159066|465034938|FG003|Part I|Adverse Event|0|||
129201410|NCT02159066|465034939|FG004|Part I|Adverse Event|0|||
129201411|NCT02159066|465034940|FG005|Part I|Adverse Event|0|||
129201412|NCT02159066|465034935|FG000|Part I|Death|11|||
129201413|NCT02159066|465034936|FG001|Part I|Death|9|||
129201414|NCT02159066|465034937|FG002|Part I|Death|0|||
129201415|NCT02159066|465034938|FG003|Part I|Death|0|||
129201416|NCT02159066|465034939|FG004|Part I|Death|0|||
129201417|NCT02159066|465034940|FG005|Part I|Death|0|||
129201418|NCT02159066|465034935|FG000|Part I|Progressive Disease|37|||
129201419|NCT02159066|465034936|FG001|Part I|Progressive Disease|46|||
129201420|NCT02159066|465034937|FG002|Part I|Progressive Disease|0|||
129201421|NCT02159066|465034938|FG003|Part I|Progressive Disease|0|||
129201422|NCT02159066|465034939|FG004|Part I|Progressive Disease|0|||
129201423|NCT02159066|465034940|FG005|Part I|Progressive Disease|0|||
129201424|NCT02159066|465034935|FG000|Part I|New Therapy for Study Indication|5|||
129201425|NCT02159066|465034936|FG001|Part I|New Therapy for Study Indication|4|||
129201426|NCT02159066|465034937|FG002|Part I|New Therapy for Study Indication|0|||
129201427|NCT02159066|465034938|FG003|Part I|New Therapy for Study Indication|0|||
129201428|NCT02159066|465034939|FG004|Part I|New Therapy for Study Indication|0|||
129201429|NCT02159066|465034940|FG005|Part I|New Therapy for Study Indication|0|||
129201430|NCT02159066|465034935|FG000|Part I|Termination of participants from the study|3|||
129201431|NCT02159066|465034936|FG001|Part I|Termination of participants from the study|3|||
129201432|NCT02159066|465034937|FG002|Part I|Termination of participants from the study|0|||
129201433|NCT02159066|465034938|FG003|Part I|Termination of participants from the study|0|||
129201434|NCT02159066|465034939|FG004|Part I|Termination of participants from the study|0|||
129201435|NCT02159066|465034940|FG005|Part I|Termination of participants from the study|0|||
129201436|NCT02159066|465034935|FG000|Part I|Physician Decision|2|||
129201437|NCT02159066|465034936|FG001|Part I|Physician Decision|9|||
129201438|NCT02159066|465034937|FG002|Part I|Physician Decision|0|||
129201439|NCT02159066|465034938|FG003|Part I|Physician Decision|0|||
129201440|NCT02159066|465034939|FG004|Part I|Physician Decision|0|||
129201441|NCT02159066|465034940|FG005|Part I|Physician Decision|0|||
129201442|NCT02159066|465034935|FG000|Part I|Participant/Guardian Decision|9|||
129201443|NCT02159066|465034936|FG001|Part I|Participant/Guardian Decision|3|||
129201444|NCT02159066|465034937|FG002|Part I|Participant/Guardian Decision|0|||
129201445|NCT02159066|465034938|FG003|Part I|Participant/Guardian Decision|0|||
129201446|NCT02159066|465034939|FG004|Part I|Participant/Guardian Decision|0|||
129201447|NCT02159066|465034940|FG005|Part I|Participant/Guardian Decision|0|||
129201448|NCT02159066|465034935|FG000|Part I|Missing Data|1|||
129201449|NCT02159066|465034936|FG001|Part I|Missing Data|0|||
129201450|NCT02159066|465034937|FG002|Part I|Missing Data|0|||
129201451|NCT02159066|465034938|FG003|Part I|Missing Data|0|||
129201452|NCT02159066|465034939|FG004|Part I|Missing Data|0|||
129201453|NCT02159066|465034940|FG005|Part I|Missing Data|0|||
129201454|NCT02159066|465034935|FG000|Part II|Adverse Event|0|||
129201455|NCT02159066|465034936|FG001|Part II|Adverse Event|0|||
129201456|NCT02159066|465034937|FG002|Part II|Adverse Event|1|||
129201457|NCT02159066|465034938|FG003|Part II|Adverse Event|0|||
129201458|NCT02159066|465034939|FG004|Part II|Adverse Event|1|||
129201459|NCT02159066|465034940|FG005|Part II|Adverse Event|1|||
129201460|NCT02159066|465034935|FG000|Part II|Death|0|||
129201461|NCT02159066|465034936|FG001|Part II|Death|0|||
129201462|NCT02159066|465034937|FG002|Part II|Death|1|||
129201463|NCT02159066|465034938|FG003|Part II|Death|0|||
129201464|NCT02159066|465034939|FG004|Part II|Death|2|||
129201465|NCT02159066|465034940|FG005|Part II|Death|1|||
129201466|NCT02159066|465034935|FG000|Part II|Progressive Disease|0|||
129201467|NCT02159066|465034936|FG001|Part II|Progressive Disease|0|||
129201468|NCT02159066|465034937|FG002|Part II|Progressive Disease|35|||
129201469|NCT02159066|465034938|FG003|Part II|Progressive Disease|1|||
129201470|NCT02159066|465034939|FG004|Part II|Progressive Disease|7|||
129201471|NCT02159066|465034940|FG005|Part II|Progressive Disease|4|||
129201472|NCT02159066|465034935|FG000|Part II|New Therapy for Study Indication|0|||
129201473|NCT02159066|465034936|FG001|Part II|New Therapy for Study Indication|0|||
129201474|NCT02159066|465034937|FG002|Part II|New Therapy for Study Indication|0|||
129201475|NCT02159066|465034938|FG003|Part II|New Therapy for Study Indication|0|||
129201476|NCT02159066|465034939|FG004|Part II|New Therapy for Study Indication|1|||
129201477|NCT02159066|465034940|FG005|Part II|New Therapy for Study Indication|0|||
129201478|NCT02159066|465034935|FG000|Part II|Physician Decision|0|||
129201479|NCT02159066|465034936|FG001|Part II|Physician Decision|0|||
129201480|NCT02159066|465034937|FG002|Part II|Physician Decision|1|||
129201481|NCT02159066|465034938|FG003|Part II|Physician Decision|0|||
129201482|NCT02159066|465034939|FG004|Part II|Physician Decision|0|||
129201483|NCT02159066|465034940|FG005|Part II|Physician Decision|0|||
129201484|NCT02159066|465034935|FG000|Part II|Participant/Guardian Decision|0|||
129201485|NCT02159066|465034936|FG001|Part II|Participant/Guardian Decision|0|||
129201486|NCT02159066|465034937|FG002|Part II|Participant/Guardian Decision|0|||
129201487|NCT02159066|465034938|FG003|Part II|Participant/Guardian Decision|0|||
129201488|NCT02159066|465034939|FG004|Part II|Participant/Guardian Decision|2|||
129201489|NCT02159066|465034940|FG005|Part II|Participant/Guardian Decision|0|||
129201490|NCT01147666|465034941|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129201491|NCT01147666|465034942|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129201492|NCT01147666|465034943|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129201493|NCT01147666|465034944|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201494|NCT01147666|465034945|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201495|NCT01147666|465034946|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201496|NCT01147666|465034947|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201497|NCT01147666|465034948|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201498|NCT01147666|465034949|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201499|NCT01147666|465034950|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201500|NCT01147666|465034951|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201501|NCT01147666|465034952|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201502|NCT01147666|465034953|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129201503|NCT01147666|465034954|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201504|NCT01147666|465034955|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129201505|NCT01147666|465034941|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129201506|NCT01147666|465034942|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129201507|NCT01147666|465034943|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129201508|NCT01147666|465034944|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129201509|NCT01147666|465034945|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
129201510|NCT01147666|465034946|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129201511|NCT01147666|465034947|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
129201512|NCT01147666|465034948|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
129201513|NCT01147666|465034949|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129201514|NCT01147666|465034950|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129201515|NCT01147666|465034951|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129201516|NCT01147666|465034952|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129201517|NCT01147666|465034953|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129201518|NCT01147666|465034954|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129201519|NCT01147666|465034955|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
128732147|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732148|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129201520|NCT01147666|465034941|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
129201521|NCT01147666|465034942|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
129201522|NCT01147666|465034943|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
129201523|NCT01147666|465034944|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
129201524|NCT01147666|465034945|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
129201525|NCT01147666|465034946|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
129201526|NCT01147666|465034947|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
128781143|NCT00372567|463490459|FG000|Phase 3 Study|Adverse Event|5|||
128732149|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732150|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
128732151|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732152|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732153|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732154|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732155|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732156|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732157|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732158|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732159|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732160|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732161|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732162|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732163|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732164|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732165|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732166|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732167|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
128732168|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732169|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732170|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732171|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732172|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732173|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732174|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732175|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732176|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
128732177|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732178|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732179|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
128732180|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732181|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
128732182|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
128732183|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732184|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732185|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732186|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732187|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732188|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732189|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732190|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732191|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
128732192|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732193|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732194|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732195|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732196|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732197|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732198|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732199|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732200|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732201|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
128732202|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732203|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732204|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732205|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732206|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732207|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732208|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732209|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732210|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732211|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732212|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732213|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732214|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732215|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
128732216|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732217|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732218|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732219|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732220|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732221|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732222|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129201527|NCT01147666|465034948|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
129201528|NCT01147666|465034949|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
129201529|NCT01147666|465034950|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
129201530|NCT01147666|465034951|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
129201531|NCT01147666|465034952|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
129201532|NCT01147666|465034953|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
129201533|NCT01147666|465034954|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
129201534|NCT01147666|465034955|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
129201535|NCT01147666|465034941|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
128732223|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732224|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732225|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732226|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
128732227|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129201536|NCT01147666|465034942|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201537|NCT01147666|465034943|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201538|NCT01147666|465034944|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
129201539|NCT01147666|465034945|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201540|NCT01147666|465034946|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201541|NCT01147666|465034947|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201542|NCT01147666|465034948|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201543|NCT01147666|465034949|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201544|NCT01147666|465034950|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201545|NCT01147666|465034951|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
129201546|NCT01147666|465034952|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201547|NCT01147666|465034953|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201548|NCT01147666|465034954|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201549|NCT01147666|465034955|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129201550|NCT01147666|465034941|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201551|NCT01147666|465034942|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201552|NCT01147666|465034943|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201553|NCT01147666|465034944|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201554|NCT01147666|465034945|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129201555|NCT01147666|465034946|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129201556|NCT01147666|465034947|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201557|NCT01147666|465034948|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129201558|NCT01147666|465034949|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201559|NCT01147666|465034950|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129201560|NCT01147666|465034951|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201561|NCT01147666|465034952|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129201562|NCT01147666|465034953|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201563|NCT01147666|465034954|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129201564|NCT01147666|465034955|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129201565|NCT01147666|465034941|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201566|NCT01147666|465034942|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201567|NCT01147666|465034943|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201568|NCT01147666|465034944|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
129201569|NCT01147666|465034945|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201570|NCT01147666|465034946|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201571|NCT01147666|465034947|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201572|NCT01147666|465034948|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201573|NCT01147666|465034949|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201574|NCT01147666|465034950|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201575|NCT01147666|465034951|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
129201576|NCT01147666|465034952|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201577|NCT01147666|465034953|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201578|NCT01147666|465034954|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201579|NCT01147666|465034955|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129201580|NCT01147666|465034941|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201581|NCT01147666|465034942|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201582|NCT01147666|465034943|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201583|NCT01147666|465034944|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201584|NCT01147666|465034945|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201585|NCT01147666|465034946|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201586|NCT01147666|465034947|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201587|NCT01147666|465034948|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201588|NCT01147666|465034949|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201589|NCT01147666|465034950|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201590|NCT01147666|465034951|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201591|NCT01147666|465034952|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
129201592|NCT01147666|465034953|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
129201593|NCT01147666|465034954|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129201594|NCT01147666|465034955|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
129201595|NCT01147666|465034941|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
129201596|NCT01147666|465034942|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
129201597|NCT01147666|465034943|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
129201598|NCT01147666|465034944|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
129201599|NCT01147666|465034945|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
129201600|NCT01147666|465034946|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
129201601|NCT01147666|465034947|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
129201602|NCT01147666|465034948|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
128732228|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732229|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732230|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732231|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732232|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732233|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732234|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732235|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732236|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129201603|NCT01147666|465034949|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
129201604|NCT01147666|465034950|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
129201605|NCT01147666|465034951|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
129201606|NCT01147666|465034952|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
129201607|NCT01147666|465034953|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
129201608|NCT01147666|465034954|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
129201609|NCT01147666|465034955|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
129201610|NCT01147666|465034941|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129201611|NCT01147666|465034942|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129201612|NCT01147666|465034943|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
128732237|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732238|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129201613|NCT01147666|465034944|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129201614|NCT01147666|465034945|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
129201615|NCT01147666|465034946|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
129201616|NCT01147666|465034947|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
129201617|NCT01147666|465034948|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
129201618|NCT01147666|465034949|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
128732239|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
128732240|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732241|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732242|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732243|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732244|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732245|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732246|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732247|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732248|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732249|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732250|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732251|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732252|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732253|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732254|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
128732255|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732256|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732257|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732258|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732259|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129201619|NCT01147666|465034950|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
129201620|NCT01147666|465034951|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129201621|NCT01147666|465034952|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129201622|NCT01147666|465034953|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
129201623|NCT01147666|465034954|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129201624|NCT01147666|465034955|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
129201625|NCT01147666|465034941|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201626|NCT01147666|465034942|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201627|NCT01147666|465034943|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201628|NCT01147666|465034944|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
129201629|NCT01147666|465034945|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201630|NCT01147666|465034946|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201631|NCT01147666|465034947|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201632|NCT01147666|465034948|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201633|NCT01147666|465034949|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201634|NCT01147666|465034950|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201635|NCT01147666|465034951|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201636|NCT01147666|465034952|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201637|NCT01147666|465034953|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201638|NCT01147666|465034954|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201639|NCT01147666|465034955|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129201640|NCT01147666|465034941|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201641|NCT01147666|465034942|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201642|NCT01147666|465034943|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201643|NCT01147666|465034944|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201644|NCT01147666|465034945|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129201645|NCT01147666|465034946|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129201646|NCT01147666|465034947|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201647|NCT01147666|465034948|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129201648|NCT01147666|465034949|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201649|NCT01147666|465034950|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129201650|NCT01147666|465034951|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201651|NCT01147666|465034952|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201652|NCT01147666|465034953|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201653|NCT01147666|465034954|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129201654|NCT01147666|465034955|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129201655|NCT01147666|465034941|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201656|NCT01147666|465034942|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201657|NCT01147666|465034943|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201658|NCT01147666|465034944|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
128732260|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732261|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129201659|NCT01147666|465034945|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201660|NCT01147666|465034946|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201661|NCT01147666|465034947|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201662|NCT01147666|465034948|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201663|NCT01147666|465034949|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201664|NCT01147666|465034950|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201665|NCT01147666|465034951|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
129201666|NCT01147666|465034952|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201667|NCT01147666|465034953|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201668|NCT01147666|465034954|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201669|NCT01147666|465034955|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129201670|NCT01147666|465034941|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201671|NCT01147666|465034942|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201672|NCT01147666|465034943|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201673|NCT01147666|465034944|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201674|NCT01147666|465034945|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201675|NCT01147666|465034946|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201676|NCT01147666|465034947|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201677|NCT01147666|465034948|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201678|NCT01147666|465034949|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201679|NCT01147666|465034950|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201680|NCT01147666|465034951|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201681|NCT01147666|465034952|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201682|NCT01147666|465034953|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
129201683|NCT01147666|465034954|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201684|NCT01147666|465034955|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129201685|NCT01147666|465034941|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201686|NCT01147666|465034942|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201687|NCT01147666|465034943|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201688|NCT01147666|465034944|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201689|NCT01147666|465034945|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201690|NCT01147666|465034946|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201691|NCT01147666|465034947|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201692|NCT01147666|465034948|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201693|NCT01147666|465034949|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201694|NCT01147666|465034950|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201695|NCT01147666|465034951|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201696|NCT01147666|465034952|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201697|NCT01147666|465034953|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
129201698|NCT01147666|465034954|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129201699|NCT01147666|465034955|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
129201700|NCT01859923|465034970|FG000|Overall Study|Adverse Event|0|||
129201701|NCT01859923|465034971|FG001|Overall Study|Adverse Event|0|||
129201702|NCT01859923|465034972|FG002|Overall Study|Adverse Event|1|||
129201703|NCT01859923|465034973|FG003|Overall Study|Adverse Event|1|||
129201704|NCT00764361|465034977|FG000|Overall Study|Withdrawal by Subject|2|||
129201705|NCT00764361|465034978|FG001|Overall Study|Withdrawal by Subject|3|||
129201706|NCT00764361|465034977|FG000|Overall Study|Adverse Event|0|||
129201707|NCT00764361|465034978|FG001|Overall Study|Adverse Event|1|||
129201708|NCT03634085|465034982|FG000|Overall Study|Adverse Event|1|||
129201709|NCT03634085|465034983|FG001|Overall Study|Adverse Event|0|||
129201710|NCT03634085|465034982|FG000|Overall Study|Withdrawal by Subject|0|||
129201711|NCT03634085|465034983|FG001|Overall Study|Withdrawal by Subject|2|||
129201712|NCT00296816|465034986|FG000|Overall Study|Disease Progression|37|||
129201713|NCT00296816|465034986|FG000|Overall Study|Adverse Event|18|||
129201714|NCT00296816|465034986|FG000|Overall Study|Investigator/Participant request|5|||
129201715|NCT00296816|465034986|FG000|Overall Study|Non-compliance|1|||
129201716|NCT00296816|465034986|FG000|Overall Study|Missing for end of treatment|4|||
129201717|NCT00296816|465034986|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
129201718|NCT00296816|465034986|FG000|Overall Study|Poor performance status|1|||
129201719|NCT00296816|465034986|FG000|Overall Study|Relocation to Florida|1|||
129201720|NCT00296816|465034986|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
129201721|NCT00296816|465034986|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
129201722|NCT00296816|465034986|FG000|Overall Study|Neuropathy/patient preference|1|||
129201723|NCT00296816|465034986|FG000|Overall Study|Proteinuria|1|||
129201724|NCT00296816|465034986|FG000|Overall Study|ineligibility due to radiation treatment|1|||
129201725|NCT01721161|465034988|FG000|Overall Study|Adverse Event|2|||
129201726|NCT01721161|465034989|FG001|Overall Study|Adverse Event|3|||
129201727|NCT01721161|465034988|FG000|Overall Study|Lost to Follow-up|1|||
129201728|NCT01721161|465034989|FG001|Overall Study|Lost to Follow-up|2|||
129201729|NCT01721161|465034988|FG000|Overall Study|Withdrawal by Subject|1|||
129201730|NCT01721161|465034989|FG001|Overall Study|Withdrawal by Subject|1|||
129201731|NCT01721161|465034988|FG000|Overall Study|Other|0|||
129201732|NCT01721161|465034989|FG001|Overall Study|Other|1|||
129201733|NCT01216202|465034990|FG000|Overall Study|Withdrawal by Subject|8|||
129201734|NCT01216202|465034991|FG001|Overall Study|Withdrawal by Subject|0|||
129201735|NCT01216202|465034990|FG000|Overall Study|Death|0|||
129201736|NCT01216202|465034991|FG001|Overall Study|Death|2|||
129201737|NCT01216202|465034990|FG000|Overall Study|Lost to Follow-up|14|||
129201738|NCT01216202|465034991|FG001|Overall Study|Lost to Follow-up|0|||
129201739|NCT03259555|465035008|FG000|Overall Study|Adverse Event|6|||
129201740|NCT03259555|465035009|FG001|Overall Study|Adverse Event|4|||
129201741|NCT03259555|465035008|FG000|Overall Study|Lack of Efficacy|6|||
129201742|NCT03259555|465035009|FG001|Overall Study|Lack of Efficacy|4|||
129201743|NCT03259555|465035008|FG000|Overall Study|Lost to Follow-up|0|||
129201744|NCT03259555|465035009|FG001|Overall Study|Lost to Follow-up|2|||
129201745|NCT03259555|465035008|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129201746|NCT03259555|465035009|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129201747|NCT03259555|465035008|FG000|Overall Study|Progressive Disease|0|||
129201748|NCT03259555|465035009|FG001|Overall Study|Progressive Disease|2|||
129201749|NCT03259555|465035008|FG000|Overall Study|Withdrawal by Subject|19|||
129201750|NCT03259555|465035009|FG001|Overall Study|Withdrawal by Subject|16|||
129201751|NCT03259555|465035008|FG000|Overall Study|Physician Decision|1|||
129201752|NCT03259555|465035009|FG001|Overall Study|Physician Decision|2|||
129201753|NCT03259555|465035008|FG000|Overall Study|Other|1|||
129201754|NCT03259555|465035009|FG001|Overall Study|Other|0|||
129201755|NCT04393493|465035011|FG000|First 4 Days of Intervention|Early improvement|5|||
129201756|NCT04393493|465035012|FG001|First 4 Days of Intervention|Early improvement|7|||
129201757|NCT01125800|465035013|FG000|Phase I|Protocol Violation|0|||
129201758|NCT01125800|465035014|FG001|Phase I|Protocol Violation|3|||
129201759|NCT01125800|465035015|FG002|Phase I|Protocol Violation|1|||
129201760|NCT01125800|465035016|FG003|Phase I|Protocol Violation|1|||
129201761|NCT01125800|465035017|FG004|Phase I|Protocol Violation|0|||
129201762|NCT01125800|465035013|FG000|Phase I|Adverse Event|2|||
129201763|NCT01125800|465035014|FG001|Phase I|Adverse Event|2|||
129201764|NCT01125800|465035015|FG002|Phase I|Adverse Event|1|||
129201765|NCT01125800|465035016|FG003|Phase I|Adverse Event|7|||
129201766|NCT01125800|465035017|FG004|Phase I|Adverse Event|0|||
129201767|NCT01125800|465035013|FG000|Phase I|Administrative problems|1|||
129201768|NCT01125800|465035014|FG001|Phase I|Administrative problems|0|||
128781144|NCT00372567|463490460|FG001|Phase 3 Study|Adverse Event|1|||
128732262|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732263|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
128732264|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732265|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732266|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732267|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732268|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732269|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732270|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732271|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732272|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732273|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732274|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732275|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732276|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732277|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732278|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
128732279|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732280|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732281|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732282|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732283|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732284|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732285|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732286|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732287|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
128732288|NCT02346240|463312863|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732289|NCT02346240|463312864|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732290|NCT02346240|463312865|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732291|NCT02346240|463312866|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732292|NCT02346240|463312867|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732293|NCT02346240|463312868|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732294|NCT02346240|463312869|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732295|NCT02346240|463312870|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732296|NCT02346240|463312871|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732297|NCT02346240|463312872|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732298|NCT02346240|463312873|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732299|NCT02346240|463312874|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732300|NCT02346240|463312875|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732301|NCT02346240|463312876|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732302|NCT02346240|463312877|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
128732303|NCT02346240|463312878|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732304|NCT02346240|463312879|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732305|NCT02346240|463312880|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732306|NCT02346240|463312881|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732307|NCT02346240|463312882|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732308|NCT02346240|463312883|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732309|NCT02346240|463312884|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732310|NCT02346240|463312885|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732311|NCT02346240|463312886|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
128732312|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732313|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732314|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732315|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732316|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129201769|NCT01125800|465035015|FG002|Phase I|Administrative problems|0|||
129201770|NCT01125800|465035016|FG003|Phase I|Administrative problems|0|||
129201771|NCT01125800|465035017|FG004|Phase I|Administrative problems|0|||
129201772|NCT01125800|465035013|FG000|Phase I|Withdrawal by Subject|0|||
129201773|NCT01125800|465035014|FG001|Phase I|Withdrawal by Subject|0|||
129201774|NCT01125800|465035015|FG002|Phase I|Withdrawal by Subject|1|||
129201775|NCT01125800|465035016|FG003|Phase I|Withdrawal by Subject|0|||
129201776|NCT01125800|465035017|FG004|Phase I|Withdrawal by Subject|0|||
129201777|NCT01125800|465035013|FG000|Phase I|Disease progression|5|||
129201778|NCT01125800|465035014|FG001|Phase I|Disease progression|4|||
129201779|NCT01125800|465035015|FG002|Phase I|Disease progression|1|||
129201780|NCT01125800|465035016|FG003|Phase I|Disease progression|3|||
129201781|NCT01125800|465035017|FG004|Phase I|Disease progression|0|||
129201782|NCT01125800|465035013|FG000|Phase II|Protocol Violation|0|||
129201783|NCT01125800|465035014|FG001|Phase II|Protocol Violation|0|||
129201784|NCT01125800|465035015|FG002|Phase II|Protocol Violation|0|||
129201785|NCT01125800|465035016|FG003|Phase II|Protocol Violation|0|||
129201786|NCT01125800|465035017|FG004|Phase II|Protocol Violation|1|||
129201787|NCT01125800|465035013|FG000|Phase II|Adverse Event|0|||
129201788|NCT01125800|465035014|FG001|Phase II|Adverse Event|0|||
129201789|NCT01125800|465035015|FG002|Phase II|Adverse Event|0|||
129201790|NCT01125800|465035016|FG003|Phase II|Adverse Event|0|||
129201791|NCT01125800|465035017|FG004|Phase II|Adverse Event|2|||
129201792|NCT01125800|465035013|FG000|Phase II|Disease progression|0|||
129201793|NCT01125800|465035014|FG001|Phase II|Disease progression|0|||
129201794|NCT01125800|465035015|FG002|Phase II|Disease progression|0|||
129201795|NCT01125800|465035016|FG003|Phase II|Disease progression|1|||
129201796|NCT01125800|465035017|FG004|Phase II|Disease progression|8|||
129201797|NCT03370718|465035022|FG000|Overall Study|Withdrawal by Subject|1|||
129201798|NCT04970654|465035025|FG000|Overall Study|Withdrawal by parents/guardian|1|||
129201799|NCT04970654|465035026|FG001|Overall Study|Withdrawal by parents/guardian|2|||
129201800|NCT04970654|465035025|FG000|Overall Study|Unclassified|2|||
129201801|NCT04970654|465035026|FG001|Overall Study|Unclassified|1|||
129201802|NCT04970654|465035025|FG000|Overall Study|Lost to Follow-up|1|||
129201803|NCT04970654|465035026|FG001|Overall Study|Lost to Follow-up|0|||
129201804|NCT02539797|465037182|FG000|Overall Study|Lost to Follow-up|0|||
129201805|NCT02539797|465037183|FG001|Overall Study|Lost to Follow-up|1|||
129201806|NCT02539797|465037184|FG002|Overall Study|Lost to Follow-up|0|||
129201807|NCT04002960|465037186|FG000|Overall Study|Withdrawn prior to Completion|2|||
129201808|NCT00383786|465037189|FG000|Overall Study|Protocol Violation|2|||
129201809|NCT00383786|465037190|FG001|Overall Study|Protocol Violation|6|||
129201810|NCT00383786|465037189|FG000|Overall Study|Withdrawal by Subject|2|||
129201811|NCT00383786|465037190|FG001|Overall Study|Withdrawal by Subject|5|||
129201812|NCT00383786|465037189|FG000|Overall Study|Physician Decision|0|||
129201813|NCT00383786|465037190|FG001|Overall Study|Physician Decision|1|||
129201814|NCT00531284|465037191|FG000|Overall Study|Progressive Disease|1|||
129201815|NCT00531284|465037192|FG001|Overall Study|Progressive Disease|3|||
129201816|NCT00531284|465037193|FG002|Overall Study|Progressive Disease|5|||
129201817|NCT00531284|465037194|FG003|Overall Study|Progressive Disease|42|||
129201818|NCT00531284|465037195|FG004|Overall Study|Progressive Disease|4|||
129201819|NCT00531284|465037196|FG005|Overall Study|Progressive Disease|4|||
129201820|NCT00531284|465037197|FG006|Overall Study|Progressive Disease|3|||
129201821|NCT00531284|465037198|FG007|Overall Study|Progressive Disease|8|||
129201822|NCT00531284|465037199|FG008|Overall Study|Progressive Disease|6|||
129201823|NCT00531284|465037200|FG009|Overall Study|Progressive Disease|3|||
129201824|NCT00531284|465037201|FG010|Overall Study|Progressive Disease|3|||
129201825|NCT00531284|465037202|FG011|Overall Study|Progressive Disease|14|||
129201826|NCT00531284|465037203|FG012|Overall Study|Progressive Disease|2|||
129201827|NCT00531284|465037204|FG013|Overall Study|Progressive Disease|1|||
129201828|NCT00531284|465037205|FG014|Overall Study|Progressive Disease|2|||
129201829|NCT00531284|465037206|FG015|Overall Study|Progressive Disease|11|||
129201830|NCT00531284|465037207|FG016|Overall Study|Progressive Disease|5|||
129201831|NCT00531284|465037191|FG000|Overall Study|Adverse Event|0|||
129201832|NCT00531284|465037192|FG001|Overall Study|Adverse Event|1|||
129201833|NCT00531284|465037193|FG002|Overall Study|Adverse Event|1|||
129201834|NCT00531284|465037194|FG003|Overall Study|Adverse Event|7|||
129201835|NCT00531284|465037195|FG004|Overall Study|Adverse Event|0|||
129201836|NCT00531284|465037196|FG005|Overall Study|Adverse Event|2|||
129201837|NCT00531284|465037197|FG006|Overall Study|Adverse Event|3|||
129201838|NCT00531284|465037198|FG007|Overall Study|Adverse Event|2|||
129201839|NCT00531284|465037199|FG008|Overall Study|Adverse Event|3|||
129201840|NCT00531284|465037200|FG009|Overall Study|Adverse Event|0|||
129201841|NCT00531284|465037201|FG010|Overall Study|Adverse Event|0|||
129201842|NCT00531284|465037202|FG011|Overall Study|Adverse Event|5|||
129201843|NCT00531284|465037203|FG012|Overall Study|Adverse Event|0|||
129201844|NCT00531284|465037204|FG013|Overall Study|Adverse Event|1|||
129201845|NCT00531284|465037205|FG014|Overall Study|Adverse Event|1|||
129201846|NCT00531284|465037206|FG015|Overall Study|Adverse Event|0|||
129201847|NCT00531284|465037207|FG016|Overall Study|Adverse Event|2|||
129201848|NCT00531284|465037191|FG000|Overall Study|Withdrawal by Subject|1|||
129201849|NCT00531284|465037192|FG001|Overall Study|Withdrawal by Subject|0|||
129201850|NCT00531284|465037193|FG002|Overall Study|Withdrawal by Subject|0|||
129201851|NCT00531284|465037194|FG003|Overall Study|Withdrawal by Subject|4|||
129201852|NCT00531284|465037195|FG004|Overall Study|Withdrawal by Subject|0|||
129201853|NCT00531284|465037196|FG005|Overall Study|Withdrawal by Subject|0|||
128732317|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732318|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732319|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732320|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732321|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732322|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732323|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732324|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732325|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129201854|NCT00531284|465037197|FG006|Overall Study|Withdrawal by Subject|0|||
129201855|NCT00531284|465037198|FG007|Overall Study|Withdrawal by Subject|0|||
129201856|NCT00531284|465037199|FG008|Overall Study|Withdrawal by Subject|0|||
129201857|NCT00531284|465037200|FG009|Overall Study|Withdrawal by Subject|0|||
129201858|NCT00531284|465037201|FG010|Overall Study|Withdrawal by Subject|0|||
129201859|NCT00531284|465037202|FG011|Overall Study|Withdrawal by Subject|3|||
129201860|NCT00531284|465037203|FG012|Overall Study|Withdrawal by Subject|0|||
129201861|NCT00531284|465037204|FG013|Overall Study|Withdrawal by Subject|1|||
129201862|NCT00531284|465037205|FG014|Overall Study|Withdrawal by Subject|0|||
129201863|NCT00531284|465037206|FG015|Overall Study|Withdrawal by Subject|1|||
129201864|NCT00531284|465037207|FG016|Overall Study|Withdrawal by Subject|1|||
129201865|NCT00531284|465037191|FG000|Overall Study|Other|1|||
129201866|NCT00531284|465037192|FG001|Overall Study|Other|0|||
129201867|NCT00531284|465037193|FG002|Overall Study|Other|0|||
129201868|NCT00531284|465037194|FG003|Overall Study|Other|10|||
129201869|NCT00531284|465037195|FG004|Overall Study|Other|2|||
129201870|NCT00531284|465037196|FG005|Overall Study|Other|1|||
129201871|NCT00531284|465037197|FG006|Overall Study|Other|0|||
129201872|NCT00531284|465037198|FG007|Overall Study|Other|0|||
129201873|NCT00531284|465037199|FG008|Overall Study|Other|2|||
129201874|NCT00531284|465037200|FG009|Overall Study|Other|1|||
129201875|NCT00531284|465037201|FG010|Overall Study|Other|0|||
129201876|NCT00531284|465037202|FG011|Overall Study|Other|2|||
129201877|NCT00531284|465037203|FG012|Overall Study|Other|0|||
129201878|NCT00531284|465037204|FG013|Overall Study|Other|0|||
129201879|NCT00531284|465037205|FG014|Overall Study|Other|1|||
129201880|NCT00531284|465037206|FG015|Overall Study|Other|0|||
129201881|NCT00531284|465037207|FG016|Overall Study|Other|0|||
129201882|NCT02544321|465037215|FG000|Overall Study|Withdrawal by Subject|1|||
129201883|NCT02544321|465037216|FG001|Overall Study|Withdrawal by Subject|2|||
129201884|NCT02544321|465037215|FG000|Overall Study|Adverse Event|1|||
129201885|NCT02544321|465037216|FG001|Overall Study|Adverse Event|1|||
129201886|NCT02544321|465037215|FG000|Overall Study|Protocol Violation|0|||
129201887|NCT02544321|465037216|FG001|Overall Study|Protocol Violation|1|||
129201888|NCT01517750|465037217|FG000|Overall Study|Lost to Follow-up|1|||
129201889|NCT01517750|465037218|FG001|Overall Study|Lost to Follow-up|2|||
129201890|NCT01517750|465037219|FG002|Overall Study|Lost to Follow-up|4|||
129201891|NCT01517750|465037220|FG003|Overall Study|Lost to Follow-up|1|||
129201892|NCT01584232|465037221|FG000|Overall Study|Adverse Event|3|||
129201893|NCT01584232|465037222|FG001|Overall Study|Adverse Event|1|||
129201894|NCT01584232|465037221|FG000|Overall Study|Withdrawal by Subject|2|||
129201895|NCT01584232|465037222|FG001|Overall Study|Withdrawal by Subject|1|||
129201896|NCT01584232|465037221|FG000|Overall Study|Physician Decision|2|||
128732326|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129201897|NCT01584232|465037222|FG001|Overall Study|Physician Decision|1|||
129201898|NCT01584232|465037221|FG000|Overall Study|Lost to Follow-up|1|||
129201899|NCT01584232|465037222|FG001|Overall Study|Lost to Follow-up|0|||
129201900|NCT01307319|465037223|FG000|Overall Study|Adverse Event|2|||
129201901|NCT01307319|465037224|FG001|Overall Study|Adverse Event|2|||
129201902|NCT01307319|465037225|FG002|Overall Study|Adverse Event|1|||
129201903|NCT01307319|465037223|FG000|Overall Study|Lost to Follow-up|1|||
129201904|NCT01307319|465037224|FG001|Overall Study|Lost to Follow-up|0|||
129201905|NCT01307319|465037225|FG002|Overall Study|Lost to Follow-up|1|||
129201906|NCT01307319|465037223|FG000|Overall Study|Protocol Violation|1|||
129201907|NCT01307319|465037224|FG001|Overall Study|Protocol Violation|1|||
129201908|NCT01307319|465037225|FG002|Overall Study|Protocol Violation|0|||
129201909|NCT01307319|465037223|FG000|Overall Study|Withdrawal by Subject|0|||
129201910|NCT01307319|465037224|FG001|Overall Study|Withdrawal by Subject|1|||
129201911|NCT01307319|465037225|FG002|Overall Study|Withdrawal by Subject|2|||
129201912|NCT01307319|465037223|FG000|Overall Study|Other|0|||
129201913|NCT01307319|465037224|FG001|Overall Study|Other|4|||
129201914|NCT01307319|465037225|FG002|Overall Study|Other|3|||
129201915|NCT02723773|465037227|FG000|Overall Study|Adverse Event|934|||
129201916|NCT02723773|465037228|FG001|Overall Study|Adverse Event|3|||
129201917|NCT02723773|465037229|FG002|Overall Study|Adverse Event|1|||
128781145|NCT00372567|463490461|FG002|Phase 3 Study|Adverse Event|1|||
128781146|NCT00372567|463490459|FG000|Phase 3 Study|Death|1|||
129201918|NCT02723773|465037230|FG003|Overall Study|Adverse Event|9|||
129201919|NCT02723773|465037227|FG000|Overall Study|Protocol Violation|1|||
129201920|NCT02723773|465037228|FG001|Overall Study|Protocol Violation|0|||
129201921|NCT02723773|465037229|FG002|Overall Study|Protocol Violation|0|||
129201922|NCT02723773|465037230|FG003|Overall Study|Protocol Violation|0|||
129201923|NCT02723773|465037227|FG000|Overall Study|Withdrawal by Subject|360|||
129201924|NCT02723773|465037228|FG001|Overall Study|Withdrawal by Subject|5|||
129201925|NCT02723773|465037229|FG002|Overall Study|Withdrawal by Subject|6|||
129201926|NCT02723773|465037230|FG003|Overall Study|Withdrawal by Subject|10|||
129201927|NCT02723773|465037227|FG000|Overall Study|Migrated/moved from study area|37|||
129201928|NCT02723773|465037228|FG001|Overall Study|Migrated/moved from study area|0|||
129201929|NCT02723773|465037229|FG002|Overall Study|Migrated/moved from study area|0|||
129201930|NCT02723773|465037230|FG003|Overall Study|Migrated/moved from study area|1|||
129201931|NCT02723773|465037227|FG000|Overall Study|Lost to Follow-up|198|||
129201932|NCT02723773|465037228|FG001|Overall Study|Lost to Follow-up|0|||
129201933|NCT02723773|465037229|FG002|Overall Study|Lost to Follow-up|0|||
129201934|NCT02723773|465037230|FG003|Overall Study|Lost to Follow-up|0|||
129201935|NCT02723773|465037227|FG000|Overall Study|Other|189|||
129201936|NCT02723773|465037228|FG001|Overall Study|Other|1|||
129201937|NCT02723773|465037229|FG002|Overall Study|Other|2|||
129201938|NCT02723773|465037230|FG003|Overall Study|Other|2|||
129201939|NCT03629886|465037231|FG000|Overall Study|Migrated / moved from the study area|0|||
129201940|NCT03629886|465037232|FG001|Overall Study|Migrated / moved from the study area|55|||
129201941|NCT03629886|465037231|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
129201942|NCT03629886|465037232|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
129201943|NCT03629886|465037231|FG000|Overall Study|Study vaccine not administrated|0|||
129201944|NCT03629886|465037232|FG001|Overall Study|Study vaccine not administrated|3|||
129201945|NCT03629886|465037231|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
129201946|NCT03629886|465037232|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
129201947|NCT03629886|465037231|FG000|Overall Study|Refused vaccination step of the study|0|||
129201948|NCT03629886|465037232|FG001|Overall Study|Refused vaccination step of the study|44|||
129201949|NCT02730728|465037233|FG000|Overall Study|Withdrawal by Subject|0|||
129201950|NCT02730728|465037234|FG001|Overall Study|Withdrawal by Subject|1|||
129201951|NCT02730728|465037235|FG002|Overall Study|Withdrawal by Subject|0|||
129201952|NCT02730728|465037233|FG000|Overall Study|Lack of Efficacy|0|||
129201953|NCT02730728|465037234|FG001|Overall Study|Lack of Efficacy|1|||
129201954|NCT02730728|465037235|FG002|Overall Study|Lack of Efficacy|1|||
129201955|NCT01855412|465037236|FG000|Overall Study|Death|77|||
129201956|NCT01855412|465037237|FG001|Overall Study|Death|123|||
129201957|NCT01855412|465037238|FG002|Overall Study|Death|30|||
129201958|NCT01855412|465037236|FG000|Overall Study|Lost to Follow-up|28|||
129201959|NCT01855412|465037237|FG001|Overall Study|Lost to Follow-up|46|||
129201960|NCT01855412|465037238|FG002|Overall Study|Lost to Follow-up|15|||
129201961|NCT01855412|465037236|FG000|Overall Study|Withdrawal by Subject|77|||
129201962|NCT01855412|465037237|FG001|Overall Study|Withdrawal by Subject|123|||
129201963|NCT01855412|465037238|FG002|Overall Study|Withdrawal by Subject|24|||
129201964|NCT01855412|465037236|FG000|Overall Study|Physician Decision|25|||
129201965|NCT01855412|465037237|FG001|Overall Study|Physician Decision|31|||
128781147|NCT00372567|463490460|FG001|Phase 3 Study|Death|1|||
129201966|NCT01855412|465037238|FG002|Overall Study|Physician Decision|3|||
129201967|NCT01855412|465037236|FG000|Overall Study|Site Closure|4|||
129201968|NCT01855412|465037237|FG001|Overall Study|Site Closure|18|||
129201969|NCT01855412|465037238|FG002|Overall Study|Site Closure|1|||
129201970|NCT01855412|465037236|FG000|Overall Study|Reason not Specified|1|||
129201971|NCT01855412|465037237|FG001|Overall Study|Reason not Specified|2|||
129201972|NCT01855412|465037238|FG002|Overall Study|Reason not Specified|3|||
129201973|NCT01702844|465037239|FG000|Overall Study|Adverse Event|9|||
129201974|NCT01702844|465037239|FG000|Overall Study|Death|1|||
129201975|NCT01702844|465037239|FG000|Overall Study|Withdrawal by Subject|3|||
129201976|NCT01702844|465037239|FG000|Overall Study|Physician Decision|6|||
129201977|NCT03431441|465037240|FG000|Overall Study|Withdrawal by Subject|2|||
129201978|NCT03431441|465037240|FG000|Overall Study|Adverse Event|2|||
129201979|NCT03431441|465037240|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
129201980|NCT00346216|465037241|FG000|Overall Study|Other|181|||
129201981|NCT00346216|465037242|FG001|Overall Study|Other|231|||
129201982|NCT00346216|465037243|FG002|Overall Study|Other|205|||
129201983|NCT00346216|465037241|FG000|Overall Study|No longer willing to participate|600|||
129201984|NCT00346216|465037242|FG001|Overall Study|No longer willing to participate|606|||
129201985|NCT00346216|465037243|FG002|Overall Study|No longer willing to participate|585|||
129201986|NCT00346216|465037241|FG000|Overall Study|Withdrawal by Subject|661|||
129201987|NCT00346216|465037242|FG001|Overall Study|Withdrawal by Subject|692|||
129201988|NCT00346216|465037243|FG002|Overall Study|Withdrawal by Subject|651|||
129201989|NCT00346216|465037241|FG000|Overall Study|Lost to Follow-up|611|||
129201990|NCT00346216|465037242|FG001|Overall Study|Lost to Follow-up|588|||
129201991|NCT00346216|465037243|FG002|Overall Study|Lost to Follow-up|542|||
129201992|NCT00346216|465037241|FG000|Overall Study|Physician Decision|80|||
129201993|NCT00346216|465037242|FG001|Overall Study|Physician Decision|76|||
129201994|NCT00346216|465037243|FG002|Overall Study|Physician Decision|59|||
129201995|NCT00346216|465037241|FG000|Overall Study|Does not meet entrance criteria|13|||
129201996|NCT00346216|465037242|FG001|Overall Study|Does not meet entrance criteria|10|||
129201997|NCT00346216|465037243|FG002|Overall Study|Does not meet entrance criteria|8|||
129201998|NCT00346216|465037241|FG000|Overall Study|Death|189|||
129201999|NCT00346216|465037242|FG001|Overall Study|Death|192|||
129202000|NCT00346216|465037243|FG002|Overall Study|Death|228|||
129202001|NCT00346216|465037241|FG000|Overall Study|Study terminated by sponsor|11|||
129202002|NCT00346216|465037242|FG001|Overall Study|Study terminated by sponsor|4|||
129202003|NCT00346216|465037243|FG002|Overall Study|Study terminated by sponsor|8|||
129202004|NCT00346216|465037241|FG000|Overall Study|Missing Subject Summary Status|62|||
129202005|NCT00346216|465037242|FG001|Overall Study|Missing Subject Summary Status|61|||
129202006|NCT00346216|465037243|FG002|Overall Study|Missing Subject Summary Status|62|||
129202007|NCT02043938|465037249|FG000|Overall Study|Withdrawal by Subject|7|||
129202008|NCT02043938|465037249|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
129202009|NCT02043938|465037249|FG000|Overall Study|No show by subject|1|||
129202010|NCT02043938|465037249|FG000|Overall Study|Investigator decision|1|||
129202011|NCT03985761|465037256|FG000|Overall Study|Withdrawal by Subject|2|||
129202012|NCT03985761|465037257|FG001|Overall Study|Withdrawal by Subject|3|||
129202013|NCT03400852|465037258|FG000|Blinded Treatment Period|Physician Decision|0|||
129202014|NCT03400852|465037259|FG001|Blinded Treatment Period|Physician Decision|1|||
129202015|NCT03400852|465037260|FG002|Blinded Treatment Period|Physician Decision|0|||
129202016|NCT03400852|465037258|FG000|Blinded Treatment Period|Adverse Event|1|||
129202017|NCT03400852|465037259|FG001|Blinded Treatment Period|Adverse Event|1|||
129202018|NCT03400852|465037260|FG002|Blinded Treatment Period|Adverse Event|0|||
129202019|NCT03400852|465037258|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
129202020|NCT03400852|465037259|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
129202021|NCT03400852|465037260|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
129202022|NCT03400852|465037258|FG000|Open Label Period|Physician Decision|0|||
129202023|NCT03400852|465037259|FG001|Open Label Period|Physician Decision|0|||
129202024|NCT03400852|465037260|FG002|Open Label Period|Physician Decision|1|||
129202025|NCT03400852|465037258|FG000|Open Label Period|Study terminated by sponsor|0|||
129202026|NCT03400852|465037259|FG001|Open Label Period|Study terminated by sponsor|0|||
129202027|NCT03400852|465037260|FG002|Open Label Period|Study terminated by sponsor|21|||
129202028|NCT00248495|465037261|FG000|Overall Study|Withdrawal by Subject|1|||
129202029|NCT03812380|465037262|FG000|Overall Study|Protocol Violation|3|||
129202030|NCT03812380|465037263|FG001|Overall Study|Protocol Violation|3|||
129202031|NCT03812380|465037262|FG000|Overall Study|Withdrawal by Subject|5|||
129202032|NCT03812380|465037263|FG001|Overall Study|Withdrawal by Subject|4|||
129202033|NCT03812380|465037262|FG000|Overall Study|Early termination of study|14|||
129202034|NCT03812380|465037263|FG001|Overall Study|Early termination of study|14|||
129202035|NCT02648204|465037264|FG000|Overall Study|Withdrawal by Subject|12|||
129202036|NCT02648204|465037265|FG001|Overall Study|Withdrawal by Subject|8|||
129202037|NCT02648204|465037266|FG002|Overall Study|Withdrawal by Subject|2|||
129202038|NCT02648204|465037267|FG003|Overall Study|Withdrawal by Subject|6|||
129202039|NCT02648204|465037264|FG000|Overall Study|Lost to Follow-up|5|||
129202040|NCT02648204|465037265|FG001|Overall Study|Lost to Follow-up|8|||
129202041|NCT02648204|465037266|FG002|Overall Study|Lost to Follow-up|4|||
129202042|NCT02648204|465037267|FG003|Overall Study|Lost to Follow-up|6|||
129202043|NCT02648204|465037264|FG000|Overall Study|Missing follow-up information|4|||
129202044|NCT02648204|465037265|FG001|Overall Study|Missing follow-up information|4|||
129202045|NCT02648204|465037266|FG002|Overall Study|Missing follow-up information|4|||
129202046|NCT02648204|465037267|FG003|Overall Study|Missing follow-up information|2|||
129202047|NCT02648204|465037264|FG000|Overall Study|Death|1|||
129202048|NCT02648204|465037265|FG001|Overall Study|Death|1|||
129202049|NCT02648204|465037266|FG002|Overall Study|Death|2|||
129202050|NCT02648204|465037267|FG003|Overall Study|Death|2|||
129202051|NCT02648204|465037264|FG000|Overall Study|Adverse Event|0|||
129202052|NCT02648204|465037265|FG001|Overall Study|Adverse Event|0|||
129202053|NCT02648204|465037266|FG002|Overall Study|Adverse Event|1|||
129202054|NCT02648204|465037267|FG003|Overall Study|Adverse Event|0|||
129202055|NCT02322281|465037268|FG000|Overall Study|Progressive Disease|42|||
129202056|NCT02322281|465037269|FG001|Overall Study|Progressive Disease|14|||
129202057|NCT02322281|465037270|FG002|Overall Study|Progressive Disease|49|||
128732327|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732328|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
128732329|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
128732330|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
128732331|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
128732332|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
128732333|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
128732334|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
128732335|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
129202058|NCT02322281|465037268|FG000|Overall Study|Adverse Event|3|||
129202059|NCT02322281|465037269|FG001|Overall Study|Adverse Event|4|||
129202060|NCT02322281|465037270|FG002|Overall Study|Adverse Event|6|||
129202061|NCT02322281|465037268|FG000|Overall Study|Death|3|||
129202062|NCT02322281|465037269|FG001|Overall Study|Death|3|||
129202063|NCT02322281|465037270|FG002|Overall Study|Death|3|||
129202064|NCT02322281|465037268|FG000|Overall Study|Withdrawal by Subject|1|||
129202065|NCT02322281|465037269|FG001|Overall Study|Withdrawal by Subject|1|||
129202066|NCT02322281|465037270|FG002|Overall Study|Withdrawal by Subject|6|||
129202067|NCT02322281|465037268|FG000|Overall Study|Physician Decision|2|||
129202068|NCT02322281|465037269|FG001|Overall Study|Physician Decision|0|||
129202069|NCT02322281|465037270|FG002|Overall Study|Physician Decision|5|||
129202070|NCT02322281|465037268|FG000|Overall Study|Study Terminated by Sponsor|2|||
129202071|NCT02322281|465037269|FG001|Overall Study|Study Terminated by Sponsor|0|||
129202072|NCT02322281|465037270|FG002|Overall Study|Study Terminated by Sponsor|0|||
129202073|NCT02322281|465037268|FG000|Overall Study|Missing|0|||
129202074|NCT02322281|465037269|FG001|Overall Study|Missing|0|||
129202075|NCT02322281|465037270|FG002|Overall Study|Missing|1|||
129202076|NCT02322281|465037268|FG000|Overall Study|Miscellaneous|0|||
129202077|NCT02322281|465037269|FG001|Overall Study|Miscellaneous|0|||
129202078|NCT02322281|465037270|FG002|Overall Study|Miscellaneous|4|||
129202079|NCT01285401|465037271|FG000|Overall Study|Prematurely withdrawn from the study|17|||
129202080|NCT01285401|465037272|FG001|Overall Study|Prematurely withdrawn from the study|29|||
129202081|NCT02366312|465037284|FG000|Overall Study|Lost to Follow-up|0|||
129202082|NCT02366312|465037285|FG001|Overall Study|Lost to Follow-up|1|||
129202083|NCT03719131|465037289|FG000|Overall Study|Death|1|||
129202084|NCT03719131|465037290|FG001|Overall Study|Death|2|||
129202085|NCT00619515|465037291|FG000|Overall Study|Study Termination by IRB|73|||
129202086|NCT03294590|465037292|FG000|Overall Study|Lost to Follow-up|105|||
129202087|NCT03294590|465037293|FG001|Overall Study|Lost to Follow-up|107|||
129202088|NCT04862065|465037296|FG000|Screening|Protocol Violation|54|||
129202089|NCT04862065|465037297|FG001|Screening|Protocol Violation|0|||
129202090|NCT04862065|465037298|FG002|Screening|Protocol Violation|0|||
129202091|NCT04862065|465037296|FG000|Screening|Insufficient Sample|1|||
129202092|NCT04862065|465037297|FG001|Screening|Insufficient Sample|0|||
129202093|NCT04862065|465037298|FG002|Screening|Insufficient Sample|0|||
129202094|NCT04862065|465037296|FG000|Follow-Up|Lost to Follow-up|3|||
129202095|NCT04862065|465037297|FG001|Follow-Up|Lost to Follow-up|0|||
129202096|NCT04862065|465037298|FG002|Follow-Up|Lost to Follow-up|0|||
129202097|NCT01272232|465037302|FG000|Weeks 0-56|Adverse Event|39|||
129202098|NCT01272232|465037303|FG001|Weeks 0-56|Adverse Event|18|||
129202099|NCT01272232|465037304|FG002|Weeks 0-56|Adverse Event|7|||
129202100|NCT01272232|465037302|FG000|Weeks 0-56|Lack of Efficacy|0|||
129202101|NCT01272232|465037303|FG001|Weeks 0-56|Lack of Efficacy|0|||
129202102|NCT01272232|465037304|FG002|Weeks 0-56|Lack of Efficacy|3|||
129202103|NCT01272232|465037302|FG000|Weeks 0-56|Protocol Violation|12|||
129202104|NCT01272232|465037303|FG001|Weeks 0-56|Protocol Violation|8|||
129202105|NCT01272232|465037304|FG002|Weeks 0-56|Protocol Violation|13|||
129202106|NCT01272232|465037302|FG000|Weeks 0-56|Withdrawal criteria|32|||
129202107|NCT01272232|465037303|FG001|Weeks 0-56|Withdrawal criteria|14|||
129202108|NCT01272232|465037304|FG002|Weeks 0-56|Withdrawal criteria|37|||
129202109|NCT01272232|465037302|FG000|Weeks 0-56|Unclassified|16|||
129202110|NCT01272232|465037303|FG001|Weeks 0-56|Unclassified|7|||
129202111|NCT01272232|465037304|FG002|Weeks 0-56|Unclassified|12|||
128732336|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732337|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
129202112|NCT01272232|465037302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
129202113|NCT01272232|465037303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
129202114|NCT01272232|465037304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
129202115|NCT01272232|465037302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
129202116|NCT01272232|465037303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
129202117|NCT01272232|465037304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
129202118|NCT01272232|465037302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
129202119|NCT01272232|465037303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
129202120|NCT01272232|465037304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
129202121|NCT01272232|465037302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
128732338|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
129202122|NCT01272232|465037303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
129202123|NCT01272232|465037304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
129202124|NCT01272232|465037302|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
129202125|NCT01272232|465037303|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
129202126|NCT01272232|465037304|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
128781148|NCT00372567|463490461|FG002|Phase 3 Study|Death|0|||
129202127|NCT00628030|465037307|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
129202128|NCT00628030|465037308|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
128732339|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732340|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732341|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732342|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732343|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732344|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732345|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732346|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732347|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732348|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732349|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732350|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732351|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
128781149|NCT00372567|463490459|FG000|Phase 3 Study|Protocol Violation|0|||
128781150|NCT00372567|463490460|FG001|Phase 3 Study|Protocol Violation|0|||
128781151|NCT00372567|463490461|FG002|Phase 3 Study|Protocol Violation|1|||
128781152|NCT00372567|463490459|FG000|Phase 3 Study|Objective progression or relapse|10|||
128781153|NCT00372567|463490460|FG001|Phase 3 Study|Objective progression or relapse|13|||
128781154|NCT00372567|463490461|FG002|Phase 3 Study|Objective progression or relapse|4|||
128781155|NCT00372567|463490459|FG000|Phase 3 Study|Global deterioration of health status|0|||
128781156|NCT00372567|463490460|FG001|Phase 3 Study|Global deterioration of health status|1|||
128781157|NCT00372567|463490461|FG002|Phase 3 Study|Global deterioration of health status|0|||
128781158|NCT00372567|463490459|FG000|Phase 3 Study|Other|2|||
128781159|NCT00372567|463490460|FG001|Phase 3 Study|Other|2|||
128781160|NCT00372567|463490461|FG002|Phase 3 Study|Other|1|||
128781161|NCT00372567|463490459|FG000|Phase 3 Study|study terminated by sponsor|13|||
128781162|NCT00372567|463490460|FG001|Phase 3 Study|study terminated by sponsor|8|||
128781163|NCT00372567|463490461|FG002|Phase 3 Study|study terminated by sponsor|5|||
128781164|NCT02347943|463490464|FG000|Overall Study|Study was cancelled|140|||
128781165|NCT02347943|463490465|FG001|Overall Study|Study was cancelled|67|||
128781166|NCT02347943|463490466|FG002|Overall Study|Study was cancelled|45|||
128781167|NCT00303303|463490470|FG000|Overall Study|Withdrawal by Subject|0|||
128781168|NCT00303303|463490471|FG001|Overall Study|Withdrawal by Subject|0|||
128781169|NCT00303303|463490472|FG002|Overall Study|Withdrawal by Subject|1|||
128781170|NCT03566680|463490474|FG000|Overall Study|Pregnancy|1|||
128781171|NCT03566680|463490474|FG000|Overall Study|Lost to Follow-up|13|||
128781172|NCT03566680|463490474|FG000|Overall Study|Withdrawal by Subject|3|||
128781173|NCT00582790|463490477|FG000|Overall Study|Rapid progression of disease|1|||
128781174|NCT00480441|463490478|FG000|Screening|Not Eligible|37|||
128781175|NCT00480441|463490479|FG001|Screening|Not Eligible|0|||
128781176|NCT00480441|463490480|FG002|Screening|Not Eligible|0|||
128781177|NCT00480441|463490478|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
128781178|NCT00480441|463490479|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
128781179|NCT00480441|463490480|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
128781180|NCT00480441|463490478|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
128781181|NCT00480441|463490479|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
128781182|NCT00480441|463490480|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
128781183|NCT00480441|463490478|FG000|Baseline Functional MRI|physical contraindication|4|||
128781184|NCT00480441|463490479|FG001|Baseline Functional MRI|physical contraindication|0|||
128781185|NCT00480441|463490480|FG002|Baseline Functional MRI|physical contraindication|0|||
128781186|NCT00480441|463490478|FG000|Randomization|Lost to Follow-up|0|||
128781187|NCT00480441|463490479|FG001|Randomization|Lost to Follow-up|7|||
128781188|NCT00480441|463490480|FG002|Randomization|Lost to Follow-up|2|||
128781189|NCT02374957|463490481|FG000|Overall Study|Patient did not complete forms correctly|1|||
128781190|NCT02374957|463490482|FG001|Overall Study|Patient did not complete forms correctly|0|||
128781191|NCT01687270|463490483|FG000|Overall Study|Lack of Efficacy|11|||
128781192|NCT01687270|463490483|FG000|Overall Study|Lost to Follow-up|1|||
128781193|NCT05349084|463490484|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
128781194|NCT01004263|463490496|FG000|Overall Study|Adverse Event|15|||
128781195|NCT01004263|463490496|FG000|Overall Study|Withdrawal by Subject|58|||
128781196|NCT01004263|463490496|FG000|Overall Study|Protocol Violation|10|||
128781197|NCT01004263|463490496|FG000|Overall Study|Lost to Follow-up|64|||
128781198|NCT01004263|463490496|FG000|Overall Study|Lack of Efficacy|13|||
128781199|NCT01004263|463490496|FG000|Overall Study|Pregnancy|2|||
128781200|NCT01004263|463490496|FG000|Overall Study|Physician Decision|15|||
128781201|NCT01004263|463490496|FG000|Overall Study|Lack of Qualifying Event|2|||
128781202|NCT00821236|463490498|FG000|Overall Study|Lost to Follow-up|3|||
128781203|NCT04668144|463490499|FG000|Overall Study|Protocol Violation|0|||
128781204|NCT04668144|463490500|FG001|Overall Study|Protocol Violation|1|||
128781205|NCT04668144|463490501|FG002|Overall Study|Protocol Violation|2|||
128781206|NCT01605136|463490504|FG000|Study Period|Withdrawal by Subject|2|||
128781207|NCT01605136|463490505|FG001|Study Period|Withdrawal by Subject|0|||
128781208|NCT01605136|463490504|FG000|Study Period|Physician Decision|1|||
128781209|NCT01605136|463490505|FG001|Study Period|Physician Decision|1|||
129202129|NCT00628030|465037307|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
129202130|NCT00628030|465037308|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
129202131|NCT00628030|465037307|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
129202132|NCT00628030|465037308|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
129202133|NCT01156480|465037310|FG000|Overall Study|change in diagnosis|0|||
129202134|NCT01156480|465037311|FG001|Overall Study|change in diagnosis|1|||
129202135|NCT03367858|465037312|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
129202136|NCT03367858|465037313|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
129202137|NCT03367858|465037312|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
129202138|NCT03367858|465037313|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
129202139|NCT03367858|465037312|FG000|3 Month Follow Up|Lost to Follow-up|8|||
129202140|NCT03367858|465037313|FG001|3 Month Follow Up|Lost to Follow-up|3|||
129202141|NCT03367858|465037312|FG000|3 Month Follow Up|Moved out of study area|2|||
129202142|NCT03367858|465037313|FG001|3 Month Follow Up|Moved out of study area|6|||
129202143|NCT03367858|465037312|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
129202144|NCT03367858|465037313|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
128732352|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732353|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732354|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
128732355|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
128732356|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732357|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
128732358|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732359|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
128732360|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732361|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732362|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732363|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732364|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732365|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732366|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732367|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732368|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732369|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732370|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732371|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732372|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732373|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732374|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732375|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732376|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732377|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732378|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
128732379|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732380|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732381|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
128732382|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732383|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
128732384|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732385|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732386|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732387|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732388|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732389|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732390|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732391|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732392|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732393|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732394|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732395|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732396|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732397|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732398|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732399|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732400|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732401|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732402|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732403|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732404|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732405|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
128732406|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732407|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
128732408|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732409|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732410|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732411|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732412|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732413|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732414|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732415|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128781210|NCT01605136|463490504|FG000|Study Period|Lost to Follow-up|0|||
128732416|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732417|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732418|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732419|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732420|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732421|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732422|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732423|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732424|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732425|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
128732426|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
128732427|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
128732428|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
128732429|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
128732430|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
128732431|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
128732432|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732433|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732434|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732435|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732436|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732437|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732438|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732439|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732440|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732441|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732442|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732443|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732444|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732445|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732446|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129202145|NCT03367858|465037312|FG000|3 Month Follow Up|MRI contraindication|2|||
129202146|NCT03367858|465037313|FG001|3 Month Follow Up|MRI contraindication|1|||
129202147|NCT03367858|465037312|FG000|3 Month Follow Up|Incarcerated|0|||
129202148|NCT03367858|465037313|FG001|3 Month Follow Up|Incarcerated|1|||
129202149|NCT03367858|465037312|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
129202150|NCT03367858|465037313|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
129202151|NCT03367858|465037312|FG000|6 Month Follow Up|Lost to Follow-up|5|||
129202152|NCT03367858|465037313|FG001|6 Month Follow Up|Lost to Follow-up|2|||
129202153|NCT03367858|465037312|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
129202154|NCT03367858|465037313|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
129202155|NCT03367858|465037312|FG000|12 Month Follow Up|Lost to Follow-up|3|||
129202156|NCT03367858|465037313|FG001|12 Month Follow Up|Lost to Follow-up|3|||
129202157|NCT03367858|465037312|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
129202158|NCT03367858|465037313|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
129202159|NCT04276233|465037314|FG000|Overall Study|Adverse Event|1|||
129202160|NCT04276233|465037314|FG000|Overall Study|Lost to Follow-up|3|||
129202161|NCT04276233|465037314|FG000|Overall Study|Physician Decision|4|||
129202162|NCT04276233|465037314|FG000|Overall Study|Withdrawal by Subject|2|||
129202163|NCT01946139|465037315|FG000|Overall Study|Withdrawal by Subject|8|||
129202164|NCT01946139|465037315|FG000|Overall Study|ineligible|8|||
129202165|NCT01946139|465037315|FG000|Overall Study|Specimens not available|4|||
129202166|NCT03275740|465037322|FG000|Overall Study|Adverse Event|0|||
129202167|NCT03275740|465037323|FG001|Overall Study|Adverse Event|0|||
129202168|NCT03275740|465037324|FG002|Overall Study|Adverse Event|0|||
129202169|NCT03275740|465037325|FG003|Overall Study|Adverse Event|0|||
129202170|NCT03275740|465037326|FG004|Overall Study|Adverse Event|1|||
129202171|NCT03275740|465037327|FG005|Overall Study|Adverse Event|0|||
129202172|NCT03275740|465037328|FG006|Overall Study|Adverse Event|0|||
129202173|NCT03275740|465037329|FG007|Overall Study|Adverse Event|0|||
129202174|NCT03275740|465037330|FG008|Overall Study|Adverse Event|0|||
129202175|NCT03275740|465037331|FG009|Overall Study|Adverse Event|0|||
129202176|NCT03275740|465037332|FG010|Overall Study|Adverse Event|0|||
129202177|NCT03275740|465037333|FG011|Overall Study|Adverse Event|0|||
129202178|NCT03275740|465037322|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202179|NCT03275740|465037323|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202180|NCT03275740|465037324|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202181|NCT03275740|465037325|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202182|NCT03275740|465037326|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202183|NCT03275740|465037327|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
129202184|NCT03275740|465037328|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202185|NCT03275740|465037329|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202186|NCT03275740|465037330|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202187|NCT03275740|465037331|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202188|NCT03275740|465037332|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202189|NCT03275740|465037333|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129202190|NCT03275740|465037322|FG000|Overall Study|Withdrawal by Subject|0|||
129202191|NCT03275740|465037323|FG001|Overall Study|Withdrawal by Subject|0|||
129202192|NCT03275740|465037324|FG002|Overall Study|Withdrawal by Subject|0|||
129202193|NCT03275740|465037325|FG003|Overall Study|Withdrawal by Subject|0|||
129202194|NCT03275740|465037326|FG004|Overall Study|Withdrawal by Subject|0|||
129202195|NCT03275740|465037327|FG005|Overall Study|Withdrawal by Subject|0|||
129202196|NCT03275740|465037328|FG006|Overall Study|Withdrawal by Subject|0|||
129202197|NCT03275740|465037329|FG007|Overall Study|Withdrawal by Subject|0|||
129202198|NCT03275740|465037330|FG008|Overall Study|Withdrawal by Subject|1|||
129202199|NCT03275740|465037331|FG009|Overall Study|Withdrawal by Subject|1|||
129202200|NCT03275740|465037332|FG010|Overall Study|Withdrawal by Subject|0|||
129202201|NCT03275740|465037333|FG011|Overall Study|Withdrawal by Subject|0|||
128732447|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732448|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732449|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732450|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
128732451|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
128732452|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
128732453|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
128732454|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
128732455|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
128732456|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732457|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732458|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732459|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732460|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732461|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732462|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732463|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732464|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732465|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732466|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732467|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732468|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732469|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732470|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732471|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732472|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732473|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732474|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
128732475|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732476|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
128732477|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
128732478|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
128732479|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
128732480|NCT02346240|463312863|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732481|NCT02346240|463312864|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732482|NCT02346240|463312865|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732483|NCT02346240|463312866|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732484|NCT02346240|463312867|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732485|NCT02346240|463312868|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732486|NCT02346240|463312869|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732487|NCT02346240|463312870|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732488|NCT02346240|463312871|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732489|NCT02346240|463312872|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732490|NCT02346240|463312873|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732491|NCT02346240|463312874|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732492|NCT02346240|463312875|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732493|NCT02346240|463312876|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732494|NCT02346240|463312877|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128781211|NCT01605136|463490505|FG001|Study Period|Lost to Follow-up|2|||
128781212|NCT01605136|463490504|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
129202202|NCT03827655|465037335|FG000|Overall Study|Death|0|||
129202203|NCT03827655|465037336|FG001|Overall Study|Death|0|||
129202204|NCT03827655|465037337|FG002|Overall Study|Death|0|||
129202205|NCT03827655|465037338|FG003|Overall Study|Death|0|||
129202206|NCT03827655|465037339|FG004|Overall Study|Death|1|||
129202207|NCT03827655|465037335|FG000|Overall Study|Protocol Deviation|1|||
129202208|NCT03827655|465037336|FG001|Overall Study|Protocol Deviation|0|||
129202209|NCT03827655|465037337|FG002|Overall Study|Protocol Deviation|1|||
129202210|NCT03827655|465037338|FG003|Overall Study|Protocol Deviation|1|||
129202211|NCT03827655|465037339|FG004|Overall Study|Protocol Deviation|0|||
129202212|NCT03827655|465037335|FG000|Overall Study|Withdrawal by Subject|3|||
129202213|NCT03827655|465037336|FG001|Overall Study|Withdrawal by Subject|2|||
129202214|NCT03827655|465037337|FG002|Overall Study|Withdrawal by Subject|2|||
129202215|NCT03827655|465037338|FG003|Overall Study|Withdrawal by Subject|0|||
128732495|NCT02346240|463312878|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732496|NCT02346240|463312879|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732497|NCT02346240|463312880|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732498|NCT02346240|463312881|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
128732499|NCT02346240|463312882|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732500|NCT02346240|463312883|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732501|NCT02346240|463312884|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732502|NCT02346240|463312885|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129202216|NCT03827655|465037339|FG004|Overall Study|Withdrawal by Subject|1|||
129202217|NCT03827655|465037335|FG000|Overall Study|Reason not Specified|3|||
129202218|NCT03827655|465037336|FG001|Overall Study|Reason not Specified|1|||
129202219|NCT03827655|465037337|FG002|Overall Study|Reason not Specified|1|||
129202220|NCT03827655|465037338|FG003|Overall Study|Reason not Specified|1|||
129202221|NCT03827655|465037339|FG004|Overall Study|Reason not Specified|1|||
129202222|NCT02336607|465037340|FG000|Overall Study|Physician Decision|1|||
129202223|NCT02336607|465037341|FG001|Overall Study|Physician Decision|4|||
129202224|NCT02336607|465037342|FG002|Overall Study|Physician Decision|3|||
129202225|NCT02336607|465037343|FG003|Overall Study|Physician Decision|15|||
129202226|NCT02336607|465037340|FG000|Overall Study|Lack of Efficacy|1|||
129202227|NCT02336607|465037341|FG001|Overall Study|Lack of Efficacy|0|||
129202228|NCT02336607|465037342|FG002|Overall Study|Lack of Efficacy|0|||
129202229|NCT02336607|465037343|FG003|Overall Study|Lack of Efficacy|2|||
129202230|NCT02336607|465037340|FG000|Overall Study|Lost to Follow-up|2|||
129202231|NCT02336607|465037341|FG001|Overall Study|Lost to Follow-up|1|||
129202232|NCT02336607|465037342|FG002|Overall Study|Lost to Follow-up|0|||
129202233|NCT02336607|465037343|FG003|Overall Study|Lost to Follow-up|21|||
129202234|NCT02336607|465037340|FG000|Overall Study|Protocol Violation|0|||
129202235|NCT02336607|465037341|FG001|Overall Study|Protocol Violation|1|||
129202236|NCT02336607|465037342|FG002|Overall Study|Protocol Violation|1|||
129202237|NCT02336607|465037343|FG003|Overall Study|Protocol Violation|3|||
129202238|NCT02336607|465037340|FG000|Overall Study|Adverse Event|0|||
129202239|NCT02336607|465037341|FG001|Overall Study|Adverse Event|2|||
129202240|NCT02336607|465037342|FG002|Overall Study|Adverse Event|2|||
129202241|NCT02336607|465037343|FG003|Overall Study|Adverse Event|26|||
129202242|NCT02336607|465037340|FG000|Overall Study|Withdrawal by Subject|0|||
129202243|NCT02336607|465037341|FG001|Overall Study|Withdrawal by Subject|2|||
129202244|NCT02336607|465037342|FG002|Overall Study|Withdrawal by Subject|0|||
129202245|NCT02336607|465037343|FG003|Overall Study|Withdrawal by Subject|20|||
128732503|NCT02346240|463312886|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
128732504|NCT01573624|463312887|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
128732505|NCT01573624|463312888|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
128732506|NCT01573624|463312889|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
128732507|NCT01573624|463312890|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
128732508|NCT01573624|463312891|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
128732509|NCT01573624|463312892|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
128732510|NCT01573624|463312893|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
128732511|NCT01573624|463312887|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
128732512|NCT01573624|463312888|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
128732513|NCT01573624|463312889|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
128732514|NCT01573624|463312890|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
128732515|NCT01573624|463312891|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
128732516|NCT01573624|463312892|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129202246|NCT02552966|465037344|FG000|Overall Study|Lost to Follow-up|2|||
129202247|NCT02552966|465037344|FG000|Overall Study|Withdrawal by Subject|3|||
128732517|NCT01573624|463312893|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
129202248|NCT01091675|465037349|FG000|Overall Study|Adverse Event|7|||
129202249|NCT01091675|465037349|FG000|Overall Study|Lack of Efficacy|27|||
129202250|NCT00614380|465037353|FG000|Overall Study|Adverse Event|14|||
129202251|NCT00614380|465037354|FG001|Overall Study|Adverse Event|4|||
129202252|NCT00614380|465037355|FG002|Overall Study|Adverse Event|0|||
129202253|NCT00614380|465037356|FG003|Overall Study|Adverse Event|0|||
129202254|NCT00614380|465037353|FG000|Overall Study|Lost to Follow-up|6|||
129202255|NCT00614380|465037354|FG001|Overall Study|Lost to Follow-up|1|||
129202256|NCT00614380|465037355|FG002|Overall Study|Lost to Follow-up|0|||
129202257|NCT00614380|465037356|FG003|Overall Study|Lost to Follow-up|0|||
129202258|NCT00614380|465037353|FG000|Overall Study|Non compliant with the protocol|12|||
129202259|NCT00614380|465037354|FG001|Overall Study|Non compliant with the protocol|2|||
129202260|NCT00614380|465037355|FG002|Overall Study|Non compliant with the protocol|1|||
129202261|NCT00614380|465037356|FG003|Overall Study|Non compliant with the protocol|2|||
129202262|NCT00614380|465037353|FG000|Overall Study|Consent withdrawn|3|||
128732518|NCT01573624|463312887|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
128732519|NCT01573624|463312888|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129202263|NCT00614380|465037354|FG001|Overall Study|Consent withdrawn|1|||
129202264|NCT00614380|465037355|FG002|Overall Study|Consent withdrawn|0|||
129202265|NCT00614380|465037356|FG003|Overall Study|Consent withdrawn|0|||
129202266|NCT01670721|465037370|FG000|Overall Study|Participant's decision|15|||
129202267|NCT01670721|465037370|FG000|Overall Study|Other than specified above|38|||
129202268|NCT01572480|465037371|FG000|Participants Enrolled|Withdrawal by Subject|1|||
129202269|NCT01572480|465037371|FG000|Drug Administration|Discontinued drug/Off Study|1|||
129202270|NCT01572480|465037371|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
129202271|NCT01572480|465037371|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
129202272|NCT06172348|465037372|FG000|Treatment Period 2|Adverse Event|0|||
129202273|NCT06172348|465037373|FG001|Treatment Period 2|Adverse Event|0|||
129202274|NCT06172348|465037374|FG002|Treatment Period 2|Adverse Event|1|||
129202275|NCT06172348|465037375|FG003|Treatment Period 2|Adverse Event|0|||
129202276|NCT06172348|465037376|FG004|Treatment Period 2|Adverse Event|0|||
129202277|NCT06172348|465037377|FG005|Treatment Period 2|Adverse Event|0|||
129202278|NCT00191334|465037378|FG000|Overall Study|Adverse Event|4|||
129202279|NCT00191334|465037378|FG000|Overall Study|Disease Progression or Relapse|8|||
129202280|NCT00191334|465037378|FG000|Overall Study|Physician Decision|1|||
129202281|NCT00191334|465037378|FG000|Overall Study|Withdrawal by Subject|4|||
129202282|NCT05274958|465037379|FG000|Overall Study|Only completed 1 set of PROMs|22|||
129202283|NCT05274958|465037380|FG001|Overall Study|Only completed 1 set of PROMs|35|||
129202284|NCT01420926|465037383|FG000|Overall Study|Adverse Event|6|||
129202285|NCT01420926|465037384|FG001|Overall Study|Adverse Event|4|||
129202286|NCT01420926|465037383|FG000|Overall Study|Death|18|||
129202287|NCT01420926|465037384|FG001|Overall Study|Death|17|||
129202288|NCT01420926|465037383|FG000|Overall Study|Withdrawal by Subject|11|||
129202289|NCT01420926|465037384|FG001|Overall Study|Withdrawal by Subject|17|||
129202290|NCT01420926|465037383|FG000|Overall Study|Non-protocol treatment|17|||
129202291|NCT01420926|465037384|FG001|Overall Study|Non-protocol treatment|20|||
129202292|NCT01420926|465037383|FG000|Overall Study|Physician Decision|8|||
129202293|NCT01420926|465037384|FG001|Overall Study|Physician Decision|5|||
128732520|NCT01573624|463312889|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129202294|NCT01232868|465039600|FG000|Overall Study|Lost to Follow-up|2|||
129202295|NCT01232868|465039601|FG001|Overall Study|Lost to Follow-up|4|||
129202296|NCT04481243|465039602|FG000|Overall Study|Withdrawal by Subject|4|||
129202297|NCT00865345|465039603|FG000|Overall Study|Withdrawal by Subject|2|||
129202298|NCT00387881|465039606|FG000|Overall Study|Lost to Follow-up|23|||
129202299|NCT00387881|465039607|FG001|Overall Study|Lost to Follow-up|23|||
129202300|NCT00387881|465039606|FG000|Overall Study|Protocol Violation|2|||
128732521|NCT01573624|463312890|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
128732522|NCT01573624|463312891|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
128732523|NCT01573624|463312892|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
128732524|NCT01573624|463312893|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
128732525|NCT01573624|463312887|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
128732526|NCT01573624|463312888|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128732527|NCT01573624|463312889|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
128732528|NCT01573624|463312890|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128732529|NCT01573624|463312891|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128732530|NCT01573624|463312892|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
128732531|NCT01573624|463312893|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128732532|NCT01573624|463312887|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
128732533|NCT01573624|463312888|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
128732534|NCT01573624|463312889|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
128732535|NCT01573624|463312890|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
128732536|NCT01573624|463312891|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
128732537|NCT01573624|463312892|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
128732538|NCT01573624|463312893|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
128732539|NCT01573624|463312887|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
128732540|NCT01573624|463312888|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
128732541|NCT01573624|463312889|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
128732542|NCT01573624|463312890|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
128732543|NCT01573624|463312891|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
128732544|NCT01573624|463312892|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
128732545|NCT01573624|463312893|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
128732546|NCT01573624|463312887|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
128732547|NCT01573624|463312888|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
128732548|NCT01573624|463312889|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
128732549|NCT01573624|463312890|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
128732550|NCT01573624|463312891|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
128732551|NCT01573624|463312892|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
128732552|NCT01573624|463312893|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
128732553|NCT01573624|463312887|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
128732554|NCT01573624|463312888|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129202301|NCT00387881|465039607|FG001|Overall Study|Protocol Violation|12|||
129202302|NCT00387881|465039606|FG000|Overall Study|Withdrawal by Subject|15|||
129202303|NCT00387881|465039607|FG001|Overall Study|Withdrawal by Subject|18|||
129202304|NCT00387881|465039606|FG000|Overall Study|Sponsor terminated Study|0|||
129202305|NCT00387881|465039607|FG001|Overall Study|Sponsor terminated Study|1|||
129202306|NCT00387881|465039606|FG000|Overall Study|Not eligible|6|||
129202307|NCT00387881|465039607|FG001|Overall Study|Not eligible|7|||
129202308|NCT00387881|465039606|FG000|Overall Study|No opportunity to treat headache|32|||
129202309|NCT00387881|465039607|FG001|Overall Study|No opportunity to treat headache|34|||
129202310|NCT00387881|465039606|FG000|Overall Study|Not otherwise specified|11|||
129202311|NCT00387881|465039607|FG001|Overall Study|Not otherwise specified|7|||
129202312|NCT03291067|465039608|FG000|Overall Study|Adverse Event|0|||
129202313|NCT03291067|465039609|FG001|Overall Study|Adverse Event|2|||
129202314|NCT03291067|465039610|FG002|Overall Study|Adverse Event|17|||
129202315|NCT03291067|465039611|FG003|Overall Study|Adverse Event|3|||
129202316|NCT03291067|465039608|FG000|Overall Study|Lost to Follow-up|2|||
129202317|NCT03291067|465039609|FG001|Overall Study|Lost to Follow-up|1|||
129202318|NCT03291067|465039610|FG002|Overall Study|Lost to Follow-up|0|||
129202319|NCT03291067|465039611|FG003|Overall Study|Lost to Follow-up|1|||
129202320|NCT03291067|465039608|FG000|Overall Study|Physician Decision|0|||
129202321|NCT03291067|465039609|FG001|Overall Study|Physician Decision|0|||
129202322|NCT03291067|465039610|FG002|Overall Study|Physician Decision|1|||
129202323|NCT03291067|465039611|FG003|Overall Study|Physician Decision|0|||
129202324|NCT03291067|465039608|FG000|Overall Study|Protocol Violation|5|||
129202325|NCT03291067|465039609|FG001|Overall Study|Protocol Violation|3|||
129202326|NCT03291067|465039610|FG002|Overall Study|Protocol Violation|4|||
129202327|NCT03291067|465039611|FG003|Overall Study|Protocol Violation|2|||
129202328|NCT03291067|465039608|FG000|Overall Study|Withdrawal by Subject|3|||
129202329|NCT03291067|465039609|FG001|Overall Study|Withdrawal by Subject|4|||
129202330|NCT03291067|465039610|FG002|Overall Study|Withdrawal by Subject|7|||
129202331|NCT03291067|465039611|FG003|Overall Study|Withdrawal by Subject|5|||
129202332|NCT03291067|465039608|FG000|Overall Study|Other|0|||
129202333|NCT03291067|465039609|FG001|Overall Study|Other|4|||
129202334|NCT03291067|465039610|FG002|Overall Study|Other|4|||
129202335|NCT03291067|465039611|FG003|Overall Study|Other|6|||
129202336|NCT01050634|465039612|FG000|Overall Study|Enrolled, but Not Treated|56|||
129202337|NCT01050634|465039612|FG000|Overall Study|Death|2|||
129202338|NCT01050634|465039612|FG000|Overall Study|Adverse Event|42|||
129202339|NCT01050634|465039612|FG000|Overall Study|Lost to Follow-up|2|||
129202340|NCT01050634|465039612|FG000|Overall Study|Other|21|||
129202341|NCT01050634|465039612|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
129202342|NCT00496015|465039613|FG000|Overall Study|Other|1|||
129202343|NCT00496015|465039614|FG001|Overall Study|Other|0|||
129202344|NCT00496015|465039615|FG002|Overall Study|Other|0|||
129202345|NCT00496015|465039616|FG003|Overall Study|Other|1|||
129202346|NCT00496015|465039617|FG004|Overall Study|Other|0|||
129202347|NCT00527735|465039618|FG000|Overall Study|Disease progression|47|||
129202348|NCT00527735|465039619|FG001|Overall Study|Disease progression|61|||
129202349|NCT00527735|465039620|FG002|Overall Study|Disease progression|53|||
129202350|NCT00527735|465039618|FG000|Overall Study|Death|23|||
129202351|NCT00527735|465039619|FG001|Overall Study|Death|13|||
129202352|NCT00527735|465039620|FG002|Overall Study|Death|15|||
129202353|NCT00527735|465039618|FG000|Overall Study|Completed treatment in treatment phase|14|||
129202354|NCT00527735|465039619|FG001|Overall Study|Completed treatment in treatment phase|13|||
129202355|NCT00527735|465039620|FG002|Overall Study|Completed treatment in treatment phase|18|||
129202356|NCT00527735|465039618|FG000|Overall Study|Adverse Event|10|||
129202357|NCT00527735|465039619|FG001|Overall Study|Adverse Event|6|||
129202358|NCT00527735|465039620|FG002|Overall Study|Adverse Event|7|||
129202359|NCT00527735|465039618|FG000|Overall Study|Not identified|5|||
129202360|NCT00527735|465039619|FG001|Overall Study|Not identified|5|||
129202361|NCT00527735|465039620|FG002|Overall Study|Not identified|5|||
128732555|NCT01573624|463312889|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
128732556|NCT01573624|463312890|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
128732557|NCT01573624|463312891|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128732558|NCT01573624|463312892|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128732559|NCT01573624|463312893|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
128732560|NCT01573624|463312887|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
128732561|NCT01573624|463312888|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
128732562|NCT01573624|463312889|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
128732563|NCT01573624|463312890|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
128732564|NCT01573624|463312891|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129202362|NCT00527735|465039618|FG000|Overall Study|Withdrawal by Subject|5|||
129202363|NCT00527735|465039619|FG001|Overall Study|Withdrawal by Subject|4|||
128732565|NCT01573624|463312892|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
128732566|NCT01573624|463312893|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
128732567|NCT01573624|463312887|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128732568|NCT01573624|463312888|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128732569|NCT01573624|463312889|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128732570|NCT01573624|463312890|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
128732571|NCT01573624|463312891|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128732572|NCT01573624|463312892|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
128732573|NCT01573624|463312893|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
128732574|NCT01573624|463312887|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
128732575|NCT01573624|463312888|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
128732576|NCT01573624|463312889|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
128732577|NCT01573624|463312890|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
128781213|NCT01605136|463490505|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
128781214|NCT01072929|463490506|FG000|Overall Study|Adverse Event|8|||
128781215|NCT01072929|463490507|FG001|Overall Study|Adverse Event|11|||
128781216|NCT01072929|463490508|FG002|Overall Study|Adverse Event|2|||
128781217|NCT01072929|463490506|FG000|Overall Study|Lack of Efficacy|7|||
128781218|NCT01072929|463490507|FG001|Overall Study|Lack of Efficacy|4|||
128781219|NCT01072929|463490508|FG002|Overall Study|Lack of Efficacy|0|||
128781220|NCT01072929|463490506|FG000|Overall Study|Withdrawal by Subject|7|||
128781221|NCT01072929|463490507|FG001|Overall Study|Withdrawal by Subject|15|||
128781222|NCT01072929|463490508|FG002|Overall Study|Withdrawal by Subject|3|||
128781223|NCT01072929|463490506|FG000|Overall Study|Protocol Violation|13|||
128781224|NCT01072929|463490507|FG001|Overall Study|Protocol Violation|11|||
128781225|NCT01072929|463490508|FG002|Overall Study|Protocol Violation|2|||
128781226|NCT01072929|463490506|FG000|Overall Study|Lost to Follow-up|8|||
128781227|NCT01072929|463490507|FG001|Overall Study|Lost to Follow-up|4|||
128781228|NCT01072929|463490508|FG002|Overall Study|Lost to Follow-up|1|||
128781229|NCT01072929|463490506|FG000|Overall Study|Noncompliance with study medication|0|||
128781230|NCT01072929|463490507|FG001|Overall Study|Noncompliance with study medication|3|||
128781231|NCT01072929|463490508|FG002|Overall Study|Noncompliance with study medication|0|||
128781232|NCT01072929|463490506|FG000|Overall Study|Noncompliance with study procedures|1|||
128781233|NCT01072929|463490507|FG001|Overall Study|Noncompliance with study procedures|0|||
128781234|NCT01072929|463490508|FG002|Overall Study|Noncompliance with study procedures|1|||
129202364|NCT00527735|465039620|FG002|Overall Study|Withdrawal by Subject|3|||
129202365|NCT00527735|465039618|FG000|Overall Study|No longer met study criteria|2|||
129202366|NCT00527735|465039619|FG001|Overall Study|No longer met study criteria|2|||
129202367|NCT00527735|465039620|FG002|Overall Study|No longer met study criteria|1|||
129202368|NCT00527735|465039618|FG000|Overall Study|Lost to Follow-up|0|||
129202369|NCT00527735|465039619|FG001|Overall Study|Lost to Follow-up|0|||
129202370|NCT00527735|465039620|FG002|Overall Study|Lost to Follow-up|3|||
129202371|NCT00527735|465039618|FG000|Overall Study|Poor compliance or noncompliance|0|||
129202372|NCT00527735|465039619|FG001|Overall Study|Poor compliance or noncompliance|1|||
129202373|NCT00527735|465039620|FG002|Overall Study|Poor compliance or noncompliance|1|||
129202374|NCT00527735|465039618|FG000|Overall Study|Completed treatment during maintenance|2|||
129202375|NCT00527735|465039619|FG001|Overall Study|Completed treatment during maintenance|2|||
129202376|NCT00527735|465039620|FG002|Overall Study|Completed treatment during maintenance|1|||
129202377|NCT01535807|465039621|FG000|Overall Study|Withdrawal by Subject|1|||
129202378|NCT01535807|465039622|FG001|Overall Study|Withdrawal by Subject|1|||
129202379|NCT01535807|465039621|FG000|Overall Study|Data collection error|1|||
129202380|NCT01535807|465039622|FG001|Overall Study|Data collection error|1|||
129202381|NCT00404651|465039626|FG000|Overall Study|Serious Adverse Event|0|||
129202382|NCT00404651|465039627|FG001|Overall Study|Serious Adverse Event|0|||
129202383|NCT00404651|465039628|FG002|Overall Study|Serious Adverse Event|2|||
129202384|NCT00404651|465039629|FG003|Overall Study|Serious Adverse Event|0|||
129202385|NCT00404651|465039626|FG000|Overall Study|Protocol Violation|10|||
129202386|NCT00404651|465039627|FG001|Overall Study|Protocol Violation|5|||
129202387|NCT00404651|465039628|FG002|Overall Study|Protocol Violation|14|||
129202388|NCT00404651|465039629|FG003|Overall Study|Protocol Violation|5|||
129202389|NCT00404651|465039626|FG000|Overall Study|Lost to Follow-up|15|||
128781235|NCT01072929|463490506|FG000|Overall Study|Other|0|||
128781236|NCT01072929|463490507|FG001|Overall Study|Other|3|||
128781237|NCT01072929|463490508|FG002|Overall Study|Other|0|||
128781238|NCT02929108|463490511|FG000|Overall Study|Hospice patient death|100|||
128781239|NCT02929108|463490512|FG001|Overall Study|Hospice patient death|64|||
129202390|NCT00404651|465039627|FG001|Overall Study|Lost to Follow-up|11|||
129202391|NCT00404651|465039628|FG002|Overall Study|Lost to Follow-up|13|||
129202392|NCT00404651|465039629|FG003|Overall Study|Lost to Follow-up|10|||
129202393|NCT00404651|465039626|FG000|Overall Study|Withdrawal by Subject|14|||
129202394|NCT00404651|465039627|FG001|Overall Study|Withdrawal by Subject|12|||
129202395|NCT00404651|465039628|FG002|Overall Study|Withdrawal by Subject|16|||
129202396|NCT00404651|465039629|FG003|Overall Study|Withdrawal by Subject|6|||
129202397|NCT02123134|465039644|FG000|Overall Study|Withdrawal of consent|3|||
129202398|NCT02123134|465039645|FG001|Overall Study|Withdrawal of consent|2|||
129202399|NCT02123134|465039644|FG000|Overall Study|Administrative decision|0|||
129202400|NCT02123134|465039645|FG001|Overall Study|Administrative decision|1|||
129202401|NCT00764699|465039654|FG000|Overall Study|PI left and study terminated|3|||
129202402|NCT01755234|465039655|FG000|Overall Study|Lost to Follow-up|11|||
129202403|NCT01755234|465039656|FG001|Overall Study|Lost to Follow-up|6|||
129202404|NCT01755234|465039655|FG000|Overall Study|Change in surgical case|2|||
129202405|NCT01755234|465039656|FG001|Overall Study|Change in surgical case|1|||
129202406|NCT01755234|465039655|FG000|Overall Study|case cancelled|1|||
129202407|NCT01755234|465039656|FG001|Overall Study|case cancelled|0|||
129202408|NCT01755234|465039655|FG000|Overall Study|Withdrawal by Subject|0|||
129202409|NCT01755234|465039656|FG001|Overall Study|Withdrawal by Subject|1|||
129202410|NCT01755234|465039655|FG000|Overall Study|unblinded|1|||
129202411|NCT01755234|465039656|FG001|Overall Study|unblinded|0|||
129202412|NCT03001557|465039660|FG000|Core Phase|Randomized but not treated|0|||
129202413|NCT03001557|465039661|FG001|Core Phase|Randomized but not treated|0|||
129202414|NCT03001557|465039662|FG002|Core Phase|Randomized but not treated|1|||
129202415|NCT03001557|465039663|FG003|Core Phase|Randomized but not treated|0|||
129202416|NCT03001557|465039664|FG004|Core Phase|Randomized but not treated|0|||
129202417|NCT03001557|465039665|FG005|Core Phase|Randomized but not treated|0|||
129202418|NCT03001557|465039666|FG006|Core Phase|Randomized but not treated|0|||
129202419|NCT03001557|465039667|FG007|Core Phase|Randomized but not treated|0|||
129202420|NCT03001557|465039660|FG000|Extension Phase|Adverse Event|0|||
129202421|NCT03001557|465039661|FG001|Extension Phase|Adverse Event|0|||
129202422|NCT03001557|465039662|FG002|Extension Phase|Adverse Event|0|||
129202423|NCT03001557|465039663|FG003|Extension Phase|Adverse Event|0|||
128732578|NCT01573624|463312891|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
128732579|NCT01573624|463312892|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
128732580|NCT01573624|463312893|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
128732581|NCT01573624|463312887|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
128732582|NCT01573624|463312888|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
128732583|NCT01573624|463312889|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
128732584|NCT01573624|463312890|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
128732585|NCT01573624|463312891|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
128732586|NCT01573624|463312892|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
128732587|NCT01573624|463312893|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
128732588|NCT01573624|463312887|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
128732589|NCT01573624|463312888|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
128732590|NCT01573624|463312889|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
128732591|NCT01573624|463312890|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
128732592|NCT01573624|463312891|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
128732593|NCT01573624|463312892|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
128732594|NCT01573624|463312893|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
128732595|NCT01573624|463312887|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
128732596|NCT01573624|463312888|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
128732597|NCT01573624|463312889|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
128732598|NCT01573624|463312890|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
128732599|NCT01573624|463312891|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
128781240|NCT02929108|463490513|FG002|Overall Study|Hospice patient death|28|||
129202424|NCT03001557|465039664|FG004|Extension Phase|Adverse Event|0|||
129202425|NCT03001557|465039665|FG005|Extension Phase|Adverse Event|2|||
129202426|NCT03001557|465039666|FG006|Extension Phase|Adverse Event|0|||
129202427|NCT03001557|465039667|FG007|Extension Phase|Adverse Event|0|||
129202428|NCT03001557|465039660|FG000|Extension Phase|Withdrawal by Subject|0|||
129202429|NCT03001557|465039661|FG001|Extension Phase|Withdrawal by Subject|0|||
129202430|NCT03001557|465039662|FG002|Extension Phase|Withdrawal by Subject|0|||
129202431|NCT03001557|465039663|FG003|Extension Phase|Withdrawal by Subject|0|||
129202432|NCT03001557|465039664|FG004|Extension Phase|Withdrawal by Subject|0|||
129202433|NCT03001557|465039665|FG005|Extension Phase|Withdrawal by Subject|1|||
129202434|NCT03001557|465039666|FG006|Extension Phase|Withdrawal by Subject|5|||
129202435|NCT03001557|465039667|FG007|Extension Phase|Withdrawal by Subject|2|||
129202436|NCT03001557|465039660|FG000|Extension Phase|Lost to Follow-up|0|||
129202437|NCT03001557|465039661|FG001|Extension Phase|Lost to Follow-up|0|||
129202438|NCT03001557|465039662|FG002|Extension Phase|Lost to Follow-up|0|||
129202439|NCT03001557|465039663|FG003|Extension Phase|Lost to Follow-up|0|||
129202440|NCT03001557|465039664|FG004|Extension Phase|Lost to Follow-up|0|||
129202441|NCT03001557|465039665|FG005|Extension Phase|Lost to Follow-up|0|||
129202442|NCT03001557|465039666|FG006|Extension Phase|Lost to Follow-up|2|||
129202443|NCT03001557|465039667|FG007|Extension Phase|Lost to Follow-up|1|||
129202444|NCT03001557|465039660|FG000|Extension Phase|Administrative Reason|0|||
129202445|NCT03001557|465039661|FG001|Extension Phase|Administrative Reason|0|||
129202446|NCT03001557|465039662|FG002|Extension Phase|Administrative Reason|0|||
129202447|NCT03001557|465039663|FG003|Extension Phase|Administrative Reason|0|||
129202448|NCT03001557|465039664|FG004|Extension Phase|Administrative Reason|0|||
129202449|NCT03001557|465039665|FG005|Extension Phase|Administrative Reason|1|||
129202450|NCT03001557|465039666|FG006|Extension Phase|Administrative Reason|3|||
129202451|NCT03001557|465039667|FG007|Extension Phase|Administrative Reason|3|||
129202452|NCT03001557|465039660|FG000|Extension Phase|Loss of caregiver|0|||
129202453|NCT03001557|465039661|FG001|Extension Phase|Loss of caregiver|0|||
129202454|NCT03001557|465039662|FG002|Extension Phase|Loss of caregiver|0|||
129202455|NCT03001557|465039663|FG003|Extension Phase|Loss of caregiver|0|||
129202456|NCT03001557|465039664|FG004|Extension Phase|Loss of caregiver|0|||
129202457|NCT03001557|465039665|FG005|Extension Phase|Loss of caregiver|0|||
129202458|NCT03001557|465039666|FG006|Extension Phase|Loss of caregiver|1|||
129202459|NCT03001557|465039667|FG007|Extension Phase|Loss of caregiver|0|||
129202460|NCT03001557|465039660|FG000|Extension Phase|Others|0|||
128781241|NCT02929108|463490514|FG003|Overall Study|Hospice patient death|46|||
129202461|NCT03001557|465039661|FG001|Extension Phase|Others|0|||
129202462|NCT03001557|465039662|FG002|Extension Phase|Others|0|||
129202463|NCT03001557|465039663|FG003|Extension Phase|Others|0|||
129202464|NCT03001557|465039664|FG004|Extension Phase|Others|0|||
129202465|NCT03001557|465039665|FG005|Extension Phase|Others|1|||
129202466|NCT03001557|465039666|FG006|Extension Phase|Others|3|||
129202467|NCT03001557|465039667|FG007|Extension Phase|Others|0|||
129202468|NCT01794000|465039668|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
129202469|NCT01794000|465039669|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
129202470|NCT01794000|465039668|FG000|Double-Blind Phase (DBP)|Death|1|||
129202471|NCT01794000|465039669|FG001|Double-Blind Phase (DBP)|Death|2|||
129202472|NCT01794000|465039668|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
129202473|NCT01794000|465039669|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
129202474|NCT01794000|465039668|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
129202475|NCT01794000|465039669|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
129202476|NCT01794000|465039668|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
129202477|NCT01794000|465039669|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
129202478|NCT01794000|465039668|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
129202479|NCT01794000|465039669|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
129202480|NCT01794000|465039668|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
129202481|NCT01794000|465039669|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
129202482|NCT01794000|465039668|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
129202483|NCT01794000|465039669|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129202484|NCT01176058|465039671|FG000|Overall Study|Adverse Event|1|||
129202485|NCT01176058|465039672|FG001|Overall Study|Adverse Event|0|||
129202486|NCT01176058|465039671|FG000|Overall Study|Insufficient clinical response|2|||
129202487|NCT01176058|465039672|FG001|Overall Study|Insufficient clinical response|2|||
129202488|NCT01176058|465039671|FG000|Overall Study|Insufficient mycological response|0|||
129202489|NCT01176058|465039672|FG001|Overall Study|Insufficient mycological response|1|||
129202490|NCT01176058|465039671|FG000|Overall Study|Withdrawal by Subject|1|||
129202491|NCT01176058|465039672|FG001|Overall Study|Withdrawal by Subject|0|||
129202492|NCT03480152|465039673|FG000|Phase I|Signed consent. Died before treatment.|1|||
129202493|NCT03480152|465039674|FG001|Phase I|Signed consent. Died before treatment.|0|||
129202494|NCT03480152|465039675|FG002|Phase I|Signed consent. Died before treatment.|0|||
129202495|NCT00687401|465039676|FG000|Overall Study|Protocol Violation|7|||
129202496|NCT00687401|465039676|FG000|Overall Study|Adverse Event|6|||
129202497|NCT00687401|465039676|FG000|Overall Study|Lack of Efficacy|6|||
129202498|NCT00687401|465039676|FG000|Overall Study|Withdrawal by Subject|4|||
129202499|NCT00687401|465039676|FG000|Overall Study|Did not return for visit|3|||
129202500|NCT00687401|465039676|FG000|Overall Study|For reasons different from those above|4|||
129202501|NCT02920892|465039677|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
129202502|NCT02920892|465039678|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
129202503|NCT02920892|465039679|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
129202504|NCT02920892|465039677|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
129202505|NCT02920892|465039678|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
129202506|NCT02920892|465039679|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
129202507|NCT02920892|465039677|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
129202508|NCT02920892|465039678|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
129202509|NCT02920892|465039679|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
129202510|NCT02920892|465039677|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
129202511|NCT02920892|465039678|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
129202512|NCT02920892|465039679|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
129202513|NCT02920892|465039677|FG000|Placebo-Controlled Period|Physician Decision|0|||
129202514|NCT02920892|465039678|FG001|Placebo-Controlled Period|Physician Decision|0|||
129202515|NCT02920892|465039679|FG002|Placebo-Controlled Period|Physician Decision|1|||
129202516|NCT02920892|465039677|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
128732600|NCT01573624|463312892|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
128732601|NCT01573624|463312893|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
128732602|NCT01573624|463312887|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
128732603|NCT01573624|463312888|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
128732604|NCT01573624|463312889|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
128732605|NCT01573624|463312890|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
128732606|NCT01573624|463312891|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129202517|NCT02920892|465039678|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
129202518|NCT02920892|465039679|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
129202519|NCT02920892|465039677|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129202520|NCT02920892|465039678|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
129202521|NCT02920892|465039679|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
129202522|NCT02920892|465039677|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
129202523|NCT02920892|465039678|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
129202524|NCT02920892|465039679|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
129202525|NCT02365649|465039680|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202526|NCT02365649|465039681|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202527|NCT02365649|465039682|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202528|NCT02365649|465039683|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
129202529|NCT02365649|465039684|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202530|NCT02365649|465039685|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202531|NCT02365649|465039686|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202532|NCT02365649|465039687|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202533|NCT02365649|465039688|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202534|NCT02365649|465039689|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129202535|NCT02365649|465039680|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
129202536|NCT02365649|465039681|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
129202537|NCT02365649|465039682|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129202538|NCT02365649|465039683|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
129202539|NCT02365649|465039684|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
129202540|NCT02365649|465039685|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
129202541|NCT02365649|465039686|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129202542|NCT02365649|465039687|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129202543|NCT02365649|465039688|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129202544|NCT02365649|465039689|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129202545|NCT02365649|465039680|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
129202546|NCT02365649|465039681|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129202547|NCT02365649|465039682|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129202548|NCT02365649|465039683|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129202549|NCT02365649|465039684|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
129202550|NCT02365649|465039685|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129202551|NCT02365649|465039686|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129202552|NCT02365649|465039687|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129202553|NCT02365649|465039688|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129202554|NCT02365649|465039689|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129202555|NCT02365649|465039680|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
129202556|NCT02365649|465039681|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
129202557|NCT02365649|465039682|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
129202558|NCT02365649|465039683|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
129202559|NCT02365649|465039684|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
128732607|NCT01573624|463312892|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129202560|NCT02365649|465039685|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
129202561|NCT02365649|465039686|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
129202562|NCT02365649|465039687|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
129202563|NCT02365649|465039688|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
129202564|NCT02365649|465039689|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
129202565|NCT02365649|465039680|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
129202566|NCT02365649|465039681|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
128732608|NCT01573624|463312893|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
128732609|NCT01573624|463312887|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
128732610|NCT01573624|463312888|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
128732611|NCT01573624|463312889|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
128732612|NCT01573624|463312890|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
128732613|NCT01573624|463312891|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
128732614|NCT01573624|463312892|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
128732615|NCT01573624|463312893|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
128732616|NCT01573624|463312887|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
128732617|NCT01573624|463312888|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
128732618|NCT01573624|463312889|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
128732619|NCT01573624|463312890|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
128732620|NCT01573624|463312891|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
128732621|NCT01573624|463312892|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
128732622|NCT01573624|463312893|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
128732623|NCT01573624|463312887|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
128732624|NCT01573624|463312888|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
128732625|NCT01573624|463312889|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
128732626|NCT01573624|463312890|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
128732627|NCT01573624|463312891|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
128732628|NCT01573624|463312892|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
128732629|NCT01573624|463312893|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
128732630|NCT01573624|463312887|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
128732631|NCT01573624|463312888|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
128732632|NCT01573624|463312889|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
128732633|NCT01573624|463312890|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
128732634|NCT01573624|463312891|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
128781242|NCT02929108|463490515|FG004|Overall Study|Hospice patient death|55|||
129202567|NCT02365649|465039682|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
129202568|NCT02365649|465039683|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129202569|NCT02365649|465039684|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
128732635|NCT01573624|463312892|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
128732636|NCT01573624|463312893|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
128732637|NCT01573624|463312887|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
128732638|NCT01573624|463312888|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
128732639|NCT01573624|463312889|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
128732640|NCT01573624|463312890|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
128732641|NCT01573624|463312891|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
128732642|NCT01573624|463312892|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
128732643|NCT01573624|463312893|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
128732644|NCT01573624|463312887|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128732645|NCT01573624|463312888|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128732646|NCT01573624|463312889|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128732647|NCT01573624|463312890|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128732648|NCT01573624|463312891|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
128732649|NCT01573624|463312892|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
128732650|NCT01573624|463312893|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
128732651|NCT01573624|463312887|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
128732652|NCT01573624|463312888|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
128732653|NCT01573624|463312889|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
128732654|NCT01573624|463312890|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
128732655|NCT01573624|463312891|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
128732656|NCT01573624|463312892|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
128732657|NCT01573624|463312893|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
128732658|NCT01573624|463312887|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
128732659|NCT01573624|463312888|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
128732660|NCT01573624|463312889|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
128732661|NCT01573624|463312890|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
128732662|NCT01573624|463312891|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
128732663|NCT01573624|463312892|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
128732664|NCT01573624|463312893|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
128732665|NCT01573624|463312887|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
128732666|NCT01573624|463312888|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
128732667|NCT01573624|463312889|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
128732668|NCT01573624|463312890|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
128732669|NCT01573624|463312891|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
128732670|NCT01573624|463312892|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
128732671|NCT01573624|463312893|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
128732672|NCT01573624|463312887|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
128732673|NCT01573624|463312888|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
128732674|NCT01573624|463312889|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
128732675|NCT01573624|463312890|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
128732676|NCT01573624|463312891|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
128732677|NCT01573624|463312892|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
128732678|NCT01573624|463312893|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
128732679|NCT01573624|463312887|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
128732680|NCT01573624|463312888|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
128732681|NCT01573624|463312889|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
128732682|NCT01573624|463312890|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
128732683|NCT01573624|463312891|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
128732684|NCT01573624|463312892|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
128732685|NCT01573624|463312893|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
128732686|NCT01573624|463312887|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
128732687|NCT01573624|463312888|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
128732688|NCT01573624|463312889|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129202570|NCT02365649|465039685|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129202571|NCT02365649|465039686|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129202572|NCT02365649|465039687|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129202573|NCT02365649|465039688|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129202574|NCT02365649|465039689|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129202575|NCT02365649|465039680|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
128732689|NCT01573624|463312890|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
128732690|NCT01573624|463312891|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
128732691|NCT01573624|463312892|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
128732692|NCT01573624|463312893|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
128732693|NCT03417141|463312895|FG000|Overall Study|Withdrawal by Subject|1|||
128732694|NCT03417141|463312895|FG000|Overall Study|Protocol Violation|3|||
128732695|NCT03706690|463312898|FG000|Overall Study|Withdrawal by Subject|8|||
128732696|NCT03706690|463312899|FG001|Overall Study|Withdrawal by Subject|8|||
128732697|NCT03706690|463312898|FG000|Overall Study|Death|143|||
128732698|NCT03706690|463312899|FG001|Overall Study|Death|75|||
128732699|NCT03706690|463312898|FG000|Overall Study|Ongoing at DCO|121|||
128732700|NCT03706690|463312899|FG001|Overall Study|Ongoing at DCO|52|||
128732701|NCT02098109|463312900|FG000|Overall Study|Protocol Violation|3|||
128732702|NCT02098109|463312901|FG001|Overall Study|Protocol Violation|0|||
128732703|NCT04745689|463312902|FG000|Overall Study|Death|9|||
128732704|NCT04745689|463312903|FG001|Overall Study|Death|6|||
128732705|NCT04745689|463312902|FG000|Overall Study|Lost to Follow-up|1|||
128732706|NCT04745689|463312903|FG001|Overall Study|Lost to Follow-up|0|||
128732707|NCT04745689|463312902|FG000|Overall Study|Withdrawal by Subject|2|||
128732708|NCT04745689|463312903|FG001|Overall Study|Withdrawal by Subject|0|||
128732709|NCT04745689|463312902|FG000|Overall Study|Study terminated by sponsor|10|||
128732710|NCT04745689|463312903|FG001|Overall Study|Study terminated by sponsor|3|||
128732711|NCT04346615|463314433|FG000|Overall Study|Lost to Follow-up|0|||
128732712|NCT04346615|463314434|FG001|Overall Study|Lost to Follow-up|2|||
128732713|NCT04346615|463314433|FG000|Overall Study|Withdrawal by Subject|1|||
128732714|NCT04346615|463314434|FG001|Overall Study|Withdrawal by Subject|0|||
128732715|NCT04346615|463314433|FG000|Overall Study|Death|5|||
128732716|NCT04346615|463314434|FG001|Overall Study|Death|1|||
128732717|NCT04346615|463314433|FG000|Overall Study|Other|0|||
128732718|NCT04346615|463314434|FG001|Overall Study|Other|2|||
129202576|NCT02365649|465039681|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129202577|NCT02365649|465039682|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
128732719|NCT04346615|463314433|FG000|Overall Study|Randomized not treated|1|||
128732720|NCT04346615|463314434|FG001|Overall Study|Randomized not treated|0|||
128732721|NCT03285646|463314444|FG000|Overall Study|Adverse Event|1|||
128732722|NCT03285646|463314445|FG001|Overall Study|Adverse Event|0|||
128732723|NCT03285646|463314444|FG000|Overall Study|Withdrawal by Subject|10|||
128732724|NCT03285646|463314445|FG001|Overall Study|Withdrawal by Subject|2|||
128732725|NCT03285646|463314444|FG000|Overall Study|Lost to Follow-up|2|||
128732726|NCT03285646|463314445|FG001|Overall Study|Lost to Follow-up|1|||
128732727|NCT03285646|463314444|FG000|Overall Study|Investigator/Sponsor Decision|0|||
128732728|NCT03285646|463314445|FG001|Overall Study|Investigator/Sponsor Decision|1|||
128732729|NCT02610192|463314447|FG000|Overall Study|Received other treatment|8|||
128732730|NCT02610192|463314447|FG000|Overall Study|Physician Decision|1|||
128732731|NCT00503841|463314448|FG000|Overall Study|All screen failures|44|||
128732732|NCT01344057|463314449|FG000|Overall Study|Premature Withdrawal|1|||
128732733|NCT00306592|463314450|FG000|Overall Study|Adverse Event|8|||
128732734|NCT00306592|463314451|FG001|Overall Study|Adverse Event|15|||
128732735|NCT00306592|463314450|FG000|Overall Study|Lost to Follow-up|1|||
128732736|NCT00306592|463314451|FG001|Overall Study|Lost to Follow-up|0|||
128732737|NCT00306592|463314450|FG000|Overall Study|Noncompliance|0|||
128732738|NCT00306592|463314451|FG001|Overall Study|Noncompliance|2|||
128732739|NCT00306592|463314450|FG000|Overall Study|Persistent Antibodies|6|||
128732740|NCT00306592|463314451|FG001|Overall Study|Persistent Antibodies|3|||
128732741|NCT00306592|463314450|FG000|Overall Study|Voluntary|10|||
129202578|NCT02365649|465039683|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129202579|NCT02365649|465039684|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
129202580|NCT02365649|465039685|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
129202581|NCT02365649|465039686|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129202582|NCT02365649|465039687|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
128732742|NCT00306592|463314451|FG001|Overall Study|Voluntary|6|||
128732743|NCT00306592|463314450|FG000|Overall Study|Other|5|||
128732744|NCT00306592|463314451|FG001|Overall Study|Other|10|||
128732745|NCT00306592|463314450|FG000|Overall Study|Other|1|||
128732746|NCT00306592|463314451|FG001|Overall Study|Other|2|||
128732747|NCT00306592|463314450|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
128732748|NCT00306592|463314451|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
128732749|NCT01440322|463314452|FG000|Overall Study|Discomfort|2|||
128732750|NCT01440322|463314453|FG001|Overall Study|Discomfort|0|||
128732751|NCT01440322|463314452|FG000|Overall Study|Biomicroscopy|1|||
128732752|NCT01440322|463314453|FG001|Overall Study|Biomicroscopy|0|||
128732753|NCT01440322|463314452|FG000|Overall Study|Symptoms and Problems|1|||
128732754|NCT01440322|463314453|FG001|Overall Study|Symptoms and Problems|0|||
128732755|NCT01440322|463314452|FG000|Overall Study|Unacceptable Subjective Vision|1|||
128732756|NCT01440322|463314453|FG001|Overall Study|Unacceptable Subjective Vision|0|||
128732757|NCT01440322|463314452|FG000|Overall Study|Other Product Related|1|||
128732758|NCT01440322|463314453|FG001|Overall Study|Other Product Related|0|||
128732759|NCT01440322|463314452|FG000|Overall Study|Unrelated Medical Problem|0|||
128732760|NCT01440322|463314453|FG001|Overall Study|Unrelated Medical Problem|1|||
128732761|NCT01440322|463314452|FG000|Overall Study|Other Non-Product Related|1|||
128732762|NCT01440322|463314453|FG001|Overall Study|Other Non-Product Related|0|||
128732763|NCT05044234|463314455|FG000|Overall Study|Lost to Follow-up|2|||
128732764|NCT05044234|463314456|FG001|Overall Study|Lost to Follow-up|1|||
128732765|NCT05044234|463314457|FG002|Overall Study|Lost to Follow-up|1|||
128732766|NCT05044234|463314458|FG003|Overall Study|Lost to Follow-up|2|||
128732767|NCT05044234|463314455|FG000|Overall Study|Withdrawal by Subject|6|||
128732768|NCT05044234|463314456|FG001|Overall Study|Withdrawal by Subject|4|||
128732769|NCT05044234|463314457|FG002|Overall Study|Withdrawal by Subject|5|||
128732770|NCT05044234|463314458|FG003|Overall Study|Withdrawal by Subject|8|||
128732771|NCT05044234|463314455|FG000|Overall Study|Study terminated by Sponsor|21|||
128732772|NCT05044234|463314456|FG001|Overall Study|Study terminated by Sponsor|21|||
128732773|NCT05044234|463314457|FG002|Overall Study|Study terminated by Sponsor|20|||
128732774|NCT05044234|463314458|FG003|Overall Study|Study terminated by Sponsor|14|||
128732775|NCT05044234|463314455|FG000|Overall Study|Other, not specified|0|||
128732776|NCT05044234|463314456|FG001|Overall Study|Other, not specified|0|||
128732777|NCT05044234|463314457|FG002|Overall Study|Other, not specified|1|||
128732778|NCT05044234|463314458|FG003|Overall Study|Other, not specified|2|||
128732779|NCT05044234|463314455|FG000|Overall Study|Delayed data entry|0|||
128732780|NCT05044234|463314456|FG001|Overall Study|Delayed data entry|0|||
128732781|NCT05044234|463314457|FG002|Overall Study|Delayed data entry|0|||
128732782|NCT05044234|463314458|FG003|Overall Study|Delayed data entry|1|||
128732783|NCT02896127|463314459|FG000|COMPLETED WEEK 52|Adverse Event|9|||
128732784|NCT02896127|463314460|FG001|COMPLETED WEEK 52|Adverse Event|2|||
128732785|NCT02896127|463314459|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
128732786|NCT02896127|463314460|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
128732787|NCT02896127|463314459|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
128732788|NCT02896127|463314460|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
128732789|NCT02896127|463314459|FG000|COMPLETED WEEK 52|Physician Decision|1|||
128732790|NCT02896127|463314460|FG001|COMPLETED WEEK 52|Physician Decision|1|||
128732791|NCT02896127|463314459|FG000|COMPLETED WEEK 52|Pregnancy|2|||
128732792|NCT02896127|463314460|FG001|COMPLETED WEEK 52|Pregnancy|0|||
128732793|NCT02896127|463314459|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
128732794|NCT02896127|463314460|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
128732795|NCT02896127|463314459|FG000|COMPLETED WEEK 52|Technical problems|1|||
128732796|NCT02896127|463314460|FG001|COMPLETED WEEK 52|Technical problems|0|||
128732797|NCT02896127|463314459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
128732798|NCT02896127|463314460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
128732799|NCT02896127|463314459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
128732800|NCT02896127|463314460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
128732801|NCT02896127|463314459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
128732802|NCT02896127|463314460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
128732803|NCT02896127|463314459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
128732804|NCT02896127|463314460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
128732805|NCT02896127|463314459|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
128732806|NCT02896127|463314460|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
128732807|NCT00279708|463314461|FG000|Overall Study|Withdrawal by Subject|2|||
128732808|NCT00279708|463314462|FG001|Overall Study|Withdrawal by Subject|3|||
128732809|NCT00279708|463314461|FG000|Overall Study|Adverse Event|1|||
128732810|NCT00279708|463314462|FG001|Overall Study|Adverse Event|1|||
128732811|NCT03354429|463314463|FG000|Overall Study|Withdrawal by Subject|8|||
128732812|NCT03354429|463314464|FG001|Overall Study|Withdrawal by Subject|7|||
128732813|NCT03354429|463314463|FG000|Overall Study|Lost to Follow-up|1|||
128732814|NCT03354429|463314464|FG001|Overall Study|Lost to Follow-up|0|||
128732815|NCT02488629|463314465|FG000|Overall Study|Lack of Efficacy|3|||
129202583|NCT02365649|465039688|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129202584|NCT02365649|465039689|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129202585|NCT02365649|465039680|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202586|NCT02365649|465039681|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202587|NCT02365649|465039682|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
129202588|NCT02365649|465039683|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202589|NCT02365649|465039684|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202590|NCT02365649|465039685|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202591|NCT02365649|465039686|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202592|NCT02365649|465039687|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202593|NCT02365649|465039688|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202594|NCT02365649|465039689|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129202595|NCT02365649|465039680|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202596|NCT02365649|465039681|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202597|NCT02365649|465039682|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202598|NCT02365649|465039683|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202599|NCT02365649|465039684|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202600|NCT02365649|465039685|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202601|NCT02365649|465039686|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
129202602|NCT02365649|465039687|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202603|NCT02365649|465039688|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202604|NCT02365649|465039689|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129202605|NCT02365649|465039680|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129202606|NCT02365649|465039681|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129202607|NCT02365649|465039682|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129202608|NCT02365649|465039683|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129202609|NCT02365649|465039684|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129202610|NCT02365649|465039685|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129202611|NCT02365649|465039686|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
129202612|NCT02365649|465039687|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129202613|NCT02365649|465039688|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
129202614|NCT02365649|465039689|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
129202615|NCT02365649|465039680|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129202616|NCT02365649|465039681|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129202617|NCT02365649|465039682|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129202618|NCT02365649|465039683|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129202619|NCT02365649|465039684|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129202620|NCT02365649|465039685|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129202621|NCT02365649|465039686|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
129202622|NCT02365649|465039687|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
129202623|NCT02365649|465039688|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
129202624|NCT02365649|465039689|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
129202625|NCT02365649|465039680|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129202626|NCT02365649|465039681|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129202627|NCT02365649|465039682|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129202628|NCT02365649|465039683|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129202629|NCT02365649|465039684|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129202630|NCT02365649|465039685|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129202631|NCT02365649|465039686|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
129202632|NCT02365649|465039687|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129202633|NCT02365649|465039688|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
129202634|NCT02365649|465039689|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
129202635|NCT02365649|465039680|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202636|NCT02365649|465039681|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202637|NCT02365649|465039682|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202638|NCT02365649|465039683|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202639|NCT02365649|465039684|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202640|NCT02365649|465039685|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202641|NCT02365649|465039686|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
128732816|NCT02488629|463314466|FG001|Overall Study|Lack of Efficacy|1|||
128732817|NCT02488629|463314467|FG002|Overall Study|Lack of Efficacy|0|||
128732818|NCT02488629|463314468|FG003|Overall Study|Lack of Efficacy|0|||
128732819|NCT02488629|463314465|FG000|Overall Study|Withdrawal by Subject|0|||
128732820|NCT02488629|463314466|FG001|Overall Study|Withdrawal by Subject|1|||
128732821|NCT02488629|463314467|FG002|Overall Study|Withdrawal by Subject|0|||
128732822|NCT02488629|463314468|FG003|Overall Study|Withdrawal by Subject|0|||
128732823|NCT02940691|463314469|FG000|Overall Study|Lost to Follow-up|5|||
128732824|NCT02940691|463314469|FG000|Overall Study|Incarceration|1|||
128732825|NCT00654628|463314470|FG000|6-week Active Treatment Period|Adverse Event|9|||
128732826|NCT00654628|463314470|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
128732827|NCT00654628|463314470|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
128732828|NCT00654628|463314470|FG000|6-week Active Treatment Period|Out of window period|1|||
128732829|NCT00654628|463314470|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
128732830|NCT00654628|463314470|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
128732831|NCT01465802|463314473|FG000|Overall Study|Study terminated by sponsor|1|||
128732832|NCT01465802|463314474|FG001|Overall Study|Study terminated by sponsor|0|||
128732833|NCT01465802|463314475|FG002|Overall Study|Study terminated by sponsor|0|||
128732834|NCT01465802|463314476|FG003|Overall Study|Study terminated by sponsor|1|||
128732835|NCT01465802|463314477|FG004|Overall Study|Study terminated by sponsor|7|||
128732836|NCT01465802|463314473|FG000|Overall Study|Withdrawal by Subject|7|||
128732837|NCT01465802|463314474|FG001|Overall Study|Withdrawal by Subject|7|||
128732838|NCT01465802|463314475|FG002|Overall Study|Withdrawal by Subject|0|||
128732839|NCT01465802|463314476|FG003|Overall Study|Withdrawal by Subject|8|||
128732840|NCT01465802|463314477|FG004|Overall Study|Withdrawal by Subject|1|||
128732841|NCT01465802|463314473|FG000|Overall Study|Lost to Follow-up|1|||
128732842|NCT01465802|463314474|FG001|Overall Study|Lost to Follow-up|1|||
128732843|NCT01465802|463314475|FG002|Overall Study|Lost to Follow-up|0|||
128732844|NCT01465802|463314476|FG003|Overall Study|Lost to Follow-up|0|||
128732845|NCT01465802|463314477|FG004|Overall Study|Lost to Follow-up|0|||
128732846|NCT01465802|463314473|FG000|Overall Study|Reason not specified|9|||
128732847|NCT01465802|463314474|FG001|Overall Study|Reason not specified|4|||
128732848|NCT01465802|463314475|FG002|Overall Study|Reason not specified|0|||
128732849|NCT01465802|463314476|FG003|Overall Study|Reason not specified|10|||
128732850|NCT01465802|463314477|FG004|Overall Study|Reason not specified|2|||
128732851|NCT01465802|463314473|FG000|Overall Study|Death|15|||
128732852|NCT01465802|463314474|FG001|Overall Study|Death|12|||
128732853|NCT01465802|463314475|FG002|Overall Study|Death|0|||
128732854|NCT01465802|463314476|FG003|Overall Study|Death|10|||
128732855|NCT01465802|463314477|FG004|Overall Study|Death|2|||
128732856|NCT02331446|463314478|FG000|Overall Study|Lost to Follow-up|2|||
128732857|NCT02331446|463314479|FG001|Overall Study|Lost to Follow-up|1|||
128732858|NCT02331446|463314480|FG002|Overall Study|Lost to Follow-up|0|||
128732859|NCT02331446|463314481|FG003|Overall Study|Lost to Follow-up|1|||
128732860|NCT02331446|463314478|FG000|Overall Study|Personal Problem|2|||
128732861|NCT02331446|463314479|FG001|Overall Study|Personal Problem|0|||
128732862|NCT02331446|463314480|FG002|Overall Study|Personal Problem|0|||
128732863|NCT02331446|463314481|FG003|Overall Study|Personal Problem|0|||
128732864|NCT02331446|463314478|FG000|Overall Study|Disease|0|||
128732865|NCT02331446|463314479|FG001|Overall Study|Disease|2|||
128732866|NCT02331446|463314480|FG002|Overall Study|Disease|2|||
128732867|NCT02331446|463314481|FG003|Overall Study|Disease|1|||
128732868|NCT02331446|463314478|FG000|Overall Study|Physician Decision|0|||
128732869|NCT02331446|463314479|FG001|Overall Study|Physician Decision|1|||
128732870|NCT02331446|463314480|FG002|Overall Study|Physician Decision|0|||
128732871|NCT02331446|463314481|FG003|Overall Study|Physician Decision|1|||
128732872|NCT02331446|463314478|FG000|Overall Study|Lost before baseline analysis|0|||
128732873|NCT02331446|463314479|FG001|Overall Study|Lost before baseline analysis|1|||
128732874|NCT02331446|463314480|FG002|Overall Study|Lost before baseline analysis|1|||
128732875|NCT02331446|463314481|FG003|Overall Study|Lost before baseline analysis|0|||
128732876|NCT02566759|463314482|FG000|All Parts|Withdrawal by Subject|0|||
128732877|NCT02566759|463314483|FG001|All Parts|Withdrawal by Subject|1|||
128732878|NCT02566759|463314484|FG002|All Parts|Withdrawal by Subject|0|||
128732879|NCT02566759|463314485|FG003|All Parts|Withdrawal by Subject|0|||
128732880|NCT02566759|463314486|FG004|All Parts|Withdrawal by Subject|0|||
128732881|NCT02566759|463314487|FG005|All Parts|Withdrawal by Subject|0|||
128732882|NCT02566759|463314488|FG006|All Parts|Withdrawal by Subject|0|||
128732883|NCT02566759|463314489|FG007|All Parts|Withdrawal by Subject|0|||
128732884|NCT02566759|463314490|FG008|All Parts|Withdrawal by Subject|0|||
128732885|NCT02566759|463314491|FG009|All Parts|Withdrawal by Subject|0|||
128732886|NCT02566759|463314492|FG010|All Parts|Withdrawal by Subject|0|||
128732887|NCT02566759|463314493|FG011|All Parts|Withdrawal by Subject|0|||
128732888|NCT02566759|463314494|FG012|All Parts|Withdrawal by Subject|0|||
128732889|NCT02566759|463314495|FG013|All Parts|Withdrawal by Subject|0|||
128732890|NCT02566759|463314496|FG014|All Parts|Withdrawal by Subject|0|||
128732891|NCT02566759|463314497|FG015|All Parts|Withdrawal by Subject|0|||
128732892|NCT02566759|463314498|FG016|All Parts|Withdrawal by Subject|0|||
128732893|NCT02566759|463314482|FG000|All Parts|Adverse Event|0|||
128732894|NCT02566759|463314483|FG001|All Parts|Adverse Event|0|||
128732895|NCT02566759|463314484|FG002|All Parts|Adverse Event|0|||
128732896|NCT02566759|463314485|FG003|All Parts|Adverse Event|0|||
128732897|NCT02566759|463314486|FG004|All Parts|Adverse Event|0|||
128732898|NCT02566759|463314487|FG005|All Parts|Adverse Event|0|||
128732899|NCT02566759|463314488|FG006|All Parts|Adverse Event|0|||
128732900|NCT02566759|463314489|FG007|All Parts|Adverse Event|0|||
128732901|NCT02566759|463314490|FG008|All Parts|Adverse Event|0|||
128732902|NCT02566759|463314491|FG009|All Parts|Adverse Event|0|||
128732903|NCT02566759|463314492|FG010|All Parts|Adverse Event|0|||
128732904|NCT02566759|463314493|FG011|All Parts|Adverse Event|0|||
128732905|NCT02566759|463314494|FG012|All Parts|Adverse Event|1|||
128732906|NCT02566759|463314495|FG013|All Parts|Adverse Event|3|||
128732907|NCT02566759|463314496|FG014|All Parts|Adverse Event|0|||
128732908|NCT02566759|463314497|FG015|All Parts|Adverse Event|0|||
128732909|NCT02566759|463314498|FG016|All Parts|Adverse Event|0|||
128732910|NCT02566759|463314482|FG000|All Parts|Other|0|||
128732911|NCT02566759|463314483|FG001|All Parts|Other|0|||
128732912|NCT02566759|463314484|FG002|All Parts|Other|0|||
128732913|NCT02566759|463314485|FG003|All Parts|Other|0|||
128732914|NCT02566759|463314486|FG004|All Parts|Other|0|||
128732915|NCT02566759|463314487|FG005|All Parts|Other|0|||
128732916|NCT02566759|463314488|FG006|All Parts|Other|0|||
128732917|NCT02566759|463314489|FG007|All Parts|Other|0|||
128732918|NCT02566759|463314490|FG008|All Parts|Other|0|||
128732919|NCT02566759|463314491|FG009|All Parts|Other|0|||
128732920|NCT02566759|463314492|FG010|All Parts|Other|0|||
128732921|NCT02566759|463314493|FG011|All Parts|Other|0|||
128732922|NCT02566759|463314494|FG012|All Parts|Other|0|||
128732923|NCT02566759|463314495|FG013|All Parts|Other|2|||
128732924|NCT02566759|463314496|FG014|All Parts|Other|0|||
128732925|NCT02566759|463314497|FG015|All Parts|Other|0|||
128732926|NCT02566759|463314498|FG016|All Parts|Other|0|||
128732927|NCT02566759|463314482|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732928|NCT02566759|463314483|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732929|NCT02566759|463314484|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732930|NCT02566759|463314485|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732931|NCT02566759|463314486|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732932|NCT02566759|463314487|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732933|NCT02566759|463314488|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732934|NCT02566759|463314489|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732935|NCT02566759|463314490|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732936|NCT02566759|463314491|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732937|NCT02566759|463314492|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732938|NCT02566759|463314493|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732939|NCT02566759|463314494|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732940|NCT02566759|463314495|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732941|NCT02566759|463314496|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732942|NCT02566759|463314497|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
128732943|NCT02566759|463314498|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
128732944|NCT01126541|463314499|FG000|Overall Study|Adverse Event|0|||
128732945|NCT01126541|463314500|FG001|Overall Study|Adverse Event|2|||
128732946|NCT01126541|463314501|FG002|Overall Study|Adverse Event|4|||
128732947|NCT01126541|463314499|FG000|Overall Study|Death|0|||
128732948|NCT01126541|463314500|FG001|Overall Study|Death|1|||
128732949|NCT01126541|463314501|FG002|Overall Study|Death|0|||
128732950|NCT01126541|463314499|FG000|Overall Study|Lack of Efficacy|6|||
128732951|NCT01126541|463314500|FG001|Overall Study|Lack of Efficacy|1|||
128732952|NCT01126541|463314501|FG002|Overall Study|Lack of Efficacy|11|||
128732953|NCT01126541|463314499|FG000|Overall Study|Lost to Follow-up|1|||
128732954|NCT01126541|463314500|FG001|Overall Study|Lost to Follow-up|2|||
128732955|NCT01126541|463314501|FG002|Overall Study|Lost to Follow-up|2|||
128732956|NCT01126541|463314499|FG000|Overall Study|Withdrawal by Subject|2|||
128732957|NCT01126541|463314500|FG001|Overall Study|Withdrawal by Subject|5|||
128732958|NCT01126541|463314501|FG002|Overall Study|Withdrawal by Subject|6|||
128732959|NCT01126541|463314499|FG000|Overall Study|Protocol Violation|0|||
128732960|NCT01126541|463314500|FG001|Overall Study|Protocol Violation|0|||
128732961|NCT01126541|463314501|FG002|Overall Study|Protocol Violation|1|||
128732962|NCT01126541|463314499|FG000|Overall Study|Administrative reason or other|1|||
128732963|NCT01126541|463314500|FG001|Overall Study|Administrative reason or other|1|||
128732964|NCT01126541|463314501|FG002|Overall Study|Administrative reason or other|2|||
128732965|NCT01358981|463314502|FG000|Period 1|Withdrawal by Subject|0|||
128732966|NCT01358981|463314503|FG001|Period 1|Withdrawal by Subject|0|||
128732967|NCT01358981|463314504|FG002|Period 1|Withdrawal by Subject|0|||
128732968|NCT01358981|463314505|FG003|Period 1|Withdrawal by Subject|1|||
128781243|NCT02929108|463490516|FG005|Overall Study|Hospice patient death|28|||
128732969|NCT01358981|463314506|FG004|Period 1|Withdrawal by Subject|0|||
128732970|NCT01358981|463314507|FG005|Period 1|Withdrawal by Subject|0|||
128732971|NCT01358981|463314508|FG006|Period 1|Withdrawal by Subject|0|||
128732972|NCT03025828|463314509|FG000|Overall Study|Lost to Follow-up|1|||
128732973|NCT01020019|463314510|FG000|Overall Study|Lost to Follow-up|21|||
128732974|NCT01020019|463314511|FG001|Overall Study|Lost to Follow-up|18|||
128732975|NCT01020019|463314510|FG000|Overall Study|Adverse Event|1|||
128732976|NCT01020019|463314511|FG001|Overall Study|Adverse Event|5|||
128732977|NCT01020019|463314510|FG000|Overall Study|not interested in treatment|4|||
128732978|NCT01020019|463314511|FG001|Overall Study|not interested in treatment|4|||
128732979|NCT01020019|463314510|FG000|Overall Study|moving|0|||
128732980|NCT01020019|463314511|FG001|Overall Study|moving|2|||
128732981|NCT04958109|463314512|FG000|Overall Study|Withdrawal by Subject|0|||
128732982|NCT04958109|463314513|FG001|Overall Study|Withdrawal by Subject|1|||
128732983|NCT04958109|463314512|FG000|Overall Study|Lost to Follow-up|0|||
128732984|NCT04958109|463314513|FG001|Overall Study|Lost to Follow-up|1|||
128732985|NCT01559311|463314514|FG000|Overall Study|Protocol Violation|0|||
128732986|NCT01559311|463314515|FG001|Overall Study|Protocol Violation|0|||
128732987|NCT01559311|463314516|FG002|Overall Study|Protocol Violation|2|||
128732988|NCT01559311|463314514|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
128732989|NCT01559311|463314515|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
128732990|NCT01559311|463314516|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
128732991|NCT01559311|463314514|FG000|Overall Study|Withdrawal by Subject|2|||
128732992|NCT01559311|463314515|FG001|Overall Study|Withdrawal by Subject|1|||
128732993|NCT01559311|463314516|FG002|Overall Study|Withdrawal by Subject|0|||
128732994|NCT01559311|463314514|FG000|Overall Study|Death|0|||
128732995|NCT01559311|463314515|FG001|Overall Study|Death|2|||
128732996|NCT01559311|463314516|FG002|Overall Study|Death|3|||
128732997|NCT01559311|463314514|FG000|Overall Study|Lost to Follow-up|0|||
128732998|NCT01559311|463314515|FG001|Overall Study|Lost to Follow-up|3|||
128732999|NCT01559311|463314516|FG002|Overall Study|Lost to Follow-up|2|||
128733000|NCT01559311|463314514|FG000|Overall Study|Adverse Event|0|||
128733001|NCT01559311|463314515|FG001|Overall Study|Adverse Event|0|||
128733002|NCT01559311|463314516|FG002|Overall Study|Adverse Event|1|||
128781244|NCT02929108|463490517|FG006|Overall Study|Hospice patient death|78|||
128733003|NCT02143843|463314517|FG000|Overall Study|Adverse Event|8|||
128733004|NCT02143843|463314517|FG000|Overall Study|Lack of Efficacy|2|||
128733005|NCT02143843|463314517|FG000|Overall Study|Withdrawal by Subject|2|||
128733006|NCT01822132|463314521|FG000|Overall Study|Lost to Follow-up|4|||
128733007|NCT01822132|463314522|FG001|Overall Study|Lost to Follow-up|2|||
128733008|NCT02519712|463314525|FG000|Overall Study|Disease Relapse|1|||
128733009|NCT02519712|463314525|FG000|Overall Study|Disease Progression|1|||
128733010|NCT02519712|463314525|FG000|Overall Study|Accruals are donors|2|||
128733011|NCT01482767|463314528|FG000|Overall Study|Death|1|||
128733012|NCT01482767|463314529|FG001|Overall Study|Death|1|||
128733013|NCT01482767|463314528|FG000|Overall Study|Withdrawal by Subject|7|||
128733014|NCT01482767|463314529|FG001|Overall Study|Withdrawal by Subject|5|||
128733015|NCT01482767|463314528|FG000|Overall Study|Lost to Follow-up|12|||
128733016|NCT01482767|463314529|FG001|Overall Study|Lost to Follow-up|6|||
128733017|NCT01482767|463314528|FG000|Overall Study|Adverse Event|0|||
128733018|NCT01482767|463314529|FG001|Overall Study|Adverse Event|3|||
128733019|NCT01482767|463314528|FG000|Overall Study|Site closure|22|||
128733020|NCT01482767|463314529|FG001|Overall Study|Site closure|14|||
128733021|NCT01482767|463314528|FG000|Overall Study|Non-adherence to study requirements|4|||
128733022|NCT01482767|463314529|FG001|Overall Study|Non-adherence to study requirements|7|||
128733023|NCT01482767|463314528|FG000|Overall Study|Alternate HCV treatment|7|||
128733024|NCT01482767|463314529|FG001|Overall Study|Alternate HCV treatment|8|||
128733025|NCT01482767|463314528|FG000|Overall Study|Ineligible|0|||
128733026|NCT01482767|463314529|FG001|Overall Study|Ineligible|5|||
129202642|NCT02365649|465039687|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202643|NCT02365649|465039688|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
129202644|NCT02365649|465039689|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129202645|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
129202646|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
129202647|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
129202648|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
129202649|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
129202650|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
129202651|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
128733027|NCT01482767|463314528|FG000|Overall Study|Nurse error|1|||
128733028|NCT01482767|463314529|FG001|Overall Study|Nurse error|0|||
128733029|NCT01247090|463314530|FG000|Overall Study|Physician Decision|1|||
128733030|NCT01247090|463314531|FG001|Overall Study|Physician Decision|0|||
128733031|NCT01247090|463314532|FG002|Overall Study|Physician Decision|0|||
128733032|NCT01247090|463314530|FG000|Overall Study|Withdrawal by Subject|0|||
129202652|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
128733033|NCT01247090|463314531|FG001|Overall Study|Withdrawal by Subject|1|||
128733034|NCT01247090|463314532|FG002|Overall Study|Withdrawal by Subject|0|||
128733035|NCT00006916|463314534|FG000|Overall Study|Device not inserted|4|||
128733036|NCT00006916|463314534|FG000|Overall Study|Complication of device insertion|1|||
128733037|NCT03385239|463314537|FG000|Overall Study|Voluntary Withdrawal|2|||
128733038|NCT03385239|463314538|FG001|Overall Study|Voluntary Withdrawal|3|||
128733039|NCT03385239|463314539|FG002|Overall Study|Voluntary Withdrawal|2|||
128733040|NCT03385239|463314540|FG003|Overall Study|Voluntary Withdrawal|3|||
128733041|NCT03385239|463314541|FG004|Overall Study|Voluntary Withdrawal|0|||
128733042|NCT03385239|463314537|FG000|Overall Study|Adverse Event|0|||
128733043|NCT03385239|463314538|FG001|Overall Study|Adverse Event|0|||
128733044|NCT03385239|463314539|FG002|Overall Study|Adverse Event|1|||
128733045|NCT03385239|463314540|FG003|Overall Study|Adverse Event|0|||
128781245|NCT00052962|463490518|FG000|Overall Study|Not evaluable|0|||
128781246|NCT00052962|463490519|FG001|Overall Study|Not evaluable|2|||
129202653|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
129202654|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
129202655|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
129202656|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
129202657|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
129202658|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
129202659|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
129202660|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
129202661|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
129202662|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
129202663|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
129202664|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
129202665|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
129202666|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
129202667|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
129202668|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
129202669|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
129202670|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
129202671|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
129202672|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
129202673|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
129202674|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
129202675|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
129202676|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
129202677|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
129202678|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
129202679|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
129202680|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
129202681|NCT02586623|465039694|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
129202682|NCT02586623|465039695|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
129202683|NCT02586623|465039696|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
129202684|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
129202685|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
129202686|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
129202687|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
129202688|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
129202689|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
129202690|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
129202691|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
129202692|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
129202693|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
129202694|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
129202695|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
129202696|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
129202697|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
129202698|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
129202699|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
129202700|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
129202701|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
128733046|NCT03385239|463314541|FG004|Overall Study|Adverse Event|0|||
128733047|NCT03385239|463314537|FG000|Overall Study|Other|0|||
129202702|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
129202703|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
129202704|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
129202705|NCT02586623|465039694|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
129202706|NCT02586623|465039695|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
129202707|NCT02586623|465039696|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
129202708|NCT02910466|465039699|FG000|Overall Study|Adverse Event|1|||
129202709|NCT02910466|465039699|FG000|Overall Study|Withdrawal by Subject|3|||
129202710|NCT02910466|465039699|FG000|Overall Study|Lost to Follow-up|5|||
129202711|NCT02910466|465039699|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
129202712|NCT02910466|465039699|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
129202713|NCT04332107|465039708|FG000|Day 3|Lost to Follow-up|23|||
129202714|NCT04332107|465039709|FG001|Day 3|Lost to Follow-up|14|||
129202715|NCT04332107|465039708|FG000|Day 3|Missing outcome data|3|||
129202716|NCT04332107|465039709|FG001|Day 3|Missing outcome data|6|||
129202717|NCT04332107|465039708|FG000|Day 14|Lost to Follow-up|13|||
129202718|NCT04332107|465039709|FG001|Day 14|Lost to Follow-up|4|||
129202719|NCT04332107|465039708|FG000|Day 14|Missing outcome data|4|||
129202720|NCT04332107|465039709|FG001|Day 14|Missing outcome data|4|||
129202721|NCT04332107|465039708|FG000|Day 21|Lost to Follow-up|10|||
129202722|NCT04332107|465039709|FG001|Day 21|Lost to Follow-up|2|||
129202723|NCT00871871|465039714|FG000|Part I|Adverse Event|0|||
129202724|NCT00871871|465039715|FG001|Part I|Adverse Event|2|||
129202725|NCT00871871|465039716|FG002|Part I|Adverse Event|0|||
129202726|NCT00871871|465039717|FG003|Part I|Adverse Event|0|||
129202727|NCT00871871|465039714|FG000|Part I|Withdrawal by Subject|3|||
129202728|NCT00871871|465039715|FG001|Part I|Withdrawal by Subject|0|||
129202729|NCT00871871|465039716|FG002|Part I|Withdrawal by Subject|0|||
129202730|NCT00871871|465039717|FG003|Part I|Withdrawal by Subject|0|||
129202731|NCT00871871|465039714|FG000|Part I|Laboratory abnormality|0|||
129202732|NCT00871871|465039715|FG001|Part I|Laboratory abnormality|1|||
129202733|NCT00871871|465039716|FG002|Part I|Laboratory abnormality|0|||
129202734|NCT00871871|465039717|FG003|Part I|Laboratory abnormality|0|||
129202735|NCT00871871|465039714|FG000|Part II|Lack of Efficacy|0|||
129202736|NCT00871871|465039715|FG001|Part II|Lack of Efficacy|0|||
129202737|NCT00871871|465039716|FG002|Part II|Lack of Efficacy|1|||
129202738|NCT00871871|465039717|FG003|Part II|Lack of Efficacy|0|||
129202739|NCT00871871|465039714|FG000|Part II|Withdrawal by Subject|0|||
129202740|NCT00871871|465039715|FG001|Part II|Withdrawal by Subject|0|||
129202741|NCT00871871|465039716|FG002|Part II|Withdrawal by Subject|2|||
129202742|NCT00871871|465039717|FG003|Part II|Withdrawal by Subject|1|||
129202743|NCT00871871|465039714|FG000|Part II|Adverse Event|0|||
129202744|NCT00871871|465039715|FG001|Part II|Adverse Event|0|||
129202745|NCT00871871|465039716|FG002|Part II|Adverse Event|1|||
129202746|NCT00871871|465039717|FG003|Part II|Adverse Event|2|||
129202747|NCT00871871|465039714|FG000|Part II|Protocol Violation|0|||
129202748|NCT00871871|465039715|FG001|Part II|Protocol Violation|0|||
129202749|NCT00871871|465039716|FG002|Part II|Protocol Violation|0|||
129202750|NCT00871871|465039717|FG003|Part II|Protocol Violation|1|||
129202751|NCT01808196|465039721|FG000|Overall Study|Lost to Follow-up|1|||
129202752|NCT00479713|465039724|FG000|Overall Study|Adverse Event|8|||
129202753|NCT00479713|465039725|FG001|Overall Study|Adverse Event|6|||
129202754|NCT00479713|465039724|FG000|Overall Study|Death|1|||
129202755|NCT00479713|465039725|FG001|Overall Study|Death|0|||
129202756|NCT00479713|465039724|FG000|Overall Study|Lost to Follow-up|0|||
129202757|NCT00479713|465039725|FG001|Overall Study|Lost to Follow-up|1|||
129202758|NCT00479713|465039724|FG000|Overall Study|Protocol Violation|0|||
129202759|NCT00479713|465039725|FG001|Overall Study|Protocol Violation|1|||
129202760|NCT00479713|465039724|FG000|Overall Study|Withdrawal by Subject|4|||
129202761|NCT00479713|465039725|FG001|Overall Study|Withdrawal by Subject|1|||
129202762|NCT00141102|465039726|FG000|Overall Study|Adverse Event|233|||
129202763|NCT00141102|465039727|FG001|Overall Study|Adverse Event|305|||
129202764|NCT00141102|465039726|FG000|Overall Study|Laboratory Abnormality|9|||
129202765|NCT00141102|465039727|FG001|Overall Study|Laboratory Abnormality|33|||
129202766|NCT00141102|465039726|FG000|Overall Study|Lack of Efficacy|21|||
129202767|NCT00141102|465039727|FG001|Overall Study|Lack of Efficacy|26|||
128733048|NCT03385239|463314538|FG001|Overall Study|Other|0|||
129202768|NCT00141102|465039726|FG000|Overall Study|Lost to Follow-up|29|||
129202769|NCT00141102|465039727|FG001|Overall Study|Lost to Follow-up|32|||
129202770|NCT00141102|465039726|FG000|Overall Study|Other|87|||
129202771|NCT00141102|465039727|FG001|Overall Study|Other|76|||
129202772|NCT00141102|465039726|FG000|Overall Study|Withdrawal by Subject|112|||
129202773|NCT00141102|465039727|FG001|Overall Study|Withdrawal by Subject|142|||
129202774|NCT00141102|465039726|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
129202775|NCT00141102|465039727|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
129202776|NCT00141102|465039726|FG000|Overall Study|Death|2|||
129202777|NCT00141102|465039727|FG001|Overall Study|Death|2|||
129202778|NCT03863509|465039728|FG000|Overall Study|COVID-19 shutdown period|0|||
128781247|NCT00052962|463490518|FG000|Overall Study|Not randomized/not evaluable|1|||
128781248|NCT00052962|463490519|FG001|Overall Study|Not randomized/not evaluable|0|||
128781249|NCT01723774|463490522|FG000|Neoadjuvant|Ki67 > 10%|4|||
128781250|NCT01723774|463490523|FG001|Neoadjuvant|Ki67 > 10%|0|||
129202779|NCT03863509|465039729|FG001|Overall Study|COVID-19 shutdown period|4|||
129202780|NCT03863509|465039730|FG002|Overall Study|COVID-19 shutdown period|0|||
129202781|NCT03863509|465039728|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
129202782|NCT03863509|465039729|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
129202783|NCT03863509|465039730|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
129202784|NCT03863509|465039728|FG000|Overall Study|Lost to Follow-up|8|||
129202785|NCT03863509|465039729|FG001|Overall Study|Lost to Follow-up|0|||
129202786|NCT03863509|465039730|FG002|Overall Study|Lost to Follow-up|2|||
129202787|NCT03863509|465039728|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
129202788|NCT03863509|465039729|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
129202789|NCT03863509|465039730|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
129202790|NCT03863509|465039728|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
129202791|NCT03863509|465039729|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
129202792|NCT03863509|465039730|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
129202793|NCT05579977|465039740|FG000|Treatment Phase|Other|0|||
129202794|NCT05579977|465039741|FG001|Treatment Phase|Other|0|||
129202795|NCT05579977|465039742|FG002|Treatment Phase|Other|0|||
128733049|NCT03385239|463314539|FG002|Overall Study|Other|0|||
128733050|NCT03385239|463314540|FG003|Overall Study|Other|1|||
128733051|NCT03385239|463314541|FG004|Overall Study|Other|0|||
128733052|NCT01574703|463314542|FG000|Overall Study|Adverse Event|0|||
128733053|NCT01574703|463314543|FG001|Overall Study|Adverse Event|2|||
128733054|NCT01574703|463314544|FG002|Overall Study|Adverse Event|1|||
128733055|NCT01574703|463314545|FG003|Overall Study|Adverse Event|1|||
128733056|NCT01574703|463314542|FG000|Overall Study|Protocol Violation|0|||
128733057|NCT01574703|463314543|FG001|Overall Study|Protocol Violation|0|||
129202796|NCT05579977|465039743|FG003|Treatment Phase|Other|2|||
129202797|NCT05579977|465039744|FG004|Treatment Phase|Other|1|||
129202798|NCT05579977|465039745|FG005|Treatment Phase|Other|2|||
129202799|NCT05579977|465039746|FG006|Treatment Phase|Other|1|||
129202800|NCT05579977|465039747|FG007|Treatment Phase|Other|2|||
128733058|NCT01574703|463314544|FG002|Overall Study|Protocol Violation|0|||
128733059|NCT01574703|463314545|FG003|Overall Study|Protocol Violation|1|||
128733060|NCT01574703|463314542|FG000|Overall Study|Unspecified Reason|27|||
128733061|NCT01574703|463314543|FG001|Overall Study|Unspecified Reason|15|||
129202801|NCT05579977|465039748|FG008|Treatment Phase|Other|2|||
129202802|NCT05579977|465039749|FG009|Treatment Phase|Other|1|||
129202803|NCT05579977|465039750|FG010|Treatment Phase|Other|0|||
129202804|NCT05579977|465039751|FG011|Treatment Phase|Other|0|||
129202805|NCT05579977|465039752|FG012|Treatment Phase|Other|3|||
128733062|NCT01574703|463314544|FG002|Overall Study|Unspecified Reason|20|||
128733063|NCT01574703|463314545|FG003|Overall Study|Unspecified Reason|16|||
128733064|NCT01574703|463314542|FG000|Overall Study|Withdrawal by Subject|53|||
128733065|NCT01574703|463314543|FG001|Overall Study|Withdrawal by Subject|52|||
128733066|NCT01574703|463314544|FG002|Overall Study|Withdrawal by Subject|36|||
128733067|NCT01574703|463314545|FG003|Overall Study|Withdrawal by Subject|61|||
129202806|NCT05579977|465039740|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
129202807|NCT05579977|465039741|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
129202808|NCT05579977|465039742|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
129202809|NCT05579977|465039743|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
129202810|NCT05579977|465039744|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
129202811|NCT05579977|465039745|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
129202812|NCT05579977|465039746|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
129202813|NCT05579977|465039747|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
129202814|NCT05579977|465039748|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
129202815|NCT05579977|465039749|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
129202816|NCT05579977|465039750|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
129202817|NCT05579977|465039751|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
129202818|NCT05579977|465039752|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
129202819|NCT05579977|465039740|FG000|Treatment Phase|Withdrawal by Subject|2|||
129202820|NCT05579977|465039741|FG001|Treatment Phase|Withdrawal by Subject|0|||
129202821|NCT05579977|465039742|FG002|Treatment Phase|Withdrawal by Subject|0|||
129202822|NCT05579977|465039743|FG003|Treatment Phase|Withdrawal by Subject|1|||
129202823|NCT05579977|465039744|FG004|Treatment Phase|Withdrawal by Subject|2|||
129202824|NCT05579977|465039745|FG005|Treatment Phase|Withdrawal by Subject|0|||
129202825|NCT05579977|465039746|FG006|Treatment Phase|Withdrawal by Subject|1|||
129202826|NCT05579977|465039747|FG007|Treatment Phase|Withdrawal by Subject|8|||
129202827|NCT05579977|465039748|FG008|Treatment Phase|Withdrawal by Subject|3|||
129202828|NCT05579977|465039749|FG009|Treatment Phase|Withdrawal by Subject|3|||
129202829|NCT05579977|465039750|FG010|Treatment Phase|Withdrawal by Subject|5|||
129202830|NCT05579977|465039751|FG011|Treatment Phase|Withdrawal by Subject|1|||
129202831|NCT05579977|465039752|FG012|Treatment Phase|Withdrawal by Subject|3|||
129202832|NCT05579977|465039740|FG000|Treatment Phase|Study terminated by sponsor|70|||
129202833|NCT05579977|465039741|FG001|Treatment Phase|Study terminated by sponsor|70|||
129202834|NCT05579977|465039742|FG002|Treatment Phase|Study terminated by sponsor|61|||
129202835|NCT05579977|465039743|FG003|Treatment Phase|Study terminated by sponsor|59|||
129202836|NCT05579977|465039744|FG004|Treatment Phase|Study terminated by sponsor|63|||
129202837|NCT05579977|465039745|FG005|Treatment Phase|Study terminated by sponsor|53|||
129202838|NCT05579977|465039746|FG006|Treatment Phase|Study terminated by sponsor|66|||
129202839|NCT05579977|465039747|FG007|Treatment Phase|Study terminated by sponsor|48|||
129202840|NCT05579977|465039748|FG008|Treatment Phase|Study terminated by sponsor|47|||
129202841|NCT05579977|465039749|FG009|Treatment Phase|Study terminated by sponsor|37|||
129202842|NCT05579977|465039750|FG010|Treatment Phase|Study terminated by sponsor|44|||
129202843|NCT05579977|465039751|FG011|Treatment Phase|Study terminated by sponsor|36|||
129202844|NCT05579977|465039752|FG012|Treatment Phase|Study terminated by sponsor|32|||
129202845|NCT05579977|465039740|FG000|Treatment Phase|Pregnancy|0|||
129202846|NCT05579977|465039741|FG001|Treatment Phase|Pregnancy|0|||
129202847|NCT05579977|465039742|FG002|Treatment Phase|Pregnancy|0|||
129202848|NCT05579977|465039743|FG003|Treatment Phase|Pregnancy|0|||
129202849|NCT05579977|465039744|FG004|Treatment Phase|Pregnancy|0|||
129202850|NCT05579977|465039745|FG005|Treatment Phase|Pregnancy|0|||
129202851|NCT05579977|465039746|FG006|Treatment Phase|Pregnancy|0|||
129202852|NCT05579977|465039747|FG007|Treatment Phase|Pregnancy|0|||
129202853|NCT05579977|465039748|FG008|Treatment Phase|Pregnancy|0|||
129202854|NCT05579977|465039749|FG009|Treatment Phase|Pregnancy|1|||
129202855|NCT05579977|465039750|FG010|Treatment Phase|Pregnancy|0|||
129202856|NCT05579977|465039751|FG011|Treatment Phase|Pregnancy|0|||
129202857|NCT05579977|465039752|FG012|Treatment Phase|Pregnancy|0|||
129202858|NCT05579977|465039740|FG000|Treatment Phase|Physician Decision|0|||
129202859|NCT05579977|465039741|FG001|Treatment Phase|Physician Decision|0|||
129202860|NCT05579977|465039742|FG002|Treatment Phase|Physician Decision|0|||
129202861|NCT05579977|465039743|FG003|Treatment Phase|Physician Decision|0|||
129202862|NCT05579977|465039744|FG004|Treatment Phase|Physician Decision|0|||
129202863|NCT05579977|465039745|FG005|Treatment Phase|Physician Decision|0|||
129202864|NCT05579977|465039746|FG006|Treatment Phase|Physician Decision|0|||
129202865|NCT05579977|465039747|FG007|Treatment Phase|Physician Decision|0|||
129202866|NCT05579977|465039748|FG008|Treatment Phase|Physician Decision|0|||
129202867|NCT05579977|465039749|FG009|Treatment Phase|Physician Decision|0|||
129202868|NCT05579977|465039750|FG010|Treatment Phase|Physician Decision|0|||
129202869|NCT05579977|465039751|FG011|Treatment Phase|Physician Decision|1|||
129202870|NCT05579977|465039752|FG012|Treatment Phase|Physician Decision|0|||
129202871|NCT05579977|465039740|FG000|Treatment Phase|Lost to Follow-up|0|||
129202872|NCT05579977|465039741|FG001|Treatment Phase|Lost to Follow-up|0|||
129202873|NCT05579977|465039742|FG002|Treatment Phase|Lost to Follow-up|0|||
129202874|NCT05579977|465039743|FG003|Treatment Phase|Lost to Follow-up|1|||
129202875|NCT05579977|465039744|FG004|Treatment Phase|Lost to Follow-up|1|||
129202876|NCT05579977|465039745|FG005|Treatment Phase|Lost to Follow-up|1|||
129202877|NCT05579977|465039746|FG006|Treatment Phase|Lost to Follow-up|0|||
129202878|NCT05579977|465039747|FG007|Treatment Phase|Lost to Follow-up|1|||
129202879|NCT05579977|465039748|FG008|Treatment Phase|Lost to Follow-up|2|||
129202880|NCT05579977|465039749|FG009|Treatment Phase|Lost to Follow-up|2|||
129202881|NCT05579977|465039750|FG010|Treatment Phase|Lost to Follow-up|1|||
129202882|NCT05579977|465039751|FG011|Treatment Phase|Lost to Follow-up|4|||
129202883|NCT05579977|465039752|FG012|Treatment Phase|Lost to Follow-up|3|||
129202884|NCT05579977|465039740|FG000|Treatment Phase|Death|1|||
129202885|NCT05579977|465039741|FG001|Treatment Phase|Death|0|||
129202886|NCT05579977|465039742|FG002|Treatment Phase|Death|0|||
129202887|NCT05579977|465039743|FG003|Treatment Phase|Death|0|||
129202888|NCT05579977|465039744|FG004|Treatment Phase|Death|0|||
129202889|NCT05579977|465039745|FG005|Treatment Phase|Death|0|||
129202890|NCT05579977|465039746|FG006|Treatment Phase|Death|0|||
129202891|NCT05579977|465039747|FG007|Treatment Phase|Death|0|||
129202892|NCT05579977|465039748|FG008|Treatment Phase|Death|0|||
129202893|NCT05579977|465039749|FG009|Treatment Phase|Death|0|||
129202894|NCT05579977|465039750|FG010|Treatment Phase|Death|0|||
129202895|NCT05579977|465039751|FG011|Treatment Phase|Death|0|||
129202896|NCT05579977|465039752|FG012|Treatment Phase|Death|0|||
129202897|NCT05579977|465039740|FG000|Treatment Phase|Adverse Event|0|||
129202898|NCT05579977|465039741|FG001|Treatment Phase|Adverse Event|3|||
129202899|NCT05579977|465039742|FG002|Treatment Phase|Adverse Event|11|||
129202900|NCT05579977|465039743|FG003|Treatment Phase|Adverse Event|10|||
129202901|NCT05579977|465039744|FG004|Treatment Phase|Adverse Event|5|||
129202902|NCT05579977|465039745|FG005|Treatment Phase|Adverse Event|17|||
129202903|NCT05579977|465039746|FG006|Treatment Phase|Adverse Event|5|||
129202904|NCT05579977|465039747|FG007|Treatment Phase|Adverse Event|5|||
129202905|NCT05579977|465039748|FG008|Treatment Phase|Adverse Event|12|||
129202906|NCT05579977|465039749|FG009|Treatment Phase|Adverse Event|20|||
129202907|NCT05579977|465039750|FG010|Treatment Phase|Adverse Event|15|||
129202908|NCT05579977|465039751|FG011|Treatment Phase|Adverse Event|24|||
129202909|NCT05579977|465039752|FG012|Treatment Phase|Adverse Event|23|||
129202910|NCT05579977|465039740|FG000|Treatment Phase|Randomized not treated|0|||
129202911|NCT05579977|465039741|FG001|Treatment Phase|Randomized not treated|0|||
129202912|NCT05579977|465039742|FG002|Treatment Phase|Randomized not treated|0|||
129202913|NCT05579977|465039743|FG003|Treatment Phase|Randomized not treated|0|||
129202914|NCT05579977|465039744|FG004|Treatment Phase|Randomized not treated|1|||
129202915|NCT05579977|465039745|FG005|Treatment Phase|Randomized not treated|0|||
129202916|NCT05579977|465039746|FG006|Treatment Phase|Randomized not treated|0|||
129202917|NCT05579977|465039747|FG007|Treatment Phase|Randomized not treated|0|||
129202918|NCT05579977|465039748|FG008|Treatment Phase|Randomized not treated|0|||
129202919|NCT05579977|465039749|FG009|Treatment Phase|Randomized not treated|0|||
129202920|NCT05579977|465039750|FG010|Treatment Phase|Randomized not treated|0|||
129202921|NCT05579977|465039751|FG011|Treatment Phase|Randomized not treated|0|||
129202922|NCT05579977|465039752|FG012|Treatment Phase|Randomized not treated|0|||
129202923|NCT05579977|465039740|FG000|Follow up|Death|1|||
129202924|NCT05579977|465039741|FG001|Follow up|Death|0|||
129202925|NCT05579977|465039742|FG002|Follow up|Death|0|||
129202926|NCT05579977|465039743|FG003|Follow up|Death|0|||
129202927|NCT05579977|465039744|FG004|Follow up|Death|0|||
129202928|NCT05579977|465039745|FG005|Follow up|Death|0|||
129202929|NCT05579977|465039746|FG006|Follow up|Death|0|||
129202930|NCT05579977|465039747|FG007|Follow up|Death|0|||
129202931|NCT05579977|465039748|FG008|Follow up|Death|0|||
129202932|NCT05579977|465039749|FG009|Follow up|Death|0|||
129202933|NCT05579977|465039750|FG010|Follow up|Death|0|||
129202934|NCT05579977|465039751|FG011|Follow up|Death|0|||
129202935|NCT05579977|465039752|FG012|Follow up|Death|0|||
129202936|NCT05579977|465039740|FG000|Follow up|Lost to Follow-up|0|||
129202937|NCT05579977|465039741|FG001|Follow up|Lost to Follow-up|0|||
129202938|NCT05579977|465039742|FG002|Follow up|Lost to Follow-up|0|||
129202939|NCT05579977|465039743|FG003|Follow up|Lost to Follow-up|1|||
129202940|NCT05579977|465039744|FG004|Follow up|Lost to Follow-up|1|||
129202941|NCT05579977|465039745|FG005|Follow up|Lost to Follow-up|2|||
129202942|NCT05579977|465039746|FG006|Follow up|Lost to Follow-up|1|||
128733068|NCT01574703|463314542|FG000|Overall Study|Met Withdrawal Criteria|0|||
128733069|NCT01574703|463314543|FG001|Overall Study|Met Withdrawal Criteria|1|||
129202943|NCT05579977|465039747|FG007|Follow up|Lost to Follow-up|1|||
129202944|NCT05579977|465039748|FG008|Follow up|Lost to Follow-up|3|||
129202945|NCT05579977|465039749|FG009|Follow up|Lost to Follow-up|2|||
129202946|NCT05579977|465039750|FG010|Follow up|Lost to Follow-up|2|||
129202947|NCT05579977|465039751|FG011|Follow up|Lost to Follow-up|4|||
129202948|NCT05579977|465039752|FG012|Follow up|Lost to Follow-up|4|||
129202949|NCT05579977|465039740|FG000|Follow up|Withdrawal by Subject|2|||
129202950|NCT05579977|465039741|FG001|Follow up|Withdrawal by Subject|0|||
129202951|NCT05579977|465039742|FG002|Follow up|Withdrawal by Subject|0|||
129202952|NCT05579977|465039743|FG003|Follow up|Withdrawal by Subject|0|||
129202953|NCT05579977|465039744|FG004|Follow up|Withdrawal by Subject|1|||
129202954|NCT05579977|465039745|FG005|Follow up|Withdrawal by Subject|0|||
129202955|NCT05579977|465039746|FG006|Follow up|Withdrawal by Subject|1|||
129202956|NCT05579977|465039747|FG007|Follow up|Withdrawal by Subject|4|||
129202957|NCT05579977|465039748|FG008|Follow up|Withdrawal by Subject|2|||
129202958|NCT05579977|465039749|FG009|Follow up|Withdrawal by Subject|3|||
129202959|NCT05579977|465039750|FG010|Follow up|Withdrawal by Subject|3|||
129202960|NCT05579977|465039751|FG011|Follow up|Withdrawal by Subject|1|||
128733070|NCT01574703|463314544|FG002|Overall Study|Met Withdrawal Criteria|1|||
128733071|NCT01574703|463314545|FG003|Overall Study|Met Withdrawal Criteria|0|||
128733072|NCT01574703|463314542|FG000|Overall Study|Lost to Follow-up|43|||
128733073|NCT01574703|463314543|FG001|Overall Study|Lost to Follow-up|41|||
128781251|NCT01723774|463490524|FG002|Neoadjuvant|Ki67 > 10%|10|||
128781252|NCT01723774|463490525|FG003|Neoadjuvant|Ki67 > 10%|0|||
128781253|NCT01723774|463490522|FG000|Neoadjuvant|Withdrawal by Subject|3|||
128781254|NCT01723774|463490523|FG001|Neoadjuvant|Withdrawal by Subject|1|||
128781255|NCT01723774|463490524|FG002|Neoadjuvant|Withdrawal by Subject|0|||
128781256|NCT01723774|463490525|FG003|Neoadjuvant|Withdrawal by Subject|0|||
128781257|NCT01723774|463490522|FG000|Neoadjuvant|Disease progression|0|||
128781258|NCT01723774|463490523|FG001|Neoadjuvant|Disease progression|1|||
128781259|NCT01723774|463490524|FG002|Neoadjuvant|Disease progression|1|||
128781260|NCT01723774|463490525|FG003|Neoadjuvant|Disease progression|0|||
128781261|NCT01723774|463490522|FG000|Neoadjuvant|Adverse Event|0|||
128781262|NCT01723774|463490523|FG001|Neoadjuvant|Adverse Event|1|||
128781263|NCT01723774|463490524|FG002|Neoadjuvant|Adverse Event|2|||
128781264|NCT01723774|463490525|FG003|Neoadjuvant|Adverse Event|0|||
128781265|NCT01723774|463490522|FG000|Neoadjuvant|High estradiol|0|||
128781266|NCT01723774|463490523|FG001|Neoadjuvant|High estradiol|1|||
128781267|NCT01723774|463490524|FG002|Neoadjuvant|High estradiol|0|||
128733074|NCT01574703|463314544|FG002|Overall Study|Lost to Follow-up|46|||
128733075|NCT01574703|463314545|FG003|Overall Study|Lost to Follow-up|35|||
128733076|NCT01574703|463314542|FG000|Overall Study|Death|2|||
128733077|NCT01574703|463314543|FG001|Overall Study|Death|1|||
128733078|NCT01574703|463314544|FG002|Overall Study|Death|1|||
128733079|NCT01574703|463314545|FG003|Overall Study|Death|0|||
128733080|NCT03467425|463314547|FG000|Overall Study|Adverse Event|9|||
128733081|NCT03467425|463314548|FG001|Overall Study|Adverse Event|9|||
128733082|NCT03467425|463314547|FG000|Overall Study|Lack of Efficacy|3|||
128733083|NCT03467425|463314548|FG001|Overall Study|Lack of Efficacy|1|||
128733084|NCT03467425|463314547|FG000|Overall Study|Protocol Violation|0|||
128733085|NCT03467425|463314548|FG001|Overall Study|Protocol Violation|1|||
128733086|NCT03467425|463314547|FG000|Overall Study|Lost to Follow-up|18|||
128733087|NCT03467425|463314548|FG001|Overall Study|Lost to Follow-up|25|||
128733088|NCT03467425|463314547|FG000|Overall Study|Physician Decision|2|||
128733089|NCT03467425|463314548|FG001|Overall Study|Physician Decision|1|||
128733090|NCT03467425|463314547|FG000|Overall Study|Withdrawal by Subject|15|||
128733091|NCT03467425|463314548|FG001|Overall Study|Withdrawal by Subject|17|||
128733092|NCT02318693|463314549|FG000|Overall Study|Protocol Violation|0|||
128733093|NCT02318693|463314550|FG001|Overall Study|Protocol Violation|1|||
128733094|NCT00025883|463314551|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
128733095|NCT00025883|463314551|FG000|Overall Study|no baseline data|1|||
128733096|NCT00025883|463314551|FG000|Overall Study|Death|1|||
128733097|NCT00025883|463314551|FG000|Overall Study|Adverse Event|1|||
128733098|NCT00025883|463314551|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
128733099|NCT01282216|463314552|FG000|Overall Study|Graft failure|0|||
128733100|NCT01282216|463314553|FG001|Overall Study|Graft failure|0|||
128733101|NCT01282216|463314554|FG002|Overall Study|Graft failure|3|||
128733102|NCT01282216|463314555|FG003|Overall Study|Graft failure|2|||
128733103|NCT01282216|463314552|FG000|Overall Study|Physician Decision|0|||
128733104|NCT01282216|463314553|FG001|Overall Study|Physician Decision|0|||
128733105|NCT01282216|463314554|FG002|Overall Study|Physician Decision|11|||
128733106|NCT01282216|463314555|FG003|Overall Study|Physician Decision|0|||
128781268|NCT01723774|463490525|FG003|Neoadjuvant|High estradiol|0|||
128781269|NCT02487446|463490531|FG000|Period 1|Physician Decision|0|||
128781270|NCT02487446|463490532|FG001|Period 1|Physician Decision|1|||
128781271|NCT02487446|463490531|FG000|Period 1|Lack of Efficacy|1|||
128781272|NCT02487446|463490532|FG001|Period 1|Lack of Efficacy|0|||
128733107|NCT01282216|463314552|FG000|Overall Study|Relapse|0|||
128733108|NCT01282216|463314553|FG001|Overall Study|Relapse|0|||
128733109|NCT01282216|463314554|FG002|Overall Study|Relapse|17|||
128781273|NCT02487446|463490531|FG000|Period 1|Protocol deviation|3|||
128781274|NCT02487446|463490532|FG001|Period 1|Protocol deviation|2|||
128733110|NCT01282216|463314555|FG003|Overall Study|Relapse|6|||
128733111|NCT01282216|463314552|FG000|Overall Study|Death|0|||
128733112|NCT01282216|463314553|FG001|Overall Study|Death|0|||
128733113|NCT01282216|463314554|FG002|Overall Study|Death|2|||
128733114|NCT01282216|463314555|FG003|Overall Study|Death|0|||
128733115|NCT01387607|463314556|FG000|Overall Study|Adverse Event|23|||
129202961|NCT05579977|465039752|FG012|Follow up|Withdrawal by Subject|3|||
129202962|NCT00866814|465039753|FG000|Overall Study|Lost to Follow-up|12|||
129202963|NCT00866814|465039753|FG000|Overall Study|Adverse Event|2|||
129202964|NCT00866814|465039753|FG000|Overall Study|Physician Decision|1|||
129202965|NCT00866814|465039753|FG000|Overall Study|Death|1|||
129202966|NCT00866814|465039753|FG000|Overall Study|No longer wished to participate|1|||
129202967|NCT00866814|465039753|FG000|Overall Study|Unable to meet follow-up requirements|2|||
129202968|NCT00866814|465039753|FG000|Overall Study|Moved to area without study site|1|||
129202969|NCT01063153|465039755|FG000|Overall Study|Found Ineligible During Screening|2|||
129202970|NCT01063153|465039756|FG001|Overall Study|Found Ineligible During Screening|0|||
129202971|NCT01063153|465039755|FG000|Overall Study|Lost to Follow-up|0|||
129202972|NCT01063153|465039756|FG001|Overall Study|Lost to Follow-up|7|||
129202973|NCT01063153|465039755|FG000|Overall Study|Withdrawal by Subject|0|||
129202974|NCT01063153|465039756|FG001|Overall Study|Withdrawal by Subject|1|||
129202975|NCT01063153|465039755|FG000|Overall Study|Physician Decision|0|||
129202976|NCT01063153|465039756|FG001|Overall Study|Physician Decision|4|||
129202977|NCT00350844|465039757|FG000|Overall Study|Lost to Follow-up|1|||
129202978|NCT02775916|465039760|FG000|Overall Study|Adverse Event|1|||
129202979|NCT02775916|465039761|FG001|Overall Study|Adverse Event|0|||
129202980|NCT02775916|465039760|FG000|Overall Study|Subject/Guardian Decision|2|||
129202981|NCT02775916|465039761|FG001|Overall Study|Subject/Guardian Decision|0|||
129202982|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129202983|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
129202984|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129202985|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129202986|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129202987|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
129202988|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
129202989|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
129202990|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
129202991|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
129202992|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
129202993|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
129202994|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
129202995|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
129202996|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
129202997|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
129202998|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
129202999|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
129203000|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
129203001|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
129203002|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
129203003|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
129203004|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
129203005|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
129203006|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
129203007|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
129203008|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
129203009|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
129203010|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
129203011|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
129203012|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
129203013|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
129203014|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
129203015|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
129203016|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
129203017|NCT02831764|465042290|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129203018|NCT02831764|465042291|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
128733116|NCT01387607|463314557|FG001|Overall Study|Adverse Event|11|||
128733117|NCT01387607|463314556|FG000|Overall Study|Lack of Efficacy|8|||
128733118|NCT01387607|463314557|FG001|Overall Study|Lack of Efficacy|6|||
128733119|NCT01387607|463314556|FG000|Overall Study|Lost to Follow-up|2|||
128733120|NCT01387607|463314557|FG001|Overall Study|Lost to Follow-up|1|||
128733121|NCT01387607|463314556|FG000|Overall Study|No longer meets eligibility criteria|0|||
128733122|NCT01387607|463314557|FG001|Overall Study|No longer meets eligibility criteria|1|||
128733123|NCT01387607|463314556|FG000|Overall Study|Protocol Violation|1|||
128733124|NCT01387607|463314557|FG001|Overall Study|Protocol Violation|5|||
128733125|NCT01387607|463314556|FG000|Overall Study|Withdrawal by Subject|13|||
128733126|NCT01387607|463314557|FG001|Overall Study|Withdrawal by Subject|14|||
128733127|NCT01387607|463314556|FG000|Overall Study|Other|1|||
128733128|NCT01387607|463314557|FG001|Overall Study|Other|1|||
128733129|NCT01387607|463314556|FG000|Overall Study|Randomized, not treated|3|||
128733130|NCT01387607|463314557|FG001|Overall Study|Randomized, not treated|6|||
128733131|NCT03080961|463314558|FG000|Overall Study|Withdrawal by Subject|3|||
128733132|NCT04084769|463314567|FG000|Overall Study|Protocol Violation|1|||
128733133|NCT04084769|463314568|FG001|Overall Study|Protocol Violation|3|||
128733134|NCT04084769|463314569|FG002|Overall Study|Protocol Violation|0|||
128733135|NCT04084769|463314570|FG003|Overall Study|Protocol Violation|1|||
128733136|NCT04084769|463314567|FG000|Overall Study|Withdrawal by Subject|0|||
128733137|NCT04084769|463314568|FG001|Overall Study|Withdrawal by Subject|1|||
128733138|NCT04084769|463314569|FG002|Overall Study|Withdrawal by Subject|0|||
128733139|NCT04084769|463314570|FG003|Overall Study|Withdrawal by Subject|0|||
128733140|NCT04084769|463314567|FG000|Overall Study|Withdrawal by parent/guardian|1|||
128733141|NCT04084769|463314568|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128733142|NCT04084769|463314569|FG002|Overall Study|Withdrawal by parent/guardian|0|||
128733143|NCT04084769|463314570|FG003|Overall Study|Withdrawal by parent/guardian|1|||
128733144|NCT04084769|463314567|FG000|Overall Study|Lost to Follow-up|2|||
128733145|NCT04084769|463314568|FG001|Overall Study|Lost to Follow-up|0|||
128733146|NCT04084769|463314569|FG002|Overall Study|Lost to Follow-up|0|||
128733147|NCT04084769|463314570|FG003|Overall Study|Lost to Follow-up|0|||
128733148|NCT03390504|463314571|FG000|Overall Study|Lost to Follow-up|2|||
128733149|NCT03390504|463314572|FG001|Overall Study|Lost to Follow-up|4|||
129203019|NCT02831764|465042292|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129203020|NCT02831764|465042293|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129203021|NCT02831764|465042294|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129203022|NCT02831764|465042290|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129203023|NCT02831764|465042291|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129203024|NCT02831764|465042292|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
129203025|NCT02831764|465042293|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
129203026|NCT02831764|465042294|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129203027|NCT02831764|465042290|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129203028|NCT02831764|465042291|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129203029|NCT02831764|465042292|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
129203030|NCT02831764|465042293|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129203031|NCT02831764|465042294|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129203032|NCT02831764|465042290|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129203033|NCT02831764|465042291|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129203034|NCT02831764|465042292|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
129203035|NCT02831764|465042293|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
129203036|NCT02831764|465042294|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129203037|NCT02831764|465042290|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129203038|NCT02831764|465042291|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129203039|NCT02831764|465042292|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
129203040|NCT02831764|465042293|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129203041|NCT02831764|465042294|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129203042|NCT02831764|465042290|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129203043|NCT02831764|465042291|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129203044|NCT02831764|465042292|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
129203045|NCT02831764|465042293|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
129203046|NCT02831764|465042294|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129203047|NCT02831764|465042290|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129203048|NCT02831764|465042291|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129203049|NCT02831764|465042292|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
129203050|NCT02831764|465042293|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
129203051|NCT02831764|465042294|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129203052|NCT02831764|465042290|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129203053|NCT02831764|465042291|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129203054|NCT02831764|465042292|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
129203055|NCT02831764|465042293|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
129203056|NCT02831764|465042294|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129203057|NCT02831764|465042290|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129203058|NCT02831764|465042291|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129203059|NCT02831764|465042292|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129203060|NCT02831764|465042293|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129203061|NCT02831764|465042294|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
129203062|NCT02831764|465042290|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129203063|NCT02831764|465042291|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129203064|NCT02831764|465042292|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129203065|NCT02831764|465042293|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129203066|NCT02831764|465042294|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
129203067|NCT02831764|465042290|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129203068|NCT02831764|465042291|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129203069|NCT02831764|465042292|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129203070|NCT02831764|465042293|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129203071|NCT02831764|465042294|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
129203072|NCT02831764|465042290|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129203073|NCT02831764|465042291|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129203074|NCT02831764|465042292|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129203075|NCT02831764|465042293|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129203076|NCT02831764|465042294|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
129203077|NCT04564846|465042295|FG000|Overall Study|Withdrawal by Subject|2|||
129203078|NCT04564846|465042296|FG001|Overall Study|Withdrawal by Subject|1|||
129203079|NCT04564846|465042295|FG000|Overall Study|Physician Decision|0|||
129203080|NCT04564846|465042296|FG001|Overall Study|Physician Decision|1|||
129203081|NCT04564846|465042295|FG000|Overall Study|Lost to Follow-up|0|||
129203082|NCT04564846|465042296|FG001|Overall Study|Lost to Follow-up|1|||
129203083|NCT04564846|465042295|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
129203084|NCT04564846|465042296|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
129203085|NCT04564846|465042295|FG000|Overall Study|Subject non-compliance|1|||
129203086|NCT04564846|465042296|FG001|Overall Study|Subject non-compliance|0|||
129203087|NCT03737123|465042297|FG000|Study Treatment|Adverse Event|2|||
129203088|NCT03737123|465042298|FG001|Study Treatment|Adverse Event|0|||
129203089|NCT03737123|465042297|FG000|Study Treatment|Disease Progression|2|||
129203090|NCT03737123|465042298|FG001|Study Treatment|Disease Progression|0|||
129203091|NCT03737123|465042297|FG000|Study Treatment|Withdrawal by Subject|2|||
129203092|NCT03737123|465042298|FG001|Study Treatment|Withdrawal by Subject|0|||
129203093|NCT03737123|465042297|FG000|Follow up|Death|1|||
129203094|NCT03737123|465042298|FG001|Follow up|Death|0|||
129203095|NCT03737123|465042297|FG000|Follow up|Withdrawal by Subject|1|||
129203096|NCT03737123|465042298|FG001|Follow up|Withdrawal by Subject|0|||
129203097|NCT03737123|465042297|FG000|Follow up|Termination of study|4|||
129203098|NCT03737123|465042298|FG001|Follow up|Termination of study|0|||
129203099|NCT02173769|465042299|FG000|Overall Study|Protocol Violation|4|||
129203100|NCT04388111|465042300|FG000|Overall Study|Lost to Follow-up|5|||
129203101|NCT04388111|465042301|FG001|Overall Study|Lost to Follow-up|3|||
129203102|NCT04388111|465042300|FG000|Overall Study|Adverse Event|1|||
129203103|NCT04388111|465042301|FG001|Overall Study|Adverse Event|1|||
129203104|NCT04388111|465042300|FG000|Overall Study|Protocol Violation|2|||
129203105|NCT04388111|465042301|FG001|Overall Study|Protocol Violation|4|||
129203106|NCT04388111|465042300|FG000|Overall Study|Withdrawal by Subject|1|||
129203107|NCT04388111|465042301|FG001|Overall Study|Withdrawal by Subject|0|||
129203108|NCT02735239|465042302|FG000|Overall Study|Adverse Event|0|||
129203109|NCT02735239|465042303|FG001|Overall Study|Adverse Event|0|||
129203110|NCT02735239|465042304|FG002|Overall Study|Adverse Event|4|||
129203111|NCT02735239|465042305|FG003|Overall Study|Adverse Event|0|||
129203112|NCT02735239|465042306|FG004|Overall Study|Adverse Event|0|||
128733150|NCT03390504|463314573|FG002|Overall Study|Lost to Follow-up|0|||
129203113|NCT02735239|465042307|FG005|Overall Study|Adverse Event|0|||
129203114|NCT02735239|465042302|FG000|Overall Study|Death|1|||
129203115|NCT02735239|465042303|FG001|Overall Study|Death|1|||
129203116|NCT02735239|465042304|FG002|Overall Study|Death|0|||
129203117|NCT02735239|465042305|FG003|Overall Study|Death|0|||
129203118|NCT02735239|465042306|FG004|Overall Study|Death|0|||
129203119|NCT02735239|465042307|FG005|Overall Study|Death|0|||
129203120|NCT02735239|465042302|FG000|Overall Study|Physician Decision|0|||
129203121|NCT02735239|465042303|FG001|Overall Study|Physician Decision|0|||
129203122|NCT02735239|465042304|FG002|Overall Study|Physician Decision|1|||
129203123|NCT02735239|465042305|FG003|Overall Study|Physician Decision|0|||
129203124|NCT02735239|465042306|FG004|Overall Study|Physician Decision|0|||
129203125|NCT02735239|465042307|FG005|Overall Study|Physician Decision|0|||
129203126|NCT02735239|465042302|FG000|Overall Study|Progressive disease|3|||
129203127|NCT02735239|465042303|FG001|Overall Study|Progressive disease|1|||
129203128|NCT02735239|465042304|FG002|Overall Study|Progressive disease|3|||
129203129|NCT02735239|465042305|FG003|Overall Study|Progressive disease|0|||
129203130|NCT02735239|465042306|FG004|Overall Study|Progressive disease|0|||
129203131|NCT02735239|465042307|FG005|Overall Study|Progressive disease|2|||
129203132|NCT02735239|465042302|FG000|Overall Study|Withdrawal by Subject|0|||
129203133|NCT02735239|465042303|FG001|Overall Study|Withdrawal by Subject|1|||
129203134|NCT02735239|465042304|FG002|Overall Study|Withdrawal by Subject|0|||
129203135|NCT02735239|465042305|FG003|Overall Study|Withdrawal by Subject|0|||
129203136|NCT02735239|465042306|FG004|Overall Study|Withdrawal by Subject|0|||
129203137|NCT02735239|465042307|FG005|Overall Study|Withdrawal by Subject|0|||
129203138|NCT01790594|465042315|FG000|Overall Study|Death|1|||
129203139|NCT01790594|465042316|FG001|Overall Study|Death|0|||
129203140|NCT01790594|465042317|FG002|Overall Study|Death|0|||
129203141|NCT01790594|465042315|FG000|Overall Study|Physician Decision|2|||
129203142|NCT01790594|465042316|FG001|Overall Study|Physician Decision|1|||
129203143|NCT01790594|465042317|FG002|Overall Study|Physician Decision|0|||
129203144|NCT01790594|465042315|FG000|Overall Study|Withdrawal by Subject|2|||
129203145|NCT01790594|465042316|FG001|Overall Study|Withdrawal by Subject|0|||
129203146|NCT01790594|465042317|FG002|Overall Study|Withdrawal by Subject|0|||
129203147|NCT01790594|465042315|FG000|Overall Study|Transplant was not done|0|||
129203148|NCT01790594|465042316|FG001|Overall Study|Transplant was not done|0|||
129203149|NCT01790594|465042317|FG002|Overall Study|Transplant was not done|3|||
129203150|NCT01790594|465042315|FG000|Overall Study|Terminated prior to week 76|0|||
129203151|NCT01790594|465042316|FG001|Overall Study|Terminated prior to week 76|2|||
129203152|NCT01790594|465042317|FG002|Overall Study|Terminated prior to week 76|0|||
129203153|NCT02038153|465042318|FG000|Overall Study|Withdrawal by Subject|1|||
129203154|NCT03016312|465042319|FG000|Overall Study|discontinued before the treatment started|0|||
129203155|NCT03016312|465042320|FG001|Overall Study|discontinued before the treatment started|1|||
129203156|NCT03016312|465042319|FG000|Overall Study|Withdrawal by Subject|37|||
129203157|NCT03016312|465042320|FG001|Overall Study|Withdrawal by Subject|44|||
129203158|NCT03016312|465042319|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
129203159|NCT03016312|465042320|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
129203160|NCT03016312|465042319|FG000|Overall Study|Physician Decision|1|||
129203161|NCT03016312|465042320|FG001|Overall Study|Physician Decision|3|||
129203162|NCT03016312|465042319|FG000|Overall Study|Lost to Follow-up|12|||
129203163|NCT03016312|465042320|FG001|Overall Study|Lost to Follow-up|12|||
129203164|NCT03016312|465042319|FG000|Overall Study|Death|210|||
129203165|NCT03016312|465042320|FG001|Overall Study|Death|184|||
129203166|NCT03016312|465042319|FG000|Overall Study|loss to contact|1|||
129203167|NCT03016312|465042320|FG001|Overall Study|loss to contact|0|||
129203168|NCT03016312|465042319|FG000|Overall Study|started a new cancer therapy|1|||
129203169|NCT03016312|465042320|FG001|Overall Study|started a new cancer therapy|0|||
129203170|NCT00308139|465042322|FG000|Overall Study|Adverse Event|20|||
129203171|NCT00308139|465042323|FG001|Overall Study|Adverse Event|14|||
129203172|NCT00308139|465042322|FG000|Overall Study|Lost to Follow-up|13|||
129203173|NCT00308139|465042323|FG001|Overall Study|Lost to Follow-up|8|||
129203174|NCT00308139|465042322|FG000|Overall Study|Protocol Violation|3|||
129203175|NCT00308139|465042323|FG001|Overall Study|Protocol Violation|2|||
129203176|NCT00308139|465042322|FG000|Overall Study|Withdrawal of Consent|40|||
129203177|NCT00308139|465042323|FG001|Overall Study|Withdrawal of Consent|42|||
129203178|NCT00308139|465042322|FG000|Overall Study|Investigator Decision|11|||
129203179|NCT00308139|465042323|FG001|Overall Study|Investigator Decision|10|||
129203180|NCT00308139|465042322|FG000|Overall Study|Loss of Glucose Control|5|||
129203181|NCT00308139|465042323|FG001|Overall Study|Loss of Glucose Control|7|||
129203182|NCT00308139|465042322|FG000|Overall Study|Administrative|1|||
129203183|NCT00308139|465042323|FG001|Overall Study|Administrative|4|||
129203184|NCT00308139|465042322|FG000|Overall Study|Other|1|||
129203185|NCT00308139|465042323|FG001|Overall Study|Other|0|||
129203186|NCT03010527|465042324|FG000|Overall Study|Death|0|||
129203187|NCT03010527|465042325|FG001|Overall Study|Death|0|||
129203188|NCT03010527|465042326|FG002|Overall Study|Death|1|||
129203189|NCT03010527|465042324|FG000|Overall Study|Adverse Event|0|||
129203190|NCT03010527|465042325|FG001|Overall Study|Adverse Event|4|||
129203191|NCT03010527|465042326|FG002|Overall Study|Adverse Event|2|||
129203192|NCT03010527|465042324|FG000|Overall Study|Protocol Violation|0|||
129203193|NCT03010527|465042325|FG001|Overall Study|Protocol Violation|1|||
129203194|NCT03010527|465042326|FG002|Overall Study|Protocol Violation|0|||
129203195|NCT03010527|465042324|FG000|Overall Study|Lost to Follow-up|0|||
129203196|NCT03010527|465042325|FG001|Overall Study|Lost to Follow-up|2|||
129203197|NCT03010527|465042326|FG002|Overall Study|Lost to Follow-up|1|||
129203198|NCT03010527|465042324|FG000|Overall Study|Withdrawal by Subject|0|||
129203199|NCT03010527|465042325|FG001|Overall Study|Withdrawal by Subject|3|||
129203200|NCT03010527|465042326|FG002|Overall Study|Withdrawal by Subject|4|||
129203201|NCT03010527|465042324|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
129203202|NCT03010527|465042325|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
129203203|NCT03010527|465042326|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
129203204|NCT03010527|465042324|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
128733151|NCT03390504|463314574|FG003|Overall Study|Lost to Follow-up|1|||
128733152|NCT03390504|463314571|FG000|Overall Study|Withdrawal by Subject|3|||
128733153|NCT03390504|463314572|FG001|Overall Study|Withdrawal by Subject|15|||
128733154|NCT03390504|463314573|FG002|Overall Study|Withdrawal by Subject|5|||
128733155|NCT03390504|463314574|FG003|Overall Study|Withdrawal by Subject|2|||
128733156|NCT03390504|463314571|FG000|Overall Study|Other|1|||
128733157|NCT03390504|463314572|FG001|Overall Study|Other|2|||
128733158|NCT03390504|463314573|FG002|Overall Study|Other|2|||
128733159|NCT03390504|463314574|FG003|Overall Study|Other|6|||
128733160|NCT03492177|463314575|FG000|Overall Study|Adverse Event|1|||
128733161|NCT03492177|463314576|FG001|Overall Study|Adverse Event|0|||
128733162|NCT03492177|463314577|FG002|Overall Study|Adverse Event|0|||
128733163|NCT03492177|463314575|FG000|Overall Study|Death|3|||
128733164|NCT03492177|463314576|FG001|Overall Study|Death|0|||
128733165|NCT03492177|463314577|FG002|Overall Study|Death|3|||
128733166|NCT03492177|463314575|FG000|Overall Study|Lack of Efficacy|1|||
128733167|NCT03492177|463314576|FG001|Overall Study|Lack of Efficacy|2|||
128733168|NCT03492177|463314577|FG002|Overall Study|Lack of Efficacy|0|||
128733169|NCT03492177|463314575|FG000|Overall Study|Other|1|||
128733170|NCT03492177|463314576|FG001|Overall Study|Other|0|||
128733171|NCT03492177|463314577|FG002|Overall Study|Other|0|||
128733172|NCT03492177|463314575|FG000|Overall Study|Ongoing|16|||
128733173|NCT03492177|463314576|FG001|Overall Study|Ongoing|19|||
128733174|NCT03492177|463314577|FG002|Overall Study|Ongoing|17|||
128733175|NCT04197713|463314578|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
128733176|NCT04197713|463314579|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
128733177|NCT01660412|463314580|FG000|Overall Study|Protocol Violation|0|||
128733178|NCT01660412|463314581|FG001|Overall Study|Protocol Violation|3|||
128733179|NCT02239536|463314582|FG000|Overall Study|Non-neoplastic polyp|23|||
128733180|NCT02239536|463314583|FG001|Overall Study|Non-neoplastic polyp|17|||
128733181|NCT01038778|463314584|FG000|Overall Study|Withdrawal by Subject|0|||
128733182|NCT01038778|463314585|FG001|Overall Study|Withdrawal by Subject|2|||
128733183|NCT01038778|463314586|FG002|Overall Study|Withdrawal by Subject|3|||
128733184|NCT04740034|463314587|FG000|Overall Study|Death|0|||
129203205|NCT03010527|465042325|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
129203206|NCT03010527|465042326|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
129203207|NCT03010527|465042324|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
129203208|NCT03010527|465042325|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
129203209|NCT03010527|465042326|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
129203210|NCT01884077|465042327|FG000|Overall Study|screen fail|0|||
129203211|NCT01884077|465042328|FG001|Overall Study|screen fail|2|||
129203212|NCT01884077|465042327|FG000|Overall Study|canceled surgery|2|||
129203213|NCT01884077|465042328|FG001|Overall Study|canceled surgery|0|||
129203214|NCT01884077|465042327|FG000|Overall Study|Lost to Follow-up|0|||
129203215|NCT01884077|465042328|FG001|Overall Study|Lost to Follow-up|4|||
129203216|NCT01884077|465042327|FG000|Overall Study|study closed|6|||
129203217|NCT01884077|465042328|FG001|Overall Study|study closed|4|||
129203218|NCT00981149|465042331|FG000|Overall Study|Lost to Follow-up|1|||
129203219|NCT00981149|465042332|FG001|Overall Study|Lost to Follow-up|2|||
129203220|NCT00981149|465042331|FG000|Overall Study|Withdrawal by Subject|1|||
129203221|NCT00981149|465042332|FG001|Overall Study|Withdrawal by Subject|1|||
129203222|NCT01220167|465042334|FG000|Period 3|Urine positive for substance abuse|0|||
129203223|NCT01220167|465042335|FG001|Period 3|Urine positive for substance abuse|1|||
129203224|NCT01220167|465042336|FG002|Period 3|Urine positive for substance abuse|0|||
129203225|NCT05789745|465042337|FG000|Overall Study|Withdrawal by Subject|0|||
129203226|NCT05789745|465042338|FG001|Overall Study|Withdrawal by Subject|0|||
129203227|NCT05789745|465042339|FG002|Overall Study|Withdrawal by Subject|0|||
129203228|NCT05789745|465042340|FG003|Overall Study|Withdrawal by Subject|0|||
129203229|NCT05789745|465042341|FG004|Overall Study|Withdrawal by Subject|1|||
129203230|NCT02634333|465042344|FG000|Overall Study|Completed out of Window|3|||
129203231|NCT02634333|465042345|FG001|Overall Study|Completed out of Window|2|||
129203232|NCT02634333|465042344|FG000|Overall Study|Missed Visit|5|||
129203233|NCT02634333|465042345|FG001|Overall Study|Missed Visit|2|||
129203234|NCT02634333|465042344|FG000|Overall Study|Lost to Follow-up|12|||
129203235|NCT02634333|465042345|FG001|Overall Study|Lost to Follow-up|7|||
129203236|NCT02634333|465042344|FG000|Overall Study|Withdrawal by Subject|9|||
129203237|NCT02634333|465042345|FG001|Overall Study|Withdrawal by Subject|13|||
129203238|NCT02634333|465042344|FG000|Overall Study|Death|11|||
129203239|NCT02634333|465042345|FG001|Overall Study|Death|8|||
129203240|NCT04537793|465042346|FG000|Part B (24 Weeks)|Adverse Event|0|||
129203241|NCT04537793|465042347|FG001|Part B (24 Weeks)|Adverse Event|1|||
129203242|NCT05470387|465042348|FG000|Overall Study|Protocol Violation|0|||
129203243|NCT05470387|465042349|FG001|Overall Study|Protocol Violation|3|||
128733185|NCT04740034|463314588|FG001|Overall Study|Death|1|||
128733186|NCT04740034|463314589|FG002|Overall Study|Death|2|||
128733187|NCT04740034|463314590|FG003|Overall Study|Death|3|||
128733188|NCT04740034|463314591|FG004|Overall Study|Death|4|||
128733189|NCT04740034|463314592|FG005|Overall Study|Death|4|||
128733190|NCT04740034|463314593|FG006|Overall Study|Death|2|||
128733191|NCT04740034|463314594|FG007|Overall Study|Death|2|||
128733192|NCT04740034|463314595|FG008|Overall Study|Death|2|||
128733193|NCT04740034|463314596|FG009|Overall Study|Death|4|||
128733194|NCT04740034|463314597|FG010|Overall Study|Death|0|||
128733195|NCT04740034|463314587|FG000|Overall Study|Lost to Follow-up|0|||
128733196|NCT04740034|463314588|FG001|Overall Study|Lost to Follow-up|0|||
128733197|NCT04740034|463314589|FG002|Overall Study|Lost to Follow-up|0|||
128733198|NCT04740034|463314590|FG003|Overall Study|Lost to Follow-up|1|||
128733199|NCT04740034|463314591|FG004|Overall Study|Lost to Follow-up|2|||
128733200|NCT04740034|463314592|FG005|Overall Study|Lost to Follow-up|2|||
128733201|NCT04740034|463314593|FG006|Overall Study|Lost to Follow-up|0|||
128733202|NCT04740034|463314594|FG007|Overall Study|Lost to Follow-up|0|||
128733203|NCT04740034|463314595|FG008|Overall Study|Lost to Follow-up|0|||
128733204|NCT04740034|463314596|FG009|Overall Study|Lost to Follow-up|1|||
128733205|NCT04740034|463314597|FG010|Overall Study|Lost to Follow-up|0|||
128733206|NCT04740034|463314587|FG000|Overall Study|Withdrawal by Subject|1|||
128733207|NCT04740034|463314588|FG001|Overall Study|Withdrawal by Subject|0|||
128733208|NCT04740034|463314589|FG002|Overall Study|Withdrawal by Subject|0|||
128733209|NCT04740034|463314590|FG003|Overall Study|Withdrawal by Subject|0|||
128733210|NCT04740034|463314591|FG004|Overall Study|Withdrawal by Subject|0|||
128733211|NCT04740034|463314592|FG005|Overall Study|Withdrawal by Subject|0|||
128733212|NCT04740034|463314593|FG006|Overall Study|Withdrawal by Subject|0|||
128733213|NCT04740034|463314594|FG007|Overall Study|Withdrawal by Subject|1|||
128733214|NCT04740034|463314595|FG008|Overall Study|Withdrawal by Subject|0|||
128733215|NCT04740034|463314596|FG009|Overall Study|Withdrawal by Subject|1|||
128733216|NCT04740034|463314597|FG010|Overall Study|Withdrawal by Subject|0|||
128733217|NCT04740034|463314587|FG000|Overall Study|Decision by sponsor|0|||
128733218|NCT04740034|463314588|FG001|Overall Study|Decision by sponsor|0|||
128733219|NCT04740034|463314589|FG002|Overall Study|Decision by sponsor|1|||
128733220|NCT04740034|463314590|FG003|Overall Study|Decision by sponsor|0|||
128733221|NCT04740034|463314591|FG004|Overall Study|Decision by sponsor|0|||
128733222|NCT04740034|463314592|FG005|Overall Study|Decision by sponsor|0|||
128733223|NCT04740034|463314593|FG006|Overall Study|Decision by sponsor|1|||
128733224|NCT04740034|463314594|FG007|Overall Study|Decision by sponsor|2|||
128733225|NCT04740034|463314595|FG008|Overall Study|Decision by sponsor|1|||
128733226|NCT04740034|463314596|FG009|Overall Study|Decision by sponsor|1|||
128733227|NCT04740034|463314597|FG010|Overall Study|Decision by sponsor|2|||
128733228|NCT00226941|463316135|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
128733229|NCT00226941|463316136|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
128733230|NCT00226941|463316137|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
128733231|NCT00226941|463316138|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
128733232|NCT00226941|463316135|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
128733233|NCT00226941|463316136|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
128733234|NCT00226941|463316137|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
128733235|NCT00226941|463316138|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
128733236|NCT01513291|463316139|FG000|Treatment Period|Adverse Event|8|||
128733237|NCT01513291|463316140|FG001|Treatment Period|Adverse Event|4|||
128733238|NCT01513291|463316141|FG002|Treatment Period|Adverse Event|0|||
128733239|NCT01513291|463316142|FG003|Treatment Period|Adverse Event|0|||
129203244|NCT01255423|465042350|FG000|Overall Study|Abnormal Laboratory value|3|||
129203245|NCT01255423|465042351|FG001|Overall Study|Abnormal Laboratory value|2|||
129203246|NCT01255423|465042350|FG000|Overall Study|Use of prohibited medications|0|||
129203247|NCT01255423|465042351|FG001|Overall Study|Use of prohibited medications|1|||
129203248|NCT02520726|465042354|FG000|Overall Study|Lost to Follow-up|3|||
129203249|NCT02520726|465042355|FG001|Overall Study|Lost to Follow-up|2|||
129203250|NCT01092728|465042356|FG000|Overall Study|Withdrawal by Subject|2|||
129203251|NCT01092728|465042357|FG001|Overall Study|Withdrawal by Subject|0|||
129203252|NCT01092728|465042356|FG000|Overall Study|Adverse Event|0|||
129203253|NCT01092728|465042357|FG001|Overall Study|Adverse Event|1|||
129203254|NCT01092728|465042356|FG000|Overall Study|Disease Progression|1|||
129203255|NCT01092728|465042357|FG001|Overall Study|Disease Progression|13|||
128733240|NCT01513291|463316143|FG004|Treatment Period|Adverse Event|0|||
128733241|NCT01513291|463316139|FG000|Treatment Period|Lack of Efficacy|3|||
128733242|NCT01513291|463316140|FG001|Treatment Period|Lack of Efficacy|0|||
128733243|NCT01513291|463316141|FG002|Treatment Period|Lack of Efficacy|0|||
128733244|NCT01513291|463316142|FG003|Treatment Period|Lack of Efficacy|0|||
128733245|NCT01513291|463316143|FG004|Treatment Period|Lack of Efficacy|0|||
128733246|NCT01513291|463316139|FG000|Treatment Period|Lost to Follow-up|2|||
128733247|NCT01513291|463316140|FG001|Treatment Period|Lost to Follow-up|3|||
128733248|NCT01513291|463316141|FG002|Treatment Period|Lost to Follow-up|0|||
128733249|NCT01513291|463316142|FG003|Treatment Period|Lost to Follow-up|0|||
128733250|NCT01513291|463316143|FG004|Treatment Period|Lost to Follow-up|0|||
129203256|NCT01092728|465042356|FG000|Overall Study|Prohibited Concomitant Medications|1|||
129203257|NCT01092728|465042357|FG001|Overall Study|Prohibited Concomitant Medications|0|||
129203258|NCT00721396|465042358|FG000|Overall Study|Adverse Event|4|||
129203259|NCT00721396|465042359|FG001|Overall Study|Adverse Event|7|||
129203260|NCT00721396|465042360|FG002|Overall Study|Adverse Event|2|||
129203261|NCT00721396|465042361|FG003|Overall Study|Adverse Event|0|||
129203262|NCT00721396|465042358|FG000|Overall Study|Withdrawal by Subject|12|||
129203263|NCT00721396|465042359|FG001|Overall Study|Withdrawal by Subject|15|||
129203264|NCT00721396|465042360|FG002|Overall Study|Withdrawal by Subject|3|||
129203265|NCT00721396|465042361|FG003|Overall Study|Withdrawal by Subject|7|||
129203266|NCT00721396|465042358|FG000|Overall Study|Lost to Follow-up|7|||
129203267|NCT00721396|465042359|FG001|Overall Study|Lost to Follow-up|9|||
129203268|NCT00721396|465042360|FG002|Overall Study|Lost to Follow-up|3|||
129203269|NCT00721396|465042361|FG003|Overall Study|Lost to Follow-up|3|||
129203270|NCT00721396|465042358|FG000|Overall Study|Protocol Violation|4|||
129203271|NCT00721396|465042359|FG001|Overall Study|Protocol Violation|3|||
129203272|NCT00721396|465042360|FG002|Overall Study|Protocol Violation|1|||
129203273|NCT00721396|465042361|FG003|Overall Study|Protocol Violation|0|||
129203274|NCT00721396|465042358|FG000|Overall Study|Inappropriate enrollment|0|||
129203275|NCT00721396|465042359|FG001|Overall Study|Inappropriate enrollment|2|||
129203276|NCT00721396|465042360|FG002|Overall Study|Inappropriate enrollment|0|||
129203277|NCT00721396|465042361|FG003|Overall Study|Inappropriate enrollment|0|||
129203278|NCT00721396|465042358|FG000|Overall Study|Administrative reason|3|||
129203279|NCT00721396|465042359|FG001|Overall Study|Administrative reason|0|||
129203280|NCT00721396|465042360|FG002|Overall Study|Administrative reason|1|||
129203281|NCT00721396|465042361|FG003|Overall Study|Administrative reason|0|||
129203282|NCT03546621|465042362|FG000|Overall Study|Withdrawal by Subject|0|||
129203283|NCT03546621|465042363|FG001|Overall Study|Withdrawal by Subject|1|||
129203284|NCT03546621|465042364|FG002|Overall Study|Withdrawal by Subject|2|||
129203285|NCT03546621|465042365|FG003|Overall Study|Withdrawal by Subject|1|||
129203286|NCT03546621|465042362|FG000|Overall Study|Lost to Follow-up|0|||
129203287|NCT03546621|465042363|FG001|Overall Study|Lost to Follow-up|1|||
129203288|NCT03546621|465042364|FG002|Overall Study|Lost to Follow-up|0|||
128781275|NCT02487446|463490531|FG000|Period 1|Lost to Follow-up|2|||
128781276|NCT02487446|463490532|FG001|Period 1|Lost to Follow-up|0|||
129203289|NCT03546621|465042365|FG003|Overall Study|Lost to Follow-up|0|||
129203290|NCT03546621|465042362|FG000|Overall Study|Adverse Event|0|||
129203291|NCT03546621|465042363|FG001|Overall Study|Adverse Event|1|||
129203292|NCT03546621|465042364|FG002|Overall Study|Adverse Event|0|||
129203293|NCT03546621|465042365|FG003|Overall Study|Adverse Event|1|||
129203294|NCT03546621|465042362|FG000|Overall Study|Progressive disease|0|||
129203295|NCT03546621|465042363|FG001|Overall Study|Progressive disease|0|||
129203296|NCT03546621|465042364|FG002|Overall Study|Progressive disease|0|||
129203297|NCT03546621|465042365|FG003|Overall Study|Progressive disease|1|||
129203298|NCT01506271|465042367|FG000|Overall Study|Progressive disease|0|||
129203299|NCT01506271|465042368|FG001|Overall Study|Progressive disease|1|||
129203300|NCT01506271|465042369|FG002|Overall Study|Progressive disease|0|||
129203301|NCT01506271|465042367|FG000|Overall Study|Protocol Violation|3|||
129203302|NCT01506271|465042368|FG001|Overall Study|Protocol Violation|1|||
129203303|NCT01506271|465042369|FG002|Overall Study|Protocol Violation|0|||
129203304|NCT01506271|465042367|FG000|Overall Study|Death|0|||
129203305|NCT01506271|465042368|FG001|Overall Study|Death|1|||
129203306|NCT01506271|465042369|FG002|Overall Study|Death|0|||
129203307|NCT01506271|465042367|FG000|Overall Study|Adverse Event|0|||
129203308|NCT01506271|465042368|FG001|Overall Study|Adverse Event|2|||
129203309|NCT01506271|465042369|FG002|Overall Study|Adverse Event|0|||
129203310|NCT01506271|465042367|FG000|Overall Study|Insufficient supply of study drug|1|||
129203311|NCT01506271|465042368|FG001|Overall Study|Insufficient supply of study drug|0|||
128781277|NCT02487446|463490531|FG000|Period 1|Withdrawal by Subject|2|||
129203312|NCT01506271|465042369|FG002|Overall Study|Insufficient supply of study drug|0|||
129203313|NCT01506271|465042367|FG000|Overall Study|Withdrawal by Subject|0|||
128733251|NCT01513291|463316139|FG000|Treatment Period|Physician Decision|1|||
128733252|NCT01513291|463316140|FG001|Treatment Period|Physician Decision|0|||
128733253|NCT01513291|463316141|FG002|Treatment Period|Physician Decision|0|||
128733254|NCT01513291|463316142|FG003|Treatment Period|Physician Decision|0|||
128733255|NCT01513291|463316143|FG004|Treatment Period|Physician Decision|0|||
128733256|NCT01513291|463316139|FG000|Treatment Period|Protocol Violation|1|||
128733257|NCT01513291|463316140|FG001|Treatment Period|Protocol Violation|2|||
128733258|NCT01513291|463316141|FG002|Treatment Period|Protocol Violation|0|||
128733259|NCT01513291|463316142|FG003|Treatment Period|Protocol Violation|0|||
128733260|NCT01513291|463316143|FG004|Treatment Period|Protocol Violation|0|||
128733261|NCT01513291|463316139|FG000|Treatment Period|Withdrawal by Subject|8|||
128733262|NCT01513291|463316140|FG001|Treatment Period|Withdrawal by Subject|5|||
128733263|NCT01513291|463316141|FG002|Treatment Period|Withdrawal by Subject|0|||
128733264|NCT01513291|463316142|FG003|Treatment Period|Withdrawal by Subject|0|||
128733265|NCT01513291|463316143|FG004|Treatment Period|Withdrawal by Subject|0|||
128733266|NCT01513291|463316139|FG000|Treatment Period|Randomized not treated|0|||
128733267|NCT01513291|463316140|FG001|Treatment Period|Randomized not treated|2|||
128733268|NCT01513291|463316141|FG002|Treatment Period|Randomized not treated|0|||
129203314|NCT01506271|465042368|FG001|Overall Study|Withdrawal by Subject|1|||
129203315|NCT01506271|465042369|FG002|Overall Study|Withdrawal by Subject|1|||
129203316|NCT01506271|465042367|FG000|Overall Study|Lost to Follow-up|0|||
129203317|NCT01506271|465042368|FG001|Overall Study|Lost to Follow-up|1|||
129203318|NCT01506271|465042369|FG002|Overall Study|Lost to Follow-up|2|||
129203319|NCT02021565|465042375|FG000|Baseline Through Intervention|Death|0|||
129203320|NCT02021565|465042376|FG001|Baseline Through Intervention|Death|1|||
129203321|NCT02021565|465042375|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
129203322|NCT02021565|465042376|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
129203323|NCT02021565|465042375|FG000|Baseline Through Intervention|Protocol Violation|0|||
129203324|NCT02021565|465042376|FG001|Baseline Through Intervention|Protocol Violation|7|||
129203325|NCT02021565|465042375|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
129203326|NCT02021565|465042376|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
129203327|NCT02021565|465042375|FG000|3-month Follow-up|Death|3|||
129203328|NCT02021565|465042376|FG001|3-month Follow-up|Death|0|||
129203329|NCT02021565|465042375|FG000|3-month Follow-up|Withdrawal by Subject|4|||
129203330|NCT02021565|465042376|FG001|3-month Follow-up|Withdrawal by Subject|0|||
129203331|NCT02021565|465042375|FG000|3-month Follow-up|Protocol Violation|3|||
129203332|NCT02021565|465042376|FG001|3-month Follow-up|Protocol Violation|2|||
129203333|NCT03040141|465042377|FG000|Overall Study|Death|1|||
129203334|NCT03040141|465042378|FG001|Overall Study|Death|2|||
129203335|NCT03040141|465042379|FG002|Overall Study|Death|3|||
129203336|NCT03040141|465042377|FG000|Overall Study|Withdrawal by Subject|3|||
129203337|NCT03040141|465042378|FG001|Overall Study|Withdrawal by Subject|1|||
129203338|NCT03040141|465042379|FG002|Overall Study|Withdrawal by Subject|1|||
129203339|NCT03040141|465042377|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
129203340|NCT03040141|465042378|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
129203341|NCT03040141|465042379|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
129203342|NCT03040141|465042377|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
129203343|NCT03040141|465042378|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
129203344|NCT03040141|465042379|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
129203345|NCT03318549|465042380|FG000|Overall Study|Withdrawal by Subject|5|||
129203346|NCT03318549|465042381|FG001|Overall Study|Withdrawal by Subject|19|||
129203347|NCT03318549|465042382|FG002|Overall Study|Withdrawal by Subject|2|||
129203348|NCT03318549|465042383|FG003|Overall Study|Withdrawal by Subject|0|||
129203349|NCT03318549|465042384|FG004|Overall Study|Withdrawal by Subject|0|||
129203350|NCT03318549|465042385|FG005|Overall Study|Withdrawal by Subject|0|||
129203351|NCT03318549|465042386|FG006|Overall Study|Withdrawal by Subject|0|||
129203352|NCT03318549|465042380|FG000|Overall Study|Physician Decision|0|||
129203353|NCT03318549|465042381|FG001|Overall Study|Physician Decision|4|||
129203354|NCT03318549|465042382|FG002|Overall Study|Physician Decision|1|||
129203355|NCT03318549|465042383|FG003|Overall Study|Physician Decision|0|||
129203356|NCT03318549|465042384|FG004|Overall Study|Physician Decision|0|||
129203357|NCT03318549|465042385|FG005|Overall Study|Physician Decision|0|||
129203358|NCT03318549|465042386|FG006|Overall Study|Physician Decision|0|||
129203359|NCT03318549|465042380|FG000|Overall Study|Lost to Follow-up|0|||
129203360|NCT03318549|465042381|FG001|Overall Study|Lost to Follow-up|3|||
129203361|NCT03318549|465042382|FG002|Overall Study|Lost to Follow-up|3|||
129203362|NCT03318549|465042383|FG003|Overall Study|Lost to Follow-up|0|||
129203363|NCT03318549|465042384|FG004|Overall Study|Lost to Follow-up|0|||
129203364|NCT03318549|465042385|FG005|Overall Study|Lost to Follow-up|0|||
129203365|NCT03318549|465042386|FG006|Overall Study|Lost to Follow-up|0|||
129203366|NCT00462306|465042387|FG000|Overall Study|insufficient data|0|||
128733269|NCT01513291|463316142|FG003|Treatment Period|Randomized not treated|0|||
128733270|NCT01513291|463316143|FG004|Treatment Period|Randomized not treated|0|||
129203367|NCT00462306|465042388|FG001|Overall Study|insufficient data|13|||
129203368|NCT01391663|465042389|FG000|Overall Study|Withdrawal by Subject|0|||
129203369|NCT01391663|465042390|FG001|Overall Study|Withdrawal by Subject|0|||
129203370|NCT01391663|465042391|FG002|Overall Study|Withdrawal by Subject|1|||
129203371|NCT01391663|465042392|FG003|Overall Study|Withdrawal by Subject|0|||
129203372|NCT03515824|465042393|FG000|Overall Study|Death|3|||
129203373|NCT03515824|465042394|FG001|Overall Study|Death|2|||
129203374|NCT03515824|465042395|FG002|Overall Study|Death|6|||
129203375|NCT03515824|465042396|FG003|Overall Study|Death|0|||
129203376|NCT03515824|465042393|FG000|Overall Study|Lost to Follow-up|0|||
129203377|NCT03515824|465042394|FG001|Overall Study|Lost to Follow-up|1|||
129203378|NCT03515824|465042395|FG002|Overall Study|Lost to Follow-up|1|||
129203379|NCT03515824|465042396|FG003|Overall Study|Lost to Follow-up|0|||
128733271|NCT01513291|463316139|FG000|Run-out Period|Lost to Follow-up|0|||
128733272|NCT01513291|463316140|FG001|Run-out Period|Lost to Follow-up|0|||
128733273|NCT01513291|463316141|FG002|Run-out Period|Lost to Follow-up|0|||
128733274|NCT01513291|463316142|FG003|Run-out Period|Lost to Follow-up|1|||
128733275|NCT01513291|463316143|FG004|Run-out Period|Lost to Follow-up|0|||
128733276|NCT01513291|463316139|FG000|Run-out Period|Withdrawal by Subject|0|||
128733277|NCT01513291|463316140|FG001|Run-out Period|Withdrawal by Subject|0|||
128733278|NCT01513291|463316141|FG002|Run-out Period|Withdrawal by Subject|0|||
128733279|NCT01513291|463316142|FG003|Run-out Period|Withdrawal by Subject|1|||
128733280|NCT01513291|463316143|FG004|Run-out Period|Withdrawal by Subject|0|||
128733281|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
128733282|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
128733283|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
128733284|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
128733285|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
128733286|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
128733287|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
128733288|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
128733289|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
128733290|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
129203380|NCT03515824|465042393|FG000|Overall Study|Study terminated by sponsor|0|||
128733291|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
129203381|NCT03515824|465042394|FG001|Overall Study|Study terminated by sponsor|1|||
129203382|NCT03515824|465042395|FG002|Overall Study|Study terminated by sponsor|6|||
129203383|NCT03515824|465042396|FG003|Overall Study|Study terminated by sponsor|0|||
128733292|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
128733293|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
129203384|NCT03515824|465042393|FG000|Overall Study|Status not recorded|0|||
129203385|NCT03515824|465042394|FG001|Overall Study|Status not recorded|0|||
128733294|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
128733295|NCT03732638|463316144|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
128733296|NCT03732638|463316145|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
128733297|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
128733298|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
128733299|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
128733300|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
128733301|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
128733302|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
128781278|NCT02487446|463490532|FG001|Period 1|Withdrawal by Subject|0|||
128781279|NCT02487446|463490531|FG000|Period 1|Adverse Event|5|||
128781280|NCT02487446|463490532|FG001|Period 1|Adverse Event|5|||
128781281|NCT02487446|463490531|FG000|Washout|Lost to Follow-up|0|||
128781282|NCT02487446|463490532|FG001|Washout|Lost to Follow-up|2|||
128781283|NCT02487446|463490531|FG000|Washout|Withdrawal by Subject|1|||
128781284|NCT02487446|463490532|FG001|Washout|Withdrawal by Subject|4|||
128781285|NCT02487446|463490531|FG000|Washout|Adverse Event|2|||
128781286|NCT02487446|463490532|FG001|Washout|Adverse Event|2|||
128781287|NCT02487446|463490531|FG000|Period 2|Protocol deviation|0|||
128781288|NCT02487446|463490532|FG001|Period 2|Protocol deviation|1|||
128781289|NCT02487446|463490531|FG000|Period 2|Lost to Follow-up|1|||
128781290|NCT02487446|463490532|FG001|Period 2|Lost to Follow-up|1|||
128781291|NCT02487446|463490531|FG000|Period 2|Withdrawal by Subject|1|||
128781292|NCT02487446|463490532|FG001|Period 2|Withdrawal by Subject|1|||
128781293|NCT02487446|463490531|FG000|Period 2|Adverse Event|6|||
128781294|NCT02487446|463490532|FG001|Period 2|Adverse Event|2|||
128781295|NCT01822821|463490533|FG000|Overall Study|Eligible surgery cancelled|1|||
128781296|NCT01822821|463490534|FG001|Overall Study|Eligible surgery cancelled|1|||
128781297|NCT01822821|463490533|FG000|Overall Study|Other reasons|1|||
128781298|NCT01822821|463490534|FG001|Overall Study|Other reasons|0|||
128781299|NCT05780047|463490535|FG000|Overall Study|Did not submit baseline urine test kit|226|||
128781300|NCT05780047|463490535|FG000|Overall Study|Lost to Follow-up|34|||
128781301|NCT05780047|463490535|FG000|Overall Study|Did not submit second urine test kit|124|||
128781302|NCT04438785|463490540|FG000|Overall Study|change of weight, give up intervention|2|||
128781303|NCT04438785|463490541|FG001|Overall Study|change of weight, give up intervention|10|||
128781304|NCT04011033|463490542|FG000|Overall Study|Physician Decision|2|||
128781305|NCT04011033|463490543|FG001|Overall Study|Physician Decision|3|||
128781306|NCT04011033|463490542|FG000|Overall Study|Withdrawal by Subject|1|||
128781307|NCT04011033|463490543|FG001|Overall Study|Withdrawal by Subject|0|||
128781308|NCT02027935|463490544|FG000|Overall Study|Death|1|||
128781309|NCT02027935|463490544|FG000|Overall Study|Lack of Efficacy|5|||
128781310|NCT02027935|463490544|FG000|Overall Study|Study Closure|1|||
128781311|NCT00689104|463490545|FG000|Overall Study|Eligibility criterion not met|5|||
128781312|NCT00689104|463490546|FG001|Overall Study|Eligibility criterion not met|8|||
128781313|NCT00689104|463490547|FG002|Overall Study|Eligibility criterion not met|0|||
128781314|NCT00689104|463490548|FG003|Overall Study|Eligibility criterion not met|4|||
128781315|NCT00689104|463490545|FG000|Overall Study|Adverse Event|13|||
128781316|NCT00689104|463490546|FG001|Overall Study|Adverse Event|25|||
128781317|NCT00689104|463490547|FG002|Overall Study|Adverse Event|16|||
128781318|NCT00689104|463490548|FG003|Overall Study|Adverse Event|24|||
128781319|NCT00689104|463490545|FG000|Overall Study|Lack of Efficacy|5|||
128781320|NCT00689104|463490546|FG001|Overall Study|Lack of Efficacy|6|||
128781321|NCT00689104|463490547|FG002|Overall Study|Lack of Efficacy|2|||
128781322|NCT00689104|463490548|FG003|Overall Study|Lack of Efficacy|3|||
128781323|NCT00689104|463490545|FG000|Overall Study|Withdrawal by Subject|12|||
128781324|NCT00689104|463490546|FG001|Overall Study|Withdrawal by Subject|11|||
128781325|NCT00689104|463490547|FG002|Overall Study|Withdrawal by Subject|18|||
128781326|NCT00689104|463490548|FG003|Overall Study|Withdrawal by Subject|11|||
128781327|NCT00689104|463490545|FG000|Overall Study|Lost to Follow-up|4|||
128781328|NCT00689104|463490546|FG001|Overall Study|Lost to Follow-up|3|||
128781329|NCT00689104|463490547|FG002|Overall Study|Lost to Follow-up|2|||
128781330|NCT00689104|463490548|FG003|Overall Study|Lost to Follow-up|5|||
128781331|NCT00689104|463490545|FG000|Overall Study|Protocol Violation|2|||
129203386|NCT03515824|465042395|FG002|Overall Study|Status not recorded|2|||
129203387|NCT03515824|465042396|FG003|Overall Study|Status not recorded|0|||
129203388|NCT00920855|465042397|FG000|Overall Study|Adverse Event|1|||
128781332|NCT00689104|463490546|FG001|Overall Study|Protocol Violation|3|||
128781333|NCT00689104|463490547|FG002|Overall Study|Protocol Violation|5|||
128781334|NCT00689104|463490548|FG003|Overall Study|Protocol Violation|3|||
128781335|NCT00689104|463490545|FG000|Overall Study|Randomized but never received study drug|2|||
128781336|NCT00689104|463490546|FG001|Overall Study|Randomized but never received study drug|1|||
128781337|NCT00689104|463490547|FG002|Overall Study|Randomized but never received study drug|1|||
128781338|NCT00689104|463490548|FG003|Overall Study|Randomized but never received study drug|0|||
128781339|NCT00689104|463490545|FG000|Overall Study|Physician Decision|1|||
128781340|NCT00689104|463490546|FG001|Overall Study|Physician Decision|0|||
128781341|NCT00689104|463490547|FG002|Overall Study|Physician Decision|0|||
129203389|NCT00920855|465042398|FG001|Overall Study|Adverse Event|1|||
128733303|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
128733304|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
128733305|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
128733306|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
128733307|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
128733308|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
128733309|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
128733310|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
128733311|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
128733312|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
128733313|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
128733314|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
128733315|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
129203390|NCT00920855|465042399|FG002|Overall Study|Adverse Event|4|||
129203391|NCT00920855|465042397|FG000|Overall Study|Withdrawal by Subject|2|||
129203392|NCT00920855|465042398|FG001|Overall Study|Withdrawal by Subject|1|||
129203393|NCT00920855|465042399|FG002|Overall Study|Withdrawal by Subject|6|||
129203394|NCT00920855|465042397|FG000|Overall Study|Disease progression|2|||
129203395|NCT00920855|465042398|FG001|Overall Study|Disease progression|1|||
129203396|NCT00920855|465042399|FG002|Overall Study|Disease progression|10|||
129203397|NCT00920855|465042397|FG000|Overall Study|Noncompliance to study medication|0|||
129203398|NCT00920855|465042398|FG001|Overall Study|Noncompliance to study medication|0|||
129203399|NCT00920855|465042399|FG002|Overall Study|Noncompliance to study medication|1|||
129203400|NCT00920855|465042397|FG000|Overall Study|Response plateau; started maintenance|0|||
129203401|NCT00920855|465042398|FG001|Overall Study|Response plateau; started maintenance|0|||
129203402|NCT00920855|465042399|FG002|Overall Study|Response plateau; started maintenance|1|||
129203403|NCT00539994|465042401|FG000|Overall Study|Lost to Follow-up|2|||
129203404|NCT00539994|465042402|FG001|Overall Study|Lost to Follow-up|1|||
129203405|NCT00539994|465042403|FG002|Overall Study|Lost to Follow-up|0|||
129203406|NCT00539994|465042401|FG000|Overall Study|Withdrawal by Subject|1|||
129203407|NCT00539994|465042402|FG001|Overall Study|Withdrawal by Subject|0|||
129203408|NCT00539994|465042403|FG002|Overall Study|Withdrawal by Subject|1|||
129203409|NCT00539994|465042401|FG000|Overall Study|Physician Decision|0|||
129203410|NCT00539994|465042402|FG001|Overall Study|Physician Decision|0|||
129203411|NCT00539994|465042403|FG002|Overall Study|Physician Decision|1|||
129203412|NCT00510835|465042405|FG000|Overall Study|Withdrawal by Subject|6|||
129203413|NCT00510835|465042406|FG001|Overall Study|Withdrawal by Subject|2|||
129203414|NCT00510835|465042407|FG002|Overall Study|Withdrawal by Subject|2|||
129203415|NCT03084796|465042408|FG000|Overall Study|Adverse Event|4|||
129203416|NCT03084796|465042409|FG001|Overall Study|Adverse Event|5|||
129203417|NCT03084796|465042410|FG002|Overall Study|Adverse Event|6|||
129203418|NCT03084796|465042411|FG003|Overall Study|Adverse Event|2|||
129203419|NCT03084796|465042412|FG004|Overall Study|Adverse Event|3|||
129203420|NCT03084796|465042413|FG005|Overall Study|Adverse Event|5|||
129203421|NCT03084796|465042408|FG000|Overall Study|Withdrawal by Subject|3|||
129203422|NCT03084796|465042409|FG001|Overall Study|Withdrawal by Subject|5|||
129203423|NCT03084796|465042410|FG002|Overall Study|Withdrawal by Subject|2|||
129203424|NCT03084796|465042411|FG003|Overall Study|Withdrawal by Subject|1|||
129203425|NCT03084796|465042412|FG004|Overall Study|Withdrawal by Subject|3|||
129203426|NCT03084796|465042413|FG005|Overall Study|Withdrawal by Subject|0|||
129203427|NCT03084796|465042408|FG000|Overall Study|Protocol Violation|0|||
129203428|NCT03084796|465042409|FG001|Overall Study|Protocol Violation|0|||
129203429|NCT03084796|465042410|FG002|Overall Study|Protocol Violation|1|||
129203430|NCT03084796|465042411|FG003|Overall Study|Protocol Violation|0|||
129203431|NCT03084796|465042412|FG004|Overall Study|Protocol Violation|1|||
129203432|NCT03084796|465042413|FG005|Overall Study|Protocol Violation|1|||
129203433|NCT03084796|465042408|FG000|Overall Study|Lack of Efficacy|0|||
129203434|NCT03084796|465042409|FG001|Overall Study|Lack of Efficacy|0|||
129203435|NCT03084796|465042410|FG002|Overall Study|Lack of Efficacy|1|||
129203436|NCT03084796|465042411|FG003|Overall Study|Lack of Efficacy|0|||
129203437|NCT03084796|465042412|FG004|Overall Study|Lack of Efficacy|1|||
129203438|NCT03084796|465042413|FG005|Overall Study|Lack of Efficacy|0|||
129203439|NCT03084796|465042408|FG000|Overall Study|Lost to Follow-up|0|||
129203440|NCT03084796|465042409|FG001|Overall Study|Lost to Follow-up|0|||
129203441|NCT03084796|465042410|FG002|Overall Study|Lost to Follow-up|1|||
129203442|NCT03084796|465042411|FG003|Overall Study|Lost to Follow-up|1|||
129203443|NCT03084796|465042412|FG004|Overall Study|Lost to Follow-up|3|||
129203444|NCT03084796|465042413|FG005|Overall Study|Lost to Follow-up|1|||
129203445|NCT03084796|465042408|FG000|Overall Study|Randomization error|0|||
129203446|NCT03084796|465042409|FG001|Overall Study|Randomization error|0|||
129203447|NCT03084796|465042410|FG002|Overall Study|Randomization error|1|||
129203448|NCT03084796|465042411|FG003|Overall Study|Randomization error|0|||
129203449|NCT03084796|465042412|FG004|Overall Study|Randomization error|0|||
129203450|NCT03084796|465042413|FG005|Overall Study|Randomization error|0|||
129203451|NCT05470985|465042414|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
128733316|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
129203452|NCT05470985|465042415|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
129203453|NCT05470985|465042414|FG000|Double Blind Treatment Period|Physician Decision|0|||
129203454|NCT05470985|465042415|FG001|Double Blind Treatment Period|Physician Decision|1|||
129203455|NCT05470985|465042414|FG000|Long Term Extension|Adverse Event|0|||
129203456|NCT05470985|465042415|FG001|Long Term Extension|Adverse Event|1|||
129203457|NCT05470985|465042414|FG000|Long Term Extension|Study terminated by sponsor|2|||
129203458|NCT05470985|465042415|FG001|Long Term Extension|Study terminated by sponsor|0|||
129203459|NCT02741245|465042419|FG000|Overall Study|Adverse Event|0|||
129203460|NCT02741245|465042420|FG001|Overall Study|Adverse Event|0|||
129203461|NCT02741245|465042421|FG002|Overall Study|Adverse Event|0|||
129203462|NCT02741245|465042422|FG003|Overall Study|Adverse Event|2|||
129203463|NCT02741245|465042423|FG004|Overall Study|Adverse Event|2|||
129203464|NCT02741245|465042419|FG000|Overall Study|Protocol Violation|0|||
129203465|NCT02741245|465042420|FG001|Overall Study|Protocol Violation|1|||
129203466|NCT02741245|465042421|FG002|Overall Study|Protocol Violation|0|||
129203467|NCT02741245|465042422|FG003|Overall Study|Protocol Violation|1|||
129203468|NCT02741245|465042423|FG004|Overall Study|Protocol Violation|0|||
129203469|NCT02741245|465042419|FG000|Overall Study|Withdrawal by Subject|0|||
129203470|NCT02741245|465042420|FG001|Overall Study|Withdrawal by Subject|0|||
129203471|NCT02741245|465042421|FG002|Overall Study|Withdrawal by Subject|0|||
129203472|NCT02741245|465042422|FG003|Overall Study|Withdrawal by Subject|1|||
129203473|NCT02741245|465042423|FG004|Overall Study|Withdrawal by Subject|0|||
129203474|NCT00607087|465042425|FG000|Overall Study|Withdrawal by Subject|9|||
129203475|NCT00607087|465042426|FG001|Overall Study|Withdrawal by Subject|4|||
129203476|NCT00607087|465042427|FG002|Overall Study|Withdrawal by Subject|4|||
129203477|NCT00607087|465042425|FG000|Overall Study|Adverse Event|3|||
129203478|NCT00607087|465042426|FG001|Overall Study|Adverse Event|2|||
129203479|NCT00607087|465042427|FG002|Overall Study|Adverse Event|3|||
129203480|NCT00607087|465042425|FG000|Overall Study|Other reason|1|||
129203481|NCT00607087|465042426|FG001|Overall Study|Other reason|5|||
129203482|NCT00607087|465042427|FG002|Overall Study|Other reason|2|||
129203483|NCT00607087|465042425|FG000|Overall Study|Poor compliance to protocol|1|||
129203484|NCT00607087|465042426|FG001|Overall Study|Poor compliance to protocol|0|||
129203485|NCT00607087|465042427|FG002|Overall Study|Poor compliance to protocol|1|||
129203486|NCT00607087|465042425|FG000|Overall Study|Lost to Follow-up|1|||
129203487|NCT00607087|465042426|FG001|Overall Study|Lost to Follow-up|0|||
129203488|NCT00607087|465042427|FG002|Overall Study|Lost to Follow-up|0|||
129203489|NCT00607087|465042425|FG000|Period 1|Withdrawal by Subject|7|||
129203490|NCT00607087|465042426|FG001|Period 1|Withdrawal by Subject|2|||
129203491|NCT00607087|465042427|FG002|Period 1|Withdrawal by Subject|3|||
129203492|NCT00607087|465042425|FG000|Period 1|Adverse Event|3|||
129203493|NCT00607087|465042426|FG001|Period 1|Adverse Event|0|||
129203494|NCT00607087|465042427|FG002|Period 1|Adverse Event|0|||
129203495|NCT00607087|465042425|FG000|Period 1|Poor compliance to protocol|1|||
129203496|NCT00607087|465042426|FG001|Period 1|Poor compliance to protocol|0|||
129203497|NCT00607087|465042427|FG002|Period 1|Poor compliance to protocol|0|||
129203498|NCT00607087|465042425|FG000|Period 1|Lost to Follow-up|1|||
129203499|NCT00607087|465042426|FG001|Period 1|Lost to Follow-up|0|||
129203500|NCT00607087|465042427|FG002|Period 1|Lost to Follow-up|0|||
129203501|NCT00607087|465042425|FG000|Period 1|Other reason|0|||
129203502|NCT00607087|465042426|FG001|Period 1|Other reason|4|||
129203503|NCT00607087|465042427|FG002|Period 1|Other reason|2|||
129203504|NCT00607087|465042425|FG000|Period 2|Withdrawal by Subject|0|||
129203505|NCT00607087|465042426|FG001|Period 2|Withdrawal by Subject|1|||
129203506|NCT00607087|465042427|FG002|Period 2|Withdrawal by Subject|1|||
129203507|NCT00607087|465042425|FG000|Period 2|Other reason|1|||
129203508|NCT00607087|465042426|FG001|Period 2|Other reason|1|||
129203509|NCT00607087|465042427|FG002|Period 2|Other reason|0|||
129203510|NCT00607087|465042425|FG000|Period 2|Adverse Event|0|||
129203511|NCT00607087|465042426|FG001|Period 2|Adverse Event|1|||
129203512|NCT00607087|465042427|FG002|Period 2|Adverse Event|3|||
129203513|NCT00607087|465042425|FG000|Period 2|Poor compliance to protocol|0|||
129203514|NCT00607087|465042426|FG001|Period 2|Poor compliance to protocol|0|||
129203515|NCT00607087|465042427|FG002|Period 2|Poor compliance to protocol|1|||
129203516|NCT00607087|465042425|FG000|Period 3|Withdrawal by Subject|2|||
129203517|NCT00607087|465042426|FG001|Period 3|Withdrawal by Subject|1|||
129203518|NCT00607087|465042427|FG002|Period 3|Withdrawal by Subject|0|||
129203519|NCT00607087|465042425|FG000|Period 3|Adverse Event|0|||
129203520|NCT00607087|465042426|FG001|Period 3|Adverse Event|1|||
129203521|NCT00607087|465042427|FG002|Period 3|Adverse Event|0|||
129203522|NCT00154297|465042429|FG000|Overall Study|Death|5|||
129203523|NCT00154297|465042430|FG001|Overall Study|Death|2|||
129203524|NCT00154297|465042429|FG000|Overall Study|Withdrawal by Subject|0|||
129203525|NCT00154297|465042430|FG001|Overall Study|Withdrawal by Subject|5|||
129203526|NCT00154297|465042429|FG000|Overall Study|Lost to Follow-up|3|||
129203527|NCT00154297|465042430|FG001|Overall Study|Lost to Follow-up|0|||
129203528|NCT00650767|465042431|FG000|Overall Study|Adverse Event|0|||
129203529|NCT00650767|465042432|FG001|Overall Study|Adverse Event|3|||
129203530|NCT00650767|465042433|FG002|Overall Study|Adverse Event|10|||
129203531|NCT00650767|465042434|FG003|Overall Study|Adverse Event|8|||
129203532|NCT00650767|465042431|FG000|Overall Study|Death|1|||
129203533|NCT00650767|465042432|FG001|Overall Study|Death|0|||
129203534|NCT00650767|465042433|FG002|Overall Study|Death|0|||
129203535|NCT00650767|465042434|FG003|Overall Study|Death|0|||
129203536|NCT00650767|465042431|FG000|Overall Study|Withdrawal by Subject|2|||
129203537|NCT00650767|465042432|FG001|Overall Study|Withdrawal by Subject|4|||
129203538|NCT00650767|465042433|FG002|Overall Study|Withdrawal by Subject|3|||
129203539|NCT00650767|465042434|FG003|Overall Study|Withdrawal by Subject|3|||
129203540|NCT00650767|465042431|FG000|Overall Study|Lost to Follow-up|1|||
129203541|NCT00650767|465042432|FG001|Overall Study|Lost to Follow-up|1|||
129203542|NCT00650767|465042433|FG002|Overall Study|Lost to Follow-up|1|||
129203543|NCT00650767|465042434|FG003|Overall Study|Lost to Follow-up|0|||
129203544|NCT00650767|465042431|FG000|Overall Study|Other|1|||
129203545|NCT00650767|465042432|FG001|Overall Study|Other|1|||
129203546|NCT00650767|465042433|FG002|Overall Study|Other|0|||
129203547|NCT00650767|465042434|FG003|Overall Study|Other|0|||
129203548|NCT01774799|465042435|FG000|Overall Study|Lost to Follow-up|1|||
129203549|NCT01774799|465042436|FG001|Overall Study|Lost to Follow-up|1|||
129203550|NCT01774799|465042437|FG002|Overall Study|Lost to Follow-up|0|||
129203551|NCT01774799|465042438|FG003|Overall Study|Lost to Follow-up|0|||
129203552|NCT00990106|465042439|FG000|Overall Study|"too busy to continue"|1|||
129203553|NCT00990106|465042440|FG001|Overall Study|"too busy to continue"|2|||
129203554|NCT00990106|465042439|FG000|Overall Study|Lost to Follow-up|1|||
129203555|NCT00990106|465042440|FG001|Overall Study|Lost to Follow-up|3|||
129203556|NCT00990106|465042439|FG000|Overall Study|Withdrawal by Subject|2|||
129203557|NCT00990106|465042440|FG001|Overall Study|Withdrawal by Subject|1|||
129203558|NCT00990106|465042439|FG000|Overall Study|opted for open label prazosin|1|||
129203559|NCT00990106|465042440|FG001|Overall Study|opted for open label prazosin|1|||
129203560|NCT00990106|465042439|FG000|Overall Study|relocation/deployment|4|||
129203561|NCT00990106|465042440|FG001|Overall Study|relocation/deployment|1|||
129203562|NCT00990106|465042439|FG000|Overall Study|started exclusionary medication|0|||
129203563|NCT00990106|465042440|FG001|Overall Study|started exclusionary medication|1|||
129203564|NCT00990106|465042439|FG000|Overall Study|planned major surgery|0|||
129203565|NCT00990106|465042440|FG001|Overall Study|planned major surgery|1|||
129203566|NCT00990106|465042439|FG000|Overall Study|scheduling conflicts|0|||
129203567|NCT00990106|465042440|FG001|Overall Study|scheduling conflicts|2|||
129203568|NCT03064490|465042443|FG000|Overall Study|Physician Decision|5|||
129203569|NCT04158583|465042447|FG000|Overall Study|Withdrawal by Subject|1|||
129203570|NCT04158583|465042448|FG001|Overall Study|Withdrawal by Subject|1|||
129203571|NCT04158583|465042449|FG002|Overall Study|Withdrawal by Subject|0|||
129203572|NCT04158583|465042450|FG003|Overall Study|Withdrawal by Subject|0|||
129203573|NCT04158583|465042451|FG004|Overall Study|Withdrawal by Subject|1|||
129203574|NCT04158583|465042452|FG005|Overall Study|Withdrawal by Subject|0|||
129203575|NCT04158583|465042453|FG006|Overall Study|Withdrawal by Subject|0|||
129203576|NCT04158583|465042454|FG007|Overall Study|Withdrawal by Subject|0|||
129203577|NCT04158583|465042455|FG008|Overall Study|Withdrawal by Subject|2|||
129203578|NCT04158583|465042456|FG009|Overall Study|Withdrawal by Subject|0|||
129203579|NCT04158583|465042447|FG000|Overall Study|Study Terminated by Sponsor|0|||
129203580|NCT04158583|465042448|FG001|Overall Study|Study Terminated by Sponsor|0|||
129203581|NCT04158583|465042449|FG002|Overall Study|Study Terminated by Sponsor|0|||
129203582|NCT04158583|465042450|FG003|Overall Study|Study Terminated by Sponsor|1|||
129203583|NCT04158583|465042451|FG004|Overall Study|Study Terminated by Sponsor|0|||
129203584|NCT04158583|465042452|FG005|Overall Study|Study Terminated by Sponsor|0|||
128733317|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
128733318|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
128733319|NCT03732638|463316144|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
128733320|NCT03732638|463316145|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
129203585|NCT04158583|465042453|FG006|Overall Study|Study Terminated by Sponsor|0|||
129203586|NCT04158583|465042454|FG007|Overall Study|Study Terminated by Sponsor|0|||
129203587|NCT04158583|465042455|FG008|Overall Study|Study Terminated by Sponsor|0|||
129203588|NCT04158583|465042456|FG009|Overall Study|Study Terminated by Sponsor|0|||
129203589|NCT04158583|465042447|FG000|Overall Study|Progressive Disease|1|||
129203590|NCT04158583|465042448|FG001|Overall Study|Progressive Disease|0|||
129203591|NCT04158583|465042449|FG002|Overall Study|Progressive Disease|3|||
129203592|NCT04158583|465042450|FG003|Overall Study|Progressive Disease|5|||
129203593|NCT04158583|465042451|FG004|Overall Study|Progressive Disease|0|||
129203594|NCT04158583|465042452|FG005|Overall Study|Progressive Disease|1|||
129203595|NCT04158583|465042453|FG006|Overall Study|Progressive Disease|6|||
129203596|NCT04158583|465042454|FG007|Overall Study|Progressive Disease|2|||
129203597|NCT04158583|465042455|FG008|Overall Study|Progressive Disease|1|||
129203598|NCT04158583|465042456|FG009|Overall Study|Progressive Disease|2|||
129203599|NCT04158583|465042447|FG000|Overall Study|Lost to Follow-up|0|||
129203600|NCT04158583|465042448|FG001|Overall Study|Lost to Follow-up|0|||
129203601|NCT04158583|465042449|FG002|Overall Study|Lost to Follow-up|1|||
129203602|NCT04158583|465042450|FG003|Overall Study|Lost to Follow-up|1|||
129203603|NCT04158583|465042451|FG004|Overall Study|Lost to Follow-up|1|||
129203604|NCT04158583|465042452|FG005|Overall Study|Lost to Follow-up|0|||
129203605|NCT04158583|465042453|FG006|Overall Study|Lost to Follow-up|0|||
129203606|NCT04158583|465042454|FG007|Overall Study|Lost to Follow-up|0|||
129203607|NCT04158583|465042455|FG008|Overall Study|Lost to Follow-up|0|||
129203608|NCT04158583|465042456|FG009|Overall Study|Lost to Follow-up|0|||
129203609|NCT04158583|465042447|FG000|Overall Study|Due To Patient Status|0|||
129203610|NCT04158583|465042448|FG001|Overall Study|Due To Patient Status|0|||
129203611|NCT04158583|465042449|FG002|Overall Study|Due To Patient Status|0|||
129203612|NCT04158583|465042450|FG003|Overall Study|Due To Patient Status|0|||
129203613|NCT04158583|465042451|FG004|Overall Study|Due To Patient Status|0|||
129203614|NCT04158583|465042452|FG005|Overall Study|Due To Patient Status|0|||
129203615|NCT04158583|465042453|FG006|Overall Study|Due To Patient Status|0|||
129203616|NCT04158583|465042454|FG007|Overall Study|Due To Patient Status|0|||
129203617|NCT04158583|465042455|FG008|Overall Study|Due To Patient Status|1|||
129203618|NCT04158583|465042456|FG009|Overall Study|Due To Patient Status|0|||
129203619|NCT04158583|465042447|FG000|Overall Study|Death|3|||
129203620|NCT04158583|465042448|FG001|Overall Study|Death|4|||
129203621|NCT04158583|465042449|FG002|Overall Study|Death|2|||
129203622|NCT04158583|465042450|FG003|Overall Study|Death|2|||
129203623|NCT04158583|465042451|FG004|Overall Study|Death|4|||
129203624|NCT04158583|465042452|FG005|Overall Study|Death|3|||
129203625|NCT04158583|465042453|FG006|Overall Study|Death|5|||
129203626|NCT04158583|465042454|FG007|Overall Study|Death|2|||
129203627|NCT04158583|465042455|FG008|Overall Study|Death|0|||
129203628|NCT04158583|465042456|FG009|Overall Study|Death|1|||
129203629|NCT04158583|465042447|FG000|Overall Study|Clinical Progression Disease|0|||
129203630|NCT04158583|465042448|FG001|Overall Study|Clinical Progression Disease|0|||
129203631|NCT04158583|465042449|FG002|Overall Study|Clinical Progression Disease|0|||
129203632|NCT04158583|465042450|FG003|Overall Study|Clinical Progression Disease|1|||
129203633|NCT04158583|465042451|FG004|Overall Study|Clinical Progression Disease|0|||
129203634|NCT04158583|465042452|FG005|Overall Study|Clinical Progression Disease|0|||
129203635|NCT04158583|465042453|FG006|Overall Study|Clinical Progression Disease|0|||
129203636|NCT04158583|465042454|FG007|Overall Study|Clinical Progression Disease|0|||
129203637|NCT04158583|465042455|FG008|Overall Study|Clinical Progression Disease|0|||
129203638|NCT04158583|465042456|FG009|Overall Study|Clinical Progression Disease|0|||
129203639|NCT04158583|465042447|FG000|Overall Study|Clinical Progression|0|||
129203640|NCT04158583|465042448|FG001|Overall Study|Clinical Progression|0|||
129203641|NCT04158583|465042449|FG002|Overall Study|Clinical Progression|0|||
129203642|NCT04158583|465042450|FG003|Overall Study|Clinical Progression|0|||
129203643|NCT04158583|465042451|FG004|Overall Study|Clinical Progression|1|||
129203644|NCT04158583|465042452|FG005|Overall Study|Clinical Progression|0|||
129203645|NCT04158583|465042453|FG006|Overall Study|Clinical Progression|2|||
129203646|NCT04158583|465042454|FG007|Overall Study|Clinical Progression|0|||
129203647|NCT04158583|465042455|FG008|Overall Study|Clinical Progression|0|||
129203648|NCT04158583|465042456|FG009|Overall Study|Clinical Progression|0|||
129203649|NCT04158583|465042447|FG000|Overall Study|Clinical Deterioration|0|||
129203650|NCT04158583|465042448|FG001|Overall Study|Clinical Deterioration|0|||
129203651|NCT04158583|465042449|FG002|Overall Study|Clinical Deterioration|0|||
129203652|NCT04158583|465042450|FG003|Overall Study|Clinical Deterioration|1|||
129203653|NCT04158583|465042451|FG004|Overall Study|Clinical Deterioration|0|||
129203654|NCT04158583|465042452|FG005|Overall Study|Clinical Deterioration|0|||
129203655|NCT04158583|465042453|FG006|Overall Study|Clinical Deterioration|0|||
129203656|NCT04158583|465042454|FG007|Overall Study|Clinical Deterioration|0|||
129203657|NCT04158583|465042455|FG008|Overall Study|Clinical Deterioration|0|||
128781342|NCT00689104|463490548|FG003|Overall Study|Physician Decision|0|||
129203658|NCT04158583|465042456|FG009|Overall Study|Clinical Deterioration|1|||
129203659|NCT01871519|465042457|FG000|Overall Study|Death|26|||
129203660|NCT01871519|465042457|FG000|Overall Study|Lost to Follow-up|15|||
129203661|NCT01871519|465042457|FG000|Overall Study|Withdrawal by Subject|49|||
129203662|NCT02485704|465042458|FG000|Overall Study|Lost to Follow-up|4|||
129203663|NCT02485704|465042459|FG001|Overall Study|Lost to Follow-up|5|||
129203664|NCT02485704|465042458|FG000|Overall Study|Withdrawal by Subject|0|||
129203665|NCT02485704|465042459|FG001|Overall Study|Withdrawal by Subject|3|||
129203666|NCT02485704|465042458|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
129203667|NCT02485704|465042459|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
129203668|NCT01777776|465042460|FG000|Overall Study|Adverse Event|2|||
129203669|NCT01777776|465042461|FG001|Overall Study|Adverse Event|4|||
129203670|NCT01777776|465042462|FG002|Overall Study|Adverse Event|0|||
129203671|NCT01777776|465042463|FG003|Overall Study|Adverse Event|0|||
129203672|NCT01777776|465042460|FG000|Overall Study|Disease Progression|4|||
129203673|NCT01777776|465042461|FG001|Overall Study|Disease Progression|8|||
129203674|NCT01777776|465042462|FG002|Overall Study|Disease Progression|6|||
129203675|NCT01777776|465042463|FG003|Overall Study|Disease Progression|3|||
129203676|NCT01777776|465042460|FG000|Overall Study|Withdrawal by Subject|0|||
129203677|NCT01777776|465042461|FG001|Overall Study|Withdrawal by Subject|0|||
129203678|NCT01777776|465042462|FG002|Overall Study|Withdrawal by Subject|0|||
129203679|NCT01777776|465042463|FG003|Overall Study|Withdrawal by Subject|1|||
129203680|NCT04617782|465043825|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
129203681|NCT04617782|465043825|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
129203682|NCT04617782|465043825|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
129203683|NCT04617782|465043825|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
129203684|NCT04617782|465043825|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
129203685|NCT04617782|465043825|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
129203686|NCT04233801|465043835|FG000|Overall Study|Other than listed|0|||
129203687|NCT04233801|465043836|FG001|Overall Study|Other than listed|0|||
129203688|NCT04233801|465043837|FG002|Overall Study|Other than listed|1|||
129203689|NCT04233801|465043835|FG000|Overall Study|Withdrawal by Subject|0|||
129203690|NCT04233801|465043836|FG001|Overall Study|Withdrawal by Subject|2|||
129203691|NCT04233801|465043837|FG002|Overall Study|Withdrawal by Subject|3|||
129203692|NCT00928486|465043838|FG000|Overall Study|Adverse Event|2|||
129203693|NCT00928486|465043838|FG000|Overall Study|Disease Progression|7|||
129203694|NCT00928486|465043838|FG000|Overall Study|Withdrawal by Subject|1|||
129203695|NCT01342913|465043839|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
129203696|NCT01342913|465043840|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129203697|NCT01342913|465043841|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129203698|NCT01342913|465043839|FG000|2-week Run-in Period|Physician Decision|6|||
129203699|NCT01342913|465043840|FG001|2-week Run-in Period|Physician Decision|0|||
129203700|NCT01342913|465043841|FG002|2-week Run-in Period|Physician Decision|0|||
129203701|NCT01342913|465043839|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
129203702|NCT01342913|465043840|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129203703|NCT01342913|465043841|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129203704|NCT01342913|465043839|FG000|2-week Run-in Period|Adverse Event|2|||
129203705|NCT01342913|465043840|FG001|2-week Run-in Period|Adverse Event|0|||
129203706|NCT01342913|465043841|FG002|2-week Run-in Period|Adverse Event|0|||
129203707|NCT01342913|465043839|FG000|2-week Run-in Period|Protocol Violation|5|||
129203708|NCT01342913|465043840|FG001|2-week Run-in Period|Protocol Violation|0|||
129203709|NCT01342913|465043841|FG002|2-week Run-in Period|Protocol Violation|0|||
129203710|NCT01342913|465043839|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
129203711|NCT01342913|465043840|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
129203712|NCT01342913|465043841|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
129203713|NCT01342913|465043839|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129203714|NCT01342913|465043840|FG001|Double-Blind Treatment Period|Adverse Event|3|||
129203715|NCT01342913|465043841|FG002|Double-Blind Treatment Period|Adverse Event|6|||
129203716|NCT01342913|465043839|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129203717|NCT01342913|465043840|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
129203718|NCT01342913|465043841|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
129203719|NCT01342913|465043839|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129203720|NCT01342913|465043840|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
129203721|NCT01342913|465043841|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
129203722|NCT01342913|465043839|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129203723|NCT01342913|465043840|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129203724|NCT01342913|465043841|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
129203725|NCT01342913|465043839|FG000|Double-Blind Treatment Period|Physician Decision|0|||
129203726|NCT01342913|465043840|FG001|Double-Blind Treatment Period|Physician Decision|2|||
129203727|NCT01342913|465043841|FG002|Double-Blind Treatment Period|Physician Decision|0|||
129203728|NCT01342913|465043839|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129203729|NCT01342913|465043840|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129203730|NCT01342913|465043841|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129203731|NCT04024891|465043845|FG000|Overall Study|Pregnancy|0|||
129203732|NCT04024891|465043846|FG001|Overall Study|Pregnancy|1|||
129203733|NCT01474317|465043850|FG000|Overall Study|Adverse Event|1|||
129203734|NCT01474317|465043850|FG000|Overall Study|Subject ineligible for study|1|||
129203735|NCT00453154|465043853|FG000|Double BIind Maintenance|Adverse Event|0|||
129203736|NCT00453154|465043854|FG001|Double BIind Maintenance|Adverse Event|0|||
129203737|NCT00453154|465043855|FG002|Double BIind Maintenance|Adverse Event|3|||
129203738|NCT00453154|465043856|FG003|Double BIind Maintenance|Adverse Event|12|||
128733321|NCT03732638|463316144|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
128733322|NCT03732638|463316145|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
128733323|NCT03732638|463316144|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
128733324|NCT03732638|463316145|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
128733325|NCT03732638|463316144|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
128733326|NCT03732638|463316145|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
128733327|NCT03732638|463316144|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
128733328|NCT03732638|463316145|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
128733329|NCT03728582|463316146|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
128733330|NCT03728582|463316147|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
128733331|NCT03728582|463316146|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
128733332|NCT03728582|463316147|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
128733333|NCT01034397|463316148|FG000|Overall Study|Lack of compliance|0|||
128733334|NCT01034397|463316149|FG001|Overall Study|Lack of compliance|1|||
129203739|NCT00453154|465043853|FG000|Double BIind Maintenance|Death|0|||
129203740|NCT00453154|465043854|FG001|Double BIind Maintenance|Death|0|||
129203741|NCT00453154|465043855|FG002|Double BIind Maintenance|Death|2|||
129203742|NCT00453154|465043856|FG003|Double BIind Maintenance|Death|1|||
129203743|NCT00453154|465043853|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
129203744|NCT00453154|465043854|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
129203745|NCT00453154|465043855|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
129203746|NCT00453154|465043856|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
129203747|NCT00453154|465043853|FG000|Double BIind Maintenance|Progression|0|||
128733335|NCT01034397|463316148|FG000|Overall Study|Lack of Efficacy|3|||
129203748|NCT00453154|465043854|FG001|Double BIind Maintenance|Progression|0|||
129203749|NCT00453154|465043855|FG002|Double BIind Maintenance|Progression|29|||
129203750|NCT00453154|465043856|FG003|Double BIind Maintenance|Progression|26|||
129203751|NCT00453154|465043853|FG000|Double BIind Maintenance|Medical Issues|0|||
129203752|NCT00453154|465043854|FG001|Double BIind Maintenance|Medical Issues|0|||
129203753|NCT00453154|465043855|FG002|Double BIind Maintenance|Medical Issues|3|||
128733336|NCT01034397|463316149|FG001|Overall Study|Lack of Efficacy|0|||
128733337|NCT01034397|463316148|FG000|Overall Study|Adverse Event|4|||
129203754|NCT00453154|465043856|FG003|Double BIind Maintenance|Medical Issues|1|||
129203755|NCT00453154|465043853|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
129203756|NCT00453154|465043854|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
129203757|NCT00453154|465043855|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
129203758|NCT00453154|465043856|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
129203759|NCT02152631|465043858|FG000|Overall Study|Adverse Event|32|||
129203760|NCT02152631|465043859|FG001|Overall Study|Adverse Event|4|||
129203761|NCT02152631|465043858|FG000|Overall Study|Withdrawal by Subject|13|||
129203762|NCT02152631|465043859|FG001|Overall Study|Withdrawal by Subject|16|||
129203763|NCT02152631|465043858|FG000|Overall Study|Noncompliance with study drug|1|||
129203764|NCT02152631|465043859|FG001|Overall Study|Noncompliance with study drug|0|||
129203765|NCT02152631|465043858|FG000|Overall Study|Physician Decision|1|||
129203766|NCT02152631|465043859|FG001|Overall Study|Physician Decision|2|||
129203767|NCT02152631|465043858|FG000|Overall Study|Lost to Follow-up|0|||
129203768|NCT02152631|465043859|FG001|Overall Study|Lost to Follow-up|1|||
129203769|NCT02152631|465043858|FG000|Overall Study|On Treatment|19|||
129203770|NCT02152631|465043859|FG001|Overall Study|On Treatment|3|||
129203771|NCT05473026|465043860|FG000|Overall Study|Lost to Follow-up|5|||
129203772|NCT05473026|465043861|FG001|Overall Study|Lost to Follow-up|2|||
129203773|NCT03683173|465043872|FG000|Completed Follow-up|Unavailable|235|||
129203774|NCT03683173|465043873|FG001|Completed Follow-up|Unavailable|217|||
129203775|NCT03683173|465043872|FG000|Completed Follow-up|Refused|69|||
129203776|NCT03683173|465043873|FG001|Completed Follow-up|Refused|59|||
129203777|NCT03683173|465043872|FG000|Completed Follow-up|Disconnected phone|65|||
129203778|NCT03683173|465043873|FG001|Completed Follow-up|Disconnected phone|95|||
129203779|NCT03683173|465043872|FG000|Completed Follow-up|Health issue/deceased|10|||
129203780|NCT03683173|465043873|FG001|Completed Follow-up|Health issue/deceased|4|||
129203781|NCT03683173|465043872|FG000|Completed Follow-up|Moved away|8|||
129203782|NCT03683173|465043873|FG001|Completed Follow-up|Moved away|1|||
129203783|NCT02647281|465043874|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203784|NCT02647281|465043875|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203785|NCT02647281|465043876|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203786|NCT02647281|465043877|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203787|NCT02647281|465043878|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203788|NCT02647281|465043879|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203789|NCT02647281|465043880|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203790|NCT02647281|465043881|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129203791|NCT02647281|465043882|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
129203792|NCT05801991|465043883|FG000|Overall Study|Lost to Follow-up|1|||
129203793|NCT05801991|465043884|FG001|Overall Study|Lost to Follow-up|0|||
129203794|NCT02210000|465043885|FG000|Overall Study|Study Terminated|11|||
129203795|NCT02210000|465043886|FG001|Overall Study|Study Terminated|12|||
129203796|NCT02210000|465043885|FG000|Overall Study|Withdrawal by Subject|7|||
128733338|NCT01034397|463316149|FG001|Overall Study|Adverse Event|0|||
128733339|NCT01034397|463316148|FG000|Overall Study|Other|0|||
128733340|NCT01034397|463316149|FG001|Overall Study|Other|1|||
128733341|NCT01018264|463316150|FG000|Overall Study|Withdrawal by Subject|1|||
129203797|NCT02210000|465043886|FG001|Overall Study|Withdrawal by Subject|1|||
129203798|NCT02210000|465043885|FG000|Overall Study|Adverse Event|1|||
129203799|NCT02210000|465043886|FG001|Overall Study|Adverse Event|5|||
129203800|NCT02210000|465043885|FG000|Overall Study|Lost to Follow-up|0|||
129203801|NCT02210000|465043886|FG001|Overall Study|Lost to Follow-up|2|||
129203802|NCT02210000|465043885|FG000|Overall Study|Physician Decision|0|||
129203803|NCT02210000|465043886|FG001|Overall Study|Physician Decision|1|||
129203804|NCT01329263|465043889|FG000|Overall Study|Lost to Follow-up|4|||
129203805|NCT01329263|465043890|FG001|Overall Study|Lost to Follow-up|21|||
129203806|NCT01329263|465043889|FG000|Overall Study|Withdrawal by Subject|1|||
129203807|NCT01329263|465043890|FG001|Overall Study|Withdrawal by Subject|2|||
128733342|NCT01018264|463316151|FG001|Overall Study|Withdrawal by Subject|0|||
129203808|NCT01421017|465043891|FG000|Overall Study|Withdrawal by Subject|2|||
128733343|NCT01018264|463316150|FG000|Overall Study|Lost to Follow-up|0|||
129203809|NCT01421017|465043892|FG001|Overall Study|Withdrawal by Subject|0|||
129203810|NCT01421017|465043893|FG002|Overall Study|Withdrawal by Subject|0|||
128733344|NCT01018264|463316151|FG001|Overall Study|Lost to Follow-up|1|||
128733345|NCT01785524|463316152|FG000|Overall Study|Withdrawal by Subject|2|||
128733346|NCT01785524|463316153|FG001|Overall Study|Withdrawal by Subject|2|||
128733347|NCT03217136|463316158|FG000|Overall Study|Lost to Follow-up|2|||
128733348|NCT03217136|463316159|FG001|Overall Study|Lost to Follow-up|1|||
129203811|NCT01421017|465043891|FG000|Overall Study|POD|0|||
129203812|NCT01421017|465043892|FG001|Overall Study|POD|6|||
129203813|NCT01421017|465043893|FG002|Overall Study|POD|3|||
129203814|NCT00833040|465043896|FG000|Overall Study|Adverse Event|0|||
129203815|NCT00833040|465043897|FG001|Overall Study|Adverse Event|0|||
129203816|NCT00833040|465043898|FG002|Overall Study|Adverse Event|0|||
129203817|NCT00833040|465043899|FG003|Overall Study|Adverse Event|0|||
129203818|NCT00833040|465043900|FG004|Overall Study|Adverse Event|0|||
129203819|NCT00833040|465043901|FG005|Overall Study|Adverse Event|1|||
129203820|NCT02313766|465043902|FG000|Overall Study|surgery cancelled|1|||
129203821|NCT02313766|465043903|FG001|Overall Study|surgery cancelled|0|||
129203822|NCT02313766|465043904|FG002|Overall Study|surgery cancelled|0|||
129203823|NCT02313766|465043902|FG000|Overall Study|Lost to Follow-up|0|||
129203824|NCT02313766|465043903|FG001|Overall Study|Lost to Follow-up|2|||
129203825|NCT02313766|465043904|FG002|Overall Study|Lost to Follow-up|0|||
129203826|NCT02313766|465043902|FG000|Overall Study|Adverse Event|0|||
129203827|NCT02313766|465043903|FG001|Overall Study|Adverse Event|1|||
129203828|NCT02313766|465043904|FG002|Overall Study|Adverse Event|0|||
129203829|NCT03489863|465043905|FG000|Overall Study|Withdrawal by Subject|0|||
129203830|NCT03489863|465043906|FG001|Overall Study|Withdrawal by Subject|1|||
129203831|NCT02193776|465043908|FG000|Overall Study|Consent withdrawn|1|||
129203832|NCT02193776|465043909|FG001|Overall Study|Consent withdrawn|0|||
129203833|NCT02193776|465043910|FG002|Overall Study|Consent withdrawn|0|||
129203834|NCT02193776|465043911|FG003|Overall Study|Consent withdrawn|0|||
129203835|NCT02193776|465043908|FG000|Overall Study|Failure to comply with protocol|0|||
129203836|NCT02193776|465043909|FG001|Overall Study|Failure to comply with protocol|1|||
129203837|NCT02193776|465043910|FG002|Overall Study|Failure to comply with protocol|0|||
129203838|NCT02193776|465043911|FG003|Overall Study|Failure to comply with protocol|0|||
129203839|NCT02193776|465043908|FG000|Overall Study|Investigator/Sponsor decision|1|||
129203840|NCT02193776|465043909|FG001|Overall Study|Investigator/Sponsor decision|1|||
129203841|NCT02193776|465043910|FG002|Overall Study|Investigator/Sponsor decision|0|||
129203842|NCT02193776|465043911|FG003|Overall Study|Investigator/Sponsor decision|0|||
129203843|NCT02193776|465043908|FG000|Overall Study|Death|1|||
129203844|NCT02193776|465043909|FG001|Overall Study|Death|0|||
129203845|NCT02193776|465043910|FG002|Overall Study|Death|0|||
129203846|NCT02193776|465043911|FG003|Overall Study|Death|0|||
129203847|NCT02193776|465043908|FG000|Overall Study|Adverse event/Specific toxicity|5|||
129203848|NCT02193776|465043909|FG001|Overall Study|Adverse event/Specific toxicity|5|||
129203849|NCT02193776|465043910|FG002|Overall Study|Adverse event/Specific toxicity|2|||
129203850|NCT02193776|465043911|FG003|Overall Study|Adverse event/Specific toxicity|2|||
129203851|NCT00962208|465043913|FG000|Overall Study|Could not achieve good vision|9|||
129203852|NCT00962208|465043914|FG001|Overall Study|Could not achieve good vision|0|||
129203853|NCT00962208|465043913|FG000|Overall Study|Contraindicated to continue study|5|||
129203854|NCT00962208|465043914|FG001|Overall Study|Contraindicated to continue study|1|||
129203855|NCT00962208|465043913|FG000|Overall Study|Lost to Follow-up|0|||
129203856|NCT00962208|465043914|FG001|Overall Study|Lost to Follow-up|9|||
129203857|NCT00791388|465043915|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129203858|NCT00791388|465043916|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
129203859|NCT00791388|465043917|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129203860|NCT00791388|465043918|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129203861|NCT00791388|465043919|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129203862|NCT00791388|465043915|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
129203863|NCT00791388|465043916|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129203864|NCT00791388|465043917|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129203865|NCT00791388|465043918|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129203866|NCT00791388|465043919|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129203867|NCT00791388|465043915|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129203868|NCT00791388|465043916|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129203869|NCT00791388|465043917|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129203870|NCT00791388|465043918|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129203871|NCT00791388|465043919|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
129203872|NCT02995980|465043920|FG000|Overall Study|Lost to Follow-up|14|||
129203873|NCT01458639|465043923|FG000|Overall Study|Physician Decision|4|||
129203874|NCT01458639|465043923|FG000|Overall Study|Equipment issue|1|||
129203875|NCT01458639|465043923|FG000|Overall Study|Inability to obtain subject blood sample|1|||
129203876|NCT02656017|465043924|FG000|Overall Study|Study burden|3|||
129203877|NCT02656017|465043925|FG001|Overall Study|Study burden|3|||
129203878|NCT02656017|465043924|FG000|Overall Study|Adverse Event|2|||
128733349|NCT03217136|463316158|FG000|Overall Study|Site Randomized Participant in Error|0|||
129203879|NCT02656017|465043925|FG001|Overall Study|Adverse Event|1|||
128733350|NCT03217136|463316159|FG001|Overall Study|Site Randomized Participant in Error|1|||
128733351|NCT03217136|463316158|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
128733352|NCT03217136|463316159|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
128733353|NCT03217136|463316158|FG000|Overall Study|Dispensing Error|1|||
128733354|NCT03217136|463316159|FG001|Overall Study|Dispensing Error|0|||
128733355|NCT03217136|463316158|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129203880|NCT02656017|465043924|FG000|Overall Study|Unable/unwilling to take study medication|2|||
129203881|NCT02656017|465043925|FG001|Overall Study|Unable/unwilling to take study medication|1|||
129203882|NCT02656017|465043924|FG000|Overall Study|Began Tolvaptan|1|||
129203883|NCT02656017|465043925|FG001|Overall Study|Began Tolvaptan|1|||
129203884|NCT02656017|465043924|FG000|Overall Study|Withdrawal by Subject|1|||
129203885|NCT02656017|465043925|FG001|Overall Study|Withdrawal by Subject|0|||
129203886|NCT02792231|465043926|FG000|Overall Study|Patient/guardian decision|32|||
129203887|NCT02792231|465043927|FG001|Overall Study|Patient/guardian decision|42|||
129203888|NCT02792231|465043926|FG000|Overall Study|Adverse Event|15|||
129203889|NCT02792231|465043927|FG001|Overall Study|Adverse Event|11|||
129203890|NCT02792231|465043926|FG000|Overall Study|Physician Decision|14|||
129203891|NCT02792231|465043927|FG001|Overall Study|Physician Decision|12|||
129203892|NCT02792231|465043926|FG000|Overall Study|Lack of Efficacy|7|||
129203893|NCT02792231|465043927|FG001|Overall Study|Lack of Efficacy|9|||
129203894|NCT02792231|465043926|FG000|Overall Study|Lost to Follow-up|9|||
129203895|NCT02792231|465043927|FG001|Overall Study|Lost to Follow-up|5|||
129203896|NCT02792231|465043926|FG000|Overall Study|Pregnancy|1|||
129203897|NCT02792231|465043927|FG001|Overall Study|Pregnancy|3|||
129203898|NCT02792231|465043926|FG000|Overall Study|Non-compliance with study treatment|2|||
129203899|NCT02792231|465043927|FG001|Overall Study|Non-compliance with study treatment|1|||
129203900|NCT02792231|465043926|FG000|Overall Study|Protocol deviation|2|||
129203901|NCT02792231|465043927|FG001|Overall Study|Protocol deviation|0|||
129203902|NCT02792231|465043926|FG000|Overall Study|Technical problems|0|||
129203903|NCT02792231|465043927|FG001|Overall Study|Technical problems|1|||
129203904|NCT05196828|465043928|FG000|Overall Study|Withdrawal by Subject|2|||
129203905|NCT05196828|465043929|FG001|Overall Study|Withdrawal by Subject|0|||
129203906|NCT05196828|465043928|FG000|Overall Study|Lost to Follow-up|0|||
129203907|NCT05196828|465043929|FG001|Overall Study|Lost to Follow-up|4|||
129203908|NCT05196828|465043928|FG000|Overall Study|Adverse Event|1|||
129203909|NCT05196828|465043929|FG001|Overall Study|Adverse Event|0|||
129203910|NCT01096316|465043930|FG000|Overall Study|Lost to Follow-up|15|||
129203911|NCT01096316|465043931|FG001|Overall Study|Lost to Follow-up|9|||
129203912|NCT02836652|465043932|FG000|Overall Study|Death|3|||
129203913|NCT02836652|465043933|FG001|Overall Study|Death|3|||
129203914|NCT02836652|465043932|FG000|Overall Study|Transplant/Explant|3|||
129203915|NCT02836652|465043933|FG001|Overall Study|Transplant/Explant|4|||
129203916|NCT02836652|465043932|FG000|Overall Study|Withdrawn|9|||
129203917|NCT02836652|465043933|FG001|Overall Study|Withdrawn|9|||
129203918|NCT02836652|465043932|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
129203919|NCT02836652|465043933|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
129203920|NCT01008943|465043935|FG000|Overall Study|Withdrawal by Subject|1|||
129203921|NCT04244253|465043936|FG000|Overall Study|Adverse Event|2|||
129203922|NCT04244253|465043937|FG001|Overall Study|Adverse Event|2|||
129203923|NCT04244253|465043938|FG002|Overall Study|Adverse Event|4|||
129203924|NCT04244253|465043936|FG000|Overall Study|Protocol Violation|1|||
129203925|NCT04244253|465043937|FG001|Overall Study|Protocol Violation|2|||
129203926|NCT04244253|465043938|FG002|Overall Study|Protocol Violation|1|||
129203927|NCT04244253|465043936|FG000|Overall Study|Withdrawal by Subject|0|||
129203928|NCT04244253|465043937|FG001|Overall Study|Withdrawal by Subject|1|||
129203929|NCT04244253|465043938|FG002|Overall Study|Withdrawal by Subject|6|||
129203930|NCT04244253|465043936|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129203931|NCT04244253|465043937|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129203932|NCT04244253|465043938|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129203933|NCT04663321|465043939|FG000|Overall Study|Study terminated by Sponsor|2|||
129203934|NCT04663321|465043940|FG001|Overall Study|Study terminated by Sponsor|1|||
128733356|NCT03217136|463316159|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129203935|NCT04663321|465043941|FG002|Overall Study|Study terminated by Sponsor|2|||
129203936|NCT04663321|465043939|FG000|Overall Study|Withdrawal by Subject|10|||
129203937|NCT04663321|465043940|FG001|Overall Study|Withdrawal by Subject|3|||
129203938|NCT04663321|465043941|FG002|Overall Study|Withdrawal by Subject|2|||
129203939|NCT04663321|465043939|FG000|Overall Study|Not provided|0|||
129203940|NCT04663321|465043940|FG001|Overall Study|Not provided|0|||
129203941|NCT04663321|465043941|FG002|Overall Study|Not provided|1|||
129203942|NCT02611479|465043942|FG000|Baseline Enrollment|Exited study|13|||
128733357|NCT03192150|463316160|FG000|Overall Study|Adverse Event|14|||
129203943|NCT02611479|465043942|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
129203944|NCT02611479|465043942|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
129203945|NCT02611479|465043942|FG000|Data Cleaning|No baseline function or pain metrics|2|||
129203946|NCT02748863|465043943|FG000|Treatment Period 1|Adverse Event|0|||
129203947|NCT02748863|465043944|FG001|Treatment Period 1|Adverse Event|1|||
129203948|NCT02748863|465043945|FG002|Treatment Period 1|Adverse Event|0|||
129203949|NCT02748863|465043946|FG003|Treatment Period 1|Adverse Event|0|||
129203950|NCT02748863|465043947|FG004|Treatment Period 1|Adverse Event|0|||
129203951|NCT02748863|465043943|FG000|Treatment Period 1|Lack of Efficacy|0|||
129203952|NCT02748863|465043944|FG001|Treatment Period 1|Lack of Efficacy|0|||
129203953|NCT02748863|465043945|FG002|Treatment Period 1|Lack of Efficacy|1|||
129203954|NCT02748863|465043946|FG003|Treatment Period 1|Lack of Efficacy|0|||
129203955|NCT02748863|465043947|FG004|Treatment Period 1|Lack of Efficacy|0|||
129203956|NCT02748863|465043943|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129203957|NCT02748863|465043944|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129203958|NCT02748863|465043945|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129203959|NCT02748863|465043946|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129203960|NCT02748863|465043947|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129203961|NCT02748863|465043943|FG000|Treatment Period 2|Lost to Follow-up|2|||
129203962|NCT02748863|465043944|FG001|Treatment Period 2|Lost to Follow-up|0|||
129203963|NCT02748863|465043945|FG002|Treatment Period 2|Lost to Follow-up|0|||
129203964|NCT02748863|465043946|FG003|Treatment Period 2|Lost to Follow-up|0|||
129203965|NCT02748863|465043947|FG004|Treatment Period 2|Lost to Follow-up|0|||
129203966|NCT02748863|465043943|FG000|Treatment Period 2|Adverse Event|3|||
129203967|NCT02748863|465043944|FG001|Treatment Period 2|Adverse Event|2|||
129203968|NCT02748863|465043945|FG002|Treatment Period 2|Adverse Event|0|||
129203969|NCT02748863|465043946|FG003|Treatment Period 2|Adverse Event|2|||
129203970|NCT02748863|465043947|FG004|Treatment Period 2|Adverse Event|0|||
129203971|NCT02748863|465043943|FG000|Treatment Period 2|Lack of Efficacy|0|||
129203972|NCT02748863|465043944|FG001|Treatment Period 2|Lack of Efficacy|1|||
129203973|NCT02748863|465043945|FG002|Treatment Period 2|Lack of Efficacy|0|||
129203974|NCT02748863|465043946|FG003|Treatment Period 2|Lack of Efficacy|0|||
129203975|NCT02748863|465043947|FG004|Treatment Period 2|Lack of Efficacy|0|||
129203976|NCT02748863|465043943|FG000|Treatment Period 2|Pregnancy|0|||
129203977|NCT02748863|465043944|FG001|Treatment Period 2|Pregnancy|0|||
129203978|NCT02748863|465043945|FG002|Treatment Period 2|Pregnancy|0|||
129203979|NCT02748863|465043946|FG003|Treatment Period 2|Pregnancy|0|||
129203980|NCT02748863|465043947|FG004|Treatment Period 2|Pregnancy|1|||
129203981|NCT02422498|465043948|FG000|Overall Study|Inevaluable|4|||
129203982|NCT01960140|465043949|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
129203983|NCT00657046|465043951|FG000|Overall Study|Adverse Event|1|||
129203984|NCT00657046|465043952|FG001|Overall Study|Adverse Event|1|||
129203985|NCT00657046|465043953|FG002|Overall Study|Adverse Event|0|||
129203986|NCT00657046|465043951|FG000|Overall Study|Protocol Violation|2|||
129203987|NCT00657046|465043952|FG001|Overall Study|Protocol Violation|2|||
129203988|NCT00657046|465043953|FG002|Overall Study|Protocol Violation|0|||
129203989|NCT00657046|465043951|FG000|Overall Study|Withdrawal by Subject|1|||
129203990|NCT00657046|465043952|FG001|Overall Study|Withdrawal by Subject|0|||
129203991|NCT00657046|465043953|FG002|Overall Study|Withdrawal by Subject|0|||
129203992|NCT00657046|465043951|FG000|Overall Study|Death|0|||
129203993|NCT00657046|465043952|FG001|Overall Study|Death|0|||
129203994|NCT00657046|465043953|FG002|Overall Study|Death|1|||
129203995|NCT00657046|465043951|FG000|Overall Study|Surgery|0|||
129203996|NCT00657046|465043952|FG001|Overall Study|Surgery|0|||
129203997|NCT00657046|465043953|FG002|Overall Study|Surgery|1|||
129203998|NCT01858363|465043954|FG000|Overall Study|Death|35|||
129203999|NCT01858363|465043955|FG001|Overall Study|Death|9|||
129204000|NCT01858363|465043954|FG000|Overall Study|Withdrawal by Subject|28|||
129204001|NCT01858363|465043955|FG001|Overall Study|Withdrawal by Subject|14|||
129204002|NCT01858363|465043954|FG000|Overall Study|Lost to Follow-up|13|||
129204003|NCT01858363|465043955|FG001|Overall Study|Lost to Follow-up|3|||
129204004|NCT00101686|465043965|FG000|Overall Study|Progressive Disease|37|||
129204005|NCT00101686|465043966|FG001|Overall Study|Progressive Disease|28|||
129204006|NCT00101686|465043967|FG002|Overall Study|Progressive Disease|37|||
129204007|NCT00101686|465043968|FG003|Overall Study|Progressive Disease|38|||
129204008|NCT00101686|465043969|FG004|Overall Study|Progressive Disease|28|||
129204009|NCT00101686|465043970|FG005|Overall Study|Progressive Disease|25|||
129204010|NCT00101686|465043971|FG006|Overall Study|Progressive Disease|5|||
129204011|NCT00101686|465043972|FG007|Overall Study|Progressive Disease|7|||
129204012|NCT00101686|465043973|FG008|Overall Study|Progressive Disease|10|||
129204013|NCT00101686|465043974|FG009|Overall Study|Progressive Disease|8|||
129204014|NCT00101686|465043965|FG000|Overall Study|initiation other anti-cancer treatment|4|||
129204015|NCT00101686|465043966|FG001|Overall Study|initiation other anti-cancer treatment|3|||
129204016|NCT00101686|465043967|FG002|Overall Study|initiation other anti-cancer treatment|4|||
129204017|NCT00101686|465043968|FG003|Overall Study|initiation other anti-cancer treatment|3|||
129204018|NCT00101686|465043969|FG004|Overall Study|initiation other anti-cancer treatment|1|||
129204019|NCT00101686|465043970|FG005|Overall Study|initiation other anti-cancer treatment|1|||
129204020|NCT00101686|465043971|FG006|Overall Study|initiation other anti-cancer treatment|2|||
129204021|NCT00101686|465043972|FG007|Overall Study|initiation other anti-cancer treatment|2|||
128733358|NCT03192150|463316161|FG001|Overall Study|Adverse Event|12|||
129204022|NCT00101686|465043973|FG008|Overall Study|initiation other anti-cancer treatment|3|||
129204023|NCT00101686|465043974|FG009|Overall Study|initiation other anti-cancer treatment|3|||
128733359|NCT03192150|463316160|FG000|Overall Study|Lack of Efficacy|23|||
128733360|NCT03192150|463316161|FG001|Overall Study|Lack of Efficacy|30|||
128733361|NCT03192150|463316160|FG000|Overall Study|Lost to Follow-up|1|||
128733362|NCT03192150|463316161|FG001|Overall Study|Lost to Follow-up|1|||
128733363|NCT03192150|463316160|FG000|Overall Study|Withdrawal by Subject|4|||
128733364|NCT03192150|463316161|FG001|Overall Study|Withdrawal by Subject|2|||
128733365|NCT03192150|463316160|FG000|Overall Study|Protocol Violation|5|||
128733366|NCT03192150|463316161|FG001|Overall Study|Protocol Violation|2|||
128733367|NCT03192150|463316160|FG000|Overall Study|Surgery Canceled|6|||
128733368|NCT03192150|463316161|FG001|Overall Study|Surgery Canceled|2|||
128733369|NCT03192150|463316160|FG000|Overall Study|Other-Various Administrative Reasons|2|||
128733370|NCT03192150|463316161|FG001|Overall Study|Other-Various Administrative Reasons|5|||
128733371|NCT02579616|463316162|FG000|Overall Study|Participants did not receive treatment|3|||
128733372|NCT00482391|463316163|FG000|Overall Study|Withdrawal by Subject|1|||
128733373|NCT00482391|463316163|FG000|Overall Study|Adverse Event|1|||
128733374|NCT00482391|463316163|FG000|Overall Study|Death|1|||
128733375|NCT06640829|463316175|FG000|Overall Study|Withdrawal by Subject|1|||
128733376|NCT06640829|463316175|FG000|Overall Study|Lost to Follow-up|1|||
128733377|NCT00261716|463316184|FG000|Overall Study|Withdrawal by Subject|6|||
128733378|NCT00261716|463316185|FG001|Overall Study|Withdrawal by Subject|8|||
128733379|NCT00261716|463316184|FG000|Overall Study|Lost to Follow-up|0|||
128733380|NCT00261716|463316185|FG001|Overall Study|Lost to Follow-up|2|||
128733381|NCT03969212|463316186|FG000|Overall Study|Adverse Event|1|||
128733382|NCT03969212|463316187|FG001|Overall Study|Adverse Event|0|||
128733383|NCT03969212|463316188|FG002|Overall Study|Adverse Event|0|||
128733384|NCT03969212|463316189|FG003|Overall Study|Adverse Event|0|||
128733385|NCT03969212|463316186|FG000|Overall Study|Lost to Follow-up|2|||
128733386|NCT03969212|463316187|FG001|Overall Study|Lost to Follow-up|2|||
128733387|NCT03969212|463316188|FG002|Overall Study|Lost to Follow-up|2|||
128733388|NCT03969212|463316189|FG003|Overall Study|Lost to Follow-up|2|||
128733389|NCT03969212|463316186|FG000|Overall Study|Protocol Violation|0|||
128733390|NCT03969212|463316187|FG001|Overall Study|Protocol Violation|0|||
128733391|NCT03969212|463316188|FG002|Overall Study|Protocol Violation|0|||
128733392|NCT03969212|463316189|FG003|Overall Study|Protocol Violation|1|||
128733393|NCT03969212|463316186|FG000|Overall Study|Withdrawal by Subject|7|||
128733394|NCT03969212|463316187|FG001|Overall Study|Withdrawal by Subject|13|||
128733395|NCT03969212|463316188|FG002|Overall Study|Withdrawal by Subject|5|||
128733396|NCT03969212|463316189|FG003|Overall Study|Withdrawal by Subject|11|||
128733397|NCT03969212|463316186|FG000|Overall Study|Physician Decision|0|||
128733398|NCT03969212|463316187|FG001|Overall Study|Physician Decision|0|||
128733399|NCT03969212|463316188|FG002|Overall Study|Physician Decision|1|||
128733400|NCT03969212|463316189|FG003|Overall Study|Physician Decision|0|||
128733401|NCT03969212|463316186|FG000|Overall Study|Reason not Specified|22|||
128733402|NCT03969212|463316187|FG001|Overall Study|Reason not Specified|23|||
128733403|NCT03969212|463316188|FG002|Overall Study|Reason not Specified|28|||
128733404|NCT03969212|463316189|FG003|Overall Study|Reason not Specified|26|||
128733405|NCT00280566|463316192|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
128733406|NCT00280566|463316193|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
128733407|NCT00280566|463316194|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
128733408|NCT00280566|463316192|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
129204024|NCT00101686|465043965|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
128733409|NCT00280566|463316193|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
128733410|NCT00280566|463316194|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
128733411|NCT00280566|463316192|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
128733412|NCT00280566|463316193|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
128733413|NCT00280566|463316194|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
128733414|NCT00280566|463316192|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
128733415|NCT00280566|463316193|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
128733416|NCT00280566|463316194|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
128733417|NCT00280566|463316192|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
128733418|NCT00280566|463316193|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
128733419|NCT00280566|463316194|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
128733420|NCT00280566|463316192|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
128733421|NCT00280566|463316193|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
128733422|NCT00280566|463316194|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
129204025|NCT00101686|465043966|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
129204026|NCT00101686|465043967|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
129204027|NCT00101686|465043968|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
128733423|NCT00280566|463316192|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
129204028|NCT00101686|465043969|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
129204029|NCT00101686|465043970|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
128733424|NCT00280566|463316193|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
128733425|NCT00280566|463316194|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
128733426|NCT00280566|463316192|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
128733427|NCT00280566|463316193|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
128733428|NCT00280566|463316194|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
128733429|NCT00280566|463316192|FG000|Period 2 Double Blind|Adverse Event|0|||
128733430|NCT00280566|463316193|FG001|Period 2 Double Blind|Adverse Event|11|||
128733431|NCT00280566|463316194|FG002|Period 2 Double Blind|Adverse Event|15|||
128733432|NCT00280566|463316192|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
128733433|NCT00280566|463316193|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
128733434|NCT00280566|463316194|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
128733435|NCT00280566|463316192|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
128733436|NCT00280566|463316193|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
128733437|NCT00280566|463316194|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
128733438|NCT00280566|463316192|FG000|Period 2 Double Blind|miscellaneous|0|||
128733439|NCT00280566|463316193|FG001|Period 2 Double Blind|miscellaneous|10|||
128733440|NCT00280566|463316194|FG002|Period 2 Double Blind|miscellaneous|5|||
128733441|NCT01147653|463316195|FG000|Year 2|Withdrawal by Subject|2|||
128733442|NCT01147653|463316196|FG001|Year 2|Withdrawal by Subject|3|||
128733443|NCT00353366|463316197|FG000|Overall Study|Adverse Event|8|||
128733444|NCT00353366|463316197|FG000|Overall Study|Protocol Violation|12|||
128733445|NCT00353366|463316197|FG000|Overall Study|Withdrawal by Subject|12|||
128733446|NCT00353366|463316197|FG000|Overall Study|Lost to Follow-up|92|||
128733447|NCT00353366|463316197|FG000|Overall Study|Other|19|||
128733448|NCT01109316|463316198|FG000|Study Period 1|Adverse Event|0|||
128733449|NCT01109316|463316199|FG001|Study Period 1|Adverse Event|0|||
128733450|NCT01109316|463316200|FG002|Study Period 1|Adverse Event|1|||
128733451|NCT01109316|463316201|FG003|Study Period 1|Adverse Event|0|||
128733452|NCT01109316|463316202|FG004|Study Period 1|Adverse Event|0|||
128733453|NCT01109316|463316203|FG005|Study Period 1|Adverse Event|0|||
128733454|NCT01109316|463316198|FG000|Study Period 1|Lost to Follow-up|0|||
128733455|NCT01109316|463316199|FG001|Study Period 1|Lost to Follow-up|0|||
128733456|NCT01109316|463316200|FG002|Study Period 1|Lost to Follow-up|1|||
128733457|NCT01109316|463316201|FG003|Study Period 1|Lost to Follow-up|1|||
128733458|NCT01109316|463316202|FG004|Study Period 1|Lost to Follow-up|0|||
128733459|NCT01109316|463316203|FG005|Study Period 1|Lost to Follow-up|0|||
128733460|NCT01109316|463316198|FG000|Study Period 1|Withdrawal by Subject|0|||
128733461|NCT01109316|463316199|FG001|Study Period 1|Withdrawal by Subject|0|||
128733462|NCT01109316|463316200|FG002|Study Period 1|Withdrawal by Subject|1|||
128733463|NCT01109316|463316201|FG003|Study Period 1|Withdrawal by Subject|0|||
128733464|NCT01109316|463316202|FG004|Study Period 1|Withdrawal by Subject|2|||
128733465|NCT01109316|463316203|FG005|Study Period 1|Withdrawal by Subject|0|||
128733466|NCT01109316|463316198|FG000|Study Period 1|Sponsor Decision|0|||
128781343|NCT00689104|463490545|FG000|Overall Study|Non-compliance with study procedures|0|||
128733467|NCT01109316|463316199|FG001|Study Period 1|Sponsor Decision|0|||
128733468|NCT01109316|463316200|FG002|Study Period 1|Sponsor Decision|0|||
128733469|NCT01109316|463316201|FG003|Study Period 1|Sponsor Decision|0|||
128733470|NCT01109316|463316202|FG004|Study Period 1|Sponsor Decision|0|||
128733471|NCT01109316|463316203|FG005|Study Period 1|Sponsor Decision|2|||
128733472|NCT01109316|463316198|FG000|Study Period 2|Entry Criteria Not Met|0|||
129204030|NCT00101686|465043971|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
129204031|NCT00101686|465043972|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
129204032|NCT00101686|465043973|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
129204033|NCT00101686|465043974|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
129204034|NCT00101686|465043965|FG000|Overall Study|unacceptable toxicity|3|||
129204035|NCT00101686|465043966|FG001|Overall Study|unacceptable toxicity|9|||
129204036|NCT00101686|465043967|FG002|Overall Study|unacceptable toxicity|10|||
129204037|NCT00101686|465043968|FG003|Overall Study|unacceptable toxicity|6|||
129204038|NCT00101686|465043969|FG004|Overall Study|unacceptable toxicity|16|||
129204039|NCT00101686|465043970|FG005|Overall Study|unacceptable toxicity|10|||
129204040|NCT00101686|465043971|FG006|Overall Study|unacceptable toxicity|4|||
129204041|NCT00101686|465043972|FG007|Overall Study|unacceptable toxicity|2|||
129204042|NCT00101686|465043973|FG008|Overall Study|unacceptable toxicity|1|||
129204043|NCT00101686|465043974|FG009|Overall Study|unacceptable toxicity|4|||
129204044|NCT00101686|465043965|FG000|Overall Study|Randomized but did not receive treament|1|||
129204045|NCT00101686|465043966|FG001|Overall Study|Randomized but did not receive treament|6|||
129204046|NCT00101686|465043967|FG002|Overall Study|Randomized but did not receive treament|2|||
129204047|NCT00101686|465043968|FG003|Overall Study|Randomized but did not receive treament|2|||
129204048|NCT00101686|465043969|FG004|Overall Study|Randomized but did not receive treament|2|||
129204049|NCT00101686|465043970|FG005|Overall Study|Randomized but did not receive treament|2|||
129204050|NCT00101686|465043971|FG006|Overall Study|Randomized but did not receive treament|0|||
129204051|NCT00101686|465043972|FG007|Overall Study|Randomized but did not receive treament|1|||
129204052|NCT00101686|465043973|FG008|Overall Study|Randomized but did not receive treament|0|||
129204053|NCT00101686|465043974|FG009|Overall Study|Randomized but did not receive treament|1|||
129204054|NCT00101686|465043965|FG000|Overall Study|intercurrent non-cancer related illness|0|||
129204055|NCT00101686|465043966|FG001|Overall Study|intercurrent non-cancer related illness|0|||
129204056|NCT00101686|465043967|FG002|Overall Study|intercurrent non-cancer related illness|2|||
129204057|NCT00101686|465043968|FG003|Overall Study|intercurrent non-cancer related illness|0|||
129204058|NCT00101686|465043969|FG004|Overall Study|intercurrent non-cancer related illness|1|||
129204059|NCT00101686|465043970|FG005|Overall Study|intercurrent non-cancer related illness|3|||
129204060|NCT00101686|465043971|FG006|Overall Study|intercurrent non-cancer related illness|1|||
129204061|NCT00101686|465043972|FG007|Overall Study|intercurrent non-cancer related illness|0|||
129204062|NCT00101686|465043973|FG008|Overall Study|intercurrent non-cancer related illness|1|||
129204063|NCT00101686|465043974|FG009|Overall Study|intercurrent non-cancer related illness|1|||
129204064|NCT00101686|465043965|FG000|Overall Study|Physician Decision|10|||
129204065|NCT00101686|465043966|FG001|Overall Study|Physician Decision|13|||
129204066|NCT00101686|465043967|FG002|Overall Study|Physician Decision|6|||
129204067|NCT00101686|465043968|FG003|Overall Study|Physician Decision|7|||
129204068|NCT00101686|465043969|FG004|Overall Study|Physician Decision|8|||
129204069|NCT00101686|465043970|FG005|Overall Study|Physician Decision|9|||
129204070|NCT00101686|465043971|FG006|Overall Study|Physician Decision|5|||
129204071|NCT00101686|465043972|FG007|Overall Study|Physician Decision|5|||
128733473|NCT01109316|463316199|FG001|Study Period 2|Entry Criteria Not Met|1|||
128733474|NCT01109316|463316200|FG002|Study Period 2|Entry Criteria Not Met|0|||
128733475|NCT01109316|463316201|FG003|Study Period 2|Entry Criteria Not Met|0|||
129204072|NCT00101686|465043973|FG008|Overall Study|Physician Decision|1|||
129204073|NCT00101686|465043974|FG009|Overall Study|Physician Decision|1|||
129204074|NCT00101686|465043965|FG000|Overall Study|Other|1|||
129204075|NCT00101686|465043966|FG001|Overall Study|Other|4|||
129204076|NCT00101686|465043967|FG002|Overall Study|Other|1|||
129204077|NCT00101686|465043968|FG003|Overall Study|Other|6|||
128733476|NCT01109316|463316202|FG004|Study Period 2|Entry Criteria Not Met|0|||
129204078|NCT00101686|465043969|FG004|Overall Study|Other|2|||
129204079|NCT00101686|465043970|FG005|Overall Study|Other|12|||
128733477|NCT01109316|463316203|FG005|Study Period 2|Entry Criteria Not Met|0|||
128733478|NCT01109316|463316198|FG000|Study Period 2|Physician Decision|0|||
128733479|NCT01109316|463316199|FG001|Study Period 2|Physician Decision|0|||
128733480|NCT01109316|463316200|FG002|Study Period 2|Physician Decision|0|||
128733481|NCT01109316|463316201|FG003|Study Period 2|Physician Decision|1|||
128733482|NCT01109316|463316202|FG004|Study Period 2|Physician Decision|0|||
128733483|NCT01109316|463316203|FG005|Study Period 2|Physician Decision|0|||
128733484|NCT01109316|463316198|FG000|Study Period 2|Protocol Violation|1|||
128733485|NCT01109316|463316199|FG001|Study Period 2|Protocol Violation|0|||
128733486|NCT01109316|463316200|FG002|Study Period 2|Protocol Violation|0|||
128733487|NCT01109316|463316201|FG003|Study Period 2|Protocol Violation|0|||
128733488|NCT01109316|463316202|FG004|Study Period 2|Protocol Violation|0|||
128733489|NCT01109316|463316203|FG005|Study Period 2|Protocol Violation|0|||
128733490|NCT01109316|463316198|FG000|Study Period 2|Withdrawal by Subject|0|||
128733491|NCT01109316|463316199|FG001|Study Period 2|Withdrawal by Subject|0|||
128733492|NCT01109316|463316200|FG002|Study Period 2|Withdrawal by Subject|1|||
128733493|NCT01109316|463316201|FG003|Study Period 2|Withdrawal by Subject|0|||
128733494|NCT01109316|463316202|FG004|Study Period 2|Withdrawal by Subject|0|||
128733495|NCT01109316|463316203|FG005|Study Period 2|Withdrawal by Subject|1|||
128733496|NCT01109316|463316198|FG000|Study Period 3|Lost to Follow-up|0|||
128733497|NCT01109316|463316199|FG001|Study Period 3|Lost to Follow-up|0|||
128733498|NCT01109316|463316200|FG002|Study Period 3|Lost to Follow-up|0|||
128733499|NCT01109316|463316201|FG003|Study Period 3|Lost to Follow-up|0|||
128733500|NCT01109316|463316202|FG004|Study Period 3|Lost to Follow-up|1|||
128733501|NCT01109316|463316203|FG005|Study Period 3|Lost to Follow-up|0|||
128733502|NCT01109316|463316198|FG000|Study Period 3|Withdrawal by Subject|1|||
128733503|NCT01109316|463316199|FG001|Study Period 3|Withdrawal by Subject|0|||
128733504|NCT01109316|463316200|FG002|Study Period 3|Withdrawal by Subject|0|||
128733505|NCT01109316|463316201|FG003|Study Period 3|Withdrawal by Subject|0|||
128733506|NCT01109316|463316202|FG004|Study Period 3|Withdrawal by Subject|1|||
128733507|NCT01109316|463316203|FG005|Study Period 3|Withdrawal by Subject|0|||
128733508|NCT01302392|463316206|FG000|Overall Study|Lost to Follow-up|1|||
128733509|NCT01302392|463316207|FG001|Overall Study|Lost to Follow-up|0|||
128733510|NCT01302392|463316206|FG000|Overall Study|Withdrawal by Subject|6|||
128733511|NCT01302392|463316207|FG001|Overall Study|Withdrawal by Subject|1|||
128733512|NCT00259857|463316208|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
128733513|NCT00259857|463316209|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
128733514|NCT00259857|463316208|FG000|24 Months Treatment|Lost to Follow-up|0|||
128733515|NCT00259857|463316209|FG001|24 Months Treatment|Lost to Follow-up|3|||
128733516|NCT00670228|463316210|FG000|Overall Study|Adverse Event|1|||
128733517|NCT00670228|463316211|FG001|Overall Study|Adverse Event|0|||
128733518|NCT00670228|463316210|FG000|Overall Study|Death or MACE|0|||
128733519|NCT00670228|463316211|FG001|Overall Study|Death or MACE|1|||
128733520|NCT00670228|463316210|FG000|Overall Study|Not treated|2|||
128733521|NCT00670228|463316211|FG001|Overall Study|Not treated|2|||
128733522|NCT00670228|463316210|FG000|Overall Study|Not meeting the selection criteria|2|||
128733523|NCT00670228|463316211|FG001|Overall Study|Not meeting the selection criteria|0|||
128733524|NCT01813019|463316221|FG000|Overall Study|Adverse Event|0|||
128733525|NCT01813019|463316222|FG001|Overall Study|Adverse Event|3|||
128733526|NCT01813019|463316221|FG000|Overall Study|Withdrawal by Subject|3|||
128733527|NCT01813019|463316222|FG001|Overall Study|Withdrawal by Subject|2|||
128733528|NCT01813019|463316221|FG000|Overall Study|administrative problems|2|||
128733529|NCT01813019|463316222|FG001|Overall Study|administrative problems|0|||
128733530|NCT01813019|463316221|FG000|Overall Study|Protocol Deviation|2|||
128733531|NCT01813019|463316222|FG001|Overall Study|Protocol Deviation|1|||
128733532|NCT00715793|463316224|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
128733533|NCT00715793|463316225|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
128733534|NCT00715793|463316224|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
128733535|NCT00715793|463316225|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
128733536|NCT01849588|463316226|FG000|Overall Study|Lack of Efficacy|3|||
128733537|NCT01541826|463316228|FG000|Overall Study|Lost to Follow-up|2|||
128733538|NCT01541826|463316229|FG001|Overall Study|Lost to Follow-up|3|||
128733539|NCT01541826|463316230|FG002|Overall Study|Lost to Follow-up|0|||
128733540|NCT01541826|463316228|FG000|Overall Study|Withdrawal by Subject|2|||
128733541|NCT01541826|463316229|FG001|Overall Study|Withdrawal by Subject|0|||
128733542|NCT01541826|463316230|FG002|Overall Study|Withdrawal by Subject|0|||
128733543|NCT01462357|463316235|FG000|Overall Study|Death|0|||
128733544|NCT01462357|463316236|FG001|Overall Study|Death|0|||
128733545|NCT01462357|463316237|FG002|Overall Study|Death|1|||
128733546|NCT01462357|463316235|FG000|Overall Study|Withdrawal by Subject|3|||
128733547|NCT01462357|463316236|FG001|Overall Study|Withdrawal by Subject|11|||
128733548|NCT01462357|463316237|FG002|Overall Study|Withdrawal by Subject|3|||
128733549|NCT01462357|463316235|FG000|Overall Study|Migrated/moved from study area|2|||
128733550|NCT01462357|463316236|FG001|Overall Study|Migrated/moved from study area|3|||
128733551|NCT01462357|463316237|FG002|Overall Study|Migrated/moved from study area|1|||
128733552|NCT01462357|463316235|FG000|Overall Study|Lost to Follow-up|3|||
128733553|NCT01462357|463316236|FG001|Overall Study|Lost to Follow-up|5|||
129204080|NCT00101686|465043971|FG006|Overall Study|Other|1|||
129204081|NCT00101686|465043972|FG007|Overall Study|Other|5|||
129204082|NCT00101686|465043973|FG008|Overall Study|Other|3|||
129204083|NCT00101686|465043974|FG009|Overall Study|Other|3|||
129204084|NCT00101686|465043965|FG000|Overall Study|Withdrawal by Subject|9|||
129204085|NCT00101686|465043966|FG001|Overall Study|Withdrawal by Subject|8|||
129204086|NCT00101686|465043967|FG002|Overall Study|Withdrawal by Subject|6|||
129204087|NCT00101686|465043968|FG003|Overall Study|Withdrawal by Subject|8|||
129204088|NCT00101686|465043969|FG004|Overall Study|Withdrawal by Subject|8|||
129204089|NCT00101686|465043970|FG005|Overall Study|Withdrawal by Subject|7|||
129204090|NCT00101686|465043971|FG006|Overall Study|Withdrawal by Subject|7|||
129204091|NCT00101686|465043972|FG007|Overall Study|Withdrawal by Subject|7|||
129204092|NCT00101686|465043973|FG008|Overall Study|Withdrawal by Subject|8|||
129204093|NCT00101686|465043974|FG009|Overall Study|Withdrawal by Subject|9|||
129204094|NCT02525471|465043975|FG000|Overall Study|Screen Failure|6|||
129204095|NCT02525471|465043975|FG000|Overall Study|Withdrawal by Subject|4|||
129204096|NCT02525471|465043975|FG000|Overall Study|Death|1|||
129204097|NCT00867165|465043976|FG000|Overall Study|Adverse Event|3|||
129204098|NCT00867165|465043977|FG001|Overall Study|Adverse Event|0|||
129204099|NCT00867165|465043976|FG000|Overall Study|Withdrawal by Subject|1|||
129204100|NCT00867165|465043977|FG001|Overall Study|Withdrawal by Subject|0|||
129204101|NCT00890825|465043978|FG000|Overall Study|Withdrawal by Subject|1|||
129204102|NCT00890825|465043979|FG001|Overall Study|Withdrawal by Subject|0|||
129204103|NCT00890825|465043978|FG000|Overall Study|Alive at data cut off (DCO)|13|||
129204104|NCT00890825|465043979|FG001|Overall Study|Alive at data cut off (DCO)|14|||
129204105|NCT01054456|465043980|FG000|Overall Study|Other|1|||
129204106|NCT04486235|465043981|FG000|Overall Study|Pregnancy|1|||
129204107|NCT04486235|465043982|FG001|Overall Study|Pregnancy|0|||
129204108|NCT04486235|465043981|FG000|Overall Study|Lost to Follow-up|1|||
129204109|NCT04486235|465043982|FG001|Overall Study|Lost to Follow-up|0|||
129204110|NCT03935126|465043983|FG000|Overall Study|Study termination by sponsor|3|||
129204111|NCT03649217|465043984|FG000|Overall Study|subject had severe ataxia not initially found|1|||
129204112|NCT03649217|465043984|FG000|Overall Study|subject had cognitive issues not initially found|1|||
129204113|NCT00377520|465043989|FG000|Overall Study|Ineligible (Prior radiation)|1|||
129204114|NCT00320515|465043994|FG000|Overall Study|Death|33|||
129204115|NCT00320515|465043994|FG000|Overall Study|Lost to Follow-up|6|||
129204116|NCT00320515|465043994|FG000|Overall Study|Physician Decision|2|||
129204117|NCT00320515|465043994|FG000|Overall Study|Withdrawal by Subject|8|||
129204118|NCT00851786|465043995|FG000|Overall Study|Withdrawal by Subject|0|||
129204119|NCT00851786|465043996|FG001|Overall Study|Withdrawal by Subject|1|||
129204120|NCT00851786|465043995|FG000|Overall Study|Protocol Violation|0|||
129204121|NCT00851786|465043996|FG001|Overall Study|Protocol Violation|1|||
129204122|NCT00851786|465043995|FG000|Overall Study|Lost to Follow-up|1|||
129204123|NCT00851786|465043996|FG001|Overall Study|Lost to Follow-up|0|||
129204124|NCT00851786|465043995|FG000|Overall Study|Incarceration|1|||
129204125|NCT00851786|465043996|FG001|Overall Study|Incarceration|0|||
129204126|NCT00851786|465043995|FG000|Overall Study|Site Closure|1|||
129204127|NCT00851786|465043996|FG001|Overall Study|Site Closure|0|||
129204128|NCT00851786|465043995|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
129204129|NCT00851786|465043996|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
129204130|NCT03858049|465045715|FG000|Overall Study|Adverse Event|16|||
129204131|NCT03858049|465045716|FG001|Overall Study|Adverse Event|9|||
129204132|NCT03858049|465045715|FG000|Overall Study|Other|1|||
129204133|NCT03858049|465045716|FG001|Overall Study|Other|1|||
129204134|NCT03493945|465045717|FG000|Phase I Dose Escalation|Ineligible|0|||
129204135|NCT03493945|465045718|FG001|Phase I Dose Escalation|Ineligible|0|||
129204136|NCT03493945|465045719|FG002|Phase I Dose Escalation|Ineligible|1|||
129204137|NCT03493945|465045720|FG003|Phase I Dose Escalation|Ineligible|0|||
129204138|NCT03493945|465045721|FG004|Phase I Dose Escalation|Ineligible|0|||
129204139|NCT03493945|465045722|FG005|Phase I Dose Escalation|Ineligible|0|||
129204140|NCT03493945|465045723|FG006|Phase I Dose Escalation|Ineligible|0|||
129204141|NCT03493945|465045717|FG000|Phase I Dose Escalation|New therapy|0|||
129204142|NCT03493945|465045718|FG001|Phase I Dose Escalation|New therapy|1|||
129204143|NCT03493945|465045719|FG002|Phase I Dose Escalation|New therapy|0|||
129204144|NCT03493945|465045720|FG003|Phase I Dose Escalation|New therapy|0|||
129204145|NCT03493945|465045721|FG004|Phase I Dose Escalation|New therapy|0|||
129204146|NCT03493945|465045722|FG005|Phase I Dose Escalation|New therapy|0|||
129204147|NCT03493945|465045723|FG006|Phase I Dose Escalation|New therapy|0|||
129204148|NCT03493945|465045717|FG000|Phase II Dose Expansion|Refused further treatment|0|||
129204149|NCT03493945|465045718|FG001|Phase II Dose Expansion|Refused further treatment|0|||
129204150|NCT03493945|465045719|FG002|Phase II Dose Expansion|Refused further treatment|0|||
129204151|NCT03493945|465045720|FG003|Phase II Dose Expansion|Refused further treatment|0|||
129204152|NCT03493945|465045721|FG004|Phase II Dose Expansion|Refused further treatment|1|||
129204153|NCT03493945|465045722|FG005|Phase II Dose Expansion|Refused further treatment|1|||
129204154|NCT03493945|465045723|FG006|Phase II Dose Expansion|Refused further treatment|0|||
129204155|NCT03493945|465045717|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
129204156|NCT03493945|465045718|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
129204157|NCT03493945|465045719|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
129204158|NCT03493945|465045720|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
129204159|NCT03493945|465045721|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
129204160|NCT03493945|465045722|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
129204161|NCT03493945|465045723|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
129204162|NCT03309878|465045731|FG000|Overall Study|Adverse Event|1|||
129204163|NCT03309878|465045732|FG001|Overall Study|Adverse Event|0|||
129204164|NCT03309878|465045733|FG002|Overall Study|Adverse Event|0|||
129204165|NCT03309878|465045734|FG003|Overall Study|Adverse Event|0|||
128733554|NCT01462357|463316237|FG002|Overall Study|Lost to Follow-up|7|||
128733555|NCT00806546|463316239|FG000|Overall Study|Enrolled, not treated|35|||
128733556|NCT00806546|463316239|FG000|Overall Study|Lost to Follow-up|32|||
128733557|NCT00806546|463316239|FG000|Overall Study|Adverse Event|74|||
128733558|NCT00806546|463316239|FG000|Overall Study|Withdrawal by Subject|75|||
128733559|NCT00806546|463316239|FG000|Overall Study|Protocol Violation|49|||
128733560|NCT00806546|463316239|FG000|Overall Study|Various|42|||
128733561|NCT01524770|463316242|FG000|First Intervention|Withdrawal by Subject|1|||
128733562|NCT01524770|463316243|FG001|First Intervention|Withdrawal by Subject|0|||
128733563|NCT01524770|463316242|FG000|First Intervention|Adverse Event|1|||
128733564|NCT01524770|463316243|FG001|First Intervention|Adverse Event|1|||
128733565|NCT01524770|463316242|FG000|First Intervention|Protocol Violation|1|||
128733566|NCT01524770|463316243|FG001|First Intervention|Protocol Violation|0|||
128733567|NCT02751983|463316244|FG000|Treatment|Stopped ACT, but Remained in study|2|||
128733568|NCT02751983|463316245|FG001|Treatment|Stopped ACT, but Remained in study|0|||
128733569|NCT02751983|463316244|FG000|Treatment|Discharged prior to beginning ACT|2|||
128733570|NCT02751983|463316245|FG001|Treatment|Discharged prior to beginning ACT|0|||
128733571|NCT02751983|463316244|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
128733572|NCT02751983|463316245|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
128733573|NCT02751983|463316244|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
128733574|NCT02751983|463316245|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
128733575|NCT02751983|463316244|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
128733576|NCT02751983|463316245|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
128733577|NCT02908529|463316247|FG000|Overall Study|Lost to Follow-up|0|||
128733578|NCT02908529|463316248|FG001|Overall Study|Lost to Follow-up|2|||
128733579|NCT02553421|463316249|FG000|Overall Study|Lost to Follow-up|21|||
128733580|NCT02553421|463316250|FG001|Overall Study|Lost to Follow-up|1|||
128733581|NCT02553421|463316249|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
128733582|NCT02553421|463316250|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
128733583|NCT02553421|463316249|FG000|Overall Study|Improper Device Placement|3|||
128733584|NCT02553421|463316250|FG001|Overall Study|Improper Device Placement|0|||
128733585|NCT03337724|463316251|FG000|Overall Study|Reason not Specified|12|||
128733586|NCT03337724|463316252|FG001|Overall Study|Reason not Specified|21|||
128733587|NCT03337724|463316253|FG002|Overall Study|Reason not Specified|9|||
128733588|NCT03337724|463316254|FG003|Overall Study|Reason not Specified|9|||
128733589|NCT03337724|463316255|FG004|Overall Study|Reason not Specified|29|||
128733590|NCT03337724|463316251|FG000|Overall Study|Withdrawal by Subject|13|||
128733591|NCT03337724|463316252|FG001|Overall Study|Withdrawal by Subject|15|||
128733592|NCT03337724|463316253|FG002|Overall Study|Withdrawal by Subject|4|||
128733593|NCT03337724|463316254|FG003|Overall Study|Withdrawal by Subject|15|||
128733594|NCT03337724|463316255|FG004|Overall Study|Withdrawal by Subject|6|||
128733595|NCT03337724|463316251|FG000|Overall Study|Protocol Deviation|0|||
128733596|NCT03337724|463316252|FG001|Overall Study|Protocol Deviation|1|||
128733597|NCT03337724|463316253|FG002|Overall Study|Protocol Deviation|1|||
128733598|NCT03337724|463316254|FG003|Overall Study|Protocol Deviation|1|||
128733599|NCT03337724|463316255|FG004|Overall Study|Protocol Deviation|0|||
128733600|NCT03337724|463316251|FG000|Overall Study|Adverse Event|1|||
128733601|NCT03337724|463316252|FG001|Overall Study|Adverse Event|1|||
128733602|NCT03337724|463316253|FG002|Overall Study|Adverse Event|0|||
128733603|NCT03337724|463316254|FG003|Overall Study|Adverse Event|1|||
128733604|NCT03337724|463316255|FG004|Overall Study|Adverse Event|0|||
128733605|NCT03337724|463316251|FG000|Overall Study|Death|40|||
128733606|NCT03337724|463316252|FG001|Overall Study|Death|89|||
128733607|NCT03337724|463316253|FG002|Overall Study|Death|43|||
128733608|NCT03337724|463316254|FG003|Overall Study|Death|76|||
128733609|NCT03337724|463316255|FG004|Overall Study|Death|50|||
128733610|NCT03337724|463316251|FG000|Overall Study|Lost to Follow-up|5|||
128733611|NCT03337724|463316252|FG001|Overall Study|Lost to Follow-up|5|||
128733612|NCT03337724|463316253|FG002|Overall Study|Lost to Follow-up|4|||
128733613|NCT03337724|463316254|FG003|Overall Study|Lost to Follow-up|7|||
128733614|NCT03337724|463316255|FG004|Overall Study|Lost to Follow-up|4|||
128733615|NCT03337724|463316251|FG000|Overall Study|Physician Decision|16|||
128733616|NCT03337724|463316252|FG001|Overall Study|Physician Decision|34|||
128733617|NCT03337724|463316253|FG002|Overall Study|Physician Decision|14|||
128733618|NCT03337724|463316254|FG003|Overall Study|Physician Decision|34|||
128733619|NCT03337724|463316255|FG004|Overall Study|Physician Decision|13|||
128733620|NCT03337724|463316251|FG000|Overall Study|Progressive Disease|0|||
128733621|NCT03337724|463316252|FG001|Overall Study|Progressive Disease|2|||
128733622|NCT03337724|463316253|FG002|Overall Study|Progressive Disease|1|||
128733623|NCT03337724|463316254|FG003|Overall Study|Progressive Disease|2|||
128733624|NCT03337724|463316255|FG004|Overall Study|Progressive Disease|0|||
128733625|NCT03337724|463316251|FG000|Overall Study|Symptomatic Deterioration|0|||
128733626|NCT03337724|463316252|FG001|Overall Study|Symptomatic Deterioration|0|||
128733627|NCT03337724|463316253|FG002|Overall Study|Symptomatic Deterioration|0|||
128733628|NCT03337724|463316254|FG003|Overall Study|Symptomatic Deterioration|1|||
128733629|NCT03337724|463316255|FG004|Overall Study|Symptomatic Deterioration|0|||
128733630|NCT05569954|463316259|FG000|Overall Study|Lost to Follow-up|3|||
128733631|NCT05569954|463316260|FG001|Overall Study|Lost to Follow-up|4|||
128733632|NCT05569954|463316259|FG000|Overall Study|Protocol Violation|1|||
128733633|NCT05569954|463316260|FG001|Overall Study|Protocol Violation|2|||
128733634|NCT05569954|463316259|FG000|Overall Study|Withdrawal by Subject|4|||
128733635|NCT05569954|463316260|FG001|Overall Study|Withdrawal by Subject|2|||
128733636|NCT03551210|463316261|FG000|Overall Study|Adverse Event|5|||
128733637|NCT03551210|463316262|FG001|Overall Study|Adverse Event|6|||
128733638|NCT03551210|463316261|FG000|Overall Study|Withdrawal by Subject|1|||
128733639|NCT03551210|463316262|FG001|Overall Study|Withdrawal by Subject|7|||
128733640|NCT03551210|463316261|FG000|Overall Study|Needed in other antibiotic treatment|2|||
128733641|NCT03551210|463316262|FG001|Overall Study|Needed in other antibiotic treatment|5|||
128733642|NCT03551210|463316261|FG000|Overall Study|Lost to Follow-up|1|||
128733643|NCT03551210|463316262|FG001|Overall Study|Lost to Follow-up|1|||
128733644|NCT03551210|463316261|FG000|Overall Study|Absence of visit 4 and 5|1|||
128733645|NCT03551210|463316262|FG001|Overall Study|Absence of visit 4 and 5|0|||
128733646|NCT03551210|463316261|FG000|Overall Study|No drug for dispensing|0|||
128733647|NCT03551210|463316262|FG001|Overall Study|No drug for dispensing|1|||
128733648|NCT03013491|463316263|FG000|Main Study|Death|2|||
128733649|NCT03013491|463316264|FG001|Main Study|Death|2|||
128733650|NCT03013491|463316265|FG002|Main Study|Death|5|||
128733651|NCT03013491|463316266|FG003|Main Study|Death|3|||
128733652|NCT03013491|463316267|FG004|Main Study|Death|9|||
128733653|NCT03013491|463316268|FG005|Main Study|Death|12|||
128733654|NCT03013491|463316269|FG006|Main Study|Death|3|||
128733655|NCT03013491|463316270|FG007|Main Study|Death|5|||
128733656|NCT03013491|463316271|FG008|Main Study|Death|1|||
128733657|NCT03013491|463316272|FG009|Main Study|Death|2|||
128733658|NCT03013491|463316273|FG010|Main Study|Death|4|||
128733659|NCT03013491|463316274|FG011|Main Study|Death|1|||
128733660|NCT03013491|463316275|FG012|Main Study|Death|1|||
128733661|NCT03013491|463316276|FG013|Main Study|Death|4|||
128733662|NCT03013491|463316277|FG014|Main Study|Death|0|||
128733663|NCT03013491|463316278|FG015|Main Study|Death|3|||
128733664|NCT03013491|463316279|FG016|Main Study|Death|5|||
128733665|NCT03013491|463316280|FG017|Main Study|Death|1|||
128733666|NCT03013491|463316281|FG018|Main Study|Death|47|||
128733667|NCT03013491|463316263|FG000|Main Study|Lost to Follow-up|0|||
128733668|NCT03013491|463316264|FG001|Main Study|Lost to Follow-up|0|||
128733669|NCT03013491|463316265|FG002|Main Study|Lost to Follow-up|1|||
128733670|NCT03013491|463316266|FG003|Main Study|Lost to Follow-up|0|||
128733671|NCT03013491|463316267|FG004|Main Study|Lost to Follow-up|1|||
128733672|NCT03013491|463316268|FG005|Main Study|Lost to Follow-up|0|||
128733673|NCT03013491|463316269|FG006|Main Study|Lost to Follow-up|0|||
128733674|NCT03013491|463316270|FG007|Main Study|Lost to Follow-up|0|||
128733675|NCT03013491|463316271|FG008|Main Study|Lost to Follow-up|0|||
128733676|NCT03013491|463316272|FG009|Main Study|Lost to Follow-up|0|||
128733677|NCT03013491|463316273|FG010|Main Study|Lost to Follow-up|0|||
128733678|NCT03013491|463316274|FG011|Main Study|Lost to Follow-up|0|||
128733679|NCT03013491|463316275|FG012|Main Study|Lost to Follow-up|0|||
128733680|NCT03013491|463316276|FG013|Main Study|Lost to Follow-up|0|||
128733681|NCT03013491|463316277|FG014|Main Study|Lost to Follow-up|0|||
128733682|NCT03013491|463316278|FG015|Main Study|Lost to Follow-up|0|||
128733683|NCT03013491|463316279|FG016|Main Study|Lost to Follow-up|0|||
128733684|NCT03013491|463316280|FG017|Main Study|Lost to Follow-up|0|||
128733685|NCT03013491|463316281|FG018|Main Study|Lost to Follow-up|3|||
128733686|NCT03013491|463316263|FG000|Main Study|Termination of the study by Sponsor|0|||
128733687|NCT03013491|463316264|FG001|Main Study|Termination of the study by Sponsor|0|||
128733688|NCT03013491|463316265|FG002|Main Study|Termination of the study by Sponsor|2|||
128733689|NCT03013491|463316266|FG003|Main Study|Termination of the study by Sponsor|0|||
128733690|NCT03013491|463316267|FG004|Main Study|Termination of the study by Sponsor|1|||
128733691|NCT03013491|463316268|FG005|Main Study|Termination of the study by Sponsor|2|||
128733692|NCT03013491|463316269|FG006|Main Study|Termination of the study by Sponsor|0|||
128733693|NCT03013491|463316270|FG007|Main Study|Termination of the study by Sponsor|0|||
128733694|NCT03013491|463316271|FG008|Main Study|Termination of the study by Sponsor|1|||
128733695|NCT03013491|463316272|FG009|Main Study|Termination of the study by Sponsor|1|||
128733696|NCT03013491|463316273|FG010|Main Study|Termination of the study by Sponsor|1|||
128733697|NCT03013491|463316274|FG011|Main Study|Termination of the study by Sponsor|2|||
128733698|NCT03013491|463316275|FG012|Main Study|Termination of the study by Sponsor|0|||
128733699|NCT03013491|463316276|FG013|Main Study|Termination of the study by Sponsor|0|||
128733700|NCT03013491|463316277|FG014|Main Study|Termination of the study by Sponsor|0|||
128733701|NCT03013491|463316278|FG015|Main Study|Termination of the study by Sponsor|0|||
128733702|NCT03013491|463316279|FG016|Main Study|Termination of the study by Sponsor|0|||
128733703|NCT03013491|463316280|FG017|Main Study|Termination of the study by Sponsor|1|||
128733704|NCT03013491|463316281|FG018|Main Study|Termination of the study by Sponsor|13|||
128733705|NCT03013491|463316263|FG000|Main Study|Withdrawal by Subject|0|||
128733706|NCT03013491|463316264|FG001|Main Study|Withdrawal by Subject|0|||
128733707|NCT03013491|463316265|FG002|Main Study|Withdrawal by Subject|0|||
128733708|NCT03013491|463316266|FG003|Main Study|Withdrawal by Subject|4|||
128733709|NCT03013491|463316267|FG004|Main Study|Withdrawal by Subject|2|||
128733710|NCT03013491|463316268|FG005|Main Study|Withdrawal by Subject|1|||
128733711|NCT03013491|463316269|FG006|Main Study|Withdrawal by Subject|0|||
128733712|NCT03013491|463316270|FG007|Main Study|Withdrawal by Subject|0|||
128733713|NCT03013491|463316271|FG008|Main Study|Withdrawal by Subject|0|||
128733714|NCT03013491|463316272|FG009|Main Study|Withdrawal by Subject|0|||
128733715|NCT03013491|463316273|FG010|Main Study|Withdrawal by Subject|1|||
128733716|NCT03013491|463316274|FG011|Main Study|Withdrawal by Subject|2|||
128733717|NCT03013491|463316275|FG012|Main Study|Withdrawal by Subject|0|||
128733718|NCT03013491|463316276|FG013|Main Study|Withdrawal by Subject|2|||
128733719|NCT03013491|463316277|FG014|Main Study|Withdrawal by Subject|0|||
128733720|NCT03013491|463316278|FG015|Main Study|Withdrawal by Subject|0|||
128733721|NCT03013491|463316279|FG016|Main Study|Withdrawal by Subject|0|||
128733722|NCT03013491|463316280|FG017|Main Study|Withdrawal by Subject|0|||
128733723|NCT03013491|463316281|FG018|Main Study|Withdrawal by Subject|18|||
128733724|NCT03013491|463316263|FG000|Main Study|Disease progression|0|||
128733725|NCT03013491|463316264|FG001|Main Study|Disease progression|0|||
128733726|NCT03013491|463316265|FG002|Main Study|Disease progression|0|||
128733727|NCT03013491|463316266|FG003|Main Study|Disease progression|1|||
128733728|NCT03013491|463316267|FG004|Main Study|Disease progression|0|||
128733729|NCT03013491|463316268|FG005|Main Study|Disease progression|0|||
128733730|NCT03013491|463316269|FG006|Main Study|Disease progression|0|||
128733731|NCT03013491|463316270|FG007|Main Study|Disease progression|0|||
128733732|NCT03013491|463316271|FG008|Main Study|Disease progression|1|||
128733733|NCT03013491|463316272|FG009|Main Study|Disease progression|0|||
128733734|NCT03013491|463316273|FG010|Main Study|Disease progression|1|||
128733735|NCT03013491|463316274|FG011|Main Study|Disease progression|0|||
128733736|NCT03013491|463316275|FG012|Main Study|Disease progression|0|||
128733737|NCT03013491|463316276|FG013|Main Study|Disease progression|0|||
128733738|NCT03013491|463316277|FG014|Main Study|Disease progression|0|||
128733739|NCT03013491|463316278|FG015|Main Study|Disease progression|0|||
128733740|NCT03013491|463316279|FG016|Main Study|Disease progression|0|||
128733741|NCT03013491|463316280|FG017|Main Study|Disease progression|0|||
128733742|NCT03013491|463316281|FG018|Main Study|Disease progression|4|||
128733743|NCT03013491|463316263|FG000|Main Study|Symptomatic deterioration|0|||
128733744|NCT03013491|463316264|FG001|Main Study|Symptomatic deterioration|0|||
128733745|NCT03013491|463316265|FG002|Main Study|Symptomatic deterioration|0|||
128733746|NCT03013491|463316266|FG003|Main Study|Symptomatic deterioration|0|||
128733747|NCT03013491|463316267|FG004|Main Study|Symptomatic deterioration|0|||
128733748|NCT03013491|463316268|FG005|Main Study|Symptomatic deterioration|1|||
128733749|NCT03013491|463316269|FG006|Main Study|Symptomatic deterioration|0|||
128733750|NCT03013491|463316270|FG007|Main Study|Symptomatic deterioration|0|||
128733751|NCT03013491|463316271|FG008|Main Study|Symptomatic deterioration|0|||
128733752|NCT03013491|463316272|FG009|Main Study|Symptomatic deterioration|0|||
128733753|NCT03013491|463316273|FG010|Main Study|Symptomatic deterioration|0|||
128733754|NCT03013491|463316274|FG011|Main Study|Symptomatic deterioration|0|||
128733755|NCT03013491|463316275|FG012|Main Study|Symptomatic deterioration|0|||
128733756|NCT03013491|463316276|FG013|Main Study|Symptomatic deterioration|0|||
128733757|NCT03013491|463316277|FG014|Main Study|Symptomatic deterioration|0|||
128733758|NCT03013491|463316278|FG015|Main Study|Symptomatic deterioration|0|||
128733759|NCT03013491|463316279|FG016|Main Study|Symptomatic deterioration|0|||
128733760|NCT03013491|463316280|FG017|Main Study|Symptomatic deterioration|0|||
128733761|NCT03013491|463316281|FG018|Main Study|Symptomatic deterioration|0|||
128733762|NCT03013491|463316263|FG000|Main Study|Protocol version 8.0 approval|0|||
128733763|NCT03013491|463316264|FG001|Main Study|Protocol version 8.0 approval|0|||
128733764|NCT03013491|463316265|FG002|Main Study|Protocol version 8.0 approval|0|||
128733765|NCT03013491|463316266|FG003|Main Study|Protocol version 8.0 approval|0|||
128733766|NCT03013491|463316267|FG004|Main Study|Protocol version 8.0 approval|0|||
128733767|NCT03013491|463316268|FG005|Main Study|Protocol version 8.0 approval|0|||
128733768|NCT03013491|463316269|FG006|Main Study|Protocol version 8.0 approval|0|||
128733769|NCT03013491|463316270|FG007|Main Study|Protocol version 8.0 approval|0|||
128733770|NCT03013491|463316271|FG008|Main Study|Protocol version 8.0 approval|0|||
128733771|NCT03013491|463316272|FG009|Main Study|Protocol version 8.0 approval|0|||
128733772|NCT03013491|463316273|FG010|Main Study|Protocol version 8.0 approval|1|||
128733773|NCT03013491|463316274|FG011|Main Study|Protocol version 8.0 approval|0|||
128733774|NCT03013491|463316275|FG012|Main Study|Protocol version 8.0 approval|0|||
128733775|NCT03013491|463316276|FG013|Main Study|Protocol version 8.0 approval|0|||
128733776|NCT03013491|463316277|FG014|Main Study|Protocol version 8.0 approval|0|||
128733777|NCT03013491|463316278|FG015|Main Study|Protocol version 8.0 approval|0|||
128733778|NCT03013491|463316279|FG016|Main Study|Protocol version 8.0 approval|0|||
128733779|NCT03013491|463316280|FG017|Main Study|Protocol version 8.0 approval|0|||
128733780|NCT03013491|463316281|FG018|Main Study|Protocol version 8.0 approval|0|||
128733781|NCT03013491|463316263|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
128733782|NCT03013491|463316264|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
128733783|NCT03013491|463316265|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
128733784|NCT03013491|463316266|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
128733785|NCT03013491|463316267|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
128733786|NCT03013491|463316268|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
128733787|NCT03013491|463316269|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
128733788|NCT03013491|463316270|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
128733789|NCT03013491|463316271|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
128733790|NCT03013491|463316272|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
128733791|NCT03013491|463316273|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
128733792|NCT03013491|463316274|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
128733793|NCT03013491|463316275|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
128733794|NCT03013491|463316276|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
128733795|NCT03013491|463316277|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
128733796|NCT03013491|463316278|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
128733797|NCT03013491|463316279|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
128733798|NCT03013491|463316280|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
128733799|NCT03013491|463316281|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
128733800|NCT03013491|463316263|FG000|Main Study|Start of new anticancer therapy|0|||
128733801|NCT03013491|463316264|FG001|Main Study|Start of new anticancer therapy|0|||
128733802|NCT03013491|463316265|FG002|Main Study|Start of new anticancer therapy|0|||
128733803|NCT03013491|463316266|FG003|Main Study|Start of new anticancer therapy|0|||
128733804|NCT03013491|463316267|FG004|Main Study|Start of new anticancer therapy|0|||
128733805|NCT03013491|463316268|FG005|Main Study|Start of new anticancer therapy|0|||
128733806|NCT03013491|463316269|FG006|Main Study|Start of new anticancer therapy|0|||
128733807|NCT03013491|463316270|FG007|Main Study|Start of new anticancer therapy|0|||
128733808|NCT03013491|463316271|FG008|Main Study|Start of new anticancer therapy|0|||
128733809|NCT03013491|463316272|FG009|Main Study|Start of new anticancer therapy|0|||
128733810|NCT03013491|463316273|FG010|Main Study|Start of new anticancer therapy|0|||
128733811|NCT03013491|463316274|FG011|Main Study|Start of new anticancer therapy|0|||
128733812|NCT03013491|463316275|FG012|Main Study|Start of new anticancer therapy|0|||
128733813|NCT03013491|463316276|FG013|Main Study|Start of new anticancer therapy|0|||
128733814|NCT03013491|463316277|FG014|Main Study|Start of new anticancer therapy|0|||
128733815|NCT03013491|463316278|FG015|Main Study|Start of new anticancer therapy|0|||
128733816|NCT03013491|463316279|FG016|Main Study|Start of new anticancer therapy|0|||
128733817|NCT03013491|463316280|FG017|Main Study|Start of new anticancer therapy|0|||
128733818|NCT03013491|463316281|FG018|Main Study|Start of new anticancer therapy|2|||
128733819|NCT03013491|463316263|FG000|Long-term Extension|Disease progression|0|||
128733820|NCT03013491|463316264|FG001|Long-term Extension|Disease progression|0|||
128733821|NCT03013491|463316265|FG002|Long-term Extension|Disease progression|0|||
128733822|NCT03013491|463316266|FG003|Long-term Extension|Disease progression|1|||
128733823|NCT03013491|463316267|FG004|Long-term Extension|Disease progression|0|||
128733824|NCT03013491|463316268|FG005|Long-term Extension|Disease progression|0|||
128733825|NCT03013491|463316269|FG006|Long-term Extension|Disease progression|0|||
128733826|NCT03013491|463316270|FG007|Long-term Extension|Disease progression|0|||
128733827|NCT03013491|463316271|FG008|Long-term Extension|Disease progression|0|||
128733828|NCT03013491|463316272|FG009|Long-term Extension|Disease progression|0|||
128733829|NCT03013491|463316273|FG010|Long-term Extension|Disease progression|0|||
128733830|NCT03013491|463316274|FG011|Long-term Extension|Disease progression|0|||
128733831|NCT03013491|463316275|FG012|Long-term Extension|Disease progression|0|||
128733832|NCT03013491|463316276|FG013|Long-term Extension|Disease progression|0|||
128733833|NCT03013491|463316277|FG014|Long-term Extension|Disease progression|0|||
128733834|NCT03013491|463316278|FG015|Long-term Extension|Disease progression|0|||
128733835|NCT03013491|463316279|FG016|Long-term Extension|Disease progression|0|||
128733836|NCT03013491|463316280|FG017|Long-term Extension|Disease progression|0|||
128733837|NCT03013491|463316281|FG018|Long-term Extension|Disease progression|1|||
128733838|NCT03013491|463316263|FG000|Long-term Extension|Withdrawal by Subject|0|||
128781344|NCT00689104|463490546|FG001|Overall Study|Non-compliance with study procedures|0|||
128781345|NCT00689104|463490547|FG002|Overall Study|Non-compliance with study procedures|1|||
128781346|NCT00689104|463490548|FG003|Overall Study|Non-compliance with study procedures|0|||
128781347|NCT04873817|463490549|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
128781348|NCT04873817|463490549|FG000|Overall Study|Lost to Follow-up|4|||
128781349|NCT04873817|463490549|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
128781350|NCT04873817|463490549|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
128781351|NCT04873817|463490549|FG000|Overall Study|Other Reasons|3|||
128781352|NCT00665561|463490552|FG000|Overall Study|Death recorded on subject summary pages|75|||
128781353|NCT00665561|463490553|FG001|Overall Study|Death recorded on subject summary pages|75|||
128781354|NCT00665561|463490552|FG000|Overall Study|Does not meet entrance criteria|19|||
128781355|NCT00665561|463490553|FG001|Overall Study|Does not meet entrance criteria|21|||
128781356|NCT00665561|463490552|FG000|Overall Study|Lost to Follow-up|203|||
128781357|NCT00665561|463490553|FG001|Overall Study|Lost to Follow-up|264|||
128781358|NCT00665561|463490552|FG000|Overall Study|Withdrawal by Subject|74|||
128781359|NCT00665561|463490553|FG001|Overall Study|Withdrawal by Subject|65|||
128781360|NCT00665561|463490552|FG000|Overall Study|Other|123|||
128781361|NCT00665561|463490553|FG001|Overall Study|Other|108|||
128781362|NCT00665561|463490552|FG000|Overall Study|Site closed|8|||
128781363|NCT00665561|463490553|FG001|Overall Study|Site closed|0|||
128781364|NCT00665561|463490552|FG000|Overall Study|Withdrawn due to pregnancy|0|||
128781365|NCT00665561|463490553|FG001|Overall Study|Withdrawn due to pregnancy|1|||
128781366|NCT01394991|463490554|FG000|Overall Study|Adverse Event|0|||
128781367|NCT01394991|463490555|FG001|Overall Study|Adverse Event|4|||
128781368|NCT01394991|463490554|FG000|Overall Study|Lack of Efficacy|5|||
128781369|NCT01394991|463490555|FG001|Overall Study|Lack of Efficacy|7|||
128781370|NCT01394991|463490554|FG000|Overall Study|Lost to Follow-up|6|||
128781371|NCT01394991|463490555|FG001|Overall Study|Lost to Follow-up|8|||
128781372|NCT01394991|463490554|FG000|Overall Study|Physician Decision|1|||
128781373|NCT01394991|463490555|FG001|Overall Study|Physician Decision|3|||
128781374|NCT01394991|463490554|FG000|Overall Study|Protocol Violation|1|||
128781375|NCT01394991|463490555|FG001|Overall Study|Protocol Violation|1|||
128781376|NCT01394991|463490554|FG000|Overall Study|Withdrawal by Subject|20|||
128781377|NCT01394991|463490555|FG001|Overall Study|Withdrawal by Subject|17|||
128781378|NCT01394991|463490554|FG000|Overall Study|Chemotherapy Termination|10|||
128781379|NCT01394991|463490555|FG001|Overall Study|Chemotherapy Termination|15|||
128781380|NCT01394991|463490554|FG000|Overall Study|Disease Progression|7|||
128781381|NCT01394991|463490555|FG001|Overall Study|Disease Progression|7|||
128781382|NCT01394991|463490554|FG000|Overall Study|Prematurely Termination of Trial|9|||
128781383|NCT01394991|463490555|FG001|Overall Study|Prematurely Termination of Trial|10|||
128781384|NCT01734811|463490565|FG000|Overall Study|Lost to Follow-up|2|||
128781385|NCT01734811|463490566|FG001|Overall Study|Lost to Follow-up|3|||
128781386|NCT01734811|463490565|FG000|Overall Study|Withdrawal by Subject|2|||
128781387|NCT01734811|463490566|FG001|Overall Study|Withdrawal by Subject|0|||
128781388|NCT00062868|463490567|FG000|Dose Level 1|Death|2|||
128781389|NCT00062868|463490568|FG001|Dose Level 1|Death|0|||
128781390|NCT00062868|463490569|FG002|Dose Level 1|Death|0|||
128733839|NCT03013491|463316264|FG001|Long-term Extension|Withdrawal by Subject|0|||
128733840|NCT03013491|463316265|FG002|Long-term Extension|Withdrawal by Subject|0|||
128733841|NCT03013491|463316266|FG003|Long-term Extension|Withdrawal by Subject|0|||
128733842|NCT03013491|463316267|FG004|Long-term Extension|Withdrawal by Subject|0|||
128733843|NCT03013491|463316268|FG005|Long-term Extension|Withdrawal by Subject|0|||
128733844|NCT03013491|463316269|FG006|Long-term Extension|Withdrawal by Subject|0|||
128733845|NCT03013491|463316270|FG007|Long-term Extension|Withdrawal by Subject|1|||
128733846|NCT03013491|463316271|FG008|Long-term Extension|Withdrawal by Subject|0|||
128733847|NCT03013491|463316272|FG009|Long-term Extension|Withdrawal by Subject|0|||
128733848|NCT03013491|463316273|FG010|Long-term Extension|Withdrawal by Subject|0|||
128733849|NCT03013491|463316274|FG011|Long-term Extension|Withdrawal by Subject|0|||
128733850|NCT03013491|463316275|FG012|Long-term Extension|Withdrawal by Subject|0|||
128733851|NCT03013491|463316276|FG013|Long-term Extension|Withdrawal by Subject|0|||
128733852|NCT03013491|463316277|FG014|Long-term Extension|Withdrawal by Subject|0|||
128733853|NCT03013491|463316278|FG015|Long-term Extension|Withdrawal by Subject|0|||
128733854|NCT03013491|463316279|FG016|Long-term Extension|Withdrawal by Subject|0|||
128733855|NCT03013491|463316280|FG017|Long-term Extension|Withdrawal by Subject|0|||
128733856|NCT03013491|463316281|FG018|Long-term Extension|Withdrawal by Subject|0|||
128733857|NCT03013491|463316263|FG000|Long-term Extension|Adverse Event|0|||
128733858|NCT03013491|463316264|FG001|Long-term Extension|Adverse Event|0|||
128733859|NCT03013491|463316265|FG002|Long-term Extension|Adverse Event|0|||
128733860|NCT03013491|463316266|FG003|Long-term Extension|Adverse Event|0|||
128733861|NCT03013491|463316267|FG004|Long-term Extension|Adverse Event|0|||
128733862|NCT03013491|463316268|FG005|Long-term Extension|Adverse Event|0|||
128733863|NCT03013491|463316269|FG006|Long-term Extension|Adverse Event|0|||
128733864|NCT03013491|463316270|FG007|Long-term Extension|Adverse Event|0|||
128733865|NCT03013491|463316271|FG008|Long-term Extension|Adverse Event|0|||
128733866|NCT03013491|463316272|FG009|Long-term Extension|Adverse Event|0|||
128733867|NCT03013491|463316273|FG010|Long-term Extension|Adverse Event|0|||
128733868|NCT03013491|463316274|FG011|Long-term Extension|Adverse Event|0|||
128733869|NCT03013491|463316275|FG012|Long-term Extension|Adverse Event|0|||
128733870|NCT03013491|463316276|FG013|Long-term Extension|Adverse Event|0|||
128733871|NCT03013491|463316277|FG014|Long-term Extension|Adverse Event|0|||
128733872|NCT03013491|463316278|FG015|Long-term Extension|Adverse Event|0|||
128733873|NCT03013491|463316279|FG016|Long-term Extension|Adverse Event|0|||
128733874|NCT03013491|463316280|FG017|Long-term Extension|Adverse Event|0|||
128733875|NCT03013491|463316281|FG018|Long-term Extension|Adverse Event|1|||
128733876|NCT03013491|463316263|FG000|Long-term Extension|Death|0|||
128733877|NCT03013491|463316264|FG001|Long-term Extension|Death|0|||
128733878|NCT03013491|463316265|FG002|Long-term Extension|Death|0|||
128733879|NCT03013491|463316266|FG003|Long-term Extension|Death|0|||
128733880|NCT03013491|463316267|FG004|Long-term Extension|Death|0|||
128733881|NCT03013491|463316268|FG005|Long-term Extension|Death|0|||
128733882|NCT03013491|463316269|FG006|Long-term Extension|Death|0|||
128733883|NCT03013491|463316270|FG007|Long-term Extension|Death|0|||
128733884|NCT03013491|463316271|FG008|Long-term Extension|Death|0|||
128733885|NCT03013491|463316272|FG009|Long-term Extension|Death|0|||
128733886|NCT03013491|463316273|FG010|Long-term Extension|Death|0|||
128733887|NCT03013491|463316274|FG011|Long-term Extension|Death|0|||
128733888|NCT03013491|463316275|FG012|Long-term Extension|Death|0|||
128733889|NCT03013491|463316276|FG013|Long-term Extension|Death|0|||
128733890|NCT03013491|463316277|FG014|Long-term Extension|Death|0|||
128733891|NCT03013491|463316278|FG015|Long-term Extension|Death|0|||
128733892|NCT03013491|463316279|FG016|Long-term Extension|Death|0|||
128733893|NCT03013491|463316280|FG017|Long-term Extension|Death|0|||
128733894|NCT03013491|463316281|FG018|Long-term Extension|Death|1|||
128733895|NCT03265119|463316282|FG000|Overall Study|Adverse Event|2|||
128733896|NCT03265119|463316283|FG001|Overall Study|Adverse Event|1|||
128733897|NCT03265119|463316282|FG000|Overall Study|Lack of Efficacy|3|||
128733898|NCT03265119|463316283|FG001|Overall Study|Lack of Efficacy|0|||
128733899|NCT03265119|463316282|FG000|Overall Study|Protocol Violation|1|||
128733900|NCT03265119|463316283|FG001|Overall Study|Protocol Violation|2|||
128733901|NCT03265119|463316282|FG000|Overall Study|Withdrawal by Subject|2|||
128733902|NCT03265119|463316283|FG001|Overall Study|Withdrawal by Subject|4|||
128733903|NCT03265119|463316282|FG000|Overall Study|Lost to Follow-up|1|||
128733904|NCT03265119|463316283|FG001|Overall Study|Lost to Follow-up|0|||
128733905|NCT03265119|463316282|FG000|Overall Study|Lack of Compliance|1|||
128733906|NCT03265119|463316283|FG001|Overall Study|Lack of Compliance|0|||
128733907|NCT03238911|463316286|FG000|Overall Study|Withdrawal by Subject|1|||
128733908|NCT03238911|463316287|FG001|Overall Study|Withdrawal by Subject|2|||
128733909|NCT03238911|463316286|FG000|Overall Study|Lost to Follow-up|2|||
128733910|NCT03238911|463316287|FG001|Overall Study|Lost to Follow-up|1|||
128781391|NCT00062868|463490570|FG003|Dose Level 1|Death|2|||
128781392|NCT00062868|463490571|FG004|Dose Level 1|Death|0|||
128781393|NCT00062868|463490572|FG005|Dose Level 1|Death|0|||
128781394|NCT00062868|463490573|FG006|Dose Level 1|Death|3|||
128781395|NCT00062868|463490574|FG007|Dose Level 1|Death|0|||
128781396|NCT00062868|463490575|FG008|Dose Level 1|Death|0|||
128781397|NCT00062868|463490576|FG009|Dose Level 1|Death|0|||
128781398|NCT00062868|463490577|FG010|Dose Level 1|Death|0|||
128733911|NCT04524403|463317940|FG000|Overall Study|Withdrawal by Subject|10|||
128733912|NCT04524403|463317941|FG001|Overall Study|Withdrawal by Subject|3|||
128733913|NCT04524403|463317942|FG002|Overall Study|Withdrawal by Subject|8|||
128733914|NCT04524403|463317940|FG000|Overall Study|Lost to Follow-up|3|||
128733915|NCT04524403|463317941|FG001|Overall Study|Lost to Follow-up|4|||
128733916|NCT04524403|463317942|FG002|Overall Study|Lost to Follow-up|3|||
128733917|NCT04524403|463317940|FG000|Overall Study|Adverse Event|3|||
128733918|NCT04524403|463317941|FG001|Overall Study|Adverse Event|1|||
128733919|NCT04524403|463317942|FG002|Overall Study|Adverse Event|4|||
128733920|NCT04524403|463317940|FG000|Overall Study|Non-compliant with study drug|1|||
128733921|NCT04524403|463317941|FG001|Overall Study|Non-compliant with study drug|2|||
128733922|NCT04524403|463317942|FG002|Overall Study|Non-compliant with study drug|3|||
128733923|NCT04524403|463317940|FG000|Overall Study|Moved|0|||
128733924|NCT04524403|463317941|FG001|Overall Study|Moved|1|||
128733925|NCT04524403|463317942|FG002|Overall Study|Moved|0|||
128733926|NCT03085927|463317945|FG000|Overall Study|Withdrawal by Subject|1|||
128733927|NCT03085927|463317946|FG001|Overall Study|Withdrawal by Subject|4|||
128733928|NCT03085927|463317945|FG000|Overall Study|Lost to Follow-up|3|||
128733929|NCT03085927|463317946|FG001|Overall Study|Lost to Follow-up|1|||
128733930|NCT03085927|463317945|FG000|Overall Study|Death|1|||
128733931|NCT03085927|463317946|FG001|Overall Study|Death|0|||
128733932|NCT03085927|463317945|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
128733933|NCT03085927|463317946|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
128733934|NCT03085927|463317945|FG000|Overall Study|Dyad Became Ineligible|0|||
128733935|NCT03085927|463317946|FG001|Overall Study|Dyad Became Ineligible|1|||
128733936|NCT02349711|463317948|FG000|Overall Study|Withdrawal by Subject|2|||
128733937|NCT02349711|463317949|FG001|Overall Study|Withdrawal by Subject|1|||
128733938|NCT02349711|463317948|FG000|Overall Study|Lost to Follow-up|1|||
128733939|NCT02349711|463317949|FG001|Overall Study|Lost to Follow-up|1|||
128733940|NCT00194012|463317950|FG000|Randomized Phase|Lack of Efficacy|8|||
128733941|NCT00194012|463317951|FG001|Randomized Phase|Lack of Efficacy|18|||
128733942|NCT00194012|463317950|FG000|Randomized Phase|Study nonadherence|2|||
128733943|NCT00194012|463317951|FG001|Randomized Phase|Study nonadherence|1|||
128733944|NCT00194012|463317950|FG000|Randomized Phase|Withdrawal by Subject|3|||
128733945|NCT00194012|463317951|FG001|Randomized Phase|Withdrawal by Subject|3|||
128733946|NCT00194012|463317950|FG000|Randomized Phase|Adverse Event|2|||
128733947|NCT00194012|463317951|FG001|Randomized Phase|Adverse Event|1|||
128733948|NCT00194012|463317950|FG000|Randomized Phase|Participant reported having a rash|1|||
128733949|NCT00194012|463317951|FG001|Randomized Phase|Participant reported having a rash|0|||
128733950|NCT00194012|463317950|FG000|Randomized Phase|Emesis and enuresis|0|||
128733951|NCT00194012|463317951|FG001|Randomized Phase|Emesis and enuresis|1|||
128733952|NCT00194012|463317950|FG000|Randomized Phase|Oral/nasal twitching|0|||
128733953|NCT00194012|463317951|FG001|Randomized Phase|Oral/nasal twitching|1|||
128733954|NCT00194012|463317950|FG000|Open Label Extension (OLE)|Weight Gain|1|||
128733955|NCT00194012|463317951|FG001|Open Label Extension (OLE)|Weight Gain|0|||
128733956|NCT00194012|463317950|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
128733957|NCT00194012|463317951|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
128733958|NCT00194012|463317950|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
128733959|NCT00194012|463317951|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
128733960|NCT00194012|463317950|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
128733961|NCT00194012|463317951|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
128733962|NCT01513317|463317957|FG000|Overall Study|Withdrawal by Subject|15|||
128733963|NCT01513317|463317958|FG001|Overall Study|Withdrawal by Subject|4|||
128781399|NCT00062868|463490578|FG011|Dose Level 1|Death|0|||
128781400|NCT00062868|463490579|FG012|Dose Level 1|Death|0|||
128781401|NCT00062868|463490580|FG013|Dose Level 1|Death|0|||
128781402|NCT00062868|463490581|FG014|Dose Level 1|Death|0|||
128781403|NCT00062868|463490582|FG015|Dose Level 1|Death|0|||
128781404|NCT00062868|463490583|FG016|Dose Level 1|Death|0|||
128781405|NCT00062868|463490584|FG017|Dose Level 1|Death|0|||
128781406|NCT00062868|463490585|FG018|Dose Level 1|Death|7|||
128781407|NCT00062868|463490586|FG019|Dose Level 1|Death|0|||
128781408|NCT00062868|463490587|FG020|Dose Level 1|Death|1|||
128781409|NCT00062868|463490567|FG000|Dose Level 1|Lost to Follow-up|0|||
128781410|NCT00062868|463490568|FG001|Dose Level 1|Lost to Follow-up|0|||
128781411|NCT00062868|463490569|FG002|Dose Level 1|Lost to Follow-up|0|||
128781412|NCT00062868|463490570|FG003|Dose Level 1|Lost to Follow-up|0|||
128781413|NCT00062868|463490571|FG004|Dose Level 1|Lost to Follow-up|0|||
128781414|NCT00062868|463490572|FG005|Dose Level 1|Lost to Follow-up|0|||
128781415|NCT00062868|463490573|FG006|Dose Level 1|Lost to Follow-up|0|||
128781416|NCT00062868|463490574|FG007|Dose Level 1|Lost to Follow-up|0|||
128781417|NCT00062868|463490575|FG008|Dose Level 1|Lost to Follow-up|0|||
128781418|NCT00062868|463490576|FG009|Dose Level 1|Lost to Follow-up|0|||
128781419|NCT00062868|463490577|FG010|Dose Level 1|Lost to Follow-up|0|||
128781420|NCT00062868|463490578|FG011|Dose Level 1|Lost to Follow-up|0|||
128781421|NCT00062868|463490579|FG012|Dose Level 1|Lost to Follow-up|1|||
128781422|NCT00062868|463490580|FG013|Dose Level 1|Lost to Follow-up|0|||
128781423|NCT00062868|463490581|FG014|Dose Level 1|Lost to Follow-up|0|||
128781424|NCT00062868|463490582|FG015|Dose Level 1|Lost to Follow-up|0|||
128781425|NCT00062868|463490583|FG016|Dose Level 1|Lost to Follow-up|0|||
128781426|NCT00062868|463490584|FG017|Dose Level 1|Lost to Follow-up|0|||
128781427|NCT00062868|463490585|FG018|Dose Level 1|Lost to Follow-up|2|||
128781428|NCT00062868|463490586|FG019|Dose Level 1|Lost to Follow-up|0|||
128781429|NCT00062868|463490587|FG020|Dose Level 1|Lost to Follow-up|1|||
128781430|NCT00062868|463490567|FG000|Dose Level 2|Death|0|||
128781431|NCT00062868|463490568|FG001|Dose Level 2|Death|3|||
128781432|NCT00062868|463490569|FG002|Dose Level 2|Death|0|||
128781433|NCT00062868|463490570|FG003|Dose Level 2|Death|0|||
128781434|NCT00062868|463490571|FG004|Dose Level 2|Death|2|||
128781435|NCT00062868|463490572|FG005|Dose Level 2|Death|0|||
128781436|NCT00062868|463490573|FG006|Dose Level 2|Death|0|||
128781437|NCT00062868|463490574|FG007|Dose Level 2|Death|0|||
128781438|NCT00062868|463490575|FG008|Dose Level 2|Death|0|||
128781439|NCT00062868|463490576|FG009|Dose Level 2|Death|0|||
128781440|NCT00062868|463490577|FG010|Dose Level 2|Death|1|||
128781441|NCT00062868|463490578|FG011|Dose Level 2|Death|0|||
128781442|NCT00062868|463490579|FG012|Dose Level 2|Death|0|||
128781443|NCT00062868|463490580|FG013|Dose Level 2|Death|0|||
128781444|NCT00062868|463490581|FG014|Dose Level 2|Death|0|||
128781445|NCT00062868|463490582|FG015|Dose Level 2|Death|0|||
128781446|NCT00062868|463490583|FG016|Dose Level 2|Death|2|||
128781447|NCT00062868|463490584|FG017|Dose Level 2|Death|0|||
128781448|NCT00062868|463490585|FG018|Dose Level 2|Death|0|||
128781449|NCT00062868|463490586|FG019|Dose Level 2|Death|0|||
128781450|NCT00062868|463490587|FG020|Dose Level 2|Death|0|||
128781451|NCT00062868|463490567|FG000|Dose Level 2|Lost to Follow-up|0|||
128781452|NCT00062868|463490568|FG001|Dose Level 2|Lost to Follow-up|0|||
128781453|NCT00062868|463490569|FG002|Dose Level 2|Lost to Follow-up|0|||
128733964|NCT01513317|463317957|FG000|Overall Study|Death|1|||
128733965|NCT01513317|463317958|FG001|Overall Study|Death|1|||
128733966|NCT01513317|463317957|FG000|Overall Study|Study terminated by sponsor|18|||
128733967|NCT01513317|463317958|FG001|Overall Study|Study terminated by sponsor|18|||
128733968|NCT01513317|463317957|FG000|Overall Study|Other|0|||
128733969|NCT01513317|463317958|FG001|Overall Study|Other|1|||
128733970|NCT02564198|463317959|FG000|Overall Study|Withdrawal by Subject|2|||
128733971|NCT02564198|463317960|FG001|Overall Study|Withdrawal by Subject|4|||
128733972|NCT02564198|463317961|FG002|Overall Study|Withdrawal by Subject|0|||
128733973|NCT02564198|463317959|FG000|Overall Study|Adverse Event|0|||
128733974|NCT02564198|463317960|FG001|Overall Study|Adverse Event|1|||
128733975|NCT02564198|463317961|FG002|Overall Study|Adverse Event|0|||
128733976|NCT02200042|463317962|FG000|Overall Study|Withdrawal by Subject|0|||
128733977|NCT02200042|463317963|FG001|Overall Study|Withdrawal by Subject|1|||
128733978|NCT02097134|463317964|FG000|Overall Study|Physician Decision|4|||
128733979|NCT02097134|463317964|FG000|Overall Study|Non-Protocol Therapy|1|||
128733980|NCT02097134|463317964|FG000|Overall Study|Progressive Disease|3|||
128733981|NCT02097134|463317964|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
128733982|NCT00298896|463317972|FG000|Overall Study|Death|3|||
128733983|NCT00298896|463317972|FG000|Overall Study|Physician Decision|2|||
128733984|NCT00298896|463317972|FG000|Overall Study|Intercurrent Illness|1|||
128733985|NCT00298896|463317972|FG000|Overall Study|Disease Progression|41|||
128733986|NCT00298896|463317972|FG000|Overall Study|Withdrawal by Subject|2|||
128733987|NCT00298896|463317972|FG000|Overall Study|Assigned to treatment in error|1|||
128733988|NCT02649972|463317975|FG000|Overall Study|Not treated|1|||
128733989|NCT03394391|463317978|FG000|Overall Study|Lost to Follow-up|1|||
128733990|NCT03394391|463317979|FG001|Overall Study|Lost to Follow-up|2|||
128733991|NCT01434823|463317982|FG000|Overall Study|Incomplete data in medical record|4|||
128733992|NCT01434823|463317983|FG001|Overall Study|Incomplete data in medical record|7|||
128733993|NCT00519649|463317984|FG000|Overall Study|Withdrawal by Subject|1|||
128733994|NCT04879745|463317985|FG000|Overall Study|Lost to Follow-up|4|||
128733995|NCT04879745|463317986|FG001|Overall Study|Lost to Follow-up|1|||
128733996|NCT00120042|463317987|FG000|Overall Study|all completed protocl|0|||
128733997|NCT00120042|463317988|FG001|Overall Study|all completed protocl|0|||
128733998|NCT00120042|463317989|FG002|Overall Study|all completed protocl|0|||
128733999|NCT03592641|463317992|FG000|Overall Study|Withdrawal by Subject|1|||
128734000|NCT00436280|463317993|FG000|Period 1: Induction|Adverse Event|8|||
128734001|NCT00436280|463317993|FG000|Period 1: Induction|Progressive Disease|12|||
128734002|NCT00436280|463317993|FG000|Period 1: Induction|Stable Disease|6|||
128734003|NCT00436280|463317993|FG000|Period 1: Induction|Withdrawal by Subject|1|||
128734004|NCT00436280|463317993|FG000|Period 1: Induction|Death|1|||
128734005|NCT00436280|463317993|FG000|Period 2: Consolidation|Adverse Event|1|||
128734006|NCT00436280|463317993|FG000|Period 2: Consolidation|Progressive Disease|10|||
128734007|NCT00436280|463317993|FG000|Period 2: Consolidation|Stable Disease|1|||
128734008|NCT00436280|463317993|FG000|Period 2: Consolidation|Physician Decision|2|||
128734009|NCT00436280|463317993|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
128734010|NCT00436280|463317993|FG000|Period 2: Consolidation|Death|1|||
128734011|NCT00436280|463317993|FG000|Period 3: Maintenance|Adverse Event|6|||
128734012|NCT00436280|463317993|FG000|Period 3: Maintenance|Progressive Disease|12|||
128734013|NCT01049919|463317997|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
128734014|NCT01049919|463317998|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
128734015|NCT01049919|463317997|FG000|Overall Study|Withdrawal by Subject|5|||
128734016|NCT01049919|463317998|FG001|Overall Study|Withdrawal by Subject|0|||
128734017|NCT01049919|463317997|FG000|Overall Study|Lost to Follow-up|6|||
128734018|NCT01049919|463317998|FG001|Overall Study|Lost to Follow-up|1|||
128781454|NCT00062868|463490570|FG003|Dose Level 2|Lost to Follow-up|0|||
128781455|NCT00062868|463490571|FG004|Dose Level 2|Lost to Follow-up|0|||
128781456|NCT00062868|463490572|FG005|Dose Level 2|Lost to Follow-up|0|||
128781457|NCT00062868|463490573|FG006|Dose Level 2|Lost to Follow-up|0|||
128781458|NCT00062868|463490574|FG007|Dose Level 2|Lost to Follow-up|0|||
128781459|NCT00062868|463490575|FG008|Dose Level 2|Lost to Follow-up|0|||
128781460|NCT00062868|463490576|FG009|Dose Level 2|Lost to Follow-up|0|||
128781461|NCT00062868|463490577|FG010|Dose Level 2|Lost to Follow-up|0|||
128781462|NCT00062868|463490578|FG011|Dose Level 2|Lost to Follow-up|0|||
128781463|NCT00062868|463490579|FG012|Dose Level 2|Lost to Follow-up|0|||
128781464|NCT00062868|463490580|FG013|Dose Level 2|Lost to Follow-up|1|||
128781465|NCT00062868|463490581|FG014|Dose Level 2|Lost to Follow-up|0|||
128781466|NCT00062868|463490582|FG015|Dose Level 2|Lost to Follow-up|0|||
128781467|NCT00062868|463490583|FG016|Dose Level 2|Lost to Follow-up|1|||
128781468|NCT00062868|463490584|FG017|Dose Level 2|Lost to Follow-up|0|||
128781469|NCT00062868|463490585|FG018|Dose Level 2|Lost to Follow-up|0|||
128781470|NCT00062868|463490586|FG019|Dose Level 2|Lost to Follow-up|0|||
128781471|NCT00062868|463490587|FG020|Dose Level 2|Lost to Follow-up|0|||
128781472|NCT00062868|463490567|FG000|Dose Level 3|Death|0|||
128781473|NCT00062868|463490568|FG001|Dose Level 3|Death|0|||
128781474|NCT00062868|463490569|FG002|Dose Level 3|Death|0|||
128781475|NCT00062868|463490570|FG003|Dose Level 3|Death|0|||
128781476|NCT00062868|463490571|FG004|Dose Level 3|Death|0|||
128781477|NCT00062868|463490572|FG005|Dose Level 3|Death|0|||
128781478|NCT00062868|463490573|FG006|Dose Level 3|Death|0|||
128781479|NCT00062868|463490574|FG007|Dose Level 3|Death|0|||
128781480|NCT00062868|463490575|FG008|Dose Level 3|Death|0|||
128781481|NCT00062868|463490576|FG009|Dose Level 3|Death|0|||
128781482|NCT00062868|463490577|FG010|Dose Level 3|Death|0|||
128781483|NCT00062868|463490578|FG011|Dose Level 3|Death|1|||
128781484|NCT00062868|463490579|FG012|Dose Level 3|Death|0|||
128781485|NCT00062868|463490580|FG013|Dose Level 3|Death|0|||
128781486|NCT00062868|463490581|FG014|Dose Level 3|Death|0|||
128781487|NCT00062868|463490582|FG015|Dose Level 3|Death|0|||
128781488|NCT00062868|463490583|FG016|Dose Level 3|Death|0|||
128781489|NCT00062868|463490584|FG017|Dose Level 3|Death|1|||
128781490|NCT00062868|463490585|FG018|Dose Level 3|Death|0|||
128781491|NCT00062868|463490586|FG019|Dose Level 3|Death|0|||
128781492|NCT00062868|463490587|FG020|Dose Level 3|Death|0|||
128781493|NCT00062868|463490567|FG000|Dose Level 3|Lost to Follow-up|0|||
128781494|NCT00062868|463490568|FG001|Dose Level 3|Lost to Follow-up|0|||
128781495|NCT00062868|463490569|FG002|Dose Level 3|Lost to Follow-up|0|||
128781496|NCT00062868|463490570|FG003|Dose Level 3|Lost to Follow-up|0|||
128781497|NCT00062868|463490571|FG004|Dose Level 3|Lost to Follow-up|0|||
128781498|NCT00062868|463490572|FG005|Dose Level 3|Lost to Follow-up|0|||
128781499|NCT00062868|463490573|FG006|Dose Level 3|Lost to Follow-up|0|||
128781500|NCT00062868|463490574|FG007|Dose Level 3|Lost to Follow-up|0|||
128781501|NCT00062868|463490575|FG008|Dose Level 3|Lost to Follow-up|0|||
128781502|NCT00062868|463490576|FG009|Dose Level 3|Lost to Follow-up|0|||
128781503|NCT00062868|463490577|FG010|Dose Level 3|Lost to Follow-up|0|||
128781504|NCT00062868|463490578|FG011|Dose Level 3|Lost to Follow-up|0|||
128781505|NCT00062868|463490579|FG012|Dose Level 3|Lost to Follow-up|0|||
128781506|NCT00062868|463490580|FG013|Dose Level 3|Lost to Follow-up|0|||
128781507|NCT00062868|463490581|FG014|Dose Level 3|Lost to Follow-up|1|||
128781508|NCT00062868|463490582|FG015|Dose Level 3|Lost to Follow-up|0|||
128781509|NCT00062868|463490583|FG016|Dose Level 3|Lost to Follow-up|0|||
128781510|NCT00062868|463490584|FG017|Dose Level 3|Lost to Follow-up|0|||
128781511|NCT00062868|463490585|FG018|Dose Level 3|Lost to Follow-up|0|||
128781512|NCT00062868|463490586|FG019|Dose Level 3|Lost to Follow-up|0|||
128781513|NCT00062868|463490587|FG020|Dose Level 3|Lost to Follow-up|0|||
128781514|NCT00062868|463490567|FG000|Dose Level 3|Withdrew|0|||
128781515|NCT00062868|463490568|FG001|Dose Level 3|Withdrew|0|||
128781516|NCT00062868|463490569|FG002|Dose Level 3|Withdrew|2|||
128781517|NCT00062868|463490570|FG003|Dose Level 3|Withdrew|0|||
128781518|NCT00062868|463490571|FG004|Dose Level 3|Withdrew|0|||
128781519|NCT00062868|463490572|FG005|Dose Level 3|Withdrew|0|||
128781520|NCT00062868|463490573|FG006|Dose Level 3|Withdrew|0|||
128781521|NCT00062868|463490574|FG007|Dose Level 3|Withdrew|0|||
128781522|NCT00062868|463490575|FG008|Dose Level 3|Withdrew|0|||
128781523|NCT00062868|463490576|FG009|Dose Level 3|Withdrew|0|||
128781524|NCT00062868|463490577|FG010|Dose Level 3|Withdrew|0|||
128781525|NCT00062868|463490578|FG011|Dose Level 3|Withdrew|0|||
128781526|NCT00062868|463490579|FG012|Dose Level 3|Withdrew|0|||
128781527|NCT00062868|463490580|FG013|Dose Level 3|Withdrew|0|||
128781528|NCT00062868|463490581|FG014|Dose Level 3|Withdrew|0|||
128781529|NCT00062868|463490582|FG015|Dose Level 3|Withdrew|0|||
128781530|NCT00062868|463490583|FG016|Dose Level 3|Withdrew|0|||
128781531|NCT00062868|463490584|FG017|Dose Level 3|Withdrew|0|||
128734019|NCT01049919|463317997|FG000|Overall Study|Physician Decision|2|||
128734020|NCT01049919|463317998|FG001|Overall Study|Physician Decision|0|||
128734021|NCT01049919|463317997|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
128734022|NCT01049919|463317998|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
128734023|NCT01049919|463317997|FG000|Overall Study|Early study termination by sponsor.|2|||
128734024|NCT01049919|463317998|FG001|Overall Study|Early study termination by sponsor.|0|||
128734025|NCT01532687|463318003|FG000|Overall Study|Death|2|||
128734026|NCT01532687|463318004|FG001|Overall Study|Death|0|||
128734027|NCT01532687|463318003|FG000|Overall Study|Adverse Event|6|||
128734028|NCT01532687|463318004|FG001|Overall Study|Adverse Event|1|||
128734029|NCT01532687|463318003|FG000|Overall Study|Withdrawal by Subject|1|||
128734030|NCT01532687|463318004|FG001|Overall Study|Withdrawal by Subject|0|||
128734031|NCT01532687|463318003|FG000|Overall Study|Physician Decision|2|||
128734032|NCT01532687|463318004|FG001|Overall Study|Physician Decision|1|||
128734033|NCT01532687|463318003|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
128734034|NCT01532687|463318004|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
128734035|NCT03160703|463318005|FG000|Overall Study|Withdrawal by Subject|0|||
128734036|NCT03160703|463318006|FG001|Overall Study|Withdrawal by Subject|0|||
128734037|NCT03160703|463318007|FG002|Overall Study|Withdrawal by Subject|0|||
128734038|NCT03160703|463318008|FG003|Overall Study|Withdrawal by Subject|1|||
128734039|NCT01448850|463318009|FG000|Overall Study|Death|3|||
128734040|NCT01448850|463318010|FG001|Overall Study|Death|6|||
128734041|NCT01448850|463318009|FG000|Overall Study|Withdrawal by Subject|13|||
128734042|NCT01448850|463318010|FG001|Overall Study|Withdrawal by Subject|21|||
128734043|NCT01448850|463318009|FG000|Overall Study|Lost to Follow-up|3|||
128734044|NCT01448850|463318010|FG001|Overall Study|Lost to Follow-up|1|||
128734045|NCT01448850|463318009|FG000|Overall Study|Other|15|||
128734046|NCT01448850|463318010|FG001|Overall Study|Other|12|||
128734047|NCT02939404|463318011|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
128734048|NCT02939404|463318012|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
128734049|NCT02939404|463318011|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
128734050|NCT02939404|463318012|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
128734051|NCT01350128|463318015|FG000|Overall Study|Withdrawal by Subject|3|||
128734052|NCT01350128|463318015|FG000|Overall Study|Protocol discontinuation criteria|8|||
128734053|NCT01350128|463318015|FG000|Overall Study|Physician Decision|1|||
128734054|NCT01350128|463318015|FG000|Overall Study|Lost to Follow-up|2|||
128734055|NCT00673452|463318019|FG000|Acute Double-Blind Phase|Adverse Event|41|||
128734056|NCT00673452|463318020|FG001|Acute Double-Blind Phase|Adverse Event|24|||
128734057|NCT00673452|463318019|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
128734058|NCT00673452|463318020|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
128734059|NCT00673452|463318019|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
128734060|NCT00673452|463318020|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
128734061|NCT00673452|463318019|FG000|Acute Double-Blind Phase|Physician Decision|0|||
128734062|NCT00673452|463318020|FG001|Acute Double-Blind Phase|Physician Decision|6|||
128734063|NCT00673452|463318019|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
128734064|NCT00673452|463318020|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
128734065|NCT00673452|463318019|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
128734066|NCT00673452|463318020|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
128734067|NCT00673452|463318019|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
128734068|NCT00673452|463318020|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
128734069|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
128734070|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
128734071|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
128734072|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
128734073|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
128734074|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
128734075|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
128734076|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
128734077|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
128734078|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
128734079|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
128734080|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
128734081|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
128734082|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
128734083|NCT00673452|463318019|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
128734084|NCT00673452|463318020|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
128734085|NCT00813124|463318021|FG000|Overall Study|Death|2|||
128734086|NCT00813124|463318021|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
128734087|NCT00813124|463318021|FG000|Overall Study|Withdrawal by Subject|1|||
128734088|NCT00767676|463318022|FG000|Overall Study|Investigator error|54|||
128734089|NCT00617240|463318023|FG000|Overall Study|Lack of Efficacy|1|||
128734090|NCT00617240|463318024|FG001|Overall Study|Lack of Efficacy|0|||
128734091|NCT01611259|463318025|FG000|Overall Study|Physician Decision|1|||
128734092|NCT01611259|463318025|FG000|Overall Study|Lack of Efficacy|2|||
128734093|NCT01611259|463318025|FG000|Overall Study|Adverse Event|4|||
128734094|NCT01611259|463318025|FG000|Overall Study|Withdrawal by Subject|7|||
128734095|NCT04936685|463318026|FG000|Overall Study|Protocol Violation|1|||
128734096|NCT04936685|463318027|FG001|Overall Study|Protocol Violation|0|||
128734097|NCT02075320|463318030|FG000|Overall Study|Withdrawal by Subject|2|||
128734098|NCT03773757|463318032|FG000|Overall Study|Withdrawal by Subject|2|||
128734099|NCT03773757|463318033|FG001|Overall Study|Withdrawal by Subject|4|||
128734100|NCT03049813|463318035|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
128734101|NCT03049813|463318036|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
128734102|NCT03049813|463318037|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
128734103|NCT03049813|463318038|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
128734104|NCT03049813|463318035|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
128734105|NCT03049813|463318036|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
128734106|NCT03049813|463318037|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
128734107|NCT03049813|463318038|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
128734108|NCT03049813|463318035|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
128734109|NCT03049813|463318036|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
128734110|NCT03049813|463318037|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
128734111|NCT03049813|463318038|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
128734112|NCT03049813|463318035|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
128734113|NCT03049813|463318036|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
128734114|NCT03049813|463318037|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
128734115|NCT03049813|463318038|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
128734116|NCT02214121|463318049|FG000|Part A|Patient decision|2|||
128734117|NCT02214121|463318050|FG001|Part A|Patient decision|0|||
128734118|NCT02214121|463318051|FG002|Part A|Patient decision|0|||
128734119|NCT02214121|463318049|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
128734120|NCT02214121|463318050|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
128734121|NCT02214121|463318051|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
128734122|NCT02214121|463318049|FG000|Part A|Other|1|||
128734123|NCT02214121|463318050|FG001|Part A|Other|0|||
128734124|NCT02214121|463318051|FG002|Part A|Other|0|||
128734125|NCT02214121|463318049|FG000|Part B|Patient decision|0|||
128734126|NCT02214121|463318050|FG001|Part B|Patient decision|1|||
128734127|NCT02214121|463318051|FG002|Part B|Patient decision|0|||
128734128|NCT02214121|463318049|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
128734129|NCT02214121|463318050|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
128734130|NCT02214121|463318051|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
128734131|NCT02214121|463318049|FG000|Part B|Lost to Follow-up|0|||
128734132|NCT02214121|463318050|FG001|Part B|Lost to Follow-up|0|||
128734133|NCT02214121|463318051|FG002|Part B|Lost to Follow-up|1|||
128734134|NCT00094653|463318052|FG000|Overall Study|Death|306|||
128734135|NCT00094653|463318053|FG001|Overall Study|Death|100|||
128734136|NCT00094653|463318054|FG002|Overall Study|Death|119|||
128734137|NCT00094653|463318052|FG000|Overall Study|Subject Withdrew Consent|10|||
128734138|NCT00094653|463318053|FG001|Overall Study|Subject Withdrew Consent|2|||
128734139|NCT00094653|463318054|FG002|Overall Study|Subject Withdrew Consent|3|||
128734140|NCT00094653|463318052|FG000|Overall Study|Other|2|||
128734141|NCT00094653|463318053|FG001|Overall Study|Other|2|||
128734142|NCT00094653|463318054|FG002|Overall Study|Other|2|||
128734143|NCT00094653|463318052|FG000|Overall Study|Lost to Follow-up|3|||
128734144|NCT00094653|463318053|FG001|Overall Study|Lost to Follow-up|2|||
128734145|NCT00094653|463318054|FG002|Overall Study|Lost to Follow-up|1|||
128734146|NCT00094653|463318052|FG000|Overall Study|Protocol Violation|0|||
128734147|NCT00094653|463318053|FG001|Overall Study|Protocol Violation|0|||
128734148|NCT00094653|463318054|FG002|Overall Study|Protocol Violation|1|||
128734149|NCT03921411|463318055|FG000|Overall Study|Withdrawal by Subject|1|||
128734150|NCT03921411|463318055|FG000|Overall Study|Protocol Deviation|2|||
128734151|NCT03921411|463318055|FG000|Overall Study|Enrolled, but never treated|2|||
128734152|NCT03120013|463318058|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128734153|NCT03120013|463318059|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
128734154|NCT01365273|463318060|FG000|Overall Study|Lost to Follow-up|1|||
128734155|NCT01365273|463318061|FG001|Overall Study|Lost to Follow-up|0|||
128734156|NCT01365273|463318060|FG000|Overall Study|Protocol Violation|0|||
128734157|NCT01365273|463318061|FG001|Overall Study|Protocol Violation|1|||
128734158|NCT01365273|463318060|FG000|Overall Study|Physician Decision|1|||
128734159|NCT01365273|463318061|FG001|Overall Study|Physician Decision|0|||
128734160|NCT00854581|463318062|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
128734161|NCT00854581|463318062|FG000|Induction (Up to Day 21)|Death|1|||
128734162|NCT00854581|463318062|FG000|Induction (Up to Day 21)|Physician Decision|1|||
128734163|NCT00854581|463318062|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
128734164|NCT01339390|463318063|FG000|Overall Study|Death|32|||
128734165|NCT01339390|463318064|FG001|Overall Study|Death|29|||
128734166|NCT01339390|463318063|FG000|Overall Study|Lost to Follow-up|125|||
128734167|NCT01339390|463318064|FG001|Overall Study|Lost to Follow-up|127|||
128781532|NCT00062868|463490585|FG018|Dose Level 3|Withdrew|0|||
128781533|NCT00062868|463490586|FG019|Dose Level 3|Withdrew|0|||
128781534|NCT00062868|463490587|FG020|Dose Level 3|Withdrew|0|||
128781535|NCT00725010|463490590|FG000|Overall Study|Toxicity|9|||
128781536|NCT00725010|463490590|FG000|Overall Study|Tumor Progression|7|||
128781537|NCT00725010|463490590|FG000|Overall Study|Withdrawal by Subject|2|||
128781538|NCT00725010|463490590|FG000|Overall Study|Death|1|||
128781539|NCT00725010|463490590|FG000|Overall Study|Lost to Follow-up|1|||
128781540|NCT00725010|463490590|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
128781541|NCT00725010|463490590|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
128781542|NCT00725010|463490590|FG000|Overall Study|No further documentation|1|||
128781543|NCT00725010|463490590|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
128781544|NCT00662909|463490596|FG000|Overall Study|Adverse Event|17|||
128781545|NCT00662909|463490597|FG001|Overall Study|Adverse Event|18|||
128781546|NCT00662909|463490598|FG002|Overall Study|Adverse Event|19|||
128781547|NCT00662909|463490596|FG000|Overall Study|Lack of Efficacy|9|||
128781548|NCT00662909|463490597|FG001|Overall Study|Lack of Efficacy|1|||
128781549|NCT00662909|463490598|FG002|Overall Study|Lack of Efficacy|5|||
128781550|NCT00662909|463490596|FG000|Overall Study|Withdrawal by Subject|29|||
128781551|NCT00662909|463490597|FG001|Overall Study|Withdrawal by Subject|22|||
128781552|NCT00662909|463490598|FG002|Overall Study|Withdrawal by Subject|16|||
128781553|NCT00662909|463490596|FG000|Overall Study|Lost to Follow-up|2|||
128781554|NCT00662909|463490597|FG001|Overall Study|Lost to Follow-up|9|||
128781555|NCT00662909|463490598|FG002|Overall Study|Lost to Follow-up|3|||
128781556|NCT00662909|463490596|FG000|Overall Study|Protocol Violation|7|||
128781557|NCT00662909|463490597|FG001|Overall Study|Protocol Violation|4|||
128781558|NCT00662909|463490598|FG002|Overall Study|Protocol Violation|5|||
128781559|NCT00662909|463490596|FG000|Overall Study|Randomized- never received study drug|1|||
128781560|NCT00662909|463490597|FG001|Overall Study|Randomized- never received study drug|0|||
128781561|NCT00662909|463490598|FG002|Overall Study|Randomized- never received study drug|0|||
128781562|NCT00662909|463490596|FG000|Overall Study|Non-compliance with study procedures|3|||
128781563|NCT00662909|463490597|FG001|Overall Study|Non-compliance with study procedures|3|||
128781564|NCT00662909|463490598|FG002|Overall Study|Non-compliance with study procedures|2|||
128781565|NCT00662909|463490596|FG000|Overall Study|Physician Decision|1|||
128781566|NCT00662909|463490597|FG001|Overall Study|Physician Decision|1|||
128781567|NCT00662909|463490598|FG002|Overall Study|Physician Decision|2|||
128781568|NCT00662909|463490596|FG000|Overall Study|Eligibility criterion not met|0|||
128781569|NCT00662909|463490597|FG001|Overall Study|Eligibility criterion not met|1|||
128781570|NCT00662909|463490598|FG002|Overall Study|Eligibility criterion not met|1|||
128781571|NCT04978363|463492869|FG000|Overall Study|Other medical issues unrelated to the study|0|||
128781572|NCT04978363|463492870|FG001|Overall Study|Other medical issues unrelated to the study|0|||
128781573|NCT04978363|463492871|FG002|Overall Study|Other medical issues unrelated to the study|0|||
128781574|NCT04978363|463492872|FG003|Overall Study|Other medical issues unrelated to the study|0|||
128781575|NCT04978363|463492873|FG004|Overall Study|Other medical issues unrelated to the study|1|||
128781576|NCT04978363|463492874|FG005|Overall Study|Other medical issues unrelated to the study|0|||
128781577|NCT04978363|463492875|FG006|Overall Study|Other medical issues unrelated to the study|0|||
128781578|NCT04978363|463492876|FG007|Overall Study|Other medical issues unrelated to the study|0|||
128781579|NCT04978363|463492877|FG008|Overall Study|Other medical issues unrelated to the study|0|||
128781580|NCT04978363|463492878|FG009|Overall Study|Other medical issues unrelated to the study|0|||
128781581|NCT04978363|463492879|FG010|Overall Study|Other medical issues unrelated to the study|0|||
128781582|NCT04978363|463492869|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
128781583|NCT04978363|463492870|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
128781584|NCT04978363|463492871|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
128781585|NCT04978363|463492872|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
128781586|NCT04978363|463492873|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
128781587|NCT04978363|463492874|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
128781588|NCT04978363|463492875|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
128781589|NCT04978363|463492876|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
128781590|NCT04978363|463492877|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
128781591|NCT04978363|463492878|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
128781592|NCT04978363|463492879|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
128781593|NCT04978363|463492869|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128781594|NCT04978363|463492870|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
128781595|NCT04978363|463492871|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128781596|NCT04978363|463492872|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128734168|NCT04847674|463318065|FG000|Overall Study|Withdrawal by Subject|0|||
128734169|NCT04847674|463318066|FG001|Overall Study|Withdrawal by Subject|1|||
128734170|NCT04847674|463318067|FG002|Overall Study|Withdrawal by Subject|0|||
128734171|NCT04847674|463318065|FG000|Overall Study|Lost to Follow-up|0|||
128734172|NCT04847674|463318066|FG001|Overall Study|Lost to Follow-up|0|||
128734173|NCT04847674|463318067|FG002|Overall Study|Lost to Follow-up|2|||
128734174|NCT04847674|463318065|FG000|Overall Study|Other than specified|21|||
128734175|NCT04847674|463318066|FG001|Overall Study|Other than specified|20|||
128734176|NCT04847674|463318067|FG002|Overall Study|Other than specified|20|||
128734177|NCT03254134|463318069|FG000|Overall Study|Not eligible patients|599|||
128734178|NCT03254134|463318070|FG001|Overall Study|Not eligible patients|3630|||
128734179|NCT02563028|463318071|FG000|Overall Study|Lack of equipment|1|||
128734180|NCT02563028|463318071|FG000|Overall Study|Unable to elicit VEP post induction|1|||
128734181|NCT00378703|463318072|FG000|Overall Study|Disease progression|59|||
128734182|NCT00378703|463318073|FG001|Overall Study|Disease progression|43|||
128734183|NCT00378703|463318074|FG002|Overall Study|Disease progression|48|||
128734184|NCT00378703|463318075|FG003|Overall Study|Disease progression|49|||
128734185|NCT00378703|463318072|FG000|Overall Study|Adverse Event|11|||
128734186|NCT00378703|463318073|FG001|Overall Study|Adverse Event|17|||
128734187|NCT00378703|463318074|FG002|Overall Study|Adverse Event|20|||
128734188|NCT00378703|463318075|FG003|Overall Study|Adverse Event|18|||
128734189|NCT00378703|463318072|FG000|Overall Study|Death|2|||
128734190|NCT00378703|463318073|FG001|Overall Study|Death|2|||
128734191|NCT00378703|463318074|FG002|Overall Study|Death|4|||
128734192|NCT00378703|463318075|FG003|Overall Study|Death|3|||
128734193|NCT00378703|463318072|FG000|Overall Study|Withdrawal by Subject|4|||
128734194|NCT00378703|463318073|FG001|Overall Study|Withdrawal by Subject|8|||
128734195|NCT00378703|463318074|FG002|Overall Study|Withdrawal by Subject|5|||
128734196|NCT00378703|463318075|FG003|Overall Study|Withdrawal by Subject|7|||
128734197|NCT00378703|463318072|FG000|Overall Study|Physician Decision|1|||
128734198|NCT00378703|463318073|FG001|Overall Study|Physician Decision|4|||
128734199|NCT00378703|463318074|FG002|Overall Study|Physician Decision|1|||
128734200|NCT00378703|463318075|FG003|Overall Study|Physician Decision|0|||
128734201|NCT00378703|463318072|FG000|Overall Study|Alternative therapy|4|||
128734202|NCT00378703|463318073|FG001|Overall Study|Alternative therapy|2|||
128734203|NCT00378703|463318074|FG002|Overall Study|Alternative therapy|0|||
128734204|NCT00378703|463318075|FG003|Overall Study|Alternative therapy|0|||
128734205|NCT00378703|463318072|FG000|Overall Study|Other complicated disease|0|||
128734206|NCT00378703|463318073|FG001|Overall Study|Other complicated disease|2|||
128734207|NCT00378703|463318074|FG002|Overall Study|Other complicated disease|2|||
128734208|NCT00378703|463318075|FG003|Overall Study|Other complicated disease|0|||
128734209|NCT00378703|463318072|FG000|Overall Study|Symptomatic deterioration|0|||
128734210|NCT00378703|463318073|FG001|Overall Study|Symptomatic deterioration|1|||
128734211|NCT00378703|463318074|FG002|Overall Study|Symptomatic deterioration|0|||
128734212|NCT00378703|463318075|FG003|Overall Study|Symptomatic deterioration|2|||
128734213|NCT00378703|463318072|FG000|Overall Study|Surgery|1|||
128734214|NCT00378703|463318073|FG001|Overall Study|Surgery|0|||
128734215|NCT00378703|463318074|FG002|Overall Study|Surgery|0|||
128734216|NCT00378703|463318075|FG003|Overall Study|Surgery|1|||
128734217|NCT00378703|463318072|FG000|Overall Study|Joint decision of physician and patient|1|||
128734218|NCT00378703|463318073|FG001|Overall Study|Joint decision of physician and patient|0|||
128734219|NCT00378703|463318074|FG002|Overall Study|Joint decision of physician and patient|0|||
128781597|NCT04978363|463492873|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128734220|NCT00378703|463318075|FG003|Overall Study|Joint decision of physician and patient|0|||
128734221|NCT00378703|463318072|FG000|Overall Study|Adverse events and progressive disease|0|||
128734222|NCT00378703|463318073|FG001|Overall Study|Adverse events and progressive disease|0|||
128734223|NCT00378703|463318074|FG002|Overall Study|Adverse events and progressive disease|0|||
128734224|NCT00378703|463318075|FG003|Overall Study|Adverse events and progressive disease|1|||
128734225|NCT00378703|463318072|FG000|Overall Study|Relocation|0|||
128781598|NCT04978363|463492874|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128781599|NCT04978363|463492875|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128734226|NCT00378703|463318073|FG001|Overall Study|Relocation|0|||
128734227|NCT00378703|463318074|FG002|Overall Study|Relocation|1|||
128734228|NCT00378703|463318075|FG003|Overall Study|Relocation|0|||
128734229|NCT00378703|463318072|FG000|Overall Study|Ineligible|4|||
128734230|NCT00378703|463318073|FG001|Overall Study|Ineligible|7|||
128734231|NCT00378703|463318074|FG002|Overall Study|Ineligible|7|||
128734232|NCT00378703|463318075|FG003|Overall Study|Ineligible|7|||
128734233|NCT00378703|463318072|FG000|Overall Study|Never started treatment|1|||
128734234|NCT00378703|463318073|FG001|Overall Study|Never started treatment|4|||
128734235|NCT00378703|463318074|FG002|Overall Study|Never started treatment|0|||
128734236|NCT00378703|463318075|FG003|Overall Study|Never started treatment|0|||
128734237|NCT00378703|463318072|FG000|Overall Study|Other|1|||
128734238|NCT00378703|463318073|FG001|Overall Study|Other|1|||
128734239|NCT00378703|463318074|FG002|Overall Study|Other|2|||
128734240|NCT00378703|463318075|FG003|Overall Study|Other|3|||
128734241|NCT02705820|463318076|FG000|Overall Study|Death|2|||
128734242|NCT02705820|463318076|FG000|Overall Study|Disease Progression|34|||
128734243|NCT02705820|463318076|FG000|Overall Study|Clinical Deterioration|3|||
128734244|NCT02702401|463318077|FG000|Overall Study|Death|242|||
128734245|NCT02702401|463318078|FG001|Overall Study|Death|125|||
128734246|NCT02702401|463318077|FG000|Overall Study|Withdrawal by Subject|15|||
128734247|NCT02702401|463318078|FG001|Overall Study|Withdrawal by Subject|5|||
128734248|NCT02702401|463318077|FG000|Overall Study|Sponsor Decision|19|||
128734249|NCT02702401|463318078|FG001|Overall Study|Sponsor Decision|3|||
128734250|NCT02702401|463318077|FG000|Overall Study|Physician Decision|1|||
128734251|NCT02702401|463318078|FG001|Overall Study|Physician Decision|2|||
128734252|NCT02702401|463318077|FG000|Overall Study|Lost to Follow-up|1|||
128734253|NCT02702401|463318078|FG001|Overall Study|Lost to Follow-up|0|||
128734254|NCT04292730|463318089|FG000|Overall Study|Lost to Follow-up|8|||
128734255|NCT04292730|463318090|FG001|Overall Study|Lost to Follow-up|12|||
128734256|NCT04292730|463318091|FG002|Overall Study|Lost to Follow-up|12|||
128734257|NCT04292730|463318092|FG003|Overall Study|Lost to Follow-up|48|||
128734258|NCT04292730|463318089|FG000|Overall Study|Death|2|||
128734259|NCT04292730|463318090|FG001|Overall Study|Death|2|||
128734260|NCT04292730|463318091|FG002|Overall Study|Death|4|||
128734261|NCT04292730|463318092|FG003|Overall Study|Death|12|||
128734262|NCT04292730|463318089|FG000|Overall Study|Withdrew Consent|2|||
128734263|NCT04292730|463318090|FG001|Overall Study|Withdrew Consent|2|||
128734264|NCT04292730|463318091|FG002|Overall Study|Withdrew Consent|5|||
128734265|NCT04292730|463318092|FG003|Overall Study|Withdrew Consent|6|||
128734266|NCT04292730|463318089|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128734267|NCT04292730|463318090|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128734268|NCT04292730|463318091|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128734269|NCT04292730|463318092|FG003|Overall Study|Non-Compliance with Study Drug|0|||
128734270|NCT04292730|463318089|FG000|Overall Study|Protocol Violation|0|||
128734271|NCT04292730|463318090|FG001|Overall Study|Protocol Violation|0|||
128734272|NCT04292730|463318091|FG002|Overall Study|Protocol Violation|1|||
128734273|NCT04292730|463318092|FG003|Overall Study|Protocol Violation|0|||
128734274|NCT04292730|463318089|FG000|Overall Study|Randomized but not Treated|8|||
128734275|NCT04292730|463318090|FG001|Overall Study|Randomized but not Treated|4|||
128734276|NCT04292730|463318091|FG002|Overall Study|Randomized but not Treated|0|||
128734277|NCT04292730|463318092|FG003|Overall Study|Randomized but not Treated|14|||
128734278|NCT01527292|463318093|FG000|Overall Study|Physician Decision|0|||
128734279|NCT01527292|463318094|FG001|Overall Study|Physician Decision|3|||
128734280|NCT01856543|463318095|FG000|Overall Study|Treatment discontinued|6|||
128734281|NCT01856543|463318096|FG001|Overall Study|Treatment discontinued|3|||
128734282|NCT01856543|463318095|FG000|Overall Study|Withdrawn before start|7|||
128781600|NCT04978363|463492876|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128734283|NCT01856543|463318096|FG001|Overall Study|Withdrawn before start|3|||
128734284|NCT02457325|463318101|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
128734285|NCT02457325|463318102|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
128734286|NCT01541930|463318103|FG000|Overall Study|Withdrawal by Subject|1|||
128734287|NCT00096044|463318104|FG000|Overall Study|Withdrawal by Subject|9|||
128734288|NCT00096044|463318104|FG000|Overall Study|Adverse Event|21|||
128734289|NCT00096044|463318104|FG000|Overall Study|Disease Progression|4|||
128734290|NCT00813358|463318107|FG000|Overall Study|Death|32|||
128734291|NCT00813358|463318107|FG000|Overall Study|Lost to Follow-up|12|||
128734292|NCT00813358|463318107|FG000|Overall Study|other endpoints|5|||
128734293|NCT00813358|463318107|FG000|Overall Study|Withdrawal by Subject|20|||
128734294|NCT00004031|463318108|FG000|Overall Study|Adverse Event|5|||
128734295|NCT00004031|463318109|FG001|Overall Study|Adverse Event|0|||
128734296|NCT00004031|463318108|FG000|Overall Study|Refusal unrelated to adverse events|2|||
128734297|NCT00004031|463318109|FG001|Overall Study|Refusal unrelated to adverse events|11|||
128734298|NCT00004031|463318108|FG000|Overall Study|Progression/relapse|9|||
128734299|NCT00004031|463318109|FG001|Overall Study|Progression/relapse|4|||
128734300|NCT00004031|463318108|FG000|Overall Study|Death|3|||
128734301|NCT00004031|463318109|FG001|Overall Study|Death|1|||
128734302|NCT00004031|463318108|FG000|Overall Study|Other- not protocol specified|3|||
128734303|NCT00004031|463318109|FG001|Overall Study|Other- not protocol specified|3|||
128734304|NCT00004031|463318108|FG000|Overall Study|Reason under review|3|||
128734305|NCT00004031|463318109|FG001|Overall Study|Reason under review|2|||
128734306|NCT03851016|463318112|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
128734307|NCT03851016|463318113|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
128734308|NCT00586469|463318114|FG000|Overall Study|Adverse Event|0|||
128734309|NCT00586469|463318115|FG001|Overall Study|Adverse Event|1|||
128734310|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
128734311|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
128734312|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
128734313|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Death|1|||
128734314|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Death|0|||
128734315|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Death|0|||
128734316|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
128734317|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
128734318|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
128734319|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
128734320|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
128734321|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
128734322|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
128734323|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
128734324|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
128734325|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
128734326|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
128734327|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
128734328|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
128734329|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
128734330|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
128734331|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
128734332|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
128734333|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
128734334|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
128734335|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
128734336|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
128734337|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
128734338|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
128734339|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
128734340|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
128734341|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
128734342|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
128734343|NCT03655236|463318117|FG000|Subject Disposition in Part 1 Period|Other|0|||
128734344|NCT03655236|463318118|FG001|Subject Disposition in Part 1 Period|Other|2|||
128734345|NCT03655236|463318119|FG002|Subject Disposition in Part 1 Period|Other|2|||
128734346|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
128734347|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
128734348|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
128734349|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
128734350|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
128734351|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
128734352|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
128734353|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
128734354|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
128734355|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
128734356|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
128734357|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
128734358|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
128734359|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
128734360|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
128734361|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
128734362|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
128734363|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
128734364|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
128781601|NCT04978363|463492877|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128781602|NCT04978363|463492878|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128781603|NCT04978363|463492879|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
128781604|NCT01251614|463492880|FG000|Overall Study|Adverse Event|1|||
128781605|NCT01251614|463492881|FG001|Overall Study|Adverse Event|0|||
128781606|NCT01251614|463492882|FG002|Overall Study|Adverse Event|1|||
128734365|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
128734366|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
128734367|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
128734368|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
128734369|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
128734370|NCT03655236|463318117|FG000|Subject Disposition in Part 2 Period|Other|1|||
128734371|NCT03655236|463318118|FG001|Subject Disposition in Part 2 Period|Other|0|||
128734372|NCT03655236|463318119|FG002|Subject Disposition in Part 2 Period|Other|0|||
128734373|NCT00991302|463319656|FG000|Overall Study|Death|0|||
128734374|NCT00991302|463319657|FG001|Overall Study|Death|1|||
128734375|NCT00991302|463319656|FG000|Overall Study|Lost to Follow-up|14|||
128734376|NCT00991302|463319657|FG001|Overall Study|Lost to Follow-up|12|||
128734377|NCT01709318|463319658|FG000|Overall Study|Adverse Event|3|||
128734378|NCT01709318|463319659|FG001|Overall Study|Adverse Event|4|||
128734379|NCT01709318|463319660|FG002|Overall Study|Adverse Event|2|||
128734380|NCT01709318|463319661|FG003|Overall Study|Adverse Event|2|||
128734381|NCT01709318|463319662|FG004|Overall Study|Adverse Event|0|||
128734382|NCT01709318|463319663|FG005|Overall Study|Adverse Event|1|||
128734383|NCT01709318|463319664|FG006|Overall Study|Adverse Event|2|||
128734384|NCT01709318|463319658|FG000|Overall Study|Lost to Follow-up|2|||
128734385|NCT01709318|463319659|FG001|Overall Study|Lost to Follow-up|0|||
128734386|NCT01709318|463319660|FG002|Overall Study|Lost to Follow-up|0|||
128734387|NCT01709318|463319661|FG003|Overall Study|Lost to Follow-up|0|||
128734388|NCT01709318|463319662|FG004|Overall Study|Lost to Follow-up|1|||
128734389|NCT01709318|463319663|FG005|Overall Study|Lost to Follow-up|1|||
128734390|NCT01709318|463319664|FG006|Overall Study|Lost to Follow-up|1|||
128734391|NCT01709318|463319658|FG000|Overall Study|Non-compliance with Study Drug|0|||
128734392|NCT01709318|463319659|FG001|Overall Study|Non-compliance with Study Drug|2|||
128734393|NCT01709318|463319660|FG002|Overall Study|Non-compliance with Study Drug|1|||
128734394|NCT01709318|463319661|FG003|Overall Study|Non-compliance with Study Drug|1|||
128734395|NCT01709318|463319662|FG004|Overall Study|Non-compliance with Study Drug|0|||
128734396|NCT01709318|463319663|FG005|Overall Study|Non-compliance with Study Drug|0|||
128734397|NCT01709318|463319664|FG006|Overall Study|Non-compliance with Study Drug|2|||
128734398|NCT01709318|463319658|FG000|Overall Study|Physician Decision|0|||
128734399|NCT01709318|463319659|FG001|Overall Study|Physician Decision|0|||
128734400|NCT01709318|463319660|FG002|Overall Study|Physician Decision|0|||
128734401|NCT01709318|463319661|FG003|Overall Study|Physician Decision|0|||
128734402|NCT01709318|463319662|FG004|Overall Study|Physician Decision|0|||
128734403|NCT01709318|463319663|FG005|Overall Study|Physician Decision|0|||
128734404|NCT01709318|463319664|FG006|Overall Study|Physician Decision|1|||
128734405|NCT01709318|463319658|FG000|Overall Study|Pregnancy|0|||
128734406|NCT01709318|463319659|FG001|Overall Study|Pregnancy|0|||
128734407|NCT01709318|463319660|FG002|Overall Study|Pregnancy|0|||
128734408|NCT01709318|463319661|FG003|Overall Study|Pregnancy|0|||
128734409|NCT01709318|463319662|FG004|Overall Study|Pregnancy|1|||
128734410|NCT01709318|463319663|FG005|Overall Study|Pregnancy|0|||
128734411|NCT01709318|463319664|FG006|Overall Study|Pregnancy|0|||
128734412|NCT01709318|463319658|FG000|Overall Study|Protocol Violation|0|||
128734413|NCT01709318|463319659|FG001|Overall Study|Protocol Violation|0|||
128734414|NCT01709318|463319660|FG002|Overall Study|Protocol Violation|0|||
128734415|NCT01709318|463319661|FG003|Overall Study|Protocol Violation|0|||
128734416|NCT01709318|463319662|FG004|Overall Study|Protocol Violation|2|||
128734417|NCT01709318|463319663|FG005|Overall Study|Protocol Violation|0|||
128734418|NCT01709318|463319664|FG006|Overall Study|Protocol Violation|1|||
128734419|NCT01709318|463319658|FG000|Overall Study|Technical Problems|1|||
128734420|NCT01709318|463319659|FG001|Overall Study|Technical Problems|0|||
128734421|NCT01709318|463319660|FG002|Overall Study|Technical Problems|0|||
128734422|NCT01709318|463319661|FG003|Overall Study|Technical Problems|0|||
128734423|NCT01709318|463319662|FG004|Overall Study|Technical Problems|0|||
128734424|NCT01709318|463319663|FG005|Overall Study|Technical Problems|0|||
128781607|NCT01251614|463492880|FG000|Overall Study|Lack of Efficacy|1|||
128781608|NCT01251614|463492881|FG001|Overall Study|Lack of Efficacy|9|||
128781609|NCT01251614|463492882|FG002|Overall Study|Lack of Efficacy|4|||
128781610|NCT01251614|463492880|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
128781611|NCT01251614|463492881|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
128781612|NCT01251614|463492882|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
128781613|NCT01251614|463492880|FG000|Overall Study|Pregnancy|0|||
128781614|NCT01251614|463492881|FG001|Overall Study|Pregnancy|0|||
128781615|NCT01251614|463492882|FG002|Overall Study|Pregnancy|2|||
128781616|NCT01251614|463492880|FG000|Overall Study|Loss of Disease Control|0|||
128781617|NCT01251614|463492881|FG001|Overall Study|Loss of Disease Control|1|||
128781618|NCT01251614|463492882|FG002|Overall Study|Loss of Disease Control|0|||
128781619|NCT01251614|463492880|FG000|Overall Study|Withdrawal by Subject|0|||
128781620|NCT01251614|463492881|FG001|Overall Study|Withdrawal by Subject|2|||
128781621|NCT01251614|463492882|FG002|Overall Study|Withdrawal by Subject|1|||
128781622|NCT01251614|463492880|FG000|Overall Study|Lost to Follow-up|0|||
128781623|NCT01251614|463492881|FG001|Overall Study|Lost to Follow-up|1|||
128781624|NCT01251614|463492882|FG002|Overall Study|Lost to Follow-up|0|||
128781625|NCT02153788|463492883|FG000|Overall Study|Physician Decision|2|||
128781626|NCT02153788|463492884|FG001|Overall Study|Physician Decision|1|||
128781627|NCT01684046|463492887|FG000|Period 1, First 30 Days|Adverse Event|0|||
128781628|NCT01684046|463492888|FG001|Period 1, First 30 Days|Adverse Event|2|||
128781629|NCT02790606|463492895|FG000|Overall Study|Death|27|||
128781630|NCT02790606|463492895|FG000|Overall Study|Lost to Follow-up|4|||
128781631|NCT02790606|463492895|FG000|Overall Study|Physician Decision|3|||
128781632|NCT02790606|463492895|FG000|Overall Study|Withdrawal by Subject|1|||
128781633|NCT02735915|463492896|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
128781634|NCT02735915|463492896|FG000|Overall Study|Withdrawal following SAE|2|||
128781635|NCT02735915|463492896|FG000|Overall Study|Withdrawal by Subject|1|||
128781636|NCT05328973|463492897|FG000|Overall Study|Withdrawal by Subject|0|||
128781637|NCT05328973|463492898|FG001|Overall Study|Withdrawal by Subject|1|||
128781638|NCT00946114|463492899|FG000|Overall Study|Death|5|||
128781639|NCT00946114|463492900|FG001|Overall Study|Death|2|||
128781640|NCT00946114|463492899|FG000|Overall Study|Other|1|||
128781641|NCT00946114|463492900|FG001|Overall Study|Other|0|||
128781642|NCT00946114|463492899|FG000|Overall Study|Withdrawal by Subject|2|||
128781643|NCT00946114|463492900|FG001|Overall Study|Withdrawal by Subject|0|||
128781644|NCT01764386|463492902|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
128781645|NCT01764386|463492903|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
128781646|NCT01764386|463492902|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
128781647|NCT01764386|463492903|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
128781648|NCT01764386|463492902|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
128781649|NCT01764386|463492903|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
128781650|NCT01764386|463492902|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
128781651|NCT01764386|463492903|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
128781652|NCT01764386|463492902|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
128781653|NCT01764386|463492903|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
128781654|NCT01764386|463492902|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
128781655|NCT01764386|463492903|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
128781656|NCT01764386|463492902|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
128781657|NCT01764386|463492903|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
128781658|NCT01764386|463492902|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
128781659|NCT01764386|463492903|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
128781660|NCT03929302|463492904|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
128781661|NCT03929302|463492905|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
128781662|NCT03929302|463492906|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
128781663|NCT03929302|463492904|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
128781664|NCT03929302|463492905|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
128781665|NCT03929302|463492906|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
128781666|NCT03929302|463492904|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
128781667|NCT03929302|463492905|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
128781668|NCT03929302|463492906|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
128781669|NCT02757885|463492907|FG000|Overall Study|Screen Failures|4|||
128781670|NCT00463151|463492915|FG000|Overall Study|Adverse Event|0|||
128781671|NCT00463151|463492916|FG001|Overall Study|Adverse Event|0|||
128781672|NCT00463151|463492917|FG002|Overall Study|Adverse Event|1|||
128781673|NCT00463151|463492918|FG003|Overall Study|Adverse Event|0|||
128781674|NCT00463151|463492915|FG000|Overall Study|Lack of Efficacy|2|||
128781675|NCT00463151|463492916|FG001|Overall Study|Lack of Efficacy|5|||
128781676|NCT00463151|463492917|FG002|Overall Study|Lack of Efficacy|2|||
128781677|NCT00463151|463492918|FG003|Overall Study|Lack of Efficacy|5|||
128781678|NCT00463151|463492915|FG000|Overall Study|Protocol Violation|0|||
128781679|NCT00463151|463492916|FG001|Overall Study|Protocol Violation|0|||
128781680|NCT00463151|463492917|FG002|Overall Study|Protocol Violation|0|||
128781681|NCT00463151|463492918|FG003|Overall Study|Protocol Violation|1|||
128781682|NCT00463151|463492915|FG000|Overall Study|Withdrawal by Subject|0|||
128781683|NCT00463151|463492916|FG001|Overall Study|Withdrawal by Subject|0|||
128781684|NCT00463151|463492917|FG002|Overall Study|Withdrawal by Subject|0|||
128781685|NCT00463151|463492918|FG003|Overall Study|Withdrawal by Subject|1|||
128781686|NCT00293462|463492919|FG000|Overall Study|Withdrawal by Subject|4|||
128781687|NCT00293462|463492920|FG001|Overall Study|Withdrawal by Subject|3|||
128781688|NCT00293462|463492921|FG002|Overall Study|Withdrawal by Subject|8|||
128781689|NCT00293462|463492919|FG000|Overall Study|Death|1|||
128781690|NCT00293462|463492920|FG001|Overall Study|Death|0|||
128781691|NCT00293462|463492921|FG002|Overall Study|Death|0|||
128781692|NCT00293462|463492919|FG000|Overall Study|Lost to Follow-up|0|||
128781693|NCT00293462|463492920|FG001|Overall Study|Lost to Follow-up|1|||
128781694|NCT00293462|463492921|FG002|Overall Study|Lost to Follow-up|0|||
128781695|NCT00293462|463492919|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
128781696|NCT00293462|463492920|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
128781697|NCT00293462|463492921|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
128781698|NCT00293462|463492919|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
128781699|NCT00293462|463492920|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
128781700|NCT00293462|463492921|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
128781701|NCT00293462|463492919|FG000|Overall Study|Refuse Radiation Treatment|1|||
128781702|NCT00293462|463492920|FG001|Overall Study|Refuse Radiation Treatment|0|||
128781703|NCT00293462|463492921|FG002|Overall Study|Refuse Radiation Treatment|0|||
128781704|NCT00293462|463492919|FG000|Overall Study|No Show|0|||
128781705|NCT00293462|463492920|FG001|Overall Study|No Show|0|||
128781706|NCT00293462|463492921|FG002|Overall Study|No Show|1|||
128781707|NCT00293462|463492919|FG000|Overall Study|Went back to his home country|0|||
128781708|NCT00293462|463492920|FG001|Overall Study|Went back to his home country|0|||
128781709|NCT00293462|463492921|FG002|Overall Study|Went back to his home country|1|||
128781710|NCT00293462|463492919|FG000|Overall Study|Blood clot after chemotherapy|0|||
128781711|NCT00293462|463492920|FG001|Overall Study|Blood clot after chemotherapy|0|||
128781712|NCT00293462|463492921|FG002|Overall Study|Blood clot after chemotherapy|1|||
128781713|NCT00293462|463492919|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
128781714|NCT00293462|463492920|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
128781715|NCT00293462|463492921|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
128781716|NCT00293462|463492919|FG000|Overall Study|Possible Tracheostomy leakage|0|||
128781717|NCT00293462|463492920|FG001|Overall Study|Possible Tracheostomy leakage|1|||
128781718|NCT00293462|463492921|FG002|Overall Study|Possible Tracheostomy leakage|0|||
128781719|NCT00293462|463492919|FG000|Overall Study|Low radiation dose in oral cavity|0|||
128734425|NCT01709318|463319664|FG006|Overall Study|Technical Problems|0|||
128734426|NCT01709318|463319658|FG000|Overall Study|Withdrawal by Subject|3|||
128734427|NCT01709318|463319659|FG001|Overall Study|Withdrawal by Subject|0|||
128734428|NCT01709318|463319660|FG002|Overall Study|Withdrawal by Subject|3|||
128734429|NCT01709318|463319661|FG003|Overall Study|Withdrawal by Subject|3|||
128734430|NCT01709318|463319662|FG004|Overall Study|Withdrawal by Subject|0|||
128734431|NCT01709318|463319663|FG005|Overall Study|Withdrawal by Subject|2|||
128734432|NCT01709318|463319664|FG006|Overall Study|Withdrawal by Subject|4|||
128734433|NCT01709318|463319658|FG000|Overall Study|Other Protocol Specified Criteria|0|||
128734434|NCT01709318|463319659|FG001|Overall Study|Other Protocol Specified Criteria|1|||
128734435|NCT01709318|463319660|FG002|Overall Study|Other Protocol Specified Criteria|0|||
128734436|NCT01709318|463319661|FG003|Overall Study|Other Protocol Specified Criteria|0|||
128734437|NCT01709318|463319662|FG004|Overall Study|Other Protocol Specified Criteria|0|||
128734438|NCT01709318|463319663|FG005|Overall Study|Other Protocol Specified Criteria|0|||
128734439|NCT01709318|463319664|FG006|Overall Study|Other Protocol Specified Criteria|0|||
128734440|NCT02383758|463319665|FG000|Overall Study|Withdrawal by Subject|0|||
128734441|NCT02383758|463319666|FG001|Overall Study|Withdrawal by Subject|2|||
128734442|NCT00600821|463319669|FG000|Overall Study|Death|45|||
128734443|NCT00600821|463319670|FG001|Overall Study|Death|46|||
128734444|NCT00600821|463319669|FG000|Overall Study|Lost to Follow-up|2|||
128734445|NCT00600821|463319670|FG001|Overall Study|Lost to Follow-up|2|||
128734446|NCT00600821|463319669|FG000|Overall Study|Withdrawal by Subject|1|||
128734447|NCT00600821|463319670|FG001|Overall Study|Withdrawal by Subject|1|||
128734448|NCT00600821|463319669|FG000|Overall Study|Terminated by sponsor|8|||
128734449|NCT00600821|463319670|FG001|Overall Study|Terminated by sponsor|6|||
128734450|NCT00600821|463319669|FG000|Overall Study|Objective progression or relapse|0|||
128734451|NCT00600821|463319670|FG001|Overall Study|Objective progression or relapse|1|||
128734452|NCT00600821|463319669|FG000|Overall Study|Randomized but not treated|0|||
128734453|NCT00600821|463319670|FG001|Overall Study|Randomized but not treated|1|||
128734454|NCT00600821|463319669|FG000|Overall Study|Other|2|||
128734455|NCT00600821|463319670|FG001|Overall Study|Other|3|||
128734456|NCT02167035|463319673|FG000|Overall Study|Adverse Event|2|||
128734457|NCT02167035|463319674|FG001|Overall Study|Adverse Event|2|||
128734458|NCT02167035|463319673|FG000|Overall Study|Lost to Follow-up|3|||
128734459|NCT02167035|463319674|FG001|Overall Study|Lost to Follow-up|3|||
128734460|NCT02167035|463319673|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
128734461|NCT02167035|463319674|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
128734462|NCT02984995|463319675|FG000|Overall Study|Required stem cell transplant|13|||
128734463|NCT02984995|463319676|FG001|Overall Study|Required stem cell transplant|2|||
128734464|NCT02984995|463319675|FG000|Overall Study|Progressive disease|11|||
128734465|NCT02984995|463319676|FG001|Overall Study|Progressive disease|1|||
128734466|NCT02984995|463319675|FG000|Overall Study|Adverse Event|1|||
128734467|NCT02984995|463319676|FG001|Overall Study|Adverse Event|0|||
128734468|NCT01263873|463319679|FG000|Overall Study|One provider unable to complete numbers|1|||
128734469|NCT01263873|463319680|FG001|Overall Study|One provider unable to complete numbers|1|||
128734470|NCT00047463|463319681|FG000|Overall Study|Withdrawal by Subject|0|||
128734471|NCT00047463|463319682|FG001|Overall Study|Withdrawal by Subject|3|||
128734472|NCT01401530|463319684|FG000|Overall Study|Disease Progression|1|||
128734473|NCT01401530|463319685|FG001|Overall Study|Disease Progression|2|||
128734474|NCT01401530|463319686|FG002|Overall Study|Disease Progression|1|||
128734475|NCT01401530|463319684|FG000|Overall Study|Adverse Event|1|||
128734476|NCT01401530|463319685|FG001|Overall Study|Adverse Event|1|||
128734477|NCT01401530|463319686|FG002|Overall Study|Adverse Event|1|||
128734478|NCT01401530|463319684|FG000|Overall Study|Participant Choice|1|||
128734479|NCT01401530|463319685|FG001|Overall Study|Participant Choice|2|||
128734480|NCT01401530|463319686|FG002|Overall Study|Participant Choice|1|||
128734481|NCT01401530|463319684|FG000|Overall Study|Physician Decision|0|||
128734482|NCT01401530|463319685|FG001|Overall Study|Physician Decision|1|||
128734483|NCT01401530|463319686|FG002|Overall Study|Physician Decision|0|||
128734484|NCT04304001|463319689|FG000|Overall Study|Lost to Follow-up|13|||
128734485|NCT04304001|463319690|FG001|Overall Study|Lost to Follow-up|9|||
128734486|NCT02664038|463319697|FG000|13 Week|Lost to Follow-up|7|||
128734487|NCT02664038|463319698|FG001|13 Week|Lost to Follow-up|14|||
128734488|NCT02664038|463319697|FG000|13 Week|Withdrawal by Subject|1|||
128734489|NCT02664038|463319698|FG001|13 Week|Withdrawal by Subject|0|||
128734490|NCT02664038|463319697|FG000|26 Week|Lost to Follow-up|5|||
128734491|NCT02664038|463319698|FG001|26 Week|Lost to Follow-up|4|||
128734492|NCT02606136|463319703|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
128734493|NCT02606136|463319703|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
128734494|NCT02606136|463319703|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
128734495|NCT02606136|463319703|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
128734496|NCT03296696|463319704|FG000|Overall Study|Started Other Antitumor Therapy|1|||
128734497|NCT03296696|463319705|FG001|Overall Study|Started Other Antitumor Therapy|2|||
128734498|NCT03296696|463319706|FG002|Overall Study|Started Other Antitumor Therapy|1|||
128734499|NCT03296696|463319707|FG003|Overall Study|Started Other Antitumor Therapy|2|||
128734500|NCT03296696|463319708|FG004|Overall Study|Started Other Antitumor Therapy|1|||
128734501|NCT03296696|463319709|FG005|Overall Study|Started Other Antitumor Therapy|1|||
128734502|NCT03296696|463319710|FG006|Overall Study|Started Other Antitumor Therapy|2|||
128734503|NCT03296696|463319711|FG007|Overall Study|Started Other Antitumor Therapy|3|||
128734504|NCT03296696|463319712|FG008|Overall Study|Started Other Antitumor Therapy|1|||
128734505|NCT03296696|463319713|FG009|Overall Study|Started Other Antitumor Therapy|0|||
128734506|NCT03296696|463319704|FG000|Overall Study|Death|0|||
128734507|NCT03296696|463319705|FG001|Overall Study|Death|1|||
128734508|NCT03296696|463319706|FG002|Overall Study|Death|1|||
128734509|NCT03296696|463319707|FG003|Overall Study|Death|2|||
128734510|NCT03296696|463319708|FG004|Overall Study|Death|2|||
128734511|NCT03296696|463319709|FG005|Overall Study|Death|3|||
128734512|NCT03296696|463319710|FG006|Overall Study|Death|1|||
128734513|NCT03296696|463319711|FG007|Overall Study|Death|2|||
128734514|NCT03296696|463319712|FG008|Overall Study|Death|0|||
128734515|NCT03296696|463319713|FG009|Overall Study|Death|0|||
128734516|NCT03296696|463319704|FG000|Overall Study|Withdrawal by Subject|0|||
128734517|NCT03296696|463319705|FG001|Overall Study|Withdrawal by Subject|0|||
128734518|NCT03296696|463319706|FG002|Overall Study|Withdrawal by Subject|1|||
128734519|NCT03296696|463319707|FG003|Overall Study|Withdrawal by Subject|0|||
128734520|NCT03296696|463319708|FG004|Overall Study|Withdrawal by Subject|1|||
128734521|NCT03296696|463319709|FG005|Overall Study|Withdrawal by Subject|0|||
128734522|NCT03296696|463319710|FG006|Overall Study|Withdrawal by Subject|0|||
128734523|NCT03296696|463319711|FG007|Overall Study|Withdrawal by Subject|0|||
128734524|NCT03296696|463319712|FG008|Overall Study|Withdrawal by Subject|0|||
128734525|NCT03296696|463319713|FG009|Overall Study|Withdrawal by Subject|1|||
128734526|NCT04694131|463319717|FG000|Overall Study|Withdrawal by Subject|7|||
128734527|NCT04694131|463319717|FG000|Overall Study|Screen Failure|1|||
128734528|NCT04694131|463319717|FG000|Overall Study|High stimulation threshold|3|||
128734529|NCT04456699|463319718|FG000|Overall Study|Death|48|||
128734530|NCT04456699|463319719|FG001|Overall Study|Death|50|||
128734531|NCT04456699|463319720|FG002|Overall Study|Death|52|||
128734532|NCT04456699|463319718|FG000|Overall Study|Physician Decision|0|||
128734533|NCT04456699|463319719|FG001|Overall Study|Physician Decision|0|||
128734534|NCT04456699|463319720|FG002|Overall Study|Physician Decision|2|||
128734535|NCT04456699|463319718|FG000|Overall Study|Sponsor Decision|55|||
128734536|NCT04456699|463319719|FG001|Overall Study|Sponsor Decision|61|||
128734537|NCT04456699|463319720|FG002|Overall Study|Sponsor Decision|50|||
128734538|NCT04456699|463319718|FG000|Overall Study|Withdrawal by Subject|8|||
128734539|NCT04456699|463319719|FG001|Overall Study|Withdrawal by Subject|4|||
128734540|NCT04456699|463319720|FG002|Overall Study|Withdrawal by Subject|5|||
128734541|NCT04112810|463319721|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
128734542|NCT01859715|463319726|FG000|Overall Study|No 2nd VAS|16|||
128734543|NCT01859715|463319727|FG001|Overall Study|No 2nd VAS|8|||
128734544|NCT01859715|463319728|FG002|Overall Study|No 2nd VAS|23|||
128734545|NCT01252290|463319729|FG000|Overall Study|Withdrawal by Subject|1|||
128734546|NCT00086580|463319730|FG000|Treatment Period|Disease progression|9|||
128734547|NCT00086580|463319731|FG001|Treatment Period|Disease progression|8|||
128734548|NCT00086580|463319730|FG000|Treatment Period|Unable to comply with protocol|3|||
128734549|NCT00086580|463319731|FG001|Treatment Period|Unable to comply with protocol|1|||
128734550|NCT00086580|463319730|FG000|Treatment Period|Withdrawal by Subject|7|||
128734551|NCT00086580|463319731|FG001|Treatment Period|Withdrawal by Subject|8|||
128734552|NCT00086580|463319730|FG000|Treatment Period|Physician Decision|13|||
128734553|NCT00086580|463319731|FG001|Treatment Period|Physician Decision|7|||
128734554|NCT00086580|463319730|FG000|Treatment Period|AE - not treatment related|7|||
128781720|NCT00293462|463492920|FG001|Overall Study|Low radiation dose in oral cavity|1|||
128781721|NCT00293462|463492921|FG002|Overall Study|Low radiation dose in oral cavity|0|||
128781722|NCT00293462|463492919|FG000|Overall Study|Physician Decision|0|||
128734555|NCT00086580|463319731|FG001|Treatment Period|AE - not treatment related|7|||
128734556|NCT00086580|463319730|FG000|Treatment Period|Toxicity - treatment related|15|||
128734557|NCT00086580|463319731|FG001|Treatment Period|Toxicity - treatment related|15|||
128734558|NCT00086580|463319730|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
128734559|NCT00086580|463319731|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
128734560|NCT00086580|463319730|FG000|Treatment Period|Death|5|||
128734561|NCT00086580|463319731|FG001|Treatment Period|Death|7|||
128781723|NCT00293462|463492920|FG001|Overall Study|Physician Decision|1|||
128781724|NCT00293462|463492921|FG002|Overall Study|Physician Decision|0|||
128734562|NCT00086580|463319730|FG000|Treatment Period|Other|5|||
128734563|NCT00086580|463319731|FG001|Treatment Period|Other|3|||
128734564|NCT00086580|463319730|FG000|Follow-up Period|Disease progression|72|||
128734565|NCT00086580|463319731|FG001|Follow-up Period|Disease progression|99|||
128734566|NCT00086580|463319730|FG000|Follow-up Period|Unable to comply with protocol|5|||
128734567|NCT00086580|463319731|FG001|Follow-up Period|Unable to comply with protocol|0|||
128734568|NCT00086580|463319730|FG000|Follow-up Period|Withdrawal by Subject|6|||
128734569|NCT00086580|463319731|FG001|Follow-up Period|Withdrawal by Subject|6|||
128734570|NCT00086580|463319730|FG000|Follow-up Period|Physician Decision|0|||
128734571|NCT00086580|463319731|FG001|Follow-up Period|Physician Decision|1|||
128734572|NCT00086580|463319730|FG000|Follow-up Period|AE - not related|1|||
128734573|NCT00086580|463319731|FG001|Follow-up Period|AE - not related|0|||
128734574|NCT00086580|463319730|FG000|Follow-up Period|Death|13|||
128734575|NCT00086580|463319731|FG001|Follow-up Period|Death|7|||
128734576|NCT00086580|463319730|FG000|Follow-up Period|Other|7|||
128734577|NCT00086580|463319731|FG001|Follow-up Period|Other|6|||
128734578|NCT00086580|463319730|FG000|Observation Period|Unable to comply with protocol|1|||
128734579|NCT00086580|463319731|FG001|Observation Period|Unable to comply with protocol|1|||
128734580|NCT00086580|463319730|FG000|Observation Period|Withdrawal by Subject|4|||
128734581|NCT00086580|463319731|FG001|Observation Period|Withdrawal by Subject|2|||
128734582|NCT00086580|463319730|FG000|Observation Period|Death|33|||
128734583|NCT00086580|463319731|FG001|Observation Period|Death|55|||
128734584|NCT00086580|463319730|FG000|Observation Period|Other|8|||
128734585|NCT00086580|463319731|FG001|Observation Period|Other|7|||
128734586|NCT02075437|463319735|FG000|Overall Study|Withdrawal by Subject|5|||
128734587|NCT02075437|463319735|FG000|Overall Study|Lost to Follow-up|1|||
128734588|NCT02047110|463319736|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
128734589|NCT02047110|463319737|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
128734590|NCT02047110|463319738|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
128734591|NCT02047110|463319739|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
128734592|NCT02047110|463319736|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
128734593|NCT02047110|463319737|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
128734594|NCT02047110|463319738|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
128734595|NCT02047110|463319739|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
128734596|NCT02047110|463319736|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
128734597|NCT02047110|463319737|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
128734598|NCT02047110|463319738|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
128734599|NCT02047110|463319739|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
128734600|NCT02047110|463319736|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
128734601|NCT02047110|463319737|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
128734602|NCT02047110|463319738|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
128734603|NCT02047110|463319739|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
128734604|NCT02047110|463319736|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
128734605|NCT02047110|463319737|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
128734606|NCT02047110|463319738|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
128734607|NCT02047110|463319739|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
128734608|NCT02047110|463319736|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
128734609|NCT02047110|463319737|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
128734610|NCT02047110|463319738|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
128734611|NCT02047110|463319739|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
128734612|NCT02047110|463319736|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
128734613|NCT02047110|463319737|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
128734614|NCT02047110|463319738|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
128734615|NCT02047110|463319739|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
128734616|NCT02047110|463319736|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
128734617|NCT02047110|463319737|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
128734618|NCT02047110|463319738|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
128734619|NCT02047110|463319739|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
128734620|NCT02047110|463319736|FG000|Escape Treatment Period|Adverse Event|1|||
128781725|NCT00688688|463492922|FG000|Overall Study|Eligibility criterion not met|7|||
128781726|NCT00688688|463492923|FG001|Overall Study|Eligibility criterion not met|7|||
128781727|NCT00688688|463492924|FG002|Overall Study|Eligibility criterion not met|10|||
128781728|NCT00688688|463492922|FG000|Overall Study|Adverse Event|52|||
128781729|NCT00688688|463492923|FG001|Overall Study|Adverse Event|51|||
128781730|NCT00688688|463492924|FG002|Overall Study|Adverse Event|50|||
128781731|NCT00688688|463492922|FG000|Overall Study|Lack of Efficacy|34|||
128781732|NCT00688688|463492923|FG001|Overall Study|Lack of Efficacy|25|||
128781733|NCT00688688|463492924|FG002|Overall Study|Lack of Efficacy|45|||
128734621|NCT02047110|463319737|FG001|Escape Treatment Period|Adverse Event|2|||
128734622|NCT02047110|463319738|FG002|Escape Treatment Period|Adverse Event|2|||
128734623|NCT02047110|463319739|FG003|Escape Treatment Period|Adverse Event|0|||
128734624|NCT02047110|463319736|FG000|Escape Treatment Period|Other than specified|1|||
128734625|NCT02047110|463319737|FG001|Escape Treatment Period|Other than specified|2|||
128734626|NCT02047110|463319738|FG002|Escape Treatment Period|Other than specified|0|||
128734627|NCT02047110|463319739|FG003|Escape Treatment Period|Other than specified|1|||
128734628|NCT02047110|463319736|FG000|OLE Treatment Period|Other than specified|0|||
128734629|NCT02047110|463319737|FG001|OLE Treatment Period|Other than specified|0|||
128734630|NCT02047110|463319738|FG002|OLE Treatment Period|Other than specified|1|||
128734631|NCT02047110|463319739|FG003|OLE Treatment Period|Other than specified|0|||
128734632|NCT04439240|463319740|FG000|Overall Study|Ineligible|2|||
128734633|NCT04439240|463319740|FG000|Overall Study|Never started treatment|2|||
128734634|NCT04439240|463319740|FG000|Overall Study|Adverse Event|12|||
128734635|NCT04439240|463319740|FG000|Overall Study|Death|2|||
128734636|NCT04439240|463319740|FG000|Overall Study|Disease progression|25|||
128734637|NCT04439240|463319740|FG000|Overall Study|Other diseases|2|||
128781734|NCT00688688|463492922|FG000|Overall Study|Withdrawal by Subject|66|||
128781735|NCT00688688|463492923|FG001|Overall Study|Withdrawal by Subject|75|||
128781736|NCT00688688|463492924|FG002|Overall Study|Withdrawal by Subject|65|||
128781737|NCT00688688|463492922|FG000|Overall Study|Lost to Follow-up|14|||
128734638|NCT04439240|463319740|FG000|Overall Study|Withdrawal by Subject|3|||
128734639|NCT04439240|463319740|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
128734640|NCT04439240|463319740|FG000|Overall Study|Symptomatic decline|1|||
128734641|NCT04439240|463319740|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
128734642|NCT04439240|463319740|FG000|Overall Study|Clinical progression|1|||
128734643|NCT00079274|463319745|FG000|Overall Study|Withdrawal by Subject|111|||
128734644|NCT00079274|463319746|FG001|Overall Study|Withdrawal by Subject|10|||
128734645|NCT00079274|463319747|FG002|Overall Study|Withdrawal by Subject|12|||
128734646|NCT00079274|463319748|FG003|Overall Study|Withdrawal by Subject|163|||
128734647|NCT00079274|463319749|FG004|Overall Study|Withdrawal by Subject|7|||
128734648|NCT00079274|463319750|FG005|Overall Study|Withdrawal by Subject|8|||
128734649|NCT00079274|463319751|FG006|Overall Study|Withdrawal by Subject|0|||
128734650|NCT00079274|463319745|FG000|Overall Study|Adverse Event|130|||
128734651|NCT00079274|463319746|FG001|Overall Study|Adverse Event|8|||
128734652|NCT00079274|463319747|FG002|Overall Study|Adverse Event|8|||
128781738|NCT00688688|463492923|FG001|Overall Study|Lost to Follow-up|7|||
128781739|NCT00688688|463492924|FG002|Overall Study|Lost to Follow-up|7|||
128781740|NCT00688688|463492922|FG000|Overall Study|Protocol Violation|6|||
128781741|NCT00688688|463492923|FG001|Overall Study|Protocol Violation|9|||
128781742|NCT00688688|463492924|FG002|Overall Study|Protocol Violation|11|||
128781743|NCT00688688|463492922|FG000|Overall Study|Randomized but never received study drug|1|||
128781744|NCT00688688|463492923|FG001|Overall Study|Randomized but never received study drug|0|||
128781745|NCT00688688|463492924|FG002|Overall Study|Randomized but never received study drug|0|||
128781746|NCT00688688|463492922|FG000|Overall Study|Non-compliance with study procedures|5|||
128781747|NCT00688688|463492923|FG001|Overall Study|Non-compliance with study procedures|3|||
128781748|NCT00688688|463492924|FG002|Overall Study|Non-compliance with study procedures|4|||
128781749|NCT00688688|463492922|FG000|Overall Study|Taking exclusionary medications|1|||
128781750|NCT00688688|463492923|FG001|Overall Study|Taking exclusionary medications|0|||
128781751|NCT00688688|463492924|FG002|Overall Study|Taking exclusionary medications|0|||
128781752|NCT00688688|463492922|FG000|Overall Study|Site closure|0|||
128781753|NCT00688688|463492923|FG001|Overall Study|Site closure|1|||
128781754|NCT00688688|463492924|FG002|Overall Study|Site closure|0|||
128781755|NCT00688688|463492922|FG000|Overall Study|Violation of exclusion criterion|0|||
128781756|NCT00688688|463492923|FG001|Overall Study|Violation of exclusion criterion|1|||
128781757|NCT00688688|463492924|FG002|Overall Study|Violation of exclusion criterion|0|||
128781758|NCT03283553|463492927|FG000|Patient Participant Flow|Death|5|||
128781759|NCT03283553|463492928|FG001|Patient Participant Flow|Death|10|||
128781760|NCT03283553|463492927|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
128781761|NCT03283553|463492928|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
128781762|NCT03283553|463492927|FG000|Patient Participant Flow|Lost to Follow-up|1|||
128781763|NCT03283553|463492928|FG001|Patient Participant Flow|Lost to Follow-up|1|||
128781764|NCT03283553|463492927|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
128781765|NCT03283553|463492928|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
128781766|NCT03283553|463492927|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
128781767|NCT03283553|463492928|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
128781768|NCT03283553|463492927|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
128781769|NCT03283553|463492928|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
128781770|NCT03686683|463492929|FG000|Overall Study|Withdrawal by Subject|52|||
128781771|NCT03686683|463492930|FG001|Overall Study|Withdrawal by Subject|32|||
128781772|NCT03686683|463492929|FG000|Overall Study|Lost to Follow-up|23|||
128781773|NCT03686683|463492930|FG001|Overall Study|Lost to Follow-up|19|||
128781774|NCT03686683|463492929|FG000|Overall Study|Adverse Event|1|||
128781775|NCT03686683|463492930|FG001|Overall Study|Adverse Event|0|||
128781776|NCT03686683|463492929|FG000|Overall Study|Death|10|||
128781777|NCT03686683|463492930|FG001|Overall Study|Death|5|||
128781778|NCT03686683|463492929|FG000|Overall Study|Progressive Disease|1|||
128781779|NCT03686683|463492930|FG001|Overall Study|Progressive Disease|1|||
128781780|NCT03686683|463492929|FG000|Overall Study|Noncompliance|1|||
128781781|NCT03686683|463492930|FG001|Overall Study|Noncompliance|0|||
128781782|NCT03686683|463492929|FG000|Overall Study|Physician Decision|1|||
128781783|NCT03686683|463492930|FG001|Overall Study|Physician Decision|1|||
128781784|NCT03686683|463492929|FG000|Overall Study|Screen fail post-randomization|1|||
128781785|NCT03686683|463492930|FG001|Overall Study|Screen fail post-randomization|0|||
128781786|NCT03686683|463492929|FG000|Overall Study|Protocol Violation|3|||
128781787|NCT03686683|463492930|FG001|Overall Study|Protocol Violation|0|||
128781788|NCT03686683|463492929|FG000|Overall Study|No data available|1|||
128781789|NCT03686683|463492930|FG001|Overall Study|No data available|0|||
128781790|NCT03255941|463492931|FG000|Overall Study|Not eligible or refused injection|37|||
128781791|NCT03255941|463492932|FG001|Overall Study|Not eligible or refused injection|44|||
128781792|NCT03255941|463492933|FG002|Overall Study|Not eligible or refused injection|5|||
128781793|NCT03255941|463492934|FG003|Overall Study|Not eligible or refused injection|6|||
128781794|NCT03255941|463492931|FG000|Overall Study|Did not complete exit interview|1|||
128781795|NCT03255941|463492932|FG001|Overall Study|Did not complete exit interview|2|||
128781796|NCT03255941|463492933|FG002|Overall Study|Did not complete exit interview|0|||
128781797|NCT03255941|463492934|FG003|Overall Study|Did not complete exit interview|0|||
128781798|NCT00372060|463492935|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
128781799|NCT00372060|463492936|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
128781800|NCT00372060|463492935|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
128781801|NCT00372060|463492936|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
128781802|NCT00372060|463492935|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
128781803|NCT00372060|463492936|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
128781804|NCT00372060|463492935|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
128781805|NCT00372060|463492936|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
128781806|NCT00372060|463492935|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
128781807|NCT00372060|463492936|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
128781808|NCT00372060|463492935|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
128781809|NCT00372060|463492936|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
128781810|NCT01579578|463492937|FG000|Overall Study|Death|4|||
128781811|NCT01579578|463492938|FG001|Overall Study|Death|1|||
128781812|NCT01579578|463492937|FG000|Overall Study|Lost to Follow-up|1|||
128781813|NCT01579578|463492938|FG001|Overall Study|Lost to Follow-up|1|||
128781814|NCT01579578|463492937|FG000|Overall Study|Withdrawal by Subject|2|||
128781815|NCT01579578|463492938|FG001|Overall Study|Withdrawal by Subject|1|||
128781816|NCT01579578|463492937|FG000|Overall Study|Eligibility criteria|3|||
128781817|NCT01579578|463492938|FG001|Overall Study|Eligibility criteria|9|||
128781818|NCT01579578|463492937|FG000|Overall Study|Ongoing|3|||
128781819|NCT01579578|463492938|FG001|Overall Study|Ongoing|0|||
128781820|NCT01528709|463492939|FG000|Overall Study|Death|2|||
128781821|NCT01528709|463492940|FG001|Overall Study|Death|0|||
128781822|NCT01528709|463492939|FG000|Overall Study|Withdrawal by Subject|10|||
128781823|NCT01528709|463492940|FG001|Overall Study|Withdrawal by Subject|15|||
128781824|NCT01528709|463492939|FG000|Overall Study|allergy|1|||
128781825|NCT01528709|463492940|FG001|Overall Study|allergy|0|||
128781826|NCT05124899|463492944|FG000|Overall Study|Lost to Follow-up|3|||
128781827|NCT01417000|463492946|FG000|Overall Study|Death|59|||
128781828|NCT01417000|463492947|FG001|Overall Study|Death|28|||
128781829|NCT01417000|463492946|FG000|Overall Study|Lost to Follow-up|1|||
128781830|NCT01417000|463492947|FG001|Overall Study|Lost to Follow-up|0|||
128781831|NCT01417000|463492946|FG000|Overall Study|Study Terminated by Sponsor|1|||
128781832|NCT01417000|463492947|FG001|Overall Study|Study Terminated by Sponsor|1|||
128781833|NCT00647348|463492954|FG000|Overall Study|Lost to Follow-up|3|||
128781834|NCT00647348|463492955|FG001|Overall Study|Lost to Follow-up|6|||
128781835|NCT02397889|463492962|FG000|Overall Study|Physician Decision|1|||
128781836|NCT02397889|463492963|FG001|Overall Study|Physician Decision|0|||
128781837|NCT00797225|463492968|FG000|Weeks 1 to 12|Adverse Event|0|||
128781838|NCT00797225|463492969|FG001|Weeks 1 to 12|Adverse Event|0|||
128781839|NCT00797225|463492970|FG002|Weeks 1 to 12|Adverse Event|1|||
128781840|NCT00797225|463492971|FG003|Weeks 1 to 12|Adverse Event|0|||
128781841|NCT00797225|463492972|FG004|Weeks 1 to 12|Adverse Event|0|||
128781842|NCT00797225|463492973|FG005|Weeks 1 to 12|Adverse Event|0|||
128781843|NCT00797225|463492974|FG006|Weeks 1 to 12|Adverse Event|0|||
128781844|NCT00797225|463492975|FG007|Weeks 1 to 12|Adverse Event|0|||
128781845|NCT00797225|463492968|FG000|Weeks 1 to 12|Non-compliance|0|||
128781846|NCT00797225|463492969|FG001|Weeks 1 to 12|Non-compliance|1|||
128781847|NCT00797225|463492970|FG002|Weeks 1 to 12|Non-compliance|0|||
128781848|NCT00797225|463492971|FG003|Weeks 1 to 12|Non-compliance|0|||
128781849|NCT00797225|463492972|FG004|Weeks 1 to 12|Non-compliance|0|||
128781850|NCT00797225|463492973|FG005|Weeks 1 to 12|Non-compliance|0|||
128781851|NCT00797225|463492974|FG006|Weeks 1 to 12|Non-compliance|0|||
128781852|NCT00797225|463492975|FG007|Weeks 1 to 12|Non-compliance|0|||
128781853|NCT00797225|463492968|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
128781854|NCT00797225|463492969|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
128781855|NCT00797225|463492970|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
128781856|NCT00797225|463492971|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
128781857|NCT00797225|463492972|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
128781858|NCT00797225|463492973|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
128781859|NCT00797225|463492974|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
128781860|NCT00797225|463492975|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
128781861|NCT00797225|463492968|FG000|Weeks 1 to 12|Sponsor Decision|1|||
128781862|NCT00797225|463492969|FG001|Weeks 1 to 12|Sponsor Decision|0|||
128781863|NCT00797225|463492970|FG002|Weeks 1 to 12|Sponsor Decision|0|||
128781864|NCT00797225|463492971|FG003|Weeks 1 to 12|Sponsor Decision|0|||
128781865|NCT00797225|463492972|FG004|Weeks 1 to 12|Sponsor Decision|0|||
128781866|NCT00797225|463492973|FG005|Weeks 1 to 12|Sponsor Decision|0|||
128781867|NCT00797225|463492974|FG006|Weeks 1 to 12|Sponsor Decision|0|||
128781868|NCT00797225|463492975|FG007|Weeks 1 to 12|Sponsor Decision|0|||
128781869|NCT00797225|463492968|FG000|Weeks 13 to 24|Non-compliance|0|||
128781870|NCT00797225|463492969|FG001|Weeks 13 to 24|Non-compliance|2|||
128781871|NCT00797225|463492970|FG002|Weeks 13 to 24|Non-compliance|0|||
128781872|NCT00797225|463492971|FG003|Weeks 13 to 24|Non-compliance|0|||
128781873|NCT00797225|463492972|FG004|Weeks 13 to 24|Non-compliance|0|||
128781874|NCT00797225|463492973|FG005|Weeks 13 to 24|Non-compliance|0|||
128781875|NCT00797225|463492974|FG006|Weeks 13 to 24|Non-compliance|0|||
128781876|NCT00797225|463492975|FG007|Weeks 13 to 24|Non-compliance|0|||
128781877|NCT00797225|463492968|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
128781878|NCT00797225|463492969|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
128781879|NCT00797225|463492970|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
128781880|NCT00797225|463492971|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
128781881|NCT00797225|463492972|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
128781882|NCT00797225|463492973|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
128781883|NCT00797225|463492974|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
128781884|NCT00797225|463492975|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
128781885|NCT00797225|463492968|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
128781886|NCT00797225|463492969|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
128781887|NCT00797225|463492970|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
128781888|NCT00797225|463492971|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
128781889|NCT00797225|463492972|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
128781890|NCT00797225|463492973|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
128781891|NCT00797225|463492974|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
128781892|NCT00797225|463492975|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
128781893|NCT00797225|463492968|FG000|Weeks 13 to 24|Adverse Event|0|||
128781894|NCT00797225|463492969|FG001|Weeks 13 to 24|Adverse Event|1|||
128734653|NCT00079274|463319748|FG003|Overall Study|Adverse Event|184|||
128734654|NCT00079274|463319749|FG004|Overall Study|Adverse Event|7|||
128734655|NCT00079274|463319750|FG005|Overall Study|Adverse Event|8|||
128734656|NCT00079274|463319751|FG006|Overall Study|Adverse Event|0|||
128734657|NCT00079274|463319745|FG000|Overall Study|Recurrence|21|||
128734658|NCT00079274|463319746|FG001|Overall Study|Recurrence|0|||
128781895|NCT00797225|463492970|FG002|Weeks 13 to 24|Adverse Event|0|||
128781896|NCT00797225|463492971|FG003|Weeks 13 to 24|Adverse Event|0|||
128781897|NCT00797225|463492972|FG004|Weeks 13 to 24|Adverse Event|0|||
128781898|NCT00797225|463492973|FG005|Weeks 13 to 24|Adverse Event|0|||
128781899|NCT00797225|463492974|FG006|Weeks 13 to 24|Adverse Event|1|||
128781900|NCT00797225|463492975|FG007|Weeks 13 to 24|Adverse Event|0|||
128781901|NCT00797225|463492968|FG000|Weeks 13 to 24|Sponsor Decision|0|||
128781902|NCT00797225|463492969|FG001|Weeks 13 to 24|Sponsor Decision|0|||
128781903|NCT00797225|463492970|FG002|Weeks 13 to 24|Sponsor Decision|0|||
128734659|NCT00079274|463319747|FG002|Overall Study|Recurrence|1|||
128734660|NCT00079274|463319748|FG003|Overall Study|Recurrence|15|||
128734661|NCT00079274|463319749|FG004|Overall Study|Recurrence|0|||
128734662|NCT00079274|463319750|FG005|Overall Study|Recurrence|2|||
128734663|NCT00079274|463319751|FG006|Overall Study|Recurrence|0|||
128734664|NCT00079274|463319745|FG000|Overall Study|Alternate Treatment|6|||
128734665|NCT00079274|463319746|FG001|Overall Study|Alternate Treatment|1|||
128734666|NCT00079274|463319747|FG002|Overall Study|Alternate Treatment|0|||
128734667|NCT00079274|463319748|FG003|Overall Study|Alternate Treatment|3|||
128734668|NCT00079274|463319749|FG004|Overall Study|Alternate Treatment|0|||
128734669|NCT00079274|463319750|FG005|Overall Study|Alternate Treatment|0|||
128734670|NCT00079274|463319751|FG006|Overall Study|Alternate Treatment|0|||
128734671|NCT00079274|463319745|FG000|Overall Study|Other Medical Problems|6|||
128734672|NCT00079274|463319746|FG001|Overall Study|Other Medical Problems|1|||
128734673|NCT00079274|463319747|FG002|Overall Study|Other Medical Problems|0|||
128734674|NCT00079274|463319748|FG003|Overall Study|Other Medical Problems|7|||
128734675|NCT00079274|463319749|FG004|Overall Study|Other Medical Problems|0|||
128734676|NCT00079274|463319750|FG005|Overall Study|Other Medical Problems|0|||
128734677|NCT00079274|463319751|FG006|Overall Study|Other Medical Problems|0|||
128734678|NCT00079274|463319745|FG000|Overall Study|Death|4|||
128734679|NCT00079274|463319746|FG001|Overall Study|Death|0|||
128734680|NCT00079274|463319747|FG002|Overall Study|Death|1|||
128734681|NCT00079274|463319748|FG003|Overall Study|Death|15|||
128734682|NCT00079274|463319749|FG004|Overall Study|Death|0|||
128734683|NCT00079274|463319750|FG005|Overall Study|Death|0|||
128734684|NCT00079274|463319751|FG006|Overall Study|Death|0|||
128734685|NCT00079274|463319745|FG000|Overall Study|Cytogenetic resistance|0|||
128734686|NCT00079274|463319746|FG001|Overall Study|Cytogenetic resistance|0|||
128734687|NCT00079274|463319747|FG002|Overall Study|Cytogenetic resistance|0|||
128734688|NCT00079274|463319748|FG003|Overall Study|Cytogenetic resistance|2|||
128734689|NCT00079274|463319749|FG004|Overall Study|Cytogenetic resistance|0|||
128734690|NCT00079274|463319750|FG005|Overall Study|Cytogenetic resistance|0|||
128734691|NCT00079274|463319751|FG006|Overall Study|Cytogenetic resistance|0|||
128734692|NCT00079274|463319745|FG000|Overall Study|Other|43|||
128734693|NCT00079274|463319746|FG001|Overall Study|Other|7|||
128734694|NCT00079274|463319747|FG002|Overall Study|Other|5|||
128734695|NCT00079274|463319748|FG003|Overall Study|Other|55|||
128734696|NCT00079274|463319749|FG004|Overall Study|Other|1|||
128734697|NCT00079274|463319750|FG005|Overall Study|Other|2|||
128734698|NCT00079274|463319751|FG006|Overall Study|Other|0|||
128734699|NCT00179413|463319753|FG000|Overall Study|Adverse Event|38|||
128734700|NCT00179413|463319754|FG001|Overall Study|Adverse Event|20|||
128734701|NCT00179413|463319753|FG000|Overall Study|Withdrawal by Subject|87|||
128734702|NCT00179413|463319754|FG001|Overall Study|Withdrawal by Subject|95|||
128734703|NCT01458171|463319757|FG000|Overall Study|Adverse Event|1|||
128734704|NCT01696032|463319758|FG000|Overall Study|Withdrawal by Subject|0|||
128734705|NCT01696032|463319759|FG001|Overall Study|Withdrawal by Subject|0|||
128734706|NCT01696032|463319760|FG002|Overall Study|Withdrawal by Subject|1|||
128734707|NCT01696032|463319761|FG003|Overall Study|Withdrawal by Subject|2|||
128734708|NCT01696032|463319758|FG000|Overall Study|Death|14|||
128734709|NCT01696032|463319759|FG001|Overall Study|Death|4|||
128734710|NCT01696032|463319760|FG002|Overall Study|Death|43|||
128734711|NCT01696032|463319761|FG003|Overall Study|Death|18|||
128734712|NCT01696032|463319758|FG000|Overall Study|Lost to Follow-up|0|||
128734713|NCT01696032|463319759|FG001|Overall Study|Lost to Follow-up|1|||
128734714|NCT01696032|463319760|FG002|Overall Study|Lost to Follow-up|0|||
128734715|NCT01696032|463319761|FG003|Overall Study|Lost to Follow-up|0|||
128734716|NCT01696032|463319758|FG000|Overall Study|Database lock|0|||
128734717|NCT01696032|463319759|FG001|Overall Study|Database lock|1|||
128734718|NCT01696032|463319760|FG002|Overall Study|Database lock|7|||
128734719|NCT01696032|463319761|FG003|Overall Study|Database lock|2|||
128734720|NCT02203591|463319765|FG000|Overall Study|Did not meet treatment day baseline|147|||
128734721|NCT02203591|463319766|FG001|Overall Study|Did not meet treatment day baseline|141|||
128734722|NCT02203591|463319767|FG002|Overall Study|Did not meet treatment day baseline|150|||
128734723|NCT02203591|463319768|FG003|Overall Study|Did not meet treatment day baseline|45|||
128734724|NCT02203591|463319769|FG004|Overall Study|Did not meet treatment day baseline|33|||
128734725|NCT02203591|463319770|FG005|Overall Study|Did not meet treatment day baseline|35|||
128734726|NCT02203591|463319771|FG006|Overall Study|Did not meet treatment day baseline|29|||
128734727|NCT02203591|463319772|FG007|Overall Study|Did not meet treatment day baseline|12|||
128734728|NCT02203591|463319765|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
128734729|NCT02203591|463319766|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
128734730|NCT02203591|463319767|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
128734731|NCT02203591|463319768|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
128734732|NCT02203591|463319769|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
128734733|NCT02203591|463319770|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
128734734|NCT02203591|463319771|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
128734735|NCT02203591|463319772|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
128734736|NCT01009099|463319776|FG000|Overall Study|Lost to Follow-up|1|||
128734737|NCT01009099|463319777|FG001|Overall Study|Lost to Follow-up|0|||
128734738|NCT01009099|463319776|FG000|Overall Study|Physician Decision|3|||
128734739|NCT01009099|463319777|FG001|Overall Study|Physician Decision|2|||
128734740|NCT01009099|463319776|FG000|Overall Study|Withdrawal by Subject|1|||
128734741|NCT01009099|463319777|FG001|Overall Study|Withdrawal by Subject|1|||
128734742|NCT01009099|463319776|FG000|Overall Study|Death|0|||
128734743|NCT01009099|463319777|FG001|Overall Study|Death|1|||
128734744|NCT02501096|463319779|FG000|Overall Study|Lost to Follow-up|0|||
128781904|NCT00797225|463492971|FG003|Weeks 13 to 24|Sponsor Decision|0|||
128781905|NCT00797225|463492972|FG004|Weeks 13 to 24|Sponsor Decision|0|||
128781906|NCT00797225|463492973|FG005|Weeks 13 to 24|Sponsor Decision|0|||
128781907|NCT00797225|463492974|FG006|Weeks 13 to 24|Sponsor Decision|1|||
128781908|NCT00797225|463492975|FG007|Weeks 13 to 24|Sponsor Decision|0|||
128781909|NCT01352507|463492978|FG000|Treatment Period 1|Adverse Event|3|||
128781910|NCT01352507|463492979|FG001|Treatment Period 1|Adverse Event|0|||
128781911|NCT01352507|463492978|FG000|Treatment Period 1|Lost to Follow-up|3|||
128781912|NCT01352507|463492979|FG001|Treatment Period 1|Lost to Follow-up|4|||
128781913|NCT01352507|463492978|FG000|Treatment Period 1|Withdrawal by Subject|7|||
128781914|NCT01352507|463492979|FG001|Treatment Period 1|Withdrawal by Subject|5|||
128781915|NCT01352507|463492978|FG000|Treatment Period 1|Physician Decision|1|||
128781916|NCT01352507|463492979|FG001|Treatment Period 1|Physician Decision|0|||
128781917|NCT01352507|463492978|FG000|Washout Period|Withdrawal by Subject|0|||
128781918|NCT01352507|463492979|FG001|Washout Period|Withdrawal by Subject|1|||
128781919|NCT01352507|463492978|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
128781920|NCT01352507|463492979|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
128781921|NCT01352507|463492978|FG000|Treatment Period 2|Withdrawal by Subject|4|||
128781922|NCT01352507|463492979|FG001|Treatment Period 2|Withdrawal by Subject|3|||
128781923|NCT01352507|463492978|FG000|Treatment Period 2|Lack of Efficacy|1|||
128781924|NCT01352507|463492979|FG001|Treatment Period 2|Lack of Efficacy|0|||
128781925|NCT02096003|463492980|FG000|Overall Study|Protocol Violation|0|||
128781926|NCT02096003|463492981|FG001|Overall Study|Protocol Violation|2|||
128781927|NCT02096003|463492980|FG000|Overall Study|additional surgery|2|||
128781928|NCT02096003|463492981|FG001|Overall Study|additional surgery|1|||
128781929|NCT01511250|463492982|FG000|Overall Study|Withdrawal of Consent|1|||
128781930|NCT01511250|463492983|FG001|Overall Study|Withdrawal of Consent|0|||
128781931|NCT01511250|463492984|FG002|Overall Study|Withdrawal of Consent|0|||
128781932|NCT01511250|463492985|FG003|Overall Study|Withdrawal of Consent|0|||
128781933|NCT01511250|463492986|FG004|Overall Study|Withdrawal of Consent|0|||
128781934|NCT01511250|463492987|FG005|Overall Study|Withdrawal of Consent|0|||
128781935|NCT01511250|463492988|FG006|Overall Study|Withdrawal of Consent|0|||
128781936|NCT01511250|463492989|FG007|Overall Study|Withdrawal of Consent|1|||
128781937|NCT01511250|463492990|FG008|Overall Study|Withdrawal of Consent|1|||
128781938|NCT01511250|463492991|FG009|Overall Study|Withdrawal of Consent|0|||
128781939|NCT01511250|463492982|FG000|Overall Study|Sponsor/Investigator Decision|1|||
128781940|NCT01511250|463492983|FG001|Overall Study|Sponsor/Investigator Decision|0|||
128781941|NCT01511250|463492984|FG002|Overall Study|Sponsor/Investigator Decision|0|||
128781942|NCT01511250|463492985|FG003|Overall Study|Sponsor/Investigator Decision|0|||
128781943|NCT01511250|463492986|FG004|Overall Study|Sponsor/Investigator Decision|0|||
128781944|NCT01511250|463492987|FG005|Overall Study|Sponsor/Investigator Decision|0|||
128781945|NCT01511250|463492988|FG006|Overall Study|Sponsor/Investigator Decision|0|||
128781946|NCT01511250|463492989|FG007|Overall Study|Sponsor/Investigator Decision|0|||
128781947|NCT01511250|463492990|FG008|Overall Study|Sponsor/Investigator Decision|0|||
128781948|NCT01511250|463492991|FG009|Overall Study|Sponsor/Investigator Decision|0|||
128781949|NCT01511250|463492982|FG000|Overall Study|Lost to Follow-up|7|||
128781950|NCT01511250|463492983|FG001|Overall Study|Lost to Follow-up|3|||
128781951|NCT01511250|463492984|FG002|Overall Study|Lost to Follow-up|3|||
128781952|NCT01511250|463492985|FG003|Overall Study|Lost to Follow-up|3|||
128781953|NCT01511250|463492986|FG004|Overall Study|Lost to Follow-up|0|||
128781954|NCT01511250|463492987|FG005|Overall Study|Lost to Follow-up|0|||
128781955|NCT01511250|463492988|FG006|Overall Study|Lost to Follow-up|2|||
128781956|NCT01511250|463492989|FG007|Overall Study|Lost to Follow-up|3|||
128781957|NCT01511250|463492990|FG008|Overall Study|Lost to Follow-up|13|||
128781958|NCT01511250|463492991|FG009|Overall Study|Lost to Follow-up|5|||
128781959|NCT01511250|463492982|FG000|Overall Study|Protocol Violation|0|||
128781960|NCT01511250|463492983|FG001|Overall Study|Protocol Violation|2|||
128781961|NCT01511250|463492984|FG002|Overall Study|Protocol Violation|1|||
128781962|NCT01511250|463492985|FG003|Overall Study|Protocol Violation|0|||
128781963|NCT01511250|463492986|FG004|Overall Study|Protocol Violation|0|||
128781964|NCT01511250|463492987|FG005|Overall Study|Protocol Violation|0|||
128781965|NCT01511250|463492988|FG006|Overall Study|Protocol Violation|0|||
128781966|NCT01511250|463492989|FG007|Overall Study|Protocol Violation|0|||
128781967|NCT01511250|463492990|FG008|Overall Study|Protocol Violation|0|||
128781968|NCT01511250|463492991|FG009|Overall Study|Protocol Violation|0|||
128781969|NCT00916006|463492997|FG000|Overall Study|Adverse Event|1|||
128781970|NCT00916006|463492998|FG001|Overall Study|Adverse Event|1|||
128781971|NCT00916006|463492997|FG000|Overall Study|Withdrawal by Subject|2|||
128781972|NCT00916006|463492998|FG001|Overall Study|Withdrawal by Subject|5|||
128781973|NCT00916006|463492997|FG000|Overall Study|Protocol Violation|0|||
128781974|NCT00916006|463492998|FG001|Overall Study|Protocol Violation|1|||
128781975|NCT05487703|463492999|FG000|Overall Study|Other|19|||
128781976|NCT05487703|463492999|FG000|Overall Study|Participant not well|5|||
128781977|NCT05487703|463492999|FG000|Overall Study|Insurance Reasons|6|||
128734745|NCT02501096|463319780|FG001|Overall Study|Lost to Follow-up|0|||
128734746|NCT02501096|463319781|FG002|Overall Study|Lost to Follow-up|0|||
128734747|NCT02501096|463319782|FG003|Overall Study|Lost to Follow-up|0|||
128734748|NCT02501096|463319783|FG004|Overall Study|Lost to Follow-up|1|||
128734749|NCT02501096|463319784|FG005|Overall Study|Lost to Follow-up|1|||
128734750|NCT02501096|463319785|FG006|Overall Study|Lost to Follow-up|3|||
128734751|NCT02501096|463319786|FG007|Overall Study|Lost to Follow-up|0|||
128734752|NCT02501096|463319787|FG008|Overall Study|Lost to Follow-up|0|||
128734753|NCT02501096|463319779|FG000|Overall Study|Withdrawal by Subject|1|||
128734754|NCT02501096|463319780|FG001|Overall Study|Withdrawal by Subject|0|||
128734755|NCT02501096|463319781|FG002|Overall Study|Withdrawal by Subject|7|||
128734756|NCT02501096|463319782|FG003|Overall Study|Withdrawal by Subject|13|||
128734757|NCT02501096|463319783|FG004|Overall Study|Withdrawal by Subject|2|||
128734758|NCT02501096|463319784|FG005|Overall Study|Withdrawal by Subject|2|||
128734759|NCT02501096|463319785|FG006|Overall Study|Withdrawal by Subject|2|||
128734760|NCT02501096|463319786|FG007|Overall Study|Withdrawal by Subject|3|||
128734761|NCT02501096|463319787|FG008|Overall Study|Withdrawal by Subject|0|||
128734762|NCT02501096|463319779|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
128734763|NCT02501096|463319780|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
128734764|NCT02501096|463319781|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
128734765|NCT02501096|463319782|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
128734766|NCT02501096|463319783|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
128734767|NCT02501096|463319784|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
128734768|NCT02501096|463319785|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
128734769|NCT02501096|463319786|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
128734770|NCT02501096|463319787|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
128734771|NCT02501096|463319779|FG000|Overall Study|Death|1|||
128734772|NCT02501096|463319780|FG001|Overall Study|Death|1|||
128734773|NCT02501096|463319781|FG002|Overall Study|Death|88|||
128734774|NCT02501096|463319782|FG003|Overall Study|Death|74|||
128734775|NCT02501096|463319783|FG004|Overall Study|Death|15|||
128734776|NCT02501096|463319784|FG005|Overall Study|Death|16|||
128734777|NCT02501096|463319785|FG006|Overall Study|Death|15|||
128734778|NCT02501096|463319786|FG007|Overall Study|Death|16|||
128734779|NCT02501096|463319787|FG008|Overall Study|Death|1|||
128734780|NCT04187196|463319788|FG000|Overall Study|Screen Failure|2|||
128734781|NCT04187196|463319789|FG001|Overall Study|Screen Failure|0|||
128734782|NCT03139916|463319792|FG000|Overall Study|Withdrawal by Subject|2|||
128734783|NCT03139916|463319792|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
128734784|NCT01957475|463319793|FG000|Test Period 1|Withdrawal by Subject|1|||
128734785|NCT01957475|463319794|FG001|Test Period 1|Withdrawal by Subject|0|||
128734786|NCT01957475|463319793|FG000|Test Period 1|Other|1|||
128734787|NCT01957475|463319794|FG001|Test Period 1|Other|0|||
128734788|NCT01957475|463319793|FG000|Test Period 1|Lack of Efficacy|0|||
128734789|NCT01957475|463319794|FG001|Test Period 1|Lack of Efficacy|1|||
128734790|NCT01957475|463319793|FG000|Test Period 2|Adverse Event|1|||
128734791|NCT01957475|463319794|FG001|Test Period 2|Adverse Event|0|||
128734792|NCT04587193|463319795|FG000|Overall Study|Screen failure after consent|3|||
128734793|NCT04587193|463319796|FG001|Overall Study|Screen failure after consent|0|||
128734794|NCT04587193|463319795|FG000|Overall Study|Device broke during study|3|||
128734795|NCT04587193|463319796|FG001|Overall Study|Device broke during study|2|||
128734796|NCT01552772|463319797|FG000|Overall Study|Lost to Follow-up|2|||
128734797|NCT01552772|463319797|FG000|Overall Study|Adverse Event|1|||
128734798|NCT01552772|463319797|FG000|Overall Study|Protocol Deviation|1|||
128734799|NCT02920983|463319798|FG000|Dispense 1|Unacceptable Lens Fit|0|||
128734800|NCT02920983|463319799|FG001|Dispense 1|Unacceptable Lens Fit|0|||
128734801|NCT02920983|463319800|FG002|Dispense 1|Unacceptable Lens Fit|0|||
128734802|NCT02920983|463319801|FG003|Dispense 1|Unacceptable Lens Fit|0|||
128734803|NCT02920983|463319802|FG004|Dispense 1|Unacceptable Lens Fit|1|||
128734804|NCT02920983|463319803|FG005|Dispense 1|Unacceptable Lens Fit|0|||
128734805|NCT02920983|463319798|FG000|Dispense 2|Unscceptable lens fit|1|||
128734806|NCT02920983|463319799|FG001|Dispense 2|Unscceptable lens fit|0|||
128734807|NCT02920983|463319800|FG002|Dispense 2|Unscceptable lens fit|0|||
128734808|NCT02920983|463319801|FG003|Dispense 2|Unscceptable lens fit|0|||
128734809|NCT02920983|463319802|FG004|Dispense 2|Unscceptable lens fit|1|||
128734810|NCT02920983|463319803|FG005|Dispense 2|Unscceptable lens fit|0|||
128734811|NCT02920983|463319798|FG000|Dispense 3|Unacceptable Lens Fit|1|||
128734812|NCT02920983|463319799|FG001|Dispense 3|Unacceptable Lens Fit|1|||
128734813|NCT02920983|463319800|FG002|Dispense 3|Unacceptable Lens Fit|0|||
128734814|NCT02920983|463319801|FG003|Dispense 3|Unacceptable Lens Fit|0|||
128734815|NCT02920983|463319802|FG004|Dispense 3|Unacceptable Lens Fit|1|||
128734816|NCT02920983|463319803|FG005|Dispense 3|Unacceptable Lens Fit|0|||
128734817|NCT03878134|463319804|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
128734818|NCT02742103|463321638|FG000|Overall Study|Protocol Violation|1|||
128734819|NCT02742103|463321639|FG001|Overall Study|Protocol Violation|0|||
128734820|NCT02742103|463321638|FG000|Overall Study|Death|2|||
128734821|NCT02742103|463321639|FG001|Overall Study|Death|2|||
128781978|NCT05487703|463492999|FG000|Overall Study|Physician Decision|19|||
128781979|NCT05487703|463492999|FG000|Overall Study|Lack of Efficacy|60|||
128781980|NCT04824131|463493000|FG000|CAB LA Oral Phase|Adverse Event|1|||
128781981|NCT04824131|463493000|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
128781982|NCT04824131|463493000|FG000|Step 3|Withdrawal by Subject|2|||
128781983|NCT05489224|463493001|FG000|Treatment Period I|Withdrawal by Subject|6|||
128734822|NCT02742103|463321638|FG000|Overall Study|Adverse Event|1|||
128781984|NCT05489224|463493002|FG001|Treatment Period I|Withdrawal by Subject|5|||
128781985|NCT05489224|463493003|FG002|Treatment Period I|Withdrawal by Subject|0|||
128781986|NCT05489224|463493001|FG000|Treatment Period I|Adverse Event|3|||
128781987|NCT05489224|463493002|FG001|Treatment Period I|Adverse Event|11|||
128781988|NCT05489224|463493003|FG002|Treatment Period I|Adverse Event|0|||
128781989|NCT05489224|463493001|FG000|Treatment Period I|Lost to Follow-up|0|||
128781990|NCT05489224|463493002|FG001|Treatment Period I|Lost to Follow-up|1|||
128781991|NCT05489224|463493003|FG002|Treatment Period I|Lost to Follow-up|0|||
128781992|NCT05489224|463493001|FG000|Treatment Period I|Physician Decision|0|||
128781993|NCT05489224|463493002|FG001|Treatment Period I|Physician Decision|1|||
128781994|NCT05489224|463493003|FG002|Treatment Period I|Physician Decision|0|||
128781995|NCT05489224|463493001|FG000|Treatment Period II up to Week 32|Ongoing|222|||
128781996|NCT05489224|463493002|FG001|Treatment Period II up to Week 32|Ongoing|107|||
128781997|NCT05489224|463493003|FG002|Treatment Period II up to Week 32|Ongoing|107|||
128781998|NCT05489224|463493001|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
128781999|NCT05489224|463493002|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
128782000|NCT05489224|463493003|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
128782001|NCT05489224|463493001|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
128782002|NCT05489224|463493002|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
128782003|NCT05489224|463493003|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
128782004|NCT04887285|463493005|FG000|Overall Study|Lost to Follow-up|0|||
128782005|NCT04887285|463493006|FG001|Overall Study|Lost to Follow-up|2|||
128782006|NCT04887285|463493007|FG002|Overall Study|Lost to Follow-up|3|||
128782007|NCT04640571|463493008|FG000|Overall Study|Withdrawal by Subject|0|||
128782008|NCT04640571|463493009|FG001|Overall Study|Withdrawal by Subject|0|||
128782009|NCT04640571|463493010|FG002|Overall Study|Withdrawal by Subject|0|||
128782010|NCT04640571|463493011|FG003|Overall Study|Withdrawal by Subject|0|||
128782011|NCT04640571|463493012|FG004|Overall Study|Withdrawal by Subject|0|||
128782012|NCT04640571|463493013|FG005|Overall Study|Withdrawal by Subject|2|||
128782013|NCT00832780|463493018|FG000|Overall Study|Death|16|||
128782014|NCT00832780|463493018|FG000|Overall Study|Lost to Follow-up|4|||
128782015|NCT00832780|463493018|FG000|Overall Study|no reason given|2|||
128782016|NCT00832780|463493018|FG000|Overall Study|other complicating condition|2|||
128782017|NCT00832780|463493018|FG000|Overall Study|Physician Decision|1|||
128782018|NCT04319094|463493023|FG000|Baseline|Lost to Follow-up|4|||
128782019|NCT04319094|463493024|FG001|Baseline|Lost to Follow-up|5|||
128782020|NCT04319094|463493023|FG000|Baseline|Protocol Violation|0|||
128782021|NCT04319094|463493024|FG001|Baseline|Protocol Violation|3|||
128782022|NCT04319094|463493023|FG000|Baseline|Withdrawal by Subject|2|||
128782023|NCT04319094|463493024|FG001|Baseline|Withdrawal by Subject|1|||
128782024|NCT04319094|463493023|FG000|Post-Intervention|Death|0|||
128782025|NCT04319094|463493024|FG001|Post-Intervention|Death|1|||
128782026|NCT04319094|463493023|FG000|Post-Intervention|Lost to Follow-up|4|||
128782027|NCT04319094|463493024|FG001|Post-Intervention|Lost to Follow-up|4|||
128782028|NCT04319094|463493023|FG000|Post-Intervention|Withdrawal by Subject|8|||
128782029|NCT04319094|463493024|FG001|Post-Intervention|Withdrawal by Subject|5|||
128782030|NCT04319094|463493023|FG000|Post-Intervention|Incomplete Data Collection|1|||
128782031|NCT04319094|463493024|FG001|Post-Intervention|Incomplete Data Collection|3|||
128782032|NCT04319094|463493023|FG000|3-month|Death|1|||
128782033|NCT04319094|463493024|FG001|3-month|Death|0|||
128782034|NCT04319094|463493023|FG000|3-month|Lost to Follow-up|2|||
128782035|NCT04319094|463493024|FG001|3-month|Lost to Follow-up|2|||
128782036|NCT04319094|463493023|FG000|3-month|Withdrawal by Subject|0|||
128782037|NCT04319094|463493024|FG001|3-month|Withdrawal by Subject|3|||
128782038|NCT04319094|463493023|FG000|3-month|Incomplete data collection|9|||
128782039|NCT04319094|463493024|FG001|3-month|Incomplete data collection|7|||
128782040|NCT04319094|463493023|FG000|6-month|Lost to Follow-up|1|||
128782041|NCT04319094|463493024|FG001|6-month|Lost to Follow-up|1|||
128782042|NCT04319094|463493023|FG000|6-month|Withdrawal by Subject|0|||
128782043|NCT04319094|463493024|FG001|6-month|Withdrawal by Subject|3|||
128782044|NCT04319094|463493023|FG000|6-month|Incomplete data collection|14|||
128782045|NCT04319094|463493024|FG001|6-month|Incomplete data collection|9|||
128782046|NCT04319094|463493023|FG000|9-month|Lost to Follow-up|8|||
128782047|NCT04319094|463493024|FG001|9-month|Lost to Follow-up|4|||
128782048|NCT04319094|463493023|FG000|9-month|Withdrawal by Subject|0|||
128782049|NCT04319094|463493024|FG001|9-month|Withdrawal by Subject|1|||
128782050|NCT04319094|463493023|FG000|9-month|Incomplete data collection|8|||
128782051|NCT04319094|463493024|FG001|9-month|Incomplete data collection|5|||
128782052|NCT04319094|463493023|FG000|12-month|Lost to Follow-up|11|||
128782053|NCT04319094|463493024|FG001|12-month|Lost to Follow-up|8|||
128782054|NCT00764868|463493026|FG000|Overall Study|Adverse Event|18|||
128782055|NCT00764868|463493026|FG000|Overall Study|Withdrawal by Subject|31|||
128782056|NCT00764868|463493026|FG000|Overall Study|Non-compliance|16|||
128782057|NCT00764868|463493026|FG000|Overall Study|Lost to Follow-up|25|||
128782058|NCT00764868|463493026|FG000|Overall Study|Lack of Efficacy|5|||
128782059|NCT00764868|463493026|FG000|Overall Study|Subject moved|7|||
128782060|NCT00764868|463493026|FG000|Overall Study|Pregnancy|3|||
128782061|NCT00764868|463493026|FG000|Overall Study|Prohibited medication|1|||
128782062|NCT00764868|463493026|FG000|Overall Study|Out of town|1|||
129204166|NCT03309878|465045731|FG000|Overall Study|Did not maintain eligibility|2|||
129204167|NCT03309878|465045732|FG001|Overall Study|Did not maintain eligibility|1|||
129204168|NCT03309878|465045733|FG002|Overall Study|Did not maintain eligibility|0|||
129204169|NCT03309878|465045734|FG003|Overall Study|Did not maintain eligibility|0|||
129204170|NCT03309878|465045731|FG000|Overall Study|Withdrawal by Subject|0|||
129204171|NCT03309878|465045732|FG001|Overall Study|Withdrawal by Subject|1|||
129204172|NCT03309878|465045733|FG002|Overall Study|Withdrawal by Subject|0|||
129204173|NCT03309878|465045734|FG003|Overall Study|Withdrawal by Subject|0|||
129204174|NCT02349633|465045736|FG000|Overall Study|Death|0|||
129204175|NCT02349633|465045737|FG001|Overall Study|Death|1|||
129204176|NCT02349633|465045738|FG002|Overall Study|Death|0|||
129204177|NCT02349633|465045739|FG003|Overall Study|Death|0|||
129204178|NCT02349633|465045740|FG004|Overall Study|Death|0|||
129204179|NCT02349633|465045741|FG005|Overall Study|Death|1|||
129204180|NCT02349633|465045742|FG006|Overall Study|Death|1|||
129204181|NCT02349633|465045743|FG007|Overall Study|Death|1|||
129204182|NCT02349633|465045744|FG008|Overall Study|Death|0|||
129204183|NCT02349633|465045745|FG009|Overall Study|Death|1|||
129204184|NCT02349633|465045746|FG010|Overall Study|Death|0|||
129204185|NCT02349633|465045747|FG011|Overall Study|Death|0|||
129204186|NCT02349633|465045748|FG012|Overall Study|Death|0|||
129204187|NCT02349633|465045749|FG013|Overall Study|Death|0|||
129204188|NCT02349633|465045736|FG000|Overall Study|Withdrawal by Subject|0|||
129204189|NCT02349633|465045737|FG001|Overall Study|Withdrawal by Subject|0|||
129204190|NCT02349633|465045738|FG002|Overall Study|Withdrawal by Subject|0|||
129204191|NCT02349633|465045739|FG003|Overall Study|Withdrawal by Subject|1|||
129204192|NCT02349633|465045740|FG004|Overall Study|Withdrawal by Subject|0|||
129204193|NCT02349633|465045741|FG005|Overall Study|Withdrawal by Subject|0|||
129204194|NCT02349633|465045742|FG006|Overall Study|Withdrawal by Subject|0|||
129204195|NCT02349633|465045743|FG007|Overall Study|Withdrawal by Subject|2|||
129204196|NCT02349633|465045744|FG008|Overall Study|Withdrawal by Subject|2|||
129204197|NCT02349633|465045745|FG009|Overall Study|Withdrawal by Subject|1|||
129204198|NCT02349633|465045746|FG010|Overall Study|Withdrawal by Subject|0|||
129204199|NCT02349633|465045747|FG011|Overall Study|Withdrawal by Subject|0|||
129204200|NCT02349633|465045748|FG012|Overall Study|Withdrawal by Subject|0|||
129204201|NCT02349633|465045749|FG013|Overall Study|Withdrawal by Subject|0|||
129204202|NCT02349633|465045736|FG000|Overall Study|Withdrawal of informed consent|0|||
129204203|NCT02349633|465045737|FG001|Overall Study|Withdrawal of informed consent|0|||
129204204|NCT02349633|465045738|FG002|Overall Study|Withdrawal of informed consent|0|||
129204205|NCT02349633|465045739|FG003|Overall Study|Withdrawal of informed consent|1|||
129204206|NCT02349633|465045740|FG004|Overall Study|Withdrawal of informed consent|1|||
129204207|NCT02349633|465045741|FG005|Overall Study|Withdrawal of informed consent|0|||
129204208|NCT02349633|465045742|FG006|Overall Study|Withdrawal of informed consent|0|||
129204209|NCT02349633|465045743|FG007|Overall Study|Withdrawal of informed consent|3|||
129204210|NCT02349633|465045744|FG008|Overall Study|Withdrawal of informed consent|0|||
129204211|NCT02349633|465045745|FG009|Overall Study|Withdrawal of informed consent|0|||
129204212|NCT02349633|465045746|FG010|Overall Study|Withdrawal of informed consent|0|||
129204213|NCT02349633|465045747|FG011|Overall Study|Withdrawal of informed consent|0|||
129204214|NCT02349633|465045748|FG012|Overall Study|Withdrawal of informed consent|0|||
129204215|NCT02349633|465045749|FG013|Overall Study|Withdrawal of informed consent|0|||
129204216|NCT02349633|465045736|FG000|Overall Study|Transition to compassionate use|0|||
129204217|NCT02349633|465045737|FG001|Overall Study|Transition to compassionate use|0|||
129204218|NCT02349633|465045738|FG002|Overall Study|Transition to compassionate use|0|||
129204219|NCT02349633|465045739|FG003|Overall Study|Transition to compassionate use|0|||
129204220|NCT02349633|465045740|FG004|Overall Study|Transition to compassionate use|1|||
129204221|NCT02349633|465045741|FG005|Overall Study|Transition to compassionate use|0|||
129204222|NCT02349633|465045742|FG006|Overall Study|Transition to compassionate use|0|||
129204223|NCT02349633|465045743|FG007|Overall Study|Transition to compassionate use|3|||
129204224|NCT02349633|465045744|FG008|Overall Study|Transition to compassionate use|0|||
129204225|NCT02349633|465045745|FG009|Overall Study|Transition to compassionate use|1|||
129204226|NCT02349633|465045746|FG010|Overall Study|Transition to compassionate use|0|||
129204227|NCT02349633|465045747|FG011|Overall Study|Transition to compassionate use|0|||
129204228|NCT02349633|465045748|FG012|Overall Study|Transition to compassionate use|0|||
129204229|NCT02349633|465045749|FG013|Overall Study|Transition to compassionate use|0|||
129204230|NCT02349633|465045736|FG000|Overall Study|Early termination of survival follow-up|0|||
129204231|NCT02349633|465045737|FG001|Overall Study|Early termination of survival follow-up|0|||
129204232|NCT02349633|465045738|FG002|Overall Study|Early termination of survival follow-up|0|||
129204233|NCT02349633|465045739|FG003|Overall Study|Early termination of survival follow-up|0|||
129204234|NCT02349633|465045740|FG004|Overall Study|Early termination of survival follow-up|0|||
129204235|NCT02349633|465045741|FG005|Overall Study|Early termination of survival follow-up|0|||
129204236|NCT02349633|465045742|FG006|Overall Study|Early termination of survival follow-up|0|||
129204237|NCT02349633|465045743|FG007|Overall Study|Early termination of survival follow-up|4|||
129204238|NCT02349633|465045744|FG008|Overall Study|Early termination of survival follow-up|0|||
128782063|NCT00764868|463493026|FG000|Overall Study|Misuse and compliance of study drug|1|||
128782064|NCT00764868|463493026|FG000|Overall Study|Subject sent to boarding school|1|||
128782065|NCT00764868|463493026|FG000|Overall Study|Met an exclusion criteria|1|||
128782066|NCT00764868|463493026|FG000|Overall Study|Positive drug screen|2|||
128782067|NCT00764868|463493026|FG000|Overall Study|Sponsor requested withdrawal|1|||
128782068|NCT02414828|463493027|FG000|Overall Study|Lost to Follow-up|0|||
128782069|NCT02414828|463493028|FG001|Overall Study|Lost to Follow-up|1|||
128782070|NCT02414828|463493029|FG002|Overall Study|Lost to Follow-up|1|||
128782071|NCT02414828|463493030|FG003|Overall Study|Lost to Follow-up|2|||
128782072|NCT04949399|463493033|FG000|Overall Study|Lost to Follow-up|11|||
128782073|NCT04949399|463493034|FG001|Overall Study|Lost to Follow-up|6|||
128782074|NCT04949399|463493033|FG000|Overall Study|Withdrawal by Subject|2|||
128782075|NCT04949399|463493034|FG001|Overall Study|Withdrawal by Subject|3|||
128782076|NCT00814489|463493035|FG000|Overall Study|Other|2|||
128782077|NCT00814489|463493036|FG001|Overall Study|Other|0|||
128782078|NCT00814489|463493037|FG002|Overall Study|Other|1|||
128782079|NCT01712685|463493063|FG000|Overall Study|pt declined to participate before trmt|1|||
128782080|NCT01866917|463493064|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
128782081|NCT01866917|463493065|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
128782082|NCT01515319|463493069|FG000|Overall Study|Withdrawal by Subject|0|||
128782083|NCT01515319|463493070|FG001|Overall Study|Withdrawal by Subject|0|||
128782084|NCT01515319|463493071|FG002|Overall Study|Withdrawal by Subject|0|||
128782085|NCT01515319|463493072|FG003|Overall Study|Withdrawal by Subject|0|||
128782086|NCT01515319|463493073|FG004|Overall Study|Withdrawal by Subject|0|||
128782087|NCT01515319|463493074|FG005|Overall Study|Withdrawal by Subject|0|||
128782088|NCT01515319|463493075|FG006|Overall Study|Withdrawal by Subject|1|||
128782089|NCT01515319|463493076|FG007|Overall Study|Withdrawal by Subject|0|||
128782090|NCT01515319|463493077|FG008|Overall Study|Withdrawal by Subject|0|||
128782091|NCT01515319|463493078|FG009|Overall Study|Withdrawal by Subject|0|||
128782092|NCT01515319|463493069|FG000|Overall Study|Adverse Event|0|||
128782093|NCT01515319|463493070|FG001|Overall Study|Adverse Event|0|||
128782094|NCT01515319|463493071|FG002|Overall Study|Adverse Event|0|||
128782095|NCT01515319|463493072|FG003|Overall Study|Adverse Event|0|||
128782096|NCT01515319|463493073|FG004|Overall Study|Adverse Event|0|||
128782097|NCT01515319|463493074|FG005|Overall Study|Adverse Event|0|||
128782098|NCT01515319|463493075|FG006|Overall Study|Adverse Event|0|||
128782099|NCT01515319|463493076|FG007|Overall Study|Adverse Event|0|||
128782100|NCT01515319|463493077|FG008|Overall Study|Adverse Event|3|||
128782101|NCT01515319|463493078|FG009|Overall Study|Adverse Event|0|||
128782102|NCT01515319|463493069|FG000|Overall Study|Protocol Violation|0|||
128782103|NCT01515319|463493070|FG001|Overall Study|Protocol Violation|0|||
128782104|NCT01515319|463493071|FG002|Overall Study|Protocol Violation|0|||
128782105|NCT01515319|463493072|FG003|Overall Study|Protocol Violation|0|||
128782106|NCT01515319|463493073|FG004|Overall Study|Protocol Violation|0|||
128782107|NCT01515319|463493074|FG005|Overall Study|Protocol Violation|0|||
128782108|NCT01515319|463493075|FG006|Overall Study|Protocol Violation|0|||
128782109|NCT01515319|463493076|FG007|Overall Study|Protocol Violation|0|||
128782110|NCT01515319|463493077|FG008|Overall Study|Protocol Violation|2|||
128782111|NCT01515319|463493078|FG009|Overall Study|Protocol Violation|0|||
128782112|NCT01959880|463493079|FG000|Overall Study|Withdrawal by Subject|11|||
128782113|NCT01959880|463493080|FG001|Overall Study|Withdrawal by Subject|13|||
128782114|NCT01959880|463493081|FG002|Overall Study|Withdrawal by Subject|8|||
128782115|NCT01959880|463493082|FG003|Overall Study|Withdrawal by Subject|7|||
128782116|NCT01959880|463493079|FG000|Overall Study|Death|1|||
128782117|NCT01959880|463493080|FG001|Overall Study|Death|10|||
128782118|NCT01959880|463493081|FG002|Overall Study|Death|1|||
128782119|NCT01959880|463493082|FG003|Overall Study|Death|2|||
128782120|NCT01959880|463493079|FG000|Overall Study|Lost to Follow-up|95|||
128782121|NCT01959880|463493080|FG001|Overall Study|Lost to Follow-up|18|||
128782122|NCT01959880|463493081|FG002|Overall Study|Lost to Follow-up|15|||
128782123|NCT01959880|463493082|FG003|Overall Study|Lost to Follow-up|8|||
128782124|NCT01959880|463493079|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
128782125|NCT01959880|463493080|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
128782126|NCT01959880|463493081|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
128782127|NCT01959880|463493082|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
128782128|NCT01959880|463493079|FG000|Overall Study|Study completed early-FDA approved|1003|||
128782129|NCT01959880|463493080|FG001|Overall Study|Study completed early-FDA approved|311|||
128782130|NCT01959880|463493081|FG002|Overall Study|Study completed early-FDA approved|179|||
128782131|NCT01959880|463493082|FG003|Overall Study|Study completed early-FDA approved|152|||
128782132|NCT01919619|463493083|FG000|Overall Study|Physician Decision|1|||
128782133|NCT01919619|463493084|FG001|Overall Study|Physician Decision|1|||
128782134|NCT04610684|463494321|FG000|Study Treatment|Withdrawal by Subject|1|||
128782135|NCT04610684|463494321|FG000|Study Treatment|Disease Progression|2|||
128782136|NCT04610684|463494321|FG000|Follow up|Death|2|||
128782137|NCT04610684|463494321|FG000|Follow up|Withdrawal by Subject|1|||
128782138|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
128782139|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
129204239|NCT02349633|465045745|FG009|Overall Study|Early termination of survival follow-up|0|||
129204240|NCT02349633|465045746|FG010|Overall Study|Early termination of survival follow-up|0|||
129204241|NCT02349633|465045747|FG011|Overall Study|Early termination of survival follow-up|0|||
129204242|NCT02349633|465045748|FG012|Overall Study|Early termination of survival follow-up|0|||
129204243|NCT02349633|465045749|FG013|Overall Study|Early termination of survival follow-up|0|||
129204244|NCT02349633|465045736|FG000|Overall Study|Termination by sponsor|0|||
129204245|NCT02349633|465045737|FG001|Overall Study|Termination by sponsor|0|||
129204246|NCT02349633|465045738|FG002|Overall Study|Termination by sponsor|0|||
129204247|NCT02349633|465045739|FG003|Overall Study|Termination by sponsor|0|||
129204248|NCT02349633|465045740|FG004|Overall Study|Termination by sponsor|0|||
129204249|NCT02349633|465045741|FG005|Overall Study|Termination by sponsor|0|||
129204250|NCT02349633|465045742|FG006|Overall Study|Termination by sponsor|0|||
129204251|NCT02349633|465045743|FG007|Overall Study|Termination by sponsor|1|||
129204252|NCT02349633|465045744|FG008|Overall Study|Termination by sponsor|0|||
129204253|NCT02349633|465045745|FG009|Overall Study|Termination by sponsor|2|||
129204254|NCT02349633|465045746|FG010|Overall Study|Termination by sponsor|0|||
128782140|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
128782141|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
128782142|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
128782143|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
129204255|NCT02349633|465045747|FG011|Overall Study|Termination by sponsor|0|||
128782144|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
128782145|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
128782146|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
128782147|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
128782148|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
128782149|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
128782150|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
128782151|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
128782152|NCT04672460|463494322|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
128782153|NCT04672460|463494323|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
128782154|NCT04672460|463494322|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
128782155|NCT04672460|463494323|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
128782156|NCT04672460|463494322|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
128782157|NCT04672460|463494323|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
128782158|NCT04672460|463494322|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
128782159|NCT04672460|463494323|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
128782160|NCT04672460|463494322|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
128782161|NCT04672460|463494323|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
128782162|NCT04672460|463494322|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
128782163|NCT04672460|463494323|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
128782164|NCT04672460|463494322|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
128782165|NCT04672460|463494323|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
128782166|NCT04672460|463494322|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
128782167|NCT04672460|463494323|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
128782168|NCT04672460|463494322|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
128782169|NCT04672460|463494323|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
128782170|NCT04672460|463494322|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
128782171|NCT04672460|463494323|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
128782172|NCT00049517|463494327|FG000|Induction|Disease progression|0|||
128782173|NCT00049517|463494328|FG001|Induction|Disease progression|0|||
128782174|NCT00049517|463494329|FG002|Induction|Disease progression|0|||
128782175|NCT00049517|463494330|FG003|Induction|Disease progression|0|||
128782176|NCT00049517|463494331|FG004|Induction|Disease progression|18|||
128782177|NCT00049517|463494332|FG005|Induction|Disease progression|11|||
128782178|NCT00049517|463494327|FG000|Induction|Adverse Event|0|||
128782179|NCT00049517|463494328|FG001|Induction|Adverse Event|0|||
128782180|NCT00049517|463494329|FG002|Induction|Adverse Event|0|||
128782181|NCT00049517|463494330|FG003|Induction|Adverse Event|0|||
128782182|NCT00049517|463494331|FG004|Induction|Adverse Event|5|||
128782183|NCT00049517|463494332|FG005|Induction|Adverse Event|7|||
128782184|NCT00049517|463494327|FG000|Induction|Death|0|||
128782185|NCT00049517|463494328|FG001|Induction|Death|0|||
128782186|NCT00049517|463494329|FG002|Induction|Death|0|||
128782187|NCT00049517|463494330|FG003|Induction|Death|0|||
128782188|NCT00049517|463494331|FG004|Induction|Death|9|||
128782189|NCT00049517|463494332|FG005|Induction|Death|6|||
128782190|NCT00049517|463494327|FG000|Induction|Withdrawal by Subject|0|||
128782191|NCT00049517|463494328|FG001|Induction|Withdrawal by Subject|0|||
128782192|NCT00049517|463494329|FG002|Induction|Withdrawal by Subject|0|||
128782193|NCT00049517|463494330|FG003|Induction|Withdrawal by Subject|0|||
128782194|NCT00049517|463494331|FG004|Induction|Withdrawal by Subject|1|||
128782195|NCT00049517|463494332|FG005|Induction|Withdrawal by Subject|3|||
128782196|NCT00049517|463494327|FG000|Induction|Alternative therapy|0|||
128782197|NCT00049517|463494328|FG001|Induction|Alternative therapy|0|||
128782198|NCT00049517|463494329|FG002|Induction|Alternative therapy|0|||
128782199|NCT00049517|463494330|FG003|Induction|Alternative therapy|0|||
128782200|NCT00049517|463494331|FG004|Induction|Alternative therapy|2|||
128782201|NCT00049517|463494332|FG005|Induction|Alternative therapy|2|||
128782202|NCT00049517|463494327|FG000|Induction|Other complicating disease|0|||
128782203|NCT00049517|463494328|FG001|Induction|Other complicating disease|0|||
128782204|NCT00049517|463494329|FG002|Induction|Other complicating disease|0|||
128782205|NCT00049517|463494330|FG003|Induction|Other complicating disease|0|||
128782206|NCT00049517|463494331|FG004|Induction|Other complicating disease|3|||
128782207|NCT00049517|463494332|FG005|Induction|Other complicating disease|0|||
128782208|NCT00049517|463494327|FG000|Induction|Reasons not reported|0|||
128782209|NCT00049517|463494328|FG001|Induction|Reasons not reported|0|||
128782210|NCT00049517|463494329|FG002|Induction|Reasons not reported|0|||
128782211|NCT00049517|463494330|FG003|Induction|Reasons not reported|0|||
128782212|NCT00049517|463494331|FG004|Induction|Reasons not reported|22|||
128782213|NCT00049517|463494332|FG005|Induction|Reasons not reported|25|||
128782214|NCT00049517|463494327|FG000|Conditioning/Transplant|Disease progression|14|||
128782215|NCT00049517|463494328|FG001|Conditioning/Transplant|Disease progression|6|||
128782216|NCT00049517|463494329|FG002|Conditioning/Transplant|Disease progression|10|||
128782217|NCT00049517|463494330|FG003|Conditioning/Transplant|Disease progression|6|||
128782218|NCT00049517|463494331|FG004|Conditioning/Transplant|Disease progression|0|||
128782219|NCT00049517|463494332|FG005|Conditioning/Transplant|Disease progression|0|||
128782220|NCT00049517|463494327|FG000|Conditioning/Transplant|Adverse Event|2|||
128782221|NCT00049517|463494328|FG001|Conditioning/Transplant|Adverse Event|1|||
128782222|NCT00049517|463494329|FG002|Conditioning/Transplant|Adverse Event|4|||
128782223|NCT00049517|463494330|FG003|Conditioning/Transplant|Adverse Event|8|||
128782224|NCT00049517|463494331|FG004|Conditioning/Transplant|Adverse Event|0|||
128782225|NCT00049517|463494332|FG005|Conditioning/Transplant|Adverse Event|0|||
128782226|NCT00049517|463494327|FG000|Conditioning/Transplant|Death|1|||
128782227|NCT00049517|463494328|FG001|Conditioning/Transplant|Death|0|||
128782228|NCT00049517|463494329|FG002|Conditioning/Transplant|Death|0|||
128782229|NCT00049517|463494330|FG003|Conditioning/Transplant|Death|2|||
128782230|NCT00049517|463494331|FG004|Conditioning/Transplant|Death|0|||
128782231|NCT00049517|463494332|FG005|Conditioning/Transplant|Death|0|||
128782232|NCT00049517|463494327|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
128782233|NCT00049517|463494328|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
128782234|NCT00049517|463494329|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
128782235|NCT00049517|463494330|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
128782236|NCT00049517|463494331|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
128782237|NCT00049517|463494332|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
128782238|NCT00049517|463494327|FG000|Conditioning/Transplant|Alternative therapy|4|||
128782239|NCT00049517|463494328|FG001|Conditioning/Transplant|Alternative therapy|4|||
128782240|NCT00049517|463494329|FG002|Conditioning/Transplant|Alternative therapy|2|||
128782241|NCT00049517|463494330|FG003|Conditioning/Transplant|Alternative therapy|1|||
128782242|NCT00049517|463494331|FG004|Conditioning/Transplant|Alternative therapy|1|||
128782243|NCT00049517|463494332|FG005|Conditioning/Transplant|Alternative therapy|0|||
128782244|NCT00049517|463494327|FG000|Conditioning/Transplant|Other complicating disease|2|||
128782245|NCT00049517|463494328|FG001|Conditioning/Transplant|Other complicating disease|0|||
128782246|NCT00049517|463494329|FG002|Conditioning/Transplant|Other complicating disease|0|||
128782247|NCT00049517|463494330|FG003|Conditioning/Transplant|Other complicating disease|4|||
128782248|NCT00049517|463494331|FG004|Conditioning/Transplant|Other complicating disease|0|||
129204256|NCT02349633|465045748|FG012|Overall Study|Termination by sponsor|0|||
129204257|NCT02349633|465045749|FG013|Overall Study|Termination by sponsor|0|||
129204258|NCT02349633|465045736|FG000|Overall Study|Other|0|||
129204259|NCT02349633|465045737|FG001|Overall Study|Other|0|||
129204260|NCT02349633|465045738|FG002|Overall Study|Other|0|||
129204261|NCT02349633|465045739|FG003|Overall Study|Other|0|||
129204262|NCT02349633|465045740|FG004|Overall Study|Other|0|||
129204263|NCT02349633|465045741|FG005|Overall Study|Other|0|||
129204264|NCT02349633|465045742|FG006|Overall Study|Other|0|||
129204265|NCT02349633|465045743|FG007|Overall Study|Other|2|||
129204266|NCT02349633|465045744|FG008|Overall Study|Other|0|||
129204267|NCT02349633|465045745|FG009|Overall Study|Other|0|||
129204268|NCT02349633|465045746|FG010|Overall Study|Other|0|||
129204269|NCT02349633|465045747|FG011|Overall Study|Other|0|||
129204270|NCT02349633|465045748|FG012|Overall Study|Other|0|||
129204271|NCT02349633|465045749|FG013|Overall Study|Other|0|||
129204272|NCT01453140|465045752|FG000|Overall Study|Adverse Event|3|||
129204273|NCT00743249|465045753|FG000|Overall Study|Adverse Event|0|||
129204274|NCT00743249|465045754|FG001|Overall Study|Adverse Event|4|||
129204275|NCT00743249|465045753|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
129204276|NCT00743249|465045754|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
129204277|NCT00743249|465045753|FG000|Overall Study|Unsuccessful insertion of stent|2|||
129204278|NCT00743249|465045754|FG001|Overall Study|Unsuccessful insertion of stent|1|||
129204279|NCT00423657|465045758|FG000|Overall Study|Withdrew consent|10|||
129204280|NCT00423657|465045759|FG001|Overall Study|Withdrew consent|8|||
129204281|NCT00423657|465045758|FG000|Overall Study|Non-compliance|0|||
129204282|NCT00423657|465045759|FG001|Overall Study|Non-compliance|1|||
129204283|NCT00423657|465045758|FG000|Overall Study|Other|15|||
129204284|NCT00423657|465045759|FG001|Overall Study|Other|16|||
129204285|NCT00423657|465045758|FG000|Overall Study|Request of sponsor/investigator|1|||
129204286|NCT00423657|465045759|FG001|Overall Study|Request of sponsor/investigator|0|||
129204287|NCT02653326|465045763|FG000|Overall Study|Lost to Follow-up|10|||
129204288|NCT02653326|465045764|FG001|Overall Study|Lost to Follow-up|7|||
129204289|NCT03206216|465045765|FG000|Overall Study|Withdrawal by Subject|0|||
128782249|NCT00049517|463494332|FG005|Conditioning/Transplant|Other complicating disease|1|||
128782250|NCT00049517|463494327|FG000|Conditioning/Transplant|Reasons not reported|25|||
128782251|NCT00049517|463494328|FG001|Conditioning/Transplant|Reasons not reported|31|||
128782252|NCT00049517|463494329|FG002|Conditioning/Transplant|Reasons not reported|18|||
128782253|NCT00049517|463494330|FG003|Conditioning/Transplant|Reasons not reported|15|||
128782254|NCT00049517|463494331|FG004|Conditioning/Transplant|Reasons not reported|5|||
128782255|NCT00049517|463494332|FG005|Conditioning/Transplant|Reasons not reported|5|||
128782256|NCT00498186|463494337|FG000|Overall Study|Protocol Violation|10|||
128782257|NCT00498186|463494337|FG000|Overall Study|Lack of Efficacy|31|||
128782258|NCT00498186|463494337|FG000|Overall Study|Adverse Event|89|||
128782259|NCT00498186|463494337|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
128782260|NCT00498186|463494337|FG000|Overall Study|Withdrawal by Subject|18|||
128782261|NCT00498186|463494337|FG000|Overall Study|Lost to Follow-up|3|||
128782262|NCT00498186|463494337|FG000|Overall Study|Other|10|||
128782263|NCT01123161|463494338|FG000|Overall Study|Lost to Follow-up|1|||
128782264|NCT01123161|463494339|FG001|Overall Study|Lost to Follow-up|0|||
128782265|NCT01123161|463494338|FG000|Overall Study|Withdrawal by Subject|1|||
128782266|NCT01123161|463494339|FG001|Overall Study|Withdrawal by Subject|0|||
128782267|NCT00886613|463494341|FG000|Overall Study|Protocol deviation (Part B)|1|||
128782268|NCT00886613|463494342|FG001|Overall Study|Protocol deviation (Part B)|0|||
128782269|NCT00886613|463494343|FG002|Overall Study|Protocol deviation (Part B)|0|||
128782270|NCT00886613|463494341|FG000|Overall Study|Lost to follow-up (Part B)|1|||
128782271|NCT00886613|463494342|FG001|Overall Study|Lost to follow-up (Part B)|0|||
128782272|NCT00886613|463494343|FG002|Overall Study|Lost to follow-up (Part B)|1|||
128782273|NCT00886613|463494341|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
128782274|NCT00886613|463494342|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
128782275|NCT00886613|463494343|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
128782276|NCT04541186|463494345|FG000|Main Study|Adverse Event|0|||
128782277|NCT04541186|463494346|FG001|Main Study|Adverse Event|0|||
128782278|NCT04541186|463494347|FG002|Main Study|Adverse Event|4|||
128782279|NCT04541186|463494348|FG003|Main Study|Adverse Event|0|||
128782280|NCT04541186|463494349|FG004|Main Study|Adverse Event|0|||
128782281|NCT04541186|463494345|FG000|Main Study|Investigator Decision|0|||
128782282|NCT04541186|463494346|FG001|Main Study|Investigator Decision|0|||
128782283|NCT04541186|463494347|FG002|Main Study|Investigator Decision|1|||
128782284|NCT04541186|463494348|FG003|Main Study|Investigator Decision|1|||
128782285|NCT04541186|463494349|FG004|Main Study|Investigator Decision|0|||
128782286|NCT04541186|463494345|FG000|Main Study|Withdrawal by Subject|1|||
128782287|NCT04541186|463494346|FG001|Main Study|Withdrawal by Subject|1|||
128782288|NCT04541186|463494347|FG002|Main Study|Withdrawal by Subject|0|||
128782289|NCT04541186|463494348|FG003|Main Study|Withdrawal by Subject|0|||
128782290|NCT04541186|463494349|FG004|Main Study|Withdrawal by Subject|0|||
128782291|NCT04541186|463494345|FG000|Main Study|COVID-19-related Dose Interruption|0|||
128782292|NCT04541186|463494346|FG001|Main Study|COVID-19-related Dose Interruption|0|||
128782293|NCT04541186|463494347|FG002|Main Study|COVID-19-related Dose Interruption|0|||
128782294|NCT04541186|463494348|FG003|Main Study|COVID-19-related Dose Interruption|0|||
128782295|NCT04541186|463494349|FG004|Main Study|COVID-19-related Dose Interruption|1|||
128782296|NCT04541186|463494345|FG000|Main Study|Randomized in Error Not Treated|0|||
128782297|NCT04541186|463494346|FG001|Main Study|Randomized in Error Not Treated|0|||
128782298|NCT04541186|463494347|FG002|Main Study|Randomized in Error Not Treated|1|||
128782299|NCT04541186|463494348|FG003|Main Study|Randomized in Error Not Treated|0|||
128782300|NCT04541186|463494349|FG004|Main Study|Randomized in Error Not Treated|0|||
128782301|NCT04541186|463494345|FG000|Fibrate Expansion Study|Other than Specified|0|||
128782302|NCT04541186|463494346|FG001|Fibrate Expansion Study|Other than Specified|0|||
128782303|NCT04541186|463494347|FG002|Fibrate Expansion Study|Other than Specified|0|||
128782304|NCT04541186|463494348|FG003|Fibrate Expansion Study|Other than Specified|0|||
128782305|NCT04541186|463494349|FG004|Fibrate Expansion Study|Other than Specified|1|||
128782306|NCT00691028|463494350|FG000|Open-label Period|Adverse Event|0|||
128782307|NCT00691028|463494351|FG001|Open-label Period|Adverse Event|0|||
128782308|NCT00691028|463494352|FG002|Open-label Period|Adverse Event|0|||
128782309|NCT00691028|463494353|FG003|Open-label Period|Adverse Event|16|||
128782310|NCT00691028|463494350|FG000|Open-label Period|Withdrawal by Subject|0|||
128782311|NCT00691028|463494351|FG001|Open-label Period|Withdrawal by Subject|0|||
128782312|NCT00691028|463494352|FG002|Open-label Period|Withdrawal by Subject|0|||
128782313|NCT00691028|463494353|FG003|Open-label Period|Withdrawal by Subject|3|||
128782314|NCT00691028|463494350|FG000|Open-label Period|not come to a hospital|0|||
128782315|NCT00691028|463494351|FG001|Open-label Period|not come to a hospital|0|||
128782316|NCT00691028|463494352|FG002|Open-label Period|not come to a hospital|0|||
128782317|NCT00691028|463494353|FG003|Open-label Period|not come to a hospital|1|||
128782318|NCT00691028|463494350|FG000|Double-blind Period|Adverse Event|8|||
128782319|NCT00691028|463494351|FG001|Double-blind Period|Adverse Event|9|||
128782320|NCT00691028|463494352|FG002|Double-blind Period|Adverse Event|6|||
128782321|NCT00691028|463494353|FG003|Double-blind Period|Adverse Event|0|||
128782322|NCT00691028|463494350|FG000|Double-blind Period|Lack of Efficacy|4|||
128782323|NCT00691028|463494351|FG001|Double-blind Period|Lack of Efficacy|3|||
128782324|NCT00691028|463494352|FG002|Double-blind Period|Lack of Efficacy|2|||
128782325|NCT00691028|463494353|FG003|Double-blind Period|Lack of Efficacy|0|||
128782326|NCT00691028|463494350|FG000|Double-blind Period|Withdrawal by Subject|1|||
128782327|NCT00691028|463494351|FG001|Double-blind Period|Withdrawal by Subject|0|||
128782328|NCT00691028|463494352|FG002|Double-blind Period|Withdrawal by Subject|1|||
128782329|NCT00691028|463494353|FG003|Double-blind Period|Withdrawal by Subject|0|||
128782330|NCT00691028|463494350|FG000|Double-blind Period|not come to a hospital.|0|||
128782331|NCT00691028|463494351|FG001|Double-blind Period|not come to a hospital.|1|||
128782332|NCT00691028|463494352|FG002|Double-blind Period|not come to a hospital.|0|||
128782333|NCT00691028|463494353|FG003|Double-blind Period|not come to a hospital.|0|||
128782334|NCT03255018|463494357|FG000|Overall Study|Death on study|0|||
128782335|NCT03255018|463494358|FG001|Overall Study|Death on study|5|||
128782336|NCT03255018|463494357|FG000|Overall Study|Withdrawal by Subject|0|||
128782337|NCT03255018|463494358|FG001|Overall Study|Withdrawal by Subject|2|||
128782338|NCT00748969|463494359|FG000|Overall Study|Withdrawal by Subject|1|||
128782339|NCT00748969|463494360|FG001|Overall Study|Withdrawal by Subject|0|||
128782340|NCT00748969|463494359|FG000|Overall Study|Withdrawal by Subject|0|||
128782341|NCT00748969|463494360|FG001|Overall Study|Withdrawal by Subject|1|||
128782342|NCT02334306|463494361|FG000|Double-blind Period|Adverse Event|0|||
128782343|NCT02334306|463494362|FG001|Double-blind Period|Adverse Event|1|||
128782344|NCT02334306|463494361|FG000|Double-blind Period|Withdrawal by Subject|1|||
128782345|NCT02334306|463494362|FG001|Double-blind Period|Withdrawal by Subject|1|||
128782346|NCT00465985|463494363|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
128782347|NCT00465985|463494364|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
128782348|NCT00465985|463494363|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
128782349|NCT00465985|463494364|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
128782350|NCT00465985|463494363|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
128782351|NCT00465985|463494364|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
128782352|NCT00465985|463494363|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
128782353|NCT00465985|463494364|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
128782354|NCT03532178|463494365|FG000|First Period|Withdrawal by Subject|1|||
128782355|NCT03532178|463494366|FG001|First Period|Withdrawal by Subject|3|||
128782356|NCT03532178|463494365|FG000|First Period|technical issues in data collection Technical issues|0|||
128782357|NCT03532178|463494366|FG001|First Period|technical issues in data collection Technical issues|1|||
128782358|NCT03532178|463494365|FG000|Second Period|Withdrawal by Subject|1|||
128782359|NCT03532178|463494366|FG001|Second Period|Withdrawal by Subject|1|||
128782360|NCT03532178|463494365|FG000|Second Period|Technical issues|0|||
128782361|NCT03532178|463494366|FG001|Second Period|Technical issues|1|||
128782362|NCT03302156|463494367|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
128782363|NCT03302156|463494368|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
128782364|NCT03302156|463494369|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
128782365|NCT02390557|463494370|FG000|Wave 2|Survey non-respondent|72|||
128782366|NCT02390557|463494371|FG001|Wave 2|Survey non-respondent|41|||
128782367|NCT02390557|463494372|FG002|Wave 2|Survey non-respondent|23|||
128782368|NCT03278028|463494376|FG000|Overall Study|Lost to Follow-up|1|||
128734823|NCT02742103|463321639|FG001|Overall Study|Adverse Event|0|||
128734824|NCT02742103|463321638|FG000|Overall Study|Moved to another town|0|||
128734825|NCT02742103|463321639|FG001|Overall Study|Moved to another town|1|||
128734826|NCT02742103|463321638|FG000|Overall Study|Withdrawal by Subject|5|||
128734827|NCT02742103|463321639|FG001|Overall Study|Withdrawal by Subject|2|||
128734828|NCT03042312|463321640|FG000|Overall Study|Administrative Reason|1|||
128734829|NCT03042312|463321641|FG001|Overall Study|Administrative Reason|1|||
128782369|NCT03278028|463494377|FG001|Overall Study|Lost to Follow-up|0|||
128782370|NCT03278028|463494376|FG000|Overall Study|Withdrawal by Subject|3|||
128782371|NCT03278028|463494377|FG001|Overall Study|Withdrawal by Subject|1|||
128734830|NCT03042312|463321640|FG000|Overall Study|Adverse Event|0|||
128782372|NCT03278028|463494376|FG000|Overall Study|Pregnancy|0|||
128734831|NCT03042312|463321641|FG001|Overall Study|Adverse Event|1|||
128734832|NCT03042312|463321640|FG000|Overall Study|Lost to Follow-up|1|||
128734833|NCT03042312|463321641|FG001|Overall Study|Lost to Follow-up|3|||
128782373|NCT03278028|463494377|FG001|Overall Study|Pregnancy|1|||
128782374|NCT01360840|463494378|FG000|Overall Study|Ongoing at data cut-off|10|||
128782375|NCT01360840|463494379|FG001|Overall Study|Ongoing at data cut-off|10|||
128782376|NCT01360840|463494380|FG002|Overall Study|Ongoing at data cut-off|9|||
128782377|NCT01813422|463494382|FG000|Overall Study|Withdrawal by Subject|14|||
128782378|NCT01813422|463494383|FG001|Overall Study|Withdrawal by Subject|8|||
128782379|NCT01813422|463494382|FG000|Overall Study|Death|2|||
128782380|NCT01813422|463494383|FG001|Overall Study|Death|3|||
128782381|NCT01813422|463494382|FG000|Overall Study|Sponsor Decision|2|||
128782382|NCT01813422|463494383|FG001|Overall Study|Sponsor Decision|1|||
128782383|NCT01813422|463494382|FG000|Overall Study|Lost to Follow-up|2|||
128782384|NCT01813422|463494383|FG001|Overall Study|Lost to Follow-up|4|||
128782385|NCT01653743|463494384|FG000|Overall Study|Withdrawal by Subject|1|||
128782386|NCT01653743|463494385|FG001|Overall Study|Withdrawal by Subject|0|||
128782387|NCT01653743|463494384|FG000|Overall Study|Investigator discretion|3|||
128782388|NCT01653743|463494385|FG001|Overall Study|Investigator discretion|0|||
128782389|NCT04889118|463494387|FG000|Overall Study|Death|33|||
128782390|NCT04889118|463494388|FG001|Overall Study|Death|37|||
128782391|NCT04889118|463494387|FG000|Overall Study|Ongoing in Study|31|||
128782392|NCT04889118|463494388|FG001|Overall Study|Ongoing in Study|30|||
128782393|NCT02820051|463494403|FG000|Overall Study|Lost to Follow-up|7|||
128782394|NCT02820051|463494404|FG001|Overall Study|Lost to Follow-up|4|||
128782395|NCT01222247|463494405|FG000|Overall Study|Lost to Follow-up|2|||
128782396|NCT01222247|463494406|FG001|Overall Study|Lost to Follow-up|2|||
128782397|NCT04939428|463494407|FG000|Overall Study|Death|0|||
128782398|NCT04939428|463494408|FG001|Overall Study|Death|1|||
128782399|NCT04939428|463494409|FG002|Overall Study|Death|0|||
128782400|NCT04939428|463494407|FG000|Overall Study|Lost to Follow-up|0|||
128782401|NCT04939428|463494408|FG001|Overall Study|Lost to Follow-up|5|||
128782402|NCT04939428|463494409|FG002|Overall Study|Lost to Follow-up|0|||
128782403|NCT04939428|463494407|FG000|Overall Study|Physician Decision|1|||
128782404|NCT04939428|463494408|FG001|Overall Study|Physician Decision|0|||
128782405|NCT04939428|463494409|FG002|Overall Study|Physician Decision|0|||
128782406|NCT04939428|463494407|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
128782407|NCT04939428|463494408|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128782408|NCT04939428|463494409|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128782409|NCT04939428|463494407|FG000|Overall Study|Withdrawal by Subject|10|||
128782410|NCT04939428|463494408|FG001|Overall Study|Withdrawal by Subject|11|||
128782411|NCT04939428|463494409|FG002|Overall Study|Withdrawal by Subject|0|||
128782412|NCT04939428|463494407|FG000|Overall Study|Unkown|6|||
128782413|NCT04939428|463494408|FG001|Overall Study|Unkown|3|||
128782414|NCT04939428|463494409|FG002|Overall Study|Unkown|0|||
128782415|NCT04939428|463494407|FG000|Overall Study|Discotinued per protocol|0|||
128782416|NCT04939428|463494408|FG001|Overall Study|Discotinued per protocol|0|||
128782417|NCT04939428|463494409|FG002|Overall Study|Discotinued per protocol|902|||
128782418|NCT04956692|463494412|FG000|Overall Study|Death|115|||
128782419|NCT04956692|463494413|FG001|Overall Study|Death|47|||
128782420|NCT04956692|463494412|FG000|Overall Study|Lost to Follow-up|0|||
128782421|NCT04956692|463494413|FG001|Overall Study|Lost to Follow-up|1|||
128782422|NCT04956692|463494412|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
128782423|NCT04956692|463494413|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128782424|NCT04956692|463494412|FG000|Overall Study|Withdrawal by Subject|5|||
128782425|NCT04956692|463494413|FG001|Overall Study|Withdrawal by Subject|2|||
128782426|NCT04956692|463494412|FG000|Overall Study|Ongoing in Study|236|||
128782427|NCT04956692|463494413|FG001|Overall Study|Ongoing in Study|123|||
128782428|NCT04639947|463494414|FG000|Overall Study|Screen fail|1|||
128782429|NCT04863898|463494417|FG000|Overall Study|Away from study clinic during intervention training period|2|||
129204290|NCT03206216|465045766|FG001|Overall Study|Withdrawal by Subject|1|||
129204291|NCT05767021|465045769|FG000|Overall Study|Adverse Event|2|||
129204292|NCT05767021|465045769|FG000|Overall Study|Protocol Deviation|1|||
129204293|NCT05767021|465045769|FG000|Overall Study|Withdrawal by Subject|1|||
129204294|NCT05767021|465045769|FG000|Overall Study|Physician Decision|1|||
129204295|NCT05767021|465045769|FG000|Overall Study|Lack of Efficacy|11|||
129204296|NCT05767021|465045769|FG000|Overall Study|Assigned Treatment by Mistake|1|||
129204297|NCT04154943|465045773|FG000|Overall Study|Study Ongoing|68|||
129204298|NCT04154943|465045773|FG000|Overall Study|Lost to Follow-up|1|||
128782430|NCT04863898|463494417|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
128782431|NCT04863898|463494417|FG000|Overall Study|Lost to Follow-up|3|||
128782432|NCT04863898|463494417|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
128782433|NCT04863898|463494417|FG000|Overall Study|No longer employed at clinic|3|||
128782434|NCT00614744|463494418|FG000|Overall Study|Lost to Follow-up|5|||
128782435|NCT00614744|463494419|FG001|Overall Study|Lost to Follow-up|4|||
128782436|NCT00614744|463494418|FG000|Overall Study|Incomplete for Behavior Issues|0|||
128782437|NCT00614744|463494419|FG001|Overall Study|Incomplete for Behavior Issues|2|||
128782438|NCT00877851|463494420|FG000|Overall Study|Lost to Follow-up|5|||
128782439|NCT00877851|463494421|FG001|Overall Study|Lost to Follow-up|5|||
128782440|NCT00877851|463494420|FG000|Overall Study|computer problem|3|||
128782441|NCT00877851|463494421|FG001|Overall Study|computer problem|0|||
128782442|NCT00877851|463494420|FG000|Overall Study|no longer interested in participating|1|||
128782443|NCT00877851|463494421|FG001|Overall Study|no longer interested in participating|0|||
128782444|NCT00770211|463494429|FG000|Overall Study|Lost to Follow-up|1|||
128782445|NCT00770211|463494430|FG001|Overall Study|Lost to Follow-up|0|||
128782446|NCT00770211|463494429|FG000|Overall Study|Withdrawal by Subject|0|||
128782447|NCT00770211|463494430|FG001|Overall Study|Withdrawal by Subject|2|||
128782448|NCT03005288|463494434|FG000|Overall Study|Withdrawal by Subject|7|||
128782449|NCT03005288|463494435|FG001|Overall Study|Withdrawal by Subject|5|||
128782450|NCT03005288|463494434|FG000|Overall Study|Lost to Follow-up|0|||
128782451|NCT03005288|463494435|FG001|Overall Study|Lost to Follow-up|1|||
128782452|NCT03005288|463494434|FG000|Overall Study|Adverse Event|5|||
128782453|NCT03005288|463494435|FG001|Overall Study|Adverse Event|0|||
128782454|NCT03005288|463494434|FG000|Overall Study|Protocol deviation|0|||
128782455|NCT03005288|463494435|FG001|Overall Study|Protocol deviation|1|||
128782456|NCT03005288|463494434|FG000|Overall Study|Physician Decision|0|||
128782457|NCT03005288|463494435|FG001|Overall Study|Physician Decision|1|||
128782458|NCT03824236|463494436|FG000|Overall Study|Lost to Follow-up|0|||
128782459|NCT03824236|463494437|FG001|Overall Study|Lost to Follow-up|0|||
128782460|NCT03824236|463494438|FG002|Overall Study|Lost to Follow-up|1|||
128782461|NCT00701311|463494439|FG000|Overall Study|Lack of Efficacy|3|||
128782462|NCT00701311|463494439|FG000|Overall Study|Adverse Event|3|||
128782463|NCT00701311|463494439|FG000|Overall Study|Withdrawal by Subject|2|||
128782464|NCT00670540|463494440|FG000|Overall Study|ineligible|17|||
128782465|NCT00670540|463494440|FG000|Overall Study|not living in France|348|||
128782466|NCT00670540|463494440|FG000|Overall Study|refused to participate|189|||
128782467|NCT00670540|463494440|FG000|Overall Study|controls randomised for no follow up|2770|||
128782468|NCT00670540|463494440|FG000|Overall Study|missing information inclusion criteria|1|||
128782469|NCT01140347|463494441|FG000|Overall Study|Lost to Follow-up|5|||
128782470|NCT01140347|463494442|FG001|Overall Study|Lost to Follow-up|6|||
128782471|NCT01140347|463494441|FG000|Overall Study|Withdrawal by Subject|13|||
128782472|NCT01140347|463494442|FG001|Overall Study|Withdrawal by Subject|8|||
128782473|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Adverse Event|5|||
128782474|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Adverse Event|13|||
128782475|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Adverse Event|0|||
128782476|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
128782477|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
128782478|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
128782479|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
128782480|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
128782481|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
128782482|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
128782483|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
128782484|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
128782485|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
128782486|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
128782487|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
128782488|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
128782489|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
128734834|NCT03042312|463321640|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
128734835|NCT03042312|463321641|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
128734836|NCT03042312|463321640|FG000|Overall Study|Withdrawal by Subject|4|||
128734837|NCT03042312|463321641|FG001|Overall Study|Withdrawal by Subject|5|||
128734838|NCT00646958|463321644|FG000|Overall Study|Lack of Efficacy|1|||
128734839|NCT00646958|463321645|FG001|Overall Study|Lack of Efficacy|0|||
128734840|NCT00646958|463321646|FG002|Overall Study|Lack of Efficacy|0|||
128734841|NCT00646958|463321644|FG000|Overall Study|Adverse Event|4|||
128734842|NCT00646958|463321645|FG001|Overall Study|Adverse Event|0|||
128734843|NCT00646958|463321646|FG002|Overall Study|Adverse Event|0|||
128734844|NCT00646958|463321644|FG000|Overall Study|Lost to Follow-up|1|||
128734845|NCT00646958|463321645|FG001|Overall Study|Lost to Follow-up|5|||
128734846|NCT00646958|463321646|FG002|Overall Study|Lost to Follow-up|7|||
128734847|NCT00646958|463321644|FG000|Overall Study|Protocol Violation|1|||
128734848|NCT00646958|463321645|FG001|Overall Study|Protocol Violation|1|||
128734849|NCT00646958|463321646|FG002|Overall Study|Protocol Violation|0|||
128734850|NCT00646958|463321644|FG000|Overall Study|Abnormal screening lab tests|1|||
128734851|NCT00646958|463321645|FG001|Overall Study|Abnormal screening lab tests|1|||
128734852|NCT00646958|463321646|FG002|Overall Study|Abnormal screening lab tests|0|||
128734853|NCT00646958|463321644|FG000|Overall Study|Withdrawal by Subject|1|||
128734854|NCT00646958|463321645|FG001|Overall Study|Withdrawal by Subject|2|||
128734855|NCT00646958|463321646|FG002|Overall Study|Withdrawal by Subject|0|||
128734856|NCT00646958|463321644|FG000|Overall Study|Did not receive study drug|2|||
128734857|NCT00646958|463321645|FG001|Overall Study|Did not receive study drug|0|||
128734858|NCT00646958|463321646|FG002|Overall Study|Did not receive study drug|2|||
128734859|NCT02573324|463321648|FG000|Overall Study|Withdrawal by Subject|26|||
128734860|NCT02573324|463321649|FG001|Overall Study|Withdrawal by Subject|23|||
128734861|NCT02573324|463321650|FG002|Overall Study|Withdrawal by Subject|3|||
128734862|NCT02573324|463321648|FG000|Overall Study|Lost to Follow-up|4|||
128734863|NCT02573324|463321649|FG001|Overall Study|Lost to Follow-up|5|||
128734864|NCT02573324|463321650|FG002|Overall Study|Lost to Follow-up|0|||
128734865|NCT02573324|463321648|FG000|Overall Study|Study Terminated by Sponsor|107|||
128734866|NCT02573324|463321649|FG001|Overall Study|Study Terminated by Sponsor|89|||
128734867|NCT02573324|463321650|FG002|Overall Study|Study Terminated by Sponsor|2|||
128734868|NCT02573324|463321648|FG000|Overall Study|Death|182|||
128782490|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
128734869|NCT02573324|463321649|FG001|Overall Study|Death|200|||
128734870|NCT02573324|463321650|FG002|Overall Study|Death|1|||
128734871|NCT02573324|463321648|FG000|Overall Study|Other, Not Specified|20|||
128734872|NCT02573324|463321649|FG001|Overall Study|Other, Not Specified|27|||
128734873|NCT02573324|463321650|FG002|Overall Study|Other, Not Specified|0|||
128734874|NCT02573324|463321648|FG000|Overall Study|Unknown Reason|2|||
128734875|NCT02573324|463321649|FG001|Overall Study|Unknown Reason|0|||
128782491|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Physician Decision|2|||
128782492|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Physician Decision|3|||
128782493|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Physician Decision|0|||
128734876|NCT02573324|463321650|FG002|Overall Study|Unknown Reason|0|||
128734877|NCT01105533|463321651|FG000|Overall Study|Death|0|||
128734878|NCT01105533|463321652|FG001|Overall Study|Death|0|||
128734879|NCT01105533|463321653|FG002|Overall Study|Death|0|||
128734880|NCT01105533|463321654|FG003|Overall Study|Death|0|||
128734881|NCT01105533|463321655|FG004|Overall Study|Death|1|||
128734882|NCT01105533|463321656|FG005|Overall Study|Death|0|||
128734883|NCT01105533|463321657|FG006|Overall Study|Death|0|||
128734884|NCT01105533|463321658|FG007|Overall Study|Death|0|||
128734885|NCT01105533|463321659|FG008|Overall Study|Death|0|||
128734886|NCT01105533|463321651|FG000|Overall Study|Lack of Efficacy|1|||
128734887|NCT01105533|463321652|FG001|Overall Study|Lack of Efficacy|1|||
128734888|NCT01105533|463321653|FG002|Overall Study|Lack of Efficacy|3|||
128734889|NCT01105533|463321654|FG003|Overall Study|Lack of Efficacy|3|||
128734890|NCT01105533|463321655|FG004|Overall Study|Lack of Efficacy|4|||
128734891|NCT01105533|463321656|FG005|Overall Study|Lack of Efficacy|5|||
128734892|NCT01105533|463321657|FG006|Overall Study|Lack of Efficacy|3|||
128734893|NCT01105533|463321658|FG007|Overall Study|Lack of Efficacy|2|||
128782494|NCT01449929|463494443|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
128782495|NCT01449929|463494444|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
128782496|NCT01449929|463494445|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
128782497|NCT01449929|463494443|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
128782498|NCT01449929|463494444|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
128782499|NCT01449929|463494445|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
128782500|NCT01449929|463494443|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
128782501|NCT01449929|463494444|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
128782502|NCT01449929|463494445|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
128782503|NCT01449929|463494443|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
128782504|NCT01449929|463494444|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
128782505|NCT01449929|463494445|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
128782506|NCT01871285|463494446|FG000|First Intervention (1 Day)|Adverse Event|1|||
128782507|NCT01871285|463494447|FG001|First Intervention (1 Day)|Adverse Event|0|||
128782508|NCT01871285|463494448|FG002|First Intervention (1 Day)|Adverse Event|0|||
128782509|NCT01871285|463494449|FG003|First Intervention (1 Day)|Adverse Event|0|||
128782510|NCT01871285|463494446|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
128782511|NCT01871285|463494447|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
128782512|NCT01871285|463494448|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
128782513|NCT01871285|463494449|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
128782514|NCT03253653|463494450|FG000|Overall Study|Withdrawal by Subject|4|||
128782515|NCT03253653|463494451|FG001|Overall Study|Withdrawal by Subject|1|||
128782516|NCT03253653|463494450|FG000|Overall Study|Protocol Violation|0|||
128782517|NCT03253653|463494451|FG001|Overall Study|Protocol Violation|5|||
128782518|NCT01211665|463496035|FG000|Overall Study|Withdrawal by Subject|1|||
128782519|NCT01211665|463496036|FG001|Overall Study|Withdrawal by Subject|0|||
128782520|NCT01211665|463496035|FG000|Overall Study|Death|1|||
128782521|NCT01211665|463496036|FG001|Overall Study|Death|0|||
128782522|NCT03681691|463496041|FG000|Overall Study|COVID|1|||
128782523|NCT03681691|463496042|FG001|Overall Study|COVID|0|||
128782524|NCT03681691|463496041|FG000|Overall Study|prolonged bleeding|1|||
128782525|NCT03681691|463496042|FG001|Overall Study|prolonged bleeding|0|||
128782526|NCT03681691|463496041|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
128782527|NCT03681691|463496042|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
128782528|NCT01582243|463496043|FG000|Overall Study|Withdrawal by Subject|1|||
128782529|NCT01582243|463496043|FG000|Overall Study|Adverse Event|1|||
128782530|NCT01582243|463496043|FG000|Overall Study|Lost to Follow-up|1|||
128782531|NCT01928940|463496046|FG000|Overall Study|Adverse Event|0|||
128782532|NCT01928940|463496047|FG001|Overall Study|Adverse Event|1|||
128782533|NCT02954055|463496048|FG000|Overall Study|Did not initiate therapy|6|||
128782534|NCT02954055|463496049|FG001|Overall Study|Did not initiate therapy|1|||
128782535|NCT01119703|463496052|FG000|Overall Study|Adverse Event|0|||
128782536|NCT01119703|463496053|FG001|Overall Study|Adverse Event|1|||
128782537|NCT03178201|463496054|FG000|Overall Study|Off study|5|||
128782538|NCT01763047|463496055|FG000|Period 1|Test Article Not Available|4|||
128782539|NCT01763047|463496056|FG001|Period 1|Test Article Not Available|1|||
128782540|NCT01763047|463496055|FG000|Period 1|Protocol Violation|4|||
128782541|NCT01763047|463496056|FG001|Period 1|Protocol Violation|4|||
128782542|NCT01763047|463496055|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
128782543|NCT01763047|463496056|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
128782544|NCT01763047|463496055|FG000|Period 1|Adverse Event|0|||
128782545|NCT01763047|463496056|FG001|Period 1|Adverse Event|1|||
128782546|NCT01763047|463496055|FG000|Period 1|Unsatisfactory Visual Response|0|||
128734894|NCT01105533|463321659|FG008|Overall Study|Lack of Efficacy|9|||
128734895|NCT01105533|463321651|FG000|Overall Study|Adverse Event|0|||
128734896|NCT01105533|463321652|FG001|Overall Study|Adverse Event|0|||
128734897|NCT01105533|463321653|FG002|Overall Study|Adverse Event|0|||
128734898|NCT01105533|463321654|FG003|Overall Study|Adverse Event|0|||
128734899|NCT01105533|463321655|FG004|Overall Study|Adverse Event|1|||
128734900|NCT01105533|463321656|FG005|Overall Study|Adverse Event|2|||
128734901|NCT01105533|463321657|FG006|Overall Study|Adverse Event|2|||
128734902|NCT01105533|463321658|FG007|Overall Study|Adverse Event|0|||
128734903|NCT01105533|463321659|FG008|Overall Study|Adverse Event|1|||
128734904|NCT01105533|463321651|FG000|Overall Study|Other|0|||
128734905|NCT01105533|463321652|FG001|Overall Study|Other|0|||
128734906|NCT01105533|463321653|FG002|Overall Study|Other|0|||
128734907|NCT01105533|463321654|FG003|Overall Study|Other|0|||
128734908|NCT01105533|463321655|FG004|Overall Study|Other|1|||
128734909|NCT01105533|463321656|FG005|Overall Study|Other|0|||
128734910|NCT01105533|463321657|FG006|Overall Study|Other|3|||
128734911|NCT01105533|463321658|FG007|Overall Study|Other|1|||
128734912|NCT01105533|463321659|FG008|Overall Study|Other|2|||
128734913|NCT01105533|463321651|FG000|Overall Study|Physician Decision|0|||
128734914|NCT01105533|463321652|FG001|Overall Study|Physician Decision|0|||
128734915|NCT01105533|463321653|FG002|Overall Study|Physician Decision|0|||
128734916|NCT01105533|463321654|FG003|Overall Study|Physician Decision|0|||
128782547|NCT01763047|463496056|FG001|Period 1|Unsatisfactory Visual Response|3|||
128734917|NCT01105533|463321655|FG004|Overall Study|Physician Decision|0|||
128734918|NCT01105533|463321656|FG005|Overall Study|Physician Decision|0|||
128734919|NCT01105533|463321657|FG006|Overall Study|Physician Decision|0|||
128734920|NCT01105533|463321658|FG007|Overall Study|Physician Decision|1|||
128734921|NCT01105533|463321659|FG008|Overall Study|Physician Decision|0|||
128734922|NCT02096835|463321661|FG000|Overall Study|Withdrawal by Subject|1|||
128734923|NCT02096835|463321662|FG001|Overall Study|Withdrawal by Subject|0|||
128734924|NCT02096835|463321663|FG002|Overall Study|Withdrawal by Subject|0|||
128734925|NCT02096835|463321661|FG000|Overall Study|converted to open procedures|1|||
128734926|NCT02096835|463321662|FG001|Overall Study|converted to open procedures|0|||
128734927|NCT02096835|463321663|FG002|Overall Study|converted to open procedures|0|||
128734928|NCT02096835|463321661|FG000|Overall Study|Lost to Follow-up|1|||
128734929|NCT02096835|463321662|FG001|Overall Study|Lost to Follow-up|0|||
128734930|NCT02096835|463321663|FG002|Overall Study|Lost to Follow-up|1|||
128734931|NCT03892889|463321664|FG000|Overall Study|Adverse Event|17|||
128734932|NCT03892889|463321664|FG000|Overall Study|Lack of Efficacy|1|||
128734933|NCT03892889|463321664|FG000|Overall Study|Lost to Follow-up|46|||
128734934|NCT03892889|463321664|FG000|Overall Study|Non-compliance with study drug|22|||
128734935|NCT03892889|463321664|FG000|Overall Study|Pregnancy|1|||
128734936|NCT03892889|463321664|FG000|Overall Study|Protocol Deviation|3|||
128734937|NCT03892889|463321664|FG000|Overall Study|Withdrawal by Subject|50|||
128734938|NCT03892889|463321664|FG000|Overall Study|Withdrawal by Caregiver|1|||
128782548|NCT01763047|463496055|FG000|Period 1|Lens Power Not Available|0|||
128734939|NCT03892889|463321664|FG000|Overall Study|Study Terminated by Sponsor|50|||
128734940|NCT03892889|463321664|FG000|Overall Study|Physician Decision|8|||
128734941|NCT03892889|463321664|FG000|Overall Study|Reason not Specified|5|||
128734942|NCT04260191|463321665|FG000|Overall Study|Decision by Sponsor|0|||
128734943|NCT04260191|463321666|FG001|Overall Study|Decision by Sponsor|1|||
128734944|NCT04260191|463321667|FG002|Overall Study|Decision by Sponsor|0|||
128734945|NCT04260191|463321665|FG000|Overall Study|Withdrawal by Subject|1|||
128734946|NCT04260191|463321666|FG001|Overall Study|Withdrawal by Subject|0|||
128734947|NCT04260191|463321667|FG002|Overall Study|Withdrawal by Subject|3|||
128734948|NCT04260191|463321665|FG000|Overall Study|Death|4|||
128734949|NCT04260191|463321666|FG001|Overall Study|Death|3|||
128734950|NCT04260191|463321667|FG002|Overall Study|Death|2|||
128734951|NCT00023673|463321670|FG000|Overall Study|Ineligible / no protocol treatment|0|||
128734952|NCT00023673|463321671|FG001|Overall Study|Ineligible / no protocol treatment|0|||
128734953|NCT00023673|463321672|FG002|Overall Study|Ineligible / no protocol treatment|0|||
128734954|NCT00023673|463321673|FG003|Overall Study|Ineligible / no protocol treatment|1|||
128734955|NCT00023673|463321670|FG000|Overall Study|Patient withdrew consent|0|||
128734956|NCT00023673|463321671|FG001|Overall Study|Patient withdrew consent|0|||
128734957|NCT00023673|463321672|FG002|Overall Study|Patient withdrew consent|0|||
128734958|NCT00023673|463321673|FG003|Overall Study|Patient withdrew consent|1|||
128734959|NCT02453594|463321674|FG000|Overall Study|Protocol Violation|0|||
128734960|NCT02453594|463321675|FG001|Overall Study|Protocol Violation|0|||
128734961|NCT02453594|463321676|FG002|Overall Study|Protocol Violation|1|||
128734962|NCT02453594|463321674|FG000|Overall Study|Cohort Was Closed|17|||
128734963|NCT02453594|463321675|FG001|Overall Study|Cohort Was Closed|21|||
128734964|NCT02453594|463321676|FG002|Overall Study|Cohort Was Closed|14|||
128734965|NCT02453594|463321674|FG000|Overall Study|Death|20|||
128734966|NCT02453594|463321675|FG001|Overall Study|Death|24|||
128734967|NCT02453594|463321676|FG002|Overall Study|Death|16|||
128734968|NCT02453594|463321674|FG000|Overall Study|Lost to Follow-up|6|||
128734969|NCT02453594|463321675|FG001|Overall Study|Lost to Follow-up|14|||
128734970|NCT02453594|463321676|FG002|Overall Study|Lost to Follow-up|2|||
128734971|NCT02453594|463321674|FG000|Overall Study|Physician Decision|2|||
128734972|NCT02453594|463321675|FG001|Overall Study|Physician Decision|4|||
128734973|NCT02453594|463321676|FG002|Overall Study|Physician Decision|0|||
128734974|NCT02453594|463321674|FG000|Overall Study|Site Terminated by Sponsor|1|||
128734975|NCT02453594|463321675|FG001|Overall Study|Site Terminated by Sponsor|0|||
128734976|NCT02453594|463321676|FG002|Overall Study|Site Terminated by Sponsor|1|||
128734977|NCT02453594|463321674|FG000|Overall Study|Transitioned to Extension Study|16|||
128734978|NCT02453594|463321675|FG001|Overall Study|Transitioned to Extension Study|9|||
128734979|NCT02453594|463321676|FG002|Overall Study|Transitioned to Extension Study|16|||
128734980|NCT02453594|463321674|FG000|Overall Study|Withdrawal by Subject|7|||
128734981|NCT02453594|463321675|FG001|Overall Study|Withdrawal by Subject|9|||
128734982|NCT02453594|463321676|FG002|Overall Study|Withdrawal by Subject|11|||
128734983|NCT02086591|463321677|FG000|Overall Study|Adverse Event|1|||
128734984|NCT02086591|463321677|FG000|Overall Study|Withdrawal by Subject|1|||
128734985|NCT02086591|463321677|FG000|Overall Study|protocol terminated|3|||
128734986|NCT02660359|463321682|FG000|Overall Study|Protocol Deviation|0|||
128734987|NCT02660359|463321683|FG001|Overall Study|Protocol Deviation|0|||
128734988|NCT02660359|463321684|FG002|Overall Study|Protocol Deviation|1|||
128734989|NCT02660359|463321682|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
128734990|NCT02660359|463321683|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
128734991|NCT02660359|463321684|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
128734992|NCT02660359|463321682|FG000|Overall Study|Lack of Efficacy|1|||
128734993|NCT02660359|463321683|FG001|Overall Study|Lack of Efficacy|1|||
128734994|NCT02660359|463321684|FG002|Overall Study|Lack of Efficacy|1|||
128734995|NCT02660359|463321682|FG000|Overall Study|Adverse Event|0|||
128734996|NCT02660359|463321683|FG001|Overall Study|Adverse Event|1|||
128734997|NCT02660359|463321684|FG002|Overall Study|Adverse Event|0|||
128734998|NCT02660359|463321682|FG000|Overall Study|Other|2|||
128734999|NCT02660359|463321683|FG001|Overall Study|Other|1|||
128735000|NCT02660359|463321684|FG002|Overall Study|Other|3|||
128735001|NCT02660359|463321682|FG000|Overall Study|Withdrawal by Subject|7|||
128735002|NCT02660359|463321683|FG001|Overall Study|Withdrawal by Subject|5|||
128735003|NCT02660359|463321684|FG002|Overall Study|Withdrawal by Subject|8|||
128735004|NCT02660359|463321682|FG000|Overall Study|Lost to Follow-up|3|||
128735005|NCT02660359|463321683|FG001|Overall Study|Lost to Follow-up|3|||
128735006|NCT02660359|463321684|FG002|Overall Study|Lost to Follow-up|0|||
128735007|NCT04101526|463321688|FG000|Overall Study|Did not complete all sleep diary entries|0|||
128735008|NCT04101526|463321689|FG001|Overall Study|Did not complete all sleep diary entries|1|||
128735009|NCT00424372|463321690|FG000|Overall Study|Death|1|||
128735010|NCT00424372|463321690|FG000|Overall Study|Adverse Event|18|||
128735011|NCT00424372|463321690|FG000|Overall Study|Lack of Efficacy|6|||
128735012|NCT00424372|463321690|FG000|Overall Study|Withdrawal by Subject|4|||
128735013|NCT00424372|463321690|FG000|Overall Study|Protocol Violation|1|||
128735014|NCT00424372|463321690|FG000|Overall Study|Health deterioration|1|||
128782549|NCT01763047|463496056|FG001|Period 1|Lens Power Not Available|1|||
128782550|NCT01763047|463496055|FG000|Period 1|Study Site office Closed|0|||
128782551|NCT01763047|463496056|FG001|Period 1|Study Site office Closed|1|||
128782552|NCT01763047|463496055|FG000|Period 2|Lens Discomfort|1|||
128782553|NCT01763047|463496056|FG001|Period 2|Lens Discomfort|0|||
128782554|NCT01763047|463496055|FG000|Period 2|No longer meets Eligibility Criteria|1|||
128782555|NCT01763047|463496056|FG001|Period 2|No longer meets Eligibility Criteria|0|||
128782556|NCT01763047|463496055|FG000|Period 2|Study Site office Closed|1|||
128782557|NCT01763047|463496056|FG001|Period 2|Study Site office Closed|1|||
128782558|NCT01763047|463496055|FG000|Period 2|Unsatisfactory Visual Response|1|||
128782559|NCT01763047|463496056|FG001|Period 2|Unsatisfactory Visual Response|1|||
128782560|NCT01763047|463496055|FG000|Period 2|Protocol Violation|0|||
128782561|NCT01763047|463496056|FG001|Period 2|Protocol Violation|2|||
128782562|NCT01763047|463496055|FG000|Period 2|Unsatisfactory lens Fitting|0|||
128782563|NCT01763047|463496056|FG001|Period 2|Unsatisfactory lens Fitting|1|||
128782564|NCT02282527|463496060|FG000|Overall Study|Lost to Follow-up|0|||
128782565|NCT02282527|463496061|FG001|Overall Study|Lost to Follow-up|1|||
128782566|NCT02282527|463496060|FG000|Overall Study|Lack of home health aid|1|||
128782567|NCT02282527|463496061|FG001|Overall Study|Lack of home health aid|0|||
128782568|NCT00941031|463496062|FG000|Induction Period|Lack of Efficacy|2|||
128782569|NCT00941031|463496063|FG001|Induction Period|Lack of Efficacy|1|||
128782570|NCT00941031|463496064|FG002|Induction Period|Lack of Efficacy|0|||
128782571|NCT00941031|463496065|FG003|Induction Period|Lack of Efficacy|5|||
128782572|NCT00941031|463496066|FG004|Induction Period|Lack of Efficacy|0|||
128782573|NCT00941031|463496067|FG005|Induction Period|Lack of Efficacy|0|||
128782574|NCT00941031|463496068|FG006|Induction Period|Lack of Efficacy|0|||
128782575|NCT00941031|463496062|FG000|Induction Period|Withdrawal by Subject|1|||
128782576|NCT00941031|463496063|FG001|Induction Period|Withdrawal by Subject|2|||
128782577|NCT00941031|463496064|FG002|Induction Period|Withdrawal by Subject|2|||
128782578|NCT00941031|463496065|FG003|Induction Period|Withdrawal by Subject|2|||
128782579|NCT00941031|463496066|FG004|Induction Period|Withdrawal by Subject|0|||
128782580|NCT00941031|463496067|FG005|Induction Period|Withdrawal by Subject|0|||
128782581|NCT00941031|463496068|FG006|Induction Period|Withdrawal by Subject|0|||
128782582|NCT00941031|463496062|FG000|Induction Period|Adminstative Problems|1|||
128782583|NCT00941031|463496063|FG001|Induction Period|Adminstative Problems|1|||
128782584|NCT00941031|463496064|FG002|Induction Period|Adminstative Problems|1|||
128782585|NCT00941031|463496065|FG003|Induction Period|Adminstative Problems|0|||
128782586|NCT00941031|463496066|FG004|Induction Period|Adminstative Problems|0|||
128782587|NCT00941031|463496067|FG005|Induction Period|Adminstative Problems|0|||
128782588|NCT00941031|463496068|FG006|Induction Period|Adminstative Problems|0|||
128782589|NCT00941031|463496062|FG000|Induction Period|Adverse Event|1|||
128782590|NCT00941031|463496063|FG001|Induction Period|Adverse Event|0|||
128782591|NCT00941031|463496064|FG002|Induction Period|Adverse Event|3|||
128782592|NCT00941031|463496065|FG003|Induction Period|Adverse Event|2|||
128782593|NCT00941031|463496066|FG004|Induction Period|Adverse Event|0|||
128782594|NCT00941031|463496067|FG005|Induction Period|Adverse Event|0|||
128782595|NCT00941031|463496068|FG006|Induction Period|Adverse Event|0|||
128782596|NCT00941031|463496062|FG000|Maintenance Period|Withdrawal by Subject|0|||
128782597|NCT00941031|463496063|FG001|Maintenance Period|Withdrawal by Subject|0|||
128782598|NCT00941031|463496064|FG002|Maintenance Period|Withdrawal by Subject|0|||
128782599|NCT00941031|463496065|FG003|Maintenance Period|Withdrawal by Subject|0|||
128782600|NCT00941031|463496066|FG004|Maintenance Period|Withdrawal by Subject|6|||
128782601|NCT00941031|463496067|FG005|Maintenance Period|Withdrawal by Subject|2|||
128782602|NCT00941031|463496068|FG006|Maintenance Period|Withdrawal by Subject|13|||
128782603|NCT00941031|463496062|FG000|Maintenance Period|Administrative Problems|0|||
128782604|NCT00941031|463496063|FG001|Maintenance Period|Administrative Problems|0|||
128782605|NCT00941031|463496064|FG002|Maintenance Period|Administrative Problems|0|||
128782606|NCT00941031|463496065|FG003|Maintenance Period|Administrative Problems|0|||
128782607|NCT00941031|463496066|FG004|Maintenance Period|Administrative Problems|1|||
128782608|NCT00941031|463496067|FG005|Maintenance Period|Administrative Problems|0|||
128782609|NCT00941031|463496068|FG006|Maintenance Period|Administrative Problems|1|||
128782610|NCT00941031|463496062|FG000|Maintenance Period|Protocol Violation|0|||
128782611|NCT00941031|463496063|FG001|Maintenance Period|Protocol Violation|0|||
128782612|NCT00941031|463496064|FG002|Maintenance Period|Protocol Violation|0|||
128782613|NCT00941031|463496065|FG003|Maintenance Period|Protocol Violation|0|||
128782614|NCT00941031|463496066|FG004|Maintenance Period|Protocol Violation|0|||
128782615|NCT00941031|463496067|FG005|Maintenance Period|Protocol Violation|0|||
128782616|NCT00941031|463496068|FG006|Maintenance Period|Protocol Violation|1|||
128782617|NCT00941031|463496062|FG000|Maintenance Period|Adverse Event|0|||
128782618|NCT00941031|463496063|FG001|Maintenance Period|Adverse Event|0|||
128782619|NCT00941031|463496064|FG002|Maintenance Period|Adverse Event|0|||
128782620|NCT00941031|463496065|FG003|Maintenance Period|Adverse Event|0|||
128782621|NCT00941031|463496066|FG004|Maintenance Period|Adverse Event|0|||
128782622|NCT00941031|463496067|FG005|Maintenance Period|Adverse Event|2|||
128782623|NCT00941031|463496068|FG006|Maintenance Period|Adverse Event|8|||
128782624|NCT00941031|463496062|FG000|Maintenance Period|Lost to Follow-up|0|||
128782625|NCT00941031|463496063|FG001|Maintenance Period|Lost to Follow-up|0|||
128735015|NCT04622254|463321691|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
128735016|NCT04622254|463321692|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
128735017|NCT04622254|463321693|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
128735018|NCT04622254|463321694|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
128735019|NCT04622254|463321695|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
128735020|NCT04622254|463321696|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
128735021|NCT04622254|463321691|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
128735022|NCT04622254|463321692|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
128735023|NCT04622254|463321693|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
128735024|NCT04622254|463321694|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
128735025|NCT04622254|463321695|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
128735026|NCT04622254|463321696|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
128735027|NCT04622254|463321691|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
128735028|NCT04622254|463321692|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
128735029|NCT04622254|463321693|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
128735030|NCT04622254|463321694|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
128735031|NCT04622254|463321695|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
128735032|NCT04622254|463321696|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
128735033|NCT04622254|463321691|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128735034|NCT04622254|463321692|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
128735035|NCT04622254|463321693|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
128735036|NCT04622254|463321694|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128735037|NCT04622254|463321695|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128735038|NCT04622254|463321696|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
128735039|NCT04622254|463321691|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128735040|NCT04622254|463321692|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128735041|NCT04622254|463321693|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128735042|NCT04622254|463321694|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
128735043|NCT04622254|463321695|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128735044|NCT04622254|463321696|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
128735045|NCT04622254|463321691|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
128735046|NCT04622254|463321692|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
128735047|NCT04622254|463321693|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
128735048|NCT04622254|463321694|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
128735049|NCT04622254|463321695|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
128735050|NCT04622254|463321696|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
128735051|NCT04622254|463321691|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128735052|NCT04622254|463321692|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128735053|NCT04622254|463321693|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128735054|NCT04622254|463321694|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
128735055|NCT04622254|463321695|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128735056|NCT04622254|463321696|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
128735057|NCT04622254|463321691|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128735058|NCT04622254|463321692|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128735059|NCT04622254|463321693|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128735060|NCT04622254|463321694|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
128735061|NCT04622254|463321695|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128735062|NCT04622254|463321696|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
128735063|NCT04622254|463321691|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
128735064|NCT04622254|463321692|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
128735065|NCT04622254|463321693|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
128735066|NCT04622254|463321694|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
128735067|NCT04622254|463321695|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
128735068|NCT04622254|463321696|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
128735069|NCT04622254|463321691|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
128735070|NCT04622254|463321692|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
128735071|NCT04622254|463321693|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
128735072|NCT04622254|463321694|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
128735073|NCT04622254|463321695|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
128735074|NCT04622254|463321696|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
128735075|NCT04622254|463321691|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
128735076|NCT04622254|463321692|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
128735077|NCT04622254|463321693|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
128735078|NCT04622254|463321694|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
128735079|NCT04622254|463321695|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
128735080|NCT04622254|463321696|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
128735081|NCT02652624|463321697|FG000|Randomized Phase|Pregnancy|3|||
128735082|NCT02652624|463321698|FG001|Randomized Phase|Pregnancy|1|||
128735083|NCT02652624|463321697|FG000|Randomized Phase|Investigator's Discretion|0|||
128782626|NCT00941031|463496064|FG002|Maintenance Period|Lost to Follow-up|0|||
128782627|NCT00941031|463496065|FG003|Maintenance Period|Lost to Follow-up|0|||
128782628|NCT00941031|463496066|FG004|Maintenance Period|Lost to Follow-up|2|||
128782629|NCT00941031|463496067|FG005|Maintenance Period|Lost to Follow-up|2|||
128782630|NCT00941031|463496068|FG006|Maintenance Period|Lost to Follow-up|7|||
128782631|NCT00941031|463496062|FG000|Maintenance Period|Lack of Efficacy|0|||
128735084|NCT02652624|463321698|FG001|Randomized Phase|Investigator's Discretion|2|||
128735085|NCT02652624|463321697|FG000|Randomized Phase|Death|0|||
128735086|NCT02652624|463321698|FG001|Randomized Phase|Death|1|||
128735087|NCT02652624|463321697|FG000|Randomized Phase|Lost to Follow-up|0|||
128735088|NCT02652624|463321698|FG001|Randomized Phase|Lost to Follow-up|1|||
128735089|NCT02652624|463321697|FG000|Extension Phase|Lost to Follow-up|3|||
128735090|NCT02652624|463321698|FG001|Extension Phase|Lost to Follow-up|1|||
128735091|NCT02652624|463321697|FG000|Extension Phase|Pregnancy|1|||
128735092|NCT02652624|463321698|FG001|Extension Phase|Pregnancy|1|||
128735093|NCT02652624|463321697|FG000|Extension Phase|Adverse Event|0|||
128735094|NCT02652624|463321698|FG001|Extension Phase|Adverse Event|1|||
128735095|NCT02652624|463321697|FG000|Extension Phase|Withdrew Consent|0|||
128735096|NCT02652624|463321698|FG001|Extension Phase|Withdrew Consent|1|||
128735097|NCT01023659|463321699|FG000|Overall Study|Lost to Follow-up|73|||
128735098|NCT01023659|463321700|FG001|Overall Study|Lost to Follow-up|228|||
128735099|NCT01023659|463321701|FG002|Overall Study|Lost to Follow-up|99|||
128782632|NCT00941031|463496063|FG001|Maintenance Period|Lack of Efficacy|0|||
128782633|NCT00941031|463496064|FG002|Maintenance Period|Lack of Efficacy|0|||
128782634|NCT00941031|463496065|FG003|Maintenance Period|Lack of Efficacy|0|||
128782635|NCT00941031|463496066|FG004|Maintenance Period|Lack of Efficacy|0|||
128782636|NCT00941031|463496067|FG005|Maintenance Period|Lack of Efficacy|0|||
128782637|NCT00941031|463496068|FG006|Maintenance Period|Lack of Efficacy|13|||
128782638|NCT01872611|463496069|FG000|Overall Study|Adverse Event|3|||
128782639|NCT01872611|463496070|FG001|Overall Study|Adverse Event|1|||
128782640|NCT01872611|463496069|FG000|Overall Study|Adverse Event, prior to treatment|0|||
128782641|NCT01872611|463496070|FG001|Overall Study|Adverse Event, prior to treatment|1|||
128782642|NCT01872611|463496069|FG000|Overall Study|Death|0|||
128782643|NCT01872611|463496070|FG001|Overall Study|Death|1|||
128782644|NCT01872611|463496069|FG000|Overall Study|Death, prior to treatment|0|||
128782645|NCT01872611|463496070|FG001|Overall Study|Death, prior to treatment|1|||
128782646|NCT01872611|463496069|FG000|Overall Study|Lost to Follow-up|8|||
128782647|NCT01872611|463496070|FG001|Overall Study|Lost to Follow-up|1|||
128782648|NCT01872611|463496069|FG000|Overall Study|Physician Decision|1|||
128782649|NCT01872611|463496070|FG001|Overall Study|Physician Decision|0|||
128782650|NCT01872611|463496069|FG000|Overall Study|Withdrawal by Subject|6|||
128782651|NCT01872611|463496070|FG001|Overall Study|Withdrawal by Subject|1|||
128782652|NCT01872611|463496069|FG000|Overall Study|Reason not provided|6|||
128782653|NCT01872611|463496070|FG001|Overall Study|Reason not provided|6|||
128782654|NCT03124108|463496071|FG000|Overall Study|Adverse Event|0|||
128782655|NCT03124108|463496072|FG001|Overall Study|Adverse Event|1|||
128782656|NCT03124108|463496073|FG002|Overall Study|Adverse Event|0|||
128782657|NCT00631917|463496074|FG000|Overall Study|Adverse Event|34|||
128782658|NCT00631917|463496075|FG001|Overall Study|Adverse Event|45|||
128782659|NCT00631917|463496074|FG000|Overall Study|Abnormal laboratory value(s)|2|||
128782660|NCT00631917|463496075|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128782661|NCT00631917|463496074|FG000|Overall Study|Abnormal test procedure result(s)|3|||
128782662|NCT00631917|463496075|FG001|Overall Study|Abnormal test procedure result(s)|2|||
128782663|NCT00631917|463496074|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
128782664|NCT00631917|463496075|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
128782665|NCT00631917|463496074|FG000|Overall Study|No longer required study drug|0|||
128782666|NCT00631917|463496075|FG001|Overall Study|No longer required study drug|1|||
128782667|NCT00631917|463496074|FG000|Overall Study|Protocol deviation|6|||
128782668|NCT00631917|463496075|FG001|Overall Study|Protocol deviation|5|||
128782669|NCT00631917|463496074|FG000|Overall Study|Subject withdrew consent|25|||
128782670|NCT00631917|463496075|FG001|Overall Study|Subject withdrew consent|33|||
128782671|NCT00631917|463496074|FG000|Overall Study|Lost to Follow-up|7|||
128782672|NCT00631917|463496075|FG001|Overall Study|Lost to Follow-up|7|||
128782673|NCT00631917|463496074|FG000|Overall Study|Administrative problems|2|||
128782674|NCT00631917|463496075|FG001|Overall Study|Administrative problems|0|||
128782675|NCT00631917|463496074|FG000|Overall Study|Death|1|||
128782676|NCT00631917|463496075|FG001|Overall Study|Death|0|||
128782677|NCT05650333|463496076|FG000|Treatment Period (7 Days)|Adverse Event|1|||
128782678|NCT02616263|463496077|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
128782679|NCT02616263|463496078|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
128782680|NCT02616263|463496077|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
128782681|NCT02616263|463496078|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
128782682|NCT02616263|463496077|FG000|6 Month to 1.5 Year|Death|1|||
128782683|NCT02616263|463496078|FG001|6 Month to 1.5 Year|Death|0|||
128782684|NCT02616263|463496077|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
128782685|NCT02616263|463496078|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
128782686|NCT02616263|463496077|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
128782687|NCT02616263|463496078|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
128782688|NCT02616263|463496077|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
128782689|NCT02616263|463496078|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
128782690|NCT03686384|463496079|FG000|Overall Study|Lack of Efficacy|4|||
128782691|NCT03686384|463496080|FG001|Overall Study|Lack of Efficacy|13|||
128782692|NCT03686384|463496079|FG000|Overall Study|Lost to Follow-up|3|||
128782693|NCT03686384|463496080|FG001|Overall Study|Lost to Follow-up|0|||
128782694|NCT03686384|463496079|FG000|Overall Study|Physician Decision|0|||
128782695|NCT03686384|463496080|FG001|Overall Study|Physician Decision|1|||
128782696|NCT03686384|463496079|FG000|Overall Study|Took prohibited medication|0|||
128782697|NCT03686384|463496080|FG001|Overall Study|Took prohibited medication|1|||
128782698|NCT01767909|463496085|FG000|Overall Study|Withdrawal by Subject|4|||
128782699|NCT01767909|463496086|FG001|Overall Study|Withdrawal by Subject|7|||
128782700|NCT01767909|463496085|FG000|Overall Study|Adverse Event|3|||
128782701|NCT01767909|463496086|FG001|Overall Study|Adverse Event|1|||
128782702|NCT01767909|463496085|FG000|Overall Study|Withdrawal by Study Partner|3|||
128782703|NCT01767909|463496086|FG001|Overall Study|Withdrawal by Study Partner|1|||
128782704|NCT01767909|463496085|FG000|Overall Study|Non-Compliance|2|||
128782705|NCT01767909|463496086|FG001|Overall Study|Non-Compliance|0|||
128782706|NCT01767909|463496085|FG000|Overall Study|Perceived Lack of Efficacy|1|||
128735100|NCT00912405|463321702|FG000|Overall Study|Lost to Follow-up|5|||
128735101|NCT00501540|463321705|FG000|Overall Study|Death|5|||
128735102|NCT01797536|463321706|FG000|Overall Study|Adverse Event|0|||
128735103|NCT01797536|463321707|FG001|Overall Study|Adverse Event|1|||
128735104|NCT01797536|463321708|FG002|Overall Study|Adverse Event|0|||
128735105|NCT01797536|463321709|FG003|Overall Study|Adverse Event|0|||
128735106|NCT00098839|463321710|FG000|Overall Study|Adverse Event|5|||
128735107|NCT00098839|463321711|FG001|Overall Study|Adverse Event|2|||
128735108|NCT00098839|463321710|FG000|Overall Study|Death|1|||
128735109|NCT00098839|463321711|FG001|Overall Study|Death|2|||
128735110|NCT00098839|463321710|FG000|Overall Study|Physician Decision|4|||
128735111|NCT00098839|463321711|FG001|Overall Study|Physician Decision|14|||
128735112|NCT00098839|463321710|FG000|Overall Study|Withdrawal by Subject|1|||
128735113|NCT00098839|463321711|FG001|Overall Study|Withdrawal by Subject|0|||
128735114|NCT00098839|463321710|FG000|Overall Study|Refusal of further protocol therapy|3|||
128735115|NCT00098839|463321711|FG001|Overall Study|Refusal of further protocol therapy|1|||
128735116|NCT00098839|463321710|FG000|Overall Study|Relapse|6|||
128735117|NCT00098839|463321711|FG001|Overall Study|Relapse|3|||
128735118|NCT00098839|463321710|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
128735119|NCT00098839|463321711|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
128735120|NCT00098839|463321710|FG000|Overall Study|Ineligible|2|||
128735121|NCT00098839|463321711|FG001|Overall Study|Ineligible|0|||
128735122|NCT03228680|463321713|FG000|Overall Study|Adverse Event|13|||
128735123|NCT03228680|463321714|FG001|Overall Study|Adverse Event|18|||
128735124|NCT03228680|463321713|FG000|Overall Study|Randomization failure|0|||
128735125|NCT03228680|463321714|FG001|Overall Study|Randomization failure|1|||
128735126|NCT03228680|463321713|FG000|Overall Study|Withdrawal by Subject|1|||
128735127|NCT03228680|463321714|FG001|Overall Study|Withdrawal by Subject|0|||
128735128|NCT03228680|463321713|FG000|Overall Study|Other|9|||
128735129|NCT03228680|463321714|FG001|Overall Study|Other|16|||
128782707|NCT01767909|463496086|FG001|Overall Study|Perceived Lack of Efficacy|0|||
128782708|NCT01767909|463496085|FG000|Overall Study|Investigator Recommendation|0|||
128782709|NCT01767909|463496086|FG001|Overall Study|Investigator Recommendation|1|||
128782710|NCT01767909|463496085|FG000|Overall Study|Lost to Follow-up|0|||
128782711|NCT01767909|463496086|FG001|Overall Study|Lost to Follow-up|1|||
128782712|NCT01767909|463496085|FG000|Overall Study|LP uncessessful|0|||
128782713|NCT01767909|463496086|FG001|Overall Study|LP uncessessful|1|||
128782714|NCT02939183|463496087|FG000|Overall Study|Death|0|||
128782715|NCT02939183|463496088|FG001|Overall Study|Death|0|||
128782716|NCT02939183|463496089|FG002|Overall Study|Death|1|||
128782717|NCT02939183|463496090|FG003|Overall Study|Death|0|||
128782718|NCT02939183|463496091|FG004|Overall Study|Death|0|||
128782719|NCT02939183|463496092|FG005|Overall Study|Death|2|||
128735130|NCT02148003|463321715|FG000|Overall Study|Failed inclusion criteria|1|||
128735131|NCT02148003|463321716|FG001|Overall Study|Failed inclusion criteria|0|||
128735132|NCT02148003|463321715|FG000|Overall Study|Met exclusion criteria|0|||
128735133|NCT02148003|463321716|FG001|Overall Study|Met exclusion criteria|1|||
128735134|NCT02148003|463321715|FG000|Overall Study|Withdrawal by Subject|0|||
128735135|NCT02148003|463321716|FG001|Overall Study|Withdrawal by Subject|1|||
128735136|NCT02489981|463321717|FG000|Overall Study|Adverse Event|21|||
128735137|NCT02489981|463321717|FG000|Overall Study|Insufficient effectiveness|16|||
128735138|NCT02489981|463321717|FG000|Overall Study|Improved|31|||
128735139|NCT02489981|463321717|FG000|Overall Study|Lost to Follow-up|31|||
128735140|NCT02489981|463321717|FG000|Overall Study|Other than listed|28|||
128735141|NCT00796861|463321718|FG000|Overall Study|Withdrawal by Subject|2|||
128735142|NCT00796861|463321718|FG000|Overall Study|Death|2|||
128735143|NCT03852316|463321721|FG000|Overall Study|Protocol Violation|1|||
128735144|NCT03852316|463321721|FG000|Overall Study|Withdrawal by Subject|2|||
128735145|NCT03852316|463321721|FG000|Overall Study|Enrolled but Device not Utilized|1|||
128735146|NCT02247349|463321722|FG000|Overall Study|Disease Progression|7|||
128735147|NCT02247349|463321723|FG001|Overall Study|Disease Progression|4|||
128735148|NCT02247349|463321724|FG002|Overall Study|Disease Progression|26|||
128735149|NCT02247349|463321725|FG003|Overall Study|Disease Progression|31|||
128735150|NCT02247349|463321726|FG004|Overall Study|Disease Progression|16|||
128735151|NCT02247349|463321727|FG005|Overall Study|Disease Progression|6|||
128735152|NCT02247349|463321722|FG000|Overall Study|Study drug toxicity|0|||
128735153|NCT02247349|463321723|FG001|Overall Study|Study drug toxicity|1|||
128735154|NCT02247349|463321724|FG002|Overall Study|Study drug toxicity|1|||
128735155|NCT02247349|463321725|FG003|Overall Study|Study drug toxicity|1|||
128735156|NCT02247349|463321726|FG004|Overall Study|Study drug toxicity|2|||
128735157|NCT02247349|463321727|FG005|Overall Study|Study drug toxicity|2|||
128735158|NCT02247349|463321722|FG000|Overall Study|Death|0|||
128735159|NCT02247349|463321723|FG001|Overall Study|Death|0|||
128735160|NCT02247349|463321724|FG002|Overall Study|Death|0|||
128735161|NCT02247349|463321725|FG003|Overall Study|Death|1|||
128735162|NCT02247349|463321726|FG004|Overall Study|Death|0|||
128735163|NCT02247349|463321727|FG005|Overall Study|Death|0|||
128735164|NCT02247349|463321722|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
128735165|NCT02247349|463321723|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
128735166|NCT02247349|463321724|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
128735167|NCT02247349|463321725|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
128735168|NCT02247349|463321726|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
128735169|NCT02247349|463321727|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
128735170|NCT02247349|463321722|FG000|Overall Study|Participant request to discontinue study treatment|0|||
128735171|NCT02247349|463321723|FG001|Overall Study|Participant request to discontinue study treatment|0|||
128735172|NCT02247349|463321724|FG002|Overall Study|Participant request to discontinue study treatment|1|||
128735173|NCT02247349|463321725|FG003|Overall Study|Participant request to discontinue study treatment|2|||
128735174|NCT02247349|463321726|FG004|Overall Study|Participant request to discontinue study treatment|1|||
128735175|NCT02247349|463321727|FG005|Overall Study|Participant request to discontinue study treatment|0|||
128735176|NCT02247349|463321722|FG000|Overall Study|Withdrawal by Subject|0|||
128735177|NCT02247349|463321723|FG001|Overall Study|Withdrawal by Subject|1|||
128735178|NCT02247349|463321724|FG002|Overall Study|Withdrawal by Subject|0|||
128735179|NCT02247349|463321725|FG003|Overall Study|Withdrawal by Subject|0|||
128735180|NCT02247349|463321726|FG004|Overall Study|Withdrawal by Subject|0|||
128735181|NCT02247349|463321727|FG005|Overall Study|Withdrawal by Subject|0|||
128735182|NCT02247349|463321722|FG000|Overall Study|Administrative reason by sponsor|0|||
128735183|NCT02247349|463321723|FG001|Overall Study|Administrative reason by sponsor|0|||
128735184|NCT02247349|463321724|FG002|Overall Study|Administrative reason by sponsor|0|||
128735185|NCT02247349|463321725|FG003|Overall Study|Administrative reason by sponsor|0|||
128782720|NCT02939183|463496093|FG006|Overall Study|Death|1|||
128782721|NCT02939183|463496094|FG007|Overall Study|Death|0|||
128782722|NCT02939183|463496095|FG008|Overall Study|Death|0|||
128782723|NCT02939183|463496087|FG000|Overall Study|Sponsor decision|0|||
128782724|NCT02939183|463496088|FG001|Overall Study|Sponsor decision|1|||
128782725|NCT02939183|463496089|FG002|Overall Study|Sponsor decision|0|||
128782726|NCT02939183|463496090|FG003|Overall Study|Sponsor decision|1|||
128782727|NCT02939183|463496091|FG004|Overall Study|Sponsor decision|2|||
128782728|NCT02939183|463496092|FG005|Overall Study|Sponsor decision|0|||
128782729|NCT02939183|463496093|FG006|Overall Study|Sponsor decision|3|||
128782730|NCT02939183|463496094|FG007|Overall Study|Sponsor decision|1|||
128782731|NCT02939183|463496095|FG008|Overall Study|Sponsor decision|4|||
128782732|NCT02939183|463496087|FG000|Overall Study|Withdrawal by Subject|0|||
128782733|NCT02939183|463496088|FG001|Overall Study|Withdrawal by Subject|2|||
128782734|NCT02939183|463496089|FG002|Overall Study|Withdrawal by Subject|0|||
128782735|NCT02939183|463496090|FG003|Overall Study|Withdrawal by Subject|1|||
128782736|NCT02939183|463496091|FG004|Overall Study|Withdrawal by Subject|0|||
128782737|NCT02939183|463496092|FG005|Overall Study|Withdrawal by Subject|0|||
128782738|NCT02939183|463496093|FG006|Overall Study|Withdrawal by Subject|2|||
128782739|NCT02939183|463496094|FG007|Overall Study|Withdrawal by Subject|2|||
128782740|NCT02939183|463496095|FG008|Overall Study|Withdrawal by Subject|2|||
128782741|NCT02939183|463496087|FG000|Overall Study|Not treated due to adverse event|0|||
128782742|NCT02939183|463496088|FG001|Overall Study|Not treated due to adverse event|0|||
128782743|NCT02939183|463496089|FG002|Overall Study|Not treated due to adverse event|0|||
128782744|NCT02939183|463496090|FG003|Overall Study|Not treated due to adverse event|1|||
128782745|NCT02939183|463496091|FG004|Overall Study|Not treated due to adverse event|0|||
128782746|NCT02939183|463496092|FG005|Overall Study|Not treated due to adverse event|0|||
128782747|NCT02939183|463496093|FG006|Overall Study|Not treated due to adverse event|1|||
128782748|NCT02939183|463496094|FG007|Overall Study|Not treated due to adverse event|0|||
128782749|NCT02939183|463496095|FG008|Overall Study|Not treated due to adverse event|0|||
128782750|NCT02696785|463496100|FG000|Blinded Treatment Period|Adverse Event|0|||
128782751|NCT02696785|463496101|FG001|Blinded Treatment Period|Adverse Event|1|||
128782752|NCT02696785|463496102|FG002|Blinded Treatment Period|Adverse Event|3|||
128782753|NCT02696785|463496103|FG003|Blinded Treatment Period|Adverse Event|0|||
128782754|NCT02696785|463496100|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
128782755|NCT02696785|463496101|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
128782756|NCT02696785|463496102|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
128782757|NCT02696785|463496103|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
128782758|NCT02696785|463496100|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
128782759|NCT02696785|463496101|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
128782760|NCT02696785|463496102|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
128782761|NCT02696785|463496103|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
128782762|NCT02696785|463496100|FG000|Blinded Treatment Period|Screen Failure|1|||
128782763|NCT02696785|463496101|FG001|Blinded Treatment Period|Screen Failure|0|||
128782764|NCT02696785|463496102|FG002|Blinded Treatment Period|Screen Failure|0|||
128782765|NCT02696785|463496103|FG003|Blinded Treatment Period|Screen Failure|0|||
128782766|NCT02696785|463496100|FG000|Washout Period|Withdrawal by Subject|0|||
128782767|NCT02696785|463496101|FG001|Washout Period|Withdrawal by Subject|1|||
128782768|NCT02696785|463496102|FG002|Washout Period|Withdrawal by Subject|0|||
128782769|NCT02696785|463496103|FG003|Washout Period|Withdrawal by Subject|0|||
128782770|NCT02696785|463496100|FG000|Washout Period|Lack of Efficacy|0|||
128782771|NCT02696785|463496101|FG001|Washout Period|Lack of Efficacy|1|||
128782772|NCT02696785|463496102|FG002|Washout Period|Lack of Efficacy|0|||
128782773|NCT02696785|463496103|FG003|Washout Period|Lack of Efficacy|0|||
128782774|NCT02696785|463496100|FG000|Extended Treatment Period|Adverse Event|2|||
128782775|NCT02696785|463496101|FG001|Extended Treatment Period|Adverse Event|3|||
128782776|NCT02696785|463496102|FG002|Extended Treatment Period|Adverse Event|2|||
128782777|NCT02696785|463496103|FG003|Extended Treatment Period|Adverse Event|1|||
128782778|NCT02696785|463496100|FG000|Extended Treatment Period|Lack of Efficacy|0|||
128782779|NCT02696785|463496101|FG001|Extended Treatment Period|Lack of Efficacy|1|||
128782780|NCT02696785|463496102|FG002|Extended Treatment Period|Lack of Efficacy|0|||
128782781|NCT02696785|463496103|FG003|Extended Treatment Period|Lack of Efficacy|0|||
128782782|NCT02696785|463496100|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
128782783|NCT02696785|463496101|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
128782784|NCT02696785|463496102|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
128782785|NCT02696785|463496103|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
128782786|NCT02696785|463496100|FG000|Follow-up Period|Adverse Event|0|||
128782787|NCT02696785|463496101|FG001|Follow-up Period|Adverse Event|0|||
128782788|NCT02696785|463496102|FG002|Follow-up Period|Adverse Event|8|||
128782789|NCT02696785|463496103|FG003|Follow-up Period|Adverse Event|2|||
128735186|NCT02247349|463321726|FG004|Overall Study|Administrative reason by sponsor|1|||
128735187|NCT02247349|463321727|FG005|Overall Study|Administrative reason by sponsor|0|||
128735188|NCT02247349|463321722|FG000|Overall Study|Other reasons|0|||
128735189|NCT02247349|463321723|FG001|Overall Study|Other reasons|0|||
128735190|NCT02247349|463321724|FG002|Overall Study|Other reasons|1|||
128735191|NCT02247349|463321725|FG003|Overall Study|Other reasons|0|||
128735192|NCT02247349|463321726|FG004|Overall Study|Other reasons|0|||
128735193|NCT02247349|463321727|FG005|Overall Study|Other reasons|0|||
128735194|NCT01959581|463321728|FG000|Overall Study|Lost to Follow-up|5|||
128735195|NCT04542070|463321729|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
128735196|NCT04542070|463321730|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
128735197|NCT04542070|463321731|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
128735198|NCT04542070|463321732|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
128735199|NCT04542070|463321729|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
128735200|NCT04542070|463321730|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
128735201|NCT04542070|463321731|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
128735202|NCT04542070|463321732|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
128735203|NCT04542070|463321729|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
128735204|NCT04542070|463321730|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
128735205|NCT04542070|463321731|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
128735206|NCT04542070|463321732|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
128735207|NCT04542070|463321729|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
128735208|NCT04542070|463321730|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
128735209|NCT04542070|463321731|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
128735210|NCT04542070|463321732|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
128735211|NCT04542070|463321729|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
128735212|NCT04542070|463321730|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
128735213|NCT04542070|463321731|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
128735214|NCT04542070|463321732|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
128735215|NCT04542070|463321729|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
128735216|NCT04542070|463321730|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
128735217|NCT04542070|463321731|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
128735218|NCT04542070|463321732|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
128735219|NCT04542070|463321729|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
128735220|NCT04542070|463321730|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
128735221|NCT04542070|463321731|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
128735222|NCT04542070|463321732|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
128735223|NCT04542070|463321729|FG000|Maintenance + Extension Period|Adverse Event|10|||
128735224|NCT04542070|463321730|FG001|Maintenance + Extension Period|Adverse Event|2|||
128735225|NCT04542070|463321731|FG002|Maintenance + Extension Period|Adverse Event|0|||
128735226|NCT04542070|463321732|FG003|Maintenance + Extension Period|Adverse Event|0|||
128735227|NCT04542070|463321729|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
128735228|NCT04542070|463321730|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
128735229|NCT04542070|463321731|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
128735230|NCT04542070|463321732|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
128735231|NCT04542070|463321729|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
128735232|NCT04542070|463321730|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
128735233|NCT04542070|463321731|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
128735234|NCT04542070|463321732|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
128735235|NCT04542070|463321729|FG000|Maintenance + Extension Period|Physician Decision|1|||
128735236|NCT04542070|463321730|FG001|Maintenance + Extension Period|Physician Decision|1|||
128735237|NCT04542070|463321731|FG002|Maintenance + Extension Period|Physician Decision|0|||
128782790|NCT02696785|463496100|FG000|Follow-up Period|Lost to Follow-up|0|||
128782791|NCT02696785|463496101|FG001|Follow-up Period|Lost to Follow-up|0|||
128782792|NCT02696785|463496102|FG002|Follow-up Period|Lost to Follow-up|0|||
128782793|NCT02696785|463496103|FG003|Follow-up Period|Lost to Follow-up|1|||
128782794|NCT02696785|463496100|FG000|Follow-up Period|Lack of Efficacy|0|||
128782795|NCT02696785|463496101|FG001|Follow-up Period|Lack of Efficacy|0|||
128782796|NCT02696785|463496102|FG002|Follow-up Period|Lack of Efficacy|0|||
128782797|NCT02696785|463496103|FG003|Follow-up Period|Lack of Efficacy|1|||
128782798|NCT02696785|463496100|FG000|Follow-up Period|Withdrawal by Subject|1|||
128782799|NCT02696785|463496101|FG001|Follow-up Period|Withdrawal by Subject|0|||
128782800|NCT02696785|463496102|FG002|Follow-up Period|Withdrawal by Subject|5|||
128782801|NCT02696785|463496103|FG003|Follow-up Period|Withdrawal by Subject|4|||
128782802|NCT03424239|463496105|FG000|Overall Study|Withdrawal by Subject|2|||
128782803|NCT01446003|463496107|FG000|Period 1|Protocol Violation|2|||
128782804|NCT01446003|463496108|FG001|Period 1|Protocol Violation|0|||
128782805|NCT01446003|463496107|FG000|Period 2|Adverse Event|1|||
128782806|NCT01446003|463496108|FG001|Period 2|Adverse Event|0|||
128782807|NCT00318656|463496109|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
128782808|NCT00318656|463496110|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
128782809|NCT00318656|463496109|FG000|Overall Study|Did not receive any treatment|0|||
128782810|NCT00318656|463496110|FG001|Overall Study|Did not receive any treatment|1|||
128782811|NCT03905135|463496111|FG000|Dose Escalation|Adverse Event|1|||
128782812|NCT03905135|463496112|FG001|Dose Escalation|Adverse Event|1|||
128782813|NCT03905135|463496111|FG000|Dose Escalation|Progressive disease|3|||
128782814|NCT03905135|463496112|FG001|Dose Escalation|Progressive disease|1|||
128782815|NCT03905135|463496111|FG000|Dose Escalation|Intercurrent illness|1|||
128782816|NCT03905135|463496112|FG001|Dose Escalation|Intercurrent illness|0|||
128782817|NCT00490555|463496113|FG000|Overall Study|noncompliant with drug administration|0|||
128782818|NCT00490555|463496114|FG001|Overall Study|noncompliant with drug administration|0|||
128782819|NCT00490555|463496115|FG002|Overall Study|noncompliant with drug administration|2|||
128782820|NCT00490555|463496116|FG003|Overall Study|noncompliant with drug administration|0|||
128782821|NCT02042443|463496119|FG000|Overall Study|Adverse Event|2|||
128782822|NCT02042443|463496120|FG001|Overall Study|Adverse Event|1|||
128782823|NCT02042443|463496119|FG000|Overall Study|Withdrawal by Subject|0|||
128782824|NCT02042443|463496120|FG001|Overall Study|Withdrawal by Subject|1|||
128782825|NCT02042443|463496119|FG000|Overall Study|Progression|21|||
128782826|NCT02042443|463496120|FG001|Overall Study|Progression|17|||
128782827|NCT02042443|463496119|FG000|Overall Study|not protocol specified|1|||
128782828|NCT02042443|463496120|FG001|Overall Study|not protocol specified|1|||
128782829|NCT02042443|463496119|FG000|Overall Study|Not eligible/not analyzable|3|||
128782830|NCT02042443|463496120|FG001|Overall Study|Not eligible/not analyzable|6|||
128782831|NCT01007149|463496123|FG000|Overall Study|Administrative problems|0|||
128782832|NCT01007149|463496124|FG001|Overall Study|Administrative problems|1|||
128782833|NCT01913340|463496125|FG000|Overall Study|Death|2|||
128782834|NCT01913340|463496126|FG001|Overall Study|Death|5|||
128782835|NCT01913340|463496125|FG000|Overall Study|Lost to Follow-up|1|||
128782836|NCT01913340|463496126|FG001|Overall Study|Lost to Follow-up|1|||
128782837|NCT02784704|463496127|FG000|Overall Study|Adverse Event|4|||
128782838|NCT02784704|463496128|FG001|Overall Study|Adverse Event|2|||
128782839|NCT02784704|463496127|FG000|Overall Study|Lost to Follow-up|6|||
128782840|NCT02784704|463496128|FG001|Overall Study|Lost to Follow-up|4|||
128782841|NCT02784704|463496127|FG000|Overall Study|Withdrawal by Subject|1|||
128782842|NCT02784704|463496128|FG001|Overall Study|Withdrawal by Subject|3|||
128782843|NCT02784704|463496127|FG000|Overall Study|Subject Non Compliance|2|||
128782844|NCT02784704|463496128|FG001|Overall Study|Subject Non Compliance|0|||
128782845|NCT02320253|463496129|FG000|Overall Study|Withdrawal by Subject|3|||
128782846|NCT02320253|463496130|FG001|Overall Study|Withdrawal by Subject|0|||
128782847|NCT02320253|463496131|FG002|Overall Study|Withdrawal by Subject|0|||
128782848|NCT02320253|463496129|FG000|Overall Study|Lost to Follow-up|2|||
128782849|NCT02320253|463496130|FG001|Overall Study|Lost to Follow-up|2|||
128782850|NCT02320253|463496131|FG002|Overall Study|Lost to Follow-up|1|||
128782851|NCT02320253|463496129|FG000|Overall Study|Death|1|||
128782852|NCT02320253|463496130|FG001|Overall Study|Death|0|||
128782853|NCT02320253|463496131|FG002|Overall Study|Death|1|||
128782854|NCT00603538|463496132|FG000|Overall Study|Adverse Event|0|||
128782855|NCT00603538|463496133|FG001|Overall Study|Adverse Event|4|||
128782856|NCT00603538|463496134|FG002|Overall Study|Adverse Event|2|||
128782857|NCT00603538|463496132|FG000|Overall Study|Objective progression or relapse|3|||
128782858|NCT00603538|463496133|FG001|Overall Study|Objective progression or relapse|0|||
128782859|NCT00603538|463496134|FG002|Overall Study|Objective progression or relapse|0|||
128782860|NCT05750745|463496136|FG000|Overall Study|Adverse Event|1|||
128782861|NCT05750745|463496137|FG001|Overall Study|Adverse Event|0|||
128782862|NCT05750745|463496138|FG002|Overall Study|Adverse Event|0|||
128782863|NCT05750745|463496136|FG000|Overall Study|Protocol Violation|1|||
128735238|NCT04542070|463321732|FG003|Maintenance + Extension Period|Physician Decision|0|||
128735239|NCT04542070|463321729|FG000|Maintenance + Extension Period|Protocol Violation|2|||
128735240|NCT04542070|463321730|FG001|Maintenance + Extension Period|Protocol Violation|5|||
128735241|NCT04542070|463321731|FG002|Maintenance + Extension Period|Protocol Violation|0|||
128735242|NCT04542070|463321732|FG003|Maintenance + Extension Period|Protocol Violation|0|||
128735243|NCT04542070|463321729|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
128735244|NCT04542070|463321730|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
128735245|NCT04542070|463321731|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
128735246|NCT04542070|463321732|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
128735247|NCT04542070|463321729|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
128735248|NCT04542070|463321730|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
128735249|NCT04542070|463321731|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
128735250|NCT04542070|463321732|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
128735251|NCT04542070|463321729|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
128735252|NCT04542070|463321730|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
128735253|NCT04542070|463321731|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
128735254|NCT04542070|463321732|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
128735255|NCT04542070|463321729|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
128735256|NCT04542070|463321730|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
128735257|NCT04542070|463321731|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
128735258|NCT04542070|463321732|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
128735259|NCT04542070|463321729|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
128735260|NCT04542070|463321730|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
128735261|NCT04542070|463321731|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
128735262|NCT04542070|463321732|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
128735263|NCT04542070|463321729|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
128735264|NCT04542070|463321730|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
128735265|NCT04542070|463321731|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
128735266|NCT04542070|463321732|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
128735267|NCT04542070|463321729|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
128735268|NCT04542070|463321730|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
128735269|NCT04542070|463321731|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
128735270|NCT04542070|463321732|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
128735271|NCT00550836|463321733|FG000|Overall Study|Withdrawal by Subject|3|||
128735272|NCT00550836|463321734|FG001|Overall Study|Withdrawal by Subject|9|||
128735273|NCT03075644|463321735|FG000|Overall Study|Withdrawal by Subject|1|||
128735274|NCT03075644|463321736|FG001|Overall Study|Withdrawal by Subject|1|||
128735275|NCT00578565|463321737|FG000|Overall Study|Adverse Event|3|||
128735276|NCT01192152|463321738|FG000|Period 1|left prematurely (while on treatment B)|0|||
128735277|NCT01192152|463321739|FG001|Period 1|left prematurely (while on treatment B)|1|||
128735278|NCT01192152|463321738|FG000|Period 3|family emergency|1|||
128735279|NCT01192152|463321739|FG001|Period 3|family emergency|0|||
128735280|NCT05013905|463321740|FG000|Overall Study|Adverse Event|1|||
128735281|NCT05013905|463321740|FG000|Overall Study|Lack of Efficacy|1|||
128735282|NCT03286140|463321741|FG000|Overall Study|Withdrawal by Subject|10|||
128735283|NCT03286140|463321742|FG001|Overall Study|Withdrawal by Subject|5|||
128735284|NCT03286140|463321741|FG000|Overall Study|Lost to Follow-up|5|||
128735285|NCT03286140|463321742|FG001|Overall Study|Lost to Follow-up|10|||
128735286|NCT03286140|463321741|FG000|Overall Study|Failure to comply|0|||
128735287|NCT03286140|463321742|FG001|Overall Study|Failure to comply|1|||
128735288|NCT04666259|463321743|FG000|Treatment Phase|Physician Decision|9|||
128735289|NCT04666259|463321744|FG001|Treatment Phase|Physician Decision|3|||
128735290|NCT04666259|463321745|FG002|Treatment Phase|Physician Decision|3|||
128735291|NCT04666259|463321743|FG000|Treatment Phase|Adverse Event|3|||
128735292|NCT04666259|463321744|FG001|Treatment Phase|Adverse Event|1|||
128735293|NCT04666259|463321745|FG002|Treatment Phase|Adverse Event|0|||
128735294|NCT04666259|463321743|FG000|Treatment Phase|Subject decision|1|||
128735295|NCT04666259|463321744|FG001|Treatment Phase|Subject decision|2|||
128735296|NCT04666259|463321745|FG002|Treatment Phase|Subject decision|0|||
128735297|NCT04666259|463321743|FG000|Treatment Phase|Progressive disease|0|||
128735298|NCT04666259|463321744|FG001|Treatment Phase|Progressive disease|1|||
128735299|NCT04666259|463321745|FG002|Treatment Phase|Progressive disease|0|||
128735300|NCT04666259|463321743|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
128735301|NCT04666259|463321744|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
128735302|NCT04666259|463321745|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
128735303|NCT04666259|463321743|FG000|Safety Follow-up Phase|Physician Decision|2|||
128735304|NCT04666259|463321744|FG001|Safety Follow-up Phase|Physician Decision|0|||
128735305|NCT04666259|463321745|FG002|Safety Follow-up Phase|Physician Decision|0|||
128735306|NCT04666259|463321743|FG000|Safety Follow-up Phase|Subject decision|1|||
128735307|NCT04666259|463321744|FG001|Safety Follow-up Phase|Subject decision|0|||
128782864|NCT05750745|463496137|FG001|Overall Study|Protocol Violation|0|||
128782865|NCT05750745|463496138|FG002|Overall Study|Protocol Violation|0|||
128782866|NCT05750745|463496136|FG000|Overall Study|Withdrawal by Subject|0|||
128782867|NCT05750745|463496137|FG001|Overall Study|Withdrawal by Subject|1|||
128782868|NCT05750745|463496138|FG002|Overall Study|Withdrawal by Subject|0|||
128782869|NCT00783692|463496142|FG000|Induction Phase|Adverse Event|7|||
128782870|NCT00783692|463496143|FG001|Induction Phase|Adverse Event|9|||
128782871|NCT00783692|463496144|FG002|Induction Phase|Adverse Event|24|||
128782872|NCT00783692|463496145|FG003|Induction Phase|Adverse Event|0|||
128782873|NCT00783692|463496146|FG004|Induction Phase|Adverse Event|0|||
128782874|NCT00783692|463496147|FG005|Induction Phase|Adverse Event|0|||
128782875|NCT00783692|463496148|FG006|Induction Phase|Adverse Event|0|||
128782876|NCT00783692|463496142|FG000|Induction Phase|Protocol Violation|0|||
128782877|NCT00783692|463496143|FG001|Induction Phase|Protocol Violation|0|||
128782878|NCT00783692|463496144|FG002|Induction Phase|Protocol Violation|1|||
128782879|NCT00783692|463496145|FG003|Induction Phase|Protocol Violation|0|||
128782880|NCT00783692|463496146|FG004|Induction Phase|Protocol Violation|0|||
128782881|NCT00783692|463496147|FG005|Induction Phase|Protocol Violation|0|||
128782882|NCT00783692|463496148|FG006|Induction Phase|Protocol Violation|0|||
128782883|NCT00783692|463496142|FG000|Induction Phase|Lack of Efficacy|1|||
128782884|NCT00783692|463496143|FG001|Induction Phase|Lack of Efficacy|3|||
128782885|NCT00783692|463496144|FG002|Induction Phase|Lack of Efficacy|28|||
128782886|NCT00783692|463496145|FG003|Induction Phase|Lack of Efficacy|0|||
128782887|NCT00783692|463496146|FG004|Induction Phase|Lack of Efficacy|0|||
128782888|NCT00783692|463496147|FG005|Induction Phase|Lack of Efficacy|0|||
128782889|NCT00783692|463496148|FG006|Induction Phase|Lack of Efficacy|0|||
128782890|NCT00783692|463496142|FG000|Induction Phase|Withdrawal by Subject|3|||
128782891|NCT00783692|463496143|FG001|Induction Phase|Withdrawal by Subject|9|||
128782892|NCT00783692|463496144|FG002|Induction Phase|Withdrawal by Subject|16|||
128782893|NCT00783692|463496145|FG003|Induction Phase|Withdrawal by Subject|0|||
128782894|NCT00783692|463496146|FG004|Induction Phase|Withdrawal by Subject|0|||
128782895|NCT00783692|463496147|FG005|Induction Phase|Withdrawal by Subject|0|||
128782896|NCT00783692|463496148|FG006|Induction Phase|Withdrawal by Subject|0|||
128782897|NCT00783692|463496142|FG000|Induction Phase|Lost to Follow-up|0|||
128782898|NCT00783692|463496143|FG001|Induction Phase|Lost to Follow-up|0|||
128782899|NCT00783692|463496144|FG002|Induction Phase|Lost to Follow-up|3|||
128782900|NCT00783692|463496145|FG003|Induction Phase|Lost to Follow-up|0|||
128782901|NCT00783692|463496146|FG004|Induction Phase|Lost to Follow-up|0|||
128782902|NCT00783692|463496147|FG005|Induction Phase|Lost to Follow-up|0|||
128782903|NCT00783692|463496148|FG006|Induction Phase|Lost to Follow-up|0|||
128782904|NCT00783692|463496142|FG000|Induction Phase|Other|0|||
128782905|NCT00783692|463496143|FG001|Induction Phase|Other|0|||
128782906|NCT00783692|463496144|FG002|Induction Phase|Other|2|||
128782907|NCT00783692|463496145|FG003|Induction Phase|Other|0|||
128782908|NCT00783692|463496146|FG004|Induction Phase|Other|0|||
128782909|NCT00783692|463496147|FG005|Induction Phase|Other|0|||
128782910|NCT00783692|463496148|FG006|Induction Phase|Other|0|||
128782911|NCT00783692|463496142|FG000|Maintenance Phase|Adverse Event|7|||
128782912|NCT00783692|463496143|FG001|Maintenance Phase|Adverse Event|0|||
128782913|NCT00783692|463496144|FG002|Maintenance Phase|Adverse Event|0|||
128782914|NCT00783692|463496145|FG003|Maintenance Phase|Adverse Event|15|||
128782915|NCT00783692|463496146|FG004|Maintenance Phase|Adverse Event|12|||
128782916|NCT00783692|463496147|FG005|Maintenance Phase|Adverse Event|9|||
128782917|NCT00783692|463496148|FG006|Maintenance Phase|Adverse Event|38|||
128782918|NCT00783692|463496142|FG000|Maintenance Phase|Protocol Violation|0|||
128782919|NCT00783692|463496143|FG001|Maintenance Phase|Protocol Violation|0|||
128782920|NCT00783692|463496144|FG002|Maintenance Phase|Protocol Violation|0|||
128782921|NCT00783692|463496145|FG003|Maintenance Phase|Protocol Violation|1|||
128782922|NCT00783692|463496146|FG004|Maintenance Phase|Protocol Violation|2|||
128782923|NCT00783692|463496147|FG005|Maintenance Phase|Protocol Violation|3|||
128782924|NCT00783692|463496148|FG006|Maintenance Phase|Protocol Violation|4|||
128782925|NCT00783692|463496142|FG000|Maintenance Phase|Lack of Efficacy|79|||
128782926|NCT00783692|463496143|FG001|Maintenance Phase|Lack of Efficacy|0|||
128782927|NCT00783692|463496144|FG002|Maintenance Phase|Lack of Efficacy|0|||
128782928|NCT00783692|463496145|FG003|Maintenance Phase|Lack of Efficacy|64|||
128782929|NCT00783692|463496146|FG004|Maintenance Phase|Lack of Efficacy|58|||
128782930|NCT00783692|463496147|FG005|Maintenance Phase|Lack of Efficacy|48|||
128782931|NCT00783692|463496148|FG006|Maintenance Phase|Lack of Efficacy|177|||
128782932|NCT00783692|463496142|FG000|Maintenance Phase|Withdrawal by Subject|7|||
128782933|NCT00783692|463496143|FG001|Maintenance Phase|Withdrawal by Subject|0|||
128782934|NCT00783692|463496144|FG002|Maintenance Phase|Withdrawal by Subject|0|||
128782935|NCT00783692|463496145|FG003|Maintenance Phase|Withdrawal by Subject|7|||
128782936|NCT00783692|463496146|FG004|Maintenance Phase|Withdrawal by Subject|6|||
128782937|NCT00783692|463496147|FG005|Maintenance Phase|Withdrawal by Subject|9|||
128782938|NCT00783692|463496148|FG006|Maintenance Phase|Withdrawal by Subject|24|||
128782939|NCT00783692|463496142|FG000|Maintenance Phase|Lost to Follow-up|2|||
128782940|NCT00783692|463496143|FG001|Maintenance Phase|Lost to Follow-up|0|||
128782941|NCT00783692|463496144|FG002|Maintenance Phase|Lost to Follow-up|0|||
128782942|NCT00783692|463496145|FG003|Maintenance Phase|Lost to Follow-up|1|||
128782943|NCT00783692|463496146|FG004|Maintenance Phase|Lost to Follow-up|3|||
128782944|NCT00783692|463496147|FG005|Maintenance Phase|Lost to Follow-up|2|||
128782945|NCT00783692|463496148|FG006|Maintenance Phase|Lost to Follow-up|5|||
128782946|NCT00783692|463496142|FG000|Maintenance Phase|Other|0|||
128782947|NCT00783692|463496143|FG001|Maintenance Phase|Other|0|||
128782948|NCT00783692|463496144|FG002|Maintenance Phase|Other|0|||
128782949|NCT00783692|463496145|FG003|Maintenance Phase|Other|1|||
128782950|NCT00783692|463496146|FG004|Maintenance Phase|Other|0|||
128782951|NCT00783692|463496147|FG005|Maintenance Phase|Other|1|||
128782952|NCT00783692|463496148|FG006|Maintenance Phase|Other|1|||
128782953|NCT00768066|463496151|FG000|Overall Study|Did not receive study product injection.|3|||
128782954|NCT00768066|463496152|FG001|Overall Study|Did not receive study product injection.|3|||
128782955|NCT00768066|463496153|FG002|Overall Study|Did not receive study product injection.|0|||
128782956|NCT04831775|463496154|FG000|Overall Study|Lost to Follow-up|11|||
128782957|NCT04831775|463496155|FG001|Overall Study|Lost to Follow-up|13|||
128782958|NCT05550337|463496158|FG000|Overall Study|Lack of Efficacy|0|||
128782959|NCT05550337|463496159|FG001|Overall Study|Lack of Efficacy|0|||
128782960|NCT05550337|463496160|FG002|Overall Study|Lack of Efficacy|1|||
128782961|NCT05550337|463496158|FG000|Overall Study|Adverse Event|1|||
128782962|NCT05550337|463496159|FG001|Overall Study|Adverse Event|5|||
128782963|NCT05550337|463496160|FG002|Overall Study|Adverse Event|0|||
128782964|NCT05550337|463496158|FG000|Overall Study|Withdrawal by Subject|8|||
128782965|NCT05550337|463496159|FG001|Overall Study|Withdrawal by Subject|14|||
128782966|NCT05550337|463496160|FG002|Overall Study|Withdrawal by Subject|10|||
128782967|NCT05550337|463496158|FG000|Overall Study|Pregnancy|0|||
128782968|NCT05550337|463496159|FG001|Overall Study|Pregnancy|0|||
128782969|NCT05550337|463496160|FG002|Overall Study|Pregnancy|1|||
128782970|NCT05550337|463496158|FG000|Overall Study|Protocol Violation|1|||
128735308|NCT04666259|463321745|FG002|Safety Follow-up Phase|Subject decision|0|||
128735309|NCT04666259|463321743|FG000|Safety Follow-up Phase|Death|0|||
128735310|NCT04666259|463321744|FG001|Safety Follow-up Phase|Death|1|||
128735311|NCT04666259|463321745|FG002|Safety Follow-up Phase|Death|0|||
128735312|NCT01565291|463321746|FG000|Overall Study|Withdrawal by Subject|1|||
128735313|NCT01565291|463321747|FG001|Overall Study|Withdrawal by Subject|0|||
128735314|NCT00515827|463321748|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
128735315|NCT00515827|463321749|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
128735316|NCT00515827|463321748|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
128735317|NCT00515827|463321749|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
128735318|NCT05402995|463321750|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
128735319|NCT05402995|463321751|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
128735320|NCT05402995|463321752|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
128735321|NCT05402995|463321753|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
128735322|NCT02188485|463321768|FG000|Overall Study|Withdrawal by Subject|2|||
128735323|NCT02188485|463321769|FG001|Overall Study|Withdrawal by Subject|1|||
128735324|NCT02188485|463321768|FG000|Overall Study|PI withdrew, lack of capacity|0|||
128735325|NCT02188485|463321769|FG001|Overall Study|PI withdrew, lack of capacity|2|||
128735326|NCT03149237|463321770|FG000|Overall Study|Withdrawal by Subject|4|||
128735327|NCT03149237|463321771|FG001|Overall Study|Withdrawal by Subject|5|||
128735328|NCT01466192|463321772|FG000|Overall Study|Physician Decision|1|||
128735329|NCT01466192|463321772|FG000|Overall Study|Withdrawal by Subject|3|||
128735330|NCT02774681|463321775|FG000|Treatment on Study|Progressive Disease|7|||
128735331|NCT02774681|463321775|FG000|Follow-Up for 3 Years|Death|11|||
128735332|NCT02774681|463321775|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
128735333|NCT01069289|463321779|FG000|Overall Study|Withdrawal by Subject|15|||
128735334|NCT01069289|463321780|FG001|Overall Study|Withdrawal by Subject|26|||
128735335|NCT01069289|463321779|FG000|Overall Study|Adverse Event|21|||
128735336|NCT01069289|463321780|FG001|Overall Study|Adverse Event|28|||
128735337|NCT01069289|463321779|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
128735338|NCT01069289|463321780|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
128735339|NCT01069289|463321779|FG000|Overall Study|Severe non-compliance to protocol|3|||
128735340|NCT01069289|463321780|FG001|Overall Study|Severe non-compliance to protocol|2|||
128735341|NCT01069289|463321779|FG000|Overall Study|Due to deteriorating health condition|1|||
128735342|NCT01069289|463321780|FG001|Overall Study|Due to deteriorating health condition|0|||
128735343|NCT00298038|463321781|FG000|Overall Study|Lost to Follow-up|0|||
128735344|NCT00298038|463321782|FG001|Overall Study|Lost to Follow-up|1|||
128782971|NCT05550337|463496159|FG001|Overall Study|Protocol Violation|3|||
128782972|NCT05550337|463496160|FG002|Overall Study|Protocol Violation|4|||
128782973|NCT05550337|463496158|FG000|Overall Study|Physician Decision|2|||
128782974|NCT05550337|463496159|FG001|Overall Study|Physician Decision|1|||
128735345|NCT00298038|463321781|FG000|Overall Study|Liver Transplant|0|||
128735346|NCT00298038|463321782|FG001|Overall Study|Liver Transplant|1|||
128735347|NCT00298038|463321781|FG000|Overall Study|Protocol Violation|1|||
128735348|NCT00298038|463321782|FG001|Overall Study|Protocol Violation|3|||
128782975|NCT05550337|463496160|FG002|Overall Study|Physician Decision|1|||
128782976|NCT05550337|463496158|FG000|Overall Study|Lost to Follow-up|16|||
128782977|NCT05550337|463496159|FG001|Overall Study|Lost to Follow-up|11|||
128782978|NCT05550337|463496160|FG002|Overall Study|Lost to Follow-up|11|||
128782979|NCT03115346|463496162|FG000|Overall Study|Did not have AAA surgery|28|||
128782980|NCT03115346|463496163|FG001|Overall Study|Did not have AAA surgery|15|||
128782981|NCT03115346|463496162|FG000|Overall Study|Death|3|||
128782982|NCT03115346|463496163|FG001|Overall Study|Death|1|||
128782983|NCT03115346|463496162|FG000|Overall Study|Withdrawal by Subject|0|||
128782984|NCT03115346|463496163|FG001|Overall Study|Withdrawal by Subject|3|||
128782985|NCT03115346|463496162|FG000|Overall Study|Lost to Follow-up|0|||
128782986|NCT03115346|463496163|FG001|Overall Study|Lost to Follow-up|3|||
128782987|NCT01737268|463496165|FG000|Overall Study|Adverse Event|6|||
128782988|NCT01737268|463496165|FG000|Overall Study|Worsening of Target Disease|2|||
128782989|NCT01737268|463496165|FG000|Overall Study|In consideration of the patient's safety|1|||
128782990|NCT00828919|463496173|FG000|Overall Study|Death|0|||
128782991|NCT00828919|463496174|FG001|Overall Study|Death|1|||
128782992|NCT00828919|463496175|FG002|Overall Study|Death|2|||
128782993|NCT00828919|463496176|FG003|Overall Study|Death|0|||
128782994|NCT00828919|463496177|FG004|Overall Study|Death|0|||
128782995|NCT00828919|463496173|FG000|Overall Study|Adverse Event|2|||
128782996|NCT00828919|463496174|FG001|Overall Study|Adverse Event|2|||
128782997|NCT00828919|463496175|FG002|Overall Study|Adverse Event|2|||
128782998|NCT00828919|463496176|FG003|Overall Study|Adverse Event|1|||
128782999|NCT00828919|463496177|FG004|Overall Study|Adverse Event|3|||
128783000|NCT00828919|463496173|FG000|Overall Study|Objective progression or relapse|4|||
128783001|NCT00828919|463496174|FG001|Overall Study|Objective progression or relapse|4|||
128783002|NCT00828919|463496175|FG002|Overall Study|Objective progression or relapse|11|||
128783003|NCT00828919|463496176|FG003|Overall Study|Objective progression or relapse|0|||
128783004|NCT00828919|463496177|FG004|Overall Study|Objective progression or relapse|5|||
128783005|NCT00828919|463496173|FG000|Overall Study|No longer willing to participate in study|0|||
128783006|NCT00828919|463496174|FG001|Overall Study|No longer willing to participate in study|0|||
128783007|NCT00828919|463496175|FG002|Overall Study|No longer willing to participate in study|2|||
128783008|NCT00828919|463496176|FG003|Overall Study|No longer willing to participate in study|0|||
128783009|NCT00828919|463496177|FG004|Overall Study|No longer willing to participate in study|0|||
128783010|NCT00828919|463496173|FG000|Overall Study|Insufficient Clinical Response|0|||
128783011|NCT00828919|463496174|FG001|Overall Study|Insufficient Clinical Response|1|||
128783012|NCT00828919|463496175|FG002|Overall Study|Insufficient Clinical Response|2|||
128783013|NCT00828919|463496176|FG003|Overall Study|Insufficient Clinical Response|0|||
128783014|NCT00828919|463496177|FG004|Overall Study|Insufficient Clinical Response|0|||
128783015|NCT00828919|463496173|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
128783016|NCT00828919|463496174|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
128783017|NCT00828919|463496175|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
128783018|NCT00828919|463496176|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
128783019|NCT00828919|463496177|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
128783020|NCT00828919|463496173|FG000|Overall Study|Other|1|||
128783021|NCT00828919|463496174|FG001|Overall Study|Other|0|||
128783022|NCT00828919|463496175|FG002|Overall Study|Other|1|||
128783023|NCT00828919|463496176|FG003|Overall Study|Other|1|||
128783024|NCT00828919|463496177|FG004|Overall Study|Other|0|||
128783025|NCT00828919|463496173|FG000|Overall Study|Lost to Follow-up|0|||
128783026|NCT00828919|463496174|FG001|Overall Study|Lost to Follow-up|1|||
128783027|NCT00828919|463496175|FG002|Overall Study|Lost to Follow-up|0|||
128783028|NCT00828919|463496176|FG003|Overall Study|Lost to Follow-up|0|||
128783029|NCT00828919|463496177|FG004|Overall Study|Lost to Follow-up|0|||
128783030|NCT05567159|463496178|FG000|Overall Study|Adverse Event|4|||
128783031|NCT05567159|463496178|FG000|Overall Study|Physician Decision|3|||
128783032|NCT05567159|463496178|FG000|Overall Study|Protocol deviation|1|||
128783033|NCT02501811|463496181|FG000|Overall Study|Death|1|||
128783034|NCT02501811|463496182|FG001|Overall Study|Death|3|||
128783035|NCT02501811|463496183|FG002|Overall Study|Death|2|||
128783036|NCT02501811|463496184|FG003|Overall Study|Death|3|||
128783037|NCT02501811|463496181|FG000|Overall Study|Withdrawal by Subject|3|||
128783038|NCT02501811|463496182|FG001|Overall Study|Withdrawal by Subject|3|||
128783039|NCT02501811|463496183|FG002|Overall Study|Withdrawal by Subject|2|||
128783040|NCT02501811|463496184|FG003|Overall Study|Withdrawal by Subject|3|||
128783041|NCT02501811|463496181|FG000|Overall Study|Lost to Follow-up|0|||
128783042|NCT02501811|463496182|FG001|Overall Study|Lost to Follow-up|0|||
128783043|NCT02501811|463496183|FG002|Overall Study|Lost to Follow-up|2|||
128783044|NCT02501811|463496184|FG003|Overall Study|Lost to Follow-up|1|||
128783045|NCT00359619|463497940|FG000|Overall Study|Adverse Event|0|||
128783046|NCT00359619|463497941|FG001|Overall Study|Adverse Event|0|||
128783047|NCT00359619|463497942|FG002|Overall Study|Adverse Event|1|||
128783048|NCT00359619|463497943|FG003|Overall Study|Adverse Event|0|||
128783049|NCT00359619|463497944|FG004|Overall Study|Adverse Event|0|||
128783050|NCT00359619|463497945|FG005|Overall Study|Adverse Event|0|||
128783051|NCT00359619|463497946|FG006|Overall Study|Adverse Event|1|||
128783052|NCT00359619|463497940|FG000|Overall Study|Withdrawal by Subject|3|||
128783053|NCT00359619|463497941|FG001|Overall Study|Withdrawal by Subject|1|||
128783054|NCT00359619|463497942|FG002|Overall Study|Withdrawal by Subject|4|||
128783055|NCT00359619|463497943|FG003|Overall Study|Withdrawal by Subject|2|||
128783056|NCT00359619|463497944|FG004|Overall Study|Withdrawal by Subject|2|||
128783057|NCT00359619|463497945|FG005|Overall Study|Withdrawal by Subject|0|||
128783058|NCT00359619|463497946|FG006|Overall Study|Withdrawal by Subject|3|||
129204299|NCT04154943|465045773|FG000|Overall Study|Decision by the Investigator|1|||
129204300|NCT04154943|465045773|FG000|Overall Study|Death|5|||
129204301|NCT04154943|465045773|FG000|Overall Study|Withdrawal by Subject|4|||
129204302|NCT01239381|465045774|FG000|Overall Study|Protocol Violation|1|||
129204303|NCT01239381|465045774|FG000|Overall Study|Withdrawal by Subject|1|||
129204304|NCT06237049|465045775|FG000|Overall Study|Death|0|||
129204305|NCT06237049|465045776|FG001|Overall Study|Death|0|||
129204306|NCT06237049|465045777|FG002|Overall Study|Death|0|||
129204307|NCT06237049|465045778|FG003|Overall Study|Death|1|||
129204308|NCT06237049|465045775|FG000|Overall Study|Lost to Follow-up|11|||
129204309|NCT06237049|465045776|FG001|Overall Study|Lost to Follow-up|5|||
129204310|NCT06237049|465045777|FG002|Overall Study|Lost to Follow-up|8|||
129204311|NCT06237049|465045778|FG003|Overall Study|Lost to Follow-up|8|||
129204312|NCT06237049|465045775|FG000|Overall Study|Protocol Violation|0|||
129204313|NCT06237049|465045776|FG001|Overall Study|Protocol Violation|1|||
129204314|NCT06237049|465045777|FG002|Overall Study|Protocol Violation|0|||
129204315|NCT06237049|465045778|FG003|Overall Study|Protocol Violation|1|||
129204316|NCT06237049|465045775|FG000|Overall Study|Withdrawal by Subject|4|||
129204317|NCT06237049|465045776|FG001|Overall Study|Withdrawal by Subject|2|||
129204318|NCT06237049|465045777|FG002|Overall Study|Withdrawal by Subject|1|||
129204319|NCT06237049|465045778|FG003|Overall Study|Withdrawal by Subject|0|||
129204320|NCT02738008|465045779|FG000|Overall Study|Study Terminated by Sponsor|1|||
129204321|NCT02738008|465045780|FG001|Overall Study|Study Terminated by Sponsor|5|||
129204322|NCT02738008|465045781|FG002|Overall Study|Study Terminated by Sponsor|3|||
129204323|NCT02738008|465045779|FG000|Overall Study|Adverse Event|0|||
129204324|NCT02738008|465045780|FG001|Overall Study|Adverse Event|1|||
129204325|NCT02738008|465045781|FG002|Overall Study|Adverse Event|2|||
129204326|NCT04621448|465045782|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
129204327|NCT04621448|465045783|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
129204328|NCT04621448|465045784|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
129204329|NCT04621448|465045785|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
129204330|NCT04621448|465045782|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
129204331|NCT04621448|465045783|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
129204332|NCT04621448|465045784|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
129204333|NCT04621448|465045785|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
129204334|NCT04621448|465045782|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
129204335|NCT04621448|465045783|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
129204336|NCT04621448|465045784|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
129204337|NCT04621448|465045785|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
129204338|NCT04621448|465045782|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
129204339|NCT04621448|465045783|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
129204340|NCT04621448|465045784|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
129204341|NCT04621448|465045785|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
129204342|NCT03550378|465045786|FG000|Overall Study|Death|0|||
129204343|NCT03550378|465045787|FG001|Overall Study|Death|1|||
129204344|NCT04590014|465045790|FG000|Overall Study|Withdrawal by Subject|1|||
129204345|NCT04590014|465045791|FG001|Overall Study|Withdrawal by Subject|0|||
129204346|NCT00468299|465045792|FG000|Overall Study|Withdrawal by Subject|0|||
129204347|NCT00468299|465045793|FG001|Overall Study|Withdrawal by Subject|1|||
128783059|NCT00359619|463497940|FG000|Overall Study|Other|1|||
128783060|NCT00359619|463497941|FG001|Overall Study|Other|0|||
128783061|NCT00359619|463497942|FG002|Overall Study|Other|0|||
128783062|NCT00359619|463497943|FG003|Overall Study|Other|0|||
128783063|NCT00359619|463497944|FG004|Overall Study|Other|0|||
128783064|NCT00359619|463497945|FG005|Overall Study|Other|0|||
128783065|NCT00359619|463497946|FG006|Overall Study|Other|0|||
128783066|NCT00359619|463497940|FG000|Overall Study|Lost to Follow-up|4|||
128783067|NCT00359619|463497941|FG001|Overall Study|Lost to Follow-up|4|||
128783068|NCT00359619|463497942|FG002|Overall Study|Lost to Follow-up|2|||
128783069|NCT00359619|463497943|FG003|Overall Study|Lost to Follow-up|1|||
128783070|NCT00359619|463497944|FG004|Overall Study|Lost to Follow-up|1|||
128783071|NCT00359619|463497945|FG005|Overall Study|Lost to Follow-up|5|||
128783072|NCT00359619|463497946|FG006|Overall Study|Lost to Follow-up|0|||
128783073|NCT00256308|463497949|FG000|Overall Study|Death|2|||
128783074|NCT01419717|463497950|FG000|Overall Study|Protocol-specified Criteria|62|||
128783075|NCT01419717|463497950|FG000|Overall Study|Adverse Event|19|||
128783076|NCT01419717|463497950|FG000|Overall Study|Death|17|||
128783077|NCT01419717|463497950|FG000|Overall Study|Withdrawal by Subject|10|||
128783078|NCT01419717|463497950|FG000|Overall Study|Disease Progression|9|||
128783079|NCT01419717|463497950|FG000|Overall Study|Other|4|||
128783080|NCT01419717|463497950|FG000|Overall Study|Lost to Follow-up|2|||
128783081|NCT01419717|463497950|FG000|Overall Study|Administrative Decision|1|||
128783082|NCT01419717|463497950|FG000|Overall Study|Noncompliance|1|||
128783083|NCT02857283|463497951|FG000|First Exposure|Withdrawal by Subject|1|||
128783084|NCT02857283|463497952|FG001|First Exposure|Withdrawal by Subject|0|||
128783085|NCT05074498|463497957|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
128783086|NCT05074498|463497958|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
128783087|NCT05074498|463497959|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
128783088|NCT05074498|463497960|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
128783089|NCT05074498|463497961|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
128783090|NCT05074498|463497962|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
128783091|NCT05074498|463497957|FG000|Part 1 (Upto Day 104)|Other|1|||
128783092|NCT05074498|463497958|FG001|Part 1 (Upto Day 104)|Other|0|||
128783093|NCT05074498|463497959|FG002|Part 1 (Upto Day 104)|Other|0|||
128783094|NCT05074498|463497960|FG003|Part 1 (Upto Day 104)|Other|0|||
128783095|NCT05074498|463497961|FG004|Part 1 (Upto Day 104)|Other|0|||
128783096|NCT05074498|463497962|FG005|Part 1 (Upto Day 104)|Other|0|||
128783097|NCT05074498|463497957|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128783098|NCT05074498|463497958|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128783099|NCT05074498|463497959|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128783100|NCT05074498|463497960|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128783101|NCT05074498|463497961|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
128783102|NCT05074498|463497962|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
128783103|NCT05074498|463497957|FG000|Part 2 (Upto Day 104)|Death|0|||
128783104|NCT05074498|463497958|FG001|Part 2 (Upto Day 104)|Death|0|||
128783105|NCT05074498|463497959|FG002|Part 2 (Upto Day 104)|Death|0|||
128783106|NCT05074498|463497960|FG003|Part 2 (Upto Day 104)|Death|0|||
128783107|NCT05074498|463497961|FG004|Part 2 (Upto Day 104)|Death|1|||
128783108|NCT05074498|463497962|FG005|Part 2 (Upto Day 104)|Death|0|||
128783109|NCT05074498|463497957|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
128783110|NCT05074498|463497958|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
128783111|NCT05074498|463497959|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
128783112|NCT05074498|463497960|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
128783113|NCT05074498|463497961|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
128783114|NCT05074498|463497962|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
128783115|NCT05074498|463497957|FG000|Part 2 (Upto Day 104)|Other|0|||
128783116|NCT05074498|463497958|FG001|Part 2 (Upto Day 104)|Other|0|||
128783117|NCT05074498|463497959|FG002|Part 2 (Upto Day 104)|Other|0|||
128783118|NCT05074498|463497960|FG003|Part 2 (Upto Day 104)|Other|0|||
128783119|NCT05074498|463497961|FG004|Part 2 (Upto Day 104)|Other|1|||
128783120|NCT05074498|463497962|FG005|Part 2 (Upto Day 104)|Other|0|||
128783121|NCT01240356|463497963|FG000|Overall Study|Withdrawal by Subject|2|||
128783122|NCT01240356|463497964|FG001|Overall Study|Withdrawal by Subject|0|||
128783123|NCT01240356|463497963|FG000|Overall Study|MRI contraindication|1|||
128783124|NCT01240356|463497964|FG001|Overall Study|MRI contraindication|0|||
128783125|NCT01390857|463497969|FG000|Overall Study|Protocol Violation|2|||
128783126|NCT01390857|463497969|FG000|Overall Study|Lost to Follow-up|1|||
128783127|NCT01390857|463497969|FG000|Overall Study|No Visit after the First Visit|7|||
128783128|NCT00058058|463497984|FG000|Overall Study|Withdrawal by Subject|4|||
128783129|NCT00058058|463497984|FG000|Overall Study|Ineligible|20|||
128783130|NCT00058058|463497984|FG000|Overall Study|Claustrophobic|5|||
128783131|NCT00058058|463497984|FG000|Overall Study|technical issues|6|||
128783132|NCT00058058|463497984|FG000|Overall Study|Poor positioning, illness,pain|3|||
128783133|NCT03085017|463497985|FG000|Overall Study|Death|0|||
128783134|NCT03085017|463497986|FG001|Overall Study|Death|3|||
128783135|NCT03613129|463497987|FG000|Pre-treatment Assessment|Protocol Violation|2|||
128783136|NCT03613129|463497988|FG001|Pre-treatment Assessment|Protocol Violation|0|||
128783137|NCT03613129|463497989|FG002|Pre-treatment Assessment|Protocol Violation|0|||
128783138|NCT03613129|463497990|FG003|Pre-treatment Assessment|Protocol Violation|0|||
128735349|NCT00298038|463321781|FG000|Overall Study|Death|6|||
128735350|NCT00298038|463321782|FG001|Overall Study|Death|3|||
128735351|NCT00298038|463321781|FG000|Overall Study|Withdrawal by Subject|6|||
128735352|NCT00298038|463321782|FG001|Overall Study|Withdrawal by Subject|9|||
128735353|NCT00298038|463321781|FG000|Overall Study|Adverse Event|8|||
128735354|NCT00298038|463321782|FG001|Overall Study|Adverse Event|7|||
128735355|NCT00298038|463321781|FG000|Overall Study|Breakthrough overt HE episode|28|||
128735356|NCT00298038|463321782|FG001|Overall Study|Breakthrough overt HE episode|69|||
128735357|NCT00298038|463321781|FG000|Overall Study|Noncompliance|1|||
128735358|NCT00298038|463321782|FG001|Overall Study|Noncompliance|0|||
128735359|NCT00298038|463321781|FG000|Overall Study|Cocaine Abuse|1|||
128783139|NCT03613129|463497991|FG004|Pre-treatment Assessment|Protocol Violation|0|||
128783140|NCT03613129|463497987|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
128735360|NCT00298038|463321782|FG001|Overall Study|Cocaine Abuse|0|||
128735361|NCT00298038|463321781|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
128735362|NCT00298038|463321782|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
128735363|NCT02696096|463321783|FG000|Overall Study|ruled out at screening|1|||
128735364|NCT02696096|463321783|FG000|Overall Study|did not attend second fMRI|1|||
128735365|NCT00773097|463321784|FG000|Overall Study|Withdrawal by Subject|1|||
128735366|NCT00773097|463321784|FG000|Overall Study|Physician Decision|6|||
128735367|NCT02707640|463321785|FG000|Overall Study|Adverse Event|4|||
128735368|NCT02707640|463321786|FG001|Overall Study|Adverse Event|2|||
128735369|NCT02707640|463321785|FG000|Overall Study|Death|1|||
128735370|NCT02707640|463321786|FG001|Overall Study|Death|2|||
128735371|NCT02707640|463321785|FG000|Overall Study|Physician Decision|2|||
128735372|NCT02707640|463321786|FG001|Overall Study|Physician Decision|0|||
128735373|NCT02707640|463321785|FG000|Overall Study|Withdrawal by Subject|0|||
128735374|NCT02707640|463321786|FG001|Overall Study|Withdrawal by Subject|1|||
128735375|NCT02707640|463321785|FG000|Overall Study|Participant's Personal Decision|1|||
128735376|NCT02707640|463321786|FG001|Overall Study|Participant's Personal Decision|2|||
128735377|NCT02707640|463321785|FG000|Overall Study|Sponsor Discretion|1|||
128735378|NCT02707640|463321786|FG001|Overall Study|Sponsor Discretion|0|||
128735379|NCT02517905|463321787|FG000|Overall Study|Lost to Follow-up|4|||
128735380|NCT02517905|463321788|FG001|Overall Study|Lost to Follow-up|0|||
128735381|NCT02517905|463321787|FG000|Overall Study|Withdrawal by Subject|4|||
128735382|NCT02517905|463321788|FG001|Overall Study|Withdrawal by Subject|0|||
128735383|NCT02517905|463321787|FG000|Overall Study|Screen failure|2|||
128735384|NCT02517905|463321788|FG001|Overall Study|Screen failure|2|||
128982145|NCT00508820|464219106|FG000|Overall Study|Requirement for alternative therapy|7|||
128982146|NCT00508820|464219107|FG001|Overall Study|Requirement for alternative therapy|15|||
128982147|NCT00508820|464219106|FG000|Overall Study|Protocol-specified Criteria|3|||
128982148|NCT00508820|464219107|FG001|Overall Study|Protocol-specified Criteria|12|||
129204348|NCT04264442|465045796|FG000|Overall Study|Lack of Efficacy|6|||
129204349|NCT04264442|465045796|FG000|Overall Study|Lost to Follow-up|2|||
129204350|NCT04264442|465045796|FG000|Overall Study|Sponsor Decision|23|||
129204351|NCT04264442|465045796|FG000|Overall Study|Withdrawal by Subject|11|||
129204352|NCT04264442|465045796|FG000|Overall Study|Study Termination|5|||
129204353|NCT01384734|465045798|FG000|Overall Study|Adverse Event|0|||
129204354|NCT01384734|465045799|FG001|Overall Study|Adverse Event|3|||
129204355|NCT01384734|465045800|FG002|Overall Study|Adverse Event|0|||
129204356|NCT01384734|465045801|FG003|Overall Study|Adverse Event|2|||
129204357|NCT01384734|465045802|FG004|Overall Study|Adverse Event|7|||
129204358|NCT01384734|465045798|FG000|Overall Study|Death|1|||
129204359|NCT01384734|465045799|FG001|Overall Study|Death|0|||
128735401|NCT01755416|463321796|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
128735402|NCT01755416|463321797|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
128735403|NCT01607905|463323271|FG000|Overall Study|Withdrawal by participant|7|||
128735404|NCT01607905|463323272|FG001|Overall Study|Withdrawal by participant|2|||
128735405|NCT01607905|463323273|FG002|Overall Study|Withdrawal by participant|4|||
128735406|NCT01607905|463323274|FG003|Overall Study|Withdrawal by participant|6|||
128735407|NCT01607905|463323275|FG004|Overall Study|Withdrawal by participant|0|||
128735408|NCT01607905|463323276|FG005|Overall Study|Withdrawal by participant|4|||
128735409|NCT01607905|463323277|FG006|Overall Study|Withdrawal by participant|12|||
128735410|NCT01607905|463323271|FG000|Overall Study|Incidence or severity of AEs|5|||
128735411|NCT01607905|463323272|FG001|Overall Study|Incidence or severity of AEs|1|||
128735412|NCT01607905|463323273|FG002|Overall Study|Incidence or severity of AEs|1|||
128735413|NCT01607905|463323274|FG003|Overall Study|Incidence or severity of AEs|3|||
128735414|NCT01607905|463323275|FG004|Overall Study|Incidence or severity of AEs|0|||
128735415|NCT01607905|463323276|FG005|Overall Study|Incidence or severity of AEs|2|||
128735416|NCT01607905|463323277|FG006|Overall Study|Incidence or severity of AEs|8|||
128735417|NCT01607905|463323271|FG000|Overall Study|Disease progression|44|||
128735418|NCT01607905|463323272|FG001|Overall Study|Disease progression|16|||
128735419|NCT01607905|463323273|FG002|Overall Study|Disease progression|15|||
128735420|NCT01607905|463323274|FG003|Overall Study|Disease progression|11|||
128735421|NCT01607905|463323275|FG004|Overall Study|Disease progression|6|||
128735422|NCT01607905|463323276|FG005|Overall Study|Disease progression|7|||
128735423|NCT01607905|463323277|FG006|Overall Study|Disease progression|21|||
128735424|NCT01607905|463323271|FG000|Overall Study|Non-compliance with study procedures|0|||
128735425|NCT01607905|463323272|FG001|Overall Study|Non-compliance with study procedures|0|||
128735426|NCT01607905|463323273|FG002|Overall Study|Non-compliance with study procedures|0|||
128735427|NCT01607905|463323274|FG003|Overall Study|Non-compliance with study procedures|0|||
128735428|NCT01607905|463323275|FG004|Overall Study|Non-compliance with study procedures|0|||
128735429|NCT01607905|463323276|FG005|Overall Study|Non-compliance with study procedures|0|||
128735430|NCT01607905|463323277|FG006|Overall Study|Non-compliance with study procedures|1|||
128735431|NCT01607905|463323271|FG000|Overall Study|Death|1|||
128735432|NCT01607905|463323272|FG001|Overall Study|Death|1|||
128735433|NCT01607905|463323273|FG002|Overall Study|Death|1|||
128735434|NCT01607905|463323274|FG003|Overall Study|Death|1|||
128735435|NCT01607905|463323275|FG004|Overall Study|Death|0|||
129204360|NCT01384734|465045800|FG002|Overall Study|Death|1|||
128783141|NCT03613129|463497988|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
128783142|NCT03613129|463497989|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
128783143|NCT03613129|463497990|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
128783144|NCT03613129|463497991|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
128783145|NCT01770860|463497994|FG000|Overall Study|Withdrawal by Subject|4|||
128783146|NCT01770860|463497994|FG000|Overall Study|Lost to Follow-up|1|||
128783147|NCT01770860|463497994|FG000|Overall Study|Administrative decision made by the PI|1|||
128783148|NCT03432533|463497995|FG000|Overall Study|Lost to Follow-up|1|||
128783149|NCT03432533|463497996|FG001|Overall Study|Lost to Follow-up|2|||
128783150|NCT03432533|463497995|FG000|Overall Study|Withdrawal by Subject|14|||
128783151|NCT03432533|463497996|FG001|Overall Study|Withdrawal by Subject|9|||
128783152|NCT02095158|463498002|FG000|Overall Study|Adverse Event|14|||
128783153|NCT02095158|463498002|FG000|Overall Study|Lack of Efficacy|3|||
128783154|NCT02095158|463498002|FG000|Overall Study|Pregnancy|1|||
128783155|NCT02095158|463498002|FG000|Overall Study|Lost to Follow-up|20|||
128783156|NCT02095158|463498002|FG000|Overall Study|Personal Reasons|35|||
128783157|NCT02095158|463498002|FG000|Overall Study|Protocol Violation|1|||
128783158|NCT02095158|463498002|FG000|Overall Study|Other Miscellaneous Reasons|1|||
128783159|NCT01008748|463498003|FG000|Overall Study|Lost to Follow-up|80|||
128783160|NCT01008748|463498003|FG000|Overall Study|Other|1|||
128783161|NCT01740557|463498004|FG000|Overall Study|Ineligible|1|||
128783162|NCT01740557|463498004|FG000|Overall Study|Screen failure|1|||
128783163|NCT01268566|463498005|FG000|Overall Study|Lost to Follow-up|1|||
128783164|NCT01268566|463498005|FG000|Overall Study|Withdrawal by Subject|12|||
128783165|NCT01268566|463498005|FG000|Overall Study|Death|30|||
128783166|NCT02138916|463498006|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
128783167|NCT02138916|463498007|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
128783168|NCT02138916|463498008|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
128783169|NCT02138916|463498006|FG000|Overall Study|Death|14|||
128783170|NCT02138916|463498007|FG001|Overall Study|Death|11|||
128783171|NCT02138916|463498008|FG002|Overall Study|Death|12|||
128783172|NCT02138916|463498006|FG000|Overall Study|Withdrawal by Subject|27|||
128783173|NCT02138916|463498007|FG001|Overall Study|Withdrawal by Subject|31|||
128783174|NCT02138916|463498008|FG002|Overall Study|Withdrawal by Subject|32|||
128783175|NCT02138916|463498006|FG000|Overall Study|Study specific withdrawal criteria|0|||
128783176|NCT02138916|463498007|FG001|Overall Study|Study specific withdrawal criteria|0|||
128783177|NCT02138916|463498008|FG002|Overall Study|Study specific withdrawal criteria|1|||
128783178|NCT02138916|463498006|FG000|Overall Study|incorrect enrolment|1|||
128783179|NCT02138916|463498007|FG001|Overall Study|incorrect enrolment|1|||
128783180|NCT02138916|463498008|FG002|Overall Study|incorrect enrolment|0|||
128783181|NCT02138916|463498006|FG000|Overall Study|Severe non-compliance|1|||
128783182|NCT02138916|463498007|FG001|Overall Study|Severe non-compliance|2|||
128783183|NCT02138916|463498008|FG002|Overall Study|Severe non-compliance|1|||
128783184|NCT02138916|463498006|FG000|Overall Study|Lost to Follow-up|4|||
128783185|NCT02138916|463498007|FG001|Overall Study|Lost to Follow-up|2|||
128783186|NCT02138916|463498008|FG002|Overall Study|Lost to Follow-up|3|||
128783187|NCT02138916|463498006|FG000|Overall Study|Adverse Event|4|||
128783188|NCT02138916|463498007|FG001|Overall Study|Adverse Event|4|||
128783189|NCT02138916|463498008|FG002|Overall Study|Adverse Event|3|||
128783190|NCT04794179|463498009|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
128783191|NCT04794179|463498010|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
128783192|NCT01190176|463498013|FG000|Overall Study|Withdrawal by Subject|1|||
128783193|NCT01190176|463498013|FG000|Overall Study|Lost to Follow-up|1|||
128783194|NCT03697460|463498014|FG000|Overall Study|Withdrawal by Subject|3|||
128783195|NCT03499600|463498016|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
128783196|NCT03499600|463498017|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
128783197|NCT00445692|463498018|FG000|Overall Study|Adverse Event|11|||
128783198|NCT00445692|463498018|FG000|Overall Study|Lack of Efficacy|5|||
128783199|NCT03425539|463498020|FG000|Overall Study|Randomized but not treated|0|||
128783200|NCT03425539|463498021|FG001|Overall Study|Randomized but not treated|1|||
128783201|NCT03425539|463498020|FG000|Overall Study|Adverse Event|2|||
128783202|NCT03425539|463498021|FG001|Overall Study|Adverse Event|2|||
128783203|NCT03425539|463498020|FG000|Overall Study|Withdrawal by Subject|3|||
128783204|NCT03425539|463498021|FG001|Overall Study|Withdrawal by Subject|0|||
128783205|NCT03425539|463498020|FG000|Overall Study|Lost to Follow-up|0|||
128783206|NCT03425539|463498021|FG001|Overall Study|Lost to Follow-up|1|||
128783207|NCT01137292|463498022|FG000|Overall Study|Death|30|||
128783208|NCT01137292|463498022|FG000|Overall Study|Adverse Event|3|||
128783209|NCT01137292|463498022|FG000|Overall Study|Lack of Efficacy|13|||
128783210|NCT01137292|463498022|FG000|Overall Study|Lost to Follow-up|1|||
128783211|NCT01137292|463498022|FG000|Overall Study|Other|7|||
128783212|NCT02040844|463498027|FG000|Overall Study|Adverse Event|0|||
128783213|NCT02040844|463498028|FG001|Overall Study|Adverse Event|0|||
128783214|NCT02040844|463498029|FG002|Overall Study|Adverse Event|1|||
128783215|NCT02040844|463498027|FG000|Overall Study|Withdrawal by Subject|16|||
128783216|NCT02040844|463498028|FG001|Overall Study|Withdrawal by Subject|22|||
128735436|NCT01607905|463323276|FG005|Overall Study|Death|0|||
128735437|NCT01607905|463323277|FG006|Overall Study|Death|3|||
128735438|NCT01607905|463323271|FG000|Overall Study|Other treatments become available|1|||
128735439|NCT01607905|463323272|FG001|Overall Study|Other treatments become available|0|||
128735440|NCT01607905|463323273|FG002|Overall Study|Other treatments become available|0|||
128783217|NCT02040844|463498029|FG002|Overall Study|Withdrawal by Subject|25|||
128783218|NCT02040844|463498027|FG000|Overall Study|Lost to Follow-up|12|||
128783219|NCT02040844|463498028|FG001|Overall Study|Lost to Follow-up|9|||
128783220|NCT02040844|463498029|FG002|Overall Study|Lost to Follow-up|13|||
128783221|NCT02040844|463498027|FG000|Overall Study|Missing|13|||
128783222|NCT02040844|463498028|FG001|Overall Study|Missing|3|||
128783223|NCT02040844|463498029|FG002|Overall Study|Missing|2|||
128783224|NCT02040844|463498027|FG000|Overall Study|Non-specified|8|||
128783225|NCT02040844|463498028|FG001|Overall Study|Non-specified|2|||
128783226|NCT02040844|463498029|FG002|Overall Study|Non-specified|5|||
128783227|NCT02040844|463498027|FG000|Overall Study|Concomitant medication|1|||
128783228|NCT02040844|463498028|FG001|Overall Study|Concomitant medication|3|||
128783229|NCT02040844|463498029|FG002|Overall Study|Concomitant medication|1|||
128783230|NCT02014558|463498030|FG000|Overall Study|Never Received Study Drug|0|||
128783231|NCT02014558|463498031|FG001|Overall Study|Never Received Study Drug|0|||
128783232|NCT02014558|463498032|FG002|Overall Study|Never Received Study Drug|0|||
128783233|NCT02014558|463498033|FG003|Overall Study|Never Received Study Drug|0|||
128783234|NCT02014558|463498034|FG004|Overall Study|Never Received Study Drug|1|||
128783235|NCT02014558|463498035|FG005|Overall Study|Never Received Study Drug|0|||
128783236|NCT02014558|463498036|FG006|Overall Study|Never Received Study Drug|1|||
128783237|NCT02014558|463498037|FG007|Overall Study|Never Received Study Drug|0|||
128783238|NCT02014558|463498038|FG008|Overall Study|Never Received Study Drug|2|||
128783239|NCT02014558|463498039|FG009|Overall Study|Never Received Study Drug|0|||
128783240|NCT02014558|463498040|FG010|Overall Study|Never Received Study Drug|2|||
128783241|NCT02014558|463498041|FG011|Overall Study|Never Received Study Drug|2|||
128783242|NCT02014558|463498042|FG012|Overall Study|Never Received Study Drug|0|||
128783243|NCT02014558|463498030|FG000|Overall Study|Adverse Event|0|||
128783244|NCT02014558|463498031|FG001|Overall Study|Adverse Event|0|||
128783245|NCT02014558|463498032|FG002|Overall Study|Adverse Event|0|||
128783246|NCT02014558|463498033|FG003|Overall Study|Adverse Event|0|||
128783247|NCT02014558|463498034|FG004|Overall Study|Adverse Event|1|||
128783248|NCT02014558|463498035|FG005|Overall Study|Adverse Event|0|||
128783249|NCT02014558|463498036|FG006|Overall Study|Adverse Event|0|||
128783250|NCT02014558|463498037|FG007|Overall Study|Adverse Event|0|||
128783251|NCT02014558|463498038|FG008|Overall Study|Adverse Event|2|||
128783252|NCT02014558|463498039|FG009|Overall Study|Adverse Event|2|||
128783253|NCT02014558|463498040|FG010|Overall Study|Adverse Event|5|||
128783254|NCT02014558|463498041|FG011|Overall Study|Adverse Event|21|||
128783255|NCT02014558|463498042|FG012|Overall Study|Adverse Event|3|||
128783256|NCT02014558|463498030|FG000|Overall Study|Death|1|||
128783257|NCT02014558|463498031|FG001|Overall Study|Death|0|||
128783258|NCT02014558|463498032|FG002|Overall Study|Death|0|||
128783259|NCT02014558|463498033|FG003|Overall Study|Death|0|||
128783260|NCT02014558|463498034|FG004|Overall Study|Death|0|||
128783261|NCT02014558|463498035|FG005|Overall Study|Death|0|||
128783262|NCT02014558|463498036|FG006|Overall Study|Death|1|||
128783263|NCT02014558|463498037|FG007|Overall Study|Death|1|||
128783264|NCT02014558|463498038|FG008|Overall Study|Death|2|||
128783265|NCT02014558|463498039|FG009|Overall Study|Death|5|||
128783266|NCT02014558|463498040|FG010|Overall Study|Death|5|||
128783267|NCT02014558|463498041|FG011|Overall Study|Death|19|||
128783268|NCT02014558|463498042|FG012|Overall Study|Death|2|||
128783269|NCT02014558|463498030|FG000|Overall Study|Lack of Efficacy|1|||
128783270|NCT02014558|463498031|FG001|Overall Study|Lack of Efficacy|2|||
128783271|NCT02014558|463498032|FG002|Overall Study|Lack of Efficacy|1|||
128783272|NCT02014558|463498033|FG003|Overall Study|Lack of Efficacy|1|||
128783273|NCT02014558|463498034|FG004|Overall Study|Lack of Efficacy|0|||
128783274|NCT02014558|463498035|FG005|Overall Study|Lack of Efficacy|0|||
128783275|NCT02014558|463498036|FG006|Overall Study|Lack of Efficacy|1|||
128783276|NCT02014558|463498037|FG007|Overall Study|Lack of Efficacy|3|||
128783277|NCT02014558|463498038|FG008|Overall Study|Lack of Efficacy|3|||
128783278|NCT02014558|463498039|FG009|Overall Study|Lack of Efficacy|3|||
128783279|NCT02014558|463498040|FG010|Overall Study|Lack of Efficacy|16|||
128783280|NCT02014558|463498041|FG011|Overall Study|Lack of Efficacy|8|||
128783281|NCT02014558|463498042|FG012|Overall Study|Lack of Efficacy|5|||
128783282|NCT02014558|463498030|FG000|Overall Study|Lost to Follow-up|0|||
128783283|NCT02014558|463498031|FG001|Overall Study|Lost to Follow-up|0|||
128735441|NCT01607905|463323274|FG003|Overall Study|Other treatments become available|0|||
128735442|NCT01607905|463323275|FG004|Overall Study|Other treatments become available|0|||
128735443|NCT01607905|463323276|FG005|Overall Study|Other treatments become available|0|||
128735444|NCT01607905|463323277|FG006|Overall Study|Other treatments become available|1|||
128735445|NCT01607905|463323271|FG000|Overall Study|Investigator discretion|0|||
128735446|NCT01607905|463323272|FG001|Overall Study|Investigator discretion|0|||
128735447|NCT01607905|463323273|FG002|Overall Study|Investigator discretion|0|||
128735448|NCT01607905|463323274|FG003|Overall Study|Investigator discretion|0|||
128735449|NCT01607905|463323275|FG004|Overall Study|Investigator discretion|0|||
128735450|NCT01607905|463323276|FG005|Overall Study|Investigator discretion|1|||
128735451|NCT01607905|463323277|FG006|Overall Study|Investigator discretion|0|||
128735452|NCT01607905|463323271|FG000|Overall Study|Other|1|||
128735453|NCT01607905|463323272|FG001|Overall Study|Other|0|||
128735454|NCT01607905|463323273|FG002|Overall Study|Other|0|||
128735455|NCT01607905|463323274|FG003|Overall Study|Other|0|||
128735456|NCT01607905|463323275|FG004|Overall Study|Other|0|||
128735457|NCT01607905|463323276|FG005|Overall Study|Other|0|||
128735458|NCT01607905|463323277|FG006|Overall Study|Other|1|||
128735459|NCT01607905|463323271|FG000|Overall Study|Randomized but not treated|1|||
128735460|NCT01607905|463323272|FG001|Overall Study|Randomized but not treated|0|||
128735461|NCT01607905|463323273|FG002|Overall Study|Randomized but not treated|0|||
128783284|NCT02014558|463498032|FG002|Overall Study|Lost to Follow-up|0|||
128783285|NCT02014558|463498033|FG003|Overall Study|Lost to Follow-up|0|||
128783286|NCT02014558|463498034|FG004|Overall Study|Lost to Follow-up|0|||
128783287|NCT02014558|463498035|FG005|Overall Study|Lost to Follow-up|0|||
128783288|NCT02014558|463498036|FG006|Overall Study|Lost to Follow-up|0|||
128783289|NCT02014558|463498037|FG007|Overall Study|Lost to Follow-up|0|||
128783290|NCT02014558|463498038|FG008|Overall Study|Lost to Follow-up|0|||
128783291|NCT02014558|463498039|FG009|Overall Study|Lost to Follow-up|0|||
128783292|NCT02014558|463498040|FG010|Overall Study|Lost to Follow-up|1|||
128783293|NCT02014558|463498041|FG011|Overall Study|Lost to Follow-up|0|||
128783294|NCT02014558|463498042|FG012|Overall Study|Lost to Follow-up|0|||
128783295|NCT02014558|463498030|FG000|Overall Study|Progressive Disease|1|||
128783296|NCT02014558|463498031|FG001|Overall Study|Progressive Disease|0|||
128783297|NCT02014558|463498032|FG002|Overall Study|Progressive Disease|1|||
128783298|NCT02014558|463498033|FG003|Overall Study|Progressive Disease|1|||
128783299|NCT02014558|463498034|FG004|Overall Study|Progressive Disease|1|||
128783300|NCT02014558|463498035|FG005|Overall Study|Progressive Disease|2|||
128783301|NCT02014558|463498036|FG006|Overall Study|Progressive Disease|1|||
128783302|NCT02014558|463498037|FG007|Overall Study|Progressive Disease|6|||
128783303|NCT02014558|463498038|FG008|Overall Study|Progressive Disease|5|||
128783304|NCT02014558|463498039|FG009|Overall Study|Progressive Disease|6|||
128783305|NCT02014558|463498040|FG010|Overall Study|Progressive Disease|22|||
128783306|NCT02014558|463498041|FG011|Overall Study|Progressive Disease|31|||
128783307|NCT02014558|463498042|FG012|Overall Study|Progressive Disease|6|||
128783308|NCT02014558|463498030|FG000|Overall Study|Withdrawal by Subject|0|||
128783309|NCT02014558|463498031|FG001|Overall Study|Withdrawal by Subject|0|||
128783310|NCT02014558|463498032|FG002|Overall Study|Withdrawal by Subject|0|||
128783311|NCT02014558|463498033|FG003|Overall Study|Withdrawal by Subject|0|||
128783312|NCT02014558|463498034|FG004|Overall Study|Withdrawal by Subject|1|||
128783313|NCT02014558|463498035|FG005|Overall Study|Withdrawal by Subject|0|||
128783314|NCT02014558|463498036|FG006|Overall Study|Withdrawal by Subject|0|||
128783315|NCT02014558|463498037|FG007|Overall Study|Withdrawal by Subject|0|||
128783316|NCT02014558|463498038|FG008|Overall Study|Withdrawal by Subject|0|||
128783317|NCT02014558|463498039|FG009|Overall Study|Withdrawal by Subject|2|||
128783318|NCT02014558|463498040|FG010|Overall Study|Withdrawal by Subject|6|||
128783319|NCT02014558|463498041|FG011|Overall Study|Withdrawal by Subject|10|||
128783320|NCT02014558|463498042|FG012|Overall Study|Withdrawal by Subject|0|||
128783321|NCT02014558|463498030|FG000|Overall Study|Miscellaneous|2|||
128783322|NCT02014558|463498031|FG001|Overall Study|Miscellaneous|1|||
128783323|NCT02014558|463498032|FG002|Overall Study|Miscellaneous|1|||
128783324|NCT02014558|463498033|FG003|Overall Study|Miscellaneous|1|||
128783325|NCT02014558|463498034|FG004|Overall Study|Miscellaneous|0|||
128783326|NCT02014558|463498035|FG005|Overall Study|Miscellaneous|1|||
128783327|NCT02014558|463498036|FG006|Overall Study|Miscellaneous|0|||
128783328|NCT02014558|463498037|FG007|Overall Study|Miscellaneous|1|||
128783329|NCT02014558|463498038|FG008|Overall Study|Miscellaneous|1|||
128783330|NCT02014558|463498039|FG009|Overall Study|Miscellaneous|3|||
128783331|NCT02014558|463498040|FG010|Overall Study|Miscellaneous|12|||
128783332|NCT02014558|463498041|FG011|Overall Study|Miscellaneous|11|||
128783333|NCT02014558|463498042|FG012|Overall Study|Miscellaneous|1|||
128783334|NCT01560949|463498045|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
128783335|NCT01560949|463498045|FG000|Surgery Phase|Physician Decision|3|||
128783336|NCT04580407|463498046|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
128783337|NCT00681811|463498051|FG000|Overall Study|Adverse Event|1|||
128783338|NCT00681811|463498052|FG001|Overall Study|Adverse Event|1|||
128783339|NCT00681811|463498051|FG000|Overall Study|Withdrawal by Subject|2|||
128783340|NCT00681811|463498052|FG001|Overall Study|Withdrawal by Subject|2|||
128783341|NCT00681811|463498051|FG000|Overall Study|Non-compliance|0|||
128783342|NCT00681811|463498052|FG001|Overall Study|Non-compliance|1|||
128783343|NCT02068885|463498053|FG000|Overall Study|Withdrew|3|||
128783344|NCT02068885|463498054|FG001|Overall Study|Withdrew|5|||
128783345|NCT02068885|463498055|FG002|Overall Study|Withdrew|8|||
128783346|NCT01562743|463498065|FG000|Overall Study|Adverse Event|29|||
128783347|NCT01562743|463498065|FG000|Overall Study|Lack of Efficacy|3|||
128783348|NCT01562743|463498065|FG000|Overall Study|Withdrawal by Subject|13|||
128783349|NCT01562743|463498065|FG000|Overall Study|Protocol Violation|1|||
128783350|NCT01562743|463498065|FG000|Overall Study|Discontinuation criteria|2|||
128735462|NCT01607905|463323274|FG003|Overall Study|Randomized but not treated|0|||
128735463|NCT01607905|463323275|FG004|Overall Study|Randomized but not treated|1|||
128783351|NCT01562743|463498065|FG000|Overall Study|Lost to Follow-up|2|||
128783352|NCT01562743|463498065|FG000|Overall Study|Physician Decision|2|||
128783353|NCT03015740|463498067|FG000|Overall Study|Adverse Event|1|||
128783354|NCT03015740|463498068|FG001|Overall Study|Adverse Event|0|||
128783355|NCT03015740|463498069|FG002|Overall Study|Adverse Event|0|||
128783356|NCT03015740|463498067|FG000|Overall Study|Death|3|||
128783357|NCT03015740|463498068|FG001|Overall Study|Death|5|||
128783358|NCT03015740|463498069|FG002|Overall Study|Death|0|||
128783359|NCT03015740|463498067|FG000|Overall Study|Withdrawal by Subject|2|||
128783360|NCT03015740|463498068|FG001|Overall Study|Withdrawal by Subject|0|||
128783361|NCT03015740|463498069|FG002|Overall Study|Withdrawal by Subject|0|||
128783362|NCT02449044|463498070|FG000|Overall Study|Lost to Follow-up|2|||
128783363|NCT02449044|463498070|FG000|Overall Study|Withdrawal by Subject|13|||
128783364|NCT02449044|463498070|FG000|Overall Study|Adverse Event|30|||
128783365|NCT02449044|463498070|FG000|Overall Study|Met Withdrawal Criteria|7|||
128783366|NCT02449044|463498070|FG000|Overall Study|Physician Decision|9|||
128783367|NCT02449044|463498070|FG000|Overall Study|Sponsor Discontinued Trial|3|||
128783368|NCT00587288|463499741|FG000|Overall Study|Adverse Event|0|||
128783369|NCT00587288|463499742|FG001|Overall Study|Adverse Event|1|||
128783370|NCT00587288|463499741|FG000|Overall Study|Lack of Efficacy|2|||
128783371|NCT00587288|463499742|FG001|Overall Study|Lack of Efficacy|8|||
128783372|NCT00587288|463499741|FG000|Overall Study|Protocol Violation|1|||
128783373|NCT00587288|463499742|FG001|Overall Study|Protocol Violation|0|||
128783374|NCT01244984|463499745|FG000|Overall Study|Adverse Event|2|||
128783375|NCT01244984|463499746|FG001|Overall Study|Adverse Event|11|||
128783376|NCT01244984|463499747|FG002|Overall Study|Adverse Event|2|||
128783377|NCT01244984|463499745|FG000|Overall Study|Protocol Violation|1|||
128783378|NCT01244984|463499746|FG001|Overall Study|Protocol Violation|0|||
128783379|NCT01244984|463499747|FG002|Overall Study|Protocol Violation|0|||
128783380|NCT01244984|463499745|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
128783381|NCT01244984|463499746|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
128783382|NCT01244984|463499747|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
128783383|NCT01244984|463499745|FG000|Overall Study|Withdrawal by Subject|1|||
128783384|NCT01244984|463499746|FG001|Overall Study|Withdrawal by Subject|2|||
128783385|NCT01244984|463499747|FG002|Overall Study|Withdrawal by Subject|2|||
128783386|NCT02072226|463499748|FG000|Overall Study|Lost to Follow-up|11|||
128783387|NCT02072226|463499749|FG001|Overall Study|Lost to Follow-up|7|||
128783388|NCT02072226|463499748|FG000|Overall Study|Patient Non-compliance|2|||
128783389|NCT02072226|463499749|FG001|Overall Study|Patient Non-compliance|3|||
128783390|NCT02072226|463499748|FG000|Overall Study|Death|1|||
128783391|NCT02072226|463499749|FG001|Overall Study|Death|0|||
128783392|NCT02072226|463499748|FG000|Overall Study|Patient Withdrawal of Consent|1|||
128783393|NCT02072226|463499749|FG001|Overall Study|Patient Withdrawal of Consent|0|||
128783394|NCT01124162|463499754|FG000|First Intervention|Adverse Event|2|||
128783395|NCT01124162|463499755|FG001|First Intervention|Adverse Event|0|||
128783396|NCT01124162|463499754|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
128783397|NCT01124162|463499755|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
128783398|NCT02680756|463499756|FG000|Overall Study|Adverse Event|10|||
128783399|NCT02680756|463499757|FG001|Overall Study|Adverse Event|2|||
128783400|NCT02680756|463499756|FG000|Overall Study|Lost to Follow-up|7|||
128783401|NCT02680756|463499757|FG001|Overall Study|Lost to Follow-up|6|||
128783402|NCT02680756|463499756|FG000|Overall Study|Withdrawal by Subject|5|||
128783403|NCT02680756|463499757|FG001|Overall Study|Withdrawal by Subject|5|||
128783404|NCT02680756|463499756|FG000|Overall Study|Physician Decision|4|||
128783405|NCT02680756|463499757|FG001|Overall Study|Physician Decision|1|||
128783406|NCT02680756|463499756|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
128783407|NCT02680756|463499757|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
128783408|NCT02680756|463499756|FG000|Overall Study|Blood transfusion for any reason|0|||
128783409|NCT02680756|463499757|FG001|Overall Study|Blood transfusion for any reason|1|||
128783410|NCT02680756|463499756|FG000|Overall Study|Death|1|||
128783411|NCT02680756|463499757|FG001|Overall Study|Death|0|||
128783412|NCT02680756|463499756|FG000|Overall Study|Protocol Violation|1|||
128783413|NCT02680756|463499757|FG001|Overall Study|Protocol Violation|0|||
128783414|NCT02680756|463499756|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
128783415|NCT02680756|463499757|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
128783416|NCT02680756|463499756|FG000|Overall Study|None of above or not recorded|3|||
128783417|NCT02680756|463499757|FG001|Overall Study|None of above or not recorded|2|||
128783418|NCT01516892|463499759|FG000|Overall Study|Adverse Event|25|||
128783419|NCT01516892|463499759|FG000|Overall Study|Lack of Efficacy|35|||
128783420|NCT01516892|463499759|FG000|Overall Study|Pregnancy|5|||
128783421|NCT01516892|463499759|FG000|Overall Study|Lost to Follow-up|82|||
128783422|NCT01516892|463499759|FG000|Overall Study|Subject Withdrew Consent|92|||
128783423|NCT01516892|463499759|FG000|Overall Study|Protocol Violation|60|||
128783424|NCT01516892|463499759|FG000|Overall Study|Other Miscellaneous Reasons|43|||
128783425|NCT01516892|463499759|FG000|Overall Study|Missing|1|||
128783426|NCT03635112|463499760|FG000|Overall Study|Adverse Event|5|||
128783427|NCT03635112|463499761|FG001|Overall Study|Adverse Event|9|||
128783428|NCT03635112|463499762|FG002|Overall Study|Adverse Event|14|||
128783429|NCT03635112|463499760|FG000|Overall Study|Lost to Follow-up|1|||
128735464|NCT01607905|463323276|FG005|Overall Study|Randomized but not treated|1|||
128735465|NCT01607905|463323277|FG006|Overall Study|Randomized but not treated|0|||
128735466|NCT00659646|463323280|FG000|Overall Study|Protocol Violation|12|||
128735467|NCT00659646|463323281|FG001|Overall Study|Protocol Violation|8|||
128735468|NCT00659646|463323280|FG000|Overall Study|Adverse Event|1|||
128735469|NCT00659646|463323281|FG001|Overall Study|Adverse Event|0|||
128735470|NCT00659646|463323280|FG000|Overall Study|Lost to Follow-up|1|||
128735471|NCT00659646|463323281|FG001|Overall Study|Lost to Follow-up|0|||
128735472|NCT00659646|463323280|FG000|Overall Study|protocol noncompliance after randomized|1|||
128735473|NCT00659646|463323281|FG001|Overall Study|protocol noncompliance after randomized|0|||
128735474|NCT02212730|463323287|FG000|Overall Study|Tumor not of the required cell histology|1|||
128735475|NCT02212730|463323288|FG001|Overall Study|Tumor not of the required cell histology|0|||
128735476|NCT02212730|463323287|FG000|Overall Study|Withdrawal by Subject|1|||
128735477|NCT02212730|463323288|FG001|Overall Study|Withdrawal by Subject|0|||
128735478|NCT02212730|463323287|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
128735479|NCT02212730|463323288|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
128735480|NCT02932891|463323289|FG000|Overall Study|Lost to Follow-up|2|||
128735481|NCT02932891|463323289|FG000|Overall Study|HPA Suppress|2|||
128735482|NCT00451282|463323290|FG000|Overall Study|Lost to Follow-up|6|||
128735483|NCT00451282|463323291|FG001|Overall Study|Lost to Follow-up|5|||
128735484|NCT00577122|463323292|FG000|Overall Study|Adverse Event|0|||
128735485|NCT00577122|463323293|FG001|Overall Study|Adverse Event|2|||
128735486|NCT00577122|463323292|FG000|Overall Study|Progression, relapse during active trt|6|||
128735487|NCT00577122|463323293|FG001|Overall Study|Progression, relapse during active trt|8|||
128783430|NCT03635112|463499761|FG001|Overall Study|Lost to Follow-up|0|||
128735488|NCT00577122|463323292|FG000|Overall Study|Prog, refract disease during active trt|8|||
128735489|NCT00577122|463323293|FG001|Overall Study|Prog, refract disease during active trt|5|||
128735490|NCT00577122|463323292|FG000|Overall Study|Alternative Therapy|0|||
128735491|NCT00577122|463323293|FG001|Overall Study|Alternative Therapy|1|||
128735492|NCT00529386|463323302|FG000|Overall Study|Lost to Follow-up|1|||
128735493|NCT04532112|463323303|FG000|Overall Study|Adverse Event|3|||
128735494|NCT04532112|463323304|FG001|Overall Study|Adverse Event|0|||
128735495|NCT03348904|463323305|FG000|Overall Study|Administrative reason by the sponsor|0|||
128735496|NCT03348904|463323306|FG001|Overall Study|Administrative reason by the sponsor|1|||
128735497|NCT03348904|463323307|FG002|Overall Study|Administrative reason by the sponsor|0|||
128735498|NCT02039427|463323313|FG000|Overall Study|Duration of surgery > 3h|1|||
128735499|NCT02039427|463323314|FG001|Overall Study|Duration of surgery > 3h|1|||
128735500|NCT02039427|463323315|FG002|Overall Study|Duration of surgery > 3h|0|||
128735501|NCT02039427|463323316|FG003|Overall Study|Duration of surgery > 3h|0|||
128735502|NCT02039427|463323313|FG000|Overall Study|Withdrawal on concent|0|||
128735503|NCT02039427|463323314|FG001|Overall Study|Withdrawal on concent|0|||
128735504|NCT02039427|463323315|FG002|Overall Study|Withdrawal on concent|0|||
128735505|NCT02039427|463323316|FG003|Overall Study|Withdrawal on concent|1|||
128735506|NCT02039427|463323313|FG000|Overall Study|Cancellation of surgery|0|||
128735507|NCT02039427|463323314|FG001|Overall Study|Cancellation of surgery|0|||
128735508|NCT02039427|463323315|FG002|Overall Study|Cancellation of surgery|1|||
128735509|NCT02039427|463323316|FG003|Overall Study|Cancellation of surgery|0|||
128735510|NCT02039427|463323313|FG000|Overall Study|Loss of follow - up|1|||
128735511|NCT02039427|463323314|FG001|Overall Study|Loss of follow - up|0|||
128735512|NCT02039427|463323315|FG002|Overall Study|Loss of follow - up|2|||
128735513|NCT02039427|463323316|FG003|Overall Study|Loss of follow - up|4|||
128735514|NCT02039427|463323313|FG000|Overall Study|Steroid Use|1|||
128735515|NCT02039427|463323314|FG001|Overall Study|Steroid Use|0|||
128735516|NCT02039427|463323315|FG002|Overall Study|Steroid Use|0|||
128735517|NCT02039427|463323316|FG003|Overall Study|Steroid Use|0|||
128735518|NCT04354831|463323317|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
128735519|NCT04354831|463323318|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
128735520|NCT02732847|463323319|FG000|Overall Study|some filled early|42|||
128735521|NCT02732847|463323320|FG001|Overall Study|some filled early|42|||
128735522|NCT02370888|463323321|FG000|Overall Study|disease progression|2|||
128735523|NCT02370888|463323321|FG000|Overall Study|did not meet chimerism criteria|6|||
128735524|NCT04574362|463323322|FG000|Overall Study|Other|0|||
128735525|NCT04574362|463323323|FG001|Overall Study|Other|5|||
128735526|NCT04574362|463323322|FG000|Overall Study|COVID-19|0|||
128735527|NCT04574362|463323323|FG001|Overall Study|COVID-19|1|||
128735528|NCT04574362|463323322|FG000|Overall Study|Adverse Event|1|||
128735529|NCT04574362|463323323|FG001|Overall Study|Adverse Event|1|||
128735530|NCT04574362|463323322|FG000|Overall Study|Withdrawal by Subject|2|||
128735531|NCT04574362|463323323|FG001|Overall Study|Withdrawal by Subject|4|||
128735532|NCT04574362|463323322|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
128735533|NCT04574362|463323323|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
128735534|NCT04574362|463323322|FG000|Overall Study|Participant refused to come to the hospital|1|||
128735535|NCT04574362|463323323|FG001|Overall Study|Participant refused to come to the hospital|0|||
128735536|NCT04574362|463323322|FG000|Overall Study|Participant refused the visit|1|||
128735537|NCT04574362|463323323|FG001|Overall Study|Participant refused the visit|0|||
128735538|NCT04574362|463323322|FG000|Overall Study|Participant quit early because of business trip|1|||
128735539|NCT04574362|463323323|FG001|Overall Study|Participant quit early because of business trip|0|||
128735540|NCT01060384|463323324|FG000|Overall Study|Withdrawal by Subject|0|||
128735541|NCT01060384|463323325|FG001|Overall Study|Withdrawal by Subject|1|||
128735542|NCT01060384|463323326|FG002|Overall Study|Withdrawal by Subject|0|||
128735543|NCT01060384|463323327|FG003|Overall Study|Withdrawal by Subject|0|||
128735544|NCT01060384|463323328|FG004|Overall Study|Withdrawal by Subject|0|||
128735545|NCT01060384|463323324|FG000|Overall Study|Death|0|||
128735546|NCT01060384|463323325|FG001|Overall Study|Death|0|||
128735547|NCT01060384|463323326|FG002|Overall Study|Death|0|||
128735548|NCT01060384|463323327|FG003|Overall Study|Death|0|||
128735549|NCT01060384|463323328|FG004|Overall Study|Death|1|||
128735550|NCT01060384|463323324|FG000|Overall Study|Intercurrent illness|0|||
128735551|NCT01060384|463323325|FG001|Overall Study|Intercurrent illness|0|||
128735552|NCT01060384|463323326|FG002|Overall Study|Intercurrent illness|0|||
128735553|NCT01060384|463323327|FG003|Overall Study|Intercurrent illness|0|||
128735554|NCT01060384|463323328|FG004|Overall Study|Intercurrent illness|1|||
128735555|NCT00812929|463323332|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
128735556|NCT00812929|463323333|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
128735557|NCT00812929|463323334|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
128735558|NCT00812929|463323335|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
128735559|NCT00812929|463323336|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
128735560|NCT00812929|463323337|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
128735561|NCT00812929|463323338|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
128783431|NCT03635112|463499762|FG002|Overall Study|Lost to Follow-up|1|||
128735562|NCT00812929|463323339|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
128735563|NCT00812929|463323340|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
128735564|NCT00812929|463323341|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
128735565|NCT00812929|463323332|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
128735566|NCT00812929|463323333|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
128735567|NCT00812929|463323334|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
128735568|NCT00812929|463323335|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
128735569|NCT00812929|463323336|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
128735570|NCT00812929|463323337|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
128735571|NCT00812929|463323338|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
128735572|NCT00812929|463323339|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
128735573|NCT00812929|463323340|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
128735574|NCT00812929|463323341|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
128735575|NCT00812929|463323332|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
128735576|NCT00812929|463323333|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
128735577|NCT00812929|463323334|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
128735578|NCT00812929|463323335|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
128735579|NCT00812929|463323336|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
128735580|NCT00812929|463323337|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
128735581|NCT00812929|463323338|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
128735582|NCT00812929|463323339|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
128735583|NCT00812929|463323340|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
128735584|NCT00812929|463323341|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
128735585|NCT00211081|463323342|FG000|Overall Study|Withdrawal by Subject|2|||
128735586|NCT01332305|463323343|FG000|Overall Study|Adverse Event|1|||
128735587|NCT01332305|463323344|FG001|Overall Study|Adverse Event|4|||
128735588|NCT01332305|463323345|FG002|Overall Study|Adverse Event|6|||
128735589|NCT01332305|463323346|FG003|Overall Study|Adverse Event|3|||
128735590|NCT01332305|463323347|FG004|Overall Study|Adverse Event|5|||
128735591|NCT01332305|463323343|FG000|Overall Study|Withdrawal by Subject|6|||
128735592|NCT01332305|463323344|FG001|Overall Study|Withdrawal by Subject|5|||
128735593|NCT01332305|463323345|FG002|Overall Study|Withdrawal by Subject|4|||
128735594|NCT01332305|463323346|FG003|Overall Study|Withdrawal by Subject|1|||
128735595|NCT01332305|463323347|FG004|Overall Study|Withdrawal by Subject|0|||
128735596|NCT01332305|463323343|FG000|Overall Study|Lost to Follow-up|0|||
128735597|NCT01332305|463323344|FG001|Overall Study|Lost to Follow-up|2|||
128735598|NCT01332305|463323345|FG002|Overall Study|Lost to Follow-up|3|||
128735599|NCT01332305|463323346|FG003|Overall Study|Lost to Follow-up|2|||
128735600|NCT01332305|463323347|FG004|Overall Study|Lost to Follow-up|3|||
128735601|NCT01332305|463323343|FG000|Overall Study|Protocol Violation|1|||
128735602|NCT01332305|463323344|FG001|Overall Study|Protocol Violation|2|||
128735603|NCT01332305|463323345|FG002|Overall Study|Protocol Violation|1|||
128735604|NCT01332305|463323346|FG003|Overall Study|Protocol Violation|0|||
128735605|NCT01332305|463323347|FG004|Overall Study|Protocol Violation|3|||
128735606|NCT01332305|463323343|FG000|Overall Study|Withdrawal by Sponsor|1|||
128735607|NCT01332305|463323344|FG001|Overall Study|Withdrawal by Sponsor|0|||
128735608|NCT01332305|463323345|FG002|Overall Study|Withdrawal by Sponsor|0|||
128735609|NCT01332305|463323346|FG003|Overall Study|Withdrawal by Sponsor|1|||
128735610|NCT01332305|463323347|FG004|Overall Study|Withdrawal by Sponsor|1|||
128735611|NCT01332305|463323343|FG000|Overall Study|Treatment Failure|1|||
128735612|NCT01332305|463323344|FG001|Overall Study|Treatment Failure|1|||
128735613|NCT01332305|463323345|FG002|Overall Study|Treatment Failure|0|||
128735614|NCT01332305|463323346|FG003|Overall Study|Treatment Failure|0|||
128735615|NCT01332305|463323347|FG004|Overall Study|Treatment Failure|0|||
128735616|NCT01332305|463323343|FG000|Overall Study|Physician Decision|0|||
128735617|NCT01332305|463323344|FG001|Overall Study|Physician Decision|0|||
128735618|NCT01332305|463323345|FG002|Overall Study|Physician Decision|0|||
128735619|NCT01332305|463323346|FG003|Overall Study|Physician Decision|1|||
128735620|NCT01332305|463323347|FG004|Overall Study|Physician Decision|0|||
128735621|NCT04027686|463323348|FG000|Overall Study|Lost to Follow-up|2|||
128735622|NCT04027686|463323349|FG001|Overall Study|Lost to Follow-up|0|||
128735623|NCT04027686|463323348|FG000|Overall Study|Withdrawal by Subject|0|||
128735624|NCT04027686|463323349|FG001|Overall Study|Withdrawal by Subject|1|||
128735625|NCT03755765|463323356|FG000|Overall Study|Withdrawal by Subject|2|||
128735626|NCT03755765|463323357|FG001|Overall Study|Withdrawal by Subject|4|||
128735627|NCT03755765|463323358|FG002|Overall Study|Withdrawal by Subject|4|||
128735628|NCT02104557|463323359|FG000|Overall Study|Adverse Event|24|||
128735629|NCT02104557|463323359|FG000|Overall Study|Lost to Follow-up|34|||
128783432|NCT03635112|463499760|FG000|Overall Study|Physician Decision|5|||
128783433|NCT03635112|463499761|FG001|Overall Study|Physician Decision|7|||
128783434|NCT03635112|463499762|FG002|Overall Study|Physician Decision|5|||
128735630|NCT02104557|463323359|FG000|Overall Study|Violated the usage and dosage|14|||
128735631|NCT02104557|463323359|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
128735632|NCT02104557|463323359|FG000|Overall Study|Administered Sayana prior to the contract|1|||
128783435|NCT03635112|463499760|FG000|Overall Study|Protocol Violation|0|||
128783436|NCT03635112|463499761|FG001|Overall Study|Protocol Violation|0|||
128783437|NCT03635112|463499762|FG002|Overall Study|Protocol Violation|1|||
128783438|NCT03635112|463499760|FG000|Overall Study|Study Terminated by Sponsor|11|||
128783439|NCT03635112|463499761|FG001|Overall Study|Study Terminated by Sponsor|17|||
128783440|NCT03635112|463499762|FG002|Overall Study|Study Terminated by Sponsor|21|||
128783441|NCT03635112|463499760|FG000|Overall Study|Withdrawal by Subject|4|||
128783442|NCT03635112|463499761|FG001|Overall Study|Withdrawal by Subject|9|||
128783443|NCT03635112|463499762|FG002|Overall Study|Withdrawal by Subject|7|||
128783444|NCT03635112|463499760|FG000|Overall Study|Miscellaneous|0|||
128783445|NCT03635112|463499761|FG001|Overall Study|Miscellaneous|0|||
128783446|NCT03635112|463499762|FG002|Overall Study|Miscellaneous|1|||
128783447|NCT02950545|463499766|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
128783448|NCT02950545|463499767|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
128783449|NCT02950545|463499768|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
128783450|NCT02950545|463499769|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
128783451|NCT02950545|463499770|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
128783452|NCT02950545|463499771|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
128783453|NCT02950545|463499766|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
128783454|NCT02950545|463499767|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
128783455|NCT02950545|463499768|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
128783456|NCT02950545|463499769|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
128783457|NCT02950545|463499770|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
128783458|NCT02950545|463499771|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
128735633|NCT02104557|463323359|FG000|Overall Study|Other|17|||
128735634|NCT02104557|463323359|FG000|Overall Study|Change to other contraception methods|5|||
128735635|NCT02104557|463323359|FG000|Overall Study|Discontinuation due to no pain|1|||
128735636|NCT02104557|463323359|FG000|Overall Study|Withdrawal consent|2|||
128735637|NCT02104557|463323359|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
128735638|NCT02104557|463323359|FG000|Overall Study|Discontinuation of contraception|9|||
128735639|NCT00111228|463323363|FG000|Overall Study|Withdrawal by Subject|5|||
128735640|NCT00111228|463323364|FG001|Overall Study|Withdrawal by Subject|1|||
128735641|NCT00111228|463323365|FG002|Overall Study|Withdrawal by Subject|0|||
128735642|NCT00678691|463323366|FG000|Overall Study|Adverse Event|6|||
128735643|NCT00678691|463323367|FG001|Overall Study|Adverse Event|4|||
128735644|NCT02178475|463323374|FG000|Overall Study|Withdrawal by Subject|7|||
128735645|NCT02178475|463323374|FG000|Overall Study|Lost to Follow-up|10|||
128735646|NCT02178475|463323374|FG000|Overall Study|Death|13|||
128735647|NCT02178475|463323374|FG000|Overall Study|Protocol-specified Criteria|99|||
128735648|NCT01430585|463323375|FG000|Overall Study|Death|1|||
128735649|NCT01430585|463323375|FG000|Overall Study|Objective Progression or Relapse|3|||
128735650|NCT01430585|463323375|FG000|Overall Study|Study Terminated by Sponsor|3|||
128735651|NCT01430585|463323375|FG000|Overall Study|Other|7|||
128735652|NCT02357576|463323376|FG000|Treatment Period|Withdrawal by Subject|0|||
128735653|NCT02357576|463323377|FG001|Treatment Period|Withdrawal by Subject|1|||
128735654|NCT02357576|463323376|FG000|Treatment Period|Physician Decision|0|||
128735655|NCT02357576|463323377|FG001|Treatment Period|Physician Decision|1|||
128735656|NCT02357576|463323376|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
128735657|NCT02357576|463323377|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
128735658|NCT02357576|463323376|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
128735659|NCT02357576|463323377|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
128735660|NCT02357576|463323376|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
128735661|NCT02357576|463323377|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
128735662|NCT02357576|463323376|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
128735663|NCT02357576|463323377|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
128735664|NCT00699699|463323380|FG000|Overall Study|Adverse Event|36|||
128735665|NCT00699699|463323380|FG000|Overall Study|Individual different reasons|21|||
128735666|NCT01632800|463323383|FG000|Overall Study|Subject did not fit in apparatus|1|||
128735667|NCT01000051|463323385|FG000|Overall Study|Withdrawal by Subject|1|||
128735668|NCT01000051|463323386|FG001|Overall Study|Withdrawal by Subject|1|||
128735669|NCT01000051|463323385|FG000|Overall Study|Disease Progression|1|||
128735670|NCT01000051|463323386|FG001|Overall Study|Disease Progression|0|||
128735671|NCT01000051|463323385|FG000|Overall Study|Serious noncompliance|1|||
128735672|NCT01000051|463323386|FG001|Overall Study|Serious noncompliance|0|||
128735673|NCT00057746|463323390|FG000|Overall Study|Withdrawal by Subject|0|||
128735674|NCT00057746|463323391|FG001|Overall Study|Withdrawal by Subject|0|||
128735675|NCT00057746|463323392|FG002|Overall Study|Withdrawal by Subject|1|||
128735676|NCT01469065|463323399|FG000|Overall Study|Lack of Efficacy|0|||
128735677|NCT01469065|463323400|FG001|Overall Study|Lack of Efficacy|0|||
128735678|NCT01469065|463323401|FG002|Overall Study|Lack of Efficacy|0|||
128735679|NCT01469065|463323402|FG003|Overall Study|Lack of Efficacy|0|||
128735680|NCT01469065|463323403|FG004|Overall Study|Lack of Efficacy|1|||
128735681|NCT01469065|463323399|FG000|Overall Study|Other|0|||
128735682|NCT01469065|463323400|FG001|Overall Study|Other|1|||
128735683|NCT01469065|463323401|FG002|Overall Study|Other|0|||
128735684|NCT01469065|463323402|FG003|Overall Study|Other|0|||
128735685|NCT01469065|463323403|FG004|Overall Study|Other|0|||
128735686|NCT01227512|463323408|FG000|Overall Study|Physician Decision|6|||
128735687|NCT01227512|463323409|FG001|Overall Study|Physician Decision|6|||
128735688|NCT01227512|463323408|FG000|Overall Study|Adverse Event|4|||
128735689|NCT01227512|463323409|FG001|Overall Study|Adverse Event|3|||
128735690|NCT01227512|463323408|FG000|Overall Study|Withdrawal by Subject|3|||
128735691|NCT01227512|463323409|FG001|Overall Study|Withdrawal by Subject|0|||
128735692|NCT01227512|463323408|FG000|Overall Study|Participant met withdrawal criteria|0|||
128735693|NCT01227512|463323409|FG001|Overall Study|Participant met withdrawal criteria|1|||
128735694|NCT04055116|463323410|FG000|First Intervention|Physician Decision|2|||
128735695|NCT04055116|463323411|FG001|First Intervention|Physician Decision|7|||
129204361|NCT01384734|465045801|FG003|Overall Study|Death|0|||
128735696|NCT04497987|463323418|FG000|Overall Study|Adverse Event|1|||
128735697|NCT04497987|463323419|FG001|Overall Study|Adverse Event|0|||
128735698|NCT04497987|463323418|FG000|Overall Study|Death|21|||
128735699|NCT04497987|463323419|FG001|Overall Study|Death|13|||
128735700|NCT04497987|463323418|FG000|Overall Study|Lost to Follow-up|19|||
129204362|NCT01384734|465045802|FG004|Overall Study|Death|0|||
129204363|NCT01384734|465045798|FG000|Overall Study|Continuation criteria not met|0|||
129204364|NCT01384734|465045799|FG001|Overall Study|Continuation criteria not met|0|||
129204365|NCT01384734|465045800|FG002|Overall Study|Continuation criteria not met|1|||
129204366|NCT01384734|465045801|FG003|Overall Study|Continuation criteria not met|1|||
129204367|NCT01384734|465045802|FG004|Overall Study|Continuation criteria not met|0|||
128783459|NCT02950545|463499766|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
128783460|NCT02950545|463499767|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
128783461|NCT02950545|463499768|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
128783462|NCT02950545|463499769|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
128783463|NCT02950545|463499770|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
128783464|NCT02950545|463499771|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
128735701|NCT04497987|463323419|FG001|Overall Study|Lost to Follow-up|17|||
128735702|NCT04497987|463323418|FG000|Overall Study|Other - as reported by the investigator|22|||
128735703|NCT04497987|463323419|FG001|Overall Study|Other - as reported by the investigator|16|||
128735704|NCT04497987|463323418|FG000|Overall Study|Physician Decision|1|||
128735705|NCT04497987|463323419|FG001|Overall Study|Physician Decision|0|||
128735706|NCT04497987|463323418|FG000|Overall Study|Withdrawal by Subject|35|||
128735707|NCT04497987|463323419|FG001|Overall Study|Withdrawal by Subject|21|||
128735708|NCT00512096|463323420|FG000|Overall Study|Adverse Event|2|||
128735709|NCT00512096|463323420|FG000|Overall Study|Withdrawal by Subject|2|||
128783465|NCT02950545|463499766|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
128783466|NCT02950545|463499767|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
128783467|NCT02950545|463499768|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
128783468|NCT02950545|463499769|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
128783469|NCT02950545|463499770|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
128783470|NCT02950545|463499771|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
128783471|NCT02950545|463499766|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
128783472|NCT02950545|463499767|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
128783473|NCT02950545|463499768|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
128783474|NCT02950545|463499769|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
128783475|NCT02950545|463499770|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
128783476|NCT02950545|463499771|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
128783477|NCT03101592|463499772|FG000|Overall Study|participant files could not be located|111|||
128783478|NCT03101592|463499773|FG001|Overall Study|participant files could not be located|170|||
128783479|NCT03101592|463499774|FG002|Overall Study|participant files could not be located|118|||
128783480|NCT03398356|463499777|FG000|Before Treatment|Lost to Follow-up|1|||
128783481|NCT03398356|463499778|FG001|Before Treatment|Lost to Follow-up|2|||
128783482|NCT03398356|463499779|FG002|Before Treatment|Lost to Follow-up|0|||
128783483|NCT03398356|463499777|FG000|Before Treatment|drug intolerance|2|||
128783484|NCT03398356|463499778|FG001|Before Treatment|drug intolerance|1|||
128783485|NCT03398356|463499779|FG002|Before Treatment|drug intolerance|0|||
128783486|NCT03398356|463499777|FG000|Before Treatment|Withdrawal by Subject|0|||
128783487|NCT03398356|463499778|FG001|Before Treatment|Withdrawal by Subject|5|||
128783488|NCT03398356|463499779|FG002|Before Treatment|Withdrawal by Subject|0|||
128783489|NCT03398356|463499777|FG000|Before Treatment|Physician Decision|0|||
128783490|NCT03398356|463499778|FG001|Before Treatment|Physician Decision|0|||
128783491|NCT03398356|463499779|FG002|Before Treatment|Physician Decision|11|||
128783492|NCT03398356|463499777|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
128783493|NCT03398356|463499778|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
128783494|NCT03398356|463499779|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
128783495|NCT01648283|463499782|FG000|Overall Study|Withdrawal by Subject|14|||
128783496|NCT00601640|463499787|FG000|Overall Study|Withdrawal by Subject|3|||
128783497|NCT00601640|463499788|FG001|Overall Study|Withdrawal by Subject|0|||
128783498|NCT00601640|463499789|FG002|Overall Study|Withdrawal by Subject|7|||
128783499|NCT00601640|463499787|FG000|Overall Study|Death|1|||
128783500|NCT00601640|463499788|FG001|Overall Study|Death|0|||
128783501|NCT00601640|463499789|FG002|Overall Study|Death|0|||
128783502|NCT00601640|463499787|FG000|Overall Study|Adverse Event|0|||
128783503|NCT00601640|463499788|FG001|Overall Study|Adverse Event|4|||
128783504|NCT00601640|463499789|FG002|Overall Study|Adverse Event|2|||
128783505|NCT00601640|463499787|FG000|Overall Study|intercurrent illness|1|||
128783506|NCT00601640|463499788|FG001|Overall Study|intercurrent illness|0|||
128783507|NCT00601640|463499789|FG002|Overall Study|intercurrent illness|0|||
128783508|NCT00601640|463499787|FG000|Overall Study|change in eligibility status|0|||
128783509|NCT00601640|463499788|FG001|Overall Study|change in eligibility status|1|||
128783510|NCT00601640|463499789|FG002|Overall Study|change in eligibility status|1|||
128783511|NCT00530777|463499790|FG000|Overall Study|Lost to Follow-up|0|||
128783512|NCT00530777|463499791|FG001|Overall Study|Lost to Follow-up|1|||
128783513|NCT00530777|463499790|FG000|Overall Study|Death|1|||
128783514|NCT00530777|463499791|FG001|Overall Study|Death|2|||
128783515|NCT00530777|463499790|FG000|Overall Study|Physician Decision|1|||
128783516|NCT00530777|463499791|FG001|Overall Study|Physician Decision|0|||
128783517|NCT00530777|463499790|FG000|Overall Study|Withdrawal by Subject|0|||
128783518|NCT00530777|463499791|FG001|Overall Study|Withdrawal by Subject|1|||
128783519|NCT00530777|463499790|FG000|Overall Study|Unable to adhere to visit schedule|5|||
128783520|NCT00530777|463499791|FG001|Overall Study|Unable to adhere to visit schedule|1|||
128783521|NCT03382821|463499798|FG000|Overall Study|Did not receive allocated intervention.|0|||
128783522|NCT03382821|463499799|FG001|Overall Study|Did not receive allocated intervention.|3|||
128783523|NCT00282438|463499800|FG000|Overall Study|Lack of Efficacy|1|||
128783524|NCT00282438|463499801|FG001|Overall Study|Lack of Efficacy|0|||
128783525|NCT00282438|463499800|FG000|Overall Study|Death|0|||
128783526|NCT00282438|463499801|FG001|Overall Study|Death|1|||
128783527|NCT01941316|463499804|FG000|Overall Study|Adverse Event|0|||
128783528|NCT01941316|463499805|FG001|Overall Study|Adverse Event|1|||
128783529|NCT01941316|463499806|FG002|Overall Study|Adverse Event|0|||
128783530|NCT01941316|463499807|FG003|Overall Study|Adverse Event|7|||
128783531|NCT01941316|463499804|FG000|Overall Study|Progressive Disease|3|||
128783532|NCT01941316|463499805|FG001|Overall Study|Progressive Disease|6|||
128783533|NCT01941316|463499806|FG002|Overall Study|Progressive Disease|2|||
128783534|NCT01941316|463499807|FG003|Overall Study|Progressive Disease|29|||
128783535|NCT01941316|463499804|FG000|Overall Study|Withdrawal by Subject|0|||
128783536|NCT01941316|463499805|FG001|Overall Study|Withdrawal by Subject|2|||
128783537|NCT01941316|463499806|FG002|Overall Study|Withdrawal by Subject|1|||
128783538|NCT01941316|463499807|FG003|Overall Study|Withdrawal by Subject|8|||
128783539|NCT01941316|463499804|FG000|Overall Study|Death|0|||
128735710|NCT00512096|463323420|FG000|Overall Study|Lack of Efficacy|3|||
128735711|NCT02047604|463323421|FG000|Overall Study|Withdrawal by Subject|0|||
128735712|NCT02047604|463323422|FG001|Overall Study|Withdrawal by Subject|0|||
128735713|NCT02047604|463323423|FG002|Overall Study|Withdrawal by Subject|0|||
128735714|NCT02047604|463323424|FG003|Overall Study|Withdrawal by Subject|0|||
128735715|NCT02047604|463323425|FG004|Overall Study|Withdrawal by Subject|1|||
128735716|NCT02047604|463323426|FG005|Overall Study|Withdrawal by Subject|1|||
128735717|NCT01519518|463325970|FG000|Overall Study|Consent not available|7|||
128735718|NCT01519518|463325971|FG001|Overall Study|Consent not available|10|||
128735719|NCT01312909|463325973|FG000|Overall Study|Randomized but not treated|1|||
128735720|NCT01312909|463325974|FG001|Overall Study|Randomized but not treated|3|||
128735721|NCT01312909|463325975|FG002|Overall Study|Randomized but not treated|1|||
128735722|NCT01312909|463325973|FG000|Overall Study|Adverse Event|1|||
128735723|NCT01312909|463325974|FG001|Overall Study|Adverse Event|0|||
128735724|NCT01312909|463325975|FG002|Overall Study|Adverse Event|3|||
128735725|NCT01312909|463325973|FG000|Overall Study|Protocol Violation|2|||
128735726|NCT01312909|463325974|FG001|Overall Study|Protocol Violation|0|||
128735727|NCT01312909|463325975|FG002|Overall Study|Protocol Violation|2|||
128735728|NCT01312909|463325973|FG000|Overall Study|Other|9|||
128735729|NCT01312909|463325974|FG001|Overall Study|Other|6|||
128735730|NCT01312909|463325975|FG002|Overall Study|Other|11|||
128735731|NCT01312909|463325973|FG000|Overall Study|Withdrawal by Subject|8|||
128735732|NCT01312909|463325974|FG001|Overall Study|Withdrawal by Subject|10|||
128735733|NCT01312909|463325975|FG002|Overall Study|Withdrawal by Subject|7|||
128735734|NCT01312909|463325973|FG000|Overall Study|Lost to Follow-up|21|||
128735735|NCT01312909|463325974|FG001|Overall Study|Lost to Follow-up|17|||
128735736|NCT01312909|463325975|FG002|Overall Study|Lost to Follow-up|20|||
128735737|NCT01312909|463325973|FG000|Overall Study|Insufficient clinical response|0|||
128735738|NCT01312909|463325974|FG001|Overall Study|Insufficient clinical response|0|||
128735739|NCT01312909|463325975|FG002|Overall Study|Insufficient clinical response|1|||
128735740|NCT01312909|463325973|FG000|Overall Study|Entrance criteria not met|0|||
128735741|NCT01312909|463325974|FG001|Overall Study|Entrance criteria not met|0|||
128735742|NCT01312909|463325975|FG002|Overall Study|Entrance criteria not met|2|||
128735743|NCT00938431|463325979|FG000|Overall Study|Adverse Event|5|||
128735744|NCT00938431|463325980|FG001|Overall Study|Adverse Event|8|||
128735745|NCT00938431|463325981|FG002|Overall Study|Adverse Event|6|||
128735746|NCT00938431|463325979|FG000|Overall Study|Lack of Efficacy|0|||
128735747|NCT00938431|463325980|FG001|Overall Study|Lack of Efficacy|1|||
128735748|NCT00938431|463325981|FG002|Overall Study|Lack of Efficacy|0|||
128735749|NCT00938431|463325979|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
128735750|NCT00938431|463325980|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
128735751|NCT00938431|463325981|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
128735752|NCT00938431|463325979|FG000|Overall Study|Dosing compliance issue|0|||
128735753|NCT00938431|463325980|FG001|Overall Study|Dosing compliance issue|0|||
128735754|NCT00938431|463325981|FG002|Overall Study|Dosing compliance issue|1|||
128735755|NCT00938431|463325979|FG000|Overall Study|Reached maximum dose early|0|||
128735756|NCT00938431|463325980|FG001|Overall Study|Reached maximum dose early|0|||
128735757|NCT00938431|463325981|FG002|Overall Study|Reached maximum dose early|1|||
128735758|NCT01774903|463325982|FG000|Overall Study|Adverse Event|7|||
128735759|NCT01774903|463325982|FG000|Overall Study|Withdrawal by Subject|2|||
128735760|NCT01774903|463325982|FG000|Overall Study|Lack of Efficacy|1|||
128735761|NCT01774903|463325982|FG000|Overall Study|Ineligible to continue the trial|1|||
128735762|NCT02880371|463325983|FG000|Phase 1b|Lost to Follow-up|1|||
128735763|NCT02880371|463325984|FG001|Phase 1b|Lost to Follow-up|0|||
128735764|NCT02880371|463325985|FG002|Phase 1b|Lost to Follow-up|0|||
128735765|NCT02880371|463325986|FG003|Phase 1b|Lost to Follow-up|0|||
128735766|NCT02880371|463325987|FG004|Phase 1b|Lost to Follow-up|0|||
128735767|NCT02880371|463325988|FG005|Phase 1b|Lost to Follow-up|0|||
128735768|NCT02880371|463325989|FG006|Phase 1b|Lost to Follow-up|0|||
128735769|NCT02880371|463325990|FG007|Phase 1b|Lost to Follow-up|0|||
128735770|NCT02880371|463325983|FG000|Phase 1b|Participants terminated by Sponsor|1|||
128735771|NCT02880371|463325984|FG001|Phase 1b|Participants terminated by Sponsor|0|||
128735772|NCT02880371|463325985|FG002|Phase 1b|Participants terminated by Sponsor|0|||
128783540|NCT01941316|463499805|FG001|Overall Study|Death|0|||
128783541|NCT01941316|463499806|FG002|Overall Study|Death|0|||
128783542|NCT01941316|463499807|FG003|Overall Study|Death|3|||
128783543|NCT01941316|463499804|FG000|Overall Study|Physician Decision|0|||
128783544|NCT01941316|463499805|FG001|Overall Study|Physician Decision|0|||
128783545|NCT01941316|463499806|FG002|Overall Study|Physician Decision|0|||
128783546|NCT01941316|463499807|FG003|Overall Study|Physician Decision|3|||
128783547|NCT01941316|463499804|FG000|Overall Study|Protocol Violation|0|||
128783548|NCT01941316|463499805|FG001|Overall Study|Protocol Violation|0|||
128783549|NCT01941316|463499806|FG002|Overall Study|Protocol Violation|0|||
128783550|NCT01941316|463499807|FG003|Overall Study|Protocol Violation|3|||
128783551|NCT01941316|463499804|FG000|Overall Study|Intercurrent illness|0|||
128783552|NCT01941316|463499805|FG001|Overall Study|Intercurrent illness|0|||
128783553|NCT01941316|463499806|FG002|Overall Study|Intercurrent illness|0|||
128783554|NCT01941316|463499807|FG003|Overall Study|Intercurrent illness|1|||
128783555|NCT01941316|463499804|FG000|Overall Study|Other, not specified|0|||
128783556|NCT01941316|463499805|FG001|Overall Study|Other, not specified|0|||
128783557|NCT01941316|463499806|FG002|Overall Study|Other, not specified|0|||
128783558|NCT01941316|463499807|FG003|Overall Study|Other, not specified|1|||
128783559|NCT02775435|463499808|FG000|Overall Study|Adverse Event|32|||
128783560|NCT02775435|463499809|FG001|Overall Study|Adverse Event|27|||
128783561|NCT02775435|463499808|FG000|Overall Study|Lost to Follow-up|2|||
128783562|NCT02775435|463499809|FG001|Overall Study|Lost to Follow-up|2|||
128783563|NCT02775435|463499808|FG000|Overall Study|Sponsor decision|44|||
128783564|NCT02775435|463499809|FG001|Overall Study|Sponsor decision|19|||
128783565|NCT02775435|463499808|FG000|Overall Study|Withdrawal by Subject|4|||
128783566|NCT02775435|463499809|FG001|Overall Study|Withdrawal by Subject|9|||
128783567|NCT02775435|463499808|FG000|Overall Study|Death|196|||
128783568|NCT02775435|463499809|FG001|Overall Study|Death|224|||
128783569|NCT03537651|463499820|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
128783570|NCT03537651|463499820|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
128783571|NCT03537651|463499820|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
128783572|NCT03537651|463499820|FG000|Part A (Up to 96 Weeks)|Other|1|||
128783573|NCT03537651|463499820|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
128783574|NCT03537651|463499820|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
128783575|NCT03537651|463499820|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
128783576|NCT03537651|463499820|FG000|Part B (Up to 192 Weeks)|Other|1|||
128783577|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
128783578|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
128783579|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
128783580|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Death|3|||
128783581|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Death|0|||
128783582|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Death|0|||
128783583|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
128783584|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
128783585|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
128783586|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
128783587|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
128783588|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
128783589|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
128783590|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
128783591|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
128783592|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
128783593|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
128783594|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
128783595|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
128783596|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
128783597|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
128783598|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Other|1|||
128783599|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Other|0|||
128783600|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Other|0|||
128783601|NCT02403323|463499821|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
128783602|NCT02403323|463499822|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
128735773|NCT02880371|463325986|FG003|Phase 1b|Participants terminated by Sponsor|0|||
128735774|NCT02880371|463325987|FG004|Phase 1b|Participants terminated by Sponsor|0|||
128735775|NCT02880371|463325988|FG005|Phase 1b|Participants terminated by Sponsor|0|||
128735776|NCT02880371|463325989|FG006|Phase 1b|Participants terminated by Sponsor|0|||
128735777|NCT02880371|463325990|FG007|Phase 1b|Participants terminated by Sponsor|0|||
128735778|NCT02880371|463325983|FG000|Phase 1b|Withdrawal by Subject|0|||
128735779|NCT02880371|463325984|FG001|Phase 1b|Withdrawal by Subject|0|||
128735780|NCT02880371|463325985|FG002|Phase 1b|Withdrawal by Subject|1|||
128783603|NCT02403323|463499823|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
128735781|NCT02880371|463325986|FG003|Phase 1b|Withdrawal by Subject|0|||
128735782|NCT02880371|463325987|FG004|Phase 1b|Withdrawal by Subject|0|||
128735783|NCT02880371|463325988|FG005|Phase 1b|Withdrawal by Subject|0|||
128735784|NCT02880371|463325989|FG006|Phase 1b|Withdrawal by Subject|0|||
128735785|NCT02880371|463325990|FG007|Phase 1b|Withdrawal by Subject|0|||
128735786|NCT02880371|463325983|FG000|Phase 1b|Death|4|||
128735787|NCT02880371|463325984|FG001|Phase 1b|Death|6|||
128735788|NCT02880371|463325985|FG002|Phase 1b|Death|5|||
128735789|NCT02880371|463325986|FG003|Phase 1b|Death|1|||
128783604|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
128783605|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
128783606|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
128783607|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
128783608|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
128783609|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
128783610|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
128783611|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
128783612|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
128783613|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
128735790|NCT02880371|463325987|FG004|Phase 1b|Death|0|||
128735791|NCT02880371|463325988|FG005|Phase 1b|Death|0|||
128735792|NCT02880371|463325989|FG006|Phase 1b|Death|0|||
128735793|NCT02880371|463325990|FG007|Phase 1b|Death|0|||
128735794|NCT02880371|463325983|FG000|Phase 1b|Enrolled but not Treated|0|||
128735795|NCT02880371|463325984|FG001|Phase 1b|Enrolled but not Treated|1|||
128735796|NCT02880371|463325985|FG002|Phase 1b|Enrolled but not Treated|0|||
128735797|NCT02880371|463325986|FG003|Phase 1b|Enrolled but not Treated|0|||
128735798|NCT02880371|463325987|FG004|Phase 1b|Enrolled but not Treated|0|||
128735799|NCT02880371|463325988|FG005|Phase 1b|Enrolled but not Treated|0|||
128735800|NCT02880371|463325989|FG006|Phase 1b|Enrolled but not Treated|0|||
128735801|NCT02880371|463325990|FG007|Phase 1b|Enrolled but not Treated|0|||
128735802|NCT02880371|463325983|FG000|Phase 2|Enrolled but not Treated|0|||
128735803|NCT02880371|463325984|FG001|Phase 2|Enrolled but not Treated|0|||
128735804|NCT02880371|463325985|FG002|Phase 2|Enrolled but not Treated|0|||
128735805|NCT02880371|463325986|FG003|Phase 2|Enrolled but not Treated|0|||
128735806|NCT02880371|463325987|FG004|Phase 2|Enrolled but not Treated|0|||
128783614|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
128783615|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
128735807|NCT02880371|463325988|FG005|Phase 2|Enrolled but not Treated|1|||
128783616|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
128735808|NCT02880371|463325989|FG006|Phase 2|Enrolled but not Treated|1|||
128735809|NCT02880371|463325990|FG007|Phase 2|Enrolled but not Treated|0|||
128735810|NCT02880371|463325983|FG000|Phase 2|Other|0|||
128735811|NCT02880371|463325984|FG001|Phase 2|Other|0|||
128735812|NCT02880371|463325985|FG002|Phase 2|Other|0|||
128735813|NCT02880371|463325986|FG003|Phase 2|Other|0|||
128735814|NCT02880371|463325987|FG004|Phase 2|Other|0|||
128783617|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
128783618|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
128783619|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
128735815|NCT02880371|463325988|FG005|Phase 2|Other|1|||
128735816|NCT02880371|463325989|FG006|Phase 2|Other|2|||
128735817|NCT02880371|463325990|FG007|Phase 2|Other|1|||
128735818|NCT02880371|463325983|FG000|Phase 2|Participants terminated by Sponsor|0|||
128735819|NCT02880371|463325984|FG001|Phase 2|Participants terminated by Sponsor|0|||
128783620|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
128783621|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
128783622|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
128783623|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
128783624|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
128735820|NCT02880371|463325985|FG002|Phase 2|Participants terminated by Sponsor|0|||
128735821|NCT02880371|463325986|FG003|Phase 2|Participants terminated by Sponsor|0|||
128735822|NCT02880371|463325987|FG004|Phase 2|Participants terminated by Sponsor|1|||
128735823|NCT02880371|463325988|FG005|Phase 2|Participants terminated by Sponsor|6|||
128735824|NCT02880371|463325989|FG006|Phase 2|Participants terminated by Sponsor|1|||
128735825|NCT02880371|463325990|FG007|Phase 2|Participants terminated by Sponsor|5|||
128735826|NCT02880371|463325983|FG000|Phase 2|Death|0|||
128735827|NCT02880371|463325984|FG001|Phase 2|Death|0|||
128735828|NCT02880371|463325985|FG002|Phase 2|Death|0|||
128735829|NCT02880371|463325986|FG003|Phase 2|Death|0|||
128735830|NCT02880371|463325987|FG004|Phase 2|Death|1|||
128735831|NCT02880371|463325988|FG005|Phase 2|Death|10|||
128735832|NCT02880371|463325989|FG006|Phase 2|Death|20|||
128735833|NCT02880371|463325990|FG007|Phase 2|Death|5|||
128735834|NCT02880371|463325983|FG000|Phase 2|Lost to Follow-up|0|||
128735835|NCT02880371|463325984|FG001|Phase 2|Lost to Follow-up|0|||
128735836|NCT02880371|463325985|FG002|Phase 2|Lost to Follow-up|0|||
128735837|NCT02880371|463325986|FG003|Phase 2|Lost to Follow-up|0|||
128735838|NCT02880371|463325987|FG004|Phase 2|Lost to Follow-up|0|||
128735839|NCT02880371|463325988|FG005|Phase 2|Lost to Follow-up|0|||
128735840|NCT02880371|463325989|FG006|Phase 2|Lost to Follow-up|3|||
128735841|NCT02880371|463325990|FG007|Phase 2|Lost to Follow-up|0|||
128735842|NCT02880371|463325983|FG000|Phase 2|Withdrawal by Subject|0|||
128735843|NCT02880371|463325984|FG001|Phase 2|Withdrawal by Subject|0|||
128735844|NCT02880371|463325985|FG002|Phase 2|Withdrawal by Subject|0|||
128735845|NCT02880371|463325986|FG003|Phase 2|Withdrawal by Subject|0|||
128735846|NCT02880371|463325987|FG004|Phase 2|Withdrawal by Subject|0|||
128735847|NCT02880371|463325988|FG005|Phase 2|Withdrawal by Subject|1|||
128735848|NCT02880371|463325989|FG006|Phase 2|Withdrawal by Subject|1|||
128735849|NCT02880371|463325990|FG007|Phase 2|Withdrawal by Subject|0|||
128735850|NCT02880371|463325983|FG000|Phase 2|End of Study page not completed by error|0|||
129204368|NCT01384734|465045798|FG000|Overall Study|Lack of Efficacy|3|||
129204369|NCT01384734|465045799|FG001|Overall Study|Lack of Efficacy|7|||
129204370|NCT01384734|465045800|FG002|Overall Study|Lack of Efficacy|4|||
129204371|NCT01384734|465045801|FG003|Overall Study|Lack of Efficacy|4|||
129204372|NCT01384734|465045802|FG004|Overall Study|Lack of Efficacy|2|||
129204373|NCT01384734|465045798|FG000|Overall Study|Lost to Follow-up|5|||
129204374|NCT01384734|465045799|FG001|Overall Study|Lost to Follow-up|3|||
129204375|NCT01384734|465045800|FG002|Overall Study|Lost to Follow-up|3|||
129204376|NCT01384734|465045801|FG003|Overall Study|Lost to Follow-up|8|||
129204377|NCT01384734|465045802|FG004|Overall Study|Lost to Follow-up|5|||
129204378|NCT01384734|465045798|FG000|Overall Study|Non-compliance with study drug|1|||
129204379|NCT01384734|465045799|FG001|Overall Study|Non-compliance with study drug|2|||
129204380|NCT01384734|465045800|FG002|Overall Study|Non-compliance with study drug|6|||
129204381|NCT01384734|465045801|FG003|Overall Study|Non-compliance with study drug|0|||
129204382|NCT01384734|465045802|FG004|Overall Study|Non-compliance with study drug|2|||
129204383|NCT01384734|465045798|FG000|Overall Study|Pregnancy|0|||
129204384|NCT01384734|465045799|FG001|Overall Study|Pregnancy|1|||
129204385|NCT01384734|465045800|FG002|Overall Study|Pregnancy|0|||
129204386|NCT01384734|465045801|FG003|Overall Study|Pregnancy|0|||
129204387|NCT01384734|465045802|FG004|Overall Study|Pregnancy|1|||
129204388|NCT01384734|465045798|FG000|Overall Study|Sponsor terminated|0|||
129204389|NCT01384734|465045799|FG001|Overall Study|Sponsor terminated|0|||
129204390|NCT01384734|465045800|FG002|Overall Study|Sponsor terminated|0|||
129204391|NCT01384734|465045801|FG003|Overall Study|Sponsor terminated|0|||
129204392|NCT01384734|465045802|FG004|Overall Study|Sponsor terminated|1|||
129204393|NCT01384734|465045798|FG000|Overall Study|Withdrawal by Subject|5|||
129204394|NCT01384734|465045799|FG001|Overall Study|Withdrawal by Subject|5|||
129204395|NCT01384734|465045800|FG002|Overall Study|Withdrawal by Subject|6|||
129204396|NCT01384734|465045801|FG003|Overall Study|Withdrawal by Subject|7|||
129204397|NCT01384734|465045802|FG004|Overall Study|Withdrawal by Subject|9|||
129204398|NCT01384734|465045798|FG000|Overall Study|Investigator relocating|0|||
129204399|NCT01384734|465045799|FG001|Overall Study|Investigator relocating|2|||
129204400|NCT01384734|465045800|FG002|Overall Study|Investigator relocating|0|||
129204401|NCT01384734|465045801|FG003|Overall Study|Investigator relocating|3|||
129204402|NCT01384734|465045802|FG004|Overall Study|Investigator relocating|1|||
129204403|NCT01384734|465045798|FG000|Overall Study|Unable to come back for visit|1|||
129204404|NCT01384734|465045799|FG001|Overall Study|Unable to come back for visit|0|||
129204405|NCT01384734|465045800|FG002|Overall Study|Unable to come back for visit|1|||
129204406|NCT01384734|465045801|FG003|Overall Study|Unable to come back for visit|1|||
129204407|NCT01384734|465045802|FG004|Overall Study|Unable to come back for visit|0|||
129204408|NCT01384734|465045798|FG000|Overall Study|Prison|0|||
129204409|NCT01384734|465045799|FG001|Overall Study|Prison|0|||
129204410|NCT01384734|465045800|FG002|Overall Study|Prison|1|||
129204411|NCT01384734|465045801|FG003|Overall Study|Prison|0|||
129204412|NCT01384734|465045802|FG004|Overall Study|Prison|0|||
129204413|NCT01384734|465045798|FG000|Overall Study|As per Exclusion criteria|0|||
129204414|NCT01384734|465045799|FG001|Overall Study|As per Exclusion criteria|1|||
128735851|NCT02880371|463325984|FG001|Phase 2|End of Study page not completed by error|0|||
128735852|NCT02880371|463325985|FG002|Phase 2|End of Study page not completed by error|0|||
128735853|NCT02880371|463325986|FG003|Phase 2|End of Study page not completed by error|0|||
128735854|NCT02880371|463325987|FG004|Phase 2|End of Study page not completed by error|0|||
128735855|NCT02880371|463325988|FG005|Phase 2|End of Study page not completed by error|1|||
128735856|NCT02880371|463325989|FG006|Phase 2|End of Study page not completed by error|0|||
128735857|NCT02880371|463325990|FG007|Phase 2|End of Study page not completed by error|0|||
128735858|NCT01777997|463325993|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
128735859|NCT01777997|463325993|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
128735860|NCT01777997|463325993|FG000|Weeks 48 to 72/96 on ART|Death|1|||
128735861|NCT01777997|463325993|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
128735862|NCT04086472|463325999|FG000|Overall Study|Lost to Follow-up|1|||
128735863|NCT04086472|463326000|FG001|Overall Study|Lost to Follow-up|0|||
128735864|NCT04086472|463326001|FG002|Overall Study|Lost to Follow-up|0|||
128735865|NCT04086472|463326002|FG003|Overall Study|Lost to Follow-up|0|||
128735866|NCT04086472|463326003|FG004|Overall Study|Lost to Follow-up|1|||
128735867|NCT04086472|463325999|FG000|Overall Study|Physician Decision|0|||
128735868|NCT04086472|463326000|FG001|Overall Study|Physician Decision|1|||
128735869|NCT04086472|463326001|FG002|Overall Study|Physician Decision|1|||
128735870|NCT04086472|463326002|FG003|Overall Study|Physician Decision|0|||
128735871|NCT04086472|463326003|FG004|Overall Study|Physician Decision|0|||
128735872|NCT04086472|463325999|FG000|Overall Study|Withdrawal by Subject|1|||
128735873|NCT04086472|463326000|FG001|Overall Study|Withdrawal by Subject|1|||
128735874|NCT04086472|463326001|FG002|Overall Study|Withdrawal by Subject|1|||
128735875|NCT04086472|463326002|FG003|Overall Study|Withdrawal by Subject|0|||
128735876|NCT04086472|463326003|FG004|Overall Study|Withdrawal by Subject|0|||
128735877|NCT04086472|463325999|FG000|Overall Study|Various reasons|2|||
128735878|NCT04086472|463326000|FG001|Overall Study|Various reasons|0|||
128735879|NCT04086472|463326001|FG002|Overall Study|Various reasons|0|||
128735880|NCT04086472|463326002|FG003|Overall Study|Various reasons|3|||
128735881|NCT04086472|463326003|FG004|Overall Study|Various reasons|1|||
128735882|NCT00048724|463326004|FG000|Overall Study|Adverse Event|53|||
128735883|NCT00048724|463326005|FG001|Overall Study|Adverse Event|12|||
128735884|NCT00048724|463326004|FG000|Overall Study|Withdrawal by Subject|34|||
128735885|NCT00048724|463326005|FG001|Overall Study|Withdrawal by Subject|54|||
128735886|NCT00048724|463326004|FG000|Overall Study|Lost to Follow-up|5|||
128735887|NCT00048724|463326005|FG001|Overall Study|Lost to Follow-up|5|||
128735888|NCT00048724|463326004|FG000|Overall Study|Protocol-defined Clinical Event|17|||
128735889|NCT00048724|463326005|FG001|Overall Study|Protocol-defined Clinical Event|32|||
128735890|NCT00048724|463326004|FG000|Overall Study|Noncompliance With Protocol|4|||
128735891|NCT00048724|463326005|FG001|Overall Study|Noncompliance With Protocol|12|||
128735892|NCT00048724|463326004|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
128735893|NCT00048724|463326005|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
128735894|NCT00048724|463326004|FG000|Overall Study|Administrative|1|||
128735895|NCT00048724|463326005|FG001|Overall Study|Administrative|1|||
128735896|NCT00844545|463326006|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
128783625|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
128783626|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
128783627|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
128783628|NCT02403323|463499821|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
128783629|NCT02403323|463499822|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
128783630|NCT02403323|463499823|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
128783631|NCT03852433|463499824|FG000|Overall Study|Withdrawal of consent|5|||
128783632|NCT03852433|463499825|FG001|Overall Study|Withdrawal of consent|8|||
128783633|NCT03852433|463499826|FG002|Overall Study|Withdrawal of consent|1|||
128783634|NCT03852433|463499827|FG003|Overall Study|Withdrawal of consent|1|||
128783635|NCT03852433|463499824|FG000|Overall Study|Adverse Event|1|||
128783636|NCT03852433|463499825|FG001|Overall Study|Adverse Event|1|||
128783637|NCT03852433|463499826|FG002|Overall Study|Adverse Event|1|||
128783638|NCT03852433|463499827|FG003|Overall Study|Adverse Event|1|||
128783639|NCT03852433|463499824|FG000|Overall Study|Lost to Follow-up|0|||
128783640|NCT03852433|463499825|FG001|Overall Study|Lost to Follow-up|1|||
128783641|NCT03852433|463499826|FG002|Overall Study|Lost to Follow-up|0|||
128783642|NCT03852433|463499827|FG003|Overall Study|Lost to Follow-up|1|||
128783643|NCT03852433|463499824|FG000|Overall Study|Pregnancy|0|||
128783644|NCT03852433|463499825|FG001|Overall Study|Pregnancy|1|||
128783645|NCT03852433|463499826|FG002|Overall Study|Pregnancy|1|||
128783646|NCT03852433|463499827|FG003|Overall Study|Pregnancy|0|||
128783647|NCT03852433|463499824|FG000|Overall Study|Protocol Violation|0|||
128783648|NCT03852433|463499825|FG001|Overall Study|Protocol Violation|0|||
128783649|NCT03852433|463499826|FG002|Overall Study|Protocol Violation|1|||
128783650|NCT03852433|463499827|FG003|Overall Study|Protocol Violation|1|||
128783651|NCT03852433|463499824|FG000|Overall Study|Death|0|||
128783652|NCT03852433|463499825|FG001|Overall Study|Death|0|||
128783653|NCT03852433|463499826|FG002|Overall Study|Death|1|||
128783654|NCT03852433|463499827|FG003|Overall Study|Death|0|||
128783655|NCT03852433|463499824|FG000|Overall Study|Lack of Efficacy|0|||
128783656|NCT03852433|463499825|FG001|Overall Study|Lack of Efficacy|1|||
128783657|NCT03852433|463499826|FG002|Overall Study|Lack of Efficacy|0|||
128783658|NCT03852433|463499827|FG003|Overall Study|Lack of Efficacy|0|||
128783659|NCT03852433|463499824|FG000|Overall Study|Non-compliance with study drug|0|||
128783660|NCT03852433|463499825|FG001|Overall Study|Non-compliance with study drug|0|||
128783661|NCT03852433|463499826|FG002|Overall Study|Non-compliance with study drug|0|||
128783662|NCT03852433|463499827|FG003|Overall Study|Non-compliance with study drug|1|||
128783663|NCT03852433|463499824|FG000|Overall Study|Physician Decision|1|||
128783664|NCT03852433|463499825|FG001|Overall Study|Physician Decision|0|||
128783665|NCT03852433|463499826|FG002|Overall Study|Physician Decision|0|||
128783666|NCT03852433|463499827|FG003|Overall Study|Physician Decision|0|||
128783667|NCT03852433|463499824|FG000|Overall Study|Randomized but never treated|1|||
128783668|NCT03852433|463499825|FG001|Overall Study|Randomized but never treated|0|||
128783669|NCT03852433|463499826|FG002|Overall Study|Randomized but never treated|0|||
128783670|NCT03852433|463499827|FG003|Overall Study|Randomized but never treated|0|||
128783671|NCT01076335|463499828|FG000|Overall Study|Withdrawal by Subject|3|||
128783672|NCT01076335|463499828|FG000|Overall Study|Withdrawal without treatment|1|||
128783673|NCT00654238|463499831|FG000|Overall Study|Screen Failures|4|||
128783674|NCT01348087|463499841|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
128783675|NCT01348087|463499841|FG000|Overall Study|Administrative problems|79|||
128783676|NCT01348087|463499841|FG000|Overall Study|protocol deviation|1|||
128783677|NCT01348087|463499841|FG000|Overall Study|Lost to Follow-up|1|||
128783678|NCT01348087|463499841|FG000|Overall Study|Subject withdrew consent|7|||
128783679|NCT01348087|463499841|FG000|Overall Study|Adverse Event|25|||
128783680|NCT00117988|463499844|FG000|Overall Study|Death|3|||
128783681|NCT00117988|463499844|FG000|Overall Study|Adverse Event|1|||
128783682|NCT01096056|463499847|FG000|Overall Study|Lost to Follow-up|0|||
128783683|NCT01096056|463499848|FG001|Overall Study|Lost to Follow-up|1|||
128783684|NCT04678830|463499850|FG000|Overall Study|Lack of Efficacy|2|||
128783685|NCT04678830|463499851|FG001|Overall Study|Lack of Efficacy|0|||
128783686|NCT04678830|463499850|FG000|Overall Study|Withdrawal by Subject|0|||
128783687|NCT04678830|463499851|FG001|Overall Study|Withdrawal by Subject|1|||
128783688|NCT01836458|463499853|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
128783689|NCT01836458|463499854|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128783690|NCT01836458|463499855|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
128783691|NCT01836458|463499856|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
128783692|NCT02189863|463499857|FG000|First 2 Weeks|Motion Sickness|4|||
128783693|NCT02189863|463499858|FG001|First 2 Weeks|Motion Sickness|2|||
128783694|NCT03369951|463499860|FG000|Overall Study|Withdrawal by Subject|3|||
128783695|NCT03369951|463499860|FG000|Overall Study|Death|1|||
128783696|NCT03369951|463499860|FG000|Overall Study|Lost to Follow-up|1|||
128783697|NCT03369951|463499860|FG000|Overall Study|Protocol Violation|1|||
128783698|NCT03677375|463499864|FG000|Overall Study|Incomplete procedure|8|||
128783699|NCT03677375|463499864|FG000|Overall Study|Adverse Event|3|||
128783700|NCT03677375|463499864|FG000|Overall Study|Physician Decision|1|||
128783701|NCT00561574|463499870|FG000|Overall Study|Adverse Event|21|||
128783702|NCT00561574|463499871|FG001|Overall Study|Adverse Event|24|||
128783703|NCT00561574|463499870|FG000|Overall Study|Lack of Efficacy|11|||
128783704|NCT00561574|463499871|FG001|Overall Study|Lack of Efficacy|21|||
128783705|NCT00561574|463499870|FG000|Overall Study|Withdrawal by Subject|4|||
128783706|NCT00561574|463499871|FG001|Overall Study|Withdrawal by Subject|4|||
128783707|NCT00561574|463499870|FG000|Overall Study|Reason Unrelated to Trial|6|||
128783708|NCT00561574|463499871|FG001|Overall Study|Reason Unrelated to Trial|2|||
128783709|NCT00561574|463499870|FG000|Overall Study|Lost to Follow-up|1|||
128783710|NCT00561574|463499871|FG001|Overall Study|Lost to Follow-up|0|||
128735897|NCT00844545|463326006|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
128735898|NCT00844545|463326006|FG000|Extension Treatment Period|Adverse Event|2|||
128735899|NCT00844545|463326006|FG000|Post Treatment Period|Withdrawal by Subject|1|||
128735900|NCT01743092|463326007|FG000|Overall Study|Lost to Follow-up|14|||
128735901|NCT01743092|463326008|FG001|Overall Study|Lost to Follow-up|15|||
128735902|NCT03586869|463326014|FG000|Overall Study|Progressive Disease|3|||
128735903|NCT00403455|463326015|FG000|Overall Study|Withdrawal by Subject|1|||
128735904|NCT02809976|463326024|FG000|Overall Study|Lost to Follow-up|1|||
128735905|NCT02809976|463326024|FG000|Overall Study|Withdrawal by Subject|1|||
128735906|NCT00087568|463326025|FG000|Overall Study|Adverse Event|4|||
128735907|NCT00087568|463326026|FG001|Overall Study|Adverse Event|0|||
128735908|NCT00087568|463326025|FG000|Overall Study|Withdrawal by Subject|1|||
128735909|NCT00087568|463326026|FG001|Overall Study|Withdrawal by Subject|1|||
128735910|NCT00087568|463326025|FG000|Overall Study|Lost to Follow-up|1|||
128735911|NCT00087568|463326026|FG001|Overall Study|Lost to Follow-up|0|||
128735912|NCT00087568|463326025|FG000|Overall Study|Lack of Efficacy|24|||
128735913|NCT00087568|463326026|FG001|Overall Study|Lack of Efficacy|1|||
128735914|NCT04394351|463326027|FG000|Part A (16 Weeks)|Adverse Event|1|||
128735915|NCT04394351|463326028|FG001|Part A (16 Weeks)|Adverse Event|0|||
128735916|NCT04394351|463326029|FG002|Part A (16 Weeks)|Adverse Event|0|||
128735917|NCT04394351|463326030|FG003|Part A (16 Weeks)|Adverse Event|0|||
128735918|NCT04394351|463326031|FG004|Part A (16 Weeks)|Adverse Event|0|||
128735919|NCT04394351|463326032|FG005|Part A (16 Weeks)|Adverse Event|0|||
128735920|NCT04394351|463326033|FG006|Part A (16 Weeks)|Adverse Event|0|||
128735921|NCT04394351|463326034|FG007|Part A (16 Weeks)|Adverse Event|0|||
128735922|NCT04394351|463326027|FG000|Part A (16 Weeks)|Physician Decision|0|||
128735923|NCT04394351|463326028|FG001|Part A (16 Weeks)|Physician Decision|1|||
128735924|NCT04394351|463326029|FG002|Part A (16 Weeks)|Physician Decision|0|||
128735925|NCT04394351|463326030|FG003|Part A (16 Weeks)|Physician Decision|0|||
128735926|NCT04394351|463326031|FG004|Part A (16 Weeks)|Physician Decision|0|||
128735927|NCT04394351|463326032|FG005|Part A (16 Weeks)|Physician Decision|0|||
128735928|NCT04394351|463326033|FG006|Part A (16 Weeks)|Physician Decision|0|||
128735929|NCT04394351|463326034|FG007|Part A (16 Weeks)|Physician Decision|0|||
128735930|NCT04394351|463326027|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
128735931|NCT04394351|463326028|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
128735932|NCT04394351|463326029|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
128735933|NCT04394351|463326030|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
128735934|NCT04394351|463326031|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
128735935|NCT04394351|463326032|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
128735936|NCT04394351|463326033|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
128735937|NCT04394351|463326034|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
128735938|NCT04394351|463326027|FG000|Part B (36 Weeks)|Adverse Event|0|||
128735939|NCT04394351|463326028|FG001|Part B (36 Weeks)|Adverse Event|0|||
128735940|NCT04394351|463326029|FG002|Part B (36 Weeks)|Adverse Event|0|||
128735941|NCT04394351|463326030|FG003|Part B (36 Weeks)|Adverse Event|0|||
128735942|NCT04394351|463326031|FG004|Part B (36 Weeks)|Adverse Event|0|||
128735943|NCT04394351|463326032|FG005|Part B (36 Weeks)|Adverse Event|0|||
128735944|NCT04394351|463326033|FG006|Part B (36 Weeks)|Adverse Event|1|||
128735945|NCT04394351|463326034|FG007|Part B (36 Weeks)|Adverse Event|0|||
128735946|NCT02738775|463326039|FG000|Overall Study|Withdrawal by Subject|0|||
128735947|NCT02738775|463326040|FG001|Overall Study|Withdrawal by Subject|1|||
128735948|NCT02738775|463326041|FG002|Overall Study|Withdrawal by Subject|0|||
128735949|NCT02738775|463326042|FG003|Overall Study|Withdrawal by Subject|0|||
128735950|NCT02738775|463326043|FG004|Overall Study|Withdrawal by Subject|0|||
128735951|NCT02738775|463326044|FG005|Overall Study|Withdrawal by Subject|0|||
128735952|NCT02738775|463326039|FG000|Overall Study|Adverse Event|0|||
128735953|NCT02738775|463326040|FG001|Overall Study|Adverse Event|0|||
128735954|NCT02738775|463326041|FG002|Overall Study|Adverse Event|0|||
128735955|NCT02738775|463326042|FG003|Overall Study|Adverse Event|1|||
128735956|NCT02738775|463326043|FG004|Overall Study|Adverse Event|0|||
128735957|NCT02738775|463326044|FG005|Overall Study|Adverse Event|0|||
128735958|NCT02738775|463326039|FG000|Overall Study|Pregnancy|0|||
128735959|NCT02738775|463326040|FG001|Overall Study|Pregnancy|1|||
128735960|NCT02738775|463326041|FG002|Overall Study|Pregnancy|0|||
128735961|NCT02738775|463326042|FG003|Overall Study|Pregnancy|0|||
128735962|NCT02738775|463326043|FG004|Overall Study|Pregnancy|0|||
128735963|NCT02738775|463326044|FG005|Overall Study|Pregnancy|0|||
128735964|NCT02738775|463326039|FG000|Overall Study|Missing|0|||
128783711|NCT00561574|463499870|FG000|Overall Study|Other|5|||
128783712|NCT00561574|463499871|FG001|Overall Study|Other|7|||
128735965|NCT02738775|463326040|FG001|Overall Study|Missing|0|||
128735966|NCT02738775|463326041|FG002|Overall Study|Missing|0|||
128735967|NCT02738775|463326042|FG003|Overall Study|Missing|0|||
128735968|NCT02738775|463326043|FG004|Overall Study|Missing|0|||
128735969|NCT02738775|463326044|FG005|Overall Study|Missing|1|||
128735970|NCT02992899|463326045|FG000|Overall Study|Withdrawal by Subject|1|||
128783713|NCT03971357|463499872|FG000|Overall Study|Lack of Efficacy|0|||
128735971|NCT02992899|463326046|FG001|Overall Study|Withdrawal by Subject|0|||
128735972|NCT02992899|463326045|FG000|Overall Study|Lost to Follow-up|1|||
128783714|NCT03971357|463499873|FG001|Overall Study|Lack of Efficacy|1|||
128735973|NCT02992899|463326046|FG001|Overall Study|Lost to Follow-up|3|||
128735974|NCT01600040|463326047|FG000|Overall Study|Withdrawal by Subject|1|||
128735975|NCT00779766|463326051|FG000|Month 24|Serious Adverse Event|2|||
128735976|NCT00779766|463326052|FG001|Month 24|Serious Adverse Event|3|||
128735977|NCT00779766|463326051|FG000|Month 24|Adverse Event|3|||
128735978|NCT00779766|463326052|FG001|Month 24|Adverse Event|3|||
128735979|NCT00779766|463326051|FG000|Month 24|Protocol Violation|3|||
128735980|NCT00779766|463326052|FG001|Month 24|Protocol Violation|1|||
128735981|NCT00779766|463326051|FG000|Month 24|Withdrawal by Subject|159|||
128735982|NCT00779766|463326052|FG001|Month 24|Withdrawal by Subject|127|||
128735983|NCT00779766|463326051|FG000|Month 24|Migrated/moved from study area|138|||
128735984|NCT00779766|463326052|FG001|Month 24|Migrated/moved from study area|162|||
128735985|NCT00779766|463326051|FG000|Month 24|Lost to Follow-up|9|||
128735986|NCT00779766|463326052|FG001|Month 24|Lost to Follow-up|9|||
128735987|NCT00779766|463326051|FG000|Month 24|Other|18|||
128735988|NCT00779766|463326052|FG001|Month 24|Other|27|||
128735989|NCT00779766|463326051|FG000|Month 48|Withdrawal by Subject|68|||
128735990|NCT00779766|463326052|FG001|Month 48|Withdrawal by Subject|63|||
128735991|NCT00779766|463326051|FG000|Month 48|Migrated/moved from study area|76|||
128735992|NCT00779766|463326052|FG001|Month 48|Migrated/moved from study area|75|||
128735993|NCT00779766|463326051|FG000|Month 48|Lost to Follow-up|29|||
128735994|NCT00779766|463326052|FG001|Month 48|Lost to Follow-up|30|||
128735995|NCT00779766|463326051|FG000|Month 48|Other|1|||
128735996|NCT00779766|463326052|FG001|Month 48|Other|0|||
128735997|NCT00779766|463326051|FG000|Month 72|Withdrawal by Subject|55|||
128735998|NCT00779766|463326052|FG001|Month 72|Withdrawal by Subject|71|||
128735999|NCT00779766|463326051|FG000|Month 72|Migrated/moved from study area|124|||
128736000|NCT00779766|463326052|FG001|Month 72|Migrated/moved from study area|109|||
128736001|NCT00779766|463326051|FG000|Month 72|Lost to Follow-up|6|||
128736002|NCT00779766|463326052|FG001|Month 72|Lost to Follow-up|8|||
128736003|NCT00779766|463326051|FG000|Month 72|Other|0|||
128736004|NCT00779766|463326052|FG001|Month 72|Other|1|||
128736005|NCT01412424|463326055|FG000|Core Treatment Period|Treatment Failure|24|||
128736006|NCT01412424|463326055|FG000|Core Treatment Period|Adverse Event|21|||
128736007|NCT01412424|463326055|FG000|Core Treatment Period|Patient Request|5|||
128736008|NCT01412424|463326055|FG000|Core Treatment Period|Lost to Follow-up|2|||
128736009|NCT01412424|463326055|FG000|Core Treatment Period|Sponsor Request|1|||
128736010|NCT01412424|463326055|FG000|Extension Treatment Period|Adverse Event|2|||
128736011|NCT01412424|463326055|FG000|Extension Treatment Period|Treatment Failure|2|||
128736012|NCT01412424|463326055|FG000|Extension Treatment Period|Patient Request|2|||
128736013|NCT01274637|463326056|FG000|Overall Study|Withdrawal by Subject|0|||
128736014|NCT01274637|463326057|FG001|Overall Study|Withdrawal by Subject|1|||
128736015|NCT01274637|463326056|FG000|Overall Study|Lost to Follow-up|0|||
128736016|NCT01274637|463326057|FG001|Overall Study|Lost to Follow-up|1|||
128736017|NCT00414050|463326065|FG000|Overall Study|Adverse Event|1|||
128736018|NCT00414050|463326066|FG001|Overall Study|Adverse Event|1|||
128736019|NCT00414050|463326067|FG002|Overall Study|Adverse Event|1|||
128736020|NCT00414050|463326068|FG003|Overall Study|Adverse Event|1|||
128736021|NCT00414050|463326065|FG000|Overall Study|Lost to Follow-up|2|||
128736022|NCT00414050|463326066|FG001|Overall Study|Lost to Follow-up|2|||
128736023|NCT00414050|463326067|FG002|Overall Study|Lost to Follow-up|1|||
128736024|NCT00414050|463326068|FG003|Overall Study|Lost to Follow-up|1|||
128736025|NCT00414050|463326065|FG000|Overall Study|Withdrawal by Subject|5|||
128736026|NCT00414050|463326066|FG001|Overall Study|Withdrawal by Subject|3|||
128736027|NCT00414050|463326067|FG002|Overall Study|Withdrawal by Subject|2|||
128736028|NCT00414050|463326068|FG003|Overall Study|Withdrawal by Subject|4|||
128736029|NCT00414050|463326065|FG000|Overall Study|Subject discontinued for other reason|1|||
128736030|NCT00414050|463326066|FG001|Overall Study|Subject discontinued for other reason|2|||
128736031|NCT00414050|463326067|FG002|Overall Study|Subject discontinued for other reason|2|||
128736032|NCT00414050|463326068|FG003|Overall Study|Subject discontinued for other reason|1|||
128736033|NCT00414050|463326065|FG000|Overall Study|Subject Moved|0|||
128736034|NCT00414050|463326066|FG001|Overall Study|Subject Moved|0|||
128736035|NCT00414050|463326067|FG002|Overall Study|Subject Moved|0|||
128736036|NCT00414050|463326068|FG003|Overall Study|Subject Moved|1|||
128736037|NCT00720876|463326069|FG000|Overall Study|found to be ineligible after starting tx|2|||
128736038|NCT03495908|463326071|FG000|Overall Study|Withdrawal by Subject|3|||
128736039|NCT03495908|463326072|FG001|Overall Study|Withdrawal by Subject|1|||
128783715|NCT00630864|463499880|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
128736040|NCT03495908|463326071|FG000|Overall Study|Lost to Follow-up|1|||
128736041|NCT03495908|463326072|FG001|Overall Study|Lost to Follow-up|4|||
128736042|NCT03495908|463326071|FG000|Overall Study|Adverse Event|0|||
128736043|NCT03495908|463326072|FG001|Overall Study|Adverse Event|2|||
128736044|NCT03495908|463326071|FG000|Overall Study|Death|1|||
128736045|NCT03495908|463326072|FG001|Overall Study|Death|0|||
128736046|NCT03495908|463326071|FG000|Overall Study|Physician Decision|5|||
128736047|NCT03495908|463326072|FG001|Overall Study|Physician Decision|4|||
128736048|NCT03495908|463326071|FG000|Overall Study|No documented reason|0|||
128736049|NCT03495908|463326072|FG001|Overall Study|No documented reason|2|||
128736050|NCT03304379|463326077|FG000|Overall Study|Protocol Violation|8|||
128736051|NCT03304379|463326078|FG001|Overall Study|Protocol Violation|10|||
128736052|NCT03304379|463326079|FG002|Overall Study|Protocol Violation|5|||
128736053|NCT03304379|463326080|FG003|Overall Study|Protocol Violation|0|||
128736054|NCT03304379|463326081|FG004|Overall Study|Protocol Violation|2|||
128736055|NCT03304379|463326077|FG000|Overall Study|Adverse Event|4|||
128736056|NCT03304379|463326078|FG001|Overall Study|Adverse Event|20|||
128736057|NCT03304379|463326079|FG002|Overall Study|Adverse Event|17|||
128736058|NCT03304379|463326080|FG003|Overall Study|Adverse Event|1|||
128736059|NCT03304379|463326081|FG004|Overall Study|Adverse Event|0|||
128736060|NCT03304379|463326077|FG000|Overall Study|Lack of Efficacy|17|||
128736061|NCT03304379|463326078|FG001|Overall Study|Lack of Efficacy|16|||
128736062|NCT03304379|463326079|FG002|Overall Study|Lack of Efficacy|20|||
128736063|NCT03304379|463326080|FG003|Overall Study|Lack of Efficacy|0|||
128736064|NCT03304379|463326081|FG004|Overall Study|Lack of Efficacy|0|||
128736065|NCT03304379|463326077|FG000|Overall Study|Physician Decision|6|||
128736066|NCT03304379|463326078|FG001|Overall Study|Physician Decision|10|||
128736067|NCT03304379|463326079|FG002|Overall Study|Physician Decision|6|||
128736068|NCT03304379|463326080|FG003|Overall Study|Physician Decision|9|||
128736069|NCT03304379|463326081|FG004|Overall Study|Physician Decision|10|||
128736070|NCT03304379|463326077|FG000|Overall Study|Withdrawal by Subject|26|||
128736071|NCT03304379|463326078|FG001|Overall Study|Withdrawal by Subject|58|||
128736072|NCT03304379|463326079|FG002|Overall Study|Withdrawal by Subject|66|||
128736073|NCT03304379|463326080|FG003|Overall Study|Withdrawal by Subject|3|||
128736074|NCT03304379|463326081|FG004|Overall Study|Withdrawal by Subject|5|||
128736075|NCT03304379|463326077|FG000|Overall Study|Lost to Follow-up|8|||
128736076|NCT03304379|463326078|FG001|Overall Study|Lost to Follow-up|24|||
128736077|NCT03304379|463326079|FG002|Overall Study|Lost to Follow-up|35|||
128736078|NCT03304379|463326080|FG003|Overall Study|Lost to Follow-up|4|||
128736079|NCT03304379|463326081|FG004|Overall Study|Lost to Follow-up|0|||
128736080|NCT03304379|463326077|FG000|Overall Study|Death|1|||
128736081|NCT03304379|463326078|FG001|Overall Study|Death|2|||
128736082|NCT03304379|463326079|FG002|Overall Study|Death|0|||
128736083|NCT03304379|463326080|FG003|Overall Study|Death|0|||
128736084|NCT03304379|463326081|FG004|Overall Study|Death|0|||
128736085|NCT03304379|463326077|FG000|Overall Study|Other|0|||
128736086|NCT03304379|463326078|FG001|Overall Study|Other|1|||
128736087|NCT03304379|463326079|FG002|Overall Study|Other|0|||
128736088|NCT03304379|463326080|FG003|Overall Study|Other|0|||
128736089|NCT03304379|463326081|FG004|Overall Study|Other|0|||
128736090|NCT00684424|463326093|FG000|Overall Study|Adverse Event|1|||
128736091|NCT00684424|463326093|FG000|Overall Study|Lost to Follow-up|2|||
128736092|NCT00684424|463326093|FG000|Overall Study|Other|2|||
128736093|NCT02410811|463326094|FG000|Overall Study|Withdrawal by Subject|0|||
128736094|NCT02410811|463326095|FG001|Overall Study|Withdrawal by Subject|0|||
128736095|NCT02410811|463326096|FG002|Overall Study|Withdrawal by Subject|1|||
128736096|NCT02410811|463326097|FG003|Overall Study|Withdrawal by Subject|0|||
128736097|NCT03511560|463326103|FG000|Overall Study|Death|0|||
128736098|NCT03511560|463326104|FG001|Overall Study|Death|1|||
128736099|NCT03511560|463326103|FG000|Overall Study|Adverse Event|0|||
128736100|NCT03511560|463326104|FG001|Overall Study|Adverse Event|2|||
128736101|NCT03511560|463326103|FG000|Overall Study|Transplant cancelled|0|||
128736102|NCT03511560|463326104|FG001|Overall Study|Transplant cancelled|1|||
128736103|NCT03511560|463326103|FG000|Overall Study|Patient switched to another drug|1|||
128736104|NCT03511560|463326104|FG001|Overall Study|Patient switched to another drug|0|||
128736105|NCT00439140|463326105|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
128736106|NCT00439140|463326106|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
128736107|NCT00439140|463326107|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
128736108|NCT00439140|463326105|FG000|Treatment Cycle 1|Personal reasons|0|||
128736109|NCT00439140|463326106|FG001|Treatment Cycle 1|Personal reasons|2|||
128736110|NCT00439140|463326107|FG002|Treatment Cycle 1|Personal reasons|0|||
128736111|NCT00439140|463326105|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
128736112|NCT00439140|463326106|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
128736113|NCT00439140|463326107|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
128736114|NCT00439140|463326105|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
128736115|NCT00439140|463326106|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
128736116|NCT00439140|463326107|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
128736117|NCT00439140|463326105|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
128736118|NCT00439140|463326106|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
128736119|NCT00439140|463326107|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
128736120|NCT02550652|463326108|FG000|Overall Study|Death|1|||
128736121|NCT02550652|463326109|FG001|Overall Study|Death|4|||
128736122|NCT02550652|463326108|FG000|Overall Study|Lack of Efficacy|1|||
128736123|NCT02550652|463326109|FG001|Overall Study|Lack of Efficacy|0|||
128736124|NCT02550652|463326108|FG000|Overall Study|Withdrawal by Subject|4|||
128736125|NCT02550652|463326109|FG001|Overall Study|Withdrawal by Subject|7|||
128736126|NCT02550652|463326108|FG000|Overall Study|Post Trial Access|1|||
128736127|NCT02550652|463326109|FG001|Overall Study|Post Trial Access|0|||
128736128|NCT02550652|463326108|FG000|Overall Study|Lost to Follow-up|1|||
128736129|NCT02550652|463326109|FG001|Overall Study|Lost to Follow-up|3|||
128736130|NCT02550652|463326108|FG000|Overall Study|Physician Decision|0|||
128736131|NCT02550652|463326109|FG001|Overall Study|Physician Decision|2|||
128736132|NCT02550652|463326108|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
128736133|NCT02550652|463326109|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
128736134|NCT01706250|463326110|FG000|Overall Study|Lost to Follow-up|2|||
128736135|NCT01858194|463326111|FG000|Overall Study|Total Artificial Heart Implant|0|||
128736136|NCT01858194|463326112|FG001|Overall Study|Total Artificial Heart Implant|1|||
128736137|NCT01858194|463326111|FG000|Overall Study|Lost to Follow-up|0|||
128783716|NCT00630864|463499880|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
128736138|NCT01858194|463326112|FG001|Overall Study|Lost to Follow-up|1|||
128736139|NCT03181542|463326116|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
128736140|NCT03181542|463326117|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
128736141|NCT00799617|463326118|FG000|Main Testosterone Trial|Randomized in error|1|||
128736142|NCT00799617|463326119|FG001|Main Testosterone Trial|Randomized in error|1|||
128736143|NCT00799617|463326118|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
128736144|NCT00799617|463326119|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
128736145|NCT00799617|463326118|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
128736146|NCT00799617|463326119|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
128736147|NCT00799617|463326118|FG000|Sexual Funtion Trial|No Baseline Data|4|||
128736148|NCT00799617|463326119|FG001|Sexual Funtion Trial|No Baseline Data|7|||
128783717|NCT00124982|463499881|FG000|Short-term Period|Death|1|||
128783718|NCT00124982|463499882|FG001|Short-term Period|Death|1|||
128783719|NCT00124982|463499883|FG002|Short-term Period|Death|0|||
128783720|NCT00124982|463499881|FG000|Short-term Period|Adverse Event|17|||
128783721|NCT00124982|463499882|FG001|Short-term Period|Adverse Event|22|||
128783722|NCT00124982|463499883|FG002|Short-term Period|Adverse Event|0|||
128783723|NCT00124982|463499881|FG000|Short-term Period|Lack of Efficacy|32|||
128783724|NCT00124982|463499882|FG001|Short-term Period|Lack of Efficacy|73|||
128783725|NCT00124982|463499883|FG002|Short-term Period|Lack of Efficacy|0|||
128783726|NCT00124982|463499881|FG000|Short-term Period|Lost to Follow-up|8|||
128783727|NCT00124982|463499882|FG001|Short-term Period|Lost to Follow-up|5|||
128783728|NCT00124982|463499883|FG002|Short-term Period|Lost to Follow-up|0|||
128783729|NCT00124982|463499881|FG000|Short-term Period|Withdrawal of Consent|7|||
128783730|NCT00124982|463499882|FG001|Short-term Period|Withdrawal of Consent|9|||
128783731|NCT00124982|463499883|FG002|Short-term Period|Withdrawal of Consent|0|||
128783732|NCT00124982|463499881|FG000|Short-term Period|Poor/Non-compliance|3|||
128783733|NCT00124982|463499882|FG001|Short-term Period|Poor/Non-compliance|1|||
128783734|NCT00124982|463499883|FG002|Short-term Period|Poor/Non-compliance|0|||
128783735|NCT00124982|463499881|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
128736149|NCT00799617|463326118|FG000|Physical Function Trial|Lost to Follow-up|6|||
128736150|NCT00799617|463326119|FG001|Physical Function Trial|Lost to Follow-up|11|||
128736151|NCT00799617|463326118|FG000|Vitality Trial|Lost to Follow-up|7|||
128736152|NCT00799617|463326119|FG001|Vitality Trial|Lost to Follow-up|22|||
128736153|NCT00799617|463326118|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
128736154|NCT00799617|463326119|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
128736155|NCT00799617|463326118|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
128736156|NCT00799617|463326119|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
128736157|NCT00799617|463326118|FG000|Bone Trial|Month 12 scan not available|6|||
128736158|NCT00799617|463326119|FG001|Bone Trial|Month 12 scan not available|16|||
128736159|NCT00799617|463326118|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
128736160|NCT00799617|463326119|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
128736161|NCT00799617|463326118|FG000|Anemia Trial|Withdrawal by Subject|3|||
128736162|NCT00799617|463326119|FG001|Anemia Trial|Withdrawal by Subject|3|||
128736163|NCT04545515|463326120|FG000|Overall Study|Adverse Event|1|||
128736164|NCT04545515|463326120|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
128736165|NCT04545515|463326120|FG000|Overall Study|Commercial drug is available for participant|7|||
128736166|NCT00958880|463326121|FG000|Overall Study|Lost to Follow-up|2|||
128736167|NCT00958880|463326122|FG001|Overall Study|Lost to Follow-up|2|||
128736168|NCT01848990|463326123|FG000|Overall Study|Adverse Event|6|||
128736169|NCT01848990|463326124|FG001|Overall Study|Adverse Event|2|||
128736170|NCT01848990|463326125|FG002|Overall Study|Adverse Event|0|||
128736171|NCT01848990|463326123|FG000|Overall Study|Lost to Follow-up|6|||
128736172|NCT01848990|463326124|FG001|Overall Study|Lost to Follow-up|2|||
128736173|NCT01848990|463326125|FG002|Overall Study|Lost to Follow-up|2|||
128736174|NCT01848990|463326123|FG000|Overall Study|Protocol Violation|1|||
128736175|NCT01848990|463326124|FG001|Overall Study|Protocol Violation|1|||
128736176|NCT01848990|463326125|FG002|Overall Study|Protocol Violation|0|||
128736177|NCT01848990|463326123|FG000|Overall Study|Withdrawal by Subject|29|||
128783736|NCT00124982|463499882|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
128783737|NCT00124982|463499883|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
128783738|NCT00124982|463499881|FG000|Short-term Period|Participant Decision|1|||
128783739|NCT00124982|463499882|FG001|Short-term Period|Participant Decision|0|||
128783740|NCT00124982|463499883|FG002|Short-term Period|Participant Decision|0|||
128783741|NCT00124982|463499881|FG000|Short-term Period|Participant Chose Own Doctor|0|||
128783742|NCT00124982|463499882|FG001|Short-term Period|Participant Chose Own Doctor|1|||
128783743|NCT00124982|463499883|FG002|Short-term Period|Participant Chose Own Doctor|0|||
128783744|NCT00124982|463499881|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
128783745|NCT00124982|463499882|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
128783746|NCT00124982|463499883|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
128783747|NCT00124982|463499881|FG000|Short-term Period|Participant Had Lymphopenia|1|||
128783748|NCT00124982|463499882|FG001|Short-term Period|Participant Had Lymphopenia|0|||
128783749|NCT00124982|463499883|FG002|Short-term Period|Participant Had Lymphopenia|0|||
128783750|NCT00124982|463499881|FG000|Long-term Period|Death|0|||
128783751|NCT00124982|463499882|FG001|Long-term Period|Death|0|||
128783752|NCT00124982|463499883|FG002|Long-term Period|Death|1|||
128783753|NCT00124982|463499881|FG000|Long-term Period|Adverse Event|0|||
128783754|NCT00124982|463499882|FG001|Long-term Period|Adverse Event|0|||
128783755|NCT00124982|463499883|FG002|Long-term Period|Adverse Event|17|||
128783756|NCT00124982|463499881|FG000|Long-term Period|Lack of Efficacy|0|||
128783757|NCT00124982|463499882|FG001|Long-term Period|Lack of Efficacy|0|||
128783758|NCT00124982|463499883|FG002|Long-term Period|Lack of Efficacy|46|||
128783759|NCT00124982|463499881|FG000|Long-term Period|Lost to Follow-up|0|||
128783760|NCT00124982|463499882|FG001|Long-term Period|Lost to Follow-up|0|||
128783761|NCT00124982|463499883|FG002|Long-term Period|Lost to Follow-up|4|||
128783762|NCT00124982|463499881|FG000|Long-term Period|Withdrawal by Subject|0|||
128783763|NCT00124982|463499882|FG001|Long-term Period|Withdrawal by Subject|0|||
128783764|NCT00124982|463499883|FG002|Long-term Period|Withdrawal by Subject|16|||
128783765|NCT00124982|463499881|FG000|Long-term Period|Pregnancy|0|||
128783766|NCT00124982|463499882|FG001|Long-term Period|Pregnancy|0|||
128783767|NCT00124982|463499883|FG002|Long-term Period|Pregnancy|1|||
128783768|NCT00124982|463499881|FG000|Long-term Period|Poor/Non-compliance|0|||
128783769|NCT00124982|463499882|FG001|Long-term Period|Poor/Non-compliance|0|||
128783770|NCT00124982|463499883|FG002|Long-term Period|Poor/Non-compliance|2|||
128783771|NCT00124982|463499881|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
128783772|NCT00124982|463499882|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
128783773|NCT00124982|463499883|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
128783774|NCT00124982|463499881|FG000|Long-term Period|Neurologist Recommendation|0|||
128783775|NCT00124982|463499882|FG001|Long-term Period|Neurologist Recommendation|0|||
128783776|NCT00124982|463499883|FG002|Long-term Period|Neurologist Recommendation|1|||
128783777|NCT00430677|463499884|FG000|Short-term Period|Death|1|||
128783778|NCT00430677|463499885|FG001|Short-term Period|Death|1|||
128783779|NCT00430677|463499886|FG002|Short-term Period|Death|5|||
128783780|NCT00430677|463499884|FG000|Short-term Period|Adverse Event|15|||
128783781|NCT00430677|463499885|FG001|Short-term Period|Adverse Event|13|||
128783782|NCT00430677|463499886|FG002|Short-term Period|Adverse Event|9|||
128783783|NCT00430677|463499884|FG000|Short-term Period|Lack of Efficacy|5|||
128783784|NCT00430677|463499885|FG001|Short-term Period|Lack of Efficacy|6|||
128783785|NCT00430677|463499886|FG002|Short-term Period|Lack of Efficacy|4|||
128783786|NCT00430677|463499884|FG000|Short-term Period|Withdrawal by Subject|1|||
128783787|NCT00430677|463499885|FG001|Short-term Period|Withdrawal by Subject|1|||
128783788|NCT00430677|463499886|FG002|Short-term Period|Withdrawal by Subject|2|||
128783789|NCT00430677|463499884|FG000|Short-term Period|Participant no longer met study criteria|1|||
128783790|NCT00430677|463499885|FG001|Short-term Period|Participant no longer met study criteria|1|||
128783791|NCT00430677|463499886|FG002|Short-term Period|Participant no longer met study criteria|2|||
128783792|NCT00430677|463499884|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
128783793|NCT00430677|463499885|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
128783794|NCT00430677|463499886|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
128783795|NCT00430677|463499884|FG000|Short-term Period|Pregnancy|0|||
128783796|NCT00430677|463499885|FG001|Short-term Period|Pregnancy|2|||
128783797|NCT00430677|463499886|FG002|Short-term Period|Pregnancy|0|||
128783798|NCT00430677|463499884|FG000|Long-term Extension Period|Death|1|||
128783799|NCT00430677|463499885|FG001|Long-term Extension Period|Death|0|||
128783800|NCT00430677|463499886|FG002|Long-term Extension Period|Death|0|||
128783801|NCT00430677|463499884|FG000|Long-term Extension Period|Adverse Event|3|||
128783802|NCT00430677|463499885|FG001|Long-term Extension Period|Adverse Event|2|||
128783803|NCT00430677|463499886|FG002|Long-term Extension Period|Adverse Event|5|||
128783804|NCT00430677|463499884|FG000|Long-term Extension Period|Lack of Efficacy|5|||
128783805|NCT00430677|463499885|FG001|Long-term Extension Period|Lack of Efficacy|3|||
128783806|NCT00430677|463499886|FG002|Long-term Extension Period|Lack of Efficacy|8|||
128783807|NCT00430677|463499884|FG000|Long-term Extension Period|Lost to Follow-up|1|||
128783808|NCT00430677|463499885|FG001|Long-term Extension Period|Lost to Follow-up|1|||
128783809|NCT00430677|463499886|FG002|Long-term Extension Period|Lost to Follow-up|1|||
128783810|NCT00430677|463499884|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
128783811|NCT00430677|463499885|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
128783812|NCT00430677|463499886|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
128783813|NCT00430677|463499884|FG000|Long-term Extension Period|Pregnancy|1|||
128783814|NCT00430677|463499885|FG001|Long-term Extension Period|Pregnancy|1|||
128783815|NCT00430677|463499886|FG002|Long-term Extension Period|Pregnancy|0|||
128783816|NCT00430677|463499884|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
128783817|NCT00430677|463499885|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
128783818|NCT00430677|463499886|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
128783819|NCT00430677|463499884|FG000|Long-term Extension Period|Other|2|||
128783820|NCT00430677|463499885|FG001|Long-term Extension Period|Other|1|||
128783821|NCT00430677|463499886|FG002|Long-term Extension Period|Other|1|||
128783822|NCT00430677|463499884|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
128783823|NCT00430677|463499885|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
128783824|NCT00430677|463499886|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
128736178|NCT01848990|463326124|FG001|Overall Study|Withdrawal by Subject|10|||
128736179|NCT01848990|463326125|FG002|Overall Study|Withdrawal by Subject|11|||
128736180|NCT01848990|463326123|FG000|Overall Study|Physician Decision|1|||
128736181|NCT01848990|463326124|FG001|Overall Study|Physician Decision|1|||
128736182|NCT01848990|463326125|FG002|Overall Study|Physician Decision|0|||
128736183|NCT01848990|463326123|FG000|Overall Study|Non Compliance|1|||
128736184|NCT01848990|463326124|FG001|Overall Study|Non Compliance|0|||
128736185|NCT01848990|463326125|FG002|Overall Study|Non Compliance|0|||
128736186|NCT01848990|463326123|FG000|Overall Study|Death|1|||
128736187|NCT01848990|463326124|FG001|Overall Study|Death|0|||
128736188|NCT01848990|463326125|FG002|Overall Study|Death|1|||
128736189|NCT01848990|463326123|FG000|Overall Study|Other|1|||
128736190|NCT01848990|463326124|FG001|Overall Study|Other|4|||
128736191|NCT01848990|463326125|FG002|Overall Study|Other|2|||
128736192|NCT00678561|463326126|FG000|Overall Study|Adverse Event|0|||
128736193|NCT00678561|463326127|FG001|Overall Study|Adverse Event|1|||
128736194|NCT00678561|463326128|FG002|Overall Study|Adverse Event|1|||
128736195|NCT00678561|463326129|FG003|Overall Study|Adverse Event|0|||
128736196|NCT00678561|463326130|FG004|Overall Study|Adverse Event|1|||
128736197|NCT00678561|463326131|FG005|Overall Study|Adverse Event|0|||
128736198|NCT00678561|463326132|FG006|Overall Study|Adverse Event|0|||
128736199|NCT00678561|463326133|FG007|Overall Study|Adverse Event|0|||
128736200|NCT00678561|463326126|FG000|Overall Study|Protocol Violation|0|||
128736201|NCT00678561|463326127|FG001|Overall Study|Protocol Violation|0|||
128736202|NCT00678561|463326128|FG002|Overall Study|Protocol Violation|0|||
128736203|NCT00678561|463326129|FG003|Overall Study|Protocol Violation|0|||
128736204|NCT00678561|463326130|FG004|Overall Study|Protocol Violation|1|||
128736205|NCT00678561|463326131|FG005|Overall Study|Protocol Violation|1|||
128736206|NCT00678561|463326132|FG006|Overall Study|Protocol Violation|0|||
128736207|NCT00678561|463326133|FG007|Overall Study|Protocol Violation|0|||
128736208|NCT00678561|463326126|FG000|Overall Study|Withdrawal by Subject|0|||
128736209|NCT00678561|463326127|FG001|Overall Study|Withdrawal by Subject|0|||
128736210|NCT00678561|463326128|FG002|Overall Study|Withdrawal by Subject|0|||
128736211|NCT00678561|463326129|FG003|Overall Study|Withdrawal by Subject|0|||
128736212|NCT00678561|463326130|FG004|Overall Study|Withdrawal by Subject|0|||
128736213|NCT00678561|463326131|FG005|Overall Study|Withdrawal by Subject|0|||
128736214|NCT00678561|463326132|FG006|Overall Study|Withdrawal by Subject|0|||
128736215|NCT00678561|463326133|FG007|Overall Study|Withdrawal by Subject|1|||
128783825|NCT01555762|463499887|FG000|Overall Study|No information on Bevacizumab intake|11|||
128783826|NCT01555762|463499887|FG000|Overall Study|Missing start date of infusion|8|||
128783827|NCT01555762|463499887|FG000|Overall Study|75 years old or more ticked No|1|||
128783828|NCT01555762|463499887|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
128783829|NCT01555762|463499887|FG000|Overall Study|Death linked to progression of disease|165|||
128783830|NCT01555762|463499887|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
128783831|NCT01555762|463499887|FG000|Overall Study|Investigator's decision|10|||
128783832|NCT01555762|463499887|FG000|Overall Study|Participant not wishing to continue|5|||
128783833|NCT01555762|463499887|FG000|Overall Study|Missing data|1|||
128783834|NCT01555762|463499887|FG000|Overall Study|Death linked to an adverse event|14|||
128783835|NCT01333514|463499888|FG000|Overall Study|Withdrawal by Subject|1|||
128783836|NCT01333514|463499889|FG001|Overall Study|Withdrawal by Subject|0|||
128783837|NCT00836810|463499892|FG000|Overall Study|New diagnosis|1|||
128783838|NCT00836810|463499893|FG001|Overall Study|New diagnosis|0|||
128783839|NCT00389519|463499894|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
128783840|NCT00389519|463499895|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
128783841|NCT00389519|463499896|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
128783842|NCT00389519|463499897|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
128783843|NCT00389519|463499894|FG000|Placebo Run-In|Withdrawal by Subject|19|||
128783844|NCT00389519|463499895|FG001|Placebo Run-In|Withdrawal by Subject|0|||
128783845|NCT00389519|463499896|FG002|Placebo Run-In|Withdrawal by Subject|0|||
128783846|NCT00389519|463499897|FG003|Placebo Run-In|Withdrawal by Subject|0|||
128783847|NCT00389519|463499894|FG000|Placebo Run-In|Reason not specified|40|||
128783848|NCT00389519|463499895|FG001|Placebo Run-In|Reason not specified|0|||
128783849|NCT00389519|463499896|FG002|Placebo Run-In|Reason not specified|0|||
128783850|NCT00389519|463499897|FG003|Placebo Run-In|Reason not specified|0|||
128783851|NCT00389519|463499894|FG000|Randomized|Did not receive study drug|2|||
128783852|NCT00389519|463499895|FG001|Randomized|Did not receive study drug|0|||
128783853|NCT00389519|463499896|FG002|Randomized|Did not receive study drug|0|||
128783854|NCT00389519|463499897|FG003|Randomized|Did not receive study drug|0|||
128783855|NCT00389519|463499894|FG000|Treated|Adverse Event|1|||
128783856|NCT00389519|463499895|FG001|Treated|Adverse Event|0|||
128783857|NCT00389519|463499896|FG002|Treated|Adverse Event|0|||
128783858|NCT00389519|463499897|FG003|Treated|Adverse Event|2|||
128783859|NCT00389519|463499894|FG000|Treated|Reason not specified|1|||
128783860|NCT00389519|463499895|FG001|Treated|Reason not specified|1|||
128783861|NCT00389519|463499896|FG002|Treated|Reason not specified|0|||
128783862|NCT00389519|463499897|FG003|Treated|Reason not specified|2|||
128783863|NCT00946192|463499898|FG000|Overall Study|Lost to Follow-up|6|||
128783864|NCT00946192|463499899|FG001|Overall Study|Lost to Follow-up|11|||
128783865|NCT00946192|463499900|FG002|Overall Study|Lost to Follow-up|9|||
128783866|NCT00946192|463499898|FG000|Overall Study|Withdrawal by Subject|10|||
128783867|NCT00946192|463499899|FG001|Overall Study|Withdrawal by Subject|7|||
128783868|NCT00946192|463499900|FG002|Overall Study|Withdrawal by Subject|3|||
128783869|NCT00946192|463499898|FG000|Overall Study|Did not start medication|2|||
128783870|NCT00946192|463499899|FG001|Overall Study|Did not start medication|0|||
128783871|NCT00946192|463499900|FG002|Overall Study|Did not start medication|0|||
128783872|NCT01080131|463499901|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
128783873|NCT01080131|463499902|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
128783874|NCT01080131|463499901|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
128783875|NCT01080131|463499902|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
128783876|NCT01080131|463499901|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
128783877|NCT01080131|463499902|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
128783878|NCT01080131|463499901|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
128783879|NCT01080131|463499902|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
128783880|NCT01080131|463499901|FG000|Core Study (0- 12 Weeks)|Death|1|||
128783881|NCT01080131|463499902|FG001|Core Study (0- 12 Weeks)|Death|0|||
128783882|NCT01080131|463499901|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
128783883|NCT01080131|463499902|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
128783884|NCT01080131|463499901|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
128783885|NCT01080131|463499902|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
128783886|NCT01080131|463499901|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
128783887|NCT01080131|463499902|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
128783888|NCT01080131|463499901|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
128783889|NCT01080131|463499902|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
128783890|NCT01080131|463499901|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
128783891|NCT01080131|463499902|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
128783892|NCT01080131|463499901|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
128783893|NCT01080131|463499902|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
128783894|NCT01080131|463499901|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
128783895|NCT01080131|463499902|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
128783896|NCT01080131|463499901|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
128783897|NCT01080131|463499902|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
128783898|NCT04155424|463499903|FG000|Overall Study|Other than specified|3|||
128783899|NCT04155424|463499903|FG000|Overall Study|Withdrawal by Subject|1|||
128783900|NCT04155424|463499903|FG000|Overall Study|Adverse Event|1|||
128783901|NCT04159506|463499904|FG000|Overall Study|Lost to Follow-up|2|||
128783902|NCT04159506|463499905|FG001|Overall Study|Lost to Follow-up|5|||
128783903|NCT02624778|463501476|FG000|Overall Study|Lost to Follow-up|0|||
128783904|NCT02624778|463501477|FG001|Overall Study|Lost to Follow-up|0|||
128783905|NCT02624778|463501478|FG002|Overall Study|Lost to Follow-up|1|||
128783906|NCT02624778|463501479|FG003|Overall Study|Lost to Follow-up|0|||
128783907|NCT02624778|463501480|FG004|Overall Study|Lost to Follow-up|0|||
128783908|NCT02624778|463501481|FG005|Overall Study|Lost to Follow-up|0|||
128783909|NCT02624778|463501482|FG006|Overall Study|Lost to Follow-up|0|||
128783910|NCT02624778|463501483|FG007|Overall Study|Lost to Follow-up|0|||
128783911|NCT02624778|463501484|FG008|Overall Study|Lost to Follow-up|0|||
128783912|NCT02624778|463501476|FG000|Overall Study|Withdrawal by Subject|0|||
128783913|NCT02624778|463501477|FG001|Overall Study|Withdrawal by Subject|1|||
128783914|NCT02624778|463501478|FG002|Overall Study|Withdrawal by Subject|0|||
128783915|NCT02624778|463501479|FG003|Overall Study|Withdrawal by Subject|0|||
128783916|NCT02624778|463501480|FG004|Overall Study|Withdrawal by Subject|0|||
128783917|NCT02624778|463501481|FG005|Overall Study|Withdrawal by Subject|1|||
128783918|NCT02624778|463501482|FG006|Overall Study|Withdrawal by Subject|1|||
128783919|NCT02624778|463501483|FG007|Overall Study|Withdrawal by Subject|1|||
128783920|NCT02624778|463501484|FG008|Overall Study|Withdrawal by Subject|1|||
128783921|NCT02624778|463501476|FG000|Overall Study|Adverse Event|0|||
128783922|NCT02624778|463501477|FG001|Overall Study|Adverse Event|0|||
128783923|NCT02624778|463501478|FG002|Overall Study|Adverse Event|0|||
128783924|NCT02624778|463501479|FG003|Overall Study|Adverse Event|0|||
128783925|NCT02624778|463501480|FG004|Overall Study|Adverse Event|0|||
128783926|NCT02624778|463501481|FG005|Overall Study|Adverse Event|0|||
128783927|NCT02624778|463501482|FG006|Overall Study|Adverse Event|0|||
128783928|NCT02624778|463501483|FG007|Overall Study|Adverse Event|0|||
128783929|NCT02624778|463501484|FG008|Overall Study|Adverse Event|2|||
128783930|NCT02624778|463501476|FG000|Overall Study|Death|0|||
128783931|NCT02624778|463501477|FG001|Overall Study|Death|0|||
128783932|NCT02624778|463501478|FG002|Overall Study|Death|0|||
128783933|NCT02624778|463501479|FG003|Overall Study|Death|0|||
128783934|NCT02624778|463501480|FG004|Overall Study|Death|0|||
128783935|NCT02624778|463501481|FG005|Overall Study|Death|0|||
128783936|NCT02624778|463501482|FG006|Overall Study|Death|1|||
128783937|NCT02624778|463501483|FG007|Overall Study|Death|0|||
128783938|NCT02624778|463501484|FG008|Overall Study|Death|0|||
128783939|NCT02624778|463501476|FG000|Overall Study|Physician Decision|0|||
128783940|NCT02624778|463501477|FG001|Overall Study|Physician Decision|0|||
128783941|NCT02624778|463501478|FG002|Overall Study|Physician Decision|0|||
128783942|NCT02624778|463501479|FG003|Overall Study|Physician Decision|0|||
128783943|NCT02624778|463501480|FG004|Overall Study|Physician Decision|0|||
128783944|NCT02624778|463501481|FG005|Overall Study|Physician Decision|0|||
128783945|NCT02624778|463501482|FG006|Overall Study|Physician Decision|0|||
128783946|NCT02624778|463501483|FG007|Overall Study|Physician Decision|3|||
128783947|NCT02624778|463501484|FG008|Overall Study|Physician Decision|3|||
128783948|NCT01537133|463501492|FG000|Overall Study|Withdrawal by Subject|2|||
128783949|NCT01537133|463501493|FG001|Overall Study|Withdrawal by Subject|0|||
128783950|NCT01537133|463501494|FG002|Overall Study|Withdrawal by Subject|0|||
128783951|NCT01537133|463501495|FG003|Overall Study|Withdrawal by Subject|0|||
128783952|NCT01537133|463501492|FG000|Overall Study|Lost to Follow-up|1|||
128783953|NCT01537133|463501493|FG001|Overall Study|Lost to Follow-up|0|||
128783954|NCT01537133|463501494|FG002|Overall Study|Lost to Follow-up|0|||
128783955|NCT01537133|463501495|FG003|Overall Study|Lost to Follow-up|0|||
128783956|NCT00531479|463501496|FG000|Overall Study|Death|68|||
128783957|NCT00531479|463501497|FG001|Overall Study|Death|71|||
128736216|NCT00437034|463326134|FG000|Overall Study|Adverse Event|1|||
128736217|NCT00437034|463326134|FG000|Overall Study|Disease progression during treatment|5|||
128736218|NCT02460224|463326137|FG000|Overall Study|Adverse Event|0|||
128783958|NCT00531479|463501496|FG000|Overall Study|Lost to Follow-up|0|||
128783959|NCT00531479|463501497|FG001|Overall Study|Lost to Follow-up|2|||
128783960|NCT00531479|463501496|FG000|Overall Study|Other|0|||
128783961|NCT00531479|463501497|FG001|Overall Study|Other|1|||
128783962|NCT00531479|463501496|FG000|Overall Study|Withdrawal by Subject|6|||
128783963|NCT00531479|463501497|FG001|Overall Study|Withdrawal by Subject|6|||
128783964|NCT00531479|463501496|FG000|Overall Study|Did not receive treatment|2|||
128783965|NCT00531479|463501497|FG001|Overall Study|Did not receive treatment|3|||
128783966|NCT02501629|463501505|FG000|Overall Study|Death|0|||
128783967|NCT02501629|463501506|FG001|Overall Study|Death|1|||
128783968|NCT02501629|463501505|FG000|Overall Study|Withdrawn from study by sponsor|1|||
128783969|NCT02501629|463501506|FG001|Overall Study|Withdrawn from study by sponsor|0|||
128783970|NCT02501629|463501505|FG000|Overall Study|Early termination by sponsor|1|||
128783971|NCT02501629|463501506|FG001|Overall Study|Early termination by sponsor|0|||
128783972|NCT02501629|463501505|FG000|Overall Study|Withdrawal by Subject|3|||
128783973|NCT02501629|463501506|FG001|Overall Study|Withdrawal by Subject|5|||
128783974|NCT02501629|463501505|FG000|Overall Study|Subject did not return to site|0|||
128783975|NCT02501629|463501506|FG001|Overall Study|Subject did not return to site|1|||
128783976|NCT00868231|463501509|FG000|Treatment Period 1|Adverse Event|0|||
128783977|NCT00868231|463501510|FG001|Treatment Period 1|Adverse Event|0|||
128783978|NCT00868231|463501511|FG002|Treatment Period 1|Adverse Event|0|||
128783979|NCT00868231|463501512|FG003|Treatment Period 1|Adverse Event|0|||
128783980|NCT00868231|463501513|FG004|Treatment Period 1|Adverse Event|1|||
128783981|NCT00868231|463501514|FG005|Treatment Period 1|Adverse Event|0|||
128783982|NCT00868231|463501509|FG000|Treatment Period 2|Adverse Event|1|||
128783983|NCT00868231|463501510|FG001|Treatment Period 2|Adverse Event|0|||
128783984|NCT00868231|463501511|FG002|Treatment Period 2|Adverse Event|0|||
128783985|NCT00868231|463501512|FG003|Treatment Period 2|Adverse Event|0|||
128783986|NCT00868231|463501513|FG004|Treatment Period 2|Adverse Event|0|||
128783987|NCT00868231|463501514|FG005|Treatment Period 2|Adverse Event|0|||
128783988|NCT00868231|463501509|FG000|Treatment Period 3|Adverse Event|0|||
128783989|NCT00868231|463501510|FG001|Treatment Period 3|Adverse Event|0|||
128783990|NCT00868231|463501511|FG002|Treatment Period 3|Adverse Event|1|||
128783991|NCT00868231|463501512|FG003|Treatment Period 3|Adverse Event|0|||
128783992|NCT00868231|463501513|FG004|Treatment Period 3|Adverse Event|0|||
128783993|NCT00868231|463501514|FG005|Treatment Period 3|Adverse Event|0|||
128783994|NCT02321540|463501520|FG000|Overall Study|Death|0|||
128783995|NCT02321540|463501521|FG001|Overall Study|Death|1|||
128783996|NCT02321540|463501520|FG000|Overall Study|Progression|3|||
128783997|NCT02321540|463501521|FG001|Overall Study|Progression|9|||
128783998|NCT00530335|463501522|FG000|Overall Study|Adverse Event|3|||
128783999|NCT00530335|463501522|FG000|Overall Study|Protocol Violation|1|||
128784000|NCT00530335|463501522|FG000|Overall Study|Withdrawal by Subject|1|||
128784001|NCT00530335|463501522|FG000|Overall Study|Physician Decision|1|||
128784002|NCT00938340|463501528|FG000|Overall Study|Withdrawal by Subject|3|||
128784003|NCT00938340|463501528|FG000|Overall Study|Protocol Violation|1|||
128784004|NCT00938340|463501528|FG000|Overall Study|Adverse Event|1|||
128784005|NCT02534896|463501531|FG000|Overall Study|Adverse Event|2|||
128784006|NCT02534896|463501532|FG001|Overall Study|Adverse Event|1|||
128784007|NCT02534896|463501533|FG002|Overall Study|Adverse Event|1|||
128784008|NCT02534896|463501531|FG000|Overall Study|Insufficient therapeutic response|2|||
128784009|NCT02534896|463501532|FG001|Overall Study|Insufficient therapeutic response|0|||
128784010|NCT02534896|463501533|FG002|Overall Study|Insufficient therapeutic response|0|||
128784011|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
128784012|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
128784013|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
128784014|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
128784015|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Adverse Event|198|||
128736219|NCT02460224|463326138|FG001|Overall Study|Adverse Event|0|||
128736220|NCT02460224|463326139|FG002|Overall Study|Adverse Event|0|||
128736221|NCT02460224|463326140|FG003|Overall Study|Adverse Event|0|||
128784016|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Adverse Event|0|||
128784017|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Adverse Event|0|||
128784018|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Adverse Event|0|||
128784019|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Death|62|||
128784020|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Death|0|||
128784021|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Death|0|||
128784022|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Death|0|||
128784023|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
128784024|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
128784025|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
128784026|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
128784027|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Complicating disease|13|||
128784028|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Complicating disease|0|||
128784029|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Complicating disease|0|||
128784030|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Complicating disease|0|||
128784031|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
128784032|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
128784033|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
128784034|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
128784035|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
128784036|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
128784037|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
128784038|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
128784039|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Non-compliance|4|||
128784040|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Non-compliance|0|||
128784041|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Non-compliance|0|||
128784042|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Non-compliance|0|||
128784043|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Pain|4|||
128784044|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Pain|0|||
128784045|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Pain|0|||
128784046|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Pain|0|||
128784047|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
128784048|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
128784049|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
128784050|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
128784051|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Hospice care|1|||
128784052|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Hospice care|0|||
128784053|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Hospice care|0|||
128784054|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Hospice care|0|||
128784055|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Physician Decision|1|||
128784056|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Physician Decision|0|||
128784057|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Physician Decision|0|||
128784058|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Physician Decision|0|||
128736222|NCT02460224|463326141|FG004|Overall Study|Adverse Event|0|||
128736223|NCT02460224|463326142|FG005|Overall Study|Adverse Event|0|||
128736224|NCT02460224|463326143|FG006|Overall Study|Adverse Event|1|||
128736225|NCT02460224|463326144|FG007|Overall Study|Adverse Event|0|||
128736226|NCT02460224|463326145|FG008|Overall Study|Adverse Event|0|||
128736227|NCT02460224|463326146|FG009|Overall Study|Adverse Event|0|||
128736228|NCT02460224|463326147|FG010|Overall Study|Adverse Event|0|||
128736229|NCT02460224|463326148|FG011|Overall Study|Adverse Event|0|||
128736230|NCT02460224|463326149|FG012|Overall Study|Adverse Event|1|||
128736231|NCT02460224|463326150|FG013|Overall Study|Adverse Event|0|||
128736232|NCT02460224|463326151|FG014|Overall Study|Adverse Event|0|||
128736233|NCT02460224|463326152|FG015|Overall Study|Adverse Event|0|||
128736234|NCT02460224|463326153|FG016|Overall Study|Adverse Event|1|||
128736235|NCT02460224|463326154|FG017|Overall Study|Adverse Event|0|||
128736236|NCT02460224|463326155|FG018|Overall Study|Adverse Event|1|||
128736237|NCT02460224|463326156|FG019|Overall Study|Adverse Event|0|||
128736238|NCT02460224|463326157|FG020|Overall Study|Adverse Event|1|||
128736239|NCT02460224|463326158|FG021|Overall Study|Adverse Event|1|||
128736240|NCT02460224|463326159|FG022|Overall Study|Adverse Event|1|||
128736241|NCT02460224|463326160|FG023|Overall Study|Adverse Event|0|||
128736242|NCT02460224|463326161|FG024|Overall Study|Adverse Event|0|||
128736243|NCT02460224|463326162|FG025|Overall Study|Adverse Event|0|||
128736244|NCT02460224|463326163|FG026|Overall Study|Adverse Event|11|||
128736245|NCT02460224|463326164|FG027|Overall Study|Adverse Event|1|||
128736246|NCT02460224|463326165|FG028|Overall Study|Adverse Event|6|||
128736247|NCT02460224|463326137|FG000|Overall Study|Death|0|||
128736248|NCT02460224|463326138|FG001|Overall Study|Death|0|||
128736249|NCT02460224|463326139|FG002|Overall Study|Death|0|||
128736250|NCT02460224|463326140|FG003|Overall Study|Death|0|||
128736251|NCT02460224|463326141|FG004|Overall Study|Death|0|||
128736252|NCT02460224|463326142|FG005|Overall Study|Death|2|||
128736253|NCT02460224|463326143|FG006|Overall Study|Death|1|||
128736254|NCT02460224|463326144|FG007|Overall Study|Death|0|||
128736255|NCT02460224|463326145|FG008|Overall Study|Death|0|||
128736256|NCT02460224|463326146|FG009|Overall Study|Death|1|||
128736257|NCT02460224|463326147|FG010|Overall Study|Death|0|||
128736258|NCT02460224|463326148|FG011|Overall Study|Death|0|||
128736259|NCT02460224|463326149|FG012|Overall Study|Death|0|||
128736260|NCT02460224|463326150|FG013|Overall Study|Death|1|||
128736261|NCT02460224|463326151|FG014|Overall Study|Death|0|||
128736262|NCT02460224|463326152|FG015|Overall Study|Death|0|||
128736263|NCT02460224|463326153|FG016|Overall Study|Death|2|||
128736264|NCT02460224|463326154|FG017|Overall Study|Death|1|||
128736265|NCT02460224|463326155|FG018|Overall Study|Death|0|||
128736266|NCT02460224|463326156|FG019|Overall Study|Death|2|||
128736267|NCT02460224|463326157|FG020|Overall Study|Death|0|||
128736268|NCT02460224|463326158|FG021|Overall Study|Death|0|||
128736269|NCT02460224|463326159|FG022|Overall Study|Death|0|||
128736270|NCT02460224|463326160|FG023|Overall Study|Death|0|||
128736271|NCT02460224|463326161|FG024|Overall Study|Death|1|||
128736272|NCT02460224|463326162|FG025|Overall Study|Death|1|||
128736273|NCT02460224|463326163|FG026|Overall Study|Death|5|||
128736274|NCT02460224|463326164|FG027|Overall Study|Death|0|||
128736275|NCT02460224|463326165|FG028|Overall Study|Death|1|||
128736276|NCT02460224|463326137|FG000|Overall Study|Lost to Follow-up|0|||
128736277|NCT02460224|463326138|FG001|Overall Study|Lost to Follow-up|0|||
128736278|NCT02460224|463326139|FG002|Overall Study|Lost to Follow-up|0|||
128736279|NCT02460224|463326140|FG003|Overall Study|Lost to Follow-up|0|||
128736280|NCT02460224|463326141|FG004|Overall Study|Lost to Follow-up|0|||
128736281|NCT02460224|463326142|FG005|Overall Study|Lost to Follow-up|0|||
128736282|NCT02460224|463326143|FG006|Overall Study|Lost to Follow-up|0|||
128736283|NCT02460224|463326144|FG007|Overall Study|Lost to Follow-up|0|||
128736284|NCT02460224|463326145|FG008|Overall Study|Lost to Follow-up|0|||
128736285|NCT02460224|463326146|FG009|Overall Study|Lost to Follow-up|0|||
128736286|NCT02460224|463326147|FG010|Overall Study|Lost to Follow-up|0|||
128736287|NCT02460224|463326148|FG011|Overall Study|Lost to Follow-up|0|||
128736288|NCT02460224|463326149|FG012|Overall Study|Lost to Follow-up|0|||
128736289|NCT02460224|463326150|FG013|Overall Study|Lost to Follow-up|0|||
128736290|NCT02460224|463326151|FG014|Overall Study|Lost to Follow-up|0|||
128736291|NCT02460224|463326152|FG015|Overall Study|Lost to Follow-up|0|||
128736292|NCT02460224|463326153|FG016|Overall Study|Lost to Follow-up|0|||
128736293|NCT02460224|463326154|FG017|Overall Study|Lost to Follow-up|0|||
128736294|NCT02460224|463326155|FG018|Overall Study|Lost to Follow-up|0|||
128736295|NCT02460224|463326156|FG019|Overall Study|Lost to Follow-up|0|||
128736296|NCT02460224|463326157|FG020|Overall Study|Lost to Follow-up|0|||
128736297|NCT02460224|463326158|FG021|Overall Study|Lost to Follow-up|0|||
128736298|NCT02460224|463326159|FG022|Overall Study|Lost to Follow-up|1|||
128736299|NCT02460224|463326160|FG023|Overall Study|Lost to Follow-up|0|||
128736300|NCT02460224|463326161|FG024|Overall Study|Lost to Follow-up|0|||
128736301|NCT02460224|463326162|FG025|Overall Study|Lost to Follow-up|0|||
128736302|NCT02460224|463326163|FG026|Overall Study|Lost to Follow-up|0|||
128736303|NCT02460224|463326164|FG027|Overall Study|Lost to Follow-up|0|||
128736304|NCT02460224|463326165|FG028|Overall Study|Lost to Follow-up|0|||
128736305|NCT02460224|463326137|FG000|Overall Study|Physician Decision|0|||
128736306|NCT02460224|463326138|FG001|Overall Study|Physician Decision|1|||
128736307|NCT02460224|463326139|FG002|Overall Study|Physician Decision|0|||
128736308|NCT02460224|463326140|FG003|Overall Study|Physician Decision|0|||
128736309|NCT02460224|463326141|FG004|Overall Study|Physician Decision|1|||
128736310|NCT02460224|463326142|FG005|Overall Study|Physician Decision|0|||
128736311|NCT02460224|463326143|FG006|Overall Study|Physician Decision|0|||
128736312|NCT02460224|463326144|FG007|Overall Study|Physician Decision|1|||
128736313|NCT02460224|463326145|FG008|Overall Study|Physician Decision|0|||
128736314|NCT02460224|463326146|FG009|Overall Study|Physician Decision|0|||
128736315|NCT02460224|463326147|FG010|Overall Study|Physician Decision|0|||
128736316|NCT02460224|463326148|FG011|Overall Study|Physician Decision|1|||
128736317|NCT02460224|463326149|FG012|Overall Study|Physician Decision|0|||
128736318|NCT02460224|463326150|FG013|Overall Study|Physician Decision|1|||
128736319|NCT02460224|463326151|FG014|Overall Study|Physician Decision|0|||
128736320|NCT02460224|463326152|FG015|Overall Study|Physician Decision|0|||
128736321|NCT02460224|463326153|FG016|Overall Study|Physician Decision|2|||
128736322|NCT02460224|463326154|FG017|Overall Study|Physician Decision|1|||
128736323|NCT02460224|463326155|FG018|Overall Study|Physician Decision|1|||
128736324|NCT02460224|463326156|FG019|Overall Study|Physician Decision|2|||
128736325|NCT02460224|463326157|FG020|Overall Study|Physician Decision|1|||
128736326|NCT02460224|463326158|FG021|Overall Study|Physician Decision|1|||
128736327|NCT02460224|463326159|FG022|Overall Study|Physician Decision|0|||
128736328|NCT02460224|463326160|FG023|Overall Study|Physician Decision|0|||
128736329|NCT02460224|463326161|FG024|Overall Study|Physician Decision|1|||
128736330|NCT02460224|463326162|FG025|Overall Study|Physician Decision|0|||
128736331|NCT02460224|463326163|FG026|Overall Study|Physician Decision|14|||
128736332|NCT02460224|463326164|FG027|Overall Study|Physician Decision|1|||
128736333|NCT02460224|463326165|FG028|Overall Study|Physician Decision|6|||
128736334|NCT02460224|463326137|FG000|Overall Study|Progressive disease|15|||
128736335|NCT02460224|463326138|FG001|Overall Study|Progressive disease|11|||
128736336|NCT02460224|463326139|FG002|Overall Study|Progressive disease|5|||
128736337|NCT02460224|463326140|FG003|Overall Study|Progressive disease|6|||
128736338|NCT02460224|463326141|FG004|Overall Study|Progressive disease|3|||
128736339|NCT02460224|463326142|FG005|Overall Study|Progressive disease|26|||
128736340|NCT02460224|463326143|FG006|Overall Study|Progressive disease|28|||
128736341|NCT02460224|463326144|FG007|Overall Study|Progressive disease|4|||
128736342|NCT02460224|463326145|FG008|Overall Study|Progressive disease|5|||
128736343|NCT02460224|463326146|FG009|Overall Study|Progressive disease|9|||
128736344|NCT02460224|463326147|FG010|Overall Study|Progressive disease|5|||
128736345|NCT02460224|463326148|FG011|Overall Study|Progressive disease|4|||
128736346|NCT02460224|463326149|FG012|Overall Study|Progressive disease|5|||
128736347|NCT02460224|463326150|FG013|Overall Study|Progressive disease|4|||
128736348|NCT02460224|463326151|FG014|Overall Study|Progressive disease|5|||
128736349|NCT02460224|463326152|FG015|Overall Study|Progressive disease|5|||
128736350|NCT02460224|463326153|FG016|Overall Study|Progressive disease|15|||
128736351|NCT02460224|463326154|FG017|Overall Study|Progressive disease|3|||
128736352|NCT02460224|463326155|FG018|Overall Study|Progressive disease|8|||
128736353|NCT02460224|463326156|FG019|Overall Study|Progressive disease|3|||
128736354|NCT02460224|463326157|FG020|Overall Study|Progressive disease|4|||
128736355|NCT02460224|463326158|FG021|Overall Study|Progressive disease|9|||
128736356|NCT02460224|463326159|FG022|Overall Study|Progressive disease|4|||
128736357|NCT02460224|463326160|FG023|Overall Study|Progressive disease|11|||
128736358|NCT02460224|463326161|FG024|Overall Study|Progressive disease|4|||
128736359|NCT02460224|463326162|FG025|Overall Study|Progressive disease|5|||
128736360|NCT02460224|463326163|FG026|Overall Study|Progressive disease|85|||
128736361|NCT02460224|463326164|FG027|Overall Study|Progressive disease|17|||
128736362|NCT02460224|463326165|FG028|Overall Study|Progressive disease|77|||
128736363|NCT02460224|463326137|FG000|Overall Study|Subject/guardian decision|2|||
128736364|NCT02460224|463326138|FG001|Overall Study|Subject/guardian decision|0|||
128736365|NCT02460224|463326139|FG002|Overall Study|Subject/guardian decision|1|||
128736366|NCT02460224|463326140|FG003|Overall Study|Subject/guardian decision|0|||
128736367|NCT02460224|463326141|FG004|Overall Study|Subject/guardian decision|2|||
128736368|NCT02460224|463326142|FG005|Overall Study|Subject/guardian decision|2|||
128736369|NCT02460224|463326143|FG006|Overall Study|Subject/guardian decision|0|||
128736370|NCT02460224|463326144|FG007|Overall Study|Subject/guardian decision|0|||
128736371|NCT02460224|463326145|FG008|Overall Study|Subject/guardian decision|1|||
128736372|NCT02460224|463326146|FG009|Overall Study|Subject/guardian decision|1|||
128736373|NCT02460224|463326147|FG010|Overall Study|Subject/guardian decision|0|||
128736374|NCT02460224|463326148|FG011|Overall Study|Subject/guardian decision|1|||
128736375|NCT02460224|463326149|FG012|Overall Study|Subject/guardian decision|0|||
128736376|NCT02460224|463326150|FG013|Overall Study|Subject/guardian decision|0|||
128736377|NCT02460224|463326151|FG014|Overall Study|Subject/guardian decision|0|||
128736378|NCT02460224|463326152|FG015|Overall Study|Subject/guardian decision|1|||
128736379|NCT02460224|463326153|FG016|Overall Study|Subject/guardian decision|0|||
128736380|NCT02460224|463326154|FG017|Overall Study|Subject/guardian decision|1|||
128736381|NCT02460224|463326155|FG018|Overall Study|Subject/guardian decision|2|||
128736382|NCT02460224|463326156|FG019|Overall Study|Subject/guardian decision|0|||
128736383|NCT02460224|463326157|FG020|Overall Study|Subject/guardian decision|0|||
128736384|NCT02460224|463326158|FG021|Overall Study|Subject/guardian decision|1|||
128736385|NCT02460224|463326159|FG022|Overall Study|Subject/guardian decision|0|||
128736386|NCT02460224|463326160|FG023|Overall Study|Subject/guardian decision|0|||
128736387|NCT02460224|463326161|FG024|Overall Study|Subject/guardian decision|0|||
128784059|NCT01107626|463501536|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
128784060|NCT01107626|463501537|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
128784061|NCT01107626|463501538|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
128784062|NCT01107626|463501539|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
128784063|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
128784064|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
128784065|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
128784066|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
128784067|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
128784068|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
128784069|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
128784070|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
128736388|NCT02460224|463326162|FG025|Overall Study|Subject/guardian decision|0|||
128736389|NCT02460224|463326163|FG026|Overall Study|Subject/guardian decision|6|||
128736390|NCT02460224|463326164|FG027|Overall Study|Subject/guardian decision|2|||
128736391|NCT02460224|463326165|FG028|Overall Study|Subject/guardian decision|3|||
128736392|NCT00853658|463326166|FG000|Overall Study|Death|713|||
128736393|NCT00853658|463326167|FG001|Overall Study|Death|768|||
128736394|NCT00853658|463326168|FG002|Overall Study|Death|753|||
128736395|NCT00853658|463326166|FG000|Overall Study|Lost to Follow-up|11|||
128736396|NCT00853658|463326167|FG001|Overall Study|Lost to Follow-up|6|||
128736397|NCT00853658|463326168|FG002|Overall Study|Lost to Follow-up|11|||
128736398|NCT00853658|463326166|FG000|Overall Study|H.A. Request|26|||
128736399|NCT00853658|463326167|FG001|Overall Study|H.A. Request|23|||
128736400|NCT00853658|463326168|FG002|Overall Study|H.A. Request|19|||
128736401|NCT00853658|463326166|FG000|Overall Study|IRB request|0|||
128736402|NCT00853658|463326167|FG001|Overall Study|IRB request|0|||
128736403|NCT00853658|463326168|FG002|Overall Study|IRB request|2|||
128736404|NCT00853658|463326166|FG000|Overall Study|Vital Status known (alive) at study end|2|||
128736405|NCT00853658|463326167|FG001|Overall Study|Vital Status known (alive) at study end|3|||
128736406|NCT00853658|463326168|FG002|Overall Study|Vital Status known (alive) at study end|3|||
128736407|NCT00853658|463326166|FG000|Overall Study|Vital Status unknown at study end|1|||
128736408|NCT00853658|463326167|FG001|Overall Study|Vital Status unknown at study end|1|||
128736409|NCT00853658|463326168|FG002|Overall Study|Vital Status unknown at study end|0|||
128736410|NCT00853658|463326166|FG000|Overall Study|Vital Status at study end N/A|8|||
128736411|NCT00853658|463326167|FG001|Overall Study|Vital Status at study end N/A|10|||
128736412|NCT00853658|463326168|FG002|Overall Study|Vital Status at study end N/A|10|||
128736413|NCT00853658|463326166|FG000|Overall Study|Patient's request|21|||
128736414|NCT00853658|463326167|FG001|Overall Study|Patient's request|17|||
128736415|NCT00853658|463326168|FG002|Overall Study|Patient's request|11|||
128736416|NCT00853658|463326166|FG000|Overall Study|Missing study completion information|5|||
128736417|NCT00853658|463326167|FG001|Overall Study|Missing study completion information|4|||
128736418|NCT00853658|463326168|FG002|Overall Study|Missing study completion information|6|||
128736419|NCT03146650|463326170|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
128736420|NCT03146650|463326170|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
128736421|NCT03146650|463326170|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
128736422|NCT03146650|463326170|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
128736423|NCT03146650|463326170|FG000|2 Year Follow-up|Death|11|||
128736424|NCT03146650|463326170|FG000|2 Year Follow-up|Still in follow-up|7|||
128736425|NCT03146650|463326170|FG000|2 Year Follow-up|Lost to Follow-up|1|||
128736426|NCT02556710|463327982|FG000|Overall Study|Surgical treatment|3|||
128736427|NCT02556710|463327983|FG001|Overall Study|Surgical treatment|0|||
128736428|NCT02556710|463327982|FG000|Overall Study|Required proscribed pain medication|2|||
128736429|NCT02556710|463327983|FG001|Overall Study|Required proscribed pain medication|1|||
128736430|NCT02556710|463327982|FG000|Overall Study|Lack of Efficacy|1|||
128736431|NCT02556710|463327983|FG001|Overall Study|Lack of Efficacy|0|||
128736432|NCT02556710|463327982|FG000|Overall Study|Worsening osteoarthritis|1|||
128736433|NCT02556710|463327983|FG001|Overall Study|Worsening osteoarthritis|0|||
128736434|NCT02556710|463327982|FG000|Overall Study|Moved out of state|1|||
128736435|NCT02556710|463327983|FG001|Overall Study|Moved out of state|0|||
128736436|NCT02556710|463327982|FG000|Overall Study|Missing reason|3|||
128736437|NCT02556710|463327983|FG001|Overall Study|Missing reason|1|||
128736438|NCT02556710|463327982|FG000|Overall Study|Pain as lack of efficacy|0|||
128736439|NCT02556710|463327983|FG001|Overall Study|Pain as lack of efficacy|4|||
128736440|NCT04258839|463327984|FG000|Overall Study|Adverse Event|2|||
128736441|NCT04258839|463327985|FG001|Overall Study|Adverse Event|4|||
128736442|NCT04258839|463327984|FG000|Overall Study|Lack of Efficacy|0|||
128736443|NCT04258839|463327985|FG001|Overall Study|Lack of Efficacy|2|||
128736444|NCT04258839|463327984|FG000|Overall Study|Lost to Follow-up|2|||
128736445|NCT04258839|463327985|FG001|Overall Study|Lost to Follow-up|0|||
128736446|NCT04258839|463327984|FG000|Overall Study|Withdrawal by Subject|1|||
128736447|NCT04258839|463327985|FG001|Overall Study|Withdrawal by Subject|2|||
128736448|NCT04258839|463327984|FG000|Overall Study|Withdrawal by Caregiver|5|||
128736449|NCT04258839|463327985|FG001|Overall Study|Withdrawal by Caregiver|6|||
128736450|NCT04258839|463327984|FG000|Overall Study|Reason not Specified|0|||
128736451|NCT04258839|463327985|FG001|Overall Study|Reason not Specified|1|||
128736452|NCT02602288|463327990|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
128736453|NCT02602288|463327991|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
128736454|NCT02602288|463327990|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
128736455|NCT02602288|463327991|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
128784071|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Death|0|||
128784072|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Death|8|||
128784073|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Death|2|||
128784074|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Death|13|||
128784075|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
128784076|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
128784077|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
128784078|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
128784079|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
128784080|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
128784081|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
128784082|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
128784083|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
128784084|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
128784085|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
128784086|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
128784087|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
128784088|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
128784089|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
128784090|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
128784091|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
128784092|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
128784093|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
128784094|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
128784095|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
128784096|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
128784097|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
128784098|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
128784099|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
128784100|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
128784101|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
128784102|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
128784103|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
128784104|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
128784105|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
128784106|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
128784107|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
128784108|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
128784109|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
128784110|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
128784111|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
128784112|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
128784113|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
128784114|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
128784115|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Pain|0|||
128784116|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Pain|0|||
128784117|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Pain|0|||
128784118|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Pain|1|||
128784119|NCT01107626|463501536|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
128784120|NCT01107626|463501537|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
128784121|NCT01107626|463501538|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
128784122|NCT01107626|463501539|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
128784123|NCT04381494|463501540|FG000|Overall Study|Early termination of trial|19|||
128784124|NCT04381494|463501540|FG000|Overall Study|Investigator's discretion|1|||
128784125|NCT04381494|463501540|FG000|Overall Study|Withdrawal by Subject|9|||
128784126|NCT04381494|463501540|FG000|Overall Study|NSCLC disease progression|4|||
128784127|NCT04381494|463501540|FG000|Overall Study|Device-Related Adverse Event|2|||
128784128|NCT04310579|463501541|FG000|Overall Study|Adverse Event|0|||
128784129|NCT04310579|463501542|FG001|Overall Study|Adverse Event|0|||
128784130|NCT04310579|463501543|FG002|Overall Study|Adverse Event|0|||
128784131|NCT04310579|463501544|FG003|Overall Study|Adverse Event|0|||
128784132|NCT04310579|463501545|FG004|Overall Study|Adverse Event|0|||
128784133|NCT04310579|463501546|FG005|Overall Study|Adverse Event|0|||
128784134|NCT04310579|463501547|FG006|Overall Study|Adverse Event|2|||
128784135|NCT04310579|463501548|FG007|Overall Study|Adverse Event|0|||
128736456|NCT02602288|463327990|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
128736457|NCT02602288|463327991|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
128736458|NCT02602288|463327990|FG000|12 Month Follow-up|Lost to Follow-up|0|||
128736459|NCT02602288|463327991|FG001|12 Month Follow-up|Lost to Follow-up|4|||
128736460|NCT02602288|463327990|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
128736461|NCT02602288|463327991|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
128784136|NCT04310579|463501549|FG008|Overall Study|Adverse Event|1|||
128784137|NCT04310579|463501550|FG009|Overall Study|Adverse Event|1|||
128784138|NCT04310579|463501551|FG010|Overall Study|Adverse Event|0|||
128784139|NCT04310579|463501541|FG000|Overall Study|Withdrawal by Subject|0|||
128784140|NCT04310579|463501542|FG001|Overall Study|Withdrawal by Subject|0|||
128784141|NCT04310579|463501543|FG002|Overall Study|Withdrawal by Subject|0|||
128784142|NCT04310579|463501544|FG003|Overall Study|Withdrawal by Subject|0|||
128784143|NCT04310579|463501545|FG004|Overall Study|Withdrawal by Subject|0|||
128784144|NCT04310579|463501546|FG005|Overall Study|Withdrawal by Subject|1|||
128784145|NCT04310579|463501547|FG006|Overall Study|Withdrawal by Subject|0|||
128784146|NCT04310579|463501548|FG007|Overall Study|Withdrawal by Subject|0|||
128784147|NCT04310579|463501549|FG008|Overall Study|Withdrawal by Subject|0|||
128784148|NCT04310579|463501550|FG009|Overall Study|Withdrawal by Subject|0|||
128784149|NCT04310579|463501551|FG010|Overall Study|Withdrawal by Subject|0|||
128784150|NCT04310579|463501541|FG000|Overall Study|Positive COVID-19 test|0|||
128784151|NCT04310579|463501542|FG001|Overall Study|Positive COVID-19 test|0|||
128784152|NCT04310579|463501543|FG002|Overall Study|Positive COVID-19 test|0|||
128784153|NCT04310579|463501544|FG003|Overall Study|Positive COVID-19 test|0|||
128784154|NCT04310579|463501545|FG004|Overall Study|Positive COVID-19 test|0|||
128784155|NCT04310579|463501546|FG005|Overall Study|Positive COVID-19 test|0|||
128784156|NCT04310579|463501547|FG006|Overall Study|Positive COVID-19 test|0|||
128784157|NCT04310579|463501548|FG007|Overall Study|Positive COVID-19 test|0|||
128784158|NCT04310579|463501549|FG008|Overall Study|Positive COVID-19 test|0|||
128784159|NCT04310579|463501550|FG009|Overall Study|Positive COVID-19 test|0|||
128784160|NCT04310579|463501551|FG010|Overall Study|Positive COVID-19 test|1|||
128784161|NCT04353037|463501552|FG000|Overall Study|Lost to Follow-up|0|||
128784162|NCT04353037|463501553|FG001|Overall Study|Lost to Follow-up|1|||
128784163|NCT04353037|463501554|FG002|Overall Study|Lost to Follow-up|2|||
128784164|NCT04353037|463501555|FG003|Overall Study|Lost to Follow-up|3|||
128784165|NCT04353037|463501552|FG000|Overall Study|Withdrawal by Subject|0|||
128784166|NCT04353037|463501553|FG001|Overall Study|Withdrawal by Subject|2|||
128784167|NCT04353037|463501554|FG002|Overall Study|Withdrawal by Subject|3|||
128784168|NCT04353037|463501555|FG003|Overall Study|Withdrawal by Subject|5|||
128784169|NCT04353037|463501552|FG000|Overall Study|Adverse Event|0|||
128784170|NCT04353037|463501553|FG001|Overall Study|Adverse Event|0|||
128784171|NCT04353037|463501554|FG002|Overall Study|Adverse Event|2|||
128784172|NCT04353037|463501555|FG003|Overall Study|Adverse Event|0|||
128784173|NCT04353037|463501552|FG000|Overall Study|Exposure Change|0|||
128784174|NCT04353037|463501553|FG001|Overall Study|Exposure Change|0|||
128784175|NCT04353037|463501554|FG002|Overall Study|Exposure Change|0|||
128784176|NCT04353037|463501555|FG003|Overall Study|Exposure Change|2|||
128784177|NCT03710564|463501556|FG000|Overall Study|Study Terminated by Sponsor|104|||
128784178|NCT03710564|463501557|FG001|Overall Study|Study Terminated by Sponsor|55|||
128784179|NCT03710564|463501556|FG000|Overall Study|Withdrawal by Subject|57|||
128784180|NCT03710564|463501557|FG001|Overall Study|Withdrawal by Subject|25|||
128784181|NCT03710564|463501556|FG000|Overall Study|Death|10|||
128784182|NCT03710564|463501557|FG001|Overall Study|Death|4|||
128784183|NCT03710564|463501556|FG000|Overall Study|Lost to Follow-up|5|||
128784184|NCT03710564|463501557|FG001|Overall Study|Lost to Follow-up|4|||
128784185|NCT03710564|463501556|FG000|Overall Study|Protocol Violation|3|||
128784186|NCT03710564|463501557|FG001|Overall Study|Protocol Violation|2|||
128784187|NCT03710564|463501556|FG000|Overall Study|Adverse Event|3|||
128784188|NCT03710564|463501557|FG001|Overall Study|Adverse Event|0|||
128784189|NCT03710564|463501556|FG000|Overall Study|Physician Decision|2|||
128784190|NCT03710564|463501557|FG001|Overall Study|Physician Decision|3|||
128784191|NCT03006341|463501558|FG000|Overall Study|Not linked in the EMR|25069|||
128784192|NCT03006341|463501559|FG001|Overall Study|Not linked in the EMR|67505|||
128784193|NCT03006341|463501560|FG002|Overall Study|Not linked in the EMR|30993|||
128784194|NCT03006341|463501561|FG003|Overall Study|Not linked in the EMR|10685|||
128784195|NCT00003656|463501562|FG000|Overall Study|Adverse Event|0|||
128784196|NCT00003656|463501563|FG001|Overall Study|Adverse Event|1|||
128784197|NCT01674569|463501564|FG000|Overall Study|Adverse Event|0|||
128784198|NCT01674569|463501565|FG001|Overall Study|Adverse Event|2|||
128784199|NCT01674569|463501566|FG002|Overall Study|Adverse Event|0|||
128784200|NCT01674569|463501567|FG003|Overall Study|Adverse Event|1|||
128784201|NCT01674569|463501568|FG004|Overall Study|Adverse Event|2|||
128784202|NCT01674569|463501569|FG005|Overall Study|Adverse Event|2|||
128784203|NCT01674569|463501564|FG000|Overall Study|Protocol Violation|0|||
128784204|NCT01674569|463501565|FG001|Overall Study|Protocol Violation|1|||
128784205|NCT01674569|463501566|FG002|Overall Study|Protocol Violation|1|||
128784206|NCT01674569|463501567|FG003|Overall Study|Protocol Violation|0|||
128784207|NCT01674569|463501568|FG004|Overall Study|Protocol Violation|0|||
128784208|NCT01674569|463501569|FG005|Overall Study|Protocol Violation|0|||
128784209|NCT01674569|463501564|FG000|Overall Study|Withdrawal by Subject|0|||
128784210|NCT01674569|463501565|FG001|Overall Study|Withdrawal by Subject|0|||
128784211|NCT01674569|463501566|FG002|Overall Study|Withdrawal by Subject|1|||
128784212|NCT01674569|463501567|FG003|Overall Study|Withdrawal by Subject|0|||
128784213|NCT01674569|463501568|FG004|Overall Study|Withdrawal by Subject|0|||
128736462|NCT01310413|463327992|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
128736463|NCT01310413|463327993|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
128736464|NCT01310413|463327994|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
128784214|NCT01674569|463501569|FG005|Overall Study|Withdrawal by Subject|0|||
128784215|NCT03885596|463501578|FG000|Overall Study|Withdrawal by Subject|2|||
128784216|NCT03885596|463501579|FG001|Overall Study|Withdrawal by Subject|1|||
128784217|NCT03885596|463501580|FG002|Overall Study|Withdrawal by Subject|0|||
128784218|NCT03885596|463501581|FG003|Overall Study|Withdrawal by Subject|0|||
128784219|NCT03168438|463501584|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
128784220|NCT03168438|463501585|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
128784221|NCT05015478|463501588|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
128784222|NCT05015478|463501589|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
128784223|NCT05015478|463501590|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
128784224|NCT05015478|463501591|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
128784225|NCT05196737|463501598|FG000|Non-intervention Week|Lost to Follow-up|2|||
128784226|NCT05196737|463501598|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
128784227|NCT05096884|463501599|FG000|Overall Study|Excluded based on negative tilt table test|4|||
128784228|NCT04927975|463501600|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
128784229|NCT04927975|463501601|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
128784230|NCT04927975|463501602|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
128784231|NCT04927975|463501603|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
128784232|NCT04927975|463501604|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
128784233|NCT04927975|463501605|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
128784234|NCT04927975|463501600|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
128784235|NCT04927975|463501601|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
128784236|NCT04927975|463501602|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
128784237|NCT04927975|463501603|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
128784238|NCT04927975|463501604|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
128784239|NCT04927975|463501605|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
128784240|NCT04927975|463501600|FG000|Period 1 (Baseline-Week 24)|Death|0|||
128784241|NCT04927975|463501601|FG001|Period 1 (Baseline-Week 24)|Death|0|||
128784242|NCT04927975|463501602|FG002|Period 1 (Baseline-Week 24)|Death|0|||
128784243|NCT04927975|463501603|FG003|Period 1 (Baseline-Week 24)|Death|0|||
128784244|NCT04927975|463501604|FG004|Period 1 (Baseline-Week 24)|Death|0|||
128784245|NCT04927975|463501605|FG005|Period 1 (Baseline-Week 24)|Death|1|||
128784246|NCT04927975|463501600|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
128784247|NCT04927975|463501601|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
128784248|NCT04927975|463501602|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
128784249|NCT04927975|463501603|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
128784250|NCT04927975|463501604|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
128784251|NCT04927975|463501605|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
128784252|NCT04927975|463501600|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
128784253|NCT04927975|463501601|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
128784254|NCT04927975|463501602|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
128784255|NCT04927975|463501603|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
128784256|NCT04927975|463501604|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
128784257|NCT04927975|463501605|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
128784258|NCT03568162|463501607|FG000|Overall Study|Adverse Event|0|||
128784259|NCT03568162|463501608|FG001|Overall Study|Adverse Event|1|||
128784260|NCT03568162|463501609|FG002|Overall Study|Adverse Event|2|||
128784261|NCT03568162|463501610|FG003|Overall Study|Adverse Event|0|||
128784262|NCT03568162|463501611|FG004|Overall Study|Adverse Event|0|||
128784263|NCT03568162|463501612|FG005|Overall Study|Adverse Event|1|||
128784264|NCT03568162|463501607|FG000|Overall Study|Death|0|||
128784265|NCT03568162|463501608|FG001|Overall Study|Death|0|||
128784266|NCT03568162|463501609|FG002|Overall Study|Death|0|||
128784267|NCT03568162|463501610|FG003|Overall Study|Death|0|||
128784268|NCT03568162|463501611|FG004|Overall Study|Death|1|||
128784269|NCT03568162|463501612|FG005|Overall Study|Death|0|||
128784270|NCT03568162|463501607|FG000|Overall Study|Lost to Follow-up|3|||
128784271|NCT03568162|463501608|FG001|Overall Study|Lost to Follow-up|2|||
128784272|NCT03568162|463501609|FG002|Overall Study|Lost to Follow-up|4|||
128784273|NCT03568162|463501610|FG003|Overall Study|Lost to Follow-up|2|||
128784274|NCT03568162|463501611|FG004|Overall Study|Lost to Follow-up|3|||
128784275|NCT03568162|463501612|FG005|Overall Study|Lost to Follow-up|2|||
128784276|NCT03568162|463501607|FG000|Overall Study|Physician Decision|0|||
128784277|NCT03568162|463501608|FG001|Overall Study|Physician Decision|1|||
128784278|NCT03568162|463501609|FG002|Overall Study|Physician Decision|1|||
128784279|NCT03568162|463501610|FG003|Overall Study|Physician Decision|0|||
128784280|NCT03568162|463501611|FG004|Overall Study|Physician Decision|1|||
128784281|NCT03568162|463501612|FG005|Overall Study|Physician Decision|0|||
128784282|NCT03568162|463501607|FG000|Overall Study|Pregnancy|0|||
128784283|NCT03568162|463501608|FG001|Overall Study|Pregnancy|0|||
128784284|NCT03568162|463501609|FG002|Overall Study|Pregnancy|0|||
128784285|NCT03568162|463501610|FG003|Overall Study|Pregnancy|1|||
128784286|NCT03568162|463501611|FG004|Overall Study|Pregnancy|0|||
128784287|NCT03568162|463501612|FG005|Overall Study|Pregnancy|0|||
128784288|NCT03568162|463501607|FG000|Overall Study|Protocol Violation|1|||
128784289|NCT03568162|463501608|FG001|Overall Study|Protocol Violation|0|||
128784290|NCT03568162|463501609|FG002|Overall Study|Protocol Violation|1|||
128784291|NCT03568162|463501610|FG003|Overall Study|Protocol Violation|1|||
128784292|NCT03568162|463501611|FG004|Overall Study|Protocol Violation|1|||
128784293|NCT03568162|463501612|FG005|Overall Study|Protocol Violation|1|||
128784294|NCT03568162|463501607|FG000|Overall Study|Withdrawal by Subject|15|||
128784295|NCT03568162|463501608|FG001|Overall Study|Withdrawal by Subject|15|||
128784296|NCT03568162|463501609|FG002|Overall Study|Withdrawal by Subject|26|||
128784297|NCT03568162|463501610|FG003|Overall Study|Withdrawal by Subject|22|||
128784298|NCT03568162|463501611|FG004|Overall Study|Withdrawal by Subject|6|||
128784299|NCT03568162|463501612|FG005|Overall Study|Withdrawal by Subject|9|||
128784300|NCT03568162|463501607|FG000|Overall Study|Others|3|||
128784301|NCT03568162|463501608|FG001|Overall Study|Others|4|||
128784302|NCT03568162|463501609|FG002|Overall Study|Others|1|||
128784303|NCT03568162|463501610|FG003|Overall Study|Others|4|||
128784304|NCT03568162|463501611|FG004|Overall Study|Others|2|||
128784305|NCT03568162|463501612|FG005|Overall Study|Others|1|||
128784306|NCT03781804|463501613|FG000|Overall Study|Adverse Event|2|||
128784307|NCT03781804|463501614|FG001|Overall Study|Adverse Event|2|||
128784308|NCT03781804|463501615|FG002|Overall Study|Adverse Event|3|||
128784309|NCT03781804|463501613|FG000|Overall Study|Lost to Follow-up|1|||
128784310|NCT03781804|463501614|FG001|Overall Study|Lost to Follow-up|1|||
128784311|NCT03781804|463501615|FG002|Overall Study|Lost to Follow-up|2|||
128784312|NCT03781804|463501613|FG000|Overall Study|Lack of Efficacy|4|||
128784313|NCT03781804|463501614|FG001|Overall Study|Lack of Efficacy|2|||
128784314|NCT03781804|463501615|FG002|Overall Study|Lack of Efficacy|9|||
128784315|NCT03781804|463501613|FG000|Overall Study|Protocol Violation|0|||
128784316|NCT03781804|463501614|FG001|Overall Study|Protocol Violation|0|||
128784317|NCT03781804|463501615|FG002|Overall Study|Protocol Violation|1|||
128784318|NCT03781804|463501613|FG000|Overall Study|Withdrawal by Subject|0|||
128784319|NCT03781804|463501614|FG001|Overall Study|Withdrawal by Subject|1|||
128784320|NCT03781804|463501615|FG002|Overall Study|Withdrawal by Subject|1|||
128784321|NCT03781804|463501613|FG000|Overall Study|Reason not provided|2|||
128784322|NCT03781804|463501614|FG001|Overall Study|Reason not provided|2|||
128784323|NCT03781804|463501615|FG002|Overall Study|Reason not provided|0|||
128784324|NCT03717194|463501616|FG000|Overall Study|Withdrawal by Subject|2|||
128784325|NCT03717194|463501617|FG001|Overall Study|Withdrawal by Subject|4|||
128784326|NCT03717194|463501616|FG000|Overall Study|Adverse Event|1|||
128784327|NCT03717194|463501617|FG001|Overall Study|Adverse Event|1|||
128784328|NCT00337818|463501618|FG000|Overall Study|Lost to Follow-up|289|||
128784329|NCT00337818|463501619|FG001|Overall Study|Lost to Follow-up|91|||
128784330|NCT00337818|463501620|FG002|Overall Study|Lost to Follow-up|107|||
128784331|NCT03563053|463501623|FG000|Overall Study|Withdrawal by Subject|17|||
128784332|NCT03563053|463501623|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
128784333|NCT03563053|463501623|FG000|Overall Study|Adverse Event|3|||
128784334|NCT03563053|463501623|FG000|Overall Study|Physician Decision|1|||
128784335|NCT03563053|463501623|FG000|Overall Study|study terminated by sponsor|71|||
128784336|NCT02081391|463501624|FG000|12-hour Treatment|Withdrawal by Subject|3|||
128784337|NCT02081391|463501625|FG001|12-hour Treatment|Withdrawal by Subject|2|||
128784338|NCT02081391|463501626|FG002|12-hour Treatment|Withdrawal by Subject|0|||
128784339|NCT02081391|463501627|FG003|12-hour Treatment|Withdrawal by Subject|0|||
128784340|NCT02081391|463501624|FG000|12-hour Treatment|Physician Decision|4|||
128784341|NCT02081391|463501625|FG001|12-hour Treatment|Physician Decision|1|||
128784342|NCT02081391|463501626|FG002|12-hour Treatment|Physician Decision|0|||
128784343|NCT02081391|463501627|FG003|12-hour Treatment|Physician Decision|0|||
128784344|NCT02081391|463501624|FG000|12-hour Treatment|Lack of Efficacy|3|||
128784345|NCT02081391|463501625|FG001|12-hour Treatment|Lack of Efficacy|0|||
128736465|NCT01310413|463327995|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
128736466|NCT01310413|463327996|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
128736467|NCT01310413|463327997|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
128784346|NCT02081391|463501626|FG002|12-hour Treatment|Lack of Efficacy|0|||
128784347|NCT02081391|463501627|FG003|12-hour Treatment|Lack of Efficacy|0|||
128784348|NCT02081391|463501624|FG000|12-hour Treatment|Adverse Event|4|||
128784349|NCT02081391|463501625|FG001|12-hour Treatment|Adverse Event|2|||
128784350|NCT02081391|463501626|FG002|12-hour Treatment|Adverse Event|0|||
128784351|NCT02081391|463501627|FG003|12-hour Treatment|Adverse Event|0|||
128784352|NCT02081391|463501624|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
128736468|NCT01310413|463327998|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
128736469|NCT01310413|463327992|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
128736470|NCT01310413|463327993|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
128736471|NCT01310413|463327994|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
128736472|NCT01310413|463327995|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
128736473|NCT01310413|463327996|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
128736474|NCT01310413|463327997|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
128736475|NCT01310413|463327998|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
128736476|NCT01310413|463327992|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
128736477|NCT01310413|463327993|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
128736478|NCT01310413|463327994|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
128736479|NCT01310413|463327995|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
128736480|NCT01310413|463327996|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
128736481|NCT01310413|463327997|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
128736482|NCT01310413|463327998|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
128736483|NCT01310413|463327992|FG000|Day 0 to Day 385|Other|1|||
128736484|NCT01310413|463327993|FG001|Day 0 to Day 385|Other|0|||
128736485|NCT01310413|463327994|FG002|Day 0 to Day 385|Other|3|||
128736486|NCT01310413|463327995|FG003|Day 0 to Day 385|Other|0|||
128736487|NCT01310413|463327996|FG004|Day 0 to Day 385|Other|0|||
128736488|NCT01310413|463327997|FG005|Day 0 to Day 385|Other|0|||
128736489|NCT01310413|463327998|FG006|Day 0 to Day 385|Other|0|||
128736490|NCT01310413|463327992|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
128736491|NCT01310413|463327993|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
128736492|NCT01310413|463327994|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
128736493|NCT01310413|463327995|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
128736494|NCT01310413|463327996|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
128736495|NCT01310413|463327997|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
128736496|NCT01310413|463327998|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
128736497|NCT01310413|463327992|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
128736498|NCT01310413|463327993|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
128736499|NCT01310413|463327994|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
128736500|NCT01310413|463327995|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
128736501|NCT01310413|463327996|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
128736502|NCT01310413|463327997|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
128736503|NCT01310413|463327998|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
128736504|NCT00941733|463327999|FG000|Overall Study|Death|24|||
128736505|NCT00941733|463328000|FG001|Overall Study|Death|10|||
128736506|NCT00941733|463327999|FG000|Overall Study|Withdrawal by Subject|14|||
128736507|NCT00941733|463328000|FG001|Overall Study|Withdrawal by Subject|6|||
128736508|NCT00941733|463327999|FG000|Overall Study|Adverse Event|20|||
128736509|NCT00941733|463328000|FG001|Overall Study|Adverse Event|4|||
128736510|NCT00941733|463327999|FG000|Overall Study|Lost to Follow-up|1|||
128736511|NCT00941733|463328000|FG001|Overall Study|Lost to Follow-up|2|||
128736512|NCT00941733|463327999|FG000|Overall Study|Protocol Violation|15|||
128736513|NCT00941733|463328000|FG001|Overall Study|Protocol Violation|6|||
128736514|NCT00612066|463328003|FG000|Overall Study|Adverse Event|1|||
128736515|NCT00630877|463328004|FG000|Overall Study|Adverse Event|11|||
128736516|NCT00630877|463328005|FG001|Overall Study|Adverse Event|8|||
128736517|NCT00630877|463328006|FG002|Overall Study|Adverse Event|7|||
128736518|NCT00630877|463328004|FG000|Overall Study|Withdrawal by Subject|3|||
128736519|NCT00630877|463328005|FG001|Overall Study|Withdrawal by Subject|4|||
128736520|NCT00630877|463328006|FG002|Overall Study|Withdrawal by Subject|0|||
128736521|NCT00630877|463328004|FG000|Overall Study|Lost to Follow-up|2|||
128736522|NCT00630877|463328005|FG001|Overall Study|Lost to Follow-up|0|||
128736523|NCT00630877|463328006|FG002|Overall Study|Lost to Follow-up|0|||
128736524|NCT00630877|463328004|FG000|Overall Study|Noncompliance|2|||
128736525|NCT00630877|463328005|FG001|Overall Study|Noncompliance|3|||
128736526|NCT00630877|463328006|FG002|Overall Study|Noncompliance|1|||
128736527|NCT00630877|463328004|FG000|Overall Study|Protocol violation|1|||
128736528|NCT00630877|463328005|FG001|Overall Study|Protocol violation|0|||
128736529|NCT00630877|463328006|FG002|Overall Study|Protocol violation|1|||
128736530|NCT00630877|463328004|FG000|Overall Study|Personal reasons|0|||
128736531|NCT00630877|463328005|FG001|Overall Study|Personal reasons|0|||
128736532|NCT00630877|463328006|FG002|Overall Study|Personal reasons|1|||
128736533|NCT01643473|463328007|FG000|Overall Study|Lost to Follow-up|1|||
128736534|NCT01643473|463328008|FG001|Overall Study|Lost to Follow-up|0|||
128736535|NCT01913041|463328009|FG000|Overall Study|Protocol Violation|35|||
128736536|NCT01913041|463328009|FG000|Overall Study|Withdrawal by Subject|3|||
128736537|NCT01913041|463328009|FG000|Overall Study|Physician Decision|1|||
128736538|NCT01265953|463328010|FG000|Overall Study|Non compliance|5|||
128736539|NCT01265953|463328011|FG001|Overall Study|Non compliance|3|||
128736540|NCT01610700|463328013|FG000|Overall Study|Adverse Event|3|||
128736541|NCT01610700|463328014|FG001|Overall Study|Adverse Event|1|||
128736542|NCT01610700|463328013|FG000|Overall Study|Withdrawal by Subject|0|||
128736543|NCT01610700|463328014|FG001|Overall Study|Withdrawal by Subject|1|||
128736544|NCT01610700|463328013|FG000|Overall Study|subject took one dose of street cannabis|0|||
128736545|NCT01610700|463328014|FG001|Overall Study|subject took one dose of street cannabis|1|||
128736546|NCT02648698|463328015|FG000|Overall Study|Protocol Violation|1|||
128736547|NCT02648698|463328016|FG001|Overall Study|Protocol Violation|5|||
128736548|NCT01640301|463328017|FG000|Overall Study|Death|0|||
128736549|NCT01640301|463328018|FG001|Overall Study|Death|8|||
128736550|NCT02391948|463328021|FG000|6-month Assessment|Death|0|||
128736551|NCT02391948|463328022|FG001|6-month Assessment|Death|0|||
128736552|NCT02391948|463328023|FG002|6-month Assessment|Death|0|||
128736553|NCT02391948|463328024|FG003|6-month Assessment|Death|0|||
128736554|NCT02391948|463328025|FG004|6-month Assessment|Death|1|||
128736555|NCT02391948|463328021|FG000|6-month Assessment|Withdrawal by Subject|0|||
128736556|NCT02391948|463328022|FG001|6-month Assessment|Withdrawal by Subject|0|||
128736557|NCT02391948|463328023|FG002|6-month Assessment|Withdrawal by Subject|1|||
128736558|NCT02391948|463328024|FG003|6-month Assessment|Withdrawal by Subject|2|||
128736559|NCT02391948|463328025|FG004|6-month Assessment|Withdrawal by Subject|0|||
128736560|NCT02391948|463328021|FG000|6-month Assessment|Lost to Follow-up|4|||
128736561|NCT02391948|463328022|FG001|6-month Assessment|Lost to Follow-up|5|||
128736562|NCT02391948|463328023|FG002|6-month Assessment|Lost to Follow-up|2|||
128736563|NCT02391948|463328024|FG003|6-month Assessment|Lost to Follow-up|3|||
128736564|NCT02391948|463328025|FG004|6-month Assessment|Lost to Follow-up|1|||
128736565|NCT02391948|463328021|FG000|6-month Assessment|Medical issue/illness|1|||
128736566|NCT02391948|463328022|FG001|6-month Assessment|Medical issue/illness|1|||
128736567|NCT02391948|463328023|FG002|6-month Assessment|Medical issue/illness|0|||
128736568|NCT02391948|463328024|FG003|6-month Assessment|Medical issue/illness|0|||
128736569|NCT02391948|463328025|FG004|6-month Assessment|Medical issue/illness|0|||
128736570|NCT02391948|463328021|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
128736571|NCT02391948|463328022|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
128736572|NCT02391948|463328023|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
128736573|NCT02391948|463328024|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
128736574|NCT02391948|463328025|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
128736575|NCT02391948|463328021|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
128736576|NCT02391948|463328022|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
128736577|NCT02391948|463328023|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
128736578|NCT02391948|463328024|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
128736579|NCT02391948|463328025|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
128736580|NCT02391948|463328021|FG000|12-month Assessment|Death|0|||
128736581|NCT02391948|463328022|FG001|12-month Assessment|Death|0|||
128736582|NCT02391948|463328023|FG002|12-month Assessment|Death|0|||
128736583|NCT02391948|463328024|FG003|12-month Assessment|Death|1|||
128736584|NCT02391948|463328025|FG004|12-month Assessment|Death|0|||
128736585|NCT02391948|463328021|FG000|12-month Assessment|Withdrawal by Subject|1|||
128736586|NCT02391948|463328022|FG001|12-month Assessment|Withdrawal by Subject|0|||
128736587|NCT02391948|463328023|FG002|12-month Assessment|Withdrawal by Subject|0|||
128736588|NCT02391948|463328024|FG003|12-month Assessment|Withdrawal by Subject|1|||
128736589|NCT02391948|463328025|FG004|12-month Assessment|Withdrawal by Subject|0|||
128736590|NCT02391948|463328021|FG000|12-month Assessment|Lost to Follow-up|5|||
128736591|NCT02391948|463328022|FG001|12-month Assessment|Lost to Follow-up|4|||
128736592|NCT02391948|463328023|FG002|12-month Assessment|Lost to Follow-up|4|||
128736593|NCT02391948|463328024|FG003|12-month Assessment|Lost to Follow-up|4|||
128736594|NCT02391948|463328025|FG004|12-month Assessment|Lost to Follow-up|5|||
128736595|NCT02391948|463328021|FG000|12-month Assessment|Medical issue/illness|0|||
128736596|NCT02391948|463328022|FG001|12-month Assessment|Medical issue/illness|1|||
128736597|NCT02391948|463328023|FG002|12-month Assessment|Medical issue/illness|0|||
128736598|NCT02391948|463328024|FG003|12-month Assessment|Medical issue/illness|1|||
128736599|NCT02391948|463328025|FG004|12-month Assessment|Medical issue/illness|0|||
128736600|NCT02391948|463328021|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
128736601|NCT02391948|463328022|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
128736602|NCT02391948|463328023|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
128736603|NCT02391948|463328024|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
128736604|NCT02391948|463328025|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
128784353|NCT02081391|463501625|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
128784354|NCT02081391|463501626|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
128784355|NCT02081391|463501627|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
128784356|NCT02081391|463501624|FG000|12-hour Treatment|Further reasons|2|||
128784357|NCT02081391|463501625|FG001|12-hour Treatment|Further reasons|1|||
128784358|NCT02081391|463501626|FG002|12-hour Treatment|Further reasons|0|||
128784359|NCT02081391|463501627|FG003|12-hour Treatment|Further reasons|0|||
128784360|NCT02081391|463501624|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
128784361|NCT02081391|463501625|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
128784362|NCT02081391|463501626|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
128784363|NCT02081391|463501627|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
128784364|NCT02081391|463501624|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
128784365|NCT02081391|463501625|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
128784366|NCT02081391|463501626|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
128784367|NCT02081391|463501627|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
128784368|NCT02081391|463501624|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
128784369|NCT02081391|463501625|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
128784370|NCT02081391|463501626|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
128784371|NCT02081391|463501627|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
128784372|NCT02081391|463501624|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
128784373|NCT02081391|463501625|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
128784374|NCT02081391|463501626|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
128784375|NCT02081391|463501627|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
128784376|NCT02081391|463501624|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
128784377|NCT02081391|463501625|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
128784378|NCT02081391|463501626|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
128784379|NCT02081391|463501627|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
128784380|NCT02081391|463501624|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
128784381|NCT02081391|463501625|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
128784382|NCT02081391|463501626|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
128784383|NCT02081391|463501627|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
128784384|NCT01458275|463501628|FG000|Overall Study|Adverse Event|3|||
128784385|NCT01458275|463501629|FG001|Overall Study|Adverse Event|4|||
128784386|NCT01458275|463501630|FG002|Overall Study|Adverse Event|1|||
128784387|NCT01458275|463501628|FG000|Overall Study|Lost to Follow-up|3|||
128784388|NCT01458275|463501629|FG001|Overall Study|Lost to Follow-up|2|||
128784389|NCT01458275|463501630|FG002|Overall Study|Lost to Follow-up|5|||
128784390|NCT01458275|463501628|FG000|Overall Study|Protocol Violation|5|||
128784391|NCT01458275|463501629|FG001|Overall Study|Protocol Violation|5|||
128784392|NCT01458275|463501630|FG002|Overall Study|Protocol Violation|2|||
128784393|NCT01458275|463501628|FG000|Overall Study|Withdrawal by Subject|3|||
128784394|NCT01458275|463501629|FG001|Overall Study|Withdrawal by Subject|2|||
128784395|NCT01458275|463501630|FG002|Overall Study|Withdrawal by Subject|1|||
128784396|NCT02926937|463501631|FG000|Overall Study|Adverse Event|0|||
128784397|NCT02926937|463501632|FG001|Overall Study|Adverse Event|1|||
128784398|NCT02926937|463501633|FG002|Overall Study|Adverse Event|1|||
128784399|NCT02926937|463501631|FG000|Overall Study|Poor Compliance to Protocol|1|||
128784400|NCT02926937|463501632|FG001|Overall Study|Poor Compliance to Protocol|0|||
128784401|NCT02926937|463501633|FG002|Overall Study|Poor Compliance to Protocol|0|||
128784402|NCT02926937|463501631|FG000|Overall Study|Lost to Follow-up|4|||
128784403|NCT02926937|463501632|FG001|Overall Study|Lost to Follow-up|5|||
128784404|NCT02926937|463501633|FG002|Overall Study|Lost to Follow-up|0|||
128784405|NCT02926937|463501631|FG000|Overall Study|At the Participant's own Request|11|||
128784406|NCT02926937|463501632|FG001|Overall Study|At the Participant's own Request|5|||
128784407|NCT02926937|463501633|FG002|Overall Study|At the Participant's own Request|8|||
128784408|NCT02926937|463501631|FG000|Overall Study|Reason not Specified|3|||
128784409|NCT02926937|463501632|FG001|Overall Study|Reason not Specified|4|||
128784410|NCT02926937|463501633|FG002|Overall Study|Reason not Specified|2|||
128784411|NCT03102242|463501636|FG000|Overall Study|Adverse Event|2|||
128784412|NCT01311713|463501639|FG000|Overall Study|Death|0|||
128784413|NCT01311713|463501640|FG001|Overall Study|Death|0|||
128784414|NCT01311713|463501641|FG002|Overall Study|Death|1|||
128784415|NCT01311713|463501642|FG003|Overall Study|Death|1|||
128784416|NCT01311713|463501643|FG004|Overall Study|Death|0|||
128784417|NCT01311713|463501644|FG005|Overall Study|Death|1|||
128784418|NCT01311713|463501645|FG006|Overall Study|Death|0|||
128784419|NCT01311713|463501639|FG000|Overall Study|Adverse Event|0|||
128784420|NCT01311713|463501640|FG001|Overall Study|Adverse Event|1|||
128784421|NCT01311713|463501641|FG002|Overall Study|Adverse Event|0|||
128784422|NCT01311713|463501642|FG003|Overall Study|Adverse Event|2|||
128784423|NCT01311713|463501643|FG004|Overall Study|Adverse Event|0|||
128784424|NCT01311713|463501644|FG005|Overall Study|Adverse Event|0|||
128736605|NCT02391948|463328021|FG000|18-month Assessment|Death|0|||
128784425|NCT01311713|463501645|FG006|Overall Study|Adverse Event|2|||
128784426|NCT01311713|463501639|FG000|Overall Study|Withdrawal by Subject|0|||
128784427|NCT01311713|463501640|FG001|Overall Study|Withdrawal by Subject|1|||
128784428|NCT01311713|463501641|FG002|Overall Study|Withdrawal by Subject|1|||
128784429|NCT01311713|463501642|FG003|Overall Study|Withdrawal by Subject|0|||
128784430|NCT01311713|463501643|FG004|Overall Study|Withdrawal by Subject|0|||
128784431|NCT01311713|463501644|FG005|Overall Study|Withdrawal by Subject|1|||
128784432|NCT01311713|463501645|FG006|Overall Study|Withdrawal by Subject|2|||
128784433|NCT01311713|463501639|FG000|Overall Study|Disease progression|3|||
128784434|NCT01311713|463501640|FG001|Overall Study|Disease progression|4|||
128784435|NCT01311713|463501641|FG002|Overall Study|Disease progression|3|||
128784436|NCT01311713|463501642|FG003|Overall Study|Disease progression|2|||
128784437|NCT01311713|463501643|FG004|Overall Study|Disease progression|4|||
128784438|NCT01311713|463501644|FG005|Overall Study|Disease progression|4|||
128784439|NCT01311713|463501645|FG006|Overall Study|Disease progression|5|||
128784440|NCT01311713|463501639|FG000|Overall Study|Lost to Follow-up|0|||
128784441|NCT01311713|463501640|FG001|Overall Study|Lost to Follow-up|0|||
128784442|NCT01311713|463501641|FG002|Overall Study|Lost to Follow-up|1|||
128784443|NCT01311713|463501642|FG003|Overall Study|Lost to Follow-up|0|||
128784444|NCT01311713|463501643|FG004|Overall Study|Lost to Follow-up|0|||
128784445|NCT01311713|463501644|FG005|Overall Study|Lost to Follow-up|0|||
128784446|NCT01311713|463501645|FG006|Overall Study|Lost to Follow-up|0|||
128784447|NCT01311713|463501639|FG000|Overall Study|Stopped taking study medication|0|||
128784448|NCT01311713|463501640|FG001|Overall Study|Stopped taking study medication|0|||
128784449|NCT01311713|463501641|FG002|Overall Study|Stopped taking study medication|0|||
128784450|NCT01311713|463501642|FG003|Overall Study|Stopped taking study medication|1|||
128784451|NCT01311713|463501643|FG004|Overall Study|Stopped taking study medication|1|||
128784452|NCT01311713|463501644|FG005|Overall Study|Stopped taking study medication|0|||
128784453|NCT01311713|463501645|FG006|Overall Study|Stopped taking study medication|0|||
128784454|NCT01311713|463501639|FG000|Overall Study|Enrolled but not treated|0|||
128784455|NCT01311713|463501640|FG001|Overall Study|Enrolled but not treated|0|||
128784456|NCT01311713|463501641|FG002|Overall Study|Enrolled but not treated|1|||
128784457|NCT01311713|463501642|FG003|Overall Study|Enrolled but not treated|0|||
128784458|NCT01311713|463501643|FG004|Overall Study|Enrolled but not treated|0|||
128784459|NCT01311713|463501644|FG005|Overall Study|Enrolled but not treated|0|||
128784460|NCT01311713|463501645|FG006|Overall Study|Enrolled but not treated|0|||
128784461|NCT01311713|463501639|FG000|Overall Study|Other than specified|0|||
128784462|NCT01311713|463501640|FG001|Overall Study|Other than specified|1|||
128784463|NCT01311713|463501641|FG002|Overall Study|Other than specified|2|||
128784464|NCT01311713|463501642|FG003|Overall Study|Other than specified|0|||
128784465|NCT01311713|463501643|FG004|Overall Study|Other than specified|0|||
128784466|NCT01311713|463501644|FG005|Overall Study|Other than specified|0|||
128784467|NCT01311713|463501645|FG006|Overall Study|Other than specified|0|||
128784468|NCT00797862|463503264|FG000|Overall Study|Adverse Event|86|||
128784469|NCT00797862|463503265|FG001|Overall Study|Adverse Event|44|||
128784470|NCT00797862|463503266|FG002|Overall Study|Adverse Event|58|||
128784471|NCT00797862|463503264|FG000|Overall Study|Abnormal Test Procedure Result|0|||
128784472|NCT00797862|463503265|FG001|Overall Study|Abnormal Test Procedure Result|1|||
128784473|NCT00797862|463503266|FG002|Overall Study|Abnormal Test Procedure Result|1|||
128784474|NCT00797862|463503264|FG000|Overall Study|Lack of Efficacy|1|||
128784475|NCT00797862|463503265|FG001|Overall Study|Lack of Efficacy|7|||
128784476|NCT00797862|463503266|FG002|Overall Study|Lack of Efficacy|6|||
128784477|NCT00797862|463503264|FG000|Overall Study|No longer required study medication|1|||
128784478|NCT00797862|463503265|FG001|Overall Study|No longer required study medication|0|||
128784479|NCT00797862|463503266|FG002|Overall Study|No longer required study medication|0|||
128784480|NCT00797862|463503264|FG000|Overall Study|Withdrawal by Subject|14|||
128736606|NCT02391948|463328022|FG001|18-month Assessment|Death|0|||
128736607|NCT02391948|463328023|FG002|18-month Assessment|Death|0|||
128736608|NCT02391948|463328024|FG003|18-month Assessment|Death|1|||
128736609|NCT02391948|463328025|FG004|18-month Assessment|Death|1|||
128736610|NCT02391948|463328021|FG000|18-month Assessment|Withdrawal by Subject|1|||
128736611|NCT02391948|463328022|FG001|18-month Assessment|Withdrawal by Subject|0|||
128736612|NCT02391948|463328023|FG002|18-month Assessment|Withdrawal by Subject|0|||
128736613|NCT02391948|463328024|FG003|18-month Assessment|Withdrawal by Subject|1|||
128736614|NCT02391948|463328025|FG004|18-month Assessment|Withdrawal by Subject|0|||
128736615|NCT02391948|463328021|FG000|18-month Assessment|Lost to Follow-up|2|||
128736616|NCT02391948|463328022|FG001|18-month Assessment|Lost to Follow-up|6|||
128736617|NCT02391948|463328023|FG002|18-month Assessment|Lost to Follow-up|2|||
128736618|NCT02391948|463328024|FG003|18-month Assessment|Lost to Follow-up|2|||
128784481|NCT00797862|463503265|FG001|Overall Study|Withdrawal by Subject|7|||
128784482|NCT00797862|463503266|FG002|Overall Study|Withdrawal by Subject|7|||
128784483|NCT00797862|463503264|FG000|Overall Study|Lost to Follow-up|11|||
128784484|NCT00797862|463503265|FG001|Overall Study|Lost to Follow-up|0|||
128784485|NCT00797862|463503266|FG002|Overall Study|Lost to Follow-up|5|||
128784486|NCT00797862|463503264|FG000|Overall Study|Administrative Problem|4|||
128784487|NCT00797862|463503265|FG001|Overall Study|Administrative Problem|0|||
128784488|NCT00797862|463503266|FG002|Overall Study|Administrative Problem|0|||
128784489|NCT00797862|463503264|FG000|Overall Study|Protocol Violation|4|||
128784490|NCT00797862|463503265|FG001|Overall Study|Protocol Violation|6|||
128784491|NCT00797862|463503266|FG002|Overall Study|Protocol Violation|8|||
128784492|NCT00797862|463503264|FG000|Overall Study|Mis-randomized|3|||
128784493|NCT00797862|463503265|FG001|Overall Study|Mis-randomized|3|||
128784494|NCT00797862|463503266|FG002|Overall Study|Mis-randomized|1|||
128784495|NCT00409708|463503270|FG000|Treatment|Abnormal test procedure result(s)|1|||
128784496|NCT00409708|463503271|FG001|Treatment|Abnormal test procedure result(s)|0|||
128784497|NCT00409708|463503270|FG000|Treatment|Lack of Efficacy|0|||
128784498|NCT00409708|463503271|FG001|Treatment|Lack of Efficacy|1|||
128784499|NCT00409708|463503270|FG000|Treatment|Protocol Violation|6|||
128784500|NCT00409708|463503271|FG001|Treatment|Protocol Violation|2|||
128784501|NCT00409708|463503270|FG000|Treatment|Withdrawal by Subject|3|||
128784502|NCT00409708|463503271|FG001|Treatment|Withdrawal by Subject|8|||
128784503|NCT00409708|463503270|FG000|Treatment|Lost to Follow-up|0|||
128784504|NCT00409708|463503271|FG001|Treatment|Lost to Follow-up|6|||
128784505|NCT00409708|463503270|FG000|Treatment|Administrative problems|5|||
128784506|NCT00409708|463503271|FG001|Treatment|Administrative problems|0|||
128784507|NCT00409708|463503270|FG000|Washout|Lack of Efficacy|9|||
128784508|NCT00409708|463503271|FG001|Washout|Lack of Efficacy|1|||
128784509|NCT00409708|463503270|FG000|Washout|Protocol Violation|0|||
128784510|NCT00409708|463503271|FG001|Washout|Protocol Violation|1|||
128784511|NCT00409708|463503270|FG000|Washout|Withdrawal by Subject|11|||
128784512|NCT00409708|463503271|FG001|Washout|Withdrawal by Subject|5|||
128784513|NCT00409708|463503270|FG000|Washout|Lost to Follow-up|1|||
128784514|NCT00409708|463503271|FG001|Washout|Lost to Follow-up|3|||
128784515|NCT01474538|463503274|FG000|Treatment Period 1|Death|1|||
128784516|NCT01474538|463503275|FG001|Treatment Period 1|Death|0|||
128784517|NCT01474538|463503274|FG000|Treatment Period 1|Physician Decision|1|||
128784518|NCT01474538|463503275|FG001|Treatment Period 1|Physician Decision|0|||
128784519|NCT01474538|463503274|FG000|Treatment Period 1|Withdrawal by Subject|1|||
128784520|NCT01474538|463503275|FG001|Treatment Period 1|Withdrawal by Subject|3|||
128784521|NCT01474538|463503274|FG000|Treatment Period 1|Protocol Violation|0|||
128784522|NCT01474538|463503275|FG001|Treatment Period 1|Protocol Violation|1|||
128784523|NCT01474538|463503274|FG000|Treatment Period 2|Death|1|||
128784524|NCT01474538|463503275|FG001|Treatment Period 2|Death|0|||
128784525|NCT01474538|463503274|FG000|Treatment Period 2|Adverse Event|1|||
128784526|NCT01474538|463503275|FG001|Treatment Period 2|Adverse Event|1|||
128784527|NCT01474538|463503274|FG000|Treatment Period 2|Withdrawal by Subject|2|||
128784528|NCT01474538|463503275|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128784529|NCT01474538|463503274|FG000|Treatment Period 2|Sponsor decision|1|||
128784530|NCT01474538|463503275|FG001|Treatment Period 2|Sponsor decision|0|||
128784531|NCT01474538|463503274|FG000|Treatment Period 2|Physician Decision|0|||
128784532|NCT01474538|463503275|FG001|Treatment Period 2|Physician Decision|1|||
128784533|NCT01474538|463503274|FG000|Treatment Period 2|Protocol Violation|1|||
128784534|NCT01474538|463503275|FG001|Treatment Period 2|Protocol Violation|0|||
128784535|NCT01456780|463503276|FG000|Overall Study|Lost to Follow-up|3|||
128784536|NCT01456780|463503277|FG001|Overall Study|Lost to Follow-up|3|||
128784537|NCT01456780|463503278|FG002|Overall Study|Lost to Follow-up|0|||
128784538|NCT03120676|463503281|FG000|Overall Study|Not treated|1|||
128784539|NCT00926393|463503282|FG000|Overall Study|Withdrawal by Subject|1|||
128784540|NCT00926393|463503283|FG001|Overall Study|Withdrawal by Subject|2|||
128784541|NCT00926393|463503282|FG000|Overall Study|Adverse Event|1|||
128784542|NCT00926393|463503283|FG001|Overall Study|Adverse Event|1|||
128784543|NCT02333630|463503284|FG000|Overall Study|Lost to Follow-up|5|||
128784544|NCT02333630|463503285|FG001|Overall Study|Lost to Follow-up|2|||
128784545|NCT05349864|463503286|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
128784546|NCT05349864|463503287|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
128784547|NCT02223793|463503288|FG000|Overall Study|Lost to Follow-up|10|||
128784548|NCT02223793|463503289|FG001|Overall Study|Lost to Follow-up|1|||
128784549|NCT02223793|463503290|FG002|Overall Study|Lost to Follow-up|2|||
128736619|NCT02391948|463328025|FG004|18-month Assessment|Lost to Follow-up|3|||
128736620|NCT02391948|463328021|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
128736621|NCT02391948|463328022|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
128736622|NCT02391948|463328023|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
128736623|NCT02391948|463328024|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
128736624|NCT02391948|463328025|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
128736625|NCT02391948|463328021|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
128736626|NCT02391948|463328022|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
128736627|NCT02391948|463328023|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
128736628|NCT02391948|463328024|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
128736629|NCT02391948|463328025|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
128736630|NCT02391948|463328021|FG000|24-month Assessment|Death|0|||
128736631|NCT02391948|463328022|FG001|24-month Assessment|Death|0|||
128736632|NCT02391948|463328023|FG002|24-month Assessment|Death|0|||
128736633|NCT02391948|463328024|FG003|24-month Assessment|Death|0|||
128736634|NCT02391948|463328025|FG004|24-month Assessment|Death|1|||
128736635|NCT02391948|463328021|FG000|24-month Assessment|Withdrawal by Subject|1|||
128736636|NCT02391948|463328022|FG001|24-month Assessment|Withdrawal by Subject|1|||
128736637|NCT02391948|463328023|FG002|24-month Assessment|Withdrawal by Subject|0|||
128736638|NCT02391948|463328024|FG003|24-month Assessment|Withdrawal by Subject|0|||
128736639|NCT02391948|463328025|FG004|24-month Assessment|Withdrawal by Subject|1|||
128736640|NCT02391948|463328021|FG000|24-month Assessment|Lost to Follow-up|5|||
128736641|NCT02391948|463328022|FG001|24-month Assessment|Lost to Follow-up|4|||
128736642|NCT02391948|463328023|FG002|24-month Assessment|Lost to Follow-up|0|||
128736643|NCT02391948|463328024|FG003|24-month Assessment|Lost to Follow-up|0|||
128736644|NCT02391948|463328025|FG004|24-month Assessment|Lost to Follow-up|0|||
128736645|NCT02391948|463328021|FG000|24-month Assessment|Medical issue/illness|0|||
128784550|NCT02223793|463503288|FG000|Overall Study|Withdrawal by Subject|3|||
128784551|NCT02223793|463503289|FG001|Overall Study|Withdrawal by Subject|2|||
128784552|NCT02223793|463503290|FG002|Overall Study|Withdrawal by Subject|3|||
128784553|NCT02223793|463503288|FG000|Overall Study|Moved/studycenter unable to participate|4|||
128736646|NCT02391948|463328022|FG001|24-month Assessment|Medical issue/illness|0|||
128736647|NCT02391948|463328023|FG002|24-month Assessment|Medical issue/illness|1|||
128736648|NCT02391948|463328024|FG003|24-month Assessment|Medical issue/illness|0|||
128736649|NCT02391948|463328025|FG004|24-month Assessment|Medical issue/illness|0|||
128736650|NCT02391948|463328021|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
128736651|NCT02391948|463328022|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
128736652|NCT02391948|463328023|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
128736653|NCT02391948|463328024|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
128736654|NCT02391948|463328025|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
128736655|NCT01529645|463328026|FG000|Overall Study|Lost to Follow-up|0|||
128736656|NCT01529645|463328027|FG001|Overall Study|Lost to Follow-up|1|||
128736657|NCT01529645|463328028|FG002|Overall Study|Lost to Follow-up|1|||
128736658|NCT01529645|463328029|FG003|Overall Study|Lost to Follow-up|1|||
128736659|NCT01529645|463328030|FG004|Overall Study|Lost to Follow-up|1|||
128736660|NCT01529645|463328031|FG005|Overall Study|Lost to Follow-up|0|||
128736661|NCT01529645|463328032|FG006|Overall Study|Lost to Follow-up|2|||
128736662|NCT01529645|463328033|FG007|Overall Study|Lost to Follow-up|0|||
128736663|NCT01529645|463328034|FG008|Overall Study|Lost to Follow-up|1|||
128736664|NCT01529645|463328035|FG009|Overall Study|Lost to Follow-up|0|||
128736665|NCT01529645|463328026|FG000|Overall Study|SAE - Premature contractions|0|||
128736666|NCT01529645|463328027|FG001|Overall Study|SAE - Premature contractions|0|||
128736667|NCT01529645|463328028|FG002|Overall Study|SAE - Premature contractions|1|||
128736668|NCT01529645|463328029|FG003|Overall Study|SAE - Premature contractions|0|||
128736669|NCT01529645|463328030|FG004|Overall Study|SAE - Premature contractions|0|||
128736670|NCT01529645|463328031|FG005|Overall Study|SAE - Premature contractions|0|||
128736671|NCT01529645|463328032|FG006|Overall Study|SAE - Premature contractions|0|||
128736672|NCT01529645|463328033|FG007|Overall Study|SAE - Premature contractions|0|||
128736673|NCT01529645|463328034|FG008|Overall Study|SAE - Premature contractions|0|||
128736674|NCT01529645|463328035|FG009|Overall Study|SAE - Premature contractions|0|||
128736675|NCT01529645|463328026|FG000|Overall Study|Withdrawal by Subject|2|||
128736676|NCT01529645|463328027|FG001|Overall Study|Withdrawal by Subject|0|||
128736677|NCT01529645|463328028|FG002|Overall Study|Withdrawal by Subject|0|||
128736678|NCT01529645|463328029|FG003|Overall Study|Withdrawal by Subject|1|||
128736679|NCT01529645|463328030|FG004|Overall Study|Withdrawal by Subject|1|||
128736680|NCT01529645|463328031|FG005|Overall Study|Withdrawal by Subject|1|||
128736681|NCT01529645|463328032|FG006|Overall Study|Withdrawal by Subject|0|||
128736682|NCT01529645|463328033|FG007|Overall Study|Withdrawal by Subject|0|||
128736683|NCT01529645|463328034|FG008|Overall Study|Withdrawal by Subject|0|||
128736684|NCT01529645|463328035|FG009|Overall Study|Withdrawal by Subject|0|||
128736685|NCT01602315|463328036|FG000|Overall Study|Protocol Violation|0|||
128736686|NCT01602315|463328037|FG001|Overall Study|Protocol Violation|0|||
128736687|NCT01602315|463328038|FG002|Overall Study|Protocol Violation|0|||
128736688|NCT01602315|463328039|FG003|Overall Study|Protocol Violation|0|||
128736689|NCT01602315|463328040|FG004|Overall Study|Protocol Violation|0|||
128736690|NCT01602315|463328041|FG005|Overall Study|Protocol Violation|1|||
128736691|NCT01602315|463328042|FG006|Overall Study|Protocol Violation|0|||
128736692|NCT01602315|463328036|FG000|Overall Study|Physician Decision|2|||
128736693|NCT01602315|463328037|FG001|Overall Study|Physician Decision|0|||
128736694|NCT01602315|463328038|FG002|Overall Study|Physician Decision|0|||
128736695|NCT01602315|463328039|FG003|Overall Study|Physician Decision|0|||
128736696|NCT01602315|463328040|FG004|Overall Study|Physician Decision|2|||
128736697|NCT01602315|463328041|FG005|Overall Study|Physician Decision|1|||
128736698|NCT01602315|463328042|FG006|Overall Study|Physician Decision|1|||
128736699|NCT01602315|463328036|FG000|Overall Study|Disease progression|6|||
128736700|NCT01602315|463328037|FG001|Overall Study|Disease progression|3|||
128736701|NCT01602315|463328038|FG002|Overall Study|Disease progression|10|||
128736702|NCT01602315|463328039|FG003|Overall Study|Disease progression|1|||
128736703|NCT01602315|463328040|FG004|Overall Study|Disease progression|41|||
128736704|NCT01602315|463328041|FG005|Overall Study|Disease progression|12|||
128736705|NCT01602315|463328042|FG006|Overall Study|Disease progression|15|||
128736706|NCT01602315|463328036|FG000|Overall Study|Death|1|||
128736707|NCT01602315|463328037|FG001|Overall Study|Death|1|||
128736708|NCT01602315|463328038|FG002|Overall Study|Death|1|||
128736709|NCT01602315|463328039|FG003|Overall Study|Death|1|||
128736710|NCT01602315|463328040|FG004|Overall Study|Death|7|||
128736711|NCT01602315|463328041|FG005|Overall Study|Death|2|||
128736712|NCT01602315|463328042|FG006|Overall Study|Death|2|||
128736713|NCT01602315|463328036|FG000|Overall Study|Withdrawal by Subject|2|||
128736714|NCT01602315|463328037|FG001|Overall Study|Withdrawal by Subject|0|||
128784554|NCT02223793|463503289|FG001|Overall Study|Moved/studycenter unable to participate|6|||
128784555|NCT02223793|463503290|FG002|Overall Study|Moved/studycenter unable to participate|8|||
128736715|NCT01602315|463328038|FG002|Overall Study|Withdrawal by Subject|2|||
128736716|NCT01602315|463328039|FG003|Overall Study|Withdrawal by Subject|0|||
128736717|NCT01602315|463328040|FG004|Overall Study|Withdrawal by Subject|6|||
128784556|NCT01704846|463503291|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128784557|NCT01704846|463503292|FG001|Treatment Period 2|Withdrawal by Subject|1|||
128784558|NCT04577183|463503293|FG000|Overall Study|Death|1|||
128784559|NCT04577183|463503293|FG000|Overall Study|Withdrawal by Subject|3|||
128784560|NCT04577183|463503293|FG000|Overall Study|Early termination|2|||
128784561|NCT01168401|463503294|FG000|Overall Study|Lost to Follow-up|1|||
128784562|NCT01168401|463503295|FG001|Overall Study|Lost to Follow-up|1|||
128784563|NCT01168401|463503296|FG002|Overall Study|Lost to Follow-up|2|||
128784564|NCT01168401|463503297|FG003|Overall Study|Lost to Follow-up|1|||
128784565|NCT01168401|463503298|FG004|Overall Study|Lost to Follow-up|0|||
128784566|NCT01168401|463503299|FG005|Overall Study|Lost to Follow-up|0|||
128784567|NCT01168401|463503300|FG006|Overall Study|Lost to Follow-up|0|||
128784568|NCT01168401|463503301|FG007|Overall Study|Lost to Follow-up|0|||
128784569|NCT01168401|463503302|FG008|Overall Study|Lost to Follow-up|0|||
128784570|NCT01168401|463503303|FG009|Overall Study|Lost to Follow-up|0|||
128784571|NCT01168401|463503304|FG010|Overall Study|Lost to Follow-up|0|||
128784572|NCT01168401|463503294|FG000|Overall Study|Withdrawal by Subject|0|||
128784573|NCT01168401|463503295|FG001|Overall Study|Withdrawal by Subject|0|||
128784574|NCT01168401|463503296|FG002|Overall Study|Withdrawal by Subject|0|||
128784575|NCT01168401|463503297|FG003|Overall Study|Withdrawal by Subject|1|||
128784576|NCT01168401|463503298|FG004|Overall Study|Withdrawal by Subject|0|||
128784577|NCT01168401|463503299|FG005|Overall Study|Withdrawal by Subject|0|||
128784578|NCT01168401|463503300|FG006|Overall Study|Withdrawal by Subject|0|||
128784579|NCT01168401|463503301|FG007|Overall Study|Withdrawal by Subject|0|||
128784580|NCT01168401|463503302|FG008|Overall Study|Withdrawal by Subject|0|||
128784581|NCT01168401|463503303|FG009|Overall Study|Withdrawal by Subject|0|||
128784582|NCT01168401|463503304|FG010|Overall Study|Withdrawal by Subject|0|||
128784583|NCT00672256|463503309|FG000|Overall Study|PI dropped, bad data|44|||
128784584|NCT01268891|463503317|FG000|Overall Study|Adverse Event|3|||
128784585|NCT01268891|463503318|FG001|Overall Study|Adverse Event|7|||
128784586|NCT01268891|463503317|FG000|Overall Study|Lack of Efficacy|1|||
128784587|NCT01268891|463503318|FG001|Overall Study|Lack of Efficacy|0|||
128784588|NCT01268891|463503317|FG000|Overall Study|Withdrawal of Consent|3|||
128784589|NCT01268891|463503318|FG001|Overall Study|Withdrawal of Consent|1|||
128784590|NCT01268891|463503317|FG000|Overall Study|Administrative or other reason(s)|1|||
128784591|NCT01268891|463503318|FG001|Overall Study|Administrative or other reason(s)|0|||
128784592|NCT01720043|463503319|FG000|Overall Study|Withdrawal by Subject|1|||
128784593|NCT01688973|463503320|FG000|Overall Study|Ineligible|2|||
128784594|NCT01688973|463503321|FG001|Overall Study|Ineligible|3|||
128784595|NCT01149681|463503322|FG000|Overall Study|Withdrawal by Subject|7|||
128784596|NCT01149681|463503322|FG000|Overall Study|Progressive disease|1|||
128784597|NCT01149681|463503322|FG000|Overall Study|Physician Decision|2|||
128784598|NCT01149681|463503322|FG000|Overall Study|adverse events nonrelated study drug|2|||
128784599|NCT02993471|463503323|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
128784600|NCT02993471|463503323|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
128784601|NCT01570751|463503324|FG000|Period A (16 Weeks)|Protocol Violation|1|||
128784602|NCT01570751|463503325|FG001|Period A (16 Weeks)|Protocol Violation|1|||
128784603|NCT01570751|463503324|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
128784604|NCT01570751|463503325|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
128784605|NCT01570751|463503324|FG000|Period A (16 Weeks)|Unclassified|2|||
128784606|NCT01570751|463503325|FG001|Period A (16 Weeks)|Unclassified|3|||
128784607|NCT01570751|463503324|FG000|Period B (16 Weeks)|Adverse Event|1|||
128784608|NCT01570751|463503325|FG001|Period B (16 Weeks)|Adverse Event|0|||
128784609|NCT01570751|463503324|FG000|Period B (16 Weeks)|Protocol Violation|0|||
128784610|NCT01570751|463503325|FG001|Period B (16 Weeks)|Protocol Violation|1|||
128784611|NCT00588666|463503327|FG000|Overall Study|Adverse Event|4|||
128784612|NCT04582877|463503330|FG000|Overall Study|Did not use device measurement|5|||
128784613|NCT04582877|463503330|FG000|Overall Study|No fractional flow reserve test results|2|||
128784614|NCT04582877|463503330|FG000|Overall Study|Protocol Violation|1|||
128784615|NCT03055767|463503331|FG000|Open-Label Period|Lost to Follow-up|0|||
128784616|NCT03055767|463503332|FG001|Open-Label Period|Lost to Follow-up|0|||
128784617|NCT03055767|463503333|FG002|Open-Label Period|Lost to Follow-up|2|||
128784618|NCT03055767|463503334|FG003|Open-Label Period|Lost to Follow-up|0|||
128784619|NCT03055767|463503331|FG000|Open-Label Period|Withdrawal by Subject|0|||
128784620|NCT03055767|463503332|FG001|Open-Label Period|Withdrawal by Subject|0|||
128784621|NCT03055767|463503333|FG002|Open-Label Period|Withdrawal by Subject|0|||
128784622|NCT03055767|463503334|FG003|Open-Label Period|Withdrawal by Subject|1|||
128784623|NCT02759731|463503335|FG000|Overall Study|Did not complete treatment.|8|||
128784624|NCT00763282|463503338|FG000|Overall Study|Withdrawal by Subject|6|||
128784625|NCT00763282|463503339|FG001|Overall Study|Withdrawal by Subject|5|||
128784626|NCT00763282|463503338|FG000|Overall Study|Death|4|||
128784627|NCT00763282|463503339|FG001|Overall Study|Death|3|||
128784628|NCT00763282|463503338|FG000|Overall Study|Lost to Follow-up|22|||
128784629|NCT00763282|463503339|FG001|Overall Study|Lost to Follow-up|26|||
128784630|NCT00335556|463503342|FG000|Overall Study|Death|0|||
128784631|NCT00335556|463503343|FG001|Overall Study|Death|5|||
128784632|NCT00335556|463503344|FG002|Overall Study|Death|0|||
128784633|NCT00335556|463503345|FG003|Overall Study|Death|0|||
128784634|NCT00335556|463503346|FG004|Overall Study|Death|1|||
128784635|NCT00335556|463503347|FG005|Overall Study|Death|0|||
128784636|NCT00335556|463503342|FG000|Overall Study|Lack of Efficacy|0|||
128784637|NCT00335556|463503343|FG001|Overall Study|Lack of Efficacy|19|||
128736718|NCT01602315|463328041|FG005|Overall Study|Withdrawal by Subject|0|||
128736719|NCT01602315|463328042|FG006|Overall Study|Withdrawal by Subject|1|||
128736720|NCT01602315|463328036|FG000|Overall Study|Adverse Event|5|||
128736721|NCT01602315|463328037|FG001|Overall Study|Adverse Event|1|||
128736722|NCT01602315|463328038|FG002|Overall Study|Adverse Event|5|||
128736723|NCT01602315|463328039|FG003|Overall Study|Adverse Event|4|||
128736724|NCT01602315|463328040|FG004|Overall Study|Adverse Event|15|||
128736725|NCT01602315|463328041|FG005|Overall Study|Adverse Event|3|||
128736726|NCT01602315|463328042|FG006|Overall Study|Adverse Event|9|||
128736727|NCT01602315|463328036|FG000|Overall Study|Subject/guardian decision|0|||
128784638|NCT00335556|463503344|FG002|Overall Study|Lack of Efficacy|3|||
128784639|NCT00335556|463503345|FG003|Overall Study|Lack of Efficacy|3|||
128784640|NCT00335556|463503346|FG004|Overall Study|Lack of Efficacy|0|||
128784641|NCT00335556|463503347|FG005|Overall Study|Lack of Efficacy|1|||
128784642|NCT00335556|463503342|FG000|Overall Study|Physician Decision|0|||
128784643|NCT00335556|463503343|FG001|Overall Study|Physician Decision|6|||
128784644|NCT00335556|463503344|FG002|Overall Study|Physician Decision|2|||
128784645|NCT00335556|463503345|FG003|Overall Study|Physician Decision|1|||
128784646|NCT00335556|463503346|FG004|Overall Study|Physician Decision|0|||
128784647|NCT00335556|463503347|FG005|Overall Study|Physician Decision|0|||
128784648|NCT00335556|463503342|FG000|Overall Study|Ineligible|2|||
128784649|NCT00335556|463503343|FG001|Overall Study|Ineligible|0|||
128784650|NCT00335556|463503344|FG002|Overall Study|Ineligible|0|||
128784651|NCT00335556|463503345|FG003|Overall Study|Ineligible|0|||
128784652|NCT00335556|463503346|FG004|Overall Study|Ineligible|0|||
128784653|NCT00335556|463503347|FG005|Overall Study|Ineligible|0|||
128784654|NCT00335556|463503342|FG000|Overall Study|Refusal of further protocol therapy|0|||
128784655|NCT00335556|463503343|FG001|Overall Study|Refusal of further protocol therapy|4|||
128784656|NCT00335556|463503344|FG002|Overall Study|Refusal of further protocol therapy|0|||
128784657|NCT00335556|463503345|FG003|Overall Study|Refusal of further protocol therapy|1|||
128784658|NCT00335556|463503346|FG004|Overall Study|Refusal of further protocol therapy|0|||
128784659|NCT00335556|463503347|FG005|Overall Study|Refusal of further protocol therapy|0|||
128784660|NCT01878890|463503348|FG000|Overall Study|Protocol Violation|0|||
128784661|NCT01878890|463503349|FG001|Overall Study|Protocol Violation|1|||
128784662|NCT01878890|463503350|FG002|Overall Study|Protocol Violation|0|||
128784663|NCT01878890|463503351|FG003|Overall Study|Protocol Violation|0|||
128784664|NCT02974010|463503352|FG000|Overall Study|Lost to Follow-up|3|||
128784665|NCT02974010|463503353|FG001|Overall Study|Lost to Follow-up|1|||
128784666|NCT02974010|463503354|FG002|Overall Study|Lost to Follow-up|0|||
128784667|NCT02974010|463503355|FG003|Overall Study|Lost to Follow-up|0|||
128784668|NCT02974010|463503352|FG000|Overall Study|Withdrawal by Subject|2|||
128784669|NCT02974010|463503353|FG001|Overall Study|Withdrawal by Subject|1|||
128736728|NCT01602315|463328037|FG001|Overall Study|Subject/guardian decision|0|||
128736729|NCT01602315|463328038|FG002|Overall Study|Subject/guardian decision|0|||
128736730|NCT01602315|463328039|FG003|Overall Study|Subject/guardian decision|0|||
128736731|NCT01602315|463328040|FG004|Overall Study|Subject/guardian decision|0|||
128736732|NCT01602315|463328041|FG005|Overall Study|Subject/guardian decision|0|||
128736733|NCT01602315|463328042|FG006|Overall Study|Subject/guardian decision|1|||
128736734|NCT01602315|463328036|FG000|Overall Study|Cross-over patients to combo treatment|0|||
128736735|NCT01602315|463328037|FG001|Overall Study|Cross-over patients to combo treatment|0|||
128736736|NCT01602315|463328038|FG002|Overall Study|Cross-over patients to combo treatment|0|||
128736737|NCT01602315|463328039|FG003|Overall Study|Cross-over patients to combo treatment|0|||
128736738|NCT01602315|463328040|FG004|Overall Study|Cross-over patients to combo treatment|0|||
128736739|NCT01602315|463328041|FG005|Overall Study|Cross-over patients to combo treatment|16|||
128736740|NCT01602315|463328042|FG006|Overall Study|Cross-over patients to combo treatment|0|||
128736741|NCT00440271|463328047|FG000|Overall Study|Protocol Violation|1|||
128736742|NCT00440271|463328048|FG001|Overall Study|Protocol Violation|1|||
128736743|NCT00440271|463328047|FG000|Overall Study|Adverse Event|0|||
128784670|NCT02974010|463503354|FG002|Overall Study|Withdrawal by Subject|0|||
128784671|NCT02974010|463503355|FG003|Overall Study|Withdrawal by Subject|0|||
128784672|NCT02974010|463503352|FG000|Overall Study|Adverse Event|0|||
128784673|NCT02974010|463503353|FG001|Overall Study|Adverse Event|1|||
128784674|NCT02974010|463503354|FG002|Overall Study|Adverse Event|0|||
128784675|NCT02974010|463503355|FG003|Overall Study|Adverse Event|0|||
128784676|NCT02974010|463503352|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
128784677|NCT02974010|463503353|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
128784678|NCT02974010|463503354|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
128784679|NCT02974010|463503355|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
128784680|NCT02974010|463503352|FG000|Overall Study|Lack of Efficacy|0|||
128784681|NCT02974010|463503353|FG001|Overall Study|Lack of Efficacy|0|||
128784682|NCT02974010|463503354|FG002|Overall Study|Lack of Efficacy|1|||
128784683|NCT02974010|463503355|FG003|Overall Study|Lack of Efficacy|0|||
128784684|NCT00320489|463503356|FG000|Overall Study|Adverse Event|26|||
128784685|NCT00320489|463503357|FG001|Overall Study|Adverse Event|25|||
128784686|NCT00320489|463503356|FG000|Overall Study|Clinical Relapse|26|||
128784687|NCT00320489|463503357|FG001|Overall Study|Clinical Relapse|20|||
128784688|NCT00320489|463503356|FG000|Overall Study|Death|0|||
128784689|NCT00320489|463503357|FG001|Overall Study|Death|2|||
128784690|NCT00320489|463503356|FG000|Overall Study|Entry Criteria Exclusion|2|||
128784691|NCT00320489|463503357|FG001|Overall Study|Entry Criteria Exclusion|4|||
128784692|NCT00320489|463503356|FG000|Overall Study|Lack of Efficacy|16|||
128784693|NCT00320489|463503357|FG001|Overall Study|Lack of Efficacy|7|||
128784694|NCT00320489|463503356|FG000|Overall Study|Lost to Follow-up|21|||
128784695|NCT00320489|463503357|FG001|Overall Study|Lost to Follow-up|22|||
128784696|NCT00320489|463503356|FG000|Overall Study|Physician Decision|8|||
128784697|NCT00320489|463503357|FG001|Overall Study|Physician Decision|8|||
128784698|NCT00320489|463503356|FG000|Overall Study|Protocol Violation|4|||
128784699|NCT00320489|463503357|FG001|Overall Study|Protocol Violation|4|||
128784700|NCT00320489|463503356|FG000|Overall Study|Sponsor Decision|3|||
128784701|NCT00320489|463503357|FG001|Overall Study|Sponsor Decision|3|||
128784702|NCT00320489|463503356|FG000|Overall Study|Withdrawal by Subject|39|||
128784703|NCT00320489|463503357|FG001|Overall Study|Withdrawal by Subject|41|||
128736744|NCT00440271|463328048|FG001|Overall Study|Adverse Event|1|||
128736745|NCT00440271|463328047|FG000|Overall Study|Lost to Follow-up|1|||
128736746|NCT00440271|463328048|FG001|Overall Study|Lost to Follow-up|0|||
128736747|NCT00440271|463328047|FG000|Overall Study|Withdrawal by Subject|0|||
128736748|NCT00440271|463328048|FG001|Overall Study|Withdrawal by Subject|2|||
128736749|NCT00440271|463328047|FG000|Overall Study|Lack of Efficacy|0|||
128736750|NCT00440271|463328048|FG001|Overall Study|Lack of Efficacy|1|||
128736751|NCT00440271|463328047|FG000|Overall Study|Due to closure of trial|8|||
128736752|NCT00440271|463328048|FG001|Overall Study|Due to closure of trial|10|||
128736753|NCT00440271|463328047|FG000|Overall Study|Other|2|||
128736754|NCT00440271|463328048|FG001|Overall Study|Other|0|||
128736755|NCT00723801|463328049|FG000|Overall Study|Lost to Follow-up|1|||
128736756|NCT00723801|463328050|FG001|Overall Study|Lost to Follow-up|2|||
128736757|NCT00723801|463328049|FG000|Overall Study|Protocol Violation|2|||
128736758|NCT00723801|463328050|FG001|Overall Study|Protocol Violation|1|||
128736759|NCT01565993|463328058|FG000|Overall Study|Physician Decision|0|||
128736760|NCT01565993|463328059|FG001|Overall Study|Physician Decision|3|||
128736761|NCT00812812|463328060|FG000|Overall Study|Adverse Event|2|||
128736762|NCT00812812|463328061|FG001|Overall Study|Adverse Event|1|||
128736763|NCT00812812|463328060|FG000|Overall Study|Lack of Efficacy|1|||
128736764|NCT00812812|463328061|FG001|Overall Study|Lack of Efficacy|0|||
128736765|NCT00812812|463328060|FG000|Overall Study|Lost to Follow-up|0|||
128736766|NCT00812812|463328061|FG001|Overall Study|Lost to Follow-up|1|||
128736767|NCT00812812|463328060|FG000|Overall Study|Withdrawal by Subject|0|||
128736768|NCT00812812|463328061|FG001|Overall Study|Withdrawal by Subject|2|||
128736769|NCT02985736|463328069|FG000|Overall Study|Lost to Follow-up|3|||
128736770|NCT00382733|463328070|FG000|Overall Study|Withdrawal by Subject|0|||
128736771|NCT00382733|463328071|FG001|Overall Study|Withdrawal by Subject|1|||
128736772|NCT00382733|463328072|FG002|Overall Study|Withdrawal by Subject|0|||
128736773|NCT00382733|463328073|FG003|Overall Study|Withdrawal by Subject|0|||
128736774|NCT00382733|463328074|FG004|Overall Study|Withdrawal by Subject|0|||
128736775|NCT01193556|463328080|FG000|Overall Study|Study termination|26|||
128736776|NCT01193556|463328081|FG001|Overall Study|Study termination|25|||
128736777|NCT01752933|463328082|FG000|Treatment|Disease Progression|3|||
128736778|NCT01752933|463328083|FG001|Treatment|Disease Progression|29|||
128736779|NCT01752933|463328082|FG000|Treatment|Withdrawal by Subject|0|||
128736780|NCT01752933|463328083|FG001|Treatment|Withdrawal by Subject|5|||
128736781|NCT01752933|463328082|FG000|Treatment|Adverse Event|1|||
128736782|NCT01752933|463328083|FG001|Treatment|Adverse Event|4|||
128736783|NCT01752933|463328082|FG000|Treatment|Physician Decision|0|||
128736784|NCT01752933|463328083|FG001|Treatment|Physician Decision|3|||
128736785|NCT01752933|463328082|FG000|Treatment|Death|0|||
128736786|NCT01752933|463328083|FG001|Treatment|Death|2|||
128736787|NCT01752933|463328082|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
128736788|NCT01752933|463328083|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
128736789|NCT01752933|463328082|FG000|Treatment|Patient noncompliant|0|||
128736790|NCT01752933|463328083|FG001|Treatment|Patient noncompliant|1|||
128736791|NCT01752933|463328082|FG000|Treatment|Patient unable to travel to appointments|0|||
128736792|NCT01752933|463328083|FG001|Treatment|Patient unable to travel to appointments|1|||
128736793|NCT01752933|463328082|FG000|Overall Study and Follow-up|Death|4|||
128736794|NCT01752933|463328083|FG001|Overall Study and Follow-up|Death|34|||
128736795|NCT01752933|463328082|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
128736796|NCT01752933|463328083|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
128736797|NCT01752933|463328082|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
128736798|NCT01752933|463328083|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
128736799|NCT01752933|463328082|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
128736800|NCT01752933|463328083|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
128736801|NCT04154631|463328088|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
128736802|NCT04154631|463328089|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
128736803|NCT00835406|463328090|FG000|Period: First Intervention|Adverse Event|0|||
128736804|NCT00835406|463328091|FG001|Period: First Intervention|Adverse Event|1|||
128736805|NCT00835406|463328090|FG000|Period: First Intervention|Withdrawal by Subject|2|||
128736806|NCT00835406|463328091|FG001|Period: First Intervention|Withdrawal by Subject|0|||
128736807|NCT00835406|463328090|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
128736808|NCT00835406|463328091|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
128736809|NCT02185768|463328092|FG000|Overall Study|Patients were not treated|2|||
128736810|NCT02486406|463328094|FG000|Overall Study|Withdrew consent|1|||
128736811|NCT02486406|463328095|FG001|Overall Study|Withdrew consent|0|||
128736812|NCT02486406|463328096|FG002|Overall Study|Withdrew consent|0|||
128736813|NCT02486406|463328097|FG003|Overall Study|Withdrew consent|1|||
128736814|NCT02486406|463328094|FG000|Overall Study|Lost to Follow-up|1|||
128736815|NCT02486406|463328095|FG001|Overall Study|Lost to Follow-up|3|||
128736816|NCT02486406|463328096|FG002|Overall Study|Lost to Follow-up|1|||
128736817|NCT02486406|463328097|FG003|Overall Study|Lost to Follow-up|3|||
128736818|NCT02486406|463328094|FG000|Overall Study|Other, not specified|0|||
128736819|NCT02486406|463328095|FG001|Overall Study|Other, not specified|0|||
128736820|NCT02486406|463328096|FG002|Overall Study|Other, not specified|1|||
128736821|NCT02486406|463328097|FG003|Overall Study|Other, not specified|0|||
128736822|NCT01826825|463328098|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
128736823|NCT01826825|463328099|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
128736824|NCT02127307|463328100|FG000|Overall Study|Protocol Violation|36|||
128736825|NCT02127307|463328100|FG000|Overall Study|Lost to Follow-up|2|||
128736826|NCT02127307|463328100|FG000|Overall Study|Death|101|||
128736827|NCT02127307|463328100|FG000|Overall Study|Other than specified above|169|||
128736828|NCT03509948|463328101|FG000|Overall Study|Protocol Violation|0|||
128736829|NCT03509948|463328102|FG001|Overall Study|Protocol Violation|1|||
128736830|NCT01071512|463328105|FG000|Overall Study|Adverse Event|1|||
128736831|NCT01071512|463328105|FG000|Overall Study|Development of antibodies to drug|2|||
128736832|NCT01071512|463328105|FG000|Overall Study|positive anti-JC virus antibody test|2|||
128784704|NCT04555044|463503362|FG000|Overall Study|Adverse Event|0|||
128784705|NCT04555044|463503363|FG001|Overall Study|Adverse Event|1|||
128784706|NCT04088188|463503365|FG000|Overall Study|Withdrawal by Subject|2|||
128784707|NCT04088188|463503366|FG001|Overall Study|Withdrawal by Subject|0|||
128784708|NCT04088188|463503365|FG000|Overall Study|Adverse Event|2|||
128736833|NCT01712984|463328116|FG000|Overall Study|Adverse Event|0|||
128736834|NCT01712984|463328117|FG001|Overall Study|Adverse Event|0|||
128736835|NCT01712984|463328118|FG002|Overall Study|Adverse Event|1|||
128784709|NCT04088188|463503366|FG001|Overall Study|Adverse Event|0|||
128784710|NCT03601507|463503369|FG000|Overall Study|Adverse Event|1|||
128736836|NCT01712984|463328116|FG000|Overall Study|Protocol Violation|2|||
128736837|NCT01712984|463328117|FG001|Overall Study|Protocol Violation|0|||
128736838|NCT01712984|463328118|FG002|Overall Study|Protocol Violation|1|||
128736839|NCT01712984|463328116|FG000|Overall Study|Lost to Follow-up|8|||
128736840|NCT01712984|463328117|FG001|Overall Study|Lost to Follow-up|10|||
128736841|NCT01712984|463328118|FG002|Overall Study|Lost to Follow-up|1|||
128736842|NCT01712984|463328116|FG000|Overall Study|Withdrawal by Subject|6|||
128736843|NCT01712984|463328117|FG001|Overall Study|Withdrawal by Subject|6|||
128736844|NCT01712984|463328118|FG002|Overall Study|Withdrawal by Subject|7|||
128736845|NCT02755831|463328123|FG000|Overall Study|Lost to Follow-up|3|||
128736846|NCT02755831|463328124|FG001|Overall Study|Lost to Follow-up|3|||
128736847|NCT00700011|463328128|FG000|Overall Study|Death|0|||
128736848|NCT00700011|463328129|FG001|Overall Study|Death|1|||
128784711|NCT02107014|463503372|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
128784712|NCT03761784|463503373|FG000|Overall Study|Adverse Event|4|||
128784713|NCT03761784|463503374|FG001|Overall Study|Adverse Event|0|||
128784714|NCT03761784|463503373|FG000|Overall Study|Lost to Follow-up|10|||
128784715|NCT03761784|463503374|FG001|Overall Study|Lost to Follow-up|7|||
128736849|NCT03333486|463328132|FG000|Overall Study|Withdrawal by Subject|1|||
128784716|NCT03761784|463503373|FG000|Overall Study|Pregnancy|1|||
128784717|NCT03761784|463503374|FG001|Overall Study|Pregnancy|0|||
128736850|NCT03333486|463328132|FG000|Overall Study|Lost to Follow-up|1|||
128736851|NCT01976845|463328135|FG000|Overall Study|Physician Decision|8|||
128784718|NCT03761784|463503373|FG000|Overall Study|Protocol Violation|2|||
128784719|NCT03761784|463503374|FG001|Overall Study|Protocol Violation|0|||
128784720|NCT03761784|463503373|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
128784721|NCT03761784|463503374|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
128784722|NCT03761784|463503373|FG000|Overall Study|Withdrawal by Subject|9|||
128736852|NCT01976845|463328136|FG001|Overall Study|Physician Decision|8|||
128736853|NCT01976845|463328137|FG002|Overall Study|Physician Decision|3|||
128736854|NCT03246529|463328139|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
128736855|NCT03246529|463328140|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
128736856|NCT03246529|463328141|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
128736857|NCT03246529|463328139|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
128736858|NCT03246529|463328140|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
128784723|NCT03761784|463503374|FG001|Overall Study|Withdrawal by Subject|4|||
128784724|NCT03761784|463503373|FG000|Overall Study|Physician Decision|1|||
128784725|NCT03761784|463503374|FG001|Overall Study|Physician Decision|0|||
128784726|NCT03761784|463503373|FG000|Overall Study|Other Than Specified|1|||
128784727|NCT03761784|463503374|FG001|Overall Study|Other Than Specified|0|||
128784728|NCT00586339|463503375|FG000|Overall Study|Withdrawal by Subject|1|||
128784729|NCT00586339|463503376|FG001|Overall Study|Withdrawal by Subject|3|||
128784730|NCT00586339|463503377|FG002|Overall Study|Withdrawal by Subject|1|||
128784731|NCT00586339|463503375|FG000|Overall Study|Migrated/moved from study area|3|||
128784732|NCT00586339|463503376|FG001|Overall Study|Migrated/moved from study area|2|||
128784733|NCT00586339|463503377|FG002|Overall Study|Migrated/moved from study area|4|||
128784734|NCT00586339|463503375|FG000|Overall Study|Lost to Follow-up|3|||
128784735|NCT00586339|463503376|FG001|Overall Study|Lost to Follow-up|2|||
128736859|NCT03246529|463328141|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
128736860|NCT03246529|463328139|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
128736861|NCT03246529|463328140|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
128736862|NCT03246529|463328141|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
128736863|NCT03246529|463328139|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
128736864|NCT03246529|463328140|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
128736865|NCT03246529|463328141|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
128736866|NCT03246529|463328139|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
128736867|NCT03246529|463328140|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
128736868|NCT03246529|463328141|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
128736869|NCT03246529|463328139|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
128736870|NCT03246529|463328140|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
128736871|NCT03246529|463328141|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
128736872|NCT03246529|463328139|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
128736873|NCT03246529|463328140|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
128736874|NCT03246529|463328141|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
128736875|NCT03246529|463328139|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
128736876|NCT03246529|463328140|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
128736877|NCT03246529|463328141|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
128736878|NCT03246529|463328139|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
128736879|NCT03246529|463328140|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
128736880|NCT03246529|463328141|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
128736881|NCT01209624|463328142|FG000|Overall Study|Death|2|||
128736882|NCT01209624|463328142|FG000|Overall Study|Adverse Event|13|||
128736883|NCT01209624|463328142|FG000|Overall Study|Lack of Efficacy|17|||
128736884|NCT01209624|463328142|FG000|Overall Study|Lost to Follow-up|290|||
128736885|NCT01209624|463328142|FG000|Overall Study|Other|4|||
128736886|NCT00827372|463329903|FG000|Overall Study|Adverse Event|5|||
128736887|NCT00827372|463329903|FG000|Overall Study|Lack of Efficacy|3|||
128736888|NCT02293005|463329904|FG000|Overall Study|Adverse Event|2|||
128736889|NCT02293005|463329904|FG000|Overall Study|Death|4|||
128736890|NCT02293005|463329904|FG000|Overall Study|Lost to Follow-up|1|||
128736891|NCT02293005|463329904|FG000|Overall Study|Withdrawal by Subject|2|||
128736892|NCT02293005|463329904|FG000|Overall Study|Progression|17|||
128736893|NCT02139644|463329905|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
128736894|NCT02139644|463329906|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128736895|NCT02139644|463329907|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128736896|NCT02139644|463329908|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128784736|NCT00586339|463503377|FG002|Overall Study|Lost to Follow-up|1|||
128784737|NCT00197236|463503382|FG000|Overall Study|Adverse Event|1|||
128784738|NCT00197236|463503383|FG001|Overall Study|Adverse Event|0|||
128784739|NCT00197236|463503384|FG002|Overall Study|Adverse Event|1|||
128736897|NCT02139644|463329909|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128736898|NCT02139644|463329910|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
128736899|NCT02139644|463329905|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
128736900|NCT02139644|463329906|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128736901|NCT02139644|463329907|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128736902|NCT02139644|463329908|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128736903|NCT02139644|463329909|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128736904|NCT02139644|463329910|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
128736905|NCT02139644|463329905|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
128736906|NCT02139644|463329906|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128736907|NCT02139644|463329907|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128736908|NCT02139644|463329908|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128784740|NCT00197236|463503382|FG000|Overall Study|Lost to Follow-up|5|||
128784741|NCT00197236|463503383|FG001|Overall Study|Lost to Follow-up|14|||
128784742|NCT00197236|463503384|FG002|Overall Study|Lost to Follow-up|6|||
128784743|NCT00197236|463503382|FG000|Overall Study|Protocol Violation|0|||
128784744|NCT00197236|463503383|FG001|Overall Study|Protocol Violation|0|||
128784745|NCT00197236|463503384|FG002|Overall Study|Protocol Violation|1|||
128784746|NCT00197236|463503382|FG000|Overall Study|Withdrawal by Subject|7|||
128784747|NCT00197236|463503383|FG001|Overall Study|Withdrawal by Subject|3|||
128784748|NCT00197236|463503384|FG002|Overall Study|Withdrawal by Subject|11|||
128784749|NCT00197236|463503382|FG000|Overall Study|Study drug/medication expiration|1|||
128784750|NCT00197236|463503383|FG001|Overall Study|Study drug/medication expiration|0|||
128784751|NCT00197236|463503384|FG002|Overall Study|Study drug/medication expiration|3|||
128784752|NCT00197236|463503382|FG000|Overall Study|Returned out of specified time window|0|||
128784753|NCT00197236|463503383|FG001|Overall Study|Returned out of specified time window|0|||
128736909|NCT02139644|463329909|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128784754|NCT00197236|463503384|FG002|Overall Study|Returned out of specified time window|1|||
128784755|NCT01835899|463503385|FG000|Overall Study|Adverse Event|0|||
128784756|NCT01835899|463503386|FG001|Overall Study|Adverse Event|0|||
128784757|NCT01835899|463503387|FG002|Overall Study|Adverse Event|1|||
128784758|NCT01835899|463503385|FG000|Overall Study|Other than stated above|0|||
128784759|NCT01835899|463503386|FG001|Overall Study|Other than stated above|1|||
128784760|NCT01835899|463503387|FG002|Overall Study|Other than stated above|0|||
128784761|NCT04305912|463503388|FG000|First Intervention|COVID-19 Suspension|2|||
128784762|NCT04305912|463503389|FG001|First Intervention|COVID-19 Suspension|0|||
128784763|NCT04305912|463503388|FG000|First Intervention|Withdrawal by Subject|0|||
128784764|NCT04305912|463503389|FG001|First Intervention|Withdrawal by Subject|1|||
128784765|NCT04305912|463503388|FG000|Second Intervention|Adverse Event|0|||
128784766|NCT04305912|463503389|FG001|Second Intervention|Adverse Event|1|||
128784767|NCT01649427|463503390|FG000|Overall Study|Adverse Event|1|||
128784768|NCT01649427|463503391|FG001|Overall Study|Adverse Event|1|||
128784769|NCT01649427|463503390|FG000|Overall Study|Withdrawal by Subject|8|||
128784770|NCT01649427|463503391|FG001|Overall Study|Withdrawal by Subject|7|||
128784771|NCT01649427|463503390|FG000|Overall Study|Lost to Follow-up|0|||
128784772|NCT01649427|463503391|FG001|Overall Study|Lost to Follow-up|1|||
128784773|NCT01649427|463503390|FG000|Overall Study|Graft loss|0|||
128784774|NCT01649427|463503391|FG001|Overall Study|Graft loss|1|||
128784775|NCT01649427|463503390|FG000|Overall Study|Surgical problems during nephrectomy|2|||
128784776|NCT01649427|463503391|FG001|Overall Study|Surgical problems during nephrectomy|2|||
128784777|NCT04888585|463503392|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
128784778|NCT04888585|463503393|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
128784779|NCT04888585|463503394|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
128784780|NCT04888585|463503395|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
128784781|NCT04888585|463503396|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
128784782|NCT04888585|463503397|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
128784783|NCT04888585|463503398|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
128784784|NCT04888585|463503399|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
128784785|NCT04888585|463503400|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
128784786|NCT04888585|463503401|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
128784787|NCT04888585|463503402|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
128784788|NCT04888585|463503392|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
128784789|NCT04888585|463503393|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
128784790|NCT04888585|463503394|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
128784791|NCT04888585|463503395|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
128784792|NCT04888585|463503396|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
128784793|NCT04888585|463503397|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
128784794|NCT04888585|463503398|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
128784795|NCT04888585|463503399|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
128784796|NCT04888585|463503400|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
128784797|NCT04888585|463503401|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
128784798|NCT04888585|463503402|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
128784799|NCT04888585|463503392|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784800|NCT04888585|463503393|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784801|NCT04888585|463503394|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
128784802|NCT04888585|463503395|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784803|NCT04888585|463503396|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
128784804|NCT04888585|463503397|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784805|NCT04888585|463503398|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784806|NCT04888585|463503399|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784807|NCT04888585|463503400|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784808|NCT04888585|463503401|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784809|NCT04888585|463503402|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
128784810|NCT04888585|463503392|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784811|NCT04888585|463503393|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784812|NCT04888585|463503394|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784813|NCT04888585|463503395|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784814|NCT04888585|463503396|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784815|NCT04888585|463503397|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784816|NCT04888585|463503398|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784817|NCT04888585|463503399|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
128784818|NCT04888585|463503400|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784819|NCT04888585|463503401|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
128784820|NCT04888585|463503402|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
128784821|NCT04888585|463503392|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
128784822|NCT04888585|463503393|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
128784823|NCT04888585|463503394|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
128784824|NCT04888585|463503395|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
128784825|NCT04888585|463503396|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
128784826|NCT04888585|463503397|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
128784827|NCT04888585|463503398|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
128784828|NCT04888585|463503399|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
128784829|NCT04888585|463503400|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
128784830|NCT04888585|463503401|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
128784831|NCT04888585|463503402|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
128784832|NCT04888585|463503392|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
128784833|NCT04888585|463503393|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
128784834|NCT04888585|463503394|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
128784835|NCT04888585|463503395|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
128784836|NCT04888585|463503396|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
128784837|NCT04888585|463503397|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
128784838|NCT04888585|463503398|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
128784839|NCT04888585|463503399|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
128784840|NCT04888585|463503400|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
128784841|NCT04888585|463503401|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
128784842|NCT04888585|463503402|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
128784843|NCT04888585|463503392|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
128784844|NCT04888585|463503393|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
128784845|NCT04888585|463503394|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
128784846|NCT04888585|463503395|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
128784847|NCT04888585|463503396|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
128784848|NCT04888585|463503397|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
128784849|NCT04888585|463503398|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
128784850|NCT04888585|463503399|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
128784851|NCT04888585|463503400|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
128784852|NCT04888585|463503401|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
128784853|NCT04888585|463503402|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
128784854|NCT04888585|463503392|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
128784855|NCT04888585|463503393|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
128784856|NCT04888585|463503394|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
128784857|NCT04888585|463503395|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
128784858|NCT04888585|463503396|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
128784859|NCT04888585|463503397|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
128784860|NCT04888585|463503398|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
128784861|NCT04888585|463503399|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
128784862|NCT04888585|463503400|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
128784863|NCT04888585|463503401|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
128784864|NCT04888585|463503402|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
128784865|NCT01559090|463503403|FG000|Stage I|Withdrawal by Subject|2|||
128784866|NCT01559090|463503404|FG001|Stage I|Withdrawal by Subject|2|||
128784867|NCT01559090|463503405|FG002|Stage I|Withdrawal by Subject|3|||
128784868|NCT01559090|463503403|FG000|Stage II|Withdrawal by Subject|1|||
128784869|NCT01559090|463503404|FG001|Stage II|Withdrawal by Subject|0|||
128784870|NCT01559090|463503405|FG002|Stage II|Withdrawal by Subject|0|||
128784871|NCT03722446|463503406|FG000|Overall Study|Protocol Violation|15|||
128784872|NCT03722446|463503407|FG001|Overall Study|Protocol Violation|2|||
128784873|NCT02908464|463503408|FG000|Overall Study|Withdrawal by Subject|2|||
128784874|NCT02908464|463503409|FG001|Overall Study|Withdrawal by Subject|1|||
128784875|NCT02908464|463503408|FG000|Overall Study|Found ineligible after randomization|0|||
128784876|NCT02908464|463503409|FG001|Overall Study|Found ineligible after randomization|2|||
128784877|NCT00349908|463505870|FG000|Overall Study|Withdrawal by Subject|0|||
128784878|NCT00349908|463505871|FG001|Overall Study|Withdrawal by Subject|4|||
128784879|NCT04565249|463505872|FG000|Overall Study|Death|0|||
128784880|NCT04565249|463505873|FG001|Overall Study|Death|0|||
128784881|NCT04565249|463505874|FG002|Overall Study|Death|0|||
128784882|NCT04565249|463505875|FG003|Overall Study|Death|1|||
128736910|NCT02139644|463329910|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
128736911|NCT02139644|463329905|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
128784883|NCT00984282|463505876|FG000|Double Blind Treatment|Adverse Event|40|||
128784884|NCT00984282|463505877|FG001|Double Blind Treatment|Adverse Event|6|||
128784885|NCT00984282|463505876|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
128784886|NCT00984282|463505877|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
128784887|NCT00984282|463505876|FG000|Double Blind Treatment|Physician Decision|1|||
128784888|NCT00984282|463505877|FG001|Double Blind Treatment|Physician Decision|2|||
128784889|NCT00984282|463505876|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
128784890|NCT00984282|463505877|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
128784891|NCT00984282|463505876|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
128784892|NCT00984282|463505877|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
128784893|NCT00984282|463505876|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
128784894|NCT00984282|463505877|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
128784895|NCT00984282|463505876|FG000|Double Blind Treatment|Lost to Follow-up|3|||
128784896|NCT00984282|463505877|FG001|Double Blind Treatment|Lost to Follow-up|0|||
128784897|NCT00984282|463505876|FG000|Double Blind Treatment|Death|8|||
128784898|NCT00984282|463505877|FG001|Double Blind Treatment|Death|4|||
128784899|NCT00984282|463505876|FG000|Double Blind Treatment|Not treated|0|||
128736912|NCT02139644|463329906|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128736913|NCT02139644|463329907|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128736914|NCT02139644|463329908|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128736915|NCT02139644|463329909|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128784900|NCT00984282|463505877|FG001|Double Blind Treatment|Not treated|1|||
128736916|NCT02139644|463329910|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
128736917|NCT02139644|463329905|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
128736918|NCT02139644|463329906|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128736919|NCT02139644|463329907|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128736920|NCT02139644|463329908|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128736921|NCT02139644|463329909|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128736922|NCT02139644|463329910|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
128736923|NCT02139644|463329905|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
128784901|NCT00984282|463505876|FG000|Double Blind Treatment|Switched to commercial drug|6|||
128784902|NCT00984282|463505877|FG001|Double Blind Treatment|Switched to commercial drug|1|||
128784903|NCT00984282|463505876|FG000|Double Blind Treatment|protocol driven decision point|1|||
128784904|NCT00984282|463505877|FG001|Double Blind Treatment|protocol driven decision point|1|||
128784905|NCT00984282|463505876|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
128784906|NCT00984282|463505877|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
128784907|NCT00984282|463505876|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
128784908|NCT00984282|463505877|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
128784909|NCT00984282|463505876|FG000|Open-label Treatment|Adverse Event|20|||
128784910|NCT00984282|463505877|FG001|Open-label Treatment|Adverse Event|30|||
128784911|NCT00984282|463505876|FG000|Open-label Treatment|Withdrawal by Subject|6|||
128784912|NCT00984282|463505877|FG001|Open-label Treatment|Withdrawal by Subject|21|||
128784913|NCT00984282|463505876|FG000|Open-label Treatment|Death|7|||
128784914|NCT00984282|463505877|FG001|Open-label Treatment|Death|15|||
128784915|NCT00984282|463505876|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
128784916|NCT00984282|463505877|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
128784917|NCT00984282|463505876|FG000|Open-label Treatment|Lost to Follow-up|1|||
128784918|NCT00984282|463505877|FG001|Open-label Treatment|Lost to Follow-up|1|||
128784919|NCT00984282|463505876|FG000|Open-label Treatment|Patient convenience|1|||
128784920|NCT00984282|463505877|FG001|Open-label Treatment|Patient convenience|0|||
128784921|NCT00984282|463505876|FG000|Open-label Treatment|Non-compliant with study medication|1|||
128784922|NCT00984282|463505877|FG001|Open-label Treatment|Non-compliant with study medication|0|||
128784923|NCT00984282|463505876|FG000|Open-label Treatment|Target lesion removed|0|||
128736924|NCT02139644|463329906|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
128736925|NCT02139644|463329907|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
128736926|NCT02139644|463329908|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
128736927|NCT02139644|463329909|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
128736928|NCT02139644|463329910|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
128736929|NCT02139644|463329905|FG000|Run-In Period (Pre-assignment)|Other|6|||
128736930|NCT02139644|463329906|FG001|Run-In Period (Pre-assignment)|Other|0|||
128736931|NCT02139644|463329907|FG002|Run-In Period (Pre-assignment)|Other|0|||
128736932|NCT02139644|463329908|FG003|Run-In Period (Pre-assignment)|Other|0|||
128736933|NCT02139644|463329909|FG004|Run-In Period (Pre-assignment)|Other|0|||
128736934|NCT02139644|463329910|FG005|Run-In Period (Pre-assignment)|Other|0|||
128736935|NCT02139644|463329905|FG000|Treatment Period|Adverse Event|0|||
128736936|NCT02139644|463329906|FG001|Treatment Period|Adverse Event|0|||
128736937|NCT02139644|463329907|FG002|Treatment Period|Adverse Event|3|||
128736938|NCT02139644|463329908|FG003|Treatment Period|Adverse Event|2|||
128736939|NCT02139644|463329909|FG004|Treatment Period|Adverse Event|1|||
128736940|NCT02139644|463329910|FG005|Treatment Period|Adverse Event|6|||
128784924|NCT00984282|463505877|FG001|Open-label Treatment|Target lesion removed|1|||
128784925|NCT00984282|463505876|FG000|Open-label Treatment|Protocol driven decision point|1|||
128784926|NCT00984282|463505877|FG001|Open-label Treatment|Protocol driven decision point|1|||
128784927|NCT00984282|463505876|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
128784928|NCT00984282|463505877|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
128784929|NCT00984282|463505876|FG000|Open-label Treatment|Switched to commercial drug|6|||
128736941|NCT02139644|463329905|FG000|Treatment Period|Withdrawal by Subject|0|||
128736942|NCT02139644|463329906|FG001|Treatment Period|Withdrawal by Subject|0|||
128736943|NCT02139644|463329907|FG002|Treatment Period|Withdrawal by Subject|2|||
128736944|NCT02139644|463329908|FG003|Treatment Period|Withdrawal by Subject|2|||
128736945|NCT02139644|463329909|FG004|Treatment Period|Withdrawal by Subject|3|||
128736946|NCT02139644|463329910|FG005|Treatment Period|Withdrawal by Subject|2|||
128736947|NCT02139644|463329905|FG000|Treatment Period|Non-compliance|0|||
128736948|NCT02139644|463329906|FG001|Treatment Period|Non-compliance|0|||
128736949|NCT02139644|463329907|FG002|Treatment Period|Non-compliance|0|||
128736950|NCT02139644|463329908|FG003|Treatment Period|Non-compliance|1|||
128736951|NCT02139644|463329909|FG004|Treatment Period|Non-compliance|0|||
128736952|NCT02139644|463329910|FG005|Treatment Period|Non-compliance|0|||
128736953|NCT02139644|463329905|FG000|Treatment Period|Protocol Violation|0|||
128736954|NCT02139644|463329906|FG001|Treatment Period|Protocol Violation|0|||
128736955|NCT02139644|463329907|FG002|Treatment Period|Protocol Violation|0|||
128736956|NCT02139644|463329908|FG003|Treatment Period|Protocol Violation|1|||
128736957|NCT02139644|463329909|FG004|Treatment Period|Protocol Violation|1|||
128736958|NCT02139644|463329910|FG005|Treatment Period|Protocol Violation|1|||
128736959|NCT02139644|463329905|FG000|Treatment Period|Disease progression|0|||
128736960|NCT02139644|463329906|FG001|Treatment Period|Disease progression|0|||
128736961|NCT02139644|463329907|FG002|Treatment Period|Disease progression|0|||
128736962|NCT02139644|463329908|FG003|Treatment Period|Disease progression|1|||
128736963|NCT02139644|463329909|FG004|Treatment Period|Disease progression|1|||
128736964|NCT02139644|463329910|FG005|Treatment Period|Disease progression|2|||
128736965|NCT02139644|463329905|FG000|Treatment Period|Lost to Follow-up|0|||
128736966|NCT02139644|463329906|FG001|Treatment Period|Lost to Follow-up|0|||
128784930|NCT00984282|463505877|FG001|Open-label Treatment|Switched to commercial drug|7|||
128784931|NCT00984282|463505876|FG000|Open-label Treatment|Physician Decision|1|||
128736967|NCT02139644|463329907|FG002|Treatment Period|Lost to Follow-up|1|||
128736968|NCT02139644|463329908|FG003|Treatment Period|Lost to Follow-up|1|||
128736969|NCT02139644|463329909|FG004|Treatment Period|Lost to Follow-up|1|||
128736970|NCT02139644|463329910|FG005|Treatment Period|Lost to Follow-up|1|||
128736971|NCT02139644|463329905|FG000|Treatment Period|Lack of Efficacy|0|||
128736972|NCT02139644|463329906|FG001|Treatment Period|Lack of Efficacy|0|||
128736973|NCT02139644|463329907|FG002|Treatment Period|Lack of Efficacy|1|||
128736974|NCT02139644|463329908|FG003|Treatment Period|Lack of Efficacy|0|||
128736975|NCT02139644|463329909|FG004|Treatment Period|Lack of Efficacy|1|||
128736976|NCT02139644|463329910|FG005|Treatment Period|Lack of Efficacy|4|||
128736977|NCT02139644|463329905|FG000|Treatment Period|Other|0|||
128736978|NCT02139644|463329906|FG001|Treatment Period|Other|3|||
128736979|NCT02139644|463329907|FG002|Treatment Period|Other|1|||
128736980|NCT02139644|463329908|FG003|Treatment Period|Other|1|||
128736981|NCT02139644|463329909|FG004|Treatment Period|Other|0|||
128736982|NCT02139644|463329910|FG005|Treatment Period|Other|1|||
128736983|NCT03328897|463329911|FG000|Randomized-treatment Epoch|Adverse Event|4|||
128736984|NCT03328897|463329912|FG001|Randomized-treatment Epoch|Adverse Event|1|||
128736985|NCT03328897|463329913|FG002|Randomized-treatment Epoch|Adverse Event|1|||
128736986|NCT03328897|463329911|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
128736987|NCT03328897|463329912|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
128736988|NCT03328897|463329913|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
128736989|NCT03328897|463329911|FG000|Randomized-treatment Epoch|Pregnancy|3|||
128736990|NCT03328897|463329912|FG001|Randomized-treatment Epoch|Pregnancy|0|||
128736991|NCT03328897|463329913|FG002|Randomized-treatment Epoch|Pregnancy|0|||
128736992|NCT03328897|463329911|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
128736993|NCT03328897|463329912|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
128736994|NCT03328897|463329913|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
128736995|NCT03328897|463329911|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
128736996|NCT03328897|463329912|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
128736997|NCT03328897|463329913|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
128736998|NCT03328897|463329911|FG000|Follow-up Epoch|Adverse Event|4|||
128736999|NCT03328897|463329912|FG001|Follow-up Epoch|Adverse Event|0|||
128737000|NCT03328897|463329913|FG002|Follow-up Epoch|Adverse Event|1|||
128737001|NCT03328897|463329911|FG000|Follow-up Epoch|Lack of Efficacy|1|||
128737002|NCT03328897|463329912|FG001|Follow-up Epoch|Lack of Efficacy|1|||
128737003|NCT03328897|463329913|FG002|Follow-up Epoch|Lack of Efficacy|1|||
128737004|NCT03328897|463329911|FG000|Follow-up Epoch|Lost to Follow-up|0|||
128737005|NCT03328897|463329912|FG001|Follow-up Epoch|Lost to Follow-up|1|||
128737006|NCT03328897|463329913|FG002|Follow-up Epoch|Lost to Follow-up|0|||
128737007|NCT03328897|463329911|FG000|Follow-up Epoch|Pregnancy|1|||
128784932|NCT00984282|463505877|FG001|Open-label Treatment|Physician Decision|0|||
128784933|NCT00984282|463505876|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
128737008|NCT03328897|463329912|FG001|Follow-up Epoch|Pregnancy|0|||
128737009|NCT03328897|463329913|FG002|Follow-up Epoch|Pregnancy|0|||
128737010|NCT03328897|463329911|FG000|Follow-up Epoch|Patient/guardian decision|2|||
128737011|NCT03328897|463329912|FG001|Follow-up Epoch|Patient/guardian decision|1|||
128737012|NCT03328897|463329913|FG002|Follow-up Epoch|Patient/guardian decision|0|||
128737013|NCT00608829|463329915|FG000|Overall Study|Death|6|||
128784934|NCT00984282|463505877|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
128784935|NCT00984282|463505876|FG000|Long Term Follow-up|Death|27|||
128784936|NCT00984282|463505877|FG001|Long Term Follow-up|Death|68|||
128737014|NCT00608829|463329915|FG000|Overall Study|Withdrawal by Subject|4|||
128737015|NCT00608829|463329915|FG000|Overall Study|Subject refuses to follow up or return.|5|||
128737016|NCT02564471|463329918|FG000|Overall Study|Adverse Event|1|||
128737017|NCT02564471|463329919|FG001|Overall Study|Adverse Event|0|||
128737018|NCT02564471|463329920|FG002|Overall Study|Adverse Event|0|||
128737019|NCT02564471|463329921|FG003|Overall Study|Adverse Event|0|||
128737020|NCT02564471|463329918|FG000|Overall Study|Withdrawal by Subject|2|||
128737021|NCT02564471|463329919|FG001|Overall Study|Withdrawal by Subject|1|||
128737022|NCT02564471|463329920|FG002|Overall Study|Withdrawal by Subject|3|||
128737023|NCT02564471|463329921|FG003|Overall Study|Withdrawal by Subject|0|||
128737024|NCT02564471|463329918|FG000|Overall Study|Lost to Follow-up|0|||
128737025|NCT02564471|463329919|FG001|Overall Study|Lost to Follow-up|2|||
128737026|NCT02564471|463329920|FG002|Overall Study|Lost to Follow-up|0|||
128737027|NCT02564471|463329921|FG003|Overall Study|Lost to Follow-up|0|||
128737028|NCT02805257|463329922|FG000|Overall Study|Lost to Follow-up|7|||
128737029|NCT02805257|463329923|FG001|Overall Study|Lost to Follow-up|6|||
128737030|NCT02805257|463329922|FG000|Overall Study|Death|0|||
128737031|NCT02805257|463329923|FG001|Overall Study|Death|1|||
128737032|NCT02944578|463329931|FG000|Overall Study|Physician Decision|1|||
128737033|NCT02944578|463329932|FG001|Overall Study|Physician Decision|0|||
128737034|NCT02691455|463329933|FG000|Overall Study|Withdrawal by Subject|1|||
128784937|NCT00984282|463505876|FG000|Long Term Follow-up|Lost to Follow-up|3|||
128737035|NCT02691455|463329934|FG001|Overall Study|Withdrawal by Subject|2|||
128737036|NCT02691455|463329933|FG000|Overall Study|Lost to Follow-up|15|||
128737037|NCT02691455|463329934|FG001|Overall Study|Lost to Follow-up|15|||
128737038|NCT01257204|463329935|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
128737039|NCT01257204|463329936|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
128737040|NCT01257204|463329937|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
128737041|NCT01257204|463329935|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
128737042|NCT01257204|463329936|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
128737043|NCT01257204|463329937|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
128737044|NCT01257204|463329935|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
128737045|NCT01257204|463329936|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
128737046|NCT01257204|463329937|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
128737047|NCT01257204|463329935|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
128737048|NCT01257204|463329936|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
128737049|NCT01257204|463329937|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
128737050|NCT01257204|463329935|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
128737051|NCT01257204|463329936|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
128784938|NCT00984282|463505877|FG001|Long Term Follow-up|Lost to Follow-up|6|||
128784939|NCT00984282|463505876|FG000|Long Term Follow-up|Protocol driven decision point|25|||
128784940|NCT00984282|463505877|FG001|Long Term Follow-up|Protocol driven decision point|26|||
128784941|NCT00984282|463505876|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
128737052|NCT01257204|463329937|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
128737053|NCT01257204|463329935|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
128737054|NCT01257204|463329936|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
128737055|NCT01257204|463329937|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
128784942|NCT00984282|463505877|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
128784943|NCT00984282|463505876|FG000|Long Term Follow-up|Switched to commercial drug|4|||
128784944|NCT00984282|463505877|FG001|Long Term Follow-up|Switched to commercial drug|2|||
128784945|NCT00984282|463505876|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
128784946|NCT00984282|463505877|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
128784947|NCT00315055|463505878|FG000|Overall Study|Protocol Violation|2|||
128784948|NCT00315055|463505879|FG001|Overall Study|Protocol Violation|4|||
128784949|NCT00315055|463505878|FG000|Overall Study|Lost to Follow-up|1|||
128784950|NCT00315055|463505879|FG001|Overall Study|Lost to Follow-up|1|||
128784951|NCT02359435|463505880|FG000|Overall Study|Lost to Follow-up|4|||
128784952|NCT02359435|463505881|FG001|Overall Study|Lost to Follow-up|4|||
128784953|NCT01289119|463505886|FG000|Overall Study|Adverse Event|2|||
128784954|NCT01289119|463505887|FG001|Overall Study|Adverse Event|1|||
128784955|NCT01289119|463505888|FG002|Overall Study|Adverse Event|0|||
128784956|NCT01289119|463505889|FG003|Overall Study|Adverse Event|2|||
128784957|NCT01289119|463505890|FG004|Overall Study|Adverse Event|1|||
128784958|NCT01289119|463505891|FG005|Overall Study|Adverse Event|0|||
128784959|NCT01289119|463505886|FG000|Overall Study|Major Protocol Deviation|2|||
128784960|NCT01289119|463505887|FG001|Overall Study|Major Protocol Deviation|1|||
128784961|NCT01289119|463505888|FG002|Overall Study|Major Protocol Deviation|3|||
128784962|NCT01289119|463505889|FG003|Overall Study|Major Protocol Deviation|0|||
128784963|NCT01289119|463505890|FG004|Overall Study|Major Protocol Deviation|2|||
128784964|NCT01289119|463505891|FG005|Overall Study|Major Protocol Deviation|1|||
128784965|NCT01289119|463505886|FG000|Overall Study|Lost to Follow-up|0|||
128784966|NCT01289119|463505887|FG001|Overall Study|Lost to Follow-up|3|||
128784967|NCT01289119|463505888|FG002|Overall Study|Lost to Follow-up|0|||
128784968|NCT01289119|463505889|FG003|Overall Study|Lost to Follow-up|0|||
128784969|NCT01289119|463505890|FG004|Overall Study|Lost to Follow-up|0|||
128784970|NCT01289119|463505891|FG005|Overall Study|Lost to Follow-up|1|||
128784971|NCT01289119|463505886|FG000|Overall Study|Withdrawal by Subject|4|||
128784972|NCT01289119|463505887|FG001|Overall Study|Withdrawal by Subject|2|||
128784973|NCT01289119|463505888|FG002|Overall Study|Withdrawal by Subject|4|||
128784974|NCT01289119|463505889|FG003|Overall Study|Withdrawal by Subject|3|||
128784975|NCT01289119|463505890|FG004|Overall Study|Withdrawal by Subject|1|||
128784976|NCT01289119|463505891|FG005|Overall Study|Withdrawal by Subject|1|||
128784977|NCT01289119|463505886|FG000|Overall Study|Pregnancy|0|||
128784978|NCT01289119|463505887|FG001|Overall Study|Pregnancy|1|||
128784979|NCT01289119|463505888|FG002|Overall Study|Pregnancy|0|||
128784980|NCT01289119|463505889|FG003|Overall Study|Pregnancy|0|||
128784981|NCT01289119|463505890|FG004|Overall Study|Pregnancy|0|||
128784982|NCT01289119|463505891|FG005|Overall Study|Pregnancy|0|||
128784983|NCT01289119|463505886|FG000|Overall Study|Lack of Efficacy|0|||
128784984|NCT01289119|463505887|FG001|Overall Study|Lack of Efficacy|1|||
128784985|NCT01289119|463505888|FG002|Overall Study|Lack of Efficacy|1|||
128784986|NCT01289119|463505889|FG003|Overall Study|Lack of Efficacy|1|||
128784987|NCT01289119|463505890|FG004|Overall Study|Lack of Efficacy|1|||
128784988|NCT01289119|463505891|FG005|Overall Study|Lack of Efficacy|1|||
128784989|NCT01289119|463505886|FG000|Overall Study|Other|1|||
128784990|NCT01289119|463505887|FG001|Overall Study|Other|0|||
128784991|NCT01289119|463505888|FG002|Overall Study|Other|1|||
128784992|NCT01289119|463505889|FG003|Overall Study|Other|0|||
128784993|NCT01289119|463505890|FG004|Overall Study|Other|0|||
128784994|NCT01289119|463505891|FG005|Overall Study|Other|0|||
128784995|NCT01649791|463505894|FG000|Overall Study|Disease Progression|2|||
128784996|NCT01649791|463505894|FG000|Overall Study|Adverse Event|1|||
128784997|NCT00991276|463505898|FG000|First Intervention Period|Adverse Event|0|||
128784998|NCT00991276|463505899|FG001|First Intervention Period|Adverse Event|1|||
128784999|NCT00991276|463505900|FG002|First Intervention Period|Adverse Event|0|||
128785000|NCT00991276|463505901|FG003|First Intervention Period|Adverse Event|1|||
128785001|NCT00991276|463505902|FG004|First Intervention Period|Adverse Event|0|||
128785002|NCT00991276|463505903|FG005|First Intervention Period|Adverse Event|0|||
128785003|NCT00991276|463505898|FG000|First Intervention Period|Protocol Violation|0|||
128785004|NCT00991276|463505899|FG001|First Intervention Period|Protocol Violation|0|||
128785005|NCT00991276|463505900|FG002|First Intervention Period|Protocol Violation|0|||
128785006|NCT00991276|463505901|FG003|First Intervention Period|Protocol Violation|0|||
128785007|NCT00991276|463505902|FG004|First Intervention Period|Protocol Violation|2|||
128785008|NCT00991276|463505903|FG005|First Intervention Period|Protocol Violation|0|||
128785009|NCT00991276|463505898|FG000|First Intervention Period|Insufficient clinical response|0|||
128737056|NCT01257204|463329935|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
128737057|NCT01257204|463329936|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
128737058|NCT01257204|463329937|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
128737059|NCT01257204|463329935|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
128737060|NCT01257204|463329936|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
128737061|NCT01257204|463329937|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
128737062|NCT01257204|463329935|FG000|Follow-up Period (up to Week 48)|Other|0|||
128737063|NCT01257204|463329936|FG001|Follow-up Period (up to Week 48)|Other|0|||
128785010|NCT00991276|463505899|FG001|First Intervention Period|Insufficient clinical response|0|||
128737064|NCT01257204|463329937|FG002|Follow-up Period (up to Week 48)|Other|5|||
128737065|NCT01824303|463329938|FG000|Randomized Study|Withdrawal by Subject|1|||
128737066|NCT01824303|463329939|FG001|Randomized Study|Withdrawal by Subject|1|||
128737067|NCT01824303|463329938|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
128737068|NCT01824303|463329939|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
128737069|NCT00807092|463329942|FG000|Overall Study|Adverse Event|0|||
128737070|NCT00807092|463329943|FG001|Overall Study|Adverse Event|1|||
128737071|NCT00807092|463329942|FG000|Overall Study|Protocol Violation|0|||
128737072|NCT00807092|463329943|FG001|Overall Study|Protocol Violation|2|||
128737073|NCT00807092|463329942|FG000|Overall Study|Withdrawal by Subject|1|||
128737074|NCT00807092|463329943|FG001|Overall Study|Withdrawal by Subject|0|||
128737075|NCT00807092|463329942|FG000|Overall Study|CGMS data collection failed|0|||
128737076|NCT00807092|463329943|FG001|Overall Study|CGMS data collection failed|1|||
128737077|NCT04116229|463329944|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
128737078|NCT04116229|463329945|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
128737079|NCT04116229|463329944|FG000|Overall Study|Scheduling not possible.|0|||
128737080|NCT04116229|463329945|FG001|Overall Study|Scheduling not possible.|1|||
128737081|NCT04713748|463329952|FG000|Overall Study|Not enough kits allocated|35|||
128737082|NCT00113516|463329953|FG000|Part 1|Adverse Event|6|||
128737083|NCT00113516|463329954|FG001|Part 1|Adverse Event|0|||
128737084|NCT00113516|463329953|FG000|Part 1|Death|3|||
128737085|NCT00113516|463329954|FG001|Part 1|Death|0|||
128737086|NCT00113516|463329953|FG000|Part 1|Other|3|||
128737087|NCT00113516|463329954|FG001|Part 1|Other|0|||
128737088|NCT00113516|463329953|FG000|Part 1|Withdrawal by Subject|2|||
128737089|NCT00113516|463329954|FG001|Part 1|Withdrawal by Subject|0|||
128737090|NCT00113516|463329953|FG000|Part 1|Lack of Efficacy|2|||
128785011|NCT00991276|463505900|FG002|First Intervention Period|Insufficient clinical response|0|||
128785012|NCT00991276|463505901|FG003|First Intervention Period|Insufficient clinical response|0|||
128785013|NCT00991276|463505902|FG004|First Intervention Period|Insufficient clinical response|1|||
128785014|NCT00991276|463505903|FG005|First Intervention Period|Insufficient clinical response|0|||
128785015|NCT00991276|463505898|FG000|First Intervention Period|Other|0|||
128785016|NCT00991276|463505899|FG001|First Intervention Period|Other|0|||
128785017|NCT00991276|463505900|FG002|First Intervention Period|Other|0|||
128785018|NCT00991276|463505901|FG003|First Intervention Period|Other|1|||
128785019|NCT00991276|463505902|FG004|First Intervention Period|Other|1|||
128785020|NCT00991276|463505903|FG005|First Intervention Period|Other|0|||
128785021|NCT00991276|463505898|FG000|First Intervention Period|Withdrawal by Subject|0|||
128785022|NCT00991276|463505899|FG001|First Intervention Period|Withdrawal by Subject|1|||
128785023|NCT00991276|463505900|FG002|First Intervention Period|Withdrawal by Subject|0|||
128785024|NCT00991276|463505901|FG003|First Intervention Period|Withdrawal by Subject|1|||
128785025|NCT00991276|463505902|FG004|First Intervention Period|Withdrawal by Subject|0|||
128785026|NCT00991276|463505903|FG005|First Intervention Period|Withdrawal by Subject|1|||
128785027|NCT00991276|463505898|FG000|First Intervention Period|Lost to Follow-up|0|||
128737091|NCT00113516|463329954|FG001|Part 1|Lack of Efficacy|0|||
128737092|NCT00113516|463329953|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
128737093|NCT00113516|463329954|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
128737094|NCT00113516|463329953|FG000|Part 1|Laboratory Abnormality|1|||
128785028|NCT00991276|463505899|FG001|First Intervention Period|Lost to Follow-up|1|||
128737095|NCT00113516|463329954|FG001|Part 1|Laboratory Abnormality|0|||
128737096|NCT00113516|463329953|FG000|Part 1|Ongoing|1|||
128737097|NCT00113516|463329954|FG001|Part 1|Ongoing|0|||
128737098|NCT00113516|463329953|FG000|Part 1|Missing|65|||
128737099|NCT00113516|463329954|FG001|Part 1|Missing|0|||
128737100|NCT00113516|463329953|FG000|Part 2|Adverse Event|0|||
128737101|NCT00113516|463329954|FG001|Part 2|Adverse Event|16|||
128737102|NCT00113516|463329953|FG000|Part 2|Death|0|||
128737103|NCT00113516|463329954|FG001|Part 2|Death|5|||
128737104|NCT00113516|463329953|FG000|Part 2|Lack of Efficacy|0|||
128737105|NCT00113516|463329954|FG001|Part 2|Lack of Efficacy|37|||
128737106|NCT00113516|463329953|FG000|Part 2|Withdrawal by Subject|0|||
128737107|NCT00113516|463329954|FG001|Part 2|Withdrawal by Subject|3|||
128737108|NCT00113516|463329953|FG000|Part 2|Other|0|||
128737109|NCT00113516|463329954|FG001|Part 2|Other|3|||
128737110|NCT00113516|463329953|FG000|Part 2|Laboratory Abnormality|0|||
128737111|NCT00113516|463329954|FG001|Part 2|Laboratory Abnormality|1|||
128737112|NCT00113516|463329953|FG000|Part 2|Ongoing|0|||
128737113|NCT00113516|463329954|FG001|Part 2|Ongoing|1|||
128737114|NCT00642304|463329955|FG000|Overall Study|Adverse Event|1|||
128737115|NCT00642304|463329955|FG000|Overall Study|Death|1|||
128737116|NCT00642304|463329955|FG000|Overall Study|Blood transfusion|2|||
128737117|NCT00642304|463329955|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
128737118|NCT00642304|463329955|FG000|Overall Study|Transplantation|1|||
128737119|NCT02863354|463329956|FG000|Year 1|Lost to Follow-up|1|||
128737120|NCT02863354|463329957|FG001|Year 1|Lost to Follow-up|1|||
128737121|NCT02863354|463329956|FG000|Year 1|Withdrawal by Subject|3|||
128737122|NCT02863354|463329957|FG001|Year 1|Withdrawal by Subject|0|||
128737123|NCT02863354|463329956|FG000|Year 1|Death|0|||
128737124|NCT02863354|463329957|FG001|Year 1|Death|1|||
128737125|NCT02863354|463329956|FG000|Year 2|Lost to Follow-up|2|||
128737126|NCT02863354|463329957|FG001|Year 2|Lost to Follow-up|2|||
128737127|NCT03235024|463329961|FG000|Overall Study|Adverse Event|2|||
128737128|NCT03235024|463329962|FG001|Overall Study|Adverse Event|2|||
128737129|NCT03235024|463329961|FG000|Overall Study|Death|1|||
128737130|NCT03235024|463329962|FG001|Overall Study|Death|0|||
128737131|NCT03235024|463329961|FG000|Overall Study|Lost to Follow-up|2|||
128737132|NCT03235024|463329962|FG001|Overall Study|Lost to Follow-up|5|||
128737133|NCT03235024|463329961|FG000|Overall Study|Protocol Violation|1|||
128737134|NCT03235024|463329962|FG001|Overall Study|Protocol Violation|0|||
128737135|NCT03235024|463329961|FG000|Overall Study|Withdrawal by Subject|0|||
128737136|NCT03235024|463329962|FG001|Overall Study|Withdrawal by Subject|3|||
128737137|NCT00705575|463329963|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128737138|NCT00705575|463329964|FG001|Overall Study|Abnormal laboratory value(s)|3|||
128737139|NCT00705575|463329963|FG000|Overall Study|Abnormal test procedure result(s)|2|||
128737140|NCT00705575|463329964|FG001|Overall Study|Abnormal test procedure result(s)|12|||
128737141|NCT00705575|463329963|FG000|Overall Study|Adverse Event|11|||
128737142|NCT00705575|463329964|FG001|Overall Study|Adverse Event|15|||
128737143|NCT00705575|463329963|FG000|Overall Study|Lost to Follow-up|3|||
128737144|NCT00705575|463329964|FG001|Overall Study|Lost to Follow-up|4|||
128737145|NCT00705575|463329963|FG000|Overall Study|Protocol Violation|2|||
128737146|NCT00705575|463329964|FG001|Overall Study|Protocol Violation|2|||
128737147|NCT00705575|463329963|FG000|Overall Study|Withdrawal by Subject|5|||
128737148|NCT00705575|463329964|FG001|Overall Study|Withdrawal by Subject|10|||
128737149|NCT02170727|463329965|FG000|Overall Study|Lost to Follow-up|1|||
128737150|NCT02170727|463329966|FG001|Overall Study|Lost to Follow-up|0|||
128737151|NCT02170727|463329965|FG000|Overall Study|Withdrawal by Subject|2|||
128785029|NCT00991276|463505900|FG002|First Intervention Period|Lost to Follow-up|0|||
128785030|NCT00991276|463505901|FG003|First Intervention Period|Lost to Follow-up|1|||
128785031|NCT00991276|463505902|FG004|First Intervention Period|Lost to Follow-up|0|||
128785032|NCT00991276|463505903|FG005|First Intervention Period|Lost to Follow-up|0|||
128785033|NCT00991276|463505898|FG000|Second Intervention Period|Adverse Event|0|||
128785034|NCT00991276|463505899|FG001|Second Intervention Period|Adverse Event|2|||
128737152|NCT02170727|463329966|FG001|Overall Study|Withdrawal by Subject|0|||
128737153|NCT01599650|463329967|FG000|Overall Study|Administrative issue|1|||
128737154|NCT01599650|463329968|FG001|Overall Study|Administrative issue|0|||
128737155|NCT01599650|463329969|FG002|Overall Study|Administrative issue|1|||
128737156|NCT01599650|463329967|FG000|Overall Study|Physician Decision|2|||
128737157|NCT01599650|463329968|FG001|Overall Study|Physician Decision|0|||
128737158|NCT01599650|463329969|FG002|Overall Study|Physician Decision|7|||
128737159|NCT01599650|463329967|FG000|Overall Study|Protocol Violation|0|||
128737160|NCT01599650|463329968|FG001|Overall Study|Protocol Violation|3|||
128737161|NCT01599650|463329969|FG002|Overall Study|Protocol Violation|0|||
128737162|NCT01599650|463329967|FG000|Overall Study|Death|2|||
128737163|NCT01599650|463329968|FG001|Overall Study|Death|1|||
128737164|NCT01599650|463329969|FG002|Overall Study|Death|2|||
128737165|NCT01599650|463329967|FG000|Overall Study|Lost to Follow-up|3|||
128737166|NCT01599650|463329968|FG001|Overall Study|Lost to Follow-up|3|||
128737167|NCT01599650|463329969|FG002|Overall Study|Lost to Follow-up|3|||
128737168|NCT01599650|463329967|FG000|Overall Study|Withdrawal by Subject|11|||
128737169|NCT01599650|463329968|FG001|Overall Study|Withdrawal by Subject|11|||
128737170|NCT01599650|463329969|FG002|Overall Study|Withdrawal by Subject|10|||
128737171|NCT01599650|463329967|FG000|Overall Study|Adverse Event|3|||
128737172|NCT01599650|463329968|FG001|Overall Study|Adverse Event|8|||
128737173|NCT01599650|463329969|FG002|Overall Study|Adverse Event|4|||
128737174|NCT02802345|463329970|FG000|Overall Study|Not Treated|0|||
128737175|NCT02802345|463329971|FG001|Overall Study|Not Treated|1|||
128737176|NCT02802345|463329970|FG000|Overall Study|Adverse Event|28|||
128737177|NCT02802345|463329971|FG001|Overall Study|Adverse Event|20|||
128737178|NCT02802345|463329970|FG000|Overall Study|Withdrawal by Subject|3|||
128737179|NCT02802345|463329971|FG001|Overall Study|Withdrawal by Subject|3|||
128737180|NCT02802345|463329970|FG000|Overall Study|Protocol Violation|0|||
128737181|NCT02802345|463329971|FG001|Overall Study|Protocol Violation|1|||
128737182|NCT02802345|463329970|FG000|Overall Study|Other than listed|1|||
128737183|NCT02802345|463329971|FG001|Overall Study|Other than listed|5|||
128737184|NCT05857527|463329974|FG000|Overall Study|Withdrawal by Subject|0|||
128737185|NCT05857527|463329975|FG001|Overall Study|Withdrawal by Subject|1|||
128737186|NCT01748994|463329980|FG000|Overall Study|Lost to Follow-up|8|||
128737187|NCT01748994|463329981|FG001|Overall Study|Lost to Follow-up|6|||
128737188|NCT02520531|463329984|FG000|Overall Study|Revision of study device components|2|||
128737189|NCT02520531|463329985|FG001|Overall Study|Revision of study device components|2|||
128737190|NCT02520531|463329984|FG000|Overall Study|Death|1|||
128737191|NCT02520531|463329985|FG001|Overall Study|Death|2|||
128737192|NCT02520531|463329984|FG000|Overall Study|Lost to Follow-up|1|||
128737193|NCT02520531|463329985|FG001|Overall Study|Lost to Follow-up|1|||
128737194|NCT02520531|463329984|FG000|Overall Study|Meet exclusion criterion|0|||
128737195|NCT02520531|463329985|FG001|Overall Study|Meet exclusion criterion|1|||
128737196|NCT02520531|463329984|FG000|Overall Study|Withdrawal by Subject|1|||
128737197|NCT02520531|463329985|FG001|Overall Study|Withdrawal by Subject|0|||
128737198|NCT02520531|463329984|FG000|Overall Study|Not study device|1|||
128737199|NCT02520531|463329985|FG001|Overall Study|Not study device|0|||
128737200|NCT01723904|463329987|FG000|Overall Study|Noncompliant|3|||
128737201|NCT01723904|463329987|FG000|Overall Study|Adverse Event|5|||
128737202|NCT01723904|463329987|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
128737203|NCT03251924|463329988|FG000|Overall Study|Disease Progression|6|||
128737204|NCT03251924|463329989|FG001|Overall Study|Disease Progression|6|||
128737205|NCT03251924|463329990|FG002|Overall Study|Disease Progression|7|||
128737206|NCT03251924|463329991|FG003|Overall Study|Disease Progression|8|||
128737207|NCT03251924|463329992|FG004|Overall Study|Disease Progression|8|||
128737208|NCT03251924|463329993|FG005|Overall Study|Disease Progression|7|||
128737209|NCT03251924|463329994|FG006|Overall Study|Disease Progression|6|||
128737210|NCT03251924|463329995|FG007|Overall Study|Disease Progression|10|||
128737211|NCT03251924|463329996|FG008|Overall Study|Disease Progression|6|||
128737212|NCT03251924|463329988|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
128737213|NCT03251924|463329989|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
128737214|NCT03251924|463329990|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
128737215|NCT03251924|463329991|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
128737216|NCT03251924|463329992|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
128737217|NCT03251924|463329993|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
128737218|NCT03251924|463329994|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
128737219|NCT03251924|463329995|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
128737220|NCT03251924|463329996|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
128737221|NCT03251924|463329988|FG000|Overall Study|Death|0|||
128737222|NCT03251924|463329989|FG001|Overall Study|Death|1|||
128737223|NCT03251924|463329990|FG002|Overall Study|Death|0|||
128737224|NCT03251924|463329991|FG003|Overall Study|Death|1|||
128737225|NCT03251924|463329992|FG004|Overall Study|Death|1|||
128737226|NCT03251924|463329993|FG005|Overall Study|Death|1|||
128737227|NCT03251924|463329994|FG006|Overall Study|Death|0|||
128737228|NCT03251924|463329995|FG007|Overall Study|Death|0|||
128737229|NCT03251924|463329996|FG008|Overall Study|Death|0|||
128737230|NCT03251924|463329988|FG000|Overall Study|Study Drug Toxicity|0|||
128737231|NCT03251924|463329989|FG001|Overall Study|Study Drug Toxicity|0|||
128737232|NCT03251924|463329990|FG002|Overall Study|Study Drug Toxicity|0|||
128737233|NCT03251924|463329991|FG003|Overall Study|Study Drug Toxicity|1|||
128737234|NCT03251924|463329992|FG004|Overall Study|Study Drug Toxicity|0|||
128737235|NCT03251924|463329993|FG005|Overall Study|Study Drug Toxicity|0|||
128737236|NCT03251924|463329994|FG006|Overall Study|Study Drug Toxicity|0|||
128737237|NCT03251924|463329995|FG007|Overall Study|Study Drug Toxicity|0|||
128737238|NCT03251924|463329996|FG008|Overall Study|Study Drug Toxicity|1|||
128737239|NCT03251924|463329988|FG000|Overall Study|Other Reasons|0|||
128737240|NCT03251924|463329989|FG001|Overall Study|Other Reasons|0|||
128737241|NCT03251924|463329990|FG002|Overall Study|Other Reasons|0|||
128737242|NCT03251924|463329991|FG003|Overall Study|Other Reasons|0|||
128737243|NCT03251924|463329992|FG004|Overall Study|Other Reasons|0|||
128737244|NCT03251924|463329993|FG005|Overall Study|Other Reasons|0|||
128737245|NCT03251924|463329994|FG006|Overall Study|Other Reasons|0|||
128737246|NCT03251924|463329995|FG007|Overall Study|Other Reasons|0|||
128737247|NCT03251924|463329996|FG008|Overall Study|Other Reasons|1|||
128737248|NCT03251924|463329988|FG000|Overall Study|Participant request to discontinue study treatment|0|||
128737249|NCT03251924|463329989|FG001|Overall Study|Participant request to discontinue study treatment|0|||
128737250|NCT03251924|463329990|FG002|Overall Study|Participant request to discontinue study treatment|0|||
128737251|NCT03251924|463329991|FG003|Overall Study|Participant request to discontinue study treatment|0|||
128737252|NCT03251924|463329992|FG004|Overall Study|Participant request to discontinue study treatment|0|||
128737253|NCT03251924|463329993|FG005|Overall Study|Participant request to discontinue study treatment|0|||
128737254|NCT03251924|463329994|FG006|Overall Study|Participant request to discontinue study treatment|0|||
128737255|NCT03251924|463329995|FG007|Overall Study|Participant request to discontinue study treatment|1|||
128737256|NCT03251924|463329996|FG008|Overall Study|Participant request to discontinue study treatment|0|||
128737257|NCT02617589|463330005|FG000|Randomization|Request to Discontinue Study Treatment|1|||
128737258|NCT02617589|463330006|FG001|Randomization|Request to Discontinue Study Treatment|3|||
128737259|NCT02617589|463330005|FG000|Randomization|Participant Withdrew Consent|1|||
128785035|NCT00991276|463505900|FG002|Second Intervention Period|Adverse Event|0|||
128785036|NCT00991276|463505901|FG003|Second Intervention Period|Adverse Event|1|||
128785037|NCT00991276|463505902|FG004|Second Intervention Period|Adverse Event|1|||
128737260|NCT02617589|463330006|FG001|Randomization|Participant Withdrew Consent|2|||
128737261|NCT02617589|463330005|FG000|Treatment|Other Reasons|3|||
128737262|NCT02617589|463330006|FG001|Treatment|Other Reasons|3|||
128737263|NCT02617589|463330005|FG000|Treatment|Poor/Non Compliance|1|||
128785038|NCT00991276|463505903|FG005|Second Intervention Period|Adverse Event|0|||
128785039|NCT00991276|463505898|FG000|Second Intervention Period|Protocol Violation|1|||
128785040|NCT00991276|463505899|FG001|Second Intervention Period|Protocol Violation|0|||
128785041|NCT00991276|463505900|FG002|Second Intervention Period|Protocol Violation|0|||
128785042|NCT00991276|463505901|FG003|Second Intervention Period|Protocol Violation|0|||
128785043|NCT00991276|463505902|FG004|Second Intervention Period|Protocol Violation|0|||
128785044|NCT00991276|463505903|FG005|Second Intervention Period|Protocol Violation|0|||
128785045|NCT00991276|463505898|FG000|Second Intervention Period|Other|0|||
128785046|NCT00991276|463505899|FG001|Second Intervention Period|Other|0|||
128785047|NCT00991276|463505900|FG002|Second Intervention Period|Other|0|||
128785048|NCT00991276|463505901|FG003|Second Intervention Period|Other|1|||
128785049|NCT00991276|463505902|FG004|Second Intervention Period|Other|0|||
128785050|NCT00991276|463505903|FG005|Second Intervention Period|Other|1|||
128785051|NCT00991276|463505898|FG000|Third Intervention Period|Protocol Violation|1|||
128785052|NCT00991276|463505899|FG001|Third Intervention Period|Protocol Violation|0|||
128785053|NCT00991276|463505900|FG002|Third Intervention Period|Protocol Violation|0|||
128785054|NCT00991276|463505901|FG003|Third Intervention Period|Protocol Violation|0|||
128785055|NCT00991276|463505902|FG004|Third Intervention Period|Protocol Violation|0|||
128785056|NCT00991276|463505903|FG005|Third Intervention Period|Protocol Violation|0|||
128785057|NCT00991276|463505898|FG000|Third Intervention Period|Other|0|||
128785058|NCT00991276|463505899|FG001|Third Intervention Period|Other|0|||
128737264|NCT02617589|463330006|FG001|Treatment|Poor/Non Compliance|1|||
128737265|NCT02617589|463330005|FG000|Treatment|Maximum Clinical Benefit|0|||
128737266|NCT02617589|463330006|FG001|Treatment|Maximum Clinical Benefit|2|||
128737267|NCT02617589|463330005|FG000|Treatment|Participant Withdrew Consent|2|||
128737268|NCT02617589|463330006|FG001|Treatment|Participant Withdrew Consent|6|||
128737269|NCT02617589|463330005|FG000|Treatment|Participant Request to Discontinue|12|||
128737270|NCT02617589|463330006|FG001|Treatment|Participant Request to Discontinue|21|||
128737271|NCT02617589|463330005|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
128737272|NCT02617589|463330006|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
128737273|NCT02617589|463330005|FG000|Treatment|Death|1|||
128737274|NCT02617589|463330006|FG001|Treatment|Death|1|||
128737275|NCT02617589|463330005|FG000|Treatment|Study Drug Toxicity|27|||
128737276|NCT02617589|463330006|FG001|Treatment|Study Drug Toxicity|20|||
128737277|NCT02617589|463330005|FG000|Treatment|Disease Progression|216|||
128737278|NCT02617589|463330006|FG001|Treatment|Disease Progression|136|||
128737279|NCT00179647|463330007|FG000|Overall Study|Adverse Event|294|||
128737280|NCT00179647|463330007|FG000|Overall Study|Lack of Efficacy|478|||
128737281|NCT00179647|463330007|FG000|Overall Study|Withdrawal by Subject|83|||
128737282|NCT00179647|463330007|FG000|Overall Study|Lost to Follow-up|4|||
128737283|NCT00179647|463330007|FG000|Overall Study|Death|94|||
128737284|NCT00179647|463330007|FG000|Overall Study|Other|960|||
128737285|NCT02138214|463330010|FG000|Overall Study|Withdrawal by Subject|0|||
128737286|NCT02138214|463330011|FG001|Overall Study|Withdrawal by Subject|1|||
128785059|NCT00991276|463505900|FG002|Third Intervention Period|Other|0|||
128737287|NCT02138214|463330012|FG002|Overall Study|Withdrawal by Subject|0|||
128737288|NCT02138214|463330010|FG000|Overall Study|Lost to Follow-up|0|||
128737289|NCT02138214|463330011|FG001|Overall Study|Lost to Follow-up|2|||
128737290|NCT02138214|463330012|FG002|Overall Study|Lost to Follow-up|4|||
128737291|NCT02138214|463330010|FG000|Overall Study|Screen Failure|0|||
128737292|NCT02138214|463330011|FG001|Overall Study|Screen Failure|1|||
128737293|NCT02138214|463330012|FG002|Overall Study|Screen Failure|0|||
128737294|NCT02158039|463330015|FG000|Overall Study|Withdrawal by Subject|1|||
128737295|NCT02158039|463330015|FG000|Overall Study|Screen Failure|9|||
128785060|NCT00991276|463505901|FG003|Third Intervention Period|Other|0|||
128785061|NCT00991276|463505902|FG004|Third Intervention Period|Other|0|||
128785062|NCT00991276|463505903|FG005|Third Intervention Period|Other|1|||
128785063|NCT00991276|463505898|FG000|Third Intervention Period|Adverse Event|0|||
128785064|NCT00991276|463505899|FG001|Third Intervention Period|Adverse Event|0|||
128785065|NCT00991276|463505900|FG002|Third Intervention Period|Adverse Event|1|||
128785066|NCT00991276|463505901|FG003|Third Intervention Period|Adverse Event|0|||
128785067|NCT00991276|463505902|FG004|Third Intervention Period|Adverse Event|0|||
128785068|NCT00991276|463505903|FG005|Third Intervention Period|Adverse Event|0|||
128785069|NCT00991276|463505898|FG000|Third Intervention Period|Withdrawal by Subject|0|||
128785070|NCT00991276|463505899|FG001|Third Intervention Period|Withdrawal by Subject|0|||
128785071|NCT00991276|463505900|FG002|Third Intervention Period|Withdrawal by Subject|0|||
128785072|NCT00991276|463505901|FG003|Third Intervention Period|Withdrawal by Subject|1|||
128785073|NCT00991276|463505902|FG004|Third Intervention Period|Withdrawal by Subject|0|||
128785074|NCT00991276|463505903|FG005|Third Intervention Period|Withdrawal by Subject|0|||
128785075|NCT00711646|463505906|FG000|Overall Study|Adverse Event|6|||
128785076|NCT00711646|463505907|FG001|Overall Study|Adverse Event|1|||
128785077|NCT00711646|463505906|FG000|Overall Study|Withdrawal by Subject|4|||
128785078|NCT00711646|463505907|FG001|Overall Study|Withdrawal by Subject|0|||
128785079|NCT00711646|463505906|FG000|Overall Study|Protocol Violation|0|||
128785080|NCT00711646|463505907|FG001|Overall Study|Protocol Violation|1|||
128785081|NCT00711646|463505906|FG000|Overall Study|Lost to Follow-up|1|||
128785082|NCT00711646|463505907|FG001|Overall Study|Lost to Follow-up|0|||
128785083|NCT00711646|463505906|FG000|Overall Study|administrative decision|0|||
128785084|NCT00711646|463505907|FG001|Overall Study|administrative decision|1|||
128785085|NCT00711646|463505906|FG000|Overall Study|patient non-compliance|1|||
128737296|NCT03221257|463330022|FG000|Overall Study|Lost to Follow-up|0|||
128737297|NCT03221257|463330023|FG001|Overall Study|Lost to Follow-up|1|||
128737298|NCT03221257|463330022|FG000|Overall Study|Withdrawal by Subject|1|||
128737299|NCT03221257|463330023|FG001|Overall Study|Withdrawal by Subject|1|||
128737300|NCT02296112|463330033|FG000|Overall Study|Disease progression|7|||
128737301|NCT02296112|463330033|FG000|Overall Study|Toxicity|1|||
128737302|NCT02296112|463330033|FG000|Overall Study|Began an alternate therapy|1|||
128737303|NCT02442830|463330034|FG000|Overall Study|Technical Failure|0|||
128785086|NCT00711646|463505907|FG001|Overall Study|patient non-compliance|0|||
128737304|NCT02442830|463330035|FG001|Overall Study|Technical Failure|1|||
128737305|NCT01516879|463330036|FG000|Overall Study|Withdrawal by Subject|9|||
128785087|NCT03467724|463505908|FG000|Overall Study|Lost to Follow-up|5|||
128785088|NCT03467724|463505908|FG000|Overall Study|Withdrawal by Subject|1|||
128785089|NCT03467724|463505908|FG000|Overall Study|Protocol Violation|1|||
128785090|NCT03467724|463505908|FG000|Overall Study|Adverse Event|1|||
128785091|NCT02236559|463505912|FG000|Overall Study|Met Exclusion|3|||
128737306|NCT01516879|463330037|FG001|Overall Study|Withdrawal by Subject|11|||
128737307|NCT01516879|463330036|FG000|Overall Study|Death|0|||
128737308|NCT01516879|463330037|FG001|Overall Study|Death|2|||
128737309|NCT01516879|463330036|FG000|Overall Study|Lost to Follow-up|2|||
128737310|NCT01516879|463330037|FG001|Overall Study|Lost to Follow-up|11|||
128737311|NCT01516879|463330036|FG000|Overall Study|Other|5|||
128737312|NCT01516879|463330037|FG001|Overall Study|Other|10|||
128737313|NCT00183872|463330038|FG000|Overall Study|Death|3|||
128737314|NCT00183872|463330038|FG000|Overall Study|Adverse Event|9|||
128737315|NCT00183872|463330038|FG000|Overall Study|Withdrawal by Subject|2|||
128737316|NCT00183872|463330038|FG000|Overall Study|Drug delayed more than 28 days|2|||
128737317|NCT01720069|463330039|FG000|Overall Study|Could not use e-diary correctly|0|||
128737318|NCT01720069|463330040|FG001|Overall Study|Could not use e-diary correctly|1|||
128737319|NCT01720069|463330041|FG002|Overall Study|Could not use e-diary correctly|1|||
128737320|NCT01720069|463330039|FG000|Overall Study|Randomised without baseline values|0|||
128737321|NCT01720069|463330040|FG001|Overall Study|Randomised without baseline values|0|||
128737322|NCT01720069|463330041|FG002|Overall Study|Randomised without baseline values|1|||
128737323|NCT01720069|463330039|FG000|Overall Study|Adverse Event|0|||
128737324|NCT01720069|463330040|FG001|Overall Study|Adverse Event|0|||
128737325|NCT01720069|463330041|FG002|Overall Study|Adverse Event|1|||
128737326|NCT01720069|463330039|FG000|Overall Study|Lack of Efficacy|0|||
128737327|NCT01720069|463330040|FG001|Overall Study|Lack of Efficacy|4|||
128737328|NCT01720069|463330041|FG002|Overall Study|Lack of Efficacy|0|||
128737329|NCT01720069|463330039|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
128737330|NCT01720069|463330040|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
128737331|NCT01720069|463330041|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
128737332|NCT01720069|463330039|FG000|Overall Study|Withdrawal by Subject|0|||
128737333|NCT01720069|463330040|FG001|Overall Study|Withdrawal by Subject|2|||
128737334|NCT01720069|463330041|FG002|Overall Study|Withdrawal by Subject|1|||
128785092|NCT02236559|463505913|FG001|Overall Study|Met Exclusion|6|||
128785093|NCT02236559|463505912|FG000|Overall Study|Did not Meet Inclusion|3|||
128737335|NCT01720069|463330039|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
128737336|NCT01720069|463330040|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
128737337|NCT01720069|463330041|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
128737338|NCT01720069|463330039|FG000|Overall Study|Non-compliance on using e-diary|0|||
128737339|NCT01720069|463330040|FG001|Overall Study|Non-compliance on using e-diary|0|||
128737340|NCT01720069|463330041|FG002|Overall Study|Non-compliance on using e-diary|1|||
128737341|NCT01720069|463330039|FG000|Overall Study|Lost to Follow-up|0|||
128737342|NCT01720069|463330040|FG001|Overall Study|Lost to Follow-up|0|||
128737343|NCT01720069|463330041|FG002|Overall Study|Lost to Follow-up|1|||
128737344|NCT00508742|463330042|FG000|Period 1: Infant Series|Adverse Event|5|||
128737345|NCT00508742|463330043|FG001|Period 1: Infant Series|Adverse Event|4|||
128737346|NCT00508742|463330042|FG000|Period 1: Infant Series|Protocol Violation|1|||
128737347|NCT00508742|463330043|FG001|Period 1: Infant Series|Protocol Violation|0|||
128737348|NCT00508742|463330042|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
128737349|NCT00508742|463330043|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
128737350|NCT00508742|463330042|FG000|Period 1: Infant Series|Physician Decision|1|||
128737351|NCT00508742|463330043|FG001|Period 1: Infant Series|Physician Decision|0|||
128737352|NCT00508742|463330042|FG000|Period 1: Infant Series|Other|4|||
128737353|NCT00508742|463330043|FG001|Period 1: Infant Series|Other|1|||
128785094|NCT02236559|463505913|FG001|Overall Study|Did not Meet Inclusion|3|||
128785095|NCT02236559|463505912|FG000|Overall Study|Subject Did Not Consent|4|||
128785096|NCT02236559|463505913|FG001|Overall Study|Subject Did Not Consent|2|||
128785097|NCT02236559|463505912|FG000|Overall Study|Physician Decision|1|||
128737354|NCT00508742|463330042|FG000|Period 2: After Infant Series|Adverse Event|2|||
128737355|NCT00508742|463330043|FG001|Period 2: After Infant Series|Adverse Event|6|||
128737356|NCT00508742|463330042|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
128785098|NCT02236559|463505913|FG001|Overall Study|Physician Decision|1|||
128785099|NCT02236559|463505912|FG000|Overall Study|Withdrawal by Subject|1|||
128737357|NCT00508742|463330043|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
128737358|NCT00508742|463330042|FG000|Period 2: After Infant Series|Protocol Violation|1|||
128737359|NCT00508742|463330043|FG001|Period 2: After Infant Series|Protocol Violation|0|||
128737360|NCT00508742|463330042|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
128737361|NCT00508742|463330043|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
128737362|NCT00508742|463330042|FG000|Period 2: After Infant Series|Failed to Return|1|||
128737363|NCT00508742|463330043|FG001|Period 2: After Infant Series|Failed to Return|0|||
128737364|NCT00508742|463330042|FG000|Period 2: After Infant Series|Other|2|||
128737365|NCT00508742|463330043|FG001|Period 2: After Infant Series|Other|1|||
128737366|NCT00508742|463330042|FG000|Period 3: Toddler Dose|Adverse Event|1|||
128737367|NCT00508742|463330043|FG001|Period 3: Toddler Dose|Adverse Event|0|||
128737368|NCT00508742|463330042|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
128737369|NCT00508742|463330043|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
128737370|NCT00508742|463330042|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
128737371|NCT00508742|463330043|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
128737372|NCT00508742|463330042|FG000|Period 3: Toddler Dose|Other|5|||
128737373|NCT00508742|463330043|FG001|Period 3: Toddler Dose|Other|4|||
128737374|NCT04568122|463330044|FG000|Overall Study|Lost to Follow-up|48|||
128737375|NCT04568122|463330045|FG001|Overall Study|Lost to Follow-up|44|||
128737376|NCT04568122|463330046|FG002|Overall Study|Lost to Follow-up|4|||
128737377|NCT04568122|463330047|FG003|Overall Study|Lost to Follow-up|0|||
128737378|NCT04568122|463330048|FG004|Overall Study|Lost to Follow-up|0|||
128737379|NCT02797262|463330051|FG000|Overall Study|Withdrawal by Subject|5|||
128785100|NCT02236559|463505913|FG001|Overall Study|Withdrawal by Subject|0|||
128785101|NCT03721016|463505914|FG000|Overall Study|Adverse Event|0|||
128737380|NCT02797262|463330052|FG001|Overall Study|Withdrawal by Subject|1|||
128737381|NCT02797262|463330051|FG000|Overall Study|Lost to Follow-up|10|||
128737382|NCT02797262|463330052|FG001|Overall Study|Lost to Follow-up|7|||
128737383|NCT02797262|463330051|FG000|Overall Study|Death|1|||
128737384|NCT02797262|463330052|FG001|Overall Study|Death|2|||
128737385|NCT02797262|463330051|FG000|Overall Study|Adverse Event|1|||
128737386|NCT02797262|463330052|FG001|Overall Study|Adverse Event|0|||
128737387|NCT02797262|463330051|FG000|Overall Study|COVID-19|2|||
128737388|NCT02797262|463330052|FG001|Overall Study|COVID-19|1|||
128737389|NCT02797262|463330051|FG000|Overall Study|Out-of-country|1|||
128737390|NCT02797262|463330052|FG001|Overall Study|Out-of-country|0|||
128737391|NCT00983814|463330053|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
128737392|NCT00983814|463330054|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
128737393|NCT00983814|463330055|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
128737394|NCT00983814|463330053|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
128737395|NCT00983814|463330054|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
128737396|NCT00983814|463330055|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
128737397|NCT00983814|463330053|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
128737398|NCT00983814|463330054|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
128737399|NCT00983814|463330055|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
128737400|NCT00983814|463330053|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
128737401|NCT00983814|463330054|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
128737402|NCT00983814|463330055|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
128737403|NCT00983814|463330053|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
128737404|NCT00983814|463330054|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
128737405|NCT00983814|463330055|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
128737406|NCT00829621|463330056|FG000|Overall Study|Death|1|||
128737407|NCT00829621|463330057|FG001|Overall Study|Death|0|||
128737408|NCT00829621|463330056|FG000|Overall Study|Lost to Follow-up|3|||
128737409|NCT00829621|463330057|FG001|Overall Study|Lost to Follow-up|4|||
128737410|NCT00774995|463330058|FG000|Overall Study|Protocol Violation|0|||
128785102|NCT03721016|463505915|FG001|Overall Study|Adverse Event|1|||
128785103|NCT03721016|463505916|FG002|Overall Study|Adverse Event|1|||
128785104|NCT03721016|463505914|FG000|Overall Study|Withdrawal by Subject|8|||
128785105|NCT03721016|463505915|FG001|Overall Study|Withdrawal by Subject|16|||
128785106|NCT03721016|463505916|FG002|Overall Study|Withdrawal by Subject|13|||
128737411|NCT00774995|463330059|FG001|Overall Study|Protocol Violation|0|||
128737412|NCT00774995|463330060|FG002|Overall Study|Protocol Violation|1|||
128737413|NCT00774995|463330061|FG003|Overall Study|Protocol Violation|0|||
128737414|NCT00441337|463330065|FG000|Overall Study|Disease Progression|6|||
128737415|NCT00441337|463330066|FG001|Overall Study|Disease Progression|6|||
128737416|NCT00441337|463330067|FG002|Overall Study|Disease Progression|4|||
128737417|NCT00441337|463330068|FG003|Overall Study|Disease Progression|18|||
128737418|NCT00441337|463330065|FG000|Overall Study|Lost to Follow-up|0|||
128737419|NCT00441337|463330066|FG001|Overall Study|Lost to Follow-up|0|||
128737420|NCT00441337|463330067|FG002|Overall Study|Lost to Follow-up|0|||
128737421|NCT00441337|463330068|FG003|Overall Study|Lost to Follow-up|1|||
128737422|NCT00441337|463330065|FG000|Overall Study|Sponsor Decision|0|||
128737423|NCT00441337|463330066|FG001|Overall Study|Sponsor Decision|0|||
128737424|NCT00441337|463330067|FG002|Overall Study|Sponsor Decision|1|||
128737425|NCT00441337|463330068|FG003|Overall Study|Sponsor Decision|2|||
128737426|NCT00441337|463330065|FG000|Overall Study|Did not meet inclusion criteria|0|||
128737427|NCT00441337|463330066|FG001|Overall Study|Did not meet inclusion criteria|0|||
128737428|NCT00441337|463330067|FG002|Overall Study|Did not meet inclusion criteria|1|||
128737429|NCT00441337|463330068|FG003|Overall Study|Did not meet inclusion criteria|0|||
128737430|NCT06748040|463330072|FG000|Overall Study|Death|3|||
128737431|NCT06748040|463330073|FG001|Overall Study|Death|4|||
128737432|NCT06748040|463330072|FG000|Overall Study|Lost to Follow-up|134|||
128737433|NCT06748040|463330073|FG001|Overall Study|Lost to Follow-up|132|||
128737434|NCT06748040|463330072|FG000|Overall Study|Withdrawal by Subject|3|||
128737435|NCT06748040|463330073|FG001|Overall Study|Withdrawal by Subject|5|||
128737436|NCT01818336|463331632|FG000|Overall Study|Declined retest visit|0|||
128737437|NCT01818336|463331633|FG001|Overall Study|Declined retest visit|11|||
128737438|NCT01818336|463331632|FG000|Overall Study|Lost to Follow-up|0|||
128737439|NCT01818336|463331633|FG001|Overall Study|Lost to Follow-up|1|||
128737440|NCT02033889|463331637|FG000|Overall Study|Adverse Event|3|||
128737441|NCT02033889|463331638|FG001|Overall Study|Adverse Event|1|||
128737442|NCT02033889|463331639|FG002|Overall Study|Adverse Event|3|||
128737443|NCT02033889|463331637|FG000|Overall Study|Death|3|||
128737444|NCT02033889|463331638|FG001|Overall Study|Death|1|||
128737445|NCT02033889|463331639|FG002|Overall Study|Death|2|||
128785107|NCT03721016|463505914|FG000|Overall Study|Lost to Follow-up|4|||
128785108|NCT03721016|463505915|FG001|Overall Study|Lost to Follow-up|6|||
128785109|NCT03721016|463505916|FG002|Overall Study|Lost to Follow-up|5|||
128737446|NCT02033889|463331637|FG000|Overall Study|Excluded Medication|1|||
128737447|NCT02033889|463331638|FG001|Overall Study|Excluded Medication|1|||
128737448|NCT02033889|463331639|FG002|Overall Study|Excluded Medication|0|||
128737449|NCT02033889|463331637|FG000|Overall Study|Lost to Follow-up|8|||
128737450|NCT02033889|463331638|FG001|Overall Study|Lost to Follow-up|5|||
128737451|NCT02033889|463331639|FG002|Overall Study|Lost to Follow-up|6|||
128737452|NCT02033889|463331637|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128737453|NCT02033889|463331638|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128737454|NCT02033889|463331639|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128737455|NCT02033889|463331637|FG000|Overall Study|Physician Decision|0|||
128737456|NCT02033889|463331638|FG001|Overall Study|Physician Decision|1|||
128737457|NCT02033889|463331639|FG002|Overall Study|Physician Decision|1|||
128737458|NCT02033889|463331637|FG000|Overall Study|Participant moved|0|||
128737459|NCT02033889|463331638|FG001|Overall Study|Participant moved|1|||
128737460|NCT02033889|463331639|FG002|Overall Study|Participant moved|0|||
128737461|NCT02033889|463331637|FG000|Overall Study|Withdrawal by Subject|18|||
128737462|NCT02033889|463331638|FG001|Overall Study|Withdrawal by Subject|10|||
128737463|NCT02033889|463331639|FG002|Overall Study|Withdrawal by Subject|13|||
128737464|NCT03143829|463331640|FG000|Overall Study|Withdrawal by Subject|2|||
128737465|NCT03143829|463331641|FG001|Overall Study|Withdrawal by Subject|5|||
128737466|NCT03143829|463331640|FG000|Overall Study|Lost to Follow-up|0|||
128737467|NCT03143829|463331641|FG001|Overall Study|Lost to Follow-up|2|||
128737468|NCT03143829|463331640|FG000|Overall Study|Death|1|||
128737469|NCT03143829|463331641|FG001|Overall Study|Death|1|||
128737470|NCT03143829|463331640|FG000|Overall Study|changed treatment, no longer eligible|2|||
128737471|NCT03143829|463331641|FG001|Overall Study|changed treatment, no longer eligible|2|||
128737472|NCT01639001|463331643|FG000|Overall Study|Refused further follow-up|9|||
128737473|NCT01639001|463331644|FG001|Overall Study|Refused further follow-up|12|||
128737474|NCT01639001|463331643|FG000|Overall Study|Lost to Follow-up|3|||
128737475|NCT01639001|463331644|FG001|Overall Study|Lost to Follow-up|0|||
128737476|NCT01639001|463331643|FG000|Overall Study|Death|62|||
128737477|NCT01639001|463331644|FG001|Overall Study|Death|61|||
128737478|NCT01639001|463331643|FG000|Overall Study|Randomized but not treated|0|||
128737479|NCT01639001|463331644|FG001|Overall Study|Randomized but not treated|2|||
128737480|NCT01639001|463331643|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
128737481|NCT01639001|463331644|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
128737482|NCT02886572|463331645|FG000|Overall Study|Death|8|||
128737483|NCT01969838|463331646|FG000|Double-blind Phase|Adverse Event|10|||
128737484|NCT01969838|463331647|FG001|Double-blind Phase|Adverse Event|4|||
128737485|NCT01969838|463331648|FG002|Double-blind Phase|Adverse Event|0|||
128737486|NCT01969838|463331649|FG003|Double-blind Phase|Adverse Event|0|||
128737487|NCT01969838|463331646|FG000|Double-blind Phase|Death|5|||
128737488|NCT01969838|463331647|FG001|Double-blind Phase|Death|2|||
128737489|NCT01969838|463331648|FG002|Double-blind Phase|Death|0|||
128737490|NCT01969838|463331649|FG003|Double-blind Phase|Death|0|||
128737491|NCT01969838|463331646|FG000|Double-blind Phase|Physician Decision|5|||
128737492|NCT01969838|463331647|FG001|Double-blind Phase|Physician Decision|1|||
128737493|NCT01969838|463331648|FG002|Double-blind Phase|Physician Decision|0|||
128737494|NCT01969838|463331649|FG003|Double-blind Phase|Physician Decision|0|||
128737495|NCT01969838|463331646|FG000|Double-blind Phase|Subject Decision|4|||
128737496|NCT01969838|463331647|FG001|Double-blind Phase|Subject Decision|2|||
128737497|NCT01969838|463331648|FG002|Double-blind Phase|Subject Decision|0|||
128737498|NCT01969838|463331649|FG003|Double-blind Phase|Subject Decision|0|||
128737499|NCT01969838|463331646|FG000|Double-blind Phase|Disease Progression|2|||
128737500|NCT01969838|463331647|FG001|Double-blind Phase|Disease Progression|0|||
128737501|NCT01969838|463331648|FG002|Double-blind Phase|Disease Progression|0|||
128737502|NCT01969838|463331649|FG003|Double-blind Phase|Disease Progression|0|||
128737503|NCT01969838|463331646|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
128737504|NCT01969838|463331647|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
128737505|NCT01969838|463331648|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
128737506|NCT01969838|463331649|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
128737507|NCT01969838|463331646|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
128737508|NCT01969838|463331647|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
128737509|NCT01969838|463331648|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
128737510|NCT01969838|463331649|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
128737511|NCT01969838|463331646|FG000|Open-label Phase|Adverse Event|0|||
128737512|NCT01969838|463331647|FG001|Open-label Phase|Adverse Event|0|||
128737513|NCT01969838|463331648|FG002|Open-label Phase|Adverse Event|37|||
128737514|NCT01969838|463331649|FG003|Open-label Phase|Adverse Event|49|||
128737515|NCT01969838|463331646|FG000|Open-label Phase|Disease Progression|0|||
128737516|NCT01969838|463331647|FG001|Open-label Phase|Disease Progression|0|||
128737517|NCT01969838|463331648|FG002|Open-label Phase|Disease Progression|26|||
128737518|NCT01969838|463331649|FG003|Open-label Phase|Disease Progression|27|||
128737519|NCT01969838|463331646|FG000|Open-label Phase|Lack of Efficacy|0|||
128737520|NCT01969838|463331647|FG001|Open-label Phase|Lack of Efficacy|0|||
128785110|NCT03721016|463505914|FG000|Overall Study|Physician Decision|0|||
128785111|NCT03721016|463505915|FG001|Overall Study|Physician Decision|1|||
128737521|NCT01969838|463331648|FG002|Open-label Phase|Lack of Efficacy|17|||
128785112|NCT03721016|463505916|FG002|Overall Study|Physician Decision|2|||
128737522|NCT01969838|463331649|FG003|Open-label Phase|Lack of Efficacy|19|||
128737523|NCT01969838|463331646|FG000|Open-label Phase|Subject Decision|0|||
128737524|NCT01969838|463331647|FG001|Open-label Phase|Subject Decision|0|||
128737525|NCT01969838|463331648|FG002|Open-label Phase|Subject Decision|14|||
128737526|NCT01969838|463331649|FG003|Open-label Phase|Subject Decision|15|||
128737527|NCT01969838|463331646|FG000|Open-label Phase|Death|0|||
128737528|NCT01969838|463331647|FG001|Open-label Phase|Death|0|||
128785113|NCT03721016|463505914|FG000|Overall Study|Protocol Violation|0|||
128737529|NCT01969838|463331648|FG002|Open-label Phase|Death|13|||
128737530|NCT01969838|463331649|FG003|Open-label Phase|Death|11|||
128737531|NCT01969838|463331646|FG000|Open-label Phase|Physician Decision|0|||
128737532|NCT01969838|463331647|FG001|Open-label Phase|Physician Decision|0|||
128737533|NCT01969838|463331648|FG002|Open-label Phase|Physician Decision|9|||
128737534|NCT01969838|463331649|FG003|Open-label Phase|Physician Decision|14|||
128737535|NCT01969838|463331646|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
128737536|NCT01969838|463331647|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
128785114|NCT03721016|463505915|FG001|Overall Study|Protocol Violation|1|||
128785115|NCT03721016|463505916|FG002|Overall Study|Protocol Violation|0|||
128785116|NCT03721016|463505914|FG000|Overall Study|Site terminated by sponsor|3|||
128785117|NCT03721016|463505915|FG001|Overall Study|Site terminated by sponsor|7|||
128785118|NCT03721016|463505916|FG002|Overall Study|Site terminated by sponsor|6|||
128785119|NCT03721016|463505914|FG000|Overall Study|Subject exited early due to COVID-19|1|||
128785120|NCT03721016|463505915|FG001|Overall Study|Subject exited early due to COVID-19|0|||
128785121|NCT03721016|463505916|FG002|Overall Study|Subject exited early due to COVID-19|0|||
128785122|NCT02232178|463505919|FG000|Overall Study|Lost to Follow-up|0|||
128785123|NCT02232178|463505920|FG001|Overall Study|Lost to Follow-up|1|||
128785124|NCT02232178|463505921|FG002|Overall Study|Lost to Follow-up|0|||
128785125|NCT02232178|463505919|FG000|Overall Study|ineligibility|0|||
128785126|NCT02232178|463505920|FG001|Overall Study|ineligibility|0|||
128785127|NCT02232178|463505921|FG002|Overall Study|ineligibility|1|||
128785128|NCT02232178|463505919|FG000|Overall Study|surgical complication|1|||
128737537|NCT01969838|463331648|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
128785129|NCT02232178|463505920|FG001|Overall Study|surgical complication|0|||
128737538|NCT01969838|463331649|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
128737539|NCT03087591|463331650|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
128785130|NCT02232178|463505921|FG002|Overall Study|surgical complication|0|||
128785131|NCT00817635|463505922|FG000|Overall Study|Adverse Event|1|||
128785132|NCT00817635|463505923|FG001|Overall Study|Adverse Event|0|||
128785133|NCT00817635|463505924|FG002|Overall Study|Adverse Event|0|||
128737540|NCT03087591|463331650|FG000|Overall Study|Withdrawal by Subject|1|||
128737541|NCT00408993|463331653|FG000|Overall Study|Adverse Event|15|||
128737542|NCT00408993|463331654|FG001|Overall Study|Adverse Event|4|||
128737543|NCT00408993|463331653|FG000|Overall Study|Protocol Violation|1|||
128737544|NCT00408993|463331654|FG001|Overall Study|Protocol Violation|6|||
128737545|NCT00408993|463331653|FG000|Overall Study|Lack of Efficacy|1|||
128737546|NCT00408993|463331654|FG001|Overall Study|Lack of Efficacy|4|||
128737547|NCT00408993|463331653|FG000|Overall Study|Withdrawal by Subject|2|||
128737548|NCT00408993|463331654|FG001|Overall Study|Withdrawal by Subject|3|||
128737549|NCT03738865|463331657|FG000|Overall Study|Withdrawal by Subject|3|||
128737550|NCT03738865|463331658|FG001|Overall Study|Withdrawal by Subject|3|||
128737551|NCT03738865|463331657|FG000|Overall Study|Adverse Event|2|||
128737552|NCT03738865|463331658|FG001|Overall Study|Adverse Event|0|||
128737553|NCT03738865|463331657|FG000|Overall Study|Physician Decision|0|||
128737554|NCT03738865|463331658|FG001|Overall Study|Physician Decision|1|||
128737555|NCT02621606|463331659|FG000|Overall Study|Withdrawal by Subject|0|||
128737556|NCT02621606|463331660|FG001|Overall Study|Withdrawal by Subject|1|||
128737557|NCT02621606|463331661|FG002|Overall Study|Withdrawal by Subject|0|||
128737558|NCT00274716|463331662|FG000|Phase A|Other non-reported reason|4|||
128737559|NCT00274716|463331663|FG001|Phase A|Other non-reported reason|2|||
128737560|NCT00274716|463331664|FG002|Phase A|Other non-reported reason|1|||
128737561|NCT00274716|463331665|FG003|Phase A|Other non-reported reason|2|||
128737562|NCT00274716|463331666|FG004|Phase A|Other non-reported reason|0|||
128737563|NCT00274716|463331667|FG005|Phase A|Other non-reported reason|1|||
128737564|NCT00274716|463331662|FG000|Phase A|Participant moved|0|||
128737565|NCT00274716|463331663|FG001|Phase A|Participant moved|0|||
128737566|NCT00274716|463331664|FG002|Phase A|Participant moved|1|||
128737567|NCT00274716|463331665|FG003|Phase A|Participant moved|0|||
128737568|NCT00274716|463331666|FG004|Phase A|Participant moved|0|||
128737569|NCT00274716|463331667|FG005|Phase A|Participant moved|1|||
128737570|NCT00274716|463331662|FG000|Phase A|Site Terminated|0|||
128737571|NCT00274716|463331663|FG001|Phase A|Site Terminated|0|||
128737572|NCT00274716|463331664|FG002|Phase A|Site Terminated|0|||
128737573|NCT00274716|463331665|FG003|Phase A|Site Terminated|1|||
128737574|NCT00274716|463331666|FG004|Phase A|Site Terminated|0|||
128737575|NCT00274716|463331667|FG005|Phase A|Site Terminated|0|||
128737576|NCT00274716|463331662|FG000|Phase A|Protocol Violation|1|||
128737577|NCT00274716|463331663|FG001|Phase A|Protocol Violation|0|||
128737578|NCT00274716|463331664|FG002|Phase A|Protocol Violation|0|||
128737579|NCT00274716|463331665|FG003|Phase A|Protocol Violation|1|||
128737580|NCT00274716|463331666|FG004|Phase A|Protocol Violation|0|||
128737581|NCT00274716|463331667|FG005|Phase A|Protocol Violation|0|||
128737582|NCT00274716|463331662|FG000|Phase A|Met criteria for discontinuation|1|||
128737583|NCT00274716|463331663|FG001|Phase A|Met criteria for discontinuation|1|||
128737584|NCT00274716|463331664|FG002|Phase A|Met criteria for discontinuation|0|||
128737585|NCT00274716|463331665|FG003|Phase A|Met criteria for discontinuation|0|||
128737586|NCT00274716|463331666|FG004|Phase A|Met criteria for discontinuation|0|||
128785134|NCT00817635|463505925|FG003|Overall Study|Adverse Event|1|||
128737587|NCT00274716|463331667|FG005|Phase A|Met criteria for discontinuation|0|||
128737588|NCT00274716|463331662|FG000|Phase A|Withdrawal by Subject|2|||
128737589|NCT00274716|463331663|FG001|Phase A|Withdrawal by Subject|2|||
128737590|NCT00274716|463331664|FG002|Phase A|Withdrawal by Subject|1|||
128737591|NCT00274716|463331665|FG003|Phase A|Withdrawal by Subject|3|||
128737592|NCT00274716|463331666|FG004|Phase A|Withdrawal by Subject|0|||
128737593|NCT00274716|463331667|FG005|Phase A|Withdrawal by Subject|1|||
128737594|NCT00274716|463331662|FG000|Phase A|Adverse Event|2|||
128737595|NCT00274716|463331663|FG001|Phase A|Adverse Event|3|||
128737596|NCT00274716|463331664|FG002|Phase A|Adverse Event|3|||
128737597|NCT00274716|463331665|FG003|Phase A|Adverse Event|0|||
128737598|NCT00274716|463331666|FG004|Phase A|Adverse Event|2|||
128737599|NCT00274716|463331667|FG005|Phase A|Adverse Event|0|||
128737600|NCT00274716|463331662|FG000|Phase A|Completed but did not enter Phase B|1|||
128737601|NCT00274716|463331663|FG001|Phase A|Completed but did not enter Phase B|2|||
128737602|NCT00274716|463331664|FG002|Phase A|Completed but did not enter Phase B|2|||
128737603|NCT00274716|463331665|FG003|Phase A|Completed but did not enter Phase B|2|||
128737604|NCT00274716|463331666|FG004|Phase A|Completed but did not enter Phase B|1|||
128737605|NCT00274716|463331667|FG005|Phase A|Completed but did not enter Phase B|1|||
128737606|NCT00274716|463331662|FG000|Phase B|Adverse Event|0|||
128737607|NCT00274716|463331663|FG001|Phase B|Adverse Event|0|||
128737608|NCT00274716|463331664|FG002|Phase B|Adverse Event|2|||
128737609|NCT00274716|463331665|FG003|Phase B|Adverse Event|0|||
128737610|NCT00274716|463331666|FG004|Phase B|Adverse Event|0|||
128737611|NCT00274716|463331667|FG005|Phase B|Adverse Event|1|||
128737612|NCT00274716|463331662|FG000|Phase B|Protocol Violation|0|||
128737613|NCT00274716|463331663|FG001|Phase B|Protocol Violation|2|||
128737614|NCT00274716|463331664|FG002|Phase B|Protocol Violation|0|||
128737615|NCT00274716|463331665|FG003|Phase B|Protocol Violation|0|||
128737616|NCT00274716|463331666|FG004|Phase B|Protocol Violation|0|||
128737617|NCT00274716|463331667|FG005|Phase B|Protocol Violation|0|||
128737618|NCT00274716|463331662|FG000|Phase B|Withdrawal by Subject|0|||
128737619|NCT00274716|463331663|FG001|Phase B|Withdrawal by Subject|1|||
128737620|NCT00274716|463331664|FG002|Phase B|Withdrawal by Subject|0|||
128737621|NCT00274716|463331665|FG003|Phase B|Withdrawal by Subject|0|||
128737622|NCT00274716|463331666|FG004|Phase B|Withdrawal by Subject|0|||
128737623|NCT00274716|463331667|FG005|Phase B|Withdrawal by Subject|0|||
128737624|NCT00274716|463331662|FG000|Phase B|Participant moved|1|||
128737625|NCT00274716|463331663|FG001|Phase B|Participant moved|0|||
128737626|NCT00274716|463331664|FG002|Phase B|Participant moved|0|||
128737627|NCT00274716|463331665|FG003|Phase B|Participant moved|0|||
128737628|NCT00274716|463331666|FG004|Phase B|Participant moved|0|||
128737629|NCT00274716|463331667|FG005|Phase B|Participant moved|0|||
128737630|NCT00274716|463331662|FG000|Phase B|Other non-reported reason|0|||
128737631|NCT00274716|463331663|FG001|Phase B|Other non-reported reason|0|||
128737632|NCT00274716|463331664|FG002|Phase B|Other non-reported reason|1|||
128737633|NCT00274716|463331665|FG003|Phase B|Other non-reported reason|1|||
128737634|NCT00274716|463331666|FG004|Phase B|Other non-reported reason|0|||
128737635|NCT00274716|463331667|FG005|Phase B|Other non-reported reason|0|||
128737636|NCT00274716|463331662|FG000|Phase B|Lost to Follow-up|0|||
128737637|NCT00274716|463331663|FG001|Phase B|Lost to Follow-up|1|||
128737638|NCT00274716|463331664|FG002|Phase B|Lost to Follow-up|0|||
128737639|NCT00274716|463331665|FG003|Phase B|Lost to Follow-up|0|||
128737640|NCT00274716|463331666|FG004|Phase B|Lost to Follow-up|0|||
128737641|NCT00274716|463331667|FG005|Phase B|Lost to Follow-up|0|||
128737642|NCT00982319|463331670|FG000|Overall Study|Surgery date change|1|||
128737643|NCT00982319|463331671|FG001|Overall Study|Surgery date change|0|||
128737644|NCT00982319|463331670|FG000|Overall Study|Preop values out of acceptable range|1|||
128737645|NCT00982319|463331671|FG001|Overall Study|Preop values out of acceptable range|1|||
128737646|NCT00982319|463331670|FG000|Overall Study|Pregnancy|0|||
128737647|NCT00982319|463331671|FG001|Overall Study|Pregnancy|1|||
128737648|NCT00961259|463331672|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
128737649|NCT00961259|463331673|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
128737650|NCT00961259|463331674|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
128737651|NCT01252251|463331675|FG000|Overall Study|Withdrawal by Subject|1|||
128737652|NCT01324024|463331676|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
128737653|NCT01324024|463331677|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
128737654|NCT01923181|463331678|FG000|Overall Study|Protocol Violation|2|||
128737655|NCT01923181|463331679|FG001|Overall Study|Protocol Violation|2|||
128737656|NCT01923181|463331680|FG002|Overall Study|Protocol Violation|0|||
128737657|NCT01923181|463331681|FG003|Overall Study|Protocol Violation|2|||
128737658|NCT01923181|463331682|FG004|Overall Study|Protocol Violation|2|||
128737659|NCT01923181|463331683|FG005|Overall Study|Protocol Violation|1|||
128737660|NCT01923181|463331684|FG006|Overall Study|Protocol Violation|1|||
128737661|NCT01923181|463331685|FG007|Overall Study|Protocol Violation|2|||
128737662|NCT01923181|463331686|FG008|Overall Study|Protocol Violation|1|||
128737663|NCT01923181|463331678|FG000|Overall Study|Withdrawal by Subject|0|||
128737664|NCT01923181|463331679|FG001|Overall Study|Withdrawal by Subject|1|||
128737665|NCT01923181|463331680|FG002|Overall Study|Withdrawal by Subject|0|||
128737666|NCT01923181|463331681|FG003|Overall Study|Withdrawal by Subject|1|||
128737667|NCT01923181|463331682|FG004|Overall Study|Withdrawal by Subject|4|||
128737668|NCT01923181|463331683|FG005|Overall Study|Withdrawal by Subject|2|||
128737669|NCT01923181|463331684|FG006|Overall Study|Withdrawal by Subject|4|||
128737670|NCT01923181|463331685|FG007|Overall Study|Withdrawal by Subject|3|||
128737671|NCT01923181|463331686|FG008|Overall Study|Withdrawal by Subject|1|||
128737672|NCT01923181|463331678|FG000|Overall Study|Other|1|||
128737673|NCT01923181|463331679|FG001|Overall Study|Other|0|||
128737674|NCT01923181|463331680|FG002|Overall Study|Other|0|||
128737675|NCT01923181|463331681|FG003|Overall Study|Other|1|||
128737676|NCT01923181|463331682|FG004|Overall Study|Other|0|||
128737677|NCT01923181|463331683|FG005|Overall Study|Other|0|||
128737678|NCT01923181|463331684|FG006|Overall Study|Other|0|||
128737679|NCT01923181|463331685|FG007|Overall Study|Other|0|||
128737680|NCT01923181|463331686|FG008|Overall Study|Other|0|||
128737681|NCT01923181|463331678|FG000|Overall Study|Lost to Follow-up|0|||
128737682|NCT01923181|463331679|FG001|Overall Study|Lost to Follow-up|3|||
128737683|NCT01923181|463331680|FG002|Overall Study|Lost to Follow-up|2|||
128737684|NCT01923181|463331681|FG003|Overall Study|Lost to Follow-up|1|||
128737685|NCT01923181|463331682|FG004|Overall Study|Lost to Follow-up|2|||
128737686|NCT01923181|463331683|FG005|Overall Study|Lost to Follow-up|1|||
128737687|NCT01923181|463331684|FG006|Overall Study|Lost to Follow-up|3|||
128737688|NCT01923181|463331685|FG007|Overall Study|Lost to Follow-up|3|||
128737689|NCT01923181|463331686|FG008|Overall Study|Lost to Follow-up|1|||
128737690|NCT01863446|463331688|FG000|Overall Study|Withdrawal by Subject|1|||
128737691|NCT01863446|463331689|FG001|Overall Study|Withdrawal by Subject|0|||
128737692|NCT01863446|463331690|FG002|Overall Study|Withdrawal by Subject|1|||
128737693|NCT01863446|463331691|FG003|Overall Study|Withdrawal by Subject|2|||
128737694|NCT01863446|463331688|FG000|Overall Study|Physician Decision|0|||
128737695|NCT01863446|463331689|FG001|Overall Study|Physician Decision|0|||
128737696|NCT01863446|463331690|FG002|Overall Study|Physician Decision|1|||
128737697|NCT01863446|463331691|FG003|Overall Study|Physician Decision|0|||
128737698|NCT02840877|463331692|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
128737699|NCT02840877|463331692|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
128737700|NCT02840877|463331692|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
128737701|NCT02840877|463331692|FG000|Baseline to 12 Weeks|Death|1|||
128737702|NCT02840877|463331692|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
128737703|NCT02840877|463331692|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
128737704|NCT02840877|463331692|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
128737705|NCT02840877|463331692|FG000|12 Weeks to 6 Months|Treatment failure|1|||
128737706|NCT02840877|463331692|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
128737707|NCT02840877|463331692|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
128737708|NCT02840877|463331692|FG000|12 Weeks to 6 Months|Death|1|||
128737709|NCT02840877|463331692|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
128737710|NCT02840877|463331692|FG000|6 Months to 18 Months|Treatment failure|7|||
128737711|NCT02840877|463331692|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
128737712|NCT02840877|463331692|FG000|6 Months to 18 Months|Moved/transferred out|6|||
128737713|NCT02840877|463331692|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
128737714|NCT02840877|463331692|FG000|6 Months to 18 Months|Death|4|||
128737715|NCT02840877|463331692|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
128737716|NCT02840877|463331692|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
128737717|NCT02840877|463331692|FG000|6 Months to 18 Months|Still in study.|14|||
128737718|NCT01276327|463331695|FG000|Overall Study|Adverse Event|1|||
128737719|NCT01276327|463331696|FG001|Overall Study|Adverse Event|3|||
128737720|NCT01276327|463331695|FG000|Overall Study|Withdrawal by Subject|1|||
128737721|NCT01276327|463331696|FG001|Overall Study|Withdrawal by Subject|0|||
128737722|NCT01794949|463331697|FG000|Overall Study|Lost to Follow-up|1|||
128737723|NCT01794949|463331698|FG001|Overall Study|Lost to Follow-up|0|||
128737724|NCT03003676|463331699|FG000|Overall Study|Lack of Efficacy|5|||
128737725|NCT03003676|463331700|FG001|Overall Study|Lack of Efficacy|7|||
128737726|NCT03003676|463331699|FG000|Overall Study|Withdrawal by Subject|0|||
128737727|NCT03003676|463331700|FG001|Overall Study|Withdrawal by Subject|1|||
128737728|NCT03003676|463331699|FG000|Overall Study|Hepatitis B infection|1|||
128737729|NCT03003676|463331700|FG001|Overall Study|Hepatitis B infection|0|||
128737730|NCT03766646|463331701|FG000|Overall Study|Withdrawal by Subject|1|||
128737731|NCT03766646|463331702|FG001|Overall Study|Withdrawal by Subject|0|||
128737732|NCT03766646|463331701|FG000|Overall Study|Protocol Violation|0|||
128737733|NCT03766646|463331702|FG001|Overall Study|Protocol Violation|3|||
128737734|NCT01243944|463331725|FG000|Overall Study|Adverse Event|15|||
128737735|NCT01243944|463331726|FG001|Overall Study|Adverse Event|13|||
128737736|NCT01243944|463331725|FG000|Overall Study|Lost to Follow-up|2|||
128737737|NCT01243944|463331726|FG001|Overall Study|Lost to Follow-up|1|||
128737738|NCT01243944|463331725|FG000|Overall Study|Physician Decision|2|||
128737739|NCT01243944|463331726|FG001|Overall Study|Physician Decision|7|||
128737740|NCT01243944|463331725|FG000|Overall Study|Disease progression|12|||
128737741|NCT01243944|463331726|FG001|Overall Study|Disease progression|11|||
128785135|NCT00817635|463505926|FG004|Overall Study|Adverse Event|1|||
128737742|NCT01243944|463331725|FG000|Overall Study|Protocol deviation|1|||
128737743|NCT01243944|463331726|FG001|Overall Study|Protocol deviation|1|||
128737744|NCT01243944|463331725|FG000|Overall Study|Participant decision|10|||
128737745|NCT01243944|463331726|FG001|Overall Study|Participant decision|15|||
128737746|NCT01243944|463331725|FG000|Overall Study|Death|2|||
128737747|NCT01243944|463331726|FG001|Overall Study|Death|3|||
128737748|NCT01243944|463331725|FG000|Overall Study|Non-compliance with study treatment|1|||
128737749|NCT01243944|463331726|FG001|Overall Study|Non-compliance with study treatment|0|||
128737750|NCT01416805|463331727|FG000|Overall Study|Lost to Follow-up|4|||
128737751|NCT01416805|463331728|FG001|Overall Study|Lost to Follow-up|4|||
128737752|NCT04632940|463331729|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
128785136|NCT00817635|463505922|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
128737753|NCT04632940|463331730|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
128737754|NCT04632940|463331729|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
128737755|NCT04632940|463331730|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
128737756|NCT04632940|463331729|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
128737757|NCT04632940|463331730|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
128737758|NCT04632940|463331729|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
128737759|NCT04632940|463331730|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
128737760|NCT04632940|463331729|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
128737761|NCT04632940|463331730|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
128737762|NCT04632940|463331729|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
128737763|NCT04632940|463331730|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
128737764|NCT04632940|463331729|FG000|OLE Period (52 Weeks)|Other than specified|0|||
128737765|NCT04632940|463331730|FG001|OLE Period (52 Weeks)|Other than specified|1|||
128737766|NCT04632940|463331729|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
128737767|NCT04632940|463331730|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
128737768|NCT00153101|463331733|FG000|Overall Study|Lost to Follow-up|14|||
128737769|NCT00153101|463331734|FG001|Overall Study|Lost to Follow-up|14|||
128737770|NCT00153101|463331735|FG002|Overall Study|Lost to Follow-up|12|||
128737771|NCT00153101|463331736|FG003|Overall Study|Lost to Follow-up|5|||
128737772|NCT00153101|463331737|FG004|Overall Study|Lost to Follow-up|5|||
128737773|NCT00153101|463331733|FG000|Overall Study|Withdrawal by Subject|3|||
128737774|NCT00153101|463331734|FG001|Overall Study|Withdrawal by Subject|4|||
128737775|NCT00153101|463331735|FG002|Overall Study|Withdrawal by Subject|3|||
128737776|NCT00153101|463331736|FG003|Overall Study|Withdrawal by Subject|3|||
128737777|NCT00153101|463331737|FG004|Overall Study|Withdrawal by Subject|5|||
128737778|NCT02610140|463331738|FG000|Randomization and Treatment Period|Radiological progression|23|||
128737779|NCT02610140|463331739|FG001|Randomization and Treatment Period|Radiological progression|15|||
128737780|NCT02610140|463331738|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
128737781|NCT02610140|463331739|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
128737782|NCT02610140|463331738|FG000|Randomization and Treatment Period|Protocol Violation|1|||
128737783|NCT02610140|463331739|FG001|Randomization and Treatment Period|Protocol Violation|0|||
128737784|NCT02610140|463331738|FG000|Randomization and Treatment Period|Physician Decision|0|||
128737785|NCT02610140|463331739|FG001|Randomization and Treatment Period|Physician Decision|1|||
128737786|NCT02610140|463331738|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
128737787|NCT02610140|463331739|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
128737788|NCT02610140|463331738|FG000|Randomization and Treatment Period|Death|7|||
128737789|NCT02610140|463331739|FG001|Randomization and Treatment Period|Death|1|||
128737790|NCT02610140|463331738|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
128737791|NCT02610140|463331739|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
128737792|NCT02610140|463331738|FG000|Randomization and Treatment Period|Adverse Event|44|||
128737793|NCT02610140|463331739|FG001|Randomization and Treatment Period|Adverse Event|13|||
128737794|NCT02610140|463331738|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
128737795|NCT02610140|463331739|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
128737796|NCT02610140|463331738|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
128737797|NCT02610140|463331739|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
128737798|NCT02610140|463331738|FG000|Randomization and Treatment Period|Not treated|3|||
128737799|NCT02610140|463331739|FG001|Randomization and Treatment Period|Not treated|10|||
128737800|NCT02610140|463331738|FG000|Safety Follow-up|Other|0|||
128737801|NCT02610140|463331739|FG001|Safety Follow-up|Other|2|||
128737802|NCT02610140|463331738|FG000|Safety Follow-up|Lost to Follow-up|1|||
128737803|NCT02610140|463331739|FG001|Safety Follow-up|Lost to Follow-up|0|||
128737804|NCT02610140|463331738|FG000|Safety Follow-up|No follow-up|5|||
128737805|NCT02610140|463331739|FG001|Safety Follow-up|No follow-up|3|||
128737806|NCT02610140|463331738|FG000|Safety Follow-up|Death|12|||
128737807|NCT02610140|463331739|FG001|Safety Follow-up|Death|2|||
128737808|NCT02610140|463331738|FG000|Safety Follow-up|Deterioration of general conditions|15|||
128737809|NCT02610140|463331739|FG001|Safety Follow-up|Deterioration of general conditions|5|||
128737810|NCT02610140|463331738|FG000|Safety Follow-up|Withdrawal by Subject|12|||
128737811|NCT02610140|463331739|FG001|Safety Follow-up|Withdrawal by Subject|12|||
128737812|NCT02610140|463331738|FG000|Active Follow-up|Progressive disease - radiological|30|||
128785137|NCT00817635|463505923|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
128785138|NCT00817635|463505924|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
128785139|NCT00817635|463505925|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
128785140|NCT00817635|463505926|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
128785141|NCT00817635|463505922|FG000|Overall Study|Withdrawal by Subject|2|||
128785142|NCT00817635|463505923|FG001|Overall Study|Withdrawal by Subject|1|||
128785143|NCT00817635|463505924|FG002|Overall Study|Withdrawal by Subject|0|||
128737813|NCT02610140|463331739|FG001|Active Follow-up|Progressive disease - radiological|22|||
128737814|NCT02610140|463331738|FG000|Active Follow-up|Death|8|||
128737815|NCT02610140|463331739|FG001|Active Follow-up|Death|1|||
128737816|NCT02610140|463331738|FG000|Active Follow-up|Withdrawal by Subject|4|||
128737817|NCT02610140|463331739|FG001|Active Follow-up|Withdrawal by Subject|0|||
128737818|NCT02610140|463331738|FG000|Active Follow-up|Progressive disease - clinical|1|||
128737819|NCT02610140|463331739|FG001|Active Follow-up|Progressive disease - clinical|2|||
128737820|NCT02610140|463331738|FG000|Active Follow-up|Deterioration of general conditions|1|||
128737821|NCT02610140|463331739|FG001|Active Follow-up|Deterioration of general conditions|0|||
128737822|NCT02610140|463331738|FG000|Active Follow-up|Ongoing but not completed|4|||
128737823|NCT02610140|463331739|FG001|Active Follow-up|Ongoing but not completed|1|||
128737824|NCT02610140|463331738|FG000|Long-term Follow-up|Death|86|||
128737825|NCT02610140|463331739|FG001|Long-term Follow-up|Death|44|||
128737826|NCT02610140|463331738|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
128737827|NCT02610140|463331739|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
128737828|NCT02610140|463331738|FG000|Long-term Follow-up|Lost to Follow-up|1|||
128737829|NCT02610140|463331739|FG001|Long-term Follow-up|Lost to Follow-up|2|||
128737830|NCT02610140|463331738|FG000|Long-term Follow-up|Ongoing but not completed|30|||
128737831|NCT02610140|463331739|FG001|Long-term Follow-up|Ongoing but not completed|17|||
128737832|NCT03169153|463331740|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
128737833|NCT03169153|463331741|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
128737834|NCT03169153|463331740|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
128737835|NCT03169153|463331741|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
128737836|NCT03169153|463331740|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
128737837|NCT03169153|463331741|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
128737838|NCT03169153|463331740|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
128737839|NCT03169153|463331741|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
128737840|NCT00887341|463331742|FG000|Overall Study|Refused treatment|1|||
128737841|NCT00887341|463331743|FG001|Overall Study|Refused treatment|0|||
128737842|NCT00887341|463331742|FG000|Overall Study|Withdrawal by Subject|1|||
128737843|NCT00887341|463331743|FG001|Overall Study|Withdrawal by Subject|1|||
128737844|NCT00887341|463331742|FG000|Overall Study|Adverse Event|0|||
128737845|NCT00887341|463331743|FG001|Overall Study|Adverse Event|1|||
128737846|NCT00887341|463331742|FG000|Overall Study|Lost to Follow-up|0|||
128737847|NCT00887341|463331743|FG001|Overall Study|Lost to Follow-up|1|||
128737848|NCT01649856|463331748|FG000|Overall Study|Withdrawal by Subject|14|||
128737849|NCT01649856|463331749|FG001|Overall Study|Withdrawal by Subject|14|||
128737850|NCT01649856|463331748|FG000|Overall Study|Protocol Violation|4|||
128737851|NCT01649856|463331749|FG001|Overall Study|Protocol Violation|4|||
128737852|NCT01649856|463331748|FG000|Overall Study|Treatment Failure|1|||
128737853|NCT01649856|463331749|FG001|Overall Study|Treatment Failure|1|||
128737854|NCT01649856|463331748|FG000|Overall Study|Death|69|||
128737855|NCT01649856|463331749|FG001|Overall Study|Death|34|||
128737856|NCT01649856|463331748|FG000|Overall Study|Stable or Progressed Disease|5|||
128737857|NCT01649856|463331749|FG001|Overall Study|Stable or Progressed Disease|3|||
128737858|NCT01649856|463331748|FG000|Overall Study|Lost to Follow-up|20|||
128737859|NCT01649856|463331749|FG001|Overall Study|Lost to Follow-up|16|||
128737860|NCT01649856|463331748|FG000|Overall Study|Lack of Compliance|6|||
128737861|NCT01649856|463331749|FG001|Overall Study|Lack of Compliance|1|||
128737862|NCT01649856|463331748|FG000|Overall Study|Other|20|||
128737863|NCT01649856|463331749|FG001|Overall Study|Other|5|||
128737864|NCT00622635|463331750|FG000|Treatment Period 1|Adverse Event|0|||
128737865|NCT00622635|463331751|FG001|Treatment Period 1|Adverse Event|0|||
128737866|NCT00622635|463331752|FG002|Treatment Period 1|Adverse Event|1|||
128737867|NCT00622635|463331753|FG003|Treatment Period 1|Adverse Event|0|||
128737868|NCT00622635|463331754|FG004|Treatment Period 1|Adverse Event|0|||
128737869|NCT00622635|463331755|FG005|Treatment Period 1|Adverse Event|0|||
128737870|NCT00622635|463331750|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128737871|NCT00622635|463331751|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128737872|NCT00622635|463331752|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128737873|NCT00622635|463331753|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128737874|NCT00622635|463331754|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128737875|NCT00622635|463331755|FG005|Treatment Period 1|Withdrawal by Subject|0|||
128737876|NCT00622635|463331750|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
128737877|NCT00622635|463331751|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
128737878|NCT00622635|463331752|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
128737879|NCT00622635|463331753|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
128737880|NCT00622635|463331754|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
128737881|NCT00622635|463331755|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
128737882|NCT00622635|463331750|FG000|Treatment Period 2|Adverse Event|1|||
128737883|NCT00622635|463331751|FG001|Treatment Period 2|Adverse Event|0|||
128737884|NCT00622635|463331752|FG002|Treatment Period 2|Adverse Event|0|||
128737885|NCT00622635|463331753|FG003|Treatment Period 2|Adverse Event|0|||
128737886|NCT00622635|463331754|FG004|Treatment Period 2|Adverse Event|0|||
128737887|NCT00622635|463331755|FG005|Treatment Period 2|Adverse Event|0|||
128737888|NCT00622635|463331750|FG000|Treatment Period 3|Adverse Event|0|||
128737889|NCT00622635|463331751|FG001|Treatment Period 3|Adverse Event|0|||
128737890|NCT00622635|463331752|FG002|Treatment Period 3|Adverse Event|0|||
128737891|NCT00622635|463331753|FG003|Treatment Period 3|Adverse Event|2|||
128737892|NCT00622635|463331754|FG004|Treatment Period 3|Adverse Event|0|||
128737893|NCT00622635|463331755|FG005|Treatment Period 3|Adverse Event|0|||
128737894|NCT00622635|463331750|FG000|Treatment Period 3|Withdrawal by Subject|0|||
128737895|NCT00622635|463331751|FG001|Treatment Period 3|Withdrawal by Subject|0|||
128737896|NCT00622635|463331752|FG002|Treatment Period 3|Withdrawal by Subject|0|||
128737897|NCT00622635|463331753|FG003|Treatment Period 3|Withdrawal by Subject|1|||
128737898|NCT00622635|463331754|FG004|Treatment Period 3|Withdrawal by Subject|0|||
128737899|NCT00622635|463331755|FG005|Treatment Period 3|Withdrawal by Subject|0|||
128737900|NCT00281840|463331756|FG000|Overall Study|Adverse Event|12|||
128737901|NCT00281840|463331756|FG000|Overall Study|Physician Decision|6|||
128737902|NCT00281840|463331756|FG000|Overall Study|Withdrawal by Subject|3|||
128737903|NCT00281840|463331756|FG000|Overall Study|Disease Progression|2|||
128737904|NCT00281840|463331756|FG000|Overall Study|exceed maximum delay in treatment|1|||
128737905|NCT00281840|463331756|FG000|Overall Study|Complicating Disease|1|||
128737906|NCT03027466|463331766|FG000|Overall Study|Opting out of the app|1869|||
128737907|NCT03027466|463331767|FG001|Overall Study|Opting out of the app|1819|||
128737908|NCT03027466|463331768|FG002|Overall Study|Opting out of the app|1743|||
128737909|NCT03027466|463331769|FG003|Overall Study|Opting out of the app|1821|||
128737910|NCT03062891|463331779|FG000|Overall Study|Withdrawal by Subject|2|||
128737911|NCT03062891|463331780|FG001|Overall Study|Withdrawal by Subject|0|||
128737912|NCT03062891|463331779|FG000|Overall Study|Lost to Follow-up|50|||
128737913|NCT03062891|463331780|FG001|Overall Study|Lost to Follow-up|38|||
128737914|NCT01334866|463331781|FG000|Overall Study|Withdrawal by Subject|10|||
128737915|NCT01334866|463331781|FG000|Overall Study|Lost to Follow-up|3|||
128737916|NCT01334866|463331781|FG000|Overall Study|Physician Decision|3|||
128737917|NCT01334866|463331781|FG000|Overall Study|medically necessary prior to procedure|2|||
128737918|NCT01334866|463331781|FG000|Overall Study|medically necessary post-procedure|1|||
128737919|NCT01687166|463331782|FG000|Overall Study|Attempt subject|2|||
128737920|NCT01687166|463331783|FG001|Overall Study|Attempt subject|3|||
128737921|NCT01687166|463331784|FG002|Overall Study|Attempt subject|2|||
128737922|NCT01687166|463331785|FG003|Overall Study|Attempt subject|0|||
128737923|NCT01687166|463331782|FG000|Overall Study|Did not meet eligibility criteria|4|||
128737924|NCT01687166|463331783|FG001|Overall Study|Did not meet eligibility criteria|6|||
128737925|NCT01687166|463331784|FG002|Overall Study|Did not meet eligibility criteria|1|||
128737926|NCT01687166|463331785|FG003|Overall Study|Did not meet eligibility criteria|1|||
128737927|NCT01687166|463331782|FG000|Overall Study|Adverse Event|2|||
128737928|NCT01687166|463331783|FG001|Overall Study|Adverse Event|1|||
128737929|NCT01687166|463331784|FG002|Overall Study|Adverse Event|0|||
128737930|NCT01687166|463331785|FG003|Overall Study|Adverse Event|0|||
128737931|NCT01687166|463331782|FG000|Overall Study|Physician Decision|3|||
128737932|NCT01687166|463331783|FG001|Overall Study|Physician Decision|2|||
128737933|NCT01687166|463331784|FG002|Overall Study|Physician Decision|1|||
128737934|NCT01687166|463331785|FG003|Overall Study|Physician Decision|0|||
128737935|NCT01687166|463331782|FG000|Overall Study|Withdrawal by Subject|11|||
128737936|NCT01687166|463331783|FG001|Overall Study|Withdrawal by Subject|4|||
128737937|NCT01687166|463331784|FG002|Overall Study|Withdrawal by Subject|3|||
128737938|NCT01687166|463331785|FG003|Overall Study|Withdrawal by Subject|0|||
128737939|NCT01687166|463331782|FG000|Overall Study|Lost to Follow-up|2|||
128737940|NCT01687166|463331783|FG001|Overall Study|Lost to Follow-up|5|||
128737941|NCT01687166|463331784|FG002|Overall Study|Lost to Follow-up|1|||
128737942|NCT01687166|463331785|FG003|Overall Study|Lost to Follow-up|0|||
128737943|NCT01687166|463331782|FG000|Overall Study|Equipment/Device Availability|0|||
128737944|NCT01687166|463331783|FG001|Overall Study|Equipment/Device Availability|1|||
128737945|NCT01687166|463331784|FG002|Overall Study|Equipment/Device Availability|0|||
128737946|NCT01687166|463331785|FG003|Overall Study|Equipment/Device Availability|0|||
128737947|NCT01687166|463331782|FG000|Overall Study|Death|1|||
128737948|NCT01687166|463331783|FG001|Overall Study|Death|1|||
128737949|NCT01687166|463331784|FG002|Overall Study|Death|0|||
128737950|NCT01687166|463331785|FG003|Overall Study|Death|0|||
128737951|NCT01687166|463331782|FG000|Overall Study|Protocol Violation|1|||
128737952|NCT01687166|463331783|FG001|Overall Study|Protocol Violation|1|||
128737953|NCT01687166|463331784|FG002|Overall Study|Protocol Violation|1|||
128737954|NCT01687166|463331785|FG003|Overall Study|Protocol Violation|0|||
128737955|NCT01687166|463331782|FG000|Overall Study|Subject moved out of state|0|||
128737956|NCT01687166|463331783|FG001|Overall Study|Subject moved out of state|1|||
128737957|NCT01687166|463331784|FG002|Overall Study|Subject moved out of state|0|||
128737958|NCT01687166|463331785|FG003|Overall Study|Subject moved out of state|0|||
128737959|NCT01687166|463331782|FG000|Overall Study|Patient unable to be compliant|1|||
128737960|NCT01687166|463331783|FG001|Overall Study|Patient unable to be compliant|0|||
128737961|NCT01687166|463331784|FG002|Overall Study|Patient unable to be compliant|0|||
128737962|NCT01687166|463331785|FG003|Overall Study|Patient unable to be compliant|0|||
128737963|NCT01687166|463331782|FG000|Overall Study|Physician choice to use different device|1|||
128737964|NCT01687166|463331783|FG001|Overall Study|Physician choice to use different device|2|||
128737965|NCT01687166|463331784|FG002|Overall Study|Physician choice to use different device|4|||
128737966|NCT01687166|463331785|FG003|Overall Study|Physician choice to use different device|0|||
128737967|NCT01687166|463331782|FG000|Overall Study|Insurance|0|||
128737968|NCT01687166|463331783|FG001|Overall Study|Insurance|0|||
128737969|NCT01687166|463331784|FG002|Overall Study|Insurance|1|||
128737970|NCT01687166|463331785|FG003|Overall Study|Insurance|1|||
128737971|NCT01600586|463331786|FG000|Overall Study|Physician Decision|3|||
128737972|NCT01600586|463331787|FG001|Overall Study|Physician Decision|3|||
128737973|NCT01898793|463331788|FG000|Overall Study|Death|2|||
128737974|NCT01898793|463331789|FG001|Overall Study|Death|1|||
128737975|NCT01898793|463331790|FG002|Overall Study|Death|4|||
128737976|NCT01898793|463331791|FG003|Overall Study|Death|0|||
128737977|NCT01898793|463331792|FG004|Overall Study|Death|0|||
128737978|NCT01898793|463331793|FG005|Overall Study|Death|0|||
128737979|NCT01898793|463331794|FG006|Overall Study|Death|0|||
128737980|NCT00931307|463331795|FG000|Overall Study|Lack of Efficacy|12|||
128737981|NCT00931307|463331795|FG000|Overall Study|Biomicroscopy|1|||
128737982|NCT02447991|463331799|FG000|Overall Study|Withdrawn by subject - no data|0|||
128737983|NCT02447991|463331800|FG001|Overall Study|Withdrawn by subject - no data|2|||
128737984|NCT02447991|463331799|FG000|Overall Study|Withdrawn by Subject - with data|4|||
128737985|NCT02447991|463331800|FG001|Overall Study|Withdrawn by Subject - with data|4|||
128737986|NCT02447991|463331799|FG000|Overall Study|Lost to Follow-up - no data|3|||
128737987|NCT02447991|463331800|FG001|Overall Study|Lost to Follow-up - no data|6|||
128737988|NCT02447991|463331799|FG000|Overall Study|Lost to follow-up - with data|0|||
128737989|NCT02447991|463331800|FG001|Overall Study|Lost to follow-up - with data|3|||
128737990|NCT02447991|463331799|FG000|Overall Study|End of study - no treatment results|3|||
128737991|NCT02447991|463331800|FG001|Overall Study|End of study - no treatment results|6|||
128737992|NCT02447991|463331799|FG000|Overall Study|End of study - partial treatment results|0|||
128737993|NCT02447991|463331800|FG001|Overall Study|End of study - partial treatment results|9|||
128737994|NCT00459134|463331801|FG000|Overall Study|Physician Decision|1|||
128737995|NCT00459134|463331802|FG001|Overall Study|Physician Decision|1|||
128737996|NCT00459134|463331801|FG000|Overall Study|Withdrawal by Subject|8|||
128737997|NCT00459134|463331802|FG001|Overall Study|Withdrawal by Subject|7|||
128737998|NCT00459134|463331801|FG000|Overall Study|Lost to Follow-up|6|||
128737999|NCT00459134|463331802|FG001|Overall Study|Lost to Follow-up|7|||
128738000|NCT00459134|463331801|FG000|Overall Study|Surgery|1|||
128738001|NCT00459134|463331802|FG001|Overall Study|Surgery|2|||
128738002|NCT00459134|463331801|FG000|Overall Study|Toxicity|4|||
128738003|NCT00459134|463331802|FG001|Overall Study|Toxicity|5|||
128738004|NCT00459134|463331801|FG000|Overall Study|Progression|1|||
128738005|NCT00459134|463331802|FG001|Overall Study|Progression|0|||
128738006|NCT00459134|463331801|FG000|Overall Study|Multiple Reasons|2|||
128738007|NCT00459134|463331802|FG001|Overall Study|Multiple Reasons|3|||
128738008|NCT03964454|463331805|FG000|Overall Study|Lost to Follow-up|13|||
128738009|NCT03964454|463331806|FG001|Overall Study|Lost to Follow-up|7|||
128738010|NCT03964454|463331805|FG000|Overall Study|Withdrawal by Subject|4|||
128738011|NCT03964454|463331806|FG001|Overall Study|Withdrawal by Subject|11|||
128738012|NCT02766608|463333844|FG000|Overall Study|Adverse Event|27|||
128738013|NCT02766608|463333845|FG001|Overall Study|Adverse Event|22|||
128738014|NCT02766608|463333846|FG002|Overall Study|Adverse Event|17|||
128738015|NCT02766608|463333847|FG003|Overall Study|Adverse Event|13|||
128738016|NCT02766608|463333848|FG004|Overall Study|Adverse Event|12|||
128738017|NCT02766608|463333844|FG000|Overall Study|Withdrawal by Subject|21|||
128738018|NCT02766608|463333845|FG001|Overall Study|Withdrawal by Subject|20|||
128738019|NCT02766608|463333846|FG002|Overall Study|Withdrawal by Subject|24|||
128738020|NCT02766608|463333847|FG003|Overall Study|Withdrawal by Subject|13|||
128738021|NCT02766608|463333848|FG004|Overall Study|Withdrawal by Subject|10|||
128738022|NCT02766608|463333844|FG000|Overall Study|Lack of Efficacy|16|||
128738023|NCT02766608|463333845|FG001|Overall Study|Lack of Efficacy|15|||
128738024|NCT02766608|463333846|FG002|Overall Study|Lack of Efficacy|32|||
128738025|NCT02766608|463333847|FG003|Overall Study|Lack of Efficacy|8|||
128738026|NCT02766608|463333848|FG004|Overall Study|Lack of Efficacy|2|||
128738027|NCT02766608|463333844|FG000|Overall Study|Lost to Follow-up|6|||
128738028|NCT02766608|463333845|FG001|Overall Study|Lost to Follow-up|3|||
128738029|NCT02766608|463333846|FG002|Overall Study|Lost to Follow-up|5|||
128738030|NCT02766608|463333847|FG003|Overall Study|Lost to Follow-up|2|||
128738031|NCT02766608|463333848|FG004|Overall Study|Lost to Follow-up|2|||
128738032|NCT02766608|463333844|FG000|Overall Study|Physician Decision|3|||
128738033|NCT02766608|463333845|FG001|Overall Study|Physician Decision|2|||
128738034|NCT02766608|463333846|FG002|Overall Study|Physician Decision|3|||
128738035|NCT02766608|463333847|FG003|Overall Study|Physician Decision|1|||
128738036|NCT02766608|463333848|FG004|Overall Study|Physician Decision|2|||
128738037|NCT02766608|463333844|FG000|Overall Study|Protocol disc criteria|3|||
128738038|NCT02766608|463333845|FG001|Overall Study|Protocol disc criteria|3|||
128738039|NCT02766608|463333846|FG002|Overall Study|Protocol disc criteria|4|||
128738040|NCT02766608|463333847|FG003|Overall Study|Protocol disc criteria|0|||
128738041|NCT02766608|463333848|FG004|Overall Study|Protocol disc criteria|0|||
128738042|NCT02766608|463333844|FG000|Overall Study|Protocol Violation|0|||
128738043|NCT02766608|463333845|FG001|Overall Study|Protocol Violation|4|||
128738044|NCT02766608|463333846|FG002|Overall Study|Protocol Violation|4|||
128738045|NCT02766608|463333847|FG003|Overall Study|Protocol Violation|0|||
128738046|NCT02766608|463333848|FG004|Overall Study|Protocol Violation|1|||
128738047|NCT02766608|463333844|FG000|Overall Study|Administrative Reasons|3|||
128738048|NCT02766608|463333845|FG001|Overall Study|Administrative Reasons|1|||
128738049|NCT02766608|463333846|FG002|Overall Study|Administrative Reasons|1|||
128738050|NCT02766608|463333847|FG003|Overall Study|Administrative Reasons|0|||
128738051|NCT02766608|463333848|FG004|Overall Study|Administrative Reasons|0|||
128738052|NCT02066298|463333849|FG000|Overall Study|Lost to Follow-up|3|||
128738053|NCT02066298|463333850|FG001|Overall Study|Lost to Follow-up|2|||
128738054|NCT02066298|463333851|FG002|Overall Study|Lost to Follow-up|3|||
128738055|NCT02066298|463333852|FG003|Overall Study|Lost to Follow-up|2|||
128738056|NCT02066298|463333853|FG004|Overall Study|Lost to Follow-up|3|||
128738057|NCT02066298|463333854|FG005|Overall Study|Lost to Follow-up|4|||
128738058|NCT02066298|463333849|FG000|Overall Study|Withdrawal by Subject|6|||
128738059|NCT02066298|463333850|FG001|Overall Study|Withdrawal by Subject|6|||
128738060|NCT02066298|463333851|FG002|Overall Study|Withdrawal by Subject|6|||
128738061|NCT02066298|463333852|FG003|Overall Study|Withdrawal by Subject|4|||
128738062|NCT02066298|463333853|FG004|Overall Study|Withdrawal by Subject|5|||
128738063|NCT02066298|463333854|FG005|Overall Study|Withdrawal by Subject|8|||
128738064|NCT02066298|463333849|FG000|Overall Study|Physician Decision|0|||
128738065|NCT02066298|463333850|FG001|Overall Study|Physician Decision|0|||
128738066|NCT02066298|463333851|FG002|Overall Study|Physician Decision|1|||
128738067|NCT02066298|463333852|FG003|Overall Study|Physician Decision|0|||
128738068|NCT02066298|463333853|FG004|Overall Study|Physician Decision|1|||
128738069|NCT02066298|463333854|FG005|Overall Study|Physician Decision|0|||
128738070|NCT02343458|463333857|FG000|Overall Study|Adverse Event|15|||
128738071|NCT02343458|463333858|FG001|Overall Study|Adverse Event|14|||
128738072|NCT02343458|463333859|FG002|Overall Study|Adverse Event|15|||
128738073|NCT02343458|463333860|FG003|Overall Study|Adverse Event|3|||
128738074|NCT02343458|463333857|FG000|Overall Study|Lack of Efficacy|3|||
128738075|NCT02343458|463333858|FG001|Overall Study|Lack of Efficacy|8|||
128738076|NCT02343458|463333859|FG002|Overall Study|Lack of Efficacy|4|||
128738077|NCT02343458|463333860|FG003|Overall Study|Lack of Efficacy|8|||
128738078|NCT02343458|463333857|FG000|Overall Study|Withdrawal by Subject|18|||
128738079|NCT02343458|463333858|FG001|Overall Study|Withdrawal by Subject|17|||
128738080|NCT02343458|463333859|FG002|Overall Study|Withdrawal by Subject|23|||
128738081|NCT02343458|463333860|FG003|Overall Study|Withdrawal by Subject|14|||
128785144|NCT00817635|463505925|FG003|Overall Study|Withdrawal by Subject|1|||
128738082|NCT02343458|463333857|FG000|Overall Study|Physician Decision|1|||
128738083|NCT02343458|463333858|FG001|Overall Study|Physician Decision|4|||
128738084|NCT02343458|463333859|FG002|Overall Study|Physician Decision|2|||
128738085|NCT02343458|463333860|FG003|Overall Study|Physician Decision|2|||
128738086|NCT02343458|463333857|FG000|Overall Study|Lost to Follow-up|5|||
128738087|NCT02343458|463333858|FG001|Overall Study|Lost to Follow-up|5|||
128738088|NCT02343458|463333859|FG002|Overall Study|Lost to Follow-up|3|||
128738089|NCT02343458|463333860|FG003|Overall Study|Lost to Follow-up|1|||
128738090|NCT02343458|463333857|FG000|Overall Study|Protocol Violation|2|||
128738091|NCT02343458|463333858|FG001|Overall Study|Protocol Violation|5|||
128738092|NCT02343458|463333859|FG002|Overall Study|Protocol Violation|2|||
128738093|NCT02343458|463333860|FG003|Overall Study|Protocol Violation|2|||
128738094|NCT02343458|463333857|FG000|Overall Study|Protocol Specified Criteria|17|||
128738095|NCT02343458|463333858|FG001|Overall Study|Protocol Specified Criteria|13|||
128738096|NCT02343458|463333859|FG002|Overall Study|Protocol Specified Criteria|14|||
128738097|NCT02343458|463333860|FG003|Overall Study|Protocol Specified Criteria|8|||
128738098|NCT02080091|463333861|FG000|Overall Study|Study Terminated|22|||
128738099|NCT02080091|463333861|FG000|Overall Study|Death|1|||
128738100|NCT02080091|463333861|FG000|Overall Study|Withdrawal by Subject|1|||
128738101|NCT02080091|463333861|FG000|Overall Study|Other|1|||
128738102|NCT00672477|463333862|FG000|Overall Study|Adverse Event|10|||
128738103|NCT00672477|463333863|FG001|Overall Study|Adverse Event|7|||
128738104|NCT00672477|463333862|FG000|Overall Study|Death|7|||
128738105|NCT00672477|463333863|FG001|Overall Study|Death|11|||
128738106|NCT00672477|463333862|FG000|Overall Study|Physician Decision|2|||
128738107|NCT00672477|463333863|FG001|Overall Study|Physician Decision|0|||
128738108|NCT00672477|463333862|FG000|Overall Study|Protocol Violation|1|||
128738109|NCT00672477|463333863|FG001|Overall Study|Protocol Violation|1|||
128738110|NCT00672477|463333862|FG000|Overall Study|Withdrawal by Subject|5|||
128738111|NCT00672477|463333863|FG001|Overall Study|Withdrawal by Subject|3|||
128738112|NCT00672477|463333862|FG000|Overall Study|Lack of Efficacy|1|||
128738113|NCT00672477|463333863|FG001|Overall Study|Lack of Efficacy|1|||
128738114|NCT00672477|463333862|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
128738115|NCT00672477|463333863|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
128738116|NCT02348489|463333866|FG000|Overall Study|Death|336|||
128738117|NCT02348489|463333867|FG001|Overall Study|Death|335|||
128738118|NCT02348489|463333866|FG000|Overall Study|Withdrawal by Subject|14|||
128738119|NCT02348489|463333867|FG001|Overall Study|Withdrawal by Subject|27|||
128738120|NCT02348489|463333866|FG000|Overall Study|Lost to Follow-up|3|||
128738121|NCT02348489|463333867|FG001|Overall Study|Lost to Follow-up|5|||
128738122|NCT02866682|463333868|FG000|Overall Study|Death|0|||
128738123|NCT02866682|463333869|FG001|Overall Study|Death|1|||
128738124|NCT02866682|463333868|FG000|Overall Study|Lost to Follow-up|0|||
128738125|NCT02866682|463333869|FG001|Overall Study|Lost to Follow-up|4|||
128738126|NCT02866682|463333868|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
128738127|NCT02866682|463333869|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
128738128|NCT02866682|463333868|FG000|Overall Study|Other|0|||
128738129|NCT02866682|463333869|FG001|Overall Study|Other|1|||
128738130|NCT00201006|463333870|FG000|Overall Study|Withdrawal by Subject|7|||
128738131|NCT00201006|463333871|FG001|Overall Study|Withdrawal by Subject|2|||
128738132|NCT00201006|463333872|FG002|Overall Study|Withdrawal by Subject|3|||
128738133|NCT00201006|463333870|FG000|Overall Study|Adverse Event|1|||
128738134|NCT00201006|463333871|FG001|Overall Study|Adverse Event|0|||
128738135|NCT00201006|463333872|FG002|Overall Study|Adverse Event|1|||
128738136|NCT01750268|463333874|FG000|Overall Study|Lost to Follow-up|0|||
128738137|NCT01750268|463333875|FG001|Overall Study|Lost to Follow-up|2|||
128738138|NCT01750268|463333874|FG000|Overall Study|Physician Decision|0|||
128738139|NCT01750268|463333875|FG001|Overall Study|Physician Decision|3|||
128738140|NCT01750268|463333874|FG000|Overall Study|Withdrawal by Subject|2|||
128738141|NCT01750268|463333875|FG001|Overall Study|Withdrawal by Subject|0|||
128738142|NCT00975975|463333879|FG000|Overall Study|Death|6|||
128738143|NCT02057757|463333886|FG000|Overall Study|Withdrawal by Subject|3|||
128738144|NCT02057757|463333887|FG001|Overall Study|Withdrawal by Subject|5|||
128738145|NCT02057757|463333886|FG000|Overall Study|Death|2|||
128738146|NCT02057757|463333887|FG001|Overall Study|Death|0|||
128738147|NCT02057757|463333886|FG000|Overall Study|Lost to Follow-up|8|||
128785145|NCT00817635|463505926|FG004|Overall Study|Withdrawal by Subject|2|||
128785146|NCT00817635|463505922|FG000|Overall Study|Lost to Follow-up|0|||
128785147|NCT00817635|463505923|FG001|Overall Study|Lost to Follow-up|1|||
128785148|NCT00817635|463505924|FG002|Overall Study|Lost to Follow-up|0|||
128785149|NCT00817635|463505925|FG003|Overall Study|Lost to Follow-up|1|||
128785150|NCT00817635|463505926|FG004|Overall Study|Lost to Follow-up|0|||
128785151|NCT00817635|463505922|FG000|Overall Study|Administrative Problems|0|||
128785152|NCT00817635|463505923|FG001|Overall Study|Administrative Problems|0|||
128738148|NCT02057757|463333887|FG001|Overall Study|Lost to Follow-up|3|||
128738149|NCT02057757|463333886|FG000|Overall Study|Non-compliance|1|||
128738150|NCT02057757|463333887|FG001|Overall Study|Non-compliance|0|||
128738151|NCT03614793|463333888|FG000|Overall Study|Lost to Follow-up|1|||
128738152|NCT03614793|463333889|FG001|Overall Study|Lost to Follow-up|2|||
128738153|NCT03614793|463333888|FG000|Overall Study|Lack of Efficacy|0|||
128738154|NCT03614793|463333889|FG001|Overall Study|Lack of Efficacy|5|||
128738155|NCT03614793|463333888|FG000|Overall Study|Withdrawal by Subject|0|||
128738156|NCT03614793|463333889|FG001|Overall Study|Withdrawal by Subject|1|||
128738157|NCT03614793|463333888|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
128738158|NCT03614793|463333889|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
128738159|NCT02082522|463333890|FG000|Overall Study|Sponsor termination|5|||
128738160|NCT02082522|463333891|FG001|Overall Study|Sponsor termination|3|||
128738161|NCT02082522|463333890|FG000|Overall Study|Withdrawal by Subject|2|||
128738162|NCT02082522|463333891|FG001|Overall Study|Withdrawal by Subject|4|||
128738163|NCT02082522|463333890|FG000|Overall Study|Death|1|||
128738164|NCT02082522|463333891|FG001|Overall Study|Death|0|||
128738165|NCT02082522|463333890|FG000|Overall Study|Lost to Follow-up|1|||
128738166|NCT02082522|463333891|FG001|Overall Study|Lost to Follow-up|0|||
128738167|NCT02082522|463333890|FG000|Overall Study|Physician Decision|3|||
128738168|NCT02082522|463333891|FG001|Overall Study|Physician Decision|1|||
128738169|NCT02082522|463333890|FG000|Overall Study|Disease progression|2|||
128738170|NCT02082522|463333891|FG001|Overall Study|Disease progression|2|||
128738171|NCT02082522|463333890|FG000|Overall Study|Chemotherapy change|1|||
128738172|NCT02082522|463333891|FG001|Overall Study|Chemotherapy change|3|||
128738173|NCT00456092|463333892|FG000|Extension Phase|Grade 2 or Greater AE|2|||
128738174|NCT00456092|463333893|FG001|Extension Phase|Grade 2 or Greater AE|2|||
128738175|NCT00456092|463333894|FG002|Extension Phase|Grade 2 or Greater AE|0|||
128738176|NCT00456092|463333895|FG003|Extension Phase|Grade 2 or Greater AE|0|||
128738177|NCT00456092|463333896|FG004|Extension Phase|Grade 2 or Greater AE|2|||
128738178|NCT00456092|463333892|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
128738179|NCT00456092|463333893|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
128738180|NCT00456092|463333894|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
128738181|NCT00456092|463333895|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
128738182|NCT00456092|463333896|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
128738183|NCT00456092|463333892|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
128738184|NCT00456092|463333893|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
128738185|NCT00456092|463333894|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
128738186|NCT00456092|463333895|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
128738187|NCT00456092|463333896|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
128738188|NCT00456092|463333892|FG000|Extension Phase|Withdrew Consent|2|||
128738189|NCT00456092|463333893|FG001|Extension Phase|Withdrew Consent|0|||
128738190|NCT00456092|463333894|FG002|Extension Phase|Withdrew Consent|0|||
128738191|NCT00456092|463333895|FG003|Extension Phase|Withdrew Consent|0|||
128738192|NCT00456092|463333896|FG004|Extension Phase|Withdrew Consent|0|||
128738193|NCT00456092|463333892|FG000|Extension Phase|Lost to Follow-up|1|||
128738194|NCT00456092|463333893|FG001|Extension Phase|Lost to Follow-up|1|||
128738195|NCT00456092|463333894|FG002|Extension Phase|Lost to Follow-up|0|||
128738196|NCT00456092|463333895|FG003|Extension Phase|Lost to Follow-up|0|||
128738197|NCT00456092|463333896|FG004|Extension Phase|Lost to Follow-up|1|||
128738198|NCT00456092|463333892|FG000|Extension Phase|Other|2|||
128738199|NCT00456092|463333893|FG001|Extension Phase|Other|0|||
128738200|NCT00456092|463333894|FG002|Extension Phase|Other|0|||
128738201|NCT00456092|463333895|FG003|Extension Phase|Other|1|||
128738202|NCT00456092|463333896|FG004|Extension Phase|Other|1|||
128738203|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
128738204|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
128738205|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
128738206|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
128738207|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
128738208|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
128738209|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
128738210|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
128738211|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
128738212|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
128738213|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
128738214|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
128738215|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
128738216|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
128738217|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
128738218|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
128738219|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
128738220|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
128738221|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
128738222|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
128738223|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
128738224|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
128738225|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
128738226|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
128738227|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
128738228|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
128738229|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
128738230|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
128738231|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
128738232|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
128738233|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
128738234|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
128738235|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
128738236|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
128738237|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
128738238|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
128738239|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
128738240|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
128738241|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
128738242|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
128738243|NCT00456092|463333892|FG000|Treatment Phase (12 Weeks)|Other|1|||
128738244|NCT00456092|463333893|FG001|Treatment Phase (12 Weeks)|Other|0|||
128738245|NCT00456092|463333894|FG002|Treatment Phase (12 Weeks)|Other|1|||
128738246|NCT00456092|463333895|FG003|Treatment Phase (12 Weeks)|Other|0|||
128738247|NCT00456092|463333896|FG004|Treatment Phase (12 Weeks)|Other|0|||
128738248|NCT02252081|463333897|FG000|Overall Study|Withdrawal by Subject|2|||
128738249|NCT02252081|463333898|FG001|Overall Study|Withdrawal by Subject|1|||
128738250|NCT02252081|463333897|FG000|Overall Study|Adverse Event|4|||
128738251|NCT02252081|463333898|FG001|Overall Study|Adverse Event|1|||
128738252|NCT02252081|463333897|FG000|Overall Study|non compliance & others|0|||
128738253|NCT02252081|463333898|FG001|Overall Study|non compliance & others|2|||
128738254|NCT01168999|463333903|FG000|Overall Study|Lost to Follow-up|2|||
128738255|NCT01168999|463333904|FG001|Overall Study|Lost to Follow-up|1|||
128738256|NCT01168999|463333905|FG002|Overall Study|Lost to Follow-up|0|||
128738257|NCT01168999|463333906|FG003|Overall Study|Lost to Follow-up|0|||
128738258|NCT03603964|463333907|FG000|Overall Study|Death|9|||
128738259|NCT03603964|463333907|FG000|Overall Study|Withdrawal by participant|7|||
128738260|NCT03603964|463333907|FG000|Overall Study|Study terminated by Sponsor|19|||
128738261|NCT04317586|463333908|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
128738262|NCT04317586|463333908|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
128738263|NCT00563797|463333909|FG000|Overall Study|Lost to Follow-up|7|||
128738264|NCT00563797|463333910|FG001|Overall Study|Lost to Follow-up|2|||
128738265|NCT03224468|463333922|FG000|Overall Study|Did not obtain MM card|53|||
128738266|NCT03224468|463333923|FG001|Overall Study|Did not obtain MM card|0|||
128738267|NCT03224468|463333922|FG000|Overall Study|Lost to Follow-up|4|||
128738268|NCT03224468|463333923|FG001|Overall Study|Lost to Follow-up|11|||
128738269|NCT03224468|463333922|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
128738270|NCT03224468|463333923|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
128738271|NCT02461589|463333924|FG000|Overall Study|Withdrawal by Subject|5|||
128738272|NCT02461589|463333925|FG001|Overall Study|Withdrawal by Subject|1|||
128738273|NCT02461589|463333926|FG002|Overall Study|Withdrawal by Subject|3|||
128738274|NCT02461589|463333927|FG003|Overall Study|Withdrawal by Subject|2|||
128738275|NCT02461589|463333928|FG004|Overall Study|Withdrawal by Subject|1|||
128738276|NCT02461589|463333929|FG005|Overall Study|Withdrawal by Subject|2|||
128738277|NCT02461589|463333930|FG006|Overall Study|Withdrawal by Subject|1|||
128738278|NCT02461589|463333931|FG007|Overall Study|Withdrawal by Subject|3|||
128738279|NCT02461589|463333932|FG008|Overall Study|Withdrawal by Subject|3|||
128738280|NCT02461589|463333933|FG009|Overall Study|Withdrawal by Subject|1|||
128738281|NCT02461589|463333924|FG000|Overall Study|Lost to Follow-up|0|||
128738282|NCT02461589|463333925|FG001|Overall Study|Lost to Follow-up|0|||
128738283|NCT02461589|463333926|FG002|Overall Study|Lost to Follow-up|2|||
128738284|NCT02461589|463333927|FG003|Overall Study|Lost to Follow-up|3|||
128738285|NCT02461589|463333928|FG004|Overall Study|Lost to Follow-up|1|||
128738286|NCT02461589|463333929|FG005|Overall Study|Lost to Follow-up|1|||
128738287|NCT02461589|463333930|FG006|Overall Study|Lost to Follow-up|3|||
128738288|NCT02461589|463333931|FG007|Overall Study|Lost to Follow-up|1|||
128738289|NCT02461589|463333932|FG008|Overall Study|Lost to Follow-up|3|||
128738290|NCT02461589|463333933|FG009|Overall Study|Lost to Follow-up|1|||
128738291|NCT02461589|463333924|FG000|Overall Study|Death|0|||
128738292|NCT02461589|463333925|FG001|Overall Study|Death|0|||
128738293|NCT02461589|463333926|FG002|Overall Study|Death|0|||
128738294|NCT02461589|463333927|FG003|Overall Study|Death|0|||
128738295|NCT02461589|463333928|FG004|Overall Study|Death|0|||
128738296|NCT02461589|463333929|FG005|Overall Study|Death|0|||
128738297|NCT02461589|463333930|FG006|Overall Study|Death|0|||
128738298|NCT02461589|463333931|FG007|Overall Study|Death|1|||
128738299|NCT02461589|463333932|FG008|Overall Study|Death|0|||
128738300|NCT02461589|463333933|FG009|Overall Study|Death|0|||
128738301|NCT02461589|463333924|FG000|Overall Study|Unclassified|0|||
128738302|NCT02461589|463333925|FG001|Overall Study|Unclassified|0|||
128738303|NCT02461589|463333926|FG002|Overall Study|Unclassified|0|||
128738304|NCT02461589|463333927|FG003|Overall Study|Unclassified|0|||
128738305|NCT02461589|463333928|FG004|Overall Study|Unclassified|0|||
128738306|NCT02461589|463333929|FG005|Overall Study|Unclassified|0|||
128738307|NCT02461589|463333930|FG006|Overall Study|Unclassified|1|||
128738308|NCT02461589|463333931|FG007|Overall Study|Unclassified|0|||
128738309|NCT02461589|463333932|FG008|Overall Study|Unclassified|0|||
128738310|NCT02461589|463333933|FG009|Overall Study|Unclassified|2|||
128738311|NCT02461589|463333924|FG000|Overall Study|Missing follow-up information|1|||
128738312|NCT02461589|463333925|FG001|Overall Study|Missing follow-up information|1|||
128738313|NCT02461589|463333926|FG002|Overall Study|Missing follow-up information|0|||
128738314|NCT02461589|463333927|FG003|Overall Study|Missing follow-up information|0|||
128738315|NCT02461589|463333928|FG004|Overall Study|Missing follow-up information|0|||
128738316|NCT02461589|463333929|FG005|Overall Study|Missing follow-up information|0|||
128738317|NCT02461589|463333930|FG006|Overall Study|Missing follow-up information|1|||
128738318|NCT02461589|463333931|FG007|Overall Study|Missing follow-up information|0|||
128738319|NCT02461589|463333932|FG008|Overall Study|Missing follow-up information|0|||
128738320|NCT02461589|463333933|FG009|Overall Study|Missing follow-up information|0|||
128738321|NCT02461589|463333924|FG000|Overall Study|Withdrawal from trial before exposure|0|||
128738322|NCT02461589|463333925|FG001|Overall Study|Withdrawal from trial before exposure|0|||
128738323|NCT02461589|463333926|FG002|Overall Study|Withdrawal from trial before exposure|0|||
128738324|NCT02461589|463333927|FG003|Overall Study|Withdrawal from trial before exposure|0|||
128738325|NCT02461589|463333928|FG004|Overall Study|Withdrawal from trial before exposure|0|||
128738326|NCT02461589|463333929|FG005|Overall Study|Withdrawal from trial before exposure|0|||
128738327|NCT02461589|463333930|FG006|Overall Study|Withdrawal from trial before exposure|0|||
128738328|NCT02461589|463333931|FG007|Overall Study|Withdrawal from trial before exposure|0|||
128738329|NCT02461589|463333932|FG008|Overall Study|Withdrawal from trial before exposure|0|||
128738330|NCT02461589|463333933|FG009|Overall Study|Withdrawal from trial before exposure|1|||
128738331|NCT04067141|463333934|FG000|First Intervention|Withdrawal by Subject|0|||
128738332|NCT04067141|463333935|FG001|First Intervention|Withdrawal by Subject|1|||
128738333|NCT04067141|463333934|FG000|Second Intervention|Adverse Event|0|||
128738334|NCT04067141|463333935|FG001|Second Intervention|Adverse Event|2|||
128738335|NCT01038921|463333936|FG000|Overall Study|Withdrawal by Subject|1|||
128738336|NCT01038921|463333937|FG001|Overall Study|Withdrawal by Subject|0|||
128738337|NCT01038921|463333936|FG000|Overall Study|Physician Decision|1|||
128738338|NCT01038921|463333937|FG001|Overall Study|Physician Decision|0|||
128738339|NCT01978119|463333938|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
128738340|NCT01978119|463333939|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
128738341|NCT01978119|463333938|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
128738342|NCT01978119|463333939|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
128738343|NCT01978119|463333938|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128738344|NCT01978119|463333939|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
128738345|NCT03295201|463333940|FG000|Overall Study|Lost to Follow-up|1|||
128738346|NCT03295201|463333941|FG001|Overall Study|Lost to Follow-up|1|||
128738347|NCT03295201|463333940|FG000|Overall Study|Hospital admission|0|||
128738348|NCT03295201|463333941|FG001|Overall Study|Hospital admission|1|||
128738349|NCT04327934|463333942|FG000|Overall Study|Did not qualify|7|||
128738350|NCT04327934|463333943|FG001|Overall Study|Did not qualify|4|||
128738351|NCT04327934|463333942|FG000|Overall Study|Physician Decision|0|||
128738352|NCT04327934|463333943|FG001|Overall Study|Physician Decision|1|||
128738353|NCT03095417|463333948|FG000|Overall Study|missed|1|||
128738354|NCT03095417|463333949|FG001|Overall Study|missed|2|||
128738355|NCT03095417|463333950|FG002|Overall Study|missed|0|||
128738356|NCT03095417|463333951|FG003|Overall Study|missed|1|||
128738357|NCT03095417|463333948|FG000|Overall Study|Lost to Follow-up|2|||
128738358|NCT03095417|463333949|FG001|Overall Study|Lost to Follow-up|2|||
128738359|NCT03095417|463333950|FG002|Overall Study|Lost to Follow-up|1|||
128738360|NCT03095417|463333951|FG003|Overall Study|Lost to Follow-up|0|||
128738361|NCT03095417|463333948|FG000|Overall Study|refusal|0|||
128738362|NCT03095417|463333949|FG001|Overall Study|refusal|1|||
128738363|NCT03095417|463333950|FG002|Overall Study|refusal|0|||
128738364|NCT03095417|463333951|FG003|Overall Study|refusal|1|||
128738365|NCT03095417|463333948|FG000|Overall Study|Withdrawal by Subject|8|||
128738366|NCT03095417|463333949|FG001|Overall Study|Withdrawal by Subject|2|||
128738367|NCT03095417|463333950|FG002|Overall Study|Withdrawal by Subject|5|||
128738368|NCT03095417|463333951|FG003|Overall Study|Withdrawal by Subject|4|||
128738369|NCT03095417|463333948|FG000|Overall Study|Physician Decision|1|||
128738370|NCT03095417|463333949|FG001|Overall Study|Physician Decision|2|||
128738371|NCT03095417|463333950|FG002|Overall Study|Physician Decision|2|||
128738372|NCT03095417|463333951|FG003|Overall Study|Physician Decision|2|||
128738373|NCT03095417|463333948|FG000|Overall Study|Death|1|||
128738374|NCT03095417|463333949|FG001|Overall Study|Death|2|||
128738375|NCT03095417|463333950|FG002|Overall Study|Death|1|||
128738376|NCT03095417|463333951|FG003|Overall Study|Death|3|||
128738377|NCT01490060|463333952|FG000|Cycle 1|Change of Treatment|0|||
128738378|NCT01490060|463333953|FG001|Cycle 1|Change of Treatment|1|||
128738379|NCT01490060|463333954|FG002|Cycle 1|Change of Treatment|1|||
128738380|NCT01490060|463333955|FG003|Cycle 1|Change of Treatment|1|||
128738381|NCT01490060|463333952|FG000|Cycle 1|Insurance Denied|0|||
128738382|NCT01490060|463333953|FG001|Cycle 1|Insurance Denied|0|||
128738383|NCT01490060|463333954|FG002|Cycle 1|Insurance Denied|2|||
128738384|NCT01490060|463333955|FG003|Cycle 1|Insurance Denied|0|||
128738385|NCT01490060|463333952|FG000|Cycle 1|Withdrawal by Subject|0|||
128738386|NCT01490060|463333953|FG001|Cycle 1|Withdrawal by Subject|0|||
128738387|NCT01490060|463333954|FG002|Cycle 1|Withdrawal by Subject|0|||
128738388|NCT01490060|463333955|FG003|Cycle 1|Withdrawal by Subject|1|||
128738389|NCT01490060|463333952|FG000|Cycle 1|Treatment at Another Facility|0|||
128738390|NCT01490060|463333953|FG001|Cycle 1|Treatment at Another Facility|0|||
128738391|NCT01490060|463333954|FG002|Cycle 1|Treatment at Another Facility|0|||
128738392|NCT01490060|463333955|FG003|Cycle 1|Treatment at Another Facility|1|||
128738393|NCT01490060|463333952|FG000|Cycle 2|Change of Treatment|1|||
128738394|NCT01490060|463333953|FG001|Cycle 2|Change of Treatment|1|||
128738395|NCT01490060|463333954|FG002|Cycle 2|Change of Treatment|0|||
128738396|NCT01490060|463333955|FG003|Cycle 2|Change of Treatment|0|||
128738397|NCT01490060|463333952|FG000|Cycle 2|Non-Compliance|0|||
128738398|NCT01490060|463333953|FG001|Cycle 2|Non-Compliance|0|||
128738399|NCT01490060|463333954|FG002|Cycle 2|Non-Compliance|1|||
128738400|NCT01490060|463333955|FG003|Cycle 2|Non-Compliance|0|||
128738401|NCT01490060|463333952|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
128738402|NCT01490060|463333953|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
128738403|NCT01490060|463333954|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
128738404|NCT01490060|463333955|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
128738405|NCT01877421|463333956|FG000|Phase 2|Lost to Follow-up|0|||
128738406|NCT01877421|463333957|FG001|Phase 2|Lost to Follow-up|0|||
128738407|NCT01877421|463333958|FG002|Phase 2|Lost to Follow-up|0|||
128738408|NCT01877421|463333959|FG003|Phase 2|Lost to Follow-up|0|||
128738409|NCT01877421|463333960|FG004|Phase 2|Lost to Follow-up|0|||
128738410|NCT01877421|463333961|FG005|Phase 2|Lost to Follow-up|0|||
128738411|NCT01877421|463333962|FG006|Phase 2|Lost to Follow-up|1|||
128738412|NCT01877421|463333963|FG007|Phase 2|Lost to Follow-up|0|||
128738413|NCT01877421|463333964|FG008|Phase 2|Lost to Follow-up|0|||
128738414|NCT01877421|463333965|FG009|Phase 2|Lost to Follow-up|0|||
128738415|NCT01877421|463333966|FG010|Phase 2|Lost to Follow-up|0|||
128738416|NCT01877421|463333967|FG011|Phase 2|Lost to Follow-up|0|||
128738417|NCT01877421|463333968|FG012|Phase 2|Lost to Follow-up|0|||
128738418|NCT01877421|463333969|FG013|Phase 2|Lost to Follow-up|0|||
128738419|NCT01877421|463333970|FG014|Phase 2|Lost to Follow-up|0|||
128738420|NCT01877421|463333971|FG015|Phase 2|Lost to Follow-up|0|||
128738421|NCT01877421|463333972|FG016|Phase 2|Lost to Follow-up|0|||
128738422|NCT01877421|463333973|FG017|Phase 2|Lost to Follow-up|0|||
128738423|NCT01877421|463333956|FG000|Phase 2|Withdrawal by Subject|0|||
128738424|NCT01877421|463333957|FG001|Phase 2|Withdrawal by Subject|0|||
128738425|NCT01877421|463333958|FG002|Phase 2|Withdrawal by Subject|0|||
128738426|NCT01877421|463333959|FG003|Phase 2|Withdrawal by Subject|0|||
128738427|NCT01877421|463333960|FG004|Phase 2|Withdrawal by Subject|0|||
128738428|NCT01877421|463333961|FG005|Phase 2|Withdrawal by Subject|0|||
128738429|NCT01877421|463333962|FG006|Phase 2|Withdrawal by Subject|0|||
128738430|NCT01877421|463333963|FG007|Phase 2|Withdrawal by Subject|0|||
128738431|NCT01877421|463333964|FG008|Phase 2|Withdrawal by Subject|1|||
128738432|NCT01877421|463333965|FG009|Phase 2|Withdrawal by Subject|0|||
128738433|NCT01877421|463333966|FG010|Phase 2|Withdrawal by Subject|1|||
128738434|NCT01877421|463333967|FG011|Phase 2|Withdrawal by Subject|0|||
128738435|NCT01877421|463333968|FG012|Phase 2|Withdrawal by Subject|1|||
128738436|NCT01877421|463333969|FG013|Phase 2|Withdrawal by Subject|0|||
128738437|NCT01877421|463333970|FG014|Phase 2|Withdrawal by Subject|0|||
128738438|NCT01877421|463333971|FG015|Phase 2|Withdrawal by Subject|1|||
128738439|NCT01877421|463333972|FG016|Phase 2|Withdrawal by Subject|0|||
128738440|NCT01877421|463333973|FG017|Phase 2|Withdrawal by Subject|0|||
128738441|NCT01877421|463333956|FG000|Phase 2|Protocol Violation|0|||
128738442|NCT01877421|463333957|FG001|Phase 2|Protocol Violation|0|||
128738443|NCT01877421|463333958|FG002|Phase 2|Protocol Violation|0|||
128738444|NCT01877421|463333959|FG003|Phase 2|Protocol Violation|0|||
128738445|NCT01877421|463333960|FG004|Phase 2|Protocol Violation|0|||
128738446|NCT01877421|463333961|FG005|Phase 2|Protocol Violation|0|||
128738447|NCT01877421|463333962|FG006|Phase 2|Protocol Violation|0|||
128738448|NCT01877421|463333963|FG007|Phase 2|Protocol Violation|0|||
128738449|NCT01877421|463333964|FG008|Phase 2|Protocol Violation|0|||
128738450|NCT01877421|463333965|FG009|Phase 2|Protocol Violation|0|||
128738451|NCT01877421|463333966|FG010|Phase 2|Protocol Violation|1|||
128738452|NCT01877421|463333967|FG011|Phase 2|Protocol Violation|0|||
128738453|NCT01877421|463333968|FG012|Phase 2|Protocol Violation|0|||
128738454|NCT01877421|463333969|FG013|Phase 2|Protocol Violation|0|||
128738455|NCT01877421|463333970|FG014|Phase 2|Protocol Violation|0|||
128738456|NCT01877421|463333971|FG015|Phase 2|Protocol Violation|0|||
128738457|NCT01877421|463333972|FG016|Phase 2|Protocol Violation|0|||
128738458|NCT01877421|463333973|FG017|Phase 2|Protocol Violation|0|||
128738459|NCT01047683|463333974|FG000|Overall Study|Adverse Event|3|||
128738460|NCT01047683|463333975|FG001|Overall Study|Adverse Event|1|||
128738461|NCT01047683|463333976|FG002|Overall Study|Adverse Event|0|||
128738462|NCT01047683|463333974|FG000|Overall Study|Withdrew Consent|1|||
128738463|NCT01047683|463333975|FG001|Overall Study|Withdrew Consent|4|||
128738464|NCT01047683|463333976|FG002|Overall Study|Withdrew Consent|2|||
128738465|NCT01047683|463333974|FG000|Overall Study|Lost to Follow-up|0|||
128738466|NCT01047683|463333975|FG001|Overall Study|Lost to Follow-up|1|||
128738467|NCT01047683|463333976|FG002|Overall Study|Lost to Follow-up|0|||
128738468|NCT01047683|463333974|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
128738469|NCT01047683|463333975|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
128738470|NCT01047683|463333976|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
128738471|NCT03698773|463333978|FG000|Overall Study|Lost to Follow-up|2|||
128738472|NCT03698773|463333979|FG001|Overall Study|Lost to Follow-up|1|||
128738473|NCT00908960|463333980|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
128738474|NCT00908960|463333981|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
128738475|NCT00908960|463333982|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
128738476|NCT05074433|463333983|FG000|Overall Study|Adverse Event|0|||
128738477|NCT05074433|463333984|FG001|Overall Study|Adverse Event|2|||
128738478|NCT05074433|463333985|FG002|Overall Study|Adverse Event|0|||
128738479|NCT05074433|463333986|FG003|Overall Study|Adverse Event|1|||
128738480|NCT05074433|463333983|FG000|Overall Study|Sponsor Request|0|||
128738481|NCT05074433|463333984|FG001|Overall Study|Sponsor Request|1|||
128738482|NCT05074433|463333985|FG002|Overall Study|Sponsor Request|1|||
128738483|NCT05074433|463333986|FG003|Overall Study|Sponsor Request|0|||
128738484|NCT05074433|463333983|FG000|Overall Study|Death|1|||
128738485|NCT05074433|463333984|FG001|Overall Study|Death|0|||
128738486|NCT05074433|463333985|FG002|Overall Study|Death|0|||
128738487|NCT05074433|463333986|FG003|Overall Study|Death|0|||
128738488|NCT05074433|463333983|FG000|Overall Study|Lost to Follow-up|0|||
128738489|NCT05074433|463333984|FG001|Overall Study|Lost to Follow-up|0|||
128738490|NCT05074433|463333985|FG002|Overall Study|Lost to Follow-up|2|||
128738491|NCT05074433|463333986|FG003|Overall Study|Lost to Follow-up|0|||
128738492|NCT05074433|463333983|FG000|Overall Study|Subject Decision|8|||
128738493|NCT05074433|463333984|FG001|Overall Study|Subject Decision|6|||
128738494|NCT05074433|463333985|FG002|Overall Study|Subject Decision|4|||
128738495|NCT05074433|463333986|FG003|Overall Study|Subject Decision|5|||
128738496|NCT01158924|463333988|FG000|Overall Study|Withdrawal by Subject|1|||
128738497|NCT01158924|463333989|FG001|Overall Study|Withdrawal by Subject|2|||
128738498|NCT01158924|463333988|FG000|Overall Study|Lost to Follow-up|0|||
128738499|NCT01158924|463333989|FG001|Overall Study|Lost to Follow-up|1|||
128738500|NCT03795922|463333990|FG000|Overall Study|Adverse Event|2|||
128738501|NCT03795922|463333991|FG001|Overall Study|Adverse Event|1|||
128738502|NCT03795922|463333990|FG000|Overall Study|Withdrawal by Subject|5|||
128738503|NCT03795922|463333991|FG001|Overall Study|Withdrawal by Subject|13|||
128738504|NCT03795922|463333990|FG000|Overall Study|Lost to Follow-up|2|||
128738505|NCT03795922|463333991|FG001|Overall Study|Lost to Follow-up|3|||
128738506|NCT03795922|463333990|FG000|Overall Study|Pregnancy|0|||
128738507|NCT03795922|463333991|FG001|Overall Study|Pregnancy|1|||
128738508|NCT03795922|463333990|FG000|Overall Study|Physician Decision|1|||
128738509|NCT03795922|463333991|FG001|Overall Study|Physician Decision|2|||
128738510|NCT03795922|463333990|FG000|Overall Study|Protocol Violation|0|||
128738511|NCT03795922|463333991|FG001|Overall Study|Protocol Violation|1|||
128738512|NCT03795922|463333990|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
128738513|NCT03795922|463333991|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
128738514|NCT00724451|463333995|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
128738515|NCT00724451|463333995|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
128738516|NCT00724451|463333995|FG000|Overall Study|Not Eligible for Treatment|431|||
128738517|NCT00724451|463333995|FG000|Overall Study|Participant Refused Treatment|89|||
128738518|NCT00724451|463333995|FG000|Overall Study|Never Started Treatment|89|||
128738519|NCT00724451|463333995|FG000|Overall Study|Unknown; No Data Sources Available|9|||
128738520|NCT00724451|463333995|FG000|Overall Study|Physician Decision|116|||
128738521|NCT00724451|463333995|FG000|Overall Study|Withdrawal by Subject|45|||
128738522|NCT00724451|463333995|FG000|Overall Study|Investigator + Participant Decision|13|||
128738523|NCT01260922|463333997|FG000|First Intervention|Withdrawal by Subject|0|||
128738524|NCT01260922|463333998|FG001|First Intervention|Withdrawal by Subject|1|||
128738525|NCT01260922|463333997|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
128738526|NCT01260922|463333998|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
128738527|NCT01260922|463333997|FG000|Second Intervention|Emesis|0|||
128738528|NCT01260922|463333998|FG001|Second Intervention|Emesis|2|||
128738529|NCT02822794|463334003|FG000|Overall Study|Withdrew Consent|1|||
128738530|NCT02822794|463334004|FG001|Overall Study|Withdrew Consent|0|||
128738531|NCT03732248|463334005|FG000|Overall Study|Withdrawal by Subject|1|||
128738532|NCT03732248|463334006|FG001|Overall Study|Withdrawal by Subject|0|||
128738533|NCT00733824|463334007|FG000|Phase I|Withdrawal by Subject|1|||
128738534|NCT00733824|463334008|FG001|Phase I|Withdrawal by Subject|0|||
128738535|NCT00733824|463334009|FG002|Phase I|Withdrawal by Subject|0|||
128738536|NCT00733824|463334010|FG003|Phase I|Withdrawal by Subject|0|||
128738537|NCT00733824|463334011|FG004|Phase I|Withdrawal by Subject|0|||
128738538|NCT02799082|463334013|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
128738539|NCT02799082|463334014|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
128738540|NCT02799082|463334013|FG000|Overall Study|Protocol Violation|0|||
128738541|NCT02799082|463334014|FG001|Overall Study|Protocol Violation|1|||
128738542|NCT01591681|463334019|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
128738543|NCT01591681|463334019|FG000|Overall Study|Failed to use system during run-in|1|||
128738544|NCT01440946|463334020|FG000|Overall Study|Lost to Follow-up|1|||
128738545|NCT01440946|463334021|FG001|Overall Study|Lost to Follow-up|1|||
128738546|NCT01440946|463334020|FG000|Overall Study|Physician Decision|1|||
128738547|NCT01440946|463334021|FG001|Overall Study|Physician Decision|0|||
128738548|NCT01079234|463334024|FG000|Main: Week 0 to 26|Adverse Event|5|||
128738549|NCT01079234|463334025|FG001|Main: Week 0 to 26|Adverse Event|4|||
128738550|NCT01079234|463334026|FG002|Main: Week 0 to 26|Adverse Event|1|||
128738551|NCT01079234|463334027|FG003|Main: Week 0 to 26|Adverse Event|0|||
128738552|NCT01079234|463334024|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
128738553|NCT01079234|463334025|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
128738554|NCT01079234|463334026|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
128738555|NCT01079234|463334027|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
128738556|NCT01079234|463334024|FG000|Main: Week 0 to 26|Protocol Violation|6|||
128738557|NCT01079234|463334025|FG001|Main: Week 0 to 26|Protocol Violation|2|||
128738558|NCT01079234|463334026|FG002|Main: Week 0 to 26|Protocol Violation|4|||
128738559|NCT01079234|463334027|FG003|Main: Week 0 to 26|Protocol Violation|0|||
128738560|NCT01079234|463334024|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
128738561|NCT01079234|463334025|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
128738562|NCT01079234|463334026|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
128738563|NCT01079234|463334027|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
128738564|NCT01079234|463334024|FG000|Main: Week 0 to 26|Unclassified|7|||
128738565|NCT01079234|463334025|FG001|Main: Week 0 to 26|Unclassified|13|||
128738566|NCT01079234|463334026|FG002|Main: Week 0 to 26|Unclassified|4|||
128738567|NCT01079234|463334027|FG003|Main: Week 0 to 26|Unclassified|0|||
128738568|NCT01079234|463334024|FG000|Extension: Week 27 to 52|Adverse Event|0|||
128738569|NCT01079234|463334025|FG001|Extension: Week 27 to 52|Adverse Event|0|||
128738570|NCT01079234|463334026|FG002|Extension: Week 27 to 52|Adverse Event|1|||
128738571|NCT01079234|463334027|FG003|Extension: Week 27 to 52|Adverse Event|0|||
128738572|NCT01079234|463334024|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
128738573|NCT01079234|463334025|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
128738574|NCT01079234|463334026|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
128738575|NCT01079234|463334027|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
128738576|NCT01079234|463334024|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
128738577|NCT01079234|463334025|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
128738578|NCT01079234|463334026|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
128738579|NCT01079234|463334027|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
128738580|NCT01079234|463334024|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
128738581|NCT01079234|463334025|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
128738582|NCT01079234|463334026|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
128738583|NCT01079234|463334027|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
128738584|NCT01079234|463334024|FG000|Extension: Week 27 to 52|Unclassified|0|||
128738585|NCT01079234|463334025|FG001|Extension: Week 27 to 52|Unclassified|0|||
128738586|NCT01079234|463334026|FG002|Extension: Week 27 to 52|Unclassified|4|||
128738587|NCT01079234|463334027|FG003|Extension: Week 27 to 52|Unclassified|7|||
128738588|NCT01312961|463334034|FG000|Overall Study|Adverse Event|3|||
128738589|NCT01312961|463334035|FG001|Overall Study|Adverse Event|3|||
128738590|NCT01312961|463334034|FG000|Overall Study|Lack of Efficacy|11|||
128738591|NCT01312961|463334035|FG001|Overall Study|Lack of Efficacy|1|||
128738592|NCT01312961|463334034|FG000|Overall Study|Poor compliance to protocol|1|||
128738593|NCT01312961|463334035|FG001|Overall Study|Poor compliance to protocol|0|||
128738594|NCT01312961|463334034|FG000|Overall Study|Other than specified above|2|||
128738595|NCT01312961|463334035|FG001|Overall Study|Other than specified above|3|||
128738596|NCT04278417|463334040|FG000|Overall Study|Withdrawal by Subject|20|||
128738597|NCT04278417|463334041|FG001|Overall Study|Withdrawal by Subject|20|||
128738598|NCT04278417|463334040|FG000|Overall Study|Progressive disease|0|||
128738599|NCT04278417|463334041|FG001|Overall Study|Progressive disease|2|||
128738600|NCT04278417|463334040|FG000|Overall Study|Physician Decision|4|||
128738601|NCT04278417|463334041|FG001|Overall Study|Physician Decision|6|||
128738602|NCT04278417|463334040|FG000|Overall Study|Lost to Follow-up|11|||
128738603|NCT04278417|463334041|FG001|Overall Study|Lost to Follow-up|13|||
128738604|NCT04278417|463334040|FG000|Overall Study|Death|8|||
128738605|NCT04278417|463334041|FG001|Overall Study|Death|9|||
128738606|NCT04278417|463334040|FG000|Overall Study|Adverse Event|3|||
128738607|NCT04278417|463334041|FG001|Overall Study|Adverse Event|5|||
128738608|NCT00205712|463334043|FG000|Overall Study|Lost to Follow-up|0|||
128738609|NCT00205712|463334044|FG001|Overall Study|Lost to Follow-up|1|||
128738610|NCT01652716|463334054|FG000|Overall Study|Loss of glucose control|1|||
128738611|NCT01652716|463334055|FG001|Overall Study|Loss of glucose control|0|||
128738612|NCT01652716|463334054|FG000|Overall Study|Administrative|0|||
128738613|NCT01652716|463334055|FG001|Overall Study|Administrative|2|||
128738614|NCT01652716|463334054|FG000|Overall Study|Investigator decision|1|||
128738615|NCT01652716|463334055|FG001|Overall Study|Investigator decision|4|||
128738616|NCT01652716|463334054|FG000|Overall Study|Lost to Follow-up|12|||
128738617|NCT01652716|463334055|FG001|Overall Study|Lost to Follow-up|11|||
128738618|NCT01652716|463334054|FG000|Overall Study|Protocol Violation|2|||
128738619|NCT01652716|463334055|FG001|Overall Study|Protocol Violation|1|||
128738620|NCT01652716|463334054|FG000|Overall Study|Adverse Event|7|||
128738621|NCT01652716|463334055|FG001|Overall Study|Adverse Event|10|||
128738622|NCT01652716|463334054|FG000|Overall Study|Withdrawal by Subject|33|||
128738623|NCT01652716|463334055|FG001|Overall Study|Withdrawal by Subject|18|||
128738624|NCT01337297|463334056|FG000|Overall Study|They entered to single anodal tDCS|4|||
128738625|NCT01337297|463334057|FG001|Overall Study|They entered to single anodal tDCS|3|||
128738626|NCT01337297|463334056|FG000|Overall Study|Lost to Follow-up|1|||
128738627|NCT01337297|463334057|FG001|Overall Study|Lost to Follow-up|3|||
128738628|NCT02778204|463334058|FG000|Overall Study|Adverse Event|1|||
128738629|NCT02778204|463334059|FG001|Overall Study|Adverse Event|0|||
128738630|NCT02778204|463334060|FG002|Overall Study|Adverse Event|0|||
128738631|NCT02778204|463334061|FG003|Overall Study|Adverse Event|0|||
128738632|NCT02778204|463334058|FG000|Overall Study|Withdrawal by Subject|0|||
128738633|NCT02778204|463334059|FG001|Overall Study|Withdrawal by Subject|0|||
128738634|NCT02778204|463334060|FG002|Overall Study|Withdrawal by Subject|1|||
128738635|NCT02778204|463334061|FG003|Overall Study|Withdrawal by Subject|2|||
128738636|NCT02778204|463334058|FG000|Overall Study|Lost to Follow-up|1|||
128738637|NCT02778204|463334059|FG001|Overall Study|Lost to Follow-up|0|||
128738638|NCT02778204|463334060|FG002|Overall Study|Lost to Follow-up|2|||
128738639|NCT02778204|463334061|FG003|Overall Study|Lost to Follow-up|1|||
128738640|NCT02778204|463334058|FG000|Overall Study|Protocol Violation|0|||
128738641|NCT02778204|463334059|FG001|Overall Study|Protocol Violation|0|||
128738642|NCT02778204|463334060|FG002|Overall Study|Protocol Violation|1|||
128738643|NCT02778204|463334061|FG003|Overall Study|Protocol Violation|0|||
128738644|NCT02778204|463334058|FG000|Overall Study|Eligibility Violation|0|||
128738645|NCT02778204|463334059|FG001|Overall Study|Eligibility Violation|0|||
128738646|NCT02778204|463334060|FG002|Overall Study|Eligibility Violation|0|||
128738647|NCT02778204|463334061|FG003|Overall Study|Eligibility Violation|1|||
128738648|NCT01694706|463335982|FG000|Overall Study|Adverse Event|0|||
128738649|NCT01694706|463335983|FG001|Overall Study|Adverse Event|1|||
128738650|NCT01694706|463335984|FG002|Overall Study|Adverse Event|0|||
128738651|NCT01694706|463335982|FG000|Overall Study|other reason not defined above|1|||
128738652|NCT01694706|463335983|FG001|Overall Study|other reason not defined above|0|||
128738653|NCT01694706|463335984|FG002|Overall Study|other reason not defined above|0|||
128738654|NCT00530023|463335985|FG000|Overall Study|Withdrawal by Subject|0|||
128738655|NCT00530023|463335986|FG001|Overall Study|Withdrawal by Subject|1|||
128738656|NCT01172938|463335990|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
128738657|NCT01172938|463335991|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
128738658|NCT01172938|463335992|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
128738659|NCT01172938|463335993|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128738660|NCT01172938|463335994|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128738661|NCT01172938|463335995|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128738662|NCT01172938|463335996|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128738663|NCT01172938|463335997|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128738664|NCT01172938|463335998|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
128738665|NCT01172938|463335990|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
128738666|NCT01172938|463335991|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
128738667|NCT01172938|463335992|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
128738668|NCT01172938|463335993|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128738669|NCT01172938|463335994|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128738670|NCT01172938|463335995|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128738671|NCT01172938|463335996|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128738672|NCT01172938|463335997|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128738673|NCT01172938|463335998|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
128738674|NCT01172938|463335990|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128738675|NCT01172938|463335991|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
128738676|NCT01172938|463335992|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
128738677|NCT01172938|463335993|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128738678|NCT01172938|463335994|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128738679|NCT01172938|463335995|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128738680|NCT01172938|463335996|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128738681|NCT01172938|463335997|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128738682|NCT01172938|463335998|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
128738683|NCT01172938|463335990|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
128738684|NCT01172938|463335991|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
128738685|NCT01172938|463335992|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
128738686|NCT01172938|463335993|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128738687|NCT01172938|463335994|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128738688|NCT01172938|463335995|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128738689|NCT01172938|463335996|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128738690|NCT01172938|463335997|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128738691|NCT01172938|463335998|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
128738692|NCT01172938|463335990|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738693|NCT01172938|463335991|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
128738694|NCT01172938|463335992|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738695|NCT01172938|463335993|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738696|NCT01172938|463335994|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738697|NCT01172938|463335995|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738698|NCT01172938|463335996|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738699|NCT01172938|463335997|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738700|NCT01172938|463335998|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
128738701|NCT01172938|463335990|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
128738702|NCT01172938|463335991|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738703|NCT01172938|463335992|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738704|NCT01172938|463335993|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738705|NCT01172938|463335994|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738706|NCT01172938|463335995|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738707|NCT01172938|463335996|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738708|NCT01172938|463335997|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738709|NCT01172938|463335998|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
128738710|NCT01172938|463335990|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
128738711|NCT01172938|463335991|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
128738712|NCT01172938|463335992|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
128738713|NCT01172938|463335993|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
128738714|NCT01172938|463335994|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
128738715|NCT01172938|463335995|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
128738716|NCT01172938|463335996|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
128738717|NCT01172938|463335997|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
128738718|NCT01172938|463335998|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
128738719|NCT01172938|463335990|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
128738720|NCT01172938|463335991|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
128738721|NCT01172938|463335992|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
128738722|NCT01172938|463335993|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
128738723|NCT01172938|463335994|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
128738724|NCT01172938|463335995|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
128738725|NCT01172938|463335996|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
128738726|NCT01172938|463335997|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
128738727|NCT01172938|463335998|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
128738728|NCT01172938|463335990|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
128738729|NCT01172938|463335991|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
128738730|NCT01172938|463335992|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
128738731|NCT01172938|463335993|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
128738732|NCT01172938|463335994|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
128738733|NCT01172938|463335995|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
128738734|NCT01172938|463335996|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
128738735|NCT01172938|463335997|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
128738736|NCT01172938|463335998|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
128738737|NCT01172938|463335990|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738738|NCT01172938|463335991|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738739|NCT01172938|463335992|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
128738740|NCT01172938|463335993|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738741|NCT01172938|463335994|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738742|NCT01172938|463335995|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738743|NCT01172938|463335996|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738744|NCT01172938|463335997|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738745|NCT01172938|463335998|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
128738746|NCT01172938|463335990|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
128738747|NCT01172938|463335991|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
128738748|NCT01172938|463335992|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
128738749|NCT01172938|463335993|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
128738750|NCT01172938|463335994|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
128738751|NCT01172938|463335995|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
128738752|NCT01172938|463335996|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
128738753|NCT01172938|463335997|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
128738754|NCT01172938|463335998|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
128738755|NCT01172938|463335990|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
128738756|NCT01172938|463335991|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
128738757|NCT01172938|463335992|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
128738758|NCT01172938|463335993|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
128738759|NCT01172938|463335994|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
128738760|NCT01172938|463335995|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
128738761|NCT01172938|463335996|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
128738762|NCT01172938|463335997|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
128738763|NCT01172938|463335998|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
128738764|NCT01172938|463335990|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
128738765|NCT01172938|463335991|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
128738766|NCT01172938|463335992|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
128738767|NCT01172938|463335993|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
128738768|NCT01172938|463335994|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
128738769|NCT01172938|463335995|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
128738770|NCT01172938|463335996|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
128738771|NCT01172938|463335997|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
128738772|NCT01172938|463335998|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
128738773|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
128738774|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
128738775|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
128738776|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
128738777|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
128738778|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
128738779|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
128738780|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
128738781|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
128738782|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
128738783|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
128738784|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
128738785|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
128738786|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
128738787|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
128738788|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
128738789|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
128738790|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
128738791|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738792|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738793|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
128738794|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738795|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738796|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738797|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738798|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738799|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
128738800|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
128738801|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
128738802|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
128738803|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
128738804|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
128738805|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
128785153|NCT00817635|463505924|FG002|Overall Study|Administrative Problems|0|||
128785154|NCT00817635|463505925|FG003|Overall Study|Administrative Problems|0|||
128785155|NCT00817635|463505926|FG004|Overall Study|Administrative Problems|1|||
128738806|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
128738807|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
128738808|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
128785156|NCT00817635|463505922|FG000|Overall Study|Protocol Violation|5|||
128738809|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738810|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738811|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
128738812|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738813|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738814|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738815|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738816|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738817|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
128738818|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
128738819|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
128738820|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
128738821|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
128738822|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
128738823|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
128738824|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
128738825|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
128738826|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
128738827|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
128738828|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
128738829|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
128738830|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
128738831|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
128738832|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
128738833|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
128738834|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
128738835|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
128738836|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738837|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
128738838|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738839|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738840|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738841|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738842|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738843|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738844|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
128738845|NCT01172938|463335990|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738846|NCT01172938|463335991|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738847|NCT01172938|463335992|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738848|NCT01172938|463335993|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738849|NCT01172938|463335994|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738850|NCT01172938|463335995|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738851|NCT01172938|463335996|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738852|NCT01172938|463335997|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
128738853|NCT01172938|463335998|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
128738854|NCT01172938|463335990|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
128738855|NCT01172938|463335991|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
128738856|NCT01172938|463335992|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
128738857|NCT01172938|463335993|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
128738858|NCT01172938|463335994|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
128738859|NCT01172938|463335995|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
128738860|NCT01172938|463335996|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
128738861|NCT01172938|463335997|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
128738862|NCT01172938|463335998|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
128738863|NCT01172938|463335990|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
128738864|NCT01172938|463335991|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
128738865|NCT01172938|463335992|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
128738866|NCT01172938|463335993|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
128738867|NCT01172938|463335994|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
128738868|NCT01172938|463335995|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
128738869|NCT01172938|463335996|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
128738870|NCT01172938|463335997|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
128785157|NCT00817635|463505923|FG001|Overall Study|Protocol Violation|1|||
128785158|NCT00817635|463505924|FG002|Overall Study|Protocol Violation|3|||
128785159|NCT00817635|463505925|FG003|Overall Study|Protocol Violation|2|||
128738871|NCT01172938|463335998|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
128738872|NCT01172938|463335990|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738873|NCT01172938|463335991|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738874|NCT01172938|463335992|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738875|NCT01172938|463335993|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738876|NCT01172938|463335994|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738877|NCT01172938|463335995|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738878|NCT01172938|463335996|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738879|NCT01172938|463335997|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
128738880|NCT01172938|463335998|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
128738881|NCT01172938|463335990|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738882|NCT01172938|463335991|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
128738883|NCT01172938|463335992|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738884|NCT01172938|463335993|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738885|NCT01172938|463335994|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738886|NCT01172938|463335995|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738887|NCT01172938|463335996|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738888|NCT01172938|463335997|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738889|NCT01172938|463335998|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
128738890|NCT01172938|463335990|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738891|NCT01172938|463335991|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738892|NCT01172938|463335992|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
128738893|NCT01172938|463335993|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738894|NCT01172938|463335994|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738895|NCT01172938|463335995|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738896|NCT01172938|463335996|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738897|NCT01172938|463335997|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738898|NCT01172938|463335998|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
128738899|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
128738900|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
128738901|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
128738902|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
128738903|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
128738904|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
128738905|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
128738906|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
128738907|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
128738908|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
128738909|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
128738910|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
128738911|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
128738912|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
128738913|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
128738914|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
128738915|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
128738916|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
128738917|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
128738918|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
128738919|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
128738920|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
128738921|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
128738922|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
128738923|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
128738924|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
128738925|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
128738926|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
128738927|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
128738928|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
128738929|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
128738930|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
128738931|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
128738932|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
128738933|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
128738934|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
128738935|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128785160|NCT00817635|463505926|FG004|Overall Study|Protocol Violation|3|||
128738936|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128738937|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128738938|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128738939|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128738940|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128738941|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128738942|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
128738943|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
128738944|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
128738945|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
128738946|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
128738947|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
128738948|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
128738949|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
128738950|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
128738951|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
128738952|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
128738953|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738954|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738955|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
128738956|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738957|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738958|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738959|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738960|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738961|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
128738962|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
128738963|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
128738964|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
128738965|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
128738966|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
128738967|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
128738968|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
128738969|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
128738970|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
128738971|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
128738972|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
128738973|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
128738974|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
128738975|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
128738976|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
128738977|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
128738978|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
128738979|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
128738980|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738981|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738982|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
128738983|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738984|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738985|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738986|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738987|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738988|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
128738989|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738990|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738991|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
128738992|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738993|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738994|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738995|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738996|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738997|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
128738998|NCT01172938|463335990|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128738999|NCT01172938|463335991|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128739000|NCT01172938|463335992|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128739001|NCT01172938|463335993|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128739002|NCT01172938|463335994|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128739003|NCT01172938|463335995|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128739004|NCT01172938|463335996|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128739005|NCT01172938|463335997|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
128739006|NCT01172938|463335998|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
128739007|NCT00003498|463335999|FG000|Overall Study|Not evaluable.|4|||
128739008|NCT05282004|463336003|FG000|Overall Study|Adverse Event|2|||
128739009|NCT00889421|463336004|FG000|Overall Study|Lack of Efficacy|3|||
128739010|NCT01958918|463336005|FG000|Overall Study|Death|1|||
128739011|NCT01958918|463336006|FG001|Overall Study|Death|3|||
128739012|NCT01958918|463336005|FG000|Overall Study|Lost to Follow-up|4|||
128739013|NCT01958918|463336006|FG001|Overall Study|Lost to Follow-up|7|||
128739014|NCT01958918|463336005|FG000|Overall Study|Withdrawal by Subject|13|||
128739015|NCT01958918|463336006|FG001|Overall Study|Withdrawal by Subject|8|||
128739016|NCT01958918|463336005|FG000|Overall Study|Lack of Efficacy|13|||
128739017|NCT01958918|463336006|FG001|Overall Study|Lack of Efficacy|10|||
128739018|NCT01958918|463336005|FG000|Overall Study|Adverse Event|12|||
128739019|NCT01958918|463336006|FG001|Overall Study|Adverse Event|12|||
128739020|NCT01958918|463336005|FG000|Overall Study|administrative problems|0|||
128739021|NCT01958918|463336006|FG001|Overall Study|administrative problems|2|||
128739022|NCT00659269|463336007|FG000|Overall Study|Physician Decision|1|||
128739023|NCT00659269|463336008|FG001|Overall Study|Physician Decision|1|||
128739024|NCT01158222|463336009|FG000|Overall Study|Not eligible for intermediate phase|17|||
128739025|NCT02443298|463336010|FG000|Overall Study|Adverse Event|3|||
128739026|NCT02443298|463336011|FG001|Overall Study|Adverse Event|3|||
128739027|NCT02443298|463336010|FG000|Overall Study|Withdrawal by Subject|1|||
128739028|NCT02443298|463336011|FG001|Overall Study|Withdrawal by Subject|2|||
128739029|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
128739030|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
128739031|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
128739032|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
128739033|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
128739034|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
128739035|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
128739036|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
128739037|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
128739038|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
128739039|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
128739040|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
128739041|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
128739042|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
128739043|NCT02464969|463336012|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
128739044|NCT02464969|463336013|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
128739045|NCT02464969|463336012|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
128739046|NCT02464969|463336013|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
128739047|NCT02464969|463336012|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
128739048|NCT02464969|463336013|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
128739049|NCT02464969|463336012|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
128739050|NCT02464969|463336013|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
128739051|NCT02399085|463336014|FG000|Overall Study|Adverse Event|16|||
128739052|NCT02399085|463336014|FG000|Overall Study|Death|2|||
128739053|NCT02399085|463336014|FG000|Overall Study|Withdrawal by Subject|8|||
128739054|NCT02399085|463336014|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
128739055|NCT02399085|463336014|FG000|Overall Study|Physician Decision|5|||
128739056|NCT00833924|463336015|FG000|Overall Study|Death|21|||
128739057|NCT00833924|463336015|FG000|Overall Study|Conversion|2|||
128739058|NCT00833924|463336015|FG000|Overall Study|Lost to Follow-up|2|||
128739059|NCT00833924|463336015|FG000|Overall Study|Withdrawal by Subject|13|||
128739060|NCT00833924|463336015|FG000|Overall Study|In study follow-up|71|||
128739061|NCT01410110|463336016|FG000|Overall Study|Withdrawal by Subject|4|||
128739062|NCT01410110|463336017|FG001|Overall Study|Withdrawal by Subject|2|||
128739063|NCT01525082|463336021|FG000|Overall Study|Death|1|||
128739064|NCT02480621|463336022|FG000|Randomization|Withdrawal by Subject|1|||
128739065|NCT02480621|463336023|FG001|Randomization|Withdrawal by Subject|0|||
128785161|NCT04176458|463505929|FG000|Overall Study|Covid 19|4|||
128785162|NCT00930813|463505930|FG000|Overall Study|Death|4|||
128739066|NCT02480621|463336022|FG000|Randomization|Surgeon did not give intervention|0|||
128739067|NCT02480621|463336023|FG001|Randomization|Surgeon did not give intervention|1|||
128739068|NCT02480621|463336022|FG000|Follow Up|Lost to Follow-up|4|||
128785163|NCT00930813|463505931|FG001|Overall Study|Death|5|||
128739069|NCT02480621|463336023|FG001|Follow Up|Lost to Follow-up|2|||
128739070|NCT02141516|463336030|FG000|Overall Study|Adverse Event|0|||
128739071|NCT02141516|463336031|FG001|Overall Study|Adverse Event|1|||
128739072|NCT02141516|463336032|FG002|Overall Study|Adverse Event|0|||
128739073|NCT02141516|463336030|FG000|Overall Study|Lost to Follow-up|0|||
128739074|NCT02141516|463336031|FG001|Overall Study|Lost to Follow-up|1|||
128739075|NCT02141516|463336032|FG002|Overall Study|Lost to Follow-up|0|||
128739076|NCT02141516|463336030|FG000|Overall Study|Other|0|||
128739077|NCT02141516|463336031|FG001|Overall Study|Other|3|||
128739078|NCT02141516|463336032|FG002|Overall Study|Other|0|||
128739079|NCT00235989|463336033|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
128739080|NCT00235989|463336034|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
128739081|NCT00235989|463336035|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
128739082|NCT00235989|463336036|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
128739083|NCT00235989|463336037|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
128739084|NCT00235989|463336038|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
128739085|NCT00235989|463336033|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
128739086|NCT00235989|463336034|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
128739087|NCT00235989|463336035|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
128739088|NCT00235989|463336036|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
128739089|NCT00235989|463336037|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
128739090|NCT00235989|463336038|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
128739091|NCT00235989|463336033|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
128739092|NCT00235989|463336034|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
128739093|NCT00235989|463336035|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
128739094|NCT00235989|463336036|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
128739095|NCT00235989|463336037|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
128739096|NCT00235989|463336038|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
128739097|NCT00235989|463336033|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
128739098|NCT00235989|463336034|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
128739099|NCT00235989|463336035|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
128739100|NCT00235989|463336036|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
128739101|NCT00235989|463336037|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
128739102|NCT00235989|463336038|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
128739103|NCT00235989|463336033|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
128739104|NCT00235989|463336034|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
128739105|NCT00235989|463336035|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
128739106|NCT00235989|463336036|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
128739107|NCT00235989|463336037|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
128739108|NCT00235989|463336038|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
128739109|NCT00983580|463336039|FG000|Overall Study|Cancel Prior to treatment|1|||
128739110|NCT00983580|463336040|FG001|Overall Study|Cancel Prior to treatment|3|||
128739111|NCT00983580|463336039|FG000|Overall Study|Protocol Violation|1|||
128739112|NCT00983580|463336040|FG001|Overall Study|Protocol Violation|1|||
128785164|NCT00930813|463505930|FG000|Overall Study|Withdrawal by Subject|2|||
128739113|NCT00983580|463336039|FG000|Overall Study|Ineligible|3|||
128739114|NCT00983580|463336040|FG001|Overall Study|Ineligible|0|||
128739115|NCT02316717|463336043|FG000|Overall Study|Adverse Event|2|||
128739116|NCT02316717|463336044|FG001|Overall Study|Adverse Event|2|||
128739117|NCT02316717|463336045|FG002|Overall Study|Adverse Event|0|||
128739118|NCT02316717|463336043|FG000|Overall Study|Lost to Follow-up|1|||
128739119|NCT02316717|463336044|FG001|Overall Study|Lost to Follow-up|2|||
128739120|NCT02316717|463336045|FG002|Overall Study|Lost to Follow-up|1|||
128739121|NCT02316717|463336043|FG000|Overall Study|Non compliance|3|||
128739122|NCT02316717|463336044|FG001|Overall Study|Non compliance|1|||
128739123|NCT02316717|463336045|FG002|Overall Study|Non compliance|0|||
128739124|NCT02316717|463336043|FG000|Overall Study|Protocol Violation|2|||
128739125|NCT02316717|463336044|FG001|Overall Study|Protocol Violation|0|||
128739126|NCT02316717|463336045|FG002|Overall Study|Protocol Violation|0|||
128739127|NCT02316717|463336043|FG000|Overall Study|Withdrawal by Subject|2|||
128739128|NCT02316717|463336044|FG001|Overall Study|Withdrawal by Subject|1|||
128739129|NCT02316717|463336045|FG002|Overall Study|Withdrawal by Subject|1|||
128739130|NCT02316717|463336043|FG000|Overall Study|Death|0|||
128739131|NCT02316717|463336044|FG001|Overall Study|Death|0|||
128739132|NCT02316717|463336045|FG002|Overall Study|Death|1|||
128739133|NCT02316717|463336043|FG000|Overall Study|Physician Decision|0|||
128739134|NCT02316717|463336044|FG001|Overall Study|Physician Decision|1|||
128739135|NCT02316717|463336045|FG002|Overall Study|Physician Decision|0|||
128739136|NCT02316717|463336043|FG000|Overall Study|TBC|1|||
128739137|NCT02316717|463336044|FG001|Overall Study|TBC|0|||
128739138|NCT02316717|463336045|FG002|Overall Study|TBC|0|||
128739139|NCT01072201|463336046|FG000|Overall Study|Lost to Follow-up|0|||
128739140|NCT01072201|463336047|FG001|Overall Study|Lost to Follow-up|1|||
128739141|NCT02052466|463336048|FG000|Overall Study|Withdrawal by Subject|1|||
128739142|NCT02052466|463336048|FG000|Overall Study|Acromial fracture|1|||
128739143|NCT00360334|463336049|FG000|Overall Study|Adverse Event|7|||
128739144|NCT00360334|463336050|FG001|Overall Study|Adverse Event|4|||
128739145|NCT00360334|463336049|FG000|Overall Study|Protocol Violation|1|||
128739146|NCT00360334|463336050|FG001|Overall Study|Protocol Violation|1|||
128739147|NCT00360334|463336049|FG000|Overall Study|Physician Decision|2|||
128739148|NCT00360334|463336050|FG001|Overall Study|Physician Decision|3|||
128739149|NCT00360334|463336049|FG000|Overall Study|Lack of Efficacy|0|||
128739150|NCT00360334|463336050|FG001|Overall Study|Lack of Efficacy|1|||
128739151|NCT00360334|463336049|FG000|Overall Study|Entry criterion not met|1|||
128739152|NCT00360334|463336050|FG001|Overall Study|Entry criterion not met|2|||
128739153|NCT00360334|463336049|FG000|Overall Study|Subject decision|8|||
128739154|NCT00360334|463336050|FG001|Overall Study|Subject decision|2|||
128739155|NCT00595582|463336051|FG000|Overall Study|Pilot study that PI terminated|2|||
128739156|NCT00595582|463336051|FG000|Overall Study|Lost to Follow-up|1|||
128739157|NCT00595582|463336051|FG000|Overall Study|Adverse Event|2|||
128739158|NCT00595582|463336051|FG000|Overall Study|Physician Decision|5|||
128739159|NCT01978184|463336053|FG000|Overall Study|Progressive disease|5|||
128739160|NCT01978184|463336054|FG001|Overall Study|Progressive disease|5|||
128739161|NCT01978184|463336053|FG000|Overall Study|Other than PDA|2|||
128739162|NCT01978184|463336054|FG001|Overall Study|Other than PDA|2|||
128739163|NCT01978184|463336053|FG000|Overall Study|Physician Decision|0|||
128739164|NCT01978184|463336054|FG001|Overall Study|Physician Decision|3|||
128739165|NCT01978184|463336053|FG000|Overall Study|Noncompliance|1|||
128739166|NCT01978184|463336054|FG001|Overall Study|Noncompliance|2|||
128739167|NCT01978184|463336053|FG000|Overall Study|Death|1|||
128739168|NCT01978184|463336054|FG001|Overall Study|Death|0|||
128739169|NCT01978184|463336053|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
128739170|NCT01978184|463336054|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
128739171|NCT00965848|463336063|FG000|Overall Study|Protocol Violation|3|||
128739172|NCT00965848|463336064|FG001|Overall Study|Protocol Violation|0|||
128739173|NCT00965848|463336065|FG002|Overall Study|Protocol Violation|1|||
128739174|NCT00965848|463336063|FG000|Overall Study|Death|11|||
128739175|NCT00965848|463336064|FG001|Overall Study|Death|1|||
128739176|NCT00965848|463336065|FG002|Overall Study|Death|5|||
128739177|NCT00965848|463336063|FG000|Overall Study|Lost to Follow-up|0|||
128739178|NCT00965848|463336064|FG001|Overall Study|Lost to Follow-up|0|||
128739179|NCT00965848|463336065|FG002|Overall Study|Lost to Follow-up|1|||
128739180|NCT00965848|463336063|FG000|Overall Study|Withdrawal by Subject|1|||
128739181|NCT00965848|463336064|FG001|Overall Study|Withdrawal by Subject|0|||
128739182|NCT00965848|463336065|FG002|Overall Study|Withdrawal by Subject|0|||
128739183|NCT00965848|463336063|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
128739184|NCT00965848|463336064|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
128739185|NCT00965848|463336065|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
128739186|NCT00965848|463336063|FG000|Overall Study|Not Clinically Evaluable|7|||
128739187|NCT00965848|463336064|FG001|Overall Study|Not Clinically Evaluable|1|||
128739188|NCT00965848|463336065|FG002|Overall Study|Not Clinically Evaluable|1|||
128739189|NCT00965848|463336063|FG000|Overall Study|Other|5|||
128739190|NCT00965848|463336064|FG001|Overall Study|Other|0|||
128739191|NCT00965848|463336065|FG002|Overall Study|Other|1|||
128739192|NCT01328002|463336067|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
128739193|NCT01328002|463336068|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
128739194|NCT01328002|463336067|FG000|Open-Label Period|Adverse Event|8|||
128739195|NCT01328002|463336068|FG001|Open-Label Period|Adverse Event|0|||
128739196|NCT01328002|463336067|FG000|Open-Label Period|Lack of Efficacy|3|||
128739197|NCT01328002|463336068|FG001|Open-Label Period|Lack of Efficacy|0|||
128739198|NCT01328002|463336067|FG000|Open-Label Period|Protocol Violation|2|||
128739199|NCT01328002|463336068|FG001|Open-Label Period|Protocol Violation|0|||
128739200|NCT01328002|463336067|FG000|Open-Label Period|Withdrawal by Subject|9|||
128739201|NCT01328002|463336068|FG001|Open-Label Period|Withdrawal by Subject|0|||
128739202|NCT01328002|463336067|FG000|Open-Label Period|Lost to Follow-up|6|||
128739203|NCT01328002|463336068|FG001|Open-Label Period|Lost to Follow-up|0|||
128739204|NCT01328002|463336067|FG000|Open-Label Period|Other Reason|2|||
128739205|NCT01328002|463336068|FG001|Open-Label Period|Other Reason|0|||
128739206|NCT01328002|463336067|FG000|Double-Blind Period|Adverse Event|1|||
128739207|NCT01328002|463336068|FG001|Double-Blind Period|Adverse Event|0|||
128739208|NCT01328002|463336067|FG000|Double-Blind Period|Lack of Efficacy|1|||
128739209|NCT01328002|463336068|FG001|Double-Blind Period|Lack of Efficacy|0|||
128739210|NCT00813761|463336069|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
128739211|NCT00813761|463336070|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
128739212|NCT00813761|463336071|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
128739213|NCT00813761|463336072|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
128739214|NCT00813761|463336069|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
128739215|NCT00813761|463336070|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
128739216|NCT00813761|463336071|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
128739217|NCT00813761|463336072|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
128739218|NCT00813761|463336069|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
128739219|NCT00813761|463336070|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
128739220|NCT00813761|463336071|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
128739221|NCT00813761|463336072|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
128739222|NCT00813761|463336069|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
128739223|NCT00813761|463336070|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
128739224|NCT00813761|463336071|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
128739225|NCT00813761|463336072|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
128739226|NCT00813761|463336069|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
128785165|NCT00930813|463505931|FG001|Overall Study|Withdrawal by Subject|5|||
128739227|NCT00813761|463336070|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
128739228|NCT00813761|463336071|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
128739229|NCT00813761|463336072|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
128739230|NCT00813761|463336069|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
128739231|NCT00813761|463336070|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
128739232|NCT00813761|463336071|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
128739233|NCT00813761|463336072|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
128739234|NCT00813761|463336069|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
128739235|NCT00813761|463336070|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
128739236|NCT00813761|463336071|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
128739237|NCT00813761|463336072|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
128739238|NCT00813761|463336069|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
128739239|NCT00813761|463336070|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
128739240|NCT00813761|463336071|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
128739241|NCT00813761|463336072|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
128739242|NCT00813761|463336069|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
128739243|NCT00813761|463336070|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
128739244|NCT00813761|463336071|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
128739245|NCT00813761|463336072|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
128739246|NCT00813761|463336069|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
128739247|NCT00813761|463336070|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
128739248|NCT00813761|463336071|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
128739249|NCT00813761|463336072|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
128739250|NCT00813761|463336069|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
128739251|NCT00813761|463336070|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
128739252|NCT00813761|463336071|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
128739253|NCT00813761|463336072|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
128739254|NCT00813761|463336069|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
128739255|NCT00813761|463336070|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
128739256|NCT00813761|463336071|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
128739257|NCT00813761|463336072|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
128739258|NCT01208233|463336074|FG000|Overall Study|Adverse Event|0|||
128739259|NCT01208233|463336075|FG001|Overall Study|Adverse Event|1|||
128739260|NCT01208233|463336076|FG002|Overall Study|Adverse Event|2|||
128739261|NCT01208233|463336077|FG003|Overall Study|Adverse Event|0|||
128739262|NCT01208233|463336078|FG004|Overall Study|Adverse Event|3|||
128739263|NCT01208233|463336079|FG005|Overall Study|Adverse Event|5|||
128739264|NCT01208233|463336074|FG000|Overall Study|Death|0|||
128739265|NCT01208233|463336075|FG001|Overall Study|Death|0|||
128739266|NCT01208233|463336076|FG002|Overall Study|Death|0|||
128739267|NCT01208233|463336077|FG003|Overall Study|Death|0|||
128739268|NCT01208233|463336078|FG004|Overall Study|Death|3|||
128739269|NCT01208233|463336079|FG005|Overall Study|Death|5|||
128739270|NCT01208233|463336074|FG000|Overall Study|Did not meet entrance criteria|2|||
128739271|NCT01208233|463336075|FG001|Overall Study|Did not meet entrance criteria|1|||
128739272|NCT01208233|463336076|FG002|Overall Study|Did not meet entrance criteria|1|||
128739273|NCT01208233|463336077|FG003|Overall Study|Did not meet entrance criteria|0|||
128739274|NCT01208233|463336078|FG004|Overall Study|Did not meet entrance criteria|1|||
128739275|NCT01208233|463336079|FG005|Overall Study|Did not meet entrance criteria|0|||
128739276|NCT01208233|463336074|FG000|Overall Study|Medication error without adverse event|0|||
128739277|NCT01208233|463336075|FG001|Overall Study|Medication error without adverse event|0|||
128739278|NCT01208233|463336076|FG002|Overall Study|Medication error without adverse event|0|||
128739279|NCT01208233|463336077|FG003|Overall Study|Medication error without adverse event|0|||
128739280|NCT01208233|463336078|FG004|Overall Study|Medication error without adverse event|0|||
128739281|NCT01208233|463336079|FG005|Overall Study|Medication error without adverse event|1|||
128739282|NCT01208233|463336074|FG000|Overall Study|Study terminated by sponsor|0|||
128739283|NCT01208233|463336075|FG001|Overall Study|Study terminated by sponsor|0|||
128739284|NCT01208233|463336076|FG002|Overall Study|Study terminated by sponsor|0|||
128739285|NCT01208233|463336077|FG003|Overall Study|Study terminated by sponsor|0|||
128739286|NCT01208233|463336078|FG004|Overall Study|Study terminated by sponsor|10|||
128739287|NCT01208233|463336079|FG005|Overall Study|Study terminated by sponsor|7|||
128739288|NCT01208233|463336074|FG000|Overall Study|Protocol Violation|0|||
128739289|NCT01208233|463336075|FG001|Overall Study|Protocol Violation|0|||
128739290|NCT01208233|463336076|FG002|Overall Study|Protocol Violation|0|||
128739291|NCT01208233|463336077|FG003|Overall Study|Protocol Violation|0|||
128739292|NCT01208233|463336078|FG004|Overall Study|Protocol Violation|3|||
128739293|NCT01208233|463336079|FG005|Overall Study|Protocol Violation|0|||
128739294|NCT01208233|463336074|FG000|Overall Study|Other|2|||
128739295|NCT01208233|463336075|FG001|Overall Study|Other|1|||
128739296|NCT01208233|463336076|FG002|Overall Study|Other|0|||
128739297|NCT01208233|463336077|FG003|Overall Study|Other|0|||
128739298|NCT01208233|463336078|FG004|Overall Study|Other|0|||
128739299|NCT01208233|463336079|FG005|Overall Study|Other|1|||
128785166|NCT00930813|463505930|FG000|Overall Study|Lost to Follow-up|2|||
128785167|NCT00930813|463505931|FG001|Overall Study|Lost to Follow-up|4|||
128785168|NCT04012853|463505934|FG000|Overall Study|Withdrawal by Subject|1|||
128785169|NCT04012853|463505935|FG001|Overall Study|Withdrawal by Subject|1|||
128785170|NCT04012853|463505934|FG000|Overall Study|Protocol Violation|1|||
128785171|NCT04012853|463505935|FG001|Overall Study|Protocol Violation|0|||
128785172|NCT04012853|463505934|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
128785173|NCT04012853|463505935|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
128785174|NCT00742274|463505938|FG000|Overall Study|Death|1|||
128739300|NCT01208233|463336074|FG000|Overall Study|Withdrawal by Subject|1|||
128739301|NCT01208233|463336075|FG001|Overall Study|Withdrawal by Subject|0|||
128739302|NCT01208233|463336076|FG002|Overall Study|Withdrawal by Subject|1|||
128739303|NCT01208233|463336077|FG003|Overall Study|Withdrawal by Subject|1|||
128739304|NCT01208233|463336078|FG004|Overall Study|Withdrawal by Subject|4|||
128739305|NCT01208233|463336079|FG005|Overall Study|Withdrawal by Subject|2|||
128739306|NCT01181895|463336080|FG000|Overall Study|Adverse Event|3|||
128739307|NCT01181895|463336081|FG001|Overall Study|Adverse Event|1|||
128739308|NCT01181895|463336082|FG002|Overall Study|Adverse Event|1|||
128739309|NCT01181895|463336080|FG000|Overall Study|Lack of Efficacy|8|||
128739310|NCT01181895|463336081|FG001|Overall Study|Lack of Efficacy|9|||
128739311|NCT01181895|463336082|FG002|Overall Study|Lack of Efficacy|9|||
128739312|NCT01181895|463336080|FG000|Overall Study|Protocol Violation|2|||
128739313|NCT01181895|463336081|FG001|Overall Study|Protocol Violation|1|||
128739314|NCT01181895|463336082|FG002|Overall Study|Protocol Violation|0|||
128739315|NCT01181895|463336080|FG000|Overall Study|Lost to Follow-up|0|||
128739316|NCT01181895|463336081|FG001|Overall Study|Lost to Follow-up|1|||
128739317|NCT01181895|463336082|FG002|Overall Study|Lost to Follow-up|2|||
128739318|NCT01181895|463336080|FG000|Overall Study|Investigator Discretion|1|||
128739319|NCT01181895|463336081|FG001|Overall Study|Investigator Discretion|2|||
128739320|NCT01181895|463336082|FG002|Overall Study|Investigator Discretion|1|||
128739321|NCT01181895|463336080|FG000|Overall Study|Withdrawal by Subject|3|||
128739322|NCT01181895|463336081|FG001|Overall Study|Withdrawal by Subject|0|||
128739323|NCT01181895|463336082|FG002|Overall Study|Withdrawal by Subject|5|||
128739324|NCT04028388|463336092|FG000|Overall Study|Evaluations missing|3|||
128739325|NCT04028388|463336093|FG001|Overall Study|Evaluations missing|6|||
128739326|NCT04028388|463336092|FG000|Overall Study|Not started|2|||
128739327|NCT04028388|463336093|FG001|Overall Study|Not started|0|||
128739328|NCT00555438|463336096|FG000|10 Days Post-operative|Death|4|||
128739329|NCT00555438|463336096|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
128739330|NCT01114516|463336100|FG000|Overall Study|Lost to Follow-up|2|||
128739331|NCT01114516|463336101|FG001|Overall Study|Lost to Follow-up|1|||
128739332|NCT00061048|463336102|FG000|Overall Study|Adverse Event|2|||
128739333|NCT00061048|463336102|FG000|Overall Study|disease progression|20|||
128739334|NCT01431508|463336103|FG000|Overall Study|Lack of Efficacy|1|||
128739335|NCT01431508|463336103|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
128739336|NCT00129259|463336104|FG000|Overall Study|Lost to Follow-up|1|||
128739337|NCT00129259|463336105|FG001|Overall Study|Lost to Follow-up|1|||
128739338|NCT00129259|463336104|FG000|Overall Study|Withdrawal by Subject|2|||
128739339|NCT00129259|463336105|FG001|Overall Study|Withdrawal by Subject|1|||
128739340|NCT00129259|463336104|FG000|Overall Study|Only available minimal phone assessments|0|||
128739341|NCT00129259|463336105|FG001|Overall Study|Only available minimal phone assessments|1|||
128739342|NCT01609556|463336110|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739343|NCT01609556|463336111|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739344|NCT01609556|463336112|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739345|NCT01609556|463336113|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739346|NCT01609556|463336114|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
128739347|NCT01609556|463336115|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739348|NCT01609556|463336116|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739349|NCT01609556|463336117|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
128739350|NCT01609556|463336118|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
128739351|NCT01609556|463336119|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739352|NCT01609556|463336120|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
128739353|NCT01609556|463336121|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
128739354|NCT01609556|463336122|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739355|NCT01609556|463336123|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739356|NCT01609556|463336124|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739357|NCT01609556|463336125|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
128739358|NCT01609556|463336110|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
128739359|NCT01609556|463336111|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
128739360|NCT01609556|463336112|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
128739361|NCT01609556|463336113|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
128739362|NCT01609556|463336114|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
128739363|NCT01609556|463336115|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
128739364|NCT01609556|463336116|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
128739365|NCT01609556|463336117|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
128739366|NCT01609556|463336118|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
128739367|NCT01609556|463336119|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
128739368|NCT01609556|463336120|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
128739369|NCT01609556|463336121|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
128739370|NCT01609556|463336122|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
128785175|NCT00742274|463505939|FG001|Overall Study|Death|0|||
128739371|NCT01609556|463336123|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
128739372|NCT01609556|463336124|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
128739373|NCT01609556|463336125|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
128739374|NCT01609556|463336110|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739375|NCT01609556|463336111|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739376|NCT01609556|463336112|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739377|NCT01609556|463336113|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739378|NCT01609556|463336114|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739379|NCT01609556|463336115|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
128739380|NCT01609556|463336116|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
128739381|NCT01609556|463336117|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739382|NCT01609556|463336118|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739383|NCT01609556|463336119|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
128739384|NCT01609556|463336120|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
128739385|NCT01609556|463336121|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
128739386|NCT01609556|463336122|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739387|NCT01609556|463336123|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739388|NCT01609556|463336124|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739389|NCT01609556|463336125|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
128739390|NCT01609556|463336110|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739391|NCT01609556|463336111|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739392|NCT01609556|463336112|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739393|NCT01609556|463336113|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739394|NCT01609556|463336114|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739395|NCT01609556|463336115|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
128739396|NCT01609556|463336116|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739397|NCT01609556|463336117|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739398|NCT01609556|463336118|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739399|NCT01609556|463336119|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739400|NCT01609556|463336120|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739401|NCT01609556|463336121|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
128739402|NCT01609556|463336122|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739403|NCT01609556|463336123|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739404|NCT01609556|463336124|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739405|NCT01609556|463336125|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
128739406|NCT01609556|463336110|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739407|NCT01609556|463336111|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739408|NCT01609556|463336112|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739409|NCT01609556|463336113|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739410|NCT01609556|463336114|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739411|NCT01609556|463336115|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
128739412|NCT01609556|463336116|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739413|NCT01609556|463336117|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739414|NCT01609556|463336118|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739415|NCT01609556|463336119|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739416|NCT01609556|463336120|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739417|NCT01609556|463336121|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739418|NCT01609556|463336122|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739419|NCT01609556|463336123|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739420|NCT01609556|463336124|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739421|NCT01609556|463336125|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
128739422|NCT01609556|463336110|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739423|NCT01609556|463336111|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739424|NCT01609556|463336112|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739425|NCT01609556|463336113|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739426|NCT01609556|463336114|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739427|NCT01609556|463336115|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739428|NCT01609556|463336116|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739429|NCT01609556|463336117|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739430|NCT01609556|463336118|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
128739431|NCT01609556|463336119|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739432|NCT01609556|463336120|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739433|NCT01609556|463336121|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739434|NCT01609556|463336122|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739435|NCT01609556|463336123|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739436|NCT01609556|463336124|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739437|NCT01609556|463336125|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
128739438|NCT01609556|463336110|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
128739439|NCT01609556|463336111|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739440|NCT01609556|463336112|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739441|NCT01609556|463336113|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739442|NCT01609556|463336114|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739443|NCT01609556|463336115|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
128739444|NCT01609556|463336116|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739445|NCT01609556|463336117|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739446|NCT01609556|463336118|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739447|NCT01609556|463336119|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739448|NCT01609556|463336120|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
128739449|NCT01609556|463336121|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739450|NCT01609556|463336122|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739451|NCT01609556|463336123|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739452|NCT01609556|463336124|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739453|NCT01609556|463336125|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
128739454|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739455|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739456|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739457|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739458|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739459|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739460|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739461|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739462|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739463|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739464|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739465|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
128739466|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
128739467|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
128739468|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
128739469|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
128739470|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739471|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739472|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739473|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739474|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739475|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739476|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739477|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739478|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739479|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739480|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739481|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
128739482|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
128739483|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
128739484|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
128739485|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
128739486|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739487|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739488|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739489|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739490|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739491|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739492|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739493|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739494|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739495|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739496|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739497|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
128739498|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
128739499|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
128739500|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
128739501|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
128739502|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739503|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739504|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739505|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739506|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739507|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739508|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739509|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739510|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739511|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739512|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739513|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739514|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
128739515|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128785176|NCT00742274|463505938|FG000|Overall Study|Withdrawal by Subject|1|||
128785177|NCT00742274|463505939|FG001|Overall Study|Withdrawal by Subject|2|||
128785178|NCT00742274|463505938|FG000|Overall Study|Removed for medical reasons|1|||
128785179|NCT00742274|463505939|FG001|Overall Study|Removed for medical reasons|1|||
128785180|NCT01101165|463505940|FG000|Period 1|Adverse Event|1|||
128785181|NCT01101165|463505941|FG001|Period 1|Adverse Event|2|||
128785182|NCT01101165|463505940|FG000|Period 1|Withdrawal by Subject|0|||
128785183|NCT01101165|463505941|FG001|Period 1|Withdrawal by Subject|2|||
128785184|NCT01101165|463505940|FG000|Period 1|Positive Drug Screen|0|||
128785185|NCT01101165|463505941|FG001|Period 1|Positive Drug Screen|1|||
128785186|NCT01101165|463505940|FG000|Period 1|Lost to Follow-up|1|||
128785187|NCT01101165|463505941|FG001|Period 1|Lost to Follow-up|0|||
128785188|NCT01101165|463505940|FG000|Period 2|Withdrawal by Subject|3|||
128785189|NCT01101165|463505941|FG001|Period 2|Withdrawal by Subject|1|||
128785190|NCT01101165|463505940|FG000|Period 2|Adverse Event|1|||
128785191|NCT01101165|463505941|FG001|Period 2|Adverse Event|0|||
128785192|NCT00015457|463505942|FG000|First Intervention|Adverse Event|0|||
128785193|NCT00015457|463505943|FG001|First Intervention|Adverse Event|2|||
128785194|NCT00015457|463505942|FG000|First Intervention|Lack of Efficacy|0|||
128785195|NCT00015457|463505943|FG001|First Intervention|Lack of Efficacy|1|||
128785196|NCT00015457|463505942|FG000|Second Intervention|Withdrawal by Subject|1|||
128785197|NCT00015457|463505943|FG001|Second Intervention|Withdrawal by Subject|0|||
128785198|NCT02317705|463505944|FG000|Overall Study|Withdrawal by Subject|3|||
128785199|NCT02317705|463505944|FG000|Overall Study|Physician Decision|1|||
128785200|NCT02317705|463505944|FG000|Overall Study|Drug not usable|1|||
128785201|NCT02219490|463505945|FG000|Overall Study|Adverse Event|24|||
128785202|NCT02219490|463505945|FG000|Overall Study|Withdrew consent|96|||
128785203|NCT02219490|463505945|FG000|Overall Study|Lost to Follow-up|126|||
128785204|NCT02219490|463505945|FG000|Overall Study|COVID-19 infection|2|||
128785205|NCT02219490|463505945|FG000|Overall Study|COVID-19 logistical restrictions|33|||
128785206|NCT02219490|463505945|FG000|Overall Study|Other, not specified|57|||
128785207|NCT01599325|463505946|FG000|Primary Parent Phase|Adverse Event|5|||
128785208|NCT01599325|463505946|FG000|Primary Parent Phase|Disease Progression|7|||
128785209|NCT01599325|463505946|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
128785210|NCT01599325|463505946|FG000|Primary Parent Phase|Death|13|||
128785211|NCT01599325|463505946|FG000|Primary Parent Phase|Protocol Violation|1|||
128785212|NCT01599325|463505946|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
128785213|NCT01599325|463505946|FG000|Primary Parent Phase|Other|2|||
128785214|NCT01599325|463505946|FG000|Extension Phase|Study Closure|1|||
128785215|NCT01599325|463505946|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
128785216|NCT01599325|463505946|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
128785217|NCT01599325|463505946|FG000|Extension Phase|Disease Progression|1|||
128785218|NCT01599325|463505946|FG000|Extension Phase|Withdrawal by Subject|8|||
128785219|NCT02365298|463505949|FG000|Period 2|incorrect Rx dispensed|1|||
128785220|NCT02365298|463505950|FG001|Period 2|incorrect Rx dispensed|0|||
128785221|NCT02365298|463505949|FG000|Period 2|Discontinued at request of Sponsor|1|||
128739516|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739517|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
128739518|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739519|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739520|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739521|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739522|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739523|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739524|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739525|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739526|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739527|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739528|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739529|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
128739530|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
128739531|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
128739532|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
128739533|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
128739534|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739535|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739536|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739537|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739538|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739539|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739540|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739541|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739542|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739543|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739544|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739545|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739546|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739547|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739548|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
128739549|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
128739550|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739551|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739552|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739553|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739554|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739555|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739556|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739557|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
128785222|NCT02365298|463505950|FG001|Period 2|Discontinued at request of Sponsor|0|||
128785223|NCT02365298|463505949|FG000|Period 2|Test Article longer available|0|||
128785224|NCT02365298|463505950|FG001|Period 2|Test Article longer available|1|||
128785225|NCT02365298|463505949|FG000|Period 2|Protocol Violation|0|||
128785226|NCT02365298|463505950|FG001|Period 2|Protocol Violation|1|||
128785227|NCT03404843|463505952|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
128785228|NCT03404843|463505953|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
128785229|NCT00567164|463505954|FG000|Overall Study|Withdrawal by Subject|171|||
128739558|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739559|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739560|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739561|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739562|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
128739563|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
128739564|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
128739565|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
128739566|NCT01609556|463336110|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739567|NCT01609556|463336111|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739568|NCT01609556|463336112|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739569|NCT01609556|463336113|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739570|NCT01609556|463336114|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739571|NCT01609556|463336115|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739572|NCT01609556|463336116|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739573|NCT01609556|463336117|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739574|NCT01609556|463336118|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739575|NCT01609556|463336119|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739576|NCT01609556|463336120|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739577|NCT01609556|463336121|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739578|NCT01609556|463336122|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
128739579|NCT01609556|463336123|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739580|NCT01609556|463336124|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739581|NCT01609556|463336125|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
128739582|NCT00023452|463336126|FG000|Overall Study|Ineligible for Study|163|||
128739583|NCT00023452|463336127|FG001|Overall Study|Ineligible for Study|159|||
128739584|NCT00023452|463336126|FG000|Overall Study|Out of Window|129|||
128739585|NCT00023452|463336127|FG001|Overall Study|Out of Window|69|||
128739586|NCT00023452|463336126|FG000|Overall Study|Death|2|||
128739587|NCT00023452|463336127|FG001|Overall Study|Death|0|||
128739588|NCT00023452|463336126|FG000|Overall Study|Withdrawal by Subject|66|||
128739589|NCT00023452|463336127|FG001|Overall Study|Withdrawal by Subject|54|||
128739590|NCT00023452|463336126|FG000|Overall Study|Adverse Event|139|||
128739591|NCT00023452|463336127|FG001|Overall Study|Adverse Event|196|||
128739592|NCT00023452|463336126|FG000|Overall Study|Lost to Follow-up|293|||
128739593|NCT00023452|463336127|FG001|Overall Study|Lost to Follow-up|60|||
128739594|NCT00023452|463336126|FG000|Overall Study|Physician Decision|49|||
128739595|NCT00023452|463336127|FG001|Overall Study|Physician Decision|21|||
128739596|NCT00023452|463336126|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
128739597|NCT00023452|463336127|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
128739598|NCT00023452|463336126|FG000|Overall Study|Pregnant|53|||
128739599|NCT00023452|463336127|FG001|Overall Study|Pregnant|20|||
128739600|NCT00023452|463336126|FG000|Overall Study|Other|204|||
128739601|NCT00023452|463336127|FG001|Overall Study|Other|69|||
128739602|NCT05789875|463336128|FG000|Overall Study|Lost to Follow-up|6|||
128739603|NCT01994395|463336129|FG000|Overall Study|Withdrawal by Subject|1|||
128739604|NCT01994395|463336130|FG001|Overall Study|Withdrawal by Subject|2|||
128785230|NCT00567164|463505955|FG001|Overall Study|Withdrawal by Subject|21|||
128785231|NCT00567164|463505956|FG002|Overall Study|Withdrawal by Subject|17|||
128785232|NCT00567164|463505954|FG000|Overall Study|Protocol Violation|23|||
128739605|NCT01940705|463336132|FG000|Overall Study|Lost to Follow-up|1|||
128739606|NCT01940705|463336133|FG001|Overall Study|Lost to Follow-up|3|||
128739607|NCT01940705|463336134|FG002|Overall Study|Lost to Follow-up|2|||
128739608|NCT01940705|463336135|FG003|Overall Study|Lost to Follow-up|2|||
128739609|NCT01940705|463336132|FG000|Overall Study|Withdrawal by Subject|2|||
128739610|NCT01940705|463336133|FG001|Overall Study|Withdrawal by Subject|2|||
128739611|NCT01940705|463336134|FG002|Overall Study|Withdrawal by Subject|3|||
128739612|NCT01940705|463336135|FG003|Overall Study|Withdrawal by Subject|2|||
128739613|NCT01940705|463336132|FG000|Overall Study|Intervention not given|0|||
128739614|NCT01940705|463336133|FG001|Overall Study|Intervention not given|3|||
128739615|NCT01940705|463336134|FG002|Overall Study|Intervention not given|3|||
128739616|NCT01940705|463336135|FG003|Overall Study|Intervention not given|0|||
128739617|NCT01940705|463336132|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
128739618|NCT01940705|463336133|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
128785233|NCT00567164|463505955|FG001|Overall Study|Protocol Violation|4|||
128785234|NCT00567164|463505956|FG002|Overall Study|Protocol Violation|2|||
128739619|NCT01940705|463336134|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
128739620|NCT01940705|463336135|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
128739621|NCT03779841|463336138|FG000|Randomized Population|Did Not Receive Treatment|3|||
128739622|NCT03779841|463336139|FG001|Randomized Population|Did Not Receive Treatment|1|||
128739623|NCT03779841|463336140|FG002|Randomized Population|Did Not Receive Treatment|0|||
128739624|NCT03779841|463336138|FG000|Treated (Safety) Population|Adverse Event|1|||
128739625|NCT03779841|463336139|FG001|Treated (Safety) Population|Adverse Event|1|||
128739626|NCT03779841|463336140|FG002|Treated (Safety) Population|Adverse Event|0|||
128739627|NCT03779841|463336138|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
128739628|NCT03779841|463336139|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
128739629|NCT03779841|463336140|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
128739630|NCT03779841|463336138|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
128739631|NCT03779841|463336139|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
128739632|NCT03779841|463336140|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
128739633|NCT03779841|463336138|FG000|Treated (Safety) Population|Death|1|||
128739634|NCT03779841|463336139|FG001|Treated (Safety) Population|Death|0|||
128739635|NCT03779841|463336140|FG002|Treated (Safety) Population|Death|2|||
128739636|NCT01632579|463336141|FG000|Washout Period|Adverse Event|1|||
128739637|NCT01632579|463336142|FG001|Washout Period|Adverse Event|0|||
128739638|NCT01632579|463336143|FG002|Washout Period|Adverse Event|0|||
128739639|NCT01632579|463336144|FG003|Washout Period|Adverse Event|0|||
128739640|NCT01632579|463336145|FG004|Washout Period|Adverse Event|0|||
128739641|NCT01632579|463336146|FG005|Washout Period|Adverse Event|0|||
128739642|NCT01632579|463336147|FG006|Washout Period|Adverse Event|0|||
128739643|NCT01632579|463336148|FG007|Washout Period|Adverse Event|0|||
128739644|NCT01632579|463336149|FG008|Washout Period|Adverse Event|0|||
128739645|NCT01632579|463336141|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
128739646|NCT01632579|463336142|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
128739647|NCT01632579|463336143|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
128739648|NCT01632579|463336144|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
128739649|NCT01632579|463336145|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
128739650|NCT01632579|463336146|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
128739651|NCT01632579|463336147|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
128739652|NCT01632579|463336148|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
128739653|NCT01632579|463336149|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
128739654|NCT02788175|463336150|FG000|Overall Study|Protocol Violation|3|||
128739655|NCT02788175|463336150|FG000|Overall Study|Withdrawal by Subject|4|||
128739656|NCT02788175|463336150|FG000|Overall Study|Ineligible prior to study agent|6|||
128739657|NCT00162136|463336151|FG000|Overall Study|Adverse Event|1|||
128739658|NCT00162136|463336151|FG000|Overall Study|Death|1|||
128739659|NCT00162136|463336151|FG000|Overall Study|Disease Progression/Relapse|23|||
128739660|NCT00162136|463336151|FG000|Overall Study|Investigator Request|5|||
128739661|NCT00162136|463336151|FG000|Overall Study|Study Drug Toxicity|4|||
128739662|NCT00162136|463336151|FG000|Overall Study|Withdrawal by Subject|1|||
128739663|NCT03930745|463336152|FG000|Overall Study|Lost to Follow-up|10|||
128739664|NCT03930745|463336153|FG001|Overall Study|Lost to Follow-up|5|||
128739665|NCT03930745|463336152|FG000|Overall Study|Withdrawal by Subject|1|||
128739666|NCT03930745|463336153|FG001|Overall Study|Withdrawal by Subject|2|||
128739667|NCT03930745|463336152|FG000|Overall Study|Protocol Violation|2|||
128739668|NCT03930745|463336153|FG001|Overall Study|Protocol Violation|2|||
128739669|NCT03930745|463336152|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
128739670|NCT03930745|463336153|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
128739671|NCT03930745|463336152|FG000|Overall Study|Adverse Event|0|||
128739672|NCT03930745|463336153|FG001|Overall Study|Adverse Event|1|||
128739673|NCT03930745|463336152|FG000|Overall Study|Pregnancy|0|||
128739674|NCT03930745|463336153|FG001|Overall Study|Pregnancy|1|||
128739675|NCT00612313|463336162|FG000|Overall Study|Withdrawal by Subject|6|||
128739676|NCT00612313|463336163|FG001|Overall Study|Withdrawal by Subject|9|||
128739677|NCT00612313|463336162|FG000|Overall Study|Lost to Follow-up|11|||
128739678|NCT00612313|463336163|FG001|Overall Study|Lost to Follow-up|4|||
128739679|NCT01040871|463337951|FG000|Overall Study|Adverse Event|6|||
128739680|NCT01040871|463337952|FG001|Overall Study|Adverse Event|2|||
128739681|NCT01040871|463337951|FG000|Overall Study|Withdrawal by Subject|2|||
128739682|NCT01040871|463337952|FG001|Overall Study|Withdrawal by Subject|0|||
128739683|NCT01040871|463337951|FG000|Overall Study|Death|1|||
128739684|NCT01040871|463337952|FG001|Overall Study|Death|3|||
128739685|NCT01040871|463337951|FG000|Overall Study|Lack of Efficacy|1|||
128739686|NCT01040871|463337952|FG001|Overall Study|Lack of Efficacy|1|||
128739687|NCT01040871|463337951|FG000|Overall Study|drug supply issue|1|||
128739688|NCT01040871|463337952|FG001|Overall Study|drug supply issue|0|||
128739689|NCT01040871|463337951|FG000|Overall Study|Randomized and Not Treated|2|||
128739690|NCT01040871|463337952|FG001|Overall Study|Randomized and Not Treated|1|||
128739691|NCT02696850|463337957|FG000|Overall Study|Withdrawal by Subject|3|||
128739692|NCT02696850|463337958|FG001|Overall Study|Withdrawal by Subject|3|||
128739693|NCT02696850|463337957|FG000|Overall Study|Lost to Follow-up|8|||
128739694|NCT02696850|463337958|FG001|Overall Study|Lost to Follow-up|5|||
128739695|NCT00673049|463337959|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
128739696|NCT00673049|463337960|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
128739697|NCT00673049|463337961|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
128739698|NCT00673049|463337962|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
128739699|NCT00673049|463337959|FG000|Before Progression on Erlotinib|Death|235|||
128739700|NCT00673049|463337960|FG001|Before Progression on Erlotinib|Death|167|||
128739701|NCT00673049|463337961|FG002|Before Progression on Erlotinib|Death|1|||
128739702|NCT00673049|463337962|FG003|Before Progression on Erlotinib|Death|0|||
128739703|NCT00673049|463337959|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
128739704|NCT00673049|463337960|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
128739705|NCT00673049|463337961|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
128739706|NCT00673049|463337962|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
128739707|NCT00673049|463337959|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
128739708|NCT00673049|463337960|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
128739709|NCT00673049|463337961|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
128739710|NCT00673049|463337962|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
128739711|NCT00673049|463337959|FG000|Before Progression on Erlotinib|Other|1|||
128739712|NCT00673049|463337960|FG001|Before Progression on Erlotinib|Other|2|||
128739713|NCT00673049|463337961|FG002|Before Progression on Erlotinib|Other|0|||
128739714|NCT00673049|463337962|FG003|Before Progression on Erlotinib|Other|0|||
128739715|NCT00673049|463337959|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
128739716|NCT00673049|463337960|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
128739717|NCT00673049|463337961|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
128739718|NCT00673049|463337962|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
128739719|NCT00673049|463337959|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
128739720|NCT00673049|463337960|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
128739721|NCT00673049|463337961|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
128739722|NCT00673049|463337962|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
128739723|NCT00673049|463337959|FG000|After Progression on Erlotinib|Death|0|||
128739724|NCT00673049|463337960|FG001|After Progression on Erlotinib|Death|0|||
128739725|NCT00673049|463337961|FG002|After Progression on Erlotinib|Death|0|||
128739726|NCT00673049|463337962|FG003|After Progression on Erlotinib|Death|71|||
128739727|NCT00673049|463337959|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
128739728|NCT00673049|463337960|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
129204415|NCT01384734|465045800|FG002|Overall Study|As per Exclusion criteria|0|||
129204416|NCT01384734|465045801|FG003|Overall Study|As per Exclusion criteria|0|||
128739729|NCT00673049|463337961|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
128739730|NCT00673049|463337962|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
128739731|NCT00673049|463337959|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
128739732|NCT00673049|463337960|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
128739733|NCT00673049|463337961|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
128739734|NCT00673049|463337962|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
128739735|NCT00673049|463337959|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
128739736|NCT00673049|463337960|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
128739737|NCT00673049|463337961|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
128739738|NCT00673049|463337962|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
128739739|NCT01175824|463337963|FG000|Overall Study|Adverse Event|2|||
128739740|NCT01175824|463337964|FG001|Overall Study|Adverse Event|1|||
128739741|NCT01175824|463337963|FG000|Overall Study|Lack of Efficacy|2|||
128739742|NCT01175824|463337964|FG001|Overall Study|Lack of Efficacy|0|||
128739743|NCT01175824|463337963|FG000|Overall Study|Lost to Follow-up|0|||
128739744|NCT01175824|463337964|FG001|Overall Study|Lost to Follow-up|1|||
128739745|NCT01175824|463337963|FG000|Overall Study|Physician Decision|0|||
128739746|NCT01175824|463337964|FG001|Overall Study|Physician Decision|4|||
128739747|NCT01175824|463337963|FG000|Overall Study|Protocol Violation|2|||
128739748|NCT01175824|463337964|FG001|Overall Study|Protocol Violation|5|||
128739749|NCT01175824|463337963|FG000|Overall Study|Withdrawal by Subject|3|||
128739750|NCT01175824|463337964|FG001|Overall Study|Withdrawal by Subject|7|||
128739751|NCT01175824|463337963|FG000|Overall Study|Sponsor Decision|1|||
128739752|NCT01175824|463337964|FG001|Overall Study|Sponsor Decision|0|||
128739753|NCT01175824|463337963|FG000|Overall Study|Entry Criteria Not Met|6|||
128739754|NCT01175824|463337964|FG001|Overall Study|Entry Criteria Not Met|4|||
128739755|NCT00924950|463337965|FG000|Overall Study|Lost to Follow-up|2|||
128739756|NCT04193202|463337966|FG000|Overall Study|Adverse Event|2|||
128739757|NCT04193202|463337967|FG001|Overall Study|Adverse Event|1|||
128739758|NCT04193202|463337966|FG000|Overall Study|Death|0|||
128739759|NCT04193202|463337967|FG001|Overall Study|Death|1|||
128739760|NCT04193202|463337966|FG000|Overall Study|Physician Decision|1|||
128739761|NCT04193202|463337967|FG001|Overall Study|Physician Decision|1|||
128739762|NCT04193202|463337966|FG000|Overall Study|Protocol Violation|2|||
128739763|NCT04193202|463337967|FG001|Overall Study|Protocol Violation|2|||
128739764|NCT04193202|463337966|FG000|Overall Study|Withdrawal by Subject|11|||
128739765|NCT04193202|463337967|FG001|Overall Study|Withdrawal by Subject|5|||
128739766|NCT02979535|463337968|FG000|Overall Study|Non compliance with the protocol|78|||
128739767|NCT02979535|463337969|FG001|Overall Study|Non compliance with the protocol|82|||
128739768|NCT02979535|463337968|FG000|Overall Study|Consent withdrawn by participant|11|||
128739769|NCT02979535|463337969|FG001|Overall Study|Consent withdrawn by participant|18|||
128739770|NCT02979535|463337968|FG000|Overall Study|Lost to Follow-up|6|||
128739771|NCT02979535|463337969|FG001|Overall Study|Lost to Follow-up|1|||
128739772|NCT04820673|463337973|FG000|Overall Study|Adverse Event|6|||
128739773|NCT04820673|463337973|FG000|Overall Study|Due to Lack of Effectiveness|1|||
128739774|NCT04820673|463337973|FG000|Overall Study|Pregnancy|1|||
128739775|NCT04820673|463337973|FG000|Overall Study|Voluntary Withdrawal|20|||
128739776|NCT04820673|463337973|FG000|Overall Study|Lost to Follow-up|10|||
128739777|NCT00767000|463337977|FG000|54-week Study|Adverse Event|4|||
128739778|NCT00767000|463337978|FG001|54-week Study|Adverse Event|6|||
128739779|NCT00767000|463337979|FG002|54-week Study|Adverse Event|6|||
128739780|NCT00767000|463337980|FG003|54-week Study|Adverse Event|8|||
128739781|NCT00767000|463337981|FG004|54-week Study|Adverse Event|4|||
128739782|NCT00767000|463337977|FG000|54-week Study|Creaninine/creatinine clearance|2|||
128739783|NCT00767000|463337978|FG001|54-week Study|Creaninine/creatinine clearance|1|||
128739784|NCT00767000|463337979|FG002|54-week Study|Creaninine/creatinine clearance|2|||
128739785|NCT00767000|463337980|FG003|54-week Study|Creaninine/creatinine clearance|2|||
128739786|NCT00767000|463337981|FG004|54-week Study|Creaninine/creatinine clearance|4|||
128739787|NCT00767000|463337977|FG000|54-week Study|Hyperglycemia|0|||
128739788|NCT00767000|463337978|FG001|54-week Study|Hyperglycemia|0|||
128739789|NCT00767000|463337979|FG002|54-week Study|Hyperglycemia|1|||
128739790|NCT00767000|463337980|FG003|54-week Study|Hyperglycemia|0|||
128739791|NCT00767000|463337981|FG004|54-week Study|Hyperglycemia|1|||
128739792|NCT00767000|463337977|FG000|54-week Study|Hypoglycemia|0|||
128739793|NCT00767000|463337978|FG001|54-week Study|Hypoglycemia|1|||
128739794|NCT00767000|463337979|FG002|54-week Study|Hypoglycemia|0|||
128739795|NCT00767000|463337980|FG003|54-week Study|Hypoglycemia|0|||
128739796|NCT00767000|463337981|FG004|54-week Study|Hypoglycemia|0|||
128739797|NCT00767000|463337977|FG000|54-week Study|Interruption of study medication|0|||
128739798|NCT00767000|463337978|FG001|54-week Study|Interruption of study medication|0|||
128739799|NCT00767000|463337979|FG002|54-week Study|Interruption of study medication|1|||
128739800|NCT00767000|463337980|FG003|54-week Study|Interruption of study medication|0|||
128739801|NCT00767000|463337981|FG004|54-week Study|Interruption of study medication|0|||
128739802|NCT00767000|463337977|FG000|54-week Study|Lack of Efficacy|2|||
128739803|NCT00767000|463337978|FG001|54-week Study|Lack of Efficacy|0|||
128739804|NCT00767000|463337979|FG002|54-week Study|Lack of Efficacy|1|||
128739805|NCT00767000|463337980|FG003|54-week Study|Lack of Efficacy|0|||
128739806|NCT00767000|463337981|FG004|54-week Study|Lack of Efficacy|5|||
128739807|NCT00767000|463337977|FG000|54-week Study|Lost to Follow-up|4|||
128739808|NCT00767000|463337978|FG001|54-week Study|Lost to Follow-up|0|||
128739809|NCT00767000|463337979|FG002|54-week Study|Lost to Follow-up|1|||
128739810|NCT00767000|463337980|FG003|54-week Study|Lost to Follow-up|4|||
128739811|NCT00767000|463337981|FG004|54-week Study|Lost to Follow-up|2|||
128739812|NCT00767000|463337977|FG000|54-week Study|Physician Decision|4|||
128739813|NCT00767000|463337978|FG001|54-week Study|Physician Decision|0|||
128739814|NCT00767000|463337979|FG002|54-week Study|Physician Decision|1|||
128739815|NCT00767000|463337980|FG003|54-week Study|Physician Decision|1|||
128739816|NCT00767000|463337981|FG004|54-week Study|Physician Decision|1|||
128739817|NCT00767000|463337977|FG000|54-week Study|Progressive disease|0|||
128739818|NCT00767000|463337978|FG001|54-week Study|Progressive disease|0|||
128739819|NCT00767000|463337979|FG002|54-week Study|Progressive disease|1|||
128739820|NCT00767000|463337980|FG003|54-week Study|Progressive disease|0|||
128785235|NCT00567164|463505954|FG000|Overall Study|Adverse Event|92|||
128785236|NCT00567164|463505955|FG001|Overall Study|Adverse Event|13|||
128785237|NCT00567164|463505956|FG002|Overall Study|Adverse Event|9|||
128785238|NCT00567164|463505954|FG000|Overall Study|Death|0|||
128785239|NCT00567164|463505955|FG001|Overall Study|Death|0|||
128785240|NCT00567164|463505956|FG002|Overall Study|Death|1|||
128785241|NCT00567164|463505954|FG000|Overall Study|Lost to Follow-up|202|||
128739821|NCT00767000|463337981|FG004|54-week Study|Progressive disease|0|||
128739822|NCT00767000|463337977|FG000|54-week Study|Protocol Violation|0|||
128739823|NCT00767000|463337978|FG001|54-week Study|Protocol Violation|0|||
128739824|NCT00767000|463337979|FG002|54-week Study|Protocol Violation|1|||
128739825|NCT00767000|463337980|FG003|54-week Study|Protocol Violation|2|||
128739826|NCT00767000|463337981|FG004|54-week Study|Protocol Violation|0|||
128739827|NCT00767000|463337977|FG000|54-week Study|Withdrawal by Subject|2|||
128739828|NCT00767000|463337978|FG001|54-week Study|Withdrawal by Subject|3|||
128739829|NCT00767000|463337979|FG002|54-week Study|Withdrawal by Subject|5|||
128739830|NCT00767000|463337980|FG003|54-week Study|Withdrawal by Subject|11|||
128739831|NCT00767000|463337981|FG004|54-week Study|Withdrawal by Subject|13|||
128739832|NCT00767000|463337977|FG000|54-week Study|Study terminated by sponsor|90|||
128739833|NCT00767000|463337978|FG001|54-week Study|Study terminated by sponsor|102|||
128739834|NCT00767000|463337979|FG002|54-week Study|Study terminated by sponsor|89|||
128739835|NCT00767000|463337980|FG003|54-week Study|Study terminated by sponsor|196|||
128739836|NCT00767000|463337981|FG004|54-week Study|Study terminated by sponsor|194|||
128739837|NCT00767000|463337977|FG000|54-week Study|Reason not reported|0|||
128739838|NCT00767000|463337978|FG001|54-week Study|Reason not reported|0|||
128785242|NCT00567164|463505955|FG001|Overall Study|Lost to Follow-up|23|||
128739839|NCT00767000|463337979|FG002|54-week Study|Reason not reported|0|||
128785243|NCT00567164|463505956|FG002|Overall Study|Lost to Follow-up|21|||
128739840|NCT00767000|463337980|FG003|54-week Study|Reason not reported|1|||
128739841|NCT00767000|463337981|FG004|54-week Study|Reason not reported|0|||
128739842|NCT00767000|463337977|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
128739843|NCT00767000|463337978|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
128739844|NCT00767000|463337979|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
128739845|NCT00767000|463337980|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
128739846|NCT00767000|463337981|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
128739847|NCT02039505|463337983|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
128739848|NCT02039505|463337984|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
128739849|NCT02039505|463337985|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
128739850|NCT02039505|463337986|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
128739851|NCT02039505|463337987|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
128739852|NCT02039505|463337988|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
128739853|NCT02039505|463337989|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
128739854|NCT02039505|463337983|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
128739855|NCT02039505|463337984|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
128739856|NCT02039505|463337985|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
128739857|NCT02039505|463337986|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
128739858|NCT02039505|463337987|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
128739859|NCT02039505|463337988|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
128739860|NCT02039505|463337989|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
128739861|NCT02039505|463337983|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
128739862|NCT02039505|463337984|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
128739863|NCT02039505|463337985|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
128739864|NCT02039505|463337986|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
128739865|NCT02039505|463337987|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
128739866|NCT02039505|463337988|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
128739867|NCT02039505|463337989|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
128739868|NCT02039505|463337983|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
128739869|NCT02039505|463337984|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
128739870|NCT02039505|463337985|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
128739871|NCT02039505|463337986|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
128739872|NCT02039505|463337987|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
128739873|NCT02039505|463337988|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
128739874|NCT02039505|463337989|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
128739875|NCT02039505|463337983|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
128739876|NCT02039505|463337984|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
128739877|NCT02039505|463337985|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
128739878|NCT02039505|463337986|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
128739879|NCT02039505|463337987|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
128739880|NCT02039505|463337988|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
128739881|NCT02039505|463337989|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
128739882|NCT02039505|463337983|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
128739883|NCT02039505|463337984|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
128739884|NCT02039505|463337985|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
128739885|NCT02039505|463337986|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
128739886|NCT02039505|463337987|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
128739887|NCT02039505|463337988|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
128739888|NCT02039505|463337989|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
128739889|NCT02039505|463337983|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
128739890|NCT02039505|463337984|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
128739891|NCT02039505|463337985|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
128785244|NCT00567164|463505954|FG000|Overall Study|Pregnancy|20|||
128785245|NCT00567164|463505955|FG001|Overall Study|Pregnancy|4|||
128739892|NCT02039505|463337986|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
128739893|NCT02039505|463337987|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
128739894|NCT02039505|463337988|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
128739895|NCT02039505|463337989|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
128739896|NCT02039505|463337983|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
128739897|NCT02039505|463337984|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
128739898|NCT02039505|463337985|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
128739899|NCT02039505|463337986|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
128739900|NCT02039505|463337987|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
128739901|NCT02039505|463337988|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
128739902|NCT02039505|463337989|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
128785246|NCT00567164|463505956|FG002|Overall Study|Pregnancy|6|||
128739903|NCT02039505|463337983|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
128739904|NCT02039505|463337984|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
128739905|NCT02039505|463337985|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
128739906|NCT02039505|463337986|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
128739907|NCT02039505|463337987|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
128739908|NCT02039505|463337988|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
128739909|NCT02039505|463337989|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
128739910|NCT02039505|463337983|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
128739911|NCT02039505|463337984|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
128739912|NCT02039505|463337985|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
128739913|NCT02039505|463337986|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
128739914|NCT02039505|463337987|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
128739915|NCT02039505|463337988|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
128739916|NCT02039505|463337989|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
128739917|NCT02039505|463337983|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
128739918|NCT02039505|463337984|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
128739919|NCT02039505|463337985|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
128739920|NCT02039505|463337986|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
128739921|NCT02039505|463337987|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
128739922|NCT02039505|463337988|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
128739923|NCT02039505|463337989|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
128739924|NCT00097591|463337990|FG000|Overall Study|Withdrawal of consent|342|||
128739925|NCT00097591|463337991|FG001|Overall Study|Withdrawal of consent|323|||
128739926|NCT00097591|463337990|FG000|Overall Study|Less than 6 months on study drug|9|||
128739927|NCT00097591|463337991|FG001|Overall Study|Less than 6 months on study drug|7|||
128739928|NCT00097591|463337990|FG000|Overall Study|Unable to attend termination visit|53|||
128739929|NCT00097591|463337991|FG001|Overall Study|Unable to attend termination visit|51|||
128739930|NCT00097591|463337990|FG000|Overall Study|Lost to follow up|6|||
128739931|NCT00097591|463337991|FG001|Overall Study|Lost to follow up|10|||
128739932|NCT00097591|463337990|FG000|Overall Study|Other|0|||
128739933|NCT00097591|463337991|FG001|Overall Study|Other|3|||
128739934|NCT02530619|463337992|FG000|Registered for Study|Withdrawal by Subject|2|||
128739935|NCT02530619|463337992|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
128739936|NCT02530619|463337992|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
128739937|NCT02530619|463337992|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
128739938|NCT02530619|463337992|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
128739939|NCT02530619|463337992|FG000|Follow-up Period (6 Months)|Death|4|||
128739940|NCT02530619|463337992|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
128739941|NCT02530619|463337992|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
128739942|NCT00009737|463337994|FG000|Overall Study|Adverse Event|112|||
128739943|NCT00009737|463337995|FG001|Overall Study|Adverse Event|75|||
128739944|NCT00009737|463337994|FG000|Overall Study|Death|4|||
128739945|NCT00009737|463337995|FG001|Overall Study|Death|6|||
128739946|NCT00009737|463337994|FG000|Overall Study|Lack of Efficacy|17|||
128739947|NCT00009737|463337995|FG001|Overall Study|Lack of Efficacy|15|||
128739948|NCT00009737|463337994|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
128739949|NCT00009737|463337995|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
128739950|NCT00009737|463337994|FG000|Overall Study|Other Protocol Violation|1|||
128739951|NCT00009737|463337995|FG001|Overall Study|Other Protocol Violation|0|||
128739952|NCT00009737|463337994|FG000|Overall Study|Refused Treatment|15|||
128739953|NCT00009737|463337995|FG001|Overall Study|Refused Treatment|16|||
128739954|NCT00009737|463337994|FG000|Overall Study|Lost to Follow-up|1|||
128739955|NCT00009737|463337995|FG001|Overall Study|Lost to Follow-up|1|||
128739956|NCT00009737|463337994|FG000|Overall Study|Administrative/Other Reasons|7|||
128739957|NCT00009737|463337995|FG001|Overall Study|Administrative/Other Reasons|1|||
128739958|NCT01163682|463337999|FG000|Overall Study|Lost to Follow-up|6|||
128739959|NCT01163682|463338000|FG001|Overall Study|Lost to Follow-up|9|||
128739960|NCT00359762|463338006|FG000|Period II|Adverse Event|17|||
128739961|NCT00359762|463338007|FG001|Period II|Adverse Event|0|||
128739962|NCT00359762|463338008|FG002|Period II|Adverse Event|0|||
128739963|NCT00359762|463338009|FG003|Period II|Adverse Event|0|||
128739964|NCT00359762|463338010|FG004|Period II|Adverse Event|49|||
128739965|NCT00359762|463338006|FG000|Period II|Protocol Violation|18|||
128739966|NCT00359762|463338007|FG001|Period II|Protocol Violation|0|||
128739967|NCT00359762|463338008|FG002|Period II|Protocol Violation|0|||
128739968|NCT00359762|463338009|FG003|Period II|Protocol Violation|0|||
128739969|NCT00359762|463338010|FG004|Period II|Protocol Violation|11|||
128739970|NCT00359762|463338006|FG000|Period II|Physician Decision|17|||
128739971|NCT00359762|463338007|FG001|Period II|Physician Decision|0|||
128739972|NCT00359762|463338008|FG002|Period II|Physician Decision|0|||
128739973|NCT00359762|463338009|FG003|Period II|Physician Decision|0|||
128739974|NCT00359762|463338010|FG004|Period II|Physician Decision|23|||
128739975|NCT00359762|463338006|FG000|Period II|Death|2|||
128739976|NCT00359762|463338007|FG001|Period II|Death|0|||
128739977|NCT00359762|463338008|FG002|Period II|Death|0|||
128739978|NCT00359762|463338009|FG003|Period II|Death|0|||
128739979|NCT00359762|463338010|FG004|Period II|Death|4|||
128739980|NCT00359762|463338006|FG000|Period II|Lack of Efficacy|11|||
128739981|NCT00359762|463338007|FG001|Period II|Lack of Efficacy|0|||
128739982|NCT00359762|463338008|FG002|Period II|Lack of Efficacy|0|||
128739983|NCT00359762|463338009|FG003|Period II|Lack of Efficacy|0|||
128739984|NCT00359762|463338010|FG004|Period II|Lack of Efficacy|8|||
128739985|NCT00359762|463338006|FG000|Period II|Lost to follow up|5|||
128739986|NCT00359762|463338007|FG001|Period II|Lost to follow up|0|||
128739987|NCT00359762|463338008|FG002|Period II|Lost to follow up|0|||
128739988|NCT00359762|463338009|FG003|Period II|Lost to follow up|0|||
128739989|NCT00359762|463338010|FG004|Period II|Lost to follow up|5|||
128739990|NCT00359762|463338006|FG000|Period II|Entry Criteria Not Met|8|||
128739991|NCT00359762|463338007|FG001|Period II|Entry Criteria Not Met|0|||
128739992|NCT00359762|463338008|FG002|Period II|Entry Criteria Not Met|0|||
128739993|NCT00359762|463338009|FG003|Period II|Entry Criteria Not Met|0|||
128739994|NCT00359762|463338010|FG004|Period II|Entry Criteria Not Met|4|||
128739995|NCT00359762|463338006|FG000|Period II|Subject Decision|50|||
128739996|NCT00359762|463338007|FG001|Period II|Subject Decision|0|||
128739997|NCT00359762|463338008|FG002|Period II|Subject Decision|0|||
128739998|NCT00359762|463338009|FG003|Period II|Subject Decision|0|||
128739999|NCT00359762|463338010|FG004|Period II|Subject Decision|70|||
128740000|NCT00359762|463338006|FG000|Period III|Protocol Violation|0|||
128740001|NCT00359762|463338007|FG001|Period III|Protocol Violation|5|||
128740002|NCT00359762|463338008|FG002|Period III|Protocol Violation|3|||
128740003|NCT00359762|463338009|FG003|Period III|Protocol Violation|8|||
128740004|NCT00359762|463338010|FG004|Period III|Protocol Violation|0|||
128740005|NCT00359762|463338006|FG000|Period III|Adverse Event|0|||
128740006|NCT00359762|463338007|FG001|Period III|Adverse Event|3|||
128740007|NCT00359762|463338008|FG002|Period III|Adverse Event|4|||
128740008|NCT00359762|463338009|FG003|Period III|Adverse Event|10|||
128740009|NCT00359762|463338010|FG004|Period III|Adverse Event|0|||
128740010|NCT00359762|463338006|FG000|Period III|Physician Decision|0|||
128740011|NCT00359762|463338007|FG001|Period III|Physician Decision|5|||
128740012|NCT00359762|463338008|FG002|Period III|Physician Decision|9|||
128740013|NCT00359762|463338009|FG003|Period III|Physician Decision|15|||
128740014|NCT00359762|463338010|FG004|Period III|Physician Decision|0|||
128740015|NCT00359762|463338006|FG000|Period III|Lack of Efficacy|0|||
128740016|NCT00359762|463338007|FG001|Period III|Lack of Efficacy|7|||
128740017|NCT00359762|463338008|FG002|Period III|Lack of Efficacy|5|||
128740018|NCT00359762|463338009|FG003|Period III|Lack of Efficacy|9|||
128740019|NCT00359762|463338010|FG004|Period III|Lack of Efficacy|0|||
128740020|NCT00359762|463338006|FG000|Period III|Lost to follow up|0|||
128740021|NCT00359762|463338007|FG001|Period III|Lost to follow up|1|||
128740022|NCT00359762|463338008|FG002|Period III|Lost to follow up|1|||
128740023|NCT00359762|463338009|FG003|Period III|Lost to follow up|2|||
128740024|NCT00359762|463338010|FG004|Period III|Lost to follow up|0|||
128740025|NCT00359762|463338006|FG000|Period III|Entry Criteria Not Met|0|||
128740026|NCT00359762|463338007|FG001|Period III|Entry Criteria Not Met|1|||
128740027|NCT00359762|463338008|FG002|Period III|Entry Criteria Not Met|0|||
128740028|NCT00359762|463338009|FG003|Period III|Entry Criteria Not Met|1|||
128740029|NCT00359762|463338010|FG004|Period III|Entry Criteria Not Met|0|||
128740030|NCT00359762|463338006|FG000|Period III|Subject Decision|0|||
128740031|NCT00359762|463338007|FG001|Period III|Subject Decision|7|||
128740032|NCT00359762|463338008|FG002|Period III|Subject Decision|8|||
128740033|NCT00359762|463338009|FG003|Period III|Subject Decision|20|||
128740034|NCT00359762|463338010|FG004|Period III|Subject Decision|0|||
128740035|NCT04808609|463338011|FG000|Overall Study|Lost to Follow-up|0|||
128740036|NCT04808609|463338012|FG001|Overall Study|Lost to Follow-up|2|||
128740037|NCT04808609|463338011|FG000|Overall Study|Administrative Withdrawal|0|||
128740038|NCT04808609|463338012|FG001|Overall Study|Administrative Withdrawal|1|||
128740039|NCT01993719|463338014|FG000|First Drug Administration|Not treated|1|||
128740040|NCT01993719|463338015|FG001|First Drug Administration|Not treated|0|||
128740041|NCT01993719|463338016|FG002|First Drug Administration|Not treated|0|||
128740042|NCT01993719|463338017|FG003|First Drug Administration|Not treated|0|||
128740043|NCT01993719|463338018|FG004|First Drug Administration|Not treated|0|||
128740044|NCT04382326|463338024|FG000|Overall Study|Adverse Event, not serious|1|||
128740045|NCT04382326|463338025|FG001|Overall Study|Adverse Event, not serious|2|||
128740046|NCT04382326|463338024|FG000|Overall Study|Other|1|||
128740047|NCT04382326|463338025|FG001|Overall Study|Other|0|||
128740048|NCT04382326|463338024|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
128740049|NCT04382326|463338025|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
128740050|NCT04382326|463338024|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
128740051|NCT04382326|463338025|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
128740052|NCT04382326|463338024|FG000|Overall Study|Protocol Violation|29|||
128740053|NCT04382326|463338025|FG001|Overall Study|Protocol Violation|23|||
128740054|NCT04382326|463338024|FG000|Overall Study|Physician Decision|0|||
128740055|NCT04382326|463338025|FG001|Overall Study|Physician Decision|1|||
128740056|NCT04382326|463338024|FG000|Overall Study|Lost to Follow-up|48|||
128740057|NCT04382326|463338025|FG001|Overall Study|Lost to Follow-up|63|||
128740058|NCT04382326|463338024|FG000|Overall Study|Adverse Event, non-fatal|1|||
128740059|NCT04382326|463338025|FG001|Overall Study|Adverse Event, non-fatal|1|||
128740060|NCT01557946|463338028|FG000|Overall Study|Adverse Event|3|||
128740061|NCT01557946|463338029|FG001|Overall Study|Adverse Event|0|||
128740062|NCT02352493|463338031|FG000|Overall Study|Pregnancy|0|||
128740063|NCT02352493|463338032|FG001|Overall Study|Pregnancy|0|||
128740064|NCT02352493|463338033|FG002|Overall Study|Pregnancy|0|||
128740065|NCT02352493|463338034|FG003|Overall Study|Pregnancy|0|||
128740066|NCT02352493|463338035|FG004|Overall Study|Pregnancy|0|||
128740067|NCT02352493|463338036|FG005|Overall Study|Pregnancy|0|||
128740068|NCT02352493|463338037|FG006|Overall Study|Pregnancy|1|||
128740069|NCT02352493|463338038|FG007|Overall Study|Pregnancy|0|||
128740070|NCT02352493|463338039|FG008|Overall Study|Pregnancy|1|||
128740071|NCT02352493|463338040|FG009|Overall Study|Pregnancy|0|||
128740072|NCT02352493|463338041|FG010|Overall Study|Pregnancy|0|||
128740073|NCT02352493|463338042|FG011|Overall Study|Pregnancy|0|||
128740074|NCT02352493|463338043|FG012|Overall Study|Pregnancy|0|||
128740075|NCT02352493|463338044|FG013|Overall Study|Pregnancy|0|||
128740076|NCT02352493|463338045|FG014|Overall Study|Pregnancy|0|||
128740077|NCT02352493|463338046|FG015|Overall Study|Pregnancy|0|||
128740078|NCT02352493|463338047|FG016|Overall Study|Pregnancy|0|||
128740079|NCT02352493|463338048|FG017|Overall Study|Pregnancy|0|||
128740080|NCT02352493|463338031|FG000|Overall Study|Withdrawal by Subject|0|||
128740081|NCT02352493|463338032|FG001|Overall Study|Withdrawal by Subject|0|||
128740082|NCT02352493|463338033|FG002|Overall Study|Withdrawal by Subject|0|||
128740083|NCT02352493|463338034|FG003|Overall Study|Withdrawal by Subject|0|||
128740084|NCT02352493|463338035|FG004|Overall Study|Withdrawal by Subject|0|||
128740085|NCT02352493|463338036|FG005|Overall Study|Withdrawal by Subject|0|||
128740086|NCT02352493|463338037|FG006|Overall Study|Withdrawal by Subject|0|||
128740087|NCT02352493|463338038|FG007|Overall Study|Withdrawal by Subject|0|||
128740088|NCT02352493|463338039|FG008|Overall Study|Withdrawal by Subject|1|||
128740089|NCT02352493|463338040|FG009|Overall Study|Withdrawal by Subject|0|||
128740090|NCT02352493|463338041|FG010|Overall Study|Withdrawal by Subject|0|||
128740091|NCT02352493|463338042|FG011|Overall Study|Withdrawal by Subject|0|||
128740092|NCT02352493|463338043|FG012|Overall Study|Withdrawal by Subject|0|||
128740093|NCT02352493|463338044|FG013|Overall Study|Withdrawal by Subject|0|||
128740094|NCT02352493|463338045|FG014|Overall Study|Withdrawal by Subject|1|||
128740095|NCT02352493|463338046|FG015|Overall Study|Withdrawal by Subject|0|||
128740096|NCT02352493|463338047|FG016|Overall Study|Withdrawal by Subject|0|||
128740097|NCT02352493|463338048|FG017|Overall Study|Withdrawal by Subject|0|||
128740098|NCT02352493|463338031|FG000|Overall Study|Lost to Follow-up|0|||
128740099|NCT02352493|463338032|FG001|Overall Study|Lost to Follow-up|0|||
128740100|NCT02352493|463338033|FG002|Overall Study|Lost to Follow-up|0|||
128740101|NCT02352493|463338034|FG003|Overall Study|Lost to Follow-up|0|||
128740102|NCT02352493|463338035|FG004|Overall Study|Lost to Follow-up|0|||
128740103|NCT02352493|463338036|FG005|Overall Study|Lost to Follow-up|0|||
128740104|NCT02352493|463338037|FG006|Overall Study|Lost to Follow-up|0|||
128740105|NCT02352493|463338038|FG007|Overall Study|Lost to Follow-up|0|||
128740106|NCT02352493|463338039|FG008|Overall Study|Lost to Follow-up|0|||
128740107|NCT02352493|463338040|FG009|Overall Study|Lost to Follow-up|1|||
128740108|NCT02352493|463338041|FG010|Overall Study|Lost to Follow-up|0|||
128740109|NCT02352493|463338042|FG011|Overall Study|Lost to Follow-up|0|||
128740110|NCT02352493|463338043|FG012|Overall Study|Lost to Follow-up|1|||
128740111|NCT02352493|463338044|FG013|Overall Study|Lost to Follow-up|2|||
128740112|NCT02352493|463338045|FG014|Overall Study|Lost to Follow-up|0|||
128740113|NCT02352493|463338046|FG015|Overall Study|Lost to Follow-up|0|||
128740114|NCT02352493|463338047|FG016|Overall Study|Lost to Follow-up|0|||
128740115|NCT02352493|463338048|FG017|Overall Study|Lost to Follow-up|0|||
128740116|NCT01465334|463338049|FG000|Overall Study|Disease Progression|1|||
128740117|NCT01465334|463338050|FG001|Overall Study|Disease Progression|0|||
128740118|NCT01465334|463338049|FG000|Overall Study|Adverse Event|1|||
128740119|NCT01465334|463338050|FG001|Overall Study|Adverse Event|0|||
128740120|NCT01465334|463338049|FG000|Overall Study|Richter's transformation|0|||
128740121|NCT01465334|463338050|FG001|Overall Study|Richter's transformation|3|||
128740122|NCT01465334|463338049|FG000|Overall Study|Refractory Disease|0|||
128740123|NCT01465334|463338050|FG001|Overall Study|Refractory Disease|3|||
128740124|NCT00572572|463338051|FG000|Overall Study|Withdrawal by Subject|3|||
128740125|NCT00572572|463338052|FG001|Overall Study|Withdrawal by Subject|6|||
128740126|NCT01831089|463338053|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
128740127|NCT01831089|463338054|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
128740128|NCT01831089|463338055|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
128740129|NCT01831089|463338056|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
128740130|NCT01831089|463338057|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
128740131|NCT01831089|463338058|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
128740132|NCT01831089|463338053|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
128740133|NCT01831089|463338054|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
128740134|NCT01831089|463338055|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
128740135|NCT01831089|463338056|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
128740136|NCT01831089|463338057|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
128740137|NCT01831089|463338058|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
128740138|NCT01831089|463338053|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
128740139|NCT01831089|463338054|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
128740140|NCT01831089|463338055|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
128740141|NCT01831089|463338056|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
128740142|NCT01831089|463338057|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
128740143|NCT01831089|463338058|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
128740144|NCT01831089|463338053|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
128740145|NCT01831089|463338054|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
128740146|NCT01831089|463338055|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
128740147|NCT01831089|463338056|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
128740148|NCT01831089|463338057|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
128740149|NCT01831089|463338058|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
128740150|NCT01831089|463338053|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
128740151|NCT01831089|463338054|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
128740152|NCT01831089|463338055|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
128740153|NCT01831089|463338056|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
128740154|NCT01831089|463338057|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
128740155|NCT01831089|463338058|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
128740156|NCT01831089|463338053|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
128740157|NCT01831089|463338054|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
128740158|NCT01831089|463338055|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
128740159|NCT01831089|463338056|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
128740160|NCT01831089|463338057|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
128740161|NCT01831089|463338058|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
128740162|NCT01831089|463338053|FG000|Cohort III: Dose Level 3|Global end of study|0|||
128740163|NCT01831089|463338054|FG001|Cohort III: Dose Level 3|Global end of study|0|||
128740164|NCT01831089|463338055|FG002|Cohort III: Dose Level 3|Global end of study|1|||
128740165|NCT01831089|463338056|FG003|Cohort III: Dose Level 3|Global end of study|0|||
128740166|NCT01831089|463338057|FG004|Cohort III: Dose Level 3|Global end of study|0|||
128740167|NCT01831089|463338058|FG005|Cohort III: Dose Level 3|Global end of study|0|||
128740168|NCT01831089|463338053|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
128740169|NCT01831089|463338054|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
128740170|NCT01831089|463338055|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
128740171|NCT01831089|463338056|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
128740172|NCT01831089|463338057|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
128740173|NCT01831089|463338058|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
128740174|NCT01831089|463338053|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
128740175|NCT01831089|463338054|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
128740176|NCT01831089|463338055|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
128740177|NCT01831089|463338056|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
128740178|NCT01831089|463338057|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
128740179|NCT01831089|463338058|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
128740180|NCT01831089|463338053|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
128740181|NCT01831089|463338054|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
128740182|NCT01831089|463338055|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
128740183|NCT01831089|463338056|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
128740184|NCT01831089|463338057|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
128740185|NCT01831089|463338058|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
128740186|NCT01831089|463338053|FG000|Cohort V: Dose Level 5|Death|0|||
128740187|NCT01831089|463338054|FG001|Cohort V: Dose Level 5|Death|0|||
128740188|NCT01831089|463338055|FG002|Cohort V: Dose Level 5|Death|0|||
128740189|NCT01831089|463338056|FG003|Cohort V: Dose Level 5|Death|0|||
128740190|NCT01831089|463338057|FG004|Cohort V: Dose Level 5|Death|1|||
128740191|NCT01831089|463338058|FG005|Cohort V: Dose Level 5|Death|0|||
128740192|NCT01831089|463338053|FG000|Cohort V: Dose Level 5|Global end of study|0|||
128740193|NCT01831089|463338054|FG001|Cohort V: Dose Level 5|Global end of study|0|||
128740194|NCT01831089|463338055|FG002|Cohort V: Dose Level 5|Global end of study|0|||
128740195|NCT01831089|463338056|FG003|Cohort V: Dose Level 5|Global end of study|0|||
128740196|NCT01831089|463338057|FG004|Cohort V: Dose Level 5|Global end of study|2|||
128740197|NCT01831089|463338058|FG005|Cohort V: Dose Level 5|Global end of study|0|||
128740198|NCT01831089|463338053|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
128740199|NCT01831089|463338054|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
128740200|NCT01831089|463338055|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
128740201|NCT01831089|463338056|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
128740202|NCT01831089|463338057|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
128740203|NCT01831089|463338058|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
128740204|NCT01831089|463338053|FG000|Cohort B: Arm B|Progressive disease|0|||
128740205|NCT01831089|463338054|FG001|Cohort B: Arm B|Progressive disease|0|||
128740206|NCT01831089|463338055|FG002|Cohort B: Arm B|Progressive disease|0|||
128740207|NCT01831089|463338056|FG003|Cohort B: Arm B|Progressive disease|0|||
128740208|NCT01831089|463338057|FG004|Cohort B: Arm B|Progressive disease|0|||
128740209|NCT01831089|463338058|FG005|Cohort B: Arm B|Progressive disease|8|||
128740210|NCT01831089|463338053|FG000|Cohort B: Arm B|Physician Decision|0|||
128740211|NCT01831089|463338054|FG001|Cohort B: Arm B|Physician Decision|0|||
128740212|NCT01831089|463338055|FG002|Cohort B: Arm B|Physician Decision|0|||
128740213|NCT01831089|463338056|FG003|Cohort B: Arm B|Physician Decision|0|||
128740214|NCT01831089|463338057|FG004|Cohort B: Arm B|Physician Decision|0|||
128740215|NCT01831089|463338058|FG005|Cohort B: Arm B|Physician Decision|2|||
128740216|NCT01831089|463338053|FG000|Cohort B: Arm B|Never treated|0|||
128740217|NCT01831089|463338054|FG001|Cohort B: Arm B|Never treated|0|||
128740218|NCT01831089|463338055|FG002|Cohort B: Arm B|Never treated|0|||
128740219|NCT01831089|463338056|FG003|Cohort B: Arm B|Never treated|0|||
128740220|NCT01831089|463338057|FG004|Cohort B: Arm B|Never treated|0|||
128740221|NCT01831089|463338058|FG005|Cohort B: Arm B|Never treated|2|||
128740222|NCT01831089|463338053|FG000|Cohort B: Arm B|Adverse Event|0|||
128740223|NCT01831089|463338054|FG001|Cohort B: Arm B|Adverse Event|0|||
128740224|NCT01831089|463338055|FG002|Cohort B: Arm B|Adverse Event|0|||
128740225|NCT01831089|463338056|FG003|Cohort B: Arm B|Adverse Event|0|||
128740226|NCT01831089|463338057|FG004|Cohort B: Arm B|Adverse Event|0|||
128740227|NCT01831089|463338058|FG005|Cohort B: Arm B|Adverse Event|1|||
128740228|NCT01831089|463338053|FG000|Cohort B: Arm B|Global end of study|0|||
128740229|NCT01831089|463338054|FG001|Cohort B: Arm B|Global end of study|0|||
128740230|NCT01831089|463338055|FG002|Cohort B: Arm B|Global end of study|0|||
128740231|NCT01831089|463338056|FG003|Cohort B: Arm B|Global end of study|0|||
128740232|NCT01831089|463338057|FG004|Cohort B: Arm B|Global end of study|0|||
128740233|NCT01831089|463338058|FG005|Cohort B: Arm B|Global end of study|1|||
128740234|NCT00718042|463338064|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
128740235|NCT00718042|463338065|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
128740236|NCT00718042|463338066|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
128740237|NCT00718042|463338067|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
128740238|NCT00718042|463338068|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
128740239|NCT00718042|463338069|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
128740240|NCT00718042|463338064|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
128740241|NCT00718042|463338065|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
128740242|NCT00718042|463338066|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
128740243|NCT00718042|463338067|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
128740244|NCT00718042|463338068|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
128740245|NCT00718042|463338069|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
128740246|NCT00718042|463338064|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
128740247|NCT00718042|463338065|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
128740248|NCT00718042|463338066|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
128740249|NCT00718042|463338067|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
128740250|NCT00718042|463338068|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
128740251|NCT00718042|463338069|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
128740252|NCT00718042|463338064|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
128740253|NCT00718042|463338065|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
128740254|NCT00718042|463338066|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
128740255|NCT00718042|463338067|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
128740256|NCT00718042|463338068|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
128740257|NCT00718042|463338069|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
128740258|NCT00718042|463338064|FG000|Donor Follow-up|Lost to Follow-up|13|||
128740259|NCT00718042|463338065|FG001|Donor Follow-up|Lost to Follow-up|0|||
128740260|NCT00718042|463338066|FG002|Donor Follow-up|Lost to Follow-up|0|||
128740261|NCT00718042|463338067|FG003|Donor Follow-up|Lost to Follow-up|0|||
128740262|NCT00718042|463338068|FG004|Donor Follow-up|Lost to Follow-up|19|||
128740263|NCT00718042|463338069|FG005|Donor Follow-up|Lost to Follow-up|0|||
128740264|NCT03525834|463338070|FG000|Overall Study|Progressive disease|1|||
128740265|NCT03586999|463338071|FG000|Overall Study|Lack of Efficacy|2|||
128740266|NCT01485861|463338076|FG000|Phase Ib|Death|1|||
128740267|NCT01485861|463338077|FG001|Phase Ib|Death|0|||
128740268|NCT01485861|463338078|FG002|Phase Ib|Death|0|||
128740269|NCT01485861|463338079|FG003|Phase Ib|Death|0|||
128740270|NCT01485861|463338080|FG004|Phase Ib|Death|0|||
128740271|NCT01485861|463338081|FG005|Phase Ib|Death|0|||
128740272|NCT01485861|463338076|FG000|Phase Ib|Physician Decision|1|||
128740273|NCT01485861|463338077|FG001|Phase Ib|Physician Decision|1|||
128740274|NCT01485861|463338078|FG002|Phase Ib|Physician Decision|0|||
128740275|NCT01485861|463338079|FG003|Phase Ib|Physician Decision|0|||
128740276|NCT01485861|463338080|FG004|Phase Ib|Physician Decision|0|||
128740277|NCT01485861|463338081|FG005|Phase Ib|Physician Decision|0|||
128740278|NCT01485861|463338076|FG000|Phase Ib|Adverse Event|0|||
128740279|NCT01485861|463338077|FG001|Phase Ib|Adverse Event|4|||
128740280|NCT01485861|463338078|FG002|Phase Ib|Adverse Event|0|||
128740281|NCT01485861|463338079|FG003|Phase Ib|Adverse Event|0|||
128740282|NCT01485861|463338080|FG004|Phase Ib|Adverse Event|0|||
128740283|NCT01485861|463338081|FG005|Phase Ib|Adverse Event|0|||
128740284|NCT01485861|463338076|FG000|Phase Ib|Progression of disease|5|||
128740285|NCT01485861|463338077|FG001|Phase Ib|Progression of disease|0|||
128740286|NCT01485861|463338078|FG002|Phase Ib|Progression of disease|0|||
128740287|NCT01485861|463338079|FG003|Phase Ib|Progression of disease|0|||
128740288|NCT01485861|463338080|FG004|Phase Ib|Progression of disease|0|||
128740289|NCT01485861|463338081|FG005|Phase Ib|Progression of disease|0|||
128740290|NCT01485861|463338076|FG000|Phase Ib|Other|3|||
128740291|NCT01485861|463338077|FG001|Phase Ib|Other|0|||
128740292|NCT01485861|463338078|FG002|Phase Ib|Other|0|||
128740293|NCT01485861|463338079|FG003|Phase Ib|Other|0|||
128740294|NCT01485861|463338080|FG004|Phase Ib|Other|0|||
128740295|NCT01485861|463338081|FG005|Phase Ib|Other|0|||
128740296|NCT01485861|463338076|FG000|Phase Ib|Withdrawal by Subject|4|||
128740297|NCT01485861|463338077|FG001|Phase Ib|Withdrawal by Subject|1|||
128740298|NCT01485861|463338078|FG002|Phase Ib|Withdrawal by Subject|0|||
128740299|NCT01485861|463338079|FG003|Phase Ib|Withdrawal by Subject|0|||
128740300|NCT01485861|463338080|FG004|Phase Ib|Withdrawal by Subject|0|||
128740301|NCT01485861|463338081|FG005|Phase Ib|Withdrawal by Subject|0|||
128740302|NCT01485861|463338076|FG000|Phase II|Death|0|||
128740303|NCT01485861|463338077|FG001|Phase II|Death|0|||
128740304|NCT01485861|463338078|FG002|Phase II|Death|67|||
128740305|NCT01485861|463338079|FG003|Phase II|Death|71|||
128740306|NCT01485861|463338080|FG004|Phase II|Death|68|||
128740307|NCT01485861|463338081|FG005|Phase II|Death|0|||
128740308|NCT01485861|463338076|FG000|Phase II|Progression of Disease|0|||
128740309|NCT01485861|463338077|FG001|Phase II|Progression of Disease|0|||
128740310|NCT01485861|463338078|FG002|Phase II|Progression of Disease|1|||
128740311|NCT01485861|463338079|FG003|Phase II|Progression of Disease|0|||
128740312|NCT01485861|463338080|FG004|Phase II|Progression of Disease|0|||
128740313|NCT01485861|463338081|FG005|Phase II|Progression of Disease|0|||
128740314|NCT01485861|463338076|FG000|Phase II|Other|0|||
128740315|NCT01485861|463338077|FG001|Phase II|Other|0|||
128740316|NCT01485861|463338078|FG002|Phase II|Other|0|||
128740317|NCT01485861|463338079|FG003|Phase II|Other|1|||
128740318|NCT01485861|463338080|FG004|Phase II|Other|0|||
128740319|NCT01485861|463338081|FG005|Phase II|Other|0|||
128740320|NCT01485861|463338076|FG000|Phase II|Withdrawal by Subject|0|||
128740321|NCT01485861|463338077|FG001|Phase II|Withdrawal by Subject|0|||
128740322|NCT01485861|463338078|FG002|Phase II|Withdrawal by Subject|6|||
128740323|NCT01485861|463338079|FG003|Phase II|Withdrawal by Subject|3|||
128740324|NCT01485861|463338080|FG004|Phase II|Withdrawal by Subject|4|||
128740325|NCT01485861|463338081|FG005|Phase II|Withdrawal by Subject|0|||
128740326|NCT01485861|463338076|FG000|Phase II|Lost to Follow-up|0|||
128740327|NCT01485861|463338077|FG001|Phase II|Lost to Follow-up|0|||
128740328|NCT01485861|463338078|FG002|Phase II|Lost to Follow-up|2|||
128740329|NCT01485861|463338079|FG003|Phase II|Lost to Follow-up|3|||
128740330|NCT01485861|463338080|FG004|Phase II|Lost to Follow-up|5|||
128740331|NCT01485861|463338081|FG005|Phase II|Lost to Follow-up|0|||
128740332|NCT01485861|463338076|FG000|Phase II|Study Ended|0|||
128740333|NCT01485861|463338077|FG001|Phase II|Study Ended|0|||
128740334|NCT01485861|463338078|FG002|Phase II|Study Ended|7|||
128740335|NCT01485861|463338079|FG003|Phase II|Study Ended|8|||
128740336|NCT01485861|463338080|FG004|Phase II|Study Ended|6|||
128740337|NCT01485861|463338081|FG005|Phase II|Study Ended|0|||
128740338|NCT01485861|463338076|FG000|Safety Phase|Death|0|||
128740339|NCT01485861|463338077|FG001|Safety Phase|Death|0|||
128740340|NCT01485861|463338078|FG002|Safety Phase|Death|0|||
128740341|NCT01485861|463338079|FG003|Safety Phase|Death|0|||
128740342|NCT01485861|463338080|FG004|Safety Phase|Death|0|||
128740343|NCT01485861|463338081|FG005|Safety Phase|Death|2|||
128740344|NCT01485861|463338076|FG000|Safety Phase|Adverse Event|0|||
128740345|NCT01485861|463338077|FG001|Safety Phase|Adverse Event|0|||
128740346|NCT01485861|463338078|FG002|Safety Phase|Adverse Event|0|||
128740347|NCT01485861|463338079|FG003|Safety Phase|Adverse Event|0|||
128740348|NCT01485861|463338080|FG004|Safety Phase|Adverse Event|0|||
128740349|NCT01485861|463338081|FG005|Safety Phase|Adverse Event|1|||
128740350|NCT01485861|463338076|FG000|Safety Phase|Other|0|||
128740351|NCT01485861|463338077|FG001|Safety Phase|Other|0|||
128740352|NCT01485861|463338078|FG002|Safety Phase|Other|0|||
128740353|NCT01485861|463338079|FG003|Safety Phase|Other|0|||
128740354|NCT01485861|463338080|FG004|Safety Phase|Other|0|||
128740355|NCT01485861|463338081|FG005|Safety Phase|Other|5|||
128740356|NCT01485861|463338076|FG000|Safety Phase|Progression of Disease|0|||
128740357|NCT01485861|463338077|FG001|Safety Phase|Progression of Disease|0|||
128740358|NCT01485861|463338078|FG002|Safety Phase|Progression of Disease|0|||
128740359|NCT01485861|463338079|FG003|Safety Phase|Progression of Disease|0|||
128740360|NCT01485861|463338080|FG004|Safety Phase|Progression of Disease|0|||
128740361|NCT01485861|463338081|FG005|Safety Phase|Progression of Disease|9|||
128740362|NCT01485861|463338076|FG000|Safety Phase|Withdrawal by Subject|0|||
128740363|NCT01485861|463338077|FG001|Safety Phase|Withdrawal by Subject|0|||
128740364|NCT01485861|463338078|FG002|Safety Phase|Withdrawal by Subject|0|||
128740365|NCT01485861|463338079|FG003|Safety Phase|Withdrawal by Subject|0|||
128740366|NCT01485861|463338080|FG004|Safety Phase|Withdrawal by Subject|0|||
128740367|NCT01485861|463338081|FG005|Safety Phase|Withdrawal by Subject|6|||
128740368|NCT01485861|463338076|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
128740369|NCT01485861|463338077|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
128740370|NCT01485861|463338078|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
128740371|NCT01485861|463338079|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
128740372|NCT01485861|463338080|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
128740373|NCT01485861|463338081|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
128740374|NCT03653429|463338086|FG000|Overall Study|Physician Decision|4|||
128740375|NCT03653429|463338087|FG001|Overall Study|Physician Decision|10|||
128740376|NCT03056690|463338091|FG000|Overall Study|Adverse Event|3|||
128740377|NCT03056690|463338092|FG001|Overall Study|Adverse Event|2|||
128740378|NCT03056690|463338091|FG000|Overall Study|Lack of Efficacy|1|||
128740379|NCT03056690|463338092|FG001|Overall Study|Lack of Efficacy|2|||
128740380|NCT03056690|463338091|FG000|Overall Study|Lost to Follow-up|3|||
128740381|NCT03056690|463338092|FG001|Overall Study|Lost to Follow-up|2|||
128740382|NCT03056690|463338091|FG000|Overall Study|Protocol Violation|2|||
128740383|NCT03056690|463338092|FG001|Overall Study|Protocol Violation|2|||
128740384|NCT03056690|463338091|FG000|Overall Study|Withdrawal by Subject|3|||
128740385|NCT03056690|463338092|FG001|Overall Study|Withdrawal by Subject|6|||
128740386|NCT03056690|463338091|FG000|Overall Study|Non-compliance with Study Drug|1|||
128740387|NCT03056690|463338092|FG001|Overall Study|Non-compliance with Study Drug|0|||
128740388|NCT03056690|463338091|FG000|Overall Study|Miscellaneous|1|||
128740389|NCT03056690|463338092|FG001|Overall Study|Miscellaneous|2|||
128740390|NCT02543346|463338093|FG000|Second Priming Visit|Withdrawal by Subject|0|||
128740391|NCT02543346|463338094|FG001|Second Priming Visit|Withdrawal by Subject|2|||
128740392|NCT02543346|463338095|FG002|Second Priming Visit|Withdrawal by Subject|2|||
128740393|NCT02543346|463338096|FG003|Second Priming Visit|Withdrawal by Subject|2|||
128740394|NCT02543346|463338093|FG000|Second Priming Visit|Adverse Event|1|||
128740395|NCT02543346|463338094|FG001|Second Priming Visit|Adverse Event|0|||
128740396|NCT02543346|463338095|FG002|Second Priming Visit|Adverse Event|0|||
128740397|NCT02543346|463338096|FG003|Second Priming Visit|Adverse Event|0|||
128740398|NCT01767116|463338097|FG000|Overall Study|Lost to Follow-up|2|||
128740399|NCT01767116|463338098|FG001|Overall Study|Lost to Follow-up|2|||
128740400|NCT01975389|463338099|FG000|Overall Study|Adverse Event|10|||
128740401|NCT01975389|463338100|FG001|Overall Study|Adverse Event|6|||
128740402|NCT01975389|463338099|FG000|Overall Study|Death|61|||
128740403|NCT01975389|463338100|FG001|Overall Study|Death|54|||
128740404|NCT01975389|463338099|FG000|Overall Study|Lost to Follow-up|81|||
128740405|NCT01975389|463338100|FG001|Overall Study|Lost to Follow-up|86|||
128740406|NCT01975389|463338099|FG000|Overall Study|Withdrawal by Subject|90|||
128740407|NCT01975389|463338100|FG001|Overall Study|Withdrawal by Subject|76|||
128740408|NCT01975389|463338099|FG000|Overall Study|Other|6|||
128740409|NCT01975389|463338100|FG001|Overall Study|Other|9|||
128740410|NCT01975389|463338099|FG000|Overall Study|Randomized, not treated|4|||
128740411|NCT01975389|463338100|FG001|Overall Study|Randomized, not treated|5|||
128740412|NCT01306617|463338107|FG000|Overall Study|Adverse Event|1|||
128740413|NCT01306617|463338108|FG001|Overall Study|Adverse Event|0|||
128740414|NCT01306617|463338109|FG002|Overall Study|Adverse Event|0|||
128740415|NCT01306617|463338107|FG000|Overall Study|Virologic Failure|0|||
128740416|NCT01306617|463338108|FG001|Overall Study|Virologic Failure|0|||
128740417|NCT01306617|463338109|FG002|Overall Study|Virologic Failure|5|||
128740418|NCT01306617|463338107|FG000|Overall Study|Non-compliance|0|||
128740419|NCT01306617|463338108|FG001|Overall Study|Non-compliance|1|||
128740420|NCT01306617|463338109|FG002|Overall Study|Non-compliance|0|||
128740421|NCT00818441|463338112|FG000|Overall Study|Death|69|||
128740422|NCT00818441|463338113|FG001|Overall Study|Death|26|||
128740423|NCT00818441|463338112|FG000|Overall Study|Other|5|||
128740424|NCT00818441|463338113|FG001|Overall Study|Other|0|||
128740425|NCT00818441|463338112|FG000|Overall Study|Lost to Follow-up|2|||
128740426|NCT00818441|463338113|FG001|Overall Study|Lost to Follow-up|1|||
128740427|NCT00818441|463338112|FG000|Overall Study|Withdrawal by Subject|2|||
128740428|NCT00818441|463338113|FG001|Overall Study|Withdrawal by Subject|0|||
128740429|NCT00818441|463338112|FG000|Overall Study|Adverse Event|0|||
128740430|NCT00818441|463338113|FG001|Overall Study|Adverse Event|1|||
128740431|NCT00818441|463338112|FG000|Overall Study|Study terminated by sponsor|11|||
128740432|NCT00818441|463338113|FG001|Overall Study|Study terminated by sponsor|2|||
128740433|NCT03483623|463338115|FG000|Overall Study|43 complete sets achieved|1|||
128740434|NCT02770391|463338116|FG000|Overall Study|Lost to Follow-up|2|||
128740435|NCT02770391|463338116|FG000|Overall Study|Withdrawal by Subject|1|||
128740436|NCT02770391|463338116|FG000|Overall Study|Surgery delayed unevaluable|2|||
128740437|NCT02770391|463338116|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
128740438|NCT03403634|463338123|FG000|Overall Study|Disease progression|3|||
128740439|NCT03403634|463338123|FG000|Overall Study|Did not meet eligibility criteria|4|||
128740440|NCT01076400|463339612|FG000|Overall Study|Adverse Event|2|||
128740441|NCT01076400|463339613|FG001|Overall Study|Adverse Event|0|||
128740442|NCT01076400|463339614|FG002|Overall Study|Adverse Event|0|||
128740443|NCT01076400|463339612|FG000|Overall Study|Progressive Disease|5|||
128740444|NCT01076400|463339613|FG001|Overall Study|Progressive Disease|0|||
128740445|NCT01076400|463339614|FG002|Overall Study|Progressive Disease|0|||
128740446|NCT03019536|463339616|FG000|Overall Study|Withdrawal by Subject|1|||
128740447|NCT03019536|463339617|FG001|Overall Study|Withdrawal by Subject|1|||
128740448|NCT03019536|463339618|FG002|Overall Study|Withdrawal by Subject|0|||
128740449|NCT03019536|463339616|FG000|Overall Study|Adverse Event|0|||
128740450|NCT03019536|463339617|FG001|Overall Study|Adverse Event|0|||
128740451|NCT03019536|463339618|FG002|Overall Study|Adverse Event|2|||
128740452|NCT01043874|463339619|FG000|Overall Study|Adverse Event|3|||
128740453|NCT01043874|463339619|FG000|Overall Study|Withdrawal by Subject|1|||
128740454|NCT01043874|463339619|FG000|Overall Study|Lack of Efficacy|1|||
128740455|NCT01043874|463339619|FG000|Overall Study|Administrative Problems|1|||
128740456|NCT00182689|463339627|FG000|Overall Study|Adverse Event|8|||
128740457|NCT00182689|463339628|FG001|Overall Study|Adverse Event|11|||
128740458|NCT00182689|463339627|FG000|Overall Study|Withdrawal by Subject|2|||
128740459|NCT00182689|463339628|FG001|Overall Study|Withdrawal by Subject|2|||
128740460|NCT00182689|463339627|FG000|Overall Study|Progression|27|||
128740461|NCT00182689|463339628|FG001|Overall Study|Progression|29|||
128740462|NCT00182689|463339627|FG000|Overall Study|Death|1|||
128740463|NCT00182689|463339628|FG001|Overall Study|Death|0|||
128740464|NCT00182689|463339627|FG000|Overall Study|not protocol specified|0|||
128740465|NCT00182689|463339628|FG001|Overall Study|not protocol specified|3|||
128740466|NCT00182689|463339627|FG000|Overall Study|Ineligible|1|||
128740467|NCT00182689|463339628|FG001|Overall Study|Ineligible|4|||
128740468|NCT00182689|463339627|FG000|Overall Study|Never received treatment|1|||
128740469|NCT00182689|463339628|FG001|Overall Study|Never received treatment|0|||
128740470|NCT03422003|463339629|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
128740471|NCT03422003|463339630|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
128740472|NCT03422003|463339629|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
128740473|NCT03422003|463339630|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
128740474|NCT01337089|463339633|FG000|Overall Study|Adverse Event|237|||
128740475|NCT01337089|463339633|FG000|Overall Study|Withdrawal by Subject|129|||
128740476|NCT01337089|463339633|FG000|Overall Study|Withdrawal by Investigator|33|||
128740477|NCT01337089|463339633|FG000|Overall Study|Met Withdrawal Criteria|3|||
128740478|NCT01337089|463339633|FG000|Overall Study|Lost to Follow-up|2|||
128740479|NCT01627249|463339636|FG000|Overall Study|Death|3|||
128740480|NCT01627249|463339637|FG001|Overall Study|Death|5|||
128740481|NCT01627249|463339638|FG002|Overall Study|Death|3|||
128740482|NCT01627249|463339636|FG000|Overall Study|Withdrawal by Subject|12|||
128740483|NCT01627249|463339637|FG001|Overall Study|Withdrawal by Subject|6|||
128740484|NCT01627249|463339638|FG002|Overall Study|Withdrawal by Subject|9|||
128740485|NCT01627249|463339636|FG000|Overall Study|Missed Visit|1|||
128740486|NCT01627249|463339637|FG001|Overall Study|Missed Visit|1|||
128740487|NCT01627249|463339638|FG002|Overall Study|Missed Visit|0|||
128740488|NCT00966940|463339640|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
128740489|NCT00966940|463339641|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
128740490|NCT00966940|463339640|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
128740491|NCT00966940|463339641|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
128740492|NCT02044510|463339642|FG000|Overall Study|Adverse Event|1|||
128740493|NCT02044510|463339643|FG001|Overall Study|Adverse Event|2|||
128785247|NCT00567164|463505954|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
128785248|NCT00567164|463505955|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
128740494|NCT03455855|463339644|FG000|Overall Study|Lost to Follow-up|4|||
128740495|NCT03455855|463339645|FG001|Overall Study|Lost to Follow-up|2|||
128740496|NCT00581945|463339648|FG000|Overall Study|Adverse Event|4|||
128740497|NCT00581945|463339649|FG001|Overall Study|Adverse Event|4|||
128740498|NCT00581945|463339648|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128740499|NCT00581945|463339649|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128740500|NCT00581945|463339648|FG000|Overall Study|Withdrawal by Subject|2|||
128740501|NCT00581945|463339649|FG001|Overall Study|Withdrawal by Subject|6|||
128740502|NCT00581945|463339648|FG000|Overall Study|Death|1|||
128740503|NCT00581945|463339649|FG001|Overall Study|Death|0|||
128740504|NCT01046110|463339650|FG000|Overall Study|Adverse Event|9|||
128740505|NCT01046110|463339651|FG001|Overall Study|Adverse Event|2|||
128740506|NCT01046110|463339650|FG000|Overall Study|Lack of Efficacy|0|||
128740507|NCT01046110|463339651|FG001|Overall Study|Lack of Efficacy|1|||
128740508|NCT01046110|463339650|FG000|Overall Study|Protocol Violation|7|||
128740509|NCT01046110|463339651|FG001|Overall Study|Protocol Violation|12|||
128740510|NCT01046110|463339650|FG000|Overall Study|Withdrawal Criteria|3|||
128740511|NCT01046110|463339651|FG001|Overall Study|Withdrawal Criteria|5|||
128740512|NCT01046110|463339650|FG000|Overall Study|Unclassified|36|||
128740513|NCT01046110|463339651|FG001|Overall Study|Unclassified|35|||
128740514|NCT02114892|463339652|FG000|Overall Study|Lost to Follow-up|1|||
128740515|NCT02114892|463339653|FG001|Overall Study|Lost to Follow-up|2|||
128740516|NCT02013765|463339659|FG000|Overall Study|Trial was terminated by sponsor|1|||
128740517|NCT00614939|463339666|FG000|Overall Study|Withdrawal by Subject|10|||
128740518|NCT00614939|463339667|FG001|Overall Study|Withdrawal by Subject|17|||
128740519|NCT00614939|463339666|FG000|Overall Study|Study specific discontinuation criteris|13|||
128740520|NCT00614939|463339667|FG001|Overall Study|Study specific discontinuation criteris|16|||
128740521|NCT00614939|463339666|FG000|Overall Study|Adverse Event|2|||
128740522|NCT00614939|463339667|FG001|Overall Study|Adverse Event|5|||
128740523|NCT00614939|463339666|FG000|Overall Study|Incorrect enrollment|1|||
128740524|NCT00614939|463339667|FG001|Overall Study|Incorrect enrollment|2|||
128740525|NCT00614939|463339666|FG000|Overall Study|Death|4|||
128740526|NCT00614939|463339667|FG001|Overall Study|Death|3|||
128740527|NCT00614939|463339666|FG000|Overall Study|Poor/non-compliance|4|||
128740528|NCT00614939|463339667|FG001|Overall Study|Poor/non-compliance|0|||
128740529|NCT00614939|463339666|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
128740530|NCT00614939|463339667|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
128740531|NCT00840970|463339668|FG000|Overall Study|Adverse Event|0|||
128740532|NCT00840970|463339669|FG001|Overall Study|Adverse Event|0|||
128740533|NCT00840970|463339670|FG002|Overall Study|Adverse Event|1|||
128740534|NCT01854827|463339671|FG000|Overall Study|Death|1|||
128740535|NCT02571452|463339672|FG000|Overall Study Treatment|Protocol Violation|0|||
128740536|NCT02571452|463339673|FG001|Overall Study Treatment|Protocol Violation|1|||
128740537|NCT02571452|463339672|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
128740538|NCT02571452|463339673|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
128740539|NCT02571452|463339672|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
128740540|NCT02571452|463339673|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
128740541|NCT01751568|463339678|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
128740542|NCT01751568|463339679|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
128740543|NCT01751568|463339680|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
128740544|NCT02660944|463339689|FG000|Overall Study|Adverse Event|3|||
128740545|NCT02660944|463339690|FG001|Overall Study|Adverse Event|4|||
128740546|NCT02660944|463339689|FG000|Overall Study|Physician Decision|3|||
128740547|NCT02660944|463339690|FG001|Overall Study|Physician Decision|1|||
128740548|NCT02660944|463339689|FG000|Overall Study|Withdrawal by Subject|5|||
128740549|NCT02660944|463339690|FG001|Overall Study|Withdrawal by Subject|3|||
128740550|NCT02660944|463339689|FG000|Overall Study|Lost to Follow-up|4|||
128740551|NCT02660944|463339690|FG001|Overall Study|Lost to Follow-up|1|||
128740552|NCT02660944|463339689|FG000|Overall Study|Subject schedule|0|||
128740553|NCT02660944|463339690|FG001|Overall Study|Subject schedule|1|||
128740554|NCT02660944|463339689|FG000|Overall Study|Exclusion criteria met|2|||
128740555|NCT02660944|463339690|FG001|Overall Study|Exclusion criteria met|0|||
128740556|NCT04096560|463339691|FG000|Overall Study|Reason not Specified|1|||
128740557|NCT04096560|463339692|FG001|Overall Study|Reason not Specified|0|||
128740558|NCT04096560|463339693|FG002|Overall Study|Reason not Specified|0|||
128740559|NCT04096560|463339694|FG003|Overall Study|Reason not Specified|0|||
128740560|NCT04096560|463339695|FG004|Overall Study|Reason not Specified|1|||
128740561|NCT04096560|463339696|FG005|Overall Study|Reason not Specified|1|||
128740562|NCT04096560|463339697|FG006|Overall Study|Reason not Specified|1|||
128740563|NCT04096560|463339698|FG007|Overall Study|Reason not Specified|0|||
128740564|NCT04096560|463339691|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
128740565|NCT04096560|463339692|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
128740566|NCT04096560|463339693|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
128740567|NCT04096560|463339694|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
128740568|NCT04096560|463339695|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
128740569|NCT04096560|463339696|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
128740570|NCT04096560|463339697|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
128740571|NCT04096560|463339698|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
128740572|NCT04096560|463339691|FG000|Overall Study|Study Terminated by Sponsor|0|||
128740573|NCT04096560|463339692|FG001|Overall Study|Study Terminated by Sponsor|0|||
128740574|NCT04096560|463339693|FG002|Overall Study|Study Terminated by Sponsor|0|||
128740575|NCT04096560|463339694|FG003|Overall Study|Study Terminated by Sponsor|5|||
128740576|NCT04096560|463339695|FG004|Overall Study|Study Terminated by Sponsor|6|||
128740577|NCT04096560|463339696|FG005|Overall Study|Study Terminated by Sponsor|4|||
128740578|NCT04096560|463339697|FG006|Overall Study|Study Terminated by Sponsor|6|||
128740579|NCT04096560|463339698|FG007|Overall Study|Study Terminated by Sponsor|1|||
128740580|NCT04096560|463339691|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
128740581|NCT04096560|463339692|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
128740582|NCT04096560|463339693|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
128740583|NCT04096560|463339694|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
128740584|NCT04096560|463339695|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
128740585|NCT04096560|463339696|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
128740586|NCT04096560|463339697|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
128740587|NCT04096560|463339698|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
128740588|NCT00534352|463339699|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
128740589|NCT00534352|463339699|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
128740590|NCT00534352|463339699|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
128740591|NCT00534352|463339699|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
128740592|NCT00534352|463339699|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
128740593|NCT00534352|463339699|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
128740594|NCT04796610|463339704|FG000|Overall Study|Withdrawal by Subject|1|||
128740595|NCT04796610|463339705|FG001|Overall Study|Withdrawal by Subject|0|||
128740596|NCT04796610|463339706|FG002|Overall Study|Withdrawal by Subject|0|||
128740597|NCT04796610|463339707|FG003|Overall Study|Withdrawal by Subject|0|||
128740598|NCT04796610|463339704|FG000|Overall Study|Lost to Follow-up|2|||
128740599|NCT04796610|463339705|FG001|Overall Study|Lost to Follow-up|0|||
128740600|NCT04796610|463339706|FG002|Overall Study|Lost to Follow-up|1|||
128740601|NCT04796610|463339707|FG003|Overall Study|Lost to Follow-up|1|||
128740602|NCT02059148|463339708|FG000|Treatment 1|Protocol Violation|0|||
128740603|NCT02059148|463339709|FG001|Treatment 1|Protocol Violation|0|||
128740604|NCT02059148|463339710|FG002|Treatment 1|Protocol Violation|0|||
128740605|NCT02059148|463339711|FG003|Treatment 1|Protocol Violation|0|||
128740606|NCT02059148|463339712|FG004|Treatment 1|Protocol Violation|0|||
128740607|NCT02059148|463339713|FG005|Treatment 1|Protocol Violation|1|||
128740608|NCT00403546|463339719|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
128740609|NCT00403546|463339720|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
128740610|NCT00403546|463339721|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
128740611|NCT00403546|463339719|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
128740612|NCT00403546|463339720|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
128740613|NCT00403546|463339721|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
128740614|NCT00403546|463339719|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
128740615|NCT00403546|463339720|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
128740616|NCT00403546|463339721|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
128740617|NCT00403546|463339719|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
128740618|NCT00403546|463339720|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
128740619|NCT00403546|463339721|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
128740620|NCT00403546|463339719|FG000|Screening Phase|Screening Failure|22|||
128740621|NCT00403546|463339720|FG001|Screening Phase|Screening Failure|0|||
128740622|NCT00403546|463339721|FG002|Screening Phase|Screening Failure|0|||
128740623|NCT00403546|463339719|FG000|Screening Phase|Adverse Event|1|||
128740624|NCT00403546|463339720|FG001|Screening Phase|Adverse Event|0|||
128740625|NCT00403546|463339721|FG002|Screening Phase|Adverse Event|0|||
128740626|NCT00403546|463339719|FG000|Screening Phase|Terminated Prior to Randomization|5|||
128740627|NCT00403546|463339720|FG001|Screening Phase|Terminated Prior to Randomization|0|||
128740628|NCT00403546|463339721|FG002|Screening Phase|Terminated Prior to Randomization|0|||
128785249|NCT00567164|463505956|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
128785250|NCT00567164|463505954|FG000|Overall Study|Missing|1|||
128740629|NCT00403546|463339719|FG000|Randomized Trial|Early Terminations|0|||
128740630|NCT00403546|463339720|FG001|Randomized Trial|Early Terminations|17|||
128740631|NCT00403546|463339721|FG002|Randomized Trial|Early Terminations|16|||
128740632|NCT02673697|463339722|FG000|Overall Study|Adverse Event|2|||
128740633|NCT02673697|463339723|FG001|Overall Study|Adverse Event|0|||
128785251|NCT00567164|463505955|FG001|Overall Study|Missing|0|||
128740634|NCT02673697|463339722|FG000|Overall Study|Death|32|||
128740635|NCT02673697|463339723|FG001|Overall Study|Death|24|||
128740636|NCT02673697|463339722|FG000|Overall Study|Lost to Follow-up|5|||
128740637|NCT02673697|463339723|FG001|Overall Study|Lost to Follow-up|2|||
128740638|NCT02673697|463339722|FG000|Overall Study|Physician Decision|2|||
128740639|NCT02673697|463339723|FG001|Overall Study|Physician Decision|1|||
128740640|NCT02673697|463339722|FG000|Overall Study|Withdrawal by Subject|10|||
128740641|NCT02673697|463339723|FG001|Overall Study|Withdrawal by Subject|7|||
128740642|NCT02673697|463339722|FG000|Overall Study|Change subj medical status|1|||
128740643|NCT02673697|463339723|FG001|Overall Study|Change subj medical status|2|||
128740644|NCT02673697|463339722|FG000|Overall Study|Explant|10|||
128740645|NCT02673697|463339723|FG001|Overall Study|Explant|5|||
128740646|NCT02673697|463339722|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
128740647|NCT02673697|463339723|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
128740648|NCT00437489|463339724|FG000|Overall Study|Study terminated by sponsor|23|||
128740649|NCT00437489|463339725|FG001|Overall Study|Study terminated by sponsor|21|||
128740650|NCT00437489|463339724|FG000|Overall Study|Lost to Follow-up|0|||
128740651|NCT00437489|463339725|FG001|Overall Study|Lost to Follow-up|1|||
128740652|NCT03893448|463339731|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
128740653|NCT03893448|463339732|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
128740654|NCT03893448|463339731|FG000|Overall Study|Physician Decision|8|||
128740655|NCT03893448|463339732|FG001|Overall Study|Physician Decision|14|||
128740656|NCT03893448|463339731|FG000|Overall Study|Lost to Follow-up|34|||
128740657|NCT03893448|463339732|FG001|Overall Study|Lost to Follow-up|27|||
128740658|NCT03893448|463339731|FG000|Overall Study|Death|1|||
128740659|NCT03893448|463339732|FG001|Overall Study|Death|0|||
128740660|NCT05061446|463339740|FG000|Overall Study|Adverse Event|2|||
128740661|NCT05061446|463339741|FG001|Overall Study|Adverse Event|0|||
128740662|NCT05061446|463339742|FG002|Overall Study|Adverse Event|0|||
128740663|NCT05061446|463339740|FG000|Overall Study|Participant no longer available due to personal reason|0|||
128740664|NCT05061446|463339741|FG001|Overall Study|Participant no longer available due to personal reason|1|||
128740665|NCT05061446|463339742|FG002|Overall Study|Participant no longer available due to personal reason|0|||
128740666|NCT03880578|463339743|FG000|Overall Study|Withdrawal by Subject|0|||
128740667|NCT03880578|463339744|FG001|Overall Study|Withdrawal by Subject|3|||
128740668|NCT03880578|463339745|FG002|Overall Study|Withdrawal by Subject|1|||
128740669|NCT03880578|463339743|FG000|Overall Study|Death|0|||
128740670|NCT03880578|463339744|FG001|Overall Study|Death|1|||
128740671|NCT03880578|463339745|FG002|Overall Study|Death|0|||
128740672|NCT03783923|463339746|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
128740673|NCT03783923|463339747|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
128740674|NCT03783923|463339746|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
128740675|NCT03783923|463339747|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
128740676|NCT03783923|463339746|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
128740677|NCT03783923|463339747|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
128740678|NCT03783923|463339746|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
128740679|NCT03783923|463339747|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
128740680|NCT03783923|463339746|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
128740681|NCT03783923|463339747|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
128740682|NCT02041429|463339749|FG000|Overall Study|Progressive Disease|2|||
128740683|NCT02041429|463339750|FG001|Overall Study|Progressive Disease|2|||
128740684|NCT02041429|463339751|FG002|Overall Study|Progressive Disease|3|||
128740685|NCT02041429|463339752|FG003|Overall Study|Progressive Disease|2|||
128740686|NCT02041429|463339749|FG000|Overall Study|Toxicity|0|||
128740687|NCT02041429|463339750|FG001|Overall Study|Toxicity|1|||
128740688|NCT02041429|463339751|FG002|Overall Study|Toxicity|4|||
128740689|NCT02041429|463339752|FG003|Overall Study|Toxicity|2|||
128740690|NCT02041429|463339749|FG000|Overall Study|Withdrawal by Subject|0|||
128740691|NCT02041429|463339750|FG001|Overall Study|Withdrawal by Subject|1|||
128740692|NCT02041429|463339751|FG002|Overall Study|Withdrawal by Subject|0|||
128740693|NCT02041429|463339752|FG003|Overall Study|Withdrawal by Subject|0|||
128740694|NCT02041429|463339749|FG000|Overall Study|On Maintenance Therapy|1|||
128740695|NCT02041429|463339750|FG001|Overall Study|On Maintenance Therapy|0|||
128740696|NCT02041429|463339751|FG002|Overall Study|On Maintenance Therapy|0|||
128740697|NCT02041429|463339752|FG003|Overall Study|On Maintenance Therapy|2|||
128740698|NCT00861341|463339753|FG000|Overall Study|Withdrawal by Subject|2|||
128740699|NCT03299192|463339754|FG000|Overall Study|Fell before classes started|1|||
128740700|NCT03299192|463339755|FG001|Overall Study|Fell before classes started|0|||
128740701|NCT03299192|463339756|FG002|Overall Study|Fell before classes started|0|||
128740702|NCT03299192|463339754|FG000|Overall Study|Other|0|||
128740703|NCT03299192|463339755|FG001|Overall Study|Other|2|||
128740704|NCT03299192|463339756|FG002|Overall Study|Other|1|||
128740705|NCT01418209|463339759|FG000|Overall Study|Withdrawal by Subject|1|||
128740706|NCT01418209|463339760|FG001|Overall Study|Withdrawal by Subject|0|||
128740707|NCT01418209|463339761|FG002|Overall Study|Withdrawal by Subject|1|||
128740708|NCT01418209|463339759|FG000|Overall Study|Did not provide hot flash diary data|1|||
128740709|NCT01418209|463339760|FG001|Overall Study|Did not provide hot flash diary data|3|||
128740710|NCT01418209|463339761|FG002|Overall Study|Did not provide hot flash diary data|3|||
128740711|NCT01603875|463339762|FG000|Overall Study|Preexisting rabies antibody|3|||
128740712|NCT01603875|463339763|FG001|Overall Study|Preexisting rabies antibody|4|||
128740713|NCT01603875|463339764|FG002|Overall Study|Preexisting rabies antibody|3|||
128740714|NCT01603875|463339762|FG000|Overall Study|Lost to Follow-up|4|||
128740715|NCT01603875|463339763|FG001|Overall Study|Lost to Follow-up|3|||
128740716|NCT01603875|463339764|FG002|Overall Study|Lost to Follow-up|6|||
128740717|NCT01603875|463339762|FG000|Overall Study|Protocol Violation|0|||
128740718|NCT01603875|463339763|FG001|Overall Study|Protocol Violation|1|||
128740719|NCT01603875|463339764|FG002|Overall Study|Protocol Violation|0|||
128740720|NCT01971346|463339765|FG000|Overall Study|Protocol Violation|3|||
128740721|NCT01971346|463339765|FG000|Overall Study|Lost to Follow-up|2|||
128740722|NCT01971346|463339765|FG000|Overall Study|Withdrawal by Subject|2|||
128740723|NCT01971346|463339765|FG000|Overall Study|Physician Decision|1|||
128740724|NCT00298831|463339767|FG000|Overall Study|Adverse Event|1|||
128740725|NCT00298831|463339767|FG000|Overall Study|Lost to Follow-up|3|||
128740726|NCT00298831|463339767|FG000|Overall Study|Withdrawal by Subject|1|||
128740727|NCT00298831|463339767|FG000|Overall Study|Participants did not receive treatment|27|||
128740728|NCT04122443|463339768|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
128740729|NCT04122443|463339769|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
128740730|NCT04122443|463339770|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
128740731|NCT04122443|463339768|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
128740732|NCT04122443|463339769|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
128740733|NCT04122443|463339770|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
128740734|NCT03149328|463339771|FG000|Overall Study|Withdrawal by Subject|30|||
128740735|NCT03149328|463339772|FG001|Overall Study|Withdrawal by Subject|26|||
128740736|NCT03149328|463339771|FG000|Overall Study|Changed Dialysis Modality|18|||
128740737|NCT03149328|463339772|FG001|Overall Study|Changed Dialysis Modality|1|||
128740738|NCT03149328|463339771|FG000|Overall Study|Transplant|9|||
128740739|NCT03149328|463339772|FG001|Overall Study|Transplant|1|||
128740740|NCT03149328|463339771|FG000|Overall Study|Lost to Follow-up|25|||
128740741|NCT03149328|463339772|FG001|Overall Study|Lost to Follow-up|16|||
128740742|NCT03149328|463339771|FG000|Overall Study|Left Study Site|1|||
128740743|NCT03149328|463339772|FG001|Overall Study|Left Study Site|2|||
128740744|NCT03149328|463339771|FG000|Overall Study|Language Barrier|1|||
128740745|NCT03149328|463339772|FG001|Overall Study|Language Barrier|0|||
128740746|NCT00691210|463339773|FG000|Overall Study|Progression of Disease|0|||
128740747|NCT00691210|463339774|FG001|Overall Study|Progression of Disease|0|||
128740748|NCT00691210|463339775|FG002|Overall Study|Progression of Disease|0|||
128740749|NCT00691210|463339776|FG003|Overall Study|Progression of Disease|2|||
128740750|NCT00691210|463339777|FG004|Overall Study|Progression of Disease|0|||
128740751|NCT00691210|463339778|FG005|Overall Study|Progression of Disease|0|||
128740752|NCT00691210|463339779|FG006|Overall Study|Progression of Disease|0|||
128740753|NCT00691210|463339780|FG007|Overall Study|Progression of Disease|0|||
128740754|NCT00691210|463339773|FG000|Overall Study|Lack of Efficacy|0|||
128740755|NCT00691210|463339774|FG001|Overall Study|Lack of Efficacy|0|||
128740756|NCT00691210|463339775|FG002|Overall Study|Lack of Efficacy|0|||
128740757|NCT00691210|463339776|FG003|Overall Study|Lack of Efficacy|1|||
128740758|NCT00691210|463339777|FG004|Overall Study|Lack of Efficacy|0|||
128740759|NCT00691210|463339778|FG005|Overall Study|Lack of Efficacy|1|||
128740760|NCT00691210|463339779|FG006|Overall Study|Lack of Efficacy|0|||
128740761|NCT00691210|463339780|FG007|Overall Study|Lack of Efficacy|0|||
128740762|NCT02758236|463339781|FG000|Overall Study|Investigator discretion|43|||
128740763|NCT03136068|463341538|FG000|Overall Study|Lost to Follow-up|1|||
128740764|NCT03136068|463341539|FG001|Overall Study|Lost to Follow-up|1|||
128740765|NCT03136068|463341538|FG000|Overall Study|Protocol Violation|1|||
128740766|NCT03136068|463341539|FG001|Overall Study|Protocol Violation|0|||
128740767|NCT00432380|463341542|FG000|Overall Study|Migrated/moved from study area|3|||
128740768|NCT00432380|463341543|FG001|Overall Study|Migrated/moved from study area|4|||
128740769|NCT00432380|463341544|FG002|Overall Study|Migrated/moved from study area|1|||
128740770|NCT00432380|463341542|FG000|Overall Study|Adverse Event|1|||
128740771|NCT00432380|463341543|FG001|Overall Study|Adverse Event|0|||
128740772|NCT00432380|463341544|FG002|Overall Study|Adverse Event|0|||
128740773|NCT01071395|463341545|FG000|Overall Study|Withdrawal by Subject|2|||
128740774|NCT01071395|463341546|FG001|Overall Study|Withdrawal by Subject|1|||
128740775|NCT01071395|463341545|FG000|Overall Study|Adverse Event|3|||
128740776|NCT01071395|463341546|FG001|Overall Study|Adverse Event|1|||
128740777|NCT01539291|463341547|FG000|Study GS-US-312-0116|Adverse Event|9|||
128740778|NCT01539291|463341548|FG001|Study GS-US-312-0116|Adverse Event|0|||
128740779|NCT01539291|463341549|FG002|Study GS-US-312-0116|Adverse Event|0|||
128740780|NCT01539291|463341550|FG003|Study GS-US-312-0116|Adverse Event|0|||
128740781|NCT01539291|463341547|FG000|Study GS-US-312-0116|Physician Decision|1|||
128740782|NCT01539291|463341548|FG001|Study GS-US-312-0116|Physician Decision|0|||
128740783|NCT01539291|463341549|FG002|Study GS-US-312-0116|Physician Decision|0|||
128740784|NCT01539291|463341550|FG003|Study GS-US-312-0116|Physician Decision|0|||
128740785|NCT01539291|463341547|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
128740786|NCT01539291|463341548|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
128740787|NCT01539291|463341549|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
128740788|NCT01539291|463341550|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
128740789|NCT01539291|463341547|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
128740790|NCT01539291|463341548|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
128740791|NCT01539291|463341549|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
128740792|NCT01539291|463341550|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
128740793|NCT01539291|463341547|FG000|Study GS-US-312-0116|Other|1|||
128740794|NCT01539291|463341548|FG001|Study GS-US-312-0116|Other|0|||
128740795|NCT01539291|463341549|FG002|Study GS-US-312-0116|Other|0|||
128740796|NCT01539291|463341550|FG003|Study GS-US-312-0116|Other|0|||
128740797|NCT01539291|463341547|FG000|Study GS-US-312-0117|Adverse Event|22|||
128740798|NCT01539291|463341548|FG001|Study GS-US-312-0117|Adverse Event|1|||
128740799|NCT01539291|463341549|FG002|Study GS-US-312-0117|Adverse Event|9|||
128740800|NCT01539291|463341550|FG003|Study GS-US-312-0117|Adverse Event|12|||
128740801|NCT01539291|463341547|FG000|Study GS-US-312-0117|Physician Decision|9|||
128740802|NCT01539291|463341548|FG001|Study GS-US-312-0117|Physician Decision|0|||
128740803|NCT01539291|463341549|FG002|Study GS-US-312-0117|Physician Decision|6|||
128740804|NCT01539291|463341550|FG003|Study GS-US-312-0117|Physician Decision|4|||
128740805|NCT01539291|463341547|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
128740806|NCT01539291|463341548|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
128740807|NCT01539291|463341549|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
128740808|NCT01539291|463341550|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
128740809|NCT01539291|463341547|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
128740810|NCT01539291|463341548|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
128740811|NCT01539291|463341549|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
128740812|NCT01539291|463341550|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
128740813|NCT01539291|463341547|FG000|Study GS-US-312-0117|Other|2|||
128740814|NCT01539291|463341548|FG001|Study GS-US-312-0117|Other|1|||
128740815|NCT01539291|463341549|FG002|Study GS-US-312-0117|Other|1|||
128740816|NCT01539291|463341550|FG003|Study GS-US-312-0117|Other|1|||
128740817|NCT02627677|463341551|FG000|Overall Study|Adverse event (not progressive disease)|1|||
128740818|NCT02627677|463341552|FG001|Overall Study|Adverse event (not progressive disease)|4|||
128740819|NCT02627677|463341553|FG002|Overall Study|Adverse event (not progressive disease)|1|||
128740820|NCT02627677|463341551|FG000|Overall Study|Progressive disease|1|||
128740821|NCT02627677|463341552|FG001|Overall Study|Progressive disease|3|||
128740822|NCT02627677|463341553|FG002|Overall Study|Progressive disease|0|||
128740823|NCT02627677|463341551|FG000|Overall Study|Lack of Efficacy|1|||
128740824|NCT02627677|463341552|FG001|Overall Study|Lack of Efficacy|2|||
128740825|NCT02627677|463341553|FG002|Overall Study|Lack of Efficacy|0|||
128740826|NCT02627677|463341551|FG000|Overall Study|Lost to Follow-up|0|||
128740827|NCT02627677|463341552|FG001|Overall Study|Lost to Follow-up|0|||
128740828|NCT02627677|463341553|FG002|Overall Study|Lost to Follow-up|1|||
128740829|NCT02627677|463341551|FG000|Overall Study|Pregnancy|0|||
128740830|NCT02627677|463341552|FG001|Overall Study|Pregnancy|1|||
128740831|NCT02627677|463341553|FG002|Overall Study|Pregnancy|0|||
128740832|NCT02627677|463341551|FG000|Overall Study|Study Terminated by Sponsor|5|||
128740833|NCT02627677|463341552|FG001|Overall Study|Study Terminated by Sponsor|10|||
128740834|NCT02627677|463341553|FG002|Overall Study|Study Terminated by Sponsor|6|||
128740835|NCT02627677|463341551|FG000|Overall Study|Physician Decision|0|||
128785252|NCT00567164|463505956|FG002|Overall Study|Missing|0|||
128785253|NCT03441984|463505957|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128785254|NCT03441984|463505958|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128785255|NCT03441984|463505959|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
128785256|NCT03441984|463505960|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128785257|NCT03441984|463505961|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128785258|NCT03441984|463505962|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128740836|NCT02627677|463341552|FG001|Overall Study|Physician Decision|0|||
128740837|NCT02627677|463341553|FG002|Overall Study|Physician Decision|2|||
128740838|NCT02627677|463341551|FG000|Overall Study|Withdrawal by Subject|2|||
128740839|NCT02627677|463341552|FG001|Overall Study|Withdrawal by Subject|1|||
128740840|NCT02627677|463341553|FG002|Overall Study|Withdrawal by Subject|1|||
128740841|NCT02627677|463341551|FG000|Overall Study|Reason not Specified|0|||
128740842|NCT02627677|463341552|FG001|Overall Study|Reason not Specified|0|||
128740843|NCT02627677|463341553|FG002|Overall Study|Reason not Specified|1|||
128740844|NCT02627677|463341551|FG000|Overall Study|Randomized but not Treated|1|||
128740845|NCT02627677|463341552|FG001|Overall Study|Randomized but not Treated|0|||
128740846|NCT02627677|463341553|FG002|Overall Study|Randomized but not Treated|0|||
128740847|NCT00587587|463341558|FG000|Overall Study|Lost to Follow-up|6|||
128740848|NCT00587587|463341559|FG001|Overall Study|Lost to Follow-up|1|||
128740849|NCT01075321|463341564|FG000|Overall Study|Withdrawal by Subject|0|||
128740850|NCT01075321|463341565|FG001|Overall Study|Withdrawal by Subject|0|||
128740851|NCT01075321|463341566|FG002|Overall Study|Withdrawal by Subject|1|||
128740852|NCT01075321|463341567|FG003|Overall Study|Withdrawal by Subject|1|||
128740853|NCT01075321|463341564|FG000|Overall Study|Protocol Violation|0|||
128740854|NCT01075321|463341565|FG001|Overall Study|Protocol Violation|0|||
128740855|NCT01075321|463341566|FG002|Overall Study|Protocol Violation|1|||
128740856|NCT01075321|463341567|FG003|Overall Study|Protocol Violation|0|||
128740857|NCT01075321|463341564|FG000|Overall Study|Treatment Incomplete due to progression|1|||
128740858|NCT01075321|463341565|FG001|Overall Study|Treatment Incomplete due to progression|0|||
128740859|NCT01075321|463341566|FG002|Overall Study|Treatment Incomplete due to progression|0|||
128740860|NCT01075321|463341567|FG003|Overall Study|Treatment Incomplete due to progression|0|||
128740861|NCT01075321|463341564|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
128740862|NCT01075321|463341565|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
128740863|NCT01075321|463341566|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
128740864|NCT01075321|463341567|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
128740865|NCT01933334|463341571|FG000|Overall Study|Adverse Event|5|||
128740866|NCT01933334|463341572|FG001|Overall Study|Adverse Event|1|||
128740867|NCT01933334|463341571|FG000|Overall Study|Withdrawal by Subject|0|||
128740868|NCT01933334|463341572|FG001|Overall Study|Withdrawal by Subject|1|||
128740869|NCT02032901|463341573|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
128740870|NCT02032901|463341574|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
128740871|NCT02032901|463341573|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
128740872|NCT02032901|463341574|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
128740873|NCT01722331|463341575|FG000|Part 1|Adverse Event|5|||
128740874|NCT01722331|463341576|FG001|Part 1|Adverse Event|0|||
128740875|NCT01722331|463341577|FG002|Part 1|Adverse Event|0|||
128740876|NCT01722331|463341578|FG003|Part 1|Adverse Event|0|||
128740877|NCT01722331|463341579|FG004|Part 1|Adverse Event|0|||
128740878|NCT01722331|463341580|FG005|Part 1|Adverse Event|0|||
128740879|NCT01722331|463341581|FG006|Part 1|Adverse Event|0|||
128740880|NCT01722331|463341575|FG000|Part 1|Lack of Efficacy|0|||
128740881|NCT01722331|463341576|FG001|Part 1|Lack of Efficacy|0|||
128740882|NCT01722331|463341577|FG002|Part 1|Lack of Efficacy|1|||
128740883|NCT01722331|463341578|FG003|Part 1|Lack of Efficacy|0|||
128740884|NCT01722331|463341579|FG004|Part 1|Lack of Efficacy|2|||
128740885|NCT01722331|463341580|FG005|Part 1|Lack of Efficacy|0|||
128740886|NCT01722331|463341581|FG006|Part 1|Lack of Efficacy|0|||
128740887|NCT01722331|463341575|FG000|Part 1|Lost to Follow-up|1|||
128740888|NCT01722331|463341576|FG001|Part 1|Lost to Follow-up|0|||
128740889|NCT01722331|463341577|FG002|Part 1|Lost to Follow-up|2|||
128740890|NCT01722331|463341578|FG003|Part 1|Lost to Follow-up|0|||
128740891|NCT01722331|463341579|FG004|Part 1|Lost to Follow-up|1|||
128740892|NCT01722331|463341580|FG005|Part 1|Lost to Follow-up|0|||
128740893|NCT01722331|463341581|FG006|Part 1|Lost to Follow-up|0|||
128740894|NCT01722331|463341575|FG000|Part 1|Physician Decision|0|||
128740895|NCT01722331|463341576|FG001|Part 1|Physician Decision|0|||
128740896|NCT01722331|463341577|FG002|Part 1|Physician Decision|3|||
128740897|NCT01722331|463341578|FG003|Part 1|Physician Decision|0|||
128740898|NCT01722331|463341579|FG004|Part 1|Physician Decision|1|||
128740899|NCT01722331|463341580|FG005|Part 1|Physician Decision|0|||
128740900|NCT01722331|463341581|FG006|Part 1|Physician Decision|0|||
128740901|NCT01722331|463341575|FG000|Part 1|Pregnancy|1|||
128740902|NCT01722331|463341576|FG001|Part 1|Pregnancy|0|||
128740903|NCT01722331|463341577|FG002|Part 1|Pregnancy|0|||
128740904|NCT01722331|463341578|FG003|Part 1|Pregnancy|0|||
128740905|NCT01722331|463341579|FG004|Part 1|Pregnancy|0|||
128740906|NCT01722331|463341580|FG005|Part 1|Pregnancy|0|||
128740907|NCT01722331|463341581|FG006|Part 1|Pregnancy|0|||
128740908|NCT01722331|463341575|FG000|Part 1|Progressive Disease|0|||
128785259|NCT03441984|463505963|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128785260|NCT03441984|463505964|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128785261|NCT03441984|463505965|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128740909|NCT01722331|463341576|FG001|Part 1|Progressive Disease|0|||
128740910|NCT01722331|463341577|FG002|Part 1|Progressive Disease|0|||
128740911|NCT01722331|463341578|FG003|Part 1|Progressive Disease|0|||
128740912|NCT01722331|463341579|FG004|Part 1|Progressive Disease|1|||
128740913|NCT01722331|463341580|FG005|Part 1|Progressive Disease|0|||
128740914|NCT01722331|463341581|FG006|Part 1|Progressive Disease|0|||
128740915|NCT01722331|463341575|FG000|Part 1|Protocol Violation|1|||
128740916|NCT01722331|463341576|FG001|Part 1|Protocol Violation|0|||
128740917|NCT01722331|463341577|FG002|Part 1|Protocol Violation|0|||
128740918|NCT01722331|463341578|FG003|Part 1|Protocol Violation|0|||
128740919|NCT01722331|463341579|FG004|Part 1|Protocol Violation|1|||
128740920|NCT01722331|463341580|FG005|Part 1|Protocol Violation|0|||
128740921|NCT01722331|463341581|FG006|Part 1|Protocol Violation|0|||
128740922|NCT01722331|463341575|FG000|Part 1|Withdrawal by Subject|2|||
128740923|NCT01722331|463341576|FG001|Part 1|Withdrawal by Subject|0|||
128740924|NCT01722331|463341577|FG002|Part 1|Withdrawal by Subject|3|||
128740925|NCT01722331|463341578|FG003|Part 1|Withdrawal by Subject|0|||
128740926|NCT01722331|463341579|FG004|Part 1|Withdrawal by Subject|3|||
128740927|NCT01722331|463341580|FG005|Part 1|Withdrawal by Subject|0|||
128740928|NCT01722331|463341581|FG006|Part 1|Withdrawal by Subject|0|||
128740929|NCT01722331|463341575|FG000|Part 2|Adverse Event|3|||
128740930|NCT01722331|463341576|FG001|Part 2|Adverse Event|0|||
128740931|NCT01722331|463341577|FG002|Part 2|Adverse Event|0|||
128740932|NCT01722331|463341578|FG003|Part 2|Adverse Event|0|||
128740933|NCT01722331|463341579|FG004|Part 2|Adverse Event|0|||
128740934|NCT01722331|463341580|FG005|Part 2|Adverse Event|1|||
128740935|NCT01722331|463341581|FG006|Part 2|Adverse Event|0|||
128740936|NCT01722331|463341575|FG000|Part 2|Lack of Efficacy|3|||
128740937|NCT01722331|463341576|FG001|Part 2|Lack of Efficacy|0|||
128740938|NCT01722331|463341577|FG002|Part 2|Lack of Efficacy|11|||
128740939|NCT01722331|463341578|FG003|Part 2|Lack of Efficacy|0|||
128740940|NCT01722331|463341579|FG004|Part 2|Lack of Efficacy|0|||
128740941|NCT01722331|463341580|FG005|Part 2|Lack of Efficacy|3|||
128740942|NCT01722331|463341581|FG006|Part 2|Lack of Efficacy|3|||
128740943|NCT01722331|463341575|FG000|Part 2|Lost to Follow-up|0|||
128740944|NCT01722331|463341576|FG001|Part 2|Lost to Follow-up|0|||
128740945|NCT01722331|463341577|FG002|Part 2|Lost to Follow-up|3|||
128740946|NCT01722331|463341578|FG003|Part 2|Lost to Follow-up|0|||
128740947|NCT01722331|463341579|FG004|Part 2|Lost to Follow-up|0|||
128740948|NCT01722331|463341580|FG005|Part 2|Lost to Follow-up|1|||
128740949|NCT01722331|463341581|FG006|Part 2|Lost to Follow-up|1|||
128740950|NCT01722331|463341575|FG000|Part 2|Non-Compliance with Study Drug|1|||
128740951|NCT01722331|463341576|FG001|Part 2|Non-Compliance with Study Drug|0|||
128740952|NCT01722331|463341577|FG002|Part 2|Non-Compliance with Study Drug|1|||
128740953|NCT01722331|463341578|FG003|Part 2|Non-Compliance with Study Drug|0|||
128740954|NCT01722331|463341579|FG004|Part 2|Non-Compliance with Study Drug|0|||
128740955|NCT01722331|463341580|FG005|Part 2|Non-Compliance with Study Drug|0|||
128740956|NCT01722331|463341581|FG006|Part 2|Non-Compliance with Study Drug|0|||
128740957|NCT01722331|463341575|FG000|Part 2|Physician Decision|0|||
128740958|NCT01722331|463341576|FG001|Part 2|Physician Decision|0|||
128740959|NCT01722331|463341577|FG002|Part 2|Physician Decision|2|||
128740960|NCT01722331|463341578|FG003|Part 2|Physician Decision|0|||
128740961|NCT01722331|463341579|FG004|Part 2|Physician Decision|0|||
128740962|NCT01722331|463341580|FG005|Part 2|Physician Decision|0|||
128740963|NCT01722331|463341581|FG006|Part 2|Physician Decision|0|||
128740964|NCT01722331|463341575|FG000|Part 2|Pregnancy|0|||
128740965|NCT01722331|463341576|FG001|Part 2|Pregnancy|0|||
128740966|NCT01722331|463341577|FG002|Part 2|Pregnancy|0|||
128740967|NCT01722331|463341578|FG003|Part 2|Pregnancy|0|||
128740968|NCT01722331|463341579|FG004|Part 2|Pregnancy|0|||
128740969|NCT01722331|463341580|FG005|Part 2|Pregnancy|1|||
128740970|NCT01722331|463341581|FG006|Part 2|Pregnancy|0|||
128740971|NCT01722331|463341575|FG000|Part 2|Progressive Disease|0|||
128740972|NCT01722331|463341576|FG001|Part 2|Progressive Disease|0|||
128740973|NCT01722331|463341577|FG002|Part 2|Progressive Disease|1|||
128740974|NCT01722331|463341578|FG003|Part 2|Progressive Disease|0|||
128740975|NCT01722331|463341579|FG004|Part 2|Progressive Disease|0|||
128740976|NCT01722331|463341580|FG005|Part 2|Progressive Disease|0|||
128740977|NCT01722331|463341581|FG006|Part 2|Progressive Disease|0|||
128740978|NCT01722331|463341575|FG000|Part 2|Protocol Violation|1|||
128740979|NCT01722331|463341576|FG001|Part 2|Protocol Violation|0|||
128740980|NCT01722331|463341577|FG002|Part 2|Protocol Violation|0|||
128740981|NCT01722331|463341578|FG003|Part 2|Protocol Violation|0|||
128740982|NCT01722331|463341579|FG004|Part 2|Protocol Violation|0|||
128740983|NCT01722331|463341580|FG005|Part 2|Protocol Violation|0|||
128740984|NCT01722331|463341581|FG006|Part 2|Protocol Violation|0|||
128740985|NCT01722331|463341575|FG000|Part 2|Withdrawal by Subject|5|||
128740986|NCT01722331|463341576|FG001|Part 2|Withdrawal by Subject|0|||
128740987|NCT01722331|463341577|FG002|Part 2|Withdrawal by Subject|3|||
128740988|NCT01722331|463341578|FG003|Part 2|Withdrawal by Subject|0|||
128740989|NCT01722331|463341579|FG004|Part 2|Withdrawal by Subject|0|||
128740990|NCT01722331|463341580|FG005|Part 2|Withdrawal by Subject|2|||
128740991|NCT01722331|463341581|FG006|Part 2|Withdrawal by Subject|2|||
128740992|NCT01722331|463341575|FG000|Part 2|Other Protocol Specified Criteria|6|||
128740993|NCT01722331|463341576|FG001|Part 2|Other Protocol Specified Criteria|0|||
128740994|NCT01722331|463341577|FG002|Part 2|Other Protocol Specified Criteria|10|||
128740995|NCT01722331|463341578|FG003|Part 2|Other Protocol Specified Criteria|0|||
128740996|NCT01722331|463341579|FG004|Part 2|Other Protocol Specified Criteria|0|||
128740997|NCT01722331|463341580|FG005|Part 2|Other Protocol Specified Criteria|2|||
128740998|NCT01722331|463341581|FG006|Part 2|Other Protocol Specified Criteria|1|||
128740999|NCT01722331|463341575|FG000|Part 3|Adverse Event|2|||
128741000|NCT01722331|463341576|FG001|Part 3|Adverse Event|2|||
128741001|NCT01722331|463341577|FG002|Part 3|Adverse Event|0|||
128741002|NCT01722331|463341578|FG003|Part 3|Adverse Event|1|||
128741003|NCT01722331|463341579|FG004|Part 3|Adverse Event|0|||
128741004|NCT01722331|463341580|FG005|Part 3|Adverse Event|0|||
128741005|NCT01722331|463341581|FG006|Part 3|Adverse Event|0|||
128741006|NCT01722331|463341575|FG000|Part 3|Death|1|||
128741007|NCT01722331|463341576|FG001|Part 3|Death|0|||
128741008|NCT01722331|463341577|FG002|Part 3|Death|0|||
128741009|NCT01722331|463341578|FG003|Part 3|Death|0|||
128741010|NCT01722331|463341579|FG004|Part 3|Death|0|||
128741011|NCT01722331|463341580|FG005|Part 3|Death|0|||
128741012|NCT01722331|463341581|FG006|Part 3|Death|0|||
128741013|NCT01722331|463341575|FG000|Part 3|Lack of Efficacy|1|||
128741014|NCT01722331|463341576|FG001|Part 3|Lack of Efficacy|0|||
128741015|NCT01722331|463341577|FG002|Part 3|Lack of Efficacy|0|||
128741016|NCT01722331|463341578|FG003|Part 3|Lack of Efficacy|0|||
128741017|NCT01722331|463341579|FG004|Part 3|Lack of Efficacy|0|||
128741018|NCT01722331|463341580|FG005|Part 3|Lack of Efficacy|0|||
128741019|NCT01722331|463341581|FG006|Part 3|Lack of Efficacy|0|||
128741020|NCT01722331|463341575|FG000|Part 3|Lost to Follow-up|3|||
128741021|NCT01722331|463341576|FG001|Part 3|Lost to Follow-up|4|||
128741022|NCT01722331|463341577|FG002|Part 3|Lost to Follow-up|0|||
128741023|NCT01722331|463341578|FG003|Part 3|Lost to Follow-up|0|||
128741024|NCT01722331|463341579|FG004|Part 3|Lost to Follow-up|0|||
128741025|NCT01722331|463341580|FG005|Part 3|Lost to Follow-up|1|||
128741026|NCT01722331|463341581|FG006|Part 3|Lost to Follow-up|0|||
128741027|NCT01722331|463341575|FG000|Part 3|Non-Compliance with Study Drug|0|||
128741028|NCT01722331|463341576|FG001|Part 3|Non-Compliance with Study Drug|1|||
128741029|NCT01722331|463341577|FG002|Part 3|Non-Compliance with Study Drug|0|||
128741030|NCT01722331|463341578|FG003|Part 3|Non-Compliance with Study Drug|0|||
128741031|NCT01722331|463341579|FG004|Part 3|Non-Compliance with Study Drug|0|||
128741032|NCT01722331|463341580|FG005|Part 3|Non-Compliance with Study Drug|0|||
128741033|NCT01722331|463341581|FG006|Part 3|Non-Compliance with Study Drug|0|||
128741034|NCT01722331|463341575|FG000|Part 3|Physician Decision|1|||
128741035|NCT01722331|463341576|FG001|Part 3|Physician Decision|1|||
128741036|NCT01722331|463341577|FG002|Part 3|Physician Decision|0|||
128741037|NCT01722331|463341578|FG003|Part 3|Physician Decision|0|||
128741038|NCT01722331|463341579|FG004|Part 3|Physician Decision|0|||
128741039|NCT01722331|463341580|FG005|Part 3|Physician Decision|0|||
128741040|NCT01722331|463341581|FG006|Part 3|Physician Decision|1|||
128741041|NCT01722331|463341575|FG000|Part 3|Protocol Violation|2|||
128741042|NCT01722331|463341576|FG001|Part 3|Protocol Violation|1|||
128741043|NCT01722331|463341577|FG002|Part 3|Protocol Violation|0|||
128741044|NCT01722331|463341578|FG003|Part 3|Protocol Violation|0|||
128741045|NCT01722331|463341579|FG004|Part 3|Protocol Violation|0|||
128741046|NCT01722331|463341580|FG005|Part 3|Protocol Violation|0|||
128741047|NCT01722331|463341581|FG006|Part 3|Protocol Violation|0|||
128741048|NCT01722331|463341575|FG000|Part 3|Withdrawal by Subject|4|||
128741049|NCT01722331|463341576|FG001|Part 3|Withdrawal by Subject|7|||
128741050|NCT01722331|463341577|FG002|Part 3|Withdrawal by Subject|0|||
128741051|NCT01722331|463341578|FG003|Part 3|Withdrawal by Subject|0|||
128741052|NCT01722331|463341579|FG004|Part 3|Withdrawal by Subject|0|||
128741053|NCT01722331|463341580|FG005|Part 3|Withdrawal by Subject|2|||
128741054|NCT01722331|463341581|FG006|Part 3|Withdrawal by Subject|1|||
128741055|NCT01722331|463341575|FG000|Part 3|Other Protocol Specified Criteria|1|||
128741056|NCT01722331|463341576|FG001|Part 3|Other Protocol Specified Criteria|1|||
128741057|NCT01722331|463341577|FG002|Part 3|Other Protocol Specified Criteria|0|||
128741058|NCT01722331|463341578|FG003|Part 3|Other Protocol Specified Criteria|0|||
128741059|NCT01722331|463341579|FG004|Part 3|Other Protocol Specified Criteria|0|||
128741060|NCT01722331|463341580|FG005|Part 3|Other Protocol Specified Criteria|0|||
128741061|NCT01722331|463341581|FG006|Part 3|Other Protocol Specified Criteria|0|||
128741062|NCT00262834|463341582|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
128741063|NCT00262834|463341583|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
128741064|NCT00003457|463341586|FG000|Overall Study|Not evaluable|9|||
128741065|NCT02525133|463341592|FG000|Overall Study|Adverse Event|0|||
128741066|NCT02525133|463341593|FG001|Overall Study|Adverse Event|1|||
128741067|NCT02525133|463341592|FG000|Overall Study|Death|0|||
128741068|NCT02525133|463341593|FG001|Overall Study|Death|1|||
128741069|NCT02525133|463341592|FG000|Overall Study|did not meet randomization criteria|1|||
128741070|NCT02525133|463341593|FG001|Overall Study|did not meet randomization criteria|0|||
128741071|NCT02525133|463341592|FG000|Overall Study|Lost to Follow-up|5|||
128741072|NCT02525133|463341593|FG001|Overall Study|Lost to Follow-up|1|||
128741073|NCT02525133|463341592|FG000|Overall Study|randomized not enrolled|3|||
128741074|NCT02525133|463341593|FG001|Overall Study|randomized not enrolled|0|||
128741075|NCT02525133|463341592|FG000|Overall Study|Withdrawal by Subject|1|||
128741076|NCT02525133|463341593|FG001|Overall Study|Withdrawal by Subject|0|||
128741077|NCT04265755|463341594|FG000|Overall Study|Withdrawal by Subject|39|||
128741078|NCT04265755|463341594|FG000|Overall Study|Decision by sponsor|2|||
128741079|NCT04265755|463341594|FG000|Overall Study|Lost to Follow-up|11|||
128741080|NCT04265755|463341594|FG000|Overall Study|Death|1|||
128741081|NCT00633984|463341595|FG000|Overall Study|Lost to Follow-up|0|||
128741082|NCT00633984|463341596|FG001|Overall Study|Lost to Follow-up|6|||
128741083|NCT00633984|463341595|FG000|Overall Study|Withdrawal by Subject|8|||
128741084|NCT00633984|463341596|FG001|Overall Study|Withdrawal by Subject|7|||
128741085|NCT00633984|463341595|FG000|Overall Study|Hospitalized|1|||
128741086|NCT00633984|463341596|FG001|Overall Study|Hospitalized|0|||
128785262|NCT03441984|463505966|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128741087|NCT02496884|463341597|FG000|Overall Study|Counted twice as enrolled|2|||
128741088|NCT02496884|463341598|FG001|Overall Study|Counted twice as enrolled|0|||
128741089|NCT02496884|463341599|FG002|Overall Study|Counted twice as enrolled|0|||
128741090|NCT02496884|463341600|FG003|Overall Study|Counted twice as enrolled|0|||
128741091|NCT02496884|463341597|FG000|Overall Study|Withdrawal by Subject|0|||
128741092|NCT02496884|463341598|FG001|Overall Study|Withdrawal by Subject|3|||
128741093|NCT02496884|463341599|FG002|Overall Study|Withdrawal by Subject|0|||
128741094|NCT02496884|463341600|FG003|Overall Study|Withdrawal by Subject|0|||
128741095|NCT01033747|463341601|FG000|Overall Study|Adverse Event|9|||
128741096|NCT01033747|463341602|FG001|Overall Study|Adverse Event|4|||
128741097|NCT01033747|463341601|FG000|Overall Study|Abnormal Laboratory Value|1|||
128741098|NCT01033747|463341602|FG001|Overall Study|Abnormal Laboratory Value|0|||
128741099|NCT01033747|463341601|FG000|Overall Study|Abnormal test procedure|0|||
128741100|NCT01033747|463341602|FG001|Overall Study|Abnormal test procedure|1|||
128741101|NCT01033747|463341601|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
128741102|NCT01033747|463341602|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
128741103|NCT01033747|463341601|FG000|Overall Study|Protocol Violation|1|||
128741104|NCT01033747|463341602|FG001|Overall Study|Protocol Violation|0|||
128741105|NCT01033747|463341601|FG000|Overall Study|Withdrawal by Subject|9|||
128741106|NCT01033747|463341602|FG001|Overall Study|Withdrawal by Subject|6|||
128741107|NCT01033747|463341601|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
128741108|NCT01033747|463341602|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
128741109|NCT01033747|463341601|FG000|Overall Study|Stopped at end of Extension 1|2|||
128741110|NCT01033747|463341602|FG001|Overall Study|Stopped at end of Extension 1|0|||
128741111|NCT02956629|463341603|FG000|Overall Study|Adverse Event|0|||
128741112|NCT02956629|463341604|FG001|Overall Study|Adverse Event|0|||
128741113|NCT02956629|463341605|FG002|Overall Study|Adverse Event|1|||
128741114|NCT02956629|463341606|FG003|Overall Study|Adverse Event|0|||
128741115|NCT02956629|463341607|FG004|Overall Study|Adverse Event|0|||
128741116|NCT02956629|463341608|FG005|Overall Study|Adverse Event|0|||
128741117|NCT02956629|463341603|FG000|Overall Study|Lost to Follow-up|2|||
128741118|NCT02956629|463341604|FG001|Overall Study|Lost to Follow-up|5|||
128741119|NCT02956629|463341605|FG002|Overall Study|Lost to Follow-up|3|||
128741120|NCT02956629|463341606|FG003|Overall Study|Lost to Follow-up|1|||
128741121|NCT02956629|463341607|FG004|Overall Study|Lost to Follow-up|0|||
128741122|NCT02956629|463341608|FG005|Overall Study|Lost to Follow-up|1|||
128741123|NCT02956629|463341603|FG000|Overall Study|Withdrawal by Subject|3|||
128741124|NCT02956629|463341604|FG001|Overall Study|Withdrawal by Subject|1|||
128741125|NCT02956629|463341605|FG002|Overall Study|Withdrawal by Subject|0|||
128741126|NCT02956629|463341606|FG003|Overall Study|Withdrawal by Subject|0|||
128741127|NCT02956629|463341607|FG004|Overall Study|Withdrawal by Subject|0|||
128741128|NCT02956629|463341608|FG005|Overall Study|Withdrawal by Subject|0|||
128741129|NCT01931839|463341613|FG000|Overall Study|Death|0|||
128741130|NCT01931839|463341614|FG001|Overall Study|Death|1|||
128741131|NCT01931839|463341615|FG002|Overall Study|Death|2|||
128741132|NCT01931839|463341616|FG003|Overall Study|Death|0|||
128741133|NCT01931839|463341617|FG004|Overall Study|Death|0|||
128741134|NCT01931839|463341618|FG005|Overall Study|Death|0|||
128741135|NCT01931839|463341619|FG006|Overall Study|Death|0|||
128741136|NCT01931839|463341613|FG000|Overall Study|Physician Decision|1|||
128741137|NCT01931839|463341614|FG001|Overall Study|Physician Decision|0|||
128741138|NCT01931839|463341615|FG002|Overall Study|Physician Decision|1|||
128741139|NCT01931839|463341616|FG003|Overall Study|Physician Decision|0|||
128741140|NCT01931839|463341617|FG004|Overall Study|Physician Decision|0|||
128741141|NCT01931839|463341618|FG005|Overall Study|Physician Decision|0|||
128741142|NCT01931839|463341619|FG006|Overall Study|Physician Decision|1|||
128741143|NCT01931839|463341613|FG000|Overall Study|Withdrawal of consent|0|||
128741144|NCT01931839|463341614|FG001|Overall Study|Withdrawal of consent|0|||
128741145|NCT01931839|463341615|FG002|Overall Study|Withdrawal of consent|0|||
128741146|NCT01931839|463341616|FG003|Overall Study|Withdrawal of consent|0|||
128741147|NCT01931839|463341617|FG004|Overall Study|Withdrawal of consent|1|||
128741148|NCT01931839|463341618|FG005|Overall Study|Withdrawal of consent|0|||
128741149|NCT01931839|463341619|FG006|Overall Study|Withdrawal of consent|0|||
128741150|NCT01931839|463341613|FG000|Overall Study|Adverse Event|9|||
128741151|NCT01931839|463341614|FG001|Overall Study|Adverse Event|4|||
128741152|NCT01931839|463341615|FG002|Overall Study|Adverse Event|1|||
128741153|NCT01931839|463341616|FG003|Overall Study|Adverse Event|3|||
128741154|NCT01931839|463341617|FG004|Overall Study|Adverse Event|0|||
128741155|NCT01931839|463341618|FG005|Overall Study|Adverse Event|0|||
128741156|NCT01931839|463341619|FG006|Overall Study|Adverse Event|1|||
128741157|NCT01931839|463341613|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
128741158|NCT01931839|463341614|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
128741159|NCT01931839|463341615|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
128741160|NCT01931839|463341616|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
128785263|NCT03441984|463505967|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128785264|NCT03441984|463505968|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
128741161|NCT01931839|463341617|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
128741162|NCT01931839|463341618|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
128741163|NCT01931839|463341619|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
128741164|NCT01931839|463341613|FG000|Overall Study|Other non-compliance|15|||
128741165|NCT01931839|463341614|FG001|Overall Study|Other non-compliance|9|||
128741166|NCT01931839|463341615|FG002|Overall Study|Other non-compliance|12|||
128741167|NCT01931839|463341616|FG003|Overall Study|Other non-compliance|3|||
128741168|NCT01931839|463341617|FG004|Overall Study|Other non-compliance|0|||
128741169|NCT01931839|463341618|FG005|Overall Study|Other non-compliance|3|||
128741170|NCT01931839|463341619|FG006|Overall Study|Other non-compliance|0|||
128741171|NCT01931839|463341613|FG000|Overall Study|Lost to Follow-up|1|||
128741172|NCT01931839|463341614|FG001|Overall Study|Lost to Follow-up|2|||
128741173|NCT01931839|463341615|FG002|Overall Study|Lost to Follow-up|4|||
128741174|NCT01931839|463341616|FG003|Overall Study|Lost to Follow-up|5|||
128741175|NCT01931839|463341617|FG004|Overall Study|Lost to Follow-up|0|||
128741176|NCT01931839|463341618|FG005|Overall Study|Lost to Follow-up|0|||
128741177|NCT01931839|463341619|FG006|Overall Study|Lost to Follow-up|0|||
128741178|NCT01931839|463341613|FG000|Overall Study|Other|4|||
128741179|NCT01931839|463341614|FG001|Overall Study|Other|2|||
128741180|NCT01931839|463341615|FG002|Overall Study|Other|6|||
128741181|NCT01931839|463341616|FG003|Overall Study|Other|0|||
128741182|NCT01931839|463341617|FG004|Overall Study|Other|0|||
128741183|NCT01931839|463341618|FG005|Overall Study|Other|0|||
128741184|NCT01931839|463341619|FG006|Overall Study|Other|0|||
128741185|NCT01762761|463341620|FG000|Overall Study|Adverse Event|15|||
128741186|NCT01762761|463341621|FG001|Overall Study|Adverse Event|17|||
128741187|NCT01762761|463341620|FG000|Overall Study|Lack of Efficacy|9|||
128741188|NCT01762761|463341621|FG001|Overall Study|Lack of Efficacy|25|||
128741189|NCT01762761|463341620|FG000|Overall Study|Protocol Violation|1|||
128741190|NCT01762761|463341621|FG001|Overall Study|Protocol Violation|1|||
128741191|NCT01762761|463341620|FG000|Overall Study|Study closed/terminated|0|||
128741192|NCT01762761|463341621|FG001|Overall Study|Study closed/terminated|2|||
128741193|NCT01762761|463341620|FG000|Overall Study|Lost to Follow-up|3|||
128741194|NCT01762761|463341621|FG001|Overall Study|Lost to Follow-up|6|||
128741195|NCT01762761|463341620|FG000|Overall Study|Physician Decision|4|||
128741196|NCT01762761|463341621|FG001|Overall Study|Physician Decision|6|||
128741197|NCT01762761|463341620|FG000|Overall Study|Withdrawal by Subject|7|||
128741198|NCT01762761|463341621|FG001|Overall Study|Withdrawal by Subject|8|||
128741199|NCT01925183|463341622|FG000|Overall Study|Adverse Event|1|||
128741200|NCT01925183|463341623|FG001|Overall Study|Adverse Event|0|||
128741201|NCT00575588|463341624|FG000|Overall Study|Adverse Event|11|||
128741202|NCT00575588|463341625|FG001|Overall Study|Adverse Event|13|||
128741203|NCT00575588|463341624|FG000|Overall Study|Withdrawal by Subject|27|||
128741204|NCT00575588|463341625|FG001|Overall Study|Withdrawal by Subject|31|||
128741205|NCT00575588|463341624|FG000|Overall Study|Lost to Follow-up|1|||
128741206|NCT00575588|463341625|FG001|Overall Study|Lost to Follow-up|3|||
128741207|NCT00575588|463341624|FG000|Overall Study|Death|4|||
128741208|NCT00575588|463341625|FG001|Overall Study|Death|2|||
128741209|NCT00575588|463341624|FG000|Overall Study|Incorrect enrollment|8|||
128741210|NCT00575588|463341625|FG001|Overall Study|Incorrect enrollment|4|||
128741211|NCT00575588|463341624|FG000|Overall Study|Study specific discontinuation criteria|203|||
128741212|NCT00575588|463341625|FG001|Overall Study|Study specific discontinuation criteria|218|||
128741213|NCT00575588|463341624|FG000|Overall Study|Severe non-compliance to protocol|5|||
128741214|NCT00575588|463341625|FG001|Overall Study|Severe non-compliance to protocol|7|||
128741215|NCT00575588|463341624|FG000|Overall Study|Safety reasons|2|||
128741216|NCT00575588|463341625|FG001|Overall Study|Safety reasons|1|||
128741217|NCT00575588|463341624|FG000|Overall Study|Elevated triglyceride|1|||
128741218|NCT00575588|463341625|FG001|Overall Study|Elevated triglyceride|0|||
128741219|NCT00575588|463341624|FG000|Overall Study|Patient moved|1|||
128741220|NCT00575588|463341625|FG001|Overall Study|Patient moved|3|||
128741221|NCT00575588|463341624|FG000|Overall Study|Impossible to determine HbA1c|0|||
128741222|NCT00575588|463341625|FG001|Overall Study|Impossible to determine HbA1c|1|||
128741223|NCT00504829|463341626|FG000|Overall Study|Protocol Violation|6|||
128741224|NCT00504829|463341627|FG001|Overall Study|Protocol Violation|4|||
128741225|NCT00504829|463341628|FG002|Overall Study|Protocol Violation|10|||
128741226|NCT01731171|463341629|FG000|Overall Study|Withdrawal by Subject|4|||
128741227|NCT01731171|463341630|FG001|Overall Study|Withdrawal by Subject|1|||
128741228|NCT01731171|463341629|FG000|Overall Study|Lost to Follow-up|3|||
128741229|NCT01731171|463341630|FG001|Overall Study|Lost to Follow-up|2|||
128741230|NCT01731171|463341629|FG000|Overall Study|Moved out of Area|0|||
128741231|NCT01731171|463341630|FG001|Overall Study|Moved out of Area|2|||
128741232|NCT01731171|463341629|FG000|Overall Study|Terminated for Lack of Adherence|0|||
128741233|NCT01731171|463341630|FG001|Overall Study|Terminated for Lack of Adherence|1|||
128741234|NCT01731171|463341629|FG000|Overall Study|Terminated for Safety Reasons|0|||
128741235|NCT01731171|463341630|FG001|Overall Study|Terminated for Safety Reasons|1|||
128741236|NCT02604589|463341633|FG000|Overall Study|catheter dislodgement|0|||
128741237|NCT02604589|463341634|FG001|Overall Study|catheter dislodgement|0|||
128741238|NCT02604589|463341635|FG002|Overall Study|catheter dislodgement|1|||
128741239|NCT00793910|463341636|FG000|Overall Study|discarded study pills|0|||
128741240|NCT00793910|463341637|FG001|Overall Study|discarded study pills|1|||
128741241|NCT00793910|463341636|FG000|Overall Study|did not pick up medications|1|||
128741242|NCT00793910|463341637|FG001|Overall Study|did not pick up medications|1|||
128741243|NCT00793910|463341636|FG000|Overall Study|ineligible based on entry criteria|2|||
128741244|NCT00793910|463341637|FG001|Overall Study|ineligible based on entry criteria|3|||
128741245|NCT00793910|463341636|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
128741246|NCT00793910|463341637|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
128741247|NCT00793910|463341636|FG000|Overall Study|Withdrawal by Subject|0|||
128741248|NCT00793910|463341637|FG001|Overall Study|Withdrawal by Subject|1|||
128741249|NCT01700946|463341638|FG000|Overall Study|Lost to Follow-up|1|||
128741250|NCT01700946|463341639|FG001|Overall Study|Lost to Follow-up|0|||
128741251|NCT01700946|463341638|FG000|Overall Study|Physician Decision|7|||
128741252|NCT01700946|463341639|FG001|Overall Study|Physician Decision|12|||
128741253|NCT01700946|463341638|FG000|Overall Study|Withdrawal by Subject|0|||
128741254|NCT01700946|463341639|FG001|Overall Study|Withdrawal by Subject|2|||
128741255|NCT01700946|463341638|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
128741256|NCT01700946|463341639|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
128741257|NCT01700946|463341638|FG000|Overall Study|Relapse|2|||
128741258|NCT01700946|463341639|FG001|Overall Study|Relapse|1|||
128741259|NCT01700946|463341638|FG000|Overall Study|Unacceptable toxicity|1|||
128741260|NCT01700946|463341639|FG001|Overall Study|Unacceptable toxicity|0|||
128741261|NCT03321981|463341647|FG000|Overall Study|Progressive Disease (PD)|15|||
128741262|NCT03321981|463341648|FG001|Overall Study|Progressive Disease (PD)|30|||
128741263|NCT03321981|463341649|FG002|Overall Study|Progressive Disease (PD)|47|||
128741264|NCT03321981|463341647|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
128741265|NCT03321981|463341648|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
128741266|NCT03321981|463341649|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
128741267|NCT03321981|463341647|FG000|Overall Study|Adverse Event|0|||
128741268|NCT03321981|463341648|FG001|Overall Study|Adverse Event|0|||
128741269|NCT03321981|463341649|FG002|Overall Study|Adverse Event|2|||
128741270|NCT03321981|463341647|FG000|Overall Study|symptomatic deterioration|0|||
128741271|NCT03321981|463341648|FG001|Overall Study|symptomatic deterioration|1|||
128741272|NCT03321981|463341649|FG002|Overall Study|symptomatic deterioration|1|||
128741273|NCT03321981|463341647|FG000|Overall Study|Lack of compliance|0|||
128741274|NCT03321981|463341648|FG001|Overall Study|Lack of compliance|1|||
128741275|NCT03321981|463341649|FG002|Overall Study|Lack of compliance|0|||
128741276|NCT03321981|463341647|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
128741277|NCT03321981|463341648|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
128741278|NCT03321981|463341649|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
128741279|NCT03321981|463341647|FG000|Overall Study|Death|0|||
128741280|NCT03321981|463341648|FG001|Overall Study|Death|1|||
128741281|NCT03321981|463341649|FG002|Overall Study|Death|0|||
128741282|NCT03321981|463341647|FG000|Overall Study|Subject withdrawal of investigational product|0|||
128741283|NCT03321981|463341648|FG001|Overall Study|Subject withdrawal of investigational product|1|||
128741284|NCT03321981|463341649|FG002|Overall Study|Subject withdrawal of investigational product|0|||
128741285|NCT03321981|463341647|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
128741286|NCT03321981|463341648|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
128741287|NCT03321981|463341649|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
128741288|NCT03321981|463341647|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
128741289|NCT03321981|463341648|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
128741290|NCT03321981|463341649|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
128741291|NCT04934670|463341650|FG000|Overall Study|Death|4|||
128741292|NCT04934670|463341651|FG001|Overall Study|Death|0|||
128741293|NCT04934670|463341650|FG000|Overall Study|Lost to Follow-up|1|||
128741294|NCT04934670|463341651|FG001|Overall Study|Lost to Follow-up|4|||
128741295|NCT00817089|463341652|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
128741296|NCT00817089|463341653|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
128741297|NCT00817089|463341654|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
128741298|NCT00817089|463341655|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
128741299|NCT00817089|463341652|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
128741300|NCT00817089|463341653|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
128741301|NCT00817089|463341654|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
128741302|NCT00817089|463341655|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
128741303|NCT01592708|463341656|FG000|Overall Study|Protocol Violation|3|||
128741304|NCT01592708|463341657|FG001|Overall Study|Protocol Violation|0|||
128741305|NCT01785602|463341661|FG000|Overall Study|Withdrawal by Subject|2|||
128741306|NCT01785602|463341662|FG001|Overall Study|Withdrawal by Subject|0|||
128741307|NCT01785602|463341661|FG000|Overall Study|Lost to Follow-up|1|||
128741308|NCT01785602|463341662|FG001|Overall Study|Lost to Follow-up|1|||
128741309|NCT01785602|463341661|FG000|Overall Study|Adverse Event|3|||
128741310|NCT01785602|463341662|FG001|Overall Study|Adverse Event|5|||
128741311|NCT01785602|463341661|FG000|Overall Study|Administrative problems|7|||
128741312|NCT01785602|463341662|FG001|Overall Study|Administrative problems|3|||
128741313|NCT00101101|463341663|FG000|Overall Study|never received vaccine|20|||
128741314|NCT01916304|463341668|FG000|Overall Study|Screening failure|17|||
128741315|NCT02460198|463341670|FG000|Overall Study|Adverse Event|1|||
128741316|NCT02460198|463341671|FG001|Overall Study|Adverse Event|3|||
128741317|NCT02460198|463341670|FG000|Overall Study|Death|36|||
128741318|NCT02460198|463341671|FG001|Overall Study|Death|28|||
128741319|NCT02460198|463341670|FG000|Overall Study|Lost to Follow-up|1|||
128741320|NCT02460198|463341671|FG001|Overall Study|Lost to Follow-up|1|||
128741321|NCT02460198|463341670|FG000|Overall Study|Transferred to Extension Study|15|||
128741322|NCT02460198|463341671|FG001|Overall Study|Transferred to Extension Study|15|||
128741323|NCT02460198|463341670|FG000|Overall Study|Withdrawal by Subject|2|||
128741324|NCT02460198|463341671|FG001|Overall Study|Withdrawal by Subject|4|||
128741325|NCT02460198|463341670|FG000|Overall Study|Site Terminated By Sponsor|0|||
128741326|NCT02460198|463341671|FG001|Overall Study|Site Terminated By Sponsor|1|||
128741327|NCT02460198|463341670|FG000|Overall Study|Did Not Continue on Extension Study|6|||
128741328|NCT02460198|463341671|FG001|Overall Study|Did Not Continue on Extension Study|11|||
128741329|NCT04382612|463341672|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
128741330|NCT04666441|463341673|FG000|Overall Study|Lost to Follow-up|1|||
128741331|NCT04666441|463341674|FG001|Overall Study|Lost to Follow-up|4|||
128741332|NCT04666441|463341675|FG002|Overall Study|Lost to Follow-up|1|||
128741333|NCT04666441|463341676|FG003|Overall Study|Lost to Follow-up|3|||
128741334|NCT04666441|463341677|FG004|Overall Study|Lost to Follow-up|0|||
128741335|NCT04666441|463341678|FG005|Overall Study|Lost to Follow-up|2|||
128741336|NCT04666441|463341679|FG006|Overall Study|Lost to Follow-up|2|||
128741337|NCT04666441|463341680|FG007|Overall Study|Lost to Follow-up|2|||
128741338|NCT04666441|463341673|FG000|Overall Study|Subject Decision|1|||
128741339|NCT04666441|463341674|FG001|Overall Study|Subject Decision|1|||
128741340|NCT04666441|463341675|FG002|Overall Study|Subject Decision|3|||
128741341|NCT04666441|463341676|FG003|Overall Study|Subject Decision|1|||
128741342|NCT04666441|463341677|FG004|Overall Study|Subject Decision|0|||
128741343|NCT04666441|463341678|FG005|Overall Study|Subject Decision|1|||
128741344|NCT04666441|463341679|FG006|Overall Study|Subject Decision|3|||
128741345|NCT04666441|463341680|FG007|Overall Study|Subject Decision|2|||
128741346|NCT00766415|463341681|FG000|Overall Study|Withdrawal by Subject|0|||
128741347|NCT00766415|463341682|FG001|Overall Study|Withdrawal by Subject|1|||
128741348|NCT01312467|463341683|FG000|Overall Study|Adverse Event|4|||
128741349|NCT01312467|463341683|FG000|Overall Study|Lost to Follow-up|1|||
128741350|NCT01312467|463341683|FG000|Overall Study|Withdrawal by Subject|2|||
128741351|NCT01312467|463341683|FG000|Overall Study|Deported to country of origin|1|||
128741352|NCT01312467|463341683|FG000|Overall Study|Another medical condition|1|||
128741353|NCT01312467|463341683|FG000|Overall Study|Ineligible|4|||
128741354|NCT02752048|463341686|FG000|Overall Study|Withdrawal by Subject|0|||
128741355|NCT02752048|463341687|FG001|Overall Study|Withdrawal by Subject|0|||
128741356|NCT02752048|463341688|FG002|Overall Study|Withdrawal by Subject|3|||
128741357|NCT00132769|463341689|FG000|Overall Study|Withdrawal by Subject|1|||
128741358|NCT00132769|463341690|FG001|Overall Study|Withdrawal by Subject|3|||
128741359|NCT00132769|463341689|FG000|Overall Study|Lack of Efficacy|7|||
128741360|NCT00132769|463341690|FG001|Overall Study|Lack of Efficacy|6|||
128741361|NCT00132769|463341689|FG000|Overall Study|Adverse Event|2|||
128741362|NCT00132769|463341690|FG001|Overall Study|Adverse Event|1|||
128741363|NCT00132769|463341689|FG000|Overall Study|Protocol Violation|1|||
128741364|NCT00132769|463341690|FG001|Overall Study|Protocol Violation|1|||
128741365|NCT04452344|463341691|FG000|Overall Study|Withdrawal by Subject|3|||
128741366|NCT04452344|463341692|FG001|Overall Study|Withdrawal by Subject|6|||
128741367|NCT04452344|463341691|FG000|Overall Study|Adverse Event|1|||
128741368|NCT04452344|463341692|FG001|Overall Study|Adverse Event|2|||
128741369|NCT04452344|463341691|FG000|Overall Study|Lost to Follow-up|2|||
128741370|NCT04452344|463341692|FG001|Overall Study|Lost to Follow-up|2|||
128741371|NCT04452344|463341691|FG000|Overall Study|No Post-Op Visit|6|||
128741372|NCT04452344|463341692|FG001|Overall Study|No Post-Op Visit|7|||
128741373|NCT04095858|463341698|FG000|Overall Study|Death|1|||
128741374|NCT04095858|463341699|FG001|Overall Study|Death|0|||
128741375|NCT04095858|463341698|FG000|Overall Study|Study terminated by Sponsor|2|||
128741376|NCT04095858|463341699|FG001|Overall Study|Study terminated by Sponsor|4|||
128741377|NCT03285477|463341700|FG000|Treatment and Response Assessment Period|Death|1|||
128741378|NCT03285477|463341701|FG001|Treatment and Response Assessment Period|Death|0|||
128741379|NCT03285477|463341700|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
128741380|NCT03285477|463341701|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
128741381|NCT03285477|463341700|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
128741382|NCT03285477|463341701|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
128741383|NCT03285477|463341700|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
128741384|NCT03285477|463341701|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
128741385|NCT03285477|463341700|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
128741386|NCT03285477|463341701|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
128741387|NCT00560833|463341702|FG000|Overall Study|Adverse Event|16|||
128741388|NCT00560833|463341703|FG001|Overall Study|Adverse Event|10|||
128741389|NCT00560833|463341704|FG002|Overall Study|Adverse Event|25|||
128741390|NCT00560833|463341705|FG003|Overall Study|Adverse Event|23|||
128741391|NCT00560833|463341706|FG004|Overall Study|Adverse Event|35|||
128741392|NCT00560833|463341702|FG000|Overall Study|Lost to Follow-up|0|||
128741393|NCT00560833|463341703|FG001|Overall Study|Lost to Follow-up|0|||
128741394|NCT00560833|463341704|FG002|Overall Study|Lost to Follow-up|1|||
128741395|NCT00560833|463341705|FG003|Overall Study|Lost to Follow-up|0|||
128741396|NCT00560833|463341706|FG004|Overall Study|Lost to Follow-up|0|||
128741397|NCT00560833|463341702|FG000|Overall Study|Lack of Efficacy|22|||
128741398|NCT00560833|463341703|FG001|Overall Study|Lack of Efficacy|9|||
128741399|NCT00560833|463341704|FG002|Overall Study|Lack of Efficacy|6|||
128741400|NCT00560833|463341705|FG003|Overall Study|Lack of Efficacy|4|||
128741401|NCT00560833|463341706|FG004|Overall Study|Lack of Efficacy|4|||
128741402|NCT00560833|463341702|FG000|Overall Study|Participant uncooperative|5|||
128741403|NCT00560833|463341703|FG001|Overall Study|Participant uncooperative|5|||
128741404|NCT00560833|463341704|FG002|Overall Study|Participant uncooperative|4|||
128741405|NCT00560833|463341705|FG003|Overall Study|Participant uncooperative|4|||
128741406|NCT00560833|463341706|FG004|Overall Study|Participant uncooperative|2|||
128741407|NCT00560833|463341702|FG000|Overall Study|Other|1|||
128741408|NCT00560833|463341703|FG001|Overall Study|Other|1|||
128741409|NCT00560833|463341704|FG002|Overall Study|Other|3|||
128741410|NCT00560833|463341705|FG003|Overall Study|Other|0|||
128741411|NCT00560833|463341706|FG004|Overall Study|Other|0|||
128741412|NCT00560833|463341702|FG000|Overall Study|Never received drug|0|||
128741413|NCT00560833|463341703|FG001|Overall Study|Never received drug|1|||
128741414|NCT00560833|463341704|FG002|Overall Study|Never received drug|0|||
128741415|NCT00560833|463341705|FG003|Overall Study|Never received drug|0|||
128741416|NCT00560833|463341706|FG004|Overall Study|Never received drug|1|||
128741417|NCT00898677|463341709|FG000|Overall Study|Adverse Event|0|||
128741418|NCT00898677|463341710|FG001|Overall Study|Adverse Event|0|||
128741419|NCT00898677|463341711|FG002|Overall Study|Adverse Event|1|||
128741420|NCT00898677|463341712|FG003|Overall Study|Adverse Event|0|||
128741421|NCT00898677|463341709|FG000|Overall Study|Lost to Follow-up|0|||
128741422|NCT00898677|463341710|FG001|Overall Study|Lost to Follow-up|0|||
128741423|NCT00898677|463341711|FG002|Overall Study|Lost to Follow-up|2|||
128741424|NCT00898677|463341712|FG003|Overall Study|Lost to Follow-up|0|||
128741425|NCT00898677|463341709|FG000|Overall Study|Protocol Violation|1|||
128741426|NCT00898677|463341710|FG001|Overall Study|Protocol Violation|1|||
128741427|NCT00898677|463341711|FG002|Overall Study|Protocol Violation|2|||
128741428|NCT00898677|463341712|FG003|Overall Study|Protocol Violation|0|||
128741429|NCT00898677|463341709|FG000|Overall Study|Withdrawal by Subject|0|||
128741430|NCT00898677|463341710|FG001|Overall Study|Withdrawal by Subject|0|||
128741431|NCT00898677|463341711|FG002|Overall Study|Withdrawal by Subject|0|||
128741432|NCT00898677|463341712|FG003|Overall Study|Withdrawal by Subject|1|||
128741433|NCT00898677|463341709|FG000|Overall Study|Not Treated: Adverse Event|0|||
128741434|NCT00898677|463341710|FG001|Overall Study|Not Treated: Adverse Event|2|||
128741435|NCT00898677|463341711|FG002|Overall Study|Not Treated: Adverse Event|1|||
128741436|NCT00898677|463341712|FG003|Overall Study|Not Treated: Adverse Event|0|||
128741437|NCT00898677|463341709|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
128741438|NCT00898677|463341710|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
128741439|NCT00898677|463341711|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
128741440|NCT00898677|463341712|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
128741441|NCT00898677|463341709|FG000|Overall Study|Not Treated: Pregnancy|0|||
128741442|NCT00898677|463341710|FG001|Overall Study|Not Treated: Pregnancy|0|||
128741443|NCT00898677|463341711|FG002|Overall Study|Not Treated: Pregnancy|1|||
128741444|NCT00898677|463341712|FG003|Overall Study|Not Treated: Pregnancy|0|||
128741445|NCT00898677|463341709|FG000|Overall Study|Not Treated: Protocol Violation|2|||
128741446|NCT00898677|463341710|FG001|Overall Study|Not Treated: Protocol Violation|0|||
128741447|NCT00898677|463341711|FG002|Overall Study|Not Treated: Protocol Violation|2|||
128741448|NCT00898677|463341712|FG003|Overall Study|Not Treated: Protocol Violation|0|||
128741449|NCT00898677|463341709|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
128741450|NCT00898677|463341710|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
128741451|NCT00898677|463341711|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
128741452|NCT00898677|463341712|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
128741453|NCT00898677|463341709|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
128741454|NCT00898677|463341710|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
128741455|NCT00898677|463341711|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
128741456|NCT00898677|463341712|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
128741457|NCT00898677|463341709|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
128741458|NCT00898677|463341710|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
128785265|NCT02430532|463505975|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
128785266|NCT02430532|463505976|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
128785267|NCT02430532|463505975|FG000|Overall Study|Consent Withdrawn|0|||
128785268|NCT02430532|463505976|FG001|Overall Study|Consent Withdrawn|2|||
128785269|NCT02430532|463505975|FG000|Overall Study|Adverse Event|0|||
128741459|NCT00898677|463341711|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
128741460|NCT00898677|463341712|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
128741461|NCT00898677|463341709|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
128741462|NCT00898677|463341710|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
128741463|NCT00898677|463341711|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
128741464|NCT00898677|463341712|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
128785270|NCT02430532|463505976|FG001|Overall Study|Adverse Event|1|||
128741465|NCT00898677|463341709|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
128741466|NCT00898677|463341710|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
128741467|NCT00898677|463341711|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
128741468|NCT00898677|463341712|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
128741469|NCT00898677|463341709|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
128741470|NCT00898677|463341710|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
128741471|NCT00898677|463341711|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
128741472|NCT00898677|463341712|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
128741473|NCT00898677|463341709|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
128741474|NCT00898677|463341710|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
128741475|NCT00898677|463341711|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
128741476|NCT00898677|463341712|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
128741477|NCT02199691|463341713|FG000|Overall Study|Protocol Violation|3|||
128741478|NCT02199691|463341714|FG001|Overall Study|Protocol Violation|3|||
128741479|NCT02199691|463341715|FG002|Overall Study|Protocol Violation|6|||
128741480|NCT02199691|463341716|FG003|Overall Study|Protocol Violation|7|||
128741481|NCT02199691|463341713|FG000|Overall Study|Withdrawal by Subject|5|||
128741482|NCT02199691|463341714|FG001|Overall Study|Withdrawal by Subject|3|||
128741483|NCT02199691|463341715|FG002|Overall Study|Withdrawal by Subject|12|||
128741484|NCT02199691|463341716|FG003|Overall Study|Withdrawal by Subject|13|||
128741485|NCT02199691|463341713|FG000|Overall Study|Lost to Follow-up|2|||
128741486|NCT02199691|463341714|FG001|Overall Study|Lost to Follow-up|1|||
128741487|NCT02199691|463341715|FG002|Overall Study|Lost to Follow-up|9|||
128741488|NCT02199691|463341716|FG003|Overall Study|Lost to Follow-up|10|||
128741489|NCT00836875|463341719|FG000|Overall Study|Death|3|||
128741490|NCT00836875|463341720|FG001|Overall Study|Death|2|||
128741491|NCT00836875|463341719|FG000|Overall Study|Withdrawal by Subject|0|||
128741492|NCT00836875|463341720|FG001|Overall Study|Withdrawal by Subject|1|||
128741493|NCT03823651|463341722|FG000|Overall Study|Death|5|||
128741494|NCT03823651|463341723|FG001|Overall Study|Death|0|||
128741495|NCT03823651|463341722|FG000|Overall Study|Physician Decision|1|||
128741496|NCT03823651|463341723|FG001|Overall Study|Physician Decision|0|||
128741497|NCT03823651|463341722|FG000|Overall Study|Caregiver to patient who died|0|||
128741498|NCT03823651|463341723|FG001|Overall Study|Caregiver to patient who died|5|||
128741499|NCT03823651|463341722|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
128741500|NCT03823651|463341723|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
128741501|NCT00428610|463341724|FG000|Overall Study|Death Due to Adverse Event|3|||
128741502|NCT00428610|463341725|FG001|Overall Study|Death Due to Adverse Event|0|||
128741503|NCT00428610|463341726|FG002|Overall Study|Death Due to Adverse Event|5|||
128741504|NCT00428610|463341724|FG000|Overall Study|Death Due to Progressive Disease|0|||
128741505|NCT00428610|463341725|FG001|Overall Study|Death Due to Progressive Disease|0|||
128741506|NCT00428610|463341726|FG002|Overall Study|Death Due to Progressive Disease|2|||
128741507|NCT00428610|463341724|FG000|Overall Study|Adverse Event|2|||
128741508|NCT00428610|463341725|FG001|Overall Study|Adverse Event|3|||
128741509|NCT00428610|463341726|FG002|Overall Study|Adverse Event|2|||
128741510|NCT00428610|463341724|FG000|Overall Study|Investigator Decision|2|||
128741511|NCT00428610|463341725|FG001|Overall Study|Investigator Decision|1|||
128741512|NCT00428610|463341726|FG002|Overall Study|Investigator Decision|1|||
128741513|NCT00428610|463341724|FG000|Overall Study|Progressive Disease|42|||
128741514|NCT00428610|463341725|FG001|Overall Study|Progressive Disease|14|||
128741515|NCT00428610|463341726|FG002|Overall Study|Progressive Disease|22|||
128741516|NCT00428610|463341724|FG000|Overall Study|Withdrawal by Subject|4|||
128741517|NCT00428610|463341725|FG001|Overall Study|Withdrawal by Subject|0|||
128741518|NCT00428610|463341726|FG002|Overall Study|Withdrawal by Subject|0|||
128741519|NCT05350449|463341727|FG000|Overall Study|Withdrawal by Subject|4|||
128741520|NCT05350449|463341728|FG001|Overall Study|Withdrawal by Subject|8|||
128741521|NCT02239510|463343701|FG000|Overall Study|Lost to Follow-up|2|||
128741522|NCT02239510|463343702|FG001|Overall Study|Lost to Follow-up|1|||
128741523|NCT01782131|463343703|FG000|Overall Study|Death|93|||
128741524|NCT01782131|463343704|FG001|Overall Study|Death|96|||
128741525|NCT01782131|463343703|FG000|Overall Study|Lost to Follow-up|1|||
128741526|NCT01782131|463343704|FG001|Overall Study|Lost to Follow-up|3|||
128741527|NCT01782131|463343703|FG000|Overall Study|Withdrawal by Subject|10|||
128741528|NCT01782131|463343704|FG001|Overall Study|Withdrawal by Subject|10|||
128741529|NCT01782131|463343703|FG000|Overall Study|Randomized but not treated|5|||
128741530|NCT01782131|463343704|FG001|Overall Study|Randomized but not treated|5|||
128741531|NCT01782131|463343703|FG000|Overall Study|Reason not provided|0|||
128741532|NCT01782131|463343704|FG001|Overall Study|Reason not provided|1|||
128741533|NCT00796718|463343705|FG000|Overall Study|Adverse Event|2|||
128741534|NCT00796718|463343705|FG000|Overall Study|Exclusion Criteria|1|||
128741535|NCT00796718|463343705|FG000|Overall Study|Lost to Follow-up|5|||
128741536|NCT00796718|463343705|FG000|Overall Study|Withdrawal by Informed Consent|1|||
128741537|NCT03266588|463343706|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
128741538|NCT03266588|463343707|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
128741539|NCT03266588|463343708|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
128741540|NCT03266588|463343706|FG000|Observational Period|Withdrawal by Subject|44|||
128741541|NCT03266588|463343707|FG001|Observational Period|Withdrawal by Subject|22|||
128741542|NCT03266588|463343708|FG002|Observational Period|Withdrawal by Subject|13|||
128741543|NCT03266588|463343706|FG000|Observational Period|Non-compliance|18|||
128741544|NCT03266588|463343707|FG001|Observational Period|Non-compliance|12|||
128741545|NCT03266588|463343708|FG002|Observational Period|Non-compliance|10|||
128741546|NCT03266588|463343706|FG000|Observational Period|Lost to Follow-up|8|||
128741547|NCT03266588|463343707|FG001|Observational Period|Lost to Follow-up|12|||
128741548|NCT03266588|463343708|FG002|Observational Period|Lost to Follow-up|4|||
128741549|NCT03266588|463343706|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
128741550|NCT03266588|463343707|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
128741551|NCT03266588|463343708|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
128741552|NCT03266588|463343706|FG000|Observational Period|Protocol Deviation|1|||
128741553|NCT03266588|463343707|FG001|Observational Period|Protocol Deviation|0|||
128741554|NCT03266588|463343708|FG002|Observational Period|Protocol Deviation|0|||
128741555|NCT03266588|463343706|FG000|Observational Period|Other Reasons|3|||
128741556|NCT03266588|463343707|FG001|Observational Period|Other Reasons|0|||
128741557|NCT03266588|463343708|FG002|Observational Period|Other Reasons|1|||
128741558|NCT03266588|463343706|FG000|Long-term Treatment Period|Adverse Event|33|||
128741559|NCT03266588|463343707|FG001|Long-term Treatment Period|Adverse Event|17|||
128741560|NCT03266588|463343708|FG002|Long-term Treatment Period|Adverse Event|8|||
128741561|NCT03266588|463343706|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
128741562|NCT03266588|463343707|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
128741563|NCT03266588|463343708|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
128741564|NCT03266588|463343706|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
128741565|NCT03266588|463343707|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
128741566|NCT03266588|463343708|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
128741567|NCT03266588|463343706|FG000|Long-term Treatment Period|Non-Compliance|126|||
128741568|NCT03266588|463343707|FG001|Long-term Treatment Period|Non-Compliance|57|||
128741569|NCT03266588|463343708|FG002|Long-term Treatment Period|Non-Compliance|7|||
128741570|NCT03266588|463343706|FG000|Long-term Treatment Period|Pregnancy|11|||
128741571|NCT03266588|463343707|FG001|Long-term Treatment Period|Pregnancy|5|||
128741572|NCT03266588|463343708|FG002|Long-term Treatment Period|Pregnancy|0|||
128741573|NCT03266588|463343706|FG000|Long-term Treatment Period|Protocol Deviation|17|||
128741574|NCT03266588|463343707|FG001|Long-term Treatment Period|Protocol Deviation|10|||
128741575|NCT03266588|463343708|FG002|Long-term Treatment Period|Protocol Deviation|4|||
128741576|NCT03266588|463343706|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
128741577|NCT03266588|463343707|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
128741578|NCT03266588|463343708|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
128785271|NCT03256344|463505977|FG000|Overall Study|Death|6|||
128785272|NCT03256344|463505978|FG001|Overall Study|Death|22|||
128741579|NCT03266588|463343706|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
128741580|NCT03266588|463343707|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
128741581|NCT03266588|463343708|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
128785273|NCT03256344|463505977|FG000|Overall Study|Withdrawal by Subject|3|||
128741582|NCT03266588|463343706|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
128741583|NCT03266588|463343707|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
128741584|NCT03266588|463343708|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
128741585|NCT03266588|463343706|FG000|Long-term Treatment Period|Other Reasons|5|||
128741586|NCT03266588|463343707|FG001|Long-term Treatment Period|Other Reasons|0|||
128741587|NCT03266588|463343708|FG002|Long-term Treatment Period|Other Reasons|0|||
128741588|NCT03266588|463343706|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
128741589|NCT03266588|463343707|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
128741590|NCT03266588|463343708|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
128741591|NCT01073618|463343709|FG000|Overall Study|Death|208|||
128741592|NCT01073618|463343709|FG000|Overall Study|Adverse Event|19|||
128741593|NCT01073618|463343709|FG000|Overall Study|Other|80|||
128741594|NCT00466193|463343710|FG000|Overall Study|Adverse Event|0|||
128741595|NCT00466193|463343711|FG001|Overall Study|Adverse Event|1|||
128741596|NCT00466193|463343710|FG000|Overall Study|Lost to Follow-up|2|||
128741597|NCT00466193|463343711|FG001|Overall Study|Lost to Follow-up|4|||
128741598|NCT00466193|463343710|FG000|Overall Study|Physician Decision|1|||
128741599|NCT00466193|463343711|FG001|Overall Study|Physician Decision|0|||
128741600|NCT00466193|463343710|FG000|Overall Study|Protocol Violation|1|||
128741601|NCT00466193|463343711|FG001|Overall Study|Protocol Violation|1|||
128741602|NCT00466193|463343710|FG000|Overall Study|Withdrawal by Subject|7|||
128741603|NCT00466193|463343711|FG001|Overall Study|Withdrawal by Subject|2|||
128741604|NCT00466193|463343710|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
128741605|NCT00466193|463343711|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
128741606|NCT02246998|463343712|FG000|Overall Study|Adverse Event|0|||
128741607|NCT02246998|463343713|FG001|Overall Study|Adverse Event|1|||
128741608|NCT02246998|463343714|FG002|Overall Study|Adverse Event|1|||
128741609|NCT02246998|463343715|FG003|Overall Study|Adverse Event|0|||
128741610|NCT02246998|463343712|FG000|Overall Study|Lost to Follow-up|1|||
128741611|NCT02246998|463343713|FG001|Overall Study|Lost to Follow-up|0|||
128741612|NCT02246998|463343714|FG002|Overall Study|Lost to Follow-up|0|||
128741613|NCT02246998|463343715|FG003|Overall Study|Lost to Follow-up|1|||
128741614|NCT02246998|463343712|FG000|Overall Study|Randomized but Never Dosed|1|||
128741615|NCT02246998|463343713|FG001|Overall Study|Randomized but Never Dosed|2|||
128741616|NCT02246998|463343714|FG002|Overall Study|Randomized but Never Dosed|2|||
128741617|NCT02246998|463343715|FG003|Overall Study|Randomized but Never Dosed|1|||
128741618|NCT01343082|463343716|FG000|The run-in Period|Not meeting criteria|3|||
128741619|NCT01343082|463343717|FG001|The run-in Period|Not meeting criteria|4|||
128741620|NCT01343082|463343718|FG002|The run-in Period|Not meeting criteria|5|||
128741621|NCT01343082|463343716|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
128741622|NCT01343082|463343717|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
128741623|NCT01343082|463343718|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
128741624|NCT01343082|463343716|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
128741625|NCT01343082|463343717|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
128741626|NCT01343082|463343718|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
128741627|NCT01343082|463343716|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
128741628|NCT01343082|463343717|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
128741629|NCT01343082|463343718|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
128741630|NCT01343082|463343716|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
128741631|NCT01343082|463343717|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
128741632|NCT01343082|463343718|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
128741633|NCT01075074|463343719|FG000|Overall Study|Surgeon changed to open incisional case|1|||
128741634|NCT01075074|463343720|FG001|Overall Study|Surgeon changed to open incisional case|2|||
128741635|NCT01075074|463343721|FG002|Overall Study|Surgeon changed to open incisional case|2|||
128741636|NCT01054729|463343722|FG000|Overall Study|Randomized but Not Treated|0|||
128741637|NCT01054729|463343723|FG001|Overall Study|Randomized but Not Treated|1|||
128741638|NCT01054729|463343724|FG002|Overall Study|Randomized but Not Treated|0|||
128741639|NCT01054729|463343725|FG003|Overall Study|Randomized but Not Treated|0|||
128741640|NCT01054729|463343722|FG000|Overall Study|Adverse Event|1|||
128741641|NCT01054729|463343723|FG001|Overall Study|Adverse Event|1|||
128741642|NCT01054729|463343724|FG002|Overall Study|Adverse Event|2|||
128741643|NCT01054729|463343725|FG003|Overall Study|Adverse Event|1|||
128741644|NCT01054729|463343722|FG000|Overall Study|Withdrawal by Subject|1|||
128741645|NCT01054729|463343723|FG001|Overall Study|Withdrawal by Subject|0|||
128741646|NCT01054729|463343724|FG002|Overall Study|Withdrawal by Subject|1|||
128741647|NCT01054729|463343725|FG003|Overall Study|Withdrawal by Subject|0|||
128741648|NCT01054729|463343722|FG000|Overall Study|Lost to Follow-up|0|||
128741649|NCT01054729|463343723|FG001|Overall Study|Lost to Follow-up|1|||
128741650|NCT01054729|463343724|FG002|Overall Study|Lost to Follow-up|0|||
128741651|NCT01054729|463343725|FG003|Overall Study|Lost to Follow-up|0|||
128741652|NCT01054729|463343722|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
128741653|NCT01054729|463343723|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
128741654|NCT01054729|463343724|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
128741655|NCT01054729|463343725|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
128741656|NCT01054729|463343722|FG000|Overall Study|Non-responder|1|||
128741657|NCT01054729|463343723|FG001|Overall Study|Non-responder|0|||
128741658|NCT01054729|463343724|FG002|Overall Study|Non-responder|1|||
128741659|NCT01054729|463343725|FG003|Overall Study|Non-responder|1|||
128741660|NCT01054729|463343722|FG000|Overall Study|PEG/RBV Non-responder|1|||
128741661|NCT01054729|463343723|FG001|Overall Study|PEG/RBV Non-responder|0|||
128741662|NCT01054729|463343724|FG002|Overall Study|PEG/RBV Non-responder|1|||
128741663|NCT01054729|463343725|FG003|Overall Study|PEG/RBV Non-responder|0|||
128741664|NCT01054729|463343722|FG000|Overall Study|Personal/Obligations|0|||
128741665|NCT01054729|463343723|FG001|Overall Study|Personal/Obligations|1|||
128741666|NCT01054729|463343724|FG002|Overall Study|Personal/Obligations|0|||
128741667|NCT01054729|463343725|FG003|Overall Study|Personal/Obligations|0|||
128741668|NCT01054729|463343722|FG000|Overall Study|Subject moved|0|||
128741669|NCT01054729|463343723|FG001|Overall Study|Subject moved|0|||
128741670|NCT01054729|463343724|FG002|Overall Study|Subject moved|1|||
128741671|NCT01054729|463343725|FG003|Overall Study|Subject moved|0|||
128741672|NCT01054729|463343722|FG000|Overall Study|Lack of Efficacy|0|||
128741673|NCT01054729|463343723|FG001|Overall Study|Lack of Efficacy|0|||
128741674|NCT01054729|463343724|FG002|Overall Study|Lack of Efficacy|0|||
128741675|NCT01054729|463343725|FG003|Overall Study|Lack of Efficacy|1|||
128741676|NCT01575561|463343726|FG000|Overall Study|Adverse Event|9|||
128741677|NCT01575561|463343726|FG000|Overall Study|Lack of Efficacy|8|||
128741678|NCT01575561|463343726|FG000|Overall Study|Lost to Follow-up|6|||
128741679|NCT01575561|463343726|FG000|Overall Study|Protocol Violation|4|||
128741680|NCT01575561|463343726|FG000|Overall Study|Withdrawal by Subject|11|||
128741681|NCT01575561|463343726|FG000|Overall Study|administration|1|||
128741682|NCT00844194|463343727|FG000|Overall Study|Adverse Event|17|||
128741683|NCT00844194|463343728|FG001|Overall Study|Adverse Event|5|||
128741684|NCT00844194|463343727|FG000|Overall Study|Protocol Violation|1|||
128741685|NCT00844194|463343728|FG001|Overall Study|Protocol Violation|1|||
128741686|NCT00844194|463343727|FG000|Overall Study|Lost to Follow-up|1|||
128741687|NCT00844194|463343728|FG001|Overall Study|Lost to Follow-up|1|||
128741688|NCT00844194|463343727|FG000|Overall Study|Withdrawal by Subject|2|||
128741689|NCT00844194|463343728|FG001|Overall Study|Withdrawal by Subject|1|||
128741690|NCT00844194|463343727|FG000|Overall Study|Lack of Efficacy|3|||
128741691|NCT00844194|463343728|FG001|Overall Study|Lack of Efficacy|0|||
128741692|NCT00844194|463343727|FG000|Overall Study|Other reason (not specified)|1|||
128741693|NCT00844194|463343728|FG001|Overall Study|Other reason (not specified)|0|||
128741694|NCT02647658|463343729|FG000|Overall Study|Consent refusal|15|||
128741695|NCT02647658|463343730|FG001|Overall Study|Consent refusal|24|||
128741696|NCT00803023|463343731|FG000|Overall Study|Adverse Event|5|||
128741697|NCT00803023|463343732|FG001|Overall Study|Adverse Event|4|||
128741698|NCT00803023|463343733|FG002|Overall Study|Adverse Event|8|||
128741699|NCT00803023|463343734|FG003|Overall Study|Adverse Event|6|||
128741700|NCT00803023|463343731|FG000|Overall Study|Withdrawal by Subject|0|||
128741701|NCT00803023|463343732|FG001|Overall Study|Withdrawal by Subject|2|||
128741702|NCT00803023|463343733|FG002|Overall Study|Withdrawal by Subject|0|||
128741703|NCT00803023|463343734|FG003|Overall Study|Withdrawal by Subject|0|||
128741704|NCT00803023|463343731|FG000|Overall Study|Lost to Follow-up|0|||
128741705|NCT00803023|463343732|FG001|Overall Study|Lost to Follow-up|1|||
128741706|NCT00803023|463343733|FG002|Overall Study|Lost to Follow-up|2|||
128741707|NCT00803023|463343734|FG003|Overall Study|Lost to Follow-up|1|||
128741708|NCT00803023|463343731|FG000|Overall Study|Lack of Efficacy|0|||
128741709|NCT00803023|463343732|FG001|Overall Study|Lack of Efficacy|1|||
128741710|NCT00803023|463343733|FG002|Overall Study|Lack of Efficacy|1|||
128741711|NCT00803023|463343734|FG003|Overall Study|Lack of Efficacy|1|||
128741712|NCT01542528|463343735|FG000|Overall Study|Lost to Follow-up|2|||
128741713|NCT01542528|463343736|FG001|Overall Study|Lost to Follow-up|1|||
128741714|NCT01542528|463343735|FG000|Overall Study|Physician Decision|1|||
128741715|NCT01542528|463343736|FG001|Overall Study|Physician Decision|0|||
128785274|NCT03256344|463505978|FG001|Overall Study|Withdrawal by Subject|3|||
128785275|NCT03256344|463505977|FG000|Overall Study|Sponsor Decision|1|||
128785276|NCT03256344|463505978|FG001|Overall Study|Sponsor Decision|0|||
128741716|NCT01542528|463343735|FG000|Overall Study|Withdrawal by Subject|9|||
128741717|NCT01542528|463343736|FG001|Overall Study|Withdrawal by Subject|6|||
128741718|NCT01992536|463343741|FG000|Overall Study|Administrative Reason|0|||
128741719|NCT01992536|463343742|FG001|Overall Study|Administrative Reason|0|||
128741720|NCT01992536|463343743|FG002|Overall Study|Administrative Reason|0|||
128741721|NCT01992536|463343744|FG003|Overall Study|Administrative Reason|0|||
128741722|NCT01992536|463343745|FG004|Overall Study|Administrative Reason|0|||
128741723|NCT01992536|463343746|FG005|Overall Study|Administrative Reason|0|||
128741724|NCT01992536|463343747|FG006|Overall Study|Administrative Reason|7|||
128741725|NCT01992536|463343748|FG007|Overall Study|Administrative Reason|0|||
128741726|NCT01992536|463343749|FG008|Overall Study|Administrative Reason|0|||
128741727|NCT01992536|463343750|FG009|Overall Study|Administrative Reason|0|||
128741728|NCT01992536|463343741|FG000|Overall Study|Lost to Follow-up|4|||
128741729|NCT01992536|463343742|FG001|Overall Study|Lost to Follow-up|2|||
128741730|NCT01992536|463343743|FG002|Overall Study|Lost to Follow-up|1|||
128741731|NCT01992536|463343744|FG003|Overall Study|Lost to Follow-up|0|||
128741732|NCT01992536|463343745|FG004|Overall Study|Lost to Follow-up|0|||
128741733|NCT01992536|463343746|FG005|Overall Study|Lost to Follow-up|1|||
128741734|NCT01992536|463343747|FG006|Overall Study|Lost to Follow-up|0|||
128741735|NCT01992536|463343748|FG007|Overall Study|Lost to Follow-up|0|||
128741736|NCT01992536|463343749|FG008|Overall Study|Lost to Follow-up|1|||
128741737|NCT01992536|463343750|FG009|Overall Study|Lost to Follow-up|1|||
128741738|NCT01992536|463343741|FG000|Overall Study|Withdrawal by Subject|0|||
128741739|NCT01992536|463343742|FG001|Overall Study|Withdrawal by Subject|1|||
128741740|NCT01992536|463343743|FG002|Overall Study|Withdrawal by Subject|0|||
128741741|NCT01992536|463343744|FG003|Overall Study|Withdrawal by Subject|2|||
128741742|NCT01992536|463343745|FG004|Overall Study|Withdrawal by Subject|0|||
128741743|NCT01992536|463343746|FG005|Overall Study|Withdrawal by Subject|0|||
128741744|NCT01992536|463343747|FG006|Overall Study|Withdrawal by Subject|0|||
128741745|NCT01992536|463343748|FG007|Overall Study|Withdrawal by Subject|0|||
128741746|NCT01992536|463343749|FG008|Overall Study|Withdrawal by Subject|0|||
128741747|NCT01992536|463343750|FG009|Overall Study|Withdrawal by Subject|0|||
128741748|NCT01709227|463343759|FG000|Overall Study|Physician Decision|1|||
128741749|NCT01709227|463343760|FG001|Overall Study|Physician Decision|0|||
128741750|NCT01709227|463343759|FG000|Overall Study|Pleural Peritoneal communication|0|||
128741751|NCT01709227|463343760|FG001|Overall Study|Pleural Peritoneal communication|9|||
128741752|NCT03669081|463343763|FG000|Overall Study|Data could not be validated|1|||
128741753|NCT03669081|463343764|FG001|Overall Study|Data could not be validated|1|||
128741754|NCT00389324|463343765|FG000|Run-In Phase|Adverse Event|1|||
128741755|NCT00389324|463343765|FG000|Run-In Phase|Lost to Follow-up|1|||
128741756|NCT00389324|463343765|FG000|Run-In Phase|Withdrawal by Subject|1|||
128741757|NCT00389324|463343765|FG000|Subcutaneous Phase|Adverse Event|2|||
128741758|NCT00389324|463343765|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
128741759|NCT00389324|463343765|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
128741760|NCT00389324|463343765|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
128741761|NCT02317575|463343766|FG000|Period 1|Difficulty with venous cannulation|0|||
128741762|NCT02317575|463343767|FG001|Period 1|Difficulty with venous cannulation|1|||
128741763|NCT02317575|463343768|FG002|Period 1|Difficulty with venous cannulation|0|||
128741764|NCT02317575|463343769|FG003|Period 1|Difficulty with venous cannulation|0|||
128741765|NCT02317575|463343770|FG004|Period 1|Difficulty with venous cannulation|0|||
128741766|NCT02317575|463343766|FG000|Period 1|Withdrawal by Subject|1|||
128741767|NCT02317575|463343767|FG001|Period 1|Withdrawal by Subject|0|||
128741768|NCT02317575|463343768|FG002|Period 1|Withdrawal by Subject|0|||
128741769|NCT02317575|463343769|FG003|Period 1|Withdrawal by Subject|0|||
128741770|NCT02317575|463343770|FG004|Period 1|Withdrawal by Subject|0|||
128741771|NCT03936244|463343771|FG000|Overall Study|Lost to Follow-up|5|||
128741772|NCT03936244|463343772|FG001|Overall Study|Lost to Follow-up|1|||
128741773|NCT03936244|463343771|FG000|Overall Study|Physician Decision|7|||
128741774|NCT03936244|463343772|FG001|Overall Study|Physician Decision|3|||
128741775|NCT01114646|463343773|FG000|Overall Study|Withdrawal by Subject|3|||
128741776|NCT01114646|463343774|FG001|Overall Study|Withdrawal by Subject|2|||
128741777|NCT01430130|463343779|FG000|Overall Study|Lost to Follow-up|1|||
128741778|NCT01430130|463343779|FG000|Overall Study|Infection on Control Side of Incision|1|||
128741779|NCT02843568|463343781|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
128741780|NCT02843568|463343782|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
128741781|NCT02843568|463343781|FG000|Overall Study|Death|3|||
128741782|NCT02843568|463343782|FG001|Overall Study|Death|3|||
128741783|NCT02843568|463343781|FG000|Overall Study|Withdrawal by Subject|1|||
128741784|NCT02843568|463343782|FG001|Overall Study|Withdrawal by Subject|1|||
128741785|NCT02843568|463343781|FG000|Overall Study|Lost to Follow-up|2|||
128741786|NCT02843568|463343782|FG001|Overall Study|Lost to Follow-up|0|||
128741787|NCT04079933|463343797|FG000|Overall Study|Withdrawal by Subject|3|||
128741788|NCT04079933|463343798|FG001|Overall Study|Withdrawal by Subject|4|||
128741789|NCT04079933|463343797|FG000|Overall Study|Lost to Follow-up|0|||
128741790|NCT04079933|463343798|FG001|Overall Study|Lost to Follow-up|1|||
128741791|NCT01229436|463343799|FG000|Overall Study|Withdrawal by Subject|2|||
128741792|NCT01229436|463343799|FG000|Overall Study|Lost to Follow-up|3|||
128741793|NCT04788147|463343800|FG000|Overall Study|Screen Failure|3|||
128741794|NCT04788147|463343801|FG001|Overall Study|Screen Failure|10|||
128741795|NCT04788147|463343800|FG000|Overall Study|Incomplete RMRS image session|2|||
128741796|NCT04788147|463343801|FG001|Overall Study|Incomplete RMRS image session|0|||
128741797|NCT02266381|463343802|FG000|Overall Study|Physician Decision|3|||
128741798|NCT02266381|463343803|FG001|Overall Study|Physician Decision|5|||
128741799|NCT02266381|463343804|FG002|Overall Study|Physician Decision|4|||
128741800|NCT05101252|463343805|FG000|Overall Study|Unsatisfactory Test Article|1|||
128741801|NCT05101252|463343806|FG001|Overall Study|Unsatisfactory Test Article|0|||
128741802|NCT05101252|463343805|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
128741803|NCT05101252|463343806|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
128741804|NCT05101252|463343805|FG000|Overall Study|Withdrew Consent during study|0|||
128741805|NCT05101252|463343806|FG001|Overall Study|Withdrew Consent during study|1|||
128741806|NCT05101252|463343805|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
128741807|NCT05101252|463343806|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
128741808|NCT02401672|463343807|FG000|Overall Study|Withdrawal by Subject|1|||
128741809|NCT02401672|463343808|FG001|Overall Study|Withdrawal by Subject|3|||
128741810|NCT00701051|463343809|FG000|Screening|Failed Screening|40|||
128741811|NCT00701051|463343810|FG001|Screening|Failed Screening|0|||
128741812|NCT00701051|463343811|FG002|Screening|Failed Screening|0|||
128741813|NCT00701051|463343809|FG000|Screening|Time conflicts|19|||
128741814|NCT00701051|463343810|FG001|Screening|Time conflicts|0|||
128741815|NCT00701051|463343811|FG002|Screening|Time conflicts|0|||
128741816|NCT00701051|463343809|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
128741817|NCT00701051|463343810|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
128741818|NCT00701051|463343811|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
128741819|NCT00345579|463343825|FG000|Overall Study|Adverse Event|9|||
128741820|NCT00345579|463343826|FG001|Overall Study|Adverse Event|6|||
128741821|NCT00345579|463343825|FG000|Overall Study|Protocol Violation|14|||
128741822|NCT00345579|463343826|FG001|Overall Study|Protocol Violation|5|||
128741823|NCT00345579|463343825|FG000|Overall Study|Withdrawal by Subject|50|||
128741824|NCT00345579|463343826|FG001|Overall Study|Withdrawal by Subject|17|||
128741825|NCT00345579|463343825|FG000|Overall Study|Lost to Follow-up|82|||
128741826|NCT00345579|463343826|FG001|Overall Study|Lost to Follow-up|36|||
128741827|NCT00345579|463343825|FG000|Overall Study|Other|9|||
128741828|NCT00345579|463343826|FG001|Overall Study|Other|1|||
128741829|NCT00413413|463343827|FG000|Single-Blind|Adverse Event|0|||
128741830|NCT00413413|463343828|FG001|Single-Blind|Adverse Event|9|||
128741831|NCT00413413|463343829|FG002|Single-Blind|Adverse Event|0|||
128741832|NCT00413413|463343827|FG000|Single-Blind|Lack of Efficacy|0|||
128741833|NCT00413413|463343828|FG001|Single-Blind|Lack of Efficacy|5|||
128741834|NCT00413413|463343829|FG002|Single-Blind|Lack of Efficacy|0|||
128741835|NCT00413413|463343827|FG000|Single-Blind|Subject no longer requires study drug|0|||
128741836|NCT00413413|463343828|FG001|Single-Blind|Subject no longer requires study drug|151|||
128741837|NCT00413413|463343829|FG002|Single-Blind|Subject no longer requires study drug|0|||
128741838|NCT00413413|463343827|FG000|Single-Blind|Protocol Violation|0|||
128741839|NCT00413413|463343828|FG001|Single-Blind|Protocol Violation|16|||
128741840|NCT00413413|463343829|FG002|Single-Blind|Protocol Violation|0|||
128741841|NCT00413413|463343827|FG000|Single-Blind|Withdrawal by Subject|0|||
128741842|NCT00413413|463343828|FG001|Single-Blind|Withdrawal by Subject|27|||
128741843|NCT00413413|463343829|FG002|Single-Blind|Withdrawal by Subject|0|||
128741844|NCT00413413|463343827|FG000|Single-Blind|Lost to Follow-up|0|||
128741845|NCT00413413|463343828|FG001|Single-Blind|Lost to Follow-up|8|||
128741846|NCT00413413|463343829|FG002|Single-Blind|Lost to Follow-up|0|||
128741847|NCT00413413|463343827|FG000|Double-Blind|Adverse Event|6|||
128741848|NCT00413413|463343828|FG001|Double-Blind|Adverse Event|0|||
128741849|NCT00413413|463343829|FG002|Double-Blind|Adverse Event|5|||
128741850|NCT00413413|463343827|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
128741851|NCT00413413|463343828|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
128741852|NCT00413413|463343829|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
128741853|NCT00413413|463343827|FG000|Double-Blind|Protocol deviation|1|||
128741854|NCT00413413|463343828|FG001|Double-Blind|Protocol deviation|2|||
128741855|NCT00413413|463343829|FG002|Double-Blind|Protocol deviation|1|||
128741856|NCT00413413|463343827|FG000|Double-Blind|Subject withdrew consent|4|||
128741857|NCT00413413|463343828|FG001|Double-Blind|Subject withdrew consent|6|||
128741858|NCT00413413|463343829|FG002|Double-Blind|Subject withdrew consent|9|||
128741859|NCT00413413|463343827|FG000|Double-Blind|Lost to Follow-up|3|||
128741860|NCT00413413|463343828|FG001|Double-Blind|Lost to Follow-up|4|||
128741861|NCT00413413|463343829|FG002|Double-Blind|Lost to Follow-up|2|||
128741862|NCT03207750|463343830|FG000|Overall Study|Adverse Event|3|||
128741863|NCT03207750|463343831|FG001|Overall Study|Adverse Event|2|||
128741864|NCT03207750|463343830|FG000|Overall Study|Lost to Follow-up|21|||
128741865|NCT03207750|463343831|FG001|Overall Study|Lost to Follow-up|29|||
128741866|NCT03207750|463343830|FG000|Overall Study|Protocol Violation|0|||
128741867|NCT03207750|463343831|FG001|Overall Study|Protocol Violation|1|||
128741868|NCT03207750|463343830|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
128741869|NCT03207750|463343831|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
128741870|NCT03207750|463343830|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
128741871|NCT03207750|463343831|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
128741872|NCT03207750|463343830|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
128741873|NCT03207750|463343831|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
128741874|NCT03207750|463343830|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
128741875|NCT03207750|463343831|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
128741876|NCT03207750|463343830|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
128741877|NCT03207750|463343831|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
128741878|NCT03634579|463343836|FG000|Overall Study|study termination|9|||
128741879|NCT04111497|463343844|FG000|Overall Study|relapse of primary disease|1|||
128741880|NCT04111497|463343844|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
128741881|NCT03321019|463343845|FG000|Overall Study|Withdrawal by Subject|0|||
128741882|NCT03321019|463343846|FG001|Overall Study|Withdrawal by Subject|6|||
128741883|NCT03321019|463343845|FG000|Overall Study|Lost to Follow-up|0|||
128741884|NCT03321019|463343846|FG001|Overall Study|Lost to Follow-up|22|||
128741885|NCT01578551|463343850|FG000|Overall Study|Adverse Event|1|||
128741886|NCT01578551|463343851|FG001|Overall Study|Adverse Event|0|||
128741887|NCT01344460|463343858|FG000|Overall Study|Withdrawal by Subject|1|||
128741888|NCT01344460|463343858|FG000|Overall Study|Lost to Follow-up|2|||
128741889|NCT03283670|463343859|FG000|Placebo Gas|Withdrawal by Subject|2|||
128741890|NCT03283670|463343859|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
128741891|NCT03283670|463343859|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
128741892|NCT00852397|463343860|FG000|Overall Study|Adverse Event|4|||
128741893|NCT00852397|463343861|FG001|Overall Study|Adverse Event|6|||
128741894|NCT00852397|463343862|FG002|Overall Study|Adverse Event|4|||
128741895|NCT00852397|463343860|FG000|Overall Study|Death|0|||
128741896|NCT00852397|463343861|FG001|Overall Study|Death|0|||
128741897|NCT00852397|463343862|FG002|Overall Study|Death|1|||
128741898|NCT00852397|463343860|FG000|Overall Study|Withdrawal by Subject|4|||
128741899|NCT00852397|463343861|FG001|Overall Study|Withdrawal by Subject|1|||
128741900|NCT00852397|463343862|FG002|Overall Study|Withdrawal by Subject|2|||
128741901|NCT00852397|463343860|FG000|Overall Study|Study terminated by sponsor|2|||
128741902|NCT00852397|463343861|FG001|Overall Study|Study terminated by sponsor|1|||
128741903|NCT00852397|463343862|FG002|Overall Study|Study terminated by sponsor|6|||
128741904|NCT00852397|463343860|FG000|Overall Study|Difficulty in study site visit|1|||
128741905|NCT00852397|463343861|FG001|Overall Study|Difficulty in study site visit|0|||
128741906|NCT00852397|463343862|FG002|Overall Study|Difficulty in study site visit|0|||
128741907|NCT00852397|463343860|FG000|Overall Study|Protocol Violation|0|||
128741908|NCT00852397|463343861|FG001|Overall Study|Protocol Violation|0|||
128741909|NCT00852397|463343862|FG002|Overall Study|Protocol Violation|1|||
128741910|NCT03859323|463345879|FG000|Overall Study|Lost to Follow-up|0|||
128741911|NCT03859323|463345880|FG001|Overall Study|Lost to Follow-up|0|||
128741912|NCT03859323|463345881|FG002|Overall Study|Lost to Follow-up|0|||
128741913|NCT03859323|463345882|FG003|Overall Study|Lost to Follow-up|0|||
128741914|NCT03859323|463345883|FG004|Overall Study|Lost to Follow-up|0|||
128741915|NCT03859323|463345884|FG005|Overall Study|Lost to Follow-up|0|||
128741916|NCT03859323|463345885|FG006|Overall Study|Lost to Follow-up|1|||
128741917|NCT03859323|463345886|FG007|Overall Study|Lost to Follow-up|0|||
128741918|NCT03859323|463345887|FG008|Overall Study|Lost to Follow-up|0|||
128741919|NCT03859323|463345888|FG009|Overall Study|Lost to Follow-up|0|||
128741920|NCT03859323|463345889|FG010|Overall Study|Lost to Follow-up|0|||
128741921|NCT03859323|463345890|FG011|Overall Study|Lost to Follow-up|0|||
128741922|NCT03859323|463345891|FG012|Overall Study|Lost to Follow-up|0|||
128741923|NCT03859323|463345879|FG000|Overall Study|Withdrawal by Subject|0|||
128741924|NCT03859323|463345880|FG001|Overall Study|Withdrawal by Subject|0|||
128741925|NCT03859323|463345881|FG002|Overall Study|Withdrawal by Subject|1|||
128741926|NCT03859323|463345882|FG003|Overall Study|Withdrawal by Subject|0|||
128741927|NCT03859323|463345883|FG004|Overall Study|Withdrawal by Subject|0|||
128741928|NCT03859323|463345884|FG005|Overall Study|Withdrawal by Subject|1|||
128741929|NCT03859323|463345885|FG006|Overall Study|Withdrawal by Subject|0|||
128741930|NCT03859323|463345886|FG007|Overall Study|Withdrawal by Subject|0|||
128741931|NCT03859323|463345887|FG008|Overall Study|Withdrawal by Subject|0|||
128741932|NCT03859323|463345888|FG009|Overall Study|Withdrawal by Subject|1|||
128741933|NCT03859323|463345889|FG010|Overall Study|Withdrawal by Subject|1|||
128741934|NCT03859323|463345890|FG011|Overall Study|Withdrawal by Subject|2|||
128741935|NCT03859323|463345891|FG012|Overall Study|Withdrawal by Subject|1|||
128741936|NCT03859323|463345879|FG000|Overall Study|Pregnancy|0|||
128741937|NCT03859323|463345880|FG001|Overall Study|Pregnancy|0|||
128741938|NCT03859323|463345881|FG002|Overall Study|Pregnancy|0|||
128741939|NCT03859323|463345882|FG003|Overall Study|Pregnancy|0|||
128785277|NCT01670019|463505988|FG000|Overall Study|Adverse Event|3|||
128741940|NCT03859323|463345883|FG004|Overall Study|Pregnancy|0|||
128741941|NCT03859323|463345884|FG005|Overall Study|Pregnancy|0|||
128741942|NCT03859323|463345885|FG006|Overall Study|Pregnancy|0|||
128741943|NCT03859323|463345886|FG007|Overall Study|Pregnancy|0|||
128741944|NCT03859323|463345887|FG008|Overall Study|Pregnancy|0|||
128741945|NCT03859323|463345888|FG009|Overall Study|Pregnancy|1|||
128741946|NCT03859323|463345889|FG010|Overall Study|Pregnancy|0|||
128741947|NCT03859323|463345890|FG011|Overall Study|Pregnancy|0|||
128741948|NCT03859323|463345891|FG012|Overall Study|Pregnancy|0|||
128741949|NCT04419493|463345892|FG000|Wash-out After Period 1|Adverse Event|1|||
128741950|NCT04419493|463345893|FG001|Wash-out After Period 1|Adverse Event|2|||
128741951|NCT04419493|463345894|FG002|Wash-out After Period 1|Adverse Event|1|||
128741952|NCT04419493|463345895|FG003|Wash-out After Period 1|Adverse Event|0|||
128741953|NCT03794089|463345896|FG000|Overall Study|Lost to Follow-up|4|||
128741954|NCT03794089|463345897|FG001|Overall Study|Lost to Follow-up|1|||
128741955|NCT03794089|463345896|FG000|Overall Study|Withdrawal by Subject|2|||
128741956|NCT03794089|463345897|FG001|Overall Study|Withdrawal by Subject|0|||
128741957|NCT03985423|463345898|FG000|Overall Study|Adverse Event|1|||
128741958|NCT03985423|463345898|FG000|Overall Study|Death|2|||
128741959|NCT03985423|463345898|FG000|Overall Study|Physician Decision|1|||
128741960|NCT03985423|463345898|FG000|Overall Study|Withdrawal by Subject|2|||
128741961|NCT03985423|463345898|FG000|Overall Study|Lack of insurance and citizenship|1|||
128741962|NCT00129987|463345899|FG000|1st Educational Session|Withdrawal by Subject|141|||
128741963|NCT00129987|463345900|FG001|1st Educational Session|Withdrawal by Subject|109|||
128741964|NCT00129987|463345899|FG000|1 Year|Withdrawal by Subject|32|||
128741965|NCT00129987|463345900|FG001|1 Year|Withdrawal by Subject|21|||
128741966|NCT00982020|463345904|FG000|Overall Study|Adverse Event|19|||
128741967|NCT00982020|463345905|FG001|Overall Study|Adverse Event|15|||
128741968|NCT00982020|463345904|FG000|Overall Study|Withdrawal by Subject|11|||
128741969|NCT00982020|463345905|FG001|Overall Study|Withdrawal by Subject|14|||
128741970|NCT00982020|463345904|FG000|Overall Study|Lost to Follow-up|5|||
128741971|NCT00982020|463345905|FG001|Overall Study|Lost to Follow-up|11|||
128741972|NCT00982020|463345904|FG000|Overall Study|Lack of Efficacy|10|||
128741973|NCT00982020|463345905|FG001|Overall Study|Lack of Efficacy|4|||
128741974|NCT00982020|463345904|FG000|Overall Study|Parent/Caregiver Decision|5|||
128741975|NCT00982020|463345905|FG001|Overall Study|Parent/Caregiver Decision|5|||
128741976|NCT00982020|463345904|FG000|Overall Study|Treatment Non-compliance|3|||
128741977|NCT00982020|463345905|FG001|Overall Study|Treatment Non-compliance|6|||
128741978|NCT00982020|463345904|FG000|Overall Study|Physician Decision|2|||
128741979|NCT00982020|463345905|FG001|Overall Study|Physician Decision|5|||
128741980|NCT00982020|463345904|FG000|Overall Study|Entry Criteria Not Met|2|||
128741981|NCT00982020|463345905|FG001|Overall Study|Entry Criteria Not Met|1|||
128741982|NCT00982020|463345904|FG000|Overall Study|Protocol Violation|0|||
128741983|NCT00982020|463345905|FG001|Overall Study|Protocol Violation|2|||
128741984|NCT00982020|463345904|FG000|Overall Study|Clinical Relapse|0|||
128741985|NCT00982020|463345905|FG001|Overall Study|Clinical Relapse|1|||
128741986|NCT01854554|463345906|FG000|Overall Study|Denial of Insurance Coverage|12|||
128741987|NCT01854554|463345907|FG001|Overall Study|Denial of Insurance Coverage|0|||
128741988|NCT01854554|463345906|FG000|Overall Study|Decided to get treatment locally|1|||
128741989|NCT01854554|463345907|FG001|Overall Study|Decided to get treatment locally|5|||
128741990|NCT01854554|463345906|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
128741991|NCT01854554|463345907|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
128741992|NCT01854554|463345906|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
128741993|NCT01854554|463345907|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
128741994|NCT01854554|463345906|FG000|Overall Study|Progression|0|||
128741995|NCT01854554|463345907|FG001|Overall Study|Progression|1|||
128741996|NCT01854554|463345906|FG000|Overall Study|Lost to Follow-up|0|||
128741997|NCT01854554|463345907|FG001|Overall Study|Lost to Follow-up|1|||
128741998|NCT02819726|463345908|FG000|Part A (All Participants)|Lost to Follow-up|0|||
128741999|NCT02819726|463345909|FG001|Part A (All Participants)|Lost to Follow-up|1|||
128742000|NCT02819726|463345910|FG002|Part A (All Participants)|Lost to Follow-up|0|||
128742001|NCT02819726|463345911|FG003|Part A (All Participants)|Lost to Follow-up|0|||
128742002|NCT02819726|463345908|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
128742003|NCT02819726|463345909|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
128742004|NCT02819726|463345910|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
128742005|NCT02819726|463345911|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
128742006|NCT02819726|463345908|FG000|Part A (All Participants)|Protocol non-compliance|3|||
128742007|NCT02819726|463345909|FG001|Part A (All Participants)|Protocol non-compliance|4|||
128742008|NCT02819726|463345910|FG002|Part A (All Participants)|Protocol non-compliance|5|||
128742009|NCT02819726|463345911|FG003|Part A (All Participants)|Protocol non-compliance|0|||
128742010|NCT02819726|463345908|FG000|Part B (All Participants)|Lost to Follow-up|1|||
128742011|NCT02819726|463345909|FG001|Part B (All Participants)|Lost to Follow-up|1|||
128742012|NCT02819726|463345910|FG002|Part B (All Participants)|Lost to Follow-up|2|||
128742013|NCT02819726|463345911|FG003|Part B (All Participants)|Lost to Follow-up|2|||
128742014|NCT02819726|463345908|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
128742015|NCT02819726|463345909|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
128742016|NCT02819726|463345910|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
128742017|NCT02819726|463345911|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
128742018|NCT02819726|463345908|FG000|Part B (All Participants)|Protocol non-compliance|0|||
128742019|NCT02819726|463345909|FG001|Part B (All Participants)|Protocol non-compliance|0|||
128742020|NCT02819726|463345910|FG002|Part B (All Participants)|Protocol non-compliance|1|||
128742021|NCT02819726|463345911|FG003|Part B (All Participants)|Protocol non-compliance|0|||
128742022|NCT02613481|463345912|FG000|Overall Study|Lost to Follow-up|7|||
128742023|NCT02613481|463345912|FG000|Overall Study|Withdrawal by Subject|2|||
128742024|NCT00406029|463345916|FG000|Overall Study|Adverse Event|12|||
128742025|NCT00406029|463345917|FG001|Overall Study|Adverse Event|2|||
128742026|NCT00406029|463345918|FG002|Overall Study|Adverse Event|5|||
128742027|NCT00406029|463345919|FG003|Overall Study|Adverse Event|10|||
128742028|NCT00406029|463345920|FG004|Overall Study|Adverse Event|7|||
128742029|NCT00406029|463345916|FG000|Overall Study|Withdrawal by Subject|3|||
128742030|NCT00406029|463345917|FG001|Overall Study|Withdrawal by Subject|4|||
128742031|NCT00406029|463345918|FG002|Overall Study|Withdrawal by Subject|2|||
128742032|NCT00406029|463345919|FG003|Overall Study|Withdrawal by Subject|2|||
128742033|NCT00406029|463345920|FG004|Overall Study|Withdrawal by Subject|0|||
128742034|NCT00406029|463345916|FG000|Overall Study|Protocol Violation|1|||
128742035|NCT00406029|463345917|FG001|Overall Study|Protocol Violation|2|||
128742036|NCT00406029|463345918|FG002|Overall Study|Protocol Violation|0|||
128742037|NCT00406029|463345919|FG003|Overall Study|Protocol Violation|2|||
128742038|NCT00406029|463345920|FG004|Overall Study|Protocol Violation|0|||
128742039|NCT00406029|463345916|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
128742040|NCT00406029|463345917|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
128742041|NCT00406029|463345918|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
128742042|NCT00406029|463345919|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
128742043|NCT00406029|463345920|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
128742044|NCT00406029|463345916|FG000|Overall Study|Randomized in Error|0|||
128742045|NCT00406029|463345917|FG001|Overall Study|Randomized in Error|0|||
128742046|NCT00406029|463345918|FG002|Overall Study|Randomized in Error|2|||
128742047|NCT00406029|463345919|FG003|Overall Study|Randomized in Error|3|||
128742048|NCT00406029|463345920|FG004|Overall Study|Randomized in Error|1|||
128742049|NCT01921348|463345921|FG000|Overall Study|Withdrawal by Subject|1|||
128742050|NCT01921348|463345922|FG001|Overall Study|Withdrawal by Subject|0|||
128742051|NCT01921348|463345921|FG000|Overall Study|Lost to Follow-up|0|||
128742052|NCT01921348|463345922|FG001|Overall Study|Lost to Follow-up|2|||
128742053|NCT00795600|463345928|FG000|Overall Study|Adverse Event|1|||
128742054|NCT00795600|463345929|FG001|Overall Study|Adverse Event|1|||
128742055|NCT00795600|463345928|FG000|Overall Study|Protocol Violation|1|||
128742056|NCT00795600|463345929|FG001|Overall Study|Protocol Violation|2|||
128742057|NCT00795600|463345928|FG000|Overall Study|Withdrawal by Subject|1|||
128742058|NCT00795600|463345929|FG001|Overall Study|Withdrawal by Subject|0|||
128742059|NCT00795600|463345928|FG000|Overall Study|Unclassified|1|||
128742060|NCT00795600|463345929|FG001|Overall Study|Unclassified|1|||
128742061|NCT01248884|463345930|FG000|Overall Study|Withdrawal by Subject|1|||
128742062|NCT01248884|463345931|FG001|Overall Study|Withdrawal by Subject|3|||
128742063|NCT01248884|463345932|FG002|Overall Study|Withdrawal by Subject|1|||
128742064|NCT01248884|463345930|FG000|Overall Study|Adverse Event|1|||
128742065|NCT01248884|463345931|FG001|Overall Study|Adverse Event|0|||
128742066|NCT01248884|463345932|FG002|Overall Study|Adverse Event|0|||
128742067|NCT02511431|463345933|FG000|Treatment|Lost to Follow-up|0|||
128742068|NCT02511431|463345934|FG001|Treatment|Lost to Follow-up|0|||
128742069|NCT02511431|463345935|FG002|Treatment|Lost to Follow-up|1|||
128742070|NCT02511431|463345936|FG003|Treatment|Lost to Follow-up|0|||
128742071|NCT02511431|463345937|FG004|Treatment|Lost to Follow-up|0|||
128742072|NCT02511431|463345938|FG005|Treatment|Lost to Follow-up|1|||
128742073|NCT02828111|463345945|FG000|Overall Study|Withdrawal by Subject|0|||
128742074|NCT02828111|463345946|FG001|Overall Study|Withdrawal by Subject|0|||
128742075|NCT02828111|463345947|FG002|Overall Study|Withdrawal by Subject|2|||
128742076|NCT02828111|463345948|FG003|Overall Study|Withdrawal by Subject|0|||
128742077|NCT02828111|463345949|FG004|Overall Study|Withdrawal by Subject|0|||
128742078|NCT02828111|463345945|FG000|Overall Study|Lost to Follow-up|0|||
128742079|NCT02828111|463345946|FG001|Overall Study|Lost to Follow-up|0|||
128742080|NCT02828111|463345947|FG002|Overall Study|Lost to Follow-up|0|||
128742081|NCT02828111|463345948|FG003|Overall Study|Lost to Follow-up|1|||
128742082|NCT02828111|463345949|FG004|Overall Study|Lost to Follow-up|1|||
128742083|NCT02667912|463345952|FG000|Overall Study|Death|3|||
128742084|NCT02667912|463345953|FG001|Overall Study|Death|1|||
128742085|NCT02667912|463345952|FG000|Overall Study|Withdrawal by Subject|1|||
128742086|NCT02667912|463345953|FG001|Overall Study|Withdrawal by Subject|2|||
128742087|NCT02667912|463345952|FG000|Overall Study|Withdrawal by Subject|1|||
128742088|NCT02667912|463345953|FG001|Overall Study|Withdrawal by Subject|0|||
128742089|NCT04443218|463345954|FG000|Overall Study|Exited study for other reasons|9|||
128742090|NCT04443218|463345954|FG000|Overall Study|Withdrawal by Subject|1|||
128742091|NCT04443218|463345954|FG000|Overall Study|Lost to Follow-up|4|||
128742092|NCT04443218|463345954|FG000|Overall Study|Death|19|||
128742093|NCT01459796|463345959|FG000|Overall Study|Non compliance with protocol|2|||
128742094|NCT01459796|463345960|FG001|Overall Study|Non compliance with protocol|4|||
128742095|NCT01459796|463345959|FG000|Overall Study|Adverse Event|5|||
128742096|NCT01459796|463345960|FG001|Overall Study|Adverse Event|5|||
128742097|NCT01459796|463345959|FG000|Overall Study|Withdrawal by Subject|6|||
128742098|NCT01459796|463345960|FG001|Overall Study|Withdrawal by Subject|3|||
128742099|NCT01459796|463345959|FG000|Overall Study|Lost to Follow-up|5|||
128742100|NCT01459796|463345960|FG001|Overall Study|Lost to Follow-up|4|||
128742101|NCT01459796|463345959|FG000|Overall Study|Reason unspecified|1|||
128742102|NCT01459796|463345960|FG001|Overall Study|Reason unspecified|2|||
128742103|NCT01459796|463345959|FG000|Overall Study|Decision by the sponsor|75|||
128742104|NCT01459796|463345960|FG001|Overall Study|Decision by the sponsor|108|||
128742105|NCT00022516|463345961|FG000|Overall Study|Adverse Event|0|||
128742106|NCT00022516|463345962|FG001|Overall Study|Adverse Event|59|||
128742107|NCT00022516|463345961|FG000|Overall Study|Lack of Efficacy|0|||
128742108|NCT00022516|463345962|FG001|Overall Study|Lack of Efficacy|27|||
128742109|NCT00022516|463345961|FG000|Overall Study|Physician Decision|0|||
128742110|NCT00022516|463345962|FG001|Overall Study|Physician Decision|1|||
128742111|NCT00022516|463345961|FG000|Overall Study|Protocol Violation|1|||
128742112|NCT00022516|463345962|FG001|Overall Study|Protocol Violation|3|||
128742113|NCT00022516|463345961|FG000|Overall Study|Withdrawal by Subject|2|||
128742114|NCT00022516|463345962|FG001|Overall Study|Withdrawal by Subject|113|||
128742115|NCT00022516|463345961|FG000|Overall Study|Incomplete documentation|0|||
128742116|NCT00022516|463345962|FG001|Overall Study|Incomplete documentation|27|||
128742117|NCT03067441|463345963|FG000|Overall Study|Withdrawal by Subject|16|||
128742118|NCT03067441|463345964|FG001|Overall Study|Withdrawal by Subject|34|||
128742119|NCT03067441|463345963|FG000|Overall Study|Lost to Follow-up|7|||
128742120|NCT03067441|463345964|FG001|Overall Study|Lost to Follow-up|5|||
128742121|NCT03067441|463345963|FG000|Overall Study|Adverse Event|7|||
128742122|NCT03067441|463345964|FG001|Overall Study|Adverse Event|14|||
128742123|NCT03067441|463345963|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
128742124|NCT03067441|463345964|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
128742125|NCT03067441|463345963|FG000|Overall Study|Physician Decision|1|||
128742126|NCT03067441|463345964|FG001|Overall Study|Physician Decision|3|||
128742127|NCT03067441|463345963|FG000|Overall Study|Other|1|||
128742128|NCT03067441|463345964|FG001|Overall Study|Other|1|||
128742129|NCT02056301|463345972|FG000|Overall Study|Protocol Violation|1|||
128742130|NCT02056301|463345973|FG001|Overall Study|Protocol Violation|2|||
128742131|NCT02056301|463345972|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
128742132|NCT02056301|463345973|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
128742133|NCT02056301|463345972|FG000|Overall Study|Withdrawal by Subject|0|||
128742134|NCT02056301|463345973|FG001|Overall Study|Withdrawal by Subject|1|||
128742135|NCT02056301|463345972|FG000|Overall Study|Issues with epidural|0|||
128742136|NCT02056301|463345973|FG001|Overall Study|Issues with epidural|3|||
128742137|NCT02209324|463345976|FG000|Overall Study|Adverse Event|2|||
128742138|NCT02209324|463345976|FG000|Overall Study|Lack of Efficacy|1|||
128742139|NCT02209324|463345976|FG000|Overall Study|Lost to Follow-up|1|||
128742140|NCT02209324|463345976|FG000|Overall Study|Physician Decision|3|||
128742141|NCT02209324|463345976|FG000|Overall Study|Protocol Violation|14|||
128742142|NCT02209324|463345976|FG000|Overall Study|Withdrawal by Subject|8|||
128742143|NCT02209324|463345976|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
128742144|NCT02209324|463345976|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
128742145|NCT02209324|463345976|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
128742146|NCT03433456|463345977|FG000|Overall Study|Death|1|||
128742147|NCT03433456|463345978|FG001|Overall Study|Death|1|||
128742148|NCT03433456|463345977|FG000|Overall Study|Lost to Follow-up|14|||
128742149|NCT03433456|463345978|FG001|Overall Study|Lost to Follow-up|11|||
128742150|NCT03433456|463345977|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
128742151|NCT03433456|463345978|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
128742152|NCT05799495|463345979|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
128742153|NCT05799495|463345980|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
128742154|NCT05799495|463345981|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
128742155|NCT05799495|463345982|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
128742156|NCT05799495|463345979|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
128742157|NCT05799495|463345980|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
128742158|NCT05799495|463345981|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
128742159|NCT05799495|463345982|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
128742160|NCT05799495|463345979|FG000|Treatment (Up to 5 Days)|Other|0|||
128742161|NCT05799495|463345980|FG001|Treatment (Up to 5 Days)|Other|1|||
128742162|NCT05799495|463345981|FG002|Treatment (Up to 5 Days)|Other|0|||
128742163|NCT05799495|463345982|FG003|Treatment (Up to 5 Days)|Other|0|||
128742164|NCT05799495|463345979|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
128742165|NCT05799495|463345980|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
128742166|NCT05799495|463345981|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
128742167|NCT05799495|463345982|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
128742168|NCT05799495|463345979|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
128742169|NCT05799495|463345980|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
128742170|NCT05799495|463345981|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
128742171|NCT05799495|463345982|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
128742172|NCT05799495|463345979|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128742173|NCT05799495|463345980|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128742174|NCT05799495|463345981|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
128742175|NCT05799495|463345982|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
128785278|NCT01670019|463505989|FG001|Overall Study|Adverse Event|0|||
128785279|NCT01670019|463505988|FG000|Overall Study|Withdrawal by Subject|6|||
128785280|NCT01670019|463505989|FG001|Overall Study|Withdrawal by Subject|0|||
128785281|NCT00580801|463505990|FG000|Overall Study|Physician Decision|1|||
128785282|NCT00580801|463505991|FG001|Overall Study|Physician Decision|0|||
128785283|NCT00580801|463505992|FG002|Overall Study|Physician Decision|0|||
128785284|NCT00580801|463505990|FG000|Overall Study|Adverse Event|2|||
128785285|NCT00580801|463505991|FG001|Overall Study|Adverse Event|0|||
128785286|NCT00580801|463505992|FG002|Overall Study|Adverse Event|0|||
128785287|NCT00580801|463505990|FG000|Overall Study|Lost to Follow-up|2|||
128785288|NCT00580801|463505991|FG001|Overall Study|Lost to Follow-up|0|||
128785289|NCT00580801|463505992|FG002|Overall Study|Lost to Follow-up|0|||
128785290|NCT00580801|463505990|FG000|Overall Study|Reached a virologic endpoint|0|||
128785291|NCT00580801|463505991|FG001|Overall Study|Reached a virologic endpoint|1|||
128785292|NCT00580801|463505992|FG002|Overall Study|Reached a virologic endpoint|2|||
128785293|NCT00580801|463505990|FG000|Overall Study|Participant non-compliant|0|||
128742176|NCT03105362|463345983|FG000|Overall Study|Withdrawal by Subject|1|||
128742177|NCT03105362|463345983|FG000|Overall Study|Lost to Follow-up|1|||
128742178|NCT01198600|463345984|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
128742179|NCT01198600|463345985|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
128742180|NCT01198600|463345986|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
128742181|NCT01198600|463345987|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
128742182|NCT01198600|463345984|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
128742183|NCT01198600|463345985|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
128742184|NCT01198600|463345986|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
128742185|NCT01198600|463345987|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
128742186|NCT01198600|463345984|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
128742187|NCT01198600|463345985|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
128742188|NCT01198600|463345986|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
128742189|NCT01198600|463345987|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
128742190|NCT01198600|463345984|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
128742191|NCT01198600|463345985|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
128742192|NCT01198600|463345986|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
128742193|NCT01198600|463345987|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
128742194|NCT01198600|463345984|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
128742195|NCT01198600|463345985|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
128742196|NCT01198600|463345986|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
128742197|NCT01198600|463345987|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
128742198|NCT01198600|463345984|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
128742199|NCT01198600|463345985|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
128742200|NCT01198600|463345986|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
128742201|NCT01198600|463345987|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
128742202|NCT01198600|463345984|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
128742203|NCT01198600|463345985|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
128742204|NCT01198600|463345986|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
128742205|NCT01198600|463345987|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
128742206|NCT03694548|463345988|FG000|Part A Survey|Protocol Violation|3|||
128742207|NCT03694548|463345989|FG001|Part A Survey|Protocol Violation|3|||
128742208|NCT03694548|463345990|FG002|Part A Survey|Protocol Violation|0|||
128742209|NCT03694548|463345988|FG000|Part B Yoga Program|Protocol Violation|0|||
128742210|NCT03694548|463345989|FG001|Part B Yoga Program|Protocol Violation|0|||
128742211|NCT03694548|463345990|FG002|Part B Yoga Program|Protocol Violation|3|||
128742212|NCT03694548|463345988|FG000|Part B Yoga Program|Did not attend intervention|0|||
128742213|NCT03694548|463345989|FG001|Part B Yoga Program|Did not attend intervention|0|||
128742214|NCT03694548|463345990|FG002|Part B Yoga Program|Did not attend intervention|8|||
128742215|NCT04177108|463345991|FG000|Overall Study|Withdrawal by Subject|4|||
128742216|NCT04177108|463345992|FG001|Overall Study|Withdrawal by Subject|8|||
128785294|NCT00580801|463505991|FG001|Overall Study|Participant non-compliant|0|||
128785295|NCT00580801|463505992|FG002|Overall Study|Participant non-compliant|1|||
128785296|NCT00580801|463505990|FG000|Overall Study|Travel|1|||
128785297|NCT00580801|463505991|FG001|Overall Study|Travel|0|||
128742217|NCT04177108|463345993|FG002|Overall Study|Withdrawal by Subject|9|||
128742218|NCT04177108|463345994|FG003|Overall Study|Withdrawal by Subject|11|||
128742219|NCT04177108|463345995|FG004|Overall Study|Withdrawal by Subject|13|||
128742220|NCT04177108|463345991|FG000|Overall Study|Physician Decision|23|||
128742221|NCT04177108|463345992|FG001|Overall Study|Physician Decision|15|||
128742222|NCT04177108|463345993|FG002|Overall Study|Physician Decision|18|||
128785298|NCT00580801|463505992|FG002|Overall Study|Travel|0|||
128785299|NCT00502593|463505993|FG000|Overall Study|Withdrawn unspecified reason|1|||
128785300|NCT00502593|463505994|FG001|Overall Study|Withdrawn unspecified reason|1|||
128785301|NCT00502593|463505995|FG002|Overall Study|Withdrawn unspecified reason|3|||
128785302|NCT00502593|463505996|FG003|Overall Study|Withdrawn unspecified reason|1|||
128742223|NCT04177108|463345994|FG003|Overall Study|Physician Decision|29|||
128742224|NCT04177108|463345995|FG004|Overall Study|Physician Decision|23|||
128742225|NCT04177108|463345991|FG000|Overall Study|Reason Not Specified|0|||
128742226|NCT04177108|463345992|FG001|Overall Study|Reason Not Specified|1|||
128742227|NCT04177108|463345993|FG002|Overall Study|Reason Not Specified|0|||
128742228|NCT04177108|463345994|FG003|Overall Study|Reason Not Specified|0|||
128742229|NCT04177108|463345995|FG004|Overall Study|Reason Not Specified|2|||
128742230|NCT04177108|463345991|FG000|Overall Study|Lost to Follow-up|0|||
128742231|NCT04177108|463345992|FG001|Overall Study|Lost to Follow-up|0|||
128742232|NCT04177108|463345993|FG002|Overall Study|Lost to Follow-up|1|||
128742233|NCT04177108|463345994|FG003|Overall Study|Lost to Follow-up|1|||
128742234|NCT04177108|463345995|FG004|Overall Study|Lost to Follow-up|1|||
128742235|NCT04177108|463345991|FG000|Overall Study|Death|16|||
128742236|NCT04177108|463345992|FG001|Overall Study|Death|19|||
128742237|NCT04177108|463345993|FG002|Overall Study|Death|13|||
128742238|NCT04177108|463345994|FG003|Overall Study|Death|17|||
128742239|NCT04177108|463345995|FG004|Overall Study|Death|18|||
128742240|NCT04496258|463345999|FG000|Overall Study|Withdrawal by Subject|2|||
128742241|NCT04496258|463346000|FG001|Overall Study|Withdrawal by Subject|1|||
128742242|NCT01669343|463346002|FG000|Part A: All Patients|Withdrawal by Subject|7|||
128742243|NCT01669343|463346002|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
128742244|NCT01669343|463346002|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
128742245|NCT01669343|463346002|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
128742246|NCT01669343|463346002|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
128742247|NCT04433767|463346004|FG000|Overall Study|Adverse Event|1|||
128742248|NCT00439777|463346005|FG000|Treatment Period|Death|29|||
128742249|NCT00439777|463346006|FG001|Treatment Period|Death|21|||
128742250|NCT00439777|463346005|FG000|Treatment Period|Study terminated by sponsor|125|||
128742251|NCT00439777|463346006|FG001|Treatment Period|Study terminated by sponsor|132|||
128742252|NCT00439777|463346005|FG000|Treatment Period|Site closed by investigator|0|||
128742253|NCT00439777|463346006|FG001|Treatment Period|Site closed by investigator|1|||
128742254|NCT00439777|463346005|FG000|Treatment Period|Did not take study treatment|7|||
128742255|NCT00439777|463346006|FG001|Treatment Period|Did not take study treatment|8|||
128742256|NCT00439777|463346005|FG000|Treatment Period|Adverse Event|111|||
128742257|NCT00439777|463346006|FG001|Treatment Period|Adverse Event|92|||
128742258|NCT00439777|463346005|FG000|Treatment Period|Protocol Violation|23|||
128742259|NCT00439777|463346006|FG001|Treatment Period|Protocol Violation|30|||
128742260|NCT00439777|463346005|FG000|Treatment Period|Withdrawal by Subject|66|||
128742261|NCT00439777|463346006|FG001|Treatment Period|Withdrawal by Subject|118|||
128742262|NCT00439777|463346005|FG000|Treatment Period|Lack of Efficacy|1|||
128742263|NCT00439777|463346006|FG001|Treatment Period|Lack of Efficacy|4|||
128742264|NCT00439777|463346005|FG000|Treatment Period|Lost to Follow-up|8|||
128742265|NCT00439777|463346006|FG001|Treatment Period|Lost to Follow-up|10|||
128742266|NCT00439777|463346005|FG000|Treatment Period|Protocol driven decision point|1|||
128742267|NCT00439777|463346006|FG001|Treatment Period|Protocol driven decision point|3|||
128742268|NCT00439777|463346005|FG000|Treatment Period|Physician Decision|7|||
128742269|NCT00439777|463346006|FG001|Treatment Period|Physician Decision|18|||
128742270|NCT00439777|463346005|FG000|Treatment Period|Clinical endpoint reached|26|||
128742271|NCT00439777|463346006|FG001|Treatment Period|Clinical endpoint reached|13|||
128742272|NCT00439777|463346005|FG000|Treatment Period|Technical problems|3|||
128742273|NCT00439777|463346006|FG001|Treatment Period|Technical problems|1|||
128742274|NCT00439777|463346005|FG000|Treatment Period|Participant convenience|12|||
128742275|NCT00439777|463346006|FG001|Treatment Period|Participant convenience|8|||
128742276|NCT00439777|463346005|FG000|Observational Period|Protocol Violation|0|||
128742277|NCT00439777|463346006|FG001|Observational Period|Protocol Violation|2|||
128742278|NCT00439777|463346005|FG000|Observational Period|Withdrawal by Subject|9|||
128742279|NCT00439777|463346006|FG001|Observational Period|Withdrawal by Subject|5|||
128742280|NCT00439777|463346005|FG000|Observational Period|Lost to Follow-up|1|||
128742281|NCT00439777|463346006|FG001|Observational Period|Lost to Follow-up|11|||
128742282|NCT00439777|463346005|FG000|Observational Period|Death|27|||
128742283|NCT00439777|463346006|FG001|Observational Period|Death|20|||
128742284|NCT00439777|463346005|FG000|Observational Period|Study terminated by sponsor|3|||
128742285|NCT00439777|463346006|FG001|Observational Period|Study terminated by sponsor|1|||
128742286|NCT00439777|463346005|FG000|Observational Period|Protocol driven decision point|0|||
128742287|NCT00439777|463346006|FG001|Observational Period|Protocol driven decision point|1|||
128742288|NCT00439777|463346005|FG000|Observational Period|Lack of Efficacy|1|||
128742289|NCT00439777|463346006|FG001|Observational Period|Lack of Efficacy|0|||
128742290|NCT00439777|463346005|FG000|Observational Period|Technical problems|0|||
128742291|NCT00439777|463346006|FG001|Observational Period|Technical problems|1|||
128742292|NCT03864900|463346007|FG000|Overall Study|Withdrawal by Subject|1|||
128742293|NCT03864900|463346008|FG001|Overall Study|Withdrawal by Subject|1|||
128742294|NCT03864900|463346007|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
128742295|NCT03864900|463346008|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
128742296|NCT00759109|463346010|FG000|Overall Study|Adverse Event|17|||
128785303|NCT00502593|463505997|FG004|Overall Study|Withdrawn unspecified reason|2|||
128785304|NCT00502593|463505998|FG005|Overall Study|Withdrawn unspecified reason|0|||
128785305|NCT00502593|463505999|FG006|Overall Study|Withdrawn unspecified reason|2|||
128785306|NCT00502593|463506000|FG007|Overall Study|Withdrawn unspecified reason|0|||
128785307|NCT00502593|463506001|FG008|Overall Study|Withdrawn unspecified reason|0|||
128785308|NCT00502593|463506002|FG009|Overall Study|Withdrawn unspecified reason|0|||
128785309|NCT00502593|463506003|FG010|Overall Study|Withdrawn unspecified reason|0|||
128785310|NCT00502593|463506004|FG011|Overall Study|Withdrawn unspecified reason|0|||
128785311|NCT00502593|463505993|FG000|Overall Study|Withdrawal by Subject|0|||
128785312|NCT00502593|463505994|FG001|Overall Study|Withdrawal by Subject|0|||
128785313|NCT00502593|463505995|FG002|Overall Study|Withdrawal by Subject|6|||
128785314|NCT00502593|463505996|FG003|Overall Study|Withdrawal by Subject|2|||
128785315|NCT00502593|463505997|FG004|Overall Study|Withdrawal by Subject|2|||
128785316|NCT00502593|463505998|FG005|Overall Study|Withdrawal by Subject|0|||
128785317|NCT00502593|463505999|FG006|Overall Study|Withdrawal by Subject|3|||
128785318|NCT00502593|463506000|FG007|Overall Study|Withdrawal by Subject|0|||
128785319|NCT00502593|463506001|FG008|Overall Study|Withdrawal by Subject|3|||
128785320|NCT00502593|463506002|FG009|Overall Study|Withdrawal by Subject|0|||
128785321|NCT00502593|463506003|FG010|Overall Study|Withdrawal by Subject|1|||
128785322|NCT00502593|463506004|FG011|Overall Study|Withdrawal by Subject|0|||
128785323|NCT00502593|463505993|FG000|Overall Study|Lost to Follow-up|2|||
128785324|NCT00502593|463505994|FG001|Overall Study|Lost to Follow-up|1|||
128785325|NCT00502593|463505995|FG002|Overall Study|Lost to Follow-up|1|||
128785326|NCT00502593|463505996|FG003|Overall Study|Lost to Follow-up|1|||
128785327|NCT00502593|463505997|FG004|Overall Study|Lost to Follow-up|0|||
128785328|NCT00502593|463505998|FG005|Overall Study|Lost to Follow-up|0|||
128785329|NCT00502593|463505999|FG006|Overall Study|Lost to Follow-up|0|||
128785330|NCT00502593|463506000|FG007|Overall Study|Lost to Follow-up|0|||
128785331|NCT00502593|463506001|FG008|Overall Study|Lost to Follow-up|3|||
128785332|NCT00502593|463506002|FG009|Overall Study|Lost to Follow-up|0|||
128785333|NCT00502593|463506003|FG010|Overall Study|Lost to Follow-up|1|||
128785334|NCT00502593|463506004|FG011|Overall Study|Lost to Follow-up|0|||
128785335|NCT01664104|463506005|FG000|Overall Study|Adverse Event|6|||
128785336|NCT01664104|463506005|FG000|Overall Study|Lack of Efficacy|2|||
128785337|NCT01664104|463506005|FG000|Overall Study|Withdrawal by Subject|1|||
128785338|NCT01664104|463506005|FG000|Overall Study|Lost to Follow-up|4|||
128785339|NCT01664104|463506005|FG000|Overall Study|Other|1|||
128785340|NCT01664104|463506005|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
128785341|NCT00746330|463506007|FG000|Period 1|Abnormal test procedure result|0|||
128785342|NCT00746330|463506008|FG001|Period 1|Abnormal test procedure result|0|||
128785343|NCT00746330|463506009|FG002|Period 1|Abnormal test procedure result|1|||
128785344|NCT00746330|463506010|FG003|Period 1|Abnormal test procedure result|0|||
128785345|NCT01981850|463506011|FG000|Main Phase Stage 1|Death|2|||
128785346|NCT01981850|463506012|FG001|Main Phase Stage 1|Death|0|||
128785347|NCT01981850|463506013|FG002|Main Phase Stage 1|Death|0|||
128785348|NCT01981850|463506014|FG003|Main Phase Stage 1|Death|0|||
128785349|NCT01981850|463506015|FG004|Main Phase Stage 1|Death|0|||
128785350|NCT01981850|463506016|FG005|Main Phase Stage 1|Death|0|||
128785351|NCT01981850|463506017|FG006|Main Phase Stage 1|Death|0|||
128785352|NCT01981850|463506018|FG007|Main Phase Stage 1|Death|0|||
128785353|NCT01981850|463506019|FG008|Main Phase Stage 1|Death|0|||
128785354|NCT01981850|463506020|FG009|Main Phase Stage 1|Death|0|||
128785355|NCT01981850|463506011|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
128785356|NCT01981850|463506012|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128742297|NCT00759109|463346011|FG001|Overall Study|Adverse Event|12|||
128742298|NCT00759109|463346010|FG000|Overall Study|Inability to comply|1|||
128742299|NCT00759109|463346011|FG001|Overall Study|Inability to comply|1|||
128742300|NCT00759109|463346010|FG000|Overall Study|Withdrawal by Subject|9|||
128742301|NCT00759109|463346011|FG001|Overall Study|Withdrawal by Subject|5|||
128742302|NCT00759109|463346010|FG000|Overall Study|Death|4|||
128742303|NCT00759109|463346011|FG001|Overall Study|Death|3|||
128742304|NCT00759109|463346010|FG000|Overall Study|Lost to Follow-up|4|||
128742305|NCT00759109|463346011|FG001|Overall Study|Lost to Follow-up|6|||
128742306|NCT00759109|463346010|FG000|Overall Study|Started new therapy|2|||
128742307|NCT00759109|463346011|FG001|Overall Study|Started new therapy|6|||
128742308|NCT00759109|463346010|FG000|Overall Study|HCV RNA negative|1|||
128742309|NCT00759109|463346011|FG001|Overall Study|HCV RNA negative|0|||
128742310|NCT00759109|463346010|FG000|Overall Study|Participant moved to a different city|0|||
128742311|NCT00759109|463346011|FG001|Overall Study|Participant moved to a different city|1|||
128742312|NCT00759109|463346010|FG000|Overall Study|Participant had a liver transplant|0|||
128742313|NCT00759109|463346011|FG001|Overall Study|Participant had a liver transplant|1|||
128742314|NCT00759109|463346010|FG000|Overall Study|Lost during study|1|||
128742315|NCT00759109|463346011|FG001|Overall Study|Lost during study|0|||
128742316|NCT03165045|463346012|FG000|Visit 1|No registration after visit 1|9|||
128742317|NCT03165045|463346012|FG000|Visit 1|No treatment documented|10|||
128742318|NCT03165045|463346012|FG000|Visit 1|No visit 1|10|||
128742319|NCT03165045|463346012|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
128742320|NCT03165045|463346012|FG000|Visit 2|No available total CCQ score at all|29|||
128742321|NCT03165045|463346012|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
128742322|NCT03238001|463346013|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
128742323|NCT03238001|463346013|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
128742324|NCT03238001|463346013|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
128742325|NCT03238001|463346013|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
128742326|NCT03238001|463346013|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
128742327|NCT03238001|463346013|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
128742328|NCT03238001|463346013|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
128742329|NCT03238001|463346013|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
128742330|NCT01827904|463346014|FG000|Main Study|Withdrawal by Subject|1|||
128742331|NCT01827904|463346015|FG001|Main Study|Withdrawal by Subject|0|||
128742332|NCT01827904|463346016|FG002|Main Study|Withdrawal by Subject|0|||
128742333|NCT01827904|463346014|FG000|Main Study|Adverse Event|1|||
128742334|NCT01827904|463346015|FG001|Main Study|Adverse Event|0|||
128742335|NCT01827904|463346016|FG002|Main Study|Adverse Event|0|||
128742336|NCT01827904|463346014|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
128742337|NCT01827904|463346015|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
128742338|NCT01827904|463346016|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
128742339|NCT01827904|463346014|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
128742340|NCT01827904|463346015|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
128742341|NCT01827904|463346016|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
128742342|NCT01827904|463346014|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
128742343|NCT01827904|463346015|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
128742344|NCT01827904|463346016|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
128742345|NCT01827904|463346014|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
128742346|NCT01827904|463346015|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
128742347|NCT01827904|463346016|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
128742348|NCT01827904|463346014|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
128742349|NCT01827904|463346015|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
128742350|NCT01827904|463346016|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
128742351|NCT01827904|463346014|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
128785357|NCT01981850|463506013|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785358|NCT01981850|463506014|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785359|NCT01981850|463506015|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785360|NCT01981850|463506016|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785361|NCT01981850|463506017|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785362|NCT01981850|463506018|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785363|NCT01981850|463506019|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785364|NCT01981850|463506020|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
128785365|NCT01981850|463506011|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
128785366|NCT01981850|463506012|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
128785367|NCT01981850|463506013|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
128785368|NCT01981850|463506014|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
128785369|NCT01981850|463506015|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
128785370|NCT01981850|463506016|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
128785371|NCT01981850|463506017|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
128785372|NCT01981850|463506018|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
128785373|NCT01981850|463506019|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
128785374|NCT01981850|463506020|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
128785375|NCT01981850|463506011|FG000|Main Phase Stage 1|Various reasons|0|||
128785376|NCT01981850|463506012|FG001|Main Phase Stage 1|Various reasons|0|||
128785377|NCT01981850|463506013|FG002|Main Phase Stage 1|Various reasons|2|||
128742352|NCT01827904|463346015|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
128742353|NCT01827904|463346016|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
128742354|NCT01827904|463346014|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
128742355|NCT01827904|463346015|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
128742356|NCT01827904|463346016|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
128742357|NCT01827904|463346014|FG000|Long-term Annual Follow-up|Physician Decision|1|||
128742358|NCT01827904|463346015|FG001|Long-term Annual Follow-up|Physician Decision|0|||
128742359|NCT01827904|463346016|FG002|Long-term Annual Follow-up|Physician Decision|0|||
128742360|NCT01827904|463346014|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
128742361|NCT01827904|463346015|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
128742362|NCT01827904|463346016|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
128742363|NCT01827904|463346014|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
128742364|NCT01827904|463346015|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
128742365|NCT01827904|463346016|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
128742366|NCT01866709|463346020|FG000|Overall Study|Adverse Event|1|||
128742367|NCT01866709|463346021|FG001|Overall Study|Adverse Event|0|||
128742368|NCT03791398|463346022|FG000|Overall Study|Progression of Disease Under Study|2|||
128742369|NCT03791398|463346023|FG001|Overall Study|Progression of Disease Under Study|0|||
128785378|NCT01981850|463506014|FG003|Main Phase Stage 1|Various reasons|0|||
128785379|NCT01981850|463506015|FG004|Main Phase Stage 1|Various reasons|0|||
128785380|NCT01981850|463506016|FG005|Main Phase Stage 1|Various reasons|0|||
128785381|NCT01981850|463506017|FG006|Main Phase Stage 1|Various reasons|0|||
128785382|NCT01981850|463506018|FG007|Main Phase Stage 1|Various reasons|0|||
128785383|NCT01981850|463506019|FG008|Main Phase Stage 1|Various reasons|0|||
128785384|NCT01981850|463506020|FG009|Main Phase Stage 1|Various reasons|0|||
128785385|NCT01981850|463506011|FG000|Main Phase Stage 2|Adverse Event|0|||
128742370|NCT03791398|463346024|FG002|Overall Study|Progression of Disease Under Study|0|||
128742371|NCT02207829|463346025|FG000|Overall Study|Adverse Event|10|||
128742372|NCT02207829|463346026|FG001|Overall Study|Adverse Event|9|||
128742373|NCT02207829|463346025|FG000|Overall Study|Lack of Efficacy|7|||
128742374|NCT02207829|463346026|FG001|Overall Study|Lack of Efficacy|5|||
128742375|NCT02207829|463346025|FG000|Overall Study|Lost to Follow-up|2|||
128742376|NCT02207829|463346026|FG001|Overall Study|Lost to Follow-up|2|||
128742377|NCT02207829|463346025|FG000|Overall Study|Protocol deviation|5|||
128742378|NCT02207829|463346026|FG001|Overall Study|Protocol deviation|4|||
128742379|NCT02207829|463346025|FG000|Overall Study|Withdrew consent|18|||
128742380|NCT02207829|463346026|FG001|Overall Study|Withdrew consent|14|||
128742381|NCT00766376|463346027|FG000|Overall Study|Withdrawal by Subject|27|||
128742382|NCT01800903|463346028|FG000|Second Test Period|unable to catheterise|1|||
128742383|NCT01800903|463346029|FG001|Second Test Period|unable to catheterise|0|||
128742384|NCT01800903|463346030|FG002|Second Test Period|unable to catheterise|0|||
128742385|NCT01800903|463346031|FG003|Second Test Period|unable to catheterise|0|||
128742386|NCT01800903|463346032|FG004|Second Test Period|unable to catheterise|0|||
128742387|NCT01800903|463346033|FG005|Second Test Period|unable to catheterise|0|||
128742388|NCT03191903|463346034|FG000|Overall Study|Withdrawal by Subject|6|||
128742389|NCT03191903|463346035|FG001|Overall Study|Withdrawal by Subject|5|||
128742390|NCT03191903|463346036|FG002|Overall Study|Withdrawal by Subject|4|||
128742391|NCT03191903|463346034|FG000|Overall Study|Adverse Event|1|||
128742392|NCT03191903|463346035|FG001|Overall Study|Adverse Event|0|||
128742393|NCT03191903|463346036|FG002|Overall Study|Adverse Event|0|||
128742394|NCT04369469|463346037|FG000|Overall Study|Lost to Follow-up|2|||
128742395|NCT04369469|463346038|FG001|Overall Study|Lost to Follow-up|4|||
128742396|NCT04369469|463346037|FG000|Overall Study|Physician Decision|2|||
128785386|NCT01981850|463506012|FG001|Main Phase Stage 2|Adverse Event|0|||
128785387|NCT01981850|463506013|FG002|Main Phase Stage 2|Adverse Event|0|||
128785388|NCT01981850|463506014|FG003|Main Phase Stage 2|Adverse Event|0|||
128785389|NCT01981850|463506015|FG004|Main Phase Stage 2|Adverse Event|6|||
128785390|NCT01981850|463506016|FG005|Main Phase Stage 2|Adverse Event|5|||
128785391|NCT01981850|463506017|FG006|Main Phase Stage 2|Adverse Event|7|||
128785392|NCT01981850|463506018|FG007|Main Phase Stage 2|Adverse Event|0|||
128785393|NCT01981850|463506019|FG008|Main Phase Stage 2|Adverse Event|0|||
128785394|NCT01981850|463506020|FG009|Main Phase Stage 2|Adverse Event|0|||
128785395|NCT01981850|463506011|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
128785396|NCT01981850|463506012|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
128785397|NCT01981850|463506013|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
128785398|NCT01981850|463506014|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
128785399|NCT01981850|463506015|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
128785400|NCT01981850|463506016|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
128785401|NCT01981850|463506017|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
128785402|NCT01981850|463506018|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
128785403|NCT01981850|463506019|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
128785404|NCT01981850|463506020|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
128785405|NCT01981850|463506011|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
128785406|NCT01981850|463506012|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
128785407|NCT01981850|463506013|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
128785408|NCT01981850|463506014|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
128785409|NCT01981850|463506015|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
128785410|NCT01981850|463506016|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
128785411|NCT01981850|463506017|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
128785412|NCT01981850|463506018|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
128785413|NCT01981850|463506019|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
128785414|NCT01981850|463506020|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
128785415|NCT01981850|463506011|FG000|Main Phase Stage 2|Various reasons|0|||
128785416|NCT01981850|463506012|FG001|Main Phase Stage 2|Various reasons|0|||
128785417|NCT01981850|463506013|FG002|Main Phase Stage 2|Various reasons|0|||
128785418|NCT01981850|463506014|FG003|Main Phase Stage 2|Various reasons|0|||
128785419|NCT01981850|463506015|FG004|Main Phase Stage 2|Various reasons|2|||
128785420|NCT01981850|463506016|FG005|Main Phase Stage 2|Various reasons|0|||
128785421|NCT01981850|463506017|FG006|Main Phase Stage 2|Various reasons|1|||
128742397|NCT04369469|463346038|FG001|Overall Study|Physician Decision|1|||
128785422|NCT01981850|463506018|FG007|Main Phase Stage 2|Various reasons|0|||
128785423|NCT01981850|463506019|FG008|Main Phase Stage 2|Various reasons|0|||
128742398|NCT04369469|463346037|FG000|Overall Study|Withdrawal by Subject|2|||
128742399|NCT04369469|463346038|FG001|Overall Study|Withdrawal by Subject|3|||
128742400|NCT04369469|463346037|FG000|Overall Study|Adverse Event|1|||
128785424|NCT01981850|463506020|FG009|Main Phase Stage 2|Various reasons|0|||
128742401|NCT04369469|463346038|FG001|Overall Study|Adverse Event|0|||
128742402|NCT04369469|463346037|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
128742403|NCT04369469|463346038|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
128742404|NCT04369469|463346037|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
128785425|NCT01981850|463506011|FG000|Main Phase Stage 2|Progressive Disease|0|||
128785426|NCT01981850|463506012|FG001|Main Phase Stage 2|Progressive Disease|0|||
128742405|NCT04369469|463346038|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
128742406|NCT04369469|463346037|FG000|Overall Study|Unable to Provide Consent|0|||
128742407|NCT04369469|463346038|FG001|Overall Study|Unable to Provide Consent|1|||
128742408|NCT03099382|463346041|FG000|Overall Study|Protocol Violation|2|||
128742409|NCT03099382|463346042|FG001|Overall Study|Protocol Violation|3|||
128742410|NCT01802411|463346043|FG000|Overall Study|Death|2|||
128742411|NCT01802411|463346044|FG001|Overall Study|Death|1|||
128742412|NCT01802411|463346043|FG000|Overall Study|Adverse Event|2|||
128742413|NCT01802411|463346044|FG001|Overall Study|Adverse Event|7|||
128742414|NCT01802411|463346043|FG000|Overall Study|Lack of Efficacy|8|||
128742415|NCT01802411|463346044|FG001|Overall Study|Lack of Efficacy|10|||
128742416|NCT01802411|463346043|FG000|Overall Study|Withdrawal by Subject|0|||
128742417|NCT01802411|463346044|FG001|Overall Study|Withdrawal by Subject|2|||
128742418|NCT01802411|463346043|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
128742419|NCT01802411|463346044|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
128742420|NCT01802411|463346043|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
128742421|NCT01802411|463346044|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
128742422|NCT01802411|463346043|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
128742423|NCT01802411|463346044|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
128742424|NCT03864614|463346051|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
128742425|NCT03864614|463346052|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
128742426|NCT03864614|463346053|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
128742427|NCT03864614|463346054|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
128742428|NCT03864614|463346051|FG000|Overall Study|Withdrawal by Subject|72|||
128742429|NCT03864614|463346052|FG001|Overall Study|Withdrawal by Subject|100|||
128742430|NCT03864614|463346053|FG002|Overall Study|Withdrawal by Subject|1|||
128742431|NCT03864614|463346054|FG003|Overall Study|Withdrawal by Subject|21|||
128742432|NCT03864614|463346051|FG000|Overall Study|Lost to Follow-up|45|||
128742433|NCT03864614|463346052|FG001|Overall Study|Lost to Follow-up|54|||
128742434|NCT03864614|463346053|FG002|Overall Study|Lost to Follow-up|0|||
128742435|NCT03864614|463346054|FG003|Overall Study|Lost to Follow-up|9|||
128742436|NCT03864614|463346051|FG000|Overall Study|Adverse Event|42|||
128742437|NCT03864614|463346052|FG001|Overall Study|Adverse Event|30|||
128742438|NCT03864614|463346053|FG002|Overall Study|Adverse Event|1|||
128742439|NCT03864614|463346054|FG003|Overall Study|Adverse Event|9|||
128742440|NCT03864614|463346051|FG000|Overall Study|Protocol Deviation|6|||
128742441|NCT03864614|463346052|FG001|Overall Study|Protocol Deviation|26|||
128742442|NCT03864614|463346053|FG002|Overall Study|Protocol Deviation|0|||
128742443|NCT03864614|463346054|FG003|Overall Study|Protocol Deviation|1|||
128742444|NCT03864614|463346051|FG000|Overall Study|Physician Decision|7|||
128742445|NCT03864614|463346052|FG001|Overall Study|Physician Decision|10|||
128742446|NCT03864614|463346053|FG002|Overall Study|Physician Decision|1|||
128742447|NCT03864614|463346054|FG003|Overall Study|Physician Decision|5|||
128742448|NCT03864614|463346051|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
128742449|NCT03864614|463346052|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
128742450|NCT03864614|463346053|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
128742451|NCT03864614|463346054|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
128742452|NCT03864614|463346051|FG000|Overall Study|Sponsor Decision|1|||
128742453|NCT03864614|463346052|FG001|Overall Study|Sponsor Decision|2|||
128742454|NCT03864614|463346053|FG002|Overall Study|Sponsor Decision|0|||
128742455|NCT03864614|463346054|FG003|Overall Study|Sponsor Decision|0|||
128742456|NCT03864614|463346051|FG000|Overall Study|Pregnancy|0|||
128742457|NCT03864614|463346052|FG001|Overall Study|Pregnancy|1|||
128742458|NCT03864614|463346053|FG002|Overall Study|Pregnancy|0|||
128742459|NCT03864614|463346054|FG003|Overall Study|Pregnancy|0|||
128742460|NCT03864614|463346051|FG000|Overall Study|Other|7|||
128742461|NCT03864614|463346052|FG001|Overall Study|Other|9|||
128742462|NCT03864614|463346053|FG002|Overall Study|Other|1|||
128742463|NCT03864614|463346054|FG003|Overall Study|Other|4|||
128742464|NCT03864614|463346051|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
128742465|NCT03864614|463346052|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
128742466|NCT03864614|463346053|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
128742467|NCT03864614|463346054|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
128742468|NCT01850004|463346055|FG000|Overall Study|Poor/Non-compliance|1|||
128742469|NCT01850004|463346055|FG000|Overall Study|Participant Withdrew Consent|9|||
128742470|NCT01850004|463346055|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
128742471|NCT01850004|463346055|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
128742472|NCT01850004|463346055|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
128742473|NCT01850004|463346055|FG000|Overall Study|Other Reasons|2|||
128742474|NCT01850004|463346055|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
128742475|NCT01850004|463346055|FG000|Overall Study|Maximum Clinical Benefit|4|||
128742476|NCT01404312|463348061|FG000|Overall Study|Death|21|||
128742477|NCT01404312|463348062|FG001|Overall Study|Death|27|||
128742478|NCT01404312|463348061|FG000|Overall Study|Withdrawal by Subject|15|||
128742479|NCT01404312|463348062|FG001|Overall Study|Withdrawal by Subject|18|||
128742480|NCT01404312|463348061|FG000|Overall Study|Participant Unable to get to clinic|93|||
128742481|NCT01404312|463348062|FG001|Overall Study|Participant Unable to get to clinic|103|||
128742482|NCT01404312|463348061|FG000|Overall Study|Lost to Follow-up|115|||
128742483|NCT01404312|463348062|FG001|Overall Study|Lost to Follow-up|111|||
128742484|NCT01404312|463348061|FG000|Overall Study|Site closed|22|||
128742485|NCT01404312|463348062|FG001|Overall Study|Site closed|21|||
128742486|NCT01404312|463348061|FG000|Overall Study|Participant not willing to adhere to req|31|||
128742487|NCT01404312|463348062|FG001|Overall Study|Participant not willing to adhere to req|29|||
128742488|NCT01404312|463348061|FG000|Overall Study|Severe debilitation, unable to continue|1|||
128742489|NCT01404312|463348062|FG001|Overall Study|Severe debilitation, unable to continue|2|||
128742490|NCT00524134|463348063|FG000|Overall Study|Withdrawal by Subject|1|||
128742491|NCT00524134|463348063|FG000|Overall Study|Physician Decision|1|||
128742492|NCT01045447|463348074|FG000|Overall Study|Adverse Event|0|||
128742493|NCT01045447|463348075|FG001|Overall Study|Adverse Event|1|||
128742494|NCT01045447|463348074|FG000|Overall Study|Lack of Efficacy|3|||
128742495|NCT01045447|463348075|FG001|Overall Study|Lack of Efficacy|1|||
128742496|NCT01045447|463348074|FG000|Overall Study|Protocol Violation|6|||
128742497|NCT01045447|463348075|FG001|Overall Study|Protocol Violation|3|||
128742498|NCT01045447|463348074|FG000|Overall Study|Withdrawal Criteria|10|||
128742499|NCT01045447|463348075|FG001|Overall Study|Withdrawal Criteria|10|||
128742500|NCT01045447|463348074|FG000|Overall Study|Unclassified|17|||
128742501|NCT01045447|463348075|FG001|Overall Study|Unclassified|13|||
128742502|NCT00116805|463348077|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
128742503|NCT00116805|463348078|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
128742504|NCT00116805|463348077|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
128742505|NCT00116805|463348078|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
128742506|NCT00116805|463348077|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
128742507|NCT00116805|463348078|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
128742508|NCT00116805|463348077|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
128742509|NCT00116805|463348078|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
128742510|NCT00116805|463348077|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
128742511|NCT00116805|463348078|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
128742512|NCT00116805|463348077|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
128742513|NCT00116805|463348078|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
128742514|NCT00116805|463348077|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
128742515|NCT00116805|463348078|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
128742516|NCT00116805|463348077|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
128742517|NCT00116805|463348078|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
128742518|NCT00116805|463348077|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
128742519|NCT00116805|463348078|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
128742520|NCT00116805|463348077|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
128742521|NCT00116805|463348078|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
128742522|NCT00116805|463348077|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
128742523|NCT00116805|463348078|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
128742524|NCT00116805|463348077|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
128742525|NCT00116805|463348078|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
128742526|NCT00116805|463348077|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
128742527|NCT00116805|463348078|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
128742528|NCT00116805|463348077|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
128742529|NCT00116805|463348078|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
128742530|NCT00116805|463348077|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
128742531|NCT00116805|463348078|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
128742532|NCT00116805|463348077|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
128742533|NCT00116805|463348078|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
128742534|NCT00116805|463348077|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
128742535|NCT00116805|463348078|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
128742536|NCT00116805|463348077|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
128742537|NCT00116805|463348078|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
128742538|NCT00116805|463348077|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
128742539|NCT00116805|463348078|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
128742540|NCT00116805|463348077|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
128742541|NCT00116805|463348078|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
128742542|NCT00116805|463348077|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
128742543|NCT00116805|463348078|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
128742544|NCT00116805|463348077|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
128742545|NCT00116805|463348078|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
128742546|NCT00116805|463348077|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
128742547|NCT00116805|463348078|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
128742548|NCT00116805|463348077|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
128742549|NCT00116805|463348078|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
128742550|NCT00116805|463348077|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
128742551|NCT00116805|463348078|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
128742552|NCT00116805|463348077|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
128742553|NCT00116805|463348078|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
128742554|NCT00116805|463348077|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
128742555|NCT00116805|463348078|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
128742556|NCT00116805|463348077|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
128742557|NCT00116805|463348078|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
128742558|NCT00116805|463348077|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
128742559|NCT00116805|463348078|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
128742560|NCT00116805|463348077|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
128742561|NCT00116805|463348078|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
128742562|NCT00116805|463348077|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
128742563|NCT00116805|463348078|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
128742564|NCT00116805|463348077|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
128742565|NCT00116805|463348078|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
128742566|NCT00116805|463348077|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
128742567|NCT00116805|463348078|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
128742568|NCT00116805|463348077|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
128742569|NCT00116805|463348078|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
128742570|NCT00116805|463348077|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
128742571|NCT00116805|463348078|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
128742572|NCT00116805|463348077|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
128742573|NCT00116805|463348078|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
128742574|NCT00116805|463348077|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
128742575|NCT00116805|463348078|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
128742576|NCT00116805|463348077|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
128742577|NCT00116805|463348078|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
128742578|NCT00116805|463348077|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
128742579|NCT00116805|463348078|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
128742580|NCT00116805|463348077|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
128742581|NCT00116805|463348078|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
128742582|NCT00116805|463348077|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
128742583|NCT00116805|463348078|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
128742584|NCT00116805|463348077|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
128742585|NCT00116805|463348078|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
128742586|NCT00116805|463348077|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
128742587|NCT00116805|463348078|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
128742588|NCT00116805|463348077|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
128742589|NCT00116805|463348078|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
128742590|NCT00116805|463348077|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
128742591|NCT00116805|463348078|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
128742592|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
128742593|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
128742594|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
128742595|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
128742596|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Adverse Event|5|||
128742597|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Adverse Event|3|||
128742598|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Adverse Event|4|||
128742599|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Adverse Event|10|||
128742600|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
128742601|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
128742602|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
128742603|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
128742604|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
128742605|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
128742606|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
128742607|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
128742608|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Pregnancy|5|||
128742609|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Pregnancy|0|||
128742610|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Pregnancy|3|||
128742611|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Pregnancy|2|||
128742612|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Non-compliance|1|||
128742613|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Non-compliance|4|||
128742614|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Non-compliance|0|||
128742615|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Non-compliance|3|||
128785427|NCT01981850|463506013|FG002|Main Phase Stage 2|Progressive Disease|0|||
128785428|NCT01981850|463506014|FG003|Main Phase Stage 2|Progressive Disease|0|||
128785429|NCT01981850|463506015|FG004|Main Phase Stage 2|Progressive Disease|0|||
128785430|NCT01981850|463506016|FG005|Main Phase Stage 2|Progressive Disease|6|||
128785431|NCT01981850|463506017|FG006|Main Phase Stage 2|Progressive Disease|6|||
128785432|NCT01981850|463506018|FG007|Main Phase Stage 2|Progressive Disease|0|||
128785433|NCT01981850|463506019|FG008|Main Phase Stage 2|Progressive Disease|0|||
128785434|NCT01981850|463506020|FG009|Main Phase Stage 2|Progressive Disease|0|||
128785435|NCT01981850|463506011|FG000|Open Label Extension (OLE)|Adverse Event|0|||
128785436|NCT01981850|463506012|FG001|Open Label Extension (OLE)|Adverse Event|0|||
128785437|NCT01981850|463506013|FG002|Open Label Extension (OLE)|Adverse Event|0|||
128785438|NCT01981850|463506014|FG003|Open Label Extension (OLE)|Adverse Event|0|||
128785439|NCT01981850|463506015|FG004|Open Label Extension (OLE)|Adverse Event|0|||
128785440|NCT01981850|463506016|FG005|Open Label Extension (OLE)|Adverse Event|0|||
128785441|NCT01981850|463506017|FG006|Open Label Extension (OLE)|Adverse Event|0|||
128785442|NCT01981850|463506018|FG007|Open Label Extension (OLE)|Adverse Event|2|||
128785443|NCT01981850|463506019|FG008|Open Label Extension (OLE)|Adverse Event|1|||
128785444|NCT01981850|463506020|FG009|Open Label Extension (OLE)|Adverse Event|8|||
128785445|NCT01981850|463506011|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
128785446|NCT01981850|463506012|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
128785447|NCT01981850|463506013|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
128785448|NCT01981850|463506014|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
128785449|NCT01981850|463506015|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
128785450|NCT01981850|463506016|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
128742616|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Other|0|||
128742617|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Other|3|||
128742618|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Other|3|||
128742619|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Other|1|||
128742620|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
128742621|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
128742622|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
128742623|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
128742624|NCT01760954|463348079|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
128742625|NCT01760954|463348080|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
128742626|NCT01760954|463348081|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
128742627|NCT01760954|463348082|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
128742628|NCT01760954|463348079|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
128742629|NCT01760954|463348080|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
128742630|NCT01760954|463348081|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
128785451|NCT01981850|463506017|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
128742631|NCT01760954|463348082|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
128785452|NCT01981850|463506018|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
128785453|NCT01981850|463506019|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
128742632|NCT01760954|463348079|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
128742633|NCT01760954|463348080|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
128742634|NCT01760954|463348081|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
128742635|NCT01760954|463348082|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
128742636|NCT01760954|463348079|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
128742637|NCT01760954|463348080|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
128742638|NCT01760954|463348081|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
128742639|NCT01760954|463348082|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
128742640|NCT01760954|463348079|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
128742641|NCT01760954|463348080|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
128742642|NCT01760954|463348081|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
128742643|NCT01760954|463348082|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
128742644|NCT01760954|463348079|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
128742645|NCT01760954|463348080|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
128742646|NCT01760954|463348081|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
128742647|NCT01760954|463348082|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
128742648|NCT01760954|463348079|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
128742649|NCT01760954|463348080|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
128742650|NCT01760954|463348081|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
128742651|NCT01760954|463348082|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
128742652|NCT03320070|463348083|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
128742653|NCT03320070|463348084|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
128742654|NCT03320070|463348083|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
128742655|NCT03320070|463348084|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
128742656|NCT03320070|463348083|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
128742657|NCT03320070|463348084|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
128742658|NCT03320070|463348083|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
128742659|NCT03320070|463348084|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
128742660|NCT03320070|463348083|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
128742661|NCT03320070|463348084|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
128742662|NCT03320070|463348083|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
128742663|NCT03320070|463348084|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
128742664|NCT00317772|463348088|FG000|Overall Study|Adverse Event|0|||
128742665|NCT00317772|463348089|FG001|Overall Study|Adverse Event|0|||
128742666|NCT00317772|463348090|FG002|Overall Study|Adverse Event|0|||
128742667|NCT00317772|463348091|FG003|Overall Study|Adverse Event|2|||
128742668|NCT00317772|463348088|FG000|Overall Study|Disease Progression|2|||
128742669|NCT00317772|463348089|FG001|Overall Study|Disease Progression|2|||
128742670|NCT00317772|463348090|FG002|Overall Study|Disease Progression|1|||
128742671|NCT00317772|463348091|FG003|Overall Study|Disease Progression|7|||
128742672|NCT01375049|463348102|FG000|Overall Study|Adverse Event|2|||
128742673|NCT01375049|463348102|FG000|Overall Study|Lost to Follow-up|1|||
128742674|NCT01375049|463348102|FG000|Overall Study|Withdrawal by Subject|2|||
128742675|NCT01375049|463348102|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
128742676|NCT01175382|463348105|FG000|Overall Study|Lost to Follow-up|4|||
128742677|NCT01175382|463348106|FG001|Overall Study|Lost to Follow-up|3|||
128742678|NCT01175382|463348107|FG002|Overall Study|Lost to Follow-up|1|||
128742679|NCT01175382|463348105|FG000|Overall Study|Physician Decision|0|||
128742680|NCT01175382|463348106|FG001|Overall Study|Physician Decision|1|||
128742681|NCT01175382|463348107|FG002|Overall Study|Physician Decision|0|||
128742682|NCT01175382|463348105|FG000|Overall Study|Withdrawal by Subject|0|||
128742683|NCT01175382|463348106|FG001|Overall Study|Withdrawal by Subject|0|||
128742684|NCT01175382|463348107|FG002|Overall Study|Withdrawal by Subject|1|||
128742685|NCT01175382|463348105|FG000|Overall Study|No longer having problem|1|||
128742686|NCT01175382|463348106|FG001|Overall Study|No longer having problem|0|||
128742687|NCT01175382|463348107|FG002|Overall Study|No longer having problem|1|||
128742688|NCT01175382|463348105|FG000|Overall Study|Unable/unwilling to attend visits|3|||
128742689|NCT01175382|463348106|FG001|Overall Study|Unable/unwilling to attend visits|1|||
128742690|NCT01175382|463348107|FG002|Overall Study|Unable/unwilling to attend visits|2|||
128742691|NCT01175382|463348105|FG000|Overall Study|Unwilling to follow protocol|0|||
128742692|NCT01175382|463348106|FG001|Overall Study|Unwilling to follow protocol|1|||
128742693|NCT01175382|463348107|FG002|Overall Study|Unwilling to follow protocol|0|||
128742694|NCT01175382|463348105|FG000|Overall Study|Unable to tolerate study meds|0|||
128742695|NCT01175382|463348106|FG001|Overall Study|Unable to tolerate study meds|1|||
128742696|NCT01175382|463348107|FG002|Overall Study|Unable to tolerate study meds|1|||
128742697|NCT00774787|463348108|FG000|Overall Study|Lost to Follow-up|1|||
128742698|NCT02554773|463348109|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
128742699|NCT02554773|463348110|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
128742700|NCT02554773|463348109|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
128742701|NCT02554773|463348110|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
128742702|NCT02554773|463348109|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
128742703|NCT02554773|463348110|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
128742704|NCT02554773|463348109|FG000|Original Dose Regimen (SAS 1)|Death|1|||
128742705|NCT02554773|463348110|FG001|Original Dose Regimen (SAS 1)|Death|0|||
128742706|NCT02554773|463348109|FG000|Original Dose Regimen (SAS 1)|Other|4|||
128742707|NCT02554773|463348110|FG001|Original Dose Regimen (SAS 1)|Other|0|||
128742708|NCT02554773|463348109|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
128742709|NCT02554773|463348110|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
128742710|NCT02554773|463348109|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
128742711|NCT02554773|463348110|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
128742712|NCT02554773|463348109|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
128742713|NCT02554773|463348110|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
128742714|NCT02554773|463348109|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
128742715|NCT02554773|463348110|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
128742716|NCT04479618|463348111|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
128742717|NCT04479618|463348112|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
128742718|NCT04479618|463348113|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
128742719|NCT04479618|463348111|FG000|Overall Study|Lack of Efficacy|1|||
128742720|NCT04479618|463348112|FG001|Overall Study|Lack of Efficacy|0|||
128742721|NCT04479618|463348113|FG002|Overall Study|Lack of Efficacy|0|||
128742722|NCT04479618|463348111|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
128742723|NCT04479618|463348112|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
128742724|NCT04479618|463348113|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
128742725|NCT04479618|463348111|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
128742726|NCT04479618|463348112|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
128742727|NCT04479618|463348113|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
128742728|NCT04479618|463348111|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
128742729|NCT04479618|463348112|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
128742730|NCT04479618|463348113|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
128742731|NCT04479618|463348111|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
128742732|NCT04479618|463348112|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
128742733|NCT04479618|463348113|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
128742734|NCT01202773|463348114|FG000|Overall Study|Adverse Event|4|||
128742735|NCT01202773|463348115|FG001|Overall Study|Adverse Event|5|||
128742736|NCT01202773|463348116|FG002|Overall Study|Adverse Event|5|||
128742737|NCT01202773|463348114|FG000|Overall Study|Lack of Efficacy|5|||
128742738|NCT01202773|463348115|FG001|Overall Study|Lack of Efficacy|4|||
128742739|NCT01202773|463348116|FG002|Overall Study|Lack of Efficacy|9|||
128742740|NCT01202773|463348114|FG000|Overall Study|Entry Criteria Not Met|2|||
128742741|NCT01202773|463348115|FG001|Overall Study|Entry Criteria Not Met|0|||
128742742|NCT01202773|463348116|FG002|Overall Study|Entry Criteria Not Met|1|||
128742743|NCT01202773|463348114|FG000|Overall Study|Lost to Follow-up|1|||
128742744|NCT01202773|463348115|FG001|Overall Study|Lost to Follow-up|2|||
128742745|NCT01202773|463348116|FG002|Overall Study|Lost to Follow-up|2|||
128742746|NCT01202773|463348114|FG000|Overall Study|Withdrawal by Subject|13|||
128742747|NCT01202773|463348115|FG001|Overall Study|Withdrawal by Subject|6|||
128742748|NCT01202773|463348116|FG002|Overall Study|Withdrawal by Subject|5|||
128742749|NCT01202773|463348114|FG000|Overall Study|Physician Decision|2|||
128742750|NCT01202773|463348115|FG001|Overall Study|Physician Decision|0|||
128742751|NCT01202773|463348116|FG002|Overall Study|Physician Decision|0|||
128742752|NCT01202773|463348114|FG000|Overall Study|Protocol Violation|11|||
128742753|NCT01202773|463348115|FG001|Overall Study|Protocol Violation|6|||
128742754|NCT01202773|463348116|FG002|Overall Study|Protocol Violation|10|||
128742755|NCT01202773|463348114|FG000|Overall Study|Sponsor Decision|19|||
128742756|NCT01202773|463348115|FG001|Overall Study|Sponsor Decision|20|||
128742757|NCT01202773|463348116|FG002|Overall Study|Sponsor Decision|23|||
128742758|NCT03465540|463348119|FG000|Overall Study|Withdrawal by Subject|0|||
128742759|NCT03465540|463348120|FG001|Overall Study|Withdrawal by Subject|0|||
128742760|NCT03465540|463348121|FG002|Overall Study|Withdrawal by Subject|1|||
128742761|NCT03465540|463348122|FG003|Overall Study|Withdrawal by Subject|1|||
128742762|NCT03465540|463348123|FG004|Overall Study|Withdrawal by Subject|1|||
128742763|NCT03465540|463348124|FG005|Overall Study|Withdrawal by Subject|0|||
128742764|NCT03465540|463348119|FG000|Overall Study|Lost to Follow-up|0|||
128742765|NCT03465540|463348120|FG001|Overall Study|Lost to Follow-up|1|||
128742766|NCT03465540|463348121|FG002|Overall Study|Lost to Follow-up|0|||
128742767|NCT03465540|463348122|FG003|Overall Study|Lost to Follow-up|0|||
128742768|NCT03465540|463348123|FG004|Overall Study|Lost to Follow-up|1|||
128742769|NCT03465540|463348124|FG005|Overall Study|Lost to Follow-up|0|||
128742770|NCT03465540|463348119|FG000|Overall Study|Death|1|||
128742771|NCT03465540|463348120|FG001|Overall Study|Death|1|||
128742772|NCT03465540|463348121|FG002|Overall Study|Death|0|||
128742773|NCT03465540|463348122|FG003|Overall Study|Death|2|||
128742774|NCT03465540|463348123|FG004|Overall Study|Death|0|||
128742775|NCT03465540|463348124|FG005|Overall Study|Death|2|||
128742776|NCT03465540|463348119|FG000|Overall Study|Protocol specified criteria|0|||
128742777|NCT03465540|463348120|FG001|Overall Study|Protocol specified criteria|2|||
128742778|NCT03465540|463348121|FG002|Overall Study|Protocol specified criteria|2|||
128742779|NCT03465540|463348122|FG003|Overall Study|Protocol specified criteria|0|||
128742780|NCT03465540|463348123|FG004|Overall Study|Protocol specified criteria|2|||
128742781|NCT03465540|463348124|FG005|Overall Study|Protocol specified criteria|0|||
128742782|NCT00736996|463348125|FG000|Overall Study|Lost to Follow-up|1|||
128742783|NCT00736996|463348126|FG001|Overall Study|Lost to Follow-up|9|||
128742784|NCT00736996|463348127|FG002|Overall Study|Lost to Follow-up|2|||
128742785|NCT02844946|463348128|FG000|Overall Study|Lost to Follow-up|7|||
128742786|NCT02844946|463348129|FG001|Overall Study|Lost to Follow-up|0|||
128742787|NCT02806986|463348130|FG000|Treatment Stage 1|Adverse Event|1|||
128742788|NCT02806986|463348130|FG000|Treatment Stage 2|Adverse Event|3|||
128742789|NCT02806986|463348130|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
128742790|NCT00462384|463348131|FG000|Overall Study|Adverse Event|2|||
128742791|NCT00462384|463348131|FG000|Overall Study|Death|2|||
128742792|NCT00462384|463348131|FG000|Overall Study|Withdrawal by Subject|1|||
128742793|NCT00462384|463348131|FG000|Overall Study|Other|4|||
128742794|NCT00346034|463348132|FG000|Overall Study|Adverse Event|34|||
128742795|NCT00346034|463348132|FG000|Overall Study|Lack of Efficacy|8|||
128742796|NCT00346034|463348132|FG000|Overall Study|Withdrawal by Subject|13|||
128742797|NCT00346034|463348132|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
128742798|NCT00346034|463348132|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
128742799|NCT01255358|463348133|FG000|Overall Study|Adverse Event|2|||
128742800|NCT01255358|463348133|FG000|Overall Study|Protocol Violation|2|||
128742801|NCT00797667|463348134|FG000|Overall Study|Lack of Efficacy|0|||
128785454|NCT01981850|463506020|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
128785455|NCT01981850|463506011|FG000|Open Label Extension (OLE)|Various reasons|0|||
128785456|NCT01981850|463506012|FG001|Open Label Extension (OLE)|Various reasons|0|||
128785457|NCT01981850|463506013|FG002|Open Label Extension (OLE)|Various reasons|0|||
128742802|NCT00797667|463348135|FG001|Overall Study|Lack of Efficacy|1|||
128742803|NCT00797667|463348136|FG002|Overall Study|Lack of Efficacy|0|||
128742804|NCT00797667|463348134|FG000|Overall Study|Lost to Follow-up|8|||
128742805|NCT00797667|463348135|FG001|Overall Study|Lost to Follow-up|12|||
128742806|NCT00797667|463348136|FG002|Overall Study|Lost to Follow-up|2|||
128742807|NCT00797667|463348134|FG000|Overall Study|Physician Decision|3|||
128742808|NCT00797667|463348135|FG001|Overall Study|Physician Decision|1|||
128742809|NCT00797667|463348136|FG002|Overall Study|Physician Decision|0|||
128742810|NCT00797667|463348134|FG000|Overall Study|Pregnancy|2|||
128742811|NCT00797667|463348135|FG001|Overall Study|Pregnancy|0|||
128742812|NCT00797667|463348136|FG002|Overall Study|Pregnancy|0|||
128742813|NCT00797667|463348134|FG000|Overall Study|Protocol Violation|2|||
128742814|NCT00797667|463348135|FG001|Overall Study|Protocol Violation|7|||
128742815|NCT00797667|463348136|FG002|Overall Study|Protocol Violation|0|||
128742816|NCT00797667|463348134|FG000|Overall Study|Study Terminated by Sponsor|217|||
128742817|NCT00797667|463348135|FG001|Overall Study|Study Terminated by Sponsor|216|||
128742818|NCT00797667|463348136|FG002|Overall Study|Study Terminated by Sponsor|115|||
128742819|NCT00797667|463348134|FG000|Overall Study|Withdrawal by Subject|9|||
128742820|NCT00797667|463348135|FG001|Overall Study|Withdrawal by Subject|14|||
128742821|NCT00797667|463348136|FG002|Overall Study|Withdrawal by Subject|2|||
128742822|NCT00797667|463348134|FG000|Overall Study|Adverse Event|19|||
128742823|NCT00797667|463348135|FG001|Overall Study|Adverse Event|8|||
128785458|NCT01981850|463506014|FG003|Open Label Extension (OLE)|Various reasons|0|||
128785459|NCT01981850|463506015|FG004|Open Label Extension (OLE)|Various reasons|0|||
128785460|NCT01981850|463506016|FG005|Open Label Extension (OLE)|Various reasons|0|||
128785461|NCT01981850|463506017|FG006|Open Label Extension (OLE)|Various reasons|0|||
128785462|NCT01981850|463506018|FG007|Open Label Extension (OLE)|Various reasons|3|||
128785463|NCT01981850|463506019|FG008|Open Label Extension (OLE)|Various reasons|1|||
128742824|NCT00797667|463348136|FG002|Overall Study|Adverse Event|8|||
128742825|NCT01986829|463348137|FG000|Overall Study|Death|1|||
128742826|NCT02504866|463348138|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
128742827|NCT02504866|463348139|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
128742828|NCT02504866|463348140|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
128742829|NCT00781326|463348143|FG000|Phase I|Adverse Event|1|||
128742830|NCT00781326|463348143|FG000|Phase I|Withdrawal by Subject|1|||
128742831|NCT00781326|463348143|FG000|Phase I|Physician Decision|2|||
128742832|NCT00096941|463348144|FG000|Overall Study|disease progression|3|||
128742833|NCT01343056|463348145|FG000|Overall Study|Lost to Follow-up|7|||
128742834|NCT01343056|463348146|FG001|Overall Study|Lost to Follow-up|5|||
128742835|NCT01343056|463348147|FG002|Overall Study|Lost to Follow-up|3|||
128742836|NCT01343056|463348148|FG003|Overall Study|Lost to Follow-up|9|||
128742837|NCT03231371|463348149|FG000|Overall Study|Withdrawal by Subject|1|||
128742838|NCT03231371|463348149|FG000|Overall Study|chose or were ineligible to have MRI|12|||
128742839|NCT03029208|463348150|FG000|Overall Study|Withdrawal by Subject|2|||
128742840|NCT03029208|463348151|FG001|Overall Study|Withdrawal by Subject|3|||
128742841|NCT03029208|463348150|FG000|Overall Study|Lost to Follow-up|0|||
128742842|NCT03029208|463348151|FG001|Overall Study|Lost to Follow-up|1|||
128742843|NCT01732835|463348154|FG000|6-month Primary Endpoint|Did not receive device|19|||
128742844|NCT01732835|463348154|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
128742845|NCT01732835|463348154|FG000|6-month Primary Endpoint|Adverse Event|3|||
128742846|NCT01732835|463348154|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
128742847|NCT01732835|463348154|FG000|2-year Extended Follow-up|Adverse Event|3|||
128742848|NCT01732835|463348154|FG000|2-year Extended Follow-up|Death|1|||
128742849|NCT02493361|463348155|FG000|Overall Study|Withdrawal by Subject|3|||
128742850|NCT02334748|463348156|FG000|Overall Study|Adverse Event|1|||
128742851|NCT02334748|463348156|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
128742852|NCT02334748|463348156|FG000|Overall Study|Patient no longer required study drug|2|||
128742853|NCT02334748|463348156|FG000|Overall Study|Lack of Efficacy|4|||
128742854|NCT01046643|463348157|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
128742855|NCT01046643|463348158|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
128742856|NCT01046643|463348159|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
128742857|NCT01046643|463348160|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
128742858|NCT00305058|463348167|FG000|Overall Study|Participant too young|1|||
128742859|NCT00305058|463348168|FG001|Overall Study|Participant too young|0|||
128742860|NCT00305058|463348167|FG000|Overall Study|Missing data collection instrument|3|||
128742861|NCT00305058|463348168|FG001|Overall Study|Missing data collection instrument|2|||
128742862|NCT00305058|463348167|FG000|Overall Study|Missing outcome data|3|||
128742863|NCT00305058|463348168|FG001|Overall Study|Missing outcome data|2|||
128742864|NCT04102501|463348169|FG000|Overall Study|Withdrawal by Subject|7|||
128742865|NCT04102501|463348170|FG001|Overall Study|Withdrawal by Subject|9|||
128742866|NCT04102501|463348169|FG000|Overall Study|Adverse Event|1|||
128742867|NCT04102501|463348170|FG001|Overall Study|Adverse Event|3|||
128742868|NCT01427712|463348171|FG000|Overall Study|Transfer to a different hospital|2|||
128742869|NCT01427712|463348171|FG000|Overall Study|Lost to Follow-up|1|||
128742870|NCT01427712|463348171|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
128742871|NCT01427712|463348171|FG000|Overall Study|Failure to visit|1|||
128742872|NCT04798586|463348172|FG000|Overall Study|Death|2|||
128742873|NCT00968617|463348173|FG000|Overall Study|Study terminated by sponsor|6|||
128742874|NCT02371369|463348178|FG000|Part 1|Physician Decision|0|||
128742875|NCT02371369|463348179|FG001|Part 1|Physician Decision|3|||
128742876|NCT02371369|463348178|FG000|Part 1|Adverse Event|8|||
128742877|NCT02371369|463348179|FG001|Part 1|Adverse Event|0|||
128742878|NCT02371369|463348178|FG000|Part 1|Withdrawal by Subject|1|||
128742879|NCT02371369|463348179|FG001|Part 1|Withdrawal by Subject|6|||
128742880|NCT02371369|463348178|FG000|Part 1|Disease progression|0|||
128742881|NCT02371369|463348179|FG001|Part 1|Disease progression|1|||
128742882|NCT02371369|463348178|FG000|Part 1|Protocol Violation|0|||
128742883|NCT02371369|463348179|FG001|Part 1|Protocol Violation|1|||
128742884|NCT02371369|463348178|FG000|Part 2|Adverse Event|6|||
128742885|NCT02371369|463348179|FG001|Part 2|Adverse Event|5|||
128742886|NCT02371369|463348178|FG000|Part 2|Withdrawal by Subject|16|||
128742887|NCT02371369|463348179|FG001|Part 2|Withdrawal by Subject|6|||
128742888|NCT02371369|463348178|FG000|Part 2|Investigator decision|1|||
128742889|NCT02371369|463348179|FG001|Part 2|Investigator decision|2|||
128742890|NCT02371369|463348178|FG000|Part 2|Death|0|||
128742891|NCT02371369|463348179|FG001|Part 2|Death|1|||
128742892|NCT02371369|463348178|FG000|Part 2|Disease progression|1|||
128742893|NCT02371369|463348179|FG001|Part 2|Disease progression|0|||
128742894|NCT02371369|463348178|FG000|Part 2|Subject Noncompliance|1|||
128742895|NCT02371369|463348179|FG001|Part 2|Subject Noncompliance|0|||
128742896|NCT02371369|463348178|FG000|Part 2|Lost to Follow-up|1|||
128742897|NCT02371369|463348179|FG001|Part 2|Lost to Follow-up|1|||
128742898|NCT02371369|463348178|FG000|Part 2|Subject transitioned to commercial supply|6|||
128742899|NCT02371369|463348179|FG001|Part 2|Subject transitioned to commercial supply|4|||
128742900|NCT02371369|463348178|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
128742901|NCT02371369|463348179|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
128742902|NCT02371369|463348178|FG000|Part 2|Surgical resection of tumor|1|||
128742903|NCT02371369|463348179|FG001|Part 2|Surgical resection of tumor|1|||
128742904|NCT02371369|463348178|FG000|Part 2|Other|0|||
128742905|NCT02371369|463348179|FG001|Part 2|Other|1|||
128742906|NCT00661492|463348185|FG000|Overall Study|Adverse Event|16|||
128742907|NCT00661492|463348186|FG001|Overall Study|Adverse Event|13|||
128742908|NCT00661492|463348185|FG000|Overall Study|Disease Progression|44|||
128742909|NCT00661492|463348186|FG001|Overall Study|Disease Progression|14|||
128742910|NCT00661492|463348185|FG000|Overall Study|Patient Request|6|||
128742911|NCT00661492|463348186|FG001|Overall Study|Patient Request|1|||
128742912|NCT00661492|463348185|FG000|Overall Study|Investigator Request|1|||
128742913|NCT00661492|463348186|FG001|Overall Study|Investigator Request|0|||
128742914|NCT00661492|463348185|FG000|Overall Study|Lost to Follow-up|0|||
128742915|NCT00661492|463348186|FG001|Overall Study|Lost to Follow-up|1|||
128742916|NCT00661492|463348185|FG000|Overall Study|Other|1|||
128742917|NCT00661492|463348186|FG001|Overall Study|Other|0|||
128742918|NCT01024387|463348187|FG000|Overall Study|Radiographic Progression|29|||
128742919|NCT01024387|463348187|FG000|Overall Study|Symptomatic Progression|10|||
128742920|NCT01024387|463348187|FG000|Overall Study|Physician Decision|5|||
128742921|NCT01024387|463348187|FG000|Overall Study|Withdrawal by Subject|5|||
128742922|NCT01024387|463348187|FG000|Overall Study|Death|2|||
128742923|NCT01024387|463348187|FG000|Overall Study|Prolonged Treatment Delay|1|||
128742924|NCT01024387|463348187|FG000|Overall Study|Adverse Event|3|||
128742925|NCT01024387|463348187|FG000|Overall Study|Other|5|||
128742926|NCT03855189|463348188|FG000|Overall Study|Adverse Event|5|||
128742927|NCT03855189|463348189|FG001|Overall Study|Adverse Event|2|||
128742928|NCT03855189|463348190|FG002|Overall Study|Adverse Event|4|||
128742929|NCT03855189|463348188|FG000|Overall Study|Treatment Failure|1|||
128742930|NCT03855189|463348189|FG001|Overall Study|Treatment Failure|1|||
128742931|NCT03855189|463348190|FG002|Overall Study|Treatment Failure|2|||
128742932|NCT03855189|463348188|FG000|Overall Study|Noncompliance with Protocol|0|||
128742933|NCT03855189|463348189|FG001|Overall Study|Noncompliance with Protocol|1|||
128742934|NCT03855189|463348190|FG002|Overall Study|Noncompliance with Protocol|0|||
128742935|NCT03855189|463348188|FG000|Overall Study|Did Not Return|4|||
128742936|NCT03855189|463348189|FG001|Overall Study|Did Not Return|3|||
128742937|NCT03855189|463348190|FG002|Overall Study|Did Not Return|0|||
128742938|NCT01143259|463348191|FG000|Overall Study|Withdrawal by Subject|3|||
128742939|NCT01143259|463348192|FG001|Overall Study|Withdrawal by Subject|2|||
128742940|NCT01143259|463348191|FG000|Overall Study|Protocol Violation|13|||
128742941|NCT01143259|463348192|FG001|Overall Study|Protocol Violation|9|||
128742942|NCT01143259|463348191|FG000|Overall Study|Screen Failure|7|||
128742943|NCT01143259|463348192|FG001|Overall Study|Screen Failure|9|||
128742944|NCT00099983|463348193|FG000|Overall Study|Lost to Follow-up|2|||
128742945|NCT00099983|463348194|FG001|Overall Study|Lost to Follow-up|3|||
128742946|NCT00099983|463348193|FG000|Overall Study|Missing Source Documents|14|||
128742947|NCT00099983|463348194|FG001|Overall Study|Missing Source Documents|15|||
128742948|NCT00099983|463348193|FG000|Overall Study|Withdrawal by Subject|3|||
128742949|NCT00099983|463348194|FG001|Overall Study|Withdrawal by Subject|2|||
128742950|NCT00099983|463348193|FG000|Overall Study|Adverse Event|1|||
128742951|NCT00099983|463348194|FG001|Overall Study|Adverse Event|1|||
128742952|NCT00099983|463348193|FG000|Overall Study|Lack of Efficacy|0|||
128742953|NCT00099983|463348194|FG001|Overall Study|Lack of Efficacy|1|||
128742954|NCT00099983|463348193|FG000|Overall Study|Unable to return for appointments|1|||
128742955|NCT00099983|463348194|FG001|Overall Study|Unable to return for appointments|1|||
128742956|NCT00099983|463348193|FG000|Overall Study|Moved|1|||
128742957|NCT00099983|463348194|FG001|Overall Study|Moved|0|||
128742958|NCT00099983|463348193|FG000|Overall Study|Other psychiatric problem|1|||
128742959|NCT00099983|463348194|FG001|Overall Study|Other psychiatric problem|0|||
128742960|NCT00099983|463348193|FG000|Overall Study|Incarcerated|0|||
128742961|NCT00099983|463348194|FG001|Overall Study|Incarcerated|1|||
128742962|NCT00099983|463348193|FG000|Overall Study|Intolerant of burden of visits|0|||
128742963|NCT00099983|463348194|FG001|Overall Study|Intolerant of burden of visits|1|||
128742964|NCT00099983|463348193|FG000|Overall Study|Other issue|1|||
128742965|NCT00099983|463348194|FG001|Overall Study|Other issue|0|||
128742966|NCT02641080|463348195|FG000|Overall Study|Physician Decision|2|||
128742967|NCT02641080|463348196|FG001|Overall Study|Physician Decision|0|||
128742968|NCT02641080|463348195|FG000|Overall Study|Withdrawal by Subject|0|||
128742969|NCT02641080|463348196|FG001|Overall Study|Withdrawal by Subject|1|||
128742970|NCT02641080|463348195|FG000|Overall Study|Rehab Center denied use of pumps|0|||
128742971|NCT02641080|463348196|FG001|Overall Study|Rehab Center denied use of pumps|3|||
128742972|NCT02641080|463348195|FG000|Overall Study|Lost to Follow-up|0|||
128742973|NCT02641080|463348196|FG001|Overall Study|Lost to Follow-up|3|||
128742974|NCT00503685|463348206|FG000|Overall Study|Adverse Event|0|||
128742975|NCT00503685|463348207|FG001|Overall Study|Adverse Event|0|||
128742976|NCT00503685|463348208|FG002|Overall Study|Adverse Event|2|||
128742977|NCT00503685|463348206|FG000|Overall Study|Withdrawal by Subject|0|||
128742978|NCT00503685|463348207|FG001|Overall Study|Withdrawal by Subject|1|||
128742979|NCT00503685|463348208|FG002|Overall Study|Withdrawal by Subject|0|||
128742980|NCT00503685|463348206|FG000|Overall Study|Protocol Violation|0|||
128742981|NCT00503685|463348207|FG001|Overall Study|Protocol Violation|1|||
128742982|NCT00503685|463348208|FG002|Overall Study|Protocol Violation|0|||
128742983|NCT00503685|463348206|FG000|Overall Study|Eligibility Criteria Not Met|0|||
128742984|NCT00503685|463348207|FG001|Overall Study|Eligibility Criteria Not Met|1|||
128742985|NCT00503685|463348208|FG002|Overall Study|Eligibility Criteria Not Met|0|||
128742986|NCT00927927|463348209|FG000|Overall Study|Withdrawal by Subject|0|||
128742987|NCT00927927|463348210|FG001|Overall Study|Withdrawal by Subject|0|||
128742988|NCT00927927|463348211|FG002|Overall Study|Withdrawal by Subject|0|||
128742989|NCT00927927|463348212|FG003|Overall Study|Withdrawal by Subject|0|||
128742990|NCT00927927|463348213|FG004|Overall Study|Withdrawal by Subject|0|||
128742991|NCT00927927|463348214|FG005|Overall Study|Withdrawal by Subject|0|||
128742992|NCT00927927|463348215|FG006|Overall Study|Withdrawal by Subject|0|||
128742993|NCT00927927|463348216|FG007|Overall Study|Withdrawal by Subject|2|||
128742994|NCT00927927|463348217|FG008|Overall Study|Withdrawal by Subject|0|||
128742995|NCT00927927|463348218|FG009|Overall Study|Withdrawal by Subject|0|||
128742996|NCT00927927|463348219|FG010|Overall Study|Withdrawal by Subject|0|||
128742997|NCT00927927|463348220|FG011|Overall Study|Withdrawal by Subject|2|||
128742998|NCT00927927|463348221|FG012|Overall Study|Withdrawal by Subject|0|||
128742999|NCT00927927|463348222|FG013|Overall Study|Withdrawal by Subject|0|||
128785464|NCT01981850|463506020|FG009|Open Label Extension (OLE)|Various reasons|3|||
128785465|NCT01981850|463506011|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
128785466|NCT01981850|463506012|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
128785467|NCT01981850|463506013|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
128785468|NCT01981850|463506014|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
128785469|NCT01981850|463506015|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
128785470|NCT01981850|463506016|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
128785471|NCT01981850|463506017|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
128785472|NCT01981850|463506018|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
128785473|NCT01981850|463506019|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
128785474|NCT01981850|463506020|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
128785475|NCT01981850|463506011|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785476|NCT01981850|463506012|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785477|NCT01981850|463506013|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785478|NCT01981850|463506014|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785479|NCT01981850|463506015|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785480|NCT01981850|463506016|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785481|NCT01981850|463506017|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785482|NCT01981850|463506018|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785483|NCT01981850|463506019|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
128785484|NCT01981850|463506020|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
128785485|NCT01981850|463506011|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785486|NCT01981850|463506012|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785487|NCT01981850|463506013|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785488|NCT01981850|463506014|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785489|NCT01981850|463506015|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785490|NCT01981850|463506016|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785491|NCT01981850|463506017|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785492|NCT01981850|463506018|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785493|NCT01981850|463506019|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
128785494|NCT01981850|463506020|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
128785495|NCT02524288|463506021|FG000|Overall Study|Adverse Event|115|||
128785496|NCT02524288|463506021|FG000|Overall Study|Lost to Follow-up|216|||
128785497|NCT02524288|463506021|FG000|Overall Study|Non-Compliance With Protocol|32|||
128743000|NCT00927927|463348223|FG014|Overall Study|Withdrawal by Subject|0|||
128743001|NCT01110239|463348230|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
128743002|NCT01110239|463348231|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
128743003|NCT01110239|463348232|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
128743004|NCT01110239|463348233|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
128743005|NCT01110239|463348230|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
128743006|NCT01110239|463348231|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
128743007|NCT01110239|463348232|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
128743008|NCT01110239|463348233|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
128743009|NCT00080223|463348236|FG000|Overall Study|Adverse Event|23|||
128743010|NCT00080223|463348236|FG000|Overall Study|Death|21|||
128743011|NCT00080223|463348236|FG000|Overall Study|Withdrawal by Subject|13|||
128743012|NCT00080223|463348236|FG000|Overall Study|Lung Transplantation|9|||
128743013|NCT00080223|463348236|FG000|Overall Study|Non-compliance With Study Treatment|7|||
128743014|NCT00080223|463348236|FG000|Overall Study|Participant unwilling to continue|2|||
128743015|NCT00080223|463348236|FG000|Overall Study|Physician Decision|1|||
128743016|NCT05204134|463348237|FG000|Overall Study|Withdrawal by Subject|3|||
128743017|NCT05204134|463348237|FG000|Overall Study|Physician Decision|1|||
128743018|NCT00499369|463348238|FG000|Overall Study|Adverse Event|2|||
128743019|NCT00499369|463348239|FG001|Overall Study|Adverse Event|2|||
128743020|NCT00499369|463348240|FG002|Overall Study|Adverse Event|3|||
128743021|NCT00499369|463348241|FG003|Overall Study|Adverse Event|1|||
128743022|NCT00499369|463348242|FG004|Overall Study|Adverse Event|2|||
128743023|NCT00499369|463348238|FG000|Overall Study|Withdrawal by Subject|0|||
128743024|NCT00499369|463348239|FG001|Overall Study|Withdrawal by Subject|1|||
128743025|NCT00499369|463348240|FG002|Overall Study|Withdrawal by Subject|1|||
128743026|NCT00499369|463348241|FG003|Overall Study|Withdrawal by Subject|0|||
128743027|NCT00499369|463348242|FG004|Overall Study|Withdrawal by Subject|0|||
128743028|NCT00499369|463348238|FG000|Overall Study|Progression|10|||
128743029|NCT00499369|463348239|FG001|Overall Study|Progression|12|||
128743030|NCT00499369|463348240|FG002|Overall Study|Progression|9|||
128743031|NCT00499369|463348241|FG003|Overall Study|Progression|6|||
128743032|NCT00499369|463348242|FG004|Overall Study|Progression|10|||
128743033|NCT00499369|463348238|FG000|Overall Study|Death|0|||
128743034|NCT00499369|463348239|FG001|Overall Study|Death|1|||
128743035|NCT00499369|463348240|FG002|Overall Study|Death|0|||
128743036|NCT00499369|463348241|FG003|Overall Study|Death|0|||
128743037|NCT00499369|463348242|FG004|Overall Study|Death|0|||
128743038|NCT00499369|463348238|FG000|Overall Study|Not protocol specified|2|||
128743039|NCT00499369|463348239|FG001|Overall Study|Not protocol specified|0|||
128743040|NCT00499369|463348240|FG002|Overall Study|Not protocol specified|3|||
128743041|NCT00499369|463348241|FG003|Overall Study|Not protocol specified|1|||
128743042|NCT00499369|463348242|FG004|Overall Study|Not protocol specified|0|||
128743043|NCT00499369|463348238|FG000|Overall Study|Ineligible|2|||
128743044|NCT00499369|463348239|FG001|Overall Study|Ineligible|2|||
128743045|NCT00499369|463348240|FG002|Overall Study|Ineligible|1|||
128743046|NCT00499369|463348241|FG003|Overall Study|Ineligible|1|||
128743047|NCT00499369|463348242|FG004|Overall Study|Ineligible|0|||
128743048|NCT01059617|463348243|FG000|Overall Study|Other|7|||
128743049|NCT01059617|463348244|FG001|Overall Study|Other|1|||
128743050|NCT01059617|463348245|FG002|Overall Study|Other|8|||
128743051|NCT01059617|463348246|FG003|Overall Study|Other|6|||
128743052|NCT00489970|463350105|FG000|Persistence Year 9|Lost to Follow-up|2|||
128743053|NCT00489970|463350106|FG001|Persistence Year 9|Lost to Follow-up|2|||
128743054|NCT00489970|463350107|FG002|Persistence Year 9|Lost to Follow-up|3|||
128743055|NCT00489970|463350105|FG000|Persistence Year 9|Other|1|||
128743056|NCT00489970|463350106|FG001|Persistence Year 9|Other|0|||
128743057|NCT00489970|463350107|FG002|Persistence Year 9|Other|2|||
128743058|NCT02707055|463350114|FG000|Phase 1|Withdrawal by Subject|1|||
128743059|NCT02707055|463350115|FG001|Phase 1|Withdrawal by Subject|2|||
128743060|NCT02707055|463350114|FG000|Phase 1|Physician Decision|0|||
128743061|NCT02707055|463350115|FG001|Phase 1|Physician Decision|1|||
128743062|NCT02707055|463350114|FG000|Phase 2|Adverse Event|1|||
128743063|NCT02707055|463350115|FG001|Phase 2|Adverse Event|2|||
128743064|NCT03564496|463350116|FG000|Overall Study|Withdrawal by Subject|1|||
128743065|NCT03564496|463350117|FG001|Overall Study|Withdrawal by Subject|1|||
128743066|NCT03564496|463350118|FG002|Overall Study|Withdrawal by Subject|0|||
128743067|NCT03564496|463350116|FG000|Overall Study|Screen failure|0|||
128743068|NCT03564496|463350117|FG001|Overall Study|Screen failure|3|||
128743069|NCT03564496|463350118|FG002|Overall Study|Screen failure|0|||
128743070|NCT01159938|463350119|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
128743071|NCT01159938|463350120|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
128743072|NCT01159938|463350121|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
128743073|NCT01159938|463350122|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
128743074|NCT01159938|463350123|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
128743075|NCT02318329|463350127|FG000|Overall Study|Progressive Disease|2|||
128743076|NCT02318329|463350128|FG001|Overall Study|Progressive Disease|3|||
128743077|NCT02318329|463350129|FG002|Overall Study|Progressive Disease|2|||
128743078|NCT02318329|463350130|FG003|Overall Study|Progressive Disease|3|||
128743079|NCT02318329|463350131|FG004|Overall Study|Progressive Disease|3|||
128743080|NCT02318329|463350132|FG005|Overall Study|Progressive Disease|3|||
128743081|NCT02318329|463350133|FG006|Overall Study|Progressive Disease|1|||
128743082|NCT02318329|463350134|FG007|Overall Study|Progressive Disease|1|||
128743083|NCT02318329|463350135|FG008|Overall Study|Progressive Disease|5|||
128743084|NCT02318329|463350136|FG009|Overall Study|Progressive Disease|39|||
128743085|NCT02318329|463350127|FG000|Overall Study|Death|0|||
128743086|NCT02318329|463350128|FG001|Overall Study|Death|0|||
128743087|NCT02318329|463350129|FG002|Overall Study|Death|0|||
128743088|NCT02318329|463350130|FG003|Overall Study|Death|0|||
128743089|NCT02318329|463350131|FG004|Overall Study|Death|0|||
128743090|NCT02318329|463350132|FG005|Overall Study|Death|0|||
128743091|NCT02318329|463350133|FG006|Overall Study|Death|0|||
128743092|NCT02318329|463350134|FG007|Overall Study|Death|0|||
128743093|NCT02318329|463350135|FG008|Overall Study|Death|0|||
128743094|NCT02318329|463350136|FG009|Overall Study|Death|5|||
128743095|NCT02318329|463350127|FG000|Overall Study|Lost to Follow-up|0|||
128743096|NCT02318329|463350128|FG001|Overall Study|Lost to Follow-up|0|||
128743097|NCT02318329|463350129|FG002|Overall Study|Lost to Follow-up|0|||
128743098|NCT02318329|463350130|FG003|Overall Study|Lost to Follow-up|0|||
128743099|NCT02318329|463350131|FG004|Overall Study|Lost to Follow-up|0|||
128743100|NCT02318329|463350132|FG005|Overall Study|Lost to Follow-up|0|||
128743101|NCT02318329|463350133|FG006|Overall Study|Lost to Follow-up|0|||
128743102|NCT02318329|463350134|FG007|Overall Study|Lost to Follow-up|0|||
128743103|NCT02318329|463350135|FG008|Overall Study|Lost to Follow-up|0|||
128743104|NCT02318329|463350136|FG009|Overall Study|Lost to Follow-up|1|||
128743105|NCT02318329|463350127|FG000|Overall Study|Withdrawal by Subject|0|||
128743106|NCT02318329|463350128|FG001|Overall Study|Withdrawal by Subject|0|||
128743107|NCT02318329|463350129|FG002|Overall Study|Withdrawal by Subject|0|||
128743108|NCT02318329|463350130|FG003|Overall Study|Withdrawal by Subject|0|||
128743109|NCT02318329|463350131|FG004|Overall Study|Withdrawal by Subject|0|||
128743110|NCT02318329|463350132|FG005|Overall Study|Withdrawal by Subject|0|||
128743111|NCT02318329|463350133|FG006|Overall Study|Withdrawal by Subject|0|||
128743112|NCT02318329|463350134|FG007|Overall Study|Withdrawal by Subject|0|||
128743113|NCT02318329|463350135|FG008|Overall Study|Withdrawal by Subject|0|||
128743114|NCT02318329|463350136|FG009|Overall Study|Withdrawal by Subject|6|||
128743115|NCT02318329|463350127|FG000|Overall Study|Other|1|||
128743116|NCT02318329|463350128|FG001|Overall Study|Other|1|||
128743117|NCT02318329|463350129|FG002|Overall Study|Other|1|||
128743118|NCT02318329|463350130|FG003|Overall Study|Other|0|||
128743119|NCT02318329|463350131|FG004|Overall Study|Other|0|||
128743120|NCT02318329|463350132|FG005|Overall Study|Other|0|||
128743121|NCT02318329|463350133|FG006|Overall Study|Other|0|||
128743122|NCT02318329|463350134|FG007|Overall Study|Other|0|||
128743123|NCT02318329|463350135|FG008|Overall Study|Other|1|||
128743124|NCT02318329|463350136|FG009|Overall Study|Other|1|||
128743125|NCT00086346|463350139|FG000|Randomization|Did not receive test article|4|||
128743126|NCT00086346|463350140|FG001|Randomization|Did not receive test article|4|||
128743127|NCT00086346|463350139|FG000|Patients Dosed With Test Article|Adverse Event|94|||
128743128|NCT00086346|463350140|FG001|Patients Dosed With Test Article|Adverse Event|11|||
128743129|NCT00086346|463350139|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
128743130|NCT00086346|463350140|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
128743131|NCT00086346|463350139|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
128743132|NCT00086346|463350140|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
128743133|NCT00086346|463350139|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
128743134|NCT00086346|463350140|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
128743135|NCT00086346|463350139|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
128743136|NCT00086346|463350140|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
128743137|NCT00086346|463350139|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
128743138|NCT00086346|463350140|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
128743139|NCT04495374|463350141|FG000|Overall Study|Protocol Violation|2|||
128743140|NCT04495374|463350142|FG001|Overall Study|Protocol Violation|1|||
128743141|NCT00353704|463350143|FG000|Overall Study|Protocol Violation|3|||
128743142|NCT00353704|463350144|FG001|Overall Study|Protocol Violation|1|||
128743143|NCT02473614|463350145|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
128743144|NCT02473614|463350146|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
128743145|NCT01303627|463350147|FG000|Overall Study|the failure while performing URS|0|||
128743146|NCT01303627|463350148|FG001|Overall Study|the failure while performing URS|1|||
128743147|NCT02416791|463350150|FG000|6 Months|Lost to Follow-up|0|||
128743148|NCT02416791|463350151|FG001|6 Months|Lost to Follow-up|0|||
128743149|NCT02416791|463350152|FG002|6 Months|Lost to Follow-up|1|||
128743150|NCT01054820|463350153|FG000|Overall Study|Withdrawal by Subject|2|||
128743151|NCT01154166|463350155|FG000|Overall Study|Adverse Event|14|||
128743152|NCT01154166|463350156|FG001|Overall Study|Adverse Event|9|||
128743153|NCT01154166|463350155|FG000|Overall Study|Lost to Follow-up|1|||
128743154|NCT01154166|463350156|FG001|Overall Study|Lost to Follow-up|1|||
128743155|NCT01154166|463350155|FG000|Overall Study|Protocol Violation|4|||
128743156|NCT01154166|463350156|FG001|Overall Study|Protocol Violation|1|||
128743157|NCT01154166|463350155|FG000|Overall Study|Withdrawal by Subject|10|||
128743158|NCT01154166|463350156|FG001|Overall Study|Withdrawal by Subject|1|||
128743159|NCT01154166|463350155|FG000|Overall Study|Lack of Efficacy|3|||
128743160|NCT01154166|463350156|FG001|Overall Study|Lack of Efficacy|0|||
128743161|NCT01154166|463350155|FG000|Overall Study|Disease Progression|1|||
128743162|NCT01154166|463350156|FG001|Overall Study|Disease Progression|0|||
128743163|NCT01154166|463350155|FG000|Overall Study|Poor Compliance|1|||
128743164|NCT01154166|463350156|FG001|Overall Study|Poor Compliance|0|||
128743165|NCT00996996|463350157|FG000|Overall Study|Progressive Disease|10|||
128743166|NCT00996996|463350157|FG000|Overall Study|Non-compliance|8|||
128743167|NCT00996996|463350157|FG000|Overall Study|Lost to Follow-up|9|||
128743168|NCT00996996|463350157|FG000|Overall Study|Death|5|||
128743169|NCT00996996|463350157|FG000|Overall Study|Did Not Receive Study Medications|1|||
128743170|NCT04121962|463350160|FG000|Overall Study|Lost to Follow-up|42|||
128743171|NCT04121962|463350161|FG001|Overall Study|Lost to Follow-up|39|||
128743172|NCT02019719|463350162|FG000|Overall Study|Adverse Event|1|||
128743173|NCT02019719|463350163|FG001|Overall Study|Adverse Event|0|||
128743174|NCT02019719|463350164|FG002|Overall Study|Adverse Event|0|||
128743175|NCT02019719|463350165|FG003|Overall Study|Adverse Event|1|||
128743176|NCT02019719|463350166|FG004|Overall Study|Adverse Event|1|||
128743177|NCT02019719|463350162|FG000|Overall Study|Protocol Violation|1|||
128743178|NCT02019719|463350163|FG001|Overall Study|Protocol Violation|1|||
128743179|NCT02019719|463350164|FG002|Overall Study|Protocol Violation|0|||
128743180|NCT02019719|463350165|FG003|Overall Study|Protocol Violation|0|||
128743181|NCT02019719|463350166|FG004|Overall Study|Protocol Violation|0|||
128743182|NCT02019719|463350162|FG000|Overall Study|Protocol defined stopping criteria|2|||
128743183|NCT02019719|463350163|FG001|Overall Study|Protocol defined stopping criteria|0|||
128743184|NCT02019719|463350164|FG002|Overall Study|Protocol defined stopping criteria|0|||
128743185|NCT02019719|463350165|FG003|Overall Study|Protocol defined stopping criteria|1|||
128743186|NCT02019719|463350166|FG004|Overall Study|Protocol defined stopping criteria|1|||
128743187|NCT02019719|463350162|FG000|Overall Study|Physician Decision|2|||
128743188|NCT02019719|463350163|FG001|Overall Study|Physician Decision|0|||
128743189|NCT02019719|463350164|FG002|Overall Study|Physician Decision|0|||
128785498|NCT02524288|463506021|FG000|Overall Study|Non-Compliance With Study Drug|14|||
128785499|NCT02524288|463506021|FG000|Overall Study|Pregnancy Wish|6|||
128785500|NCT02524288|463506021|FG000|Overall Study|Protocol Violation|6|||
128785501|NCT02524288|463506021|FG000|Overall Study|Screen Failure|2|||
128743190|NCT02019719|463350165|FG003|Overall Study|Physician Decision|0|||
128743191|NCT02019719|463350166|FG004|Overall Study|Physician Decision|0|||
128743192|NCT04535037|463350169|FG000|Overall Study|Protocol Violation|1|||
128743193|NCT04535037|463350170|FG001|Overall Study|Protocol Violation|0|||
128743194|NCT04535037|463350169|FG000|Overall Study|Withdrawal by Subject|8|||
128743195|NCT04535037|463350170|FG001|Overall Study|Withdrawal by Subject|9|||
128743196|NCT04535037|463350169|FG000|Overall Study|Migrated / moved from the study area|1|||
128743197|NCT04535037|463350170|FG001|Overall Study|Migrated / moved from the study area|4|||
128743198|NCT04535037|463350169|FG000|Overall Study|Other|2|||
128743199|NCT04535037|463350170|FG001|Overall Study|Other|5|||
128743200|NCT02031276|463350171|FG000|Period 1 Double-blind IV|Adverse Event|6|||
128743201|NCT02031276|463350172|FG001|Period 1 Double-blind IV|Adverse Event|5|||
128743202|NCT02031276|463350173|FG002|Period 1 Double-blind IV|Adverse Event|1|||
128743203|NCT02031276|463350171|FG000|Period 1 Double-blind IV|Other|0|||
128743204|NCT02031276|463350172|FG001|Period 1 Double-blind IV|Other|1|||
128743205|NCT02031276|463350173|FG002|Period 1 Double-blind IV|Other|0|||
128743206|NCT02031276|463350171|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
128743207|NCT02031276|463350172|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
128743208|NCT02031276|463350173|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
128743209|NCT02031276|463350171|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
128743210|NCT02031276|463350172|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
128743211|NCT02031276|463350173|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
128743212|NCT02031276|463350171|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
128743213|NCT02031276|463350172|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
128743214|NCT02031276|463350173|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
128743215|NCT02031276|463350171|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
128743216|NCT02031276|463350172|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
128743217|NCT02031276|463350173|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
128743218|NCT02031276|463350171|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
128743219|NCT02031276|463350172|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
128743220|NCT02031276|463350173|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
128743221|NCT02031276|463350171|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
128743222|NCT02031276|463350172|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
128743223|NCT02031276|463350173|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
128743224|NCT02031276|463350171|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
128743225|NCT02031276|463350172|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
128743226|NCT02031276|463350173|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
128743227|NCT01148810|463350174|FG000|Overall Study|Adverse Event|0|||
128743228|NCT01148810|463350175|FG001|Overall Study|Adverse Event|2|||
128743229|NCT01148810|463350174|FG000|Overall Study|Lack of Efficacy|0|||
128743230|NCT01148810|463350175|FG001|Overall Study|Lack of Efficacy|1|||
128743231|NCT01148810|463350174|FG000|Overall Study|Withdrawal by Subject|0|||
128743232|NCT01148810|463350175|FG001|Overall Study|Withdrawal by Subject|2|||
128743233|NCT01148810|463350174|FG000|Overall Study|Protocol Violation|1|||
128743234|NCT01148810|463350175|FG001|Overall Study|Protocol Violation|0|||
128743235|NCT02731131|463350183|FG000|Overall Study|Psychiatric Disorder|0|||
128743236|NCT02731131|463350184|FG001|Overall Study|Psychiatric Disorder|1|||
128743237|NCT02731131|463350183|FG000|Overall Study|Refused Therapy|0|||
128743238|NCT02731131|463350184|FG001|Overall Study|Refused Therapy|1|||
128743239|NCT02348216|463350189|FG000|Overall Study|Death|5|||
128743240|NCT02348216|463350190|FG001|Overall Study|Death|53|||
128743241|NCT02348216|463350191|FG002|Overall Study|Death|11|||
128743242|NCT02348216|463350192|FG003|Overall Study|Death|20|||
128743243|NCT02348216|463350193|FG004|Overall Study|Death|16|||
128743244|NCT02348216|463350194|FG005|Overall Study|Death|32|||
128743245|NCT02348216|463350195|FG006|Overall Study|Death|17|||
128743246|NCT02348216|463350189|FG000|Overall Study|Full consent withdrawal|0|||
128743247|NCT02348216|463350190|FG001|Overall Study|Full consent withdrawal|0|||
128743248|NCT02348216|463350191|FG002|Overall Study|Full consent withdrawal|0|||
128743249|NCT02348216|463350192|FG003|Overall Study|Full consent withdrawal|1|||
128743250|NCT02348216|463350193|FG004|Overall Study|Full consent withdrawal|3|||
128743251|NCT02348216|463350194|FG005|Overall Study|Full consent withdrawal|0|||
128743252|NCT02348216|463350195|FG006|Overall Study|Full consent withdrawal|3|||
128743253|NCT02348216|463350189|FG000|Overall Study|Lost to Follow-up|0|||
128743254|NCT02348216|463350190|FG001|Overall Study|Lost to Follow-up|5|||
128743255|NCT02348216|463350191|FG002|Overall Study|Lost to Follow-up|2|||
128743256|NCT02348216|463350192|FG003|Overall Study|Lost to Follow-up|0|||
128743257|NCT02348216|463350193|FG004|Overall Study|Lost to Follow-up|1|||
128743258|NCT02348216|463350194|FG005|Overall Study|Lost to Follow-up|1|||
128743259|NCT02348216|463350195|FG006|Overall Study|Lost to Follow-up|1|||
128743260|NCT02348216|463350189|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
128743261|NCT02348216|463350190|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
128743262|NCT02348216|463350191|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
128743263|NCT02348216|463350192|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
128743264|NCT02348216|463350193|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
128743265|NCT02348216|463350194|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
128743266|NCT02348216|463350195|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
128743267|NCT02348216|463350189|FG000|Overall Study|Reason not specified|2|||
128743268|NCT02348216|463350190|FG001|Overall Study|Reason not specified|19|||
128743269|NCT02348216|463350191|FG002|Overall Study|Reason not specified|11|||
128743270|NCT02348216|463350192|FG003|Overall Study|Reason not specified|17|||
128743271|NCT02348216|463350193|FG004|Overall Study|Reason not specified|21|||
128743272|NCT02348216|463350194|FG005|Overall Study|Reason not specified|17|||
128743273|NCT02348216|463350195|FG006|Overall Study|Reason not specified|19|||
128743274|NCT01055639|463350196|FG000|Overall Study|Adverse Event|0|||
128743275|NCT01055639|463350197|FG001|Overall Study|Adverse Event|1|||
128743276|NCT01055639|463350196|FG000|Overall Study|Lack of Efficacy|0|||
128743277|NCT01055639|463350197|FG001|Overall Study|Lack of Efficacy|1|||
128743278|NCT01055639|463350196|FG000|Overall Study|Lost to Follow-up|8|||
128743279|NCT01055639|463350197|FG001|Overall Study|Lost to Follow-up|11|||
128743280|NCT01055639|463350196|FG000|Overall Study|Protocol Violation|5|||
128743281|NCT01055639|463350197|FG001|Overall Study|Protocol Violation|5|||
128743282|NCT01055639|463350196|FG000|Overall Study|Withdrawal by Subject|8|||
128743283|NCT01055639|463350197|FG001|Overall Study|Withdrawal by Subject|11|||
128743284|NCT00562159|463350198|FG000|Overall Study|Adverse Event|11|||
128743285|NCT00562159|463350199|FG001|Overall Study|Adverse Event|8|||
128743286|NCT00562159|463350198|FG000|Overall Study|Lost to Follow-up|5|||
128743287|NCT00562159|463350199|FG001|Overall Study|Lost to Follow-up|4|||
128743288|NCT00562159|463350198|FG000|Overall Study|Withdrawal by Subject|9|||
128743289|NCT00562159|463350199|FG001|Overall Study|Withdrawal by Subject|8|||
128743290|NCT00562159|463350198|FG000|Overall Study|Protocol Violation|12|||
128743291|NCT00562159|463350199|FG001|Overall Study|Protocol Violation|12|||
128743292|NCT00562159|463350198|FG000|Overall Study|Did not meet protocol eligibility|1|||
128743293|NCT00562159|463350199|FG001|Overall Study|Did not meet protocol eligibility|1|||
128743294|NCT00765245|463350200|FG000|Overall Study|disease progression|3|||
128743295|NCT00765245|463350201|FG001|Overall Study|disease progression|2|||
128743296|NCT00765245|463350200|FG000|Overall Study|Withdrawal by Subject|3|||
128743297|NCT00765245|463350201|FG001|Overall Study|Withdrawal by Subject|0|||
128743298|NCT00765245|463350200|FG000|Overall Study|Adverse Event|5|||
128743299|NCT00765245|463350201|FG001|Overall Study|Adverse Event|0|||
128743300|NCT00765245|463350200|FG000|Overall Study|Physician Decision|1|||
128743301|NCT00765245|463350201|FG001|Overall Study|Physician Decision|0|||
128743302|NCT00765245|463350200|FG000|Overall Study|Death|1|||
128743303|NCT00765245|463350201|FG001|Overall Study|Death|0|||
128743304|NCT02417246|463350202|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
128743305|NCT02417246|463350203|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
128743306|NCT02417246|463350202|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
128743307|NCT02417246|463350203|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
128743308|NCT02417246|463350202|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
128743309|NCT02417246|463350203|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
128743310|NCT02417246|463350202|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
128743311|NCT02417246|463350203|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
128743312|NCT01181921|463350207|FG000|Overall Study|Lost to Follow-up|1|||
128743313|NCT04408469|463350208|FG000|Overall Study|Lost to Follow-up|6|||
128743314|NCT04408469|463350209|FG001|Overall Study|Lost to Follow-up|9|||
128743315|NCT04408469|463350208|FG000|Overall Study|Withdrawal by Subject|6|||
128743316|NCT04408469|463350209|FG001|Overall Study|Withdrawal by Subject|1|||
128743317|NCT04408469|463350208|FG000|Overall Study|Dismissal due to ineligibility|0|||
128743318|NCT04408469|463350209|FG001|Overall Study|Dismissal due to ineligibility|1|||
128743319|NCT04321460|463350210|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
128743320|NCT04321460|463350211|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
128743321|NCT02162810|463350214|FG000|Overall Study|Protocol Violation|1|||
128743322|NCT02162810|463350215|FG001|Overall Study|Protocol Violation|0|||
128743323|NCT02162810|463350214|FG000|Overall Study|patients did not report compliance|4|||
128743324|NCT02162810|463350215|FG001|Overall Study|patients did not report compliance|1|||
128743325|NCT01308749|463350220|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
128743326|NCT01308749|463350221|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
128743327|NCT01308749|463350220|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
128743328|NCT01308749|463350221|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
128743329|NCT01308749|463350220|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
128743330|NCT01308749|463350221|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
128743331|NCT02519504|463350222|FG000|Overall Study|Protocol Violation|6|||
128743332|NCT02519504|463350223|FG001|Overall Study|Protocol Violation|5|||
128743333|NCT02519504|463350222|FG000|Overall Study|Ineligible for direct testing|12|||
128743334|NCT02519504|463350223|FG001|Overall Study|Ineligible for direct testing|12|||
128743335|NCT02519504|463350222|FG000|Overall Study|Did not participate in direct testing|95|||
128743336|NCT02519504|463350223|FG001|Overall Study|Did not participate in direct testing|86|||
128743337|NCT04726709|463350224|FG000|Overall Study|Withdrawal by Subject|2|||
128743338|NCT04726709|463350225|FG001|Overall Study|Withdrawal by Subject|2|||
128743339|NCT02546544|463350226|FG000|Overall Study|Disease Progression|14|||
128743340|NCT02546544|463350226|FG000|Overall Study|Adverse Event|1|||
128743341|NCT02546544|463350226|FG000|Overall Study|Withdrawal by Subject|1|||
128743342|NCT02223390|463350227|FG000|Overall Study|Lost to Follow-up|9|||
128743343|NCT02223390|463350228|FG001|Overall Study|Lost to Follow-up|4|||
128743344|NCT02548962|463350230|FG000|Overall Study|Withdrawal by Subject|1|||
128743345|NCT02548962|463350231|FG001|Overall Study|Withdrawal by Subject|0|||
128743346|NCT01197950|463350232|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
128743347|NCT01197950|463350233|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
128743348|NCT01197950|463350234|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
128743349|NCT04831736|463350235|FG000|Overall Study|Withdrawal by Subject|0|||
128743350|NCT04831736|463350236|FG001|Overall Study|Withdrawal by Subject|1|||
128743351|NCT01666002|463350239|FG000|Overall Study|Lost to Follow-up|5|||
128743352|NCT01666002|463350240|FG001|Overall Study|Lost to Follow-up|0|||
128743353|NCT01233817|463350241|FG000|Overall Study|Lost to Follow-up|1|||
128743354|NCT01233817|463350241|FG000|Overall Study|Withdrawal by Subject|2|||
128743355|NCT02159482|463350242|FG000|Overall Study|Withdrawal by Subject|2|||
128743356|NCT02159482|463350242|FG000|Overall Study|Physician Decision|3|||
128743357|NCT04000165|463350250|FG000|Overall Study|Physician Decision|1|||
128743358|NCT04000165|463350250|FG000|Overall Study|Withdrawal by Subject|1|||
128743359|NCT01753193|463350251|FG000|Overall Study|Withdrawal by Subject|23|||
128743360|NCT01753193|463350251|FG000|Overall Study|Lost to Follow-up|6|||
128743361|NCT01753193|463350251|FG000|Overall Study|Death|1|||
128743362|NCT01753193|463350251|FG000|Overall Study|Other|16|||
128743363|NCT01131312|463350252|FG000|Overall Study|Lost to Follow-up|425|||
128743364|NCT01131312|463350253|FG001|Overall Study|Lost to Follow-up|229|||
128743365|NCT01131312|463350254|FG002|Overall Study|Lost to Follow-up|351|||
128743366|NCT00803634|463350256|FG000|Overall Study|Withdrew Consent|1|||
128743367|NCT00803634|463350257|FG001|Overall Study|Withdrew Consent|0|||
128743368|NCT00803634|463350256|FG000|Overall Study|Lost to Follow-up|2|||
128743369|NCT00803634|463350257|FG001|Overall Study|Lost to Follow-up|3|||
128743370|NCT00803634|463350256|FG000|Overall Study|Death|3|||
128743371|NCT00803634|463350257|FG001|Overall Study|Death|2|||
128743372|NCT04307186|463350260|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
128743373|NCT04307186|463350260|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
128743374|NCT04307186|463350260|FG000|Washout 3-14 Days|Progressive disease|1|||
128743375|NCT04307186|463350260|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
128743376|NCT04307186|463350260|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
128743377|NCT03135522|463350267|FG000|Overall Study|Adverse Event|1|||
128743378|NCT03135522|463350268|FG001|Overall Study|Adverse Event|0|||
128743379|NCT02838017|463350270|FG000|Overall Study|Lost to Follow-up|14|||
128743380|NCT02838017|463350271|FG001|Overall Study|Lost to Follow-up|11|||
128743381|NCT02120924|463350272|FG000|Overall Study|Lack of Efficacy|1|||
128743382|NCT02120924|463350273|FG001|Overall Study|Lack of Efficacy|2|||
128743383|NCT02120924|463350274|FG002|Overall Study|Lack of Efficacy|3|||
128743384|NCT02120924|463350272|FG000|Overall Study|Adverse Event|0|||
128743385|NCT02120924|463350273|FG001|Overall Study|Adverse Event|1|||
128743386|NCT02120924|463350274|FG002|Overall Study|Adverse Event|3|||
128743387|NCT02120924|463350272|FG000|Overall Study|Withdrawal by Subject|16|||
128743388|NCT02120924|463350273|FG001|Overall Study|Withdrawal by Subject|20|||
128743389|NCT02120924|463350274|FG002|Overall Study|Withdrawal by Subject|8|||
128743390|NCT02120924|463350272|FG000|Overall Study|Lost to Follow-up|14|||
128743391|NCT02120924|463350273|FG001|Overall Study|Lost to Follow-up|14|||
128743392|NCT02120924|463350274|FG002|Overall Study|Lost to Follow-up|11|||
128743393|NCT02120924|463350272|FG000|Overall Study|Pregnancy|2|||
128743394|NCT02120924|463350273|FG001|Overall Study|Pregnancy|0|||
128743395|NCT02120924|463350274|FG002|Overall Study|Pregnancy|0|||
128743396|NCT02120924|463350272|FG000|Overall Study|Protocol Violation|3|||
128743397|NCT02120924|463350273|FG001|Overall Study|Protocol Violation|7|||
128743398|NCT02120924|463350274|FG002|Overall Study|Protocol Violation|2|||
128743399|NCT02120924|463350272|FG000|Overall Study|Physician Decision|0|||
128743400|NCT02120924|463350273|FG001|Overall Study|Physician Decision|1|||
128743401|NCT02120924|463350274|FG002|Overall Study|Physician Decision|1|||
128743402|NCT02120924|463350272|FG000|Overall Study|Death|1|||
128743403|NCT02120924|463350273|FG001|Overall Study|Death|0|||
128743404|NCT02120924|463350274|FG002|Overall Study|Death|0|||
128743405|NCT02120924|463350272|FG000|Overall Study|Compliance with IP|5|||
128743406|NCT02120924|463350273|FG001|Overall Study|Compliance with IP|1|||
128743407|NCT02120924|463350274|FG002|Overall Study|Compliance with IP|1|||
128743408|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
128743409|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
128743410|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
128743411|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
128743412|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
128743413|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
128743414|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
128743415|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
128743416|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
128743417|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
128743418|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
128743419|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
128743420|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
128743421|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
128743422|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
128743423|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
128743424|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
128743425|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
128743426|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
128743427|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
128743428|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
128743429|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
128743430|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
128743431|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
128743432|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
128743433|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
128743434|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
128743435|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
128743436|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
128743437|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
128743438|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
128743439|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
128743440|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
128743441|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
128743442|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
128743443|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
128743444|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
128743445|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
128743446|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
128743447|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
128743448|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
128743449|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
128743450|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
128743451|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
128743452|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
128743453|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
128743454|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
128743455|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
128743456|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
128743457|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
128743458|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
128743459|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
128743460|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
128743461|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
128743462|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
128743463|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
128743464|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
128743465|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
128743466|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
128743467|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
128743468|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
128743469|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
128743470|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
128743471|NCT01884350|463350275|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
128743472|NCT01884350|463350276|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
128743473|NCT01884350|463350277|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
128743474|NCT02345512|463350278|FG000|Overall Study|Adverse Event|1|||
128743475|NCT02345512|463350278|FG000|Overall Study|Withdrawal by Subject|1|||
128785502|NCT02524288|463506021|FG000|Overall Study|Site Discontinued Study Participation|1|||
128785503|NCT02524288|463506021|FG000|Overall Study|Study Terminated By Sponsor|1417|||
128743476|NCT01968434|463350281|FG000|Overall Study|Lost to Follow-up|3|||
128743477|NCT01968434|463350282|FG001|Overall Study|Lost to Follow-up|6|||
128743478|NCT00074282|463351680|FG000|Step 1|Adverse Event|32|||
128743479|NCT00074282|463351681|FG001|Step 1|Adverse Event|0|||
128743480|NCT00074282|463351682|FG002|Step 1|Adverse Event|0|||
128743481|NCT00074282|463351680|FG000|Step 1|Death|6|||
128743482|NCT00074282|463351681|FG001|Step 1|Death|0|||
128743483|NCT00074282|463351682|FG002|Step 1|Death|0|||
128743484|NCT00074282|463351680|FG000|Step 1|Withdrawal by Subject|7|||
128743485|NCT00074282|463351681|FG001|Step 1|Withdrawal by Subject|0|||
128743486|NCT00074282|463351682|FG002|Step 1|Withdrawal by Subject|0|||
128785504|NCT02524288|463506021|FG000|Overall Study|Subject Moved|32|||
128785505|NCT02524288|463506021|FG000|Overall Study|Withdrawal by Subject|76|||
128785506|NCT02524288|463506021|FG000|Overall Study|Pregnancy|22|||
128785507|NCT02524288|463506021|FG000|Overall Study|Physician Decision|2|||
128785508|NCT00517933|463506022|FG000|Period 1|Death|2|||
128785509|NCT00517933|463506023|FG001|Period 1|Death|1|||
128785510|NCT00517933|463506022|FG000|Period 1|Adverse Event|4|||
128785511|NCT00517933|463506023|FG001|Period 1|Adverse Event|4|||
128743487|NCT00074282|463351680|FG000|Step 1|Disease progression|2|||
128743488|NCT00074282|463351681|FG001|Step 1|Disease progression|0|||
128743489|NCT00074282|463351682|FG002|Step 1|Disease progression|0|||
128743490|NCT00074282|463351680|FG000|Step 1|Alternative therapy|2|||
128743491|NCT00074282|463351681|FG001|Step 1|Alternative therapy|0|||
128743492|NCT00074282|463351682|FG002|Step 1|Alternative therapy|0|||
128743493|NCT00074282|463351680|FG000|Step 1|Other complicating disease|2|||
128743494|NCT00074282|463351681|FG001|Step 1|Other complicating disease|0|||
128743495|NCT00074282|463351682|FG002|Step 1|Other complicating disease|0|||
128743496|NCT00074282|463351680|FG000|Step 1|Physician Decision|1|||
128743497|NCT00074282|463351681|FG001|Step 1|Physician Decision|0|||
128743498|NCT00074282|463351682|FG002|Step 1|Physician Decision|0|||
128743499|NCT00074282|463351680|FG000|Step 1|Ineligible|4|||
128743500|NCT00074282|463351681|FG001|Step 1|Ineligible|0|||
128743501|NCT00074282|463351682|FG002|Step 1|Ineligible|0|||
128743502|NCT00074282|463351680|FG000|Step 1|Never started treatment|2|||
128743503|NCT00074282|463351681|FG001|Step 1|Never started treatment|0|||
128743504|NCT00074282|463351682|FG002|Step 1|Never started treatment|0|||
128743505|NCT00074282|463351680|FG000|Step 2|Adverse Event|0|||
128743506|NCT00074282|463351681|FG001|Step 2|Adverse Event|2|||
128743507|NCT00074282|463351682|FG002|Step 2|Adverse Event|12|||
128743508|NCT00074282|463351680|FG000|Step 2|Disease progression|0|||
128743509|NCT00074282|463351681|FG001|Step 2|Disease progression|0|||
128743510|NCT00074282|463351682|FG002|Step 2|Disease progression|5|||
128743511|NCT00074282|463351680|FG000|Step 2|Death|0|||
128743512|NCT00074282|463351681|FG001|Step 2|Death|0|||
128743513|NCT00074282|463351682|FG002|Step 2|Death|3|||
128743514|NCT00074282|463351680|FG000|Step 2|Withdrawal by Subject|0|||
128743515|NCT00074282|463351681|FG001|Step 2|Withdrawal by Subject|0|||
128743516|NCT00074282|463351682|FG002|Step 2|Withdrawal by Subject|2|||
128743517|NCT00074282|463351680|FG000|Step 2|Physician Decision|0|||
128743518|NCT00074282|463351681|FG001|Step 2|Physician Decision|0|||
128743519|NCT00074282|463351682|FG002|Step 2|Physician Decision|1|||
128743520|NCT00074282|463351680|FG000|Step 2|Ineligible|0|||
128743521|NCT00074282|463351681|FG001|Step 2|Ineligible|0|||
128743522|NCT00074282|463351682|FG002|Step 2|Ineligible|1|||
128743523|NCT00464542|463351683|FG000|Pre-treatment|Withdrawal by Subject|2|||
128743524|NCT01773226|463351684|FG000|Overall Study|Withdrawal by Subject|1|||
128743525|NCT02055352|463351686|FG000|Overall Study|Adverse Event|0|||
128743526|NCT02055352|463351687|FG001|Overall Study|Adverse Event|1|||
128743527|NCT02055352|463351686|FG000|Overall Study|Non-eligible|0|||
128743528|NCT02055352|463351687|FG001|Overall Study|Non-eligible|1|||
128743529|NCT02055352|463351686|FG000|Overall Study|Poor compliance|1|||
128743530|NCT02055352|463351687|FG001|Overall Study|Poor compliance|1|||
128743531|NCT02055352|463351686|FG000|Overall Study|Death|1|||
128743532|NCT02055352|463351687|FG001|Overall Study|Death|2|||
128743533|NCT02055352|463351686|FG000|Overall Study|Patient decision|1|||
128743534|NCT02055352|463351687|FG001|Overall Study|Patient decision|1|||
128743535|NCT02055352|463351686|FG000|Overall Study|Use of prohibited treatment|0|||
128743536|NCT02055352|463351687|FG001|Overall Study|Use of prohibited treatment|3|||
128743537|NCT02055352|463351686|FG000|Overall Study|AE, study drug would be detrimental|1|||
128743538|NCT02055352|463351687|FG001|Overall Study|AE, study drug would be detrimental|3|||
128743539|NCT02055352|463351686|FG000|Overall Study|Withdrawal of informed consent|1|||
128743540|NCT02055352|463351687|FG001|Overall Study|Withdrawal of informed consent|0|||
128743541|NCT02055352|463351686|FG000|Overall Study|Reason unknown|1|||
128743542|NCT02055352|463351687|FG001|Overall Study|Reason unknown|5|||
128743543|NCT02553330|463351692|FG000|Overall Study|Study Terminated by Sponsor|2|||
128743544|NCT02553330|463351693|FG001|Overall Study|Study Terminated by Sponsor|13|||
128743545|NCT02553330|463351694|FG002|Overall Study|Study Terminated by Sponsor|12|||
128743546|NCT02553330|463351692|FG000|Overall Study|Withdrawal by Subject|3|||
128743547|NCT02553330|463351693|FG001|Overall Study|Withdrawal by Subject|19|||
128743548|NCT02553330|463351694|FG002|Overall Study|Withdrawal by Subject|21|||
128743549|NCT02553330|463351692|FG000|Overall Study|Other|0|||
128743550|NCT02553330|463351693|FG001|Overall Study|Other|1|||
128743551|NCT02553330|463351694|FG002|Overall Study|Other|0|||
128743552|NCT02553330|463351692|FG000|Overall Study|Non compliance to study treatment|0|||
128743553|NCT02553330|463351693|FG001|Overall Study|Non compliance to study treatment|1|||
128743554|NCT02553330|463351694|FG002|Overall Study|Non compliance to study treatment|0|||
128743555|NCT02553330|463351692|FG000|Overall Study|Adverse Event|0|||
128743556|NCT02553330|463351693|FG001|Overall Study|Adverse Event|1|||
128743557|NCT02553330|463351694|FG002|Overall Study|Adverse Event|0|||
128743558|NCT02553330|463351692|FG000|Overall Study|Lost to Follow-up|0|||
128743559|NCT02553330|463351693|FG001|Overall Study|Lost to Follow-up|4|||
128743560|NCT02553330|463351694|FG002|Overall Study|Lost to Follow-up|4|||
128743561|NCT03551938|463351698|FG000|3-Month Follow Up|Lost to Follow-up|39|||
128743562|NCT03551938|463351699|FG001|3-Month Follow Up|Lost to Follow-up|38|||
128743563|NCT03551938|463351698|FG000|6-Month Follow Up|Lost to Follow-up|46|||
128743564|NCT03551938|463351699|FG001|6-Month Follow Up|Lost to Follow-up|42|||
128743565|NCT03551938|463351698|FG000|9-Month Follow Up|Lost to Follow-up|44|||
128743566|NCT03551938|463351699|FG001|9-Month Follow Up|Lost to Follow-up|43|||
128743567|NCT04137380|463351704|FG000|Overall Study|Physician Decision|0|||
128743568|NCT04137380|463351705|FG001|Overall Study|Physician Decision|0|||
128743569|NCT04137380|463351706|FG002|Overall Study|Physician Decision|0|||
128743570|NCT04137380|463351707|FG003|Overall Study|Physician Decision|1|||
128743571|NCT04137380|463351708|FG004|Overall Study|Physician Decision|0|||
128743572|NCT04137380|463351709|FG005|Overall Study|Physician Decision|0|||
128743573|NCT04137380|463351710|FG006|Overall Study|Physician Decision|0|||
128743574|NCT02265705|463351715|FG000|Treatment Period Week 0-24|Adverse Event|3|||
128743575|NCT02265705|463351716|FG001|Treatment Period Week 0-24|Adverse Event|2|||
128743576|NCT02265705|463351717|FG002|Treatment Period Week 0-24|Adverse Event|0|||
128743577|NCT02265705|463351718|FG003|Treatment Period Week 0-24|Adverse Event|0|||
128743578|NCT02265705|463351719|FG004|Treatment Period Week 0-24|Adverse Event|0|||
128743579|NCT02265705|463351720|FG005|Treatment Period Week 0-24|Adverse Event|0|||
128743580|NCT02265705|463351721|FG006|Treatment Period Week 0-24|Adverse Event|0|||
128743581|NCT02265705|463351715|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
128743582|NCT02265705|463351716|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
128743583|NCT02265705|463351717|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
128743584|NCT02265705|463351718|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
128743585|NCT02265705|463351719|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
128743586|NCT02265705|463351720|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
128743587|NCT02265705|463351721|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
128743588|NCT02265705|463351715|FG000|Treatment Period Week 0-24|Physician Decision|1|||
128743589|NCT02265705|463351716|FG001|Treatment Period Week 0-24|Physician Decision|0|||
128743590|NCT02265705|463351717|FG002|Treatment Period Week 0-24|Physician Decision|0|||
128743591|NCT02265705|463351718|FG003|Treatment Period Week 0-24|Physician Decision|0|||
128743592|NCT02265705|463351719|FG004|Treatment Period Week 0-24|Physician Decision|0|||
128743593|NCT02265705|463351720|FG005|Treatment Period Week 0-24|Physician Decision|0|||
128743594|NCT02265705|463351721|FG006|Treatment Period Week 0-24|Physician Decision|0|||
128785512|NCT00517933|463506022|FG000|Period 1|Lost to Follow-up|2|||
128785513|NCT00517933|463506023|FG001|Period 1|Lost to Follow-up|0|||
128743595|NCT02265705|463351715|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
128743596|NCT02265705|463351716|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
128743597|NCT02265705|463351717|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
128743598|NCT02265705|463351718|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
128743599|NCT02265705|463351719|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
128743600|NCT02265705|463351720|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
128743601|NCT02265705|463351721|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
128743602|NCT02265705|463351715|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
128743603|NCT02265705|463351716|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
128743604|NCT02265705|463351717|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
128743605|NCT02265705|463351718|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
128743606|NCT02265705|463351719|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
128743607|NCT02265705|463351720|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
128743608|NCT02265705|463351721|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
128743609|NCT02265705|463351715|FG000|Rescue Period|Withdrawal by Subject|0|||
128743610|NCT02265705|463351716|FG001|Rescue Period|Withdrawal by Subject|0|||
128743611|NCT02265705|463351717|FG002|Rescue Period|Withdrawal by Subject|1|||
128743612|NCT02265705|463351718|FG003|Rescue Period|Withdrawal by Subject|0|||
128743613|NCT02265705|463351719|FG004|Rescue Period|Withdrawal by Subject|0|||
128743614|NCT02265705|463351720|FG005|Rescue Period|Withdrawal by Subject|0|||
128743615|NCT02265705|463351721|FG006|Rescue Period|Withdrawal by Subject|0|||
128743616|NCT02265705|463351715|FG000|Rescue Period|Death|0|||
128743617|NCT02265705|463351716|FG001|Rescue Period|Death|0|||
128743618|NCT02265705|463351717|FG002|Rescue Period|Death|1|||
128743619|NCT02265705|463351718|FG003|Rescue Period|Death|0|||
128743620|NCT02265705|463351719|FG004|Rescue Period|Death|0|||
128743621|NCT02265705|463351720|FG005|Rescue Period|Death|0|||
128743622|NCT02265705|463351721|FG006|Rescue Period|Death|0|||
128743623|NCT02265705|463351715|FG000|Rescue Period|Lack of Efficacy|0|||
128743624|NCT02265705|463351716|FG001|Rescue Period|Lack of Efficacy|0|||
128743625|NCT02265705|463351717|FG002|Rescue Period|Lack of Efficacy|1|||
128743626|NCT02265705|463351718|FG003|Rescue Period|Lack of Efficacy|0|||
128743627|NCT02265705|463351719|FG004|Rescue Period|Lack of Efficacy|0|||
128743628|NCT02265705|463351720|FG005|Rescue Period|Lack of Efficacy|0|||
128743629|NCT02265705|463351721|FG006|Rescue Period|Lack of Efficacy|0|||
128743630|NCT02265705|463351715|FG000|Open Label Period|Adverse Event|0|||
128743631|NCT02265705|463351716|FG001|Open Label Period|Adverse Event|0|||
128743632|NCT02265705|463351717|FG002|Open Label Period|Adverse Event|0|||
128743633|NCT02265705|463351718|FG003|Open Label Period|Adverse Event|2|||
128743634|NCT02265705|463351719|FG004|Open Label Period|Adverse Event|2|||
128743635|NCT02265705|463351720|FG005|Open Label Period|Adverse Event|0|||
128743636|NCT02265705|463351721|FG006|Open Label Period|Adverse Event|0|||
128743637|NCT02265705|463351715|FG000|Open Label Period|Physician Decision|0|||
128743638|NCT02265705|463351716|FG001|Open Label Period|Physician Decision|0|||
128743639|NCT02265705|463351717|FG002|Open Label Period|Physician Decision|0|||
128743640|NCT02265705|463351718|FG003|Open Label Period|Physician Decision|0|||
128743641|NCT02265705|463351719|FG004|Open Label Period|Physician Decision|1|||
128743642|NCT02265705|463351720|FG005|Open Label Period|Physician Decision|0|||
128743643|NCT02265705|463351721|FG006|Open Label Period|Physician Decision|0|||
128743644|NCT02265705|463351715|FG000|Open Label Period|Withdrawal by Subject|0|||
128743645|NCT02265705|463351716|FG001|Open Label Period|Withdrawal by Subject|0|||
128743646|NCT02265705|463351717|FG002|Open Label Period|Withdrawal by Subject|0|||
128743647|NCT02265705|463351718|FG003|Open Label Period|Withdrawal by Subject|0|||
128743648|NCT02265705|463351719|FG004|Open Label Period|Withdrawal by Subject|2|||
128743649|NCT02265705|463351720|FG005|Open Label Period|Withdrawal by Subject|0|||
128743650|NCT02265705|463351721|FG006|Open Label Period|Withdrawal by Subject|0|||
128743651|NCT02265705|463351715|FG000|Follow-up Period|Sponsor Decision|0|||
128743652|NCT02265705|463351716|FG001|Follow-up Period|Sponsor Decision|0|||
128743653|NCT02265705|463351717|FG002|Follow-up Period|Sponsor Decision|0|||
128743654|NCT02265705|463351718|FG003|Follow-up Period|Sponsor Decision|0|||
128743655|NCT02265705|463351719|FG004|Follow-up Period|Sponsor Decision|0|||
128743656|NCT02265705|463351720|FG005|Follow-up Period|Sponsor Decision|1|||
128743657|NCT02265705|463351721|FG006|Follow-up Period|Sponsor Decision|6|||
128743658|NCT02265705|463351715|FG000|Follow-up Period|Adverse Event|0|||
128743659|NCT02265705|463351716|FG001|Follow-up Period|Adverse Event|0|||
128743660|NCT02265705|463351717|FG002|Follow-up Period|Adverse Event|0|||
128743661|NCT02265705|463351718|FG003|Follow-up Period|Adverse Event|0|||
128743662|NCT02265705|463351719|FG004|Follow-up Period|Adverse Event|0|||
128743663|NCT02265705|463351720|FG005|Follow-up Period|Adverse Event|0|||
128743664|NCT02265705|463351721|FG006|Follow-up Period|Adverse Event|3|||
128743665|NCT02265705|463351715|FG000|Follow-up Period|Physician Decision|0|||
128743666|NCT02265705|463351716|FG001|Follow-up Period|Physician Decision|0|||
128743667|NCT02265705|463351717|FG002|Follow-up Period|Physician Decision|0|||
128743668|NCT02265705|463351718|FG003|Follow-up Period|Physician Decision|0|||
128743669|NCT02265705|463351719|FG004|Follow-up Period|Physician Decision|0|||
128743670|NCT02265705|463351720|FG005|Follow-up Period|Physician Decision|0|||
128743671|NCT02265705|463351721|FG006|Follow-up Period|Physician Decision|1|||
128743672|NCT02265705|463351715|FG000|Follow-up Period|Withdrawal by Subject|0|||
128743673|NCT02265705|463351716|FG001|Follow-up Period|Withdrawal by Subject|0|||
128743674|NCT02265705|463351717|FG002|Follow-up Period|Withdrawal by Subject|0|||
128743675|NCT02265705|463351718|FG003|Follow-up Period|Withdrawal by Subject|0|||
128743676|NCT02265705|463351719|FG004|Follow-up Period|Withdrawal by Subject|0|||
128743677|NCT02265705|463351720|FG005|Follow-up Period|Withdrawal by Subject|0|||
128743678|NCT02265705|463351721|FG006|Follow-up Period|Withdrawal by Subject|1|||
128743679|NCT00779246|463351722|FG000|Overall Study|Missing sufficient data for analysis|33|||
128743680|NCT00779246|463351723|FG001|Overall Study|Missing sufficient data for analysis|53|||
128743681|NCT02079805|463351724|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
128743682|NCT02079805|463351725|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
128743683|NCT02079805|463351724|FG000|Overall Study|Voluntary Withdrawal|0|||
128743684|NCT02079805|463351725|FG001|Overall Study|Voluntary Withdrawal|1|||
128743685|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
128743686|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
128743687|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
128743688|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
128743689|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
128743690|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
128743691|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
128743692|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
128743693|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
128743694|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
128743695|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
128743696|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
128743697|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
128743698|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
128743699|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
128743700|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
128743701|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
128743702|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
128743703|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
128743704|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
128743705|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
128743706|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
128743707|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
128743708|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
128743709|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
128743710|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
128743711|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
128743712|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
128743713|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
128743714|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
128743715|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
128743716|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
128743717|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
128743718|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
128743719|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
128743720|NCT00383435|463351726|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
128743721|NCT00383435|463351727|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
128743722|NCT00383435|463351728|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
128743723|NCT00383435|463351729|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
128743724|NCT00383435|463351730|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
128743725|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
128743726|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
128743727|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
128743728|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
128743729|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
128743730|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
128743731|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
128743732|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
128743733|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
128743734|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
128743735|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
128743736|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
128743737|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
128743738|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
128743739|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
128743740|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
128743741|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
128743742|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
128743743|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
128743744|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
128743745|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
128743746|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
128743747|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
128743748|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
128743749|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
128743750|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
128743751|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
128743752|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
128743753|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
128743754|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
128785514|NCT00517933|463506022|FG000|Period 1|Underwent lung transplant|0|||
128743755|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
128743756|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
128743757|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
128743758|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
128743759|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
128743760|NCT00383435|463351726|FG000|26-Week Treatment Safety Extension|Administrative|1|||
128743761|NCT00383435|463351727|FG001|26-Week Treatment Safety Extension|Administrative|1|||
128743762|NCT00383435|463351728|FG002|26-Week Treatment Safety Extension|Administrative|0|||
128743763|NCT00383435|463351729|FG003|26-Week Treatment Safety Extension|Administrative|1|||
128743764|NCT00383435|463351730|FG004|26-Week Treatment Safety Extension|Administrative|0|||
128743765|NCT02682264|463351731|FG000|Overall Study|Withdrawal by Subject|56|||
128743766|NCT02682264|463351732|FG001|Overall Study|Withdrawal by Subject|45|||
128743767|NCT02682264|463351731|FG000|Overall Study|Lost to Follow-up|49|||
128743768|NCT02682264|463351732|FG001|Overall Study|Lost to Follow-up|41|||
128743769|NCT02682264|463351731|FG000|Overall Study|Lack of Efficacy|14|||
128743770|NCT02682264|463351732|FG001|Overall Study|Lack of Efficacy|16|||
128743771|NCT02682264|463351731|FG000|Overall Study|Withdrawal by Parent|6|||
128743772|NCT02682264|463351732|FG001|Overall Study|Withdrawal by Parent|7|||
128743773|NCT02682264|463351731|FG000|Overall Study|Adverse Event|9|||
128743774|NCT02682264|463351732|FG001|Overall Study|Adverse Event|0|||
128743775|NCT02682264|463351731|FG000|Overall Study|Noncompliance with study drug|1|||
128743776|NCT02682264|463351732|FG001|Overall Study|Noncompliance with study drug|4|||
128743777|NCT02682264|463351731|FG000|Overall Study|Pregnancy|1|||
128743778|NCT02682264|463351732|FG001|Overall Study|Pregnancy|2|||
128743779|NCT02682264|463351731|FG000|Overall Study|Recovery|1|||
128743780|NCT02682264|463351732|FG001|Overall Study|Recovery|2|||
128743781|NCT02682264|463351731|FG000|Overall Study|Progressive Disease|1|||
128743782|NCT02682264|463351732|FG001|Overall Study|Progressive Disease|0|||
128743783|NCT02682264|463351731|FG000|Overall Study|Technical Problems|0|||
128743784|NCT02682264|463351732|FG001|Overall Study|Technical Problems|1|||
128743785|NCT02682264|463351731|FG000|Overall Study|Moved abroad and unable to continue|0|||
128743786|NCT02682264|463351732|FG001|Overall Study|Moved abroad and unable to continue|3|||
128743787|NCT02682264|463351731|FG000|Overall Study|Stopped test article application|0|||
128743788|NCT02682264|463351732|FG001|Overall Study|Stopped test article application|1|||
128743789|NCT03447769|463351733|FG000|Overall Study|Progressive disease|138|||
128743790|NCT03447769|463351734|FG001|Overall Study|Progressive disease|148|||
128743791|NCT03447769|463351733|FG000|Overall Study|Study terminated by Sponsor|60|||
128743792|NCT03447769|463351734|FG001|Overall Study|Study terminated by Sponsor|44|||
128743793|NCT03447769|463351733|FG000|Overall Study|Adverse Event|34|||
128743794|NCT03447769|463351734|FG001|Overall Study|Adverse Event|31|||
128743795|NCT03447769|463351733|FG000|Overall Study|Patient decision|27|||
128743796|NCT03447769|463351734|FG001|Overall Study|Patient decision|27|||
128743797|NCT03447769|463351733|FG000|Overall Study|Protocol deviation|4|||
128743798|NCT03447769|463351734|FG001|Overall Study|Protocol deviation|6|||
128743799|NCT03447769|463351733|FG000|Overall Study|Death|2|||
128743800|NCT03447769|463351734|FG001|Overall Study|Death|7|||
128743801|NCT03447769|463351733|FG000|Overall Study|Technical problems|1|||
128743802|NCT03447769|463351734|FG001|Overall Study|Technical problems|0|||
128743803|NCT03447769|463351733|FG000|Overall Study|Lost to Follow-up|0|||
128743804|NCT03447769|463351734|FG001|Overall Study|Lost to Follow-up|1|||
128743805|NCT03447769|463351733|FG000|Overall Study|Physician Decision|13|||
128743806|NCT03447769|463351734|FG001|Overall Study|Physician Decision|5|||
128743807|NCT01343407|463351736|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
128743808|NCT01343407|463351737|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
128743809|NCT01343407|463351738|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
128743810|NCT01343407|463351739|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
128743811|NCT01343407|463351740|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
128743812|NCT01343407|463351741|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
128743813|NCT01343407|463351736|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
128743814|NCT01343407|463351737|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
128743815|NCT01343407|463351738|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
128743816|NCT01343407|463351739|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
128743817|NCT01343407|463351740|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
128743818|NCT01343407|463351741|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
128743819|NCT03950739|463351742|FG000|Treatment Phase|Adverse Event|2|||
128743820|NCT03950739|463351742|FG000|Optional Extension Phase|Death|1|||
128743821|NCT03950739|463351742|FG000|Optional Extension Phase|Progressive Disease|5|||
128743822|NCT03950739|463351742|FG000|Optional Extension Phase|Adverse Event|7|||
128743823|NCT03950739|463351742|FG000|Optional Extension Phase|Lost to Follow-up|2|||
128743824|NCT03950739|463351742|FG000|Optional Extension Phase|Site Closure|2|||
128785515|NCT00517933|463506023|FG001|Period 1|Underwent lung transplant|1|||
128743825|NCT03950739|463351742|FG000|Optional Extension Phase|Pregnancy|1|||
128743826|NCT03264989|463351746|FG000|Overall Study|Lost to Follow-up|1|||
128743827|NCT03264989|463351747|FG001|Overall Study|Lost to Follow-up|0|||
128743828|NCT03264989|463351746|FG000|Overall Study|New Therapy for study Indication|1|||
128743829|NCT03264989|463351747|FG001|Overall Study|New Therapy for study Indication|0|||
128785516|NCT00517933|463506022|FG000|Period 2|Death|2|||
128743830|NCT03264989|463351746|FG000|Overall Study|Protocol Violation|0|||
128743831|NCT03264989|463351747|FG001|Overall Study|Protocol Violation|1|||
128743832|NCT03264989|463351746|FG000|Overall Study|Patient decision|13|||
128743833|NCT03264989|463351747|FG001|Overall Study|Patient decision|0|||
128743834|NCT03264989|463351746|FG000|Overall Study|Physician Decision|6|||
128743835|NCT03264989|463351747|FG001|Overall Study|Physician Decision|4|||
128743836|NCT03264989|463351746|FG000|Overall Study|Adverse Event|2|||
128743837|NCT03264989|463351747|FG001|Overall Study|Adverse Event|1|||
128743838|NCT03264989|463351746|FG000|Overall Study|Death|1|||
128743839|NCT03264989|463351747|FG001|Overall Study|Death|1|||
128743840|NCT03264989|463351746|FG000|Overall Study|Pregnancy|2|||
128743841|NCT03264989|463351747|FG001|Overall Study|Pregnancy|0|||
128743842|NCT03264989|463351746|FG000|Overall Study|End of Study|19|||
128743843|NCT03264989|463351747|FG001|Overall Study|End of Study|5|||
128743844|NCT01775137|463351748|FG000|Overall Study|Death|1|||
128743845|NCT01775137|463351748|FG000|Overall Study|Protocol deviation|2|||
128743846|NCT01775137|463351748|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128743847|NCT01775137|463351748|FG000|Overall Study|Adverse Event|1|||
128743848|NCT01775137|463351748|FG000|Overall Study|Withdrawal by participants|5|||
128743849|NCT01175668|463351756|FG000|Overall Study|Withdrawal by Subject|2|||
128743850|NCT01175668|463351757|FG001|Overall Study|Withdrawal by Subject|0|||
128743851|NCT00874029|463351758|FG000|Overall Study|Withdrawal by Subject|10|||
128743852|NCT00874029|463351758|FG000|Overall Study|Pregnancy|4|||
128743853|NCT00874029|463351758|FG000|Overall Study|Physician Decision|1|||
128743854|NCT00874029|463351758|FG000|Overall Study|Adverse Event|1|||
128743855|NCT00874029|463351758|FG000|Overall Study|Lost to Follow-up|5|||
128743856|NCT00856583|463351759|FG000|Overall Study|Lack of Efficacy|389|||
128743857|NCT00856583|463351760|FG001|Overall Study|Lack of Efficacy|377|||
128743858|NCT00856583|463351759|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
128743859|NCT00856583|463351760|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
128743860|NCT00856583|463351759|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
128743861|NCT00856583|463351760|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
128743862|NCT00856583|463351759|FG000|Overall Study|Non-compliance|305|||
128743863|NCT00856583|463351760|FG001|Overall Study|Non-compliance|262|||
128743864|NCT00856583|463351759|FG000|Overall Study|Withdrawal by Subject|1092|||
128743865|NCT00856583|463351760|FG001|Overall Study|Withdrawal by Subject|919|||
128743866|NCT00856583|463351759|FG000|Overall Study|Physician Decision|59|||
128743867|NCT00856583|463351760|FG001|Overall Study|Physician Decision|82|||
128743868|NCT00856583|463351759|FG000|Overall Study|Pregnancy|14|||
128743869|NCT00856583|463351760|FG001|Overall Study|Pregnancy|5|||
128743870|NCT00856583|463351759|FG000|Overall Study|Other|92|||
128743871|NCT00856583|463351760|FG001|Overall Study|Other|104|||
128743872|NCT00856583|463351759|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
128743873|NCT00856583|463351760|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
128743874|NCT02328326|463351763|FG000|Overall Study|Withdrawal by Subject|10|||
128743875|NCT02328326|463351764|FG001|Overall Study|Withdrawal by Subject|3|||
128743876|NCT02328326|463351763|FG000|Overall Study|Death|2|||
128743877|NCT02328326|463351764|FG001|Overall Study|Death|1|||
128743878|NCT02328326|463351763|FG000|Overall Study|Lost to Follow-up|10|||
128743879|NCT02328326|463351764|FG001|Overall Study|Lost to Follow-up|4|||
128743880|NCT01618838|463351778|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
128743881|NCT03965052|463351782|FG000|Overall Study|Protocol Violation|1|||
128743882|NCT03965052|463351783|FG001|Overall Study|Protocol Violation|0|||
128743883|NCT00499889|463351792|FG000|Overall Study|Infection prior to treatment|1|||
128743884|NCT00142909|463351796|FG000|Randomization|Various Reasons|7|||
128743885|NCT00142909|463351797|FG001|Randomization|Various Reasons|10|||
128743886|NCT00142909|463351796|FG000|Medications Begin|Protocol Violation|2|||
128743887|NCT00142909|463351797|FG001|Medications Begin|Protocol Violation|0|||
128743888|NCT00142909|463351796|FG000|Medications Begin|Withdrawal by Subject|5|||
128743889|NCT00142909|463351797|FG001|Medications Begin|Withdrawal by Subject|3|||
128743890|NCT00142909|463351796|FG000|Medications Begin|Withdrawal by Subject|2|||
128743891|NCT00142909|463351797|FG001|Medications Begin|Withdrawal by Subject|0|||
128743892|NCT01910519|463351798|FG000|Overall Study|Withdrawal by Subject|2|||
128743893|NCT01910519|463351799|FG001|Overall Study|Withdrawal by Subject|0|||
128743894|NCT01910519|463351798|FG000|Overall Study|Adverse Event|2|||
128743895|NCT01910519|463351799|FG001|Overall Study|Adverse Event|0|||
128743896|NCT04266028|463351800|FG000|Overall Study|Adverse Event|0|||
128743897|NCT04266028|463351801|FG001|Overall Study|Adverse Event|0|||
128743898|NCT04266028|463351802|FG002|Overall Study|Adverse Event|1|||
128743899|NCT04266028|463351803|FG003|Overall Study|Adverse Event|0|||
128743900|NCT04266028|463351804|FG004|Overall Study|Adverse Event|1|||
128743901|NCT04266028|463351805|FG005|Overall Study|Adverse Event|0|||
128743902|NCT04266028|463351806|FG006|Overall Study|Adverse Event|2|||
128743903|NCT04266028|463351807|FG007|Overall Study|Adverse Event|0|||
128743904|NCT04266028|463351800|FG000|Overall Study|temporary halt of the study|0|||
128743905|NCT04266028|463351801|FG001|Overall Study|temporary halt of the study|0|||
128743906|NCT04266028|463351802|FG002|Overall Study|temporary halt of the study|0|||
128743907|NCT04266028|463351803|FG003|Overall Study|temporary halt of the study|0|||
128743908|NCT04266028|463351804|FG004|Overall Study|temporary halt of the study|0|||
128743909|NCT04266028|463351805|FG005|Overall Study|temporary halt of the study|0|||
128743910|NCT04266028|463351806|FG006|Overall Study|temporary halt of the study|2|||
128743911|NCT04266028|463351807|FG007|Overall Study|temporary halt of the study|1|||
128743912|NCT04266028|463351800|FG000|Overall Study|Onset of birch pollen season|0|||
128785517|NCT00517933|463506023|FG001|Period 2|Death|4|||
128743913|NCT04266028|463351801|FG001|Overall Study|Onset of birch pollen season|0|||
128743914|NCT04266028|463351802|FG002|Overall Study|Onset of birch pollen season|0|||
128743915|NCT04266028|463351803|FG003|Overall Study|Onset of birch pollen season|0|||
128743916|NCT04266028|463351804|FG004|Overall Study|Onset of birch pollen season|1|||
128743917|NCT04266028|463351805|FG005|Overall Study|Onset of birch pollen season|0|||
128743918|NCT04266028|463351806|FG006|Overall Study|Onset of birch pollen season|0|||
128743919|NCT04266028|463351807|FG007|Overall Study|Onset of birch pollen season|0|||
128743920|NCT01898195|463351808|FG000|Smoking Abstinence|Did not have good measurements|35|||
128743921|NCT01898195|463351809|FG001|Smoking Abstinence|Did not have good measurements|38|||
128743922|NCT01898195|463351810|FG002|Smoking Abstinence|Did not have good measurements|36|||
128743923|NCT02720484|463351812|FG000|Treatment on Study|Adverse Event|1|||
128743924|NCT02720484|463351812|FG000|Treatment on Study|Withdrawal by Subject|1|||
128743925|NCT02720484|463351812|FG000|Treatment on Study|Progressive Disease|4|||
128743926|NCT02720484|463351812|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
128743927|NCT02720484|463351812|FG000|Follow Up for 2 Years|Death|3|||
128743928|NCT02720484|463351812|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
128743929|NCT05070897|463351818|FG000|Overall Study|Protocol Violation|123|||
128743930|NCT05070897|463351819|FG001|Overall Study|Protocol Violation|68|||
128743931|NCT01617629|463351820|FG000|Overall Study|Death|2|||
128743932|NCT01617629|463351820|FG000|Overall Study|Investigator's Clinical Judgement|1|||
128743933|NCT01617629|463351820|FG000|Overall Study|Reason Not Specified|1|||
128743934|NCT01617629|463351820|FG000|Overall Study|Participant Withdrew Consent|2|||
128743935|NCT01663636|463351821|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
128743936|NCT01663636|463351822|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
128743937|NCT03832946|463351823|FG000|Overall Study|Adverse Event|3|||
128743938|NCT03832946|463351824|FG001|Overall Study|Adverse Event|1|||
128743939|NCT03832946|463351823|FG000|Overall Study|Lost to Follow-up|1|||
128743940|NCT03832946|463351824|FG001|Overall Study|Lost to Follow-up|0|||
128743941|NCT03832946|463351823|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
128743942|NCT03832946|463351824|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
128743943|NCT03832946|463351823|FG000|Overall Study|Lack of Efficacy|1|||
128743944|NCT03832946|463351824|FG001|Overall Study|Lack of Efficacy|0|||
128743945|NCT03832946|463351823|FG000|Overall Study|Withdrawal by Subject|12|||
128743946|NCT03832946|463351824|FG001|Overall Study|Withdrawal by Subject|9|||
128743947|NCT02863991|463351825|FG000|Overall Study|Death|0|||
128743948|NCT02863991|463351826|FG001|Overall Study|Death|3|||
128743949|NCT02863991|463351825|FG000|Overall Study|Lack of Efficacy|0|||
128743950|NCT02863991|463351826|FG001|Overall Study|Lack of Efficacy|1|||
128743951|NCT02863991|463351825|FG000|Overall Study|Study Terminated|2|||
128743952|NCT02863991|463351826|FG001|Overall Study|Study Terminated|8|||
128743953|NCT02663817|463351827|FG000|Overall Study|Screen failure|2|||
128743954|NCT01438541|463351831|FG000|Overall Study|Physician Decision|1|||
128743955|NCT01438541|463351831|FG000|Overall Study|Withdrawal by Subject|1|||
128743956|NCT01438541|463351831|FG000|Overall Study|discharge from the hospital|5|||
128743957|NCT04401579|463354320|FG000|Overall Study|Death|23|||
128743958|NCT04401579|463354321|FG001|Overall Study|Death|36|||
128743959|NCT04401579|463354320|FG000|Overall Study|Lost to Follow-up|40|||
128743960|NCT04401579|463354321|FG001|Overall Study|Lost to Follow-up|41|||
128743961|NCT04401579|463354320|FG000|Overall Study|Withdrawal by Subject|8|||
128743962|NCT04401579|463354321|FG001|Overall Study|Withdrawal by Subject|16|||
128743963|NCT04401579|463354320|FG000|Overall Study|Physician Decision|1|||
128743964|NCT04401579|463354321|FG001|Overall Study|Physician Decision|2|||
128743965|NCT04401579|463354320|FG000|Overall Study|Became ineligible after enrollment|1|||
128743966|NCT04401579|463354321|FG001|Overall Study|Became ineligible after enrollment|1|||
128743967|NCT04401579|463354320|FG000|Overall Study|Enrolled but treatment not administered|7|||
128743968|NCT04401579|463354321|FG001|Overall Study|Enrolled but treatment not administered|9|||
128743969|NCT04401579|463354320|FG000|Overall Study|Adverse Event|2|||
128743970|NCT04401579|463354321|FG001|Overall Study|Adverse Event|1|||
128743971|NCT04401579|463354320|FG000|Overall Study|Scheduling error|1|||
128743972|NCT04401579|463354321|FG001|Overall Study|Scheduling error|2|||
128743973|NCT04401579|463354320|FG000|Overall Study|Transferred to another hospital|1|||
128743974|NCT04401579|463354321|FG001|Overall Study|Transferred to another hospital|2|||
128743975|NCT03521635|463354322|FG000|Overall Study|Adverse Event|1|||
128743976|NCT03521635|463354323|FG001|Overall Study|Adverse Event|1|||
128743977|NCT03521635|463354322|FG000|Overall Study|Refused to complete study visit|1|||
128743978|NCT03521635|463354323|FG001|Overall Study|Refused to complete study visit|0|||
128743979|NCT03521635|463354322|FG000|Overall Study|Refused to continue trial medication|2|||
128743980|NCT03521635|463354323|FG001|Overall Study|Refused to continue trial medication|2|||
128785518|NCT00517933|463506022|FG000|Period 2|Adverse Event|2|||
128743981|NCT03521635|463354322|FG000|Overall Study|Lost to Follow-up|0|||
128743982|NCT03521635|463354323|FG001|Overall Study|Lost to Follow-up|1|||
128743983|NCT03521635|463354322|FG000|Overall Study|Meet exclusion criteria|0|||
128743984|NCT03521635|463354323|FG001|Overall Study|Meet exclusion criteria|1|||
128743985|NCT03521635|463354322|FG000|Overall Study|Patient not taken study medicine|0|||
128743986|NCT03521635|463354323|FG001|Overall Study|Patient not taken study medicine|1|||
128743987|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Adverse Event|5|||
128743988|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Adverse Event|8|||
128743989|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Adverse Event|4|||
128743990|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Adverse Event|8|||
128743991|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
128743992|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
128743993|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
128743994|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
128743995|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
128743996|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
128743997|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
128743998|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
128743999|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Physician Decision|1|||
128744000|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Physician Decision|0|||
128744001|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Physician Decision|0|||
128744002|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Physician Decision|0|||
128744003|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
128744004|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
128744005|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
128744006|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
128744007|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Pregnancy|0|||
128744008|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Pregnancy|1|||
128744009|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Pregnancy|0|||
128744010|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Pregnancy|0|||
128744011|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
128744012|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
128744013|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
128744014|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
128744015|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Death|0|||
128744016|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Death|1|||
128744017|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Death|0|||
128744018|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Death|0|||
128744019|NCT00071487|463354327|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
128744020|NCT00071487|463354328|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
128744021|NCT00071487|463354329|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
128744022|NCT00071487|463354330|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
128744023|NCT00071487|463354327|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
128744024|NCT00071487|463354328|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
128744025|NCT00071487|463354329|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
128744026|NCT00071487|463354330|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
128744027|NCT00071487|463354327|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
128744028|NCT00071487|463354328|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
128744029|NCT00071487|463354329|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
128744030|NCT00071487|463354330|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
128744031|NCT00071487|463354327|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128744032|NCT00071487|463354328|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128744033|NCT00071487|463354329|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
128744034|NCT00071487|463354330|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
128744035|NCT00071487|463354327|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
128744036|NCT00071487|463354328|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
128744037|NCT00071487|463354329|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
128744038|NCT00071487|463354330|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
128744039|NCT00071487|463354327|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
128744040|NCT00071487|463354328|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
128744041|NCT00071487|463354329|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
128744042|NCT00071487|463354330|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
128744043|NCT00071487|463354327|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
128744044|NCT00071487|463354328|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
128744045|NCT00071487|463354329|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
128744046|NCT00071487|463354330|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
128785519|NCT00517933|463506023|FG001|Period 2|Adverse Event|4|||
128744047|NCT01227889|463354331|FG000|Randomized Phase (RP)|Adverse Event|13|||
128744048|NCT01227889|463354332|FG001|Randomized Phase (RP)|Adverse Event|0|||
128744049|NCT01227889|463354331|FG000|Randomized Phase (RP)|Physician Decision|13|||
128744050|NCT01227889|463354332|FG001|Randomized Phase (RP)|Physician Decision|5|||
128744051|NCT01227889|463354331|FG000|Randomized Phase (RP)|Progressive Disease|135|||
128744052|NCT01227889|463354332|FG001|Randomized Phase (RP)|Progressive Disease|52|||
128744053|NCT01227889|463354331|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
128744054|NCT01227889|463354332|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
128744055|NCT01227889|463354331|FG000|Randomized Phase (RP)|Missing|1|||
128744056|NCT01227889|463354332|FG001|Randomized Phase (RP)|Missing|3|||
128744057|NCT01227889|463354331|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
128744058|NCT01227889|463354332|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
128744059|NCT01227889|463354331|FG000|Crossover Phase|Adverse Event|0|||
128744060|NCT01227889|463354332|FG001|Crossover Phase|Adverse Event|1|||
128744061|NCT01227889|463354331|FG000|Crossover Phase|Physician Decision|0|||
128744062|NCT01227889|463354332|FG001|Crossover Phase|Physician Decision|3|||
128744063|NCT01227889|463354331|FG000|Crossover Phase|Progressive Disease|0|||
128744064|NCT01227889|463354332|FG001|Crossover Phase|Progressive Disease|31|||
128744065|NCT01227889|463354331|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
128744066|NCT01227889|463354332|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
128744067|NCT01227889|463354331|FG000|Crossover Phase|Withdrawal by Subject|0|||
128744068|NCT01227889|463354332|FG001|Crossover Phase|Withdrawal by Subject|1|||
128744069|NCT03268811|463354333|FG000|Overall Study|Adverse Event|0|||
128744070|NCT03268811|463354334|FG001|Overall Study|Adverse Event|1|||
128744071|NCT04827212|463354339|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
128744072|NCT04827212|463354340|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
128744073|NCT04827212|463354339|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
128744074|NCT04827212|463354340|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
128744075|NCT02528214|463354356|FG000|Overall Study|Protocol Violation|0|||
128744076|NCT02528214|463354357|FG001|Overall Study|Protocol Violation|1|||
128744077|NCT02528214|463354356|FG000|Overall Study|Adverse Event|0|||
128744078|NCT02528214|463354357|FG001|Overall Study|Adverse Event|1|||
128744079|NCT02528214|463354356|FG000|Overall Study|Other than specified above|0|||
128744080|NCT02528214|463354357|FG001|Overall Study|Other than specified above|1|||
128744081|NCT00941603|463354361|FG000|Overall Study|Adverse Event|10|||
128744082|NCT00941603|463354362|FG001|Overall Study|Adverse Event|15|||
128744083|NCT00941603|463354363|FG002|Overall Study|Adverse Event|5|||
128744084|NCT00941603|463354364|FG003|Overall Study|Adverse Event|1|||
128744085|NCT00941603|463354365|FG004|Overall Study|Adverse Event|4|||
128744086|NCT00941603|463354366|FG005|Overall Study|Adverse Event|0|||
128744087|NCT00941603|463354361|FG000|Overall Study|Lost to Follow-up|0|||
128744088|NCT00941603|463354362|FG001|Overall Study|Lost to Follow-up|0|||
128744089|NCT00941603|463354363|FG002|Overall Study|Lost to Follow-up|0|||
128744090|NCT00941603|463354364|FG003|Overall Study|Lost to Follow-up|1|||
128744091|NCT00941603|463354365|FG004|Overall Study|Lost to Follow-up|0|||
128744092|NCT00941603|463354366|FG005|Overall Study|Lost to Follow-up|2|||
128744093|NCT00941603|463354361|FG000|Overall Study|Withdrawal by Subject|0|||
128744094|NCT00941603|463354362|FG001|Overall Study|Withdrawal by Subject|0|||
128744095|NCT00941603|463354363|FG002|Overall Study|Withdrawal by Subject|0|||
128744096|NCT00941603|463354364|FG003|Overall Study|Withdrawal by Subject|2|||
128744097|NCT00941603|463354365|FG004|Overall Study|Withdrawal by Subject|0|||
128744098|NCT00941603|463354366|FG005|Overall Study|Withdrawal by Subject|1|||
128744099|NCT00941603|463354361|FG000|Overall Study|Protocol Violation|0|||
128744100|NCT00941603|463354362|FG001|Overall Study|Protocol Violation|1|||
128744101|NCT00941603|463354363|FG002|Overall Study|Protocol Violation|0|||
128744102|NCT00941603|463354364|FG003|Overall Study|Protocol Violation|0|||
128744103|NCT00941603|463354365|FG004|Overall Study|Protocol Violation|0|||
128744104|NCT00941603|463354366|FG005|Overall Study|Protocol Violation|0|||
128744105|NCT00941603|463354361|FG000|Overall Study|Did not meet protocol eligibility|1|||
128744106|NCT00941603|463354362|FG001|Overall Study|Did not meet protocol eligibility|0|||
128744107|NCT00941603|463354363|FG002|Overall Study|Did not meet protocol eligibility|0|||
128744108|NCT00941603|463354364|FG003|Overall Study|Did not meet protocol eligibility|0|||
128744109|NCT00941603|463354365|FG004|Overall Study|Did not meet protocol eligibility|0|||
128744110|NCT00941603|463354366|FG005|Overall Study|Did not meet protocol eligibility|0|||
128744111|NCT02014116|463354368|FG000|Overall Study|Progressive Disease|3|||
128744112|NCT02014116|463354369|FG001|Overall Study|Progressive Disease|4|||
128744113|NCT02014116|463354370|FG002|Overall Study|Progressive Disease|2|||
128744114|NCT02014116|463354371|FG003|Overall Study|Progressive Disease|6|||
128744115|NCT02014116|463354372|FG004|Overall Study|Progressive Disease|1|||
128744116|NCT02014116|463354373|FG005|Overall Study|Progressive Disease|13|||
128744117|NCT02014116|463354374|FG006|Overall Study|Progressive Disease|1|||
128744118|NCT02014116|463354375|FG007|Overall Study|Progressive Disease|3|||
128744119|NCT02014116|463354376|FG008|Overall Study|Progressive Disease|7|||
128744120|NCT02014116|463354368|FG000|Overall Study|Adverse Event|0|||
128744121|NCT02014116|463354369|FG001|Overall Study|Adverse Event|0|||
128744122|NCT02014116|463354370|FG002|Overall Study|Adverse Event|0|||
128744123|NCT02014116|463354371|FG003|Overall Study|Adverse Event|0|||
128744124|NCT02014116|463354372|FG004|Overall Study|Adverse Event|1|||
128744125|NCT02014116|463354373|FG005|Overall Study|Adverse Event|0|||
128744126|NCT02014116|463354374|FG006|Overall Study|Adverse Event|0|||
128744127|NCT02014116|463354375|FG007|Overall Study|Adverse Event|1|||
128744128|NCT02014116|463354376|FG008|Overall Study|Adverse Event|0|||
128744129|NCT02014116|463354368|FG000|Overall Study|Lost to Follow-up|0|||
128744130|NCT02014116|463354369|FG001|Overall Study|Lost to Follow-up|0|||
128744131|NCT02014116|463354370|FG002|Overall Study|Lost to Follow-up|0|||
128744132|NCT02014116|463354371|FG003|Overall Study|Lost to Follow-up|0|||
128744133|NCT02014116|463354372|FG004|Overall Study|Lost to Follow-up|0|||
128744134|NCT02014116|463354373|FG005|Overall Study|Lost to Follow-up|1|||
128744135|NCT02014116|463354374|FG006|Overall Study|Lost to Follow-up|0|||
128744136|NCT02014116|463354375|FG007|Overall Study|Lost to Follow-up|0|||
128744137|NCT02014116|463354376|FG008|Overall Study|Lost to Follow-up|1|||
128744138|NCT02014116|463354368|FG000|Overall Study|Death|0|||
128744139|NCT02014116|463354369|FG001|Overall Study|Death|0|||
128744140|NCT02014116|463354370|FG002|Overall Study|Death|0|||
128744141|NCT02014116|463354371|FG003|Overall Study|Death|0|||
128744142|NCT02014116|463354372|FG004|Overall Study|Death|0|||
128744143|NCT02014116|463354373|FG005|Overall Study|Death|0|||
128744144|NCT02014116|463354374|FG006|Overall Study|Death|0|||
128744145|NCT02014116|463354375|FG007|Overall Study|Death|1|||
128744146|NCT02014116|463354376|FG008|Overall Study|Death|1|||
128744147|NCT02014116|463354368|FG000|Overall Study|Withdrawal by Subject|0|||
128744148|NCT02014116|463354369|FG001|Overall Study|Withdrawal by Subject|0|||
128744149|NCT02014116|463354370|FG002|Overall Study|Withdrawal by Subject|1|||
128744150|NCT02014116|463354371|FG003|Overall Study|Withdrawal by Subject|1|||
128744151|NCT02014116|463354372|FG004|Overall Study|Withdrawal by Subject|0|||
128744152|NCT02014116|463354373|FG005|Overall Study|Withdrawal by Subject|1|||
128744153|NCT02014116|463354374|FG006|Overall Study|Withdrawal by Subject|0|||
128744154|NCT02014116|463354375|FG007|Overall Study|Withdrawal by Subject|0|||
128744155|NCT02014116|463354376|FG008|Overall Study|Withdrawal by Subject|0|||
128744156|NCT02014116|463354368|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
128744157|NCT02014116|463354369|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
128744158|NCT02014116|463354370|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
128744159|NCT02014116|463354371|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
128744160|NCT02014116|463354372|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
128744161|NCT02014116|463354373|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
128744162|NCT02014116|463354374|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
128744163|NCT02014116|463354375|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
128744164|NCT02014116|463354376|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
128744165|NCT02014116|463354368|FG000|Overall Study|Physician Decision|0|||
128744166|NCT02014116|463354369|FG001|Overall Study|Physician Decision|0|||
128744167|NCT02014116|463354370|FG002|Overall Study|Physician Decision|0|||
128744168|NCT02014116|463354371|FG003|Overall Study|Physician Decision|0|||
128744169|NCT02014116|463354372|FG004|Overall Study|Physician Decision|0|||
128744170|NCT02014116|463354373|FG005|Overall Study|Physician Decision|0|||
128744171|NCT02014116|463354374|FG006|Overall Study|Physician Decision|0|||
128744172|NCT02014116|463354375|FG007|Overall Study|Physician Decision|0|||
128744173|NCT02014116|463354376|FG008|Overall Study|Physician Decision|1|||
128744174|NCT00583557|463354377|FG000|Overall Study|Withdrawal by Subject|18|||
128744175|NCT00583557|463354377|FG000|Overall Study|Adverse Event|9|||
128744176|NCT00583557|463354377|FG000|Overall Study|Lack of Efficacy|31|||
128744177|NCT00583557|463354377|FG000|Overall Study|Lack of Compliance|5|||
128744178|NCT00583557|463354377|FG000|Overall Study|Other|5|||
128744179|NCT00583557|463354377|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
128744180|NCT02347761|463354378|FG000|All Collected|Death|1|||
128744181|NCT02347761|463354379|FG001|All Collected|Death|0|||
128744182|NCT02347761|463354380|FG002|All Collected|Death|0|||
128744183|NCT02347761|463354378|FG000|All Collected|Lost to Follow-up|3|||
128744184|NCT02347761|463354379|FG001|All Collected|Lost to Follow-up|2|||
128744185|NCT02347761|463354380|FG002|All Collected|Lost to Follow-up|3|||
128744186|NCT02347761|463354378|FG000|All Collected|Withdrawal by Subject|11|||
128744187|NCT02347761|463354379|FG001|All Collected|Withdrawal by Subject|11|||
128744188|NCT02347761|463354380|FG002|All Collected|Withdrawal by Subject|22|||
128744189|NCT02347761|463354378|FG000|All Collected|invetigator disretion|2|||
128744190|NCT02347761|463354379|FG001|All Collected|invetigator disretion|0|||
128744191|NCT02347761|463354380|FG002|All Collected|invetigator disretion|0|||
128744192|NCT02347761|463354378|FG000|All Collected|instillation site pain|0|||
128744193|NCT02347761|463354379|FG001|All Collected|instillation site pain|0|||
128744194|NCT02347761|463354380|FG002|All Collected|instillation site pain|1|||
128744195|NCT02347761|463354378|FG000|All Collected|exacerbation of COPD|0|||
128744196|NCT02347761|463354379|FG001|All Collected|exacerbation of COPD|0|||
128744197|NCT02347761|463354380|FG002|All Collected|exacerbation of COPD|1|||
128744198|NCT02347761|463354378|FG000|All Collected|moved/travel|0|||
128744199|NCT02347761|463354379|FG001|All Collected|moved/travel|1|||
128744200|NCT02347761|463354380|FG002|All Collected|moved/travel|0|||
128744201|NCT02347761|463354378|FG000|On Study Treatment|Lack of Efficacy|2|||
128744202|NCT02347761|463354379|FG001|On Study Treatment|Lack of Efficacy|3|||
128744203|NCT02347761|463354380|FG002|On Study Treatment|Lack of Efficacy|4|||
128744204|NCT02347761|463354378|FG000|On Study Treatment|non-compliance with study medication|0|||
128744205|NCT02347761|463354379|FG001|On Study Treatment|non-compliance with study medication|0|||
128744206|NCT02347761|463354380|FG002|On Study Treatment|non-compliance with study medication|2|||
128744207|NCT02347761|463354378|FG000|On Study Treatment|Withdrawal by Subject|7|||
128744208|NCT02347761|463354379|FG001|On Study Treatment|Withdrawal by Subject|3|||
128744209|NCT02347761|463354380|FG002|On Study Treatment|Withdrawal by Subject|5|||
128744210|NCT02347761|463354378|FG000|On Study Treatment|move/travel|2|||
128744211|NCT02347761|463354379|FG001|On Study Treatment|move/travel|6|||
128744212|NCT02347761|463354380|FG002|On Study Treatment|move/travel|5|||
128744213|NCT02347761|463354378|FG000|On Study Treatment|dissastisfaction with device|2|||
128744214|NCT02347761|463354379|FG001|On Study Treatment|dissastisfaction with device|1|||
128744215|NCT02347761|463354380|FG002|On Study Treatment|dissastisfaction with device|4|||
128744216|NCT02347761|463354378|FG000|On Study Treatment|Lost to Follow-up|2|||
128744217|NCT02347761|463354379|FG001|On Study Treatment|Lost to Follow-up|1|||
128744218|NCT02347761|463354380|FG002|On Study Treatment|Lost to Follow-up|1|||
128744219|NCT02347761|463354378|FG000|On Study Treatment|investigator discretion|2|||
128744220|NCT02347761|463354379|FG001|On Study Treatment|investigator discretion|0|||
128744221|NCT02347761|463354380|FG002|On Study Treatment|investigator discretion|0|||
128744222|NCT02347761|463354378|FG000|On Study Treatment|durg not working|0|||
128744223|NCT02347761|463354379|FG001|On Study Treatment|durg not working|1|||
128744224|NCT02347761|463354380|FG002|On Study Treatment|durg not working|1|||
128744225|NCT02347761|463354378|FG000|On Study Treatment|Adverse Event|10|||
128744226|NCT02347761|463354379|FG001|On Study Treatment|Adverse Event|8|||
128744227|NCT02347761|463354380|FG002|On Study Treatment|Adverse Event|20|||
128744228|NCT03879798|463354381|FG000|Overall Study|Adverse Event|0|||
128744229|NCT03879798|463354382|FG001|Overall Study|Adverse Event|0|||
128744230|NCT03879798|463354383|FG002|Overall Study|Adverse Event|0|||
128744231|NCT03879798|463354384|FG003|Overall Study|Adverse Event|0|||
128744232|NCT03879798|463354385|FG004|Overall Study|Adverse Event|0|||
128744233|NCT03879798|463354386|FG005|Overall Study|Adverse Event|1|||
128744234|NCT03879798|463354381|FG000|Overall Study|Lack of Efficacy|0|||
128744235|NCT03879798|463354382|FG001|Overall Study|Lack of Efficacy|0|||
128744236|NCT03879798|463354383|FG002|Overall Study|Lack of Efficacy|0|||
128744237|NCT03879798|463354384|FG003|Overall Study|Lack of Efficacy|0|||
128744238|NCT03879798|463354385|FG004|Overall Study|Lack of Efficacy|0|||
128744239|NCT03879798|463354386|FG005|Overall Study|Lack of Efficacy|1|||
128744240|NCT03879798|463354381|FG000|Overall Study|Withdrawal by Subject|0|||
128744241|NCT03879798|463354382|FG001|Overall Study|Withdrawal by Subject|0|||
128744242|NCT03879798|463354383|FG002|Overall Study|Withdrawal by Subject|0|||
128744243|NCT03879798|463354384|FG003|Overall Study|Withdrawal by Subject|0|||
128744244|NCT03879798|463354385|FG004|Overall Study|Withdrawal by Subject|0|||
128744245|NCT03879798|463354386|FG005|Overall Study|Withdrawal by Subject|1|||
128744246|NCT03625570|463354387|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
128744247|NCT03625570|463354388|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
128744248|NCT03625570|463354387|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
128744249|NCT03625570|463354388|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
128744250|NCT03625570|463354387|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
128744251|NCT03625570|463354388|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
128744252|NCT01040130|463354396|FG000|Overall Study|Adverse Event|1|||
128744253|NCT01040130|463354397|FG001|Overall Study|Adverse Event|1|||
128744254|NCT01040130|463354398|FG002|Overall Study|Adverse Event|0|||
128744255|NCT01040130|463354399|FG003|Overall Study|Adverse Event|5|||
128744256|NCT01040130|463354400|FG004|Overall Study|Adverse Event|0|||
128744257|NCT01040130|463354401|FG005|Overall Study|Adverse Event|3|||
128744258|NCT01040130|463354396|FG000|Overall Study|Protocol Violation|0|||
128744259|NCT01040130|463354397|FG001|Overall Study|Protocol Violation|0|||
128744260|NCT01040130|463354398|FG002|Overall Study|Protocol Violation|2|||
128744261|NCT01040130|463354399|FG003|Overall Study|Protocol Violation|0|||
128744262|NCT01040130|463354400|FG004|Overall Study|Protocol Violation|0|||
128744263|NCT01040130|463354401|FG005|Overall Study|Protocol Violation|0|||
128744264|NCT01040130|463354396|FG000|Overall Study|Withdrawal by Subject|0|||
128785520|NCT00517933|463506022|FG000|Period 2|Physician Decision|1|||
128785521|NCT00517933|463506023|FG001|Period 2|Physician Decision|0|||
128785522|NCT00517933|463506022|FG000|Period 2|Withdrawal by Subject|1|||
128744265|NCT01040130|463354397|FG001|Overall Study|Withdrawal by Subject|2|||
128744266|NCT01040130|463354398|FG002|Overall Study|Withdrawal by Subject|0|||
128744267|NCT01040130|463354399|FG003|Overall Study|Withdrawal by Subject|0|||
128744268|NCT01040130|463354400|FG004|Overall Study|Withdrawal by Subject|0|||
128744269|NCT01040130|463354401|FG005|Overall Study|Withdrawal by Subject|1|||
128744270|NCT01040130|463354396|FG000|Overall Study|Other reasons not listed above|2|||
128744271|NCT01040130|463354397|FG001|Overall Study|Other reasons not listed above|0|||
128744272|NCT01040130|463354398|FG002|Overall Study|Other reasons not listed above|0|||
128744273|NCT01040130|463354399|FG003|Overall Study|Other reasons not listed above|0|||
128744274|NCT01040130|463354400|FG004|Overall Study|Other reasons not listed above|0|||
128744275|NCT01040130|463354401|FG005|Overall Study|Other reasons not listed above|0|||
128744276|NCT01310036|463354406|FG000|Overall Study|Administrative/other|10|||
128744277|NCT01310036|463354406|FG000|Overall Study|Withdrew Consent|11|||
128744278|NCT01310036|463354406|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
128744279|NCT01310036|463354406|FG000|Overall Study|Progression of Disease|164|||
128744280|NCT01310036|463354406|FG000|Overall Study|Death|1|||
128744281|NCT01310036|463354406|FG000|Overall Study|Adverse event or intercurrent illness|12|||
128744282|NCT00553267|463354407|FG000|Overall Study|Adverse Event|8|||
128744283|NCT00553267|463354408|FG001|Overall Study|Adverse Event|10|||
128744284|NCT00553267|463354409|FG002|Overall Study|Adverse Event|5|||
128744285|NCT00553267|463354407|FG000|Overall Study|Non compliant with protocol|3|||
128744286|NCT00553267|463354408|FG001|Overall Study|Non compliant with protocol|3|||
128744287|NCT00553267|463354409|FG002|Overall Study|Non compliant with protocol|2|||
128744288|NCT00553267|463354407|FG000|Overall Study|Lost to Follow-up|0|||
128744289|NCT00553267|463354408|FG001|Overall Study|Lost to Follow-up|0|||
128744290|NCT00553267|463354409|FG002|Overall Study|Lost to Follow-up|1|||
128744291|NCT00553267|463354407|FG000|Overall Study|Consent withdrawn|2|||
128744292|NCT00553267|463354408|FG001|Overall Study|Consent withdrawn|3|||
128744293|NCT00553267|463354409|FG002|Overall Study|Consent withdrawn|1|||
128744294|NCT00553267|463354407|FG000|Overall Study|Specified category|1|||
128744295|NCT00553267|463354408|FG001|Overall Study|Specified category|2|||
128744296|NCT00553267|463354409|FG002|Overall Study|Specified category|1|||
128744297|NCT00096135|463354410|FG000|Overall Study|Physician Decision|20|||
128744298|NCT00096135|463354411|FG001|Overall Study|Physician Decision|4|||
128744299|NCT00096135|463354410|FG000|Overall Study|Refusal of further protocol therapy|4|||
128744300|NCT00096135|463354411|FG001|Overall Study|Refusal of further protocol therapy|1|||
128744301|NCT00096135|463354410|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
128744302|NCT00096135|463354411|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
128744303|NCT00096135|463354410|FG000|Overall Study|Other, specify|15|||
128744304|NCT00096135|463354411|FG001|Overall Study|Other, specify|3|||
128744305|NCT00096135|463354410|FG000|Overall Study|Ineligible|2|||
128744306|NCT00096135|463354411|FG001|Overall Study|Ineligible|0|||
128744307|NCT01568047|463354413|FG000|Overall Study|Ineligibility|1|||
128744308|NCT01568047|463354414|FG001|Overall Study|Ineligibility|0|||
128744309|NCT01568047|463354415|FG002|Overall Study|Ineligibility|0|||
128744310|NCT01568047|463354416|FG003|Overall Study|Ineligibility|0|||
128744311|NCT01568047|463354413|FG000|Overall Study|Withdrawal by Subject|0|||
128744312|NCT01568047|463354414|FG001|Overall Study|Withdrawal by Subject|1|||
128744313|NCT01568047|463354415|FG002|Overall Study|Withdrawal by Subject|0|||
128744314|NCT01568047|463354416|FG003|Overall Study|Withdrawal by Subject|0|||
128744315|NCT01568047|463354413|FG000|Overall Study|Adverse Event|0|||
128744316|NCT01568047|463354414|FG001|Overall Study|Adverse Event|0|||
128744317|NCT01568047|463354415|FG002|Overall Study|Adverse Event|1|||
128744318|NCT01568047|463354416|FG003|Overall Study|Adverse Event|1|||
128744319|NCT01944046|463354417|FG000|Randomized to DB|Adverse Event|5|||
128744320|NCT01944046|463354418|FG001|Randomized to DB|Adverse Event|2|||
128744321|NCT01944046|463354417|FG000|Randomized to DB|Clinical Worsening|3|||
128744322|NCT01944046|463354418|FG001|Randomized to DB|Clinical Worsening|2|||
128744323|NCT01944046|463354417|FG000|Randomized to DB|Lost to Follow-up|3|||
128744324|NCT01944046|463354418|FG001|Randomized to DB|Lost to Follow-up|3|||
128744325|NCT01944046|463354417|FG000|Randomized to DB|Withdrawal by Subject|2|||
128744326|NCT01944046|463354418|FG001|Randomized to DB|Withdrawal by Subject|4|||
128744327|NCT01944046|463354417|FG000|Randomized to DB|Physician Decision|1|||
128744328|NCT01944046|463354418|FG001|Randomized to DB|Physician Decision|2|||
128744329|NCT01944046|463354417|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
128744330|NCT01944046|463354418|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
128744331|NCT01944046|463354417|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
128744332|NCT01944046|463354418|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
128744333|NCT01944046|463354417|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
128744334|NCT01944046|463354418|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
128744335|NCT01944046|463354417|FG000|Open Label Eligible and Consented|Adverse Event|6|||
128744336|NCT01944046|463354418|FG001|Open Label Eligible and Consented|Adverse Event|1|||
128744337|NCT01944046|463354417|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
128744338|NCT01944046|463354418|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
128744339|NCT01944046|463354417|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
128744340|NCT01944046|463354418|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
128744341|NCT02007577|463354420|FG000|Overall Study|Adverse Event|1|||
128744342|NCT02007577|463354421|FG001|Overall Study|Adverse Event|0|||
128744343|NCT02007577|463354420|FG000|Overall Study|Withdrawal by Subject|0|||
128744344|NCT02007577|463354421|FG001|Overall Study|Withdrawal by Subject|1|||
128744345|NCT02504294|463354422|FG000|Overall Study|Adverse Event|15|||
128744346|NCT02504294|463354423|FG001|Overall Study|Adverse Event|12|||
128785523|NCT00517933|463506023|FG001|Period 2|Withdrawal by Subject|3|||
128785524|NCT00517933|463506022|FG000|Period 2|Underwent lung transplant|0|||
128785525|NCT00517933|463506023|FG001|Period 2|Underwent lung transplant|2|||
128785526|NCT01467700|463506024|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
128785527|NCT01467700|463506025|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
128785528|NCT01467700|463506026|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
128785529|NCT01467700|463506027|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
128785530|NCT01467700|463506024|FG000|Overall Study|Major Protocol Deviation|3|||
128785531|NCT01467700|463506025|FG001|Overall Study|Major Protocol Deviation|3|||
128785532|NCT01467700|463506026|FG002|Overall Study|Major Protocol Deviation|2|||
128785533|NCT01467700|463506027|FG003|Overall Study|Major Protocol Deviation|3|||
128785534|NCT01467700|463506024|FG000|Overall Study|Lost to Follow-up|6|||
128785535|NCT01467700|463506025|FG001|Overall Study|Lost to Follow-up|5|||
128785536|NCT01467700|463506026|FG002|Overall Study|Lost to Follow-up|2|||
128785537|NCT01467700|463506027|FG003|Overall Study|Lost to Follow-up|3|||
128785538|NCT01467700|463506024|FG000|Overall Study|Voluntary Withdrawal|5|||
128785539|NCT01467700|463506025|FG001|Overall Study|Voluntary Withdrawal|7|||
128785540|NCT01467700|463506026|FG002|Overall Study|Voluntary Withdrawal|6|||
128785541|NCT01467700|463506027|FG003|Overall Study|Voluntary Withdrawal|2|||
128785542|NCT01467700|463506024|FG000|Overall Study|Study Termination|6|||
128785543|NCT01467700|463506025|FG001|Overall Study|Study Termination|5|||
128785544|NCT01467700|463506026|FG002|Overall Study|Study Termination|10|||
128744347|NCT02504294|463354422|FG000|Overall Study|Withdrawal by Subject|7|||
128744348|NCT02504294|463354423|FG001|Overall Study|Withdrawal by Subject|1|||
128744349|NCT02504294|463354422|FG000|Overall Study|Protocol Violation|27|||
128744350|NCT02504294|463354423|FG001|Overall Study|Protocol Violation|26|||
128744351|NCT02504294|463354422|FG000|Overall Study|Physician Decision|1|||
128744352|NCT02504294|463354423|FG001|Overall Study|Physician Decision|2|||
128744353|NCT02504294|463354422|FG000|Overall Study|Lost to Follow-up|6|||
128744354|NCT02504294|463354423|FG001|Overall Study|Lost to Follow-up|7|||
128744355|NCT01985126|463354424|FG000|Overall Study|Death|15|||
128744356|NCT01985126|463354425|FG001|Overall Study|Death|69|||
128744357|NCT01985126|463354424|FG000|Overall Study|Lost to Follow-up|0|||
128744358|NCT01985126|463354425|FG001|Overall Study|Lost to Follow-up|8|||
128744359|NCT01985126|463354424|FG000|Overall Study|Study Terminated By Sponsor|1|||
128744360|NCT01985126|463354425|FG001|Overall Study|Study Terminated By Sponsor|22|||
128744361|NCT01985126|463354424|FG000|Overall Study|Withdrawal by Subject|2|||
128744362|NCT01985126|463354425|FG001|Overall Study|Withdrawal by Subject|7|||
128744363|NCT01953926|463354428|FG000|Overall Study|Withdrawal by Subject|23|||
128744364|NCT01953926|463354429|FG001|Overall Study|Withdrawal by Subject|3|||
128744365|NCT01953926|463354430|FG002|Overall Study|Withdrawal by Subject|3|||
128744366|NCT01953926|463354431|FG003|Overall Study|Withdrawal by Subject|5|||
128744367|NCT01953926|463354432|FG004|Overall Study|Withdrawal by Subject|6|||
128744368|NCT01953926|463354433|FG005|Overall Study|Withdrawal by Subject|0|||
128744369|NCT01953926|463354434|FG006|Overall Study|Withdrawal by Subject|1|||
128744370|NCT01953926|463354428|FG000|Overall Study|Physician Decision|1|||
128744371|NCT01953926|463354429|FG001|Overall Study|Physician Decision|0|||
128744372|NCT01953926|463354430|FG002|Overall Study|Physician Decision|0|||
128744373|NCT01953926|463354431|FG003|Overall Study|Physician Decision|0|||
128744374|NCT01953926|463354432|FG004|Overall Study|Physician Decision|2|||
128744375|NCT01953926|463354433|FG005|Overall Study|Physician Decision|0|||
128744376|NCT01953926|463354434|FG006|Overall Study|Physician Decision|0|||
128744377|NCT01953926|463354428|FG000|Overall Study|Lost to Follow-up|18|||
128744378|NCT01953926|463354429|FG001|Overall Study|Lost to Follow-up|3|||
128744379|NCT01953926|463354430|FG002|Overall Study|Lost to Follow-up|0|||
128744380|NCT01953926|463354431|FG003|Overall Study|Lost to Follow-up|5|||
128744381|NCT01953926|463354432|FG004|Overall Study|Lost to Follow-up|3|||
128744382|NCT01953926|463354433|FG005|Overall Study|Lost to Follow-up|0|||
128744383|NCT01953926|463354434|FG006|Overall Study|Lost to Follow-up|0|||
128744384|NCT01953926|463354428|FG000|Overall Study|Protocol Violation|1|||
128744385|NCT01953926|463354429|FG001|Overall Study|Protocol Violation|0|||
128744386|NCT01953926|463354430|FG002|Overall Study|Protocol Violation|0|||
128744387|NCT01953926|463354431|FG003|Overall Study|Protocol Violation|0|||
128744388|NCT01953926|463354432|FG004|Overall Study|Protocol Violation|0|||
128744389|NCT01953926|463354433|FG005|Overall Study|Protocol Violation|0|||
128744390|NCT01953926|463354434|FG006|Overall Study|Protocol Violation|0|||
128744391|NCT01953926|463354428|FG000|Overall Study|Other, Disease progression|2|||
128744392|NCT01953926|463354429|FG001|Overall Study|Other, Disease progression|1|||
128744393|NCT01953926|463354430|FG002|Overall Study|Other, Disease progression|0|||
128744394|NCT01953926|463354431|FG003|Overall Study|Other, Disease progression|0|||
128744395|NCT01953926|463354432|FG004|Overall Study|Other, Disease progression|1|||
128744396|NCT01953926|463354433|FG005|Overall Study|Other, Disease progression|0|||
128744397|NCT01953926|463354434|FG006|Overall Study|Other, Disease progression|0|||
128744398|NCT01953926|463354428|FG000|Overall Study|Discontinuation of study by sponsor|41|||
128744399|NCT01953926|463354429|FG001|Overall Study|Discontinuation of study by sponsor|7|||
128744400|NCT01953926|463354430|FG002|Overall Study|Discontinuation of study by sponsor|5|||
128744401|NCT01953926|463354431|FG003|Overall Study|Discontinuation of study by sponsor|12|||
128744402|NCT01953926|463354432|FG004|Overall Study|Discontinuation of study by sponsor|46|||
128744403|NCT01953926|463354433|FG005|Overall Study|Discontinuation of study by sponsor|5|||
128744404|NCT01953926|463354434|FG006|Overall Study|Discontinuation of study by sponsor|6|||
128744405|NCT01953926|463354428|FG000|Overall Study|Not Treated|1|||
128744406|NCT01953926|463354429|FG001|Overall Study|Not Treated|0|||
128785545|NCT01467700|463506027|FG003|Overall Study|Study Termination|7|||
128744407|NCT01953926|463354430|FG002|Overall Study|Not Treated|1|||
128744408|NCT01953926|463354431|FG003|Overall Study|Not Treated|0|||
128744409|NCT01953926|463354432|FG004|Overall Study|Not Treated|0|||
128744410|NCT01953926|463354433|FG005|Overall Study|Not Treated|0|||
128744411|NCT01953926|463354434|FG006|Overall Study|Not Treated|0|||
128744412|NCT00784043|463354438|FG000|Overall Study|Withdrawal by Subject|8|||
128744413|NCT00784043|463354439|FG001|Overall Study|Withdrawal by Subject|5|||
128744414|NCT00784043|463354438|FG000|Overall Study|Protocol Terminated|23|||
128744415|NCT00784043|463354439|FG001|Overall Study|Protocol Terminated|1|||
128744416|NCT03585244|463354444|FG000|Overall Study|Withdrawal by Subject|15|||
128744417|NCT06281548|463354446|FG000|Overall Study|Lost to Follow-up|3|||
128785546|NCT01467700|463506024|FG000|Overall Study|Pregnancy|0|||
128744418|NCT03538626|463354447|FG000|Overall Study|Withdrawal by Subject|0|||
128744419|NCT03538626|463354448|FG001|Overall Study|Withdrawal by Subject|1|||
128744420|NCT03538626|463354449|FG002|Overall Study|Withdrawal by Subject|0|||
128785547|NCT01467700|463506025|FG001|Overall Study|Pregnancy|1|||
128744421|NCT03538626|463354450|FG003|Overall Study|Withdrawal by Subject|0|||
128744422|NCT03538626|463354451|FG004|Overall Study|Withdrawal by Subject|0|||
128744423|NCT03538626|463354452|FG005|Overall Study|Withdrawal by Subject|0|||
128744424|NCT03538626|463354453|FG006|Overall Study|Withdrawal by Subject|0|||
128744425|NCT03538626|463354454|FG007|Overall Study|Withdrawal by Subject|0|||
128744426|NCT03538626|463354447|FG000|Overall Study|Lost to Follow-up|0|||
128744427|NCT03538626|463354448|FG001|Overall Study|Lost to Follow-up|0|||
128744428|NCT03538626|463354449|FG002|Overall Study|Lost to Follow-up|0|||
128744429|NCT03538626|463354450|FG003|Overall Study|Lost to Follow-up|0|||
128744430|NCT03538626|463354451|FG004|Overall Study|Lost to Follow-up|0|||
128744431|NCT03538626|463354452|FG005|Overall Study|Lost to Follow-up|0|||
128744432|NCT03538626|463354453|FG006|Overall Study|Lost to Follow-up|1|||
128744433|NCT03538626|463354454|FG007|Overall Study|Lost to Follow-up|0|||
128744434|NCT00288587|463354455|FG000|Overall Study|Death|4|||
128744435|NCT00288587|463354456|FG001|Overall Study|Death|4|||
128744436|NCT00288587|463354455|FG000|Overall Study|Transplant|0|||
128744437|NCT00288587|463354456|FG001|Overall Study|Transplant|3|||
128744438|NCT00288587|463354455|FG000|Overall Study|Adverse Event|0|||
128744439|NCT00288587|463354456|FG001|Overall Study|Adverse Event|1|||
128744440|NCT00288587|463354455|FG000|Overall Study|Physician Decision|0|||
128744441|NCT00288587|463354456|FG001|Overall Study|Physician Decision|2|||
128744442|NCT00288587|463354455|FG000|Overall Study|Severe Aortic Stenosis|1|||
128785548|NCT01467700|463506026|FG002|Overall Study|Pregnancy|1|||
128785549|NCT01467700|463506027|FG003|Overall Study|Pregnancy|0|||
128785550|NCT01467700|463506024|FG000|Overall Study|Lack of Efficacy|2|||
128785551|NCT01467700|463506025|FG001|Overall Study|Lack of Efficacy|0|||
128785552|NCT01467700|463506026|FG002|Overall Study|Lack of Efficacy|2|||
128785553|NCT01467700|463506027|FG003|Overall Study|Lack of Efficacy|1|||
128785554|NCT01467700|463506024|FG000|Overall Study|Reason not Specified|1|||
128785555|NCT01467700|463506025|FG001|Overall Study|Reason not Specified|3|||
128785556|NCT01467700|463506026|FG002|Overall Study|Reason not Specified|2|||
128785557|NCT01467700|463506027|FG003|Overall Study|Reason not Specified|8|||
128785558|NCT00121199|463506029|FG000|Overall Study|Adverse Event|11|||
128785559|NCT00121199|463506029|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
128785560|NCT00121199|463506029|FG000|Overall Study|Progression/Relapse|1|||
128785561|NCT00121199|463506029|FG000|Overall Study|Death|3|||
128785562|NCT00121199|463506029|FG000|Overall Study|Other - Not Protocol Specified|3|||
128785563|NCT00121199|463506029|FG000|Overall Study|Ineligible|9|||
128785564|NCT04109118|463506032|FG000|Overall Study|Lost to Follow-up|3|||
128785565|NCT03235349|463506035|FG000|Overall Study|Adverse Event|1|||
128785566|NCT03235349|463506035|FG000|Overall Study|Other|1|||
128785567|NCT03396913|463506039|FG000|Overall Study|Lost to Follow-up|0|||
128785568|NCT03396913|463506040|FG001|Overall Study|Lost to Follow-up|6|||
128744443|NCT00288587|463354456|FG001|Overall Study|Severe Aortic Stenosis|0|||
128744444|NCT01434602|463354461|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
128744445|NCT01434602|463354462|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
128744446|NCT01434602|463354463|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
128744447|NCT01434602|463354464|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
128744448|NCT01434602|463354465|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
128785569|NCT00819910|463506041|FG000|Overall Study|Adverse Event|0|||
128785570|NCT00819910|463506042|FG001|Overall Study|Adverse Event|0|||
128785571|NCT00819910|463506043|FG002|Overall Study|Adverse Event|2|||
128785572|NCT00819910|463506044|FG003|Overall Study|Adverse Event|1|||
128785573|NCT00819910|463506041|FG000|Overall Study|Withdrawal by Subject|1|||
128785574|NCT00819910|463506042|FG001|Overall Study|Withdrawal by Subject|1|||
128785575|NCT00819910|463506043|FG002|Overall Study|Withdrawal by Subject|1|||
128785576|NCT00819910|463506044|FG003|Overall Study|Withdrawal by Subject|0|||
128785577|NCT00819910|463506041|FG000|Overall Study|Lost to Follow-up|1|||
128785578|NCT00819910|463506042|FG001|Overall Study|Lost to Follow-up|0|||
128785579|NCT00819910|463506043|FG002|Overall Study|Lost to Follow-up|0|||
128785580|NCT00819910|463506044|FG003|Overall Study|Lost to Follow-up|0|||
128785581|NCT00299702|463506045|FG000|Overall Study|Death|1|||
128744449|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
128744450|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
128744451|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
128744452|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
128744453|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
128744454|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
128785582|NCT00299702|463506046|FG001|Overall Study|Death|0|||
128785583|NCT00299702|463506045|FG000|Overall Study|Adverse Event|0|||
128785584|NCT00299702|463506046|FG001|Overall Study|Adverse Event|4|||
128785585|NCT00299702|463506045|FG000|Overall Study|Lost to Follow-up|18|||
128785586|NCT00299702|463506046|FG001|Overall Study|Lost to Follow-up|10|||
128785587|NCT00299702|463506045|FG000|Overall Study|Withdrawal by Subject|25|||
128744455|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
128744456|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
128744457|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
128744458|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
128744459|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
128744460|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
128744461|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
128744462|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
128744463|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
128744464|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
128744465|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
128744466|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
128744467|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
128744468|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
128744469|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
128744470|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
128744471|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
128744472|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
128744473|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
128744474|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
128744475|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
128744476|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
128744477|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
128744478|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
128744479|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
128744480|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
128744481|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
128744482|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
128744483|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
128744484|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
128744485|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
128744486|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
128744487|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
128744488|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
128744489|NCT01434602|463354461|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
128744490|NCT01434602|463354462|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
128744491|NCT01434602|463354463|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
128744492|NCT01434602|463354464|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
128744493|NCT01434602|463354465|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
128744494|NCT00586105|463354472|FG000|Overall Study|Adverse Event|4|||
128744495|NCT00586105|463354472|FG000|Overall Study|Death|2|||
128744496|NCT00586105|463354472|FG000|Overall Study|Protocol Violation|1|||
128744497|NCT00586105|463354472|FG000|Overall Study|Withdrawal by Subject|3|||
128744498|NCT00586105|463354472|FG000|Overall Study|Disease progression|19|||
128744499|NCT00586105|463354472|FG000|Overall Study|Switched to commercial drug|9|||
128744500|NCT00586105|463354472|FG000|Overall Study|Reason not reported|1|||
128744501|NCT03835533|463354475|FG000|Overall Study|Death|5|||
128744502|NCT03835533|463354476|FG001|Overall Study|Death|10|||
128744503|NCT03835533|463354477|FG002|Overall Study|Death|9|||
128744504|NCT03835533|463354475|FG000|Overall Study|Withdrawal by Subject|2|||
128744505|NCT03835533|463354476|FG001|Overall Study|Withdrawal by Subject|2|||
128744506|NCT03835533|463354477|FG002|Overall Study|Withdrawal by Subject|2|||
128744507|NCT03835533|463354475|FG000|Overall Study|Lost to Follow-up|1|||
128744508|NCT03835533|463354476|FG001|Overall Study|Lost to Follow-up|0|||
128744509|NCT03835533|463354477|FG002|Overall Study|Lost to Follow-up|0|||
128744510|NCT01136291|463354478|FG000|Overall Study|Lost to Follow-up|1|||
128744511|NCT01136291|463354479|FG001|Overall Study|Lost to Follow-up|1|||
128744512|NCT02308033|463354487|FG000|Overall Study|Normal Gram stain at Baseline|13|||
128744513|NCT02308033|463354488|FG001|Overall Study|Normal Gram stain at Baseline|10|||
128744514|NCT02308033|463354487|FG000|Overall Study|Positive for STD at Baseline|7|||
128744515|NCT02308033|463354488|FG001|Overall Study|Positive for STD at Baseline|4|||
128744516|NCT02308033|463354487|FG000|Overall Study|Lost to Follow-up|6|||
128744517|NCT02308033|463354488|FG001|Overall Study|Lost to Follow-up|5|||
128744518|NCT00345397|463354489|FG000|Overall Study|Death|1|||
128744519|NCT01870843|463354490|FG000|Overall Study|Adverse Event|10|||
128744520|NCT01870843|463354490|FG000|Overall Study|Lost to Follow-up|24|||
128744521|NCT01870843|463354490|FG000|Overall Study|Death|1|||
128744522|NCT01870843|463354490|FG000|Overall Study|Withdrawal by Subject|18|||
128744523|NCT03021187|463354495|FG000|Overall Study|Death|0|||
128744524|NCT03021187|463354496|FG001|Overall Study|Death|0|||
128744525|NCT03021187|463354497|FG002|Overall Study|Death|3|||
128744526|NCT03021187|463354498|FG003|Overall Study|Death|0|||
128744527|NCT03021187|463354495|FG000|Overall Study|Withdrawal by Subject|0|||
128744528|NCT03021187|463354496|FG001|Overall Study|Withdrawal by Subject|6|||
128744529|NCT03021187|463354497|FG002|Overall Study|Withdrawal by Subject|2|||
128744530|NCT03021187|463354498|FG003|Overall Study|Withdrawal by Subject|5|||
128744531|NCT03021187|463354495|FG000|Overall Study|Lost to Follow-up|10|||
128744532|NCT03021187|463354496|FG001|Overall Study|Lost to Follow-up|3|||
128744533|NCT03021187|463354497|FG002|Overall Study|Lost to Follow-up|1|||
128744534|NCT03021187|463354498|FG003|Overall Study|Lost to Follow-up|4|||
128744535|NCT01664078|463354499|FG000|Overall Study|Death|9|||
128744536|NCT01664078|463354499|FG000|Overall Study|Withdrawal by Subject|4|||
128744537|NCT01664078|463354499|FG000|Overall Study|Lost to Follow-up|2|||
128744538|NCT01664078|463354499|FG000|Overall Study|missed 5 year visit|1|||
128744539|NCT01664078|463354499|FG000|Overall Study|Other|53|||
128744540|NCT03351049|463354502|FG000|Overall Study|Withdrawal|26|||
128744541|NCT03351049|463354503|FG001|Overall Study|Withdrawal|22|||
128744542|NCT01337245|463354506|FG000|Overall Study|Lost to Follow-up|1|||
128744543|NCT01307501|463354507|FG000|Overall Study|Treatment Failure|1|||
128744544|NCT01307501|463354507|FG000|Overall Study|Death|20|||
128744545|NCT01307501|463354507|FG000|Overall Study|Lost to Follow-up|1|||
128744546|NCT01307501|463354507|FG000|Overall Study|Starting Hospice|1|||
128744547|NCT00558285|463354508|FG000|Overall Study|Adverse Event|1|||
128744548|NCT00558285|463354509|FG001|Overall Study|Adverse Event|1|||
128744549|NCT00558285|463354510|FG002|Overall Study|Adverse Event|4|||
128744550|NCT00558285|463354511|FG003|Overall Study|Adverse Event|1|||
128744551|NCT00558285|463354512|FG004|Overall Study|Adverse Event|2|||
128744552|NCT00558285|463354508|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128744553|NCT00558285|463354509|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128744554|NCT00558285|463354510|FG002|Overall Study|Abnormal test procedure result(s)|0|||
128744555|NCT00558285|463354511|FG003|Overall Study|Abnormal test procedure result(s)|0|||
128744556|NCT00558285|463354512|FG004|Overall Study|Abnormal test procedure result(s)|0|||
128744557|NCT00558285|463354508|FG000|Overall Study|Subject withdrew consent|2|||
128744558|NCT00558285|463354509|FG001|Overall Study|Subject withdrew consent|0|||
128744559|NCT00558285|463354510|FG002|Overall Study|Subject withdrew consent|1|||
128744560|NCT00558285|463354511|FG003|Overall Study|Subject withdrew consent|1|||
128744561|NCT00558285|463354512|FG004|Overall Study|Subject withdrew consent|1|||
128744562|NCT00558285|463354508|FG000|Overall Study|Lost to Follow-up|1|||
128744563|NCT00558285|463354509|FG001|Overall Study|Lost to Follow-up|1|||
128744564|NCT00558285|463354510|FG002|Overall Study|Lost to Follow-up|0|||
128744565|NCT00558285|463354511|FG003|Overall Study|Lost to Follow-up|0|||
128744566|NCT00558285|463354512|FG004|Overall Study|Lost to Follow-up|0|||
128744567|NCT00558285|463354508|FG000|Overall Study|Administrative problems|0|||
128744568|NCT00558285|463354509|FG001|Overall Study|Administrative problems|0|||
128744569|NCT00558285|463354510|FG002|Overall Study|Administrative problems|0|||
128744570|NCT00558285|463354511|FG003|Overall Study|Administrative problems|1|||
128744571|NCT00558285|463354512|FG004|Overall Study|Administrative problems|1|||
128744572|NCT00558285|463354508|FG000|Overall Study|Protocol deviation|1|||
128744573|NCT00558285|463354509|FG001|Overall Study|Protocol deviation|1|||
128744574|NCT00558285|463354510|FG002|Overall Study|Protocol deviation|0|||
128744575|NCT00558285|463354511|FG003|Overall Study|Protocol deviation|1|||
128744576|NCT00558285|463354512|FG004|Overall Study|Protocol deviation|0|||
128744577|NCT02730819|463354513|FG000|Overall Study|Lost to Follow-up|9|||
128744578|NCT01660906|463354514|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
128744579|NCT02121847|463354515|FG000|Overall Study|Administrative Reasons|1|||
128744580|NCT02121847|463354515|FG000|Overall Study|Adverse Event|2|||
128744581|NCT03478891|463354516|FG000|Overall Study|Enrolled, but product never administered|0|||
128744582|NCT03478891|463354517|FG001|Overall Study|Enrolled, but product never administered|0|||
128744583|NCT03478891|463354518|FG002|Overall Study|Enrolled, but product never administered|1|||
128744584|NCT03478891|463354516|FG000|Overall Study|Moved from area|0|||
128744585|NCT03478891|463354517|FG001|Overall Study|Moved from area|0|||
128744586|NCT03478891|463354518|FG002|Overall Study|Moved from area|1|||
128744587|NCT03478891|463354516|FG000|Overall Study|Lost to Follow-up|1|||
128744588|NCT03478891|463354517|FG001|Overall Study|Lost to Follow-up|0|||
128744589|NCT03478891|463354518|FG002|Overall Study|Lost to Follow-up|1|||
128744590|NCT02091167|463354519|FG000|Overall Study|Lost to Follow-up|0|||
128744591|NCT02091167|463354520|FG001|Overall Study|Lost to Follow-up|2|||
128744592|NCT03096782|463354521|FG000|Overall Study|Death|1|||
128744593|NCT03096782|463354521|FG000|Overall Study|Participant Relapsed|1|||
128744594|NCT03662750|463354522|FG000|Overall Study|Withdrawal by Subject|1|||
128744595|NCT00932893|463354529|FG000|Overall Study|Death|115|||
128744596|NCT00932893|463354530|FG001|Overall Study|Death|24|||
128744597|NCT00932893|463354529|FG000|Overall Study|Lost to Follow-up|8|||
128744598|NCT00932893|463354530|FG001|Overall Study|Lost to Follow-up|0|||
128744599|NCT00932893|463354529|FG000|Overall Study|Withdrawal by Subject|5|||
128744600|NCT00932893|463354530|FG001|Overall Study|Withdrawal by Subject|2|||
128744601|NCT00932893|463354529|FG000|Overall Study|Other|5|||
128744602|NCT00932893|463354530|FG001|Overall Study|Other|144|||
128744603|NCT04450264|463356225|FG000|Overall Study|Incomplete survey|13|||
128744604|NCT04450264|463356226|FG001|Overall Study|Incomplete survey|19|||
128744605|NCT00993447|463356227|FG000|Overall Study|Withdrawal by Subject|23|||
128744606|NCT00993447|463356228|FG001|Overall Study|Withdrawal by Subject|8|||
128744607|NCT00993447|463356227|FG000|Overall Study|Protocol Violation|12|||
128744608|NCT00993447|463356228|FG001|Overall Study|Protocol Violation|8|||
128744609|NCT00993447|463356227|FG000|Overall Study|Lost to Follow-up|1|||
128785588|NCT00299702|463506046|FG001|Overall Study|Withdrawal by Subject|23|||
128785589|NCT00299702|463506045|FG000|Overall Study|Pregnancy|0|||
128785590|NCT00299702|463506046|FG001|Overall Study|Pregnancy|1|||
128785591|NCT00299702|463506045|FG000|Overall Study|Insufficient Response|4|||
128744610|NCT00993447|463356228|FG001|Overall Study|Lost to Follow-up|3|||
128744611|NCT00993447|463356227|FG000|Overall Study|Adverse Event|1|||
128744612|NCT00993447|463356228|FG001|Overall Study|Adverse Event|0|||
128744613|NCT00970502|463356230|FG000|Overall Study|Withdrawal by Subject|1|||
128744614|NCT03811912|463356231|FG000|Overall Study|Withdrew Consent|4|||
128744615|NCT03811912|463356232|FG001|Overall Study|Withdrew Consent|2|||
128744616|NCT00566228|463356233|FG000|Overall Study|Withdrawal by Subject|1|||
128744617|NCT00566228|463356234|FG001|Overall Study|Withdrawal by Subject|0|||
128744618|NCT00566228|463356233|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
128744619|NCT00566228|463356234|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
128744620|NCT00566228|463356233|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
128744621|NCT00566228|463356234|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
128744622|NCT00566228|463356233|FG000|Overall Study|progressed before infusion could occur|0|||
128744623|NCT00566228|463356234|FG001|Overall Study|progressed before infusion could occur|1|||
128744624|NCT02367911|463356237|FG000|Overall Study|Withdrawal by Subject|3|||
128744625|NCT02367911|463356238|FG001|Overall Study|Withdrawal by Subject|2|||
128744626|NCT02367911|463356237|FG000|Overall Study|Lost to Follow-up|2|||
128744627|NCT02367911|463356238|FG001|Overall Study|Lost to Follow-up|2|||
128744628|NCT00902304|463356239|FG000|Overall Study|Adverse Event|4|||
128744629|NCT00902304|463356240|FG001|Overall Study|Adverse Event|10|||
128744630|NCT00902304|463356241|FG002|Overall Study|Adverse Event|25|||
128744631|NCT00902304|463356239|FG000|Overall Study|Investigator discretion|3|||
128744632|NCT00902304|463356240|FG001|Overall Study|Investigator discretion|5|||
128744633|NCT00902304|463356241|FG002|Overall Study|Investigator discretion|13|||
128744634|NCT00902304|463356239|FG000|Overall Study|Lost to Follow-up|7|||
128744635|NCT00902304|463356240|FG001|Overall Study|Lost to Follow-up|7|||
128744636|NCT00902304|463356241|FG002|Overall Study|Lost to Follow-up|7|||
128744637|NCT00902304|463356239|FG000|Overall Study|Protocol Violation|9|||
128744638|NCT00902304|463356240|FG001|Overall Study|Protocol Violation|18|||
128744639|NCT00902304|463356241|FG002|Overall Study|Protocol Violation|20|||
128744640|NCT00902304|463356239|FG000|Overall Study|Withdrawal by Subject|32|||
128744641|NCT00902304|463356240|FG001|Overall Study|Withdrawal by Subject|22|||
128744642|NCT00902304|463356241|FG002|Overall Study|Withdrawal by Subject|43|||
128744643|NCT00902304|463356239|FG000|Overall Study|includes pregnancy|3|||
128744644|NCT00902304|463356240|FG001|Overall Study|includes pregnancy|9|||
128744645|NCT00902304|463356241|FG002|Overall Study|includes pregnancy|2|||
128744646|NCT04579757|463356242|FG000|Overall Study|Adverse Event|0|||
128744647|NCT04579757|463356243|FG001|Overall Study|Adverse Event|0|||
128744648|NCT04579757|463356244|FG002|Overall Study|Adverse Event|0|||
128744649|NCT04579757|463356245|FG003|Overall Study|Adverse Event|2|||
128744650|NCT04579757|463356246|FG004|Overall Study|Adverse Event|1|||
128744651|NCT04579757|463356247|FG005|Overall Study|Adverse Event|1|||
128744652|NCT04579757|463356248|FG006|Overall Study|Adverse Event|0|||
128744653|NCT04579757|463356249|FG007|Overall Study|Adverse Event|0|||
128744654|NCT04579757|463356250|FG008|Overall Study|Adverse Event|0|||
128744655|NCT04579757|463356242|FG000|Overall Study|Death|4|||
128744656|NCT04579757|463356243|FG001|Overall Study|Death|1|||
128744657|NCT04579757|463356244|FG002|Overall Study|Death|14|||
128744658|NCT04579757|463356245|FG003|Overall Study|Death|3|||
128744659|NCT04579757|463356246|FG004|Overall Study|Death|2|||
128744660|NCT04579757|463356247|FG005|Overall Study|Death|7|||
128744661|NCT04579757|463356248|FG006|Overall Study|Death|0|||
128744662|NCT04579757|463356249|FG007|Overall Study|Death|1|||
128744663|NCT04579757|463356250|FG008|Overall Study|Death|3|||
128744664|NCT04579757|463356242|FG000|Overall Study|Physician Decision|0|||
128744665|NCT04579757|463356243|FG001|Overall Study|Physician Decision|0|||
128744666|NCT04579757|463356244|FG002|Overall Study|Physician Decision|0|||
128744667|NCT04579757|463356245|FG003|Overall Study|Physician Decision|2|||
128744668|NCT04579757|463356246|FG004|Overall Study|Physician Decision|1|||
128744669|NCT04579757|463356247|FG005|Overall Study|Physician Decision|1|||
128744670|NCT04579757|463356248|FG006|Overall Study|Physician Decision|1|||
128744671|NCT04579757|463356249|FG007|Overall Study|Physician Decision|0|||
128744672|NCT04579757|463356250|FG008|Overall Study|Physician Decision|0|||
128744673|NCT04579757|463356242|FG000|Overall Study|Study Terminated By Sponsor|0|||
128744674|NCT04579757|463356243|FG001|Overall Study|Study Terminated By Sponsor|0|||
128744675|NCT04579757|463356244|FG002|Overall Study|Study Terminated By Sponsor|0|||
128744676|NCT04579757|463356245|FG003|Overall Study|Study Terminated By Sponsor|0|||
128744677|NCT04579757|463356246|FG004|Overall Study|Study Terminated By Sponsor|2|||
128744678|NCT04579757|463356247|FG005|Overall Study|Study Terminated By Sponsor|0|||
128744679|NCT04579757|463356248|FG006|Overall Study|Study Terminated By Sponsor|0|||
128744680|NCT04579757|463356249|FG007|Overall Study|Study Terminated By Sponsor|2|||
128744681|NCT04579757|463356250|FG008|Overall Study|Study Terminated By Sponsor|0|||
128744682|NCT04579757|463356242|FG000|Overall Study|Withdrawal by Subject|1|||
128744683|NCT04579757|463356243|FG001|Overall Study|Withdrawal by Subject|1|||
128744684|NCT04579757|463356244|FG002|Overall Study|Withdrawal by Subject|0|||
128744685|NCT04579757|463356245|FG003|Overall Study|Withdrawal by Subject|0|||
128744686|NCT04579757|463356246|FG004|Overall Study|Withdrawal by Subject|2|||
128744687|NCT04579757|463356247|FG005|Overall Study|Withdrawal by Subject|1|||
128744688|NCT04579757|463356248|FG006|Overall Study|Withdrawal by Subject|0|||
128744689|NCT04579757|463356249|FG007|Overall Study|Withdrawal by Subject|3|||
128744690|NCT04579757|463356250|FG008|Overall Study|Withdrawal by Subject|0|||
128744691|NCT04579757|463356242|FG000|Overall Study|Radiological or Clinical PD|1|||
128744692|NCT04579757|463356243|FG001|Overall Study|Radiological or Clinical PD|4|||
128744693|NCT04579757|463356244|FG002|Overall Study|Radiological or Clinical PD|1|||
128744694|NCT04579757|463356245|FG003|Overall Study|Radiological or Clinical PD|3|||
128744695|NCT04579757|463356246|FG004|Overall Study|Radiological or Clinical PD|9|||
128744696|NCT04579757|463356247|FG005|Overall Study|Radiological or Clinical PD|4|||
128744697|NCT04579757|463356248|FG006|Overall Study|Radiological or Clinical PD|2|||
128744698|NCT04579757|463356249|FG007|Overall Study|Radiological or Clinical PD|2|||
128744699|NCT04579757|463356250|FG008|Overall Study|Radiological or Clinical PD|0|||
128744700|NCT04579757|463356242|FG000|Overall Study|Start of New Therapy|0|||
128744701|NCT04579757|463356243|FG001|Overall Study|Start of New Therapy|0|||
128744702|NCT04579757|463356244|FG002|Overall Study|Start of New Therapy|0|||
128744703|NCT04579757|463356245|FG003|Overall Study|Start of New Therapy|0|||
128744704|NCT04579757|463356246|FG004|Overall Study|Start of New Therapy|2|||
128744705|NCT04579757|463356247|FG005|Overall Study|Start of New Therapy|1|||
128744706|NCT04579757|463356248|FG006|Overall Study|Start of New Therapy|0|||
128744707|NCT04579757|463356249|FG007|Overall Study|Start of New Therapy|0|||
128744708|NCT04579757|463356250|FG008|Overall Study|Start of New Therapy|0|||
128744709|NCT05706506|463356251|FG000|Overall Study|Adverse Event|1|||
128744710|NCT05706506|463356251|FG000|Overall Study|Withdrawal by Subject|4|||
128744711|NCT05706506|463356251|FG000|Overall Study|Lost to Follow-up|2|||
128744712|NCT05706506|463356251|FG000|Overall Study|Inadvertent Enrolment|12|||
128744713|NCT05706506|463356251|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
128744714|NCT05706506|463356251|FG000|Overall Study|Participant Moved Out of State|1|||
128744715|NCT01153633|463356252|FG000|Overall Study|Protocol Violation|1|||
128744716|NCT01153633|463356253|FG001|Overall Study|Protocol Violation|1|||
128744717|NCT01153633|463356252|FG000|Overall Study|Therapeutic failure|3|||
128744718|NCT01153633|463356253|FG001|Overall Study|Therapeutic failure|3|||
128744719|NCT00384085|463356254|FG000|Overall Study|Adverse Event|5|||
128744720|NCT00384085|463356255|FG001|Overall Study|Adverse Event|5|||
128744721|NCT00384085|463356256|FG002|Overall Study|Adverse Event|4|||
128744722|NCT00384085|463356254|FG000|Overall Study|Lack of Efficacy|0|||
128744723|NCT00384085|463356255|FG001|Overall Study|Lack of Efficacy|3|||
128744724|NCT00384085|463356256|FG002|Overall Study|Lack of Efficacy|2|||
128744725|NCT00384085|463356254|FG000|Overall Study|No longer Requires Study Treatment|1|||
128744726|NCT00384085|463356255|FG001|Overall Study|No longer Requires Study Treatment|0|||
128744727|NCT00384085|463356256|FG002|Overall Study|No longer Requires Study Treatment|1|||
128744728|NCT00384085|463356254|FG000|Overall Study|Protocol Violation|2|||
128744729|NCT00384085|463356255|FG001|Overall Study|Protocol Violation|2|||
128744730|NCT00384085|463356256|FG002|Overall Study|Protocol Violation|2|||
128744731|NCT00384085|463356254|FG000|Overall Study|Lost to Follow-up|9|||
128744732|NCT00384085|463356255|FG001|Overall Study|Lost to Follow-up|9|||
128744733|NCT00384085|463356256|FG002|Overall Study|Lost to Follow-up|10|||
128744734|NCT00384085|463356254|FG000|Overall Study|Progressive Disease|0|||
128744735|NCT00384085|463356255|FG001|Overall Study|Progressive Disease|1|||
128744736|NCT00384085|463356256|FG002|Overall Study|Progressive Disease|0|||
128744737|NCT00384085|463356254|FG000|Overall Study|Withdrawal by Subject|14|||
128744738|NCT00384085|463356255|FG001|Overall Study|Withdrawal by Subject|19|||
128744739|NCT00384085|463356256|FG002|Overall Study|Withdrawal by Subject|29|||
128744740|NCT00384085|463356254|FG000|Overall Study|Patient non-compliant|4|||
128744741|NCT00384085|463356255|FG001|Overall Study|Patient non-compliant|4|||
128744742|NCT00384085|463356256|FG002|Overall Study|Patient non-compliant|5|||
128744743|NCT00384085|463356254|FG000|Overall Study|Physician Decision|1|||
128744744|NCT00384085|463356255|FG001|Overall Study|Physician Decision|0|||
128744745|NCT00384085|463356256|FG002|Overall Study|Physician Decision|0|||
128744746|NCT00384085|463356254|FG000|Overall Study|Loss of site personnel|1|||
128744747|NCT00384085|463356255|FG001|Overall Study|Loss of site personnel|0|||
128744748|NCT00384085|463356256|FG002|Overall Study|Loss of site personnel|1|||
128744749|NCT00384085|463356254|FG000|Overall Study|Sponsor decision|1|||
128744750|NCT00384085|463356255|FG001|Overall Study|Sponsor decision|2|||
128744751|NCT00384085|463356256|FG002|Overall Study|Sponsor decision|1|||
128785592|NCT00299702|463506046|FG001|Overall Study|Insufficient Response|3|||
128744752|NCT00384085|463356254|FG000|Overall Study|Patient moved|1|||
128785593|NCT00299702|463506045|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
128785594|NCT00299702|463506046|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
128744753|NCT00384085|463356255|FG001|Overall Study|Patient moved|0|||
128744754|NCT00384085|463356256|FG002|Overall Study|Patient moved|1|||
128744755|NCT00384085|463356254|FG000|Overall Study|Patient required surgery|0|||
128744756|NCT00384085|463356255|FG001|Overall Study|Patient required surgery|1|||
128744757|NCT00384085|463356256|FG002|Overall Study|Patient required surgery|0|||
128744758|NCT03725982|463356259|FG000|First Intervention|Withdrawal by Subject|0|||
128744759|NCT03725982|463356260|FG001|First Intervention|Withdrawal by Subject|1|||
128744760|NCT03725982|463356259|FG000|First Intervention|Physician Decision|1|||
128744761|NCT03725982|463356260|FG001|First Intervention|Physician Decision|1|||
128744762|NCT00352365|463356261|FG000|Induction Therapy|Adverse Event|7|||
128744763|NCT00352365|463356261|FG000|Induction Therapy|Progression/Relapse|8|||
128744764|NCT00352365|463356261|FG000|Induction Therapy|Death|7|||
128744765|NCT00352365|463356261|FG000|Induction Therapy|Not protocol specified|1|||
128744766|NCT00352365|463356261|FG000|Induction Therapy|Not eligible|3|||
128744767|NCT00352365|463356261|FG000|Induction Therapy|Death before starting protocol therapy|1|||
128744768|NCT00352365|463356261|FG000|Maintenance Therapy|Progression/Relapse|3|||
128744769|NCT00352365|463356261|FG000|Maintenance Therapy|Death|2|||
128744770|NCT00352365|463356261|FG000|Maintenance Therapy|Not protocol specified|3|||
128744771|NCT00352365|463356261|FG000|Maintenance Therapy|Not eligible|4|||
128744772|NCT04743908|463356262|FG000|Overall Study|Death|1|||
128744773|NCT04743908|463356263|FG001|Overall Study|Death|0|||
128744774|NCT04743908|463356262|FG000|Overall Study|Lost to Follow-up|181|||
128744775|NCT04743908|463356263|FG001|Overall Study|Lost to Follow-up|180|||
128744776|NCT04743908|463356262|FG000|Overall Study|Withdrawal by Subject|1|||
128744777|NCT04743908|463356263|FG001|Overall Study|Withdrawal by Subject|2|||
128744778|NCT04837482|463356264|FG000|Period 2|Withdrawal by Subject|0|||
128744779|NCT04837482|463356265|FG001|Period 2|Withdrawal by Subject|1|||
128744780|NCT00987467|463356271|FG000|Overall Study|Lost to Follow-up|2|||
128744781|NCT00512135|463356272|FG000|Overall Study|Not Treated|5|||
128744782|NCT00512135|463356272|FG000|Overall Study|Lack of Efficacy|2|||
128744783|NCT00512135|463356272|FG000|Overall Study|Adverse Event|6|||
128744784|NCT00512135|463356272|FG000|Overall Study|Withdrawal by Subject|22|||
128744785|NCT00512135|463356272|FG000|Overall Study|Lost to Follow-up|27|||
128744786|NCT00512135|463356272|FG000|Overall Study|Other|22|||
128744787|NCT02646423|463356273|FG000|Overall Study|Adverse Event|5|||
128744788|NCT02646423|463356274|FG001|Overall Study|Adverse Event|7|||
128744789|NCT02646423|463356273|FG000|Overall Study|Ineligible|2|||
128744790|NCT02646423|463356274|FG001|Overall Study|Ineligible|1|||
128744791|NCT02807948|463356275|FG000|Overall Study|Physician Decision|1|||
128744792|NCT02807948|463356276|FG001|Overall Study|Physician Decision|0|||
128744793|NCT02624804|463356277|FG000|Overall Study|Screen Failure|5|||
128744794|NCT03073603|463356286|FG000|Overall Study|Noncompliance|3|||
128744795|NCT03073603|463356287|FG001|Overall Study|Noncompliance|1|||
128744796|NCT03073603|463356286|FG000|Overall Study|Adverse Event|5|||
128744797|NCT03073603|463356287|FG001|Overall Study|Adverse Event|3|||
128744798|NCT03073603|463356286|FG000|Overall Study|Physician Decision|1|||
128744799|NCT03073603|463356287|FG001|Overall Study|Physician Decision|2|||
128744800|NCT03073603|463356286|FG000|Overall Study|Required treatment not allowed by protocol|1|||
128744801|NCT03073603|463356287|FG001|Overall Study|Required treatment not allowed by protocol|0|||
128744802|NCT03073603|463356286|FG000|Overall Study|Financial or insurance-related|8|||
128744803|NCT03073603|463356287|FG001|Overall Study|Financial or insurance-related|0|||
128744804|NCT03073603|463356286|FG000|Overall Study|Withdrawal by Subject|0|||
128744805|NCT03073603|463356287|FG001|Overall Study|Withdrawal by Subject|1|||
128744806|NCT03073603|463356286|FG000|Overall Study|Discontinued DMT|4|||
128744807|NCT03073603|463356287|FG001|Overall Study|Discontinued DMT|0|||
128744808|NCT03073603|463356286|FG000|Overall Study|Restarted DMT|0|||
128744809|NCT03073603|463356287|FG001|Overall Study|Restarted DMT|1|||
128744810|NCT01659021|463356292|FG000|Main Study|Adverse Event|2|||
128744811|NCT01659021|463356293|FG001|Main Study|Adverse Event|3|||
128744812|NCT01659021|463356292|FG000|Main Study|Lost to Follow-up|1|||
128744813|NCT01659021|463356293|FG001|Main Study|Lost to Follow-up|0|||
128744814|NCT01659021|463356292|FG000|Main Study|Unknown Reasons|2|||
128744815|NCT01659021|463356293|FG001|Main Study|Unknown Reasons|1|||
128744816|NCT01659021|463356292|FG000|Main Study|Physician Decision|34|||
128744817|NCT01659021|463356293|FG001|Main Study|Physician Decision|16|||
128744818|NCT01659021|463356292|FG000|Main Study|Withdrawal by Subject|19|||
128744819|NCT01659021|463356293|FG001|Main Study|Withdrawal by Subject|16|||
128744820|NCT01659021|463356292|FG000|Main Study|Study Terminated by Sponsor|16|||
128744821|NCT01659021|463356293|FG001|Main Study|Study Terminated by Sponsor|1|||
128744822|NCT01659021|463356292|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
128744823|NCT01659021|463356293|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
128744824|NCT01659021|463356292|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
128744825|NCT01659021|463356293|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
128744826|NCT01205685|463356294|FG000|Overall Study|Disease Progression|10|||
128744827|NCT01205685|463356294|FG000|Overall Study|Withdrawal by Subject|1|||
128744828|NCT03058679|463356296|FG000|Baseline to Week 6|Lost to Follow-up|3|||
128744829|NCT03058679|463356297|FG001|Baseline to Week 6|Lost to Follow-up|2|||
128744830|NCT03058679|463356296|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
128744831|NCT03058679|463356297|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
128744832|NCT03058679|463356296|FG000|Baseline to Week 6|Adverse Event|6|||
128744833|NCT03058679|463356297|FG001|Baseline to Week 6|Adverse Event|6|||
128744834|NCT03058679|463356296|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
128744835|NCT03058679|463356297|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
128744836|NCT03058679|463356296|FG000|Baseline to Week 6|Difficulty following the diet|0|||
128744837|NCT03058679|463356297|FG001|Baseline to Week 6|Difficulty following the diet|2|||
128744838|NCT03058679|463356296|FG000|Baseline to Week 6|Physician Decision|1|||
128744839|NCT03058679|463356297|FG001|Baseline to Week 6|Physician Decision|0|||
128744840|NCT03058679|463356296|FG000|Week 6 to Week 12|Change in medication|5|||
128744841|NCT03058679|463356297|FG001|Week 6 to Week 12|Change in medication|7|||
128744842|NCT03058679|463356296|FG000|Week 6 to Week 12|Adverse Event|4|||
128744843|NCT03058679|463356297|FG001|Week 6 to Week 12|Adverse Event|3|||
128744844|NCT03058679|463356296|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
128744845|NCT03058679|463356297|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
128744846|NCT03058679|463356296|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
128744847|NCT03058679|463356297|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
128744848|NCT00599326|463356298|FG000|Overall Study|Lost to Follow-up|1|||
128744849|NCT00599326|463356298|FG000|Overall Study|Noncompliant|1|||
128744850|NCT00784810|463356301|FG000|Overall Study|Adverse Event|32|||
128744851|NCT00784810|463356302|FG001|Overall Study|Adverse Event|20|||
128744852|NCT00784810|463356301|FG000|Overall Study|Lack of Efficacy|14|||
128744853|NCT00784810|463356302|FG001|Overall Study|Lack of Efficacy|11|||
128744854|NCT00784810|463356301|FG000|Overall Study|Withdrawal by Subject|11|||
128744855|NCT00784810|463356302|FG001|Overall Study|Withdrawal by Subject|9|||
128744856|NCT00784810|463356301|FG000|Overall Study|Administrative|5|||
128744857|NCT00784810|463356302|FG001|Overall Study|Administrative|8|||
128744858|NCT00784810|463356301|FG000|Overall Study|Lost to Follow-up|1|||
128744859|NCT00784810|463356302|FG001|Overall Study|Lost to Follow-up|1|||
128744860|NCT02862106|463356303|FG000|Overall Study|Adverse Event|4|||
128744861|NCT02862106|463356304|FG001|Overall Study|Adverse Event|0|||
128744862|NCT02862106|463356303|FG000|Overall Study|Protocol Violation|16|||
128744863|NCT02862106|463356304|FG001|Overall Study|Protocol Violation|1|||
128744864|NCT02862106|463356303|FG000|Overall Study|Lost to Follow-up|15|||
128744865|NCT02862106|463356304|FG001|Overall Study|Lost to Follow-up|5|||
128744866|NCT02862106|463356303|FG000|Overall Study|Withdrawal by Subject|2|||
128744867|NCT02862106|463356304|FG001|Overall Study|Withdrawal by Subject|0|||
128744868|NCT02862106|463356303|FG000|Overall Study|Subjects moved to other city|1|||
128744869|NCT02862106|463356304|FG001|Overall Study|Subjects moved to other city|0|||
128744870|NCT00563784|463356307|FG000|Overall Study|Withdrawal by Subject|2|||
128744871|NCT00563784|463356307|FG000|Overall Study|Screen Failures|20|||
128744872|NCT03434119|463356308|FG000|Overall Study|Randomized but not treated|1|||
128744873|NCT03434119|463356309|FG001|Overall Study|Randomized but not treated|0|||
128744874|NCT03434119|463356308|FG000|Overall Study|Adverse Event|1|||
128744875|NCT03434119|463356309|FG001|Overall Study|Adverse Event|0|||
128744876|NCT03434119|463356308|FG000|Overall Study|Poor Compliance to Protocol|0|||
128744877|NCT03434119|463356309|FG001|Overall Study|Poor Compliance to Protocol|1|||
128744878|NCT03434119|463356308|FG000|Overall Study|Study Terminated by Sponsor|91|||
128744879|NCT03434119|463356309|FG001|Overall Study|Study Terminated by Sponsor|102|||
128744880|NCT03434119|463356308|FG000|Overall Study|Withdrawal by Subject|7|||
128785595|NCT00751036|463506047|FG000|Overall Study|Disease Progression|28|||
128744881|NCT03434119|463356309|FG001|Overall Study|Withdrawal by Subject|5|||
128744882|NCT03434119|463356308|FG000|Overall Study|Other than specified|7|||
128744883|NCT03434119|463356309|FG001|Overall Study|Other than specified|5|||
128744884|NCT04360824|463356310|FG000|Overall Study|Withdrawal by Subject|2|||
128744885|NCT04360824|463356311|FG001|Overall Study|Withdrawal by Subject|1|||
128744886|NCT04360824|463356310|FG000|Overall Study|Did not receive assigned treatment|1|||
128744887|NCT04360824|463356311|FG001|Overall Study|Did not receive assigned treatment|3|||
128744888|NCT00304070|463356312|FG000|Overall Study|Death|0|||
128744889|NCT00304070|463356313|FG001|Overall Study|Death|0|||
128744890|NCT00304070|463356314|FG002|Overall Study|Death|3|||
128744891|NCT00304070|463356312|FG000|Overall Study|Lost to Follow-up|0|||
128744892|NCT00304070|463356313|FG001|Overall Study|Lost to Follow-up|0|||
128744893|NCT00304070|463356314|FG002|Overall Study|Lost to Follow-up|1|||
128744894|NCT00304070|463356312|FG000|Overall Study|Physician Decision|0|||
128744895|NCT00304070|463356313|FG001|Overall Study|Physician Decision|0|||
128744896|NCT00304070|463356314|FG002|Overall Study|Physician Decision|3|||
128744897|NCT00304070|463356312|FG000|Overall Study|Withdrawal by Subject|0|||
128785596|NCT00751036|463506048|FG001|Overall Study|Disease Progression|29|||
128785597|NCT00751036|463506047|FG000|Overall Study|Adverse Event|6|||
128785598|NCT00751036|463506048|FG001|Overall Study|Adverse Event|4|||
128785599|NCT00751036|463506047|FG000|Overall Study|Administrative Problems|3|||
128785600|NCT00751036|463506048|FG001|Overall Study|Administrative Problems|4|||
128785601|NCT00751036|463506047|FG000|Overall Study|Withdrawal by Subject|5|||
128785602|NCT00751036|463506048|FG001|Overall Study|Withdrawal by Subject|2|||
128785603|NCT00751036|463506047|FG000|Overall Study|Death|3|||
128785604|NCT00751036|463506048|FG001|Overall Study|Death|3|||
128785605|NCT00751036|463506047|FG000|Overall Study|Lost to Follow-up|0|||
128785606|NCT00751036|463506048|FG001|Overall Study|Lost to Follow-up|1|||
128744898|NCT00304070|463356313|FG001|Overall Study|Withdrawal by Subject|0|||
128744899|NCT00304070|463356314|FG002|Overall Study|Withdrawal by Subject|1|||
128744900|NCT00304070|463356312|FG000|Overall Study|Progressive Disease|3|||
128744901|NCT00304070|463356313|FG001|Overall Study|Progressive Disease|7|||
128744902|NCT00304070|463356314|FG002|Overall Study|Progressive Disease|4|||
128744903|NCT00320216|463356315|FG000|Overall Study|Adverse Event|0|||
128744904|NCT00320216|463356316|FG001|Overall Study|Adverse Event|6|||
128744905|NCT00320216|463356317|FG002|Overall Study|Adverse Event|0|||
128744906|NCT00320216|463356318|FG003|Overall Study|Adverse Event|2|||
128744907|NCT00320216|463356319|FG004|Overall Study|Adverse Event|2|||
128744908|NCT00320216|463356315|FG000|Overall Study|Lack of Efficacy|6|||
128744909|NCT00320216|463356316|FG001|Overall Study|Lack of Efficacy|2|||
128744910|NCT00320216|463356317|FG002|Overall Study|Lack of Efficacy|1|||
128744911|NCT00320216|463356318|FG003|Overall Study|Lack of Efficacy|0|||
128744912|NCT00320216|463356319|FG004|Overall Study|Lack of Efficacy|1|||
128744913|NCT00320216|463356315|FG000|Overall Study|Lost to Follow-up|3|||
128744914|NCT00320216|463356316|FG001|Overall Study|Lost to Follow-up|0|||
128744915|NCT00320216|463356317|FG002|Overall Study|Lost to Follow-up|0|||
128744916|NCT00320216|463356318|FG003|Overall Study|Lost to Follow-up|0|||
128744917|NCT00320216|463356319|FG004|Overall Study|Lost to Follow-up|0|||
128744918|NCT00320216|463356315|FG000|Overall Study|Other|7|||
128744919|NCT00320216|463356316|FG001|Overall Study|Other|2|||
128744920|NCT00320216|463356317|FG002|Overall Study|Other|5|||
128744921|NCT00320216|463356318|FG003|Overall Study|Other|1|||
128744922|NCT00320216|463356319|FG004|Overall Study|Other|3|||
128744923|NCT00377676|463356320|FG000|Overall Study|Adverse Event|498|||
128744924|NCT00377676|463356321|FG001|Overall Study|Adverse Event|107|||
128744925|NCT00377676|463356320|FG000|Overall Study|Protocol Violation|33|||
128744926|NCT00377676|463356321|FG001|Overall Study|Protocol Violation|27|||
128744927|NCT00377676|463356320|FG000|Overall Study|Death|5|||
128744928|NCT00377676|463356321|FG001|Overall Study|Death|2|||
128744929|NCT00377676|463356320|FG000|Overall Study|Withdrawal by Subject|187|||
128744930|NCT00377676|463356321|FG001|Overall Study|Withdrawal by Subject|72|||
128744931|NCT00377676|463356320|FG000|Overall Study|Lost to Follow-up|120|||
128744932|NCT00377676|463356321|FG001|Overall Study|Lost to Follow-up|56|||
128744933|NCT00377676|463356320|FG000|Overall Study|Other|118|||
128744934|NCT00377676|463356321|FG001|Overall Study|Other|58|||
128744935|NCT03579459|463356326|FG000|Overall Study|Adverse Event|7|||
128744936|NCT03579459|463356327|FG001|Overall Study|Adverse Event|6|||
128744937|NCT03579459|463356328|FG002|Overall Study|Adverse Event|2|||
128744938|NCT03579459|463356329|FG003|Overall Study|Adverse Event|6|||
128744939|NCT03579459|463356326|FG000|Overall Study|Death|1|||
128744940|NCT03579459|463356327|FG001|Overall Study|Death|0|||
128744941|NCT03579459|463356328|FG002|Overall Study|Death|1|||
128744942|NCT03579459|463356329|FG003|Overall Study|Death|2|||
128744943|NCT03579459|463356326|FG000|Overall Study|Lost to Follow-up|6|||
128744944|NCT03579459|463356327|FG001|Overall Study|Lost to Follow-up|2|||
128744945|NCT03579459|463356328|FG002|Overall Study|Lost to Follow-up|4|||
128744946|NCT03579459|463356329|FG003|Overall Study|Lost to Follow-up|1|||
128744947|NCT03579459|463356326|FG000|Overall Study|Physician Decision|0|||
128744948|NCT03579459|463356327|FG001|Overall Study|Physician Decision|1|||
128744949|NCT03579459|463356328|FG002|Overall Study|Physician Decision|0|||
128744950|NCT03579459|463356329|FG003|Overall Study|Physician Decision|1|||
128744951|NCT03579459|463356326|FG000|Overall Study|Protocol Violation|1|||
128744952|NCT03579459|463356327|FG001|Overall Study|Protocol Violation|2|||
128744953|NCT03579459|463356328|FG002|Overall Study|Protocol Violation|3|||
128744954|NCT03579459|463356329|FG003|Overall Study|Protocol Violation|5|||
128744955|NCT03579459|463356326|FG000|Overall Study|Withdrawal by Subject|12|||
128744956|NCT03579459|463356327|FG001|Overall Study|Withdrawal by Subject|8|||
128744957|NCT03579459|463356328|FG002|Overall Study|Withdrawal by Subject|11|||
128744958|NCT03579459|463356329|FG003|Overall Study|Withdrawal by Subject|8|||
128744959|NCT03579459|463356326|FG000|Overall Study|Medication error without associated adverse event|2|||
128744960|NCT03579459|463356327|FG001|Overall Study|Medication error without associated adverse event|1|||
128744961|NCT03579459|463356328|FG002|Overall Study|Medication error without associated adverse event|1|||
128744962|NCT03579459|463356329|FG003|Overall Study|Medication error without associated adverse event|0|||
128744963|NCT03579459|463356326|FG000|Overall Study|Other|0|||
128744964|NCT03579459|463356327|FG001|Overall Study|Other|1|||
128744965|NCT03579459|463356328|FG002|Overall Study|Other|1|||
128744966|NCT03579459|463356329|FG003|Overall Study|Other|0|||
128744967|NCT03579459|463356326|FG000|Overall Study|Randomized not vaccinated|0|||
128744968|NCT03579459|463356327|FG001|Overall Study|Randomized not vaccinated|2|||
128744969|NCT03579459|463356328|FG002|Overall Study|Randomized not vaccinated|0|||
128744970|NCT03579459|463356329|FG003|Overall Study|Randomized not vaccinated|1|||
128744971|NCT00148343|463356332|FG000|Overall Study|Withdrawal by Subject|12|||
128744972|NCT00148343|463356333|FG001|Overall Study|Withdrawal by Subject|7|||
128744973|NCT00148343|463356332|FG000|Overall Study|Physician Decision|3|||
128744974|NCT00148343|463356333|FG001|Overall Study|Physician Decision|4|||
128744975|NCT00407537|463356334|FG000|Overall Study|Death|5|||
128744976|NCT00407537|463356335|FG001|Overall Study|Death|2|||
128744977|NCT00407537|463356334|FG000|Overall Study|Adverse Event|36|||
128785607|NCT00751036|463506047|FG000|Overall Study|Protocol Violation|1|||
128785608|NCT00751036|463506048|FG001|Overall Study|Protocol Violation|0|||
128785609|NCT00751036|463506047|FG000|Overall Study|Missing end of Treatment Page|2|||
128785610|NCT00751036|463506048|FG001|Overall Study|Missing end of Treatment Page|3|||
128785611|NCT05460663|463506049|FG000|Overall Study|Withdrawal by Subject|2|||
128785612|NCT05460663|463506050|FG001|Overall Study|Withdrawal by Subject|5|||
128785613|NCT05273801|463506051|FG000|Overall Study|Physician Decision|1|||
128785614|NCT05526911|463507309|FG000|Overall Study|Adverse Event|2|||
128785615|NCT05025449|463507310|FG000|Overall Study|Withdrawal by Subject|1|||
128785616|NCT05025449|463507310|FG000|Overall Study|Patient emergently taken to operating room|1|||
128785617|NCT00613301|463507311|FG000|Overall Study|Adverse Event|49|||
128785618|NCT00613301|463507311|FG000|Overall Study|Lost to Follow-up|88|||
128785619|NCT00613301|463507311|FG000|Overall Study|Withdrawal by Subject|5|||
128785620|NCT00613301|463507311|FG000|Overall Study|Death|6|||
128785621|NCT00613301|463507311|FG000|Overall Study|Lack of Efficacy|13|||
128744978|NCT00407537|463356335|FG001|Overall Study|Adverse Event|0|||
128744979|NCT00407537|463356334|FG000|Overall Study|Lost to Follow-up|12|||
128744980|NCT00407537|463356335|FG001|Overall Study|Lost to Follow-up|19|||
128744981|NCT00407537|463356334|FG000|Overall Study|Other|6|||
128744982|NCT00407537|463356335|FG001|Overall Study|Other|7|||
128744983|NCT00407537|463356334|FG000|Overall Study|Withdrawal by Subject|34|||
128744984|NCT00407537|463356335|FG001|Overall Study|Withdrawal by Subject|16|||
128744985|NCT05348681|463356336|FG000|Overall Study|Study terminated by Sponsor|8|||
128744986|NCT05348681|463356337|FG001|Overall Study|Study terminated by Sponsor|3|||
128744987|NCT05348681|463356336|FG000|Overall Study|Withdrawal by Subject|1|||
128744988|NCT05348681|463356337|FG001|Overall Study|Withdrawal by Subject|1|||
128744989|NCT05348681|463356336|FG000|Overall Study|Lost to Follow-up|1|||
128744990|NCT05348681|463356337|FG001|Overall Study|Lost to Follow-up|1|||
128744991|NCT05348681|463356336|FG000|Overall Study|Adverse Event|1|||
128744992|NCT05348681|463356337|FG001|Overall Study|Adverse Event|0|||
128744993|NCT05348681|463356336|FG000|Overall Study|Other|2|||
128744994|NCT05348681|463356337|FG001|Overall Study|Other|1|||
128744995|NCT00782340|463356338|FG000|Open Label Titration|Adverse Event|12|||
128744996|NCT00782340|463356339|FG001|Open Label Titration|Adverse Event|0|||
128744997|NCT00782340|463356340|FG002|Open Label Titration|Adverse Event|0|||
128744998|NCT00782340|463356338|FG000|Open Label Titration|Treatment failure|50|||
128744999|NCT00782340|463356339|FG001|Open Label Titration|Treatment failure|0|||
128745000|NCT00782340|463356340|FG002|Open Label Titration|Treatment failure|0|||
128745001|NCT00782340|463356338|FG000|Open Label Titration|Protocol Violation|5|||
128745002|NCT00782340|463356339|FG001|Open Label Titration|Protocol Violation|0|||
128745003|NCT00782340|463356340|FG002|Open Label Titration|Protocol Violation|0|||
128745004|NCT00782340|463356338|FG000|Open Label Titration|Withdrawal by Subject|5|||
128745005|NCT00782340|463356339|FG001|Open Label Titration|Withdrawal by Subject|0|||
128745006|NCT00782340|463356340|FG002|Open Label Titration|Withdrawal by Subject|0|||
128745007|NCT00782340|463356338|FG000|Open Label Titration|Enrollment capped|16|||
128745008|NCT00782340|463356339|FG001|Open Label Titration|Enrollment capped|0|||
128745009|NCT00782340|463356340|FG002|Open Label Titration|Enrollment capped|0|||
128745010|NCT00782340|463356338|FG000|Open Label Titration|Did not meet responder criteria|2|||
128785622|NCT00613301|463507311|FG000|Overall Study|Physician Decision|2|||
128785623|NCT00613301|463507311|FG000|Overall Study|No data was collected|53|||
128745011|NCT00782340|463356339|FG001|Open Label Titration|Did not meet responder criteria|0|||
128745012|NCT00782340|463356340|FG002|Open Label Titration|Did not meet responder criteria|0|||
128745013|NCT00782340|463356338|FG000|Open Label Titration|Lost to Follow-up|5|||
128745014|NCT00782340|463356339|FG001|Open Label Titration|Lost to Follow-up|0|||
128745015|NCT00782340|463356340|FG002|Open Label Titration|Lost to Follow-up|0|||
128745016|NCT00782340|463356338|FG000|Open Label Titration|Randomized in error|6|||
128745017|NCT00782340|463356339|FG001|Open Label Titration|Randomized in error|0|||
128745018|NCT00782340|463356340|FG002|Open Label Titration|Randomized in error|0|||
128785624|NCT00613301|463507311|FG000|Overall Study|Irregularly enrolled patients|12|||
128745019|NCT03359096|463356346|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
128745020|NCT03359096|463356347|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
128745021|NCT03359096|463356346|FG000|First Intervention (4 Weeks)|Death|1|||
128745022|NCT03359096|463356347|FG001|First Intervention (4 Weeks)|Death|0|||
128745023|NCT03359096|463356346|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
128745024|NCT03359096|463356347|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
128745025|NCT02937545|463356348|FG000|Overall Study|Withdrawal by Subject|1|||
128745026|NCT02937545|463356349|FG001|Overall Study|Withdrawal by Subject|2|||
128745027|NCT02937545|463356350|FG002|Overall Study|Withdrawal by Subject|6|||
128745028|NCT02937545|463356351|FG003|Overall Study|Withdrawal by Subject|7|||
128745029|NCT02937545|463356348|FG000|Overall Study|Lost to Follow-up|1|||
128745030|NCT02937545|463356349|FG001|Overall Study|Lost to Follow-up|0|||
128745031|NCT02937545|463356350|FG002|Overall Study|Lost to Follow-up|0|||
128745032|NCT02937545|463356351|FG003|Overall Study|Lost to Follow-up|0|||
128745033|NCT02338362|463356354|FG000|Overall Study|Withdrawal by Subject|1|||
128745034|NCT02338362|463356355|FG001|Overall Study|Withdrawal by Subject|1|||
128745035|NCT01764945|463356357|FG000|Overall Study|Adverse Event|0|||
128745036|NCT01764945|463356358|FG001|Overall Study|Adverse Event|1|||
128745037|NCT01764945|463356359|FG002|Overall Study|Adverse Event|0|||
128745038|NCT01764945|463356360|FG003|Overall Study|Adverse Event|0|||
128745039|NCT01764945|463356361|FG004|Overall Study|Adverse Event|0|||
128745040|NCT01764945|463356362|FG005|Overall Study|Adverse Event|0|||
128745041|NCT01764945|463356363|FG006|Overall Study|Adverse Event|1|||
128745042|NCT01764945|463356364|FG007|Overall Study|Adverse Event|0|||
128745043|NCT05077267|463356365|FG000|Treatment Period|Lost to Follow-up|0|||
128745044|NCT05077267|463356366|FG001|Treatment Period|Lost to Follow-up|1|||
128745045|NCT05077267|463356367|FG002|Treatment Period|Lost to Follow-up|0|||
128745046|NCT05077267|463356365|FG000|Treatment Period|Withdrawal by Subject|0|||
128745047|NCT05077267|463356366|FG001|Treatment Period|Withdrawal by Subject|1|||
128745048|NCT05077267|463356367|FG002|Treatment Period|Withdrawal by Subject|0|||
128745049|NCT05077267|463356365|FG000|Follow-up Period|Lost to Follow-up|0|||
128745050|NCT05077267|463356366|FG001|Follow-up Period|Lost to Follow-up|5|||
128745051|NCT05077267|463356367|FG002|Follow-up Period|Lost to Follow-up|7|||
128745052|NCT05077267|463356365|FG000|Follow-up Period|Withdrawal by Subject|0|||
128745053|NCT05077267|463356366|FG001|Follow-up Period|Withdrawal by Subject|2|||
128745054|NCT05077267|463356367|FG002|Follow-up Period|Withdrawal by Subject|5|||
128745055|NCT05077267|463356365|FG000|Follow-up Period|Study terminated by sponsor|0|||
128745056|NCT05077267|463356366|FG001|Follow-up Period|Study terminated by sponsor|27|||
128745057|NCT05077267|463356367|FG002|Follow-up Period|Study terminated by sponsor|23|||
128745058|NCT05077267|463356365|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
128745059|NCT05077267|463356366|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
128745060|NCT05077267|463356367|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
128745061|NCT05077267|463356365|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
128745062|NCT05077267|463356366|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
128745063|NCT05077267|463356367|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
128745064|NCT02911948|463356368|FG000|Overall Study|Protocol Violation|0|||
128745065|NCT02911948|463356369|FG001|Overall Study|Protocol Violation|1|||
128745066|NCT02911948|463356368|FG000|Overall Study|Withdrawal by Subject|0|||
128745067|NCT02911948|463356369|FG001|Overall Study|Withdrawal by Subject|2|||
128745068|NCT02911948|463356368|FG000|Overall Study|Lack of Efficacy|0|||
128745069|NCT02911948|463356369|FG001|Overall Study|Lack of Efficacy|1|||
128785625|NCT00569946|463507312|FG000|Overall Study|Adverse Event|16|||
128745070|NCT02911948|463356368|FG000|Overall Study|Unclassified|0|||
128745071|NCT02911948|463356369|FG001|Overall Study|Unclassified|3|||
128745072|NCT00364858|463356376|FG000|Overall Study|Adverse Event|1|||
128745073|NCT00364858|463356377|FG001|Overall Study|Adverse Event|5|||
128785626|NCT00569946|463507312|FG000|Overall Study|Objective Progression or Relapse|42|||
128745074|NCT00364858|463356376|FG000|Overall Study|Withdrawal by Subject|1|||
128745075|NCT00364858|463356377|FG001|Overall Study|Withdrawal by Subject|1|||
128745076|NCT00364858|463356376|FG000|Overall Study|Pregnancy|1|||
128745077|NCT00364858|463356377|FG001|Overall Study|Pregnancy|1|||
128745078|NCT00364858|463356376|FG000|Overall Study|Clinical failure|2|||
128745079|NCT00364858|463356377|FG001|Overall Study|Clinical failure|13|||
128745080|NCT00364858|463356376|FG000|Overall Study|Discontinuation at baseline|1|||
128745081|NCT00364858|463356377|FG001|Overall Study|Discontinuation at baseline|0|||
128745082|NCT00364858|463356376|FG000|Overall Study|Non-compliant|1|||
128745083|NCT00364858|463356377|FG001|Overall Study|Non-compliant|0|||
128745084|NCT00364858|463356376|FG000|Overall Study|Return to Q2 regimen|0|||
128745085|NCT00364858|463356377|FG001|Overall Study|Return to Q2 regimen|1|||
128745086|NCT00364858|463356376|FG000|Overall Study|Clinical baseline issue|0|||
128745087|NCT00364858|463356377|FG001|Overall Study|Clinical baseline issue|1|||
128745088|NCT03712917|463356381|FG000|Overall Study|Pregnancy|0|||
128745089|NCT03712917|463356382|FG001|Overall Study|Pregnancy|0|||
128745090|NCT03712917|463356383|FG002|Overall Study|Pregnancy|1|||
128745091|NCT03712917|463356381|FG000|Overall Study|Adverse Event|0|||
128745092|NCT03712917|463356382|FG001|Overall Study|Adverse Event|4|||
128745093|NCT03712917|463356383|FG002|Overall Study|Adverse Event|3|||
128745094|NCT03712917|463356381|FG000|Overall Study|Lost to Follow-up|9|||
128745095|NCT03712917|463356382|FG001|Overall Study|Lost to Follow-up|4|||
128745096|NCT03712917|463356383|FG002|Overall Study|Lost to Follow-up|5|||
128745097|NCT01218438|463356384|FG000|Epoch 1|Physician Decision|2|||
128745098|NCT01218438|463356384|FG000|Epoch 1|Adverse Event|1|||
128745099|NCT01218438|463356384|FG000|Epoch 3|Withdrawal by Subject|3|||
128745100|NCT01218438|463356384|FG000|Epoch 3|Adverse Event|1|||
128745101|NCT01218438|463356384|FG000|Epoch 4|Physician Decision|1|||
128745102|NCT01218438|463356384|FG000|Epoch 4|Withdrawal by Subject|2|||
128745103|NCT00136955|463358188|FG000|Overall Study|Adverse Event|8|||
128745104|NCT00136955|463358188|FG000|Overall Study|Lost to Follow-up|1|||
128745105|NCT00136955|463358188|FG000|Overall Study|Withdrawal by Subject|2|||
128745106|NCT00136955|463358188|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
128745107|NCT05349617|463358189|FG000|Overall Study|Death|1|||
128745108|NCT05349617|463358190|FG001|Overall Study|Death|1|||
128745109|NCT05349617|463358189|FG000|Overall Study|Lost to Follow-up|3|||
128745110|NCT05349617|463358190|FG001|Overall Study|Lost to Follow-up|8|||
128745111|NCT05349617|463358189|FG000|Overall Study|Withdrawal by Subject|2|||
128745112|NCT05349617|463358190|FG001|Overall Study|Withdrawal by Subject|10|||
128745113|NCT01438411|463358194|FG000|Overall Study|Adverse Event|8|||
128745114|NCT01438411|463358194|FG000|Overall Study|Lost to Follow-up|1|||
128745115|NCT01438411|463358194|FG000|Overall Study|Lack of Efficacy|1|||
128745116|NCT01438411|463358194|FG000|Overall Study|Withdrawal by Subject|3|||
128745117|NCT01863680|463358195|FG000|Overall Study|Adverse Event|17|||
128745118|NCT01863680|463358195|FG000|Overall Study|Risk of OHSS|17|||
128745119|NCT01863680|463358195|FG000|Overall Study|Spontaneous pregnancy|2|||
128745120|NCT01863680|463358195|FG000|Overall Study|Withdrawal by Subject|1|||
128745121|NCT01863680|463358195|FG000|Overall Study|Did not undergo IVF/ET|14|||
128745122|NCT01863680|463358195|FG000|Overall Study|Other|6|||
128745123|NCT00618514|463358196|FG000|Overall Study|Lost to Follow-up|11|||
128745124|NCT00618514|463358197|FG001|Overall Study|Lost to Follow-up|12|||
128745125|NCT00618514|463358198|FG002|Overall Study|Lost to Follow-up|4|||
128745126|NCT02053350|463358199|FG000|Overall Study|Withdrawal by Subject|1|||
128745127|NCT02053350|463358199|FG000|Overall Study|Adverse Event|4|||
128745128|NCT02244944|463358200|FG000|Overall Study|Withdrawal by Subject|1|||
128745129|NCT02244944|463358200|FG000|Overall Study|Study Terminated|1|||
128745130|NCT05732454|463358203|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
128745131|NCT05732454|463358204|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
128745132|NCT05732454|463358203|FG000|Part 1: DB Period|Adverse Event|1|||
128745133|NCT05732454|463358204|FG001|Part 1: DB Period|Adverse Event|0|||
128745134|NCT05732454|463358203|FG000|Part 1: DB Period|Lost to Follow-up|1|||
128745135|NCT05732454|463358204|FG001|Part 1: DB Period|Lost to Follow-up|0|||
128745136|NCT05732454|463358203|FG000|Part 1: DB Period|Protocol Violation|0|||
128745137|NCT05732454|463358204|FG001|Part 1: DB Period|Protocol Violation|1|||
128745138|NCT05732454|463358203|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
128745139|NCT05732454|463358204|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
128745140|NCT05732454|463358203|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
128745141|NCT05732454|463358204|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
128745142|NCT05732454|463358203|FG000|Part 1: OLE Period|Adverse Event|0|||
128745143|NCT05732454|463358204|FG001|Part 1: OLE Period|Adverse Event|1|||
128785627|NCT00569946|463507312|FG000|Overall Study|Global Deterioration of Health Status|1|||
128745144|NCT05732454|463358203|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
128745145|NCT05732454|463358204|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
128745146|NCT00328510|463358207|FG000|Overall Study|Gag disorder, could not use frame|4|||
128745147|NCT00328510|463358208|FG001|Overall Study|Gag disorder, could not use frame|0|||
128745148|NCT00328510|463358207|FG000|Overall Study|Dentition problems, could not use frame|1|||
128745149|NCT00328510|463358208|FG001|Overall Study|Dentition problems, could not use frame|0|||
128745150|NCT00328510|463358207|FG000|Overall Study|Withdrawal by Subject|4|||
128745151|NCT00328510|463358208|FG001|Overall Study|Withdrawal by Subject|2|||
128745152|NCT00328510|463358207|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
128745153|NCT00328510|463358208|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
128745154|NCT00328510|463358207|FG000|Overall Study|Treatment changed to a single fraction|1|||
128745155|NCT00328510|463358208|FG001|Overall Study|Treatment changed to a single fraction|1|||
128745156|NCT00377819|463358209|FG000|Overall Study|Adverse Event|2|||
128745157|NCT00377819|463358210|FG001|Overall Study|Adverse Event|3|||
128745158|NCT00377819|463358209|FG000|Overall Study|Withdrawal by Subject|10|||
128745159|NCT00377819|463358210|FG001|Overall Study|Withdrawal by Subject|4|||
128745160|NCT00377819|463358209|FG000|Overall Study|Death|0|||
128745161|NCT00377819|463358210|FG001|Overall Study|Death|1|||
128745162|NCT00377819|463358209|FG000|Overall Study|Lost to Follow-up|0|||
128745163|NCT00377819|463358210|FG001|Overall Study|Lost to Follow-up|1|||
128745164|NCT00377819|463358209|FG000|Overall Study|Protocol Violation|1|||
128745165|NCT00377819|463358210|FG001|Overall Study|Protocol Violation|1|||
128745166|NCT03727750|463358211|FG000|Overall Study|Death|45|||
128745167|NCT03727750|463358211|FG000|Overall Study|Withdrawal by Subject|2|||
128745168|NCT03727750|463358211|FG000|Overall Study|Lost to Follow-up|1|||
128745169|NCT03727750|463358211|FG000|Overall Study|Other|1|||
128745170|NCT00467870|463358212|FG000|Overall Study|Adverse Event|13|||
128745171|NCT00467870|463358213|FG001|Overall Study|Adverse Event|9|||
128745172|NCT00467870|463358214|FG002|Overall Study|Adverse Event|1|||
128745173|NCT00467870|463358215|FG003|Overall Study|Adverse Event|15|||
128745174|NCT00467870|463358216|FG004|Overall Study|Adverse Event|15|||
128745175|NCT00467870|463358217|FG005|Overall Study|Adverse Event|1|||
128745176|NCT00467870|463358212|FG000|Overall Study|Protocol Violation|2|||
128745177|NCT00467870|463358213|FG001|Overall Study|Protocol Violation|1|||
128745178|NCT00467870|463358214|FG002|Overall Study|Protocol Violation|1|||
128745179|NCT00467870|463358215|FG003|Overall Study|Protocol Violation|2|||
128745180|NCT00467870|463358216|FG004|Overall Study|Protocol Violation|0|||
128745181|NCT00467870|463358217|FG005|Overall Study|Protocol Violation|0|||
128745182|NCT00467870|463358212|FG000|Overall Study|Withdrawal by Subject|14|||
128745183|NCT00467870|463358213|FG001|Overall Study|Withdrawal by Subject|21|||
128745184|NCT00467870|463358214|FG002|Overall Study|Withdrawal by Subject|0|||
128745185|NCT00467870|463358215|FG003|Overall Study|Withdrawal by Subject|9|||
128745186|NCT00467870|463358216|FG004|Overall Study|Withdrawal by Subject|10|||
128745187|NCT00467870|463358217|FG005|Overall Study|Withdrawal by Subject|1|||
128745188|NCT00467870|463358212|FG000|Overall Study|Lost to Follow-up|5|||
128745189|NCT00467870|463358213|FG001|Overall Study|Lost to Follow-up|3|||
128745190|NCT00467870|463358214|FG002|Overall Study|Lost to Follow-up|1|||
128745191|NCT00467870|463358215|FG003|Overall Study|Lost to Follow-up|1|||
128745192|NCT00467870|463358216|FG004|Overall Study|Lost to Follow-up|3|||
128745193|NCT00467870|463358217|FG005|Overall Study|Lost to Follow-up|0|||
128745194|NCT00467870|463358212|FG000|Overall Study|Subject Non-compliance|3|||
128745195|NCT00467870|463358213|FG001|Overall Study|Subject Non-compliance|4|||
128745196|NCT00467870|463358214|FG002|Overall Study|Subject Non-compliance|0|||
128745197|NCT00467870|463358215|FG003|Overall Study|Subject Non-compliance|1|||
128745198|NCT00467870|463358216|FG004|Overall Study|Subject Non-compliance|5|||
128745199|NCT00467870|463358217|FG005|Overall Study|Subject Non-compliance|0|||
128745200|NCT00467870|463358212|FG000|Overall Study|Other/Unknown|8|||
128745201|NCT00467870|463358213|FG001|Overall Study|Other/Unknown|5|||
128745202|NCT00467870|463358214|FG002|Overall Study|Other/Unknown|1|||
128745203|NCT00467870|463358215|FG003|Overall Study|Other/Unknown|5|||
128745204|NCT00467870|463358216|FG004|Overall Study|Other/Unknown|4|||
128745205|NCT00467870|463358217|FG005|Overall Study|Other/Unknown|0|||
128745206|NCT00321919|463358218|FG000|Overall Study|Adverse Event|17|||
128745207|NCT00321919|463358219|FG001|Overall Study|Adverse Event|10|||
128745208|NCT00321919|463358218|FG000|Overall Study|Death|21|||
128745209|NCT00321919|463358219|FG001|Overall Study|Death|17|||
128745210|NCT00321919|463358218|FG000|Overall Study|Insufficient Therapeutic Response|1|||
128745211|NCT00321919|463358219|FG001|Overall Study|Insufficient Therapeutic Response|0|||
128745212|NCT00321919|463358218|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
128745213|NCT00321919|463358219|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
128745214|NCT00321919|463358218|FG000|Overall Study|Refused Treatment|23|||
128745215|NCT00321919|463358219|FG001|Overall Study|Refused Treatment|14|||
128745216|NCT00321919|463358218|FG000|Overall Study|Other Protocol Violation|2|||
128745217|NCT00321919|463358219|FG001|Overall Study|Other Protocol Violation|3|||
128745218|NCT00321919|463358218|FG000|Overall Study|Failure to Return|3|||
128745219|NCT00321919|463358219|FG001|Overall Study|Failure to Return|1|||
128745220|NCT00321919|463358218|FG000|Overall Study|Other withdrawal reason|7|||
128745221|NCT00321919|463358219|FG001|Overall Study|Other withdrawal reason|6|||
128745222|NCT02261363|463358220|FG000|Overall Study|Lost to Follow-up|21|||
128745223|NCT01517802|463358221|FG000|Overall Study|Death|1|||
128745224|NCT02590354|463358222|FG000|Phase 1|Active hepatitis B or C infection|1|||
128745225|NCT02590354|463358222|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
128745226|NCT02590354|463358222|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
128745227|NCT02590354|463358222|FG000|Phase 1|Subject does not want to participate|20|||
128745228|NCT02590354|463358222|FG000|Phase 1|Lost to Follow-up|1|||
128745229|NCT02590354|463358222|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
128745230|NCT00760929|463358223|FG000|Overall Study|Adverse Event|2|||
128745231|NCT00760929|463358224|FG001|Overall Study|Adverse Event|0|||
128745232|NCT00760929|463358225|FG002|Overall Study|Adverse Event|6|||
128745233|NCT00760929|463358226|FG003|Overall Study|Adverse Event|10|||
128745234|NCT00760929|463358223|FG000|Overall Study|Lack of Efficacy|0|||
128745235|NCT00760929|463358224|FG001|Overall Study|Lack of Efficacy|2|||
128745236|NCT00760929|463358225|FG002|Overall Study|Lack of Efficacy|1|||
128745237|NCT00760929|463358226|FG003|Overall Study|Lack of Efficacy|0|||
128745238|NCT00760929|463358223|FG000|Overall Study|Withdrawal by Subject|1|||
128745239|NCT00760929|463358224|FG001|Overall Study|Withdrawal by Subject|0|||
128745240|NCT00760929|463358225|FG002|Overall Study|Withdrawal by Subject|9|||
128745241|NCT00760929|463358226|FG003|Overall Study|Withdrawal by Subject|1|||
128745242|NCT00760929|463358223|FG000|Overall Study|Lost to Follow-up|0|||
128745243|NCT00760929|463358224|FG001|Overall Study|Lost to Follow-up|0|||
128745244|NCT00760929|463358225|FG002|Overall Study|Lost to Follow-up|1|||
128745245|NCT00760929|463358226|FG003|Overall Study|Lost to Follow-up|0|||
128745246|NCT00760929|463358223|FG000|Overall Study|Progression of Disease|21|||
128745247|NCT00760929|463358224|FG001|Overall Study|Progression of Disease|26|||
128745248|NCT00760929|463358225|FG002|Overall Study|Progression of Disease|38|||
128745249|NCT00760929|463358226|FG003|Overall Study|Progression of Disease|42|||
128745250|NCT00760929|463358223|FG000|Overall Study|Other|2|||
128745251|NCT00760929|463358224|FG001|Overall Study|Other|0|||
128745252|NCT00760929|463358225|FG002|Overall Study|Other|2|||
128745253|NCT00760929|463358226|FG003|Overall Study|Other|1|||
128745254|NCT00760929|463358223|FG000|Overall Study|Death|0|||
128745255|NCT00760929|463358224|FG001|Overall Study|Death|0|||
128745256|NCT00760929|463358225|FG002|Overall Study|Death|1|||
128745257|NCT00760929|463358226|FG003|Overall Study|Death|0|||
128745258|NCT00760929|463358223|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
128745259|NCT00760929|463358224|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
128745260|NCT00760929|463358225|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
128745261|NCT00760929|463358226|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
128745262|NCT02099838|463358227|FG000|Overall Study|Death|1|||
128745263|NCT02099838|463358228|FG001|Overall Study|Death|0|||
128745264|NCT02099838|463358227|FG000|Overall Study|Lost to Follow-up|3|||
128745265|NCT02099838|463358228|FG001|Overall Study|Lost to Follow-up|1|||
128745266|NCT02099838|463358227|FG000|Overall Study|Withdrawal by Subject|0|||
128745267|NCT02099838|463358228|FG001|Overall Study|Withdrawal by Subject|1|||
128745268|NCT02301143|463358229|FG000|Induction Period|Enrolled But Not Treated|1|||
128745269|NCT02301143|463358230|FG001|Induction Period|Enrolled But Not Treated|0|||
128745270|NCT02301143|463358229|FG000|Induction Period|Death|1|||
128745271|NCT02301143|463358230|FG001|Induction Period|Death|0|||
128745272|NCT02301143|463358229|FG000|Induction Period|Adverse Event|22|||
128745273|NCT02301143|463358230|FG001|Induction Period|Adverse Event|0|||
128745274|NCT02301143|463358229|FG000|Induction Period|Progressive Disease|8|||
128745275|NCT02301143|463358230|FG001|Induction Period|Progressive Disease|0|||
128745276|NCT02301143|463358229|FG000|Induction Period|Withdrawal by Subject|3|||
128745277|NCT02301143|463358230|FG001|Induction Period|Withdrawal by Subject|0|||
128745278|NCT02301143|463358229|FG000|Induction Period|Noncompliance with Study Drug|1|||
128745279|NCT02301143|463358230|FG001|Induction Period|Noncompliance with Study Drug|0|||
128745280|NCT02301143|463358229|FG000|Induction Period|Physician Decision|4|||
128745281|NCT02301143|463358230|FG001|Induction Period|Physician Decision|0|||
128745282|NCT02301143|463358229|FG000|Induction Period|Symptomatic Deterioration|2|||
128745283|NCT02301143|463358230|FG001|Induction Period|Symptomatic Deterioration|0|||
128745284|NCT02301143|463358229|FG000|Induction Period|Protocol Violation|2|||
128745285|NCT02301143|463358230|FG001|Induction Period|Protocol Violation|0|||
128745286|NCT02301143|463358229|FG000|Induction Period|Other|1|||
128745287|NCT02301143|463358230|FG001|Induction Period|Other|0|||
128745288|NCT02301143|463358229|FG000|Investigator's Choice|Adverse Event|0|||
128745289|NCT02301143|463358230|FG001|Investigator's Choice|Adverse Event|3|||
128745290|NCT02301143|463358229|FG000|Investigator's Choice|Progressive Disease|0|||
128745291|NCT02301143|463358230|FG001|Investigator's Choice|Progressive Disease|3|||
128745292|NCT02301143|463358229|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
128745293|NCT02301143|463358230|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
128745294|NCT02301143|463358229|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
128745295|NCT02301143|463358230|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
128745296|NCT02301143|463358229|FG000|Investigator's Choice|Other|0|||
128745297|NCT02301143|463358230|FG001|Investigator's Choice|Other|1|||
128745298|NCT02301143|463358229|FG000|Investigator's Choice|Unresectable Surgery|0|||
128745299|NCT02301143|463358230|FG001|Investigator's Choice|Unresectable Surgery|1|||
128745300|NCT02536508|463358233|FG000|Overall Study|Withdrawal by Subject|18|||
128745301|NCT02536508|463358234|FG001|Overall Study|Withdrawal by Subject|13|||
128745302|NCT02536508|463358235|FG002|Overall Study|Withdrawal by Subject|7|||
128745303|NCT02536508|463358233|FG000|Overall Study|Adverse Event|14|||
128745304|NCT02536508|463358234|FG001|Overall Study|Adverse Event|13|||
128745305|NCT02536508|463358235|FG002|Overall Study|Adverse Event|6|||
128745306|NCT02536508|463358233|FG000|Overall Study|Lost to Follow-up|12|||
128745307|NCT02536508|463358234|FG001|Overall Study|Lost to Follow-up|4|||
128745308|NCT02536508|463358235|FG002|Overall Study|Lost to Follow-up|0|||
128745309|NCT02536508|463358233|FG000|Overall Study|Lack of Efficacy|3|||
128745310|NCT02536508|463358234|FG001|Overall Study|Lack of Efficacy|5|||
128745311|NCT02536508|463358235|FG002|Overall Study|Lack of Efficacy|4|||
128745312|NCT02536508|463358233|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
128745313|NCT02536508|463358234|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
128745314|NCT02536508|463358235|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
128745315|NCT02536508|463358233|FG000|Overall Study|Physician Decision|0|||
128745316|NCT02536508|463358234|FG001|Overall Study|Physician Decision|4|||
128745317|NCT02536508|463358235|FG002|Overall Study|Physician Decision|2|||
128745318|NCT02536508|463358233|FG000|Overall Study|Major Protocol Deviation|2|||
128745319|NCT02536508|463358234|FG001|Overall Study|Major Protocol Deviation|2|||
128745320|NCT02536508|463358235|FG002|Overall Study|Major Protocol Deviation|2|||
128745321|NCT02536508|463358233|FG000|Overall Study|Administrative Reasons|0|||
128745322|NCT02536508|463358234|FG001|Overall Study|Administrative Reasons|1|||
128745323|NCT02536508|463358235|FG002|Overall Study|Administrative Reasons|0|||
128745324|NCT00823719|463358239|FG000|Overall Study|Adverse Event|1|||
128745325|NCT00823719|463358240|FG001|Overall Study|Adverse Event|2|||
128745326|NCT00823719|463358239|FG000|Overall Study|Physician Decision|1|||
128745327|NCT00823719|463358240|FG001|Overall Study|Physician Decision|4|||
128745328|NCT00823719|463358239|FG000|Overall Study|Withdrawal by Subject|0|||
128745329|NCT00823719|463358240|FG001|Overall Study|Withdrawal by Subject|1|||
128745330|NCT00823719|463358239|FG000|Overall Study|Disease Progression|4|||
128745331|NCT00823719|463358240|FG001|Overall Study|Disease Progression|4|||
128745332|NCT04757649|463358242|FG000|Overall Study|Withdrawal by Subject|1|||
128745333|NCT04757649|463358242|FG000|Overall Study|Adverse Event|1|||
128745334|NCT01286779|463358243|FG000|Overall Study|Withdrawal by Subject|9|||
128745335|NCT01286779|463358243|FG000|Overall Study|Protocol Violation|5|||
128745336|NCT01286779|463358243|FG000|Overall Study|Physician Decision|2|||
128745337|NCT01286779|463358243|FG000|Overall Study|Participant had scheduled surgery|1|||
128745338|NCT01286779|463358243|FG000|Overall Study|Participant moved to another country|1|||
128745339|NCT01286779|463358243|FG000|Overall Study|Discontinued by sponsor|1|||
128745340|NCT02896855|463358246|FG000|Overall Study|Death|50|||
128745341|NCT02896855|463358247|FG001|Overall Study|Death|40|||
128745342|NCT02896855|463358246|FG000|Overall Study|Lost to Follow-up|15|||
128745343|NCT02896855|463358247|FG001|Overall Study|Lost to Follow-up|9|||
128745344|NCT02896855|463358246|FG000|Overall Study|Withdrawal by Subject|7|||
128745345|NCT02896855|463358247|FG001|Overall Study|Withdrawal by Subject|4|||
128745346|NCT02508311|463358248|FG000|Overall Study|Withdrawal by Subject|1|||
128785628|NCT00762463|463507314|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
128785629|NCT00762463|463507315|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
128785630|NCT00762463|463507316|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
128785631|NCT00762463|463507317|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
128785632|NCT00762463|463507314|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
128785633|NCT00762463|463507315|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
128785634|NCT00762463|463507316|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
128785635|NCT00762463|463507317|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
128785636|NCT00762463|463507314|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
128785637|NCT00762463|463507315|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
128785638|NCT00762463|463507316|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
128785639|NCT00762463|463507317|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
128785640|NCT00762463|463507314|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
128785641|NCT00762463|463507315|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
128785642|NCT00762463|463507316|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
128785643|NCT00762463|463507317|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
128785644|NCT00762463|463507314|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
128785645|NCT00762463|463507315|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
128785646|NCT00762463|463507316|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
128785647|NCT00762463|463507317|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
128785648|NCT00762463|463507314|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
128745347|NCT02508311|463358249|FG001|Overall Study|Withdrawal by Subject|0|||
128745348|NCT02169674|463358250|FG000|Overall Study|Withdrawal by Subject|2|||
128745349|NCT02169674|463358251|FG001|Overall Study|Withdrawal by Subject|1|||
128745350|NCT02169674|463358250|FG000|Overall Study|Seroprotected|30|||
128745351|NCT02169674|463358251|FG001|Overall Study|Seroprotected|76|||
128745352|NCT02169674|463358250|FG000|Overall Study|Lost to Follow-up|0|||
128745353|NCT02169674|463358251|FG001|Overall Study|Lost to Follow-up|1|||
128745354|NCT00574080|463358256|FG000|Overall Study|Death|10|||
128745355|NCT00574080|463358257|FG001|Overall Study|Death|10|||
128745356|NCT01380327|463358258|FG000|Overall Study|Lost to Follow-up|0|||
128745357|NCT01380327|463358259|FG001|Overall Study|Lost to Follow-up|1|||
128745358|NCT01380327|463358260|FG002|Overall Study|Lost to Follow-up|1|||
128745359|NCT01380327|463358258|FG000|Overall Study|Protocol Violation|3|||
128745360|NCT01380327|463358259|FG001|Overall Study|Protocol Violation|2|||
128745361|NCT01380327|463358260|FG002|Overall Study|Protocol Violation|3|||
128745362|NCT01380327|463358258|FG000|Overall Study|Withdrawal by Subject|0|||
128745363|NCT01380327|463358259|FG001|Overall Study|Withdrawal by Subject|0|||
128745364|NCT01380327|463358260|FG002|Overall Study|Withdrawal by Subject|1|||
128745365|NCT01380327|463358258|FG000|Overall Study|Housing situation precluded ability to k|0|||
128745366|NCT01380327|463358259|FG001|Overall Study|Housing situation precluded ability to k|0|||
128745367|NCT01380327|463358260|FG002|Overall Study|Housing situation precluded ability to k|1|||
128745368|NCT01380327|463358258|FG000|Overall Study|Questionable onset of epilepsy|0|||
128745369|NCT01380327|463358259|FG001|Overall Study|Questionable onset of epilepsy|0|||
128745370|NCT01380327|463358260|FG002|Overall Study|Questionable onset of epilepsy|1|||
128745371|NCT03646513|463358266|FG000|Overall Study|Premature study termination|4|||
128745372|NCT02219932|463358272|FG000|Overall Study|Other|5|||
128745373|NCT02219932|463358273|FG001|Overall Study|Other|11|||
128745374|NCT02219932|463358272|FG000|Overall Study|Death|1|||
128745375|NCT02219932|463358273|FG001|Overall Study|Death|1|||
128745376|NCT02219932|463358272|FG000|Overall Study|Investigator Decision|0|||
128745377|NCT02219932|463358273|FG001|Overall Study|Investigator Decision|1|||
128745378|NCT02219932|463358272|FG000|Overall Study|Consent Withdrawn|11|||
128745379|NCT02219932|463358273|FG001|Overall Study|Consent Withdrawn|7|||
128745380|NCT02219932|463358272|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
128745381|NCT02219932|463358273|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
128745382|NCT02219932|463358272|FG000|Overall Study|Protocol Violation|10|||
128745383|NCT02219932|463358273|FG001|Overall Study|Protocol Violation|6|||
128745384|NCT02219932|463358272|FG000|Overall Study|Pregnancy|1|||
128785649|NCT00762463|463507315|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
128785650|NCT00762463|463507316|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
128745385|NCT02219932|463358273|FG001|Overall Study|Pregnancy|0|||
128745386|NCT02219932|463358272|FG000|Overall Study|Lost to Follow-up|4|||
128745387|NCT02219932|463358273|FG001|Overall Study|Lost to Follow-up|2|||
128745388|NCT02219932|463358272|FG000|Overall Study|Adverse Event|23|||
128745389|NCT02219932|463358273|FG001|Overall Study|Adverse Event|21|||
128745390|NCT00093145|463358274|FG000|Overall Study|Unacceptable Toxicity Only|2|||
128745391|NCT00093145|463358274|FG000|Overall Study|Physician Decision|5|||
128745392|NCT00093145|463358274|FG000|Overall Study|Withdrawal by Subject|9|||
128745393|NCT00093145|463358274|FG000|Overall Study|Other|1|||
128745394|NCT04389840|463358275|FG000|Overall Study|Adverse Event|0|||
128745395|NCT04389840|463358276|FG001|Overall Study|Adverse Event|0|||
128745396|NCT04389840|463358277|FG002|Overall Study|Adverse Event|0|||
128745397|NCT04389840|463358278|FG003|Overall Study|Adverse Event|1|||
128745398|NCT04389840|463358279|FG004|Overall Study|Adverse Event|0|||
128745399|NCT04389840|463358280|FG005|Overall Study|Adverse Event|0|||
128745400|NCT04389840|463358275|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
128745401|NCT04389840|463358276|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
128745402|NCT04389840|463358277|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
128745403|NCT04389840|463358278|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
128745404|NCT04389840|463358279|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
128745405|NCT04389840|463358280|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
128745406|NCT04389840|463358275|FG000|Overall Study|Death|0|||
128745407|NCT04389840|463358276|FG001|Overall Study|Death|1|||
128745408|NCT04389840|463358277|FG002|Overall Study|Death|0|||
128745409|NCT04389840|463358278|FG003|Overall Study|Death|0|||
128745410|NCT04389840|463358279|FG004|Overall Study|Death|0|||
128745411|NCT04389840|463358280|FG005|Overall Study|Death|0|||
128745412|NCT02252211|463358281|FG000|Overall Study|Adverse Event|0|||
128745413|NCT02252211|463358282|FG001|Overall Study|Adverse Event|1|||
128745414|NCT02252211|463358283|FG002|Overall Study|Adverse Event|0|||
128745415|NCT02252211|463358281|FG000|Overall Study|Progressive disease|3|||
128745416|NCT02252211|463358282|FG001|Overall Study|Progressive disease|2|||
128745417|NCT02252211|463358283|FG002|Overall Study|Progressive disease|0|||
128745418|NCT02252211|463358281|FG000|Overall Study|Withdrawal by Subject|1|||
128745419|NCT02252211|463358282|FG001|Overall Study|Withdrawal by Subject|0|||
128745420|NCT02252211|463358283|FG002|Overall Study|Withdrawal by Subject|0|||
128745421|NCT02252211|463358281|FG000|Overall Study|Serious Adverse Event During Screening|1|||
128745422|NCT02252211|463358282|FG001|Overall Study|Serious Adverse Event During Screening|0|||
128745423|NCT02252211|463358283|FG002|Overall Study|Serious Adverse Event During Screening|1|||
128745424|NCT00968669|463358284|FG000|Overall Study|Lost to Follow-up|5|||
128745425|NCT00968669|463358285|FG001|Overall Study|Lost to Follow-up|2|||
128745426|NCT00968669|463358286|FG002|Overall Study|Lost to Follow-up|1|||
128745427|NCT00968669|463358287|FG003|Overall Study|Lost to Follow-up|4|||
128745428|NCT00968669|463358284|FG000|Overall Study|Withdrawal by Subject|9|||
128745429|NCT00968669|463358285|FG001|Overall Study|Withdrawal by Subject|7|||
128745430|NCT00968669|463358286|FG002|Overall Study|Withdrawal by Subject|5|||
128745431|NCT00968669|463358287|FG003|Overall Study|Withdrawal by Subject|3|||
128745432|NCT00968669|463358284|FG000|Overall Study|Pregnancy|0|||
128745433|NCT00968669|463358285|FG001|Overall Study|Pregnancy|0|||
128745434|NCT00968669|463358286|FG002|Overall Study|Pregnancy|2|||
128745435|NCT00968669|463358287|FG003|Overall Study|Pregnancy|0|||
128745436|NCT00968669|463358284|FG000|Overall Study|AE|1|||
128745437|NCT00968669|463358285|FG001|Overall Study|AE|0|||
128745438|NCT00968669|463358286|FG002|Overall Study|AE|0|||
128745439|NCT00968669|463358287|FG003|Overall Study|AE|0|||
128745440|NCT00968669|463358284|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
128745441|NCT00968669|463358285|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
128745442|NCT00968669|463358286|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
128745443|NCT00968669|463358287|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
128745444|NCT00968669|463358284|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
128745445|NCT00968669|463358285|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
128745446|NCT00968669|463358286|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
128745447|NCT00968669|463358287|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
128745448|NCT00968669|463358284|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
128745449|NCT00968669|463358285|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
128745450|NCT00968669|463358286|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
128745451|NCT00968669|463358287|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
128745452|NCT00968669|463358284|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
128745453|NCT00968669|463358285|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
128745454|NCT00968669|463358286|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
128745455|NCT00968669|463358287|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
128745456|NCT00968669|463358284|FG000|Overall Study|EARLY WITHDRAWAL|0|||
128745457|NCT00968669|463358285|FG001|Overall Study|EARLY WITHDRAWAL|1|||
128745458|NCT00968669|463358286|FG002|Overall Study|EARLY WITHDRAWAL|0|||
128745459|NCT00968669|463358287|FG003|Overall Study|EARLY WITHDRAWAL|0|||
128745460|NCT00968669|463358284|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
128745461|NCT00968669|463358285|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
128745462|NCT00968669|463358286|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
128745463|NCT00968669|463358287|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
128745464|NCT00968669|463358284|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
128745465|NCT00968669|463358285|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
128745466|NCT00968669|463358286|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
128745467|NCT00968669|463358287|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
128745468|NCT00968669|463358284|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
128745469|NCT00968669|463358285|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
128745470|NCT00968669|463358286|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
128745471|NCT00968669|463358287|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
128745472|NCT00968669|463358284|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
128745473|NCT00968669|463358285|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
128745474|NCT00968669|463358286|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
128745475|NCT00968669|463358287|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
128745476|NCT00968669|463358284|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
128745477|NCT00968669|463358285|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
128745478|NCT00968669|463358286|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
128745479|NCT00968669|463358287|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
128745480|NCT00968669|463358284|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
128745481|NCT00968669|463358285|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
128745482|NCT00968669|463358286|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
128745483|NCT00968669|463358287|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
128745484|NCT00968669|463358284|FG000|Overall Study|SPONSOR DECISION|0|||
128745485|NCT00968669|463358285|FG001|Overall Study|SPONSOR DECISION|1|||
128745486|NCT00968669|463358286|FG002|Overall Study|SPONSOR DECISION|0|||
128745487|NCT00968669|463358287|FG003|Overall Study|SPONSOR DECISION|0|||
128745488|NCT00968669|463358284|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
128745489|NCT00968669|463358285|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
128745490|NCT00968669|463358286|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
128745491|NCT00968669|463358287|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
128745492|NCT00968669|463358284|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
128745493|NCT00968669|463358285|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
128745494|NCT00968669|463358286|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
128745495|NCT00968669|463358287|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
128745496|NCT00968669|463358284|FG000|Overall Study|SUBJECT INCARCERATED|0|||
128745497|NCT00968669|463358285|FG001|Overall Study|SUBJECT INCARCERATED|1|||
128745498|NCT00968669|463358286|FG002|Overall Study|SUBJECT INCARCERATED|0|||
128745499|NCT00968669|463358287|FG003|Overall Study|SUBJECT INCARCERATED|0|||
128745500|NCT00968669|463358284|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
128745501|NCT00968669|463358285|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
128745502|NCT00968669|463358286|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
128745503|NCT00968669|463358287|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
128745504|NCT00968669|463358284|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
128745505|NCT00968669|463358285|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
128745506|NCT00968669|463358286|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
128745507|NCT00968669|463358287|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
128745508|NCT00144339|463358288|FG000|Overall Study|Adverse Event|746|||
128745509|NCT00144339|463358289|FG001|Overall Study|Adverse Event|627|||
128745510|NCT00144339|463358288|FG000|Overall Study|Protocol Violation|75|||
128745511|NCT00144339|463358289|FG001|Overall Study|Protocol Violation|48|||
128745512|NCT00144339|463358288|FG000|Overall Study|Withdrawal by Subject|403|||
128745513|NCT00144339|463358289|FG001|Overall Study|Withdrawal by Subject|300|||
128745514|NCT00144339|463358288|FG000|Overall Study|Lost to Follow-up|76|||
128745515|NCT00144339|463358289|FG001|Overall Study|Lost to Follow-up|64|||
128745516|NCT00144339|463358288|FG000|Overall Study|Other|58|||
128785651|NCT00762463|463507317|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
128785652|NCT00762463|463507314|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
128745517|NCT00144339|463358289|FG001|Overall Study|Other|60|||
128745518|NCT01109992|463358290|FG000|Overall Study|Withdrawal by Subject|0|||
128745519|NCT01109992|463358291|FG001|Overall Study|Withdrawal by Subject|1|||
128745520|NCT01109992|463358290|FG000|Overall Study|Movement during rest scan.|0|||
128745521|NCT01109992|463358291|FG001|Overall Study|Movement during rest scan.|1|||
128745522|NCT00690755|463358292|FG000|Overall Study|Physician Decision|2|||
128745523|NCT00690755|463358293|FG001|Overall Study|Physician Decision|0|||
128745524|NCT00690755|463358294|FG002|Overall Study|Physician Decision|46|||
128745525|NCT00690755|463358295|FG003|Overall Study|Physician Decision|5|||
128745526|NCT00690755|463358296|FG004|Overall Study|Physician Decision|0|||
128745527|NCT00690755|463358297|FG005|Overall Study|Physician Decision|4|||
128745528|NCT00690755|463358298|FG006|Overall Study|Physician Decision|0|||
128745529|NCT03867734|463358299|FG000|Overall Study|Lost to Follow-up|2|||
128745530|NCT03832192|463358309|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
128745531|NCT03832192|463358310|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
128745532|NCT03738150|463358311|FG000|Base Study|Withdrawal by Subject|1|||
128745533|NCT03738150|463358311|FG000|Extension Study|Withdrawal by Subject|1|||
128745534|NCT02276482|463358312|FG000|Overall Study|Adverse Event|1|||
128745535|NCT02276482|463358313|FG001|Overall Study|Adverse Event|0|||
128745536|NCT02276482|463358312|FG000|Overall Study|Withdrawal by Subject|1|||
128745537|NCT02276482|463358313|FG001|Overall Study|Withdrawal by Subject|0|||
128745538|NCT02276482|463358312|FG000|Overall Study|Gram-negative infection|1|||
128745539|NCT02276482|463358313|FG001|Overall Study|Gram-negative infection|0|||
128745540|NCT02276482|463358312|FG000|Overall Study|Reason not specified|0|||
128745541|NCT02276482|463358313|FG001|Overall Study|Reason not specified|1|||
128745542|NCT01165281|463358321|FG000|Overall Study|Adverse Event|12|||
128745543|NCT01165281|463358322|FG001|Overall Study|Adverse Event|14|||
128745544|NCT01165281|463358321|FG000|Overall Study|Death|3|||
128745545|NCT01165281|463358322|FG001|Overall Study|Death|4|||
128745546|NCT01165281|463358321|FG000|Overall Study|Lack of Efficacy|4|||
128745547|NCT01165281|463358322|FG001|Overall Study|Lack of Efficacy|1|||
128745548|NCT01165281|463358321|FG000|Overall Study|Lost to Follow-up|0|||
128745549|NCT01165281|463358322|FG001|Overall Study|Lost to Follow-up|1|||
128745550|NCT01165281|463358321|FG000|Overall Study|Physician Decision|8|||
128745551|NCT01165281|463358322|FG001|Overall Study|Physician Decision|1|||
128745552|NCT01165281|463358321|FG000|Overall Study|Protocol Violation|6|||
128745553|NCT01165281|463358322|FG001|Overall Study|Protocol Violation|5|||
128745554|NCT01165281|463358321|FG000|Overall Study|Withdrawal by Subject|8|||
128745555|NCT01165281|463358322|FG001|Overall Study|Withdrawal by Subject|7|||
128745556|NCT01165281|463358321|FG000|Overall Study|Noncompliance with Study Drug|1|||
128745557|NCT01165281|463358322|FG001|Overall Study|Noncompliance with Study Drug|4|||
128745558|NCT01165281|463358321|FG000|Overall Study|Progressive Disease|10|||
128745559|NCT01165281|463358322|FG001|Overall Study|Progressive Disease|14|||
128745560|NCT01165281|463358321|FG000|Overall Study|Other|6|||
128745561|NCT01165281|463358322|FG001|Overall Study|Other|0|||
128745562|NCT00363766|463358327|FG000|Overall Study|Progressive Disease|15|||
128745563|NCT00363766|463358328|FG001|Overall Study|Progressive Disease|9|||
128745564|NCT00363766|463358327|FG000|Overall Study|Adverse Event|10|||
128745565|NCT00363766|463358328|FG001|Overall Study|Adverse Event|2|||
128745566|NCT00363766|463358327|FG000|Overall Study|Disease Related Death|1|||
128745567|NCT00363766|463358328|FG001|Overall Study|Disease Related Death|3|||
128745568|NCT00363766|463358327|FG000|Overall Study|Not Disease Related Death|3|||
128745569|NCT00363766|463358328|FG001|Overall Study|Not Disease Related Death|4|||
128745570|NCT00363766|463358327|FG000|Overall Study|Withdrawal by Subject|2|||
128745571|NCT00363766|463358328|FG001|Overall Study|Withdrawal by Subject|0|||
128745572|NCT00363766|463358327|FG000|Overall Study|Physician Decision|1|||
128745573|NCT00363766|463358328|FG001|Overall Study|Physician Decision|2|||
128745574|NCT02005471|463358329|FG000|Main Study|Adverse Event|0|||
128745575|NCT02005471|463358330|FG001|Main Study|Adverse Event|1|||
128745576|NCT02005471|463358331|FG002|Main Study|Adverse Event|0|||
128745577|NCT02005471|463358332|FG003|Main Study|Adverse Event|0|||
128745578|NCT02005471|463358329|FG000|Main Study|Death|83|||
128745579|NCT02005471|463358330|FG001|Main Study|Death|52|||
128745580|NCT02005471|463358331|FG002|Main Study|Death|0|||
128745581|NCT02005471|463358332|FG003|Main Study|Death|0|||
128745582|NCT02005471|463358329|FG000|Main Study|Lost to Follow-up|4|||
128745583|NCT02005471|463358330|FG001|Main Study|Lost to Follow-up|5|||
128745584|NCT02005471|463358331|FG002|Main Study|Lost to Follow-up|0|||
128745585|NCT02005471|463358332|FG003|Main Study|Lost to Follow-up|0|||
128745586|NCT02005471|463358329|FG000|Main Study|Physician Decision|3|||
128745587|NCT02005471|463358330|FG001|Main Study|Physician Decision|1|||
128745588|NCT02005471|463358331|FG002|Main Study|Physician Decision|0|||
128745589|NCT02005471|463358332|FG003|Main Study|Physician Decision|0|||
128745590|NCT02005471|463358329|FG000|Main Study|Withdrawal by Subject|26|||
128745591|NCT02005471|463358330|FG001|Main Study|Withdrawal by Subject|11|||
128745592|NCT02005471|463358331|FG002|Main Study|Withdrawal by Subject|0|||
128745593|NCT02005471|463358332|FG003|Main Study|Withdrawal by Subject|0|||
128745594|NCT02005471|463358329|FG000|Main Study|Reason not Specified|0|||
128745595|NCT02005471|463358330|FG001|Main Study|Reason not Specified|6|||
128745596|NCT02005471|463358331|FG002|Main Study|Reason not Specified|0|||
128745597|NCT02005471|463358332|FG003|Main Study|Reason not Specified|0|||
128745598|NCT02005471|463358329|FG000|Main Study|Randomized but not Dosed|8|||
128745599|NCT02005471|463358330|FG001|Main Study|Randomized but not Dosed|0|||
128745600|NCT02005471|463358331|FG002|Main Study|Randomized but not Dosed|0|||
128745601|NCT02005471|463358332|FG003|Main Study|Randomized but not Dosed|0|||
128745602|NCT02005471|463358329|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
128745603|NCT02005471|463358330|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
128745604|NCT02005471|463358331|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
128745605|NCT02005471|463358332|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
128745606|NCT02005471|463358329|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
128745607|NCT02005471|463358330|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
128745608|NCT02005471|463358331|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
128745609|NCT02005471|463358332|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
128745610|NCT02005471|463358329|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
128745611|NCT02005471|463358330|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
128745612|NCT02005471|463358331|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
128745613|NCT02005471|463358332|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
128745614|NCT00627705|463358333|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
128745615|NCT00627705|463358334|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
128745616|NCT00627705|463358333|FG000|Overall Study|Adverse Event|1|||
128745617|NCT00627705|463358334|FG001|Overall Study|Adverse Event|0|||
128745618|NCT00627705|463358333|FG000|Overall Study|Withdrawal by Subject|0|||
128745619|NCT00627705|463358334|FG001|Overall Study|Withdrawal by Subject|2|||
128745620|NCT00627705|463358333|FG000|Overall Study|Lost to Follow-up|0|||
128745621|NCT00627705|463358334|FG001|Overall Study|Lost to Follow-up|1|||
128745622|NCT00809757|463358340|FG000|Overall Study|Adverse Event|2|||
128745623|NCT00809757|463358341|FG001|Overall Study|Adverse Event|3|||
128745624|NCT00809757|463358342|FG002|Overall Study|Adverse Event|3|||
128745625|NCT00809757|463358340|FG000|Overall Study|Lost to Follow-up|0|||
128745626|NCT00809757|463358341|FG001|Overall Study|Lost to Follow-up|0|||
128745627|NCT00809757|463358342|FG002|Overall Study|Lost to Follow-up|1|||
128745628|NCT00809757|463358340|FG000|Overall Study|Protocol Violation|1|||
128745629|NCT00809757|463358341|FG001|Overall Study|Protocol Violation|1|||
128745630|NCT00809757|463358342|FG002|Overall Study|Protocol Violation|1|||
128745631|NCT00809757|463358340|FG000|Overall Study|Withdrawal by Subject|2|||
128745632|NCT00809757|463358341|FG001|Overall Study|Withdrawal by Subject|1|||
128745633|NCT00809757|463358342|FG002|Overall Study|Withdrawal by Subject|3|||
128745634|NCT00809757|463358340|FG000|Overall Study|Subject Uncooperative|1|||
128745635|NCT00809757|463358341|FG001|Overall Study|Subject Uncooperative|0|||
128745636|NCT00809757|463358342|FG002|Overall Study|Subject Uncooperative|2|||
128745637|NCT00809757|463358340|FG000|Overall Study|Noncompliance with Medication|0|||
128745638|NCT00809757|463358341|FG001|Overall Study|Noncompliance with Medication|0|||
128745639|NCT00809757|463358342|FG002|Overall Study|Noncompliance with Medication|1|||
128745640|NCT00253864|463358343|FG000|Overall Study|Lost to Follow-up|5|||
128745641|NCT00253864|463358344|FG001|Overall Study|Lost to Follow-up|8|||
128745642|NCT01410448|463358345|FG000|Overall Study|No conversion to everolimus|0|||
128745643|NCT01410448|463358346|FG001|Overall Study|No conversion to everolimus|24|||
128745644|NCT01410448|463358345|FG000|Overall Study|Graft loss|4|||
128745645|NCT01410448|463358346|FG001|Overall Study|Graft loss|1|||
128745646|NCT01410448|463358345|FG000|Overall Study|Administrative issues|2|||
128745647|NCT01410448|463358346|FG001|Overall Study|Administrative issues|1|||
128745648|NCT01410448|463358345|FG000|Overall Study|Lost to Follow-up|1|||
128745649|NCT01410448|463358346|FG001|Overall Study|Lost to Follow-up|0|||
128745650|NCT01410448|463358345|FG000|Overall Study|Withdrawal by Subject|3|||
128745651|NCT01410448|463358346|FG001|Overall Study|Withdrawal by Subject|2|||
128745652|NCT01410448|463358345|FG000|Overall Study|Protocol Violation|0|||
128745653|NCT01410448|463358346|FG001|Overall Study|Protocol Violation|4|||
128745654|NCT01410448|463358345|FG000|Overall Study|Death|2|||
128745655|NCT01410448|463358346|FG001|Overall Study|Death|3|||
128745656|NCT00360529|463358347|FG000|Overall Study|Adverse Event|10|||
128745657|NCT00360529|463358348|FG001|Overall Study|Adverse Event|23|||
128745658|NCT00360529|463358349|FG002|Overall Study|Adverse Event|33|||
128745659|NCT00360529|463358347|FG000|Overall Study|Protocol Violation|3|||
128745660|NCT00360529|463358348|FG001|Overall Study|Protocol Violation|3|||
128745661|NCT00360529|463358349|FG002|Overall Study|Protocol Violation|11|||
128745662|NCT00360529|463358347|FG000|Overall Study|Lost to Follow-up|14|||
128745663|NCT00360529|463358348|FG001|Overall Study|Lost to Follow-up|10|||
128745664|NCT00360529|463358349|FG002|Overall Study|Lost to Follow-up|13|||
128745665|NCT00360529|463358347|FG000|Overall Study|Withdrawal by Subject|22|||
128745666|NCT00360529|463358348|FG001|Overall Study|Withdrawal by Subject|14|||
128745667|NCT00360529|463358349|FG002|Overall Study|Withdrawal by Subject|18|||
128745668|NCT00360529|463358347|FG000|Overall Study|Lack of Efficacy|8|||
128745669|NCT00360529|463358348|FG001|Overall Study|Lack of Efficacy|6|||
128745670|NCT00360529|463358349|FG002|Overall Study|Lack of Efficacy|5|||
128745671|NCT00360529|463358347|FG000|Overall Study|Reason discontinued not explained above|4|||
128745672|NCT00360529|463358348|FG001|Overall Study|Reason discontinued not explained above|9|||
128745673|NCT00360529|463358349|FG002|Overall Study|Reason discontinued not explained above|11|||
128745674|NCT04295564|463360471|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
128745675|NCT04295564|463360472|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
128745676|NCT01682460|463360473|FG000|Overall Study|Withdrawal by Subject|2|||
128745677|NCT01682460|463360473|FG000|Overall Study|Did not meet inclusion criteria|2|||
128745678|NCT00724282|463360475|FG000|Overall Study|Withdrawal by Subject|3|||
128745679|NCT00724282|463360475|FG000|Overall Study|Physician Decision|1|||
128745680|NCT01928719|463360478|FG000|Overall Study|Lost to Follow-up|26|||
128745681|NCT01928719|463360479|FG001|Overall Study|Lost to Follow-up|11|||
128745682|NCT01928719|463360478|FG000|Overall Study|Withdrawal by Subject|22|||
128745683|NCT01928719|463360479|FG001|Overall Study|Withdrawal by Subject|7|||
128745684|NCT01928719|463360478|FG000|Overall Study|Protocol Violation|3|||
128745685|NCT01928719|463360479|FG001|Overall Study|Protocol Violation|1|||
128745686|NCT01928719|463360478|FG000|Overall Study|Adverse Event|1|||
128745687|NCT01928719|463360479|FG001|Overall Study|Adverse Event|0|||
128745688|NCT02105116|463360480|FG000|Overall Study|not eligible for step 2 of trial|5|||
128745689|NCT02105116|463360480|FG000|Overall Study|Death|1|||
128745690|NCT00263666|463360481|FG000|Overall Study|Adverse Event|6|||
128745691|NCT00263666|463360482|FG001|Overall Study|Adverse Event|8|||
128745692|NCT00263666|463360481|FG000|Overall Study|Lost to Follow-up|1|||
128745693|NCT00263666|463360482|FG001|Overall Study|Lost to Follow-up|2|||
128745694|NCT00263666|463360481|FG000|Overall Study|Withdrawal by Subject|0|||
128745695|NCT00263666|463360482|FG001|Overall Study|Withdrawal by Subject|1|||
128745696|NCT00838110|463360483|FG000|Overall Study|Death|0|||
128745697|NCT00838110|463360484|FG001|Overall Study|Death|0|||
128745698|NCT00838110|463360485|FG002|Overall Study|Death|1|||
128745699|NCT00838110|463360486|FG003|Overall Study|Death|2|||
128745700|NCT00838110|463360483|FG000|Overall Study|Adverse Event|11|||
128745701|NCT00838110|463360484|FG001|Overall Study|Adverse Event|10|||
128745702|NCT00838110|463360485|FG002|Overall Study|Adverse Event|8|||
128745703|NCT00838110|463360486|FG003|Overall Study|Adverse Event|7|||
128745704|NCT00838110|463360483|FG000|Overall Study|Withdrawal by Subject|5|||
128745705|NCT00838110|463360484|FG001|Overall Study|Withdrawal by Subject|6|||
128745706|NCT00838110|463360485|FG002|Overall Study|Withdrawal by Subject|3|||
128745707|NCT00838110|463360486|FG003|Overall Study|Withdrawal by Subject|4|||
128745708|NCT00838110|463360483|FG000|Overall Study|Other|3|||
128745709|NCT00838110|463360484|FG001|Overall Study|Other|3|||
128745710|NCT00838110|463360485|FG002|Overall Study|Other|3|||
128745711|NCT00838110|463360486|FG003|Overall Study|Other|2|||
128745712|NCT00838110|463360483|FG000|Overall Study|Protocol Violation|0|||
128745713|NCT00838110|463360484|FG001|Overall Study|Protocol Violation|2|||
128745714|NCT00838110|463360485|FG002|Overall Study|Protocol Violation|1|||
128745715|NCT00838110|463360486|FG003|Overall Study|Protocol Violation|1|||
128745716|NCT00838110|463360483|FG000|Overall Study|Lost to Follow-up|3|||
128745717|NCT00838110|463360484|FG001|Overall Study|Lost to Follow-up|0|||
128745718|NCT00838110|463360485|FG002|Overall Study|Lost to Follow-up|0|||
128745719|NCT00838110|463360486|FG003|Overall Study|Lost to Follow-up|0|||
128745720|NCT00838110|463360483|FG000|Overall Study|Did not meet eligibility criteria|0|||
128745721|NCT00838110|463360484|FG001|Overall Study|Did not meet eligibility criteria|0|||
128745722|NCT00838110|463360485|FG002|Overall Study|Did not meet eligibility criteria|1|||
128745723|NCT00838110|463360486|FG003|Overall Study|Did not meet eligibility criteria|2|||
128745724|NCT00838110|463360483|FG000|Overall Study|Randomized but not treated|0|||
128745725|NCT00838110|463360484|FG001|Overall Study|Randomized but not treated|1|||
128745726|NCT00838110|463360485|FG002|Overall Study|Randomized but not treated|0|||
128745727|NCT00838110|463360486|FG003|Overall Study|Randomized but not treated|0|||
128745728|NCT01262651|463360487|FG000|Overall Study|Adverse Event|40|||
128745729|NCT01262651|463360488|FG001|Overall Study|Adverse Event|35|||
128745730|NCT01262651|463360487|FG000|Overall Study|Withdrawal by Subject|15|||
128745731|NCT01262651|463360488|FG001|Overall Study|Withdrawal by Subject|11|||
128745732|NCT01262651|463360487|FG000|Overall Study|Withdrawal by Investigator|2|||
128745733|NCT01262651|463360488|FG001|Overall Study|Withdrawal by Investigator|2|||
128745734|NCT01262651|463360487|FG000|Overall Study|Met Withdrawal Criteria|1|||
128745735|NCT01262651|463360488|FG001|Overall Study|Met Withdrawal Criteria|0|||
128745736|NCT04969783|463360489|FG000|Overall Study|Lost to Follow-up|2|||
128745737|NCT04969783|463360490|FG001|Overall Study|Lost to Follow-up|0|||
128745738|NCT04969783|463360489|FG000|Overall Study|Withdrawal by Subject|4|||
128745739|NCT04969783|463360490|FG001|Overall Study|Withdrawal by Subject|0|||
128745740|NCT04969783|463360489|FG000|Overall Study|Physician Decision|6|||
128745741|NCT04969783|463360490|FG001|Overall Study|Physician Decision|0|||
128745742|NCT03240588|463360491|FG000|Overall Study|Death|3|||
128745743|NCT03240588|463360492|FG001|Overall Study|Death|0|||
128745744|NCT03240588|463360493|FG002|Overall Study|Death|0|||
128745745|NCT03240588|463360491|FG000|Overall Study|Adverse Event|5|||
128745746|NCT03240588|463360492|FG001|Overall Study|Adverse Event|4|||
128745747|NCT03240588|463360493|FG002|Overall Study|Adverse Event|0|||
128745748|NCT03240588|463360491|FG000|Overall Study|Lost to Follow-up|9|||
128745749|NCT03240588|463360492|FG001|Overall Study|Lost to Follow-up|4|||
128745750|NCT03240588|463360493|FG002|Overall Study|Lost to Follow-up|0|||
128745751|NCT03240588|463360491|FG000|Overall Study|Physician Decision|3|||
128745752|NCT03240588|463360492|FG001|Overall Study|Physician Decision|2|||
128745753|NCT03240588|463360493|FG002|Overall Study|Physician Decision|0|||
128745754|NCT03240588|463360491|FG000|Overall Study|Did not meet eligibility criteria|0|||
128745755|NCT03240588|463360492|FG001|Overall Study|Did not meet eligibility criteria|6|||
128745756|NCT03240588|463360493|FG002|Overall Study|Did not meet eligibility criteria|0|||
128745757|NCT03240588|463360491|FG000|Overall Study|No longer meets protocol criteria|12|||
128745758|NCT03240588|463360492|FG001|Overall Study|No longer meets protocol criteria|7|||
128745759|NCT03240588|463360493|FG002|Overall Study|No longer meets protocol criteria|0|||
128745760|NCT03240588|463360491|FG000|Overall Study|Withdrawal by Subject|60|||
128745761|NCT03240588|463360492|FG001|Overall Study|Withdrawal by Subject|52|||
128745762|NCT03240588|463360493|FG002|Overall Study|Withdrawal by Subject|7|||
128745763|NCT03240588|463360491|FG000|Overall Study|Other, additional details not available.|0|||
128745764|NCT03240588|463360492|FG001|Overall Study|Other, additional details not available.|12|||
128745765|NCT03240588|463360493|FG002|Overall Study|Other, additional details not available.|1|||
128745766|NCT03240588|463360491|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
128745767|NCT03240588|463360492|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
128785653|NCT00762463|463507315|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
128745768|NCT03240588|463360493|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
128745769|NCT03240588|463360491|FG000|Overall Study|Closure of study|55|||
128745770|NCT03240588|463360492|FG001|Overall Study|Closure of study|3|||
128745771|NCT03240588|463360493|FG002|Overall Study|Closure of study|0|||
128745772|NCT03240588|463360491|FG000|Overall Study|Subject non-compliance|23|||
128745773|NCT03240588|463360492|FG001|Overall Study|Subject non-compliance|2|||
128745774|NCT03240588|463360493|FG002|Overall Study|Subject non-compliance|1|||
128745775|NCT03240588|463360491|FG000|Overall Study|Device Deficiency|1|||
128745776|NCT03240588|463360492|FG001|Overall Study|Device Deficiency|0|||
128745777|NCT03240588|463360493|FG002|Overall Study|Device Deficiency|0|||
128745778|NCT03240588|463360491|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
128745779|NCT03240588|463360492|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
128745780|NCT03240588|463360493|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
128745781|NCT02091726|463360496|FG000|Overall Study|Lost to Follow-up|6|||
128745782|NCT01914926|463360510|FG000|Overall Study|Adverse Event|1|||
128745783|NCT01914926|463360511|FG001|Overall Study|Adverse Event|0|||
128745784|NCT01914926|463360510|FG000|Overall Study|uncooperative, agitated and removed|0|||
128745785|NCT01914926|463360511|FG001|Overall Study|uncooperative, agitated and removed|1|||
128745786|NCT00434057|463360512|FG000|Overall Study|Withdrawal by Subject|1|||
128745787|NCT02117570|463360513|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
128745788|NCT02117570|463360514|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
128745789|NCT02117570|463360515|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
128745790|NCT02117570|463360513|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
128745791|NCT02117570|463360514|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
128745792|NCT02117570|463360515|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
128745793|NCT02117570|463360513|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
128745794|NCT02117570|463360514|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
128745795|NCT02117570|463360515|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
128745796|NCT02117570|463360513|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
128745797|NCT02117570|463360514|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
128745798|NCT02117570|463360515|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
128745799|NCT02117570|463360513|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
128745800|NCT02117570|463360514|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
128745801|NCT02117570|463360515|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
128745802|NCT02117570|463360513|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
128745803|NCT02117570|463360514|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
128745804|NCT02117570|463360515|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
128745805|NCT02117570|463360513|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
128745806|NCT02117570|463360514|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
128745807|NCT02117570|463360515|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
128745808|NCT03701555|463360516|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
128745809|NCT03701555|463360517|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
128745810|NCT03701555|463360518|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
128745811|NCT03701555|463360519|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
128745812|NCT03701555|463360520|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
128745813|NCT03701555|463360521|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
128745814|NCT03701555|463360522|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
128745815|NCT03701555|463360523|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
128745816|NCT03701555|463360524|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
128745817|NCT03701555|463360525|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
128745818|NCT03701555|463360526|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
128745819|NCT03701555|463360527|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
128745820|NCT03701555|463360528|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
128745821|NCT03701555|463360529|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
128745822|NCT03701555|463360530|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
128745823|NCT03701555|463360531|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
128745824|NCT03701555|463360532|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
128745825|NCT03701555|463360533|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
128745826|NCT03701555|463360534|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
128745827|NCT03701555|463360535|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
128745828|NCT03701555|463360536|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
128745829|NCT03701555|463360537|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
128745830|NCT03701555|463360538|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
128745831|NCT03701555|463360539|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
128745832|NCT03701555|463360540|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
128745833|NCT03701555|463360541|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
128745834|NCT03701555|463360542|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
128745835|NCT03701555|463360543|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
128745836|NCT03701555|463360544|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
128745837|NCT03701555|463360545|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
128745838|NCT03701555|463360546|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
128745839|NCT03701555|463360547|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
128745840|NCT03701555|463360548|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
128745841|NCT03701555|463360549|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
128745842|NCT03701555|463360550|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
128745843|NCT03701555|463360551|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
128745844|NCT03701555|463360516|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
128745845|NCT03701555|463360517|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
128745846|NCT03701555|463360518|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
128745847|NCT03701555|463360519|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
128745848|NCT03701555|463360520|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
128745849|NCT03701555|463360521|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
128745850|NCT03701555|463360522|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
128745851|NCT03701555|463360523|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
128745852|NCT03701555|463360524|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
128745853|NCT03701555|463360525|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
128745854|NCT03701555|463360526|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
128745855|NCT03701555|463360527|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
128745856|NCT03701555|463360528|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
128745857|NCT03701555|463360529|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
128745858|NCT03701555|463360530|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
128745859|NCT03701555|463360531|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
128745860|NCT03701555|463360532|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
128745861|NCT03701555|463360533|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
128745862|NCT03701555|463360534|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
128745863|NCT03701555|463360535|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
128745864|NCT03701555|463360536|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
128745865|NCT03701555|463360537|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
128745866|NCT03701555|463360538|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
128745867|NCT03701555|463360539|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
128745868|NCT03701555|463360540|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
128745869|NCT03701555|463360541|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
128745870|NCT03701555|463360542|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
128745871|NCT03701555|463360543|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
128745872|NCT03701555|463360544|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
128745873|NCT03701555|463360545|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
128745874|NCT03701555|463360546|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
128745875|NCT03701555|463360547|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
128745876|NCT03701555|463360548|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
128745877|NCT03701555|463360549|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
128745878|NCT03701555|463360550|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
128745879|NCT03701555|463360551|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
128745880|NCT03701555|463360516|FG000|Part 2 (Day 1)|Other|0|||
128745881|NCT03701555|463360517|FG001|Part 2 (Day 1)|Other|0|||
128745882|NCT03701555|463360518|FG002|Part 2 (Day 1)|Other|0|||
128745883|NCT03701555|463360519|FG003|Part 2 (Day 1)|Other|0|||
128745884|NCT03701555|463360520|FG004|Part 2 (Day 1)|Other|0|||
128745885|NCT03701555|463360521|FG005|Part 2 (Day 1)|Other|0|||
128745886|NCT03701555|463360522|FG006|Part 2 (Day 1)|Other|0|||
128745887|NCT03701555|463360523|FG007|Part 2 (Day 1)|Other|0|||
128745888|NCT03701555|463360524|FG008|Part 2 (Day 1)|Other|0|||
128745889|NCT03701555|463360525|FG009|Part 2 (Day 1)|Other|0|||
128745890|NCT03701555|463360526|FG010|Part 2 (Day 1)|Other|3|||
128745891|NCT03701555|463360527|FG011|Part 2 (Day 1)|Other|1|||
128745892|NCT03701555|463360528|FG012|Part 2 (Day 1)|Other|0|||
128745893|NCT03701555|463360529|FG013|Part 2 (Day 1)|Other|1|||
128745894|NCT03701555|463360530|FG014|Part 2 (Day 1)|Other|0|||
128745895|NCT03701555|463360531|FG015|Part 2 (Day 1)|Other|2|||
128745896|NCT03701555|463360532|FG016|Part 2 (Day 1)|Other|2|||
128745897|NCT03701555|463360533|FG017|Part 2 (Day 1)|Other|0|||
128745898|NCT03701555|463360534|FG018|Part 2 (Day 1)|Other|0|||
128745899|NCT03701555|463360535|FG019|Part 2 (Day 1)|Other|0|||
128745900|NCT03701555|463360536|FG020|Part 2 (Day 1)|Other|0|||
128745901|NCT03701555|463360537|FG021|Part 2 (Day 1)|Other|0|||
128745902|NCT03701555|463360538|FG022|Part 2 (Day 1)|Other|0|||
128745903|NCT03701555|463360539|FG023|Part 2 (Day 1)|Other|0|||
128745904|NCT03701555|463360540|FG024|Part 2 (Day 1)|Other|0|||
128745905|NCT03701555|463360541|FG025|Part 2 (Day 1)|Other|0|||
128745906|NCT03701555|463360542|FG026|Part 2 (Day 1)|Other|0|||
128745907|NCT03701555|463360543|FG027|Part 2 (Day 1)|Other|0|||
128745908|NCT03701555|463360544|FG028|Part 2 (Day 1)|Other|0|||
128745909|NCT03701555|463360545|FG029|Part 2 (Day 1)|Other|0|||
128745910|NCT03701555|463360546|FG030|Part 2 (Day 1)|Other|0|||
128745911|NCT03701555|463360547|FG031|Part 2 (Day 1)|Other|0|||
128745912|NCT03701555|463360548|FG032|Part 2 (Day 1)|Other|0|||
128745913|NCT03701555|463360549|FG033|Part 2 (Day 1)|Other|0|||
128745914|NCT03701555|463360550|FG034|Part 2 (Day 1)|Other|0|||
128745915|NCT03701555|463360551|FG035|Part 2 (Day 1)|Other|0|||
128745916|NCT03701555|463360516|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
128745917|NCT03701555|463360517|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
128745918|NCT03701555|463360518|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
128745919|NCT03701555|463360519|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
128745920|NCT03701555|463360520|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
128745921|NCT03701555|463360521|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
128745922|NCT03701555|463360522|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
128745923|NCT03701555|463360523|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
128745924|NCT03701555|463360524|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
128745925|NCT03701555|463360525|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
128745926|NCT03701555|463360526|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
128745927|NCT03701555|463360527|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
128745928|NCT03701555|463360528|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
128745929|NCT03701555|463360529|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
128745930|NCT03701555|463360530|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
128745931|NCT03701555|463360531|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
128745932|NCT03701555|463360532|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
128745933|NCT03701555|463360533|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
128745934|NCT03701555|463360534|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
128745935|NCT03701555|463360535|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
128745936|NCT03701555|463360536|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
128745937|NCT03701555|463360537|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
128745938|NCT03701555|463360538|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
128745939|NCT03701555|463360539|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
128745940|NCT03701555|463360540|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
128745941|NCT03701555|463360541|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
128745942|NCT03701555|463360542|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
128745943|NCT03701555|463360543|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
128745944|NCT03701555|463360544|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
128745945|NCT03701555|463360545|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
128745946|NCT03701555|463360546|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
128745947|NCT03701555|463360547|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
128745948|NCT03701555|463360548|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
128745949|NCT03701555|463360549|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
128745950|NCT03701555|463360550|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
128745951|NCT03701555|463360551|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
128745952|NCT03701555|463360516|FG000|Part 3 (Day 1)|Subject Decision|0|||
128745953|NCT03701555|463360517|FG001|Part 3 (Day 1)|Subject Decision|0|||
128745954|NCT03701555|463360518|FG002|Part 3 (Day 1)|Subject Decision|0|||
128745955|NCT03701555|463360519|FG003|Part 3 (Day 1)|Subject Decision|0|||
128745956|NCT03701555|463360520|FG004|Part 3 (Day 1)|Subject Decision|0|||
128745957|NCT03701555|463360521|FG005|Part 3 (Day 1)|Subject Decision|0|||
128745958|NCT03701555|463360522|FG006|Part 3 (Day 1)|Subject Decision|0|||
128745959|NCT03701555|463360523|FG007|Part 3 (Day 1)|Subject Decision|0|||
128745960|NCT03701555|463360524|FG008|Part 3 (Day 1)|Subject Decision|0|||
128745961|NCT03701555|463360525|FG009|Part 3 (Day 1)|Subject Decision|0|||
128745962|NCT03701555|463360526|FG010|Part 3 (Day 1)|Subject Decision|0|||
128745963|NCT03701555|463360527|FG011|Part 3 (Day 1)|Subject Decision|0|||
128745964|NCT03701555|463360528|FG012|Part 3 (Day 1)|Subject Decision|0|||
128745965|NCT03701555|463360529|FG013|Part 3 (Day 1)|Subject Decision|0|||
128745966|NCT03701555|463360530|FG014|Part 3 (Day 1)|Subject Decision|0|||
128745967|NCT03701555|463360531|FG015|Part 3 (Day 1)|Subject Decision|0|||
128745968|NCT03701555|463360532|FG016|Part 3 (Day 1)|Subject Decision|0|||
128745969|NCT03701555|463360533|FG017|Part 3 (Day 1)|Subject Decision|0|||
128745970|NCT03701555|463360534|FG018|Part 3 (Day 1)|Subject Decision|0|||
128745971|NCT03701555|463360535|FG019|Part 3 (Day 1)|Subject Decision|0|||
128745972|NCT03701555|463360536|FG020|Part 3 (Day 1)|Subject Decision|0|||
128745973|NCT03701555|463360537|FG021|Part 3 (Day 1)|Subject Decision|0|||
128745974|NCT03701555|463360538|FG022|Part 3 (Day 1)|Subject Decision|0|||
128745975|NCT03701555|463360539|FG023|Part 3 (Day 1)|Subject Decision|0|||
128745976|NCT03701555|463360540|FG024|Part 3 (Day 1)|Subject Decision|0|||
128745977|NCT03701555|463360541|FG025|Part 3 (Day 1)|Subject Decision|0|||
128745978|NCT03701555|463360542|FG026|Part 3 (Day 1)|Subject Decision|1|||
128745979|NCT03701555|463360543|FG027|Part 3 (Day 1)|Subject Decision|0|||
128745980|NCT03701555|463360544|FG028|Part 3 (Day 1)|Subject Decision|0|||
128745981|NCT03701555|463360545|FG029|Part 3 (Day 1)|Subject Decision|0|||
128745982|NCT03701555|463360546|FG030|Part 3 (Day 1)|Subject Decision|0|||
128745983|NCT03701555|463360547|FG031|Part 3 (Day 1)|Subject Decision|2|||
128745984|NCT03701555|463360548|FG032|Part 3 (Day 1)|Subject Decision|1|||
128745985|NCT03701555|463360549|FG033|Part 3 (Day 1)|Subject Decision|1|||
128745986|NCT03701555|463360550|FG034|Part 3 (Day 1)|Subject Decision|0|||
128745987|NCT03701555|463360551|FG035|Part 3 (Day 1)|Subject Decision|0|||
128745988|NCT03701555|463360516|FG000|Part 3 (Day 1)|Other|0|||
128745989|NCT03701555|463360517|FG001|Part 3 (Day 1)|Other|0|||
128745990|NCT03701555|463360518|FG002|Part 3 (Day 1)|Other|0|||
128745991|NCT03701555|463360519|FG003|Part 3 (Day 1)|Other|0|||
128745992|NCT03701555|463360520|FG004|Part 3 (Day 1)|Other|0|||
128745993|NCT03701555|463360521|FG005|Part 3 (Day 1)|Other|0|||
128745994|NCT03701555|463360522|FG006|Part 3 (Day 1)|Other|0|||
128745995|NCT03701555|463360523|FG007|Part 3 (Day 1)|Other|0|||
128745996|NCT03701555|463360524|FG008|Part 3 (Day 1)|Other|0|||
128745997|NCT03701555|463360525|FG009|Part 3 (Day 1)|Other|0|||
128745998|NCT03701555|463360526|FG010|Part 3 (Day 1)|Other|0|||
128745999|NCT03701555|463360527|FG011|Part 3 (Day 1)|Other|0|||
128746000|NCT03701555|463360528|FG012|Part 3 (Day 1)|Other|0|||
128746001|NCT03701555|463360529|FG013|Part 3 (Day 1)|Other|0|||
128746002|NCT03701555|463360530|FG014|Part 3 (Day 1)|Other|0|||
128746003|NCT03701555|463360531|FG015|Part 3 (Day 1)|Other|0|||
128746004|NCT03701555|463360532|FG016|Part 3 (Day 1)|Other|0|||
128746005|NCT03701555|463360533|FG017|Part 3 (Day 1)|Other|0|||
128746006|NCT03701555|463360534|FG018|Part 3 (Day 1)|Other|0|||
128746007|NCT03701555|463360535|FG019|Part 3 (Day 1)|Other|0|||
128746008|NCT03701555|463360536|FG020|Part 3 (Day 1)|Other|0|||
128746009|NCT03701555|463360537|FG021|Part 3 (Day 1)|Other|0|||
128746010|NCT03701555|463360538|FG022|Part 3 (Day 1)|Other|0|||
128746011|NCT03701555|463360539|FG023|Part 3 (Day 1)|Other|0|||
128746012|NCT03701555|463360540|FG024|Part 3 (Day 1)|Other|1|||
128746013|NCT03701555|463360541|FG025|Part 3 (Day 1)|Other|1|||
128746014|NCT03701555|463360542|FG026|Part 3 (Day 1)|Other|0|||
128746015|NCT03701555|463360543|FG027|Part 3 (Day 1)|Other|0|||
128746016|NCT03701555|463360544|FG028|Part 3 (Day 1)|Other|0|||
128746017|NCT03701555|463360545|FG029|Part 3 (Day 1)|Other|1|||
128746018|NCT03701555|463360546|FG030|Part 3 (Day 1)|Other|1|||
128746019|NCT03701555|463360547|FG031|Part 3 (Day 1)|Other|0|||
128746020|NCT03701555|463360548|FG032|Part 3 (Day 1)|Other|1|||
128746021|NCT03701555|463360549|FG033|Part 3 (Day 1)|Other|1|||
128746022|NCT03701555|463360550|FG034|Part 3 (Day 1)|Other|0|||
128746023|NCT03701555|463360551|FG035|Part 3 (Day 1)|Other|0|||
128746024|NCT03349710|463360552|FG000|Treatment Period|Death|0|||
128746025|NCT03349710|463360553|FG001|Treatment Period|Death|0|||
128746026|NCT03349710|463360554|FG002|Treatment Period|Death|1|||
128746027|NCT03349710|463360555|FG003|Treatment Period|Death|0|||
128746028|NCT03349710|463360552|FG000|Treatment Period|Disease Progression|0|||
128746029|NCT03349710|463360553|FG001|Treatment Period|Disease Progression|2|||
128746030|NCT03349710|463360554|FG002|Treatment Period|Disease Progression|0|||
128746031|NCT03349710|463360555|FG003|Treatment Period|Disease Progression|1|||
128746032|NCT03349710|463360552|FG000|Treatment Period|Study Drug Toxicity|1|||
128746033|NCT03349710|463360553|FG001|Treatment Period|Study Drug Toxicity|0|||
128746034|NCT03349710|463360554|FG002|Treatment Period|Study Drug Toxicity|1|||
128746035|NCT03349710|463360555|FG003|Treatment Period|Study Drug Toxicity|1|||
128746036|NCT03349710|463360552|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
128746037|NCT03349710|463360553|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
128746038|NCT03349710|463360554|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
128746039|NCT03349710|463360555|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
128746040|NCT03349710|463360552|FG000|Treatment Period|admin reason by sponsor|0|||
128746041|NCT03349710|463360553|FG001|Treatment Period|admin reason by sponsor|7|||
128746042|NCT03349710|463360554|FG002|Treatment Period|admin reason by sponsor|0|||
128746043|NCT03349710|463360555|FG003|Treatment Period|admin reason by sponsor|19|||
128746044|NCT03349710|463360552|FG000|Treatment Period|Other Reason|2|||
128746045|NCT03349710|463360553|FG001|Treatment Period|Other Reason|0|||
128746046|NCT03349710|463360554|FG002|Treatment Period|Other Reason|2|||
128746047|NCT03349710|463360555|FG003|Treatment Period|Other Reason|1|||
128746048|NCT03349710|463360552|FG000|Treatment Period|completed|6|||
128746049|NCT03349710|463360553|FG001|Treatment Period|completed|0|||
128746050|NCT03349710|463360554|FG002|Treatment Period|completed|18|||
128746051|NCT03349710|463360555|FG003|Treatment Period|completed|1|||
128746052|NCT03349710|463360552|FG000|Treatment Period|participant request to discontinue|0|||
128746053|NCT03349710|463360553|FG001|Treatment Period|participant request to discontinue|0|||
128746054|NCT03349710|463360554|FG002|Treatment Period|participant request to discontinue|4|||
128746055|NCT03349710|463360555|FG003|Treatment Period|participant request to discontinue|0|||
128746056|NCT03349710|463360552|FG000|Treatment Period|participant withdrew consent|1|||
128746057|NCT03349710|463360553|FG001|Treatment Period|participant withdrew consent|0|||
128746058|NCT03349710|463360554|FG002|Treatment Period|participant withdrew consent|0|||
128746059|NCT03349710|463360555|FG003|Treatment Period|participant withdrew consent|0|||
128746060|NCT04258020|463360556|FG000|Overall Study|Withdrawal by Subject|1|||
128746061|NCT04258020|463360557|FG001|Overall Study|Withdrawal by Subject|0|||
128746062|NCT01519206|463360558|FG000|Overall Study|Lost to Follow-up|3|||
128746063|NCT01519206|463360558|FG000|Overall Study|Missed Visit|2|||
128746064|NCT04139317|463360559|FG000|Overall Study|Adverse Event|10|||
128746065|NCT04139317|463360560|FG001|Overall Study|Adverse Event|2|||
128746066|NCT04139317|463360559|FG000|Overall Study|Death|6|||
128746067|NCT04139317|463360560|FG001|Overall Study|Death|4|||
128746068|NCT04139317|463360559|FG000|Overall Study|Lost to Follow-up|1|||
128746069|NCT04139317|463360560|FG001|Overall Study|Lost to Follow-up|0|||
128746070|NCT04139317|463360559|FG000|Overall Study|Physician Decision|3|||
128746071|NCT04139317|463360560|FG001|Overall Study|Physician Decision|1|||
128746072|NCT04139317|463360559|FG000|Overall Study|Progressive Disease|19|||
128746073|NCT04139317|463360560|FG001|Overall Study|Progressive Disease|9|||
128746074|NCT04139317|463360559|FG000|Overall Study|Subject Decision|2|||
128746075|NCT04139317|463360560|FG001|Overall Study|Subject Decision|2|||
128746076|NCT06027216|463360561|FG000|Overall Study|Did not qualify|8|||
128746077|NCT02365467|463360562|FG000|Overall Study|Death|3|||
128746078|NCT02043782|463360563|FG000|Period 1|Adverse Event|0|||
128746079|NCT02043782|463360564|FG001|Period 1|Adverse Event|0|||
128746080|NCT02043782|463360565|FG002|Period 1|Adverse Event|1|||
128746081|NCT02043782|463360566|FG003|Period 1|Adverse Event|0|||
128746082|NCT02043782|463360567|FG004|Period 1|Adverse Event|0|||
128746083|NCT02043782|463360568|FG005|Period 1|Adverse Event|0|||
128746084|NCT01306162|463360571|FG000|Period 1|Adverse Event|0|||
128746085|NCT01306162|463360572|FG001|Period 1|Adverse Event|0|||
128746086|NCT01306162|463360573|FG002|Period 1|Adverse Event|0|||
128746087|NCT01306162|463360574|FG003|Period 1|Adverse Event|1|||
128746088|NCT01306162|463360571|FG000|Washout 1|Non-compliance to protocol|0|||
128746089|NCT01306162|463360572|FG001|Washout 1|Non-compliance to protocol|1|||
128746090|NCT01306162|463360573|FG002|Washout 1|Non-compliance to protocol|0|||
128746091|NCT01306162|463360574|FG003|Washout 1|Non-compliance to protocol|0|||
128746092|NCT02959437|463360575|FG000|Overall Study|Death|33|||
128746093|NCT02959437|463360576|FG001|Overall Study|Death|3|||
128746094|NCT02959437|463360577|FG002|Overall Study|Death|0|||
128746095|NCT02959437|463360578|FG003|Overall Study|Death|0|||
128746096|NCT02959437|463360575|FG000|Overall Study|Lost to Follow-up|3|||
128746097|NCT02959437|463360576|FG001|Overall Study|Lost to Follow-up|1|||
128746098|NCT02959437|463360577|FG002|Overall Study|Lost to Follow-up|0|||
128746099|NCT02959437|463360578|FG003|Overall Study|Lost to Follow-up|0|||
128746100|NCT02959437|463360575|FG000|Overall Study|Withdrawal by Subject|11|||
128746101|NCT02959437|463360576|FG001|Overall Study|Withdrawal by Subject|3|||
128746102|NCT02959437|463360577|FG002|Overall Study|Withdrawal by Subject|0|||
128746103|NCT02959437|463360578|FG003|Overall Study|Withdrawal by Subject|0|||
128746104|NCT02959437|463360575|FG000|Overall Study|Progressive Disease|9|||
128746105|NCT02959437|463360576|FG001|Overall Study|Progressive Disease|1|||
128746106|NCT02959437|463360577|FG002|Overall Study|Progressive Disease|0|||
128746107|NCT02959437|463360578|FG003|Overall Study|Progressive Disease|0|||
128746108|NCT02959437|463360575|FG000|Overall Study|Study Terminated by Sponsor|4|||
128746109|NCT02959437|463360576|FG001|Overall Study|Study Terminated by Sponsor|0|||
128746110|NCT02959437|463360577|FG002|Overall Study|Study Terminated by Sponsor|0|||
128746111|NCT02959437|463360578|FG003|Overall Study|Study Terminated by Sponsor|0|||
128746112|NCT02959437|463360575|FG000|Overall Study|Other Unspecified|2|||
128746113|NCT02959437|463360576|FG001|Overall Study|Other Unspecified|0|||
128746114|NCT02959437|463360577|FG002|Overall Study|Other Unspecified|0|||
128746115|NCT02959437|463360578|FG003|Overall Study|Other Unspecified|0|||
128746116|NCT00833989|463360580|FG000|Overall Study|Physician Decision|0|||
128746117|NCT00833989|463360581|FG001|Overall Study|Physician Decision|0|||
128746118|NCT00833989|463360582|FG002|Overall Study|Physician Decision|0|||
128746119|NCT00833989|463360583|FG003|Overall Study|Physician Decision|1|||
128746120|NCT00833989|463360580|FG000|Overall Study|Withdrawal by Subject|3|||
128746121|NCT00833989|463360581|FG001|Overall Study|Withdrawal by Subject|0|||
128746122|NCT00833989|463360582|FG002|Overall Study|Withdrawal by Subject|1|||
128746123|NCT00833989|463360583|FG003|Overall Study|Withdrawal by Subject|1|||
128746124|NCT01949480|463360584|FG000|Overall Study|Physician Decision|5|||
128746125|NCT01949480|463360585|FG001|Overall Study|Physician Decision|8|||
128746126|NCT00214136|463360586|FG000|Overall Study|Death|5|||
128746127|NCT04287920|463360587|FG000|Overall Study|Lost to Follow-up|1|||
128746128|NCT04287920|463360588|FG001|Overall Study|Lost to Follow-up|1|||
128746129|NCT04287920|463360587|FG000|Overall Study|Withdrawal by Subject|0|||
128746130|NCT04287920|463360588|FG001|Overall Study|Withdrawal by Subject|3|||
128746131|NCT04313634|463360589|FG000|Overall Study|Adverse Event|2|||
128746132|NCT04313634|463360590|FG001|Overall Study|Adverse Event|2|||
128746133|NCT04313634|463360591|FG002|Overall Study|Adverse Event|0|||
128746134|NCT04313634|463360589|FG000|Overall Study|Withdrawal by Subject|1|||
128746135|NCT04313634|463360590|FG001|Overall Study|Withdrawal by Subject|0|||
128746136|NCT04313634|463360591|FG002|Overall Study|Withdrawal by Subject|1|||
128746137|NCT04313634|463360589|FG000|Overall Study|Protocol Violation|0|||
128746138|NCT04313634|463360590|FG001|Overall Study|Protocol Violation|0|||
128746139|NCT04313634|463360591|FG002|Overall Study|Protocol Violation|1|||
128746140|NCT02952924|463360596|FG000|Overall Study|Protocol Violation|0|||
128746141|NCT02952924|463360597|FG001|Overall Study|Protocol Violation|0|||
128746142|NCT02952924|463360598|FG002|Overall Study|Protocol Violation|0|||
128746143|NCT02952924|463360599|FG003|Overall Study|Protocol Violation|0|||
128746144|NCT02952924|463360600|FG004|Overall Study|Protocol Violation|0|||
128746145|NCT02952924|463360601|FG005|Overall Study|Protocol Violation|0|||
128746146|NCT02952924|463360602|FG006|Overall Study|Protocol Violation|0|||
128746147|NCT02952924|463360603|FG007|Overall Study|Protocol Violation|0|||
128746148|NCT02952924|463360604|FG008|Overall Study|Protocol Violation|0|||
128746149|NCT02952924|463360605|FG009|Overall Study|Protocol Violation|0|||
128746150|NCT02952924|463360606|FG010|Overall Study|Protocol Violation|0|||
128746151|NCT02952924|463360607|FG011|Overall Study|Protocol Violation|0|||
128746152|NCT02952924|463360608|FG012|Overall Study|Protocol Violation|0|||
128746153|NCT02952924|463360609|FG013|Overall Study|Protocol Violation|0|||
128746154|NCT02952924|463360610|FG014|Overall Study|Protocol Violation|0|||
128746155|NCT02952924|463360611|FG015|Overall Study|Protocol Violation|0|||
128746156|NCT02952924|463360612|FG016|Overall Study|Protocol Violation|0|||
128746157|NCT02952924|463360613|FG017|Overall Study|Protocol Violation|0|||
128746158|NCT02952924|463360614|FG018|Overall Study|Protocol Violation|0|||
128746159|NCT02952924|463360615|FG019|Overall Study|Protocol Violation|1|||
128746160|NCT02952924|463360616|FG020|Overall Study|Protocol Violation|0|||
128746161|NCT02952924|463360617|FG021|Overall Study|Protocol Violation|0|||
128746162|NCT02952924|463360596|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
128746163|NCT02952924|463360597|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
128746164|NCT02952924|463360598|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
128746165|NCT02952924|463360599|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
128746166|NCT02952924|463360600|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
128746167|NCT02952924|463360601|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
128746168|NCT02952924|463360602|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
128746169|NCT02952924|463360603|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
128746170|NCT02952924|463360604|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
128746171|NCT02952924|463360605|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
128746172|NCT02952924|463360606|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
128746173|NCT02952924|463360607|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
128746174|NCT02952924|463360608|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
128746175|NCT02952924|463360609|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
128746176|NCT02952924|463360610|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
128746177|NCT02952924|463360611|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
128746178|NCT02952924|463360612|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
128746179|NCT02952924|463360613|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
128746180|NCT02952924|463360614|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
128746181|NCT02952924|463360615|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
128746182|NCT02952924|463360616|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
128746183|NCT02952924|463360617|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
128746184|NCT02952924|463360596|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746185|NCT02952924|463360597|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746186|NCT02952924|463360598|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746187|NCT02952924|463360599|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746188|NCT02952924|463360600|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746189|NCT02952924|463360601|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746190|NCT02952924|463360602|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746191|NCT02952924|463360603|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746192|NCT02952924|463360604|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746193|NCT02952924|463360605|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746194|NCT02952924|463360606|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746195|NCT02952924|463360607|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746196|NCT02952924|463360608|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746197|NCT02952924|463360609|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746198|NCT02952924|463360610|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746199|NCT02952924|463360611|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746200|NCT02952924|463360612|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746201|NCT02952924|463360613|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746202|NCT02952924|463360614|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746203|NCT02952924|463360615|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746204|NCT02952924|463360616|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
128746205|NCT02952924|463360617|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
128746206|NCT02952924|463360596|FG000|Overall Study|Noncompliance with study drug|0|||
128746207|NCT02952924|463360597|FG001|Overall Study|Noncompliance with study drug|0|||
128746208|NCT02952924|463360598|FG002|Overall Study|Noncompliance with study drug|0|||
128746209|NCT02952924|463360599|FG003|Overall Study|Noncompliance with study drug|0|||
128746210|NCT02952924|463360600|FG004|Overall Study|Noncompliance with study drug|0|||
128746211|NCT02952924|463360601|FG005|Overall Study|Noncompliance with study drug|0|||
128746212|NCT02952924|463360602|FG006|Overall Study|Noncompliance with study drug|0|||
128746213|NCT02952924|463360603|FG007|Overall Study|Noncompliance with study drug|0|||
128746214|NCT02952924|463360604|FG008|Overall Study|Noncompliance with study drug|0|||
128746215|NCT02952924|463360605|FG009|Overall Study|Noncompliance with study drug|0|||
128746216|NCT02952924|463360606|FG010|Overall Study|Noncompliance with study drug|0|||
128746217|NCT02952924|463360607|FG011|Overall Study|Noncompliance with study drug|0|||
128746218|NCT02952924|463360608|FG012|Overall Study|Noncompliance with study drug|0|||
128746219|NCT02952924|463360609|FG013|Overall Study|Noncompliance with study drug|0|||
128746220|NCT02952924|463360610|FG014|Overall Study|Noncompliance with study drug|0|||
128746221|NCT02952924|463360611|FG015|Overall Study|Noncompliance with study drug|0|||
128746222|NCT02952924|463360612|FG016|Overall Study|Noncompliance with study drug|0|||
128746223|NCT02952924|463360613|FG017|Overall Study|Noncompliance with study drug|0|||
128746224|NCT02952924|463360614|FG018|Overall Study|Noncompliance with study drug|0|||
128746225|NCT02952924|463360615|FG019|Overall Study|Noncompliance with study drug|0|||
128746226|NCT02952924|463360616|FG020|Overall Study|Noncompliance with study drug|0|||
128746227|NCT02952924|463360617|FG021|Overall Study|Noncompliance with study drug|1|||
128746228|NCT02105948|463360622|FG000|Overall Study|Adverse Event|10|||
128746229|NCT02105948|463360623|FG001|Overall Study|Adverse Event|7|||
128746230|NCT02105948|463360624|FG002|Overall Study|Adverse Event|11|||
128746231|NCT02105948|463360625|FG003|Overall Study|Adverse Event|11|||
128746232|NCT02105948|463360622|FG000|Overall Study|Lack of Efficacy|0|||
128746233|NCT02105948|463360623|FG001|Overall Study|Lack of Efficacy|1|||
128746234|NCT02105948|463360624|FG002|Overall Study|Lack of Efficacy|3|||
128746235|NCT02105948|463360625|FG003|Overall Study|Lack of Efficacy|2|||
128746236|NCT02105948|463360622|FG000|Overall Study|Lost to Follow-up|0|||
128746237|NCT02105948|463360623|FG001|Overall Study|Lost to Follow-up|0|||
128746238|NCT02105948|463360624|FG002|Overall Study|Lost to Follow-up|2|||
128746239|NCT02105948|463360625|FG003|Overall Study|Lost to Follow-up|1|||
128746240|NCT02105948|463360622|FG000|Overall Study|Physician Decision|2|||
128746241|NCT02105948|463360623|FG001|Overall Study|Physician Decision|2|||
128746242|NCT02105948|463360624|FG002|Overall Study|Physician Decision|2|||
128746243|NCT02105948|463360625|FG003|Overall Study|Physician Decision|2|||
128746244|NCT02105948|463360622|FG000|Overall Study|Withdrawal by Subject|15|||
128746245|NCT02105948|463360623|FG001|Overall Study|Withdrawal by Subject|10|||
128746246|NCT02105948|463360624|FG002|Overall Study|Withdrawal by Subject|10|||
128746247|NCT02105948|463360625|FG003|Overall Study|Withdrawal by Subject|11|||
128746248|NCT01934218|463360627|FG000|Double-blind Phase|Adverse Event|8|||
128746249|NCT01934218|463360628|FG001|Double-blind Phase|Adverse Event|8|||
128746250|NCT01934218|463360627|FG000|Double-blind Phase|Lack of Efficacy|6|||
128746251|NCT01934218|463360628|FG001|Double-blind Phase|Lack of Efficacy|7|||
128746252|NCT01934218|463360627|FG000|Double-blind Phase|Lost to Follow-up|7|||
128746253|NCT01934218|463360628|FG001|Double-blind Phase|Lost to Follow-up|14|||
128746254|NCT01934218|463360627|FG000|Double-blind Phase|Physician Decision|1|||
128746255|NCT01934218|463360628|FG001|Double-blind Phase|Physician Decision|2|||
128746256|NCT01934218|463360627|FG000|Double-blind Phase|Protocol Violation|4|||
128746257|NCT01934218|463360628|FG001|Double-blind Phase|Protocol Violation|0|||
128746258|NCT01934218|463360627|FG000|Double-blind Phase|Withdrawal by Subject|16|||
128746259|NCT01934218|463360628|FG001|Double-blind Phase|Withdrawal by Subject|13|||
128746260|NCT01934218|463360627|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
128746261|NCT01934218|463360628|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
128746262|NCT01934218|463360627|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
128746263|NCT01934218|463360628|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
128746264|NCT01934218|463360627|FG000|Open-Label Phase|Adverse Event|2|||
128746265|NCT01934218|463360628|FG001|Open-Label Phase|Adverse Event|4|||
128746266|NCT01934218|463360627|FG000|Open-Label Phase|Lack of Efficacy|1|||
128746267|NCT01934218|463360628|FG001|Open-Label Phase|Lack of Efficacy|4|||
128746268|NCT01934218|463360627|FG000|Open-Label Phase|Lost to Follow-up|4|||
128746269|NCT01934218|463360628|FG001|Open-Label Phase|Lost to Follow-up|2|||
128746270|NCT01934218|463360627|FG000|Open-Label Phase|Physician Decision|1|||
128746271|NCT01934218|463360628|FG001|Open-Label Phase|Physician Decision|0|||
128746272|NCT01934218|463360627|FG000|Open-Label Phase|Protocol Violation|1|||
128746273|NCT01934218|463360628|FG001|Open-Label Phase|Protocol Violation|0|||
128746274|NCT01934218|463360627|FG000|Open-Label Phase|Withdrawal by Subject|13|||
128746275|NCT01934218|463360628|FG001|Open-Label Phase|Withdrawal by Subject|11|||
128746276|NCT01934218|463360627|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
128746277|NCT01934218|463360628|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
128746278|NCT01934218|463360627|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
128746279|NCT01934218|463360628|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
128746280|NCT02232893|463360629|FG000|Overall Study|Withdrawal by Subject|4|||
128746281|NCT02232893|463360630|FG001|Overall Study|Withdrawal by Subject|1|||
128746282|NCT02232893|463360629|FG000|Overall Study|Adverse Event|0|||
128746283|NCT02232893|463360630|FG001|Overall Study|Adverse Event|1|||
128746284|NCT02232893|463360629|FG000|Overall Study|Sponsor request early termination|0|||
128746285|NCT02232893|463360630|FG001|Overall Study|Sponsor request early termination|1|||
128746286|NCT02232893|463360629|FG000|Overall Study|Developed exclusion criteria|0|||
128746287|NCT02232893|463360630|FG001|Overall Study|Developed exclusion criteria|1|||
128746288|NCT02232893|463360629|FG000|Overall Study|Other|0|||
128746289|NCT02232893|463360630|FG001|Overall Study|Other|3|||
128746290|NCT01587651|463360634|FG000|Overall Study|Adverse Event|0|||
128746291|NCT01587651|463360635|FG001|Overall Study|Adverse Event|1|||
128746292|NCT01587651|463360636|FG002|Overall Study|Adverse Event|0|||
128746293|NCT01587651|463360634|FG000|Overall Study|Protocol Violation|0|||
128746294|NCT01587651|463360635|FG001|Overall Study|Protocol Violation|1|||
128746295|NCT01587651|463360636|FG002|Overall Study|Protocol Violation|1|||
128746296|NCT01587651|463360634|FG000|Overall Study|Withdrawal by Subject|0|||
128746297|NCT01587651|463360635|FG001|Overall Study|Withdrawal by Subject|1|||
128746298|NCT01587651|463360636|FG002|Overall Study|Withdrawal by Subject|0|||
128746299|NCT04323436|463360637|FG000|Overall Study|Adverse Event|7|||
128746300|NCT04323436|463360638|FG001|Overall Study|Adverse Event|0|||
128746301|NCT04323436|463360639|FG002|Overall Study|Adverse Event|0|||
128746302|NCT04323436|463360637|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
128746303|NCT04323436|463360638|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
128746304|NCT04323436|463360639|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
128746305|NCT04323436|463360637|FG000|Overall Study|Death|1|||
128746306|NCT04323436|463360638|FG001|Overall Study|Death|0|||
128746307|NCT04323436|463360639|FG002|Overall Study|Death|0|||
128746308|NCT04323436|463360637|FG000|Overall Study|Physician Decision|2|||
128746309|NCT04323436|463360638|FG001|Overall Study|Physician Decision|0|||
128746310|NCT04323436|463360639|FG002|Overall Study|Physician Decision|0|||
128746311|NCT04323436|463360637|FG000|Overall Study|Progressive disease|10|||
128746312|NCT04323436|463360638|FG001|Overall Study|Progressive disease|0|||
128746313|NCT04323436|463360639|FG002|Overall Study|Progressive disease|0|||
128746314|NCT04323436|463360637|FG000|Overall Study|Subject decision|3|||
128746315|NCT04323436|463360638|FG001|Overall Study|Subject decision|0|||
128746316|NCT04323436|463360639|FG002|Overall Study|Subject decision|0|||
128746317|NCT01660763|463360643|FG000|Overall Study|Lack of Efficacy|45|||
128746318|NCT01660763|463360644|FG001|Overall Study|Lack of Efficacy|50|||
128746319|NCT01660763|463360643|FG000|Overall Study|Adverse Event|22|||
128746320|NCT01660763|463360644|FG001|Overall Study|Adverse Event|7|||
128746321|NCT01660763|463360643|FG000|Overall Study|Protocol Violation|1|||
128746322|NCT01660763|463360644|FG001|Overall Study|Protocol Violation|0|||
128746323|NCT01660763|463360643|FG000|Overall Study|Withdrawal by Subject|4|||
128746324|NCT01660763|463360644|FG001|Overall Study|Withdrawal by Subject|0|||
128746325|NCT01660763|463360643|FG000|Overall Study|Patient ready for early discharge|28|||
128746326|NCT01660763|463360644|FG001|Overall Study|Patient ready for early discharge|4|||
128746327|NCT03325712|463360645|FG000|Overall Study|Protocol Violation|0|||
128746328|NCT03325712|463360646|FG001|Overall Study|Protocol Violation|0|||
128746329|NCT03325712|463360647|FG002|Overall Study|Protocol Violation|0|||
128746330|NCT03325712|463360648|FG003|Overall Study|Protocol Violation|0|||
128746331|NCT03325712|463360649|FG004|Overall Study|Protocol Violation|1|||
128746332|NCT03325712|463360650|FG005|Overall Study|Protocol Violation|0|||
128746333|NCT03325712|463360651|FG006|Overall Study|Protocol Violation|0|||
128746334|NCT03325712|463360652|FG007|Overall Study|Protocol Violation|0|||
128746335|NCT03325712|463360645|FG000|Overall Study|Adverse Event|0|||
128746336|NCT03325712|463360646|FG001|Overall Study|Adverse Event|0|||
128746337|NCT03325712|463360647|FG002|Overall Study|Adverse Event|0|||
128746338|NCT03325712|463360648|FG003|Overall Study|Adverse Event|0|||
128746339|NCT03325712|463360649|FG004|Overall Study|Adverse Event|1|||
128746340|NCT03325712|463360650|FG005|Overall Study|Adverse Event|0|||
128746341|NCT03325712|463360651|FG006|Overall Study|Adverse Event|0|||
128746342|NCT03325712|463360652|FG007|Overall Study|Adverse Event|0|||
128746343|NCT02265237|463360654|FG000|As Treated (Overall Study)|Adverse Event|1|||
128746344|NCT02265237|463360655|FG001|As Treated (Overall Study)|Adverse Event|1|||
128746345|NCT02265237|463360656|FG002|As Treated (Overall Study)|Adverse Event|0|||
128746346|NCT02265237|463360657|FG003|As Treated (Overall Study)|Adverse Event|0|||
128746347|NCT02265237|463360654|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
128746348|NCT02265237|463360655|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
128746349|NCT02265237|463360656|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
128746350|NCT02265237|463360657|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
128746351|NCT02265237|463360654|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
128746352|NCT02265237|463360655|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
128746353|NCT02265237|463360656|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
128746354|NCT02265237|463360657|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
128746355|NCT02265237|463360654|FG000|As Treated (Overall Study)|Other|2|||
128746356|NCT02265237|463360655|FG001|As Treated (Overall Study)|Other|0|||
128746357|NCT02265237|463360656|FG002|As Treated (Overall Study)|Other|3|||
128746358|NCT02265237|463360657|FG003|As Treated (Overall Study)|Other|1|||
128746359|NCT01178853|463360659|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
128746360|NCT01178853|463360660|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
128746361|NCT01178853|463360659|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
128746362|NCT01178853|463360660|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
128746363|NCT01178853|463360659|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
128746364|NCT01178853|463360660|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
128746365|NCT01178853|463360659|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
128746366|NCT01178853|463360660|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
128746367|NCT01178853|463360659|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
128746368|NCT01178853|463360660|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
128746369|NCT03550313|463360661|FG000|Overall Study|Adverse Event|0|||
128746370|NCT03550313|463360662|FG001|Overall Study|Adverse Event|1|||
128746371|NCT03550313|463360663|FG002|Overall Study|Adverse Event|0|||
128746372|NCT03550313|463360661|FG000|Overall Study|Lost to Follow-up|5|||
128746373|NCT03550313|463360662|FG001|Overall Study|Lost to Follow-up|7|||
128746374|NCT03550313|463360663|FG002|Overall Study|Lost to Follow-up|12|||
128746375|NCT03550313|463360661|FG000|Overall Study|Study terminated by sponsor|44|||
128746376|NCT03550313|463360662|FG001|Overall Study|Study terminated by sponsor|37|||
128746377|NCT03550313|463360663|FG002|Overall Study|Study terminated by sponsor|48|||
128746378|NCT03550313|463360661|FG000|Overall Study|No longer met eligibility criteria|3|||
128746379|NCT03550313|463360662|FG001|Overall Study|No longer met eligibility criteria|5|||
128746380|NCT03550313|463360663|FG002|Overall Study|No longer met eligibility criteria|6|||
128746381|NCT03550313|463360661|FG000|Overall Study|Withdrawal by parent/guardian|20|||
128746382|NCT03550313|463360662|FG001|Overall Study|Withdrawal by parent/guardian|18|||
128746383|NCT03550313|463360663|FG002|Overall Study|Withdrawal by parent/guardian|26|||
128746384|NCT03550313|463360661|FG000|Overall Study|Other|4|||
128746385|NCT03550313|463360662|FG001|Overall Study|Other|2|||
128746386|NCT03550313|463360663|FG002|Overall Study|Other|2|||
128746387|NCT03550313|463360661|FG000|Overall Study|Randomized but not vaccinated|3|||
128746388|NCT03550313|463360662|FG001|Overall Study|Randomized but not vaccinated|23|||
128746389|NCT03550313|463360663|FG002|Overall Study|Randomized but not vaccinated|2|||
128746390|NCT03550313|463360661|FG000|Overall Study|Sites terminated due to quality issues|18|||
128746391|NCT03550313|463360662|FG001|Overall Study|Sites terminated due to quality issues|17|||
128746392|NCT03550313|463360663|FG002|Overall Study|Sites terminated due to quality issues|18|||
128746393|NCT00839072|463360664|FG000|First Intervention Period|Withdrawal by Subject|1|||
128746394|NCT00839072|463360665|FG001|First Intervention Period|Withdrawal by Subject|0|||
128746395|NCT00839072|463360664|FG000|First Intervention Period|Adverse Event|1|||
128746396|NCT00839072|463360665|FG001|First Intervention Period|Adverse Event|1|||
128746397|NCT00839072|463360664|FG000|Second Intervention Period|Withdrawal by Subject|1|||
128746398|NCT00839072|463360665|FG001|Second Intervention Period|Withdrawal by Subject|0|||
128746399|NCT00380068|463360667|FG000|Overall Study|Adverse Event|40|||
128746400|NCT00380068|463360667|FG000|Overall Study|Withdrawal by Subject|10|||
128746401|NCT00380068|463360667|FG000|Overall Study|Not compliant|6|||
128746402|NCT00380068|463360667|FG000|Overall Study|Lost to Follow-up|1|||
128746403|NCT00380068|463360667|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
128746404|NCT00380068|463360667|FG000|Overall Study|Lung transplant|3|||
128746405|NCT00380068|463360667|FG000|Overall Study|Physician Decision|2|||
128746406|NCT00380068|463360667|FG000|Overall Study|Partipant moved away|1|||
128746407|NCT00380068|463360667|FG000|Overall Study|Lack of Efficacy|5|||
128746408|NCT01297062|463360668|FG000|Overall Study|Adverse Event|2|||
128746409|NCT01297062|463360669|FG001|Overall Study|Adverse Event|0|||
128746410|NCT01297062|463360670|FG002|Overall Study|Adverse Event|1|||
128746411|NCT01297062|463360671|FG003|Overall Study|Adverse Event|0|||
128746412|NCT01297062|463360672|FG004|Overall Study|Adverse Event|0|||
128746413|NCT01297062|463360673|FG005|Overall Study|Adverse Event|0|||
128746414|NCT01297062|463360674|FG006|Overall Study|Adverse Event|0|||
128746415|NCT01297062|463360668|FG000|Overall Study|Physician Decision|1|||
128746416|NCT01297062|463360669|FG001|Overall Study|Physician Decision|0|||
128746417|NCT01297062|463360670|FG002|Overall Study|Physician Decision|1|||
128746418|NCT01297062|463360671|FG003|Overall Study|Physician Decision|0|||
128746419|NCT01297062|463360672|FG004|Overall Study|Physician Decision|0|||
128746420|NCT01297062|463360673|FG005|Overall Study|Physician Decision|0|||
128746421|NCT01297062|463360674|FG006|Overall Study|Physician Decision|6|||
128746422|NCT01297062|463360668|FG000|Overall Study|Protocol Violation|0|||
128746423|NCT01297062|463360669|FG001|Overall Study|Protocol Violation|0|||
128746424|NCT01297062|463360670|FG002|Overall Study|Protocol Violation|0|||
128746425|NCT01297062|463360671|FG003|Overall Study|Protocol Violation|0|||
128746426|NCT01297062|463360672|FG004|Overall Study|Protocol Violation|1|||
128746427|NCT01297062|463360673|FG005|Overall Study|Protocol Violation|0|||
128746428|NCT01297062|463360674|FG006|Overall Study|Protocol Violation|0|||
128746429|NCT01297062|463360668|FG000|Overall Study|Subject Decision|1|||
128746430|NCT01297062|463360669|FG001|Overall Study|Subject Decision|1|||
128746431|NCT01297062|463360670|FG002|Overall Study|Subject Decision|0|||
128746432|NCT01297062|463360671|FG003|Overall Study|Subject Decision|1|||
128746433|NCT01297062|463360672|FG004|Overall Study|Subject Decision|1|||
128746434|NCT01297062|463360673|FG005|Overall Study|Subject Decision|1|||
128746435|NCT01297062|463360674|FG006|Overall Study|Subject Decision|2|||
128746436|NCT01458574|463360675|FG000|Overall Study|Adverse Event|5|||
128746437|NCT01458574|463360676|FG001|Overall Study|Adverse Event|9|||
128746438|NCT01458574|463360677|FG002|Overall Study|Adverse Event|7|||
128746439|NCT01458574|463360675|FG000|Overall Study|Lack of Efficacy|70|||
128746440|NCT01458574|463360676|FG001|Overall Study|Lack of Efficacy|53|||
128746441|NCT01458574|463360677|FG002|Overall Study|Lack of Efficacy|132|||
128746442|NCT01458574|463360675|FG000|Overall Study|Lost to Follow-up|3|||
128746443|NCT01458574|463360676|FG001|Overall Study|Lost to Follow-up|2|||
128746444|NCT01458574|463360677|FG002|Overall Study|Lost to Follow-up|1|||
128746445|NCT01458574|463360675|FG000|Overall Study|Pregnancy|1|||
128746446|NCT01458574|463360676|FG001|Overall Study|Pregnancy|1|||
128746447|NCT01458574|463360677|FG002|Overall Study|Pregnancy|0|||
128746448|NCT01458574|463360675|FG000|Overall Study|Protocol Violation|0|||
128746449|NCT01458574|463360676|FG001|Overall Study|Protocol Violation|1|||
128746450|NCT01458574|463360677|FG002|Overall Study|Protocol Violation|0|||
128746451|NCT01458574|463360675|FG000|Overall Study|Withdrawal by Subject|6|||
128746452|NCT01458574|463360676|FG001|Overall Study|Withdrawal by Subject|3|||
128746453|NCT01458574|463360677|FG002|Overall Study|Withdrawal by Subject|5|||
128746454|NCT01458574|463360675|FG000|Overall Study|Other|2|||
128746455|NCT01458574|463360676|FG001|Overall Study|Other|1|||
128746456|NCT01458574|463360677|FG002|Overall Study|Other|0|||
128746457|NCT01458574|463360675|FG000|Overall Study|Randomized but not treated|0|||
128746458|NCT01458574|463360676|FG001|Overall Study|Randomized but not treated|1|||
128746459|NCT01458574|463360677|FG002|Overall Study|Randomized but not treated|0|||
128746460|NCT02125786|463360678|FG000|Overall Study|Still in Follow-up|3|||
128746461|NCT02125786|463360678|FG000|Overall Study|Screen Failure|2|||
128746462|NCT02125786|463360678|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
128746463|NCT02125786|463360678|FG000|Overall Study|Progressive Disease|44|||
128746464|NCT02125786|463360678|FG000|Overall Study|Death|8|||
128746465|NCT04964089|463360679|FG000|Overall Study|Adverse Event|8|||
128746466|NCT04964089|463360680|FG001|Overall Study|Adverse Event|6|||
128746467|NCT04964089|463360679|FG000|Overall Study|Non-compliance with study schedule|1|||
128746468|NCT04964089|463360680|FG001|Overall Study|Non-compliance with study schedule|0|||
128746469|NCT04964089|463360679|FG000|Overall Study|Withdrawal by Subject|6|||
128746470|NCT04964089|463360680|FG001|Overall Study|Withdrawal by Subject|5|||
128785654|NCT00762463|463507316|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
128785655|NCT00762463|463507317|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
128785656|NCT00762463|463507314|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
128785657|NCT00762463|463507315|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
128785658|NCT00762463|463507316|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
128746471|NCT04964089|463360679|FG000|Overall Study|Lost to Follow-up|1|||
128746472|NCT04964089|463360680|FG001|Overall Study|Lost to Follow-up|1|||
128746473|NCT04964089|463360679|FG000|Overall Study|Progressive disease|4|||
128746474|NCT04964089|463360680|FG001|Overall Study|Progressive disease|0|||
128746475|NCT04964089|463360679|FG000|Overall Study|Physician Decision|1|||
128746476|NCT04964089|463360680|FG001|Overall Study|Physician Decision|0|||
128746477|NCT04964089|463360679|FG000|Overall Study|Participant did not want to continue study treatment|1|||
128746478|NCT04964089|463360680|FG001|Overall Study|Participant did not want to continue study treatment|0|||
128746479|NCT04964089|463360679|FG000|Overall Study|Participant moved to different state|1|||
128746480|NCT04964089|463360680|FG001|Overall Study|Participant moved to different state|0|||
128746481|NCT04964089|463360679|FG000|Overall Study|Participant decided to discontinue|0|||
128746482|NCT04964089|463360680|FG001|Overall Study|Participant decided to discontinue|1|||
128746483|NCT01682837|463360681|FG000|Baseline|Withdrawal by Subject|5|||
128746484|NCT00724971|463360686|FG000|Overall Study|Adverse Event|5|||
128746485|NCT00724971|463360686|FG000|Overall Study|Withdrawal by Subject|1|||
128746486|NCT01692197|463360687|FG000|Overall Study|Failed Screening|3|||
128746487|NCT03086447|463360689|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
128746488|NCT03086447|463360690|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
128746489|NCT03086447|463360689|FG000|Overall Study|Lost Lens|2|||
128746490|NCT03086447|463360690|FG001|Overall Study|Lost Lens|5|||
128746491|NCT03086447|463360689|FG000|Overall Study|Product quality complaint|0|||
128746492|NCT03086447|463360690|FG001|Overall Study|Product quality complaint|1|||
128746493|NCT03086447|463360689|FG000|Overall Study|Lens Damage|1|||
128746494|NCT03086447|463360690|FG001|Overall Study|Lens Damage|6|||
128785659|NCT00762463|463507317|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
128785660|NCT01306331|463507318|FG000|Overall Study|Adverse Event|28|||
128746495|NCT03086447|463360689|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
128746496|NCT03086447|463360690|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
128746497|NCT03086447|463360689|FG000|Overall Study|Test Article No Longer Available|1|||
128746498|NCT03086447|463360690|FG001|Overall Study|Test Article No Longer Available|0|||
128746499|NCT03086447|463360689|FG000|Overall Study|Protocol Violation|2|||
128746500|NCT03086447|463360690|FG001|Overall Study|Protocol Violation|4|||
128746501|NCT03086447|463360689|FG000|Overall Study|Lost to Follow-up|0|||
128746502|NCT03086447|463360690|FG001|Overall Study|Lost to Follow-up|1|||
128746503|NCT03086447|463360689|FG000|Overall Study|Adverse Event|3|||
128746504|NCT03086447|463360690|FG001|Overall Study|Adverse Event|0|||
128746505|NCT03086447|463360689|FG000|Overall Study|Lens Discomfort|2|||
128785661|NCT01306331|463507319|FG001|Overall Study|Adverse Event|25|||
128746506|NCT03086447|463360690|FG001|Overall Study|Lens Discomfort|1|||
128785662|NCT01306331|463507318|FG000|Overall Study|Lost to Follow-up|321|||
128746507|NCT00659334|463360695|FG000|Overall Study|Screen Failure|8|||
128746508|NCT00659334|463360696|FG001|Overall Study|Screen Failure|5|||
128746509|NCT00659334|463360697|FG002|Overall Study|Screen Failure|0|||
128746510|NCT00659334|463360698|FG003|Overall Study|Screen Failure|0|||
128746511|NCT00659334|463360699|FG004|Overall Study|Screen Failure|0|||
128746512|NCT00659334|463360700|FG005|Overall Study|Screen Failure|0|||
128746513|NCT00659334|463360701|FG006|Overall Study|Screen Failure|1|||
128746514|NCT01174342|463360702|FG000|Overall Study|Conversion to cesarean section|4|||
128746515|NCT01308580|463360703|FG000|Overall Study|Lost to Follow-up|12|||
128746516|NCT01308580|463360704|FG001|Overall Study|Lost to Follow-up|7|||
128746517|NCT01218646|463360705|FG000|Overall Study|Adverse Event|0|||
128746518|NCT01218646|463360706|FG001|Overall Study|Adverse Event|0|||
128746519|NCT01218646|463360707|FG002|Overall Study|Adverse Event|1|||
128746520|NCT01218646|463360708|FG003|Overall Study|Adverse Event|0|||
128746521|NCT01218646|463360705|FG000|Overall Study|Lost to Follow-up|1|||
128746522|NCT01218646|463360706|FG001|Overall Study|Lost to Follow-up|0|||
128746523|NCT01218646|463360707|FG002|Overall Study|Lost to Follow-up|0|||
128746524|NCT01218646|463360708|FG003|Overall Study|Lost to Follow-up|0|||
128746525|NCT01218646|463360705|FG000|Overall Study|Protocol Violation|0|||
128746526|NCT01218646|463360706|FG001|Overall Study|Protocol Violation|0|||
128746527|NCT01218646|463360707|FG002|Overall Study|Protocol Violation|1|||
128746528|NCT01218646|463360708|FG003|Overall Study|Protocol Violation|1|||
128746529|NCT01159691|463362618|FG000|Overall Study|Lost to Follow-up|2|||
128746530|NCT01159691|463362618|FG000|Overall Study|Unknown reasons|1|||
128746531|NCT01159691|463362618|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
128746532|NCT01159691|463362618|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
128746533|NCT01159691|463362618|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
128746534|NCT01159691|463362618|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
128746535|NCT01159691|463362618|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
128746536|NCT01159691|463362618|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
128746537|NCT00773968|463362624|FG000|Overall Study|Adverse Event|2|||
128746538|NCT00773968|463362624|FG000|Overall Study|Death|1|||
128746539|NCT00773968|463362624|FG000|Overall Study|Failure to Return|2|||
128746540|NCT00773968|463362624|FG000|Overall Study|Lack of Efficacy|3|||
128746541|NCT00773968|463362624|FG000|Overall Study|Protocol Violation|1|||
128746542|NCT00773968|463362624|FG000|Overall Study|Withdrawal by Subject|11|||
128746543|NCT00773968|463362624|FG000|Overall Study|Screen Failure|17|||
128746544|NCT00773968|463362624|FG000|Overall Study|Other|8|||
128746545|NCT02492100|463362625|FG000|Overall Study|Death|1|||
128746546|NCT02332720|463362626|FG000|Part A and Part B|Lost to Follow-up|1|||
128746547|NCT02332720|463362627|FG001|Part A and Part B|Lost to Follow-up|0|||
128746548|NCT02332720|463362628|FG002|Part A and Part B|Lost to Follow-up|0|||
128746549|NCT02332720|463362629|FG003|Part A and Part B|Lost to Follow-up|0|||
128746550|NCT02332720|463362630|FG004|Part A and Part B|Lost to Follow-up|0|||
128746551|NCT02332720|463362631|FG005|Part A and Part B|Lost to Follow-up|2|||
128746552|NCT02332720|463362632|FG006|Part A and Part B|Lost to Follow-up|1|||
128746553|NCT02332720|463362633|FG007|Part A and Part B|Lost to Follow-up|1|||
128746554|NCT02332720|463362634|FG008|Part A and Part B|Lost to Follow-up|0|||
128746555|NCT02332720|463362635|FG009|Part A and Part B|Lost to Follow-up|0|||
128746556|NCT02332720|463362636|FG010|Part A and Part B|Lost to Follow-up|0|||
128746557|NCT02332720|463362637|FG011|Part A and Part B|Lost to Follow-up|0|||
128746558|NCT02332720|463362638|FG012|Part A and Part B|Lost to Follow-up|0|||
128746559|NCT02332720|463362639|FG013|Part A and Part B|Lost to Follow-up|0|||
128746560|NCT02332720|463362640|FG014|Part A and Part B|Lost to Follow-up|0|||
128746561|NCT02332720|463362641|FG015|Part A and Part B|Lost to Follow-up|1|||
128746562|NCT02332720|463362642|FG016|Part A and Part B|Lost to Follow-up|0|||
128746563|NCT02332720|463362643|FG017|Part A and Part B|Lost to Follow-up|0|||
128746564|NCT02332720|463362644|FG018|Part A and Part B|Lost to Follow-up|0|||
128746565|NCT02332720|463362645|FG019|Part A and Part B|Lost to Follow-up|0|||
128746566|NCT02332720|463362646|FG020|Part A and Part B|Lost to Follow-up|0|||
128746567|NCT02332720|463362647|FG021|Part A and Part B|Lost to Follow-up|0|||
128746568|NCT02332720|463362648|FG022|Part A and Part B|Lost to Follow-up|0|||
128746569|NCT02332720|463362626|FG000|Part A and Part B|Adverse Event|0|||
128746570|NCT02332720|463362627|FG001|Part A and Part B|Adverse Event|0|||
128746571|NCT02332720|463362628|FG002|Part A and Part B|Adverse Event|0|||
128746572|NCT02332720|463362629|FG003|Part A and Part B|Adverse Event|0|||
128746573|NCT02332720|463362630|FG004|Part A and Part B|Adverse Event|0|||
128746574|NCT02332720|463362631|FG005|Part A and Part B|Adverse Event|0|||
128746575|NCT02332720|463362632|FG006|Part A and Part B|Adverse Event|0|||
128746576|NCT02332720|463362633|FG007|Part A and Part B|Adverse Event|0|||
128746577|NCT02332720|463362634|FG008|Part A and Part B|Adverse Event|0|||
128746578|NCT02332720|463362635|FG009|Part A and Part B|Adverse Event|0|||
128746579|NCT02332720|463362636|FG010|Part A and Part B|Adverse Event|0|||
128746580|NCT02332720|463362637|FG011|Part A and Part B|Adverse Event|0|||
128746581|NCT02332720|463362638|FG012|Part A and Part B|Adverse Event|0|||
128746582|NCT02332720|463362639|FG013|Part A and Part B|Adverse Event|0|||
128746583|NCT02332720|463362640|FG014|Part A and Part B|Adverse Event|0|||
128746584|NCT02332720|463362641|FG015|Part A and Part B|Adverse Event|0|||
128746585|NCT02332720|463362642|FG016|Part A and Part B|Adverse Event|0|||
128746586|NCT02332720|463362643|FG017|Part A and Part B|Adverse Event|1|||
128746587|NCT02332720|463362644|FG018|Part A and Part B|Adverse Event|0|||
128746588|NCT02332720|463362645|FG019|Part A and Part B|Adverse Event|0|||
128746589|NCT02332720|463362646|FG020|Part A and Part B|Adverse Event|0|||
128746590|NCT02332720|463362647|FG021|Part A and Part B|Adverse Event|0|||
128746591|NCT02332720|463362648|FG022|Part A and Part B|Adverse Event|0|||
128746592|NCT02332720|463362626|FG000|Part A and Part B|Physician Decision|0|||
128746593|NCT02332720|463362627|FG001|Part A and Part B|Physician Decision|0|||
128746594|NCT02332720|463362628|FG002|Part A and Part B|Physician Decision|0|||
128746595|NCT02332720|463362629|FG003|Part A and Part B|Physician Decision|0|||
128746596|NCT02332720|463362630|FG004|Part A and Part B|Physician Decision|0|||
128746597|NCT02332720|463362631|FG005|Part A and Part B|Physician Decision|0|||
128746598|NCT02332720|463362632|FG006|Part A and Part B|Physician Decision|0|||
128746599|NCT02332720|463362633|FG007|Part A and Part B|Physician Decision|0|||
128746600|NCT02332720|463362634|FG008|Part A and Part B|Physician Decision|0|||
128746601|NCT02332720|463362635|FG009|Part A and Part B|Physician Decision|0|||
128746602|NCT02332720|463362636|FG010|Part A and Part B|Physician Decision|0|||
128746603|NCT02332720|463362637|FG011|Part A and Part B|Physician Decision|0|||
128746604|NCT02332720|463362638|FG012|Part A and Part B|Physician Decision|0|||
128746605|NCT02332720|463362639|FG013|Part A and Part B|Physician Decision|0|||
128746606|NCT02332720|463362640|FG014|Part A and Part B|Physician Decision|0|||
128746607|NCT02332720|463362641|FG015|Part A and Part B|Physician Decision|0|||
128746608|NCT02332720|463362642|FG016|Part A and Part B|Physician Decision|0|||
128746609|NCT02332720|463362643|FG017|Part A and Part B|Physician Decision|0|||
128746610|NCT02332720|463362644|FG018|Part A and Part B|Physician Decision|1|||
128746611|NCT02332720|463362645|FG019|Part A and Part B|Physician Decision|0|||
128746612|NCT02332720|463362646|FG020|Part A and Part B|Physician Decision|0|||
128746613|NCT02332720|463362647|FG021|Part A and Part B|Physician Decision|0|||
128746614|NCT02332720|463362648|FG022|Part A and Part B|Physician Decision|0|||
128746615|NCT02332720|463362626|FG000|Part A and Part B|Withdrawal by Subject|0|||
128746616|NCT02332720|463362627|FG001|Part A and Part B|Withdrawal by Subject|0|||
128746617|NCT02332720|463362628|FG002|Part A and Part B|Withdrawal by Subject|0|||
128746618|NCT02332720|463362629|FG003|Part A and Part B|Withdrawal by Subject|0|||
128746619|NCT02332720|463362630|FG004|Part A and Part B|Withdrawal by Subject|0|||
128746620|NCT02332720|463362631|FG005|Part A and Part B|Withdrawal by Subject|1|||
128746621|NCT02332720|463362632|FG006|Part A and Part B|Withdrawal by Subject|0|||
128746622|NCT02332720|463362633|FG007|Part A and Part B|Withdrawal by Subject|0|||
128746623|NCT02332720|463362634|FG008|Part A and Part B|Withdrawal by Subject|0|||
128746624|NCT02332720|463362635|FG009|Part A and Part B|Withdrawal by Subject|0|||
128746625|NCT02332720|463362636|FG010|Part A and Part B|Withdrawal by Subject|0|||
128746626|NCT02332720|463362637|FG011|Part A and Part B|Withdrawal by Subject|0|||
128746627|NCT02332720|463362638|FG012|Part A and Part B|Withdrawal by Subject|0|||
128746628|NCT02332720|463362639|FG013|Part A and Part B|Withdrawal by Subject|0|||
128746629|NCT02332720|463362640|FG014|Part A and Part B|Withdrawal by Subject|0|||
128746630|NCT02332720|463362641|FG015|Part A and Part B|Withdrawal by Subject|0|||
128746631|NCT02332720|463362642|FG016|Part A and Part B|Withdrawal by Subject|0|||
128746632|NCT02332720|463362643|FG017|Part A and Part B|Withdrawal by Subject|0|||
128746633|NCT02332720|463362644|FG018|Part A and Part B|Withdrawal by Subject|0|||
128746634|NCT02332720|463362645|FG019|Part A and Part B|Withdrawal by Subject|1|||
128746635|NCT02332720|463362646|FG020|Part A and Part B|Withdrawal by Subject|0|||
128746636|NCT02332720|463362647|FG021|Part A and Part B|Withdrawal by Subject|0|||
128746637|NCT02332720|463362648|FG022|Part A and Part B|Withdrawal by Subject|0|||
128746638|NCT03832010|463362649|FG000|Overall Study|Withdrawal by Subject|2|||
128746639|NCT03832010|463362650|FG001|Overall Study|Withdrawal by Subject|1|||
128746640|NCT03832010|463362651|FG002|Overall Study|Withdrawal by Subject|0|||
128746641|NCT03832010|463362649|FG000|Overall Study|Lost to Follow-up|2|||
128746642|NCT03832010|463362650|FG001|Overall Study|Lost to Follow-up|1|||
128746643|NCT03832010|463362651|FG002|Overall Study|Lost to Follow-up|1|||
128746644|NCT02349295|463362657|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
128746645|NCT02349295|463362658|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
128746646|NCT02349295|463362659|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
128746647|NCT02349295|463362660|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746648|NCT02349295|463362661|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746649|NCT02349295|463362662|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746650|NCT02349295|463362663|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746651|NCT02349295|463362664|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746652|NCT02349295|463362665|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746653|NCT02349295|463362666|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746654|NCT02349295|463362667|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746655|NCT02349295|463362668|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746656|NCT02349295|463362669|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746657|NCT02349295|463362670|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
128746658|NCT02349295|463362657|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
128746659|NCT02349295|463362658|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
128746660|NCT02349295|463362659|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
128746661|NCT02349295|463362660|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746662|NCT02349295|463362661|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746663|NCT02349295|463362662|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746664|NCT02349295|463362663|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746665|NCT02349295|463362664|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746666|NCT02349295|463362665|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746667|NCT02349295|463362666|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746668|NCT02349295|463362667|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746669|NCT02349295|463362668|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746670|NCT02349295|463362669|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746671|NCT02349295|463362670|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
128746672|NCT02349295|463362657|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
128746673|NCT02349295|463362658|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
128746674|NCT02349295|463362659|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
128746675|NCT02349295|463362660|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746676|NCT02349295|463362661|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746677|NCT02349295|463362662|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746678|NCT02349295|463362663|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746679|NCT02349295|463362664|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746680|NCT02349295|463362665|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746681|NCT02349295|463362666|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746682|NCT02349295|463362667|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128785663|NCT01306331|463507319|FG001|Overall Study|Lost to Follow-up|323|||
128746683|NCT02349295|463362668|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746684|NCT02349295|463362669|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746685|NCT02349295|463362670|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
128746686|NCT02349295|463362657|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
128746687|NCT02349295|463362658|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
128746688|NCT02349295|463362659|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
128746689|NCT02349295|463362660|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746690|NCT02349295|463362661|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746691|NCT02349295|463362662|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746692|NCT02349295|463362663|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746693|NCT02349295|463362664|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746694|NCT02349295|463362665|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746695|NCT02349295|463362666|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746696|NCT02349295|463362667|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746697|NCT02349295|463362668|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746698|NCT02349295|463362669|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746699|NCT02349295|463362670|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
128746700|NCT02349295|463362657|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746701|NCT02349295|463362658|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
128746702|NCT02349295|463362659|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
128746703|NCT02349295|463362660|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746704|NCT02349295|463362661|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746705|NCT02349295|463362662|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746706|NCT02349295|463362663|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746707|NCT02349295|463362664|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746708|NCT02349295|463362665|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746709|NCT02349295|463362666|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746710|NCT02349295|463362667|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746711|NCT02349295|463362668|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746712|NCT02349295|463362669|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746713|NCT02349295|463362670|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
128746714|NCT02349295|463362657|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
128746715|NCT02349295|463362658|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
128746716|NCT02349295|463362659|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
128746717|NCT02349295|463362660|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
128746718|NCT02349295|463362661|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
128746719|NCT02349295|463362662|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
128746720|NCT02349295|463362663|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
128746721|NCT02349295|463362664|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
128746722|NCT02349295|463362665|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
128746723|NCT02349295|463362666|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
128746724|NCT02349295|463362667|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
128746725|NCT02349295|463362668|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
128746726|NCT02349295|463362669|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
128746727|NCT02349295|463362670|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
128746728|NCT02349295|463362657|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746729|NCT02349295|463362658|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746730|NCT02349295|463362659|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746731|NCT02349295|463362660|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746732|NCT02349295|463362661|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746733|NCT02349295|463362662|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746734|NCT02349295|463362663|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746735|NCT02349295|463362664|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
128785664|NCT01306331|463507318|FG000|Overall Study|Physician Decision|26|||
128746736|NCT02349295|463362665|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
128746737|NCT02349295|463362666|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
128746738|NCT02349295|463362667|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
128746739|NCT02349295|463362668|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746740|NCT02349295|463362669|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746741|NCT02349295|463362670|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
128746742|NCT02349295|463362657|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128785665|NCT01306331|463507319|FG001|Overall Study|Physician Decision|22|||
128746743|NCT02349295|463362658|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746744|NCT02349295|463362659|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746745|NCT02349295|463362660|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746746|NCT02349295|463362661|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746747|NCT02349295|463362662|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128785666|NCT01306331|463507318|FG000|Overall Study|Pregnancy|136|||
128746748|NCT02349295|463362663|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746749|NCT02349295|463362664|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
128746750|NCT02349295|463362665|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
128746751|NCT02349295|463362666|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
128746752|NCT02349295|463362667|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
128746753|NCT02349295|463362668|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746754|NCT02349295|463362669|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746755|NCT02349295|463362670|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
128746756|NCT02349295|463362657|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746757|NCT02349295|463362658|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746758|NCT02349295|463362659|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746759|NCT02349295|463362660|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746760|NCT02349295|463362661|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746761|NCT02349295|463362662|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746762|NCT02349295|463362663|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746763|NCT02349295|463362664|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
128746764|NCT02349295|463362665|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746765|NCT02349295|463362666|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
128746766|NCT02349295|463362667|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746767|NCT02349295|463362668|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746768|NCT02349295|463362669|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746769|NCT02349295|463362670|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
128746770|NCT02349295|463362657|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
128746771|NCT02349295|463362658|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
128746772|NCT02349295|463362659|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
128746773|NCT02349295|463362660|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
128746774|NCT02349295|463362661|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
128746775|NCT02349295|463362662|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
128746776|NCT02349295|463362663|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
128746777|NCT02349295|463362664|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
128746778|NCT02349295|463362665|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
128746779|NCT02349295|463362666|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
128746780|NCT02349295|463362667|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
128746781|NCT02349295|463362668|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
128746782|NCT02349295|463362669|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
128746783|NCT02349295|463362670|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
128746784|NCT02349295|463362657|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746785|NCT02349295|463362658|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746786|NCT02349295|463362659|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746787|NCT02349295|463362660|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746788|NCT02349295|463362661|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746789|NCT02349295|463362662|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746790|NCT02349295|463362663|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746791|NCT02349295|463362664|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
128746792|NCT02349295|463362665|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
128746793|NCT02349295|463362666|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
128746794|NCT02349295|463362667|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
128746795|NCT02349295|463362668|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746796|NCT02349295|463362669|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746797|NCT02349295|463362670|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
128746798|NCT02349295|463362657|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746799|NCT02349295|463362658|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746800|NCT02349295|463362659|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746801|NCT02349295|463362660|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746802|NCT02349295|463362661|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746803|NCT02349295|463362662|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746804|NCT02349295|463362663|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746805|NCT02349295|463362664|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
128746806|NCT02349295|463362665|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
128746807|NCT02349295|463362666|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746808|NCT02349295|463362667|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746809|NCT02349295|463362668|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746810|NCT02349295|463362669|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746811|NCT02349295|463362670|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
128746812|NCT02349295|463362657|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746813|NCT02349295|463362658|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746814|NCT02349295|463362659|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746815|NCT02349295|463362660|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746816|NCT02349295|463362661|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746817|NCT02349295|463362662|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746818|NCT02349295|463362663|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746819|NCT02349295|463362664|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
128746820|NCT02349295|463362665|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
128746821|NCT02349295|463362666|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746822|NCT02349295|463362667|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746823|NCT02349295|463362668|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746824|NCT02349295|463362669|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746825|NCT02349295|463362670|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
128746826|NCT02349295|463362657|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746827|NCT02349295|463362658|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746828|NCT02349295|463362659|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746829|NCT02349295|463362660|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746830|NCT02349295|463362661|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746831|NCT02349295|463362662|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746832|NCT02349295|463362663|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746833|NCT02349295|463362664|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128785667|NCT01306331|463507319|FG001|Overall Study|Pregnancy|151|||
128746834|NCT02349295|463362665|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746835|NCT02349295|463362666|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746836|NCT02349295|463362667|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
128746837|NCT02349295|463362668|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
128746838|NCT02349295|463362669|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
128746839|NCT02349295|463362670|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
128746840|NCT02349295|463362657|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746841|NCT02349295|463362658|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746842|NCT02349295|463362659|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746843|NCT02349295|463362660|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746844|NCT02349295|463362661|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746845|NCT02349295|463362662|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746846|NCT02349295|463362663|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746847|NCT02349295|463362664|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746848|NCT02349295|463362665|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746849|NCT02349295|463362666|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746850|NCT02349295|463362667|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746851|NCT02349295|463362668|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
128746852|NCT02349295|463362669|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
128746853|NCT02349295|463362670|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
128746854|NCT02349295|463362657|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746855|NCT02349295|463362658|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746856|NCT02349295|463362659|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746857|NCT02349295|463362660|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746858|NCT02349295|463362661|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746859|NCT02349295|463362662|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746860|NCT02349295|463362663|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746861|NCT02349295|463362664|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746862|NCT02349295|463362665|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746863|NCT02349295|463362666|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746864|NCT02349295|463362667|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746865|NCT02349295|463362668|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
128746866|NCT02349295|463362669|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
128746867|NCT02349295|463362670|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
128746868|NCT02349295|463362657|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746869|NCT02349295|463362658|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746870|NCT02349295|463362659|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746871|NCT02349295|463362660|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746872|NCT02349295|463362661|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746873|NCT02349295|463362662|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746874|NCT02349295|463362663|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746875|NCT02349295|463362664|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746876|NCT02349295|463362665|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746877|NCT02349295|463362666|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746878|NCT02349295|463362667|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746879|NCT02349295|463362668|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
128746880|NCT02349295|463362669|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746881|NCT02349295|463362670|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
128746882|NCT02349295|463362657|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746883|NCT02349295|463362658|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746884|NCT02349295|463362659|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746885|NCT02349295|463362660|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746886|NCT02349295|463362661|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746887|NCT02349295|463362662|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746888|NCT02349295|463362663|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746889|NCT02349295|463362664|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746890|NCT02349295|463362665|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746891|NCT02349295|463362666|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746892|NCT02349295|463362667|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746893|NCT02349295|463362668|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
128746894|NCT02349295|463362669|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746895|NCT02349295|463362670|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
128746896|NCT02863926|463362671|FG000|Overall Study|Physician Decision|1|||
128746897|NCT02863926|463362672|FG001|Overall Study|Physician Decision|0|||
128746898|NCT02863926|463362671|FG000|Overall Study|Lost to Follow-up|1|||
128746899|NCT02863926|463362672|FG001|Overall Study|Lost to Follow-up|1|||
128746900|NCT03422250|463362674|FG000|Intervention|Adverse Event|0|||
128746901|NCT03422250|463362675|FG001|Intervention|Adverse Event|1|||
128746902|NCT03422250|463362676|FG002|Intervention|Adverse Event|0|||
128746903|NCT03422250|463362677|FG003|Intervention|Adverse Event|1|||
128746904|NCT03422250|463362674|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
128746905|NCT03422250|463362675|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
128746906|NCT03422250|463362676|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
128746907|NCT03422250|463362677|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
128746908|NCT03422250|463362674|FG000|Follow-up|Withdrawal by Subject|0|||
128746909|NCT03422250|463362675|FG001|Follow-up|Withdrawal by Subject|0|||
128746910|NCT03422250|463362676|FG002|Follow-up|Withdrawal by Subject|0|||
128746911|NCT03422250|463362677|FG003|Follow-up|Withdrawal by Subject|1|||
128746912|NCT03422250|463362674|FG000|Follow-up|Adverse Event|0|||
128746913|NCT03422250|463362675|FG001|Follow-up|Adverse Event|0|||
128746914|NCT03422250|463362676|FG002|Follow-up|Adverse Event|0|||
128746915|NCT03422250|463362677|FG003|Follow-up|Adverse Event|1|||
128746916|NCT01917526|463362680|FG000|Overall Study|Protocol Violation|1|||
128746917|NCT01917526|463362681|FG001|Overall Study|Protocol Violation|1|||
128746918|NCT04717596|463362682|FG000|Overall Study|Withdrawal by Subject|4|||
128746919|NCT02460991|463362684|FG000|Overall Study|Withdrawal by Subject|0|||
128746920|NCT02460991|463362685|FG001|Overall Study|Withdrawal by Subject|2|||
128746921|NCT00455195|463362687|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
128746922|NCT00455195|463362688|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
128746923|NCT00455195|463362687|FG000|Double-blind Study AGLU02704|Death|1|||
128746924|NCT00455195|463362688|FG001|Double-blind Study AGLU02704|Death|0|||
128746925|NCT00455195|463362687|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
128746926|NCT00455195|463362688|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
128746927|NCT00455195|463362687|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
128746928|NCT00455195|463362688|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
128746929|NCT02148250|463362689|FG000|Screening|Withdrawal by Subject|5|||
128746930|NCT02148250|463362690|FG001|Screening|Withdrawal by Subject|0|||
128746931|NCT02370602|463362693|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
128746932|NCT02370602|463362694|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
128746933|NCT02370602|463362695|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
128746934|NCT02370602|463362696|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
128746935|NCT02370602|463362697|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
128746936|NCT02370602|463362698|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
128746937|NCT01296568|463362699|FG000|Continued Access Phase|Lost to Follow-up|1|||
128746938|NCT01296568|463362699|FG000|Continued Access Phase|Withdrawal by Subject|1|||
128746939|NCT01296568|463362699|FG000|Continued Access Phase|Disease Progression|1|||
128746940|NCT00237744|463362700|FG000|Overall Study|Withdrawal by Subject|3|||
128746941|NCT00237744|463362701|FG001|Overall Study|Withdrawal by Subject|1|||
128746942|NCT00237744|463362702|FG002|Overall Study|Withdrawal by Subject|0|||
128746943|NCT03305016|463362703|FG000|Overall Study|Withdrawal by Subject|2|||
128746944|NCT01127178|463362704|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
128746945|NCT01127178|463362705|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
128746946|NCT01127178|463362704|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
128746947|NCT01127178|463362705|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
128746948|NCT01127178|463362704|FG000|Dose Escalation: Treatment Phase|Other|2|||
128746949|NCT01127178|463362705|FG001|Dose Escalation: Treatment Phase|Other|0|||
128746950|NCT01127178|463362704|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
128746951|NCT01127178|463362705|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
128746952|NCT01127178|463362704|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
128746953|NCT01127178|463362705|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
128746954|NCT01127178|463362704|FG000|Dose Escalation: Extension Phase|Other|1|||
128746955|NCT01127178|463362705|FG001|Dose Escalation: Extension Phase|Other|0|||
128746956|NCT05177770|463362706|FG000|Overall Study|Death|4|||
128746957|NCT05177770|463362706|FG000|Overall Study|Withdrawal by Subject|1|||
128746958|NCT05177770|463362706|FG000|Overall Study|Adverse Event prior to dosing|1|||
128746959|NCT00709722|463362707|FG000|Overall Study|Adverse Event|1|||
128746960|NCT04667117|463362708|FG000|Investigational Period|Lost to Follow-up|0|||
128746961|NCT04667117|463362709|FG001|Investigational Period|Lost to Follow-up|0|||
128746962|NCT04667117|463362710|FG002|Investigational Period|Lost to Follow-up|1|||
128746963|NCT04667117|463362708|FG000|Investigational Period|Protocol Deviation|0|||
128746964|NCT04667117|463362709|FG001|Investigational Period|Protocol Deviation|1|||
128746965|NCT04667117|463362710|FG002|Investigational Period|Protocol Deviation|0|||
128746966|NCT04667117|463362708|FG000|Extension Period|Lost to Follow-up|1|||
128746967|NCT04667117|463362709|FG001|Extension Period|Lost to Follow-up|0|||
128746968|NCT04667117|463362710|FG002|Extension Period|Lost to Follow-up|0|||
128746969|NCT02372396|463362727|FG000|Overall Study|Lost to Follow-up|7|||
128746970|NCT02372396|463362728|FG001|Overall Study|Lost to Follow-up|9|||
128746971|NCT01272934|463362729|FG000|Overall Study|Adverse Event|0|||
128746972|NCT01272934|463362730|FG001|Overall Study|Adverse Event|1|||
128746973|NCT01272934|463362729|FG000|Overall Study|Abnormal Laboratory Value|0|||
128746974|NCT01272934|463362730|FG001|Overall Study|Abnormal Laboratory Value|1|||
128746975|NCT01226745|463362731|FG000|Overall Study|Did not complete schedule of assessments|8|||
128746976|NCT01226745|463362732|FG001|Overall Study|Did not complete schedule of assessments|3|||
128746977|NCT01226745|463362733|FG002|Overall Study|Did not complete schedule of assessments|6|||
128746978|NCT01226745|463362734|FG003|Overall Study|Did not complete schedule of assessments|0|||
128746979|NCT01226745|463362735|FG004|Overall Study|Did not complete schedule of assessments|0|||
128746980|NCT01226745|463362736|FG005|Overall Study|Did not complete schedule of assessments|1|||
128746981|NCT01226745|463362731|FG000|Overall Study|Lost to Follow-up|2|||
128746982|NCT01226745|463362732|FG001|Overall Study|Lost to Follow-up|6|||
128746983|NCT01226745|463362733|FG002|Overall Study|Lost to Follow-up|6|||
128746984|NCT01226745|463362734|FG003|Overall Study|Lost to Follow-up|1|||
128746985|NCT01226745|463362735|FG004|Overall Study|Lost to Follow-up|1|||
128746986|NCT01226745|463362736|FG005|Overall Study|Lost to Follow-up|2|||
128746987|NCT01226745|463362731|FG000|Overall Study|Death|1|||
128746988|NCT01226745|463362732|FG001|Overall Study|Death|0|||
128746989|NCT01226745|463362733|FG002|Overall Study|Death|0|||
128746990|NCT01226745|463362734|FG003|Overall Study|Death|0|||
128746991|NCT01226745|463362735|FG004|Overall Study|Death|0|||
128746992|NCT01226745|463362736|FG005|Overall Study|Death|1|||
128746993|NCT01226745|463362731|FG000|Overall Study|Other|6|||
128746994|NCT01226745|463362732|FG001|Overall Study|Other|7|||
128746995|NCT01226745|463362733|FG002|Overall Study|Other|8|||
128746996|NCT01226745|463362734|FG003|Overall Study|Other|4|||
128746997|NCT01226745|463362735|FG004|Overall Study|Other|3|||
128746998|NCT01226745|463362736|FG005|Overall Study|Other|1|||
128746999|NCT01435577|463362737|FG000|Overall Study|Adverse Event|10|||
128747000|NCT01435577|463362738|FG001|Overall Study|Adverse Event|0|||
128747001|NCT01435577|463362737|FG000|Overall Study|Lack of Efficacy|7|||
128747002|NCT01435577|463362738|FG001|Overall Study|Lack of Efficacy|51|||
128747003|NCT01435577|463362737|FG000|Overall Study|Alternative treatment started|0|||
128747004|NCT01435577|463362738|FG001|Overall Study|Alternative treatment started|1|||
128747005|NCT01196975|463362739|FG000|Overall Study|Adverse Event|2|||
128747006|NCT01196975|463362740|FG001|Overall Study|Adverse Event|2|||
128747007|NCT01196975|463362741|FG002|Overall Study|Adverse Event|0|||
128747008|NCT01196975|463362742|FG003|Overall Study|Adverse Event|0|||
128747009|NCT01196975|463362743|FG004|Overall Study|Adverse Event|2|||
128747010|NCT01196975|463362739|FG000|Overall Study|Withdrawal by Subject|2|||
128747011|NCT01196975|463362740|FG001|Overall Study|Withdrawal by Subject|1|||
128747012|NCT01196975|463362741|FG002|Overall Study|Withdrawal by Subject|0|||
128747013|NCT01196975|463362742|FG003|Overall Study|Withdrawal by Subject|1|||
128747014|NCT01196975|463362743|FG004|Overall Study|Withdrawal by Subject|0|||
128747015|NCT01196975|463362739|FG000|Overall Study|Lost to Follow-up|11|||
128747016|NCT01196975|463362740|FG001|Overall Study|Lost to Follow-up|6|||
128747017|NCT01196975|463362741|FG002|Overall Study|Lost to Follow-up|5|||
128747018|NCT01196975|463362742|FG003|Overall Study|Lost to Follow-up|5|||
128747019|NCT01196975|463362743|FG004|Overall Study|Lost to Follow-up|11|||
128747020|NCT01365494|463362744|FG000|Overall Study|Adverse Event|1|||
128747021|NCT01365494|463362745|FG001|Overall Study|Adverse Event|0|||
128747022|NCT01365494|463362744|FG000|Overall Study|Withdrawal by Subject|0|||
128747023|NCT01365494|463362745|FG001|Overall Study|Withdrawal by Subject|1|||
128747024|NCT01365494|463362744|FG000|Overall Study|Lost to Follow-up|1|||
128747025|NCT01365494|463362745|FG001|Overall Study|Lost to Follow-up|2|||
128747026|NCT04782323|463362746|FG000|Overall Study|Death|1|||
128747027|NCT04782323|463362747|FG001|Overall Study|Death|0|||
128747028|NCT04782323|463362748|FG002|Overall Study|Death|0|||
128747029|NCT04782323|463362749|FG003|Overall Study|Death|0|||
128747030|NCT04782323|463362750|FG004|Overall Study|Death|1|||
128747031|NCT04782323|463362751|FG005|Overall Study|Death|1|||
128747032|NCT04782323|463362752|FG006|Overall Study|Death|1|||
128747033|NCT04782323|463362753|FG007|Overall Study|Death|0|||
128747034|NCT04782323|463362746|FG000|Overall Study|Withdrawal by Subject|0|||
128747035|NCT04782323|463362747|FG001|Overall Study|Withdrawal by Subject|0|||
128747036|NCT04782323|463362748|FG002|Overall Study|Withdrawal by Subject|1|||
128747037|NCT04782323|463362749|FG003|Overall Study|Withdrawal by Subject|0|||
128747038|NCT04782323|463362750|FG004|Overall Study|Withdrawal by Subject|0|||
128747039|NCT04782323|463362751|FG005|Overall Study|Withdrawal by Subject|1|||
128747040|NCT04782323|463362752|FG006|Overall Study|Withdrawal by Subject|0|||
128747041|NCT04782323|463362753|FG007|Overall Study|Withdrawal by Subject|1|||
128747042|NCT04782323|463362746|FG000|Overall Study|Lost to Follow-up|0|||
128747043|NCT04782323|463362747|FG001|Overall Study|Lost to Follow-up|1|||
128747044|NCT04782323|463362748|FG002|Overall Study|Lost to Follow-up|1|||
128747045|NCT04782323|463362749|FG003|Overall Study|Lost to Follow-up|0|||
128747046|NCT04782323|463362750|FG004|Overall Study|Lost to Follow-up|0|||
128747047|NCT04782323|463362751|FG005|Overall Study|Lost to Follow-up|1|||
128747048|NCT04782323|463362752|FG006|Overall Study|Lost to Follow-up|1|||
128747049|NCT04782323|463362753|FG007|Overall Study|Lost to Follow-up|2|||
128747050|NCT04782323|463362746|FG000|Overall Study|randomization in error|1|||
128747051|NCT04782323|463362747|FG001|Overall Study|randomization in error|0|||
128747052|NCT04782323|463362748|FG002|Overall Study|randomization in error|0|||
128747053|NCT04782323|463362749|FG003|Overall Study|randomization in error|0|||
128747054|NCT04782323|463362750|FG004|Overall Study|randomization in error|0|||
128747055|NCT04782323|463362751|FG005|Overall Study|randomization in error|0|||
128747056|NCT04782323|463362752|FG006|Overall Study|randomization in error|0|||
128747057|NCT04782323|463362753|FG007|Overall Study|randomization in error|0|||
128747058|NCT04558346|463362760|FG000|Overall Study|Withdrawal by Subject|2|||
128747059|NCT04558346|463362761|FG001|Overall Study|Withdrawal by Subject|0|||
128747060|NCT04558346|463362760|FG000|Overall Study|Lost to Follow-up|0|||
128747061|NCT04558346|463362761|FG001|Overall Study|Lost to Follow-up|1|||
128747062|NCT04558346|463362760|FG000|Overall Study|Adverse Event|0|||
128747063|NCT04558346|463362761|FG001|Overall Study|Adverse Event|1|||
128747064|NCT02715765|463362762|FG000|Overall Study|Study Termination|3|||
128747065|NCT02715765|463362763|FG001|Overall Study|Study Termination|0|||
128747066|NCT02715765|463362764|FG002|Overall Study|Study Termination|0|||
128747067|NCT01462344|463362765|FG000|Overall Study|Withdrawal by Subject|245|||
128747068|NCT01462344|463362766|FG001|Overall Study|Withdrawal by Subject|226|||
128747069|NCT01462344|463362765|FG000|Overall Study|Adverse Event|24|||
128747070|NCT01462344|463362766|FG001|Overall Study|Adverse Event|23|||
128747071|NCT01462344|463362765|FG000|Overall Study|Asthma Exacerbation|34|||
128747072|NCT01462344|463362766|FG001|Overall Study|Asthma Exacerbation|35|||
128747073|NCT01462344|463362765|FG000|Overall Study|Lack of Efficacy|5|||
128747074|NCT01462344|463362766|FG001|Overall Study|Lack of Efficacy|6|||
128747075|NCT01462344|463362765|FG000|Overall Study|Protocol Violation|68|||
128747076|NCT01462344|463362766|FG001|Overall Study|Protocol Violation|53|||
128747077|NCT01462344|463362765|FG000|Overall Study|Lost to Follow-up|7|||
128747078|NCT01462344|463362766|FG001|Overall Study|Lost to Follow-up|7|||
128747079|NCT01003249|463362767|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
128747080|NCT01003249|463362768|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
128747081|NCT01003249|463362767|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
128747082|NCT01003249|463362768|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
128747083|NCT01003249|463362767|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
128747084|NCT01003249|463362768|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
128747085|NCT01003249|463362767|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
128747086|NCT01003249|463362768|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
128747087|NCT03394924|463362772|FG000|Overall Study|Adverse Event|0|||
128747088|NCT03394924|463362773|FG001|Overall Study|Adverse Event|5|||
128747089|NCT03394924|463362774|FG002|Overall Study|Adverse Event|0|||
128747090|NCT03394924|463362772|FG000|Overall Study|Withdrawal by Subject|2|||
128747091|NCT03394924|463362773|FG001|Overall Study|Withdrawal by Subject|0|||
128747092|NCT03394924|463362774|FG002|Overall Study|Withdrawal by Subject|0|||
128747093|NCT03394924|463362772|FG000|Overall Study|Lost to Follow-up|0|||
128747094|NCT03394924|463362773|FG001|Overall Study|Lost to Follow-up|1|||
128747095|NCT03394924|463362774|FG002|Overall Study|Lost to Follow-up|0|||
128747096|NCT03394924|463362772|FG000|Overall Study|Did not meet all inclusion criteria|1|||
128747097|NCT03394924|463362773|FG001|Overall Study|Did not meet all inclusion criteria|0|||
128747098|NCT03394924|463362774|FG002|Overall Study|Did not meet all inclusion criteria|0|||
128747099|NCT03588572|463362777|FG000|Visitation 1|Lack of Efficacy|1|||
128747100|NCT03588572|463362778|FG001|Visitation 1|Lack of Efficacy|1|||
128747101|NCT03588572|463362777|FG000|Visitation 2|Lost to Follow-up|1|||
128747102|NCT03588572|463362778|FG001|Visitation 2|Lost to Follow-up|1|||
128747103|NCT03588572|463362777|FG000|Visitation 2|Lack of Efficacy|0|||
128747104|NCT03588572|463362778|FG001|Visitation 2|Lack of Efficacy|1|||
128747105|NCT03588572|463362777|FG000|Visitation 2|Withdrawal by Subject|1|||
128747106|NCT03588572|463362778|FG001|Visitation 2|Withdrawal by Subject|0|||
128747107|NCT03588572|463362777|FG000|Visitation 3|Lost to Follow-up|1|||
128747108|NCT03588572|463362778|FG001|Visitation 3|Lost to Follow-up|1|||
128747109|NCT03588572|463362777|FG000|Visitation 3|Physician Decision|1|||
128747110|NCT03588572|463362778|FG001|Visitation 3|Physician Decision|1|||
128747111|NCT03588572|463362777|FG000|Visitation 3|Withdrawal by Subject|1|||
128747112|NCT03588572|463362778|FG001|Visitation 3|Withdrawal by Subject|0|||
128747113|NCT03387852|463362780|FG000|Overall Study|Adverse event (AE)|3|||
128747114|NCT03387852|463362781|FG001|Overall Study|Adverse event (AE)|0|||
128747115|NCT03387852|463362782|FG002|Overall Study|Adverse event (AE)|2|||
128747116|NCT03387852|463362783|FG003|Overall Study|Adverse event (AE)|0|||
128747117|NCT03387852|463362780|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
128747118|NCT03387852|463362781|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
128747119|NCT03387852|463362782|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
128747120|NCT03387852|463362783|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
128747121|NCT03387852|463362780|FG000|Overall Study|Withdrawal by participant|1|||
128747122|NCT03387852|463362781|FG001|Overall Study|Withdrawal by participant|1|||
128747123|NCT03387852|463362782|FG002|Overall Study|Withdrawal by participant|3|||
128747124|NCT03387852|463362783|FG003|Overall Study|Withdrawal by participant|2|||
128747125|NCT03387852|463362780|FG000|Overall Study|Other- Unspecified|1|||
128747126|NCT03387852|463362781|FG001|Overall Study|Other- Unspecified|1|||
128747127|NCT03387852|463362782|FG002|Overall Study|Other- Unspecified|2|||
128747128|NCT03387852|463362783|FG003|Overall Study|Other- Unspecified|1|||
128747129|NCT03387852|463362780|FG000|Overall Study|Poor compliance to protocol|0|||
128747130|NCT03387852|463362781|FG001|Overall Study|Poor compliance to protocol|0|||
128747131|NCT03387852|463362782|FG002|Overall Study|Poor compliance to protocol|0|||
128747132|NCT03387852|463362783|FG003|Overall Study|Poor compliance to protocol|1|||
128747133|NCT03387852|463362780|FG000|Overall Study|Randomized and not treated|0|||
128747134|NCT03387852|463362781|FG001|Overall Study|Randomized and not treated|0|||
128747135|NCT03387852|463362782|FG002|Overall Study|Randomized and not treated|0|||
128747136|NCT03387852|463362783|FG003|Overall Study|Randomized and not treated|1|||
128747137|NCT02535065|463362792|FG000|Overall Study|Death|13|||
128747138|NCT02535065|463362792|FG000|Overall Study|Lost to Follow-up|1|||
128747139|NCT02535065|463362792|FG000|Overall Study|Withdrawal by Subject|6|||
128747140|NCT00110617|463362794|FG000|Overall Study|Adverse Event|2|||
128747141|NCT00110617|463362795|FG001|Overall Study|Adverse Event|4|||
128747142|NCT00110617|463362794|FG000|Overall Study|Abnormal Laboratory Value|4|||
128747143|NCT00110617|463362795|FG001|Overall Study|Abnormal Laboratory Value|2|||
128747144|NCT00110617|463362794|FG000|Overall Study|Lack of Efficacy|1|||
128747145|NCT00110617|463362795|FG001|Overall Study|Lack of Efficacy|0|||
128747146|NCT00110617|463362794|FG000|Overall Study|Patient no longer requires study drug|1|||
128747147|NCT00110617|463362795|FG001|Overall Study|Patient no longer requires study drug|0|||
128747148|NCT00110617|463362794|FG000|Overall Study|Protocol Violation|5|||
128747149|NCT00110617|463362795|FG001|Overall Study|Protocol Violation|0|||
128747150|NCT00110617|463362794|FG000|Overall Study|Withdrawal by Subject|10|||
128747151|NCT00110617|463362795|FG001|Overall Study|Withdrawal by Subject|4|||
128747152|NCT00110617|463362794|FG000|Overall Study|Lost to Follow-up|9|||
128747153|NCT00110617|463362795|FG001|Overall Study|Lost to Follow-up|1|||
128747154|NCT00110617|463362794|FG000|Overall Study|Administrative problems|6|||
128747155|NCT00110617|463362795|FG001|Overall Study|Administrative problems|5|||
128747156|NCT00110617|463362794|FG000|Overall Study|Death|1|||
128747157|NCT00110617|463362795|FG001|Overall Study|Death|1|||
128747158|NCT00110617|463362794|FG000|Overall Study|Did not receive study drug|0|||
128747159|NCT00110617|463362795|FG001|Overall Study|Did not receive study drug|12|||
128747160|NCT00045110|463362797|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
128747161|NCT00045110|463362798|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
128747162|NCT00045110|463362799|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
128747163|NCT00045110|463362797|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
128747164|NCT00045110|463362798|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
128747165|NCT00045110|463362799|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
128747166|NCT00045110|463362797|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
128747167|NCT00045110|463362798|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
128747168|NCT00045110|463362799|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
128747169|NCT04745169|463365021|FG000|Overall Study|Kidney transplantation|1|||
128747170|NCT04745169|463365021|FG000|Overall Study|Participant health problems|3|||
128747171|NCT04745169|463365021|FG000|Overall Study|Physician Decision|2|||
128747172|NCT02891187|463365022|FG000|Overall Study|Lost to Follow-up|1|||
128747173|NCT02891187|463365023|FG001|Overall Study|Lost to Follow-up|2|||
128747174|NCT02041195|463365026|FG000|Overall Study|Adverse Event|1|||
128747175|NCT02041195|463365027|FG001|Overall Study|Adverse Event|2|||
128747176|NCT02041195|463365028|FG002|Overall Study|Adverse Event|0|||
128747177|NCT02041195|463365029|FG003|Overall Study|Adverse Event|0|||
128747178|NCT02041195|463365030|FG004|Overall Study|Adverse Event|0|||
128747179|NCT02041195|463365031|FG005|Overall Study|Adverse Event|0|||
128747180|NCT02041195|463365032|FG006|Overall Study|Adverse Event|3|||
128747181|NCT02041195|463365033|FG007|Overall Study|Adverse Event|0|||
128747182|NCT02041195|463365026|FG000|Overall Study|Withdrawal by Subject|1|||
128747183|NCT02041195|463365027|FG001|Overall Study|Withdrawal by Subject|0|||
128747184|NCT02041195|463365028|FG002|Overall Study|Withdrawal by Subject|0|||
128747185|NCT02041195|463365029|FG003|Overall Study|Withdrawal by Subject|0|||
128747186|NCT02041195|463365030|FG004|Overall Study|Withdrawal by Subject|0|||
128747187|NCT02041195|463365031|FG005|Overall Study|Withdrawal by Subject|0|||
128747188|NCT02041195|463365032|FG006|Overall Study|Withdrawal by Subject|4|||
128747189|NCT02041195|463365033|FG007|Overall Study|Withdrawal by Subject|3|||
128747190|NCT02041195|463365026|FG000|Overall Study|Unable to comply with study visits|0|||
128747191|NCT02041195|463365027|FG001|Overall Study|Unable to comply with study visits|1|||
128747192|NCT02041195|463365028|FG002|Overall Study|Unable to comply with study visits|0|||
128747193|NCT02041195|463365029|FG003|Overall Study|Unable to comply with study visits|0|||
128747194|NCT02041195|463365030|FG004|Overall Study|Unable to comply with study visits|1|||
128747195|NCT02041195|463365031|FG005|Overall Study|Unable to comply with study visits|0|||
128747196|NCT02041195|463365032|FG006|Overall Study|Unable to comply with study visits|0|||
128747197|NCT02041195|463365033|FG007|Overall Study|Unable to comply with study visits|0|||
128747198|NCT02395120|463365034|FG000|Overall Study|Missed follow-up dental exam|57|||
128747199|NCT02395120|463365035|FG001|Overall Study|Missed follow-up dental exam|62|||
128747200|NCT02395120|463365036|FG002|Overall Study|Missed follow-up dental exam|6|||
128747201|NCT02395120|463365037|FG003|Overall Study|Missed follow-up dental exam|6|||
128747202|NCT02395120|463365038|FG004|Overall Study|Missed follow-up dental exam|51|||
128747203|NCT00674986|463365039|FG000|Overall Study|Adverse Event|2|||
128747204|NCT00674986|463365040|FG001|Overall Study|Adverse Event|1|||
128747205|NCT00674986|463365039|FG000|Overall Study|Subject withdrew consent|12|||
128747206|NCT00674986|463365040|FG001|Overall Study|Subject withdrew consent|19|||
128747207|NCT00674986|463365039|FG000|Overall Study|Lost to Follow-up|25|||
128747208|NCT00674986|463365040|FG001|Overall Study|Lost to Follow-up|53|||
128747209|NCT00674986|463365039|FG000|Overall Study|Other reasons|4|||
128747210|NCT00674986|463365040|FG001|Overall Study|Other reasons|8|||
128747211|NCT04546581|463365046|FG000|Overall Study|Adverse Event|9|||
128747212|NCT04546581|463365047|FG001|Overall Study|Adverse Event|3|||
128747213|NCT04546581|463365046|FG000|Overall Study|Physician Decision|0|||
128747214|NCT04546581|463365047|FG001|Overall Study|Physician Decision|1|||
128747215|NCT04546581|463365046|FG000|Overall Study|Protocol Violation|1|||
128747216|NCT04546581|463365047|FG001|Overall Study|Protocol Violation|2|||
128747217|NCT04546581|463365046|FG000|Overall Study|Withdrawal by Subject|3|||
128747218|NCT04546581|463365047|FG001|Overall Study|Withdrawal by Subject|7|||
128747219|NCT02526693|463365048|FG000|Overall Study|Physician Decision|3|||
128747220|NCT02526693|463365049|FG001|Overall Study|Physician Decision|1|||
128747221|NCT01983293|463365050|FG000|Overall Study|Withdrawal by Subject|29|||
128747222|NCT01983293|463365051|FG001|Overall Study|Withdrawal by Subject|15|||
128747223|NCT01983293|463365050|FG000|Overall Study|Missing 12-month visit|3|||
128747224|NCT01983293|463365051|FG001|Overall Study|Missing 12-month visit|3|||
128747225|NCT01983293|463365050|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
128747226|NCT01983293|463365051|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
128747227|NCT01275625|463365052|FG000|Overall Study|Death|1|||
128747228|NCT01275625|463365052|FG000|Overall Study|Lack of Efficacy|2|||
128747229|NCT01275625|463365052|FG000|Overall Study|Lost to Follow-up|1|||
128747230|NCT01275625|463365052|FG000|Overall Study|Withdrawal by Subject|3|||
128747231|NCT01275625|463365052|FG000|Overall Study|Protocol Violation|1|||
128747232|NCT01275625|463365052|FG000|Overall Study|Adverse Event|4|||
128747233|NCT01275625|463365052|FG000|Overall Study|Other|1|||
128747234|NCT01585103|463365054|FG000|Overall Study|Unable to swallow Cytosponge|6|||
128747235|NCT01349569|463365056|FG000|Overall Study|Lack of Efficacy|4|||
128747236|NCT03581305|463365057|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
128747237|NCT03581305|463365058|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
128747238|NCT03581305|463365057|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
128747239|NCT03581305|463365058|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
128747240|NCT03581305|463365057|FG000|Serotonergic Study|Withdrawal by Subject|5|||
128747241|NCT03581305|463365058|FG001|Serotonergic Study|Withdrawal by Subject|1|||
128747242|NCT01747772|463365061|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
128747243|NCT01798927|463365062|FG000|Overall Study|Withdrawal by Subject|1|||
128747244|NCT03750552|463365063|FG000|Overall Study|Adverse Event|5|||
128747245|NCT03750552|463365064|FG001|Overall Study|Adverse Event|1|||
128747246|NCT03750552|463365063|FG000|Overall Study|Withdrawal by Subject|1|||
128747247|NCT03750552|463365064|FG001|Overall Study|Withdrawal by Subject|1|||
128747248|NCT03750552|463365063|FG000|Overall Study|Other|2|||
128747249|NCT03750552|463365064|FG001|Overall Study|Other|0|||
128747250|NCT00626522|463365065|FG000|Overall Study|Protocol Violation|0|||
128747251|NCT00626522|463365066|FG001|Overall Study|Protocol Violation|0|||
128747252|NCT00626522|463365067|FG002|Overall Study|Protocol Violation|0|||
128747253|NCT00626522|463365068|FG003|Overall Study|Protocol Violation|0|||
128747254|NCT00626522|463365069|FG004|Overall Study|Protocol Violation|1|||
128747255|NCT00626522|463365070|FG005|Overall Study|Protocol Violation|0|||
128747256|NCT00626522|463365065|FG000|Overall Study|Adverse Event|2|||
128747257|NCT00626522|463365066|FG001|Overall Study|Adverse Event|1|||
128747258|NCT00626522|463365067|FG002|Overall Study|Adverse Event|2|||
128747259|NCT00626522|463365068|FG003|Overall Study|Adverse Event|0|||
128747260|NCT00626522|463365069|FG004|Overall Study|Adverse Event|1|||
128747261|NCT00626522|463365070|FG005|Overall Study|Adverse Event|1|||
128747262|NCT00626522|463365065|FG000|Overall Study|Withdrawal by Subject|2|||
128747263|NCT00626522|463365066|FG001|Overall Study|Withdrawal by Subject|5|||
128747264|NCT00626522|463365067|FG002|Overall Study|Withdrawal by Subject|5|||
128747265|NCT00626522|463365068|FG003|Overall Study|Withdrawal by Subject|0|||
128747266|NCT00626522|463365069|FG004|Overall Study|Withdrawal by Subject|4|||
128747267|NCT00626522|463365070|FG005|Overall Study|Withdrawal by Subject|1|||
128747268|NCT00626522|463365065|FG000|Overall Study|COPD exacerbation|0|||
128747269|NCT00626522|463365066|FG001|Overall Study|COPD exacerbation|0|||
128747270|NCT00626522|463365067|FG002|Overall Study|COPD exacerbation|0|||
128747271|NCT00626522|463365068|FG003|Overall Study|COPD exacerbation|1|||
128747272|NCT00626522|463365069|FG004|Overall Study|COPD exacerbation|1|||
128747273|NCT00626522|463365070|FG005|Overall Study|COPD exacerbation|0|||
128747274|NCT00626522|463365065|FG000|Overall Study|Lost to Follow-up|0|||
128747275|NCT00626522|463365066|FG001|Overall Study|Lost to Follow-up|1|||
128747276|NCT00626522|463365067|FG002|Overall Study|Lost to Follow-up|0|||
128747277|NCT00626522|463365068|FG003|Overall Study|Lost to Follow-up|0|||
128747278|NCT00626522|463365069|FG004|Overall Study|Lost to Follow-up|0|||
128747279|NCT00626522|463365070|FG005|Overall Study|Lost to Follow-up|0|||
128747280|NCT00626522|463365065|FG000|Overall Study|Inconsistent reason reported|1|||
128747281|NCT00626522|463365066|FG001|Overall Study|Inconsistent reason reported|0|||
128747282|NCT00626522|463365067|FG002|Overall Study|Inconsistent reason reported|0|||
128747283|NCT00626522|463365068|FG003|Overall Study|Inconsistent reason reported|0|||
128747284|NCT00626522|463365069|FG004|Overall Study|Inconsistent reason reported|0|||
128747285|NCT00626522|463365070|FG005|Overall Study|Inconsistent reason reported|0|||
128747286|NCT00626522|463365065|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
128747287|NCT00626522|463365066|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
128747288|NCT00626522|463365067|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
128747289|NCT00626522|463365068|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
128747290|NCT00626522|463365069|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
128747291|NCT00626522|463365070|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
128747292|NCT02280044|463365071|FG000|Overall Study|Planned alternate|0|||
128747293|NCT02280044|463365072|FG001|Overall Study|Planned alternate|2|||
128747294|NCT00896168|463365074|FG000|Overall Study|Adverse Event|4|||
128747295|NCT00896168|463365075|FG001|Overall Study|Adverse Event|7|||
128747296|NCT00896168|463365074|FG000|Overall Study|Treatment failure|8|||
128747297|NCT00896168|463365075|FG001|Overall Study|Treatment failure|10|||
128747298|NCT00896168|463365074|FG000|Overall Study|Lost to Follow-up|1|||
128747299|NCT00896168|463365075|FG001|Overall Study|Lost to Follow-up|1|||
128747300|NCT00896168|463365074|FG000|Overall Study|Other|1|||
128747301|NCT00896168|463365075|FG001|Overall Study|Other|1|||
128747302|NCT01944631|463365084|FG000|Overall Study|Adverse Event|1|||
128747303|NCT01944631|463365085|FG001|Overall Study|Adverse Event|0|||
128747304|NCT01944631|463365084|FG000|Overall Study|Lost to Follow-up|3|||
128747305|NCT01944631|463365085|FG001|Overall Study|Lost to Follow-up|1|||
128747306|NCT01944631|463365084|FG000|Overall Study|Withdrawal by Subject|0|||
128747307|NCT01944631|463365085|FG001|Overall Study|Withdrawal by Subject|1|||
128747308|NCT01003899|463365086|FG000|Overall Study|Other Adverse Event|8|||
128747309|NCT01003899|463365086|FG000|Overall Study|Not entered|4|||
128747310|NCT01003899|463365086|FG000|Overall Study|Not treated|1|||
128747311|NCT01003899|463365086|FG000|Overall Study|Progressive disease|34|||
128747312|NCT03822533|463365088|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
128747313|NCT03822533|463365089|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
128747314|NCT03822533|463365088|FG000|3 Month Follow-up|Lost to Follow-up|2|||
128747315|NCT03822533|463365089|FG001|3 Month Follow-up|Lost to Follow-up|2|||
128747316|NCT03822533|463365088|FG000|6 Month Follow-up|Lost to Follow-up|3|||
128747317|NCT03822533|463365089|FG001|6 Month Follow-up|Lost to Follow-up|0|||
128747318|NCT03822533|463365088|FG000|12 Month Follow-up|Lost to Follow-up|2|||
128747319|NCT03822533|463365089|FG001|12 Month Follow-up|Lost to Follow-up|3|||
128747320|NCT03822533|463365088|FG000|12 Month Follow-up|Pregnancy|0|||
128747321|NCT03822533|463365089|FG001|12 Month Follow-up|Pregnancy|1|||
128747322|NCT03822533|463365088|FG000|12 Month Follow-up|Surgery|2|||
128747323|NCT03822533|463365089|FG001|12 Month Follow-up|Surgery|0|||
128785668|NCT01306331|463507318|FG000|Overall Study|Protocol Violation|154|||
128747324|NCT03822533|463365088|FG000|12 Month Follow-up|Wrong address|1|||
128747325|NCT03822533|463365089|FG001|12 Month Follow-up|Wrong address|0|||
128747326|NCT03822533|463365088|FG000|12 Month Follow-up|No symptoms|1|||
128747327|NCT03822533|463365089|FG001|12 Month Follow-up|No symptoms|0|||
128747328|NCT03822533|463365088|FG000|12 Month Follow-up|Changed primary care center|0|||
128747329|NCT03822533|463365089|FG001|12 Month Follow-up|Changed primary care center|1|||
128747330|NCT02489500|463365090|FG000|Overall Study|Death|1|||
128747331|NCT02489500|463365091|FG001|Overall Study|Death|1|||
128747332|NCT01412944|463365093|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
128747333|NCT01412944|463365094|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
128747334|NCT01412944|463365095|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
128747335|NCT01412944|463365096|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
128747336|NCT01412944|463365097|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
128747337|NCT01412944|463365098|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
128747338|NCT01412944|463365093|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
128747339|NCT01412944|463365094|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
128747340|NCT01412944|463365095|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
128747341|NCT01412944|463365096|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
128747342|NCT01412944|463365097|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
128747343|NCT01412944|463365098|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
128747344|NCT01412944|463365093|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
128747345|NCT01412944|463365094|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
128747346|NCT01412944|463365095|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
128747347|NCT01412944|463365096|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
128747348|NCT01412944|463365097|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
128747349|NCT01412944|463365098|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
128747350|NCT01412944|463365093|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
128747351|NCT01412944|463365094|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
128747352|NCT01412944|463365095|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
128747353|NCT01412944|463365096|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
128747354|NCT01412944|463365097|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
128747355|NCT01412944|463365098|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
128747356|NCT01412944|463365093|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
128747357|NCT01412944|463365094|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
128747358|NCT01412944|463365095|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
128747359|NCT01412944|463365096|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
128747360|NCT01412944|463365097|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
128747361|NCT01412944|463365098|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
128747362|NCT01412944|463365093|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
128747363|NCT01412944|463365094|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
128747364|NCT01412944|463365095|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
128747365|NCT01412944|463365096|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
128747366|NCT01412944|463365097|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
128747367|NCT01412944|463365098|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
128747368|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
128747369|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
128747370|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
128747371|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
128747372|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
128747373|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
128747374|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Adverse Event|0|||
128747375|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Adverse Event|0|||
128747376|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Adverse Event|0|||
128747377|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Adverse Event|0|||
128747378|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Adverse Event|1|||
128747379|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Adverse Event|0|||
128747380|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
128747381|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
128747382|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
128747383|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
128747384|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
128747385|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
128747386|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747387|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747388|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747389|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747390|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747391|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
128747392|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747393|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747394|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747395|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747396|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
128747397|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747398|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
128747399|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
128747400|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
128747401|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
128747402|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
128747403|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
128747404|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
128747405|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
128747406|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
128747407|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
128747408|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
128747409|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
128747410|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747411|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
128747412|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747413|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747414|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747415|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
128747416|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747417|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
128747418|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747419|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747420|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747421|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
128747422|NCT01412944|463365093|FG000|Entire: IV + Maintenance|Adverse Event|0|||
128747423|NCT01412944|463365094|FG001|Entire: IV + Maintenance|Adverse Event|1|||
128747424|NCT01412944|463365095|FG002|Entire: IV + Maintenance|Adverse Event|0|||
128747425|NCT01412944|463365096|FG003|Entire: IV + Maintenance|Adverse Event|0|||
128747426|NCT01412944|463365097|FG004|Entire: IV + Maintenance|Adverse Event|0|||
128747427|NCT01412944|463365098|FG005|Entire: IV + Maintenance|Adverse Event|0|||
128747428|NCT01990950|463365099|FG000|Overall Study|Death|3|||
128747429|NCT01990950|463365099|FG000|Overall Study|Lost to Follow-up|2|||
128747430|NCT01990950|463365099|FG000|Overall Study|Withdrawal by Subject|6|||
128747431|NCT01259713|463365101|FG000|Overall Study|Adverse Event|54|||
128747432|NCT01259713|463365102|FG001|Overall Study|Adverse Event|23|||
128747433|NCT01259713|463365101|FG000|Overall Study|Death Not Related to IFI|8|||
128747434|NCT01259713|463365102|FG001|Overall Study|Death Not Related to IFI|1|||
128747435|NCT01259713|463365101|FG000|Overall Study|Investigators Discretion|14|||
128747436|NCT01259713|463365102|FG001|Overall Study|Investigators Discretion|6|||
128747437|NCT01259713|463365101|FG000|Overall Study|Lack of Efficacy|2|||
128747438|NCT01259713|463365102|FG001|Overall Study|Lack of Efficacy|0|||
128747439|NCT01259713|463365101|FG000|Overall Study|Protocol Violation|5|||
128747440|NCT01259713|463365102|FG001|Overall Study|Protocol Violation|4|||
128747441|NCT01259713|463365101|FG000|Overall Study|Subject Withdrew Consent|12|||
128747442|NCT01259713|463365102|FG001|Overall Study|Subject Withdrew Consent|7|||
128747443|NCT06111742|463365103|FG000|Overall Study|Did not receive intervention|1|||
128747444|NCT06111742|463365104|FG001|Overall Study|Did not receive intervention|0|||
128747445|NCT06111742|463365105|FG002|Overall Study|Did not receive intervention|0|||
128747446|NCT06111742|463365103|FG000|Overall Study|Withdrawal by Subject|2|||
128747447|NCT06111742|463365104|FG001|Overall Study|Withdrawal by Subject|0|||
128747448|NCT06111742|463365105|FG002|Overall Study|Withdrawal by Subject|0|||
128747449|NCT02473952|463365106|FG000|Overall Study|Adverse Event|2|||
128747450|NCT02473952|463365107|FG001|Overall Study|Adverse Event|2|||
128747451|NCT02473952|463365106|FG000|Overall Study|Withdrawal by Subject|0|||
128747452|NCT02473952|463365107|FG001|Overall Study|Withdrawal by Subject|6|||
128747453|NCT00695903|463365108|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
128747454|NCT00695903|463365109|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
128747455|NCT00695903|463365108|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
128747456|NCT00695903|463365109|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
128785669|NCT01306331|463507319|FG001|Overall Study|Protocol Violation|124|||
128785670|NCT01306331|463507318|FG000|Overall Study|Withdrawal by Subject|163|||
128747457|NCT00695903|463365108|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
128747458|NCT00695903|463365109|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
128747459|NCT00695903|463365108|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
128747460|NCT00695903|463365109|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
128747461|NCT00695903|463365108|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
128785671|NCT01306331|463507319|FG001|Overall Study|Withdrawal by Subject|152|||
128785672|NCT01306331|463507318|FG000|Overall Study|Not sexually active|29|||
128747462|NCT00695903|463365109|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
128747463|NCT00695903|463365108|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
128747464|NCT00695903|463365109|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
128747465|NCT00695903|463365108|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
128747466|NCT00695903|463365109|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
128747467|NCT00695903|463365108|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
128747468|NCT00695903|463365109|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
128747469|NCT00695903|463365108|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
128747470|NCT00695903|463365109|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
128747471|NCT02097472|463365110|FG000|Received Vaccination 2|Adverse Event|0|||
128747472|NCT02097472|463365111|FG001|Received Vaccination 2|Adverse Event|0|||
128747473|NCT02097472|463365112|FG002|Received Vaccination 2|Adverse Event|0|||
128747474|NCT02097472|463365113|FG003|Received Vaccination 2|Adverse Event|0|||
128747475|NCT02097472|463365114|FG004|Received Vaccination 2|Adverse Event|0|||
128747476|NCT02097472|463365115|FG005|Received Vaccination 2|Adverse Event|0|||
128747477|NCT02097472|463365116|FG006|Received Vaccination 2|Adverse Event|1|||
128747478|NCT02097472|463365117|FG007|Received Vaccination 2|Adverse Event|0|||
128747479|NCT03966157|463365118|FG000|Overall Study|Physician Decision|1|||
128747480|NCT03966157|463365119|FG001|Overall Study|Physician Decision|0|||
128747481|NCT02119416|463365120|FG000|Overall Study|Protocol Violation|1|||
128747482|NCT02119416|463365121|FG001|Overall Study|Protocol Violation|1|||
128747483|NCT02119416|463365122|FG002|Overall Study|Protocol Violation|1|||
128747484|NCT02119416|463365120|FG000|Overall Study|wrong pubertal stage|1|||
128747485|NCT02119416|463365121|FG001|Overall Study|wrong pubertal stage|0|||
128747486|NCT02119416|463365122|FG002|Overall Study|wrong pubertal stage|1|||
128747487|NCT03593655|463365125|FG000|First Product Use Period|Withdrawal by Subject|1|||
128747488|NCT03593655|463365126|FG001|First Product Use Period|Withdrawal by Subject|1|||
128747489|NCT03593655|463365125|FG000|First Product Use Period|Lost to Follow-up|1|||
128747490|NCT03593655|463365126|FG001|First Product Use Period|Lost to Follow-up|3|||
128747491|NCT03593655|463365125|FG000|Second Product Use Period|Withdrawal by Subject|1|||
128747492|NCT03593655|463365126|FG001|Second Product Use Period|Withdrawal by Subject|1|||
128747493|NCT03593655|463365125|FG000|Second Product Use Period|Lost to Follow-up|1|||
128747494|NCT03593655|463365126|FG001|Second Product Use Period|Lost to Follow-up|0|||
128747495|NCT03593655|463365125|FG000|Third Product Use Period|Lost to Follow-up|1|||
128785673|NCT01306331|463507319|FG001|Overall Study|Not sexually active|28|||
128785674|NCT01306331|463507318|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
128785675|NCT01306331|463507319|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
128785676|NCT01306331|463507318|FG000|Overall Study|Other|34|||
128785677|NCT01306331|463507319|FG001|Overall Study|Other|32|||
128785678|NCT04048135|463507322|FG000|Overall Study|Withdrawal by Subject|1|||
128785679|NCT04048135|463507323|FG001|Overall Study|Withdrawal by Subject|1|||
128785680|NCT04048135|463507324|FG002|Overall Study|Withdrawal by Subject|1|||
128785681|NCT04048135|463507325|FG003|Overall Study|Withdrawal by Subject|2|||
128785682|NCT04048135|463507326|FG004|Overall Study|Withdrawal by Subject|0|||
128785683|NCT04048135|463507327|FG005|Overall Study|Withdrawal by Subject|0|||
128785684|NCT04048135|463507328|FG006|Overall Study|Withdrawal by Subject|1|||
128747496|NCT03593655|463365126|FG001|Third Product Use Period|Lost to Follow-up|2|||
128785685|NCT04048135|463507329|FG007|Overall Study|Withdrawal by Subject|1|||
128785686|NCT04048135|463507322|FG000|Overall Study|Adverse Event|0|||
128747497|NCT03593655|463365125|FG000|Third Product Use Period|Physician Decision|0|||
128747498|NCT03593655|463365126|FG001|Third Product Use Period|Physician Decision|1|||
128785687|NCT04048135|463507323|FG001|Overall Study|Adverse Event|0|||
128747499|NCT03593655|463365125|FG000|Third Product Use Period|Withdrawal by Subject|0|||
128747500|NCT03593655|463365126|FG001|Third Product Use Period|Withdrawal by Subject|1|||
128747501|NCT03732209|463365127|FG000|Overall Study|Lost to Follow-up|4|||
128747502|NCT03732209|463365128|FG001|Overall Study|Lost to Follow-up|4|||
128747503|NCT03732209|463365127|FG000|Overall Study|Withdrawal by Subject|8|||
128747504|NCT03732209|463365128|FG001|Overall Study|Withdrawal by Subject|9|||
128747505|NCT05046795|463365129|FG000|Overall Study|Adverse Event|13|||
128747506|NCT05046795|463365130|FG001|Overall Study|Adverse Event|15|||
128747507|NCT05046795|463365129|FG000|Overall Study|Withdrawal by Subject|4|||
128747508|NCT05046795|463365130|FG001|Overall Study|Withdrawal by Subject|7|||
128747509|NCT05046795|463365129|FG000|Overall Study|Physician Decision|1|||
128747510|NCT05046795|463365130|FG001|Overall Study|Physician Decision|2|||
128747511|NCT05046795|463365129|FG000|Overall Study|Protocol Violation|1|||
128747512|NCT05046795|463365130|FG001|Overall Study|Protocol Violation|2|||
128747513|NCT05046795|463365129|FG000|Overall Study|Death|1|||
128747514|NCT05046795|463365130|FG001|Overall Study|Death|0|||
128747515|NCT05046795|463365129|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
128747516|NCT05046795|463365130|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
128747517|NCT02864082|463365131|FG000|Overall Study|Adverse Event|1|||
128747518|NCT02864082|463365132|FG001|Overall Study|Adverse Event|1|||
128747519|NCT02864082|463365131|FG000|Overall Study|Lost to Follow-up|0|||
128747520|NCT02864082|463365132|FG001|Overall Study|Lost to Follow-up|1|||
128747521|NCT02864082|463365131|FG000|Overall Study|Withdrawal by Subject|2|||
128747522|NCT02864082|463365132|FG001|Overall Study|Withdrawal by Subject|2|||
128747523|NCT03621696|463365133|FG000|Overall Study|Not eligible|0|||
128747524|NCT03621696|463365134|FG001|Overall Study|Not eligible|0|||
128747525|NCT03621696|463365135|FG002|Overall Study|Not eligible|0|||
128747526|NCT03621696|463365136|FG003|Overall Study|Not eligible|5|||
128747527|NCT03621696|463365133|FG000|Overall Study|Withdrawal by Subject|1|||
128747528|NCT03621696|463365134|FG001|Overall Study|Withdrawal by Subject|1|||
128747529|NCT03621696|463365135|FG002|Overall Study|Withdrawal by Subject|1|||
128747530|NCT03621696|463365136|FG003|Overall Study|Withdrawal by Subject|0|||
128747531|NCT03621696|463365133|FG000|Overall Study|Physician Decision|0|||
128747532|NCT03621696|463365134|FG001|Overall Study|Physician Decision|0|||
128747533|NCT03621696|463365135|FG002|Overall Study|Physician Decision|1|||
128747534|NCT03621696|463365136|FG003|Overall Study|Physician Decision|0|||
128747535|NCT04349553|463365137|FG000|Overall Study|Withdrawal by Subject|1|||
128747536|NCT04349553|463365138|FG001|Overall Study|Withdrawal by Subject|0|||
128747537|NCT04349553|463365139|FG002|Overall Study|Withdrawal by Subject|1|||
128747538|NCT04349553|463365140|FG003|Overall Study|Withdrawal by Subject|0|||
128747539|NCT02063724|463365141|FG000|Overall Study|Disease progression|1|||
128747540|NCT01715805|463365142|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
128747541|NCT01715805|463365143|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
128747542|NCT01715805|463365144|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
128747543|NCT01715805|463365145|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
128747544|NCT01715805|463365142|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
128747545|NCT01715805|463365143|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
128747546|NCT01715805|463365144|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
128747547|NCT01715805|463365145|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
128747548|NCT01715805|463365142|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
128747549|NCT01715805|463365143|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
128747550|NCT01715805|463365144|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
128747551|NCT01715805|463365145|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
128747552|NCT01715805|463365142|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
128747553|NCT01715805|463365143|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
128747554|NCT01715805|463365144|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
128747555|NCT01715805|463365145|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
128747556|NCT01715805|463365142|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
128747557|NCT01715805|463365143|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
128747558|NCT01715805|463365144|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
128747559|NCT01715805|463365145|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
128747560|NCT01715805|463365142|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
128747561|NCT01715805|463365143|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
128747562|NCT01715805|463365144|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
128747563|NCT01715805|463365145|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
128747564|NCT01715805|463365142|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
128747565|NCT01715805|463365143|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
128747566|NCT01715805|463365144|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
128747567|NCT01715805|463365145|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
128747568|NCT01715805|463365142|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
128747569|NCT01715805|463365143|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
128747570|NCT01715805|463365144|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
128747571|NCT01715805|463365145|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
128747572|NCT01715805|463365142|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
128747573|NCT01715805|463365143|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
128747574|NCT01715805|463365144|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
128747575|NCT01715805|463365145|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
128747576|NCT01715805|463365142|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
128747577|NCT01715805|463365143|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
128747578|NCT01715805|463365144|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
128747579|NCT01715805|463365145|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
128747580|NCT01715805|463365142|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
128747581|NCT01715805|463365143|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
128747582|NCT01715805|463365144|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
128747583|NCT01715805|463365145|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
128747584|NCT01715805|463365142|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
128747585|NCT01715805|463365143|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
128747586|NCT01715805|463365144|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
128747587|NCT01715805|463365145|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
128747588|NCT01715805|463365142|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
128747589|NCT01715805|463365143|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
128747590|NCT01715805|463365144|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
128747591|NCT01715805|463365145|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
128747592|NCT01715805|463365142|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
128747593|NCT01715805|463365143|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
128747594|NCT01715805|463365144|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
128747595|NCT01715805|463365145|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
128747596|NCT02310750|463365152|FG000|HP Period 1|Lost to Follow-up|0|||
128747597|NCT02310750|463365153|FG001|HP Period 1|Lost to Follow-up|0|||
128747598|NCT02310750|463365154|FG002|HP Period 1|Lost to Follow-up|0|||
128747599|NCT02310750|463365155|FG003|HP Period 1|Lost to Follow-up|0|||
128747600|NCT02310750|463365156|FG004|HP Period 1|Lost to Follow-up|0|||
128747601|NCT02310750|463365157|FG005|HP Period 1|Lost to Follow-up|0|||
128747602|NCT02310750|463365158|FG006|HP Period 1|Lost to Follow-up|1|||
128747603|NCT02310750|463365159|FG007|HP Period 1|Lost to Follow-up|0|||
128747604|NCT02310750|463365160|FG008|HP Period 1|Lost to Follow-up|0|||
128747605|NCT02310750|463365161|FG009|HP Period 1|Lost to Follow-up|0|||
128747606|NCT02310750|463365162|FG010|HP Period 1|Lost to Follow-up|0|||
128747607|NCT02310750|463365163|FG011|HP Period 1|Lost to Follow-up|0|||
128747608|NCT02310750|463365164|FG012|HP Period 1|Lost to Follow-up|0|||
128747609|NCT02310750|463365165|FG013|HP Period 1|Lost to Follow-up|0|||
128747610|NCT02310750|463365166|FG014|HP Period 1|Lost to Follow-up|0|||
128747611|NCT02310750|463365167|FG015|HP Period 1|Lost to Follow-up|0|||
128747612|NCT02310750|463365152|FG000|HP Period 1|Withdrawal by Subject|1|||
128747613|NCT02310750|463365153|FG001|HP Period 1|Withdrawal by Subject|0|||
128747614|NCT02310750|463365154|FG002|HP Period 1|Withdrawal by Subject|0|||
128747615|NCT02310750|463365155|FG003|HP Period 1|Withdrawal by Subject|1|||
128747616|NCT02310750|463365156|FG004|HP Period 1|Withdrawal by Subject|0|||
128747617|NCT02310750|463365157|FG005|HP Period 1|Withdrawal by Subject|0|||
128747618|NCT02310750|463365158|FG006|HP Period 1|Withdrawal by Subject|0|||
128747619|NCT02310750|463365159|FG007|HP Period 1|Withdrawal by Subject|0|||
128747620|NCT02310750|463365160|FG008|HP Period 1|Withdrawal by Subject|0|||
128747621|NCT02310750|463365161|FG009|HP Period 1|Withdrawal by Subject|0|||
128747622|NCT02310750|463365162|FG010|HP Period 1|Withdrawal by Subject|0|||
128747623|NCT02310750|463365163|FG011|HP Period 1|Withdrawal by Subject|0|||
128747624|NCT02310750|463365164|FG012|HP Period 1|Withdrawal by Subject|0|||
128747625|NCT02310750|463365165|FG013|HP Period 1|Withdrawal by Subject|0|||
128747626|NCT02310750|463365166|FG014|HP Period 1|Withdrawal by Subject|0|||
128747627|NCT02310750|463365167|FG015|HP Period 1|Withdrawal by Subject|0|||
128747628|NCT02310750|463365152|FG000|HP Washout 1|Lost to Follow-up|0|||
128747629|NCT02310750|463365153|FG001|HP Washout 1|Lost to Follow-up|0|||
128747630|NCT02310750|463365154|FG002|HP Washout 1|Lost to Follow-up|1|||
128747631|NCT02310750|463365155|FG003|HP Washout 1|Lost to Follow-up|1|||
128747632|NCT02310750|463365156|FG004|HP Washout 1|Lost to Follow-up|2|||
128747633|NCT02310750|463365157|FG005|HP Washout 1|Lost to Follow-up|2|||
128747634|NCT02310750|463365158|FG006|HP Washout 1|Lost to Follow-up|3|||
128747635|NCT02310750|463365159|FG007|HP Washout 1|Lost to Follow-up|0|||
128747636|NCT02310750|463365160|FG008|HP Washout 1|Lost to Follow-up|0|||
128747637|NCT02310750|463365161|FG009|HP Washout 1|Lost to Follow-up|0|||
128747638|NCT02310750|463365162|FG010|HP Washout 1|Lost to Follow-up|0|||
128747639|NCT02310750|463365163|FG011|HP Washout 1|Lost to Follow-up|0|||
128747640|NCT02310750|463365164|FG012|HP Washout 1|Lost to Follow-up|0|||
128747641|NCT02310750|463365165|FG013|HP Washout 1|Lost to Follow-up|0|||
128747642|NCT02310750|463365166|FG014|HP Washout 1|Lost to Follow-up|0|||
128747643|NCT02310750|463365167|FG015|HP Washout 1|Lost to Follow-up|0|||
128747644|NCT02310750|463365152|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747645|NCT02310750|463365153|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747646|NCT02310750|463365154|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747647|NCT02310750|463365155|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
128747648|NCT02310750|463365156|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747649|NCT02310750|463365157|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
128747650|NCT02310750|463365158|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747651|NCT02310750|463365159|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747652|NCT02310750|463365160|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
128747653|NCT02310750|463365161|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
128747654|NCT02310750|463365162|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747655|NCT02310750|463365163|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747656|NCT02310750|463365164|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747657|NCT02310750|463365165|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747658|NCT02310750|463365166|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747659|NCT02310750|463365167|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
128747660|NCT02310750|463365152|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747661|NCT02310750|463365153|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747662|NCT02310750|463365154|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747663|NCT02310750|463365155|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747664|NCT02310750|463365156|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747665|NCT02310750|463365157|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747666|NCT02310750|463365158|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747667|NCT02310750|463365159|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747668|NCT02310750|463365160|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747669|NCT02310750|463365161|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
128747670|NCT02310750|463365162|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747671|NCT02310750|463365163|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747672|NCT02310750|463365164|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747673|NCT02310750|463365165|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747674|NCT02310750|463365166|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747675|NCT02310750|463365167|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
128747676|NCT02310750|463365152|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747677|NCT02310750|463365153|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747678|NCT02310750|463365154|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747679|NCT02310750|463365155|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747680|NCT02310750|463365156|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747681|NCT02310750|463365157|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747682|NCT02310750|463365158|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747683|NCT02310750|463365159|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
128747684|NCT02310750|463365160|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
128747685|NCT02310750|463365161|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
128747686|NCT02310750|463365162|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747687|NCT02310750|463365163|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747688|NCT02310750|463365164|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747689|NCT02310750|463365165|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747690|NCT02310750|463365166|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747691|NCT02310750|463365167|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
128747692|NCT02310750|463365152|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747693|NCT02310750|463365153|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747694|NCT02310750|463365154|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747695|NCT02310750|463365155|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747696|NCT02310750|463365156|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747697|NCT02310750|463365157|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747698|NCT02310750|463365158|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747699|NCT02310750|463365159|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
128747700|NCT02310750|463365160|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
128747701|NCT02310750|463365161|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747702|NCT02310750|463365162|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747703|NCT02310750|463365163|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747704|NCT02310750|463365164|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747705|NCT02310750|463365165|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747706|NCT02310750|463365166|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747707|NCT02310750|463365167|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
128747708|NCT02310750|463365152|FG000|HP Washout 2|Lost to Follow-up|0|||
128747709|NCT02310750|463365153|FG001|HP Washout 2|Lost to Follow-up|0|||
128747710|NCT02310750|463365154|FG002|HP Washout 2|Lost to Follow-up|0|||
128747711|NCT02310750|463365155|FG003|HP Washout 2|Lost to Follow-up|0|||
128747712|NCT02310750|463365156|FG004|HP Washout 2|Lost to Follow-up|1|||
128747713|NCT02310750|463365157|FG005|HP Washout 2|Lost to Follow-up|0|||
128747714|NCT02310750|463365158|FG006|HP Washout 2|Lost to Follow-up|7|||
128747715|NCT02310750|463365159|FG007|HP Washout 2|Lost to Follow-up|0|||
128747716|NCT02310750|463365160|FG008|HP Washout 2|Lost to Follow-up|0|||
128747717|NCT02310750|463365161|FG009|HP Washout 2|Lost to Follow-up|0|||
128747718|NCT02310750|463365162|FG010|HP Washout 2|Lost to Follow-up|0|||
128747719|NCT02310750|463365163|FG011|HP Washout 2|Lost to Follow-up|0|||
128747720|NCT02310750|463365164|FG012|HP Washout 2|Lost to Follow-up|0|||
128747721|NCT02310750|463365165|FG013|HP Washout 2|Lost to Follow-up|0|||
128747722|NCT02310750|463365166|FG014|HP Washout 2|Lost to Follow-up|0|||
128747723|NCT02310750|463365167|FG015|HP Washout 2|Lost to Follow-up|0|||
128747724|NCT01220557|463365171|FG000|Overall Study|Lost to Follow-up|5|||
128747725|NCT01220557|463365172|FG001|Overall Study|Lost to Follow-up|3|||
128747726|NCT01220557|463365171|FG000|Overall Study|attended less than 6 lessons|1|||
128747727|NCT01220557|463365172|FG001|Overall Study|attended less than 6 lessons|2|||
128747728|NCT00718718|463365176|FG000|Prior to Week 12|Adverse Event|0|||
128747729|NCT00718718|463365177|FG001|Prior to Week 12|Adverse Event|0|||
128747730|NCT00718718|463365178|FG002|Prior to Week 12|Adverse Event|0|||
128747731|NCT00718718|463365179|FG003|Prior to Week 12|Adverse Event|0|||
128747732|NCT00718718|463365180|FG004|Prior to Week 12|Adverse Event|0|||
128747733|NCT00718718|463365181|FG005|Prior to Week 12|Adverse Event|0|||
128747734|NCT00718718|463365182|FG006|Prior to Week 12|Adverse Event|0|||
128747735|NCT00718718|463365183|FG007|Prior to Week 12|Adverse Event|1|||
128747736|NCT00718718|463365184|FG008|Prior to Week 12|Adverse Event|1|||
128747737|NCT00718718|463365185|FG009|Prior to Week 12|Adverse Event|0|||
128747738|NCT00718718|463365176|FG000|Prior to Week 12|Withdrawal by Subject|0|||
128747739|NCT00718718|463365177|FG001|Prior to Week 12|Withdrawal by Subject|0|||
128747740|NCT00718718|463365178|FG002|Prior to Week 12|Withdrawal by Subject|0|||
128747741|NCT00718718|463365179|FG003|Prior to Week 12|Withdrawal by Subject|0|||
128747742|NCT00718718|463365180|FG004|Prior to Week 12|Withdrawal by Subject|3|||
128747743|NCT00718718|463365181|FG005|Prior to Week 12|Withdrawal by Subject|0|||
128747744|NCT00718718|463365182|FG006|Prior to Week 12|Withdrawal by Subject|1|||
128747745|NCT00718718|463365183|FG007|Prior to Week 12|Withdrawal by Subject|1|||
128747746|NCT00718718|463365184|FG008|Prior to Week 12|Withdrawal by Subject|1|||
128747747|NCT00718718|463365185|FG009|Prior to Week 12|Withdrawal by Subject|0|||
128747748|NCT00718718|463365176|FG000|Prior to Week 12|Other|1|||
128747749|NCT00718718|463365177|FG001|Prior to Week 12|Other|0|||
128747750|NCT00718718|463365178|FG002|Prior to Week 12|Other|1|||
128747751|NCT00718718|463365179|FG003|Prior to Week 12|Other|0|||
128747752|NCT00718718|463365180|FG004|Prior to Week 12|Other|0|||
128747753|NCT00718718|463365181|FG005|Prior to Week 12|Other|0|||
128747754|NCT00718718|463365182|FG006|Prior to Week 12|Other|0|||
128747755|NCT00718718|463365183|FG007|Prior to Week 12|Other|0|||
128747756|NCT00718718|463365184|FG008|Prior to Week 12|Other|0|||
128747757|NCT00718718|463365185|FG009|Prior to Week 12|Other|0|||
128785688|NCT04048135|463507324|FG002|Overall Study|Adverse Event|0|||
128747758|NCT00718718|463365176|FG000|Week 12 to End of Study|Adverse Event|0|||
128747759|NCT00718718|463365177|FG001|Week 12 to End of Study|Adverse Event|0|||
128747760|NCT00718718|463365178|FG002|Week 12 to End of Study|Adverse Event|0|||
128747761|NCT00718718|463365179|FG003|Week 12 to End of Study|Adverse Event|0|||
128747762|NCT00718718|463365180|FG004|Week 12 to End of Study|Adverse Event|0|||
128747763|NCT00718718|463365181|FG005|Week 12 to End of Study|Adverse Event|0|||
128747764|NCT00718718|463365182|FG006|Week 12 to End of Study|Adverse Event|0|||
128747765|NCT00718718|463365183|FG007|Week 12 to End of Study|Adverse Event|1|||
128747766|NCT00718718|463365184|FG008|Week 12 to End of Study|Adverse Event|0|||
128747767|NCT00718718|463365185|FG009|Week 12 to End of Study|Adverse Event|0|||
128747768|NCT00718718|463365176|FG000|Week 12 to End of Study|Death|0|||
128747769|NCT00718718|463365177|FG001|Week 12 to End of Study|Death|0|||
128747770|NCT00718718|463365178|FG002|Week 12 to End of Study|Death|0|||
128747771|NCT00718718|463365179|FG003|Week 12 to End of Study|Death|0|||
128747772|NCT00718718|463365180|FG004|Week 12 to End of Study|Death|0|||
128747773|NCT00718718|463365181|FG005|Week 12 to End of Study|Death|1|||
128747774|NCT00718718|463365182|FG006|Week 12 to End of Study|Death|0|||
128747775|NCT00718718|463365183|FG007|Week 12 to End of Study|Death|0|||
128747776|NCT00718718|463365184|FG008|Week 12 to End of Study|Death|0|||
128747777|NCT00718718|463365185|FG009|Week 12 to End of Study|Death|0|||
128747778|NCT00718718|463365176|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
128747779|NCT00718718|463365177|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
128747780|NCT00718718|463365178|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
128747781|NCT00718718|463365179|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
128747782|NCT00718718|463365180|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
128747783|NCT00718718|463365181|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
128747784|NCT00718718|463365182|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
128747785|NCT00718718|463365183|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
128747786|NCT00718718|463365184|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
128747787|NCT00718718|463365185|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
128747788|NCT00718718|463365176|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
128747789|NCT00718718|463365177|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
128747790|NCT00718718|463365178|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
128747791|NCT00718718|463365179|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
128747792|NCT00718718|463365180|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
128747793|NCT00718718|463365181|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
128747794|NCT00718718|463365182|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
128747795|NCT00718718|463365183|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
128747796|NCT00718718|463365184|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
128747797|NCT00718718|463365185|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
128747798|NCT00718718|463365176|FG000|Week 12 to End of Study|Other|0|||
128747799|NCT00718718|463365177|FG001|Week 12 to End of Study|Other|1|||
128747800|NCT00718718|463365178|FG002|Week 12 to End of Study|Other|0|||
128747801|NCT00718718|463365179|FG003|Week 12 to End of Study|Other|1|||
128747802|NCT00718718|463365180|FG004|Week 12 to End of Study|Other|0|||
128747803|NCT00718718|463365181|FG005|Week 12 to End of Study|Other|0|||
128747804|NCT00718718|463365182|FG006|Week 12 to End of Study|Other|1|||
128747805|NCT00718718|463365183|FG007|Week 12 to End of Study|Other|0|||
128747806|NCT00718718|463365184|FG008|Week 12 to End of Study|Other|0|||
128747807|NCT00718718|463365185|FG009|Week 12 to End of Study|Other|0|||
128747808|NCT01962974|463365192|FG000|Overall Study|Study termination|7|||
128747809|NCT04177758|463365193|FG000|Overall Study|Lost to Follow-up|19|||
128747810|NCT04177758|463365194|FG001|Overall Study|Lost to Follow-up|11|||
128747811|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
128747812|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
128747813|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
128747814|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
128747815|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
128747816|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
128747817|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
128747818|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
128747819|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
128747820|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
128747821|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
128747822|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
128747823|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
128747824|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
128747825|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
128747826|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
128747827|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
128747828|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
128747829|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
128747830|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
128747831|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
128747832|NCT01781572|463365195|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
128747833|NCT01781572|463365196|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
128747834|NCT01781572|463365197|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
128747835|NCT01781572|463365195|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
128747836|NCT01781572|463365196|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
128747837|NCT01781572|463365197|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
128747838|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
128747839|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
128747840|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
128747841|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
128747842|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
128747843|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
128747844|NCT01781572|463365195|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
128747845|NCT01781572|463365196|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
128747846|NCT01781572|463365197|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
128747847|NCT01781572|463365195|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
128747848|NCT01781572|463365196|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
128747849|NCT01781572|463365197|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
128747850|NCT01781572|463365195|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
128747851|NCT01781572|463365196|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
128747852|NCT01781572|463365197|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
128747853|NCT01781572|463365195|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
128747854|NCT01781572|463365196|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
128747855|NCT01781572|463365197|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
128747856|NCT01781572|463365195|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
128747857|NCT01781572|463365196|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
128747858|NCT01781572|463365197|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
128747859|NCT01781572|463365195|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
128747860|NCT01781572|463365196|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
128747861|NCT01781572|463365197|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
128747862|NCT01781572|463365195|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
128747863|NCT01781572|463365196|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
128747864|NCT01781572|463365197|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
128747865|NCT03156023|463365198|FG000|Overall Study|Withdrawal by Subject|1|||
128747866|NCT03156023|463365199|FG001|Overall Study|Withdrawal by Subject|0|||
128747867|NCT03156023|463365200|FG002|Overall Study|Withdrawal by Subject|2|||
128747868|NCT03156023|463365201|FG003|Overall Study|Withdrawal by Subject|1|||
128747869|NCT03156023|463365202|FG004|Overall Study|Withdrawal by Subject|1|||
128747870|NCT03156023|463365198|FG000|Overall Study|Lost to Follow-up|0|||
128747871|NCT03156023|463365199|FG001|Overall Study|Lost to Follow-up|0|||
128747872|NCT03156023|463365200|FG002|Overall Study|Lost to Follow-up|0|||
128747873|NCT03156023|463365201|FG003|Overall Study|Lost to Follow-up|0|||
128747874|NCT03156023|463365202|FG004|Overall Study|Lost to Follow-up|1|||
128747875|NCT00726752|463365203|FG000|Overall Study|Lack of Efficacy|6|||
128747876|NCT04827576|463367097|FG000|Overall Study|Death|5|||
128747877|NCT04827576|463367098|FG001|Overall Study|Death|17|||
128747878|NCT04827576|463367099|FG002|Overall Study|Death|17|||
128747879|NCT04827576|463367100|FG003|Overall Study|Death|32|||
128747880|NCT04827576|463367097|FG000|Overall Study|Study Terminated by Sponsor|2|||
128747881|NCT04827576|463367098|FG001|Overall Study|Study Terminated by Sponsor|9|||
128747882|NCT04827576|463367099|FG002|Overall Study|Study Terminated by Sponsor|7|||
128747883|NCT04827576|463367100|FG003|Overall Study|Study Terminated by Sponsor|5|||
128747884|NCT04827576|463367097|FG000|Overall Study|Investigator's Discretion|1|||
128747885|NCT04827576|463367098|FG001|Overall Study|Investigator's Discretion|0|||
128747886|NCT04827576|463367099|FG002|Overall Study|Investigator's Discretion|2|||
128747887|NCT04827576|463367100|FG003|Overall Study|Investigator's Discretion|5|||
128785689|NCT04048135|463507325|FG003|Overall Study|Adverse Event|1|||
128747888|NCT04827576|463367097|FG000|Overall Study|Withdrew Consent|0|||
128747889|NCT04827576|463367098|FG001|Overall Study|Withdrew Consent|3|||
128747890|NCT04827576|463367099|FG002|Overall Study|Withdrew Consent|0|||
128747891|NCT04827576|463367100|FG003|Overall Study|Withdrew Consent|0|||
128747892|NCT04827576|463367097|FG000|Overall Study|Lost to Follow-up|1|||
128747893|NCT04827576|463367098|FG001|Overall Study|Lost to Follow-up|0|||
128747894|NCT04827576|463367099|FG002|Overall Study|Lost to Follow-up|0|||
128747895|NCT04827576|463367100|FG003|Overall Study|Lost to Follow-up|0|||
128747896|NCT04537923|463367101|FG000|Overall Study|Adverse Event|2|||
128747897|NCT04537923|463367102|FG001|Overall Study|Adverse Event|1|||
128747898|NCT04537923|463367103|FG002|Overall Study|Adverse Event|2|||
128747899|NCT04537923|463367104|FG003|Overall Study|Adverse Event|4|||
128747900|NCT04537923|463367101|FG000|Overall Study|Death|3|||
128747901|NCT04537923|463367102|FG001|Overall Study|Death|3|||
128747902|NCT04537923|463367103|FG002|Overall Study|Death|1|||
128747903|NCT04537923|463367104|FG003|Overall Study|Death|11|||
128747904|NCT04537923|463367101|FG000|Overall Study|Lost to Follow-up|1|||
128747905|NCT04537923|463367102|FG001|Overall Study|Lost to Follow-up|2|||
128747906|NCT04537923|463367103|FG002|Overall Study|Lost to Follow-up|1|||
128747907|NCT04537923|463367104|FG003|Overall Study|Lost to Follow-up|6|||
128747908|NCT04537923|463367101|FG000|Overall Study|Physician Decision|1|||
128747909|NCT04537923|463367102|FG001|Overall Study|Physician Decision|0|||
128747910|NCT04537923|463367103|FG002|Overall Study|Physician Decision|2|||
128747911|NCT04537923|463367104|FG003|Overall Study|Physician Decision|5|||
128747912|NCT04537923|463367101|FG000|Overall Study|Pregnancy|1|||
128747913|NCT04537923|463367102|FG001|Overall Study|Pregnancy|0|||
128747914|NCT04537923|463367103|FG002|Overall Study|Pregnancy|0|||
128747915|NCT04537923|463367104|FG003|Overall Study|Pregnancy|0|||
128747916|NCT04537923|463367101|FG000|Overall Study|Withdrawal by Subject|4|||
128747917|NCT04537923|463367102|FG001|Overall Study|Withdrawal by Subject|4|||
128747918|NCT04537923|463367103|FG002|Overall Study|Withdrawal by Subject|4|||
128747919|NCT04537923|463367104|FG003|Overall Study|Withdrawal by Subject|58|||
128747920|NCT04537923|463367101|FG000|Overall Study|Missed study visits|2|||
128747921|NCT04537923|463367102|FG001|Overall Study|Missed study visits|0|||
128747922|NCT04537923|463367103|FG002|Overall Study|Missed study visits|0|||
128747923|NCT04537923|463367104|FG003|Overall Study|Missed study visits|3|||
128747924|NCT04537923|463367101|FG000|Overall Study|Sponsor's decision|0|||
128747925|NCT04537923|463367102|FG001|Overall Study|Sponsor's decision|0|||
128747926|NCT04537923|463367103|FG002|Overall Study|Sponsor's decision|1|||
128747927|NCT04537923|463367104|FG003|Overall Study|Sponsor's decision|1|||
128747928|NCT04537923|463367101|FG000|Overall Study|Safety reasons|1|||
128747929|NCT04537923|463367102|FG001|Overall Study|Safety reasons|0|||
128747930|NCT04537923|463367103|FG002|Overall Study|Safety reasons|0|||
128747931|NCT04537923|463367104|FG003|Overall Study|Safety reasons|0|||
128747932|NCT01261611|463367105|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
128747933|NCT01261611|463367106|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
128747934|NCT01261611|463367107|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
128747935|NCT01261611|463367105|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
128747936|NCT01261611|463367106|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
128747937|NCT01261611|463367107|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
128747938|NCT01261611|463367105|FG000|Treatment Cycle 1|Adverse Event|0|||
128747939|NCT01261611|463367106|FG001|Treatment Cycle 1|Adverse Event|1|||
128747940|NCT01261611|463367107|FG002|Treatment Cycle 1|Adverse Event|0|||
128747941|NCT01261611|463367105|FG000|Treatment Cycle 1|Protocol Violation|0|||
128747942|NCT01261611|463367106|FG001|Treatment Cycle 1|Protocol Violation|0|||
128747943|NCT01261611|463367107|FG002|Treatment Cycle 1|Protocol Violation|2|||
128747944|NCT01261611|463367105|FG000|Treatment Cycle 2|Completed study|4|||
128747945|NCT01261611|463367106|FG001|Treatment Cycle 2|Completed study|0|||
128747946|NCT01261611|463367107|FG002|Treatment Cycle 2|Completed study|0|||
128747947|NCT01261611|463367105|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
128747948|NCT01261611|463367106|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
128747949|NCT01261611|463367107|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
128747950|NCT01261611|463367105|FG000|Treatment Cycle 2|Adverse Event|1|||
128747951|NCT01261611|463367106|FG001|Treatment Cycle 2|Adverse Event|0|||
128747952|NCT01261611|463367107|FG002|Treatment Cycle 2|Adverse Event|0|||
128747953|NCT01261611|463367105|FG000|Treatment Cycle 2|Protocol Violation|2|||
128747954|NCT01261611|463367106|FG001|Treatment Cycle 2|Protocol Violation|0|||
128747955|NCT01261611|463367107|FG002|Treatment Cycle 2|Protocol Violation|0|||
128747956|NCT01261611|463367105|FG000|Treatment Cycle 2|Not otherwise specified|2|||
128747957|NCT01261611|463367106|FG001|Treatment Cycle 2|Not otherwise specified|0|||
128747958|NCT01261611|463367107|FG002|Treatment Cycle 2|Not otherwise specified|0|||
128747959|NCT01261611|463367105|FG000|Treatment Cycle 3|Completed study|24|||
128747960|NCT01261611|463367106|FG001|Treatment Cycle 3|Completed study|0|||
128747961|NCT01261611|463367107|FG002|Treatment Cycle 3|Completed study|0|||
128747962|NCT01261611|463367105|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
128747963|NCT01261611|463367106|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
128747964|NCT01261611|463367107|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
128747965|NCT01261611|463367105|FG000|Treatment Cycle 3|Adverse Event|1|||
128747966|NCT01261611|463367106|FG001|Treatment Cycle 3|Adverse Event|0|||
128747967|NCT01261611|463367107|FG002|Treatment Cycle 3|Adverse Event|0|||
128747968|NCT01261611|463367105|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
128747969|NCT01261611|463367106|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
128747970|NCT01261611|463367107|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
128747971|NCT01261611|463367105|FG000|Treatment Cycle 4|Completed study|87|||
128747972|NCT01261611|463367106|FG001|Treatment Cycle 4|Completed study|0|||
128747973|NCT01261611|463367107|FG002|Treatment Cycle 4|Completed study|0|||
128747974|NCT01261611|463367105|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
128747975|NCT01261611|463367106|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
128747976|NCT01261611|463367107|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
128747977|NCT01261611|463367105|FG000|Treatment Cycle 4|Adverse Event|1|||
128747978|NCT01261611|463367106|FG001|Treatment Cycle 4|Adverse Event|0|||
128747979|NCT01261611|463367107|FG002|Treatment Cycle 4|Adverse Event|0|||
128747980|NCT01261611|463367105|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
128747981|NCT01261611|463367106|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
128747982|NCT01261611|463367107|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
128747983|NCT01261611|463367105|FG000|Treatment Cycle 4|Not otherwise specified|3|||
128747984|NCT01261611|463367106|FG001|Treatment Cycle 4|Not otherwise specified|0|||
128747985|NCT01261611|463367107|FG002|Treatment Cycle 4|Not otherwise specified|0|||
128747986|NCT01261611|463367105|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
128747987|NCT01261611|463367106|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
128747988|NCT01261611|463367107|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
128747989|NCT01261611|463367105|FG000|Treatment Cycle 5|Adverse Event|1|||
128747990|NCT01261611|463367106|FG001|Treatment Cycle 5|Adverse Event|0|||
128747991|NCT01261611|463367107|FG002|Treatment Cycle 5|Adverse Event|0|||
128747992|NCT01261611|463367105|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
128747993|NCT01261611|463367106|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
128747994|NCT01261611|463367107|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
128747995|NCT02527798|463367108|FG000|Overall Study|Physician Decision|1|||
128747996|NCT02527798|463367109|FG001|Overall Study|Physician Decision|0|||
128747997|NCT02527798|463367110|FG002|Overall Study|Physician Decision|1|||
128747998|NCT02527798|463367111|FG003|Overall Study|Physician Decision|1|||
128747999|NCT02527798|463367112|FG004|Overall Study|Physician Decision|0|||
128748000|NCT02527798|463367113|FG005|Overall Study|Physician Decision|0|||
128748001|NCT02527798|463367108|FG000|Overall Study|Death|0|||
128748002|NCT02527798|463367109|FG001|Overall Study|Death|0|||
128748003|NCT02527798|463367110|FG002|Overall Study|Death|1|||
128748004|NCT02527798|463367111|FG003|Overall Study|Death|0|||
128748005|NCT02527798|463367112|FG004|Overall Study|Death|0|||
128748006|NCT02527798|463367113|FG005|Overall Study|Death|0|||
128748007|NCT02527798|463367108|FG000|Overall Study|Withdrawal by Subject|0|||
128748008|NCT02527798|463367109|FG001|Overall Study|Withdrawal by Subject|1|||
128748009|NCT02527798|463367110|FG002|Overall Study|Withdrawal by Subject|2|||
128748010|NCT02527798|463367111|FG003|Overall Study|Withdrawal by Subject|0|||
128748011|NCT02527798|463367112|FG004|Overall Study|Withdrawal by Subject|0|||
128748012|NCT02527798|463367113|FG005|Overall Study|Withdrawal by Subject|0|||
128748013|NCT02527798|463367108|FG000|Overall Study|Reason undisclosed|1|||
128748014|NCT02527798|463367109|FG001|Overall Study|Reason undisclosed|0|||
128748015|NCT02527798|463367110|FG002|Overall Study|Reason undisclosed|1|||
128748016|NCT02527798|463367111|FG003|Overall Study|Reason undisclosed|0|||
128748017|NCT02527798|463367112|FG004|Overall Study|Reason undisclosed|0|||
128748018|NCT02527798|463367113|FG005|Overall Study|Reason undisclosed|0|||
128748019|NCT02527798|463367108|FG000|Overall Study|Did not receive intervention|1|||
128748020|NCT02527798|463367109|FG001|Overall Study|Did not receive intervention|1|||
128748021|NCT02527798|463367110|FG002|Overall Study|Did not receive intervention|0|||
128748022|NCT02527798|463367111|FG003|Overall Study|Did not receive intervention|0|||
128748023|NCT02527798|463367112|FG004|Overall Study|Did not receive intervention|0|||
128785690|NCT04048135|463507326|FG004|Overall Study|Adverse Event|1|||
128785691|NCT04048135|463507327|FG005|Overall Study|Adverse Event|0|||
128785692|NCT04048135|463507328|FG006|Overall Study|Adverse Event|0|||
128748024|NCT02527798|463367113|FG005|Overall Study|Did not receive intervention|0|||
128748025|NCT02062632|463367117|FG000|Overall Study|No treatment data|1|||
128748026|NCT01490632|463367122|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
128748027|NCT01490632|463367123|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
128748028|NCT01490632|463367124|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
128748029|NCT01490632|463367125|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
128748030|NCT01490632|463367126|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
128748031|NCT01490632|463367127|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
128748032|NCT01490632|463367128|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
128748033|NCT01490632|463367129|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
128785693|NCT04048135|463507329|FG007|Overall Study|Adverse Event|0|||
128785694|NCT04048135|463507322|FG000|Overall Study|Protocol Violation|0|||
128748034|NCT01490632|463367130|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
128748035|NCT01490632|463367131|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
128748036|NCT01490632|463367132|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
128748037|NCT01490632|463367133|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
128748038|NCT01490632|463367134|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
128748039|NCT01490632|463367135|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
128748040|NCT01490632|463367136|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
128748041|NCT01490632|463367137|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
128748042|NCT01490632|463367138|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
128748043|NCT01490632|463367139|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
128748044|NCT01490632|463367140|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
128748045|NCT01490632|463367141|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
128748046|NCT01490632|463367122|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
128748047|NCT01490632|463367123|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
128748048|NCT01490632|463367124|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
128748049|NCT01490632|463367125|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
128748050|NCT01490632|463367126|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748051|NCT01490632|463367127|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748052|NCT01490632|463367128|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748053|NCT01490632|463367129|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748054|NCT01490632|463367130|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748055|NCT01490632|463367131|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748056|NCT01490632|463367132|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748057|NCT01490632|463367133|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748058|NCT01490632|463367134|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748059|NCT01490632|463367135|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748060|NCT01490632|463367136|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748061|NCT01490632|463367137|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748062|NCT01490632|463367138|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748063|NCT01490632|463367139|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748064|NCT01490632|463367140|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748065|NCT01490632|463367141|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
128748066|NCT01490632|463367122|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748067|NCT01490632|463367123|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748068|NCT01490632|463367124|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
128748069|NCT01490632|463367125|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
128748070|NCT01490632|463367126|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
128748071|NCT01490632|463367127|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748072|NCT01490632|463367128|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748073|NCT01490632|463367129|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748074|NCT01490632|463367130|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748075|NCT01490632|463367131|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748076|NCT01490632|463367132|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748077|NCT01490632|463367133|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748078|NCT01490632|463367134|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748079|NCT01490632|463367135|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748080|NCT01490632|463367136|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748081|NCT01490632|463367137|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748082|NCT01490632|463367138|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748083|NCT01490632|463367139|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748084|NCT01490632|463367140|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748085|NCT01490632|463367141|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
128748086|NCT01490632|463367122|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
128748087|NCT01490632|463367123|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
128748088|NCT01490632|463367124|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
128748089|NCT01490632|463367125|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
128748090|NCT01490632|463367126|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
128748091|NCT01490632|463367127|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
128748092|NCT01490632|463367128|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
128748093|NCT01490632|463367129|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
128748094|NCT01490632|463367130|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
128748095|NCT01490632|463367131|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
128748096|NCT01490632|463367132|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
128748097|NCT01490632|463367133|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
128748098|NCT01490632|463367134|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
128748099|NCT01490632|463367135|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
128748100|NCT01490632|463367136|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
128748101|NCT01490632|463367137|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
128748102|NCT01490632|463367138|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
128748103|NCT01490632|463367139|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
128748104|NCT01490632|463367140|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
128748105|NCT01490632|463367141|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
128748106|NCT01490632|463367122|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
128748107|NCT01490632|463367123|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748108|NCT01490632|463367124|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748109|NCT01490632|463367125|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748110|NCT01490632|463367126|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748111|NCT01490632|463367127|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748112|NCT01490632|463367128|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748113|NCT01490632|463367129|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748114|NCT01490632|463367130|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748115|NCT01490632|463367131|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748116|NCT01490632|463367132|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748117|NCT01490632|463367133|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748118|NCT01490632|463367134|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748119|NCT01490632|463367135|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748120|NCT01490632|463367136|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748121|NCT01490632|463367137|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748122|NCT01490632|463367138|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748123|NCT01490632|463367139|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748124|NCT01490632|463367140|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748125|NCT01490632|463367141|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
128748126|NCT01490632|463367122|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
128748127|NCT01490632|463367123|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
128748128|NCT01490632|463367124|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748129|NCT01490632|463367125|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
128748130|NCT01490632|463367126|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
128748131|NCT01490632|463367127|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748132|NCT01490632|463367128|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748133|NCT01490632|463367129|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748134|NCT01490632|463367130|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748135|NCT01490632|463367131|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748136|NCT01490632|463367132|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748137|NCT01490632|463367133|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748138|NCT01490632|463367134|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748139|NCT01490632|463367135|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748140|NCT01490632|463367136|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748141|NCT01490632|463367137|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748142|NCT01490632|463367138|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748143|NCT01490632|463367139|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748144|NCT01490632|463367140|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748145|NCT01490632|463367141|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
128748146|NCT01490632|463367122|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748147|NCT01490632|463367123|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748148|NCT01490632|463367124|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748149|NCT01490632|463367125|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748150|NCT01490632|463367126|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
128748151|NCT01490632|463367127|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748152|NCT01490632|463367128|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748153|NCT01490632|463367129|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748154|NCT01490632|463367130|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748155|NCT01490632|463367131|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748156|NCT01490632|463367132|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748157|NCT01490632|463367133|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748158|NCT01490632|463367134|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748159|NCT01490632|463367135|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748160|NCT01490632|463367136|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748161|NCT01490632|463367137|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748162|NCT01490632|463367138|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128785695|NCT04048135|463507323|FG001|Overall Study|Protocol Violation|0|||
128748163|NCT01490632|463367139|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748164|NCT01490632|463367140|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748165|NCT01490632|463367141|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
128748166|NCT01490632|463367122|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748167|NCT01490632|463367123|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748168|NCT01490632|463367124|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748169|NCT01490632|463367125|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748170|NCT01490632|463367126|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748171|NCT01490632|463367127|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
128748172|NCT01490632|463367128|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
128748173|NCT01490632|463367129|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748174|NCT01490632|463367130|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748175|NCT01490632|463367131|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
128748176|NCT01490632|463367132|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
128748177|NCT01490632|463367133|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
128748178|NCT01490632|463367134|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748179|NCT01490632|463367135|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748180|NCT01490632|463367136|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748181|NCT01490632|463367137|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748182|NCT01490632|463367138|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748183|NCT01490632|463367139|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748184|NCT01490632|463367140|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748185|NCT01490632|463367141|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
128748186|NCT01490632|463367122|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748187|NCT01490632|463367123|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748188|NCT01490632|463367124|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748189|NCT01490632|463367125|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748190|NCT01490632|463367126|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748191|NCT01490632|463367127|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748192|NCT01490632|463367128|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
128748193|NCT01490632|463367129|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748194|NCT01490632|463367130|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
128748195|NCT01490632|463367131|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
128748196|NCT01490632|463367132|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
128748197|NCT01490632|463367133|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748198|NCT01490632|463367134|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748199|NCT01490632|463367135|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748200|NCT01490632|463367136|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748201|NCT01490632|463367137|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748202|NCT01490632|463367138|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748203|NCT01490632|463367139|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748204|NCT01490632|463367140|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748205|NCT01490632|463367141|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
128748206|NCT01490632|463367122|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748207|NCT01490632|463367123|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748208|NCT01490632|463367124|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748209|NCT01490632|463367125|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748210|NCT01490632|463367126|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748211|NCT01490632|463367127|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748212|NCT01490632|463367128|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
128748213|NCT01490632|463367129|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748214|NCT01490632|463367130|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748215|NCT01490632|463367131|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
128748216|NCT01490632|463367132|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748217|NCT01490632|463367133|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748218|NCT01490632|463367134|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748219|NCT01490632|463367135|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748220|NCT01490632|463367136|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748221|NCT01490632|463367137|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748222|NCT01490632|463367138|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748223|NCT01490632|463367139|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748224|NCT01490632|463367140|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748225|NCT01490632|463367141|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
128748226|NCT01490632|463367122|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748227|NCT01490632|463367123|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748228|NCT01490632|463367124|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748229|NCT01490632|463367125|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748230|NCT01490632|463367126|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748231|NCT01490632|463367127|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748232|NCT01490632|463367128|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
128748233|NCT01490632|463367129|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748234|NCT01490632|463367130|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748235|NCT01490632|463367131|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748236|NCT01490632|463367132|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748237|NCT01490632|463367133|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748238|NCT01490632|463367134|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748239|NCT01490632|463367135|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748240|NCT01490632|463367136|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748241|NCT01490632|463367137|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748242|NCT01490632|463367138|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748243|NCT01490632|463367139|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748244|NCT01490632|463367140|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748245|NCT01490632|463367141|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
128748246|NCT01490632|463367122|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748247|NCT01490632|463367123|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748248|NCT01490632|463367124|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748249|NCT01490632|463367125|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748250|NCT01490632|463367126|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748251|NCT01490632|463367127|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
128748252|NCT01490632|463367128|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748253|NCT01490632|463367129|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748254|NCT01490632|463367130|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748255|NCT01490632|463367131|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748256|NCT01490632|463367132|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748257|NCT01490632|463367133|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748258|NCT01490632|463367134|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748259|NCT01490632|463367135|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748260|NCT01490632|463367136|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748261|NCT01490632|463367137|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748262|NCT01490632|463367138|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748263|NCT01490632|463367139|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748264|NCT01490632|463367140|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748265|NCT01490632|463367141|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
128748266|NCT01490632|463367122|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748267|NCT01490632|463367123|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748268|NCT01490632|463367124|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748269|NCT01490632|463367125|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748270|NCT01490632|463367126|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748271|NCT01490632|463367127|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748272|NCT01490632|463367128|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
128748273|NCT01490632|463367129|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748274|NCT01490632|463367130|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
128748275|NCT01490632|463367131|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748276|NCT01490632|463367132|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
128748277|NCT01490632|463367133|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
128748278|NCT01490632|463367134|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748279|NCT01490632|463367135|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748280|NCT01490632|463367136|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748281|NCT01490632|463367137|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128785696|NCT04048135|463507324|FG002|Overall Study|Protocol Violation|0|||
128748282|NCT01490632|463367138|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748283|NCT01490632|463367139|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748284|NCT01490632|463367140|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748285|NCT01490632|463367141|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
128748286|NCT01490632|463367122|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748287|NCT01490632|463367123|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748288|NCT01490632|463367124|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748289|NCT01490632|463367125|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748290|NCT01490632|463367126|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748291|NCT01490632|463367127|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
128748292|NCT01490632|463367128|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
128748293|NCT01490632|463367129|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
128748294|NCT01490632|463367130|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
128748295|NCT01490632|463367131|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
128748296|NCT01490632|463367132|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
128748297|NCT01490632|463367133|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
128748298|NCT01490632|463367134|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748299|NCT01490632|463367135|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748300|NCT01490632|463367136|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748301|NCT01490632|463367137|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748302|NCT01490632|463367138|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748303|NCT01490632|463367139|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748304|NCT01490632|463367140|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748305|NCT01490632|463367141|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
128748306|NCT01490632|463367122|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748307|NCT01490632|463367123|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748308|NCT01490632|463367124|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748309|NCT01490632|463367125|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748310|NCT01490632|463367126|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748311|NCT01490632|463367127|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748312|NCT01490632|463367128|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748313|NCT01490632|463367129|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748314|NCT01490632|463367130|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748315|NCT01490632|463367131|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748316|NCT01490632|463367132|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748317|NCT01490632|463367133|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748318|NCT01490632|463367134|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748319|NCT01490632|463367135|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748320|NCT01490632|463367136|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
128748321|NCT01490632|463367137|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
128748322|NCT01490632|463367138|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748323|NCT01490632|463367139|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748324|NCT01490632|463367140|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748325|NCT01490632|463367141|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
128748326|NCT01490632|463367122|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748327|NCT01490632|463367123|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748328|NCT01490632|463367124|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748329|NCT01490632|463367125|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748330|NCT01490632|463367126|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748331|NCT01490632|463367127|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748332|NCT01490632|463367128|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748333|NCT01490632|463367129|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748334|NCT01490632|463367130|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748335|NCT01490632|463367131|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748336|NCT01490632|463367132|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748337|NCT01490632|463367133|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748338|NCT01490632|463367134|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748339|NCT01490632|463367135|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
128748340|NCT01490632|463367136|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748341|NCT01490632|463367137|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748342|NCT01490632|463367138|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748343|NCT01490632|463367139|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748344|NCT01490632|463367140|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748345|NCT01490632|463367141|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
128748346|NCT01490632|463367122|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748347|NCT01490632|463367123|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748348|NCT01490632|463367124|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748349|NCT01490632|463367125|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748350|NCT01490632|463367126|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748351|NCT01490632|463367127|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748352|NCT01490632|463367128|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748353|NCT01490632|463367129|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748354|NCT01490632|463367130|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748355|NCT01490632|463367131|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748356|NCT01490632|463367132|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748357|NCT01490632|463367133|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748358|NCT01490632|463367134|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748359|NCT01490632|463367135|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748360|NCT01490632|463367136|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
128748361|NCT01490632|463367137|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
128748362|NCT01490632|463367138|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748363|NCT01490632|463367139|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748364|NCT01490632|463367140|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748365|NCT01490632|463367141|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
128748366|NCT01490632|463367122|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748367|NCT01490632|463367123|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748368|NCT01490632|463367124|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748369|NCT01490632|463367125|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748370|NCT01490632|463367126|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748371|NCT01490632|463367127|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748372|NCT01490632|463367128|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748373|NCT01490632|463367129|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748374|NCT01490632|463367130|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748375|NCT01490632|463367131|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748376|NCT01490632|463367132|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748377|NCT01490632|463367133|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748378|NCT01490632|463367134|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
128748379|NCT01490632|463367135|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
128748380|NCT01490632|463367136|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
128748381|NCT01490632|463367137|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
128748382|NCT01490632|463367138|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748383|NCT01490632|463367139|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748384|NCT01490632|463367140|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748385|NCT01490632|463367141|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
128748386|NCT01490632|463367122|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
128748387|NCT01490632|463367123|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
128748388|NCT01490632|463367124|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
128748389|NCT01490632|463367125|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
128748390|NCT01490632|463367126|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
128748391|NCT01490632|463367127|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
128748392|NCT01490632|463367128|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
128748393|NCT01490632|463367129|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
128748394|NCT01490632|463367130|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
128748395|NCT01490632|463367131|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
128748396|NCT01490632|463367132|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
128748397|NCT01490632|463367133|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
128748398|NCT01490632|463367134|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
128748399|NCT01490632|463367135|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
128748400|NCT01490632|463367136|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
128748401|NCT01490632|463367137|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
128748402|NCT01490632|463367138|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
128748403|NCT01490632|463367139|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
128748404|NCT01490632|463367140|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
128748405|NCT01490632|463367141|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
128748406|NCT01490632|463367122|FG000|Part D: Re-Treatment Period|Death|0|||
128748407|NCT01490632|463367123|FG001|Part D: Re-Treatment Period|Death|0|||
128748408|NCT01490632|463367124|FG002|Part D: Re-Treatment Period|Death|0|||
128748409|NCT01490632|463367125|FG003|Part D: Re-Treatment Period|Death|0|||
128748410|NCT01490632|463367126|FG004|Part D: Re-Treatment Period|Death|0|||
128748411|NCT01490632|463367127|FG005|Part D: Re-Treatment Period|Death|0|||
128748412|NCT01490632|463367128|FG006|Part D: Re-Treatment Period|Death|0|||
128748413|NCT01490632|463367129|FG007|Part D: Re-Treatment Period|Death|0|||
128748414|NCT01490632|463367130|FG008|Part D: Re-Treatment Period|Death|0|||
128748415|NCT01490632|463367131|FG009|Part D: Re-Treatment Period|Death|0|||
128748416|NCT01490632|463367132|FG010|Part D: Re-Treatment Period|Death|0|||
128748417|NCT01490632|463367133|FG011|Part D: Re-Treatment Period|Death|0|||
128748418|NCT01490632|463367134|FG012|Part D: Re-Treatment Period|Death|0|||
128748419|NCT01490632|463367135|FG013|Part D: Re-Treatment Period|Death|0|||
128748420|NCT01490632|463367136|FG014|Part D: Re-Treatment Period|Death|0|||
128748421|NCT01490632|463367137|FG015|Part D: Re-Treatment Period|Death|0|||
128748422|NCT01490632|463367138|FG016|Part D: Re-Treatment Period|Death|0|||
128748423|NCT01490632|463367139|FG017|Part D: Re-Treatment Period|Death|0|||
128748424|NCT01490632|463367140|FG018|Part D: Re-Treatment Period|Death|1|||
128748425|NCT01490632|463367141|FG019|Part D: Re-Treatment Period|Death|0|||
128748426|NCT01490632|463367122|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748427|NCT01490632|463367123|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748428|NCT01490632|463367124|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748429|NCT01490632|463367125|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748430|NCT01490632|463367126|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748431|NCT01490632|463367127|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748432|NCT01490632|463367128|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748433|NCT01490632|463367129|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748434|NCT01490632|463367130|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748435|NCT01490632|463367131|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748436|NCT01490632|463367132|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748437|NCT01490632|463367133|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748438|NCT01490632|463367134|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748439|NCT01490632|463367135|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748440|NCT01490632|463367136|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748441|NCT01490632|463367137|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748442|NCT01490632|463367138|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
128748443|NCT01490632|463367139|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
128748444|NCT01490632|463367140|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
128748445|NCT01490632|463367141|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
128748446|NCT01490632|463367122|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748447|NCT01490632|463367123|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748448|NCT01490632|463367124|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748449|NCT01490632|463367125|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748450|NCT01490632|463367126|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748451|NCT01490632|463367127|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748452|NCT01490632|463367128|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748453|NCT01490632|463367129|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748454|NCT01490632|463367130|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748455|NCT01490632|463367131|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748456|NCT01490632|463367132|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748457|NCT01490632|463367133|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748458|NCT01490632|463367134|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748459|NCT01490632|463367135|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748460|NCT01490632|463367136|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748461|NCT01490632|463367137|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748462|NCT01490632|463367138|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748463|NCT01490632|463367139|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748464|NCT01490632|463367140|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
128748465|NCT01490632|463367141|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
128748466|NCT01490632|463367122|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
128748467|NCT01490632|463367123|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
128748468|NCT01490632|463367124|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
128748469|NCT01490632|463367125|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
128748470|NCT01490632|463367126|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
128748471|NCT01490632|463367127|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
128748472|NCT01490632|463367128|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
128748473|NCT01490632|463367129|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
128748474|NCT01490632|463367130|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
128748475|NCT01490632|463367131|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
128748476|NCT01490632|463367132|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
128748477|NCT01490632|463367133|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
128748478|NCT01490632|463367134|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
128748479|NCT01490632|463367135|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
128748480|NCT01490632|463367136|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
128748481|NCT01490632|463367137|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
128748482|NCT01490632|463367138|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
128748483|NCT01490632|463367139|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
128748484|NCT01490632|463367140|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
128748485|NCT01490632|463367141|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
128748486|NCT01490632|463367122|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
128748487|NCT01490632|463367123|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
128748488|NCT01490632|463367124|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
128748489|NCT01490632|463367125|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
128748490|NCT01490632|463367126|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
128748491|NCT01490632|463367127|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
128748492|NCT01490632|463367128|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
128748493|NCT01490632|463367129|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
128748494|NCT01490632|463367130|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
128748495|NCT01490632|463367131|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
128748496|NCT01490632|463367132|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
128748497|NCT01490632|463367133|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
128748498|NCT01490632|463367134|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
128748499|NCT01490632|463367135|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
128748500|NCT01490632|463367136|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
128748501|NCT01490632|463367137|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
128748502|NCT01490632|463367138|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
128748503|NCT01490632|463367139|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
128748504|NCT01490632|463367140|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
128748505|NCT01490632|463367141|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
128748506|NCT01490632|463367122|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748507|NCT01490632|463367123|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748508|NCT01490632|463367124|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748509|NCT01490632|463367125|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748510|NCT01490632|463367126|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748511|NCT01490632|463367127|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748512|NCT01490632|463367128|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748513|NCT01490632|463367129|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748514|NCT01490632|463367130|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748515|NCT01490632|463367131|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748516|NCT01490632|463367132|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748517|NCT01490632|463367133|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748518|NCT01490632|463367134|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128785697|NCT04048135|463507325|FG003|Overall Study|Protocol Violation|0|||
128785698|NCT04048135|463507326|FG004|Overall Study|Protocol Violation|0|||
128785699|NCT04048135|463507327|FG005|Overall Study|Protocol Violation|1|||
128785700|NCT04048135|463507328|FG006|Overall Study|Protocol Violation|0|||
128785701|NCT04048135|463507329|FG007|Overall Study|Protocol Violation|0|||
128785702|NCT00172185|463507330|FG000|Overall Study|Adverse Event|0|||
128748519|NCT01490632|463367135|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748520|NCT01490632|463367136|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748521|NCT01490632|463367137|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748522|NCT01490632|463367138|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
128748523|NCT01490632|463367139|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
128748524|NCT01490632|463367140|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
128748525|NCT01490632|463367141|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
128748526|NCT00856856|463367147|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
128748527|NCT00856856|463367147|FG000|4-year Clinical Follow-up|Missed visit|1|||
128748528|NCT00922428|463367154|FG000|Overall Study|retrospective/extremely implausible data|2|||
128748529|NCT00922428|463367154|FG000|Overall Study|no medication use or questionable use|13|||
128748530|NCT00448539|463367155|FG000|Overall Study|Medication non-compliance|4|||
128748531|NCT00448539|463367156|FG001|Overall Study|Medication non-compliance|1|||
128748532|NCT00448539|463367155|FG000|Overall Study|Protocol Violation|1|||
128748533|NCT00448539|463367156|FG001|Overall Study|Protocol Violation|0|||
128748534|NCT00448539|463367155|FG000|Overall Study|Request of the investigator or sponsor|67|||
128748535|NCT00448539|463367156|FG001|Overall Study|Request of the investigator or sponsor|54|||
128748536|NCT00448539|463367155|FG000|Overall Study|Withdrawal by Subject|20|||
128748537|NCT00448539|463367156|FG001|Overall Study|Withdrawal by Subject|24|||
128748538|NCT00448539|463367155|FG000|Overall Study|Diary non-compliance|1|||
128748539|NCT00448539|463367156|FG001|Overall Study|Diary non-compliance|0|||
128748540|NCT00448539|463367155|FG000|Overall Study|Adverse Event|9|||
128748541|NCT00448539|463367156|FG001|Overall Study|Adverse Event|26|||
128748542|NCT00448539|463367155|FG000|Overall Study|Lack of Efficacy|27|||
128748543|NCT00448539|463367156|FG001|Overall Study|Lack of Efficacy|40|||
128748544|NCT00448539|463367155|FG000|Overall Study|Miscellaneous|2|||
128748545|NCT00448539|463367156|FG001|Overall Study|Miscellaneous|1|||
128748546|NCT00448539|463367155|FG000|Overall Study|Change of meds|2|||
128748547|NCT00448539|463367156|FG001|Overall Study|Change of meds|3|||
128748548|NCT00448539|463367155|FG000|Overall Study|Lost to Follow-up|1|||
128748549|NCT00448539|463367156|FG001|Overall Study|Lost to Follow-up|3|||
128748550|NCT02103439|463367158|FG000|Overall Study|Adverse Event|0|||
128748551|NCT02103439|463367159|FG001|Overall Study|Adverse Event|2|||
128748552|NCT02103439|463367158|FG000|Overall Study|Withdrawal by Subject|3|||
128748553|NCT02103439|463367159|FG001|Overall Study|Withdrawal by Subject|1|||
128748554|NCT02696317|463367160|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
128748555|NCT02696317|463367161|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
128748556|NCT02696317|463367160|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
128748557|NCT02696317|463367161|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
128748558|NCT01343368|463367162|FG000|Overall Study|Death|1|||
128748559|NCT01343368|463367163|FG001|Overall Study|Death|0|||
128748560|NCT01343368|463367162|FG000|Overall Study|Lost to Follow-up|1|||
128748561|NCT01343368|463367163|FG001|Overall Study|Lost to Follow-up|0|||
128748562|NCT04955639|463367164|FG000|Overall Study|Withdrawal by Subject|2|||
128748563|NCT04955639|463367165|FG001|Overall Study|Withdrawal by Subject|2|||
128748564|NCT04955639|463367164|FG000|Overall Study|Week 26 survey not completed|2|||
128748565|NCT04955639|463367165|FG001|Overall Study|Week 26 survey not completed|2|||
128748566|NCT04447404|463367166|FG000|Overall Study|Death|2|||
128748567|NCT04447404|463367167|FG001|Overall Study|Death|0|||
128748568|NCT00321854|463367168|FG000|Overall Study|Adverse Event|41|||
128748569|NCT00321854|463367169|FG001|Overall Study|Adverse Event|43|||
128748570|NCT00321854|463367168|FG000|Overall Study|Lack of Efficacy|9|||
128748571|NCT00321854|463367169|FG001|Overall Study|Lack of Efficacy|14|||
128748572|NCT00321854|463367168|FG000|Overall Study|Protocol Violation|6|||
128748573|NCT00321854|463367169|FG001|Overall Study|Protocol Violation|5|||
128748574|NCT00321854|463367168|FG000|Overall Study|Lost to Follow-up|0|||
128748575|NCT00321854|463367169|FG001|Overall Study|Lost to Follow-up|2|||
128748576|NCT00321854|463367168|FG000|Overall Study|Withdrawal by Subject|6|||
128748577|NCT00321854|463367169|FG001|Overall Study|Withdrawal by Subject|17|||
128748578|NCT00321854|463367168|FG000|Overall Study|Other|1|||
128748579|NCT00321854|463367169|FG001|Overall Study|Other|1|||
128748580|NCT04723576|463367170|FG000|Overall Study|Withdrawal by Subject|2133|||
128748581|NCT04723576|463367171|FG001|Overall Study|Withdrawal by Subject|3234|||
128748582|NCT02384759|463367173|FG000|Overall Study|Patients not treated|3|||
128748583|NCT02384759|463367174|FG001|Overall Study|Patients not treated|2|||
128748584|NCT03043664|463367175|FG000|Overall Study|Lost to Follow-up|1|||
128748585|NCT03759873|463367183|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
128785703|NCT00172185|463507331|FG001|Overall Study|Adverse Event|1|||
128785704|NCT00172185|463507332|FG002|Overall Study|Adverse Event|3|||
128785705|NCT00172185|463507333|FG003|Overall Study|Adverse Event|4|||
128785706|NCT00172185|463507330|FG000|Overall Study|Physician Decision|0|||
128785707|NCT00172185|463507331|FG001|Overall Study|Physician Decision|0|||
128785708|NCT00172185|463507332|FG002|Overall Study|Physician Decision|1|||
128785709|NCT00172185|463507333|FG003|Overall Study|Physician Decision|0|||
128785710|NCT00172185|463507330|FG000|Overall Study|SPONSOR Decision|0|||
128748586|NCT03759873|463367184|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
128748587|NCT03759873|463367185|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
128748588|NCT03759873|463367186|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
128748589|NCT03759873|463367183|FG000|Overall Study|Moved outside eligible area|0|||
128748590|NCT03759873|463367184|FG001|Overall Study|Moved outside eligible area|2|||
128748591|NCT03759873|463367185|FG002|Overall Study|Moved outside eligible area|0|||
128748592|NCT03759873|463367186|FG003|Overall Study|Moved outside eligible area|0|||
128748593|NCT03759873|463367183|FG000|Overall Study|Withdrawal by Subject|0|||
128748594|NCT03759873|463367184|FG001|Overall Study|Withdrawal by Subject|0|||
128748595|NCT03759873|463367185|FG002|Overall Study|Withdrawal by Subject|1|||
128748596|NCT03759873|463367186|FG003|Overall Study|Withdrawal by Subject|0|||
128748597|NCT03579563|463367187|FG000|Overall Study|Lost to Follow-up|0|||
128748598|NCT03579563|463367188|FG001|Overall Study|Lost to Follow-up|0|||
128748599|NCT03579563|463367189|FG002|Overall Study|Lost to Follow-up|0|||
128748600|NCT03579563|463367190|FG003|Overall Study|Lost to Follow-up|0|||
128748601|NCT03579563|463367191|FG004|Overall Study|Lost to Follow-up|1|||
128748602|NCT03579563|463367192|FG005|Overall Study|Lost to Follow-up|0|||
128748603|NCT03579563|463367187|FG000|Overall Study|Lack of Efficacy|1|||
128748604|NCT03579563|463367188|FG001|Overall Study|Lack of Efficacy|1|||
128748605|NCT03579563|463367189|FG002|Overall Study|Lack of Efficacy|4|||
128748606|NCT03579563|463367190|FG003|Overall Study|Lack of Efficacy|1|||
128748607|NCT03579563|463367191|FG004|Overall Study|Lack of Efficacy|2|||
128748608|NCT03579563|463367192|FG005|Overall Study|Lack of Efficacy|3|||
128748609|NCT03579563|463367187|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
128748610|NCT03579563|463367188|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
128748611|NCT03579563|463367189|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
128748612|NCT03579563|463367190|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
128748613|NCT03579563|463367191|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
128748614|NCT03579563|463367192|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
128748615|NCT03579563|463367187|FG000|Overall Study|Time/distance concern|0|||
128748616|NCT03579563|463367188|FG001|Overall Study|Time/distance concern|0|||
128748617|NCT03579563|463367189|FG002|Overall Study|Time/distance concern|1|||
128748618|NCT03579563|463367190|FG003|Overall Study|Time/distance concern|0|||
128748619|NCT03579563|463367191|FG004|Overall Study|Time/distance concern|0|||
128748620|NCT03579563|463367192|FG005|Overall Study|Time/distance concern|1|||
128748621|NCT03579563|463367187|FG000|Overall Study|COVID shutdown|2|||
128748622|NCT03579563|463367188|FG001|Overall Study|COVID shutdown|3|||
128748623|NCT03579563|463367189|FG002|Overall Study|COVID shutdown|4|||
128748624|NCT03579563|463367190|FG003|Overall Study|COVID shutdown|3|||
128748625|NCT03579563|463367191|FG004|Overall Study|COVID shutdown|1|||
128748626|NCT03579563|463367192|FG005|Overall Study|COVID shutdown|2|||
128748627|NCT03579563|463367187|FG000|Overall Study|Protocol administration error|1|||
128748628|NCT03579563|463367188|FG001|Overall Study|Protocol administration error|0|||
128748629|NCT03579563|463367189|FG002|Overall Study|Protocol administration error|1|||
128748630|NCT03579563|463367190|FG003|Overall Study|Protocol administration error|0|||
128748631|NCT03579563|463367191|FG004|Overall Study|Protocol administration error|1|||
128748632|NCT03579563|463367192|FG005|Overall Study|Protocol administration error|5|||
128748633|NCT03526250|463367193|FG000|Overall Study|Adverse Event|4|||
128748634|NCT03526250|463367193|FG000|Overall Study|Progressive Disease|16|||
128748635|NCT03526250|463367193|FG000|Overall Study|No Treatment|3|||
128748636|NCT01618864|463367194|FG000|Overall Study|Withdrawal by Subject|2|||
128748637|NCT01618864|463367194|FG000|Overall Study|Lost to Follow-up|2|||
128748638|NCT01650259|463367204|FG000|Overall Study|Improvement|105|||
128748639|NCT01650259|463367205|FG001|Overall Study|Improvement|0|||
128748640|NCT01650259|463367204|FG000|Overall Study|Adverse Event|127|||
128748641|NCT01650259|463367205|FG001|Overall Study|Adverse Event|0|||
128748642|NCT01650259|463367204|FG000|Overall Study|Lack of Efficacy|143|||
128748643|NCT01650259|463367205|FG001|Overall Study|Lack of Efficacy|0|||
128748644|NCT01650259|463367204|FG000|Overall Study|Lost to Follow-up|435|||
128748645|NCT01650259|463367205|FG001|Overall Study|Lost to Follow-up|0|||
128748646|NCT01650259|463367204|FG000|Overall Study|Patients had no visit after entry|70|||
128748647|NCT01650259|463367205|FG001|Overall Study|Patients had no visit after entry|0|||
128748648|NCT01650259|463367204|FG000|Overall Study|CRF not collected|98|||
128748649|NCT01650259|463367205|FG001|Overall Study|CRF not collected|82|||
128748650|NCT01650259|463367204|FG000|Overall Study|Not treated|1|||
128748651|NCT01650259|463367205|FG001|Overall Study|Not treated|7|||
128748652|NCT01650259|463367204|FG000|Overall Study|Other than listed|64|||
128748653|NCT01650259|463367205|FG001|Overall Study|Other than listed|146|||
128748654|NCT00355082|463367206|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
128748655|NCT00355082|463367207|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
128748656|NCT00355082|463367208|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
128748657|NCT00355082|463367206|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
128748658|NCT00355082|463367207|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
128748659|NCT00355082|463367208|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
128748660|NCT00355082|463367206|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
128748661|NCT00355082|463367207|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
128748662|NCT00355082|463367208|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
128748663|NCT00355082|463367206|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
128748664|NCT00355082|463367207|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
128748665|NCT00355082|463367208|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
128748666|NCT00355082|463367206|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
128748667|NCT00355082|463367207|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
128748668|NCT00355082|463367208|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
128748669|NCT00355082|463367206|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
128748670|NCT00355082|463367207|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
128748671|NCT00355082|463367208|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
128748672|NCT00355082|463367206|FG000|Continuation Phase|Adverse Event|2|||
128748673|NCT00355082|463367207|FG001|Continuation Phase|Adverse Event|0|||
128748674|NCT00355082|463367208|FG002|Continuation Phase|Adverse Event|1|||
128748675|NCT00355082|463367206|FG000|Continuation Phase|Lost to Follow-up|2|||
128748676|NCT00355082|463367207|FG001|Continuation Phase|Lost to Follow-up|0|||
128748677|NCT00355082|463367208|FG002|Continuation Phase|Lost to Follow-up|1|||
128748678|NCT00355082|463367206|FG000|Continuation Phase|Protocol Violation|1|||
128748679|NCT00355082|463367207|FG001|Continuation Phase|Protocol Violation|0|||
128748680|NCT00355082|463367208|FG002|Continuation Phase|Protocol Violation|1|||
128748681|NCT00355082|463367206|FG000|Continuation Phase|Withdrawal by Subject|4|||
128748682|NCT00355082|463367207|FG001|Continuation Phase|Withdrawal by Subject|0|||
128748683|NCT00355082|463367208|FG002|Continuation Phase|Withdrawal by Subject|0|||
128748684|NCT00355082|463367206|FG000|Continuation Phase|Lack of Efficacy|5|||
128748685|NCT00355082|463367207|FG001|Continuation Phase|Lack of Efficacy|0|||
128748686|NCT00355082|463367208|FG002|Continuation Phase|Lack of Efficacy|0|||
128748687|NCT00355082|463367206|FG000|Continuation Phase|Site Closed by Sponsor|8|||
128748688|NCT00355082|463367207|FG001|Continuation Phase|Site Closed by Sponsor|0|||
128748689|NCT00355082|463367208|FG002|Continuation Phase|Site Closed by Sponsor|0|||
128748690|NCT00355082|463367206|FG000|Continuation Phase|Scheduling Error|1|||
128748691|NCT00355082|463367207|FG001|Continuation Phase|Scheduling Error|0|||
128748692|NCT00355082|463367208|FG002|Continuation Phase|Scheduling Error|0|||
128748693|NCT00355082|463367206|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
128748694|NCT00355082|463367207|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
128748695|NCT00355082|463367208|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
128748696|NCT02663128|463367217|FG000|Period 2|Physician Decision|0|||
128748697|NCT02663128|463367218|FG001|Period 2|Physician Decision|0|||
128748698|NCT02663128|463367219|FG002|Period 2|Physician Decision|0|||
128748699|NCT02663128|463367220|FG003|Period 2|Physician Decision|0|||
128748700|NCT02663128|463367221|FG004|Period 2|Physician Decision|1|||
128748701|NCT02663128|463367222|FG005|Period 2|Physician Decision|0|||
128748702|NCT01358526|463367229|FG000|Open-label Titration Period|Adverse Event|95|||
128748703|NCT01358526|463367230|FG001|Open-label Titration Period|Adverse Event|0|||
128748704|NCT01358526|463367231|FG002|Open-label Titration Period|Adverse Event|0|||
128748705|NCT01358526|463367229|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
128748706|NCT01358526|463367230|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
128748707|NCT01358526|463367231|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
128748708|NCT01358526|463367229|FG000|Open-label Titration Period|Lost to Follow-up|25|||
128748709|NCT01358526|463367230|FG001|Open-label Titration Period|Lost to Follow-up|0|||
128748710|NCT01358526|463367231|FG002|Open-label Titration Period|Lost to Follow-up|0|||
128748711|NCT01358526|463367229|FG000|Open-label Titration Period|Lack of Efficacy|107|||
128748712|NCT01358526|463367230|FG001|Open-label Titration Period|Lack of Efficacy|0|||
128748713|NCT01358526|463367231|FG002|Open-label Titration Period|Lack of Efficacy|0|||
128748714|NCT01358526|463367229|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
128748715|NCT01358526|463367230|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
128748716|NCT01358526|463367231|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
128748717|NCT01358526|463367229|FG000|Open-label Titration Period|Administrative|8|||
128748718|NCT01358526|463367230|FG001|Open-label Titration Period|Administrative|0|||
128748719|NCT01358526|463367231|FG002|Open-label Titration Period|Administrative|0|||
128748720|NCT01358526|463367229|FG000|Open-label Titration Period|Did not qualify|178|||
128748721|NCT01358526|463367230|FG001|Open-label Titration Period|Did not qualify|0|||
128748722|NCT01358526|463367231|FG002|Open-label Titration Period|Did not qualify|0|||
128748723|NCT01358526|463367229|FG000|Double-blind Phase|Adverse Event|0|||
128748724|NCT01358526|463367230|FG001|Double-blind Phase|Adverse Event|24|||
128748725|NCT01358526|463367231|FG002|Double-blind Phase|Adverse Event|23|||
128748726|NCT01358526|463367229|FG000|Double-blind Phase|Withdrawal by Subject|0|||
128748727|NCT01358526|463367230|FG001|Double-blind Phase|Withdrawal by Subject|10|||
128748728|NCT01358526|463367231|FG002|Double-blind Phase|Withdrawal by Subject|8|||
128748729|NCT01358526|463367229|FG000|Double-blind Phase|Lost to Follow-up|0|||
128748730|NCT01358526|463367230|FG001|Double-blind Phase|Lost to Follow-up|4|||
128748731|NCT01358526|463367231|FG002|Double-blind Phase|Lost to Follow-up|1|||
128785711|NCT00172185|463507331|FG001|Overall Study|SPONSOR Decision|1|||
128748732|NCT01358526|463367229|FG000|Double-blind Phase|Lack of Efficacy|0|||
128748733|NCT01358526|463367230|FG001|Double-blind Phase|Lack of Efficacy|31|||
128748734|NCT01358526|463367231|FG002|Double-blind Phase|Lack of Efficacy|73|||
128748735|NCT01358526|463367229|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
128748736|NCT01358526|463367230|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
128748737|NCT01358526|463367231|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
128748738|NCT01358526|463367229|FG000|Double-blind Phase|Administrative|0|||
128748739|NCT01358526|463367230|FG001|Double-blind Phase|Administrative|6|||
128748740|NCT01358526|463367231|FG002|Double-blind Phase|Administrative|10|||
128748741|NCT03277313|463367243|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
128748742|NCT03277313|463367244|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
128748743|NCT03277313|463367243|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
128748744|NCT03277313|463367244|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
128748745|NCT03277313|463367243|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
128748746|NCT03277313|463367244|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
128748747|NCT03277313|463367243|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
128748748|NCT03277313|463367244|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
128748749|NCT03277313|463367243|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
128748750|NCT03277313|463367244|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
128748751|NCT02132611|463367247|FG000|Overall Study|Death|2|||
128748752|NCT02194621|463367249|FG000|Overall Study|6 withdrew prior to randomization|2|||
128748753|NCT02194621|463367250|FG001|Overall Study|6 withdrew prior to randomization|2|||
128748754|NCT02194621|463367251|FG002|Overall Study|6 withdrew prior to randomization|2|||
128748755|NCT02194621|463367249|FG000|Overall Study|Withdrawal by Subject|4|||
128748756|NCT02194621|463367250|FG001|Overall Study|Withdrawal by Subject|4|||
128748757|NCT02194621|463367251|FG002|Overall Study|Withdrawal by Subject|7|||
128748758|NCT02763384|463367259|FG000|Overall Study|Physician Decision|1|||
128748759|NCT02763384|463367259|FG000|Overall Study|Rapid decline - went on hospice|1|||
128748760|NCT02493127|463367260|FG000|Overall Study|Lost to Follow-up|1|||
128748761|NCT02493127|463367261|FG001|Overall Study|Lost to Follow-up|1|||
128748762|NCT03034577|463367265|FG000|Overall Study|Withdrawal by Subject|6|||
128748763|NCT03034577|463367266|FG001|Overall Study|Withdrawal by Subject|9|||
128748764|NCT03034577|463367265|FG000|Overall Study|Lost to Follow-up|25|||
128748765|NCT03034577|463367266|FG001|Overall Study|Lost to Follow-up|26|||
128748766|NCT00660010|463367269|FG000|Overall Study|Withdrawal by Subject|2|||
128748767|NCT00660010|463367269|FG000|Overall Study|Lost to Follow-up|3|||
128748768|NCT00660010|463367269|FG000|Overall Study|Adverse Event|1|||
128748769|NCT00660010|463367269|FG000|Overall Study|Noncompliance with visit schedule|3|||
128748770|NCT03069482|463368680|FG000|Overall Study|Lost to Follow-up|0|||
128748771|NCT03069482|463368681|FG001|Overall Study|Lost to Follow-up|1|||
128748772|NCT03069482|463368680|FG000|Overall Study|Physician Decision|1|||
128748773|NCT03069482|463368681|FG001|Overall Study|Physician Decision|0|||
128748774|NCT00791765|463368682|FG000|Weeks 1 to 12|Adverse Event|0|||
128748775|NCT00791765|463368683|FG001|Weeks 1 to 12|Adverse Event|1|||
128748776|NCT00791765|463368682|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
128748777|NCT00791765|463368683|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
128748778|NCT00791765|463368682|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
128748779|NCT00791765|463368683|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
128748780|NCT00791765|463368682|FG000|Weeks 1 to 12|Physician Decision|1|||
128748781|NCT00791765|463368683|FG001|Weeks 1 to 12|Physician Decision|0|||
128748782|NCT00791765|463368682|FG000|Weeks 1 to 12|Disease progression|3|||
128748783|NCT00791765|463368683|FG001|Weeks 1 to 12|Disease progression|0|||
128748784|NCT00791765|463368682|FG000|Weeks 1 to 12|Ineligibility determined|0|||
128748785|NCT00791765|463368683|FG001|Weeks 1 to 12|Ineligibility determined|3|||
128748786|NCT00791765|463368682|FG000|Weeks 13 to 24|Protocol deviation|2|||
128748787|NCT00791765|463368683|FG001|Weeks 13 to 24|Protocol deviation|0|||
128748788|NCT00791765|463368682|FG000|Weeks 13 to 24|Adverse Event|0|||
128748789|NCT00791765|463368683|FG001|Weeks 13 to 24|Adverse Event|3|||
128748790|NCT00791765|463368682|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
128748791|NCT00791765|463368683|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
128748792|NCT00791765|463368682|FG000|Weeks 13 to 24|Disease progression|0|||
128748793|NCT00791765|463368683|FG001|Weeks 13 to 24|Disease progression|1|||
128748794|NCT00791765|463368682|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
128748795|NCT00791765|463368683|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
128748796|NCT00791765|463368682|FG000|Weeks 13 to 24|Other|0|||
128748797|NCT00791765|463368683|FG001|Weeks 13 to 24|Other|1|||
128748798|NCT01877408|463368694|FG000|Overall Study|Lost to Follow-up|0|||
128748799|NCT01877408|463368695|FG001|Overall Study|Lost to Follow-up|2|||
128748800|NCT00156065|463368696|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
128748801|NCT00156065|463368697|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
128748802|NCT00156065|463368698|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
128748803|NCT00156065|463368696|FG000|Overall Study|Adverse Event|8|||
128748804|NCT00156065|463368697|FG001|Overall Study|Adverse Event|11|||
128748805|NCT00156065|463368698|FG002|Overall Study|Adverse Event|4|||
128748806|NCT00156065|463368696|FG000|Overall Study|Lack of Efficacy|2|||
128748807|NCT00156065|463368697|FG001|Overall Study|Lack of Efficacy|9|||
128748808|NCT00156065|463368698|FG002|Overall Study|Lack of Efficacy|3|||
128748809|NCT00156065|463368696|FG000|Overall Study|Withdrawal by Subject|13|||
128748810|NCT00156065|463368697|FG001|Overall Study|Withdrawal by Subject|26|||
128748811|NCT00156065|463368698|FG002|Overall Study|Withdrawal by Subject|16|||
128748812|NCT00156065|463368696|FG000|Overall Study|Lost to Follow-up|5|||
128748813|NCT00156065|463368697|FG001|Overall Study|Lost to Follow-up|7|||
128748814|NCT00156065|463368698|FG002|Overall Study|Lost to Follow-up|1|||
128748815|NCT00156065|463368696|FG000|Overall Study|Other|2|||
128748816|NCT00156065|463368697|FG001|Overall Study|Other|9|||
128748817|NCT00156065|463368698|FG002|Overall Study|Other|3|||
128748818|NCT00920426|463368699|FG000|ITZ111451|Adverse Event|1|||
128748819|NCT00920426|463368700|FG001|ITZ111451|Adverse Event|0|||
128748820|NCT00920426|463368701|FG002|ITZ111451|Adverse Event|0|||
128748821|NCT00920426|463368702|FG003|ITZ111451|Adverse Event|0|||
128748822|NCT01292603|463368703|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
128748823|NCT01292603|463368704|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
128748824|NCT01292603|463368705|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
128748825|NCT01292603|463368706|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
128748826|NCT01292603|463368707|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
128748827|NCT01292603|463368708|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
128748828|NCT01292603|463368703|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
128748829|NCT01292603|463368704|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
128748830|NCT01292603|463368705|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
128748831|NCT01292603|463368706|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
128748832|NCT01292603|463368707|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
128748833|NCT01292603|463368708|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
128748834|NCT01292603|463368703|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
128748835|NCT01292603|463368704|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
128748836|NCT01292603|463368705|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
128748837|NCT01292603|463368706|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
128748838|NCT01292603|463368707|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
128748839|NCT01292603|463368708|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
128748840|NCT01292603|463368703|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
128748841|NCT01292603|463368704|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
128748842|NCT01292603|463368705|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
128748843|NCT01292603|463368706|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
128748844|NCT01292603|463368707|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
128748845|NCT01292603|463368708|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
128748846|NCT01292603|463368703|FG000|Part 1: Regular Follow-Up Period|Death|3|||
128748847|NCT01292603|463368704|FG001|Part 1: Regular Follow-Up Period|Death|1|||
128748848|NCT01292603|463368705|FG002|Part 1: Regular Follow-Up Period|Death|3|||
128748849|NCT01292603|463368706|FG003|Part 1: Regular Follow-Up Period|Death|1|||
128748850|NCT01292603|463368707|FG004|Part 1: Regular Follow-Up Period|Death|0|||
128748851|NCT01292603|463368708|FG005|Part 1: Regular Follow-Up Period|Death|0|||
128748852|NCT01292603|463368703|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
128748853|NCT01292603|463368704|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
128748854|NCT01292603|463368705|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
128748855|NCT01292603|463368706|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
128748856|NCT01292603|463368707|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
128748857|NCT01292603|463368708|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
128748858|NCT01292603|463368703|FG000|Part 2: Dose Confirmation Period|Death|0|||
128748859|NCT01292603|463368704|FG001|Part 2: Dose Confirmation Period|Death|0|||
128748860|NCT01292603|463368705|FG002|Part 2: Dose Confirmation Period|Death|0|||
128748861|NCT01292603|463368706|FG003|Part 2: Dose Confirmation Period|Death|0|||
128748862|NCT01292603|463368707|FG004|Part 2: Dose Confirmation Period|Death|1|||
128748863|NCT01292603|463368708|FG005|Part 2: Dose Confirmation Period|Death|0|||
128748864|NCT01292603|463368703|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
128748865|NCT01292603|463368704|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
128748866|NCT01292603|463368705|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
128748867|NCT01292603|463368706|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
128748868|NCT01292603|463368707|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
128748869|NCT01292603|463368708|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
128748870|NCT01292603|463368703|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
128748871|NCT01292603|463368704|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
128748872|NCT01292603|463368705|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
128748873|NCT01292603|463368706|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
128748874|NCT01292603|463368707|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
128748875|NCT01292603|463368708|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
128748876|NCT01292603|463368703|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
128748877|NCT01292603|463368704|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
128748878|NCT01292603|463368705|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
128785712|NCT00172185|463507332|FG002|Overall Study|SPONSOR Decision|0|||
128748879|NCT01292603|463368706|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
128748880|NCT01292603|463368707|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
128748881|NCT01292603|463368708|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
128748882|NCT01292603|463368703|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
128748883|NCT01292603|463368704|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
128748884|NCT01292603|463368705|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
128748885|NCT01292603|463368706|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
128748886|NCT01292603|463368707|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
128748887|NCT01292603|463368708|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
128748888|NCT01292603|463368703|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
128748889|NCT01292603|463368704|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
128748890|NCT01292603|463368705|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
128748891|NCT01292603|463368706|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
128748892|NCT01292603|463368707|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
128748893|NCT01292603|463368708|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
128748894|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Death|0|||
128748895|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Death|0|||
128748896|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Death|0|||
128748897|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Death|0|||
128748898|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Death|6|||
128748899|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Death|3|||
128748900|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
128748901|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
128748902|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
128748903|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
128748904|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
128748905|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
128748906|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
128748907|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
128748908|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
128748909|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
128748910|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
128748911|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
128748912|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
128748913|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
128748914|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
128748915|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
128748916|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
128748917|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
128748918|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
128748919|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
128748920|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
128748921|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
128748922|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
128748923|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
128748924|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
128748925|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
128748926|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
128748927|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
128748928|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
128748929|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
128748930|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
128748931|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
128748932|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
128748933|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
128748934|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
128748935|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
128748936|NCT01292603|463368703|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
128748937|NCT01292603|463368704|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
128748938|NCT01292603|463368705|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
128748939|NCT01292603|463368706|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
128748940|NCT01292603|463368707|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
128748941|NCT01292603|463368708|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
128748942|NCT01292603|463368703|FG000|Overall Survival Status|Death|3|||
128748943|NCT01292603|463368704|FG001|Overall Survival Status|Death|1|||
128785713|NCT00172185|463507333|FG003|Overall Study|SPONSOR Decision|0|||
128748944|NCT01292603|463368705|FG002|Overall Survival Status|Death|3|||
128748945|NCT01292603|463368706|FG003|Overall Survival Status|Death|1|||
128748946|NCT01292603|463368707|FG004|Overall Survival Status|Death|16|||
128748947|NCT01292603|463368708|FG005|Overall Survival Status|Death|10|||
128748948|NCT01432366|463368711|FG000|Overall Study|Non-Responder|7|||
128748949|NCT01432366|463368711|FG000|Overall Study|Adverse Event|8|||
128748950|NCT01432366|463368711|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
128748951|NCT01432366|463368711|FG000|Overall Study|Pregnancy|1|||
128748952|NCT01432366|463368711|FG000|Overall Study|Lost to Follow-up|13|||
128748953|NCT01432366|463368711|FG000|Overall Study|Lack of Efficacy|1|||
128748954|NCT01432366|463368711|FG000|Overall Study|Site Closed|20|||
128748955|NCT01432366|463368711|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
128748956|NCT01432366|463368711|FG000|Overall Study|Other|14|||
128748957|NCT01808690|463368712|FG000|Overall Study|Withdrawal by Subject|1|||
128748958|NCT01808690|463368713|FG001|Overall Study|Withdrawal by Subject|2|||
128748959|NCT03870763|463368714|FG000|Overall Study|Study terminated by sponsor|0|||
128748960|NCT03870763|463368715|FG001|Overall Study|Study terminated by sponsor|2|||
128748961|NCT03870763|463368716|FG002|Overall Study|Study terminated by sponsor|0|||
128748962|NCT03870763|463368714|FG000|Overall Study|Withdrawal by Subject|0|||
128748963|NCT03870763|463368715|FG001|Overall Study|Withdrawal by Subject|1|||
128748964|NCT03870763|463368716|FG002|Overall Study|Withdrawal by Subject|0|||
128748965|NCT03870763|463368714|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
128748966|NCT03870763|463368715|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
128748967|NCT03870763|463368716|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
128748968|NCT03586648|463368719|FG000|Period 1|Withdrawal by Subject|0|||
128748969|NCT03586648|463368720|FG001|Period 1|Withdrawal by Subject|1|||
128748970|NCT03586648|463368719|FG000|Period 1|Lost to Follow-up|1|||
128748971|NCT03586648|463368720|FG001|Period 1|Lost to Follow-up|1|||
128748972|NCT03586648|463368719|FG000|Period 1|Adverse Event|1|||
128748973|NCT03586648|463368720|FG001|Period 1|Adverse Event|0|||
128748974|NCT03586648|463368719|FG000|Period 1|Study related symptoms or complaints|2|||
128748975|NCT03586648|463368720|FG001|Period 1|Study related symptoms or complaints|1|||
128748976|NCT03586648|463368719|FG000|Period 1|Physician Decision|0|||
128748977|NCT03586648|463368720|FG001|Period 1|Physician Decision|1|||
128748978|NCT03586648|463368719|FG000|Period 2|Adverse Event|1|||
128748979|NCT03586648|463368720|FG001|Period 2|Adverse Event|0|||
128748980|NCT00377234|463368725|FG000|Overall Study|Adverse Event|14|||
128748981|NCT00377234|463368726|FG001|Overall Study|Adverse Event|17|||
128748982|NCT00377234|463368725|FG000|Overall Study|Withdrawal by Subject|11|||
128748983|NCT00377234|463368726|FG001|Overall Study|Withdrawal by Subject|9|||
128748984|NCT00377234|463368725|FG000|Overall Study|Lost to Follow-up|4|||
128748985|NCT00377234|463368726|FG001|Overall Study|Lost to Follow-up|2|||
128748986|NCT00377234|463368725|FG000|Overall Study|Administrative|2|||
128748987|NCT00377234|463368726|FG001|Overall Study|Administrative|1|||
128748988|NCT00377234|463368725|FG000|Overall Study|Not assigned|3|||
128748989|NCT00377234|463368726|FG001|Overall Study|Not assigned|2|||
128748990|NCT01880424|463368727|FG000|Overall Study|Adverse Event|7|||
128748991|NCT01880424|463368728|FG001|Overall Study|Adverse Event|6|||
128748992|NCT01880424|463368727|FG000|Overall Study|Lack of Efficacy|1|||
128748993|NCT01880424|463368728|FG001|Overall Study|Lack of Efficacy|4|||
128748994|NCT01880424|463368727|FG000|Overall Study|Lost to Follow-up|3|||
128748995|NCT01880424|463368728|FG001|Overall Study|Lost to Follow-up|2|||
128748996|NCT01880424|463368727|FG000|Overall Study|Protocol Violation|11|||
128748997|NCT01880424|463368728|FG001|Overall Study|Protocol Violation|13|||
128748998|NCT01880424|463368727|FG000|Overall Study|Withdrawal by Subject|10|||
128748999|NCT01880424|463368728|FG001|Overall Study|Withdrawal by Subject|30|||
128749000|NCT01880424|463368727|FG000|Overall Study|Other|1|||
128749001|NCT01880424|463368728|FG001|Overall Study|Other|0|||
128749002|NCT00907153|463368729|FG000|Overall Study|Lost to Follow-up|1|||
128749003|NCT00907153|463368730|FG001|Overall Study|Lost to Follow-up|1|||
128749004|NCT00907153|463368729|FG000|Overall Study|Withdrawal by Subject|1|||
128749005|NCT00907153|463368730|FG001|Overall Study|Withdrawal by Subject|3|||
128749006|NCT03147248|463368731|FG000|Overall Study|Adverse Event|0|||
128749007|NCT03147248|463368732|FG001|Overall Study|Adverse Event|2|||
128749008|NCT03147248|463368733|FG002|Overall Study|Adverse Event|2|||
128749009|NCT03147248|463368734|FG003|Overall Study|Adverse Event|2|||
128749010|NCT03147248|463368735|FG004|Overall Study|Adverse Event|6|||
128749011|NCT03147248|463368736|FG005|Overall Study|Adverse Event|11|||
128749012|NCT03147248|463368731|FG000|Overall Study|Disease progression|1|||
128749013|NCT03147248|463368732|FG001|Overall Study|Disease progression|0|||
128749014|NCT03147248|463368733|FG002|Overall Study|Disease progression|0|||
128749015|NCT03147248|463368734|FG003|Overall Study|Disease progression|0|||
128749016|NCT03147248|463368735|FG004|Overall Study|Disease progression|0|||
128749017|NCT03147248|463368736|FG005|Overall Study|Disease progression|2|||
128749018|NCT03147248|463368731|FG000|Overall Study|Withdrawal by Subject|0|||
128749019|NCT03147248|463368732|FG001|Overall Study|Withdrawal by Subject|0|||
128749020|NCT03147248|463368733|FG002|Overall Study|Withdrawal by Subject|0|||
128749021|NCT03147248|463368734|FG003|Overall Study|Withdrawal by Subject|0|||
128749022|NCT03147248|463368735|FG004|Overall Study|Withdrawal by Subject|12|||
128749023|NCT03147248|463368736|FG005|Overall Study|Withdrawal by Subject|9|||
128749024|NCT03147248|463368731|FG000|Overall Study|Protocol Violation|0|||
128749025|NCT03147248|463368732|FG001|Overall Study|Protocol Violation|0|||
128749026|NCT03147248|463368733|FG002|Overall Study|Protocol Violation|0|||
128749027|NCT03147248|463368734|FG003|Overall Study|Protocol Violation|0|||
128749028|NCT03147248|463368735|FG004|Overall Study|Protocol Violation|2|||
128749029|NCT03147248|463368736|FG005|Overall Study|Protocol Violation|0|||
128749030|NCT03147248|463368731|FG000|Overall Study|Lost to Follow-up|0|||
128749031|NCT03147248|463368732|FG001|Overall Study|Lost to Follow-up|0|||
128749032|NCT03147248|463368733|FG002|Overall Study|Lost to Follow-up|0|||
128749033|NCT03147248|463368734|FG003|Overall Study|Lost to Follow-up|0|||
128749034|NCT03147248|463368735|FG004|Overall Study|Lost to Follow-up|2|||
128749035|NCT03147248|463368736|FG005|Overall Study|Lost to Follow-up|0|||
128749036|NCT03147248|463368731|FG000|Overall Study|Pregnancy|0|||
128749037|NCT03147248|463368732|FG001|Overall Study|Pregnancy|0|||
128749038|NCT03147248|463368733|FG002|Overall Study|Pregnancy|0|||
128749039|NCT03147248|463368734|FG003|Overall Study|Pregnancy|0|||
128749040|NCT03147248|463368735|FG004|Overall Study|Pregnancy|1|||
128749041|NCT03147248|463368736|FG005|Overall Study|Pregnancy|0|||
128749042|NCT03147248|463368731|FG000|Overall Study|Death|0|||
128749043|NCT03147248|463368732|FG001|Overall Study|Death|0|||
128749044|NCT03147248|463368733|FG002|Overall Study|Death|0|||
128749045|NCT03147248|463368734|FG003|Overall Study|Death|0|||
128749046|NCT03147248|463368735|FG004|Overall Study|Death|0|||
128749047|NCT03147248|463368736|FG005|Overall Study|Death|4|||
128749048|NCT03147248|463368731|FG000|Overall Study|Physician Decision|0|||
128749049|NCT03147248|463368732|FG001|Overall Study|Physician Decision|0|||
128749050|NCT03147248|463368733|FG002|Overall Study|Physician Decision|0|||
128749051|NCT03147248|463368734|FG003|Overall Study|Physician Decision|0|||
128749052|NCT03147248|463368735|FG004|Overall Study|Physician Decision|2|||
128749053|NCT03147248|463368736|FG005|Overall Study|Physician Decision|4|||
128749054|NCT03147248|463368731|FG000|Overall Study|Prolonged Dosing Interval|0|||
128749055|NCT03147248|463368732|FG001|Overall Study|Prolonged Dosing Interval|0|||
128749056|NCT03147248|463368733|FG002|Overall Study|Prolonged Dosing Interval|0|||
128749057|NCT03147248|463368734|FG003|Overall Study|Prolonged Dosing Interval|0|||
128749058|NCT03147248|463368735|FG004|Overall Study|Prolonged Dosing Interval|1|||
128749059|NCT03147248|463368736|FG005|Overall Study|Prolonged Dosing Interval|1|||
128749060|NCT02388724|463368739|FG000|Overall Study|Reason not Specified|0|||
128749061|NCT02388724|463368740|FG001|Overall Study|Reason not Specified|1|||
128749062|NCT02388724|463368739|FG000|Overall Study|Major Protocol Deviation|3|||
128749063|NCT02388724|463368740|FG001|Overall Study|Major Protocol Deviation|3|||
128749064|NCT02388724|463368739|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
128749065|NCT02388724|463368740|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
128749066|NCT02388724|463368739|FG000|Overall Study|Voluntary Withdrawal|6|||
128749067|NCT02388724|463368740|FG001|Overall Study|Voluntary Withdrawal|5|||
128749068|NCT02388724|463368739|FG000|Overall Study|Randomized but not Treated|0|||
128749069|NCT02388724|463368740|FG001|Overall Study|Randomized but not Treated|2|||
128749070|NCT02605954|463368741|FG000|Overall Study|Adverse Event|5|||
128749071|NCT02605954|463368742|FG001|Overall Study|Adverse Event|1|||
128749072|NCT02605954|463368741|FG000|Overall Study|Investigator's Discretion|1|||
128749073|NCT02605954|463368742|FG001|Overall Study|Investigator's Discretion|0|||
128749074|NCT02605954|463368741|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128749075|NCT02605954|463368742|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128749076|NCT02605954|463368741|FG000|Overall Study|Withdrew Consent|2|||
128749077|NCT02605954|463368742|FG001|Overall Study|Withdrew Consent|2|||
128749078|NCT02605954|463368741|FG000|Overall Study|Lost to Follow-up|3|||
128749079|NCT02605954|463368742|FG001|Overall Study|Lost to Follow-up|0|||
128749080|NCT02605954|463368741|FG000|Overall Study|Randomized but not treated|0|||
128749081|NCT02605954|463368742|FG001|Overall Study|Randomized but not treated|1|||
128749082|NCT04969250|463368745|FG000|Overall Study|Protocol Violation|0|||
128749083|NCT04969250|463368746|FG001|Overall Study|Protocol Violation|2|||
128749084|NCT04969250|463368747|FG002|Overall Study|Protocol Violation|3|||
128749085|NCT04969250|463368748|FG003|Overall Study|Protocol Violation|8|||
128749086|NCT04969250|463368745|FG000|Overall Study|Withdrawal by Subject|0|||
128749087|NCT04969250|463368746|FG001|Overall Study|Withdrawal by Subject|1|||
128749088|NCT04969250|463368747|FG002|Overall Study|Withdrawal by Subject|0|||
128749089|NCT04969250|463368748|FG003|Overall Study|Withdrawal by Subject|0|||
128749090|NCT00130533|463368751|FG000|Overall Study|Withdrawal by Subject|33|||
128749091|NCT00130533|463368752|FG001|Overall Study|Withdrawal by Subject|6|||
128749092|NCT00130533|463368751|FG000|Overall Study|Adverse Event|34|||
128749093|NCT00130533|463368752|FG001|Overall Study|Adverse Event|1|||
128749094|NCT00130533|463368751|FG000|Overall Study|Disease relapse|9|||
128749095|NCT00130533|463368752|FG001|Overall Study|Disease relapse|13|||
128749096|NCT00130533|463368751|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
128749097|NCT00130533|463368752|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
128749098|NCT00130533|463368751|FG000|Overall Study|Death|4|||
128749099|NCT00130533|463368752|FG001|Overall Study|Death|2|||
128749100|NCT00130533|463368751|FG000|Overall Study|Protocol Violation|5|||
128749101|NCT00130533|463368752|FG001|Overall Study|Protocol Violation|1|||
128749102|NCT00130533|463368751|FG000|Overall Study|Lost to Follow-up|1|||
128749103|NCT00130533|463368752|FG001|Overall Study|Lost to Follow-up|1|||
128749104|NCT00130533|463368751|FG000|Overall Study|Sponsor´s decision|2|||
128749105|NCT00130533|463368752|FG001|Overall Study|Sponsor´s decision|0|||
128749106|NCT00130533|463368751|FG000|Overall Study|Second Primary Malignancy|0|||
128749107|NCT00130533|463368752|FG001|Overall Study|Second Primary Malignancy|1|||
128749108|NCT00130533|463368751|FG000|Overall Study|Other|12|||
128749109|NCT00130533|463368752|FG001|Overall Study|Other|5|||
128749110|NCT01059565|463368753|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
128749111|NCT01059565|463368754|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
128749112|NCT01059565|463368753|FG000|24-Week Randomized Phase|Adverse Event|5|||
128749113|NCT01059565|463368754|FG001|24-Week Randomized Phase|Adverse Event|0|||
128749114|NCT01059565|463368753|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
128749115|NCT01059565|463368754|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
128749116|NCT01059565|463368753|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
128749117|NCT01059565|463368754|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
128749118|NCT01059565|463368753|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
128749119|NCT01059565|463368754|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
128749120|NCT01059565|463368753|FG000|24-Week Open-Label Phase|Adverse Event|2|||
128749121|NCT01059565|463368754|FG001|24-Week Open-Label Phase|Adverse Event|0|||
128749122|NCT01059565|463368753|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
128749123|NCT01059565|463368754|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
128749124|NCT01059565|463368753|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
128749125|NCT01059565|463368754|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
128749126|NCT01059565|463368753|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
128749127|NCT01059565|463368754|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
128749128|NCT01059565|463368753|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
128749129|NCT01059565|463368754|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
128749130|NCT01059565|463368753|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
128749131|NCT01059565|463368754|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
128749132|NCT03263429|463368759|FG000|Overall Study|Withdrawal by Subject|0|||
128749133|NCT03263429|463368760|FG001|Overall Study|Withdrawal by Subject|1|||
128749134|NCT03263429|463368761|FG002|Overall Study|Withdrawal by Subject|0|||
128749135|NCT03263429|463368759|FG000|Overall Study|Follow-Up Period Completed|0|||
128749136|NCT03263429|463368760|FG001|Overall Study|Follow-Up Period Completed|2|||
128749137|NCT03263429|463368761|FG002|Overall Study|Follow-Up Period Completed|0|||
128749138|NCT03263429|463368759|FG000|Overall Study|Death|3|||
128749139|NCT03263429|463368760|FG001|Overall Study|Death|5|||
128749140|NCT03263429|463368761|FG002|Overall Study|Death|16|||
128749141|NCT03263429|463368759|FG000|Overall Study|Participant unable to return|0|||
128749142|NCT03263429|463368760|FG001|Overall Study|Participant unable to return|0|||
128749143|NCT03263429|463368761|FG002|Overall Study|Participant unable to return|1|||
128749144|NCT03263429|463368759|FG000|Overall Study|Study Closed|0|||
128749145|NCT03263429|463368760|FG001|Overall Study|Study Closed|0|||
128749146|NCT03263429|463368761|FG002|Overall Study|Study Closed|1|||
128749147|NCT01605617|463368762|FG000|First Intervention|Adverse Event|0|||
128749148|NCT01605617|463368763|FG001|First Intervention|Adverse Event|1|||
128749149|NCT01605617|463368762|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
128749150|NCT01605617|463368763|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
128749151|NCT03638141|463368764|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
128749152|NCT02647359|463368768|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
128749153|NCT02647359|463368769|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
128749154|NCT02647359|463368768|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
128749155|NCT02647359|463368769|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
128749156|NCT02647359|463368768|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
128749157|NCT02647359|463368769|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
128749158|NCT02647359|463368768|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
128749159|NCT02647359|463368769|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
128749160|NCT02647359|463368768|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
128749161|NCT02647359|463368769|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
128749162|NCT02647359|463368768|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
128749163|NCT02647359|463368769|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
128749164|NCT02513563|463368770|FG000|Overall Study|Death|4|||
128749165|NCT02513563|463368770|FG000|Overall Study|Withdrawal by Subject|4|||
128749166|NCT02513563|463368770|FG000|Overall Study|Physician Decision|1|||
128749167|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
128749168|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
128749169|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
128749170|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
128749171|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
128749172|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
128749173|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
128749174|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
128749175|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
128749176|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
128749177|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
128749178|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
128749179|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
128749180|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
128749181|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
128749182|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
128749183|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
128749184|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
128749185|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
128749186|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
128749187|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
128749188|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
128749189|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
128749190|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
128749191|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
128749192|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
128749193|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
128749194|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
128749195|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
128749196|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
128749197|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
128749198|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
128749199|NCT04818346|463368775|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
128749200|NCT04818346|463368776|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
128749201|NCT04818346|463368777|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
128749202|NCT04818346|463368778|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
128749203|NCT04818346|463368775|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
128749204|NCT04818346|463368776|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
128749205|NCT04818346|463368777|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
128749206|NCT04818346|463368778|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
128749207|NCT04818346|463368775|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
128749208|NCT04818346|463368776|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
128749209|NCT04818346|463368777|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
128749210|NCT04818346|463368778|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
128749211|NCT04818346|463368775|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
128749212|NCT04818346|463368776|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
128749213|NCT04818346|463368777|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
128749214|NCT04818346|463368778|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
128749215|NCT04818346|463368775|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
128749216|NCT04818346|463368776|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
128749217|NCT04818346|463368777|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
128749218|NCT04818346|463368778|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
128749219|NCT04818346|463368775|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
128749220|NCT04818346|463368776|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
128749221|NCT04818346|463368777|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
128749222|NCT04818346|463368778|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
128749223|NCT04818346|463368775|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
128749224|NCT04818346|463368776|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
128749225|NCT04818346|463368777|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
128749226|NCT04818346|463368778|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
128749227|NCT01672801|463368779|FG000|Overall Study|Screen Failure|0|||
128749228|NCT01672801|463368780|FG001|Overall Study|Screen Failure|1|||
128749229|NCT01362140|463368781|FG000|Overall Study|Noncompliance|1|||
128749230|NCT01362140|463368782|FG001|Overall Study|Noncompliance|0|||
128749231|NCT01362140|463368781|FG000|Overall Study|Adverse Event|2|||
128749232|NCT01362140|463368782|FG001|Overall Study|Adverse Event|2|||
128749233|NCT01362140|463368781|FG000|Overall Study|Withdrawal by Subject|3|||
128749234|NCT01362140|463368782|FG001|Overall Study|Withdrawal by Subject|3|||
128749235|NCT01362140|463368781|FG000|Overall Study|Administrative Decision|0|||
128749236|NCT01362140|463368782|FG001|Overall Study|Administrative Decision|1|||
128749237|NCT01362140|463368781|FG000|Overall Study|Death|2|||
128749238|NCT01362140|463368782|FG001|Overall Study|Death|1|||
128749239|NCT01362140|463368781|FG000|Overall Study|Other|1|||
128749240|NCT01362140|463368782|FG001|Overall Study|Other|1|||
128749241|NCT01362140|463368781|FG000|Overall Study|Protocol-specified Criteria|1|||
128749242|NCT01362140|463368782|FG001|Overall Study|Protocol-specified Criteria|2|||
128749243|NCT01362140|463368781|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
128749244|NCT01362140|463368782|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
128749245|NCT00492284|463368784|FG000|Overall Study|Adverse Event|0|||
128749246|NCT00492284|463368785|FG001|Overall Study|Adverse Event|1|||
128749247|NCT00492284|463368786|FG002|Overall Study|Adverse Event|1|||
128749248|NCT00492284|463368787|FG003|Overall Study|Adverse Event|2|||
128749249|NCT00492284|463368784|FG000|Overall Study|Lost to Follow-up|0|||
128749250|NCT00492284|463368785|FG001|Overall Study|Lost to Follow-up|0|||
128749251|NCT00492284|463368786|FG002|Overall Study|Lost to Follow-up|3|||
128749252|NCT00492284|463368787|FG003|Overall Study|Lost to Follow-up|1|||
128749253|NCT00492284|463368784|FG000|Overall Study|Death|0|||
128749254|NCT00492284|463368785|FG001|Overall Study|Death|3|||
128749255|NCT00492284|463368786|FG002|Overall Study|Death|2|||
128749256|NCT00492284|463368787|FG003|Overall Study|Death|5|||
128749257|NCT00492284|463368784|FG000|Overall Study|Withdrawal by Subject|1|||
128749258|NCT00492284|463368785|FG001|Overall Study|Withdrawal by Subject|0|||
128749259|NCT00492284|463368786|FG002|Overall Study|Withdrawal by Subject|0|||
128785714|NCT00172185|463507330|FG000|Overall Study|Withdrawal by Subject|0|||
128785715|NCT00172185|463507331|FG001|Overall Study|Withdrawal by Subject|0|||
128749260|NCT00492284|463368787|FG003|Overall Study|Withdrawal by Subject|2|||
128749261|NCT06476366|463368788|FG000|Overall Study|Lost to Follow-up|1|||
128749262|NCT06476366|463368789|FG001|Overall Study|Lost to Follow-up|3|||
128749263|NCT06476366|463368788|FG000|Overall Study|Adverse Event|1|||
128749264|NCT06476366|463368789|FG001|Overall Study|Adverse Event|0|||
128749265|NCT04598152|463368793|FG000|Overall Study|Lost to Follow-up|0|||
128749266|NCT04598152|463368794|FG001|Overall Study|Lost to Follow-up|1|||
128749267|NCT03346759|463368795|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
128749268|NCT03346759|463368796|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
128749269|NCT03346759|463368795|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
128749270|NCT03346759|463368796|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
128749271|NCT03346759|463368795|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
128749272|NCT03346759|463368796|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
128749273|NCT02096900|463368797|FG000|Overall Study|Did not receive medication|3|||
128749274|NCT02096900|463368798|FG001|Overall Study|Did not receive medication|1|||
128749275|NCT02096900|463368797|FG000|Overall Study|Surgery cancelled- medication received|1|||
128749276|NCT02096900|463368798|FG001|Overall Study|Surgery cancelled- medication received|1|||
128749277|NCT01128413|463368801|FG000|Overall Study|Withdrawal by Subject|1|||
128749278|NCT01128413|463368802|FG001|Overall Study|Withdrawal by Subject|0|||
128749279|NCT01128413|463368801|FG000|Overall Study|NICOM Monitor Problems|2|||
128749280|NCT01128413|463368802|FG001|Overall Study|NICOM Monitor Problems|1|||
128749281|NCT01128413|463368801|FG000|Overall Study|Pt made DNR|1|||
128749282|NCT01128413|463368802|FG001|Overall Study|Pt made DNR|0|||
128749283|NCT02075593|463368804|FG000|Overall Study|Withdrawal by Subject|1|||
128749284|NCT02010060|463368805|FG000|Overall Study|Lost to Follow-up|1|||
128749285|NCT02010060|463368806|FG001|Overall Study|Lost to Follow-up|2|||
128749286|NCT02010060|463368807|FG002|Overall Study|Lost to Follow-up|2|||
128749287|NCT02010060|463368805|FG000|Overall Study|Injury|0|||
128749288|NCT02010060|463368806|FG001|Overall Study|Injury|1|||
128749289|NCT02010060|463368807|FG002|Overall Study|Injury|0|||
128749290|NCT05819749|463368808|FG000|Overall Study|Lost to Follow-up|1|||
128749291|NCT00680407|463368809|FG000|Overall Study|Lost to Follow-up|3|||
128749292|NCT00680407|463368810|FG001|Overall Study|Lost to Follow-up|3|||
128749293|NCT00680407|463368811|FG002|Overall Study|Lost to Follow-up|1|||
128749294|NCT00680407|463368809|FG000|Overall Study|Withdrawal by Subject|5|||
128749295|NCT00680407|463368810|FG001|Overall Study|Withdrawal by Subject|2|||
128749296|NCT00680407|463368811|FG002|Overall Study|Withdrawal by Subject|2|||
128749297|NCT06167031|463368812|FG000|Overall Study|Lost to Follow-up|5|||
128749298|NCT06167031|463368813|FG001|Overall Study|Lost to Follow-up|1|||
128749299|NCT03214367|463371156|FG000|Lead-in Period|Withdrawal by Subject|50|||
128749300|NCT03214367|463371157|FG001|Lead-in Period|Withdrawal by Subject|0|||
128749301|NCT03214367|463371158|FG002|Lead-in Period|Withdrawal by Subject|0|||
128749302|NCT03214367|463371159|FG003|Lead-in Period|Withdrawal by Subject|0|||
128749303|NCT03214367|463371160|FG004|Lead-in Period|Withdrawal by Subject|2|||
128749304|NCT03214367|463371161|FG005|Lead-in Period|Withdrawal by Subject|0|||
128749305|NCT03214367|463371162|FG006|Lead-in Period|Withdrawal by Subject|0|||
128749306|NCT03214367|463371163|FG007|Lead-in Period|Withdrawal by Subject|0|||
128749307|NCT03214367|463371156|FG000|Lead-in Period|Adverse Event|3|||
128749308|NCT03214367|463371157|FG001|Lead-in Period|Adverse Event|0|||
128749309|NCT03214367|463371158|FG002|Lead-in Period|Adverse Event|0|||
128749310|NCT03214367|463371159|FG003|Lead-in Period|Adverse Event|0|||
128749311|NCT03214367|463371160|FG004|Lead-in Period|Adverse Event|0|||
128749312|NCT03214367|463371161|FG005|Lead-in Period|Adverse Event|0|||
128749313|NCT03214367|463371162|FG006|Lead-in Period|Adverse Event|0|||
128749314|NCT03214367|463371163|FG007|Lead-in Period|Adverse Event|0|||
128749315|NCT03214367|463371156|FG000|Lead-in Period|Lost to Follow-up|12|||
128749316|NCT03214367|463371157|FG001|Lead-in Period|Lost to Follow-up|0|||
128749317|NCT03214367|463371158|FG002|Lead-in Period|Lost to Follow-up|0|||
128749318|NCT03214367|463371159|FG003|Lead-in Period|Lost to Follow-up|0|||
128749319|NCT03214367|463371160|FG004|Lead-in Period|Lost to Follow-up|0|||
128749320|NCT03214367|463371161|FG005|Lead-in Period|Lost to Follow-up|0|||
128749321|NCT03214367|463371162|FG006|Lead-in Period|Lost to Follow-up|0|||
128749322|NCT03214367|463371163|FG007|Lead-in Period|Lost to Follow-up|0|||
128749323|NCT03214367|463371156|FG000|Lead-in Period|Sponsor Decision|11|||
128749324|NCT03214367|463371157|FG001|Lead-in Period|Sponsor Decision|0|||
128749325|NCT03214367|463371158|FG002|Lead-in Period|Sponsor Decision|0|||
128749326|NCT03214367|463371159|FG003|Lead-in Period|Sponsor Decision|0|||
128749327|NCT03214367|463371160|FG004|Lead-in Period|Sponsor Decision|0|||
128749328|NCT03214367|463371161|FG005|Lead-in Period|Sponsor Decision|0|||
128749329|NCT03214367|463371162|FG006|Lead-in Period|Sponsor Decision|0|||
128749330|NCT03214367|463371163|FG007|Lead-in Period|Sponsor Decision|0|||
128749331|NCT03214367|463371156|FG000|Lead-in Period|Physician Decision|12|||
128749332|NCT03214367|463371157|FG001|Lead-in Period|Physician Decision|0|||
128749333|NCT03214367|463371158|FG002|Lead-in Period|Physician Decision|0|||
128749334|NCT03214367|463371159|FG003|Lead-in Period|Physician Decision|0|||
128749335|NCT03214367|463371160|FG004|Lead-in Period|Physician Decision|0|||
128749336|NCT03214367|463371161|FG005|Lead-in Period|Physician Decision|0|||
128749337|NCT03214367|463371162|FG006|Lead-in Period|Physician Decision|0|||
128749338|NCT03214367|463371163|FG007|Lead-in Period|Physician Decision|0|||
128749339|NCT03214367|463371156|FG000|Lead-in Period|Protocol Violation|5|||
128749340|NCT03214367|463371157|FG001|Lead-in Period|Protocol Violation|0|||
128749341|NCT03214367|463371158|FG002|Lead-in Period|Protocol Violation|0|||
128749342|NCT03214367|463371159|FG003|Lead-in Period|Protocol Violation|0|||
128749343|NCT03214367|463371160|FG004|Lead-in Period|Protocol Violation|0|||
128749344|NCT03214367|463371161|FG005|Lead-in Period|Protocol Violation|0|||
128749345|NCT03214367|463371162|FG006|Lead-in Period|Protocol Violation|0|||
128749346|NCT03214367|463371163|FG007|Lead-in Period|Protocol Violation|0|||
128749347|NCT03214367|463371156|FG000|Lead-in Period|Treatment Interruption|1|||
128749348|NCT03214367|463371157|FG001|Lead-in Period|Treatment Interruption|0|||
128749349|NCT03214367|463371158|FG002|Lead-in Period|Treatment Interruption|0|||
128749350|NCT03214367|463371159|FG003|Lead-in Period|Treatment Interruption|0|||
128749351|NCT03214367|463371160|FG004|Lead-in Period|Treatment Interruption|0|||
128749352|NCT03214367|463371161|FG005|Lead-in Period|Treatment Interruption|0|||
128749353|NCT03214367|463371162|FG006|Lead-in Period|Treatment Interruption|0|||
128749354|NCT03214367|463371163|FG007|Lead-in Period|Treatment Interruption|0|||
128749355|NCT03214367|463371156|FG000|Treatment Period|Adverse Event|0|||
128749356|NCT03214367|463371157|FG001|Treatment Period|Adverse Event|1|||
128749357|NCT03214367|463371158|FG002|Treatment Period|Adverse Event|4|||
128749358|NCT03214367|463371159|FG003|Treatment Period|Adverse Event|2|||
128749359|NCT03214367|463371160|FG004|Treatment Period|Adverse Event|0|||
128749360|NCT03214367|463371161|FG005|Treatment Period|Adverse Event|0|||
128749361|NCT03214367|463371162|FG006|Treatment Period|Adverse Event|0|||
128749362|NCT03214367|463371163|FG007|Treatment Period|Adverse Event|0|||
128749363|NCT03214367|463371156|FG000|Treatment Period|Death|0|||
128749364|NCT03214367|463371157|FG001|Treatment Period|Death|1|||
128749365|NCT03214367|463371158|FG002|Treatment Period|Death|1|||
128749366|NCT03214367|463371159|FG003|Treatment Period|Death|1|||
128749367|NCT03214367|463371160|FG004|Treatment Period|Death|0|||
128749368|NCT03214367|463371161|FG005|Treatment Period|Death|0|||
128749369|NCT03214367|463371162|FG006|Treatment Period|Death|0|||
128749370|NCT03214367|463371163|FG007|Treatment Period|Death|0|||
128749371|NCT03214367|463371156|FG000|Treatment Period|Lost to Follow-up|0|||
128749372|NCT03214367|463371157|FG001|Treatment Period|Lost to Follow-up|5|||
128749373|NCT03214367|463371158|FG002|Treatment Period|Lost to Follow-up|3|||
128749374|NCT03214367|463371159|FG003|Treatment Period|Lost to Follow-up|2|||
128749375|NCT03214367|463371160|FG004|Treatment Period|Lost to Follow-up|0|||
128749376|NCT03214367|463371161|FG005|Treatment Period|Lost to Follow-up|2|||
128749377|NCT03214367|463371162|FG006|Treatment Period|Lost to Follow-up|1|||
128749378|NCT03214367|463371163|FG007|Treatment Period|Lost to Follow-up|0|||
128749379|NCT03214367|463371156|FG000|Treatment Period|Sponsor Decision|0|||
128749380|NCT03214367|463371157|FG001|Treatment Period|Sponsor Decision|3|||
128749381|NCT03214367|463371158|FG002|Treatment Period|Sponsor Decision|0|||
128749382|NCT03214367|463371159|FG003|Treatment Period|Sponsor Decision|0|||
128749383|NCT03214367|463371160|FG004|Treatment Period|Sponsor Decision|0|||
128749384|NCT03214367|463371161|FG005|Treatment Period|Sponsor Decision|0|||
128749385|NCT03214367|463371162|FG006|Treatment Period|Sponsor Decision|0|||
128749386|NCT03214367|463371163|FG007|Treatment Period|Sponsor Decision|0|||
128749387|NCT03214367|463371156|FG000|Treatment Period|Physician Decision|0|||
128749388|NCT03214367|463371157|FG001|Treatment Period|Physician Decision|1|||
128749389|NCT03214367|463371158|FG002|Treatment Period|Physician Decision|2|||
128749390|NCT03214367|463371159|FG003|Treatment Period|Physician Decision|0|||
128749391|NCT03214367|463371160|FG004|Treatment Period|Physician Decision|0|||
128749392|NCT03214367|463371161|FG005|Treatment Period|Physician Decision|0|||
128749393|NCT03214367|463371162|FG006|Treatment Period|Physician Decision|0|||
128749394|NCT03214367|463371163|FG007|Treatment Period|Physician Decision|0|||
128749395|NCT03214367|463371156|FG000|Treatment Period|Protocol Violation|0|||
128749396|NCT03214367|463371157|FG001|Treatment Period|Protocol Violation|3|||
128749397|NCT03214367|463371158|FG002|Treatment Period|Protocol Violation|0|||
128749398|NCT03214367|463371159|FG003|Treatment Period|Protocol Violation|0|||
128749399|NCT03214367|463371160|FG004|Treatment Period|Protocol Violation|0|||
128749400|NCT03214367|463371161|FG005|Treatment Period|Protocol Violation|0|||
128749401|NCT03214367|463371162|FG006|Treatment Period|Protocol Violation|0|||
128749402|NCT03214367|463371163|FG007|Treatment Period|Protocol Violation|0|||
128749403|NCT03214367|463371156|FG000|Treatment Period|Withdrawal by Subject|0|||
128749404|NCT03214367|463371157|FG001|Treatment Period|Withdrawal by Subject|20|||
128749405|NCT03214367|463371158|FG002|Treatment Period|Withdrawal by Subject|23|||
128749406|NCT03214367|463371159|FG003|Treatment Period|Withdrawal by Subject|14|||
128749407|NCT03214367|463371160|FG004|Treatment Period|Withdrawal by Subject|0|||
128749408|NCT03214367|463371161|FG005|Treatment Period|Withdrawal by Subject|1|||
128749409|NCT03214367|463371162|FG006|Treatment Period|Withdrawal by Subject|1|||
128749410|NCT03214367|463371163|FG007|Treatment Period|Withdrawal by Subject|1|||
128749411|NCT03508843|463371164|FG000|Overall Study|Withdrawal by Subject|1|||
128749412|NCT03508843|463371164|FG000|Overall Study|technical difficulties|2|||
128749413|NCT03555396|463371165|FG000|Overall Study|Death|3|||
128749414|NCT03555396|463371166|FG001|Overall Study|Death|1|||
128749415|NCT03555396|463371165|FG000|Overall Study|Lost to Follow-up|0|||
128749416|NCT03555396|463371166|FG001|Overall Study|Lost to Follow-up|2|||
128749417|NCT01369342|463371174|FG000|Overall Study|Withdrawal by Subject|7|||
128749418|NCT01369342|463371175|FG001|Overall Study|Withdrawal by Subject|7|||
128749419|NCT01369342|463371176|FG002|Overall Study|Withdrawal by Subject|2|||
128749420|NCT01369342|463371174|FG000|Overall Study|Lost to Follow-up|5|||
128749421|NCT01369342|463371175|FG001|Overall Study|Lost to Follow-up|2|||
128749422|NCT01369342|463371176|FG002|Overall Study|Lost to Follow-up|1|||
128749423|NCT01369342|463371174|FG000|Overall Study|Not Treated|1|||
128749424|NCT01369342|463371175|FG001|Overall Study|Not Treated|0|||
128749425|NCT01369342|463371176|FG002|Overall Study|Not Treated|0|||
128749426|NCT01816594|463371177|FG000|Overall Study|Local Progress|0|||
128749427|NCT01816594|463371178|FG001|Overall Study|Local Progress|2|||
128749428|NCT01816594|463371177|FG000|Overall Study|Adverse Event|9|||
128749429|NCT01816594|463371178|FG001|Overall Study|Adverse Event|0|||
128749430|NCT01816594|463371177|FG000|Overall Study|Withdrawal by Subject|1|||
128749431|NCT01816594|463371178|FG001|Overall Study|Withdrawal by Subject|0|||
128749432|NCT01816594|463371177|FG000|Overall Study|Physician Decision|1|||
128749433|NCT01816594|463371178|FG001|Overall Study|Physician Decision|0|||
128749434|NCT03905655|463371179|FG000|Overall Study|Adverse Event|1|||
128749435|NCT03905655|463371180|FG001|Overall Study|Adverse Event|0|||
128749436|NCT03905655|463371181|FG002|Overall Study|Adverse Event|1|||
128749437|NCT03905655|463371182|FG003|Overall Study|Adverse Event|1|||
128749438|NCT02566031|463371183|FG000|Overall Study|Patient/guardian decision|14|||
128749439|NCT02566031|463371184|FG001|Overall Study|Patient/guardian decision|7|||
128749440|NCT02566031|463371183|FG000|Overall Study|Protocol deviation|2|||
128749441|NCT02566031|463371184|FG001|Overall Study|Protocol deviation|3|||
128749442|NCT02566031|463371183|FG000|Overall Study|Adverse Event|3|||
128749443|NCT02566031|463371184|FG001|Overall Study|Adverse Event|1|||
128749444|NCT02566031|463371183|FG000|Overall Study|Lost to Follow-up|1|||
128749445|NCT02566031|463371184|FG001|Overall Study|Lost to Follow-up|1|||
128749446|NCT00413153|463371185|FG000|Overall Study|Withdrawal by Subject|1|||
128749447|NCT00413153|463371186|FG001|Overall Study|Withdrawal by Subject|1|||
128749448|NCT00413153|463371185|FG000|Overall Study|Adverse Event|1|||
128749449|NCT00413153|463371186|FG001|Overall Study|Adverse Event|0|||
128749450|NCT03204279|463371187|FG000|Overall Study|Withdrawal by Subject|0|||
128749451|NCT03204279|463371188|FG001|Overall Study|Withdrawal by Subject|1|||
128749452|NCT02277106|463371189|FG000|Stage 2|Adverse Event|0|||
128749453|NCT02277106|463371190|FG001|Stage 2|Adverse Event|0|||
128749454|NCT02277106|463371191|FG002|Stage 2|Adverse Event|1|||
128749455|NCT01064739|463371192|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
128749456|NCT01669629|463371196|FG000|Period 1|protocol deviation|1|||
128749457|NCT01669629|463371197|FG001|Period 1|protocol deviation|2|||
128749458|NCT01221597|463371198|FG000|Overall Study|Adverse Event|4|||
128749459|NCT01221597|463371199|FG001|Overall Study|Adverse Event|1|||
128749460|NCT01221597|463371198|FG000|Overall Study|Withdrawal by Subject|20|||
128749461|NCT01221597|463371199|FG001|Overall Study|Withdrawal by Subject|6|||
128749462|NCT01221597|463371198|FG000|Overall Study|Lost to Follow-up|6|||
128749463|NCT01221597|463371199|FG001|Overall Study|Lost to Follow-up|5|||
128749464|NCT01221597|463371198|FG000|Overall Study|Protocol Violation|1|||
128749465|NCT01221597|463371199|FG001|Overall Study|Protocol Violation|0|||
128749466|NCT01221597|463371198|FG000|Overall Study|Other|3|||
128749467|NCT01221597|463371199|FG001|Overall Study|Other|4|||
128749468|NCT01221597|463371198|FG000|Overall Study|Death|2|||
128749469|NCT01221597|463371199|FG001|Overall Study|Death|0|||
128749470|NCT02278328|463371200|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
128749471|NCT02278328|463371201|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
128749472|NCT02278328|463371202|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
128749473|NCT02278328|463371200|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
128749474|NCT02278328|463371201|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
128749475|NCT02278328|463371202|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
128749476|NCT02278328|463371200|FG000|Neuropsych Screening|incomplete consent|0|||
128749477|NCT02278328|463371201|FG001|Neuropsych Screening|incomplete consent|0|||
128749478|NCT02278328|463371202|FG002|Neuropsych Screening|incomplete consent|2|||
128749479|NCT03834779|463371203|FG000|Overall Study|Death|1|||
128785716|NCT00172185|463507332|FG002|Overall Study|Withdrawal by Subject|1|||
128785717|NCT00172185|463507333|FG003|Overall Study|Withdrawal by Subject|0|||
128749480|NCT03834779|463371204|FG001|Overall Study|Death|2|||
128749481|NCT03834779|463371203|FG000|Overall Study|Lost to Follow-up|6|||
128785718|NCT01677936|463507334|FG000|Overall Study|Lost to Follow-up|4|||
128749482|NCT03834779|463371204|FG001|Overall Study|Lost to Follow-up|4|||
128749483|NCT03280121|463371212|FG000|Overall Study|Physician Decision|1|||
128749484|NCT03280121|463371212|FG000|Overall Study|Lost to Follow-up|1|||
128749485|NCT03280121|463371212|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
128749486|NCT04420221|463371215|FG000|Overall Study|Withdrawal by Subject|0|||
128749487|NCT04420221|463371216|FG001|Overall Study|Withdrawal by Subject|0|||
128749488|NCT04420221|463371217|FG002|Overall Study|Withdrawal by Subject|0|||
128749489|NCT04420221|463371218|FG003|Overall Study|Withdrawal by Subject|0|||
128749490|NCT04420221|463371219|FG004|Overall Study|Withdrawal by Subject|0|||
128749491|NCT04420221|463371220|FG005|Overall Study|Withdrawal by Subject|20|||
128749492|NCT04420221|463371221|FG006|Overall Study|Withdrawal by Subject|5|||
128749493|NCT04420221|463371215|FG000|Overall Study|Other|0|||
128749494|NCT04420221|463371216|FG001|Overall Study|Other|0|||
128749495|NCT04420221|463371217|FG002|Overall Study|Other|0|||
128749496|NCT04420221|463371218|FG003|Overall Study|Other|0|||
128749497|NCT04420221|463371219|FG004|Overall Study|Other|0|||
128749498|NCT04420221|463371220|FG005|Overall Study|Other|1|||
128749499|NCT04420221|463371221|FG006|Overall Study|Other|1|||
128749500|NCT04420221|463371215|FG000|Overall Study|Lost to Follow-up|0|||
128749501|NCT04420221|463371216|FG001|Overall Study|Lost to Follow-up|0|||
128749502|NCT04420221|463371217|FG002|Overall Study|Lost to Follow-up|0|||
128749503|NCT04420221|463371218|FG003|Overall Study|Lost to Follow-up|0|||
128749504|NCT04420221|463371219|FG004|Overall Study|Lost to Follow-up|0|||
128749505|NCT04420221|463371220|FG005|Overall Study|Lost to Follow-up|3|||
128749506|NCT04420221|463371221|FG006|Overall Study|Lost to Follow-up|2|||
128749507|NCT04420221|463371215|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
128749508|NCT04420221|463371216|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
128749509|NCT04420221|463371217|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
128749510|NCT04420221|463371218|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
128749511|NCT04420221|463371219|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
128749512|NCT04420221|463371220|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
128749513|NCT04420221|463371221|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
128749514|NCT00511004|463371222|FG000|Overall Study|Lost to Follow-up|0|||
128749515|NCT00511004|463371223|FG001|Overall Study|Lost to Follow-up|0|||
128749516|NCT00511004|463371224|FG002|Overall Study|Lost to Follow-up|4|||
128749517|NCT00990652|463371225|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
128749518|NCT00990652|463371225|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
128749519|NCT02085408|463371227|FG000|Step 1: Induction|Disease Progression|19|||
128749520|NCT02085408|463371228|FG001|Step 1: Induction|Disease Progression|19|||
128749521|NCT02085408|463371227|FG000|Step 1: Induction|Adverse Event|18|||
128749522|NCT02085408|463371228|FG001|Step 1: Induction|Adverse Event|17|||
128749523|NCT02085408|463371227|FG000|Step 1: Induction|Death|33|||
128749524|NCT02085408|463371228|FG001|Step 1: Induction|Death|30|||
128749525|NCT02085408|463371227|FG000|Step 1: Induction|Withdrawal by Subject|16|||
128749526|NCT02085408|463371228|FG001|Step 1: Induction|Withdrawal by Subject|8|||
128749527|NCT02085408|463371227|FG000|Step 1: Induction|Alternative Therapy|15|||
128749528|NCT02085408|463371228|FG001|Step 1: Induction|Alternative Therapy|19|||
128749529|NCT02085408|463371227|FG000|Step 1: Induction|Complicating Disease|2|||
128749530|NCT02085408|463371228|FG001|Step 1: Induction|Complicating Disease|3|||
128749531|NCT02085408|463371227|FG000|Step 1: Induction|Other|27|||
128749532|NCT02085408|463371228|FG001|Step 1: Induction|Other|39|||
128749533|NCT02085408|463371227|FG000|Step 1: Induction|Never started treatment|6|||
128749534|NCT02085408|463371228|FG001|Step 1: Induction|Never started treatment|4|||
128749535|NCT02085408|463371227|FG000|Step 2: Consolidation|Disease Progression|5|||
128785719|NCT01677936|463507335|FG001|Overall Study|Lost to Follow-up|1|||
128785720|NCT01677936|463507334|FG000|Overall Study|Protocol Violation|3|||
128785721|NCT01677936|463507335|FG001|Overall Study|Protocol Violation|0|||
128785722|NCT01677936|463507334|FG000|Overall Study|Adverse Event|1|||
128785723|NCT01677936|463507335|FG001|Overall Study|Adverse Event|0|||
128785724|NCT01677936|463507334|FG000|Overall Study|Lost to Follow-up|1|||
128785725|NCT01677936|463507335|FG001|Overall Study|Lost to Follow-up|0|||
128785726|NCT01677936|463507334|FG000|Overall Study|Protocol Violation|0|||
128749536|NCT02085408|463371228|FG001|Step 2: Consolidation|Disease Progression|20|||
128749537|NCT02085408|463371227|FG000|Step 2: Consolidation|Adverse Event|9|||
128749538|NCT02085408|463371228|FG001|Step 2: Consolidation|Adverse Event|8|||
128749539|NCT02085408|463371227|FG000|Step 2: Consolidation|Death|4|||
128749540|NCT02085408|463371228|FG001|Step 2: Consolidation|Death|3|||
128749541|NCT02085408|463371227|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
128749542|NCT02085408|463371228|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
128749543|NCT02085408|463371227|FG000|Step 2: Consolidation|Alternative Therapy|9|||
128749544|NCT02085408|463371228|FG001|Step 2: Consolidation|Alternative Therapy|3|||
128749545|NCT02085408|463371227|FG000|Step 2: Consolidation|Complicating Disease|0|||
128749546|NCT02085408|463371228|FG001|Step 2: Consolidation|Complicating Disease|2|||
128749547|NCT02085408|463371227|FG000|Step 2: Consolidation|Other|6|||
128749548|NCT02085408|463371228|FG001|Step 2: Consolidation|Other|6|||
128749549|NCT02085408|463371227|FG000|Step 2: Consolidation|Never started treatment|4|||
128749550|NCT02085408|463371228|FG001|Step 2: Consolidation|Never started treatment|3|||
128749551|NCT02085408|463371227|FG000|Step 3: Maintenance|Disease Progression|13|||
128749552|NCT02085408|463371228|FG001|Step 3: Maintenance|Disease Progression|11|||
128749553|NCT02085408|463371227|FG000|Step 3: Maintenance|Adverse Event|2|||
128749554|NCT02085408|463371228|FG001|Step 3: Maintenance|Adverse Event|4|||
128749555|NCT02085408|463371227|FG000|Step 3: Maintenance|Death|1|||
128749556|NCT02085408|463371228|FG001|Step 3: Maintenance|Death|2|||
128749557|NCT02085408|463371227|FG000|Step 3: Maintenance|Alternative Therapy|1|||
128749558|NCT02085408|463371228|FG001|Step 3: Maintenance|Alternative Therapy|1|||
128749559|NCT02085408|463371227|FG000|Step 3: Maintenance|Complicating Disease|0|||
128749560|NCT02085408|463371228|FG001|Step 3: Maintenance|Complicating Disease|1|||
128749561|NCT02085408|463371227|FG000|Step 3: Maintenance|Other|3|||
128749562|NCT02085408|463371228|FG001|Step 3: Maintenance|Other|2|||
128749563|NCT02085408|463371227|FG000|Step 3: Maintenance|Never started treatment|5|||
128749564|NCT02085408|463371228|FG001|Step 3: Maintenance|Never started treatment|1|||
128785727|NCT01677936|463507335|FG001|Overall Study|Protocol Violation|4|||
128785728|NCT00151996|463507342|FG000|Overall Study|Adverse Event|3|||
128749565|NCT01556438|463371231|FG000|Overall Study|Adverse Event|4|||
128749566|NCT01556438|463371232|FG001|Overall Study|Adverse Event|2|||
128785729|NCT00151996|463507343|FG001|Overall Study|Adverse Event|2|||
128785730|NCT00151996|463507342|FG000|Overall Study|Withdrawal by Subject|1|||
128785731|NCT00151996|463507343|FG001|Overall Study|Withdrawal by Subject|1|||
128785732|NCT00151996|463507342|FG000|Overall Study|Protocol Violation|1|||
128785733|NCT00151996|463507343|FG001|Overall Study|Protocol Violation|2|||
128785734|NCT00151996|463507342|FG000|Overall Study|Sponsor's decision|0|||
128785735|NCT00151996|463507343|FG001|Overall Study|Sponsor's decision|2|||
128785736|NCT01801930|463507344|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
128785737|NCT01801930|463507345|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
128785738|NCT01801930|463507346|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
128785739|NCT01801930|463507347|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
128749567|NCT01556438|463371231|FG000|Overall Study|Sponsor Decision|0|||
128749568|NCT01556438|463371232|FG001|Overall Study|Sponsor Decision|2|||
128749569|NCT01556438|463371231|FG000|Overall Study|Progressive Disease|0|||
128749570|NCT01556438|463371232|FG001|Overall Study|Progressive Disease|6|||
128749571|NCT01556438|463371231|FG000|Overall Study|Death|0|||
128749572|NCT01556438|463371232|FG001|Overall Study|Death|1|||
128749573|NCT03695172|463371233|FG000|Overall Study|Withdrawal by Subject|1|||
128785740|NCT01801930|463507344|FG000|Overall Study|DLT occurs|0|||
128749574|NCT03695172|463371234|FG001|Overall Study|Withdrawal by Subject|1|||
128785741|NCT01801930|463507345|FG001|Overall Study|DLT occurs|1|||
128749575|NCT03695172|463371235|FG002|Overall Study|Withdrawal by Subject|0|||
128785742|NCT01801930|463507346|FG002|Overall Study|DLT occurs|0|||
128785743|NCT01801930|463507347|FG003|Overall Study|DLT occurs|0|||
128749576|NCT02734212|463371236|FG000|Overall Study|Lost to Follow-up|5|||
128749577|NCT02734212|463371237|FG001|Overall Study|Lost to Follow-up|10|||
128749578|NCT01910129|463371242|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
128749579|NCT01910129|463371243|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
128749580|NCT01910129|463371244|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
128749581|NCT01910129|463371242|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
128749582|NCT01910129|463371243|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
128749583|NCT01910129|463371244|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
128749584|NCT00319098|463371245|FG000|Overall Study|Serious adverse event|3|||
128749585|NCT00319098|463371246|FG001|Overall Study|Serious adverse event|0|||
128749586|NCT00319098|463371245|FG000|Overall Study|Adverse Event|20|||
128749587|NCT00319098|463371246|FG001|Overall Study|Adverse Event|1|||
128749588|NCT00319098|463371245|FG000|Overall Study|Withdrawal by Subject|37|||
128749589|NCT00319098|463371246|FG001|Overall Study|Withdrawal by Subject|8|||
128749590|NCT00319098|463371245|FG000|Overall Study|Migrated/moved from study area|2|||
128749591|NCT00319098|463371246|FG001|Overall Study|Migrated/moved from study area|1|||
128749592|NCT00319098|463371245|FG000|Overall Study|Lost to Follow-up|37|||
128749593|NCT00319098|463371246|FG001|Overall Study|Lost to Follow-up|13|||
128749594|NCT00319098|463371245|FG000|Overall Study|Others|33|||
128785744|NCT03441360|463507351|FG000|Overall Study|Radiological disease progression|5|||
128785745|NCT03441360|463507352|FG001|Overall Study|Radiological disease progression|6|||
128749595|NCT00319098|463371246|FG001|Overall Study|Others|8|||
128749596|NCT00319098|463371245|FG000|Overall Study|Protocol Violation|3|||
128749597|NCT00319098|463371246|FG001|Overall Study|Protocol Violation|1|||
128749598|NCT03150056|463371247|FG000|Overall Study|Withdrawal by Subject|0|||
128749599|NCT03150056|463371248|FG001|Overall Study|Withdrawal by Subject|0|||
128749600|NCT03150056|463371249|FG002|Overall Study|Withdrawal by Subject|0|||
128749601|NCT03150056|463371250|FG003|Overall Study|Withdrawal by Subject|0|||
128749602|NCT03150056|463371251|FG004|Overall Study|Withdrawal by Subject|0|||
128785746|NCT03441360|463507353|FG002|Overall Study|Radiological disease progression|4|||
128749603|NCT03150056|463371252|FG005|Overall Study|Withdrawal by Subject|2|||
128749604|NCT03150056|463371247|FG000|Overall Study|Study terminated by Sponsor|1|||
128749605|NCT03150056|463371248|FG001|Overall Study|Study terminated by Sponsor|3|||
128785747|NCT03441360|463507351|FG000|Overall Study|Clinical disease progression|2|||
128785748|NCT03441360|463507352|FG001|Overall Study|Clinical disease progression|2|||
128785749|NCT03441360|463507353|FG002|Overall Study|Clinical disease progression|0|||
128785750|NCT03441360|463507351|FG000|Overall Study|Adverse Event|1|||
128785751|NCT03441360|463507352|FG001|Overall Study|Adverse Event|0|||
128785752|NCT03441360|463507353|FG002|Overall Study|Adverse Event|1|||
128785753|NCT00269399|463507354|FG000|Overall Study|Lack of Efficacy|27|||
128785754|NCT00269399|463507355|FG001|Overall Study|Lack of Efficacy|10|||
128785755|NCT00269399|463507354|FG000|Overall Study|Adverse Event|10|||
128785756|NCT00269399|463507355|FG001|Overall Study|Adverse Event|4|||
128785757|NCT00269399|463507354|FG000|Overall Study|Withdrawal by Subject|2|||
128785758|NCT00269399|463507355|FG001|Overall Study|Withdrawal by Subject|5|||
128785759|NCT00269399|463507354|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
128785760|NCT00269399|463507355|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
128785761|NCT00269399|463507354|FG000|Overall Study|Other|0|||
128785762|NCT00269399|463507355|FG001|Overall Study|Other|4|||
128785763|NCT00269399|463507354|FG000|Overall Study|Development of exclusion criteria|0|||
128785764|NCT00269399|463507355|FG001|Overall Study|Development of exclusion criteria|1|||
128785765|NCT03396835|463507356|FG000|Overall Study|Withdrawn prior to completion|1|||
128785766|NCT03396835|463507356|FG000|Overall Study|Did not meet criteria for data analysis|1|||
128785767|NCT01020838|463507366|FG000|Overall Study|Death|90|||
128785768|NCT01020838|463507366|FG000|Overall Study|Adverse Event|1|||
128785769|NCT01020838|463507366|FG000|Overall Study|Withdrawal by Subject|9|||
128785770|NCT01020838|463507366|FG000|Overall Study|Lost to Follow-up|6|||
128785771|NCT01020838|463507366|FG000|Overall Study|Most common: Study ended by sponsor|77|||
128785772|NCT01167426|463507367|FG000|Overall Study|Lost to Follow-up|6|||
128785773|NCT01167426|463507367|FG000|Overall Study|Protocol Violation|1|||
128785774|NCT01167426|463507367|FG000|Overall Study|Withdrawal by Subject|2|||
128785775|NCT01167426|463507367|FG000|Overall Study|Sponsor Decision|1|||
128785776|NCT01908634|463507368|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
128785777|NCT01908634|463507368|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
128785778|NCT05790408|463507374|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
128785779|NCT02145182|463507376|FG000|Overall Study|Adverse Event|4|||
128785780|NCT02145182|463507377|FG001|Overall Study|Adverse Event|1|||
128785781|NCT02145182|463507376|FG000|Overall Study|Death|7|||
128785782|NCT02145182|463507377|FG001|Overall Study|Death|7|||
128785783|NCT02145182|463507376|FG000|Overall Study|Lost to Follow-up|2|||
128785784|NCT02145182|463507377|FG001|Overall Study|Lost to Follow-up|2|||
128785785|NCT02145182|463507376|FG000|Overall Study|Pre-transplant Withdrawal|0|||
128785786|NCT02145182|463507377|FG001|Overall Study|Pre-transplant Withdrawal|2|||
128785787|NCT02145182|463507376|FG000|Overall Study|Withdrawal by Subject|5|||
128785788|NCT02145182|463507377|FG001|Overall Study|Withdrawal by Subject|4|||
128785789|NCT03999554|463507378|FG000|Overall Study|Lost to Follow-up|4|||
128785790|NCT03999554|463507379|FG001|Overall Study|Lost to Follow-up|5|||
128785791|NCT03999554|463507380|FG002|Overall Study|Lost to Follow-up|4|||
128785792|NCT03999554|463507381|FG003|Overall Study|Lost to Follow-up|5|||
128785793|NCT03999554|463507382|FG004|Overall Study|Lost to Follow-up|8|||
128785794|NCT03999554|463507378|FG000|Overall Study|Protocol Violation|0|||
128785795|NCT03999554|463507379|FG001|Overall Study|Protocol Violation|0|||
128785796|NCT03999554|463507380|FG002|Overall Study|Protocol Violation|5|||
128785797|NCT03999554|463507381|FG003|Overall Study|Protocol Violation|0|||
128785798|NCT03999554|463507382|FG004|Overall Study|Protocol Violation|0|||
128785799|NCT03999554|463507378|FG000|Overall Study|Pregnancy|0|||
128785800|NCT03999554|463507379|FG001|Overall Study|Pregnancy|0|||
128785801|NCT03999554|463507380|FG002|Overall Study|Pregnancy|1|||
128785802|NCT03999554|463507381|FG003|Overall Study|Pregnancy|0|||
128785803|NCT03999554|463507382|FG004|Overall Study|Pregnancy|0|||
128785804|NCT03999554|463507378|FG000|Overall Study|Withdrawal by Subject|2|||
128785805|NCT03999554|463507379|FG001|Overall Study|Withdrawal by Subject|2|||
128785806|NCT03999554|463507380|FG002|Overall Study|Withdrawal by Subject|2|||
128785807|NCT03999554|463507381|FG003|Overall Study|Withdrawal by Subject|1|||
128785808|NCT03999554|463507382|FG004|Overall Study|Withdrawal by Subject|1|||
128785809|NCT03999554|463507378|FG000|Overall Study|failure to comply with protocol requirements|0|||
128785810|NCT03999554|463507379|FG001|Overall Study|failure to comply with protocol requirements|0|||
128785811|NCT03999554|463507380|FG002|Overall Study|failure to comply with protocol requirements|0|||
128785812|NCT03999554|463507381|FG003|Overall Study|failure to comply with protocol requirements|1|||
128749606|NCT03150056|463371249|FG002|Overall Study|Study terminated by Sponsor|1|||
128749607|NCT03150056|463371250|FG003|Overall Study|Study terminated by Sponsor|1|||
128749608|NCT03150056|463371251|FG004|Overall Study|Study terminated by Sponsor|5|||
128749609|NCT03150056|463371252|FG005|Overall Study|Study terminated by Sponsor|6|||
128749610|NCT03150056|463371247|FG000|Overall Study|Death|9|||
128749611|NCT03150056|463371248|FG001|Overall Study|Death|2|||
128749612|NCT03150056|463371249|FG002|Overall Study|Death|2|||
128749613|NCT03150056|463371250|FG003|Overall Study|Death|7|||
128749614|NCT03150056|463371251|FG004|Overall Study|Death|8|||
128749615|NCT03150056|463371252|FG005|Overall Study|Death|10|||
128749616|NCT00965523|463371253|FG000|Study 221|Progressive Disease|4|||
128749617|NCT00965523|463371253|FG000|Study 221|Physician Decision|3|||
128749618|NCT00965523|463371253|FG000|Study 224|Progressive Disease|5|||
128749619|NCT00965523|463371253|FG000|Study 224|Physician Decision|1|||
128749620|NCT01581281|463371254|FG000|Overall Study|Early Study Closure|15|||
128749621|NCT01581281|463371255|FG001|Overall Study|Early Study Closure|6|||
128749622|NCT01581281|463371256|FG002|Overall Study|Early Study Closure|12|||
128749623|NCT02187991|463371257|FG000|Overall Study|Adverse Event|13|||
128749624|NCT02187991|463371258|FG001|Overall Study|Adverse Event|14|||
128749625|NCT02187991|463371259|FG002|Overall Study|Adverse Event|3|||
128749626|NCT02187991|463371260|FG003|Overall Study|Adverse Event|2|||
128749627|NCT02187991|463371257|FG000|Overall Study|Withdrawal by Subject|9|||
128749628|NCT02187991|463371258|FG001|Overall Study|Withdrawal by Subject|6|||
128749629|NCT02187991|463371259|FG002|Overall Study|Withdrawal by Subject|3|||
128749630|NCT02187991|463371260|FG003|Overall Study|Withdrawal by Subject|2|||
128749631|NCT02187991|463371257|FG000|Overall Study|Physician Decision|4|||
128749632|NCT02187991|463371258|FG001|Overall Study|Physician Decision|4|||
128749633|NCT02187991|463371259|FG002|Overall Study|Physician Decision|0|||
128749634|NCT02187991|463371260|FG003|Overall Study|Physician Decision|2|||
128749635|NCT02187991|463371257|FG000|Overall Study|Other, unrelated complication|7|||
128749636|NCT02187991|463371258|FG001|Overall Study|Other, unrelated complication|1|||
128749637|NCT02187991|463371259|FG002|Overall Study|Other, unrelated complication|1|||
128749638|NCT02187991|463371260|FG003|Overall Study|Other, unrelated complication|2|||
128785813|NCT03999554|463507382|FG004|Overall Study|failure to comply with protocol requirements|0|||
128785814|NCT02274493|463507383|FG000|Overall Study|Withdrawal by Subject|1|||
128785815|NCT00558363|463507384|FG000|Overall Study|Physician Decision|18|||
128749639|NCT02187991|463371257|FG000|Overall Study|Death|1|||
128749640|NCT02187991|463371258|FG001|Overall Study|Death|3|||
128749641|NCT02187991|463371259|FG002|Overall Study|Death|0|||
128749642|NCT02187991|463371260|FG003|Overall Study|Death|0|||
128749643|NCT01392560|463371261|FG000|Overall Study|Adverse Event|2|||
128749644|NCT01392560|463371261|FG000|Overall Study|not entered|8|||
128749645|NCT01392560|463371261|FG000|Overall Study|discontinued during placebo run-in|2|||
128749646|NCT01939028|463371266|FG000|Overall Study|Withdrawal by Subject|5|||
128749647|NCT01939028|463371266|FG000|Overall Study|Physician Decision|7|||
128749648|NCT00700401|463371272|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
128749649|NCT00700401|463371272|FG000|Overall Study|Adverse Event|5|||
128749650|NCT00700401|463371272|FG000|Overall Study|Refused Treatment|2|||
128749651|NCT00700401|463371272|FG000|Overall Study|Lost to Follow-up|1|||
128749652|NCT00700401|463371272|FG000|Overall Study|Treatment never started|1|||
128749653|NCT00700401|463371272|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
128749654|NCT00700401|463371272|FG000|Overall Study|Withdrawal by Subject|2|||
128749655|NCT03273946|463371273|FG000|Overall Study|Withdrawal by Subject|5|||
128749656|NCT03273946|463371273|FG000|Overall Study|Unwillingness of the guardian|1|||
128749657|NCT03273946|463371273|FG000|Overall Study|Participant refused to use the drug|2|||
128749658|NCT03273946|463371273|FG000|Overall Study|Participant relative refused to use drug|1|||
128749659|NCT02199028|463371276|FG000|Week 1|Adverse Event|1|||
128749660|NCT02199028|463371277|FG001|Week 1|Adverse Event|0|||
128749661|NCT02199028|463371276|FG000|Week 3|Adverse Event|1|||
128749662|NCT02199028|463371277|FG001|Week 3|Adverse Event|0|||
128749663|NCT00522275|463371278|FG000|Overall Study|Adverse Event|35|||
128749664|NCT00522275|463371278|FG000|Overall Study|Lack of Efficacy|80|||
128749665|NCT00522275|463371278|FG000|Overall Study|Subject withdrew consent|16|||
128749666|NCT00522275|463371278|FG000|Overall Study|Protocol deviation|1|||
128749667|NCT00522275|463371278|FG000|Overall Study|Unsatisfactory compliance|11|||
128749668|NCT00522275|463371278|FG000|Overall Study|Lost to Follow-up|8|||
128749669|NCT00522275|463371278|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
128749670|NCT00522275|463371278|FG000|Overall Study|Other: Subject is pregnant|2|||
128749671|NCT00522275|463371278|FG000|Overall Study|Other: Subject relocated|2|||
128749672|NCT00522275|463371278|FG000|Overall Study|Other: Subject arrested|1|||
128749673|NCT00522275|463371278|FG000|Overall Study|Other: Site / clinic closed|4|||
128749674|NCT00522275|463371278|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
128749675|NCT00522275|463371278|FG000|Overall Study|Other: Sponsor request|2|||
128749676|NCT00522275|463371278|FG000|Overall Study|Other: Subject ran out of medication|1|||
128749677|NCT00522275|463371278|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
128749678|NCT00092131|463371279|FG000|Treatment Period I|Adverse Event|1|||
128749679|NCT00092131|463371280|FG001|Treatment Period I|Adverse Event|0|||
128749680|NCT00092131|463371279|FG000|Treatment Period II|Adverse Event|0|||
128749681|NCT00092131|463371280|FG001|Treatment Period II|Adverse Event|1|||
128749682|NCT02341417|463371281|FG000|Overall Study|Withdrawal by Subject|0|||
128749683|NCT02341417|463371282|FG001|Overall Study|Withdrawal by Subject|2|||
128749684|NCT02341417|463371283|FG002|Overall Study|Withdrawal by Subject|0|||
128749685|NCT02341417|463371281|FG000|Overall Study|Decision by sponsor|2|||
128785816|NCT00558363|463507385|FG001|Overall Study|Physician Decision|4|||
128785817|NCT00558363|463507384|FG000|Overall Study|Withdrawal by Subject|11|||
128785818|NCT00558363|463507385|FG001|Overall Study|Withdrawal by Subject|4|||
128785819|NCT00558363|463507384|FG000|Overall Study|Adverse Event|5|||
128785820|NCT00558363|463507385|FG001|Overall Study|Adverse Event|5|||
128785821|NCT00558363|463507384|FG000|Overall Study|Lack of Efficacy|2|||
128785822|NCT00558363|463507385|FG001|Overall Study|Lack of Efficacy|2|||
128749686|NCT02341417|463371282|FG001|Overall Study|Decision by sponsor|0|||
128749687|NCT02341417|463371283|FG002|Overall Study|Decision by sponsor|0|||
128749688|NCT02341417|463371281|FG000|Overall Study|Death|0|||
128749689|NCT02341417|463371282|FG001|Overall Study|Death|0|||
128749690|NCT02341417|463371283|FG002|Overall Study|Death|1|||
128749691|NCT02576067|463371284|FG000|Overall Study|Death|0|||
128749692|NCT02576067|463371285|FG001|Overall Study|Death|1|||
128749693|NCT02576067|463371284|FG000|Overall Study|Lack of Efficacy|1|||
128749694|NCT02576067|463371285|FG001|Overall Study|Lack of Efficacy|0|||
128785823|NCT00558363|463507384|FG000|Overall Study|Protocol Violation|2|||
128785824|NCT00558363|463507385|FG001|Overall Study|Protocol Violation|1|||
128785825|NCT00558363|463507384|FG000|Overall Study|Lost to Follow-up|0|||
128785826|NCT00558363|463507385|FG001|Overall Study|Lost to Follow-up|1|||
128785827|NCT00558363|463507384|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
128785828|NCT00558363|463507385|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
128785829|NCT00558363|463507384|FG000|Overall Study|Randomized in Error|1|||
128785830|NCT00558363|463507385|FG001|Overall Study|Randomized in Error|2|||
128785831|NCT00558363|463507384|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
128785832|NCT00558363|463507385|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
128785833|NCT03102710|463507386|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
128785834|NCT03102710|463507387|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
128785835|NCT03102710|463507388|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
128785836|NCT03102710|463507386|FG000|Overall Study|Technical issues during final MRI scan|0|||
128785837|NCT03102710|463507387|FG001|Overall Study|Technical issues during final MRI scan|1|||
128785838|NCT03102710|463507388|FG002|Overall Study|Technical issues during final MRI scan|0|||
128785839|NCT03102710|463507386|FG000|Overall Study|Nausea during MRI scan|0|||
128785840|NCT03102710|463507387|FG001|Overall Study|Nausea during MRI scan|1|||
128785841|NCT03102710|463507388|FG002|Overall Study|Nausea during MRI scan|0|||
128785842|NCT03102710|463507386|FG000|Overall Study|Subject unable to attend final session|0|||
128785843|NCT03102710|463507387|FG001|Overall Study|Subject unable to attend final session|1|||
128785844|NCT03102710|463507388|FG002|Overall Study|Subject unable to attend final session|0|||
128785845|NCT00544440|463507393|FG000|Overall Study|Other|1|||
128785846|NCT00544440|463507393|FG000|Overall Study|Adverse Event|1|||
128785847|NCT00544440|463507393|FG000|Overall Study|Withdrawal by Subject|2|||
128785848|NCT00544440|463507393|FG000|Overall Study|Subject Non-compliance|1|||
128785849|NCT00544440|463507393|FG000|Overall Study|Progressive Disease|47|||
128785850|NCT00544440|463507393|FG000|Overall Study|Other|5|||
128785851|NCT03586167|463507395|FG000|Overall Study|Other|1|||
128785852|NCT03586167|463507396|FG001|Overall Study|Other|0|||
128785853|NCT00591838|463507397|FG000|Overall Study|Withdrawal by Subject|0|||
128785854|NCT00591838|463507398|FG001|Overall Study|Withdrawal by Subject|0|||
128785855|NCT00591838|463507399|FG002|Overall Study|Withdrawal by Subject|0|||
128785856|NCT00591838|463507400|FG003|Overall Study|Withdrawal by Subject|1|||
128785857|NCT00591838|463507401|FG004|Overall Study|Withdrawal by Subject|0|||
128785858|NCT04163458|463507404|FG000|Overall Study|Protocol Deviation|7|||
128785859|NCT04163458|463507405|FG001|Overall Study|Protocol Deviation|13|||
128785860|NCT04163458|463507404|FG000|Overall Study|Adverse Event|5|||
128785861|NCT04163458|463507405|FG001|Overall Study|Adverse Event|8|||
128785862|NCT04163458|463507404|FG000|Overall Study|Due to COVID-19 pandemic|4|||
128785863|NCT04163458|463507405|FG001|Overall Study|Due to COVID-19 pandemic|2|||
128785864|NCT04163458|463507404|FG000|Overall Study|Participant withdrew consent|2|||
128785865|NCT04163458|463507405|FG001|Overall Study|Participant withdrew consent|3|||
128785866|NCT04163458|463507404|FG000|Overall Study|Randomization failure|2|||
128785867|NCT04163458|463507405|FG001|Overall Study|Randomization failure|2|||
128785868|NCT04163458|463507404|FG000|Overall Study|Other|4|||
128785869|NCT04163458|463507405|FG001|Overall Study|Other|2|||
128785870|NCT00881335|463507407|FG000|Overall Study|Lost to Follow-up|3|||
128785871|NCT00881335|463507408|FG001|Overall Study|Lost to Follow-up|2|||
128785872|NCT05824351|463507411|FG000|Overall Study|Adverse Event|6|||
128785873|NCT00828945|463507412|FG000|Overall Study|Death|4|||
128785874|NCT00828945|463507412|FG000|Overall Study|Participant was missing|1|||
128785875|NCT00828945|463507412|FG000|Overall Study|Other|36|||
128785876|NCT02482233|463507413|FG000|Overall Study|Lost to Follow-up|1|||
128785877|NCT02482233|463507414|FG001|Overall Study|Lost to Follow-up|1|||
128785878|NCT01772719|463507420|FG000|Overall Study|Withdrawal by Subject|3|||
128785879|NCT01772719|463507420|FG000|Overall Study|Adverse Event|2|||
128785880|NCT01772719|463507420|FG000|Overall Study|Protocol Violation|1|||
128785881|NCT01772719|463507420|FG000|Overall Study|Lost to Follow-up|1|||
128749695|NCT02576067|463371284|FG000|Overall Study|Lost to Follow-up|11|||
128749696|NCT02576067|463371285|FG001|Overall Study|Lost to Follow-up|0|||
128749697|NCT02576067|463371284|FG000|Overall Study|Withdrawal by Subject|11|||
128749698|NCT02576067|463371285|FG001|Overall Study|Withdrawal by Subject|2|||
128749699|NCT02576067|463371284|FG000|Overall Study|study closure of main CIRT trial)|0|||
128749700|NCT02576067|463371285|FG001|Overall Study|study closure of main CIRT trial)|8|||
128749701|NCT02576067|463371284|FG000|Overall Study|not randomized, failed run-in|7|||
128749702|NCT02576067|463371285|FG001|Overall Study|not randomized, failed run-in|0|||
128749703|NCT02576067|463371284|FG000|Overall Study|screen failure/ re-enrolled|0|||
128749704|NCT02576067|463371285|FG001|Overall Study|screen failure/ re-enrolled|25|||
128749705|NCT02576067|463371284|FG000|Overall Study|Physician Decision|4|||
128749706|NCT02576067|463371285|FG001|Overall Study|Physician Decision|0|||
128749707|NCT04773587|463371288|FG000|Overall Study|Lost to Follow-up|11|||
128749708|NCT04773587|463371289|FG001|Overall Study|Lost to Follow-up|3|||
128785882|NCT00477412|463507421|FG000|Overall Study|Death|0|||
128785883|NCT00477412|463507422|FG001|Overall Study|Death|0|||
128785884|NCT00477412|463507423|FG002|Overall Study|Death|0|||
128785885|NCT00477412|463507424|FG003|Overall Study|Death|4|||
128785886|NCT00477412|463507421|FG000|Overall Study|Lost to Follow-up|0|||
128785887|NCT00477412|463507422|FG001|Overall Study|Lost to Follow-up|0|||
128785888|NCT00477412|463507423|FG002|Overall Study|Lost to Follow-up|0|||
128785889|NCT00477412|463507424|FG003|Overall Study|Lost to Follow-up|1|||
128785890|NCT00477412|463507421|FG000|Overall Study|Withdrawal by Subject|0|||
128785891|NCT00477412|463507422|FG001|Overall Study|Withdrawal by Subject|0|||
128785892|NCT00477412|463507423|FG002|Overall Study|Withdrawal by Subject|0|||
128785893|NCT00477412|463507424|FG003|Overall Study|Withdrawal by Subject|2|||
128785894|NCT00477412|463507421|FG000|Overall Study|Second Malignancy|0|||
128785895|NCT00477412|463507422|FG001|Overall Study|Second Malignancy|0|||
128785896|NCT00477412|463507423|FG002|Overall Study|Second Malignancy|0|||
128785897|NCT00477412|463507424|FG003|Overall Study|Second Malignancy|1|||
128785898|NCT00477412|463507421|FG000|Overall Study|Adverse Event|1|||
128785899|NCT00477412|463507422|FG001|Overall Study|Adverse Event|0|||
128785900|NCT00477412|463507423|FG002|Overall Study|Adverse Event|1|||
128785901|NCT00477412|463507424|FG003|Overall Study|Adverse Event|0|||
128785902|NCT03820986|463507426|FG000|Overall Study|Death|177|||
128785903|NCT03820986|463507427|FG001|Overall Study|Death|156|||
128785904|NCT03820986|463507426|FG000|Overall Study|Lost to Follow-up|0|||
128785905|NCT03820986|463507427|FG001|Overall Study|Lost to Follow-up|1|||
128785906|NCT03820986|463507426|FG000|Overall Study|Withdrawal by Subject|8|||
128785907|NCT03820986|463507427|FG001|Overall Study|Withdrawal by Subject|3|||
128785908|NCT03820986|463507426|FG000|Overall Study|Ongoing|149|||
128785909|NCT03820986|463507427|FG001|Overall Study|Ongoing|180|||
128785910|NCT04358549|463509288|FG000|Overall Study|Adverse Event|0|||
128785911|NCT04358549|463509289|FG001|Overall Study|Adverse Event|1|||
128785912|NCT04358549|463509288|FG000|Overall Study|Death|1|||
128785913|NCT04358549|463509289|FG001|Overall Study|Death|0|||
128785914|NCT04358549|463509288|FG000|Overall Study|Lost to Follow-up|2|||
128785915|NCT04358549|463509289|FG001|Overall Study|Lost to Follow-up|1|||
128785916|NCT04358549|463509288|FG000|Overall Study|Withdrawal by Subject|6|||
128785917|NCT04358549|463509289|FG001|Overall Study|Withdrawal by Subject|6|||
128785918|NCT04358549|463509288|FG000|Overall Study|Start remdesivir|1|||
128785919|NCT04358549|463509289|FG001|Overall Study|Start remdesivir|0|||
128785920|NCT01118377|463509290|FG000|Overall Study|Did Not Receive Study Medication|1|||
128785921|NCT01118377|463509290|FG000|Overall Study|Death|38|||
128785922|NCT01118377|463509290|FG000|Overall Study|Failure to Return|3|||
128785923|NCT03837028|463509291|FG000|Overall Study|Lost to Follow-up|4|||
128785924|NCT03837028|463509292|FG001|Overall Study|Lost to Follow-up|0|||
128785925|NCT03837028|463509293|FG002|Overall Study|Lost to Follow-up|2|||
128785926|NCT03837028|463509294|FG003|Overall Study|Lost to Follow-up|0|||
128785927|NCT03837028|463509291|FG000|Overall Study|Withdrawal by Subject|12|||
128785928|NCT03837028|463509292|FG001|Overall Study|Withdrawal by Subject|11|||
128785929|NCT03837028|463509293|FG002|Overall Study|Withdrawal by Subject|11|||
128785930|NCT03837028|463509294|FG003|Overall Study|Withdrawal by Subject|7|||
128785931|NCT04867902|463509295|FG000|Overall Study|Lost to Follow-up|1|||
128785932|NCT04867902|463509295|FG000|Overall Study|Withdrawal by Subject|2|||
128785933|NCT04867902|463509295|FG000|Overall Study|Protocol Violation|1|||
128785934|NCT00470626|463509298|FG000|Overall Study|Lost to Follow-up|10|||
128785935|NCT00470626|463509298|FG000|Overall Study|Withdrawal by Subject|7|||
128785936|NCT01729819|463509301|FG000|Overall Study|Adverse Event|2|||
128785937|NCT01729819|463509302|FG001|Overall Study|Adverse Event|4|||
128785938|NCT01729819|463509301|FG000|Overall Study|Lack of Efficacy|1|||
128785939|NCT01729819|463509302|FG001|Overall Study|Lack of Efficacy|0|||
128785940|NCT01729819|463509301|FG000|Overall Study|Lost to Follow-up|2|||
128785941|NCT01729819|463509302|FG001|Overall Study|Lost to Follow-up|0|||
128785942|NCT01729819|463509301|FG000|Overall Study|Other reason|1|||
128785943|NCT01729819|463509302|FG001|Overall Study|Other reason|0|||
128785944|NCT01729819|463509301|FG000|Overall Study|Protocol Violation|0|||
128785945|NCT01729819|463509302|FG001|Overall Study|Protocol Violation|1|||
128785946|NCT01729819|463509301|FG000|Overall Study|Withdrawal by Subject|0|||
128785947|NCT01729819|463509302|FG001|Overall Study|Withdrawal by Subject|2|||
128785948|NCT03439124|463509303|FG000|Overall Study|Adverse Event|2|||
128785949|NCT03439124|463509304|FG001|Overall Study|Adverse Event|0|||
128785950|NCT03439124|463509303|FG000|Overall Study|Lost to Follow-up|1|||
128785951|NCT03439124|463509304|FG001|Overall Study|Lost to Follow-up|0|||
128785952|NCT03439124|463509303|FG000|Overall Study|Other reasons|1|||
128785953|NCT03439124|463509304|FG001|Overall Study|Other reasons|0|||
128785954|NCT02049866|463509305|FG000|Overall Study|Withdrawal by Subject|1|||
128785955|NCT01117480|463509307|FG000|Overall Study|Protocol Violation|8|||
128785956|NCT01117480|463509307|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
128785957|NCT02955069|463509308|FG000|Overall Study|Adverse Event|7|||
128785958|NCT02955069|463509309|FG001|Overall Study|Adverse Event|2|||
128785959|NCT02955069|463509308|FG000|Overall Study|Death|7|||
128785960|NCT02955069|463509309|FG001|Overall Study|Death|3|||
128785961|NCT02955069|463509308|FG000|Overall Study|Physician Decision|10|||
128785962|NCT02955069|463509309|FG001|Overall Study|Physician Decision|2|||
128749709|NCT04773587|463371288|FG000|Overall Study|Adverse Event|6|||
128749710|NCT04773587|463371289|FG001|Overall Study|Adverse Event|3|||
128749711|NCT04773587|463371288|FG000|Overall Study|Lack of Efficacy|5|||
128749712|NCT04773587|463371289|FG001|Overall Study|Lack of Efficacy|2|||
128749713|NCT04773587|463371288|FG000|Overall Study|Withdrawal by Subject|4|||
128749714|NCT04773587|463371289|FG001|Overall Study|Withdrawal by Subject|5|||
128749715|NCT04773587|463371288|FG000|Overall Study|Noncompliance|1|||
128749716|NCT04773587|463371289|FG001|Overall Study|Noncompliance|0|||
128749717|NCT04773587|463371288|FG000|Overall Study|Protocol Violation|1|||
128749718|NCT04773587|463371289|FG001|Overall Study|Protocol Violation|0|||
128749719|NCT04773587|463371288|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
128749720|NCT04773587|463371289|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
128749721|NCT02372409|463371290|FG000|Overall Study|Lost to Follow-up|1|||
128749722|NCT02372409|463371291|FG001|Overall Study|Lost to Follow-up|0|||
128749723|NCT02372409|463371290|FG000|Overall Study|Disease progression|1|||
128749724|NCT02372409|463371291|FG001|Overall Study|Disease progression|1|||
128749725|NCT04656847|463371293|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
128749726|NCT03301051|463371294|FG000|Overall Study|Adverse Event|0|||
128749727|NCT03301051|463371295|FG001|Overall Study|Adverse Event|4|||
128749728|NCT03301051|463371294|FG000|Overall Study|Withdrawal by Subject|59|||
128749729|NCT03301051|463371295|FG001|Overall Study|Withdrawal by Subject|65|||
128749730|NCT03301051|463371294|FG000|Overall Study|Lost to Follow-up|263|||
128749731|NCT03301051|463371295|FG001|Overall Study|Lost to Follow-up|282|||
128749732|NCT03301051|463371294|FG000|Overall Study|Protocol Violation|1|||
128749733|NCT03301051|463371295|FG001|Overall Study|Protocol Violation|3|||
128749734|NCT03301051|463371294|FG000|Overall Study|Physician Decision|1|||
128749735|NCT03301051|463371295|FG001|Overall Study|Physician Decision|3|||
128749736|NCT03301051|463371294|FG000|Overall Study|Death|1|||
128749737|NCT03301051|463371295|FG001|Overall Study|Death|1|||
128749738|NCT03301051|463371294|FG000|Overall Study|Miscellaneous|8|||
128749739|NCT03301051|463371295|FG001|Overall Study|Miscellaneous|4|||
128749740|NCT03301051|463371294|FG000|Overall Study|Randomized, not vaccinated|13|||
128749741|NCT03301051|463371295|FG001|Overall Study|Randomized, not vaccinated|10|||
128749742|NCT00622167|463371296|FG000|Overall Study|Did not meet angiographic criteria|20|||
128749743|NCT01954017|463371300|FG000|Overall Study|Adverse Event|0|||
128749744|NCT01954017|463371301|FG001|Overall Study|Adverse Event|0|||
128749745|NCT01954017|463371302|FG002|Overall Study|Adverse Event|1|||
128749746|NCT01954017|463371300|FG000|Overall Study|Death|2|||
128749747|NCT01954017|463371301|FG001|Overall Study|Death|1|||
128785963|NCT02955069|463509308|FG000|Overall Study|Progressive disease|64|||
128785964|NCT02955069|463509309|FG001|Overall Study|Progressive disease|13|||
128785965|NCT02955069|463509308|FG000|Overall Study|Study terminated by sponsor|4|||
128785966|NCT02955069|463509309|FG001|Overall Study|Study terminated by sponsor|0|||
128785967|NCT02955069|463509308|FG000|Overall Study|Subject/Guardian decision|3|||
128785968|NCT02955069|463509309|FG001|Overall Study|Subject/Guardian decision|1|||
128785969|NCT00943605|463509311|FG000|Overall Study|Study termination|30|||
128785970|NCT00943605|463509312|FG001|Overall Study|Study termination|30|||
128785971|NCT04148937|463509315|FG000|Overall Study|Withdrawal by Subject|0|||
128785972|NCT04148937|463509316|FG001|Overall Study|Withdrawal by Subject|0|||
128785973|NCT04148937|463509317|FG002|Overall Study|Withdrawal by Subject|0|||
128785974|NCT04148937|463509318|FG003|Overall Study|Withdrawal by Subject|1|||
128785975|NCT04148937|463509319|FG004|Overall Study|Withdrawal by Subject|0|||
128785976|NCT04148937|463509320|FG005|Overall Study|Withdrawal by Subject|1|||
128785977|NCT04148937|463509321|FG006|Overall Study|Withdrawal by Subject|1|||
128785978|NCT04148937|463509322|FG007|Overall Study|Withdrawal by Subject|0|||
128785979|NCT04148937|463509315|FG000|Overall Study|Lost to Follow-up|0|||
128785980|NCT04148937|463509316|FG001|Overall Study|Lost to Follow-up|0|||
128785981|NCT04148937|463509317|FG002|Overall Study|Lost to Follow-up|1|||
128785982|NCT04148937|463509318|FG003|Overall Study|Lost to Follow-up|0|||
128749748|NCT01954017|463371302|FG002|Overall Study|Death|1|||
128749749|NCT01954017|463371300|FG000|Overall Study|Withdrawal by Subject|0|||
128749750|NCT01954017|463371301|FG001|Overall Study|Withdrawal by Subject|1|||
128749751|NCT01954017|463371302|FG002|Overall Study|Withdrawal by Subject|0|||
128749752|NCT01954017|463371300|FG000|Overall Study|Protocol Violation|0|||
128749753|NCT01954017|463371301|FG001|Overall Study|Protocol Violation|3|||
128749754|NCT01954017|463371302|FG002|Overall Study|Protocol Violation|2|||
128749755|NCT01954017|463371300|FG000|Overall Study|Necrotizing enterocolitis|1|||
128749756|NCT01954017|463371301|FG001|Overall Study|Necrotizing enterocolitis|0|||
128749757|NCT01954017|463371302|FG002|Overall Study|Necrotizing enterocolitis|1|||
128749758|NCT01954017|463371300|FG000|Overall Study|Enteral intake stopped >7 days|0|||
128749759|NCT01954017|463371301|FG001|Overall Study|Enteral intake stopped >7 days|1|||
128749760|NCT01954017|463371302|FG002|Overall Study|Enteral intake stopped >7 days|1|||
128749761|NCT01954017|463371300|FG000|Overall Study|All other reasons|2|||
128749762|NCT01954017|463371301|FG001|Overall Study|All other reasons|2|||
128749763|NCT01954017|463371302|FG002|Overall Study|All other reasons|7|||
128749764|NCT03674177|463371304|FG000|Overall Study|Lost to Follow-up|2|||
128749765|NCT03674177|463371305|FG001|Overall Study|Lost to Follow-up|1|||
128749766|NCT03674177|463371306|FG002|Overall Study|Lost to Follow-up|0|||
128749767|NCT03674177|463371307|FG003|Overall Study|Lost to Follow-up|2|||
128749768|NCT03230916|463371315|FG000|Overall Study|Withdrawal by Subject|0|||
128749769|NCT03230916|463371316|FG001|Overall Study|Withdrawal by Subject|0|||
128749770|NCT03230916|463371317|FG002|Overall Study|Withdrawal by Subject|0|||
128749771|NCT03230916|463371318|FG003|Overall Study|Withdrawal by Subject|0|||
128749772|NCT03230916|463371319|FG004|Overall Study|Withdrawal by Subject|0|||
128749773|NCT03230916|463371320|FG005|Overall Study|Withdrawal by Subject|1|||
128749774|NCT03230916|463371321|FG006|Overall Study|Withdrawal by Subject|0|||
128749775|NCT03230916|463371322|FG007|Overall Study|Withdrawal by Subject|0|||
128749776|NCT03230916|463371323|FG008|Overall Study|Withdrawal by Subject|0|||
128749777|NCT03230916|463371324|FG009|Overall Study|Withdrawal by Subject|0|||
128749778|NCT03230916|463371325|FG010|Overall Study|Withdrawal by Subject|0|||
128749779|NCT04370054|463371326|FG000|Treatment Phase|Lost to Follow-up|1|||
128749780|NCT04370054|463371326|FG000|Treatment Phase|Withdrawal by Subject|1|||
128749781|NCT04370054|463371326|FG000|Follow-Up Phase|Ongoing|75|||
128749782|NCT00722761|463371327|FG000|Overall Study|Lost to Follow-up|1|||
128749783|NCT00722761|463371328|FG001|Overall Study|Lost to Follow-up|4|||
128749784|NCT00722761|463371327|FG000|Overall Study|Withdrawal by Subject|5|||
128749785|NCT00722761|463371328|FG001|Overall Study|Withdrawal by Subject|2|||
128749786|NCT06273774|463371330|FG000|Overall Study|Participant was out of state.|0|||
128749787|NCT06273774|463371331|FG001|Overall Study|Participant was out of state.|0|||
128749788|NCT06273774|463371332|FG002|Overall Study|Participant was out of state.|0|||
128749789|NCT06273774|463371333|FG003|Overall Study|Participant was out of state.|0|||
128749790|NCT06273774|463371334|FG004|Overall Study|Participant was out of state.|0|||
128749791|NCT06273774|463371335|FG005|Overall Study|Participant was out of state.|1|||
128749792|NCT06273774|463371330|FG000|Overall Study|Lost to Follow-up|0|||
128749793|NCT06273774|463371331|FG001|Overall Study|Lost to Follow-up|0|||
128749794|NCT06273774|463371332|FG002|Overall Study|Lost to Follow-up|0|||
128749795|NCT06273774|463371333|FG003|Overall Study|Lost to Follow-up|0|||
128749796|NCT06273774|463371334|FG004|Overall Study|Lost to Follow-up|1|||
128749797|NCT06273774|463371335|FG005|Overall Study|Lost to Follow-up|0|||
128749798|NCT01625897|463373772|FG000|Overall Study|Adverse Event|27|||
128749799|NCT01625897|463373773|FG001|Overall Study|Adverse Event|10|||
128749800|NCT01625897|463373772|FG000|Overall Study|Physician Decision|0|||
128749801|NCT01625897|463373773|FG001|Overall Study|Physician Decision|1|||
128749802|NCT01625897|463373772|FG000|Overall Study|Withdrawal by Subject|25|||
128749803|NCT01625897|463373773|FG001|Overall Study|Withdrawal by Subject|3|||
128749804|NCT01912612|463373776|FG000|Overall Study|Adverse Event|4|||
128749805|NCT01912612|463373777|FG001|Overall Study|Adverse Event|0|||
128749806|NCT01912612|463373778|FG002|Overall Study|Adverse Event|0|||
128749807|NCT01912612|463373776|FG000|Overall Study|Withdrew consent|1|||
128749808|NCT01912612|463373777|FG001|Overall Study|Withdrew consent|0|||
128749809|NCT01912612|463373778|FG002|Overall Study|Withdrew consent|0|||
128785983|NCT04148937|463509319|FG004|Overall Study|Lost to Follow-up|0|||
128785984|NCT04148937|463509320|FG005|Overall Study|Lost to Follow-up|2|||
128785985|NCT04148937|463509321|FG006|Overall Study|Lost to Follow-up|0|||
128785986|NCT04148937|463509322|FG007|Overall Study|Lost to Follow-up|0|||
128749810|NCT01912612|463373776|FG000|Overall Study|Study design change|0|||
128749811|NCT01912612|463373777|FG001|Overall Study|Study design change|0|||
128749812|NCT01912612|463373778|FG002|Overall Study|Study design change|3|||
128749813|NCT05912400|463373779|FG000|Overall Study|Lost to Follow-up|1|||
128749814|NCT05912400|463373780|FG001|Overall Study|Lost to Follow-up|0|||
128749815|NCT05912400|463373779|FG000|Overall Study|Physician Decision|6|||
128749816|NCT05912400|463373780|FG001|Overall Study|Physician Decision|0|||
128749817|NCT05912400|463373779|FG000|Overall Study|Withdrawal by Subject|1|||
128749818|NCT05912400|463373780|FG001|Overall Study|Withdrawal by Subject|0|||
128749819|NCT03461003|463373783|FG000|Overall Study|Lost to Follow-up|2|||
128749820|NCT03461003|463373784|FG001|Overall Study|Lost to Follow-up|2|||
128749821|NCT03461003|463373783|FG000|Overall Study|Withdrawal by Subject|3|||
128749822|NCT03461003|463373784|FG001|Overall Study|Withdrawal by Subject|1|||
128749823|NCT03489304|463373785|FG000|Overall Study|Lost to Follow-up|4|||
128785987|NCT01720446|463509324|FG000|Overall Study|Lost to Follow-up|12|||
128785988|NCT01720446|463509325|FG001|Overall Study|Lost to Follow-up|6|||
128785989|NCT01720446|463509326|FG002|Overall Study|Lost to Follow-up|16|||
128785990|NCT01720446|463509327|FG003|Overall Study|Lost to Follow-up|16|||
128785991|NCT01720446|463509324|FG000|Overall Study|Withdrawal by Subject|2|||
128785992|NCT01720446|463509325|FG001|Overall Study|Withdrawal by Subject|5|||
128785993|NCT01720446|463509326|FG002|Overall Study|Withdrawal by Subject|4|||
128785994|NCT01720446|463509327|FG003|Overall Study|Withdrawal by Subject|4|||
128785995|NCT04464421|463509328|FG000|Overall Study|Lost to Follow-up|2|||
128785996|NCT04464421|463509329|FG001|Overall Study|Lost to Follow-up|2|||
128785997|NCT01695317|463509332|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
128785998|NCT01695317|463509333|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
128785999|NCT01695317|463509332|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
128786000|NCT01695317|463509333|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
128786001|NCT00957229|463509335|FG000|Study Start|Adverse Event|0|||
128786002|NCT00957229|463509336|FG001|Study Start|Adverse Event|3|||
128786003|NCT00957229|463509335|FG000|Study Start|Disease Progression|1|||
128786004|NCT00957229|463509336|FG001|Study Start|Disease Progression|0|||
128786005|NCT00957229|463509335|FG000|Reallocated to or Continued Vismodegib|Death|1|||
128786006|NCT00957229|463509336|FG001|Reallocated to or Continued Vismodegib|Death|1|||
128786007|NCT00957229|463509335|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
128786008|NCT00957229|463509336|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
128786009|NCT00606580|463509337|FG000|Overall Study|Lost to Follow-up|1|||
128786010|NCT00606580|463509338|FG001|Overall Study|Lost to Follow-up|1|||
128786011|NCT00606580|463509339|FG002|Overall Study|Lost to Follow-up|4|||
128786012|NCT00606580|463509337|FG000|Overall Study|Clinical failures|1|||
128749824|NCT02239679|463373789|FG000|Overall Study|Lost to Follow-up|1|||
128749825|NCT02239679|463373790|FG001|Overall Study|Lost to Follow-up|0|||
128749826|NCT02239679|463373791|FG002|Overall Study|Lost to Follow-up|0|||
128749827|NCT02239679|463373789|FG000|Overall Study|Withdrawal by Subject|2|||
128749828|NCT02239679|463373790|FG001|Overall Study|Withdrawal by Subject|3|||
128749829|NCT02239679|463373791|FG002|Overall Study|Withdrawal by Subject|1|||
128749830|NCT02047045|463373792|FG000|Baseline|Withdrawal by Subject|3|||
128749831|NCT02047045|463373793|FG001|Baseline|Withdrawal by Subject|2|||
128749832|NCT02047045|463373792|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
128749833|NCT02047045|463373793|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
128749834|NCT02047045|463373792|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
128749835|NCT02047045|463373793|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
128749836|NCT02047045|463373792|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
128749837|NCT02047045|463373793|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
128749838|NCT02047045|463373792|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
128749839|NCT02047045|463373793|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
128749840|NCT02047045|463373792|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
128749841|NCT02047045|463373793|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
128749842|NCT02047045|463373792|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
128749843|NCT02047045|463373793|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
128749844|NCT02047045|463373792|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
128749845|NCT02047045|463373793|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
128749846|NCT02047045|463373792|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
128749847|NCT02047045|463373793|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
128749848|NCT00765843|463373794|FG000|Overall Study|Lost to Follow-up|1|||
128749849|NCT00765843|463373795|FG001|Overall Study|Lost to Follow-up|3|||
128749850|NCT00765843|463373796|FG002|Overall Study|Lost to Follow-up|2|||
128749851|NCT00765843|463373794|FG000|Overall Study|did not return to receive intervention|0|||
128749852|NCT00765843|463373795|FG001|Overall Study|did not return to receive intervention|1|||
128749853|NCT00765843|463373796|FG002|Overall Study|did not return to receive intervention|0|||
128749854|NCT00765843|463373794|FG000|Overall Study|Adverse Event|0|||
128749855|NCT00765843|463373795|FG001|Overall Study|Adverse Event|0|||
128749856|NCT00765843|463373796|FG002|Overall Study|Adverse Event|1|||
128786013|NCT00606580|463509338|FG001|Overall Study|Clinical failures|0|||
128786014|NCT00606580|463509339|FG002|Overall Study|Clinical failures|12|||
128786015|NCT00606580|463509337|FG000|Overall Study|Withdrawal by investigator|0|||
128786016|NCT00606580|463509338|FG001|Overall Study|Withdrawal by investigator|1|||
128786017|NCT00606580|463509339|FG002|Overall Study|Withdrawal by investigator|6|||
128786018|NCT00606580|463509337|FG000|Overall Study|Withdrawal by Subject|0|||
128786019|NCT00606580|463509338|FG001|Overall Study|Withdrawal by Subject|1|||
128749857|NCT02564523|463373797|FG000|Overall Study|Withdrawal by Subject|3|||
128749858|NCT02564523|463373798|FG001|Overall Study|Withdrawal by Subject|0|||
128749859|NCT02564523|463373799|FG002|Overall Study|Withdrawal by Subject|1|||
128749860|NCT02564523|463373800|FG003|Overall Study|Withdrawal by Subject|0|||
128749861|NCT02564523|463373801|FG004|Overall Study|Withdrawal by Subject|1|||
128749862|NCT02564523|463373802|FG005|Overall Study|Withdrawal by Subject|0|||
128749863|NCT02564523|463373803|FG006|Overall Study|Withdrawal by Subject|1|||
128749864|NCT02564523|463373804|FG007|Overall Study|Withdrawal by Subject|0|||
128749865|NCT02564523|463373805|FG008|Overall Study|Withdrawal by Subject|0|||
128749866|NCT02564523|463373806|FG009|Overall Study|Withdrawal by Subject|0|||
128749867|NCT02564523|463373807|FG010|Overall Study|Withdrawal by Subject|1|||
128749868|NCT02564523|463373808|FG011|Overall Study|Withdrawal by Subject|0|||
128749869|NCT02564523|463373809|FG012|Overall Study|Withdrawal by Subject|1|||
128749870|NCT02564523|463373810|FG013|Overall Study|Withdrawal by Subject|0|||
128749871|NCT02564523|463373811|FG014|Overall Study|Withdrawal by Subject|0|||
128749872|NCT02564523|463373812|FG015|Overall Study|Withdrawal by Subject|0|||
128786020|NCT00606580|463509339|FG002|Overall Study|Withdrawal by Subject|0|||
128786021|NCT01250002|463509344|FG000|Overall Study|Change to open surgical procedure|4|||
128786022|NCT01250002|463509345|FG001|Overall Study|Change to open surgical procedure|3|||
128786023|NCT04044664|463509360|FG000|Stage 1|Adverse Event|3|||
128749873|NCT02564523|463373813|FG016|Overall Study|Withdrawal by Subject|0|||
128749874|NCT02564523|463373814|FG017|Overall Study|Withdrawal by Subject|0|||
128749875|NCT02564523|463373797|FG000|Overall Study|Adverse Event|0|||
128749876|NCT02564523|463373798|FG001|Overall Study|Adverse Event|0|||
128749877|NCT02564523|463373799|FG002|Overall Study|Adverse Event|0|||
128749878|NCT02564523|463373800|FG003|Overall Study|Adverse Event|0|||
128749879|NCT02564523|463373801|FG004|Overall Study|Adverse Event|0|||
128749880|NCT02564523|463373802|FG005|Overall Study|Adverse Event|0|||
128749881|NCT02564523|463373803|FG006|Overall Study|Adverse Event|0|||
128749882|NCT02564523|463373804|FG007|Overall Study|Adverse Event|0|||
128749883|NCT02564523|463373805|FG008|Overall Study|Adverse Event|0|||
128749884|NCT02564523|463373806|FG009|Overall Study|Adverse Event|0|||
128749885|NCT02564523|463373807|FG010|Overall Study|Adverse Event|0|||
128749886|NCT02564523|463373808|FG011|Overall Study|Adverse Event|0|||
128749887|NCT02564523|463373809|FG012|Overall Study|Adverse Event|0|||
128749888|NCT02564523|463373810|FG013|Overall Study|Adverse Event|0|||
128749889|NCT02564523|463373811|FG014|Overall Study|Adverse Event|0|||
128749890|NCT02564523|463373812|FG015|Overall Study|Adverse Event|0|||
128749891|NCT02564523|463373813|FG016|Overall Study|Adverse Event|0|||
128749892|NCT02564523|463373814|FG017|Overall Study|Adverse Event|1|||
128786024|NCT04044664|463509361|FG001|Stage 1|Adverse Event|3|||
128749893|NCT02564523|463373797|FG000|Overall Study|Death|0|||
128749894|NCT02564523|463373798|FG001|Overall Study|Death|0|||
128749895|NCT02564523|463373799|FG002|Overall Study|Death|0|||
128749896|NCT02564523|463373800|FG003|Overall Study|Death|0|||
128749897|NCT02564523|463373801|FG004|Overall Study|Death|0|||
128749898|NCT02564523|463373802|FG005|Overall Study|Death|0|||
128749899|NCT02564523|463373803|FG006|Overall Study|Death|1|||
128749900|NCT02564523|463373804|FG007|Overall Study|Death|0|||
128749901|NCT02564523|463373805|FG008|Overall Study|Death|0|||
128749902|NCT02564523|463373806|FG009|Overall Study|Death|0|||
128749903|NCT02564523|463373807|FG010|Overall Study|Death|1|||
128749904|NCT02564523|463373808|FG011|Overall Study|Death|0|||
128749905|NCT02564523|463373809|FG012|Overall Study|Death|0|||
128749906|NCT02564523|463373810|FG013|Overall Study|Death|0|||
128749907|NCT02564523|463373811|FG014|Overall Study|Death|0|||
128749908|NCT02564523|463373812|FG015|Overall Study|Death|0|||
128749909|NCT02564523|463373813|FG016|Overall Study|Death|0|||
128749910|NCT02564523|463373814|FG017|Overall Study|Death|0|||
128749911|NCT02564523|463373797|FG000|Overall Study|Lost to Follow-up|2|||
128749912|NCT02564523|463373798|FG001|Overall Study|Lost to Follow-up|1|||
128749913|NCT02564523|463373799|FG002|Overall Study|Lost to Follow-up|4|||
128749914|NCT02564523|463373800|FG003|Overall Study|Lost to Follow-up|0|||
128749915|NCT02564523|463373801|FG004|Overall Study|Lost to Follow-up|1|||
128749916|NCT02564523|463373802|FG005|Overall Study|Lost to Follow-up|0|||
128749917|NCT02564523|463373803|FG006|Overall Study|Lost to Follow-up|1|||
128749918|NCT02564523|463373804|FG007|Overall Study|Lost to Follow-up|0|||
128749919|NCT02564523|463373805|FG008|Overall Study|Lost to Follow-up|0|||
128749920|NCT02564523|463373806|FG009|Overall Study|Lost to Follow-up|0|||
128749921|NCT02564523|463373807|FG010|Overall Study|Lost to Follow-up|0|||
128749922|NCT02564523|463373808|FG011|Overall Study|Lost to Follow-up|1|||
128749923|NCT02564523|463373809|FG012|Overall Study|Lost to Follow-up|1|||
128749924|NCT02564523|463373810|FG013|Overall Study|Lost to Follow-up|0|||
128749925|NCT02564523|463373811|FG014|Overall Study|Lost to Follow-up|0|||
128749926|NCT02564523|463373812|FG015|Overall Study|Lost to Follow-up|0|||
128749927|NCT02564523|463373813|FG016|Overall Study|Lost to Follow-up|0|||
128749928|NCT02564523|463373814|FG017|Overall Study|Lost to Follow-up|0|||
128749929|NCT02564523|463373797|FG000|Overall Study|Physician Decision|0|||
128749930|NCT02564523|463373798|FG001|Overall Study|Physician Decision|0|||
128749931|NCT02564523|463373799|FG002|Overall Study|Physician Decision|0|||
128749932|NCT02564523|463373800|FG003|Overall Study|Physician Decision|0|||
128749933|NCT02564523|463373801|FG004|Overall Study|Physician Decision|1|||
128749934|NCT02564523|463373802|FG005|Overall Study|Physician Decision|0|||
128749935|NCT02564523|463373803|FG006|Overall Study|Physician Decision|0|||
128749936|NCT02564523|463373804|FG007|Overall Study|Physician Decision|0|||
128749937|NCT02564523|463373805|FG008|Overall Study|Physician Decision|0|||
128749938|NCT02564523|463373806|FG009|Overall Study|Physician Decision|0|||
128749939|NCT02564523|463373807|FG010|Overall Study|Physician Decision|1|||
128749940|NCT02564523|463373808|FG011|Overall Study|Physician Decision|0|||
128749941|NCT02564523|463373809|FG012|Overall Study|Physician Decision|0|||
128749942|NCT02564523|463373810|FG013|Overall Study|Physician Decision|0|||
128749943|NCT02564523|463373811|FG014|Overall Study|Physician Decision|0|||
128749944|NCT02564523|463373812|FG015|Overall Study|Physician Decision|0|||
128749945|NCT02564523|463373813|FG016|Overall Study|Physician Decision|0|||
128749946|NCT02564523|463373814|FG017|Overall Study|Physician Decision|0|||
128749947|NCT02564523|463373797|FG000|Overall Study|Protocol Violation|2|||
128749948|NCT02564523|463373798|FG001|Overall Study|Protocol Violation|2|||
128749949|NCT02564523|463373799|FG002|Overall Study|Protocol Violation|5|||
128749950|NCT02564523|463373800|FG003|Overall Study|Protocol Violation|0|||
128749951|NCT02564523|463373801|FG004|Overall Study|Protocol Violation|1|||
128749952|NCT02564523|463373802|FG005|Overall Study|Protocol Violation|0|||
128749953|NCT02564523|463373803|FG006|Overall Study|Protocol Violation|0|||
128786025|NCT04044664|463509362|FG002|Stage 1|Adverse Event|1|||
128786026|NCT04044664|463509360|FG000|Stage 1|Lost to Follow-up|3|||
128786027|NCT04044664|463509361|FG001|Stage 1|Lost to Follow-up|2|||
128786028|NCT04044664|463509362|FG002|Stage 1|Lost to Follow-up|2|||
128786029|NCT04044664|463509360|FG000|Stage 1|Withdrawal by Subject|9|||
128786030|NCT04044664|463509361|FG001|Stage 1|Withdrawal by Subject|1|||
128786031|NCT04044664|463509362|FG002|Stage 1|Withdrawal by Subject|0|||
128749954|NCT02564523|463373804|FG007|Overall Study|Protocol Violation|0|||
128749955|NCT02564523|463373805|FG008|Overall Study|Protocol Violation|0|||
128749956|NCT02564523|463373806|FG009|Overall Study|Protocol Violation|0|||
128749957|NCT02564523|463373807|FG010|Overall Study|Protocol Violation|0|||
128749958|NCT02564523|463373808|FG011|Overall Study|Protocol Violation|0|||
128749959|NCT02564523|463373809|FG012|Overall Study|Protocol Violation|0|||
128749960|NCT02564523|463373810|FG013|Overall Study|Protocol Violation|0|||
128749961|NCT02564523|463373811|FG014|Overall Study|Protocol Violation|0|||
128749962|NCT02564523|463373812|FG015|Overall Study|Protocol Violation|0|||
128749963|NCT02564523|463373813|FG016|Overall Study|Protocol Violation|0|||
128749964|NCT02564523|463373814|FG017|Overall Study|Protocol Violation|0|||
128749965|NCT02564523|463373797|FG000|Overall Study|Other|3|||
128749966|NCT02564523|463373798|FG001|Overall Study|Other|0|||
128749967|NCT02564523|463373799|FG002|Overall Study|Other|0|||
128749968|NCT02564523|463373800|FG003|Overall Study|Other|1|||
128749969|NCT02564523|463373801|FG004|Overall Study|Other|0|||
128749970|NCT02564523|463373802|FG005|Overall Study|Other|0|||
128749971|NCT02564523|463373803|FG006|Overall Study|Other|0|||
128749972|NCT02564523|463373804|FG007|Overall Study|Other|0|||
128749973|NCT02564523|463373805|FG008|Overall Study|Other|0|||
128749974|NCT02564523|463373806|FG009|Overall Study|Other|0|||
128749975|NCT02564523|463373807|FG010|Overall Study|Other|0|||
128749976|NCT02564523|463373808|FG011|Overall Study|Other|0|||
128749977|NCT02564523|463373809|FG012|Overall Study|Other|0|||
128749978|NCT02564523|463373810|FG013|Overall Study|Other|0|||
128749979|NCT02564523|463373811|FG014|Overall Study|Other|0|||
128749980|NCT02564523|463373812|FG015|Overall Study|Other|0|||
128749981|NCT02564523|463373813|FG016|Overall Study|Other|0|||
128749982|NCT02564523|463373814|FG017|Overall Study|Other|0|||
128749983|NCT04862143|463373818|FG000|Overall Study|Adverse Event|1|||
128749984|NCT04862143|463373818|FG000|Overall Study|Study terminated by sponsor|1|||
128749985|NCT03031938|463373819|FG000|Overall Study|Death|1|||
128749986|NCT03031938|463373820|FG001|Overall Study|Death|0|||
128749987|NCT02479412|463373823|FG000|Overall Study|Adverse Event|0|||
128749988|NCT02479412|463373824|FG001|Overall Study|Adverse Event|0|||
128749989|NCT02479412|463373825|FG002|Overall Study|Adverse Event|1|||
128749990|NCT02479412|463373826|FG003|Overall Study|Adverse Event|0|||
128749991|NCT02479412|463373827|FG004|Overall Study|Adverse Event|0|||
128749992|NCT02479412|463373828|FG005|Overall Study|Adverse Event|0|||
128749993|NCT02479412|463373829|FG006|Overall Study|Adverse Event|0|||
128749994|NCT02479412|463373830|FG007|Overall Study|Adverse Event|0|||
128749995|NCT02479412|463373831|FG008|Overall Study|Adverse Event|0|||
128749996|NCT02479412|463373823|FG000|Overall Study|Study-specific withdrawal criteria|0|||
128749997|NCT02479412|463373824|FG001|Overall Study|Study-specific withdrawal criteria|0|||
128749998|NCT02479412|463373825|FG002|Overall Study|Study-specific withdrawal criteria|1|||
128749999|NCT02479412|463373826|FG003|Overall Study|Study-specific withdrawal criteria|1|||
128750000|NCT02479412|463373827|FG004|Overall Study|Study-specific withdrawal criteria|0|||
128750001|NCT02479412|463373828|FG005|Overall Study|Study-specific withdrawal criteria|0|||
128750002|NCT02479412|463373829|FG006|Overall Study|Study-specific withdrawal criteria|0|||
128750003|NCT02479412|463373830|FG007|Overall Study|Study-specific withdrawal criteria|1|||
128750004|NCT02479412|463373831|FG008|Overall Study|Study-specific withdrawal criteria|1|||
128750005|NCT02479412|463373823|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
128750006|NCT02479412|463373824|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
128750007|NCT02479412|463373825|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
128750008|NCT02479412|463373826|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
128750009|NCT02479412|463373827|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
128750010|NCT02479412|463373828|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
128750011|NCT02479412|463373829|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
128750012|NCT02479412|463373830|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
128750013|NCT02479412|463373831|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
128750014|NCT01571362|463373832|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
128750015|NCT01571362|463373833|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
128750016|NCT01571362|463373834|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
128750017|NCT01571362|463373832|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
128750018|NCT01571362|463373833|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
128750019|NCT01571362|463373834|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
128750020|NCT01571362|463373832|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
128750021|NCT01571362|463373833|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
128750022|NCT01571362|463373834|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
128750023|NCT01571362|463373832|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
128750024|NCT01571362|463373833|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
128750025|NCT01571362|463373834|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
128750026|NCT01571362|463373832|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
128750027|NCT01571362|463373833|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
128750028|NCT01571362|463373834|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
128750029|NCT01571362|463373832|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
128750030|NCT01571362|463373833|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
128750031|NCT01571362|463373834|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
128750032|NCT01571362|463373832|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
128750033|NCT01571362|463373833|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
128750034|NCT01571362|463373834|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
128750035|NCT01571362|463373832|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
128750036|NCT01571362|463373833|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
128750037|NCT01571362|463373834|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
128750038|NCT01571362|463373832|FG000|Double-Blind Treatment Period|Adverse Event|0|||
128750039|NCT01571362|463373833|FG001|Double-Blind Treatment Period|Adverse Event|9|||
128750040|NCT01571362|463373834|FG002|Double-Blind Treatment Period|Adverse Event|14|||
128750041|NCT01571362|463373832|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
128750042|NCT01571362|463373833|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
128786032|NCT04044664|463509360|FG000|Stage 1|noncompliance, personal reason|2|||
128750043|NCT01571362|463373834|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
128750044|NCT01571362|463373832|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
128750045|NCT01571362|463373833|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
128750046|NCT01571362|463373834|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
128750047|NCT01571362|463373832|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
128750048|NCT01571362|463373833|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
128750049|NCT01571362|463373834|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
128750050|NCT03667053|463373836|FG000|Overall Study|Withdrawal by Subject|1|||
128750051|NCT03667053|463373837|FG001|Overall Study|Withdrawal by Subject|0|||
128750052|NCT03667053|463373838|FG002|Overall Study|Withdrawal by Subject|0|||
128750053|NCT00487162|463373843|FG000|Overall Study|Adverse Event|0|||
128750054|NCT00487162|463373844|FG001|Overall Study|Adverse Event|1|||
128750055|NCT00487162|463373843|FG000|Overall Study|Physician Decision|0|||
128750056|NCT00487162|463373844|FG001|Overall Study|Physician Decision|1|||
128750057|NCT00487162|463373843|FG000|Overall Study|Withdrawal by Subject|2|||
128750058|NCT00487162|463373844|FG001|Overall Study|Withdrawal by Subject|3|||
128750059|NCT01292928|463373848|FG000|Overall Study|Death|8|||
128750060|NCT01292928|463373848|FG000|Overall Study|Withdrawal by Subject|8|||
128750061|NCT01292928|463373848|FG000|Overall Study|Lost to Follow-up|6|||
128750062|NCT01292928|463373848|FG000|Overall Study|Physician Decision|2|||
128750063|NCT01491854|463373849|FG000|Overall Study|mainly due to premature termination|93|||
128750064|NCT01491854|463373849|FG000|Overall Study|Death|1|||
128750065|NCT01491854|463373849|FG000|Overall Study|Withdrawal by Subject|3|||
128750066|NCT01491854|463373849|FG000|Overall Study|Lost to Follow-up|33|||
128750067|NCT00121238|463373850|FG000|Overall Study|disease progression before intervention|1|||
128750068|NCT00121238|463373850|FG000|Overall Study|Protocol Violation|2|||
128750069|NCT01026974|463373859|FG000|Overall Study|Withdrawal by Subject|0|||
128750070|NCT01026974|463373860|FG001|Overall Study|Withdrawal by Subject|1|||
128750071|NCT01026974|463373861|FG002|Overall Study|Withdrawal by Subject|7|||
128750072|NCT01026974|463373862|FG003|Overall Study|Withdrawal by Subject|2|||
128750073|NCT01026974|463373859|FG000|Overall Study|Lost to Follow-up|1|||
128750074|NCT01026974|463373860|FG001|Overall Study|Lost to Follow-up|1|||
128750075|NCT01026974|463373861|FG002|Overall Study|Lost to Follow-up|4|||
128750076|NCT01026974|463373862|FG003|Overall Study|Lost to Follow-up|0|||
128750077|NCT01026974|463373859|FG000|Overall Study|Adverse Event|0|||
128750078|NCT01026974|463373860|FG001|Overall Study|Adverse Event|0|||
128750079|NCT01026974|463373861|FG002|Overall Study|Adverse Event|0|||
128750080|NCT01026974|463373862|FG003|Overall Study|Adverse Event|1|||
128750081|NCT01026974|463373859|FG000|Overall Study|Inappropriate enrollment|0|||
128750082|NCT01026974|463373860|FG001|Overall Study|Inappropriate enrollment|0|||
128750083|NCT01026974|463373861|FG002|Overall Study|Inappropriate enrollment|1|||
128750084|NCT01026974|463373862|FG003|Overall Study|Inappropriate enrollment|0|||
128750085|NCT00325468|463373863|FG000|Overall Study|Adverse Event|1|||
128750086|NCT00325468|463373864|FG001|Overall Study|Adverse Event|1|||
128750087|NCT00325468|463373865|FG002|Overall Study|Adverse Event|0|||
128750088|NCT00325468|463373866|FG003|Overall Study|Adverse Event|5|||
128750089|NCT00325468|463373867|FG004|Overall Study|Adverse Event|1|||
128750090|NCT00325468|463373863|FG000|Overall Study|Death|2|||
128750091|NCT00325468|463373864|FG001|Overall Study|Death|0|||
128750092|NCT00325468|463373865|FG002|Overall Study|Death|2|||
128750093|NCT00325468|463373866|FG003|Overall Study|Death|4|||
128750094|NCT00325468|463373867|FG004|Overall Study|Death|0|||
128750095|NCT00325468|463373863|FG000|Overall Study|Lost to Follow-up|0|||
128750096|NCT00325468|463373864|FG001|Overall Study|Lost to Follow-up|0|||
128750097|NCT00325468|463373865|FG002|Overall Study|Lost to Follow-up|1|||
128750098|NCT00325468|463373866|FG003|Overall Study|Lost to Follow-up|2|||
128750099|NCT00325468|463373867|FG004|Overall Study|Lost to Follow-up|2|||
128750100|NCT00325468|463373863|FG000|Overall Study|Physician Decision|1|||
128750101|NCT00325468|463373864|FG001|Overall Study|Physician Decision|1|||
128750102|NCT00325468|463373865|FG002|Overall Study|Physician Decision|0|||
128750103|NCT00325468|463373866|FG003|Overall Study|Physician Decision|1|||
128750104|NCT00325468|463373867|FG004|Overall Study|Physician Decision|0|||
128750105|NCT00325468|463373863|FG000|Overall Study|Withdrawal by Subject|3|||
128750106|NCT00325468|463373864|FG001|Overall Study|Withdrawal by Subject|1|||
128750107|NCT00325468|463373865|FG002|Overall Study|Withdrawal by Subject|0|||
128750108|NCT00325468|463373866|FG003|Overall Study|Withdrawal by Subject|14|||
128750109|NCT00325468|463373867|FG004|Overall Study|Withdrawal by Subject|4|||
128750110|NCT00325468|463373863|FG000|Overall Study|site closure etc|4|||
128750111|NCT00325468|463373864|FG001|Overall Study|site closure etc|2|||
128750112|NCT00325468|463373865|FG002|Overall Study|site closure etc|1|||
128750113|NCT00325468|463373866|FG003|Overall Study|site closure etc|8|||
128750114|NCT00325468|463373867|FG004|Overall Study|site closure etc|1|||
128750115|NCT01314118|463373873|FG000|Overall Study|Adverse Event|9|||
128750116|NCT01314118|463373873|FG000|Overall Study|Progressive disease|27|||
128750117|NCT01314118|463373873|FG000|Overall Study|Physician Decision|11|||
128750118|NCT01314118|463373873|FG000|Overall Study|Death|4|||
128786033|NCT04044664|463509361|FG001|Stage 1|noncompliance, personal reason|0|||
128750119|NCT01314118|463373873|FG000|Overall Study|Protocol Violation|5|||
128750120|NCT01314118|463373873|FG000|Overall Study|Withdrawal by Subject|11|||
128750121|NCT01314118|463373873|FG000|Overall Study|Other|2|||
128750122|NCT01314118|463373873|FG000|Overall Study|Ongoing|62|||
128750123|NCT05545072|463373879|FG000|Overall Study|Lost to Follow-up|1|||
128750124|NCT05545072|463373880|FG001|Overall Study|Lost to Follow-up|0|||
128750125|NCT05545072|463373879|FG000|Overall Study|Study ended prematurely due to funding|2|||
128750126|NCT05545072|463373880|FG001|Overall Study|Study ended prematurely due to funding|2|||
128750127|NCT05585307|463373881|FG000|Overall Study|Lost to Follow-up|0|||
128750128|NCT05585307|463373882|FG001|Overall Study|Lost to Follow-up|0|||
128750129|NCT05585307|463373883|FG002|Overall Study|Lost to Follow-up|0|||
128750130|NCT05585307|463373884|FG003|Overall Study|Lost to Follow-up|0|||
128750131|NCT05585307|463373885|FG004|Overall Study|Lost to Follow-up|0|||
128750132|NCT05585307|463373886|FG005|Overall Study|Lost to Follow-up|0|||
128750133|NCT05585307|463373887|FG006|Overall Study|Lost to Follow-up|1|||
128750134|NCT05585307|463373888|FG007|Overall Study|Lost to Follow-up|0|||
128786034|NCT04044664|463509362|FG002|Stage 1|noncompliance, personal reason|0|||
128786035|NCT04044664|463509360|FG000|Stage 1|randomization error|0|||
128750135|NCT04642638|463373889|FG000|Overall Study|Withdrawal by Subject|23|||
128750136|NCT04642638|463373890|FG001|Overall Study|Withdrawal by Subject|29|||
128750137|NCT04642638|463373891|FG002|Overall Study|Withdrawal by Subject|9|||
128750138|NCT04642638|463373892|FG003|Overall Study|Withdrawal by Subject|7|||
128750139|NCT04642638|463373893|FG004|Overall Study|Withdrawal by Subject|61|||
128750140|NCT04642638|463373894|FG005|Overall Study|Withdrawal by Subject|27|||
128750141|NCT04642638|463373889|FG000|Overall Study|Lost to Follow-up|17|||
128750142|NCT04642638|463373890|FG001|Overall Study|Lost to Follow-up|18|||
128750143|NCT04642638|463373891|FG002|Overall Study|Lost to Follow-up|5|||
128750144|NCT04642638|463373892|FG003|Overall Study|Lost to Follow-up|5|||
128750145|NCT04642638|463373893|FG004|Overall Study|Lost to Follow-up|6|||
128750146|NCT04642638|463373894|FG005|Overall Study|Lost to Follow-up|3|||
128750147|NCT04642638|463373889|FG000|Overall Study|Adverse Event|0|||
128750148|NCT04642638|463373890|FG001|Overall Study|Adverse Event|0|||
128750149|NCT04642638|463373891|FG002|Overall Study|Adverse Event|1|||
128786036|NCT04044664|463509361|FG001|Stage 1|randomization error|1|||
128786037|NCT04044664|463509362|FG002|Stage 1|randomization error|0|||
128786038|NCT04044664|463509360|FG000|Stage 2|Adverse Event|2|||
128786039|NCT04044664|463509361|FG001|Stage 2|Adverse Event|0|||
128786040|NCT04044664|463509362|FG002|Stage 2|Adverse Event|0|||
128786041|NCT04044664|463509360|FG000|Stage 2|Lost to Follow-up|3|||
128786042|NCT04044664|463509361|FG001|Stage 2|Lost to Follow-up|2|||
128786043|NCT04044664|463509362|FG002|Stage 2|Lost to Follow-up|1|||
128786044|NCT04044664|463509360|FG000|Stage 2|Withdrawal by Subject|3|||
128786045|NCT04044664|463509361|FG001|Stage 2|Withdrawal by Subject|0|||
128786046|NCT04044664|463509362|FG002|Stage 2|Withdrawal by Subject|0|||
128786047|NCT04044664|463509360|FG000|Stage 2|protocol deviation|1|||
128786048|NCT04044664|463509361|FG001|Stage 2|protocol deviation|0|||
128786049|NCT04044664|463509362|FG002|Stage 2|protocol deviation|0|||
128786050|NCT03736785|463509363|FG000|Overall Study|Adverse Event|1|||
128786051|NCT03736785|463509364|FG001|Overall Study|Adverse Event|1|||
128786052|NCT03736785|463509365|FG002|Overall Study|Adverse Event|1|||
128786053|NCT03736785|463509363|FG000|Overall Study|Death|1|||
128786054|NCT03736785|463509364|FG001|Overall Study|Death|0|||
128786055|NCT03736785|463509365|FG002|Overall Study|Death|1|||
128786056|NCT03736785|463509363|FG000|Overall Study|Lost to Follow-up|0|||
128786057|NCT03736785|463509364|FG001|Overall Study|Lost to Follow-up|2|||
128786058|NCT03736785|463509365|FG002|Overall Study|Lost to Follow-up|3|||
128786059|NCT03736785|463509363|FG000|Overall Study|Non compliance with study drug|1|||
128786060|NCT03736785|463509364|FG001|Overall Study|Non compliance with study drug|1|||
128786061|NCT03736785|463509365|FG002|Overall Study|Non compliance with study drug|0|||
128786062|NCT03736785|463509363|FG000|Overall Study|Physician Decision|0|||
128786063|NCT03736785|463509364|FG001|Overall Study|Physician Decision|1|||
128786064|NCT03736785|463509365|FG002|Overall Study|Physician Decision|1|||
128786065|NCT03736785|463509363|FG000|Overall Study|Protocol Violation|1|||
128786066|NCT03736785|463509364|FG001|Overall Study|Protocol Violation|4|||
128786067|NCT03736785|463509365|FG002|Overall Study|Protocol Violation|3|||
128786068|NCT03736785|463509363|FG000|Overall Study|Sponsor Decision|1|||
128786069|NCT03736785|463509364|FG001|Overall Study|Sponsor Decision|0|||
128786070|NCT03736785|463509365|FG002|Overall Study|Sponsor Decision|0|||
128786071|NCT03736785|463509363|FG000|Overall Study|Unknown/Missing data|3|||
128786072|NCT03736785|463509364|FG001|Overall Study|Unknown/Missing data|2|||
128786073|NCT03736785|463509365|FG002|Overall Study|Unknown/Missing data|1|||
128786074|NCT03736785|463509363|FG000|Overall Study|Withdrawal by Subject|9|||
128786075|NCT03736785|463509364|FG001|Overall Study|Withdrawal by Subject|6|||
128786076|NCT03736785|463509365|FG002|Overall Study|Withdrawal by Subject|4|||
128786077|NCT01744691|463509367|FG000|Overall Study|Progressive Disease|18|||
128786078|NCT01744691|463509367|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
128786079|NCT01744691|463509367|FG000|Overall Study|Withdrawal of consent for treatment|3|||
128786080|NCT01744691|463509367|FG000|Overall Study|Physician Decision|4|||
128786081|NCT04588480|463509368|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
128786082|NCT04588480|463509369|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
128786083|NCT04588480|463509370|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
128786084|NCT04588480|463509368|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
128786085|NCT04588480|463509369|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
128786086|NCT04588480|463509370|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
128786087|NCT01549652|463509371|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
128786088|NCT01549652|463509372|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
128750150|NCT04642638|463373892|FG003|Overall Study|Adverse Event|0|||
128750151|NCT04642638|463373893|FG004|Overall Study|Adverse Event|10|||
128786089|NCT01549652|463509373|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
128786090|NCT01549652|463509374|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
128786091|NCT01549652|463509371|FG000|Overall Study|Study Drug Titration Failure|5|||
128786092|NCT01549652|463509372|FG001|Overall Study|Study Drug Titration Failure|6|||
128786093|NCT01549652|463509373|FG002|Overall Study|Study Drug Titration Failure|0|||
128786094|NCT01549652|463509374|FG003|Overall Study|Study Drug Titration Failure|0|||
128750152|NCT04642638|463373894|FG005|Overall Study|Adverse Event|3|||
128750153|NCT04642638|463373889|FG000|Overall Study|Reason Not Specified|1|||
128786095|NCT01549652|463509371|FG000|Overall Study|Withdrawal Effect|0|||
128786096|NCT01549652|463509372|FG001|Overall Study|Withdrawal Effect|2|||
128786097|NCT01549652|463509373|FG002|Overall Study|Withdrawal Effect|0|||
128786098|NCT01549652|463509374|FG003|Overall Study|Withdrawal Effect|0|||
128750154|NCT04642638|463373890|FG001|Overall Study|Reason Not Specified|4|||
128750155|NCT04642638|463373891|FG002|Overall Study|Reason Not Specified|0|||
128750156|NCT04642638|463373892|FG003|Overall Study|Reason Not Specified|0|||
128750157|NCT04642638|463373893|FG004|Overall Study|Reason Not Specified|38|||
128750158|NCT04642638|463373894|FG005|Overall Study|Reason Not Specified|16|||
128750159|NCT04642638|463373889|FG000|Overall Study|Physician Decision|0|||
128750160|NCT04642638|463373890|FG001|Overall Study|Physician Decision|0|||
128750161|NCT04642638|463373891|FG002|Overall Study|Physician Decision|0|||
128750162|NCT04642638|463373892|FG003|Overall Study|Physician Decision|0|||
128750163|NCT04642638|463373893|FG004|Overall Study|Physician Decision|2|||
128750164|NCT04642638|463373894|FG005|Overall Study|Physician Decision|1|||
128750165|NCT04642638|463373889|FG000|Overall Study|Protocol Deviation|0|||
128750166|NCT04642638|463373890|FG001|Overall Study|Protocol Deviation|0|||
128750167|NCT04642638|463373891|FG002|Overall Study|Protocol Deviation|0|||
128750168|NCT04642638|463373892|FG003|Overall Study|Protocol Deviation|0|||
128750169|NCT04642638|463373893|FG004|Overall Study|Protocol Deviation|1|||
128750170|NCT04642638|463373894|FG005|Overall Study|Protocol Deviation|3|||
128750171|NCT04642638|463373889|FG000|Overall Study|Study Terminated|0|||
128750172|NCT04642638|463373890|FG001|Overall Study|Study Terminated|0|||
128750173|NCT04642638|463373891|FG002|Overall Study|Study Terminated|0|||
128750174|NCT04642638|463373892|FG003|Overall Study|Study Terminated|0|||
128750175|NCT04642638|463373893|FG004|Overall Study|Study Terminated|484|||
128750176|NCT04642638|463373894|FG005|Overall Study|Study Terminated|250|||
128750177|NCT04642638|463373889|FG000|Overall Study|Pregnancy|0|||
128750178|NCT04642638|463373890|FG001|Overall Study|Pregnancy|0|||
128750179|NCT04642638|463373891|FG002|Overall Study|Pregnancy|0|||
128750180|NCT04642638|463373892|FG003|Overall Study|Pregnancy|0|||
128750181|NCT04642638|463373893|FG004|Overall Study|Pregnancy|1|||
128750182|NCT04642638|463373894|FG005|Overall Study|Pregnancy|0|||
128750183|NCT00688636|463373901|FG000|Overall Study|Adverse Event|2|||
128750184|NCT00688636|463373902|FG001|Overall Study|Adverse Event|1|||
128750185|NCT04053764|463373903|FG000|Overall Study|Withdrawal by Subject|6|||
128750186|NCT04053764|463373904|FG001|Overall Study|Withdrawal by Subject|2|||
128750187|NCT04053764|463373903|FG000|Overall Study|Physician Decision|2|||
128750188|NCT04053764|463373904|FG001|Overall Study|Physician Decision|1|||
128750189|NCT04053764|463373903|FG000|Overall Study|Adverse Event|1|||
128750190|NCT04053764|463373904|FG001|Overall Study|Adverse Event|0|||
128750191|NCT04053764|463373903|FG000|Overall Study|Pregnancy|1|||
128750192|NCT04053764|463373904|FG001|Overall Study|Pregnancy|0|||
128750193|NCT02384954|463373908|FG000|Phase 1|Progressive Disease|2|||
128750194|NCT02384954|463373909|FG001|Phase 1|Progressive Disease|0|||
128750195|NCT02384954|463373910|FG002|Phase 1|Progressive Disease|1|||
128750196|NCT02384954|463373911|FG003|Phase 1|Progressive Disease|1|||
128750197|NCT02384954|463373912|FG004|Phase 1|Progressive Disease|0|||
128750198|NCT02384954|463373913|FG005|Phase 1|Progressive Disease|0|||
128750199|NCT02384954|463373914|FG006|Phase 1|Progressive Disease|0|||
128750200|NCT02384954|463373915|FG007|Phase 1|Progressive Disease|0|||
128750201|NCT02384954|463373916|FG008|Phase 1|Progressive Disease|0|||
128750202|NCT02384954|463373908|FG000|Phase 1|Adverse Event|0|||
128750203|NCT02384954|463373909|FG001|Phase 1|Adverse Event|0|||
128750204|NCT02384954|463373910|FG002|Phase 1|Adverse Event|1|||
128750205|NCT02384954|463373911|FG003|Phase 1|Adverse Event|0|||
128750206|NCT02384954|463373912|FG004|Phase 1|Adverse Event|0|||
128750207|NCT02384954|463373913|FG005|Phase 1|Adverse Event|0|||
128750208|NCT02384954|463373914|FG006|Phase 1|Adverse Event|0|||
128750209|NCT02384954|463373915|FG007|Phase 1|Adverse Event|0|||
128750210|NCT02384954|463373916|FG008|Phase 1|Adverse Event|0|||
128750211|NCT02384954|463373908|FG000|Phase 2|Progressive Disease|0|||
128750212|NCT02384954|463373909|FG001|Phase 2|Progressive Disease|0|||
128750213|NCT02384954|463373910|FG002|Phase 2|Progressive Disease|0|||
128750214|NCT02384954|463373911|FG003|Phase 2|Progressive Disease|0|||
128750215|NCT02384954|463373912|FG004|Phase 2|Progressive Disease|0|||
128750216|NCT02384954|463373913|FG005|Phase 2|Progressive Disease|0|||
128750217|NCT02384954|463373914|FG006|Phase 2|Progressive Disease|0|||
128750218|NCT02384954|463373915|FG007|Phase 2|Progressive Disease|1|||
128750219|NCT02384954|463373916|FG008|Phase 2|Progressive Disease|2|||
128750220|NCT02384954|463373908|FG000|Phase 2|Adverse Event|0|||
128750221|NCT02384954|463373909|FG001|Phase 2|Adverse Event|0|||
128750222|NCT02384954|463373910|FG002|Phase 2|Adverse Event|0|||
128750223|NCT02384954|463373911|FG003|Phase 2|Adverse Event|0|||
128750224|NCT02384954|463373912|FG004|Phase 2|Adverse Event|0|||
128750225|NCT02384954|463373913|FG005|Phase 2|Adverse Event|0|||
128750226|NCT02384954|463373914|FG006|Phase 2|Adverse Event|0|||
128750227|NCT02384954|463373915|FG007|Phase 2|Adverse Event|1|||
128750228|NCT02384954|463373916|FG008|Phase 2|Adverse Event|1|||
128750229|NCT02384954|463373908|FG000|Phase 2|Failure to meet continuation criteria|0|||
128750230|NCT02384954|463373909|FG001|Phase 2|Failure to meet continuation criteria|0|||
128750231|NCT02384954|463373910|FG002|Phase 2|Failure to meet continuation criteria|0|||
128750232|NCT02384954|463373911|FG003|Phase 2|Failure to meet continuation criteria|0|||
128750233|NCT02384954|463373912|FG004|Phase 2|Failure to meet continuation criteria|0|||
128750234|NCT02384954|463373913|FG005|Phase 2|Failure to meet continuation criteria|0|||
128750235|NCT02384954|463373914|FG006|Phase 2|Failure to meet continuation criteria|0|||
128750236|NCT02384954|463373915|FG007|Phase 2|Failure to meet continuation criteria|1|||
128750237|NCT02384954|463373916|FG008|Phase 2|Failure to meet continuation criteria|0|||
128750238|NCT04732286|463373917|FG000|Overall Study|Progressive Disease|2|||
128750239|NCT04732286|463373917|FG000|Overall Study|Physician Decision|1|||
128750240|NCT04732286|463373917|FG000|Overall Study|Study Terminated by Sponsor|31|||
128750241|NCT04732286|463373917|FG000|Overall Study|Withdrawal by Subject|10|||
128750242|NCT04732286|463373917|FG000|Overall Study|Non-compliance With Study Drug|1|||
128750243|NCT04732286|463373917|FG000|Overall Study|Lost to Follow-up|4|||
128750244|NCT04732286|463373917|FG000|Overall Study|Death|51|||
128750245|NCT01474681|463373918|FG000|Overall Study|Death|0|||
128750246|NCT01474681|463373919|FG001|Overall Study|Death|3|||
128750247|NCT01474681|463373920|FG002|Overall Study|Death|2|||
128750248|NCT01474681|463373921|FG003|Overall Study|Death|6|||
128750249|NCT03595904|463373926|FG000|Overall Study|Protocol Violation|3|||
128750250|NCT03595904|463373927|FG001|Overall Study|Protocol Violation|1|||
128750251|NCT03595904|463373926|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
128750252|NCT03595904|463373927|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
128750253|NCT03595904|463373926|FG000|Overall Study|Insurance complications|1|||
128750254|NCT03595904|463373927|FG001|Overall Study|Insurance complications|0|||
128750255|NCT03595904|463373926|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
128750256|NCT03595904|463373927|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
128750257|NCT02081846|463373928|FG000|Overall Study|Withdrawal by Subject|1|||
128750258|NCT02081846|463373929|FG001|Overall Study|Withdrawal by Subject|0|||
128750259|NCT02081846|463373928|FG000|Overall Study|invalid consent|1|||
128750260|NCT02081846|463373929|FG001|Overall Study|invalid consent|0|||
128750261|NCT00295750|463373933|FG000|Overall Study|Adverse Event|19|||
128750262|NCT00295750|463373934|FG001|Overall Study|Adverse Event|15|||
128750263|NCT00295750|463373935|FG002|Overall Study|Adverse Event|12|||
128750264|NCT00295750|463373933|FG000|Overall Study|Lack of Efficacy|1|||
128750265|NCT00295750|463373934|FG001|Overall Study|Lack of Efficacy|1|||
128750266|NCT00295750|463373935|FG002|Overall Study|Lack of Efficacy|0|||
128750267|NCT00295750|463373933|FG000|Overall Study|Lost to Follow-up|1|||
128750268|NCT00295750|463373934|FG001|Overall Study|Lost to Follow-up|4|||
128750269|NCT00295750|463373935|FG002|Overall Study|Lost to Follow-up|1|||
128750270|NCT00295750|463373933|FG000|Overall Study|Taking prohibited therapy|2|||
128750271|NCT00295750|463373934|FG001|Overall Study|Taking prohibited therapy|3|||
128750272|NCT00295750|463373935|FG002|Overall Study|Taking prohibited therapy|2|||
128750273|NCT00295750|463373933|FG000|Overall Study|Administrative errors|2|||
128750274|NCT00295750|463373934|FG001|Overall Study|Administrative errors|4|||
128750275|NCT00295750|463373935|FG002|Overall Study|Administrative errors|5|||
128750276|NCT00295750|463373933|FG000|Overall Study|Trial drug errors|1|||
128750277|NCT00295750|463373934|FG001|Overall Study|Trial drug errors|1|||
128750278|NCT00295750|463373935|FG002|Overall Study|Trial drug errors|0|||
128750279|NCT00295750|463373933|FG000|Overall Study|Disease progression|2|||
128750280|NCT00295750|463373934|FG001|Overall Study|Disease progression|1|||
128750281|NCT00295750|463373935|FG002|Overall Study|Disease progression|0|||
128750282|NCT00295750|463373933|FG000|Overall Study|Personal reasons|0|||
128750283|NCT00295750|463373934|FG001|Overall Study|Personal reasons|1|||
128750284|NCT00295750|463373935|FG002|Overall Study|Personal reasons|0|||
128750285|NCT00295750|463373933|FG000|Overall Study|Randomized but never received trial drug|4|||
128750286|NCT00295750|463373934|FG001|Overall Study|Randomized but never received trial drug|3|||
128750287|NCT00295750|463373935|FG002|Overall Study|Randomized but never received trial drug|3|||
128750288|NCT00295750|463373933|FG000|Overall Study|Withdrawal by Subject|9|||
128750289|NCT00295750|463373934|FG001|Overall Study|Withdrawal by Subject|4|||
128750290|NCT00295750|463373935|FG002|Overall Study|Withdrawal by Subject|7|||
128750291|NCT00295750|463373933|FG000|Overall Study|Protocol Violation|2|||
128750292|NCT00295750|463373934|FG001|Overall Study|Protocol Violation|4|||
128750293|NCT00295750|463373935|FG002|Overall Study|Protocol Violation|2|||
128750294|NCT01881126|463373947|FG000|Overall Study|Non-compliance|1|||
128750295|NCT01881126|463373948|FG001|Overall Study|Non-compliance|1|||
128750296|NCT01881126|463373947|FG000|Overall Study|Adverse Event|0|||
128750297|NCT01881126|463373948|FG001|Overall Study|Adverse Event|1|||
128750298|NCT01808313|463373949|FG000|Overall Study|Adverse Event|5|||
128750299|NCT01808313|463373949|FG000|Overall Study|Protocol Violation|2|||
128750300|NCT01808313|463373949|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128750301|NCT01808313|463373949|FG000|Overall Study|Lost to Follow-up|1|||
128750302|NCT01808313|463373949|FG000|Overall Study|Physician Decision|1|||
128750303|NCT00047879|463373951|FG000|Overall Study|Progressive disease|4|||
128750304|NCT00047879|463373952|FG001|Overall Study|Progressive disease|3|||
128750305|NCT00714168|463373959|FG000|Overall Study|Pregnancy|5|||
128750306|NCT00714168|463373960|FG001|Overall Study|Pregnancy|4|||
128750307|NCT00714168|463373959|FG000|Overall Study|Lost to Follow-up|32|||
128750308|NCT00714168|463373960|FG001|Overall Study|Lost to Follow-up|50|||
128750309|NCT00714168|463373959|FG000|Overall Study|Relocation|4|||
128750310|NCT00714168|463373960|FG001|Overall Study|Relocation|3|||
128750311|NCT00714168|463373959|FG000|Overall Study|Non-study medical condition|3|||
128750312|NCT00714168|463373960|FG001|Overall Study|Non-study medical condition|2|||
128750313|NCT04764396|463373967|FG000|Overall Study|Physician Decision|1|||
128750314|NCT04764396|463373968|FG001|Overall Study|Physician Decision|0|||
128750315|NCT02653482|463373970|FG000|Overall Study|Death|1|||
128750316|NCT02653482|463373971|FG001|Overall Study|Death|1|||
128750317|NCT01864564|463373974|FG000|Overall Study|Lost to Follow-up|17|||
128750318|NCT01864564|463373975|FG001|Overall Study|Lost to Follow-up|23|||
128750319|NCT01864564|463373974|FG000|Overall Study|Withdrawal by Subject|20|||
128750320|NCT01864564|463373975|FG001|Overall Study|Withdrawal by Subject|11|||
128750321|NCT01864564|463373974|FG000|Overall Study|Protocol Violation|0|||
128750322|NCT01864564|463373975|FG001|Overall Study|Protocol Violation|27|||
128750323|NCT01864564|463373974|FG000|Overall Study|not reported|0|||
128750324|NCT01864564|463373975|FG001|Overall Study|not reported|34|||
128750325|NCT03077724|463373976|FG000|Overall Study|Lost to Follow-up|5|||
128750326|NCT03077724|463373977|FG001|Overall Study|Lost to Follow-up|1|||
128750327|NCT03077724|463373976|FG000|Overall Study|Withdrawal by Subject|3|||
128750328|NCT03077724|463373977|FG001|Overall Study|Withdrawal by Subject|1|||
128750329|NCT02269670|463373978|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
128750330|NCT04657211|463373981|FG000|Overall Study|Withdrawal by Subject|21|||
128750331|NCT04657211|463373981|FG000|Overall Study|Lost to Follow-up|113|||
128750332|NCT04657211|463373981|FG000|Overall Study|Death|47|||
128750333|NCT04657211|463373981|FG000|Overall Study|Transfer to another institution|21|||
128750334|NCT04657211|463373981|FG000|Overall Study|Other|29|||
128750335|NCT02693665|463373982|FG000|Overall Study|Death|3|||
128750336|NCT02693665|463373983|FG001|Overall Study|Death|2|||
128750337|NCT02693665|463373982|FG000|Overall Study|Lost to Follow-up|7|||
128750338|NCT02693665|463373983|FG001|Overall Study|Lost to Follow-up|3|||
128750339|NCT02693665|463373982|FG000|Overall Study|Protocol Violation|1|||
128750340|NCT02693665|463373983|FG001|Overall Study|Protocol Violation|0|||
128750341|NCT02693665|463373982|FG000|Overall Study|Withdrawal by Subject|2|||
128750342|NCT02693665|463373983|FG001|Overall Study|Withdrawal by Subject|0|||
128750343|NCT02693665|463373982|FG000|Overall Study|patient wanted to leave it behind|1|||
128750344|NCT02693665|463373983|FG001|Overall Study|patient wanted to leave it behind|0|||
128750345|NCT02693665|463373982|FG000|Overall Study|anxiety|1|||
128750346|NCT02693665|463373983|FG001|Overall Study|anxiety|0|||
128750347|NCT02693665|463373982|FG000|Overall Study|family issues|1|||
128750348|NCT02693665|463373983|FG001|Overall Study|family issues|0|||
128750349|NCT02693665|463373982|FG000|Overall Study|no reason given|1|||
128750350|NCT02693665|463373983|FG001|Overall Study|no reason given|0|||
128750351|NCT01962493|463373986|FG000|Overall Study|Adverse Event|1|||
128750352|NCT01962493|463373987|FG001|Overall Study|Adverse Event|2|||
128750353|NCT01962493|463373986|FG000|Overall Study|Protocol Violation|0|||
128750354|NCT01962493|463373987|FG001|Overall Study|Protocol Violation|1|||
128750355|NCT01962493|463373986|FG000|Overall Study|Withdrawal by Subject|4|||
128750356|NCT01962493|463373987|FG001|Overall Study|Withdrawal by Subject|2|||
128750357|NCT03776136|463373988|FG000|Overall Study|Death|85|||
128750358|NCT03776136|463373988|FG000|Overall Study|Withdrawal by Subject|3|||
128750359|NCT03776136|463373988|FG000|Overall Study|Sponsor Decision|15|||
128750360|NCT04414696|463373989|FG000|3-month Follow up|Withdrawal by Subject|1|||
128750361|NCT04414696|463373990|FG001|3-month Follow up|Withdrawal by Subject|0|||
128750362|NCT04414696|463373989|FG000|3-month Follow up|Lost to Follow-up|22|||
128750363|NCT04414696|463373990|FG001|3-month Follow up|Lost to Follow-up|23|||
128750364|NCT04414696|463373989|FG000|6-month Follow up|Withdrawal by Subject|1|||
128750365|NCT04414696|463373990|FG001|6-month Follow up|Withdrawal by Subject|2|||
128750366|NCT04414696|463373989|FG000|6-month Follow up|Lost to Follow-up|5|||
128750367|NCT04414696|463373990|FG001|6-month Follow up|Lost to Follow-up|2|||
128750368|NCT00924287|463375783|FG000|Overall Study|Death|1|||
128750369|NCT02621931|463375784|FG000|Overall Study|Death|0|||
128750370|NCT02621931|463375785|FG001|Overall Study|Death|1|||
128750371|NCT02621931|463375786|FG002|Overall Study|Death|0|||
128750372|NCT02621931|463375784|FG000|Overall Study|Adverse Event|8|||
128750373|NCT02621931|463375785|FG001|Overall Study|Adverse Event|5|||
128750374|NCT02621931|463375786|FG002|Overall Study|Adverse Event|7|||
128750375|NCT02621931|463375784|FG000|Overall Study|Withdrawal by Subject|12|||
128750376|NCT02621931|463375785|FG001|Overall Study|Withdrawal by Subject|10|||
128750377|NCT02621931|463375786|FG002|Overall Study|Withdrawal by Subject|11|||
128750378|NCT02621931|463375784|FG000|Overall Study|Protocol Violation|2|||
128750379|NCT02621931|463375785|FG001|Overall Study|Protocol Violation|2|||
128750380|NCT02621931|463375786|FG002|Overall Study|Protocol Violation|2|||
128750381|NCT02621931|463375784|FG000|Overall Study|Pregnancy|2|||
128750382|NCT02621931|463375785|FG001|Overall Study|Pregnancy|0|||
128750383|NCT02621931|463375786|FG002|Overall Study|Pregnancy|0|||
128750384|NCT02621931|463375784|FG000|Overall Study|Noncompliance to study procedures|0|||
128750385|NCT02621931|463375785|FG001|Overall Study|Noncompliance to study procedures|1|||
128750386|NCT02621931|463375786|FG002|Overall Study|Noncompliance to study procedures|2|||
128750387|NCT02621931|463375784|FG000|Overall Study|Lost to Follow-up|8|||
128750388|NCT02621931|463375785|FG001|Overall Study|Lost to Follow-up|7|||
128750389|NCT02621931|463375786|FG002|Overall Study|Lost to Follow-up|10|||
128750390|NCT02621931|463375784|FG000|Overall Study|Lack of Efficacy|0|||
128750391|NCT02621931|463375785|FG001|Overall Study|Lack of Efficacy|0|||
128750392|NCT02621931|463375786|FG002|Overall Study|Lack of Efficacy|1|||
128750393|NCT02621931|463375784|FG000|Overall Study|Other|1|||
128750394|NCT02621931|463375785|FG001|Overall Study|Other|1|||
128750395|NCT02621931|463375786|FG002|Overall Study|Other|3|||
128750396|NCT01588184|463375787|FG000|Overall Study|Death|1|||
128750397|NCT01588184|463375788|FG001|Overall Study|Death|0|||
128750398|NCT01588184|463375789|FG002|Overall Study|Death|0|||
128750399|NCT01588184|463375790|FG003|Overall Study|Death|1|||
128750400|NCT01588184|463375791|FG004|Overall Study|Death|1|||
128750401|NCT01588184|463375792|FG005|Overall Study|Death|1|||
128750402|NCT01588184|463375787|FG000|Overall Study|Withdrawal by Subject|2|||
128750403|NCT01588184|463375788|FG001|Overall Study|Withdrawal by Subject|4|||
128750404|NCT01588184|463375789|FG002|Overall Study|Withdrawal by Subject|0|||
128750405|NCT01588184|463375790|FG003|Overall Study|Withdrawal by Subject|1|||
128750406|NCT01588184|463375791|FG004|Overall Study|Withdrawal by Subject|0|||
128750407|NCT01588184|463375792|FG005|Overall Study|Withdrawal by Subject|0|||
128750408|NCT01588184|463375787|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
128750409|NCT01588184|463375788|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
128750410|NCT01588184|463375789|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
128750411|NCT01588184|463375790|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
128750412|NCT01588184|463375791|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
128750413|NCT01588184|463375792|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
128750414|NCT01588184|463375787|FG000|Overall Study|multiple reasons|0|||
128750415|NCT01588184|463375788|FG001|Overall Study|multiple reasons|3|||
128750416|NCT01588184|463375789|FG002|Overall Study|multiple reasons|0|||
128750417|NCT01588184|463375790|FG003|Overall Study|multiple reasons|1|||
128750418|NCT01588184|463375791|FG004|Overall Study|multiple reasons|0|||
128750419|NCT01588184|463375792|FG005|Overall Study|multiple reasons|0|||
128750420|NCT02008890|463375794|FG000|Period 1|Withdrawal by Subject|7|||
128750421|NCT02008890|463375795|FG001|Period 1|Withdrawal by Subject|7|||
128750422|NCT02008890|463375796|FG002|Period 1|Withdrawal by Subject|5|||
128750423|NCT02008890|463375797|FG003|Period 1|Withdrawal by Subject|0|||
128750424|NCT02008890|463375798|FG004|Period 1|Withdrawal by Subject|0|||
128750425|NCT02008890|463375794|FG000|Period 1|Pregnancy|1|||
128750426|NCT02008890|463375795|FG001|Period 1|Pregnancy|0|||
128750427|NCT02008890|463375796|FG002|Period 1|Pregnancy|0|||
128750428|NCT02008890|463375797|FG003|Period 1|Pregnancy|0|||
128750429|NCT02008890|463375798|FG004|Period 1|Pregnancy|0|||
128750430|NCT02008890|463375794|FG000|Period 1|Physician Decision|1|||
128750431|NCT02008890|463375795|FG001|Period 1|Physician Decision|0|||
128750432|NCT02008890|463375796|FG002|Period 1|Physician Decision|1|||
128750433|NCT02008890|463375797|FG003|Period 1|Physician Decision|0|||
128750434|NCT02008890|463375798|FG004|Period 1|Physician Decision|0|||
128750435|NCT02008890|463375794|FG000|Period 1|Adverse Event|6|||
128750436|NCT02008890|463375795|FG001|Period 1|Adverse Event|8|||
128750437|NCT02008890|463375796|FG002|Period 1|Adverse Event|6|||
128750438|NCT02008890|463375797|FG003|Period 1|Adverse Event|0|||
128750439|NCT02008890|463375798|FG004|Period 1|Adverse Event|0|||
128750440|NCT02008890|463375794|FG000|Period 2|Adverse Event|12|||
128750441|NCT02008890|463375795|FG001|Period 2|Adverse Event|7|||
128750442|NCT02008890|463375796|FG002|Period 2|Adverse Event|0|||
128750443|NCT02008890|463375797|FG003|Period 2|Adverse Event|5|||
128750444|NCT02008890|463375798|FG004|Period 2|Adverse Event|5|||
128786099|NCT01549652|463509371|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
128750445|NCT02008890|463375794|FG000|Period 2|Withdrawal by Subject|11|||
128750446|NCT02008890|463375795|FG001|Period 2|Withdrawal by Subject|8|||
128750447|NCT02008890|463375796|FG002|Period 2|Withdrawal by Subject|0|||
128750448|NCT02008890|463375797|FG003|Period 2|Withdrawal by Subject|7|||
128750449|NCT02008890|463375798|FG004|Period 2|Withdrawal by Subject|2|||
128750450|NCT02008890|463375794|FG000|Period 2|Physician Decision|4|||
128750451|NCT02008890|463375795|FG001|Period 2|Physician Decision|0|||
128750452|NCT02008890|463375796|FG002|Period 2|Physician Decision|0|||
128750453|NCT02008890|463375797|FG003|Period 2|Physician Decision|2|||
128750454|NCT02008890|463375798|FG004|Period 2|Physician Decision|1|||
128750455|NCT02008890|463375794|FG000|Period 2|Lost to Follow-up|0|||
128750456|NCT02008890|463375795|FG001|Period 2|Lost to Follow-up|0|||
128750457|NCT02008890|463375796|FG002|Period 2|Lost to Follow-up|1|||
128750458|NCT02008890|463375797|FG003|Period 2|Lost to Follow-up|0|||
128750459|NCT02008890|463375798|FG004|Period 2|Lost to Follow-up|0|||
128750460|NCT02008890|463375794|FG000|Extension Period|Withdrawal by Subject|3|||
128750461|NCT02008890|463375795|FG001|Extension Period|Withdrawal by Subject|2|||
128750462|NCT02008890|463375796|FG002|Extension Period|Withdrawal by Subject|0|||
128750463|NCT02008890|463375797|FG003|Extension Period|Withdrawal by Subject|4|||
128750464|NCT02008890|463375798|FG004|Extension Period|Withdrawal by Subject|2|||
128750465|NCT02008890|463375794|FG000|Extension Period|Lost to Follow-up|1|||
128750466|NCT02008890|463375795|FG001|Extension Period|Lost to Follow-up|0|||
128750467|NCT02008890|463375796|FG002|Extension Period|Lost to Follow-up|0|||
128750468|NCT02008890|463375797|FG003|Extension Period|Lost to Follow-up|0|||
128750469|NCT02008890|463375798|FG004|Extension Period|Lost to Follow-up|0|||
128750470|NCT02008890|463375794|FG000|Extension Period|Adverse Event|1|||
128750471|NCT02008890|463375795|FG001|Extension Period|Adverse Event|3|||
128750472|NCT02008890|463375796|FG002|Extension Period|Adverse Event|0|||
128750473|NCT02008890|463375797|FG003|Extension Period|Adverse Event|0|||
128750474|NCT02008890|463375798|FG004|Extension Period|Adverse Event|2|||
128750475|NCT02207816|463375799|FG000|Overall Study|Serious Adverse Event|0|||
128750476|NCT02207816|463375800|FG001|Overall Study|Serious Adverse Event|5|||
128750477|NCT02207816|463375801|FG002|Overall Study|Serious Adverse Event|2|||
128750478|NCT02207816|463375799|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
128750479|NCT02207816|463375800|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
128750480|NCT02207816|463375801|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
128750481|NCT02207816|463375799|FG000|Overall Study|Withdrawal by Subject|4|||
128750482|NCT02207816|463375800|FG001|Overall Study|Withdrawal by Subject|9|||
128750483|NCT02207816|463375801|FG002|Overall Study|Withdrawal by Subject|7|||
128750484|NCT02207816|463375799|FG000|Overall Study|Migrated/Moved From Study Area|41|||
128750485|NCT02207816|463375800|FG001|Overall Study|Migrated/Moved From Study Area|60|||
128750486|NCT02207816|463375801|FG002|Overall Study|Migrated/Moved From Study Area|51|||
128750487|NCT02207816|463375799|FG000|Overall Study|Lost to Follow-up|3|||
128750488|NCT02207816|463375800|FG001|Overall Study|Lost to Follow-up|9|||
128750489|NCT02207816|463375801|FG002|Overall Study|Lost to Follow-up|1|||
128750490|NCT02207816|463375799|FG000|Overall Study|Other|1|||
128750491|NCT02207816|463375800|FG001|Overall Study|Other|2|||
128750492|NCT02207816|463375801|FG002|Overall Study|Other|4|||
128750493|NCT02522494|463375802|FG000|Overall Study|Lost to Follow-up|6|||
128750494|NCT02522494|463375803|FG001|Overall Study|Lost to Follow-up|2|||
128750495|NCT02522494|463375802|FG000|Overall Study|Withdrawal by Subject|1|||
128750496|NCT02522494|463375803|FG001|Overall Study|Withdrawal by Subject|0|||
128750497|NCT02522494|463375802|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
128750498|NCT02522494|463375803|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
128750499|NCT02522494|463375802|FG000|Overall Study|Participant did not watch the video|1|||
128750500|NCT02522494|463375803|FG001|Overall Study|Participant did not watch the video|0|||
128750501|NCT02522494|463375802|FG000|Overall Study|Death|0|||
128750502|NCT02522494|463375803|FG001|Overall Study|Death|1|||
128750503|NCT02811861|463375804|FG000|Overall Study|Radiological Disease Progression|123|||
128750504|NCT02811861|463375805|FG001|Overall Study|Radiological Disease Progression|97|||
128750505|NCT02811861|463375806|FG002|Overall Study|Radiological Disease Progression|174|||
128750506|NCT02811861|463375804|FG000|Overall Study|Clinical Disease Progression|20|||
128750507|NCT02811861|463375805|FG001|Overall Study|Clinical Disease Progression|19|||
128750508|NCT02811861|463375806|FG002|Overall Study|Clinical Disease Progression|22|||
128750509|NCT02811861|463375804|FG000|Overall Study|Adverse Event|63|||
128750510|NCT02811861|463375805|FG001|Overall Study|Adverse Event|60|||
128750511|NCT02811861|463375806|FG002|Overall Study|Adverse Event|41|||
128750512|NCT02811861|463375804|FG000|Overall Study|Lost to Follow-up|0|||
128750513|NCT02811861|463375805|FG001|Overall Study|Lost to Follow-up|0|||
128750514|NCT02811861|463375806|FG002|Overall Study|Lost to Follow-up|1|||
128750515|NCT02811861|463375804|FG000|Overall Study|Subject Choice|29|||
128750516|NCT02811861|463375805|FG001|Overall Study|Subject Choice|17|||
128750517|NCT02811861|463375806|FG002|Overall Study|Subject Choice|23|||
128750518|NCT02811861|463375804|FG000|Overall Study|Withdrawal by Subject|4|||
128750519|NCT02811861|463375805|FG001|Overall Study|Withdrawal by Subject|4|||
128750520|NCT02811861|463375806|FG002|Overall Study|Withdrawal by Subject|9|||
128750521|NCT02811861|463375804|FG000|Overall Study|Other|4|||
128750522|NCT02811861|463375805|FG001|Overall Study|Other|13|||
128750523|NCT02811861|463375806|FG002|Overall Study|Other|3|||
128750524|NCT02811861|463375804|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
128750525|NCT02811861|463375805|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
128750526|NCT02811861|463375806|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
128750527|NCT02811861|463375804|FG000|Overall Study|Randomized but not treated|2|||
128750528|NCT02811861|463375805|FG001|Overall Study|Randomized but not treated|3|||
128750529|NCT02811861|463375806|FG002|Overall Study|Randomized but not treated|17|||
128750530|NCT02925455|463375807|FG000|Overall Study|Withdrawal by Subject|2|||
128750531|NCT02925455|463375808|FG001|Overall Study|Withdrawal by Subject|0|||
128750532|NCT00360308|463375811|FG000|Overall Study|Adverse Event|15|||
128750533|NCT00360308|463375812|FG001|Overall Study|Adverse Event|14|||
128750534|NCT00360308|463375813|FG002|Overall Study|Adverse Event|25|||
128750535|NCT00360308|463375811|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
128750536|NCT00360308|463375812|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
128750537|NCT00360308|463375813|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
128750538|NCT00360308|463375811|FG000|Overall Study|Protocol Violation|2|||
128750539|NCT00360308|463375812|FG001|Overall Study|Protocol Violation|1|||
128750540|NCT00360308|463375813|FG002|Overall Study|Protocol Violation|2|||
128750541|NCT00360308|463375811|FG000|Overall Study|Withdrawal by Subject|11|||
128750542|NCT00360308|463375812|FG001|Overall Study|Withdrawal by Subject|7|||
128750543|NCT00360308|463375813|FG002|Overall Study|Withdrawal by Subject|14|||
128750544|NCT00360308|463375811|FG000|Overall Study|Lack of Efficacy|3|||
128750545|NCT00360308|463375812|FG001|Overall Study|Lack of Efficacy|0|||
128750546|NCT00360308|463375813|FG002|Overall Study|Lack of Efficacy|2|||
128750547|NCT00360308|463375811|FG000|Overall Study|Other|2|||
128750548|NCT00360308|463375812|FG001|Overall Study|Other|1|||
128750549|NCT00360308|463375813|FG002|Overall Study|Other|1|||
128750550|NCT00360308|463375811|FG000|Overall Study|Study termination by sponsor|43|||
128750551|NCT00360308|463375812|FG001|Overall Study|Study termination by sponsor|55|||
128750552|NCT00360308|463375813|FG002|Overall Study|Study termination by sponsor|44|||
128750553|NCT01217073|463375814|FG000|Base Period|Adverse Event|1|||
128750554|NCT01217073|463375815|FG001|Base Period|Adverse Event|0|||
128750555|NCT01217073|463375816|FG002|Base Period|Adverse Event|1|||
128750556|NCT01217073|463375817|FG003|Base Period|Adverse Event|0|||
128750557|NCT01217073|463375818|FG004|Base Period|Adverse Event|4|||
128750558|NCT01217073|463375819|FG005|Base Period|Adverse Event|1|||
128750559|NCT01217073|463375820|FG006|Base Period|Adverse Event|0|||
128750560|NCT01217073|463375821|FG007|Base Period|Adverse Event|0|||
128750561|NCT01217073|463375814|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
128750562|NCT01217073|463375815|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
128750563|NCT01217073|463375816|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
128750564|NCT01217073|463375817|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
128750565|NCT01217073|463375818|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
128750566|NCT01217073|463375819|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
128750567|NCT01217073|463375820|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
128750568|NCT01217073|463375821|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
128750569|NCT01217073|463375814|FG000|Base Period|Excluded medication|0|||
128750570|NCT01217073|463375815|FG001|Base Period|Excluded medication|0|||
128750571|NCT01217073|463375816|FG002|Base Period|Excluded medication|0|||
128750572|NCT01217073|463375817|FG003|Base Period|Excluded medication|0|||
128750573|NCT01217073|463375818|FG004|Base Period|Excluded medication|1|||
128750574|NCT01217073|463375819|FG005|Base Period|Excluded medication|0|||
128750575|NCT01217073|463375820|FG006|Base Period|Excluded medication|0|||
128750576|NCT01217073|463375821|FG007|Base Period|Excluded medication|0|||
128750577|NCT01217073|463375814|FG000|Base Period|Lack of Efficacy|0|||
128750578|NCT01217073|463375815|FG001|Base Period|Lack of Efficacy|0|||
128750579|NCT01217073|463375816|FG002|Base Period|Lack of Efficacy|0|||
128750580|NCT01217073|463375817|FG003|Base Period|Lack of Efficacy|0|||
128750581|NCT01217073|463375818|FG004|Base Period|Lack of Efficacy|0|||
128750582|NCT01217073|463375819|FG005|Base Period|Lack of Efficacy|1|||
128750583|NCT01217073|463375820|FG006|Base Period|Lack of Efficacy|0|||
128750584|NCT01217073|463375821|FG007|Base Period|Lack of Efficacy|0|||
128750585|NCT01217073|463375814|FG000|Base Period|Lost to Follow-up|0|||
128750586|NCT01217073|463375815|FG001|Base Period|Lost to Follow-up|0|||
128750587|NCT01217073|463375816|FG002|Base Period|Lost to Follow-up|1|||
128750588|NCT01217073|463375817|FG003|Base Period|Lost to Follow-up|1|||
128750589|NCT01217073|463375818|FG004|Base Period|Lost to Follow-up|3|||
128750590|NCT01217073|463375819|FG005|Base Period|Lost to Follow-up|0|||
128750591|NCT01217073|463375820|FG006|Base Period|Lost to Follow-up|0|||
128750592|NCT01217073|463375821|FG007|Base Period|Lost to Follow-up|0|||
128750593|NCT01217073|463375814|FG000|Base Period|Physician Decision|0|||
128750594|NCT01217073|463375815|FG001|Base Period|Physician Decision|0|||
128750595|NCT01217073|463375816|FG002|Base Period|Physician Decision|0|||
128750596|NCT01217073|463375817|FG003|Base Period|Physician Decision|0|||
128750597|NCT01217073|463375818|FG004|Base Period|Physician Decision|1|||
128750598|NCT01217073|463375819|FG005|Base Period|Physician Decision|0|||
128750599|NCT01217073|463375820|FG006|Base Period|Physician Decision|0|||
128750600|NCT01217073|463375821|FG007|Base Period|Physician Decision|0|||
128750601|NCT01217073|463375814|FG000|Base Period|Protocol Violation|1|||
128750602|NCT01217073|463375815|FG001|Base Period|Protocol Violation|0|||
128750603|NCT01217073|463375816|FG002|Base Period|Protocol Violation|0|||
128750604|NCT01217073|463375817|FG003|Base Period|Protocol Violation|0|||
128750605|NCT01217073|463375818|FG004|Base Period|Protocol Violation|1|||
128750606|NCT01217073|463375819|FG005|Base Period|Protocol Violation|2|||
128750607|NCT01217073|463375820|FG006|Base Period|Protocol Violation|0|||
128750608|NCT01217073|463375821|FG007|Base Period|Protocol Violation|0|||
128750609|NCT01217073|463375814|FG000|Base Period|Withdrawal by Subject|4|||
128750610|NCT01217073|463375815|FG001|Base Period|Withdrawal by Subject|5|||
128750611|NCT01217073|463375816|FG002|Base Period|Withdrawal by Subject|5|||
128750612|NCT01217073|463375817|FG003|Base Period|Withdrawal by Subject|1|||
128750613|NCT01217073|463375818|FG004|Base Period|Withdrawal by Subject|5|||
128750614|NCT01217073|463375819|FG005|Base Period|Withdrawal by Subject|5|||
128750615|NCT01217073|463375820|FG006|Base Period|Withdrawal by Subject|0|||
128750616|NCT01217073|463375821|FG007|Base Period|Withdrawal by Subject|0|||
128750617|NCT01217073|463375814|FG000|Extension Period|Adverse Event|0|||
128750618|NCT01217073|463375815|FG001|Extension Period|Adverse Event|0|||
128750619|NCT01217073|463375816|FG002|Extension Period|Adverse Event|0|||
128750620|NCT01217073|463375817|FG003|Extension Period|Adverse Event|0|||
128750621|NCT01217073|463375818|FG004|Extension Period|Adverse Event|0|||
128750622|NCT01217073|463375819|FG005|Extension Period|Adverse Event|0|||
128750623|NCT01217073|463375820|FG006|Extension Period|Adverse Event|19|||
128750624|NCT01217073|463375821|FG007|Extension Period|Adverse Event|5|||
128750625|NCT01217073|463375814|FG000|Extension Period|ALT/AST|0|||
128750626|NCT01217073|463375815|FG001|Extension Period|ALT/AST|0|||
128750627|NCT01217073|463375816|FG002|Extension Period|ALT/AST|0|||
128750628|NCT01217073|463375817|FG003|Extension Period|ALT/AST|0|||
128750629|NCT01217073|463375818|FG004|Extension Period|ALT/AST|0|||
128750630|NCT01217073|463375819|FG005|Extension Period|ALT/AST|0|||
128750631|NCT01217073|463375820|FG006|Extension Period|ALT/AST|2|||
128750632|NCT01217073|463375821|FG007|Extension Period|ALT/AST|0|||
128750633|NCT01217073|463375814|FG000|Extension Period|Contraindication to study medication|0|||
128750634|NCT01217073|463375815|FG001|Extension Period|Contraindication to study medication|0|||
128750635|NCT01217073|463375816|FG002|Extension Period|Contraindication to study medication|0|||
128750636|NCT01217073|463375817|FG003|Extension Period|Contraindication to study medication|0|||
128750637|NCT01217073|463375818|FG004|Extension Period|Contraindication to study medication|0|||
128750638|NCT01217073|463375819|FG005|Extension Period|Contraindication to study medication|0|||
128750639|NCT01217073|463375820|FG006|Extension Period|Contraindication to study medication|1|||
128750640|NCT01217073|463375821|FG007|Extension Period|Contraindication to study medication|0|||
128750641|NCT01217073|463375814|FG000|Extension Period|Creatinine/eGFR|0|||
128750642|NCT01217073|463375815|FG001|Extension Period|Creatinine/eGFR|0|||
128750643|NCT01217073|463375816|FG002|Extension Period|Creatinine/eGFR|0|||
128750644|NCT01217073|463375817|FG003|Extension Period|Creatinine/eGFR|0|||
128750645|NCT01217073|463375818|FG004|Extension Period|Creatinine/eGFR|0|||
128750646|NCT01217073|463375819|FG005|Extension Period|Creatinine/eGFR|0|||
128750647|NCT01217073|463375820|FG006|Extension Period|Creatinine/eGFR|11|||
128750648|NCT01217073|463375821|FG007|Extension Period|Creatinine/eGFR|1|||
128750649|NCT01217073|463375814|FG000|Extension Period|Death|0|||
128750650|NCT01217073|463375815|FG001|Extension Period|Death|0|||
128750651|NCT01217073|463375816|FG002|Extension Period|Death|0|||
128750652|NCT01217073|463375817|FG003|Extension Period|Death|0|||
128750653|NCT01217073|463375818|FG004|Extension Period|Death|0|||
128750654|NCT01217073|463375819|FG005|Extension Period|Death|0|||
128750655|NCT01217073|463375820|FG006|Extension Period|Death|1|||
128750656|NCT01217073|463375821|FG007|Extension Period|Death|0|||
128750657|NCT01217073|463375814|FG000|Extension Period|Excluded medication|0|||
128750658|NCT01217073|463375815|FG001|Extension Period|Excluded medication|0|||
128750659|NCT01217073|463375816|FG002|Extension Period|Excluded medication|0|||
128750660|NCT01217073|463375817|FG003|Extension Period|Excluded medication|0|||
128750661|NCT01217073|463375818|FG004|Extension Period|Excluded medication|0|||
128750662|NCT01217073|463375819|FG005|Extension Period|Excluded medication|0|||
128750663|NCT01217073|463375820|FG006|Extension Period|Excluded medication|2|||
128750664|NCT01217073|463375821|FG007|Extension Period|Excluded medication|0|||
128750665|NCT01217073|463375814|FG000|Extension Period|Lack of Efficacy|0|||
128750666|NCT01217073|463375815|FG001|Extension Period|Lack of Efficacy|0|||
128750667|NCT01217073|463375816|FG002|Extension Period|Lack of Efficacy|0|||
128750668|NCT01217073|463375817|FG003|Extension Period|Lack of Efficacy|0|||
128750669|NCT01217073|463375818|FG004|Extension Period|Lack of Efficacy|0|||
128750670|NCT01217073|463375819|FG005|Extension Period|Lack of Efficacy|0|||
128750671|NCT01217073|463375820|FG006|Extension Period|Lack of Efficacy|3|||
128750672|NCT01217073|463375821|FG007|Extension Period|Lack of Efficacy|0|||
128750673|NCT01217073|463375814|FG000|Extension Period|Lost to Follow-up|0|||
128750674|NCT01217073|463375815|FG001|Extension Period|Lost to Follow-up|0|||
128750675|NCT01217073|463375816|FG002|Extension Period|Lost to Follow-up|0|||
128750676|NCT01217073|463375817|FG003|Extension Period|Lost to Follow-up|0|||
128750677|NCT01217073|463375818|FG004|Extension Period|Lost to Follow-up|0|||
128750678|NCT01217073|463375819|FG005|Extension Period|Lost to Follow-up|0|||
128750679|NCT01217073|463375820|FG006|Extension Period|Lost to Follow-up|9|||
128750680|NCT01217073|463375821|FG007|Extension Period|Lost to Follow-up|1|||
128750681|NCT01217073|463375814|FG000|Extension Period|Non-compliance with study drug|0|||
128750682|NCT01217073|463375815|FG001|Extension Period|Non-compliance with study drug|0|||
128750683|NCT01217073|463375816|FG002|Extension Period|Non-compliance with study drug|0|||
128750684|NCT01217073|463375817|FG003|Extension Period|Non-compliance with study drug|0|||
128750685|NCT01217073|463375818|FG004|Extension Period|Non-compliance with study drug|0|||
128750686|NCT01217073|463375819|FG005|Extension Period|Non-compliance with study drug|0|||
128750687|NCT01217073|463375820|FG006|Extension Period|Non-compliance with study drug|0|||
128750688|NCT01217073|463375821|FG007|Extension Period|Non-compliance with study drug|1|||
128750689|NCT01217073|463375814|FG000|Extension Period|Physician Decision|0|||
128750690|NCT01217073|463375815|FG001|Extension Period|Physician Decision|0|||
128750691|NCT01217073|463375816|FG002|Extension Period|Physician Decision|0|||
128750692|NCT01217073|463375817|FG003|Extension Period|Physician Decision|0|||
128750693|NCT01217073|463375818|FG004|Extension Period|Physician Decision|0|||
128750694|NCT01217073|463375819|FG005|Extension Period|Physician Decision|0|||
128750695|NCT01217073|463375820|FG006|Extension Period|Physician Decision|4|||
128750696|NCT01217073|463375821|FG007|Extension Period|Physician Decision|1|||
128750697|NCT01217073|463375814|FG000|Extension Period|Protocol Violation|0|||
128750698|NCT01217073|463375815|FG001|Extension Period|Protocol Violation|0|||
128750699|NCT01217073|463375816|FG002|Extension Period|Protocol Violation|0|||
128750700|NCT01217073|463375817|FG003|Extension Period|Protocol Violation|0|||
128750701|NCT01217073|463375818|FG004|Extension Period|Protocol Violation|0|||
128750702|NCT01217073|463375819|FG005|Extension Period|Protocol Violation|0|||
128750703|NCT01217073|463375820|FG006|Extension Period|Protocol Violation|2|||
128750704|NCT01217073|463375821|FG007|Extension Period|Protocol Violation|1|||
128750705|NCT01217073|463375814|FG000|Extension Period|Site discontinued study participation|0|||
128750706|NCT01217073|463375815|FG001|Extension Period|Site discontinued study participation|0|||
128750707|NCT01217073|463375816|FG002|Extension Period|Site discontinued study participation|0|||
128750708|NCT01217073|463375817|FG003|Extension Period|Site discontinued study participation|0|||
128750709|NCT01217073|463375818|FG004|Extension Period|Site discontinued study participation|0|||
128750710|NCT01217073|463375819|FG005|Extension Period|Site discontinued study participation|0|||
128750711|NCT01217073|463375820|FG006|Extension Period|Site discontinued study participation|7|||
128750712|NCT01217073|463375821|FG007|Extension Period|Site discontinued study participation|2|||
128750713|NCT01217073|463375814|FG000|Extension Period|Withdrawal by Subject|0|||
128750714|NCT01217073|463375815|FG001|Extension Period|Withdrawal by Subject|0|||
128750715|NCT01217073|463375816|FG002|Extension Period|Withdrawal by Subject|0|||
128750716|NCT01217073|463375817|FG003|Extension Period|Withdrawal by Subject|0|||
128750717|NCT01217073|463375818|FG004|Extension Period|Withdrawal by Subject|0|||
128750718|NCT01217073|463375819|FG005|Extension Period|Withdrawal by Subject|0|||
128750719|NCT01217073|463375820|FG006|Extension Period|Withdrawal by Subject|30|||
128750720|NCT01217073|463375821|FG007|Extension Period|Withdrawal by Subject|8|||
128750721|NCT00454051|463375833|FG000|Overall Study|Adverse Event|1|||
128750722|NCT00454051|463375834|FG001|Overall Study|Adverse Event|2|||
128750723|NCT00454051|463375833|FG000|Overall Study|Withdrawal by Subject|1|||
128750724|NCT00454051|463375834|FG001|Overall Study|Withdrawal by Subject|0|||
128750725|NCT00454051|463375833|FG000|Overall Study|Protocol Violation|1|||
128750726|NCT00454051|463375834|FG001|Overall Study|Protocol Violation|1|||
128750727|NCT01270347|463375843|FG000|Core Phase|Adverse Event|1|||
128750728|NCT01270347|463375844|FG001|Core Phase|Adverse Event|6|||
128750729|NCT01270347|463375843|FG000|Core Phase|Withdrawal by Subject|1|||
128750730|NCT01270347|463375844|FG001|Core Phase|Withdrawal by Subject|2|||
128750731|NCT01270347|463375843|FG000|Core Phase|Lost to Follow-up|0|||
128750732|NCT01270347|463375844|FG001|Core Phase|Lost to Follow-up|1|||
128750733|NCT01270347|463375843|FG000|Core Phase|Miscellaneous|8|||
128750734|NCT01270347|463375844|FG001|Core Phase|Miscellaneous|14|||
128750735|NCT01270347|463375843|FG000|Extension Phase|Adverse Event|1|||
128750736|NCT01270347|463375844|FG001|Extension Phase|Adverse Event|3|||
128750737|NCT01270347|463375843|FG000|Extension Phase|Withdrawal by Subject|3|||
128750738|NCT01270347|463375844|FG001|Extension Phase|Withdrawal by Subject|4|||
128750739|NCT01270347|463375843|FG000|Extension Phase|Miscellaneous|2|||
128750740|NCT01270347|463375844|FG001|Extension Phase|Miscellaneous|2|||
128750741|NCT02189798|463375845|FG000|Extended Use Phase|Withdrawal by Subject|0|||
128750742|NCT02189798|463375846|FG001|Extended Use Phase|Withdrawal by Subject|4|||
128750743|NCT02189798|463375845|FG000|Extended Use Phase|Physician Decision|1|||
128750744|NCT02189798|463375846|FG001|Extended Use Phase|Physician Decision|0|||
128750745|NCT02189798|463375845|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
128750746|NCT02189798|463375846|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
128750747|NCT02189798|463375845|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
128750748|NCT02189798|463375846|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
128750749|NCT02189798|463375845|FG000|Extended Use Phase|Travel Issues|2|||
128750750|NCT02189798|463375846|FG001|Extended Use Phase|Travel Issues|1|||
128750751|NCT02189798|463375845|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
128750752|NCT02189798|463375846|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
128750753|NCT02273141|463375847|FG000|Overall Study|Adverse Event|0|||
128750754|NCT02273141|463375848|FG001|Overall Study|Adverse Event|1|||
128750755|NCT02273141|463375847|FG000|Overall Study|Lost to Follow-up|1|||
128750756|NCT02273141|463375848|FG001|Overall Study|Lost to Follow-up|3|||
128750757|NCT02273141|463375847|FG000|Overall Study|Withdrawal by Subject|10|||
128750758|NCT02273141|463375848|FG001|Overall Study|Withdrawal by Subject|15|||
128750759|NCT02273141|463375847|FG000|Overall Study|Various|6|||
128750760|NCT02273141|463375848|FG001|Overall Study|Various|6|||
128750761|NCT00529399|463375849|FG000|Overall Study|Lost to Follow-up|1|||
128750762|NCT00529399|463375850|FG001|Overall Study|Lost to Follow-up|0|||
128750763|NCT00529399|463375851|FG002|Overall Study|Lost to Follow-up|1|||
128750764|NCT00529399|463375849|FG000|Overall Study|Withdrawal by Subject|1|||
128750765|NCT00529399|463375850|FG001|Overall Study|Withdrawal by Subject|0|||
128750766|NCT00529399|463375851|FG002|Overall Study|Withdrawal by Subject|1|||
128750767|NCT00529399|463375849|FG000|Overall Study|Non-compliant|0|||
128750768|NCT00529399|463375850|FG001|Overall Study|Non-compliant|1|||
128750769|NCT00529399|463375851|FG002|Overall Study|Non-compliant|0|||
128750770|NCT04313881|463375858|FG000|Overall Study|Death|138|||
128750771|NCT04313881|463375859|FG001|Overall Study|Death|126|||
128750772|NCT04313881|463375858|FG000|Overall Study|Study terminated by sponsor|108|||
128750773|NCT04313881|463375859|FG001|Overall Study|Study terminated by sponsor|129|||
128750774|NCT04313881|463375858|FG000|Overall Study|Consent withdrawn|19|||
128750775|NCT04313881|463375859|FG001|Overall Study|Consent withdrawn|15|||
128750776|NCT04313881|463375858|FG000|Overall Study|Reason not Specified|3|||
128750777|NCT04313881|463375859|FG001|Overall Study|Reason not Specified|1|||
128750778|NCT01572727|463375860|FG000|Overall Study|Adverse Event|43|||
128750779|NCT01572727|463375861|FG001|Overall Study|Adverse Event|15|||
128750780|NCT01572727|463375860|FG000|Overall Study|Lost to Follow-up|1|||
128750781|NCT01572727|463375861|FG001|Overall Study|Lost to Follow-up|1|||
128750782|NCT01572727|463375860|FG000|Overall Study|Physician Decision|23|||
128750783|NCT01572727|463375861|FG001|Overall Study|Physician Decision|9|||
128750784|NCT01572727|463375860|FG000|Overall Study|Progressive disease|59|||
128750785|NCT01572727|463375861|FG001|Overall Study|Progressive disease|82|||
128750786|NCT01572727|463375860|FG000|Overall Study|Protocol Violation|0|||
128750787|NCT01572727|463375861|FG001|Overall Study|Protocol Violation|1|||
128750788|NCT01572727|463375860|FG000|Overall Study|Study terminated by sponsor|61|||
128750789|NCT01572727|463375861|FG001|Overall Study|Study terminated by sponsor|83|||
128750790|NCT01572727|463375860|FG000|Overall Study|Parent/guardian decision|14|||
128750791|NCT01572727|463375861|FG001|Overall Study|Parent/guardian decision|9|||
128750792|NCT01572727|463375860|FG000|Overall Study|Death|2|||
128750793|NCT01572727|463375861|FG001|Overall Study|Death|2|||
128750794|NCT01572727|463375860|FG000|Overall Study|Untreated|4|||
128750795|NCT01572727|463375861|FG001|Overall Study|Untreated|7|||
128750796|NCT03998618|463375862|FG000|Overall Study|Death|7|||
128750797|NCT03998618|463375863|FG001|Overall Study|Death|11|||
128750798|NCT03998618|463375862|FG000|Overall Study|hospice enrollment|3|||
128750799|NCT03998618|463375863|FG001|Overall Study|hospice enrollment|3|||
128750800|NCT03998618|463375862|FG000|Overall Study|Not feeling well/health problems|3|||
128750801|NCT03998618|463375863|FG001|Overall Study|Not feeling well/health problems|5|||
128750802|NCT03998618|463375862|FG000|Overall Study|Lost to Follow-up|6|||
128750803|NCT03998618|463375863|FG001|Overall Study|Lost to Follow-up|6|||
128750804|NCT03998618|463375862|FG000|Overall Study|Withdrawal by Subject|0|||
128750805|NCT03998618|463375863|FG001|Overall Study|Withdrawal by Subject|4|||
128750806|NCT02834780|463375864|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
128750807|NCT02834780|463375865|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
128750808|NCT02834780|463375866|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
128750809|NCT02834780|463375867|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
128750810|NCT02834780|463375868|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
128750811|NCT02834780|463375869|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
128750812|NCT02834780|463375870|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
128750813|NCT02834780|463375871|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
128750814|NCT02834780|463375872|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
128750815|NCT02834780|463375873|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
128750816|NCT02834780|463375874|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
128750817|NCT02834780|463375875|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
128750818|NCT02834780|463375876|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
128750819|NCT02834780|463375864|FG000|Overall Study|Withdrawal by Subject|0|||
128750820|NCT02834780|463375865|FG001|Overall Study|Withdrawal by Subject|0|||
128750821|NCT02834780|463375866|FG002|Overall Study|Withdrawal by Subject|1|||
128750822|NCT02834780|463375867|FG003|Overall Study|Withdrawal by Subject|0|||
128750823|NCT02834780|463375868|FG004|Overall Study|Withdrawal by Subject|0|||
128750824|NCT02834780|463375869|FG005|Overall Study|Withdrawal by Subject|0|||
128750825|NCT02834780|463375870|FG006|Overall Study|Withdrawal by Subject|0|||
128750826|NCT02834780|463375871|FG007|Overall Study|Withdrawal by Subject|0|||
128750827|NCT02834780|463375872|FG008|Overall Study|Withdrawal by Subject|0|||
128750828|NCT02834780|463375873|FG009|Overall Study|Withdrawal by Subject|0|||
128750829|NCT02834780|463375874|FG010|Overall Study|Withdrawal by Subject|1|||
128750830|NCT02834780|463375875|FG011|Overall Study|Withdrawal by Subject|0|||
128750831|NCT02834780|463375876|FG012|Overall Study|Withdrawal by Subject|0|||
128750832|NCT02834780|463375864|FG000|Overall Study|Adverse Event|0|||
128750833|NCT02834780|463375865|FG001|Overall Study|Adverse Event|0|||
128750834|NCT02834780|463375866|FG002|Overall Study|Adverse Event|0|||
128750835|NCT02834780|463375867|FG003|Overall Study|Adverse Event|0|||
128750836|NCT02834780|463375868|FG004|Overall Study|Adverse Event|1|||
128750837|NCT02834780|463375869|FG005|Overall Study|Adverse Event|0|||
128750838|NCT02834780|463375870|FG006|Overall Study|Adverse Event|1|||
128750839|NCT02834780|463375871|FG007|Overall Study|Adverse Event|1|||
128750840|NCT02834780|463375872|FG008|Overall Study|Adverse Event|0|||
128750841|NCT02834780|463375873|FG009|Overall Study|Adverse Event|2|||
128750842|NCT02834780|463375874|FG010|Overall Study|Adverse Event|0|||
128750843|NCT02834780|463375875|FG011|Overall Study|Adverse Event|3|||
128750844|NCT02834780|463375876|FG012|Overall Study|Adverse Event|2|||
128750845|NCT02834780|463375864|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
128750846|NCT02834780|463375865|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
128750847|NCT02834780|463375866|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
128750848|NCT02834780|463375867|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
128750849|NCT02834780|463375868|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
128750850|NCT02834780|463375869|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
128750851|NCT02834780|463375870|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
128750852|NCT02834780|463375871|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
128750853|NCT02834780|463375872|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
128750854|NCT02834780|463375873|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
128750855|NCT02834780|463375874|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
128750856|NCT02834780|463375875|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
128750857|NCT02834780|463375876|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
128750858|NCT02834780|463375864|FG000|Overall Study|Other|1|||
128750859|NCT02834780|463375865|FG001|Overall Study|Other|0|||
128750860|NCT02834780|463375866|FG002|Overall Study|Other|1|||
128750861|NCT02834780|463375867|FG003|Overall Study|Other|2|||
128750862|NCT02834780|463375868|FG004|Overall Study|Other|0|||
128750863|NCT02834780|463375869|FG005|Overall Study|Other|0|||
128750864|NCT02834780|463375870|FG006|Overall Study|Other|0|||
128750865|NCT02834780|463375871|FG007|Overall Study|Other|0|||
128750866|NCT02834780|463375872|FG008|Overall Study|Other|0|||
128750867|NCT02834780|463375873|FG009|Overall Study|Other|0|||
128750868|NCT02834780|463375874|FG010|Overall Study|Other|0|||
128750869|NCT02834780|463375875|FG011|Overall Study|Other|0|||
128750870|NCT02834780|463375876|FG012|Overall Study|Other|1|||
128750871|NCT02270450|463375877|FG000|Overall Study|Refusal unrelated to adverse event|3|||
128750872|NCT02270450|463375878|FG001|Overall Study|Refusal unrelated to adverse event|1|||
128750873|NCT02270450|463375879|FG002|Overall Study|Refusal unrelated to adverse event|5|||
128750874|NCT02270450|463375880|FG003|Overall Study|Refusal unrelated to adverse event|14|||
128750875|NCT02270450|463375877|FG000|Overall Study|Progression/relapse|1|||
128750876|NCT02270450|463375878|FG001|Overall Study|Progression/relapse|2|||
128750877|NCT02270450|463375879|FG002|Overall Study|Progression/relapse|4|||
128750878|NCT02270450|463375880|FG003|Overall Study|Progression/relapse|9|||
128750879|NCT02270450|463375877|FG000|Overall Study|Death|19|||
128750880|NCT02270450|463375878|FG001|Overall Study|Death|19|||
128750881|NCT02270450|463375879|FG002|Overall Study|Death|31|||
128750882|NCT02270450|463375880|FG003|Overall Study|Death|59|||
128750883|NCT02363738|463375881|FG000|Overall Study|Adverse Event|5|||
128750884|NCT02363738|463375882|FG001|Overall Study|Adverse Event|2|||
128750885|NCT02363738|463375881|FG000|Overall Study|Lack of Efficacy|1|||
128750886|NCT02363738|463375882|FG001|Overall Study|Lack of Efficacy|2|||
128750887|NCT02363738|463375881|FG000|Overall Study|Lost to Follow-up|2|||
128750888|NCT02363738|463375882|FG001|Overall Study|Lost to Follow-up|1|||
128750889|NCT03282227|463375888|FG000|Overall Study|Exposure Goals Achieved|60|||
128750890|NCT03282227|463375888|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
128750891|NCT03282227|463375888|FG000|Overall Study|Adverse Event|15|||
128750892|NCT03282227|463375888|FG000|Overall Study|Lost to Follow-up|21|||
128750893|NCT03282227|463375888|FG000|Overall Study|Withdrawal by Subject|20|||
128750894|NCT03282227|463375888|FG000|Overall Study|Lack of Efficacy|12|||
128750895|NCT03282227|463375888|FG000|Overall Study|Sponsor decision|3|||
128750896|NCT03282227|463375888|FG000|Overall Study|Physician Decision|2|||
128750897|NCT03282227|463375888|FG000|Overall Study|Pregnancy|2|||
128750898|NCT03282227|463375888|FG000|Overall Study|Other|1|||
128750899|NCT02576678|463375889|FG000|Overall Study|Adverse Event|0|||
128750900|NCT02576678|463375890|FG001|Overall Study|Adverse Event|0|||
128750901|NCT02576678|463375891|FG002|Overall Study|Adverse Event|2|||
128750902|NCT02576678|463375889|FG000|Overall Study|Withdrawal by Subject|3|||
128750903|NCT02576678|463375890|FG001|Overall Study|Withdrawal by Subject|1|||
128750904|NCT02576678|463375891|FG002|Overall Study|Withdrawal by Subject|2|||
128750905|NCT02576678|463375889|FG000|Overall Study|Lost to Follow-up|0|||
128750906|NCT02576678|463375890|FG001|Overall Study|Lost to Follow-up|0|||
128750907|NCT02576678|463375891|FG002|Overall Study|Lost to Follow-up|1|||
128750908|NCT02576678|463375889|FG000|Overall Study|Miscellaneous|2|||
128750909|NCT02576678|463375890|FG001|Overall Study|Miscellaneous|0|||
128750910|NCT02576678|463375891|FG002|Overall Study|Miscellaneous|0|||
128750911|NCT02251990|463375898|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
128750912|NCT02251990|463375899|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
128750913|NCT02251990|463375898|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
128750914|NCT02251990|463375899|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
128750915|NCT02251990|463375898|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
128750916|NCT02251990|463375899|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
128750917|NCT02251990|463375898|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
128750918|NCT02251990|463375899|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
128750919|NCT02251990|463375898|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
128750920|NCT02251990|463375899|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
128750921|NCT02251990|463375898|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
128750922|NCT02251990|463375899|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
128750923|NCT00695669|463375903|FG000|Overall Study|Adverse Event|0|||
128750924|NCT00695669|463375904|FG001|Overall Study|Adverse Event|0|||
128750925|NCT00695669|463375905|FG002|Overall Study|Adverse Event|2|||
128750926|NCT00695669|463375906|FG003|Overall Study|Adverse Event|0|||
128750927|NCT00695669|463375903|FG000|Overall Study|Lost to Follow-up|4|||
128750928|NCT00695669|463375904|FG001|Overall Study|Lost to Follow-up|4|||
128750929|NCT00695669|463375905|FG002|Overall Study|Lost to Follow-up|1|||
128750930|NCT00695669|463375906|FG003|Overall Study|Lost to Follow-up|4|||
128750931|NCT01857531|463375920|FG000|Overall Study|Withdrawal by Subject|4|||
128750932|NCT00435370|463375921|FG000|Overall Study|Adverse Event|8|||
128750933|NCT00435370|463375922|FG001|Overall Study|Adverse Event|8|||
128750934|NCT00435370|463375921|FG000|Overall Study|Withdrawal by Subject|10|||
128750935|NCT00435370|463375922|FG001|Overall Study|Withdrawal by Subject|10|||
128750936|NCT00435370|463375921|FG000|Overall Study|Antipsychotic medication changed|4|||
128750937|NCT00435370|463375922|FG001|Overall Study|Antipsychotic medication changed|2|||
128750938|NCT01965834|463375923|FG000|Overall Study|Lack of Efficacy|4|||
128750939|NCT03943095|463375924|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
128750940|NCT03943095|463375925|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
128750941|NCT03943095|463375924|FG000|Overall Study|Withdrawal by Subject|1|||
128750942|NCT03943095|463375925|FG001|Overall Study|Withdrawal by Subject|0|||
128750943|NCT00744653|463375927|FG000|Overall Study|antineoplastic treatment|11|||
128750944|NCT00744653|463375927|FG000|Overall Study|Death|1|||
128750945|NCT00744653|463375927|FG000|Overall Study|Lost to Follow-up|1|||
128750946|NCT00744653|463375927|FG000|Overall Study|Physician Decision|3|||
128750947|NCT03826667|463375928|FG000|Overall Study|Protocol deviation|21|||
128750948|NCT02298192|463375929|FG000|Overall Study|Unclassified|3|||
128750949|NCT02298192|463375930|FG001|Overall Study|Unclassified|2|||
128750950|NCT02298192|463375929|FG000|Overall Study|Withdrawal criteria|2|||
128750951|NCT02298192|463375930|FG001|Overall Study|Withdrawal criteria|0|||
128750952|NCT02298192|463375929|FG000|Overall Study|Withdrawal by Subject|6|||
128750953|NCT02298192|463375930|FG001|Overall Study|Withdrawal by Subject|1|||
128750954|NCT02298192|463375929|FG000|Overall Study|Lost to Follow-up|2|||
128750955|NCT02298192|463375930|FG001|Overall Study|Lost to Follow-up|1|||
128750956|NCT02298192|463375929|FG000|Overall Study|Adverse Event|6|||
128750957|NCT02298192|463375930|FG001|Overall Study|Adverse Event|2|||
128750958|NCT00617344|463375931|FG000|Overall Study|Serious adverse event|1|||
128750959|NCT00617344|463375932|FG001|Overall Study|Serious adverse event|0|||
128750960|NCT00617344|463375933|FG002|Overall Study|Serious adverse event|0|||
128750961|NCT00617344|463375931|FG000|Overall Study|Other Adverse Event|1|||
128750962|NCT00617344|463375932|FG001|Overall Study|Other Adverse Event|1|||
128750963|NCT00617344|463375933|FG002|Overall Study|Other Adverse Event|0|||
128750964|NCT00617344|463375931|FG000|Overall Study|Protocol Violation|10|||
128750965|NCT00617344|463375932|FG001|Overall Study|Protocol Violation|8|||
128750966|NCT00617344|463375933|FG002|Overall Study|Protocol Violation|5|||
128750967|NCT00617344|463375931|FG000|Overall Study|Lost to Follow-up|5|||
128750968|NCT00617344|463375932|FG001|Overall Study|Lost to Follow-up|4|||
128750969|NCT00617344|463375933|FG002|Overall Study|Lost to Follow-up|1|||
128750970|NCT00617344|463375931|FG000|Overall Study|Withdrawal by Subject|8|||
128750971|NCT00617344|463375932|FG001|Overall Study|Withdrawal by Subject|9|||
128750972|NCT00617344|463375933|FG002|Overall Study|Withdrawal by Subject|2|||
128750973|NCT00679939|463375936|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
128750974|NCT00679939|463375937|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
128750975|NCT00679939|463375936|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
128750976|NCT00679939|463375937|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
128750977|NCT00679939|463375936|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
128750978|NCT00679939|463375937|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
128750979|NCT00679939|463375936|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
128750980|NCT00679939|463375937|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
128750981|NCT00679939|463375936|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
128750982|NCT00679939|463375937|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
128750983|NCT00679939|463375936|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
128750984|NCT00679939|463375937|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
128750985|NCT00679939|463375936|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
128750986|NCT00679939|463375937|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
128750987|NCT00679939|463375936|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
128750988|NCT00679939|463375937|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
128750989|NCT00679939|463375936|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
128750990|NCT00679939|463375937|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
128750991|NCT00679939|463375936|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
128750992|NCT00679939|463375937|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
128750993|NCT00941330|463375942|FG000|Overall Study|Other|1|||
128750994|NCT00941330|463375943|FG001|Overall Study|Other|0|||
128750995|NCT00941330|463375942|FG000|Overall Study|Physician Decision|0|||
128750996|NCT00941330|463375943|FG001|Overall Study|Physician Decision|2|||
128750997|NCT00710424|463375946|FG000|Overall Study|Adverse Event|30|||
128750998|NCT00710424|463375947|FG001|Overall Study|Adverse Event|12|||
128750999|NCT00710424|463375946|FG000|Overall Study|Lack of Efficacy|4|||
128751000|NCT00710424|463375947|FG001|Overall Study|Lack of Efficacy|5|||
128751001|NCT00710424|463375946|FG000|Overall Study|Withdrawal by Subject|5|||
128751002|NCT00710424|463375947|FG001|Overall Study|Withdrawal by Subject|3|||
128751003|NCT00710424|463375946|FG000|Overall Study|Lost to Follow-up|0|||
128786100|NCT01549652|463509372|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
128786101|NCT01549652|463509373|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
128786102|NCT01549652|463509374|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
128786103|NCT01549652|463509371|FG000|Overall Study|Problem with Infusion|1|||
128751004|NCT00710424|463375947|FG001|Overall Study|Lost to Follow-up|1|||
128751005|NCT00710424|463375946|FG000|Overall Study|Refused medication, no side effects|1|||
128751006|NCT00710424|463375947|FG001|Overall Study|Refused medication, no side effects|0|||
128751007|NCT00710424|463375946|FG000|Overall Study|Non-compliance with stable analgesia|1|||
128751008|NCT00710424|463375947|FG001|Overall Study|Non-compliance with stable analgesia|0|||
128751009|NCT00710424|463375946|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
128751010|NCT00710424|463375947|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
128751011|NCT00710424|463375946|FG000|Overall Study|Subject thought medication changed|1|||
128751012|NCT00710424|463375947|FG001|Overall Study|Subject thought medication changed|0|||
128751013|NCT00710424|463375946|FG000|Overall Study|Ceased treatment due to travel|1|||
128751014|NCT00710424|463375947|FG001|Overall Study|Ceased treatment due to travel|0|||
128751015|NCT00710424|463375946|FG000|Overall Study|Subject preferred paracetamol|0|||
128751016|NCT00710424|463375947|FG001|Overall Study|Subject preferred paracetamol|1|||
128751017|NCT00710424|463375946|FG000|Overall Study|Felt good so stopped treatment|0|||
128751018|NCT00710424|463375947|FG001|Overall Study|Felt good so stopped treatment|1|||
128751019|NCT02985866|463377577|FG000|Overall Study|Poor CGM data|1|||
128751020|NCT02985866|463377578|FG001|Overall Study|Poor CGM data|1|||
128751021|NCT04066114|463377579|FG000|Overall Study|Adverse Event|1|||
128751022|NCT04066114|463377580|FG001|Overall Study|Adverse Event|0|||
128751023|NCT04066114|463377581|FG002|Overall Study|Adverse Event|0|||
128751024|NCT04066114|463377579|FG000|Overall Study|Withdrawal by Subject|1|||
128751025|NCT04066114|463377580|FG001|Overall Study|Withdrawal by Subject|0|||
128751026|NCT04066114|463377581|FG002|Overall Study|Withdrawal by Subject|0|||
128751027|NCT04066114|463377579|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
128751028|NCT04066114|463377580|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
128751029|NCT04066114|463377581|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
128751030|NCT03117738|463377584|FG000|Overall Study|Withdrawal by Subject|3|||
128751031|NCT03117738|463377585|FG001|Overall Study|Withdrawal by Subject|1|||
128751032|NCT03117738|463377584|FG000|Overall Study|Lost to Follow-up|1|||
128751033|NCT03117738|463377585|FG001|Overall Study|Lost to Follow-up|4|||
128751034|NCT04004611|463377586|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751035|NCT04004611|463377587|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751036|NCT04004611|463377588|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751037|NCT04004611|463377589|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751038|NCT04004611|463377590|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751039|NCT04004611|463377591|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751040|NCT04004611|463377592|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751041|NCT04004611|463377593|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
128751042|NCT04004611|463377594|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
128751043|NCT04004611|463377586|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
128751044|NCT04004611|463377587|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
128751045|NCT04004611|463377588|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
128751046|NCT04004611|463377589|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
128751047|NCT04004611|463377590|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
128751048|NCT04004611|463377591|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
128751049|NCT04004611|463377592|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
128751050|NCT04004611|463377593|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
128751051|NCT04004611|463377594|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
128751052|NCT04004611|463377586|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751053|NCT04004611|463377587|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751054|NCT04004611|463377588|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751055|NCT04004611|463377589|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751056|NCT04004611|463377590|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
128751057|NCT04004611|463377591|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751058|NCT04004611|463377592|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751059|NCT04004611|463377593|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751060|NCT04004611|463377594|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
128751061|NCT04004611|463377586|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
128751062|NCT04004611|463377587|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
128751063|NCT04004611|463377588|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
128751064|NCT04004611|463377589|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
128751065|NCT04004611|463377590|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
128751066|NCT04004611|463377591|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
128751067|NCT04004611|463377592|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
128751068|NCT04004611|463377593|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
128751069|NCT04004611|463377594|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
128751070|NCT04004611|463377586|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
128751071|NCT04004611|463377587|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
128751072|NCT04004611|463377588|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
128751073|NCT04004611|463377589|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
128751074|NCT04004611|463377590|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
128751075|NCT04004611|463377591|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
128751076|NCT04004611|463377592|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
128751077|NCT04004611|463377593|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
128751078|NCT04004611|463377594|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
128751079|NCT04004611|463377586|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751080|NCT04004611|463377587|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
128751081|NCT04004611|463377588|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751082|NCT04004611|463377589|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751083|NCT04004611|463377590|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751084|NCT04004611|463377591|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751085|NCT04004611|463377592|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751086|NCT04004611|463377593|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751087|NCT04004611|463377594|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
128751088|NCT04420689|463377595|FG000|Overall Study|COVID-19 related hospitalization|0|||
128751089|NCT04420689|463377596|FG001|Overall Study|COVID-19 related hospitalization|0|||
128751090|NCT04420689|463377597|FG002|Overall Study|COVID-19 related hospitalization|0|||
128751091|NCT04420689|463377598|FG003|Overall Study|COVID-19 related hospitalization|0|||
128751092|NCT04420689|463377599|FG004|Overall Study|COVID-19 related hospitalization|1|||
128751093|NCT04420689|463377600|FG005|Overall Study|COVID-19 related hospitalization|0|||
128751094|NCT04420689|463377601|FG006|Overall Study|COVID-19 related hospitalization|0|||
128751095|NCT04420689|463377595|FG000|Overall Study|Physician Decision|0|||
128751096|NCT04420689|463377596|FG001|Overall Study|Physician Decision|0|||
128751097|NCT04420689|463377597|FG002|Overall Study|Physician Decision|0|||
128751098|NCT04420689|463377598|FG003|Overall Study|Physician Decision|0|||
128751099|NCT04420689|463377599|FG004|Overall Study|Physician Decision|0|||
128751100|NCT04420689|463377600|FG005|Overall Study|Physician Decision|1|||
128751101|NCT04420689|463377601|FG006|Overall Study|Physician Decision|0|||
128751102|NCT00515502|463377602|FG000|Treatment Period 1|Adverse Event|0|||
128751103|NCT00515502|463377603|FG001|Treatment Period 1|Adverse Event|0|||
128751104|NCT00515502|463377604|FG002|Treatment Period 1|Adverse Event|0|||
128751105|NCT00515502|463377605|FG003|Treatment Period 1|Adverse Event|0|||
128751106|NCT00515502|463377606|FG004|Treatment Period 1|Adverse Event|0|||
128751107|NCT00515502|463377607|FG005|Treatment Period 1|Adverse Event|0|||
128751108|NCT00515502|463377608|FG006|Treatment Period 1|Adverse Event|1|||
128751109|NCT00515502|463377609|FG007|Treatment Period 1|Adverse Event|0|||
128751110|NCT00515502|463377610|FG008|Treatment Period 1|Adverse Event|1|||
128751111|NCT00515502|463377611|FG009|Treatment Period 1|Adverse Event|0|||
128751112|NCT00515502|463377612|FG010|Treatment Period 1|Adverse Event|0|||
128751113|NCT00515502|463377613|FG011|Treatment Period 1|Adverse Event|1|||
128751114|NCT00515502|463377602|FG000|Treatment Period 2|Adverse Event|0|||
128751115|NCT00515502|463377603|FG001|Treatment Period 2|Adverse Event|1|||
128751116|NCT00515502|463377604|FG002|Treatment Period 2|Adverse Event|0|||
128751117|NCT00515502|463377605|FG003|Treatment Period 2|Adverse Event|0|||
128751118|NCT00515502|463377606|FG004|Treatment Period 2|Adverse Event|0|||
128751119|NCT00515502|463377607|FG005|Treatment Period 2|Adverse Event|0|||
128751120|NCT00515502|463377608|FG006|Treatment Period 2|Adverse Event|0|||
128751121|NCT00515502|463377609|FG007|Treatment Period 2|Adverse Event|0|||
128751122|NCT00515502|463377610|FG008|Treatment Period 2|Adverse Event|0|||
128751123|NCT00515502|463377611|FG009|Treatment Period 2|Adverse Event|0|||
128751124|NCT00515502|463377612|FG010|Treatment Period 2|Adverse Event|0|||
128751125|NCT00515502|463377613|FG011|Treatment Period 2|Adverse Event|0|||
128751126|NCT02732938|463377617|FG000|Overall Study|Death|0|||
128751127|NCT02732938|463377618|FG001|Overall Study|Death|11|||
128751128|NCT02732938|463377619|FG002|Overall Study|Death|0|||
128751129|NCT02732938|463377617|FG000|Overall Study|Randomized but did not receive treatment|0|||
128751130|NCT02732938|463377618|FG001|Overall Study|Randomized but did not receive treatment|1|||
128751131|NCT02732938|463377619|FG002|Overall Study|Randomized but did not receive treatment|0|||
128751132|NCT02732938|463377617|FG000|Overall Study|Refused further follow-up|1|||
128751133|NCT02732938|463377618|FG001|Overall Study|Refused further follow-up|0|||
128751134|NCT02732938|463377619|FG002|Overall Study|Refused further follow-up|0|||
128751135|NCT02732938|463377617|FG000|Overall Study|Study terminated by sponsor|3|||
128751136|NCT02732938|463377618|FG001|Overall Study|Study terminated by sponsor|6|||
128751137|NCT02732938|463377619|FG002|Overall Study|Study terminated by sponsor|0|||
128751138|NCT03927950|463377620|FG000|Overall Study|Adverse Event|9|||
128751139|NCT03647501|463377621|FG000|Overall Study|Lost to Follow-up|1|||
128751140|NCT03647501|463377622|FG001|Overall Study|Lost to Follow-up|1|||
128751141|NCT03647501|463377621|FG000|Overall Study|Withdrawal by Subject|0|||
128751142|NCT03647501|463377622|FG001|Overall Study|Withdrawal by Subject|1|||
128751143|NCT04530448|463377623|FG000|Overall Study|Physician Decision|3|||
128751144|NCT04530448|463377624|FG001|Overall Study|Physician Decision|0|||
128751145|NCT01613248|463377625|FG000|Overall Study|Adverse Event|0|||
128751146|NCT01613248|463377626|FG001|Overall Study|Adverse Event|0|||
128751147|NCT01613248|463377627|FG002|Overall Study|Adverse Event|0|||
128751148|NCT01613248|463377628|FG003|Overall Study|Adverse Event|1|||
128751149|NCT01613248|463377629|FG004|Overall Study|Adverse Event|0|||
128751150|NCT01613248|463377630|FG005|Overall Study|Adverse Event|0|||
128751151|NCT01613248|463377625|FG000|Overall Study|Withdrawal by Subject|3|||
128751152|NCT01613248|463377626|FG001|Overall Study|Withdrawal by Subject|2|||
128751153|NCT01613248|463377627|FG002|Overall Study|Withdrawal by Subject|2|||
128751154|NCT01613248|463377628|FG003|Overall Study|Withdrawal by Subject|5|||
128751155|NCT01613248|463377629|FG004|Overall Study|Withdrawal by Subject|0|||
128751156|NCT01613248|463377630|FG005|Overall Study|Withdrawal by Subject|1|||
128751157|NCT01613248|463377625|FG000|Overall Study|Lost to Follow-up|5|||
128751158|NCT01613248|463377626|FG001|Overall Study|Lost to Follow-up|7|||
128751159|NCT01613248|463377627|FG002|Overall Study|Lost to Follow-up|4|||
128751160|NCT01613248|463377628|FG003|Overall Study|Lost to Follow-up|8|||
128751161|NCT01613248|463377629|FG004|Overall Study|Lost to Follow-up|4|||
128751162|NCT01613248|463377630|FG005|Overall Study|Lost to Follow-up|2|||
128751163|NCT01613248|463377625|FG000|Overall Study|Study Terminated by Sponsor|4|||
128751164|NCT01613248|463377626|FG001|Overall Study|Study Terminated by Sponsor|6|||
128751165|NCT01613248|463377627|FG002|Overall Study|Study Terminated by Sponsor|8|||
128751166|NCT01613248|463377628|FG003|Overall Study|Study Terminated by Sponsor|8|||
128751167|NCT01613248|463377629|FG004|Overall Study|Study Terminated by Sponsor|9|||
128751168|NCT01613248|463377630|FG005|Overall Study|Study Terminated by Sponsor|11|||
128751169|NCT01613248|463377625|FG000|Overall Study|Physician Decision|8|||
128751170|NCT01613248|463377626|FG001|Overall Study|Physician Decision|8|||
128751171|NCT01613248|463377627|FG002|Overall Study|Physician Decision|9|||
128751172|NCT01613248|463377628|FG003|Overall Study|Physician Decision|4|||
128751173|NCT01613248|463377629|FG004|Overall Study|Physician Decision|7|||
128751174|NCT01613248|463377630|FG005|Overall Study|Physician Decision|6|||
128751175|NCT01613248|463377625|FG000|Overall Study|Lack of Qualifying Event|9|||
128751176|NCT01613248|463377626|FG001|Overall Study|Lack of Qualifying Event|11|||
128751177|NCT01613248|463377627|FG002|Overall Study|Lack of Qualifying Event|10|||
128751178|NCT01613248|463377628|FG003|Overall Study|Lack of Qualifying Event|11|||
128751179|NCT01613248|463377629|FG004|Overall Study|Lack of Qualifying Event|15|||
128751180|NCT01613248|463377630|FG005|Overall Study|Lack of Qualifying Event|18|||
128751181|NCT01613248|463377625|FG000|Overall Study|Pregnancy|0|||
128751182|NCT01613248|463377626|FG001|Overall Study|Pregnancy|0|||
128751183|NCT01613248|463377627|FG002|Overall Study|Pregnancy|0|||
128751184|NCT01613248|463377628|FG003|Overall Study|Pregnancy|1|||
128751185|NCT01613248|463377629|FG004|Overall Study|Pregnancy|0|||
128751186|NCT01613248|463377630|FG005|Overall Study|Pregnancy|0|||
128751187|NCT01433354|463377631|FG000|Overall Study|Adverse Event|6|||
128751188|NCT01433354|463377631|FG000|Overall Study|Lost to Follow-up|1|||
128751189|NCT01433354|463377631|FG000|Overall Study|Administrative problems|90|||
128751190|NCT01433354|463377631|FG000|Overall Study|Protocol Violation|2|||
128751191|NCT01433354|463377631|FG000|Overall Study|Lack of Efficacy|17|||
128751192|NCT01433354|463377631|FG000|Overall Study|Subject Withdrew Consent|3|||
128751193|NCT02015676|463377643|FG000|Overall Study|Adverse Event|2|||
128751194|NCT02015676|463377644|FG001|Overall Study|Adverse Event|18|||
128751195|NCT02015676|463377645|FG002|Overall Study|Adverse Event|0|||
128751196|NCT02015676|463377643|FG000|Overall Study|Lack of Efficacy|2|||
128751197|NCT02015676|463377644|FG001|Overall Study|Lack of Efficacy|4|||
128751198|NCT02015676|463377645|FG002|Overall Study|Lack of Efficacy|0|||
128751199|NCT02015676|463377643|FG000|Overall Study|Protocol Violation|1|||
128751200|NCT02015676|463377644|FG001|Overall Study|Protocol Violation|0|||
128751201|NCT02015676|463377645|FG002|Overall Study|Protocol Violation|0|||
128751202|NCT02015676|463377643|FG000|Overall Study|Withdrawal by Subject|1|||
128751203|NCT02015676|463377644|FG001|Overall Study|Withdrawal by Subject|7|||
128751204|NCT02015676|463377645|FG002|Overall Study|Withdrawal by Subject|1|||
128751205|NCT02015676|463377643|FG000|Overall Study|Administrative reasons|0|||
128751206|NCT02015676|463377644|FG001|Overall Study|Administrative reasons|3|||
128751207|NCT02015676|463377645|FG002|Overall Study|Administrative reasons|1|||
128751208|NCT02015676|463377643|FG000|Overall Study|Death|0|||
128751209|NCT02015676|463377644|FG001|Overall Study|Death|1|||
128751210|NCT02015676|463377645|FG002|Overall Study|Death|0|||
128751211|NCT02015676|463377643|FG000|Overall Study|Disease progression|3|||
128751212|NCT02015676|463377644|FG001|Overall Study|Disease progression|1|||
128751213|NCT02015676|463377645|FG002|Overall Study|Disease progression|1|||
128751214|NCT02013622|463377647|FG000|Overall Study|Lost to Follow-up|10|||
128751215|NCT02013622|463377647|FG000|Overall Study|Adverse Event|3|||
128751216|NCT02013622|463377647|FG000|Overall Study|Met Withdrawal Criteria|3|||
128751217|NCT02013622|463377647|FG000|Overall Study|Withdrawal by Subject|6|||
128751218|NCT02013622|463377647|FG000|Overall Study|Protocol Deviation|1|||
128751219|NCT02013622|463377647|FG000|Overall Study|Lack of Efficacy|1|||
128751220|NCT04307004|463377655|FG000|Randomization 1|Withdrawal by Subject|25|||
128751221|NCT04307004|463377656|FG001|Randomization 1|Withdrawal by Subject|26|||
128751222|NCT04307004|463377657|FG002|Randomization 1|Withdrawal by Subject|0|||
128751223|NCT04307004|463377658|FG003|Randomization 1|Withdrawal by Subject|0|||
128751224|NCT04307004|463377655|FG000|Randomization 2|Withdrawal by Subject|0|||
128751225|NCT04307004|463377656|FG001|Randomization 2|Withdrawal by Subject|0|||
128751226|NCT04307004|463377657|FG002|Randomization 2|Withdrawal by Subject|28|||
128751227|NCT04307004|463377658|FG003|Randomization 2|Withdrawal by Subject|23|||
128751228|NCT04391023|463377659|FG000|Overall Study|Withdrawal by Subject|2|||
128751229|NCT04391023|463377660|FG001|Overall Study|Withdrawal by Subject|2|||
128751230|NCT01381692|463377661|FG000|Overall Study|Adverse Event|1|||
128751231|NCT01381692|463377662|FG001|Overall Study|Adverse Event|0|||
128751232|NCT01381692|463377663|FG002|Overall Study|Adverse Event|0|||
128751233|NCT01381692|463377664|FG003|Overall Study|Adverse Event|0|||
128751234|NCT01381692|463377665|FG004|Overall Study|Adverse Event|0|||
128751235|NCT01381692|463377666|FG005|Overall Study|Adverse Event|0|||
128751236|NCT02195986|463377667|FG000|Overall Study|Adverse Event|3|||
128751237|NCT02195986|463377668|FG001|Overall Study|Adverse Event|0|||
128751238|NCT02195986|463377669|FG002|Overall Study|Adverse Event|0|||
128751239|NCT02195986|463377667|FG000|Overall Study|Withdrawal by Subject|0|||
128751240|NCT02195986|463377668|FG001|Overall Study|Withdrawal by Subject|3|||
128751241|NCT02195986|463377669|FG002|Overall Study|Withdrawal by Subject|0|||
128751242|NCT02195986|463377667|FG000|Overall Study|Family Emergency|0|||
128751243|NCT02195986|463377668|FG001|Overall Study|Family Emergency|0|||
128751244|NCT02195986|463377669|FG002|Overall Study|Family Emergency|1|||
128751245|NCT02195986|463377667|FG000|Overall Study|Protocol Violation|0|||
128751246|NCT02195986|463377668|FG001|Overall Study|Protocol Violation|1|||
128751247|NCT02195986|463377669|FG002|Overall Study|Protocol Violation|1|||
128751248|NCT02195986|463377667|FG000|Overall Study|Non-compliance|0|||
128751249|NCT02195986|463377668|FG001|Overall Study|Non-compliance|1|||
128751250|NCT02195986|463377669|FG002|Overall Study|Non-compliance|0|||
128751251|NCT03449030|463377672|FG000|Overall Study|Withdrawal by Subject|0|||
128751252|NCT03449030|463377673|FG001|Overall Study|Withdrawal by Subject|0|||
128751253|NCT03449030|463377674|FG002|Overall Study|Withdrawal by Subject|0|||
128751254|NCT03449030|463377675|FG003|Overall Study|Withdrawal by Subject|1|||
128751255|NCT03449030|463377676|FG004|Overall Study|Withdrawal by Subject|1|||
128751256|NCT03449030|463377677|FG005|Overall Study|Withdrawal by Subject|1|||
128751257|NCT03449030|463377678|FG006|Overall Study|Withdrawal by Subject|1|||
128751258|NCT03449030|463377679|FG007|Overall Study|Withdrawal by Subject|2|||
128751259|NCT03449030|463377680|FG008|Overall Study|Withdrawal by Subject|0|||
128751260|NCT03449030|463377681|FG009|Overall Study|Withdrawal by Subject|0|||
128751261|NCT03449030|463377672|FG000|Overall Study|Symptomatic Deterioration|0|||
128751262|NCT03449030|463377673|FG001|Overall Study|Symptomatic Deterioration|1|||
128751263|NCT03449030|463377674|FG002|Overall Study|Symptomatic Deterioration|0|||
128751264|NCT03449030|463377675|FG003|Overall Study|Symptomatic Deterioration|0|||
128751265|NCT03449030|463377676|FG004|Overall Study|Symptomatic Deterioration|0|||
128751266|NCT03449030|463377677|FG005|Overall Study|Symptomatic Deterioration|1|||
128751267|NCT03449030|463377678|FG006|Overall Study|Symptomatic Deterioration|1|||
128751268|NCT03449030|463377679|FG007|Overall Study|Symptomatic Deterioration|0|||
128751269|NCT03449030|463377680|FG008|Overall Study|Symptomatic Deterioration|2|||
128751270|NCT03449030|463377681|FG009|Overall Study|Symptomatic Deterioration|0|||
128751271|NCT03449030|463377672|FG000|Overall Study|Progressive Disease|1|||
128751272|NCT03449030|463377673|FG001|Overall Study|Progressive Disease|0|||
128751273|NCT03449030|463377674|FG002|Overall Study|Progressive Disease|1|||
128751274|NCT03449030|463377675|FG003|Overall Study|Progressive Disease|4|||
128751275|NCT03449030|463377676|FG004|Overall Study|Progressive Disease|5|||
128751276|NCT03449030|463377677|FG005|Overall Study|Progressive Disease|3|||
128751277|NCT03449030|463377678|FG006|Overall Study|Progressive Disease|0|||
128751278|NCT03449030|463377679|FG007|Overall Study|Progressive Disease|1|||
128751279|NCT03449030|463377680|FG008|Overall Study|Progressive Disease|1|||
128751280|NCT03449030|463377681|FG009|Overall Study|Progressive Disease|1|||
128751281|NCT03449030|463377672|FG000|Overall Study|Adverse Event|0|||
128751282|NCT03449030|463377673|FG001|Overall Study|Adverse Event|0|||
128751283|NCT03449030|463377674|FG002|Overall Study|Adverse Event|0|||
128751284|NCT03449030|463377675|FG003|Overall Study|Adverse Event|0|||
128751285|NCT03449030|463377676|FG004|Overall Study|Adverse Event|0|||
128751286|NCT03449030|463377677|FG005|Overall Study|Adverse Event|2|||
128751287|NCT03449030|463377678|FG006|Overall Study|Adverse Event|0|||
128751288|NCT03449030|463377679|FG007|Overall Study|Adverse Event|0|||
128751289|NCT03449030|463377680|FG008|Overall Study|Adverse Event|0|||
128751290|NCT03449030|463377681|FG009|Overall Study|Adverse Event|0|||
128751291|NCT03449030|463377672|FG000|Overall Study|Death|0|||
128751292|NCT03449030|463377673|FG001|Overall Study|Death|0|||
128751293|NCT03449030|463377674|FG002|Overall Study|Death|0|||
128751294|NCT03449030|463377675|FG003|Overall Study|Death|0|||
128751295|NCT03449030|463377676|FG004|Overall Study|Death|1|||
128751296|NCT03449030|463377677|FG005|Overall Study|Death|0|||
128751297|NCT03449030|463377678|FG006|Overall Study|Death|0|||
128751298|NCT03449030|463377679|FG007|Overall Study|Death|0|||
128751299|NCT03449030|463377680|FG008|Overall Study|Death|0|||
128751300|NCT03449030|463377681|FG009|Overall Study|Death|0|||
128751301|NCT02415400|463377682|FG000|Overall Study|Adverse Event|0|||
128751302|NCT02415400|463377683|FG001|Overall Study|Adverse Event|1|||
128751303|NCT02415400|463377684|FG002|Overall Study|Adverse Event|1|||
128751304|NCT02415400|463377685|FG003|Overall Study|Adverse Event|2|||
128751305|NCT02415400|463377682|FG000|Overall Study|Participant request to stop therapy|4|||
128751306|NCT02415400|463377683|FG001|Overall Study|Participant request to stop therapy|3|||
128751307|NCT02415400|463377684|FG002|Overall Study|Participant request to stop therapy|8|||
128751308|NCT02415400|463377685|FG003|Overall Study|Participant request to stop therapy|6|||
128751309|NCT02415400|463377682|FG000|Overall Study|Participant withdrew consent|14|||
128751310|NCT02415400|463377683|FG001|Overall Study|Participant withdrew consent|12|||
128751311|NCT02415400|463377684|FG002|Overall Study|Participant withdrew consent|30|||
128751312|NCT02415400|463377685|FG003|Overall Study|Participant withdrew consent|21|||
128751313|NCT02415400|463377682|FG000|Overall Study|Death|39|||
128751314|NCT02415400|463377683|FG001|Overall Study|Death|41|||
128751315|NCT02415400|463377684|FG002|Overall Study|Death|35|||
128751316|NCT02415400|463377685|FG003|Overall Study|Death|42|||
128751317|NCT02415400|463377682|FG000|Overall Study|Lost to Follow-up|3|||
128751318|NCT02415400|463377683|FG001|Overall Study|Lost to Follow-up|3|||
128751319|NCT02415400|463377684|FG002|Overall Study|Lost to Follow-up|2|||
128751320|NCT02415400|463377685|FG003|Overall Study|Lost to Follow-up|5|||
128751321|NCT02415400|463377682|FG000|Overall Study|Poor/Non-Compliance|0|||
128751322|NCT02415400|463377683|FG001|Overall Study|Poor/Non-Compliance|1|||
128751323|NCT02415400|463377684|FG002|Overall Study|Poor/Non-Compliance|3|||
128751324|NCT02415400|463377685|FG003|Overall Study|Poor/Non-Compliance|4|||
128751325|NCT02415400|463377682|FG000|Overall Study|Participant no longer meets criteria|2|||
128751326|NCT02415400|463377683|FG001|Overall Study|Participant no longer meets criteria|0|||
128751327|NCT02415400|463377684|FG002|Overall Study|Participant no longer meets criteria|0|||
128751328|NCT02415400|463377685|FG003|Overall Study|Participant no longer meets criteria|1|||
128751329|NCT02415400|463377682|FG000|Overall Study|Participant doesn't answer phone|1|||
128751330|NCT02415400|463377683|FG001|Overall Study|Participant doesn't answer phone|0|||
128751331|NCT02415400|463377684|FG002|Overall Study|Participant doesn't answer phone|0|||
128751332|NCT02415400|463377685|FG003|Overall Study|Participant doesn't answer phone|0|||
128751333|NCT02415400|463377682|FG000|Overall Study|Participant wanted home visits|1|||
128751334|NCT02415400|463377683|FG001|Overall Study|Participant wanted home visits|0|||
128751335|NCT02415400|463377684|FG002|Overall Study|Participant wanted home visits|0|||
128751336|NCT02415400|463377685|FG003|Overall Study|Participant wanted home visits|0|||
128751337|NCT02415400|463377682|FG000|Overall Study|Randomized in error|2|||
128751338|NCT02415400|463377683|FG001|Overall Study|Randomized in error|0|||
128751339|NCT02415400|463377684|FG002|Overall Study|Randomized in error|0|||
128751340|NCT02415400|463377685|FG003|Overall Study|Randomized in error|0|||
128751341|NCT02415400|463377682|FG000|Overall Study|No study drug on site|0|||
128751342|NCT02415400|463377683|FG001|Overall Study|No study drug on site|1|||
128751343|NCT02415400|463377684|FG002|Overall Study|No study drug on site|0|||
128751344|NCT02415400|463377685|FG003|Overall Study|No study drug on site|0|||
128751345|NCT02415400|463377682|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
128751346|NCT02415400|463377683|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
128751347|NCT02415400|463377684|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
128751348|NCT02415400|463377685|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
128751349|NCT02415400|463377682|FG000|Overall Study|Coagulation values cannot be set|0|||
128751350|NCT02415400|463377683|FG001|Overall Study|Coagulation values cannot be set|0|||
128751351|NCT02415400|463377684|FG002|Overall Study|Coagulation values cannot be set|1|||
128751352|NCT02415400|463377685|FG003|Overall Study|Coagulation values cannot be set|0|||
128751353|NCT02415400|463377682|FG000|Overall Study|State regulations prevent participation|0|||
128751354|NCT02415400|463377683|FG001|Overall Study|State regulations prevent participation|0|||
128751355|NCT02415400|463377684|FG002|Overall Study|State regulations prevent participation|1|||
128751356|NCT02415400|463377685|FG003|Overall Study|State regulations prevent participation|0|||
128751357|NCT02415400|463377682|FG000|Overall Study|Poor treatment monitoring|0|||
128751358|NCT02415400|463377683|FG001|Overall Study|Poor treatment monitoring|0|||
128751359|NCT02415400|463377684|FG002|Overall Study|Poor treatment monitoring|1|||
128751360|NCT02415400|463377685|FG003|Overall Study|Poor treatment monitoring|0|||
128751361|NCT02415400|463377682|FG000|Overall Study|Participant in jail|0|||
128751362|NCT02415400|463377683|FG001|Overall Study|Participant in jail|0|||
128751363|NCT02415400|463377684|FG002|Overall Study|Participant in jail|1|||
128751364|NCT02415400|463377685|FG003|Overall Study|Participant in jail|0|||
128751365|NCT02415400|463377682|FG000|Overall Study|Investigator decision|0|||
128751366|NCT02415400|463377683|FG001|Overall Study|Investigator decision|0|||
128751367|NCT02415400|463377684|FG002|Overall Study|Investigator decision|1|||
128751368|NCT02415400|463377685|FG003|Overall Study|Investigator decision|1|||
128751369|NCT02415400|463377682|FG000|Overall Study|Site closure; participant won't transfer|0|||
128751370|NCT02415400|463377683|FG001|Overall Study|Site closure; participant won't transfer|0|||
128751371|NCT02415400|463377684|FG002|Overall Study|Site closure; participant won't transfer|0|||
128751372|NCT02415400|463377685|FG003|Overall Study|Site closure; participant won't transfer|1|||
128751373|NCT02491671|463377686|FG000|Overall Study|Adverse Event|6|||
128751374|NCT02491671|463377687|FG001|Overall Study|Adverse Event|8|||
128751375|NCT02491671|463377686|FG000|Overall Study|Death|0|||
128751376|NCT02491671|463377687|FG001|Overall Study|Death|2|||
128751377|NCT02491671|463377686|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
128751378|NCT02491671|463377687|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
128751379|NCT03265600|463377688|FG000|Overall Study|Lost to Follow-up|17|||
128751380|NCT03265600|463377689|FG001|Overall Study|Lost to Follow-up|5|||
128751381|NCT03265600|463377688|FG000|Overall Study|Withdrawal by Subject|4|||
128751382|NCT03265600|463377689|FG001|Overall Study|Withdrawal by Subject|2|||
128751383|NCT03265600|463377688|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
128751384|NCT03265600|463377689|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
128751385|NCT04330638|463377690|FG000|Overall Study|Adverse Event|9|||
128751386|NCT04330638|463377691|FG001|Overall Study|Adverse Event|10|||
128751387|NCT04330638|463377692|FG002|Overall Study|Adverse Event|15|||
128751388|NCT04330638|463377693|FG003|Overall Study|Adverse Event|6|||
128751389|NCT04330638|463377694|FG004|Overall Study|Adverse Event|10|||
128751390|NCT04330638|463377695|FG005|Overall Study|Adverse Event|5|||
128751391|NCT04330638|463377690|FG000|Overall Study|Other|2|||
128751392|NCT04330638|463377691|FG001|Overall Study|Other|2|||
128751393|NCT04330638|463377692|FG002|Overall Study|Other|5|||
128751394|NCT04330638|463377693|FG003|Overall Study|Other|1|||
128751395|NCT04330638|463377694|FG004|Overall Study|Other|3|||
128751396|NCT04330638|463377695|FG005|Overall Study|Other|2|||
128751397|NCT04330638|463377690|FG000|Overall Study|Withdrawal by Subject|4|||
128751398|NCT04330638|463377691|FG001|Overall Study|Withdrawal by Subject|0|||
128751399|NCT04330638|463377692|FG002|Overall Study|Withdrawal by Subject|0|||
128751400|NCT04330638|463377693|FG003|Overall Study|Withdrawal by Subject|0|||
128751401|NCT04330638|463377694|FG004|Overall Study|Withdrawal by Subject|0|||
128751402|NCT04330638|463377695|FG005|Overall Study|Withdrawal by Subject|0|||
128751403|NCT04330638|463377690|FG000|Overall Study|Lost to Follow-up|3|||
128751404|NCT04330638|463377691|FG001|Overall Study|Lost to Follow-up|2|||
128751405|NCT04330638|463377692|FG002|Overall Study|Lost to Follow-up|3|||
128751406|NCT04330638|463377693|FG003|Overall Study|Lost to Follow-up|2|||
128751407|NCT04330638|463377694|FG004|Overall Study|Lost to Follow-up|3|||
128751408|NCT04330638|463377695|FG005|Overall Study|Lost to Follow-up|0|||
128751409|NCT02293538|463377696|FG000|Overall Study|Adverse Event|0|||
128751410|NCT02293538|463377697|FG001|Overall Study|Adverse Event|1|||
128751411|NCT02293538|463377696|FG000|Overall Study|Lost to Follow-up|1|||
128751412|NCT02293538|463377697|FG001|Overall Study|Lost to Follow-up|0|||
128751413|NCT02293538|463377696|FG000|Overall Study|Withdrawal by Subject|0|||
128751414|NCT02293538|463377697|FG001|Overall Study|Withdrawal by Subject|1|||
128751415|NCT00322348|463377698|FG000|Overall Study|Adverse Event|0|||
128751416|NCT00322348|463377699|FG001|Overall Study|Adverse Event|1|||
128751417|NCT00322348|463377698|FG000|Overall Study|Withdrawal by Subject|1|||
128751418|NCT00322348|463377699|FG001|Overall Study|Withdrawal by Subject|4|||
128751419|NCT00322348|463377698|FG000|Overall Study|Lost to Follow-up|1|||
128751420|NCT00322348|463377699|FG001|Overall Study|Lost to Follow-up|0|||
128751421|NCT00322348|463377698|FG000|Overall Study|Death|0|||
128751422|NCT00322348|463377699|FG001|Overall Study|Death|2|||
128751423|NCT00322348|463377698|FG000|Overall Study|Disease Progression|30|||
128751424|NCT00322348|463377699|FG001|Overall Study|Disease Progression|25|||
128751425|NCT00322348|463377698|FG000|Overall Study|Reasons not specified|5|||
128751426|NCT00322348|463377699|FG001|Overall Study|Reasons not specified|1|||
128751427|NCT01090453|463377708|FG000|Overall Study|Withdrawal by Subject|1|||
128751428|NCT01090453|463377709|FG001|Overall Study|Withdrawal by Subject|2|||
128751429|NCT01090453|463377708|FG000|Overall Study|Lost to Follow-up|7|||
128751430|NCT01090453|463377709|FG001|Overall Study|Lost to Follow-up|7|||
128751431|NCT01090453|463377708|FG000|Overall Study|Non serious AEs|1|||
128751432|NCT01090453|463377709|FG001|Overall Study|Non serious AEs|0|||
128751433|NCT01090453|463377708|FG000|Overall Study|Protocol Violation|2|||
128751434|NCT01090453|463377709|FG001|Overall Study|Protocol Violation|0|||
128751435|NCT01090453|463377708|FG000|Overall Study|Other|2|||
128751436|NCT01090453|463377709|FG001|Overall Study|Other|4|||
128751437|NCT01090453|463377708|FG000|Overall Study|Eligibility Criteria|0|||
128751438|NCT01090453|463377709|FG001|Overall Study|Eligibility Criteria|1|||
128751439|NCT04072159|463377710|FG000|Overall Study|Lost to Follow-up|6|||
128751440|NCT04072159|463377711|FG001|Overall Study|Lost to Follow-up|6|||
128751441|NCT04072159|463377710|FG000|Overall Study|Withdrawal by Subject|2|||
128751442|NCT04072159|463377711|FG001|Overall Study|Withdrawal by Subject|0|||
128751443|NCT05045625|463377717|FG000|Overall Study|Lost to Follow-up|3|||
128751444|NCT04899349|463377721|FG000|Overall Study|Study terminated by Sponsor|2|||
128751445|NCT04899349|463377722|FG001|Overall Study|Study terminated by Sponsor|0|||
128751446|NCT01022762|463377724|FG000|Overall Study|Adverse Event|3|||
128751447|NCT01022762|463377725|FG001|Overall Study|Adverse Event|1|||
128751448|NCT01022762|463377724|FG000|Overall Study|Lack of Efficacy|0|||
128751449|NCT01022762|463377725|FG001|Overall Study|Lack of Efficacy|1|||
128751450|NCT01022762|463377724|FG000|Overall Study|Protocol Violation|7|||
128751451|NCT01022762|463377725|FG001|Overall Study|Protocol Violation|6|||
128751452|NCT01022762|463377724|FG000|Overall Study|Unclassified|12|||
128751453|NCT01022762|463377725|FG001|Overall Study|Unclassified|20|||
128751454|NCT01302119|463377726|FG000|Overall Study|Withdrawal by Subject|30|||
128751455|NCT01302119|463377727|FG001|Overall Study|Withdrawal by Subject|20|||
128751456|NCT01302119|463377726|FG000|Overall Study|Lost to Follow-up|10|||
128751457|NCT01302119|463377727|FG001|Overall Study|Lost to Follow-up|4|||
128751458|NCT01302119|463377726|FG000|Overall Study|Adverse Event|2|||
128751459|NCT01302119|463377727|FG001|Overall Study|Adverse Event|1|||
128751460|NCT01302119|463377726|FG000|Overall Study|Non-compliance|4|||
128751461|NCT01302119|463377727|FG001|Overall Study|Non-compliance|2|||
128751462|NCT01302119|463377726|FG000|Overall Study|Non-specific|4|||
128751463|NCT01302119|463377727|FG001|Overall Study|Non-specific|1|||
128751464|NCT04084314|463377728|FG000|Overall Study|Subject/guardian decision|91|||
128751465|NCT04084314|463377728|FG000|Overall Study|Adverse Event|24|||
128751466|NCT04084314|463377728|FG000|Overall Study|Lost to Follow-up|19|||
128751467|NCT04084314|463377728|FG000|Overall Study|New therapy for study indication|9|||
128751468|NCT04084314|463377728|FG000|Overall Study|Pregnancy|9|||
128751469|NCT04084314|463377728|FG000|Overall Study|Withdrawal of informed consent|8|||
128751470|NCT04084314|463377728|FG000|Overall Study|Physician Decision|4|||
128751471|NCT04084314|463377728|FG000|Overall Study|Protocol Deviation|3|||
128751472|NCT00802074|463377732|FG000|Overall Study|Adverse Event|1|||
128751473|NCT00802074|463377733|FG001|Overall Study|Adverse Event|1|||
128751474|NCT00802074|463377734|FG002|Overall Study|Adverse Event|1|||
128751475|NCT00802074|463377735|FG003|Overall Study|Adverse Event|0|||
128751476|NCT00802074|463377736|FG004|Overall Study|Adverse Event|0|||
128751477|NCT00802074|463377737|FG005|Overall Study|Adverse Event|0|||
128751478|NCT00802074|463377732|FG000|Overall Study|Withdrawal by Subject|1|||
128751479|NCT00802074|463377733|FG001|Overall Study|Withdrawal by Subject|0|||
128751480|NCT00802074|463377734|FG002|Overall Study|Withdrawal by Subject|0|||
128751481|NCT00802074|463377735|FG003|Overall Study|Withdrawal by Subject|0|||
128751482|NCT00802074|463377736|FG004|Overall Study|Withdrawal by Subject|0|||
128751483|NCT00802074|463377737|FG005|Overall Study|Withdrawal by Subject|0|||
128751484|NCT03743038|463377738|FG000|Overall Study|Physician Decision|1|||
128751485|NCT03336619|463377739|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
128751486|NCT03336619|463377740|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
128751487|NCT03336619|463377739|FG000|Overall Study|Withdrawal by Subject|17|||
128751488|NCT03336619|463377740|FG001|Overall Study|Withdrawal by Subject|16|||
128751489|NCT03336619|463377739|FG000|Overall Study|Adverse Event|2|||
128751490|NCT03336619|463377740|FG001|Overall Study|Adverse Event|5|||
128751491|NCT03336619|463377739|FG000|Overall Study|Physician Decision|3|||
128751492|NCT03336619|463377740|FG001|Overall Study|Physician Decision|0|||
128751493|NCT01300546|463377741|FG000|Overall Study|Withdrawal by Subject|1|||
128751494|NCT01300546|463377742|FG001|Overall Study|Withdrawal by Subject|0|||
128751495|NCT01300546|463377741|FG000|Overall Study|Lost to Follow-up|0|||
128751496|NCT01300546|463377742|FG001|Overall Study|Lost to Follow-up|2|||
128751497|NCT01300546|463377741|FG000|Overall Study|Lack of Efficacy|0|||
128751498|NCT01300546|463377742|FG001|Overall Study|Lack of Efficacy|3|||
128751499|NCT01300546|463377741|FG000|Overall Study|Adverse Event|0|||
128751500|NCT01300546|463377742|FG001|Overall Study|Adverse Event|1|||
128751501|NCT02820623|463377743|FG000|Overall Study|Withdrawal by Subject|1|||
128751502|NCT02820623|463377744|FG001|Overall Study|Withdrawal by Subject|3|||
128751503|NCT02820623|463377745|FG002|Overall Study|Withdrawal by Subject|3|||
128786104|NCT01549652|463509372|FG001|Overall Study|Problem with Infusion|0|||
128751504|NCT02820623|463377743|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
128751505|NCT02820623|463377744|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
128751506|NCT02820623|463377745|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
128751507|NCT02820623|463377743|FG000|Overall Study|Therapist unable to enroll clients|1|||
128751508|NCT02820623|463377744|FG001|Overall Study|Therapist unable to enroll clients|1|||
128751509|NCT02820623|463377745|FG002|Overall Study|Therapist unable to enroll clients|3|||
128786105|NCT01549652|463509373|FG002|Overall Study|Problem with Infusion|0|||
128751510|NCT02820623|463377743|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
128751511|NCT02820623|463377744|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
128751512|NCT02820623|463377745|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
128751513|NCT00613951|463377754|FG000|Overall Study|Adverse Event|1|||
128751514|NCT00613951|463377755|FG001|Overall Study|Adverse Event|0|||
128751515|NCT00613951|463377756|FG002|Overall Study|Adverse Event|1|||
128751516|NCT00613951|463377754|FG000|Overall Study|Lack of Efficacy|0|||
128751517|NCT00613951|463377755|FG001|Overall Study|Lack of Efficacy|1|||
128751518|NCT00613951|463377756|FG002|Overall Study|Lack of Efficacy|1|||
128751519|NCT00613951|463377754|FG000|Overall Study|Protocol Violation|1|||
128751520|NCT00613951|463377755|FG001|Overall Study|Protocol Violation|1|||
128751521|NCT00613951|463377756|FG002|Overall Study|Protocol Violation|1|||
128751522|NCT00613951|463377754|FG000|Overall Study|Unclassified|5|||
128751523|NCT00613951|463377755|FG001|Overall Study|Unclassified|3|||
128751524|NCT00613951|463377756|FG002|Overall Study|Unclassified|2|||
128751525|NCT04439110|463377757|FG000|Overall Study|Ineligible|2|||
128751526|NCT04439110|463377757|FG000|Overall Study|Adverse Event|4|||
128751527|NCT04439110|463377757|FG000|Overall Study|Death|2|||
128751528|NCT04439110|463377757|FG000|Overall Study|Disease proression|25|||
128751529|NCT04439110|463377757|FG000|Overall Study|Withdrawal by Subject|1|||
128751530|NCT04439110|463377757|FG000|Overall Study|Alternative therapy|1|||
128751531|NCT04439110|463377757|FG000|Overall Study|Other complicating disease|1|||
128751532|NCT04439110|463377757|FG000|Overall Study|Personal reasons|1|||
128751533|NCT04439110|463377757|FG000|Overall Study|Still on treatment|1|||
128751534|NCT00127608|463377758|FG000|Overall Study|VZV DNA negative|1|||
128751535|NCT00506493|463377764|FG000|Overall Study|Death|6|||
128751536|NCT00506493|463377764|FG000|Overall Study|Withdrawal by Subject|5|||
128751537|NCT01266642|463377765|FG000|Overall Study|Protocol Violation|0|||
128751538|NCT01266642|463377766|FG001|Overall Study|Protocol Violation|1|||
128751539|NCT00686166|463379475|FG000|Overall Study|Adverse Event|7|||
128751540|NCT00686166|463379475|FG000|Overall Study|Withdrawal by Subject|1|||
128751541|NCT00686166|463379475|FG000|Overall Study|Progression/Relapse|1|||
128751542|NCT00686166|463379475|FG000|Overall Study|Death|1|||
128751543|NCT00686166|463379475|FG000|Overall Study|Not Protocol Specified|1|||
128751544|NCT00686166|463379475|FG000|Overall Study|Ineligible|5|||
128751545|NCT00686166|463379475|FG000|Overall Study|Did not begin protocol therapy|4|||
128751546|NCT01549613|463379478|FG000|Overall Study|Lost to Follow-up|11|||
128751547|NCT01549613|463379479|FG001|Overall Study|Lost to Follow-up|11|||
128751548|NCT02216123|463379480|FG000|Overall Study|Lost to Follow-up|4|||
128751549|NCT02216123|463379481|FG001|Overall Study|Lost to Follow-up|2|||
128751550|NCT02216123|463379480|FG000|Overall Study|Withdrawal by Subject|2|||
128751551|NCT02216123|463379481|FG001|Overall Study|Withdrawal by Subject|0|||
128751552|NCT00254982|463379483|FG000|Overall Study|Other|2|||
128751553|NCT00254982|463379484|FG001|Overall Study|Other|1|||
128751554|NCT00254982|463379483|FG000|Overall Study|Lack of Efficacy|5|||
128751555|NCT00254982|463379484|FG001|Overall Study|Lack of Efficacy|3|||
128751556|NCT00254982|463379483|FG000|Overall Study|Lost to Follow-up|5|||
128751557|NCT00254982|463379484|FG001|Overall Study|Lost to Follow-up|3|||
128751558|NCT00254982|463379483|FG000|Overall Study|Adverse Event|18|||
128751559|NCT00254982|463379484|FG001|Overall Study|Adverse Event|16|||
128751560|NCT00254982|463379483|FG000|Overall Study|Withdrawal by Subject|1|||
128751561|NCT00254982|463379484|FG001|Overall Study|Withdrawal by Subject|1|||
128751562|NCT00254982|463379483|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
128751563|NCT00254982|463379484|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
128751564|NCT00254982|463379483|FG000|Overall Study|Protocol deviation|1|||
128751565|NCT00254982|463379484|FG001|Overall Study|Protocol deviation|1|||
128751566|NCT00254982|463379483|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
128751567|NCT00254982|463379484|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
128751568|NCT00254982|463379483|FG000|Overall Study|Malignancy|0|||
128751569|NCT00254982|463379484|FG001|Overall Study|Malignancy|2|||
128751570|NCT00254982|463379483|FG000|Overall Study|Opportunistic infection|1|||
128751571|NCT00254982|463379484|FG001|Overall Study|Opportunistic infection|0|||
128751572|NCT00254982|463379483|FG000|Overall Study|Abnormal liver function tests|2|||
128751573|NCT00254982|463379484|FG001|Overall Study|Abnormal liver function tests|1|||
128751574|NCT01540851|463379486|FG000|Overall Study|Lost to Follow-up|14|||
128751575|NCT01540851|463379487|FG001|Overall Study|Lost to Follow-up|15|||
128751576|NCT01540851|463379486|FG000|Overall Study|Withdrawal by Subject|7|||
128751577|NCT01540851|463379487|FG001|Overall Study|Withdrawal by Subject|3|||
128751578|NCT01324271|463379488|FG000|Overall Study|Lost to Follow-up|3|||
128751579|NCT01324271|463379489|FG001|Overall Study|Lost to Follow-up|0|||
128751580|NCT01324271|463379488|FG000|Overall Study|Physician Decision|1|||
128751581|NCT01324271|463379489|FG001|Overall Study|Physician Decision|0|||
128751582|NCT05130970|463379490|FG000|Overall Study|Adverse Event|1|||
128751583|NCT05130970|463379491|FG001|Overall Study|Adverse Event|1|||
128751584|NCT05130970|463379490|FG000|Overall Study|Death|0|||
128751585|NCT05130970|463379491|FG001|Overall Study|Death|1|||
128751586|NCT05130970|463379490|FG000|Overall Study|Lost to Follow-up|0|||
128751587|NCT05130970|463379491|FG001|Overall Study|Lost to Follow-up|1|||
128751588|NCT05130970|463379490|FG000|Overall Study|Physician Decision|0|||
128751589|NCT05130970|463379491|FG001|Overall Study|Physician Decision|1|||
128751590|NCT05130970|463379490|FG000|Overall Study|Withdrawal by Subject|1|||
128751591|NCT05130970|463379491|FG001|Overall Study|Withdrawal by Subject|1|||
128751592|NCT03996473|463379492|FG000|Treatment Assignment|Withdrawal by Subject|1|||
128751593|NCT03996473|463379492|FG000|Treatment Assignment|Progressive disease|6|||
128751594|NCT03996473|463379492|FG000|Treatment Assignment|Study drug never administered|1|||
128751595|NCT03996473|463379492|FG000|Active Follow-up|Death|1|||
128751596|NCT03996473|463379492|FG000|Long-term Follow-up|Death|5|||
128751597|NCT06116591|463379493|FG000|Overall Study|No longer met eligibility criteria|0|||
128751598|NCT06116591|463379494|FG001|Overall Study|No longer met eligibility criteria|1|||
128751599|NCT06116591|463379493|FG000|Overall Study|Other: Change in life situation|0|||
128751600|NCT06116591|463379494|FG001|Overall Study|Other: Change in life situation|1|||
128751601|NCT03644186|463379495|FG000|Overall Study|Withdrawal by Subject|1|||
128751602|NCT03644186|463379496|FG001|Overall Study|Withdrawal by Subject|1|||
128751603|NCT01869491|463379497|FG000|Overall Study|Adverse Event|3|||
128751604|NCT01869491|463379498|FG001|Overall Study|Adverse Event|5|||
128751605|NCT01869491|463379497|FG000|Overall Study|Lack of Efficacy|0|||
128751606|NCT01869491|463379498|FG001|Overall Study|Lack of Efficacy|3|||
128751607|NCT01869491|463379497|FG000|Overall Study|Withdrawal by Subject|6|||
128751608|NCT01869491|463379498|FG001|Overall Study|Withdrawal by Subject|7|||
128751609|NCT01869491|463379497|FG000|Overall Study|Lost to Follow-up|11|||
128751610|NCT01869491|463379498|FG001|Overall Study|Lost to Follow-up|9|||
128751611|NCT01869491|463379497|FG000|Overall Study|No further need of investigational product|1|||
128751612|NCT01869491|463379498|FG001|Overall Study|No further need of investigational product|0|||
128751613|NCT04009291|463379499|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
128751614|NCT04009291|463379500|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
128751615|NCT04009291|463379501|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
128751616|NCT04009291|463379502|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
128751617|NCT04009291|463379503|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
128751618|NCT04009291|463379499|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
128751619|NCT04009291|463379500|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
128751620|NCT04009291|463379501|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
128751621|NCT04009291|463379502|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
128751622|NCT04009291|463379503|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
128751623|NCT05553808|463379506|FG000|Overall Study|Death|25|||
128751624|NCT05553808|463379507|FG001|Overall Study|Death|62|||
128751625|NCT05553808|463379506|FG000|Overall Study|Site Closed|6|||
128751626|NCT05553808|463379507|FG001|Overall Study|Site Closed|6|||
128751627|NCT05553808|463379506|FG000|Overall Study|Lost to Follow-up|1|||
128751628|NCT05553808|463379507|FG001|Overall Study|Lost to Follow-up|0|||
128751629|NCT05553808|463379506|FG000|Overall Study|Withdrawal by Subject|3|||
128751630|NCT05553808|463379507|FG001|Overall Study|Withdrawal by Subject|2|||
128751631|NCT00727272|463379514|FG000|Washout Period A|Adverse Event|0|||
128751632|NCT00727272|463379515|FG001|Washout Period A|Adverse Event|0|||
128751633|NCT00727272|463379516|FG002|Washout Period A|Adverse Event|1|||
128751634|NCT00727272|463379514|FG000|Washout Period B|Withdrawal by Subject|0|||
128751635|NCT00727272|463379515|FG001|Washout Period B|Withdrawal by Subject|0|||
128751636|NCT00727272|463379516|FG002|Washout Period B|Withdrawal by Subject|1|||
128751637|NCT00651664|463379517|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
128751638|NCT00651664|463379518|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
128751639|NCT00651664|463379519|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
128751640|NCT00651664|463379520|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
128751641|NCT00651664|463379521|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
128751642|NCT00651664|463379522|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
128751643|NCT00651664|463379523|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
128751644|NCT00651664|463379524|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
128751645|NCT00651664|463379525|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
128751646|NCT00651664|463379526|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
128751647|NCT00651664|463379517|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
128751648|NCT00651664|463379518|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
128751649|NCT00651664|463379519|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
128751650|NCT00651664|463379520|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
128751651|NCT00651664|463379521|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
128751652|NCT00651664|463379522|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
128751653|NCT00651664|463379523|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
128751654|NCT00651664|463379524|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
128751655|NCT00651664|463379525|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
128751656|NCT00651664|463379526|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
128751657|NCT00651664|463379517|FG000|Overall Study|Progressive Disease|3|||
128751658|NCT00651664|463379518|FG001|Overall Study|Progressive Disease|3|||
128751659|NCT00651664|463379519|FG002|Overall Study|Progressive Disease|3|||
128751660|NCT00651664|463379520|FG003|Overall Study|Progressive Disease|12|||
128751661|NCT00651664|463379521|FG004|Overall Study|Progressive Disease|4|||
128751662|NCT00651664|463379522|FG005|Overall Study|Progressive Disease|1|||
128751663|NCT00651664|463379523|FG006|Overall Study|Progressive Disease|3|||
128751664|NCT00651664|463379524|FG007|Overall Study|Progressive Disease|6|||
128751665|NCT00651664|463379525|FG008|Overall Study|Progressive Disease|5|||
128751666|NCT00651664|463379526|FG009|Overall Study|Progressive Disease|5|||
128751667|NCT00651664|463379517|FG000|Overall Study|Patient Declined Further Treatment|0|||
128751668|NCT00651664|463379518|FG001|Overall Study|Patient Declined Further Treatment|0|||
128751669|NCT00651664|463379519|FG002|Overall Study|Patient Declined Further Treatment|0|||
128751670|NCT00651664|463379520|FG003|Overall Study|Patient Declined Further Treatment|1|||
128751671|NCT00651664|463379521|FG004|Overall Study|Patient Declined Further Treatment|1|||
128751672|NCT00651664|463379522|FG005|Overall Study|Patient Declined Further Treatment|1|||
128751673|NCT00651664|463379523|FG006|Overall Study|Patient Declined Further Treatment|0|||
128751674|NCT00651664|463379524|FG007|Overall Study|Patient Declined Further Treatment|0|||
128751675|NCT00651664|463379525|FG008|Overall Study|Patient Declined Further Treatment|0|||
128751676|NCT00651664|463379526|FG009|Overall Study|Patient Declined Further Treatment|1|||
128751677|NCT00651664|463379517|FG000|Overall Study|Symptomatic Deterioration|0|||
128751678|NCT00651664|463379518|FG001|Overall Study|Symptomatic Deterioration|0|||
128751679|NCT00651664|463379519|FG002|Overall Study|Symptomatic Deterioration|0|||
128751680|NCT00651664|463379520|FG003|Overall Study|Symptomatic Deterioration|1|||
128751681|NCT00651664|463379521|FG004|Overall Study|Symptomatic Deterioration|0|||
128751682|NCT00651664|463379522|FG005|Overall Study|Symptomatic Deterioration|0|||
128751683|NCT00651664|463379523|FG006|Overall Study|Symptomatic Deterioration|1|||
128751684|NCT00651664|463379524|FG007|Overall Study|Symptomatic Deterioration|0|||
128751685|NCT00651664|463379525|FG008|Overall Study|Symptomatic Deterioration|1|||
128751686|NCT00651664|463379526|FG009|Overall Study|Symptomatic Deterioration|0|||
128751687|NCT00651664|463379517|FG000|Overall Study|Reason not Specified|0|||
128751688|NCT00651664|463379518|FG001|Overall Study|Reason not Specified|0|||
128751689|NCT00651664|463379519|FG002|Overall Study|Reason not Specified|0|||
128751690|NCT00651664|463379520|FG003|Overall Study|Reason not Specified|0|||
128751691|NCT00651664|463379521|FG004|Overall Study|Reason not Specified|0|||
128751692|NCT00651664|463379522|FG005|Overall Study|Reason not Specified|0|||
128751693|NCT00651664|463379523|FG006|Overall Study|Reason not Specified|1|||
128751694|NCT00651664|463379524|FG007|Overall Study|Reason not Specified|0|||
128751695|NCT00651664|463379525|FG008|Overall Study|Reason not Specified|0|||
128751696|NCT00651664|463379526|FG009|Overall Study|Reason not Specified|0|||
128751697|NCT00535730|463379535|FG000|Overall Study|Adverse Event|1|||
128751698|NCT00535730|463379536|FG001|Overall Study|Adverse Event|1|||
128751699|NCT00535730|463379535|FG000|Overall Study|Lost to Follow-up|0|||
128751700|NCT00535730|463379536|FG001|Overall Study|Lost to Follow-up|1|||
128751701|NCT00535730|463379535|FG000|Overall Study|Physician Decision|0|||
128751702|NCT00535730|463379536|FG001|Overall Study|Physician Decision|1|||
128751703|NCT00535730|463379535|FG000|Overall Study|Protocol Violation|1|||
128751704|NCT00535730|463379536|FG001|Overall Study|Protocol Violation|0|||
128786106|NCT01549652|463509374|FG003|Overall Study|Problem with Infusion|0|||
128751705|NCT00535730|463379535|FG000|Overall Study|Withdrawal by Subject|0|||
128751706|NCT00535730|463379536|FG001|Overall Study|Withdrawal by Subject|4|||
128751707|NCT00936858|463379537|FG000|Overall Study|Death|3|||
128751708|NCT00936858|463379537|FG000|Overall Study|Progression|29|||
128751709|NCT00936858|463379537|FG000|Overall Study|Withdrawal by Subject|5|||
128751710|NCT00936858|463379537|FG000|Overall Study|Adverse Event|1|||
128751711|NCT00936858|463379537|FG000|Overall Study|Physician Decision|7|||
128751712|NCT00936858|463379537|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
128751713|NCT00936858|463379537|FG000|Overall Study|Lost to Follow-up|1|||
128751714|NCT00989287|463379540|FG000|Overall Study|Adverse Event|1|||
128751715|NCT00989287|463379541|FG001|Overall Study|Adverse Event|0|||
128751716|NCT00989287|463379540|FG000|Overall Study|Lost to Follow-up|0|||
128751717|NCT00989287|463379541|FG001|Overall Study|Lost to Follow-up|1|||
128751718|NCT00729833|463379542|FG000|Overall Study|Death|5|||
128751719|NCT00729833|463379543|FG001|Overall Study|Death|1|||
128786107|NCT01549652|463509371|FG000|Overall Study|Titration Non-Compliance|1|||
128751720|NCT00729833|463379544|FG002|Overall Study|Death|3|||
128751721|NCT00729833|463379545|FG003|Overall Study|Death|5|||
128751722|NCT00729833|463379542|FG000|Overall Study|Study Terminated by Sponsor|0|||
128751723|NCT00729833|463379543|FG001|Overall Study|Study Terminated by Sponsor|0|||
128751724|NCT00729833|463379544|FG002|Overall Study|Study Terminated by Sponsor|1|||
128751725|NCT00729833|463379545|FG003|Overall Study|Study Terminated by Sponsor|0|||
128751726|NCT00729833|463379542|FG000|Overall Study|Lost to Follow-up|1|||
128751727|NCT00729833|463379543|FG001|Overall Study|Lost to Follow-up|0|||
128751728|NCT00729833|463379544|FG002|Overall Study|Lost to Follow-up|0|||
128751729|NCT00729833|463379545|FG003|Overall Study|Lost to Follow-up|0|||
128751730|NCT00729833|463379542|FG000|Overall Study|Withdrawal by Subject|3|||
128751731|NCT00729833|463379543|FG001|Overall Study|Withdrawal by Subject|1|||
128751732|NCT00729833|463379544|FG002|Overall Study|Withdrawal by Subject|3|||
128751733|NCT00729833|463379545|FG003|Overall Study|Withdrawal by Subject|0|||
128751734|NCT00729833|463379542|FG000|Overall Study|Unspecified Reasons|11|||
128751735|NCT00729833|463379543|FG001|Overall Study|Unspecified Reasons|5|||
128751736|NCT00729833|463379544|FG002|Overall Study|Unspecified Reasons|5|||
128751737|NCT00729833|463379545|FG003|Overall Study|Unspecified Reasons|1|||
128751738|NCT00417079|463379546|FG000|Overall Study|Disease progression|267|||
128751739|NCT00417079|463379547|FG001|Overall Study|Disease progression|180|||
128751740|NCT00417079|463379546|FG000|Overall Study|Adverse Event|32|||
128751741|NCT00417079|463379547|FG001|Overall Study|Adverse Event|67|||
128751742|NCT00417079|463379546|FG000|Overall Study|Non-compliance to protocol|0|||
128751743|NCT00417079|463379547|FG001|Overall Study|Non-compliance to protocol|1|||
128751744|NCT00417079|463379546|FG000|Overall Study|Lost to Follow-up|2|||
128751745|NCT00417079|463379547|FG001|Overall Study|Lost to Follow-up|0|||
128751746|NCT00417079|463379546|FG000|Overall Study|Withdrawal by Subject|17|||
128751747|NCT00417079|463379547|FG001|Overall Study|Withdrawal by Subject|8|||
128751748|NCT00417079|463379546|FG000|Overall Study|Not treated|6|||
128751749|NCT00417079|463379547|FG001|Overall Study|Not treated|7|||
128751750|NCT00417079|463379546|FG000|Overall Study|Screened failure|2|||
128751751|NCT00417079|463379547|FG001|Overall Study|Screened failure|1|||
128751752|NCT00417079|463379546|FG000|Overall Study|Investigator's decision|1|||
128751753|NCT00417079|463379547|FG001|Overall Study|Investigator's decision|4|||
128751754|NCT00417079|463379546|FG000|Overall Study|Non-confirmed Disease progression|1|||
128751755|NCT00417079|463379547|FG001|Overall Study|Non-confirmed Disease progression|1|||
128751756|NCT00417079|463379546|FG000|Overall Study|Clinical deterioration|1|||
128751757|NCT00417079|463379547|FG001|Overall Study|Clinical deterioration|0|||
128751758|NCT00417079|463379546|FG000|Overall Study|Screening error|2|||
128751759|NCT00417079|463379547|FG001|Overall Study|Screening error|1|||
128751760|NCT00417079|463379546|FG000|Overall Study|Withdrawal by subject's family|0|||
128751761|NCT00417079|463379547|FG001|Overall Study|Withdrawal by subject's family|1|||
128751762|NCT00417079|463379546|FG000|Overall Study|Patient unable to come to the clinic|0|||
128751763|NCT00417079|463379547|FG001|Overall Study|Patient unable to come to the clinic|1|||
128751764|NCT00417079|463379546|FG000|Overall Study|abnormal liver function tests|0|||
128751765|NCT00417079|463379547|FG001|Overall Study|abnormal liver function tests|1|||
128751766|NCT04403698|463379548|FG000|Overall Study|Adverse Event|1|||
128751767|NCT04403698|463379549|FG001|Overall Study|Adverse Event|1|||
128751768|NCT04403698|463379548|FG000|Overall Study|Lost to Follow-up|1|||
128751769|NCT04403698|463379549|FG001|Overall Study|Lost to Follow-up|0|||
128751770|NCT04403698|463379548|FG000|Overall Study|Protocol Violation|0|||
128751771|NCT04403698|463379549|FG001|Overall Study|Protocol Violation|1|||
128751772|NCT03152552|463379550|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
128751773|NCT03152552|463379551|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
128751774|NCT03152552|463379552|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
128751775|NCT03152552|463379553|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
128751776|NCT03152552|463379554|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
128751777|NCT03152552|463379550|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
128751778|NCT03152552|463379551|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
128751779|NCT03152552|463379552|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
128751780|NCT03152552|463379553|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
128751781|NCT03152552|463379554|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
128751782|NCT03152552|463379550|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
128751783|NCT03152552|463379551|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
128751784|NCT03152552|463379552|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
128751785|NCT03152552|463379553|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
128751786|NCT03152552|463379554|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
128751787|NCT03152552|463379550|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128751788|NCT03152552|463379551|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128751789|NCT03152552|463379552|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
128751790|NCT03152552|463379553|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128751791|NCT03152552|463379554|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
128751792|NCT03152552|463379550|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
128751793|NCT03152552|463379551|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
128751794|NCT03152552|463379552|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
128751795|NCT03152552|463379553|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
128751796|NCT03152552|463379554|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
128751797|NCT03152552|463379550|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
128751798|NCT03152552|463379551|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
128751799|NCT03152552|463379552|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
128751800|NCT03152552|463379553|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
128751801|NCT03152552|463379554|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
128751802|NCT03152552|463379550|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
128751803|NCT03152552|463379551|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
128751804|NCT03152552|463379552|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
128751805|NCT03152552|463379553|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
128751806|NCT03152552|463379554|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
128751807|NCT03570619|463379555|FG000|Overall Study|Adverse Event|2|||
128751808|NCT03570619|463379556|FG001|Overall Study|Adverse Event|0|||
128751809|NCT03570619|463379557|FG002|Overall Study|Adverse Event|1|||
128751810|NCT03570619|463379555|FG000|Overall Study|new diagnosis of new malignancy|1|||
128751811|NCT03570619|463379556|FG001|Overall Study|new diagnosis of new malignancy|0|||
128751812|NCT03570619|463379557|FG002|Overall Study|new diagnosis of new malignancy|0|||
128751813|NCT03570619|463379555|FG000|Overall Study|Physician Decision|1|||
128751814|NCT03570619|463379556|FG001|Overall Study|Physician Decision|1|||
128751815|NCT03570619|463379557|FG002|Overall Study|Physician Decision|0|||
128751816|NCT03570619|463379555|FG000|Overall Study|Withdrawal by Subject|0|||
128751817|NCT03570619|463379556|FG001|Overall Study|Withdrawal by Subject|2|||
128751818|NCT03570619|463379557|FG002|Overall Study|Withdrawal by Subject|0|||
128751819|NCT00808808|463379560|FG000|Overall Study|Vaccinated; survey not completed|131|||
128751820|NCT00808808|463379561|FG001|Overall Study|Vaccinated; survey not completed|169|||
128751821|NCT00808808|463379562|FG002|Overall Study|Vaccinated; survey not completed|302|||
128751822|NCT00808808|463379560|FG000|Overall Study|Employee was not vaccinated.|2686|||
128751823|NCT00808808|463379561|FG001|Overall Study|Employee was not vaccinated.|2268|||
128751824|NCT00808808|463379562|FG002|Overall Study|Employee was not vaccinated.|2255|||
128751825|NCT01371851|463379564|FG000|Overall Study|Lost to Follow-up|5|||
128751826|NCT01371851|463379565|FG001|Overall Study|Lost to Follow-up|8|||
128751827|NCT01371851|463379564|FG000|Overall Study|was arrested and put in jail|0|||
128751828|NCT01371851|463379565|FG001|Overall Study|was arrested and put in jail|1|||
128751829|NCT01371851|463379564|FG000|Overall Study|non study related adverse event|1|||
128751830|NCT01371851|463379565|FG001|Overall Study|non study related adverse event|0|||
128751831|NCT01371851|463379564|FG000|Overall Study|Blood Pressure outside study parameters|2|||
128751832|NCT01371851|463379565|FG001|Overall Study|Blood Pressure outside study parameters|0|||
128751833|NCT00833638|463379566|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
128751834|NCT00833638|463379567|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
128751835|NCT00833638|463379568|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
128751836|NCT00833638|463379566|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
128751837|NCT00833638|463379567|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
128751838|NCT00833638|463379568|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
128751839|NCT00833638|463379566|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
128751840|NCT00833638|463379567|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
128751841|NCT00833638|463379568|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
128751842|NCT00833638|463379566|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
128751843|NCT00833638|463379567|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
128751844|NCT00833638|463379568|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
128751845|NCT00833638|463379566|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
128751846|NCT00833638|463379567|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
128751847|NCT00833638|463379568|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
128751848|NCT00833638|463379566|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
128751849|NCT00833638|463379567|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
128751850|NCT00833638|463379568|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
128751851|NCT00833638|463379566|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
128751852|NCT00833638|463379567|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
128751853|NCT00833638|463379568|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
128751854|NCT00833638|463379566|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
128751855|NCT00833638|463379567|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
128751856|NCT00833638|463379568|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
128751857|NCT00833638|463379566|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
128751858|NCT00833638|463379567|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
128751859|NCT00833638|463379568|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
128751860|NCT00490646|463379569|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
128751861|NCT00490646|463379570|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
128751862|NCT00490646|463379569|FG000|Overall Study|Never Treated (had an adverse event)|1|||
128751863|NCT00490646|463379570|FG001|Overall Study|Never Treated (had an adverse event)|0|||
128751864|NCT00490646|463379569|FG000|Overall Study|Never Treated (withdrew consent)|0|||
128751865|NCT00490646|463379570|FG001|Overall Study|Never Treated (withdrew consent)|1|||
128751866|NCT05608629|463379572|FG000|Overall Study|Lost to Follow-up|2|||
128751867|NCT01453595|463379573|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
128751868|NCT01453595|463379574|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
128751869|NCT01453595|463379575|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
128751870|NCT00983073|463379576|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
128751871|NCT00983073|463379576|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
128751872|NCT00983073|463379576|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
128751873|NCT00983073|463379576|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
128751874|NCT00983073|463379576|FG000|Titration and Optimal Dose Period|Other reason|4|||
128751875|NCT00983073|463379576|FG000|Maintenance Period|Adverse Event|5|||
128751876|NCT00983073|463379576|FG000|Maintenance Period|Withdrawal by Subject|2|||
128751877|NCT00983073|463379576|FG000|Maintenance Period|Lack of Efficacy|2|||
128751878|NCT00983073|463379576|FG000|Maintenance Period|Other Reason|7|||
128751879|NCT02313428|463379579|FG000|Overall Study|Lost to Follow-up|1|||
128751880|NCT02313428|463379580|FG001|Overall Study|Lost to Follow-up|1|||
128751881|NCT05374421|463379581|FG000|Overall Study|Withdrawal by Subject|3|||
128751882|NCT05374421|463379582|FG001|Overall Study|Withdrawal by Subject|4|||
128751883|NCT02899728|463379583|FG000|Overall Study|Withdrawal by Subject|1|||
128751884|NCT02899728|463379584|FG001|Overall Study|Withdrawal by Subject|1|||
128751885|NCT05557942|463379585|FG000|Overall Study|Death|0|||
128751886|NCT05557942|463379586|FG001|Overall Study|Death|0|||
128751887|NCT05557942|463379587|FG002|Overall Study|Death|0|||
128751888|NCT05557942|463379588|FG003|Overall Study|Death|2|||
128751889|NCT05557942|463379589|FG004|Overall Study|Death|1|||
128751890|NCT05557942|463379590|FG005|Overall Study|Death|1|||
128751891|NCT05557942|463379585|FG000|Overall Study|Physician Decision|1|||
128751892|NCT05557942|463379586|FG001|Overall Study|Physician Decision|1|||
128751893|NCT05557942|463379587|FG002|Overall Study|Physician Decision|2|||
128751894|NCT05557942|463379588|FG003|Overall Study|Physician Decision|3|||
128751895|NCT05557942|463379589|FG004|Overall Study|Physician Decision|0|||
128751896|NCT05557942|463379590|FG005|Overall Study|Physician Decision|2|||
128751897|NCT05557942|463379585|FG000|Overall Study|Study terminated by sponsor|17|||
128751898|NCT05557942|463379586|FG001|Overall Study|Study terminated by sponsor|17|||
128751899|NCT05557942|463379587|FG002|Overall Study|Study terminated by sponsor|14|||
128751900|NCT05557942|463379588|FG003|Overall Study|Study terminated by sponsor|40|||
128751901|NCT05557942|463379589|FG004|Overall Study|Study terminated by sponsor|45|||
128751902|NCT05557942|463379590|FG005|Overall Study|Study terminated by sponsor|37|||
128751903|NCT05557942|463379585|FG000|Overall Study|Protocol Violation|0|||
128751904|NCT05557942|463379586|FG001|Overall Study|Protocol Violation|0|||
128751905|NCT05557942|463379587|FG002|Overall Study|Protocol Violation|0|||
128751906|NCT05557942|463379588|FG003|Overall Study|Protocol Violation|0|||
128751907|NCT05557942|463379589|FG004|Overall Study|Protocol Violation|0|||
128751908|NCT05557942|463379590|FG005|Overall Study|Protocol Violation|1|||
128751909|NCT05557942|463379585|FG000|Overall Study|Withdrawal by Subject|0|||
128751910|NCT05557942|463379586|FG001|Overall Study|Withdrawal by Subject|0|||
128751911|NCT05557942|463379587|FG002|Overall Study|Withdrawal by Subject|0|||
128751912|NCT05557942|463379588|FG003|Overall Study|Withdrawal by Subject|0|||
128751913|NCT05557942|463379589|FG004|Overall Study|Withdrawal by Subject|2|||
128751914|NCT05557942|463379590|FG005|Overall Study|Withdrawal by Subject|0|||
128751915|NCT02477618|463379591|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
128751916|NCT02477618|463379592|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
128751917|NCT02477618|463379591|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
128751918|NCT02477618|463379592|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
128751919|NCT02477618|463379591|FG000|Overall Study|Adverse Event|1|||
128751920|NCT02477618|463379592|FG001|Overall Study|Adverse Event|1|||
128751921|NCT02477618|463379591|FG000|Overall Study|Transferred Away from Study Site|1|||
128751922|NCT02477618|463379592|FG001|Overall Study|Transferred Away from Study Site|0|||
128751923|NCT02477618|463379591|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
128751924|NCT02477618|463379592|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
128786108|NCT01549652|463509372|FG001|Overall Study|Titration Non-Compliance|3|||
128786109|NCT01549652|463509373|FG002|Overall Study|Titration Non-Compliance|4|||
128751925|NCT00655980|463379596|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
128751926|NCT00655980|463379597|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
128751927|NCT00655980|463379598|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
128751928|NCT05540522|463379599|FG000|Overall Study|Adverse Event|1|||
128751929|NCT05540522|463379600|FG001|Overall Study|Adverse Event|0|||
128751930|NCT05540522|463379601|FG002|Overall Study|Adverse Event|2|||
128751931|NCT05540522|463379602|FG003|Overall Study|Adverse Event|5|||
128751932|NCT05540522|463379599|FG000|Overall Study|Lost to Follow-up|487|||
128751933|NCT05540522|463379600|FG001|Overall Study|Lost to Follow-up|427|||
128751934|NCT05540522|463379601|FG002|Overall Study|Lost to Follow-up|146|||
128751935|NCT05540522|463379602|FG003|Overall Study|Lost to Follow-up|166|||
128751936|NCT05540522|463379599|FG000|Overall Study|Physician Decision|11|||
128751937|NCT05540522|463379600|FG001|Overall Study|Physician Decision|19|||
128751938|NCT05540522|463379601|FG002|Overall Study|Physician Decision|8|||
128751939|NCT05540522|463379602|FG003|Overall Study|Physician Decision|13|||
128751940|NCT05540522|463379599|FG000|Overall Study|Pregnancy|1|||
128751941|NCT05540522|463379600|FG001|Overall Study|Pregnancy|0|||
128751942|NCT05540522|463379601|FG002|Overall Study|Pregnancy|0|||
128751943|NCT05540522|463379602|FG003|Overall Study|Pregnancy|0|||
128751944|NCT05540522|463379599|FG000|Overall Study|Protocol Violation|3|||
128751945|NCT05540522|463379600|FG001|Overall Study|Protocol Violation|1|||
128751946|NCT05540522|463379601|FG002|Overall Study|Protocol Violation|9|||
128751947|NCT05540522|463379602|FG003|Overall Study|Protocol Violation|7|||
128751948|NCT05540522|463379599|FG000|Overall Study|Withdrawal by Subject|168|||
128751949|NCT05540522|463379600|FG001|Overall Study|Withdrawal by Subject|134|||
128751950|NCT05540522|463379601|FG002|Overall Study|Withdrawal by Subject|331|||
128751951|NCT05540522|463379602|FG003|Overall Study|Withdrawal by Subject|322|||
128751952|NCT05540522|463379599|FG000|Overall Study|Death|7|||
128751953|NCT05540522|463379600|FG001|Overall Study|Death|9|||
128751954|NCT05540522|463379601|FG002|Overall Study|Death|49|||
128751955|NCT05540522|463379602|FG003|Overall Study|Death|46|||
128751956|NCT05540522|463379599|FG000|Overall Study|Not vaccinated|34|||
128751957|NCT05540522|463379600|FG001|Overall Study|Not vaccinated|53|||
128751958|NCT05540522|463379601|FG002|Overall Study|Not vaccinated|57|||
128751959|NCT05540522|463379602|FG003|Overall Study|Not vaccinated|50|||
128751960|NCT05540522|463379599|FG000|Overall Study|No longer meets eligibility criteria|0|||
128751961|NCT05540522|463379600|FG001|Overall Study|No longer meets eligibility criteria|0|||
128751962|NCT05540522|463379601|FG002|Overall Study|No longer meets eligibility criteria|3|||
128751963|NCT05540522|463379602|FG003|Overall Study|No longer meets eligibility criteria|2|||
128751964|NCT05540522|463379599|FG000|Overall Study|Other (Unspecified)|8|||
128751965|NCT05540522|463379600|FG001|Overall Study|Other (Unspecified)|10|||
128751966|NCT05540522|463379601|FG002|Overall Study|Other (Unspecified)|4|||
128751967|NCT05540522|463379602|FG003|Overall Study|Other (Unspecified)|2|||
128751968|NCT03754803|463379603|FG000|Overall Study|Withdrawal by Subject|2|||
128751969|NCT05239039|463379604|FG000|Overall Study|Withdrawal by Subject|0|||
128751970|NCT05239039|463379605|FG001|Overall Study|Withdrawal by Subject|1|||
128751971|NCT00936390|463379608|FG000|Overall Study|Protocol Violation|21|||
128751972|NCT00936390|463379609|FG001|Overall Study|Protocol Violation|25|||
128751973|NCT04348604|463379610|FG000|Week 8|Withdrawal by Subject|1|||
128751974|NCT04348604|463379611|FG001|Week 8|Withdrawal by Subject|1|||
128751975|NCT04348604|463379610|FG000|Week 8|Lost to Follow-up|1|||
128751976|NCT04348604|463379611|FG001|Week 8|Lost to Follow-up|2|||
128751977|NCT04348604|463379610|FG000|Week 8|Suspended|0|||
128751978|NCT04348604|463379611|FG001|Week 8|Suspended|1|||
128751979|NCT04348604|463379610|FG000|Week 12|Lost to Follow-up|1|||
128751980|NCT04348604|463379611|FG001|Week 12|Lost to Follow-up|2|||
128751981|NCT04348604|463379610|FG000|Week 12|Withdrawal by Subject|1|||
128751982|NCT04348604|463379611|FG001|Week 12|Withdrawal by Subject|0|||
128751983|NCT04348604|463379610|FG000|Week 24|Lost to Follow-up|2|||
128751984|NCT04348604|463379611|FG001|Week 24|Lost to Follow-up|1|||
128751985|NCT02097108|463379612|FG000|Overall Study|Adverse Event|1|||
128751986|NCT02097108|463379612|FG000|Overall Study|patient was abroad for 6 months|1|||
128751987|NCT05245864|463379613|FG000|Overall Study|Withdrawal by Subject|1|||
128751988|NCT05245864|463379614|FG001|Overall Study|Withdrawal by Subject|1|||
128751989|NCT01329029|463379615|FG000|Overall Study|Withdrawal by Subject|117|||
128751990|NCT01329029|463379616|FG001|Overall Study|Withdrawal by Subject|87|||
128751991|NCT01329029|463379615|FG000|Overall Study|Adverse Event|82|||
128751992|NCT01329029|463379616|FG001|Overall Study|Adverse Event|29|||
128751993|NCT01329029|463379615|FG000|Overall Study|Death|16|||
128751994|NCT01329029|463379616|FG001|Overall Study|Death|19|||
128751995|NCT01329029|463379615|FG000|Overall Study|Other|14|||
128751996|NCT01329029|463379616|FG001|Overall Study|Other|20|||
128751997|NCT01329029|463379615|FG000|Overall Study|COPD Exacerbation|11|||
128751998|NCT01329029|463379616|FG001|Overall Study|COPD Exacerbation|18|||
128751999|NCT01329029|463379615|FG000|Overall Study|Physician Decision|16|||
128752000|NCT01329029|463379616|FG001|Overall Study|Physician Decision|13|||
128752001|NCT01329029|463379615|FG000|Overall Study|Lost to Follow-up|8|||
128752002|NCT01329029|463379616|FG001|Overall Study|Lost to Follow-up|5|||
128752003|NCT01329029|463379615|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
128752004|NCT01329029|463379616|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
128752005|NCT02119260|463381536|FG000|Overall Study|Adverse Event|1|||
128752006|NCT02119260|463381537|FG001|Overall Study|Adverse Event|0|||
128752007|NCT02119260|463381538|FG002|Overall Study|Adverse Event|0|||
128752008|NCT02119260|463381539|FG003|Overall Study|Adverse Event|0|||
128752009|NCT02119260|463381540|FG004|Overall Study|Adverse Event|0|||
128752010|NCT02119260|463381541|FG005|Overall Study|Adverse Event|0|||
128752011|NCT02119260|463381542|FG006|Overall Study|Adverse Event|0|||
128752012|NCT02119260|463381536|FG000|Overall Study|Withdrew consent|0|||
128752013|NCT02119260|463381537|FG001|Overall Study|Withdrew consent|1|||
128752014|NCT02119260|463381538|FG002|Overall Study|Withdrew consent|1|||
128752015|NCT02119260|463381539|FG003|Overall Study|Withdrew consent|0|||
128752016|NCT02119260|463381540|FG004|Overall Study|Withdrew consent|0|||
128752017|NCT02119260|463381541|FG005|Overall Study|Withdrew consent|0|||
128752018|NCT02119260|463381542|FG006|Overall Study|Withdrew consent|0|||
128752019|NCT00857207|463381543|FG000|Overall Study|Withdrawal by Subject|13|||
128752020|NCT00857207|463381544|FG001|Overall Study|Withdrawal by Subject|0|||
128752021|NCT00857207|463381543|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
128752022|NCT00857207|463381544|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
128752023|NCT00857207|463381543|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
128752024|NCT00857207|463381544|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
128752025|NCT01258608|463381545|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
128752026|NCT01258608|463381546|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
128752027|NCT01258608|463381545|FG000|Overall Study|Clinical progression|1|||
128752028|NCT01258608|463381546|FG001|Overall Study|Clinical progression|0|||
128752029|NCT01258608|463381545|FG000|Overall Study|Sponsor decision|0|||
128752030|NCT01258608|463381546|FG001|Overall Study|Sponsor decision|1|||
128752031|NCT01258608|463381545|FG000|Overall Study|Physician Decision|6|||
128752032|NCT01258608|463381546|FG001|Overall Study|Physician Decision|1|||
128752033|NCT01258608|463381545|FG000|Overall Study|Lost to Follow-up|0|||
128752034|NCT01258608|463381546|FG001|Overall Study|Lost to Follow-up|1|||
128752035|NCT01258608|463381545|FG000|Overall Study|Lack of compliance|1|||
128752036|NCT01258608|463381546|FG001|Overall Study|Lack of compliance|0|||
128752037|NCT01258608|463381545|FG000|Overall Study|Lack of Efficacy|0|||
128752038|NCT01258608|463381546|FG001|Overall Study|Lack of Efficacy|1|||
128752039|NCT01258608|463381545|FG000|Overall Study|Adverse Event|6|||
128752040|NCT01258608|463381546|FG001|Overall Study|Adverse Event|10|||
128752041|NCT01258608|463381545|FG000|Overall Study|Withdrawal by Subject|6|||
128752042|NCT01258608|463381546|FG001|Overall Study|Withdrawal by Subject|5|||
128752043|NCT00440531|463381548|FG000|Overall Study|Adverse Event|1|||
128752044|NCT00440531|463381549|FG001|Overall Study|Adverse Event|0|||
128752045|NCT00440531|463381550|FG002|Overall Study|Adverse Event|2|||
128752046|NCT00440531|463381548|FG000|Overall Study|Withdrawal by Subject|2|||
128752047|NCT00440531|463381549|FG001|Overall Study|Withdrawal by Subject|0|||
128752048|NCT00440531|463381550|FG002|Overall Study|Withdrawal by Subject|0|||
128752049|NCT00440531|463381548|FG000|Overall Study|Protocol Violation|1|||
128752050|NCT00440531|463381549|FG001|Overall Study|Protocol Violation|2|||
128752051|NCT00440531|463381550|FG002|Overall Study|Protocol Violation|0|||
128752052|NCT00440531|463381548|FG000|Overall Study|Lost to Follow-up|4|||
128752053|NCT00440531|463381549|FG001|Overall Study|Lost to Follow-up|3|||
128752054|NCT00440531|463381550|FG002|Overall Study|Lost to Follow-up|5|||
128752055|NCT00440531|463381548|FG000|Overall Study|see pre-assignment details|2|||
128752056|NCT00440531|463381549|FG001|Overall Study|see pre-assignment details|0|||
128752057|NCT00440531|463381550|FG002|Overall Study|see pre-assignment details|0|||
128752058|NCT03912259|463381556|FG000|Overall Study|Adverse Event (AE)|2|||
128752059|NCT03912259|463381557|FG001|Overall Study|Adverse Event (AE)|4|||
128752060|NCT03912259|463381556|FG000|Overall Study|Lack of Efficacy|4|||
128752061|NCT03912259|463381557|FG001|Overall Study|Lack of Efficacy|1|||
128752062|NCT03912259|463381556|FG000|Overall Study|Withdrawal by Subject|11|||
128752063|NCT03912259|463381557|FG001|Overall Study|Withdrawal by Subject|1|||
128752064|NCT02131272|463381558|FG000|Overall Study|Withdrawal by parent|0|||
128752065|NCT02131272|463381559|FG001|Overall Study|Withdrawal by parent|1|||
128752066|NCT02131272|463381558|FG000|Overall Study|Withdrawal by Subject|0|||
128752067|NCT02131272|463381559|FG001|Overall Study|Withdrawal by Subject|1|||
128752068|NCT02131272|463381558|FG000|Overall Study|Withdrawal Criteria|1|||
128752069|NCT02131272|463381559|FG001|Overall Study|Withdrawal Criteria|0|||
128752070|NCT01925950|463381560|FG000|Part 2|Withdrawal by Subject|1|||
128752071|NCT01925950|463381561|FG001|Part 2|Withdrawal by Subject|0|||
128752072|NCT00381940|463381564|FG000|Overall Study|Lack of Efficacy|3|||
128752073|NCT00381940|463381564|FG000|Overall Study|Protocol Violation|1|||
128752074|NCT00381940|463381564|FG000|Overall Study|Ineligible|1|||
128752075|NCT03162224|463381565|FG000|Overall Study|Death|4|||
128752076|NCT03162224|463381566|FG001|Overall Study|Death|5|||
128752077|NCT03162224|463381567|FG002|Overall Study|Death|8|||
128752078|NCT03162224|463381565|FG000|Overall Study|Withdrawal by Subject|1|||
128752079|NCT03162224|463381566|FG001|Overall Study|Withdrawal by Subject|0|||
128752080|NCT03162224|463381567|FG002|Overall Study|Withdrawal by Subject|1|||
128752081|NCT03162224|463381565|FG000|Overall Study|Lost to Follow-up|0|||
128752082|NCT03162224|463381566|FG001|Overall Study|Lost to Follow-up|1|||
128752083|NCT03162224|463381567|FG002|Overall Study|Lost to Follow-up|0|||
128752084|NCT03162224|463381565|FG000|Overall Study|Other|6|||
128752085|NCT03162224|463381566|FG001|Overall Study|Other|2|||
128752086|NCT03162224|463381567|FG002|Overall Study|Other|1|||
128752087|NCT04162769|463381571|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
128752088|NCT04162769|463381572|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
128752089|NCT04162769|463381573|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
128752090|NCT04162769|463381574|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
128752091|NCT04162769|463381571|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
128752092|NCT04162769|463381572|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
128752093|NCT04162769|463381573|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
128752094|NCT04162769|463381574|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
128752095|NCT04162769|463381571|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
128752096|NCT04162769|463381572|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
128752097|NCT04162769|463381573|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
128752098|NCT04162769|463381574|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
128752099|NCT04162769|463381571|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
128752100|NCT04162769|463381572|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
128752101|NCT04162769|463381573|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
128752102|NCT04162769|463381574|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
128752103|NCT04162769|463381571|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
128752104|NCT04162769|463381572|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
128752105|NCT04162769|463381573|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
128752106|NCT04162769|463381574|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
128752107|NCT04162769|463381571|FG000|Double-blind Treatment (12-Week)|Other|0|||
128752108|NCT04162769|463381572|FG001|Double-blind Treatment (12-Week)|Other|1|||
128752109|NCT04162769|463381573|FG002|Double-blind Treatment (12-Week)|Other|1|||
128752110|NCT04162769|463381574|FG003|Double-blind Treatment (12-Week)|Other|0|||
128752111|NCT04162769|463381571|FG000|OLE Period (52-Week)|Adverse Event|0|||
128752112|NCT04162769|463381572|FG001|OLE Period (52-Week)|Adverse Event|0|||
128752113|NCT04162769|463381573|FG002|OLE Period (52-Week)|Adverse Event|0|||
128752114|NCT04162769|463381574|FG003|OLE Period (52-Week)|Adverse Event|5|||
128752115|NCT04162769|463381571|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
128752116|NCT04162769|463381572|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
128752117|NCT04162769|463381573|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
128752118|NCT04162769|463381574|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
128752119|NCT04162769|463381571|FG000|OLE Period (52-Week)|Physician Decision|0|||
128752120|NCT04162769|463381572|FG001|OLE Period (52-Week)|Physician Decision|0|||
128752121|NCT04162769|463381573|FG002|OLE Period (52-Week)|Physician Decision|0|||
128752122|NCT04162769|463381574|FG003|OLE Period (52-Week)|Physician Decision|1|||
128752123|NCT04162769|463381571|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
128752124|NCT04162769|463381572|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
128752125|NCT04162769|463381573|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
128752126|NCT04162769|463381574|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
128752127|NCT04162769|463381571|FG000|OLE Period (52-Week)|Protocol deviation|0|||
128752128|NCT04162769|463381572|FG001|OLE Period (52-Week)|Protocol deviation|0|||
128752129|NCT04162769|463381573|FG002|OLE Period (52-Week)|Protocol deviation|0|||
128752130|NCT04162769|463381574|FG003|OLE Period (52-Week)|Protocol deviation|2|||
128752131|NCT00725452|463381577|FG000|Overall Study|Adverse Event|3|||
128752132|NCT00725452|463381577|FG000|Overall Study|Lack of Efficacy|2|||
128752133|NCT00725452|463381577|FG000|Overall Study|Reason not specified|1|||
128752134|NCT00725452|463381577|FG000|Overall Study|Physician Decision|1|||
128752135|NCT00725452|463381577|FG000|Overall Study|Withdrawal by Subject|3|||
128752136|NCT00725452|463381577|FG000|Overall Study|Lost to Follow-up|1|||
128752137|NCT00620750|463381579|FG000|Overall Study|Lost to Follow-up|25|||
128752138|NCT02163733|463381580|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
128752139|NCT02163733|463381581|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
128752140|NCT02163733|463381582|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
128752141|NCT02163733|463381580|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
128752142|NCT02163733|463381581|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
128752143|NCT02163733|463381582|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
128752144|NCT04477187|463381583|FG000|Overall Study|Lost to Follow-up|2|||
128752145|NCT00746590|463381584|FG000|Overall Study|Death|1|||
128752146|NCT00464815|463381585|FG000|Overall Study|Withdrawal by Subject|6|||
128752147|NCT00464815|463381586|FG001|Overall Study|Withdrawal by Subject|3|||
128752148|NCT04402866|463381589|FG000|Overall Study|Discontinued Prior to Treatment|0|||
128752149|NCT04402866|463381590|FG001|Overall Study|Discontinued Prior to Treatment|0|||
128752150|NCT04402866|463381591|FG002|Overall Study|Discontinued Prior to Treatment|0|||
128752151|NCT04402866|463381592|FG003|Overall Study|Discontinued Prior to Treatment|0|||
128752152|NCT04402866|463381593|FG004|Overall Study|Discontinued Prior to Treatment|2|||
128752153|NCT04402866|463381594|FG005|Overall Study|Discontinued Prior to Treatment|3|||
128752154|NCT04402866|463381589|FG000|Overall Study|Adverse Event|2|||
128752155|NCT04402866|463381590|FG001|Overall Study|Adverse Event|1|||
128752156|NCT04402866|463381591|FG002|Overall Study|Adverse Event|0|||
128752157|NCT04402866|463381592|FG003|Overall Study|Adverse Event|0|||
128752158|NCT04402866|463381593|FG004|Overall Study|Adverse Event|13|||
128752159|NCT04402866|463381594|FG005|Overall Study|Adverse Event|8|||
128752160|NCT04402866|463381589|FG000|Overall Study|Miscellaneous|0|||
128752161|NCT04402866|463381590|FG001|Overall Study|Miscellaneous|0|||
128752162|NCT04402866|463381591|FG002|Overall Study|Miscellaneous|1|||
128752163|NCT04402866|463381592|FG003|Overall Study|Miscellaneous|0|||
128752164|NCT04402866|463381593|FG004|Overall Study|Miscellaneous|0|||
128752165|NCT04402866|463381594|FG005|Overall Study|Miscellaneous|0|||
128752166|NCT04402866|463381589|FG000|Overall Study|Lost to Follow-up|0|||
128752167|NCT04402866|463381590|FG001|Overall Study|Lost to Follow-up|0|||
128752168|NCT04402866|463381591|FG002|Overall Study|Lost to Follow-up|0|||
128752169|NCT04402866|463381592|FG003|Overall Study|Lost to Follow-up|0|||
128752170|NCT04402866|463381593|FG004|Overall Study|Lost to Follow-up|0|||
128752171|NCT04402866|463381594|FG005|Overall Study|Lost to Follow-up|1|||
128752172|NCT04402866|463381589|FG000|Overall Study|Withdrawal by Subject|0|||
128752173|NCT04402866|463381590|FG001|Overall Study|Withdrawal by Subject|0|||
128752174|NCT04402866|463381591|FG002|Overall Study|Withdrawal by Subject|0|||
128752175|NCT04402866|463381592|FG003|Overall Study|Withdrawal by Subject|0|||
128752176|NCT04402866|463381593|FG004|Overall Study|Withdrawal by Subject|0|||
128752177|NCT04402866|463381594|FG005|Overall Study|Withdrawal by Subject|2|||
128752178|NCT00868439|463381598|FG000|Overall Study|Adverse Event|4|||
128752179|NCT00868439|463381599|FG001|Overall Study|Adverse Event|3|||
128752180|NCT00868439|463381598|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
128752181|NCT00868439|463381599|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
128752182|NCT00868439|463381598|FG000|Overall Study|Death|0|||
128752183|NCT00868439|463381599|FG001|Overall Study|Death|1|||
128752184|NCT00868439|463381598|FG000|Overall Study|Protocol Violation|1|||
128752185|NCT00868439|463381599|FG001|Overall Study|Protocol Violation|1|||
128752186|NCT00868439|463381598|FG000|Overall Study|Physician Decision|1|||
128752187|NCT00868439|463381599|FG001|Overall Study|Physician Decision|0|||
128752188|NCT00868439|463381598|FG000|Overall Study|Withdrawal by Subject|0|||
128752189|NCT00868439|463381599|FG001|Overall Study|Withdrawal by Subject|1|||
128752190|NCT00476476|463381600|FG000|Overall Study|Adverse Event|2|||
128752191|NCT00476476|463381601|FG001|Overall Study|Adverse Event|7|||
128752192|NCT00476476|463381600|FG000|Overall Study|Progressive Disease|0|||
128752193|NCT00476476|463381601|FG001|Overall Study|Progressive Disease|17|||
128752194|NCT00971048|463381606|FG000|Overall Study|Protocol Violation|1|||
128752195|NCT00971048|463381607|FG001|Overall Study|Protocol Violation|2|||
128752196|NCT00971048|463381608|FG002|Overall Study|Protocol Violation|0|||
128752197|NCT00971048|463381609|FG003|Overall Study|Protocol Violation|1|||
128752198|NCT00971048|463381606|FG000|Overall Study|Adverse Event|0|||
128752199|NCT00971048|463381607|FG001|Overall Study|Adverse Event|0|||
128752200|NCT00971048|463381608|FG002|Overall Study|Adverse Event|1|||
128752201|NCT00971048|463381609|FG003|Overall Study|Adverse Event|0|||
128752202|NCT00971048|463381606|FG000|Overall Study|Physician Decision|0|||
128752203|NCT00971048|463381607|FG001|Overall Study|Physician Decision|0|||
128752204|NCT00971048|463381608|FG002|Overall Study|Physician Decision|0|||
128752205|NCT00971048|463381609|FG003|Overall Study|Physician Decision|1|||
128752206|NCT03321396|463381615|FG000|Overall Study|Physician Decision|1|||
128752207|NCT01654549|463381620|FG000|Overall Study|H.pylori eradication not successful|0|||
128752208|NCT01654549|463381621|FG001|Overall Study|H.pylori eradication not successful|1|||
128752209|NCT00937924|463381622|FG000|Overall Study|Lost to Follow-up|44|||
128752210|NCT00937924|463381623|FG001|Overall Study|Lost to Follow-up|44|||
128752211|NCT00937924|463381624|FG002|Overall Study|Lost to Follow-up|41|||
128752212|NCT00224874|463381625|FG000|Overall Study|Withdrawal by Subject|0|||
128752213|NCT00224874|463381626|FG001|Overall Study|Withdrawal by Subject|0|||
128752214|NCT00224874|463381627|FG002|Overall Study|Withdrawal by Subject|1|||
128752215|NCT00224874|463381628|FG003|Overall Study|Withdrawal by Subject|0|||
128752216|NCT05072080|463381631|FG000|Overall Study|Death|0|||
128752217|NCT05072080|463381632|FG001|Overall Study|Death|0|||
128752218|NCT05072080|463381633|FG002|Overall Study|Death|1|||
128752219|NCT05072080|463381634|FG003|Overall Study|Death|0|||
128752220|NCT05072080|463381631|FG000|Overall Study|Lost to Follow-up|65|||
128752221|NCT05072080|463381632|FG001|Overall Study|Lost to Follow-up|70|||
128752222|NCT05072080|463381633|FG002|Overall Study|Lost to Follow-up|58|||
128752223|NCT05072080|463381634|FG003|Overall Study|Lost to Follow-up|23|||
128752224|NCT05072080|463381631|FG000|Overall Study|Physician Decision|2|||
128752225|NCT05072080|463381632|FG001|Overall Study|Physician Decision|1|||
128752226|NCT05072080|463381633|FG002|Overall Study|Physician Decision|1|||
128752227|NCT05072080|463381634|FG003|Overall Study|Physician Decision|0|||
128752228|NCT05072080|463381631|FG000|Overall Study|Withdrawal by Subject|45|||
128752229|NCT05072080|463381632|FG001|Overall Study|Withdrawal by Subject|30|||
128752230|NCT05072080|463381633|FG002|Overall Study|Withdrawal by Subject|27|||
128752231|NCT05072080|463381634|FG003|Overall Study|Withdrawal by Subject|7|||
128752232|NCT05072080|463381631|FG000|Overall Study|Sponsor Decision|0|||
128752233|NCT05072080|463381632|FG001|Overall Study|Sponsor Decision|1|||
128752234|NCT05072080|463381633|FG002|Overall Study|Sponsor Decision|0|||
128752235|NCT05072080|463381634|FG003|Overall Study|Sponsor Decision|0|||
128752236|NCT05072080|463381631|FG000|Overall Study|Subject moved|1|||
128752237|NCT05072080|463381632|FG001|Overall Study|Subject moved|3|||
128752238|NCT05072080|463381633|FG002|Overall Study|Subject moved|5|||
128752239|NCT05072080|463381634|FG003|Overall Study|Subject moved|2|||
128752240|NCT05072080|463381631|FG000|Overall Study|Withdrawal by parent|0|||
128752241|NCT05072080|463381632|FG001|Overall Study|Withdrawal by parent|0|||
128752242|NCT05072080|463381633|FG002|Overall Study|Withdrawal by parent|1|||
128752243|NCT05072080|463381634|FG003|Overall Study|Withdrawal by parent|0|||
128752244|NCT05072080|463381631|FG000|Overall Study|Subject was deployed|0|||
128752245|NCT05072080|463381632|FG001|Overall Study|Subject was deployed|1|||
128752246|NCT05072080|463381633|FG002|Overall Study|Subject was deployed|0|||
128752247|NCT05072080|463381634|FG003|Overall Study|Subject was deployed|0|||
128752248|NCT05072080|463381631|FG000|Overall Study|Subject left site without receiving dose|0|||
128752249|NCT05072080|463381632|FG001|Overall Study|Subject left site without receiving dose|1|||
128752250|NCT05072080|463381633|FG002|Overall Study|Subject left site without receiving dose|0|||
128752251|NCT05072080|463381634|FG003|Overall Study|Subject left site without receiving dose|0|||
128752252|NCT05072080|463381631|FG000|Overall Study|Subject incarcerated|0|||
128752253|NCT05072080|463381632|FG001|Overall Study|Subject incarcerated|1|||
128752254|NCT05072080|463381633|FG002|Overall Study|Subject incarcerated|0|||
128752255|NCT05072080|463381634|FG003|Overall Study|Subject incarcerated|1|||
128752256|NCT05072080|463381631|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
128752257|NCT05072080|463381632|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
128752258|NCT05072080|463381633|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
128752259|NCT05072080|463381634|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
128752260|NCT05072080|463381631|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
128752261|NCT05072080|463381632|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
128752262|NCT05072080|463381633|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
128752263|NCT05072080|463381634|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
128752264|NCT02633137|463381639|FG000|Overall Study|Adverse Event|1|||
128752265|NCT02633137|463381639|FG000|Overall Study|Lack of Efficacy|2|||
128752266|NCT02633137|463381639|FG000|Overall Study|Withdrawal by Subject|1|||
128752267|NCT01972841|463381642|FG000|Overall Study|Randomized but Never Received Treatment|2|||
128752268|NCT01972841|463381643|FG001|Overall Study|Randomized but Never Received Treatment|5|||
128752269|NCT01972841|463381644|FG002|Overall Study|Randomized but Never Received Treatment|4|||
128752270|NCT01972841|463381645|FG003|Overall Study|Randomized but Never Received Treatment|2|||
128752271|NCT01972841|463381646|FG004|Overall Study|Randomized but Never Received Treatment|6|||
128752272|NCT01972841|463381647|FG005|Overall Study|Randomized but Never Received Treatment|13|||
128752273|NCT01972841|463381642|FG000|Overall Study|Adverse Event|13|||
128752274|NCT01972841|463381643|FG001|Overall Study|Adverse Event|8|||
128752275|NCT01972841|463381644|FG002|Overall Study|Adverse Event|12|||
128752276|NCT01972841|463381645|FG003|Overall Study|Adverse Event|9|||
128752277|NCT01972841|463381646|FG004|Overall Study|Adverse Event|21|||
128752278|NCT01972841|463381647|FG005|Overall Study|Adverse Event|26|||
128752279|NCT01972841|463381642|FG000|Overall Study|Lack of Efficacy|1|||
128752280|NCT01972841|463381643|FG001|Overall Study|Lack of Efficacy|0|||
128752281|NCT01972841|463381644|FG002|Overall Study|Lack of Efficacy|0|||
128752282|NCT01972841|463381645|FG003|Overall Study|Lack of Efficacy|2|||
128752283|NCT01972841|463381646|FG004|Overall Study|Lack of Efficacy|4|||
128752284|NCT01972841|463381647|FG005|Overall Study|Lack of Efficacy|1|||
128752285|NCT01972841|463381642|FG000|Overall Study|Lost to Follow-up|4|||
128752286|NCT01972841|463381643|FG001|Overall Study|Lost to Follow-up|2|||
128752287|NCT01972841|463381644|FG002|Overall Study|Lost to Follow-up|4|||
128752288|NCT01972841|463381645|FG003|Overall Study|Lost to Follow-up|2|||
128752289|NCT01972841|463381646|FG004|Overall Study|Lost to Follow-up|9|||
128752290|NCT01972841|463381647|FG005|Overall Study|Lost to Follow-up|3|||
128752291|NCT01972841|463381642|FG000|Overall Study|Protocol Violation|2|||
128752292|NCT01972841|463381643|FG001|Overall Study|Protocol Violation|2|||
128752293|NCT01972841|463381644|FG002|Overall Study|Protocol Violation|3|||
128752294|NCT01972841|463381645|FG003|Overall Study|Protocol Violation|5|||
128752295|NCT01972841|463381646|FG004|Overall Study|Protocol Violation|9|||
128752296|NCT01972841|463381647|FG005|Overall Study|Protocol Violation|4|||
128752297|NCT01972841|463381642|FG000|Overall Study|Withdrawal by participants|21|||
128752298|NCT01972841|463381643|FG001|Overall Study|Withdrawal by participants|27|||
128752299|NCT01972841|463381644|FG002|Overall Study|Withdrawal by participants|23|||
128752300|NCT01972841|463381645|FG003|Overall Study|Withdrawal by participants|16|||
128752301|NCT01972841|463381646|FG004|Overall Study|Withdrawal by participants|33|||
128752302|NCT01972841|463381647|FG005|Overall Study|Withdrawal by participants|34|||
128752303|NCT01972841|463381642|FG000|Overall Study|Miscellaneous|0|||
128752304|NCT01972841|463381643|FG001|Overall Study|Miscellaneous|0|||
128752305|NCT01972841|463381644|FG002|Overall Study|Miscellaneous|4|||
128752306|NCT01972841|463381645|FG003|Overall Study|Miscellaneous|1|||
128752307|NCT01972841|463381646|FG004|Overall Study|Miscellaneous|0|||
128752308|NCT01972841|463381647|FG005|Overall Study|Miscellaneous|4|||
128752309|NCT01972841|463381642|FG000|Overall Study|Did not have end of treatment page|0|||
128752310|NCT01972841|463381643|FG001|Overall Study|Did not have end of treatment page|0|||
128752311|NCT01972841|463381644|FG002|Overall Study|Did not have end of treatment page|0|||
128752312|NCT01972841|463381645|FG003|Overall Study|Did not have end of treatment page|0|||
128752313|NCT01972841|463381646|FG004|Overall Study|Did not have end of treatment page|1|||
128752314|NCT01972841|463381647|FG005|Overall Study|Did not have end of treatment page|0|||
128752315|NCT04969198|463381650|FG000|Overall Study|Withdrawal by Subject|20|||
128752316|NCT04969198|463381650|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
128752317|NCT04969198|463381650|FG000|Overall Study|Lost to Follow-up|20|||
128752318|NCT02701985|463381651|FG000|Overall Study|Withdrawal by Subject|1|||
128752319|NCT02701985|463381652|FG001|Overall Study|Withdrawal by Subject|1|||
128752320|NCT02701985|463381651|FG000|Overall Study|Lost to Follow-up|1|||
128752321|NCT02701985|463381652|FG001|Overall Study|Lost to Follow-up|0|||
128752322|NCT02701985|463381651|FG000|Overall Study|Death|1|||
128752323|NCT02701985|463381652|FG001|Overall Study|Death|0|||
128752324|NCT02701985|463381651|FG000|Overall Study|Adverse Event|0|||
128752325|NCT02701985|463381652|FG001|Overall Study|Adverse Event|5|||
128752326|NCT01640808|463381654|FG000|Overall Study|Unable to continue dynamic CT|14|||
128752327|NCT01640808|463381655|FG001|Overall Study|Unable to continue dynamic CT|4|||
128752328|NCT01640808|463381654|FG000|Overall Study|Withdrawal by Subject|12|||
128752329|NCT01640808|463381655|FG001|Overall Study|Withdrawal by Subject|4|||
128752330|NCT01640808|463381654|FG000|Overall Study|Lost to Follow-up|4|||
128752331|NCT01640808|463381655|FG001|Overall Study|Lost to Follow-up|0|||
128752332|NCT01640808|463381654|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
128752333|NCT01640808|463381655|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
128752334|NCT01640808|463381654|FG000|Overall Study|Administration of anticancer drugs|2|||
128752335|NCT01640808|463381655|FG001|Overall Study|Administration of anticancer drugs|1|||
128752336|NCT01640808|463381654|FG000|Overall Study|Physician Decision|19|||
128752337|NCT01640808|463381655|FG001|Overall Study|Physician Decision|5|||
128752338|NCT01640808|463381654|FG000|Overall Study|Randomized but not treated|4|||
128752339|NCT01640808|463381655|FG001|Overall Study|Randomized but not treated|2|||
128752340|NCT02308748|463381661|FG000|Period 1|Withdrawal by Subject|0|||
128752341|NCT02308748|463381662|FG001|Period 1|Withdrawal by Subject|0|||
128752342|NCT02308748|463381663|FG002|Period 1|Withdrawal by Subject|1|||
128752343|NCT02308748|463381664|FG003|Period 1|Withdrawal by Subject|0|||
128752344|NCT02308748|463381665|FG004|Period 1|Withdrawal by Subject|0|||
128752345|NCT02308748|463381666|FG005|Period 1|Withdrawal by Subject|0|||
128752346|NCT02308748|463381667|FG006|Period 1|Withdrawal by Subject|0|||
128752347|NCT02308748|463381668|FG007|Period 1|Withdrawal by Subject|0|||
128752348|NCT02308748|463381669|FG008|Period 1|Withdrawal by Subject|0|||
128752349|NCT02308748|463381670|FG009|Period 1|Withdrawal by Subject|0|||
128752350|NCT02308748|463381661|FG000|Period 2|Adverse Event|0|||
128752351|NCT02308748|463381662|FG001|Period 2|Adverse Event|0|||
128752352|NCT02308748|463381663|FG002|Period 2|Adverse Event|0|||
128752353|NCT02308748|463381664|FG003|Period 2|Adverse Event|0|||
128752354|NCT02308748|463381665|FG004|Period 2|Adverse Event|0|||
128752355|NCT02308748|463381666|FG005|Period 2|Adverse Event|0|||
128752356|NCT02308748|463381667|FG006|Period 2|Adverse Event|0|||
128752357|NCT02308748|463381668|FG007|Period 2|Adverse Event|1|||
128752358|NCT02308748|463381669|FG008|Period 2|Adverse Event|0|||
128752359|NCT02308748|463381670|FG009|Period 2|Adverse Event|0|||
128752360|NCT02308748|463381661|FG000|Period 3|Protocol Violation|0|||
128752361|NCT02308748|463381662|FG001|Period 3|Protocol Violation|0|||
128752362|NCT02308748|463381663|FG002|Period 3|Protocol Violation|0|||
128752363|NCT02308748|463381664|FG003|Period 3|Protocol Violation|0|||
128752364|NCT02308748|463381665|FG004|Period 3|Protocol Violation|0|||
128752365|NCT02308748|463381666|FG005|Period 3|Protocol Violation|0|||
128752366|NCT02308748|463381667|FG006|Period 3|Protocol Violation|0|||
128752367|NCT02308748|463381668|FG007|Period 3|Protocol Violation|0|||
128752368|NCT02308748|463381669|FG008|Period 3|Protocol Violation|0|||
128752369|NCT02308748|463381670|FG009|Period 3|Protocol Violation|1|||
128752370|NCT02308748|463381661|FG000|Period 5|Adverse Event|1|||
128752371|NCT02308748|463381662|FG001|Period 5|Adverse Event|0|||
128752372|NCT02308748|463381663|FG002|Period 5|Adverse Event|0|||
128752373|NCT02308748|463381664|FG003|Period 5|Adverse Event|0|||
128752374|NCT02308748|463381665|FG004|Period 5|Adverse Event|0|||
128752375|NCT02308748|463381666|FG005|Period 5|Adverse Event|0|||
128752376|NCT02308748|463381667|FG006|Period 5|Adverse Event|0|||
128752377|NCT02308748|463381668|FG007|Period 5|Adverse Event|0|||
128752378|NCT02308748|463381669|FG008|Period 5|Adverse Event|1|||
128752379|NCT02308748|463381670|FG009|Period 5|Adverse Event|0|||
128752380|NCT01041638|463381671|FG000|Overall Study|Adverse Event|4|||
128752381|NCT01041638|463381671|FG000|Overall Study|Death|1|||
128752382|NCT01041638|463381671|FG000|Overall Study|Lack of Efficacy|7|||
128752383|NCT01041638|463381671|FG000|Overall Study|Physician Decision|4|||
128752384|NCT01041638|463381671|FG000|Overall Study|Withdrawal by Subject|11|||
128752385|NCT01687257|463381673|FG000|Overall Study|Efficacy Failure|6|||
128752386|NCT01687257|463381674|FG001|Overall Study|Efficacy Failure|0|||
128752387|NCT01687257|463381675|FG002|Overall Study|Efficacy Failure|5|||
128752388|NCT01687257|463381673|FG000|Overall Study|Subject Withdrew Consent|1|||
128752389|NCT01687257|463381674|FG001|Overall Study|Subject Withdrew Consent|1|||
128752390|NCT01687257|463381675|FG002|Overall Study|Subject Withdrew Consent|1|||
128752391|NCT01687257|463381673|FG000|Overall Study|Adverse Event|1|||
128752392|NCT01687257|463381674|FG001|Overall Study|Adverse Event|0|||
128752393|NCT01687257|463381675|FG002|Overall Study|Adverse Event|0|||
128752394|NCT01687257|463381673|FG000|Overall Study|Investigator's Discretion|0|||
128752395|NCT01687257|463381674|FG001|Overall Study|Investigator's Discretion|3|||
128752396|NCT01687257|463381675|FG002|Overall Study|Investigator's Discretion|0|||
128752397|NCT01565707|463381677|FG000|Overall Study|Adverse Event|1|||
128752398|NCT01565707|463381678|FG001|Overall Study|Adverse Event|6|||
128752399|NCT01565707|463381679|FG002|Overall Study|Adverse Event|2|||
128752400|NCT01565707|463381680|FG003|Overall Study|Adverse Event|1|||
128752401|NCT01565707|463381677|FG000|Overall Study|Lost to Follow-up|1|||
128752402|NCT01565707|463381678|FG001|Overall Study|Lost to Follow-up|0|||
128752403|NCT01565707|463381679|FG002|Overall Study|Lost to Follow-up|0|||
128752404|NCT01565707|463381680|FG003|Overall Study|Lost to Follow-up|0|||
128752405|NCT01565707|463381677|FG000|Overall Study|Protocol Violation|1|||
128752406|NCT01565707|463381678|FG001|Overall Study|Protocol Violation|0|||
128752407|NCT01565707|463381679|FG002|Overall Study|Protocol Violation|0|||
128752408|NCT01565707|463381680|FG003|Overall Study|Protocol Violation|1|||
128752409|NCT01565707|463381677|FG000|Overall Study|Withdrawal by Subject|3|||
128752410|NCT01565707|463381678|FG001|Overall Study|Withdrawal by Subject|1|||
128752411|NCT01565707|463381679|FG002|Overall Study|Withdrawal by Subject|1|||
128752412|NCT01565707|463381680|FG003|Overall Study|Withdrawal by Subject|1|||
128752413|NCT01565707|463381677|FG000|Overall Study|Randomized but not evaluable|2|||
128752414|NCT01565707|463381678|FG001|Overall Study|Randomized but not evaluable|0|||
128752415|NCT01565707|463381679|FG002|Overall Study|Randomized but not evaluable|0|||
128752416|NCT01565707|463381680|FG003|Overall Study|Randomized but not evaluable|0|||
128752417|NCT01565707|463381677|FG000|Overall Study|Miscellaneous|1|||
128752418|NCT01565707|463381678|FG001|Overall Study|Miscellaneous|1|||
128752419|NCT01565707|463381679|FG002|Overall Study|Miscellaneous|0|||
128752420|NCT01565707|463381680|FG003|Overall Study|Miscellaneous|2|||
128752421|NCT05207813|463381681|FG000|Overall Study|Lost to Follow-up|2|||
128752422|NCT04988308|463381685|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
128752423|NCT04988308|463381686|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
128752424|NCT04988308|463381687|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
128752425|NCT04988308|463381688|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
128752426|NCT04988308|463381689|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
128752427|NCT04988308|463381690|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
128752428|NCT04988308|463381685|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
128752429|NCT04988308|463381686|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
128752430|NCT04988308|463381687|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
128752431|NCT04988308|463381688|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
128752432|NCT04988308|463381689|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
128752433|NCT04988308|463381690|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
128752434|NCT04988308|463381685|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
128752435|NCT04988308|463381686|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
128752436|NCT04988308|463381687|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
128752437|NCT04988308|463381688|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
128752438|NCT04988308|463381689|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
128752439|NCT04988308|463381690|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
128752440|NCT04988308|463381685|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
128752441|NCT04988308|463381686|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
128752442|NCT04988308|463381687|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
128752443|NCT04988308|463381688|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
128752444|NCT04988308|463381689|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
128752445|NCT04988308|463381690|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
128752446|NCT04988308|463381685|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
128752447|NCT04988308|463381686|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
128752448|NCT04988308|463381687|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
128752449|NCT04988308|463381688|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
128752450|NCT04988308|463381689|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
128752451|NCT04988308|463381690|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
128752452|NCT04988308|463381685|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
128752453|NCT04988308|463381686|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
128752454|NCT04988308|463381687|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
128752455|NCT04988308|463381688|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
128752456|NCT04988308|463381689|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
128752457|NCT04988308|463381690|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
128752458|NCT04988308|463381685|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
128752459|NCT04988308|463381686|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
128752460|NCT04988308|463381687|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
128752461|NCT04988308|463381688|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
128786110|NCT01549652|463509374|FG003|Overall Study|Titration Non-Compliance|5|||
128786111|NCT01549652|463509371|FG000|Overall Study|Titration Side Effects|0|||
128786112|NCT01549652|463509372|FG001|Overall Study|Titration Side Effects|0|||
128786113|NCT01549652|463509373|FG002|Overall Study|Titration Side Effects|6|||
128786114|NCT01549652|463509374|FG003|Overall Study|Titration Side Effects|3|||
128786115|NCT01549652|463509371|FG000|Overall Study|Withdrawal by Subject|0|||
128786116|NCT01549652|463509372|FG001|Overall Study|Withdrawal by Subject|0|||
128752462|NCT04988308|463381689|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
128752463|NCT04988308|463381690|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
128752464|NCT04988308|463381685|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
128752465|NCT04988308|463381686|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
128752466|NCT04988308|463381687|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
128752467|NCT04988308|463381688|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
128752468|NCT04988308|463381689|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
128752469|NCT04988308|463381690|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
128752470|NCT04988308|463381685|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
128752471|NCT04988308|463381686|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
128752472|NCT04988308|463381687|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
128752473|NCT04988308|463381688|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
128752474|NCT04988308|463381689|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
128752475|NCT04988308|463381690|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
128752476|NCT02625623|463381692|FG000|Overall Study|Participants randomized but not treated|9|||
128752477|NCT02625623|463381693|FG001|Overall Study|Participants randomized but not treated|1|||
128752478|NCT02352948|463381694|FG000|Overall Study|Death|47|||
128752479|NCT02352948|463381695|FG001|Overall Study|Death|48|||
128752480|NCT02352948|463381696|FG002|Overall Study|Death|114|||
128752481|NCT02352948|463381697|FG003|Overall Study|Death|74|||
128752482|NCT02352948|463381698|FG004|Overall Study|Death|77|||
128752483|NCT02352948|463381699|FG005|Overall Study|Death|44|||
128752484|NCT02352948|463381694|FG000|Overall Study|Lost to Follow-up|1|||
128752485|NCT02352948|463381695|FG001|Overall Study|Lost to Follow-up|0|||
128752486|NCT02352948|463381696|FG002|Overall Study|Lost to Follow-up|2|||
128752487|NCT02352948|463381697|FG003|Overall Study|Lost to Follow-up|1|||
128752488|NCT02352948|463381698|FG004|Overall Study|Lost to Follow-up|2|||
128752489|NCT02352948|463381699|FG005|Overall Study|Lost to Follow-up|1|||
128752490|NCT02352948|463381694|FG000|Overall Study|Withdrawal by Subject|1|||
128752491|NCT02352948|463381695|FG001|Overall Study|Withdrawal by Subject|10|||
128752492|NCT02352948|463381696|FG002|Overall Study|Withdrawal by Subject|11|||
128752493|NCT02352948|463381697|FG003|Overall Study|Withdrawal by Subject|23|||
128752494|NCT02352948|463381698|FG004|Overall Study|Withdrawal by Subject|9|||
128752495|NCT02352948|463381699|FG005|Overall Study|Withdrawal by Subject|4|||
128752496|NCT02352948|463381694|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128752497|NCT02352948|463381695|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
128752498|NCT02352948|463381696|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
128752499|NCT02352948|463381697|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
128752500|NCT02352948|463381698|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
128752501|NCT02352948|463381699|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
128752502|NCT02352948|463381694|FG000|Overall Study|Other|0|||
128752503|NCT02352948|463381695|FG001|Overall Study|Other|0|||
128752504|NCT02352948|463381696|FG002|Overall Study|Other|2|||
128752505|NCT02352948|463381697|FG003|Overall Study|Other|0|||
128752506|NCT02352948|463381698|FG004|Overall Study|Other|0|||
128752507|NCT02352948|463381699|FG005|Overall Study|Other|0|||
128752508|NCT01178086|463381700|FG000|Overall Study|Participant refusal|7|||
128752509|NCT01178086|463381700|FG000|Overall Study|Physician Decision|44|||
128752510|NCT01178086|463381700|FG000|Overall Study|Switch to other CLL therapy|113|||
128752511|NCT01178086|463381700|FG000|Overall Study|Death|59|||
128752512|NCT01178086|463381700|FG000|Overall Study|Other unspecified|89|||
128752513|NCT01178086|463381700|FG000|Overall Study|Excluded from EAS|20|||
128752514|NCT02962908|463381701|FG000|Overall Study|Lost to Follow-up|0|||
128752515|NCT02962908|463381702|FG001|Overall Study|Lost to Follow-up|3|||
128752516|NCT02962908|463381703|FG002|Overall Study|Lost to Follow-up|0|||
128752517|NCT02962908|463381704|FG003|Overall Study|Lost to Follow-up|1|||
128752518|NCT02962908|463381701|FG000|Overall Study|Withdrawal by Subject|0|||
128752519|NCT02962908|463381702|FG001|Overall Study|Withdrawal by Subject|3|||
128752520|NCT02962908|463381703|FG002|Overall Study|Withdrawal by Subject|0|||
128752521|NCT02962908|463381704|FG003|Overall Study|Withdrawal by Subject|2|||
128752522|NCT02962908|463381701|FG000|Overall Study|Protocol Violation|0|||
128752523|NCT02962908|463381702|FG001|Overall Study|Protocol Violation|1|||
128752524|NCT02962908|463381703|FG002|Overall Study|Protocol Violation|0|||
128752525|NCT02962908|463381704|FG003|Overall Study|Protocol Violation|0|||
128752526|NCT02962908|463381701|FG000|Overall Study|Physician Decision|0|||
128752527|NCT02962908|463381702|FG001|Overall Study|Physician Decision|1|||
128752528|NCT02962908|463381703|FG002|Overall Study|Physician Decision|0|||
128752529|NCT02962908|463381704|FG003|Overall Study|Physician Decision|0|||
128752530|NCT03543254|463381705|FG000|Overall Study|Lost to Follow-up|1|||
128752531|NCT01261338|463381706|FG000|Overall Study|Withdrawal by Subject|3|||
128752532|NCT01261338|463381707|FG001|Overall Study|Withdrawal by Subject|2|||
128752533|NCT00234065|463381708|FG000|Overall Study|Adverse Event|268|||
128752534|NCT00234065|463381709|FG001|Overall Study|Adverse Event|166|||
128752535|NCT00234065|463381708|FG000|Overall Study|Withdrawal by Subject|73|||
128752536|NCT00234065|463381709|FG001|Overall Study|Withdrawal by Subject|56|||
128752537|NCT00234065|463381708|FG000|Overall Study|Physician Decision|23|||
128752538|NCT00234065|463381709|FG001|Overall Study|Physician Decision|22|||
128752539|NCT00234065|463381708|FG000|Overall Study|Not Classified|111|||
128752540|NCT00234065|463381709|FG001|Overall Study|Not Classified|112|||
128752541|NCT00126438|463381710|FG000|Overall Study|Withdrawal due to adverse event|1|||
128752542|NCT00126438|463381711|FG001|Overall Study|Withdrawal due to adverse event|0|||
128752543|NCT00126438|463381710|FG000|Overall Study|Lost to Follow-up|22|||
128752544|NCT00126438|463381711|FG001|Overall Study|Lost to Follow-up|0|||
128752545|NCT00126438|463381710|FG000|Overall Study|Protocol Violation|8|||
128752546|NCT00126438|463381711|FG001|Overall Study|Protocol Violation|8|||
128752547|NCT00126438|463381710|FG000|Overall Study|Withdrawal by Subject|3|||
128752548|NCT00126438|463381711|FG001|Overall Study|Withdrawal by Subject|2|||
128752549|NCT02057874|463383392|FG000|Overall Study|participant did not return for scan|1|||
128752550|NCT01738984|463383393|FG000|Overall Study|Pregnancy|4|||
128752551|NCT01738984|463383394|FG001|Overall Study|Pregnancy|0|||
128752552|NCT01738984|463383393|FG000|Overall Study|Withdrawal by Subject|1|||
128752553|NCT01738984|463383394|FG001|Overall Study|Withdrawal by Subject|0|||
128752554|NCT01738984|463383393|FG000|Overall Study|Lost to Follow-up|59|||
128752555|NCT01738984|463383394|FG001|Overall Study|Lost to Follow-up|39|||
128752556|NCT00955357|463383399|FG000|Titration Phase|Adverse Event|9|||
128752557|NCT00955357|463383400|FG001|Titration Phase|Adverse Event|46|||
128752558|NCT00955357|463383399|FG000|Titration Phase|Lack of Efficacy|0|||
128752559|NCT00955357|463383400|FG001|Titration Phase|Lack of Efficacy|2|||
128752560|NCT00955357|463383399|FG000|Titration Phase|Protocol Violation|3|||
128752561|NCT00955357|463383400|FG001|Titration Phase|Protocol Violation|7|||
128752562|NCT00955357|463383399|FG000|Titration Phase|Lost to Follow-up|1|||
128752563|NCT00955357|463383400|FG001|Titration Phase|Lost to Follow-up|3|||
128752564|NCT00955357|463383399|FG000|Titration Phase|Withdrawal by Subject|3|||
128752565|NCT00955357|463383400|FG001|Titration Phase|Withdrawal by Subject|5|||
128752566|NCT00955357|463383399|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
128752567|NCT00955357|463383400|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
128752568|NCT00955357|463383399|FG000|Titration Phase|Study medication not tolerated|0|||
128752569|NCT00955357|463383400|FG001|Titration Phase|Study medication not tolerated|1|||
128752570|NCT00955357|463383399|FG000|Titration Phase|Non compliance to study procedures|0|||
128752571|NCT00955357|463383400|FG001|Titration Phase|Non compliance to study procedures|1|||
128752572|NCT00955357|463383399|FG000|Maintenance Phase|Adverse Event|3|||
128752573|NCT00955357|463383400|FG001|Maintenance Phase|Adverse Event|23|||
128752574|NCT00955357|463383399|FG000|Maintenance Phase|Lack of Efficacy|0|||
128752575|NCT00955357|463383400|FG001|Maintenance Phase|Lack of Efficacy|4|||
128752576|NCT00955357|463383399|FG000|Maintenance Phase|Protocol Violation|2|||
128752577|NCT00955357|463383400|FG001|Maintenance Phase|Protocol Violation|6|||
128752578|NCT00955357|463383399|FG000|Maintenance Phase|Lost to Follow-up|2|||
128752579|NCT00955357|463383400|FG001|Maintenance Phase|Lost to Follow-up|7|||
128752580|NCT00955357|463383399|FG000|Maintenance Phase|Withdrawal by Subject|4|||
128752581|NCT00955357|463383400|FG001|Maintenance Phase|Withdrawal by Subject|4|||
128752582|NCT00955357|463383399|FG000|Maintenance Phase|Patient moving out of area|0|||
128752583|NCT00955357|463383400|FG001|Maintenance Phase|Patient moving out of area|1|||
128752584|NCT00955357|463383399|FG000|Maintenance Phase|Non compliance to study procedures|1|||
128752585|NCT00955357|463383400|FG001|Maintenance Phase|Non compliance to study procedures|0|||
128752586|NCT02943408|463383403|FG000|Overall Study|Lost to Follow-up|7|||
128752587|NCT02943408|463383404|FG001|Overall Study|Lost to Follow-up|1|||
128752588|NCT02943408|463383403|FG000|Overall Study|Withdrawal by Subject|0|||
128752589|NCT02943408|463383404|FG001|Overall Study|Withdrawal by Subject|1|||
128752590|NCT01621126|463383407|FG000|Overall Study|Physician Decision|6|||
128752591|NCT00886340|463383409|FG000|Overall Study|Withdrawal by Subject|0|||
128752592|NCT00886340|463383410|FG001|Overall Study|Withdrawal by Subject|7|||
128752593|NCT01949311|463383411|FG000|Overall Study|Lost to Follow-up|73|||
128752594|NCT01949311|463383411|FG000|Overall Study|Terminated by Sponsor|708|||
128752595|NCT01949311|463383411|FG000|Overall Study|Withdrawal by Subject|375|||
128752596|NCT01949311|463383411|FG000|Overall Study|Lack of Efficacy|50|||
128752597|NCT01949311|463383411|FG000|Overall Study|Protocol Deviation|34|||
128752598|NCT01949311|463383411|FG000|Overall Study|Pregnancy|20|||
128752599|NCT01949311|463383411|FG000|Overall Study|Physician Decision|9|||
128752600|NCT01949311|463383411|FG000|Overall Study|Other|4|||
128752601|NCT01949311|463383411|FG000|Overall Study|Adverse Event|107|||
128752602|NCT02338154|463383412|FG000|Overall Study|Death|46|||
128752603|NCT02338154|463383412|FG000|Overall Study|Valve Implant Failure|17|||
128752604|NCT02338154|463383412|FG000|Overall Study|Valve Explant|11|||
128752605|NCT02338154|463383412|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
128752606|NCT02338154|463383412|FG000|Overall Study|Lost to Follow-up|8|||
128752607|NCT02338154|463383412|FG000|Overall Study|Other Reason|3|||
128752608|NCT02338154|463383412|FG000|Overall Study|Patients Without Exit Form|47|||
128752609|NCT02338154|463383412|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
128752610|NCT02120027|463383415|FG000|Overall Study|Adverse Event|4|||
128752611|NCT02120027|463383416|FG001|Overall Study|Adverse Event|5|||
128752612|NCT02120027|463383415|FG000|Overall Study|Lack of Efficacy|3|||
128752613|NCT02120027|463383416|FG001|Overall Study|Lack of Efficacy|5|||
128752614|NCT02120027|463383415|FG000|Overall Study|Lost to Follow-up|5|||
128752615|NCT02120027|463383416|FG001|Overall Study|Lost to Follow-up|13|||
128752616|NCT02120027|463383415|FG000|Overall Study|Other|4|||
128752617|NCT02120027|463383416|FG001|Overall Study|Other|0|||
128752618|NCT02120027|463383415|FG000|Overall Study|Physician Decision|4|||
128752619|NCT02120027|463383416|FG001|Overall Study|Physician Decision|3|||
128752620|NCT02120027|463383415|FG000|Overall Study|Protocol Violation|18|||
128752621|NCT02120027|463383416|FG001|Overall Study|Protocol Violation|21|||
128752622|NCT02120027|463383415|FG000|Overall Study|Study terminated by Sponsor|45|||
128752623|NCT02120027|463383416|FG001|Overall Study|Study terminated by Sponsor|47|||
128752624|NCT02120027|463383415|FG000|Overall Study|Withdrawal by Subject|33|||
128752625|NCT02120027|463383416|FG001|Overall Study|Withdrawal by Subject|25|||
128752626|NCT00447057|463383421|FG000|Overall Study|Adverse Event|4|||
128752627|NCT00447057|463383422|FG001|Overall Study|Adverse Event|10|||
128752628|NCT00447057|463383423|FG002|Overall Study|Adverse Event|0|||
128752629|NCT00447057|463383424|FG003|Overall Study|Adverse Event|3|||
128752630|NCT00447057|463383421|FG000|Overall Study|Death due to study disease|6|||
128752631|NCT00447057|463383422|FG001|Overall Study|Death due to study disease|4|||
128752632|NCT00447057|463383423|FG002|Overall Study|Death due to study disease|1|||
128752633|NCT00447057|463383424|FG003|Overall Study|Death due to study disease|1|||
128752634|NCT00447057|463383421|FG000|Overall Study|Lost to Follow-up|0|||
128752635|NCT00447057|463383422|FG001|Overall Study|Lost to Follow-up|1|||
128752636|NCT00447057|463383423|FG002|Overall Study|Lost to Follow-up|0|||
128752637|NCT00447057|463383424|FG003|Overall Study|Lost to Follow-up|0|||
128752638|NCT00447057|463383421|FG000|Overall Study|Entry criteria not met|1|||
128752639|NCT00447057|463383422|FG001|Overall Study|Entry criteria not met|1|||
128752640|NCT00447057|463383423|FG002|Overall Study|Entry criteria not met|0|||
128752641|NCT00447057|463383424|FG003|Overall Study|Entry criteria not met|0|||
128752642|NCT00447057|463383421|FG000|Overall Study|Protocol Violation|0|||
128752643|NCT00447057|463383422|FG001|Overall Study|Protocol Violation|1|||
128752644|NCT00447057|463383423|FG002|Overall Study|Protocol Violation|0|||
128752645|NCT00447057|463383424|FG003|Overall Study|Protocol Violation|0|||
128752646|NCT00447057|463383421|FG000|Overall Study|Withdrawal by Subject|4|||
128752647|NCT00447057|463383422|FG001|Overall Study|Withdrawal by Subject|5|||
128752648|NCT00447057|463383423|FG002|Overall Study|Withdrawal by Subject|1|||
128752649|NCT00447057|463383424|FG003|Overall Study|Withdrawal by Subject|1|||
128752650|NCT00447057|463383421|FG000|Overall Study|Physician Decision|9|||
128752651|NCT00447057|463383422|FG001|Overall Study|Physician Decision|6|||
128752652|NCT00447057|463383423|FG002|Overall Study|Physician Decision|3|||
128752653|NCT00447057|463383424|FG003|Overall Study|Physician Decision|1|||
128752654|NCT00447057|463383421|FG000|Overall Study|Sponsor decision|1|||
128752655|NCT00447057|463383422|FG001|Overall Study|Sponsor decision|1|||
128752656|NCT00447057|463383423|FG002|Overall Study|Sponsor decision|0|||
128752657|NCT00447057|463383424|FG003|Overall Study|Sponsor decision|0|||
128752658|NCT00447057|463383421|FG000|Overall Study|Progressive disease|58|||
128752659|NCT00447057|463383422|FG001|Overall Study|Progressive disease|43|||
128752660|NCT00447057|463383423|FG002|Overall Study|Progressive disease|13|||
128752661|NCT00447057|463383424|FG003|Overall Study|Progressive disease|18|||
128752662|NCT00447057|463383421|FG000|Overall Study|Death due to adverse event|0|||
128752663|NCT00447057|463383422|FG001|Overall Study|Death due to adverse event|0|||
128752664|NCT00447057|463383423|FG002|Overall Study|Death due to adverse event|1|||
128752665|NCT00447057|463383424|FG003|Overall Study|Death due to adverse event|2|||
128752666|NCT00447057|463383421|FG000|Overall Study|Death, study drug related|0|||
128752667|NCT00447057|463383422|FG001|Overall Study|Death, study drug related|1|||
128752668|NCT00447057|463383423|FG002|Overall Study|Death, study drug related|0|||
128752669|NCT00447057|463383424|FG003|Overall Study|Death, study drug related|0|||
128752670|NCT01471054|463383425|FG000|Overall Study|Study terminated prematurely|4|||
128786117|NCT01549652|463509373|FG002|Overall Study|Withdrawal by Subject|5|||
128752671|NCT01471054|463383426|FG001|Overall Study|Study terminated prematurely|0|||
128752672|NCT01843192|463383427|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
128752673|NCT01843192|463383428|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
128752674|NCT01843192|463383429|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
128752675|NCT04493216|463383430|FG000|Overall Study|Study terminated by sponsor|30|||
128752676|NCT04493216|463383431|FG001|Overall Study|Study terminated by sponsor|33|||
128786118|NCT01549652|463509374|FG003|Overall Study|Withdrawal by Subject|3|||
128752677|NCT04493216|463383432|FG002|Overall Study|Study terminated by sponsor|28|||
128752678|NCT04493216|463383433|FG003|Overall Study|Study terminated by sponsor|27|||
128752679|NCT04493216|463383430|FG000|Overall Study|Withdrawal by Subject|2|||
128752680|NCT04493216|463383431|FG001|Overall Study|Withdrawal by Subject|1|||
128752681|NCT04493216|463383432|FG002|Overall Study|Withdrawal by Subject|1|||
128752682|NCT04493216|463383433|FG003|Overall Study|Withdrawal by Subject|2|||
128752683|NCT04493216|463383430|FG000|Overall Study|Protocol Violation|1|||
128752684|NCT04493216|463383431|FG001|Overall Study|Protocol Violation|2|||
128786119|NCT03523962|463509376|FG000|Closed Fractures|Death|86|||
128752685|NCT04493216|463383432|FG002|Overall Study|Protocol Violation|0|||
128752686|NCT04493216|463383433|FG003|Overall Study|Protocol Violation|2|||
128752687|NCT04493216|463383430|FG000|Overall Study|Physician Decision|0|||
128786120|NCT03523962|463509377|FG001|Closed Fractures|Death|71|||
128752688|NCT04493216|463383431|FG001|Overall Study|Physician Decision|0|||
128752689|NCT04493216|463383432|FG002|Overall Study|Physician Decision|1|||
128752690|NCT04493216|463383433|FG003|Overall Study|Physician Decision|0|||
128752691|NCT04493216|463383430|FG000|Overall Study|Lost to Follow-up|2|||
128752692|NCT04493216|463383431|FG001|Overall Study|Lost to Follow-up|1|||
128752693|NCT04493216|463383432|FG002|Overall Study|Lost to Follow-up|0|||
128752694|NCT04493216|463383433|FG003|Overall Study|Lost to Follow-up|1|||
128752695|NCT04493216|463383430|FG000|Overall Study|Adverse Event|1|||
128752696|NCT04493216|463383431|FG001|Overall Study|Adverse Event|4|||
128752697|NCT04493216|463383432|FG002|Overall Study|Adverse Event|5|||
128752698|NCT04493216|463383433|FG003|Overall Study|Adverse Event|2|||
128752699|NCT04493216|463383430|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
128752700|NCT04493216|463383431|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
128752701|NCT04493216|463383432|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
128752702|NCT04493216|463383433|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
128752703|NCT01559844|463383434|FG000|Overall Study|Consent Withdrawn|7|||
128752704|NCT01559844|463383434|FG000|Overall Study|Death|5|||
128752705|NCT01559844|463383434|FG000|Overall Study|Efficacy Failure|10|||
128752706|NCT01559844|463383434|FG000|Overall Study|No Longer A Transplant Candidate|3|||
128752707|NCT02181803|463383435|FG000|Overall Study|Withdrawal by Subject|0|||
128752708|NCT02181803|463383436|FG001|Overall Study|Withdrawal by Subject|2|||
128752709|NCT02181803|463383437|FG002|Overall Study|Withdrawal by Subject|0|||
128752710|NCT02181803|463383438|FG003|Overall Study|Withdrawal by Subject|0|||
128752711|NCT02181803|463383439|FG004|Overall Study|Withdrawal by Subject|0|||
128752712|NCT02181803|463383440|FG005|Overall Study|Withdrawal by Subject|0|||
128752713|NCT02181803|463383441|FG006|Overall Study|Withdrawal by Subject|0|||
128752714|NCT02181803|463383442|FG007|Overall Study|Withdrawal by Subject|0|||
128752715|NCT02181803|463383443|FG008|Overall Study|Withdrawal by Subject|0|||
128752716|NCT02181803|463383435|FG000|Overall Study|Physician Decision|0|||
128752717|NCT02181803|463383436|FG001|Overall Study|Physician Decision|0|||
128752718|NCT02181803|463383437|FG002|Overall Study|Physician Decision|0|||
128752719|NCT02181803|463383438|FG003|Overall Study|Physician Decision|1|||
128752720|NCT02181803|463383439|FG004|Overall Study|Physician Decision|0|||
128752721|NCT02181803|463383440|FG005|Overall Study|Physician Decision|0|||
128752722|NCT02181803|463383441|FG006|Overall Study|Physician Decision|0|||
128752723|NCT02181803|463383442|FG007|Overall Study|Physician Decision|1|||
128752724|NCT02181803|463383443|FG008|Overall Study|Physician Decision|0|||
128752725|NCT02181803|463383435|FG000|Overall Study|Adverse Event|0|||
128752726|NCT02181803|463383436|FG001|Overall Study|Adverse Event|2|||
128752727|NCT02181803|463383437|FG002|Overall Study|Adverse Event|0|||
128752728|NCT02181803|463383438|FG003|Overall Study|Adverse Event|1|||
128752729|NCT02181803|463383439|FG004|Overall Study|Adverse Event|0|||
128752730|NCT02181803|463383440|FG005|Overall Study|Adverse Event|0|||
128752731|NCT02181803|463383441|FG006|Overall Study|Adverse Event|1|||
128752732|NCT02181803|463383442|FG007|Overall Study|Adverse Event|0|||
128752733|NCT02181803|463383443|FG008|Overall Study|Adverse Event|0|||
128752734|NCT00951041|463383444|FG000|Overall Study|Withdrawal by Subject|1|||
128752735|NCT00951041|463383445|FG001|Overall Study|Withdrawal by Subject|1|||
128752736|NCT00951041|463383444|FG000|Overall Study|Lost to Follow-up|1|||
128752737|NCT00951041|463383445|FG001|Overall Study|Lost to Follow-up|0|||
128752738|NCT00951041|463383444|FG000|Overall Study|Other|3|||
128752739|NCT00951041|463383445|FG001|Overall Study|Other|0|||
128786121|NCT03523962|463509378|FG002|Closed Fractures|Death|0|||
128752740|NCT01514448|463383446|FG000|Overall Study|Death|7|||
128752741|NCT01514448|463383447|FG001|Overall Study|Death|8|||
128752742|NCT01514448|463383446|FG000|Overall Study|Withdrawal by Subject|2|||
128752743|NCT01514448|463383447|FG001|Overall Study|Withdrawal by Subject|0|||
128786122|NCT03523962|463509379|FG003|Closed Fractures|Death|0|||
128786123|NCT03523962|463509376|FG000|Closed Fractures|Lost to Follow-up|62|||
128752744|NCT01514448|463383446|FG000|Overall Study|Lost to Follow-up|2|||
128752745|NCT01514448|463383447|FG001|Overall Study|Lost to Follow-up|0|||
128752746|NCT01514448|463383446|FG000|Overall Study|New Cancer Therapy|1|||
128752747|NCT01514448|463383447|FG001|Overall Study|New Cancer Therapy|0|||
128752748|NCT02314624|463383448|FG000|Overall Study|No participating patient|16|||
128752749|NCT02314624|463383449|FG001|Overall Study|No participating patient|13|||
128752750|NCT02314624|463383448|FG000|Overall Study|Participant withdrew|7|||
128752751|NCT02314624|463383449|FG001|Overall Study|Participant withdrew|2|||
128752752|NCT02314624|463383448|FG000|Overall Study|Lost to Follow-up|2|||
128752753|NCT02314624|463383449|FG001|Overall Study|Lost to Follow-up|5|||
128752754|NCT02314624|463383448|FG000|Overall Study|Dropped/Excluded by PI|6|||
128752755|NCT02314624|463383449|FG001|Overall Study|Dropped/Excluded by PI|6|||
128752756|NCT03151005|463383450|FG000|Overall Study|Lost to Follow-up|5|||
128752757|NCT03151005|463383451|FG001|Overall Study|Lost to Follow-up|5|||
128752758|NCT04786444|463383454|FG000|Overall Study|Withdrawal by Subject|4|||
128752759|NCT04786444|463383455|FG001|Overall Study|Withdrawal by Subject|7|||
128752760|NCT04786444|463383456|FG002|Overall Study|Withdrawal by Subject|2|||
128752761|NCT04786444|463383454|FG000|Overall Study|Lost to Follow-up|11|||
128752762|NCT04786444|463383455|FG001|Overall Study|Lost to Follow-up|9|||
128752763|NCT04786444|463383456|FG002|Overall Study|Lost to Follow-up|10|||
128752764|NCT04786444|463383454|FG000|Overall Study|Subject would like to become pregnant|0|||
128752765|NCT04786444|463383455|FG001|Overall Study|Subject would like to become pregnant|1|||
128752766|NCT04786444|463383456|FG002|Overall Study|Subject would like to become pregnant|0|||
128752767|NCT02462876|463383457|FG000|Overall Study|Death|3|||
128752768|NCT02462876|463383457|FG000|Overall Study|Lost to Follow-up|7|||
128752769|NCT02462876|463383457|FG000|Overall Study|Surgical Bypass|9|||
128752770|NCT02462876|463383457|FG000|Overall Study|Amputation Above the Metatarsals|1|||
128752771|NCT02462876|463383457|FG000|Overall Study|36 months follow-up visit missed|1|||
128752772|NCT02462876|463383457|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
128752773|NCT02462876|463383457|FG000|Overall Study|Patient did not come back to the vascular department|1|||
128752774|NCT02462876|463383457|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
128752775|NCT02462876|463383457|FG000|Overall Study|Patient refused to come back|1|||
128752776|NCT02462876|463383457|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
128752777|NCT02462876|463383457|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
128752778|NCT01786512|463383462|FG000|Overall Study|Lost to Follow-up|0|||
128752779|NCT01786512|463383463|FG001|Overall Study|Lost to Follow-up|0|||
128752780|NCT01786512|463383464|FG002|Overall Study|Lost to Follow-up|0|||
128752781|NCT01786512|463383465|FG003|Overall Study|Lost to Follow-up|0|||
128752782|NCT01786512|463383466|FG004|Overall Study|Lost to Follow-up|0|||
128752783|NCT01786512|463383467|FG005|Overall Study|Lost to Follow-up|0|||
128752784|NCT01786512|463383468|FG006|Overall Study|Lost to Follow-up|0|||
128752785|NCT01786512|463383469|FG007|Overall Study|Lost to Follow-up|0|||
128752786|NCT01786512|463383470|FG008|Overall Study|Lost to Follow-up|0|||
128752787|NCT01786512|463383471|FG009|Overall Study|Lost to Follow-up|1|||
128752788|NCT01786512|463383472|FG010|Overall Study|Lost to Follow-up|0|||
128752789|NCT01786512|463383462|FG000|Overall Study|Decision by sponsor|0|||
128752790|NCT01786512|463383463|FG001|Overall Study|Decision by sponsor|0|||
128752791|NCT01786512|463383464|FG002|Overall Study|Decision by sponsor|0|||
128752792|NCT01786512|463383465|FG003|Overall Study|Decision by sponsor|0|||
128752793|NCT01786512|463383466|FG004|Overall Study|Decision by sponsor|0|||
128752794|NCT01786512|463383467|FG005|Overall Study|Decision by sponsor|0|||
128752795|NCT01786512|463383468|FG006|Overall Study|Decision by sponsor|0|||
128752796|NCT01786512|463383469|FG007|Overall Study|Decision by sponsor|0|||
128752797|NCT01786512|463383470|FG008|Overall Study|Decision by sponsor|0|||
128752798|NCT01786512|463383471|FG009|Overall Study|Decision by sponsor|0|||
128752799|NCT01786512|463383472|FG010|Overall Study|Decision by sponsor|2|||
128752800|NCT01786512|463383462|FG000|Overall Study|Withdrawal by Subject|0|||
128752801|NCT01786512|463383463|FG001|Overall Study|Withdrawal by Subject|1|||
128752802|NCT01786512|463383464|FG002|Overall Study|Withdrawal by Subject|0|||
128752803|NCT01786512|463383465|FG003|Overall Study|Withdrawal by Subject|0|||
128752804|NCT01786512|463383466|FG004|Overall Study|Withdrawal by Subject|0|||
128752805|NCT01786512|463383467|FG005|Overall Study|Withdrawal by Subject|0|||
128752806|NCT01786512|463383468|FG006|Overall Study|Withdrawal by Subject|1|||
128752807|NCT01786512|463383469|FG007|Overall Study|Withdrawal by Subject|0|||
128752808|NCT01786512|463383470|FG008|Overall Study|Withdrawal by Subject|0|||
128752809|NCT01786512|463383471|FG009|Overall Study|Withdrawal by Subject|3|||
128786124|NCT03523962|463509377|FG001|Closed Fractures|Lost to Follow-up|36|||
128752810|NCT01786512|463383472|FG010|Overall Study|Withdrawal by Subject|7|||
128752811|NCT01786512|463383462|FG000|Overall Study|Death|0|||
128752812|NCT01786512|463383463|FG001|Overall Study|Death|0|||
128752813|NCT01786512|463383464|FG002|Overall Study|Death|0|||
128752814|NCT01786512|463383465|FG003|Overall Study|Death|0|||
128752815|NCT01786512|463383466|FG004|Overall Study|Death|0|||
128752816|NCT01786512|463383467|FG005|Overall Study|Death|0|||
128752817|NCT01786512|463383468|FG006|Overall Study|Death|0|||
128752818|NCT01786512|463383469|FG007|Overall Study|Death|0|||
128752819|NCT01786512|463383470|FG008|Overall Study|Death|4|||
128752820|NCT01786512|463383471|FG009|Overall Study|Death|1|||
128752821|NCT01786512|463383472|FG010|Overall Study|Death|3|||
128752822|NCT03166618|463383473|FG000|Overall Study|Study was Terminated|0|||
128752823|NCT03166618|463383474|FG001|Overall Study|Study was Terminated|1|||
128752824|NCT00605293|463383475|FG000|Overall Study|Death|2|||
128752825|NCT00605293|463383476|FG001|Overall Study|Death|1|||
128752826|NCT00605293|463383475|FG000|Overall Study|Insufficient Therapeutic Response|2|||
128752827|NCT00605293|463383476|FG001|Overall Study|Insufficient Therapeutic Response|0|||
128752828|NCT00605293|463383475|FG000|Overall Study|Adverse Event|1|||
128752829|NCT00605293|463383476|FG001|Overall Study|Adverse Event|0|||
128752830|NCT00605293|463383475|FG000|Overall Study|Holidays Dialysis Out|1|||
128752831|NCT00605293|463383476|FG001|Overall Study|Holidays Dialysis Out|0|||
128752832|NCT00605293|463383475|FG000|Overall Study|Blood Transfusion|7|||
128752833|NCT00605293|463383476|FG001|Overall Study|Blood Transfusion|1|||
128752834|NCT00605293|463383475|FG000|Overall Study|Renal Transplantation|3|||
128752835|NCT00605293|463383476|FG001|Overall Study|Renal Transplantation|1|||
128752836|NCT00605293|463383475|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
128752837|NCT00605293|463383476|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
128752838|NCT00605293|463383475|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
128752839|NCT00605293|463383476|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
128752840|NCT00605293|463383475|FG000|Overall Study|Principal Investigator Decision|0|||
128752841|NCT00605293|463383476|FG001|Overall Study|Principal Investigator Decision|1|||
128752842|NCT03137303|463383477|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
128752843|NCT03137303|463383478|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
128752844|NCT03137303|463383477|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
128752845|NCT03137303|463383478|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
128752846|NCT03137303|463383477|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
128752847|NCT03137303|463383478|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
128752848|NCT03137303|463383477|FG000|T3: 9-month Follow-up|Death|1|||
128752849|NCT03137303|463383478|FG001|T3: 9-month Follow-up|Death|0|||
128752850|NCT03137303|463383477|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
128752851|NCT03137303|463383478|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
128752852|NCT03137303|463383477|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
128752853|NCT03137303|463383478|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
128752854|NCT03137303|463383477|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
128752855|NCT03137303|463383478|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
128752856|NCT03561090|463383479|FG000|Overall Study|Adverse Event|11|||
128752857|NCT03561090|463383480|FG001|Overall Study|Adverse Event|7|||
128752858|NCT03561090|463383479|FG000|Overall Study|Non-Compliance With Study Drug|2|||
128752859|NCT03561090|463383480|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128752860|NCT03561090|463383479|FG000|Overall Study|Protocol Violation|2|||
128752861|NCT03561090|463383480|FG001|Overall Study|Protocol Violation|2|||
128752862|NCT03561090|463383479|FG000|Overall Study|Withdrawal by Subject|7|||
128752863|NCT03561090|463383480|FG001|Overall Study|Withdrawal by Subject|7|||
128752864|NCT03561090|463383479|FG000|Overall Study|Lost to Follow-up|7|||
128752865|NCT03561090|463383480|FG001|Overall Study|Lost to Follow-up|2|||
128752866|NCT03561090|463383479|FG000|Overall Study|Study Terminated by Sponsor|10|||
128752867|NCT03561090|463383480|FG001|Overall Study|Study Terminated by Sponsor|15|||
128752868|NCT03561090|463383479|FG000|Overall Study|Randomized by Mistake|1|||
128752869|NCT03561090|463383480|FG001|Overall Study|Randomized by Mistake|1|||
128752870|NCT03561090|463383479|FG000|Overall Study|Other Not Specified|0|||
128752871|NCT03561090|463383480|FG001|Overall Study|Other Not Specified|2|||
128752872|NCT00713648|463383487|FG000|Overall Study|Adverse Event|1|||
128752873|NCT00713648|463383487|FG000|Overall Study|Unclassified|2|||
128752874|NCT00713648|463383487|FG000|Overall Study|According to Protocol|2|||
128752875|NCT00713648|463383487|FG000|Overall Study|Development of antibodies|3|||
128752876|NCT02633800|463383488|FG000|Overall Study|Death|3|||
128752877|NCT02633800|463383489|FG001|Overall Study|Death|3|||
128752878|NCT02633800|463383488|FG000|Overall Study|Reason not provided|1|||
128752879|NCT02633800|463383489|FG001|Overall Study|Reason not provided|0|||
128752880|NCT02633800|463383488|FG000|Overall Study|Radiologic(al) progression|23|||
128752881|NCT02633800|463383489|FG001|Overall Study|Radiologic(al) progression|23|||
128752882|NCT02633800|463383488|FG000|Overall Study|Clinical progression|3|||
128752883|NCT02633800|463383489|FG001|Overall Study|Clinical progression|6|||
128752884|NCT02633800|463383488|FG000|Overall Study|Study terminated by sponsor|6|||
128752885|NCT02633800|463383489|FG001|Overall Study|Study terminated by sponsor|5|||
128752886|NCT02633800|463383488|FG000|Overall Study|Adverse event, non-fatal|7|||
128752887|NCT02633800|463383489|FG001|Overall Study|Adverse event, non-fatal|2|||
128752888|NCT02633800|463383488|FG000|Overall Study|Withdrawal by Subject|0|||
128752889|NCT02633800|463383489|FG001|Overall Study|Withdrawal by Subject|3|||
128752890|NCT02633800|463383488|FG000|Overall Study|Patient Request|1|||
128752891|NCT02633800|463383489|FG001|Overall Study|Patient Request|1|||
128752892|NCT00082173|463383490|FG000|Overall Study|Withdrawal by Subject|3|||
128752893|NCT00082173|463383491|FG001|Overall Study|Withdrawal by Subject|5|||
128752894|NCT00082173|463383490|FG000|Overall Study|Lost to Follow-up|1|||
128752895|NCT00082173|463383491|FG001|Overall Study|Lost to Follow-up|0|||
128752896|NCT00082173|463383490|FG000|Overall Study|Adverse Event|1|||
128752897|NCT00082173|463383491|FG001|Overall Study|Adverse Event|0|||
128752898|NCT00082173|463383490|FG000|Overall Study|Culture negative or resistant at baselin|5|||
128752899|NCT00082173|463383491|FG001|Overall Study|Culture negative or resistant at baselin|6|||
128752900|NCT01733732|463383492|FG000|Overall Study|Adverse Event|1|||
128752901|NCT01733732|463383493|FG001|Overall Study|Adverse Event|0|||
128752902|NCT01733732|463383492|FG000|Overall Study|Did not attend all study visits|1|||
128752903|NCT01733732|463383493|FG001|Overall Study|Did not attend all study visits|0|||
128752904|NCT01260350|463383505|FG000|Overall Study|Lack of Efficacy|0|||
128752905|NCT01260350|463383506|FG001|Overall Study|Lack of Efficacy|0|||
128752906|NCT01260350|463383507|FG002|Overall Study|Lack of Efficacy|0|||
128752907|NCT01260350|463383508|FG003|Overall Study|Lack of Efficacy|0|||
128752908|NCT01260350|463383509|FG004|Overall Study|Lack of Efficacy|0|||
128752909|NCT01260350|463383510|FG005|Overall Study|Lack of Efficacy|0|||
128752910|NCT01260350|463383511|FG006|Overall Study|Lack of Efficacy|0|||
128752911|NCT01260350|463383512|FG007|Overall Study|Lack of Efficacy|0|||
128752912|NCT01260350|463383513|FG008|Overall Study|Lack of Efficacy|0|||
128752913|NCT01260350|463383514|FG009|Overall Study|Lack of Efficacy|0|||
128752914|NCT01260350|463383515|FG010|Overall Study|Lack of Efficacy|0|||
128752915|NCT01260350|463383516|FG011|Overall Study|Lack of Efficacy|0|||
128752916|NCT01260350|463383517|FG012|Overall Study|Lack of Efficacy|0|||
128752917|NCT01260350|463383518|FG013|Overall Study|Lack of Efficacy|0|||
128752918|NCT01260350|463383519|FG014|Overall Study|Lack of Efficacy|0|||
128752919|NCT01260350|463383520|FG015|Overall Study|Lack of Efficacy|0|||
128752920|NCT01260350|463383521|FG016|Overall Study|Lack of Efficacy|0|||
128752921|NCT01260350|463383522|FG017|Overall Study|Lack of Efficacy|1|||
128752922|NCT01260350|463383523|FG018|Overall Study|Lack of Efficacy|0|||
128752923|NCT01260350|463383524|FG019|Overall Study|Lack of Efficacy|0|||
128752924|NCT01260350|463383525|FG020|Overall Study|Lack of Efficacy|3|||
128752925|NCT01260350|463383526|FG021|Overall Study|Lack of Efficacy|0|||
128752926|NCT01260350|463383505|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752927|NCT01260350|463383506|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752928|NCT01260350|463383507|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752929|NCT01260350|463383508|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752930|NCT01260350|463383509|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752931|NCT01260350|463383510|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752932|NCT01260350|463383511|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752933|NCT01260350|463383512|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752934|NCT01260350|463383513|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
128752935|NCT01260350|463383514|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752936|NCT01260350|463383515|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752937|NCT01260350|463383516|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752938|NCT01260350|463383517|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752939|NCT01260350|463383518|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752940|NCT01260350|463383519|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752941|NCT01260350|463383520|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752942|NCT01260350|463383521|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752943|NCT01260350|463383522|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752944|NCT01260350|463383523|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752945|NCT01260350|463383524|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752946|NCT01260350|463383525|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752947|NCT01260350|463383526|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
128752948|NCT01358968|463383529|FG000|Period 2|Adverse Event|0|||
128752949|NCT01358968|463383530|FG001|Period 2|Adverse Event|1|||
128752950|NCT01358968|463383531|FG002|Period 2|Adverse Event|0|||
128752951|NCT01358968|463383532|FG003|Period 2|Adverse Event|0|||
128752952|NCT01358968|463383529|FG000|Continued Access Phase|Progression of Disease|0|||
128752953|NCT01358968|463383530|FG001|Continued Access Phase|Progression of Disease|0|||
128752954|NCT01358968|463383531|FG002|Continued Access Phase|Progression of Disease|8|||
128752955|NCT01358968|463383532|FG003|Continued Access Phase|Progression of Disease|4|||
128752956|NCT01358968|463383529|FG000|Continued Access Phase|Protocol Violation|0|||
128752957|NCT01358968|463383530|FG001|Continued Access Phase|Protocol Violation|0|||
128752958|NCT01358968|463383531|FG002|Continued Access Phase|Protocol Violation|0|||
128752959|NCT01358968|463383532|FG003|Continued Access Phase|Protocol Violation|2|||
128752960|NCT01358968|463383529|FG000|Continued Access Phase|Withdrawal by Subject|0|||
128752961|NCT01358968|463383530|FG001|Continued Access Phase|Withdrawal by Subject|0|||
128752962|NCT01358968|463383531|FG002|Continued Access Phase|Withdrawal by Subject|3|||
128752963|NCT01358968|463383532|FG003|Continued Access Phase|Withdrawal by Subject|0|||
128752964|NCT01358968|463383529|FG000|Continued Access Phase|Death|0|||
128752965|NCT01358968|463383530|FG001|Continued Access Phase|Death|0|||
128752966|NCT01358968|463383531|FG002|Continued Access Phase|Death|1|||
128752967|NCT01358968|463383532|FG003|Continued Access Phase|Death|1|||
128752968|NCT01814371|463383533|FG000|Overall Study|Lost to Follow-up|30|||
128752969|NCT01814371|463383534|FG001|Overall Study|Lost to Follow-up|27|||
128752970|NCT02794285|463383535|FG000|Overall Study|Adverse Event|11|||
128752971|NCT02794285|463383536|FG001|Overall Study|Adverse Event|4|||
128752972|NCT02794285|463383537|FG002|Overall Study|Adverse Event|5|||
128752973|NCT02794285|463383538|FG003|Overall Study|Adverse Event|8|||
128752974|NCT02794285|463383535|FG000|Overall Study|Condition Under Investigation Improved|1|||
128752975|NCT02794285|463383536|FG001|Overall Study|Condition Under Investigation Improved|0|||
128752976|NCT02794285|463383537|FG002|Overall Study|Condition Under Investigation Improved|0|||
128752977|NCT02794285|463383538|FG003|Overall Study|Condition Under Investigation Improved|0|||
128752978|NCT02794285|463383535|FG000|Overall Study|Condition Under Investigation Worsened|0|||
128752979|NCT02794285|463383536|FG001|Overall Study|Condition Under Investigation Worsened|2|||
128752980|NCT02794285|463383537|FG002|Overall Study|Condition Under Investigation Worsened|1|||
128752981|NCT02794285|463383538|FG003|Overall Study|Condition Under Investigation Worsened|0|||
128752982|NCT02794285|463383535|FG000|Overall Study|Death|2|||
128752983|NCT02794285|463383536|FG001|Overall Study|Death|1|||
128752984|NCT02794285|463383537|FG002|Overall Study|Death|2|||
128752985|NCT02794285|463383538|FG003|Overall Study|Death|0|||
128752986|NCT02794285|463383535|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
128752987|NCT02794285|463383536|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
128752988|NCT02794285|463383537|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
128752989|NCT02794285|463383538|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
128752990|NCT02794285|463383535|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
128752991|NCT02794285|463383536|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
128752992|NCT02794285|463383537|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
128752993|NCT02794285|463383538|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
128752994|NCT02794285|463383535|FG000|Overall Study|Lack of Efficacy|10|||
128752995|NCT02794285|463383536|FG001|Overall Study|Lack of Efficacy|6|||
128752996|NCT02794285|463383537|FG002|Overall Study|Lack of Efficacy|3|||
128752997|NCT02794285|463383538|FG003|Overall Study|Lack of Efficacy|3|||
128752998|NCT02794285|463383535|FG000|Overall Study|Lost to Follow-up|5|||
128752999|NCT02794285|463383536|FG001|Overall Study|Lost to Follow-up|6|||
128753000|NCT02794285|463383537|FG002|Overall Study|Lost to Follow-up|3|||
128753001|NCT02794285|463383538|FG003|Overall Study|Lost to Follow-up|1|||
128753002|NCT02794285|463383535|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
128753003|NCT02794285|463383536|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
128753004|NCT02794285|463383537|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
128753005|NCT02794285|463383538|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
128753006|NCT02794285|463383535|FG000|Overall Study|Withdrawal by Subject|38|||
128753007|NCT02794285|463383536|FG001|Overall Study|Withdrawal by Subject|29|||
128753008|NCT02794285|463383537|FG002|Overall Study|Withdrawal by Subject|20|||
128753009|NCT02794285|463383538|FG003|Overall Study|Withdrawal by Subject|12|||
128753010|NCT02794285|463383535|FG000|Overall Study|Missing|1|||
128753011|NCT02794285|463383536|FG001|Overall Study|Missing|0|||
128753012|NCT02794285|463383537|FG002|Overall Study|Missing|0|||
128753013|NCT02794285|463383538|FG003|Overall Study|Missing|0|||
128753014|NCT02794285|463383535|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
128753015|NCT02794285|463383536|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
128753016|NCT02794285|463383537|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
128753017|NCT02794285|463383538|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
128753018|NCT02794285|463383535|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
128753019|NCT02794285|463383536|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
128753020|NCT02794285|463383537|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
128753021|NCT02794285|463383538|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
128753022|NCT04052204|463383539|FG000|Overall Study|Death|1|||
128753023|NCT04052204|463383540|FG001|Overall Study|Death|0|||
128753024|NCT04052204|463383541|FG002|Overall Study|Death|0|||
128753025|NCT04052204|463383539|FG000|Overall Study|Progressive disease|1|||
128753026|NCT04052204|463383540|FG001|Overall Study|Progressive disease|0|||
128753027|NCT04052204|463383541|FG002|Overall Study|Progressive disease|0|||
128753028|NCT04052204|463383539|FG000|Overall Study|Other|1|||
128753029|NCT04052204|463383540|FG001|Overall Study|Other|0|||
128753030|NCT04052204|463383541|FG002|Overall Study|Other|0|||
128753031|NCT02395042|463383547|FG000|Treatment 1 Period|Adverse Event|1|||
128753032|NCT02395042|463383548|FG001|Treatment 1 Period|Adverse Event|3|||
128753033|NCT02395042|463383549|FG002|Treatment 1 Period|Adverse Event|1|||
128753034|NCT02395042|463383547|FG000|Treatment 1 Period|Lack of Efficacy|1|||
128753035|NCT02395042|463383548|FG001|Treatment 1 Period|Lack of Efficacy|1|||
128753036|NCT02395042|463383549|FG002|Treatment 1 Period|Lack of Efficacy|0|||
128753037|NCT02395042|463383547|FG000|Treatment 1 Period|Lost to Follow-up|1|||
128753038|NCT02395042|463383548|FG001|Treatment 1 Period|Lost to Follow-up|0|||
128753039|NCT02395042|463383549|FG002|Treatment 1 Period|Lost to Follow-up|0|||
128753040|NCT02395042|463383547|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
128753041|NCT02395042|463383548|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
128753042|NCT02395042|463383549|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
128753043|NCT02395042|463383547|FG000|Treatment 2 Period|Lack of Efficacy|1|||
128753044|NCT02395042|463383548|FG001|Treatment 2 Period|Lack of Efficacy|1|||
128753045|NCT02395042|463383549|FG002|Treatment 2 Period|Lack of Efficacy|0|||
128753046|NCT02192502|463383551|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
128753047|NCT02192502|463383552|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
128753048|NCT02192502|463383551|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
128753049|NCT02192502|463383552|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
128753050|NCT02192502|463383551|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
128753051|NCT02192502|463383552|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
128753052|NCT00003298|463383558|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
128753053|NCT00003298|463383558|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
128753054|NCT00003298|463383558|FG000|Surgery|Unresectable at surgery|3|||
128753055|NCT00003298|463383558|FG000|Surgery|Progression before surgery|2|||
128753056|NCT00003298|463383558|FG000|Surgery|Unevaluable and off study|2|||
128753057|NCT00003298|463383558|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
128753058|NCT00003298|463383558|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
128753059|NCT00003298|463383558|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
128753060|NCT00003298|463383558|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
128753061|NCT00003298|463383558|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
128753062|NCT00003298|463383558|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
128753063|NCT00003298|463383558|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
128753064|NCT00003298|463383558|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
128753065|NCT00003298|463383558|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
128753066|NCT00003298|463383558|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
128753067|NCT00844857|463386065|FG000|Overall Study|Adverse Event|24|||
128753068|NCT00844857|463386066|FG001|Overall Study|Adverse Event|5|||
128753069|NCT00844857|463386065|FG000|Overall Study|Sponsor Decision|1|||
128753070|NCT00844857|463386066|FG001|Overall Study|Sponsor Decision|1|||
128753071|NCT00844857|463386065|FG000|Overall Study|Physician Decision|2|||
128753072|NCT00844857|463386066|FG001|Overall Study|Physician Decision|0|||
128753073|NCT00844857|463386065|FG000|Overall Study|Parent/Caregiver Decision|6|||
128753074|NCT00844857|463386066|FG001|Overall Study|Parent/Caregiver Decision|2|||
128753075|NCT00844857|463386065|FG000|Overall Study|Withdrawal by Subject|8|||
128753076|NCT00844857|463386066|FG001|Overall Study|Withdrawal by Subject|7|||
128753077|NCT00844857|463386065|FG000|Overall Study|Protocol Violation|6|||
128753078|NCT00844857|463386066|FG001|Overall Study|Protocol Violation|0|||
128753079|NCT00844857|463386065|FG000|Overall Study|Lack of Efficacy|5|||
128753080|NCT00844857|463386066|FG001|Overall Study|Lack of Efficacy|5|||
128753081|NCT00844857|463386065|FG000|Overall Study|Clinical Relapse|0|||
128753082|NCT00844857|463386066|FG001|Overall Study|Clinical Relapse|1|||
128753083|NCT00844857|463386065|FG000|Overall Study|Entry Criteria Not Met|0|||
128753084|NCT00844857|463386066|FG001|Overall Study|Entry Criteria Not Met|1|||
128753085|NCT00844857|463386065|FG000|Overall Study|Lost to Follow-up|2|||
128753086|NCT00844857|463386066|FG001|Overall Study|Lost to Follow-up|3|||
128753087|NCT00844857|463386065|FG000|Overall Study|Did Not Take Study Drug|3|||
128753088|NCT00844857|463386066|FG001|Overall Study|Did Not Take Study Drug|1|||
128753089|NCT00844857|463386065|FG000|Overall Study|Good Clinical Practice Violations|21|||
128753090|NCT00844857|463386066|FG001|Overall Study|Good Clinical Practice Violations|11|||
128753091|NCT03393000|463386073|FG000|Overall Study|Death|11|||
128753092|NCT03393000|463386073|FG000|Overall Study|Withdrawal by Subject|2|||
128753093|NCT03393000|463386073|FG000|Overall Study|Physician Decision|1|||
128753094|NCT01773070|463386074|FG000|Overall Study|Withdrawal by Subject|24|||
128753095|NCT01773070|463386074|FG000|Overall Study|Lost to Follow-up|39|||
128753096|NCT01773070|463386074|FG000|Overall Study|Other|15|||
128753097|NCT01773070|463386074|FG000|Overall Study|Death (unrelated to study procedures)|3|||
128753098|NCT03643952|463386075|FG000|Overall Study|Lack of Efficacy|1|||
128753099|NCT04528069|463386079|FG000|Overall Study|Adverse Event|1|||
128753100|NCT04528069|463386079|FG000|Overall Study|Lost to Follow-up|1|||
128753101|NCT04528069|463386079|FG000|Overall Study|Patient Unable to Come|1|||
128753102|NCT04528069|463386079|FG000|Overall Study|Patient Unable to Attend|1|||
128753103|NCT02525874|463386082|FG000|Overall Study|Other|1|||
128753104|NCT02525874|463386082|FG000|Overall Study|Investigator Decision|1|||
128753105|NCT02525874|463386082|FG000|Overall Study|Consent withdrawn|22|||
128753106|NCT02525874|463386082|FG000|Overall Study|Non-compliance with study drug|3|||
128753107|NCT02525874|463386082|FG000|Overall Study|Adverse Event|17|||
128753108|NCT02525874|463386082|FG000|Overall Study|Lost to Follow-up|7|||
128753109|NCT02525874|463386082|FG000|Overall Study|Disease progression, defined by protocol|2|||
128753110|NCT02525874|463386082|FG000|Overall Study|Disease relapse|4|||
128753111|NCT02525874|463386082|FG000|Overall Study|Alternative Treatment for MS|2|||
128786125|NCT03523962|463509378|FG002|Closed Fractures|Lost to Follow-up|0|||
128786126|NCT03523962|463509379|FG003|Closed Fractures|Lost to Follow-up|0|||
128786127|NCT03523962|463509376|FG000|Closed Fractures|Withdrawal by Subject|19|||
128786128|NCT03523962|463509377|FG001|Closed Fractures|Withdrawal by Subject|29|||
128786129|NCT03523962|463509378|FG002|Closed Fractures|Withdrawal by Subject|0|||
128786130|NCT03523962|463509379|FG003|Closed Fractures|Withdrawal by Subject|0|||
128786131|NCT03523962|463509376|FG000|Closed Fractures|Incarceration|1|||
128786132|NCT03523962|463509377|FG001|Closed Fractures|Incarceration|4|||
128786133|NCT03523962|463509378|FG002|Closed Fractures|Incarceration|0|||
128786134|NCT03523962|463509379|FG003|Closed Fractures|Incarceration|0|||
128786135|NCT03523962|463509376|FG000|Open Fractures|Death|0|||
128786136|NCT03523962|463509377|FG001|Open Fractures|Death|0|||
128786137|NCT03523962|463509378|FG002|Open Fractures|Death|11|||
128786138|NCT03523962|463509379|FG003|Open Fractures|Death|6|||
128786139|NCT03523962|463509376|FG000|Open Fractures|Lost to Follow-up|0|||
128786140|NCT03523962|463509377|FG001|Open Fractures|Lost to Follow-up|0|||
128786141|NCT03523962|463509378|FG002|Open Fractures|Lost to Follow-up|15|||
128786142|NCT03523962|463509379|FG003|Open Fractures|Lost to Follow-up|8|||
128786143|NCT03523962|463509376|FG000|Open Fractures|Withdrawal by Subject|0|||
128786144|NCT03523962|463509377|FG001|Open Fractures|Withdrawal by Subject|0|||
128786145|NCT03523962|463509378|FG002|Open Fractures|Withdrawal by Subject|6|||
128786146|NCT03523962|463509379|FG003|Open Fractures|Withdrawal by Subject|2|||
128786147|NCT03523962|463509376|FG000|Open Fractures|Incarceration|0|||
128786148|NCT03523962|463509377|FG001|Open Fractures|Incarceration|0|||
128786149|NCT03523962|463509378|FG002|Open Fractures|Incarceration|1|||
128786150|NCT03523962|463509379|FG003|Open Fractures|Incarceration|0|||
128786151|NCT01081145|463509390|FG000|Open-Label Phase|Lack of Efficacy|56|||
128786152|NCT01081145|463509391|FG001|Open-Label Phase|Lack of Efficacy|0|||
128786153|NCT01081145|463509390|FG000|Open-Label Phase|Response criteria not met|46|||
128786154|NCT01081145|463509391|FG001|Open-Label Phase|Response criteria not met|0|||
128786155|NCT01081145|463509390|FG000|Open-Label Phase|Adverse Event|42|||
128786156|NCT01081145|463509391|FG001|Open-Label Phase|Adverse Event|0|||
128786157|NCT01081145|463509390|FG000|Open-Label Phase|Withdrawal by Subject|41|||
128786158|NCT01081145|463509391|FG001|Open-Label Phase|Withdrawal by Subject|0|||
128786159|NCT01081145|463509390|FG000|Open-Label Phase|Other|12|||
128786160|NCT01081145|463509391|FG001|Open-Label Phase|Other|0|||
128786161|NCT01081145|463509390|FG000|Open-Label Phase|Lost to Follow-up|11|||
128786162|NCT01081145|463509391|FG001|Open-Label Phase|Lost to Follow-up|0|||
128786163|NCT01081145|463509390|FG000|Open-Label Phase|Protocol Violation|4|||
128786164|NCT01081145|463509391|FG001|Open-Label Phase|Protocol Violation|0|||
128786165|NCT01081145|463509390|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
128786166|NCT01081145|463509391|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
128786167|NCT01081145|463509390|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
128786168|NCT01081145|463509391|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
128786169|NCT01081145|463509390|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
128786170|NCT01081145|463509391|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
128786171|NCT01081145|463509390|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
128786172|NCT01081145|463509391|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
128786173|NCT01081145|463509390|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
128786174|NCT01081145|463509391|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
128786175|NCT01081145|463509390|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
128753112|NCT02525874|463386082|FG000|Overall Study|New lesions in Brain|1|||
128753113|NCT01692782|463386085|FG000|Overall Study|Adverse Event|12|||
128753114|NCT01692782|463386086|FG001|Overall Study|Adverse Event|32|||
128753115|NCT01692782|463386087|FG002|Overall Study|Adverse Event|2|||
128753116|NCT01692782|463386085|FG000|Overall Study|Lack of Efficacy|1|||
128753117|NCT01692782|463386086|FG001|Overall Study|Lack of Efficacy|2|||
128753118|NCT01692782|463386087|FG002|Overall Study|Lack of Efficacy|0|||
128753119|NCT01692782|463386085|FG000|Overall Study|Lost to Follow-up|2|||
128753120|NCT01692782|463386086|FG001|Overall Study|Lost to Follow-up|7|||
128753121|NCT01692782|463386087|FG002|Overall Study|Lost to Follow-up|1|||
128753122|NCT01692782|463386085|FG000|Overall Study|Pregnancy|1|||
128786176|NCT01081145|463509391|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
128786177|NCT01081145|463509390|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
128753123|NCT01692782|463386086|FG001|Overall Study|Pregnancy|0|||
128753124|NCT01692782|463386087|FG002|Overall Study|Pregnancy|0|||
128753125|NCT01692782|463386085|FG000|Overall Study|Protocol Violation|1|||
128786178|NCT01081145|463509391|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
128786179|NCT00988637|463509393|FG000|Overall Study|Lost to Follow-up|2|||
128786180|NCT00988637|463509394|FG001|Overall Study|Lost to Follow-up|1|||
128753126|NCT01692782|463386086|FG001|Overall Study|Protocol Violation|0|||
128753127|NCT01692782|463386087|FG002|Overall Study|Protocol Violation|2|||
128786181|NCT00988637|463509393|FG000|Overall Study|Withdrawal by Subject|1|||
128786182|NCT00988637|463509394|FG001|Overall Study|Withdrawal by Subject|1|||
128786183|NCT00988637|463509393|FG000|Overall Study|non-compliance with study drug|0|||
128786184|NCT00988637|463509394|FG001|Overall Study|non-compliance with study drug|1|||
128753128|NCT01692782|463386085|FG000|Overall Study|Non-complance with study drug|0|||
128753129|NCT01692782|463386086|FG001|Overall Study|Non-complance with study drug|4|||
128753130|NCT01692782|463386087|FG002|Overall Study|Non-complance with study drug|1|||
128753131|NCT01692782|463386085|FG000|Overall Study|Non-compliant with study visits|0|||
128753132|NCT01692782|463386086|FG001|Overall Study|Non-compliant with study visits|0|||
128753133|NCT01692782|463386087|FG002|Overall Study|Non-compliant with study visits|1|||
128753134|NCT01692782|463386085|FG000|Overall Study|SAE not related to study drug|0|||
128753135|NCT01692782|463386086|FG001|Overall Study|SAE not related to study drug|1|||
128753136|NCT01692782|463386087|FG002|Overall Study|SAE not related to study drug|0|||
128753137|NCT01692782|463386085|FG000|Overall Study|Withdrawal by Subject|3|||
128753138|NCT01692782|463386086|FG001|Overall Study|Withdrawal by Subject|10|||
128753139|NCT01692782|463386087|FG002|Overall Study|Withdrawal by Subject|3|||
128753140|NCT03252587|463386088|FG000|Overall Study|Adverse Event|3|||
128753141|NCT03252587|463386089|FG001|Overall Study|Adverse Event|8|||
128753142|NCT03252587|463386090|FG002|Overall Study|Adverse Event|6|||
128753143|NCT03252587|463386091|FG003|Overall Study|Adverse Event|12|||
128753144|NCT03252587|463386088|FG000|Overall Study|Lack of Efficacy|7|||
128753145|NCT03252587|463386089|FG001|Overall Study|Lack of Efficacy|2|||
128753146|NCT03252587|463386090|FG002|Overall Study|Lack of Efficacy|2|||
128753147|NCT03252587|463386091|FG003|Overall Study|Lack of Efficacy|4|||
128753148|NCT03252587|463386088|FG000|Overall Study|Lost to Follow-up|2|||
128753149|NCT03252587|463386089|FG001|Overall Study|Lost to Follow-up|0|||
128753150|NCT03252587|463386090|FG002|Overall Study|Lost to Follow-up|0|||
128753151|NCT03252587|463386091|FG003|Overall Study|Lost to Follow-up|2|||
128753152|NCT03252587|463386088|FG000|Overall Study|Pregnancy|2|||
128753153|NCT03252587|463386089|FG001|Overall Study|Pregnancy|1|||
128753154|NCT03252587|463386090|FG002|Overall Study|Pregnancy|0|||
128753155|NCT03252587|463386091|FG003|Overall Study|Pregnancy|1|||
128753156|NCT03252587|463386088|FG000|Overall Study|Withdrawal by Subject|8|||
128753157|NCT03252587|463386089|FG001|Overall Study|Withdrawal by Subject|4|||
128753158|NCT03252587|463386090|FG002|Overall Study|Withdrawal by Subject|4|||
128753159|NCT03252587|463386091|FG003|Overall Study|Withdrawal by Subject|4|||
128753160|NCT03252587|463386088|FG000|Overall Study|Other Reasons|2|||
128753161|NCT03252587|463386089|FG001|Overall Study|Other Reasons|5|||
128753162|NCT03252587|463386090|FG002|Overall Study|Other Reasons|5|||
128753163|NCT03252587|463386091|FG003|Overall Study|Other Reasons|4|||
128753164|NCT03945188|463386097|FG000|Overall Study|Protocol Violation|1|||
128753165|NCT03945188|463386098|FG001|Overall Study|Protocol Violation|0|||
128753166|NCT03945188|463386097|FG000|Overall Study|Disease worsening|79|||
128753167|NCT03945188|463386098|FG001|Overall Study|Disease worsening|73|||
128753168|NCT03945188|463386097|FG000|Overall Study|Physician Decision|2|||
128753169|NCT03945188|463386098|FG001|Overall Study|Physician Decision|2|||
128753170|NCT03945188|463386097|FG000|Overall Study|Lack of Efficacy|7|||
128753171|NCT03945188|463386098|FG001|Overall Study|Lack of Efficacy|4|||
128753172|NCT03945188|463386097|FG000|Overall Study|Pregnancy|2|||
128753173|NCT03945188|463386098|FG001|Overall Study|Pregnancy|0|||
128753174|NCT03945188|463386097|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
128753175|NCT03945188|463386098|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
128753176|NCT03945188|463386097|FG000|Overall Study|Adverse Event|10|||
128753177|NCT03945188|463386098|FG001|Overall Study|Adverse Event|5|||
128753178|NCT03945188|463386097|FG000|Overall Study|Other|2|||
128753179|NCT03945188|463386098|FG001|Overall Study|Other|2|||
128753180|NCT03945188|463386097|FG000|Overall Study|Lost to Follow-up|1|||
128753181|NCT03945188|463386098|FG001|Overall Study|Lost to Follow-up|2|||
128753182|NCT01618162|463386126|FG000|Overall Study|Protocol Violation|13|||
128753183|NCT01618162|463386127|FG001|Overall Study|Protocol Violation|10|||
128753184|NCT01618162|463386126|FG000|Overall Study|Adverse Event|9|||
128753185|NCT01618162|463386127|FG001|Overall Study|Adverse Event|2|||
128753186|NCT01618162|463386126|FG000|Overall Study|Withdrawal Criteria|2|||
128753187|NCT01618162|463386127|FG001|Overall Study|Withdrawal Criteria|10|||
128753188|NCT01618162|463386126|FG000|Overall Study|Unclassified|14|||
128753189|NCT01618162|463386127|FG001|Overall Study|Unclassified|13|||
128753190|NCT04124926|463386128|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
128753191|NCT04124926|463386129|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
128753192|NCT04124926|463386130|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
128753193|NCT04124926|463386131|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
128753194|NCT04124926|463386132|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
128786185|NCT03593070|463509395|FG000|Overall Study|administrative withdrawal|1|||
128786186|NCT03593070|463509396|FG001|Overall Study|administrative withdrawal|1|||
128753195|NCT04124926|463386128|FG000|Healing Phase|Protocol Violation|0|||
128753196|NCT04124926|463386129|FG001|Healing Phase|Protocol Violation|1|||
128753197|NCT04124926|463386130|FG002|Healing Phase|Protocol Violation|0|||
128753198|NCT04124926|463386131|FG003|Healing Phase|Protocol Violation|0|||
128753199|NCT04124926|463386132|FG004|Healing Phase|Protocol Violation|0|||
128786187|NCT03394027|463509399|FG000|Overall Study|Ineligible|3|||
128753200|NCT04124926|463386128|FG000|Healing Phase|Lost to Follow-up|5|||
128753201|NCT04124926|463386129|FG001|Healing Phase|Lost to Follow-up|4|||
128753202|NCT04124926|463386130|FG002|Healing Phase|Lost to Follow-up|0|||
128753203|NCT04124926|463386131|FG003|Healing Phase|Lost to Follow-up|0|||
128753204|NCT04124926|463386132|FG004|Healing Phase|Lost to Follow-up|0|||
128753205|NCT04124926|463386128|FG000|Healing Phase|Voluntary Withdrawal|10|||
128753206|NCT04124926|463386129|FG001|Healing Phase|Voluntary Withdrawal|7|||
128753207|NCT04124926|463386130|FG002|Healing Phase|Voluntary Withdrawal|0|||
128753208|NCT04124926|463386131|FG003|Healing Phase|Voluntary Withdrawal|0|||
128753209|NCT04124926|463386132|FG004|Healing Phase|Voluntary Withdrawal|0|||
128753210|NCT04124926|463386128|FG000|Healing Phase|Withdrawal of Consent|5|||
128753211|NCT04124926|463386129|FG001|Healing Phase|Withdrawal of Consent|3|||
128753212|NCT04124926|463386130|FG002|Healing Phase|Withdrawal of Consent|0|||
128753213|NCT04124926|463386131|FG003|Healing Phase|Withdrawal of Consent|0|||
128753214|NCT04124926|463386132|FG004|Healing Phase|Withdrawal of Consent|0|||
128753215|NCT04124926|463386128|FG000|Healing Phase|Miscellaneous|8|||
128753216|NCT04124926|463386129|FG001|Healing Phase|Miscellaneous|7|||
128753217|NCT04124926|463386130|FG002|Healing Phase|Miscellaneous|0|||
128753218|NCT04124926|463386131|FG003|Healing Phase|Miscellaneous|0|||
128753219|NCT04124926|463386132|FG004|Healing Phase|Miscellaneous|0|||
128753220|NCT04124926|463386128|FG000|Healing Phase|Randomized but not Treated|0|||
128753221|NCT04124926|463386129|FG001|Healing Phase|Randomized but not Treated|3|||
128753222|NCT04124926|463386130|FG002|Healing Phase|Randomized but not Treated|0|||
128753223|NCT04124926|463386131|FG003|Healing Phase|Randomized but not Treated|0|||
128753224|NCT04124926|463386132|FG004|Healing Phase|Randomized but not Treated|0|||
128753225|NCT04124926|463386128|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
128753226|NCT04124926|463386129|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
128753227|NCT04124926|463386130|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
128753228|NCT04124926|463386131|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
128753229|NCT04124926|463386132|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
128753230|NCT04124926|463386128|FG000|Maintenance Phase|Protocol Violation|0|||
128753231|NCT04124926|463386129|FG001|Maintenance Phase|Protocol Violation|0|||
128753232|NCT04124926|463386130|FG002|Maintenance Phase|Protocol Violation|3|||
128753233|NCT04124926|463386131|FG003|Maintenance Phase|Protocol Violation|0|||
128753234|NCT04124926|463386132|FG004|Maintenance Phase|Protocol Violation|0|||
128753235|NCT04124926|463386128|FG000|Maintenance Phase|Lost to Follow-up|0|||
128753236|NCT04124926|463386129|FG001|Maintenance Phase|Lost to Follow-up|0|||
128753237|NCT04124926|463386130|FG002|Maintenance Phase|Lost to Follow-up|7|||
128753238|NCT04124926|463386131|FG003|Maintenance Phase|Lost to Follow-up|8|||
128753239|NCT04124926|463386132|FG004|Maintenance Phase|Lost to Follow-up|9|||
128753240|NCT04124926|463386128|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
128753241|NCT04124926|463386129|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
128753242|NCT04124926|463386130|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
128753243|NCT04124926|463386131|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
128753244|NCT04124926|463386132|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
128753245|NCT04124926|463386128|FG000|Maintenance Phase|Pregnancy|0|||
128753246|NCT04124926|463386129|FG001|Maintenance Phase|Pregnancy|0|||
128753247|NCT04124926|463386130|FG002|Maintenance Phase|Pregnancy|0|||
128753248|NCT04124926|463386131|FG003|Maintenance Phase|Pregnancy|1|||
128753249|NCT04124926|463386132|FG004|Maintenance Phase|Pregnancy|0|||
128753250|NCT04124926|463386128|FG000|Maintenance Phase|Lack of Efficacy|0|||
128753251|NCT04124926|463386129|FG001|Maintenance Phase|Lack of Efficacy|0|||
128753252|NCT04124926|463386130|FG002|Maintenance Phase|Lack of Efficacy|0|||
128753253|NCT04124926|463386131|FG003|Maintenance Phase|Lack of Efficacy|0|||
128753254|NCT04124926|463386132|FG004|Maintenance Phase|Lack of Efficacy|1|||
128753255|NCT04124926|463386128|FG000|Maintenance Phase|Withdrawal of Consent|0|||
128753256|NCT04124926|463386129|FG001|Maintenance Phase|Withdrawal of Consent|0|||
128753257|NCT04124926|463386130|FG002|Maintenance Phase|Withdrawal of Consent|5|||
128753258|NCT04124926|463386131|FG003|Maintenance Phase|Withdrawal of Consent|5|||
128753259|NCT04124926|463386132|FG004|Maintenance Phase|Withdrawal of Consent|5|||
128753260|NCT04124926|463386128|FG000|Maintenance Phase|Miscellaneous|0|||
128753261|NCT04124926|463386129|FG001|Maintenance Phase|Miscellaneous|0|||
128753262|NCT04124926|463386130|FG002|Maintenance Phase|Miscellaneous|1|||
128753263|NCT04124926|463386131|FG003|Maintenance Phase|Miscellaneous|2|||
128753264|NCT04124926|463386132|FG004|Maintenance Phase|Miscellaneous|4|||
128753265|NCT04124926|463386128|FG000|Maintenance Phase|Randomized but not Treated|0|||
128753266|NCT04124926|463386129|FG001|Maintenance Phase|Randomized but not Treated|0|||
128753267|NCT04124926|463386130|FG002|Maintenance Phase|Randomized but not Treated|2|||
128753268|NCT04124926|463386131|FG003|Maintenance Phase|Randomized but not Treated|2|||
128753269|NCT04124926|463386132|FG004|Maintenance Phase|Randomized but not Treated|0|||
128753270|NCT00423176|463386133|FG000|Overall Study|Adverse Event|4|||
128753271|NCT00423176|463386134|FG001|Overall Study|Adverse Event|6|||
128753272|NCT00423176|463386133|FG000|Overall Study|Treatment Failure|1|||
128753273|NCT00423176|463386134|FG001|Overall Study|Treatment Failure|6|||
128753274|NCT00423176|463386133|FG000|Overall Study|Lost to Follow-up|4|||
128753275|NCT00423176|463386134|FG001|Overall Study|Lost to Follow-up|7|||
128753276|NCT00423176|463386133|FG000|Overall Study|Withdrawal by Subject|4|||
128753277|NCT00423176|463386134|FG001|Overall Study|Withdrawal by Subject|3|||
128753278|NCT00423176|463386133|FG000|Overall Study|Protocol Violation|1|||
128753279|NCT00423176|463386134|FG001|Overall Study|Protocol Violation|3|||
128753280|NCT00423176|463386133|FG000|Overall Study|Did not meet protocol eligibility|2|||
128753281|NCT00423176|463386134|FG001|Overall Study|Did not meet protocol eligibility|4|||
128753282|NCT03152526|463386137|FG000|Overall Study|Withdrawal by Subject|0|||
128753283|NCT03152526|463386138|FG001|Overall Study|Withdrawal by Subject|1|||
128753284|NCT04867369|463386139|FG000|Overall Study|Withdrawal by Subject|1|||
128753285|NCT04867369|463386140|FG001|Overall Study|Withdrawal by Subject|0|||
128753286|NCT05554237|463386141|FG000|Part 2 (7 Days)|Adverse Event|0|||
128753287|NCT05554237|463386142|FG001|Part 2 (7 Days)|Adverse Event|0|||
128753288|NCT05554237|463386143|FG002|Part 2 (7 Days)|Adverse Event|0|||
128753289|NCT05554237|463386144|FG003|Part 2 (7 Days)|Adverse Event|0|||
128753290|NCT05554237|463386145|FG004|Part 2 (7 Days)|Adverse Event|2|||
128753291|NCT05554237|463386146|FG005|Part 2 (7 Days)|Adverse Event|0|||
128753292|NCT05554237|463386147|FG006|Part 2 (7 Days)|Adverse Event|0|||
128753293|NCT05554237|463386148|FG007|Part 2 (7 Days)|Adverse Event|0|||
128753294|NCT05554237|463386149|FG008|Part 2 (7 Days)|Adverse Event|0|||
128753295|NCT05554237|463386150|FG009|Part 2 (7 Days)|Adverse Event|1|||
128753296|NCT05554237|463386151|FG010|Part 2 (7 Days)|Adverse Event|0|||
128753297|NCT05554237|463386152|FG011|Part 2 (7 Days)|Adverse Event|0|||
128753298|NCT05554237|463386153|FG012|Part 2 (7 Days)|Adverse Event|1|||
128753299|NCT05554237|463386154|FG013|Part 2 (7 Days)|Adverse Event|0|||
128753300|NCT02807558|463386155|FG000|Overall Study|Consent withdrawn by participant|4|||
128753301|NCT02807558|463386156|FG001|Overall Study|Consent withdrawn by participant|0|||
128753302|NCT02807558|463386157|FG002|Overall Study|Consent withdrawn by participant|4|||
128753303|NCT02807558|463386158|FG003|Overall Study|Consent withdrawn by participant|2|||
128753304|NCT02807558|463386159|FG004|Overall Study|Consent withdrawn by participant|1|||
128753305|NCT02807558|463386160|FG005|Overall Study|Consent withdrawn by participant|0|||
128753306|NCT02807558|463386155|FG000|Overall Study|Non-compliance with Study Drug|0|||
128753307|NCT02807558|463386156|FG001|Overall Study|Non-compliance with Study Drug|0|||
128753308|NCT02807558|463386157|FG002|Overall Study|Non-compliance with Study Drug|1|||
128753309|NCT02807558|463386158|FG003|Overall Study|Non-compliance with Study Drug|0|||
128753310|NCT02807558|463386159|FG004|Overall Study|Non-compliance with Study Drug|0|||
128753311|NCT02807558|463386160|FG005|Overall Study|Non-compliance with Study Drug|0|||
128753312|NCT02807558|463386155|FG000|Overall Study|Adverse Event|0|||
128753313|NCT02807558|463386156|FG001|Overall Study|Adverse Event|0|||
128753314|NCT02807558|463386157|FG002|Overall Study|Adverse Event|9|||
128753315|NCT02807558|463386158|FG003|Overall Study|Adverse Event|0|||
128753316|NCT02807558|463386159|FG004|Overall Study|Adverse Event|0|||
128753317|NCT02807558|463386160|FG005|Overall Study|Adverse Event|0|||
128753318|NCT02807558|463386155|FG000|Overall Study|Death|23|||
128753319|NCT02807558|463386156|FG001|Overall Study|Death|2|||
128786188|NCT03394027|463509400|FG001|Overall Study|Ineligible|1|||
128786189|NCT03394027|463509401|FG002|Overall Study|Ineligible|3|||
128786190|NCT03394027|463509399|FG000|Overall Study|Participant declined to participate before treatment started|0|||
128786191|NCT03394027|463509400|FG001|Overall Study|Participant declined to participate before treatment started|0|||
128786192|NCT03394027|463509401|FG002|Overall Study|Participant declined to participate before treatment started|1|||
128786193|NCT02197234|463509402|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
128786194|NCT02197234|463509402|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
128786195|NCT02197234|463509402|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
128786196|NCT02197234|463509402|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
128786197|NCT02197234|463509402|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
128786198|NCT02197234|463509402|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
128786199|NCT01018511|463509404|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
128786200|NCT01018511|463509405|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
128786201|NCT01018511|463509406|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
128786202|NCT01018511|463509407|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
128786203|NCT01018511|463509404|FG000|Overall Study|Adverse Event|5|||
128786204|NCT01018511|463509405|FG001|Overall Study|Adverse Event|9|||
128786205|NCT01018511|463509406|FG002|Overall Study|Adverse Event|13|||
128786206|NCT01018511|463509407|FG003|Overall Study|Adverse Event|10|||
128786207|NCT01018511|463509404|FG000|Overall Study|Lack of Efficacy|4|||
128786208|NCT01018511|463509405|FG001|Overall Study|Lack of Efficacy|1|||
128786209|NCT01018511|463509406|FG002|Overall Study|Lack of Efficacy|1|||
128786210|NCT01018511|463509407|FG003|Overall Study|Lack of Efficacy|2|||
128753320|NCT02807558|463386157|FG002|Overall Study|Death|3|||
128753321|NCT02807558|463386158|FG003|Overall Study|Death|43|||
128753322|NCT02807558|463386159|FG004|Overall Study|Death|24|||
128753323|NCT02807558|463386160|FG005|Overall Study|Death|15|||
128753324|NCT02807558|463386155|FG000|Overall Study|Progressive Disease|0|||
128753325|NCT02807558|463386156|FG001|Overall Study|Progressive Disease|0|||
128753326|NCT02807558|463386157|FG002|Overall Study|Progressive Disease|1|||
128753327|NCT02807558|463386158|FG003|Overall Study|Progressive Disease|0|||
128753328|NCT02807558|463386159|FG004|Overall Study|Progressive Disease|0|||
128753329|NCT02807558|463386160|FG005|Overall Study|Progressive Disease|0|||
128753330|NCT02807558|463386155|FG000|Overall Study|Other than specified|1|||
129204417|NCT01384734|465045802|FG004|Overall Study|As per Exclusion criteria|0|||
129204418|NCT01384734|465045798|FG000|Overall Study|Missed End of treatment visit|0|||
128753331|NCT02807558|463386156|FG001|Overall Study|Other than specified|0|||
128753332|NCT02807558|463386157|FG002|Overall Study|Other than specified|2|||
128753333|NCT02807558|463386158|FG003|Overall Study|Other than specified|0|||
128753334|NCT02807558|463386159|FG004|Overall Study|Other than specified|1|||
128753335|NCT02807558|463386160|FG005|Overall Study|Other than specified|1|||
128753336|NCT02807558|463386155|FG000|Overall Study|Lack of Efficacy|0|||
128753337|NCT02807558|463386156|FG001|Overall Study|Lack of Efficacy|0|||
128753338|NCT02807558|463386157|FG002|Overall Study|Lack of Efficacy|9|||
128753339|NCT02807558|463386158|FG003|Overall Study|Lack of Efficacy|0|||
128753340|NCT02807558|463386159|FG004|Overall Study|Lack of Efficacy|0|||
128753341|NCT02807558|463386160|FG005|Overall Study|Lack of Efficacy|0|||
128753342|NCT04435366|463386161|FG000|Year 1 (12 Months)|Adverse Event|3|||
128753343|NCT04435366|463386162|FG001|Year 1 (12 Months)|Adverse Event|0|||
128753344|NCT04435366|463386163|FG002|Year 1 (12 Months)|Adverse Event|2|||
128753345|NCT04435366|463386161|FG000|Year 1 (12 Months)|Death|2|||
128753346|NCT04435366|463386162|FG001|Year 1 (12 Months)|Death|0|||
128753347|NCT04435366|463386163|FG002|Year 1 (12 Months)|Death|1|||
128753348|NCT04435366|463386161|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
128753349|NCT04435366|463386162|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
128753350|NCT04435366|463386163|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
128753351|NCT04435366|463386161|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
128753352|NCT04435366|463386162|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
128753353|NCT04435366|463386163|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
128753354|NCT04435366|463386161|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
128753355|NCT04435366|463386162|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
128753356|NCT04435366|463386163|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
128753357|NCT04435366|463386161|FG000|Year 1 (12 Months)|Not treated|0|||
128753358|NCT04435366|463386162|FG001|Year 1 (12 Months)|Not treated|0|||
128753359|NCT04435366|463386163|FG002|Year 1 (12 Months)|Not treated|1|||
128753360|NCT04435366|463386161|FG000|Year 2 (12 Months)|Death|1|||
128753361|NCT04435366|463386162|FG001|Year 2 (12 Months)|Death|4|||
128753362|NCT04435366|463386163|FG002|Year 2 (12 Months)|Death|6|||
128753363|NCT04435366|463386161|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
128753364|NCT04435366|463386162|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
128753365|NCT04435366|463386163|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
128753366|NCT04435366|463386161|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
128753367|NCT04435366|463386162|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
128753368|NCT04435366|463386163|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
128753369|NCT04435366|463386161|FG000|Year 2 (12 Months)|Adverse Event|2|||
128753370|NCT04435366|463386162|FG001|Year 2 (12 Months)|Adverse Event|1|||
128753371|NCT04435366|463386163|FG002|Year 2 (12 Months)|Adverse Event|6|||
128753372|NCT02477111|463386164|FG000|Overall Study|Death|28|||
128753373|NCT02477111|463386164|FG000|Overall Study|Withdrawal by Subject|19|||
128753374|NCT02477111|463386164|FG000|Overall Study|Lost to Follow-up|4|||
128753375|NCT03492281|463386168|FG000|Overall Study|Withdrawal by Subject|21|||
128753376|NCT03492281|463386169|FG001|Overall Study|Withdrawal by Subject|14|||
128753377|NCT03492281|463386170|FG002|Overall Study|Withdrawal by Subject|13|||
128753378|NCT03492281|463386168|FG000|Overall Study|Lost to Follow-up|14|||
128753379|NCT03492281|463386169|FG001|Overall Study|Lost to Follow-up|15|||
128753380|NCT03492281|463386170|FG002|Overall Study|Lost to Follow-up|10|||
128753381|NCT03492281|463386168|FG000|Overall Study|Adverse Event|6|||
128753382|NCT03492281|463386169|FG001|Overall Study|Adverse Event|8|||
128753383|NCT03492281|463386170|FG002|Overall Study|Adverse Event|13|||
128753384|NCT03492281|463386168|FG000|Overall Study|Lack of Efficacy|3|||
128753385|NCT03492281|463386169|FG001|Overall Study|Lack of Efficacy|0|||
128753386|NCT03492281|463386170|FG002|Overall Study|Lack of Efficacy|1|||
128753387|NCT03492281|463386168|FG000|Overall Study|Physician Decision|1|||
128753388|NCT03492281|463386169|FG001|Overall Study|Physician Decision|0|||
128753389|NCT03492281|463386170|FG002|Overall Study|Physician Decision|3|||
128753390|NCT03492281|463386168|FG000|Overall Study|Protocol Violation|0|||
128753391|NCT03492281|463386169|FG001|Overall Study|Protocol Violation|2|||
128753392|NCT03492281|463386170|FG002|Overall Study|Protocol Violation|1|||
128753393|NCT03492281|463386168|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
128753394|NCT03492281|463386169|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
128786211|NCT01018511|463509404|FG000|Overall Study|Withdrawal by Subject|6|||
128753395|NCT03492281|463386170|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
128753396|NCT03492281|463386168|FG000|Overall Study|Death|0|||
128753397|NCT03492281|463386169|FG001|Overall Study|Death|0|||
128753398|NCT03492281|463386170|FG002|Overall Study|Death|1|||
128753399|NCT03492281|463386168|FG000|Overall Study|Captured as Other in Database|8|||
128753400|NCT03492281|463386169|FG001|Overall Study|Captured as Other in Database|6|||
128753401|NCT03492281|463386170|FG002|Overall Study|Captured as Other in Database|3|||
128753402|NCT04575467|463386174|FG000|Overall Study|Adverse Event|0|||
128753403|NCT04575467|463386175|FG001|Overall Study|Adverse Event|1|||
128753404|NCT04575467|463386176|FG002|Overall Study|Adverse Event|0|||
129204419|NCT01384734|465045799|FG001|Overall Study|Missed End of treatment visit|0|||
128786212|NCT01018511|463509405|FG001|Overall Study|Withdrawal by Subject|5|||
128753405|NCT04575467|463386177|FG003|Overall Study|Adverse Event|0|||
128753406|NCT01328574|463386178|FG000|Overall Study|Refused further treatment|1|||
128753407|NCT01483924|463386179|FG000|Overall Study|Withdrawal by Subject|2|||
128753408|NCT01483924|463386180|FG001|Overall Study|Withdrawal by Subject|0|||
128753409|NCT01483924|463386181|FG002|Overall Study|Withdrawal by Subject|0|||
128753410|NCT01483924|463386182|FG003|Overall Study|Withdrawal by Subject|1|||
128753411|NCT01483924|463386183|FG004|Overall Study|Withdrawal by Subject|1|||
128753412|NCT01483924|463386179|FG000|Overall Study|Adverse Event|0|||
128753413|NCT01483924|463386180|FG001|Overall Study|Adverse Event|0|||
128753414|NCT01483924|463386181|FG002|Overall Study|Adverse Event|1|||
128753415|NCT01483924|463386182|FG003|Overall Study|Adverse Event|1|||
128753416|NCT01483924|463386183|FG004|Overall Study|Adverse Event|0|||
128753417|NCT01483924|463386179|FG000|Overall Study|Non-compliance|0|||
128753418|NCT01483924|463386180|FG001|Overall Study|Non-compliance|0|||
128753419|NCT01483924|463386181|FG002|Overall Study|Non-compliance|0|||
128753420|NCT01483924|463386182|FG003|Overall Study|Non-compliance|1|||
128753421|NCT01483924|463386183|FG004|Overall Study|Non-compliance|1|||
128753422|NCT01483924|463386179|FG000|Overall Study|Sponsor concern over ECG result|0|||
128753423|NCT01483924|463386180|FG001|Overall Study|Sponsor concern over ECG result|0|||
128753424|NCT01483924|463386181|FG002|Overall Study|Sponsor concern over ECG result|0|||
128753425|NCT01483924|463386182|FG003|Overall Study|Sponsor concern over ECG result|1|||
128753426|NCT01483924|463386183|FG004|Overall Study|Sponsor concern over ECG result|0|||
128753427|NCT03565887|463386191|FG000|Overall Study|Adverse Event|1|||
128753428|NCT03565887|463386192|FG001|Overall Study|Adverse Event|0|||
128753429|NCT03565887|463386191|FG000|Overall Study|Withdrawal by Subject|0|||
128753430|NCT03565887|463386192|FG001|Overall Study|Withdrawal by Subject|2|||
128753431|NCT01994954|463386194|FG000|Overall Study|Death|1|||
128753432|NCT01994954|463386195|FG001|Overall Study|Death|0|||
128753433|NCT01994954|463386194|FG000|Overall Study|Withdrawal by Subject|9|||
128753434|NCT01994954|463386195|FG001|Overall Study|Withdrawal by Subject|14|||
128753435|NCT01994954|463386194|FG000|Overall Study|Physician Decision|2|||
128753436|NCT01994954|463386195|FG001|Overall Study|Physician Decision|2|||
128753437|NCT01994954|463386194|FG000|Overall Study|Lost to Follow-up|8|||
128753438|NCT01994954|463386195|FG001|Overall Study|Lost to Follow-up|10|||
128753439|NCT01994954|463386194|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
128753440|NCT01994954|463386195|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
128753441|NCT00449176|463386196|FG000|Overall Study|Withdrawal by Subject|39|||
128753442|NCT00449176|463386197|FG001|Overall Study|Withdrawal by Subject|43|||
128753443|NCT00449176|463386198|FG002|Overall Study|Withdrawal by Subject|59|||
128753444|NCT00449176|463386196|FG000|Overall Study|Lost to Follow-up|13|||
128753445|NCT00449176|463386197|FG001|Overall Study|Lost to Follow-up|8|||
128753446|NCT00449176|463386198|FG002|Overall Study|Lost to Follow-up|12|||
128753447|NCT00449176|463386196|FG000|Overall Study|Adverse Event|51|||
128753448|NCT00449176|463386197|FG001|Overall Study|Adverse Event|107|||
128753449|NCT00449176|463386198|FG002|Overall Study|Adverse Event|15|||
128753450|NCT00449176|463386196|FG000|Overall Study|Lack of Efficacy|13|||
128753451|NCT00449176|463386197|FG001|Overall Study|Lack of Efficacy|7|||
128753452|NCT00449176|463386198|FG002|Overall Study|Lack of Efficacy|50|||
128753453|NCT00449176|463386196|FG000|Overall Study|Study drug non-compliant|14|||
128753454|NCT00449176|463386197|FG001|Overall Study|Study drug non-compliant|11|||
128753455|NCT00449176|463386198|FG002|Overall Study|Study drug non-compliant|11|||
128753456|NCT00449176|463386196|FG000|Overall Study|all other|22|||
128753457|NCT00449176|463386197|FG001|Overall Study|all other|19|||
128753458|NCT00449176|463386198|FG002|Overall Study|all other|20|||
128753459|NCT01454583|463386205|FG000|1st Year|Lost to Follow-up|1057|||
128753460|NCT01454583|463386206|FG001|1st Year|Lost to Follow-up|318|||
128753461|NCT01454583|463386207|FG002|1st Year|Lost to Follow-up|180|||
128753462|NCT01454583|463386205|FG000|2nd Year|Lost to Follow-up|3965|||
128753463|NCT01454583|463386206|FG001|2nd Year|Lost to Follow-up|1049|||
128753464|NCT01454583|463386207|FG002|2nd Year|Lost to Follow-up|737|||
128753465|NCT01454583|463386205|FG000|3rd Year|Lost to Follow-up|1959|||
128753466|NCT01454583|463386206|FG001|3rd Year|Lost to Follow-up|512|||
128753467|NCT01454583|463386207|FG002|3rd Year|Lost to Follow-up|297|||
128753468|NCT02677116|463386210|FG000|Overall Study|Adverse Event|0|||
128753469|NCT02677116|463386211|FG001|Overall Study|Adverse Event|1|||
128753470|NCT02677116|463386212|FG002|Overall Study|Adverse Event|0|||
128753471|NCT02677116|463386213|FG003|Overall Study|Adverse Event|0|||
128753472|NCT02677116|463386214|FG004|Overall Study|Adverse Event|0|||
128753473|NCT02677116|463386215|FG005|Overall Study|Adverse Event|1|||
128753474|NCT02677116|463386216|FG006|Overall Study|Adverse Event|1|||
128753475|NCT02677116|463386217|FG007|Overall Study|Adverse Event|0|||
128753476|NCT02677116|463386218|FG008|Overall Study|Adverse Event|0|||
128753477|NCT02677116|463386210|FG000|Overall Study|Physician Decision|0|||
128753478|NCT02677116|463386211|FG001|Overall Study|Physician Decision|2|||
128753479|NCT02677116|463386212|FG002|Overall Study|Physician Decision|3|||
128753480|NCT02677116|463386213|FG003|Overall Study|Physician Decision|2|||
128753481|NCT02677116|463386214|FG004|Overall Study|Physician Decision|1|||
128753482|NCT02677116|463386215|FG005|Overall Study|Physician Decision|3|||
128786213|NCT01018511|463509406|FG002|Overall Study|Withdrawal by Subject|11|||
128786214|NCT01018511|463509407|FG003|Overall Study|Withdrawal by Subject|9|||
128786215|NCT01018511|463509404|FG000|Overall Study|Lost to Follow-up|0|||
128786216|NCT01018511|463509405|FG001|Overall Study|Lost to Follow-up|0|||
128786217|NCT01018511|463509406|FG002|Overall Study|Lost to Follow-up|1|||
128786218|NCT01018511|463509407|FG003|Overall Study|Lost to Follow-up|0|||
128786219|NCT01018511|463509404|FG000|Overall Study|Protocol Violation|5|||
128786220|NCT01018511|463509405|FG001|Overall Study|Protocol Violation|8|||
128786221|NCT01018511|463509406|FG002|Overall Study|Protocol Violation|7|||
128786222|NCT01018511|463509407|FG003|Overall Study|Protocol Violation|9|||
128786223|NCT01018511|463509404|FG000|Overall Study|Miscellaneous|0|||
128786224|NCT01018511|463509405|FG001|Overall Study|Miscellaneous|2|||
128786225|NCT01018511|463509406|FG002|Overall Study|Miscellaneous|0|||
128786226|NCT01018511|463509407|FG003|Overall Study|Miscellaneous|0|||
128786227|NCT04523181|463509408|FG000|Overall Study|Withdrawal by Subject|4|||
128786228|NCT04523181|463509409|FG001|Overall Study|Withdrawal by Subject|5|||
128786229|NCT04523181|463509408|FG000|Overall Study|Lost to Follow-up|2|||
128786230|NCT04523181|463509409|FG001|Overall Study|Lost to Follow-up|3|||
128786231|NCT04523181|463509408|FG000|Overall Study|Physician Decision|1|||
128786232|NCT04523181|463509409|FG001|Overall Study|Physician Decision|0|||
128786233|NCT04523181|463509408|FG000|Overall Study|Transferred to external facility.|1|||
128786234|NCT04523181|463509409|FG001|Overall Study|Transferred to external facility.|1|||
128786235|NCT04550039|463509410|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
128786236|NCT04550039|463509411|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
128786237|NCT04550039|463509410|FG000|Overall Study|patient self-withdrew from study|0|||
128786238|NCT04550039|463509411|FG001|Overall Study|patient self-withdrew from study|1|||
128786239|NCT04391309|463509412|FG000|Overall Study|Death|1|||
128786240|NCT04391309|463509413|FG001|Overall Study|Death|1|||
128786241|NCT04391309|463509412|FG000|Overall Study|Lost to Follow-up|3|||
128786242|NCT04391309|463509413|FG001|Overall Study|Lost to Follow-up|2|||
128786243|NCT04391309|463509412|FG000|Overall Study|Withdrawal by Subject|2|||
128786244|NCT04391309|463509413|FG001|Overall Study|Withdrawal by Subject|2|||
128786245|NCT03822351|463509423|FG000|Overall Study|Death|27|||
128786246|NCT03822351|463509424|FG001|Overall Study|Death|23|||
128786247|NCT03822351|463509425|FG002|Overall Study|Death|24|||
128786248|NCT03822351|463509423|FG000|Overall Study|Lost to Follow-up|6|||
128786249|NCT03822351|463509424|FG001|Overall Study|Lost to Follow-up|2|||
128786250|NCT03822351|463509425|FG002|Overall Study|Lost to Follow-up|1|||
128786251|NCT03822351|463509423|FG000|Overall Study|Withdrawal by Subject|10|||
128786252|NCT03822351|463509424|FG001|Overall Study|Withdrawal by Subject|4|||
128786253|NCT03822351|463509425|FG002|Overall Study|Withdrawal by Subject|6|||
128786254|NCT03822351|463509423|FG000|Overall Study|Progressive Disease|2|||
128786255|NCT03822351|463509424|FG001|Overall Study|Progressive Disease|1|||
128786256|NCT03822351|463509425|FG002|Overall Study|Progressive Disease|0|||
128786257|NCT03822351|463509423|FG000|Overall Study|Not Treated|1|||
128786258|NCT03822351|463509424|FG001|Overall Study|Not Treated|1|||
128786259|NCT03822351|463509425|FG002|Overall Study|Not Treated|1|||
128786260|NCT00462943|463509426|FG000|Overall Study|Failure to achieve a response|5|||
128786261|NCT00462943|463509427|FG001|Overall Study|Failure to achieve a response|5|||
128786262|NCT00462943|463509428|FG002|Overall Study|Failure to achieve a response|1|||
128786263|NCT00462943|463509426|FG000|Overall Study|Adverse Event|6|||
128786264|NCT00462943|463509427|FG001|Overall Study|Adverse Event|4|||
128786265|NCT00462943|463509428|FG002|Overall Study|Adverse Event|1|||
128786266|NCT00462943|463509426|FG000|Overall Study|Protocol Violation|1|||
128786267|NCT00462943|463509427|FG001|Overall Study|Protocol Violation|0|||
128786268|NCT00462943|463509428|FG002|Overall Study|Protocol Violation|0|||
128753483|NCT02677116|463386216|FG006|Overall Study|Physician Decision|1|||
128753484|NCT02677116|463386217|FG007|Overall Study|Physician Decision|1|||
128753485|NCT02677116|463386218|FG008|Overall Study|Physician Decision|2|||
128753486|NCT02677116|463386210|FG000|Overall Study|Withdrawal by parent or guardian|2|||
128753487|NCT02677116|463386211|FG001|Overall Study|Withdrawal by parent or guardian|1|||
128753488|NCT02677116|463386212|FG002|Overall Study|Withdrawal by parent or guardian|0|||
128753489|NCT02677116|463386213|FG003|Overall Study|Withdrawal by parent or guardian|1|||
128753490|NCT02677116|463386214|FG004|Overall Study|Withdrawal by parent or guardian|0|||
128753491|NCT02677116|463386215|FG005|Overall Study|Withdrawal by parent or guardian|0|||
128753492|NCT02677116|463386216|FG006|Overall Study|Withdrawal by parent or guardian|2|||
128753493|NCT02677116|463386217|FG007|Overall Study|Withdrawal by parent or guardian|1|||
128753494|NCT02677116|463386218|FG008|Overall Study|Withdrawal by parent or guardian|0|||
128753495|NCT02677116|463386210|FG000|Overall Study|Withdrawal by Subject|1|||
128753496|NCT02677116|463386211|FG001|Overall Study|Withdrawal by Subject|0|||
128753497|NCT02677116|463386212|FG002|Overall Study|Withdrawal by Subject|0|||
128753498|NCT02677116|463386213|FG003|Overall Study|Withdrawal by Subject|0|||
128753499|NCT02677116|463386214|FG004|Overall Study|Withdrawal by Subject|0|||
128753500|NCT02677116|463386215|FG005|Overall Study|Withdrawal by Subject|0|||
128753501|NCT02677116|463386216|FG006|Overall Study|Withdrawal by Subject|0|||
128753502|NCT02677116|463386217|FG007|Overall Study|Withdrawal by Subject|0|||
128753503|NCT02677116|463386218|FG008|Overall Study|Withdrawal by Subject|0|||
128753504|NCT03182868|463386219|FG000|Overall Study|Protocol Violation|3|||
128753505|NCT03182868|463386220|FG001|Overall Study|Protocol Violation|0|||
128753506|NCT03182868|463386221|FG002|Overall Study|Protocol Violation|4|||
128753507|NCT03182868|463386222|FG003|Overall Study|Protocol Violation|1|||
128753508|NCT03182868|463386223|FG004|Overall Study|Protocol Violation|8|||
128753509|NCT02363946|463386225|FG000|Overall Study|Lost to Follow-up|0|||
128753510|NCT02363946|463386226|FG001|Overall Study|Lost to Follow-up|0|||
128753511|NCT02363946|463386227|FG002|Overall Study|Lost to Follow-up|0|||
128753512|NCT02363946|463386228|FG003|Overall Study|Lost to Follow-up|0|||
128753513|NCT02363946|463386229|FG004|Overall Study|Lost to Follow-up|0|||
128753514|NCT02363946|463386230|FG005|Overall Study|Lost to Follow-up|0|||
128753515|NCT02363946|463386231|FG006|Overall Study|Lost to Follow-up|0|||
128753516|NCT02363946|463386232|FG007|Overall Study|Lost to Follow-up|1|||
128753517|NCT02363946|463386233|FG008|Overall Study|Lost to Follow-up|0|||
128753518|NCT02363946|463386234|FG009|Overall Study|Lost to Follow-up|0|||
128753519|NCT02363946|463386235|FG010|Overall Study|Lost to Follow-up|0|||
128753520|NCT02363946|463386236|FG011|Overall Study|Lost to Follow-up|0|||
128753521|NCT02363946|463386237|FG012|Overall Study|Lost to Follow-up|0|||
128753522|NCT01967732|463386238|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
128753523|NCT01967732|463386239|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
128753524|NCT01967732|463386240|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
128753525|NCT01967732|463386241|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
128753526|NCT01967732|463386238|FG000|First Intervention (Day 1)|Poor venous access|0|||
128753527|NCT01967732|463386239|FG001|First Intervention (Day 1)|Poor venous access|1|||
128753528|NCT01967732|463386240|FG002|First Intervention (Day 1)|Poor venous access|0|||
128753529|NCT01967732|463386241|FG003|First Intervention (Day 1)|Poor venous access|0|||
128753530|NCT03342638|463386242|FG000|Overall Study|Withdrawal by Subject|1|||
128753531|NCT03342638|463386243|FG001|Overall Study|Withdrawal by Subject|0|||
128753532|NCT03342638|463386242|FG000|Overall Study|Physician Decision|0|||
128753533|NCT03342638|463386243|FG001|Overall Study|Physician Decision|1|||
128753534|NCT01292239|463386259|FG000|Overall Study|Other|1|||
128753535|NCT01292239|463386260|FG001|Overall Study|Other|1|||
128753536|NCT01292239|463386259|FG000|Overall Study|Withdrawal by Subject|3|||
128753537|NCT01292239|463386260|FG001|Overall Study|Withdrawal by Subject|6|||
128753538|NCT00113568|463386261|FG000|Overall Study|Adverse Event|97|||
128753539|NCT00113568|463386261|FG000|Overall Study|Death|1|||
128753540|NCT00113568|463386261|FG000|Overall Study|Lack of Efficacy|30|||
128753541|NCT00113568|463386261|FG000|Overall Study|Lost to Follow-up|156|||
128753542|NCT00113568|463386261|FG000|Overall Study|Protocol Violation|32|||
128753543|NCT00113568|463386261|FG000|Overall Study|Withdrawal by Subject|117|||
128753544|NCT00113568|463386261|FG000|Overall Study|Other|112|||
128753545|NCT00262821|463386262|FG000|Overall Study|Ineligible - wrong stage|0|||
128753546|NCT00262821|463386263|FG001|Overall Study|Ineligible - wrong stage|3|||
128753547|NCT00262821|463386262|FG000|Overall Study|Ineligible - wrong cell type|2|||
128753548|NCT00262821|463386263|FG001|Overall Study|Ineligible - wrong cell type|2|||
128753549|NCT00262821|463386262|FG000|Overall Study|Ineligible - wrong primary|0|||
128753550|NCT00262821|463386263|FG001|Overall Study|Ineligible - wrong primary|1|||
128753551|NCT00262821|463386262|FG000|Overall Study|Ineligible - inadequate pathology|1|||
128753552|NCT00262821|463386263|FG001|Overall Study|Ineligible - inadequate pathology|3|||
128753553|NCT00262821|463386262|FG000|Overall Study|Ineligible - elevated creatinine|0|||
128753554|NCT00262821|463386263|FG001|Overall Study|Ineligible - elevated creatinine|2|||
128753555|NCT00262821|463386262|FG000|Overall Study|Ineligible - required test not done|1|||
128753556|NCT00262821|463386263|FG001|Overall Study|Ineligible - required test not done|4|||
128753557|NCT00262821|463386262|FG000|Overall Study|Inevaluable - inadequate data|0|||
128753558|NCT00262821|463386263|FG001|Overall Study|Inevaluable - inadequate data|4|||
128753559|NCT01988779|463386265|FG000|Overall Study|Withdrawal by Subject|2|||
128753560|NCT01988779|463386266|FG001|Overall Study|Withdrawal by Subject|2|||
128753561|NCT01988779|463386265|FG000|Overall Study|Protocol Violation|1|||
128753562|NCT01988779|463386266|FG001|Overall Study|Protocol Violation|0|||
128753563|NCT00584727|463386267|FG000|First Intervention|Discontinuation|0|||
128753564|NCT00584727|463386268|FG001|First Intervention|Discontinuation|0|||
128753565|NCT00584727|463386269|FG002|First Intervention|Discontinuation|1|||
128753566|NCT00584727|463386270|FG003|First Intervention|Discontinuation|0|||
128753567|NCT00584727|463386271|FG004|First Intervention|Discontinuation|0|||
128753568|NCT00584727|463386272|FG005|First Intervention|Discontinuation|0|||
128753569|NCT00584727|463386267|FG000|Third Intervention|Protocol Violation|0|||
128753570|NCT00584727|463386268|FG001|Third Intervention|Protocol Violation|0|||
128753571|NCT00584727|463386269|FG002|Third Intervention|Protocol Violation|1|||
128753572|NCT00584727|463386270|FG003|Third Intervention|Protocol Violation|0|||
128753573|NCT00584727|463386271|FG004|Third Intervention|Protocol Violation|4|||
128753574|NCT00584727|463386272|FG005|Third Intervention|Protocol Violation|2|||
128753575|NCT00377403|463386274|FG000|Overall Study|Unable to contact for telephone intervie|4|||
128753576|NCT00377403|463386275|FG001|Overall Study|Unable to contact for telephone intervie|7|||
128753577|NCT01922076|463386276|FG000|Overall Study|Adverse Event|0|||
128753578|NCT01922076|463386277|FG001|Overall Study|Adverse Event|0|||
128753579|NCT01922076|463386278|FG002|Overall Study|Adverse Event|0|||
128753580|NCT01922076|463386279|FG003|Overall Study|Adverse Event|0|||
128753581|NCT01922076|463386280|FG004|Overall Study|Adverse Event|1|||
128753582|NCT01922076|463386281|FG005|Overall Study|Adverse Event|0|||
128753583|NCT01922076|463386282|FG006|Overall Study|Adverse Event|0|||
128753584|NCT01922076|463386276|FG000|Overall Study|Physician Decision|0|||
128753585|NCT01922076|463386277|FG001|Overall Study|Physician Decision|0|||
128753586|NCT01922076|463386278|FG002|Overall Study|Physician Decision|1|||
128753587|NCT01922076|463386279|FG003|Overall Study|Physician Decision|0|||
128753588|NCT01922076|463386280|FG004|Overall Study|Physician Decision|0|||
128753589|NCT01922076|463386281|FG005|Overall Study|Physician Decision|0|||
128753590|NCT01922076|463386282|FG006|Overall Study|Physician Decision|0|||
128753591|NCT01922076|463386276|FG000|Overall Study|Withdrawal by Subject|0|||
128753592|NCT01922076|463386277|FG001|Overall Study|Withdrawal by Subject|0|||
128753593|NCT01922076|463386278|FG002|Overall Study|Withdrawal by Subject|0|||
128753594|NCT01922076|463386279|FG003|Overall Study|Withdrawal by Subject|1|||
128753595|NCT01922076|463386280|FG004|Overall Study|Withdrawal by Subject|0|||
128753596|NCT01922076|463386281|FG005|Overall Study|Withdrawal by Subject|1|||
128753597|NCT01922076|463386282|FG006|Overall Study|Withdrawal by Subject|1|||
128753598|NCT01018394|463386285|FG000|Overall Study|Withdrawal by Subject|5|||
128753599|NCT01018394|463386286|FG001|Overall Study|Withdrawal by Subject|5|||
128753600|NCT01018394|463386285|FG000|Overall Study|Lost to Follow-up|4|||
128753601|NCT01018394|463386286|FG001|Overall Study|Lost to Follow-up|3|||
128753602|NCT00683644|463386287|FG000|Overall Study|Withdrawal by Subject|4|||
128753603|NCT00683644|463386288|FG001|Overall Study|Withdrawal by Subject|2|||
128753604|NCT00683644|463386287|FG000|Overall Study|Lost to Follow-up|1|||
128753605|NCT00683644|463386288|FG001|Overall Study|Lost to Follow-up|4|||
128753606|NCT00683644|463386287|FG000|Overall Study|Adverse Event|1|||
128753607|NCT00683644|463386288|FG001|Overall Study|Adverse Event|2|||
128753608|NCT00683644|463386287|FG000|Overall Study|Low copper, other health problems,|7|||
128753609|NCT00683644|463386288|FG001|Overall Study|Low copper, other health problems,|6|||
128753610|NCT01669122|463386289|FG000|Period I|Lost to Follow-up|1|||
128753611|NCT01669122|463386289|FG000|Washout Period II|Protocol Violation|2|||
128753612|NCT03762473|463386290|FG000|Overall Study|Death|1|||
128753613|NCT03762473|463386291|FG001|Overall Study|Death|0|||
128753614|NCT05132699|463386292|FG000|Overall Study|Withdrawal by Subject|3|||
128753615|NCT05132699|463386293|FG001|Overall Study|Withdrawal by Subject|0|||
128753616|NCT02858895|463386296|FG000|Overall Study|Disease progression|31|||
128753617|NCT02858895|463386296|FG000|Overall Study|Death|2|||
128753618|NCT02858895|463386296|FG000|Overall Study|Adverse Event|1|||
128753619|NCT02858895|463386296|FG000|Overall Study|Withdrawal by Subject|3|||
128753620|NCT02858895|463386296|FG000|Overall Study|hospice,|1|||
128753621|NCT02858895|463386296|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
128753622|NCT02277444|463386308|FG000|Overall Study|Adverse Event|10|||
128753623|NCT02277444|463386308|FG000|Overall Study|Withdrawal by Subject|3|||
128753624|NCT02277444|463386308|FG000|Overall Study|Other|1|||
128753625|NCT02277444|463386308|FG000|Overall Study|Enrolled and not Treated|3|||
128753626|NCT02277444|463386308|FG000|Overall Study|Ongoing|113|||
128753627|NCT02160314|463388582|FG000|Overall Study|Adverse Event|0|||
128753628|NCT02160314|463388583|FG001|Overall Study|Adverse Event|6|||
128753629|NCT02160314|463388582|FG000|Overall Study|Protocol Violation|0|||
128753630|NCT02160314|463388583|FG001|Overall Study|Protocol Violation|4|||
128753631|NCT02160314|463388582|FG000|Overall Study|Withdrawal by Subject|1|||
128753632|NCT02160314|463388583|FG001|Overall Study|Withdrawal by Subject|2|||
128753633|NCT02160314|463388582|FG000|Overall Study|Lost to Follow-up|0|||
128753634|NCT02160314|463388583|FG001|Overall Study|Lost to Follow-up|1|||
128753635|NCT00593567|463388587|FG000|Overall Study|Adverse Event|2|||
128753636|NCT00593567|463388588|FG001|Overall Study|Adverse Event|0|||
128753637|NCT00593567|463388587|FG000|Overall Study|Physician Decision|2|||
128753638|NCT00593567|463388588|FG001|Overall Study|Physician Decision|0|||
128753639|NCT00593567|463388587|FG000|Overall Study|Protocol Violation|13|||
128753640|NCT00593567|463388588|FG001|Overall Study|Protocol Violation|7|||
128753641|NCT00593567|463388587|FG000|Overall Study|Lack of Efficacy|2|||
128753642|NCT00593567|463388588|FG001|Overall Study|Lack of Efficacy|1|||
128753643|NCT00593567|463388587|FG000|Overall Study|Withdrawal by Subject|1|||
128753644|NCT00593567|463388588|FG001|Overall Study|Withdrawal by Subject|2|||
128753645|NCT00785291|463388589|FG000|Overall Study|Never began treatment|8|||
128753646|NCT00785291|463388590|FG001|Overall Study|Never began treatment|4|||
128753647|NCT00785291|463388591|FG002|Overall Study|Never began treatment|4|||
128753648|NCT00785291|463388589|FG000|Overall Study|Adverse Event|39|||
128753649|NCT00785291|463388590|FG001|Overall Study|Adverse Event|70|||
128753650|NCT00785291|463388591|FG002|Overall Study|Adverse Event|56|||
128753651|NCT00785291|463388589|FG000|Overall Study|Death|7|||
128753652|NCT00785291|463388590|FG001|Overall Study|Death|4|||
128753653|NCT00785291|463388591|FG002|Overall Study|Death|3|||
128753654|NCT00785291|463388589|FG000|Overall Study|Withdrawal by Subject|35|||
128753655|NCT00785291|463388590|FG001|Overall Study|Withdrawal by Subject|36|||
128753656|NCT00785291|463388591|FG002|Overall Study|Withdrawal by Subject|17|||
128753657|NCT00785291|463388589|FG000|Overall Study|Alternative Therapy|12|||
128753658|NCT00785291|463388590|FG001|Overall Study|Alternative Therapy|6|||
128753659|NCT00785291|463388591|FG002|Overall Study|Alternative Therapy|7|||
128753660|NCT00785291|463388589|FG000|Overall Study|Complicating illness|6|||
128753661|NCT00785291|463388590|FG001|Overall Study|Complicating illness|4|||
128753662|NCT00785291|463388591|FG002|Overall Study|Complicating illness|4|||
128753663|NCT00785291|463388589|FG000|Overall Study|Other Medical Reasons|29|||
128753664|NCT00785291|463388590|FG001|Overall Study|Other Medical Reasons|25|||
128753665|NCT00785291|463388591|FG002|Overall Study|Other Medical Reasons|15|||
128753666|NCT00570674|463388592|FG000|Overall Study|Withdrawal by Subject|0|||
128753667|NCT00570674|463388593|FG001|Overall Study|Withdrawal by Subject|0|||
128753668|NCT00570674|463388594|FG002|Overall Study|Withdrawal by Subject|1|||
128753669|NCT00570674|463388595|FG003|Overall Study|Withdrawal by Subject|0|||
128753670|NCT00570674|463388596|FG004|Overall Study|Withdrawal by Subject|0|||
128753671|NCT00570674|463388597|FG005|Overall Study|Withdrawal by Subject|0|||
128753672|NCT00570674|463388598|FG006|Overall Study|Withdrawal by Subject|0|||
128753673|NCT02979639|463388599|FG000|Overall Study|Withdrawal based on medical judgement|1|||
128753674|NCT02979639|463388599|FG000|Overall Study|Lost to Follow-up|8|||
128753675|NCT02979639|463388599|FG000|Overall Study|Withdrawal by Subject|3|||
128753676|NCT02979639|463388599|FG000|Overall Study|Adverse Event|2|||
128753677|NCT04050865|463388602|FG000|Overall Study|Adverse Event|1|||
128753678|NCT04050865|463388603|FG001|Overall Study|Adverse Event|0|||
128753679|NCT04050865|463388602|FG000|Overall Study|no insert|1|||
128753680|NCT04050865|463388603|FG001|Overall Study|no insert|0|||
128753681|NCT04050865|463388602|FG000|Overall Study|Only 1 insert|2|||
128753682|NCT04050865|463388603|FG001|Overall Study|Only 1 insert|3|||
128753683|NCT04050865|463388602|FG000|Overall Study|Physician Decision|0|||
128753684|NCT04050865|463388603|FG001|Overall Study|Physician Decision|1|||
128753685|NCT04050865|463388602|FG000|Overall Study|Withdrawal by Subject|0|||
128753686|NCT04050865|463388603|FG001|Overall Study|Withdrawal by Subject|1|||
128753687|NCT04205630|463388608|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
128753688|NCT04205630|463388608|FG000|Overall Study|Disease clinical progression|7|||
128753689|NCT04205630|463388608|FG000|Overall Study|Withdrawal by Subject|2|||
128753690|NCT04205630|463388608|FG000|Overall Study|Adverse Event|17|||
128753691|NCT04205630|463388608|FG000|Overall Study|Other|1|||
128753692|NCT01597050|463388612|FG000|Overall Study|Withdrawal by Subject|1|||
128753693|NCT01597050|463388613|FG001|Overall Study|Withdrawal by Subject|0|||
129204420|NCT01384734|465045800|FG002|Overall Study|Missed End of treatment visit|0|||
129204421|NCT01384734|465045801|FG003|Overall Study|Missed End of treatment visit|1|||
129204422|NCT01384734|465045802|FG004|Overall Study|Missed End of treatment visit|0|||
129204423|NCT01384734|465045798|FG000|Overall Study|Adhesion problem|0|||
129204424|NCT01384734|465045799|FG001|Overall Study|Adhesion problem|0|||
129204425|NCT01384734|465045800|FG002|Overall Study|Adhesion problem|0|||
129204426|NCT01384734|465045801|FG003|Overall Study|Adhesion problem|1|||
129204427|NCT01384734|465045802|FG004|Overall Study|Adhesion problem|0|||
129204428|NCT01384734|465045798|FG000|Overall Study|Early termination|0|||
129204429|NCT01384734|465045799|FG001|Overall Study|Early termination|0|||
129204430|NCT01384734|465045800|FG002|Overall Study|Early termination|0|||
129204431|NCT01384734|465045801|FG003|Overall Study|Early termination|0|||
129204432|NCT01384734|465045802|FG004|Overall Study|Early termination|1|||
129204433|NCT01384734|465045798|FG000|Overall Study|Physician Decision|1|||
129204434|NCT01384734|465045799|FG001|Overall Study|Physician Decision|0|||
129204435|NCT01384734|465045800|FG002|Overall Study|Physician Decision|0|||
129204436|NCT01384734|465045801|FG003|Overall Study|Physician Decision|0|||
129204437|NCT01384734|465045802|FG004|Overall Study|Physician Decision|0|||
129204438|NCT01290523|465045803|FG000|Overall Study|Death|3|||
129204439|NCT03071263|465045804|FG000|Overall Study|Adverse Event|1|||
129204440|NCT03071263|465045805|FG001|Overall Study|Adverse Event|3|||
129204441|NCT03071263|465045804|FG000|Overall Study|Withdrawal by Subject|1|||
129204442|NCT03071263|465045805|FG001|Overall Study|Withdrawal by Subject|3|||
129204443|NCT03071263|465045804|FG000|Overall Study|Physician Decision|1|||
129204444|NCT03071263|465045805|FG001|Overall Study|Physician Decision|0|||
129204445|NCT03071263|465045804|FG000|Overall Study|Participant moved to another city|0|||
129204446|NCT03071263|465045805|FG001|Overall Study|Participant moved to another city|1|||
129204447|NCT01917747|465045806|FG000|Overall Study|Withdrawal by Subject|1|||
129204448|NCT01917747|465045807|FG001|Overall Study|Withdrawal by Subject|2|||
128753694|NCT01292876|463388614|FG000|Overall Study|Physician Decision|4|||
128753695|NCT02219048|463388618|FG000|Overall Study|Adverse Event|2|||
128753696|NCT02219048|463388619|FG001|Overall Study|Adverse Event|5|||
128753697|NCT02219048|463388618|FG000|Overall Study|No longer meets eligibility criteria|1|||
128753698|NCT02219048|463388619|FG001|Overall Study|No longer meets eligibility criteria|0|||
128753699|NCT02219048|463388618|FG000|Overall Study|Study terminated by sponsor|16|||
128753700|NCT02219048|463388619|FG001|Overall Study|Study terminated by sponsor|15|||
128753701|NCT02219048|463388618|FG000|Overall Study|Withdrawal by Subject|2|||
128753702|NCT02219048|463388619|FG001|Overall Study|Withdrawal by Subject|0|||
128753703|NCT02219048|463388618|FG000|Overall Study|Other|0|||
128753704|NCT02219048|463388619|FG001|Overall Study|Other|1|||
128753705|NCT04794803|463388620|FG000|Overall Study|Death|1|||
128753706|NCT04794803|463388621|FG001|Overall Study|Death|3|||
128753707|NCT04794803|463388620|FG000|Overall Study|Lost to Follow-up|2|||
128753708|NCT04794803|463388621|FG001|Overall Study|Lost to Follow-up|2|||
129204449|NCT01917747|465045806|FG000|Overall Study|Lost to Follow-up|18|||
128753709|NCT04794803|463388620|FG000|Overall Study|Withdrawal by Subject|1|||
128753710|NCT04794803|463388621|FG001|Overall Study|Withdrawal by Subject|0|||
128753711|NCT04794803|463388620|FG000|Overall Study|Physician Decision|1|||
128753712|NCT04794803|463388621|FG001|Overall Study|Physician Decision|1|||
128753713|NCT04794803|463388620|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
128753714|NCT04794803|463388621|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
128753715|NCT04794803|463388620|FG000|Overall Study|Refused to continue the treatment|1|||
129204450|NCT01917747|465045807|FG001|Overall Study|Lost to Follow-up|9|||
129204451|NCT00152503|465045809|FG000|Overall Study|Adverse Event|4|||
129204452|NCT02922725|465045810|FG000|Overall Study|Withdrawal by Subject|1|||
129204453|NCT02922725|465045811|FG001|Overall Study|Withdrawal by Subject|0|||
128786269|NCT00462943|463509426|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
128786270|NCT00462943|463509427|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
128786271|NCT00462943|463509428|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
128786272|NCT00462943|463509426|FG000|Overall Study|Disease Progression|15|||
128786273|NCT00462943|463509427|FG001|Overall Study|Disease Progression|15|||
128786274|NCT00462943|463509428|FG002|Overall Study|Disease Progression|9|||
128786275|NCT00462943|463509426|FG000|Overall Study|Death|5|||
128786276|NCT00462943|463509427|FG001|Overall Study|Death|2|||
128786277|NCT00462943|463509428|FG002|Overall Study|Death|7|||
128786278|NCT00462943|463509426|FG000|Overall Study|Stem Cell Transplant|1|||
128786279|NCT00462943|463509427|FG001|Overall Study|Stem Cell Transplant|1|||
128786280|NCT00462943|463509428|FG002|Overall Study|Stem Cell Transplant|0|||
128786281|NCT00462943|463509426|FG000|Overall Study|Bone Marrow Transplant|1|||
128786282|NCT00462943|463509427|FG001|Overall Study|Bone Marrow Transplant|0|||
128786283|NCT00462943|463509428|FG002|Overall Study|Bone Marrow Transplant|0|||
128786284|NCT00462943|463509426|FG000|Overall Study|Required Lymphocyte Infusion|1|||
128786285|NCT00462943|463509427|FG001|Overall Study|Required Lymphocyte Infusion|0|||
128786286|NCT00462943|463509428|FG002|Overall Study|Required Lymphocyte Infusion|0|||
128786287|NCT00462943|463509426|FG000|Overall Study|Transplant - not specified|1|||
128786288|NCT00462943|463509427|FG001|Overall Study|Transplant - not specified|0|||
128786289|NCT00462943|463509428|FG002|Overall Study|Transplant - not specified|1|||
128786290|NCT00462943|463509426|FG000|Overall Study|Physician Decision|1|||
128786291|NCT00462943|463509427|FG001|Overall Study|Physician Decision|0|||
128786292|NCT00462943|463509428|FG002|Overall Study|Physician Decision|0|||
128786293|NCT00462943|463509426|FG000|Overall Study|Withdrawal by Subject|0|||
128786294|NCT00462943|463509427|FG001|Overall Study|Withdrawal by Subject|1|||
128786295|NCT00462943|463509428|FG002|Overall Study|Withdrawal by Subject|0|||
128786296|NCT00813488|463509432|FG000|Titration Period 1|Adverse Event|6|||
128786297|NCT00813488|463509433|FG001|Titration Period 1|Adverse Event|1|||
128786298|NCT00813488|463509432|FG000|Titration Period 1|Lack of Efficacy|9|||
128786299|NCT00813488|463509433|FG001|Titration Period 1|Lack of Efficacy|7|||
128786300|NCT00813488|463509432|FG000|Titration Period 1|Withdrawal by Subject|2|||
128786301|NCT00813488|463509433|FG001|Titration Period 1|Withdrawal by Subject|2|||
128786302|NCT00813488|463509432|FG000|Titration Period 1|Protocol Violation|4|||
128786303|NCT00813488|463509433|FG001|Titration Period 1|Protocol Violation|3|||
128786304|NCT00813488|463509432|FG000|Titration Period 1|Non-compliance to study medication|4|||
128786305|NCT00813488|463509433|FG001|Titration Period 1|Non-compliance to study medication|1|||
128786306|NCT00813488|463509432|FG000|Titration Period 1|Non-compliance to study procedures|2|||
128786307|NCT00813488|463509433|FG001|Titration Period 1|Non-compliance to study procedures|2|||
128786308|NCT00813488|463509432|FG000|Titration Period 1|Technical Difficulties|0|||
128786309|NCT00813488|463509433|FG001|Titration Period 1|Technical Difficulties|1|||
128786310|NCT00813488|463509432|FG000|Titration Period 2|Adverse Event|2|||
128786311|NCT00813488|463509433|FG001|Titration Period 2|Adverse Event|3|||
128786312|NCT00813488|463509432|FG000|Titration Period 2|Lack of Efficacy|8|||
128786313|NCT00813488|463509433|FG001|Titration Period 2|Lack of Efficacy|4|||
128786314|NCT00813488|463509432|FG000|Titration Period 2|Protocol Violation|3|||
128786315|NCT00813488|463509433|FG001|Titration Period 2|Protocol Violation|2|||
128786316|NCT00813488|463509432|FG000|Titration Period 2|Lost to Follow-up|1|||
128786317|NCT00813488|463509433|FG001|Titration Period 2|Lost to Follow-up|0|||
128786318|NCT00813488|463509432|FG000|Titration Period 2|Non-compliance with study procedures|2|||
128786319|NCT00813488|463509433|FG001|Titration Period 2|Non-compliance with study procedures|1|||
128786320|NCT00813488|463509432|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
128786321|NCT00813488|463509433|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
128786322|NCT00813488|463509432|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
128786323|NCT00813488|463509433|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
128786324|NCT00813488|463509432|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
128786325|NCT00813488|463509433|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
128786326|NCT00813488|463509432|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
128786327|NCT00813488|463509433|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
128786328|NCT00813488|463509432|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
128786329|NCT00813488|463509433|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
128786330|NCT00813488|463509432|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
128786331|NCT00813488|463509433|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
128786332|NCT00813488|463509432|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
128753716|NCT04794803|463388621|FG001|Overall Study|Refused to continue the treatment|0|||
128753717|NCT04794803|463388620|FG000|Overall Study|Patient admitted to ICU|0|||
128753718|NCT04794803|463388621|FG001|Overall Study|Patient admitted to ICU|1|||
128753719|NCT00911534|463388622|FG000|Overall Study|Adverse Event|4|||
128753720|NCT00911534|463388623|FG001|Overall Study|Adverse Event|4|||
128753721|NCT00911534|463388622|FG000|Overall Study|Lost to Follow-up|2|||
128753722|NCT00911534|463388623|FG001|Overall Study|Lost to Follow-up|4|||
128753723|NCT00911534|463388622|FG000|Overall Study|Withdrawal by Subject|2|||
128753724|NCT00911534|463388623|FG001|Overall Study|Withdrawal by Subject|1|||
128753725|NCT00911534|463388622|FG000|Overall Study|Lack of Efficacy|4|||
128753726|NCT00911534|463388623|FG001|Overall Study|Lack of Efficacy|1|||
128753727|NCT00911534|463388622|FG000|Overall Study|Withdrawal of consent|1|||
128753728|NCT00911534|463388623|FG001|Overall Study|Withdrawal of consent|4|||
128753729|NCT00911534|463388622|FG000|Overall Study|Other|2|||
128753730|NCT00911534|463388623|FG001|Overall Study|Other|2|||
128753731|NCT03896035|463388624|FG000|Overall Study|Lost to Follow-up|2|||
128753732|NCT03896035|463388625|FG001|Overall Study|Lost to Follow-up|6|||
128753733|NCT03896035|463388624|FG000|Overall Study|Withdrawal by Subject|0|||
128753734|NCT03896035|463388625|FG001|Overall Study|Withdrawal by Subject|1|||
128753735|NCT03896035|463388624|FG000|Overall Study|Health/family health issues during COVID|0|||
128753736|NCT03896035|463388625|FG001|Overall Study|Health/family health issues during COVID|4|||
128753737|NCT01506193|463388626|FG000|Overall Study|Protocol Violation|1|||
128753738|NCT01506193|463388627|FG001|Overall Study|Protocol Violation|0|||
128753739|NCT01506193|463388628|FG002|Overall Study|Protocol Violation|1|||
128753740|NCT01506193|463388626|FG000|Overall Study|Migrated/moved from study area|0|||
128753741|NCT01506193|463388627|FG001|Overall Study|Migrated/moved from study area|0|||
128753742|NCT01506193|463388628|FG002|Overall Study|Migrated/moved from study area|1|||
128753743|NCT01506193|463388626|FG000|Overall Study|Adverse event, non-fatal|0|||
128753744|NCT01506193|463388627|FG001|Overall Study|Adverse event, non-fatal|0|||
128753745|NCT01506193|463388628|FG002|Overall Study|Adverse event, non-fatal|1|||
128753746|NCT01506193|463388626|FG000|Overall Study|Withdrawal by Subject|5|||
128753747|NCT01506193|463388627|FG001|Overall Study|Withdrawal by Subject|1|||
128753748|NCT01506193|463388628|FG002|Overall Study|Withdrawal by Subject|8|||
128753749|NCT01506193|463388626|FG000|Overall Study|Lost to Follow-up|8|||
128753750|NCT01506193|463388627|FG001|Overall Study|Lost to Follow-up|3|||
128753751|NCT01506193|463388628|FG002|Overall Study|Lost to Follow-up|3|||
128753752|NCT01388816|463388629|FG000|Overall Study|Adverse Event|0|||
128753753|NCT01388816|463388630|FG001|Overall Study|Adverse Event|2|||
128753754|NCT01388816|463388631|FG002|Overall Study|Adverse Event|0|||
128753755|NCT01388816|463388632|FG003|Overall Study|Adverse Event|0|||
128753756|NCT01388816|463388629|FG000|Overall Study|Lost to Follow-up|0|||
128753757|NCT01388816|463388630|FG001|Overall Study|Lost to Follow-up|1|||
128753758|NCT01388816|463388631|FG002|Overall Study|Lost to Follow-up|0|||
128753759|NCT01388816|463388632|FG003|Overall Study|Lost to Follow-up|0|||
128753760|NCT01388816|463388629|FG000|Overall Study|Withdrawal by Subject|2|||
128753761|NCT01388816|463388630|FG001|Overall Study|Withdrawal by Subject|1|||
128753762|NCT01388816|463388631|FG002|Overall Study|Withdrawal by Subject|1|||
128753763|NCT01388816|463388632|FG003|Overall Study|Withdrawal by Subject|0|||
128753764|NCT01388816|463388629|FG000|Overall Study|Protocol Violation|0|||
128753765|NCT01388816|463388630|FG001|Overall Study|Protocol Violation|0|||
128753766|NCT01388816|463388631|FG002|Overall Study|Protocol Violation|2|||
128753767|NCT01388816|463388632|FG003|Overall Study|Protocol Violation|0|||
128753768|NCT01152580|463388633|FG000|Overall Study|Withdrawal by Subject|0|||
128753769|NCT01152580|463388634|FG001|Overall Study|Withdrawal by Subject|1|||
128753770|NCT00675766|463388635|FG000|Overall Study|Lost to Follow-up|6|||
128753771|NCT00675766|463388636|FG001|Overall Study|Lost to Follow-up|5|||
128753772|NCT00675766|463388637|FG002|Overall Study|Lost to Follow-up|21|||
128753773|NCT00675766|463388638|FG003|Overall Study|Lost to Follow-up|26|||
128753774|NCT02275065|463388640|FG000|Overall Study|Randomized but not treated|1|||
128753775|NCT02275065|463388641|FG001|Overall Study|Randomized but not treated|0|||
128753776|NCT02275065|463388642|FG002|Overall Study|Randomized but not treated|1|||
128753777|NCT02275065|463388643|FG003|Overall Study|Randomized but not treated|1|||
128753778|NCT02275065|463388644|FG004|Overall Study|Randomized but not treated|0|||
128753779|NCT03015402|463388645|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
128753780|NCT03015402|463388646|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
128753781|NCT03015402|463388645|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
128753782|NCT03015402|463388646|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
128753783|NCT03213158|463388647|FG000|Overall Study|Withdrawal by Subject|1|||
128753784|NCT03213158|463388647|FG000|Overall Study|Physician Decision|2|||
128753785|NCT01995461|463388648|FG000|Overall Study|Death|1|||
128753786|NCT01995461|463388648|FG000|Overall Study|Lost to Follow-up|2|||
128753787|NCT01995461|463388648|FG000|Overall Study|Withdrawal by Subject|2|||
128753788|NCT00736645|463388651|FG000|Overall Study|Adverse Event|0|||
128753789|NCT00736645|463388652|FG001|Overall Study|Adverse Event|2|||
128753790|NCT00736645|463388653|FG002|Overall Study|Adverse Event|0|||
128753791|NCT00736645|463388654|FG003|Overall Study|Adverse Event|0|||
128753792|NCT00295022|463388657|FG000|Overall Study|Adverse Event|1|||
128753793|NCT00295022|463388658|FG001|Overall Study|Adverse Event|1|||
128753794|NCT00295022|463388659|FG002|Overall Study|Adverse Event|2|||
128753795|NCT00295022|463388657|FG000|Overall Study|Lost to Follow-up|0|||
128753796|NCT00295022|463388658|FG001|Overall Study|Lost to Follow-up|0|||
128753797|NCT00295022|463388659|FG002|Overall Study|Lost to Follow-up|1|||
128753798|NCT00295022|463388657|FG000|Overall Study|Withdrawal by Subject|0|||
128753799|NCT00295022|463388658|FG001|Overall Study|Withdrawal by Subject|0|||
128753800|NCT00295022|463388659|FG002|Overall Study|Withdrawal by Subject|2|||
128753801|NCT00734630|463388660|FG000|Overall Study|Lack of Efficacy|4|||
128753802|NCT00734630|463388661|FG001|Overall Study|Lack of Efficacy|4|||
128753803|NCT00734630|463388660|FG000|Overall Study|Withdrawal by Subject|7|||
128753804|NCT00734630|463388661|FG001|Overall Study|Withdrawal by Subject|9|||
128753805|NCT00734630|463388660|FG000|Overall Study|Lost to Follow-up|13|||
128753806|NCT00734630|463388661|FG001|Overall Study|Lost to Follow-up|7|||
128753807|NCT00734630|463388660|FG000|Overall Study|Protocol Violation|0|||
128753808|NCT00734630|463388661|FG001|Overall Study|Protocol Violation|3|||
128753809|NCT00734630|463388660|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
128753810|NCT00734630|463388661|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
128753811|NCT00734630|463388660|FG000|Overall Study|Adverse Event|3|||
128753812|NCT00734630|463388661|FG001|Overall Study|Adverse Event|6|||
128753813|NCT00734630|463388660|FG000|Overall Study|Randomized in Error|0|||
128753814|NCT00734630|463388661|FG001|Overall Study|Randomized in Error|1|||
128753815|NCT00734630|463388660|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
128753816|NCT00734630|463388661|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
128753817|NCT00734630|463388660|FG000|Overall Study|Poor Compliance|1|||
128753818|NCT00734630|463388661|FG001|Overall Study|Poor Compliance|1|||
128753819|NCT03792126|463388669|FG000|Overall Study|Adverse Event|1|||
128753820|NCT03792126|463388670|FG001|Overall Study|Adverse Event|2|||
128753821|NCT03792126|463388669|FG000|Overall Study|Death|0|||
128753822|NCT03792126|463388670|FG001|Overall Study|Death|1|||
128753823|NCT03792126|463388669|FG000|Overall Study|Lost to Follow-up|1|||
128753824|NCT03792126|463388670|FG001|Overall Study|Lost to Follow-up|0|||
128753825|NCT03792126|463388669|FG000|Overall Study|Withdrawal by Subject|0|||
128753826|NCT03792126|463388670|FG001|Overall Study|Withdrawal by Subject|1|||
128753827|NCT03792126|463388669|FG000|Overall Study|COVID-19 Restrictions|1|||
128753828|NCT03792126|463388670|FG001|Overall Study|COVID-19 Restrictions|3|||
128753829|NCT03792126|463388669|FG000|Overall Study|Symptoms resolved|0|||
128753830|NCT03792126|463388670|FG001|Overall Study|Symptoms resolved|3|||
128753831|NCT03240692|463388671|FG000|Overall Study|Physician Decision|1|||
128753832|NCT03240692|463388671|FG000|Overall Study|Withdrawal by Subject|1|||
128753833|NCT02300220|463388672|FG000|Overall Study|Lost to Follow-up|1|||
128753834|NCT02300220|463388673|FG001|Overall Study|Lost to Follow-up|2|||
128753835|NCT02300220|463388672|FG000|Overall Study|Death|1|||
128753836|NCT02300220|463388673|FG001|Overall Study|Death|1|||
128753837|NCT02300220|463388672|FG000|Overall Study|Adverse Event|1|||
128753838|NCT02300220|463388673|FG001|Overall Study|Adverse Event|1|||
128753839|NCT02300220|463388672|FG000|Overall Study|Protocol Violation|1|||
128753840|NCT02300220|463388673|FG001|Overall Study|Protocol Violation|0|||
128753841|NCT02300220|463388672|FG000|Overall Study|Withdrawal by Subject|0|||
128753842|NCT02300220|463388673|FG001|Overall Study|Withdrawal by Subject|2|||
128753843|NCT02300220|463388672|FG000|Overall Study|Did not tolerate IMP|0|||
128753844|NCT02300220|463388673|FG001|Overall Study|Did not tolerate IMP|1|||
128753845|NCT04322682|463388674|FG000|Overall Study|Withdrawal by Subject|33|||
128753846|NCT04322682|463388675|FG001|Overall Study|Withdrawal by Subject|47|||
128753847|NCT04322682|463388674|FG000|Overall Study|Death|5|||
128753848|NCT04322682|463388675|FG001|Overall Study|Death|9|||
128753849|NCT04322682|463388674|FG000|Overall Study|Lost to Follow-up|4|||
128753850|NCT04322682|463388675|FG001|Overall Study|Lost to Follow-up|8|||
128753851|NCT04322682|463388674|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
128753852|NCT04322682|463388675|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
128753853|NCT02238379|463388677|FG000|Overall Study|Lost to Follow-up|1|||
128753854|NCT02238379|463388678|FG001|Overall Study|Lost to Follow-up|0|||
128786333|NCT00813488|463509433|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
128786334|NCT00813488|463509432|FG000|Double-blind Treatment Period 2|Other|1|||
128786335|NCT00813488|463509433|FG001|Double-blind Treatment Period 2|Other|0|||
128786336|NCT00813488|463509432|FG000|Open-label Extension|Adverse Event|1|||
128753855|NCT04123067|463388679|FG000|Overall Study|Lost to Follow-up|0|||
128753856|NCT04123067|463388680|FG001|Overall Study|Lost to Follow-up|1|||
128753857|NCT00441090|463388681|FG000|Overall Study|Adverse Event|0|||
128753858|NCT00441090|463388682|FG001|Overall Study|Adverse Event|1|||
128753859|NCT00441090|463388683|FG002|Overall Study|Adverse Event|1|||
128753860|NCT00441090|463388684|FG003|Overall Study|Adverse Event|0|||
128753861|NCT00441090|463388685|FG004|Overall Study|Adverse Event|0|||
128753862|NCT00441090|463388681|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
128753863|NCT00441090|463388682|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
128753864|NCT00441090|463388683|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
128753865|NCT00441090|463388684|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
128753866|NCT00441090|463388685|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
128753867|NCT00441090|463388681|FG000|Overall Study|Withdrawal by Subject|1|||
128753868|NCT00441090|463388682|FG001|Overall Study|Withdrawal by Subject|0|||
128753869|NCT00441090|463388683|FG002|Overall Study|Withdrawal by Subject|1|||
128753870|NCT00441090|463388684|FG003|Overall Study|Withdrawal by Subject|0|||
128753871|NCT00441090|463388685|FG004|Overall Study|Withdrawal by Subject|0|||
128753872|NCT00441090|463388681|FG000|Overall Study|Lack of Efficacy|1|||
128753873|NCT00441090|463388682|FG001|Overall Study|Lack of Efficacy|0|||
128753874|NCT00441090|463388683|FG002|Overall Study|Lack of Efficacy|0|||
128753875|NCT00441090|463388684|FG003|Overall Study|Lack of Efficacy|0|||
128753876|NCT00441090|463388685|FG004|Overall Study|Lack of Efficacy|0|||
128753877|NCT01441102|463388686|FG000|Overall Study|Adverse Event|1|||
128753878|NCT01441102|463388686|FG000|Overall Study|Withdrawal by Subject|2|||
128753879|NCT03085485|463388687|FG000|Overall Study|Death|1|||
128753880|NCT03085485|463388688|FG001|Overall Study|Death|0|||
128753881|NCT03085485|463388687|FG000|Overall Study|Lost to Follow-up|1|||
128753882|NCT03085485|463388688|FG001|Overall Study|Lost to Follow-up|0|||
128753883|NCT00605280|463388689|FG000|Year 1|Protocol Violation|0|||
128753884|NCT00605280|463388690|FG001|Year 1|Protocol Violation|0|||
128753885|NCT00605280|463388691|FG002|Year 1|Protocol Violation|0|||
128753886|NCT00605280|463388692|FG003|Year 1|Protocol Violation|1|||
128753887|NCT00605280|463388689|FG000|Year 1|Adverse Event|3|||
128753888|NCT00605280|463388690|FG001|Year 1|Adverse Event|1|||
128753889|NCT00605280|463388691|FG002|Year 1|Adverse Event|1|||
128753890|NCT00605280|463388692|FG003|Year 1|Adverse Event|5|||
128753891|NCT00605280|463388689|FG000|Year 1|Physician Decision|7|||
128753892|NCT00605280|463388690|FG001|Year 1|Physician Decision|4|||
128753893|NCT00605280|463388691|FG002|Year 1|Physician Decision|0|||
128753894|NCT00605280|463388692|FG003|Year 1|Physician Decision|6|||
128753895|NCT00605280|463388689|FG000|Year 1|Withdrawal by Subject|2|||
128753896|NCT00605280|463388690|FG001|Year 1|Withdrawal by Subject|4|||
128753897|NCT00605280|463388691|FG002|Year 1|Withdrawal by Subject|0|||
128753898|NCT00605280|463388692|FG003|Year 1|Withdrawal by Subject|4|||
128753899|NCT00605280|463388689|FG000|Year 1|Other|2|||
128753900|NCT00605280|463388690|FG001|Year 1|Other|1|||
128753901|NCT00605280|463388691|FG002|Year 1|Other|0|||
128753902|NCT00605280|463388692|FG003|Year 1|Other|1|||
128753903|NCT00605280|463388689|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
128753904|NCT00605280|463388690|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
128753905|NCT00605280|463388691|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
128753906|NCT00605280|463388692|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
128753907|NCT00605280|463388689|FG000|Year 2|Adverse Event|4|||
128753908|NCT00605280|463388690|FG001|Year 2|Adverse Event|0|||
128753909|NCT00605280|463388691|FG002|Year 2|Adverse Event|2|||
128753910|NCT00605280|463388692|FG003|Year 2|Adverse Event|4|||
128753911|NCT00605280|463388689|FG000|Year 2|Physician Decision|11|||
128753912|NCT00605280|463388690|FG001|Year 2|Physician Decision|6|||
128753913|NCT00605280|463388691|FG002|Year 2|Physician Decision|4|||
128753914|NCT00605280|463388692|FG003|Year 2|Physician Decision|11|||
128753915|NCT00605280|463388689|FG000|Year 2|Withdrawal by Subject|4|||
128753916|NCT00605280|463388690|FG001|Year 2|Withdrawal by Subject|0|||
128753917|NCT00605280|463388691|FG002|Year 2|Withdrawal by Subject|0|||
128753918|NCT00605280|463388692|FG003|Year 2|Withdrawal by Subject|4|||
128753919|NCT00605280|463388689|FG000|Year 2|Other|1|||
128753920|NCT00605280|463388690|FG001|Year 2|Other|0|||
128753921|NCT00605280|463388691|FG002|Year 2|Other|0|||
128753922|NCT00605280|463388692|FG003|Year 2|Other|1|||
128753923|NCT00605280|463388689|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
128753924|NCT00605280|463388690|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
128753925|NCT00605280|463388691|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
128786337|NCT00813488|463509433|FG001|Open-label Extension|Adverse Event|2|||
128786338|NCT00813488|463509432|FG000|Open-label Extension|Lack of Efficacy|3|||
128786339|NCT00813488|463509433|FG001|Open-label Extension|Lack of Efficacy|0|||
128786340|NCT00813488|463509432|FG000|Open-label Extension|Withdrawal by Subject|0|||
128786341|NCT00813488|463509433|FG001|Open-label Extension|Withdrawal by Subject|2|||
128786342|NCT00813488|463509432|FG000|Open-label Extension|Protocol Violation|1|||
128786343|NCT00813488|463509433|FG001|Open-label Extension|Protocol Violation|2|||
128753926|NCT00605280|463388692|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
128753927|NCT00605280|463388689|FG000|Year 3 Extension|Adverse Event|2|||
128753928|NCT00605280|463388690|FG001|Year 3 Extension|Adverse Event|0|||
128753929|NCT00605280|463388691|FG002|Year 3 Extension|Adverse Event|0|||
128753930|NCT00605280|463388692|FG003|Year 3 Extension|Adverse Event|2|||
128753931|NCT00605280|463388689|FG000|Year 3 Extension|Physician Decision|0|||
128753932|NCT00605280|463388690|FG001|Year 3 Extension|Physician Decision|0|||
128753933|NCT00605280|463388691|FG002|Year 3 Extension|Physician Decision|0|||
128753934|NCT00605280|463388692|FG003|Year 3 Extension|Physician Decision|2|||
128753935|NCT00605280|463388689|FG000|Year 3 Extension|Withdrawal by Subject|2|||
128753936|NCT00605280|463388690|FG001|Year 3 Extension|Withdrawal by Subject|0|||
128753937|NCT00605280|463388691|FG002|Year 3 Extension|Withdrawal by Subject|0|||
128753938|NCT00605280|463388692|FG003|Year 3 Extension|Withdrawal by Subject|5|||
128753939|NCT00605280|463388689|FG000|Year 3 Extension|Other|2|||
128753940|NCT00605280|463388690|FG001|Year 3 Extension|Other|0|||
128753941|NCT00605280|463388691|FG002|Year 3 Extension|Other|0|||
128753942|NCT00605280|463388692|FG003|Year 3 Extension|Other|0|||
128753943|NCT00605280|463388689|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
128753944|NCT00605280|463388690|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
128753945|NCT00605280|463388691|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
128753946|NCT00605280|463388692|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
128753947|NCT01775904|463388696|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
128753948|NCT01775904|463388696|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
128753949|NCT00518115|463388697|FG000|Overall Study|Adverse Event|6|||
128753950|NCT00518115|463388698|FG001|Overall Study|Adverse Event|1|||
128753951|NCT00518115|463388699|FG002|Overall Study|Adverse Event|5|||
128753952|NCT00518115|463388700|FG003|Overall Study|Adverse Event|6|||
128753953|NCT00518115|463388701|FG004|Overall Study|Adverse Event|5|||
128753954|NCT00518115|463388702|FG005|Overall Study|Adverse Event|5|||
128753955|NCT00518115|463388703|FG006|Overall Study|Adverse Event|5|||
128753956|NCT00518115|463388704|FG007|Overall Study|Adverse Event|10|||
128753957|NCT00518115|463388705|FG008|Overall Study|Adverse Event|2|||
128753958|NCT00518115|463388706|FG009|Overall Study|Adverse Event|9|||
128753959|NCT00518115|463388697|FG000|Overall Study|Lost to Follow-up|0|||
128753960|NCT00518115|463388698|FG001|Overall Study|Lost to Follow-up|0|||
128753961|NCT00518115|463388699|FG002|Overall Study|Lost to Follow-up|2|||
128753962|NCT00518115|463388700|FG003|Overall Study|Lost to Follow-up|3|||
128753963|NCT00518115|463388701|FG004|Overall Study|Lost to Follow-up|1|||
128753964|NCT00518115|463388702|FG005|Overall Study|Lost to Follow-up|3|||
128753965|NCT00518115|463388703|FG006|Overall Study|Lost to Follow-up|0|||
128753966|NCT00518115|463388704|FG007|Overall Study|Lost to Follow-up|1|||
128753967|NCT00518115|463388705|FG008|Overall Study|Lost to Follow-up|1|||
128753968|NCT00518115|463388706|FG009|Overall Study|Lost to Follow-up|1|||
128753969|NCT00518115|463388697|FG000|Overall Study|Protocol Violation|1|||
128753970|NCT00518115|463388698|FG001|Overall Study|Protocol Violation|3|||
128753971|NCT00518115|463388699|FG002|Overall Study|Protocol Violation|1|||
128753972|NCT00518115|463388700|FG003|Overall Study|Protocol Violation|0|||
128753973|NCT00518115|463388701|FG004|Overall Study|Protocol Violation|0|||
128753974|NCT00518115|463388702|FG005|Overall Study|Protocol Violation|0|||
128753975|NCT00518115|463388703|FG006|Overall Study|Protocol Violation|0|||
128753976|NCT00518115|463388704|FG007|Overall Study|Protocol Violation|0|||
128753977|NCT00518115|463388705|FG008|Overall Study|Protocol Violation|0|||
128753978|NCT00518115|463388706|FG009|Overall Study|Protocol Violation|0|||
128753979|NCT00518115|463388697|FG000|Overall Study|Withdrawal by Subject|1|||
128753980|NCT00518115|463388698|FG001|Overall Study|Withdrawal by Subject|1|||
128753981|NCT00518115|463388699|FG002|Overall Study|Withdrawal by Subject|5|||
128753982|NCT00518115|463388700|FG003|Overall Study|Withdrawal by Subject|0|||
128753983|NCT00518115|463388701|FG004|Overall Study|Withdrawal by Subject|2|||
128753984|NCT00518115|463388702|FG005|Overall Study|Withdrawal by Subject|1|||
128753985|NCT00518115|463388703|FG006|Overall Study|Withdrawal by Subject|0|||
128753986|NCT00518115|463388704|FG007|Overall Study|Withdrawal by Subject|2|||
128753987|NCT00518115|463388705|FG008|Overall Study|Withdrawal by Subject|1|||
128753988|NCT00518115|463388706|FG009|Overall Study|Withdrawal by Subject|3|||
128753989|NCT00518115|463388697|FG000|Overall Study|Lack of Efficacy|1|||
128753990|NCT00518115|463388698|FG001|Overall Study|Lack of Efficacy|0|||
128753991|NCT00518115|463388699|FG002|Overall Study|Lack of Efficacy|1|||
128753992|NCT00518115|463388700|FG003|Overall Study|Lack of Efficacy|1|||
128753993|NCT00518115|463388701|FG004|Overall Study|Lack of Efficacy|0|||
128753994|NCT00518115|463388702|FG005|Overall Study|Lack of Efficacy|0|||
128753995|NCT00518115|463388703|FG006|Overall Study|Lack of Efficacy|0|||
128753996|NCT00518115|463388704|FG007|Overall Study|Lack of Efficacy|1|||
128753997|NCT00518115|463388705|FG008|Overall Study|Lack of Efficacy|0|||
128753998|NCT00518115|463388706|FG009|Overall Study|Lack of Efficacy|0|||
128753999|NCT00518115|463388697|FG000|Overall Study|Non-Compliance|1|||
128754000|NCT00518115|463388698|FG001|Overall Study|Non-Compliance|0|||
128754001|NCT00518115|463388699|FG002|Overall Study|Non-Compliance|1|||
128754002|NCT00518115|463388700|FG003|Overall Study|Non-Compliance|0|||
128754003|NCT00518115|463388701|FG004|Overall Study|Non-Compliance|1|||
128754004|NCT00518115|463388702|FG005|Overall Study|Non-Compliance|1|||
128754005|NCT00518115|463388703|FG006|Overall Study|Non-Compliance|1|||
128754006|NCT00518115|463388704|FG007|Overall Study|Non-Compliance|1|||
128754007|NCT00518115|463388705|FG008|Overall Study|Non-Compliance|0|||
128754008|NCT00518115|463388706|FG009|Overall Study|Non-Compliance|1|||
128754009|NCT00518115|463388697|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
128754010|NCT00518115|463388698|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
128754011|NCT00518115|463388699|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
128754012|NCT00518115|463388700|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
128754013|NCT00518115|463388701|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
128754014|NCT00518115|463388702|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
128754015|NCT00518115|463388703|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
128754016|NCT00518115|463388704|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
128754017|NCT00518115|463388705|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
128754018|NCT00518115|463388706|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
128754019|NCT00518115|463388697|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
128754020|NCT00518115|463388698|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754021|NCT00518115|463388699|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754022|NCT00518115|463388700|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754023|NCT00518115|463388701|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754024|NCT00518115|463388702|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754025|NCT00518115|463388703|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754026|NCT00518115|463388704|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754027|NCT00518115|463388705|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754028|NCT00518115|463388706|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
128754029|NCT00518115|463388697|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754030|NCT00518115|463388698|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754031|NCT00518115|463388699|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
128754032|NCT00518115|463388700|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754033|NCT00518115|463388701|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754034|NCT00518115|463388702|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754035|NCT00518115|463388703|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754036|NCT00518115|463388704|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754037|NCT00518115|463388705|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
128754038|NCT00518115|463388706|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
128754039|NCT00518115|463388697|FG000|Overall Study|Wrong Monotherapy Administered|0|||
128754040|NCT00518115|463388698|FG001|Overall Study|Wrong Monotherapy Administered|0|||
128754041|NCT00518115|463388699|FG002|Overall Study|Wrong Monotherapy Administered|1|||
128754042|NCT00518115|463388700|FG003|Overall Study|Wrong Monotherapy Administered|0|||
128754043|NCT00518115|463388701|FG004|Overall Study|Wrong Monotherapy Administered|0|||
128754044|NCT00518115|463388702|FG005|Overall Study|Wrong Monotherapy Administered|0|||
128754045|NCT00518115|463388703|FG006|Overall Study|Wrong Monotherapy Administered|1|||
128754046|NCT00518115|463388704|FG007|Overall Study|Wrong Monotherapy Administered|0|||
128754047|NCT00518115|463388705|FG008|Overall Study|Wrong Monotherapy Administered|0|||
128754048|NCT00518115|463388706|FG009|Overall Study|Wrong Monotherapy Administered|0|||
128754049|NCT00518115|463388697|FG000|Overall Study|Violation of Exclusion Criteria|0|||
128754050|NCT00518115|463388698|FG001|Overall Study|Violation of Exclusion Criteria|0|||
128754051|NCT00518115|463388699|FG002|Overall Study|Violation of Exclusion Criteria|0|||
128754052|NCT00518115|463388700|FG003|Overall Study|Violation of Exclusion Criteria|1|||
128754053|NCT00518115|463388701|FG004|Overall Study|Violation of Exclusion Criteria|0|||
128754054|NCT00518115|463388702|FG005|Overall Study|Violation of Exclusion Criteria|0|||
128754055|NCT00518115|463388703|FG006|Overall Study|Violation of Exclusion Criteria|1|||
128754056|NCT00518115|463388704|FG007|Overall Study|Violation of Exclusion Criteria|0|||
128754057|NCT00518115|463388705|FG008|Overall Study|Violation of Exclusion Criteria|0|||
128754058|NCT00518115|463388706|FG009|Overall Study|Violation of Exclusion Criteria|0|||
128754059|NCT00518115|463388697|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
128754060|NCT00518115|463388698|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
128754061|NCT00518115|463388699|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
128754062|NCT00518115|463388700|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
128754063|NCT00518115|463388701|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
128754064|NCT00518115|463388702|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
128754065|NCT00518115|463388703|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
128754066|NCT00518115|463388704|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
128754067|NCT00518115|463388705|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
128754068|NCT00518115|463388706|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
128754069|NCT00518115|463388697|FG000|Overall Study|Withdrew Consent|0|||
128786344|NCT00813488|463509432|FG000|Open-label Extension|Non-compliance study medication|4|||
128754070|NCT00518115|463388698|FG001|Overall Study|Withdrew Consent|0|||
128754071|NCT00518115|463388699|FG002|Overall Study|Withdrew Consent|0|||
128754072|NCT00518115|463388700|FG003|Overall Study|Withdrew Consent|0|||
128754073|NCT00518115|463388701|FG004|Overall Study|Withdrew Consent|0|||
128754074|NCT00518115|463388702|FG005|Overall Study|Withdrew Consent|1|||
128754075|NCT00518115|463388703|FG006|Overall Study|Withdrew Consent|0|||
128754076|NCT00518115|463388704|FG007|Overall Study|Withdrew Consent|0|||
128754077|NCT00518115|463388705|FG008|Overall Study|Withdrew Consent|0|||
128754078|NCT00518115|463388706|FG009|Overall Study|Withdrew Consent|0|||
128754079|NCT00518115|463388697|FG000|Overall Study|Moved Out of State|0|||
128754080|NCT00518115|463388698|FG001|Overall Study|Moved Out of State|0|||
128754081|NCT00518115|463388699|FG002|Overall Study|Moved Out of State|0|||
128754082|NCT00518115|463388700|FG003|Overall Study|Moved Out of State|0|||
128754083|NCT00518115|463388701|FG004|Overall Study|Moved Out of State|0|||
128754084|NCT00518115|463388702|FG005|Overall Study|Moved Out of State|0|||
128754085|NCT00518115|463388703|FG006|Overall Study|Moved Out of State|0|||
128754086|NCT00518115|463388704|FG007|Overall Study|Moved Out of State|0|||
128754087|NCT00518115|463388705|FG008|Overall Study|Moved Out of State|0|||
128754088|NCT00518115|463388706|FG009|Overall Study|Moved Out of State|1|||
128754089|NCT04891419|463388707|FG000|Overall Study|Withdrawal by Subject|4|||
128754090|NCT04891419|463388708|FG001|Overall Study|Withdrawal by Subject|0|||
128754091|NCT04891419|463388707|FG000|Overall Study|Lost to Follow-up|1|||
128754092|NCT04891419|463388708|FG001|Overall Study|Lost to Follow-up|3|||
128754093|NCT00827918|463388709|FG000|Overall Study|Adverse Event|4|||
128754094|NCT00827918|463388710|FG001|Overall Study|Adverse Event|0|||
128754095|NCT00827918|463388711|FG002|Overall Study|Adverse Event|0|||
128754096|NCT00827918|463388709|FG000|Overall Study|Lack of Efficacy|16|||
128754097|NCT00827918|463388710|FG001|Overall Study|Lack of Efficacy|4|||
128754098|NCT00827918|463388711|FG002|Overall Study|Lack of Efficacy|15|||
128754099|NCT00827918|463388709|FG000|Overall Study|Physician Decision|1|||
128754100|NCT00827918|463388710|FG001|Overall Study|Physician Decision|0|||
128754101|NCT00827918|463388711|FG002|Overall Study|Physician Decision|0|||
128754102|NCT00827918|463388709|FG000|Overall Study|Pregnancy|0|||
128754103|NCT00827918|463388710|FG001|Overall Study|Pregnancy|1|||
128754104|NCT00827918|463388711|FG002|Overall Study|Pregnancy|0|||
128754105|NCT00827918|463388709|FG000|Overall Study|Progressive Disease|1|||
128754106|NCT00827918|463388710|FG001|Overall Study|Progressive Disease|1|||
128754107|NCT00827918|463388711|FG002|Overall Study|Progressive Disease|0|||
128754108|NCT00827918|463388709|FG000|Overall Study|Protocol Violation|0|||
128754109|NCT00827918|463388710|FG001|Overall Study|Protocol Violation|1|||
128754110|NCT00827918|463388711|FG002|Overall Study|Protocol Violation|0|||
128754111|NCT00827918|463388709|FG000|Overall Study|Withdrawal by Subject|6|||
128754112|NCT00827918|463388710|FG001|Overall Study|Withdrawal by Subject|2|||
128754113|NCT00827918|463388711|FG002|Overall Study|Withdrawal by Subject|6|||
128754114|NCT00127101|463388712|FG000|Base Protocol|Adverse Event|0|||
128754115|NCT00127101|463388713|FG001|Base Protocol|Adverse Event|2|||
128754116|NCT00127101|463388714|FG002|Base Protocol|Adverse Event|1|||
128754117|NCT00127101|463388715|FG003|Base Protocol|Adverse Event|0|||
128754118|NCT00127101|463388716|FG004|Base Protocol|Adverse Event|0|||
128754119|NCT00127101|463388717|FG005|Base Protocol|Adverse Event|0|||
128754120|NCT00127101|463388712|FG000|Base Protocol|Lack of Efficacy|1|||
128754121|NCT00127101|463388713|FG001|Base Protocol|Lack of Efficacy|0|||
128754122|NCT00127101|463388714|FG002|Base Protocol|Lack of Efficacy|0|||
128754123|NCT00127101|463388715|FG003|Base Protocol|Lack of Efficacy|0|||
128754124|NCT00127101|463388716|FG004|Base Protocol|Lack of Efficacy|2|||
128754125|NCT00127101|463388717|FG005|Base Protocol|Lack of Efficacy|0|||
128754126|NCT00127101|463388712|FG000|Base Protocol|Withdrawal by Subject|1|||
128754127|NCT00127101|463388713|FG001|Base Protocol|Withdrawal by Subject|2|||
128786345|NCT00813488|463509433|FG001|Open-label Extension|Non-compliance study medication|0|||
128786346|NCT00813488|463509432|FG000|Open-label Extension|Non-compliance study procedures|2|||
128786347|NCT00813488|463509433|FG001|Open-label Extension|Non-compliance study procedures|1|||
128786348|NCT00813488|463509432|FG000|Open-label Extension|Other|1|||
128786349|NCT00813488|463509433|FG001|Open-label Extension|Other|0|||
128754128|NCT00127101|463388714|FG002|Base Protocol|Withdrawal by Subject|1|||
128754129|NCT00127101|463388715|FG003|Base Protocol|Withdrawal by Subject|0|||
128754130|NCT00127101|463388716|FG004|Base Protocol|Withdrawal by Subject|0|||
128754131|NCT00127101|463388717|FG005|Base Protocol|Withdrawal by Subject|1|||
128754132|NCT00127101|463388712|FG000|Continuation Phase|Adverse Event|0|||
128754133|NCT00127101|463388713|FG001|Continuation Phase|Adverse Event|0|||
128754134|NCT00127101|463388714|FG002|Continuation Phase|Adverse Event|0|||
128754135|NCT00127101|463388715|FG003|Continuation Phase|Adverse Event|0|||
128754136|NCT00127101|463388716|FG004|Continuation Phase|Adverse Event|1|||
128754137|NCT00127101|463388717|FG005|Continuation Phase|Adverse Event|1|||
128754138|NCT00127101|463388712|FG000|Continuation Phase|Lack of Efficacy|0|||
128754139|NCT00127101|463388713|FG001|Continuation Phase|Lack of Efficacy|0|||
128754140|NCT00127101|463388714|FG002|Continuation Phase|Lack of Efficacy|0|||
128754141|NCT00127101|463388715|FG003|Continuation Phase|Lack of Efficacy|0|||
128786350|NCT01729871|463509435|FG000|Overall Study|Adverse Event|7|||
128786351|NCT01729871|463509436|FG001|Overall Study|Adverse Event|7|||
128786352|NCT01729871|463509435|FG000|Overall Study|Death|0|||
128786353|NCT01729871|463509436|FG001|Overall Study|Death|1|||
128786354|NCT01729871|463509435|FG000|Overall Study|Lack of Efficacy|0|||
128786355|NCT01729871|463509436|FG001|Overall Study|Lack of Efficacy|1|||
128786356|NCT01729871|463509435|FG000|Overall Study|Physician Decision|0|||
128786357|NCT01729871|463509436|FG001|Overall Study|Physician Decision|2|||
128786358|NCT01729871|463509435|FG000|Overall Study|Protocol Violation|1|||
128786359|NCT01729871|463509436|FG001|Overall Study|Protocol Violation|0|||
128786360|NCT01729871|463509435|FG000|Overall Study|Withdrawal by Subject|0|||
128786361|NCT01729871|463509436|FG001|Overall Study|Withdrawal by Subject|3|||
128786362|NCT01729871|463509435|FG000|Overall Study|Other|4|||
128786363|NCT01729871|463509436|FG001|Overall Study|Other|9|||
128786364|NCT01143077|463509437|FG000|Overall Study|Lack of Efficacy|0|||
128786365|NCT01143077|463509438|FG001|Overall Study|Lack of Efficacy|2|||
128786366|NCT01143077|463509439|FG002|Overall Study|Lack of Efficacy|1|||
128786367|NCT01143077|463509437|FG000|Overall Study|Adverse Event|5|||
128786368|NCT01143077|463509438|FG001|Overall Study|Adverse Event|6|||
128786369|NCT01143077|463509439|FG002|Overall Study|Adverse Event|5|||
128786370|NCT01143077|463509437|FG000|Overall Study|Lost to Follow-up|2|||
128786371|NCT01143077|463509438|FG001|Overall Study|Lost to Follow-up|3|||
128786372|NCT01143077|463509439|FG002|Overall Study|Lost to Follow-up|4|||
128786373|NCT01143077|463509437|FG000|Overall Study|Protocol Violation|2|||
128786374|NCT01143077|463509438|FG001|Overall Study|Protocol Violation|0|||
128786375|NCT01143077|463509439|FG002|Overall Study|Protocol Violation|0|||
128786376|NCT01143077|463509437|FG000|Overall Study|Withdrawal by Subject|4|||
128786377|NCT01143077|463509438|FG001|Overall Study|Withdrawal by Subject|3|||
128786378|NCT01143077|463509439|FG002|Overall Study|Withdrawal by Subject|3|||
128786379|NCT01143077|463509437|FG000|Overall Study|Non-compliance with study drug|0|||
128786380|NCT01143077|463509438|FG001|Overall Study|Non-compliance with study drug|1|||
128786381|NCT01143077|463509439|FG002|Overall Study|Non-compliance with study drug|1|||
128786382|NCT01143077|463509437|FG000|Overall Study|Administrative|1|||
128786383|NCT01143077|463509438|FG001|Overall Study|Administrative|0|||
128786384|NCT01143077|463509439|FG002|Overall Study|Administrative|0|||
128786385|NCT01143077|463509437|FG000|Overall Study|Principal Investigator Decision|2|||
128786386|NCT01143077|463509438|FG001|Overall Study|Principal Investigator Decision|0|||
128786387|NCT01143077|463509439|FG002|Overall Study|Principal Investigator Decision|1|||
128786388|NCT00871429|463509444|FG000|Overall Study|Lost to Follow-up|6|||
128786389|NCT00871429|463509444|FG000|Overall Study|Withdrawal by Subject|17|||
128786390|NCT00871429|463509444|FG000|Overall Study|Questionnaire not completed|1|||
128786391|NCT00708097|463509446|FG000|Period 1|Protocol Violation|0|||
128786392|NCT00708097|463509447|FG001|Period 1|Protocol Violation|1|||
128786393|NCT00708097|463509448|FG002|Period 1|Protocol Violation|0|||
128786394|NCT00708097|463509449|FG003|Period 1|Protocol Violation|2|||
128786395|NCT00708097|463509450|FG004|Period 1|Protocol Violation|0|||
128786396|NCT00708097|463509446|FG000|Period 1|Other Reason|0|||
128786397|NCT00708097|463509447|FG001|Period 1|Other Reason|0|||
128786398|NCT00708097|463509448|FG002|Period 1|Other Reason|0|||
128786399|NCT00708097|463509449|FG003|Period 1|Other Reason|0|||
128786400|NCT00708097|463509450|FG004|Period 1|Other Reason|1|||
128786401|NCT00708097|463509446|FG000|Period 2|Protocol Violation|0|||
128786402|NCT00708097|463509447|FG001|Period 2|Protocol Violation|1|||
128786403|NCT00708097|463509448|FG002|Period 2|Protocol Violation|1|||
128786404|NCT00708097|463509449|FG003|Period 2|Protocol Violation|1|||
128786405|NCT00708097|463509450|FG004|Period 2|Protocol Violation|0|||
128786406|NCT03895034|463511170|FG000|Overall Study|Lost to Follow-up|2|||
128786407|NCT03784963|463511171|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
128786408|NCT03784963|463511172|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
128786409|NCT03784963|463511173|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
128786410|NCT03784963|463511174|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
128786411|NCT00157014|463511175|FG000|Overall Study|Death|4|||
128786412|NCT00157014|463511176|FG001|Overall Study|Death|2|||
128786413|NCT00157014|463511177|FG002|Overall Study|Death|1|||
128786414|NCT00157014|463511178|FG003|Overall Study|Death|1|||
128786415|NCT00157014|463511175|FG000|Overall Study|Physician Decision|0|||
128786416|NCT00157014|463511176|FG001|Overall Study|Physician Decision|1|||
128786417|NCT00157014|463511177|FG002|Overall Study|Physician Decision|0|||
128786418|NCT00157014|463511178|FG003|Overall Study|Physician Decision|0|||
128786419|NCT00157014|463511175|FG000|Overall Study|Medications withdrawn on family request|0|||
128786420|NCT00157014|463511176|FG001|Overall Study|Medications withdrawn on family request|1|||
128786421|NCT00157014|463511177|FG002|Overall Study|Medications withdrawn on family request|0|||
128786422|NCT00157014|463511178|FG003|Overall Study|Medications withdrawn on family request|0|||
128786423|NCT00157014|463511175|FG000|Overall Study|Patient withdrawn by investigator|1|||
128786424|NCT00157014|463511176|FG001|Overall Study|Patient withdrawn by investigator|0|||
128786425|NCT00157014|463511177|FG002|Overall Study|Patient withdrawn by investigator|0|||
128786426|NCT00157014|463511178|FG003|Overall Study|Patient withdrawn by investigator|0|||
128786427|NCT00157014|463511175|FG000|Overall Study|Patient unable to return in nursing home|1|||
128754142|NCT00127101|463388716|FG004|Continuation Phase|Lack of Efficacy|0|||
128754143|NCT00127101|463388717|FG005|Continuation Phase|Lack of Efficacy|1|||
128754144|NCT00127101|463388712|FG000|Continuation Phase|Withdrawal by Subject|0|||
128754145|NCT00127101|463388713|FG001|Continuation Phase|Withdrawal by Subject|0|||
128754146|NCT00127101|463388714|FG002|Continuation Phase|Withdrawal by Subject|1|||
128754147|NCT00127101|463388715|FG003|Continuation Phase|Withdrawal by Subject|0|||
128754148|NCT00127101|463388716|FG004|Continuation Phase|Withdrawal by Subject|2|||
128754149|NCT00127101|463388717|FG005|Continuation Phase|Withdrawal by Subject|1|||
128754150|NCT00843167|463388718|FG000|Treatment Period|Adverse Event|1|||
128754151|NCT00843167|463388719|FG001|Treatment Period|Adverse Event|5|||
128754152|NCT00843167|463388718|FG000|Treatment Period|Withdrawal by Subject|2|||
128754153|NCT00843167|463388719|FG001|Treatment Period|Withdrawal by Subject|3|||
128754154|NCT02291614|463388722|FG000|Overall Study|Lost to Follow-up|0|||
128754155|NCT02291614|463388723|FG001|Overall Study|Lost to Follow-up|0|||
128754156|NCT02291614|463388724|FG002|Overall Study|Lost to Follow-up|0|||
128754157|NCT02291614|463388725|FG003|Overall Study|Lost to Follow-up|0|||
128754158|NCT02291614|463388726|FG004|Overall Study|Lost to Follow-up|0|||
128754159|NCT02291614|463388727|FG005|Overall Study|Lost to Follow-up|0|||
128754160|NCT02291614|463388728|FG006|Overall Study|Lost to Follow-up|0|||
128754161|NCT02291614|463388729|FG007|Overall Study|Lost to Follow-up|1|||
128754162|NCT02291614|463388730|FG008|Overall Study|Lost to Follow-up|0|||
128754163|NCT02291614|463388731|FG009|Overall Study|Lost to Follow-up|0|||
128754164|NCT02291614|463388732|FG010|Overall Study|Lost to Follow-up|0|||
128754165|NCT02291614|463388722|FG000|Overall Study|Withdrawal by Subject|0|||
128754166|NCT02291614|463388723|FG001|Overall Study|Withdrawal by Subject|1|||
128754167|NCT02291614|463388724|FG002|Overall Study|Withdrawal by Subject|0|||
128754168|NCT02291614|463388725|FG003|Overall Study|Withdrawal by Subject|0|||
128754169|NCT02291614|463388726|FG004|Overall Study|Withdrawal by Subject|0|||
128754170|NCT02291614|463388727|FG005|Overall Study|Withdrawal by Subject|0|||
128754171|NCT02291614|463388728|FG006|Overall Study|Withdrawal by Subject|0|||
128754172|NCT02291614|463388729|FG007|Overall Study|Withdrawal by Subject|0|||
128754173|NCT02291614|463388730|FG008|Overall Study|Withdrawal by Subject|0|||
128754174|NCT02291614|463388731|FG009|Overall Study|Withdrawal by Subject|2|||
128754175|NCT02291614|463388732|FG010|Overall Study|Withdrawal by Subject|2|||
128754176|NCT02291614|463388722|FG000|Overall Study|Decision by sponsor|0|||
128754177|NCT02291614|463388723|FG001|Overall Study|Decision by sponsor|0|||
128754178|NCT02291614|463388724|FG002|Overall Study|Decision by sponsor|0|||
128754179|NCT02291614|463388725|FG003|Overall Study|Decision by sponsor|1|||
128754180|NCT02291614|463388726|FG004|Overall Study|Decision by sponsor|0|||
128754181|NCT02291614|463388727|FG005|Overall Study|Decision by sponsor|0|||
128754182|NCT02291614|463388728|FG006|Overall Study|Decision by sponsor|0|||
128754183|NCT02291614|463388729|FG007|Overall Study|Decision by sponsor|0|||
128754184|NCT02291614|463388730|FG008|Overall Study|Decision by sponsor|0|||
128754185|NCT02291614|463388731|FG009|Overall Study|Decision by sponsor|0|||
128754186|NCT02291614|463388732|FG010|Overall Study|Decision by sponsor|0|||
128754187|NCT02291614|463388722|FG000|Overall Study|Death|0|||
128754188|NCT02291614|463388723|FG001|Overall Study|Death|0|||
128754189|NCT02291614|463388724|FG002|Overall Study|Death|1|||
128754190|NCT02291614|463388725|FG003|Overall Study|Death|0|||
128754191|NCT02291614|463388726|FG004|Overall Study|Death|1|||
128754192|NCT02291614|463388727|FG005|Overall Study|Death|1|||
128754193|NCT02291614|463388728|FG006|Overall Study|Death|1|||
128754194|NCT02291614|463388729|FG007|Overall Study|Death|0|||
128754195|NCT02291614|463388730|FG008|Overall Study|Death|0|||
128754196|NCT02291614|463388731|FG009|Overall Study|Death|0|||
128754197|NCT02291614|463388732|FG010|Overall Study|Death|0|||
128754198|NCT01662310|463388733|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
128754199|NCT01662310|463388734|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
128754200|NCT01662310|463388735|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
128754201|NCT01662310|463388736|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
128754202|NCT01662310|463388737|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
128754203|NCT01662310|463388733|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
128754204|NCT01662310|463388734|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
128786428|NCT00157014|463511176|FG001|Overall Study|Patient unable to return in nursing home|0|||
128754205|NCT01662310|463388735|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
128754206|NCT01662310|463388736|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
128754207|NCT01662310|463388737|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
128754208|NCT01662310|463388733|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
128754209|NCT01662310|463388734|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
128754210|NCT01662310|463388735|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
128754211|NCT01662310|463388736|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
128754212|NCT01662310|463388737|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
128754213|NCT01662310|463388733|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
128754214|NCT01662310|463388734|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
128754215|NCT01662310|463388735|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
128754216|NCT01662310|463388736|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
128754217|NCT01662310|463388737|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
128754218|NCT01662310|463388733|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
128754219|NCT01662310|463388734|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
128754220|NCT01662310|463388735|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
128754221|NCT01662310|463388736|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
128754222|NCT01662310|463388737|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
128754223|NCT01662310|463388733|FG000|Run-In or Stabilization Phase|Other|1|||
128754224|NCT01662310|463388734|FG001|Run-In or Stabilization Phase|Other|0|||
128754225|NCT01662310|463388735|FG002|Run-In or Stabilization Phase|Other|0|||
128754226|NCT01662310|463388736|FG003|Run-In or Stabilization Phase|Other|0|||
128754227|NCT01662310|463388737|FG004|Run-In or Stabilization Phase|Other|0|||
128754228|NCT01662310|463388733|FG000|Double-Blind Phase|Adverse Event|0|||
128754229|NCT01662310|463388734|FG001|Double-Blind Phase|Adverse Event|0|||
128754230|NCT01662310|463388735|FG002|Double-Blind Phase|Adverse Event|1|||
128754231|NCT01662310|463388736|FG003|Double-Blind Phase|Adverse Event|0|||
128754232|NCT01662310|463388737|FG004|Double-Blind Phase|Adverse Event|0|||
128754233|NCT01662310|463388733|FG000|Double-Blind Phase|Lost to Follow-up|0|||
128754234|NCT01662310|463388734|FG001|Double-Blind Phase|Lost to Follow-up|3|||
128754235|NCT01662310|463388735|FG002|Double-Blind Phase|Lost to Follow-up|0|||
128754236|NCT01662310|463388736|FG003|Double-Blind Phase|Lost to Follow-up|0|||
128754237|NCT01662310|463388737|FG004|Double-Blind Phase|Lost to Follow-up|0|||
128754238|NCT01662310|463388733|FG000|Double-Blind Phase|Pregnancy|0|||
128754239|NCT01662310|463388734|FG001|Double-Blind Phase|Pregnancy|2|||
128754240|NCT01662310|463388735|FG002|Double-Blind Phase|Pregnancy|0|||
128754241|NCT01662310|463388736|FG003|Double-Blind Phase|Pregnancy|0|||
128754242|NCT01662310|463388737|FG004|Double-Blind Phase|Pregnancy|0|||
128754243|NCT01662310|463388733|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
128754244|NCT01662310|463388734|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
128754245|NCT01662310|463388735|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
128754246|NCT01662310|463388736|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
128754247|NCT01662310|463388737|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
128754248|NCT01662310|463388733|FG000|Double-Blind Phase|Other|0|||
128754249|NCT01662310|463388734|FG001|Double-Blind Phase|Other|0|||
128754250|NCT01662310|463388735|FG002|Double-Blind Phase|Other|1|||
128754251|NCT01662310|463388736|FG003|Double-Blind Phase|Other|0|||
128754252|NCT01662310|463388737|FG004|Double-Blind Phase|Other|0|||
128754253|NCT01662310|463388733|FG000|Double-Blind Phase|Randomized but not treated|0|||
128754254|NCT01662310|463388734|FG001|Double-Blind Phase|Randomized but not treated|1|||
128754255|NCT01662310|463388735|FG002|Double-Blind Phase|Randomized but not treated|0|||
128754256|NCT01662310|463388736|FG003|Double-Blind Phase|Randomized but not treated|0|||
128754257|NCT01662310|463388737|FG004|Double-Blind Phase|Randomized but not treated|0|||
128754258|NCT01662310|463388733|FG000|Open-Label Extension Phase|Adverse Event|0|||
128754259|NCT01662310|463388734|FG001|Open-Label Extension Phase|Adverse Event|0|||
128754260|NCT01662310|463388735|FG002|Open-Label Extension Phase|Adverse Event|0|||
128754261|NCT01662310|463388736|FG003|Open-Label Extension Phase|Adverse Event|3|||
128754262|NCT01662310|463388737|FG004|Open-Label Extension Phase|Adverse Event|0|||
128754263|NCT01662310|463388733|FG000|Open-Label Extension Phase|Death|0|||
128754264|NCT01662310|463388734|FG001|Open-Label Extension Phase|Death|0|||
128754265|NCT01662310|463388735|FG002|Open-Label Extension Phase|Death|0|||
128754266|NCT01662310|463388736|FG003|Open-Label Extension Phase|Death|1|||
128754267|NCT01662310|463388737|FG004|Open-Label Extension Phase|Death|0|||
128754268|NCT01662310|463388733|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
128754269|NCT01662310|463388734|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
128754270|NCT01662310|463388735|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
128754271|NCT01662310|463388736|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
128754272|NCT01662310|463388737|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
128754273|NCT01662310|463388733|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
128754274|NCT01662310|463388734|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
128754275|NCT01662310|463388735|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
128754276|NCT01662310|463388736|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
128754277|NCT01662310|463388737|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
128754278|NCT01662310|463388733|FG000|Open-Label Extension Phase|Pregnancy|0|||
128754279|NCT01662310|463388734|FG001|Open-Label Extension Phase|Pregnancy|0|||
128754280|NCT01662310|463388735|FG002|Open-Label Extension Phase|Pregnancy|0|||
128754281|NCT01662310|463388736|FG003|Open-Label Extension Phase|Pregnancy|1|||
128754282|NCT01662310|463388737|FG004|Open-Label Extension Phase|Pregnancy|0|||
128754283|NCT01662310|463388733|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
128754284|NCT01662310|463388734|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
128754285|NCT01662310|463388735|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
128754286|NCT01662310|463388736|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
128754287|NCT01662310|463388737|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
128754288|NCT01302847|463388741|FG000|Overall Study|Death|0|||
128754289|NCT01302847|463388742|FG001|Overall Study|Death|1|||
128754290|NCT01302847|463388743|FG002|Overall Study|Death|0|||
128754291|NCT01302847|463388744|FG003|Overall Study|Death|0|||
128754292|NCT01302847|463388745|FG004|Overall Study|Death|0|||
128754293|NCT01302847|463388746|FG005|Overall Study|Death|1|||
128754294|NCT01302847|463388747|FG006|Overall Study|Death|1|||
128754295|NCT01302847|463388748|FG007|Overall Study|Death|0|||
128754296|NCT01302847|463388741|FG000|Overall Study|Pregnancy|2|||
128754297|NCT01302847|463388742|FG001|Overall Study|Pregnancy|0|||
128754298|NCT01302847|463388743|FG002|Overall Study|Pregnancy|0|||
128754299|NCT01302847|463388744|FG003|Overall Study|Pregnancy|0|||
128754300|NCT01302847|463388745|FG004|Overall Study|Pregnancy|0|||
128754301|NCT01302847|463388746|FG005|Overall Study|Pregnancy|0|||
128754302|NCT01302847|463388747|FG006|Overall Study|Pregnancy|0|||
128754303|NCT01302847|463388748|FG007|Overall Study|Pregnancy|0|||
128754304|NCT01302847|463388741|FG000|Overall Study|Virologic failure|0|||
128754305|NCT01302847|463388742|FG001|Overall Study|Virologic failure|2|||
128754306|NCT01302847|463388743|FG002|Overall Study|Virologic failure|0|||
128754307|NCT01302847|463388744|FG003|Overall Study|Virologic failure|2|||
128754308|NCT01302847|463388745|FG004|Overall Study|Virologic failure|1|||
128754309|NCT01302847|463388746|FG005|Overall Study|Virologic failure|3|||
128754310|NCT01302847|463388747|FG006|Overall Study|Virologic failure|1|||
128754311|NCT01302847|463388748|FG007|Overall Study|Virologic failure|2|||
128754312|NCT01302847|463388741|FG000|Overall Study|Severe debilitation, unable to continue|0|||
128754313|NCT01302847|463388742|FG001|Overall Study|Severe debilitation, unable to continue|0|||
128754314|NCT01302847|463388743|FG002|Overall Study|Severe debilitation, unable to continue|0|||
128754315|NCT01302847|463388744|FG003|Overall Study|Severe debilitation, unable to continue|0|||
128754316|NCT01302847|463388745|FG004|Overall Study|Severe debilitation, unable to continue|0|||
128754317|NCT01302847|463388746|FG005|Overall Study|Severe debilitation, unable to continue|1|||
128754318|NCT01302847|463388747|FG006|Overall Study|Severe debilitation, unable to continue|1|||
128754319|NCT01302847|463388748|FG007|Overall Study|Severe debilitation, unable to continue|0|||
128754320|NCT01302847|463388741|FG000|Overall Study|Not able to get to clinic|1|||
128754321|NCT01302847|463388742|FG001|Overall Study|Not able to get to clinic|1|||
128754322|NCT01302847|463388743|FG002|Overall Study|Not able to get to clinic|0|||
128754323|NCT01302847|463388744|FG003|Overall Study|Not able to get to clinic|0|||
128754324|NCT01302847|463388745|FG004|Overall Study|Not able to get to clinic|0|||
128754325|NCT01302847|463388746|FG005|Overall Study|Not able to get to clinic|0|||
128754326|NCT01302847|463388747|FG006|Overall Study|Not able to get to clinic|0|||
128754327|NCT01302847|463388748|FG007|Overall Study|Not able to get to clinic|0|||
128754328|NCT01302847|463388741|FG000|Overall Study|Site closing|2|||
128754329|NCT01302847|463388742|FG001|Overall Study|Site closing|2|||
128754330|NCT01302847|463388743|FG002|Overall Study|Site closing|0|||
128754331|NCT01302847|463388744|FG003|Overall Study|Site closing|0|||
128754332|NCT01302847|463388745|FG004|Overall Study|Site closing|0|||
128754333|NCT01302847|463388746|FG005|Overall Study|Site closing|0|||
128754334|NCT01302847|463388747|FG006|Overall Study|Site closing|0|||
128754335|NCT01302847|463388748|FG007|Overall Study|Site closing|0|||
128754336|NCT01302847|463388741|FG000|Overall Study|Withdrawal by Subject|1|||
128754337|NCT01302847|463388742|FG001|Overall Study|Withdrawal by Subject|0|||
128754338|NCT01302847|463388743|FG002|Overall Study|Withdrawal by Subject|0|||
128754339|NCT01302847|463388744|FG003|Overall Study|Withdrawal by Subject|0|||
128754340|NCT01302847|463388745|FG004|Overall Study|Withdrawal by Subject|1|||
128754341|NCT01302847|463388746|FG005|Overall Study|Withdrawal by Subject|0|||
128754342|NCT01302847|463388747|FG006|Overall Study|Withdrawal by Subject|0|||
128754343|NCT01302847|463388748|FG007|Overall Study|Withdrawal by Subject|1|||
128754344|NCT01302847|463388741|FG000|Overall Study|Not willing to adhere to requirements|5|||
128754345|NCT01302847|463388742|FG001|Overall Study|Not willing to adhere to requirements|0|||
128754346|NCT01302847|463388743|FG002|Overall Study|Not willing to adhere to requirements|1|||
128754347|NCT01302847|463388744|FG003|Overall Study|Not willing to adhere to requirements|0|||
128754348|NCT01302847|463388745|FG004|Overall Study|Not willing to adhere to requirements|0|||
128754349|NCT01302847|463388746|FG005|Overall Study|Not willing to adhere to requirements|0|||
128754350|NCT01302847|463388747|FG006|Overall Study|Not willing to adhere to requirements|0|||
128754351|NCT01302847|463388748|FG007|Overall Study|Not willing to adhere to requirements|2|||
128754352|NCT01302847|463388741|FG000|Overall Study|Site unable to contact participant|2|||
128754353|NCT01302847|463388742|FG001|Overall Study|Site unable to contact participant|1|||
128754354|NCT01302847|463388743|FG002|Overall Study|Site unable to contact participant|0|||
128754355|NCT01302847|463388744|FG003|Overall Study|Site unable to contact participant|0|||
128754356|NCT01302847|463388745|FG004|Overall Study|Site unable to contact participant|0|||
128754357|NCT01302847|463388746|FG005|Overall Study|Site unable to contact participant|0|||
128754358|NCT01302847|463388747|FG006|Overall Study|Site unable to contact participant|2|||
128754359|NCT01302847|463388748|FG007|Overall Study|Site unable to contact participant|0|||
128754360|NCT04302350|463388751|FG000|Overall Study|Physician Decision|1|||
128754361|NCT04302350|463388752|FG001|Overall Study|Physician Decision|1|||
128754362|NCT04302350|463388753|FG002|Overall Study|Physician Decision|2|||
128754363|NCT04302350|463388751|FG000|Overall Study|Lack of Efficacy|1|||
128754364|NCT04302350|463388752|FG001|Overall Study|Lack of Efficacy|1|||
128754365|NCT04302350|463388753|FG002|Overall Study|Lack of Efficacy|4|||
128754366|NCT04302350|463388751|FG000|Overall Study|Adverse Event|0|||
128754367|NCT04302350|463388752|FG001|Overall Study|Adverse Event|1|||
128754368|NCT04302350|463388753|FG002|Overall Study|Adverse Event|2|||
128754369|NCT00374322|463388756|FG000|Overall Study|Lost to Follow-up|92|||
128786429|NCT00157014|463511177|FG002|Overall Study|Patient unable to return in nursing home|0|||
128786430|NCT00157014|463511178|FG003|Overall Study|Patient unable to return in nursing home|0|||
128786431|NCT00157014|463511175|FG000|Overall Study|Patient would not receive transplant|0|||
128786432|NCT00157014|463511176|FG001|Overall Study|Patient would not receive transplant|1|||
128754370|NCT00374322|463388757|FG001|Overall Study|Lost to Follow-up|90|||
128754371|NCT00374322|463388756|FG000|Overall Study|Protocol Violation|8|||
128754372|NCT00374322|463388757|FG001|Overall Study|Protocol Violation|3|||
128754373|NCT00374322|463388756|FG000|Overall Study|Withdrawal by Subject|235|||
128754374|NCT00374322|463388757|FG001|Overall Study|Withdrawal by Subject|167|||
128754375|NCT00374322|463388756|FG000|Overall Study|Sponsor Terminated Study|866|||
128754376|NCT00374322|463388757|FG001|Overall Study|Sponsor Terminated Study|990|||
128754377|NCT00374322|463388756|FG000|Overall Study|Physician Decision|36|||
128754378|NCT00374322|463388757|FG001|Overall Study|Physician Decision|32|||
128754379|NCT00374322|463388756|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
128754380|NCT00374322|463388757|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
128754381|NCT00374322|463388756|FG000|Overall Study|Sponsor Decision|2|||
128754382|NCT00374322|463388757|FG001|Overall Study|Sponsor Decision|3|||
128754383|NCT00374322|463388756|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
128754384|NCT00374322|463388757|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
128754385|NCT00374322|463388756|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
128754386|NCT00374322|463388757|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
128754387|NCT00374322|463388756|FG000|Overall Study|Severe Toxicity|1|||
128754388|NCT00374322|463388757|FG001|Overall Study|Severe Toxicity|0|||
128754389|NCT00374322|463388756|FG000|Overall Study|Site Closed|2|||
128754390|NCT00374322|463388757|FG001|Overall Study|Site Closed|2|||
128754391|NCT00374322|463388756|FG000|Overall Study|Participant Changed Physician|1|||
128754392|NCT00374322|463388757|FG001|Overall Study|Participant Changed Physician|0|||
128754393|NCT00374322|463388756|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
128754394|NCT00374322|463388757|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
128754395|NCT00374322|463388756|FG000|Overall Study|Noncompliance with Study Requirements|0|||
128754396|NCT00374322|463388757|FG001|Overall Study|Noncompliance with Study Requirements|1|||
128754397|NCT00374322|463388756|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
128754398|NCT00374322|463388757|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
128754399|NCT00374322|463388756|FG000|Overall Study|Did Not Receive Study Medication|8|||
128754400|NCT00374322|463388757|FG001|Overall Study|Did Not Receive Study Medication|6|||
128754401|NCT02012491|463388758|FG000|Overall Study|Lost to Follow-up|1|||
128754402|NCT02012491|463388759|FG001|Overall Study|Lost to Follow-up|0|||
128754403|NCT02012491|463388758|FG000|Overall Study|Protocol Violation|0|||
128754404|NCT02012491|463388759|FG001|Overall Study|Protocol Violation|1|||
128754405|NCT02012491|463388758|FG000|Overall Study|Withdrawal by Subject|1|||
128754406|NCT02012491|463388759|FG001|Overall Study|Withdrawal by Subject|0|||
128754407|NCT00450411|463388760|FG000|Overall Study|Protocol Violation|6|||
128754408|NCT00450411|463388760|FG000|Overall Study|No protocol treatment|2|||
128754409|NCT02137369|463388771|FG000|Overall Study|Withdrawal by Subject|3|||
128754410|NCT02137369|463388772|FG001|Overall Study|Withdrawal by Subject|2|||
128754411|NCT02137369|463388771|FG000|Overall Study|Adverse Event|2|||
128754412|NCT02137369|463388772|FG001|Overall Study|Adverse Event|0|||
128754413|NCT02137369|463388771|FG000|Overall Study|Lost to Follow-up|1|||
128754414|NCT02137369|463388772|FG001|Overall Study|Lost to Follow-up|0|||
128754415|NCT02137369|463388771|FG000|Overall Study|Moved away|2|||
128754416|NCT02137369|463388772|FG001|Overall Study|Moved away|0|||
128754417|NCT03969719|463388773|FG000|Overall Study|Other reasons not specified|1|||
128754418|NCT03969719|463388774|FG001|Overall Study|Other reasons not specified|1|||
128754419|NCT03969719|463388775|FG002|Overall Study|Other reasons not specified|3|||
128754420|NCT03969719|463388773|FG000|Overall Study|Withdrawal by Subject|2|||
128754421|NCT03969719|463388774|FG001|Overall Study|Withdrawal by Subject|3|||
128754422|NCT03969719|463388775|FG002|Overall Study|Withdrawal by Subject|2|||
128754423|NCT03969719|463388773|FG000|Overall Study|Protocol Violation|1|||
128754424|NCT03969719|463388774|FG001|Overall Study|Protocol Violation|2|||
128786433|NCT00157014|463511177|FG002|Overall Study|Patient would not receive transplant|0|||
128786434|NCT00157014|463511178|FG003|Overall Study|Patient would not receive transplant|0|||
128754425|NCT03969719|463388775|FG002|Overall Study|Protocol Violation|0|||
128754426|NCT03969719|463388773|FG000|Overall Study|Adverse Event|0|||
128754427|NCT03969719|463388774|FG001|Overall Study|Adverse Event|2|||
128754428|NCT03969719|463388775|FG002|Overall Study|Adverse Event|0|||
128754429|NCT03969719|463388773|FG000|Overall Study|Lost to Follow-up|0|||
128754430|NCT03969719|463388774|FG001|Overall Study|Lost to Follow-up|1|||
128754431|NCT03969719|463388775|FG002|Overall Study|Lost to Follow-up|0|||
128754432|NCT02130193|463388779|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
128754433|NCT02130193|463388780|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
128754434|NCT02130193|463388781|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
128754435|NCT02130193|463388779|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
128754436|NCT02130193|463388780|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
128754437|NCT02130193|463388781|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
128754438|NCT02130193|463388779|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
128754439|NCT02130193|463388780|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
128754440|NCT02130193|463388781|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
128754441|NCT02130193|463388779|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
128754442|NCT02130193|463388780|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
128754443|NCT02130193|463388781|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
128754444|NCT01297959|463388782|FG000|Overall Study|Adverse Event|0|||
128754445|NCT01297959|463388783|FG001|Overall Study|Adverse Event|1|||
128754446|NCT01297959|463388782|FG000|Overall Study|Protocol Violation|2|||
128754447|NCT01297959|463388783|FG001|Overall Study|Protocol Violation|1|||
128754448|NCT01297959|463388782|FG000|Overall Study|Withdrawal by Subject|5|||
128754449|NCT01297959|463388783|FG001|Overall Study|Withdrawal by Subject|4|||
128754450|NCT01297959|463388782|FG000|Overall Study|Physician Decision|0|||
128754451|NCT01297959|463388783|FG001|Overall Study|Physician Decision|1|||
128754452|NCT01297959|463388782|FG000|Overall Study|Unrelated medical illness / complication|0|||
128754453|NCT01297959|463388783|FG001|Overall Study|Unrelated medical illness / complication|2|||
128754454|NCT01297959|463388782|FG000|Overall Study|Other|13|||
128754455|NCT01297959|463388783|FG001|Overall Study|Other|7|||
128754456|NCT01667432|463388784|FG000|Overall Study|Premature Study Termination|26|||
128754457|NCT01667432|463388784|FG000|Overall Study|Failure to Return|10|||
128754458|NCT01667432|463388784|FG000|Overall Study|Moved to Another Center|3|||
128754459|NCT01667432|463388784|FG000|Overall Study|Lost to Follow-up|3|||
128754460|NCT01667432|463388784|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
128754461|NCT01667432|463388784|FG000|Overall Study|Insufficient Therapeutic Response|4|||
128754462|NCT01667432|463388784|FG000|Overall Study|Adverse Event|1|||
128754463|NCT01667432|463388784|FG000|Overall Study|Protocol Deviation|2|||
128754464|NCT01667432|463388784|FG000|Overall Study|Principal Investigator Decision|1|||
128754465|NCT01667432|463388784|FG000|Overall Study|Reason Not Specified|2|||
128754466|NCT01667432|463388784|FG000|Overall Study|Missing Information|4|||
128754467|NCT02077166|463388785|FG000|Overall Study|Death|6|||
128754468|NCT02077166|463388786|FG001|Overall Study|Death|7|||
128754469|NCT02077166|463388787|FG002|Overall Study|Death|5|||
128754470|NCT02077166|463388788|FG003|Overall Study|Death|6|||
128754471|NCT02077166|463388789|FG004|Overall Study|Death|4|||
128754472|NCT02077166|463388790|FG005|Overall Study|Death|32|||
128754473|NCT02077166|463388791|FG006|Overall Study|Death|22|||
128754474|NCT02077166|463388785|FG000|Overall Study|Study Closure by Sponsor|3|||
128754475|NCT02077166|463388786|FG001|Overall Study|Study Closure by Sponsor|0|||
128754476|NCT02077166|463388787|FG002|Overall Study|Study Closure by Sponsor|2|||
128754477|NCT02077166|463388788|FG003|Overall Study|Study Closure by Sponsor|2|||
128754478|NCT02077166|463388789|FG004|Overall Study|Study Closure by Sponsor|2|||
128754479|NCT02077166|463388790|FG005|Overall Study|Study Closure by Sponsor|12|||
128754480|NCT02077166|463388791|FG006|Overall Study|Study Closure by Sponsor|4|||
128754481|NCT02077166|463388785|FG000|Overall Study|Lost to Follow-up|0|||
128754482|NCT02077166|463388786|FG001|Overall Study|Lost to Follow-up|0|||
128754483|NCT02077166|463388787|FG002|Overall Study|Lost to Follow-up|0|||
128754484|NCT02077166|463388788|FG003|Overall Study|Lost to Follow-up|0|||
128754485|NCT02077166|463388789|FG004|Overall Study|Lost to Follow-up|0|||
128754486|NCT02077166|463388790|FG005|Overall Study|Lost to Follow-up|1|||
128754487|NCT02077166|463388791|FG006|Overall Study|Lost to Follow-up|0|||
128754488|NCT02077166|463388785|FG000|Overall Study|Withdrawal by Subject|3|||
128754489|NCT02077166|463388786|FG001|Overall Study|Withdrawal by Subject|0|||
128754490|NCT02077166|463388787|FG002|Overall Study|Withdrawal by Subject|1|||
128754491|NCT02077166|463388788|FG003|Overall Study|Withdrawal by Subject|1|||
128754492|NCT02077166|463388789|FG004|Overall Study|Withdrawal by Subject|1|||
128754493|NCT02077166|463388790|FG005|Overall Study|Withdrawal by Subject|3|||
128754494|NCT02077166|463388791|FG006|Overall Study|Withdrawal by Subject|0|||
128754495|NCT02077166|463388785|FG000|Overall Study|Other, Not Specified|0|||
128754496|NCT02077166|463388786|FG001|Overall Study|Other, Not Specified|0|||
128754497|NCT02077166|463388787|FG002|Overall Study|Other, Not Specified|1|||
128754498|NCT02077166|463388788|FG003|Overall Study|Other, Not Specified|0|||
128754499|NCT02077166|463388789|FG004|Overall Study|Other, Not Specified|1|||
128754500|NCT02077166|463388790|FG005|Overall Study|Other, Not Specified|7|||
128754501|NCT02077166|463388791|FG006|Overall Study|Other, Not Specified|8|||
128754502|NCT00707031|463388792|FG000|Overall Study|Adverse Event|45|||
128754503|NCT00707031|463388793|FG001|Overall Study|Adverse Event|45|||
128754504|NCT00707031|463388792|FG000|Overall Study|Lack of Efficacy|19|||
128754505|NCT00707031|463388793|FG001|Overall Study|Lack of Efficacy|6|||
128754506|NCT00707031|463388792|FG000|Overall Study|Lost to Follow-up|2|||
128754507|NCT00707031|463388793|FG001|Overall Study|Lost to Follow-up|1|||
128754508|NCT00707031|463388792|FG000|Overall Study|Protocol Violation|1|||
128754509|NCT00707031|463388793|FG001|Overall Study|Protocol Violation|0|||
128754510|NCT00707031|463388792|FG000|Overall Study|Withdrawal by Subject|7|||
128754511|NCT00707031|463388793|FG001|Overall Study|Withdrawal by Subject|8|||
128754512|NCT00707031|463388792|FG000|Overall Study|Poor Compliance to Protocol|7|||
128754513|NCT00707031|463388793|FG001|Overall Study|Poor Compliance to Protocol|13|||
128754514|NCT00707031|463388792|FG000|Overall Study|Familial or Personal Reasons|12|||
128754515|NCT00707031|463388793|FG001|Overall Study|Familial or Personal Reasons|15|||
128754516|NCT00707031|463388792|FG000|Overall Study|Serious Noncompliance|2|||
128754517|NCT00707031|463388793|FG001|Overall Study|Serious Noncompliance|3|||
128754518|NCT00707031|463388792|FG000|Overall Study|Sponsor Decision|9|||
128754519|NCT00707031|463388793|FG001|Overall Study|Sponsor Decision|8|||
128754520|NCT00003508|463390573|FG000|Overall Study|Not evaluable|5|||
128754521|NCT04918784|463390574|FG000|Overall Study|Amputation - no longer eligible|1|||
128754522|NCT04918784|463390575|FG001|Overall Study|Amputation - no longer eligible|2|||
128754523|NCT04918784|463390574|FG000|Overall Study|Death|1|||
128754524|NCT04918784|463390575|FG001|Overall Study|Death|0|||
128754525|NCT04918784|463390574|FG000|Overall Study|patient non-compliance|3|||
128754526|NCT04918784|463390575|FG001|Overall Study|patient non-compliance|1|||
128754527|NCT04918784|463390574|FG000|Overall Study|Adverse Event|1|||
128754528|NCT04918784|463390575|FG001|Overall Study|Adverse Event|0|||
128754529|NCT01712009|463390576|FG000|Overall Study|Withdrawal by Subject|24|||
128754530|NCT01712009|463390577|FG001|Overall Study|Withdrawal by Subject|15|||
128754531|NCT01712009|463390578|FG002|Overall Study|Withdrawal by Subject|8|||
128754532|NCT01712009|463390576|FG000|Overall Study|Lost to Follow-up|2|||
128754533|NCT01712009|463390577|FG001|Overall Study|Lost to Follow-up|0|||
128754534|NCT01712009|463390578|FG002|Overall Study|Lost to Follow-up|1|||
128754535|NCT01712009|463390576|FG000|Overall Study|Decision by Sponsor|12|||
128754536|NCT01712009|463390577|FG001|Overall Study|Decision by Sponsor|14|||
128754537|NCT01712009|463390578|FG002|Overall Study|Decision by Sponsor|12|||
128754538|NCT01377480|463390579|FG000|Overall Study|Protocol Violation|0|||
128754539|NCT01377480|463390580|FG001|Overall Study|Protocol Violation|0|||
128754540|NCT01377480|463390581|FG002|Overall Study|Protocol Violation|0|||
128754541|NCT01377480|463390582|FG003|Overall Study|Protocol Violation|4|||
128754542|NCT01377480|463390579|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
128754543|NCT01377480|463390580|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
128754544|NCT01377480|463390581|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
128754545|NCT01377480|463390582|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
128754546|NCT01377480|463390579|FG000|Overall Study|Withdrawal by Subject|0|||
128754547|NCT01377480|463390580|FG001|Overall Study|Withdrawal by Subject|0|||
128754548|NCT01377480|463390581|FG002|Overall Study|Withdrawal by Subject|1|||
128754549|NCT01377480|463390582|FG003|Overall Study|Withdrawal by Subject|0|||
128754550|NCT01377480|463390579|FG000|Overall Study|Serious adverse event|0|||
128754551|NCT01377480|463390580|FG001|Overall Study|Serious adverse event|0|||
128754552|NCT01377480|463390581|FG002|Overall Study|Serious adverse event|1|||
128754553|NCT01377480|463390582|FG003|Overall Study|Serious adverse event|1|||
128754554|NCT01377480|463390579|FG000|Overall Study|Other|0|||
128754555|NCT01377480|463390580|FG001|Overall Study|Other|0|||
128754556|NCT01377480|463390581|FG002|Overall Study|Other|7|||
128754557|NCT01377480|463390582|FG003|Overall Study|Other|6|||
128754558|NCT03576768|463390586|FG000|Overall Study|Lost to Follow-up|3|||
128754559|NCT03576768|463390587|FG001|Overall Study|Lost to Follow-up|3|||
128754560|NCT03576768|463390588|FG002|Overall Study|Lost to Follow-up|0|||
128754561|NCT03576768|463390589|FG003|Overall Study|Lost to Follow-up|0|||
128754562|NCT00590902|463390590|FG000|Overall Study|Death|1|||
128754563|NCT01986881|463390594|FG000|Overall Study|Death|228|||
128754564|NCT01986881|463390595|FG001|Overall Study|Death|233|||
128754565|NCT01986881|463390596|FG002|Overall Study|Death|247|||
128754566|NCT01986881|463390594|FG000|Overall Study|Lost to Follow-up|51|||
128754567|NCT01986881|463390595|FG001|Overall Study|Lost to Follow-up|44|||
128754568|NCT01986881|463390596|FG002|Overall Study|Lost to Follow-up|55|||
128754569|NCT01986881|463390594|FG000|Overall Study|Physician Decision|7|||
128754570|NCT01986881|463390595|FG001|Overall Study|Physician Decision|4|||
128754571|NCT01986881|463390596|FG002|Overall Study|Physician Decision|6|||
128754572|NCT01986881|463390594|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
128754573|NCT01986881|463390595|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
128754574|NCT01986881|463390596|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
128754575|NCT01986881|463390594|FG000|Overall Study|Withdrawal by Subject|41|||
128754576|NCT01986881|463390595|FG001|Overall Study|Withdrawal by Subject|60|||
128754577|NCT01986881|463390596|FG002|Overall Study|Withdrawal by Subject|45|||
128754578|NCT01986881|463390594|FG000|Overall Study|Subject Moved|0|||
128754579|NCT01986881|463390595|FG001|Overall Study|Subject Moved|1|||
128754580|NCT01986881|463390596|FG002|Overall Study|Subject Moved|0|||
128754581|NCT01986881|463390594|FG000|Overall Study|Other|1|||
128754582|NCT01986881|463390595|FG001|Overall Study|Other|2|||
128754583|NCT01986881|463390596|FG002|Overall Study|Other|2|||
128786435|NCT00157014|463511175|FG000|Overall Study|Withdrawal by Subject|1|||
128754584|NCT02586025|463390606|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
128754585|NCT02586025|463390607|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
128754586|NCT02586025|463390606|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
128754587|NCT02586025|463390607|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
128754588|NCT02586025|463390606|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
128754589|NCT02586025|463390607|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
128754590|NCT02586025|463390606|FG000|Neoadjuvant Treatment|Death|1|||
128754591|NCT02586025|463390607|FG001|Neoadjuvant Treatment|Death|0|||
128754592|NCT02586025|463390606|FG000|Neoadjuvant Treatment|Adverse Event|1|||
128754593|NCT02586025|463390607|FG001|Neoadjuvant Treatment|Adverse Event|0|||
128754594|NCT02586025|463390606|FG000|Neoadjuvant Treatment|Physician Decision|2|||
128754595|NCT02586025|463390607|FG001|Neoadjuvant Treatment|Physician Decision|1|||
128754596|NCT02586025|463390606|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
128754597|NCT02586025|463390607|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
128754598|NCT02586025|463390606|FG000|Adjuvant Treatment|Recurrent Disease|4|||
128754599|NCT02586025|463390607|FG001|Adjuvant Treatment|Recurrent Disease|5|||
128754600|NCT02586025|463390606|FG000|Adjuvant Treatment|Physician Decision|0|||
128754601|NCT02586025|463390607|FG001|Adjuvant Treatment|Physician Decision|1|||
128754602|NCT02586025|463390606|FG000|Adjuvant Treatment|Pregnancy|1|||
128754603|NCT02586025|463390607|FG001|Adjuvant Treatment|Pregnancy|0|||
128754604|NCT02586025|463390606|FG000|Treatment-Free Follow-Up|Death|11|||
128754605|NCT02586025|463390607|FG001|Treatment-Free Follow-Up|Death|11|||
128754606|NCT02586025|463390606|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
128754607|NCT02586025|463390607|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
128754608|NCT02586025|463390606|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
128754609|NCT02586025|463390607|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
128754610|NCT02586025|463390606|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
128754611|NCT02586025|463390607|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
128754612|NCT02586025|463390606|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
128754613|NCT02586025|463390607|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
128754614|NCT00175825|463390608|FG000|Overall Study|Adverse Event|3|||
128754615|NCT00175825|463390609|FG001|Overall Study|Adverse Event|2|||
128754616|NCT00175825|463390610|FG002|Overall Study|Adverse Event|1|||
128754617|NCT00175825|463390611|FG003|Overall Study|Adverse Event|1|||
128754618|NCT00175825|463390608|FG000|Overall Study|Lost to Follow-up|1|||
128754619|NCT00175825|463390609|FG001|Overall Study|Lost to Follow-up|2|||
128754620|NCT00175825|463390610|FG002|Overall Study|Lost to Follow-up|0|||
128754621|NCT00175825|463390611|FG003|Overall Study|Lost to Follow-up|0|||
128754622|NCT00175825|463390608|FG000|Overall Study|Withdrawal by Subject|1|||
128754623|NCT00175825|463390609|FG001|Overall Study|Withdrawal by Subject|0|||
128754624|NCT00175825|463390610|FG002|Overall Study|Withdrawal by Subject|0|||
128754625|NCT00175825|463390611|FG003|Overall Study|Withdrawal by Subject|0|||
128754626|NCT02030015|463390612|FG000|Overall Study|Withdrawal by Subject|3|||
128754627|NCT02030015|463390612|FG000|Overall Study|Death|13|||
128754628|NCT00608582|463390614|FG000|Overall Study|Lost to Follow-up|2|||
128754629|NCT00608582|463390615|FG001|Overall Study|Lost to Follow-up|0|||
128754630|NCT00608582|463390614|FG000|Overall Study|No Best Response in Phase 1 located|1|||
128754631|NCT00608582|463390615|FG001|Overall Study|No Best Response in Phase 1 located|1|||
128754632|NCT00608582|463390614|FG000|Overall Study|Illicit Drug Use|1|||
128754633|NCT00608582|463390615|FG001|Overall Study|Illicit Drug Use|0|||
128754634|NCT00608582|463390614|FG000|Overall Study|Early stage Design Change|0|||
128754635|NCT00608582|463390615|FG001|Overall Study|Early stage Design Change|3|||
128754636|NCT04279314|463390627|FG000|Overall Study|Adverse Event|55|||
128754637|NCT04279314|463390627|FG000|Overall Study|Withdrawal by Subject|5|||
128754638|NCT04279314|463390627|FG000|Overall Study|Lack of Efficacy|5|||
128754639|NCT04279314|463390627|FG000|Overall Study|Protocol Violation|3|||
128754640|NCT04279314|463390627|FG000|Overall Study|Other (not COVID-19 related)|2|||
128754641|NCT00160680|463390628|FG000|Overall Study|Adverse Event|0|||
128754642|NCT00160680|463390629|FG001|Overall Study|Adverse Event|1|||
128754643|NCT00160680|463390628|FG000|Overall Study|Lack of Efficacy|2|||
128754644|NCT00160680|463390629|FG001|Overall Study|Lack of Efficacy|1|||
128754645|NCT00160680|463390628|FG000|Overall Study|Lost to Follow-up|3|||
128754646|NCT00160680|463390629|FG001|Overall Study|Lost to Follow-up|2|||
128754647|NCT00160680|463390628|FG000|Overall Study|Withdrawal by Subject|4|||
128754648|NCT00160680|463390629|FG001|Overall Study|Withdrawal by Subject|9|||
128754649|NCT02450331|463390635|FG000|Overall Study|Death|162|||
128754650|NCT02450331|463390636|FG001|Overall Study|Death|171|||
128754651|NCT02450331|463390635|FG000|Overall Study|Lost to Follow-up|14|||
128754652|NCT02450331|463390636|FG001|Overall Study|Lost to Follow-up|12|||
128754653|NCT02450331|463390635|FG000|Overall Study|Withdrawal by Subject|55|||
128754654|NCT02450331|463390636|FG001|Overall Study|Withdrawal by Subject|44|||
128754655|NCT02450331|463390635|FG000|Overall Study|Non-specified other|1|||
128754656|NCT02450331|463390636|FG001|Overall Study|Non-specified other|1|||
128754657|NCT02723864|463390637|FG000|Overall Study|Refused further treatment|1|||
128754658|NCT02723864|463390638|FG001|Overall Study|Refused further treatment|0|||
128754659|NCT02723864|463390639|FG002|Overall Study|Refused further treatment|0|||
128754660|NCT02723864|463390640|FG003|Overall Study|Refused further treatment|0|||
128754661|NCT02723864|463390641|FG004|Overall Study|Refused further treatment|1|||
128754662|NCT02723864|463390642|FG005|Overall Study|Refused further treatment|2|||
128754663|NCT02723864|463390643|FG006|Overall Study|Refused further treatment|0|||
128754664|NCT02723864|463390637|FG000|Overall Study|Exceed treatment hold time|0|||
128754665|NCT02723864|463390638|FG001|Overall Study|Exceed treatment hold time|1|||
128754666|NCT02723864|463390639|FG002|Overall Study|Exceed treatment hold time|0|||
128786436|NCT00157014|463511176|FG001|Overall Study|Withdrawal by Subject|0|||
128786437|NCT00157014|463511177|FG002|Overall Study|Withdrawal by Subject|0|||
128786438|NCT00157014|463511178|FG003|Overall Study|Withdrawal by Subject|0|||
128786439|NCT01362491|463511179|FG000|Overall Study|Ineligible|1|||
128786440|NCT01362491|463511180|FG001|Overall Study|Ineligible|0|||
128786441|NCT01362491|463511181|FG002|Overall Study|Ineligible|0|||
128786442|NCT03181958|463511182|FG000|Overall Study|Lost to Follow-up|17|||
128786443|NCT03181958|463511183|FG001|Overall Study|Lost to Follow-up|21|||
128786444|NCT03181958|463511184|FG002|Overall Study|Lost to Follow-up|15|||
128786445|NCT01257503|463511185|FG000|Overall Study|Lost to Follow-up|7|||
128786446|NCT01257503|463511186|FG001|Overall Study|Lost to Follow-up|10|||
128786447|NCT01257503|463511185|FG000|Overall Study|Over 5 years old at enrollment|0|||
128786448|NCT01257503|463511186|FG001|Overall Study|Over 5 years old at enrollment|1|||
128786449|NCT01257503|463511185|FG000|Overall Study|strep culture positive at enrollment|1|||
128786450|NCT01257503|463511186|FG001|Overall Study|strep culture positive at enrollment|0|||
128786451|NCT05355116|463511187|FG000|Overall Study|Withdrawal by Subject|2|||
128786452|NCT01090024|463511188|FG000|Period 1|Met exclusion criteria|0|||
128786453|NCT01090024|463511189|FG001|Period 1|Met exclusion criteria|0|||
128786454|NCT01090024|463511190|FG002|Period 1|Met exclusion criteria|0|||
128786455|NCT01090024|463511191|FG003|Period 1|Met exclusion criteria|0|||
128786456|NCT01090024|463511192|FG004|Period 1|Met exclusion criteria|0|||
128786457|NCT01090024|463511193|FG005|Period 1|Met exclusion criteria|0|||
128786458|NCT01090024|463511194|FG006|Period 1|Met exclusion criteria|0|||
128786459|NCT01090024|463511195|FG007|Period 1|Met exclusion criteria|0|||
128786460|NCT01090024|463511196|FG008|Period 1|Met exclusion criteria|0|||
128786461|NCT01090024|463511197|FG009|Period 1|Met exclusion criteria|0|||
128786462|NCT01090024|463511198|FG010|Period 1|Met exclusion criteria|0|||
128786463|NCT01090024|463511199|FG011|Period 1|Met exclusion criteria|0|||
128786464|NCT01090024|463511200|FG012|Period 1|Met exclusion criteria|0|||
128786465|NCT01090024|463511201|FG013|Period 1|Met exclusion criteria|0|||
128786466|NCT01090024|463511202|FG014|Period 1|Met exclusion criteria|1|||
128786467|NCT01090024|463511203|FG015|Period 1|Met exclusion criteria|0|||
128786468|NCT01090024|463511204|FG016|Period 1|Met exclusion criteria|0|||
128786469|NCT01090024|463511205|FG017|Period 1|Met exclusion criteria|0|||
128754667|NCT02723864|463390640|FG003|Overall Study|Exceed treatment hold time|0|||
128754668|NCT02723864|463390641|FG004|Overall Study|Exceed treatment hold time|0|||
128754669|NCT02723864|463390642|FG005|Overall Study|Exceed treatment hold time|0|||
128754670|NCT02723864|463390643|FG006|Overall Study|Exceed treatment hold time|0|||
128754671|NCT02723864|463390637|FG000|Overall Study|Clinical progression|0|||
128754672|NCT02723864|463390638|FG001|Overall Study|Clinical progression|0|||
128754673|NCT02723864|463390639|FG002|Overall Study|Clinical progression|1|||
128754674|NCT02723864|463390640|FG003|Overall Study|Clinical progression|0|||
128754675|NCT02723864|463390641|FG004|Overall Study|Clinical progression|0|||
128754676|NCT02723864|463390642|FG005|Overall Study|Clinical progression|3|||
128754677|NCT02723864|463390643|FG006|Overall Study|Clinical progression|1|||
128754678|NCT02723864|463390637|FG000|Overall Study|Physician Decision|0|||
128754679|NCT02723864|463390638|FG001|Overall Study|Physician Decision|0|||
128754680|NCT02723864|463390639|FG002|Overall Study|Physician Decision|0|||
128754681|NCT02723864|463390640|FG003|Overall Study|Physician Decision|0|||
128754682|NCT02723864|463390641|FG004|Overall Study|Physician Decision|0|||
128754683|NCT02723864|463390642|FG005|Overall Study|Physician Decision|0|||
128754684|NCT02723864|463390643|FG006|Overall Study|Physician Decision|1|||
128754685|NCT02723864|463390637|FG000|Overall Study|Changes in patient condition|0|||
128754686|NCT02723864|463390638|FG001|Overall Study|Changes in patient condition|0|||
128754687|NCT02723864|463390639|FG002|Overall Study|Changes in patient condition|0|||
128754688|NCT02723864|463390640|FG003|Overall Study|Changes in patient condition|0|||
128754689|NCT02723864|463390641|FG004|Overall Study|Changes in patient condition|0|||
128754690|NCT02723864|463390642|FG005|Overall Study|Changes in patient condition|1|||
128754691|NCT02723864|463390643|FG006|Overall Study|Changes in patient condition|0|||
128754692|NCT02723864|463390637|FG000|Overall Study|Patient choice|0|||
128754693|NCT02723864|463390638|FG001|Overall Study|Patient choice|0|||
128754694|NCT02723864|463390639|FG002|Overall Study|Patient choice|0|||
128754695|NCT02723864|463390640|FG003|Overall Study|Patient choice|0|||
128754696|NCT02723864|463390641|FG004|Overall Study|Patient choice|0|||
128754697|NCT02723864|463390642|FG005|Overall Study|Patient choice|1|||
128754698|NCT02723864|463390643|FG006|Overall Study|Patient choice|0|||
128754699|NCT02723864|463390637|FG000|Overall Study|Adverse Event|0|||
128754700|NCT02723864|463390638|FG001|Overall Study|Adverse Event|0|||
128754701|NCT02723864|463390639|FG002|Overall Study|Adverse Event|0|||
128754702|NCT02723864|463390640|FG003|Overall Study|Adverse Event|0|||
128754703|NCT02723864|463390641|FG004|Overall Study|Adverse Event|0|||
128786470|NCT01090024|463511188|FG000|Period 1|Adverse Event|0|||
128786471|NCT01090024|463511189|FG001|Period 1|Adverse Event|0|||
128786472|NCT01090024|463511190|FG002|Period 1|Adverse Event|0|||
128786473|NCT01090024|463511191|FG003|Period 1|Adverse Event|0|||
128786474|NCT01090024|463511192|FG004|Period 1|Adverse Event|0|||
128786475|NCT01090024|463511193|FG005|Period 1|Adverse Event|0|||
128786476|NCT01090024|463511194|FG006|Period 1|Adverse Event|0|||
128754704|NCT02723864|463390642|FG005|Overall Study|Adverse Event|1|||
128754705|NCT02723864|463390643|FG006|Overall Study|Adverse Event|0|||
128754706|NCT02723864|463390637|FG000|Overall Study|Started new treatment|0|||
128754707|NCT02723864|463390638|FG001|Overall Study|Started new treatment|0|||
128754708|NCT02723864|463390639|FG002|Overall Study|Started new treatment|0|||
128754709|NCT02723864|463390640|FG003|Overall Study|Started new treatment|0|||
128754710|NCT02723864|463390641|FG004|Overall Study|Started new treatment|0|||
128754711|NCT02723864|463390642|FG005|Overall Study|Started new treatment|1|||
128754712|NCT02723864|463390643|FG006|Overall Study|Started new treatment|0|||
128754713|NCT02723864|463390637|FG000|Overall Study|Switched to alternative treatment|0|||
128754714|NCT02723864|463390638|FG001|Overall Study|Switched to alternative treatment|0|||
128754715|NCT02723864|463390639|FG002|Overall Study|Switched to alternative treatment|0|||
128754716|NCT02723864|463390640|FG003|Overall Study|Switched to alternative treatment|0|||
128754717|NCT02723864|463390641|FG004|Overall Study|Switched to alternative treatment|0|||
128754718|NCT02723864|463390642|FG005|Overall Study|Switched to alternative treatment|1|||
128754719|NCT02723864|463390643|FG006|Overall Study|Switched to alternative treatment|0|||
128754720|NCT02723864|463390637|FG000|Overall Study|Late determination of ineligibility|0|||
128754721|NCT02723864|463390638|FG001|Overall Study|Late determination of ineligibility|0|||
128754722|NCT02723864|463390639|FG002|Overall Study|Late determination of ineligibility|0|||
128754723|NCT02723864|463390640|FG003|Overall Study|Late determination of ineligibility|0|||
128754724|NCT02723864|463390641|FG004|Overall Study|Late determination of ineligibility|0|||
128754725|NCT02723864|463390642|FG005|Overall Study|Late determination of ineligibility|1|||
128754726|NCT02723864|463390643|FG006|Overall Study|Late determination of ineligibility|0|||
128754727|NCT03232983|463390646|FG000|Period 1|Physician Decision|0|||
128754728|NCT03232983|463390647|FG001|Period 1|Physician Decision|0|||
128754729|NCT03232983|463390648|FG002|Period 1|Physician Decision|1|||
128754730|NCT03232983|463390649|FG003|Period 1|Physician Decision|0|||
128754731|NCT03232983|463390646|FG000|Washout Period 2|Physician Decision|0|||
128754732|NCT03232983|463390647|FG001|Washout Period 2|Physician Decision|0|||
128754733|NCT03232983|463390648|FG002|Washout Period 2|Physician Decision|1|||
128754734|NCT03232983|463390649|FG003|Washout Period 2|Physician Decision|0|||
128754735|NCT03232983|463390646|FG000|Washout Period 2|Withdrawal by Subject|0|||
128754736|NCT03232983|463390647|FG001|Washout Period 2|Withdrawal by Subject|0|||
128754737|NCT03232983|463390648|FG002|Washout Period 2|Withdrawal by Subject|0|||
128754738|NCT03232983|463390649|FG003|Washout Period 2|Withdrawal by Subject|1|||
128754739|NCT03232983|463390646|FG000|Period 4|Withdrawal by Subject|1|||
128754740|NCT03232983|463390647|FG001|Period 4|Withdrawal by Subject|0|||
128754741|NCT03232983|463390648|FG002|Period 4|Withdrawal by Subject|0|||
128754742|NCT03232983|463390649|FG003|Period 4|Withdrawal by Subject|0|||
128754743|NCT00483184|463390652|FG000|Overall Study|Withdrawal by Subject|2|||
128754744|NCT00483184|463390653|FG001|Overall Study|Withdrawal by Subject|2|||
128754745|NCT00483184|463390654|FG002|Overall Study|Withdrawal by Subject|0|||
128754746|NCT00483184|463390652|FG000|Overall Study|Lost to Follow-up|1|||
128754747|NCT00483184|463390653|FG001|Overall Study|Lost to Follow-up|0|||
128754748|NCT00483184|463390654|FG002|Overall Study|Lost to Follow-up|0|||
128754749|NCT00483184|463390652|FG000|Overall Study|Adverse Event|1|||
128754750|NCT00483184|463390653|FG001|Overall Study|Adverse Event|2|||
128754751|NCT00483184|463390654|FG002|Overall Study|Adverse Event|2|||
128754752|NCT00483184|463390652|FG000|Overall Study|Protocol Violation|1|||
128754753|NCT00483184|463390653|FG001|Overall Study|Protocol Violation|0|||
128754754|NCT00483184|463390654|FG002|Overall Study|Protocol Violation|1|||
128754755|NCT00558428|463390655|FG000|Overall Study|Adverse Event|6|||
128754756|NCT00558428|463390656|FG001|Overall Study|Adverse Event|22|||
128754757|NCT00558428|463390657|FG002|Overall Study|Adverse Event|3|||
128754758|NCT00558428|463390658|FG003|Overall Study|Adverse Event|4|||
128754759|NCT00558428|463390655|FG000|Overall Study|Lost to Follow-up|0|||
128754760|NCT00558428|463390656|FG001|Overall Study|Lost to Follow-up|1|||
128754761|NCT00558428|463390657|FG002|Overall Study|Lost to Follow-up|0|||
128754762|NCT00558428|463390658|FG003|Overall Study|Lost to Follow-up|0|||
128754763|NCT00558428|463390655|FG000|Overall Study|Lack of Efficacy|0|||
128754764|NCT00558428|463390656|FG001|Overall Study|Lack of Efficacy|0|||
128754765|NCT00558428|463390657|FG002|Overall Study|Lack of Efficacy|1|||
128754766|NCT00558428|463390658|FG003|Overall Study|Lack of Efficacy|2|||
128754767|NCT00558428|463390655|FG000|Overall Study|Non compliant with protocol|1|||
128754768|NCT00558428|463390656|FG001|Overall Study|Non compliant with protocol|0|||
128754769|NCT00558428|463390657|FG002|Overall Study|Non compliant with protocol|0|||
128754770|NCT00558428|463390658|FG003|Overall Study|Non compliant with protocol|3|||
128754771|NCT00558428|463390655|FG000|Overall Study|Consent withdrawn|2|||
128754772|NCT00558428|463390656|FG001|Overall Study|Consent withdrawn|1|||
128754773|NCT00558428|463390657|FG002|Overall Study|Consent withdrawn|0|||
128754774|NCT00558428|463390658|FG003|Overall Study|Consent withdrawn|1|||
128754775|NCT00558428|463390655|FG000|Overall Study|Other|3|||
128754776|NCT00558428|463390656|FG001|Overall Study|Other|0|||
128754777|NCT00558428|463390657|FG002|Overall Study|Other|0|||
128754778|NCT00558428|463390658|FG003|Overall Study|Other|1|||
128754779|NCT00530855|463390659|FG000|Overall Study|Lack of Efficacy|20|||
128786477|NCT01090024|463511195|FG007|Period 1|Adverse Event|0|||
128786478|NCT01090024|463511196|FG008|Period 1|Adverse Event|0|||
128786479|NCT01090024|463511197|FG009|Period 1|Adverse Event|1|||
128786480|NCT01090024|463511198|FG010|Period 1|Adverse Event|0|||
128786481|NCT01090024|463511199|FG011|Period 1|Adverse Event|1|||
128786482|NCT01090024|463511200|FG012|Period 1|Adverse Event|0|||
128786483|NCT01090024|463511201|FG013|Period 1|Adverse Event|0|||
128786484|NCT01090024|463511202|FG014|Period 1|Adverse Event|0|||
128786485|NCT01090024|463511203|FG015|Period 1|Adverse Event|0|||
128786486|NCT01090024|463511204|FG016|Period 1|Adverse Event|0|||
128786487|NCT01090024|463511205|FG017|Period 1|Adverse Event|1|||
128786488|NCT01090024|463511188|FG000|Period 1|Withdrawal by Subject|0|||
128786489|NCT01090024|463511189|FG001|Period 1|Withdrawal by Subject|0|||
128786490|NCT01090024|463511190|FG002|Period 1|Withdrawal by Subject|0|||
128786491|NCT01090024|463511191|FG003|Period 1|Withdrawal by Subject|1|||
128786492|NCT01090024|463511192|FG004|Period 1|Withdrawal by Subject|0|||
128786493|NCT01090024|463511193|FG005|Period 1|Withdrawal by Subject|0|||
128786494|NCT01090024|463511194|FG006|Period 1|Withdrawal by Subject|0|||
128786495|NCT01090024|463511195|FG007|Period 1|Withdrawal by Subject|0|||
128786496|NCT01090024|463511196|FG008|Period 1|Withdrawal by Subject|0|||
128786497|NCT01090024|463511197|FG009|Period 1|Withdrawal by Subject|0|||
128786498|NCT01090024|463511198|FG010|Period 1|Withdrawal by Subject|0|||
128786499|NCT01090024|463511199|FG011|Period 1|Withdrawal by Subject|0|||
128786500|NCT01090024|463511200|FG012|Period 1|Withdrawal by Subject|0|||
128786501|NCT01090024|463511201|FG013|Period 1|Withdrawal by Subject|0|||
128786502|NCT01090024|463511202|FG014|Period 1|Withdrawal by Subject|0|||
128786503|NCT01090024|463511203|FG015|Period 1|Withdrawal by Subject|0|||
128786504|NCT01090024|463511204|FG016|Period 1|Withdrawal by Subject|0|||
128786505|NCT01090024|463511205|FG017|Period 1|Withdrawal by Subject|0|||
128786506|NCT01090024|463511188|FG000|Period 1|Lost to Follow-up|0|||
128786507|NCT01090024|463511189|FG001|Period 1|Lost to Follow-up|1|||
128786508|NCT01090024|463511190|FG002|Period 1|Lost to Follow-up|0|||
128786509|NCT01090024|463511191|FG003|Period 1|Lost to Follow-up|0|||
128786510|NCT01090024|463511192|FG004|Period 1|Lost to Follow-up|0|||
128786511|NCT01090024|463511193|FG005|Period 1|Lost to Follow-up|0|||
128786512|NCT01090024|463511194|FG006|Period 1|Lost to Follow-up|0|||
128786513|NCT01090024|463511195|FG007|Period 1|Lost to Follow-up|0|||
128786514|NCT01090024|463511196|FG008|Period 1|Lost to Follow-up|0|||
128786515|NCT01090024|463511197|FG009|Period 1|Lost to Follow-up|0|||
128786516|NCT01090024|463511198|FG010|Period 1|Lost to Follow-up|0|||
128786517|NCT01090024|463511199|FG011|Period 1|Lost to Follow-up|0|||
128786518|NCT01090024|463511200|FG012|Period 1|Lost to Follow-up|0|||
128786519|NCT01090024|463511201|FG013|Period 1|Lost to Follow-up|0|||
128786520|NCT01090024|463511202|FG014|Period 1|Lost to Follow-up|0|||
128786521|NCT01090024|463511203|FG015|Period 1|Lost to Follow-up|0|||
128786522|NCT01090024|463511204|FG016|Period 1|Lost to Follow-up|0|||
128754780|NCT00530855|463390659|FG000|Overall Study|Withdrawal by Subject|30|||
128754781|NCT00530855|463390659|FG000|Overall Study|Fatal Serious AE|3|||
128754782|NCT00530855|463390659|FG000|Overall Study|Non Fatal Serious AE|7|||
128754783|NCT00530855|463390659|FG000|Overall Study|Non Fatal Non Serious AE|12|||
128754784|NCT00530855|463390659|FG000|Overall Study|Protocol Violation|3|||
128754785|NCT00530855|463390659|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
128754786|NCT00530855|463390659|FG000|Overall Study|Lost to Follow-up|9|||
128754787|NCT00530855|463390659|FG000|Overall Study|Other reason for premature termination|17|||
128754788|NCT00815295|463390660|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
128754789|NCT00815295|463390661|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
128754790|NCT00815295|463390662|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
128754791|NCT05224050|463390663|FG000|Overall Study|Withdrawal by Subject|9|||
128754792|NCT05224050|463390663|FG000|Overall Study|Lost to Follow-up|3|||
128754793|NCT01627327|463390664|FG000|Overall Study|Adverse Event|6|||
128786523|NCT01090024|463511205|FG017|Period 1|Lost to Follow-up|0|||
128786524|NCT01090024|463511188|FG000|Period 2|Lost to Follow-up|0|||
128786525|NCT01090024|463511189|FG001|Period 2|Lost to Follow-up|0|||
128786526|NCT01090024|463511190|FG002|Period 2|Lost to Follow-up|0|||
128754794|NCT01627327|463390665|FG001|Overall Study|Adverse Event|12|||
128754795|NCT01627327|463390664|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
128754796|NCT01627327|463390665|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
128754797|NCT01627327|463390664|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
128754798|NCT01627327|463390665|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
128786527|NCT01090024|463511191|FG003|Period 2|Lost to Follow-up|1|||
128786528|NCT01090024|463511192|FG004|Period 2|Lost to Follow-up|0|||
128786529|NCT01090024|463511193|FG005|Period 2|Lost to Follow-up|0|||
128786530|NCT01090024|463511194|FG006|Period 2|Lost to Follow-up|0|||
128786531|NCT01090024|463511195|FG007|Period 2|Lost to Follow-up|0|||
128786532|NCT01090024|463511196|FG008|Period 2|Lost to Follow-up|0|||
128786533|NCT01090024|463511197|FG009|Period 2|Lost to Follow-up|0|||
128786534|NCT01090024|463511198|FG010|Period 2|Lost to Follow-up|0|||
128786535|NCT01090024|463511199|FG011|Period 2|Lost to Follow-up|0|||
128786536|NCT01090024|463511200|FG012|Period 2|Lost to Follow-up|0|||
128786537|NCT01090024|463511201|FG013|Period 2|Lost to Follow-up|0|||
128754799|NCT01627327|463390664|FG000|Overall Study|Protocol Violation|4|||
128754800|NCT01627327|463390665|FG001|Overall Study|Protocol Violation|10|||
128754801|NCT01627327|463390664|FG000|Overall Study|Lost to Follow-up|1|||
128754802|NCT01627327|463390665|FG001|Overall Study|Lost to Follow-up|3|||
128754803|NCT01627327|463390664|FG000|Overall Study|Physician Decision|1|||
128754804|NCT01627327|463390665|FG001|Overall Study|Physician Decision|0|||
128754805|NCT01627327|463390664|FG000|Overall Study|Withdrawal by Subject|3|||
128754806|NCT01627327|463390665|FG001|Overall Study|Withdrawal by Subject|3|||
128754807|NCT01137474|463390668|FG000|Overall Study|Adverse Event|3|||
128754808|NCT01137474|463390669|FG001|Overall Study|Adverse Event|5|||
128754809|NCT01137474|463390670|FG002|Overall Study|Adverse Event|1|||
128754810|NCT01137474|463390671|FG003|Overall Study|Adverse Event|3|||
128754811|NCT01137474|463390668|FG000|Overall Study|Withdrawal by Subject|7|||
128754812|NCT01137474|463390669|FG001|Overall Study|Withdrawal by Subject|2|||
128754813|NCT01137474|463390670|FG002|Overall Study|Withdrawal by Subject|6|||
128754814|NCT01137474|463390671|FG003|Overall Study|Withdrawal by Subject|9|||
128754815|NCT01137474|463390668|FG000|Overall Study|No longer met study criteria|6|||
128754816|NCT01137474|463390669|FG001|Overall Study|No longer met study criteria|1|||
128754817|NCT01137474|463390670|FG002|Overall Study|No longer met study criteria|0|||
128754818|NCT01137474|463390671|FG003|Overall Study|No longer met study criteria|5|||
128754819|NCT01137474|463390668|FG000|Overall Study|Lost to Follow-up|5|||
128754820|NCT01137474|463390669|FG001|Overall Study|Lost to Follow-up|1|||
128754821|NCT01137474|463390670|FG002|Overall Study|Lost to Follow-up|0|||
128754822|NCT01137474|463390671|FG003|Overall Study|Lost to Follow-up|2|||
128754823|NCT01137474|463390668|FG000|Overall Study|Lack of Efficacy|0|||
128754824|NCT01137474|463390669|FG001|Overall Study|Lack of Efficacy|0|||
128754825|NCT01137474|463390670|FG002|Overall Study|Lack of Efficacy|0|||
128754826|NCT01137474|463390671|FG003|Overall Study|Lack of Efficacy|2|||
128754827|NCT01137474|463390668|FG000|Overall Study|Other|3|||
128754828|NCT01137474|463390669|FG001|Overall Study|Other|1|||
128754829|NCT01137474|463390670|FG002|Overall Study|Other|0|||
128754830|NCT01137474|463390671|FG003|Overall Study|Other|0|||
128754831|NCT01137474|463390668|FG000|Overall Study|Pregnancy|0|||
128754832|NCT01137474|463390669|FG001|Overall Study|Pregnancy|1|||
128754833|NCT01137474|463390670|FG002|Overall Study|Pregnancy|0|||
128754834|NCT01137474|463390671|FG003|Overall Study|Pregnancy|0|||
128754835|NCT01137474|463390668|FG000|Overall Study|Administrative reason by sponsor|0|||
128754836|NCT01137474|463390669|FG001|Overall Study|Administrative reason by sponsor|1|||
128754837|NCT01137474|463390670|FG002|Overall Study|Administrative reason by sponsor|0|||
128754838|NCT01137474|463390671|FG003|Overall Study|Administrative reason by sponsor|0|||
128754839|NCT00743366|463390674|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
128754840|NCT00743366|463390675|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
128754841|NCT03206203|463390676|FG000|Treatment|Death|38|||
128754842|NCT03206203|463390677|FG001|Treatment|Death|26|||
128754843|NCT03206203|463390678|FG002|Treatment|Death|0|||
128754844|NCT03206203|463390676|FG000|Treatment|Withdrawal by Subject|1|||
128754845|NCT03206203|463390677|FG001|Treatment|Withdrawal by Subject|0|||
128754846|NCT03206203|463390678|FG002|Treatment|Withdrawal by Subject|0|||
128754847|NCT03206203|463390676|FG000|Treatment|Lost to Follow-up|4|||
128754848|NCT03206203|463390677|FG001|Treatment|Lost to Follow-up|0|||
128754849|NCT03206203|463390678|FG002|Treatment|Lost to Follow-up|0|||
128754850|NCT03206203|463390676|FG000|Treatment|N/A in Follow-Up|8|||
128754851|NCT03206203|463390677|FG001|Treatment|N/A in Follow-Up|1|||
128754852|NCT03206203|463390678|FG002|Treatment|N/A in Follow-Up|0|||
128754853|NCT03206203|463390676|FG000|Treatment|Disease progression|0|||
128754854|NCT03206203|463390677|FG001|Treatment|Disease progression|1|||
128754855|NCT03206203|463390678|FG002|Treatment|Disease progression|0|||
128754856|NCT03206203|463390676|FG000|Treatment|Refused follow-up|0|||
128754857|NCT03206203|463390677|FG001|Treatment|Refused follow-up|1|||
128754858|NCT03206203|463390678|FG002|Treatment|Refused follow-up|0|||
128754859|NCT03206203|463390676|FG000|Treatment|Cross over to Arm 1|0|||
128754860|NCT03206203|463390677|FG001|Treatment|Cross over to Arm 1|19|||
128754861|NCT03206203|463390678|FG002|Treatment|Cross over to Arm 1|0|||
128754862|NCT03206203|463390676|FG000|Optional Cross-Over|Death|0|||
128754863|NCT03206203|463390677|FG001|Optional Cross-Over|Death|0|||
128754864|NCT03206203|463390678|FG002|Optional Cross-Over|Death|14|||
128754865|NCT03206203|463390676|FG000|Optional Cross-Over|Refused follow-up|0|||
128754866|NCT03206203|463390677|FG001|Optional Cross-Over|Refused follow-up|0|||
128754867|NCT03206203|463390678|FG002|Optional Cross-Over|Refused follow-up|2|||
128754868|NCT00335322|463390679|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
128754869|NCT00335322|463390680|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
128754870|NCT00335322|463390681|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
128754871|NCT03364751|463390684|FG000|Overall Study|Withdrawal by Subject|1|||
128786538|NCT01090024|463511202|FG014|Period 2|Lost to Follow-up|0|||
128786539|NCT01090024|463511203|FG015|Period 2|Lost to Follow-up|0|||
128754872|NCT03364751|463390685|FG001|Overall Study|Withdrawal by Subject|0|||
128754873|NCT03364751|463390686|FG002|Overall Study|Withdrawal by Subject|0|||
128754874|NCT03364751|463390687|FG003|Overall Study|Withdrawal by Subject|0|||
128754875|NCT03364751|463390684|FG000|Overall Study|Lost to Follow-up|0|||
128754876|NCT03364751|463390685|FG001|Overall Study|Lost to Follow-up|1|||
128754877|NCT03364751|463390686|FG002|Overall Study|Lost to Follow-up|0|||
128754878|NCT03364751|463390687|FG003|Overall Study|Lost to Follow-up|0|||
128754879|NCT01328080|463390688|FG000|Overall Study|Lost to Follow-up|5|||
128754880|NCT00862134|463390689|FG000|Overall Study|Death|1|||
128754881|NCT00862134|463390690|FG001|Overall Study|Death|0|||
128754882|NCT00862134|463390689|FG000|Overall Study|Physician Decision|0|||
128754883|NCT00862134|463390690|FG001|Overall Study|Physician Decision|1|||
128754884|NCT00862134|463390689|FG000|Overall Study|Withdrawal by Subject|1|||
128754885|NCT00862134|463390690|FG001|Overall Study|Withdrawal by Subject|2|||
128754886|NCT00862134|463390689|FG000|Overall Study|Sponsor terminated study|5|||
128754887|NCT00862134|463390690|FG001|Overall Study|Sponsor terminated study|7|||
128754888|NCT00862134|463390689|FG000|Overall Study|Adverse Event|2|||
128754889|NCT00862134|463390690|FG001|Overall Study|Adverse Event|2|||
128754890|NCT00862134|463390689|FG000|Overall Study|Withdrew prior to dosing|2|||
128754891|NCT00862134|463390690|FG001|Overall Study|Withdrew prior to dosing|0|||
128754892|NCT02191267|463390691|FG000|Overall Study|Withdrawal by Subject|1|||
128754893|NCT02191267|463390692|FG001|Overall Study|Withdrawal by Subject|0|||
128754894|NCT02191267|463390693|FG002|Overall Study|Withdrawal by Subject|0|||
128754895|NCT00818753|463390694|FG000|Overall Study|Protocol Violation|1|||
128754896|NCT00818753|463390695|FG001|Overall Study|Protocol Violation|0|||
128754897|NCT00818753|463390696|FG002|Overall Study|Protocol Violation|0|||
128754898|NCT00818753|463390694|FG000|Overall Study|Other reason (not specified)|0|||
128754899|NCT00818753|463390695|FG001|Overall Study|Other reason (not specified)|0|||
128754900|NCT00818753|463390696|FG002|Overall Study|Other reason (not specified)|1|||
128754901|NCT00818753|463390694|FG000|Overall Study|Randomised and not treated|2|||
128754902|NCT00818753|463390695|FG001|Overall Study|Randomised and not treated|0|||
128754903|NCT00818753|463390696|FG002|Overall Study|Randomised and not treated|0|||
128754904|NCT01389973|463390697|FG000|Overall Study|Lost to Follow-up|1|||
128754905|NCT01389973|463390697|FG000|Overall Study|Trial Stopped by Sponsor|9|||
128754906|NCT01389973|463390697|FG000|Overall Study|Other|10|||
128754907|NCT02626780|463390698|FG000|Overall Study|Withdrawal by Subject|3|||
128754908|NCT04304833|463390699|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
128754909|NCT04304833|463390700|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
128754910|NCT03456700|463390701|FG000|Overall Study|Withdrawal by Subject|1|||
128754911|NCT04154787|463390702|FG000|Overall Study|Adverse Event|0|||
128754912|NCT04154787|463390703|FG001|Overall Study|Adverse Event|1|||
128754913|NCT04154787|463390704|FG002|Overall Study|Adverse Event|0|||
128754914|NCT04154787|463390702|FG000|Overall Study|Patient Requires Other Treatment|0|||
128754915|NCT04154787|463390703|FG001|Overall Study|Patient Requires Other Treatment|1|||
128754916|NCT04154787|463390704|FG002|Overall Study|Patient Requires Other Treatment|0|||
128754917|NCT04154787|463390702|FG000|Overall Study|Study Terminated By Sponsor|0|||
128754918|NCT04154787|463390703|FG001|Overall Study|Study Terminated By Sponsor|6|||
128754919|NCT04154787|463390704|FG002|Overall Study|Study Terminated By Sponsor|1|||
128754920|NCT04154787|463390702|FG000|Overall Study|Subject Decision|0|||
128754921|NCT04154787|463390703|FG001|Overall Study|Subject Decision|1|||
128754922|NCT04154787|463390704|FG002|Overall Study|Subject Decision|0|||
128754923|NCT04154787|463390702|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
128754924|NCT04154787|463390703|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
128754925|NCT04154787|463390704|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
128754926|NCT01951625|463390705|FG000|Treatment Period|Protocol Violation|2|||
128754927|NCT01951625|463390706|FG001|Treatment Period|Protocol Violation|0|||
128754928|NCT01951625|463390707|FG002|Treatment Period|Protocol Violation|1|||
128754929|NCT01951625|463390708|FG003|Treatment Period|Protocol Violation|3|||
128754930|NCT01951625|463390709|FG004|Treatment Period|Protocol Violation|2|||
128754931|NCT01951625|463390705|FG000|Treatment Period|Physician Decision|0|||
128754932|NCT01951625|463390706|FG001|Treatment Period|Physician Decision|0|||
128754933|NCT01951625|463390707|FG002|Treatment Period|Physician Decision|0|||
128754934|NCT01951625|463390708|FG003|Treatment Period|Physician Decision|0|||
128754935|NCT01951625|463390709|FG004|Treatment Period|Physician Decision|1|||
128754936|NCT01951625|463390705|FG000|Treatment Period|Protocol driven decision point|0|||
128754937|NCT01951625|463390706|FG001|Treatment Period|Protocol driven decision point|5|||
128754938|NCT01951625|463390707|FG002|Treatment Period|Protocol driven decision point|0|||
128754939|NCT01951625|463390708|FG003|Treatment Period|Protocol driven decision point|2|||
128754940|NCT01951625|463390709|FG004|Treatment Period|Protocol driven decision point|1|||
128754941|NCT01951625|463390705|FG000|Treatment Period|Non compliance with study drug|1|||
128754942|NCT01951625|463390706|FG001|Treatment Period|Non compliance with study drug|2|||
128754943|NCT01951625|463390707|FG002|Treatment Period|Non compliance with study drug|2|||
128754944|NCT01951625|463390708|FG003|Treatment Period|Non compliance with study drug|0|||
128754945|NCT01951625|463390709|FG004|Treatment Period|Non compliance with study drug|0|||
128754946|NCT01951625|463390705|FG000|Treatment Period|Death|3|||
128754947|NCT01951625|463390706|FG001|Treatment Period|Death|2|||
128754948|NCT01951625|463390707|FG002|Treatment Period|Death|2|||
128754949|NCT01951625|463390708|FG003|Treatment Period|Death|1|||
128754950|NCT01951625|463390709|FG004|Treatment Period|Death|2|||
128754951|NCT01951625|463390705|FG000|Treatment Period|Adverse Event|7|||
128754952|NCT01951625|463390706|FG001|Treatment Period|Adverse Event|10|||
128754953|NCT01951625|463390707|FG002|Treatment Period|Adverse Event|9|||
128754954|NCT01951625|463390708|FG003|Treatment Period|Adverse Event|8|||
128754955|NCT01951625|463390709|FG004|Treatment Period|Adverse Event|8|||
128754956|NCT01951625|463390705|FG000|Treatment Period|Withdrawal by Subject|5|||
128754957|NCT01951625|463390706|FG001|Treatment Period|Withdrawal by Subject|2|||
128786540|NCT01090024|463511204|FG016|Period 2|Lost to Follow-up|0|||
128754958|NCT01951625|463390707|FG002|Treatment Period|Withdrawal by Subject|1|||
128754959|NCT01951625|463390708|FG003|Treatment Period|Withdrawal by Subject|7|||
128754960|NCT01951625|463390709|FG004|Treatment Period|Withdrawal by Subject|3|||
128754961|NCT01951625|463390705|FG000|Treatment Period|Lost to Follow-up|1|||
128754962|NCT01951625|463390706|FG001|Treatment Period|Lost to Follow-up|0|||
128754963|NCT01951625|463390707|FG002|Treatment Period|Lost to Follow-up|0|||
128754964|NCT01951625|463390708|FG003|Treatment Period|Lost to Follow-up|1|||
128754965|NCT01951625|463390709|FG004|Treatment Period|Lost to Follow-up|0|||
128754966|NCT01951625|463390705|FG000|Follow Up Period|Non-compliance with study drug|1|||
128754967|NCT01951625|463390706|FG001|Follow Up Period|Non-compliance with study drug|0|||
128754968|NCT01951625|463390707|FG002|Follow Up Period|Non-compliance with study drug|0|||
128754969|NCT01951625|463390708|FG003|Follow Up Period|Non-compliance with study drug|0|||
128754970|NCT01951625|463390709|FG004|Follow Up Period|Non-compliance with study drug|0|||
128754971|NCT01951625|463390705|FG000|Follow Up Period|Death|1|||
128754972|NCT01951625|463390706|FG001|Follow Up Period|Death|3|||
128754973|NCT01951625|463390707|FG002|Follow Up Period|Death|2|||
128754974|NCT01951625|463390708|FG003|Follow Up Period|Death|2|||
128754975|NCT01951625|463390709|FG004|Follow Up Period|Death|1|||
128754976|NCT01951625|463390705|FG000|Follow Up Period|Logistical difficulties|1|||
128754977|NCT01951625|463390706|FG001|Follow Up Period|Logistical difficulties|2|||
128754978|NCT01951625|463390707|FG002|Follow Up Period|Logistical difficulties|0|||
128754979|NCT01951625|463390708|FG003|Follow Up Period|Logistical difficulties|0|||
128754980|NCT01951625|463390709|FG004|Follow Up Period|Logistical difficulties|0|||
128754981|NCT01951625|463390705|FG000|Follow Up Period|Adverse Event|0|||
128754982|NCT01951625|463390706|FG001|Follow Up Period|Adverse Event|3|||
128754983|NCT01951625|463390707|FG002|Follow Up Period|Adverse Event|2|||
128754984|NCT01951625|463390708|FG003|Follow Up Period|Adverse Event|3|||
128754985|NCT01951625|463390709|FG004|Follow Up Period|Adverse Event|5|||
128754986|NCT01951625|463390705|FG000|Follow Up Period|Withdrawal by Subject|4|||
128754987|NCT01951625|463390706|FG001|Follow Up Period|Withdrawal by Subject|1|||
128754988|NCT01951625|463390707|FG002|Follow Up Period|Withdrawal by Subject|0|||
128754989|NCT01951625|463390708|FG003|Follow Up Period|Withdrawal by Subject|5|||
128754990|NCT01951625|463390709|FG004|Follow Up Period|Withdrawal by Subject|3|||
128754991|NCT01951625|463390705|FG000|Follow Up Period|Lost to Follow-up|1|||
128754992|NCT01951625|463390706|FG001|Follow Up Period|Lost to Follow-up|0|||
128754993|NCT01951625|463390707|FG002|Follow Up Period|Lost to Follow-up|0|||
128754994|NCT01951625|463390708|FG003|Follow Up Period|Lost to Follow-up|1|||
128754995|NCT01951625|463390709|FG004|Follow Up Period|Lost to Follow-up|1|||
128754996|NCT02459574|463390712|FG000|Overall Study|Withdrawal by Subject|6|||
128754997|NCT02459574|463390713|FG001|Overall Study|Withdrawal by Subject|6|||
128754998|NCT02459574|463390714|FG002|Overall Study|Withdrawal by Subject|2|||
128754999|NCT02459574|463390712|FG000|Overall Study|Lost to Follow-up|1|||
128755000|NCT02459574|463390713|FG001|Overall Study|Lost to Follow-up|1|||
128755001|NCT02459574|463390714|FG002|Overall Study|Lost to Follow-up|0|||
128755002|NCT02459574|463390712|FG000|Overall Study|Death|0|||
128755003|NCT02459574|463390713|FG001|Overall Study|Death|1|||
128755004|NCT02459574|463390714|FG002|Overall Study|Death|0|||
128755005|NCT00251745|463390715|FG000|Overall Study|Adverse Event|7|||
128755006|NCT00251745|463390716|FG001|Overall Study|Adverse Event|9|||
128755007|NCT00251745|463390717|FG002|Overall Study|Adverse Event|11|||
128755008|NCT00251745|463390715|FG000|Overall Study|Lost to Follow-up|4|||
128755009|NCT00251745|463390716|FG001|Overall Study|Lost to Follow-up|2|||
128755010|NCT00251745|463390717|FG002|Overall Study|Lost to Follow-up|5|||
128755011|NCT00251745|463390715|FG000|Overall Study|Withdrawal by Subject|13|||
128755012|NCT00251745|463390716|FG001|Overall Study|Withdrawal by Subject|7|||
128755013|NCT00251745|463390717|FG002|Overall Study|Withdrawal by Subject|3|||
128755014|NCT00251745|463390715|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
128755015|NCT00251745|463390716|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
128755016|NCT00251745|463390717|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
128755017|NCT00251745|463390715|FG000|Overall Study|Lack of Efficacy|3|||
128755018|NCT00251745|463390716|FG001|Overall Study|Lack of Efficacy|0|||
128755019|NCT00251745|463390717|FG002|Overall Study|Lack of Efficacy|0|||
128755020|NCT00251745|463390715|FG000|Overall Study|Noncompliant|0|||
128755021|NCT00251745|463390716|FG001|Overall Study|Noncompliant|2|||
128755022|NCT00251745|463390717|FG002|Overall Study|Noncompliant|2|||
128755023|NCT00251745|463390715|FG000|Overall Study|Pregnancy|0|||
128755024|NCT00251745|463390716|FG001|Overall Study|Pregnancy|1|||
128755025|NCT00251745|463390717|FG002|Overall Study|Pregnancy|0|||
128755026|NCT00251745|463390715|FG000|Overall Study|Per Subject Request|0|||
128755027|NCT00251745|463390716|FG001|Overall Study|Per Subject Request|0|||
128755028|NCT00251745|463390717|FG002|Overall Study|Per Subject Request|1|||
128755029|NCT00251745|463390715|FG000|Overall Study|Per Investigator Request|1|||
128755030|NCT00251745|463390716|FG001|Overall Study|Per Investigator Request|0|||
128755031|NCT00251745|463390717|FG002|Overall Study|Per Investigator Request|0|||
128755032|NCT04866017|463390720|FG000|Overall Study|Study Terminated by Sponsor|13|||
128755033|NCT04866017|463390721|FG001|Overall Study|Study Terminated by Sponsor|14|||
128755034|NCT04866017|463390722|FG002|Overall Study|Study Terminated by Sponsor|13|||
128755035|NCT04866017|463390720|FG000|Overall Study|Death|8|||
128755036|NCT04866017|463390721|FG001|Overall Study|Death|4|||
128755037|NCT04866017|463390722|FG002|Overall Study|Death|8|||
128755038|NCT04866017|463390720|FG000|Overall Study|Withdrawal by Subject|1|||
128755039|NCT04866017|463390721|FG001|Overall Study|Withdrawal by Subject|0|||
128755040|NCT04866017|463390722|FG002|Overall Study|Withdrawal by Subject|1|||
128755041|NCT04866017|463390720|FG000|Overall Study|Physician Decision|0|||
128755042|NCT04866017|463390721|FG001|Overall Study|Physician Decision|1|||
128755043|NCT04866017|463390722|FG002|Overall Study|Physician Decision|0|||
128755044|NCT01475136|463390723|FG000|Overall Study|Sponsor Decision|0|||
128755045|NCT01475136|463390724|FG001|Overall Study|Sponsor Decision|1|||
128755046|NCT01475136|463390725|FG002|Overall Study|Sponsor Decision|0|||
128755047|NCT01475136|463390726|FG003|Overall Study|Sponsor Decision|0|||
128755048|NCT01475136|463390723|FG000|Overall Study|Entry Criteria Not Met|0|||
128755049|NCT01475136|463390724|FG001|Overall Study|Entry Criteria Not Met|2|||
128755050|NCT01475136|463390725|FG002|Overall Study|Entry Criteria Not Met|3|||
128755051|NCT01475136|463390726|FG003|Overall Study|Entry Criteria Not Met|1|||
128755052|NCT01475136|463390723|FG000|Overall Study|Withdrawal by Subject|0|||
128755053|NCT01475136|463390724|FG001|Overall Study|Withdrawal by Subject|0|||
128755054|NCT01475136|463390725|FG002|Overall Study|Withdrawal by Subject|0|||
128755055|NCT01475136|463390726|FG003|Overall Study|Withdrawal by Subject|2|||
128755056|NCT01475136|463390723|FG000|Overall Study|Adverse Event|1|||
128755057|NCT01475136|463390724|FG001|Overall Study|Adverse Event|0|||
128755058|NCT01475136|463390725|FG002|Overall Study|Adverse Event|0|||
128755059|NCT01475136|463390726|FG003|Overall Study|Adverse Event|1|||
128755060|NCT01475136|463390723|FG000|Overall Study|Death|0|||
128755061|NCT01475136|463390724|FG001|Overall Study|Death|0|||
128755062|NCT01475136|463390725|FG002|Overall Study|Death|0|||
128755063|NCT01475136|463390726|FG003|Overall Study|Death|1|||
128755064|NCT03355326|463390727|FG000|Overall Study|Protocol Violation|3|||
128755065|NCT03355326|463390728|FG001|Overall Study|Protocol Violation|3|||
128755066|NCT04179175|463392381|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
128755067|NCT04179175|463392382|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
128755068|NCT04179175|463392383|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
128755069|NCT04179175|463392384|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
128755070|NCT04179175|463392385|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
128755071|NCT04179175|463392386|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
128755072|NCT04179175|463392381|FG000|Overall Study|Adverse Event|5|||
128755073|NCT04179175|463392382|FG001|Overall Study|Adverse Event|3|||
128755074|NCT04179175|463392383|FG002|Overall Study|Adverse Event|3|||
128755075|NCT04179175|463392384|FG003|Overall Study|Adverse Event|4|||
128755076|NCT04179175|463392385|FG004|Overall Study|Adverse Event|6|||
128755077|NCT04179175|463392386|FG005|Overall Study|Adverse Event|6|||
128755078|NCT04179175|463392381|FG000|Overall Study|Lack of Efficacy|5|||
128755079|NCT04179175|463392382|FG001|Overall Study|Lack of Efficacy|1|||
128755080|NCT04179175|463392383|FG002|Overall Study|Lack of Efficacy|3|||
128755081|NCT04179175|463392384|FG003|Overall Study|Lack of Efficacy|2|||
128755082|NCT04179175|463392385|FG004|Overall Study|Lack of Efficacy|18|||
128755083|NCT04179175|463392386|FG005|Overall Study|Lack of Efficacy|7|||
128755084|NCT04179175|463392381|FG000|Overall Study|Lost to Follow-up|5|||
128755085|NCT04179175|463392382|FG001|Overall Study|Lost to Follow-up|3|||
128755086|NCT04179175|463392383|FG002|Overall Study|Lost to Follow-up|2|||
128755087|NCT04179175|463392384|FG003|Overall Study|Lost to Follow-up|2|||
128755088|NCT04179175|463392385|FG004|Overall Study|Lost to Follow-up|4|||
128755089|NCT04179175|463392386|FG005|Overall Study|Lost to Follow-up|5|||
128755090|NCT04179175|463392381|FG000|Overall Study|Physician Decision|2|||
128755091|NCT04179175|463392382|FG001|Overall Study|Physician Decision|0|||
128755092|NCT04179175|463392383|FG002|Overall Study|Physician Decision|2|||
128755093|NCT04179175|463392384|FG003|Overall Study|Physician Decision|3|||
128755094|NCT04179175|463392385|FG004|Overall Study|Physician Decision|1|||
128755095|NCT04179175|463392386|FG005|Overall Study|Physician Decision|1|||
128755096|NCT04179175|463392381|FG000|Overall Study|Pregnancy|3|||
128755097|NCT04179175|463392382|FG001|Overall Study|Pregnancy|0|||
128755098|NCT04179175|463392383|FG002|Overall Study|Pregnancy|3|||
128755099|NCT04179175|463392384|FG003|Overall Study|Pregnancy|0|||
128755100|NCT04179175|463392385|FG004|Overall Study|Pregnancy|1|||
128755101|NCT04179175|463392386|FG005|Overall Study|Pregnancy|2|||
128755102|NCT04179175|463392381|FG000|Overall Study|Withdrawal by Subject|22|||
128755103|NCT04179175|463392382|FG001|Overall Study|Withdrawal by Subject|10|||
128755104|NCT04179175|463392383|FG002|Overall Study|Withdrawal by Subject|12|||
128755105|NCT04179175|463392384|FG003|Overall Study|Withdrawal by Subject|8|||
128755106|NCT04179175|463392385|FG004|Overall Study|Withdrawal by Subject|23|||
128755107|NCT04179175|463392386|FG005|Overall Study|Withdrawal by Subject|31|||
128755108|NCT04179175|463392381|FG000|Overall Study|Technical problems|0|||
128755109|NCT04179175|463392382|FG001|Overall Study|Technical problems|0|||
128755110|NCT04179175|463392383|FG002|Overall Study|Technical problems|1|||
128755111|NCT04179175|463392384|FG003|Overall Study|Technical problems|1|||
128755112|NCT04179175|463392385|FG004|Overall Study|Technical problems|0|||
128755113|NCT04179175|463392386|FG005|Overall Study|Technical problems|0|||
128755114|NCT03014674|463392388|FG000|Overall Study|Withdrawal by Subject|1|||
128755115|NCT03014674|463392389|FG001|Overall Study|Withdrawal by Subject|0|||
128755116|NCT03014674|463392390|FG002|Overall Study|Withdrawal by Subject|0|||
128755117|NCT03224182|463392391|FG000|Overall Study|Study Drug Not Instilled|6|||
128755118|NCT03224182|463392392|FG001|Overall Study|Study Drug Not Instilled|1|||
128755119|NCT03224182|463392391|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
128755120|NCT03224182|463392392|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
128755121|NCT03224182|463392391|FG000|Overall Study|Withdrew of Consent|4|||
128755122|NCT03224182|463392392|FG001|Overall Study|Withdrew of Consent|2|||
128755123|NCT03224182|463392391|FG000|Overall Study|Investigator Decision|3|||
128755124|NCT03224182|463392392|FG001|Overall Study|Investigator Decision|1|||
128755125|NCT03224182|463392391|FG000|Overall Study|Sponsor Decision|26|||
128755126|NCT03224182|463392392|FG001|Overall Study|Sponsor Decision|12|||
128755127|NCT03224182|463392391|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
128755128|NCT03224182|463392392|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
128755129|NCT03224182|463392391|FG000|Overall Study|Lost to Follow-up|1|||
128755130|NCT03224182|463392392|FG001|Overall Study|Lost to Follow-up|0|||
128755131|NCT03224182|463392391|FG000|Overall Study|Participant Had Recurrence|11|||
128755132|NCT03224182|463392392|FG001|Overall Study|Participant Had Recurrence|5|||
128755133|NCT03224182|463392391|FG000|Overall Study|Death|0|||
128755134|NCT03224182|463392392|FG001|Overall Study|Death|1|||
128755135|NCT03224182|463392391|FG000|Overall Study|Reason not Specified|3|||
128755136|NCT03224182|463392392|FG001|Overall Study|Reason not Specified|3|||
128755137|NCT03224182|463392391|FG000|Overall Study|Other|1|||
128755138|NCT03224182|463392392|FG001|Overall Study|Other|0|||
128755139|NCT02822222|463392393|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
128755140|NCT02822222|463392394|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
128755141|NCT02481310|463392395|FG000|Follow up|Still in follow up|0|||
128755142|NCT02481310|463392396|FG001|Follow up|Still in follow up|3|||
128755143|NCT02481310|463392397|FG002|Follow up|Still in follow up|0|||
128755144|NCT00833560|463392398|FG000|Overall Study|Toxicity|13|||
128755145|NCT00833560|463392398|FG000|Overall Study|Adverse Event|11|||
128755146|NCT00833560|463392398|FG000|Overall Study|Protocol Violation|6|||
128755147|NCT00833560|463392398|FG000|Overall Study|Lack of Efficacy|4|||
128755148|NCT00833560|463392398|FG000|Overall Study|Death|2|||
128755149|NCT00833560|463392398|FG000|Overall Study|Pregression of other disease|1|||
128755150|NCT00833560|463392398|FG000|Overall Study|Other|5|||
128786541|NCT01090024|463511205|FG017|Period 2|Lost to Follow-up|0|||
128786542|NCT01090024|463511188|FG000|Period 2|Adverse Event|1|||
128755151|NCT00643916|463392399|FG000|Overall Study|Protocol Violation|0|||
128755152|NCT00643916|463392400|FG001|Overall Study|Protocol Violation|1|||
128755153|NCT00643916|463392401|FG002|Overall Study|Protocol Violation|1|||
128755154|NCT00643916|463392402|FG003|Overall Study|Protocol Violation|1|||
128755155|NCT00643916|463392403|FG004|Overall Study|Protocol Violation|0|||
128755156|NCT00643916|463392404|FG005|Overall Study|Protocol Violation|0|||
128755157|NCT00643916|463392399|FG000|Overall Study|Lost to Follow-up|0|||
128755158|NCT00643916|463392400|FG001|Overall Study|Lost to Follow-up|1|||
128755159|NCT00643916|463392401|FG002|Overall Study|Lost to Follow-up|0|||
128755160|NCT00643916|463392402|FG003|Overall Study|Lost to Follow-up|0|||
128786543|NCT01090024|463511189|FG001|Period 2|Adverse Event|0|||
128755161|NCT00643916|463392403|FG004|Overall Study|Lost to Follow-up|0|||
128755162|NCT00643916|463392404|FG005|Overall Study|Lost to Follow-up|0|||
128755163|NCT00643916|463392399|FG000|Overall Study|Withdrawal by Subject|2|||
128755164|NCT00643916|463392400|FG001|Overall Study|Withdrawal by Subject|2|||
128755165|NCT00643916|463392401|FG002|Overall Study|Withdrawal by Subject|2|||
128755166|NCT00643916|463392402|FG003|Overall Study|Withdrawal by Subject|1|||
128755167|NCT00643916|463392403|FG004|Overall Study|Withdrawal by Subject|0|||
128755168|NCT00643916|463392404|FG005|Overall Study|Withdrawal by Subject|1|||
128755169|NCT00643916|463392399|FG000|Overall Study|Not Vaccinated|2|||
128755170|NCT00643916|463392400|FG001|Overall Study|Not Vaccinated|2|||
128755171|NCT00643916|463392401|FG002|Overall Study|Not Vaccinated|3|||
128755172|NCT00643916|463392402|FG003|Overall Study|Not Vaccinated|0|||
128755173|NCT00643916|463392403|FG004|Overall Study|Not Vaccinated|2|||
128755174|NCT00643916|463392404|FG005|Overall Study|Not Vaccinated|0|||
128755175|NCT00499031|463392405|FG000|Overall Study|Improper pre-protocol treatment|1|||
128755176|NCT00499031|463392405|FG000|Overall Study|Required test not done|1|||
128755177|NCT00499031|463392405|FG000|Overall Study|Never treated|1|||
128755178|NCT02606279|463392415|FG000|Overall Study|Lost to Follow-up|0|||
128755179|NCT02606279|463392416|FG001|Overall Study|Lost to Follow-up|1|||
128755180|NCT02184611|463392417|FG000|Overall Study|Lack of Efficacy|11|||
128755181|NCT02184611|463392418|FG001|Overall Study|Lack of Efficacy|15|||
128755182|NCT02184611|463392417|FG000|Overall Study|Withdrawal by Subject|5|||
128755183|NCT02184611|463392418|FG001|Overall Study|Withdrawal by Subject|6|||
128755184|NCT02184611|463392417|FG000|Overall Study|Adverse Event|4|||
128755185|NCT02184611|463392418|FG001|Overall Study|Adverse Event|5|||
128755186|NCT02184611|463392417|FG000|Overall Study|Protocol Violation|1|||
128755187|NCT02184611|463392418|FG001|Overall Study|Protocol Violation|1|||
128755188|NCT02184611|463392417|FG000|Overall Study|Protocol defined stopping criteria|0|||
128755189|NCT02184611|463392418|FG001|Overall Study|Protocol defined stopping criteria|1|||
128755190|NCT00985725|463392421|FG000|Overall Study|Adverse Event|4|||
128755191|NCT00985725|463392422|FG001|Overall Study|Adverse Event|1|||
128755192|NCT00985725|463392421|FG000|Overall Study|Protocol Violation|1|||
128755193|NCT00985725|463392422|FG001|Overall Study|Protocol Violation|3|||
128755194|NCT00985725|463392421|FG000|Overall Study|Withdrawal by Subject|4|||
128755195|NCT00985725|463392422|FG001|Overall Study|Withdrawal by Subject|4|||
128755196|NCT00985725|463392421|FG000|Overall Study|Lost to Follow-up|1|||
128755197|NCT00985725|463392422|FG001|Overall Study|Lost to Follow-up|1|||
128755198|NCT00985725|463392421|FG000|Overall Study|Lack of Efficacy|0|||
128755199|NCT00985725|463392422|FG001|Overall Study|Lack of Efficacy|1|||
128755200|NCT00985725|463392421|FG000|Overall Study|Non-compliance|1|||
128755201|NCT00985725|463392422|FG001|Overall Study|Non-compliance|2|||
128755202|NCT00985725|463392421|FG000|Overall Study|Out-of-window visits|0|||
128755203|NCT00985725|463392422|FG001|Overall Study|Out-of-window visits|1|||
128755204|NCT03563716|463392423|FG000|Overall Study|Death|20|||
128755205|NCT03563716|463392424|FG001|Overall Study|Death|14|||
128755206|NCT03563716|463392423|FG000|Overall Study|Withdrawal by Subject|3|||
128755207|NCT03563716|463392424|FG001|Overall Study|Withdrawal by Subject|3|||
128755208|NCT03563716|463392423|FG000|Overall Study|Still on Study|45|||
128755209|NCT03563716|463392424|FG001|Overall Study|Still on Study|50|||
128755210|NCT02583425|463392425|FG000|Screening|Did not meet entry criteria|12|||
128755211|NCT02583425|463392425|FG000|Baseline|Did not meet continued criteria|5|||
128755212|NCT02583425|463392425|FG000|Treatment Period|Adverse Event|1|||
128755213|NCT02428296|463392428|FG000|Overall Study|Adverse Event|7|||
128755214|NCT02428296|463392428|FG000|Overall Study|Withdrawal by Subject|2|||
128755215|NCT02548455|463392431|FG000|Overall Study|Withdrawal by Subject|27|||
128786544|NCT01090024|463511190|FG002|Period 2|Adverse Event|0|||
128786545|NCT01090024|463511191|FG003|Period 2|Adverse Event|0|||
128786546|NCT01090024|463511192|FG004|Period 2|Adverse Event|0|||
128786547|NCT01090024|463511193|FG005|Period 2|Adverse Event|0|||
128786548|NCT01090024|463511194|FG006|Period 2|Adverse Event|0|||
128786549|NCT01090024|463511195|FG007|Period 2|Adverse Event|0|||
128755216|NCT02548455|463392431|FG000|Overall Study|Death|26|||
128755217|NCT02548455|463392431|FG000|Overall Study|Lost to Follow-up|14|||
128755218|NCT02548455|463392431|FG000|Overall Study|Visit not completed|173|||
128755219|NCT02261493|463392434|FG000|Overall Study|Noncompliance|0|||
128755220|NCT02261493|463392435|FG001|Overall Study|Noncompliance|0|||
128786550|NCT01090024|463511196|FG008|Period 2|Adverse Event|0|||
128755221|NCT02261493|463392436|FG002|Overall Study|Noncompliance|2|||
128786551|NCT01090024|463511197|FG009|Period 2|Adverse Event|0|||
128755222|NCT02261493|463392434|FG000|Overall Study|Physician Decision|0|||
128786552|NCT01090024|463511198|FG010|Period 2|Adverse Event|0|||
128786553|NCT01090024|463511199|FG011|Period 2|Adverse Event|0|||
128755223|NCT02261493|463392435|FG001|Overall Study|Physician Decision|1|||
128755224|NCT02261493|463392436|FG002|Overall Study|Physician Decision|0|||
128755225|NCT02261493|463392434|FG000|Overall Study|Undisclosed alcohol abuse|0|||
128755226|NCT02261493|463392435|FG001|Overall Study|Undisclosed alcohol abuse|1|||
128786554|NCT01090024|463511200|FG012|Period 2|Adverse Event|0|||
128786555|NCT01090024|463511201|FG013|Period 2|Adverse Event|0|||
128786556|NCT01090024|463511202|FG014|Period 2|Adverse Event|0|||
128755227|NCT02261493|463392436|FG002|Overall Study|Undisclosed alcohol abuse|0|||
128755228|NCT02261493|463392434|FG000|Overall Study|Protocol Violation|1|||
128786557|NCT01090024|463511203|FG015|Period 2|Adverse Event|0|||
128755229|NCT02261493|463392435|FG001|Overall Study|Protocol Violation|0|||
128755230|NCT02261493|463392436|FG002|Overall Study|Protocol Violation|0|||
128755231|NCT02261493|463392434|FG000|Overall Study|Personal Reasons|14|||
128755232|NCT02261493|463392435|FG001|Overall Study|Personal Reasons|14|||
129204454|NCT02922725|465045812|FG002|Overall Study|Withdrawal by Subject|0|||
129204455|NCT01300234|465045813|FG000|Overall Study|Adverse Event|1|||
129204456|NCT01300234|465045814|FG001|Overall Study|Adverse Event|1|||
129204457|NCT01300234|465045813|FG000|Overall Study|Protocol Violation|2|||
129204458|NCT01300234|465045814|FG001|Overall Study|Protocol Violation|3|||
129204459|NCT01300234|465045813|FG000|Overall Study|Withdrawal by Subject|5|||
129204460|NCT01300234|465045814|FG001|Overall Study|Withdrawal by Subject|9|||
129204461|NCT01300234|465045813|FG000|Overall Study|Lost to Follow-up|14|||
129204462|NCT01300234|465045814|FG001|Overall Study|Lost to Follow-up|12|||
129204463|NCT01300234|465045813|FG000|Overall Study|Pregnancy|2|||
129204464|NCT01300234|465045814|FG001|Overall Study|Pregnancy|1|||
129204465|NCT01300234|465045813|FG000|Overall Study|Participant reached stopping critera|2|||
129204466|NCT01300234|465045814|FG001|Overall Study|Participant reached stopping critera|0|||
129204467|NCT01300234|465045813|FG000|Overall Study|Participant stopped medication|1|||
129204468|NCT01300234|465045814|FG001|Overall Study|Participant stopped medication|1|||
129204469|NCT01300234|465045813|FG000|Overall Study|Participant refused return to hospital|1|||
129204470|NCT01300234|465045814|FG001|Overall Study|Participant refused return to hospital|0|||
129204471|NCT03253679|465045815|FG000|Overall Study|Screen Failure|1|||
129204472|NCT04816214|465045817|FG000|Overall Study|Progressive Disease|4|||
129204473|NCT04816214|465045818|FG001|Overall Study|Progressive Disease|0|||
129204474|NCT04816214|465045819|FG002|Overall Study|Progressive Disease|0|||
129204475|NCT04816214|465045817|FG000|Overall Study|Death|1|||
129204476|NCT04816214|465045818|FG001|Overall Study|Death|0|||
129204477|NCT04816214|465045819|FG002|Overall Study|Death|0|||
129204478|NCT04816214|465045817|FG000|Overall Study|Study Terminated by Sponsor|1|||
129204479|NCT04816214|465045818|FG001|Overall Study|Study Terminated by Sponsor|0|||
129204480|NCT04816214|465045819|FG002|Overall Study|Study Terminated by Sponsor|0|||
129204481|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
129204482|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
129204483|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
129204484|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
129204485|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
129204486|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
129204487|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
129204488|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
129204489|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
129204490|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
129204491|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
129204492|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
129204493|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
129204494|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
129204495|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
129204496|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
129204497|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
129204498|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
129204499|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
129204500|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
129204501|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
129204502|NCT00550407|465045820|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
129204503|NCT00550407|465045821|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
129204504|NCT00550407|465045822|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
129204505|NCT00550407|465045820|FG000|26-Week Randomized Phase|Adverse Event|0|||
129204506|NCT00550407|465045821|FG001|26-Week Randomized Phase|Adverse Event|5|||
129204507|NCT00550407|465045822|FG002|26-Week Randomized Phase|Adverse Event|2|||
129204508|NCT00550407|465045820|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
128755233|NCT02261493|463392436|FG002|Overall Study|Personal Reasons|16|||
128755234|NCT02261493|463392434|FG000|Overall Study|Lost to Follow-up|14|||
128755235|NCT02261493|463392435|FG001|Overall Study|Lost to Follow-up|27|||
128755236|NCT02261493|463392436|FG002|Overall Study|Lost to Follow-up|8|||
128755237|NCT02261493|463392434|FG000|Overall Study|Pregnancy|1|||
128755238|NCT02261493|463392435|FG001|Overall Study|Pregnancy|2|||
128755239|NCT02261493|463392436|FG002|Overall Study|Pregnancy|0|||
128755240|NCT02261493|463392434|FG000|Overall Study|Lack of Efficacy|0|||
128755241|NCT02261493|463392435|FG001|Overall Study|Lack of Efficacy|1|||
128755242|NCT02261493|463392436|FG002|Overall Study|Lack of Efficacy|0|||
128755243|NCT02261493|463392434|FG000|Overall Study|Adverse Event|0|||
128755244|NCT02261493|463392435|FG001|Overall Study|Adverse Event|1|||
128755245|NCT02261493|463392436|FG002|Overall Study|Adverse Event|0|||
128755246|NCT02436330|463392438|FG000|Cohort 1|Lost to Follow-up|5|||
128755247|NCT02436330|463392439|FG001|Cohort 1|Lost to Follow-up|2|||
128755248|NCT02436330|463392438|FG000|Cohort 1|Withdrawal by Subject|0|||
128755249|NCT02436330|463392439|FG001|Cohort 1|Withdrawal by Subject|1|||
128755250|NCT02436330|463392438|FG000|Cohort 2|Lost to Follow-up|2|||
128755251|NCT02436330|463392439|FG001|Cohort 2|Lost to Follow-up|0|||
128755252|NCT02436330|463392438|FG000|Cohort 2|Withdrawal by Subject|2|||
128755253|NCT02436330|463392439|FG001|Cohort 2|Withdrawal by Subject|3|||
128755254|NCT02436330|463392438|FG000|Cohort 3|Lost to Follow-up|1|||
128755255|NCT02436330|463392439|FG001|Cohort 3|Lost to Follow-up|0|||
128755256|NCT02436330|463392438|FG000|Cohort 3|Withdrawal by Subject|4|||
128755257|NCT02436330|463392439|FG001|Cohort 3|Withdrawal by Subject|0|||
128755258|NCT02436330|463392438|FG000|Cohort 4|Lost to Follow-up|1|||
128755259|NCT02436330|463392439|FG001|Cohort 4|Lost to Follow-up|0|||
128755260|NCT02436330|463392438|FG000|Cohort 4|Withdrawal by Subject|1|||
128755261|NCT02436330|463392439|FG001|Cohort 4|Withdrawal by Subject|0|||
128755262|NCT02436330|463392438|FG000|Cohort 5|Lost to Follow-up|3|||
128755263|NCT02436330|463392439|FG001|Cohort 5|Lost to Follow-up|2|||
128755264|NCT02436330|463392438|FG000|Cohort 5|Withdrawal by Subject|3|||
128755265|NCT02436330|463392439|FG001|Cohort 5|Withdrawal by Subject|2|||
128755266|NCT02436330|463392438|FG000|Cohort 6|Lost to Follow-up|2|||
128755267|NCT02436330|463392439|FG001|Cohort 6|Lost to Follow-up|0|||
128755268|NCT02436330|463392438|FG000|Cohort 6|Withdrawal by Subject|1|||
128755269|NCT02436330|463392439|FG001|Cohort 6|Withdrawal by Subject|1|||
128755270|NCT02230956|463392440|FG000|Overall Study|Adverse Event|1|||
128755271|NCT02230956|463392441|FG001|Overall Study|Adverse Event|1|||
128755272|NCT02230956|463392442|FG002|Overall Study|Adverse Event|0|||
128755273|NCT02230956|463392440|FG000|Overall Study|Lack of Efficacy|1|||
128755274|NCT02230956|463392441|FG001|Overall Study|Lack of Efficacy|1|||
128755275|NCT02230956|463392442|FG002|Overall Study|Lack of Efficacy|1|||
128755276|NCT02230956|463392440|FG000|Overall Study|Lost to Follow-up|1|||
128755277|NCT02230956|463392441|FG001|Overall Study|Lost to Follow-up|1|||
128755278|NCT02230956|463392442|FG002|Overall Study|Lost to Follow-up|2|||
128755279|NCT02230956|463392440|FG000|Overall Study|Personal Reasons|2|||
128755280|NCT02230956|463392441|FG001|Overall Study|Personal Reasons|1|||
128755281|NCT02230956|463392442|FG002|Overall Study|Personal Reasons|1|||
128755282|NCT02230956|463392440|FG000|Overall Study|Protocol Violation|0|||
128755283|NCT02230956|463392441|FG001|Overall Study|Protocol Violation|1|||
128755284|NCT02230956|463392442|FG002|Overall Study|Protocol Violation|1|||
128755285|NCT02230956|463392440|FG000|Overall Study|Other Miscellaneous Reason|0|||
128755286|NCT02230956|463392441|FG001|Overall Study|Other Miscellaneous Reason|1|||
128755287|NCT02230956|463392442|FG002|Overall Study|Other Miscellaneous Reason|2|||
128755288|NCT00338884|463392443|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
128755289|NCT00338884|463392443|FG000|Overall Study|Adverse Event|14|||
128755290|NCT00338884|463392443|FG000|Overall Study|Death|8|||
128755291|NCT00338884|463392443|FG000|Overall Study|Other|4|||
128755292|NCT00338884|463392443|FG000|Overall Study|Global Deterioration of Health Status|3|||
128755293|NCT00338884|463392443|FG000|Overall Study|Withdrawal by Subject|3|||
128755294|NCT00338884|463392443|FG000|Overall Study|Lost to Follow-up|1|||
128755295|NCT00338884|463392443|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
128755296|NCT01970982|463392445|FG000|Overall Study|Withdrawal by Subject|0|||
128755297|NCT01970982|463392446|FG001|Overall Study|Withdrawal by Subject|0|||
128755298|NCT01970982|463392447|FG002|Overall Study|Withdrawal by Subject|2|||
128755299|NCT05711641|463392451|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
128755300|NCT05711641|463392452|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
128755301|NCT05711641|463392451|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
128755302|NCT05711641|463392452|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
128755303|NCT00162370|463392453|FG000|Efficacy Population|Lost to Follow-up|51|||
128755304|NCT04040751|463392454|FG000|Overall Study|Withdrawal by Subject|2|||
128786558|NCT01090024|463511204|FG016|Period 2|Adverse Event|0|||
128755305|NCT04040751|463392455|FG001|Overall Study|Withdrawal by Subject|0|||
128755306|NCT04040751|463392456|FG002|Overall Study|Withdrawal by Subject|2|||
128755307|NCT04040751|463392457|FG003|Overall Study|Withdrawal by Subject|0|||
128786559|NCT01090024|463511205|FG017|Period 2|Adverse Event|0|||
128755308|NCT04575051|463392458|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
128755309|NCT04575051|463392459|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
128755310|NCT04575051|463392460|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
128755311|NCT04575051|463392461|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
128755312|NCT04575051|463392462|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
128755313|NCT04575051|463392458|FG000|Time Period 1|Missing follow up|1|||
128755314|NCT04575051|463392459|FG001|Time Period 1|Missing follow up|3|||
128755315|NCT04575051|463392460|FG002|Time Period 1|Missing follow up|1|||
128755316|NCT04575051|463392461|FG003|Time Period 1|Missing follow up|3|||
128755317|NCT04575051|463392462|FG004|Time Period 1|Missing follow up|2|||
128755318|NCT04575051|463392458|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
128755319|NCT04575051|463392459|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
128755320|NCT04575051|463392460|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
128755321|NCT04575051|463392461|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
128755322|NCT04575051|463392462|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
128755323|NCT04575051|463392458|FG000|Time Period 2|Missing follow up|1|||
128755324|NCT04575051|463392459|FG001|Time Period 2|Missing follow up|8|||
128755325|NCT04575051|463392460|FG002|Time Period 2|Missing follow up|7|||
128755326|NCT04575051|463392461|FG003|Time Period 2|Missing follow up|0|||
128755327|NCT04575051|463392462|FG004|Time Period 2|Missing follow up|1|||
128755328|NCT04575051|463392458|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
128755329|NCT04575051|463392459|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
128755330|NCT04575051|463392460|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
128755331|NCT04575051|463392461|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
128755332|NCT04575051|463392462|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
128755333|NCT04575051|463392458|FG000|Time Period 3|Missing follow up|8|||
128755334|NCT04575051|463392459|FG001|Time Period 3|Missing follow up|6|||
128755335|NCT04575051|463392460|FG002|Time Period 3|Missing follow up|4|||
128755336|NCT04575051|463392461|FG003|Time Period 3|Missing follow up|3|||
128755337|NCT04575051|463392462|FG004|Time Period 3|Missing follow up|0|||
128755338|NCT04575051|463392458|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
128755339|NCT04575051|463392459|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
128755340|NCT04575051|463392460|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
128755341|NCT04575051|463392461|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
128755342|NCT04575051|463392462|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
128755343|NCT04575051|463392458|FG000|Time Period 4|Missing follow up|17|||
128755344|NCT04575051|463392459|FG001|Time Period 4|Missing follow up|3|||
128755345|NCT04575051|463392460|FG002|Time Period 4|Missing follow up|4|||
128755346|NCT04575051|463392461|FG003|Time Period 4|Missing follow up|2|||
128755347|NCT04575051|463392462|FG004|Time Period 4|Missing follow up|1|||
128755348|NCT04575051|463392458|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
128755349|NCT04575051|463392459|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
128755350|NCT04575051|463392460|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
128755351|NCT04575051|463392461|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
128755352|NCT04575051|463392462|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
128755353|NCT04575051|463392458|FG000|Time Period 5|Missing follow up|11|||
128755354|NCT04575051|463392459|FG001|Time Period 5|Missing follow up|8|||
128755355|NCT04575051|463392460|FG002|Time Period 5|Missing follow up|12|||
128755356|NCT04575051|463392461|FG003|Time Period 5|Missing follow up|3|||
128755357|NCT04575051|463392462|FG004|Time Period 5|Missing follow up|11|||
128755358|NCT03624504|463392463|FG000|Overall Study|Unsuccessful Implant|1|||
128755359|NCT02862457|463392464|FG000|Overall Study|Death|1|||
128755360|NCT02862457|463392465|FG001|Overall Study|Death|3|||
128755361|NCT02862457|463392466|FG002|Overall Study|Death|2|||
128755362|NCT02862457|463392467|FG003|Overall Study|Death|3|||
128755363|NCT02862457|463392468|FG004|Overall Study|Death|0|||
128755364|NCT02862457|463392469|FG005|Overall Study|Death|2|||
128755365|NCT02862457|463392470|FG006|Overall Study|Death|1|||
128755366|NCT02862457|463392464|FG000|Overall Study|Lost to Follow-up|1|||
128755367|NCT02862457|463392465|FG001|Overall Study|Lost to Follow-up|0|||
128755368|NCT02862457|463392466|FG002|Overall Study|Lost to Follow-up|0|||
128755369|NCT02862457|463392467|FG003|Overall Study|Lost to Follow-up|1|||
128755370|NCT02862457|463392468|FG004|Overall Study|Lost to Follow-up|0|||
128755371|NCT02862457|463392469|FG005|Overall Study|Lost to Follow-up|0|||
128755372|NCT02862457|463392470|FG006|Overall Study|Lost to Follow-up|0|||
128755373|NCT02862457|463392464|FG000|Overall Study|Withdrawal by Subject|0|||
128755374|NCT02862457|463392465|FG001|Overall Study|Withdrawal by Subject|0|||
128755375|NCT02862457|463392466|FG002|Overall Study|Withdrawal by Subject|1|||
128755376|NCT02862457|463392467|FG003|Overall Study|Withdrawal by Subject|0|||
128755377|NCT02862457|463392468|FG004|Overall Study|Withdrawal by Subject|0|||
128755378|NCT02862457|463392469|FG005|Overall Study|Withdrawal by Subject|1|||
128755379|NCT02862457|463392470|FG006|Overall Study|Withdrawal by Subject|0|||
128755380|NCT00951483|463392473|FG000|Overall Study|Physician Decision|4|||
128755381|NCT00951483|463392474|FG001|Overall Study|Physician Decision|0|||
128755382|NCT00951483|463392473|FG000|Overall Study|Withdrawal by Subject|15|||
128755383|NCT00951483|463392474|FG001|Overall Study|Withdrawal by Subject|0|||
128755384|NCT03583554|463392475|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
128755385|NCT03583554|463392476|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
128755386|NCT03583554|463392477|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
128755387|NCT03178266|463392478|FG000|Overall Study|Death|0|||
128755388|NCT03178266|463392479|FG001|Overall Study|Death|1|||
128755389|NCT03178266|463392478|FG000|Overall Study|Disont. Early|0|||
128755390|NCT03178266|463392479|FG001|Overall Study|Disont. Early|1|||
128755391|NCT03178266|463392478|FG000|Overall Study|Withdrawal by Subject|0|||
128755392|NCT03178266|463392479|FG001|Overall Study|Withdrawal by Subject|2|||
128755393|NCT02342886|463392480|FG000|Overall Study|Treatment non-compliance|1|||
128755394|NCT02342886|463392481|FG001|Overall Study|Treatment non-compliance|0|||
128755395|NCT02342886|463392482|FG002|Overall Study|Treatment non-compliance|0|||
128755396|NCT02342886|463392483|FG003|Overall Study|Treatment non-compliance|1|||
128755397|NCT02342886|463392484|FG004|Overall Study|Treatment non-compliance|0|||
128755398|NCT02342886|463392480|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
128755399|NCT02342886|463392481|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
128755400|NCT02342886|463392482|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
128755401|NCT02342886|463392483|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
128755402|NCT02342886|463392484|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
128755403|NCT02342886|463392480|FG000|Overall Study|Adverse event/specific toxicity|4|||
128755404|NCT02342886|463392481|FG001|Overall Study|Adverse event/specific toxicity|3|||
128755405|NCT02342886|463392482|FG002|Overall Study|Adverse event/specific toxicity|11|||
128755406|NCT02342886|463392483|FG003|Overall Study|Adverse event/specific toxicity|2|||
128755407|NCT02342886|463392484|FG004|Overall Study|Adverse event/specific toxicity|1|||
128755408|NCT02342886|463392480|FG000|Overall Study|Lost to Follow-up|1|||
128755409|NCT02342886|463392481|FG001|Overall Study|Lost to Follow-up|0|||
128755410|NCT02342886|463392482|FG002|Overall Study|Lost to Follow-up|0|||
128755411|NCT02342886|463392483|FG003|Overall Study|Lost to Follow-up|0|||
128755412|NCT02342886|463392484|FG004|Overall Study|Lost to Follow-up|0|||
128755413|NCT02342886|463392480|FG000|Overall Study|Death|1|||
128755414|NCT02342886|463392481|FG001|Overall Study|Death|2|||
128755415|NCT02342886|463392482|FG002|Overall Study|Death|1|||
128755416|NCT02342886|463392483|FG003|Overall Study|Death|0|||
128755417|NCT02342886|463392484|FG004|Overall Study|Death|1|||
128755418|NCT02342886|463392480|FG000|Overall Study|Withdrawal by Subject|0|||
128755419|NCT02342886|463392481|FG001|Overall Study|Withdrawal by Subject|1|||
128755420|NCT02342886|463392482|FG002|Overall Study|Withdrawal by Subject|0|||
128755421|NCT02342886|463392483|FG003|Overall Study|Withdrawal by Subject|1|||
128755422|NCT02342886|463392484|FG004|Overall Study|Withdrawal by Subject|0|||
128755423|NCT02342886|463392480|FG000|Overall Study|Investigator/sponsor decision|0|||
128755424|NCT02342886|463392481|FG001|Overall Study|Investigator/sponsor decision|2|||
128755425|NCT02342886|463392482|FG002|Overall Study|Investigator/sponsor decision|0|||
128755426|NCT02342886|463392483|FG003|Overall Study|Investigator/sponsor decision|3|||
128755427|NCT02342886|463392484|FG004|Overall Study|Investigator/sponsor decision|1|||
128755428|NCT02342886|463392480|FG000|Overall Study|Pregnancy|0|||
128755429|NCT02342886|463392481|FG001|Overall Study|Pregnancy|0|||
128755430|NCT02342886|463392482|FG002|Overall Study|Pregnancy|2|||
128755431|NCT02342886|463392483|FG003|Overall Study|Pregnancy|0|||
128755432|NCT02342886|463392484|FG004|Overall Study|Pregnancy|0|||
128755433|NCT02342886|463392480|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
128755434|NCT02342886|463392481|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
128755435|NCT02342886|463392482|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
128755436|NCT02342886|463392483|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
128755437|NCT02342886|463392484|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
128755438|NCT02342886|463392480|FG000|Overall Study|Protocol Violation|0|||
128755439|NCT02342886|463392481|FG001|Overall Study|Protocol Violation|0|||
128755440|NCT02342886|463392482|FG002|Overall Study|Protocol Violation|0|||
128755441|NCT02342886|463392483|FG003|Overall Study|Protocol Violation|2|||
128755442|NCT02342886|463392484|FG004|Overall Study|Protocol Violation|0|||
128755443|NCT00765674|463392485|FG000|Overall Study|Adverse Event|7|||
128755444|NCT00765674|463392486|FG001|Overall Study|Adverse Event|2|||
128755445|NCT00765674|463392487|FG002|Overall Study|Adverse Event|8|||
128755446|NCT00765674|463392488|FG003|Overall Study|Adverse Event|11|||
128755447|NCT00765674|463392485|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
128755448|NCT00765674|463392486|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
128755449|NCT00765674|463392487|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
128755450|NCT00765674|463392488|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
128755451|NCT00765674|463392485|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
128755452|NCT00765674|463392486|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
128755453|NCT00765674|463392487|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
128755454|NCT00765674|463392488|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
128755455|NCT00765674|463392485|FG000|Overall Study|Lack of Efficacy|2|||
128755456|NCT00765674|463392486|FG001|Overall Study|Lack of Efficacy|3|||
128755457|NCT00765674|463392487|FG002|Overall Study|Lack of Efficacy|1|||
128755458|NCT00765674|463392488|FG003|Overall Study|Lack of Efficacy|2|||
128755459|NCT00765674|463392485|FG000|Overall Study|Protocol Violation|2|||
128755460|NCT00765674|463392486|FG001|Overall Study|Protocol Violation|0|||
128755461|NCT00765674|463392487|FG002|Overall Study|Protocol Violation|1|||
128755462|NCT00765674|463392488|FG003|Overall Study|Protocol Violation|0|||
128755463|NCT00765674|463392485|FG000|Overall Study|Withdrawal by Subject|5|||
128755464|NCT00765674|463392486|FG001|Overall Study|Withdrawal by Subject|7|||
128755465|NCT00765674|463392487|FG002|Overall Study|Withdrawal by Subject|3|||
128755466|NCT00765674|463392488|FG003|Overall Study|Withdrawal by Subject|8|||
128755467|NCT00765674|463392485|FG000|Overall Study|Lost to Follow-up|4|||
128755468|NCT00765674|463392486|FG001|Overall Study|Lost to Follow-up|6|||
128755469|NCT00765674|463392487|FG002|Overall Study|Lost to Follow-up|2|||
128755470|NCT00765674|463392488|FG003|Overall Study|Lost to Follow-up|1|||
128755471|NCT00765674|463392485|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
128755472|NCT00765674|463392486|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
128755473|NCT00765674|463392487|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
128755474|NCT00765674|463392488|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
128755475|NCT01813474|463392489|FG000|Overall Study|Withdrawal by Subject|0|||
128755476|NCT01813474|463392490|FG001|Overall Study|Withdrawal by Subject|0|||
128755477|NCT01813474|463392491|FG002|Overall Study|Withdrawal by Subject|1|||
128755478|NCT01813474|463392489|FG000|Overall Study|Adverse Event|1|||
128755479|NCT01813474|463392490|FG001|Overall Study|Adverse Event|1|||
128755480|NCT01813474|463392491|FG002|Overall Study|Adverse Event|0|||
128755481|NCT01813474|463392489|FG000|Overall Study|Lack of Efficacy|2|||
128755482|NCT01813474|463392490|FG001|Overall Study|Lack of Efficacy|6|||
128755483|NCT01813474|463392491|FG002|Overall Study|Lack of Efficacy|9|||
128755484|NCT01813474|463392489|FG000|Overall Study|Death|0|||
128755485|NCT01813474|463392490|FG001|Overall Study|Death|0|||
128755486|NCT01813474|463392491|FG002|Overall Study|Death|1|||
128755487|NCT00316082|463392492|FG000|Overall Study|Lack of Efficacy|2|||
128755488|NCT00316082|463392493|FG001|Overall Study|Lack of Efficacy|3|||
128755489|NCT00316082|463392494|FG002|Overall Study|Lack of Efficacy|3|||
128755490|NCT00316082|463392495|FG003|Overall Study|Lack of Efficacy|4|||
128755491|NCT00316082|463392496|FG004|Overall Study|Lack of Efficacy|6|||
128755492|NCT00316082|463392492|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
128786560|NCT01090024|463511188|FG000|Period 3|Withdrawal by Subject|0|||
128786561|NCT01090024|463511189|FG001|Period 3|Withdrawal by Subject|0|||
128786562|NCT01090024|463511190|FG002|Period 3|Withdrawal by Subject|0|||
128786563|NCT01090024|463511191|FG003|Period 3|Withdrawal by Subject|0|||
128786564|NCT01090024|463511192|FG004|Period 3|Withdrawal by Subject|0|||
128786565|NCT01090024|463511193|FG005|Period 3|Withdrawal by Subject|0|||
128786566|NCT01090024|463511194|FG006|Period 3|Withdrawal by Subject|0|||
128755493|NCT00316082|463392493|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
128755494|NCT00316082|463392494|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
128755495|NCT00316082|463392495|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
128755496|NCT00316082|463392496|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
128755497|NCT00316082|463392492|FG000|Overall Study|Lost to Follow-up|7|||
128755498|NCT00316082|463392493|FG001|Overall Study|Lost to Follow-up|6|||
128755499|NCT00316082|463392494|FG002|Overall Study|Lost to Follow-up|7|||
128755500|NCT00316082|463392495|FG003|Overall Study|Lost to Follow-up|8|||
128755501|NCT00316082|463392496|FG004|Overall Study|Lost to Follow-up|6|||
128786567|NCT01090024|463511195|FG007|Period 3|Withdrawal by Subject|0|||
128786568|NCT01090024|463511196|FG008|Period 3|Withdrawal by Subject|0|||
128786569|NCT01090024|463511197|FG009|Period 3|Withdrawal by Subject|0|||
128755502|NCT00316082|463392492|FG000|Overall Study|Poor/noncompliance|6|||
128755503|NCT00316082|463392493|FG001|Overall Study|Poor/noncompliance|1|||
128755504|NCT00316082|463392494|FG002|Overall Study|Poor/noncompliance|4|||
128755505|NCT00316082|463392495|FG003|Overall Study|Poor/noncompliance|1|||
128755506|NCT00316082|463392496|FG004|Overall Study|Poor/noncompliance|4|||
128755507|NCT00316082|463392492|FG000|Overall Study|Adverse Event|4|||
128755508|NCT00316082|463392493|FG001|Overall Study|Adverse Event|2|||
128786570|NCT01090024|463511198|FG010|Period 3|Withdrawal by Subject|0|||
128755509|NCT00316082|463392494|FG002|Overall Study|Adverse Event|5|||
128755510|NCT00316082|463392495|FG003|Overall Study|Adverse Event|1|||
128755511|NCT00316082|463392496|FG004|Overall Study|Adverse Event|3|||
128755512|NCT00316082|463392492|FG000|Overall Study|Subject no longer meets study criteria|3|||
128755513|NCT00316082|463392493|FG001|Overall Study|Subject no longer meets study criteria|1|||
128755514|NCT00316082|463392494|FG002|Overall Study|Subject no longer meets study criteria|2|||
128755515|NCT00316082|463392495|FG003|Overall Study|Subject no longer meets study criteria|2|||
128755516|NCT00316082|463392496|FG004|Overall Study|Subject no longer meets study criteria|1|||
128755517|NCT00316082|463392492|FG000|Overall Study|Physician Decision|1|||
128786571|NCT01090024|463511199|FG011|Period 3|Withdrawal by Subject|0|||
128786572|NCT01090024|463511200|FG012|Period 3|Withdrawal by Subject|0|||
128786573|NCT01090024|463511201|FG013|Period 3|Withdrawal by Subject|0|||
128755518|NCT00316082|463392493|FG001|Overall Study|Physician Decision|1|||
128755519|NCT00316082|463392494|FG002|Overall Study|Physician Decision|2|||
128755520|NCT00316082|463392495|FG003|Overall Study|Physician Decision|1|||
128755521|NCT00316082|463392496|FG004|Overall Study|Physician Decision|1|||
128755522|NCT00316082|463392492|FG000|Overall Study|Death|0|||
128755523|NCT00316082|463392493|FG001|Overall Study|Death|0|||
128755524|NCT00316082|463392494|FG002|Overall Study|Death|1|||
128755525|NCT00316082|463392495|FG003|Overall Study|Death|0|||
128755526|NCT00316082|463392496|FG004|Overall Study|Death|0|||
128755527|NCT00316082|463392492|FG000|Overall Study|Administrative reason by sponsor|0|||
128755528|NCT00316082|463392493|FG001|Overall Study|Administrative reason by sponsor|0|||
128755529|NCT00316082|463392494|FG002|Overall Study|Administrative reason by sponsor|1|||
128755530|NCT00316082|463392495|FG003|Overall Study|Administrative reason by sponsor|0|||
128755531|NCT00316082|463392496|FG004|Overall Study|Administrative reason by sponsor|0|||
128755532|NCT00528775|463392501|FG000|Overall Study|Other not specified|1|||
128755533|NCT00540124|463392505|FG000|Overall Study|Adverse Event|0|||
128755534|NCT00540124|463392506|FG001|Overall Study|Adverse Event|2|||
128755535|NCT00540124|463392507|FG002|Overall Study|Adverse Event|1|||
128755536|NCT00540124|463392505|FG000|Overall Study|Entry Criteria Not Met|2|||
128755537|NCT00540124|463392506|FG001|Overall Study|Entry Criteria Not Met|0|||
128755538|NCT00540124|463392507|FG002|Overall Study|Entry Criteria Not Met|0|||
128755539|NCT00540124|463392505|FG000|Overall Study|Lack of Efficacy|1|||
128755540|NCT00540124|463392506|FG001|Overall Study|Lack of Efficacy|0|||
128755541|NCT00540124|463392507|FG002|Overall Study|Lack of Efficacy|0|||
128755542|NCT00540124|463392505|FG000|Overall Study|Withdrawal by Subject|1|||
128755543|NCT00540124|463392506|FG001|Overall Study|Withdrawal by Subject|1|||
128755544|NCT00540124|463392507|FG002|Overall Study|Withdrawal by Subject|0|||
128755545|NCT00587964|463392509|FG000|Overall Study|Withdrawal by Subject|1|||
128755546|NCT00587964|463392509|FG000|Overall Study|Lost to Follow-up|1|||
128755547|NCT00587964|463392509|FG000|Overall Study|Patient found to be ineligible|1|||
128755548|NCT00587964|463392509|FG000|Overall Study|Patient did not receive intervention|5|||
128755549|NCT00587964|463392509|FG000|Overall Study|Progression of Disease|4|||
128755550|NCT01569438|463392514|FG000|Overall Study|Lack of Efficacy|1|||
128755551|NCT01569438|463392515|FG001|Overall Study|Lack of Efficacy|2|||
128755552|NCT01569438|463392514|FG000|Overall Study|Withdrawal by Subject|0|||
128755553|NCT01569438|463392515|FG001|Overall Study|Withdrawal by Subject|3|||
128755554|NCT01569438|463392514|FG000|Overall Study|Adverse Event|2|||
128755555|NCT01569438|463392515|FG001|Overall Study|Adverse Event|15|||
128755556|NCT01569438|463392514|FG000|Overall Study|Protocol Violation|2|||
128755557|NCT01569438|463392515|FG001|Overall Study|Protocol Violation|0|||
128755558|NCT01569438|463392514|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
128755559|NCT01569438|463392515|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
128755560|NCT01569438|463392514|FG000|Overall Study|Sponsor/Physician decision|1|||
128755561|NCT01569438|463392515|FG001|Overall Study|Sponsor/Physician decision|1|||
128755562|NCT01569438|463392514|FG000|Overall Study|Unable to adhere to study schedule|0|||
128755563|NCT01569438|463392515|FG001|Overall Study|Unable to adhere to study schedule|1|||
128755564|NCT01207102|463392516|FG000|Overall Study|Withdrawal by Subject|5|||
128755565|NCT01207102|463392516|FG000|Overall Study|Adverse Event|2|||
128755566|NCT01207102|463392516|FG000|Overall Study|progression|2|||
128755567|NCT01207102|463392516|FG000|Overall Study|Withdrawal by Treating Physician|1|||
128755568|NCT01777854|463392519|FG000|Overall Study|Physician Decision|3|||
128755569|NCT01777854|463392520|FG001|Overall Study|Physician Decision|3|||
128755570|NCT03649230|463392521|FG000|Overall Study|Adverse Event|12|||
128755571|NCT03649230|463392521|FG000|Overall Study|Death|8|||
128755572|NCT03649230|463392521|FG000|Overall Study|Withdrawal by Subject|6|||
128755573|NCT03649230|463392521|FG000|Overall Study|Physician Decision|5|||
128755574|NCT03649230|463392521|FG000|Overall Study|Disease progression|5|||
128755575|NCT03649230|463392521|FG000|Overall Study|Switched to non-HEC|5|||
128755576|NCT03649230|463392521|FG000|Overall Study|Chemotherapy discontinued|4|||
128755577|NCT03649230|463392521|FG000|Overall Study|Received only 3 HEC cycles|4|||
128755578|NCT03649230|463392521|FG000|Overall Study|Screen Failure|3|||
128755579|NCT03649230|463392521|FG000|Overall Study|Patient stopped treatment|2|||
128786574|NCT01090024|463511202|FG014|Period 3|Withdrawal by Subject|0|||
128755580|NCT03649230|463392521|FG000|Overall Study|Protocol Violation|1|||
128755581|NCT03649230|463392521|FG000|Overall Study|Non-compliance|1|||
128755582|NCT03649230|463392521|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
128755583|NCT01693068|463392523|FG000|Randomization Period|On-study|2|||
128755584|NCT01693068|463392524|FG001|Randomization Period|On-study|5|||
128755585|NCT01693068|463392525|FG002|Randomization Period|On-study|0|||
128755586|NCT01693068|463392523|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
128755587|NCT01693068|463392524|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
128755588|NCT01693068|463392525|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
128755589|NCT01239030|463392534|FG000|Double Blind|Adverse Event|0|||
128755590|NCT01239030|463392535|FG001|Double Blind|Adverse Event|1|||
128755591|NCT01239030|463392536|FG002|Double Blind|Adverse Event|0|||
128755592|NCT01239030|463392537|FG003|Double Blind|Adverse Event|2|||
128755593|NCT01239030|463392538|FG004|Double Blind|Adverse Event|0|||
128755594|NCT01239030|463392534|FG000|Double Blind|Withdrawal by Subject|0|||
128755595|NCT01239030|463392535|FG001|Double Blind|Withdrawal by Subject|1|||
128755596|NCT01239030|463392536|FG002|Double Blind|Withdrawal by Subject|1|||
128755597|NCT01239030|463392537|FG003|Double Blind|Withdrawal by Subject|0|||
128755598|NCT01239030|463392538|FG004|Double Blind|Withdrawal by Subject|1|||
128755599|NCT01239030|463392534|FG000|Double Blind|Lost to Follow-up|1|||
128755600|NCT01239030|463392535|FG001|Double Blind|Lost to Follow-up|1|||
128755601|NCT01239030|463392536|FG002|Double Blind|Lost to Follow-up|0|||
128755602|NCT01239030|463392537|FG003|Double Blind|Lost to Follow-up|0|||
128755603|NCT01239030|463392538|FG004|Double Blind|Lost to Follow-up|0|||
128755604|NCT01239030|463392534|FG000|Double Blind|Physician Decision|0|||
128755605|NCT01239030|463392535|FG001|Double Blind|Physician Decision|1|||
128755606|NCT01239030|463392536|FG002|Double Blind|Physician Decision|0|||
128755607|NCT01239030|463392537|FG003|Double Blind|Physician Decision|0|||
128755608|NCT01239030|463392538|FG004|Double Blind|Physician Decision|0|||
128755609|NCT01239030|463392534|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
128755610|NCT01239030|463392535|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
128755611|NCT01239030|463392536|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
128755612|NCT01239030|463392537|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
128755613|NCT01239030|463392538|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
128755614|NCT01239030|463392534|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
128755615|NCT01239030|463392535|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
128755616|NCT01239030|463392536|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
128755617|NCT01239030|463392537|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
128755618|NCT01239030|463392538|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
128755619|NCT01239030|463392534|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
128755620|NCT01239030|463392535|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
128755621|NCT01239030|463392536|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
128755622|NCT01239030|463392537|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
128755623|NCT01239030|463392538|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
128755624|NCT01239030|463392534|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
128755625|NCT01239030|463392535|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
128755626|NCT01239030|463392536|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
128755627|NCT01239030|463392537|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
128755628|NCT01239030|463392538|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
128755629|NCT00058123|463392540|FG000|Overall Study|Wrong histology|9|||
128755630|NCT00058123|463392540|FG000|Overall Study|Received >3 prior treatments|1|||
128755631|NCT00829387|463392543|FG000|Overall Study|Withdrawal by Subject|2|||
128755632|NCT00829387|463392544|FG001|Overall Study|Withdrawal by Subject|3|||
128755633|NCT00829387|463392543|FG000|Overall Study|Disqualified by PI|1|||
128755634|NCT00829387|463392544|FG001|Overall Study|Disqualified by PI|0|||
128755635|NCT03519854|463392547|FG000|Overall Study|Technical Error|0|||
128755636|NCT03519854|463392548|FG001|Overall Study|Technical Error|0|||
128755637|NCT03519854|463392549|FG002|Overall Study|Technical Error|1|||
128755638|NCT03519854|463392550|FG003|Overall Study|Technical Error|0|||
128755639|NCT03519854|463392551|FG004|Overall Study|Technical Error|0|||
128755640|NCT03519854|463392552|FG005|Overall Study|Technical Error|0|||
128755641|NCT03519854|463392553|FG006|Overall Study|Technical Error|0|||
128755642|NCT03519854|463392554|FG007|Overall Study|Technical Error|0|||
128755643|NCT03519854|463392555|FG008|Overall Study|Technical Error|0|||
128755644|NCT03519854|463392556|FG009|Overall Study|Technical Error|0|||
128755645|NCT03519854|463392557|FG010|Overall Study|Technical Error|0|||
128755646|NCT03519854|463392558|FG011|Overall Study|Technical Error|0|||
128755647|NCT03519854|463392559|FG012|Overall Study|Technical Error|0|||
128755648|NCT03519854|463392560|FG013|Overall Study|Technical Error|0|||
128755649|NCT03519854|463392561|FG014|Overall Study|Technical Error|0|||
128755650|NCT03519854|463392562|FG015|Overall Study|Technical Error|0|||
128755651|NCT03519854|463392563|FG016|Overall Study|Technical Error|0|||
128755652|NCT03519854|463392564|FG017|Overall Study|Technical Error|0|||
128755653|NCT02747238|463392565|FG000|Overall Study|Lack of Efficacy|0|||
128755654|NCT02747238|463392566|FG001|Overall Study|Lack of Efficacy|1|||
128755655|NCT02747238|463392565|FG000|Overall Study|Data lost|3|||
128755656|NCT02747238|463392566|FG001|Overall Study|Data lost|5|||
128755657|NCT00951275|463392567|FG000|Overall Study|Administrative Reason|1|||
128755658|NCT00951275|463392567|FG000|Overall Study|Adverse Event|7|||
128755659|NCT00951275|463392567|FG000|Overall Study|Withdrawal by Subject|4|||
128755660|NCT00951275|463392567|FG000|Overall Study|Protocol Violation|1|||
128755661|NCT01112579|463392571|FG000|Overall Study|Missed Visit|1|||
128755662|NCT01112579|463392572|FG001|Overall Study|Missed Visit|1|||
128755663|NCT01112579|463392571|FG000|Overall Study|Death|0|||
128755664|NCT01112579|463392572|FG001|Overall Study|Death|2|||
128755665|NCT03053050|463392573|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
128755666|NCT03053050|463392574|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
128755667|NCT03053050|463392575|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
128755668|NCT03053050|463392576|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
128755669|NCT03053050|463392573|FG000|Randomized Phase|Withdrew Consent|16|||
128755670|NCT03053050|463392574|FG001|Randomized Phase|Withdrew Consent|8|||
128755671|NCT03053050|463392575|FG002|Randomized Phase|Withdrew Consent|9|||
128755672|NCT03053050|463392576|FG003|Randomized Phase|Withdrew Consent|0|||
128755673|NCT03053050|463392573|FG000|Randomized Phase|Investigator's Discretion|6|||
128755674|NCT03053050|463392574|FG001|Randomized Phase|Investigator's Discretion|6|||
128755675|NCT03053050|463392575|FG002|Randomized Phase|Investigator's Discretion|3|||
128755676|NCT03053050|463392576|FG003|Randomized Phase|Investigator's Discretion|0|||
128755677|NCT03053050|463392573|FG000|Randomized Phase|Lost to Follow-up|5|||
128755678|NCT03053050|463392574|FG001|Randomized Phase|Lost to Follow-up|1|||
128755679|NCT03053050|463392575|FG002|Randomized Phase|Lost to Follow-up|1|||
128755680|NCT03053050|463392576|FG003|Randomized Phase|Lost to Follow-up|0|||
128755681|NCT03053050|463392573|FG000|Randomized Phase|Adverse Event|0|||
128755682|NCT03053050|463392574|FG001|Randomized Phase|Adverse Event|1|||
128755683|NCT03053050|463392575|FG002|Randomized Phase|Adverse Event|0|||
128755684|NCT03053050|463392576|FG003|Randomized Phase|Adverse Event|0|||
128755685|NCT03053050|463392573|FG000|Randomized Phase|Randomized but Never Treated|2|||
128755686|NCT03053050|463392574|FG001|Randomized Phase|Randomized but Never Treated|2|||
128755687|NCT03053050|463392575|FG002|Randomized Phase|Randomized but Never Treated|2|||
128755688|NCT03053050|463392576|FG003|Randomized Phase|Randomized but Never Treated|0|||
128755689|NCT03053050|463392573|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
128755690|NCT03053050|463392574|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
128755691|NCT03053050|463392575|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
128755692|NCT03053050|463392576|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
128755693|NCT03053050|463392573|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
128755694|NCT03053050|463392574|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
128755695|NCT03053050|463392575|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
128755696|NCT03053050|463392576|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
128755697|NCT03053050|463392573|FG000|Open-label Phase|Withdrew Consent|0|||
128755698|NCT03053050|463392574|FG001|Open-label Phase|Withdrew Consent|0|||
128755699|NCT03053050|463392575|FG002|Open-label Phase|Withdrew Consent|0|||
128755700|NCT03053050|463392576|FG003|Open-label Phase|Withdrew Consent|6|||
128755701|NCT03053050|463392573|FG000|Open-label Phase|Investigator's Discretion|0|||
128755702|NCT03053050|463392574|FG001|Open-label Phase|Investigator's Discretion|0|||
128755703|NCT03053050|463392575|FG002|Open-label Phase|Investigator's Discretion|0|||
128755704|NCT03053050|463392576|FG003|Open-label Phase|Investigator's Discretion|4|||
128755705|NCT03703466|463392577|FG000|Overall Study|Death|2|||
128755706|NCT03703466|463392578|FG001|Overall Study|Death|1|||
128755707|NCT03703466|463392579|FG002|Overall Study|Death|0|||
128755708|NCT03703466|463392577|FG000|Overall Study|Withdrawal by Subject|0|||
128755709|NCT03703466|463392578|FG001|Overall Study|Withdrawal by Subject|3|||
128755710|NCT03703466|463392579|FG002|Overall Study|Withdrawal by Subject|0|||
128755711|NCT03703466|463392577|FG000|Overall Study|Completed < 3 Cycles|2|||
128755712|NCT03703466|463392578|FG001|Overall Study|Completed < 3 Cycles|2|||
128755713|NCT03703466|463392579|FG002|Overall Study|Completed < 3 Cycles|2|||
128755714|NCT05338333|463392580|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
128755715|NCT05338333|463392581|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
128755716|NCT03409666|463394253|FG000|Overall Study|Physician Decision|0|||
128755717|NCT03409666|463394254|FG001|Overall Study|Physician Decision|1|||
128755718|NCT03409666|463394253|FG000|Overall Study|Protocol Violation|0|||
128755719|NCT03409666|463394254|FG001|Overall Study|Protocol Violation|3|||
128755720|NCT01791725|463394255|FG000|Overall Study|Withdrawal by Subject|0|||
128755721|NCT01791725|463394256|FG001|Overall Study|Withdrawal by Subject|1|||
128755722|NCT01791725|463394257|FG002|Overall Study|Withdrawal by Subject|0|||
128755723|NCT00512148|463394258|FG000|Primay Study Period|Withdrawal by Subject|1|||
128755724|NCT00677833|463394259|FG000|Overall Study|Withdrawal by Subject|4|||
128755725|NCT00677833|463394260|FG001|Overall Study|Withdrawal by Subject|0|||
128755726|NCT00677833|463394261|FG002|Overall Study|Withdrawal by Subject|1|||
128755727|NCT00677833|463394262|FG003|Overall Study|Withdrawal by Subject|3|||
128755728|NCT00677833|463394259|FG000|Overall Study|Lost to Follow-up|0|||
128755729|NCT00677833|463394260|FG001|Overall Study|Lost to Follow-up|0|||
128755730|NCT00677833|463394261|FG002|Overall Study|Lost to Follow-up|1|||
128755731|NCT00677833|463394262|FG003|Overall Study|Lost to Follow-up|0|||
128755732|NCT02001194|463394264|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
128755733|NCT02001194|463394265|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
128755734|NCT02001194|463394266|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
128755735|NCT02001194|463394267|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
128755736|NCT02001194|463394264|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
128755737|NCT02001194|463394265|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
128755738|NCT02001194|463394266|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
128755739|NCT02001194|463394267|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
128755740|NCT02690974|463394268|FG000|Overall Study|Adverse Event|16|||
128755741|NCT02690974|463394268|FG000|Overall Study|Death|9|||
128755742|NCT02690974|463394268|FG000|Overall Study|Subject/guardian decision|4|||
128755743|NCT02690974|463394268|FG000|Overall Study|Lost to Follow-up|3|||
128755744|NCT02690974|463394268|FG000|Overall Study|Withdrawal of Informed Consent|3|||
128755745|NCT02690974|463394268|FG000|Overall Study|Physician Decision|2|||
128755746|NCT02690974|463394268|FG000|Overall Study|Non-compliance with study treatment|1|||
128755747|NCT02690974|463394268|FG000|Overall Study|Protocol-defined stopping criteria|1|||
128755748|NCT02690974|463394268|FG000|Overall Study|Protocol Deviation|1|||
128755749|NCT01666951|463394273|FG000|Overall Study|Not dosed|1|||
128755750|NCT01666951|463394274|FG001|Overall Study|Not dosed|1|||
128755751|NCT00522301|463394275|FG000|Overall Study|Withdrawal by Subject|1|||
128755752|NCT00522301|463394275|FG000|Overall Study|Adverse Event|5|||
128755753|NCT02366910|463394279|FG000|Overall Study|Withdrawal by Subject|2|||
128755754|NCT02366910|463394279|FG000|Overall Study|Screen Failure|3|||
128755755|NCT02623322|463394283|FG000|Overall Study|Lost to Follow-up|2|||
128755756|NCT02623322|463394284|FG001|Overall Study|Lost to Follow-up|1|||
128755757|NCT02623322|463394285|FG002|Overall Study|Lost to Follow-up|0|||
128755758|NCT01690130|463394289|FG000|Overall Study|Subject have cancelled visit.|1|||
128755759|NCT01690130|463394290|FG001|Overall Study|Subject have cancelled visit.|0|||
128755760|NCT05159622|463394291|FG000|Overall Study|Lost to Follow-up|4|||
128755761|NCT05159622|463394292|FG001|Overall Study|Lost to Follow-up|5|||
128755762|NCT03318523|463394293|FG000|PC Period: Up to Year 1|Adverse Event|1|||
128755763|NCT03318523|463394294|FG001|PC Period: Up to Year 1|Adverse Event|0|||
128755764|NCT03318523|463394295|FG002|PC Period: Up to Year 1|Adverse Event|2|||
128755765|NCT03318523|463394296|FG003|PC Period: Up to Year 1|Adverse Event|0|||
128755766|NCT03318523|463394297|FG004|PC Period: Up to Year 1|Adverse Event|0|||
128755767|NCT03318523|463394298|FG005|PC Period: Up to Year 1|Adverse Event|0|||
128755768|NCT03318523|463394299|FG006|PC Period: Up to Year 1|Adverse Event|0|||
128755769|NCT03318523|463394300|FG007|PC Period: Up to Year 1|Adverse Event|0|||
128755770|NCT03318523|463394301|FG008|PC Period: Up to Year 1|Adverse Event|0|||
128755771|NCT03318523|463394302|FG009|PC Period: Up to Year 1|Adverse Event|0|||
128755772|NCT03318523|463394293|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
128755773|NCT03318523|463394294|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
128755774|NCT03318523|463394295|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
128755775|NCT03318523|463394296|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
128755776|NCT03318523|463394297|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
128755777|NCT03318523|463394298|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
128755778|NCT03318523|463394299|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
128755779|NCT03318523|463394300|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
128755780|NCT03318523|463394301|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
128755781|NCT03318523|463394302|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
128755782|NCT03318523|463394293|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
128755783|NCT03318523|463394294|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
128755784|NCT03318523|463394295|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
128755785|NCT03318523|463394296|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
128755786|NCT03318523|463394297|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
128755787|NCT03318523|463394298|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
128755788|NCT03318523|463394299|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
128755789|NCT03318523|463394300|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
128755790|NCT03318523|463394301|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
128755791|NCT03318523|463394302|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
128755792|NCT03318523|463394293|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
128755793|NCT03318523|463394294|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
128755794|NCT03318523|463394295|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
128755795|NCT03318523|463394296|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
128755796|NCT03318523|463394297|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
128755797|NCT03318523|463394298|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
128755798|NCT03318523|463394299|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
128755799|NCT03318523|463394300|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
128755800|NCT03318523|463394301|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
128755801|NCT03318523|463394302|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
128755802|NCT03318523|463394293|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755803|NCT03318523|463394294|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755804|NCT03318523|463394295|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755805|NCT03318523|463394296|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755806|NCT03318523|463394297|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755807|NCT03318523|463394298|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
128755808|NCT03318523|463394299|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755809|NCT03318523|463394300|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755810|NCT03318523|463394301|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755811|NCT03318523|463394302|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
128755812|NCT03318523|463394293|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755813|NCT03318523|463394294|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755814|NCT03318523|463394295|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755815|NCT03318523|463394296|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755816|NCT03318523|463394297|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755817|NCT03318523|463394298|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755818|NCT03318523|463394299|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755819|NCT03318523|463394300|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755820|NCT03318523|463394301|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
128755821|NCT03318523|463394302|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
128755822|NCT03318523|463394293|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
128755823|NCT03318523|463394294|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
128755824|NCT03318523|463394295|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
128755825|NCT03318523|463394296|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
128755826|NCT03318523|463394297|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
128755827|NCT03318523|463394298|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
128755828|NCT03318523|463394299|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
128755829|NCT03318523|463394300|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
128755830|NCT03318523|463394301|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
128755831|NCT03318523|463394302|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
128755832|NCT03318523|463394293|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
128755833|NCT03318523|463394294|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
128755834|NCT03318523|463394295|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
128755835|NCT03318523|463394296|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
128755836|NCT03318523|463394297|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
128755837|NCT03318523|463394298|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
128755838|NCT03318523|463394299|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
128755839|NCT03318523|463394300|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
128755840|NCT03318523|463394301|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
128755841|NCT03318523|463394302|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
128755842|NCT03581981|463394306|FG000|Overall Study|Withdrawal by Subject|12|||
128755843|NCT03581981|463394307|FG001|Overall Study|Withdrawal by Subject|13|||
128755844|NCT03581981|463394306|FG000|Overall Study|Physician Decision|1|||
128755845|NCT03581981|463394307|FG001|Overall Study|Physician Decision|2|||
128755846|NCT03581981|463394306|FG000|Overall Study|Lost to Follow-up|0|||
128755847|NCT03581981|463394307|FG001|Overall Study|Lost to Follow-up|4|||
128755848|NCT02080871|463394308|FG000|Overall Study|Death|1|||
128755849|NCT02080871|463394308|FG000|Overall Study|Lost to Follow-up|1|||
128755850|NCT00234052|463394309|FG000|Treatment|Withdrawal by Subject|3|||
128755851|NCT00234052|463394309|FG000|Treatment|Adverse Event|5|||
128755852|NCT00234052|463394309|FG000|Treatment|Death|2|||
128755853|NCT00234052|463394309|FG000|Treatment|Progressive Disease|11|||
128755854|NCT00234052|463394309|FG000|Follow-up for 5 Years|Death|41|||
128755855|NCT00234052|463394309|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
128755856|NCT00234052|463394309|FG000|Follow-up for 5 Years|Other|7|||
128755857|NCT01410474|463394310|FG000|Overall Study|Withdrawal by Subject|0|||
128755858|NCT01410474|463394311|FG001|Overall Study|Withdrawal by Subject|1|||
128755859|NCT00828984|463394313|FG000|Overall Study|Adverse Event|2|||
128755860|NCT00828984|463394314|FG001|Overall Study|Adverse Event|3|||
128755861|NCT00828984|463394315|FG002|Overall Study|Adverse Event|0|||
128755862|NCT00828984|463394313|FG000|Overall Study|Lost to Follow-up|5|||
128755863|NCT00828984|463394314|FG001|Overall Study|Lost to Follow-up|3|||
128755864|NCT00828984|463394315|FG002|Overall Study|Lost to Follow-up|1|||
128755865|NCT00828984|463394313|FG000|Overall Study|Withdrawal by Subject|4|||
128755866|NCT00828984|463394314|FG001|Overall Study|Withdrawal by Subject|4|||
128755867|NCT00828984|463394315|FG002|Overall Study|Withdrawal by Subject|4|||
128755868|NCT00828984|463394313|FG000|Overall Study|Ineligable|1|||
128755869|NCT00828984|463394314|FG001|Overall Study|Ineligable|2|||
128755870|NCT00828984|463394315|FG002|Overall Study|Ineligable|0|||
128755871|NCT00828984|463394313|FG000|Overall Study|Medical Contraindication|0|||
128755872|NCT00828984|463394314|FG001|Overall Study|Medical Contraindication|1|||
128755873|NCT00828984|463394315|FG002|Overall Study|Medical Contraindication|0|||
128755874|NCT00828984|463394313|FG000|Overall Study|Noncompliant|1|||
128755875|NCT00828984|463394314|FG001|Overall Study|Noncompliant|2|||
128755876|NCT00828984|463394315|FG002|Overall Study|Noncompliant|3|||
128755877|NCT00828984|463394313|FG000|Overall Study|ConMed|1|||
128755878|NCT00828984|463394314|FG001|Overall Study|ConMed|1|||
128755879|NCT00828984|463394315|FG002|Overall Study|ConMed|1|||
128755880|NCT01615328|463394319|FG000|Overall Study|Lost to Follow-up|3|||
128755881|NCT01615328|463394320|FG001|Overall Study|Lost to Follow-up|5|||
128755882|NCT03338894|463394321|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
128755883|NCT00863655|463394322|FG000|Overall Study|Protocol Violation|4|||
128755884|NCT00863655|463394323|FG001|Overall Study|Protocol Violation|0|||
128755885|NCT00863655|463394322|FG000|Overall Study|Adverse Event|52|||
128755886|NCT00863655|463394323|FG001|Overall Study|Adverse Event|8|||
128786575|NCT01090024|463511203|FG015|Period 3|Withdrawal by Subject|1|||
128755887|NCT00863655|463394322|FG000|Overall Study|Withdrawal by Subject|47|||
128755888|NCT00863655|463394323|FG001|Overall Study|Withdrawal by Subject|7|||
128755889|NCT00863655|463394322|FG000|Overall Study|Administrative problems|1|||
128755890|NCT00863655|463394323|FG001|Overall Study|Administrative problems|0|||
128755891|NCT00863655|463394322|FG000|Overall Study|Death|7|||
128755892|NCT00863655|463394323|FG001|Overall Study|Death|1|||
128755893|NCT00863655|463394322|FG000|Overall Study|New cancer therapy|5|||
128755894|NCT00863655|463394323|FG001|Overall Study|New cancer therapy|1|||
128755895|NCT00863655|463394322|FG000|Overall Study|Disease progression|364|||
128755896|NCT00863655|463394323|FG001|Overall Study|Disease progression|221|||
128755897|NCT00863655|463394322|FG000|Overall Study|Treatment completed as per protocol|5|||
128755898|NCT00863655|463394323|FG001|Overall Study|Treatment completed as per protocol|1|||
128755899|NCT04465357|463394324|FG000|Overall Study|Adverse Event|2|||
128755900|NCT04465357|463394324|FG000|Overall Study|Lack of Efficacy|1|||
128755901|NCT04465357|463394324|FG000|Overall Study|Lost to Follow-up|2|||
128755902|NCT04465357|463394324|FG000|Overall Study|Withdrawal by Subject|6|||
128755903|NCT04465357|463394324|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
128755904|NCT02157779|463394327|FG000|Overall Study|Logistical|9|||
128755905|NCT02157779|463394328|FG001|Overall Study|Logistical|3|||
128755906|NCT02157779|463394327|FG000|Overall Study|Stopped attending, reason unknown|11|||
128755907|NCT02157779|463394328|FG001|Overall Study|Stopped attending, reason unknown|7|||
128755908|NCT02157779|463394327|FG000|Overall Study|No response to outreach after Baseline|1|||
128755909|NCT02157779|463394328|FG001|Overall Study|No response to outreach after Baseline|1|||
128755910|NCT02157779|463394327|FG000|Overall Study|Moved|1|||
128755911|NCT02157779|463394328|FG001|Overall Study|Moved|0|||
128755912|NCT02157779|463394327|FG000|Overall Study|Medical|1|||
128755913|NCT02157779|463394328|FG001|Overall Study|Medical|0|||
128755914|NCT02157779|463394327|FG000|Overall Study|Legal issue|1|||
128755915|NCT02157779|463394328|FG001|Overall Study|Legal issue|0|||
128755916|NCT00002558|463394333|FG000|Overall Study|Withdrawal by Subject|0|||
128755917|NCT00002558|463394334|FG001|Overall Study|Withdrawal by Subject|1|||
128755918|NCT02065336|463394335|FG000|Extension Phase|Study Terminated by Sponsor|0|||
128755919|NCT02065336|463394336|FG001|Extension Phase|Study Terminated by Sponsor|0|||
128755920|NCT02065336|463394337|FG002|Extension Phase|Study Terminated by Sponsor|0|||
128755921|NCT02065336|463394338|FG003|Extension Phase|Study Terminated by Sponsor|0|||
128755922|NCT02065336|463394339|FG004|Extension Phase|Study Terminated by Sponsor|0|||
128755923|NCT02065336|463394340|FG005|Extension Phase|Study Terminated by Sponsor|0|||
128755924|NCT02065336|463394341|FG006|Extension Phase|Study Terminated by Sponsor|0|||
128755925|NCT02065336|463394342|FG007|Extension Phase|Study Terminated by Sponsor|0|||
128755926|NCT02065336|463394343|FG008|Extension Phase|Study Terminated by Sponsor|2|||
128755927|NCT02065336|463394344|FG009|Extension Phase|Study Terminated by Sponsor|8|||
128755928|NCT00626028|463394345|FG000|Overall Study|Adverse Event|1|||
128755929|NCT00626028|463394346|FG001|Overall Study|Adverse Event|1|||
128755930|NCT00626028|463394345|FG000|Overall Study|Device Failure|0|||
128755931|NCT00626028|463394346|FG001|Overall Study|Device Failure|1|||
128755932|NCT00626028|463394345|FG000|Overall Study|Physician Decision|2|||
128755933|NCT00626028|463394346|FG001|Overall Study|Physician Decision|1|||
128755934|NCT00626028|463394345|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
128755935|NCT00626028|463394346|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
128755936|NCT00831779|463394347|FG000|Overall Study|Lost to Follow-up|1|||
128755937|NCT00831779|463394348|FG001|Overall Study|Lost to Follow-up|0|||
128755938|NCT00831779|463394347|FG000|Overall Study|No longer met criteria|0|||
128755939|NCT00831779|463394348|FG001|Overall Study|No longer met criteria|1|||
128755940|NCT01984684|463394349|FG000|Overall Study|Lost to Follow-up|25|||
128755941|NCT01984684|463394350|FG001|Overall Study|Lost to Follow-up|24|||
128755942|NCT01984684|463394349|FG000|Overall Study|Adverse Event|8|||
128755943|NCT01984684|463394350|FG001|Overall Study|Adverse Event|12|||
128755944|NCT01984684|463394349|FG000|Overall Study|Withdrawal by Subject|9|||
128755945|NCT01984684|463394350|FG001|Overall Study|Withdrawal by Subject|9|||
128755946|NCT01984684|463394349|FG000|Overall Study|Lack of Efficacy|3|||
128755947|NCT01984684|463394350|FG001|Overall Study|Lack of Efficacy|6|||
128755948|NCT01984684|463394349|FG000|Overall Study|Physician Decision|4|||
128755949|NCT01984684|463394350|FG001|Overall Study|Physician Decision|2|||
128755950|NCT01984684|463394349|FG000|Overall Study|Protocol Violation|4|||
128755951|NCT01984684|463394350|FG001|Overall Study|Protocol Violation|2|||
128755952|NCT01984684|463394349|FG000|Overall Study|Death|0|||
128755953|NCT01984684|463394350|FG001|Overall Study|Death|1|||
128755954|NCT01984684|463394349|FG000|Overall Study|Noncompliance with study drug|2|||
128755955|NCT01984684|463394350|FG001|Overall Study|Noncompliance with study drug|1|||
128755956|NCT01984684|463394349|FG000|Overall Study|Subject incarcerated|1|||
128755957|NCT01984684|463394350|FG001|Overall Study|Subject incarcerated|0|||
128755958|NCT01984684|463394349|FG000|Overall Study|Study drug not available at site|1|||
128755959|NCT01984684|463394350|FG001|Overall Study|Study drug not available at site|1|||
128755960|NCT01984684|463394349|FG000|Overall Study|Subject had inadequate IV access|0|||
128755961|NCT01984684|463394350|FG001|Overall Study|Subject had inadequate IV access|1|||
128755962|NCT02432105|463394358|FG000|Overall Study|Lost to Follow-up|1|||
128755963|NCT02432105|463394359|FG001|Overall Study|Lost to Follow-up|1|||
128755964|NCT02432105|463394360|FG002|Overall Study|Lost to Follow-up|0|||
128755965|NCT02432105|463394358|FG000|Overall Study|Withdrawal by Subject|1|||
128755966|NCT02432105|463394359|FG001|Overall Study|Withdrawal by Subject|0|||
128755967|NCT02432105|463394360|FG002|Overall Study|Withdrawal by Subject|1|||
128755968|NCT02432105|463394358|FG000|Overall Study|Culture positive for yeast|0|||
128755969|NCT02432105|463394359|FG001|Overall Study|Culture positive for yeast|1|||
128755970|NCT02432105|463394360|FG002|Overall Study|Culture positive for yeast|0|||
128755971|NCT02432105|463394358|FG000|Overall Study|Randomized in error|0|||
128755972|NCT02432105|463394359|FG001|Overall Study|Randomized in error|0|||
128755973|NCT02432105|463394360|FG002|Overall Study|Randomized in error|2|||
128755974|NCT01400503|463394361|FG000|Overall Study|Withdrawal by Subject|1|||
128755975|NCT01400503|463394361|FG000|Overall Study|Study Terminated by Sponsor|58|||
128755976|NCT01400503|463394361|FG000|Overall Study|Other|1|||
128755977|NCT01212770|463394362|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
128755978|NCT01212770|463394363|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
128755979|NCT01212770|463394364|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
128755980|NCT01212770|463394365|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128755981|NCT01212770|463394366|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128755982|NCT01212770|463394367|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128755983|NCT01212770|463394368|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128755984|NCT01212770|463394369|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128755985|NCT01212770|463394370|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128755986|NCT01212770|463394362|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
128755987|NCT01212770|463394363|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
128755988|NCT01212770|463394364|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
128755989|NCT01212770|463394365|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128755990|NCT01212770|463394366|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128755991|NCT01212770|463394367|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128755992|NCT01212770|463394368|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128755993|NCT01212770|463394369|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128755994|NCT01212770|463394370|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128755995|NCT01212770|463394362|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
128755996|NCT01212770|463394363|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
128755997|NCT01212770|463394364|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
128755998|NCT01212770|463394365|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128755999|NCT01212770|463394366|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128756000|NCT01212770|463394367|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128756001|NCT01212770|463394368|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128756002|NCT01212770|463394369|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128756003|NCT01212770|463394370|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128756004|NCT01212770|463394362|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
128756005|NCT01212770|463394363|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128756006|NCT01212770|463394364|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
128756007|NCT01212770|463394365|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128756008|NCT01212770|463394366|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128756009|NCT01212770|463394367|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128756010|NCT01212770|463394368|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128756011|NCT01212770|463394369|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128756012|NCT01212770|463394370|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128756013|NCT01212770|463394362|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756014|NCT01212770|463394363|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756015|NCT01212770|463394364|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
128756016|NCT01212770|463394365|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756017|NCT01212770|463394366|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756018|NCT01212770|463394367|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756019|NCT01212770|463394368|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756020|NCT01212770|463394369|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756021|NCT01212770|463394370|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128756022|NCT01212770|463394362|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
128756023|NCT01212770|463394363|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
128756024|NCT01212770|463394364|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
128756025|NCT01212770|463394365|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
128756026|NCT01212770|463394366|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
128756027|NCT01212770|463394367|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
128756028|NCT01212770|463394368|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
128756029|NCT01212770|463394369|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
128756030|NCT01212770|463394370|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
128756031|NCT01212770|463394362|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
128756032|NCT01212770|463394363|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
128756033|NCT01212770|463394364|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
128756034|NCT01212770|463394365|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
128756035|NCT01212770|463394366|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
128756036|NCT01212770|463394367|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
128786576|NCT01090024|463511204|FG016|Period 3|Withdrawal by Subject|0|||
128786577|NCT01090024|463511205|FG017|Period 3|Withdrawal by Subject|0|||
128786578|NCT01090024|463511188|FG000|Period 3|Protocol Violation|0|||
128786579|NCT01090024|463511189|FG001|Period 3|Protocol Violation|0|||
128786580|NCT01090024|463511190|FG002|Period 3|Protocol Violation|0|||
128786581|NCT01090024|463511191|FG003|Period 3|Protocol Violation|0|||
128786582|NCT01090024|463511192|FG004|Period 3|Protocol Violation|0|||
128786583|NCT01090024|463511193|FG005|Period 3|Protocol Violation|0|||
128786584|NCT01090024|463511194|FG006|Period 3|Protocol Violation|0|||
128786585|NCT01090024|463511195|FG007|Period 3|Protocol Violation|0|||
128786586|NCT01090024|463511196|FG008|Period 3|Protocol Violation|1|||
128786587|NCT01090024|463511197|FG009|Period 3|Protocol Violation|0|||
128786588|NCT01090024|463511198|FG010|Period 3|Protocol Violation|0|||
128786589|NCT01090024|463511199|FG011|Period 3|Protocol Violation|0|||
128786590|NCT01090024|463511200|FG012|Period 3|Protocol Violation|0|||
128786591|NCT01090024|463511201|FG013|Period 3|Protocol Violation|0|||
128786592|NCT01090024|463511202|FG014|Period 3|Protocol Violation|0|||
128786593|NCT01090024|463511203|FG015|Period 3|Protocol Violation|0|||
128786594|NCT01090024|463511204|FG016|Period 3|Protocol Violation|0|||
128786595|NCT01090024|463511205|FG017|Period 3|Protocol Violation|0|||
128786596|NCT01090024|463511188|FG000|Period 3|Adverse Event|0|||
128786597|NCT01090024|463511189|FG001|Period 3|Adverse Event|0|||
128786598|NCT01090024|463511190|FG002|Period 3|Adverse Event|0|||
128786599|NCT01090024|463511191|FG003|Period 3|Adverse Event|0|||
128786600|NCT01090024|463511192|FG004|Period 3|Adverse Event|0|||
128786601|NCT01090024|463511193|FG005|Period 3|Adverse Event|1|||
128786602|NCT01090024|463511194|FG006|Period 3|Adverse Event|0|||
128786603|NCT01090024|463511195|FG007|Period 3|Adverse Event|0|||
128786604|NCT01090024|463511196|FG008|Period 3|Adverse Event|0|||
128786605|NCT01090024|463511197|FG009|Period 3|Adverse Event|0|||
128786606|NCT01090024|463511198|FG010|Period 3|Adverse Event|0|||
128786607|NCT01090024|463511199|FG011|Period 3|Adverse Event|0|||
128786608|NCT01090024|463511200|FG012|Period 3|Adverse Event|0|||
128786609|NCT01090024|463511201|FG013|Period 3|Adverse Event|0|||
128786610|NCT01090024|463511202|FG014|Period 3|Adverse Event|0|||
128786611|NCT01090024|463511203|FG015|Period 3|Adverse Event|0|||
128786612|NCT01090024|463511204|FG016|Period 3|Adverse Event|0|||
128786613|NCT01090024|463511205|FG017|Period 3|Adverse Event|0|||
128786614|NCT00567879|463511208|FG000|Overall Study|Adverse Event|2|||
128786615|NCT00567879|463511209|FG001|Overall Study|Adverse Event|0|||
128786616|NCT00567879|463511210|FG002|Overall Study|Adverse Event|1|||
128786617|NCT00567879|463511211|FG003|Overall Study|Adverse Event|0|||
128786618|NCT00567879|463511212|FG004|Overall Study|Adverse Event|1|||
128786619|NCT00567879|463511213|FG005|Overall Study|Adverse Event|0|||
128786620|NCT00567879|463511208|FG000|Overall Study|Abnormal test procedure(s)|0|||
128786621|NCT00567879|463511209|FG001|Overall Study|Abnormal test procedure(s)|0|||
128786622|NCT00567879|463511210|FG002|Overall Study|Abnormal test procedure(s)|1|||
128786623|NCT00567879|463511211|FG003|Overall Study|Abnormal test procedure(s)|0|||
128756037|NCT01212770|463394368|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
128756038|NCT01212770|463394369|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
128756039|NCT01212770|463394370|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
128756040|NCT01212770|463394362|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
128756041|NCT01212770|463394363|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
128756042|NCT01212770|463394364|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
128756043|NCT01212770|463394365|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
128756044|NCT01212770|463394366|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
128756045|NCT01212770|463394367|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
128756046|NCT01212770|463394368|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
128756047|NCT01212770|463394369|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
128756048|NCT01212770|463394370|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
128756049|NCT01212770|463394362|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
128756050|NCT01212770|463394363|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
128756051|NCT01212770|463394364|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
128756052|NCT01212770|463394365|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
128756053|NCT01212770|463394366|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
128756054|NCT01212770|463394367|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
128756055|NCT01212770|463394368|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
128756056|NCT01212770|463394369|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
128756057|NCT01212770|463394370|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
128756058|NCT01212770|463394362|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756059|NCT01212770|463394363|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756060|NCT01212770|463394364|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
128756061|NCT01212770|463394365|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756062|NCT01212770|463394366|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756063|NCT01212770|463394367|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756064|NCT01212770|463394368|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756065|NCT01212770|463394369|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756066|NCT01212770|463394370|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
128756067|NCT01212770|463394362|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756068|NCT01212770|463394363|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756069|NCT01212770|463394364|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756070|NCT01212770|463394365|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
128756071|NCT01212770|463394366|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756072|NCT01212770|463394367|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756073|NCT01212770|463394368|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756074|NCT01212770|463394369|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756075|NCT01212770|463394370|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
128756076|NCT01212770|463394362|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
128756077|NCT01212770|463394363|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
128756078|NCT01212770|463394364|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
128756079|NCT01212770|463394365|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
128756080|NCT01212770|463394366|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
128756081|NCT01212770|463394367|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
128756082|NCT01212770|463394368|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
128756083|NCT01212770|463394369|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
128756084|NCT01212770|463394370|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
128756085|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128756086|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
128756087|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
128756088|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128756089|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128756090|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128756091|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128756092|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
128756093|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
128756094|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128756095|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
128756096|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
128756097|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128756098|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128756099|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128756100|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
128756101|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
128756102|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
128756103|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756104|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
128756105|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756106|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756107|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756108|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756109|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756110|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756111|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
128756112|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128756113|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
128756114|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
128756115|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128756116|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128756117|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128756118|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128756119|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
128756120|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
128756121|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
128756122|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
128756123|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
128756124|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
128756125|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
128756126|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
128756127|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
128756128|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
128756129|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
128756130|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128756131|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
128756132|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
128756133|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128756134|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128756135|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128756136|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128756137|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
128756138|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
128756139|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128756140|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
128756141|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
128756142|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128756143|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128756144|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128756145|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
128756146|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
128756147|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
128756148|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128756149|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
128756150|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
128756151|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128756152|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128756153|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128756154|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
128756155|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
128756156|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
128756157|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128756158|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
128756159|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
128756160|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128756161|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128756162|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128756163|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128756164|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
128756165|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
128756166|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128756167|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
128756168|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128786624|NCT00567879|463511212|FG004|Overall Study|Abnormal test procedure(s)|0|||
128786625|NCT00567879|463511213|FG005|Overall Study|Abnormal test procedure(s)|0|||
128786626|NCT00567879|463511208|FG000|Overall Study|Withdrawal by Subject|0|||
128786627|NCT00567879|463511209|FG001|Overall Study|Withdrawal by Subject|0|||
128786628|NCT00567879|463511210|FG002|Overall Study|Withdrawal by Subject|3|||
128786629|NCT00567879|463511211|FG003|Overall Study|Withdrawal by Subject|1|||
128786630|NCT00567879|463511212|FG004|Overall Study|Withdrawal by Subject|0|||
128786631|NCT00567879|463511213|FG005|Overall Study|Withdrawal by Subject|0|||
128786632|NCT00567879|463511208|FG000|Overall Study|New cancer therapy|0|||
128786633|NCT00567879|463511209|FG001|Overall Study|New cancer therapy|0|||
128786634|NCT00567879|463511210|FG002|Overall Study|New cancer therapy|1|||
128786635|NCT00567879|463511211|FG003|Overall Study|New cancer therapy|0|||
128786636|NCT00567879|463511212|FG004|Overall Study|New cancer therapy|0|||
128786637|NCT00567879|463511213|FG005|Overall Study|New cancer therapy|0|||
128786638|NCT00567879|463511208|FG000|Overall Study|Disease progression|5|||
128786639|NCT00567879|463511209|FG001|Overall Study|Disease progression|7|||
128786640|NCT00567879|463511210|FG002|Overall Study|Disease progression|15|||
128786641|NCT00567879|463511211|FG003|Overall Study|Disease progression|5|||
128786642|NCT00567879|463511212|FG004|Overall Study|Disease progression|11|||
128786643|NCT00567879|463511213|FG005|Overall Study|Disease progression|3|||
128786644|NCT00777556|463511214|FG000|Overall Study|Inappropriate self-selection|34|||
128786645|NCT00777556|463511214|FG000|Overall Study|Dispensed but did not use product|12|||
128786646|NCT00777556|463511214|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
128786647|NCT03646669|463511217|FG000|Overall Study|Withdrawal by Subject|5|||
128786648|NCT03646669|463511218|FG001|Overall Study|Withdrawal by Subject|0|||
128786649|NCT01451814|463511223|FG000|Overall Study|Withdrawal by Subject|1|||
128786650|NCT01451814|463511224|FG001|Overall Study|Withdrawal by Subject|1|||
128786651|NCT01451814|463511223|FG000|Overall Study|Lost to Follow-up|5|||
128786652|NCT01451814|463511224|FG001|Overall Study|Lost to Follow-up|4|||
128786653|NCT03107611|463511225|FG000|Overall Study|Adverse Event|1|||
128786654|NCT03107611|463511226|FG001|Overall Study|Adverse Event|0|||
128786655|NCT03107611|463511227|FG002|Overall Study|Adverse Event|2|||
128786656|NCT03107611|463511225|FG000|Overall Study|Lost to Follow-up|3|||
128786657|NCT03107611|463511226|FG001|Overall Study|Lost to Follow-up|3|||
128786658|NCT03107611|463511227|FG002|Overall Study|Lost to Follow-up|3|||
128786659|NCT03107611|463511225|FG000|Overall Study|Protocol Violation|0|||
128786660|NCT03107611|463511226|FG001|Overall Study|Protocol Violation|0|||
128786661|NCT03107611|463511227|FG002|Overall Study|Protocol Violation|1|||
128786662|NCT03107611|463511225|FG000|Overall Study|Withdrawal by Subject|1|||
128786663|NCT03107611|463511226|FG001|Overall Study|Withdrawal by Subject|0|||
128786664|NCT03107611|463511227|FG002|Overall Study|Withdrawal by Subject|1|||
128786665|NCT03107611|463511225|FG000|Overall Study|Worsening signs/symptoms|2|||
128786666|NCT03107611|463511226|FG001|Overall Study|Worsening signs/symptoms|1|||
128786667|NCT03107611|463511227|FG002|Overall Study|Worsening signs/symptoms|2|||
128786668|NCT01956669|463511228|FG000|Overall Study|Disease Progression|12|||
128786669|NCT01956669|463511229|FG001|Overall Study|Disease Progression|7|||
128786670|NCT01956669|463511230|FG002|Overall Study|Disease Progression|7|||
128786671|NCT01956669|463511231|FG003|Overall Study|Disease Progression|8|||
128786672|NCT01956669|463511232|FG004|Overall Study|Disease Progression|4|||
128786673|NCT01956669|463511233|FG005|Overall Study|Disease Progression|3|||
128786674|NCT01956669|463511234|FG006|Overall Study|Disease Progression|5|||
128786675|NCT01956669|463511228|FG000|Overall Study|Adverse Event|0|||
128786676|NCT01956669|463511229|FG001|Overall Study|Adverse Event|2|||
128786677|NCT01956669|463511230|FG002|Overall Study|Adverse Event|2|||
128786678|NCT01956669|463511231|FG003|Overall Study|Adverse Event|1|||
128786679|NCT01956669|463511232|FG004|Overall Study|Adverse Event|0|||
128786680|NCT01956669|463511233|FG005|Overall Study|Adverse Event|0|||
128786681|NCT01956669|463511234|FG006|Overall Study|Adverse Event|0|||
128786682|NCT01956669|463511228|FG000|Overall Study|Physician Decision|0|||
128786683|NCT01956669|463511229|FG001|Overall Study|Physician Decision|2|||
128786684|NCT01956669|463511230|FG002|Overall Study|Physician Decision|0|||
128786685|NCT01956669|463511231|FG003|Overall Study|Physician Decision|0|||
128786686|NCT01956669|463511232|FG004|Overall Study|Physician Decision|0|||
128786687|NCT01956669|463511233|FG005|Overall Study|Physician Decision|1|||
128786688|NCT01956669|463511234|FG006|Overall Study|Physician Decision|0|||
128786689|NCT01956669|463511228|FG000|Overall Study|Withdrawal by Subject|0|||
128786690|NCT01956669|463511229|FG001|Overall Study|Withdrawal by Subject|0|||
128786691|NCT01956669|463511230|FG002|Overall Study|Withdrawal by Subject|1|||
128786692|NCT01956669|463511231|FG003|Overall Study|Withdrawal by Subject|1|||
128786693|NCT01956669|463511232|FG004|Overall Study|Withdrawal by Subject|0|||
128786694|NCT01956669|463511233|FG005|Overall Study|Withdrawal by Subject|0|||
128786695|NCT01956669|463511234|FG006|Overall Study|Withdrawal by Subject|1|||
128786696|NCT01072357|463511235|FG000|Overall Study|Lost to Follow-up|0|||
128786697|NCT01072357|463511236|FG001|Overall Study|Lost to Follow-up|1|||
128786698|NCT02131324|463511237|FG000|Overall Study|Withdrawal by Subject|1|||
128786699|NCT02131324|463511238|FG001|Overall Study|Withdrawal by Subject|2|||
128786700|NCT02131324|463511237|FG000|Overall Study|Lost to Follow-up|1|||
128756169|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128756170|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128756171|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128756172|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128756173|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128756174|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
128756175|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756176|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756177|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756178|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756179|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756180|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756181|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756182|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
128756183|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
128756184|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128756185|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
128756186|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
128756187|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128756188|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128756189|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128756190|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
128756191|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
128756192|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
128756193|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128756194|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
128756195|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
128756196|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128756197|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128756198|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128756199|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128756200|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
128756201|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
128756202|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128756203|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
128756204|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
128756205|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128756206|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128756207|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128756208|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128756209|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
128756210|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
128756211|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
128756212|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
128756213|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
128756214|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
128756215|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
128756216|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
128756217|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
128756218|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
128756219|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
128756220|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128756221|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
128756222|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
128786701|NCT02131324|463511238|FG001|Overall Study|Lost to Follow-up|1|||
128786702|NCT00891618|463511239|FG000|Overall Study|Withdrawal by Subject|1|||
128786703|NCT01693614|463511240|FG000|Overall Study|Adverse Event|7|||
128786704|NCT01693614|463511241|FG001|Overall Study|Adverse Event|11|||
128756223|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128756224|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128756225|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128756226|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128756227|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128756228|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128756229|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756230|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756231|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
128786705|NCT01693614|463511242|FG002|Overall Study|Adverse Event|5|||
128786706|NCT01693614|463511240|FG000|Overall Study|Disease progression|11|||
128756232|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756233|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756234|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756235|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756236|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756237|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
128756238|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128756239|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
128756240|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128756241|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128756242|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128756243|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128756244|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128756245|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
128756246|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
128756247|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
128756248|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
128756249|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
128756250|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
128756251|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
128756252|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
128756253|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
128756254|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
128756255|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
128756256|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756257|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756258|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
128756259|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756260|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756261|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756262|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756263|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756264|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
128756265|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128756266|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128756267|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
128756268|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128756269|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128756270|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128756271|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128756272|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
128756273|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
128756274|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756275|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756276|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
128756277|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756278|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756279|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756280|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756281|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756282|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
128756283|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128756284|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
128756285|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
128756286|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128756287|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128756288|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128756289|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128756290|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
128756291|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128756292|NCT01212770|463394362|FG000|Long-term Safety Phase (Year 5)|Death|0|||
128756293|NCT01212770|463394363|FG001|Long-term Safety Phase (Year 5)|Death|0|||
128756294|NCT01212770|463394364|FG002|Long-term Safety Phase (Year 5)|Death|0|||
128756295|NCT01212770|463394365|FG003|Long-term Safety Phase (Year 5)|Death|0|||
128756296|NCT01212770|463394366|FG004|Long-term Safety Phase (Year 5)|Death|0|||
128756297|NCT01212770|463394367|FG005|Long-term Safety Phase (Year 5)|Death|0|||
128756298|NCT01212770|463394368|FG006|Long-term Safety Phase (Year 5)|Death|0|||
128756299|NCT01212770|463394369|FG007|Long-term Safety Phase (Year 5)|Death|1|||
128756300|NCT01212770|463394370|FG008|Long-term Safety Phase (Year 5)|Death|0|||
128756301|NCT02085252|463394384|FG000|Overall Study|Withdrawal of Consent|1|||
128756302|NCT02085252|463394385|FG001|Overall Study|Withdrawal of Consent|0|||
128756303|NCT02085252|463394384|FG000|Overall Study|Adverse Event|0|||
128756304|NCT02085252|463394385|FG001|Overall Study|Adverse Event|1|||
128756305|NCT02085252|463394384|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
128756306|NCT02085252|463394385|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
128756307|NCT02085252|463394384|FG000|Overall Study|Reason Not Specified|0|||
128756308|NCT02085252|463394385|FG001|Overall Study|Reason Not Specified|1|||
128756309|NCT02085252|463394384|FG000|Overall Study|Reason Unknown|0|||
128756310|NCT02085252|463394385|FG001|Overall Study|Reason Unknown|1|||
128756311|NCT03260868|463394387|FG000|Overall Study|Poor Compliance to Protocol|0|||
128756312|NCT03260868|463394388|FG001|Overall Study|Poor Compliance to Protocol|2|||
128756313|NCT03260868|463394387|FG000|Overall Study|Study Terminated By Sponsor|2|||
128756314|NCT03260868|463394388|FG001|Overall Study|Study Terminated By Sponsor|1|||
128756315|NCT03260868|463394387|FG000|Overall Study|Other than specified above|1|||
128756316|NCT03260868|463394388|FG001|Overall Study|Other than specified above|0|||
128756317|NCT02925676|463394389|FG000|Overall Study|Withdrawal by Subject|1|||
128756318|NCT00541450|463394390|FG000|Phase A|Adverse Event|3|||
128756319|NCT00541450|463394391|FG001|Phase A|Adverse Event|0|||
128756320|NCT00541450|463394390|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
128756321|NCT00541450|463394391|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
128756322|NCT00541450|463394390|FG000|Phase A|Hyperglycemia|0|||
128756323|NCT00541450|463394391|FG001|Phase A|Hyperglycemia|1|||
128756324|NCT00541450|463394390|FG000|Phase A|Lost to Follow-up|6|||
128756325|NCT00541450|463394391|FG001|Phase A|Lost to Follow-up|4|||
128756326|NCT00541450|463394390|FG000|Phase A|Physician Decision|2|||
128756327|NCT00541450|463394391|FG001|Phase A|Physician Decision|0|||
128756328|NCT00541450|463394390|FG000|Phase A|Protocol Violation|2|||
128756329|NCT00541450|463394391|FG001|Phase A|Protocol Violation|3|||
128756330|NCT00541450|463394390|FG000|Phase A|Withdrawal by Subject|7|||
128756331|NCT00541450|463394391|FG001|Phase A|Withdrawal by Subject|7|||
128756332|NCT00541450|463394390|FG000|Phase B|Adverse Event|6|||
128756333|NCT00541450|463394391|FG001|Phase B|Adverse Event|6|||
128756334|NCT00541450|463394390|FG000|Phase B|Hyperglycemia|10|||
128756335|NCT00541450|463394391|FG001|Phase B|Hyperglycemia|9|||
128756336|NCT00541450|463394390|FG000|Phase B|Lost to Follow-up|6|||
128756337|NCT00541450|463394391|FG001|Phase B|Lost to Follow-up|4|||
128756338|NCT00541450|463394390|FG000|Phase B|Physician Decision|4|||
128756339|NCT00541450|463394391|FG001|Phase B|Physician Decision|2|||
128756340|NCT00541450|463394390|FG000|Phase B|Pregnancy|0|||
128756341|NCT00541450|463394391|FG001|Phase B|Pregnancy|1|||
128756342|NCT00541450|463394390|FG000|Phase B|Protocol Violation|3|||
128756343|NCT00541450|463394391|FG001|Phase B|Protocol Violation|3|||
128756344|NCT00541450|463394390|FG000|Phase B|Withdrawal by Subject|8|||
128756345|NCT00541450|463394391|FG001|Phase B|Withdrawal by Subject|6|||
128756346|NCT01298999|463394392|FG000|Overall Study|Physician Decision|0|||
128756347|NCT01298999|463394393|FG001|Overall Study|Physician Decision|1|||
128756348|NCT01298999|463394392|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
128756349|NCT01298999|463394393|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
128756350|NCT00803452|463394394|FG000|Overall Study|Adverse Event|0|||
128756351|NCT00803452|463394395|FG001|Overall Study|Adverse Event|2|||
128756352|NCT00803452|463394394|FG000|Overall Study|Lost to Follow-up|0|||
128756353|NCT00803452|463394395|FG001|Overall Study|Lost to Follow-up|3|||
128756354|NCT00725296|463394396|FG000|Overall Study|Adverse Event|11|||
128756355|NCT00725296|463394396|FG000|Overall Study|Lack of Efficacy|7|||
128756356|NCT00725296|463394396|FG000|Overall Study|Withdrawal by Subject|3|||
128756357|NCT00725296|463394396|FG000|Overall Study|Non-Compliance|2|||
128756358|NCT00725296|463394396|FG000|Overall Study|Lost to Follow-up|1|||
128756359|NCT00725296|463394396|FG000|Overall Study|Other|38|||
128756360|NCT03360942|463394397|FG000|Overall Study|Device explanted|2|||
128756361|NCT03360942|463394397|FG000|Overall Study|Study closure|1|||
128756362|NCT03360942|463394397|FG000|Overall Study|Withdrawal by Subject|2|||
128756363|NCT05073133|463394398|FG000|Overall Study|Death|2|||
128756364|NCT04508699|463394400|FG000|Overall Study|Lack of Efficacy|2|||
128756365|NCT04508699|463394401|FG001|Overall Study|Lack of Efficacy|15|||
128756366|NCT04508699|463394400|FG000|Overall Study|Withdrawal by Subject|0|||
128756367|NCT04508699|463394401|FG001|Overall Study|Withdrawal by Subject|2|||
128756368|NCT00289887|463396069|FG000|Overall Study|Adverse Event|3|||
128756369|NCT00289887|463396070|FG001|Overall Study|Adverse Event|3|||
128756370|NCT00289887|463396069|FG000|Overall Study|Lack of Efficacy|3|||
128756371|NCT00289887|463396070|FG001|Overall Study|Lack of Efficacy|11|||
128756372|NCT00289887|463396069|FG000|Overall Study|Lost to Follow-up|3|||
128756373|NCT00289887|463396070|FG001|Overall Study|Lost to Follow-up|3|||
128756374|NCT00289887|463396069|FG000|Overall Study|Protocol Violation|3|||
128756375|NCT00289887|463396070|FG001|Overall Study|Protocol Violation|1|||
128756376|NCT00289887|463396069|FG000|Overall Study|Withdrawal by Subject|3|||
128756377|NCT00289887|463396070|FG001|Overall Study|Withdrawal by Subject|8|||
128756378|NCT00289887|463396069|FG000|Overall Study|Other|7|||
128756379|NCT00289887|463396070|FG001|Overall Study|Other|3|||
128756380|NCT01266850|463396071|FG000|Overall Study|Lost to Follow-up|19|||
128756381|NCT01266850|463396072|FG001|Overall Study|Lost to Follow-up|19|||
128756382|NCT01266850|463396073|FG002|Overall Study|Lost to Follow-up|13|||
128756383|NCT01266850|463396074|FG003|Overall Study|Lost to Follow-up|13|||
128756384|NCT01266850|463396075|FG004|Overall Study|Lost to Follow-up|12|||
128756385|NCT01266850|463396071|FG000|Overall Study|Withdrawal by Subject|8|||
128756386|NCT01266850|463396072|FG001|Overall Study|Withdrawal by Subject|9|||
128756387|NCT01266850|463396073|FG002|Overall Study|Withdrawal by Subject|6|||
128756388|NCT01266850|463396074|FG003|Overall Study|Withdrawal by Subject|9|||
128756389|NCT01266850|463396075|FG004|Overall Study|Withdrawal by Subject|12|||
128756390|NCT01266850|463396071|FG000|Overall Study|Physician Decision|3|||
128756391|NCT01266850|463396072|FG001|Overall Study|Physician Decision|6|||
128756392|NCT01266850|463396073|FG002|Overall Study|Physician Decision|4|||
128756393|NCT01266850|463396074|FG003|Overall Study|Physician Decision|4|||
128756394|NCT01266850|463396075|FG004|Overall Study|Physician Decision|3|||
128756395|NCT01266850|463396071|FG000|Overall Study|Protocol Violation|0|||
128756396|NCT01266850|463396072|FG001|Overall Study|Protocol Violation|1|||
128756397|NCT01266850|463396073|FG002|Overall Study|Protocol Violation|0|||
128756398|NCT01266850|463396074|FG003|Overall Study|Protocol Violation|1|||
128756399|NCT01266850|463396075|FG004|Overall Study|Protocol Violation|2|||
128756400|NCT01266850|463396071|FG000|Overall Study|Adverse Event|0|||
128756401|NCT01266850|463396072|FG001|Overall Study|Adverse Event|0|||
128756402|NCT01266850|463396073|FG002|Overall Study|Adverse Event|0|||
128756403|NCT01266850|463396074|FG003|Overall Study|Adverse Event|0|||
128756404|NCT01266850|463396075|FG004|Overall Study|Adverse Event|1|||
128756405|NCT01266850|463396071|FG000|Overall Study|Site Closure|0|||
128756406|NCT01266850|463396072|FG001|Overall Study|Site Closure|1|||
128756407|NCT01266850|463396073|FG002|Overall Study|Site Closure|1|||
128756408|NCT01266850|463396074|FG003|Overall Study|Site Closure|1|||
128756409|NCT01266850|463396075|FG004|Overall Study|Site Closure|0|||
128756410|NCT00437645|463396077|FG000|Overall Study|Adverse Event|15|||
128756411|NCT00437645|463396078|FG001|Overall Study|Adverse Event|84|||
128756412|NCT00437645|463396077|FG000|Overall Study|Withdrawal by Subject|10|||
128756413|NCT00437645|463396078|FG001|Overall Study|Withdrawal by Subject|22|||
128756414|NCT00437645|463396077|FG000|Overall Study|Protocol Violation|3|||
128756415|NCT00437645|463396078|FG001|Overall Study|Protocol Violation|3|||
128756416|NCT00437645|463396077|FG000|Overall Study|Lost to Follow-up|2|||
128756417|NCT00437645|463396078|FG001|Overall Study|Lost to Follow-up|3|||
128756418|NCT00437645|463396077|FG000|Overall Study|Administrative problems|2|||
128756419|NCT00437645|463396078|FG001|Overall Study|Administrative problems|1|||
128756420|NCT00437645|463396077|FG000|Overall Study|Lack of Efficacy|2|||
128756421|NCT00437645|463396078|FG001|Overall Study|Lack of Efficacy|1|||
128756422|NCT00437645|463396077|FG000|Overall Study|Condition no longer requires study drug|1|||
128756423|NCT00437645|463396078|FG001|Overall Study|Condition no longer requires study drug|1|||
128756424|NCT03751631|463396079|FG000|Overall Study|Withdrawal by Subject|0|||
128756425|NCT03751631|463396080|FG001|Overall Study|Withdrawal by Subject|0|||
128756426|NCT03751631|463396081|FG002|Overall Study|Withdrawal by Subject|1|||
128756427|NCT03751631|463396082|FG003|Overall Study|Withdrawal by Subject|1|||
128756428|NCT03751631|463396083|FG004|Overall Study|Withdrawal by Subject|0|||
128756429|NCT03751631|463396084|FG005|Overall Study|Withdrawal by Subject|0|||
128756430|NCT03382782|463396089|FG000|Cohort 1|Withdrawal by Subject|11|||
128756431|NCT03382782|463396090|FG001|Cohort 1|Withdrawal by Subject|5|||
128756432|NCT03382782|463396091|FG002|Cohort 1|Withdrawal by Subject|0|||
128756433|NCT03382782|463396089|FG000|Cohort 2|Withdrawal by Subject|1|||
128756434|NCT03382782|463396090|FG001|Cohort 2|Withdrawal by Subject|1|||
128756435|NCT03382782|463396091|FG002|Cohort 2|Withdrawal by Subject|0|||
128756436|NCT03382782|463396089|FG000|Cohort 3|Withdrawal by Subject|1|||
128756437|NCT03382782|463396090|FG001|Cohort 3|Withdrawal by Subject|2|||
128756438|NCT03382782|463396091|FG002|Cohort 3|Withdrawal by Subject|0|||
128756439|NCT00428090|463396094|FG000|Overall Study|Adverse Event|10|||
128756440|NCT00428090|463396095|FG001|Overall Study|Adverse Event|8|||
128756441|NCT00428090|463396096|FG002|Overall Study|Adverse Event|10|||
128756442|NCT00428090|463396097|FG003|Overall Study|Adverse Event|11|||
128756443|NCT00428090|463396094|FG000|Overall Study|Lost to Follow-up|3|||
128756444|NCT00428090|463396095|FG001|Overall Study|Lost to Follow-up|6|||
128756445|NCT00428090|463396096|FG002|Overall Study|Lost to Follow-up|1|||
128756446|NCT00428090|463396097|FG003|Overall Study|Lost to Follow-up|4|||
128756447|NCT00428090|463396094|FG000|Overall Study|Protocol Violation|3|||
128756448|NCT00428090|463396095|FG001|Overall Study|Protocol Violation|1|||
128756449|NCT00428090|463396096|FG002|Overall Study|Protocol Violation|3|||
128756450|NCT00428090|463396097|FG003|Overall Study|Protocol Violation|3|||
128756451|NCT00428090|463396094|FG000|Overall Study|Withdrawal by Subject|10|||
128756452|NCT00428090|463396095|FG001|Overall Study|Withdrawal by Subject|12|||
128756453|NCT00428090|463396096|FG002|Overall Study|Withdrawal by Subject|15|||
128756454|NCT00428090|463396097|FG003|Overall Study|Withdrawal by Subject|5|||
128756455|NCT00428090|463396094|FG000|Overall Study|Sponsor terminated study|0|||
128756456|NCT00428090|463396095|FG001|Overall Study|Sponsor terminated study|1|||
128756457|NCT00428090|463396096|FG002|Overall Study|Sponsor terminated study|0|||
128756458|NCT00428090|463396097|FG003|Overall Study|Sponsor terminated study|0|||
128756459|NCT00428090|463396094|FG000|Overall Study|Non-compliance|4|||
128756460|NCT00428090|463396095|FG001|Overall Study|Non-compliance|0|||
128756461|NCT00428090|463396096|FG002|Overall Study|Non-compliance|1|||
128756462|NCT00428090|463396097|FG003|Overall Study|Non-compliance|3|||
128756463|NCT00428090|463396094|FG000|Overall Study|Par. did not returned to visit|1|||
128756464|NCT00428090|463396095|FG001|Overall Study|Par. did not returned to visit|0|||
128756465|NCT00428090|463396096|FG002|Overall Study|Par. did not returned to visit|0|||
128756466|NCT00428090|463396097|FG003|Overall Study|Par. did not returned to visit|1|||
128756467|NCT00428090|463396094|FG000|Overall Study|Follow-Up visit not possible|1|||
128756468|NCT00428090|463396095|FG001|Overall Study|Follow-Up visit not possible|0|||
128756469|NCT00428090|463396096|FG002|Overall Study|Follow-Up visit not possible|0|||
128756470|NCT00428090|463396097|FG003|Overall Study|Follow-Up visit not possible|0|||
128756471|NCT00428090|463396094|FG000|Overall Study|Prohibited medication used for SAE|1|||
128756472|NCT00428090|463396095|FG001|Overall Study|Prohibited medication used for SAE|0|||
128756473|NCT00428090|463396096|FG002|Overall Study|Prohibited medication used for SAE|0|||
128756474|NCT00428090|463396097|FG003|Overall Study|Prohibited medication used for SAE|0|||
128756475|NCT00428090|463396094|FG000|Overall Study|Death of par.|1|||
128756476|NCT00428090|463396095|FG001|Overall Study|Death of par.|0|||
128756477|NCT00428090|463396096|FG002|Overall Study|Death of par.|1|||
128756478|NCT00428090|463396097|FG003|Overall Study|Death of par.|0|||
128756479|NCT00428090|463396094|FG000|Overall Study|Visit 7 exceed the visit window|0|||
128756480|NCT00428090|463396095|FG001|Overall Study|Visit 7 exceed the visit window|1|||
128756481|NCT00428090|463396096|FG002|Overall Study|Visit 7 exceed the visit window|0|||
128756482|NCT00428090|463396097|FG003|Overall Study|Visit 7 exceed the visit window|0|||
128756483|NCT00428090|463396094|FG000|Overall Study|Medical monitor terminated par.|0|||
128756484|NCT00428090|463396095|FG001|Overall Study|Medical monitor terminated par.|1|||
128756485|NCT00428090|463396096|FG002|Overall Study|Medical monitor terminated par.|0|||
128756486|NCT00428090|463396097|FG003|Overall Study|Medical monitor terminated par.|0|||
128756487|NCT00428090|463396094|FG000|Overall Study|Mental status of par. was|0|||
128756488|NCT00428090|463396095|FG001|Overall Study|Mental status of par. was|1|||
128756489|NCT00428090|463396096|FG002|Overall Study|Mental status of par. was|0|||
128756490|NCT00428090|463396097|FG003|Overall Study|Mental status of par. was|0|||
128756491|NCT00428090|463396094|FG000|Overall Study|Worsening of AD|0|||
128756492|NCT00428090|463396095|FG001|Overall Study|Worsening of AD|0|||
128756493|NCT00428090|463396096|FG002|Overall Study|Worsening of AD|1|||
128756494|NCT00428090|463396097|FG003|Overall Study|Worsening of AD|0|||
128756495|NCT00428090|463396094|FG000|Overall Study|Excluded for concerning QTc value|0|||
128756496|NCT00428090|463396095|FG001|Overall Study|Excluded for concerning QTc value|0|||
128756497|NCT00428090|463396096|FG002|Overall Study|Excluded for concerning QTc value|1|||
128756498|NCT00428090|463396097|FG003|Overall Study|Excluded for concerning QTc value|0|||
128756499|NCT00428090|463396094|FG000|Overall Study|Insufficient AD documentation|0|||
128756500|NCT00428090|463396095|FG001|Overall Study|Insufficient AD documentation|0|||
128756501|NCT00428090|463396096|FG002|Overall Study|Insufficient AD documentation|1|||
128756502|NCT00428090|463396097|FG003|Overall Study|Insufficient AD documentation|0|||
128756503|NCT00428090|463396094|FG000|Overall Study|High MMSE scores|0|||
128756504|NCT00428090|463396095|FG001|Overall Study|High MMSE scores|0|||
128756505|NCT00428090|463396096|FG002|Overall Study|High MMSE scores|1|||
128756506|NCT00428090|463396097|FG003|Overall Study|High MMSE scores|0|||
128756507|NCT00428090|463396094|FG000|Overall Study|Deterioration of cognitive status|0|||
128756508|NCT00428090|463396095|FG001|Overall Study|Deterioration of cognitive status|0|||
128756509|NCT00428090|463396096|FG002|Overall Study|Deterioration of cognitive status|1|||
128756510|NCT00428090|463396097|FG003|Overall Study|Deterioration of cognitive status|0|||
128756511|NCT00428090|463396094|FG000|Overall Study|Serious adverse event|0|||
128756512|NCT00428090|463396095|FG001|Overall Study|Serious adverse event|0|||
128756513|NCT00428090|463396096|FG002|Overall Study|Serious adverse event|1|||
128756514|NCT00428090|463396097|FG003|Overall Study|Serious adverse event|0|||
128756515|NCT00428090|463396094|FG000|Overall Study|Excluded for heart insufficiency|0|||
128756516|NCT00428090|463396095|FG001|Overall Study|Excluded for heart insufficiency|0|||
128756517|NCT00428090|463396096|FG002|Overall Study|Excluded for heart insufficiency|1|||
128756518|NCT00428090|463396097|FG003|Overall Study|Excluded for heart insufficiency|0|||
128756519|NCT00428090|463396094|FG000|Overall Study|Raised Creatinine Value|0|||
128756520|NCT00428090|463396095|FG001|Overall Study|Raised Creatinine Value|0|||
128756521|NCT00428090|463396096|FG002|Overall Study|Raised Creatinine Value|0|||
128756522|NCT00428090|463396097|FG003|Overall Study|Raised Creatinine Value|1|||
128756523|NCT03255824|463396101|FG000|Overall Study|Under-sedation|2|||
128756524|NCT03255824|463396102|FG001|Overall Study|Under-sedation|1|||
128756525|NCT00337272|463396106|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
128756526|NCT00337272|463396107|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
128756527|NCT00337272|463396106|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
128756528|NCT00337272|463396107|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
128756529|NCT00337272|463396106|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
128756530|NCT00337272|463396107|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
128756531|NCT00337272|463396106|FG000|Treatment Period|Non-compliance|1|||
128756532|NCT00337272|463396107|FG001|Treatment Period|Non-compliance|1|||
128756533|NCT00337272|463396106|FG000|Treatment Period|Withdrawal by Subject|0|||
128756534|NCT00337272|463396107|FG001|Treatment Period|Withdrawal by Subject|1|||
128756535|NCT00337272|463396106|FG000|Withdrawal Period|Non-compliance|0|||
128756536|NCT00337272|463396107|FG001|Withdrawal Period|Non-compliance|1|||
128756537|NCT04605978|463396111|FG000|Overall Study|Adverse Event|2|||
128756538|NCT04605978|463396112|FG001|Overall Study|Adverse Event|1|||
128756539|NCT04605978|463396111|FG000|Overall Study|Withdrawal nonmedical reason|1|||
128756540|NCT04605978|463396112|FG001|Overall Study|Withdrawal nonmedical reason|1|||
128756541|NCT03813238|463396113|FG000|Overall Study|Adverse Event|0|||
128756542|NCT03813238|463396114|FG001|Overall Study|Adverse Event|6|||
128756543|NCT03813238|463396113|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128756544|NCT03813238|463396114|FG001|Overall Study|Withdrawal by parent/guardian|2|||
128756545|NCT03813238|463396113|FG000|Overall Study|Lost to Follow-up|0|||
128756546|NCT03813238|463396114|FG001|Overall Study|Lost to Follow-up|1|||
128756547|NCT03813238|463396113|FG000|Overall Study|Other than specified|1|||
128756548|NCT03813238|463396114|FG001|Overall Study|Other than specified|2|||
128756549|NCT01644734|463396115|FG000|Overall Study|Adverse Event|4|||
128756550|NCT01644734|463396115|FG000|Overall Study|Lost to Follow-up|17|||
128756551|NCT01644734|463396115|FG000|Overall Study|Reasons other than stated above|7|||
128756552|NCT01644734|463396115|FG000|Overall Study|Missing documentation|238|||
128756553|NCT01375114|463396118|FG000|Overall Study|Lost to Follow-up|1|||
128756554|NCT01375114|463396119|FG001|Overall Study|Lost to Follow-up|0|||
128756555|NCT01375114|463396120|FG002|Overall Study|Lost to Follow-up|1|||
128756556|NCT01375114|463396118|FG000|Overall Study|Disease Progression|3|||
128756557|NCT01375114|463396119|FG001|Overall Study|Disease Progression|2|||
128756558|NCT01375114|463396120|FG002|Overall Study|Disease Progression|2|||
128756559|NCT01375114|463396118|FG000|Overall Study|Patient Changed Mind|0|||
128756560|NCT01375114|463396119|FG001|Overall Study|Patient Changed Mind|0|||
128756561|NCT01375114|463396120|FG002|Overall Study|Patient Changed Mind|2|||
128756562|NCT01375114|463396118|FG000|Overall Study|Pruritus|0|||
128756563|NCT01375114|463396119|FG001|Overall Study|Pruritus|0|||
128756564|NCT01375114|463396120|FG002|Overall Study|Pruritus|1|||
128756565|NCT01375114|463396118|FG000|Overall Study|Restlessness|0|||
128756566|NCT01375114|463396119|FG001|Overall Study|Restlessness|0|||
128756567|NCT01375114|463396120|FG002|Overall Study|Restlessness|1|||
128756568|NCT01375114|463396118|FG000|Overall Study|Diarrhea|0|||
128756569|NCT01375114|463396119|FG001|Overall Study|Diarrhea|0|||
128756570|NCT01375114|463396120|FG002|Overall Study|Diarrhea|1|||
128756571|NCT01375114|463396118|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
128756572|NCT01375114|463396119|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
128756573|NCT01375114|463396120|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
128756574|NCT01375114|463396118|FG000|Overall Study|Nausea|0|||
128756575|NCT01375114|463396119|FG001|Overall Study|Nausea|1|||
128756576|NCT01375114|463396120|FG002|Overall Study|Nausea|0|||
128756577|NCT01375114|463396118|FG000|Overall Study|Increased AST/ALT|0|||
128756578|NCT01375114|463396119|FG001|Overall Study|Increased AST/ALT|1|||
128756579|NCT01375114|463396120|FG002|Overall Study|Increased AST/ALT|0|||
128756580|NCT01375114|463396118|FG000|Overall Study|Vaginal Hemorrhage|0|||
128756581|NCT01375114|463396119|FG001|Overall Study|Vaginal Hemorrhage|1|||
128756582|NCT01375114|463396120|FG002|Overall Study|Vaginal Hemorrhage|0|||
128756583|NCT01375114|463396118|FG000|Overall Study|Family problem|0|||
128756584|NCT01375114|463396119|FG001|Overall Study|Family problem|1|||
128756585|NCT01375114|463396120|FG002|Overall Study|Family problem|0|||
128756586|NCT01375114|463396118|FG000|Overall Study|Protocol Violation|2|||
128756587|NCT01375114|463396119|FG001|Overall Study|Protocol Violation|0|||
128756588|NCT01375114|463396120|FG002|Overall Study|Protocol Violation|0|||
128756589|NCT04393441|463396121|FG000|Overall Study|Adverse Event|0|||
128756590|NCT04393441|463396122|FG001|Overall Study|Adverse Event|3|||
128756591|NCT04393441|463396121|FG000|Overall Study|Withdrawal by Subject|5|||
128756592|NCT04393441|463396122|FG001|Overall Study|Withdrawal by Subject|7|||
128756593|NCT04393441|463396121|FG000|Overall Study|Lost to Follow-up|0|||
128756594|NCT04393441|463396122|FG001|Overall Study|Lost to Follow-up|2|||
128756595|NCT04393441|463396121|FG000|Overall Study|Protocol Deviation|2|||
128756596|NCT04393441|463396122|FG001|Overall Study|Protocol Deviation|1|||
128756597|NCT04393441|463396121|FG000|Overall Study|Reason not Specified|1|||
128756598|NCT04393441|463396122|FG001|Overall Study|Reason not Specified|1|||
128756599|NCT02472964|463396125|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
128756600|NCT02472964|463396126|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
128756601|NCT02472964|463396125|FG000|Part 1 (up to Week 24)|disease progression|58|||
128756602|NCT02472964|463396126|FG001|Part 1 (up to Week 24)|disease progression|47|||
128756603|NCT02472964|463396125|FG000|Part 1 (up to Week 24)|Death|3|||
128756604|NCT02472964|463396126|FG001|Part 1 (up to Week 24)|Death|6|||
128756605|NCT02472964|463396125|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
128756606|NCT02472964|463396126|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
128756607|NCT02472964|463396125|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
128756608|NCT02472964|463396126|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
128756609|NCT02472964|463396125|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
128756610|NCT02472964|463396126|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
128756611|NCT02472964|463396125|FG000|Part 1 (up to Week 24)|Other|2|||
128756612|NCT02472964|463396126|FG001|Part 1 (up to Week 24)|Other|1|||
128756613|NCT02472964|463396125|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
128756614|NCT02472964|463396126|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
128756615|NCT02472964|463396125|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
128756616|NCT02472964|463396126|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
128756617|NCT02472964|463396125|FG000|Part 2 (Week 24-week 48)|Death|0|||
128756618|NCT02472964|463396126|FG001|Part 2 (Week 24-week 48)|Death|1|||
128756619|NCT02472964|463396125|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
128756620|NCT02472964|463396126|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
128756621|NCT02472964|463396125|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
128756622|NCT02472964|463396126|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
128756623|NCT02472964|463396125|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
128756624|NCT02472964|463396126|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
128756625|NCT02472964|463396125|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
128756626|NCT02472964|463396126|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
128756627|NCT00689221|463396132|FG000|Overall Study|Ongoing at cut-off date|39|||
128756628|NCT00689221|463396133|FG001|Overall Study|Ongoing at cut-off date|36|||
128756629|NCT01749982|463396134|FG000|Overall Study|Physician Decision|0|||
128756630|NCT01749982|463396135|FG001|Overall Study|Physician Decision|0|||
128756631|NCT01749982|463396136|FG002|Overall Study|Physician Decision|0|||
128756632|NCT01749982|463396137|FG003|Overall Study|Physician Decision|1|||
128756633|NCT01749982|463396134|FG000|Overall Study|Lost to Follow-up|0|||
128756634|NCT01749982|463396135|FG001|Overall Study|Lost to Follow-up|0|||
128756635|NCT01749982|463396136|FG002|Overall Study|Lost to Follow-up|0|||
128756636|NCT01749982|463396137|FG003|Overall Study|Lost to Follow-up|1|||
128756637|NCT01749982|463396134|FG000|Overall Study|Withdrawal by Subject|0|||
128756638|NCT01749982|463396135|FG001|Overall Study|Withdrawal by Subject|0|||
128756639|NCT01749982|463396136|FG002|Overall Study|Withdrawal by Subject|0|||
128756640|NCT01749982|463396137|FG003|Overall Study|Withdrawal by Subject|1|||
128756641|NCT01812655|463396138|FG000|Overall Study|Protocol Violation|1|||
128756642|NCT01812655|463396139|FG001|Overall Study|Protocol Violation|1|||
128756643|NCT01812655|463396140|FG002|Overall Study|Protocol Violation|0|||
128756644|NCT01596582|463396142|FG000|Overall Study|Deemed ineligible after study visit|3|||
128756645|NCT01596582|463396143|FG001|Overall Study|Deemed ineligible after study visit|6|||
128756646|NCT01596582|463396142|FG000|Overall Study|Missing all outcome data|1|||
128756647|NCT01596582|463396143|FG001|Overall Study|Missing all outcome data|1|||
128756648|NCT04435665|463396144|FG000|Overall Study|Lost to Follow-up|0|||
128756649|NCT04435665|463396145|FG001|Overall Study|Lost to Follow-up|0|||
128756650|NCT04435665|463396146|FG002|Overall Study|Lost to Follow-up|0|||
128756651|NCT04435665|463396147|FG003|Overall Study|Lost to Follow-up|1|||
128756652|NCT00765388|463396149|FG000|Period 1|Lack of Efficacy|1|||
128756653|NCT00765388|463396150|FG001|Period 1|Lack of Efficacy|2|||
128756654|NCT00765388|463396149|FG000|Period 1|Lost to Follow-up|0|||
128756655|NCT00765388|463396150|FG001|Period 1|Lost to Follow-up|1|||
128756656|NCT00765388|463396149|FG000|Period 1|Herpes Zoster|0|||
128756657|NCT00765388|463396150|FG001|Period 1|Herpes Zoster|1|||
128756658|NCT00765388|463396149|FG000|Period 1|Hip operation|0|||
128756659|NCT00765388|463396150|FG001|Period 1|Hip operation|1|||
128756660|NCT03923933|463396154|FG000|Overall Study|Lost to Follow-up|1|||
128756661|NCT03923933|463396155|FG001|Overall Study|Lost to Follow-up|0|||
128756662|NCT03923933|463396154|FG000|Overall Study|Withdrawal by Subject|0|||
128756663|NCT03923933|463396155|FG001|Overall Study|Withdrawal by Subject|1|||
128756664|NCT00419263|463396156|FG000|Overall Study|Lost to Follow-up|2|||
128756665|NCT00419263|463396157|FG001|Overall Study|Lost to Follow-up|1|||
128756666|NCT00419263|463396158|FG002|Overall Study|Lost to Follow-up|1|||
128756667|NCT00419263|463396156|FG000|Overall Study|Randomized in Error, Not Treated|1|||
128756668|NCT00419263|463396157|FG001|Overall Study|Randomized in Error, Not Treated|1|||
128756669|NCT00419263|463396158|FG002|Overall Study|Randomized in Error, Not Treated|0|||
128756670|NCT00419263|463396156|FG000|Overall Study|Adverse Event|0|||
128756671|NCT00419263|463396157|FG001|Overall Study|Adverse Event|0|||
128756672|NCT00419263|463396158|FG002|Overall Study|Adverse Event|1|||
128756673|NCT00419263|463396156|FG000|Overall Study|Withdrawal by Subject|0|||
128756674|NCT00419263|463396157|FG001|Overall Study|Withdrawal by Subject|0|||
128756675|NCT00419263|463396158|FG002|Overall Study|Withdrawal by Subject|1|||
128756676|NCT03311373|463396161|FG000|Overall Study|Adverse Event|1|||
128756677|NCT03311373|463396161|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
128756678|NCT03311373|463396161|FG000|Overall Study|Lost to Follow-up|1|||
128756679|NCT03311373|463396161|FG000|Overall Study|Physician Decision|1|||
128756680|NCT03311373|463396161|FG000|Overall Study|Withdrawal by Subject|3|||
128756681|NCT00977665|463396162|FG000|Overall Study|Withdrawal by Subject|1|||
128756682|NCT00977665|463396163|FG001|Overall Study|Withdrawal by Subject|3|||
128756683|NCT00977665|463396162|FG000|Overall Study|Physician Decision|2|||
128756684|NCT00977665|463396163|FG001|Overall Study|Physician Decision|1|||
128756685|NCT00977665|463396162|FG000|Overall Study|Sponsor requested withdrawal|0|||
128756686|NCT00977665|463396163|FG001|Overall Study|Sponsor requested withdrawal|1|||
128756687|NCT00977665|463396162|FG000|Overall Study|Lost to Follow-up|1|||
128756688|NCT00977665|463396163|FG001|Overall Study|Lost to Follow-up|0|||
128756689|NCT00977665|463396162|FG000|Overall Study|Death|3|||
128756690|NCT00977665|463396163|FG001|Overall Study|Death|2|||
128756691|NCT00977665|463396162|FG000|Overall Study|Adverse Event|14|||
128756692|NCT00977665|463396163|FG001|Overall Study|Adverse Event|7|||
128756693|NCT00977665|463396162|FG000|Overall Study|Treatment failure|0|||
128756694|NCT00977665|463396163|FG001|Overall Study|Treatment failure|1|||
128756695|NCT01563536|463396172|FG000|Overall Study|Withdrawal by Subject|0|||
128756696|NCT01563536|463396173|FG001|Overall Study|Withdrawal by Subject|2|||
128756697|NCT01563536|463396172|FG000|Overall Study|Lost to Follow-up|1|||
128756698|NCT01563536|463396173|FG001|Overall Study|Lost to Follow-up|0|||
128756699|NCT00538590|463396179|FG000|Overall Study|Death|1|||
128756700|NCT00538590|463396180|FG001|Overall Study|Death|0|||
128756701|NCT01256567|463396181|FG000|Overall Study|Withdrawal by Subject|1|||
128756702|NCT00671931|463396189|FG000|Overall Study|Physician Decision|1|||
128756703|NCT00671931|463396190|FG001|Overall Study|Physician Decision|0|||
128756704|NCT00671931|463396191|FG002|Overall Study|Physician Decision|0|||
128756705|NCT00671931|463396192|FG003|Overall Study|Physician Decision|2|||
128756706|NCT00671931|463396193|FG004|Overall Study|Physician Decision|1|||
128756707|NCT02151266|463396197|FG000|Overall Study|Lost to Follow-up|1|||
128756708|NCT02151266|463396198|FG001|Overall Study|Lost to Follow-up|4|||
128756709|NCT02151266|463396199|FG002|Overall Study|Lost to Follow-up|1|||
128756710|NCT02151266|463396197|FG000|Overall Study|Did NOT receive intervention|3|||
128756711|NCT02151266|463396198|FG001|Overall Study|Did NOT receive intervention|6|||
128756712|NCT02151266|463396199|FG002|Overall Study|Did NOT receive intervention|2|||
128756713|NCT02151266|463396197|FG000|Overall Study|Not able to exercise|4|||
128756714|NCT02151266|463396198|FG001|Overall Study|Not able to exercise|5|||
128756715|NCT02151266|463396199|FG002|Overall Study|Not able to exercise|4|||
128756716|NCT01169675|463396202|FG000|Overall Study|Progressive disease|13|||
128756717|NCT01169675|463396203|FG001|Overall Study|Progressive disease|2|||
128756718|NCT01169675|463396204|FG002|Overall Study|Progressive disease|5|||
128756719|NCT01169675|463396205|FG003|Overall Study|Progressive disease|15|||
128756720|NCT01169675|463396206|FG004|Overall Study|Progressive disease|1|||
128756721|NCT01169675|463396202|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
128756722|NCT01169675|463396203|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128756723|NCT01169675|463396204|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128756724|NCT01169675|463396205|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128756725|NCT01169675|463396206|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
128756726|NCT01169675|463396202|FG000|Overall Study|Adverse Event|5|||
128756727|NCT01169675|463396203|FG001|Overall Study|Adverse Event|1|||
128756728|NCT01169675|463396204|FG002|Overall Study|Adverse Event|2|||
128756729|NCT01169675|463396205|FG003|Overall Study|Adverse Event|0|||
128756730|NCT01169675|463396206|FG004|Overall Study|Adverse Event|0|||
128756731|NCT01169675|463396202|FG000|Overall Study|Withdrawal by Subject|1|||
128756732|NCT01169675|463396203|FG001|Overall Study|Withdrawal by Subject|0|||
128756733|NCT01169675|463396204|FG002|Overall Study|Withdrawal by Subject|0|||
128756734|NCT01169675|463396205|FG003|Overall Study|Withdrawal by Subject|1|||
128756735|NCT01169675|463396206|FG004|Overall Study|Withdrawal by Subject|2|||
128756736|NCT01169675|463396202|FG000|Overall Study|Other Reason Not Defined Above|0|||
128756737|NCT01169675|463396203|FG001|Overall Study|Other Reason Not Defined Above|0|||
128756738|NCT01169675|463396204|FG002|Overall Study|Other Reason Not Defined Above|0|||
128756739|NCT01169675|463396205|FG003|Overall Study|Other Reason Not Defined Above|1|||
128756740|NCT01169675|463396206|FG004|Overall Study|Other Reason Not Defined Above|1|||
128756741|NCT02816138|463396210|FG000|Overall Study|Adverse Event|1|||
128756742|NCT04839965|463396211|FG000|Overall Study|Death|6|||
128756743|NCT04839965|463396212|FG001|Overall Study|Death|6|||
128756744|NCT04839965|463396211|FG000|Overall Study|Lost to Follow-up|1|||
128756745|NCT04839965|463396212|FG001|Overall Study|Lost to Follow-up|0|||
128756746|NCT02365519|463396213|FG000|Randomized and Treated|Adverse Event|0|||
128756747|NCT02365519|463396214|FG001|Randomized and Treated|Adverse Event|1|||
128756748|NCT02365519|463396215|FG002|Randomized and Treated|Adverse Event|0|||
128756749|NCT02365519|463396213|FG000|Randomized and Treated|Withdrawal by Subject|0|||
128756750|NCT02365519|463396214|FG001|Randomized and Treated|Withdrawal by Subject|1|||
128756751|NCT02365519|463396215|FG002|Randomized and Treated|Withdrawal by Subject|1|||
128756752|NCT00981084|463396216|FG000|Post Intervention (Data Analysis)|poor effort|1|||
128756753|NCT00981084|463396217|FG001|Post Intervention (Data Analysis)|poor effort|1|||
128756754|NCT00981084|463396216|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
128756755|NCT00981084|463396217|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
128756756|NCT02291679|463396218|FG000|Overall Study|Adverse Event|2|||
128756757|NCT02291679|463396219|FG001|Overall Study|Adverse Event|12|||
128756758|NCT02291679|463396220|FG002|Overall Study|Adverse Event|19|||
128756759|NCT02291679|463396218|FG000|Overall Study|Protocol Violation|5|||
128756760|NCT02291679|463396219|FG001|Overall Study|Protocol Violation|1|||
128756761|NCT02291679|463396220|FG002|Overall Study|Protocol Violation|7|||
128756762|NCT02291679|463396218|FG000|Overall Study|Withdrew Consent|18|||
128756763|NCT02291679|463396219|FG001|Overall Study|Withdrew Consent|10|||
128756764|NCT02291679|463396220|FG002|Overall Study|Withdrew Consent|15|||
128756765|NCT02291679|463396218|FG000|Overall Study|Lost to Follow-up|12|||
128756766|NCT02291679|463396219|FG001|Overall Study|Lost to Follow-up|10|||
128756767|NCT02291679|463396220|FG002|Overall Study|Lost to Follow-up|9|||
128756768|NCT02291679|463396218|FG000|Overall Study|Insufficient Therapeutic Response|5|||
128756769|NCT02291679|463396219|FG001|Overall Study|Insufficient Therapeutic Response|5|||
128756770|NCT02291679|463396220|FG002|Overall Study|Insufficient Therapeutic Response|7|||
128756771|NCT02291679|463396218|FG000|Overall Study|Other|2|||
128756772|NCT02291679|463396219|FG001|Overall Study|Other|4|||
128756773|NCT02291679|463396220|FG002|Overall Study|Other|2|||
128756774|NCT02048072|463396221|FG000|Overall Study|Adverse Event|3|||
128756775|NCT02048072|463396221|FG000|Overall Study|Lost to Follow-up|1|||
128756776|NCT02355028|463396222|FG000|Overall Study|Adverse Event|2|||
128756777|NCT02355028|463396223|FG001|Overall Study|Adverse Event|0|||
128756778|NCT02355028|463396222|FG000|Overall Study|Withdrawal by Subject|1|||
128756779|NCT02355028|463396223|FG001|Overall Study|Withdrawal by Subject|1|||
128756780|NCT02355028|463396222|FG000|Overall Study|Deemed ineligible after randomization|8|||
128756781|NCT02355028|463396223|FG001|Overall Study|Deemed ineligible after randomization|4|||
128756782|NCT02276222|463396224|FG000|Overall Study|Adverse Event|62|||
128756783|NCT02276222|463396225|FG001|Overall Study|Adverse Event|11|||
128756784|NCT02276222|463396224|FG000|Overall Study|Death|3|||
128756785|NCT02276222|463396225|FG001|Overall Study|Death|4|||
128756786|NCT02276222|463396224|FG000|Overall Study|Lack of Efficacy|13|||
128756787|NCT02276222|463396225|FG001|Overall Study|Lack of Efficacy|3|||
128756788|NCT02276222|463396224|FG000|Overall Study|Protocol Violation|3|||
128756789|NCT02276222|463396225|FG001|Overall Study|Protocol Violation|2|||
128756790|NCT02276222|463396224|FG000|Overall Study|Withdrawal by Subject|79|||
128756791|NCT02276222|463396225|FG001|Overall Study|Withdrawal by Subject|33|||
128756792|NCT02276222|463396224|FG000|Overall Study|non compliance with study medication|6|||
128756793|NCT02276222|463396225|FG001|Overall Study|non compliance with study medication|2|||
128756794|NCT02276222|463396224|FG000|Overall Study|sponsor decision|0|||
128756795|NCT02276222|463396225|FG001|Overall Study|sponsor decision|3|||
128756796|NCT02276222|463396224|FG000|Overall Study|Lost to Follow-up|15|||
128756797|NCT02276222|463396225|FG001|Overall Study|Lost to Follow-up|5|||
128756798|NCT02276222|463396224|FG000|Overall Study|Physician Decision|2|||
128756799|NCT02276222|463396225|FG001|Overall Study|Physician Decision|1|||
128756800|NCT02276222|463396224|FG000|Overall Study|sheduling conflict|1|||
128756801|NCT02276222|463396225|FG001|Overall Study|sheduling conflict|0|||
128756802|NCT02276222|463396224|FG000|Overall Study|subject withdrew after randomization|1|||
128756803|NCT02276222|463396225|FG001|Overall Study|subject withdrew after randomization|0|||
128756804|NCT01592370|463396232|FG000|Overall Study|Disease Progression|62|||
128756805|NCT01592370|463396233|FG001|Overall Study|Disease Progression|16|||
128756806|NCT01592370|463396234|FG002|Overall Study|Disease Progression|52|||
128756807|NCT01592370|463396235|FG003|Overall Study|Disease Progression|3|||
128756808|NCT01592370|463396236|FG004|Overall Study|Disease Progression|3|||
128756809|NCT01592370|463396237|FG005|Overall Study|Disease Progression|31|||
128756810|NCT01592370|463396238|FG006|Overall Study|Disease Progression|14|||
128756811|NCT01592370|463396232|FG000|Overall Study|Study Drug Toxicity|14|||
128756812|NCT01592370|463396233|FG001|Overall Study|Study Drug Toxicity|3|||
128756813|NCT01592370|463396234|FG002|Overall Study|Study Drug Toxicity|0|||
128756814|NCT01592370|463396235|FG003|Overall Study|Study Drug Toxicity|0|||
128756815|NCT01592370|463396236|FG004|Overall Study|Study Drug Toxicity|0|||
128756816|NCT01592370|463396237|FG005|Overall Study|Study Drug Toxicity|0|||
128756817|NCT01592370|463396238|FG006|Overall Study|Study Drug Toxicity|1|||
128756818|NCT01592370|463396232|FG000|Overall Study|AE unrelated to study drug|4|||
128756819|NCT01592370|463396233|FG001|Overall Study|AE unrelated to study drug|3|||
128786707|NCT01693614|463511241|FG001|Overall Study|Disease progression|8|||
128786708|NCT01693614|463511242|FG002|Overall Study|Disease progression|7|||
128786709|NCT01693614|463511240|FG000|Overall Study|Protocol Violation|5|||
128756820|NCT01592370|463396234|FG002|Overall Study|AE unrelated to study drug|0|||
128756821|NCT01592370|463396235|FG003|Overall Study|AE unrelated to study drug|0|||
128756822|NCT01592370|463396236|FG004|Overall Study|AE unrelated to study drug|0|||
128756823|NCT01592370|463396237|FG005|Overall Study|AE unrelated to study drug|0|||
128756824|NCT01592370|463396238|FG006|Overall Study|AE unrelated to study drug|1|||
128756825|NCT01592370|463396232|FG000|Overall Study|Request to discontinue study treatment|5|||
128756826|NCT01592370|463396233|FG001|Overall Study|Request to discontinue study treatment|0|||
128756827|NCT01592370|463396234|FG002|Overall Study|Request to discontinue study treatment|2|||
128756828|NCT01592370|463396235|FG003|Overall Study|Request to discontinue study treatment|0|||
128756829|NCT01592370|463396236|FG004|Overall Study|Request to discontinue study treatment|1|||
128786710|NCT01693614|463511241|FG001|Overall Study|Protocol Violation|2|||
128756830|NCT01592370|463396237|FG005|Overall Study|Request to discontinue study treatment|2|||
128786711|NCT01693614|463511242|FG002|Overall Study|Protocol Violation|1|||
128786712|NCT01693614|463511240|FG000|Overall Study|Death|1|||
128786713|NCT01693614|463511241|FG001|Overall Study|Death|0|||
128756831|NCT01592370|463396238|FG006|Overall Study|Request to discontinue study treatment|0|||
128756832|NCT01592370|463396232|FG000|Overall Study|Withdrew consent|1|||
128756833|NCT01592370|463396233|FG001|Overall Study|Withdrew consent|2|||
128756834|NCT01592370|463396234|FG002|Overall Study|Withdrew consent|1|||
128756835|NCT01592370|463396235|FG003|Overall Study|Withdrew consent|1|||
128756836|NCT01592370|463396236|FG004|Overall Study|Withdrew consent|0|||
128756837|NCT01592370|463396237|FG005|Overall Study|Withdrew consent|0|||
128756838|NCT01592370|463396238|FG006|Overall Study|Withdrew consent|0|||
128756839|NCT01592370|463396232|FG000|Overall Study|Maximum clinical benefit|11|||
128756840|NCT01592370|463396233|FG001|Overall Study|Maximum clinical benefit|1|||
128756841|NCT01592370|463396234|FG002|Overall Study|Maximum clinical benefit|7|||
128756842|NCT01592370|463396235|FG003|Overall Study|Maximum clinical benefit|1|||
128756843|NCT01592370|463396236|FG004|Overall Study|Maximum clinical benefit|0|||
128756844|NCT01592370|463396237|FG005|Overall Study|Maximum clinical benefit|0|||
128756845|NCT01592370|463396238|FG006|Overall Study|Maximum clinical benefit|0|||
128756846|NCT01592370|463396232|FG000|Overall Study|No longer meets study criteria|1|||
128756847|NCT01592370|463396233|FG001|Overall Study|No longer meets study criteria|0|||
128756848|NCT01592370|463396234|FG002|Overall Study|No longer meets study criteria|0|||
128756849|NCT01592370|463396235|FG003|Overall Study|No longer meets study criteria|0|||
128756850|NCT01592370|463396236|FG004|Overall Study|No longer meets study criteria|0|||
128756851|NCT01592370|463396237|FG005|Overall Study|No longer meets study criteria|0|||
128756852|NCT01592370|463396238|FG006|Overall Study|No longer meets study criteria|0|||
128756853|NCT01592370|463396232|FG000|Overall Study|Other Reasons|6|||
128756854|NCT01592370|463396233|FG001|Overall Study|Other Reasons|0|||
128756855|NCT01592370|463396234|FG002|Overall Study|Other Reasons|10|||
128756856|NCT01592370|463396235|FG003|Overall Study|Other Reasons|0|||
128756857|NCT01592370|463396236|FG004|Overall Study|Other Reasons|0|||
128756858|NCT01592370|463396237|FG005|Overall Study|Other Reasons|1|||
128756859|NCT01592370|463396238|FG006|Overall Study|Other Reasons|0|||
128756860|NCT03432364|463397872|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
128756861|NCT03320018|463397873|FG000|Treatment Period|Withdrawal by Subject|1|||
128756862|NCT03320018|463397874|FG001|Treatment Period|Withdrawal by Subject|0|||
128756863|NCT03320018|463397873|FG000|Day 90 Follow up|Death|0|||
128756864|NCT03320018|463397874|FG001|Day 90 Follow up|Death|1|||
128756865|NCT03284788|463397875|FG000|Overall Study|Withdrawal by Subject|2|||
128756866|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
128756867|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
128756868|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
128756869|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
128756870|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
128756871|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
128756872|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
128756873|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
128756874|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
128756875|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
128756876|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
128756877|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
128756878|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Death|6|||
128756879|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Death|3|||
128756880|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Death|0|||
128756881|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Death|1|||
128756882|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Death|1|||
128756883|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Death|0|||
128756884|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
128756885|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
128756886|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
128756887|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
128756888|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
128756889|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
128756890|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
128756891|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
128756892|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
128756893|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
128756894|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
128756895|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
128756896|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
128756897|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
128756898|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
128756899|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
128756900|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
128756901|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
128756902|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
128756903|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
128756904|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
128756905|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
128756906|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
128756907|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
128756908|NCT03104699|463397882|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
128756909|NCT03104699|463397883|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
128756910|NCT03104699|463397884|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
128756911|NCT03104699|463397885|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
128756912|NCT03104699|463397886|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
128756913|NCT03104699|463397887|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
128756914|NCT03104699|463397882|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128756915|NCT03104699|463397883|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128756916|NCT03104699|463397884|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128756917|NCT03104699|463397885|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128756918|NCT03104699|463397886|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
128756919|NCT03104699|463397887|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
128756920|NCT03104699|463397882|FG000|Phase 2: Dose Expansion|Death|0|||
128756921|NCT03104699|463397883|FG001|Phase 2: Dose Expansion|Death|0|||
128756922|NCT03104699|463397884|FG002|Phase 2: Dose Expansion|Death|0|||
128756923|NCT03104699|463397885|FG003|Phase 2: Dose Expansion|Death|0|||
128756924|NCT03104699|463397886|FG004|Phase 2: Dose Expansion|Death|0|||
128756925|NCT03104699|463397887|FG005|Phase 2: Dose Expansion|Death|107|||
128756926|NCT03104699|463397882|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
128756927|NCT03104699|463397883|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
128756928|NCT03104699|463397884|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
128756929|NCT03104699|463397885|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
128756930|NCT03104699|463397886|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
128756931|NCT03104699|463397887|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
128756932|NCT03104699|463397882|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
128786714|NCT01693614|463511242|FG002|Overall Study|Death|0|||
128786715|NCT01693614|463511240|FG000|Overall Study|Physician Decision|1|||
128786716|NCT01693614|463511241|FG001|Overall Study|Physician Decision|1|||
128786717|NCT01693614|463511242|FG002|Overall Study|Physician Decision|4|||
128786718|NCT01693614|463511240|FG000|Overall Study|Withdrawal by subject/guardian|0|||
128786719|NCT01693614|463511241|FG001|Overall Study|Withdrawal by subject/guardian|0|||
128786720|NCT01693614|463511242|FG002|Overall Study|Withdrawal by subject/guardian|2|||
128786721|NCT01693614|463511240|FG000|Overall Study|Withdrawal by Subject|1|||
128786722|NCT01693614|463511241|FG001|Overall Study|Withdrawal by Subject|0|||
128786723|NCT01693614|463511242|FG002|Overall Study|Withdrawal by Subject|5|||
128786724|NCT01048788|463511243|FG000|Overall Study|Adverse Event|5|||
128786725|NCT01048788|463511244|FG001|Overall Study|Adverse Event|1|||
128786726|NCT01048788|463511245|FG002|Overall Study|Adverse Event|1|||
128786727|NCT01048788|463511243|FG000|Overall Study|Lack of Efficacy|0|||
128786728|NCT01048788|463511244|FG001|Overall Study|Lack of Efficacy|0|||
128786729|NCT01048788|463511245|FG002|Overall Study|Lack of Efficacy|1|||
128786730|NCT01048788|463511243|FG000|Overall Study|Withdrawal by Subject|0|||
128786731|NCT01048788|463511244|FG001|Overall Study|Withdrawal by Subject|1|||
128786732|NCT01048788|463511245|FG002|Overall Study|Withdrawal by Subject|0|||
128786733|NCT00420316|463511246|FG000|Overall Study|Withdrawal by Subject|0|||
128786734|NCT00420316|463511247|FG001|Overall Study|Withdrawal by Subject|1|||
128786735|NCT00420316|463511246|FG000|Overall Study|Lost to Follow-up|12|||
128756933|NCT03104699|463397883|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
128756934|NCT03104699|463397884|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
128756935|NCT03104699|463397885|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
128756936|NCT03104699|463397886|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
128756937|NCT03104699|463397887|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
128756938|NCT03104699|463397882|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128756939|NCT03104699|463397883|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128756940|NCT03104699|463397884|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128756941|NCT03104699|463397885|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128756942|NCT03104699|463397886|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
128786736|NCT00420316|463511247|FG001|Overall Study|Lost to Follow-up|8|||
128786737|NCT01196988|463511248|FG000|Overall Study|Adverse Event|1|||
128786738|NCT01196988|463511249|FG001|Overall Study|Adverse Event|2|||
128786739|NCT01196988|463511250|FG002|Overall Study|Adverse Event|0|||
128786740|NCT01196988|463511251|FG003|Overall Study|Adverse Event|0|||
128756943|NCT03104699|463397887|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
128756944|NCT03104699|463397882|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
128756945|NCT03104699|463397883|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
128756946|NCT03104699|463397884|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
128756947|NCT03104699|463397885|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
128756948|NCT03104699|463397886|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
128756949|NCT03104699|463397887|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
128756950|NCT00152464|463397888|FG000|Overall Study|Adverse Event|3|||
128756951|NCT00152464|463397889|FG001|Overall Study|Adverse Event|6|||
128756952|NCT00152464|463397888|FG000|Overall Study|Lost to Follow-up|8|||
128756953|NCT00152464|463397889|FG001|Overall Study|Lost to Follow-up|4|||
128756954|NCT00152464|463397888|FG000|Overall Study|Protocol Violation|3|||
128756955|NCT00152464|463397889|FG001|Overall Study|Protocol Violation|1|||
128756956|NCT00152464|463397888|FG000|Overall Study|Withdrawal by Subject|21|||
128756957|NCT00152464|463397889|FG001|Overall Study|Withdrawal by Subject|22|||
128756958|NCT00152464|463397888|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
128756959|NCT00152464|463397889|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
128756960|NCT00152464|463397888|FG000|Overall Study|Eczema deterioration|0|||
128756961|NCT00152464|463397889|FG001|Overall Study|Eczema deterioration|1|||
128756962|NCT00152464|463397888|FG000|Overall Study|Parent decision|1|||
128756963|NCT00152464|463397889|FG001|Overall Study|Parent decision|1|||
128756964|NCT00152464|463397888|FG000|Overall Study|Investigator decision|1|||
128756965|NCT00152464|463397889|FG001|Overall Study|Investigator decision|0|||
128756966|NCT00152464|463397888|FG000|Overall Study|Lack of Efficacy|1|||
128756967|NCT00152464|463397889|FG001|Overall Study|Lack of Efficacy|0|||
128756968|NCT00152464|463397888|FG000|Overall Study|Eczema poorly controlled|1|||
128756969|NCT00152464|463397889|FG001|Overall Study|Eczema poorly controlled|0|||
128756970|NCT00152464|463397888|FG000|Overall Study|Patient relocated|1|||
128756971|NCT00152464|463397889|FG001|Overall Study|Patient relocated|0|||
128756972|NCT00420199|463397890|FG000|Overall Study|Participant no longer met study criteria|1|||
128756973|NCT00420199|463397891|FG001|Overall Study|Participant no longer met study criteria|0|||
128756974|NCT00430248|463397892|FG000|Overall Study|Adverse Event|49|||
128756975|NCT00430248|463397893|FG001|Overall Study|Adverse Event|61|||
128756976|NCT00430248|463397894|FG002|Overall Study|Adverse Event|64|||
128756977|NCT00430248|463397892|FG000|Overall Study|Protocol Violation|10|||
128756978|NCT00430248|463397893|FG001|Overall Study|Protocol Violation|2|||
128756979|NCT00430248|463397894|FG002|Overall Study|Protocol Violation|4|||
128756980|NCT00430248|463397892|FG000|Overall Study|Personal Reasons|12|||
128756981|NCT00430248|463397893|FG001|Overall Study|Personal Reasons|24|||
128756982|NCT00430248|463397894|FG002|Overall Study|Personal Reasons|9|||
128756983|NCT00430248|463397892|FG000|Overall Study|Lost to Follow-up|28|||
128756984|NCT00430248|463397893|FG001|Overall Study|Lost to Follow-up|33|||
128756985|NCT00430248|463397894|FG002|Overall Study|Lost to Follow-up|28|||
128756986|NCT00430248|463397892|FG000|Overall Study|Therapeutic Failure|1|||
128756987|NCT00430248|463397893|FG001|Overall Study|Therapeutic Failure|1|||
128756988|NCT00430248|463397894|FG002|Overall Study|Therapeutic Failure|1|||
128756989|NCT00430248|463397892|FG000|Overall Study|Withdrawal by Subject|14|||
128756990|NCT00430248|463397893|FG001|Overall Study|Withdrawal by Subject|20|||
128756991|NCT00430248|463397894|FG002|Overall Study|Withdrawal by Subject|16|||
128756992|NCT00430248|463397892|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128756993|NCT00430248|463397893|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
128756994|NCT00430248|463397894|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128756995|NCT00430248|463397892|FG000|Overall Study|Gout Flare|3|||
128756996|NCT00430248|463397893|FG001|Overall Study|Gout Flare|7|||
128756997|NCT00430248|463397894|FG002|Overall Study|Gout Flare|2|||
128756998|NCT00430248|463397892|FG000|Overall Study|Reason Not Specified|8|||
128756999|NCT00430248|463397893|FG001|Overall Study|Reason Not Specified|8|||
128757000|NCT00430248|463397894|FG002|Overall Study|Reason Not Specified|11|||
128757001|NCT01754467|463397898|FG000|Overall Study|Lost to Follow-up|1|||
128786741|NCT01196988|463511248|FG000|Overall Study|Withdrawal by Subject|5|||
128757002|NCT01970462|463397899|FG000|Overall Study|Lost to Follow-up|0|||
128757003|NCT01970462|463397900|FG001|Overall Study|Lost to Follow-up|2|||
128757004|NCT04020341|463397903|FG000|Overall Study|Adverse Event|8|||
128757005|NCT04020341|463397904|FG001|Overall Study|Adverse Event|6|||
128757006|NCT04020341|463397903|FG000|Overall Study|Lost to Follow-up|8|||
128757007|NCT04020341|463397904|FG001|Overall Study|Lost to Follow-up|2|||
128757008|NCT04020341|463397903|FG000|Overall Study|Withdrawal by Subject|16|||
128757009|NCT04020341|463397904|FG001|Overall Study|Withdrawal by Subject|16|||
128757010|NCT04020341|463397903|FG000|Overall Study|Participant not able to swallow the tablet|1|||
128757011|NCT04020341|463397904|FG001|Overall Study|Participant not able to swallow the tablet|0|||
128757012|NCT04020341|463397903|FG000|Overall Study|Physician Decision|0|||
128757013|NCT04020341|463397904|FG001|Overall Study|Physician Decision|2|||
128757014|NCT04020341|463397903|FG000|Overall Study|Protocol Deviation|0|||
128757015|NCT04020341|463397904|FG001|Overall Study|Protocol Deviation|2|||
128757016|NCT05763628|463397905|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
128757017|NCT05763628|463397906|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
128757018|NCT05763628|463397905|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
128757019|NCT05763628|463397906|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
128757020|NCT05763628|463397905|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
128757021|NCT05763628|463397906|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
128757022|NCT04683926|463397907|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
128757023|NCT04683926|463397908|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
128757024|NCT04683926|463397909|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
128757025|NCT04683926|463397910|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
128757026|NCT02123108|463397913|FG000|Overall Study|Death|2|||
128757027|NCT02123108|463397914|FG001|Overall Study|Death|3|||
128757028|NCT00716092|463397915|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
128757029|NCT00716092|463397916|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
128757030|NCT00716092|463397917|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
128757031|NCT01132326|463397918|FG000|Overall Study|Lack of Efficacy|25|||
128757032|NCT01132326|463397918|FG000|Overall Study|Adverse Event|37|||
128757033|NCT01132326|463397918|FG000|Overall Study|Protocol Violation|1|||
128757034|NCT01132326|463397918|FG000|Overall Study|Lost to Follow-up|16|||
128757035|NCT01132326|463397918|FG000|Overall Study|Withdrawal by Subject|40|||
128757036|NCT01132326|463397918|FG000|Overall Study|Physician Decision|10|||
128757037|NCT01132326|463397918|FG000|Overall Study|Study Termination|80|||
128757038|NCT01132326|463397918|FG000|Overall Study|Declining Health|1|||
128757039|NCT01132326|463397918|FG000|Overall Study|Pregnancy|1|||
128757040|NCT01132326|463397918|FG000|Overall Study|Caregiver Withdrew Consent|1|||
128757041|NCT01132326|463397918|FG000|Overall Study|Death|5|||
128757042|NCT01132326|463397918|FG000|Overall Study|Subject Unable to Come To Visits|1|||
128757043|NCT00677235|463397919|FG000|Overall Study|Withdrawal by Subject|1|||
128757044|NCT00677235|463397920|FG001|Overall Study|Withdrawal by Subject|1|||
128757045|NCT00677235|463397919|FG000|Overall Study|Lost to Follow-up|2|||
128757046|NCT00677235|463397920|FG001|Overall Study|Lost to Follow-up|1|||
128757047|NCT00677235|463397919|FG000|Overall Study|Death|37|||
128757048|NCT00677235|463397920|FG001|Overall Study|Death|36|||
128757049|NCT00677235|463397919|FG000|Overall Study|Adverse Experience|1|||
128757050|NCT00677235|463397920|FG001|Overall Study|Adverse Experience|0|||
128757051|NCT00952367|463397921|FG000|Overall Study|Withdrawal by Subject|2|||
128757052|NCT00952367|463397921|FG000|Overall Study|Noncoordination|1|||
128757053|NCT00952367|463397921|FG000|Overall Study|Protocol Violation|3|||
128757054|NCT01040260|463397922|FG000|Overall Study|Withdrawal by Subject|12|||
128757055|NCT01040260|463397923|FG001|Overall Study|Withdrawal by Subject|6|||
128757056|NCT01040260|463397922|FG000|Overall Study|Lost to Follow-up|3|||
128757057|NCT01040260|463397923|FG001|Overall Study|Lost to Follow-up|5|||
128757058|NCT04570436|463397927|FG000|Overall Study|Adverse Event|0|||
128757059|NCT04570436|463397928|FG001|Overall Study|Adverse Event|0|||
128757060|NCT04570436|463397929|FG002|Overall Study|Adverse Event|1|||
128757061|NCT04570436|463397930|FG003|Overall Study|Adverse Event|0|||
128757062|NCT04570436|463397931|FG004|Overall Study|Adverse Event|0|||
128757063|NCT04570436|463397932|FG005|Overall Study|Adverse Event|0|||
128757064|NCT04570436|463397933|FG006|Overall Study|Adverse Event|0|||
128757065|NCT04570436|463397934|FG007|Overall Study|Adverse Event|0|||
128757066|NCT04570436|463397935|FG008|Overall Study|Adverse Event|0|||
128757067|NCT04570436|463397936|FG009|Overall Study|Adverse Event|0|||
128757068|NCT04570436|463397927|FG000|Overall Study|Physician Decision|1|||
128757069|NCT04570436|463397928|FG001|Overall Study|Physician Decision|0|||
128757070|NCT04570436|463397929|FG002|Overall Study|Physician Decision|0|||
128757071|NCT04570436|463397930|FG003|Overall Study|Physician Decision|0|||
128757072|NCT04570436|463397931|FG004|Overall Study|Physician Decision|0|||
128757073|NCT04570436|463397932|FG005|Overall Study|Physician Decision|0|||
128757074|NCT04570436|463397933|FG006|Overall Study|Physician Decision|0|||
128757075|NCT04570436|463397934|FG007|Overall Study|Physician Decision|0|||
128757076|NCT04570436|463397935|FG008|Overall Study|Physician Decision|0|||
128757077|NCT04570436|463397936|FG009|Overall Study|Physician Decision|0|||
128757078|NCT00781391|463397937|FG000|Overall Study|never received study drug|24|||
128757079|NCT00781391|463397938|FG001|Overall Study|never received study drug|23|||
128757080|NCT00781391|463397939|FG002|Overall Study|never received study drug|32|||
128757081|NCT00781391|463397937|FG000|Overall Study|Protocol Violation|19|||
128757082|NCT00781391|463397938|FG001|Overall Study|Protocol Violation|17|||
128757083|NCT00781391|463397939|FG002|Overall Study|Protocol Violation|20|||
128757084|NCT00781391|463397937|FG000|Overall Study|Death|789|||
128757085|NCT00781391|463397938|FG001|Overall Study|Death|730|||
128757086|NCT00781391|463397939|FG002|Overall Study|Death|706|||
128757087|NCT00781391|463397937|FG000|Overall Study|Withdrawal by Subject|47|||
128757088|NCT00781391|463397938|FG001|Overall Study|Withdrawal by Subject|37|||
128757089|NCT00781391|463397939|FG002|Overall Study|Withdrawal by Subject|25|||
128757090|NCT00781391|463397937|FG000|Overall Study|Lost to Follow-up|0|||
128757091|NCT00781391|463397938|FG001|Overall Study|Lost to Follow-up|0|||
128757092|NCT00781391|463397939|FG002|Overall Study|Lost to Follow-up|1|||
128757093|NCT00929162|463397942|FG000|Overall Study|Adverse Event|8|||
128757094|NCT00929162|463397943|FG001|Overall Study|Adverse Event|5|||
128757095|NCT00929162|463397942|FG000|Overall Study|Withdrawal by Subject|3|||
128757096|NCT00929162|463397943|FG001|Overall Study|Withdrawal by Subject|1|||
128757097|NCT00929162|463397942|FG000|Overall Study|Protocol Violation|32|||
128757098|NCT00929162|463397943|FG001|Overall Study|Protocol Violation|30|||
128757099|NCT00929162|463397942|FG000|Overall Study|Other termination reason|5|||
128757100|NCT00929162|463397943|FG001|Overall Study|Other termination reason|6|||
128757101|NCT01274182|463397944|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
128757102|NCT01274182|463397945|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
128757103|NCT01274182|463397946|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
128757104|NCT01274182|463397944|FG000|Overall Study|Adverse Event|4|||
128757105|NCT01274182|463397945|FG001|Overall Study|Adverse Event|5|||
128757106|NCT01274182|463397946|FG002|Overall Study|Adverse Event|3|||
128757107|NCT01274182|463397944|FG000|Overall Study|Withdrawal by Subject|5|||
128757108|NCT01274182|463397945|FG001|Overall Study|Withdrawal by Subject|5|||
128757109|NCT01274182|463397946|FG002|Overall Study|Withdrawal by Subject|3|||
128757110|NCT01274182|463397944|FG000|Overall Study|Lost to Follow-up|2|||
128757111|NCT01274182|463397945|FG001|Overall Study|Lost to Follow-up|3|||
128757112|NCT01274182|463397946|FG002|Overall Study|Lost to Follow-up|1|||
128757113|NCT01274182|463397944|FG000|Overall Study|Protocol Violation|3|||
128757114|NCT01274182|463397945|FG001|Overall Study|Protocol Violation|2|||
128757115|NCT01274182|463397946|FG002|Overall Study|Protocol Violation|0|||
128757116|NCT01274182|463397944|FG000|Overall Study|Death|1|||
128757117|NCT01274182|463397945|FG001|Overall Study|Death|0|||
128757118|NCT01274182|463397946|FG002|Overall Study|Death|1|||
128757119|NCT01822587|463397947|FG000|Overall Study|Lost to Follow-up|7|||
128757120|NCT01822587|463397948|FG001|Overall Study|Lost to Follow-up|9|||
128757121|NCT01822587|463397949|FG002|Overall Study|Lost to Follow-up|12|||
128757122|NCT01822587|463397947|FG000|Overall Study|Physician Decision|9|||
128757123|NCT01822587|463397948|FG001|Overall Study|Physician Decision|6|||
128757124|NCT01822587|463397949|FG002|Overall Study|Physician Decision|6|||
128757125|NCT02355002|463397950|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
128757126|NCT02355002|463397951|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
128757127|NCT02355002|463397950|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
128757128|NCT02355002|463397951|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
128757129|NCT02355002|463397950|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
128757130|NCT02355002|463397951|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
128757131|NCT02355002|463397950|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
128757132|NCT02355002|463397951|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
128757133|NCT02355002|463397950|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
128757134|NCT02355002|463397951|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
128757135|NCT02355002|463397950|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
128757136|NCT02355002|463397951|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
128757137|NCT02355002|463397950|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
128757138|NCT02355002|463397951|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
128757139|NCT00708916|463397952|FG000|Overall Study|Subject Noncompliance|2|||
128757140|NCT00708916|463397952|FG000|Overall Study|Adverse Event|2|||
128757141|NCT03205371|463397962|FG000|Overall Study|Withdrawal by Subject|4|||
128757142|NCT03205371|463397963|FG001|Overall Study|Withdrawal by Subject|1|||
128757143|NCT03205371|463397964|FG002|Overall Study|Withdrawal by Subject|0|||
128786742|NCT01196988|463511249|FG001|Overall Study|Withdrawal by Subject|1|||
128786743|NCT01196988|463511250|FG002|Overall Study|Withdrawal by Subject|4|||
128786744|NCT01196988|463511251|FG003|Overall Study|Withdrawal by Subject|0|||
128757144|NCT03205371|463397965|FG003|Overall Study|Withdrawal by Subject|0|||
128757145|NCT03205371|463397966|FG004|Overall Study|Withdrawal by Subject|0|||
128757146|NCT03205371|463397967|FG005|Overall Study|Withdrawal by Subject|0|||
128757147|NCT03205371|463397968|FG006|Overall Study|Withdrawal by Subject|4|||
128757148|NCT03205371|463397969|FG007|Overall Study|Withdrawal by Subject|0|||
128786745|NCT01196988|463511248|FG000|Overall Study|Lost to Follow-up|16|||
128786746|NCT01196988|463511249|FG001|Overall Study|Lost to Follow-up|29|||
128786747|NCT01196988|463511250|FG002|Overall Study|Lost to Follow-up|21|||
128786748|NCT01196988|463511251|FG003|Overall Study|Lost to Follow-up|1|||
128786749|NCT01196988|463511248|FG000|Overall Study|Other|2|||
128786750|NCT01196988|463511249|FG001|Overall Study|Other|0|||
128786751|NCT01196988|463511250|FG002|Overall Study|Other|0|||
128786752|NCT01196988|463511251|FG003|Overall Study|Other|0|||
128786753|NCT05419557|463511252|FG000|Overall Study|Lost to Follow-up|11|||
128786754|NCT05419557|463511253|FG001|Overall Study|Lost to Follow-up|4|||
128786755|NCT00920686|463511255|FG000|Overall Study|Lost to Follow-up|2|||
128786756|NCT00920686|463511256|FG001|Overall Study|Lost to Follow-up|3|||
128786757|NCT00920686|463511257|FG002|Overall Study|Lost to Follow-up|1|||
128786758|NCT00920686|463511255|FG000|Overall Study|Study drug dosing criteria not met|17|||
128786759|NCT00920686|463511256|FG001|Overall Study|Study drug dosing criteria not met|19|||
128786760|NCT00920686|463511257|FG002|Overall Study|Study drug dosing criteria not met|12|||
128786761|NCT00868192|463511258|FG000|Overall Study|Ineligible|4|||
128786762|NCT04304534|463511259|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
128786763|NCT04304534|463511260|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
128786764|NCT04304534|463511261|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
128786765|NCT04304534|463511262|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
128786766|NCT04304534|463511259|FG000|Overall Study|Non-Compliance with study drug|0|||
128786767|NCT04304534|463511260|FG001|Overall Study|Non-Compliance with study drug|1|||
128786768|NCT04304534|463511261|FG002|Overall Study|Non-Compliance with study drug|1|||
128786769|NCT04304534|463511262|FG003|Overall Study|Non-Compliance with study drug|1|||
128786770|NCT04304534|463511259|FG000|Overall Study|Lost to Follow-up|0|||
128786771|NCT04304534|463511260|FG001|Overall Study|Lost to Follow-up|1|||
128786772|NCT04304534|463511261|FG002|Overall Study|Lost to Follow-up|2|||
128786773|NCT04304534|463511262|FG003|Overall Study|Lost to Follow-up|3|||
128786774|NCT04304534|463511259|FG000|Overall Study|Unspecific|4|||
128786775|NCT04304534|463511260|FG001|Overall Study|Unspecific|2|||
128786776|NCT04304534|463511261|FG002|Overall Study|Unspecific|2|||
128786777|NCT04304534|463511262|FG003|Overall Study|Unspecific|2|||
128786778|NCT04304534|463511259|FG000|Overall Study|Technical Problems|2|||
128786779|NCT04304534|463511260|FG001|Overall Study|Technical Problems|2|||
128786780|NCT04304534|463511261|FG002|Overall Study|Technical Problems|3|||
128786781|NCT04304534|463511262|FG003|Overall Study|Technical Problems|4|||
128786782|NCT04304534|463511259|FG000|Overall Study|Death|7|||
128786783|NCT04304534|463511260|FG001|Overall Study|Death|2|||
128786784|NCT04304534|463511261|FG002|Overall Study|Death|4|||
128786785|NCT04304534|463511262|FG003|Overall Study|Death|3|||
128786786|NCT04304534|463511259|FG000|Overall Study|Withdrawal by Subject|7|||
128786787|NCT04304534|463511260|FG001|Overall Study|Withdrawal by Subject|2|||
128786788|NCT04304534|463511261|FG002|Overall Study|Withdrawal by Subject|7|||
128786789|NCT04304534|463511262|FG003|Overall Study|Withdrawal by Subject|4|||
128786790|NCT04304534|463511259|FG000|Overall Study|Physician Decision|4|||
128786791|NCT04304534|463511260|FG001|Overall Study|Physician Decision|9|||
128786792|NCT04304534|463511261|FG002|Overall Study|Physician Decision|9|||
128786793|NCT04304534|463511262|FG003|Overall Study|Physician Decision|5|||
128786794|NCT04304534|463511259|FG000|Overall Study|Subject Decision|34|||
128786795|NCT04304534|463511260|FG001|Overall Study|Subject Decision|25|||
128786796|NCT04304534|463511261|FG002|Overall Study|Subject Decision|25|||
128786797|NCT04304534|463511262|FG003|Overall Study|Subject Decision|26|||
128786798|NCT04304534|463511259|FG000|Overall Study|Adverse Event|35|||
128786799|NCT04304534|463511260|FG001|Overall Study|Adverse Event|40|||
128786800|NCT04304534|463511261|FG002|Overall Study|Adverse Event|39|||
128786801|NCT04304534|463511262|FG003|Overall Study|Adverse Event|44|||
128786802|NCT01313182|463511263|FG000|Overall Study|Protocol Violation|66|||
128786803|NCT01313182|463511264|FG001|Overall Study|Protocol Violation|92|||
128786804|NCT00464672|463511265|FG000|Overall Study|withdrawal of consent|0|||
128786805|NCT00464672|463511266|FG001|Overall Study|withdrawal of consent|0|||
128786806|NCT00464672|463511267|FG002|Overall Study|withdrawal of consent|0|||
128786807|NCT00464672|463511268|FG003|Overall Study|withdrawal of consent|1|||
128786808|NCT00464672|463511269|FG004|Overall Study|withdrawal of consent|9|||
128786809|NCT00464672|463511270|FG005|Overall Study|withdrawal of consent|4|||
128786810|NCT00464672|463511265|FG000|Overall Study|Lost to Follow-up|25|||
128786811|NCT00464672|463511266|FG001|Overall Study|Lost to Follow-up|10|||
128786812|NCT00464672|463511267|FG002|Overall Study|Lost to Follow-up|0|||
128786813|NCT00464672|463511268|FG003|Overall Study|Lost to Follow-up|0|||
128786814|NCT00464672|463511269|FG004|Overall Study|Lost to Follow-up|1|||
128786815|NCT00464672|463511270|FG005|Overall Study|Lost to Follow-up|0|||
128786816|NCT00001575|463511271|FG000|Overall Study|Screening failures-Ph I portion|22|||
128786817|NCT00001575|463511271|FG000|Overall Study|Withdrawn/deaths|23|||
128786818|NCT02701361|463511281|FG000|Overall Study|Lost to Follow-up|5|||
128786819|NCT02701361|463511282|FG001|Overall Study|Lost to Follow-up|2|||
128786820|NCT02701361|463511283|FG002|Overall Study|Lost to Follow-up|1|||
128786821|NCT02701361|463511281|FG000|Overall Study|Withdrawal by Subject|4|||
128786822|NCT02701361|463511282|FG001|Overall Study|Withdrawal by Subject|0|||
128786823|NCT02701361|463511283|FG002|Overall Study|Withdrawal by Subject|0|||
128786824|NCT02701361|463511281|FG000|Overall Study|timed out in rehab center|0|||
128786825|NCT02701361|463511282|FG001|Overall Study|timed out in rehab center|1|||
128786826|NCT02701361|463511283|FG002|Overall Study|timed out in rehab center|0|||
128786827|NCT02701361|463511281|FG000|Overall Study|incarceration|0|||
128786828|NCT02701361|463511282|FG001|Overall Study|incarceration|0|||
128786829|NCT02701361|463511283|FG002|Overall Study|incarceration|1|||
128786830|NCT01190150|463511288|FG000|First Treatment|Withdrawal by Subject|1|||
128786831|NCT01190150|463511289|FG001|First Treatment|Withdrawal by Subject|0|||
128786832|NCT01190150|463511288|FG000|Washout|Withdrawal by Subject|0|||
128786833|NCT01190150|463511289|FG001|Washout|Withdrawal by Subject|1|||
128786834|NCT01190150|463511288|FG000|Washout|Difficulty in adherence|0|||
128786835|NCT01190150|463511289|FG001|Washout|Difficulty in adherence|1|||
128786836|NCT00843193|463511293|FG000|Overall Study|Adverse Event|2|||
128786837|NCT00843193|463511294|FG001|Overall Study|Adverse Event|4|||
128786838|NCT00843193|463511293|FG000|Overall Study|Lack of Efficacy|1|||
128786839|NCT00843193|463511294|FG001|Overall Study|Lack of Efficacy|1|||
128786840|NCT00843193|463511293|FG000|Overall Study|Protocol Violation|1|||
128786841|NCT00843193|463511294|FG001|Overall Study|Protocol Violation|2|||
128786842|NCT00843193|463511293|FG000|Overall Study|Lost to Follow-up|1|||
128786843|NCT00843193|463511294|FG001|Overall Study|Lost to Follow-up|0|||
128786844|NCT00843193|463511293|FG000|Overall Study|Physician Decision|0|||
128786845|NCT00843193|463511294|FG001|Overall Study|Physician Decision|1|||
128786846|NCT00843193|463511293|FG000|Overall Study|Withdrawal by Subject|3|||
128757149|NCT03205371|463397970|FG008|Overall Study|Withdrawal by Subject|2|||
128757150|NCT03205371|463397971|FG009|Overall Study|Withdrawal by Subject|0|||
128757151|NCT03205371|463397972|FG010|Overall Study|Withdrawal by Subject|0|||
128757152|NCT03205371|463397973|FG011|Overall Study|Withdrawal by Subject|1|||
128757153|NCT03205371|463397962|FG000|Overall Study|Lost to Follow-up|0|||
128757154|NCT03205371|463397963|FG001|Overall Study|Lost to Follow-up|0|||
128757155|NCT03205371|463397964|FG002|Overall Study|Lost to Follow-up|0|||
128757156|NCT03205371|463397965|FG003|Overall Study|Lost to Follow-up|0|||
128757157|NCT03205371|463397966|FG004|Overall Study|Lost to Follow-up|0|||
128757158|NCT03205371|463397967|FG005|Overall Study|Lost to Follow-up|0|||
128757159|NCT03205371|463397968|FG006|Overall Study|Lost to Follow-up|5|||
128757160|NCT03205371|463397969|FG007|Overall Study|Lost to Follow-up|2|||
128757161|NCT03205371|463397970|FG008|Overall Study|Lost to Follow-up|3|||
128757162|NCT03205371|463397971|FG009|Overall Study|Lost to Follow-up|0|||
128757163|NCT03205371|463397972|FG010|Overall Study|Lost to Follow-up|0|||
128757164|NCT03205371|463397973|FG011|Overall Study|Lost to Follow-up|0|||
128757165|NCT03205371|463397962|FG000|Overall Study|Protocol Violation|0|||
128757166|NCT03205371|463397963|FG001|Overall Study|Protocol Violation|0|||
128757167|NCT03205371|463397964|FG002|Overall Study|Protocol Violation|0|||
128757168|NCT03205371|463397965|FG003|Overall Study|Protocol Violation|0|||
128757169|NCT03205371|463397966|FG004|Overall Study|Protocol Violation|0|||
128757170|NCT03205371|463397967|FG005|Overall Study|Protocol Violation|0|||
128757171|NCT03205371|463397968|FG006|Overall Study|Protocol Violation|1|||
128757172|NCT03205371|463397969|FG007|Overall Study|Protocol Violation|0|||
128757173|NCT03205371|463397970|FG008|Overall Study|Protocol Violation|0|||
128757174|NCT03205371|463397971|FG009|Overall Study|Protocol Violation|0|||
128757175|NCT03205371|463397972|FG010|Overall Study|Protocol Violation|0|||
128757176|NCT03205371|463397973|FG011|Overall Study|Protocol Violation|0|||
128757177|NCT03205371|463397962|FG000|Overall Study|Adverse Event|0|||
128757178|NCT03205371|463397963|FG001|Overall Study|Adverse Event|0|||
128757179|NCT03205371|463397964|FG002|Overall Study|Adverse Event|0|||
128757180|NCT03205371|463397965|FG003|Overall Study|Adverse Event|0|||
128757181|NCT03205371|463397966|FG004|Overall Study|Adverse Event|0|||
128757182|NCT03205371|463397967|FG005|Overall Study|Adverse Event|0|||
128786847|NCT00843193|463511294|FG001|Overall Study|Withdrawal by Subject|3|||
128786848|NCT04511650|463511295|FG000|Overall Study|Lost to Follow-up|1|||
128786849|NCT04511650|463511296|FG001|Overall Study|Lost to Follow-up|0|||
128786850|NCT04511650|463511297|FG002|Overall Study|Lost to Follow-up|0|||
128786851|NCT04511650|463511295|FG000|Overall Study|Withdrawal by Subject|1|||
128786852|NCT04511650|463511296|FG001|Overall Study|Withdrawal by Subject|0|||
128786853|NCT04511650|463511297|FG002|Overall Study|Withdrawal by Subject|0|||
128786854|NCT04511650|463511295|FG000|Overall Study|reason not provided|0|||
128786855|NCT04511650|463511296|FG001|Overall Study|reason not provided|0|||
128786856|NCT04511650|463511297|FG002|Overall Study|reason not provided|1|||
128757183|NCT03205371|463397968|FG006|Overall Study|Adverse Event|0|||
128757184|NCT03205371|463397969|FG007|Overall Study|Adverse Event|1|||
128757185|NCT03205371|463397970|FG008|Overall Study|Adverse Event|0|||
128757186|NCT03205371|463397971|FG009|Overall Study|Adverse Event|0|||
128757187|NCT03205371|463397972|FG010|Overall Study|Adverse Event|0|||
128757188|NCT03205371|463397973|FG011|Overall Study|Adverse Event|0|||
128757189|NCT01077544|463397977|FG000|Overall Study|New Cancer Therapy|3|||
128757190|NCT01077544|463397978|FG001|Overall Study|New Cancer Therapy|3|||
128757191|NCT01077544|463397977|FG000|Overall Study|Adverse Event|0|||
128757192|NCT01077544|463397978|FG001|Overall Study|Adverse Event|1|||
128786857|NCT04511650|463511295|FG000|Overall Study|Death|1|||
128786858|NCT04511650|463511296|FG001|Overall Study|Death|1|||
128786859|NCT04511650|463511297|FG002|Overall Study|Death|1|||
128786860|NCT02982213|463511298|FG000|Overall Study|Did not complete follow up questionnaire|5|||
128757193|NCT01077544|463397977|FG000|Overall Study|Disease Progression|0|||
128757194|NCT01077544|463397978|FG001|Overall Study|Disease Progression|1|||
128757195|NCT03575325|463397980|FG000|Overall Study|Death|1|||
128757196|NCT02618967|463397981|FG000|Overall Study|Lost to Follow-up|0|||
128757197|NCT02618967|463397982|FG001|Overall Study|Lost to Follow-up|0|||
128757198|NCT02618967|463397983|FG002|Overall Study|Lost to Follow-up|1|||
128757199|NCT02618967|463397984|FG003|Overall Study|Lost to Follow-up|0|||
128757200|NCT02618967|463397985|FG004|Overall Study|Lost to Follow-up|2|||
128757201|NCT02618967|463397986|FG005|Overall Study|Lost to Follow-up|0|||
128757202|NCT02618967|463397987|FG006|Overall Study|Lost to Follow-up|0|||
128757203|NCT02618967|463397988|FG007|Overall Study|Lost to Follow-up|0|||
128757204|NCT02618967|463397981|FG000|Overall Study|Withdrawal by Subject|1|||
128757205|NCT02618967|463397982|FG001|Overall Study|Withdrawal by Subject|0|||
128757206|NCT02618967|463397983|FG002|Overall Study|Withdrawal by Subject|0|||
128757207|NCT02618967|463397984|FG003|Overall Study|Withdrawal by Subject|0|||
128757208|NCT02618967|463397985|FG004|Overall Study|Withdrawal by Subject|0|||
128757209|NCT02618967|463397986|FG005|Overall Study|Withdrawal by Subject|0|||
128757210|NCT02618967|463397987|FG006|Overall Study|Withdrawal by Subject|0|||
128757211|NCT02618967|463397988|FG007|Overall Study|Withdrawal by Subject|0|||
128757212|NCT02612311|463397989|FG000|Overall Study|Adverse Event|16|||
128757213|NCT02612311|463397990|FG001|Overall Study|Adverse Event|12|||
128757214|NCT02612311|463397991|FG002|Overall Study|Adverse Event|7|||
128757215|NCT02612311|463397992|FG003|Overall Study|Adverse Event|13|||
128757216|NCT02612311|463397989|FG000|Overall Study|Death|29|||
128757217|NCT02612311|463397990|FG001|Overall Study|Death|10|||
128757218|NCT02612311|463397991|FG002|Overall Study|Death|11|||
128757219|NCT02612311|463397992|FG003|Overall Study|Death|11|||
128757220|NCT02612311|463397989|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
128757221|NCT02612311|463397990|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
128757222|NCT02612311|463397991|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
128757223|NCT02612311|463397992|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
128757224|NCT02612311|463397989|FG000|Overall Study|Investigator's Decision|11|||
128757225|NCT02612311|463397990|FG001|Overall Study|Investigator's Decision|15|||
128757226|NCT02612311|463397991|FG002|Overall Study|Investigator's Decision|6|||
128757227|NCT02612311|463397992|FG003|Overall Study|Investigator's Decision|6|||
128757228|NCT02612311|463397989|FG000|Overall Study|Lack of Efficacy|0|||
128757229|NCT02612311|463397990|FG001|Overall Study|Lack of Efficacy|0|||
128757230|NCT02612311|463397991|FG002|Overall Study|Lack of Efficacy|1|||
128757231|NCT02612311|463397992|FG003|Overall Study|Lack of Efficacy|1|||
128757232|NCT02612311|463397989|FG000|Overall Study|Lost to Follow-up|2|||
128757233|NCT02612311|463397990|FG001|Overall Study|Lost to Follow-up|2|||
128757234|NCT02612311|463397991|FG002|Overall Study|Lost to Follow-up|1|||
128757235|NCT02612311|463397992|FG003|Overall Study|Lost to Follow-up|2|||
128757236|NCT02612311|463397989|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
128757237|NCT02612311|463397990|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
128757238|NCT02612311|463397991|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
128757239|NCT02612311|463397992|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
128757240|NCT02612311|463397989|FG000|Overall Study|Site Terminated by Sponsor|29|||
128757241|NCT02612311|463397990|FG001|Overall Study|Site Terminated by Sponsor|12|||
128757242|NCT02612311|463397991|FG002|Overall Study|Site Terminated by Sponsor|13|||
128757243|NCT02612311|463397992|FG003|Overall Study|Site Terminated by Sponsor|5|||
128757244|NCT02612311|463397989|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
128757245|NCT02612311|463397990|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
128757246|NCT02612311|463397991|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
128757247|NCT02612311|463397992|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
128757248|NCT02612311|463397989|FG000|Overall Study|Reason Not Specified|3|||
128757249|NCT02612311|463397990|FG001|Overall Study|Reason Not Specified|7|||
128757250|NCT02612311|463397991|FG002|Overall Study|Reason Not Specified|4|||
128757251|NCT02612311|463397992|FG003|Overall Study|Reason Not Specified|5|||
128757252|NCT02612311|463397989|FG000|Overall Study|Unknown/Missing|10|||
128757253|NCT02612311|463397990|FG001|Overall Study|Unknown/Missing|13|||
128757254|NCT02612311|463397991|FG002|Overall Study|Unknown/Missing|4|||
128757255|NCT02612311|463397992|FG003|Overall Study|Unknown/Missing|0|||
128757256|NCT02612311|463397989|FG000|Overall Study|Non-Compliance with Study|1|||
128757257|NCT02612311|463397990|FG001|Overall Study|Non-Compliance with Study|0|||
128757258|NCT02612311|463397991|FG002|Overall Study|Non-Compliance with Study|0|||
128757259|NCT02612311|463397992|FG003|Overall Study|Non-Compliance with Study|0|||
128757260|NCT04672941|463397993|FG000|Overall Study|Investigator decision|1|||
128757261|NCT04672941|463397993|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
128757262|NCT04672941|463397993|FG000|Overall Study|COVID-19 related but no adverse event|1|||
128757263|NCT04672941|463397993|FG000|Overall Study|Adverse Event|2|||
128757264|NCT04672941|463397993|FG000|Overall Study|Lost to Follow-up|2|||
128757265|NCT00686881|463397994|FG000|Overall Study|Withdrawal by Subject|11|||
128757266|NCT00686881|463397995|FG001|Overall Study|Withdrawal by Subject|18|||
128757267|NCT00686881|463397994|FG000|Overall Study|Lost to Follow-up|0|||
128757268|NCT00686881|463397995|FG001|Overall Study|Lost to Follow-up|1|||
128757269|NCT00686881|463397994|FG000|Overall Study|Treatment-related adverse event|10|||
128757270|NCT00686881|463397995|FG001|Overall Study|Treatment-related adverse event|9|||
128757271|NCT00686881|463397994|FG000|Overall Study|Met discontinuation criteria|5|||
128757272|NCT00686881|463397995|FG001|Overall Study|Met discontinuation criteria|0|||
128757273|NCT00686881|463397994|FG000|Overall Study|Onset of malignant tumor|11|||
128757274|NCT00686881|463397995|FG001|Overall Study|Onset of malignant tumor|11|||
128757275|NCT00686881|463397994|FG000|Overall Study|Lack of Efficacy|4|||
128757276|NCT00686881|463397995|FG001|Overall Study|Lack of Efficacy|3|||
128757277|NCT00686881|463397994|FG000|Overall Study|Physician Decision|1|||
128757278|NCT00686881|463397995|FG001|Overall Study|Physician Decision|0|||
128757279|NCT00686881|463397994|FG000|Overall Study|Circumstances of site|1|||
128757280|NCT00686881|463397995|FG001|Overall Study|Circumstances of site|1|||
128757281|NCT00686881|463397994|FG000|Overall Study|Did not meet protocol eligibility|1|||
128757282|NCT00686881|463397995|FG001|Overall Study|Did not meet protocol eligibility|0|||
128757283|NCT00686881|463397994|FG000|Overall Study|Irregular visits|1|||
128757284|NCT00686881|463397995|FG001|Overall Study|Irregular visits|0|||
128757285|NCT00686881|463397994|FG000|Overall Study|Study discontinuation|35|||
128757286|NCT00686881|463397995|FG001|Overall Study|Study discontinuation|32|||
128757287|NCT00686881|463397994|FG000|Overall Study|Never received study drug|2|||
128757288|NCT00686881|463397995|FG001|Overall Study|Never received study drug|6|||
128757289|NCT01971723|463397996|FG000|Overall Study|Withdrawal by Subject|1|||
128757290|NCT01971723|463397997|FG001|Overall Study|Withdrawal by Subject|1|||
128757291|NCT01971723|463397996|FG000|Overall Study|Protocol Violation|1|||
128757292|NCT01971723|463397997|FG001|Overall Study|Protocol Violation|2|||
128757293|NCT05899686|463397998|FG000|Overall Study|Protocol Violation|1|||
128757294|NCT03645759|463397999|FG000|Overall Study|Lost to Follow-up|3|||
128757295|NCT03645759|463398000|FG001|Overall Study|Lost to Follow-up|2|||
128757296|NCT01648270|463398001|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
128757297|NCT00902694|463398002|FG000|Overall Study|Death|1|||
128757298|NCT00902694|463398003|FG001|Overall Study|Death|3|||
128757299|NCT00902694|463398002|FG000|Overall Study|Lost to Follow-up|1|||
128757300|NCT00902694|463398003|FG001|Overall Study|Lost to Follow-up|0|||
128757301|NCT00902694|463398002|FG000|Overall Study|Censored per protocol|3|||
128757302|NCT00902694|463398003|FG001|Overall Study|Censored per protocol|1|||
128757303|NCT00902694|463398002|FG000|Overall Study|Pregnancy|1|||
128757304|NCT00902694|463398003|FG001|Overall Study|Pregnancy|1|||
128757305|NCT00902694|463398002|FG000|Overall Study|Incarceration|1|||
128757306|NCT00902694|463398003|FG001|Overall Study|Incarceration|0|||
128757307|NCT04969263|463398004|FG000|Overall Study|Death|1|||
128757308|NCT04969263|463398004|FG000|Overall Study|Lost to Follow-up|2|||
128757309|NCT04969263|463398004|FG000|Overall Study|Withdrawal by Subject|5|||
128757310|NCT04969263|463398004|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
128757311|NCT03657277|463398006|FG000|Overall Study|Physician Decision|2|||
128757312|NCT03657277|463398006|FG000|Overall Study|Lost to Follow-up|1|||
128757313|NCT03657277|463398006|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
128757314|NCT02693743|463398007|FG000|Overall Study|Physician Decision|1|||
128757315|NCT02693743|463398008|FG001|Overall Study|Physician Decision|0|||
128757316|NCT01024608|463398009|FG000|Overall Study|Adverse Event|1|||
128757317|NCT01024608|463398010|FG001|Overall Study|Adverse Event|0|||
128757318|NCT01024608|463398009|FG000|Overall Study|Withdrawal by Subject|1|||
128757319|NCT01024608|463398010|FG001|Overall Study|Withdrawal by Subject|0|||
128757320|NCT01024608|463398009|FG000|Overall Study|Lost to Follow-up|0|||
128757321|NCT01024608|463398010|FG001|Overall Study|Lost to Follow-up|1|||
128757322|NCT01024608|463398009|FG000|Overall Study|Protocol Violation|0|||
128757323|NCT01024608|463398010|FG001|Overall Study|Protocol Violation|3|||
128757324|NCT01024608|463398009|FG000|Overall Study|Never received study treatment|2|||
128757325|NCT01024608|463398010|FG001|Overall Study|Never received study treatment|0|||
128757326|NCT00657618|463398017|FG000|Overall Study|Adverse Event|32|||
128757327|NCT00657618|463398017|FG000|Overall Study|Withdrawal by Subject|8|||
128757328|NCT00657618|463398017|FG000|Overall Study|negative for leishmaniasis|2|||
128757329|NCT00657618|463398017|FG000|Overall Study|didn't start due to schedule conflicts|1|||
128757330|NCT02412137|463398022|FG000|Overall Study|Withdrawal by Subject|2|||
128757331|NCT02412137|463398023|FG001|Overall Study|Withdrawal by Subject|0|||
128757332|NCT02412137|463398022|FG000|Overall Study|Lost to Follow-up|21|||
128757333|NCT02412137|463398023|FG001|Overall Study|Lost to Follow-up|14|||
128757334|NCT02412137|463398022|FG000|Overall Study|Physician Decision|28|||
128757335|NCT02412137|463398023|FG001|Overall Study|Physician Decision|9|||
128757336|NCT04922554|463398030|FG000|Overall Study|Adverse Event|4|||
128757337|NCT04922554|463398031|FG001|Overall Study|Adverse Event|0|||
128757338|NCT04922554|463398030|FG000|Overall Study|Withdrawal by Subject|1|||
128757339|NCT04922554|463398031|FG001|Overall Study|Withdrawal by Subject|0|||
128757340|NCT01323530|463399746|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
128757341|NCT01323530|463399747|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128757342|NCT01323530|463399748|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128757343|NCT01323530|463399749|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128757344|NCT01323530|463399750|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128757345|NCT01323530|463399751|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
128757346|NCT01323530|463399752|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
128757347|NCT01323530|463399746|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
128757348|NCT01323530|463399747|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
128757349|NCT01323530|463399748|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
128757350|NCT01323530|463399749|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128757351|NCT01323530|463399750|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
128757352|NCT01323530|463399751|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128757353|NCT01323530|463399752|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
128757354|NCT01323530|463399746|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
128757355|NCT01323530|463399747|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
128757356|NCT01323530|463399748|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
128757357|NCT01323530|463399749|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
128757358|NCT01323530|463399750|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
128757359|NCT01323530|463399751|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
128757360|NCT01323530|463399752|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
128757361|NCT01323530|463399746|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
128757362|NCT01323530|463399747|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
128757363|NCT01323530|463399748|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
128757364|NCT01323530|463399749|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
128757365|NCT01323530|463399750|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
128757366|NCT01323530|463399751|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
128757367|NCT01323530|463399752|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
128757368|NCT01323530|463399746|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
128757369|NCT01323530|463399747|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
128757370|NCT01323530|463399748|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
128757371|NCT01323530|463399749|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
128757372|NCT01323530|463399750|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
128757373|NCT01323530|463399751|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
128757374|NCT01323530|463399752|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
128757375|NCT01323530|463399746|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
128757376|NCT01323530|463399747|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
128757377|NCT01323530|463399748|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
128757378|NCT01323530|463399749|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
128786861|NCT02982213|463511299|FG001|Overall Study|Did not complete follow up questionnaire|1|||
128786862|NCT01972152|463511300|FG000|First Treatment Visit|Lost to Follow-up|0|||
128786863|NCT01972152|463511301|FG001|First Treatment Visit|Lost to Follow-up|1|||
128786864|NCT01972152|463511302|FG002|First Treatment Visit|Lost to Follow-up|0|||
128757379|NCT01323530|463399750|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
128757380|NCT01323530|463399751|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
128757381|NCT01323530|463399752|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
128757382|NCT01323530|463399746|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
128757383|NCT01323530|463399747|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
128757384|NCT01323530|463399748|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
128757385|NCT01323530|463399749|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
128757386|NCT01323530|463399750|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
128757387|NCT01323530|463399751|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
128757388|NCT01323530|463399752|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
128786865|NCT01972152|463511303|FG003|First Treatment Visit|Lost to Follow-up|0|||
128757389|NCT01323530|463399746|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
128757390|NCT01323530|463399747|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
128757391|NCT01323530|463399748|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
128757392|NCT01323530|463399749|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
128757393|NCT01323530|463399750|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
128757394|NCT01323530|463399751|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
128757395|NCT01323530|463399752|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
128757396|NCT01735201|463399753|FG000|Overall Study|Adverse Event|1|||
128757397|NCT01735201|463399754|FG001|Overall Study|Adverse Event|1|||
128757398|NCT01735201|463399755|FG002|Overall Study|Adverse Event|0|||
128757399|NCT01735201|463399756|FG003|Overall Study|Adverse Event|1|||
128757400|NCT01735201|463399757|FG004|Overall Study|Adverse Event|1|||
128757401|NCT01735201|463399758|FG005|Overall Study|Adverse Event|3|||
128757402|NCT01735201|463399759|FG006|Overall Study|Adverse Event|2|||
128757403|NCT01735201|463399760|FG007|Overall Study|Adverse Event|1|||
128757404|NCT01735201|463399753|FG000|Overall Study|Personal Reasons|1|||
128757405|NCT01735201|463399754|FG001|Overall Study|Personal Reasons|0|||
128757406|NCT01735201|463399755|FG002|Overall Study|Personal Reasons|0|||
128757407|NCT01735201|463399756|FG003|Overall Study|Personal Reasons|0|||
128757408|NCT01735201|463399757|FG004|Overall Study|Personal Reasons|0|||
128757409|NCT01735201|463399758|FG005|Overall Study|Personal Reasons|0|||
128757410|NCT01735201|463399759|FG006|Overall Study|Personal Reasons|0|||
128757411|NCT01735201|463399760|FG007|Overall Study|Personal Reasons|0|||
128757412|NCT01735201|463399753|FG000|Overall Study|Protocol Violation|1|||
128757413|NCT01735201|463399754|FG001|Overall Study|Protocol Violation|0|||
128757414|NCT01735201|463399755|FG002|Overall Study|Protocol Violation|0|||
128757415|NCT01735201|463399756|FG003|Overall Study|Protocol Violation|0|||
128757416|NCT01735201|463399757|FG004|Overall Study|Protocol Violation|0|||
128757417|NCT01735201|463399758|FG005|Overall Study|Protocol Violation|0|||
128757418|NCT01735201|463399759|FG006|Overall Study|Protocol Violation|0|||
128757419|NCT01735201|463399760|FG007|Overall Study|Protocol Violation|0|||
128757420|NCT01735201|463399753|FG000|Overall Study|Other Miscellaneous Reasons|0|||
128757421|NCT01735201|463399754|FG001|Overall Study|Other Miscellaneous Reasons|0|||
128757422|NCT01735201|463399755|FG002|Overall Study|Other Miscellaneous Reasons|0|||
128757423|NCT01735201|463399756|FG003|Overall Study|Other Miscellaneous Reasons|1|||
128757424|NCT01735201|463399757|FG004|Overall Study|Other Miscellaneous Reasons|0|||
128757425|NCT01735201|463399758|FG005|Overall Study|Other Miscellaneous Reasons|2|||
128757426|NCT01735201|463399759|FG006|Overall Study|Other Miscellaneous Reasons|1|||
128757427|NCT01735201|463399760|FG007|Overall Study|Other Miscellaneous Reasons|1|||
128757428|NCT01553318|463399761|FG000|Overall Study|Protocol Violation|3|||
128757429|NCT01553318|463399762|FG001|Overall Study|Protocol Violation|2|||
128757430|NCT02127372|463399765|FG000|Overall Study|Withdrawal by Subject|1|||
128757431|NCT02127372|463399766|FG001|Overall Study|Withdrawal by Subject|0|||
128757432|NCT04493931|463399770|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
128757433|NCT04493931|463399771|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
128757434|NCT04493931|463399772|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
128757435|NCT04493931|463399773|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
128757436|NCT04493931|463399774|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
128757437|NCT04493931|463399775|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
128757438|NCT04493931|463399776|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
128757439|NCT04493931|463399770|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
128786866|NCT01972152|463511304|FG004|First Treatment Visit|Lost to Follow-up|0|||
128786867|NCT01972152|463511305|FG005|First Treatment Visit|Lost to Follow-up|0|||
128786868|NCT01972152|463511300|FG000|Second Treatment Visit|Protocol Violation|0|||
128786869|NCT01972152|463511301|FG001|Second Treatment Visit|Protocol Violation|1|||
128786870|NCT01972152|463511302|FG002|Second Treatment Visit|Protocol Violation|0|||
128786871|NCT01972152|463511303|FG003|Second Treatment Visit|Protocol Violation|0|||
128786872|NCT01972152|463511304|FG004|Second Treatment Visit|Protocol Violation|0|||
128786873|NCT01972152|463511305|FG005|Second Treatment Visit|Protocol Violation|0|||
128786874|NCT02512042|463511306|FG000|Overall Study|Adverse Event|0|||
128786875|NCT02512042|463511307|FG001|Overall Study|Adverse Event|4|||
128786876|NCT02512042|463511306|FG000|Overall Study|Withdrawal by Subject|6|||
128786877|NCT02512042|463511307|FG001|Overall Study|Withdrawal by Subject|6|||
128786878|NCT02512042|463511306|FG000|Overall Study|Non-compliance with study drug|1|||
128786879|NCT02512042|463511307|FG001|Overall Study|Non-compliance with study drug|2|||
128786880|NCT02512042|463511306|FG000|Overall Study|Lost to Follow-up|5|||
128786881|NCT02512042|463511307|FG001|Overall Study|Lost to Follow-up|2|||
128786882|NCT02512042|463511306|FG000|Overall Study|Other|11|||
128786883|NCT02512042|463511307|FG001|Overall Study|Other|11|||
128786884|NCT01194258|463511308|FG000|Titration Period|Withdrawal by Subject|6|||
128786885|NCT01194258|463511309|FG001|Titration Period|Withdrawal by Subject|0|||
128786886|NCT01194258|463511310|FG002|Titration Period|Withdrawal by Subject|0|||
128757440|NCT04493931|463399771|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
128757441|NCT04493931|463399772|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
128757442|NCT04493931|463399773|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
128757443|NCT04493931|463399774|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
128757444|NCT04493931|463399775|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
128757445|NCT04493931|463399776|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
128757446|NCT04493931|463399770|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
128757447|NCT04493931|463399771|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
128757448|NCT04493931|463399772|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
128757449|NCT04493931|463399773|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
128757450|NCT04493931|463399774|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
128786887|NCT01194258|463511311|FG003|Titration Period|Withdrawal by Subject|0|||
128786888|NCT01194258|463511312|FG004|Titration Period|Withdrawal by Subject|0|||
128757451|NCT04493931|463399775|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
128757452|NCT04493931|463399776|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
128757453|NCT04493931|463399770|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
128757454|NCT04493931|463399771|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
128757455|NCT04493931|463399772|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
128757456|NCT04493931|463399773|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
128786889|NCT01194258|463511308|FG000|Titration Period|Lost to Follow-up|2|||
128786890|NCT01194258|463511309|FG001|Titration Period|Lost to Follow-up|0|||
128786891|NCT01194258|463511310|FG002|Titration Period|Lost to Follow-up|0|||
128757457|NCT04493931|463399774|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
128757458|NCT04493931|463399775|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
128757459|NCT04493931|463399776|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
128757460|NCT00917579|463399783|FG000|Washout >= 2 Weeks|Adverse Event|1|||
128757461|NCT00917579|463399784|FG001|Washout >= 2 Weeks|Adverse Event|0|||
128757462|NCT00917579|463399783|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
128757463|NCT00917579|463399784|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
128757464|NCT04385368|463399786|FG000|Overall Study|Death|5|||
128757465|NCT04385368|463399787|FG001|Overall Study|Death|5|||
128757466|NCT04385368|463399786|FG000|Overall Study|Physician Decision|3|||
128757467|NCT04385368|463399787|FG001|Overall Study|Physician Decision|0|||
128757468|NCT04385368|463399786|FG000|Overall Study|Withdrawal by Subject|4|||
128757469|NCT04385368|463399787|FG001|Overall Study|Withdrawal by Subject|3|||
128757470|NCT04721925|463399788|FG000|2-Month Assessment|Lost to Follow-up|5|||
128757471|NCT04721925|463399789|FG001|2-Month Assessment|Lost to Follow-up|3|||
128757472|NCT04721925|463399788|FG000|4-Month Assessment|Lost to Follow-up|3|||
128757473|NCT04721925|463399789|FG001|4-Month Assessment|Lost to Follow-up|6|||
128757474|NCT04535947|463399793|FG000|Overall Study|Adverse Event|1|||
128757475|NCT04535947|463399794|FG001|Overall Study|Adverse Event|4|||
128757476|NCT04535947|463399793|FG000|Overall Study|Other reasons not specified|2|||
128757477|NCT04535947|463399794|FG001|Overall Study|Other reasons not specified|0|||
128757478|NCT04535947|463399793|FG000|Overall Study|Withdrawal by Subject|1|||
128757479|NCT04535947|463399794|FG001|Overall Study|Withdrawal by Subject|1|||
128757480|NCT03802123|463399795|FG000|Overall Study|Withdrawal by Subject|3|||
128757481|NCT03802123|463399795|FG000|Overall Study|Physician Decision|1|||
128757482|NCT03802123|463399795|FG000|Overall Study|Subject moved to hospice care|1|||
128757483|NCT03802123|463399795|FG000|Overall Study|technician error|1|||
128757484|NCT03802123|463399795|FG000|Overall Study|Death|3|||
128757485|NCT02835339|463399797|FG000|Overall Study|Did not receive allocated intervention|13|||
128757486|NCT02835339|463399798|FG001|Overall Study|Did not receive allocated intervention|16|||
128757487|NCT03923959|463399799|FG000|Overall Study|Death|16|||
128757488|NCT03923959|463399800|FG001|Overall Study|Death|12|||
128757489|NCT03923959|463399799|FG000|Overall Study|Lost to Follow-up|56|||
128757490|NCT03923959|463399800|FG001|Overall Study|Lost to Follow-up|56|||
128757491|NCT03923959|463399799|FG000|Overall Study|Withdrawal by Subject|1|||
128757492|NCT03923959|463399800|FG001|Overall Study|Withdrawal by Subject|1|||
128757493|NCT03923959|463399799|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
128757494|NCT03923959|463399800|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
128757495|NCT04918147|463399801|FG000|Overall Study|Disease flare as defined in protocol|0|||
128757496|NCT04918147|463399802|FG001|Overall Study|Disease flare as defined in protocol|2|||
128757497|NCT02954354|463399803|FG000|Overall Study|Adverse Event|2|||
128757498|NCT02954354|463399804|FG001|Overall Study|Adverse Event|2|||
128757499|NCT02954354|463399805|FG002|Overall Study|Adverse Event|4|||
128757500|NCT02954354|463399803|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
128757501|NCT02954354|463399804|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
128757502|NCT02954354|463399805|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
128757503|NCT02954354|463399803|FG000|Overall Study|Lack of Efficacy|0|||
128757504|NCT02954354|463399804|FG001|Overall Study|Lack of Efficacy|2|||
128757505|NCT02954354|463399805|FG002|Overall Study|Lack of Efficacy|0|||
128757506|NCT02954354|463399803|FG000|Overall Study|Withdrawal by Subject|17|||
128757507|NCT02954354|463399804|FG001|Overall Study|Withdrawal by Subject|9|||
128757508|NCT02954354|463399805|FG002|Overall Study|Withdrawal by Subject|11|||
128757509|NCT02954354|463399803|FG000|Overall Study|Lost to Follow-up|12|||
128757510|NCT02954354|463399804|FG001|Overall Study|Lost to Follow-up|5|||
128757511|NCT02954354|463399805|FG002|Overall Study|Lost to Follow-up|0|||
128757512|NCT02954354|463399803|FG000|Overall Study|Miscellaneous|2|||
128757513|NCT02954354|463399804|FG001|Overall Study|Miscellaneous|2|||
128757514|NCT02954354|463399805|FG002|Overall Study|Miscellaneous|1|||
128757515|NCT03338829|463399806|FG000|Overall Study|Lost to Follow-up|4|||
128757516|NCT03338829|463399807|FG001|Overall Study|Lost to Follow-up|2|||
128757517|NCT03338829|463399808|FG002|Overall Study|Lost to Follow-up|4|||
128757518|NCT03338829|463399806|FG000|Overall Study|Pregnancy loss|1|||
128757519|NCT03338829|463399807|FG001|Overall Study|Pregnancy loss|1|||
128757520|NCT03338829|463399808|FG002|Overall Study|Pregnancy loss|0|||
128757521|NCT03338829|463399806|FG000|Overall Study|Protocol Violation|0|||
128757522|NCT03338829|463399807|FG001|Overall Study|Protocol Violation|1|||
128757523|NCT03338829|463399808|FG002|Overall Study|Protocol Violation|0|||
128757524|NCT02684006|463399809|FG000|Overall Study|Other|18|||
128757525|NCT02684006|463399810|FG001|Overall Study|Other|6|||
128757526|NCT02684006|463399809|FG000|Overall Study|Protocol Violation|2|||
128757527|NCT02684006|463399810|FG001|Overall Study|Protocol Violation|1|||
128757528|NCT02684006|463399809|FG000|Overall Study|Non-compliance with study drug|1|||
128757529|NCT02684006|463399810|FG001|Overall Study|Non-compliance with study drug|1|||
128757530|NCT02684006|463399809|FG000|Overall Study|No longer met eligibility criteria|6|||
128757531|NCT02684006|463399810|FG001|Overall Study|No longer met eligibility criteria|2|||
128757532|NCT02684006|463399809|FG000|Overall Study|Lost to Follow-up|0|||
128757533|NCT02684006|463399810|FG001|Overall Study|Lost to Follow-up|1|||
128757534|NCT02684006|463399809|FG000|Overall Study|Death|25|||
128757535|NCT02684006|463399810|FG001|Overall Study|Death|22|||
128757536|NCT02684006|463399809|FG000|Overall Study|Global deterioration of health status|18|||
128757537|NCT02684006|463399810|FG001|Overall Study|Global deterioration of health status|20|||
128757538|NCT02684006|463399809|FG000|Overall Study|Physician Decision|15|||
128757539|NCT02684006|463399810|FG001|Overall Study|Physician Decision|8|||
128757540|NCT02684006|463399809|FG000|Overall Study|Adverse Event|86|||
128757541|NCT02684006|463399810|FG001|Overall Study|Adverse Event|65|||
128757542|NCT02684006|463399809|FG000|Overall Study|Withdrawal by Subject|29|||
128757543|NCT02684006|463399810|FG001|Overall Study|Withdrawal by Subject|43|||
128757544|NCT02684006|463399809|FG000|Overall Study|Progressive disease|236|||
128757545|NCT02684006|463399810|FG001|Overall Study|Progressive disease|266|||
128757546|NCT02684006|463399809|FG000|Overall Study|Participation terminated by sponsor|6|||
128757547|NCT02684006|463399810|FG001|Overall Study|Participation terminated by sponsor|9|||
128757548|NCT04495179|463399811|FG000|Overall Study|Lost to Follow-up|0|||
128757549|NCT04495179|463399812|FG001|Overall Study|Lost to Follow-up|1|||
128757550|NCT04495179|463399811|FG000|Overall Study|Withdrawal by Subject|2|||
128757551|NCT04495179|463399812|FG001|Overall Study|Withdrawal by Subject|4|||
128757552|NCT04495179|463399811|FG000|Overall Study|Study terminated by sponsor|0|||
128786892|NCT01194258|463511311|FG003|Titration Period|Lost to Follow-up|0|||
128786893|NCT01194258|463511312|FG004|Titration Period|Lost to Follow-up|0|||
128786894|NCT01194258|463511308|FG000|Titration Period|Titration failure|3|||
128786895|NCT01194258|463511309|FG001|Titration Period|Titration failure|0|||
128786896|NCT01194258|463511310|FG002|Titration Period|Titration failure|0|||
128786897|NCT01194258|463511311|FG003|Titration Period|Titration failure|0|||
128786898|NCT01194258|463511312|FG004|Titration Period|Titration failure|0|||
128786899|NCT01194258|463511308|FG000|Period 1 (12 Weeks)|Death|0|||
128786900|NCT01194258|463511309|FG001|Period 1 (12 Weeks)|Death|0|||
128786901|NCT01194258|463511310|FG002|Period 1 (12 Weeks)|Death|0|||
128786902|NCT01194258|463511311|FG003|Period 1 (12 Weeks)|Death|0|||
128786903|NCT01194258|463511312|FG004|Period 1 (12 Weeks)|Death|1|||
128786904|NCT01194258|463511308|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
128786905|NCT01194258|463511309|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
128786906|NCT01194258|463511310|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
128786907|NCT01194258|463511311|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
128786908|NCT01194258|463511312|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
128786909|NCT01194258|463511308|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
128786910|NCT01194258|463511309|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
128786911|NCT01194258|463511310|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
128786912|NCT01194258|463511311|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
128786913|NCT01194258|463511312|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
128786914|NCT01194258|463511308|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128786915|NCT01194258|463511309|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128786916|NCT01194258|463511310|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
128786917|NCT01194258|463511311|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128786918|NCT01194258|463511312|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
128786919|NCT01253226|463511315|FG000|Overall Study|Adverse Event|0|||
128786920|NCT01253226|463511316|FG001|Overall Study|Adverse Event|0|||
128786921|NCT01253226|463511317|FG002|Overall Study|Adverse Event|1|||
128786922|NCT01253226|463511318|FG003|Overall Study|Adverse Event|0|||
128786923|NCT01253226|463511319|FG004|Overall Study|Adverse Event|0|||
128786924|NCT01253226|463511315|FG000|Overall Study|Death|0|||
128786925|NCT01253226|463511316|FG001|Overall Study|Death|1|||
128786926|NCT01253226|463511317|FG002|Overall Study|Death|0|||
128786927|NCT01253226|463511318|FG003|Overall Study|Death|0|||
128786928|NCT01253226|463511319|FG004|Overall Study|Death|0|||
128786929|NCT01253226|463511315|FG000|Overall Study|Physician Decision|0|||
128786930|NCT01253226|463511316|FG001|Overall Study|Physician Decision|0|||
128786931|NCT01253226|463511317|FG002|Overall Study|Physician Decision|0|||
128786932|NCT01253226|463511318|FG003|Overall Study|Physician Decision|0|||
128786933|NCT01253226|463511319|FG004|Overall Study|Physician Decision|2|||
128786934|NCT01253226|463511315|FG000|Overall Study|Withdrawal by Subject|0|||
128786935|NCT01253226|463511316|FG001|Overall Study|Withdrawal by Subject|0|||
128786936|NCT01253226|463511317|FG002|Overall Study|Withdrawal by Subject|0|||
128786937|NCT01253226|463511318|FG003|Overall Study|Withdrawal by Subject|1|||
128786938|NCT01253226|463511319|FG004|Overall Study|Withdrawal by Subject|0|||
128786939|NCT01582945|463511320|FG000|Overall Study|Intolerable side-effects|1|||
128786940|NCT01582945|463511320|FG000|Overall Study|Scheduling conflicts|1|||
128786941|NCT03310983|463511321|FG000|Overall Study|Lost to Follow-up|15|||
128786942|NCT03310983|463511322|FG001|Overall Study|Lost to Follow-up|17|||
128786943|NCT01656304|463511327|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
128786944|NCT05826431|463511328|FG000|Overall Study|Withdrawal by Subject|1|||
128786945|NCT04771273|463511329|FG000|Dose Escalation Period|Not treated with trial medication|0|||
128786946|NCT04771273|463511330|FG001|Dose Escalation Period|Not treated with trial medication|1|||
128786947|NCT04771273|463511331|FG002|Dose Escalation Period|Not treated with trial medication|1|||
128786948|NCT04771273|463511332|FG003|Dose Escalation Period|Not treated with trial medication|0|||
128786949|NCT04771273|463511329|FG000|Dose Escalation Period|Other reasons than listed|2|||
128786950|NCT04771273|463511330|FG001|Dose Escalation Period|Other reasons than listed|0|||
128786951|NCT04771273|463511331|FG002|Dose Escalation Period|Other reasons than listed|2|||
128786952|NCT04771273|463511332|FG003|Dose Escalation Period|Other reasons than listed|1|||
128786953|NCT04771273|463511329|FG000|Dose Escalation Period|Protocol Violation|0|||
128786954|NCT04771273|463511330|FG001|Dose Escalation Period|Protocol Violation|0|||
128786955|NCT04771273|463511331|FG002|Dose Escalation Period|Protocol Violation|3|||
128786956|NCT04771273|463511332|FG003|Dose Escalation Period|Protocol Violation|1|||
128786957|NCT04771273|463511329|FG000|Dose Escalation Period|Burden of study procedures|1|||
128786958|NCT04771273|463511330|FG001|Dose Escalation Period|Burden of study procedures|0|||
128786959|NCT04771273|463511331|FG002|Dose Escalation Period|Burden of study procedures|0|||
128786960|NCT04771273|463511332|FG003|Dose Escalation Period|Burden of study procedures|0|||
128786961|NCT04771273|463511329|FG000|Dose Escalation Period|Change of residence|0|||
128786962|NCT04771273|463511330|FG001|Dose Escalation Period|Change of residence|0|||
128786963|NCT04771273|463511331|FG002|Dose Escalation Period|Change of residence|0|||
128786964|NCT04771273|463511332|FG003|Dose Escalation Period|Change of residence|1|||
128786965|NCT04771273|463511329|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
128786966|NCT04771273|463511330|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
128786967|NCT04771273|463511331|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
128786968|NCT04771273|463511332|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
128786969|NCT04771273|463511329|FG000|Dose Escalation Period|Adverse Event|8|||
128786970|NCT04771273|463511330|FG001|Dose Escalation Period|Adverse Event|9|||
128786971|NCT04771273|463511331|FG002|Dose Escalation Period|Adverse Event|12|||
128786972|NCT04771273|463511332|FG003|Dose Escalation Period|Adverse Event|2|||
128757553|NCT04495179|463399812|FG001|Overall Study|Study terminated by sponsor|18|||
128757554|NCT04495179|463399811|FG000|Overall Study|Death|0|||
128757555|NCT04495179|463399812|FG001|Overall Study|Death|4|||
128757556|NCT04495179|463399811|FG000|Overall Study|Adverse Event|0|||
128757557|NCT04495179|463399812|FG001|Overall Study|Adverse Event|1|||
128757558|NCT01368965|463399816|FG000|Overall Study|Lost to Follow-up|12|||
128757559|NCT02355743|463399827|FG000|Overall Study|Withdrawal by Subject|1|||
128757560|NCT02355743|463399827|FG000|Overall Study|Lost to Follow-up|1|||
128757561|NCT04212091|463399828|FG000|Overall Study|Lost to Follow-up|0|||
128757562|NCT04212091|463399829|FG001|Overall Study|Lost to Follow-up|0|||
128757563|NCT04212091|463399830|FG002|Overall Study|Lost to Follow-up|0|||
128757564|NCT04212091|463399831|FG003|Overall Study|Lost to Follow-up|0|||
128757565|NCT04212091|463399832|FG004|Overall Study|Lost to Follow-up|1|||
128757566|NCT04212091|463399833|FG005|Overall Study|Lost to Follow-up|1|||
128757567|NCT04212091|463399828|FG000|Overall Study|Participant unable to adhere to visit|0|||
128757568|NCT04212091|463399829|FG001|Overall Study|Participant unable to adhere to visit|0|||
128757569|NCT04212091|463399830|FG002|Overall Study|Participant unable to adhere to visit|0|||
128757570|NCT04212091|463399831|FG003|Overall Study|Participant unable to adhere to visit|0|||
128757571|NCT04212091|463399832|FG004|Overall Study|Participant unable to adhere to visit|1|||
128757572|NCT04212091|463399833|FG005|Overall Study|Participant unable to adhere to visit|0|||
128757573|NCT00715429|463399834|FG000|Overall Study|Did not complete the study diary|0|||
128757574|NCT00715429|463399835|FG001|Overall Study|Did not complete the study diary|1|||
128757575|NCT04085328|463399836|FG000|Overall Study|Witihdrew Consent|16|||
128757576|NCT04085328|463399837|FG001|Overall Study|Witihdrew Consent|16|||
128757577|NCT04085328|463399836|FG000|Overall Study|Adverse Event|8|||
128757578|NCT04085328|463399837|FG001|Overall Study|Adverse Event|7|||
128757579|NCT04085328|463399836|FG000|Overall Study|Lost to Follow-up|7|||
128757580|NCT04085328|463399837|FG001|Overall Study|Lost to Follow-up|2|||
128786973|NCT04771273|463511329|FG000|Maintenance Period|Other than listed|4|||
128786974|NCT04771273|463511330|FG001|Maintenance Period|Other than listed|2|||
128757581|NCT04085328|463399836|FG000|Overall Study|Physician Decision|0|||
128757582|NCT04085328|463399837|FG001|Overall Study|Physician Decision|1|||
128757583|NCT04085328|463399836|FG000|Overall Study|Pregnancy|0|||
128757584|NCT04085328|463399837|FG001|Overall Study|Pregnancy|1|||
128757585|NCT04085328|463399836|FG000|Overall Study|Reasons Related to COVID-19|5|||
128757586|NCT04085328|463399837|FG001|Overall Study|Reasons Related to COVID-19|8|||
128757587|NCT04085328|463399836|FG000|Overall Study|Did not meet inclusion criteria|1|||
128757588|NCT04085328|463399837|FG001|Overall Study|Did not meet inclusion criteria|1|||
128757589|NCT04085328|463399836|FG000|Overall Study|Early termination|1|||
128757590|NCT04085328|463399837|FG001|Overall Study|Early termination|0|||
128757591|NCT00514735|463399838|FG000|Overall Study|Withdrawal by Subject|13|||
128757592|NCT00514735|463399839|FG001|Overall Study|Withdrawal by Subject|5|||
128757593|NCT00514735|463399838|FG000|Overall Study|Death|1|||
128757594|NCT00514735|463399839|FG001|Overall Study|Death|0|||
128757595|NCT00514735|463399838|FG000|Overall Study|Lost to Follow-up|0|||
128757596|NCT00514735|463399839|FG001|Overall Study|Lost to Follow-up|1|||
128757597|NCT03804710|463399848|FG000|Overall Study|Adverse Event|0|||
128786975|NCT04771273|463511331|FG002|Maintenance Period|Other than listed|0|||
128757598|NCT03804710|463399849|FG001|Overall Study|Adverse Event|3|||
128757599|NCT03804710|463399848|FG000|Overall Study|Withdrawal by Subject|2|||
128786976|NCT04771273|463511332|FG003|Maintenance Period|Other than listed|3|||
128786977|NCT04771273|463511329|FG000|Maintenance Period|Burden of study procedures|1|||
128786978|NCT04771273|463511330|FG001|Maintenance Period|Burden of study procedures|0|||
128786979|NCT04771273|463511331|FG002|Maintenance Period|Burden of study procedures|0|||
128786980|NCT04771273|463511332|FG003|Maintenance Period|Burden of study procedures|0|||
128786981|NCT04771273|463511329|FG000|Maintenance Period|Change of residence|0|||
128786982|NCT04771273|463511330|FG001|Maintenance Period|Change of residence|1|||
128786983|NCT04771273|463511331|FG002|Maintenance Period|Change of residence|3|||
128786984|NCT04771273|463511332|FG003|Maintenance Period|Change of residence|0|||
128786985|NCT04771273|463511329|FG000|Maintenance Period|Perceived lack of efficacy|0|||
128786986|NCT04771273|463511330|FG001|Maintenance Period|Perceived lack of efficacy|0|||
128786987|NCT04771273|463511331|FG002|Maintenance Period|Perceived lack of efficacy|0|||
128786988|NCT04771273|463511332|FG003|Maintenance Period|Perceived lack of efficacy|1|||
128786989|NCT04771273|463511329|FG000|Maintenance Period|Adverse Event|4|||
128786990|NCT04771273|463511330|FG001|Maintenance Period|Adverse Event|5|||
128786991|NCT04771273|463511331|FG002|Maintenance Period|Adverse Event|5|||
128786992|NCT04771273|463511332|FG003|Maintenance Period|Adverse Event|0|||
128786993|NCT02163915|463511333|FG000|Overall Study|Withdrawal by Subject|2|||
128786994|NCT02163915|463511334|FG001|Overall Study|Withdrawal by Subject|0|||
128786995|NCT02163915|463511335|FG002|Overall Study|Withdrawal by Subject|2|||
128786996|NCT02163915|463511336|FG003|Overall Study|Withdrawal by Subject|2|||
128786997|NCT02163915|463511337|FG004|Overall Study|Withdrawal by Subject|2|||
128786998|NCT02163915|463511333|FG000|Overall Study|Study termination|1|||
128786999|NCT02163915|463511334|FG001|Overall Study|Study termination|0|||
128787000|NCT02163915|463511335|FG002|Overall Study|Study termination|0|||
128787001|NCT02163915|463511336|FG003|Overall Study|Study termination|0|||
128787002|NCT02163915|463511337|FG004|Overall Study|Study termination|2|||
128757600|NCT03804710|463399849|FG001|Overall Study|Withdrawal by Subject|1|||
128757601|NCT03804710|463399848|FG000|Overall Study|Other|0|||
128757602|NCT03804710|463399849|FG001|Overall Study|Other|1|||
128757603|NCT04542018|463399850|FG000|Overall Study|Withdrawal by Subject|0|||
128757604|NCT04542018|463399851|FG001|Overall Study|Withdrawal by Subject|0|||
128757605|NCT04542018|463399852|FG002|Overall Study|Withdrawal by Subject|4|||
128757606|NCT04542018|463399850|FG000|Overall Study|Protocol Violation|0|||
128757607|NCT04542018|463399851|FG001|Overall Study|Protocol Violation|0|||
128757608|NCT04542018|463399852|FG002|Overall Study|Protocol Violation|2|||
128757609|NCT01428076|463399856|FG000|Overall Study|Adverse Event|0|||
128787003|NCT02163915|463511333|FG000|Overall Study|Physician Decision|0|||
128787004|NCT02163915|463511334|FG001|Overall Study|Physician Decision|0|||
128787005|NCT02163915|463511335|FG002|Overall Study|Physician Decision|0|||
128787006|NCT02163915|463511336|FG003|Overall Study|Physician Decision|1|||
128787007|NCT02163915|463511337|FG004|Overall Study|Physician Decision|0|||
128787008|NCT02465359|463511340|FG000|Overall Study|Lack of Efficacy|1|||
128787009|NCT02465359|463511340|FG000|Overall Study|Withdrawal by Subject|1|||
128787010|NCT02465359|463511340|FG000|Overall Study|Adverse Event|1|||
128787011|NCT05233085|463511342|FG000|Overall Study|Adverse Event|1|||
128787012|NCT05233085|463511343|FG001|Overall Study|Adverse Event|0|||
128787013|NCT05233085|463511344|FG002|Overall Study|Adverse Event|0|||
128787014|NCT05233085|463511345|FG003|Overall Study|Adverse Event|0|||
128787015|NCT00798265|463511346|FG000|Overall Study|Lost to Follow-up|1|||
128787016|NCT00798265|463511347|FG001|Overall Study|Lost to Follow-up|10|||
128787017|NCT00798265|463511346|FG000|Overall Study|Study closing|7|||
128787018|NCT00798265|463511347|FG001|Overall Study|Study closing|6|||
128787019|NCT00798265|463511346|FG000|Overall Study|Withdrawal by Subject|0|||
128787020|NCT00798265|463511347|FG001|Overall Study|Withdrawal by Subject|1|||
128787021|NCT00798265|463511346|FG000|Overall Study|Screen failure|0|||
128787022|NCT00798265|463511347|FG001|Overall Study|Screen failure|1|||
128787023|NCT01311648|463512577|FG000|Main Study|Protocol Violation|0|||
128787024|NCT01311648|463512578|FG001|Main Study|Protocol Violation|1|||
128787025|NCT01311648|463512577|FG000|Main Study|Adverse Event|0|||
128787026|NCT01311648|463512578|FG001|Main Study|Adverse Event|1|||
128787027|NCT01311648|463512577|FG000|Main Study|Inhibitor management|0|||
128787028|NCT01311648|463512578|FG001|Main Study|Inhibitor management|17|||
128787029|NCT01311648|463512577|FG000|Main Study|Withdrawal by Subject|0|||
128787030|NCT01311648|463512578|FG001|Main Study|Withdrawal by Subject|2|||
128787031|NCT01311648|463512577|FG000|Extension Study|Physician Decision|0|||
128787032|NCT01311648|463512578|FG001|Extension Study|Physician Decision|1|||
128787033|NCT01311648|463512577|FG000|Extension Study|ITI therapy with marketed product|0|||
128787034|NCT01311648|463512578|FG001|Extension Study|ITI therapy with marketed product|1|||
128787035|NCT01311648|463512577|FG000|Extension Study|Incorrect visit planning|0|||
128787036|NCT01311648|463512578|FG001|Extension Study|Incorrect visit planning|1|||
128787037|NCT01311648|463512577|FG000|Extension Study|Family's decision|0|||
128787038|NCT01311648|463512578|FG001|Extension Study|Family's decision|1|||
128787039|NCT01311648|463512577|FG000|Extension Study|Failure of ITI therapy|0|||
128787040|NCT01311648|463512578|FG001|Extension Study|Failure of ITI therapy|3|||
128787041|NCT01311648|463512577|FG000|Extension Study|Long travel|0|||
128787042|NCT01311648|463512578|FG001|Extension Study|Long travel|1|||
128787043|NCT01311648|463512577|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
128787044|NCT01311648|463512578|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
128787045|NCT01311648|463512577|FG000|Extension Study|Withdrawal by Subject|0|||
128787046|NCT01311648|463512578|FG001|Extension Study|Withdrawal by Subject|1|||
128787047|NCT01311648|463512577|FG000|Extension Study|Inhibitor management|0|||
128787048|NCT01311648|463512578|FG001|Extension Study|Inhibitor management|2|||
128787049|NCT03712930|463512580|FG000|Overall Study|Death|7|||
128787050|NCT03712930|463512580|FG000|Overall Study|Physician Decision|1|||
128787051|NCT03712930|463512580|FG000|Overall Study|Study Terminated by Sponsor|3|||
128787052|NCT03712930|463512580|FG000|Overall Study|Progressive Disease|2|||
128787053|NCT00739102|463512585|FG000|Overall Study|Death|5|||
128787054|NCT00739102|463512585|FG000|Overall Study|Withdrawal by Subject|10|||
128787055|NCT01091454|463512586|FG000|Overall Study|Ineligible|1|||
128787056|NCT01510912|463512589|FG000|Overall Study|Adverse Event|99|||
128787057|NCT01510912|463512589|FG000|Overall Study|Lack of Efficacy|12|||
128787058|NCT01510912|463512589|FG000|Overall Study|Non-compliance with trial drug|23|||
128787059|NCT01510912|463512589|FG000|Overall Study|Withdrawal by Subject|49|||
128787060|NCT01510912|463512589|FG000|Overall Study|Physician Decision|1|||
128787061|NCT01510912|463512589|FG000|Overall Study|Protocol Violation|27|||
128787062|NCT01510912|463512589|FG000|Overall Study|Lost to Follow-up|26|||
128787063|NCT01510912|463512589|FG000|Overall Study|Other, including joint replacement|5|||
128787064|NCT03179787|463512590|FG000|Overall Study|Lost to Follow-up|15|||
128787065|NCT03179787|463512590|FG000|Overall Study|Case report failures|2|||
128787066|NCT03179787|463512590|FG000|Overall Study|Treatment not administered|1|||
128787067|NCT02030028|463512591|FG000|Overall Study|Withdrawal by Subject|4|||
128787068|NCT02030028|463512591|FG000|Overall Study|lack of transportation|1|||
128787069|NCT02380742|463512592|FG000|Overall Study|Withdrawal by Subject|1|||
128787070|NCT02380742|463512593|FG001|Overall Study|Withdrawal by Subject|0|||
128787071|NCT02930343|463512595|FG000|Overall Study|Lost to Follow-up|9|||
128787072|NCT02930343|463512596|FG001|Overall Study|Lost to Follow-up|7|||
128787073|NCT02987543|463512601|FG000|Overall Study|Ongoing study at data cut off|49|||
128787074|NCT02987543|463512602|FG001|Overall Study|Ongoing study at data cut off|21|||
128787075|NCT02987543|463512603|FG002|Overall Study|Ongoing study at data cut off|19|||
128787076|NCT02987543|463512604|FG003|Overall Study|Ongoing study at data cut off|12|||
128787077|NCT02987543|463512601|FG000|Overall Study|Death|88|||
128787078|NCT02987543|463512602|FG001|Overall Study|Death|54|||
128787079|NCT02987543|463512603|FG002|Overall Study|Death|67|||
128787080|NCT02987543|463512604|FG003|Overall Study|Death|28|||
128757610|NCT01428076|463399857|FG001|Overall Study|Adverse Event|1|||
128787081|NCT02987543|463512601|FG000|Overall Study|Lost to Follow-up|3|||
128787082|NCT02987543|463512602|FG001|Overall Study|Lost to Follow-up|0|||
128787083|NCT02987543|463512603|FG002|Overall Study|Lost to Follow-up|1|||
128787084|NCT02987543|463512604|FG003|Overall Study|Lost to Follow-up|0|||
128787085|NCT02987543|463512601|FG000|Overall Study|Screen failure|0|||
128787086|NCT02987543|463512602|FG001|Overall Study|Screen failure|0|||
128787087|NCT02987543|463512603|FG002|Overall Study|Screen failure|0|||
128787088|NCT02987543|463512604|FG003|Overall Study|Screen failure|1|||
128787089|NCT02987543|463512601|FG000|Overall Study|Withdrawal by Subject|21|||
128787090|NCT02987543|463512602|FG001|Overall Study|Withdrawal by Subject|7|||
128787091|NCT02987543|463512603|FG002|Overall Study|Withdrawal by Subject|7|||
128787092|NCT02987543|463512604|FG003|Overall Study|Withdrawal by Subject|6|||
128787093|NCT02987543|463512601|FG000|Overall Study|Study terminated by sponsor|1|||
128787094|NCT02987543|463512602|FG001|Overall Study|Study terminated by sponsor|0|||
128787095|NCT02987543|463512603|FG002|Overall Study|Study terminated by sponsor|0|||
128787096|NCT02987543|463512604|FG003|Overall Study|Study terminated by sponsor|0|||
128787097|NCT02987543|463512601|FG000|Overall Study|Investigator decision|0|||
128787098|NCT02987543|463512602|FG001|Overall Study|Investigator decision|1|||
128787099|NCT02987543|463512603|FG002|Overall Study|Investigator decision|0|||
128787100|NCT02987543|463512604|FG003|Overall Study|Investigator decision|0|||
128787101|NCT02987543|463512601|FG000|Overall Study|Disease progression|0|||
128787102|NCT02987543|463512602|FG001|Overall Study|Disease progression|0|||
128787103|NCT02987543|463512603|FG002|Overall Study|Disease progression|0|||
128787104|NCT02987543|463512604|FG003|Overall Study|Disease progression|1|||
128787105|NCT01977612|463512607|FG000|Overall Study|Lost to Follow-up|1|||
128787106|NCT01977612|463512608|FG001|Overall Study|Lost to Follow-up|1|||
128787107|NCT01280591|463512610|FG000|Overall Study|Withdrawal by Subject|0|||
128787108|NCT01280591|463512611|FG001|Overall Study|Withdrawal by Subject|0|||
128787109|NCT01280591|463512612|FG002|Overall Study|Withdrawal by Subject|0|||
128787110|NCT01280591|463512613|FG003|Overall Study|Withdrawal by Subject|2|||
128787111|NCT01280591|463512610|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
128787112|NCT01280591|463512611|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
128787113|NCT01280591|463512612|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
128787114|NCT01280591|463512613|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
128787115|NCT01883492|463512615|FG000|Overall Study|Lost to Follow-up|3|||
128787116|NCT01883492|463512616|FG001|Overall Study|Lost to Follow-up|4|||
128787117|NCT01883492|463512615|FG000|Overall Study|Surgery on contra-lateral hip|0|||
128787118|NCT01883492|463512616|FG001|Overall Study|Surgery on contra-lateral hip|1|||
128787119|NCT01883492|463512615|FG000|Overall Study|Poor X-ray quality|7|||
128787120|NCT01883492|463512616|FG001|Overall Study|Poor X-ray quality|4|||
128787121|NCT01883492|463512615|FG000|Overall Study|Withdrawal by Subject|1|||
128787122|NCT01883492|463512616|FG001|Overall Study|Withdrawal by Subject|0|||
128787123|NCT01883492|463512615|FG000|Overall Study|inappropriate implant used|1|||
128787124|NCT01883492|463512616|FG001|Overall Study|inappropriate implant used|1|||
128787125|NCT01883492|463512615|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
128787126|NCT01883492|463512616|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
128787127|NCT01259102|463512617|FG000|Overall Study|Adverse Event|1|||
128787128|NCT01259102|463512618|FG001|Overall Study|Adverse Event|0|||
128787129|NCT01259102|463512619|FG002|Overall Study|Adverse Event|1|||
128787130|NCT01259102|463512620|FG003|Overall Study|Adverse Event|1|||
128787131|NCT01259102|463512621|FG004|Overall Study|Adverse Event|0|||
128757611|NCT02454101|463399858|FG000|Overall Study|Adverse Event|2|||
128757612|NCT02454101|463399859|FG001|Overall Study|Adverse Event|3|||
128757613|NCT02454101|463399858|FG000|Overall Study|Lost to Follow-up|3|||
128787132|NCT01259102|463512617|FG000|Overall Study|Other|0|||
128787133|NCT01259102|463512618|FG001|Overall Study|Other|0|||
128787134|NCT01259102|463512619|FG002|Overall Study|Other|1|||
128757614|NCT02454101|463399859|FG001|Overall Study|Lost to Follow-up|4|||
128757615|NCT02216773|463399860|FG000|Overall Study|Disease progression|4|||
128757616|NCT02216773|463399861|FG001|Overall Study|Disease progression|2|||
128757617|NCT02216773|463399860|FG000|Overall Study|Insufficient FLRV|4|||
128757618|NCT02216773|463399861|FG001|Overall Study|Insufficient FLRV|0|||
128757619|NCT02216773|463399860|FG000|Overall Study|Abandoned|4|||
128787135|NCT01259102|463512620|FG003|Overall Study|Other|1|||
128787136|NCT01259102|463512621|FG004|Overall Study|Other|1|||
128787137|NCT01876511|463512623|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
128787138|NCT01876511|463512624|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
128787139|NCT01876511|463512625|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
128787140|NCT01876511|463512623|FG000|Overall Study|Death (unrelated)|3|||
128787141|NCT01876511|463512624|FG001|Overall Study|Death (unrelated)|0|||
128787142|NCT01876511|463512625|FG002|Overall Study|Death (unrelated)|2|||
128787143|NCT01876511|463512623|FG000|Overall Study|Drug-related Toxicity|5|||
128787144|NCT01876511|463512624|FG001|Overall Study|Drug-related Toxicity|1|||
128787145|NCT01876511|463512625|FG002|Overall Study|Drug-related Toxicity|6|||
128787146|NCT01876511|463512623|FG000|Overall Study|Patient Decision|3|||
128787147|NCT01876511|463512624|FG001|Overall Study|Patient Decision|0|||
128787148|NCT01876511|463512625|FG002|Overall Study|Patient Decision|6|||
128787149|NCT01876511|463512623|FG000|Overall Study|Physician Decision|1|||
128787150|NCT01876511|463512624|FG001|Overall Study|Physician Decision|0|||
128787151|NCT01876511|463512625|FG002|Overall Study|Physician Decision|1|||
128787152|NCT01233050|463512628|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
128787153|NCT01233050|463512629|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
128787154|NCT01064817|463512630|FG000|Study Completion|Physician Decision|1|||
128787155|NCT01064817|463512631|FG001|Study Completion|Physician Decision|0|||
128787156|NCT01064817|463512630|FG000|Study Completion|Withdrawal by Subject|1|||
128787157|NCT01064817|463512631|FG001|Study Completion|Withdrawal by Subject|0|||
128787158|NCT01466881|463512633|FG000|Overall Study|Ineligible|5|||
128787159|NCT01466881|463512633|FG000|Overall Study|Adverse Event|6|||
128787160|NCT01466881|463512633|FG000|Overall Study|Progression/relapse|20|||
128787161|NCT01466881|463512633|FG000|Overall Study|Death|4|||
128787162|NCT01466881|463512633|FG000|Overall Study|Other reason not protocol specified|5|||
128787163|NCT04580303|463512636|FG000|Overall Study|Adverse Event|0|||
128787164|NCT04580303|463512637|FG001|Overall Study|Adverse Event|1|||
128787165|NCT04580303|463512638|FG002|Overall Study|Adverse Event|0|||
128787166|NCT04580303|463512639|FG003|Overall Study|Adverse Event|0|||
128787167|NCT04580303|463512636|FG000|Overall Study|Withdrawal by Subject|0|||
128787168|NCT04580303|463512637|FG001|Overall Study|Withdrawal by Subject|0|||
128787169|NCT04580303|463512638|FG002|Overall Study|Withdrawal by Subject|1|||
128757620|NCT02216773|463399861|FG001|Overall Study|Abandoned|3|||
128757621|NCT04274894|463399862|FG000|Overall Study|Adverse Event|7|||
128757622|NCT04274894|463399862|FG000|Overall Study|Withdrew consent|5|||
128757623|NCT04274894|463399862|FG000|Overall Study|Lost to Follow-up|9|||
128787170|NCT04580303|463512639|FG003|Overall Study|Withdrawal by Subject|0|||
128787171|NCT00927823|463512643|FG000|Continuous Dosing Period|Death|0|||
128787172|NCT00927823|463512644|FG001|Continuous Dosing Period|Death|0|||
128787173|NCT00927823|463512645|FG002|Continuous Dosing Period|Death|6|||
128787174|NCT00927823|463512646|FG003|Continuous Dosing Period|Death|0|||
128787175|NCT00927823|463512643|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
128787176|NCT00927823|463512644|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
128787177|NCT00927823|463512645|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
128787178|NCT00927823|463512646|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
128787179|NCT00927823|463512643|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
128787180|NCT00927823|463512644|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
128787181|NCT00927823|463512645|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
128787182|NCT00927823|463512646|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
128787183|NCT00927823|463512643|FG000|Continuous Dosing Period|Other|1|||
128787184|NCT00927823|463512644|FG001|Continuous Dosing Period|Other|2|||
128787185|NCT00927823|463512645|FG002|Continuous Dosing Period|Other|9|||
128787186|NCT00927823|463512646|FG003|Continuous Dosing Period|Other|3|||
128787187|NCT02299635|463512647|FG000|Overall Study|Adverse Event|2|||
128787188|NCT02299635|463512647|FG000|Overall Study|Death|1|||
128787189|NCT02299635|463512647|FG000|Overall Study|Global deterioration of health status|1|||
128787190|NCT02299635|463512647|FG000|Overall Study|Objective progression or relapse|10|||
128787191|NCT02299635|463512647|FG000|Overall Study|Withdrawal by Subject|2|||
128787192|NCT02299635|463512647|FG000|Overall Study|Other|3|||
128787193|NCT00828672|463512648|FG000|Study Treatment|Lost to Follow-up|1|||
128787194|NCT00828672|463512649|FG001|Study Treatment|Lost to Follow-up|0|||
128787195|NCT00828672|463512648|FG000|Study Treatment|Adverse Event|0|||
128787196|NCT00828672|463512649|FG001|Study Treatment|Adverse Event|1|||
128787197|NCT00828672|463512648|FG000|Study Treatment|Complete response, no surgery|1|||
128787198|NCT00828672|463512649|FG001|Study Treatment|Complete response, no surgery|1|||
128787199|NCT00828672|463512648|FG000|Post-surgery (<30 Days)|No central review materials|0|||
128787200|NCT00828672|463512649|FG001|Post-surgery (<30 Days)|No central review materials|1|||
128787201|NCT02750709|463512659|FG000|Treatment Period 1|Adverse Event|0|||
128787202|NCT02750709|463512660|FG001|Treatment Period 1|Adverse Event|0|||
128787203|NCT02750709|463512661|FG002|Treatment Period 1|Adverse Event|0|||
128787204|NCT02750709|463512662|FG003|Treatment Period 1|Adverse Event|0|||
128787205|NCT02750709|463512663|FG004|Treatment Period 1|Adverse Event|0|||
128787206|NCT02750709|463512664|FG005|Treatment Period 1|Adverse Event|1|||
128787207|NCT00290732|463512665|FG000|Overall Study|Inability to instill drug intraductally.|0|||
128787208|NCT00290732|463512666|FG001|Overall Study|Inability to instill drug intraductally.|1|||
128787209|NCT00290732|463512667|FG002|Overall Study|Inability to instill drug intraductally.|1|||
128787210|NCT00290732|463512668|FG003|Overall Study|Inability to instill drug intraductally.|0|||
128787211|NCT00290732|463512669|FG004|Overall Study|Inability to instill drug intraductally.|0|||
128787212|NCT02595398|463512670|FG000|Overall Study|Non-compliance|1|||
128787213|NCT02595398|463512671|FG001|Overall Study|Non-compliance|0|||
128787214|NCT02595398|463512670|FG000|Overall Study|Withdrawal by Subject|2|||
128787215|NCT02595398|463512671|FG001|Overall Study|Withdrawal by Subject|1|||
128787216|NCT02595398|463512670|FG000|Overall Study|Lost to Follow-up|1|||
128787217|NCT02595398|463512671|FG001|Overall Study|Lost to Follow-up|0|||
128787218|NCT00542386|463512672|FG000|Overall Study|Adverse Event|1|||
128787219|NCT00542386|463512673|FG001|Overall Study|Adverse Event|7|||
128787220|NCT00542386|463512674|FG002|Overall Study|Adverse Event|7|||
128787221|NCT00542386|463512675|FG003|Overall Study|Adverse Event|8|||
128787222|NCT00542386|463512676|FG004|Overall Study|Adverse Event|13|||
128787223|NCT00542386|463512677|FG005|Overall Study|Adverse Event|4|||
128787224|NCT00542386|463512672|FG000|Overall Study|Death|0|||
128787225|NCT00542386|463512673|FG001|Overall Study|Death|0|||
128787226|NCT00542386|463512674|FG002|Overall Study|Death|1|||
128787227|NCT00542386|463512675|FG003|Overall Study|Death|2|||
128787228|NCT00542386|463512676|FG004|Overall Study|Death|1|||
128787229|NCT00542386|463512677|FG005|Overall Study|Death|2|||
128787230|NCT00542386|463512672|FG000|Overall Study|Lack of Efficacy|32|||
128787231|NCT00542386|463512673|FG001|Overall Study|Lack of Efficacy|12|||
128787232|NCT00542386|463512674|FG002|Overall Study|Lack of Efficacy|10|||
128787233|NCT00542386|463512675|FG003|Overall Study|Lack of Efficacy|13|||
128787234|NCT00542386|463512676|FG004|Overall Study|Lack of Efficacy|7|||
128787235|NCT00542386|463512677|FG005|Overall Study|Lack of Efficacy|31|||
128787236|NCT00542386|463512672|FG000|Overall Study|Physician Decision|1|||
128787237|NCT00542386|463512673|FG001|Overall Study|Physician Decision|0|||
128787238|NCT00542386|463512674|FG002|Overall Study|Physician Decision|0|||
128787239|NCT00542386|463512675|FG003|Overall Study|Physician Decision|1|||
128787240|NCT00542386|463512676|FG004|Overall Study|Physician Decision|0|||
128787241|NCT00542386|463512677|FG005|Overall Study|Physician Decision|0|||
128787242|NCT00542386|463512672|FG000|Overall Study|Protocol Violation|0|||
128787243|NCT00542386|463512673|FG001|Overall Study|Protocol Violation|0|||
128787244|NCT00542386|463512674|FG002|Overall Study|Protocol Violation|1|||
128787245|NCT00542386|463512675|FG003|Overall Study|Protocol Violation|0|||
128787246|NCT00542386|463512676|FG004|Overall Study|Protocol Violation|0|||
128787247|NCT00542386|463512677|FG005|Overall Study|Protocol Violation|4|||
128787248|NCT00542386|463512672|FG000|Overall Study|Withdrawal by Subject|5|||
128787249|NCT00542386|463512673|FG001|Overall Study|Withdrawal by Subject|8|||
128787250|NCT00542386|463512674|FG002|Overall Study|Withdrawal by Subject|10|||
128787251|NCT00542386|463512675|FG003|Overall Study|Withdrawal by Subject|11|||
128787252|NCT00542386|463512676|FG004|Overall Study|Withdrawal by Subject|15|||
128757624|NCT04274894|463399862|FG000|Overall Study|COVID-19 infection|1|||
128757625|NCT04274894|463399862|FG000|Overall Study|Other, not specified|20|||
128757626|NCT01936857|463399863|FG000|Overall Study|Sent to prison or 06 center|11|||
128757627|NCT01936857|463399864|FG001|Overall Study|Sent to prison or 06 center|12|||
128757628|NCT01936857|463399863|FG000|Overall Study|Lost to Follow-up|10|||
128757629|NCT01936857|463399864|FG001|Overall Study|Lost to Follow-up|7|||
128757630|NCT01936857|463399863|FG000|Overall Study|Death|7|||
128757631|NCT01936857|463399864|FG001|Overall Study|Death|3|||
128757632|NCT01936857|463399863|FG000|Overall Study|Moved|2|||
128757633|NCT01936857|463399864|FG001|Overall Study|Moved|1|||
128757634|NCT01936857|463399863|FG000|Overall Study|Withdrawal by Subject|1|||
128757635|NCT01936857|463399864|FG001|Overall Study|Withdrawal by Subject|0|||
128757636|NCT01936857|463399863|FG000|Overall Study|Side effect of medication|1|||
128757637|NCT01936857|463399864|FG001|Overall Study|Side effect of medication|0|||
128757638|NCT01936857|463399863|FG000|Overall Study|Other|2|||
128757639|NCT01936857|463399864|FG001|Overall Study|Other|2|||
128757640|NCT02279043|463399865|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
128757641|NCT02279043|463399866|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
128757642|NCT02279043|463399867|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
128757643|NCT02279043|463399865|FG000|Overall Study|Lost to Follow-up|46|||
128757644|NCT02279043|463399866|FG001|Overall Study|Lost to Follow-up|88|||
128757645|NCT02279043|463399867|FG002|Overall Study|Lost to Follow-up|0|||
128757646|NCT02124265|463399868|FG000|Overall Study|Adverse Event|1|||
128757647|NCT00490282|463399869|FG000|Overall Study|Withdrawal by Subject|3|||
128757648|NCT04510675|463399870|FG000|Overall Study|Withdrawal by Subject|5|||
128757649|NCT04198805|463399871|FG000|Overall Study|Death|0|||
128757650|NCT04198805|463399872|FG001|Overall Study|Death|0|||
128757651|NCT04198805|463399873|FG002|Overall Study|Death|0|||
128757652|NCT04198805|463399874|FG003|Overall Study|Death|1|||
128757653|NCT04198805|463399871|FG000|Overall Study|Early Termination|8|||
128757654|NCT04198805|463399872|FG001|Overall Study|Early Termination|4|||
128757655|NCT04198805|463399873|FG002|Overall Study|Early Termination|6|||
128757656|NCT04198805|463399874|FG003|Overall Study|Early Termination|9|||
128757657|NCT01330433|463399875|FG000|Overall Study|Death|1|||
128757658|NCT01330433|463399876|FG001|Overall Study|Death|3|||
128757659|NCT01330433|463399875|FG000|Overall Study|Lost to Follow-up|1|||
128757660|NCT01330433|463399876|FG001|Overall Study|Lost to Follow-up|0|||
128757661|NCT01499082|463399877|FG000|Overall Study|Randomized but not Treated|0|||
128757662|NCT01499082|463399878|FG001|Overall Study|Randomized but not Treated|1|||
128757663|NCT01499082|463399877|FG000|Overall Study|Adverse Event|12|||
128757664|NCT01499082|463399878|FG001|Overall Study|Adverse Event|16|||
128757665|NCT01499082|463399877|FG000|Overall Study|Lack of Efficacy|1|||
128757666|NCT01499082|463399878|FG001|Overall Study|Lack of Efficacy|1|||
128757667|NCT01499082|463399877|FG000|Overall Study|Protocol Violation|6|||
128757668|NCT01499082|463399878|FG001|Overall Study|Protocol Violation|8|||
128757669|NCT01499082|463399877|FG000|Overall Study|Diverse Reasons|18|||
128757670|NCT01499082|463399878|FG001|Overall Study|Diverse Reasons|14|||
128757671|NCT01499082|463399877|FG000|Overall Study|Site Closure for Noncompliance|5|||
128757672|NCT01499082|463399878|FG001|Overall Study|Site Closure for Noncompliance|2|||
128757673|NCT01499082|463399877|FG000|Overall Study|Hypoglycemia|2|||
128757674|NCT01499082|463399878|FG001|Overall Study|Hypoglycemia|3|||
128757675|NCT01499082|463399877|FG000|Overall Study|Lost to Follow-up|1|||
128757676|NCT01499082|463399878|FG001|Overall Study|Lost to Follow-up|3|||
128757677|NCT03599349|463399879|FG000|Overall Study|Lost to Follow-up|1|||
128757678|NCT01830127|463399885|FG000|Overall Study|Adverse Event|1|||
128757679|NCT01830127|463399886|FG001|Overall Study|Adverse Event|6|||
128757680|NCT01830127|463399885|FG000|Overall Study|Lack of Efficacy|3|||
128757681|NCT01830127|463399886|FG001|Overall Study|Lack of Efficacy|0|||
128757682|NCT01830127|463399885|FG000|Overall Study|Withdrawal by Subject|1|||
128757683|NCT01830127|463399886|FG001|Overall Study|Withdrawal by Subject|1|||
128757684|NCT01830127|463399885|FG000|Overall Study|Other reason not defined above|0|||
128757685|NCT01830127|463399886|FG001|Overall Study|Other reason not defined above|2|||
128757686|NCT00567190|463399892|FG000|Overall Study|Death|235|||
128757687|NCT00567190|463399893|FG001|Overall Study|Death|280|||
128757688|NCT00567190|463399892|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
128757689|NCT00567190|463399893|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
128757690|NCT00344461|463399899|FG000|Overall Study|Adverse Event|6|||
128757691|NCT00344461|463399899|FG000|Overall Study|Death|1|||
128757692|NCT00344461|463399899|FG000|Overall Study|Lack of Efficacy|2|||
128757693|NCT00344461|463399899|FG000|Overall Study|Lost to Follow-up|2|||
128757694|NCT00344461|463399899|FG000|Overall Study|Physician Decision|2|||
128757695|NCT00344461|463399899|FG000|Overall Study|Protocol Violation|6|||
128757696|NCT00344461|463399899|FG000|Overall Study|Withdrawal by Subject|2|||
128757697|NCT00636610|463399900|FG000|Overall Study|Adverse Event|4|||
128787253|NCT00542386|463512677|FG005|Overall Study|Withdrawal by Subject|7|||
128787254|NCT00542386|463512672|FG000|Overall Study|Other Reasons|4|||
128787255|NCT00542386|463512673|FG001|Overall Study|Other Reasons|1|||
128787256|NCT00542386|463512674|FG002|Overall Study|Other Reasons|4|||
128787257|NCT00542386|463512675|FG003|Overall Study|Other Reasons|3|||
128787258|NCT00542386|463512676|FG004|Overall Study|Other Reasons|4|||
128787259|NCT00542386|463512677|FG005|Overall Study|Other Reasons|2|||
128787260|NCT00197015|463512678|FG000|Overall Study|Adverse Event|3|||
128787261|NCT00197015|463512679|FG001|Overall Study|Adverse Event|0|||
128787262|NCT00197015|463512680|FG002|Overall Study|Adverse Event|1|||
128787263|NCT00197015|463512678|FG000|Overall Study|Protocol Violation|0|||
128787264|NCT00197015|463512679|FG001|Overall Study|Protocol Violation|3|||
128787265|NCT00197015|463512680|FG002|Overall Study|Protocol Violation|3|||
128787266|NCT00197015|463512678|FG000|Overall Study|Withdrawal by Subject|17|||
128787267|NCT00197015|463512679|FG001|Overall Study|Withdrawal by Subject|37|||
128787268|NCT00197015|463512680|FG002|Overall Study|Withdrawal by Subject|34|||
128787269|NCT00197015|463512678|FG000|Overall Study|Lost to Follow-up|28|||
128787270|NCT00197015|463512679|FG001|Overall Study|Lost to Follow-up|46|||
128787271|NCT00197015|463512680|FG002|Overall Study|Lost to Follow-up|37|||
128787272|NCT00197015|463512678|FG000|Overall Study|Other|2|||
128787273|NCT00197015|463512679|FG001|Overall Study|Other|3|||
128787274|NCT00197015|463512680|FG002|Overall Study|Other|2|||
128787275|NCT01155869|463512686|FG000|Overall Study|Lost to Follow-up|3|||
128787276|NCT01155869|463512687|FG001|Overall Study|Lost to Follow-up|1|||
128787277|NCT02824432|463512688|FG000|Overall Study|Major Protocol Deviation|1|||
128787278|NCT02824432|463512689|FG001|Overall Study|Major Protocol Deviation|0|||
128787279|NCT01543685|463512691|FG000|Overall Study|Lack of Efficacy|1|||
128787280|NCT01543685|463512692|FG001|Overall Study|Lack of Efficacy|2|||
128787281|NCT01543685|463512693|FG002|Overall Study|Lack of Efficacy|2|||
128787282|NCT01543685|463512694|FG003|Overall Study|Lack of Efficacy|0|||
128787283|NCT01543685|463512695|FG004|Overall Study|Lack of Efficacy|2|||
128787284|NCT01543685|463512691|FG000|Overall Study|Adverse Event|2|||
128787285|NCT01543685|463512692|FG001|Overall Study|Adverse Event|1|||
128787286|NCT01543685|463512693|FG002|Overall Study|Adverse Event|0|||
128787287|NCT01543685|463512694|FG003|Overall Study|Adverse Event|0|||
128787288|NCT01543685|463512695|FG004|Overall Study|Adverse Event|2|||
128787289|NCT02931396|463512696|FG000|Overall Study|Lost to Follow-up|3|||
128787290|NCT02931396|463512697|FG001|Overall Study|Lost to Follow-up|0|||
128787291|NCT02931396|463512696|FG000|Overall Study|Withdrawal by Subject|2|||
128787292|NCT02931396|463512697|FG001|Overall Study|Withdrawal by Subject|0|||
128787293|NCT01304147|463512698|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
128787294|NCT01304147|463512699|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
128787295|NCT01244828|463512700|FG000|Overall Study|Adverse Event|37|||
128787296|NCT01244828|463512700|FG000|Overall Study|Withdrawal by Subject|31|||
128787297|NCT01244828|463512700|FG000|Overall Study|Lack of Efficacy|7|||
128787298|NCT01244828|463512700|FG000|Overall Study|Lost to Follow-up|2|||
128787299|NCT01244828|463512700|FG000|Overall Study|Other reason (not specified)|1|||
128787300|NCT01278862|463512701|FG000|Overall Study|Lost to Follow-up|1|||
128787301|NCT01278862|463512702|FG001|Overall Study|Lost to Follow-up|1|||
128787302|NCT00603447|463512703|FG000|Overall Study|Adverse Event|0|||
128787303|NCT00603447|463512704|FG001|Overall Study|Adverse Event|1|||
128787304|NCT00603447|463512705|FG002|Overall Study|Adverse Event|1|||
128787305|NCT00603447|463512706|FG003|Overall Study|Adverse Event|2|||
128787306|NCT00603447|463512707|FG004|Overall Study|Adverse Event|1|||
128787307|NCT00603447|463512708|FG005|Overall Study|Adverse Event|2|||
128787308|NCT00603447|463512709|FG006|Overall Study|Adverse Event|10|||
128787309|NCT00603447|463512703|FG000|Overall Study|Other|0|||
128787310|NCT00603447|463512704|FG001|Overall Study|Other|0|||
128787311|NCT00603447|463512705|FG002|Overall Study|Other|1|||
128787312|NCT00603447|463512706|FG003|Overall Study|Other|0|||
128787313|NCT00603447|463512707|FG004|Overall Study|Other|3|||
128787314|NCT00603447|463512708|FG005|Overall Study|Other|0|||
128787315|NCT00603447|463512709|FG006|Overall Study|Other|13|||
128787316|NCT00603447|463512703|FG000|Overall Study|Withdrew Consent|0|||
128787317|NCT00603447|463512704|FG001|Overall Study|Withdrew Consent|2|||
128787318|NCT00603447|463512705|FG002|Overall Study|Withdrew Consent|0|||
128787319|NCT00603447|463512706|FG003|Overall Study|Withdrew Consent|0|||
128787320|NCT00603447|463512707|FG004|Overall Study|Withdrew Consent|1|||
128787321|NCT00603447|463512708|FG005|Overall Study|Withdrew Consent|0|||
128787322|NCT00603447|463512709|FG006|Overall Study|Withdrew Consent|1|||
128787323|NCT02952261|463512710|FG000|Overall Study|Withdrawal by Subject|4|||
128787324|NCT02952261|463512711|FG001|Overall Study|Withdrawal by Subject|5|||
128787325|NCT02952261|463512710|FG000|Overall Study|Protocol Violation|1|||
128787326|NCT02952261|463512711|FG001|Overall Study|Protocol Violation|0|||
128787327|NCT01838200|463512714|FG000|Overall Study|Adverse Event|0|||
128787328|NCT01838200|463512715|FG001|Overall Study|Adverse Event|2|||
128787329|NCT01838200|463512714|FG000|Overall Study|Progressive disease|3|||
128787330|NCT01838200|463512715|FG001|Overall Study|Progressive disease|0|||
128787331|NCT02738840|463514535|FG000|Overall Study|MRI Scan not Performed|5|||
128787332|NCT02738840|463514535|FG000|Overall Study|Lost to Follow-up|1|||
128787333|NCT02738840|463514535|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
128787334|NCT02738840|463514535|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
128787335|NCT01645111|463514537|FG000|Overall Study|Did not require Clevidipine|15|||
128787336|NCT04057196|463514539|FG000|Overall Study|Withdrawal by Subject|3|||
128787337|NCT04057196|463514539|FG000|Overall Study|Death|3|||
128787338|NCT02466516|463514540|FG000|Overall Study|Adverse Event|1|||
128787339|NCT02466516|463514541|FG001|Overall Study|Adverse Event|1|||
128787340|NCT02466516|463514542|FG002|Overall Study|Adverse Event|0|||
128787341|NCT02466516|463514543|FG003|Overall Study|Adverse Event|0|||
128787342|NCT02466516|463514544|FG004|Overall Study|Adverse Event|0|||
128787343|NCT02466516|463514540|FG000|Overall Study|Withdrew Consent|1|||
128787344|NCT02466516|463514541|FG001|Overall Study|Withdrew Consent|0|||
128787345|NCT02466516|463514542|FG002|Overall Study|Withdrew Consent|0|||
128787346|NCT02466516|463514543|FG003|Overall Study|Withdrew Consent|0|||
128787347|NCT02466516|463514544|FG004|Overall Study|Withdrew Consent|0|||
128787348|NCT02466516|463514540|FG000|Overall Study|Lost to Follow-up|2|||
128787349|NCT02466516|463514541|FG001|Overall Study|Lost to Follow-up|0|||
128787350|NCT02466516|463514542|FG002|Overall Study|Lost to Follow-up|1|||
128787351|NCT02466516|463514543|FG003|Overall Study|Lost to Follow-up|0|||
128787352|NCT02466516|463514544|FG004|Overall Study|Lost to Follow-up|0|||
128787353|NCT01331824|463514545|FG000|Overall Study|Adverse Event|2|||
128787354|NCT01331824|463514545|FG000|Overall Study|Death|1|||
128787355|NCT01331824|463514545|FG000|Overall Study|Disease Progression|9|||
128787356|NCT01331824|463514545|FG000|Overall Study|Withdrawal by Subject|1|||
128787357|NCT00646451|463514546|FG000|Overall Study|Adverse Event|3|||
128787358|NCT00646451|463514547|FG001|Overall Study|Adverse Event|0|||
128787359|NCT00646451|463514546|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
128787360|NCT00646451|463514547|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
128787361|NCT01249092|463514549|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
128787362|NCT01249092|463514549|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
128787363|NCT03357341|463514552|FG000|Overall Study|Withdrawal by Subject|3|||
128787364|NCT03357341|463514553|FG001|Overall Study|Withdrawal by Subject|6|||
128787365|NCT03357341|463514552|FG000|Overall Study|Lost to Follow-up|4|||
128787366|NCT03357341|463514553|FG001|Overall Study|Lost to Follow-up|5|||
128787367|NCT03357341|463514552|FG000|Overall Study|Death|0|||
128787368|NCT03357341|463514553|FG001|Overall Study|Death|1|||
128787369|NCT01456936|463514556|FG000|Overall Study|Other reason|41|||
128787370|NCT01456936|463514557|FG001|Overall Study|Other reason|30|||
128787371|NCT01456936|463514558|FG002|Overall Study|Other reason|36|||
128787372|NCT01456936|463514559|FG003|Overall Study|Other reason|33|||
128787373|NCT01456936|463514556|FG000|Overall Study|No longer meets eligibility criteria|4|||
128787374|NCT01456936|463514557|FG001|Overall Study|No longer meets eligibility criteria|8|||
128787375|NCT01456936|463514558|FG002|Overall Study|No longer meets eligibility criteria|6|||
128787376|NCT01456936|463514559|FG003|Overall Study|No longer meets eligibility criteria|5|||
128787377|NCT01456936|463514556|FG000|Overall Study|Protocol Violation|4|||
128787378|NCT01456936|463514557|FG001|Overall Study|Protocol Violation|2|||
128787379|NCT01456936|463514558|FG002|Overall Study|Protocol Violation|5|||
128787380|NCT01456936|463514559|FG003|Overall Study|Protocol Violation|5|||
128787381|NCT01456936|463514556|FG000|Overall Study|Pregnancy|1|||
128787382|NCT01456936|463514557|FG001|Overall Study|Pregnancy|0|||
128787383|NCT01456936|463514558|FG002|Overall Study|Pregnancy|0|||
128787384|NCT01456936|463514559|FG003|Overall Study|Pregnancy|1|||
128787385|NCT01456936|463514556|FG000|Overall Study|Insufficient clinical response|4|||
128787386|NCT01456936|463514557|FG001|Overall Study|Insufficient clinical response|4|||
128787387|NCT01456936|463514558|FG002|Overall Study|Insufficient clinical response|14|||
128787388|NCT01456936|463514559|FG003|Overall Study|Insufficient clinical response|13|||
128787389|NCT01456936|463514556|FG000|Overall Study|No longer willing to participate|195|||
128787390|NCT01456936|463514557|FG001|Overall Study|No longer willing to participate|218|||
128787391|NCT01456936|463514558|FG002|Overall Study|No longer willing to participate|224|||
128787392|NCT01456936|463514559|FG003|Overall Study|No longer willing to participate|248|||
128787393|NCT01456936|463514556|FG000|Overall Study|Lost to Follow-up|135|||
128787394|NCT01456936|463514557|FG001|Overall Study|Lost to Follow-up|126|||
128787395|NCT01456936|463514558|FG002|Overall Study|Lost to Follow-up|144|||
128787396|NCT01456936|463514559|FG003|Overall Study|Lost to Follow-up|127|||
128787397|NCT01456936|463514556|FG000|Overall Study|Medication error|0|||
128787398|NCT01456936|463514557|FG001|Overall Study|Medication error|1|||
128787399|NCT01456936|463514558|FG002|Overall Study|Medication error|0|||
128787400|NCT01456936|463514559|FG003|Overall Study|Medication error|1|||
128787401|NCT01456936|463514556|FG000|Overall Study|Adverse event (study drug)|25|||
128787402|NCT01456936|463514557|FG001|Overall Study|Adverse event (study drug)|21|||
128787403|NCT01456936|463514558|FG002|Overall Study|Adverse event (study drug)|26|||
128787404|NCT01456936|463514559|FG003|Overall Study|Adverse event (study drug)|17|||
128787405|NCT01456936|463514556|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
128787406|NCT01456936|463514557|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
128787407|NCT01456936|463514558|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
128787408|NCT01456936|463514559|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
128787409|NCT01456936|463514556|FG000|Overall Study|Death|0|||
128787410|NCT01456936|463514557|FG001|Overall Study|Death|3|||
128787411|NCT01456936|463514558|FG002|Overall Study|Death|1|||
128787412|NCT01456936|463514559|FG003|Overall Study|Death|3|||
128787413|NCT01456936|463514556|FG000|Overall Study|Randomized but not treated|21|||
128787414|NCT01456936|463514557|FG001|Overall Study|Randomized but not treated|28|||
128787415|NCT01456936|463514558|FG002|Overall Study|Randomized but not treated|16|||
128787416|NCT01456936|463514559|FG003|Overall Study|Randomized but not treated|21|||
128787417|NCT01710514|463514561|FG000|Overall Study|Adverse Event|6|||
128757698|NCT00636610|463399901|FG001|Overall Study|Adverse Event|4|||
128757699|NCT00636610|463399900|FG000|Overall Study|Death|6|||
128787418|NCT01710514|463514562|FG001|Overall Study|Adverse Event|7|||
128787419|NCT01710514|463514561|FG000|Overall Study|Withdrawal by Subject|1|||
128787420|NCT01710514|463514562|FG001|Overall Study|Withdrawal by Subject|0|||
128787421|NCT02846415|463514563|FG000|Overall Study|Lost to Follow-up|2|||
128787422|NCT02846415|463514564|FG001|Overall Study|Lost to Follow-up|0|||
128787423|NCT02846415|463514563|FG000|Overall Study|Withdrawal by Subject|1|||
128787424|NCT02846415|463514564|FG001|Overall Study|Withdrawal by Subject|1|||
128787425|NCT03383887|463514565|FG000|Overall Study|Lost to Follow-up|0|||
128787426|NCT03383887|463514566|FG001|Overall Study|Lost to Follow-up|1|||
128787427|NCT00831792|463514567|FG000|Overall Study|Not Eligible|3|||
128787428|NCT00831792|463514567|FG000|Overall Study|Adverse Event|1|||
128787429|NCT00831792|463514567|FG000|Overall Study|Death|1|||
128787430|NCT00831792|463514567|FG000|Overall Study|Lack of Efficacy|1|||
128787431|NCT01242085|463514570|FG000|Overall Study|Withdrawal by Subject|4|||
128787432|NCT01242085|463514571|FG001|Overall Study|Withdrawal by Subject|2|||
128787433|NCT01242085|463514572|FG002|Overall Study|Withdrawal by Subject|0|||
128787434|NCT01242085|463514570|FG000|Overall Study|medically unable to have surgery|4|||
128787435|NCT01242085|463514571|FG001|Overall Study|medically unable to have surgery|5|||
128787436|NCT01242085|463514572|FG002|Overall Study|medically unable to have surgery|0|||
128787437|NCT02469064|463514579|FG000|Overall Study|Request not to receive intervention.|1|||
128787438|NCT02469064|463514580|FG001|Overall Study|Request not to receive intervention.|3|||
128787439|NCT02155829|463514581|FG000|Overall Study|Adverse Event|1|||
128787440|NCT02155829|463514582|FG001|Overall Study|Adverse Event|0|||
128787441|NCT02155829|463514581|FG000|Overall Study|Withdrawal by Subject|3|||
128787442|NCT02155829|463514582|FG001|Overall Study|Withdrawal by Subject|3|||
128787443|NCT02155829|463514581|FG000|Overall Study|Protocol Violation|2|||
128787444|NCT02155829|463514582|FG001|Overall Study|Protocol Violation|0|||
128787445|NCT00678795|463514583|FG000|Overall Study|Adverse Event|7|||
128787446|NCT00678795|463514584|FG001|Overall Study|Adverse Event|3|||
128787447|NCT00678795|463514583|FG000|Overall Study|Withdrawal by Subject|3|||
128787448|NCT00678795|463514584|FG001|Overall Study|Withdrawal by Subject|0|||
128787449|NCT00678795|463514583|FG000|Overall Study|Protocol Violation|0|||
128787450|NCT00678795|463514584|FG001|Overall Study|Protocol Violation|1|||
128787451|NCT00678795|463514583|FG000|Overall Study|Lost to Follow-up|0|||
128787452|NCT00678795|463514584|FG001|Overall Study|Lost to Follow-up|1|||
128787453|NCT00678795|463514583|FG000|Overall Study|Lack of Efficacy|1|||
128787454|NCT00678795|463514584|FG001|Overall Study|Lack of Efficacy|1|||
128787455|NCT00404079|463514585|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
128787456|NCT00404079|463514586|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
128787457|NCT01120275|463514587|FG000|Overall Study|Adverse Event|3|||
128787458|NCT01120275|463514587|FG000|Overall Study|Progression|27|||
128787459|NCT01120275|463514587|FG000|Overall Study|Ineligible|3|||
128757700|NCT00636610|463399901|FG001|Overall Study|Death|3|||
128757701|NCT00636610|463399900|FG000|Overall Study|Physician decision to withdraw patient|15|||
128757702|NCT00636610|463399901|FG001|Overall Study|Physician decision to withdraw patient|9|||
128787460|NCT01120275|463514587|FG000|Overall Study|Withdrawal by Subject|1|||
128787461|NCT01120275|463514587|FG000|Overall Study|Refusal|1|||
128787462|NCT01120275|463514587|FG000|Overall Study|Not specific|1|||
128787463|NCT00880906|463514590|FG000|Overall Study|Lost to Follow-up|0|||
128787464|NCT00880906|463514591|FG001|Overall Study|Lost to Follow-up|1|||
128787465|NCT00880906|463514590|FG000|Overall Study|Did not meet criteria following patholog|12|||
128787466|NCT00880906|463514591|FG001|Overall Study|Did not meet criteria following patholog|6|||
128787467|NCT00559949|463514598|FG000|Overall Study|Progressive Disease during cycle 1|1|||
128787468|NCT00559949|463514598|FG000|Overall Study|Adverse Event|1|||
128787469|NCT00559949|463514598|FG000|Overall Study|Withdrawal by Subject|4|||
128787470|NCT00559949|463514598|FG000|Overall Study|No disease evaluation per protocol|1|||
128787471|NCT02596035|463514599|FG000|Overall Study|Disease Progression|64|||
128787472|NCT02596035|463514600|FG001|Overall Study|Disease Progression|32|||
128787473|NCT02596035|463514601|FG002|Overall Study|Disease Progression|1|||
128787474|NCT02596035|463514599|FG000|Overall Study|study drug toxicity|12|||
128787475|NCT02596035|463514600|FG001|Overall Study|study drug toxicity|3|||
128787476|NCT02596035|463514601|FG002|Overall Study|study drug toxicity|0|||
128787477|NCT02596035|463514599|FG000|Overall Study|AE unrelated to study drug|5|||
128787478|NCT02596035|463514600|FG001|Overall Study|AE unrelated to study drug|2|||
128787479|NCT02596035|463514601|FG002|Overall Study|AE unrelated to study drug|0|||
128787480|NCT02596035|463514599|FG000|Overall Study|participant request to discontinue study treatment|2|||
128787481|NCT02596035|463514600|FG001|Overall Study|participant request to discontinue study treatment|0|||
128787482|NCT02596035|463514601|FG002|Overall Study|participant request to discontinue study treatment|0|||
128787483|NCT02596035|463514599|FG000|Overall Study|participant withdrew consent|2|||
128787484|NCT02596035|463514600|FG001|Overall Study|participant withdrew consent|2|||
128787485|NCT02596035|463514601|FG002|Overall Study|participant withdrew consent|0|||
128787486|NCT02596035|463514599|FG000|Overall Study|Poor/Non Comlpiance|0|||
128787487|NCT02596035|463514600|FG001|Overall Study|Poor/Non Comlpiance|1|||
128787488|NCT02596035|463514601|FG002|Overall Study|Poor/Non Comlpiance|0|||
128787489|NCT02596035|463514599|FG000|Overall Study|participant no longer meets study criteria|1|||
128757703|NCT00636610|463399900|FG000|Overall Study|Subject decision to withdraw|15|||
128757704|NCT00636610|463399901|FG001|Overall Study|Subject decision to withdraw|11|||
128757705|NCT00636610|463399900|FG000|Overall Study|Disease progression - radiographic|41|||
128757706|NCT00636610|463399901|FG001|Overall Study|Disease progression - radiographic|51|||
128757707|NCT00636610|463399900|FG000|Overall Study|Disease progression - clinical|8|||
128757708|NCT00636610|463399901|FG001|Overall Study|Disease progression - clinical|3|||
128787490|NCT02596035|463514600|FG001|Overall Study|participant no longer meets study criteria|0|||
128787491|NCT02596035|463514601|FG002|Overall Study|participant no longer meets study criteria|0|||
128787492|NCT02596035|463514599|FG000|Overall Study|other reasons|11|||
128787493|NCT02596035|463514600|FG001|Overall Study|other reasons|4|||
128787494|NCT02596035|463514601|FG002|Overall Study|other reasons|0|||
128787495|NCT00414648|463514602|FG000|Overall Study|Adverse Event|5|||
128787496|NCT00414648|463514603|FG001|Overall Study|Adverse Event|5|||
128787497|NCT00414648|463514602|FG000|Overall Study|Death|0|||
128787498|NCT00414648|463514603|FG001|Overall Study|Death|1|||
128787499|NCT00414648|463514602|FG000|Overall Study|Lack of Efficacy|0|||
128787500|NCT00414648|463514603|FG001|Overall Study|Lack of Efficacy|2|||
128787501|NCT00414648|463514602|FG000|Overall Study|Withdrawal by Subject|0|||
128787502|NCT00414648|463514603|FG001|Overall Study|Withdrawal by Subject|1|||
128787503|NCT01235949|463514608|FG000|Primary Phase|Migrated/moved from study area|1|||
128757709|NCT00636610|463399900|FG000|Overall Study|Reason for discontinuation not available|3|||
128757710|NCT00636610|463399901|FG001|Overall Study|Reason for discontinuation not available|2|||
128757711|NCT00553696|463399909|FG000|Overall Study|Adverse Event|2|||
128757712|NCT00553696|463399910|FG001|Overall Study|Adverse Event|4|||
128757713|NCT00553696|463399911|FG002|Overall Study|Adverse Event|0|||
128757714|NCT00553696|463399912|FG003|Overall Study|Adverse Event|1|||
128757715|NCT00553696|463399909|FG000|Overall Study|Global deterioration of health status|0|||
128757716|NCT00553696|463399910|FG001|Overall Study|Global deterioration of health status|2|||
128787504|NCT01235949|463514609|FG001|Primary Phase|Migrated/moved from study area|1|||
128757717|NCT00553696|463399911|FG002|Overall Study|Global deterioration of health status|0|||
128757718|NCT00553696|463399912|FG003|Overall Study|Global deterioration of health status|0|||
128757719|NCT00553696|463399909|FG000|Overall Study|Objective progression or relapse|2|||
128757720|NCT00553696|463399910|FG001|Overall Study|Objective progression or relapse|9|||
128757721|NCT00553696|463399911|FG002|Overall Study|Objective progression or relapse|6|||
128757722|NCT00553696|463399912|FG003|Overall Study|Objective progression or relapse|0|||
128757723|NCT00553696|463399909|FG000|Overall Study|Withdrawal by Subject|0|||
128757724|NCT00553696|463399910|FG001|Overall Study|Withdrawal by Subject|1|||
128757725|NCT00553696|463399911|FG002|Overall Study|Withdrawal by Subject|0|||
128757726|NCT00553696|463399912|FG003|Overall Study|Withdrawal by Subject|0|||
128757727|NCT02170025|463399913|FG000|Overall Study|Adverse Event|2|||
128757728|NCT02170025|463399914|FG001|Overall Study|Adverse Event|0|||
128757729|NCT00572195|463399915|FG000|Overall Study|Withdrawal by Subject|50|||
128757730|NCT00572195|463399915|FG000|Overall Study|Death|9|||
128757731|NCT00572195|463399915|FG000|Overall Study|Adverse Event|4|||
128757732|NCT00572195|463399915|FG000|Overall Study|Lost to Follow-up|5|||
128757733|NCT04981678|463399916|FG000|Overall Study|Lost to Follow-up|0|||
128757734|NCT04981678|463399917|FG001|Overall Study|Lost to Follow-up|1|||
128757735|NCT02532179|463402055|FG000|Overall Study|Lost to Follow-up|1|||
128757736|NCT02532179|463402055|FG000|Overall Study|Pregnancy|1|||
128757737|NCT02532179|463402055|FG000|Overall Study|Subject received depot steroid injection|1|||
128757738|NCT04128293|463402064|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
128757739|NCT04128293|463402065|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
128757740|NCT04128293|463402066|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
128757741|NCT04128293|463402067|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
128757742|NCT03597568|463402072|FG000|Overall Study|Withdrawal by Subject|1|||
128757743|NCT03597568|463402073|FG001|Overall Study|Withdrawal by Subject|1|||
128757744|NCT03597568|463402072|FG000|Overall Study|Unable to analyze vascular data|1|||
128757745|NCT03597568|463402073|FG001|Overall Study|Unable to analyze vascular data|1|||
128757746|NCT01357616|463402074|FG000|Overall Study|Adverse Event|1|||
128757747|NCT01357616|463402075|FG001|Overall Study|Adverse Event|1|||
128757748|NCT01357616|463402074|FG000|Overall Study|Lost to Follow-up|4|||
128757749|NCT01357616|463402075|FG001|Overall Study|Lost to Follow-up|3|||
128757750|NCT01357616|463402074|FG000|Overall Study|Protocol Violation|0|||
128757751|NCT01357616|463402075|FG001|Overall Study|Protocol Violation|2|||
128757752|NCT01357616|463402074|FG000|Overall Study|Inadequate Control of IOP|1|||
128757753|NCT01357616|463402075|FG001|Overall Study|Inadequate Control of IOP|2|||
128757754|NCT01357616|463402074|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
128757755|NCT01357616|463402075|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
128757756|NCT01357616|463402074|FG000|Overall Study|Withdrawal by Subject|1|||
128757757|NCT01357616|463402075|FG001|Overall Study|Withdrawal by Subject|0|||
128757758|NCT01699022|463402081|FG000|Overall Study|Early discontinuation from the study|3|||
128757759|NCT02052310|463402082|FG000|Overall Study|Death|64|||
128757760|NCT02052310|463402083|FG001|Overall Study|Death|54|||
128787505|NCT01235949|463514610|FG002|Primary Phase|Migrated/moved from study area|0|||
128757761|NCT02052310|463402082|FG000|Overall Study|Withdrawal by Subject|37|||
128757762|NCT02052310|463402083|FG001|Overall Study|Withdrawal by Subject|49|||
128757763|NCT02052310|463402082|FG000|Overall Study|Other than specified|32|||
128757764|NCT02052310|463402083|FG001|Overall Study|Other than specified|29|||
128757765|NCT02052310|463402082|FG000|Overall Study|Adverse Event|29|||
128757766|NCT02052310|463402083|FG001|Overall Study|Adverse Event|22|||
128757767|NCT02052310|463402082|FG000|Overall Study|Kidney Transplant|23|||
128757768|NCT02052310|463402083|FG001|Overall Study|Kidney Transplant|29|||
128757769|NCT02052310|463402082|FG000|Overall Study|Physician Decision|14|||
128757770|NCT02052310|463402083|FG001|Overall Study|Physician Decision|7|||
128757771|NCT02052310|463402082|FG000|Overall Study|Lack of Efficacy|6|||
128757772|NCT02052310|463402083|FG001|Overall Study|Lack of Efficacy|1|||
128757773|NCT02052310|463402082|FG000|Overall Study|Site Terminated by Sponsor|5|||
128757774|NCT02052310|463402083|FG001|Overall Study|Site Terminated by Sponsor|13|||
128757775|NCT02052310|463402082|FG000|Overall Study|Lost to Follow-up|4|||
128757776|NCT02052310|463402083|FG001|Overall Study|Lost to Follow-up|2|||
128757777|NCT02052310|463402082|FG000|Overall Study|Protocol Violation|1|||
128757778|NCT02052310|463402083|FG001|Overall Study|Protocol Violation|6|||
128757779|NCT02066402|463402086|FG000|Overall Study|Adverse Event|1|||
128757780|NCT02066402|463402087|FG001|Overall Study|Adverse Event|2|||
128757781|NCT02066402|463402086|FG000|Overall Study|Lost to Follow-up|11|||
128757782|NCT02066402|463402087|FG001|Overall Study|Lost to Follow-up|8|||
128757783|NCT02066402|463402086|FG000|Overall Study|Withdrawal by Subject|14|||
128757784|NCT02066402|463402087|FG001|Overall Study|Withdrawal by Subject|11|||
128757785|NCT02066402|463402086|FG000|Overall Study|Progressive disease-clinical progression|0|||
128757786|NCT02066402|463402087|FG001|Overall Study|Progressive disease-clinical progression|1|||
128757787|NCT02066402|463402086|FG000|Overall Study|Protocol driven decision point|0|||
128757788|NCT02066402|463402087|FG001|Overall Study|Protocol driven decision point|1|||
128757789|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
128757790|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
128757791|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
128757792|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
128757793|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
128757794|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
128757795|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
128757796|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
128757797|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Other|18|||
128757798|NCT02565914|463402088|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
128757799|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
128757800|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Other|1|||
128757801|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
128757802|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
128757803|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
128757804|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
128757805|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
128757806|NCT02565914|463402088|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
128757807|NCT02565914|463402088|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
128757808|NCT02565914|463402088|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
128757809|NCT02565914|463402088|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
128757810|NCT02565914|463402088|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
128757811|NCT02565914|463402088|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
128757812|NCT02565914|463402088|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
128757813|NCT01505387|463402089|FG000|Overall Study|Protocol Violation|1|||
128757814|NCT01505387|463402090|FG001|Overall Study|Protocol Violation|0|||
128757815|NCT01505387|463402089|FG000|Overall Study|Withdrawal by Subject|1|||
128757816|NCT01505387|463402090|FG001|Overall Study|Withdrawal by Subject|1|||
128757817|NCT01197508|463402097|FG000|Overall Study|Withdrawal by Subject|8|||
128757818|NCT01197508|463402098|FG001|Overall Study|Withdrawal by Subject|7|||
128757819|NCT01197508|463402099|FG002|Overall Study|Withdrawal by Subject|15|||
128757820|NCT01197508|463402100|FG003|Overall Study|Withdrawal by Subject|4|||
128757821|NCT01197508|463402097|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
128757822|NCT01197508|463402098|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
128757823|NCT01197508|463402099|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
128757824|NCT01197508|463402100|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
128757825|NCT01197508|463402097|FG000|Overall Study|Adverse Event|10|||
128757826|NCT01197508|463402098|FG001|Overall Study|Adverse Event|13|||
128757827|NCT01197508|463402099|FG002|Overall Study|Adverse Event|23|||
128757828|NCT01197508|463402100|FG003|Overall Study|Adverse Event|3|||
128757829|NCT01197508|463402097|FG000|Overall Study|Severe non-compliance to protocol|0|||
128757830|NCT01197508|463402098|FG001|Overall Study|Severe non-compliance to protocol|3|||
128757831|NCT01197508|463402099|FG002|Overall Study|Severe non-compliance to protocol|1|||
128757832|NCT01197508|463402100|FG003|Overall Study|Severe non-compliance to protocol|3|||
128757833|NCT01197508|463402097|FG000|Overall Study|Condition under investigation worsened|1|||
128757834|NCT01197508|463402098|FG001|Overall Study|Condition under investigation worsened|1|||
128757835|NCT01197508|463402099|FG002|Overall Study|Condition under investigation worsened|1|||
128757836|NCT01197508|463402100|FG003|Overall Study|Condition under investigation worsened|1|||
128757837|NCT01197508|463402097|FG000|Overall Study|Lack of Efficacy|1|||
128757838|NCT01197508|463402098|FG001|Overall Study|Lack of Efficacy|2|||
128757839|NCT01197508|463402099|FG002|Overall Study|Lack of Efficacy|2|||
128757840|NCT01197508|463402100|FG003|Overall Study|Lack of Efficacy|1|||
128757841|NCT01197508|463402097|FG000|Overall Study|Study-specific withdrawal criteria|0|||
128757842|NCT01197508|463402098|FG001|Overall Study|Study-specific withdrawal criteria|0|||
128757843|NCT01197508|463402099|FG002|Overall Study|Study-specific withdrawal criteria|1|||
128757844|NCT01197508|463402100|FG003|Overall Study|Study-specific withdrawal criteria|2|||
128757845|NCT01197508|463402097|FG000|Overall Study|Lost to Follow-up|1|||
128757846|NCT01197508|463402098|FG001|Overall Study|Lost to Follow-up|1|||
128757847|NCT01197508|463402099|FG002|Overall Study|Lost to Follow-up|2|||
128757848|NCT01197508|463402100|FG003|Overall Study|Lost to Follow-up|0|||
128757849|NCT01197508|463402097|FG000|Overall Study|Other|2|||
128757850|NCT01197508|463402098|FG001|Overall Study|Other|3|||
128757851|NCT01197508|463402099|FG002|Overall Study|Other|2|||
128757852|NCT01197508|463402100|FG003|Overall Study|Other|2|||
128757853|NCT00266825|463402101|FG000|Completed Follow-Up|Lost to Follow-up|14|||
128757854|NCT00266825|463402102|FG001|Completed Follow-Up|Lost to Follow-up|19|||
128757855|NCT00266825|463402101|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
128757856|NCT00266825|463402102|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
128757857|NCT01301391|463402105|FG000|Overall Study|Death|13|||
128757858|NCT01301391|463402105|FG000|Overall Study|Lost to Follow-up|3|||
128757859|NCT01301391|463402105|FG000|Overall Study|Physician Decision|2|||
128757860|NCT01301391|463402105|FG000|Overall Study|Sponsor's decision|8|||
128757861|NCT02799784|463402109|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
128757862|NCT02799784|463402110|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
128757863|NCT02799784|463402109|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
128757864|NCT02799784|463402110|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
128757865|NCT02799784|463402109|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
128757866|NCT02799784|463402110|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
128757867|NCT02799784|463402109|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
128757868|NCT02799784|463402110|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
128757869|NCT02799784|463402109|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
128757870|NCT02799784|463402110|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
128757871|NCT02799784|463402109|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
128757872|NCT02799784|463402110|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
128757873|NCT03466086|463402111|FG000|Period 1|Sponsor decision due to study timeline|1|||
128757874|NCT03466086|463402112|FG001|Period 1|Sponsor decision due to study timeline|0|||
128757875|NCT03466086|463402111|FG000|Period 1|Withdrawal by Subject|1|||
128757876|NCT03466086|463402112|FG001|Period 1|Withdrawal by Subject|0|||
128757877|NCT00595504|463402113|FG000|Overall Study|Withdrawal by Subject|1|||
128757878|NCT00595504|463402114|FG001|Overall Study|Withdrawal by Subject|3|||
128757879|NCT00595504|463402113|FG000|Overall Study|Physician Decision|1|||
128757880|NCT00595504|463402114|FG001|Overall Study|Physician Decision|0|||
128757881|NCT01949870|463402116|FG000|Overall Study|Lack of Efficacy|2|||
128757882|NCT01949870|463402116|FG000|Overall Study|Adverse Event|1|||
128757883|NCT01949870|463402116|FG000|Overall Study|Study termination|1|||
128757884|NCT01949870|463402116|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
128757885|NCT02570126|463402117|FG000|Overall Study|Lost to Follow-up|2|||
128757886|NCT02570126|463402118|FG001|Overall Study|Lost to Follow-up|0|||
128757887|NCT02570126|463402117|FG000|Overall Study|Unable To Arrange Visit 3|1|||
128757888|NCT02570126|463402118|FG001|Overall Study|Unable To Arrange Visit 3|0|||
128757889|NCT02570126|463402117|FG000|Overall Study|Violation Of Procedures GSK|0|||
128757890|NCT02570126|463402118|FG001|Overall Study|Violation Of Procedures GSK|1|||
128757891|NCT02570126|463402117|FG000|Overall Study|Protocol Violation|0|||
128757892|NCT02570126|463402118|FG001|Overall Study|Protocol Violation|1|||
128757893|NCT02570126|463402117|FG000|Overall Study|Withdrawal by Subject|3|||
128757894|NCT02570126|463402118|FG001|Overall Study|Withdrawal by Subject|7|||
128757895|NCT00754338|463402119|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
128757896|NCT00754338|463402120|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
128757897|NCT00754338|463402121|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
128757898|NCT00754338|463402122|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
128757899|NCT00754338|463402119|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
128757900|NCT00754338|463402120|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
128757901|NCT00754338|463402121|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
128787506|NCT01235949|463514611|FG003|Primary Phase|Migrated/moved from study area|0|||
128787507|NCT01235949|463514612|FG004|Primary Phase|Migrated/moved from study area|1|||
128787508|NCT01235949|463514613|FG005|Primary Phase|Migrated/moved from study area|2|||
128787509|NCT01235949|463514614|FG006|Primary Phase|Migrated/moved from study area|0|||
128787510|NCT01235949|463514615|FG007|Primary Phase|Migrated/moved from study area|0|||
128787511|NCT01235949|463514616|FG008|Primary Phase|Migrated/moved from study area|0|||
128787512|NCT01235949|463514617|FG009|Primary Phase|Migrated/moved from study area|0|||
128787513|NCT01235949|463514618|FG010|Primary Phase|Migrated/moved from study area|0|||
128787514|NCT01235949|463514619|FG011|Primary Phase|Migrated/moved from study area|0|||
128787515|NCT01235949|463514620|FG012|Primary Phase|Migrated/moved from study area|0|||
128787516|NCT01235949|463514621|FG013|Primary Phase|Migrated/moved from study area|0|||
128787517|NCT01235949|463514622|FG014|Primary Phase|Migrated/moved from study area|0|||
128787518|NCT01235949|463514623|FG015|Primary Phase|Migrated/moved from study area|0|||
128787519|NCT01235949|463514624|FG016|Primary Phase|Migrated/moved from study area|0|||
128787520|NCT01235949|463514625|FG017|Primary Phase|Migrated/moved from study area|0|||
128787521|NCT01235949|463514608|FG000|Primary Phase|Adverse Event|0|||
128787522|NCT01235949|463514609|FG001|Primary Phase|Adverse Event|0|||
128787523|NCT01235949|463514610|FG002|Primary Phase|Adverse Event|0|||
128787524|NCT01235949|463514611|FG003|Primary Phase|Adverse Event|1|||
128787525|NCT01235949|463514612|FG004|Primary Phase|Adverse Event|0|||
128787526|NCT01235949|463514613|FG005|Primary Phase|Adverse Event|0|||
128787527|NCT01235949|463514614|FG006|Primary Phase|Adverse Event|0|||
128787528|NCT01235949|463514615|FG007|Primary Phase|Adverse Event|0|||
128787529|NCT01235949|463514616|FG008|Primary Phase|Adverse Event|0|||
128787530|NCT01235949|463514617|FG009|Primary Phase|Adverse Event|0|||
128787531|NCT01235949|463514618|FG010|Primary Phase|Adverse Event|0|||
128787532|NCT01235949|463514619|FG011|Primary Phase|Adverse Event|0|||
128787533|NCT01235949|463514620|FG012|Primary Phase|Adverse Event|0|||
128787534|NCT01235949|463514621|FG013|Primary Phase|Adverse Event|0|||
128787535|NCT01235949|463514622|FG014|Primary Phase|Adverse Event|0|||
128757902|NCT00754338|463402122|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
128757903|NCT00677352|463402123|FG000|Treatment Phase|Adverse Event|14|||
128787536|NCT01235949|463514623|FG015|Primary Phase|Adverse Event|0|||
128787537|NCT01235949|463514624|FG016|Primary Phase|Adverse Event|0|||
128787538|NCT01235949|463514625|FG017|Primary Phase|Adverse Event|0|||
128787539|NCT01235949|463514608|FG000|Primary Phase|Withdrawal by Subject|3|||
128787540|NCT01235949|463514609|FG001|Primary Phase|Withdrawal by Subject|2|||
128787541|NCT01235949|463514610|FG002|Primary Phase|Withdrawal by Subject|2|||
128787542|NCT01235949|463514611|FG003|Primary Phase|Withdrawal by Subject|0|||
128757904|NCT00677352|463402124|FG001|Treatment Phase|Adverse Event|22|||
128757905|NCT00677352|463402123|FG000|Treatment Phase|Lack of Efficacy|2|||
128757906|NCT00677352|463402124|FG001|Treatment Phase|Lack of Efficacy|3|||
128757907|NCT00677352|463402123|FG000|Treatment Phase|Lost to Follow-up|0|||
128757908|NCT00677352|463402124|FG001|Treatment Phase|Lost to Follow-up|1|||
128757909|NCT00677352|463402123|FG000|Treatment Phase|Withdrawal by Subject|7|||
128757910|NCT00677352|463402124|FG001|Treatment Phase|Withdrawal by Subject|7|||
128757911|NCT00677352|463402123|FG000|Treatment Phase|Physician Decision|1|||
128757912|NCT00677352|463402124|FG001|Treatment Phase|Physician Decision|0|||
128757913|NCT00677352|463402123|FG000|Treatment Phase|Pregnancy|0|||
128757914|NCT00677352|463402124|FG001|Treatment Phase|Pregnancy|1|||
128757915|NCT00677352|463402123|FG000|Treatment Phase|Protocol Violation|1|||
128757916|NCT00677352|463402124|FG001|Treatment Phase|Protocol Violation|1|||
128757917|NCT00677352|463402123|FG000|Treatment Phase|Transference or work related matter|0|||
128757918|NCT00677352|463402124|FG001|Treatment Phase|Transference or work related matter|5|||
128757919|NCT00677352|463402123|FG000|Treatment Phase|Not treated|0|||
128757920|NCT00677352|463402124|FG001|Treatment Phase|Not treated|2|||
128757921|NCT00677352|463402123|FG000|Tapering Phase|Adverse Event|1|||
128757922|NCT00677352|463402124|FG001|Tapering Phase|Adverse Event|5|||
128757923|NCT00677352|463402123|FG000|Tapering Phase|Withdrawal by Subject|5|||
128757924|NCT00677352|463402124|FG001|Tapering Phase|Withdrawal by Subject|3|||
128757925|NCT00677352|463402123|FG000|Tapering Phase|Pregnancy|0|||
128757926|NCT00677352|463402124|FG001|Tapering Phase|Pregnancy|1|||
128757927|NCT00677352|463402123|FG000|Tapering Phase|Job transfer|0|||
128757928|NCT00677352|463402124|FG001|Tapering Phase|Job transfer|1|||
128757929|NCT02182973|463402131|FG000|Overall Study|Withdrawal by Subject|3|||
128757930|NCT02182973|463402132|FG001|Overall Study|Withdrawal by Subject|0|||
128757931|NCT01235546|463402134|FG000|Overall Study|Staff error, medication not administered|1|||
128757932|NCT01235546|463402135|FG001|Overall Study|Staff error, medication not administered|0|||
128757933|NCT01235546|463402134|FG000|Overall Study|Protocol Violation|1|||
128757934|NCT01235546|463402135|FG001|Overall Study|Protocol Violation|1|||
128757935|NCT01123382|463402136|FG000|Overall Study|Withdrawal by Subject|1|||
128757936|NCT01123382|463402137|FG001|Overall Study|Withdrawal by Subject|4|||
128757937|NCT01123382|463402136|FG000|Overall Study|Lost to Follow-up|1|||
128757938|NCT01123382|463402137|FG001|Overall Study|Lost to Follow-up|2|||
128757939|NCT02740049|463402138|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
128757940|NCT01256411|463402139|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
128757941|NCT01256411|463402140|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
128757942|NCT01256411|463402141|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
128757943|NCT01256411|463402142|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
128787543|NCT01235949|463514612|FG004|Primary Phase|Withdrawal by Subject|0|||
128757944|NCT01256411|463402143|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
128757945|NCT01256411|463402144|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
128757946|NCT01256411|463402139|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
128757947|NCT01256411|463402140|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
128757948|NCT01256411|463402141|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
128757949|NCT01256411|463402142|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
128757950|NCT01256411|463402143|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
128757951|NCT01256411|463402144|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
128757952|NCT01256411|463402139|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
128757953|NCT01256411|463402140|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
128757954|NCT01256411|463402141|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
128757955|NCT01256411|463402142|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
128757956|NCT01256411|463402143|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
128757957|NCT01256411|463402144|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
128757958|NCT01256411|463402139|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
128757959|NCT01256411|463402140|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
128757960|NCT01256411|463402141|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
128757961|NCT01256411|463402142|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
128757962|NCT01256411|463402143|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
128757963|NCT01256411|463402144|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
128757964|NCT01256411|463402139|FG000|Extension by Maximum Treatment|Adverse Event|4|||
128757965|NCT01256411|463402140|FG001|Extension by Maximum Treatment|Adverse Event|2|||
128757966|NCT01256411|463402141|FG002|Extension by Maximum Treatment|Adverse Event|1|||
128757967|NCT01256411|463402142|FG003|Extension by Maximum Treatment|Adverse Event|0|||
128757968|NCT01256411|463402143|FG004|Extension by Maximum Treatment|Adverse Event|0|||
128757969|NCT01256411|463402144|FG005|Extension by Maximum Treatment|Adverse Event|0|||
128757970|NCT01256411|463402139|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
128757971|NCT01256411|463402140|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
128757972|NCT01256411|463402141|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
128757973|NCT01256411|463402142|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
128787544|NCT01235949|463514613|FG005|Primary Phase|Withdrawal by Subject|3|||
128787545|NCT01235949|463514614|FG006|Primary Phase|Withdrawal by Subject|0|||
128787546|NCT01235949|463514615|FG007|Primary Phase|Withdrawal by Subject|0|||
128787547|NCT01235949|463514616|FG008|Primary Phase|Withdrawal by Subject|0|||
128787548|NCT01235949|463514617|FG009|Primary Phase|Withdrawal by Subject|0|||
128787549|NCT01235949|463514618|FG010|Primary Phase|Withdrawal by Subject|0|||
128787550|NCT01235949|463514619|FG011|Primary Phase|Withdrawal by Subject|0|||
128787551|NCT01235949|463514620|FG012|Primary Phase|Withdrawal by Subject|0|||
128787552|NCT01235949|463514621|FG013|Primary Phase|Withdrawal by Subject|0|||
128787553|NCT01235949|463514622|FG014|Primary Phase|Withdrawal by Subject|0|||
128787554|NCT01235949|463514623|FG015|Primary Phase|Withdrawal by Subject|0|||
128787555|NCT01235949|463514624|FG016|Primary Phase|Withdrawal by Subject|0|||
128787556|NCT01235949|463514625|FG017|Primary Phase|Withdrawal by Subject|0|||
128787557|NCT01235949|463514608|FG000|Primary Phase|Lost to Follow-up|0|||
128787558|NCT01235949|463514609|FG001|Primary Phase|Lost to Follow-up|0|||
128787559|NCT01235949|463514610|FG002|Primary Phase|Lost to Follow-up|1|||
128787560|NCT01235949|463514611|FG003|Primary Phase|Lost to Follow-up|1|||
128787561|NCT01235949|463514612|FG004|Primary Phase|Lost to Follow-up|0|||
128787562|NCT01235949|463514613|FG005|Primary Phase|Lost to Follow-up|2|||
128787563|NCT01235949|463514614|FG006|Primary Phase|Lost to Follow-up|0|||
128787564|NCT01235949|463514615|FG007|Primary Phase|Lost to Follow-up|0|||
128787565|NCT01235949|463514616|FG008|Primary Phase|Lost to Follow-up|0|||
128787566|NCT01235949|463514617|FG009|Primary Phase|Lost to Follow-up|0|||
128787567|NCT01235949|463514618|FG010|Primary Phase|Lost to Follow-up|0|||
128787568|NCT01235949|463514619|FG011|Primary Phase|Lost to Follow-up|0|||
128787569|NCT01235949|463514620|FG012|Primary Phase|Lost to Follow-up|0|||
128787570|NCT01235949|463514621|FG013|Primary Phase|Lost to Follow-up|0|||
128787571|NCT01235949|463514622|FG014|Primary Phase|Lost to Follow-up|0|||
128787572|NCT01235949|463514623|FG015|Primary Phase|Lost to Follow-up|0|||
128787573|NCT01235949|463514624|FG016|Primary Phase|Lost to Follow-up|0|||
128787574|NCT01235949|463514625|FG017|Primary Phase|Lost to Follow-up|0|||
128787575|NCT01235949|463514608|FG000|Booster Phase|Migrated/moved from study area|0|||
128787576|NCT01235949|463514609|FG001|Booster Phase|Migrated/moved from study area|0|||
128787577|NCT01235949|463514610|FG002|Booster Phase|Migrated/moved from study area|0|||
128787578|NCT01235949|463514611|FG003|Booster Phase|Migrated/moved from study area|0|||
128787579|NCT01235949|463514612|FG004|Booster Phase|Migrated/moved from study area|0|||
128787580|NCT01235949|463514613|FG005|Booster Phase|Migrated/moved from study area|0|||
128787581|NCT01235949|463514614|FG006|Booster Phase|Migrated/moved from study area|0|||
128787582|NCT01235949|463514615|FG007|Booster Phase|Migrated/moved from study area|0|||
128787583|NCT01235949|463514616|FG008|Booster Phase|Migrated/moved from study area|0|||
128787584|NCT01235949|463514617|FG009|Booster Phase|Migrated/moved from study area|0|||
128787585|NCT01235949|463514618|FG010|Booster Phase|Migrated/moved from study area|0|||
128757974|NCT01256411|463402143|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
128787586|NCT01235949|463514619|FG011|Booster Phase|Migrated/moved from study area|1|||
128787587|NCT01235949|463514620|FG012|Booster Phase|Migrated/moved from study area|1|||
128787588|NCT01235949|463514621|FG013|Booster Phase|Migrated/moved from study area|0|||
128787589|NCT01235949|463514622|FG014|Booster Phase|Migrated/moved from study area|0|||
128787590|NCT01235949|463514623|FG015|Booster Phase|Migrated/moved from study area|0|||
128787591|NCT01235949|463514624|FG016|Booster Phase|Migrated/moved from study area|0|||
128757975|NCT01256411|463402144|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
128757976|NCT01256411|463402139|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
128757977|NCT01256411|463402140|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
128757978|NCT01256411|463402141|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
128757979|NCT01256411|463402142|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
128757980|NCT01256411|463402143|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
128757981|NCT01256411|463402144|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
128757982|NCT01256411|463402139|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
128757983|NCT01256411|463402140|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
128757984|NCT01256411|463402141|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
128757985|NCT01256411|463402142|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
128757986|NCT01256411|463402143|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
128757987|NCT01256411|463402144|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
128757988|NCT01256411|463402139|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
128757989|NCT01256411|463402140|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
128757990|NCT01256411|463402141|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
128757991|NCT01256411|463402142|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
128757992|NCT01256411|463402143|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
128757993|NCT01256411|463402144|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
128757994|NCT01256411|463402139|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
128757995|NCT01256411|463402140|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
128757996|NCT01256411|463402141|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
128757997|NCT01256411|463402142|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
128757998|NCT01256411|463402143|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
128757999|NCT01256411|463402144|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
128758000|NCT02316769|463402145|FG000|Overall Study|Physician Decision|1|||
128758001|NCT02316769|463402146|FG001|Overall Study|Physician Decision|0|||
128758002|NCT02316769|463402145|FG000|Overall Study|Withdrawal by Subject|1|||
128758003|NCT02316769|463402146|FG001|Overall Study|Withdrawal by Subject|0|||
128758004|NCT01755702|463402147|FG000|Wash Out Period I|Other Reason|3|||
128758005|NCT01755702|463402147|FG000|Washout Period II|Other Reason|5|||
128758006|NCT00594854|463402148|FG000|Overall Study|Study terminated|7|||
128758007|NCT00594854|463402149|FG001|Overall Study|Study terminated|10|||
128758008|NCT03172702|463402150|FG000|Overall Study|Adverse Event|9|||
128758009|NCT03172702|463402150|FG000|Overall Study|Death|2|||
128758010|NCT03172702|463402150|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
128758011|NCT03172702|463402150|FG000|Overall Study|Withdrawal by Subject|5|||
128758012|NCT03172702|463402150|FG000|Overall Study|Other|2|||
128758013|NCT06134180|463402161|FG000|Overall Study|Lost to Follow-up|4|||
128758014|NCT02152982|463402162|FG000|Overall Study|Ineligible|4|||
128758015|NCT02152982|463402163|FG001|Overall Study|Ineligible|4|||
128758016|NCT02152982|463402162|FG000|Overall Study|Did not start treatment|12|||
128758017|NCT02152982|463402163|FG001|Overall Study|Did not start treatment|6|||
128758018|NCT02782169|463402167|FG000|Overall Study|Lost to Follow-up|1|||
128758019|NCT02782169|463402168|FG001|Overall Study|Lost to Follow-up|2|||
128758020|NCT00045305|463402172|FG000|Overall Study|Lack of Efficacy|6|||
128758021|NCT00045305|463402172|FG000|Overall Study|Adverse Event|3|||
128758022|NCT00045305|463402172|FG000|Overall Study|Death|3|||
128758023|NCT00045305|463402172|FG000|Overall Study|site error|2|||
128758024|NCT03848403|463402178|FG000|Period 2 (Day 8)|Adverse Event|1|||
128758025|NCT03848403|463402179|FG001|Period 2 (Day 8)|Adverse Event|2|||
128758026|NCT03848403|463402180|FG002|Period 2 (Day 8)|Adverse Event|2|||
128758027|NCT03848403|463402178|FG000|Period 2 (Day 8)|Physician Decision|0|||
128758028|NCT03848403|463402179|FG001|Period 2 (Day 8)|Physician Decision|1|||
128758029|NCT03848403|463402180|FG002|Period 2 (Day 8)|Physician Decision|0|||
128758030|NCT03848403|463402178|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
128758031|NCT03848403|463402179|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
128758032|NCT03848403|463402180|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
128758033|NCT01939548|463402181|FG000|Overall Study|Non compliance|0|||
128758034|NCT01939548|463402182|FG001|Overall Study|Non compliance|2|||
128758035|NCT01939548|463402183|FG002|Overall Study|Non compliance|0|||
128758036|NCT01939548|463402181|FG000|Overall Study|Study Terminated by Sponsor|17|||
128758037|NCT01939548|463402182|FG001|Overall Study|Study Terminated by Sponsor|19|||
128758038|NCT01939548|463402183|FG002|Overall Study|Study Terminated by Sponsor|12|||
128758039|NCT01939548|463402181|FG000|Overall Study|Insufficient Clinical Response|1|||
128758040|NCT01939548|463402182|FG001|Overall Study|Insufficient Clinical Response|0|||
128758041|NCT01939548|463402183|FG002|Overall Study|Insufficient Clinical Response|0|||
128758042|NCT01939548|463402181|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
128758043|NCT01939548|463402182|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
128758044|NCT01939548|463402183|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
128758045|NCT01939548|463402181|FG000|Overall Study|Withdrawal by Subject|4|||
128758046|NCT01939548|463402182|FG001|Overall Study|Withdrawal by Subject|4|||
128758047|NCT01939548|463402183|FG002|Overall Study|Withdrawal by Subject|1|||
128758048|NCT01939548|463402181|FG000|Overall Study|Protocol Violation|7|||
128758049|NCT01939548|463402182|FG001|Overall Study|Protocol Violation|6|||
128758050|NCT01939548|463402183|FG002|Overall Study|Protocol Violation|5|||
128758051|NCT01939548|463402181|FG000|Overall Study|Lost to Follow-up|5|||
128758052|NCT01939548|463402182|FG001|Overall Study|Lost to Follow-up|5|||
128758053|NCT01939548|463402183|FG002|Overall Study|Lost to Follow-up|3|||
128758054|NCT01939548|463402181|FG000|Overall Study|Adverse Event|2|||
128758055|NCT01939548|463402182|FG001|Overall Study|Adverse Event|9|||
128758056|NCT01939548|463402183|FG002|Overall Study|Adverse Event|7|||
128758057|NCT01939548|463402181|FG000|Overall Study|Death|0|||
128758058|NCT01939548|463402182|FG001|Overall Study|Death|0|||
128758059|NCT01939548|463402183|FG002|Overall Study|Death|1|||
128758060|NCT01939548|463402181|FG000|Overall Study|Participant dropped|0|||
128758061|NCT01939548|463402182|FG001|Overall Study|Participant dropped|0|||
128758062|NCT01939548|463402183|FG002|Overall Study|Participant dropped|1|||
128758063|NCT01939548|463402181|FG000|Overall Study|Participant unwilling to continue|0|||
128758064|NCT01939548|463402182|FG001|Overall Study|Participant unwilling to continue|1|||
128758065|NCT01939548|463402183|FG002|Overall Study|Participant unwilling to continue|0|||
128758066|NCT01939548|463402181|FG000|Overall Study|Participant withdrew consent|0|||
128758067|NCT01939548|463402182|FG001|Overall Study|Participant withdrew consent|2|||
128758068|NCT01939548|463402183|FG002|Overall Study|Participant withdrew consent|0|||
128758069|NCT01939548|463402181|FG000|Overall Study|Did not complete follow-up|0|||
128758070|NCT01939548|463402182|FG001|Overall Study|Did not complete follow-up|1|||
128758071|NCT01939548|463402183|FG002|Overall Study|Did not complete follow-up|0|||
128758072|NCT02114151|463402191|FG000|Overall Study|Death|1|||
128758073|NCT02114151|463402191|FG000|Overall Study|Lost to Follow-up|1|||
128758074|NCT02114151|463402191|FG000|Overall Study|Withdrawal by Subject|5|||
128758075|NCT01494584|463402192|FG000|Overall Study|Study Closed/Terminated|1|||
128758076|NCT01666808|463402193|FG000|Overall Study|Lost to Follow-up|9|||
128758077|NCT01666808|463402194|FG001|Overall Study|Lost to Follow-up|15|||
128758078|NCT01666808|463402193|FG000|Overall Study|Withdrawal by Subject|3|||
128758079|NCT01666808|463402194|FG001|Overall Study|Withdrawal by Subject|1|||
128758080|NCT01666808|463402193|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
128758081|NCT01666808|463402194|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
128758082|NCT02638948|463402197|FG000|Overall Study|Withdrawal by Subject|4|||
128758083|NCT02638948|463402198|FG001|Overall Study|Withdrawal by Subject|5|||
128758084|NCT02638948|463402199|FG002|Overall Study|Withdrawal by Subject|3|||
128758085|NCT02638948|463402200|FG003|Overall Study|Withdrawal by Subject|1|||
128758086|NCT02638948|463402197|FG000|Overall Study|Administrative Reason by Sponsor|0|||
128758087|NCT02638948|463402198|FG001|Overall Study|Administrative Reason by Sponsor|1|||
128758088|NCT02638948|463402199|FG002|Overall Study|Administrative Reason by Sponsor|0|||
128758089|NCT02638948|463402200|FG003|Overall Study|Administrative Reason by Sponsor|4|||
128758090|NCT02638948|463402197|FG000|Overall Study|Adverse Event|0|||
128758091|NCT02638948|463402198|FG001|Overall Study|Adverse Event|0|||
128758092|NCT02638948|463402199|FG002|Overall Study|Adverse Event|1|||
128787592|NCT01235949|463514625|FG017|Booster Phase|Migrated/moved from study area|1|||
128787593|NCT01235949|463514608|FG000|Booster Phase|Adverse Event|0|||
128787594|NCT01235949|463514609|FG001|Booster Phase|Adverse Event|0|||
128787595|NCT01235949|463514610|FG002|Booster Phase|Adverse Event|0|||
128787596|NCT01235949|463514611|FG003|Booster Phase|Adverse Event|0|||
128787597|NCT01235949|463514612|FG004|Booster Phase|Adverse Event|0|||
128787598|NCT01235949|463514613|FG005|Booster Phase|Adverse Event|0|||
128787599|NCT01235949|463514614|FG006|Booster Phase|Adverse Event|0|||
128787600|NCT01235949|463514615|FG007|Booster Phase|Adverse Event|0|||
128787601|NCT01235949|463514616|FG008|Booster Phase|Adverse Event|0|||
128787602|NCT01235949|463514617|FG009|Booster Phase|Adverse Event|0|||
128758093|NCT02638948|463402200|FG003|Overall Study|Adverse Event|1|||
128787603|NCT01235949|463514618|FG010|Booster Phase|Adverse Event|0|||
128787604|NCT01235949|463514619|FG011|Booster Phase|Adverse Event|0|||
128787605|NCT01235949|463514620|FG012|Booster Phase|Adverse Event|0|||
128787606|NCT01235949|463514621|FG013|Booster Phase|Adverse Event|0|||
128787607|NCT01235949|463514622|FG014|Booster Phase|Adverse Event|0|||
128787608|NCT01235949|463514623|FG015|Booster Phase|Adverse Event|1|||
128787609|NCT01235949|463514624|FG016|Booster Phase|Adverse Event|0|||
128787610|NCT01235949|463514625|FG017|Booster Phase|Adverse Event|0|||
128787611|NCT01235949|463514608|FG000|Booster Phase|Withdrawal by Subject|0|||
128787612|NCT01235949|463514609|FG001|Booster Phase|Withdrawal by Subject|0|||
128787613|NCT01235949|463514610|FG002|Booster Phase|Withdrawal by Subject|0|||
128787614|NCT01235949|463514611|FG003|Booster Phase|Withdrawal by Subject|0|||
128787615|NCT01235949|463514612|FG004|Booster Phase|Withdrawal by Subject|0|||
128787616|NCT01235949|463514613|FG005|Booster Phase|Withdrawal by Subject|0|||
128787617|NCT01235949|463514614|FG006|Booster Phase|Withdrawal by Subject|0|||
128787618|NCT01235949|463514615|FG007|Booster Phase|Withdrawal by Subject|1|||
128787619|NCT01235949|463514616|FG008|Booster Phase|Withdrawal by Subject|1|||
128787620|NCT01235949|463514617|FG009|Booster Phase|Withdrawal by Subject|0|||
128787621|NCT01235949|463514618|FG010|Booster Phase|Withdrawal by Subject|1|||
128787622|NCT01235949|463514619|FG011|Booster Phase|Withdrawal by Subject|1|||
128787623|NCT01235949|463514620|FG012|Booster Phase|Withdrawal by Subject|2|||
128787624|NCT01235949|463514621|FG013|Booster Phase|Withdrawal by Subject|0|||
128787625|NCT01235949|463514622|FG014|Booster Phase|Withdrawal by Subject|2|||
128787626|NCT01235949|463514623|FG015|Booster Phase|Withdrawal by Subject|0|||
128787627|NCT01235949|463514624|FG016|Booster Phase|Withdrawal by Subject|0|||
128787628|NCT01235949|463514625|FG017|Booster Phase|Withdrawal by Subject|0|||
128787629|NCT01235949|463514608|FG000|Booster Phase|Lost to Follow-up|0|||
128787630|NCT01235949|463514609|FG001|Booster Phase|Lost to Follow-up|0|||
128787631|NCT01235949|463514610|FG002|Booster Phase|Lost to Follow-up|0|||
128787632|NCT01235949|463514611|FG003|Booster Phase|Lost to Follow-up|0|||
128787633|NCT01235949|463514612|FG004|Booster Phase|Lost to Follow-up|0|||
128787634|NCT01235949|463514613|FG005|Booster Phase|Lost to Follow-up|0|||
128787635|NCT01235949|463514614|FG006|Booster Phase|Lost to Follow-up|0|||
128787636|NCT01235949|463514615|FG007|Booster Phase|Lost to Follow-up|0|||
128787637|NCT01235949|463514616|FG008|Booster Phase|Lost to Follow-up|1|||
128787638|NCT01235949|463514617|FG009|Booster Phase|Lost to Follow-up|1|||
128787639|NCT01235949|463514618|FG010|Booster Phase|Lost to Follow-up|1|||
128787640|NCT01235949|463514619|FG011|Booster Phase|Lost to Follow-up|1|||
128787641|NCT01235949|463514620|FG012|Booster Phase|Lost to Follow-up|0|||
128787642|NCT01235949|463514621|FG013|Booster Phase|Lost to Follow-up|0|||
128787643|NCT01235949|463514622|FG014|Booster Phase|Lost to Follow-up|0|||
128787644|NCT01235949|463514623|FG015|Booster Phase|Lost to Follow-up|0|||
128787645|NCT01235949|463514624|FG016|Booster Phase|Lost to Follow-up|0|||
128787646|NCT01235949|463514625|FG017|Booster Phase|Lost to Follow-up|1|||
128787647|NCT04173572|463514626|FG000|Overall Study|Withdrawal by Subject|1|||
128758094|NCT02638948|463402197|FG000|Overall Study|Lack of Efficacy|1|||
128758095|NCT02638948|463402198|FG001|Overall Study|Lack of Efficacy|1|||
128758096|NCT02638948|463402199|FG002|Overall Study|Lack of Efficacy|0|||
128758097|NCT02638948|463402200|FG003|Overall Study|Lack of Efficacy|0|||
128758098|NCT02638948|463402197|FG000|Overall Study|Lost to Follow-up|0|||
128758099|NCT02638948|463402198|FG001|Overall Study|Lost to Follow-up|0|||
128758100|NCT02638948|463402199|FG002|Overall Study|Lost to Follow-up|1|||
128758101|NCT02638948|463402200|FG003|Overall Study|Lost to Follow-up|1|||
128758102|NCT02638948|463402197|FG000|Overall Study|Poor/Non-Compliance|0|||
128758103|NCT02638948|463402198|FG001|Overall Study|Poor/Non-Compliance|2|||
128758104|NCT02638948|463402199|FG002|Overall Study|Poor/Non-Compliance|1|||
128758105|NCT02638948|463402200|FG003|Overall Study|Poor/Non-Compliance|0|||
128758106|NCT02638948|463402197|FG000|Overall Study|Participant no longer met study criteria|0|||
128758107|NCT02638948|463402198|FG001|Overall Study|Participant no longer met study criteria|1|||
128758108|NCT02638948|463402199|FG002|Overall Study|Participant no longer met study criteria|0|||
128758109|NCT02638948|463402200|FG003|Overall Study|Participant no longer met study criteria|0|||
128787648|NCT04173572|463514627|FG001|Overall Study|Withdrawal by Subject|5|||
128787649|NCT04173572|463514626|FG000|Overall Study|Lost to Follow-up|3|||
128787650|NCT04173572|463514627|FG001|Overall Study|Lost to Follow-up|1|||
128787651|NCT00383188|463514628|FG000|Overall Study|Adverse Event|4|||
128787652|NCT00383188|463514629|FG001|Overall Study|Adverse Event|7|||
128758110|NCT02638948|463402197|FG000|Overall Study|Other than specified above|4|||
128758111|NCT02638948|463402198|FG001|Overall Study|Other than specified above|1|||
128758112|NCT02638948|463402199|FG002|Overall Study|Other than specified above|1|||
128758113|NCT02638948|463402200|FG003|Overall Study|Other than specified above|1|||
128758114|NCT00810264|463402204|FG000|Overall Study|Lost to Follow-up|191|||
128758115|NCT00810264|463402204|FG000|Overall Study|Withdrawal by subject or physician|721|||
128758116|NCT00810264|463402204|FG000|Overall Study|Death|641|||
128758117|NCT06213701|463402205|FG000|Overall Study|Withdrawal by Subject|2|||
128758118|NCT06213701|463402206|FG001|Overall Study|Withdrawal by Subject|1|||
128758119|NCT06213701|463402207|FG002|Overall Study|Withdrawal by Subject|0|||
128758120|NCT02495025|463402214|FG000|Overall Study|Lost to Follow-up|21|||
128758121|NCT02495025|463402215|FG001|Overall Study|Lost to Follow-up|14|||
128758122|NCT02495025|463402214|FG000|Overall Study|Withdrawal by Subject|5|||
128758123|NCT02495025|463402215|FG001|Overall Study|Withdrawal by Subject|0|||
128758124|NCT01515748|463402220|FG000|Overall Study|Withdrawal by Subject|32|||
128758125|NCT01515748|463402221|FG001|Overall Study|Withdrawal by Subject|41|||
128758126|NCT01515748|463402220|FG000|Overall Study|Lost to Follow-up|2|||
128758127|NCT01515748|463402221|FG001|Overall Study|Lost to Follow-up|4|||
128758128|NCT01515748|463402220|FG000|Overall Study|Other than specified above|5|||
128758129|NCT01515748|463402221|FG001|Overall Study|Other than specified above|10|||
128758130|NCT03221387|463402222|FG000|Overall Study|Lost to Follow-up|1|||
128758131|NCT03221387|463402222|FG000|Overall Study|Lung transplant|1|||
128758132|NCT04102579|463402226|FG000|Overall Study|Withdrawal by Subject|3|||
128758133|NCT04102579|463402227|FG001|Overall Study|Withdrawal by Subject|4|||
128758134|NCT04102579|463402226|FG000|Overall Study|Lost to Follow-up|0|||
128758135|NCT04102579|463402227|FG001|Overall Study|Lost to Follow-up|1|||
128758136|NCT04102579|463402226|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
128758137|NCT04102579|463402227|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
128758138|NCT04102579|463402226|FG000|Overall Study|Other than Specified|1|||
128758139|NCT04102579|463402227|FG001|Overall Study|Other than Specified|0|||
128758140|NCT04102579|463402226|FG000|Overall Study|Not Dosed with Study Drug|0|||
128758141|NCT04102579|463402227|FG001|Overall Study|Not Dosed with Study Drug|1|||
128758142|NCT01525602|463402228|FG000|Overall Study|Adverse Event|1|||
128758143|NCT01525602|463402229|FG001|Overall Study|Adverse Event|0|||
128758144|NCT01525602|463402230|FG002|Overall Study|Adverse Event|1|||
128758145|NCT01525602|463402231|FG003|Overall Study|Adverse Event|1|||
128758146|NCT01525602|463402232|FG004|Overall Study|Adverse Event|3|||
128758147|NCT01525602|463402233|FG005|Overall Study|Adverse Event|3|||
128758148|NCT01525602|463402234|FG006|Overall Study|Adverse Event|0|||
128758149|NCT01525602|463402235|FG007|Overall Study|Adverse Event|1|||
128758150|NCT01525602|463402228|FG000|Overall Study|Disease progression|6|||
128758151|NCT01525602|463402229|FG001|Overall Study|Disease progression|3|||
128758152|NCT01525602|463402230|FG002|Overall Study|Disease progression|2|||
128758153|NCT01525602|463402231|FG003|Overall Study|Disease progression|5|||
128758154|NCT01525602|463402232|FG004|Overall Study|Disease progression|22|||
128758155|NCT01525602|463402233|FG005|Overall Study|Disease progression|2|||
128758156|NCT01525602|463402234|FG006|Overall Study|Disease progression|3|||
128758157|NCT01525602|463402235|FG007|Overall Study|Disease progression|3|||
128758158|NCT01525602|463402228|FG000|Overall Study|Clinical progression|2|||
128758159|NCT01525602|463402229|FG001|Overall Study|Clinical progression|0|||
128787653|NCT00383188|463514630|FG002|Overall Study|Adverse Event|9|||
128787654|NCT00383188|463514631|FG003|Overall Study|Adverse Event|8|||
128787655|NCT00383188|463514632|FG004|Overall Study|Adverse Event|8|||
128787656|NCT00383188|463514628|FG000|Overall Study|Lack of Efficacy|9|||
128787657|NCT00383188|463514629|FG001|Overall Study|Lack of Efficacy|3|||
128787658|NCT00383188|463514630|FG002|Overall Study|Lack of Efficacy|3|||
128787659|NCT00383188|463514631|FG003|Overall Study|Lack of Efficacy|2|||
128787660|NCT00383188|463514632|FG004|Overall Study|Lack of Efficacy|6|||
128787661|NCT00383188|463514628|FG000|Overall Study|Other|3|||
128787662|NCT00383188|463514629|FG001|Overall Study|Other|1|||
128787663|NCT00383188|463514630|FG002|Overall Study|Other|0|||
128787664|NCT00383188|463514631|FG003|Overall Study|Other|2|||
128787665|NCT00383188|463514632|FG004|Overall Study|Other|6|||
128787666|NCT00383188|463514628|FG000|Overall Study|No longer willing to participate|1|||
128787667|NCT00383188|463514629|FG001|Overall Study|No longer willing to participate|0|||
128787668|NCT00383188|463514630|FG002|Overall Study|No longer willing to participate|1|||
128787669|NCT00383188|463514631|FG003|Overall Study|No longer willing to participate|0|||
128787670|NCT00383188|463514632|FG004|Overall Study|No longer willing to participate|2|||
128787671|NCT00383188|463514628|FG000|Overall Study|Lost to Follow-up|0|||
128787672|NCT00383188|463514629|FG001|Overall Study|Lost to Follow-up|0|||
128787673|NCT00383188|463514630|FG002|Overall Study|Lost to Follow-up|0|||
128787674|NCT00383188|463514631|FG003|Overall Study|Lost to Follow-up|0|||
128787675|NCT00383188|463514632|FG004|Overall Study|Lost to Follow-up|1|||
128787676|NCT00835380|463514637|FG000|Overall Study|Withdrawal by Subject|2|||
128787677|NCT03247543|463514638|FG000|Overall Study|Adverse Event|3|||
128787678|NCT03247543|463514639|FG001|Overall Study|Adverse Event|6|||
128787679|NCT03247543|463514640|FG002|Overall Study|Adverse Event|4|||
128787680|NCT03247543|463514638|FG000|Overall Study|Lost to Follow-up|10|||
128787681|NCT03247543|463514639|FG001|Overall Study|Lost to Follow-up|7|||
128787682|NCT03247543|463514640|FG002|Overall Study|Lost to Follow-up|8|||
128787683|NCT03247543|463514638|FG000|Overall Study|Consent withdrawn by caregiver|2|||
128787684|NCT03247543|463514639|FG001|Overall Study|Consent withdrawn by caregiver|2|||
128787685|NCT03247543|463514640|FG002|Overall Study|Consent withdrawn by caregiver|9|||
128787686|NCT03247543|463514638|FG000|Overall Study|Withdrawal by Subject|0|||
128787687|NCT03247543|463514639|FG001|Overall Study|Withdrawal by Subject|0|||
128787688|NCT03247543|463514640|FG002|Overall Study|Withdrawal by Subject|1|||
128787689|NCT03247543|463514638|FG000|Overall Study|Failure to Follow study procedures|1|||
128787690|NCT03247543|463514639|FG001|Overall Study|Failure to Follow study procedures|3|||
128787691|NCT03247543|463514640|FG002|Overall Study|Failure to Follow study procedures|1|||
128787692|NCT03247543|463514638|FG000|Overall Study|Lack of Efficacy|1|||
128787693|NCT03247543|463514639|FG001|Overall Study|Lack of Efficacy|0|||
128787694|NCT03247543|463514640|FG002|Overall Study|Lack of Efficacy|0|||
128787695|NCT03247543|463514638|FG000|Overall Study|Non-compliance with study visits|0|||
128787696|NCT03247543|463514639|FG001|Overall Study|Non-compliance with study visits|1|||
128787697|NCT03247543|463514640|FG002|Overall Study|Non-compliance with study visits|0|||
128787698|NCT02059980|463514643|FG000|Overall Study|Lost to Follow-up|2|||
128787699|NCT02059980|463514644|FG001|Overall Study|Lost to Follow-up|1|||
128787700|NCT01104415|463514645|FG000|Core Phase|Consent withdrawn by subjects|1|||
128787701|NCT01104415|463514646|FG001|Core Phase|Consent withdrawn by subjects|0|||
128787702|NCT01104415|463514645|FG000|Extension Period|Progressive disease|0|||
128787703|NCT01104415|463514646|FG001|Extension Period|Progressive disease|4|||
128787704|NCT01104415|463514645|FG000|Extension Period|Death|0|||
128787705|NCT01104415|463514646|FG001|Extension Period|Death|1|||
128787706|NCT01104415|463514645|FG000|Extension Period|Physician Decision|0|||
128787707|NCT01104415|463514646|FG001|Extension Period|Physician Decision|1|||
128787708|NCT01104415|463514645|FG000|Extension Period|Transition to Study LX1606.302|0|||
128787709|NCT01104415|463514646|FG001|Extension Period|Transition to Study LX1606.302|4|||
128787710|NCT01104415|463514645|FG000|Extension Period|Heart surgery/feeling miserable|0|||
128787711|NCT01104415|463514646|FG001|Extension Period|Heart surgery/feeling miserable|1|||
128787712|NCT02341625|463514651|FG000|Overall Study|Disease Progression|2|||
128787713|NCT02341625|463514652|FG001|Overall Study|Disease Progression|2|||
128787714|NCT02341625|463514653|FG002|Overall Study|Disease Progression|3|||
128787715|NCT02341625|463514654|FG003|Overall Study|Disease Progression|6|||
128787716|NCT02341625|463514655|FG004|Overall Study|Disease Progression|7|||
128787717|NCT02341625|463514656|FG005|Overall Study|Disease Progression|7|||
128787718|NCT02341625|463514657|FG006|Overall Study|Disease Progression|28|||
128787719|NCT02341625|463514658|FG007|Overall Study|Disease Progression|5|||
128787720|NCT02341625|463514659|FG008|Overall Study|Disease Progression|4|||
128787721|NCT02341625|463514660|FG009|Overall Study|Disease Progression|19|||
128787722|NCT02341625|463514651|FG000|Overall Study|Study Drug Toxicity|0|||
128787723|NCT02341625|463514652|FG001|Overall Study|Study Drug Toxicity|0|||
128787724|NCT02341625|463514653|FG002|Overall Study|Study Drug Toxicity|0|||
128787725|NCT02341625|463514654|FG003|Overall Study|Study Drug Toxicity|1|||
128787726|NCT02341625|463514655|FG004|Overall Study|Study Drug Toxicity|0|||
128787727|NCT02341625|463514656|FG005|Overall Study|Study Drug Toxicity|3|||
128787728|NCT02341625|463514657|FG006|Overall Study|Study Drug Toxicity|10|||
128787729|NCT02341625|463514658|FG007|Overall Study|Study Drug Toxicity|0|||
128787730|NCT02341625|463514659|FG008|Overall Study|Study Drug Toxicity|0|||
128787731|NCT02341625|463514660|FG009|Overall Study|Study Drug Toxicity|3|||
128787732|NCT02341625|463514651|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128787733|NCT02341625|463514652|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128787734|NCT02341625|463514653|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128787735|NCT02341625|463514654|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128787736|NCT02341625|463514655|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128787737|NCT02341625|463514656|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128787738|NCT02341625|463514657|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
128787739|NCT02341625|463514658|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
128787740|NCT02341625|463514659|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
128787741|NCT02341625|463514660|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
128787742|NCT02341625|463514651|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787743|NCT02341625|463514652|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787744|NCT02341625|463514653|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787745|NCT02341625|463514654|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787746|NCT02341625|463514655|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787747|NCT02341625|463514656|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787748|NCT02341625|463514657|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
128787749|NCT02341625|463514658|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
128787750|NCT02341625|463514659|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787751|NCT02341625|463514660|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
128787752|NCT02341625|463514651|FG000|Overall Study|Participant Withdrew Consent|0|||
128787753|NCT02341625|463514652|FG001|Overall Study|Participant Withdrew Consent|0|||
128787754|NCT02341625|463514653|FG002|Overall Study|Participant Withdrew Consent|0|||
128787755|NCT02341625|463514654|FG003|Overall Study|Participant Withdrew Consent|1|||
128787756|NCT02341625|463514655|FG004|Overall Study|Participant Withdrew Consent|0|||
128787757|NCT02341625|463514656|FG005|Overall Study|Participant Withdrew Consent|0|||
128787758|NCT02341625|463514657|FG006|Overall Study|Participant Withdrew Consent|0|||
128787759|NCT02341625|463514658|FG007|Overall Study|Participant Withdrew Consent|0|||
128787760|NCT02341625|463514659|FG008|Overall Study|Participant Withdrew Consent|0|||
128787761|NCT02341625|463514660|FG009|Overall Study|Participant Withdrew Consent|0|||
128787762|NCT02341625|463514651|FG000|Overall Study|Completed Treatment as per Protocol|0|||
128787763|NCT02341625|463514652|FG001|Overall Study|Completed Treatment as per Protocol|0|||
128787764|NCT02341625|463514653|FG002|Overall Study|Completed Treatment as per Protocol|0|||
128787765|NCT02341625|463514654|FG003|Overall Study|Completed Treatment as per Protocol|0|||
128787766|NCT02341625|463514655|FG004|Overall Study|Completed Treatment as per Protocol|0|||
128787767|NCT02341625|463514656|FG005|Overall Study|Completed Treatment as per Protocol|0|||
128787768|NCT02341625|463514657|FG006|Overall Study|Completed Treatment as per Protocol|0|||
128787769|NCT02341625|463514658|FG007|Overall Study|Completed Treatment as per Protocol|0|||
128787770|NCT02341625|463514659|FG008|Overall Study|Completed Treatment as per Protocol|0|||
128787771|NCT02341625|463514660|FG009|Overall Study|Completed Treatment as per Protocol|1|||
128787772|NCT02341625|463514651|FG000|Overall Study|Other Reasons|0|||
128787773|NCT02341625|463514652|FG001|Overall Study|Other Reasons|0|||
128787774|NCT02341625|463514653|FG002|Overall Study|Other Reasons|0|||
128787775|NCT02341625|463514654|FG003|Overall Study|Other Reasons|0|||
128787776|NCT02341625|463514655|FG004|Overall Study|Other Reasons|1|||
128787777|NCT02341625|463514656|FG005|Overall Study|Other Reasons|0|||
128787778|NCT02341625|463514657|FG006|Overall Study|Other Reasons|5|||
128787779|NCT02341625|463514658|FG007|Overall Study|Other Reasons|0|||
128787780|NCT02341625|463514659|FG008|Overall Study|Other Reasons|0|||
128787781|NCT02341625|463514660|FG009|Overall Study|Other Reasons|2|||
128787782|NCT02341625|463514651|FG000|Overall Study|Not Reported|0|||
128787783|NCT02341625|463514652|FG001|Overall Study|Not Reported|0|||
128787784|NCT02341625|463514653|FG002|Overall Study|Not Reported|0|||
128787785|NCT02341625|463514654|FG003|Overall Study|Not Reported|0|||
128787786|NCT02341625|463514655|FG004|Overall Study|Not Reported|0|||
128787787|NCT02341625|463514656|FG005|Overall Study|Not Reported|0|||
128787788|NCT02341625|463514657|FG006|Overall Study|Not Reported|0|||
128787789|NCT02341625|463514658|FG007|Overall Study|Not Reported|0|||
128787790|NCT02341625|463514659|FG008|Overall Study|Not Reported|0|||
128787791|NCT02341625|463514660|FG009|Overall Study|Not Reported|3|||
128787792|NCT01839877|463514664|FG000|Overall Study|Protocol Violation|1|||
128787793|NCT03098030|463514665|FG000|Overall Study|Death|10|||
128787794|NCT03098030|463514666|FG001|Overall Study|Death|156|||
128787795|NCT03098030|463514667|FG002|Overall Study|Death|156|||
128787796|NCT03098030|463514668|FG003|Overall Study|Death|82|||
128787797|NCT03098030|463514665|FG000|Overall Study|Withdrawal by Subject|0|||
128787798|NCT03098030|463514666|FG001|Overall Study|Withdrawal by Subject|7|||
128787799|NCT03098030|463514667|FG002|Overall Study|Withdrawal by Subject|8|||
128787800|NCT03098030|463514668|FG003|Overall Study|Withdrawal by Subject|2|||
128787801|NCT03098030|463514665|FG000|Overall Study|Lost to Follow-up|0|||
128787802|NCT03098030|463514666|FG001|Overall Study|Lost to Follow-up|0|||
128787803|NCT03098030|463514667|FG002|Overall Study|Lost to Follow-up|2|||
128787804|NCT03098030|463514668|FG003|Overall Study|Lost to Follow-up|1|||
128787805|NCT01726023|463514669|FG000|Overall Study|Death|1|||
128787806|NCT01726023|463514670|FG001|Overall Study|Death|1|||
128787807|NCT01726023|463514669|FG000|Overall Study|Lost to Follow-up|5|||
128787808|NCT01726023|463514670|FG001|Overall Study|Lost to Follow-up|10|||
128787809|NCT01726023|463514669|FG000|Overall Study|Other Eligibility criteria|7|||
128787810|NCT01726023|463514670|FG001|Overall Study|Other Eligibility criteria|7|||
128787811|NCT01726023|463514669|FG000|Overall Study|Withdrawal by Subject|16|||
128787812|NCT01726023|463514670|FG001|Overall Study|Withdrawal by Subject|8|||
128787813|NCT03643211|463514674|FG000|Overall Study|Contract violation/deficiency|12|||
128787814|NCT03643211|463514674|FG000|Overall Study|Invalid registration|3|||
128787815|NCT03643211|463514674|FG000|Overall Study|No treatment information|2|||
128787816|NCT03643211|463514674|FG000|Overall Study|No adverse event information - No revisit|4|||
128787817|NCT04858425|463514675|FG000|Overall Study|Adverse Event|2|||
128787818|NCT04858425|463514676|FG001|Overall Study|Adverse Event|2|||
128787819|NCT04858425|463514675|FG000|Overall Study|Withdrawal by Subject|3|||
128787820|NCT04858425|463514676|FG001|Overall Study|Withdrawal by Subject|1|||
128787821|NCT04858425|463514675|FG000|Overall Study|Lost to Follow-up|4|||
128787822|NCT04858425|463514676|FG001|Overall Study|Lost to Follow-up|2|||
128787823|NCT04858425|463514675|FG000|Overall Study|Lost to Follow-up|1|||
128787824|NCT04858425|463514676|FG001|Overall Study|Lost to Follow-up|0|||
128787825|NCT04536077|463514678|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
128787826|NCT04536077|463514679|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
128787827|NCT04536077|463514678|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
128787828|NCT04536077|463514679|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
128787829|NCT03368001|463514680|FG000|Allocation|Lost to Pretest|16|||
128787830|NCT03368001|463514681|FG001|Allocation|Lost to Pretest|25|||
128787831|NCT03368001|463514680|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
128787832|NCT03368001|463514681|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
128787833|NCT03368001|463514680|FG000|Posttest|Lost to Posttest|7|||
128787834|NCT03368001|463514681|FG001|Posttest|Lost to Posttest|11|||
128787835|NCT03368001|463514680|FG000|Posttest|Discontinued Intervention|6|||
128787836|NCT03368001|463514681|FG001|Posttest|Discontinued Intervention|19|||
128787837|NCT03368001|463514680|FG000|Follow-up|Lost to Follow-up|6|||
128787838|NCT03368001|463514681|FG001|Follow-up|Lost to Follow-up|3|||
128787839|NCT00554801|463514682|FG000|Overall Study|left area before completion|5|||
128787840|NCT00554801|463514683|FG001|Overall Study|left area before completion|0|||
128787841|NCT00554801|463514682|FG000|Overall Study|Withdrawal by Subject|14|||
128787842|NCT00554801|463514683|FG001|Overall Study|Withdrawal by Subject|0|||
128787843|NCT04436120|463514689|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
128787844|NCT04436120|463514690|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
128787845|NCT04436120|463514691|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
128787846|NCT04436120|463514692|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
128787847|NCT04436120|463514693|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
128787848|NCT04436120|463514694|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
128787849|NCT04436120|463514695|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
128787850|NCT02357784|463514696|FG000|Overall Study|Withdrawal by Subject|1|||
128787851|NCT02698241|463514698|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
128787852|NCT02698241|463514698|FG000|Overall Study|Screening not met|7|||
128787853|NCT02698241|463514698|FG000|Overall Study|Withdrawal by Subject|7|||
128787854|NCT02698241|463514698|FG000|Overall Study|Physician Decision|2|||
128787855|NCT02698241|463514698|FG000|Overall Study|Subject underwent system modification|2|||
128787856|NCT02698241|463514698|FG000|Overall Study|Lost to Follow-up|3|||
128787857|NCT02698241|463514698|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
128787858|NCT02698241|463514698|FG000|Overall Study|geographic and licensing issue|1|||
128787859|NCT02698241|463514698|FG000|Overall Study|Death|2|||
128787860|NCT04776213|463514699|FG000|Overall Study|Other|1|||
128787861|NCT04776213|463514699|FG000|Overall Study|Withdrawal by Subject|7|||
128787862|NCT04776213|463514699|FG000|Overall Study|Protocol Violation|1|||
128787863|NCT04776213|463514699|FG000|Overall Study|Lost to Follow-up|2|||
128787864|NCT00906282|463514702|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
128787865|NCT00906282|463514702|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
128787866|NCT00906282|463514702|FG000|Preoperative Chemotherapy|Progressive disease|6|||
128787867|NCT00906282|463514702|FG000|Preoperative Chemotherapy|Toxicity|1|||
128787868|NCT02540213|463514703|FG000|Overall Study|Death/adverse event|18|||
128787869|NCT02540213|463514703|FG000|Overall Study|Administrative reasons|3|||
128787870|NCT02540213|463514703|FG000|Overall Study|Kidney transplant|3|||
128787871|NCT02540213|463514703|FG000|Overall Study|Lack of Efficacy|6|||
128787872|NCT02540213|463514703|FG000|Overall Study|Consent withdrawn|7|||
128787873|NCT02540213|463514703|FG000|Overall Study|Enrolled but not treated|2|||
128787874|NCT00290706|463514710|FG000|Overall Study|Withdrawal by Subject|2|||
128787875|NCT00290706|463514711|FG001|Overall Study|Withdrawal by Subject|0|||
128787876|NCT00290706|463514712|FG002|Overall Study|Withdrawal by Subject|0|||
128787877|NCT00290706|463514713|FG003|Overall Study|Withdrawal by Subject|0|||
128787878|NCT00290706|463514710|FG000|Overall Study|Progressive Disease|3|||
128787879|NCT00290706|463514711|FG001|Overall Study|Progressive Disease|5|||
128787880|NCT00290706|463514712|FG002|Overall Study|Progressive Disease|4|||
128787881|NCT00290706|463514713|FG003|Overall Study|Progressive Disease|10|||
128787882|NCT00290706|463514710|FG000|Overall Study|Adverse Event|0|||
128787883|NCT00290706|463514711|FG001|Overall Study|Adverse Event|1|||
128787884|NCT00290706|463514712|FG002|Overall Study|Adverse Event|2|||
128787885|NCT00290706|463514713|FG003|Overall Study|Adverse Event|0|||
128787886|NCT00290706|463514710|FG000|Overall Study|Receive auto transplant or radiation|0|||
128787887|NCT00290706|463514711|FG001|Overall Study|Receive auto transplant or radiation|0|||
128787888|NCT00290706|463514712|FG002|Overall Study|Receive auto transplant or radiation|0|||
128787889|NCT00290706|463514713|FG003|Overall Study|Receive auto transplant or radiation|1|||
128787890|NCT00290706|463514710|FG000|Overall Study|Physician Decision|0|||
128787891|NCT00290706|463514711|FG001|Overall Study|Physician Decision|0|||
128787892|NCT00290706|463514712|FG002|Overall Study|Physician Decision|0|||
128787893|NCT00290706|463514713|FG003|Overall Study|Physician Decision|1|||
128787894|NCT02685033|463514716|FG000|Overall Study|Withdrawal of Consent|0|||
128787895|NCT02685033|463514717|FG001|Overall Study|Withdrawal of Consent|1|||
128787896|NCT02685033|463514716|FG000|Overall Study|Lost to Follow-up|2|||
128787897|NCT02685033|463514717|FG001|Overall Study|Lost to Follow-up|1|||
128787898|NCT02685033|463514716|FG000|Overall Study|Adverse Event|1|||
128787899|NCT02685033|463514717|FG001|Overall Study|Adverse Event|0|||
128787900|NCT02013037|463514718|FG000|Overall Study|Death|6|||
128787901|NCT02013037|463514718|FG000|Overall Study|Withdrawal by Subject|1|||
128787902|NCT02013037|463514718|FG000|Overall Study|Awaiting Transplantation|7|||
128787903|NCT02013037|463514718|FG000|Overall Study|Transplanted without DSA|2|||
128787904|NCT02960659|463516075|FG000|Overall Study|Withdrawal by Subject|1|||
128787905|NCT02960659|463516076|FG001|Overall Study|Withdrawal by Subject|0|||
128787906|NCT02960659|463516075|FG000|Overall Study|Poor compliance|0|||
128787907|NCT02960659|463516076|FG001|Overall Study|Poor compliance|1|||
128787908|NCT03068468|463516079|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
128787909|NCT03068468|463516080|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
128787910|NCT03068468|463516081|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
128787911|NCT03068468|463516082|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
128787912|NCT03068468|463516079|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
128787913|NCT03068468|463516080|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
128787914|NCT03068468|463516081|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
128787915|NCT03068468|463516082|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
128787916|NCT03068468|463516079|FG000|Placebo-Controlled Period|Adverse Event|16|||
128787917|NCT03068468|463516080|FG001|Placebo-Controlled Period|Adverse Event|21|||
128787918|NCT03068468|463516081|FG002|Placebo-Controlled Period|Adverse Event|0|||
128787919|NCT03068468|463516082|FG003|Placebo-Controlled Period|Adverse Event|0|||
128787920|NCT03068468|463516079|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
128787921|NCT03068468|463516080|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
128787922|NCT03068468|463516081|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
128787923|NCT03068468|463516082|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
128787924|NCT03068468|463516079|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
128787925|NCT03068468|463516080|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
128787926|NCT03068468|463516081|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128787927|NCT03068468|463516082|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128787928|NCT03068468|463516079|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
128787929|NCT03068468|463516080|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
128787930|NCT03068468|463516081|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
128787931|NCT03068468|463516082|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
128787932|NCT03068468|463516079|FG000|Placebo-Controlled Period|Death|0|||
128787933|NCT03068468|463516080|FG001|Placebo-Controlled Period|Death|1|||
128787934|NCT03068468|463516081|FG002|Placebo-Controlled Period|Death|0|||
128787935|NCT03068468|463516082|FG003|Placebo-Controlled Period|Death|0|||
128787936|NCT03068468|463516079|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
128787937|NCT03068468|463516080|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
128787938|NCT03068468|463516081|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
128787939|NCT03068468|463516082|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
128787940|NCT03068468|463516079|FG000|Open-Label Extension Period|Adverse Event|0|||
128787941|NCT03068468|463516080|FG001|Open-Label Extension Period|Adverse Event|0|||
128787942|NCT03068468|463516081|FG002|Open-Label Extension Period|Adverse Event|13|||
128787943|NCT03068468|463516082|FG003|Open-Label Extension Period|Adverse Event|17|||
128787944|NCT03068468|463516079|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
128787945|NCT03068468|463516080|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
128787946|NCT03068468|463516081|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
128787947|NCT03068468|463516082|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
128787948|NCT03068468|463516079|FG000|Open-Label Extension Period|Death|0|||
128787949|NCT03068468|463516080|FG001|Open-Label Extension Period|Death|0|||
128787950|NCT03068468|463516081|FG002|Open-Label Extension Period|Death|0|||
128787951|NCT03068468|463516082|FG003|Open-Label Extension Period|Death|1|||
128787952|NCT03068468|463516079|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
128787953|NCT03068468|463516080|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
128787954|NCT03068468|463516081|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
128787955|NCT03068468|463516082|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
128787956|NCT03068468|463516079|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
128787957|NCT03068468|463516080|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
128787958|NCT03068468|463516081|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
128787959|NCT03068468|463516082|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
128787960|NCT03068468|463516079|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
128787961|NCT03068468|463516080|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
128787962|NCT03068468|463516081|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
128787963|NCT03068468|463516082|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
128787964|NCT03068468|463516079|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
128787965|NCT03068468|463516080|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
128787966|NCT03068468|463516081|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
128787967|NCT03068468|463516082|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
128787968|NCT03068468|463516079|FG000|Open-Label Extension Period|Reason not Specified|0|||
128787969|NCT03068468|463516080|FG001|Open-Label Extension Period|Reason not Specified|0|||
128787970|NCT03068468|463516081|FG002|Open-Label Extension Period|Reason not Specified|1|||
128787971|NCT03068468|463516082|FG003|Open-Label Extension Period|Reason not Specified|4|||
128787972|NCT01062126|463516084|FG000|Overall Study|Death|209|||
128787973|NCT01062126|463516084|FG000|Overall Study|All Withdrawals|324|||
128787974|NCT00486759|463516088|FG000|Treatment|Adverse event/intercurrent illness|86|||
128787975|NCT00486759|463516089|FG001|Treatment|Adverse event/intercurrent illness|39|||
128787976|NCT00486759|463516088|FG000|Treatment|Insufficient therapeutic response|37|||
128787977|NCT00486759|463516089|FG001|Treatment|Insufficient therapeutic response|39|||
128787978|NCT00486759|463516088|FG000|Treatment|Death|17|||
128787979|NCT00486759|463516089|FG001|Treatment|Death|10|||
128787980|NCT00486759|463516088|FG000|Treatment|Withdrew consent|15|||
128787981|NCT00486759|463516089|FG001|Treatment|Withdrew consent|12|||
128787982|NCT00486759|463516088|FG000|Treatment|Administrative/reason not specified|17|||
128787983|NCT00486759|463516089|FG001|Treatment|Administrative/reason not specified|21|||
128787984|NCT00486759|463516088|FG000|Treatment|Refused treatment|10|||
128787985|NCT00486759|463516089|FG001|Treatment|Refused treatment|7|||
128787986|NCT00486759|463516088|FG000|Treatment|Violation of selection criteria at entry|3|||
128787987|NCT00486759|463516089|FG001|Treatment|Violation of selection criteria at entry|3|||
128787988|NCT00486759|463516088|FG000|Treatment|Other protocol violation|1|||
128787989|NCT00486759|463516089|FG001|Treatment|Other protocol violation|5|||
128787990|NCT00486759|463516088|FG000|Treatment|Failure to return|1|||
128787991|NCT00486759|463516089|FG001|Treatment|Failure to return|1|||
128787992|NCT00486759|463516088|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
128787993|NCT00486759|463516089|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
128787994|NCT00486759|463516088|FG000|Safety Follow-up|Death|40|||
128787995|NCT00486759|463516089|FG001|Safety Follow-up|Death|29|||
128787996|NCT00486759|463516088|FG000|Safety Follow-up|Withdrew consent|32|||
128787997|NCT00486759|463516089|FG001|Safety Follow-up|Withdrew consent|23|||
128787998|NCT00486759|463516088|FG000|Safety Follow-up|Failure to return|9|||
128787999|NCT00486759|463516089|FG001|Safety Follow-up|Failure to return|6|||
128788000|NCT00486759|463516088|FG000|Safety Follow-up|Administrative/not specified|8|||
128788001|NCT00486759|463516089|FG001|Safety Follow-up|Administrative/not specified|6|||
128788002|NCT00486759|463516088|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
128788003|NCT00486759|463516089|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
128788004|NCT00486759|463516088|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
128788005|NCT00486759|463516089|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
128788006|NCT01185522|463516090|FG000|Overall Study|Lack of Efficacy|28|||
128788007|NCT01185522|463516090|FG000|Overall Study|Lost to Follow-up|19|||
128788008|NCT01185522|463516090|FG000|Overall Study|Withdrawal by Subject|10|||
128788009|NCT01185522|463516090|FG000|Overall Study|Poor tolerance|39|||
128788010|NCT01185522|463516090|FG000|Overall Study|Other reasons|12|||
128788011|NCT00109967|463516091|FG000|Overall Study|Cancel Prior to Treatment|2|||
128788012|NCT00109967|463516092|FG001|Overall Study|Cancel Prior to Treatment|0|||
128788013|NCT00109967|463516091|FG000|Overall Study|Adverse Event|12|||
128788014|NCT00109967|463516092|FG001|Overall Study|Adverse Event|1|||
128788015|NCT00109967|463516091|FG000|Overall Study|Withdrawal by Subject|5|||
128788016|NCT00109967|463516092|FG001|Overall Study|Withdrawal by Subject|0|||
128788017|NCT00109967|463516091|FG000|Overall Study|Physician Decision|1|||
128788018|NCT00109967|463516092|FG001|Overall Study|Physician Decision|3|||
128788019|NCT00109967|463516091|FG000|Overall Study|Death|0|||
128788020|NCT00109967|463516092|FG001|Overall Study|Death|2|||
128788021|NCT00918957|463516099|FG000|Overall Study|Adverse Event|2|||
128788022|NCT00918957|463516100|FG001|Overall Study|Adverse Event|0|||
128788023|NCT00918957|463516099|FG000|Overall Study|Withdrawal by Subject|1|||
128788024|NCT00918957|463516100|FG001|Overall Study|Withdrawal by Subject|0|||
128788025|NCT01803646|463516103|FG000|Overall Study|Protocol Violation|1|||
128788026|NCT01803646|463516104|FG001|Overall Study|Protocol Violation|0|||
128788027|NCT01803646|463516103|FG000|Overall Study|Adverse Event|1|||
128788028|NCT01803646|463516104|FG001|Overall Study|Adverse Event|1|||
128788029|NCT01803646|463516103|FG000|Overall Study|Withdrawal by Subject|9|||
128788030|NCT01803646|463516104|FG001|Overall Study|Withdrawal by Subject|6|||
128788031|NCT01803646|463516103|FG000|Overall Study|Randomization error|1|||
128788032|NCT01803646|463516104|FG001|Overall Study|Randomization error|2|||
128788033|NCT01803646|463516103|FG000|Overall Study|Lost to Follow-up|5|||
128788034|NCT01803646|463516104|FG001|Overall Study|Lost to Follow-up|1|||
128788035|NCT01131494|463516105|FG000|Overall Study|Withdrawal by Subject|2|||
128788036|NCT01368406|463516106|FG000|Overall Study|Lost to Follow-up|8|||
128788037|NCT01368406|463516107|FG001|Overall Study|Lost to Follow-up|4|||
128788038|NCT01368406|463516106|FG000|Overall Study|Withdrawal by Subject|8|||
128788039|NCT01368406|463516107|FG001|Overall Study|Withdrawal by Subject|4|||
128788040|NCT01368406|463516106|FG000|Overall Study|relapse of the disease|3|||
128788041|NCT01368406|463516107|FG001|Overall Study|relapse of the disease|2|||
128788042|NCT01368406|463516106|FG000|Overall Study|started working|2|||
128788043|NCT01368406|463516107|FG001|Overall Study|started working|3|||
128788044|NCT03670602|463516114|FG000|Overall Study|Lost to Follow-up|1|||
128788045|NCT03670602|463516115|FG001|Overall Study|Lost to Follow-up|0|||
128788046|NCT03670602|463516114|FG000|Overall Study|Withdrawal by Subject|0|||
128788047|NCT03670602|463516115|FG001|Overall Study|Withdrawal by Subject|3|||
128788048|NCT00543725|463516116|FG000|Overall Study|Adverse Event|18|||
128788049|NCT00543725|463516117|FG001|Overall Study|Adverse Event|27|||
128788050|NCT00543725|463516116|FG000|Overall Study|Sponsor's Decision|0|||
128788051|NCT00543725|463516117|FG001|Overall Study|Sponsor's Decision|1|||
128788052|NCT00543725|463516116|FG000|Overall Study|Subject Non-Compliant|4|||
128788053|NCT00543725|463516117|FG001|Overall Study|Subject Non-Compliant|4|||
128788054|NCT00543725|463516116|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
128788055|NCT00543725|463516117|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
128788056|NCT00543725|463516116|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
128788057|NCT00543725|463516117|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
128788058|NCT00543725|463516116|FG000|Overall Study|Protocol Violation|0|||
128788059|NCT00543725|463516117|FG001|Overall Study|Protocol Violation|1|||
128788060|NCT00543725|463516116|FG000|Overall Study|Withdrawal by Subject|4|||
128788061|NCT00543725|463516117|FG001|Overall Study|Withdrawal by Subject|13|||
128788062|NCT00543725|463516116|FG000|Overall Study|Lost to Follow-up|15|||
128788063|NCT00543725|463516117|FG001|Overall Study|Lost to Follow-up|11|||
128788064|NCT00543725|463516116|FG000|Overall Study|Other|3|||
128788065|NCT00543725|463516117|FG001|Overall Study|Other|3|||
128788066|NCT00906698|463516118|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
128788067|NCT00906698|463516119|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
128788068|NCT00906698|463516120|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
128788069|NCT00906698|463516121|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
128788070|NCT00906698|463516122|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
128788071|NCT00906698|463516123|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
128788072|NCT00906698|463516118|FG000|Overall Study|Adverse Event|0|||
128788073|NCT00906698|463516119|FG001|Overall Study|Adverse Event|0|||
128788074|NCT00906698|463516120|FG002|Overall Study|Adverse Event|2|||
128788075|NCT00906698|463516121|FG003|Overall Study|Adverse Event|0|||
128788076|NCT00906698|463516122|FG004|Overall Study|Adverse Event|4|||
128788077|NCT00906698|463516123|FG005|Overall Study|Adverse Event|1|||
128788078|NCT00906698|463516118|FG000|Overall Study|Disease progression|3|||
128788079|NCT00906698|463516119|FG001|Overall Study|Disease progression|12|||
128788080|NCT00906698|463516120|FG002|Overall Study|Disease progression|4|||
128788081|NCT00906698|463516121|FG003|Overall Study|Disease progression|4|||
128788082|NCT00906698|463516122|FG004|Overall Study|Disease progression|12|||
128788083|NCT00906698|463516123|FG005|Overall Study|Disease progression|4|||
128788084|NCT00906698|463516118|FG000|Overall Study|Withdrawal by Subject|0|||
128788085|NCT00906698|463516119|FG001|Overall Study|Withdrawal by Subject|0|||
128788086|NCT00906698|463516120|FG002|Overall Study|Withdrawal by Subject|0|||
128788087|NCT00906698|463516121|FG003|Overall Study|Withdrawal by Subject|0|||
128788088|NCT00906698|463516122|FG004|Overall Study|Withdrawal by Subject|1|||
128788089|NCT00906698|463516123|FG005|Overall Study|Withdrawal by Subject|0|||
128788090|NCT00906698|463516118|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
128788091|NCT00906698|463516119|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
128788092|NCT00906698|463516120|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
128788093|NCT00906698|463516121|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
128788094|NCT00906698|463516122|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
128788095|NCT00906698|463516123|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
128788096|NCT03095508|463516124|FG000|Overall Study|Adverse Event|0|||
128788097|NCT03095508|463516125|FG001|Overall Study|Adverse Event|1|||
128788098|NCT03201809|463516126|FG000|Overall Study|Lost to Follow-up|2|||
128788099|NCT03201809|463516127|FG001|Overall Study|Lost to Follow-up|0|||
128788100|NCT00246012|463516129|FG000|Overall Study|Adverse Event|0|||
128788101|NCT00246012|463516130|FG001|Overall Study|Adverse Event|0|||
128788102|NCT00246012|463516131|FG002|Overall Study|Adverse Event|0|||
128788103|NCT00246012|463516132|FG003|Overall Study|Adverse Event|0|||
128788104|NCT00246012|463516133|FG004|Overall Study|Adverse Event|0|||
128788105|NCT00246012|463516134|FG005|Overall Study|Adverse Event|1|||
128788106|NCT00246012|463516135|FG006|Overall Study|Adverse Event|0|||
128788107|NCT00246012|463516136|FG007|Overall Study|Adverse Event|0|||
128788108|NCT00246012|463516137|FG008|Overall Study|Adverse Event|2|||
128788109|NCT00246012|463516129|FG000|Overall Study|Withdrawal by Subject|0|||
128788110|NCT00246012|463516130|FG001|Overall Study|Withdrawal by Subject|0|||
128788111|NCT00246012|463516131|FG002|Overall Study|Withdrawal by Subject|0|||
128788112|NCT00246012|463516132|FG003|Overall Study|Withdrawal by Subject|0|||
128788113|NCT00246012|463516133|FG004|Overall Study|Withdrawal by Subject|0|||
128788114|NCT00246012|463516134|FG005|Overall Study|Withdrawal by Subject|1|||
128788115|NCT00246012|463516135|FG006|Overall Study|Withdrawal by Subject|0|||
128788116|NCT00246012|463516136|FG007|Overall Study|Withdrawal by Subject|0|||
128788117|NCT00246012|463516137|FG008|Overall Study|Withdrawal by Subject|0|||
128788118|NCT00246012|463516129|FG000|Overall Study|Disease progression|3|||
128788119|NCT00246012|463516130|FG001|Overall Study|Disease progression|1|||
128788120|NCT00246012|463516131|FG002|Overall Study|Disease progression|2|||
128788121|NCT00246012|463516132|FG003|Overall Study|Disease progression|3|||
128788122|NCT00246012|463516133|FG004|Overall Study|Disease progression|3|||
128788123|NCT00246012|463516134|FG005|Overall Study|Disease progression|25|||
128788124|NCT00246012|463516135|FG006|Overall Study|Disease progression|30|||
128788125|NCT00246012|463516136|FG007|Overall Study|Disease progression|27|||
128788126|NCT00246012|463516137|FG008|Overall Study|Disease progression|26|||
128788127|NCT00246012|463516129|FG000|Overall Study|Other|0|||
128788128|NCT00246012|463516130|FG001|Overall Study|Other|0|||
128788129|NCT00246012|463516131|FG002|Overall Study|Other|0|||
128788130|NCT00246012|463516132|FG003|Overall Study|Other|0|||
128788131|NCT00246012|463516133|FG004|Overall Study|Other|0|||
128788132|NCT00246012|463516134|FG005|Overall Study|Other|0|||
128788133|NCT00246012|463516135|FG006|Overall Study|Other|0|||
128788134|NCT00246012|463516136|FG007|Overall Study|Other|1|||
128788135|NCT00246012|463516137|FG008|Overall Study|Other|0|||
128788136|NCT00246012|463516129|FG000|Overall Study|Randomly assigned but not treated|0|||
128788137|NCT00246012|463516130|FG001|Overall Study|Randomly assigned but not treated|0|||
128788138|NCT00246012|463516131|FG002|Overall Study|Randomly assigned but not treated|0|||
128788139|NCT00246012|463516132|FG003|Overall Study|Randomly assigned but not treated|0|||
128788140|NCT00246012|463516133|FG004|Overall Study|Randomly assigned but not treated|0|||
128788141|NCT00246012|463516134|FG005|Overall Study|Randomly assigned but not treated|1|||
128788142|NCT00246012|463516135|FG006|Overall Study|Randomly assigned but not treated|1|||
128788143|NCT00246012|463516136|FG007|Overall Study|Randomly assigned but not treated|0|||
128788144|NCT00246012|463516137|FG008|Overall Study|Randomly assigned but not treated|0|||
128788145|NCT01178762|463516138|FG000|Overall Study|Lost to Follow-up|15|||
128788146|NCT02322216|463516139|FG000|Overall Study|Adverse Event|1|||
128788147|NCT02322216|463516140|FG001|Overall Study|Adverse Event|0|||
128788148|NCT02322216|463516139|FG000|Overall Study|Withdrawal by Subject|1|||
128788149|NCT02322216|463516140|FG001|Overall Study|Withdrawal by Subject|4|||
128788150|NCT01651949|463516141|FG000|Overall Study|Unknown status|4|||
128788151|NCT01651949|463516142|FG001|Overall Study|Unknown status|4|||
128788152|NCT01651949|463516143|FG002|Overall Study|Unknown status|0|||
128788153|NCT01651949|463516141|FG000|Overall Study|Lost to Follow-up|30|||
128788154|NCT01651949|463516142|FG001|Overall Study|Lost to Follow-up|56|||
128788155|NCT01651949|463516143|FG002|Overall Study|Lost to Follow-up|20|||
128788156|NCT01651949|463516141|FG000|Overall Study|Protocol Violation|0|||
128788157|NCT01651949|463516142|FG001|Overall Study|Protocol Violation|2|||
128788158|NCT01651949|463516143|FG002|Overall Study|Protocol Violation|1|||
128788159|NCT01651949|463516141|FG000|Overall Study|Physician Decision|0|||
128788160|NCT01651949|463516142|FG001|Overall Study|Physician Decision|2|||
128788161|NCT01651949|463516143|FG002|Overall Study|Physician Decision|0|||
128788162|NCT01651949|463516141|FG000|Overall Study|Adverse Event|0|||
128788163|NCT01651949|463516142|FG001|Overall Study|Adverse Event|2|||
128788164|NCT01651949|463516143|FG002|Overall Study|Adverse Event|1|||
128788165|NCT01651949|463516141|FG000|Overall Study|Screen failure|2|||
128788166|NCT01651949|463516142|FG001|Overall Study|Screen failure|2|||
128788167|NCT01651949|463516143|FG002|Overall Study|Screen failure|0|||
128788168|NCT01651949|463516141|FG000|Overall Study|Withdrawal by Subject|17|||
128788169|NCT01651949|463516142|FG001|Overall Study|Withdrawal by Subject|18|||
128788170|NCT01651949|463516143|FG002|Overall Study|Withdrawal by Subject|9|||
128788171|NCT01806714|463516144|FG000|Overall Study|No functioning phone number|200|||
128788172|NCT01806714|463516145|FG001|Overall Study|No functioning phone number|170|||
128788173|NCT01585038|463516146|FG000|Overall Study|Adverse Event|2|||
128788174|NCT01585038|463516147|FG001|Overall Study|Adverse Event|2|||
128788175|NCT04107805|463516150|FG000|Overall Study|Adverse Event|0|||
128788176|NCT04107805|463516151|FG001|Overall Study|Adverse Event|0|||
128788177|NCT04107805|463516152|FG002|Overall Study|Adverse Event|0|||
128788178|NCT04107805|463516153|FG003|Overall Study|Adverse Event|1|||
128788179|NCT04107805|463516154|FG004|Overall Study|Adverse Event|0|||
128788180|NCT04107805|463516155|FG005|Overall Study|Adverse Event|1|||
128788181|NCT04107805|463516156|FG006|Overall Study|Adverse Event|0|||
128788182|NCT04107805|463516157|FG007|Overall Study|Adverse Event|0|||
128788183|NCT04107805|463516158|FG008|Overall Study|Adverse Event|1|||
128788184|NCT00853827|463516162|FG000|Single Blind Period (1 Week)|Other|4|||
128788185|NCT00853827|463516163|FG001|Single Blind Period (1 Week)|Other|0|||
128788186|NCT00853827|463516162|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
128788187|NCT00853827|463516163|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
128788188|NCT00853827|463516162|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
128788189|NCT00853827|463516163|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
128788190|NCT00853827|463516162|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
128788191|NCT00853827|463516163|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
128788192|NCT00853827|463516162|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
128788193|NCT00853827|463516163|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
128788194|NCT00853827|463516162|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
128788195|NCT00853827|463516163|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
128788196|NCT00853827|463516162|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
128788197|NCT00853827|463516163|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
128788198|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
128788199|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
128788200|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
128788201|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
128788202|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
128788203|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
128788204|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
128788205|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
128788206|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
128788207|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
128788208|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
128788209|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
128788210|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
128788211|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
128788212|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
128788213|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
128788214|NCT00853827|463516162|FG000|Double Blind Period (103 Weeks)|Death|1|||
128788215|NCT00853827|463516163|FG001|Double Blind Period (103 Weeks)|Death|6|||
128788216|NCT01156116|463516169|FG000|Overall Study|Withdrawal by Subject|3|||
128788217|NCT01156116|463516170|FG001|Overall Study|Withdrawal by Subject|1|||
128788218|NCT01156116|463516169|FG000|Overall Study|CPAP intolerance|2|||
128788219|NCT01156116|463516170|FG001|Overall Study|CPAP intolerance|0|||
128788220|NCT01191788|463516171|FG000|Overall Study|Lost to Follow-up|21|||
128788221|NCT01191788|463516172|FG001|Overall Study|Lost to Follow-up|22|||
128788222|NCT00509769|463516174|FG000|Overall Study|Progressive disease|77|||
128788223|NCT00509769|463516174|FG000|Overall Study|Adverse Event|4|||
128788224|NCT00509769|463516174|FG000|Overall Study|Patient's decision|1|||
128788225|NCT00509769|463516174|FG000|Overall Study|Physician Decision|8|||
128788226|NCT00509769|463516174|FG000|Overall Study|Use of prohibited therapies during study|1|||
128788227|NCT00754936|463516175|FG000|Overall Study|Lost to Follow-up|3|||
128788228|NCT00754936|463516175|FG000|Overall Study|Physician Decision|1|||
128788229|NCT00754936|463516175|FG000|Overall Study|Withdrawal by Subject|2|||
128788230|NCT00754936|463516175|FG000|Overall Study|Side Effects|3|||
128788231|NCT00754936|463516175|FG000|Overall Study|Inter-current medical events|3|||
128788232|NCT00604721|463516179|FG000|Overall Study|Physician Decision|1|||
128788233|NCT00604721|463516179|FG000|Overall Study|Withdrawal by Subject|1|||
128788234|NCT01838551|463516181|FG000|Overall Study|Adverse Event|16|||
128788235|NCT01838551|463516181|FG000|Overall Study|Death|1|||
128788236|NCT01838551|463516181|FG000|Overall Study|Lack of Efficacy|10|||
128788237|NCT01838551|463516181|FG000|Overall Study|Physician Decision|4|||
128788238|NCT01838551|463516181|FG000|Overall Study|Withdrawal by Subject|10|||
128788239|NCT01838551|463516181|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
128788240|NCT02289560|463516182|FG000|Overall Study|Lost to Follow-up|6|||
128788241|NCT02289560|463516182|FG000|Overall Study|Alternative Treatment|4|||
128788242|NCT02289560|463516182|FG000|Overall Study|Inadequate Treatment|2|||
128788243|NCT02289560|463516182|FG000|Overall Study|Withdrawal by Subject|23|||
128788244|NCT01981356|463516185|FG000|Overall Study|Lost to Follow-up|4|||
128788245|NCT01981356|463516186|FG001|Overall Study|Lost to Follow-up|1|||
128788246|NCT01981356|463516185|FG000|Overall Study|Withdrawal by Subject|1|||
128788247|NCT01981356|463516186|FG001|Overall Study|Withdrawal by Subject|1|||
128788248|NCT01981356|463516185|FG000|Overall Study|Protocol Violation|2|||
128788249|NCT01981356|463516186|FG001|Overall Study|Protocol Violation|0|||
128788250|NCT02317016|463516187|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
128788251|NCT02317016|463516187|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
128788252|NCT02317016|463516187|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
128788253|NCT02317016|463516187|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
128788254|NCT02317016|463516187|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
128788255|NCT02317016|463516187|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
128788256|NCT02317016|463516187|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
128788257|NCT00536380|463516188|FG000|Overall Study|Adverse Event|0|||
128788258|NCT00536380|463516189|FG001|Overall Study|Adverse Event|2|||
128788259|NCT00536380|463516190|FG002|Overall Study|Adverse Event|2|||
128788260|NCT00536380|463516188|FG000|Overall Study|Lost to Follow-up|0|||
128788261|NCT00536380|463516189|FG001|Overall Study|Lost to Follow-up|0|||
128788262|NCT00536380|463516190|FG002|Overall Study|Lost to Follow-up|1|||
128788263|NCT00536380|463516188|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
128788264|NCT00536380|463516189|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
128788265|NCT00536380|463516190|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
128788266|NCT00536380|463516188|FG000|Overall Study|Withdrawal related to study drug|7|||
128788267|NCT00536380|463516189|FG001|Overall Study|Withdrawal related to study drug|5|||
128788268|NCT00536380|463516190|FG002|Overall Study|Withdrawal related to study drug|2|||
128788269|NCT00536380|463516188|FG000|Overall Study|Noncompliance with protocol|3|||
128788270|NCT00536380|463516189|FG001|Overall Study|Noncompliance with protocol|2|||
128788271|NCT00536380|463516190|FG002|Overall Study|Noncompliance with protocol|2|||
128788272|NCT00536380|463516188|FG000|Overall Study|Did not meet protocol eligibility|0|||
128788273|NCT00536380|463516189|FG001|Overall Study|Did not meet protocol eligibility|0|||
128788274|NCT00536380|463516190|FG002|Overall Study|Did not meet protocol eligibility|1|||
128788275|NCT00536380|463516188|FG000|Overall Study|Administrative|0|||
128788276|NCT00536380|463516189|FG001|Overall Study|Administrative|0|||
128788277|NCT00536380|463516190|FG002|Overall Study|Administrative|1|||
128788278|NCT01768676|463516195|FG000|Overall Study|Adverse Event|3|||
128788279|NCT01768676|463516196|FG001|Overall Study|Adverse Event|3|||
128788280|NCT01768676|463516195|FG000|Overall Study|Lost to Follow-up|13|||
128788281|NCT01768676|463516196|FG001|Overall Study|Lost to Follow-up|16|||
128788282|NCT01768676|463516195|FG000|Overall Study|Protocol Violation|1|||
128788283|NCT01768676|463516196|FG001|Overall Study|Protocol Violation|1|||
128788284|NCT01768676|463516195|FG000|Overall Study|Physician Decision|4|||
128788285|NCT01768676|463516196|FG001|Overall Study|Physician Decision|1|||
128788286|NCT01768676|463516195|FG000|Overall Study|Withdrawal by Subject|3|||
128788287|NCT01768676|463516196|FG001|Overall Study|Withdrawal by Subject|10|||
128788288|NCT03395353|463516198|FG000|Overall Study|Adverse Event|20|||
128788289|NCT03395353|463516198|FG000|Overall Study|Protocol Violation|1|||
128788290|NCT03395353|463516198|FG000|Overall Study|Lack of Efficacy|3|||
128788291|NCT03395353|463516198|FG000|Overall Study|Withdrawal by Subject|24|||
128788292|NCT03395353|463516198|FG000|Overall Study|Discontinued visit|1|||
128788293|NCT03395353|463516198|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
128788294|NCT03395353|463516198|FG000|Overall Study|Physician Decision|4|||
128788295|NCT03395353|463516198|FG000|Overall Study|Early termination of overall study|33|||
128788296|NCT01196429|463516199|FG000|Overall Study|Ineligible - inadequate pathology|1|||
128788297|NCT01196429|463516200|FG001|Overall Study|Ineligible - inadequate pathology|0|||
128788298|NCT01196429|463516199|FG000|Overall Study|Ineligible - wrong cell type|1|||
128788299|NCT01196429|463516200|FG001|Overall Study|Ineligible - wrong cell type|0|||
128788300|NCT01196429|463516199|FG000|Overall Study|Refused - Never Treated|1|||
128788301|NCT01196429|463516200|FG001|Overall Study|Refused - Never Treated|0|||
128788302|NCT02486588|463516201|FG000|Overall Study|Randomized in error- ineligible|738|||
128788303|NCT02486588|463516202|FG001|Overall Study|Randomized in error- ineligible|750|||
128788304|NCT02486588|463516203|FG002|Overall Study|Randomized in error- ineligible|755|||
128788305|NCT02486588|463516204|FG003|Overall Study|Randomized in error- ineligible|738|||
128788306|NCT02486588|463516205|FG004|Overall Study|Randomized in error- ineligible|746|||
128788307|NCT02486588|463516206|FG005|Overall Study|Randomized in error- ineligible|746|||
128788308|NCT04248829|463516207|FG000|Overall Study|Disease progression|44|||
128788309|NCT04248829|463516208|FG001|Overall Study|Disease progression|109|||
128788310|NCT04248829|463516207|FG000|Overall Study|Adverse Event|19|||
128788311|NCT04248829|463516208|FG001|Overall Study|Adverse Event|18|||
128788312|NCT04248829|463516207|FG000|Overall Study|Withdrawal by Subject|11|||
128788313|NCT04248829|463516208|FG001|Overall Study|Withdrawal by Subject|2|||
128788314|NCT04248829|463516207|FG000|Overall Study|Lost to Follow-up|0|||
128788315|NCT04248829|463516208|FG001|Overall Study|Lost to Follow-up|1|||
128788316|NCT04248829|463516207|FG000|Overall Study|Death|12|||
128788317|NCT04248829|463516208|FG001|Overall Study|Death|14|||
128788318|NCT04248829|463516207|FG000|Overall Study|Physician Decision|2|||
128788319|NCT04248829|463516208|FG001|Overall Study|Physician Decision|4|||
128788320|NCT04248829|463516207|FG000|Overall Study|Any reason not specifically recorded|0|||
128788321|NCT04248829|463516208|FG001|Overall Study|Any reason not specifically recorded|2|||
128788322|NCT02132702|463516209|FG000|Overall Study|Protocol Violation|2|||
128788323|NCT02132702|463516209|FG000|Overall Study|Adverse Event|3|||
128788324|NCT02132702|463516209|FG000|Overall Study|Withdrawal by Subject|3|||
128788325|NCT03140176|463517983|FG000|Overall Study|Reason missing|23|||
128788326|NCT03140176|463517983|FG000|Overall Study|Death|33|||
128788327|NCT03140176|463517983|FG000|Overall Study|Disease progression|1|||
128788328|NCT03140176|463517983|FG000|Overall Study|Physician Decision|1|||
128788329|NCT03140176|463517983|FG000|Overall Study|Withdrawal by Subject|1|||
128788330|NCT03140176|463517983|FG000|Overall Study|Lost to Follow-up|15|||
128788331|NCT00954707|463517987|FG000|Overall Study|Death|34|||
128788332|NCT00954707|463517987|FG000|Overall Study|Withdrawal by Subject|100|||
128788333|NCT00954707|463517987|FG000|Overall Study|Lost to Follow-up|33|||
128788334|NCT02001623|463517988|FG000|Overall Study|Disease Progression|2|||
128788335|NCT02001623|463517989|FG001|Overall Study|Disease Progression|2|||
128788336|NCT02001623|463517990|FG002|Overall Study|Disease Progression|3|||
128788337|NCT02001623|463517991|FG003|Overall Study|Disease Progression|2|||
128788338|NCT02001623|463517992|FG004|Overall Study|Disease Progression|3|||
128788339|NCT02001623|463517993|FG005|Overall Study|Disease Progression|2|||
128788340|NCT02001623|463517994|FG006|Overall Study|Disease Progression|3|||
128788341|NCT02001623|463517995|FG007|Overall Study|Disease Progression|3|||
128788342|NCT02001623|463517996|FG008|Overall Study|Disease Progression|7|||
128788343|NCT02001623|463517997|FG009|Overall Study|Disease Progression|40|||
128788344|NCT02001623|463517998|FG010|Overall Study|Disease Progression|5|||
128788345|NCT02001623|463517999|FG011|Overall Study|Disease Progression|9|||
128788346|NCT02001623|463518000|FG012|Overall Study|Disease Progression|9|||
128788347|NCT02001623|463518001|FG013|Overall Study|Disease Progression|20|||
128788348|NCT02001623|463518002|FG014|Overall Study|Disease Progression|9|||
128788349|NCT02001623|463517988|FG000|Overall Study|Physician Decision|0|||
128788350|NCT02001623|463517989|FG001|Overall Study|Physician Decision|0|||
128788351|NCT02001623|463517990|FG002|Overall Study|Physician Decision|0|||
128788352|NCT02001623|463517991|FG003|Overall Study|Physician Decision|0|||
128788353|NCT02001623|463517992|FG004|Overall Study|Physician Decision|0|||
128788354|NCT02001623|463517993|FG005|Overall Study|Physician Decision|0|||
128788355|NCT02001623|463517994|FG006|Overall Study|Physician Decision|0|||
128788356|NCT02001623|463517995|FG007|Overall Study|Physician Decision|0|||
128788357|NCT02001623|463517996|FG008|Overall Study|Physician Decision|3|||
128788358|NCT02001623|463517997|FG009|Overall Study|Physician Decision|2|||
128788359|NCT02001623|463517998|FG010|Overall Study|Physician Decision|3|||
128788360|NCT02001623|463517999|FG011|Overall Study|Physician Decision|3|||
128788361|NCT02001623|463518000|FG012|Overall Study|Physician Decision|1|||
128788362|NCT02001623|463518001|FG013|Overall Study|Physician Decision|2|||
128788363|NCT02001623|463518002|FG014|Overall Study|Physician Decision|1|||
128788364|NCT02001623|463517988|FG000|Overall Study|Death|0|||
128788365|NCT02001623|463517989|FG001|Overall Study|Death|1|||
128788366|NCT02001623|463517990|FG002|Overall Study|Death|0|||
128788367|NCT02001623|463517991|FG003|Overall Study|Death|0|||
128788368|NCT02001623|463517992|FG004|Overall Study|Death|0|||
128788369|NCT02001623|463517993|FG005|Overall Study|Death|0|||
128788370|NCT02001623|463517994|FG006|Overall Study|Death|0|||
128788371|NCT02001623|463517995|FG007|Overall Study|Death|0|||
128788372|NCT02001623|463517996|FG008|Overall Study|Death|0|||
128788373|NCT02001623|463517997|FG009|Overall Study|Death|0|||
128788374|NCT02001623|463517998|FG010|Overall Study|Death|0|||
128788375|NCT02001623|463517999|FG011|Overall Study|Death|0|||
128788376|NCT02001623|463518000|FG012|Overall Study|Death|0|||
128788377|NCT02001623|463518001|FG013|Overall Study|Death|0|||
128788378|NCT02001623|463518002|FG014|Overall Study|Death|0|||
128788379|NCT02001623|463517988|FG000|Overall Study|Adverse Event|0|||
128788380|NCT02001623|463517989|FG001|Overall Study|Adverse Event|0|||
128788381|NCT02001623|463517990|FG002|Overall Study|Adverse Event|0|||
128788382|NCT02001623|463517991|FG003|Overall Study|Adverse Event|0|||
128788383|NCT02001623|463517992|FG004|Overall Study|Adverse Event|0|||
128788384|NCT02001623|463517993|FG005|Overall Study|Adverse Event|1|||
128788385|NCT02001623|463517994|FG006|Overall Study|Adverse Event|0|||
128788386|NCT02001623|463517995|FG007|Overall Study|Adverse Event|3|||
128788387|NCT02001623|463517996|FG008|Overall Study|Adverse Event|4|||
128788388|NCT02001623|463517997|FG009|Overall Study|Adverse Event|6|||
128788389|NCT02001623|463517998|FG010|Overall Study|Adverse Event|4|||
128788390|NCT02001623|463517999|FG011|Overall Study|Adverse Event|0|||
128788391|NCT02001623|463518000|FG012|Overall Study|Adverse Event|3|||
128788392|NCT02001623|463518001|FG013|Overall Study|Adverse Event|5|||
128788393|NCT02001623|463518002|FG014|Overall Study|Adverse Event|6|||
128788394|NCT02001623|463517988|FG000|Overall Study|Other - Miscellaneous|0|||
128788395|NCT02001623|463517989|FG001|Overall Study|Other - Miscellaneous|0|||
128788396|NCT02001623|463517990|FG002|Overall Study|Other - Miscellaneous|0|||
128788397|NCT02001623|463517991|FG003|Overall Study|Other - Miscellaneous|0|||
128788398|NCT02001623|463517992|FG004|Overall Study|Other - Miscellaneous|0|||
128788399|NCT02001623|463517993|FG005|Overall Study|Other - Miscellaneous|0|||
128788400|NCT02001623|463517994|FG006|Overall Study|Other - Miscellaneous|0|||
128788401|NCT02001623|463517995|FG007|Overall Study|Other - Miscellaneous|0|||
128788402|NCT02001623|463517996|FG008|Overall Study|Other - Miscellaneous|0|||
128788403|NCT02001623|463517997|FG009|Overall Study|Other - Miscellaneous|1|||
128788404|NCT02001623|463517998|FG010|Overall Study|Other - Miscellaneous|0|||
128788405|NCT02001623|463517999|FG011|Overall Study|Other - Miscellaneous|0|||
128788406|NCT02001623|463518000|FG012|Overall Study|Other - Miscellaneous|0|||
128788407|NCT02001623|463518001|FG013|Overall Study|Other - Miscellaneous|1|||
128788408|NCT02001623|463518002|FG014|Overall Study|Other - Miscellaneous|0|||
128788409|NCT02001623|463517988|FG000|Overall Study|Withdrawal by Subject|1|||
128788410|NCT02001623|463517989|FG001|Overall Study|Withdrawal by Subject|0|||
128788411|NCT02001623|463517990|FG002|Overall Study|Withdrawal by Subject|0|||
128788412|NCT02001623|463517991|FG003|Overall Study|Withdrawal by Subject|0|||
128788413|NCT02001623|463517992|FG004|Overall Study|Withdrawal by Subject|0|||
128788414|NCT02001623|463517993|FG005|Overall Study|Withdrawal by Subject|0|||
128788415|NCT02001623|463517994|FG006|Overall Study|Withdrawal by Subject|0|||
128788416|NCT02001623|463517995|FG007|Overall Study|Withdrawal by Subject|0|||
128788417|NCT02001623|463517996|FG008|Overall Study|Withdrawal by Subject|1|||
128788418|NCT02001623|463517997|FG009|Overall Study|Withdrawal by Subject|3|||
128788419|NCT02001623|463517998|FG010|Overall Study|Withdrawal by Subject|2|||
128788420|NCT02001623|463517999|FG011|Overall Study|Withdrawal by Subject|2|||
128788421|NCT02001623|463518000|FG012|Overall Study|Withdrawal by Subject|1|||
128788422|NCT02001623|463518001|FG013|Overall Study|Withdrawal by Subject|5|||
128788423|NCT02001623|463518002|FG014|Overall Study|Withdrawal by Subject|2|||
128788424|NCT02001623|463517988|FG000|Overall Study|Lost to Follow-up|0|||
128788425|NCT02001623|463517989|FG001|Overall Study|Lost to Follow-up|0|||
128788426|NCT02001623|463517990|FG002|Overall Study|Lost to Follow-up|0|||
128788427|NCT02001623|463517991|FG003|Overall Study|Lost to Follow-up|0|||
128788428|NCT02001623|463517992|FG004|Overall Study|Lost to Follow-up|0|||
128788429|NCT02001623|463517993|FG005|Overall Study|Lost to Follow-up|0|||
128788430|NCT02001623|463517994|FG006|Overall Study|Lost to Follow-up|0|||
128788431|NCT02001623|463517995|FG007|Overall Study|Lost to Follow-up|0|||
128788432|NCT02001623|463517996|FG008|Overall Study|Lost to Follow-up|0|||
128788433|NCT02001623|463517997|FG009|Overall Study|Lost to Follow-up|1|||
128788434|NCT02001623|463517998|FG010|Overall Study|Lost to Follow-up|0|||
128788435|NCT02001623|463517999|FG011|Overall Study|Lost to Follow-up|0|||
128788436|NCT02001623|463518000|FG012|Overall Study|Lost to Follow-up|0|||
128788437|NCT02001623|463518001|FG013|Overall Study|Lost to Follow-up|0|||
128788438|NCT02001623|463518002|FG014|Overall Study|Lost to Follow-up|0|||
128788439|NCT02001623|463517988|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
128788440|NCT02001623|463517989|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
128788441|NCT02001623|463517990|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
128788442|NCT02001623|463517991|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
128788443|NCT02001623|463517992|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
128788444|NCT02001623|463517993|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
128788445|NCT02001623|463517994|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
128788446|NCT02001623|463517995|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
128788447|NCT02001623|463517996|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
128788448|NCT02001623|463517997|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
128788449|NCT02001623|463517998|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
128788450|NCT02001623|463517999|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
128788451|NCT02001623|463518000|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
128788452|NCT02001623|463518001|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
128788453|NCT02001623|463518002|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
128788454|NCT02001623|463517988|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
128788455|NCT02001623|463517989|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
128788456|NCT02001623|463517990|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
128788457|NCT02001623|463517991|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
128788458|NCT02001623|463517992|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
128788459|NCT02001623|463517993|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
128788460|NCT02001623|463517994|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
128788461|NCT02001623|463517995|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
128788462|NCT02001623|463517996|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
128788463|NCT02001623|463517997|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
128788464|NCT02001623|463517998|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
128788465|NCT02001623|463517999|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
128788466|NCT02001623|463518000|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
128788467|NCT02001623|463518001|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
128788468|NCT02001623|463518002|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
128788469|NCT00309452|463518003|FG000|Overall Study|Withdrawal by Subject|3|||
128788470|NCT00309452|463518004|FG001|Overall Study|Withdrawal by Subject|0|||
128788471|NCT00771667|463518005|FG000|Induction Phase|Adverse Event|5|||
128788472|NCT00771667|463518006|FG001|Induction Phase|Adverse Event|2|||
128788473|NCT00771667|463518007|FG002|Induction Phase|Adverse Event|4|||
128788474|NCT00771667|463518008|FG003|Induction Phase|Adverse Event|1|||
128788475|NCT00771667|463518009|FG004|Induction Phase|Adverse Event|0|||
128788476|NCT00771667|463518010|FG005|Induction Phase|Adverse Event|0|||
128788477|NCT00771667|463518011|FG006|Induction Phase|Adverse Event|0|||
128788478|NCT00771667|463518012|FG007|Induction Phase|Adverse Event|0|||
128788479|NCT00771667|463518013|FG008|Induction Phase|Adverse Event|0|||
128788480|NCT00771667|463518014|FG009|Induction Phase|Adverse Event|0|||
128788481|NCT00771667|463518005|FG000|Induction Phase|Lack of Efficacy|9|||
128788482|NCT00771667|463518006|FG001|Induction Phase|Lack of Efficacy|2|||
128788483|NCT00771667|463518007|FG002|Induction Phase|Lack of Efficacy|4|||
128788484|NCT00771667|463518008|FG003|Induction Phase|Lack of Efficacy|3|||
128788485|NCT00771667|463518009|FG004|Induction Phase|Lack of Efficacy|0|||
128788486|NCT00771667|463518010|FG005|Induction Phase|Lack of Efficacy|0|||
128788487|NCT00771667|463518011|FG006|Induction Phase|Lack of Efficacy|0|||
128788488|NCT00771667|463518012|FG007|Induction Phase|Lack of Efficacy|0|||
128788489|NCT00771667|463518013|FG008|Induction Phase|Lack of Efficacy|0|||
128788490|NCT00771667|463518014|FG009|Induction Phase|Lack of Efficacy|0|||
128788491|NCT00771667|463518005|FG000|Induction Phase|Lost to Follow-up|1|||
128788492|NCT00771667|463518006|FG001|Induction Phase|Lost to Follow-up|0|||
128788493|NCT00771667|463518007|FG002|Induction Phase|Lost to Follow-up|1|||
128788494|NCT00771667|463518008|FG003|Induction Phase|Lost to Follow-up|0|||
128788495|NCT00771667|463518009|FG004|Induction Phase|Lost to Follow-up|0|||
128788496|NCT00771667|463518010|FG005|Induction Phase|Lost to Follow-up|0|||
128788497|NCT00771667|463518011|FG006|Induction Phase|Lost to Follow-up|0|||
128788498|NCT00771667|463518012|FG007|Induction Phase|Lost to Follow-up|0|||
128788499|NCT00771667|463518013|FG008|Induction Phase|Lost to Follow-up|0|||
128788500|NCT00771667|463518014|FG009|Induction Phase|Lost to Follow-up|0|||
128788501|NCT00771667|463518005|FG000|Induction Phase|Other|4|||
128788502|NCT00771667|463518006|FG001|Induction Phase|Other|6|||
128788503|NCT00771667|463518007|FG002|Induction Phase|Other|3|||
128788504|NCT00771667|463518008|FG003|Induction Phase|Other|4|||
128788505|NCT00771667|463518009|FG004|Induction Phase|Other|0|||
128788506|NCT00771667|463518010|FG005|Induction Phase|Other|0|||
128788507|NCT00771667|463518011|FG006|Induction Phase|Other|0|||
128788508|NCT00771667|463518012|FG007|Induction Phase|Other|0|||
128788509|NCT00771667|463518013|FG008|Induction Phase|Other|0|||
128788510|NCT00771667|463518014|FG009|Induction Phase|Other|0|||
128788511|NCT00771667|463518005|FG000|Maintenance Phase|Adverse Event|0|||
128788512|NCT00771667|463518006|FG001|Maintenance Phase|Adverse Event|0|||
128788513|NCT00771667|463518007|FG002|Maintenance Phase|Adverse Event|0|||
128788514|NCT00771667|463518008|FG003|Maintenance Phase|Adverse Event|0|||
128788515|NCT00771667|463518009|FG004|Maintenance Phase|Adverse Event|1|||
128788516|NCT00771667|463518010|FG005|Maintenance Phase|Adverse Event|3|||
128788517|NCT00771667|463518011|FG006|Maintenance Phase|Adverse Event|5|||
128788518|NCT00771667|463518012|FG007|Maintenance Phase|Adverse Event|1|||
128788519|NCT00771667|463518013|FG008|Maintenance Phase|Adverse Event|8|||
128788520|NCT00771667|463518014|FG009|Maintenance Phase|Adverse Event|7|||
128788521|NCT00771667|463518005|FG000|Maintenance Phase|Lack of Efficacy|0|||
128788522|NCT00771667|463518006|FG001|Maintenance Phase|Lack of Efficacy|0|||
128788523|NCT00771667|463518007|FG002|Maintenance Phase|Lack of Efficacy|0|||
128788524|NCT00771667|463518008|FG003|Maintenance Phase|Lack of Efficacy|0|||
128788525|NCT00771667|463518009|FG004|Maintenance Phase|Lack of Efficacy|1|||
128788526|NCT00771667|463518010|FG005|Maintenance Phase|Lack of Efficacy|3|||
128788527|NCT00771667|463518011|FG006|Maintenance Phase|Lack of Efficacy|3|||
128788528|NCT00771667|463518012|FG007|Maintenance Phase|Lack of Efficacy|2|||
128788529|NCT00771667|463518013|FG008|Maintenance Phase|Lack of Efficacy|11|||
128788530|NCT00771667|463518014|FG009|Maintenance Phase|Lack of Efficacy|7|||
128788531|NCT00771667|463518005|FG000|Maintenance Phase|Other|0|||
128788532|NCT00771667|463518006|FG001|Maintenance Phase|Other|0|||
128788533|NCT00771667|463518007|FG002|Maintenance Phase|Other|0|||
128788534|NCT00771667|463518008|FG003|Maintenance Phase|Other|0|||
128788535|NCT00771667|463518009|FG004|Maintenance Phase|Other|0|||
128788536|NCT00771667|463518010|FG005|Maintenance Phase|Other|1|||
128788537|NCT00771667|463518011|FG006|Maintenance Phase|Other|2|||
128788538|NCT00771667|463518012|FG007|Maintenance Phase|Other|2|||
128788539|NCT00771667|463518013|FG008|Maintenance Phase|Other|3|||
128788540|NCT00771667|463518014|FG009|Maintenance Phase|Other|3|||
128788541|NCT00628862|463518015|FG000|Overall Study|Adverse Event|6|||
128788542|NCT00628862|463518016|FG001|Overall Study|Adverse Event|8|||
128788543|NCT00628862|463518017|FG002|Overall Study|Adverse Event|10|||
128788544|NCT00628862|463518015|FG000|Overall Study|Withdrawal by Subject|4|||
128788545|NCT00628862|463518016|FG001|Overall Study|Withdrawal by Subject|6|||
128788546|NCT00628862|463518017|FG002|Overall Study|Withdrawal by Subject|11|||
128788547|NCT00628862|463518015|FG000|Overall Study|Lost to Follow-up|0|||
128788548|NCT00628862|463518016|FG001|Overall Study|Lost to Follow-up|2|||
128788549|NCT00628862|463518017|FG002|Overall Study|Lost to Follow-up|1|||
128788550|NCT00628862|463518015|FG000|Overall Study|Protocol Violation|1|||
128788551|NCT00628862|463518016|FG001|Overall Study|Protocol Violation|0|||
128788552|NCT00628862|463518017|FG002|Overall Study|Protocol Violation|0|||
128788553|NCT00628862|463518015|FG000|Overall Study|COPD Exacerbation|0|||
128788554|NCT00628862|463518016|FG001|Overall Study|COPD Exacerbation|1|||
128788555|NCT00628862|463518017|FG002|Overall Study|COPD Exacerbation|0|||
128788556|NCT01063036|463518018|FG000|Participants Treated With Study Drug|Adverse Event|1|||
128788557|NCT01063036|463518018|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
128788558|NCT01063036|463518018|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
128788559|NCT01063036|463518018|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
128788560|NCT01063036|463518018|FG000|Participants Treated With Study Drug|Pregnancy|1|||
128788561|NCT01063036|463518018|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
128788562|NCT01063036|463518018|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
128788563|NCT01063036|463518018|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
128788564|NCT02715258|463518019|FG000|Overall Study|Withdrawal by Subject|6|||
128788565|NCT02715258|463518020|FG001|Overall Study|Withdrawal by Subject|1|||
128788566|NCT02715258|463518019|FG000|Overall Study|Lost to Follow-up|7|||
128788567|NCT02715258|463518020|FG001|Overall Study|Lost to Follow-up|1|||
128788568|NCT02715258|463518019|FG000|Overall Study|Terminated by Sponsor|0|||
128788569|NCT02715258|463518020|FG001|Overall Study|Terminated by Sponsor|1|||
128788570|NCT02715258|463518019|FG000|Overall Study|Death|0|||
128788571|NCT02715258|463518020|FG001|Overall Study|Death|1|||
128788572|NCT02715258|463518019|FG000|Overall Study|Subject non-compliant|1|||
128788573|NCT02715258|463518020|FG001|Overall Study|Subject non-compliant|1|||
128788574|NCT02715258|463518019|FG000|Overall Study|GCP violation|2|||
128788575|NCT02715258|463518020|FG001|Overall Study|GCP violation|1|||
128788576|NCT02814643|463518021|FG000|Overall Study|Lost to Follow-up|0|||
128788577|NCT02814643|463518022|FG001|Overall Study|Lost to Follow-up|1|||
128788578|NCT02814643|463518021|FG000|Overall Study|Withdrawal by Subject|1|||
128788579|NCT02814643|463518022|FG001|Overall Study|Withdrawal by Subject|2|||
128788580|NCT02263508|463518023|FG000|Overall Study|Withdrawal by Subject|1|||
128788581|NCT02263508|463518024|FG001|Overall Study|Withdrawal by Subject|23|||
128788582|NCT02263508|463518025|FG002|Overall Study|Withdrawal by Subject|17|||
128788583|NCT02263508|463518023|FG000|Overall Study|Sponsor Decision|12|||
128788584|NCT02263508|463518024|FG001|Overall Study|Sponsor Decision|165|||
128788585|NCT02263508|463518025|FG002|Overall Study|Sponsor Decision|182|||
128788586|NCT02263508|463518023|FG000|Overall Study|Lost to Follow-up|2|||
128788587|NCT02263508|463518024|FG001|Overall Study|Lost to Follow-up|7|||
128788588|NCT02263508|463518025|FG002|Overall Study|Lost to Follow-up|7|||
128788589|NCT02263508|463518023|FG000|Overall Study|Death|6|||
128788590|NCT02263508|463518024|FG001|Overall Study|Death|151|||
128788591|NCT02263508|463518025|FG002|Overall Study|Death|140|||
128788592|NCT03265210|463518028|FG000|Overall Study|Withdrawal by Subject|7|||
128788593|NCT03265210|463518029|FG001|Overall Study|Withdrawal by Subject|9|||
128788594|NCT03265210|463518028|FG000|Overall Study|Lost to Follow-up|2|||
128788595|NCT03265210|463518029|FG001|Overall Study|Lost to Follow-up|0|||
128788596|NCT03265210|463518028|FG000|Overall Study|Physician Decision|2|||
128788597|NCT03265210|463518029|FG001|Overall Study|Physician Decision|0|||
128788598|NCT03265210|463518028|FG000|Overall Study|Adverse Event|1|||
128788599|NCT03265210|463518029|FG001|Overall Study|Adverse Event|0|||
128788600|NCT00686517|463518030|FG000|Treatment|Serious Adverse Event|1|||
128788601|NCT00686517|463518031|FG001|Treatment|Serious Adverse Event|2|||
128788602|NCT00686517|463518032|FG002|Treatment|Serious Adverse Event|1|||
128788603|NCT00686517|463518030|FG000|Treatment|Adverse Event|2|||
128788604|NCT00686517|463518031|FG001|Treatment|Adverse Event|0|||
128788605|NCT00686517|463518032|FG002|Treatment|Adverse Event|0|||
128788606|NCT00686517|463518030|FG000|Treatment|Poor Protocol Compliance|1|||
128788607|NCT00686517|463518031|FG001|Treatment|Poor Protocol Compliance|0|||
128788608|NCT00686517|463518032|FG002|Treatment|Poor Protocol Compliance|0|||
128788609|NCT00686517|463518030|FG000|Treatment|Protocol Violation|2|||
128788610|NCT00686517|463518031|FG001|Treatment|Protocol Violation|1|||
128788611|NCT00686517|463518032|FG002|Treatment|Protocol Violation|0|||
128788612|NCT02281318|463518033|FG000|Overall Study|Adverse Event|2|||
128788613|NCT02281318|463518034|FG001|Overall Study|Adverse Event|2|||
128788614|NCT02281318|463518033|FG000|Overall Study|Lack of Efficacy|2|||
128788615|NCT02281318|463518034|FG001|Overall Study|Lack of Efficacy|0|||
128788616|NCT02281318|463518033|FG000|Overall Study|Lost to Follow-up|2|||
128788617|NCT02281318|463518034|FG001|Overall Study|Lost to Follow-up|1|||
128788618|NCT02281318|463518033|FG000|Overall Study|Physician Decision|2|||
128788619|NCT02281318|463518034|FG001|Overall Study|Physician Decision|0|||
128788620|NCT02281318|463518033|FG000|Overall Study|Withdrawal by Subject|6|||
128788621|NCT02281318|463518034|FG001|Overall Study|Withdrawal by Subject|2|||
128788622|NCT02614560|463518037|FG000|Overall Study|Death|6|||
128788623|NCT02614560|463518038|FG001|Overall Study|Death|2|||
128788624|NCT00703911|463518041|FG000|Overall Study|Death|1|||
128788625|NCT00703911|463518041|FG000|Overall Study|Physician Decision|6|||
128788626|NCT00703911|463518041|FG000|Overall Study|Lost to Follow-up|1|||
128788627|NCT00703911|463518041|FG000|Overall Study|Withdrawal by Subject|2|||
128788628|NCT02174562|463518044|FG000|Overall Study|Withdrawal by Subject|7|||
128788629|NCT02174562|463518045|FG001|Overall Study|Withdrawal by Subject|2|||
128788630|NCT02174562|463518044|FG000|Overall Study|Death|2|||
128788631|NCT02174562|463518045|FG001|Overall Study|Death|0|||
128788632|NCT02174562|463518044|FG000|Overall Study|Lost to Follow-up|0|||
128788633|NCT02174562|463518045|FG001|Overall Study|Lost to Follow-up|3|||
128788634|NCT05193318|463518046|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
128788635|NCT05193318|463518046|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
128788636|NCT00798096|463518047|FG000|Overall Study|Ongoing|2|||
128788637|NCT01833065|463518048|FG000|Overall Study|Adverse Event|6|||
128788638|NCT01833065|463518049|FG001|Overall Study|Adverse Event|1|||
128788639|NCT01833065|463518050|FG002|Overall Study|Adverse Event|0|||
128788640|NCT01833065|463518051|FG003|Overall Study|Adverse Event|2|||
128788641|NCT01833065|463518052|FG004|Overall Study|Adverse Event|3|||
128788642|NCT01833065|463518048|FG000|Overall Study|Protocol Violation|1|||
128788643|NCT01833065|463518049|FG001|Overall Study|Protocol Violation|0|||
128788644|NCT01833065|463518050|FG002|Overall Study|Protocol Violation|0|||
128788645|NCT01833065|463518051|FG003|Overall Study|Protocol Violation|0|||
128788646|NCT01833065|463518052|FG004|Overall Study|Protocol Violation|2|||
128788647|NCT01833065|463518048|FG000|Overall Study|Lost to Follow-up|1|||
128788648|NCT01833065|463518049|FG001|Overall Study|Lost to Follow-up|0|||
128788649|NCT01833065|463518050|FG002|Overall Study|Lost to Follow-up|0|||
128788650|NCT01833065|463518051|FG003|Overall Study|Lost to Follow-up|0|||
128788651|NCT01833065|463518052|FG004|Overall Study|Lost to Follow-up|3|||
128788652|NCT01833065|463518048|FG000|Overall Study|Withdrawal by Subject|6|||
128788653|NCT01833065|463518049|FG001|Overall Study|Withdrawal by Subject|2|||
128788654|NCT01833065|463518050|FG002|Overall Study|Withdrawal by Subject|4|||
128788655|NCT01833065|463518051|FG003|Overall Study|Withdrawal by Subject|3|||
128788656|NCT01833065|463518052|FG004|Overall Study|Withdrawal by Subject|11|||
128788657|NCT01833065|463518048|FG000|Overall Study|Subject's substantial non-compliance|0|||
128788658|NCT01833065|463518049|FG001|Overall Study|Subject's substantial non-compliance|1|||
128758160|NCT01525602|463402230|FG002|Overall Study|Clinical progression|0|||
128758161|NCT01525602|463402231|FG003|Overall Study|Clinical progression|0|||
128758162|NCT01525602|463402232|FG004|Overall Study|Clinical progression|0|||
128758163|NCT01525602|463402233|FG005|Overall Study|Clinical progression|0|||
128758164|NCT01525602|463402234|FG006|Overall Study|Clinical progression|1|||
128758165|NCT01525602|463402235|FG007|Overall Study|Clinical progression|1|||
128758166|NCT01525602|463402228|FG000|Overall Study|Non-compliance|0|||
128758167|NCT01525602|463402229|FG001|Overall Study|Non-compliance|0|||
128758168|NCT01525602|463402230|FG002|Overall Study|Non-compliance|0|||
128758169|NCT01525602|463402231|FG003|Overall Study|Non-compliance|0|||
128758170|NCT01525602|463402232|FG004|Overall Study|Non-compliance|1|||
128758171|NCT01525602|463402233|FG005|Overall Study|Non-compliance|0|||
128758172|NCT01525602|463402234|FG006|Overall Study|Non-compliance|0|||
128758173|NCT01525602|463402235|FG007|Overall Study|Non-compliance|0|||
128758174|NCT01525602|463402228|FG000|Overall Study|Withdrawal by Subject|0|||
128758175|NCT01525602|463402229|FG001|Overall Study|Withdrawal by Subject|0|||
128758176|NCT01525602|463402230|FG002|Overall Study|Withdrawal by Subject|0|||
128758177|NCT01525602|463402231|FG003|Overall Study|Withdrawal by Subject|0|||
128788659|NCT01833065|463518050|FG002|Overall Study|Subject's substantial non-compliance|0|||
128788660|NCT01833065|463518051|FG003|Overall Study|Subject's substantial non-compliance|0|||
128788661|NCT01833065|463518052|FG004|Overall Study|Subject's substantial non-compliance|0|||
128788662|NCT01833065|463518048|FG000|Overall Study|Trial terminated by sponsor|8|||
128788663|NCT01833065|463518049|FG001|Overall Study|Trial terminated by sponsor|8|||
128788664|NCT01833065|463518050|FG002|Overall Study|Trial terminated by sponsor|7|||
128788665|NCT01833065|463518051|FG003|Overall Study|Trial terminated by sponsor|3|||
128788666|NCT01833065|463518052|FG004|Overall Study|Trial terminated by sponsor|13|||
128788667|NCT01833065|463518048|FG000|Overall Study|Others|2|||
128788668|NCT01833065|463518049|FG001|Overall Study|Others|1|||
128788669|NCT01833065|463518050|FG002|Overall Study|Others|1|||
128788670|NCT01833065|463518051|FG003|Overall Study|Others|1|||
128788671|NCT01833065|463518052|FG004|Overall Study|Others|4|||
128788672|NCT00094809|463518057|FG000|Overall Study|Protocol deviation|2|||
128788673|NCT00094809|463518058|FG001|Overall Study|Protocol deviation|2|||
128788674|NCT00094809|463518057|FG000|Overall Study|Noncompliance|1|||
128788675|NCT00094809|463518058|FG001|Overall Study|Noncompliance|0|||
128788676|NCT00094809|463518057|FG000|Overall Study|Adverse Event|3|||
128788677|NCT00094809|463518058|FG001|Overall Study|Adverse Event|1|||
128788678|NCT00094809|463518057|FG000|Overall Study|Withdrawal by Subject|8|||
128788679|NCT00094809|463518058|FG001|Overall Study|Withdrawal by Subject|9|||
128788680|NCT00094809|463518057|FG000|Overall Study|Disease progression|3|||
128788681|NCT00094809|463518058|FG001|Overall Study|Disease progression|3|||
128788682|NCT00094809|463518057|FG000|Overall Study|Physician Decision|3|||
128788683|NCT00094809|463518058|FG001|Overall Study|Physician Decision|5|||
128788684|NCT00094809|463518057|FG000|Overall Study|Lost to Follow-up|6|||
128788685|NCT00094809|463518058|FG001|Overall Study|Lost to Follow-up|6|||
128788686|NCT00094809|463518057|FG000|Overall Study|Death|19|||
128788687|NCT00094809|463518058|FG001|Overall Study|Death|25|||
128788688|NCT00094809|463518057|FG000|Overall Study|Protocol-specified criteria|1|||
128788689|NCT00094809|463518058|FG001|Overall Study|Protocol-specified criteria|1|||
128788690|NCT00094809|463518057|FG000|Overall Study|Other|2|||
128788691|NCT00094809|463518058|FG001|Overall Study|Other|4|||
128788692|NCT00094809|463518057|FG000|Overall Study|Informed consent signed after treatment|1|||
128788693|NCT00094809|463518058|FG001|Overall Study|Informed consent signed after treatment|0|||
128788694|NCT00094809|463518057|FG000|Overall Study|Study drug not received|2|||
128788695|NCT00094809|463518058|FG001|Overall Study|Study drug not received|8|||
128788696|NCT00094809|463518057|FG000|Overall Study|Other|1|||
128788697|NCT00094809|463518058|FG001|Overall Study|Other|1|||
128788698|NCT04889664|463518059|FG000|Screen|Lost to Follow-up|1|||
128788699|NCT04889664|463518059|FG000|Screen|Failed to meet screening criteria|1|||
128788700|NCT04889664|463518059|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
128788701|NCT01191086|463518074|FG000|Overall Study|Adverse Event|20|||
128788702|NCT01191086|463518074|FG000|Overall Study|Lack of Efficacy|10|||
128788703|NCT01191086|463518074|FG000|Overall Study|Lost to Follow-up|4|||
128788704|NCT01191086|463518074|FG000|Overall Study|Physician Decision|2|||
128788705|NCT01191086|463518074|FG000|Overall Study|Withdrawal by Subject|24|||
128788706|NCT01191086|463518074|FG000|Overall Study|Discontinuation criterion met|1|||
128788707|NCT01191086|463518074|FG000|Overall Study|Other|1|||
128788708|NCT00771849|463518075|FG000|Overall Study|Lost to Follow-up|1|||
128788709|NCT00771849|463518076|FG001|Overall Study|Lost to Follow-up|2|||
128788710|NCT00771849|463518075|FG000|Overall Study|Withdrawal by Subject|1|||
128788711|NCT00771849|463518076|FG001|Overall Study|Withdrawal by Subject|1|||
128788712|NCT00771849|463518075|FG000|Overall Study|Not vaccinated|0|||
128788713|NCT00771849|463518076|FG001|Overall Study|Not vaccinated|1|||
128788714|NCT02046616|463518079|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
128788715|NCT02046616|463518079|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
128788716|NCT02046616|463518079|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
128788717|NCT02046616|463518079|FG000|24-Week Treatment Period|Physician Decision|3|||
128788718|NCT02046616|463518079|FG000|24-Week Treatment Period|Other|1|||
128788719|NCT02046616|463518079|FG000|8-Week FU Period|Lost to Follow-up|1|||
128788720|NCT02736799|463518080|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
128788721|NCT02736799|463518081|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
128788722|NCT02736799|463518082|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
128788723|NCT02736799|463518083|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
128788724|NCT00344019|463518086|FG000|Overall Study|did not meet final inclusion criteria|0|||
128788725|NCT00344019|463518087|FG001|Overall Study|did not meet final inclusion criteria|0|||
128788726|NCT00344019|463518088|FG002|Overall Study|did not meet final inclusion criteria|74|||
128788727|NCT02057718|463518089|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
128788728|NCT02057718|463518090|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
128788729|NCT02057718|463518089|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
128788730|NCT02057718|463518090|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
128788731|NCT02057718|463518089|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
128788732|NCT02057718|463518090|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
128788733|NCT02057718|463518089|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
128788734|NCT02057718|463518090|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
128788735|NCT02057718|463518089|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
128788736|NCT02057718|463518090|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
128788737|NCT02057718|463518089|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
128788738|NCT02057718|463518090|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
128788739|NCT02057718|463518089|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
128788740|NCT02057718|463518090|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
128788741|NCT02057718|463518089|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
128788742|NCT02057718|463518090|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
128788743|NCT02057718|463518089|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
128788744|NCT02057718|463518090|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
128788745|NCT02057718|463518089|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
128788746|NCT02057718|463518090|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
128788747|NCT02057718|463518089|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
128788748|NCT02057718|463518090|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
128788749|NCT02503202|463518091|FG000|Base Study: Up to Month 6|Death|1|||
128788750|NCT02503202|463518092|FG001|Base Study: Up to Month 6|Death|1|||
128788751|NCT02503202|463518093|FG002|Base Study: Up to Month 6|Death|0|||
128788752|NCT02503202|463518094|FG003|Base Study: Up to Month 6|Death|0|||
128788753|NCT02503202|463518095|FG004|Base Study: Up to Month 6|Death|0|||
128788754|NCT02503202|463518091|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
128788755|NCT02503202|463518092|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
128788756|NCT02503202|463518093|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
128788757|NCT02503202|463518094|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
128788758|NCT02503202|463518095|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
128788759|NCT02503202|463518091|FG000|Base Study: Up to Month 6|Physician Decision|0|||
128788760|NCT02503202|463518092|FG001|Base Study: Up to Month 6|Physician Decision|0|||
128788761|NCT02503202|463518093|FG002|Base Study: Up to Month 6|Physician Decision|0|||
128788762|NCT02503202|463518094|FG003|Base Study: Up to Month 6|Physician Decision|0|||
128788763|NCT02503202|463518095|FG004|Base Study: Up to Month 6|Physician Decision|1|||
128788764|NCT02503202|463518091|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
128788765|NCT02503202|463518092|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
128788766|NCT02503202|463518093|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
128788767|NCT02503202|463518094|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
128788768|NCT02503202|463518095|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
128788769|NCT02503202|463518091|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
128788770|NCT02503202|463518092|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
128788771|NCT02503202|463518093|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
128788772|NCT02503202|463518094|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
128788773|NCT02503202|463518095|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
128788774|NCT02503202|463518091|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
128788775|NCT02503202|463518092|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
128788776|NCT02503202|463518093|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
128788777|NCT02503202|463518094|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
128788778|NCT02503202|463518095|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
128788779|NCT02503202|463518091|FG000|Extension: Month 6 to 24|Death|1|||
128788780|NCT02503202|463518092|FG001|Extension: Month 6 to 24|Death|0|||
128788781|NCT02503202|463518093|FG002|Extension: Month 6 to 24|Death|0|||
128788782|NCT02503202|463518094|FG003|Extension: Month 6 to 24|Death|0|||
128788783|NCT02503202|463518095|FG004|Extension: Month 6 to 24|Death|0|||
128788784|NCT02503202|463518091|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
128788785|NCT02503202|463518092|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
128788786|NCT02503202|463518093|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
128788787|NCT02503202|463518094|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
128788788|NCT02503202|463518095|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
128788789|NCT02503202|463518091|FG000|Extension: Month 6 to 24|Physician Decision|1|||
128788790|NCT02503202|463518092|FG001|Extension: Month 6 to 24|Physician Decision|0|||
128788791|NCT02503202|463518093|FG002|Extension: Month 6 to 24|Physician Decision|1|||
128788792|NCT02503202|463518094|FG003|Extension: Month 6 to 24|Physician Decision|3|||
128788793|NCT02503202|463518095|FG004|Extension: Month 6 to 24|Physician Decision|0|||
128788794|NCT02503202|463518091|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
128788795|NCT02503202|463518092|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
128788796|NCT02503202|463518093|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
128788797|NCT02503202|463518094|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
128788798|NCT02503202|463518095|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
128788799|NCT00906035|463518099|FG000|Overall Study|Withdrawal by Subject|2|||
128788800|NCT00906035|463518100|FG001|Overall Study|Withdrawal by Subject|3|||
128788801|NCT00906035|463518101|FG002|Overall Study|Withdrawal by Subject|0|||
128788802|NCT03058991|463518104|FG000|Overall Study|Lost to Follow-up|17|||
128788803|NCT03058991|463518105|FG001|Overall Study|Lost to Follow-up|12|||
128788804|NCT03058991|463518106|FG002|Overall Study|Lost to Follow-up|12|||
128788805|NCT03058991|463518104|FG000|Overall Study|Withdrawal by Subject|1|||
128788806|NCT03058991|463518105|FG001|Overall Study|Withdrawal by Subject|0|||
128788807|NCT03058991|463518106|FG002|Overall Study|Withdrawal by Subject|0|||
128788808|NCT00130637|463518107|FG000|Overall Study|Adverse Event|2|||
128788809|NCT00130637|463518107|FG000|Overall Study|Withdrawal by Subject|1|||
128788810|NCT01460342|463518109|FG000|Overall Study|Adverse Event|5|||
128788811|NCT01460342|463518110|FG001|Overall Study|Adverse Event|4|||
128788812|NCT01460342|463518109|FG000|Overall Study|Lost to Follow-up|1|||
128788813|NCT01460342|463518110|FG001|Overall Study|Lost to Follow-up|2|||
128788814|NCT01460342|463518109|FG000|Overall Study|Protocol Violation|0|||
128788815|NCT01460342|463518110|FG001|Overall Study|Protocol Violation|1|||
128788816|NCT01460342|463518109|FG000|Overall Study|Withdrawal by Subject|3|||
128788817|NCT01460342|463518110|FG001|Overall Study|Withdrawal by Subject|4|||
128788818|NCT01460342|463518109|FG000|Overall Study|Physician Decision|1|||
128788819|NCT01460342|463518110|FG001|Overall Study|Physician Decision|3|||
128788820|NCT01460342|463518109|FG000|Overall Study|Lack of Efficacy|1|||
128788821|NCT01460342|463518110|FG001|Overall Study|Lack of Efficacy|0|||
128788822|NCT01689519|463518111|FG000|Intent to Treat|Death|157|||
128788823|NCT01689519|463518112|FG001|Intent to Treat|Death|167|||
128788824|NCT01689519|463518111|FG000|Intent to Treat|Lost to Follow-up|4|||
128788825|NCT01689519|463518112|FG001|Intent to Treat|Lost to Follow-up|8|||
128788826|NCT01689519|463518111|FG000|Intent to Treat|Other|2|||
128788827|NCT01689519|463518112|FG001|Intent to Treat|Other|4|||
128788828|NCT01689519|463518111|FG000|Intent to Treat|Physician Decision|4|||
128788829|NCT01689519|463518112|FG001|Intent to Treat|Physician Decision|1|||
128788830|NCT01689519|463518111|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
128788831|NCT01689519|463518112|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
128788832|NCT01689519|463518111|FG000|Intent to Treat|Withdrawal by Subject|21|||
128788833|NCT01689519|463518112|FG001|Intent to Treat|Withdrawal by Subject|20|||
128788834|NCT01689519|463518111|FG000|Safety Population|Death|158|||
128788835|NCT01689519|463518112|FG001|Safety Population|Death|165|||
128788836|NCT01689519|463518111|FG000|Safety Population|Lost to Follow-up|4|||
128788837|NCT01689519|463518112|FG001|Safety Population|Lost to Follow-up|8|||
128788838|NCT01689519|463518111|FG000|Safety Population|Other|2|||
128788839|NCT01689519|463518112|FG001|Safety Population|Other|4|||
128788840|NCT01689519|463518111|FG000|Safety Population|Physician Decision|4|||
128788841|NCT01689519|463518112|FG001|Safety Population|Physician Decision|1|||
128788842|NCT01689519|463518111|FG000|Safety Population|Study Terminated By Sponsor|60|||
128788843|NCT01689519|463518112|FG001|Safety Population|Study Terminated By Sponsor|47|||
128788844|NCT01689519|463518111|FG000|Safety Population|Withdrawal by Subject|20|||
128788845|NCT01689519|463518112|FG001|Safety Population|Withdrawal by Subject|20|||
128788846|NCT01713530|463518116|FG000|Overall Study|Adverse Event|0|||
128788847|NCT01713530|463518117|FG001|Overall Study|Adverse Event|5|||
128788848|NCT01713530|463518116|FG000|Overall Study|Withdrawal criteria|21|||
128788849|NCT01713530|463518117|FG001|Overall Study|Withdrawal criteria|12|||
128788850|NCT01713530|463518116|FG000|Overall Study|Unclassified|4|||
128788851|NCT01713530|463518117|FG001|Overall Study|Unclassified|2|||
128788852|NCT05046132|463518118|FG000|Overall Study|Adverse Event|4|||
128788853|NCT05046132|463518119|FG001|Overall Study|Adverse Event|0|||
128788854|NCT05046132|463518120|FG002|Overall Study|Adverse Event|0|||
128788855|NCT05046132|463518118|FG000|Overall Study|Withdrawal by Subject|3|||
128788856|NCT05046132|463518119|FG001|Overall Study|Withdrawal by Subject|0|||
128788857|NCT05046132|463518120|FG002|Overall Study|Withdrawal by Subject|0|||
128788858|NCT05046132|463518118|FG000|Overall Study|Positive Covid19 Result.|0|||
128788859|NCT05046132|463518119|FG001|Overall Study|Positive Covid19 Result.|1|||
128788860|NCT05046132|463518120|FG002|Overall Study|Positive Covid19 Result.|0|||
128788861|NCT01959412|463518121|FG000|Overall Study|Protocol deviation|1|||
128788862|NCT01959412|463518122|FG001|Overall Study|Protocol deviation|1|||
128788863|NCT01959412|463518123|FG002|Overall Study|Protocol deviation|0|||
128788864|NCT01959412|463518124|FG003|Overall Study|Protocol deviation|1|||
128788865|NCT01959412|463518125|FG004|Overall Study|Protocol deviation|3|||
128788866|NCT01959412|463518126|FG005|Overall Study|Protocol deviation|0|||
128788867|NCT01959412|463518121|FG000|Overall Study|Adverse Event|0|||
128788868|NCT01959412|463518122|FG001|Overall Study|Adverse Event|0|||
128788869|NCT01959412|463518123|FG002|Overall Study|Adverse Event|0|||
128788870|NCT01959412|463518124|FG003|Overall Study|Adverse Event|1|||
128788871|NCT01959412|463518125|FG004|Overall Study|Adverse Event|0|||
128788872|NCT01959412|463518126|FG005|Overall Study|Adverse Event|0|||
128788873|NCT00619645|463518128|FG000|Overall Study|Adverse Event|1|||
128788874|NCT04364269|463518129|FG000|Overall Study|Adverse Event|1|||
128788875|NCT04364269|463518130|FG001|Overall Study|Adverse Event|0|||
128788876|NCT04364269|463518131|FG002|Overall Study|Adverse Event|0|||
128788877|NCT04364269|463518129|FG000|Overall Study|Withdrawal by Subject|0|||
128788878|NCT04364269|463518130|FG001|Overall Study|Withdrawal by Subject|1|||
128788879|NCT04364269|463518131|FG002|Overall Study|Withdrawal by Subject|0|||
128788880|NCT04246762|463518132|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
128788881|NCT00597519|463518133|FG000|Overall Study|Death|1|||
128788882|NCT01227707|463518134|FG000|Overall Study|Adverse Event|10|||
128788883|NCT01227707|463518134|FG000|Overall Study|Progression of disease|3|||
128788884|NCT01227707|463518134|FG000|Overall Study|Withdrawal by Subject|1|||
128788885|NCT01227707|463518134|FG000|Overall Study|Patient non-compliance|3|||
128788886|NCT01227707|463518134|FG000|Overall Study|Medical decision|6|||
128788887|NCT01227707|463518134|FG000|Overall Study|Death|1|||
128788888|NCT05484726|463518137|FG000|Overall Study|Protocol Violation|3|||
128788889|NCT05484726|463518138|FG001|Overall Study|Protocol Violation|3|||
128788890|NCT05484726|463518137|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
128788891|NCT05484726|463518138|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
128788892|NCT05484726|463518137|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
128788893|NCT05484726|463518138|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
128788894|NCT05484726|463518137|FG000|Overall Study|continued need of mechanical ventilation|2|||
128788895|NCT05484726|463518138|FG001|Overall Study|continued need of mechanical ventilation|3|||
128788896|NCT05484726|463518137|FG000|Overall Study|Withdrawal by Subject|2|||
128788897|NCT05484726|463518138|FG001|Overall Study|Withdrawal by Subject|3|||
128788898|NCT05484726|463518137|FG000|Overall Study|IVH (G III & IV)|2|||
128788899|NCT05484726|463518138|FG001|Overall Study|IVH (G III & IV)|1|||
128788900|NCT05484726|463518137|FG000|Overall Study|NEC (stage II & III)|2|||
128788901|NCT05484726|463518138|FG001|Overall Study|NEC (stage II & III)|3|||
128788902|NCT01093534|463518141|FG000|Overall Study|Adverse Event|2|||
128788903|NCT01093534|463518142|FG001|Overall Study|Adverse Event|5|||
128788904|NCT01093534|463518143|FG002|Overall Study|Adverse Event|2|||
128788905|NCT01093534|463518141|FG000|Overall Study|Lack of Efficacy|2|||
128788906|NCT01093534|463518142|FG001|Overall Study|Lack of Efficacy|1|||
128788907|NCT01093534|463518143|FG002|Overall Study|Lack of Efficacy|1|||
128788908|NCT01093534|463518141|FG000|Overall Study|Withdrawal by Subject|5|||
128788909|NCT01093534|463518142|FG001|Overall Study|Withdrawal by Subject|7|||
128788910|NCT01093534|463518143|FG002|Overall Study|Withdrawal by Subject|2|||
128788911|NCT01093534|463518141|FG000|Overall Study|Other|1|||
128788912|NCT01093534|463518142|FG001|Overall Study|Other|3|||
128788913|NCT01093534|463518143|FG002|Overall Study|Other|4|||
128788914|NCT01837641|463518152|FG000|Overall Study|Sponsor decision|1|||
128788915|NCT01837641|463518153|FG001|Overall Study|Sponsor decision|0|||
128788916|NCT01837641|463518154|FG002|Overall Study|Sponsor decision|0|||
128788917|NCT01837641|463518155|FG003|Overall Study|Sponsor decision|0|||
128788918|NCT01837641|463518156|FG004|Overall Study|Sponsor decision|0|||
128788919|NCT01837641|463518157|FG005|Overall Study|Sponsor decision|1|||
128788920|NCT01837641|463518158|FG006|Overall Study|Sponsor decision|0|||
128788921|NCT01837641|463518159|FG007|Overall Study|Sponsor decision|0|||
128788922|NCT01837641|463518152|FG000|Overall Study|Adverse Event|0|||
128788923|NCT01837641|463518153|FG001|Overall Study|Adverse Event|0|||
128788924|NCT01837641|463518154|FG002|Overall Study|Adverse Event|0|||
128788925|NCT01837641|463518155|FG003|Overall Study|Adverse Event|0|||
128788926|NCT01837641|463518156|FG004|Overall Study|Adverse Event|0|||
128788927|NCT01837641|463518157|FG005|Overall Study|Adverse Event|1|||
128788928|NCT01837641|463518158|FG006|Overall Study|Adverse Event|0|||
128788929|NCT01837641|463518159|FG007|Overall Study|Adverse Event|0|||
128788930|NCT01837641|463518152|FG000|Overall Study|Withdrawal by Subject|0|||
128788931|NCT01837641|463518153|FG001|Overall Study|Withdrawal by Subject|0|||
128788932|NCT01837641|463518154|FG002|Overall Study|Withdrawal by Subject|0|||
128788933|NCT01837641|463518155|FG003|Overall Study|Withdrawal by Subject|0|||
128788934|NCT01837641|463518156|FG004|Overall Study|Withdrawal by Subject|1|||
128788935|NCT01837641|463518157|FG005|Overall Study|Withdrawal by Subject|0|||
128788936|NCT01837641|463518158|FG006|Overall Study|Withdrawal by Subject|1|||
128788937|NCT01837641|463518159|FG007|Overall Study|Withdrawal by Subject|0|||
128788938|NCT00605033|463518166|FG000|Overall Study|Adverse Event|2|||
128788939|NCT00605033|463518167|FG001|Overall Study|Adverse Event|2|||
128788940|NCT00605033|463518166|FG000|Overall Study|Lost to Follow-up|1|||
128788941|NCT00605033|463518167|FG001|Overall Study|Lost to Follow-up|1|||
128788942|NCT00605033|463518166|FG000|Overall Study|Withdrawal by Subject|3|||
128788943|NCT00605033|463518167|FG001|Overall Study|Withdrawal by Subject|4|||
128788944|NCT00605033|463518166|FG000|Overall Study|Protocol Violation|1|||
128788945|NCT00605033|463518167|FG001|Overall Study|Protocol Violation|1|||
128788946|NCT03354390|463518168|FG000|Level 1|Death|2|||
128788947|NCT03354390|463518169|FG001|Level 1|Death|0|||
128788948|NCT03354390|463518170|FG002|Level 1|Death|0|||
128788949|NCT03354390|463518171|FG003|Level 1|Death|0|||
128788950|NCT03354390|463518168|FG000|Level 1|Physician Decision|1|||
128788951|NCT03354390|463518169|FG001|Level 1|Physician Decision|0|||
128788952|NCT03354390|463518170|FG002|Level 1|Physician Decision|0|||
128788953|NCT03354390|463518171|FG003|Level 1|Physician Decision|0|||
128788954|NCT03354390|463518168|FG000|Level 2|Physician Decision|0|||
128788955|NCT03354390|463518169|FG001|Level 2|Physician Decision|2|||
128788956|NCT03354390|463518170|FG002|Level 2|Physician Decision|0|||
128788957|NCT03354390|463518171|FG003|Level 2|Physician Decision|0|||
128788958|NCT03354390|463518168|FG000|Level 2|Lack of Efficacy|0|||
128788959|NCT03354390|463518169|FG001|Level 2|Lack of Efficacy|1|||
128788960|NCT03354390|463518170|FG002|Level 2|Lack of Efficacy|0|||
128788961|NCT03354390|463518171|FG003|Level 2|Lack of Efficacy|0|||
128788962|NCT03354390|463518168|FG000|Level 2|Lost to Follow-up|0|||
128788963|NCT03354390|463518169|FG001|Level 2|Lost to Follow-up|1|||
128788964|NCT03354390|463518170|FG002|Level 2|Lost to Follow-up|0|||
128788965|NCT03354390|463518171|FG003|Level 2|Lost to Follow-up|0|||
128788966|NCT03354390|463518168|FG000|Level 3|Death|0|||
128788967|NCT03354390|463518169|FG001|Level 3|Death|0|||
128788968|NCT03354390|463518170|FG002|Level 3|Death|1|||
128788969|NCT03354390|463518171|FG003|Level 3|Death|0|||
128788970|NCT03354390|463518168|FG000|Level 3|Physician Decision|0|||
128788971|NCT03354390|463518169|FG001|Level 3|Physician Decision|0|||
128788972|NCT03354390|463518170|FG002|Level 3|Physician Decision|2|||
128788973|NCT03354390|463518171|FG003|Level 3|Physician Decision|0|||
128788974|NCT03354390|463518168|FG000|Level 4|Death|0|||
128788975|NCT03354390|463518169|FG001|Level 4|Death|0|||
128788976|NCT03354390|463518170|FG002|Level 4|Death|0|||
128788977|NCT03354390|463518171|FG003|Level 4|Death|3|||
128788978|NCT01066923|463518172|FG000|Overall Study|Withdrawal by Subject|3|||
128788979|NCT01066923|463518173|FG001|Overall Study|Withdrawal by Subject|3|||
128788980|NCT01066923|463518174|FG002|Overall Study|Withdrawal by Subject|8|||
128788981|NCT01066923|463518175|FG003|Overall Study|Withdrawal by Subject|8|||
128788982|NCT03227757|463519913|FG000|Overall Study|Death|25|||
128788983|NCT03227757|463519913|FG000|Overall Study|Withdrawal|10|||
128788984|NCT03227757|463519913|FG000|Overall Study|Missed visits|1|||
128788985|NCT03227757|463519913|FG000|Overall Study|Lost to Follow-up|2|||
128788986|NCT01144468|463519914|FG000|Overall Study|Lost to Follow-up|4|||
128788987|NCT01144468|463519915|FG001|Overall Study|Lost to Follow-up|7|||
128788988|NCT01144468|463519914|FG000|Overall Study|Adverse Event|3|||
128788989|NCT01144468|463519915|FG001|Overall Study|Adverse Event|2|||
128788990|NCT01144468|463519914|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
128788991|NCT01144468|463519915|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
128788992|NCT01875250|463519918|FG000|Overall Study|Adverse Event|2|||
128788993|NCT01875250|463519919|FG001|Overall Study|Adverse Event|0|||
128788994|NCT00149630|463519925|FG000|Overall Study|Incarceration|2|||
128788995|NCT00149630|463519926|FG001|Overall Study|Incarceration|0|||
128788996|NCT00149630|463519925|FG000|Overall Study|Treatment Programs|4|||
128788997|NCT00149630|463519926|FG001|Overall Study|Treatment Programs|5|||
128788998|NCT00149630|463519925|FG000|Overall Study|Adverse Event|2|||
128788999|NCT00149630|463519926|FG001|Overall Study|Adverse Event|0|||
128789000|NCT05298111|463519928|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
128789001|NCT05298111|463519929|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
128789002|NCT02689349|463519930|FG000|Overall Study|Not implanted|4|||
128789003|NCT02689349|463519931|FG001|Overall Study|Not implanted|0|||
128789004|NCT02689349|463519930|FG000|Overall Study|Withdrawal by Subject|9|||
128789005|NCT02689349|463519931|FG001|Overall Study|Withdrawal by Subject|0|||
128789006|NCT03518112|463519932|FG000|Overall Study|Withdrawal by Subject|1|||
128789007|NCT01546155|463519933|FG000|Overall Study|could not tolerate long scan duration|3|||
128789008|NCT02034916|463519934|FG000|Overall Study|Death|39|||
128789009|NCT02034916|463519935|FG001|Overall Study|Death|28|||
128789010|NCT02034916|463519934|FG000|Overall Study|Withdrawal by Subject|2|||
128789011|NCT02034916|463519935|FG001|Overall Study|Withdrawal by Subject|1|||
128789012|NCT02034916|463519934|FG000|Overall Study|Lost to Follow-up|4|||
128789013|NCT02034916|463519935|FG001|Overall Study|Lost to Follow-up|1|||
128789014|NCT02034916|463519934|FG000|Overall Study|Study terminated by sponsor|4|||
128789015|NCT02034916|463519935|FG001|Overall Study|Study terminated by sponsor|5|||
128789016|NCT01616654|463519940|FG000|Overall Study|Lack of Efficacy|1|||
128789017|NCT01616654|463519941|FG001|Overall Study|Lack of Efficacy|0|||
128789018|NCT01616654|463519942|FG002|Overall Study|Lack of Efficacy|0|||
128789019|NCT01616654|463519943|FG003|Overall Study|Lack of Efficacy|0|||
128789020|NCT01616654|463519944|FG004|Overall Study|Lack of Efficacy|1|||
128789021|NCT01616654|463519940|FG000|Overall Study|Adverse Event|0|||
128789022|NCT01616654|463519941|FG001|Overall Study|Adverse Event|1|||
128789023|NCT01616654|463519942|FG002|Overall Study|Adverse Event|2|||
128789024|NCT01616654|463519943|FG003|Overall Study|Adverse Event|1|||
128789025|NCT01616654|463519944|FG004|Overall Study|Adverse Event|0|||
128789026|NCT01616654|463519940|FG000|Overall Study|Withdrawal by Subject|2|||
128789027|NCT01616654|463519941|FG001|Overall Study|Withdrawal by Subject|2|||
128789028|NCT01616654|463519942|FG002|Overall Study|Withdrawal by Subject|3|||
128789029|NCT01616654|463519943|FG003|Overall Study|Withdrawal by Subject|1|||
128789030|NCT01616654|463519944|FG004|Overall Study|Withdrawal by Subject|5|||
128789031|NCT01616654|463519940|FG000|Overall Study|Protocol Violation|0|||
128789032|NCT01616654|463519941|FG001|Overall Study|Protocol Violation|5|||
128789033|NCT01616654|463519942|FG002|Overall Study|Protocol Violation|2|||
128789034|NCT01616654|463519943|FG003|Overall Study|Protocol Violation|4|||
128789035|NCT01616654|463519944|FG004|Overall Study|Protocol Violation|4|||
128789036|NCT01616654|463519940|FG000|Overall Study|Lost to Follow-up|1|||
128789037|NCT01616654|463519941|FG001|Overall Study|Lost to Follow-up|0|||
128789038|NCT01616654|463519942|FG002|Overall Study|Lost to Follow-up|3|||
128789039|NCT01616654|463519943|FG003|Overall Study|Lost to Follow-up|2|||
128789040|NCT01616654|463519944|FG004|Overall Study|Lost to Follow-up|1|||
128789041|NCT01616654|463519940|FG000|Overall Study|Pregnancy|1|||
128789042|NCT01616654|463519941|FG001|Overall Study|Pregnancy|0|||
128789043|NCT01616654|463519942|FG002|Overall Study|Pregnancy|0|||
128789044|NCT01616654|463519943|FG003|Overall Study|Pregnancy|0|||
128789045|NCT01616654|463519944|FG004|Overall Study|Pregnancy|1|||
128789046|NCT02057692|463519948|FG000|Overall Study|Adverse Event|1|||
128789047|NCT02057692|463519949|FG001|Overall Study|Adverse Event|0|||
128789048|NCT02057692|463519950|FG002|Overall Study|Adverse Event|0|||
128789049|NCT02057692|463519951|FG003|Overall Study|Adverse Event|0|||
128789050|NCT02057692|463519948|FG000|Overall Study|Lost to Follow-up|0|||
128789051|NCT02057692|463519949|FG001|Overall Study|Lost to Follow-up|0|||
128789052|NCT02057692|463519950|FG002|Overall Study|Lost to Follow-up|0|||
128789053|NCT02057692|463519951|FG003|Overall Study|Lost to Follow-up|1|||
128789054|NCT00864682|463519952|FG000|Overall Study|Protocol Violation|2|||
128789055|NCT00864682|463519953|FG001|Overall Study|Protocol Violation|1|||
128789056|NCT00864682|463519954|FG002|Overall Study|Protocol Violation|2|||
128789057|NCT00545844|463519955|FG000|Overall Study|Lost to Follow-up|9|||
128789058|NCT00545844|463519955|FG000|Overall Study|Protocol Violation|1|||
128789059|NCT00545844|463519955|FG000|Overall Study|Withdrawal by Subject|2|||
128789060|NCT00957658|463519956|FG000|Overall Study|Death|1|||
128789061|NCT00957658|463519956|FG000|Overall Study|Lost to Follow-up|4|||
128789062|NCT00957658|463519956|FG000|Overall Study|Withdrawal by Subject|12|||
128789063|NCT00957658|463519956|FG000|Overall Study|Revision|1|||
128789064|NCT00957658|463519956|FG000|Overall Study|Incomplete 2 yr data|28|||
128789065|NCT00957658|463519956|FG000|Overall Study|Site termination|10|||
128789066|NCT00957658|463519956|FG000|Overall Study|unwilling/unable to return|2|||
128789067|NCT00957658|463519956|FG000|Overall Study|surgery cancelled|2|||
128789068|NCT00957658|463519956|FG000|Overall Study|Protocol Violation|5|||
128789069|NCT00975806|463519957|FG000|Overall Study|Adverse Event|2|||
128789070|NCT00975806|463519958|FG001|Overall Study|Adverse Event|1|||
128789071|NCT00975806|463519959|FG002|Overall Study|Adverse Event|2|||
128789072|NCT00975806|463519957|FG000|Overall Study|Disease Progression|1|||
128789073|NCT00975806|463519958|FG001|Overall Study|Disease Progression|5|||
128789074|NCT00975806|463519959|FG002|Overall Study|Disease Progression|1|||
128789075|NCT00975806|463519957|FG000|Overall Study|Withdrawal by Subject|1|||
128789076|NCT00975806|463519958|FG001|Overall Study|Withdrawal by Subject|0|||
128789077|NCT00975806|463519959|FG002|Overall Study|Withdrawal by Subject|0|||
128789078|NCT00975806|463519957|FG000|Overall Study|Death|0|||
128789079|NCT00975806|463519958|FG001|Overall Study|Death|1|||
128789080|NCT00975806|463519959|FG002|Overall Study|Death|0|||
128789081|NCT00975806|463519957|FG000|Overall Study|Physician decision and disease related|1|||
128789082|NCT00975806|463519958|FG001|Overall Study|Physician decision and disease related|0|||
128789083|NCT00975806|463519959|FG002|Overall Study|Physician decision and disease related|1|||
128789084|NCT02377362|463519960|FG000|Part A Second Treatment|Protocol Violation|0|||
128789085|NCT02377362|463519961|FG001|Part A Second Treatment|Protocol Violation|0|||
128789086|NCT02377362|463519962|FG002|Part A Second Treatment|Protocol Violation|0|||
128789087|NCT02377362|463519963|FG003|Part A Second Treatment|Protocol Violation|0|||
128789088|NCT02377362|463519964|FG004|Part A Second Treatment|Protocol Violation|1|||
128789089|NCT02377362|463519965|FG005|Part A Second Treatment|Protocol Violation|0|||
128789090|NCT02377362|463519966|FG006|Part A Second Treatment|Protocol Violation|0|||
128789091|NCT02377362|463519967|FG007|Part A Second Treatment|Protocol Violation|0|||
128789092|NCT02377362|463519968|FG008|Part A Second Treatment|Protocol Violation|0|||
128789093|NCT02377362|463519969|FG009|Part A Second Treatment|Protocol Violation|0|||
128789094|NCT02377362|463519970|FG010|Part A Second Treatment|Protocol Violation|0|||
128789095|NCT02377362|463519971|FG011|Part A Second Treatment|Protocol Violation|0|||
128789096|NCT02377362|463519972|FG012|Part A Second Treatment|Protocol Violation|0|||
128789097|NCT02377362|463519960|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789098|NCT02377362|463519961|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789099|NCT02377362|463519962|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789100|NCT02377362|463519963|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
128789101|NCT02377362|463519964|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
128789102|NCT02377362|463519965|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
128789103|NCT02377362|463519966|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789104|NCT02377362|463519967|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789105|NCT02377362|463519968|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789106|NCT02377362|463519969|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789107|NCT02377362|463519970|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789108|NCT02377362|463519971|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789109|NCT02377362|463519972|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
128789110|NCT02377362|463519960|FG000|Part B Overall|Protocol Violation|0|||
128789111|NCT02377362|463519961|FG001|Part B Overall|Protocol Violation|0|||
128789112|NCT02377362|463519962|FG002|Part B Overall|Protocol Violation|0|||
128789113|NCT02377362|463519963|FG003|Part B Overall|Protocol Violation|0|||
128789114|NCT02377362|463519964|FG004|Part B Overall|Protocol Violation|0|||
128789115|NCT02377362|463519965|FG005|Part B Overall|Protocol Violation|0|||
128789116|NCT02377362|463519966|FG006|Part B Overall|Protocol Violation|0|||
128789117|NCT02377362|463519967|FG007|Part B Overall|Protocol Violation|0|||
128789118|NCT02377362|463519968|FG008|Part B Overall|Protocol Violation|0|||
128789119|NCT02377362|463519969|FG009|Part B Overall|Protocol Violation|1|||
128789120|NCT02377362|463519970|FG010|Part B Overall|Protocol Violation|0|||
128789121|NCT02377362|463519971|FG011|Part B Overall|Protocol Violation|0|||
128789122|NCT02377362|463519972|FG012|Part B Overall|Protocol Violation|0|||
128789123|NCT02377362|463519960|FG000|Part B Overall|Adverse Event|0|||
128789124|NCT02377362|463519961|FG001|Part B Overall|Adverse Event|0|||
128789125|NCT02377362|463519962|FG002|Part B Overall|Adverse Event|0|||
128789126|NCT02377362|463519963|FG003|Part B Overall|Adverse Event|0|||
128789127|NCT02377362|463519964|FG004|Part B Overall|Adverse Event|0|||
128789128|NCT02377362|463519965|FG005|Part B Overall|Adverse Event|0|||
128789129|NCT02377362|463519966|FG006|Part B Overall|Adverse Event|1|||
128789130|NCT02377362|463519967|FG007|Part B Overall|Adverse Event|1|||
128789131|NCT02377362|463519968|FG008|Part B Overall|Adverse Event|0|||
128789132|NCT02377362|463519969|FG009|Part B Overall|Adverse Event|0|||
128789133|NCT02377362|463519970|FG010|Part B Overall|Adverse Event|0|||
128789134|NCT02377362|463519971|FG011|Part B Overall|Adverse Event|0|||
128789135|NCT02377362|463519972|FG012|Part B Overall|Adverse Event|0|||
128789136|NCT02377362|463519960|FG000|Part B Overall|Withdrawal by Subject|0|||
128789137|NCT02377362|463519961|FG001|Part B Overall|Withdrawal by Subject|0|||
128789138|NCT02377362|463519962|FG002|Part B Overall|Withdrawal by Subject|0|||
128789139|NCT02377362|463519963|FG003|Part B Overall|Withdrawal by Subject|0|||
128789140|NCT02377362|463519964|FG004|Part B Overall|Withdrawal by Subject|0|||
128789141|NCT02377362|463519965|FG005|Part B Overall|Withdrawal by Subject|0|||
128789142|NCT02377362|463519966|FG006|Part B Overall|Withdrawal by Subject|1|||
128789143|NCT02377362|463519967|FG007|Part B Overall|Withdrawal by Subject|0|||
128789144|NCT02377362|463519968|FG008|Part B Overall|Withdrawal by Subject|0|||
128789145|NCT02377362|463519969|FG009|Part B Overall|Withdrawal by Subject|0|||
128789146|NCT02377362|463519970|FG010|Part B Overall|Withdrawal by Subject|0|||
128789147|NCT02377362|463519971|FG011|Part B Overall|Withdrawal by Subject|1|||
128789148|NCT02377362|463519972|FG012|Part B Overall|Withdrawal by Subject|0|||
128789149|NCT01833832|463519973|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
128789150|NCT02148133|463519975|FG000|Overall Study|Investigator discretion|1|||
128789151|NCT02148133|463519975|FG000|Overall Study|Lack of Efficacy|1|||
128789152|NCT02148133|463519975|FG000|Overall Study|Protocol deviation|1|||
128789153|NCT02148133|463519975|FG000|Overall Study|Protocol-defined stopping criteria|2|||
128789154|NCT00079183|463519976|FG000|Overall Study|Withdrawal by Subject|4|||
128789155|NCT00079183|463519976|FG000|Overall Study|Study medication non-compliance|2|||
128789156|NCT00079183|463519976|FG000|Overall Study|Specimen collection non-compliance|1|||
128789157|NCT00371566|463519977|FG000|Treatment Phase|Withdrawal by Subject|0|||
128789158|NCT00371566|463519978|FG001|Treatment Phase|Withdrawal by Subject|1|||
128789159|NCT00371566|463519977|FG000|Treatment Phase|Adverse Event|0|||
128789160|NCT00371566|463519978|FG001|Treatment Phase|Adverse Event|1|||
128789161|NCT00371566|463519977|FG000|Treatment Phase|Protocol Violation|0|||
128789162|NCT00371566|463519978|FG001|Treatment Phase|Protocol Violation|1|||
128789163|NCT00371566|463519977|FG000|Chemoradiation Phase|Physician Decision|2|||
128789164|NCT00371566|463519978|FG001|Chemoradiation Phase|Physician Decision|0|||
128789165|NCT00371566|463519977|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
128789166|NCT00371566|463519978|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
128789167|NCT00371566|463519977|FG000|Chemoradiation Phase|Non compliant|0|||
128789168|NCT00371566|463519978|FG001|Chemoradiation Phase|Non compliant|1|||
128789169|NCT00371566|463519977|FG000|Chemoradiation Phase|Progressive Disease|1|||
128789170|NCT00371566|463519978|FG001|Chemoradiation Phase|Progressive Disease|1|||
128789171|NCT00371566|463519977|FG000|Chemoradiation Phase|Death|2|||
128789172|NCT00371566|463519978|FG001|Chemoradiation Phase|Death|0|||
128789173|NCT00371566|463519977|FG000|Follow Up Phase|Death|0|||
128789174|NCT00371566|463519978|FG001|Follow Up Phase|Death|5|||
128789175|NCT00371566|463519977|FG000|Follow Up Phase|Disease progression|1|||
128789176|NCT00371566|463519978|FG001|Follow Up Phase|Disease progression|0|||
128789177|NCT00371566|463519977|FG000|Follow Up Phase|Withdrawal by Subject|0|||
128789178|NCT00371566|463519978|FG001|Follow Up Phase|Withdrawal by Subject|1|||
128789179|NCT00371566|463519977|FG000|Follow Up Phase|Physician Decision|1|||
128789180|NCT00371566|463519978|FG001|Follow Up Phase|Physician Decision|1|||
128789181|NCT00371566|463519977|FG000|Follow Up Phase|Lost to Follow-up|1|||
128789182|NCT00371566|463519978|FG001|Follow Up Phase|Lost to Follow-up|0|||
128789183|NCT00972504|463519979|FG000|Overall Study|Adverse Event|2|||
128789184|NCT00972504|463519979|FG000|Overall Study|Investigator discretion|1|||
128789185|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
128789186|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
128789187|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
128789188|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
128789189|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
128789190|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
128789191|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
128789192|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
128789193|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
128789194|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
128789195|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
128789196|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
128789197|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Death|7|||
128789198|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Death|4|||
128789199|NCT00410124|463519980|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
128789200|NCT00410124|463519981|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
128789201|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
128789202|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
128789203|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
128789204|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
128789205|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
128789206|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
128789207|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
128789208|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
128789209|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
128789210|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
128789211|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
128789212|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
128789213|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
128789214|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
128789215|NCT00410124|463519980|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
128789216|NCT00410124|463519981|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
128789217|NCT02807493|463519984|FG000|Overall Study|Adverse Event|5|||
128789218|NCT02807493|463519985|FG001|Overall Study|Adverse Event|2|||
128789219|NCT02807493|463519984|FG000|Overall Study|Lost to Follow-up|6|||
128789220|NCT02807493|463519985|FG001|Overall Study|Lost to Follow-up|0|||
128789221|NCT02807493|463519984|FG000|Overall Study|Physician Decision|4|||
128789222|NCT02807493|463519985|FG001|Overall Study|Physician Decision|1|||
128789223|NCT02807493|463519984|FG000|Overall Study|Protocol Violation|7|||
128789224|NCT02807493|463519985|FG001|Overall Study|Protocol Violation|0|||
128789225|NCT02807493|463519984|FG000|Overall Study|Withdrawal by Subject|17|||
128789226|NCT02807493|463519985|FG001|Overall Study|Withdrawal by Subject|10|||
128789227|NCT02807493|463519984|FG000|Overall Study|Other withdrawal|17|||
128789228|NCT02807493|463519985|FG001|Overall Study|Other withdrawal|0|||
128789229|NCT02807493|463519984|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
128789230|NCT02807493|463519985|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
128789231|NCT00741988|463519987|FG000|Overall Study|Adverse Event|2|||
128789232|NCT00741988|463519988|FG001|Overall Study|Adverse Event|4|||
128789233|NCT00741988|463519987|FG000|Overall Study|Lack of Efficacy|2|||
128789234|NCT00741988|463519988|FG001|Overall Study|Lack of Efficacy|0|||
128789235|NCT00811057|463519989|FG000|Overall Study|Protocol Violation|5|||
128789236|NCT00811057|463519990|FG001|Overall Study|Protocol Violation|10|||
128789237|NCT00811057|463519991|FG002|Overall Study|Protocol Violation|10|||
128789238|NCT00768651|463519996|FG000|Overall Study|Withdrawal by Subject|1|||
128789239|NCT02104765|463519997|FG000|Overall Study|Lost to Follow-up|0|||
128789240|NCT02104765|463519998|FG001|Overall Study|Lost to Follow-up|0|||
128789241|NCT02104765|463519999|FG002|Overall Study|Lost to Follow-up|1|||
128789242|NCT02104765|463520000|FG003|Overall Study|Lost to Follow-up|0|||
128789243|NCT02104765|463520001|FG004|Overall Study|Lost to Follow-up|0|||
128789244|NCT02104765|463520002|FG005|Overall Study|Lost to Follow-up|0|||
128789245|NCT02104765|463520003|FG006|Overall Study|Lost to Follow-up|0|||
128789246|NCT02104765|463519997|FG000|Overall Study|Withdrawal by Subject|0|||
128789247|NCT02104765|463519998|FG001|Overall Study|Withdrawal by Subject|0|||
128789248|NCT02104765|463519999|FG002|Overall Study|Withdrawal by Subject|0|||
128789249|NCT02104765|463520000|FG003|Overall Study|Withdrawal by Subject|1|||
128789250|NCT02104765|463520001|FG004|Overall Study|Withdrawal by Subject|1|||
128789251|NCT02104765|463520002|FG005|Overall Study|Withdrawal by Subject|0|||
128789252|NCT02104765|463520003|FG006|Overall Study|Withdrawal by Subject|1|||
128789253|NCT00995709|463520008|FG000|Overall Study|Adverse Event|4|||
128789254|NCT00995709|463520009|FG001|Overall Study|Adverse Event|2|||
128789255|NCT00995709|463520010|FG002|Overall Study|Adverse Event|0|||
128789256|NCT00995709|463520008|FG000|Overall Study|Lack of Efficacy|0|||
128789257|NCT00995709|463520009|FG001|Overall Study|Lack of Efficacy|1|||
128789258|NCT00995709|463520010|FG002|Overall Study|Lack of Efficacy|4|||
128789259|NCT00995709|463520008|FG000|Overall Study|Withdrawal by Subject|0|||
128789260|NCT00995709|463520009|FG001|Overall Study|Withdrawal by Subject|4|||
128789261|NCT00995709|463520010|FG002|Overall Study|Withdrawal by Subject|1|||
128789262|NCT00995709|463520008|FG000|Overall Study|Lost to Follow-up|1|||
128789263|NCT00995709|463520009|FG001|Overall Study|Lost to Follow-up|0|||
128789264|NCT00995709|463520010|FG002|Overall Study|Lost to Follow-up|0|||
128789265|NCT00995709|463520008|FG000|Overall Study|Death|0|||
128789266|NCT00995709|463520009|FG001|Overall Study|Death|1|||
128789267|NCT00995709|463520010|FG002|Overall Study|Death|0|||
128789268|NCT00995709|463520008|FG000|Overall Study|Protocol Violation|2|||
128789269|NCT00995709|463520009|FG001|Overall Study|Protocol Violation|1|||
128789270|NCT00995709|463520010|FG002|Overall Study|Protocol Violation|0|||
128789271|NCT01697319|463520011|FG000|Primary Phase|Withdrawal by Subject|1|||
128789272|NCT01697319|463520011|FG000|Extension Phase|Terminated by Sponsor|15|||
128789273|NCT04222959|463520012|FG000|Overall Study|Lost to Follow-up|76|||
128789274|NCT04222959|463520013|FG001|Overall Study|Lost to Follow-up|28|||
128789275|NCT03008915|463520014|FG000|Treatment 1|Withdrawal by Subject|0|||
128789276|NCT03008915|463520015|FG001|Treatment 1|Withdrawal by Subject|1|||
128789277|NCT00712166|463520018|FG000|Overall Study|Noncompliance|0|||
128789278|NCT00712166|463520019|FG001|Overall Study|Noncompliance|1|||
128789279|NCT01773122|463520020|FG000|Overall Study|Due to amended age eligibility criteria|3|||
128789280|NCT01773122|463520021|FG001|Overall Study|Due to amended age eligibility criteria|1|||
128789281|NCT01773122|463520022|FG002|Overall Study|Due to amended age eligibility criteria|0|||
128789282|NCT01773122|463520023|FG003|Overall Study|Due to amended age eligibility criteria|1|||
128789283|NCT01264718|463520024|FG000|Overall Study|Lost to Follow-up|3|||
128789284|NCT01264718|463520025|FG001|Overall Study|Lost to Follow-up|2|||
128789285|NCT01264718|463520024|FG000|Overall Study|Withdrawal by Subject|9|||
128789286|NCT01264718|463520025|FG001|Overall Study|Withdrawal by Subject|15|||
128789287|NCT01264718|463520024|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
128789288|NCT01264718|463520025|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
128789289|NCT01769391|463520028|FG000|Overall Study|Death|10|||
128789290|NCT01769391|463520029|FG001|Overall Study|Death|1|||
128789291|NCT01769391|463520028|FG000|Overall Study|Adverse Event|0|||
128789292|NCT01769391|463520029|FG001|Overall Study|Adverse Event|3|||
128789293|NCT01769391|463520028|FG000|Overall Study|Progressive Disease|1|||
128789294|NCT01769391|463520029|FG001|Overall Study|Progressive Disease|2|||
128789295|NCT01769391|463520028|FG000|Overall Study|Withdrawal by Subject|4|||
128789296|NCT01769391|463520029|FG001|Overall Study|Withdrawal by Subject|3|||
128789297|NCT01769391|463520028|FG000|Overall Study|Investigator Decision|2|||
128789298|NCT01769391|463520029|FG001|Overall Study|Investigator Decision|0|||
128789299|NCT01144182|463520031|FG000|Overall Study|Death|5|||
128789300|NCT01144182|463520032|FG001|Overall Study|Death|6|||
128789301|NCT01144182|463520031|FG000|Overall Study|Withdrawal by Subject|3|||
128789302|NCT01144182|463520032|FG001|Overall Study|Withdrawal by Subject|6|||
128789303|NCT01144182|463520031|FG000|Overall Study|Lost to Follow-up|9|||
128789304|NCT01144182|463520032|FG001|Overall Study|Lost to Follow-up|9|||
128789305|NCT03264456|463520037|FG000|Overall Study|Withdrawal by Subject|3|||
128789306|NCT03264456|463520037|FG000|Overall Study|Lost to Follow-up|1|||
128789307|NCT03538054|463520038|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
128789308|NCT03538054|463520038|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
128789309|NCT03538054|463520038|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
128789310|NCT03254394|463520039|FG000|Overall Study|Withdrawal by Subject|0|||
128789311|NCT03254394|463520040|FG001|Overall Study|Withdrawal by Subject|2|||
128789312|NCT02351180|463520043|FG000|Overall Study|Withdrawal by Subject|1|||
128789313|NCT02351180|463520044|FG001|Overall Study|Withdrawal by Subject|0|||
128789314|NCT01123083|463520051|FG000|Overall Study|Investigator recommendation|1|||
128789315|NCT01123083|463520052|FG001|Overall Study|Investigator recommendation|1|||
128789316|NCT01123083|463520051|FG000|Overall Study|Administrative reasons|0|||
128789317|NCT01123083|463520052|FG001|Overall Study|Administrative reasons|4|||
128789318|NCT01123083|463520051|FG000|Overall Study|Lost to Follow-up|2|||
128789319|NCT01123083|463520052|FG001|Overall Study|Lost to Follow-up|6|||
128789320|NCT01123083|463520051|FG000|Overall Study|Adverse Event|1|||
128789321|NCT01123083|463520052|FG001|Overall Study|Adverse Event|0|||
128789322|NCT01123083|463520051|FG000|Overall Study|Withdrew for another reason not covered|0|||
128789323|NCT01123083|463520052|FG001|Overall Study|Withdrew for another reason not covered|1|||
128789324|NCT01123083|463520051|FG000|Overall Study|Participant/legal representative request|7|||
128789325|NCT01123083|463520052|FG001|Overall Study|Participant/legal representative request|3|||
128789326|NCT03418324|463520053|FG000|Overall Study|Death|0|||
128789327|NCT03418324|463520054|FG001|Overall Study|Death|1|||
128789328|NCT03418324|463520053|FG000|Overall Study|Physician Decision|1|||
128789329|NCT03418324|463520054|FG001|Overall Study|Physician Decision|1|||
128789330|NCT01751724|463520055|FG000|Overall Study|extubated bef.start assigned treatment|1|||
128789331|NCT01751724|463520056|FG001|Overall Study|extubated bef.start assigned treatment|0|||
128789332|NCT01751724|463520055|FG000|Overall Study|withdrawn by parent|0|||
128789333|NCT01751724|463520056|FG001|Overall Study|withdrawn by parent|2|||
128789334|NCT03121950|463520058|FG000|Overall Study|Withdrawal by Subject|11|||
128789335|NCT03121950|463520059|FG001|Overall Study|Withdrawal by Subject|2|||
128789336|NCT01867580|463520060|FG000|Overall Study|Withdrawal by Subject|2|||
128789337|NCT01867580|463520061|FG001|Overall Study|Withdrawal by Subject|3|||
128789338|NCT01867580|463520060|FG000|Overall Study|Physician Decision|17|||
128789339|NCT01867580|463520061|FG001|Overall Study|Physician Decision|12|||
128789340|NCT01867580|463520060|FG000|Overall Study|Lost to Follow-up|3|||
128789341|NCT01867580|463520061|FG001|Overall Study|Lost to Follow-up|5|||
128789342|NCT01867580|463520060|FG000|Overall Study|Sponsor terminated study|1|||
128789343|NCT01867580|463520061|FG001|Overall Study|Sponsor terminated study|0|||
128789344|NCT01867580|463520060|FG000|Overall Study|Missed follow-up assessment|2|||
128789345|NCT01867580|463520061|FG001|Overall Study|Missed follow-up assessment|1|||
128789346|NCT01867580|463520060|FG000|Overall Study|Interruption to therapy|3|||
128789347|NCT01867580|463520061|FG001|Overall Study|Interruption to therapy|0|||
128789348|NCT01867580|463520060|FG000|Overall Study|Osteomyelitis|0|||
128789349|NCT01867580|463520061|FG001|Overall Study|Osteomyelitis|1|||
128789350|NCT01867580|463520060|FG000|Overall Study|Continuation of therapy|0|||
128789351|NCT01867580|463520061|FG001|Overall Study|Continuation of therapy|1|||
128789352|NCT01867580|463520060|FG000|Overall Study|Wound recurrence|0|||
128789353|NCT01867580|463520061|FG001|Overall Study|Wound recurrence|1|||
128789354|NCT03141788|463520062|FG000|Overall Study|Lost to Follow-up|1|||
128789355|NCT03141788|463520062|FG000|Overall Study|Protocol Violation|3|||
128789356|NCT03141788|463520062|FG000|Overall Study|Withdrawal by Subject|4|||
128789357|NCT01025843|463521262|FG000|Washout 4|Withdrawal by Subject|0|||
128789358|NCT01025843|463521263|FG001|Washout 4|Withdrawal by Subject|0|||
128789359|NCT01025843|463521264|FG002|Washout 4|Withdrawal by Subject|1|||
128789360|NCT01025843|463521265|FG003|Washout 4|Withdrawal by Subject|1|||
128789361|NCT01025843|463521266|FG004|Washout 4|Withdrawal by Subject|0|||
128789362|NCT01025843|463521267|FG005|Washout 4|Withdrawal by Subject|0|||
128789363|NCT01025843|463521268|FG006|Washout 4|Withdrawal by Subject|0|||
128789364|NCT01025843|463521269|FG007|Washout 4|Withdrawal by Subject|0|||
128789365|NCT01025843|463521270|FG008|Washout 4|Withdrawal by Subject|0|||
128789366|NCT01025843|463521271|FG009|Washout 4|Withdrawal by Subject|0|||
128789367|NCT00377455|463521274|FG000|Overall Study|Withdrawal by Subject|1|||
128789368|NCT01897233|463521277|FG000|Part B (24 Weeks)|Adverse Event|1|||
128789369|NCT01897233|463521277|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
128789370|NCT01897233|463521277|FG000|Part B (24 Weeks)|Physician Decision|1|||
128789371|NCT01281813|463521292|FG000|Overall Study|Adverse Event|0|||
128789372|NCT01281813|463521293|FG001|Overall Study|Adverse Event|0|||
128789373|NCT01281813|463521294|FG002|Overall Study|Adverse Event|10|||
128789374|NCT01281813|463521292|FG000|Overall Study|Lost to Follow-up|0|||
128789375|NCT01281813|463521293|FG001|Overall Study|Lost to Follow-up|0|||
128789376|NCT01281813|463521294|FG002|Overall Study|Lost to Follow-up|31|||
128789377|NCT01281813|463521292|FG000|Overall Study|Withdrawal by Subject|0|||
128789378|NCT01281813|463521293|FG001|Overall Study|Withdrawal by Subject|0|||
128789379|NCT01281813|463521294|FG002|Overall Study|Withdrawal by Subject|13|||
128789380|NCT01281813|463521292|FG000|Overall Study|Subject Non-Compliant|0|||
128789381|NCT01281813|463521293|FG001|Overall Study|Subject Non-Compliant|0|||
128789382|NCT01281813|463521294|FG002|Overall Study|Subject Non-Compliant|6|||
128789383|NCT01281813|463521292|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
128789384|NCT01281813|463521293|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
128789385|NCT01281813|463521294|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
128789386|NCT01281813|463521292|FG000|Overall Study|Sponsor's Decision|4|||
128789387|NCT01281813|463521293|FG001|Overall Study|Sponsor's Decision|3|||
128789388|NCT01281813|463521294|FG002|Overall Study|Sponsor's Decision|7|||
128789389|NCT01281813|463521292|FG000|Overall Study|Switched to Commercially Available Medication|0|||
128789390|NCT01281813|463521293|FG001|Overall Study|Switched to Commercially Available Medication|0|||
128789391|NCT01281813|463521294|FG002|Overall Study|Switched to Commercially Available Medication|26|||
128789392|NCT01281813|463521292|FG000|Overall Study|Other|0|||
128789393|NCT01281813|463521293|FG001|Overall Study|Other|1|||
128789394|NCT01281813|463521294|FG002|Overall Study|Other|39|||
128789395|NCT03546907|463521295|FG000|Overall Study|Lack of Efficacy|1|||
128789396|NCT03546907|463521296|FG001|Overall Study|Lack of Efficacy|1|||
128789397|NCT03546907|463521295|FG000|Overall Study|Withdrawal by Subject|8|||
128789398|NCT03546907|463521296|FG001|Overall Study|Withdrawal by Subject|9|||
128789399|NCT03546907|463521295|FG000|Overall Study|Adverse events (AEs)|7|||
128789400|NCT03546907|463521296|FG001|Overall Study|Adverse events (AEs)|10|||
128789401|NCT03546907|463521295|FG000|Overall Study|Other-unspecified|1|||
128789402|NCT03546907|463521296|FG001|Overall Study|Other-unspecified|1|||
128789403|NCT02810080|463521297|FG000|Overall Study|Adverse Event|3|||
128789404|NCT02810080|463521298|FG001|Overall Study|Adverse Event|0|||
128789405|NCT02810080|463521297|FG000|Overall Study|Death|0|||
128789406|NCT02810080|463521298|FG001|Overall Study|Death|2|||
128789407|NCT02810080|463521297|FG000|Overall Study|Physician Decision|4|||
128789408|NCT02810080|463521298|FG001|Overall Study|Physician Decision|0|||
128789409|NCT02810080|463521297|FG000|Overall Study|Withdrawal by Subject|0|||
128789410|NCT02810080|463521298|FG001|Overall Study|Withdrawal by Subject|2|||
128789411|NCT04033432|463521301|FG000|Overall Study|Progressive Disease|8|||
128789412|NCT04033432|463521301|FG000|Overall Study|Adverse Event|4|||
128789413|NCT04033432|463521301|FG000|Overall Study|Death|1|||
128789414|NCT00393848|463521302|FG000|Overall Study|Surgical schedule|0|||
128789415|NCT00393848|463521303|FG001|Overall Study|Surgical schedule|0|||
128789416|NCT00393848|463521304|FG002|Overall Study|Surgical schedule|0|||
128789417|NCT00393848|463521305|FG003|Overall Study|Surgical schedule|1|||
128789418|NCT00393848|463521302|FG000|Overall Study|Personal reasons|0|||
128789419|NCT00393848|463521303|FG001|Overall Study|Personal reasons|0|||
128789420|NCT00393848|463521304|FG002|Overall Study|Personal reasons|2|||
128789421|NCT00393848|463521305|FG003|Overall Study|Personal reasons|0|||
128789422|NCT02192606|463521309|FG000|Overall Study|surgery type was changed|1|||
128789423|NCT02192606|463521310|FG001|Overall Study|surgery type was changed|1|||
128789424|NCT02192606|463521309|FG000|Overall Study|Physician Decision|1|||
128789425|NCT02192606|463521310|FG001|Overall Study|Physician Decision|2|||
128789426|NCT02192606|463521309|FG000|Overall Study|3D equipment rep unable to join|0|||
128789427|NCT02192606|463521310|FG001|Overall Study|3D equipment rep unable to join|1|||
128789428|NCT01458210|463521311|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
128789429|NCT01458210|463521311|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
128789430|NCT01458210|463521311|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
128789431|NCT01458210|463521311|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
128789432|NCT03923491|463521312|FG000|Overall Study|Lost to Follow-up|5|||
128789433|NCT03923491|463521313|FG001|Overall Study|Lost to Follow-up|8|||
128789434|NCT03923491|463521312|FG000|Overall Study|Withdrawal by Subject|4|||
128789435|NCT03923491|463521313|FG001|Overall Study|Withdrawal by Subject|6|||
128789436|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
128789437|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
128789438|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
128789439|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
128789440|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
128789441|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
128789442|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
128789443|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
128789444|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
128789445|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
128789446|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
128789447|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
128789448|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
128789449|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
128789450|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
128789451|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
128789452|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
128789453|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
128789454|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
128789455|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
128789456|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
128789457|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
128789458|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
128789459|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
128789460|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
128789461|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
128789462|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
128789463|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
128789464|NCT00241644|463521317|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
128789465|NCT00241644|463521318|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
128789466|NCT00241644|463521319|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
128789467|NCT00241644|463521320|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
128789468|NCT00241644|463521317|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
128789469|NCT00241644|463521318|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
128789470|NCT00241644|463521319|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
128789471|NCT00241644|463521320|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
128789472|NCT00241644|463521317|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
128789473|NCT00241644|463521318|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
128789474|NCT00241644|463521319|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
128789475|NCT00241644|463521320|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
128789476|NCT00241644|463521317|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
128789477|NCT00241644|463521318|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
128789478|NCT00241644|463521319|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
128789479|NCT00241644|463521320|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
128789480|NCT00241644|463521317|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
128789481|NCT00241644|463521318|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
128789482|NCT00241644|463521319|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
128789483|NCT00241644|463521320|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
128789484|NCT00241644|463521317|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
128789485|NCT00241644|463521318|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
128789486|NCT00241644|463521319|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
128789487|NCT00241644|463521320|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
128789488|NCT01027286|463521321|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
128789489|NCT01027286|463521322|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
128789490|NCT01027286|463521321|FG000|Overall Study|Lost to Follow-up|0|||
128789491|NCT01027286|463521322|FG001|Overall Study|Lost to Follow-up|1|||
128789492|NCT01563354|463521323|FG000|Core Phase|Adverse Event|5|||
128789493|NCT01563354|463521324|FG001|Core Phase|Adverse Event|15|||
128789494|NCT01563354|463521325|FG002|Core Phase|Adverse Event|13|||
128789495|NCT01563354|463521323|FG000|Core Phase|Withdrawal by Subject|1|||
128789496|NCT01563354|463521324|FG001|Core Phase|Withdrawal by Subject|0|||
128789497|NCT01563354|463521325|FG002|Core Phase|Withdrawal by Subject|3|||
128789498|NCT01563354|463521323|FG000|Core Phase|Lost to Follow-up|1|||
128789499|NCT01563354|463521324|FG001|Core Phase|Lost to Follow-up|0|||
128789500|NCT01563354|463521325|FG002|Core Phase|Lost to Follow-up|0|||
128789501|NCT01563354|463521323|FG000|Core Phase|Death|1|||
128789502|NCT01563354|463521324|FG001|Core Phase|Death|5|||
128789503|NCT01563354|463521325|FG002|Core Phase|Death|2|||
128789504|NCT01563354|463521323|FG000|Core Phase|Diseasse progression|18|||
128789505|NCT01563354|463521324|FG001|Core Phase|Diseasse progression|7|||
128789506|NCT01563354|463521325|FG002|Core Phase|Diseasse progression|8|||
128789507|NCT01563354|463521323|FG000|Core Phase|Protocol deviation|2|||
128789508|NCT01563354|463521324|FG001|Core Phase|Protocol deviation|0|||
128789509|NCT01563354|463521325|FG002|Core Phase|Protocol deviation|0|||
128789510|NCT01563354|463521323|FG000|Core Phase|PI decision - did not enter extension|0|||
128789511|NCT01563354|463521324|FG001|Core Phase|PI decision - did not enter extension|1|||
128789512|NCT01563354|463521325|FG002|Core Phase|PI decision - did not enter extension|0|||
128789513|NCT01563354|463521323|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
128789514|NCT01563354|463521324|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
128789515|NCT01563354|463521325|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
128789516|NCT01563354|463521323|FG000|Extension Phase|Adverse Event|0|||
128789517|NCT01563354|463521324|FG001|Extension Phase|Adverse Event|3|||
128789518|NCT01563354|463521325|FG002|Extension Phase|Adverse Event|2|||
128789519|NCT01563354|463521323|FG000|Extension Phase|Withdrawal by Subject|0|||
128789520|NCT01563354|463521324|FG001|Extension Phase|Withdrawal by Subject|1|||
128789521|NCT01563354|463521325|FG002|Extension Phase|Withdrawal by Subject|0|||
128789522|NCT01563354|463521323|FG000|Extension Phase|Administration problems|3|||
128789523|NCT01563354|463521324|FG001|Extension Phase|Administration problems|2|||
128789524|NCT01563354|463521325|FG002|Extension Phase|Administration problems|3|||
128789525|NCT01563354|463521323|FG000|Extension Phase|Disease progression|9|||
128789526|NCT01563354|463521324|FG001|Extension Phase|Disease progression|8|||
128789527|NCT01563354|463521325|FG002|Extension Phase|Disease progression|10|||
128789528|NCT01565928|463521326|FG000|Overall Study|Adverse Event|3|||
128789529|NCT01565928|463521326|FG000|Overall Study|Other|3|||
128789530|NCT01565928|463521326|FG000|Overall Study|Progressive Disease|13|||
128789531|NCT01565928|463521326|FG000|Overall Study|Withdrawal by Subject|1|||
128789532|NCT01565928|463521326|FG000|Overall Study|Death|2|||
128789533|NCT00608907|463521329|FG000|Overall Study|Adverse Event|6|||
128789534|NCT00608907|463521330|FG001|Overall Study|Adverse Event|0|||
128789535|NCT00608907|463521331|FG002|Overall Study|Adverse Event|1|||
128789536|NCT00608907|463521329|FG000|Overall Study|Death|1|||
128789537|NCT00608907|463521330|FG001|Overall Study|Death|0|||
128789538|NCT00608907|463521331|FG002|Overall Study|Death|0|||
128789539|NCT00608907|463521329|FG000|Overall Study|Withdrawal by Subject|4|||
128789540|NCT00608907|463521330|FG001|Overall Study|Withdrawal by Subject|0|||
128789541|NCT00608907|463521331|FG002|Overall Study|Withdrawal by Subject|0|||
128789542|NCT00608907|463521329|FG000|Overall Study|Progressive Disease|1|||
128789543|NCT00608907|463521330|FG001|Overall Study|Progressive Disease|0|||
128789544|NCT00608907|463521331|FG002|Overall Study|Progressive Disease|0|||
128789545|NCT01988233|463521334|FG000|Overall Study|Lost to Follow-up|64|||
128789546|NCT01988233|463521335|FG001|Overall Study|Lost to Follow-up|51|||
128789547|NCT03621761|463521340|FG000|Overall Study|Lost to Follow-up|1|||
128789548|NCT03621761|463521341|FG001|Overall Study|Lost to Follow-up|1|||
128789549|NCT03621761|463521342|FG002|Overall Study|Lost to Follow-up|2|||
128789550|NCT03621761|463521340|FG000|Overall Study|Withdrawal by Subject|2|||
128789551|NCT03621761|463521341|FG001|Overall Study|Withdrawal by Subject|1|||
128789552|NCT03621761|463521342|FG002|Overall Study|Withdrawal by Subject|1|||
128789553|NCT03621761|463521340|FG000|Overall Study|Became Ineligible|0|||
128789554|NCT03621761|463521341|FG001|Overall Study|Became Ineligible|2|||
128789555|NCT03621761|463521342|FG002|Overall Study|Became Ineligible|0|||
128789556|NCT01050569|463521343|FG000|Overall Study|Lost to Follow-up|20|||
128789557|NCT01050569|463521344|FG001|Overall Study|Lost to Follow-up|14|||
128789558|NCT01050569|463521345|FG002|Overall Study|Lost to Follow-up|16|||
128789559|NCT01050569|463521343|FG000|Overall Study|Withdrawal by Subject|9|||
128789560|NCT01050569|463521344|FG001|Overall Study|Withdrawal by Subject|3|||
128789561|NCT01050569|463521345|FG002|Overall Study|Withdrawal by Subject|11|||
128789562|NCT01050569|463521343|FG000|Overall Study|Lack of Efficacy|5|||
128789563|NCT01050569|463521344|FG001|Overall Study|Lack of Efficacy|4|||
128789564|NCT01050569|463521345|FG002|Overall Study|Lack of Efficacy|3|||
128789565|NCT01050569|463521343|FG000|Overall Study|Adverse Event|1|||
128789566|NCT01050569|463521344|FG001|Overall Study|Adverse Event|0|||
128789567|NCT01050569|463521345|FG002|Overall Study|Adverse Event|0|||
128789568|NCT01050569|463521343|FG000|Overall Study|Physician Decision|3|||
128789569|NCT01050569|463521344|FG001|Overall Study|Physician Decision|3|||
128789570|NCT01050569|463521345|FG002|Overall Study|Physician Decision|3|||
128789571|NCT03525119|463521346|FG000|Overall Study|Adverse Event|0|||
128789572|NCT03525119|463521347|FG001|Overall Study|Adverse Event|1|||
128789573|NCT03525119|463521348|FG002|Overall Study|Adverse Event|0|||
128789574|NCT03525119|463521346|FG000|Overall Study|Lost to Follow-up|32|||
128789575|NCT03525119|463521347|FG001|Overall Study|Lost to Follow-up|33|||
128789576|NCT03525119|463521348|FG002|Overall Study|Lost to Follow-up|37|||
128789577|NCT03525119|463521346|FG000|Overall Study|Withdrawal by Subject|5|||
128789578|NCT03525119|463521347|FG001|Overall Study|Withdrawal by Subject|4|||
128789579|NCT03525119|463521348|FG002|Overall Study|Withdrawal by Subject|2|||
128789580|NCT03525119|463521346|FG000|Overall Study|Reason not Specified|2|||
128789581|NCT03525119|463521347|FG001|Overall Study|Reason not Specified|1|||
128789582|NCT03525119|463521348|FG002|Overall Study|Reason not Specified|2|||
128789583|NCT03525119|463521346|FG000|Overall Study|Randomized but not Vaccinated|1|||
128789584|NCT03525119|463521347|FG001|Overall Study|Randomized but not Vaccinated|0|||
128789585|NCT03525119|463521348|FG002|Overall Study|Randomized but not Vaccinated|2|||
128789586|NCT03939819|463521349|FG000|Overall Study|Death|2|||
128789587|NCT03939819|463521350|FG001|Overall Study|Death|0|||
128789588|NCT01186848|463521356|FG000|Overall Study|Lost to Follow-up|4|||
128789589|NCT01186848|463521356|FG000|Overall Study|Withdrawal by Subject|2|||
128789590|NCT01186848|463521356|FG000|Overall Study|Adverse Event|2|||
128789591|NCT01183780|463521364|FG000|Overall Study|Withdrawal by Subject|25|||
128789592|NCT01183780|463521365|FG001|Overall Study|Withdrawal by Subject|14|||
128789593|NCT01183780|463521364|FG000|Overall Study|Lost to Follow-up|6|||
128789594|NCT01183780|463521365|FG001|Overall Study|Lost to Follow-up|11|||
128789595|NCT04379713|463521366|FG000|Overall Study|Adverse Event|2|||
128789596|NCT04379713|463521367|FG001|Overall Study|Adverse Event|0|||
128789597|NCT04379713|463521366|FG000|Overall Study|Physician Decision|2|||
128789598|NCT04379713|463521367|FG001|Overall Study|Physician Decision|1|||
128789599|NCT04379713|463521366|FG000|Overall Study|Protocol Violation|11|||
128789600|NCT04379713|463521367|FG001|Overall Study|Protocol Violation|6|||
128789601|NCT04379713|463521366|FG000|Overall Study|No longer met eligibility criteria|14|||
128789602|NCT04379713|463521367|FG001|Overall Study|No longer met eligibility criteria|11|||
128789603|NCT04379713|463521366|FG000|Overall Study|Withdrawal by parent/guardian|36|||
128789604|NCT04379713|463521367|FG001|Overall Study|Withdrawal by parent/guardian|15|||
128789605|NCT04379713|463521366|FG000|Overall Study|Lost to Follow-up|31|||
128789606|NCT04379713|463521367|FG001|Overall Study|Lost to Follow-up|21|||
128789607|NCT03808883|463521369|FG000|Overall Study|Withdrawal by Subject|2|||
128789608|NCT03808883|463521370|FG001|Overall Study|Withdrawal by Subject|0|||
128789609|NCT03808883|463521369|FG000|Overall Study|Did not complete pre test or post test survey|4|||
128789610|NCT03808883|463521370|FG001|Overall Study|Did not complete pre test or post test survey|3|||
128789611|NCT00158054|463521372|FG000|Overall Study|Refused to continue|3|||
128789612|NCT00158054|463521373|FG001|Overall Study|Refused to continue|0|||
128789613|NCT00158054|463521372|FG000|Overall Study|Unavailable for follow up|7|||
128789614|NCT00158054|463521373|FG001|Overall Study|Unavailable for follow up|3|||
128789615|NCT00855465|463521376|FG000|Treatment Period|Adverse Event|4|||
128789616|NCT00855465|463521377|FG001|Treatment Period|Adverse Event|2|||
128789617|NCT00855465|463521376|FG000|Treatment Period|Death|2|||
128789618|NCT00855465|463521377|FG001|Treatment Period|Death|2|||
128789619|NCT00855465|463521376|FG000|Treatment Period|Lack of Efficacy|2|||
128789620|NCT00855465|463521377|FG001|Treatment Period|Lack of Efficacy|1|||
128789621|NCT00855465|463521376|FG000|Treatment Period|Non-compliance|1|||
128789622|NCT00855465|463521377|FG001|Treatment Period|Non-compliance|0|||
128789623|NCT00855465|463521376|FG000|Treatment Period|Protocol Violation|2|||
128789624|NCT00855465|463521377|FG001|Treatment Period|Protocol Violation|0|||
128789625|NCT00855465|463521376|FG000|Treatment Period|Withdrawal by Subject|2|||
128789626|NCT00855465|463521377|FG001|Treatment Period|Withdrawal by Subject|0|||
128789627|NCT00855465|463521376|FG000|Treatment Period|Not treated|1|||
128789628|NCT00855465|463521377|FG001|Treatment Period|Not treated|0|||
128789629|NCT00855465|463521376|FG000|Follow-up Period (FUP)|Adverse Event|0|||
128789630|NCT00855465|463521377|FG001|Follow-up Period (FUP)|Adverse Event|1|||
128789631|NCT00855465|463521376|FG000|Follow-up Period (FUP)|Death|0|||
128789632|NCT00855465|463521377|FG001|Follow-up Period (FUP)|Death|1|||
128789633|NCT00855465|463521376|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
128789634|NCT00855465|463521377|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
128789635|NCT00855465|463521376|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
128789636|NCT00855465|463521377|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
128789637|NCT00855465|463521376|FG000|Follow-up Period (FUP)|Missing|1|||
128789638|NCT00855465|463521377|FG001|Follow-up Period (FUP)|Missing|0|||
128789639|NCT04567888|463521391|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
128789640|NCT04567888|463521392|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
128789641|NCT04567888|463521391|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
128789642|NCT04567888|463521392|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
128789643|NCT04567888|463521391|FG000|Overall Study|Reported Unusual Birth Year|2|||
128789644|NCT04567888|463521392|FG001|Overall Study|Reported Unusual Birth Year|3|||
128789645|NCT04567888|463521391|FG000|Overall Study|Duplicate Responses|0|||
128789646|NCT04567888|463521392|FG001|Overall Study|Duplicate Responses|1|||
128789647|NCT02613364|463521394|FG000|Overall Study|Other|19|||
128789648|NCT02613364|463521395|FG001|Overall Study|Other|29|||
128789649|NCT02613364|463521396|FG002|Overall Study|Other|17|||
128789650|NCT02613364|463521394|FG000|Overall Study|Too time consuming|21|||
128789651|NCT02613364|463521395|FG001|Overall Study|Too time consuming|26|||
128789652|NCT02613364|463521396|FG002|Overall Study|Too time consuming|26|||
128789653|NCT02613364|463521394|FG000|Overall Study|Withdrawal by Subject|13|||
128789654|NCT02613364|463521395|FG001|Overall Study|Withdrawal by Subject|18|||
128789655|NCT02613364|463521396|FG002|Overall Study|Withdrawal by Subject|17|||
128789656|NCT02613364|463521394|FG000|Overall Study|Medical|12|||
128789657|NCT02613364|463521395|FG001|Overall Study|Medical|13|||
128789658|NCT02613364|463521396|FG002|Overall Study|Medical|9|||
128789659|NCT02613364|463521394|FG000|Overall Study|Disliked Study Procedure|1|||
128789660|NCT02613364|463521395|FG001|Overall Study|Disliked Study Procedure|1|||
128789661|NCT02613364|463521396|FG002|Overall Study|Disliked Study Procedure|4|||
128789662|NCT02613364|463521394|FG000|Overall Study|Disliked Intervention|0|||
128789663|NCT02613364|463521395|FG001|Overall Study|Disliked Intervention|3|||
128789664|NCT02613364|463521396|FG002|Overall Study|Disliked Intervention|3|||
128789665|NCT00436644|463521397|FG000|Overall Study|Adverse Event|2|||
128789666|NCT00436644|463521397|FG000|Overall Study|Death|1|||
128789667|NCT01490580|463521402|FG000|Overall Study|Parents withdrew consent|0|||
128789668|NCT01490580|463521403|FG001|Overall Study|Parents withdrew consent|2|||
128789669|NCT02873754|463521406|FG000|Overall Study|Lost to Follow-up|5|||
128789670|NCT02873754|463521406|FG000|Overall Study|Couldn't complete study procedures|1|||
128789671|NCT02631148|463523472|FG000|Overall Study|8 were ineligible|8|||
128789672|NCT02631148|463523473|FG001|Overall Study|8 were ineligible|0|||
128789673|NCT02631148|463523472|FG000|Overall Study|Withdrawal by Subject|1|||
128789674|NCT02631148|463523473|FG001|Overall Study|Withdrawal by Subject|0|||
128789675|NCT02631148|463523472|FG000|Overall Study|PAH not available to study participant|1|||
128789676|NCT02631148|463523473|FG001|Overall Study|PAH not available to study participant|0|||
128789677|NCT02525796|463523479|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
128789678|NCT02525796|463523480|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
128789679|NCT02525796|463523481|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
128789680|NCT02525796|463523479|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
128789681|NCT02525796|463523480|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
128789682|NCT02525796|463523481|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
128789683|NCT02525796|463523479|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
128789684|NCT02525796|463523480|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
128789685|NCT02525796|463523481|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
128789686|NCT02525796|463523479|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
128789687|NCT02525796|463523480|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
128789688|NCT02525796|463523481|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
128789689|NCT02525796|463523479|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
128789690|NCT02525796|463523480|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
128789691|NCT02525796|463523481|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
128789692|NCT02488980|463523482|FG000|Overall Study|Protocol Violation|2|||
128789693|NCT02488980|463523483|FG001|Overall Study|Protocol Violation|2|||
128789694|NCT02488980|463523484|FG002|Overall Study|Protocol Violation|2|||
128789695|NCT02385669|463523487|FG000|Overall Study|Adverse Event|2|||
128789696|NCT00970307|463523488|FG000|Overall Study|Serious Adverse Event|1|||
128789697|NCT00970307|463523489|FG001|Overall Study|Serious Adverse Event|0|||
128789698|NCT00970307|463523490|FG002|Overall Study|Serious Adverse Event|0|||
128789699|NCT00970307|463523488|FG000|Overall Study|Withdrawal by Subject|2|||
128789700|NCT00970307|463523489|FG001|Overall Study|Withdrawal by Subject|3|||
128789701|NCT00970307|463523490|FG002|Overall Study|Withdrawal by Subject|2|||
128789702|NCT03020745|463523492|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789703|NCT03020745|463523493|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789704|NCT03020745|463523494|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789705|NCT03020745|463523495|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789706|NCT03020745|463523496|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789707|NCT03020745|463523497|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789708|NCT03020745|463523498|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789709|NCT03020745|463523499|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789710|NCT03020745|463523500|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
128789711|NCT03020745|463523501|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
128789712|NCT03020745|463523492|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789713|NCT03020745|463523493|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789714|NCT03020745|463523494|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789715|NCT03020745|463523495|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789716|NCT03020745|463523496|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789717|NCT03020745|463523497|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789718|NCT03020745|463523498|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789719|NCT03020745|463523499|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
128789720|NCT03020745|463523500|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789721|NCT03020745|463523501|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
128789722|NCT03020745|463523492|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789723|NCT03020745|463523493|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789724|NCT03020745|463523494|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789725|NCT03020745|463523495|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789726|NCT03020745|463523496|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789727|NCT03020745|463523497|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
128789728|NCT03020745|463523498|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789729|NCT03020745|463523499|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789730|NCT03020745|463523500|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
128789731|NCT03020745|463523501|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
128789732|NCT03020745|463523492|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789733|NCT03020745|463523493|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789734|NCT03020745|463523494|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789735|NCT03020745|463523495|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789736|NCT03020745|463523496|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789737|NCT03020745|463523497|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789738|NCT03020745|463523498|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789739|NCT03020745|463523499|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789740|NCT03020745|463523500|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
128789741|NCT03020745|463523501|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
128789742|NCT00753012|463523506|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
128789743|NCT00753012|463523507|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
128789744|NCT00753012|463523506|FG000|Overall Study|Adverse Event|2|||
128789745|NCT00753012|463523507|FG001|Overall Study|Adverse Event|0|||
128789746|NCT00753012|463523506|FG000|Overall Study|Withdrawal by Subject|0|||
128789747|NCT00753012|463523507|FG001|Overall Study|Withdrawal by Subject|1|||
128789748|NCT00753012|463523506|FG000|Overall Study|Lost to Follow-up|4|||
128789749|NCT00753012|463523507|FG001|Overall Study|Lost to Follow-up|0|||
128789750|NCT00753012|463523506|FG000|Overall Study|Confounded endpoint data|1|||
128789751|NCT00753012|463523507|FG001|Overall Study|Confounded endpoint data|0|||
128789752|NCT00943735|463523510|FG000|Overall Study|Adverse Event|12|||
128789753|NCT00943735|463523510|FG000|Overall Study|Withdrawal by Subject|8|||
128789754|NCT00943735|463523510|FG000|Overall Study|Death|1|||
128789755|NCT00943735|463523510|FG000|Overall Study|Other|8|||
128789756|NCT00943735|463523510|FG000|Overall Study|Other|3|||
128789757|NCT03804918|463523511|FG000|Overall Study|Participant did not use the app|1|||
128789758|NCT01329328|463523512|FG000|Overall Study|Withdrawal by Subject|2|||
128789759|NCT01329328|463523513|FG001|Overall Study|Withdrawal by Subject|4|||
128789760|NCT01329328|463523514|FG002|Overall Study|Withdrawal by Subject|3|||
128789761|NCT04842604|463523521|FG000|Overall Study|Death|1|||
128789762|NCT04842604|463523522|FG001|Overall Study|Death|0|||
128789763|NCT04842604|463523521|FG000|Overall Study|Other|4|||
128789764|NCT04842604|463523522|FG001|Overall Study|Other|4|||
128789765|NCT04842604|463523521|FG000|Overall Study|Randomized but not treated|1|||
128789766|NCT04842604|463523522|FG001|Overall Study|Randomized but not treated|0|||
128789767|NCT01193153|463523523|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
128789768|NCT01193153|463523524|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
128789769|NCT01193153|463523523|FG000|Open-label Lead in Period|Pregnancy|1|||
128789770|NCT01193153|463523524|FG001|Open-label Lead in Period|Pregnancy|0|||
128789771|NCT01193153|463523523|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
128789772|NCT01193153|463523524|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
128789773|NCT01193153|463523523|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
128789774|NCT01193153|463523524|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
128789775|NCT01193153|463523523|FG000|Open-label Lead in Period|Other|14|||
128789776|NCT01193153|463523524|FG001|Open-label Lead in Period|Other|0|||
128789777|NCT01193153|463523523|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
128789778|NCT01193153|463523524|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
128789779|NCT01193153|463523523|FG000|Open-label Lead in Period|Adverse Event|41|||
128789780|NCT01193153|463523524|FG001|Open-label Lead in Period|Adverse Event|0|||
128789781|NCT01193153|463523523|FG000|Open-label Lead in Period|Death|1|||
128789782|NCT01193153|463523524|FG001|Open-label Lead in Period|Death|0|||
128789783|NCT01193153|463523523|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
128789784|NCT01193153|463523524|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
128789785|NCT01193153|463523523|FG000|Open-label Stabilization Period|Adverse Event|9|||
128789786|NCT01193153|463523524|FG001|Open-label Stabilization Period|Adverse Event|0|||
128789787|NCT01193153|463523523|FG000|Open-label Stabilization Period|Death|2|||
128789788|NCT01193153|463523524|FG001|Open-label Stabilization Period|Death|0|||
128789789|NCT01193153|463523523|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
128789790|NCT01193153|463523524|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
128789791|NCT01193153|463523523|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
128789792|NCT01193153|463523524|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
128789793|NCT01193153|463523523|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
128789794|NCT01193153|463523524|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
128789795|NCT01193153|463523523|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
128789796|NCT01193153|463523524|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
128789797|NCT01193153|463523523|FG000|Open-label Stabilization Period|Other|8|||
128789798|NCT01193153|463523524|FG001|Open-label Stabilization Period|Other|0|||
128789799|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|Other|2|||
128789800|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|Other|3|||
128789801|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
128789802|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
128789803|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|Death|2|||
128789804|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|Death|0|||
128789805|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
128789806|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
128789807|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
128789808|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
128789809|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
128789810|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
128789811|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
128789812|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
128789813|NCT01193153|463523523|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
128789814|NCT01193153|463523524|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
128789815|NCT01648140|463523525|FG000|Overall Study|Physician Decision|1|||
128789816|NCT01648140|463523526|FG001|Overall Study|Physician Decision|0|||
128789817|NCT01648140|463523527|FG002|Overall Study|Physician Decision|0|||
128789818|NCT01648140|463523528|FG003|Overall Study|Physician Decision|0|||
128789819|NCT01648140|463523525|FG000|Overall Study|Lack of Efficacy|4|||
128789820|NCT01648140|463523526|FG001|Overall Study|Lack of Efficacy|7|||
128789821|NCT01648140|463523527|FG002|Overall Study|Lack of Efficacy|1|||
128789822|NCT01648140|463523528|FG003|Overall Study|Lack of Efficacy|0|||
128789823|NCT01648140|463523525|FG000|Overall Study|Adverse Event|3|||
128789824|NCT01648140|463523526|FG001|Overall Study|Adverse Event|1|||
128789825|NCT01648140|463523527|FG002|Overall Study|Adverse Event|2|||
128789826|NCT01648140|463523528|FG003|Overall Study|Adverse Event|0|||
128789827|NCT01648140|463523525|FG000|Overall Study|Withdrawal by Subject|2|||
128789828|NCT01648140|463523526|FG001|Overall Study|Withdrawal by Subject|3|||
128789829|NCT01648140|463523527|FG002|Overall Study|Withdrawal by Subject|3|||
128789830|NCT01648140|463523528|FG003|Overall Study|Withdrawal by Subject|2|||
128789831|NCT01648140|463523525|FG000|Overall Study|Lost to Follow-up|2|||
128789832|NCT01648140|463523526|FG001|Overall Study|Lost to Follow-up|1|||
128789833|NCT01648140|463523527|FG002|Overall Study|Lost to Follow-up|2|||
128789834|NCT01648140|463523528|FG003|Overall Study|Lost to Follow-up|0|||
128789835|NCT01119950|463523529|FG000|Overall Study|Adverse Event|25|||
128789836|NCT01119950|463523529|FG000|Overall Study|Withdrawal by Subject|9|||
128789837|NCT01119950|463523529|FG000|Overall Study|Protocol Violation|5|||
128789838|NCT01119950|463523529|FG000|Overall Study|Lost to Follow-up|4|||
128789839|NCT01119950|463523529|FG000|Overall Study|Administrative|2|||
128789840|NCT01119950|463523529|FG000|Overall Study|Abnormal lab value|1|||
128789841|NCT01119950|463523529|FG000|Overall Study|Death|1|||
128789842|NCT00217672|463523533|FG000|Allocation|Ineligible|2|||
128789843|NCT00217672|463523534|FG001|Allocation|Ineligible|0|||
128789844|NCT00217672|463523533|FG000|Treatment|disease progression|33|||
128789845|NCT00217672|463523534|FG001|Treatment|disease progression|4|||
128789846|NCT00217672|463523533|FG000|Treatment|Adverse Event|18|||
128789847|NCT00217672|463523534|FG001|Treatment|Adverse Event|2|||
128789848|NCT00217672|463523533|FG000|Treatment|reqd treatment not permitted by protocol|6|||
128789849|NCT00217672|463523534|FG001|Treatment|reqd treatment not permitted by protocol|0|||
128789850|NCT00217672|463523533|FG000|Treatment|Physician Decision|6|||
128789851|NCT00217672|463523534|FG001|Treatment|Physician Decision|0|||
128789852|NCT00217672|463523533|FG000|Treatment|insurance issues|1|||
128789853|NCT00217672|463523534|FG001|Treatment|insurance issues|1|||
128789854|NCT00217672|463523533|FG000|Treatment|Death|2|||
128789855|NCT00217672|463523534|FG001|Treatment|Death|0|||
128789856|NCT00217672|463523533|FG000|Treatment|secondary malignancy|1|||
128789857|NCT00217672|463523534|FG001|Treatment|secondary malignancy|0|||
128789858|NCT00217672|463523533|FG000|Follow-up|Withdrawal by Subject|4|||
128789859|NCT00217672|463523534|FG001|Follow-up|Withdrawal by Subject|0|||
128789860|NCT00217672|463523533|FG000|Follow-up|Lost to Follow-up|1|||
128789861|NCT00217672|463523534|FG001|Follow-up|Lost to Follow-up|0|||
128789862|NCT01591616|463523542|FG000|Overall Study|Withdrawal by Subject|1|||
128789863|NCT00758602|463523543|FG000|Overall Study|Adverse Event|11|||
128789864|NCT00758602|463523544|FG001|Overall Study|Adverse Event|10|||
128789865|NCT00758602|463523543|FG000|Overall Study|Lost to Follow-up|4|||
128789866|NCT00758602|463523544|FG001|Overall Study|Lost to Follow-up|3|||
128789867|NCT00758602|463523543|FG000|Overall Study|Withdrawal by Subject|1|||
128789868|NCT00758602|463523544|FG001|Overall Study|Withdrawal by Subject|3|||
128789869|NCT00758602|463523543|FG000|Overall Study|Protocol Violation|0|||
128789870|NCT00758602|463523544|FG001|Overall Study|Protocol Violation|2|||
128789871|NCT00758602|463523543|FG000|Overall Study|Death|0|||
128789872|NCT00758602|463523544|FG001|Overall Study|Death|1|||
128789873|NCT00758602|463523543|FG000|Overall Study|Reason not specified|3|||
128789874|NCT00758602|463523544|FG001|Overall Study|Reason not specified|3|||
128789875|NCT02371746|463523545|FG000|Overall Study|Consent withdrawn|0|||
128789876|NCT02371746|463523546|FG001|Overall Study|Consent withdrawn|0|||
128789877|NCT02371746|463523547|FG002|Overall Study|Consent withdrawn|0|||
128789878|NCT02371746|463523548|FG003|Overall Study|Consent withdrawn|0|||
128789879|NCT02371746|463523549|FG004|Overall Study|Consent withdrawn|0|||
128789880|NCT02371746|463523550|FG005|Overall Study|Consent withdrawn|0|||
128789881|NCT02371746|463523551|FG006|Overall Study|Consent withdrawn|1|||
128789882|NCT00878722|463523553|FG000|Overall Study|Progressive disease|3|||
128789883|NCT00878722|463523554|FG001|Overall Study|Progressive disease|3|||
128789884|NCT00878722|463523555|FG002|Overall Study|Progressive disease|3|||
128789885|NCT00878722|463523556|FG003|Overall Study|Progressive disease|7|||
128789886|NCT00878722|463523557|FG004|Overall Study|Progressive disease|7|||
128789887|NCT00878722|463523558|FG005|Overall Study|Progressive disease|1|||
128789888|NCT00878722|463523559|FG006|Overall Study|Progressive disease|4|||
128789889|NCT00878722|463523560|FG007|Overall Study|Progressive disease|3|||
128789890|NCT00878722|463523553|FG000|Overall Study|Death|0|||
128789891|NCT00878722|463523554|FG001|Overall Study|Death|0|||
128789892|NCT00878722|463523555|FG002|Overall Study|Death|0|||
128789893|NCT00878722|463523556|FG003|Overall Study|Death|1|||
128789894|NCT00878722|463523557|FG004|Overall Study|Death|0|||
128789895|NCT00878722|463523558|FG005|Overall Study|Death|1|||
128789896|NCT00878722|463523559|FG006|Overall Study|Death|0|||
128789897|NCT00878722|463523560|FG007|Overall Study|Death|2|||
128789898|NCT00878722|463523553|FG000|Overall Study|Adverse Event|0|||
128789899|NCT00878722|463523554|FG001|Overall Study|Adverse Event|0|||
128789900|NCT00878722|463523555|FG002|Overall Study|Adverse Event|0|||
128789901|NCT00878722|463523556|FG003|Overall Study|Adverse Event|0|||
128789902|NCT00878722|463523557|FG004|Overall Study|Adverse Event|0|||
128789903|NCT00878722|463523558|FG005|Overall Study|Adverse Event|0|||
128789904|NCT00878722|463523559|FG006|Overall Study|Adverse Event|2|||
128789905|NCT00878722|463523560|FG007|Overall Study|Adverse Event|0|||
128789906|NCT00878722|463523553|FG000|Overall Study|Withdrawal by Subject|0|||
128789907|NCT00878722|463523554|FG001|Overall Study|Withdrawal by Subject|0|||
128789908|NCT00878722|463523555|FG002|Overall Study|Withdrawal by Subject|0|||
128789909|NCT00878722|463523556|FG003|Overall Study|Withdrawal by Subject|0|||
128789910|NCT00878722|463523557|FG004|Overall Study|Withdrawal by Subject|0|||
128789911|NCT00878722|463523558|FG005|Overall Study|Withdrawal by Subject|0|||
128789912|NCT00878722|463523559|FG006|Overall Study|Withdrawal by Subject|0|||
128789913|NCT00878722|463523560|FG007|Overall Study|Withdrawal by Subject|2|||
128789914|NCT00878722|463523553|FG000|Overall Study|Relapse|0|||
128789915|NCT00878722|463523554|FG001|Overall Study|Relapse|0|||
128789916|NCT00878722|463523555|FG002|Overall Study|Relapse|0|||
128789917|NCT00878722|463523556|FG003|Overall Study|Relapse|1|||
128789918|NCT00878722|463523557|FG004|Overall Study|Relapse|0|||
128789919|NCT00878722|463523558|FG005|Overall Study|Relapse|0|||
128789920|NCT00878722|463523559|FG006|Overall Study|Relapse|0|||
128789921|NCT00878722|463523560|FG007|Overall Study|Relapse|0|||
128789922|NCT00716144|463523561|FG000|Overall Study|Withdrawal by Subject|4|||
128789923|NCT00716144|463523562|FG001|Overall Study|Withdrawal by Subject|2|||
128789924|NCT00716144|463523563|FG002|Overall Study|Withdrawal by Subject|6|||
128789925|NCT00716144|463523564|FG003|Overall Study|Withdrawal by Subject|6|||
128789926|NCT00716144|463523561|FG000|Overall Study|Lost to Follow-up|2|||
128789927|NCT00716144|463523562|FG001|Overall Study|Lost to Follow-up|2|||
128789928|NCT00716144|463523563|FG002|Overall Study|Lost to Follow-up|1|||
128789929|NCT00716144|463523564|FG003|Overall Study|Lost to Follow-up|2|||
128789930|NCT00716144|463523561|FG000|Overall Study|Adverse Event|0|||
128789931|NCT00716144|463523562|FG001|Overall Study|Adverse Event|0|||
128789932|NCT00716144|463523563|FG002|Overall Study|Adverse Event|0|||
128789933|NCT00716144|463523564|FG003|Overall Study|Adverse Event|2|||
128789934|NCT00716144|463523561|FG000|Overall Study|Non-compliance|1|||
128789935|NCT00716144|463523562|FG001|Overall Study|Non-compliance|0|||
128789936|NCT00716144|463523563|FG002|Overall Study|Non-compliance|0|||
128789937|NCT00716144|463523564|FG003|Overall Study|Non-compliance|0|||
128789938|NCT00716144|463523561|FG000|Overall Study|Protocol Violation|2|||
128789939|NCT00716144|463523562|FG001|Overall Study|Protocol Violation|0|||
128789940|NCT00716144|463523563|FG002|Overall Study|Protocol Violation|1|||
128789941|NCT00716144|463523564|FG003|Overall Study|Protocol Violation|0|||
128789942|NCT00716144|463523561|FG000|Overall Study|Physician Decision|0|||
128789943|NCT00716144|463523562|FG001|Overall Study|Physician Decision|1|||
128789944|NCT00716144|463523563|FG002|Overall Study|Physician Decision|2|||
128789945|NCT00716144|463523564|FG003|Overall Study|Physician Decision|2|||
128789946|NCT00716144|463523561|FG000|Overall Study|Intercurrent illness|0|||
128789947|NCT00716144|463523562|FG001|Overall Study|Intercurrent illness|0|||
128789948|NCT00716144|463523563|FG002|Overall Study|Intercurrent illness|1|||
128789949|NCT00716144|463523564|FG003|Overall Study|Intercurrent illness|0|||
128789950|NCT00716144|463523561|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
128789951|NCT00716144|463523562|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
128789952|NCT00716144|463523563|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
128789953|NCT00716144|463523564|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
128789954|NCT00716144|463523561|FG000|Overall Study|Adverse event: left foot pain|0|||
128789955|NCT00716144|463523562|FG001|Overall Study|Adverse event: left foot pain|1|||
128789956|NCT00716144|463523563|FG002|Overall Study|Adverse event: left foot pain|0|||
128789957|NCT00716144|463523564|FG003|Overall Study|Adverse event: left foot pain|0|||
128789958|NCT00716144|463523561|FG000|Overall Study|Clinical Depression|0|||
128789959|NCT00716144|463523562|FG001|Overall Study|Clinical Depression|1|||
128789960|NCT00716144|463523563|FG002|Overall Study|Clinical Depression|0|||
128789961|NCT00716144|463523564|FG003|Overall Study|Clinical Depression|0|||
128789962|NCT00082810|463523565|FG000|Overall Study|Adverse Event|3|||
128789963|NCT00082810|463523565|FG000|Overall Study|Progressive disease|24|||
128789964|NCT00082810|463523565|FG000|Overall Study|Withdrawal by Subject|4|||
128789965|NCT02950558|463523566|FG000|Overall Study|Lost to Follow-up|2|||
128789966|NCT02950558|463523567|FG001|Overall Study|Lost to Follow-up|0|||
128789967|NCT00756730|463523570|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
128789968|NCT00756730|463523571|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
128789969|NCT00756730|463523570|FG000|Overall Study|persistent low-level viremmia|0|||
128789970|NCT00756730|463523571|FG001|Overall Study|persistent low-level viremmia|1|||
128789971|NCT01161498|463523572|FG000|Overall Study|Disease Progression|0|||
128789972|NCT01161498|463523573|FG001|Overall Study|Disease Progression|1|||
128789973|NCT05686421|463523576|FG000|Overall Study|Screen failure|22|||
128789974|NCT05686421|463523577|FG001|Overall Study|Screen failure|0|||
128789975|NCT05686421|463523578|FG002|Overall Study|Screen failure|0|||
128789976|NCT05686421|463523579|FG003|Overall Study|Screen failure|0|||
128789977|NCT00367055|463523580|FG000|Overall Study|Adverse Event|6|||
128789978|NCT00367055|463523581|FG001|Overall Study|Adverse Event|3|||
128789979|NCT00367055|463523580|FG000|Overall Study|Patient's Willing|3|||
128789980|NCT00367055|463523581|FG001|Overall Study|Patient's Willing|2|||
128789981|NCT00367055|463523580|FG000|Overall Study|Lack of Efficacy|1|||
128789982|NCT00367055|463523581|FG001|Overall Study|Lack of Efficacy|2|||
128789983|NCT00367055|463523580|FG000|Overall Study|Lost to Follow-up|1|||
128789984|NCT00367055|463523581|FG001|Overall Study|Lost to Follow-up|1|||
128789985|NCT00367055|463523580|FG000|Overall Study|Protocol Violation|0|||
128789986|NCT00367055|463523581|FG001|Overall Study|Protocol Violation|1|||
128789987|NCT00367055|463523580|FG000|Overall Study|Stopping Criterion Met|0|||
128789988|NCT00367055|463523581|FG001|Overall Study|Stopping Criterion Met|1|||
128789989|NCT00367055|463523580|FG000|Overall Study|Participant Living too Far from Hospital|0|||
128789990|NCT00367055|463523581|FG001|Overall Study|Participant Living too Far from Hospital|1|||
128789991|NCT03612804|463523582|FG000|Overall Study|Death|0|||
128789992|NCT03612804|463523583|FG001|Overall Study|Death|7|||
128789993|NCT03612804|463523584|FG002|Overall Study|Death|0|||
128789994|NCT03612804|463523585|FG003|Overall Study|Death|8|||
128789995|NCT03612804|463523582|FG000|Overall Study|Medication copay coverage issues|0|||
128789996|NCT03612804|463523583|FG001|Overall Study|Medication copay coverage issues|0|||
128789997|NCT03612804|463523584|FG002|Overall Study|Medication copay coverage issues|0|||
128789998|NCT03612804|463523585|FG003|Overall Study|Medication copay coverage issues|17|||
128789999|NCT03612804|463523582|FG000|Overall Study|Not current smoker at time of screening|0|||
128790000|NCT03612804|463523583|FG001|Overall Study|Not current smoker at time of screening|1|||
128790001|NCT03612804|463523584|FG002|Overall Study|Not current smoker at time of screening|0|||
128790002|NCT03612804|463523585|FG003|Overall Study|Not current smoker at time of screening|3|||
128790003|NCT03612804|463523582|FG000|Overall Study|Non-veteran status|0|||
128790004|NCT03612804|463523583|FG001|Overall Study|Non-veteran status|1|||
128790005|NCT03612804|463523584|FG002|Overall Study|Non-veteran status|0|||
128790006|NCT03612804|463523585|FG003|Overall Study|Non-veteran status|0|||
128790007|NCT03612804|463523582|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
128790008|NCT03612804|463523583|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
128790009|NCT03612804|463523584|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
128790010|NCT03612804|463523585|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
128790011|NCT03612804|463523582|FG000|Overall Study|Provider retired from VA|0|||
128790012|NCT03612804|463523583|FG001|Overall Study|Provider retired from VA|0|||
128790013|NCT03612804|463523584|FG002|Overall Study|Provider retired from VA|2|||
128790014|NCT03612804|463523585|FG003|Overall Study|Provider retired from VA|0|||
128790015|NCT03612804|463523582|FG000|Overall Study|Withdrawal by Subject|0|||
128790016|NCT03612804|463523583|FG001|Overall Study|Withdrawal by Subject|0|||
128790017|NCT03612804|463523584|FG002|Overall Study|Withdrawal by Subject|7|||
128790018|NCT03612804|463523585|FG003|Overall Study|Withdrawal by Subject|0|||
128790019|NCT03612804|463523582|FG000|Overall Study|Provider involved with study activities|1|||
128790020|NCT03612804|463523583|FG001|Overall Study|Provider involved with study activities|0|||
128790021|NCT03612804|463523584|FG002|Overall Study|Provider involved with study activities|0|||
128790022|NCT03612804|463523585|FG003|Overall Study|Provider involved with study activities|0|||
128790023|NCT03386929|463523597|FG000|Overall Study|Death|0|||
128790024|NCT03386929|463523598|FG001|Overall Study|Death|0|||
128790025|NCT03386929|463523599|FG002|Overall Study|Death|1|||
128790026|NCT03386929|463523597|FG000|Overall Study|Withdrawal by Subject|0|||
128790027|NCT03386929|463523598|FG001|Overall Study|Withdrawal by Subject|1|||
128790028|NCT03386929|463523599|FG002|Overall Study|Withdrawal by Subject|0|||
128790029|NCT03386929|463523597|FG000|Overall Study|Physician Decision|0|||
128790030|NCT03386929|463523598|FG001|Overall Study|Physician Decision|0|||
128790031|NCT03386929|463523599|FG002|Overall Study|Physician Decision|1|||
128790032|NCT03386929|463523597|FG000|Overall Study|Progression|4|||
128790033|NCT03386929|463523598|FG001|Overall Study|Progression|4|||
128790034|NCT03386929|463523599|FG002|Overall Study|Progression|0|||
128790035|NCT03386929|463523597|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
128790036|NCT03386929|463523598|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
128790037|NCT03386929|463523599|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
128790038|NCT03386929|463523597|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
128790039|NCT03386929|463523598|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
128790040|NCT03386929|463523599|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
128790041|NCT00387465|463523602|FG000|Overall Study|Withdrawal by Subject|0|||
128790042|NCT00387465|463523603|FG001|Overall Study|Withdrawal by Subject|1|||
128790043|NCT00387465|463523604|FG002|Overall Study|Withdrawal by Subject|0|||
128790044|NCT05052983|463523611|FG000|Overall Study|Lack of Efficacy|3|||
128790045|NCT05052983|463523612|FG001|Overall Study|Lack of Efficacy|12|||
128790046|NCT05052983|463523611|FG000|Overall Study|Adverse Event|1|||
128790047|NCT05052983|463523612|FG001|Overall Study|Adverse Event|0|||
128790048|NCT03425643|463523613|FG000|Overall Study|Withdrawal by Subject|10|||
128790049|NCT03425643|463523614|FG001|Overall Study|Withdrawal by Subject|12|||
128790050|NCT03425643|463523613|FG000|Overall Study|Lost to Follow-up|2|||
128790051|NCT03425643|463523614|FG001|Overall Study|Lost to Follow-up|0|||
128790052|NCT03425643|463523613|FG000|Overall Study|Death|109|||
128790053|NCT03425643|463523614|FG001|Overall Study|Death|141|||
128790054|NCT03425643|463523613|FG000|Overall Study|Ongoing in study|276|||
128790055|NCT03425643|463523614|FG001|Overall Study|Ongoing in study|247|||
128790056|NCT04133363|463523615|FG000|Overall Study|Lost to Follow-up|2|||
128790057|NCT04133363|463523616|FG001|Overall Study|Lost to Follow-up|1|||
128790058|NCT04133363|463523617|FG002|Overall Study|Lost to Follow-up|4|||
128790059|NCT00849147|463523621|FG000|Overall Study|Withdrawal by Subject|1|||
128790060|NCT00849147|463523621|FG000|Overall Study|Protocol Violation|2|||
128790061|NCT00849147|463523621|FG000|Overall Study|Disease Relapse/Progression|2|||
128790062|NCT04257058|463525584|FG000|Overall Study|Lost to Follow-up|31|||
128790063|NCT04199728|463525593|FG000|Overall Study|Adverse Event|1|||
128790064|NCT04199728|463525594|FG001|Overall Study|Adverse Event|0|||
128790065|NCT04199728|463525593|FG000|Overall Study|Withdrawal by Subject|8|||
128790066|NCT04199728|463525594|FG001|Overall Study|Withdrawal by Subject|3|||
128790067|NCT04199728|463525593|FG000|Overall Study|Screen fail after consent|0|||
128790068|NCT04199728|463525594|FG001|Overall Study|Screen fail after consent|1|||
128790069|NCT04199728|463525593|FG000|Overall Study|Early withdraw criteria met|0|||
128790070|NCT04199728|463525594|FG001|Overall Study|Early withdraw criteria met|1|||
128790071|NCT04199728|463525593|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
128790072|NCT04199728|463525594|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
128790073|NCT00482729|463525595|FG000|Overall Study|Adverse Event|29|||
128790074|NCT00482729|463525596|FG001|Overall Study|Adverse Event|33|||
128790075|NCT00482729|463525595|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
128790076|NCT00482729|463525596|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
128790077|NCT00482729|463525595|FG000|Overall Study|Hyperglycemia Criteria|7|||
128790078|NCT00482729|463525596|FG001|Overall Study|Hyperglycemia Criteria|5|||
128790079|NCT00482729|463525595|FG000|Overall Study|Lack of Efficacy|4|||
128790080|NCT00482729|463525596|FG001|Overall Study|Lack of Efficacy|16|||
128790081|NCT00482729|463525595|FG000|Overall Study|Lost to Follow-up|86|||
128790082|NCT00482729|463525596|FG001|Overall Study|Lost to Follow-up|66|||
128790083|NCT00482729|463525595|FG000|Overall Study|Physician Decision|10|||
128790084|NCT00482729|463525596|FG001|Overall Study|Physician Decision|7|||
128790085|NCT00482729|463525595|FG000|Overall Study|Pregnancy|4|||
128790086|NCT00482729|463525596|FG001|Overall Study|Pregnancy|2|||
128790087|NCT00482729|463525595|FG000|Overall Study|Protocol Violation|10|||
128790088|NCT00482729|463525596|FG001|Overall Study|Protocol Violation|18|||
128790089|NCT00482729|463525595|FG000|Overall Study|Withdrawal by Subject|67|||
128790090|NCT00482729|463525596|FG001|Overall Study|Withdrawal by Subject|69|||
128790091|NCT00661778|463525605|FG000|Overall Study|Disease Progression|23|||
128790092|NCT00661778|463525605|FG000|Overall Study|Adverse Event|18|||
128790093|NCT00661778|463525605|FG000|Overall Study|Reason not Specified|6|||
128790094|NCT00661778|463525605|FG000|Overall Study|Protocol Violation|2|||
128790095|NCT00661778|463525605|FG000|Overall Study|Withdrawal of Consent|1|||
128790096|NCT01070888|463525606|FG000|First Intervention (14 Days)|Adverse Event|0|||
128790097|NCT01070888|463525607|FG001|First Intervention (14 Days)|Adverse Event|1|||
128790098|NCT01070888|463525606|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
128790099|NCT01070888|463525607|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
128790100|NCT01070888|463525606|FG000|Washout (14 Days)|Physician Decision|1|||
128790101|NCT01070888|463525607|FG001|Washout (14 Days)|Physician Decision|0|||
128790102|NCT02577523|463525611|FG000|Overall Study|Adverse Event|1|||
128790103|NCT02577523|463525612|FG001|Overall Study|Adverse Event|1|||
128790104|NCT02577523|463525611|FG000|Overall Study|Lack of Efficacy|1|||
128790105|NCT02577523|463525612|FG001|Overall Study|Lack of Efficacy|1|||
128790106|NCT02577523|463525611|FG000|Overall Study|Withdrawal by Subject|1|||
128790107|NCT02577523|463525612|FG001|Overall Study|Withdrawal by Subject|0|||
128790108|NCT04860258|463525614|FG000|Overall Study|Withdrawal by Subject|0|||
128790109|NCT04860258|463525615|FG001|Overall Study|Withdrawal by Subject|0|||
128790110|NCT04860258|463525616|FG002|Overall Study|Withdrawal by Subject|4|||
128790111|NCT04860258|463525617|FG003|Overall Study|Withdrawal by Subject|1|||
128790112|NCT04860258|463525618|FG004|Overall Study|Withdrawal by Subject|4|||
128790113|NCT04860258|463525619|FG005|Overall Study|Withdrawal by Subject|1|||
128790114|NCT04860258|463525620|FG006|Overall Study|Withdrawal by Subject|0|||
128790115|NCT00487578|463525621|FG000|Overall Study|Adverse Event|1|||
128790116|NCT00487578|463525622|FG001|Overall Study|Adverse Event|2|||
128790117|NCT00487578|463525621|FG000|Overall Study|Lack of Efficacy|0|||
128790118|NCT00487578|463525622|FG001|Overall Study|Lack of Efficacy|1|||
128790119|NCT00487578|463525621|FG000|Overall Study|Lost to Follow-up|0|||
128790120|NCT00487578|463525622|FG001|Overall Study|Lost to Follow-up|1|||
128790121|NCT00726999|463525625|FG000|Overall Study|Physician Decision|0|||
128790122|NCT00726999|463525626|FG001|Overall Study|Physician Decision|1|||
128790123|NCT00726999|463525625|FG000|Overall Study|Withdrawal by Subject|2|||
128790124|NCT00726999|463525626|FG001|Overall Study|Withdrawal by Subject|0|||
128790125|NCT00726999|463525625|FG000|Overall Study|Protocol Violation|1|||
128790126|NCT00726999|463525626|FG001|Overall Study|Protocol Violation|0|||
128790127|NCT00955825|463525627|FG000|Overall Study|Adverse Event|15|||
128790128|NCT00955825|463525628|FG001|Overall Study|Adverse Event|2|||
128790129|NCT00955825|463525627|FG000|Overall Study|Withdrawal by Subject|4|||
128790130|NCT00955825|463525628|FG001|Overall Study|Withdrawal by Subject|6|||
128790131|NCT00955825|463525627|FG000|Overall Study|Any other reason not above-mentioned|7|||
128790132|NCT00955825|463525628|FG001|Overall Study|Any other reason not above-mentioned|9|||
128790133|NCT01499134|463525629|FG000|Overall Study|Withdrawal by Subject|0|||
128790134|NCT01499134|463525630|FG001|Overall Study|Withdrawal by Subject|1|||
128790135|NCT01198275|463525631|FG000|Overall Study|Adverse Event|2|||
128790136|NCT01198275|463525632|FG001|Overall Study|Adverse Event|3|||
128790137|NCT01198275|463525631|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
128790138|NCT01198275|463525632|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
128790139|NCT00391846|463525633|FG000|Overall Study|Adverse Event|4|||
128790140|NCT00391846|463525634|FG001|Overall Study|Adverse Event|1|||
128790141|NCT00391846|463525633|FG000|Overall Study|Did not meet the required elig. crit|2|||
128790142|NCT00391846|463525634|FG001|Overall Study|Did not meet the required elig. crit|2|||
128790143|NCT00391846|463525633|FG000|Overall Study|Withdrawal by Subject|2|||
128790144|NCT00391846|463525634|FG001|Overall Study|Withdrawal by Subject|3|||
128790145|NCT00391846|463525633|FG000|Overall Study|Developed study specific DC criteria|0|||
128790146|NCT00391846|463525634|FG001|Overall Study|Developed study specific DC criteria|1|||
128790147|NCT00150176|463525635|FG000|Overall Study|Adverse Event|16|||
128790148|NCT00150176|463525636|FG001|Overall Study|Adverse Event|53|||
128790149|NCT00150176|463525635|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
128790150|NCT00150176|463525636|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
128790151|NCT00150176|463525635|FG000|Overall Study|Withdrawal by Subject|19|||
128790152|NCT00150176|463525636|FG001|Overall Study|Withdrawal by Subject|12|||
128790153|NCT00150176|463525635|FG000|Overall Study|Lost to Follow-up|3|||
128790154|NCT00150176|463525636|FG001|Overall Study|Lost to Follow-up|3|||
128790155|NCT00150176|463525635|FG000|Overall Study|OTHER|11|||
128790156|NCT00150176|463525636|FG001|Overall Study|OTHER|13|||
128790157|NCT05257798|463525638|FG000|Follow-up Phase|Lost to Follow-up|1|||
128790158|NCT05257798|463525639|FG001|Follow-up Phase|Lost to Follow-up|0|||
128790159|NCT02082158|463525644|FG000|Overall Study|Withdrawal by Subject|0|||
128790160|NCT02082158|463525645|FG001|Overall Study|Withdrawal by Subject|0|||
128790161|NCT02082158|463525646|FG002|Overall Study|Withdrawal by Subject|0|||
128790162|NCT02082158|463525647|FG003|Overall Study|Withdrawal by Subject|0|||
128790163|NCT02082158|463525648|FG004|Overall Study|Withdrawal by Subject|1|||
128790164|NCT02082158|463525649|FG005|Overall Study|Withdrawal by Subject|0|||
128790165|NCT02082158|463525644|FG000|Overall Study|Failed Fit-testing|8|||
128790166|NCT02082158|463525645|FG001|Overall Study|Failed Fit-testing|8|||
128790167|NCT02082158|463525646|FG002|Overall Study|Failed Fit-testing|14|||
128790168|NCT02082158|463525647|FG003|Overall Study|Failed Fit-testing|4|||
128790169|NCT02082158|463525648|FG004|Overall Study|Failed Fit-testing|3|||
128790170|NCT02082158|463525649|FG005|Overall Study|Failed Fit-testing|7|||
128790171|NCT00738699|463525650|FG000|Overall Study|Withdrawal by Subject|5|||
128790172|NCT00738699|463525651|FG001|Overall Study|Withdrawal by Subject|0|||
128790173|NCT00738699|463525650|FG000|Overall Study|Lost to Follow-up|1|||
128790174|NCT00738699|463525651|FG001|Overall Study|Lost to Follow-up|0|||
128790175|NCT00738699|463525650|FG000|Overall Study|Death|144|||
128790176|NCT00738699|463525651|FG001|Overall Study|Death|68|||
128790177|NCT00738699|463525650|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
128790178|NCT00738699|463525651|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
128790179|NCT00738699|463525650|FG000|Overall Study|Other|2|||
128790180|NCT00738699|463525651|FG001|Overall Study|Other|0|||
128790181|NCT00549848|463525656|FG000|Overall Study|Death|1|||
128790182|NCT00549848|463525657|FG001|Overall Study|Death|4|||
128790183|NCT00549848|463525658|FG002|Overall Study|Death|13|||
128790184|NCT00549848|463525656|FG000|Overall Study|Physician Decision|0|||
128790185|NCT00549848|463525657|FG001|Overall Study|Physician Decision|0|||
128790186|NCT00549848|463525658|FG002|Overall Study|Physician Decision|4|||
128790187|NCT00549848|463525656|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
128790188|NCT00549848|463525657|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
128790189|NCT00549848|463525658|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
128790190|NCT00549848|463525656|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
128790191|NCT00549848|463525657|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
128790192|NCT00549848|463525658|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
128790193|NCT00549848|463525656|FG000|Overall Study|Participant/Family Withdraw|2|||
128790194|NCT00549848|463525657|FG001|Overall Study|Participant/Family Withdraw|3|||
128790195|NCT00549848|463525658|FG002|Overall Study|Participant/Family Withdraw|5|||
128790196|NCT00549848|463525656|FG000|Overall Study|Second Malignancy|1|||
128790197|NCT00549848|463525657|FG001|Overall Study|Second Malignancy|0|||
128790198|NCT00549848|463525658|FG002|Overall Study|Second Malignancy|0|||
128790199|NCT00549848|463525656|FG000|Overall Study|Transplant|3|||
128790200|NCT00549848|463525657|FG001|Overall Study|Transplant|3|||
128790201|NCT00549848|463525658|FG002|Overall Study|Transplant|18|||
128790202|NCT00549848|463525656|FG000|Overall Study|Unacceptable Toxicity|1|||
128790203|NCT00549848|463525657|FG001|Overall Study|Unacceptable Toxicity|6|||
128790204|NCT00549848|463525658|FG002|Overall Study|Unacceptable Toxicity|6|||
128790205|NCT03262935|463525659|FG000|Overall Study|Withdrawal by Subject|6|||
128790206|NCT03262935|463525660|FG001|Overall Study|Withdrawal by Subject|7|||
128790207|NCT03262935|463525659|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
128790208|NCT03262935|463525660|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
128790209|NCT03262935|463525659|FG000|Overall Study|Death|181|||
128790210|NCT03262935|463525660|FG001|Overall Study|Death|94|||
128790211|NCT03262935|463525659|FG000|Overall Study|Lost to Follow-up|9|||
128790212|NCT03262935|463525660|FG001|Overall Study|Lost to Follow-up|4|||
128790213|NCT03262935|463525659|FG000|Overall Study|Other reason|5|||
128790214|NCT03262935|463525660|FG001|Overall Study|Other reason|0|||
128790215|NCT00419094|463525661|FG000|Overall Study|Adverse Event|3|||
128790216|NCT00419094|463525662|FG001|Overall Study|Adverse Event|7|||
128790217|NCT00419094|463525661|FG000|Overall Study|Lack of Efficacy|1|||
128790218|NCT00419094|463525662|FG001|Overall Study|Lack of Efficacy|0|||
128790219|NCT00419094|463525661|FG000|Overall Study|Lost to Follow-up|0|||
128790220|NCT00419094|463525662|FG001|Overall Study|Lost to Follow-up|2|||
128790221|NCT00419094|463525661|FG000|Overall Study|Protocol Violation|1|||
128790222|NCT00419094|463525662|FG001|Overall Study|Protocol Violation|14|||
128790223|NCT00419094|463525661|FG000|Overall Study|Withdrawal of consent|1|||
128790224|NCT00419094|463525662|FG001|Overall Study|Withdrawal of consent|5|||
128790225|NCT00419094|463525661|FG000|Overall Study|Other: Error determining exit criteria|1|||
128790226|NCT00419094|463525662|FG001|Overall Study|Other: Error determining exit criteria|0|||
128790227|NCT00419094|463525661|FG000|Overall Study|Other: Patient non-compliant|0|||
128790228|NCT00419094|463525662|FG001|Overall Study|Other: Patient non-compliant|1|||
128790229|NCT00419094|463525661|FG000|Overall Study|Other: No contact for extended period|0|||
128790230|NCT00419094|463525662|FG001|Overall Study|Other: No contact for extended period|1|||
128790231|NCT01811706|463525663|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
128790232|NCT01811706|463525664|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
128790233|NCT02224924|463525665|FG000|Overall Study|Withdrawal by Subject|7|||
128790234|NCT02224924|463525666|FG001|Overall Study|Withdrawal by Subject|6|||
128790235|NCT02224924|463525665|FG000|Overall Study|Biopsy cancelled|20|||
128790236|NCT02224924|463525666|FG001|Overall Study|Biopsy cancelled|14|||
128790237|NCT02224924|463525665|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
128790238|NCT02224924|463525666|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
128790239|NCT02224924|463525665|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
128790240|NCT02224924|463525666|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
128790241|NCT03823300|463525670|FG000|Overall Study|Withdrawal by Subject|16|||
128790242|NCT03823300|463525671|FG001|Overall Study|Withdrawal by Subject|22|||
128790243|NCT03823300|463525670|FG000|Overall Study|Death|10|||
128790244|NCT03823300|463525671|FG001|Overall Study|Death|14|||
128790245|NCT03823300|463525670|FG000|Overall Study|Adverse Event|3|||
128790246|NCT03823300|463525671|FG001|Overall Study|Adverse Event|5|||
128790247|NCT03823300|463525670|FG000|Overall Study|Physician Decision|1|||
128790248|NCT03823300|463525671|FG001|Overall Study|Physician Decision|7|||
128790249|NCT03823300|463525670|FG000|Overall Study|Lost to Follow-up|1|||
128790250|NCT03823300|463525671|FG001|Overall Study|Lost to Follow-up|3|||
128790251|NCT03823300|463525670|FG000|Overall Study|Protocol Violation|1|||
128790252|NCT03823300|463525671|FG001|Overall Study|Protocol Violation|1|||
128790253|NCT03823300|463525670|FG000|Overall Study|Lack of Efficacy|1|||
128790254|NCT03823300|463525671|FG001|Overall Study|Lack of Efficacy|1|||
128790255|NCT03823300|463525670|FG000|Overall Study|Not Eligible|0|||
128790256|NCT03823300|463525671|FG001|Overall Study|Not Eligible|1|||
128790257|NCT03823300|463525670|FG000|Overall Study|Other|1|||
128790258|NCT03823300|463525671|FG001|Overall Study|Other|0|||
128790259|NCT00964366|463525672|FG000|Overall Study|Did not qualify at Day 1|1|||
128790260|NCT00964366|463525673|FG001|Overall Study|Did not qualify at Day 1|0|||
128790261|NCT00964366|463525672|FG000|Overall Study|Withdrawal by Subject|0|||
128790262|NCT00964366|463525673|FG001|Overall Study|Withdrawal by Subject|1|||
128790263|NCT01370694|463525674|FG000|Overall Study|Switched to rituximab|4|||
128790264|NCT01370694|463525674|FG000|Overall Study|Progressive disease|2|||
128790265|NCT02393716|463525675|FG000|Overall Study|Death|29|||
128790266|NCT02393716|463525675|FG000|Overall Study|Withdrawal by Subject|8|||
128790267|NCT02393716|463525675|FG000|Overall Study|Device Explanted|8|||
128790268|NCT02393716|463525675|FG000|Overall Study|Missed visit|16|||
128790269|NCT02957539|463525676|FG000|Baseline to Week 16|Lost to Follow-up|8|||
128790270|NCT02957539|463525677|FG001|Baseline to Week 16|Lost to Follow-up|10|||
128790271|NCT02957539|463525678|FG002|Baseline to Week 16|Lost to Follow-up|16|||
128790272|NCT02957539|463525676|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
128790273|NCT02957539|463525677|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
128790274|NCT02957539|463525678|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
128790275|NCT02957539|463525676|FG000|Week 16 to 32|Withdrawal by Subject|3|||
128790276|NCT02957539|463525677|FG001|Week 16 to 32|Withdrawal by Subject|3|||
128790277|NCT02957539|463525678|FG002|Week 16 to 32|Withdrawal by Subject|1|||
128790278|NCT02957539|463525676|FG000|Week 16 to 32|Lost to Follow-up|8|||
128790279|NCT02957539|463525677|FG001|Week 16 to 32|Lost to Follow-up|7|||
128790280|NCT02957539|463525678|FG002|Week 16 to 32|Lost to Follow-up|5|||
128790281|NCT02957539|463525676|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
128790282|NCT02957539|463525677|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
128790283|NCT02957539|463525678|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
128790284|NCT02957539|463525676|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
128790285|NCT02957539|463525677|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
128790286|NCT02957539|463525678|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
128790287|NCT01157182|463525683|FG000|Washout of 28 Days|Adverse Event|2|||
128790288|NCT01157182|463525684|FG001|Washout of 28 Days|Adverse Event|0|||
128790289|NCT01596504|463525685|FG000|Overall Study|Participant's Private Reason|0|||
128790290|NCT01596504|463525686|FG001|Overall Study|Participant's Private Reason|1|||
128790291|NCT01596504|463525687|FG002|Overall Study|Participant's Private Reason|0|||
128790292|NCT01596504|463525685|FG000|Overall Study|Adverse Event|1|||
128790293|NCT01596504|463525686|FG001|Overall Study|Adverse Event|2|||
128790294|NCT01596504|463525687|FG002|Overall Study|Adverse Event|1|||
128790295|NCT01596504|463525685|FG000|Overall Study|Withdrawal by Subject|1|||
128790296|NCT01596504|463525686|FG001|Overall Study|Withdrawal by Subject|0|||
128790297|NCT01596504|463525687|FG002|Overall Study|Withdrawal by Subject|0|||
128790298|NCT03743246|463525688|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
128790299|NCT03743246|463525689|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
128790300|NCT03743246|463525690|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
128790301|NCT03743246|463525691|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
128790302|NCT03743246|463525688|FG000|Pre-Treatment Period|Death|0|||
128790303|NCT03743246|463525689|FG001|Pre-Treatment Period|Death|1|||
128790304|NCT03743246|463525690|FG002|Pre-Treatment Period|Death|0|||
128790305|NCT03743246|463525691|FG003|Pre-Treatment Period|Death|1|||
128790306|NCT03743246|463525688|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
128790307|NCT03743246|463525689|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
128790308|NCT03743246|463525690|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
128790309|NCT03743246|463525691|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
128790310|NCT03743246|463525688|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
128790311|NCT03743246|463525689|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
128790312|NCT03743246|463525690|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
128790313|NCT03743246|463525691|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
128790314|NCT03743246|463525688|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
128790315|NCT03743246|463525689|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
128790316|NCT03743246|463525690|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
128790317|NCT03743246|463525691|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
128790318|NCT03743246|463525688|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
128790319|NCT03743246|463525689|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
128790320|NCT03743246|463525690|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
128790321|NCT03743246|463525691|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
128790322|NCT03743246|463525688|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
128790323|NCT03743246|463525689|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
128790324|NCT03743246|463525690|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
128790325|NCT03743246|463525691|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
128790326|NCT03743246|463525688|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
128790327|NCT03743246|463525689|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
128790328|NCT03743246|463525690|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
128790329|NCT03743246|463525691|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
128790330|NCT03743246|463525688|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
128790331|NCT03743246|463525689|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
128790332|NCT03743246|463525690|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
128790333|NCT03743246|463525691|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
128790334|NCT00949975|463525692|FG000|Overall Study|Voluntary discontinuation|6|||
128790335|NCT00949975|463525693|FG001|Overall Study|Voluntary discontinuation|5|||
128790336|NCT00949975|463525694|FG002|Overall Study|Voluntary discontinuation|3|||
128790337|NCT00949975|463525695|FG003|Overall Study|Voluntary discontinuation|6|||
128790338|NCT00949975|463525692|FG000|Overall Study|Adverse Event|11|||
128790339|NCT00949975|463525693|FG001|Overall Study|Adverse Event|11|||
128790340|NCT00949975|463525694|FG002|Overall Study|Adverse Event|10|||
128790341|NCT00949975|463525695|FG003|Overall Study|Adverse Event|10|||
128790342|NCT00949975|463525692|FG000|Overall Study|Safety reason|0|||
128790343|NCT00949975|463525693|FG001|Overall Study|Safety reason|1|||
128790344|NCT00949975|463525694|FG002|Overall Study|Safety reason|0|||
128790345|NCT00949975|463525695|FG003|Overall Study|Safety reason|0|||
128790346|NCT00949975|463525692|FG000|Overall Study|Study-specific criteria|0|||
128790347|NCT00949975|463525693|FG001|Overall Study|Study-specific criteria|1|||
128790348|NCT00949975|463525694|FG002|Overall Study|Study-specific criteria|1|||
128790349|NCT00949975|463525695|FG003|Overall Study|Study-specific criteria|0|||
128790350|NCT00949975|463525692|FG000|Overall Study|Incorrect enrolment|5|||
128790351|NCT00949975|463525693|FG001|Overall Study|Incorrect enrolment|10|||
128790352|NCT00949975|463525694|FG002|Overall Study|Incorrect enrolment|4|||
128790353|NCT00949975|463525695|FG003|Overall Study|Incorrect enrolment|7|||
128790354|NCT00949975|463525692|FG000|Overall Study|Severe non-compliance|3|||
128790355|NCT00949975|463525693|FG001|Overall Study|Severe non-compliance|1|||
128790356|NCT00949975|463525694|FG002|Overall Study|Severe non-compliance|0|||
128790357|NCT00949975|463525695|FG003|Overall Study|Severe non-compliance|2|||
128790358|NCT00949975|463525692|FG000|Overall Study|Lost to Follow-up|1|||
128790359|NCT00949975|463525693|FG001|Overall Study|Lost to Follow-up|0|||
128790360|NCT00949975|463525694|FG002|Overall Study|Lost to Follow-up|1|||
128790361|NCT00949975|463525695|FG003|Overall Study|Lost to Follow-up|3|||
128790362|NCT00949975|463525692|FG000|Overall Study|Other|1|||
128790363|NCT00949975|463525693|FG001|Overall Study|Other|0|||
128790364|NCT00949975|463525694|FG002|Overall Study|Other|0|||
128790365|NCT00949975|463525695|FG003|Overall Study|Other|0|||
128790366|NCT04347954|463525696|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
128790367|NCT04347954|463525697|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
128790368|NCT04347954|463525698|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
128790369|NCT04347954|463525696|FG000|Overall Study|Lost to Follow-up|0|||
128790370|NCT04347954|463525697|FG001|Overall Study|Lost to Follow-up|1|||
128790371|NCT04347954|463525698|FG002|Overall Study|Lost to Follow-up|0|||
128790372|NCT03257813|463525714|FG000|Overall Study|Protocol Violation|6|||
128790373|NCT03257813|463525715|FG001|Overall Study|Protocol Violation|3|||
128790374|NCT05641311|463525716|FG000|Dosing Period 1|Adverse Event|1|||
128790375|NCT05641311|463525717|FG001|Dosing Period 1|Adverse Event|0|||
128790376|NCT00909363|463525718|FG000|Overall Study|Withdrawal by Subject|1|||
128790377|NCT00909363|463525719|FG001|Overall Study|Withdrawal by Subject|0|||
128790378|NCT00909363|463525720|FG002|Overall Study|Withdrawal by Subject|0|||
128790379|NCT00909363|463525718|FG000|Overall Study|Lack of Efficacy|1|||
128790380|NCT00909363|463525719|FG001|Overall Study|Lack of Efficacy|0|||
128790381|NCT00909363|463525720|FG002|Overall Study|Lack of Efficacy|0|||
128790382|NCT00319436|463525721|FG000|Overall Study|Withdrawal by Subject|6|||
128790383|NCT00319436|463525722|FG001|Overall Study|Withdrawal by Subject|7|||
128790384|NCT01321606|463525723|FG000|Overall Study|Lost to Follow-up|0|||
128790385|NCT01321606|463525724|FG001|Overall Study|Lost to Follow-up|0|||
128790386|NCT01321606|463525725|FG002|Overall Study|Lost to Follow-up|0|||
128790387|NCT01321606|463525726|FG003|Overall Study|Lost to Follow-up|1|||
128790388|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
128790389|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
128790390|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
128790391|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
128790392|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
128790393|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
128790394|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
128790395|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
128790396|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
128790397|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
128790398|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
128790399|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
128790400|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
128790401|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
128790402|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
128790403|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
128790404|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
128790405|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
128790406|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
128790407|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
128790408|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
128790409|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
128790410|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
128790411|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
128790412|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
128790413|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
128790414|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
128790415|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
128790416|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
128790417|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
128790418|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
128790419|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
128790420|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
128790421|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128790422|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
128790423|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
128790424|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
128790425|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128790426|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128790427|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128790428|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128758178|NCT01525602|463402232|FG004|Overall Study|Withdrawal by Subject|3|||
128758179|NCT01525602|463402233|FG005|Overall Study|Withdrawal by Subject|1|||
128758180|NCT01525602|463402234|FG006|Overall Study|Withdrawal by Subject|0|||
128758181|NCT01525602|463402235|FG007|Overall Study|Withdrawal by Subject|1|||
128758182|NCT01525602|463402228|FG000|Overall Study|Physician Decision|0|||
128758183|NCT01525602|463402229|FG001|Overall Study|Physician Decision|0|||
128758184|NCT01525602|463402230|FG002|Overall Study|Physician Decision|0|||
128758185|NCT01525602|463402231|FG003|Overall Study|Physician Decision|0|||
128758186|NCT01525602|463402232|FG004|Overall Study|Physician Decision|3|||
128758187|NCT01525602|463402233|FG005|Overall Study|Physician Decision|0|||
128758188|NCT01525602|463402234|FG006|Overall Study|Physician Decision|1|||
128758189|NCT01525602|463402235|FG007|Overall Study|Physician Decision|0|||
128758190|NCT01525602|463402228|FG000|Overall Study|Death|0|||
128758191|NCT01525602|463402229|FG001|Overall Study|Death|0|||
128758192|NCT01525602|463402230|FG002|Overall Study|Death|0|||
128758193|NCT01525602|463402231|FG003|Overall Study|Death|0|||
128758194|NCT01525602|463402232|FG004|Overall Study|Death|1|||
128758195|NCT01525602|463402233|FG005|Overall Study|Death|1|||
128758196|NCT01525602|463402234|FG006|Overall Study|Death|0|||
128758197|NCT01525602|463402235|FG007|Overall Study|Death|0|||
128758198|NCT01525602|463402228|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
128758199|NCT01525602|463402229|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
128758200|NCT01525602|463402230|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
128758201|NCT01525602|463402231|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
128758202|NCT01525602|463402232|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
128758203|NCT01525602|463402233|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
128758204|NCT01525602|463402234|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
128758205|NCT01525602|463402235|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
128758206|NCT04349280|463402236|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
128758207|NCT04349280|463402237|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
128758208|NCT04349280|463402236|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
128758209|NCT04349280|463402237|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
128758210|NCT04349280|463402236|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
128758211|NCT04349280|463402237|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
128758212|NCT01194570|463403333|FG000|Overall Study|Adverse Event|22|||
128758213|NCT01194570|463403334|FG001|Overall Study|Adverse Event|40|||
128758214|NCT01194570|463403333|FG000|Overall Study|Death|6|||
128758215|NCT01194570|463403334|FG001|Overall Study|Death|20|||
128758216|NCT01194570|463403333|FG000|Overall Study|Lack of Efficacy|32|||
128758217|NCT01194570|463403334|FG001|Overall Study|Lack of Efficacy|33|||
128758218|NCT01194570|463403333|FG000|Overall Study|Lost to Follow-up|4|||
128758219|NCT01194570|463403334|FG001|Overall Study|Lost to Follow-up|15|||
128758220|NCT01194570|463403333|FG000|Overall Study|Non-Compliance|2|||
128758221|NCT01194570|463403334|FG001|Overall Study|Non-Compliance|2|||
128758222|NCT01194570|463403333|FG000|Overall Study|Non-Compliance With Study Drug|2|||
128758223|NCT01194570|463403334|FG001|Overall Study|Non-Compliance With Study Drug|2|||
128758224|NCT01194570|463403333|FG000|Overall Study|Other|18|||
128758225|NCT01194570|463403334|FG001|Overall Study|Other|47|||
128758226|NCT01194570|463403333|FG000|Overall Study|Physician Decision|10|||
128758227|NCT01194570|463403334|FG001|Overall Study|Physician Decision|25|||
128758228|NCT01194570|463403333|FG000|Overall Study|Protocol Violation|1|||
128758229|NCT01194570|463403334|FG001|Overall Study|Protocol Violation|2|||
128758230|NCT01194570|463403333|FG000|Overall Study|Study Terminated By Sponsor|0|||
128758231|NCT01194570|463403334|FG001|Overall Study|Study Terminated By Sponsor|1|||
128790429|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128758232|NCT01194570|463403333|FG000|Overall Study|Withdrawal by Subject|57|||
128758233|NCT01194570|463403334|FG001|Overall Study|Withdrawal by Subject|82|||
128758234|NCT01194570|463403333|FG000|Overall Study|Pregnancy|1|||
128758235|NCT01194570|463403334|FG001|Overall Study|Pregnancy|1|||
128758236|NCT01337674|463403338|FG000|Treatment Period 1|Adverse Event|0|||
128758237|NCT01337674|463403339|FG001|Treatment Period 1|Adverse Event|1|||
128758238|NCT01337674|463403340|FG002|Treatment Period 1|Adverse Event|0|||
128790430|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128758239|NCT01337674|463403341|FG003|Treatment Period 1|Adverse Event|0|||
128758240|NCT01337674|463403338|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
128790431|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
128790432|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790433|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790434|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790435|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790436|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
128790437|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790438|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790439|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790440|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790441|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790442|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
128790443|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
128790444|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790445|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790446|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790447|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790448|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790449|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790450|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790451|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790452|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790453|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
128790454|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
128790455|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
128790456|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
128790457|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
128790458|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
128790459|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
128790460|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
128790461|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
128790462|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
128790463|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
128790464|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
128790465|NCT02914522|463525727|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790466|NCT02914522|463525728|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
128790467|NCT02914522|463525729|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790468|NCT02914522|463525730|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790469|NCT02914522|463525731|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
128790470|NCT02914522|463525732|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
128790471|NCT02914522|463525733|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790472|NCT02914522|463525734|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790473|NCT02914522|463525735|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790474|NCT02914522|463525736|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790475|NCT02914522|463525737|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
128790476|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
128790477|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
128790478|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
128790479|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
128790480|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
128790481|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
128790482|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
128790483|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
128790484|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
128790485|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
128790486|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
128790487|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
128790488|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
128790489|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
128790490|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
128790491|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
128790492|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
128790493|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
128790494|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
128790495|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
128790496|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
128790497|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
128790498|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
128790499|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
128790500|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
128790501|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
128790502|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
128790503|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
128790504|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
128790505|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
128790506|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
128790507|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
128790508|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
128790509|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
128790510|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
128790511|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
128790512|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
128790513|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
128790514|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
128790515|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
128790516|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
128790517|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
128790518|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
128790519|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
128790520|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
128790521|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
128790522|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
128790523|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
128790524|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
128790525|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
128790526|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
128790527|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
128790528|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
128790529|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
128790530|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
128790531|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790532|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790533|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790534|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790535|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790536|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790537|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790538|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
128790539|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
128790540|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790541|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
128790542|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790543|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790544|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790545|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790546|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790547|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790548|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790549|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790550|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
128790551|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
128790552|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
128790553|NCT02914522|463525727|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790554|NCT02914522|463525728|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790555|NCT02914522|463525729|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790556|NCT02914522|463525730|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790557|NCT02914522|463525731|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790558|NCT02914522|463525732|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790559|NCT02914522|463525733|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128758241|NCT01337674|463403339|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
128758242|NCT01337674|463403340|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
128758243|NCT01337674|463403341|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
128758244|NCT01337674|463403338|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128758245|NCT01337674|463403339|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128758246|NCT01337674|463403340|FG002|Treatment Period 2|Withdrawal by Subject|1|||
128758247|NCT01337674|463403341|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128758248|NCT03076970|463403342|FG000|Washout Period 2|Adverse Event|0|||
128758249|NCT03076970|463403343|FG001|Washout Period 2|Adverse Event|0|||
128758250|NCT03076970|463403344|FG002|Washout Period 2|Adverse Event|0|||
128758251|NCT03076970|463403345|FG003|Washout Period 2|Adverse Event|0|||
128758252|NCT03076970|463403346|FG004|Washout Period 2|Adverse Event|1|||
128758253|NCT03076970|463403347|FG005|Washout Period 2|Adverse Event|0|||
128758254|NCT03076970|463403342|FG000|Period 3|Withdrawal by Subject|0|||
128758255|NCT03076970|463403343|FG001|Period 3|Withdrawal by Subject|0|||
128758256|NCT03076970|463403344|FG002|Period 3|Withdrawal by Subject|0|||
128758257|NCT03076970|463403345|FG003|Period 3|Withdrawal by Subject|0|||
128758258|NCT03076970|463403346|FG004|Period 3|Withdrawal by Subject|0|||
128758259|NCT03076970|463403347|FG005|Period 3|Withdrawal by Subject|1|||
128758260|NCT03076970|463403342|FG000|Period 3|Failure to meet I/E criteria|0|||
128758261|NCT03076970|463403343|FG001|Period 3|Failure to meet I/E criteria|0|||
128758262|NCT03076970|463403344|FG002|Period 3|Failure to meet I/E criteria|0|||
128758263|NCT03076970|463403345|FG003|Period 3|Failure to meet I/E criteria|0|||
128758264|NCT03076970|463403346|FG004|Period 3|Failure to meet I/E criteria|1|||
128758265|NCT03076970|463403347|FG005|Period 3|Failure to meet I/E criteria|0|||
128758266|NCT01111123|463403353|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
128758267|NCT01111123|463403354|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
128758268|NCT01111123|463403353|FG000|Maintenance Phase|Lost to Follow-up|0|||
128758269|NCT01111123|463403354|FG001|Maintenance Phase|Lost to Follow-up|2|||
128758270|NCT00119405|463403355|FG000|Overall Study|Withdrawal by Subject|1|||
128758271|NCT01203930|463403366|FG000|Overall Study|Disease Progression|0|||
128758272|NCT01203930|463403367|FG001|Overall Study|Disease Progression|4|||
128758273|NCT01203930|463403366|FG000|Overall Study|Death|3|||
128758274|NCT01203930|463403367|FG001|Overall Study|Death|1|||
128758275|NCT01203930|463403366|FG000|Overall Study|Withdrew Consent|1|||
128758276|NCT01203930|463403367|FG001|Overall Study|Withdrew Consent|10|||
128758277|NCT01203930|463403366|FG000|Overall Study|Investigator Request|0|||
128758278|NCT01203930|463403367|FG001|Overall Study|Investigator Request|8|||
128758279|NCT01203930|463403366|FG000|Overall Study|Study Terminated by Sponsor|0|||
128758280|NCT01203930|463403367|FG001|Overall Study|Study Terminated by Sponsor|12|||
128758281|NCT01203930|463403366|FG000|Overall Study|Poor tolerance of study drug|0|||
128758282|NCT01203930|463403367|FG001|Overall Study|Poor tolerance of study drug|1|||
128758283|NCT01203930|463403366|FG000|Overall Study|Adverse Event|17|||
128758284|NCT01203930|463403367|FG001|Overall Study|Adverse Event|5|||
128758285|NCT02178059|463403368|FG000|Washout|Physician Decision|1|||
128758286|NCT02178059|463403369|FG001|Washout|Physician Decision|0|||
128758287|NCT05178121|463403370|FG000|Overall Study|Other|4|||
128758288|NCT05178121|463403370|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
128758289|NCT00662857|463403374|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
128758290|NCT00662857|463403375|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
128758291|NCT00662857|463403374|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
128758292|NCT00662857|463403375|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
128758293|NCT00662857|463403374|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
128758294|NCT00662857|463403375|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
128758295|NCT03966053|463403376|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
128758296|NCT00989092|463403377|FG000|Overall Study|Physician Decision|9|||
128758297|NCT00989092|463403378|FG001|Overall Study|Physician Decision|6|||
128758298|NCT00989092|463403377|FG000|Overall Study|Adverse Event|20|||
128758299|NCT00989092|463403378|FG001|Overall Study|Adverse Event|1|||
128758300|NCT00989092|463403377|FG000|Overall Study|Chemotherapy initiated|12|||
128758301|NCT00989092|463403378|FG001|Overall Study|Chemotherapy initiated|4|||
128758302|NCT00989092|463403377|FG000|Overall Study|Withdrawal by Subject|17|||
128758303|NCT00989092|463403378|FG001|Overall Study|Withdrawal by Subject|9|||
128758304|NCT00989092|463403377|FG000|Overall Study|Death|14|||
128758305|NCT00989092|463403378|FG001|Overall Study|Death|2|||
128758306|NCT00989092|463403377|FG000|Overall Study|Ineligibility determined|3|||
128758307|NCT00989092|463403378|FG001|Overall Study|Ineligibility determined|3|||
128758308|NCT00989092|463403377|FG000|Overall Study|Lost to Follow-up|6|||
128758309|NCT00989092|463403378|FG001|Overall Study|Lost to Follow-up|2|||
128758310|NCT00989092|463403377|FG000|Overall Study|Other|3|||
128758311|NCT00989092|463403378|FG001|Overall Study|Other|1|||
128758312|NCT00989092|463403377|FG000|Overall Study|Protocol deviation|2|||
128758313|NCT00989092|463403378|FG001|Overall Study|Protocol deviation|0|||
128758314|NCT00989092|463403377|FG000|Overall Study|Erythropoietin therapy initiated|2|||
128758315|NCT00989092|463403378|FG001|Overall Study|Erythropoietin therapy initiated|0|||
128758316|NCT00989092|463403377|FG000|Overall Study|Did not receive study drug|2|||
128790560|NCT02914522|463525734|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790561|NCT02914522|463525735|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790562|NCT02914522|463525736|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
128790563|NCT02914522|463525737|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
128790564|NCT00639002|463525739|FG000|Overall Study|Death|1|||
128790565|NCT00639002|463525739|FG000|Overall Study|Adverse Event|1|||
128790566|NCT00639002|463525739|FG000|Overall Study|Protocol Violation|1|||
128790567|NCT00639002|463525739|FG000|Overall Study|Disease progression|3|||
128790568|NCT00639002|463525739|FG000|Overall Study|Physician Decision|6|||
128790569|NCT00639002|463525739|FG000|Overall Study|Lack of Efficacy|1|||
128790570|NCT05382104|463525740|FG000|Period 2 (2 Days)|Adverse Event|0|||
128790571|NCT05382104|463525741|FG001|Period 2 (2 Days)|Adverse Event|1|||
128790572|NCT05382104|463525742|FG002|Period 2 (2 Days)|Adverse Event|0|||
128790573|NCT05382104|463525743|FG003|Period 2 (2 Days)|Adverse Event|0|||
128790574|NCT05382104|463525744|FG004|Period 2 (2 Days)|Adverse Event|0|||
128790575|NCT05382104|463525745|FG005|Period 2 (2 Days)|Adverse Event|0|||
128790576|NCT00940992|463525754|FG000|Overall Study|Adverse Event|2|||
128790577|NCT00940992|463525755|FG001|Overall Study|Adverse Event|0|||
128790578|NCT00940992|463525756|FG002|Overall Study|Adverse Event|1|||
128790579|NCT00940992|463525754|FG000|Overall Study|subject request|2|||
128790580|NCT00940992|463525755|FG001|Overall Study|subject request|1|||
128790581|NCT00940992|463525756|FG002|Overall Study|subject request|0|||
128790582|NCT00940992|463525754|FG000|Overall Study|Lost to Follow-up|0|||
128790583|NCT00940992|463525755|FG001|Overall Study|Lost to Follow-up|1|||
128790584|NCT00940992|463525756|FG002|Overall Study|Lost to Follow-up|1|||
128790585|NCT02781584|463525769|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
128790586|NCT02781584|463525770|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
128790587|NCT02781584|463525771|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
128790588|NCT02781584|463525772|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
128790589|NCT02781584|463525773|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
128790590|NCT02781584|463525774|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
128790591|NCT02781584|463525775|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
128790592|NCT02781584|463525776|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
128790593|NCT02781584|463525777|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
128790594|NCT02781584|463525778|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
128790595|NCT02781584|463525779|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
128790596|NCT02781584|463525780|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
128790597|NCT02781584|463525781|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
128790598|NCT02781584|463525769|FG000|Pre-treatment Phase|Adverse Event|0|||
128790599|NCT02781584|463525770|FG001|Pre-treatment Phase|Adverse Event|0|||
128790600|NCT02781584|463525771|FG002|Pre-treatment Phase|Adverse Event|0|||
128790601|NCT02781584|463525772|FG003|Pre-treatment Phase|Adverse Event|0|||
128790602|NCT02781584|463525773|FG004|Pre-treatment Phase|Adverse Event|0|||
128790603|NCT02781584|463525774|FG005|Pre-treatment Phase|Adverse Event|0|||
128790604|NCT02781584|463525775|FG006|Pre-treatment Phase|Adverse Event|0|||
128790605|NCT02781584|463525776|FG007|Pre-treatment Phase|Adverse Event|0|||
128790606|NCT02781584|463525777|FG008|Pre-treatment Phase|Adverse Event|0|||
128790607|NCT02781584|463525778|FG009|Pre-treatment Phase|Adverse Event|0|||
128790608|NCT02781584|463525779|FG010|Pre-treatment Phase|Adverse Event|0|||
128790609|NCT02781584|463525780|FG011|Pre-treatment Phase|Adverse Event|1|||
128790610|NCT02781584|463525781|FG012|Pre-treatment Phase|Adverse Event|0|||
128790611|NCT02781584|463525769|FG000|Treatment Phase|Withdrew Consent|0|||
128790612|NCT02781584|463525770|FG001|Treatment Phase|Withdrew Consent|0|||
128790613|NCT02781584|463525771|FG002|Treatment Phase|Withdrew Consent|0|||
128790614|NCT02781584|463525772|FG003|Treatment Phase|Withdrew Consent|0|||
128790615|NCT02781584|463525773|FG004|Treatment Phase|Withdrew Consent|0|||
128790616|NCT02781584|463525774|FG005|Treatment Phase|Withdrew Consent|1|||
128790617|NCT02781584|463525775|FG006|Treatment Phase|Withdrew Consent|0|||
128790618|NCT02781584|463525776|FG007|Treatment Phase|Withdrew Consent|0|||
128790619|NCT02781584|463525777|FG008|Treatment Phase|Withdrew Consent|0|||
128790620|NCT02781584|463525778|FG009|Treatment Phase|Withdrew Consent|0|||
128790621|NCT02781584|463525779|FG010|Treatment Phase|Withdrew Consent|1|||
128790622|NCT02781584|463525780|FG011|Treatment Phase|Withdrew Consent|2|||
128790623|NCT02781584|463525781|FG012|Treatment Phase|Withdrew Consent|0|||
128790624|NCT02781584|463525769|FG000|Treatment Phase|Adverse Event|0|||
128790625|NCT02781584|463525770|FG001|Treatment Phase|Adverse Event|0|||
128790626|NCT02781584|463525771|FG002|Treatment Phase|Adverse Event|0|||
128790627|NCT02781584|463525772|FG003|Treatment Phase|Adverse Event|0|||
128790628|NCT02781584|463525773|FG004|Treatment Phase|Adverse Event|0|||
128790629|NCT02781584|463525774|FG005|Treatment Phase|Adverse Event|0|||
128790630|NCT02781584|463525775|FG006|Treatment Phase|Adverse Event|0|||
128790631|NCT02781584|463525776|FG007|Treatment Phase|Adverse Event|1|||
128790632|NCT02781584|463525777|FG008|Treatment Phase|Adverse Event|0|||
128790633|NCT02781584|463525778|FG009|Treatment Phase|Adverse Event|0|||
128790634|NCT02781584|463525779|FG010|Treatment Phase|Adverse Event|0|||
128790635|NCT02781584|463525780|FG011|Treatment Phase|Adverse Event|0|||
128790636|NCT02781584|463525781|FG012|Treatment Phase|Adverse Event|0|||
128790637|NCT05019729|463525782|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
128790638|NCT05019729|463525783|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
128790639|NCT05019729|463525784|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
128790640|NCT05019729|463525785|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
128790641|NCT05019729|463525786|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
128790642|NCT05019729|463525787|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
128790643|NCT05147233|463527487|FG000|Overall Study|Adverse Event|0|||
128790644|NCT05147233|463527488|FG001|Overall Study|Adverse Event|1|||
128790645|NCT05147233|463527487|FG000|Overall Study|Lost to Follow-up|1|||
128790646|NCT05147233|463527488|FG001|Overall Study|Lost to Follow-up|1|||
128790647|NCT05147233|463527487|FG000|Overall Study|Protocol Violation|0|||
128790648|NCT05147233|463527488|FG001|Overall Study|Protocol Violation|1|||
128790649|NCT05147233|463527487|FG000|Overall Study|Withdrawal by Subject|2|||
128790650|NCT05147233|463527488|FG001|Overall Study|Withdrawal by Subject|1|||
128790651|NCT04517864|463527491|FG000|Placebo-Controlled Phase|Adverse Event|1|||
128790652|NCT04517864|463527492|FG001|Placebo-Controlled Phase|Adverse Event|0|||
128790653|NCT04517864|463527493|FG002|Placebo-Controlled Phase|Adverse Event|0|||
128790654|NCT04517864|463527491|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
128790655|NCT04517864|463527492|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
128790656|NCT04517864|463527493|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
128790657|NCT04517864|463527491|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
128790658|NCT04517864|463527492|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
128790659|NCT04517864|463527493|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
128790660|NCT04517864|463527491|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
128790661|NCT04517864|463527492|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
128790662|NCT04517864|463527493|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
128790663|NCT04517864|463527491|FG000|Active Therapy Extension Phase|Adverse Event|1|||
128790664|NCT04517864|463527492|FG001|Active Therapy Extension Phase|Adverse Event|0|||
128790665|NCT04517864|463527493|FG002|Active Therapy Extension Phase|Adverse Event|0|||
128790666|NCT04517864|463527491|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
128790667|NCT04517864|463527492|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
128790668|NCT04517864|463527493|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
128790669|NCT04517864|463527491|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
128790670|NCT04517864|463527492|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
128790671|NCT04517864|463527493|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
128790672|NCT04517864|463527491|FG000|Active Therapy Extension Phase|Physician Decision|1|||
128790673|NCT04517864|463527492|FG001|Active Therapy Extension Phase|Physician Decision|0|||
128790674|NCT04517864|463527493|FG002|Active Therapy Extension Phase|Physician Decision|0|||
128790675|NCT04517864|463527491|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
128790676|NCT04517864|463527492|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
128790677|NCT04517864|463527493|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
128790678|NCT04517864|463527491|FG000|Extension Phase|Adverse Event|0|||
128790679|NCT04517864|463527492|FG001|Extension Phase|Adverse Event|0|||
128790680|NCT04517864|463527493|FG002|Extension Phase|Adverse Event|1|||
128790681|NCT04517864|463527491|FG000|Extension Phase|Lack of Efficacy|0|||
128790682|NCT04517864|463527492|FG001|Extension Phase|Lack of Efficacy|0|||
128790683|NCT04517864|463527493|FG002|Extension Phase|Lack of Efficacy|2|||
128790684|NCT04517864|463527491|FG000|Extension Phase|Study Terminated By Sponsor|0|||
128790685|NCT04517864|463527492|FG001|Extension Phase|Study Terminated By Sponsor|0|||
128790686|NCT04517864|463527493|FG002|Extension Phase|Study Terminated By Sponsor|32|||
128790687|NCT04517864|463527491|FG000|Extension Phase|Withdrawal by Subject|0|||
128790688|NCT04517864|463527492|FG001|Extension Phase|Withdrawal by Subject|0|||
128790689|NCT04517864|463527493|FG002|Extension Phase|Withdrawal by Subject|3|||
128790690|NCT04517864|463527491|FG000|Extension Phase|Approved Drug Available for Indication|0|||
128790691|NCT04517864|463527492|FG001|Extension Phase|Approved Drug Available for Indication|0|||
128790692|NCT04517864|463527493|FG002|Extension Phase|Approved Drug Available for Indication|7|||
128790693|NCT04722003|463527494|FG000|Overall Study|Lost to Follow-up|2|||
128790694|NCT04722003|463527495|FG001|Overall Study|Lost to Follow-up|0|||
128790695|NCT04722003|463527494|FG000|Overall Study|Physician Decision|1|||
128790696|NCT04722003|463527495|FG001|Overall Study|Physician Decision|0|||
128790697|NCT00726596|463527496|FG000|Overall Study|Adverse Event|2|||
128790698|NCT00726596|463527497|FG001|Overall Study|Adverse Event|1|||
128790699|NCT00726596|463527496|FG000|Overall Study|Withdrawal by Subject|3|||
128790700|NCT00726596|463527497|FG001|Overall Study|Withdrawal by Subject|3|||
128790701|NCT02974634|463527498|FG000|Overall Study|Advanced disease|12|||
128790702|NCT02974634|463527499|FG001|Overall Study|Advanced disease|3|||
128790703|NCT02974634|463527498|FG000|Overall Study|Noncompliance|3|||
128790704|NCT02974634|463527499|FG001|Overall Study|Noncompliance|7|||
128790705|NCT02974634|463527498|FG000|Overall Study|intervention technology related issues|5|||
128790706|NCT02974634|463527499|FG001|Overall Study|intervention technology related issues|0|||
128790707|NCT02974634|463527498|FG000|Overall Study|Death|8|||
128790708|NCT02974634|463527499|FG001|Overall Study|Death|11|||
128790709|NCT00364286|463527505|FG000|Overall Study|Withdrawal by Subject|1|||
128790710|NCT00364286|463527505|FG000|Overall Study|Adverse Event|2|||
128790711|NCT01134562|463527506|FG000|Overall Study|Adverse Event|0|||
128790712|NCT01134562|463527507|FG001|Overall Study|Adverse Event|1|||
128790713|NCT01134562|463527508|FG002|Overall Study|Adverse Event|0|||
128790714|NCT01134562|463527509|FG003|Overall Study|Adverse Event|0|||
128790715|NCT01134562|463527510|FG004|Overall Study|Adverse Event|0|||
128790716|NCT00357396|463527511|FG000|Overall Study|Adverse Event|1|||
128790717|NCT00357396|463527512|FG001|Overall Study|Adverse Event|0|||
128790718|NCT01227278|463527513|FG000|Overall Study|Withdrawal by Subject|4|||
128790719|NCT01227278|463527514|FG001|Overall Study|Withdrawal by Subject|4|||
128790720|NCT01227278|463527513|FG000|Overall Study|Death|0|||
128790721|NCT01227278|463527514|FG001|Overall Study|Death|2|||
128790722|NCT01227278|463527513|FG000|Overall Study|Other|1|||
128790723|NCT01227278|463527514|FG001|Overall Study|Other|2|||
128790724|NCT00516386|463527515|FG000|Overall Study|not interested in the study|4|||
128790725|NCT00516386|463527515|FG000|Overall Study|Lost to Follow-up|2|||
128790726|NCT01376089|463527516|FG000|Overall Study|Patient received no contrast media|3|||
128790727|NCT01376089|463527517|FG001|Overall Study|Patient received no contrast media|4|||
128790728|NCT02506257|463527520|FG000|Overall Study|Adverse Event|0|||
128790729|NCT02506257|463527521|FG001|Overall Study|Adverse Event|2|||
128790730|NCT02506257|463527522|FG002|Overall Study|Adverse Event|3|||
128790731|NCT02506257|463527523|FG003|Overall Study|Adverse Event|0|||
128790732|NCT02506257|463527520|FG000|Overall Study|Protocol Violation|0|||
128790733|NCT02506257|463527521|FG001|Overall Study|Protocol Violation|0|||
128790734|NCT02506257|463527522|FG002|Overall Study|Protocol Violation|1|||
128790735|NCT02506257|463527523|FG003|Overall Study|Protocol Violation|0|||
128790736|NCT03781336|463527527|FG000|Overall Study|Withdrawal by Subject|2|||
128790737|NCT03781336|463527528|FG001|Overall Study|Withdrawal by Subject|2|||
128790738|NCT03460756|463527529|FG000|Overall Study|Adverse Event|0|||
128790739|NCT03460756|463527530|FG001|Overall Study|Adverse Event|0|||
128790740|NCT03460756|463527531|FG002|Overall Study|Adverse Event|0|||
128790741|NCT03460756|463527532|FG003|Overall Study|Adverse Event|1|||
128790742|NCT03460756|463527529|FG000|Overall Study|Lack of Efficacy|0|||
128790743|NCT03460756|463527530|FG001|Overall Study|Lack of Efficacy|0|||
128790744|NCT03460756|463527531|FG002|Overall Study|Lack of Efficacy|0|||
128790745|NCT03460756|463527532|FG003|Overall Study|Lack of Efficacy|2|||
128790746|NCT03460756|463527529|FG000|Overall Study|Lost to Follow-up|0|||
128790747|NCT03460756|463527530|FG001|Overall Study|Lost to Follow-up|1|||
128790748|NCT03460756|463527531|FG002|Overall Study|Lost to Follow-up|2|||
128790749|NCT03460756|463527532|FG003|Overall Study|Lost to Follow-up|1|||
128790750|NCT03460756|463527529|FG000|Overall Study|Pregnancy|0|||
128790751|NCT03460756|463527530|FG001|Overall Study|Pregnancy|0|||
128790752|NCT03460756|463527531|FG002|Overall Study|Pregnancy|0|||
128790753|NCT03460756|463527532|FG003|Overall Study|Pregnancy|1|||
128790754|NCT03460756|463527529|FG000|Overall Study|Protocol Violation|0|||
128790755|NCT03460756|463527530|FG001|Overall Study|Protocol Violation|0|||
128790756|NCT03460756|463527531|FG002|Overall Study|Protocol Violation|0|||
128790757|NCT03460756|463527532|FG003|Overall Study|Protocol Violation|1|||
128790758|NCT03460756|463527529|FG000|Overall Study|Withdrawal by Subject|0|||
128790759|NCT03460756|463527530|FG001|Overall Study|Withdrawal by Subject|4|||
128790760|NCT03460756|463527531|FG002|Overall Study|Withdrawal by Subject|7|||
128790761|NCT03460756|463527532|FG003|Overall Study|Withdrawal by Subject|3|||
128790762|NCT03987451|463527533|FG000|Overall Study|Lost to Follow-up|1|||
128790763|NCT03987451|463527534|FG001|Overall Study|Lost to Follow-up|0|||
128790764|NCT03987451|463527533|FG000|Overall Study|Withdrawal by Subject|1|||
128790765|NCT03987451|463527534|FG001|Overall Study|Withdrawal by Subject|1|||
128790766|NCT02441036|463527535|FG000|Overall Study|No tissue resected|0|||
128790767|NCT02441036|463527536|FG001|Overall Study|No tissue resected|1|||
128790768|NCT02441036|463527537|FG002|Overall Study|No tissue resected|0|||
128790769|NCT02441036|463527538|FG003|Overall Study|No tissue resected|1|||
128790770|NCT02441036|463527539|FG004|Overall Study|No tissue resected|0|||
128790771|NCT01901276|463527540|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
128790772|NCT01901276|463527541|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
128790773|NCT02026258|463527542|FG000|Randomized|Did not start treatment|2|||
128790774|NCT02026258|463527543|FG001|Randomized|Did not start treatment|1|||
128790775|NCT02026258|463527542|FG000|Randomized|Change in treatment plan|1|||
128790776|NCT02026258|463527543|FG001|Randomized|Change in treatment plan|0|||
128790777|NCT02026258|463527542|FG000|Randomized|Presence of periodontal disease|1|||
128790778|NCT02026258|463527543|FG001|Randomized|Presence of periodontal disease|1|||
128790779|NCT02026258|463527542|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
128790780|NCT02026258|463527543|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
128790781|NCT02026258|463527542|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
128790782|NCT02026258|463527543|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
128790783|NCT02534350|463527544|FG000|Overall Study|Randomized But Not Treated|1|||
128790784|NCT02534350|463527545|FG001|Overall Study|Randomized But Not Treated|0|||
128790785|NCT02534350|463527544|FG000|Overall Study|Protocol Violation|1|||
128790786|NCT02534350|463527545|FG001|Overall Study|Protocol Violation|0|||
128790787|NCT02534350|463527544|FG000|Overall Study|Withdrew Consent|2|||
128790788|NCT02534350|463527545|FG001|Overall Study|Withdrew Consent|0|||
128790789|NCT02878330|463527546|FG000|Overall Study|Death|3|||
128790790|NCT02878330|463527547|FG001|Overall Study|Death|2|||
128790791|NCT02878330|463527546|FG000|Overall Study|Lost to Follow-up|11|||
128790792|NCT02878330|463527547|FG001|Overall Study|Lost to Follow-up|26|||
128790793|NCT02878330|463527546|FG000|Overall Study|Withdrawal by Subject|11|||
128790794|NCT02878330|463527547|FG001|Overall Study|Withdrawal by Subject|21|||
128790795|NCT02878330|463527546|FG000|Overall Study|Other|4|||
128790796|NCT02878330|463527547|FG001|Overall Study|Other|7|||
128790797|NCT01069341|463527554|FG000|Overall Study|Lost to Follow-up|1|||
128790798|NCT01802632|463527555|FG000|Overall Study|Death|28|||
128790799|NCT01802632|463527556|FG001|Overall Study|Death|1|||
128790800|NCT01802632|463527557|FG002|Overall Study|Death|38|||
128790801|NCT01802632|463527558|FG003|Overall Study|Death|0|||
128790802|NCT01802632|463527559|FG004|Overall Study|Death|2|||
128790803|NCT01802632|463527560|FG005|Overall Study|Death|0|||
128790804|NCT01802632|463527555|FG000|Overall Study|Withdrawal by Subject|4|||
128790805|NCT01802632|463527556|FG001|Overall Study|Withdrawal by Subject|2|||
128790806|NCT01802632|463527557|FG002|Overall Study|Withdrawal by Subject|7|||
128790807|NCT01802632|463527558|FG003|Overall Study|Withdrawal by Subject|3|||
128790808|NCT01802632|463527559|FG004|Overall Study|Withdrawal by Subject|0|||
128790809|NCT01802632|463527560|FG005|Overall Study|Withdrawal by Subject|1|||
128790810|NCT01802632|463527555|FG000|Overall Study|Objective Disease Progression|1|||
128790811|NCT01802632|463527556|FG001|Overall Study|Objective Disease Progression|12|||
128790812|NCT01802632|463527557|FG002|Overall Study|Objective Disease Progression|104|||
128790813|NCT01802632|463527558|FG003|Overall Study|Objective Disease Progression|6|||
128790814|NCT01802632|463527559|FG004|Overall Study|Objective Disease Progression|4|||
128790815|NCT01802632|463527560|FG005|Overall Study|Objective Disease Progression|4|||
128790816|NCT01802632|463527555|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
128790817|NCT01802632|463527556|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
128790818|NCT01802632|463527557|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
128790819|NCT01802632|463527558|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
128790820|NCT01802632|463527559|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
128790821|NCT01802632|463527560|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
128790822|NCT01802632|463527555|FG000|Overall Study|Other (not specified)|0|||
128790823|NCT01802632|463527556|FG001|Overall Study|Other (not specified)|0|||
128790824|NCT01802632|463527557|FG002|Overall Study|Other (not specified)|7|||
128790825|NCT01802632|463527558|FG003|Overall Study|Other (not specified)|1|||
128790826|NCT01802632|463527559|FG004|Overall Study|Other (not specified)|0|||
128790827|NCT01802632|463527560|FG005|Overall Study|Other (not specified)|1|||
128790828|NCT02880241|463527573|FG000|Overall Study|Lack of Efficacy|1|||
128790829|NCT02880241|463527574|FG001|Overall Study|Lack of Efficacy|0|||
128790830|NCT02880241|463527575|FG002|Overall Study|Lack of Efficacy|0|||
128790831|NCT02880241|463527576|FG003|Overall Study|Lack of Efficacy|0|||
128790832|NCT02880241|463527577|FG004|Overall Study|Lack of Efficacy|0|||
128790833|NCT02880241|463527578|FG005|Overall Study|Lack of Efficacy|0|||
128790834|NCT02705586|463527580|FG000|Overall Study|Health Issues|2|||
128790835|NCT02705586|463527580|FG000|Overall Study|Transportation Difficulties|5|||
128790836|NCT02705586|463527580|FG000|Overall Study|Vacation/Planned Absence|1|||
128790837|NCT02194933|463527584|FG000|Overall Study|Lost to Follow-up|1|||
128790838|NCT02194933|463527585|FG001|Overall Study|Lost to Follow-up|2|||
128790839|NCT02194933|463527584|FG000|Overall Study|Participant met withdrawal criteria|1|||
128790840|NCT02194933|463527585|FG001|Overall Study|Participant met withdrawal criteria|3|||
128790841|NCT02194933|463527584|FG000|Overall Study|Withdrawal by Subject|0|||
128790842|NCT02194933|463527585|FG001|Overall Study|Withdrawal by Subject|2|||
128790843|NCT02194933|463527584|FG000|Overall Study|Lack of Efficacy|1|||
128790844|NCT02194933|463527585|FG001|Overall Study|Lack of Efficacy|2|||
128790845|NCT02045836|463527589|FG000|Overall Study|Adverse Event|4|||
128790846|NCT02045836|463527590|FG001|Overall Study|Adverse Event|4|||
128790847|NCT02045836|463527589|FG000|Overall Study|Withdrawal by Subject|1|||
128790848|NCT02045836|463527590|FG001|Overall Study|Withdrawal by Subject|1|||
128790849|NCT02045836|463527589|FG000|Overall Study|Lost to Follow-up|4|||
128790850|NCT02045836|463527590|FG001|Overall Study|Lost to Follow-up|7|||
128790851|NCT02045836|463527589|FG000|Overall Study|Migrated from study area|0|||
128790852|NCT02045836|463527590|FG001|Overall Study|Migrated from study area|2|||
128790853|NCT03920215|463527594|FG000|Overall Study|Lost to Follow-up|1|||
128790854|NCT03920215|463527595|FG001|Overall Study|Lost to Follow-up|2|||
128790855|NCT03920215|463527596|FG002|Overall Study|Lost to Follow-up|0|||
128790856|NCT03920215|463527597|FG003|Overall Study|Lost to Follow-up|0|||
128790857|NCT03920215|463527594|FG000|Overall Study|Death|0|||
128790858|NCT03920215|463527595|FG001|Overall Study|Death|0|||
128790859|NCT03920215|463527596|FG002|Overall Study|Death|0|||
128790860|NCT03920215|463527597|FG003|Overall Study|Death|1|||
128790861|NCT02000817|463527598|FG000|Overall Study|Withdrawal by Subject|2|||
128790862|NCT02000817|463527599|FG001|Overall Study|Withdrawal by Subject|0|||
128790863|NCT02000817|463527600|FG002|Overall Study|Withdrawal by Subject|0|||
128790864|NCT02000817|463527601|FG003|Overall Study|Withdrawal by Subject|0|||
128790865|NCT02000817|463527598|FG000|Overall Study|Adverse Event|0|||
128790866|NCT02000817|463527599|FG001|Overall Study|Adverse Event|1|||
128790867|NCT02000817|463527600|FG002|Overall Study|Adverse Event|0|||
128790868|NCT02000817|463527601|FG003|Overall Study|Adverse Event|0|||
128790869|NCT02000817|463527598|FG000|Overall Study|Lost to Follow-up|0|||
128790870|NCT02000817|463527599|FG001|Overall Study|Lost to Follow-up|0|||
128790871|NCT02000817|463527600|FG002|Overall Study|Lost to Follow-up|1|||
128790872|NCT02000817|463527601|FG003|Overall Study|Lost to Follow-up|0|||
128790873|NCT00177216|463527602|FG000|Overall Study|Withdrawal by Subject|6|||
128790874|NCT00177216|463527603|FG001|Overall Study|Withdrawal by Subject|3|||
128790875|NCT00177216|463527604|FG002|Overall Study|Withdrawal by Subject|1|||
128790876|NCT03383146|463527605|FG000|Overall Study|Screen Failure|1|||
128790877|NCT03383146|463527606|FG001|Overall Study|Screen Failure|0|||
128790878|NCT03383146|463527605|FG000|Overall Study|Adverse Event|6|||
128790879|NCT03383146|463527606|FG001|Overall Study|Adverse Event|18|||
128790880|NCT03383146|463527605|FG000|Overall Study|Lack of Efficacy|0|||
128790881|NCT03383146|463527606|FG001|Overall Study|Lack of Efficacy|3|||
128790882|NCT03383146|463527605|FG000|Overall Study|Withdrawal by Subject|20|||
128790883|NCT03383146|463527606|FG001|Overall Study|Withdrawal by Subject|36|||
128790884|NCT03383146|463527605|FG000|Overall Study|Lost to Follow-up|5|||
128790885|NCT03383146|463527606|FG001|Overall Study|Lost to Follow-up|15|||
128790886|NCT03383146|463527605|FG000|Overall Study|Death|0|||
128790887|NCT03383146|463527606|FG001|Overall Study|Death|2|||
128790888|NCT03383146|463527605|FG000|Overall Study|Physician Decision|0|||
128790889|NCT03383146|463527606|FG001|Overall Study|Physician Decision|1|||
128790890|NCT03383146|463527605|FG000|Overall Study|Protocol Deviation|1|||
128790891|NCT03383146|463527606|FG001|Overall Study|Protocol Deviation|8|||
128790892|NCT03383146|463527605|FG000|Overall Study|Study Terminated by the Sponsor|48|||
128790893|NCT03383146|463527606|FG001|Overall Study|Study Terminated by the Sponsor|95|||
128790894|NCT03383146|463527605|FG000|Overall Study|Reason not Specified|4|||
128790895|NCT03383146|463527606|FG001|Overall Study|Reason not Specified|6|||
128790896|NCT02459899|463527611|FG000|Overall Study|Adverse Event|1|||
128790897|NCT02459899|463527612|FG001|Overall Study|Adverse Event|1|||
128790898|NCT02459899|463527613|FG002|Overall Study|Adverse Event|0|||
128790899|NCT02459899|463527614|FG003|Overall Study|Adverse Event|0|||
128790900|NCT02459899|463527611|FG000|Overall Study|Lost to Follow-up|1|||
128790901|NCT02459899|463527612|FG001|Overall Study|Lost to Follow-up|2|||
128790902|NCT02459899|463527613|FG002|Overall Study|Lost to Follow-up|0|||
128790903|NCT02459899|463527614|FG003|Overall Study|Lost to Follow-up|1|||
128790904|NCT02459899|463527611|FG000|Overall Study|Non-compliance with the treatment|0|||
128790905|NCT02459899|463527612|FG001|Overall Study|Non-compliance with the treatment|0|||
128790906|NCT02459899|463527613|FG002|Overall Study|Non-compliance with the treatment|0|||
128790907|NCT02459899|463527614|FG003|Overall Study|Non-compliance with the treatment|1|||
128790908|NCT02459899|463527611|FG000|Overall Study|Withdrawal by Subject|1|||
128790909|NCT02459899|463527612|FG001|Overall Study|Withdrawal by Subject|3|||
128790910|NCT02459899|463527613|FG002|Overall Study|Withdrawal by Subject|0|||
128790911|NCT02459899|463527614|FG003|Overall Study|Withdrawal by Subject|0|||
128790912|NCT02739035|463527617|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
128790913|NCT02739035|463527618|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
128790914|NCT02739035|463527617|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
128790915|NCT02739035|463527618|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
128790916|NCT02739035|463527617|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
128790917|NCT02739035|463527618|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
128790918|NCT02739035|463527617|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
128790919|NCT02739035|463527618|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
128790920|NCT03210402|463527619|FG000|Overall Study|Withdrawal by Subject|0|||
128790921|NCT03210402|463527620|FG001|Overall Study|Withdrawal by Subject|1|||
128790922|NCT02517307|463527625|FG000|Overall Study|Withdrawal by Subject|1|||
128790923|NCT02517307|463527626|FG001|Overall Study|Withdrawal by Subject|0|||
128790924|NCT02517307|463527627|FG002|Overall Study|Withdrawal by Subject|1|||
128790925|NCT02517307|463527628|FG003|Overall Study|Withdrawal by Subject|0|||
128790926|NCT02517307|463527625|FG000|Overall Study|Protocol Violation|0|||
128790927|NCT02517307|463527626|FG001|Overall Study|Protocol Violation|0|||
128790928|NCT02517307|463527627|FG002|Overall Study|Protocol Violation|1|||
128790929|NCT02517307|463527628|FG003|Overall Study|Protocol Violation|1|||
128790930|NCT00823979|463527629|FG000|Overall Study|Lack of Efficacy|13|||
128790931|NCT00823979|463527630|FG001|Overall Study|Lack of Efficacy|16|||
128790932|NCT00823979|463527631|FG002|Overall Study|Lack of Efficacy|9|||
128790933|NCT00823979|463527629|FG000|Overall Study|Lost to Follow-up|2|||
128790934|NCT00823979|463527630|FG001|Overall Study|Lost to Follow-up|1|||
128790935|NCT00823979|463527631|FG002|Overall Study|Lost to Follow-up|0|||
128790936|NCT00823979|463527629|FG000|Overall Study|Withdrawal by Subject|2|||
128790937|NCT00823979|463527630|FG001|Overall Study|Withdrawal by Subject|3|||
128790938|NCT00823979|463527631|FG002|Overall Study|Withdrawal by Subject|2|||
128790939|NCT00823979|463527629|FG000|Overall Study|Protocol Violation|1|||
128790940|NCT00823979|463527630|FG001|Overall Study|Protocol Violation|1|||
128790941|NCT00823979|463527631|FG002|Overall Study|Protocol Violation|0|||
128790942|NCT00823979|463527629|FG000|Overall Study|Pregnancy|0|||
128790943|NCT00823979|463527630|FG001|Overall Study|Pregnancy|1|||
128790944|NCT00823979|463527631|FG002|Overall Study|Pregnancy|0|||
128790945|NCT00823979|463527629|FG000|Overall Study|Adverse Event|0|||
128790946|NCT00823979|463527630|FG001|Overall Study|Adverse Event|2|||
128790947|NCT00823979|463527631|FG002|Overall Study|Adverse Event|4|||
128790948|NCT00823979|463527629|FG000|Overall Study|Other|2|||
128790949|NCT00823979|463527630|FG001|Overall Study|Other|0|||
128790950|NCT00823979|463527631|FG002|Overall Study|Other|1|||
128790951|NCT00823979|463527629|FG000|Overall Study|Randomized but not Treated|4|||
128790952|NCT00823979|463527630|FG001|Overall Study|Randomized but not Treated|3|||
128790953|NCT00823979|463527631|FG002|Overall Study|Randomized but not Treated|1|||
128790954|NCT00823979|463527629|FG000|Overall Study|Study Terminated by Sponsor|5|||
128790955|NCT00823979|463527630|FG001|Overall Study|Study Terminated by Sponsor|5|||
128790956|NCT00823979|463527631|FG002|Overall Study|Study Terminated by Sponsor|7|||
128790957|NCT03586544|463527632|FG000|First Intervention|Adverse Event|0|||
128790958|NCT03586544|463527633|FG001|First Intervention|Adverse Event|1|||
128790959|NCT03586544|463527632|FG000|Second Intervention|Withdrawal by Subject|0|||
128790960|NCT03586544|463527633|FG001|Second Intervention|Withdrawal by Subject|1|||
128790961|NCT03523091|463527634|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
128790962|NCT03523091|463527635|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
128790963|NCT03523091|463527634|FG000|Overall Study|Withdrawal by Subject|0|||
128790964|NCT03523091|463527635|FG001|Overall Study|Withdrawal by Subject|3|||
128790965|NCT03523091|463527634|FG000|Overall Study|Increase Botox dose|0|||
128790966|NCT03523091|463527635|FG001|Overall Study|Increase Botox dose|1|||
128790967|NCT03863834|463527641|FG000|Overall Study|Lost to Follow-up|3|||
128790968|NCT02685488|463527642|FG000|Overall Study|Withdrawal by Subject|0|||
128790969|NCT02685488|463527643|FG001|Overall Study|Withdrawal by Subject|1|||
128790970|NCT00361283|463527647|FG000|Overall Study|Lost to Follow-up|27|||
128790971|NCT00038103|463527648|FG000|Overall Study|Adverse Event|5|||
128790972|NCT00038103|463527649|FG001|Overall Study|Adverse Event|6|||
128790973|NCT00038103|463527648|FG000|Overall Study|Lack of Efficacy|48|||
128790974|NCT00038103|463527649|FG001|Overall Study|Lack of Efficacy|41|||
128790975|NCT00038103|463527648|FG000|Overall Study|Withdrawal by Subject|0|||
128790976|NCT00038103|463527649|FG001|Overall Study|Withdrawal by Subject|3|||
128790977|NCT00038103|463527648|FG000|Overall Study|Lost to Follow-up|0|||
128790978|NCT00038103|463527649|FG001|Overall Study|Lost to Follow-up|3|||
128790979|NCT00038103|463527648|FG000|Overall Study|Protocol Violation|0|||
128790980|NCT00038103|463527649|FG001|Overall Study|Protocol Violation|2|||
128790981|NCT00038103|463527648|FG000|Overall Study|Sponsor Decision|0|||
128790982|NCT00038103|463527649|FG001|Overall Study|Sponsor Decision|1|||
128790983|NCT00038103|463527648|FG000|Overall Study|Randomized/never treated|2|||
128790984|NCT00038103|463527649|FG001|Overall Study|Randomized/never treated|0|||
128790985|NCT00208767|463527652|FG000|Overall Study|Adverse Event|9|||
128790986|NCT00208767|463527653|FG001|Overall Study|Adverse Event|1|||
128790987|NCT00208767|463527652|FG000|Overall Study|Withdrawal by Subject|14|||
128790988|NCT00208767|463527653|FG001|Overall Study|Withdrawal by Subject|3|||
128790989|NCT00208767|463527652|FG000|Overall Study|Death|1|||
128790990|NCT00208767|463527653|FG001|Overall Study|Death|0|||
128790991|NCT00208767|463527652|FG000|Overall Study|Lost to Follow-up|3|||
128790992|NCT00208767|463527653|FG001|Overall Study|Lost to Follow-up|3|||
128790993|NCT03545984|463527654|FG000|Overall Study|CSF cases not present during rotation|11|||
128790994|NCT03545984|463527655|FG001|Overall Study|CSF cases not present during rotation|9|||
128790995|NCT01212757|463527656|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
128790996|NCT01212757|463527657|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
128790997|NCT01212757|463527658|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
128790998|NCT01212757|463527659|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128790999|NCT01212757|463527660|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128791000|NCT01212757|463527661|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128791001|NCT01212757|463527662|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128791002|NCT01212757|463527663|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128791003|NCT01212757|463527664|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
128791004|NCT01212757|463527656|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
128791005|NCT01212757|463527657|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
128791006|NCT01212757|463527658|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
128791007|NCT01212757|463527659|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128791008|NCT01212757|463527660|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128791009|NCT01212757|463527661|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128791010|NCT01212757|463527662|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128791011|NCT01212757|463527663|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128791012|NCT01212757|463527664|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
128791013|NCT01212757|463527656|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
128791014|NCT01212757|463527657|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
128791015|NCT01212757|463527658|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
128791016|NCT01212757|463527659|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128791017|NCT01212757|463527660|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128791018|NCT01212757|463527661|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128791019|NCT01212757|463527662|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128791020|NCT01212757|463527663|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128791021|NCT01212757|463527664|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
128791022|NCT01212757|463527656|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
128791023|NCT01212757|463527657|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128791024|NCT01212757|463527658|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
128791025|NCT01212757|463527659|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128791026|NCT01212757|463527660|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128791027|NCT01212757|463527661|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128791028|NCT01212757|463527662|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128791029|NCT01212757|463527663|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128791030|NCT01212757|463527664|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
128791031|NCT01212757|463527656|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
128791032|NCT01212757|463527657|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
128791033|NCT01212757|463527658|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
128791034|NCT01212757|463527659|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128791035|NCT01212757|463527660|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128791036|NCT01212757|463527661|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128791037|NCT01212757|463527662|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128791038|NCT01212757|463527663|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128791039|NCT01212757|463527664|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
128791040|NCT01212757|463527656|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128791041|NCT01212757|463527657|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
128791042|NCT01212757|463527658|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
128791043|NCT01212757|463527659|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128791044|NCT01212757|463527660|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128791045|NCT01212757|463527661|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128791046|NCT01212757|463527662|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128791047|NCT01212757|463527663|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128791048|NCT01212757|463527664|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
128791049|NCT01212757|463527656|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
128791050|NCT01212757|463527657|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
128791051|NCT01212757|463527658|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128791052|NCT01212757|463527659|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128791053|NCT01212757|463527660|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128791054|NCT01212757|463527661|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128791055|NCT01212757|463527662|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128791056|NCT01212757|463527663|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128791057|NCT01212757|463527664|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
128791058|NCT01212757|463527656|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
128791059|NCT01212757|463527657|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
128791060|NCT01212757|463527658|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
128791061|NCT01212757|463527659|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
128791062|NCT01212757|463527660|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
128791063|NCT01212757|463527661|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
128791064|NCT01212757|463527662|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
128791065|NCT01212757|463527663|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
128791066|NCT01212757|463527664|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
128791067|NCT01212757|463527656|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
128791068|NCT01212757|463527657|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
128791069|NCT01212757|463527658|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
128791070|NCT01212757|463527659|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
128791071|NCT01212757|463527660|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
128791072|NCT01212757|463527661|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
128791073|NCT01212757|463527662|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
128791074|NCT01212757|463527663|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
128791075|NCT01212757|463527664|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
128791076|NCT01212757|463527656|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791077|NCT01212757|463527657|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791078|NCT01212757|463527658|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
128791079|NCT01212757|463527659|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791080|NCT01212757|463527660|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791081|NCT01212757|463527661|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791082|NCT01212757|463527662|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791083|NCT01212757|463527663|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791084|NCT01212757|463527664|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
128791085|NCT01212757|463527656|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
128791086|NCT01212757|463527657|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
128791087|NCT01212757|463527658|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
128791088|NCT01212757|463527659|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
128791089|NCT01212757|463527660|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
128791090|NCT01212757|463527661|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
128791091|NCT01212757|463527662|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
128791092|NCT01212757|463527663|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
128791093|NCT01212757|463527664|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
128791094|NCT01212757|463527656|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
128791095|NCT01212757|463527657|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
128791096|NCT01212757|463527658|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
128791097|NCT01212757|463527659|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
128791098|NCT01212757|463527660|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
128791099|NCT01212757|463527661|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
128791100|NCT01212757|463527662|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
128791101|NCT01212757|463527663|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
128791102|NCT01212757|463527664|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
128791103|NCT01212757|463527656|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
128791104|NCT01212757|463527657|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
128791105|NCT01212757|463527658|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
128791106|NCT01212757|463527659|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
128791107|NCT01212757|463527660|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
128791108|NCT01212757|463527661|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
128791109|NCT01212757|463527662|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
128791110|NCT01212757|463527663|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
128758317|NCT00989092|463403378|FG001|Overall Study|Did not receive study drug|0|||
128758318|NCT01332227|463403380|FG000|Overall Study|Adverse Event|4|||
128758319|NCT01332227|463403381|FG001|Overall Study|Adverse Event|1|||
128758320|NCT01332227|463403380|FG000|Overall Study|Withdrawal by Subject|5|||
128758321|NCT01332227|463403381|FG001|Overall Study|Withdrawal by Subject|1|||
128758322|NCT01332227|463403380|FG000|Overall Study|Lost to Follow-up|2|||
128758323|NCT01332227|463403381|FG001|Overall Study|Lost to Follow-up|0|||
128758324|NCT01332227|463403380|FG000|Overall Study|Lack of Efficacy|3|||
128758325|NCT01332227|463403381|FG001|Overall Study|Lack of Efficacy|1|||
128758326|NCT01332227|463403380|FG000|Overall Study|Poor compliance/noncompliance|1|||
128758327|NCT01332227|463403381|FG001|Overall Study|Poor compliance/noncompliance|1|||
128758328|NCT01332227|463403380|FG000|Overall Study|Patient moved from area|1|||
128758329|NCT01332227|463403381|FG001|Overall Study|Patient moved from area|0|||
128758330|NCT01332227|463403380|FG000|Overall Study|Patient began prohibited medication|0|||
128758331|NCT01332227|463403381|FG001|Overall Study|Patient began prohibited medication|1|||
128758332|NCT00514943|463403382|FG000|Stage 1|Progressive disease|4|||
128758333|NCT00514943|463403383|FG001|Stage 1|Progressive disease|8|||
128758334|NCT00514943|463403382|FG000|Stage 1|Other Adverse Event|16|||
128758335|NCT00514943|463403383|FG001|Stage 1|Other Adverse Event|6|||
128758336|NCT00514943|463403382|FG000|Stage 1|Not treated|1|||
128758337|NCT00514943|463403383|FG001|Stage 1|Not treated|2|||
128758338|NCT00514943|463403382|FG000|Stage 1|Patient refused to continue study meds|8|||
128758339|NCT00514943|463403383|FG001|Stage 1|Patient refused to continue study meds|3|||
128758340|NCT00514943|463403382|FG000|Stage 1|Other than stated above|1|||
128758341|NCT00514943|463403383|FG001|Stage 1|Other than stated above|7|||
128758342|NCT00514943|463403382|FG000|Stage 2|Progressive disease|27|||
128758343|NCT00514943|463403383|FG001|Stage 2|Progressive disease|24|||
128758344|NCT00514943|463403382|FG000|Stage 2|Other Adverse Event|3|||
128758345|NCT00514943|463403383|FG001|Stage 2|Other Adverse Event|10|||
128758346|NCT00514943|463403382|FG000|Stage 2|Patient refused to continue study meds|2|||
128758347|NCT00514943|463403383|FG001|Stage 2|Patient refused to continue study meds|0|||
128758348|NCT00514943|463403382|FG000|Stage 2|Other than stated above|0|||
128758349|NCT00514943|463403383|FG001|Stage 2|Other than stated above|2|||
128758350|NCT02173548|463403386|FG000|Overall Study|Lost to Follow-up|0|||
128758351|NCT02173548|463403387|FG001|Overall Study|Lost to Follow-up|2|||
128758352|NCT02173548|463403386|FG000|Overall Study|Withdrawal by Subject|1|||
128758353|NCT02173548|463403387|FG001|Overall Study|Withdrawal by Subject|0|||
128758354|NCT03040713|463403393|FG000|Overall Study|Positive amyloid scan|3|||
128758355|NCT04539821|463403394|FG000|Overall Study|Withdrawal by Subject|2|||
128758356|NCT04539821|463403394|FG000|Overall Study|continued care with their physician|20|||
128758357|NCT04539821|463403394|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
128758358|NCT02641392|463403395|FG000|Overall Study|Lost to Follow-up|0|||
128758359|NCT02641392|463403396|FG001|Overall Study|Lost to Follow-up|0|||
128758360|NCT02641392|463403397|FG002|Overall Study|Lost to Follow-up|2|||
128758361|NCT02641392|463403395|FG000|Overall Study|Withdrawal by Subject|0|||
128758362|NCT02641392|463403396|FG001|Overall Study|Withdrawal by Subject|0|||
128758363|NCT02641392|463403397|FG002|Overall Study|Withdrawal by Subject|17|||
128758364|NCT02641392|463403395|FG000|Overall Study|Adverse Event|0|||
128758365|NCT02641392|463403396|FG001|Overall Study|Adverse Event|1|||
128758366|NCT02641392|463403397|FG002|Overall Study|Adverse Event|25|||
128758367|NCT02641392|463403395|FG000|Overall Study|Study Terminated by Sponsor|4|||
128758368|NCT02641392|463403396|FG001|Overall Study|Study Terminated by Sponsor|12|||
128758369|NCT02641392|463403397|FG002|Overall Study|Study Terminated by Sponsor|144|||
128758370|NCT02641392|463403395|FG000|Overall Study|Lack of Efficacy|0|||
128758371|NCT02641392|463403396|FG001|Overall Study|Lack of Efficacy|0|||
128758372|NCT02641392|463403397|FG002|Overall Study|Lack of Efficacy|101|||
128758373|NCT02641392|463403395|FG000|Overall Study|Miscellaneous|0|||
128758374|NCT02641392|463403396|FG001|Overall Study|Miscellaneous|0|||
128758375|NCT02641392|463403397|FG002|Overall Study|Miscellaneous|3|||
128758376|NCT02641392|463403395|FG000|Overall Study|Death|0|||
128758377|NCT02641392|463403396|FG001|Overall Study|Death|0|||
128758378|NCT02641392|463403397|FG002|Overall Study|Death|1|||
128758379|NCT02691182|463403398|FG000|Overall Study|Withdrawal by Subject|4|||
128758380|NCT02691182|463403399|FG001|Overall Study|Withdrawal by Subject|7|||
128758381|NCT02691182|463403400|FG002|Overall Study|Withdrawal by Subject|6|||
128758382|NCT02691182|463403401|FG003|Overall Study|Withdrawal by Subject|8|||
128758383|NCT02691182|463403398|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
128758384|NCT02691182|463403399|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
128758385|NCT02691182|463403400|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
128758386|NCT02691182|463403401|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
128758387|NCT02691182|463403398|FG000|Overall Study|Lost to Follow-up|8|||
128758388|NCT02691182|463403399|FG001|Overall Study|Lost to Follow-up|33|||
128758389|NCT02691182|463403400|FG002|Overall Study|Lost to Follow-up|19|||
128758390|NCT02691182|463403401|FG003|Overall Study|Lost to Follow-up|22|||
128758391|NCT02691182|463403398|FG000|Overall Study|Adverse Event|3|||
128758392|NCT02691182|463403399|FG001|Overall Study|Adverse Event|10|||
128758393|NCT02691182|463403400|FG002|Overall Study|Adverse Event|10|||
128791111|NCT01212757|463527664|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
128791112|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791113|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791114|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791115|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791116|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791117|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791118|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791119|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
128791120|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
128791121|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
128791122|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
128791123|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
128791124|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
128791125|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
128791126|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
128791127|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
128791128|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
128791129|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
128791130|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
128791131|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
128791132|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
128791133|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
128791134|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
128791135|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
128791136|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
128791137|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
128791138|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
128791139|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128791140|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
128791141|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
128791142|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128791143|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128791144|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128791145|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
128791146|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
128791147|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
128791148|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791149|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791150|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
128791151|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791152|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791153|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791154|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791155|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791156|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
128791157|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
128791158|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
128791159|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
128791160|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
128791161|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
128791162|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
128791163|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
128791164|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
128791165|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
128791166|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
128791167|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
128791168|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
128791169|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
128791170|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
128791171|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
128791172|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
128791173|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
128791174|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
128791175|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791176|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791177|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
128791178|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791179|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791180|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791181|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791182|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791183|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
128791184|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128791185|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
128791186|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
128791187|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128791188|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128791189|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128791190|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
128791191|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
128791192|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
128791193|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791194|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791195|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791196|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791197|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791198|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791199|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791200|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
128791201|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
128791202|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791203|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
128791204|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791205|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791206|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791207|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791208|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791209|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791210|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
128791211|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
128791212|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
128791213|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
128791214|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
128791215|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
128791216|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
128791217|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
128791218|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
128791219|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
128791220|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
128791221|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
128791222|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
128791223|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
128791224|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
128791225|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
128791226|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
128791227|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
128791228|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
128791229|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
128791230|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
128791231|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
128791232|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
128791233|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
128791234|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
128791235|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
128791236|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
128791237|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
128791238|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
128791239|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
128791240|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
128791241|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
128791242|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
128791243|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
128791244|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
128791245|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
128791246|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
128791247|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128758394|NCT02691182|463403401|FG003|Overall Study|Adverse Event|11|||
128758395|NCT02691182|463403398|FG000|Overall Study|Physician Decision|3|||
128758396|NCT02691182|463403399|FG001|Overall Study|Physician Decision|7|||
128758397|NCT02691182|463403400|FG002|Overall Study|Physician Decision|14|||
128758398|NCT02691182|463403401|FG003|Overall Study|Physician Decision|8|||
128758399|NCT02691182|463403398|FG000|Overall Study|Lack of Efficacy|0|||
128758400|NCT02691182|463403399|FG001|Overall Study|Lack of Efficacy|0|||
128758401|NCT02691182|463403400|FG002|Overall Study|Lack of Efficacy|0|||
128758402|NCT02691182|463403401|FG003|Overall Study|Lack of Efficacy|4|||
128758403|NCT02691182|463403398|FG000|Overall Study|Protocol Violation|2|||
128758404|NCT02691182|463403399|FG001|Overall Study|Protocol Violation|6|||
128758405|NCT02691182|463403400|FG002|Overall Study|Protocol Violation|6|||
128758406|NCT02691182|463403401|FG003|Overall Study|Protocol Violation|8|||
128758407|NCT02691182|463403398|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
128758408|NCT02691182|463403399|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
128758409|NCT02691182|463403400|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
128758410|NCT02691182|463403401|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
128758411|NCT02691182|463403398|FG000|Overall Study|Missing|0|||
128758412|NCT02691182|463403399|FG001|Overall Study|Missing|5|||
128758413|NCT02691182|463403400|FG002|Overall Study|Missing|1|||
128758414|NCT02691182|463403401|FG003|Overall Study|Missing|5|||
128758415|NCT02563002|463403404|FG000|Overall Study|Death|72|||
128758416|NCT02563002|463403405|FG001|Overall Study|Death|87|||
128758417|NCT02563002|463403404|FG000|Overall Study|Lost to Follow-up|5|||
128758418|NCT02563002|463403405|FG001|Overall Study|Lost to Follow-up|0|||
128758419|NCT02563002|463403404|FG000|Overall Study|Physician Decision|0|||
128758420|NCT02563002|463403405|FG001|Overall Study|Physician Decision|2|||
128758421|NCT02563002|463403404|FG000|Overall Study|Withdrawal by Subject|2|||
128758422|NCT02563002|463403405|FG001|Overall Study|Withdrawal by Subject|10|||
128758423|NCT02563002|463403404|FG000|Overall Study|Sponsor decision|74|||
128758424|NCT02563002|463403405|FG001|Overall Study|Sponsor decision|55|||
128758425|NCT02054806|463403407|FG000|Overall Study|Sponsor Decision|31|||
128758426|NCT02054806|463403407|FG000|Overall Study|Withdrawal by Subject|43|||
128758427|NCT02054806|463403407|FG000|Overall Study|Protocol Violation|2|||
128758428|NCT02054806|463403407|FG000|Overall Study|Lost to Follow-up|10|||
128758429|NCT02054806|463403407|FG000|Overall Study|Death|391|||
128758430|NCT01113502|463403410|FG000|Overall Study|Withdrawal by Subject|1|||
128758431|NCT01113502|463403411|FG001|Overall Study|Withdrawal by Subject|0|||
128758432|NCT01113502|463403412|FG002|Overall Study|Withdrawal by Subject|1|||
128758433|NCT01113502|463403413|FG003|Overall Study|Withdrawal by Subject|1|||
128758434|NCT01113502|463403414|FG004|Overall Study|Withdrawal by Subject|0|||
128758435|NCT01113502|463403410|FG000|Overall Study|Adverse Event|0|||
128758436|NCT01113502|463403411|FG001|Overall Study|Adverse Event|0|||
128758437|NCT01113502|463403412|FG002|Overall Study|Adverse Event|3|||
128758438|NCT01113502|463403413|FG003|Overall Study|Adverse Event|2|||
128758439|NCT01113502|463403414|FG004|Overall Study|Adverse Event|0|||
128758440|NCT03002610|463403423|FG000|Overall Study|Withdrawal by Subject|6|||
128758441|NCT03002610|463403424|FG001|Overall Study|Withdrawal by Subject|25|||
128758442|NCT03002610|463403425|FG002|Overall Study|Withdrawal by Subject|13|||
128758443|NCT01362439|463403428|FG000|Overall Study|Adverse Event|1|||
128758444|NCT01362439|463403428|FG000|Overall Study|Lack of Efficacy|3|||
128758445|NCT01362439|463403428|FG000|Overall Study|Lost to Follow-up|2|||
128758446|NCT01362439|463403428|FG000|Overall Study|Study medication non-compliant|1|||
128758447|NCT01362439|463403428|FG000|Overall Study|Participant who withdrew consent|8|||
128758448|NCT00658567|463403430|FG000|Overall Study|Adverse Event|5|||
128758449|NCT00658567|463403431|FG001|Overall Study|Adverse Event|2|||
128758450|NCT00658567|463403432|FG002|Overall Study|Adverse Event|3|||
128758451|NCT00658567|463403430|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
128758452|NCT00658567|463403431|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
128758453|NCT00658567|463403432|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
128758454|NCT00658567|463403430|FG000|Overall Study|Physician Decision|0|||
128758455|NCT00658567|463403431|FG001|Overall Study|Physician Decision|1|||
128758456|NCT00658567|463403432|FG002|Overall Study|Physician Decision|0|||
128758457|NCT00658567|463403430|FG000|Overall Study|At Discretion of Sponsor|1|||
128758458|NCT00658567|463403431|FG001|Overall Study|At Discretion of Sponsor|1|||
128758459|NCT00658567|463403432|FG002|Overall Study|At Discretion of Sponsor|1|||
128758460|NCT01281644|463403433|FG000|Overall Study|Lost to Follow-up|3|||
128758461|NCT01281644|463403433|FG000|Overall Study|Withdrawal by Subject|2|||
128758462|NCT00569582|463403434|FG000|Overall Study|Withdrawal by Subject|5|||
128758463|NCT00569582|463403434|FG000|Overall Study|Death|2|||
128758464|NCT00569582|463403434|FG000|Overall Study|Adverse Event|7|||
128758465|NCT00569582|463403434|FG000|Overall Study|Subject was too ill to travel.|1|||
128758466|NCT00569582|463403434|FG000|Overall Study|Subject was non-compliant.|1|||
128758467|NCT02975973|463403440|FG000|Overall Study|Adverse Event|1|||
128758468|NCT02975973|463403441|FG001|Overall Study|Adverse Event|1|||
128758469|NCT02975973|463403442|FG002|Overall Study|Adverse Event|1|||
128791248|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
128791249|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
128791250|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128791251|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128791252|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128791253|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
128791254|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
128791255|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
128791256|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
128791257|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
128791258|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
128791259|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
128791260|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
128791261|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
128791262|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
128791263|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
128791264|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
128791265|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791266|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791267|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791268|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791269|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791270|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791271|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791272|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
128791273|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
128791274|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128791275|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
128791276|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
128791277|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128791278|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128791279|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128791280|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
128791281|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
128791282|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
128791283|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
128791284|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
128791285|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
128791286|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
128791287|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
128791288|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
128791289|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
128791290|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
128791291|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
128791292|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
128791293|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
128791294|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
128791295|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
128791296|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
128791297|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
128791298|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
128791299|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
128791300|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
128791301|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791302|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
128791303|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791304|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791305|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791306|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791307|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791308|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791309|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
128791310|NCT01212757|463527656|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
128791311|NCT01212757|463527657|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
128791312|NCT01212757|463527658|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
128791313|NCT01212757|463527659|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
128791314|NCT01212757|463527660|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
128791315|NCT01212757|463527661|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
128791316|NCT01212757|463527662|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
128791317|NCT01212757|463527663|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
128791318|NCT01212757|463527664|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
128791319|NCT02812966|463527665|FG000|Overall Study|Death|1|||
128791320|NCT02812966|463527666|FG001|Overall Study|Death|0|||
128791321|NCT01049503|463529590|FG000|Overall Study|Lost to Follow-up|11|||
128791322|NCT01049503|463529591|FG001|Overall Study|Lost to Follow-up|12|||
128791323|NCT01049503|463529592|FG002|Overall Study|Lost to Follow-up|24|||
128758470|NCT02975973|463403443|FG003|Overall Study|Adverse Event|0|||
128758471|NCT00771810|463403444|FG000|Overall Study|Adverse Event|3|||
128758472|NCT00771810|463403445|FG001|Overall Study|Adverse Event|0|||
128758473|NCT00771810|463403446|FG002|Overall Study|Adverse Event|2|||
128758474|NCT00771810|463403444|FG000|Overall Study|Lost to Follow-up|0|||
128758475|NCT00771810|463403445|FG001|Overall Study|Lost to Follow-up|0|||
128758476|NCT00771810|463403446|FG002|Overall Study|Lost to Follow-up|1|||
128758477|NCT00771810|463403444|FG000|Overall Study|Physician Decision|1|||
128758478|NCT00771810|463403445|FG001|Overall Study|Physician Decision|2|||
128758479|NCT00771810|463403446|FG002|Overall Study|Physician Decision|2|||
128758480|NCT00771810|463403444|FG000|Overall Study|Protocol Violation|0|||
128758481|NCT00771810|463403445|FG001|Overall Study|Protocol Violation|1|||
128758482|NCT00771810|463403446|FG002|Overall Study|Protocol Violation|1|||
128758483|NCT00771810|463403444|FG000|Overall Study|Withdrawal by Subject|1|||
128758484|NCT00771810|463403445|FG001|Overall Study|Withdrawal by Subject|2|||
128758485|NCT00771810|463403446|FG002|Overall Study|Withdrawal by Subject|0|||
128758486|NCT00771810|463403444|FG000|Overall Study|Other|0|||
128758487|NCT00771810|463403445|FG001|Overall Study|Other|0|||
128758488|NCT00771810|463403446|FG002|Overall Study|Other|1|||
128758489|NCT02660827|463403447|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
128758490|NCT02660827|463403447|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
128758491|NCT02660827|463403447|FG000|From Study to End of Continued Access|Adverse Event|3|||
128758492|NCT02660827|463403447|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
128758493|NCT02660827|463403447|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
128758494|NCT02660827|463403447|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
128758495|NCT02660827|463403447|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
128758496|NCT02660827|463403447|FG000|Period 2: Continued Access Period|Adverse Event|3|||
128758497|NCT02953938|463403448|FG000|Overall Study|Adverse Event|0|||
128758498|NCT02953938|463403449|FG001|Overall Study|Adverse Event|1|||
128758499|NCT02953938|463403448|FG000|Overall Study|Withdrawal by Subject|1|||
128758500|NCT02953938|463403449|FG001|Overall Study|Withdrawal by Subject|1|||
128758501|NCT00313820|463403453|FG000|Assigned to Treatment|Other|1|||
128758502|NCT00313820|463403454|FG001|Assigned to Treatment|Other|0|||
128758503|NCT00313820|463403453|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
128758504|NCT00313820|463403454|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
128758505|NCT00313820|463403453|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
128758506|NCT00313820|463403454|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
128758507|NCT00313820|463403453|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
128758508|NCT00313820|463403454|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
128758509|NCT00313820|463403453|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
128758510|NCT00313820|463403454|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
128758511|NCT00313820|463403453|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
128758512|NCT00313820|463403454|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
128758513|NCT00265889|463403457|FG000|Overall Study|Physician Decision|1|||
128758514|NCT00265889|463403457|FG000|Overall Study|Protocol Violation|1|||
128758515|NCT00265889|463403457|FG000|Overall Study|Insurance denied the request|3|||
128758516|NCT02134587|463403458|FG000|Overall Study|Did not completed all meetings|30|||
128758517|NCT02543658|463405215|FG000|Overall Study|Lack of Efficacy|0|||
128758518|NCT02543658|463405216|FG001|Overall Study|Lack of Efficacy|4|||
128758519|NCT00789815|463405217|FG000|Overall Study|Protocol Violation|6|||
128758520|NCT00789815|463405218|FG001|Overall Study|Protocol Violation|1|||
128758521|NCT00789815|463405217|FG000|Overall Study|Intubation due to massive bleeding|1|||
128758522|NCT00789815|463405218|FG001|Overall Study|Intubation due to massive bleeding|0|||
128758523|NCT02035332|463405220|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
128758524|NCT00838682|463405221|FG000|Overall Study|Lost to Follow-up|21|||
128758525|NCT00838682|463405222|FG001|Overall Study|Lost to Follow-up|14|||
128758526|NCT00838682|463405221|FG000|Overall Study|detection of exclusion criteria|4|||
128758527|NCT00838682|463405222|FG001|Overall Study|detection of exclusion criteria|3|||
128758528|NCT00838682|463405221|FG000|Overall Study|Protocol Violation|0|||
128758529|NCT00838682|463405222|FG001|Overall Study|Protocol Violation|1|||
128758530|NCT00838682|463405221|FG000|Overall Study|Withdrawal by Subject|0|||
128758531|NCT00838682|463405222|FG001|Overall Study|Withdrawal by Subject|1|||
128758532|NCT04098406|463405227|FG000|Overall Study|Adverse Event|2|||
128791324|NCT01049503|463529593|FG003|Overall Study|Lost to Follow-up|26|||
128791325|NCT01049503|463529594|FG004|Overall Study|Lost to Follow-up|27|||
128791326|NCT01049503|463529595|FG005|Overall Study|Lost to Follow-up|8|||
128791327|NCT02962674|463529599|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
128791328|NCT00028769|463529602|FG000|Overall Study|Adverse Event|2|||
128791329|NCT00028769|463529602|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
128791330|NCT00028769|463529602|FG000|Overall Study|Progression or Death|31|||
128791331|NCT00028769|463529602|FG000|Overall Study|Other - Not Protocol Specified|1|||
128791332|NCT00028769|463529602|FG000|Overall Study|Ineligible|5|||
128791333|NCT00028769|463529602|FG000|Overall Study|Not Analyzable|1|||
128791334|NCT02496702|463529605|FG000|Overall Study|Lost to Follow-up|8|||
128791335|NCT02496702|463529606|FG001|Overall Study|Lost to Follow-up|6|||
128791336|NCT02496702|463529605|FG000|Overall Study|Only partially tested|0|||
128791337|NCT02496702|463529606|FG001|Overall Study|Only partially tested|2|||
128791338|NCT00708032|463529609|FG000|Overall Study|Adverse Event|0|||
128791339|NCT00708032|463529610|FG001|Overall Study|Adverse Event|2|||
128791340|NCT00708032|463529609|FG000|Overall Study|Lost to Follow-up|1|||
128791341|NCT00708032|463529610|FG001|Overall Study|Lost to Follow-up|2|||
128791342|NCT00708032|463529609|FG000|Overall Study|Pregnancy|0|||
128791343|NCT00708032|463529610|FG001|Overall Study|Pregnancy|1|||
128791344|NCT00708032|463529609|FG000|Overall Study|Poor vision|0|||
128791345|NCT00708032|463529610|FG001|Overall Study|Poor vision|6|||
128791346|NCT00708032|463529609|FG000|Overall Study|Visit out of range at month 12|4|||
128791347|NCT00708032|463529610|FG001|Overall Study|Visit out of range at month 12|1|||
128791348|NCT00708032|463529609|FG000|Overall Study|Did not meet protocol criteria|1|||
128791349|NCT00708032|463529610|FG001|Overall Study|Did not meet protocol criteria|2|||
128791350|NCT00708032|463529609|FG000|Overall Study|Protocol Violation|4|||
128791351|NCT00708032|463529610|FG001|Overall Study|Protocol Violation|1|||
128791352|NCT00708032|463529609|FG000|Overall Study|Withdrawal by Subject|0|||
128791353|NCT00708032|463529610|FG001|Overall Study|Withdrawal by Subject|1|||
128791354|NCT01400776|463529611|FG000|Overall Study|Adverse Event|7|||
128791355|NCT01400776|463529612|FG001|Overall Study|Adverse Event|2|||
128791356|NCT01400776|463529613|FG002|Overall Study|Adverse Event|9|||
128791357|NCT01400776|463529614|FG003|Overall Study|Adverse Event|2|||
128791358|NCT01400776|463529611|FG000|Overall Study|Lost to Follow-up|1|||
128791359|NCT01400776|463529612|FG001|Overall Study|Lost to Follow-up|0|||
128791360|NCT01400776|463529613|FG002|Overall Study|Lost to Follow-up|4|||
128791361|NCT01400776|463529614|FG003|Overall Study|Lost to Follow-up|1|||
128791362|NCT01400776|463529611|FG000|Overall Study|Withdrew Consent|4|||
128791363|NCT01400776|463529612|FG001|Overall Study|Withdrew Consent|2|||
128791364|NCT01400776|463529613|FG002|Overall Study|Withdrew Consent|6|||
128791365|NCT01400776|463529614|FG003|Overall Study|Withdrew Consent|1|||
128791366|NCT01400776|463529611|FG000|Overall Study|Protocol Deviation|6|||
128791367|NCT01400776|463529612|FG001|Overall Study|Protocol Deviation|1|||
128791368|NCT01400776|463529613|FG002|Overall Study|Protocol Deviation|5|||
128791369|NCT01400776|463529614|FG003|Overall Study|Protocol Deviation|2|||
128791370|NCT01400776|463529611|FG000|Overall Study|Reason not Specified|3|||
128791371|NCT01400776|463529612|FG001|Overall Study|Reason not Specified|0|||
128791372|NCT01400776|463529613|FG002|Overall Study|Reason not Specified|4|||
128791373|NCT01400776|463529614|FG003|Overall Study|Reason not Specified|3|||
128791374|NCT04035668|463529615|FG000|Overall Study|Adverse Event|3|||
128791375|NCT04035668|463529616|FG001|Overall Study|Adverse Event|4|||
128791376|NCT04035668|463529617|FG002|Overall Study|Adverse Event|2|||
128791377|NCT04035668|463529615|FG000|Overall Study|Lost to Follow-up|0|||
128791378|NCT04035668|463529616|FG001|Overall Study|Lost to Follow-up|1|||
128791379|NCT04035668|463529617|FG002|Overall Study|Lost to Follow-up|0|||
128791380|NCT04035668|463529615|FG000|Overall Study|Physician Decision|2|||
128791381|NCT04035668|463529616|FG001|Overall Study|Physician Decision|1|||
128791382|NCT04035668|463529617|FG002|Overall Study|Physician Decision|1|||
128791383|NCT04035668|463529615|FG000|Overall Study|Subject Decision|2|||
128791384|NCT04035668|463529616|FG001|Overall Study|Subject Decision|2|||
128791385|NCT04035668|463529617|FG002|Overall Study|Subject Decision|0|||
128791386|NCT02320123|463529619|FG000|Overall Study|Lost to Follow-up|4|||
128791387|NCT02320123|463529620|FG001|Overall Study|Lost to Follow-up|6|||
128791388|NCT02320123|463529619|FG000|Overall Study|Death|6|||
128791389|NCT02320123|463529620|FG001|Overall Study|Death|5|||
128791390|NCT00941655|463529625|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
128791391|NCT00941655|463529626|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
128791392|NCT00941655|463529625|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
128791393|NCT00941655|463529626|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
128791394|NCT00941655|463529625|FG000|Overall Study|progressed while on chemo|0|||
128791395|NCT00941655|463529626|FG001|Overall Study|progressed while on chemo|2|||
128791396|NCT00941655|463529625|FG000|Overall Study|refused further treatment|0|||
128791397|NCT00941655|463529626|FG001|Overall Study|refused further treatment|1|||
128791398|NCT00941655|463529625|FG000|Overall Study|withdrew consent|0|||
128791399|NCT00941655|463529626|FG001|Overall Study|withdrew consent|1|||
128791400|NCT00941655|463529625|FG000|Overall Study|non-compliant|0|||
128791401|NCT00941655|463529626|FG001|Overall Study|non-compliant|1|||
128791402|NCT02477670|463529629|FG000|Stage 1|Adverse Event|2|||
128791403|NCT02477670|463529630|FG001|Stage 1|Adverse Event|7|||
128791404|NCT02477670|463529631|FG002|Stage 1|Adverse Event|0|||
128791405|NCT02477670|463529632|FG003|Stage 1|Adverse Event|0|||
128791406|NCT02477670|463529633|FG004|Stage 1|Adverse Event|0|||
128791407|NCT02477670|463529634|FG005|Stage 1|Adverse Event|0|||
128791408|NCT02477670|463529635|FG006|Stage 1|Adverse Event|0|||
128791409|NCT02477670|463529629|FG000|Stage 1|Lost to Follow-up|0|||
128791410|NCT02477670|463529630|FG001|Stage 1|Lost to Follow-up|2|||
128791411|NCT02477670|463529631|FG002|Stage 1|Lost to Follow-up|0|||
128791412|NCT02477670|463529632|FG003|Stage 1|Lost to Follow-up|0|||
128791413|NCT02477670|463529633|FG004|Stage 1|Lost to Follow-up|0|||
128791414|NCT02477670|463529634|FG005|Stage 1|Lost to Follow-up|0|||
128791415|NCT02477670|463529635|FG006|Stage 1|Lost to Follow-up|0|||
128791416|NCT02477670|463529629|FG000|Stage 1|Withdrawal by Subject|1|||
128791417|NCT02477670|463529630|FG001|Stage 1|Withdrawal by Subject|2|||
128791418|NCT02477670|463529631|FG002|Stage 1|Withdrawal by Subject|0|||
128791419|NCT02477670|463529632|FG003|Stage 1|Withdrawal by Subject|0|||
128791420|NCT02477670|463529633|FG004|Stage 1|Withdrawal by Subject|0|||
128791421|NCT02477670|463529634|FG005|Stage 1|Withdrawal by Subject|0|||
128791422|NCT02477670|463529635|FG006|Stage 1|Withdrawal by Subject|0|||
128791423|NCT02477670|463529629|FG000|Stage 1|Non-compliance with Study Drug|1|||
128791424|NCT02477670|463529630|FG001|Stage 1|Non-compliance with Study Drug|2|||
128791425|NCT02477670|463529631|FG002|Stage 1|Non-compliance with Study Drug|0|||
128791426|NCT02477670|463529632|FG003|Stage 1|Non-compliance with Study Drug|0|||
128791427|NCT02477670|463529633|FG004|Stage 1|Non-compliance with Study Drug|0|||
128791428|NCT02477670|463529634|FG005|Stage 1|Non-compliance with Study Drug|0|||
128791429|NCT02477670|463529635|FG006|Stage 1|Non-compliance with Study Drug|0|||
128791430|NCT02477670|463529629|FG000|Stage 2|Adverse Event|0|||
128791431|NCT02477670|463529630|FG001|Stage 2|Adverse Event|0|||
128791432|NCT02477670|463529631|FG002|Stage 2|Adverse Event|1|||
128791433|NCT02477670|463529632|FG003|Stage 2|Adverse Event|0|||
128791434|NCT02477670|463529633|FG004|Stage 2|Adverse Event|0|||
128791435|NCT02477670|463529634|FG005|Stage 2|Adverse Event|0|||
128791436|NCT02477670|463529635|FG006|Stage 2|Adverse Event|0|||
128791437|NCT02477670|463529629|FG000|Stage 2|Antipsychotic Medication Changed|0|||
128791438|NCT02477670|463529630|FG001|Stage 2|Antipsychotic Medication Changed|0|||
128791439|NCT02477670|463529631|FG002|Stage 2|Antipsychotic Medication Changed|1|||
128791440|NCT02477670|463529632|FG003|Stage 2|Antipsychotic Medication Changed|0|||
128791441|NCT02477670|463529633|FG004|Stage 2|Antipsychotic Medication Changed|0|||
128791442|NCT02477670|463529634|FG005|Stage 2|Antipsychotic Medication Changed|0|||
128791443|NCT02477670|463529635|FG006|Stage 2|Antipsychotic Medication Changed|0|||
128791444|NCT02477670|463529629|FG000|Stage 2|Withdrawal by Subject|0|||
128791445|NCT02477670|463529630|FG001|Stage 2|Withdrawal by Subject|0|||
128791446|NCT02477670|463529631|FG002|Stage 2|Withdrawal by Subject|0|||
128791447|NCT02477670|463529632|FG003|Stage 2|Withdrawal by Subject|1|||
128791448|NCT02477670|463529633|FG004|Stage 2|Withdrawal by Subject|0|||
128791449|NCT02477670|463529634|FG005|Stage 2|Withdrawal by Subject|0|||
128791450|NCT02477670|463529635|FG006|Stage 2|Withdrawal by Subject|0|||
128791451|NCT00446550|463529637|FG000|Overall Study|Adverse Event|1|||
128791452|NCT00446550|463529638|FG001|Overall Study|Adverse Event|0|||
128791453|NCT02937831|463529639|FG000|Overall Study|Protocol Violation|4|||
128791454|NCT02983617|463529640|FG000|Overall Study|Adverse Event|0|||
128791455|NCT02983617|463529641|FG001|Overall Study|Adverse Event|7|||
128791456|NCT02983617|463529640|FG000|Overall Study|Death|0|||
128791457|NCT02983617|463529641|FG001|Overall Study|Death|1|||
128791458|NCT02983617|463529640|FG000|Overall Study|Investigator's Discretion|0|||
128791459|NCT02983617|463529641|FG001|Overall Study|Investigator's Discretion|1|||
128791460|NCT00711958|463529648|FG000|Overall Study|Withdrawal by Subject|6|||
128791461|NCT00711958|463529649|FG001|Overall Study|Withdrawal by Subject|8|||
128791462|NCT00711958|463529648|FG000|Overall Study|Lack of Efficacy|3|||
128791463|NCT00711958|463529649|FG001|Overall Study|Lack of Efficacy|1|||
128791464|NCT00711958|463529648|FG000|Overall Study|Clinical deterioration|1|||
128791465|NCT00711958|463529649|FG001|Overall Study|Clinical deterioration|0|||
128791466|NCT00711958|463529648|FG000|Overall Study|Adverse Event|9|||
128791467|NCT00711958|463529649|FG001|Overall Study|Adverse Event|7|||
128791468|NCT00711958|463529648|FG000|Overall Study|Protocol Violation|1|||
128791469|NCT00711958|463529649|FG001|Overall Study|Protocol Violation|0|||
128791470|NCT00711958|463529648|FG000|Overall Study|Lost to Follow-up|2|||
128758533|NCT04098406|463405228|FG001|Overall Study|Adverse Event|1|||
128758534|NCT04098406|463405227|FG000|Overall Study|Withdrawal by Subject|1|||
128791471|NCT00711958|463529649|FG001|Overall Study|Lost to Follow-up|2|||
128791472|NCT00711958|463529648|FG000|Overall Study|Death|10|||
128791473|NCT00711958|463529649|FG001|Overall Study|Death|5|||
128791474|NCT00711958|463529648|FG000|Overall Study|Progression of disease|1|||
128791475|NCT00711958|463529649|FG001|Overall Study|Progression of disease|0|||
128791476|NCT01613716|463529650|FG000|Overall Study|screen failures|3|||
128791477|NCT01613716|463529650|FG000|Overall Study|Lost to Follow-up|4|||
128758535|NCT04098406|463405228|FG001|Overall Study|Withdrawal by Subject|0|||
128758536|NCT01783418|463405231|FG000|Overall Study|Withdrawal by Subject|1|||
128758537|NCT01783418|463405232|FG001|Overall Study|Withdrawal by Subject|0|||
128758538|NCT03548207|463405233|FG000|Overall Study|Death|10|||
128758539|NCT03548207|463405234|FG001|Overall Study|Death|23|||
128791478|NCT01171625|463529651|FG000|Overall Study|On-Protocol|67|||
128791479|NCT01171625|463529651|FG000|Overall Study|Death|38|||
128791480|NCT01171625|463529651|FG000|Overall Study|Withdrawal by Subject|31|||
128791481|NCT01171625|463529651|FG000|Overall Study|Explanted|10|||
128791482|NCT01171625|463529651|FG000|Overall Study|Lost to Follow-up|5|||
128791483|NCT01171625|463529651|FG000|Overall Study|Patient received valve-in-valve|3|||
128791484|NCT01171625|463529651|FG000|Overall Study|Other|1|||
128791485|NCT01171625|463529651|FG000|Overall Study|Consented but did not receive device|25|||
128791486|NCT05174013|463529658|FG000|Overall Study|Lost to Follow-up|0|||
128791487|NCT05174013|463529659|FG001|Overall Study|Lost to Follow-up|0|||
128791488|NCT05174013|463529660|FG002|Overall Study|Lost to Follow-up|0|||
128791489|NCT05174013|463529661|FG003|Overall Study|Lost to Follow-up|1|||
128791490|NCT05174013|463529662|FG004|Overall Study|Lost to Follow-up|0|||
128791491|NCT05174013|463529663|FG005|Overall Study|Lost to Follow-up|0|||
128791492|NCT05174013|463529658|FG000|Overall Study|Withdrawal by Subject|0|||
128791493|NCT05174013|463529659|FG001|Overall Study|Withdrawal by Subject|0|||
128791494|NCT05174013|463529660|FG002|Overall Study|Withdrawal by Subject|1|||
128791495|NCT05174013|463529661|FG003|Overall Study|Withdrawal by Subject|0|||
128758540|NCT03548207|463405235|FG002|Overall Study|Death|3|||
128758541|NCT03548207|463405233|FG000|Overall Study|Lost to Follow-up|0|||
128758542|NCT03548207|463405234|FG001|Overall Study|Lost to Follow-up|2|||
128791496|NCT05174013|463529662|FG004|Overall Study|Withdrawal by Subject|0|||
128791497|NCT05174013|463529663|FG005|Overall Study|Withdrawal by Subject|0|||
128791498|NCT03287622|463529664|FG000|Overall Study|Withdrawal by Subject|1|||
128758543|NCT03548207|463405235|FG002|Overall Study|Lost to Follow-up|0|||
128758544|NCT03548207|463405233|FG000|Overall Study|Withdrawal by Subject|0|||
128758545|NCT03548207|463405234|FG001|Overall Study|Withdrawal by Subject|3|||
128758546|NCT03548207|463405235|FG002|Overall Study|Withdrawal by Subject|0|||
128758547|NCT03548207|463405233|FG000|Overall Study|Sponsor decision|19|||
128758548|NCT03548207|463405234|FG001|Overall Study|Sponsor decision|40|||
128758549|NCT03548207|463405235|FG002|Overall Study|Sponsor decision|6|||
128758550|NCT03548207|463405233|FG000|Overall Study|Randomized but not treated|6|||
128758551|NCT03548207|463405234|FG001|Overall Study|Randomized but not treated|10|||
128758552|NCT03548207|463405235|FG002|Overall Study|Randomized but not treated|4|||
128758553|NCT00415610|463405236|FG000|Overall Study|Death|3|||
128791499|NCT03287622|463529665|FG001|Overall Study|Withdrawal by Subject|0|||
128791500|NCT03287622|463529664|FG000|Overall Study|Lost to Follow-up|27|||
128791501|NCT03287622|463529665|FG001|Overall Study|Lost to Follow-up|15|||
128791502|NCT03287622|463529664|FG000|Overall Study|No prescripion after surgery|28|||
128791503|NCT03287622|463529665|FG001|Overall Study|No prescripion after surgery|31|||
128791504|NCT03287622|463529664|FG000|Overall Study|prolonged Length of stay|2|||
128791505|NCT03287622|463529665|FG001|Overall Study|prolonged Length of stay|0|||
128791506|NCT03287622|463529664|FG000|Overall Study|surgery related|0|||
128791507|NCT03287622|463529665|FG001|Overall Study|surgery related|2|||
128791508|NCT01786564|463529666|FG000|Overall Study|Lost to Follow-up|47|||
128791509|NCT01786564|463529666|FG000|Overall Study|Ineligible|17|||
128791510|NCT01924767|463529667|FG000|Overall Study|Adverse Event|1|||
128791511|NCT01924767|463529668|FG001|Overall Study|Adverse Event|0|||
128791512|NCT01924767|463529669|FG002|Overall Study|Adverse Event|1|||
128791513|NCT01924767|463529670|FG003|Overall Study|Adverse Event|0|||
128791514|NCT01924767|463529671|FG004|Overall Study|Adverse Event|0|||
128791515|NCT00139737|463529676|FG000|Overall Study|Withdrawal by Subject|190|||
128791516|NCT00139737|463529676|FG000|Overall Study|Adverse Event|58|||
128791517|NCT00139737|463529676|FG000|Overall Study|Lack of Efficacy|40|||
128791518|NCT00139737|463529676|FG000|Overall Study|Lost to Follow-up|8|||
128791519|NCT00139737|463529676|FG000|Overall Study|Death|3|||
128791520|NCT00139737|463529676|FG000|Overall Study|Laboratory Abnormality|2|||
128791521|NCT00139737|463529676|FG000|Overall Study|Protocol Violation|18|||
128791522|NCT00139737|463529676|FG000|Overall Study|Withdrew During Screening Phase|8|||
128791523|NCT00139737|463529676|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
128791524|NCT00139737|463529676|FG000|Overall Study|Screened, Not Treated|13|||
128791525|NCT00612586|463529680|FG000|Overall Study|Adverse Event|6|||
128791526|NCT00612586|463529681|FG001|Overall Study|Adverse Event|2|||
128791527|NCT00612586|463529680|FG000|Overall Study|Death|1|||
128791528|NCT00612586|463529681|FG001|Overall Study|Death|0|||
128791529|NCT00612586|463529680|FG000|Overall Study|Entry Criteria Not Met|0|||
128791530|NCT00612586|463529681|FG001|Overall Study|Entry Criteria Not Met|2|||
128791531|NCT00612586|463529680|FG000|Overall Study|Withdrawal by Subject|7|||
128791532|NCT00612586|463529681|FG001|Overall Study|Withdrawal by Subject|9|||
128791533|NCT00612586|463529680|FG000|Overall Study|Physician Decision|1|||
128791534|NCT00612586|463529681|FG001|Overall Study|Physician Decision|2|||
128791535|NCT00612586|463529680|FG000|Overall Study|Sponsor Decision|1|||
128791536|NCT00612586|463529681|FG001|Overall Study|Sponsor Decision|1|||
128791537|NCT00612586|463529680|FG000|Overall Study|Progressive Disease|26|||
128791538|NCT00612586|463529681|FG001|Overall Study|Progressive Disease|24|||
128791539|NCT00612586|463529680|FG000|Overall Study|Randomized and Not Treated|1|||
128791540|NCT00612586|463529681|FG001|Overall Study|Randomized and Not Treated|1|||
128791541|NCT01909336|463529682|FG000|Overall Study|Lost to Follow-up|4|||
128791542|NCT01909336|463529683|FG001|Overall Study|Lost to Follow-up|2|||
128791543|NCT01909336|463529684|FG002|Overall Study|Lost to Follow-up|2|||
128791544|NCT01909336|463529682|FG000|Overall Study|Physician Decision|0|||
128791545|NCT01909336|463529683|FG001|Overall Study|Physician Decision|1|||
128791546|NCT01909336|463529684|FG002|Overall Study|Physician Decision|1|||
128791547|NCT01194154|463529685|FG000|Overall Study|Adverse Event|12|||
128791548|NCT01194154|463529686|FG001|Overall Study|Adverse Event|7|||
128791549|NCT01194154|463529685|FG000|Overall Study|Lost to Follow-up|2|||
128791550|NCT01194154|463529686|FG001|Overall Study|Lost to Follow-up|3|||
128791551|NCT01194154|463529685|FG000|Overall Study|Protocol Violation|0|||
128791552|NCT01194154|463529686|FG001|Overall Study|Protocol Violation|1|||
128791553|NCT01194154|463529685|FG000|Overall Study|Withdrawal by Subject|5|||
128791554|NCT01194154|463529686|FG001|Overall Study|Withdrawal by Subject|6|||
128791555|NCT01194154|463529685|FG000|Overall Study|Blood pressure increase|5|||
128791556|NCT01194154|463529686|FG001|Overall Study|Blood pressure increase|3|||
128791557|NCT01194154|463529685|FG000|Overall Study|Hemoglobin decrease|0|||
128791558|NCT01194154|463529686|FG001|Overall Study|Hemoglobin decrease|1|||
128791559|NCT01194154|463529685|FG000|Overall Study|Hemoglobin increase|12|||
128791560|NCT01194154|463529686|FG001|Overall Study|Hemoglobin increase|3|||
128791561|NCT01194154|463529685|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
128791562|NCT01194154|463529686|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
128758554|NCT00415610|463405237|FG001|Overall Study|Death|2|||
128758555|NCT00415610|463405238|FG002|Overall Study|Death|5|||
128758556|NCT00999466|463405239|FG000|Main Part|Withdrawal by Subject|0|||
128758557|NCT00999466|463405240|FG001|Main Part|Withdrawal by Subject|0|||
128758558|NCT00999466|463405241|FG002|Main Part|Withdrawal by Subject|2|||
128758559|NCT00999466|463405239|FG000|Main Part|Adverse Event|0|||
128758560|NCT00999466|463405240|FG001|Main Part|Adverse Event|4|||
128758561|NCT00999466|463405241|FG002|Main Part|Adverse Event|2|||
128758562|NCT00645164|463405242|FG000|Overall Study|Lost to Follow-up|2|||
128758563|NCT00645164|463405242|FG000|Overall Study|Withdrawal by Subject|4|||
128758564|NCT00645164|463405242|FG000|Overall Study|Protocol Violation|1|||
128758565|NCT00117676|463405243|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
128758566|NCT00117676|463405244|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
128758567|NCT00117676|463405243|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
128758568|NCT00117676|463405244|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
128758569|NCT00117676|463405243|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
128758570|NCT00117676|463405244|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
128758571|NCT00117676|463405243|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
128758572|NCT00117676|463405244|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
128758573|NCT00117676|463405243|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
128758574|NCT00117676|463405244|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
128758575|NCT00117676|463405243|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
128758576|NCT00117676|463405244|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
128758577|NCT00117676|463405243|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
128758578|NCT00117676|463405244|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
128758579|NCT00117676|463405243|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
128758580|NCT00117676|463405244|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
128758581|NCT00117676|463405243|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
128758582|NCT00117676|463405244|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
128758583|NCT00117676|463405243|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
128758584|NCT00117676|463405244|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
128758585|NCT00117676|463405243|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
128758586|NCT00117676|463405244|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
128758587|NCT00117676|463405243|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
128758588|NCT00117676|463405244|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
128758589|NCT00117676|463405243|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
128758590|NCT00117676|463405244|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
128758591|NCT00117676|463405243|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
128758592|NCT00117676|463405244|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
128758593|NCT00117676|463405243|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
128758594|NCT00117676|463405244|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
128758595|NCT00117676|463405243|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
128758596|NCT00117676|463405244|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
128791563|NCT01194154|463529685|FG000|Overall Study|Treatment with prohibited medication|4|||
128791564|NCT01194154|463529686|FG001|Overall Study|Treatment with prohibited medication|5|||
128758597|NCT00117676|463405243|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
128791565|NCT01194154|463529685|FG000|Overall Study|Other|4|||
128791566|NCT01194154|463529686|FG001|Overall Study|Other|0|||
128791567|NCT01194154|463529685|FG000|Overall Study|Did not receive study medication|2|||
128791568|NCT01194154|463529686|FG001|Overall Study|Did not receive study medication|4|||
128791569|NCT02314117|463529687|FG000|Overall Study|Lost to Follow-up|9|||
128791570|NCT02314117|463529688|FG001|Overall Study|Lost to Follow-up|14|||
128758598|NCT00117676|463405244|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
128758599|NCT00117676|463405243|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
128758600|NCT00117676|463405244|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
128758601|NCT00117676|463405243|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
128758602|NCT00117676|463405244|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
128791571|NCT02314117|463529687|FG000|Overall Study|Withdrawal by Subject|3|||
128791572|NCT02314117|463529688|FG001|Overall Study|Withdrawal by Subject|2|||
128791573|NCT00530842|463529689|FG000|Overall Study|Adverse Event|10|||
128791574|NCT00530842|463529690|FG001|Overall Study|Adverse Event|6|||
128791575|NCT00530842|463529689|FG000|Overall Study|Lack of Efficacy|2|||
128791576|NCT00530842|463529690|FG001|Overall Study|Lack of Efficacy|1|||
128791577|NCT00530842|463529689|FG000|Overall Study|Lost to Follow-up|0|||
128791578|NCT00530842|463529690|FG001|Overall Study|Lost to Follow-up|4|||
128791579|NCT00530842|463529689|FG000|Overall Study|Protocol Violation|3|||
128791580|NCT00530842|463529690|FG001|Overall Study|Protocol Violation|2|||
128791581|NCT00530842|463529689|FG000|Overall Study|Withdrawal by Subject|4|||
128791582|NCT00530842|463529690|FG001|Overall Study|Withdrawal by Subject|5|||
128758603|NCT00117676|463405243|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
128758604|NCT00117676|463405244|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
128791583|NCT00530842|463529689|FG000|Overall Study|Individual different reasons|4|||
128791584|NCT00530842|463529690|FG001|Overall Study|Individual different reasons|3|||
128791585|NCT00530842|463529689|FG000|Period 1|Adverse Event|7|||
128791586|NCT00530842|463529690|FG001|Period 1|Adverse Event|3|||
128791587|NCT00530842|463529689|FG000|Period 1|Lack of Efficacy|1|||
128791588|NCT00530842|463529690|FG001|Period 1|Lack of Efficacy|1|||
128791589|NCT00530842|463529689|FG000|Period 1|Protocol Violation|2|||
128791590|NCT00530842|463529690|FG001|Period 1|Protocol Violation|1|||
128791591|NCT00530842|463529689|FG000|Period 1|Withdrawal by Subject|2|||
128791592|NCT00530842|463529690|FG001|Period 1|Withdrawal by Subject|3|||
128791593|NCT00530842|463529689|FG000|Period 1|Individual different reasons|2|||
128791594|NCT00530842|463529690|FG001|Period 1|Individual different reasons|3|||
128791595|NCT00530842|463529689|FG000|Period 2|Adverse Event|3|||
128791596|NCT00530842|463529690|FG001|Period 2|Adverse Event|3|||
128791597|NCT00530842|463529689|FG000|Period 2|Lack of Efficacy|1|||
128791598|NCT00530842|463529690|FG001|Period 2|Lack of Efficacy|0|||
128791599|NCT00530842|463529689|FG000|Period 2|Lost to Follow-up|0|||
128791600|NCT00530842|463529690|FG001|Period 2|Lost to Follow-up|4|||
128791601|NCT00530842|463529689|FG000|Period 2|Protocol Violation|1|||
128791602|NCT00530842|463529690|FG001|Period 2|Protocol Violation|0|||
128791603|NCT00530842|463529689|FG000|Period 2|Withdrawal by Subject|1|||
128791604|NCT00530842|463529690|FG001|Period 2|Withdrawal by Subject|2|||
128791605|NCT00530842|463529689|FG000|Period 2|Individual different reasons|2|||
128791606|NCT00530842|463529690|FG001|Period 2|Individual different reasons|0|||
128791607|NCT02954848|463529691|FG000|Overall Study|Randomized but Not Treated|0|||
128791608|NCT02954848|463529692|FG001|Overall Study|Randomized but Not Treated|1|||
128791609|NCT02954848|463529691|FG000|Overall Study|Adverse Event|2|||
128791610|NCT02954848|463529692|FG001|Overall Study|Adverse Event|3|||
128791611|NCT02954848|463529691|FG000|Overall Study|Withdrawal by Participant|0|||
128791612|NCT02954848|463529692|FG001|Overall Study|Withdrawal by Participant|1|||
128791613|NCT00922207|463529693|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
128791614|NCT00922207|463529694|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
128791615|NCT00922207|463529695|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
128791616|NCT00922207|463529693|FG000|Overall Study|Insufficient Therapeutic Response|0|||
128791617|NCT00922207|463529694|FG001|Overall Study|Insufficient Therapeutic Response|0|||
128791618|NCT00922207|463529695|FG002|Overall Study|Insufficient Therapeutic Response|1|||
128791619|NCT00922207|463529693|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
128791620|NCT00922207|463529694|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
128791621|NCT00922207|463529695|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
128791622|NCT00922207|463529693|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
128791623|NCT00922207|463529694|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
128791624|NCT00922207|463529695|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
128791625|NCT00922207|463529693|FG000|Overall Study|Withdrew Consent|2|||
128791626|NCT00922207|463529694|FG001|Overall Study|Withdrew Consent|5|||
128791627|NCT00922207|463529695|FG002|Overall Study|Withdrew Consent|2|||
128791628|NCT00922207|463529693|FG000|Overall Study|Abnormality of Laboratory Test|0|||
128791629|NCT00922207|463529694|FG001|Overall Study|Abnormality of Laboratory Test|1|||
128791630|NCT00922207|463529695|FG002|Overall Study|Abnormality of Laboratory Test|1|||
128791631|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
128791632|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
128791633|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
128791634|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
128791635|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
128791636|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
128791637|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
128791638|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
128791639|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
128791640|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
128791641|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
128791642|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
128791643|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
128791644|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
128791645|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
128791646|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791647|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791648|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
128791649|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791650|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791651|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791652|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791653|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791654|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791655|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791656|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
128791657|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
128791658|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
128791659|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
128791660|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
128791661|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
128791662|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
128791663|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
128791664|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
128791665|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
128791666|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
128791667|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
128791668|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
128791669|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
128791670|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791671|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
128791672|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
128791673|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791674|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
128791675|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791676|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791677|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791678|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791679|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791680|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791681|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791682|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
128791683|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
128791684|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
128791685|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
128791686|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
128791687|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
128791688|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
128791689|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
128791690|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
128791691|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
128791692|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
128791693|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
128791694|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
128791695|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
128791696|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
128791697|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791698|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791699|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791700|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791701|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
128791702|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
128791703|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
128791704|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791705|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791706|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791707|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791708|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
128791709|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
128791710|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
128791711|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
128791712|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
128791713|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
128791714|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
128791715|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
128791716|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
128791717|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
128791718|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
128791719|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
128791720|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
128791721|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
128791722|NCT04707313|463529708|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791723|NCT04707313|463529709|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791724|NCT04707313|463529710|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
128791725|NCT04707313|463529711|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791726|NCT04707313|463529712|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791727|NCT04707313|463529713|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791728|NCT04707313|463529714|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791729|NCT04707313|463529715|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
128791730|NCT04707313|463529716|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791731|NCT04707313|463529717|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791732|NCT04707313|463529718|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791733|NCT04707313|463529719|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791734|NCT04707313|463529720|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
128791735|NCT04707313|463529708|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791736|NCT04707313|463529709|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791737|NCT04707313|463529710|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791738|NCT04707313|463529711|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791739|NCT04707313|463529712|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791740|NCT04707313|463529713|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791741|NCT04707313|463529714|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791742|NCT04707313|463529715|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791743|NCT04707313|463529716|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791744|NCT04707313|463529717|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
128791745|NCT04707313|463529718|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
128791746|NCT04707313|463529719|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
128791747|NCT04707313|463529720|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
128791748|NCT04707313|463529708|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791749|NCT04707313|463529709|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791750|NCT04707313|463529710|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791751|NCT04707313|463529711|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791752|NCT04707313|463529712|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791753|NCT04707313|463529713|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791754|NCT04707313|463529714|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791755|NCT04707313|463529715|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791756|NCT04707313|463529716|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791757|NCT04707313|463529717|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
128791758|NCT04707313|463529718|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
128791759|NCT04707313|463529719|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
128791760|NCT04707313|463529720|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
128791761|NCT04707313|463529708|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791762|NCT04707313|463529709|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791763|NCT04707313|463529710|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791764|NCT04707313|463529711|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791765|NCT04707313|463529712|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791766|NCT04707313|463529713|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791767|NCT04707313|463529714|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791768|NCT04707313|463529715|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791769|NCT04707313|463529716|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
128791770|NCT04707313|463529717|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
128791771|NCT04707313|463529718|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
128791772|NCT04707313|463529719|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
128791773|NCT04707313|463529720|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
128791774|NCT04707313|463529708|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791775|NCT04707313|463529709|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791776|NCT04707313|463529710|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791777|NCT04707313|463529711|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791778|NCT04707313|463529712|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791779|NCT04707313|463529713|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791780|NCT04707313|463529714|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791781|NCT04707313|463529715|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791782|NCT04707313|463529716|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791783|NCT04707313|463529717|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791784|NCT04707313|463529718|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
128791785|NCT04707313|463529719|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
128791786|NCT04707313|463529720|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
128791787|NCT04707313|463529708|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791788|NCT04707313|463529709|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791789|NCT04707313|463529710|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791790|NCT04707313|463529711|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791791|NCT04707313|463529712|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791792|NCT04707313|463529713|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791793|NCT04707313|463529714|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791794|NCT04707313|463529715|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791795|NCT04707313|463529716|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791796|NCT04707313|463529717|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
128791797|NCT04707313|463529718|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
128791798|NCT04707313|463529719|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791799|NCT04707313|463529720|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
128791800|NCT04707313|463529708|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791801|NCT04707313|463529709|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791802|NCT04707313|463529710|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791803|NCT04707313|463529711|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791804|NCT04707313|463529712|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791805|NCT04707313|463529713|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791806|NCT04707313|463529714|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791807|NCT04707313|463529715|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791808|NCT04707313|463529716|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
128791809|NCT04707313|463529717|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
128791810|NCT04707313|463529718|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
128791811|NCT04707313|463529719|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
128791812|NCT04707313|463529720|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
128791813|NCT00324038|463529724|FG000|Overall Study|Adverse Event|38|||
128791814|NCT00324038|463529725|FG001|Overall Study|Adverse Event|23|||
128791815|NCT00324038|463529724|FG000|Overall Study|Lack of Efficacy|5|||
128791816|NCT00324038|463529725|FG001|Overall Study|Lack of Efficacy|13|||
128791817|NCT00324038|463529724|FG000|Overall Study|Lost to Follow-up|0|||
128791818|NCT00324038|463529725|FG001|Overall Study|Lost to Follow-up|2|||
128791819|NCT00324038|463529724|FG000|Overall Study|Other|6|||
128791820|NCT00324038|463529725|FG001|Overall Study|Other|13|||
128791821|NCT03070483|463529726|FG000|Overall Study|Lost to Follow-up|2|||
128791822|NCT02770248|463529727|FG000|Overall Study|Adverse Event|0|||
128791823|NCT02770248|463529728|FG001|Overall Study|Adverse Event|1|||
128791824|NCT02770248|463529727|FG000|Overall Study|Randomized in error, prior to treatment|0|||
128758605|NCT00117676|463405243|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
128758606|NCT00117676|463405244|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
128758607|NCT00117676|463405243|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
128758608|NCT00117676|463405244|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
128758609|NCT00117676|463405243|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
128758610|NCT00117676|463405244|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
128758611|NCT00117676|463405243|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
128758612|NCT00117676|463405244|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
128758613|NCT00117676|463405243|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
128758614|NCT00117676|463405244|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
128758615|NCT00117676|463405243|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
128758616|NCT00117676|463405244|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
128758617|NCT00117676|463405243|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
128758618|NCT00117676|463405244|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
128758619|NCT00117676|463405243|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
128758620|NCT00117676|463405244|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
128758621|NCT00117676|463405243|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
128758622|NCT00117676|463405244|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
128758623|NCT00117676|463405243|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
128758624|NCT00117676|463405244|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
128758625|NCT00117676|463405243|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
128758626|NCT00117676|463405244|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
128758627|NCT00117676|463405243|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
128758628|NCT00117676|463405244|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
128758629|NCT00117676|463405243|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
128758630|NCT00117676|463405244|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
128758631|NCT00117676|463405243|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
128758632|NCT00117676|463405244|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
128758633|NCT00117676|463405243|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
128758634|NCT00117676|463405244|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
128758635|NCT00952822|463405245|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
128758636|NCT00952822|463405246|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
128758637|NCT00952822|463405247|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
128758638|NCT00952822|463405248|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
128758639|NCT00952822|463405245|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
128758640|NCT00952822|463405246|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
128758641|NCT00952822|463405247|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
128758642|NCT00952822|463405248|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
128758643|NCT00691938|463405251|FG000|Overall Study|QTc prolongation|1|||
128758644|NCT00691938|463405252|FG001|Overall Study|QTc prolongation|0|||
128758645|NCT00691938|463405253|FG002|Overall Study|QTc prolongation|0|||
128758646|NCT00691938|463405254|FG003|Overall Study|QTc prolongation|0|||
128758647|NCT00691938|463405255|FG004|Overall Study|QTc prolongation|0|||
128758648|NCT00691938|463405256|FG005|Overall Study|QTc prolongation|0|||
128758649|NCT00691938|463405257|FG006|Overall Study|QTc prolongation|0|||
128758650|NCT04860518|463405261|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
128758651|NCT04860518|463405262|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
128758652|NCT04555096|463405267|FG000|Overall Study|Death|4|||
128758653|NCT04555096|463405268|FG001|Overall Study|Death|4|||
128758654|NCT04555096|463405267|FG000|Overall Study|Withdrawal by Subject|1|||
128758655|NCT04555096|463405268|FG001|Overall Study|Withdrawal by Subject|0|||
128758656|NCT04555096|463405267|FG000|Overall Study|Other|0|||
128758657|NCT04555096|463405268|FG001|Overall Study|Other|1|||
128758658|NCT00611858|463405269|FG000|Overall Study|Adverse Event|2|||
128758659|NCT00611858|463405269|FG000|Overall Study|Withdrawal by Subject|2|||
128758660|NCT01844284|463405270|FG000|Overall Study|Lost to Follow-up|12|||
128758661|NCT01844284|463405271|FG001|Overall Study|Lost to Follow-up|7|||
128758662|NCT01058304|463405272|FG000|Overall Study|Withdrawal by Subject|8|||
128758663|NCT01058304|463405273|FG001|Overall Study|Withdrawal by Subject|5|||
128758664|NCT01058304|463405272|FG000|Overall Study|Lost to Follow-up|13|||
128758665|NCT01058304|463405273|FG001|Overall Study|Lost to Follow-up|16|||
128758666|NCT01058304|463405272|FG000|Overall Study|Developed exclusion criterion|6|||
128758667|NCT01058304|463405273|FG001|Overall Study|Developed exclusion criterion|12|||
128758668|NCT01820559|463405274|FG000|Overall Study|Adverse Event|4|||
128758669|NCT01820559|463405275|FG001|Overall Study|Adverse Event|6|||
128758670|NCT01820559|463405276|FG002|Overall Study|Adverse Event|13|||
128758671|NCT01820559|463405274|FG000|Overall Study|Withdrawal by Subject|1|||
128758672|NCT01820559|463405275|FG001|Overall Study|Withdrawal by Subject|2|||
128758673|NCT01820559|463405276|FG002|Overall Study|Withdrawal by Subject|5|||
128791825|NCT02770248|463529728|FG001|Overall Study|Randomized in error, prior to treatment|1|||
128791826|NCT03768206|463529731|FG000|Overall Study|Lost to Follow-up|2|||
128791827|NCT03768206|463529732|FG001|Overall Study|Lost to Follow-up|1|||
128791828|NCT03768206|463529731|FG000|Overall Study|Withdrawal by Subject|0|||
128791829|NCT03768206|463529732|FG001|Overall Study|Withdrawal by Subject|1|||
128791830|NCT01713946|463529733|FG000|Overall Study|Death|0|||
128791831|NCT01713946|463529734|FG001|Overall Study|Death|2|||
128791832|NCT01713946|463529735|FG002|Overall Study|Death|2|||
128791833|NCT01713946|463529733|FG000|Overall Study|Adverse Event|19|||
128791834|NCT01713946|463529734|FG001|Overall Study|Adverse Event|14|||
128791835|NCT01713946|463529735|FG002|Overall Study|Adverse Event|13|||
128791836|NCT01713946|463529733|FG000|Overall Study|Withdrawal by Subject|12|||
128791837|NCT01713946|463529734|FG001|Overall Study|Withdrawal by Subject|12|||
128791838|NCT01713946|463529735|FG002|Overall Study|Withdrawal by Subject|8|||
128791839|NCT01713946|463529733|FG000|Overall Study|Lack of Efficacy|8|||
128791840|NCT01713946|463529734|FG001|Overall Study|Lack of Efficacy|8|||
128791841|NCT01713946|463529735|FG002|Overall Study|Lack of Efficacy|14|||
128791842|NCT01713946|463529733|FG000|Overall Study|Protocol Violation|2|||
128791843|NCT01713946|463529734|FG001|Overall Study|Protocol Violation|4|||
128791844|NCT01713946|463529735|FG002|Overall Study|Protocol Violation|1|||
128791845|NCT01713946|463529733|FG000|Overall Study|Lost to Follow-up|0|||
128791846|NCT01713946|463529734|FG001|Overall Study|Lost to Follow-up|0|||
128791847|NCT01713946|463529735|FG002|Overall Study|Lost to Follow-up|1|||
128791848|NCT01713946|463529733|FG000|Overall Study|Administrative problems|1|||
128791849|NCT01713946|463529734|FG001|Overall Study|Administrative problems|0|||
128791850|NCT01713946|463529735|FG002|Overall Study|Administrative problems|0|||
128791851|NCT01713946|463529733|FG000|Overall Study|Did not continue in Ext|0|||
128791852|NCT01713946|463529734|FG001|Overall Study|Did not continue in Ext|3|||
128791853|NCT01713946|463529735|FG002|Overall Study|Did not continue in Ext|0|||
128791854|NCT01713946|463529733|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
128791855|NCT01713946|463529734|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
128791856|NCT01713946|463529735|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
128791857|NCT01713946|463529733|FG000|Overall Study|Patients never switched to everolimus|0|||
128791858|NCT01713946|463529734|FG001|Overall Study|Patients never switched to everolimus|0|||
128791859|NCT01713946|463529735|FG002|Overall Study|Patients never switched to everolimus|5|||
128791860|NCT03183518|463529736|FG000|Overall Study|Other (Not specified)|2|||
128791861|NCT03183518|463529736|FG000|Overall Study|Other (Withdrawal of consent)|1|||
128791862|NCT04513522|463531784|FG000|Overall Study|Other reasons|1|||
128791863|NCT04513522|463531784|FG000|Overall Study|Adverse event unrelated to study drug|9|||
128791864|NCT04513522|463531784|FG000|Overall Study|Study drug toxicity|14|||
128791865|NCT04513522|463531784|FG000|Overall Study|Disease progression|39|||
128791866|NCT04513522|463531784|FG000|Overall Study|Participants withdrew consent|2|||
128791867|NCT00589667|463531785|FG000|Overall Study|Adverse Event|2|||
128791868|NCT00589667|463531785|FG000|Overall Study|Withdrawal by Subject|1|||
128791869|NCT03538041|463531788|FG000|12-Week Treatment Period|Adverse Event|1|||
128791870|NCT03538041|463531789|FG001|12-Week Treatment Period|Adverse Event|1|||
128791871|NCT03538041|463531788|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
128791872|NCT03538041|463531789|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
128791873|NCT03538041|463531788|FG000|Treatment Extension Period|Adverse Event|4|||
128791874|NCT03538041|463531789|FG001|Treatment Extension Period|Adverse Event|1|||
128791875|NCT03538041|463531788|FG000|Treatment Extension Period|Physician Decision|1|||
128791876|NCT03538041|463531789|FG001|Treatment Extension Period|Physician Decision|1|||
128791877|NCT03538041|463531788|FG000|Treatment Extension Period|Lack of Efficacy|1|||
128791878|NCT03538041|463531789|FG001|Treatment Extension Period|Lack of Efficacy|4|||
128791879|NCT03538041|463531788|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
128791880|NCT03538041|463531789|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
128791881|NCT03538041|463531788|FG000|Treatment Extension Period|Death|0|||
128791882|NCT03538041|463531789|FG001|Treatment Extension Period|Death|1|||
128791883|NCT01266265|463531790|FG000|Overall Study|Death|95|||
128791884|NCT01266265|463531791|FG001|Overall Study|Death|73|||
128791885|NCT01266265|463531790|FG000|Overall Study|Lost to Follow-up|23|||
128791886|NCT01266265|463531791|FG001|Overall Study|Lost to Follow-up|28|||
128791887|NCT01266265|463531790|FG000|Overall Study|Withdrawal by Subject|13|||
128791888|NCT01266265|463531791|FG001|Overall Study|Withdrawal by Subject|11|||
128791889|NCT01266265|463531790|FG000|Overall Study|Respiratory-related adverse event|2|||
128791890|NCT01266265|463531791|FG001|Overall Study|Respiratory-related adverse event|1|||
128791891|NCT01266265|463531790|FG000|Overall Study|Transferred care to another provider|22|||
128791892|NCT01266265|463531791|FG001|Overall Study|Transferred care to another provider|28|||
128791893|NCT01266265|463531790|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
128791894|NCT01266265|463531791|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
128791895|NCT01266265|463531790|FG000|Overall Study|Enrolled in another clinical study|15|||
128791896|NCT01266265|463531791|FG001|Overall Study|Enrolled in another clinical study|26|||
128791897|NCT01266265|463531790|FG000|Overall Study|Non-compliance|8|||
128791898|NCT01266265|463531791|FG001|Overall Study|Non-compliance|5|||
128791899|NCT01266265|463531790|FG000|Overall Study|Lung transplant|6|||
128791900|NCT01266265|463531791|FG001|Overall Study|Lung transplant|5|||
128791901|NCT01266265|463531790|FG000|Overall Study|Site closed early|4|||
128791902|NCT01266265|463531791|FG001|Overall Study|Site closed early|3|||
128791903|NCT01266265|463531790|FG000|Overall Study|Clinical worsening|1|||
128791904|NCT01266265|463531791|FG001|Overall Study|Clinical worsening|1|||
128791905|NCT01580293|463531792|FG000|Part A_Main Trial|Adverse Event|0|||
128791906|NCT01580293|463531793|FG001|Part A_Main Trial|Adverse Event|2|||
128791907|NCT01580293|463531794|FG002|Part A_Main Trial|Adverse Event|0|||
128791908|NCT01580293|463531792|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
128791909|NCT01580293|463531793|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
128791910|NCT01580293|463531794|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
128791911|NCT01580293|463531792|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
128791912|NCT01580293|463531793|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
128791913|NCT01580293|463531794|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
128791914|NCT01580293|463531792|FG000|Part A_Extension|Adverse Event|0|||
128791915|NCT01580293|463531793|FG001|Part A_Extension|Adverse Event|2|||
128791916|NCT01580293|463531794|FG002|Part A_Extension|Adverse Event|0|||
128791917|NCT01580293|463531792|FG000|Part A_Extension|Withdrawal by Subject|0|||
128791918|NCT01580293|463531793|FG001|Part A_Extension|Withdrawal by Subject|3|||
128791919|NCT01580293|463531794|FG002|Part A_Extension|Withdrawal by Subject|0|||
128791920|NCT01580293|463531792|FG000|Part A_Extension|Lost to Follow-up|0|||
128791921|NCT01580293|463531793|FG001|Part A_Extension|Lost to Follow-up|1|||
128791922|NCT01580293|463531794|FG002|Part A_Extension|Lost to Follow-up|0|||
128791923|NCT01580293|463531792|FG000|Part A_Extension|Other Reason|0|||
128791924|NCT01580293|463531793|FG001|Part A_Extension|Other Reason|1|||
128791925|NCT01580293|463531794|FG002|Part A_Extension|Other Reason|0|||
128791926|NCT01580293|463531792|FG000|Part A_Extension|Completed Japan only|0|||
128791927|NCT01580293|463531793|FG001|Part A_Extension|Completed Japan only|5|||
128791928|NCT01580293|463531794|FG002|Part A_Extension|Completed Japan only|0|||
128791929|NCT01580293|463531792|FG000|Part B|Withdrawal by Subject|0|||
128791930|NCT01580293|463531793|FG001|Part B|Withdrawal by Subject|0|||
128791931|NCT01580293|463531794|FG002|Part B|Withdrawal by Subject|1|||
128791932|NCT01580293|463531792|FG000|Part B|Other reason|0|||
128791933|NCT01580293|463531793|FG001|Part B|Other reason|0|||
128791934|NCT01580293|463531794|FG002|Part B|Other reason|1|||
128791935|NCT00768664|463531795|FG000|Overall Study|Death|57|||
128791936|NCT00768664|463531795|FG000|Overall Study|Lost to Follow-up|2|||
128791937|NCT00768664|463531795|FG000|Overall Study|Other|9|||
128791938|NCT00768664|463531795|FG000|Overall Study|Participant refused|1|||
128791939|NCT00423098|463531796|FG000|Overall Study|Adverse Event|1|||
128791940|NCT00423098|463531797|FG001|Overall Study|Adverse Event|2|||
128791941|NCT00423098|463531796|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128791942|NCT00423098|463531797|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128791943|NCT00423098|463531796|FG000|Overall Study|Administrative problems|0|||
128791944|NCT00423098|463531797|FG001|Overall Study|Administrative problems|1|||
128791945|NCT00423098|463531796|FG000|Overall Study|Death|2|||
128791946|NCT00423098|463531797|FG001|Overall Study|Death|0|||
128791947|NCT04480827|463531798|FG000|Overall Study|Adverse Event|0|||
128791948|NCT04480827|463531799|FG001|Overall Study|Adverse Event|0|||
128791949|NCT04480827|463531800|FG002|Overall Study|Adverse Event|0|||
128791950|NCT04480827|463531801|FG003|Overall Study|Adverse Event|0|||
128791951|NCT04480827|463531802|FG004|Overall Study|Adverse Event|0|||
128791952|NCT04480827|463531803|FG005|Overall Study|Adverse Event|1|||
128791953|NCT04480827|463531804|FG006|Overall Study|Adverse Event|0|||
128791954|NCT03720210|463531810|FG000|Overall Study|Lost to Follow-up|1|||
128791955|NCT02698891|463531811|FG000|Overall Study|Withdrawal by Subject|2|||
128791956|NCT02698891|463531811|FG000|Overall Study|deemed ineligible|1|||
128791957|NCT02698891|463531811|FG000|Overall Study|Adverse Event|9|||
128791958|NCT00114244|463531812|FG000|Overall Study|Adverse Event|2|||
128791959|NCT00114244|463531813|FG001|Overall Study|Adverse Event|5|||
128791960|NCT00114244|463531812|FG000|Overall Study|Withdrawal by Subject|0|||
128791961|NCT00114244|463531813|FG001|Overall Study|Withdrawal by Subject|2|||
128791962|NCT02694978|463531816|FG000|Overall Study|Adverse Event|10|||
128791963|NCT02694978|463531817|FG001|Overall Study|Adverse Event|9|||
128791964|NCT02694978|463531816|FG000|Overall Study|Withdrawal by Subject|22|||
128791965|NCT02694978|463531817|FG001|Overall Study|Withdrawal by Subject|19|||
128791966|NCT02694978|463531816|FG000|Overall Study|Lost to Follow-up|14|||
128791967|NCT02694978|463531817|FG001|Overall Study|Lost to Follow-up|17|||
128791968|NCT02694978|463531816|FG000|Overall Study|Death|4|||
128791969|NCT02694978|463531817|FG001|Overall Study|Death|1|||
128791970|NCT02694978|463531816|FG000|Overall Study|Other-Decision of Participant|6|||
128791971|NCT02694978|463531817|FG001|Overall Study|Other-Decision of Participant|1|||
128791972|NCT02694978|463531816|FG000|Overall Study|Other-Investigator's decision|1|||
128791973|NCT02694978|463531817|FG001|Overall Study|Other-Investigator's decision|0|||
128791974|NCT02694978|463531816|FG000|Overall Study|Other-Unable to be reached|0|||
128791975|NCT02694978|463531817|FG001|Overall Study|Other-Unable to be reached|1|||
128791976|NCT02694978|463531816|FG000|Overall Study|Other-Protocol noncompliant|2|||
128791977|NCT02694978|463531817|FG001|Overall Study|Other-Protocol noncompliant|1|||
128791978|NCT02694978|463531816|FG000|Overall Study|Other-Personal reasons|3|||
128791979|NCT02694978|463531817|FG001|Overall Study|Other-Personal reasons|3|||
128791980|NCT02694978|463531816|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
128791981|NCT02694978|463531817|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
128791982|NCT00818454|463531818|FG000|Treatment Period 1|Adverse Event|0|||
128791983|NCT00818454|463531819|FG001|Treatment Period 1|Adverse Event|1|||
128758674|NCT01820559|463405274|FG000|Overall Study|Protocol Violation|2|||
128758675|NCT01820559|463405275|FG001|Overall Study|Protocol Violation|1|||
128758676|NCT01820559|463405276|FG002|Overall Study|Protocol Violation|3|||
128758677|NCT01820559|463405274|FG000|Overall Study|Subject's non-compliance|1|||
128758678|NCT01820559|463405275|FG001|Overall Study|Subject's non-compliance|0|||
128758679|NCT01820559|463405276|FG002|Overall Study|Subject's non-compliance|2|||
128758680|NCT01820559|463405274|FG000|Overall Study|Lost to Follow-up|3|||
128758681|NCT01820559|463405275|FG001|Overall Study|Lost to Follow-up|2|||
128758682|NCT01820559|463405276|FG002|Overall Study|Lost to Follow-up|2|||
128758683|NCT01820559|463405274|FG000|Overall Study|At sponsor request|0|||
128758684|NCT01820559|463405275|FG001|Overall Study|At sponsor request|0|||
128758685|NCT01820559|463405276|FG002|Overall Study|At sponsor request|1|||
128758686|NCT01820559|463405274|FG000|Overall Study|Lack of Efficacy|3|||
128758687|NCT01820559|463405275|FG001|Overall Study|Lack of Efficacy|2|||
128758688|NCT01820559|463405276|FG002|Overall Study|Lack of Efficacy|3|||
128758689|NCT02755597|463405277|FG000|Overall Study|Withdrew consent|27|||
128758690|NCT02755597|463405278|FG001|Overall Study|Withdrew consent|11|||
128758691|NCT02755597|463405277|FG000|Overall Study|Lost to Follow-up|1|||
128758692|NCT02755597|463405278|FG001|Overall Study|Lost to Follow-up|0|||
128758693|NCT02755597|463405277|FG000|Overall Study|Death|78|||
128758694|NCT02755597|463405278|FG001|Overall Study|Death|36|||
128758695|NCT02755597|463405277|FG000|Overall Study|Study terminated by Sponsor|67|||
128758696|NCT02755597|463405278|FG001|Overall Study|Study terminated by Sponsor|47|||
128758697|NCT02755597|463405277|FG000|Overall Study|Other, not specified|20|||
128758698|NCT02755597|463405278|FG001|Overall Study|Other, not specified|3|||
128758699|NCT02755597|463405277|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
128758700|NCT02755597|463405278|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
128758701|NCT03641313|463405282|FG000|Overall Study|Death|1|||
128758702|NCT03641313|463405282|FG000|Overall Study|Withdrawal by Subject|2|||
128758703|NCT03641313|463405282|FG000|Overall Study|Declining health|1|||
128758704|NCT03641313|463405282|FG000|Overall Study|Adverse Event|1|||
128758705|NCT04642898|463405283|FG000|Overall Study|Withdrawal by Subject|2|||
128758706|NCT04642898|463405284|FG001|Overall Study|Withdrawal by Subject|4|||
128758707|NCT04642898|463405285|FG002|Overall Study|Withdrawal by Subject|4|||
128758708|NCT04642898|463405286|FG003|Overall Study|Withdrawal by Subject|6|||
128758709|NCT04642898|463405287|FG004|Overall Study|Withdrawal by Subject|2|||
128758710|NCT04642898|463405288|FG005|Overall Study|Withdrawal by Subject|6|||
128758711|NCT04642898|463405283|FG000|Overall Study|Lost to Follow-up|0|||
128758712|NCT04642898|463405284|FG001|Overall Study|Lost to Follow-up|0|||
128758713|NCT04642898|463405285|FG002|Overall Study|Lost to Follow-up|0|||
128758714|NCT04642898|463405286|FG003|Overall Study|Lost to Follow-up|2|||
128758715|NCT04642898|463405287|FG004|Overall Study|Lost to Follow-up|0|||
128758716|NCT04642898|463405288|FG005|Overall Study|Lost to Follow-up|1|||
128758717|NCT04642898|463405283|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
128758718|NCT04642898|463405284|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
128758719|NCT04642898|463405285|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
128758720|NCT04642898|463405286|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
128758721|NCT04642898|463405287|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
128758722|NCT04642898|463405288|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
128758723|NCT04642898|463405283|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
128758724|NCT04642898|463405284|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
128758725|NCT04642898|463405285|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
128758726|NCT04642898|463405286|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
128758727|NCT04642898|463405287|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
128758728|NCT04642898|463405288|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
128758729|NCT03574597|463405289|FG000|Overall Study|Withdrawal by Subject|67|||
128758730|NCT03574597|463405290|FG001|Overall Study|Withdrawal by Subject|96|||
128758731|NCT03574597|463405289|FG000|Overall Study|Lost to Follow-up|192|||
128758732|NCT03574597|463405290|FG001|Overall Study|Lost to Follow-up|188|||
128758733|NCT03434678|463405291|FG000|Overall Study|Withdrawal by Subject|13|||
128758734|NCT03434678|463405292|FG001|Overall Study|Withdrawal by Subject|13|||
128758735|NCT03434678|463405291|FG000|Overall Study|Found to be ineligible post randomization|2|||
128758736|NCT03434678|463405292|FG001|Overall Study|Found to be ineligible post randomization|1|||
128758737|NCT06060457|463405295|FG000|Overall Study|Adverse Event|1|||
128758738|NCT06060457|463405296|FG001|Overall Study|Adverse Event|1|||
128758739|NCT06060457|463405295|FG000|Overall Study|Death|2|||
128758740|NCT06060457|463405296|FG001|Overall Study|Death|2|||
128791984|NCT00818454|463531820|FG002|Treatment Period 1|Adverse Event|0|||
128791985|NCT00818454|463531821|FG003|Treatment Period 1|Adverse Event|0|||
128791986|NCT00818454|463531818|FG000|Treatment Period 1|Other|3|||
128791987|NCT00818454|463531819|FG001|Treatment Period 1|Other|0|||
128791988|NCT00818454|463531820|FG002|Treatment Period 1|Other|0|||
128791989|NCT00818454|463531821|FG003|Treatment Period 1|Other|0|||
128791990|NCT00818454|463531818|FG000|Washout Period of 1 Week|Adverse Event|1|||
128791991|NCT00818454|463531819|FG001|Washout Period of 1 Week|Adverse Event|1|||
128791992|NCT00818454|463531820|FG002|Washout Period of 1 Week|Adverse Event|0|||
128791993|NCT00818454|463531821|FG003|Washout Period of 1 Week|Adverse Event|0|||
128791994|NCT00818454|463531818|FG000|Washout Period of 1 Week|Protocol Violation|2|||
128791995|NCT00818454|463531819|FG001|Washout Period of 1 Week|Protocol Violation|0|||
128791996|NCT00818454|463531820|FG002|Washout Period of 1 Week|Protocol Violation|0|||
128791997|NCT00818454|463531821|FG003|Washout Period of 1 Week|Protocol Violation|0|||
128791998|NCT00818454|463531818|FG000|Washout Period of 1 Week|Other|1|||
128791999|NCT00818454|463531819|FG001|Washout Period of 1 Week|Other|2|||
128792000|NCT00818454|463531820|FG002|Washout Period of 1 Week|Other|0|||
128792001|NCT00818454|463531821|FG003|Washout Period of 1 Week|Other|0|||
128792002|NCT00818454|463531818|FG000|Treatment Period 2|Other|2|||
128792003|NCT00818454|463531819|FG001|Treatment Period 2|Other|1|||
128792004|NCT00818454|463531820|FG002|Treatment Period 2|Other|0|||
128792005|NCT00818454|463531821|FG003|Treatment Period 2|Other|0|||
128792006|NCT00818454|463531818|FG000|Treatment Period 3|Adverse Event|0|||
128792007|NCT00818454|463531819|FG001|Treatment Period 3|Adverse Event|0|||
128792008|NCT00818454|463531820|FG002|Treatment Period 3|Adverse Event|0|||
128792009|NCT00818454|463531821|FG003|Treatment Period 3|Adverse Event|1|||
128792010|NCT00807144|463531823|FG000|Overall Study|Lost to Follow-up|0|||
128792011|NCT00807144|463531824|FG001|Overall Study|Lost to Follow-up|1|||
128792012|NCT00854906|463531827|FG000|Overall Study|One person had no ocular history|1|||
128792013|NCT01930045|463531830|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
128792014|NCT01930045|463531831|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
128792015|NCT01930045|463531832|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
128792016|NCT01930045|463531833|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
128792017|NCT01930045|463531834|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
128792018|NCT01930045|463531835|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
128792019|NCT01930045|463531830|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
128792020|NCT01930045|463531831|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
128792021|NCT01930045|463531832|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
128792022|NCT01930045|463531833|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
128792023|NCT01930045|463531834|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
128792024|NCT01930045|463531835|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
128792025|NCT00507689|463531836|FG000|Pre-Randomization Period|Adverse Event|1|||
128792026|NCT00507689|463531837|FG001|Pre-Randomization Period|Adverse Event|0|||
128792027|NCT00507689|463531836|FG000|Pre-Randomization Period|Physician Decision|1|||
128792028|NCT00507689|463531837|FG001|Pre-Randomization Period|Physician Decision|0|||
128792029|NCT00507689|463531836|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
128792030|NCT00507689|463531837|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
128792031|NCT00507689|463531836|FG000|Randomized Period|Adverse Event|1|||
128792032|NCT00507689|463531837|FG001|Randomized Period|Adverse Event|1|||
128792033|NCT00507689|463531836|FG000|Randomized Period|Withdrawal by Subject|0|||
128792034|NCT00507689|463531837|FG001|Randomized Period|Withdrawal by Subject|1|||
128792035|NCT00486330|463531838|FG000|Overall Study|Adverse Event|2|||
128792036|NCT01290224|463531839|FG000|Overall Study|Adverse Event|1|||
128792037|NCT01290224|463531839|FG000|Overall Study|Refused Further Treatment|4|||
128792038|NCT01241292|463531840|FG000|Overall Study|Administrative Reason by Sponsor|1|||
128792039|NCT01241292|463531841|FG001|Overall Study|Administrative Reason by Sponsor|0|||
128792040|NCT01241292|463531840|FG000|Overall Study|Disease Progression|2|||
128792041|NCT01241292|463531841|FG001|Overall Study|Disease Progression|0|||
128792042|NCT01241292|463531840|FG000|Overall Study|Study Drug Toxicity|0|||
128792043|NCT01241292|463531841|FG001|Overall Study|Study Drug Toxicity|1|||
128792044|NCT01241292|463531840|FG000|Overall Study|Participant Discontinued Treatment|0|||
128792045|NCT01241292|463531841|FG001|Overall Study|Participant Discontinued Treatment|2|||
128792046|NCT03184558|463531842|FG000|Overall Study|Withdrawal by Subject|2|||
128792047|NCT03184558|463531842|FG000|Overall Study|Death|16|||
128792048|NCT03184558|463531842|FG000|Overall Study|Lost to Follow-up|2|||
128792049|NCT03184558|463531842|FG000|Overall Study|Other|9|||
128792050|NCT00723450|463531847|FG000|Open-Label Phase|Adverse Event|26|||
128792051|NCT00723450|463531848|FG001|Open-Label Phase|Adverse Event|0|||
128792052|NCT00723450|463531849|FG002|Open-Label Phase|Adverse Event|0|||
128792053|NCT00723450|463531847|FG000|Open-Label Phase|Lack of Efficacy|18|||
128792054|NCT00723450|463531848|FG001|Open-Label Phase|Lack of Efficacy|0|||
128792055|NCT00723450|463531849|FG002|Open-Label Phase|Lack of Efficacy|0|||
128792056|NCT00723450|463531847|FG000|Open-Label Phase|Protocol Violation|35|||
128792057|NCT00723450|463531848|FG001|Open-Label Phase|Protocol Violation|0|||
128792058|NCT00723450|463531849|FG002|Open-Label Phase|Protocol Violation|0|||
128792059|NCT00723450|463531847|FG000|Open-Label Phase|Lost to Follow-up|7|||
128792060|NCT00723450|463531848|FG001|Open-Label Phase|Lost to Follow-up|0|||
128792061|NCT00723450|463531849|FG002|Open-Label Phase|Lost to Follow-up|0|||
128792062|NCT00723450|463531847|FG000|Open-Label Phase|Physician Decision|2|||
128792063|NCT00723450|463531848|FG001|Open-Label Phase|Physician Decision|0|||
128792064|NCT00723450|463531849|FG002|Open-Label Phase|Physician Decision|0|||
128792065|NCT00723450|463531847|FG000|Open-Label Phase|Withdrawal by Subject|37|||
128792066|NCT00723450|463531848|FG001|Open-Label Phase|Withdrawal by Subject|0|||
128792067|NCT00723450|463531849|FG002|Open-Label Phase|Withdrawal by Subject|0|||
128792068|NCT00723450|463531847|FG000|Randomized Phase|Adverse Event|0|||
128792069|NCT00723450|463531848|FG001|Randomized Phase|Adverse Event|26|||
128792070|NCT00723450|463531849|FG002|Randomized Phase|Adverse Event|17|||
128792071|NCT00723450|463531847|FG000|Randomized Phase|Lack of Efficacy|0|||
128792072|NCT00723450|463531848|FG001|Randomized Phase|Lack of Efficacy|11|||
128792073|NCT00723450|463531849|FG002|Randomized Phase|Lack of Efficacy|11|||
128792074|NCT00723450|463531847|FG000|Randomized Phase|Protocol Violation|0|||
128792075|NCT00723450|463531848|FG001|Randomized Phase|Protocol Violation|9|||
128792076|NCT00723450|463531849|FG002|Randomized Phase|Protocol Violation|13|||
128792077|NCT00723450|463531847|FG000|Randomized Phase|Lost to Follow-up|0|||
128792078|NCT00723450|463531848|FG001|Randomized Phase|Lost to Follow-up|2|||
128792079|NCT00723450|463531849|FG002|Randomized Phase|Lost to Follow-up|3|||
128792080|NCT00723450|463531847|FG000|Randomized Phase|Physician Decision|0|||
128792081|NCT00723450|463531848|FG001|Randomized Phase|Physician Decision|3|||
128792082|NCT00723450|463531849|FG002|Randomized Phase|Physician Decision|1|||
128792083|NCT00723450|463531847|FG000|Randomized Phase|Withdrawal by Subject|0|||
128792084|NCT00723450|463531848|FG001|Randomized Phase|Withdrawal by Subject|14|||
128792085|NCT00723450|463531849|FG002|Randomized Phase|Withdrawal by Subject|22|||
128792086|NCT00770965|463531850|FG000|Safety Set|Withdrawal by Subject|0|||
128792087|NCT00770965|463531851|FG001|Safety Set|Withdrawal by Subject|0|||
128792088|NCT00770965|463531852|FG002|Safety Set|Withdrawal by Subject|0|||
128792089|NCT00770965|463531853|FG003|Safety Set|Withdrawal by Subject|1|||
128792090|NCT00770965|463531850|FG000|Safety Set|Protocol deviation|0|||
128792091|NCT00770965|463531851|FG001|Safety Set|Protocol deviation|0|||
128792092|NCT00770965|463531852|FG002|Safety Set|Protocol deviation|1|||
128792093|NCT00770965|463531853|FG003|Safety Set|Protocol deviation|0|||
128792094|NCT00770965|463531850|FG000|Excluded Set|Administrative problems|14|||
128792095|NCT00770965|463531851|FG001|Excluded Set|Administrative problems|12|||
128792096|NCT00770965|463531852|FG002|Excluded Set|Administrative problems|12|||
128792097|NCT00770965|463531853|FG003|Excluded Set|Administrative problems|10|||
128792098|NCT00770965|463531850|FG000|Excluded Set|Withdrawal by Subject|1|||
128792099|NCT00770965|463531851|FG001|Excluded Set|Withdrawal by Subject|1|||
128792100|NCT00770965|463531852|FG002|Excluded Set|Withdrawal by Subject|2|||
128792101|NCT00770965|463531853|FG003|Excluded Set|Withdrawal by Subject|3|||
128792102|NCT03192046|463531855|FG000|Overall Study|Withdrawal by Subject|1|||
128792103|NCT03192046|463531856|FG001|Overall Study|Withdrawal by Subject|1|||
128792104|NCT00762606|463531857|FG000|Overall Study|Lost to Follow-up|18|||
128792105|NCT00762606|463531858|FG001|Overall Study|Lost to Follow-up|13|||
128792106|NCT01505881|463531859|FG000|Overall Study|Adverse Event|0|||
128792107|NCT01505881|463531860|FG001|Overall Study|Adverse Event|1|||
128792108|NCT01505881|463531859|FG000|Overall Study|Lost to Follow-up|2|||
128792109|NCT01505881|463531860|FG001|Overall Study|Lost to Follow-up|0|||
128792110|NCT01505881|463531859|FG000|Overall Study|Withdrawal by Subject|2|||
128792111|NCT01505881|463531860|FG001|Overall Study|Withdrawal by Subject|0|||
128792112|NCT00842257|463531861|FG000|Overall Study|Adverse Event|1|||
128792113|NCT00395018|463531862|FG000|On-Treatment|Death|4|||
128792114|NCT00395018|463531862|FG000|On-Treatment|Other Reason|2|||
128792115|NCT00395018|463531862|FG000|On-Treatment|Poor/non-compliance|2|||
128792116|NCT00395018|463531862|FG000|On-Treatment|Subject no longer meets study criteria|2|||
128792117|NCT00395018|463531862|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
128792118|NCT00395018|463531862|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
128792119|NCT00395018|463531862|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
128792120|NCT04439799|463531863|FG000|Overall Study|Lost to Follow-up|6|||
128792121|NCT04439799|463531864|FG001|Overall Study|Lost to Follow-up|6|||
128792122|NCT04439799|463531863|FG000|Overall Study|Withdrawal by Subject|2|||
128792123|NCT04439799|463531864|FG001|Overall Study|Withdrawal by Subject|6|||
128792124|NCT04439799|463531863|FG000|Overall Study|Adverse Event|2|||
128792125|NCT04439799|463531864|FG001|Overall Study|Adverse Event|5|||
128792126|NCT01391130|463531872|FG000|Overall Study|Withdrawal by Subject|3|||
128792127|NCT01391130|463531873|FG001|Overall Study|Withdrawal by Subject|2|||
128792128|NCT01391130|463531872|FG000|Overall Study|Physician Decision|2|||
128792129|NCT01391130|463531873|FG001|Overall Study|Physician Decision|3|||
128792130|NCT01391130|463531872|FG000|Overall Study|Did not Receive Drug|1|||
128792131|NCT01391130|463531873|FG001|Overall Study|Did not Receive Drug|1|||
128792132|NCT00880048|463531877|FG000|Overall Study|Adverse Event|2|||
128792133|NCT00880048|463531878|FG001|Overall Study|Adverse Event|3|||
128792134|NCT00880048|463531879|FG002|Overall Study|Adverse Event|5|||
128792135|NCT00880048|463531877|FG000|Overall Study|Lack of Efficacy|1|||
128792136|NCT00880048|463531878|FG001|Overall Study|Lack of Efficacy|2|||
128792137|NCT00880048|463531879|FG002|Overall Study|Lack of Efficacy|2|||
128792138|NCT00880048|463531877|FG000|Overall Study|Protocol Violation|4|||
128792139|NCT00880048|463531878|FG001|Overall Study|Protocol Violation|6|||
128792140|NCT00880048|463531879|FG002|Overall Study|Protocol Violation|5|||
128792141|NCT00880048|463531877|FG000|Overall Study|Lost to Follow-up|6|||
128792142|NCT00880048|463531878|FG001|Overall Study|Lost to Follow-up|6|||
128792143|NCT00880048|463531879|FG002|Overall Study|Lost to Follow-up|5|||
128792144|NCT00880048|463531877|FG000|Overall Study|Physician Decision|1|||
128792145|NCT00880048|463531878|FG001|Overall Study|Physician Decision|1|||
128792146|NCT00880048|463531879|FG002|Overall Study|Physician Decision|7|||
128792147|NCT00880048|463531877|FG000|Overall Study|Withdrawal by Subject|5|||
128792148|NCT00880048|463531878|FG001|Overall Study|Withdrawal by Subject|8|||
128792149|NCT00880048|463531879|FG002|Overall Study|Withdrawal by Subject|5|||
128792150|NCT00880048|463531877|FG000|Overall Study|Study closed/terminated|9|||
128792151|NCT00880048|463531878|FG001|Overall Study|Study closed/terminated|7|||
128792152|NCT00880048|463531879|FG002|Overall Study|Study closed/terminated|6|||
128792153|NCT01184508|463531884|FG000|Overall Study|Adverse Event|4|||
128792154|NCT01184508|463531885|FG001|Overall Study|Adverse Event|6|||
128792155|NCT01184508|463531884|FG000|Overall Study|Lack of Efficacy|1|||
128792156|NCT01184508|463531885|FG001|Overall Study|Lack of Efficacy|1|||
128792157|NCT01184508|463531884|FG000|Overall Study|Lost to Follow-up|1|||
128792158|NCT01184508|463531885|FG001|Overall Study|Lost to Follow-up|1|||
128792159|NCT01184508|463531884|FG000|Overall Study|Physician Decision|1|||
128792160|NCT01184508|463531885|FG001|Overall Study|Physician Decision|0|||
128792161|NCT01184508|463531884|FG000|Overall Study|Protocol Violation|3|||
128792162|NCT01184508|463531885|FG001|Overall Study|Protocol Violation|1|||
128792163|NCT01184508|463531884|FG000|Overall Study|Sponsor Decision|5|||
128792164|NCT01184508|463531885|FG001|Overall Study|Sponsor Decision|2|||
128792165|NCT01184508|463531884|FG000|Overall Study|Withdrawal by Subject|1|||
128792166|NCT01184508|463531885|FG001|Overall Study|Withdrawal by Subject|3|||
128792167|NCT01184508|463531884|FG000|Overall Study|Randomized, Not Treated|0|||
128792168|NCT01184508|463531885|FG001|Overall Study|Randomized, Not Treated|1|||
128792169|NCT02798835|463531889|FG000|Overall Study|Protocol Violation|0|||
128792170|NCT02798835|463531890|FG001|Overall Study|Protocol Violation|0|||
128792171|NCT02798835|463531891|FG002|Overall Study|Protocol Violation|3|||
128792172|NCT01585558|463531893|FG000|Overall Study|Withdrawal by Subject|4|||
128792173|NCT01585558|463531894|FG001|Overall Study|Withdrawal by Subject|5|||
128792174|NCT01585558|463531895|FG002|Overall Study|Withdrawal by Subject|8|||
128792175|NCT01585558|463531893|FG000|Overall Study|Lost to Follow-up|2|||
128792176|NCT01585558|463531894|FG001|Overall Study|Lost to Follow-up|0|||
128792177|NCT01585558|463531895|FG002|Overall Study|Lost to Follow-up|3|||
128792178|NCT01585558|463531893|FG000|Overall Study|Adverse Event|3|||
128792179|NCT01585558|463531894|FG001|Overall Study|Adverse Event|4|||
128792180|NCT01585558|463531895|FG002|Overall Study|Adverse Event|1|||
128792181|NCT01585558|463531893|FG000|Overall Study|Protocol Violation|4|||
128792182|NCT01585558|463531894|FG001|Overall Study|Protocol Violation|3|||
128792183|NCT01585558|463531895|FG002|Overall Study|Protocol Violation|2|||
128792184|NCT01585558|463531893|FG000|Overall Study|Lack of Efficacy|0|||
128792185|NCT01585558|463531894|FG001|Overall Study|Lack of Efficacy|0|||
128792186|NCT01585558|463531895|FG002|Overall Study|Lack of Efficacy|1|||
128792187|NCT00841035|463531896|FG000|Phase 1 Overall Study|Physician Decision|13|||
128792188|NCT01390402|463531911|FG000|Overall Study|Death|1|||
128792189|NCT01390402|463531911|FG000|Overall Study|Disease Progression|4|||
128792190|NCT02551055|463531914|FG000|Overall Study|Death|2|||
128792191|NCT02551055|463531915|FG001|Overall Study|Death|4|||
128792192|NCT02551055|463531916|FG002|Overall Study|Death|2|||
128792193|NCT02551055|463531917|FG003|Overall Study|Death|2|||
128792194|NCT02551055|463531918|FG004|Overall Study|Death|2|||
128792195|NCT02551055|463531919|FG005|Overall Study|Death|1|||
128792196|NCT02551055|463531920|FG006|Overall Study|Death|2|||
128792197|NCT02551055|463531921|FG007|Overall Study|Death|0|||
128792198|NCT02551055|463531914|FG000|Overall Study|Study Terminated by Sponsor|1|||
128792199|NCT02551055|463531915|FG001|Overall Study|Study Terminated by Sponsor|1|||
128792200|NCT02551055|463531916|FG002|Overall Study|Study Terminated by Sponsor|0|||
128792201|NCT02551055|463531917|FG003|Overall Study|Study Terminated by Sponsor|2|||
128792202|NCT02551055|463531918|FG004|Overall Study|Study Terminated by Sponsor|2|||
128792203|NCT02551055|463531919|FG005|Overall Study|Study Terminated by Sponsor|0|||
128792204|NCT02551055|463531920|FG006|Overall Study|Study Terminated by Sponsor|0|||
128792205|NCT02551055|463531921|FG007|Overall Study|Study Terminated by Sponsor|0|||
128792206|NCT02551055|463531914|FG000|Overall Study|Withdrawal by Subject|1|||
128792207|NCT02551055|463531915|FG001|Overall Study|Withdrawal by Subject|1|||
128792208|NCT02551055|463531916|FG002|Overall Study|Withdrawal by Subject|0|||
128792209|NCT02551055|463531917|FG003|Overall Study|Withdrawal by Subject|1|||
128792210|NCT02551055|463531918|FG004|Overall Study|Withdrawal by Subject|2|||
128792211|NCT02551055|463531919|FG005|Overall Study|Withdrawal by Subject|0|||
128792212|NCT02551055|463531920|FG006|Overall Study|Withdrawal by Subject|0|||
128792213|NCT02551055|463531921|FG007|Overall Study|Withdrawal by Subject|0|||
128792214|NCT02551055|463531914|FG000|Overall Study|Reason not specified|0|||
128792215|NCT02551055|463531915|FG001|Overall Study|Reason not specified|0|||
128792216|NCT02551055|463531916|FG002|Overall Study|Reason not specified|0|||
128792217|NCT02551055|463531917|FG003|Overall Study|Reason not specified|0|||
128758741|NCT06060457|463405295|FG000|Overall Study|Lost to Follow-up|17|||
128758742|NCT06060457|463405296|FG001|Overall Study|Lost to Follow-up|19|||
128758743|NCT06060457|463405295|FG000|Overall Study|Physician Decision|0|||
128758744|NCT06060457|463405296|FG001|Overall Study|Physician Decision|1|||
128758745|NCT06060457|463405295|FG000|Overall Study|Protocol Violation|1|||
128758746|NCT06060457|463405296|FG001|Overall Study|Protocol Violation|1|||
128758747|NCT06060457|463405295|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
128758748|NCT06060457|463405296|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
128758749|NCT06060457|463405295|FG000|Overall Study|Withdrawal by Subject|12|||
128758750|NCT06060457|463405296|FG001|Overall Study|Withdrawal by Subject|15|||
128758751|NCT06060457|463405295|FG000|Overall Study|Other Than Specified|2|||
128758752|NCT06060457|463405296|FG001|Overall Study|Other Than Specified|1|||
128758753|NCT02061202|463405297|FG000|Overall Study|Lost to Follow-up|1|||
128758754|NCT02061202|463405298|FG001|Overall Study|Lost to Follow-up|1|||
128758755|NCT01533493|463405299|FG000|Overall Study|Adverse Event|2|||
128758756|NCT01533493|463405300|FG001|Overall Study|Adverse Event|1|||
128758757|NCT01533493|463405299|FG000|Overall Study|Withdrawal by Subject|1|||
128758758|NCT01533493|463405300|FG001|Overall Study|Withdrawal by Subject|2|||
128758759|NCT01533493|463405299|FG000|Overall Study|Lost to Follow-up|2|||
128758760|NCT01533493|463405300|FG001|Overall Study|Lost to Follow-up|0|||
128758761|NCT02657031|463405305|FG000|Overall Study|Adverse Event|1|||
128758762|NCT02657031|463405306|FG001|Overall Study|Adverse Event|2|||
128758763|NCT05007392|463405307|FG000|Overall Study|Randomized but not treated|1|||
128758764|NCT05007392|463405308|FG001|Overall Study|Randomized but not treated|2|||
128758765|NCT05007392|463405307|FG000|Overall Study|Other|5|||
128758766|NCT05007392|463405308|FG001|Overall Study|Other|4|||
128758767|NCT05007392|463405307|FG000|Overall Study|Lost to Follow-up|1|||
128758768|NCT05007392|463405308|FG001|Overall Study|Lost to Follow-up|2|||
128758769|NCT05007392|463405307|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
128758770|NCT05007392|463405308|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
128758771|NCT05007392|463405307|FG000|Overall Study|Use of prohibited concomitant drug|1|||
128758772|NCT05007392|463405308|FG001|Overall Study|Use of prohibited concomitant drug|1|||
128758773|NCT05007392|463405307|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
128758774|NCT05007392|463405308|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
128758775|NCT05007392|463405307|FG000|Overall Study|Adverse Event|10|||
128758776|NCT05007392|463405308|FG001|Overall Study|Adverse Event|6|||
128758777|NCT05007392|463405307|FG000|Overall Study|Participant choice|5|||
128758778|NCT05007392|463405308|FG001|Overall Study|Participant choice|10|||
128758779|NCT05007392|463405307|FG000|Overall Study|Withdrawal of consent|5|||
128758780|NCT05007392|463405308|FG001|Overall Study|Withdrawal of consent|4|||
128758781|NCT01218126|463405309|FG000|Overall Study|Adverse Event|8|||
128758782|NCT01218126|463405310|FG001|Overall Study|Adverse Event|10|||
128758783|NCT01218126|463405311|FG002|Overall Study|Adverse Event|12|||
128758784|NCT01218126|463405312|FG003|Overall Study|Adverse Event|16|||
128758785|NCT01218126|463405309|FG000|Overall Study|Lack of Efficacy|7|||
128758786|NCT01218126|463405310|FG001|Overall Study|Lack of Efficacy|2|||
128758787|NCT01218126|463405311|FG002|Overall Study|Lack of Efficacy|2|||
128758788|NCT01218126|463405312|FG003|Overall Study|Lack of Efficacy|6|||
128758789|NCT01218126|463405309|FG000|Overall Study|Protocol Violation|5|||
128758790|NCT01218126|463405310|FG001|Overall Study|Protocol Violation|2|||
128758791|NCT01218126|463405311|FG002|Overall Study|Protocol Violation|2|||
128758792|NCT01218126|463405312|FG003|Overall Study|Protocol Violation|3|||
128758793|NCT01218126|463405309|FG000|Overall Study|Protocol-defined stopping criteria|1|||
128758794|NCT01218126|463405310|FG001|Overall Study|Protocol-defined stopping criteria|1|||
128758795|NCT01218126|463405311|FG002|Overall Study|Protocol-defined stopping criteria|0|||
128758796|NCT01218126|463405312|FG003|Overall Study|Protocol-defined stopping criteria|0|||
128758797|NCT01218126|463405309|FG000|Overall Study|Lost to Follow-up|0|||
128758798|NCT01218126|463405310|FG001|Overall Study|Lost to Follow-up|0|||
128758799|NCT01218126|463405311|FG002|Overall Study|Lost to Follow-up|0|||
128758800|NCT01218126|463405312|FG003|Overall Study|Lost to Follow-up|2|||
128758801|NCT01218126|463405309|FG000|Overall Study|Physician Decision|1|||
128758802|NCT01218126|463405310|FG001|Overall Study|Physician Decision|2|||
128758803|NCT01218126|463405311|FG002|Overall Study|Physician Decision|4|||
128758804|NCT01218126|463405312|FG003|Overall Study|Physician Decision|2|||
128758805|NCT01218126|463405309|FG000|Overall Study|Withdrawal by Subject|2|||
128758806|NCT01218126|463405310|FG001|Overall Study|Withdrawal by Subject|5|||
128758807|NCT01218126|463405311|FG002|Overall Study|Withdrawal by Subject|4|||
128758808|NCT01218126|463405312|FG003|Overall Study|Withdrawal by Subject|6|||
128758809|NCT00453986|463405316|FG000|Overall Study|Lost to Follow-up|6|||
128758810|NCT00453986|463405317|FG001|Overall Study|Lost to Follow-up|5|||
128758811|NCT00453986|463405318|FG002|Overall Study|Lost to Follow-up|6|||
128758812|NCT00453986|463405319|FG003|Overall Study|Lost to Follow-up|2|||
128758813|NCT00453986|463405320|FG004|Overall Study|Lost to Follow-up|0|||
128758814|NCT00522626|463405323|FG000|Overall Study|Lost to Follow-up|7|||
128758815|NCT03419364|463405324|FG000|Overall Study|Delivery due to maternal condition|2|||
128758816|NCT03419364|463405325|FG001|Overall Study|Delivery due to maternal condition|0|||
128792218|NCT02551055|463531918|FG004|Overall Study|Reason not specified|1|||
128792219|NCT02551055|463531919|FG005|Overall Study|Reason not specified|0|||
128792220|NCT02551055|463531920|FG006|Overall Study|Reason not specified|1|||
128792221|NCT02551055|463531921|FG007|Overall Study|Reason not specified|0|||
128792222|NCT00430300|463531925|FG000|Overall Study|Adverse Event|0|||
128792223|NCT00430300|463531926|FG001|Overall Study|Adverse Event|2|||
128792224|NCT00430300|463531927|FG002|Overall Study|Adverse Event|1|||
128792225|NCT00430300|463531928|FG003|Overall Study|Adverse Event|1|||
128792226|NCT00430300|463531925|FG000|Overall Study|Withdrawal by Subject|1|||
128792227|NCT00430300|463531926|FG001|Overall Study|Withdrawal by Subject|0|||
128792228|NCT00430300|463531927|FG002|Overall Study|Withdrawal by Subject|5|||
128792229|NCT00430300|463531928|FG003|Overall Study|Withdrawal by Subject|0|||
128792230|NCT00430300|463531925|FG000|Overall Study|Laboratory abnormality|1|||
128792231|NCT00430300|463531926|FG001|Overall Study|Laboratory abnormality|0|||
128792232|NCT00430300|463531927|FG002|Overall Study|Laboratory abnormality|0|||
128792233|NCT00430300|463531928|FG003|Overall Study|Laboratory abnormality|0|||
128792234|NCT00430300|463531925|FG000|Overall Study|Other|0|||
128792235|NCT00430300|463531926|FG001|Overall Study|Other|0|||
128792236|NCT00430300|463531927|FG002|Overall Study|Other|0|||
128792237|NCT00430300|463531928|FG003|Overall Study|Other|1|||
128792238|NCT02754479|463531929|FG000|Overall Study|Lost to Follow-up|1|||
128792239|NCT01063517|463531934|FG000|Overall Study|Consent withdrawal|1|||
128792240|NCT01063517|463531935|FG001|Overall Study|Consent withdrawal|0|||
128792241|NCT01063517|463531934|FG000|Overall Study|Study reached data cut-off|19|||
128792242|NCT01063517|463531935|FG001|Overall Study|Study reached data cut-off|7|||
128792243|NCT01063517|463531934|FG000|Overall Study|Lost to Follow-up|4|||
128792244|NCT01063517|463531935|FG001|Overall Study|Lost to Follow-up|3|||
128792245|NCT01063517|463531934|FG000|Overall Study|Withdrawal by Subject|1|||
128792246|NCT01063517|463531935|FG001|Overall Study|Withdrawal by Subject|2|||
128792247|NCT01063517|463531934|FG000|Overall Study|Death|33|||
128792248|NCT01063517|463531935|FG001|Overall Study|Death|48|||
128792249|NCT02041104|463531936|FG000|Overall Study|Lost to Follow-up|1|||
128792250|NCT02041104|463531937|FG001|Overall Study|Lost to Follow-up|4|||
128792251|NCT02041104|463531936|FG000|Overall Study|discomfort during OGTT|0|||
128792252|NCT02041104|463531937|FG001|Overall Study|discomfort during OGTT|3|||
128792253|NCT00617201|463531940|FG000|Overall Study|Lost to Follow-up|9|||
128792254|NCT00617201|463531941|FG001|Overall Study|Lost to Follow-up|13|||
128792255|NCT00546871|463531942|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
128792256|NCT00546871|463531943|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
128792257|NCT00546871|463531942|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
128792258|NCT00546871|463531943|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
128792259|NCT00546871|463531942|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
128792260|NCT00546871|463531943|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
128792261|NCT00546871|463531942|FG000|Study Extension Period|Protocol Violation|1|||
128792262|NCT00546871|463531943|FG001|Study Extension Period|Protocol Violation|0|||
128792263|NCT00546871|463531942|FG000|Study Extension Period|Withdrawal by Subject|0|||
128792264|NCT00546871|463531943|FG001|Study Extension Period|Withdrawal by Subject|1|||
128792265|NCT04493242|463531946|FG000|Overall Study|Death|10|||
128792266|NCT04493242|463531947|FG001|Overall Study|Death|14|||
128792267|NCT04493242|463531948|FG002|Overall Study|Death|16|||
128792268|NCT04493242|463531946|FG000|Overall Study|Lost to Follow-up|1|||
128792269|NCT04493242|463531947|FG001|Overall Study|Lost to Follow-up|1|||
128792270|NCT04493242|463531948|FG002|Overall Study|Lost to Follow-up|0|||
128792271|NCT04493242|463531946|FG000|Overall Study|Withdrawal by Subject|1|||
128792272|NCT04493242|463531947|FG001|Overall Study|Withdrawal by Subject|0|||
128792273|NCT04493242|463531948|FG002|Overall Study|Withdrawal by Subject|0|||
128792274|NCT04493242|463531946|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
128792275|NCT04493242|463531947|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
128792276|NCT04493242|463531948|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
128792277|NCT04493242|463531946|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
128792278|NCT04493242|463531947|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
128792279|NCT04493242|463531948|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
128792280|NCT03762668|463534111|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
128792281|NCT03762668|463534112|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
128792282|NCT00465816|463534114|FG000|Overall Study|Lost to Follow-up|0|||
128792283|NCT00465816|463534115|FG001|Overall Study|Lost to Follow-up|0|||
128792284|NCT00465816|463534116|FG002|Overall Study|Lost to Follow-up|2|||
128792285|NCT00004124|463534117|FG000|Overall Study|Received no protocol therapy|12|||
128792286|NCT00004124|463534118|FG001|Overall Study|Received no protocol therapy|20|||
128792287|NCT02027558|463534119|FG000|Overall Study|Death|0|||
128792288|NCT02027558|463534120|FG001|Overall Study|Death|1|||
128792289|NCT02027558|463534119|FG000|Overall Study|Withdrawal by Subject|2|||
128792290|NCT02027558|463534120|FG001|Overall Study|Withdrawal by Subject|0|||
128792291|NCT02027558|463534119|FG000|Overall Study|Lost to Follow-up|4|||
128792292|NCT02027558|463534120|FG001|Overall Study|Lost to Follow-up|1|||
128792293|NCT02027558|463534119|FG000|Overall Study|Refused assessment|3|||
128792294|NCT02027558|463534120|FG001|Overall Study|Refused assessment|0|||
128792295|NCT02383472|463534121|FG000|Overall Study|Withdrawal by Subject|1|||
128792296|NCT02383472|463534122|FG001|Overall Study|Withdrawal by Subject|1|||
128792297|NCT02013830|463534123|FG000|Overall Study|Adverse Event|3|||
128792298|NCT02013830|463534123|FG000|Overall Study|Death|1|||
128792299|NCT02013830|463534123|FG000|Overall Study|Insufficient therapeutic response|25|||
128792300|NCT02013830|463534123|FG000|Overall Study|Refused treatment|1|||
128792301|NCT01111526|463534124|FG000|Overall Study|GVHD Disease Progression|0|||
128792302|NCT01111526|463534125|FG001|Overall Study|GVHD Disease Progression|1|||
128792303|NCT01111526|463534126|FG002|Overall Study|GVHD Disease Progression|2|||
128792304|NCT04424641|463534127|FG000|Overall Study|Death|1|||
128792305|NCT04424641|463534128|FG001|Overall Study|Death|2|||
128792306|NCT04424641|463534129|FG002|Overall Study|Death|3|||
128792307|NCT04424641|463534130|FG003|Overall Study|Death|0|||
128792308|NCT04424641|463534131|FG004|Overall Study|Death|3|||
128792309|NCT04424641|463534132|FG005|Overall Study|Death|0|||
128792310|NCT04424641|463534133|FG006|Overall Study|Death|1|||
128792311|NCT04424641|463534134|FG007|Overall Study|Death|2|||
128792312|NCT04424641|463534127|FG000|Overall Study|Sponsor decision|0|||
128792313|NCT04424641|463534128|FG001|Overall Study|Sponsor decision|2|||
128792314|NCT04424641|463534129|FG002|Overall Study|Sponsor decision|3|||
128792315|NCT04424641|463534130|FG003|Overall Study|Sponsor decision|7|||
128792316|NCT04424641|463534131|FG004|Overall Study|Sponsor decision|2|||
128792317|NCT04424641|463534132|FG005|Overall Study|Sponsor decision|2|||
128792318|NCT04424641|463534133|FG006|Overall Study|Sponsor decision|3|||
128792319|NCT04424641|463534134|FG007|Overall Study|Sponsor decision|4|||
128792320|NCT04424641|463534127|FG000|Overall Study|Withdrawal by Subject|0|||
128792321|NCT04424641|463534128|FG001|Overall Study|Withdrawal by Subject|0|||
128792322|NCT04424641|463534129|FG002|Overall Study|Withdrawal by Subject|0|||
128792323|NCT04424641|463534130|FG003|Overall Study|Withdrawal by Subject|0|||
128792324|NCT04424641|463534131|FG004|Overall Study|Withdrawal by Subject|1|||
128792325|NCT04424641|463534132|FG005|Overall Study|Withdrawal by Subject|0|||
128792326|NCT04424641|463534133|FG006|Overall Study|Withdrawal by Subject|0|||
128792327|NCT04424641|463534134|FG007|Overall Study|Withdrawal by Subject|0|||
128792328|NCT04424641|463534127|FG000|Overall Study|Other|0|||
128792329|NCT04424641|463534128|FG001|Overall Study|Other|0|||
128792330|NCT04424641|463534129|FG002|Overall Study|Other|1|||
128792331|NCT04424641|463534130|FG003|Overall Study|Other|0|||
128792332|NCT04424641|463534131|FG004|Overall Study|Other|0|||
128792333|NCT04424641|463534132|FG005|Overall Study|Other|0|||
128792334|NCT04424641|463534133|FG006|Overall Study|Other|0|||
128792335|NCT04424641|463534134|FG007|Overall Study|Other|0|||
128792336|NCT02296424|463534141|FG000|Part 1|New therapy for study indication|0|||
128792337|NCT02296424|463534142|FG001|Part 1|New therapy for study indication|1|||
128792338|NCT02296424|463534143|FG002|Part 1|New therapy for study indication|0|||
128792339|NCT02296424|463534144|FG003|Part 1|New therapy for study indication|0|||
128792340|NCT02296424|463534141|FG000|Part 1|Protocol Violation|0|||
128792341|NCT02296424|463534142|FG001|Part 1|Protocol Violation|1|||
128792342|NCT02296424|463534143|FG002|Part 1|Protocol Violation|0|||
128792343|NCT02296424|463534144|FG003|Part 1|Protocol Violation|0|||
128792344|NCT02296424|463534141|FG000|Part 1|Withdrawal by Subject|0|||
128792345|NCT02296424|463534142|FG001|Part 1|Withdrawal by Subject|2|||
128792346|NCT02296424|463534143|FG002|Part 1|Withdrawal by Subject|0|||
128792347|NCT02296424|463534144|FG003|Part 1|Withdrawal by Subject|0|||
128792348|NCT02296424|463534141|FG000|Part 1|Study terminated by sponsor|0|||
128792349|NCT02296424|463534142|FG001|Part 1|Study terminated by sponsor|1|||
128792350|NCT02296424|463534143|FG002|Part 1|Study terminated by sponsor|0|||
128792351|NCT02296424|463534144|FG003|Part 1|Study terminated by sponsor|0|||
128792352|NCT02296424|463534141|FG000|Part 1|Adverse Event|2|||
128792353|NCT02296424|463534142|FG001|Part 1|Adverse Event|11|||
128792354|NCT02296424|463534143|FG002|Part 1|Adverse Event|0|||
128792355|NCT02296424|463534144|FG003|Part 1|Adverse Event|0|||
128792356|NCT02296424|463534141|FG000|Part 1|Lack of Efficacy|5|||
128792357|NCT02296424|463534142|FG001|Part 1|Lack of Efficacy|17|||
128792358|NCT02296424|463534143|FG002|Part 1|Lack of Efficacy|0|||
128792359|NCT02296424|463534144|FG003|Part 1|Lack of Efficacy|0|||
128792360|NCT02296424|463534141|FG000|Part 1|16 directly started part II|16|||
128792361|NCT02296424|463534142|FG001|Part 1|16 directly started part II|0|||
128792362|NCT02296424|463534143|FG002|Part 1|16 directly started part II|0|||
128792363|NCT02296424|463534144|FG003|Part 1|16 directly started part II|0|||
128792364|NCT02296424|463534141|FG000|Part 2|Lack of Efficacy|0|||
128792365|NCT02296424|463534142|FG001|Part 2|Lack of Efficacy|0|||
128792366|NCT02296424|463534143|FG002|Part 2|Lack of Efficacy|1|||
128792367|NCT02296424|463534144|FG003|Part 2|Lack of Efficacy|0|||
128792368|NCT02296424|463534141|FG000|Part 2|Adverse Event|0|||
128792369|NCT02296424|463534142|FG001|Part 2|Adverse Event|0|||
128792370|NCT02296424|463534143|FG002|Part 2|Adverse Event|1|||
128792371|NCT02296424|463534144|FG003|Part 2|Adverse Event|0|||
128792372|NCT02296424|463534141|FG000|Part 2|Lost to Follow-up|0|||
128792373|NCT02296424|463534142|FG001|Part 2|Lost to Follow-up|0|||
128792374|NCT02296424|463534143|FG002|Part 2|Lost to Follow-up|1|||
128792375|NCT02296424|463534144|FG003|Part 2|Lost to Follow-up|0|||
128792376|NCT00743444|463534145|FG000|First Intervention|Catheter placement problems|0|||
128792377|NCT00743444|463534146|FG001|First Intervention|Catheter placement problems|1|||
128792378|NCT00743444|463534145|FG000|Washout Period|Adverse Event|0|||
128792379|NCT00743444|463534146|FG001|Washout Period|Adverse Event|1|||
128792380|NCT01337635|463534149|FG000|Overall Study|Lost to Follow-up|0|||
128792381|NCT01337635|463534150|FG001|Overall Study|Lost to Follow-up|1|||
128792382|NCT01307267|463534151|FG000|Overall Study|Death|4|||
128792383|NCT01307267|463534152|FG001|Overall Study|Death|3|||
128792384|NCT01307267|463534153|FG002|Overall Study|Death|5|||
128792385|NCT01307267|463534154|FG003|Overall Study|Death|3|||
128792386|NCT01307267|463534155|FG004|Overall Study|Death|1|||
128792387|NCT01307267|463534156|FG005|Overall Study|Death|26|||
128792388|NCT01307267|463534157|FG006|Overall Study|Death|2|||
128792389|NCT01307267|463534158|FG007|Overall Study|Death|2|||
128792390|NCT01307267|463534159|FG008|Overall Study|Death|21|||
128792391|NCT01307267|463534160|FG009|Overall Study|Death|2|||
128792392|NCT01307267|463534161|FG010|Overall Study|Death|3|||
128792393|NCT01307267|463534162|FG011|Overall Study|Death|9|||
128792394|NCT01307267|463534163|FG012|Overall Study|Death|0|||
128792395|NCT01307267|463534164|FG013|Overall Study|Death|0|||
128792396|NCT01307267|463534165|FG014|Overall Study|Death|0|||
128792397|NCT01307267|463534166|FG015|Overall Study|Death|0|||
128792398|NCT01307267|463534167|FG016|Overall Study|Death|1|||
128792399|NCT01307267|463534168|FG017|Overall Study|Death|1|||
128792400|NCT01307267|463534169|FG018|Overall Study|Death|2|||
128792401|NCT01307267|463534170|FG019|Overall Study|Death|8|||
128792402|NCT01307267|463534171|FG020|Overall Study|Death|1|||
128792403|NCT01307267|463534172|FG021|Overall Study|Death|2|||
128792404|NCT01307267|463534173|FG022|Overall Study|Death|2|||
128792405|NCT01307267|463534151|FG000|Overall Study|Lost to Follow-up|0|||
128792406|NCT01307267|463534152|FG001|Overall Study|Lost to Follow-up|0|||
128792407|NCT01307267|463534153|FG002|Overall Study|Lost to Follow-up|0|||
128792408|NCT01307267|463534154|FG003|Overall Study|Lost to Follow-up|0|||
128792409|NCT01307267|463534155|FG004|Overall Study|Lost to Follow-up|0|||
128792410|NCT01307267|463534156|FG005|Overall Study|Lost to Follow-up|7|||
128792411|NCT01307267|463534157|FG006|Overall Study|Lost to Follow-up|0|||
128792412|NCT01307267|463534158|FG007|Overall Study|Lost to Follow-up|0|||
128792413|NCT01307267|463534159|FG008|Overall Study|Lost to Follow-up|1|||
128792414|NCT01307267|463534160|FG009|Overall Study|Lost to Follow-up|2|||
128792415|NCT01307267|463534161|FG010|Overall Study|Lost to Follow-up|1|||
128792416|NCT01307267|463534162|FG011|Overall Study|Lost to Follow-up|0|||
128792417|NCT01307267|463534163|FG012|Overall Study|Lost to Follow-up|0|||
128792418|NCT01307267|463534164|FG013|Overall Study|Lost to Follow-up|0|||
128792419|NCT01307267|463534165|FG014|Overall Study|Lost to Follow-up|0|||
128792420|NCT01307267|463534166|FG015|Overall Study|Lost to Follow-up|0|||
128792421|NCT01307267|463534167|FG016|Overall Study|Lost to Follow-up|0|||
128792422|NCT01307267|463534168|FG017|Overall Study|Lost to Follow-up|0|||
128792423|NCT01307267|463534169|FG018|Overall Study|Lost to Follow-up|0|||
128792424|NCT01307267|463534170|FG019|Overall Study|Lost to Follow-up|2|||
128792425|NCT01307267|463534171|FG020|Overall Study|Lost to Follow-up|0|||
128792426|NCT01307267|463534172|FG021|Overall Study|Lost to Follow-up|0|||
128792427|NCT01307267|463534173|FG022|Overall Study|Lost to Follow-up|0|||
128792428|NCT01307267|463534151|FG000|Overall Study|Withdrawal by Subject|0|||
128792429|NCT01307267|463534152|FG001|Overall Study|Withdrawal by Subject|0|||
128792430|NCT01307267|463534153|FG002|Overall Study|Withdrawal by Subject|0|||
128792431|NCT01307267|463534154|FG003|Overall Study|Withdrawal by Subject|0|||
128792432|NCT01307267|463534155|FG004|Overall Study|Withdrawal by Subject|0|||
128792433|NCT01307267|463534156|FG005|Overall Study|Withdrawal by Subject|1|||
128792434|NCT01307267|463534157|FG006|Overall Study|Withdrawal by Subject|0|||
128792435|NCT01307267|463534158|FG007|Overall Study|Withdrawal by Subject|1|||
128792436|NCT01307267|463534159|FG008|Overall Study|Withdrawal by Subject|5|||
128792437|NCT01307267|463534160|FG009|Overall Study|Withdrawal by Subject|1|||
128792438|NCT01307267|463534161|FG010|Overall Study|Withdrawal by Subject|1|||
128792439|NCT01307267|463534162|FG011|Overall Study|Withdrawal by Subject|1|||
128792440|NCT01307267|463534163|FG012|Overall Study|Withdrawal by Subject|0|||
128792441|NCT01307267|463534164|FG013|Overall Study|Withdrawal by Subject|0|||
128792442|NCT01307267|463534165|FG014|Overall Study|Withdrawal by Subject|0|||
128792443|NCT01307267|463534166|FG015|Overall Study|Withdrawal by Subject|0|||
128792444|NCT01307267|463534167|FG016|Overall Study|Withdrawal by Subject|0|||
128792445|NCT01307267|463534168|FG017|Overall Study|Withdrawal by Subject|0|||
128792446|NCT01307267|463534169|FG018|Overall Study|Withdrawal by Subject|0|||
128792447|NCT01307267|463534170|FG019|Overall Study|Withdrawal by Subject|3|||
128792448|NCT01307267|463534171|FG020|Overall Study|Withdrawal by Subject|0|||
128792449|NCT01307267|463534172|FG021|Overall Study|Withdrawal by Subject|0|||
128792450|NCT01307267|463534173|FG022|Overall Study|Withdrawal by Subject|0|||
128792451|NCT01307267|463534151|FG000|Overall Study|Other|0|||
128792452|NCT01307267|463534152|FG001|Overall Study|Other|0|||
128792453|NCT01307267|463534153|FG002|Overall Study|Other|0|||
128792454|NCT01307267|463534154|FG003|Overall Study|Other|0|||
128792455|NCT01307267|463534155|FG004|Overall Study|Other|0|||
128792456|NCT01307267|463534156|FG005|Overall Study|Other|7|||
128792457|NCT01307267|463534157|FG006|Overall Study|Other|0|||
128792458|NCT01307267|463534158|FG007|Overall Study|Other|1|||
128792459|NCT01307267|463534159|FG008|Overall Study|Other|3|||
128792460|NCT01307267|463534160|FG009|Overall Study|Other|0|||
128792461|NCT01307267|463534161|FG010|Overall Study|Other|1|||
128792462|NCT01307267|463534162|FG011|Overall Study|Other|1|||
128792463|NCT01307267|463534163|FG012|Overall Study|Other|1|||
128792464|NCT01307267|463534164|FG013|Overall Study|Other|0|||
128792465|NCT01307267|463534165|FG014|Overall Study|Other|2|||
128792466|NCT01307267|463534166|FG015|Overall Study|Other|1|||
128792467|NCT01307267|463534167|FG016|Overall Study|Other|0|||
128792468|NCT01307267|463534168|FG017|Overall Study|Other|0|||
128792469|NCT01307267|463534169|FG018|Overall Study|Other|0|||
128792470|NCT01307267|463534170|FG019|Overall Study|Other|19|||
128792471|NCT01307267|463534171|FG020|Overall Study|Other|2|||
128792472|NCT01307267|463534172|FG021|Overall Study|Other|3|||
128792473|NCT01307267|463534173|FG022|Overall Study|Other|2|||
128792474|NCT04956575|463534174|FG000|Overall Study|Death|1|||
128792475|NCT04956575|463534175|FG001|Overall Study|Death|0|||
128792476|NCT04956575|463534176|FG002|Overall Study|Death|0|||
128792477|NCT04956575|463534177|FG003|Overall Study|Death|0|||
128792478|NCT04956575|463534178|FG004|Overall Study|Death|0|||
128792479|NCT04956575|463534179|FG005|Overall Study|Death|0|||
128792480|NCT04956575|463534180|FG006|Overall Study|Death|0|||
128792481|NCT04956575|463534181|FG007|Overall Study|Death|1|||
128792482|NCT04956575|463534182|FG008|Overall Study|Death|0|||
128792483|NCT04956575|463534183|FG009|Overall Study|Death|1|||
128792484|NCT04956575|463534184|FG010|Overall Study|Death|0|||
128792485|NCT04956575|463534185|FG011|Overall Study|Death|0|||
128792486|NCT04956575|463534174|FG000|Overall Study|Lost to Follow-up|3|||
128792487|NCT04956575|463534175|FG001|Overall Study|Lost to Follow-up|4|||
128792488|NCT04956575|463534176|FG002|Overall Study|Lost to Follow-up|2|||
128792489|NCT04956575|463534177|FG003|Overall Study|Lost to Follow-up|3|||
128792490|NCT04956575|463534178|FG004|Overall Study|Lost to Follow-up|1|||
128792491|NCT04956575|463534179|FG005|Overall Study|Lost to Follow-up|10|||
128792492|NCT04956575|463534180|FG006|Overall Study|Lost to Follow-up|11|||
128792493|NCT04956575|463534181|FG007|Overall Study|Lost to Follow-up|7|||
128792494|NCT04956575|463534182|FG008|Overall Study|Lost to Follow-up|4|||
128792495|NCT04956575|463534183|FG009|Overall Study|Lost to Follow-up|2|||
128792496|NCT04956575|463534184|FG010|Overall Study|Lost to Follow-up|3|||
128792497|NCT04956575|463534185|FG011|Overall Study|Lost to Follow-up|8|||
128792498|NCT04956575|463534174|FG000|Overall Study|Withdrawal by Subject|1|||
128792499|NCT04956575|463534175|FG001|Overall Study|Withdrawal by Subject|2|||
128792500|NCT04956575|463534176|FG002|Overall Study|Withdrawal by Subject|1|||
128792501|NCT04956575|463534177|FG003|Overall Study|Withdrawal by Subject|4|||
128792502|NCT04956575|463534178|FG004|Overall Study|Withdrawal by Subject|2|||
128792503|NCT04956575|463534179|FG005|Overall Study|Withdrawal by Subject|8|||
128792504|NCT04956575|463534180|FG006|Overall Study|Withdrawal by Subject|5|||
128792505|NCT04956575|463534181|FG007|Overall Study|Withdrawal by Subject|1|||
128792506|NCT04956575|463534182|FG008|Overall Study|Withdrawal by Subject|1|||
128792507|NCT04956575|463534183|FG009|Overall Study|Withdrawal by Subject|0|||
128792508|NCT04956575|463534184|FG010|Overall Study|Withdrawal by Subject|3|||
128792509|NCT04956575|463534185|FG011|Overall Study|Withdrawal by Subject|1|||
128792510|NCT03593876|463534186|FG000|Overall Study|Withdrawal by Subject|1|||
128792511|NCT03593876|463534186|FG000|Overall Study|Discharged home before intervention completion|2|||
128792512|NCT00814346|463534192|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
128792513|NCT00814346|463534193|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
128792514|NCT00814346|463534192|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
128792515|NCT00814346|463534193|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
128792516|NCT00814346|463534192|FG000|Open Phase (17 Months)|Adverse Event|5|||
128792517|NCT00814346|463534193|FG001|Open Phase (17 Months)|Adverse Event|0|||
128792518|NCT00814346|463534192|FG000|Open Phase (17 Months)|Consent|2|||
128792519|NCT00814346|463534193|FG001|Open Phase (17 Months)|Consent|0|||
128792520|NCT00814346|463534192|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
128792521|NCT00814346|463534193|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
128792522|NCT00814346|463534192|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
128792523|NCT00814346|463534193|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
128792524|NCT03622580|463534199|FG000|Overall Study|Death|16|||
128792525|NCT03622580|463534200|FG001|Overall Study|Death|21|||
128792526|NCT03622580|463534201|FG002|Overall Study|Death|13|||
128792527|NCT03622580|463534199|FG000|Overall Study|Adverse Event|6|||
128792528|NCT03622580|463534200|FG001|Overall Study|Adverse Event|6|||
128792529|NCT03622580|463534201|FG002|Overall Study|Adverse Event|5|||
128792530|NCT03622580|463534199|FG000|Overall Study|Withdrawal by Subject|12|||
128792531|NCT03622580|463534200|FG001|Overall Study|Withdrawal by Subject|7|||
128792532|NCT03622580|463534201|FG002|Overall Study|Withdrawal by Subject|19|||
128792533|NCT03622580|463534199|FG000|Overall Study|Lost to Follow-up|12|||
128792534|NCT03622580|463534200|FG001|Overall Study|Lost to Follow-up|9|||
128792535|NCT03622580|463534201|FG002|Overall Study|Lost to Follow-up|9|||
128792536|NCT03622580|463534199|FG000|Overall Study|Protocol Violation|1|||
128792537|NCT03622580|463534200|FG001|Overall Study|Protocol Violation|0|||
128792538|NCT03622580|463534201|FG002|Overall Study|Protocol Violation|1|||
128792539|NCT03622580|463534199|FG000|Overall Study|Physician Decision|3|||
128792540|NCT03622580|463534200|FG001|Overall Study|Physician Decision|0|||
128792541|NCT03622580|463534201|FG002|Overall Study|Physician Decision|1|||
128792542|NCT03622580|463534199|FG000|Overall Study|Pregnancy|0|||
128792543|NCT03622580|463534200|FG001|Overall Study|Pregnancy|1|||
128792544|NCT03622580|463534201|FG002|Overall Study|Pregnancy|0|||
128792545|NCT03622580|463534199|FG000|Overall Study|Lack of Efficacy|0|||
128792546|NCT03622580|463534200|FG001|Overall Study|Lack of Efficacy|0|||
128792547|NCT03622580|463534201|FG002|Overall Study|Lack of Efficacy|1|||
128792548|NCT03622580|463534199|FG000|Overall Study|Other|2|||
128792549|NCT03622580|463534200|FG001|Overall Study|Other|0|||
128792550|NCT03622580|463534201|FG002|Overall Study|Other|3|||
128792551|NCT05136443|463534202|FG000|Overall Study|Lost to Follow-up|2|||
128792552|NCT05136443|463534202|FG000|Overall Study|Adverse Event|2|||
128792553|NCT02613871|463534207|FG000|Overall Study|Death|2|||
128792554|NCT02613871|463534207|FG000|Overall Study|Withdrew Consent|1|||
128792555|NCT00494442|463534208|FG000|Overall Study|Death|1|||
128792556|NCT00494442|463534209|FG001|Overall Study|Death|1|||
128792557|NCT00494442|463534208|FG000|Overall Study|Lack of Efficacy|16|||
128792558|NCT00494442|463534209|FG001|Overall Study|Lack of Efficacy|10|||
128792559|NCT00494442|463534208|FG000|Overall Study|Adverse Event|0|||
128792560|NCT00494442|463534209|FG001|Overall Study|Adverse Event|2|||
128792561|NCT00494442|463534208|FG000|Overall Study|Physician Decision|0|||
128792562|NCT00494442|463534209|FG001|Overall Study|Physician Decision|1|||
128792563|NCT00494442|463534208|FG000|Overall Study|Non-compliance|0|||
128792564|NCT00494442|463534209|FG001|Overall Study|Non-compliance|1|||
128792565|NCT00494442|463534208|FG000|Overall Study|Intercurrent illness|0|||
128792566|NCT00494442|463534209|FG001|Overall Study|Intercurrent illness|1|||
128792567|NCT00831415|463534212|FG000|Overall Study|Adverse Event|14|||
128792568|NCT00831415|463534212|FG000|Overall Study|Failed to return|3|||
128792569|NCT00831415|463534212|FG000|Overall Study|Physician Decision|6|||
128792570|NCT00831415|463534212|FG000|Overall Study|Lost to Follow-up|9|||
128792571|NCT00831415|463534212|FG000|Overall Study|Protocol Violation|3|||
128792572|NCT00831415|463534212|FG000|Overall Study|Withdrawal by Subject|35|||
128792573|NCT00831415|463534212|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
128792574|NCT00831415|463534212|FG000|Overall Study|Death|1|||
128792575|NCT03034915|463534215|FG000|Overall Study|Adverse Event|29|||
128792576|NCT03034915|463534216|FG001|Overall Study|Adverse Event|32|||
128792577|NCT03034915|463534217|FG002|Overall Study|Adverse Event|22|||
128792578|NCT03034915|463534215|FG000|Overall Study|Lost to Follow-up|5|||
128792579|NCT03034915|463534216|FG001|Overall Study|Lost to Follow-up|13|||
128792580|NCT03034915|463534217|FG002|Overall Study|Lost to Follow-up|3|||
128792581|NCT03034915|463534215|FG000|Overall Study|Withdrawal by Subject|29|||
128792582|NCT03034915|463534216|FG001|Overall Study|Withdrawal by Subject|46|||
128792583|NCT03034915|463534217|FG002|Overall Study|Withdrawal by Subject|41|||
128792584|NCT03034915|463534215|FG000|Overall Study|Protocol Deviation|2|||
128792585|NCT03034915|463534216|FG001|Overall Study|Protocol Deviation|14|||
128792586|NCT03034915|463534217|FG002|Overall Study|Protocol Deviation|7|||
128792587|NCT03034915|463534215|FG000|Overall Study|Lack of Efficacy|8|||
128792588|NCT03034915|463534216|FG001|Overall Study|Lack of Efficacy|16|||
128792589|NCT03034915|463534217|FG002|Overall Study|Lack of Efficacy|18|||
128792590|NCT03034915|463534215|FG000|Overall Study|Site closed|2|||
128792591|NCT03034915|463534216|FG001|Overall Study|Site closed|2|||
128792592|NCT03034915|463534217|FG002|Overall Study|Site closed|4|||
128792593|NCT03034915|463534215|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
128792594|NCT03034915|463534216|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
128792595|NCT03034915|463534217|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
128792596|NCT03034915|463534215|FG000|Overall Study|Physician Decision|1|||
128792597|NCT03034915|463534216|FG001|Overall Study|Physician Decision|5|||
128792598|NCT03034915|463534217|FG002|Overall Study|Physician Decision|2|||
128792599|NCT03861767|463534220|FG000|Overall Study|Withdrawal by Subject|2|||
128792600|NCT03861767|463534221|FG001|Overall Study|Withdrawal by Subject|1|||
128792601|NCT03861767|463534222|FG002|Overall Study|Withdrawal by Subject|0|||
128792602|NCT03861767|463534223|FG003|Overall Study|Withdrawal by Subject|5|||
128792603|NCT03861767|463534224|FG004|Overall Study|Withdrawal by Subject|2|||
128792604|NCT03861767|463534225|FG005|Overall Study|Withdrawal by Subject|1|||
128792605|NCT03861767|463534226|FG006|Overall Study|Withdrawal by Subject|3|||
128792606|NCT03861767|463534227|FG007|Overall Study|Withdrawal by Subject|1|||
128792607|NCT03861767|463534228|FG008|Overall Study|Withdrawal by Subject|0|||
128792608|NCT03861767|463534229|FG009|Overall Study|Withdrawal by Subject|5|||
128792609|NCT00346333|463534230|FG000|Overall Study|Death|1|||
128792610|NCT00346333|463534231|FG001|Overall Study|Death|0|||
128792611|NCT00346333|463534230|FG000|Overall Study|unwilling or unable to continue|4|||
128792612|NCT00346333|463534231|FG001|Overall Study|unwilling or unable to continue|8|||
128792613|NCT00813904|463534232|FG000|Overall Study|Death|1|||
128792614|NCT01087762|463534233|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
128792615|NCT01087762|463534234|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
128792616|NCT01087762|463534235|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
128792617|NCT01087762|463534236|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
128792618|NCT01087762|463534237|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
128792619|NCT01087762|463534233|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
128792620|NCT01087762|463534234|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
128792621|NCT01087762|463534235|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
128792622|NCT01087762|463534236|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
128792623|NCT01087762|463534237|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
128792624|NCT01087762|463534233|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
128792625|NCT01087762|463534234|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
128792626|NCT01087762|463534235|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
128792627|NCT01087762|463534236|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
128792628|NCT01087762|463534237|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
128792629|NCT01087762|463534233|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
128792630|NCT01087762|463534234|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
128792631|NCT01087762|463534235|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
128792632|NCT01087762|463534236|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
128792633|NCT01087762|463534237|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
128792634|NCT01087762|463534233|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
128792635|NCT01087762|463534234|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
128792636|NCT01087762|463534235|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
128792637|NCT01087762|463534236|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
128792638|NCT01087762|463534237|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
128792639|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
128792640|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
128792641|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
128792642|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
128758817|NCT03419364|463405326|FG002|Overall Study|Delivery due to maternal condition|0|||
128758818|NCT01338025|463405330|FG000|Overall Study|Unexpected closure of study|10|||
128792643|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
128792644|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
128792645|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
128792646|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
128792647|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
128792648|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
128792649|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
128792650|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
128792651|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
128792652|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
128792653|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
128792654|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
128792655|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
128792656|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
128792657|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
128792658|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
128792659|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
128792660|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
128792661|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
128792662|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
128792663|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
128792664|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
128792665|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
128792666|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
128792667|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
128792668|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
128792669|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
128792670|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
128792671|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
128792672|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
128792673|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
128792674|NCT01087762|463534233|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
128792675|NCT01087762|463534234|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
128792676|NCT01087762|463534235|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
128792677|NCT01087762|463534236|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
128792678|NCT01087762|463534237|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
128792679|NCT00424762|463534243|FG000|Overall Study|Withdrawal by Subject|18|||
128792680|NCT00424762|463534244|FG001|Overall Study|Withdrawal by Subject|19|||
128792681|NCT00424762|463534243|FG000|Overall Study|Lost to Follow-up|2|||
128792682|NCT00424762|463534244|FG001|Overall Study|Lost to Follow-up|3|||
128792683|NCT01405924|463534247|FG000|Overall Study|Protocol Violation|8|||
128792684|NCT01405924|463534247|FG000|Overall Study|Missing/Incomplete Data|2|||
128792685|NCT01147341|463534253|FG000|Double Blind Period|Lack of Efficacy|1|||
128792686|NCT01147341|463534254|FG001|Double Blind Period|Lack of Efficacy|1|||
128792687|NCT01147341|463534253|FG000|Double Blind Period|Withdrawal by Subject|0|||
128792688|NCT01147341|463534254|FG001|Double Blind Period|Withdrawal by Subject|1|||
128792689|NCT01147341|463534253|FG000|Open Label Period|Lack of Efficacy|3|||
128792690|NCT01147341|463534254|FG001|Open Label Period|Lack of Efficacy|0|||
128792691|NCT01147341|463534253|FG000|Open Label Period|Subject moved|1|||
128792692|NCT01147341|463534254|FG001|Open Label Period|Subject moved|0|||
128792693|NCT03478696|463534255|FG000|Overall Study|Adverse Event|1|||
128792694|NCT03478696|463534256|FG001|Overall Study|Adverse Event|5|||
128792695|NCT03478696|463534255|FG000|Overall Study|Lost to Follow-up|1|||
128792696|NCT03478696|463534256|FG001|Overall Study|Lost to Follow-up|0|||
128792697|NCT03478696|463534255|FG000|Overall Study|Physician Decision|6|||
128792698|NCT03478696|463534256|FG001|Overall Study|Physician Decision|3|||
128792699|NCT03478696|463534255|FG000|Overall Study|Withdrawal by Subject|9|||
128792700|NCT03478696|463534256|FG001|Overall Study|Withdrawal by Subject|4|||
128792701|NCT03615924|463534257|FG000|Overall Study|Withdrawal by Subject|2|||
128792702|NCT03615924|463534258|FG001|Overall Study|Withdrawal by Subject|5|||
128792703|NCT03615924|463534257|FG000|Overall Study|Death|3|||
128792704|NCT03615924|463534258|FG001|Overall Study|Death|1|||
128792705|NCT03615924|463534257|FG000|Overall Study|Lost to Follow-up|1|||
128792706|NCT03615924|463534258|FG001|Overall Study|Lost to Follow-up|0|||
128792707|NCT03615924|463534257|FG000|Overall Study|Randomized in error|1|||
128792708|NCT03615924|463534258|FG001|Overall Study|Randomized in error|0|||
128792709|NCT03615924|463534257|FG000|Overall Study|Study termination by Sponsor|94|||
128792710|NCT03615924|463534258|FG001|Overall Study|Study termination by Sponsor|86|||
128792711|NCT00790790|463534270|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
128792712|NCT00790790|463534271|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
128792713|NCT00790790|463534272|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
128792714|NCT00790790|463534270|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
128792715|NCT00790790|463534271|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
128792716|NCT00790790|463534272|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
128792717|NCT00790790|463534270|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
128792718|NCT00790790|463534271|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
128792719|NCT00790790|463534272|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
128792720|NCT00790790|463534270|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
128792721|NCT00790790|463534271|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
128792722|NCT00790790|463534272|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
128792723|NCT00790790|463534270|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
128792724|NCT00790790|463534271|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
128792725|NCT00790790|463534272|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
128792726|NCT02808338|463534273|FG000|Screening|Screen Failure|10|||
128792727|NCT02808338|463534273|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
128792728|NCT02808338|463534273|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
128792729|NCT00057837|463534274|FG000|Overall Study|Progression/relapse|12|||
128792730|NCT00057837|463534275|FG001|Overall Study|Progression/relapse|14|||
128792731|NCT00057837|463534274|FG000|Overall Study|Adverse Event|2|||
128792732|NCT00057837|463534275|FG001|Overall Study|Adverse Event|12|||
128792733|NCT00057837|463534274|FG000|Overall Study|Death|5|||
128792734|NCT00057837|463534275|FG001|Overall Study|Death|4|||
128792735|NCT00057837|463534274|FG000|Overall Study|Withdrawal by Subject|5|||
128792736|NCT00057837|463534275|FG001|Overall Study|Withdrawal by Subject|3|||
128792737|NCT00057837|463534274|FG000|Overall Study|Alternative therapy|0|||
128792738|NCT00057837|463534275|FG001|Overall Study|Alternative therapy|1|||
128792739|NCT00057837|463534274|FG000|Overall Study|Other complicating disease|2|||
128792740|NCT00057837|463534275|FG001|Overall Study|Other complicating disease|1|||
128792741|NCT00057837|463534274|FG000|Overall Study|Physician Decision|1|||
128792742|NCT00057837|463534275|FG001|Overall Study|Physician Decision|0|||
128792743|NCT00057837|463534274|FG000|Overall Study|Ineligible|3|||
128792744|NCT00057837|463534275|FG001|Overall Study|Ineligible|3|||
128792745|NCT00057837|463534274|FG000|Overall Study|Never started treatment|1|||
128792746|NCT00057837|463534275|FG001|Overall Study|Never started treatment|1|||
128792747|NCT02537522|463534276|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
128792748|NCT02537522|463534277|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
128792749|NCT02537522|463534278|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
128792750|NCT02537522|463534279|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
128792751|NCT02537522|463534276|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
128792752|NCT02537522|463534277|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
128792753|NCT02537522|463534278|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
128792754|NCT02537522|463534279|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
128792755|NCT02537522|463534276|FG000|Phase I - Contralateral|incorrect randomization|0|||
128792756|NCT02537522|463534277|FG001|Phase I - Contralateral|incorrect randomization|1|||
128792757|NCT02537522|463534278|FG002|Phase I - Contralateral|incorrect randomization|0|||
128792758|NCT02537522|463534279|FG003|Phase I - Contralateral|incorrect randomization|0|||
128792759|NCT02537522|463534276|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
128792760|NCT02537522|463534277|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
128792761|NCT02537522|463534278|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
128792762|NCT02537522|463534279|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
128792763|NCT02537522|463534276|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
128792764|NCT02537522|463534277|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
128792765|NCT02537522|463534278|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
128792766|NCT02537522|463534279|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
128792767|NCT02570711|463534281|FG000|Overall Study|Death|1|||
128792768|NCT02570711|463534282|FG001|Overall Study|Death|0|||
128792769|NCT02570711|463534281|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
128792770|NCT02570711|463534282|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
128792771|NCT00094575|463534283|FG000|Overall Study|Death|146|||
128792772|NCT00094575|463534284|FG001|Overall Study|Death|146|||
128792773|NCT00961636|463534286|FG000|Overall Study|Adverse Event|35|||
128792774|NCT00961636|463534287|FG001|Overall Study|Adverse Event|54|||
128792775|NCT00961636|463534288|FG002|Overall Study|Adverse Event|13|||
128792776|NCT00961636|463534286|FG000|Overall Study|Flushing Symptoms|29|||
128792777|NCT00961636|463534287|FG001|Overall Study|Flushing Symptoms|46|||
128792778|NCT00961636|463534288|FG002|Overall Study|Flushing Symptoms|3|||
128792779|NCT00961636|463534286|FG000|Overall Study|Lost to Follow-up|2|||
128792780|NCT00961636|463534287|FG001|Overall Study|Lost to Follow-up|3|||
128792781|NCT00961636|463534288|FG002|Overall Study|Lost to Follow-up|1|||
128792782|NCT00961636|463534286|FG000|Overall Study|Physician Decision|3|||
128792783|NCT00961636|463534287|FG001|Overall Study|Physician Decision|1|||
128792784|NCT00961636|463534288|FG002|Overall Study|Physician Decision|1|||
128792785|NCT00961636|463534286|FG000|Overall Study|Protocol Violation|9|||
128792786|NCT00961636|463534287|FG001|Overall Study|Protocol Violation|5|||
128792787|NCT00961636|463534288|FG002|Overall Study|Protocol Violation|1|||
128792788|NCT00961636|463534286|FG000|Overall Study|Withdrawal by Subject|29|||
128792789|NCT00961636|463534287|FG001|Overall Study|Withdrawal by Subject|22|||
128792790|NCT00961636|463534288|FG002|Overall Study|Withdrawal by Subject|13|||
128792791|NCT05328297|463535724|FG000|Overall Study|Adverse Event|5|||
128792792|NCT05328297|463535725|FG001|Overall Study|Adverse Event|7|||
128792793|NCT05328297|463535724|FG000|Overall Study|Withdrawal by Subject|4|||
128792794|NCT05328297|463535725|FG001|Overall Study|Withdrawal by Subject|3|||
128792795|NCT05328297|463535724|FG000|Overall Study|Lack of Efficacy|1|||
128792796|NCT05328297|463535725|FG001|Overall Study|Lack of Efficacy|0|||
128792797|NCT05328297|463535724|FG000|Overall Study|Lost to Follow-up|1|||
128792798|NCT05328297|463535725|FG001|Overall Study|Lost to Follow-up|0|||
128792799|NCT05328297|463535724|FG000|Overall Study|Protocol Violation|1|||
128792800|NCT05328297|463535725|FG001|Overall Study|Protocol Violation|0|||
128792801|NCT05328297|463535724|FG000|Overall Study|Randomized but not treated|1|||
128792802|NCT05328297|463535725|FG001|Overall Study|Randomized but not treated|1|||
128792803|NCT01393119|463535729|FG000|Overall Study|Adverse Event|1|||
128792804|NCT01393119|463535730|FG001|Overall Study|Adverse Event|1|||
128792805|NCT01393119|463535731|FG002|Overall Study|Adverse Event|0|||
128792806|NCT01393119|463535732|FG003|Overall Study|Adverse Event|1|||
128792807|NCT01393119|463535729|FG000|Overall Study|Withdrawal by Subject|0|||
128792808|NCT01393119|463535730|FG001|Overall Study|Withdrawal by Subject|1|||
128792809|NCT01393119|463535731|FG002|Overall Study|Withdrawal by Subject|1|||
128792810|NCT01393119|463535732|FG003|Overall Study|Withdrawal by Subject|0|||
128792811|NCT01393119|463535729|FG000|Overall Study|Lack of Efficacy|1|||
128792812|NCT01393119|463535730|FG001|Overall Study|Lack of Efficacy|0|||
128792813|NCT01393119|463535731|FG002|Overall Study|Lack of Efficacy|2|||
128792814|NCT01393119|463535732|FG003|Overall Study|Lack of Efficacy|1|||
128792815|NCT01393119|463535729|FG000|Overall Study|Protocol Violation|0|||
128792816|NCT01393119|463535730|FG001|Overall Study|Protocol Violation|0|||
128792817|NCT01393119|463535731|FG002|Overall Study|Protocol Violation|1|||
128792818|NCT01393119|463535732|FG003|Overall Study|Protocol Violation|0|||
128792819|NCT01393119|463535729|FG000|Overall Study|Death|0|||
128792820|NCT01393119|463535730|FG001|Overall Study|Death|0|||
128792821|NCT01393119|463535731|FG002|Overall Study|Death|0|||
128792822|NCT01393119|463535732|FG003|Overall Study|Death|1|||
128792823|NCT01393119|463535729|FG000|Overall Study|Randomized but Not treated|1|||
128792824|NCT01393119|463535730|FG001|Overall Study|Randomized but Not treated|0|||
128792825|NCT01393119|463535731|FG002|Overall Study|Randomized but Not treated|1|||
128792826|NCT01393119|463535732|FG003|Overall Study|Randomized but Not treated|1|||
128792827|NCT01393119|463535729|FG000|Overall Study|Sponsor Termination of Study|11|||
128792828|NCT01393119|463535730|FG001|Overall Study|Sponsor Termination of Study|12|||
128792829|NCT01393119|463535731|FG002|Overall Study|Sponsor Termination of Study|9|||
128792830|NCT01393119|463535732|FG003|Overall Study|Sponsor Termination of Study|12|||
128792831|NCT02544152|463535733|FG000|Overall Study|Adverse Event|0|||
128792832|NCT02544152|463535734|FG001|Overall Study|Adverse Event|4|||
128792833|NCT02544152|463535733|FG000|Overall Study|Withdrawal by Subject|0|||
128792834|NCT02544152|463535734|FG001|Overall Study|Withdrawal by Subject|3|||
128792835|NCT02544152|463535733|FG000|Overall Study|Other|1|||
128792836|NCT02544152|463535734|FG001|Overall Study|Other|0|||
128792837|NCT01759264|463535737|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
128792838|NCT01759264|463535737|FG000|Overall Study|Adverse Event|1|||
128792839|NCT01759264|463535737|FG000|Overall Study|Other|2|||
128792840|NCT01759264|463535737|FG000|Overall Study|Lost to Follow-up|2|||
128792841|NCT01759264|463535737|FG000|Overall Study|Withdrawal by Subject|3|||
128792842|NCT01759264|463535737|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
128792843|NCT02015546|463535739|FG000|Overall Study|Withdrawal by Subject|1|||
128792844|NCT02015546|463535740|FG001|Overall Study|Withdrawal by Subject|1|||
128792845|NCT02015546|463535741|FG002|Overall Study|Withdrawal by Subject|1|||
128792846|NCT02015546|463535739|FG000|Overall Study|Screem Failure|2|||
128792847|NCT02015546|463535740|FG001|Overall Study|Screem Failure|1|||
128792848|NCT02015546|463535741|FG002|Overall Study|Screem Failure|3|||
128792849|NCT01426269|463535742|FG000|Period 1: 12 Weeks|Adverse Event|5|||
128792850|NCT01426269|463535743|FG001|Period 1: 12 Weeks|Adverse Event|0|||
128792851|NCT01426269|463535744|FG002|Period 1: 12 Weeks|Adverse Event|0|||
128792852|NCT01426269|463535742|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
128792853|NCT01426269|463535743|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
128792854|NCT01426269|463535744|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
128792855|NCT01426269|463535742|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
128792856|NCT01426269|463535743|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
128792857|NCT01426269|463535744|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
128792858|NCT01426269|463535742|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
128792859|NCT01426269|463535743|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
128792860|NCT01426269|463535744|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
128792861|NCT01426269|463535742|FG000|Period 1: 12 Weeks|Pregnancy|1|||
128792862|NCT01426269|463535743|FG001|Period 1: 12 Weeks|Pregnancy|0|||
128792863|NCT01426269|463535744|FG002|Period 1: 12 Weeks|Pregnancy|0|||
128792864|NCT01426269|463535742|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
128792865|NCT01426269|463535743|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
128792866|NCT01426269|463535744|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
128792867|NCT01426269|463535742|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
128792868|NCT01426269|463535743|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
128792869|NCT01426269|463535744|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
128792870|NCT01426269|463535742|FG000|Period 2: 40 Weeks|Adverse Event|0|||
128792871|NCT01426269|463535743|FG001|Period 2: 40 Weeks|Adverse Event|1|||
128792872|NCT01426269|463535744|FG002|Period 2: 40 Weeks|Adverse Event|2|||
128792873|NCT01426269|463535742|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
128792874|NCT01426269|463535743|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
128792875|NCT01426269|463535744|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
128792876|NCT01426269|463535742|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
128792877|NCT01426269|463535743|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
128792878|NCT01426269|463535744|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
128792879|NCT01426269|463535742|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
128792880|NCT01426269|463535743|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
128792881|NCT01426269|463535744|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
128792882|NCT01426269|463535742|FG000|Period 2: 40 Weeks|Site closed|0|||
128792883|NCT01426269|463535743|FG001|Period 2: 40 Weeks|Site closed|6|||
128792884|NCT01426269|463535744|FG002|Period 2: 40 Weeks|Site closed|5|||
128792885|NCT01426269|463535742|FG000|Period 2: 40 Weeks|Relapsed|0|||
128792886|NCT01426269|463535743|FG001|Period 2: 40 Weeks|Relapsed|9|||
128792887|NCT01426269|463535744|FG002|Period 2: 40 Weeks|Relapsed|18|||
128792888|NCT00186186|463535748|FG000|Overall Study|Lack of Efficacy|3|||
128792889|NCT00186186|463535748|FG000|Overall Study|Withdrawal by Subject|3|||
128792890|NCT00186186|463535748|FG000|Overall Study|Not reported as to reason|2|||
128792891|NCT02567656|463535751|FG000|Overall Study|Premature discontinuation due to PD|1|||
128792892|NCT02567656|463535752|FG001|Overall Study|Premature discontinuation due to PD|1|||
128792893|NCT02567656|463535753|FG002|Overall Study|Premature discontinuation due to PD|2|||
128792894|NCT02567656|463535754|FG003|Overall Study|Premature discontinuation due to PD|0|||
128792895|NCT02567656|463535755|FG004|Overall Study|Premature discontinuation due to PD|0|||
128792896|NCT02567656|463535756|FG005|Overall Study|Premature discontinuation due to PD|0|||
128792897|NCT00367991|463535761|FG000|Overall Study|Withdrawal by Subject|1|||
128792898|NCT00367991|463535762|FG001|Overall Study|Withdrawal by Subject|1|||
128792899|NCT00367991|463535761|FG000|Overall Study|Adverse Event|1|||
128792900|NCT00367991|463535762|FG001|Overall Study|Adverse Event|1|||
128792901|NCT00463788|463535765|FG000|Overall Study|Progressive Disease|86|||
128792902|NCT00463788|463535766|FG001|Overall Study|Progressive Disease|42|||
128792903|NCT00463788|463535765|FG000|Overall Study|Adverse Event|6|||
128792904|NCT00463788|463535766|FG001|Overall Study|Adverse Event|2|||
128792905|NCT00463788|463535765|FG000|Overall Study|Withdrawal by Subject|6|||
128792906|NCT00463788|463535766|FG001|Overall Study|Withdrawal by Subject|2|||
128792907|NCT00463788|463535765|FG000|Overall Study|Death|4|||
128792908|NCT00463788|463535766|FG001|Overall Study|Death|3|||
128792909|NCT00463788|463535765|FG000|Overall Study|Symptomatic Deterioration|2|||
128792910|NCT00463788|463535766|FG001|Overall Study|Symptomatic Deterioration|3|||
128792911|NCT00463788|463535765|FG000|Overall Study|Lost to Follow-up|1|||
128792912|NCT00463788|463535766|FG001|Overall Study|Lost to Follow-up|0|||
128792913|NCT00463788|463535765|FG000|Overall Study|Protocol Violation|0|||
128792914|NCT00463788|463535766|FG001|Overall Study|Protocol Violation|1|||
128792915|NCT00463788|463535765|FG000|Overall Study|Other|3|||
128792916|NCT00463788|463535766|FG001|Overall Study|Other|0|||
128792917|NCT00463788|463535765|FG000|Overall Study|Randomized but not treated|1|||
128792918|NCT00463788|463535766|FG001|Overall Study|Randomized but not treated|1|||
128792919|NCT00360698|463535767|FG000|Run-In|Physician Decision|0|||
128792920|NCT00360698|463535768|FG001|Run-In|Physician Decision|1|||
128792921|NCT00360698|463535767|FG000|Run-In|Withdrawal by Subject|0|||
128792922|NCT00360698|463535768|FG001|Run-In|Withdrawal by Subject|2|||
128792923|NCT00360698|463535767|FG000|Run-In|Non compliance with treatment procedure|0|||
128792924|NCT00360698|463535768|FG001|Run-In|Non compliance with treatment procedure|1|||
128792925|NCT00360698|463535767|FG000|Run-In|Sponsor request|0|||
128792926|NCT00360698|463535768|FG001|Run-In|Sponsor request|2|||
128792927|NCT00360698|463535767|FG000|Run-In|Patient did not meet inclusion criteria|0|||
128792928|NCT00360698|463535768|FG001|Run-In|Patient did not meet inclusion criteria|1|||
128792929|NCT00360698|463535767|FG000|Run-In|Patient personal reasons|0|||
128792930|NCT00360698|463535768|FG001|Run-In|Patient personal reasons|2|||
128792931|NCT00360698|463535767|FG000|Run-In|Need of insulin with meals|0|||
128792932|NCT00360698|463535768|FG001|Run-In|Need of insulin with meals|1|||
128792933|NCT00360698|463535767|FG000|Treatment Period|Non compliance with treatment procedure|1|||
128792934|NCT00360698|463535768|FG001|Treatment Period|Non compliance with treatment procedure|0|||
128792935|NCT00360698|463535767|FG000|Treatment Period|Early termination by error|0|||
128792936|NCT00360698|463535768|FG001|Treatment Period|Early termination by error|1|||
128792937|NCT03024606|463535771|FG000|Overall Study|Withdrawal by Subject|9|||
128792938|NCT03024606|463535772|FG001|Overall Study|Withdrawal by Subject|10|||
128792939|NCT02547922|463535775|FG000|Overall Study|Withdrawal by Subject|9|||
128792940|NCT02547922|463535776|FG001|Overall Study|Withdrawal by Subject|6|||
128792941|NCT02547922|463535777|FG002|Overall Study|Withdrawal by Subject|10|||
128792942|NCT02547922|463535775|FG000|Overall Study|Adverse Event|3|||
128792943|NCT02547922|463535776|FG001|Overall Study|Adverse Event|1|||
128792944|NCT02547922|463535777|FG002|Overall Study|Adverse Event|2|||
128792945|NCT02547922|463535775|FG000|Overall Study|Lost to Follow-up|1|||
128792946|NCT02547922|463535776|FG001|Overall Study|Lost to Follow-up|0|||
128792947|NCT02547922|463535777|FG002|Overall Study|Lost to Follow-up|0|||
128792948|NCT02547922|463535775|FG000|Overall Study|Lack of Efficacy|5|||
128792949|NCT02547922|463535776|FG001|Overall Study|Lack of Efficacy|7|||
128792950|NCT02547922|463535777|FG002|Overall Study|Lack of Efficacy|4|||
128792951|NCT02547922|463535775|FG000|Overall Study|Death|1|||
128792952|NCT02547922|463535776|FG001|Overall Study|Death|0|||
128792953|NCT02547922|463535777|FG002|Overall Study|Death|0|||
128792954|NCT02547922|463535775|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
128792955|NCT02547922|463535776|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
128792956|NCT02547922|463535777|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
128792957|NCT02547922|463535775|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
128792958|NCT02547922|463535776|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
128792959|NCT02547922|463535777|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
128792960|NCT02547922|463535775|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
128792961|NCT02547922|463535776|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
128792962|NCT02547922|463535777|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
128792963|NCT02547922|463535775|FG000|Overall Study|Physician Decision|2|||
128792964|NCT02547922|463535776|FG001|Overall Study|Physician Decision|1|||
128792965|NCT02547922|463535777|FG002|Overall Study|Physician Decision|2|||
128792966|NCT02547922|463535775|FG000|Overall Study|Patients did not receive IP|1|||
128792967|NCT02547922|463535776|FG001|Overall Study|Patients did not receive IP|1|||
128792968|NCT02547922|463535777|FG002|Overall Study|Patients did not receive IP|0|||
128792969|NCT01317420|463535783|FG000|Overall Study|Progressive disease according to RECIST|2|||
128792970|NCT01317420|463535784|FG001|Overall Study|Progressive disease according to RECIST|3|||
128792971|NCT01317420|463535785|FG002|Overall Study|Progressive disease according to RECIST|3|||
128792972|NCT01317420|463535786|FG003|Overall Study|Progressive disease according to RECIST|3|||
128792973|NCT01317420|463535787|FG004|Overall Study|Progressive disease according to RECIST|3|||
128792974|NCT01317420|463535788|FG005|Overall Study|Progressive disease according to RECIST|3|||
128792975|NCT01317420|463535789|FG006|Overall Study|Progressive disease according to RECIST|3|||
128792976|NCT01317420|463535790|FG007|Overall Study|Progressive disease according to RECIST|3|||
128792977|NCT01317420|463535791|FG008|Overall Study|Progressive disease according to RECIST|3|||
128792978|NCT01317420|463535792|FG009|Overall Study|Progressive disease according to RECIST|2|||
128792979|NCT01317420|463535793|FG010|Overall Study|Progressive disease according to RECIST|3|||
128758819|NCT01338025|463405331|FG001|Overall Study|Unexpected closure of study|9|||
128758820|NCT01338025|463405330|FG000|Overall Study|Withdrawal by Subject|0|||
128758821|NCT01338025|463405331|FG001|Overall Study|Withdrawal by Subject|2|||
128758822|NCT01338025|463405330|FG000|Overall Study|Found ineligible after starting|1|||
128758823|NCT01338025|463405331|FG001|Overall Study|Found ineligible after starting|0|||
128758824|NCT04120233|463405332|FG000|Overall Study|Adverse Event|0|||
128758825|NCT04120233|463405333|FG001|Overall Study|Adverse Event|0|||
128758826|NCT04120233|463405334|FG002|Overall Study|Adverse Event|0|||
128758827|NCT04120233|463405335|FG003|Overall Study|Adverse Event|0|||
128758828|NCT04120233|463405336|FG004|Overall Study|Adverse Event|1|||
128758829|NCT04120233|463405337|FG005|Overall Study|Adverse Event|0|||
128758830|NCT02553460|463405341|FG000|Overall Study|Death|3|||
128758831|NCT02553460|463405341|FG000|Overall Study|Withdrawal by Subject|1|||
128758832|NCT02553460|463405341|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
128758833|NCT02553460|463405341|FG000|Overall Study|Relapse or Transplant|14|||
128758834|NCT02553460|463405341|FG000|Overall Study|No response to treatment|2|||
128758835|NCT02553460|463405341|FG000|Overall Study|CAR T cells|2|||
128758836|NCT00939484|463406806|FG000|Overall Study|Progression/Relapse|8|||
128758837|NCT00939484|463406807|FG001|Overall Study|Progression/Relapse|20|||
128758838|NCT00939484|463406808|FG002|Overall Study|Progression/Relapse|3|||
128758839|NCT01224925|463406809|FG000|Overall Study|Lost to Follow-up|3|||
128758840|NCT01224925|463406810|FG001|Overall Study|Lost to Follow-up|2|||
128758841|NCT00245102|463406812|FG000|Overall Study|Not Treated|1|||
128758842|NCT00245102|463406813|FG001|Overall Study|Not Treated|0|||
128758843|NCT00245102|463406814|FG002|Overall Study|Not Treated|1|||
128758844|NCT00245102|463406815|FG003|Overall Study|Not Treated|0|||
128758845|NCT00245102|463406816|FG004|Overall Study|Not Treated|0|||
128758846|NCT00245102|463406817|FG005|Overall Study|Not Treated|0|||
128758847|NCT00245102|463406812|FG000|Overall Study|Protocol Violation|1|||
128758848|NCT00245102|463406813|FG001|Overall Study|Protocol Violation|0|||
128758849|NCT00245102|463406814|FG002|Overall Study|Protocol Violation|0|||
128758850|NCT00245102|463406815|FG003|Overall Study|Protocol Violation|0|||
128758851|NCT00245102|463406816|FG004|Overall Study|Protocol Violation|0|||
128758852|NCT00245102|463406817|FG005|Overall Study|Protocol Violation|0|||
128758853|NCT00245102|463406812|FG000|Overall Study|Death|0|||
128758854|NCT00245102|463406813|FG001|Overall Study|Death|0|||
128758855|NCT00245102|463406814|FG002|Overall Study|Death|0|||
128758856|NCT00245102|463406815|FG003|Overall Study|Death|1|||
128758857|NCT00245102|463406816|FG004|Overall Study|Death|0|||
128758858|NCT00245102|463406817|FG005|Overall Study|Death|0|||
128758859|NCT00245102|463406812|FG000|Overall Study|Adverse Event|4|||
128758860|NCT00245102|463406813|FG001|Overall Study|Adverse Event|2|||
128758861|NCT00245102|463406814|FG002|Overall Study|Adverse Event|5|||
128758862|NCT00245102|463406815|FG003|Overall Study|Adverse Event|1|||
128758863|NCT00245102|463406816|FG004|Overall Study|Adverse Event|0|||
128758864|NCT00245102|463406817|FG005|Overall Study|Adverse Event|2|||
128758865|NCT00245102|463406812|FG000|Overall Study|Decline in performance|0|||
128758866|NCT00245102|463406813|FG001|Overall Study|Decline in performance|2|||
128758867|NCT00245102|463406814|FG002|Overall Study|Decline in performance|0|||
128758868|NCT00245102|463406815|FG003|Overall Study|Decline in performance|1|||
128758869|NCT00245102|463406816|FG004|Overall Study|Decline in performance|0|||
128758870|NCT00245102|463406817|FG005|Overall Study|Decline in performance|2|||
128758871|NCT00245102|463406812|FG000|Overall Study|Participant needed surgery|0|||
128758872|NCT00245102|463406813|FG001|Overall Study|Participant needed surgery|0|||
128758873|NCT00245102|463406814|FG002|Overall Study|Participant needed surgery|1|||
128758874|NCT00245102|463406815|FG003|Overall Study|Participant needed surgery|0|||
128758875|NCT00245102|463406816|FG004|Overall Study|Participant needed surgery|0|||
128758876|NCT00245102|463406817|FG005|Overall Study|Participant needed surgery|0|||
128758877|NCT00245102|463406812|FG000|Overall Study|Clinical progression|1|||
128758878|NCT00245102|463406813|FG001|Overall Study|Clinical progression|0|||
128758879|NCT00245102|463406814|FG002|Overall Study|Clinical progression|0|||
128758880|NCT00245102|463406815|FG003|Overall Study|Clinical progression|0|||
128758881|NCT00245102|463406816|FG004|Overall Study|Clinical progression|0|||
128758882|NCT00245102|463406817|FG005|Overall Study|Clinical progression|0|||
128758883|NCT01756352|463406820|FG000|Overall Study|moved away and lost to followup|1|||
128758884|NCT03315143|463406821|FG000|Overall Study|Death|240|||
128758885|NCT03315143|463406822|FG001|Overall Study|Death|246|||
128758886|NCT03315143|463406821|FG000|Overall Study|Withdrawal by Subject|57|||
128758887|NCT03315143|463406822|FG001|Overall Study|Withdrawal by Subject|68|||
128758888|NCT03315143|463406821|FG000|Overall Study|Site Terminated by Sponsor|256|||
128758889|NCT03315143|463406822|FG001|Overall Study|Site Terminated by Sponsor|282|||
128758890|NCT03315143|463406821|FG000|Overall Study|Study Terminated by Sponsor|4723|||
128758891|NCT03315143|463406822|FG001|Overall Study|Study Terminated by Sponsor|4664|||
128758892|NCT03315143|463406821|FG000|Overall Study|Reason not Specified|16|||
128792980|NCT01317420|463535794|FG011|Overall Study|Progressive disease according to RECIST|11|||
128792981|NCT01317420|463535795|FG012|Overall Study|Progressive disease according to RECIST|16|||
128792982|NCT01317420|463535783|FG000|Overall Study|Other adverse event|1|||
128792983|NCT01317420|463535784|FG001|Overall Study|Other adverse event|0|||
128792984|NCT01317420|463535785|FG002|Overall Study|Other adverse event|0|||
128792985|NCT01317420|463535786|FG003|Overall Study|Other adverse event|0|||
128792986|NCT01317420|463535787|FG004|Overall Study|Other adverse event|0|||
128792987|NCT01317420|463535788|FG005|Overall Study|Other adverse event|0|||
128792988|NCT01317420|463535789|FG006|Overall Study|Other adverse event|0|||
128792989|NCT01317420|463535790|FG007|Overall Study|Other adverse event|0|||
128792990|NCT01317420|463535791|FG008|Overall Study|Other adverse event|0|||
128792991|NCT01317420|463535792|FG009|Overall Study|Other adverse event|0|||
128792992|NCT01317420|463535793|FG010|Overall Study|Other adverse event|0|||
128792993|NCT01317420|463535794|FG011|Overall Study|Other adverse event|0|||
128792994|NCT01317420|463535795|FG012|Overall Study|Other adverse event|2|||
128792995|NCT01317420|463535783|FG000|Overall Study|Non-compliant with protocol|0|||
128792996|NCT01317420|463535784|FG001|Overall Study|Non-compliant with protocol|0|||
128792997|NCT01317420|463535785|FG002|Overall Study|Non-compliant with protocol|0|||
128792998|NCT01317420|463535786|FG003|Overall Study|Non-compliant with protocol|0|||
128792999|NCT01317420|463535787|FG004|Overall Study|Non-compliant with protocol|0|||
128758893|NCT03315143|463406822|FG001|Overall Study|Reason not Specified|32|||
128793000|NCT01317420|463535788|FG005|Overall Study|Non-compliant with protocol|0|||
128793001|NCT01317420|463535789|FG006|Overall Study|Non-compliant with protocol|0|||
128793002|NCT01317420|463535790|FG007|Overall Study|Non-compliant with protocol|0|||
128793003|NCT01317420|463535791|FG008|Overall Study|Non-compliant with protocol|0|||
128793004|NCT01317420|463535792|FG009|Overall Study|Non-compliant with protocol|0|||
128793005|NCT01317420|463535793|FG010|Overall Study|Non-compliant with protocol|0|||
128793006|NCT01317420|463535794|FG011|Overall Study|Non-compliant with protocol|0|||
128793007|NCT01317420|463535795|FG012|Overall Study|Non-compliant with protocol|1|||
128793008|NCT01317420|463535783|FG000|Overall Study|Refused to cont. taking trial medication|0|||
128793009|NCT01317420|463535784|FG001|Overall Study|Refused to cont. taking trial medication|0|||
128793010|NCT01317420|463535785|FG002|Overall Study|Refused to cont. taking trial medication|0|||
128793011|NCT01317420|463535786|FG003|Overall Study|Refused to cont. taking trial medication|0|||
128793012|NCT01317420|463535787|FG004|Overall Study|Refused to cont. taking trial medication|0|||
128793013|NCT01317420|463535788|FG005|Overall Study|Refused to cont. taking trial medication|0|||
128793014|NCT01317420|463535789|FG006|Overall Study|Refused to cont. taking trial medication|0|||
128793015|NCT01317420|463535790|FG007|Overall Study|Refused to cont. taking trial medication|0|||
128793016|NCT01317420|463535791|FG008|Overall Study|Refused to cont. taking trial medication|0|||
128758894|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
128758895|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
128758896|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
128758897|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
128793017|NCT01317420|463535792|FG009|Overall Study|Refused to cont. taking trial medication|0|||
128793018|NCT01317420|463535793|FG010|Overall Study|Refused to cont. taking trial medication|0|||
128793019|NCT01317420|463535794|FG011|Overall Study|Refused to cont. taking trial medication|0|||
128793020|NCT01317420|463535795|FG012|Overall Study|Refused to cont. taking trial medication|1|||
128793021|NCT01317420|463535783|FG000|Overall Study|Reason other than those specified|0|||
128793022|NCT01317420|463535784|FG001|Overall Study|Reason other than those specified|0|||
128793023|NCT01317420|463535785|FG002|Overall Study|Reason other than those specified|0|||
128793024|NCT01317420|463535786|FG003|Overall Study|Reason other than those specified|0|||
128793025|NCT01317420|463535787|FG004|Overall Study|Reason other than those specified|0|||
128793026|NCT01317420|463535788|FG005|Overall Study|Reason other than those specified|0|||
128793027|NCT01317420|463535789|FG006|Overall Study|Reason other than those specified|0|||
128793028|NCT01317420|463535790|FG007|Overall Study|Reason other than those specified|0|||
128793029|NCT01317420|463535791|FG008|Overall Study|Reason other than those specified|0|||
128793030|NCT01317420|463535792|FG009|Overall Study|Reason other than those specified|1|||
128758898|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
128793031|NCT01317420|463535793|FG010|Overall Study|Reason other than those specified|0|||
128793032|NCT01317420|463535794|FG011|Overall Study|Reason other than those specified|0|||
128793033|NCT01317420|463535795|FG012|Overall Study|Reason other than those specified|0|||
128793034|NCT03194958|463535796|FG000|Overall Study|Death|0|||
128793035|NCT03194958|463535797|FG001|Overall Study|Death|1|||
128793036|NCT03194958|463535798|FG002|Overall Study|Death|1|||
128793037|NCT03194958|463535799|FG003|Overall Study|Death|1|||
128793038|NCT03194958|463535796|FG000|Overall Study|Withdrawal by Subject|24|||
128793039|NCT03194958|463535797|FG001|Overall Study|Withdrawal by Subject|27|||
128793040|NCT03194958|463535798|FG002|Overall Study|Withdrawal by Subject|7|||
128793041|NCT03194958|463535799|FG003|Overall Study|Withdrawal by Subject|22|||
128793042|NCT03194958|463535796|FG000|Overall Study|Lost to Follow-up|168|||
128793043|NCT03194958|463535797|FG001|Overall Study|Lost to Follow-up|196|||
128793044|NCT03194958|463535798|FG002|Overall Study|Lost to Follow-up|174|||
128793045|NCT03194958|463535799|FG003|Overall Study|Lost to Follow-up|186|||
128793046|NCT01968226|463535801|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
128793047|NCT04975308|463535809|FG000|Overall Study|Withdrawal by Subject|6|||
128793048|NCT04975308|463535810|FG001|Overall Study|Withdrawal by Subject|16|||
128793049|NCT04975308|463535811|FG002|Overall Study|Withdrawal by Subject|6|||
128793050|NCT04975308|463535809|FG000|Overall Study|Physician Decision|0|||
128793051|NCT04975308|463535810|FG001|Overall Study|Physician Decision|3|||
128793052|NCT04975308|463535811|FG002|Overall Study|Physician Decision|1|||
128793053|NCT04975308|463535809|FG000|Overall Study|Adverse Event|10|||
128793054|NCT04975308|463535810|FG001|Overall Study|Adverse Event|1|||
128793055|NCT04975308|463535811|FG002|Overall Study|Adverse Event|12|||
128793056|NCT04975308|463535809|FG000|Overall Study|On study treatment (Ongoing)|65|||
128793057|NCT04975308|463535810|FG001|Overall Study|On study treatment (Ongoing)|43|||
128793058|NCT04975308|463535811|FG002|Overall Study|On study treatment (Ongoing)|75|||
128793059|NCT04975308|463535809|FG000|Overall Study|Protocol Deviation|4|||
128793060|NCT04975308|463535810|FG001|Overall Study|Protocol Deviation|3|||
128793061|NCT04975308|463535811|FG002|Overall Study|Protocol Deviation|2|||
128793062|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
128793063|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
128793064|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
128793065|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
128793066|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
128793067|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
128793068|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
128793069|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
128793070|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
128793071|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
128793072|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
128793073|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
128793074|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
128793075|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
128793076|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
128793077|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
128793078|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
128793079|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
128793080|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
128793081|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
128793082|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
128793083|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
128793084|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
128793085|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
128793086|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
128793087|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
128793088|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
128793089|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
128793090|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
128793091|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
128793092|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
128793093|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
128793094|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
128793095|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
128793096|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
128793097|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
128793098|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
128793099|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
128793100|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
128793101|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
128793102|NCT02709655|463535812|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
128793103|NCT02709655|463535813|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
128793104|NCT02709655|463535814|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
128793105|NCT02709655|463535815|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
128793106|NCT02709655|463535816|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
128793107|NCT02709655|463535812|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
128793108|NCT02709655|463535813|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
128793109|NCT02709655|463535814|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
128793110|NCT02709655|463535815|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
128793111|NCT02709655|463535816|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
128793112|NCT02709655|463535812|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
128793113|NCT02709655|463535813|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
128793114|NCT02709655|463535814|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
128793115|NCT02709655|463535815|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
128793116|NCT02709655|463535816|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
128793117|NCT02709655|463535812|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
128793118|NCT02709655|463535813|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
128793119|NCT02709655|463535814|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
128793120|NCT02709655|463535815|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
128793121|NCT02709655|463535816|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
128793122|NCT02709655|463535812|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
128793123|NCT02709655|463535813|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
128793124|NCT02709655|463535814|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
128793125|NCT02709655|463535815|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
128793126|NCT02709655|463535816|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
128793127|NCT02709655|463535812|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
128793128|NCT02709655|463535813|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
128793129|NCT02709655|463535814|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
128793130|NCT02709655|463535815|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
128793131|NCT02709655|463535816|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
128793132|NCT02709655|463535812|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
128793133|NCT02709655|463535813|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
128793134|NCT02709655|463535814|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
128793135|NCT02709655|463535815|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
128793136|NCT02709655|463535816|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
128793137|NCT02709655|463535812|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
128793138|NCT02709655|463535813|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
128793139|NCT02709655|463535814|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
128793140|NCT02709655|463535815|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
128793141|NCT02709655|463535816|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
128793142|NCT00102063|463535817|FG000|Overall Study|Lack of Efficacy|5|||
128793143|NCT00102063|463535818|FG001|Overall Study|Lack of Efficacy|1|||
128793144|NCT00102063|463535819|FG002|Overall Study|Lack of Efficacy|1|||
128793145|NCT00102063|463535817|FG000|Overall Study|Adverse Event|7|||
128793146|NCT00102063|463535818|FG001|Overall Study|Adverse Event|4|||
128793147|NCT00102063|463535819|FG002|Overall Study|Adverse Event|2|||
128793148|NCT00102063|463535817|FG000|Overall Study|Withdrawal by Subject|4|||
128793149|NCT00102063|463535818|FG001|Overall Study|Withdrawal by Subject|12|||
128793150|NCT00102063|463535819|FG002|Overall Study|Withdrawal by Subject|5|||
128793151|NCT00102063|463535817|FG000|Overall Study|Lost to Follow-up|0|||
128793152|NCT00102063|463535818|FG001|Overall Study|Lost to Follow-up|0|||
128793153|NCT00102063|463535819|FG002|Overall Study|Lost to Follow-up|1|||
128793154|NCT00102063|463535817|FG000|Overall Study|Protocol Violation|0|||
128793155|NCT00102063|463535818|FG001|Overall Study|Protocol Violation|1|||
128793156|NCT00102063|463535819|FG002|Overall Study|Protocol Violation|1|||
128793157|NCT01493778|463535820|FG000|Overall Study|Withdrawal by Subject|8|||
128793158|NCT05082025|463535821|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
128793159|NCT04210180|463535822|FG000|Overall Study|Withdrawal by Subject|2|||
128793160|NCT01179334|463535823|FG000|Treatment Period|Adverse Event|1|||
128793161|NCT01179334|463535824|FG001|Treatment Period|Adverse Event|0|||
128793162|NCT01179334|463535823|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
128793163|NCT01179334|463535824|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
128793164|NCT01179334|463535823|FG000|Long-term Extension (LTE) Period|Death|3|||
128793165|NCT01179334|463535824|FG001|Long-term Extension (LTE) Period|Death|0|||
128793166|NCT01179334|463535823|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
128793167|NCT01179334|463535824|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
128793168|NCT00857649|463535825|FG000|Overall Study|Adverse Event|15|||
128793169|NCT00857649|463535826|FG001|Overall Study|Adverse Event|10|||
128793170|NCT00857649|463535825|FG000|Overall Study|Non-compliance|1|||
128793171|NCT00857649|463535826|FG001|Overall Study|Non-compliance|1|||
128793172|NCT00857649|463535825|FG000|Overall Study|Protocol Violation|2|||
128793173|NCT00857649|463535826|FG001|Overall Study|Protocol Violation|2|||
128793174|NCT00857649|463535825|FG000|Overall Study|Withdrawal of Consent|10|||
128793175|NCT00857649|463535826|FG001|Overall Study|Withdrawal of Consent|7|||
128793176|NCT00857649|463535825|FG000|Overall Study|Nursing Home Placement|2|||
128793177|NCT00857649|463535826|FG001|Overall Study|Nursing Home Placement|9|||
128793178|NCT00857649|463535825|FG000|Overall Study|Other Reasons|1|||
128793179|NCT00857649|463535826|FG001|Overall Study|Other Reasons|3|||
128793180|NCT05190419|463535827|FG000|Overall Study|Lack of Efficacy|8|||
128793181|NCT05190419|463535828|FG001|Overall Study|Lack of Efficacy|0|||
128793182|NCT05190419|463535829|FG002|Overall Study|Lack of Efficacy|1|||
128793183|NCT05190419|463535830|FG003|Overall Study|Lack of Efficacy|0|||
128793184|NCT05190419|463535827|FG000|Overall Study|Withdrawal by Subject|7|||
128793185|NCT05190419|463535828|FG001|Overall Study|Withdrawal by Subject|1|||
128793186|NCT05190419|463535829|FG002|Overall Study|Withdrawal by Subject|2|||
128793187|NCT05190419|463535830|FG003|Overall Study|Withdrawal by Subject|2|||
128793188|NCT05190419|463535827|FG000|Overall Study|Adverse Event|2|||
128793189|NCT05190419|463535828|FG001|Overall Study|Adverse Event|10|||
128793190|NCT05190419|463535829|FG002|Overall Study|Adverse Event|11|||
128793191|NCT05190419|463535830|FG003|Overall Study|Adverse Event|21|||
128793192|NCT05190419|463535827|FG000|Overall Study|Lost to Follow-up|1|||
128793193|NCT05190419|463535828|FG001|Overall Study|Lost to Follow-up|2|||
128793194|NCT05190419|463535829|FG002|Overall Study|Lost to Follow-up|3|||
128793195|NCT05190419|463535830|FG003|Overall Study|Lost to Follow-up|1|||
128793196|NCT05190419|463535827|FG000|Overall Study|Other|1|||
128793197|NCT05190419|463535828|FG001|Overall Study|Other|1|||
128793198|NCT05190419|463535829|FG002|Overall Study|Other|0|||
128793199|NCT05190419|463535830|FG003|Overall Study|Other|3|||
128793200|NCT00919763|463535831|FG000|Overall Study|Adverse Event|7|||
128793201|NCT00919763|463535832|FG001|Overall Study|Adverse Event|1|||
128793202|NCT00919763|463535831|FG000|Overall Study|Lost to Follow-up|1|||
128793203|NCT00919763|463535832|FG001|Overall Study|Lost to Follow-up|0|||
128793204|NCT00919763|463535831|FG000|Overall Study|Protocol Violation|1|||
128793205|NCT00919763|463535832|FG001|Overall Study|Protocol Violation|1|||
128793206|NCT00919763|463535831|FG000|Overall Study|Withdrawal by Subject|3|||
128793207|NCT00919763|463535832|FG001|Overall Study|Withdrawal by Subject|1|||
128793208|NCT00919763|463535831|FG000|Overall Study|Non-compliance|0|||
128793209|NCT00919763|463535832|FG001|Overall Study|Non-compliance|1|||
128793210|NCT05323734|463535841|FG000|Overall Study|Adverse Event|5|||
128793211|NCT05323734|463535842|FG001|Overall Study|Adverse Event|2|||
128793212|NCT05323734|463535841|FG000|Overall Study|Physician Decision|1|||
128793213|NCT05323734|463535842|FG001|Overall Study|Physician Decision|0|||
128793214|NCT05323734|463535841|FG000|Overall Study|Lack of Efficacy|1|||
128793215|NCT05323734|463535842|FG001|Overall Study|Lack of Efficacy|2|||
128793216|NCT05323734|463535841|FG000|Overall Study|Withdrawal by Subject|2|||
128793217|NCT05323734|463535842|FG001|Overall Study|Withdrawal by Subject|0|||
128793218|NCT05323734|463535841|FG000|Overall Study|Participant Withdrawn Due|0|||
128793219|NCT05323734|463535842|FG001|Overall Study|Participant Withdrawn Due|1|||
129204509|NCT00550407|465045821|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
129204510|NCT00550407|465045822|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
129204511|NCT00550407|465045820|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
129204512|NCT00550407|465045821|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
129204513|NCT00550407|465045822|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
129204514|NCT00550407|465045820|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
129204515|NCT00550407|465045821|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
129204516|NCT00550407|465045822|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
129204517|NCT00584415|465045823|FG000|Overall Study|Adverse Event|7|||
129204518|NCT05051579|465045824|FG000|Overall Study|Withdrawal by Subject|3|||
129204519|NCT05051579|465045825|FG001|Overall Study|Withdrawal by Subject|5|||
129204520|NCT05051579|465045826|FG002|Overall Study|Withdrawal by Subject|2|||
129204521|NCT05051579|465045827|FG003|Overall Study|Withdrawal by Subject|1|||
129204522|NCT05051579|465045828|FG004|Overall Study|Withdrawal by Subject|4|||
129204523|NCT05051579|465045829|FG005|Overall Study|Withdrawal by Subject|0|||
129204524|NCT05051579|465045830|FG006|Overall Study|Withdrawal by Subject|4|||
129204525|NCT05051579|465045824|FG000|Overall Study|Lost to Follow-up|1|||
129204526|NCT05051579|465045825|FG001|Overall Study|Lost to Follow-up|0|||
129204527|NCT05051579|465045826|FG002|Overall Study|Lost to Follow-up|0|||
129204528|NCT05051579|465045827|FG003|Overall Study|Lost to Follow-up|0|||
129204529|NCT05051579|465045828|FG004|Overall Study|Lost to Follow-up|1|||
129204530|NCT05051579|465045829|FG005|Overall Study|Lost to Follow-up|0|||
129204531|NCT05051579|465045830|FG006|Overall Study|Lost to Follow-up|1|||
129204532|NCT05051579|465045824|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129204533|NCT05051579|465045825|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129204534|NCT05051579|465045826|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129204535|NCT05051579|465045827|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129204536|NCT05051579|465045828|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129204537|NCT05051579|465045829|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129204538|NCT05051579|465045830|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
129204539|NCT05051579|465045824|FG000|Overall Study|Adverse Event|2|||
129204540|NCT05051579|465045825|FG001|Overall Study|Adverse Event|1|||
129204541|NCT05051579|465045826|FG002|Overall Study|Adverse Event|0|||
129204542|NCT05051579|465045827|FG003|Overall Study|Adverse Event|4|||
129204543|NCT05051579|465045828|FG004|Overall Study|Adverse Event|1|||
129204544|NCT05051579|465045829|FG005|Overall Study|Adverse Event|2|||
129204545|NCT05051579|465045830|FG006|Overall Study|Adverse Event|0|||
129204546|NCT05051579|465045824|FG000|Overall Study|Inadvertent Enrollment|0|||
129204547|NCT05051579|465045825|FG001|Overall Study|Inadvertent Enrollment|0|||
129204548|NCT05051579|465045826|FG002|Overall Study|Inadvertent Enrollment|0|||
129204549|NCT05051579|465045827|FG003|Overall Study|Inadvertent Enrollment|0|||
129204550|NCT05051579|465045828|FG004|Overall Study|Inadvertent Enrollment|0|||
129204551|NCT05051579|465045829|FG005|Overall Study|Inadvertent Enrollment|0|||
129204552|NCT05051579|465045830|FG006|Overall Study|Inadvertent Enrollment|1|||
129204553|NCT05051579|465045824|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
128793268|NCT00256243|463535846|FG000|Overall Study|Lost to Follow-up|2|||
128793269|NCT00256243|463535846|FG000|Overall Study|Death|7|||
128793270|NCT00256243|463535846|FG000|Overall Study|Not treated|1|||
128793271|NCT01350804|463535848|FG000|Core Study|Withdrawal by Subject|11|||
128793272|NCT01350804|463535849|FG001|Core Study|Withdrawal by Subject|17|||
128793273|NCT01350804|463535850|FG002|Core Study|Withdrawal by Subject|16|||
128793274|NCT01350804|463535851|FG003|Core Study|Withdrawal by Subject|7|||
128793275|NCT01350804|463535848|FG000|Core Study|Study terminated by Sponsor|0|||
128793276|NCT01350804|463535849|FG001|Core Study|Study terminated by Sponsor|0|||
128793277|NCT01350804|463535850|FG002|Core Study|Study terminated by Sponsor|0|||
128793278|NCT01350804|463535851|FG003|Core Study|Study terminated by Sponsor|2|||
128793279|NCT01350804|463535848|FG000|Core Study|Protocol deviation|1|||
128793280|NCT01350804|463535849|FG001|Core Study|Protocol deviation|0|||
128793281|NCT01350804|463535850|FG002|Core Study|Protocol deviation|1|||
128793282|NCT01350804|463535851|FG003|Core Study|Protocol deviation|0|||
128793283|NCT01350804|463535848|FG000|Core Study|Physician Decision|1|||
128793284|NCT01350804|463535849|FG001|Core Study|Physician Decision|0|||
128793285|NCT01350804|463535850|FG002|Core Study|Physician Decision|1|||
128793286|NCT01350804|463535851|FG003|Core Study|Physician Decision|3|||
128793287|NCT01350804|463535848|FG000|Core Study|Lost to Follow-up|3|||
128793288|NCT01350804|463535849|FG001|Core Study|Lost to Follow-up|0|||
128793289|NCT01350804|463535850|FG002|Core Study|Lost to Follow-up|2|||
128793290|NCT01350804|463535851|FG003|Core Study|Lost to Follow-up|1|||
128793291|NCT01350804|463535848|FG000|Core Study|Lack of Efficacy|16|||
128793292|NCT01350804|463535849|FG001|Core Study|Lack of Efficacy|19|||
128793293|NCT01350804|463535850|FG002|Core Study|Lack of Efficacy|18|||
128793294|NCT01350804|463535851|FG003|Core Study|Lack of Efficacy|5|||
128793295|NCT01350804|463535848|FG000|Core Study|Death|1|||
128793296|NCT01350804|463535849|FG001|Core Study|Death|1|||
128793297|NCT01350804|463535850|FG002|Core Study|Death|1|||
128793298|NCT01350804|463535851|FG003|Core Study|Death|0|||
128793299|NCT01350804|463535848|FG000|Core Study|Adverse Event|8|||
128793300|NCT01350804|463535849|FG001|Core Study|Adverse Event|10|||
128793301|NCT01350804|463535850|FG002|Core Study|Adverse Event|8|||
128793302|NCT01350804|463535851|FG003|Core Study|Adverse Event|8|||
128793303|NCT01350804|463535848|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
128793304|NCT01350804|463535849|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
128793305|NCT01350804|463535850|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
128793306|NCT01350804|463535851|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
128793307|NCT01350804|463535848|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
128793308|NCT01350804|463535849|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
128793309|NCT01350804|463535850|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
128793310|NCT01350804|463535851|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
128793311|NCT01350804|463535848|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
128793312|NCT01350804|463535849|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
128793313|NCT01350804|463535850|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
128793314|NCT01350804|463535851|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
128793315|NCT01350804|463535848|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
128793316|NCT01350804|463535849|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
128793317|NCT01350804|463535850|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
128793318|NCT01350804|463535851|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
128793319|NCT01350804|463535848|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
128793320|NCT01350804|463535849|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
128793321|NCT01350804|463535850|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
128793322|NCT01350804|463535851|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
128793323|NCT01350804|463535848|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
128793324|NCT01350804|463535849|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
128793325|NCT01350804|463535850|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
128793326|NCT01350804|463535851|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
128793327|NCT02299336|463535852|FG000|Overall Study|Withdrawal by Subject|11|||
128793328|NCT02299336|463535852|FG000|Overall Study|Adverse Event|1|||
128793329|NCT02299336|463535852|FG000|Overall Study|Death|1|||
128793330|NCT02299336|463535852|FG000|Overall Study|Lost to Follow-up|1|||
128793331|NCT02106442|463535854|FG000|Overall Study|Case Report Forms Uncollected|7|||
128793332|NCT02106442|463535854|FG000|Overall Study|Protocol Deviation|30|||
128793333|NCT00516321|463536946|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
128793334|NCT00516321|463536947|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
128793335|NCT00516321|463536948|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
128793336|NCT00516321|463536946|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
128793337|NCT00516321|463536947|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
128793338|NCT00516321|463536948|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
128793339|NCT00516321|463536946|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
128793340|NCT00516321|463536947|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
128793341|NCT00516321|463536948|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
128793342|NCT00516321|463536946|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
128793343|NCT00516321|463536947|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
128793344|NCT00516321|463536948|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
128793345|NCT00516321|463536946|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
128793346|NCT00516321|463536947|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
128793347|NCT00516321|463536948|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
128793348|NCT00516321|463536946|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
128793349|NCT00516321|463536947|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
128793350|NCT00516321|463536948|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
128793351|NCT00516321|463536946|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
128793352|NCT00516321|463536947|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
128793353|NCT00516321|463536948|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
128793354|NCT00516321|463536946|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
128793355|NCT00516321|463536947|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
128793356|NCT00516321|463536948|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
128793357|NCT00516321|463536946|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
128793358|NCT00516321|463536947|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
128793359|NCT00516321|463536948|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
128793360|NCT00516321|463536946|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
128793361|NCT00516321|463536947|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
128793362|NCT00516321|463536948|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
128793363|NCT00516321|463536946|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
128793364|NCT00516321|463536947|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
128793365|NCT00516321|463536948|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
128793366|NCT01113931|463536951|FG000|Overall Study|Adverse Event|2|||
128793367|NCT01113931|463536952|FG001|Overall Study|Adverse Event|2|||
128793368|NCT01113931|463536951|FG000|Overall Study|Physician Decision|0|||
128793369|NCT01113931|463536952|FG001|Overall Study|Physician Decision|2|||
128793370|NCT01113931|463536951|FG000|Overall Study|Lost to Follow-up|12|||
128793371|NCT01113931|463536952|FG001|Overall Study|Lost to Follow-up|9|||
128793372|NCT01113931|463536951|FG000|Overall Study|Various|2|||
128793373|NCT01113931|463536952|FG001|Overall Study|Various|4|||
128793374|NCT01113931|463536951|FG000|Overall Study|Withdrawal by Subject|3|||
128793375|NCT01113931|463536952|FG001|Overall Study|Withdrawal by Subject|0|||
128793376|NCT03959241|463536954|FG000|Overall Study|Withdrawal by Subject|7|||
128793377|NCT03959241|463536955|FG001|Overall Study|Withdrawal by Subject|8|||
128793378|NCT03959241|463536954|FG000|Overall Study|Lost to Follow-up|1|||
128793379|NCT03959241|463536955|FG001|Overall Study|Lost to Follow-up|0|||
128793380|NCT03959241|463536954|FG000|Overall Study|Move to Hospice Care|1|||
128793381|NCT03959241|463536955|FG001|Overall Study|Move to Hospice Care|0|||
128793382|NCT03959241|463536954|FG000|Overall Study|Screen Failure|1|||
128793383|NCT03959241|463536955|FG001|Overall Study|Screen Failure|0|||
128793384|NCT03959241|463536954|FG000|Overall Study|Disease Relapse|0|||
128793385|NCT03959241|463536955|FG001|Overall Study|Disease Relapse|1|||
128793386|NCT03959241|463536954|FG000|Overall Study|Off Study|1|||
128793387|NCT03959241|463536955|FG001|Overall Study|Off Study|0|||
128793388|NCT00346151|463536956|FG000|Overall Study|Withdrawal by Subject|3|||
128793389|NCT01692938|463536964|FG000|Overall Study|Protocol Deviation|1|||
128793390|NCT01692938|463536965|FG001|Overall Study|Protocol Deviation|1|||
128793391|NCT01692938|463536964|FG000|Overall Study|Study completed prior to site completion|3|||
128793392|NCT01692938|463536965|FG001|Overall Study|Study completed prior to site completion|3|||
128793393|NCT02423291|463536966|FG000|Overall Study|Lack of Efficacy|14|||
128793394|NCT02423291|463536966|FG000|Overall Study|Adverse Event|1|||
128793395|NCT05283395|463536968|FG000|Overall Study|Adverse Event|4|||
128793396|NCT05283395|463536969|FG001|Overall Study|Adverse Event|4|||
128793397|NCT05283395|463536970|FG002|Overall Study|Adverse Event|0|||
128793398|NCT05283395|463536968|FG000|Overall Study|Patient Lost to Follow-Up|0|||
128793399|NCT05283395|463536969|FG001|Overall Study|Patient Lost to Follow-Up|0|||
128793400|NCT05283395|463536970|FG002|Overall Study|Patient Lost to Follow-Up|1|||
128793401|NCT05283395|463536968|FG000|Overall Study|Patient Withdrawal|2|||
128793402|NCT05283395|463536969|FG001|Overall Study|Patient Withdrawal|4|||
128793403|NCT05283395|463536970|FG002|Overall Study|Patient Withdrawal|2|||
128793404|NCT05283395|463536968|FG000|Overall Study|Investigator Decision|1|||
128793405|NCT05283395|463536969|FG001|Overall Study|Investigator Decision|0|||
128793406|NCT05283395|463536970|FG002|Overall Study|Investigator Decision|1|||
128793407|NCT05283395|463536968|FG000|Overall Study|Enrolled in error|0|||
128793408|NCT05283395|463536969|FG001|Overall Study|Enrolled in error|0|||
128793409|NCT05283395|463536970|FG002|Overall Study|Enrolled in error|1|||
128793410|NCT00712335|463536974|FG000|Overall Study|Withdrawal by Subject|0|||
128793411|NCT00712335|463536975|FG001|Overall Study|Withdrawal by Subject|7|||
128793412|NCT00712335|463536976|FG002|Overall Study|Withdrawal by Subject|2|||
128793413|NCT00712335|463536977|FG003|Overall Study|Withdrawal by Subject|3|||
128793414|NCT00712335|463536978|FG004|Overall Study|Withdrawal by Subject|0|||
128793415|NCT00712335|463536974|FG000|Overall Study|Lost to Follow-up|2|||
128793416|NCT00712335|463536975|FG001|Overall Study|Lost to Follow-up|5|||
128793417|NCT00712335|463536976|FG002|Overall Study|Lost to Follow-up|0|||
128793418|NCT00712335|463536977|FG003|Overall Study|Lost to Follow-up|1|||
128793419|NCT00712335|463536978|FG004|Overall Study|Lost to Follow-up|0|||
128793420|NCT00712335|463536974|FG000|Overall Study|Protocol Violation|1|||
128793421|NCT00712335|463536975|FG001|Overall Study|Protocol Violation|2|||
128793422|NCT00712335|463536976|FG002|Overall Study|Protocol Violation|1|||
128793423|NCT00712335|463536977|FG003|Overall Study|Protocol Violation|0|||
128793424|NCT00712335|463536978|FG004|Overall Study|Protocol Violation|0|||
128793425|NCT00712335|463536974|FG000|Overall Study|Lack of Efficacy|0|||
128793426|NCT00712335|463536975|FG001|Overall Study|Lack of Efficacy|0|||
128793427|NCT00712335|463536976|FG002|Overall Study|Lack of Efficacy|1|||
128793428|NCT00712335|463536977|FG003|Overall Study|Lack of Efficacy|1|||
128793429|NCT00712335|463536978|FG004|Overall Study|Lack of Efficacy|0|||
128793430|NCT00712335|463536974|FG000|Overall Study|Other Reason|0|||
128793431|NCT00712335|463536975|FG001|Overall Study|Other Reason|3|||
128793432|NCT00712335|463536976|FG002|Overall Study|Other Reason|1|||
128793433|NCT00712335|463536977|FG003|Overall Study|Other Reason|0|||
128793434|NCT00712335|463536978|FG004|Overall Study|Other Reason|0|||
128793435|NCT03401112|463536979|FG000|Overall Study|Adverse Event|1|||
128793436|NCT03401112|463536980|FG001|Overall Study|Adverse Event|2|||
128793437|NCT03401112|463536981|FG002|Overall Study|Adverse Event|3|||
128793438|NCT03401112|463536982|FG003|Overall Study|Adverse Event|2|||
128793439|NCT03401112|463536983|FG004|Overall Study|Adverse Event|0|||
128793440|NCT03401112|463536979|FG000|Overall Study|Lost to Follow-up|1|||
128793441|NCT03401112|463536980|FG001|Overall Study|Lost to Follow-up|0|||
128793442|NCT03401112|463536981|FG002|Overall Study|Lost to Follow-up|0|||
128793443|NCT03401112|463536982|FG003|Overall Study|Lost to Follow-up|0|||
128793444|NCT03401112|463536983|FG004|Overall Study|Lost to Follow-up|0|||
128793445|NCT03401112|463536979|FG000|Overall Study|Noncompliance|1|||
128793446|NCT03401112|463536980|FG001|Overall Study|Noncompliance|2|||
128793447|NCT03401112|463536981|FG002|Overall Study|Noncompliance|3|||
128793448|NCT03401112|463536982|FG003|Overall Study|Noncompliance|0|||
128793449|NCT03401112|463536983|FG004|Overall Study|Noncompliance|0|||
128793450|NCT03401112|463536979|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
128793451|NCT03401112|463536980|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
128793452|NCT03401112|463536981|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
128793453|NCT03401112|463536982|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
128793454|NCT03401112|463536983|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
128793455|NCT03401112|463536979|FG000|Overall Study|Withdrawal by Subject|0|||
128793456|NCT03401112|463536980|FG001|Overall Study|Withdrawal by Subject|3|||
128793457|NCT03401112|463536981|FG002|Overall Study|Withdrawal by Subject|2|||
128793458|NCT03401112|463536982|FG003|Overall Study|Withdrawal by Subject|1|||
128793459|NCT03401112|463536983|FG004|Overall Study|Withdrawal by Subject|0|||
128793460|NCT03401112|463536979|FG000|Overall Study|Physician Decision|0|||
128793461|NCT03401112|463536980|FG001|Overall Study|Physician Decision|0|||
128793462|NCT03401112|463536981|FG002|Overall Study|Physician Decision|0|||
128793463|NCT03401112|463536982|FG003|Overall Study|Physician Decision|2|||
128793464|NCT03401112|463536983|FG004|Overall Study|Physician Decision|0|||
128793465|NCT03401112|463536979|FG000|Overall Study|Study was Terminated by Sponsor|0|||
128793466|NCT03401112|463536980|FG001|Overall Study|Study was Terminated by Sponsor|0|||
128793467|NCT03401112|463536981|FG002|Overall Study|Study was Terminated by Sponsor|0|||
128793468|NCT03401112|463536982|FG003|Overall Study|Study was Terminated by Sponsor|1|||
128793469|NCT03401112|463536983|FG004|Overall Study|Study was Terminated by Sponsor|0|||
128793470|NCT03401112|463536979|FG000|Overall Study|Day 1 Assessment not Done|1|||
128793471|NCT03401112|463536980|FG001|Overall Study|Day 1 Assessment not Done|0|||
128793472|NCT03401112|463536981|FG002|Overall Study|Day 1 Assessment not Done|0|||
128793473|NCT03401112|463536982|FG003|Overall Study|Day 1 Assessment not Done|0|||
128793474|NCT03401112|463536983|FG004|Overall Study|Day 1 Assessment not Done|0|||
128793475|NCT03401112|463536979|FG000|Overall Study|Not Dosed|0|||
128793476|NCT03401112|463536980|FG001|Overall Study|Not Dosed|0|||
128793477|NCT03401112|463536981|FG002|Overall Study|Not Dosed|1|||
128793478|NCT03401112|463536982|FG003|Overall Study|Not Dosed|0|||
128793479|NCT03401112|463536983|FG004|Overall Study|Not Dosed|0|||
128793480|NCT03401112|463536979|FG000|Overall Study|Missed Clinical Visit|0|||
128793481|NCT03401112|463536980|FG001|Overall Study|Missed Clinical Visit|0|||
128793482|NCT03401112|463536981|FG002|Overall Study|Missed Clinical Visit|1|||
128793483|NCT03401112|463536982|FG003|Overall Study|Missed Clinical Visit|0|||
128793484|NCT03401112|463536983|FG004|Overall Study|Missed Clinical Visit|0|||
128793485|NCT03401112|463536979|FG000|Overall Study|Missed Doses|0|||
128793486|NCT03401112|463536980|FG001|Overall Study|Missed Doses|0|||
128793487|NCT03401112|463536981|FG002|Overall Study|Missed Doses|1|||
128793488|NCT03401112|463536982|FG003|Overall Study|Missed Doses|0|||
128793489|NCT03401112|463536983|FG004|Overall Study|Missed Doses|0|||
128793490|NCT01202955|463536984|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
128793491|NCT01202955|463536985|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
128793492|NCT02115139|463536986|FG000|Overall Study|Protocol Violation|1|||
128793493|NCT02115139|463536986|FG000|Overall Study|treatment discontinuation|6|||
128793494|NCT01909778|463536987|FG000|Overall Study|failed screening|1|||
128793495|NCT02471755|463536989|FG000|Overall Study|Withdrawal by Subject|1|||
128793496|NCT02471755|463536990|FG001|Overall Study|Withdrawal by Subject|0|||
128793497|NCT02471755|463536989|FG000|Overall Study|Lost to Follow-up|0|||
128793498|NCT02471755|463536990|FG001|Overall Study|Lost to Follow-up|1|||
128793499|NCT04740164|463536991|FG000|Overall Study|Lack of Efficacy|4|||
128793500|NCT04740164|463536992|FG001|Overall Study|Lack of Efficacy|0|||
128793501|NCT04740164|463536991|FG000|Overall Study|Physician Decision|3|||
128793502|NCT04740164|463536992|FG001|Overall Study|Physician Decision|3|||
128793503|NCT04177394|463536993|FG000|Overall Study|Death|16|||
128793504|NCT04177394|463536993|FG000|Overall Study|Withdrawal by Subject|19|||
128793505|NCT04177394|463536993|FG000|Overall Study|Missed visits|61|||
128793506|NCT04177394|463536993|FG000|Overall Study|Expected Visits|15|||
128793507|NCT05061693|463536994|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
128793508|NCT05061693|463536995|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
128793509|NCT05061693|463536996|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
128793510|NCT05061693|463536997|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793511|NCT05061693|463536998|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793512|NCT05061693|463536999|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793513|NCT05061693|463537000|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793514|NCT05061693|463537001|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793515|NCT05061693|463537002|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793516|NCT05061693|463537003|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793517|NCT05061693|463537004|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793518|NCT05061693|463537005|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
128793519|NCT05061693|463536994|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
128793520|NCT05061693|463536995|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
128793521|NCT05061693|463536996|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
128793522|NCT05061693|463536997|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
128793523|NCT05061693|463536998|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
128793524|NCT05061693|463536999|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
128793525|NCT05061693|463537000|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
128793526|NCT05061693|463537001|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
128793527|NCT05061693|463537002|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
128793528|NCT05061693|463537003|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
128793529|NCT05061693|463537004|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
128793530|NCT05061693|463537005|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
128793531|NCT05061693|463536994|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
128793532|NCT05061693|463536995|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793533|NCT05061693|463536996|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793534|NCT05061693|463536997|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793535|NCT05061693|463536998|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793536|NCT05061693|463536999|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793537|NCT05061693|463537000|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793538|NCT05061693|463537001|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793539|NCT05061693|463537002|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793540|NCT05061693|463537003|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793541|NCT05061693|463537004|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793542|NCT05061693|463537005|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
128793543|NCT05061693|463536994|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793544|NCT05061693|463536995|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793545|NCT05061693|463536996|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
128793546|NCT05061693|463536997|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793547|NCT05061693|463536998|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793548|NCT05061693|463536999|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793549|NCT05061693|463537000|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793550|NCT05061693|463537001|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793551|NCT05061693|463537002|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793552|NCT05061693|463537003|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793553|NCT05061693|463537004|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793554|NCT05061693|463537005|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
128793555|NCT05061693|463536994|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
128793556|NCT05061693|463536995|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
128793557|NCT05061693|463536996|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
128793558|NCT05061693|463536997|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
128793559|NCT05061693|463536998|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128793560|NCT05061693|463536999|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128793561|NCT05061693|463537000|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128793562|NCT05061693|463537001|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128793563|NCT05061693|463537002|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128793564|NCT05061693|463537003|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128758899|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
128758900|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
128758901|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
128758902|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
128758903|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
128758904|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
128758905|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
128758906|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
128758907|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
128758908|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
128758909|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
128758910|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
128758911|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
128758912|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
128758913|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
128758914|NCT00549757|463406823|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
128758915|NCT00549757|463406824|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
128758916|NCT00549757|463406823|FG000|Extension Period (in Average 9 Months)|Death|143|||
128758917|NCT00549757|463406824|FG001|Extension Period (in Average 9 Months)|Death|136|||
128793565|NCT05061693|463537004|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128793566|NCT05061693|463537005|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
128793567|NCT05061693|463536994|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
128793568|NCT05061693|463536995|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
128793569|NCT05061693|463536996|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
128793570|NCT05061693|463536997|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
128793571|NCT05061693|463536998|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793572|NCT05061693|463536999|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793573|NCT05061693|463537000|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793574|NCT05061693|463537001|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793575|NCT05061693|463537002|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793576|NCT05061693|463537003|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793577|NCT05061693|463537004|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793578|NCT05061693|463537005|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
128793579|NCT05061693|463536994|FG000|24-week Extension Period|Adverse Event|0|||
128793580|NCT05061693|463536995|FG001|24-week Extension Period|Adverse Event|0|||
128793581|NCT05061693|463536996|FG002|24-week Extension Period|Adverse Event|0|||
128793582|NCT05061693|463536997|FG003|24-week Extension Period|Adverse Event|0|||
128793583|NCT05061693|463536998|FG004|24-week Extension Period|Adverse Event|0|||
128793584|NCT05061693|463536999|FG005|24-week Extension Period|Adverse Event|0|||
128793585|NCT05061693|463537000|FG006|24-week Extension Period|Adverse Event|0|||
128793586|NCT05061693|463537001|FG007|24-week Extension Period|Adverse Event|2|||
128793587|NCT05061693|463537002|FG008|24-week Extension Period|Adverse Event|2|||
128793588|NCT05061693|463537003|FG009|24-week Extension Period|Adverse Event|0|||
128793589|NCT05061693|463537004|FG010|24-week Extension Period|Adverse Event|1|||
128793590|NCT05061693|463537005|FG011|24-week Extension Period|Adverse Event|3|||
128793591|NCT05061693|463536994|FG000|24-week Extension Period|Lack of Efficacy|0|||
128793592|NCT05061693|463536995|FG001|24-week Extension Period|Lack of Efficacy|0|||
128793593|NCT05061693|463536996|FG002|24-week Extension Period|Lack of Efficacy|0|||
128793594|NCT05061693|463536997|FG003|24-week Extension Period|Lack of Efficacy|0|||
128793595|NCT05061693|463536998|FG004|24-week Extension Period|Lack of Efficacy|0|||
128793596|NCT05061693|463536999|FG005|24-week Extension Period|Lack of Efficacy|0|||
128793597|NCT05061693|463537000|FG006|24-week Extension Period|Lack of Efficacy|0|||
128793598|NCT05061693|463537001|FG007|24-week Extension Period|Lack of Efficacy|0|||
128793599|NCT05061693|463537002|FG008|24-week Extension Period|Lack of Efficacy|0|||
128793600|NCT05061693|463537003|FG009|24-week Extension Period|Lack of Efficacy|0|||
128793601|NCT05061693|463537004|FG010|24-week Extension Period|Lack of Efficacy|2|||
128793602|NCT05061693|463537005|FG011|24-week Extension Period|Lack of Efficacy|0|||
128793603|NCT05061693|463536994|FG000|24-week Extension Period|Lost to Follow-up|0|||
128793604|NCT05061693|463536995|FG001|24-week Extension Period|Lost to Follow-up|0|||
128793605|NCT05061693|463536996|FG002|24-week Extension Period|Lost to Follow-up|0|||
128793606|NCT05061693|463536997|FG003|24-week Extension Period|Lost to Follow-up|0|||
128793607|NCT05061693|463536998|FG004|24-week Extension Period|Lost to Follow-up|0|||
128793608|NCT05061693|463536999|FG005|24-week Extension Period|Lost to Follow-up|0|||
128793609|NCT05061693|463537000|FG006|24-week Extension Period|Lost to Follow-up|1|||
128793610|NCT05061693|463537001|FG007|24-week Extension Period|Lost to Follow-up|0|||
128793611|NCT05061693|463537002|FG008|24-week Extension Period|Lost to Follow-up|1|||
128793612|NCT05061693|463537003|FG009|24-week Extension Period|Lost to Follow-up|1|||
128793613|NCT05061693|463537004|FG010|24-week Extension Period|Lost to Follow-up|0|||
128793614|NCT05061693|463537005|FG011|24-week Extension Period|Lost to Follow-up|0|||
128793615|NCT05061693|463536994|FG000|24-week Extension Period|Withdrawal by Subject|0|||
128793616|NCT05061693|463536995|FG001|24-week Extension Period|Withdrawal by Subject|0|||
128793617|NCT05061693|463536996|FG002|24-week Extension Period|Withdrawal by Subject|0|||
128793618|NCT05061693|463536997|FG003|24-week Extension Period|Withdrawal by Subject|0|||
128793619|NCT05061693|463536998|FG004|24-week Extension Period|Withdrawal by Subject|0|||
128793620|NCT05061693|463536999|FG005|24-week Extension Period|Withdrawal by Subject|0|||
128793621|NCT05061693|463537000|FG006|24-week Extension Period|Withdrawal by Subject|0|||
128793622|NCT05061693|463537001|FG007|24-week Extension Period|Withdrawal by Subject|0|||
128793623|NCT05061693|463537002|FG008|24-week Extension Period|Withdrawal by Subject|1|||
128793624|NCT05061693|463537003|FG009|24-week Extension Period|Withdrawal by Subject|2|||
128793625|NCT05061693|463537004|FG010|24-week Extension Period|Withdrawal by Subject|2|||
128793626|NCT05061693|463537005|FG011|24-week Extension Period|Withdrawal by Subject|1|||
128793627|NCT05061693|463536994|FG000|24-week Extension Period|Sponsor Decision|0|||
128793628|NCT05061693|463536995|FG001|24-week Extension Period|Sponsor Decision|0|||
128793629|NCT05061693|463536996|FG002|24-week Extension Period|Sponsor Decision|0|||
128793630|NCT05061693|463536997|FG003|24-week Extension Period|Sponsor Decision|0|||
128793631|NCT05061693|463536998|FG004|24-week Extension Period|Sponsor Decision|0|||
128793632|NCT05061693|463536999|FG005|24-week Extension Period|Sponsor Decision|0|||
128793633|NCT05061693|463537000|FG006|24-week Extension Period|Sponsor Decision|0|||
128793634|NCT05061693|463537001|FG007|24-week Extension Period|Sponsor Decision|1|||
128793635|NCT05061693|463537002|FG008|24-week Extension Period|Sponsor Decision|0|||
128793636|NCT05061693|463537003|FG009|24-week Extension Period|Sponsor Decision|0|||
128793637|NCT05061693|463537004|FG010|24-week Extension Period|Sponsor Decision|0|||
128793638|NCT05061693|463537005|FG011|24-week Extension Period|Sponsor Decision|0|||
128793639|NCT05061693|463536994|FG000|24-week Extension Period|Site Closure|0|||
128793640|NCT05061693|463536995|FG001|24-week Extension Period|Site Closure|0|||
128793641|NCT05061693|463536996|FG002|24-week Extension Period|Site Closure|0|||
128793642|NCT05061693|463536997|FG003|24-week Extension Period|Site Closure|0|||
128793643|NCT05061693|463536998|FG004|24-week Extension Period|Site Closure|0|||
128793644|NCT05061693|463536999|FG005|24-week Extension Period|Site Closure|0|||
128793645|NCT05061693|463537000|FG006|24-week Extension Period|Site Closure|0|||
128793646|NCT05061693|463537001|FG007|24-week Extension Period|Site Closure|0|||
128793647|NCT05061693|463537002|FG008|24-week Extension Period|Site Closure|1|||
128793648|NCT05061693|463537003|FG009|24-week Extension Period|Site Closure|0|||
128793649|NCT05061693|463537004|FG010|24-week Extension Period|Site Closure|0|||
128793650|NCT05061693|463537005|FG011|24-week Extension Period|Site Closure|1|||
128793651|NCT01152190|463537006|FG000|Overall Study|Adverse Event|2|||
128793652|NCT01152190|463537007|FG001|Overall Study|Adverse Event|4|||
128793653|NCT01152190|463537006|FG000|Overall Study|Death|1|||
128793654|NCT01152190|463537007|FG001|Overall Study|Death|0|||
128793655|NCT01152190|463537006|FG000|Overall Study|Protocol Violation|1|||
128793656|NCT01152190|463537007|FG001|Overall Study|Protocol Violation|1|||
128793657|NCT01152190|463537006|FG000|Overall Study|Withdrawal by Subject|1|||
128793658|NCT01152190|463537007|FG001|Overall Study|Withdrawal by Subject|3|||
128793659|NCT03823911|463537008|FG000|Overall Study|Lost to Follow-up|1|||
128793660|NCT03823911|463537009|FG001|Overall Study|Lost to Follow-up|5|||
128793661|NCT03823911|463537010|FG002|Overall Study|Lost to Follow-up|2|||
128793662|NCT03823911|463537008|FG000|Overall Study|Did not meet eligibility criteria|13|||
128793663|NCT03823911|463537009|FG001|Overall Study|Did not meet eligibility criteria|7|||
128793664|NCT03823911|463537010|FG002|Overall Study|Did not meet eligibility criteria|4|||
128793665|NCT03823911|463537008|FG000|Overall Study|Death|0|||
128793666|NCT03823911|463537009|FG001|Overall Study|Death|1|||
128793667|NCT03823911|463537010|FG002|Overall Study|Death|0|||
128793668|NCT00258895|463537011|FG000|Overall Study|Lost to Follow-up|3|||
128793669|NCT00258895|463537012|FG001|Overall Study|Lost to Follow-up|1|||
128793670|NCT00258895|463537011|FG000|Overall Study|Protocol Violation|6|||
128793671|NCT00258895|463537012|FG001|Overall Study|Protocol Violation|2|||
128793672|NCT00258895|463537011|FG000|Overall Study|Withdrawal by Subject|1|||
128793673|NCT00258895|463537012|FG001|Overall Study|Withdrawal by Subject|0|||
128793674|NCT00547118|463537013|FG000|Overall Study|Did not qualify prior to starting drug|1|||
128793675|NCT00547118|463537014|FG001|Overall Study|Did not qualify prior to starting drug|1|||
128793676|NCT00547118|463537013|FG000|Overall Study|Study suspended|7|||
128793677|NCT00547118|463537014|FG001|Overall Study|Study suspended|8|||
128793678|NCT02248480|463537017|FG000|Overall Study|Lack of Efficacy|4|||
128793679|NCT02248480|463537018|FG001|Overall Study|Lack of Efficacy|6|||
128793680|NCT02248480|463537017|FG000|Overall Study|Adverse Event|11|||
128793681|NCT02248480|463537018|FG001|Overall Study|Adverse Event|2|||
128793682|NCT02248480|463537017|FG000|Overall Study|Withdrawal by Subject|2|||
128793683|NCT02248480|463537018|FG001|Overall Study|Withdrawal by Subject|4|||
128793684|NCT02248480|463537017|FG000|Overall Study|Entry Criteria Not Met|0|||
128793685|NCT02248480|463537018|FG001|Overall Study|Entry Criteria Not Met|1|||
128793686|NCT02248480|463537017|FG000|Overall Study|Other:Physician Decision|0|||
128793687|NCT02248480|463537018|FG001|Overall Study|Other:Physician Decision|1|||
128793688|NCT01595321|463537019|FG000|Overall Study|Adverse Event|1|||
128793689|NCT01595321|463537020|FG001|Overall Study|Adverse Event|1|||
128793690|NCT01595321|463537021|FG002|Overall Study|Adverse Event|1|||
128793691|NCT01595321|463537019|FG000|Overall Study|Lack of Efficacy|0|||
128793692|NCT01595321|463537020|FG001|Overall Study|Lack of Efficacy|0|||
128793693|NCT01595321|463537021|FG002|Overall Study|Lack of Efficacy|4|||
128793694|NCT04504916|463537022|FG000|Overall Study|Study terminated|7|||
128793695|NCT04504916|463537023|FG001|Overall Study|Study terminated|8|||
128793696|NCT04504916|463537022|FG000|Overall Study|Death|54|||
128793697|NCT04504916|463537023|FG001|Overall Study|Death|18|||
128793698|NCT04504916|463537022|FG000|Overall Study|Lost to Follow-up|1|||
128793699|NCT04504916|463537023|FG001|Overall Study|Lost to Follow-up|1|||
128793700|NCT04504916|463537022|FG000|Overall Study|Withdrawal by Subject|8|||
128793701|NCT04504916|463537023|FG001|Overall Study|Withdrawal by Subject|4|||
128793702|NCT04504916|463537022|FG000|Overall Study|Did not agree to follow-up|0|||
128793703|NCT04504916|463537023|FG001|Overall Study|Did not agree to follow-up|1|||
128793704|NCT00834834|463537024|FG000|Overall Study|Withdrawal by Subject|4|||
128793705|NCT00834834|463537025|FG001|Overall Study|Withdrawal by Subject|3|||
128793706|NCT00373529|463537026|FG000|Overall Study|Physician Decision|19|||
128793707|NCT00373529|463537026|FG000|Overall Study|Withdrawal by Subject|7|||
128793708|NCT00373529|463537026|FG000|Overall Study|Adverse Event|7|||
128793709|NCT00373529|463537026|FG000|Overall Study|Treatment failure|36|||
128793710|NCT00373529|463537026|FG000|Overall Study|Disease recurrence|10|||
128793711|NCT00373529|463537026|FG000|Overall Study|Death|16|||
128793712|NCT00373529|463537026|FG000|Overall Study|Need for treatment prohibited by study|1|||
128793713|NCT00373529|463537026|FG000|Overall Study|Other|8|||
128793714|NCT00373529|463537026|FG000|Overall Study|Failed independent confirmation of AML|3|||
128793715|NCT00373529|463537026|FG000|Overall Study|Consent violation|1|||
128793716|NCT00442117|463537027|FG000|Overall Study|Adverse Event|3|||
128793717|NCT00442117|463537028|FG001|Overall Study|Adverse Event|2|||
128793718|NCT00442117|463537027|FG000|Overall Study|Lack of Efficacy|2|||
128793719|NCT00442117|463537028|FG001|Overall Study|Lack of Efficacy|6|||
128793720|NCT00442117|463537027|FG000|Overall Study|Lost to Follow-up|1|||
128793721|NCT00442117|463537028|FG001|Overall Study|Lost to Follow-up|2|||
128793722|NCT00442117|463537027|FG000|Overall Study|Withdrawal by Subject|2|||
128793723|NCT00442117|463537028|FG001|Overall Study|Withdrawal by Subject|2|||
128793724|NCT00442117|463537027|FG000|Overall Study|Major Deviation|25|||
128793725|NCT00442117|463537028|FG001|Overall Study|Major Deviation|20|||
128793726|NCT00442117|463537027|FG000|Overall Study|Non compliance with protocol|3|||
128793727|NCT00442117|463537028|FG001|Overall Study|Non compliance with protocol|5|||
128793728|NCT00442117|463537027|FG000|Overall Study|Met Withdrawal Criteria|2|||
128793729|NCT00442117|463537028|FG001|Overall Study|Met Withdrawal Criteria|1|||
128793730|NCT00539292|463537034|FG000|Overall Study|Physician Decision|1|||
128793731|NCT00539292|463537035|FG001|Overall Study|Physician Decision|0|||
128793732|NCT00630786|463537036|FG000|Overall Study|Physician Decision|0|||
128793733|NCT00630786|463537037|FG001|Overall Study|Physician Decision|0|||
128793734|NCT00630786|463537038|FG002|Overall Study|Physician Decision|1|||
128793735|NCT00630786|463537036|FG000|Overall Study|Withdrawal by Subject|0|||
128793736|NCT00630786|463537037|FG001|Overall Study|Withdrawal by Subject|1|||
128793737|NCT00630786|463537038|FG002|Overall Study|Withdrawal by Subject|1|||
128793738|NCT00630786|463537036|FG000|Overall Study|Lost to Follow-up|0|||
128793739|NCT00630786|463537037|FG001|Overall Study|Lost to Follow-up|1|||
128793740|NCT00630786|463537038|FG002|Overall Study|Lost to Follow-up|0|||
128793741|NCT00630786|463537036|FG000|Overall Study|Other|1|||
128793742|NCT00630786|463537037|FG001|Overall Study|Other|0|||
128793743|NCT00630786|463537038|FG002|Overall Study|Other|0|||
128793744|NCT02020616|463537040|FG000|Overall Study|Adverse Event|0|||
128793745|NCT02020616|463537041|FG001|Overall Study|Adverse Event|0|||
128793746|NCT02020616|463537042|FG002|Overall Study|Adverse Event|0|||
128793747|NCT02020616|463537043|FG003|Overall Study|Adverse Event|0|||
128758918|NCT00549757|463406823|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
128758919|NCT00549757|463406824|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
128758920|NCT00549757|463406823|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
128758921|NCT00549757|463406824|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
128758922|NCT00549757|463406823|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
128758923|NCT00549757|463406824|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
128758924|NCT00293267|463406825|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
128758925|NCT00293267|463406826|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
128758926|NCT00293267|463406825|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
128758927|NCT00293267|463406826|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
128758928|NCT00293267|463406825|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
128758929|NCT00293267|463406826|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
128758930|NCT00293267|463406825|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
128758931|NCT00293267|463406826|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
128758932|NCT00293267|463406825|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
128758933|NCT00293267|463406826|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
128758934|NCT00293267|463406825|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
128758935|NCT00293267|463406826|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
128758936|NCT00293267|463406825|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
128758937|NCT00293267|463406826|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
128758938|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
128758939|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
128758940|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
128758941|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
128758942|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
128758943|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
128758944|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
128758945|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
128758946|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Death|3|||
128758947|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Death|0|||
128758948|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
128758949|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
128758950|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
128758951|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
128758952|NCT00293267|463406825|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
128758953|NCT00293267|463406826|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
128758954|NCT00293267|463406825|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
128758955|NCT00293267|463406826|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
128758956|NCT00293267|463406825|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
128758957|NCT00293267|463406826|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
128758958|NCT00293267|463406825|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
128758959|NCT00293267|463406826|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
128758960|NCT00293267|463406825|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
128758961|NCT00293267|463406826|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
128758962|NCT00293267|463406825|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
128758963|NCT00293267|463406826|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
128758964|NCT00293267|463406825|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
128758965|NCT00293267|463406826|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
128758966|NCT00293267|463406825|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
128758967|NCT00293267|463406826|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
128758968|NCT00293267|463406825|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
128758969|NCT00293267|463406826|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
128758970|NCT00293267|463406825|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
128758971|NCT00293267|463406826|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
128758972|NCT00293267|463406825|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
128758973|NCT00293267|463406826|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
128758974|NCT00293267|463406825|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
128758975|NCT00293267|463406826|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
128758976|NCT00293267|463406825|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
128758977|NCT00293267|463406826|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
128758978|NCT00293267|463406825|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
128758979|NCT00293267|463406826|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
128758980|NCT01477853|463406827|FG000|Phase A|Adverse Event|1|||
128793748|NCT02020616|463537044|FG004|Overall Study|Adverse Event|0|||
128793749|NCT02020616|463537045|FG005|Overall Study|Adverse Event|1|||
128793750|NCT02020616|463537046|FG006|Overall Study|Adverse Event|1|||
128793751|NCT02020616|463537040|FG000|Overall Study|Physician Decision|0|||
128793752|NCT02020616|463537041|FG001|Overall Study|Physician Decision|0|||
128793753|NCT02020616|463537042|FG002|Overall Study|Physician Decision|0|||
128793754|NCT02020616|463537043|FG003|Overall Study|Physician Decision|0|||
128793755|NCT02020616|463537044|FG004|Overall Study|Physician Decision|0|||
128793756|NCT02020616|463537045|FG005|Overall Study|Physician Decision|1|||
128793757|NCT02020616|463537046|FG006|Overall Study|Physician Decision|2|||
128793758|NCT02020616|463537040|FG000|Overall Study|Withdrawal by Subject|0|||
128793759|NCT02020616|463537041|FG001|Overall Study|Withdrawal by Subject|0|||
128793760|NCT02020616|463537042|FG002|Overall Study|Withdrawal by Subject|1|||
128793761|NCT02020616|463537043|FG003|Overall Study|Withdrawal by Subject|0|||
128793762|NCT02020616|463537044|FG004|Overall Study|Withdrawal by Subject|0|||
128793763|NCT02020616|463537045|FG005|Overall Study|Withdrawal by Subject|1|||
128793764|NCT02020616|463537046|FG006|Overall Study|Withdrawal by Subject|1|||
128793765|NCT02020616|463537040|FG000|Overall Study|Lost to Follow-up|0|||
128793766|NCT02020616|463537041|FG001|Overall Study|Lost to Follow-up|1|||
128793767|NCT02020616|463537042|FG002|Overall Study|Lost to Follow-up|0|||
128793768|NCT02020616|463537043|FG003|Overall Study|Lost to Follow-up|1|||
128793769|NCT02020616|463537044|FG004|Overall Study|Lost to Follow-up|1|||
128793770|NCT02020616|463537045|FG005|Overall Study|Lost to Follow-up|1|||
128793771|NCT02020616|463537046|FG006|Overall Study|Lost to Follow-up|0|||
128793772|NCT02020616|463537040|FG000|Overall Study|Early Termination Criteria Met|0|||
128793773|NCT02020616|463537041|FG001|Overall Study|Early Termination Criteria Met|0|||
128793774|NCT02020616|463537042|FG002|Overall Study|Early Termination Criteria Met|1|||
128793775|NCT02020616|463537043|FG003|Overall Study|Early Termination Criteria Met|0|||
128793776|NCT02020616|463537044|FG004|Overall Study|Early Termination Criteria Met|0|||
128793777|NCT02020616|463537045|FG005|Overall Study|Early Termination Criteria Met|1|||
128793778|NCT02020616|463537046|FG006|Overall Study|Early Termination Criteria Met|0|||
128793779|NCT02020616|463537040|FG000|Overall Study|Randomized in Error|0|||
128793780|NCT02020616|463537041|FG001|Overall Study|Randomized in Error|0|||
128793781|NCT02020616|463537042|FG002|Overall Study|Randomized in Error|0|||
128793782|NCT02020616|463537043|FG003|Overall Study|Randomized in Error|1|||
128793783|NCT02020616|463537044|FG004|Overall Study|Randomized in Error|0|||
128793784|NCT02020616|463537045|FG005|Overall Study|Randomized in Error|0|||
128793785|NCT02020616|463537046|FG006|Overall Study|Randomized in Error|0|||
128793786|NCT02020616|463537040|FG000|Overall Study|Lack of Efficacy|0|||
128793787|NCT02020616|463537041|FG001|Overall Study|Lack of Efficacy|0|||
128793788|NCT02020616|463537042|FG002|Overall Study|Lack of Efficacy|0|||
128793789|NCT02020616|463537043|FG003|Overall Study|Lack of Efficacy|0|||
128793790|NCT02020616|463537044|FG004|Overall Study|Lack of Efficacy|1|||
128793791|NCT02020616|463537045|FG005|Overall Study|Lack of Efficacy|0|||
128793792|NCT02020616|463537046|FG006|Overall Study|Lack of Efficacy|0|||
128793793|NCT02031471|463537049|FG000|24 Week Treatment Period|Adverse Event|6|||
128793794|NCT02031471|463537049|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
128793795|NCT02031471|463537049|FG000|24 Week Treatment Period|Protocol Violation|1|||
128793796|NCT02031471|463537049|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
128793797|NCT02031471|463537049|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
128793798|NCT02031471|463537049|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
128793799|NCT02031471|463537049|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
128793800|NCT00997386|463537051|FG000|Overall Study|Death|7|||
128793801|NCT01579916|463537053|FG000|Overall Study|Lost to Follow-up|6|||
128793802|NCT01579916|463537054|FG001|Overall Study|Lost to Follow-up|1|||
128793803|NCT01579916|463537053|FG000|Overall Study|Withdrawal by Subject|1|||
128793804|NCT01579916|463537054|FG001|Overall Study|Withdrawal by Subject|1|||
128793805|NCT01579916|463537053|FG000|Overall Study|Death|1|||
128793806|NCT01579916|463537054|FG001|Overall Study|Death|0|||
128793807|NCT02994654|463537056|FG000|Overall Study|Lost to Follow-up|1|||
128793808|NCT03603717|463537065|FG000|Overall Study|Lost to Follow-up|20|||
128793809|NCT03603717|463537066|FG001|Overall Study|Lost to Follow-up|20|||
128793810|NCT03603717|463537065|FG000|Overall Study|Withdrawal by Subject|16|||
128793811|NCT03603717|463537066|FG001|Overall Study|Withdrawal by Subject|10|||
128793812|NCT00732381|463537067|FG000|Overall Study|Adverse Event|1|||
128793813|NCT00732381|463537068|FG001|Overall Study|Adverse Event|0|||
128793814|NCT00732381|463537067|FG000|Overall Study|Treatment Failure|1|||
128793815|NCT00732381|463537068|FG001|Overall Study|Treatment Failure|1|||
128793816|NCT00573833|463537072|FG000|Overall Study|Not Treated|2|||
128793817|NCT03544515|463538536|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
128793818|NCT03544515|463538537|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
128793819|NCT03544515|463538536|FG000|Overall Study|Lost to Follow-up|2|||
128793820|NCT03544515|463538537|FG001|Overall Study|Lost to Follow-up|0|||
128793821|NCT03175172|463538538|FG000|Overall Study|Death|3|||
128793822|NCT03175172|463538538|FG000|Overall Study|Withdrawal by Subject|3|||
128793823|NCT03175172|463538538|FG000|Overall Study|Lost to Follow-up|1|||
128793824|NCT03175172|463538538|FG000|Overall Study|Study Terminated by Sponsor|3|||
128793825|NCT03169244|463538539|FG000|Overall Study|Lost to Follow-up|1|||
128793826|NCT03169244|463538540|FG001|Overall Study|Lost to Follow-up|2|||
128793827|NCT03169244|463538539|FG000|Overall Study|Adverse Event|1|||
128793828|NCT03169244|463538540|FG001|Overall Study|Adverse Event|0|||
128793829|NCT03169244|463538539|FG000|Overall Study|Withdrawal by Subject|2|||
128793830|NCT03169244|463538540|FG001|Overall Study|Withdrawal by Subject|2|||
128793831|NCT03169244|463538539|FG000|Overall Study|Physician Decision|1|||
128793832|NCT03169244|463538540|FG001|Overall Study|Physician Decision|0|||
128793833|NCT01662336|463538541|FG000|Overall Study|Adverse Event|1|||
128793834|NCT01662336|463538541|FG000|Overall Study|No longer on LPV/r|30|||
128793835|NCT01662336|463538541|FG000|Overall Study|Other|29|||
128793836|NCT01662336|463538541|FG000|Overall Study|Withdrawal by Subject|6|||
128793837|NCT04668339|463538542|FG000|Overall Study|Physician Decision|1|||
128793838|NCT04668339|463538543|FG001|Overall Study|Physician Decision|0|||
128793839|NCT04668339|463538544|FG002|Overall Study|Physician Decision|1|||
128793840|NCT04668339|463538545|FG003|Overall Study|Physician Decision|1|||
128793841|NCT04668339|463538542|FG000|Overall Study|Lost to Follow-up|14|||
128793842|NCT04668339|463538543|FG001|Overall Study|Lost to Follow-up|12|||
128793843|NCT04668339|463538544|FG002|Overall Study|Lost to Follow-up|8|||
128793844|NCT04668339|463538545|FG003|Overall Study|Lost to Follow-up|5|||
128793845|NCT04668339|463538542|FG000|Overall Study|Adverse Event|0|||
128793846|NCT04668339|463538543|FG001|Overall Study|Adverse Event|0|||
128793847|NCT04668339|463538544|FG002|Overall Study|Adverse Event|1|||
128793848|NCT04668339|463538545|FG003|Overall Study|Adverse Event|0|||
128793849|NCT04668339|463538542|FG000|Overall Study|Other than specified|3|||
128793850|NCT04668339|463538543|FG001|Overall Study|Other than specified|0|||
128793851|NCT04668339|463538544|FG002|Overall Study|Other than specified|1|||
128793852|NCT04668339|463538545|FG003|Overall Study|Other than specified|0|||
128793853|NCT04668339|463538542|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
128793854|NCT04668339|463538543|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
128793855|NCT04668339|463538544|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
128793856|NCT04668339|463538545|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
128793857|NCT04668339|463538542|FG000|Overall Study|Vaccine not Administered|0|||
128793858|NCT04668339|463538543|FG001|Overall Study|Vaccine not Administered|0|||
128793859|NCT04668339|463538544|FG002|Overall Study|Vaccine not Administered|1|||
128793860|NCT04668339|463538545|FG003|Overall Study|Vaccine not Administered|0|||
128793861|NCT04668339|463538542|FG000|Overall Study|Protocol Violation|18|||
128793862|NCT04668339|463538543|FG001|Overall Study|Protocol Violation|23|||
128793863|NCT04668339|463538544|FG002|Overall Study|Protocol Violation|12|||
128793864|NCT04668339|463538545|FG003|Overall Study|Protocol Violation|20|||
128793865|NCT04668339|463538542|FG000|Overall Study|Withdrawal by Subject|45|||
128793866|NCT04668339|463538543|FG001|Overall Study|Withdrawal by Subject|46|||
128793867|NCT04668339|463538544|FG002|Overall Study|Withdrawal by Subject|46|||
128793868|NCT04668339|463538545|FG003|Overall Study|Withdrawal by Subject|27|||
128793869|NCT04668339|463538542|FG000|Overall Study|Study Terminated by Sponsor|59|||
128793870|NCT04668339|463538543|FG001|Overall Study|Study Terminated by Sponsor|59|||
128793871|NCT04668339|463538544|FG002|Overall Study|Study Terminated by Sponsor|71|||
128793872|NCT04668339|463538545|FG003|Overall Study|Study Terminated by Sponsor|1|||
128793873|NCT03622593|463538546|FG000|Overall Study|Withdrawal by Subject|11|||
128793874|NCT03622593|463538547|FG001|Overall Study|Withdrawal by Subject|9|||
128793875|NCT03622593|463538548|FG002|Overall Study|Withdrawal by Subject|13|||
128793876|NCT03622593|463538546|FG000|Overall Study|Death|12|||
128793877|NCT03622593|463538547|FG001|Overall Study|Death|9|||
128793878|NCT03622593|463538548|FG002|Overall Study|Death|10|||
128793879|NCT03622593|463538546|FG000|Overall Study|Lost to Follow-up|11|||
128793880|NCT03622593|463538547|FG001|Overall Study|Lost to Follow-up|5|||
128793881|NCT03622593|463538548|FG002|Overall Study|Lost to Follow-up|8|||
128793882|NCT03622593|463538546|FG000|Overall Study|Adverse Event|4|||
128793883|NCT03622593|463538547|FG001|Overall Study|Adverse Event|5|||
128793884|NCT03622593|463538548|FG002|Overall Study|Adverse Event|6|||
128793885|NCT03622593|463538546|FG000|Overall Study|Physician Decision|2|||
128793886|NCT03622593|463538547|FG001|Overall Study|Physician Decision|1|||
128793887|NCT03622593|463538548|FG002|Overall Study|Physician Decision|6|||
128793888|NCT03622593|463538546|FG000|Overall Study|Other|2|||
128793889|NCT03622593|463538547|FG001|Overall Study|Other|2|||
128793890|NCT03622593|463538548|FG002|Overall Study|Other|3|||
128793891|NCT03622593|463538546|FG000|Overall Study|Protocol Violation|0|||
128793892|NCT03622593|463538547|FG001|Overall Study|Protocol Violation|0|||
128793893|NCT03622593|463538548|FG002|Overall Study|Protocol Violation|1|||
128793894|NCT03622593|463538546|FG000|Overall Study|Pregnancy|0|||
128793895|NCT03622593|463538547|FG001|Overall Study|Pregnancy|0|||
128793896|NCT03622593|463538548|FG002|Overall Study|Pregnancy|1|||
128793897|NCT00178399|463538549|FG000|Overall Study|Physician Decision|4|||
128793898|NCT00178399|463538549|FG000|Overall Study|Withdrawal by Subject|8|||
128793899|NCT00178399|463538549|FG000|Overall Study|Lost to Follow-up|1|||
128793900|NCT02139046|463538550|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
128793901|NCT02139046|463538551|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
128793902|NCT02139046|463538552|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
128793903|NCT02139046|463538553|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
128793904|NCT02139046|463538554|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
128793905|NCT02139046|463538550|FG000|Overall Study|Major Protocol Deviation|9|||
128793906|NCT02139046|463538551|FG001|Overall Study|Major Protocol Deviation|10|||
128793907|NCT02139046|463538552|FG002|Overall Study|Major Protocol Deviation|16|||
128793908|NCT02139046|463538553|FG003|Overall Study|Major Protocol Deviation|12|||
128793909|NCT02139046|463538554|FG004|Overall Study|Major Protocol Deviation|6|||
128793910|NCT02139046|463538550|FG000|Overall Study|Lost to Follow-up|13|||
128793911|NCT02139046|463538551|FG001|Overall Study|Lost to Follow-up|16|||
128793912|NCT02139046|463538552|FG002|Overall Study|Lost to Follow-up|16|||
128793913|NCT02139046|463538553|FG003|Overall Study|Lost to Follow-up|18|||
128793914|NCT02139046|463538554|FG004|Overall Study|Lost to Follow-up|13|||
128793915|NCT02139046|463538550|FG000|Overall Study|Voluntary Withdrawal|20|||
128793916|NCT02139046|463538551|FG001|Overall Study|Voluntary Withdrawal|8|||
128793917|NCT02139046|463538552|FG002|Overall Study|Voluntary Withdrawal|10|||
128793918|NCT02139046|463538553|FG003|Overall Study|Voluntary Withdrawal|15|||
128793919|NCT02139046|463538554|FG004|Overall Study|Voluntary Withdrawal|16|||
128793920|NCT02139046|463538550|FG000|Overall Study|Lack of Efficacy|0|||
128793921|NCT02139046|463538551|FG001|Overall Study|Lack of Efficacy|1|||
128793922|NCT02139046|463538552|FG002|Overall Study|Lack of Efficacy|2|||
128793923|NCT02139046|463538553|FG003|Overall Study|Lack of Efficacy|1|||
128793924|NCT02139046|463538554|FG004|Overall Study|Lack of Efficacy|2|||
128793925|NCT02139046|463538550|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
128793926|NCT02139046|463538551|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
128793927|NCT02139046|463538552|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
128793928|NCT02139046|463538553|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
128793929|NCT02139046|463538554|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
128793930|NCT02139046|463538550|FG000|Overall Study|Other Miscellaneous Reasons|10|||
128793931|NCT02139046|463538551|FG001|Overall Study|Other Miscellaneous Reasons|9|||
128793932|NCT02139046|463538552|FG002|Overall Study|Other Miscellaneous Reasons|4|||
128793933|NCT02139046|463538553|FG003|Overall Study|Other Miscellaneous Reasons|9|||
128793934|NCT02139046|463538554|FG004|Overall Study|Other Miscellaneous Reasons|12|||
128793935|NCT03557008|463538555|FG000|Overall Study|Withdrawal by Subject|2|||
128793936|NCT03557008|463538556|FG001|Overall Study|Withdrawal by Subject|2|||
128793937|NCT03557008|463538555|FG000|Overall Study|Early termination from study|3|||
128793938|NCT03557008|463538556|FG001|Overall Study|Early termination from study|1|||
128793939|NCT01765543|463538558|FG000|Overall Study|Death|1|||
128793940|NCT01765543|463538558|FG000|Overall Study|Withdrawal by Subject|2|||
128793941|NCT05876949|463538559|FG000|Overall Study|Withdrawal by Subject|1|||
128793942|NCT05876949|463538560|FG001|Overall Study|Withdrawal by Subject|3|||
128793943|NCT05876949|463538559|FG000|Overall Study|Physician Decision|0|||
128793944|NCT05876949|463538560|FG001|Overall Study|Physician Decision|2|||
128793945|NCT05876949|463538559|FG000|Overall Study|Death|0|||
128793946|NCT05876949|463538560|FG001|Overall Study|Death|1|||
128793947|NCT03644849|463538561|FG000|Overall Study|Lost to Follow-up|1|||
128793948|NCT03644849|463538562|FG001|Overall Study|Lost to Follow-up|3|||
128793949|NCT01177670|463538563|FG000|Overall Study|Study Terminated|115|||
128793950|NCT01177670|463538563|FG000|Overall Study|Physician Decision|50|||
128793951|NCT01177670|463538563|FG000|Overall Study|Withdrawal by Subject|4|||
128793952|NCT01145885|463538566|FG000|Overall Study|Progressive Disease|7|||
128793953|NCT03691428|463538567|FG000|Overall Study|Withdrawal by Subject|6|||
128793954|NCT03691428|463538568|FG001|Overall Study|Withdrawal by Subject|8|||
128793955|NCT02527148|463538569|FG000|Overall Study|Did not receive study intervention|1|||
128793956|NCT02527148|463538570|FG001|Overall Study|Did not receive study intervention|0|||
128793957|NCT01140048|463538571|FG000|Overall Study|Physician Decision|1|||
128793958|NCT01140048|463538571|FG000|Overall Study|Withdrawal by Subject|13|||
128793959|NCT01140048|463538571|FG000|Overall Study|Lost to Follow-up|31|||
128793960|NCT01831791|463538572|FG000|Overall Study|Withdrawal by Subject|10|||
128793961|NCT00494780|463538573|FG000|Overall Study|Adverse Event|1|||
128793962|NCT00494780|463538574|FG001|Overall Study|Adverse Event|0|||
128793963|NCT00494780|463538573|FG000|Overall Study|Withdrew before Dosed|0|||
128793964|NCT00494780|463538574|FG001|Overall Study|Withdrew before Dosed|1|||
128793965|NCT00494780|463538573|FG000|Overall Study|Progression of Study Disease|7|||
128793966|NCT00494780|463538574|FG001|Overall Study|Progression of Study Disease|8|||
128793967|NCT00494780|463538573|FG000|Overall Study|New Treatment|2|||
128793968|NCT00494780|463538574|FG001|Overall Study|New Treatment|2|||
128793969|NCT00494780|463538573|FG000|Overall Study|Non-compliance|1|||
128793970|NCT00494780|463538574|FG001|Overall Study|Non-compliance|0|||
128793971|NCT00494780|463538573|FG000|Overall Study|Residual Tumour Mass|0|||
128793972|NCT00494780|463538574|FG001|Overall Study|Residual Tumour Mass|1|||
128793973|NCT00494780|463538573|FG000|Overall Study|Insurance Issues|0|||
128793974|NCT00494780|463538574|FG001|Overall Study|Insurance Issues|1|||
128793975|NCT01254019|463538575|FG000|Overall Study|Adverse Event|0|||
128793976|NCT01254019|463538576|FG001|Overall Study|Adverse Event|2|||
128793977|NCT01254019|463538575|FG000|Overall Study|Protocol Violation|1|||
128793978|NCT01254019|463538576|FG001|Overall Study|Protocol Violation|0|||
128793979|NCT01254019|463538575|FG000|Overall Study|Withdrawal by Subject|0|||
128793980|NCT01254019|463538576|FG001|Overall Study|Withdrawal by Subject|2|||
128793981|NCT03061474|463538577|FG000|Overall Study|Adverse Event|2|||
128793982|NCT03061474|463538578|FG001|Overall Study|Adverse Event|0|||
128793983|NCT03061474|463538577|FG000|Overall Study|Safety Risk|0|||
128793984|NCT03061474|463538578|FG001|Overall Study|Safety Risk|1|||
128793985|NCT03061474|463538577|FG000|Overall Study|Participant unwilling or unable to participate|0|||
128793986|NCT03061474|463538578|FG001|Overall Study|Participant unwilling or unable to participate|2|||
128793987|NCT03061474|463538577|FG000|Overall Study|Lost to Follow-up|0|||
128793988|NCT03061474|463538578|FG001|Overall Study|Lost to Follow-up|1|||
128793989|NCT00980330|463538579|FG000|Overall Study|Adverse Event|0|||
128793990|NCT00980330|463538580|FG001|Overall Study|Adverse Event|0|||
128793991|NCT00980330|463538581|FG002|Overall Study|Adverse Event|0|||
128793992|NCT00980330|463538582|FG003|Overall Study|Adverse Event|1|||
128793993|NCT00980330|463538583|FG004|Overall Study|Adverse Event|0|||
128793994|NCT00980330|463538584|FG005|Overall Study|Adverse Event|0|||
128793995|NCT00980330|463538585|FG006|Overall Study|Adverse Event|0|||
128793996|NCT00980330|463538579|FG000|Overall Study|Lost to Follow-up|1|||
128793997|NCT00980330|463538580|FG001|Overall Study|Lost to Follow-up|1|||
128793998|NCT00980330|463538581|FG002|Overall Study|Lost to Follow-up|4|||
128793999|NCT00980330|463538582|FG003|Overall Study|Lost to Follow-up|2|||
128794000|NCT00980330|463538583|FG004|Overall Study|Lost to Follow-up|1|||
128794001|NCT00980330|463538584|FG005|Overall Study|Lost to Follow-up|1|||
128794002|NCT00980330|463538585|FG006|Overall Study|Lost to Follow-up|2|||
128794003|NCT00980330|463538579|FG000|Overall Study|Withdrawal by Subject|2|||
128794004|NCT00980330|463538580|FG001|Overall Study|Withdrawal by Subject|4|||
128794005|NCT00980330|463538581|FG002|Overall Study|Withdrawal by Subject|4|||
128794006|NCT00980330|463538582|FG003|Overall Study|Withdrawal by Subject|1|||
128794007|NCT00980330|463538583|FG004|Overall Study|Withdrawal by Subject|3|||
128794008|NCT00980330|463538584|FG005|Overall Study|Withdrawal by Subject|2|||
128794009|NCT00980330|463538585|FG006|Overall Study|Withdrawal by Subject|5|||
128794010|NCT00980330|463538579|FG000|Overall Study|(not specified)|2|||
128794011|NCT00980330|463538580|FG001|Overall Study|(not specified)|0|||
128794012|NCT00980330|463538581|FG002|Overall Study|(not specified)|0|||
128794013|NCT00980330|463538582|FG003|Overall Study|(not specified)|1|||
128794014|NCT00980330|463538583|FG004|Overall Study|(not specified)|1|||
128794015|NCT00980330|463538584|FG005|Overall Study|(not specified)|1|||
128794016|NCT00980330|463538585|FG006|Overall Study|(not specified)|0|||
128794017|NCT00666276|463538586|FG000|Overall Study|Protocol Violation|34|||
128794018|NCT00665444|463538589|FG000|Overall Study|Physician Decision|1|||
128794019|NCT00665444|463538589|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
128794020|NCT00545077|463538598|FG000|Overall Study|Treatment not received|5|||
128794021|NCT00545077|463538599|FG001|Overall Study|Treatment not received|1|||
128794022|NCT00545077|463538598|FG000|Overall Study|Disease Progression|131|||
128794023|NCT00545077|463538599|FG001|Overall Study|Disease Progression|98|||
128794024|NCT00545077|463538598|FG000|Overall Study|Withdrawal by Subject|3|||
128794025|NCT00545077|463538599|FG001|Overall Study|Withdrawal by Subject|14|||
128794026|NCT00545077|463538598|FG000|Overall Study|Physician Decision|6|||
128794027|NCT00545077|463538599|FG001|Overall Study|Physician Decision|3|||
128794028|NCT00545077|463538598|FG000|Overall Study|Lost to Follow-up|2|||
128794029|NCT00545077|463538599|FG001|Overall Study|Lost to Follow-up|0|||
128794030|NCT00545077|463538598|FG000|Overall Study|Protocol Violation|1|||
128794031|NCT00545077|463538599|FG001|Overall Study|Protocol Violation|0|||
128794032|NCT00545077|463538598|FG000|Overall Study|Adverse Event|0|||
128794033|NCT00545077|463538599|FG001|Overall Study|Adverse Event|31|||
128794034|NCT00545077|463538598|FG000|Overall Study|Death|0|||
128794035|NCT00545077|463538599|FG001|Overall Study|Death|8|||
128794036|NCT02202499|463538600|FG000|Overall Study|Cancer diagnosis|0|||
128794037|NCT02202499|463538601|FG001|Overall Study|Cancer diagnosis|0|||
128794038|NCT02202499|463538602|FG002|Overall Study|Cancer diagnosis|1|||
128794039|NCT02202499|463538600|FG000|Overall Study|Moved from area|0|||
128794040|NCT02202499|463538601|FG001|Overall Study|Moved from area|0|||
128794041|NCT02202499|463538602|FG002|Overall Study|Moved from area|1|||
128794042|NCT02202499|463538600|FG000|Overall Study|Declined before randomization|1|||
128794043|NCT02202499|463538601|FG001|Overall Study|Declined before randomization|0|||
128794044|NCT02202499|463538602|FG002|Overall Study|Declined before randomization|0|||
128794045|NCT02202499|463538600|FG000|Overall Study|Auto accident|1|||
128794046|NCT02202499|463538601|FG001|Overall Study|Auto accident|0|||
128794047|NCT02202499|463538602|FG002|Overall Study|Auto accident|0|||
128794048|NCT00535145|463538604|FG000|Phase I|Adverse Event|3|||
128794049|NCT00535145|463538604|FG000|Phase I|Lost to Follow-up|7|||
128794050|NCT00535145|463538604|FG000|Phase I|Withdrawal by Subject|6|||
128794051|NCT00535145|463538604|FG000|Phase I|(eligibility)|8|||
128794052|NCT00535145|463538604|FG000|Phase I|(protocol violation)|1|||
128794053|NCT00535145|463538604|FG000|Phase I|(PI decision)|1|||
128794054|NCT00535145|463538604|FG000|Phase I|(diagnosis)|3|||
128794055|NCT00535145|463538604|FG000|Phase II|Adverse Event|2|||
128794056|NCT00535145|463538604|FG000|Phase II|Lack of Efficacy|1|||
128794057|NCT00535145|463538604|FG000|Phase II|Lost to Follow-up|5|||
128794058|NCT00535145|463538604|FG000|Phase II|Withdrawal by Subject|5|||
128794059|NCT00535145|463538604|FG000|Phase II|Subject non-compliance|2|||
128794060|NCT03260140|463538605|FG000|Overall Study|Death|4|||
128794061|NCT03260140|463538606|FG001|Overall Study|Death|1|||
128794062|NCT03260140|463538605|FG000|Overall Study|Withdrawal by Subject|1|||
128794063|NCT03260140|463538606|FG001|Overall Study|Withdrawal by Subject|4|||
128794064|NCT00424645|463538608|FG000|Overall Study|Death|1|||
128794065|NCT00424645|463538609|FG001|Overall Study|Death|0|||
128794066|NCT00959946|463538612|FG000|Overall Study|Adverse Event|0|||
128794067|NCT00959946|463538613|FG001|Overall Study|Adverse Event|0|||
128794068|NCT00959946|463538614|FG002|Overall Study|Adverse Event|2|||
128794069|NCT00959946|463538615|FG003|Overall Study|Adverse Event|1|||
128794070|NCT00959946|463538616|FG004|Overall Study|Adverse Event|0|||
128794071|NCT00959946|463538617|FG005|Overall Study|Adverse Event|1|||
128794072|NCT00959946|463538618|FG006|Overall Study|Adverse Event|0|||
128794073|NCT00959946|463538619|FG007|Overall Study|Adverse Event|0|||
128794074|NCT00959946|463538612|FG000|Overall Study|Death|0|||
128794075|NCT00959946|463538613|FG001|Overall Study|Death|0|||
128794076|NCT00959946|463538614|FG002|Overall Study|Death|0|||
128794077|NCT00959946|463538615|FG003|Overall Study|Death|0|||
128794078|NCT00959946|463538616|FG004|Overall Study|Death|0|||
128794079|NCT00959946|463538617|FG005|Overall Study|Death|1|||
128794080|NCT00959946|463538618|FG006|Overall Study|Death|0|||
128794081|NCT00959946|463538619|FG007|Overall Study|Death|0|||
128794082|NCT00959946|463538612|FG000|Overall Study|Disease Progression|2|||
128794083|NCT00959946|463538613|FG001|Overall Study|Disease Progression|4|||
128794084|NCT00959946|463538614|FG002|Overall Study|Disease Progression|2|||
128794085|NCT00959946|463538615|FG003|Overall Study|Disease Progression|4|||
128794086|NCT00959946|463538616|FG004|Overall Study|Disease Progression|4|||
128794087|NCT00959946|463538617|FG005|Overall Study|Disease Progression|6|||
128794088|NCT00959946|463538618|FG006|Overall Study|Disease Progression|2|||
128794089|NCT00959946|463538619|FG007|Overall Study|Disease Progression|2|||
128794090|NCT00959946|463538612|FG000|Overall Study|Withdrawal by Subject|0|||
128794091|NCT00959946|463538613|FG001|Overall Study|Withdrawal by Subject|0|||
128794092|NCT00959946|463538614|FG002|Overall Study|Withdrawal by Subject|0|||
128794093|NCT00959946|463538615|FG003|Overall Study|Withdrawal by Subject|0|||
128794094|NCT00959946|463538616|FG004|Overall Study|Withdrawal by Subject|0|||
128794095|NCT00959946|463538617|FG005|Overall Study|Withdrawal by Subject|1|||
128794096|NCT00959946|463538618|FG006|Overall Study|Withdrawal by Subject|0|||
128794097|NCT00959946|463538619|FG007|Overall Study|Withdrawal by Subject|0|||
128794098|NCT04009577|463538622|FG000|Core Study|Adverse Event|1|||
128794099|NCT04009577|463538623|FG001|Core Study|Adverse Event|0|||
128794100|NCT04009577|463538624|FG002|Core Study|Adverse Event|2|||
128794101|NCT04009577|463538625|FG003|Core Study|Adverse Event|4|||
128794102|NCT04009577|463538622|FG000|Core Study|Withdrawal by Subject|0|||
128794103|NCT04009577|463538623|FG001|Core Study|Withdrawal by Subject|0|||
128794104|NCT04009577|463538624|FG002|Core Study|Withdrawal by Subject|2|||
128794105|NCT04009577|463538625|FG003|Core Study|Withdrawal by Subject|0|||
128794106|NCT04009577|463538622|FG000|Core Study|Other|0|||
128794107|NCT04009577|463538623|FG001|Core Study|Other|0|||
128794108|NCT04009577|463538624|FG002|Core Study|Other|0|||
128794109|NCT04009577|463538625|FG003|Core Study|Other|1|||
128794110|NCT04009577|463538622|FG000|Extension Phase|Adverse Event|0|||
128794111|NCT04009577|463538623|FG001|Extension Phase|Adverse Event|0|||
128794112|NCT04009577|463538624|FG002|Extension Phase|Adverse Event|0|||
128794113|NCT04009577|463538625|FG003|Extension Phase|Adverse Event|1|||
128794114|NCT04009577|463538622|FG000|Extension Phase|Inadequate therapeutic effect|0|||
128794115|NCT04009577|463538623|FG001|Extension Phase|Inadequate therapeutic effect|0|||
128794116|NCT04009577|463538624|FG002|Extension Phase|Inadequate therapeutic effect|1|||
128794117|NCT04009577|463538625|FG003|Extension Phase|Inadequate therapeutic effect|0|||
128794118|NCT04009577|463538622|FG000|Extension Phase|Withdrawal by Subject|0|||
128794119|NCT04009577|463538623|FG001|Extension Phase|Withdrawal by Subject|0|||
128794120|NCT04009577|463538624|FG002|Extension Phase|Withdrawal by Subject|1|||
128794121|NCT04009577|463538625|FG003|Extension Phase|Withdrawal by Subject|0|||
128794122|NCT04009577|463538622|FG000|Extension Phase|Not Treated|0|||
128794123|NCT04009577|463538623|FG001|Extension Phase|Not Treated|0|||
128794124|NCT04009577|463538624|FG002|Extension Phase|Not Treated|2|||
128794125|NCT04009577|463538625|FG003|Extension Phase|Not Treated|0|||
128794126|NCT00305695|463538633|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
128794127|NCT00305695|463538634|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
128794128|NCT00305695|463538633|FG000|Overall Study|Did not have baseline scan|1|||
128794129|NCT00305695|463538634|FG001|Overall Study|Did not have baseline scan|1|||
128794130|NCT00658996|463538637|FG000|First Intervention|Positive slit lamp finding|1|||
128794131|NCT00658996|463538638|FG001|First Intervention|Positive slit lamp finding|0|||
128794132|NCT00658996|463538637|FG000|First Intervention|Lack of lenses|0|||
128794133|NCT00658996|463538638|FG001|First Intervention|Lack of lenses|1|||
128794134|NCT00658996|463538637|FG000|Crossover Period|Physician Decision|1|||
128794135|NCT00658996|463538638|FG001|Crossover Period|Physician Decision|0|||
128794136|NCT00658996|463538637|FG000|Crossover Period|Ineligible|1|||
128794137|NCT00658996|463538638|FG001|Crossover Period|Ineligible|1|||
128794138|NCT00658996|463538637|FG000|Second Intervention|Developed a stye on upper lid|1|||
128794139|NCT00658996|463538638|FG001|Second Intervention|Developed a stye on upper lid|0|||
128794140|NCT00658996|463538637|FG000|Second Intervention|Positive slit lamp finding|0|||
128794141|NCT00658996|463538638|FG001|Second Intervention|Positive slit lamp finding|1|||
128794142|NCT00206375|463538639|FG000|Overall Study|Lost to Follow-up|1|||
128794143|NCT00206375|463538640|FG001|Overall Study|Lost to Follow-up|0|||
128794144|NCT00206375|463538641|FG002|Overall Study|Lost to Follow-up|0|||
128794145|NCT00206375|463538639|FG000|Overall Study|Withdrawal by Subject|2|||
128794146|NCT00206375|463538640|FG001|Overall Study|Withdrawal by Subject|1|||
128794147|NCT00206375|463538641|FG002|Overall Study|Withdrawal by Subject|3|||
128794148|NCT00206375|463538639|FG000|Overall Study|Study terminated due to lack of funds|0|||
128794149|NCT00206375|463538640|FG001|Overall Study|Study terminated due to lack of funds|1|||
128794150|NCT00206375|463538641|FG002|Overall Study|Study terminated due to lack of funds|1|||
128794151|NCT01810263|463538648|FG000|Overall Study|Lost to Follow-up|8|||
128794152|NCT01810263|463538649|FG001|Overall Study|Lost to Follow-up|7|||
128794153|NCT00688519|463538650|FG000|Overall Study|Adverse Event|2|||
128794154|NCT00688519|463538651|FG001|Overall Study|Adverse Event|3|||
128794155|NCT00688519|463538650|FG000|Overall Study|Lost to Follow-up|3|||
128794156|NCT00688519|463538651|FG001|Overall Study|Lost to Follow-up|3|||
128794157|NCT00688519|463538650|FG000|Overall Study|Lack of Efficacy|3|||
128794158|NCT00688519|463538651|FG001|Overall Study|Lack of Efficacy|1|||
128794159|NCT00688519|463538650|FG000|Overall Study|Withdrawal by Subject|7|||
128794160|NCT00688519|463538651|FG001|Overall Study|Withdrawal by Subject|6|||
128794161|NCT00688519|463538650|FG000|Overall Study|Prohibited medication|1|||
128794162|NCT00688519|463538651|FG001|Overall Study|Prohibited medication|0|||
128794163|NCT00688519|463538650|FG000|Overall Study|Non-compliance|0|||
128794164|NCT00688519|463538651|FG001|Overall Study|Non-compliance|1|||
128794165|NCT00688519|463538650|FG000|Overall Study|Subject moved out of state|1|||
128794166|NCT00688519|463538651|FG001|Overall Study|Subject moved out of state|0|||
128794167|NCT00688519|463538650|FG000|Overall Study|Investigator decision|1|||
128794168|NCT00688519|463538651|FG001|Overall Study|Investigator decision|0|||
128794169|NCT00688519|463538650|FG000|Overall Study|Subject moved out of area|1|||
128794170|NCT00688519|463538651|FG001|Overall Study|Subject moved out of area|0|||
128794171|NCT00688519|463538650|FG000|Overall Study|Pregnancy|0|||
128794172|NCT00688519|463538651|FG001|Overall Study|Pregnancy|1|||
128794173|NCT01353963|463538652|FG000|Overall Study|Adverse Event|2|||
128794174|NCT03351075|463540051|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
128794175|NCT03351075|463540052|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
128794176|NCT03351075|463540051|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
128794177|NCT03351075|463540052|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
128794178|NCT03351075|463540051|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
128794179|NCT03351075|463540052|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
128794180|NCT03351075|463540051|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
128794181|NCT03351075|463540052|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
128794182|NCT00493649|463540053|FG000|Overall Study|Adverse Event|44|||
128794183|NCT00493649|463540053|FG000|Overall Study|Patient Request|21|||
128794184|NCT00493649|463540053|FG000|Overall Study|Investigator Request|2|||
128794185|NCT00493649|463540053|FG000|Overall Study|Disease Progression|1|||
128794186|NCT00493649|463540053|FG000|Overall Study|Lost to Follow-up|1|||
128794187|NCT00493649|463540053|FG000|Overall Study|Other|13|||
128794188|NCT05219253|463540054|FG000|Overall Study|Withdrawal by Subject|1|||
128794189|NCT05219253|463540055|FG001|Overall Study|Withdrawal by Subject|2|||
128794190|NCT03086369|463540056|FG000|Overall Study|Lost to Follow-up|1|||
128794191|NCT03086369|463540057|FG001|Overall Study|Lost to Follow-up|0|||
128794192|NCT03086369|463540058|FG002|Overall Study|Lost to Follow-up|0|||
128794193|NCT03086369|463540059|FG003|Overall Study|Lost to Follow-up|2|||
128794194|NCT03086369|463540060|FG004|Overall Study|Lost to Follow-up|1|||
128794195|NCT03086369|463540056|FG000|Overall Study|Physician Decision|0|||
128794196|NCT03086369|463540057|FG001|Overall Study|Physician Decision|0|||
128794197|NCT03086369|463540058|FG002|Overall Study|Physician Decision|0|||
128794198|NCT03086369|463540059|FG003|Overall Study|Physician Decision|1|||
128794199|NCT03086369|463540060|FG004|Overall Study|Physician Decision|2|||
128794200|NCT03086369|463540056|FG000|Overall Study|Withdrawal by Subject|0|||
128794201|NCT03086369|463540057|FG001|Overall Study|Withdrawal by Subject|0|||
128794202|NCT03086369|463540058|FG002|Overall Study|Withdrawal by Subject|0|||
128794203|NCT03086369|463540059|FG003|Overall Study|Withdrawal by Subject|5|||
128794204|NCT03086369|463540060|FG004|Overall Study|Withdrawal by Subject|3|||
128794205|NCT03086369|463540056|FG000|Overall Study|Progressive Disease|0|||
128794206|NCT03086369|463540057|FG001|Overall Study|Progressive Disease|0|||
128794207|NCT03086369|463540058|FG002|Overall Study|Progressive Disease|0|||
128794208|NCT03086369|463540059|FG003|Overall Study|Progressive Disease|1|||
128794209|NCT03086369|463540060|FG004|Overall Study|Progressive Disease|1|||
128794210|NCT04603924|463540063|FG000|Overall Study|Not Dosed|2|||
128794211|NCT04603924|463540064|FG001|Overall Study|Not Dosed|1|||
128794212|NCT04603924|463540063|FG000|Overall Study|Withdrawal by Subject|6|||
128794213|NCT04603924|463540064|FG001|Overall Study|Withdrawal by Subject|6|||
128794214|NCT04603924|463540063|FG000|Overall Study|Adverse Event|2|||
128794215|NCT04603924|463540064|FG001|Overall Study|Adverse Event|2|||
128794216|NCT01424397|463540072|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794217|NCT01424397|463540073|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794218|NCT01424397|463540074|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
128794219|NCT01424397|463540075|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794220|NCT01424397|463540076|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794221|NCT01424397|463540077|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794222|NCT01424397|463540078|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794223|NCT01424397|463540079|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794224|NCT01424397|463540080|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794225|NCT01424397|463540081|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794226|NCT01424397|463540082|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794227|NCT01424397|463540083|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
128794228|NCT00071799|463540084|FG000|Overall Study|Adverse Event|19|||
128794229|NCT00071799|463540085|FG001|Overall Study|Adverse Event|10|||
128794230|NCT00071799|463540084|FG000|Overall Study|Protocol Violation|1|||
128794231|NCT00071799|463540085|FG001|Overall Study|Protocol Violation|7|||
128794232|NCT00071799|463540084|FG000|Overall Study|Lost to Follow-up|1|||
128794233|NCT00071799|463540085|FG001|Overall Study|Lost to Follow-up|1|||
128794234|NCT00071799|463540084|FG000|Overall Study|Withdrawal by Subject|15|||
128794235|NCT00071799|463540085|FG001|Overall Study|Withdrawal by Subject|37|||
128794236|NCT00071799|463540084|FG000|Overall Study|Physician Decision|0|||
128794237|NCT00071799|463540085|FG001|Overall Study|Physician Decision|2|||
128794238|NCT00071799|463540084|FG000|Overall Study|Lack of Efficacy|11|||
128794239|NCT00071799|463540085|FG001|Overall Study|Lack of Efficacy|18|||
128794240|NCT00071799|463540084|FG000|Overall Study|Disease Progression|23|||
128794241|NCT00071799|463540085|FG001|Overall Study|Disease Progression|20|||
128794242|NCT00071799|463540084|FG000|Overall Study|Different Central+Local Pathology Review|0|||
128794243|NCT00071799|463540085|FG001|Overall Study|Different Central+Local Pathology Review|1|||
128794244|NCT00071799|463540084|FG000|Overall Study|Not Documented|0|||
128794245|NCT00071799|463540085|FG001|Overall Study|Not Documented|2|||
128794246|NCT03299816|463540086|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
128794247|NCT03299816|463540087|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
128794248|NCT03299816|463540086|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
128794249|NCT03299816|463540087|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
128794250|NCT03299816|463540086|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
128794251|NCT03299816|463540087|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
128794252|NCT03520413|463540088|FG000|Overall Study|Lost to Follow-up|1|||
128794253|NCT03520413|463540089|FG001|Overall Study|Lost to Follow-up|1|||
128794254|NCT03520413|463540088|FG000|Overall Study|Withdrawal by Subject|1|||
128794255|NCT03520413|463540089|FG001|Overall Study|Withdrawal by Subject|2|||
128794256|NCT03520413|463540088|FG000|Overall Study|Death|0|||
128794257|NCT03520413|463540089|FG001|Overall Study|Death|1|||
128794258|NCT03520413|463540088|FG000|Overall Study|Physician Decision|3|||
128794259|NCT03520413|463540089|FG001|Overall Study|Physician Decision|3|||
128794260|NCT03520413|463540088|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
128794261|NCT03520413|463540089|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
128794262|NCT00869323|463540094|FG000|Maintenance Therapy|concurrent illness|1|||
128794263|NCT01135511|463540097|FG000|Overall Study|Adverse Event|0|||
128794264|NCT01135511|463540098|FG001|Overall Study|Adverse Event|1|||
128794265|NCT01135511|463540099|FG002|Overall Study|Adverse Event|2|||
128794266|NCT01135511|463540100|FG003|Overall Study|Adverse Event|0|||
128794267|NCT01135511|463540101|FG004|Overall Study|Adverse Event|0|||
128794268|NCT01135511|463540102|FG005|Overall Study|Adverse Event|1|||
128794269|NCT01135511|463540103|FG006|Overall Study|Adverse Event|0|||
128794270|NCT01135511|463540104|FG007|Overall Study|Adverse Event|1|||
128794271|NCT01135511|463540105|FG008|Overall Study|Adverse Event|0|||
128794272|NCT01135511|463540097|FG000|Overall Study|Lack of Efficacy|0|||
128794273|NCT01135511|463540098|FG001|Overall Study|Lack of Efficacy|1|||
128794274|NCT01135511|463540099|FG002|Overall Study|Lack of Efficacy|1|||
128794275|NCT01135511|463540100|FG003|Overall Study|Lack of Efficacy|2|||
128794276|NCT01135511|463540101|FG004|Overall Study|Lack of Efficacy|0|||
128794277|NCT01135511|463540102|FG005|Overall Study|Lack of Efficacy|0|||
128794278|NCT01135511|463540103|FG006|Overall Study|Lack of Efficacy|0|||
128794279|NCT01135511|463540104|FG007|Overall Study|Lack of Efficacy|0|||
128794280|NCT01135511|463540105|FG008|Overall Study|Lack of Efficacy|0|||
128794281|NCT01135511|463540097|FG000|Overall Study|Protocol Violation|0|||
128794282|NCT01135511|463540098|FG001|Overall Study|Protocol Violation|0|||
128794283|NCT01135511|463540099|FG002|Overall Study|Protocol Violation|3|||
128794284|NCT01135511|463540100|FG003|Overall Study|Protocol Violation|0|||
128794285|NCT01135511|463540101|FG004|Overall Study|Protocol Violation|0|||
128794286|NCT01135511|463540102|FG005|Overall Study|Protocol Violation|0|||
128794287|NCT01135511|463540103|FG006|Overall Study|Protocol Violation|0|||
128794288|NCT01135511|463540104|FG007|Overall Study|Protocol Violation|0|||
128794289|NCT01135511|463540105|FG008|Overall Study|Protocol Violation|0|||
128794290|NCT01135511|463540097|FG000|Overall Study|Pregnancy|0|||
128794291|NCT01135511|463540098|FG001|Overall Study|Pregnancy|0|||
128794292|NCT01135511|463540099|FG002|Overall Study|Pregnancy|0|||
128794293|NCT01135511|463540100|FG003|Overall Study|Pregnancy|1|||
128794294|NCT01135511|463540101|FG004|Overall Study|Pregnancy|0|||
128794295|NCT01135511|463540102|FG005|Overall Study|Pregnancy|0|||
128794296|NCT01135511|463540103|FG006|Overall Study|Pregnancy|0|||
128794297|NCT01135511|463540104|FG007|Overall Study|Pregnancy|0|||
128794298|NCT01135511|463540105|FG008|Overall Study|Pregnancy|0|||
128794299|NCT01135511|463540097|FG000|Overall Study|could not visit the clinic|0|||
128794300|NCT01135511|463540098|FG001|Overall Study|could not visit the clinic|1|||
128794301|NCT01135511|463540099|FG002|Overall Study|could not visit the clinic|2|||
128794302|NCT01135511|463540100|FG003|Overall Study|could not visit the clinic|0|||
128794303|NCT01135511|463540101|FG004|Overall Study|could not visit the clinic|0|||
128794304|NCT01135511|463540102|FG005|Overall Study|could not visit the clinic|0|||
128794305|NCT01135511|463540103|FG006|Overall Study|could not visit the clinic|0|||
128794306|NCT01135511|463540104|FG007|Overall Study|could not visit the clinic|0|||
128794307|NCT01135511|463540105|FG008|Overall Study|could not visit the clinic|0|||
128794308|NCT01135511|463540097|FG000|Overall Study|noncompliance with study drug taken|0|||
128794309|NCT01135511|463540098|FG001|Overall Study|noncompliance with study drug taken|0|||
128794310|NCT01135511|463540099|FG002|Overall Study|noncompliance with study drug taken|0|||
128794311|NCT01135511|463540100|FG003|Overall Study|noncompliance with study drug taken|0|||
128794312|NCT01135511|463540101|FG004|Overall Study|noncompliance with study drug taken|1|||
128794313|NCT01135511|463540102|FG005|Overall Study|noncompliance with study drug taken|0|||
128794314|NCT01135511|463540103|FG006|Overall Study|noncompliance with study drug taken|0|||
128794315|NCT01135511|463540104|FG007|Overall Study|noncompliance with study drug taken|0|||
128794316|NCT01135511|463540105|FG008|Overall Study|noncompliance with study drug taken|0|||
128794317|NCT01135511|463540097|FG000|Overall Study|Withdrawal by Subject|0|||
128794318|NCT01135511|463540098|FG001|Overall Study|Withdrawal by Subject|0|||
128794319|NCT01135511|463540099|FG002|Overall Study|Withdrawal by Subject|0|||
128794320|NCT01135511|463540100|FG003|Overall Study|Withdrawal by Subject|0|||
128794321|NCT01135511|463540101|FG004|Overall Study|Withdrawal by Subject|0|||
128794322|NCT01135511|463540102|FG005|Overall Study|Withdrawal by Subject|0|||
128794323|NCT01135511|463540103|FG006|Overall Study|Withdrawal by Subject|1|||
128794324|NCT01135511|463540104|FG007|Overall Study|Withdrawal by Subject|0|||
128794325|NCT01135511|463540105|FG008|Overall Study|Withdrawal by Subject|1|||
128794326|NCT04054635|463540106|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
128794327|NCT04054635|463540107|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
128794328|NCT04054635|463540108|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
128794329|NCT04054635|463540106|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
128794330|NCT04054635|463540107|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
128794331|NCT04054635|463540108|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
128794332|NCT00891930|463540109|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
128794333|NCT00891930|463540109|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
128794334|NCT00891930|463540109|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
128794335|NCT00891930|463540109|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
128794336|NCT00891930|463540109|FG000|Part 2 Panitumumab + AMG479|Death|30|||
128794337|NCT00638963|463540110|FG000|Overall Study|Withdrawal by Subject|1|||
128794338|NCT00638963|463540111|FG001|Overall Study|Withdrawal by Subject|0|||
128794339|NCT05001945|463540114|FG000|Overall Study|Adverse Event|0|||
128794340|NCT05001945|463540115|FG001|Overall Study|Adverse Event|0|||
128794341|NCT05001945|463540116|FG002|Overall Study|Adverse Event|0|||
128794342|NCT05001945|463540117|FG003|Overall Study|Adverse Event|1|||
128794343|NCT05001945|463540118|FG004|Overall Study|Adverse Event|0|||
128794344|NCT05001945|463540119|FG005|Overall Study|Adverse Event|0|||
128794345|NCT05001945|463540120|FG006|Overall Study|Adverse Event|0|||
128794346|NCT05001945|463540121|FG007|Overall Study|Adverse Event|0|||
128794347|NCT05001945|463540114|FG000|Overall Study|Lost to Follow-up|0|||
128794348|NCT05001945|463540115|FG001|Overall Study|Lost to Follow-up|1|||
128794349|NCT05001945|463540116|FG002|Overall Study|Lost to Follow-up|1|||
128794350|NCT05001945|463540117|FG003|Overall Study|Lost to Follow-up|2|||
128794351|NCT05001945|463540118|FG004|Overall Study|Lost to Follow-up|0|||
128794352|NCT05001945|463540119|FG005|Overall Study|Lost to Follow-up|1|||
128794353|NCT05001945|463540120|FG006|Overall Study|Lost to Follow-up|0|||
128794354|NCT05001945|463540121|FG007|Overall Study|Lost to Follow-up|0|||
128794355|NCT05001945|463540114|FG000|Overall Study|Protocol Violation|1|||
128794356|NCT05001945|463540115|FG001|Overall Study|Protocol Violation|0|||
128794357|NCT05001945|463540116|FG002|Overall Study|Protocol Violation|1|||
128794358|NCT05001945|463540117|FG003|Overall Study|Protocol Violation|1|||
128794359|NCT05001945|463540118|FG004|Overall Study|Protocol Violation|0|||
128794360|NCT05001945|463540119|FG005|Overall Study|Protocol Violation|1|||
128794361|NCT05001945|463540120|FG006|Overall Study|Protocol Violation|0|||
128794362|NCT05001945|463540121|FG007|Overall Study|Protocol Violation|0|||
128794363|NCT05001945|463540114|FG000|Overall Study|Withdrawal by Subject|0|||
128794364|NCT05001945|463540115|FG001|Overall Study|Withdrawal by Subject|0|||
128758981|NCT01477853|463406828|FG001|Phase A|Adverse Event|2|||
128758982|NCT01477853|463406829|FG002|Phase A|Adverse Event|2|||
128758983|NCT01477853|463406827|FG000|Phase A|Lost to Follow-up|4|||
128758984|NCT01477853|463406828|FG001|Phase A|Lost to Follow-up|3|||
128758985|NCT01477853|463406829|FG002|Phase A|Lost to Follow-up|2|||
128758986|NCT01477853|463406827|FG000|Phase A|Physician Decision|1|||
128758987|NCT01477853|463406828|FG001|Phase A|Physician Decision|0|||
128758988|NCT01477853|463406829|FG002|Phase A|Physician Decision|1|||
128758989|NCT01477853|463406827|FG000|Phase A|Study terminated by sponsor|37|||
128758990|NCT01477853|463406828|FG001|Phase A|Study terminated by sponsor|40|||
128758991|NCT01477853|463406829|FG002|Phase A|Study terminated by sponsor|39|||
128758992|NCT01477853|463406827|FG000|Phase B|Lost to Follow-up|0|||
128758993|NCT01477853|463406828|FG001|Phase B|Lost to Follow-up|1|||
128758994|NCT01477853|463406829|FG002|Phase B|Lost to Follow-up|0|||
128758995|NCT01477853|463406827|FG000|Phase B|Study terminated by sponsor|12|||
128758996|NCT01477853|463406828|FG001|Phase B|Study terminated by sponsor|10|||
128758997|NCT01477853|463406829|FG002|Phase B|Study terminated by sponsor|11|||
128758998|NCT01050816|463406830|FG000|Overall Study|Lost to Follow-up|2|||
128758999|NCT01050816|463406830|FG000|Overall Study|patient's refusal|2|||
128759000|NCT03086330|463406831|FG000|Overall Study|Withdrawal by Subject|3|||
128759001|NCT03086330|463406832|FG001|Overall Study|Withdrawal by Subject|2|||
128759002|NCT03086330|463406831|FG000|Overall Study|Lost to Follow-up|1|||
128759003|NCT03086330|463406832|FG001|Overall Study|Lost to Follow-up|2|||
128759004|NCT00238433|463406840|FG000|Overall Study|Screen failure|1|||
128759005|NCT00238433|463406840|FG000|Overall Study|Lost to Follow-up|1|||
128759006|NCT00238433|463406840|FG000|Overall Study|Death|1|||
128759007|NCT01814748|463406843|FG000|Overall Study|Lost to Follow-up|1|||
128759008|NCT01814748|463406844|FG001|Overall Study|Lost to Follow-up|2|||
128759009|NCT01814748|463406843|FG000|Overall Study|Study site terminated by sponsor|1|||
128759010|NCT01814748|463406844|FG001|Overall Study|Study site terminated by sponsor|1|||
128759011|NCT01814748|463406843|FG000|Overall Study|Withdrawal by Subject|6|||
128759012|NCT01814748|463406844|FG001|Overall Study|Withdrawal by Subject|4|||
128759013|NCT04044456|463406845|FG000|Overall Study|Lost to Follow-up|4|||
128759014|NCT04044456|463406846|FG001|Overall Study|Lost to Follow-up|1|||
128759015|NCT04044456|463406845|FG000|Overall Study|Withdrawal by Subject|1|||
128759016|NCT04044456|463406846|FG001|Overall Study|Withdrawal by Subject|0|||
128759017|NCT01972529|463406847|FG000|Overall Study|Adverse Event|0|||
128759018|NCT01972529|463406848|FG001|Overall Study|Adverse Event|1|||
128759019|NCT01972529|463406849|FG002|Overall Study|Adverse Event|0|||
128759020|NCT01972529|463406850|FG003|Overall Study|Adverse Event|0|||
128759021|NCT01972529|463406847|FG000|Overall Study|Lost to Follow-up|1|||
128759022|NCT01972529|463406848|FG001|Overall Study|Lost to Follow-up|0|||
128759023|NCT01972529|463406849|FG002|Overall Study|Lost to Follow-up|0|||
128759024|NCT01972529|463406850|FG003|Overall Study|Lost to Follow-up|0|||
128759025|NCT01972529|463406847|FG000|Overall Study|Participant Choice|0|||
128759026|NCT01972529|463406848|FG001|Overall Study|Participant Choice|1|||
128759027|NCT01972529|463406849|FG002|Overall Study|Participant Choice|0|||
128759028|NCT01972529|463406850|FG003|Overall Study|Participant Choice|0|||
128759029|NCT01972529|463406847|FG000|Overall Study|Withdrawl of Consent|1|||
128759030|NCT01972529|463406848|FG001|Overall Study|Withdrawl of Consent|2|||
128759031|NCT01972529|463406849|FG002|Overall Study|Withdrawl of Consent|0|||
128759032|NCT01972529|463406850|FG003|Overall Study|Withdrawl of Consent|1|||
128759033|NCT01972529|463406847|FG000|Overall Study|Other|0|||
128759034|NCT01972529|463406848|FG001|Overall Study|Other|0|||
128759035|NCT01972529|463406849|FG002|Overall Study|Other|0|||
128759036|NCT01972529|463406850|FG003|Overall Study|Other|2|||
128759037|NCT01972529|463406847|FG000|Overall Study|Not treated|0|||
128759038|NCT01972529|463406848|FG001|Overall Study|Not treated|1|||
128759039|NCT01972529|463406849|FG002|Overall Study|Not treated|2|||
128759040|NCT01972529|463406850|FG003|Overall Study|Not treated|1|||
128759041|NCT02274857|463406851|FG000|Overall Study|Adverse Event|1|||
128759042|NCT02274857|463406852|FG001|Overall Study|Adverse Event|0|||
128759043|NCT02274857|463406851|FG000|Overall Study|Death|1|||
128759044|NCT02274857|463406852|FG001|Overall Study|Death|2|||
128759045|NCT02274857|463406851|FG000|Overall Study|Lost to Follow-up|3|||
128759046|NCT02274857|463406852|FG001|Overall Study|Lost to Follow-up|0|||
128759047|NCT02274857|463406851|FG000|Overall Study|Physician Decision|2|||
128759048|NCT02274857|463406852|FG001|Overall Study|Physician Decision|0|||
128759049|NCT02274857|463406851|FG000|Overall Study|Trial screen failure|0|||
128759050|NCT02274857|463406852|FG001|Overall Study|Trial screen failure|2|||
128759051|NCT02274857|463406851|FG000|Overall Study|Withdrawal by Subject|11|||
128759052|NCT02274857|463406852|FG001|Overall Study|Withdrawal by Subject|2|||
128759053|NCT02274857|463406851|FG000|Overall Study|Other|2|||
128759054|NCT02274857|463406852|FG001|Overall Study|Other|0|||
128794365|NCT05001945|463540116|FG002|Overall Study|Withdrawal by Subject|0|||
128794366|NCT05001945|463540117|FG003|Overall Study|Withdrawal by Subject|1|||
128794367|NCT05001945|463540118|FG004|Overall Study|Withdrawal by Subject|1|||
128794368|NCT05001945|463540119|FG005|Overall Study|Withdrawal by Subject|1|||
128794369|NCT05001945|463540120|FG006|Overall Study|Withdrawal by Subject|0|||
128794370|NCT05001945|463540121|FG007|Overall Study|Withdrawal by Subject|1|||
128794371|NCT05001945|463540114|FG000|Overall Study|Not specified by Investigator|0|||
128794372|NCT05001945|463540115|FG001|Overall Study|Not specified by Investigator|3|||
128794373|NCT05001945|463540116|FG002|Overall Study|Not specified by Investigator|0|||
128794374|NCT05001945|463540117|FG003|Overall Study|Not specified by Investigator|0|||
128794375|NCT05001945|463540118|FG004|Overall Study|Not specified by Investigator|1|||
128794376|NCT05001945|463540119|FG005|Overall Study|Not specified by Investigator|0|||
128794377|NCT05001945|463540120|FG006|Overall Study|Not specified by Investigator|0|||
128794378|NCT05001945|463540121|FG007|Overall Study|Not specified by Investigator|0|||
128794379|NCT02448446|463540122|FG000|Overall Study|Withdrawal by Subject|1|||
128794380|NCT02448446|463540123|FG001|Overall Study|Withdrawal by Subject|0|||
128794381|NCT02425111|463540124|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
128794382|NCT02425111|463540124|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
128794383|NCT02425111|463540124|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
128794384|NCT02425111|463540124|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
128794385|NCT02425111|463540124|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
128794386|NCT02425111|463540124|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
128794387|NCT01444417|463540125|FG000|Overall Study|Ineligibility Determined|0|||
128794388|NCT01444417|463540126|FG001|Overall Study|Ineligibility Determined|1|||
128794389|NCT01444417|463540125|FG000|Overall Study|Withdrawal by Subject|2|||
128794390|NCT01444417|463540126|FG001|Overall Study|Withdrawal by Subject|0|||
128794391|NCT03475316|463540129|FG000|6 Month Intervention|Adverse Event|2|||
128794392|NCT03475316|463540130|FG001|6 Month Intervention|Adverse Event|1|||
128794393|NCT03475316|463540129|FG000|6 Month Intervention|Withdrawal by Subject|2|||
128794394|NCT03475316|463540130|FG001|6 Month Intervention|Withdrawal by Subject|0|||
128794395|NCT03475316|463540129|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
128794396|NCT03475316|463540130|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
128794397|NCT03475316|463540129|FG000|9 Months|Study stopped due to COVID pandemic|3|||
128794398|NCT03475316|463540130|FG001|9 Months|Study stopped due to COVID pandemic|4|||
128794399|NCT02555215|463540131|FG000|Overall Study|Other|1|||
128794400|NCT02555215|463540131|FG000|Overall Study|Investigator Decision|2|||
128794401|NCT00468052|463540132|FG000|Overall Study|Protocol Violation|7|||
128794402|NCT00468052|463540133|FG001|Overall Study|Protocol Violation|8|||
128794403|NCT00457743|463540136|FG000|Overall Study|Adverse Event|0|||
128794404|NCT00457743|463540137|FG001|Overall Study|Adverse Event|4|||
128794405|NCT00457743|463540138|FG002|Overall Study|Adverse Event|0|||
128794406|NCT00457743|463540136|FG000|Overall Study|Lack of Efficacy|3|||
128794407|NCT00457743|463540137|FG001|Overall Study|Lack of Efficacy|23|||
128794408|NCT00457743|463540138|FG002|Overall Study|Lack of Efficacy|3|||
128794409|NCT00566527|463540139|FG000|Overall Study|Reason not provided|3|||
128794410|NCT00566527|463540140|FG001|Overall Study|Reason not provided|11|||
128794411|NCT00566527|463540141|FG002|Overall Study|Reason not provided|10|||
128794412|NCT00566527|463540139|FG000|Overall Study|Adverse Event|2|||
128794413|NCT00566527|463540140|FG001|Overall Study|Adverse Event|0|||
128794414|NCT00566527|463540141|FG002|Overall Study|Adverse Event|1|||
128794415|NCT00566527|463540139|FG000|Overall Study|Physician Decision|3|||
128794416|NCT00566527|463540140|FG001|Overall Study|Physician Decision|8|||
128794417|NCT00566527|463540141|FG002|Overall Study|Physician Decision|20|||
128794418|NCT00566527|463540139|FG000|Overall Study|Lost to Follow-up|3|||
128794419|NCT00566527|463540140|FG001|Overall Study|Lost to Follow-up|4|||
128794420|NCT00566527|463540141|FG002|Overall Study|Lost to Follow-up|4|||
128794421|NCT00566527|463540139|FG000|Overall Study|Withdrawal by Subject|6|||
128794422|NCT00566527|463540140|FG001|Overall Study|Withdrawal by Subject|43|||
128794423|NCT00566527|463540141|FG002|Overall Study|Withdrawal by Subject|43|||
128794424|NCT00356265|463540142|FG000|Overall Study|Withdrawal by Subject|0|||
128794425|NCT00356265|463540143|FG001|Overall Study|Withdrawal by Subject|0|||
128794426|NCT00356265|463540144|FG002|Overall Study|Withdrawal by Subject|1|||
128794427|NCT01837966|463540145|FG000|Overall Study|Withdrawal by Subject|2|||
128794428|NCT01837966|463540146|FG001|Overall Study|Withdrawal by Subject|1|||
128794429|NCT00159783|463540150|FG000|Overall Study|Adverse Event|5|||
128794430|NCT00159783|463540151|FG001|Overall Study|Adverse Event|7|||
128794431|NCT00159783|463540152|FG002|Overall Study|Adverse Event|9|||
128794432|NCT00159783|463540150|FG000|Overall Study|Lack of Efficacy|1|||
128794433|NCT00159783|463540151|FG001|Overall Study|Lack of Efficacy|2|||
128794434|NCT00159783|463540152|FG002|Overall Study|Lack of Efficacy|3|||
128794435|NCT00159783|463540150|FG000|Overall Study|Withdrawal by Subject|7|||
128794436|NCT00159783|463540151|FG001|Overall Study|Withdrawal by Subject|11|||
128794437|NCT00159783|463540152|FG002|Overall Study|Withdrawal by Subject|12|||
128794438|NCT00159783|463540150|FG000|Overall Study|Lost to Follow-up|6|||
128794439|NCT00159783|463540151|FG001|Overall Study|Lost to Follow-up|5|||
128794440|NCT00159783|463540152|FG002|Overall Study|Lost to Follow-up|11|||
128794441|NCT00159783|463540150|FG000|Overall Study|Other|0|||
128794442|NCT00159783|463540151|FG001|Overall Study|Other|2|||
128794443|NCT00159783|463540152|FG002|Overall Study|Other|4|||
128794444|NCT02928224|463540153|FG000|Overall Study|Lost to Follow-up|1|||
128794445|NCT02928224|463540154|FG001|Overall Study|Lost to Follow-up|1|||
128794446|NCT02928224|463540155|FG002|Overall Study|Lost to Follow-up|3|||
128794447|NCT02928224|463540156|FG003|Overall Study|Lost to Follow-up|0|||
128794448|NCT02928224|463540153|FG000|Overall Study|Death|30|||
128794449|NCT02928224|463540154|FG001|Overall Study|Death|209|||
128794450|NCT02928224|463540155|FG002|Overall Study|Death|193|||
128794451|NCT02928224|463540156|FG003|Overall Study|Death|198|||
128794452|NCT02928224|463540153|FG000|Overall Study|Withdrawal by Subject|0|||
128794453|NCT02928224|463540154|FG001|Overall Study|Withdrawal by Subject|3|||
128794454|NCT02928224|463540155|FG002|Overall Study|Withdrawal by Subject|7|||
128794455|NCT02928224|463540156|FG003|Overall Study|Withdrawal by Subject|20|||
128794456|NCT02928224|463540153|FG000|Overall Study|Study participation terminated by sponsor|3|||
128794457|NCT02928224|463540154|FG001|Overall Study|Study participation terminated by sponsor|8|||
128794458|NCT02928224|463540155|FG002|Overall Study|Study participation terminated by sponsor|12|||
128794459|NCT02928224|463540156|FG003|Overall Study|Study participation terminated by sponsor|3|||
128794460|NCT02928224|463540153|FG000|Overall Study|Other|3|||
128794461|NCT02928224|463540154|FG001|Overall Study|Other|3|||
128794462|NCT02928224|463540155|FG002|Overall Study|Other|5|||
128794463|NCT02928224|463540156|FG003|Overall Study|Other|0|||
128794464|NCT01278394|463540159|FG000|Overall Study|Lost to Follow-up|1|||
128794465|NCT01236560|463540160|FG000|Overall Study|Adverse Event|0|||
128794466|NCT01236560|463540161|FG001|Overall Study|Adverse Event|2|||
128794467|NCT01236560|463540162|FG002|Overall Study|Adverse Event|1|||
128794468|NCT01236560|463540163|FG003|Overall Study|Adverse Event|3|||
128794469|NCT01236560|463540164|FG004|Overall Study|Adverse Event|0|||
128794470|NCT01236560|463540165|FG005|Overall Study|Adverse Event|0|||
128794471|NCT01236560|463540160|FG000|Overall Study|Death|0|||
128794472|NCT01236560|463540161|FG001|Overall Study|Death|1|||
128794473|NCT01236560|463540162|FG002|Overall Study|Death|0|||
128794474|NCT01236560|463540163|FG003|Overall Study|Death|1|||
128794475|NCT01236560|463540164|FG004|Overall Study|Death|0|||
128794476|NCT01236560|463540165|FG005|Overall Study|Death|0|||
128794477|NCT01236560|463540160|FG000|Overall Study|Lost to Follow-up|0|||
128794478|NCT01236560|463540161|FG001|Overall Study|Lost to Follow-up|1|||
128794479|NCT01236560|463540162|FG002|Overall Study|Lost to Follow-up|1|||
128794480|NCT01236560|463540163|FG003|Overall Study|Lost to Follow-up|0|||
128794481|NCT01236560|463540164|FG004|Overall Study|Lost to Follow-up|0|||
128794482|NCT01236560|463540165|FG005|Overall Study|Lost to Follow-up|0|||
128794483|NCT01236560|463540160|FG000|Overall Study|Physician Decision|0|||
128794484|NCT01236560|463540161|FG001|Overall Study|Physician Decision|1|||
128794485|NCT01236560|463540162|FG002|Overall Study|Physician Decision|8|||
128794486|NCT01236560|463540163|FG003|Overall Study|Physician Decision|0|||
128794487|NCT01236560|463540164|FG004|Overall Study|Physician Decision|0|||
128794488|NCT01236560|463540165|FG005|Overall Study|Physician Decision|0|||
128794489|NCT01236560|463540160|FG000|Overall Study|Withdrawal by Subject|0|||
128794490|NCT01236560|463540161|FG001|Overall Study|Withdrawal by Subject|0|||
128794491|NCT01236560|463540162|FG002|Overall Study|Withdrawal by Subject|1|||
128794492|NCT01236560|463540163|FG003|Overall Study|Withdrawal by Subject|2|||
128794493|NCT01236560|463540164|FG004|Overall Study|Withdrawal by Subject|0|||
128794494|NCT01236560|463540165|FG005|Overall Study|Withdrawal by Subject|0|||
128794495|NCT01236560|463540160|FG000|Overall Study|Progressive disease|5|||
128794496|NCT01236560|463540161|FG001|Overall Study|Progressive disease|19|||
128794497|NCT01236560|463540162|FG002|Overall Study|Progressive disease|9|||
128794498|NCT01236560|463540163|FG003|Overall Study|Progressive disease|16|||
128794499|NCT01236560|463540164|FG004|Overall Study|Progressive disease|0|||
128794500|NCT01236560|463540165|FG005|Overall Study|Progressive disease|0|||
128794501|NCT00468910|463540166|FG000|Overall Study|Lost to Follow-up|2|||
128794502|NCT00468910|463540167|FG001|Overall Study|Lost to Follow-up|1|||
128794503|NCT00468910|463540166|FG000|Overall Study|Withdrawal by Subject|2|||
128794504|NCT00468910|463540167|FG001|Overall Study|Withdrawal by Subject|1|||
128794505|NCT00468910|463540166|FG000|Overall Study|Medical Contraindication|0|||
128794506|NCT00468910|463540167|FG001|Overall Study|Medical Contraindication|1|||
128794507|NCT00457691|463540169|FG000|Overall Study|Adverse Event|4|||
128794508|NCT00457691|463540170|FG001|Overall Study|Adverse Event|1|||
128794509|NCT00457691|463540169|FG000|Overall Study|Death|163|||
128794510|NCT00457691|463540170|FG001|Overall Study|Death|148|||
128794511|NCT00457691|463540169|FG000|Overall Study|Protocol Violation|1|||
128794512|NCT00457691|463540170|FG001|Overall Study|Protocol Violation|3|||
128794513|NCT00457691|463540169|FG000|Overall Study|Lost to Follow-up|23|||
128794514|NCT00457691|463540170|FG001|Overall Study|Lost to Follow-up|14|||
128794515|NCT00457691|463540169|FG000|Overall Study|Study terminated by Sponsor|1|||
128794516|NCT00457691|463540170|FG001|Overall Study|Study terminated by Sponsor|1|||
128794517|NCT00457691|463540169|FG000|Overall Study|Subject refused (reason other than AE)|14|||
128794518|NCT00457691|463540170|FG001|Overall Study|Subject refused (reason other than AE)|19|||
128794519|NCT00457691|463540169|FG000|Overall Study|Disease progression, study terminated|180|||
128794520|NCT00457691|463540170|FG001|Overall Study|Disease progression, study terminated|196|||
128794521|NCT01121549|463540171|FG000|Overall Study|Adverse Event|10|||
128794522|NCT01121549|463540171|FG000|Overall Study|Lack of Efficacy|11|||
128794523|NCT01121549|463540171|FG000|Overall Study|Lost to Follow-up|12|||
128794524|NCT01121549|463540171|FG000|Overall Study|Did not meet entrance criteria|9|||
128794525|NCT01121549|463540171|FG000|Overall Study|Study terminated by sponsor|197|||
128794526|NCT01121549|463540171|FG000|Overall Study|Pregnancy|1|||
128794527|NCT01121549|463540171|FG000|Overall Study|Protocol Violation|33|||
128794528|NCT01121549|463540171|FG000|Overall Study|Withdrawal by Subject|16|||
128794529|NCT01121549|463540171|FG000|Overall Study|Other|58|||
128794530|NCT00002842|463541762|FG000|Overall Study|ineligible for surgical resection|27|||
128794531|NCT00508924|463541763|FG000|Overall Study|Protocol Violation|0|||
128794532|NCT00508924|463541764|FG001|Overall Study|Protocol Violation|0|||
128794533|NCT00508924|463541765|FG002|Overall Study|Protocol Violation|1|||
128794534|NCT00508924|463541766|FG003|Overall Study|Protocol Violation|1|||
128794535|NCT02755805|463541767|FG000|Overall Study|Lost to Follow-up|1|||
128794536|NCT02755805|463541768|FG001|Overall Study|Lost to Follow-up|2|||
128794537|NCT02755805|463541767|FG000|Overall Study|Refused assessments|1|||
128794538|NCT02755805|463541768|FG001|Overall Study|Refused assessments|0|||
128794539|NCT02755805|463541767|FG000|Overall Study|Withdrawal by Subject|0|||
128794540|NCT02755805|463541768|FG001|Overall Study|Withdrawal by Subject|2|||
128794541|NCT02252042|463541773|FG000|Overall Study|Adverse Event|9|||
128794542|NCT02252042|463541774|FG001|Overall Study|Adverse Event|6|||
128794543|NCT02252042|463541773|FG000|Overall Study|Death|209|||
128794544|NCT02252042|463541774|FG001|Overall Study|Death|217|||
128794545|NCT02252042|463541773|FG000|Overall Study|Physician Decision|0|||
128794546|NCT02252042|463541774|FG001|Overall Study|Physician Decision|2|||
128794547|NCT02252042|463541773|FG000|Overall Study|Transferred to Extension Study|7|||
128794548|NCT02252042|463541774|FG001|Overall Study|Transferred to Extension Study|1|||
128794549|NCT02252042|463541773|FG000|Overall Study|Did Not Continue on Extension Study|7|||
128794550|NCT02252042|463541774|FG001|Overall Study|Did Not Continue on Extension Study|2|||
128794551|NCT02252042|463541773|FG000|Overall Study|Withdrawal by Subject|15|||
128794552|NCT02252042|463541774|FG001|Overall Study|Withdrawal by Subject|20|||
128794553|NCT02593149|463541775|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
128794554|NCT02593149|463541776|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
128794555|NCT02593149|463541775|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
128794556|NCT02593149|463541776|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
128794557|NCT00979992|463541778|FG000|Overall Study|Ineligible - inadequate pathology|1|||
128794558|NCT00979992|463541778|FG000|Overall Study|Ineligible - wrong cell type|2|||
128794559|NCT00979992|463541778|FG000|Overall Study|Refused - Never Treated|2|||
128794560|NCT04532528|463541782|FG000|Overall Study|Adverse Event|12|||
128794561|NCT04532528|463541783|FG001|Overall Study|Adverse Event|17|||
128794562|NCT04532528|463541782|FG000|Overall Study|Withdrawal of consent|16|||
128794563|NCT04532528|463541783|FG001|Overall Study|Withdrawal of consent|17|||
128794564|NCT04532528|463541782|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
128794565|NCT04532528|463541783|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
128794566|NCT04532528|463541782|FG000|Overall Study|Lost to Follow-up|69|||
128794567|NCT04532528|463541783|FG001|Overall Study|Lost to Follow-up|68|||
128794568|NCT04532528|463541782|FG000|Overall Study|Administrative problems|12|||
128794569|NCT04532528|463541783|FG001|Overall Study|Administrative problems|14|||
128794570|NCT04532528|463541782|FG000|Overall Study|Death|3|||
128794571|NCT04532528|463541783|FG001|Overall Study|Death|3|||
128794572|NCT04532528|463541782|FG000|Overall Study|Other|38|||
128794573|NCT04532528|463541783|FG001|Overall Study|Other|46|||
128794574|NCT01636687|463541784|FG000|Induction Period|Withdrawal by Subject|1|||
128794575|NCT01636687|463541785|FG001|Induction Period|Withdrawal by Subject|0|||
128794576|NCT01636687|463541786|FG002|Induction Period|Withdrawal by Subject|0|||
128794577|NCT01636687|463541787|FG003|Induction Period|Withdrawal by Subject|0|||
128794578|NCT01636687|463541788|FG004|Induction Period|Withdrawal by Subject|0|||
128794579|NCT01636687|463541784|FG000|Induction Period|Adverse Event|1|||
128794580|NCT01636687|463541785|FG001|Induction Period|Adverse Event|0|||
128794581|NCT01636687|463541786|FG002|Induction Period|Adverse Event|0|||
128794582|NCT01636687|463541787|FG003|Induction Period|Adverse Event|0|||
128794583|NCT01636687|463541788|FG004|Induction Period|Adverse Event|1|||
128794584|NCT01636687|463541784|FG000|Induction Period|Lack of Efficacy|0|||
128794585|NCT01636687|463541785|FG001|Induction Period|Lack of Efficacy|0|||
128794586|NCT01636687|463541786|FG002|Induction Period|Lack of Efficacy|0|||
128794587|NCT01636687|463541787|FG003|Induction Period|Lack of Efficacy|0|||
128794588|NCT01636687|463541788|FG004|Induction Period|Lack of Efficacy|1|||
128794589|NCT01636687|463541784|FG000|Induction Period|Physician Decision|1|||
128794590|NCT01636687|463541785|FG001|Induction Period|Physician Decision|0|||
128794591|NCT01636687|463541786|FG002|Induction Period|Physician Decision|0|||
128794592|NCT01636687|463541787|FG003|Induction Period|Physician Decision|0|||
128794593|NCT01636687|463541788|FG004|Induction Period|Physician Decision|0|||
128794594|NCT01636687|463541784|FG000|Maintenance Period|Withdrawal by Subject|2|||
128794595|NCT01636687|463541785|FG001|Maintenance Period|Withdrawal by Subject|0|||
128794596|NCT01636687|463541786|FG002|Maintenance Period|Withdrawal by Subject|2|||
128794597|NCT01636687|463541787|FG003|Maintenance Period|Withdrawal by Subject|0|||
128794598|NCT01636687|463541788|FG004|Maintenance Period|Withdrawal by Subject|0|||
128794599|NCT01636687|463541784|FG000|Maintenance Period|Adverse Event|1|||
128794600|NCT01636687|463541785|FG001|Maintenance Period|Adverse Event|0|||
128794601|NCT01636687|463541786|FG002|Maintenance Period|Adverse Event|0|||
128794602|NCT01636687|463541787|FG003|Maintenance Period|Adverse Event|0|||
128794603|NCT01636687|463541788|FG004|Maintenance Period|Adverse Event|0|||
128794604|NCT01636687|463541784|FG000|Maintenance Period|Lack of Efficacy|4|||
128794605|NCT01636687|463541785|FG001|Maintenance Period|Lack of Efficacy|1|||
128794606|NCT01636687|463541786|FG002|Maintenance Period|Lack of Efficacy|0|||
128794607|NCT01636687|463541787|FG003|Maintenance Period|Lack of Efficacy|0|||
128794608|NCT01636687|463541788|FG004|Maintenance Period|Lack of Efficacy|0|||
128794609|NCT01636687|463541784|FG000|Maintenance Period|Lost to Follow-up|1|||
128794610|NCT01636687|463541785|FG001|Maintenance Period|Lost to Follow-up|1|||
128794611|NCT01636687|463541786|FG002|Maintenance Period|Lost to Follow-up|0|||
128794612|NCT01636687|463541787|FG003|Maintenance Period|Lost to Follow-up|0|||
128794613|NCT01636687|463541788|FG004|Maintenance Period|Lost to Follow-up|1|||
128794614|NCT01636687|463541784|FG000|Maintenance Period|Physician Decision|0|||
128794615|NCT01636687|463541785|FG001|Maintenance Period|Physician Decision|0|||
128794616|NCT01636687|463541786|FG002|Maintenance Period|Physician Decision|0|||
128794617|NCT01636687|463541787|FG003|Maintenance Period|Physician Decision|0|||
128794618|NCT01636687|463541788|FG004|Maintenance Period|Physician Decision|1|||
128794619|NCT01636687|463541784|FG000|Extension Period|technical problems|0|||
128794620|NCT01636687|463541785|FG001|Extension Period|technical problems|1|||
128794621|NCT01636687|463541786|FG002|Extension Period|technical problems|2|||
128794622|NCT01636687|463541787|FG003|Extension Period|technical problems|1|||
128794623|NCT01636687|463541788|FG004|Extension Period|technical problems|0|||
128794624|NCT01636687|463541784|FG000|Extension Period|Adverse Event|4|||
128794625|NCT01636687|463541785|FG001|Extension Period|Adverse Event|3|||
128794626|NCT01636687|463541786|FG002|Extension Period|Adverse Event|2|||
128794627|NCT01636687|463541787|FG003|Extension Period|Adverse Event|1|||
128794628|NCT01636687|463541788|FG004|Extension Period|Adverse Event|0|||
128794629|NCT01636687|463541784|FG000|Extension Period|Lack of Efficacy|7|||
128794630|NCT01636687|463541785|FG001|Extension Period|Lack of Efficacy|0|||
128794631|NCT01636687|463541786|FG002|Extension Period|Lack of Efficacy|2|||
128794632|NCT01636687|463541787|FG003|Extension Period|Lack of Efficacy|1|||
128794633|NCT01636687|463541788|FG004|Extension Period|Lack of Efficacy|0|||
128794634|NCT01636687|463541784|FG000|Extension Period|Lost to Follow-up|1|||
128794635|NCT01636687|463541785|FG001|Extension Period|Lost to Follow-up|0|||
128794636|NCT01636687|463541786|FG002|Extension Period|Lost to Follow-up|1|||
128794637|NCT01636687|463541787|FG003|Extension Period|Lost to Follow-up|0|||
128794638|NCT01636687|463541788|FG004|Extension Period|Lost to Follow-up|0|||
128794639|NCT01636687|463541784|FG000|Extension Period|Physician Decision|1|||
128794640|NCT01636687|463541785|FG001|Extension Period|Physician Decision|0|||
128794641|NCT01636687|463541786|FG002|Extension Period|Physician Decision|0|||
128794642|NCT01636687|463541787|FG003|Extension Period|Physician Decision|1|||
128794643|NCT01636687|463541788|FG004|Extension Period|Physician Decision|0|||
128794644|NCT01636687|463541784|FG000|Extension Period|study terminated by sponsor|33|||
128794645|NCT01636687|463541785|FG001|Extension Period|study terminated by sponsor|50|||
128794646|NCT01636687|463541786|FG002|Extension Period|study terminated by sponsor|17|||
128794647|NCT01636687|463541787|FG003|Extension Period|study terminated by sponsor|23|||
128794648|NCT01636687|463541788|FG004|Extension Period|study terminated by sponsor|0|||
128794649|NCT01636687|463541784|FG000|Extension Period|Withdrawal by Subject|1|||
128794650|NCT01636687|463541785|FG001|Extension Period|Withdrawal by Subject|0|||
128794651|NCT01636687|463541786|FG002|Extension Period|Withdrawal by Subject|1|||
128794652|NCT01636687|463541787|FG003|Extension Period|Withdrawal by Subject|1|||
128794653|NCT01636687|463541788|FG004|Extension Period|Withdrawal by Subject|0|||
128794654|NCT01636687|463541784|FG000|Follow-up Period|Withdrawal by Subject|1|||
128794655|NCT01636687|463541785|FG001|Follow-up Period|Withdrawal by Subject|0|||
128794656|NCT01636687|463541786|FG002|Follow-up Period|Withdrawal by Subject|0|||
128794657|NCT01636687|463541787|FG003|Follow-up Period|Withdrawal by Subject|0|||
128794658|NCT01636687|463541788|FG004|Follow-up Period|Withdrawal by Subject|1|||
128794659|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
128794660|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
128794661|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
128794662|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
128794663|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
128794664|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
128794665|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
128794666|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
128794667|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
128794668|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
128794669|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
128794670|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
128794671|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
128794672|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
128794673|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
128794674|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
128794675|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
128794676|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
128794677|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
128794678|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
128794679|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
128794680|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
128794681|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
128794682|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
128794683|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
128794684|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
128794685|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
128794686|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
128794687|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
128794688|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
128794689|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
128794690|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
128794691|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
128794692|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
128794693|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
128794694|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
128794695|NCT03593213|463541794|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
128794696|NCT03593213|463541795|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
128794697|NCT03593213|463541796|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
128794698|NCT03593213|463541797|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
128794699|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
128794700|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
128794701|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
128794702|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
128794703|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
128794704|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
128794705|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
128794706|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
128794707|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
128794708|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
128794709|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
128794710|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
128794711|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
128794712|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
128794713|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
128794714|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
128794715|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
128794716|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
128794717|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
128794718|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
128794719|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
128794720|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
128794721|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
128794722|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
128794723|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
128794724|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
128794725|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
128794726|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
128794727|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
128794728|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
128794729|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
128794730|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
128794731|NCT03593213|463541794|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
128794732|NCT03593213|463541795|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
128794733|NCT03593213|463541796|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
128794734|NCT03593213|463541797|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
128794735|NCT01460290|463541800|FG000|Overall Study|Adverse Event|3|||
128794736|NCT01460290|463541800|FG000|Overall Study|Elevated liver function|1|||
128794737|NCT02888080|463541809|FG000|Overall Study|Subject / Guardian decision|1|||
128794738|NCT02888080|463541810|FG001|Overall Study|Subject / Guardian decision|3|||
128794739|NCT02888080|463541809|FG000|Overall Study|New Therapy for study indication|1|||
128794740|NCT02888080|463541810|FG001|Overall Study|New Therapy for study indication|0|||
128794741|NCT02888080|463541809|FG000|Overall Study|Lack of Efficacy|0|||
128794742|NCT02888080|463541810|FG001|Overall Study|Lack of Efficacy|1|||
128794743|NCT02888080|463541809|FG000|Overall Study|Adverse Event|0|||
128794744|NCT02888080|463541810|FG001|Overall Study|Adverse Event|1|||
128794745|NCT00845832|463541811|FG000|Treatment Period|Adverse Event|0|||
128794746|NCT00845832|463541812|FG001|Treatment Period|Adverse Event|2|||
128794747|NCT00845832|463541813|FG002|Treatment Period|Adverse Event|0|||
128794748|NCT00845832|463541811|FG000|Treatment Period|Protocol Violation|1|||
128794749|NCT00845832|463541812|FG001|Treatment Period|Protocol Violation|1|||
128794750|NCT00845832|463541813|FG002|Treatment Period|Protocol Violation|0|||
128794751|NCT00845832|463541811|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
128794752|NCT00845832|463541812|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
128794753|NCT00845832|463541813|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
128794754|NCT00845832|463541811|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
128794755|NCT00845832|463541812|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
128794756|NCT00845832|463541813|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
128794757|NCT00189202|463541818|FG000|Overall Study|Physician Decision|5|||
128794758|NCT01039688|463541821|FG000|Overall Study|Adverse Event|38|||
128794759|NCT01039688|463541822|FG001|Overall Study|Adverse Event|39|||
128794760|NCT01039688|463541823|FG002|Overall Study|Adverse Event|24|||
128794761|NCT01039688|463541821|FG000|Overall Study|Lack of Efficacy|20|||
128794762|NCT01039688|463541822|FG001|Overall Study|Lack of Efficacy|11|||
128794763|NCT01039688|463541823|FG002|Overall Study|Lack of Efficacy|26|||
128794764|NCT01039688|463541821|FG000|Overall Study|Lost to Follow-up|11|||
128794765|NCT01039688|463541822|FG001|Overall Study|Lost to Follow-up|9|||
128794766|NCT01039688|463541823|FG002|Overall Study|Lost to Follow-up|5|||
128794767|NCT01039688|463541821|FG000|Overall Study|Other|13|||
128794768|NCT01039688|463541822|FG001|Overall Study|Other|25|||
128794769|NCT01039688|463541823|FG002|Overall Study|Other|12|||
128794770|NCT01039688|463541821|FG000|Overall Study|Withdrawal by Subject|23|||
128794771|NCT01039688|463541822|FG001|Overall Study|Withdrawal by Subject|27|||
128794772|NCT01039688|463541823|FG002|Overall Study|Withdrawal by Subject|13|||
128794773|NCT01039688|463541821|FG000|Overall Study|Death|2|||
128794774|NCT01039688|463541822|FG001|Overall Study|Death|0|||
128794775|NCT01039688|463541823|FG002|Overall Study|Death|0|||
128794776|NCT00668863|463541824|FG000|Overall Study|Objective Progression or Relapse|42|||
128794777|NCT00668863|463541824|FG000|Overall Study|Adverse Event|13|||
128794778|NCT00668863|463541824|FG000|Overall Study|Study Terminated by Sponsor|8|||
128794779|NCT00668863|463541824|FG000|Overall Study|Global Deterioration of Health Status|4|||
128794780|NCT00668863|463541824|FG000|Overall Study|Withdrawal by Subject|1|||
128794781|NCT00668863|463541824|FG000|Overall Study|Surgery|1|||
128794782|NCT00668863|463541824|FG000|Overall Study|Subject's work scheduling problem|1|||
128794783|NCT00668863|463541824|FG000|Overall Study|Physician Decision|1|||
128794784|NCT03844269|463541829|FG000|Overall Study|Withdrawal pre-intervention|1|||
128794785|NCT03844269|463541829|FG000|Overall Study|Did not complete the intervention|2|||
128794786|NCT00101010|463541831|FG000|Overall Study|Physician Decision|1|||
128794787|NCT02755116|463541838|FG000|Overall Study|surgery converted to open, pt admitted|3|||
128794788|NCT02755116|463541839|FG001|Overall Study|surgery converted to open, pt admitted|1|||
128794789|NCT01124734|463541840|FG000|Overall Study|Disease progression|13|||
128794790|NCT01124734|463541840|FG000|Overall Study|Adverse Event|1|||
128794791|NCT01124734|463541840|FG000|Overall Study|Withdrawal by Subject|1|||
128794792|NCT01124734|463541840|FG000|Overall Study|Elected for alternative treatment|2|||
128794793|NCT02214160|463541841|FG000|Overall Study|Withdrawal by Subject|1|||
128794794|NCT02214160|463541842|FG001|Overall Study|Withdrawal by Subject|0|||
128794795|NCT02214160|463541843|FG002|Overall Study|Withdrawal by Subject|6|||
128794796|NCT02214160|463541841|FG000|Overall Study|Death|2|||
128794797|NCT02214160|463541842|FG001|Overall Study|Death|2|||
128794798|NCT02214160|463541843|FG002|Overall Study|Death|1|||
128794799|NCT02214160|463541841|FG000|Overall Study|Subject Non-Compliance|0|||
128794800|NCT02214160|463541842|FG001|Overall Study|Subject Non-Compliance|3|||
128794801|NCT02214160|463541843|FG002|Overall Study|Subject Non-Compliance|1|||
128794802|NCT02214160|463541841|FG000|Overall Study|Adverse Event|0|||
128794803|NCT02214160|463541842|FG001|Overall Study|Adverse Event|1|||
128794804|NCT02214160|463541843|FG002|Overall Study|Adverse Event|1|||
128794805|NCT02214160|463541841|FG000|Overall Study|Sponsor Decision|0|||
128794806|NCT02214160|463541842|FG001|Overall Study|Sponsor Decision|2|||
128794807|NCT02214160|463541843|FG002|Overall Study|Sponsor Decision|0|||
128794808|NCT02214160|463541841|FG000|Overall Study|Protocol Violation|1|||
128794809|NCT02214160|463541842|FG001|Overall Study|Protocol Violation|0|||
128794810|NCT02214160|463541843|FG002|Overall Study|Protocol Violation|0|||
128794811|NCT02214160|463541841|FG000|Overall Study|Physician Decision|0|||
128794812|NCT02214160|463541842|FG001|Overall Study|Physician Decision|0|||
128794813|NCT02214160|463541843|FG002|Overall Study|Physician Decision|1|||
128794814|NCT02423798|463541844|FG000|Overall Study|Withdrawal by Subject|3|||
128794815|NCT01063972|463541845|FG000|Overall Study|Death|12|||
128794816|NCT01063972|463541846|FG001|Overall Study|Death|11|||
128794817|NCT01063972|463541845|FG000|Overall Study|Incarcerated|2|||
128794818|NCT01063972|463541846|FG001|Overall Study|Incarcerated|1|||
128794819|NCT01264679|463541848|FG000|Overall Study|Participation in Another Clinical Trial|1|||
128794820|NCT01264679|463541848|FG000|Overall Study|Physician Decision|1|||
128794821|NCT01264679|463541848|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
128794822|NCT01264679|463541848|FG000|Overall Study|Withdrawal by Subject|1|||
128794823|NCT01430611|463541852|FG000|Overall Study|Adverse Event|0|||
128794824|NCT01430611|463541853|FG001|Overall Study|Adverse Event|1|||
128794825|NCT01430611|463541852|FG000|Overall Study|Protocol Violation|1|||
128794826|NCT01430611|463541853|FG001|Overall Study|Protocol Violation|0|||
128794827|NCT01430611|463541852|FG000|Overall Study|Lost to Follow-up|1|||
128794828|NCT01430611|463541853|FG001|Overall Study|Lost to Follow-up|0|||
128794829|NCT01430611|463541852|FG000|Overall Study|Withdrawal by Subject|15|||
128794830|NCT01430611|463541853|FG001|Overall Study|Withdrawal by Subject|14|||
128794831|NCT01792830|463541857|FG000|Overall Study|Withdrawal by Subject|22|||
128794832|NCT01792830|463541858|FG001|Overall Study|Withdrawal by Subject|0|||
128794833|NCT01792830|463541859|FG002|Overall Study|Withdrawal by Subject|0|||
128794834|NCT01792830|463541860|FG003|Overall Study|Withdrawal by Subject|2|||
128794835|NCT01792830|463541861|FG004|Overall Study|Withdrawal by Subject|1|||
128794836|NCT01792830|463541862|FG005|Overall Study|Withdrawal by Subject|1|||
128794837|NCT01792830|463541863|FG006|Overall Study|Withdrawal by Subject|1|||
128794838|NCT01792830|463541864|FG007|Overall Study|Withdrawal by Subject|1|||
128794839|NCT01792830|463541865|FG008|Overall Study|Withdrawal by Subject|7|||
128794840|NCT01792830|463541866|FG009|Overall Study|Withdrawal by Subject|0|||
128794841|NCT01792830|463541867|FG010|Overall Study|Withdrawal by Subject|2|||
128794842|NCT01792830|463541857|FG000|Overall Study|Death|3|||
128794843|NCT01792830|463541858|FG001|Overall Study|Death|0|||
128794844|NCT01792830|463541859|FG002|Overall Study|Death|0|||
128794845|NCT01792830|463541860|FG003|Overall Study|Death|1|||
128794846|NCT01792830|463541861|FG004|Overall Study|Death|0|||
128794847|NCT01792830|463541862|FG005|Overall Study|Death|0|||
128794848|NCT01792830|463541863|FG006|Overall Study|Death|1|||
128794849|NCT01792830|463541864|FG007|Overall Study|Death|0|||
128794850|NCT01792830|463541865|FG008|Overall Study|Death|1|||
128794851|NCT01792830|463541866|FG009|Overall Study|Death|0|||
128794852|NCT01792830|463541867|FG010|Overall Study|Death|1|||
128794853|NCT01792830|463541857|FG000|Overall Study|Adverse Event|0|||
128794854|NCT01792830|463541858|FG001|Overall Study|Adverse Event|0|||
128794855|NCT01792830|463541859|FG002|Overall Study|Adverse Event|0|||
128794856|NCT01792830|463541860|FG003|Overall Study|Adverse Event|0|||
128794857|NCT01792830|463541861|FG004|Overall Study|Adverse Event|0|||
128794858|NCT01792830|463541862|FG005|Overall Study|Adverse Event|0|||
128794859|NCT01792830|463541863|FG006|Overall Study|Adverse Event|0|||
128794860|NCT01792830|463541864|FG007|Overall Study|Adverse Event|0|||
128794861|NCT01792830|463541865|FG008|Overall Study|Adverse Event|1|||
128794862|NCT01792830|463541866|FG009|Overall Study|Adverse Event|0|||
128794863|NCT01792830|463541867|FG010|Overall Study|Adverse Event|0|||
128794864|NCT03144674|463541887|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
128794865|NCT03144674|463541888|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
128794866|NCT03144674|463541889|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
128794867|NCT03144674|463541890|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
128794868|NCT03144674|463541887|FG000|Overall Study|Death|3|||
128794869|NCT03144674|463541888|FG001|Overall Study|Death|2|||
128794870|NCT03144674|463541889|FG002|Overall Study|Death|6|||
128794871|NCT03144674|463541890|FG003|Overall Study|Death|24|||
128794872|NCT03144674|463541887|FG000|Overall Study|Lost to Follow-up|0|||
128794873|NCT03144674|463541888|FG001|Overall Study|Lost to Follow-up|1|||
128794874|NCT03144674|463541889|FG002|Overall Study|Lost to Follow-up|0|||
128794875|NCT03144674|463541890|FG003|Overall Study|Lost to Follow-up|4|||
128794876|NCT03144674|463541887|FG000|Overall Study|Withdrawal by Participant|0|||
128794877|NCT03144674|463541888|FG001|Overall Study|Withdrawal by Participant|0|||
128794878|NCT03144674|463541889|FG002|Overall Study|Withdrawal by Participant|2|||
128794879|NCT03144674|463541890|FG003|Overall Study|Withdrawal by Participant|6|||
128794880|NCT03144674|463541887|FG000|Overall Study|Discharged from the Trust|0|||
128794881|NCT03144674|463541888|FG001|Overall Study|Discharged from the Trust|0|||
128794882|NCT03144674|463541889|FG002|Overall Study|Discharged from the Trust|1|||
128794883|NCT03144674|463541890|FG003|Overall Study|Discharged from the Trust|0|||
128794884|NCT03144674|463541887|FG000|Overall Study|Exclusion Criteria Met|0|||
128794885|NCT03144674|463541888|FG001|Overall Study|Exclusion Criteria Met|0|||
128794886|NCT03144674|463541889|FG002|Overall Study|Exclusion Criteria Met|1|||
128794887|NCT03144674|463541890|FG003|Overall Study|Exclusion Criteria Met|0|||
128794888|NCT03144674|463541887|FG000|Overall Study|Changed Physicians|0|||
128794889|NCT03144674|463541888|FG001|Overall Study|Changed Physicians|0|||
128794890|NCT03144674|463541889|FG002|Overall Study|Changed Physicians|0|||
128794891|NCT03144674|463541890|FG003|Overall Study|Changed Physicians|1|||
128794892|NCT03144674|463541887|FG000|Overall Study|Removed for Safety|0|||
128794893|NCT03144674|463541888|FG001|Overall Study|Removed for Safety|0|||
128794894|NCT03144674|463541889|FG002|Overall Study|Removed for Safety|0|||
128794895|NCT03144674|463541890|FG003|Overall Study|Removed for Safety|1|||
128794896|NCT03144674|463541887|FG000|Overall Study|Site Closed|0|||
128794897|NCT03144674|463541888|FG001|Overall Study|Site Closed|0|||
128794898|NCT03144674|463541889|FG002|Overall Study|Site Closed|0|||
128794899|NCT03144674|463541890|FG003|Overall Study|Site Closed|1|||
128794900|NCT03144674|463541887|FG000|Overall Study|Histological Criteria Not Met|0|||
128794901|NCT03144674|463541888|FG001|Overall Study|Histological Criteria Not Met|0|||
128794902|NCT03144674|463541889|FG002|Overall Study|Histological Criteria Not Met|0|||
128794903|NCT03144674|463541890|FG003|Overall Study|Histological Criteria Not Met|1|||
128794904|NCT03144674|463541887|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
128794905|NCT03144674|463541888|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
128794906|NCT03144674|463541889|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
128794907|NCT03144674|463541890|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
128794908|NCT03144674|463541887|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
128794909|NCT03144674|463541888|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
128794910|NCT03144674|463541889|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
128794911|NCT03144674|463541890|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
128794912|NCT03368664|463541891|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
128794913|NCT03368664|463541891|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
128794914|NCT03368664|463541891|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
128794915|NCT03368664|463541891|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
128794916|NCT00837616|463541892|FG000|Overall Study|Withdrawal by Subject|0|||
128794917|NCT00837616|463541893|FG001|Overall Study|Withdrawal by Subject|1|||
128794918|NCT04789408|463541897|FG000|Overall Study|Death|4|||
128794919|NCT04789408|463541898|FG001|Overall Study|Death|3|||
128794920|NCT04789408|463541899|FG002|Overall Study|Death|6|||
128794921|NCT04789408|463541897|FG000|Overall Study|Did not meet eligibility criteria|1|||
128794922|NCT04789408|463541898|FG001|Overall Study|Did not meet eligibility criteria|0|||
128794923|NCT04789408|463541899|FG002|Overall Study|Did not meet eligibility criteria|0|||
128794924|NCT04789408|463541897|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
128794925|NCT04789408|463541898|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
128794926|NCT04789408|463541899|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
128794927|NCT02079844|463541900|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
128794928|NCT02079844|463541901|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
128794929|NCT02079844|463541902|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
128794930|NCT02079844|463541900|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
128794931|NCT02079844|463541901|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
128794932|NCT02079844|463541902|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
128794933|NCT01420549|463541903|FG000|Overall Study|Adverse Event|1|||
128794934|NCT01420549|463541904|FG001|Overall Study|Adverse Event|1|||
128794935|NCT01420549|463541903|FG000|Overall Study|Lost to Follow-up|2|||
128794936|NCT01420549|463541904|FG001|Overall Study|Lost to Follow-up|2|||
128794937|NCT01420549|463541903|FG000|Overall Study|Protocol Violation|0|||
128794938|NCT01420549|463541904|FG001|Overall Study|Protocol Violation|1|||
128794939|NCT01420549|463541903|FG000|Overall Study|Non-adherence to medication|4|||
128794940|NCT01420549|463541904|FG001|Overall Study|Non-adherence to medication|1|||
128794941|NCT00840177|463543120|FG000|Overall Study|Adverse Event|5|||
128794942|NCT00840177|463543121|FG001|Overall Study|Adverse Event|1|||
128794943|NCT00840177|463543122|FG002|Overall Study|Adverse Event|1|||
128794944|NCT00840177|463543120|FG000|Overall Study|Refusal unrelated to adverse events|1|||
128794945|NCT00840177|463543121|FG001|Overall Study|Refusal unrelated to adverse events|0|||
128794946|NCT00840177|463543122|FG002|Overall Study|Refusal unrelated to adverse events|1|||
128794947|NCT00840177|463543120|FG000|Overall Study|Progression/relapse|2|||
128794948|NCT00840177|463543121|FG001|Overall Study|Progression/relapse|0|||
128794949|NCT00840177|463543122|FG002|Overall Study|Progression/relapse|0|||
128794950|NCT00840177|463543120|FG000|Overall Study|Death|4|||
128794951|NCT00840177|463543121|FG001|Overall Study|Death|5|||
128794952|NCT00840177|463543122|FG002|Overall Study|Death|5|||
128794953|NCT00840177|463543120|FG000|Overall Study|not protocol specified|6|||
128794954|NCT00840177|463543121|FG001|Overall Study|not protocol specified|3|||
128794955|NCT00840177|463543122|FG002|Overall Study|not protocol specified|0|||
128794956|NCT00840177|463543120|FG000|Overall Study|Ineligible|0|||
128794957|NCT00840177|463543121|FG001|Overall Study|Ineligible|0|||
128794958|NCT00840177|463543122|FG002|Overall Study|Ineligible|3|||
128794959|NCT00840177|463543120|FG000|Overall Study|Did not start treatment|0|||
128794960|NCT00840177|463543121|FG001|Overall Study|Did not start treatment|0|||
128794961|NCT00840177|463543122|FG002|Overall Study|Did not start treatment|1|||
128794962|NCT01391832|463543123|FG000|Overall Study|Withdrawal by Subject|21|||
128794963|NCT01391832|463543124|FG001|Overall Study|Withdrawal by Subject|22|||
128794964|NCT01391832|463543123|FG000|Overall Study|Lost to Follow-up|0|||
128794965|NCT01391832|463543124|FG001|Overall Study|Lost to Follow-up|1|||
128794966|NCT00686855|463543128|FG000|Overall Study|Lost to Follow-up|1|||
128794967|NCT00686855|463543129|FG001|Overall Study|Lost to Follow-up|0|||
128794968|NCT00686855|463543128|FG000|Overall Study|Progressive GVHD|0|||
128794969|NCT00686855|463543129|FG001|Overall Study|Progressive GVHD|1|||
128794970|NCT01460446|463543135|FG000|Overall Study|Non-compliance|2|||
128794971|NCT01460446|463543136|FG001|Overall Study|Non-compliance|9|||
128794972|NCT01460446|463543135|FG000|Overall Study|Consent Withdrawn|0|||
128794973|NCT01460446|463543136|FG001|Overall Study|Consent Withdrawn|4|||
128794974|NCT01460446|463543135|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
128794975|NCT01460446|463543136|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
128794976|NCT01460446|463543135|FG000|Overall Study|Surgery/Illness|1|||
128794977|NCT01460446|463543136|FG001|Overall Study|Surgery/Illness|1|||
128794978|NCT01460446|463543135|FG000|Overall Study|Pregnancy|1|||
128794979|NCT01460446|463543136|FG001|Overall Study|Pregnancy|0|||
128794980|NCT01460446|463543135|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
128794981|NCT01460446|463543136|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
128794982|NCT01867216|463543137|FG000|Overall Study|Withdrawal by Subject|2|||
128794983|NCT01867216|463543138|FG001|Overall Study|Withdrawal by Subject|0|||
128794984|NCT01867216|463543139|FG002|Overall Study|Withdrawal by Subject|0|||
128794985|NCT01867216|463543140|FG003|Overall Study|Withdrawal by Subject|0|||
128794986|NCT01867216|463543141|FG004|Overall Study|Withdrawal by Subject|1|||
128794987|NCT01867216|463543142|FG005|Overall Study|Withdrawal by Subject|0|||
128794988|NCT01867216|463543143|FG006|Overall Study|Withdrawal by Subject|1|||
128794989|NCT01867216|463543137|FG000|Overall Study|Physician Decision|1|||
128794990|NCT01867216|463543138|FG001|Overall Study|Physician Decision|0|||
128794991|NCT01867216|463543139|FG002|Overall Study|Physician Decision|0|||
128794992|NCT01867216|463543140|FG003|Overall Study|Physician Decision|0|||
128794993|NCT01867216|463543141|FG004|Overall Study|Physician Decision|0|||
128794994|NCT01867216|463543142|FG005|Overall Study|Physician Decision|0|||
128794995|NCT01867216|463543143|FG006|Overall Study|Physician Decision|0|||
128794996|NCT01867216|463543137|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
128794997|NCT01867216|463543138|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
128794998|NCT01867216|463543139|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
128794999|NCT01867216|463543140|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
128795000|NCT01867216|463543141|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
128795001|NCT01867216|463543142|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
128795002|NCT01867216|463543143|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
128795003|NCT01318382|463543146|FG000|Overall Study|Physician Decision|2|||
128795004|NCT01318382|463543146|FG000|Overall Study|Device Malfunction|10|||
128795005|NCT01318382|463543146|FG000|Overall Study|Protocol Violation|1|||
128795006|NCT00714714|463543147|FG000|Overall Study|Adverse Event|1|||
128795007|NCT01308567|463543158|FG000|Overall Study|Lost to Follow-up|2|||
128795008|NCT01308567|463543159|FG001|Overall Study|Lost to Follow-up|4|||
128795009|NCT01308567|463543160|FG002|Overall Study|Lost to Follow-up|4|||
128795010|NCT00542789|463543161|FG000|Overall Study|Adverse Event|18|||
128795011|NCT00542789|463543162|FG001|Overall Study|Adverse Event|17|||
128795012|NCT00542789|463543161|FG000|Overall Study|Withdrawal by Subject|7|||
128795013|NCT00542789|463543162|FG001|Overall Study|Withdrawal by Subject|3|||
128795014|NCT00542789|463543161|FG000|Overall Study|Protocol Violation|8|||
128795015|NCT00542789|463543162|FG001|Overall Study|Protocol Violation|1|||
128795016|NCT00542789|463543161|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
128795017|NCT00542789|463543162|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
128795018|NCT03454529|463543172|FG000|Overall Study|Did not receive treatment|6|||
128795019|NCT03454529|463543172|FG000|Overall Study|Received < 80% doses|1|||
128795020|NCT01582100|463543176|FG000|Overall Study|Adverse Event|1|||
128795021|NCT01582100|463543176|FG000|Overall Study|Withdrawal by Subject|1|||
128795022|NCT01040689|463543179|FG000|Overall Study|Adverse Event|0|||
128795023|NCT01040689|463543180|FG001|Overall Study|Adverse Event|0|||
128795024|NCT01040689|463543181|FG002|Overall Study|Adverse Event|2|||
128795025|NCT01040689|463543182|FG003|Overall Study|Adverse Event|4|||
128795026|NCT01040689|463543179|FG000|Overall Study|Lack of Efficacy|0|||
128795027|NCT01040689|463543180|FG001|Overall Study|Lack of Efficacy|0|||
128795028|NCT01040689|463543181|FG002|Overall Study|Lack of Efficacy|1|||
128795029|NCT01040689|463543182|FG003|Overall Study|Lack of Efficacy|0|||
128795030|NCT01040689|463543179|FG000|Overall Study|Lost to Follow-up|1|||
128795031|NCT01040689|463543180|FG001|Overall Study|Lost to Follow-up|0|||
128795032|NCT01040689|463543181|FG002|Overall Study|Lost to Follow-up|0|||
128795033|NCT01040689|463543182|FG003|Overall Study|Lost to Follow-up|0|||
128795034|NCT01040689|463543179|FG000|Overall Study|Withdrawal by Subject|2|||
128795035|NCT01040689|463543180|FG001|Overall Study|Withdrawal by Subject|1|||
128795036|NCT01040689|463543181|FG002|Overall Study|Withdrawal by Subject|1|||
128795037|NCT01040689|463543182|FG003|Overall Study|Withdrawal by Subject|0|||
128795038|NCT01040689|463543179|FG000|Overall Study|Other reasons not listed above|0|||
128795039|NCT01040689|463543180|FG001|Overall Study|Other reasons not listed above|1|||
128795040|NCT01040689|463543181|FG002|Overall Study|Other reasons not listed above|0|||
128795041|NCT01040689|463543182|FG003|Overall Study|Other reasons not listed above|0|||
128795042|NCT01185561|463543183|FG000|Overall Study|Lost to Follow-up|0|||
128795043|NCT01185561|463543184|FG001|Overall Study|Lost to Follow-up|4|||
128795044|NCT01185561|463543183|FG000|Overall Study|Withdrawal by Subject|2|||
128795045|NCT01185561|463543184|FG001|Overall Study|Withdrawal by Subject|8|||
128795046|NCT02616900|463543185|FG000|Overall Study|Lack of Efficacy|7|||
128795047|NCT02616900|463543185|FG000|Overall Study|Lost to Follow-up|2|||
128795048|NCT02616900|463543185|FG000|Overall Study|Protocol Violation|5|||
128795049|NCT02616900|463543185|FG000|Overall Study|Withdrawal by Subject|3|||
128795050|NCT02616900|463543185|FG000|Overall Study|Incomplete data|6|||
128795051|NCT02499159|463543186|FG000|Randomization|Protocol Violation|1|||
128795052|NCT02499159|463543187|FG001|Randomization|Protocol Violation|1|||
128795053|NCT02499159|463543186|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
128795054|NCT02499159|463543187|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
128795055|NCT02499159|463543186|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
128795056|NCT02499159|463543187|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
128795057|NCT02499159|463543186|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
128795058|NCT02499159|463543187|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
128795059|NCT02499159|463543186|FG000|30-Day Follow-Up Phone Call|Other|1|||
128795060|NCT02499159|463543187|FG001|30-Day Follow-Up Phone Call|Other|0|||
128795061|NCT02564744|463543188|FG000|Overall Study|Investigator decision|0|||
128795062|NCT02564744|463543189|FG001|Overall Study|Investigator decision|0|||
128795063|NCT02564744|463543190|FG002|Overall Study|Investigator decision|0|||
128795064|NCT02564744|463543191|FG003|Overall Study|Investigator decision|0|||
128795065|NCT02564744|463543192|FG004|Overall Study|Investigator decision|1|||
128795066|NCT02564744|463543188|FG000|Overall Study|Death|10|||
128795067|NCT02564744|463543189|FG001|Overall Study|Death|5|||
128795068|NCT02564744|463543190|FG002|Overall Study|Death|4|||
128795069|NCT02564744|463543191|FG003|Overall Study|Death|16|||
128795070|NCT02564744|463543192|FG004|Overall Study|Death|16|||
128795071|NCT02564744|463543188|FG000|Overall Study|End of study Page Missing|0|||
128795072|NCT02564744|463543189|FG001|Overall Study|End of study Page Missing|0|||
128795073|NCT02564744|463543190|FG002|Overall Study|End of study Page Missing|3|||
128795074|NCT02564744|463543191|FG003|Overall Study|End of study Page Missing|3|||
128759055|NCT00330174|463406856|FG000|Overall Study|Withdrawal by Subject|7|||
128759056|NCT00330174|463406857|FG001|Overall Study|Withdrawal by Subject|7|||
128759057|NCT00330174|463406856|FG000|Overall Study|Lost to Follow-up|4|||
128759058|NCT00330174|463406857|FG001|Overall Study|Lost to Follow-up|1|||
128759059|NCT00330174|463406856|FG000|Overall Study|Clinical deterioration|1|||
128759060|NCT00330174|463406857|FG001|Overall Study|Clinical deterioration|2|||
128759061|NCT00330174|463406856|FG000|Overall Study|Excessive missed visits|3|||
128759062|NCT00330174|463406857|FG001|Overall Study|Excessive missed visits|8|||
128759063|NCT00330174|463406856|FG000|Overall Study|Miscellaneous reasons|7|||
128759064|NCT00330174|463406857|FG001|Overall Study|Miscellaneous reasons|1|||
128759065|NCT02403180|463406860|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
128759066|NCT02403180|463406861|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
128759067|NCT02403180|463406860|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
128759068|NCT02403180|463406861|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
128759069|NCT01445652|463406865|FG000|Overall Study|Not comfortable in lenses|5|||
128759070|NCT01445652|463406866|FG001|Overall Study|Not comfortable in lenses|0|||
128759071|NCT01445652|463406865|FG000|Overall Study|Failed to attend scheduled visit|2|||
128759072|NCT01445652|463406866|FG001|Overall Study|Failed to attend scheduled visit|3|||
128759073|NCT01445652|463406865|FG000|Overall Study|Failed teach session|2|||
128759074|NCT01445652|463406866|FG001|Overall Study|Failed teach session|0|||
128759075|NCT01445652|463406865|FG000|Overall Study|Adverse Event|1|||
128759076|NCT01445652|463406866|FG001|Overall Study|Adverse Event|0|||
128759077|NCT03595332|463406869|FG000|Overall Study|Lost to Follow-up|16|||
128759078|NCT03595332|463406870|FG001|Overall Study|Lost to Follow-up|22|||
128759079|NCT03595332|463406869|FG000|Overall Study|Unable to retrieve ID from school|0|||
128759080|NCT03595332|463406870|FG001|Overall Study|Unable to retrieve ID from school|2|||
128759081|NCT02227875|463406871|FG000|Overall Study|Protocol Violation|10|||
128759082|NCT02227875|463406872|FG001|Overall Study|Protocol Violation|7|||
128759083|NCT02227875|463406871|FG000|Overall Study|Other|1|||
128759084|NCT02227875|463406872|FG001|Overall Study|Other|3|||
128759085|NCT02227875|463406871|FG000|Overall Study|Physician Decision|1|||
128759086|NCT02227875|463406872|FG001|Overall Study|Physician Decision|0|||
128759087|NCT02227875|463406871|FG000|Overall Study|Adverse Event|3|||
128759088|NCT02227875|463406872|FG001|Overall Study|Adverse Event|0|||
128759089|NCT02227875|463406871|FG000|Overall Study|Withdrawal by Subject|12|||
128759090|NCT02227875|463406872|FG001|Overall Study|Withdrawal by Subject|13|||
128759091|NCT02227875|463406871|FG000|Overall Study|Lost to Follow-up|10|||
128759092|NCT02227875|463406872|FG001|Overall Study|Lost to Follow-up|10|||
128759093|NCT04209725|463406875|FG000|Overall Study|Adverse Event|1|||
128759094|NCT05163522|463406887|FG000|Overall Study|Withdrawal by Subject|0|||
128759095|NCT05163522|463406888|FG001|Overall Study|Withdrawal by Subject|0|||
128759096|NCT05163522|463406889|FG002|Overall Study|Withdrawal by Subject|1|||
128759097|NCT05163522|463406890|FG003|Overall Study|Withdrawal by Subject|0|||
128759098|NCT05163522|463406891|FG004|Overall Study|Withdrawal by Subject|0|||
128759099|NCT05163522|463406892|FG005|Overall Study|Withdrawal by Subject|0|||
128759100|NCT05163522|463406893|FG006|Overall Study|Withdrawal by Subject|0|||
128759101|NCT05163522|463406894|FG007|Overall Study|Withdrawal by Subject|0|||
128759102|NCT05163522|463406895|FG008|Overall Study|Withdrawal by Subject|0|||
128759103|NCT05163522|463406896|FG009|Overall Study|Withdrawal by Subject|0|||
128759104|NCT05163522|463406897|FG010|Overall Study|Withdrawal by Subject|0|||
128759105|NCT03412396|463406898|FG000|Overall Study|Withdrawal by Subject|2|||
128759106|NCT03412396|463406898|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
128759107|NCT03412396|463406898|FG000|Overall Study|Did not undergo RP|2|||
128759108|NCT04899245|463406907|FG000|Overall Study|Withdrawal by Subject|3|||
128759109|NCT04899245|463406908|FG001|Overall Study|Withdrawal by Subject|5|||
128759110|NCT04899245|463406909|FG002|Overall Study|Withdrawal by Subject|2|||
128759111|NCT04899245|463406907|FG000|Overall Study|No longer eligible - Left staff position|0|||
128759112|NCT04899245|463406908|FG001|Overall Study|No longer eligible - Left staff position|0|||
128759113|NCT04899245|463406909|FG002|Overall Study|No longer eligible - Left staff position|1|||
128759114|NCT04899245|463406907|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
128759115|NCT04899245|463406908|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
128759116|NCT04899245|463406909|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
128759117|NCT04899245|463406907|FG000|Overall Study|No longer eligible - Moved away from area|2|||
128759118|NCT04899245|463406908|FG001|Overall Study|No longer eligible - Moved away from area|2|||
128759119|NCT04899245|463406909|FG002|Overall Study|No longer eligible - Moved away from area|0|||
128759120|NCT02753595|463406915|FG000|Overall Study|Sponsor termination|2|||
128759121|NCT02753595|463406916|FG001|Overall Study|Sponsor termination|2|||
128759122|NCT01570868|463406917|FG000|Overall Study|Adverse Event|8|||
128759123|NCT01570868|463406918|FG001|Overall Study|Adverse Event|1|||
128759124|NCT01570868|463406917|FG000|Overall Study|FDA Recommendation|23|||
128759125|NCT01570868|463406918|FG001|Overall Study|FDA Recommendation|3|||
128759126|NCT01570868|463406917|FG000|Overall Study|Physician Decision|10|||
128759127|NCT01570868|463406918|FG001|Overall Study|Physician Decision|4|||
128759128|NCT01570868|463406917|FG000|Overall Study|Lost to Follow-up|1|||
128759129|NCT01570868|463406918|FG001|Overall Study|Lost to Follow-up|0|||
128795075|NCT02564744|463543192|FG004|Overall Study|End of study Page Missing|0|||
128795076|NCT02564744|463543188|FG000|Overall Study|Subject Withdrew Consent|1|||
128795077|NCT02564744|463543189|FG001|Overall Study|Subject Withdrew Consent|1|||
128795078|NCT02564744|463543190|FG002|Overall Study|Subject Withdrew Consent|1|||
128795079|NCT02564744|463543191|FG003|Overall Study|Subject Withdrew Consent|0|||
128795080|NCT02564744|463543192|FG004|Overall Study|Subject Withdrew Consent|2|||
128795081|NCT02564744|463543188|FG000|Overall Study|Lost to Follow-up|0|||
128795082|NCT02564744|463543189|FG001|Overall Study|Lost to Follow-up|1|||
128795083|NCT02564744|463543190|FG002|Overall Study|Lost to Follow-up|0|||
128795084|NCT02564744|463543191|FG003|Overall Study|Lost to Follow-up|0|||
128795085|NCT02564744|463543192|FG004|Overall Study|Lost to Follow-up|1|||
128795086|NCT02564744|463543188|FG000|Overall Study|Reason not specified|1|||
128795087|NCT02564744|463543189|FG001|Overall Study|Reason not specified|0|||
128795088|NCT02564744|463543190|FG002|Overall Study|Reason not specified|0|||
128795089|NCT02564744|463543191|FG003|Overall Study|Reason not specified|0|||
128795090|NCT02564744|463543192|FG004|Overall Study|Reason not specified|0|||
128795091|NCT01190007|463543193|FG000|Overall Study|Withdrawal by Subject|4|||
128795092|NCT01190007|463543193|FG000|Overall Study|Adverse Event|8|||
128795093|NCT01190007|463543193|FG000|Overall Study|Difficulty of visit for complications|1|||
128795094|NCT01190007|463543193|FG000|Overall Study|Participant was arrested|1|||
128795095|NCT02594735|463543196|FG000|Overall Study|Adverse Event|1|||
128795096|NCT02969863|463543201|FG000|Overall Study|Physician Decision|1|||
128795097|NCT02969863|463543202|FG001|Overall Study|Physician Decision|0|||
128795098|NCT02969863|463543203|FG002|Overall Study|Physician Decision|0|||
128795099|NCT02969863|463543204|FG003|Overall Study|Physician Decision|0|||
128795100|NCT02969863|463543205|FG004|Overall Study|Physician Decision|0|||
128795101|NCT02969863|463543206|FG005|Overall Study|Physician Decision|0|||
128795102|NCT03737240|463543207|FG000|Overall Study|Lost to Follow-up|16|||
128795103|NCT03737240|463543208|FG001|Overall Study|Lost to Follow-up|15|||
128795104|NCT00585533|463543209|FG000|Overall Study|objective or symptomatic progression|9|||
128795105|NCT01254188|463543210|FG000|Overall Study|Disease Progression|6|||
128795106|NCT01254188|463543210|FG000|Overall Study|Protocol Violation|6|||
128795107|NCT01254188|463543210|FG000|Overall Study|Pregnancy|2|||
128795108|NCT01254188|463543210|FG000|Overall Study|Death|4|||
128795109|NCT01254188|463543210|FG000|Overall Study|Lost to Follow-up|5|||
128795110|NCT01254188|463543210|FG000|Overall Study|Withdrawal by Subject|7|||
128795111|NCT01254188|463543210|FG000|Overall Study|Adverse Event|43|||
128795112|NCT01254188|463543210|FG000|Overall Study|per investigator discretion|20|||
128795113|NCT01369498|463543211|FG000|Overall Study|Lack of Efficacy|9|||
128795114|NCT01369498|463543212|FG001|Overall Study|Lack of Efficacy|9|||
128795115|NCT01369498|463543213|FG002|Overall Study|Lack of Efficacy|1|||
128795116|NCT01369498|463543214|FG003|Overall Study|Lack of Efficacy|3|||
128795117|NCT01369498|463543211|FG000|Overall Study|Adverse Event|1|||
128795118|NCT01369498|463543212|FG001|Overall Study|Adverse Event|2|||
128795119|NCT01369498|463543213|FG002|Overall Study|Adverse Event|0|||
128795120|NCT01369498|463543214|FG003|Overall Study|Adverse Event|1|||
128795121|NCT01369498|463543211|FG000|Overall Study|Withdrawal of Consent|0|||
128795122|NCT01369498|463543212|FG001|Overall Study|Withdrawal of Consent|1|||
128795123|NCT01369498|463543213|FG002|Overall Study|Withdrawal of Consent|1|||
128795124|NCT01369498|463543214|FG003|Overall Study|Withdrawal of Consent|1|||
128795125|NCT01369498|463543211|FG000|Overall Study|Death|0|||
128795126|NCT01369498|463543212|FG001|Overall Study|Death|0|||
128795127|NCT01369498|463543213|FG002|Overall Study|Death|1|||
128795128|NCT01369498|463543214|FG003|Overall Study|Death|0|||
128795129|NCT01369498|463543211|FG000|Overall Study|Investigator's Discretion|1|||
128795130|NCT01369498|463543212|FG001|Overall Study|Investigator's Discretion|0|||
128795131|NCT01369498|463543213|FG002|Overall Study|Investigator's Discretion|1|||
128795132|NCT01369498|463543214|FG003|Overall Study|Investigator's Discretion|3|||
128795133|NCT01369498|463543211|FG000|Overall Study|Unknown Reason|1|||
128795134|NCT01369498|463543212|FG001|Overall Study|Unknown Reason|0|||
128795135|NCT01369498|463543213|FG002|Overall Study|Unknown Reason|11|||
128795136|NCT01369498|463543214|FG003|Overall Study|Unknown Reason|6|||
128795137|NCT01369498|463543211|FG000|Overall Study|Disease Progression|0|||
128795138|NCT01369498|463543212|FG001|Overall Study|Disease Progression|0|||
128795139|NCT01369498|463543213|FG002|Overall Study|Disease Progression|0|||
128795140|NCT01369498|463543214|FG003|Overall Study|Disease Progression|1|||
128795141|NCT05082935|463543226|FG000|Overall Study|Lost to Follow-up|549|||
128795142|NCT05082935|463543227|FG001|Overall Study|Lost to Follow-up|631|||
128795143|NCT05082935|463543226|FG000|Overall Study|Withdrawal by Subject|27|||
128795144|NCT05082935|463543227|FG001|Overall Study|Withdrawal by Subject|58|||
128795145|NCT02957136|463543229|FG000|Overall Study|Withdrawal by Subject|2|||
128795146|NCT02957136|463543230|FG001|Overall Study|Withdrawal by Subject|1|||
128795147|NCT00439569|463543231|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
128795148|NCT00439569|463543231|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
128795149|NCT00439569|463543231|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
128795150|NCT02200770|463543232|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
128795151|NCT02200770|463543233|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
128795152|NCT02200770|463543232|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
128795153|NCT02200770|463543233|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
128795154|NCT02200770|463543232|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
128795155|NCT02200770|463543233|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
128795156|NCT02200770|463543232|FG000|Randomized-controlled Period (RCP)|Other|1|||
128795157|NCT02200770|463543233|FG001|Randomized-controlled Period (RCP)|Other|2|||
128795158|NCT02200770|463543232|FG000|Open-label Period (OLP)|Adverse Event|1|||
128795159|NCT02200770|463543233|FG001|Open-label Period (OLP)|Adverse Event|2|||
128795160|NCT02200770|463543232|FG000|Open-label Period (OLP)|Death|1|||
128795161|NCT02200770|463543233|FG001|Open-label Period (OLP)|Death|2|||
128795162|NCT02200770|463543232|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
128795163|NCT02200770|463543233|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
128795164|NCT02200770|463543232|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
128795165|NCT02200770|463543233|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
128795166|NCT02200770|463543232|FG000|Open-label Period (OLP)|Other|6|||
128795167|NCT02200770|463543233|FG001|Open-label Period (OLP)|Other|15|||
128795168|NCT01510717|463543236|FG000|Overall Study|Adverse Event|1|||
128795169|NCT01510717|463543237|FG001|Overall Study|Adverse Event|2|||
128795170|NCT01510717|463543236|FG000|Overall Study|Death|1|||
128795171|NCT01510717|463543237|FG001|Overall Study|Death|0|||
128795172|NCT01510717|463543236|FG000|Overall Study|Lost to Follow-up|0|||
128795173|NCT01510717|463543237|FG001|Overall Study|Lost to Follow-up|1|||
128795174|NCT01510717|463543236|FG000|Overall Study|Withdrawal by Subject|0|||
128795175|NCT01510717|463543237|FG001|Overall Study|Withdrawal by Subject|2|||
128795176|NCT03482011|463543238|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
128795177|NCT03482011|463543239|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
128795178|NCT03482011|463543240|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
128795179|NCT03482011|463543241|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
128795180|NCT03482011|463543242|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
128795181|NCT03482011|463543243|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
128795182|NCT03482011|463543244|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
128795183|NCT03482011|463543245|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
128795184|NCT03482011|463543238|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
128795185|NCT03482011|463543239|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
128795186|NCT03482011|463543240|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
128795187|NCT03482011|463543241|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
128795188|NCT03482011|463543242|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
128795189|NCT03482011|463543243|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
128795190|NCT03482011|463543244|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
128795191|NCT03482011|463543245|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
128795192|NCT03482011|463543238|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
128795193|NCT03482011|463543239|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
128795194|NCT03482011|463543240|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
128795195|NCT03482011|463543241|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
128795196|NCT03482011|463543242|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
128795197|NCT03482011|463543243|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
128795198|NCT03482011|463543244|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
128795199|NCT03482011|463543245|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
128795200|NCT03482011|463543238|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
128795201|NCT03482011|463543239|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
128795202|NCT03482011|463543240|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
128795203|NCT03482011|463543241|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
128795204|NCT03482011|463543242|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
128795205|NCT03482011|463543243|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
128795206|NCT03482011|463543244|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
128795207|NCT03482011|463543245|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
128795208|NCT03482011|463543238|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
128795209|NCT03482011|463543239|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
128795210|NCT03482011|463543240|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128795211|NCT03482011|463543241|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128795212|NCT03482011|463543242|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128795213|NCT03482011|463543243|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128795214|NCT03482011|463543244|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128795215|NCT03482011|463543245|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
128795216|NCT03482011|463543238|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
128795217|NCT03482011|463543239|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
128795218|NCT03482011|463543240|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
128795219|NCT03482011|463543241|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
128795220|NCT03482011|463543242|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
128795221|NCT03482011|463543243|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
128795222|NCT03482011|463543244|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
128795223|NCT03482011|463543245|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
128795224|NCT03482011|463543238|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
128759130|NCT01570868|463406917|FG000|Overall Study|Withdrawal by Subject|1|||
128759131|NCT01570868|463406918|FG001|Overall Study|Withdrawal by Subject|0|||
128759132|NCT02515279|463406922|FG000|Overall Study|Adverse Event|7|||
128759133|NCT02515279|463406922|FG000|Overall Study|Lack of Efficacy|31|||
128759134|NCT02515279|463406922|FG000|Overall Study|Lost to Follow-up|9|||
128759135|NCT02515279|463406922|FG000|Overall Study|Withdrawal by Subject|18|||
128759136|NCT02515279|463406922|FG000|Overall Study|End-of-treatment visit not attended|17|||
128759137|NCT02515279|463406922|FG000|Overall Study|Other|22|||
128759138|NCT01800968|463406924|FG000|Overall Study|Death|23|||
128759139|NCT01800968|463406925|FG001|Overall Study|Death|16|||
128759140|NCT01800968|463406924|FG000|Overall Study|Lost to Follow-up|5|||
128759141|NCT01800968|463406925|FG001|Overall Study|Lost to Follow-up|7|||
128759142|NCT01800968|463406924|FG000|Overall Study|Withdrawal by Subject|7|||
128759143|NCT01800968|463406925|FG001|Overall Study|Withdrawal by Subject|9|||
128759144|NCT01800968|463406924|FG000|Overall Study|Physician Decision|1|||
128759145|NCT01800968|463406925|FG001|Overall Study|Physician Decision|0|||
128759146|NCT03185481|463406929|FG000|Overall Study|Adverse Event|1|||
128759147|NCT03185481|463406929|FG000|Overall Study|Study Terminated by Sponsor|4|||
128759148|NCT01422408|463406930|FG000|Overall Study|Adverse Event|1|||
128759149|NCT01422408|463406930|FG000|Overall Study|Withdrawal by Subject|3|||
128759150|NCT03078816|463406940|FG000|Overall Study|Withdrawal by Subject|1|||
128759151|NCT01860703|463406942|FG000|Overall Study|Adverse Event|1|||
128759152|NCT01860703|463406943|FG001|Overall Study|Adverse Event|4|||
128759153|NCT01860703|463406944|FG002|Overall Study|Adverse Event|0|||
128759154|NCT01860703|463406945|FG003|Overall Study|Adverse Event|2|||
128759155|NCT01860703|463406942|FG000|Overall Study|Withdrawal by Subject|0|||
128759156|NCT01860703|463406943|FG001|Overall Study|Withdrawal by Subject|1|||
128759157|NCT01860703|463406944|FG002|Overall Study|Withdrawal by Subject|0|||
128759158|NCT01860703|463406945|FG003|Overall Study|Withdrawal by Subject|0|||
128759159|NCT01860703|463406942|FG000|Overall Study|Personal reason|1|||
128759160|NCT01860703|463406943|FG001|Overall Study|Personal reason|0|||
128759161|NCT01860703|463406944|FG002|Overall Study|Personal reason|1|||
128759162|NCT01860703|463406945|FG003|Overall Study|Personal reason|0|||
128759163|NCT02453685|463406947|FG000|Overall Study|Adverse Event|0|||
128759164|NCT02453685|463406948|FG001|Overall Study|Adverse Event|1|||
128759165|NCT02453685|463406947|FG000|Overall Study|Protocol Violation|7|||
128759166|NCT02453685|463406948|FG001|Overall Study|Protocol Violation|4|||
128759167|NCT02453685|463406947|FG000|Overall Study|Lost to Follow-up|0|||
128759168|NCT02453685|463406948|FG001|Overall Study|Lost to Follow-up|1|||
128759169|NCT02453685|463406947|FG000|Overall Study|Withdrawal by Subject|8|||
128759170|NCT02453685|463406948|FG001|Overall Study|Withdrawal by Subject|4|||
128759171|NCT02453685|463406947|FG000|Overall Study|Unclassified|4|||
128759172|NCT02453685|463406948|FG001|Overall Study|Unclassified|2|||
128759173|NCT02778100|463406950|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
128759174|NCT02778100|463406951|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
128759175|NCT03779906|463406960|FG000|Overall Study|Lost to Follow-up|7|||
128759176|NCT03779906|463406960|FG000|Overall Study|COVID pandemic|1|||
128759177|NCT04814368|463406961|FG000|Overall Study|Study Terminated by Sponsor|0|||
128759178|NCT04814368|463406962|FG001|Overall Study|Study Terminated by Sponsor|3|||
128759179|NCT04814368|463406963|FG002|Overall Study|Study Terminated by Sponsor|0|||
128759180|NCT04814368|463406964|FG003|Overall Study|Study Terminated by Sponsor|2|||
128759181|NCT04814368|463406961|FG000|Overall Study|Subject Decision|1|||
128759182|NCT04814368|463406962|FG001|Overall Study|Subject Decision|2|||
128759183|NCT04814368|463406963|FG002|Overall Study|Subject Decision|0|||
128759184|NCT04814368|463406964|FG003|Overall Study|Subject Decision|0|||
128759185|NCT01953003|463408777|FG000|Overall Study|Not treated|0|||
128759186|NCT01953003|463408778|FG001|Overall Study|Not treated|1|||
128759187|NCT01953003|463408777|FG000|Overall Study|Progressive disease|35|||
128759188|NCT01953003|463408778|FG001|Overall Study|Progressive disease|45|||
128759189|NCT01953003|463408777|FG000|Overall Study|Related Adverse events|7|||
128759190|NCT01953003|463408778|FG001|Overall Study|Related Adverse events|2|||
128759191|NCT01953003|463408777|FG000|Overall Study|Non-related adverse events|0|||
128759192|NCT01953003|463408778|FG001|Overall Study|Non-related adverse events|2|||
128759193|NCT01953003|463408777|FG000|Overall Study|Protocol Violation|0|||
128759194|NCT01953003|463408778|FG001|Overall Study|Protocol Violation|1|||
128759195|NCT01953003|463408777|FG000|Overall Study|Withdrawal by Subject|14|||
128759196|NCT01953003|463408778|FG001|Overall Study|Withdrawal by Subject|4|||
128759197|NCT00224770|463408787|FG000|Overall Study|Lost to Follow-up|4|||
128759198|NCT00224770|463408788|FG001|Overall Study|Lost to Follow-up|2|||
128759199|NCT00224770|463408789|FG002|Overall Study|Lost to Follow-up|0|||
128759200|NCT01106430|463408790|FG000|Overall Study|Adverse Event|8|||
128759201|NCT01106430|463408791|FG001|Overall Study|Adverse Event|10|||
128759202|NCT01106430|463408790|FG000|Overall Study|Lack of Efficacy|2|||
128759203|NCT01106430|463408791|FG001|Overall Study|Lack of Efficacy|13|||
128759204|NCT01106430|463408790|FG000|Overall Study|Lost to Follow-up|5|||
128795225|NCT03482011|463543239|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
128795226|NCT03482011|463543240|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
128795227|NCT03482011|463543241|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
128795228|NCT03482011|463543242|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
128795229|NCT03482011|463543243|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
128795230|NCT03482011|463543244|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
128795231|NCT03482011|463543245|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
128795232|NCT03482011|463543238|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
128795233|NCT03482011|463543239|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
128795234|NCT03482011|463543240|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
128795235|NCT03482011|463543241|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
128795236|NCT03482011|463543242|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
128795237|NCT03482011|463543243|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
128795238|NCT03482011|463543244|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
128795239|NCT03482011|463543245|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
128795240|NCT03482011|463543238|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
128795241|NCT03482011|463543239|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
128795242|NCT03482011|463543240|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
128795243|NCT03482011|463543241|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
128795244|NCT03482011|463543242|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
128795245|NCT03482011|463543243|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
128795246|NCT03482011|463543244|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
128795247|NCT03482011|463543245|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
128795248|NCT03482011|463543238|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
128795249|NCT03482011|463543239|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
128795250|NCT03482011|463543240|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
128795251|NCT03482011|463543241|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
128795252|NCT03482011|463543242|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
128795253|NCT03482011|463543243|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
128795254|NCT03482011|463543244|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
128795255|NCT03482011|463543245|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
128795256|NCT03482011|463543238|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128795257|NCT03482011|463543239|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128795258|NCT03482011|463543240|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128795259|NCT03482011|463543241|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
128795260|NCT03482011|463543242|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
128795261|NCT03482011|463543243|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
128795262|NCT03482011|463543244|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
128795263|NCT03482011|463543245|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
128795264|NCT03482011|463543238|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
128795265|NCT03482011|463543239|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
128795266|NCT03482011|463543240|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
128795267|NCT03482011|463543241|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
128795268|NCT03482011|463543242|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
128795269|NCT03482011|463543243|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
128795270|NCT03482011|463543244|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
128795271|NCT03482011|463543245|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
128795272|NCT03482011|463543238|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
128795273|NCT03482011|463543239|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
128795274|NCT03482011|463543240|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
128795275|NCT03482011|463543241|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
128795276|NCT03482011|463543242|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
128795277|NCT03482011|463543243|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
128795278|NCT03482011|463543244|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
128795279|NCT03482011|463543245|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
128795280|NCT03482011|463543238|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
128795281|NCT03482011|463543239|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
128795282|NCT03482011|463543240|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
128795283|NCT03482011|463543241|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
128795284|NCT03482011|463543242|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
128795285|NCT03482011|463543243|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
128795286|NCT03482011|463543244|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
128795287|NCT03482011|463543245|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
128795288|NCT03482011|463543238|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128795289|NCT03482011|463543239|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128795290|NCT03482011|463543240|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128795291|NCT03482011|463543241|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128795292|NCT03482011|463543242|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128795293|NCT03482011|463543243|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128795294|NCT03482011|463543244|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128795295|NCT03482011|463543245|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
128795296|NCT01595061|463543248|FG000|Overall Study|Never Treated|3|||
128795297|NCT01595061|463543248|FG000|Overall Study|Inadequate Pathology|1|||
128795298|NCT00529789|463543249|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
128795299|NCT00529789|463543249|FG000|Study Period II/III|Adverse Event|3|||
128795300|NCT00529789|463543249|FG000|Study Period II/III|Lack of Efficacy|2|||
128795301|NCT00529789|463543249|FG000|Study Period II/III|Withdrawal by Subject|1|||
128795302|NCT00529789|463543249|FG000|Study Period II/III|Protocol Violation|3|||
128795303|NCT00529789|463543249|FG000|Study Period II/III|Physician Decision|3|||
128795304|NCT00529789|463543249|FG000|Study Period II/III|Lost to Follow-up|3|||
128795305|NCT00529789|463543249|FG000|Study Period IV|Parent/Caregiver Decision|1|||
128795306|NCT00529789|463543249|FG000|Study Period IV|Adverse Event|1|||
128795307|NCT00529789|463543249|FG000|Study Period IV|Lack of Efficacy|1|||
128795308|NCT00529789|463543249|FG000|Study Period IV|Lost to Follow-up|3|||
128795309|NCT02204982|463543250|FG000|Overall Study|Patient ineligible-medical monitor|1|||
128795310|NCT02204982|463543251|FG001|Overall Study|Patient ineligible-medical monitor|0|||
128795311|NCT02204982|463543250|FG000|Overall Study|Withdrawal by Subject|1|||
128795312|NCT02204982|463543251|FG001|Overall Study|Withdrawal by Subject|0|||
128795313|NCT02204982|463543250|FG000|Overall Study|Adverse Event|1|||
128795314|NCT02204982|463543251|FG001|Overall Study|Adverse Event|0|||
128795315|NCT02204982|463543250|FG000|Overall Study|Adverse Event and Investigator decision|1|||
128795316|NCT02204982|463543251|FG001|Overall Study|Adverse Event and Investigator decision|0|||
128795317|NCT02204982|463543250|FG000|Overall Study|Physician Decision|0|||
128795318|NCT02204982|463543251|FG001|Overall Study|Physician Decision|2|||
128795319|NCT02204982|463543250|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
128795320|NCT02204982|463543251|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
128795321|NCT02204982|463543250|FG000|Overall Study|Termination of Study bySponsor|0|||
128795322|NCT02204982|463543251|FG001|Overall Study|Termination of Study bySponsor|1|||
128795323|NCT00960141|463543252|FG000|Overall Study|Adverse Event|4|||
128795324|NCT00960141|463543253|FG001|Overall Study|Adverse Event|8|||
128795325|NCT00960141|463543254|FG002|Overall Study|Adverse Event|2|||
128795326|NCT00960141|463543252|FG000|Overall Study|Lack of Efficacy|3|||
128795327|NCT00960141|463543253|FG001|Overall Study|Lack of Efficacy|4|||
128795328|NCT00960141|463543254|FG002|Overall Study|Lack of Efficacy|2|||
128795329|NCT00960141|463543252|FG000|Overall Study|Lost to Follow-up|1|||
128795330|NCT00960141|463543253|FG001|Overall Study|Lost to Follow-up|0|||
128795331|NCT00960141|463543254|FG002|Overall Study|Lost to Follow-up|0|||
128795332|NCT00960141|463543252|FG000|Overall Study|Protocol Violation|1|||
128795333|NCT00960141|463543253|FG001|Overall Study|Protocol Violation|3|||
128795334|NCT00960141|463543254|FG002|Overall Study|Protocol Violation|2|||
128795335|NCT00960141|463543252|FG000|Overall Study|Withdrawal by Subject|1|||
128795336|NCT00960141|463543253|FG001|Overall Study|Withdrawal by Subject|2|||
128795337|NCT00960141|463543254|FG002|Overall Study|Withdrawal by Subject|1|||
128795338|NCT02538107|463543255|FG000|Overall Study|Did not receive any Mircera dose|11|||
128795339|NCT02538107|463543255|FG000|Overall Study|Missing|5|||
128795340|NCT02538107|463543255|FG000|Overall Study|Necessity of dialysis|20|||
128795341|NCT02538107|463543255|FG000|Overall Study|Administration of other ESA|11|||
128795342|NCT02538107|463543255|FG000|Overall Study|No further treatment necessary|18|||
128795343|NCT02538107|463543255|FG000|Overall Study|Withdrawal by Subject|17|||
128795344|NCT02538107|463543255|FG000|Overall Study|Death|4|||
128795345|NCT02538107|463543255|FG000|Overall Study|Administrative reason|5|||
128795346|NCT02538107|463543255|FG000|Overall Study|Adverse Event|4|||
128795347|NCT02538107|463543255|FG000|Overall Study|Surgery|1|||
128795348|NCT02538107|463543255|FG000|Overall Study|Other|7|||
128795349|NCT02538107|463543255|FG000|Overall Study|Not recorded|7|||
128795350|NCT01198028|463543258|FG000|Overall Study|Adverse Event|5|||
128795351|NCT01198028|463543258|FG000|Overall Study|Death|3|||
128795352|NCT01198028|463543258|FG000|Overall Study|Physician Decision|2|||
128795353|NCT01597258|463543265|FG000|Overall Study|No Drug Administration|1|||
128795354|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
128795355|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
128795356|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
128795357|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
128795358|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
128795359|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
128795360|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
128795361|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
128795362|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
128795363|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
128795364|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
128795365|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
128795366|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
128795367|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
128795368|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
128795369|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
128795370|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
128795371|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
128795372|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
128795373|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
128795374|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
128795375|NCT00304031|463545660|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
128795376|NCT00304031|463545661|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
128795377|NCT00304031|463545662|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
128795378|NCT00304031|463545660|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
128795379|NCT00304031|463545661|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
128795380|NCT00304031|463545662|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
128795381|NCT00925899|463545663|FG000|Part 1|Death|1|||
128795382|NCT00925899|463545664|FG001|Part 1|Death|2|||
128795383|NCT00925899|463545663|FG000|Part 1|Withdrawal by Subject|10|||
128795384|NCT00925899|463545664|FG001|Part 1|Withdrawal by Subject|9|||
128795385|NCT00683696|463545665|FG000|Overall Study|Withdrawn due to study closure|337|||
128795386|NCT00683696|463545666|FG001|Overall Study|Withdrawn due to study closure|338|||
128795387|NCT00683696|463545665|FG000|Overall Study|Withdrawn prior to study closure|13|||
128795388|NCT00683696|463545666|FG001|Overall Study|Withdrawn prior to study closure|28|||
128795389|NCT00683696|463545665|FG000|Overall Study|Lost to Follow-up|5|||
128795390|NCT00683696|463545666|FG001|Overall Study|Lost to Follow-up|6|||
128795391|NCT00683696|463545665|FG000|Overall Study|Vital status follow-up only|3|||
128795392|NCT00683696|463545666|FG001|Overall Study|Vital status follow-up only|3|||
128795393|NCT00683696|463545665|FG000|Overall Study|Death|46|||
128795394|NCT00683696|463545666|FG001|Overall Study|Death|30|||
128795395|NCT02396316|463545667|FG000|Overall Study|Physician Decision|1|||
128795396|NCT02396316|463545668|FG001|Overall Study|Physician Decision|0|||
128795397|NCT02396316|463545667|FG000|Overall Study|Progressive disease|6|||
128795398|NCT02396316|463545668|FG001|Overall Study|Progressive disease|3|||
128795399|NCT02396316|463545667|FG000|Overall Study|Protocol Violation|0|||
128795400|NCT02396316|463545668|FG001|Overall Study|Protocol Violation|1|||
128795401|NCT02396316|463545667|FG000|Overall Study|Treatment unblinded|0|||
128795402|NCT02396316|463545668|FG001|Overall Study|Treatment unblinded|1|||
128795403|NCT01823536|463545669|FG000|Overall Study|Lost to Follow-up|1|||
128795404|NCT01823536|463545670|FG001|Overall Study|Lost to Follow-up|0|||
128795405|NCT01823536|463545671|FG002|Overall Study|Lost to Follow-up|0|||
128795406|NCT01823536|463545672|FG003|Overall Study|Lost to Follow-up|1|||
128795407|NCT01823536|463545673|FG004|Overall Study|Lost to Follow-up|1|||
128795408|NCT01823536|463545674|FG005|Overall Study|Lost to Follow-up|0|||
128795409|NCT01823536|463545669|FG000|Overall Study|Protocol Violation|0|||
128795410|NCT01823536|463545670|FG001|Overall Study|Protocol Violation|1|||
128795411|NCT01823536|463545671|FG002|Overall Study|Protocol Violation|0|||
128795412|NCT01823536|463545672|FG003|Overall Study|Protocol Violation|0|||
128795413|NCT01823536|463545673|FG004|Overall Study|Protocol Violation|0|||
128795414|NCT01823536|463545674|FG005|Overall Study|Protocol Violation|0|||
128795415|NCT01823536|463545669|FG000|Overall Study|Withdrawal by Subject|1|||
128795416|NCT01823536|463545670|FG001|Overall Study|Withdrawal by Subject|1|||
128795417|NCT01823536|463545671|FG002|Overall Study|Withdrawal by Subject|0|||
128795418|NCT01823536|463545672|FG003|Overall Study|Withdrawal by Subject|0|||
128795419|NCT01823536|463545673|FG004|Overall Study|Withdrawal by Subject|0|||
128795420|NCT01823536|463545674|FG005|Overall Study|Withdrawal by Subject|0|||
128795421|NCT01823536|463545669|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
128795422|NCT01823536|463545670|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
128795423|NCT01823536|463545671|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
128795424|NCT01823536|463545672|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
128795425|NCT01823536|463545673|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
128795426|NCT01823536|463545674|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
128795427|NCT01823536|463545669|FG000|Overall Study|Met exclusion criterion No 6|0|||
128795428|NCT01823536|463545670|FG001|Overall Study|Met exclusion criterion No 6|0|||
128795429|NCT01823536|463545671|FG002|Overall Study|Met exclusion criterion No 6|0|||
128795430|NCT01823536|463545672|FG003|Overall Study|Met exclusion criterion No 6|1|||
128795431|NCT01823536|463545673|FG004|Overall Study|Met exclusion criterion No 6|0|||
128795432|NCT01823536|463545674|FG005|Overall Study|Met exclusion criterion No 6|0|||
128795433|NCT01823536|463545669|FG000|Overall Study|Subject moved out of the state|0|||
128795434|NCT01823536|463545670|FG001|Overall Study|Subject moved out of the state|0|||
128795435|NCT01823536|463545671|FG002|Overall Study|Subject moved out of the state|0|||
128795436|NCT01823536|463545672|FG003|Overall Study|Subject moved out of the state|0|||
128795437|NCT01823536|463545673|FG004|Overall Study|Subject moved out of the state|1|||
128795438|NCT01823536|463545674|FG005|Overall Study|Subject moved out of the state|0|||
128795439|NCT03648762|463545678|FG000|Overall Study|Lost to Follow-up|1|||
128795440|NCT03648762|463545679|FG001|Overall Study|Lost to Follow-up|2|||
128795441|NCT03648762|463545680|FG002|Overall Study|Lost to Follow-up|0|||
128795442|NCT03648762|463545678|FG000|Overall Study|Withdrawal by Subject|5|||
128795443|NCT03648762|463545679|FG001|Overall Study|Withdrawal by Subject|2|||
128795444|NCT03648762|463545680|FG002|Overall Study|Withdrawal by Subject|1|||
128795445|NCT01875848|463545688|FG000|Overall Study|Withdrawal by Subject|2|||
128795446|NCT01875848|463545689|FG001|Overall Study|Withdrawal by Subject|0|||
128795447|NCT02189252|463545690|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
128795448|NCT02189252|463545691|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
128795449|NCT02189252|463545692|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
128795450|NCT02189252|463545693|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
128795451|NCT02189252|463545690|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
128795452|NCT02189252|463545691|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
128795453|NCT02189252|463545692|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
128795454|NCT02189252|463545693|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
128795455|NCT03345901|463545699|FG000|Overall Study|The study was terminated|18|||
128795456|NCT00566735|463545700|FG000|Overall Study|Withdrawal by Subject|0|||
128795457|NCT00566735|463545701|FG001|Overall Study|Withdrawal by Subject|1|||
128795458|NCT00566735|463545700|FG000|Overall Study|Refused neuropsychological testing|2|||
128795459|NCT00566735|463545701|FG001|Overall Study|Refused neuropsychological testing|5|||
128795460|NCT00566735|463545700|FG000|Overall Study|Switched into a manic episode|0|||
128795461|NCT00566735|463545701|FG001|Overall Study|Switched into a manic episode|1|||
128795462|NCT00722046|463545702|FG000|Overall Study|Adverse Event|0|||
128795463|NCT00722046|463545703|FG001|Overall Study|Adverse Event|1|||
128795464|NCT00722046|463545704|FG002|Overall Study|Adverse Event|2|||
128795465|NCT00722046|463545705|FG003|Overall Study|Adverse Event|1|||
128795466|NCT00722046|463545706|FG004|Overall Study|Adverse Event|2|||
128795467|NCT00722046|463545707|FG005|Overall Study|Adverse Event|1|||
128795468|NCT00722046|463545708|FG006|Overall Study|Adverse Event|0|||
128795469|NCT00722046|463545702|FG000|Overall Study|Death|0|||
128795470|NCT00722046|463545703|FG001|Overall Study|Death|1|||
128795471|NCT00722046|463545704|FG002|Overall Study|Death|0|||
128795472|NCT00722046|463545705|FG003|Overall Study|Death|0|||
128795473|NCT00722046|463545706|FG004|Overall Study|Death|0|||
128795474|NCT00722046|463545707|FG005|Overall Study|Death|0|||
128795475|NCT00722046|463545708|FG006|Overall Study|Death|2|||
128795476|NCT00722046|463545702|FG000|Overall Study|Protocol Violation|1|||
128795477|NCT00722046|463545703|FG001|Overall Study|Protocol Violation|0|||
128795478|NCT00722046|463545704|FG002|Overall Study|Protocol Violation|0|||
128795479|NCT00722046|463545705|FG003|Overall Study|Protocol Violation|0|||
128795480|NCT00722046|463545706|FG004|Overall Study|Protocol Violation|0|||
128795481|NCT00722046|463545707|FG005|Overall Study|Protocol Violation|1|||
128795482|NCT00722046|463545708|FG006|Overall Study|Protocol Violation|0|||
128795483|NCT00722046|463545702|FG000|Overall Study|Withdrawal by Subject|3|||
128795484|NCT00722046|463545703|FG001|Overall Study|Withdrawal by Subject|3|||
128795485|NCT00722046|463545704|FG002|Overall Study|Withdrawal by Subject|4|||
128795486|NCT00722046|463545705|FG003|Overall Study|Withdrawal by Subject|4|||
128795487|NCT00722046|463545706|FG004|Overall Study|Withdrawal by Subject|4|||
128795488|NCT00722046|463545707|FG005|Overall Study|Withdrawal by Subject|7|||
128795489|NCT00722046|463545708|FG006|Overall Study|Withdrawal by Subject|3|||
128795490|NCT00722046|463545702|FG000|Overall Study|Randomized, but not treated|1|||
128795491|NCT00722046|463545703|FG001|Overall Study|Randomized, but not treated|1|||
128795492|NCT00722046|463545704|FG002|Overall Study|Randomized, but not treated|0|||
128795493|NCT00722046|463545705|FG003|Overall Study|Randomized, but not treated|2|||
128795494|NCT00722046|463545706|FG004|Overall Study|Randomized, but not treated|0|||
128795495|NCT00722046|463545707|FG005|Overall Study|Randomized, but not treated|0|||
128759205|NCT01106430|463408791|FG001|Overall Study|Lost to Follow-up|1|||
128759206|NCT01106430|463408790|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
128759207|NCT01106430|463408791|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
128759208|NCT01106430|463408790|FG000|Overall Study|Moved Out Of State|0|||
128759209|NCT01106430|463408791|FG001|Overall Study|Moved Out Of State|1|||
128759210|NCT01106430|463408790|FG000|Overall Study|Refused To Take Medication|0|||
128759211|NCT01106430|463408791|FG001|Overall Study|Refused To Take Medication|1|||
128759212|NCT01106430|463408790|FG000|Overall Study|Noncompliance|0|||
128759213|NCT01106430|463408791|FG001|Overall Study|Noncompliance|1|||
128759214|NCT01106430|463408790|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
128759215|NCT01106430|463408791|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
128759216|NCT01106430|463408790|FG000|Overall Study|Previous Use Of Marijuana|1|||
128759217|NCT01106430|463408791|FG001|Overall Study|Previous Use Of Marijuana|0|||
128759218|NCT01106430|463408790|FG000|Overall Study|Protocol Violation|7|||
128759219|NCT01106430|463408791|FG001|Overall Study|Protocol Violation|2|||
128759220|NCT01106430|463408790|FG000|Overall Study|Withdrawal by Subject|8|||
128759221|NCT01106430|463408791|FG001|Overall Study|Withdrawal by Subject|4|||
128759222|NCT03704584|463408795|FG000|Overall Study|Withdrawal by Subject|1|||
128759223|NCT03704584|463408796|FG001|Overall Study|Withdrawal by Subject|0|||
128759224|NCT03439189|463408797|FG000|Overall Study|Protocol Violation|19|||
128759225|NCT03439189|463408797|FG000|Overall Study|Lack of Efficacy|63|||
128759226|NCT04791761|463408801|FG000|Overall Study|Lost to Follow-up|8|||
128759227|NCT04791761|463408802|FG001|Overall Study|Lost to Follow-up|6|||
128759228|NCT04791761|463408803|FG002|Overall Study|Lost to Follow-up|10|||
128759229|NCT04791761|463408801|FG000|Overall Study|Withdrawal by Subject|0|||
128759230|NCT04791761|463408802|FG001|Overall Study|Withdrawal by Subject|1|||
128759231|NCT04791761|463408803|FG002|Overall Study|Withdrawal by Subject|1|||
128759232|NCT04791761|463408801|FG000|Overall Study|Protocol Violation|0|||
128759233|NCT04791761|463408802|FG001|Overall Study|Protocol Violation|1|||
128759234|NCT04791761|463408803|FG002|Overall Study|Protocol Violation|1|||
128759235|NCT00508261|463408806|FG000|Overall Study|Other|0|||
128759236|NCT00508261|463408807|FG001|Overall Study|Other|1|||
128759237|NCT00508261|463408808|FG002|Overall Study|Other|1|||
128759238|NCT00508261|463408809|FG003|Overall Study|Other|0|||
128759239|NCT00508261|463408806|FG000|Overall Study|Serious Adverse Event|0|||
128759240|NCT00508261|463408807|FG001|Overall Study|Serious Adverse Event|1|||
128759241|NCT00508261|463408808|FG002|Overall Study|Serious Adverse Event|0|||
128759242|NCT00508261|463408809|FG003|Overall Study|Serious Adverse Event|0|||
128759243|NCT00508261|463408806|FG000|Overall Study|Withdrawal by Subject|3|||
128759244|NCT00508261|463408807|FG001|Overall Study|Withdrawal by Subject|4|||
128759245|NCT00508261|463408808|FG002|Overall Study|Withdrawal by Subject|4|||
128759246|NCT00508261|463408809|FG003|Overall Study|Withdrawal by Subject|0|||
128759247|NCT00508261|463408806|FG000|Overall Study|Migrated/ moved from study area|0|||
128759248|NCT00508261|463408807|FG001|Overall Study|Migrated/ moved from study area|1|||
128759249|NCT00508261|463408808|FG002|Overall Study|Migrated/ moved from study area|0|||
128759250|NCT00508261|463408809|FG003|Overall Study|Migrated/ moved from study area|0|||
128759251|NCT00508261|463408806|FG000|Overall Study|Lost to Follow-up|0|||
128759252|NCT00508261|463408807|FG001|Overall Study|Lost to Follow-up|1|||
128759253|NCT00508261|463408808|FG002|Overall Study|Lost to Follow-up|1|||
128759254|NCT00508261|463408809|FG003|Overall Study|Lost to Follow-up|1|||
128759255|NCT00180479|463408810|FG000|Overall Study|Death|4|||
128759256|NCT00180479|463408811|FG001|Overall Study|Death|2|||
128759257|NCT00180479|463408810|FG000|Overall Study|Lost to Follow-up|9|||
128759258|NCT00180479|463408811|FG001|Overall Study|Lost to Follow-up|7|||
128759259|NCT00180479|463408810|FG000|Overall Study|Withdrawal by Subject|3|||
128759260|NCT00180479|463408811|FG001|Overall Study|Withdrawal by Subject|3|||
128759261|NCT00180479|463408810|FG000|Overall Study|Informed consent not signed|0|||
128759262|NCT00180479|463408811|FG001|Overall Study|Informed consent not signed|1|||
128759263|NCT00526630|463408820|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
128759264|NCT00526630|463408821|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
128759265|NCT00526630|463408820|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
128759266|NCT00526630|463408821|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
128759267|NCT02459262|463408822|FG000|Overall Study|Withdrawal by Subject|0|||
128759268|NCT02459262|463408823|FG001|Overall Study|Withdrawal by Subject|0|||
128759269|NCT02459262|463408824|FG002|Overall Study|Withdrawal by Subject|0|||
128759270|NCT02459262|463408825|FG003|Overall Study|Withdrawal by Subject|0|||
128759271|NCT02459262|463408826|FG004|Overall Study|Withdrawal by Subject|0|||
128759272|NCT02459262|463408827|FG005|Overall Study|Withdrawal by Subject|0|||
128759273|NCT02459262|463408828|FG006|Overall Study|Withdrawal by Subject|0|||
128759274|NCT02459262|463408829|FG007|Overall Study|Withdrawal by Subject|0|||
128759275|NCT02459262|463408830|FG008|Overall Study|Withdrawal by Subject|0|||
128759276|NCT02459262|463408831|FG009|Overall Study|Withdrawal by Subject|1|||
128759277|NCT02459262|463408832|FG010|Overall Study|Withdrawal by Subject|0|||
128795496|NCT00722046|463545708|FG006|Overall Study|Randomized, but not treated|0|||
128795497|NCT00722046|463545702|FG000|Overall Study|Other|0|||
128795498|NCT00722046|463545703|FG001|Overall Study|Other|0|||
128795499|NCT00722046|463545704|FG002|Overall Study|Other|1|||
128795500|NCT00722046|463545705|FG003|Overall Study|Other|1|||
128795501|NCT00722046|463545706|FG004|Overall Study|Other|3|||
128795502|NCT00722046|463545707|FG005|Overall Study|Other|2|||
128795503|NCT00722046|463545708|FG006|Overall Study|Other|1|||
128795504|NCT00925587|463545709|FG000|Overall Study|Protocol Specified Criteria|6|||
128795505|NCT00925587|463545710|FG001|Overall Study|Protocol Specified Criteria|6|||
128795506|NCT00925587|463545709|FG000|Overall Study|Physician Decision|4|||
128795507|NCT00925587|463545710|FG001|Overall Study|Physician Decision|1|||
128795508|NCT00925587|463545709|FG000|Overall Study|Protocol Violation|6|||
128795509|NCT00925587|463545710|FG001|Overall Study|Protocol Violation|4|||
128795510|NCT00925587|463545709|FG000|Overall Study|Withdrawal by Subject|9|||
128795511|NCT00925587|463545710|FG001|Overall Study|Withdrawal by Subject|6|||
128795512|NCT00925587|463545709|FG000|Overall Study|Death|5|||
128795513|NCT00925587|463545710|FG001|Overall Study|Death|5|||
128795514|NCT00925587|463545709|FG000|Overall Study|Adverse Event|6|||
128795515|NCT00925587|463545710|FG001|Overall Study|Adverse Event|2|||
128795516|NCT00925587|463545709|FG000|Overall Study|Lost to Follow-up|0|||
128795517|NCT00925587|463545710|FG001|Overall Study|Lost to Follow-up|1|||
128795518|NCT02731755|463545716|FG000|First Intervention|Withdrawal by Subject|0|||
128795519|NCT02731755|463545717|FG001|First Intervention|Withdrawal by Subject|2|||
128795520|NCT04425629|463545718|FG000|Overall Study|Adverse Event|0|||
128795521|NCT04425629|463545719|FG001|Overall Study|Adverse Event|0|||
128795522|NCT04425629|463545720|FG002|Overall Study|Adverse Event|0|||
128795523|NCT04425629|463545721|FG003|Overall Study|Adverse Event|0|||
128795524|NCT04425629|463545722|FG004|Overall Study|Adverse Event|1|||
128795525|NCT04425629|463545723|FG005|Overall Study|Adverse Event|0|||
128795526|NCT04425629|463545724|FG006|Overall Study|Adverse Event|0|||
128795527|NCT04425629|463545725|FG007|Overall Study|Adverse Event|0|||
128795528|NCT04425629|463545726|FG008|Overall Study|Adverse Event|0|||
128795529|NCT04425629|463545727|FG009|Overall Study|Adverse Event|3|||
128795530|NCT04425629|463545728|FG010|Overall Study|Adverse Event|2|||
128795531|NCT04425629|463545729|FG011|Overall Study|Adverse Event|1|||
128795532|NCT04425629|463545730|FG012|Overall Study|Adverse Event|1|||
128795533|NCT04425629|463545731|FG013|Overall Study|Adverse Event|0|||
128795534|NCT04425629|463545732|FG014|Overall Study|Adverse Event|0|||
128795535|NCT04425629|463545733|FG015|Overall Study|Adverse Event|0|||
128795536|NCT04425629|463545734|FG016|Overall Study|Adverse Event|0|||
128795537|NCT04425629|463545735|FG017|Overall Study|Adverse Event|0|||
128795538|NCT04425629|463545736|FG018|Overall Study|Adverse Event|0|||
128795539|NCT04425629|463545718|FG000|Overall Study|Lost to Follow-up|1|||
128795540|NCT04425629|463545719|FG001|Overall Study|Lost to Follow-up|3|||
128795541|NCT04425629|463545720|FG002|Overall Study|Lost to Follow-up|1|||
128795542|NCT04425629|463545721|FG003|Overall Study|Lost to Follow-up|7|||
128795543|NCT04425629|463545722|FG004|Overall Study|Lost to Follow-up|1|||
128795544|NCT04425629|463545723|FG005|Overall Study|Lost to Follow-up|2|||
128795545|NCT04425629|463545724|FG006|Overall Study|Lost to Follow-up|1|||
128795546|NCT04425629|463545725|FG007|Overall Study|Lost to Follow-up|0|||
128795547|NCT04425629|463545726|FG008|Overall Study|Lost to Follow-up|1|||
128795548|NCT04425629|463545727|FG009|Overall Study|Lost to Follow-up|64|||
128795549|NCT04425629|463545728|FG010|Overall Study|Lost to Follow-up|70|||
128795550|NCT04425629|463545729|FG011|Overall Study|Lost to Follow-up|98|||
128795551|NCT04425629|463545730|FG012|Overall Study|Lost to Follow-up|30|||
128795552|NCT04425629|463545731|FG013|Overall Study|Lost to Follow-up|0|||
128795553|NCT04425629|463545732|FG014|Overall Study|Lost to Follow-up|5|||
128795554|NCT04425629|463545733|FG015|Overall Study|Lost to Follow-up|4|||
128795555|NCT04425629|463545734|FG016|Overall Study|Lost to Follow-up|0|||
128795556|NCT04425629|463545735|FG017|Overall Study|Lost to Follow-up|3|||
128795557|NCT04425629|463545736|FG018|Overall Study|Lost to Follow-up|1|||
128795558|NCT04425629|463545718|FG000|Overall Study|Subject Decision|0|||
128795559|NCT04425629|463545719|FG001|Overall Study|Subject Decision|2|||
128795560|NCT04425629|463545720|FG002|Overall Study|Subject Decision|1|||
128795561|NCT04425629|463545721|FG003|Overall Study|Subject Decision|3|||
128795562|NCT04425629|463545722|FG004|Overall Study|Subject Decision|6|||
128795563|NCT04425629|463545723|FG005|Overall Study|Subject Decision|6|||
128795564|NCT04425629|463545724|FG006|Overall Study|Subject Decision|3|||
128795565|NCT04425629|463545725|FG007|Overall Study|Subject Decision|3|||
128795566|NCT04425629|463545726|FG008|Overall Study|Subject Decision|1|||
128795567|NCT04425629|463545727|FG009|Overall Study|Subject Decision|70|||
128795568|NCT04425629|463545728|FG010|Overall Study|Subject Decision|95|||
128795569|NCT04425629|463545729|FG011|Overall Study|Subject Decision|124|||
128795570|NCT04425629|463545730|FG012|Overall Study|Subject Decision|25|||
128795571|NCT04425629|463545731|FG013|Overall Study|Subject Decision|0|||
128795572|NCT04425629|463545732|FG014|Overall Study|Subject Decision|1|||
128795573|NCT04425629|463545733|FG015|Overall Study|Subject Decision|4|||
128795574|NCT04425629|463545734|FG016|Overall Study|Subject Decision|1|||
128795575|NCT04425629|463545735|FG017|Overall Study|Subject Decision|0|||
128795576|NCT04425629|463545736|FG018|Overall Study|Subject Decision|2|||
128795577|NCT04425629|463545718|FG000|Overall Study|Death|0|||
128795578|NCT04425629|463545719|FG001|Overall Study|Death|0|||
128795579|NCT04425629|463545720|FG002|Overall Study|Death|0|||
128795580|NCT04425629|463545721|FG003|Overall Study|Death|0|||
128795581|NCT04425629|463545722|FG004|Overall Study|Death|0|||
128795582|NCT04425629|463545723|FG005|Overall Study|Death|0|||
128795583|NCT04425629|463545724|FG006|Overall Study|Death|0|||
128795584|NCT04425629|463545725|FG007|Overall Study|Death|0|||
128795585|NCT04425629|463545726|FG008|Overall Study|Death|0|||
128795586|NCT04425629|463545727|FG009|Overall Study|Death|11|||
128795587|NCT04425629|463545728|FG010|Overall Study|Death|2|||
128795588|NCT04425629|463545729|FG011|Overall Study|Death|4|||
128795589|NCT04425629|463545730|FG012|Overall Study|Death|0|||
128795590|NCT04425629|463545731|FG013|Overall Study|Death|0|||
128795591|NCT04425629|463545732|FG014|Overall Study|Death|0|||
128795592|NCT04425629|463545733|FG015|Overall Study|Death|0|||
128795593|NCT04425629|463545734|FG016|Overall Study|Death|0|||
128795594|NCT04425629|463545735|FG017|Overall Study|Death|0|||
128795595|NCT04425629|463545736|FG018|Overall Study|Death|0|||
128795596|NCT04425629|463545718|FG000|Overall Study|Sponsor Request|0|||
128795597|NCT04425629|463545719|FG001|Overall Study|Sponsor Request|0|||
128795598|NCT04425629|463545720|FG002|Overall Study|Sponsor Request|0|||
128795599|NCT04425629|463545721|FG003|Overall Study|Sponsor Request|2|||
128795600|NCT04425629|463545722|FG004|Overall Study|Sponsor Request|2|||
128795601|NCT04425629|463545723|FG005|Overall Study|Sponsor Request|2|||
128795602|NCT04425629|463545724|FG006|Overall Study|Sponsor Request|1|||
128795603|NCT04425629|463545725|FG007|Overall Study|Sponsor Request|0|||
128795604|NCT04425629|463545726|FG008|Overall Study|Sponsor Request|0|||
128795605|NCT04425629|463545727|FG009|Overall Study|Sponsor Request|9|||
128795606|NCT04425629|463545728|FG010|Overall Study|Sponsor Request|9|||
128795607|NCT04425629|463545729|FG011|Overall Study|Sponsor Request|10|||
128795608|NCT04425629|463545730|FG012|Overall Study|Sponsor Request|8|||
128795609|NCT04425629|463545731|FG013|Overall Study|Sponsor Request|0|||
128795610|NCT04425629|463545732|FG014|Overall Study|Sponsor Request|0|||
128795611|NCT04425629|463545733|FG015|Overall Study|Sponsor Request|1|||
128795612|NCT04425629|463545734|FG016|Overall Study|Sponsor Request|0|||
128795613|NCT04425629|463545735|FG017|Overall Study|Sponsor Request|0|||
128795614|NCT04425629|463545736|FG018|Overall Study|Sponsor Request|0|||
128795615|NCT04425629|463545718|FG000|Overall Study|Physician Decision|0|||
128795616|NCT04425629|463545719|FG001|Overall Study|Physician Decision|0|||
128795617|NCT04425629|463545720|FG002|Overall Study|Physician Decision|0|||
128795618|NCT04425629|463545721|FG003|Overall Study|Physician Decision|0|||
128795619|NCT04425629|463545722|FG004|Overall Study|Physician Decision|0|||
128795620|NCT04425629|463545723|FG005|Overall Study|Physician Decision|0|||
128759278|NCT01242748|463408833|FG000|Overall Study|Adverse Event|10|||
128759279|NCT01242748|463408834|FG001|Overall Study|Adverse Event|5|||
128759280|NCT01242748|463408833|FG000|Overall Study|Lost to Follow-up|6|||
128759281|NCT01242748|463408834|FG001|Overall Study|Lost to Follow-up|2|||
128759282|NCT01242748|463408833|FG000|Overall Study|Physician Decision|3|||
128759283|NCT01242748|463408834|FG001|Overall Study|Physician Decision|2|||
128759284|NCT01242748|463408833|FG000|Overall Study|Protocol Violation|1|||
128759285|NCT01242748|463408834|FG001|Overall Study|Protocol Violation|0|||
128759286|NCT01242748|463408833|FG000|Overall Study|Withdrawal by Subject|10|||
128759287|NCT01242748|463408834|FG001|Overall Study|Withdrawal by Subject|2|||
128759288|NCT01242748|463408833|FG000|Overall Study|Miscellaneous reasons|8|||
128759289|NCT01242748|463408834|FG001|Overall Study|Miscellaneous reasons|3|||
128759290|NCT03518125|463408838|FG000|Overall Study|Lost to Follow-up|0|||
128759291|NCT03518125|463408839|FG001|Overall Study|Lost to Follow-up|2|||
128759292|NCT03518125|463408840|FG002|Overall Study|Lost to Follow-up|0|||
128759293|NCT03518125|463408841|FG003|Overall Study|Lost to Follow-up|0|||
128759294|NCT03518125|463408842|FG004|Overall Study|Lost to Follow-up|3|||
128759295|NCT03518125|463408843|FG005|Overall Study|Lost to Follow-up|5|||
128759296|NCT03518125|463408838|FG000|Overall Study|Physician Decision|0|||
128759297|NCT03518125|463408839|FG001|Overall Study|Physician Decision|1|||
128759298|NCT03518125|463408840|FG002|Overall Study|Physician Decision|0|||
128759299|NCT03518125|463408841|FG003|Overall Study|Physician Decision|0|||
128759300|NCT03518125|463408842|FG004|Overall Study|Physician Decision|0|||
128795621|NCT04425629|463545724|FG006|Overall Study|Physician Decision|0|||
128795622|NCT04425629|463545725|FG007|Overall Study|Physician Decision|0|||
128795623|NCT04425629|463545726|FG008|Overall Study|Physician Decision|0|||
128795624|NCT04425629|463545727|FG009|Overall Study|Physician Decision|4|||
128795625|NCT04425629|463545728|FG010|Overall Study|Physician Decision|3|||
128795626|NCT04425629|463545729|FG011|Overall Study|Physician Decision|5|||
128795627|NCT04425629|463545730|FG012|Overall Study|Physician Decision|1|||
128795628|NCT04425629|463545731|FG013|Overall Study|Physician Decision|0|||
128795629|NCT04425629|463545732|FG014|Overall Study|Physician Decision|0|||
128795630|NCT04425629|463545733|FG015|Overall Study|Physician Decision|1|||
128795631|NCT04425629|463545734|FG016|Overall Study|Physician Decision|0|||
128795632|NCT04425629|463545735|FG017|Overall Study|Physician Decision|0|||
128795633|NCT04425629|463545736|FG018|Overall Study|Physician Decision|0|||
128795634|NCT04425629|463545718|FG000|Overall Study|Lack of Efficacy|0|||
128795635|NCT04425629|463545719|FG001|Overall Study|Lack of Efficacy|0|||
128795636|NCT04425629|463545720|FG002|Overall Study|Lack of Efficacy|0|||
128795637|NCT04425629|463545721|FG003|Overall Study|Lack of Efficacy|0|||
128795638|NCT04425629|463545722|FG004|Overall Study|Lack of Efficacy|0|||
128795639|NCT04425629|463545723|FG005|Overall Study|Lack of Efficacy|0|||
128795640|NCT04425629|463545724|FG006|Overall Study|Lack of Efficacy|0|||
128795641|NCT04425629|463545725|FG007|Overall Study|Lack of Efficacy|0|||
128795642|NCT04425629|463545726|FG008|Overall Study|Lack of Efficacy|0|||
128795643|NCT04425629|463545727|FG009|Overall Study|Lack of Efficacy|0|||
128795644|NCT04425629|463545728|FG010|Overall Study|Lack of Efficacy|1|||
128795645|NCT04425629|463545729|FG011|Overall Study|Lack of Efficacy|0|||
128795646|NCT04425629|463545730|FG012|Overall Study|Lack of Efficacy|0|||
128795647|NCT04425629|463545731|FG013|Overall Study|Lack of Efficacy|0|||
128795648|NCT04425629|463545732|FG014|Overall Study|Lack of Efficacy|0|||
128795649|NCT04425629|463545733|FG015|Overall Study|Lack of Efficacy|0|||
128795650|NCT04425629|463545734|FG016|Overall Study|Lack of Efficacy|0|||
128795651|NCT04425629|463545735|FG017|Overall Study|Lack of Efficacy|0|||
128795652|NCT04425629|463545736|FG018|Overall Study|Lack of Efficacy|0|||
128795653|NCT04218110|463545737|FG000|Overall Study|Withdrawal by Subject|0|||
128795654|NCT04218110|463545738|FG001|Overall Study|Withdrawal by Subject|0|||
128795655|NCT04218110|463545739|FG002|Overall Study|Withdrawal by Subject|0|||
128795656|NCT04218110|463545740|FG003|Overall Study|Withdrawal by Subject|1|||
128795657|NCT00799396|463545741|FG000|Clopidogrel Treatment|Adverse Event|6|||
128795658|NCT00799396|463545741|FG000|Clopidogrel Treatment|Physician Decision|5|||
128795659|NCT00799396|463545741|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
128795660|NCT00799396|463545741|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
128795661|NCT00799396|463545741|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
128795662|NCT01599104|463545742|FG000|Overall Study|Withdrawal by Subject|1|||
128795663|NCT01599104|463545743|FG001|Overall Study|Withdrawal by Subject|1|||
128795664|NCT01599104|463545744|FG002|Overall Study|Withdrawal by Subject|2|||
128795665|NCT01599104|463545742|FG000|Overall Study|Technical Problems|1|||
128795666|NCT01599104|463545743|FG001|Overall Study|Technical Problems|0|||
128795667|NCT01599104|463545744|FG002|Overall Study|Technical Problems|0|||
128795668|NCT01599104|463545742|FG000|Overall Study|Physician Decision|3|||
128795669|NCT01599104|463545743|FG001|Overall Study|Physician Decision|2|||
128795670|NCT01599104|463545744|FG002|Overall Study|Physician Decision|2|||
128795671|NCT01599104|463545742|FG000|Overall Study|Non-compliance with study treatment|0|||
128795672|NCT01599104|463545743|FG001|Overall Study|Non-compliance with study treatment|1|||
128795673|NCT01599104|463545744|FG002|Overall Study|Non-compliance with study treatment|0|||
128795674|NCT01599104|463545742|FG000|Overall Study|Lack of Efficacy|4|||
128795675|NCT01599104|463545743|FG001|Overall Study|Lack of Efficacy|4|||
128795676|NCT01599104|463545744|FG002|Overall Study|Lack of Efficacy|10|||
128795677|NCT01599104|463545742|FG000|Overall Study|Adverse Event|7|||
128795678|NCT01599104|463545743|FG001|Overall Study|Adverse Event|6|||
128795679|NCT01599104|463545744|FG002|Overall Study|Adverse Event|12|||
128795680|NCT01149369|463545745|FG000|Overall Study|Adverse Event|6|||
128795681|NCT01149369|463545746|FG001|Overall Study|Adverse Event|3|||
128795682|NCT01078116|463545751|FG000|Overall Study|Lost to Follow-up|17|||
128795683|NCT01078116|463545751|FG000|Overall Study|Adverse Event|5|||
128795684|NCT01078116|463545751|FG000|Overall Study|Withdrawal by Subject|8|||
129204554|NCT05051579|465045825|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
129204555|NCT05051579|465045826|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129204556|NCT05051579|465045827|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129204557|NCT05051579|465045828|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129204558|NCT05051579|465045829|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129204559|NCT05051579|465045830|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
128795685|NCT01078116|463545751|FG000|Overall Study|Lack of effectiveness|15|||
128795686|NCT01078116|463545751|FG000|Overall Study|Case report form not completed|3|||
128795687|NCT02601820|463545752|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
128795688|NCT02601820|463545752|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
128795689|NCT02601820|463545752|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
129204560|NCT05051579|465045824|FG000|Overall Study|Sponsor Decision|0|||
129204561|NCT05051579|465045825|FG001|Overall Study|Sponsor Decision|0|||
129204562|NCT05051579|465045826|FG002|Overall Study|Sponsor Decision|0|||
129204563|NCT05051579|465045827|FG003|Overall Study|Sponsor Decision|0|||
129204564|NCT05051579|465045828|FG004|Overall Study|Sponsor Decision|1|||
129204565|NCT05051579|465045829|FG005|Overall Study|Sponsor Decision|0|||
128795690|NCT02601820|463545752|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
128795691|NCT02242487|463545753|FG000|Overall Study|Adverse Event|13|||
128795692|NCT02242487|463545754|FG001|Overall Study|Adverse Event|15|||
128795693|NCT02242487|463545753|FG000|Overall Study|Lack of Efficacy|4|||
128795694|NCT02242487|463545754|FG001|Overall Study|Lack of Efficacy|6|||
128795695|NCT02242487|463545753|FG000|Overall Study|Protocol Violation|2|||
128795696|NCT02242487|463545754|FG001|Overall Study|Protocol Violation|0|||
128795697|NCT02242487|463545753|FG000|Overall Study|Lost to Follow-up|2|||
128795698|NCT02242487|463545754|FG001|Overall Study|Lost to Follow-up|1|||
128795699|NCT02242487|463545753|FG000|Overall Study|Other - Miscellaneous|4|||
128795700|NCT02242487|463545754|FG001|Overall Study|Other - Miscellaneous|6|||
128795701|NCT02242487|463545753|FG000|Overall Study|Withdrawal by Subject|37|||
128795702|NCT02242487|463545754|FG001|Overall Study|Withdrawal by Subject|19|||
128795703|NCT01599793|463545755|FG000|Overall Study|Adverse Event|2|||
128795704|NCT00636207|463545762|FG000|Overall Study|Adverse Event|1|||
128795705|NCT00636207|463545763|FG001|Overall Study|Adverse Event|0|||
128795706|NCT00636207|463545764|FG002|Overall Study|Adverse Event|0|||
128795707|NCT00636207|463545765|FG003|Overall Study|Adverse Event|0|||
128795708|NCT00636207|463545766|FG004|Overall Study|Adverse Event|0|||
128795709|NCT00636207|463545767|FG005|Overall Study|Adverse Event|0|||
128795710|NCT00636207|463545768|FG006|Overall Study|Adverse Event|0|||
128795711|NCT00636207|463545762|FG000|Overall Study|Withdrawal by Subject|0|||
128795712|NCT00636207|463545763|FG001|Overall Study|Withdrawal by Subject|1|||
128795713|NCT00636207|463545764|FG002|Overall Study|Withdrawal by Subject|0|||
128795714|NCT00636207|463545765|FG003|Overall Study|Withdrawal by Subject|0|||
128795715|NCT00636207|463545766|FG004|Overall Study|Withdrawal by Subject|1|||
128795716|NCT00636207|463545767|FG005|Overall Study|Withdrawal by Subject|0|||
128795717|NCT00636207|463545768|FG006|Overall Study|Withdrawal by Subject|0|||
128795718|NCT01075217|463545771|FG000|Overall Study|Adverse Event|1|||
128795719|NCT01075217|463545772|FG001|Overall Study|Adverse Event|1|||
128795720|NCT01075217|463545771|FG000|Overall Study|Physician Decision|1|||
128795721|NCT01075217|463545772|FG001|Overall Study|Physician Decision|0|||
128795722|NCT00364013|463545773|FG000|Overall Study|Ineligibility determined|4|||
128795723|NCT00364013|463545774|FG001|Overall Study|Ineligibility determined|2|||
128795724|NCT00364013|463545773|FG000|Overall Study|Adverse Event|4|||
128795725|NCT00364013|463545774|FG001|Overall Study|Adverse Event|3|||
128795726|NCT00364013|463545773|FG000|Overall Study|Withdrawal by Subject|13|||
128795727|NCT00364013|463545774|FG001|Overall Study|Withdrawal by Subject|18|||
128795728|NCT00364013|463545773|FG000|Overall Study|Physician Decision|3|||
128795729|NCT00364013|463545774|FG001|Overall Study|Physician Decision|3|||
128795730|NCT00364013|463545773|FG000|Overall Study|Lost to Follow-up|10|||
128795731|NCT00364013|463545774|FG001|Overall Study|Lost to Follow-up|3|||
128795732|NCT00364013|463545773|FG000|Overall Study|Protocol-specified criteria|6|||
128795733|NCT00364013|463545774|FG001|Overall Study|Protocol-specified criteria|6|||
128795734|NCT00364013|463545773|FG000|Overall Study|Other|41|||
128795735|NCT00364013|463545774|FG001|Overall Study|Other|47|||
128795736|NCT00364013|463545773|FG000|Overall Study|Ongoing|20|||
128795737|NCT00364013|463545774|FG001|Overall Study|Ongoing|13|||
128795738|NCT01576484|463545775|FG000|Overall Study|Adverse Event|1|||
128795739|NCT01576484|463545776|FG001|Overall Study|Adverse Event|1|||
128795740|NCT01576484|463545775|FG000|Overall Study|Protocol Violation|0|||
128795741|NCT01576484|463545776|FG001|Overall Study|Protocol Violation|2|||
128795742|NCT01576484|463545775|FG000|Overall Study|Sponsor Decision|2|||
128795743|NCT01576484|463545776|FG001|Overall Study|Sponsor Decision|8|||
128795744|NCT01576484|463545775|FG000|Overall Study|Withdrawal by Subject|0|||
128795745|NCT01576484|463545776|FG001|Overall Study|Withdrawal by Subject|3|||
128795746|NCT01576484|463545775|FG000|Overall Study|Other|2|||
128795747|NCT01576484|463545776|FG001|Overall Study|Other|5|||
128795748|NCT01943799|463545777|FG000|Overall Study|Lost to Follow-up|0|||
128795749|NCT01943799|463545778|FG001|Overall Study|Lost to Follow-up|1|||
128795750|NCT01943799|463545779|FG002|Overall Study|Lost to Follow-up|1|||
128795751|NCT01943799|463545780|FG003|Overall Study|Lost to Follow-up|0|||
128795752|NCT01943799|463545777|FG000|Overall Study|Protocol Violation|1|||
128795753|NCT01943799|463545778|FG001|Overall Study|Protocol Violation|0|||
128795754|NCT01943799|463545779|FG002|Overall Study|Protocol Violation|0|||
128795755|NCT01943799|463545780|FG003|Overall Study|Protocol Violation|0|||
128795756|NCT01943799|463545777|FG000|Overall Study|Withdrawal by Subject|4|||
128795757|NCT01943799|463545778|FG001|Overall Study|Withdrawal by Subject|2|||
128795758|NCT01943799|463545779|FG002|Overall Study|Withdrawal by Subject|1|||
128795759|NCT01943799|463545780|FG003|Overall Study|Withdrawal by Subject|0|||
128795760|NCT04594759|463545781|FG000|Overall Study|Lost to Follow-up|3|||
129204566|NCT05051579|465045830|FG006|Overall Study|Sponsor Decision|0|||
129204567|NCT05051579|465045824|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
128795761|NCT03811574|463545784|FG000|Overall Study|Withdrawal by Subject|2|||
128795762|NCT03811574|463545785|FG001|Overall Study|Withdrawal by Subject|4|||
128795763|NCT03811574|463545786|FG002|Overall Study|Withdrawal by Subject|0|||
128795764|NCT01832480|463545787|FG000|Overall Study|Lost to Follow-up|33|||
128795765|NCT01832480|463545788|FG001|Overall Study|Lost to Follow-up|30|||
128795766|NCT01832480|463545787|FG000|Overall Study|Withdrawal by Subject|0|||
128795767|NCT01832480|463545788|FG001|Overall Study|Withdrawal by Subject|2|||
128795768|NCT01832480|463545787|FG000|Overall Study|post randomization ineligible|8|||
128795769|NCT01832480|463545788|FG001|Overall Study|post randomization ineligible|10|||
128795770|NCT05609032|463545789|FG000|Overall Study|Lost to Follow-up|3|||
128795771|NCT05609032|463545790|FG001|Overall Study|Lost to Follow-up|1|||
128795772|NCT05609032|463545789|FG000|Overall Study|Withdrawal by Subject|1|||
128795773|NCT05609032|463545790|FG001|Overall Study|Withdrawal by Subject|0|||
128795774|NCT00958633|463545791|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
128795775|NCT00958633|463545792|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
128795776|NCT00958633|463545793|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
128795777|NCT00958633|463545791|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
128795778|NCT00958633|463545792|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
128795779|NCT00958633|463545793|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
128795780|NCT00958633|463545791|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
128795781|NCT00958633|463545792|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
128795782|NCT00958633|463545793|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
128795783|NCT00958633|463545791|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
128795784|NCT00958633|463545792|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
128795785|NCT00958633|463545793|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
128795786|NCT00958633|463545791|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
128795787|NCT00958633|463545792|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
128795788|NCT00958633|463545793|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
128795789|NCT00958633|463545791|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
128795790|NCT00958633|463545792|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
128795791|NCT00958633|463545793|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
128795792|NCT00958633|463545791|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
128795793|NCT00958633|463545792|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
128795794|NCT00958633|463545793|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
128795795|NCT01373346|463545804|FG000|Overall Study|Death|1|||
128795796|NCT01395758|463545806|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
128795797|NCT01395758|463545807|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
128795798|NCT01395758|463545808|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
128795799|NCT00433199|463545809|FG000|Double-Blind Period|Adverse Event|0|||
128795800|NCT00433199|463545810|FG001|Double-Blind Period|Adverse Event|25|||
128795801|NCT00433199|463545809|FG000|Double-Blind Period|Lack of Efficacy|0|||
128795802|NCT00433199|463545810|FG001|Double-Blind Period|Lack of Efficacy|2|||
128795803|NCT00433199|463545809|FG000|Double-Blind Period|Lost to Follow-up|2|||
128795804|NCT00433199|463545810|FG001|Double-Blind Period|Lost to Follow-up|5|||
128795805|NCT00433199|463545809|FG000|Double-Blind Period|Withdrawal by Subject|8|||
128795806|NCT00433199|463545810|FG001|Double-Blind Period|Withdrawal by Subject|19|||
128795807|NCT00433199|463545809|FG000|Double-Blind Period|Protocol Violation|1|||
128795808|NCT00433199|463545810|FG001|Double-Blind Period|Protocol Violation|10|||
128795809|NCT00433199|463545809|FG000|Double-Blind Period|Administrative|1|||
128795810|NCT00433199|463545810|FG001|Double-Blind Period|Administrative|5|||
128795811|NCT00433199|463545809|FG000|Open-Label Period|Adverse Event|0|||
128795812|NCT00433199|463545810|FG001|Open-Label Period|Adverse Event|19|||
128795813|NCT00433199|463545809|FG000|Open-Label Period|Lack of Efficacy|0|||
128795814|NCT00433199|463545810|FG001|Open-Label Period|Lack of Efficacy|2|||
128795815|NCT00433199|463545809|FG000|Open-Label Period|Lost to Follow-up|0|||
128795816|NCT00433199|463545810|FG001|Open-Label Period|Lost to Follow-up|3|||
128795817|NCT00433199|463545809|FG000|Open-Label Period|Withdrawal by Subject|0|||
128795818|NCT00433199|463545810|FG001|Open-Label Period|Withdrawal by Subject|7|||
128795819|NCT00433199|463545809|FG000|Open-Label Period|Protocol Violation|0|||
128795820|NCT00433199|463545810|FG001|Open-Label Period|Protocol Violation|2|||
128795821|NCT00433199|463545809|FG000|Open-Label Period|Administrative|0|||
128795822|NCT00433199|463545810|FG001|Open-Label Period|Administrative|1|||
128795823|NCT00357097|463545811|FG000|Overall Study|Did not meet inclusion criteria|5|||
128795824|NCT00357097|463545812|FG001|Overall Study|Did not meet inclusion criteria|3|||
128795825|NCT00357097|463545811|FG000|Overall Study|Adverse Event|34|||
128795826|NCT00357097|463545812|FG001|Overall Study|Adverse Event|6|||
128795827|NCT00357097|463545811|FG000|Overall Study|Withdrawal by Subject|8|||
128795828|NCT00357097|463545812|FG001|Overall Study|Withdrawal by Subject|7|||
128795829|NCT00357097|463545811|FG000|Overall Study|Non-compliance|1|||
128795830|NCT00357097|463545812|FG001|Overall Study|Non-compliance|2|||
128795831|NCT00357097|463545811|FG000|Overall Study|Lack of Efficacy|2|||
128795832|NCT00357097|463545812|FG001|Overall Study|Lack of Efficacy|8|||
128795833|NCT00357097|463545811|FG000|Overall Study|Met Exclusion Criteria|3|||
128795834|NCT00357097|463545812|FG001|Overall Study|Met Exclusion Criteria|1|||
128795835|NCT00357097|463545811|FG000|Overall Study|Other|1|||
128795836|NCT00357097|463545812|FG001|Overall Study|Other|1|||
128795837|NCT00357097|463545811|FG000|Overall Study|Increase of RLS Symptoms|0|||
128795838|NCT00357097|463545812|FG001|Overall Study|Increase of RLS Symptoms|1|||
128795839|NCT00794118|463545813|FG000|Overall Study|Lost to Follow-up|16|||
128795840|NCT00794118|463545813|FG000|Overall Study|Withdrawal by Subject|9|||
128795841|NCT00794118|463545813|FG000|Overall Study|Changed hospital center|2|||
128795842|NCT04305405|463545814|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128795843|NCT04305405|463545815|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128795844|NCT00529659|463545816|FG000|Overall Study|Adverse Event|8|||
128795845|NCT00529659|463545817|FG001|Overall Study|Adverse Event|7|||
128795846|NCT00529659|463545816|FG000|Overall Study|Lost to Follow-up|0|||
128795847|NCT00529659|463545817|FG001|Overall Study|Lost to Follow-up|2|||
128795848|NCT00529659|463545816|FG000|Overall Study|Physician Decision|0|||
128795849|NCT00529659|463545817|FG001|Overall Study|Physician Decision|2|||
128795850|NCT00529659|463545816|FG000|Overall Study|Protocol Violation|2|||
128795851|NCT00529659|463545817|FG001|Overall Study|Protocol Violation|6|||
128795852|NCT00529659|463545816|FG000|Overall Study|Withdrawal by Subject|1|||
128795853|NCT00529659|463545817|FG001|Overall Study|Withdrawal by Subject|6|||
128795854|NCT03887650|463545819|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
128795855|NCT03887650|463545820|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
128795856|NCT03887650|463545819|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
128795857|NCT03887650|463545820|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
128795858|NCT03887650|463545819|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
128795859|NCT03887650|463545820|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
128795860|NCT01170962|463545821|FG000|Treatment Period|Lack of Efficacy|96|||
128795861|NCT01170962|463545822|FG001|Treatment Period|Lack of Efficacy|91|||
128795862|NCT01170962|463545823|FG002|Treatment Period|Lack of Efficacy|7|||
128795863|NCT01170962|463545821|FG000|Treatment Period|Adverse Event|11|||
128795864|NCT01170962|463545822|FG001|Treatment Period|Adverse Event|12|||
128795865|NCT01170962|463545823|FG002|Treatment Period|Adverse Event|3|||
128795866|NCT01170962|463545821|FG000|Treatment Period|Withdrawal by Subject|2|||
128795867|NCT01170962|463545822|FG001|Treatment Period|Withdrawal by Subject|1|||
128795868|NCT01170962|463545823|FG002|Treatment Period|Withdrawal by Subject|0|||
128795869|NCT01170962|463545821|FG000|Treatment Period|Lost to Follow-up|1|||
128795870|NCT01170962|463545822|FG001|Treatment Period|Lost to Follow-up|1|||
128795871|NCT01170962|463545823|FG002|Treatment Period|Lost to Follow-up|1|||
128795872|NCT01170962|463545821|FG000|Treatment Period|Participant no longer meets criteria|0|||
128795873|NCT01170962|463545822|FG001|Treatment Period|Participant no longer meets criteria|1|||
128795874|NCT01170962|463545823|FG002|Treatment Period|Participant no longer meets criteria|0|||
128795875|NCT01170962|463545821|FG000|Treatment Period|Request to discontinue treatment|7|||
128795876|NCT01170962|463545822|FG001|Treatment Period|Request to discontinue treatment|3|||
128795877|NCT01170962|463545823|FG002|Treatment Period|Request to discontinue treatment|1|||
128795878|NCT01170962|463545821|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
128795879|NCT01170962|463545822|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
128795880|NCT01170962|463545823|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
128795881|NCT01170962|463545821|FG000|Follow up Period|Withdrawal by Subject|14|||
128795882|NCT01170962|463545822|FG001|Follow up Period|Withdrawal by Subject|10|||
128795883|NCT01170962|463545823|FG002|Follow up Period|Withdrawal by Subject|2|||
128795884|NCT01170962|463545821|FG000|Follow up Period|Lost to Follow-up|13|||
128795885|NCT01170962|463545822|FG001|Follow up Period|Lost to Follow-up|8|||
128795886|NCT01170962|463545823|FG002|Follow up Period|Lost to Follow-up|1|||
128795887|NCT01170962|463545821|FG000|Follow up Period|Death|2|||
128795888|NCT01170962|463545822|FG001|Follow up Period|Death|2|||
128795889|NCT01170962|463545823|FG002|Follow up Period|Death|0|||
128795890|NCT01170962|463545821|FG000|Follow up Period|Others|10|||
128795891|NCT01170962|463545822|FG001|Follow up Period|Others|7|||
128795892|NCT01170962|463545823|FG002|Follow up Period|Others|3|||
128795893|NCT02674750|463545832|FG000|Overall Study|Death|4|||
128795894|NCT02674750|463545833|FG001|Overall Study|Death|5|||
128795895|NCT02674750|463545834|FG002|Overall Study|Death|8|||
128795896|NCT02674750|463545832|FG000|Overall Study|Lost to Follow-up|0|||
128795897|NCT02674750|463545833|FG001|Overall Study|Lost to Follow-up|8|||
128795898|NCT02674750|463545834|FG002|Overall Study|Lost to Follow-up|0|||
128795899|NCT02674750|463545832|FG000|Overall Study|Lack of Efficacy|1|||
128795900|NCT02674750|463545833|FG001|Overall Study|Lack of Efficacy|17|||
128795901|NCT02674750|463545834|FG002|Overall Study|Lack of Efficacy|3|||
128795902|NCT02674750|463545832|FG000|Overall Study|Withdrawal by Subject|0|||
128795903|NCT02674750|463545833|FG001|Overall Study|Withdrawal by Subject|7|||
128795904|NCT02674750|463545834|FG002|Overall Study|Withdrawal by Subject|1|||
128795905|NCT02674750|463545832|FG000|Overall Study|Other|0|||
128795906|NCT02674750|463545833|FG001|Overall Study|Other|8|||
128795907|NCT02674750|463545834|FG002|Overall Study|Other|0|||
128795908|NCT01685606|463545837|FG000|Overall Study|Withdrawal by Subject|1|||
128795909|NCT01199705|463545838|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
128795910|NCT01415349|463545839|FG000|Treatment Period 1|Adverse Event|0|||
128795911|NCT01415349|463545840|FG001|Treatment Period 1|Adverse Event|1|||
128795912|NCT01415349|463545839|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128795913|NCT01415349|463545840|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128795914|NCT01616459|463545843|FG000|Overall Study|Adverse Event|1|||
128795915|NCT01616459|463545844|FG001|Overall Study|Adverse Event|1|||
128795916|NCT01616459|463545845|FG002|Overall Study|Adverse Event|2|||
128795917|NCT01616459|463545846|FG003|Overall Study|Adverse Event|0|||
128795918|NCT01616459|463545843|FG000|Overall Study|Lost to Follow-up|1|||
128795919|NCT01616459|463545844|FG001|Overall Study|Lost to Follow-up|11|||
128795920|NCT01616459|463545845|FG002|Overall Study|Lost to Follow-up|3|||
128795921|NCT01616459|463545846|FG003|Overall Study|Lost to Follow-up|2|||
128795922|NCT01616459|463545843|FG000|Overall Study|Protocol Violation|0|||
128795923|NCT01616459|463545844|FG001|Overall Study|Protocol Violation|0|||
128795924|NCT01616459|463545845|FG002|Overall Study|Protocol Violation|0|||
128795925|NCT01616459|463545846|FG003|Overall Study|Protocol Violation|2|||
128795926|NCT01616459|463545843|FG000|Overall Study|Withdrawal by Subject|2|||
128795927|NCT01616459|463545844|FG001|Overall Study|Withdrawal by Subject|4|||
128795928|NCT01616459|463545845|FG002|Overall Study|Withdrawal by Subject|4|||
128795929|NCT01616459|463545846|FG003|Overall Study|Withdrawal by Subject|4|||
128795930|NCT01616459|463545843|FG000|Overall Study|Other reason|0|||
128795931|NCT01616459|463545844|FG001|Overall Study|Other reason|1|||
128795932|NCT01616459|463545845|FG002|Overall Study|Other reason|1|||
128795933|NCT01616459|463545846|FG003|Overall Study|Other reason|0|||
128795934|NCT04980755|463545847|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
128795935|NCT04980755|463545847|FG000|Body Reprogramming Courses|Work commitment|2|||
128795936|NCT04980755|463545847|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
128795937|NCT04980755|463545847|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
128795938|NCT03215927|463546756|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
128795939|NCT03215927|463546757|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
128795940|NCT03215927|463546756|FG000|Open Label Extension|Adverse Event|1|||
128795941|NCT03215927|463546757|FG001|Open Label Extension|Adverse Event|0|||
128795942|NCT03215927|463546756|FG000|Open Label Extension|Lack of Efficacy|1|||
128795943|NCT03215927|463546757|FG001|Open Label Extension|Lack of Efficacy|0|||
128795944|NCT03215927|463546756|FG000|Open Label Extension|Death|0|||
128795945|NCT03215927|463546757|FG001|Open Label Extension|Death|1|||
128795946|NCT03889925|463546758|FG000|Overall Study|Lost to Follow-up|11|||
128795947|NCT03889925|463546759|FG001|Overall Study|Lost to Follow-up|10|||
128795948|NCT03073941|463546760|FG000|Overall Study|Received non-study device intraoperatively|0|||
128795949|NCT03073941|463546761|FG001|Overall Study|Received non-study device intraoperatively|2|||
128795950|NCT03073941|463546760|FG000|Overall Study|Death|1|||
128795951|NCT03073941|463546761|FG001|Overall Study|Death|0|||
128795952|NCT03073941|463546760|FG000|Overall Study|Withdrawal by Subject|1|||
128795953|NCT03073941|463546761|FG001|Overall Study|Withdrawal by Subject|3|||
128795954|NCT03073941|463546760|FG000|Overall Study|Lost to Follow-up|5|||
128795955|NCT03073941|463546761|FG001|Overall Study|Lost to Follow-up|4|||
128795956|NCT03073941|463546760|FG000|Overall Study|Adverse Event|4|||
128795957|NCT03073941|463546761|FG001|Overall Study|Adverse Event|2|||
128795958|NCT03073941|463546760|FG000|Overall Study|Met an exclusion criterion|0|||
128795959|NCT03073941|463546761|FG001|Overall Study|Met an exclusion criterion|1|||
128795960|NCT04250883|463546763|FG000|Overall Study|Lost to Follow-up|1|||
128795961|NCT04250883|463546764|FG001|Overall Study|Lost to Follow-up|0|||
128795962|NCT01188655|463546766|FG000|Overall Study|Lack of Efficacy|1|||
128795963|NCT01188655|463546766|FG000|Overall Study|Lost to Follow-up|1|||
128795964|NCT01188655|463546766|FG000|Overall Study|Other|11|||
128795965|NCT00089544|463546767|FG000|Overall Study|Ineligible|1|||
128795966|NCT00089544|463546768|FG001|Overall Study|Ineligible|0|||
128795967|NCT02407249|463546773|FG000|Overall Study|Did not complete 12-month follow-up|13|||
128795968|NCT02407249|463546773|FG000|Overall Study|Not treated|13|||
128795969|NCT00610649|463546774|FG000|Overall Study|Adverse Event|1|||
128795970|NCT00610649|463546775|FG001|Overall Study|Adverse Event|0|||
128795971|NCT00610649|463546776|FG002|Overall Study|Adverse Event|0|||
128795972|NCT00610649|463546777|FG003|Overall Study|Adverse Event|0|||
128795973|NCT00610649|463546778|FG004|Overall Study|Adverse Event|0|||
128795974|NCT00610649|463546779|FG005|Overall Study|Adverse Event|0|||
128795975|NCT00610649|463546780|FG006|Overall Study|Adverse Event|0|||
128795976|NCT00610649|463546781|FG007|Overall Study|Adverse Event|0|||
128795977|NCT00610649|463546782|FG008|Overall Study|Adverse Event|0|||
128795978|NCT00610649|463546783|FG009|Overall Study|Adverse Event|0|||
128795979|NCT00610649|463546784|FG010|Overall Study|Adverse Event|1|||
128795980|NCT00610649|463546774|FG000|Overall Study|Family Emergency|0|||
128795981|NCT00610649|463546775|FG001|Overall Study|Family Emergency|1|||
128795982|NCT00610649|463546776|FG002|Overall Study|Family Emergency|0|||
128795983|NCT00610649|463546777|FG003|Overall Study|Family Emergency|0|||
128795984|NCT00610649|463546778|FG004|Overall Study|Family Emergency|0|||
128795985|NCT00610649|463546779|FG005|Overall Study|Family Emergency|0|||
128795986|NCT00610649|463546780|FG006|Overall Study|Family Emergency|0|||
128795987|NCT00610649|463546781|FG007|Overall Study|Family Emergency|0|||
128795988|NCT00610649|463546782|FG008|Overall Study|Family Emergency|0|||
128795989|NCT00610649|463546783|FG009|Overall Study|Family Emergency|0|||
128795990|NCT00610649|463546784|FG010|Overall Study|Family Emergency|0|||
128795991|NCT00610649|463546774|FG000|Overall Study|Withdrawal by Subject|0|||
128795992|NCT00610649|463546775|FG001|Overall Study|Withdrawal by Subject|0|||
128795993|NCT00610649|463546776|FG002|Overall Study|Withdrawal by Subject|0|||
128795994|NCT00610649|463546777|FG003|Overall Study|Withdrawal by Subject|0|||
128795995|NCT00610649|463546778|FG004|Overall Study|Withdrawal by Subject|0|||
128795996|NCT00610649|463546779|FG005|Overall Study|Withdrawal by Subject|0|||
128795997|NCT00610649|463546780|FG006|Overall Study|Withdrawal by Subject|0|||
128795998|NCT00610649|463546781|FG007|Overall Study|Withdrawal by Subject|0|||
128795999|NCT00610649|463546782|FG008|Overall Study|Withdrawal by Subject|0|||
128796000|NCT00610649|463546783|FG009|Overall Study|Withdrawal by Subject|1|||
128796001|NCT00610649|463546784|FG010|Overall Study|Withdrawal by Subject|0|||
128796002|NCT00414544|463546787|FG000|Overall Study|Lost to Follow-up|14|||
128796003|NCT02271854|463546789|FG000|Overall Study|Withdrawal by Subject|2|||
128796004|NCT02271854|463546789|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
128796005|NCT02271854|463546789|FG000|Overall Study|Lost to Follow-up|1|||
128796006|NCT02529995|463546790|FG000|Part A|Ongoing Study at Data Cut-off|14|||
128796007|NCT02529995|463546791|FG001|Part A|Ongoing Study at Data Cut-off|16|||
128796008|NCT02529995|463546790|FG000|Part A|Discontinued Study|1|||
128796009|NCT02529995|463546791|FG001|Part A|Discontinued Study|0|||
128796010|NCT02529995|463546790|FG000|Part B|Ongoing Study at Data Cut-off|0|||
128796011|NCT02529995|463546791|FG001|Part B|Ongoing Study at Data Cut-off|7|||
128796012|NCT02529995|463546790|FG000|Part B|Discontinued Study|6|||
128796013|NCT02529995|463546791|FG001|Part B|Discontinued Study|5|||
128796014|NCT01236001|463546793|FG000|Overall Study|Adverse Event|5|||
128796015|NCT01236001|463546794|FG001|Overall Study|Adverse Event|14|||
128796016|NCT01236001|463546793|FG000|Overall Study|Lack of Efficacy|6|||
128796017|NCT01236001|463546794|FG001|Overall Study|Lack of Efficacy|6|||
128796018|NCT01236001|463546793|FG000|Overall Study|Lost to Follow-up|6|||
128796019|NCT01236001|463546794|FG001|Overall Study|Lost to Follow-up|1|||
128796020|NCT01236001|463546793|FG000|Overall Study|Incompliance|1|||
128796021|NCT01236001|463546794|FG001|Overall Study|Incompliance|0|||
128796022|NCT01236001|463546793|FG000|Overall Study|Planned Visit After End of Study|0|||
128796023|NCT01236001|463546794|FG001|Overall Study|Planned Visit After End of Study|1|||
128796024|NCT01943916|463546796|FG000|Overall Study|Technically invalid images|10|||
128796025|NCT01943916|463546796|FG000|Overall Study|Enrollment Failure|23|||
129204568|NCT05051579|465045825|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129204569|NCT05051579|465045826|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129204570|NCT05051579|465045827|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129204571|NCT05051579|465045828|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
129204572|NCT05051579|465045829|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129204573|NCT05051579|465045830|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129204574|NCT00717249|465045831|FG000|Overall Study|Lens Discomfort|4|||
129204575|NCT00717249|465045832|FG001|Overall Study|Lens Discomfort|1|||
129204576|NCT00717249|465045831|FG000|Overall Study|Unsatisfactory visual Response|0|||
129204577|NCT00717249|465045832|FG001|Overall Study|Unsatisfactory visual Response|2|||
128796026|NCT01943916|463546796|FG000|Overall Study|Pilot Phase exclusion|100|||
128796027|NCT01943916|463546796|FG000|Overall Study|Quality Assurance Reader Fail|130|||
128796028|NCT01943916|463546796|FG000|Overall Study|Technical Failure|39|||
128796029|NCT01943916|463546796|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
128796030|NCT01943916|463546796|FG000|Overall Study|No Truth Panel Review|38|||
128796031|NCT01943916|463546796|FG000|Overall Study|Protocol Deviation|1|||
128796032|NCT05274217|463546797|FG000|Overall Study|Study terminated.|11|||
128796033|NCT05274217|463546798|FG001|Overall Study|Study terminated.|0|||
128796034|NCT02261467|463546799|FG000|Overall Study|Enrolled in Error|1|||
128796035|NCT02261467|463546800|FG001|Overall Study|Enrolled in Error|0|||
128759301|NCT03518125|463408843|FG005|Overall Study|Physician Decision|0|||
128759302|NCT03518125|463408838|FG000|Overall Study|Withdrawal by Subject|1|||
128759303|NCT03518125|463408839|FG001|Overall Study|Withdrawal by Subject|1|||
128759304|NCT03518125|463408840|FG002|Overall Study|Withdrawal by Subject|0|||
128759305|NCT03518125|463408841|FG003|Overall Study|Withdrawal by Subject|1|||
128759306|NCT03518125|463408842|FG004|Overall Study|Withdrawal by Subject|1|||
128759307|NCT03518125|463408843|FG005|Overall Study|Withdrawal by Subject|3|||
128759308|NCT03518125|463408838|FG000|Overall Study|Missed Day 394 Visit|1|||
128759309|NCT03518125|463408839|FG001|Overall Study|Missed Day 394 Visit|0|||
128759310|NCT03518125|463408840|FG002|Overall Study|Missed Day 394 Visit|0|||
128759311|NCT03518125|463408841|FG003|Overall Study|Missed Day 394 Visit|0|||
128759312|NCT03518125|463408842|FG004|Overall Study|Missed Day 394 Visit|0|||
128796036|NCT02261467|463546799|FG000|Overall Study|Protocol Violation|0|||
128796037|NCT02261467|463546800|FG001|Overall Study|Protocol Violation|1|||
128796038|NCT02261467|463546799|FG000|Overall Study|Personal Reasons|17|||
128796039|NCT02261467|463546800|FG001|Overall Study|Personal Reasons|22|||
128796040|NCT02261467|463546799|FG000|Overall Study|Lost to Follow-up|2|||
128796041|NCT02261467|463546800|FG001|Overall Study|Lost to Follow-up|13|||
128796042|NCT02261467|463546799|FG000|Overall Study|Adverse Event|1|||
128796043|NCT02261467|463546800|FG001|Overall Study|Adverse Event|1|||
128796044|NCT01787760|463546802|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
128796045|NCT01787760|463546803|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
128796046|NCT01787760|463546804|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
128796047|NCT01787760|463546802|FG000|Overall Study|Decompensated on left exotropia|0|||
128796048|NCT01787760|463546803|FG001|Overall Study|Decompensated on left exotropia|0|||
128796049|NCT01787760|463546804|FG002|Overall Study|Decompensated on left exotropia|1|||
128796050|NCT01787760|463546802|FG000|Overall Study|Dryness|0|||
128796051|NCT01787760|463546803|FG001|Overall Study|Dryness|1|||
128796052|NCT01787760|463546804|FG002|Overall Study|Dryness|0|||
128796053|NCT01787760|463546802|FG000|Overall Study|Relocation|1|||
128796054|NCT01787760|463546803|FG001|Overall Study|Relocation|1|||
128796055|NCT01787760|463546804|FG002|Overall Study|Relocation|0|||
128796056|NCT01787760|463546802|FG000|Overall Study|Lens discomfort|3|||
128796057|NCT01787760|463546803|FG001|Overall Study|Lens discomfort|0|||
128796058|NCT01787760|463546804|FG002|Overall Study|Lens discomfort|0|||
128796059|NCT01787760|463546802|FG000|Overall Study|Lens handling difficulty|1|||
128796060|NCT01787760|463546803|FG001|Overall Study|Lens handling difficulty|2|||
128796061|NCT01787760|463546804|FG002|Overall Study|Lens handling difficulty|0|||
128796062|NCT01787760|463546802|FG000|Overall Study|Protocol Violation|6|||
128796063|NCT01787760|463546803|FG001|Overall Study|Protocol Violation|0|||
128796064|NCT01787760|463546804|FG002|Overall Study|Protocol Violation|1|||
128796065|NCT01787760|463546802|FG000|Overall Study|Withdrawal by Subject|5|||
128796066|NCT01787760|463546803|FG001|Overall Study|Withdrawal by Subject|1|||
128796067|NCT01787760|463546804|FG002|Overall Study|Withdrawal by Subject|2|||
128796068|NCT01787760|463546802|FG000|Overall Study|Lost to Follow-up|1|||
128796069|NCT01787760|463546803|FG001|Overall Study|Lost to Follow-up|0|||
128796070|NCT01787760|463546804|FG002|Overall Study|Lost to Follow-up|1|||
128796071|NCT01787760|463546802|FG000|Overall Study|Stroke|1|||
128796072|NCT01787760|463546803|FG001|Overall Study|Stroke|0|||
128796073|NCT01787760|463546804|FG002|Overall Study|Stroke|0|||
128796074|NCT01787760|463546802|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
128796075|NCT01787760|463546803|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
128796076|NCT01787760|463546804|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
128796077|NCT01787760|463546802|FG000|Overall Study|Unsatisfactory physiological response|2|||
128796078|NCT01787760|463546803|FG001|Overall Study|Unsatisfactory physiological response|4|||
128796079|NCT01787760|463546804|FG002|Overall Study|Unsatisfactory physiological response|0|||
128796080|NCT01787760|463546802|FG000|Overall Study|Unsatisfactory visual response|1|||
128796081|NCT01787760|463546803|FG001|Overall Study|Unsatisfactory visual response|1|||
128796082|NCT01787760|463546804|FG002|Overall Study|Unsatisfactory visual response|0|||
128796083|NCT01787760|463546802|FG000|Overall Study|Near vision blur|1|||
128796084|NCT01787760|463546803|FG001|Overall Study|Near vision blur|0|||
128796085|NCT01787760|463546804|FG002|Overall Study|Near vision blur|0|||
128796086|NCT03512756|463546805|FG000|Part 1|Death|23|||
128796087|NCT03512756|463546806|FG001|Part 1|Death|18|||
128796088|NCT03512756|463546807|FG002|Part 1|Death|0|||
128796089|NCT03512756|463546808|FG003|Part 1|Death|0|||
128796090|NCT03512756|463546805|FG000|Part 1|Lost to Follow-up|0|||
128796091|NCT03512756|463546806|FG001|Part 1|Lost to Follow-up|3|||
128796092|NCT03512756|463546807|FG002|Part 1|Lost to Follow-up|0|||
128796093|NCT03512756|463546808|FG003|Part 1|Lost to Follow-up|0|||
128796094|NCT03512756|463546805|FG000|Part 1|Physician Decision|0|||
128796095|NCT03512756|463546806|FG001|Part 1|Physician Decision|1|||
128796096|NCT03512756|463546807|FG002|Part 1|Physician Decision|0|||
128796097|NCT03512756|463546808|FG003|Part 1|Physician Decision|0|||
129204578|NCT00717249|465045831|FG000|Overall Study|Adverse Event|4|||
129204579|NCT00717249|465045832|FG001|Overall Study|Adverse Event|2|||
129204580|NCT00717249|465045831|FG000|Overall Study|Lost to Follow-up|2|||
129204581|NCT00717249|465045832|FG001|Overall Study|Lost to Follow-up|0|||
129204582|NCT00717249|465045831|FG000|Overall Study|Withdrawal by Subject|1|||
129204583|NCT00717249|465045832|FG001|Overall Study|Withdrawal by Subject|2|||
129204584|NCT00717249|465045831|FG000|Overall Study|Pregnancy|6|||
129204585|NCT00717249|465045832|FG001|Overall Study|Pregnancy|3|||
129204586|NCT00717249|465045831|FG000|Overall Study|Protocol Violation|0|||
129204587|NCT00717249|465045832|FG001|Overall Study|Protocol Violation|2|||
129204588|NCT00717249|465045831|FG000|Overall Study|Subject became Ineligible|1|||
129204589|NCT00717249|465045832|FG001|Overall Study|Subject became Ineligible|1|||
129204590|NCT00717249|465045831|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
129204591|NCT00717249|465045832|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
129204592|NCT00717249|465045831|FG000|Overall Study|Gastric Surgery|0|||
129204593|NCT00717249|465045832|FG001|Overall Study|Gastric Surgery|1|||
129204594|NCT00717249|465045831|FG000|Overall Study|Diagnosed with Diabetes|1|||
129204595|NCT00717249|465045832|FG001|Overall Study|Diagnosed with Diabetes|0|||
129204596|NCT00717249|465045831|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
129204597|NCT00717249|465045832|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
129204598|NCT00717249|465045831|FG000|Overall Study|Subject relocated|1|||
129204599|NCT00717249|465045832|FG001|Overall Study|Subject relocated|0|||
129204600|NCT00717249|465045831|FG000|Overall Study|Headaches|1|||
129204601|NCT00717249|465045832|FG001|Overall Study|Headaches|0|||
129204602|NCT00360412|465045833|FG000|Overall Study|Adverse Event|37|||
129204603|NCT00360412|465045834|FG001|Overall Study|Adverse Event|65|||
129204604|NCT00360412|465045833|FG000|Overall Study|Protocol Violation|2|||
129204605|NCT00360412|465045834|FG001|Overall Study|Protocol Violation|5|||
129204606|NCT00360412|465045833|FG000|Overall Study|Patient withdrew consent|27|||
129204607|NCT00360412|465045834|FG001|Overall Study|Patient withdrew consent|52|||
129204608|NCT00360412|465045833|FG000|Overall Study|Lack of therapeutic efficacy|46|||
129204609|NCT00360412|465045834|FG001|Overall Study|Lack of therapeutic efficacy|61|||
129204610|NCT00360412|465045833|FG000|Overall Study|Physician Decision|2|||
129204611|NCT00360412|465045834|FG001|Overall Study|Physician Decision|4|||
129204612|NCT00360412|465045833|FG000|Overall Study|Other|5|||
129204613|NCT00360412|465045834|FG001|Overall Study|Other|6|||
128796098|NCT03512756|463546805|FG000|Part 1|Withdrawal by Subject|2|||
128796099|NCT03512756|463546806|FG001|Part 1|Withdrawal by Subject|2|||
128796100|NCT03512756|463546807|FG002|Part 1|Withdrawal by Subject|0|||
128796101|NCT03512756|463546808|FG003|Part 1|Withdrawal by Subject|0|||
128796102|NCT03512756|463546805|FG000|Part 2|Death|0|||
128796103|NCT03512756|463546806|FG001|Part 2|Death|0|||
128796104|NCT03512756|463546807|FG002|Part 2|Death|32|||
128796105|NCT03512756|463546808|FG003|Part 2|Death|21|||
128796106|NCT03512756|463546805|FG000|Part 2|Lost to Follow-up|0|||
128796107|NCT03512756|463546806|FG001|Part 2|Lost to Follow-up|0|||
128796108|NCT03512756|463546807|FG002|Part 2|Lost to Follow-up|1|||
128796109|NCT03512756|463546808|FG003|Part 2|Lost to Follow-up|0|||
128796110|NCT03512756|463546805|FG000|Part 2|Physician Decision|0|||
128796111|NCT03512756|463546806|FG001|Part 2|Physician Decision|0|||
128796112|NCT03512756|463546807|FG002|Part 2|Physician Decision|2|||
128796113|NCT03512756|463546808|FG003|Part 2|Physician Decision|4|||
128796114|NCT03512756|463546805|FG000|Part 2|Study Terminated by Sponsor|0|||
128796115|NCT03512756|463546806|FG001|Part 2|Study Terminated by Sponsor|0|||
128796116|NCT03512756|463546807|FG002|Part 2|Study Terminated by Sponsor|2|||
128796117|NCT03512756|463546808|FG003|Part 2|Study Terminated by Sponsor|6|||
128796118|NCT03512756|463546805|FG000|Part 2|Protocol Violation|0|||
128796119|NCT03512756|463546806|FG001|Part 2|Protocol Violation|0|||
128796120|NCT03512756|463546807|FG002|Part 2|Protocol Violation|1|||
128796121|NCT03512756|463546808|FG003|Part 2|Protocol Violation|0|||
128796122|NCT03512756|463546805|FG000|Part 2|Withdrawal by Subject|0|||
128796123|NCT03512756|463546806|FG001|Part 2|Withdrawal by Subject|0|||
128796124|NCT03512756|463546807|FG002|Part 2|Withdrawal by Subject|3|||
129204614|NCT00360412|465045833|FG000|Overall Study|Study termination by Sponsor|214|||
129204615|NCT00360412|465045834|FG001|Overall Study|Study termination by Sponsor|469|||
129204616|NCT05148234|465045835|FG000|Phase I|Ineligible|0|||
129204617|NCT05148234|465045836|FG001|Phase I|Ineligible|0|||
129204618|NCT05148234|465045837|FG002|Phase I|Ineligible|0|||
129204619|NCT05148234|465045838|FG003|Phase I|Ineligible|0|||
128796125|NCT03512756|463546808|FG003|Part 2|Withdrawal by Subject|9|||
128796126|NCT00736853|463546809|FG000|Open-Label Period|Physician Decision|2|||
128796127|NCT00736853|463546810|FG001|Open-Label Period|Physician Decision|0|||
128796128|NCT00736853|463546811|FG002|Open-Label Period|Physician Decision|0|||
129204620|NCT05148234|465045839|FG004|Phase I|Ineligible|0|||
129204621|NCT05148234|465045840|FG005|Phase I|Ineligible|0|||
128796129|NCT00736853|463546809|FG000|Open-Label Period|Adverse Event|31|||
128796130|NCT00736853|463546810|FG001|Open-Label Period|Adverse Event|0|||
128796131|NCT00736853|463546811|FG002|Open-Label Period|Adverse Event|0|||
128796132|NCT00736853|463546809|FG000|Open-Label Period|Withdrawal by Subject|16|||
128796133|NCT00736853|463546810|FG001|Open-Label Period|Withdrawal by Subject|0|||
128796134|NCT00736853|463546811|FG002|Open-Label Period|Withdrawal by Subject|0|||
128796135|NCT00736853|463546809|FG000|Open-Label Period|Started but not treated|42|||
128796136|NCT00736853|463546810|FG001|Open-Label Period|Started but not treated|0|||
128796137|NCT00736853|463546811|FG002|Open-Label Period|Started but not treated|0|||
128796138|NCT00736853|463546809|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
128796139|NCT00736853|463546810|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
128796140|NCT00736853|463546811|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
128796141|NCT00736853|463546809|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
128796142|NCT00736853|463546810|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
128796143|NCT00736853|463546811|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
128796144|NCT00736853|463546809|FG000|Double-Blind Period|Lack of Efficacy|0|||
128796145|NCT00736853|463546810|FG001|Double-Blind Period|Lack of Efficacy|19|||
128796146|NCT00736853|463546811|FG002|Double-Blind Period|Lack of Efficacy|42|||
128796147|NCT00736853|463546809|FG000|Double-Blind Period|Adverse Event|0|||
128796148|NCT00736853|463546810|FG001|Double-Blind Period|Adverse Event|3|||
128796149|NCT00736853|463546811|FG002|Double-Blind Period|Adverse Event|2|||
128796150|NCT00736853|463546809|FG000|Double-Blind Period|Withdrawal by Subject|0|||
128796151|NCT00736853|463546810|FG001|Double-Blind Period|Withdrawal by Subject|1|||
128796152|NCT00736853|463546811|FG002|Double-Blind Period|Withdrawal by Subject|4|||
128796153|NCT00736853|463546809|FG000|Double-Blind Period|Ineligible to participate the study|0|||
128796154|NCT00736853|463546810|FG001|Double-Blind Period|Ineligible to participate the study|1|||
128796155|NCT00736853|463546811|FG002|Double-Blind Period|Ineligible to participate the study|0|||
128796156|NCT01041417|463546814|FG000|Overall Study|Adverse Event|5|||
128796157|NCT01041417|463546815|FG001|Overall Study|Adverse Event|2|||
128796158|NCT01041417|463546814|FG000|Overall Study|Lost to Follow-up|1|||
128796159|NCT01041417|463546815|FG001|Overall Study|Lost to Follow-up|1|||
128796160|NCT01041417|463546814|FG000|Overall Study|Death|1|||
128796161|NCT01041417|463546815|FG001|Overall Study|Death|0|||
128796162|NCT02299375|463546818|FG000|Overall Study|Adverse Event, serious fatal|1|||
128796163|NCT02299375|463546819|FG001|Overall Study|Adverse Event, serious fatal|3|||
128796164|NCT02299375|463546818|FG000|Overall Study|Adverse Event, non-fatal|8|||
128796165|NCT02299375|463546819|FG001|Overall Study|Adverse Event, non-fatal|9|||
128796166|NCT02299375|463546818|FG000|Overall Study|Lack of Efficacy|1|||
128796167|NCT02299375|463546819|FG001|Overall Study|Lack of Efficacy|3|||
128796168|NCT02299375|463546818|FG000|Overall Study|Protocol Violation|1|||
128796169|NCT02299375|463546819|FG001|Overall Study|Protocol Violation|3|||
128796170|NCT02299375|463546818|FG000|Overall Study|Other: Met stopping criteria|1|||
128796171|NCT02299375|463546819|FG001|Overall Study|Other: Met stopping criteria|0|||
128796172|NCT02299375|463546818|FG000|Overall Study|Other: Study closed/terminated|66|||
128796173|NCT02299375|463546819|FG001|Overall Study|Other: Study closed/terminated|55|||
128796174|NCT02299375|463546818|FG000|Overall Study|Lost to Follow-up|0|||
128796175|NCT02299375|463546819|FG001|Overall Study|Lost to Follow-up|2|||
128796176|NCT02299375|463546818|FG000|Overall Study|Physician Decision|1|||
128796177|NCT02299375|463546819|FG001|Overall Study|Physician Decision|1|||
128796178|NCT02299375|463546818|FG000|Overall Study|Withdrawal by Subject|1|||
128796179|NCT02299375|463546819|FG001|Overall Study|Withdrawal by Subject|4|||
128796180|NCT00704184|463546820|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
128796181|NCT00704184|463546821|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
128796182|NCT00704184|463546822|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
128796183|NCT00704184|463546823|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
128796184|NCT00704184|463546824|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
128796185|NCT00704184|463546820|FG000|Open-Label Treatment|Adverse Event|0|||
128796186|NCT00704184|463546821|FG001|Open-Label Treatment|Adverse Event|0|||
128796187|NCT00704184|463546822|FG002|Open-Label Treatment|Adverse Event|2|||
128796188|NCT00704184|463546823|FG003|Open-Label Treatment|Adverse Event|0|||
128796189|NCT00704184|463546824|FG004|Open-Label Treatment|Adverse Event|1|||
128796190|NCT00704184|463546820|FG000|Open-Label Treatment|Lack of Efficacy|0|||
128796191|NCT00704184|463546821|FG001|Open-Label Treatment|Lack of Efficacy|2|||
128796192|NCT00704184|463546822|FG002|Open-Label Treatment|Lack of Efficacy|2|||
128796193|NCT00704184|463546823|FG003|Open-Label Treatment|Lack of Efficacy|2|||
128796194|NCT00704184|463546824|FG004|Open-Label Treatment|Lack of Efficacy|1|||
128796195|NCT00704184|463546820|FG000|Open-Label Treatment|Physician Decision|0|||
128796196|NCT00704184|463546821|FG001|Open-Label Treatment|Physician Decision|0|||
128796197|NCT00704184|463546822|FG002|Open-Label Treatment|Physician Decision|0|||
128796198|NCT00704184|463546823|FG003|Open-Label Treatment|Physician Decision|0|||
128796199|NCT00704184|463546824|FG004|Open-Label Treatment|Physician Decision|1|||
128796200|NCT00704184|463546820|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
128796201|NCT00704184|463546821|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
128796202|NCT00704184|463546822|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
128796203|NCT00704184|463546823|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
128796204|NCT00704184|463546824|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
128796205|NCT01764464|463546825|FG000|First Intervention|Withdrawal by Subject|1|||
128796206|NCT01764464|463546826|FG001|First Intervention|Withdrawal by Subject|0|||
128796207|NCT01764464|463546825|FG000|First Intervention|Lost to Follow-up|1|||
128796208|NCT01764464|463546826|FG001|First Intervention|Lost to Follow-up|0|||
128796209|NCT01764464|463546825|FG000|First Intervention|Adverse Event|0|||
128796210|NCT01764464|463546826|FG001|First Intervention|Adverse Event|2|||
128796211|NCT01764464|463546825|FG000|First Intervention|did not receive study drug|0|||
128796212|NCT01764464|463546826|FG001|First Intervention|did not receive study drug|1|||
128796213|NCT01764464|463546825|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
128796214|NCT01764464|463546826|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
128796215|NCT03473340|463546828|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
128796216|NCT03473340|463546829|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
128796217|NCT03473340|463546828|FG000|Overall Study|Withdrawal by Subject|1|||
128796218|NCT03473340|463546829|FG001|Overall Study|Withdrawal by Subject|0|||
128796219|NCT03473340|463546828|FG000|Overall Study|Lost to Follow-up|1|||
128796220|NCT03473340|463546829|FG001|Overall Study|Lost to Follow-up|2|||
128796221|NCT03394885|463546831|FG000|Overall Study|Adverse Event|4|||
128796222|NCT03394885|463546831|FG000|Overall Study|Lack of Efficacy|1|||
128796223|NCT03394885|463546831|FG000|Overall Study|Physician Decision|1|||
128796224|NCT03394885|463546831|FG000|Overall Study|Withdrawal by Subject|8|||
128796225|NCT03394885|463546831|FG000|Overall Study|Alternative Therapy|1|||
128796226|NCT01212991|463546837|FG000|Double-blind|Lost to Follow-up|8|||
128796227|NCT01212991|463546838|FG001|Double-blind|Lost to Follow-up|4|||
128796228|NCT01212991|463546839|FG002|Double-blind|Lost to Follow-up|0|||
128796229|NCT01212991|463546837|FG000|Double-blind|Death|699|||
128796230|NCT01212991|463546838|FG001|Double-blind|Death|550|||
128796231|NCT01212991|463546839|FG002|Double-blind|Death|0|||
128796232|NCT01212991|463546837|FG000|Double-blind|Withdrawal by Subject|16|||
128796233|NCT01212991|463546838|FG001|Double-blind|Withdrawal by Subject|19|||
128796234|NCT01212991|463546839|FG002|Double-blind|Withdrawal by Subject|0|||
128796235|NCT01212991|463546837|FG000|Double-blind|Other|7|||
128796236|NCT01212991|463546838|FG001|Double-blind|Other|0|||
128796237|NCT01212991|463546839|FG002|Double-blind|Other|0|||
128796238|NCT01212991|463546837|FG000|Double-blind|Sponsor decision|142|||
128796239|NCT01212991|463546838|FG001|Double-blind|Sponsor decision|38|||
128796240|NCT01212991|463546839|FG002|Double-blind|Sponsor decision|0|||
128796241|NCT01212991|463546837|FG000|Open-label|Death|0|||
128796242|NCT01212991|463546838|FG001|Open-label|Death|0|||
128796243|NCT01212991|463546839|FG002|Open-label|Death|166|||
128796244|NCT01212991|463546837|FG000|Open-label|Lost to Follow-up|0|||
128796245|NCT01212991|463546838|FG001|Open-label|Lost to Follow-up|0|||
128796246|NCT01212991|463546839|FG002|Open-label|Lost to Follow-up|5|||
128796247|NCT01212991|463546837|FG000|Open-label|Withdrawal by Subject|0|||
128796248|NCT01212991|463546838|FG001|Open-label|Withdrawal by Subject|0|||
128796249|NCT01212991|463546839|FG002|Open-label|Withdrawal by Subject|7|||
128796250|NCT01212991|463546837|FG000|Open-label|Sponsor decision|0|||
128796251|NCT01212991|463546838|FG001|Open-label|Sponsor decision|0|||
128796252|NCT01212991|463546839|FG002|Open-label|Sponsor decision|53|||
128796253|NCT01212991|463546837|FG000|Open-label|Other|0|||
128796254|NCT01212991|463546838|FG001|Open-label|Other|0|||
128796255|NCT01212991|463546839|FG002|Open-label|Other|3|||
128796256|NCT00801983|463546842|FG000|Period 1|Lost to Follow-up|2|||
128796257|NCT00801983|463546843|FG001|Period 1|Lost to Follow-up|0|||
128796258|NCT00801983|463546842|FG000|Period 1|Withdrawal by Subject|2|||
128796259|NCT00801983|463546843|FG001|Period 1|Withdrawal by Subject|8|||
128796260|NCT00801983|463546842|FG000|Period 2|Withdrawal by Subject|2|||
128796261|NCT00801983|463546843|FG001|Period 2|Withdrawal by Subject|1|||
128796262|NCT01622868|463548253|FG000|Overall Study|Protocol Violation|7|||
128796263|NCT01622868|463548254|FG001|Overall Study|Protocol Violation|0|||
128796264|NCT04512482|463548259|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
128796265|NCT04512482|463548260|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
128796266|NCT00446459|463548263|FG000|8 Months|Protocol Violation|12|||
128796267|NCT00446459|463548263|FG000|12 Months|Protocol Violation|4|||
128796268|NCT00446459|463548263|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
128796269|NCT00391898|463548278|FG000|Overall Study|Adverse Event|3|||
128796270|NCT00391898|463548279|FG001|Overall Study|Adverse Event|0|||
128796271|NCT00391898|463548278|FG000|Overall Study|Other|8|||
128796272|NCT00391898|463548279|FG001|Overall Study|Other|10|||
128796273|NCT02918279|463548282|FG000|Overall Study|Lost to Follow-up|3|||
128796274|NCT02918279|463548283|FG001|Overall Study|Lost to Follow-up|6|||
128796275|NCT02918279|463548282|FG000|Overall Study|Withdrawal by Subject|5|||
128796276|NCT02918279|463548283|FG001|Overall Study|Withdrawal by Subject|15|||
128796277|NCT02918279|463548282|FG000|Overall Study|Withdrawal by parent/guardian|2|||
128796278|NCT02918279|463548283|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128796279|NCT02918279|463548282|FG000|Overall Study|Other|3|||
128796280|NCT02918279|463548283|FG001|Overall Study|Other|1|||
128796281|NCT00309907|463548284|FG000|Overall Study|Death|4|||
128796282|NCT00309907|463548284|FG000|Overall Study|Physician Decision|1|||
128796283|NCT00309907|463548284|FG000|Overall Study|Ineligible|11|||
128796284|NCT00309907|463548284|FG000|Overall Study|Major infectious event|4|||
128796285|NCT00244855|463548285|FG000|Overall Study|Withdrawal by Subject|0|||
128796286|NCT00244855|463548286|FG001|Overall Study|Withdrawal by Subject|1|||
128796287|NCT00869258|463548287|FG000|Overall Study|Physician Decision|1|||
128796288|NCT01641198|463548288|FG000|After 12 Months of Function|Lost to Follow-up|3|||
128796289|NCT01641198|463548289|FG001|After 12 Months of Function|Lost to Follow-up|2|||
128796290|NCT01641198|463548290|FG002|After 12 Months of Function|Lost to Follow-up|2|||
128796291|NCT01641198|463548288|FG000|After 12 Months of Function|Protocol Violation|1|||
128796292|NCT01641198|463548289|FG001|After 12 Months of Function|Protocol Violation|0|||
128796293|NCT01641198|463548290|FG002|After 12 Months of Function|Protocol Violation|0|||
128796294|NCT01641198|463548288|FG000|After 12 Months of Function|Adverse Event|0|||
128796295|NCT01641198|463548289|FG001|After 12 Months of Function|Adverse Event|1|||
128796296|NCT01641198|463548290|FG002|After 12 Months of Function|Adverse Event|0|||
128796297|NCT01641198|463548288|FG000|After 24 Months of Function|Lost to Follow-up|4|||
128796298|NCT01641198|463548289|FG001|After 24 Months of Function|Lost to Follow-up|9|||
128796299|NCT01641198|463548290|FG002|After 24 Months of Function|Lost to Follow-up|6|||
128796300|NCT01641198|463548288|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
128796301|NCT01641198|463548289|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
128796302|NCT01641198|463548290|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
128796303|NCT01641198|463548288|FG000|At 15-20 Years of Function|Death|1|||
128796304|NCT01641198|463548289|FG001|At 15-20 Years of Function|Death|0|||
128796305|NCT01641198|463548290|FG002|At 15-20 Years of Function|Death|1|||
128796306|NCT01068743|463548292|FG000|Period 3|Adverse Event|0|||
128796307|NCT01068743|463548293|FG001|Period 3|Adverse Event|1|||
128796308|NCT01068743|463548294|FG002|Period 3|Adverse Event|0|||
128796309|NCT01068743|463548295|FG003|Period 3|Adverse Event|0|||
128796310|NCT02507752|463548296|FG000|Overall Study|Adverse Event|1|||
128796311|NCT02507752|463548296|FG000|Overall Study|Protocol Violation|6|||
128796312|NCT02507752|463548296|FG000|Overall Study|Lost to Follow-up|7|||
128796313|NCT02507752|463548296|FG000|Overall Study|Infusion reaction at first infusion|1|||
128796314|NCT02507752|463548296|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
128796315|NCT02507752|463548296|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
128796316|NCT00939510|463548305|FG000|Overall Study|Withdrawal by Subject|1|||
128796317|NCT05782231|463548319|FG000|Overall Study|Withdrawal by Subject|1|||
128796318|NCT02528188|463548323|FG000|Overall Study|Adverse Event|23|||
128796319|NCT02528188|463548324|FG001|Overall Study|Adverse Event|22|||
128796320|NCT02528188|463548325|FG002|Overall Study|Adverse Event|8|||
128796321|NCT02528188|463548323|FG000|Overall Study|Protocol Violation|4|||
128796322|NCT02528188|463548324|FG001|Overall Study|Protocol Violation|6|||
128796323|NCT02528188|463548325|FG002|Overall Study|Protocol Violation|4|||
128796324|NCT02528188|463548323|FG000|Overall Study|Lack of Efficacy|19|||
128796325|NCT02528188|463548324|FG001|Overall Study|Lack of Efficacy|21|||
128796326|NCT02528188|463548325|FG002|Overall Study|Lack of Efficacy|22|||
128796327|NCT02528188|463548323|FG000|Overall Study|Withdrawal by Subject|97|||
128796328|NCT02528188|463548324|FG001|Overall Study|Withdrawal by Subject|104|||
128796329|NCT02528188|463548325|FG002|Overall Study|Withdrawal by Subject|100|||
128796330|NCT02528188|463548323|FG000|Overall Study|Lost to Follow-up|25|||
128796331|NCT02528188|463548324|FG001|Overall Study|Lost to Follow-up|21|||
128796332|NCT02528188|463548325|FG002|Overall Study|Lost to Follow-up|31|||
128796333|NCT02528188|463548323|FG000|Overall Study|Death|4|||
128796334|NCT02528188|463548324|FG001|Overall Study|Death|4|||
128796335|NCT02528188|463548325|FG002|Overall Study|Death|0|||
128796336|NCT02528188|463548323|FG000|Overall Study|Other|89|||
128796337|NCT02528188|463548324|FG001|Overall Study|Other|91|||
128796338|NCT02528188|463548325|FG002|Overall Study|Other|74|||
128796339|NCT02528188|463548323|FG000|Overall Study|Randomized but not treated|6|||
128796340|NCT02528188|463548324|FG001|Overall Study|Randomized but not treated|7|||
128796341|NCT02528188|463548325|FG002|Overall Study|Randomized but not treated|12|||
128796342|NCT00933400|463548326|FG000|Overall Study|Withdrawal by Subject|21|||
128796343|NCT00933400|463548327|FG001|Overall Study|Withdrawal by Subject|1|||
128796344|NCT00716859|463548328|FG000|Overall Study|Adverse Event|4|||
128796345|NCT00716859|463548329|FG001|Overall Study|Adverse Event|1|||
128796346|NCT00716859|463548328|FG000|Overall Study|Lack of Efficacy|3|||
128796347|NCT00716859|463548329|FG001|Overall Study|Lack of Efficacy|0|||
128796348|NCT00716859|463548328|FG000|Overall Study|Withdrawal by Subject|1|||
128796349|NCT00716859|463548329|FG001|Overall Study|Withdrawal by Subject|3|||
128796350|NCT00716859|463548328|FG000|Overall Study|Not treated|1|||
128796351|NCT00716859|463548329|FG001|Overall Study|Not treated|1|||
128796352|NCT00411216|463548340|FG000|Overall Study|Ten participants were entered into the c|0|||
128796353|NCT00411216|463548341|FG001|Overall Study|Ten participants were entered into the c|2|||
128796354|NCT02918071|463548342|FG000|Overall Study|Withdrawal by Subject|2|||
128796355|NCT02918071|463548342|FG000|Overall Study|Lost to Follow-up|1|||
128796356|NCT00203411|463548345|FG000|Follow-up|Progressive Disease|4|||
128796357|NCT01251354|463548348|FG000|Overall Study|Adverse Event|1|||
128796358|NCT01251354|463548348|FG000|Overall Study|Investigator's Decision|1|||
128796359|NCT01251354|463548348|FG000|Overall Study|Disease Progression|4|||
128796360|NCT05135000|463548352|FG000|Overall Study|Adverse Event|2|||
128796361|NCT05135000|463548353|FG001|Overall Study|Adverse Event|0|||
128796362|NCT05135000|463548352|FG000|Overall Study|Lost to Follow-up|1|||
128796363|NCT05135000|463548353|FG001|Overall Study|Lost to Follow-up|0|||
128796364|NCT05135000|463548352|FG000|Overall Study|Study Terminated by Sponsor|6|||
128796365|NCT05135000|463548353|FG001|Overall Study|Study Terminated by Sponsor|3|||
128796366|NCT05094141|463548356|FG000|Overall Study|Death|0|||
128796367|NCT05094141|463548357|FG001|Overall Study|Death|0|||
128796368|NCT05094141|463548358|FG002|Overall Study|Death|1|||
128796369|NCT05094141|463548356|FG000|Overall Study|Withdrawal by Subject|0|||
128796370|NCT05094141|463548357|FG001|Overall Study|Withdrawal by Subject|0|||
128796371|NCT05094141|463548358|FG002|Overall Study|Withdrawal by Subject|1|||
128796372|NCT05094141|463548356|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
128796373|NCT05094141|463548357|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
128796374|NCT05094141|463548358|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
128796375|NCT05094141|463548356|FG000|Overall Study|Did not participate in randomization|0|||
128796376|NCT05094141|463548357|FG001|Overall Study|Did not participate in randomization|0|||
128796377|NCT05094141|463548358|FG002|Overall Study|Did not participate in randomization|33|||
128796378|NCT01170026|463549836|FG000|Overall Study|Lost to Follow-up|4|||
128796379|NCT01170026|463549837|FG001|Overall Study|Lost to Follow-up|2|||
128796380|NCT04623008|463549838|FG000|Baseline to T2|Withdrawal by Subject|4|||
128796381|NCT04623008|463549839|FG001|Baseline to T2|Withdrawal by Subject|2|||
128796382|NCT04623008|463549838|FG000|Baseline to T3|Withdrawal by Subject|4|||
128796383|NCT04623008|463549839|FG001|Baseline to T3|Withdrawal by Subject|2|||
128796384|NCT03785782|463549848|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
128796385|NCT03785782|463549849|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
128796386|NCT03785782|463549848|FG000|Overall Study|Withdrawal by Subject|1|||
128796387|NCT03785782|463549849|FG001|Overall Study|Withdrawal by Subject|1|||
128796388|NCT03785782|463549848|FG000|Overall Study|insufficient image quality.|3|||
128796389|NCT03785782|463549849|FG001|Overall Study|insufficient image quality.|0|||
128796390|NCT03779048|463549850|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
128796391|NCT03779048|463549851|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
128796392|NCT03779048|463549852|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
128796393|NCT03779048|463549850|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
128796394|NCT03779048|463549851|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
128796395|NCT03779048|463549852|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
128796396|NCT03779048|463549850|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
128796397|NCT03779048|463549851|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
128796398|NCT03779048|463549852|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
128796399|NCT05777785|463549853|FG000|Overall Study|Withdrawal by Subject|5|||
128796400|NCT05777785|463549853|FG000|Overall Study|Lost to Follow-up|1|||
128796401|NCT04588259|463549855|FG000|Run-in Period|Run-in failure|0|||
128796402|NCT04588259|463549856|FG001|Run-in Period|Run-in failure|23|||
128796403|NCT04588259|463549855|FG000|Run-in Period|Withdrawn before randomisation|0|||
128796404|NCT04588259|463549856|FG001|Run-in Period|Withdrawn before randomisation|8|||
128796405|NCT04588259|463549855|FG000|Treatment Period|Withdrawal by Subject|6|||
128796406|NCT04588259|463549856|FG001|Treatment Period|Withdrawal by Subject|6|||
128796407|NCT02763319|463549860|FG000|Overall Study|Adverse Event|12|||
128796408|NCT02763319|463549861|FG001|Overall Study|Adverse Event|3|||
128796409|NCT02763319|463549860|FG000|Overall Study|Death|123|||
128796410|NCT02763319|463549861|FG001|Overall Study|Death|123|||
128796411|NCT02763319|463549860|FG000|Overall Study|Lost to Follow-up|6|||
128796412|NCT02763319|463549861|FG001|Overall Study|Lost to Follow-up|7|||
128796413|NCT02763319|463549860|FG000|Overall Study|Noncompliance with Study Drug|2|||
128796414|NCT02763319|463549861|FG001|Overall Study|Noncompliance with Study Drug|0|||
128796415|NCT02763319|463549860|FG000|Overall Study|"Captured as Other in Database"|29|||
128796416|NCT02763319|463549861|FG001|Overall Study|"Captured as Other in Database"|34|||
128796417|NCT02763319|463549860|FG000|Overall Study|Physician Decision|1|||
128796418|NCT02763319|463549861|FG001|Overall Study|Physician Decision|7|||
128796419|NCT02763319|463549860|FG000|Overall Study|Progressive Disease|24|||
128796420|NCT02763319|463549861|FG001|Overall Study|Progressive Disease|27|||
128796421|NCT02763319|463549860|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
128796422|NCT02763319|463549861|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
128796423|NCT02763319|463549860|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
128796424|NCT02763319|463549861|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
128796425|NCT02763319|463549860|FG000|Overall Study|Withdrawal by Subject|26|||
128796426|NCT02763319|463549861|FG001|Overall Study|Withdrawal by Subject|25|||
128796427|NCT04252586|463549864|FG000|Overall Study|Withdrawal by parent/guardian|3|||
128796428|NCT04252586|463549864|FG000|Overall Study|Adverse Event|1|||
128796429|NCT04252586|463549864|FG000|Overall Study|Death|2|||
128796430|NCT04252586|463549864|FG000|Overall Study|Study terminated by sponsor|4|||
128796431|NCT04252586|463549864|FG000|Overall Study|Sponsor request|10|||
128796432|NCT04252586|463549864|FG000|Overall Study|Did not complete treatment period|1|||
128796433|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Death|186|||
128796434|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Death|222|||
128796435|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Death|0|||
128796436|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
128796437|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
128796438|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
128796439|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
128796440|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
128796441|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
128796442|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
128796443|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
128796444|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
128796445|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Adverse Event|83|||
128796446|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Adverse Event|100|||
128796447|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Adverse Event|0|||
128796448|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Other|70|||
128796449|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Other|75|||
128796450|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Other|0|||
128796451|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
128796452|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
128796453|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
128796454|NCT00232180|463549865|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
128796455|NCT00232180|463549866|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
128796456|NCT00232180|463549867|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
128796457|NCT00232180|463549865|FG000|Open Label Phase|Death|0|||
128796458|NCT00232180|463549866|FG001|Open Label Phase|Death|0|||
128796459|NCT00232180|463549867|FG002|Open Label Phase|Death|48|||
128796460|NCT00232180|463549865|FG000|Open Label Phase|Lost to Follow-up|0|||
128796461|NCT00232180|463549866|FG001|Open Label Phase|Lost to Follow-up|0|||
128796462|NCT00232180|463549867|FG002|Open Label Phase|Lost to Follow-up|5|||
128796463|NCT00232180|463549865|FG000|Open Label Phase|Protocol Violation|0|||
128796464|NCT00232180|463549866|FG001|Open Label Phase|Protocol Violation|0|||
128796465|NCT00232180|463549867|FG002|Open Label Phase|Protocol Violation|3|||
128796466|NCT00232180|463549865|FG000|Open Label Phase|Study terminated by sponsor|0|||
128796467|NCT00232180|463549866|FG001|Open Label Phase|Study terminated by sponsor|0|||
128796468|NCT00232180|463549867|FG002|Open Label Phase|Study terminated by sponsor|3|||
128796469|NCT00232180|463549865|FG000|Open Label Phase|Withdrawal by Subject|0|||
128796470|NCT00232180|463549866|FG001|Open Label Phase|Withdrawal by Subject|0|||
128796471|NCT00232180|463549867|FG002|Open Label Phase|Withdrawal by Subject|37|||
128796472|NCT00232180|463549865|FG000|Open Label Phase|Other|0|||
128796473|NCT00232180|463549866|FG001|Open Label Phase|Other|0|||
128796474|NCT00232180|463549867|FG002|Open Label Phase|Other|16|||
128796475|NCT00232180|463549865|FG000|Open Label Phase|Adverse Event|0|||
128796476|NCT00232180|463549866|FG001|Open Label Phase|Adverse Event|0|||
128796477|NCT00232180|463549867|FG002|Open Label Phase|Adverse Event|25|||
128796478|NCT00232180|463549865|FG000|Open Label Phase|Laboratory abnormality|0|||
128796479|NCT00232180|463549866|FG001|Open Label Phase|Laboratory abnormality|0|||
128796480|NCT00232180|463549867|FG002|Open Label Phase|Laboratory abnormality|10|||
128796481|NCT00232180|463549865|FG000|Open Label Phase|Randomized but not treated|0|||
128796482|NCT00232180|463549866|FG001|Open Label Phase|Randomized but not treated|0|||
128796483|NCT00232180|463549867|FG002|Open Label Phase|Randomized but not treated|1|||
128796484|NCT03452189|463549868|FG000|First Intervention (3 Months)|Adverse Event|1|||
128796485|NCT03452189|463549869|FG001|First Intervention (3 Months)|Adverse Event|0|||
128796486|NCT03452189|463549868|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
128796487|NCT03452189|463549869|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
128796488|NCT01571596|463549872|FG000|Overall Study|Adverse Event|2|||
128796489|NCT01571596|463549873|FG001|Overall Study|Adverse Event|0|||
128796490|NCT01571596|463549874|FG002|Overall Study|Adverse Event|0|||
128796491|NCT01571596|463549872|FG000|Overall Study|Study Terminated by the Sponsor|0|||
128796492|NCT01571596|463549873|FG001|Overall Study|Study Terminated by the Sponsor|1|||
128796493|NCT01571596|463549874|FG002|Overall Study|Study Terminated by the Sponsor|1|||
128796494|NCT02767765|463549875|FG000|Overall Study|Adverse Event|4|||
128796495|NCT02767765|463549875|FG000|Overall Study|Death|1|||
128796496|NCT02767765|463549875|FG000|Overall Study|Insufficient response|1|||
128796497|NCT02767765|463549875|FG000|Overall Study|Lost to Follow-up|2|||
128796498|NCT02767765|463549875|FG000|Overall Study|Investigator decision|1|||
128796499|NCT02767765|463549875|FG000|Overall Study|Non-Compliance|1|||
128796500|NCT02767765|463549875|FG000|Overall Study|Withdrawal by Subject|1|||
128796501|NCT01951170|463549876|FG000|Overall Study|Investigator decision|1|||
128796502|NCT02706717|463549880|FG000|Overall Study|Withdrawal by Subject|1|||
128796503|NCT02706717|463549881|FG001|Overall Study|Withdrawal by Subject|8|||
128796504|NCT02706717|463549880|FG000|Overall Study|Lost to Follow-up|0|||
128796505|NCT02706717|463549881|FG001|Overall Study|Lost to Follow-up|1|||
128796506|NCT02706717|463549880|FG000|Overall Study|Physician Decision|0|||
128796507|NCT02706717|463549881|FG001|Overall Study|Physician Decision|1|||
128796508|NCT02706717|463549880|FG000|Overall Study|Death|0|||
128796509|NCT02706717|463549881|FG001|Overall Study|Death|1|||
128796510|NCT02512965|463549886|FG000|Overall Study|Withdrawal by Subject|0|||
128796511|NCT02512965|463549887|FG001|Overall Study|Withdrawal by Subject|4|||
128796512|NCT00835770|463549888|FG000|Overall Study|MS Relapse|17|||
128796513|NCT00835770|463549889|FG001|Overall Study|MS Relapse|23|||
128796514|NCT00835770|463549888|FG000|Overall Study|MS Progression|14|||
128796515|NCT00835770|463549889|FG001|Overall Study|MS Progression|9|||
128796516|NCT00835770|463549888|FG000|Overall Study|Adverse Event|113|||
128796517|NCT00835770|463549889|FG001|Overall Study|Adverse Event|124|||
128796518|NCT00835770|463549888|FG000|Overall Study|Lost to Follow-up|22|||
128796519|NCT00835770|463549889|FG001|Overall Study|Lost to Follow-up|19|||
128796520|NCT00835770|463549888|FG000|Overall Study|Consent Withdrawn|144|||
128796521|NCT00835770|463549889|FG001|Overall Study|Consent Withdrawn|156|||
128796522|NCT00835770|463549888|FG000|Overall Study|Investigator Decision|42|||
128796523|NCT00835770|463549889|FG001|Overall Study|Investigator Decision|42|||
128796524|NCT00835770|463549888|FG000|Overall Study|Participant Non-Compliance|11|||
128796525|NCT00835770|463549889|FG001|Overall Study|Participant Non-Compliance|9|||
128796526|NCT00835770|463549888|FG000|Overall Study|Death|4|||
128796527|NCT00835770|463549889|FG001|Overall Study|Death|6|||
128796528|NCT00835770|463549888|FG000|Overall Study|Other|115|||
128796529|NCT00835770|463549889|FG001|Overall Study|Other|104|||
128796530|NCT00835770|463549888|FG000|Overall Study|Other|2|||
128796531|NCT00835770|463549889|FG001|Overall Study|Other|1|||
128796532|NCT01185782|463549890|FG000|Overall Study|Adverse Event|0|||
128796533|NCT01185782|463549891|FG001|Overall Study|Adverse Event|1|||
128796534|NCT01185782|463549890|FG000|Overall Study|Protocol Violation|1|||
128796535|NCT01185782|463549891|FG001|Overall Study|Protocol Violation|0|||
128796536|NCT01185782|463549890|FG000|Overall Study|Poor Response to Treatment|3|||
128796537|NCT01185782|463549891|FG001|Overall Study|Poor Response to Treatment|1|||
128796538|NCT01185782|463549890|FG000|Overall Study|Other|2|||
128796539|NCT01185782|463549891|FG001|Overall Study|Other|5|||
128796540|NCT01185782|463549890|FG000|Overall Study|Randomized but not treated|0|||
128796541|NCT01185782|463549891|FG001|Overall Study|Randomized but not treated|4|||
128796542|NCT04530747|463549898|FG000|Overall Study|Withdrawal by Subject|1|||
128796543|NCT04530747|463549899|FG001|Overall Study|Withdrawal by Subject|0|||
128796544|NCT03292913|463549900|FG000|Overall Study|Death|9|||
128796545|NCT03292913|463549901|FG001|Overall Study|Death|3|||
128796546|NCT03292913|463549900|FG000|Overall Study|Lost to Follow-up|49|||
128796547|NCT03292913|463549901|FG001|Overall Study|Lost to Follow-up|49|||
128796548|NCT03292913|463549900|FG000|Overall Study|Withdrawal by Subject|2|||
128796549|NCT03292913|463549901|FG001|Overall Study|Withdrawal by Subject|0|||
128796550|NCT03292913|463549900|FG000|Overall Study|Clinic closed due to COVID|22|||
128796551|NCT03292913|463549901|FG001|Overall Study|Clinic closed due to COVID|36|||
128796552|NCT03950622|463549902|FG000|Overall Study|Withdrawal by Subject|1|||
128796553|NCT03950622|463549903|FG001|Overall Study|Withdrawal by Subject|0|||
128796554|NCT03950622|463549902|FG000|Overall Study|Protocol Deviation|0|||
128796555|NCT03950622|463549903|FG001|Overall Study|Protocol Deviation|1|||
128796556|NCT03950622|463549902|FG000|Overall Study|Physician Decision|1|||
128796557|NCT03950622|463549903|FG001|Overall Study|Physician Decision|0|||
128796558|NCT03950622|463549902|FG000|Overall Study|Lost to Follow-up|5|||
128796559|NCT03950622|463549903|FG001|Overall Study|Lost to Follow-up|5|||
128796560|NCT03950622|463549902|FG000|Overall Study|Death|1|||
128796561|NCT03950622|463549903|FG001|Overall Study|Death|1|||
128796562|NCT00529516|463549904|FG000|Overall Study|Adverse Event|2|||
128796563|NCT00529516|463549905|FG001|Overall Study|Adverse Event|1|||
128796564|NCT00529516|463549906|FG002|Overall Study|Adverse Event|0|||
128796565|NCT00529516|463549904|FG000|Overall Study|Withdrawal by Subject|1|||
128796566|NCT00529516|463549905|FG001|Overall Study|Withdrawal by Subject|1|||
128796567|NCT00529516|463549906|FG002|Overall Study|Withdrawal by Subject|0|||
128796568|NCT00529516|463549904|FG000|Overall Study|Lost to Follow-up|0|||
128796569|NCT00529516|463549905|FG001|Overall Study|Lost to Follow-up|0|||
128796570|NCT00529516|463549906|FG002|Overall Study|Lost to Follow-up|1|||
128796571|NCT03752151|463549907|FG000|Overall Study|Withdrawal by Subject|1|||
128796572|NCT03752151|463549907|FG000|Overall Study|Protocol Violation|1|||
128796573|NCT03051165|463549910|FG000|Overall Study|Withdrawal by Subject|1|||
128796574|NCT03051165|463549910|FG000|Overall Study|Early termination of study|12|||
128796575|NCT03074331|463549912|FG000|Overall Study|Enrolled but Not Treated|1|||
128796576|NCT03074331|463549912|FG000|Overall Study|Lost to Follow-up|5|||
128796577|NCT03074331|463549912|FG000|Overall Study|Withdrew Consent|1|||
128796578|NCT01546753|463549917|FG000|Overall Study|anxiety|1|||
128796579|NCT01546753|463549918|FG001|Overall Study|anxiety|1|||
128796580|NCT01546753|463549917|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
128796581|NCT01546753|463549918|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
128796582|NCT00546754|463549922|FG000|Overall Study|Serious Adverse Event|1|||
128796583|NCT00546754|463549923|FG001|Overall Study|Serious Adverse Event|1|||
128796584|NCT00546754|463549922|FG000|Overall Study|Adverse Event|11|||
128796585|NCT00546754|463549923|FG001|Overall Study|Adverse Event|16|||
128796586|NCT00546754|463549922|FG000|Overall Study|Lack of Efficacy|1|||
128796587|NCT00546754|463549923|FG001|Overall Study|Lack of Efficacy|1|||
128796588|NCT00546754|463549922|FG000|Overall Study|Lost to Follow-up|9|||
128796589|NCT00546754|463549923|FG001|Overall Study|Lost to Follow-up|15|||
128796590|NCT00546754|463549922|FG000|Overall Study|Protocol Violation|3|||
128796591|NCT00546754|463549923|FG001|Overall Study|Protocol Violation|0|||
128796592|NCT00546754|463549922|FG000|Overall Study|Withdrawal by Subject|6|||
128796593|NCT00546754|463549923|FG001|Overall Study|Withdrawal by Subject|7|||
128796594|NCT00546754|463549922|FG000|Overall Study|Dyspnea|1|||
128796595|NCT00546754|463549923|FG001|Overall Study|Dyspnea|0|||
128796596|NCT00546754|463549922|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
128796597|NCT00546754|463549923|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
128796598|NCT00546754|463549922|FG000|Overall Study|Hip Replacement|1|||
128796599|NCT00546754|463549923|FG001|Overall Study|Hip Replacement|0|||
128796600|NCT00546754|463549922|FG000|Overall Study|Suicide|1|||
128796601|NCT00546754|463549923|FG001|Overall Study|Suicide|0|||
128796602|NCT00546754|463549922|FG000|Overall Study|Missing Cooperation|1|||
128796603|NCT00546754|463549923|FG001|Overall Study|Missing Cooperation|0|||
128796604|NCT00546754|463549922|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
128796605|NCT00546754|463549923|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
128796606|NCT00546754|463549922|FG000|Overall Study|Patient's Decision|0|||
128796607|NCT00546754|463549923|FG001|Overall Study|Patient's Decision|1|||
128796608|NCT00546754|463549922|FG000|Overall Study|Missing|14|||
128796609|NCT00546754|463549923|FG001|Overall Study|Missing|7|||
128796610|NCT03830866|463549926|FG000|Overall Study|Death|90|||
128796611|NCT03830866|463549927|FG001|Overall Study|Death|111|||
128796612|NCT03830866|463549926|FG000|Overall Study|Lost to Follow-up|7|||
128796613|NCT03830866|463549927|FG001|Overall Study|Lost to Follow-up|7|||
128796614|NCT03830866|463549926|FG000|Overall Study|Withdrawal by Subject|19|||
128796615|NCT03830866|463549927|FG001|Overall Study|Withdrawal by Subject|16|||
128796616|NCT03830866|463549926|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
128796617|NCT03830866|463549927|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
128796618|NCT03830866|463549926|FG000|Overall Study|Other|1|||
128796619|NCT03830866|463549927|FG001|Overall Study|Other|1|||
128796620|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
128796621|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
128796622|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
128796623|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
128796624|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
128796625|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
128796626|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
128796627|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
128796628|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
128796629|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
128796630|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
128796631|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
128796632|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
128796633|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
128796634|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
128796635|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
128796636|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
128796637|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
128796638|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
128796639|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
128796640|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
128796641|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
128796642|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
128796643|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
128796644|NCT00311363|463549928|FG000|24-Week Single-Blind Treatment Period|Death|1|||
128796645|NCT00311363|463549929|FG001|24-Week Single-Blind Treatment Period|Death|0|||
128796646|NCT00311363|463549930|FG002|24-Week Single-Blind Treatment Period|Death|0|||
128796647|NCT00311363|463549928|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
128796648|NCT00311363|463549929|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
128796649|NCT00311363|463549930|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
128796650|NCT00311363|463549928|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
128796651|NCT00311363|463549929|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
128796652|NCT00311363|463549930|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
128796653|NCT00311363|463549928|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
128796654|NCT00311363|463549929|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
128796655|NCT00311363|463549930|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
128796656|NCT00311363|463549928|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
128796657|NCT00311363|463549929|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
128796658|NCT00311363|463549930|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
128796659|NCT00311363|463549928|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
128796660|NCT00311363|463549929|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
128796661|NCT00311363|463549930|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
128796662|NCT00311363|463549928|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
128796663|NCT00311363|463549929|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
128796664|NCT00311363|463549930|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
128796665|NCT03764475|463549932|FG000|Overall Study|Adverse Event|11|||
128796666|NCT03764475|463549933|FG001|Overall Study|Adverse Event|2|||
128796667|NCT03764475|463549932|FG000|Overall Study|Lost to Follow-up|24|||
128796668|NCT03764475|463549933|FG001|Overall Study|Lost to Follow-up|10|||
128796669|NCT03764475|463549932|FG000|Overall Study|Withdrawal by Subject|26|||
128796670|NCT03764475|463549933|FG001|Overall Study|Withdrawal by Subject|10|||
128796671|NCT03764475|463549932|FG000|Overall Study|Lack of Efficacy|3|||
128796672|NCT03764475|463549933|FG001|Overall Study|Lack of Efficacy|0|||
128796673|NCT03764475|463549932|FG000|Overall Study|COVID-19 Disruption|2|||
128796674|NCT03764475|463549933|FG001|Overall Study|COVID-19 Disruption|0|||
128796675|NCT05510245|463549934|FG000|Overall Study|Withdrawal by Subject|1|||
128796676|NCT05510245|463549935|FG001|Overall Study|Withdrawal by Subject|0|||
128796677|NCT05510245|463549936|FG002|Overall Study|Withdrawal by Subject|0|||
128796678|NCT03942042|463549940|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
128796679|NCT03942042|463549941|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
128796680|NCT03942042|463549940|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
128796681|NCT03942042|463549941|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
128796682|NCT01692730|463549949|FG000|Overall Study|Lost to Follow-up|225|||
128796683|NCT01692730|463549950|FG001|Overall Study|Lost to Follow-up|227|||
128796684|NCT01849055|463549951|FG000|Overall Study|Withdrawal by Subject|0|||
128796685|NCT01849055|463549952|FG001|Overall Study|Withdrawal by Subject|0|||
128796686|NCT01849055|463549953|FG002|Overall Study|Withdrawal by Subject|1|||
128796687|NCT01849055|463549954|FG003|Overall Study|Withdrawal by Subject|0|||
128796688|NCT01849055|463549955|FG004|Overall Study|Withdrawal by Subject|0|||
128796689|NCT01849055|463549956|FG005|Overall Study|Withdrawal by Subject|0|||
128796690|NCT01239316|463549957|FG000|Overall Study|Progression/Relapse|11|||
128796691|NCT01239316|463549957|FG000|Overall Study|Adverse Event|1|||
128796692|NCT02139943|463549958|FG000|Overall Study|Adverse Event|0|||
128796693|NCT02139943|463549959|FG001|Overall Study|Adverse Event|1|||
128796694|NCT02139943|463549960|FG002|Overall Study|Adverse Event|2|||
128796695|NCT02139943|463549958|FG000|Overall Study|Lost to Follow-up|3|||
128796696|NCT02139943|463549959|FG001|Overall Study|Lost to Follow-up|2|||
128796697|NCT02139943|463549960|FG002|Overall Study|Lost to Follow-up|2|||
128796698|NCT02139943|463549958|FG000|Overall Study|Withdrawal by Subject|4|||
128796699|NCT02139943|463549959|FG001|Overall Study|Withdrawal by Subject|3|||
128796700|NCT02139943|463549960|FG002|Overall Study|Withdrawal by Subject|0|||
128796701|NCT02139943|463549958|FG000|Overall Study|Other|0|||
128796702|NCT02139943|463549959|FG001|Overall Study|Other|0|||
128796703|NCT02139943|463549960|FG002|Overall Study|Other|1|||
128796704|NCT02139943|463549958|FG000|Overall Study|Participant wishes to discontinue|2|||
128796705|NCT02139943|463549959|FG001|Overall Study|Participant wishes to discontinue|0|||
128796706|NCT02139943|463549960|FG002|Overall Study|Participant wishes to discontinue|0|||
128796707|NCT02139943|463549958|FG000|Overall Study|Participant in Poor Compliance|1|||
128796708|NCT02139943|463549959|FG001|Overall Study|Participant in Poor Compliance|0|||
128796709|NCT02139943|463549960|FG002|Overall Study|Participant in Poor Compliance|1|||
128796710|NCT02139943|463549958|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
128796711|NCT02139943|463549959|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
128796712|NCT02139943|463549960|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
128796713|NCT03750968|463549961|FG000|Overall Study|Adverse Event|2|||
128796714|NCT03750968|463549962|FG001|Overall Study|Adverse Event|0|||
128796715|NCT03750968|463549961|FG000|Overall Study|Lost to Follow-up|1|||
128796716|NCT03750968|463549962|FG001|Overall Study|Lost to Follow-up|3|||
128796717|NCT04411056|463551669|FG000|Overall Study|surgery cancelled|1|||
128796718|NCT04411056|463551670|FG001|Overall Study|surgery cancelled|0|||
128796719|NCT04411056|463551669|FG000|Overall Study|Equipment problem during intubation|0|||
128796720|NCT04411056|463551670|FG001|Overall Study|Equipment problem during intubation|1|||
128796721|NCT03122886|463551674|FG000|Overall Study|Withdrawal by Subject|1|||
128796722|NCT03122886|463551675|FG001|Overall Study|Withdrawal by Subject|2|||
128796723|NCT03422276|463551676|FG000|Overall Study|Withdrawal by Subject|21|||
128796724|NCT03422276|463551677|FG001|Overall Study|Withdrawal by Subject|25|||
128796725|NCT03422276|463551678|FG002|Overall Study|Withdrawal by Subject|14|||
128796726|NCT03422276|463551679|FG003|Overall Study|Withdrawal by Subject|16|||
128796727|NCT03422276|463551676|FG000|Overall Study|Death|14|||
128796728|NCT03422276|463551677|FG001|Overall Study|Death|21|||
128796729|NCT03422276|463551678|FG002|Overall Study|Death|3|||
128796730|NCT03422276|463551679|FG003|Overall Study|Death|1|||
128796731|NCT03422276|463551676|FG000|Overall Study|Discontinued, ineligible|4|||
128796732|NCT03422276|463551677|FG001|Overall Study|Discontinued, ineligible|3|||
128796733|NCT03422276|463551678|FG002|Overall Study|Discontinued, ineligible|0|||
128796734|NCT03422276|463551679|FG003|Overall Study|Discontinued, ineligible|0|||
128796735|NCT03422276|463551676|FG000|Overall Study|Lost to Follow-up|15|||
128796736|NCT03422276|463551677|FG001|Overall Study|Lost to Follow-up|8|||
128796737|NCT03422276|463551678|FG002|Overall Study|Lost to Follow-up|13|||
128796738|NCT03422276|463551679|FG003|Overall Study|Lost to Follow-up|4|||
128796739|NCT03422276|463551676|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
128796740|NCT03422276|463551677|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
128796741|NCT03422276|463551678|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
128796742|NCT03422276|463551679|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
128796743|NCT03422276|463551676|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
128796744|NCT03422276|463551677|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
128796745|NCT03422276|463551678|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
128796746|NCT03422276|463551679|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
128796747|NCT03422276|463551676|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
128796748|NCT03422276|463551677|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
128796749|NCT03422276|463551678|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
128796750|NCT03422276|463551679|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
128796751|NCT03422276|463551676|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
128796752|NCT03422276|463551677|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
128796753|NCT03422276|463551678|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
128796754|NCT03422276|463551679|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
128796755|NCT03422276|463551676|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
128796756|NCT03422276|463551677|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
128796757|NCT03422276|463551678|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
128796758|NCT03422276|463551679|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
128796759|NCT05985044|463551680|FG000|Overall Study|Death|6|||
128796760|NCT05985044|463551680|FG000|Overall Study|Lost to Follow-up|4|||
128796761|NCT05985044|463551680|FG000|Overall Study|Incapacitation|3|||
128796762|NCT05985044|463551680|FG000|Overall Study|Withdrawal by Subject|2|||
128796763|NCT02279095|463551683|FG000|Overall Study|Non-Compliance|1|||
128796764|NCT02279095|463551683|FG000|Overall Study|Withdrawal by Subject|8|||
128796765|NCT02279095|463551683|FG000|Overall Study|Adverse Event|2|||
128796766|NCT02279095|463551683|FG000|Overall Study|Other|7|||
128796767|NCT02279095|463551683|FG000|Overall Study|Lost to Follow-up|1|||
128796768|NCT05644444|463551688|FG000|Tolerance Phase|Adverse Event|0|||
128796769|NCT05644444|463551689|FG001|Tolerance Phase|Adverse Event|2|||
128796770|NCT05644444|463551688|FG000|Treatment Phase|Adverse Event|0|||
128796771|NCT05644444|463551689|FG001|Treatment Phase|Adverse Event|2|||
128796772|NCT04817670|463551690|FG000|Overall Study|Withdrawal by Subject|1|||
128796773|NCT04817670|463551691|FG001|Overall Study|Withdrawal by Subject|0|||
128796774|NCT04817670|463551692|FG002|Overall Study|Withdrawal by Subject|0|||
128796775|NCT04817670|463551693|FG003|Overall Study|Withdrawal by Subject|0|||
128796776|NCT04817670|463551694|FG004|Overall Study|Withdrawal by Subject|0|||
128796777|NCT04817670|463551690|FG000|Overall Study|Lost to Follow-up|0|||
128796778|NCT04817670|463551691|FG001|Overall Study|Lost to Follow-up|0|||
128796779|NCT04817670|463551692|FG002|Overall Study|Lost to Follow-up|1|||
128796780|NCT04817670|463551693|FG003|Overall Study|Lost to Follow-up|0|||
128796781|NCT04817670|463551694|FG004|Overall Study|Lost to Follow-up|0|||
128796782|NCT03312907|463551695|FG000|Overall Study|Adverse Event|1|||
128796783|NCT03312907|463551696|FG001|Overall Study|Adverse Event|6|||
128796784|NCT03312907|463551697|FG002|Overall Study|Adverse Event|1|||
128796785|NCT03312907|463551695|FG000|Overall Study|Protocol Violation|2|||
128796786|NCT03312907|463551696|FG001|Overall Study|Protocol Violation|3|||
128796787|NCT03312907|463551697|FG002|Overall Study|Protocol Violation|4|||
128796788|NCT03312907|463551695|FG000|Overall Study|Lost to Follow-up|2|||
128796789|NCT03312907|463551696|FG001|Overall Study|Lost to Follow-up|3|||
128796790|NCT03312907|463551697|FG002|Overall Study|Lost to Follow-up|2|||
128796791|NCT03312907|463551695|FG000|Overall Study|Physician Decision|3|||
128796792|NCT03312907|463551696|FG001|Overall Study|Physician Decision|4|||
128796793|NCT03312907|463551697|FG002|Overall Study|Physician Decision|2|||
128796794|NCT03312907|463551695|FG000|Overall Study|Withdrawal by Subject|9|||
128796795|NCT03312907|463551696|FG001|Overall Study|Withdrawal by Subject|14|||
128796796|NCT03312907|463551697|FG002|Overall Study|Withdrawal by Subject|10|||
128796797|NCT04723394|463551709|FG000|Overall Study|Adverse Event|0|||
128796798|NCT04723394|463551710|FG001|Overall Study|Adverse Event|3|||
128796799|NCT04723394|463551709|FG000|Overall Study|Death|8|||
128796800|NCT04723394|463551710|FG001|Overall Study|Death|8|||
128796801|NCT04723394|463551709|FG000|Overall Study|Lost to Follow-up|20|||
128796802|NCT04723394|463551710|FG001|Overall Study|Lost to Follow-up|17|||
128796803|NCT04723394|463551709|FG000|Overall Study|Physician Decision|1|||
128796804|NCT04723394|463551710|FG001|Overall Study|Physician Decision|0|||
128796805|NCT04723394|463551709|FG000|Overall Study|Withdrawal by Subject|20|||
128796806|NCT04723394|463551710|FG001|Overall Study|Withdrawal by Subject|34|||
128796807|NCT04723394|463551709|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
128796808|NCT04723394|463551710|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
128796809|NCT00774397|463551711|FG000|Overall Study|Adverse Event|1|||
128796810|NCT00774397|463551712|FG001|Overall Study|Adverse Event|3|||
128796811|NCT00774397|463551713|FG002|Overall Study|Adverse Event|16|||
128796812|NCT00774397|463551714|FG003|Overall Study|Adverse Event|8|||
128796813|NCT00774397|463551715|FG004|Overall Study|Adverse Event|8|||
128796814|NCT00774397|463551716|FG005|Overall Study|Adverse Event|3|||
128796815|NCT00774397|463551717|FG006|Overall Study|Adverse Event|16|||
128796816|NCT00774397|463551711|FG000|Overall Study|Lack of Efficacy|11|||
128796817|NCT00774397|463551712|FG001|Overall Study|Lack of Efficacy|4|||
128796818|NCT00774397|463551713|FG002|Overall Study|Lack of Efficacy|5|||
128796819|NCT00774397|463551714|FG003|Overall Study|Lack of Efficacy|3|||
128796820|NCT00774397|463551715|FG004|Overall Study|Lack of Efficacy|27|||
128796821|NCT00774397|463551716|FG005|Overall Study|Lack of Efficacy|15|||
128796822|NCT00774397|463551717|FG006|Overall Study|Lack of Efficacy|9|||
128796823|NCT00774397|463551711|FG000|Overall Study|Protocol Violation|0|||
128796824|NCT00774397|463551712|FG001|Overall Study|Protocol Violation|1|||
128796825|NCT00774397|463551713|FG002|Overall Study|Protocol Violation|3|||
128796826|NCT00774397|463551714|FG003|Overall Study|Protocol Violation|1|||
128796827|NCT00774397|463551715|FG004|Overall Study|Protocol Violation|2|||
128796828|NCT00774397|463551716|FG005|Overall Study|Protocol Violation|1|||
128796829|NCT00774397|463551717|FG006|Overall Study|Protocol Violation|0|||
128796830|NCT00774397|463551711|FG000|Overall Study|Lost to Follow-up|0|||
128796831|NCT00774397|463551712|FG001|Overall Study|Lost to Follow-up|1|||
128796832|NCT00774397|463551713|FG002|Overall Study|Lost to Follow-up|1|||
128796833|NCT00774397|463551714|FG003|Overall Study|Lost to Follow-up|1|||
128796834|NCT00774397|463551715|FG004|Overall Study|Lost to Follow-up|0|||
128796835|NCT00774397|463551716|FG005|Overall Study|Lost to Follow-up|1|||
128796836|NCT00774397|463551717|FG006|Overall Study|Lost to Follow-up|0|||
128796837|NCT00774397|463551711|FG000|Overall Study|Refused to continue trial medication|1|||
128796838|NCT00774397|463551712|FG001|Overall Study|Refused to continue trial medication|3|||
128796839|NCT00774397|463551713|FG002|Overall Study|Refused to continue trial medication|2|||
128796840|NCT00774397|463551714|FG003|Overall Study|Refused to continue trial medication|2|||
128796841|NCT00774397|463551715|FG004|Overall Study|Refused to continue trial medication|6|||
128796842|NCT00774397|463551716|FG005|Overall Study|Refused to continue trial medication|2|||
128796843|NCT00774397|463551717|FG006|Overall Study|Refused to continue trial medication|3|||
128796844|NCT00774397|463551711|FG000|Overall Study|Not treated|0|||
128796845|NCT00774397|463551712|FG001|Overall Study|Not treated|0|||
128796846|NCT00774397|463551713|FG002|Overall Study|Not treated|0|||
128796847|NCT00774397|463551714|FG003|Overall Study|Not treated|0|||
128796848|NCT00774397|463551715|FG004|Overall Study|Not treated|1|||
128796849|NCT00774397|463551716|FG005|Overall Study|Not treated|0|||
128796850|NCT00774397|463551717|FG006|Overall Study|Not treated|1|||
128796851|NCT00774397|463551711|FG000|Overall Study|Other than those stated above|1|||
128796852|NCT00774397|463551712|FG001|Overall Study|Other than those stated above|1|||
128796853|NCT00774397|463551713|FG002|Overall Study|Other than those stated above|3|||
128796854|NCT00774397|463551714|FG003|Overall Study|Other than those stated above|2|||
128796855|NCT00774397|463551715|FG004|Overall Study|Other than those stated above|2|||
128796856|NCT00774397|463551716|FG005|Overall Study|Other than those stated above|0|||
128796857|NCT00774397|463551717|FG006|Overall Study|Other than those stated above|1|||
128796858|NCT00077675|463551723|FG000|Overall Study|Adverse Event|1|||
128796859|NCT00077675|463551724|FG001|Overall Study|Adverse Event|2|||
128796860|NCT00077675|463551723|FG000|Overall Study|Lost to Follow-up|6|||
128796861|NCT00077675|463551724|FG001|Overall Study|Lost to Follow-up|3|||
128796862|NCT00077675|463551723|FG000|Overall Study|Withdrawal by Subject|1|||
128796863|NCT00077675|463551724|FG001|Overall Study|Withdrawal by Subject|0|||
128796864|NCT00077675|463551723|FG000|Overall Study|Other|0|||
128796865|NCT00077675|463551724|FG001|Overall Study|Other|1|||
128796866|NCT00077675|463551723|FG000|Overall Study|Never received study treatment|3|||
128796867|NCT00077675|463551724|FG001|Overall Study|Never received study treatment|3|||
128796868|NCT02765100|463551727|FG000|Overall Study|subject found ineligible after baseline|1|||
128796869|NCT02765100|463551728|FG001|Overall Study|subject found ineligible after baseline|1|||
128796870|NCT02765100|463551727|FG000|Overall Study|Lost to Follow-up|0|||
128796871|NCT02765100|463551728|FG001|Overall Study|Lost to Follow-up|1|||
128796872|NCT02675244|463551729|FG000|Overall Study|Death|9|||
128796873|NCT02675244|463551730|FG001|Overall Study|Death|6|||
128796874|NCT02675244|463551729|FG000|Overall Study|Withdrawal by Subject|3|||
128796875|NCT02675244|463551730|FG001|Overall Study|Withdrawal by Subject|6|||
128796876|NCT02675244|463551729|FG000|Overall Study|Lost to Follow-up|1|||
128796877|NCT02675244|463551730|FG001|Overall Study|Lost to Follow-up|1|||
128796878|NCT02675244|463551729|FG000|Overall Study|Ongoing at 2 Years|190|||
128796879|NCT02675244|463551730|FG001|Overall Study|Ongoing at 2 Years|185|||
128796880|NCT02652442|463551731|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
128796881|NCT00293293|463551734|FG000|Overall Study|Withdrawal by Subject|1|||
128796882|NCT00293293|463551735|FG001|Overall Study|Withdrawal by Subject|1|||
128796883|NCT00293293|463551734|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
128796884|NCT00293293|463551735|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
128796885|NCT00293293|463551734|FG000|Overall Study|Patient discontinued chemotherapy|0|||
128796886|NCT00293293|463551735|FG001|Overall Study|Patient discontinued chemotherapy|1|||
128796887|NCT01061151|463551739|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
128796888|NCT01061151|463551740|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
128796889|NCT01061151|463551741|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
128796890|NCT01061151|463551742|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
128796891|NCT01061151|463551739|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
128796892|NCT01061151|463551740|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
128796893|NCT01061151|463551741|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
128796894|NCT01061151|463551742|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
128796895|NCT01061151|463551739|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
128796896|NCT01061151|463551740|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
128796897|NCT01061151|463551741|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
128796898|NCT01061151|463551742|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
128796899|NCT01061151|463551739|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
128796900|NCT01061151|463551740|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
128796901|NCT01061151|463551741|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
128796902|NCT01061151|463551742|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
128796903|NCT01061151|463551739|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
128796904|NCT01061151|463551740|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
128796905|NCT01061151|463551741|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
128796906|NCT01061151|463551742|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
128796907|NCT01061151|463551739|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
128796908|NCT01061151|463551740|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
128796909|NCT01061151|463551741|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
128796910|NCT01061151|463551742|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
128796911|NCT01061151|463551739|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
128796912|NCT01061151|463551740|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
128796913|NCT01061151|463551741|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
128796914|NCT01061151|463551742|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
128796915|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
128796916|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
128796917|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
128796918|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
128796919|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
128796920|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
128796921|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
128796922|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
128796923|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
128796924|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
128796925|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
128796926|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
128796927|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
128796928|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
128796929|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
128796930|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
128796931|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
128796932|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
128796933|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
128796934|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
128796935|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
128796936|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
128796937|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
128796938|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
128796939|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
128796940|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
128796941|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
128796942|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
128796943|NCT01061151|463551739|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
128796944|NCT01061151|463551740|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
128796945|NCT01061151|463551741|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
128796946|NCT01061151|463551742|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
128796947|NCT03740009|463551743|FG000|Overall Study|Physician Decision|9|||
128796948|NCT03740009|463551743|FG000|Overall Study|Lost to Follow-up|1|||
128796949|NCT02988817|463551744|FG000|Overall Study|Withdrawal by Subject|1|||
128796950|NCT02988817|463551745|FG001|Overall Study|Withdrawal by Subject|0|||
128796951|NCT02988817|463551746|FG002|Overall Study|Withdrawal by Subject|0|||
128796952|NCT02988817|463551747|FG003|Overall Study|Withdrawal by Subject|1|||
128796953|NCT02988817|463551748|FG004|Overall Study|Withdrawal by Subject|3|||
128796954|NCT02988817|463551749|FG005|Overall Study|Withdrawal by Subject|1|||
128796955|NCT02988817|463551750|FG006|Overall Study|Withdrawal by Subject|2|||
128796956|NCT02988817|463551751|FG007|Overall Study|Withdrawal by Subject|1|||
128796957|NCT02988817|463551752|FG008|Overall Study|Withdrawal by Subject|1|||
128796958|NCT02988817|463551753|FG009|Overall Study|Withdrawal by Subject|1|||
128796959|NCT02988817|463551754|FG010|Overall Study|Withdrawal by Subject|1|||
128796960|NCT02988817|463551755|FG011|Overall Study|Withdrawal by Subject|12|||
128796961|NCT02988817|463551756|FG012|Overall Study|Withdrawal by Subject|6|||
128796962|NCT02988817|463551757|FG013|Overall Study|Withdrawal by Subject|6|||
128796963|NCT02988817|463551758|FG014|Overall Study|Withdrawal by Subject|4|||
128796964|NCT02988817|463551759|FG015|Overall Study|Withdrawal by Subject|5|||
128796965|NCT02988817|463551760|FG016|Overall Study|Withdrawal by Subject|4|||
128796966|NCT02988817|463551761|FG017|Overall Study|Withdrawal by Subject|11|||
128796967|NCT02988817|463551762|FG018|Overall Study|Withdrawal by Subject|4|||
128796968|NCT02988817|463551763|FG019|Overall Study|Withdrawal by Subject|2|||
128796969|NCT02988817|463551744|FG000|Overall Study|Death|0|||
128796970|NCT02988817|463551745|FG001|Overall Study|Death|1|||
128796971|NCT02988817|463551746|FG002|Overall Study|Death|3|||
128796972|NCT02988817|463551747|FG003|Overall Study|Death|1|||
128796973|NCT02988817|463551748|FG004|Overall Study|Death|6|||
128796974|NCT02988817|463551749|FG005|Overall Study|Death|10|||
128796975|NCT02988817|463551750|FG006|Overall Study|Death|1|||
128796976|NCT02988817|463551751|FG007|Overall Study|Death|2|||
128796977|NCT02988817|463551752|FG008|Overall Study|Death|1|||
128796978|NCT02988817|463551753|FG009|Overall Study|Death|5|||
128796979|NCT02988817|463551754|FG010|Overall Study|Death|1|||
128796980|NCT02988817|463551755|FG011|Overall Study|Death|8|||
128796981|NCT02988817|463551756|FG012|Overall Study|Death|9|||
128796982|NCT02988817|463551757|FG013|Overall Study|Death|17|||
128796983|NCT02988817|463551758|FG014|Overall Study|Death|18|||
128796984|NCT02988817|463551759|FG015|Overall Study|Death|30|||
128796985|NCT02988817|463551760|FG016|Overall Study|Death|17|||
128796986|NCT02988817|463551761|FG017|Overall Study|Death|38|||
128796987|NCT02988817|463551762|FG018|Overall Study|Death|14|||
128796988|NCT02988817|463551763|FG019|Overall Study|Death|16|||
128796989|NCT02988817|463551744|FG000|Overall Study|Other|0|||
128796990|NCT02988817|463551745|FG001|Overall Study|Other|0|||
128796991|NCT02988817|463551746|FG002|Overall Study|Other|0|||
128796992|NCT02988817|463551747|FG003|Overall Study|Other|1|||
128796993|NCT02988817|463551748|FG004|Overall Study|Other|1|||
128796994|NCT02988817|463551749|FG005|Overall Study|Other|0|||
128796995|NCT02988817|463551750|FG006|Overall Study|Other|0|||
128796996|NCT02988817|463551751|FG007|Overall Study|Other|0|||
128796997|NCT02988817|463551752|FG008|Overall Study|Other|0|||
128796998|NCT02988817|463551753|FG009|Overall Study|Other|0|||
128796999|NCT02988817|463551754|FG010|Overall Study|Other|0|||
128797000|NCT02988817|463551755|FG011|Overall Study|Other|0|||
128797001|NCT02988817|463551756|FG012|Overall Study|Other|0|||
128797002|NCT02988817|463551757|FG013|Overall Study|Other|0|||
128797003|NCT02988817|463551758|FG014|Overall Study|Other|0|||
128797004|NCT02988817|463551759|FG015|Overall Study|Other|1|||
128797005|NCT02988817|463551760|FG016|Overall Study|Other|0|||
128797006|NCT02988817|463551761|FG017|Overall Study|Other|0|||
128797007|NCT02988817|463551762|FG018|Overall Study|Other|0|||
128797008|NCT02988817|463551763|FG019|Overall Study|Other|0|||
128797009|NCT02988817|463551744|FG000|Overall Study|Lost to Follow-up|0|||
128797010|NCT02988817|463551745|FG001|Overall Study|Lost to Follow-up|0|||
128797011|NCT02988817|463551746|FG002|Overall Study|Lost to Follow-up|0|||
128797012|NCT02988817|463551747|FG003|Overall Study|Lost to Follow-up|0|||
128797013|NCT02988817|463551748|FG004|Overall Study|Lost to Follow-up|0|||
128797014|NCT02988817|463551749|FG005|Overall Study|Lost to Follow-up|0|||
128797015|NCT02988817|463551750|FG006|Overall Study|Lost to Follow-up|0|||
128797016|NCT02988817|463551751|FG007|Overall Study|Lost to Follow-up|0|||
128797017|NCT02988817|463551752|FG008|Overall Study|Lost to Follow-up|1|||
128797018|NCT02988817|463551753|FG009|Overall Study|Lost to Follow-up|0|||
128797019|NCT02988817|463551754|FG010|Overall Study|Lost to Follow-up|1|||
128797020|NCT02988817|463551755|FG011|Overall Study|Lost to Follow-up|1|||
128797021|NCT02988817|463551756|FG012|Overall Study|Lost to Follow-up|0|||
128797022|NCT02988817|463551757|FG013|Overall Study|Lost to Follow-up|0|||
128797023|NCT02988817|463551758|FG014|Overall Study|Lost to Follow-up|1|||
128797024|NCT02988817|463551759|FG015|Overall Study|Lost to Follow-up|1|||
128797025|NCT02988817|463551760|FG016|Overall Study|Lost to Follow-up|2|||
128797026|NCT02988817|463551761|FG017|Overall Study|Lost to Follow-up|3|||
128797027|NCT02988817|463551762|FG018|Overall Study|Lost to Follow-up|0|||
128797028|NCT02988817|463551763|FG019|Overall Study|Lost to Follow-up|0|||
128797029|NCT02988817|463551744|FG000|Overall Study|Sponsor decision|0|||
128797030|NCT02988817|463551745|FG001|Overall Study|Sponsor decision|0|||
128797031|NCT02988817|463551746|FG002|Overall Study|Sponsor decision|0|||
128797032|NCT02988817|463551747|FG003|Overall Study|Sponsor decision|0|||
128797033|NCT02988817|463551748|FG004|Overall Study|Sponsor decision|0|||
128797034|NCT02988817|463551749|FG005|Overall Study|Sponsor decision|0|||
128797035|NCT02988817|463551750|FG006|Overall Study|Sponsor decision|0|||
128797036|NCT02988817|463551751|FG007|Overall Study|Sponsor decision|0|||
128797037|NCT02988817|463551752|FG008|Overall Study|Sponsor decision|0|||
128797038|NCT02988817|463551753|FG009|Overall Study|Sponsor decision|0|||
128797039|NCT02988817|463551754|FG010|Overall Study|Sponsor decision|0|||
128797040|NCT02988817|463551755|FG011|Overall Study|Sponsor decision|1|||
128797041|NCT02988817|463551756|FG012|Overall Study|Sponsor decision|1|||
128797042|NCT02988817|463551757|FG013|Overall Study|Sponsor decision|2|||
128797043|NCT02988817|463551758|FG014|Overall Study|Sponsor decision|2|||
128797044|NCT02988817|463551759|FG015|Overall Study|Sponsor decision|6|||
128797045|NCT02988817|463551760|FG016|Overall Study|Sponsor decision|2|||
128797046|NCT02988817|463551761|FG017|Overall Study|Sponsor decision|3|||
128797047|NCT02988817|463551762|FG018|Overall Study|Sponsor decision|2|||
128797048|NCT02988817|463551763|FG019|Overall Study|Sponsor decision|7|||
128797049|NCT02988817|463551744|FG000|Overall Study|Physician Decision|0|||
128797050|NCT02988817|463551745|FG001|Overall Study|Physician Decision|0|||
128797051|NCT02988817|463551746|FG002|Overall Study|Physician Decision|0|||
128797052|NCT02988817|463551747|FG003|Overall Study|Physician Decision|0|||
128797053|NCT02988817|463551748|FG004|Overall Study|Physician Decision|0|||
128797054|NCT02988817|463551749|FG005|Overall Study|Physician Decision|0|||
128797055|NCT02988817|463551750|FG006|Overall Study|Physician Decision|0|||
128797056|NCT02988817|463551751|FG007|Overall Study|Physician Decision|0|||
128797057|NCT02988817|463551752|FG008|Overall Study|Physician Decision|0|||
128797058|NCT02988817|463551753|FG009|Overall Study|Physician Decision|0|||
128797059|NCT02988817|463551754|FG010|Overall Study|Physician Decision|0|||
128797060|NCT02988817|463551755|FG011|Overall Study|Physician Decision|0|||
128797061|NCT02988817|463551756|FG012|Overall Study|Physician Decision|0|||
128797062|NCT02988817|463551757|FG013|Overall Study|Physician Decision|0|||
128797063|NCT02988817|463551758|FG014|Overall Study|Physician Decision|0|||
128797064|NCT02988817|463551759|FG015|Overall Study|Physician Decision|1|||
128797065|NCT02988817|463551760|FG016|Overall Study|Physician Decision|0|||
128797066|NCT02988817|463551761|FG017|Overall Study|Physician Decision|0|||
128797067|NCT02988817|463551762|FG018|Overall Study|Physician Decision|1|||
128797068|NCT02988817|463551763|FG019|Overall Study|Physician Decision|1|||
128797069|NCT02092116|463551766|FG000|Overall Study|Withdrawal by Subject|0|||
128797070|NCT02092116|463551767|FG001|Overall Study|Withdrawal by Subject|3|||
128797071|NCT02092116|463551766|FG000|Overall Study|Adverse Event|0|||
128797072|NCT02092116|463551767|FG001|Overall Study|Adverse Event|1|||
128797073|NCT03733119|463551768|FG000|Overall Study|Physician Decision|2|||
128797074|NCT03733119|463551769|FG001|Overall Study|Physician Decision|1|||
128797075|NCT03733119|463551768|FG000|Overall Study|ineligible to treat per protocol|0|||
128797076|NCT03733119|463551769|FG001|Overall Study|ineligible to treat per protocol|1|||
128797077|NCT00510887|463551777|FG000|Overall Study|Lost to Follow-up|1|||
128797078|NCT03485950|463551780|FG000|Overall Study|Adverse Event|1|||
128797079|NCT03485950|463551781|FG001|Overall Study|Adverse Event|0|||
128797080|NCT03485950|463551780|FG000|Overall Study|Death|3|||
128797081|NCT03485950|463551781|FG001|Overall Study|Death|2|||
128797082|NCT03485950|463551780|FG000|Overall Study|Withdrawal by Subject|3|||
128797083|NCT03485950|463551781|FG001|Overall Study|Withdrawal by Subject|0|||
128797084|NCT00988858|463551782|FG000|Overall Study|Adverse Event|7|||
128797085|NCT00988858|463551782|FG000|Overall Study|Death|1|||
128797086|NCT00988858|463551782|FG000|Overall Study|Physician Decision|1|||
128797087|NCT00988858|463551782|FG000|Overall Study|Sponsor Decision|1|||
128797088|NCT01759771|463551793|FG000|Overall Study|Withdrawal by Subject|1|||
128797089|NCT01759771|463551794|FG001|Overall Study|Withdrawal by Subject|1|||
128797090|NCT00088413|463551798|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
128797091|NCT00088413|463551799|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
128797092|NCT00088413|463551800|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
128797093|NCT00088413|463551801|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
128797094|NCT00088413|463551798|FG000|Overall Study|Adverse Events/Side Effects|0|||
128797095|NCT00088413|463551799|FG001|Overall Study|Adverse Events/Side Effects|1|||
128797096|NCT00088413|463551800|FG002|Overall Study|Adverse Events/Side Effects|1|||
128797097|NCT00088413|463551801|FG003|Overall Study|Adverse Events/Side Effects|0|||
128797098|NCT00088413|463551798|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
128797099|NCT00088413|463551799|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
128797100|NCT00088413|463551800|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
128797101|NCT00088413|463551801|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
128797102|NCT00088413|463551798|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
128797103|NCT00088413|463551799|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
128797104|NCT00088413|463551800|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
128797105|NCT00088413|463551801|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
128797106|NCT00088413|463551798|FG000|Overall Study|Death|0|||
128797107|NCT00088413|463551799|FG001|Overall Study|Death|1|||
128797108|NCT00088413|463551800|FG002|Overall Study|Death|0|||
128797109|NCT00088413|463551801|FG003|Overall Study|Death|0|||
128797110|NCT00088413|463551798|FG000|Overall Study|Progressive disease|9|||
128797111|NCT00088413|463551799|FG001|Overall Study|Progressive disease|11|||
128797112|NCT00088413|463551800|FG002|Overall Study|Progressive disease|8|||
128797113|NCT00088413|463551801|FG003|Overall Study|Progressive disease|14|||
128797114|NCT00088413|463551798|FG000|Overall Study|Other|0|||
128797115|NCT00088413|463551799|FG001|Overall Study|Other|1|||
128797116|NCT00088413|463551800|FG002|Overall Study|Other|0|||
128797117|NCT00088413|463551801|FG003|Overall Study|Other|0|||
128797118|NCT00088413|463551798|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
128797119|NCT00088413|463551799|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
128797120|NCT00088413|463551800|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
128797121|NCT00088413|463551801|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
128797122|NCT00632424|463551804|FG000|Overall Study|Disease Progression|17|||
128797123|NCT00632424|463551804|FG000|Overall Study|Study Drug Toxicity|1|||
128797124|NCT02531113|463551805|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
128797125|NCT02531113|463551805|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
128797126|NCT02531113|463551805|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
128797127|NCT02531113|463551805|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
128797128|NCT02531113|463551805|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
128797129|NCT02531113|463551805|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
128797130|NCT02531113|463551805|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
128797131|NCT02531113|463551805|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
128797132|NCT03807778|463551806|FG000|Overall Study|Adverse Event|0|||
128797133|NCT03807778|463551807|FG001|Overall Study|Adverse Event|0|||
128797134|NCT03807778|463551808|FG002|Overall Study|Adverse Event|3|||
128797135|NCT03807778|463551809|FG003|Overall Study|Adverse Event|5|||
128797136|NCT03807778|463551806|FG000|Overall Study|Progressive Disease|4|||
128797137|NCT03807778|463551807|FG001|Overall Study|Progressive Disease|2|||
128797138|NCT03807778|463551808|FG002|Overall Study|Progressive Disease|8|||
128797139|NCT03807778|463551809|FG003|Overall Study|Progressive Disease|15|||
128797140|NCT03807778|463551806|FG000|Overall Study|Symptomatic Deterioration|0|||
128797141|NCT03807778|463551807|FG001|Overall Study|Symptomatic Deterioration|1|||
128797142|NCT03807778|463551808|FG002|Overall Study|Symptomatic Deterioration|0|||
128797143|NCT03807778|463551809|FG003|Overall Study|Symptomatic Deterioration|1|||
128797144|NCT03807778|463551806|FG000|Overall Study|Withdrawal by Subject|0|||
128797145|NCT03807778|463551807|FG001|Overall Study|Withdrawal by Subject|1|||
128797146|NCT03807778|463551808|FG002|Overall Study|Withdrawal by Subject|0|||
128797147|NCT03807778|463551809|FG003|Overall Study|Withdrawal by Subject|1|||
128797148|NCT03807778|463551806|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
128797149|NCT03807778|463551807|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
128797150|NCT03807778|463551808|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
128797151|NCT03807778|463551809|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
128797152|NCT05938413|463553233|FG000|Overall Study|Lost to Follow-up|1|||
128797153|NCT05938413|463553234|FG001|Overall Study|Lost to Follow-up|7|||
128797154|NCT05938413|463553233|FG000|Overall Study|Withdrawal by Subject|1|||
128797155|NCT05938413|463553234|FG001|Overall Study|Withdrawal by Subject|1|||
128797156|NCT03936660|463553240|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
128797157|NCT03936660|463553241|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
128797158|NCT03112174|463553242|FG000|Overall Study|Withdrawal by Subject|3|||
128797159|NCT03112174|463553243|FG001|Overall Study|Withdrawal by Subject|0|||
128797160|NCT03112174|463553244|FG002|Overall Study|Withdrawal by Subject|11|||
128797161|NCT03112174|463553245|FG003|Overall Study|Withdrawal by Subject|9|||
128797162|NCT03112174|463553246|FG004|Overall Study|Withdrawal by Subject|7|||
128797163|NCT03112174|463553242|FG000|Overall Study|Lost to Follow-up|1|||
128797164|NCT03112174|463553243|FG001|Overall Study|Lost to Follow-up|1|||
128797165|NCT03112174|463553244|FG002|Overall Study|Lost to Follow-up|2|||
128797166|NCT03112174|463553245|FG003|Overall Study|Lost to Follow-up|3|||
128797167|NCT03112174|463553246|FG004|Overall Study|Lost to Follow-up|2|||
128797168|NCT03112174|463553242|FG000|Overall Study|Death|8|||
128797169|NCT03112174|463553243|FG001|Overall Study|Death|3|||
128797170|NCT03112174|463553244|FG002|Overall Study|Death|67|||
128797171|NCT03112174|463553245|FG003|Overall Study|Death|73|||
128797172|NCT03112174|463553246|FG004|Overall Study|Death|18|||
128797173|NCT03112174|463553242|FG000|Overall Study|Other, Not Specified|1|||
128797174|NCT03112174|463553243|FG001|Overall Study|Other, Not Specified|0|||
128797175|NCT03112174|463553244|FG002|Overall Study|Other, Not Specified|1|||
128797176|NCT03112174|463553245|FG003|Overall Study|Other, Not Specified|2|||
128797177|NCT03112174|463553246|FG004|Overall Study|Other, Not Specified|0|||
128797178|NCT01534494|463553249|FG000|Overall Study|Withdrawal by Subject|1|||
128797179|NCT02724592|463553250|FG000|Overall Study|Lost to Follow-up|4|||
128797180|NCT02724592|463553251|FG001|Overall Study|Lost to Follow-up|1|||
128797181|NCT02584829|463553252|FG000|Overall Study|Physician Decision|1|||
128797182|NCT02584829|463553253|FG001|Overall Study|Physician Decision|0|||
128797183|NCT02584829|463553252|FG000|Overall Study|Withdrawal by Subject|0|||
128797184|NCT02584829|463553253|FG001|Overall Study|Withdrawal by Subject|1|||
128797185|NCT02584829|463553252|FG000|Overall Study|Progressive Disease|0|||
128797186|NCT02584829|463553253|FG001|Overall Study|Progressive Disease|3|||
128797187|NCT02374463|463553255|FG000|Overall Study|Withdrawal by Subject|3|||
128797188|NCT02374463|463553256|FG001|Overall Study|Withdrawal by Subject|3|||
128797189|NCT01939899|463553257|FG000|Lead-in Dose Finding Phase|Death|0|||
128797190|NCT01939899|463553258|FG001|Lead-in Dose Finding Phase|Death|3|||
128797191|NCT01939899|463553259|FG002|Lead-in Dose Finding Phase|Death|1|||
128797192|NCT01939899|463553260|FG003|Lead-in Dose Finding Phase|Death|0|||
128797193|NCT01939899|463553261|FG004|Lead-in Dose Finding Phase|Death|0|||
128797194|NCT01939899|463553257|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
128797195|NCT01939899|463553258|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
128797196|NCT01939899|463553259|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
128797197|NCT01939899|463553260|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
128797198|NCT01939899|463553261|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
128797199|NCT01939899|463553257|FG000|Lead-in Dose Finding Phase|Other|0|||
128797200|NCT01939899|463553258|FG001|Lead-in Dose Finding Phase|Other|0|||
128797201|NCT01939899|463553259|FG002|Lead-in Dose Finding Phase|Other|1|||
128797202|NCT01939899|463553260|FG003|Lead-in Dose Finding Phase|Other|0|||
128797203|NCT01939899|463553261|FG004|Lead-in Dose Finding Phase|Other|0|||
128797204|NCT01939899|463553257|FG000|Phase 2|Withdrawal by Subject|0|||
128797205|NCT01939899|463553258|FG001|Phase 2|Withdrawal by Subject|0|||
128797206|NCT01939899|463553259|FG002|Phase 2|Withdrawal by Subject|0|||
128797207|NCT01939899|463553260|FG003|Phase 2|Withdrawal by Subject|2|||
128797208|NCT01939899|463553261|FG004|Phase 2|Withdrawal by Subject|0|||
128797209|NCT01939899|463553257|FG000|Phase 2|Disease Progression|0|||
128797210|NCT01939899|463553258|FG001|Phase 2|Disease Progression|0|||
128797211|NCT01939899|463553259|FG002|Phase 2|Disease Progression|0|||
128797212|NCT01939899|463553260|FG003|Phase 2|Disease Progression|9|||
128797213|NCT01939899|463553261|FG004|Phase 2|Disease Progression|1|||
128797214|NCT00585052|463553262|FG000|Overall Study|Withdrawal by Subject|1|||
128797215|NCT05489484|463553266|FG000|Overall Study|withdrawn|1|||
128797216|NCT00444600|463553269|FG000|Overall Study|Death|7|||
128797217|NCT00444600|463553270|FG001|Overall Study|Death|5|||
128797218|NCT00444600|463553271|FG002|Overall Study|Death|3|||
128797219|NCT00444600|463553272|FG003|Overall Study|Death|2|||
128797220|NCT00444600|463553269|FG000|Overall Study|Dropped|11|||
128797221|NCT00444600|463553270|FG001|Overall Study|Dropped|11|||
128797222|NCT00444600|463553271|FG002|Overall Study|Dropped|7|||
128797223|NCT00444600|463553272|FG003|Overall Study|Dropped|7|||
128797224|NCT00444600|463553269|FG000|Overall Study|Missed visit|1|||
128797225|NCT00444600|463553270|FG001|Overall Study|Missed visit|0|||
128797226|NCT00444600|463553271|FG002|Overall Study|Missed visit|0|||
128797227|NCT00444600|463553272|FG003|Overall Study|Missed visit|1|||
128797228|NCT05132478|463553273|FG000|Overall Study|did not complete survey after consent|1|||
128797229|NCT05132478|463553274|FG001|Overall Study|did not complete survey after consent|1|||
128797230|NCT05132478|463553273|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
128797231|NCT05132478|463553274|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
128797232|NCT00106080|463553275|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
128797233|NCT00106080|463553276|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
128797234|NCT01414738|463553279|FG000|Overall Study|Death|26|||
128797235|NCT01414738|463553279|FG000|Overall Study|Refused testing|5|||
128797236|NCT01414738|463553279|FG000|Overall Study|Lost to Follow-up|2|||
128797237|NCT01414738|463553279|FG000|Overall Study|Refused, disease progression|8|||
128797238|NCT01414738|463553279|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
128797239|NCT01839331|463553280|FG000|Overall Study|Early Termination|3|||
128797240|NCT01839331|463553281|FG001|Overall Study|Early Termination|0|||
128797241|NCT01839331|463553282|FG002|Overall Study|Early Termination|1|||
128797242|NCT01839331|463553283|FG003|Overall Study|Early Termination|2|||
128797243|NCT01839331|463553280|FG000|Overall Study|Protocol Violation|1|||
128797244|NCT01839331|463553281|FG001|Overall Study|Protocol Violation|6|||
128797245|NCT01839331|463553282|FG002|Overall Study|Protocol Violation|4|||
128797246|NCT01839331|463553283|FG003|Overall Study|Protocol Violation|3|||
128797247|NCT04056624|463553284|FG000|Overall Study|Withdrawal by Subject|0|||
128797248|NCT04056624|463553285|FG001|Overall Study|Withdrawal by Subject|0|||
128797249|NCT04056624|463553286|FG002|Overall Study|Withdrawal by Subject|1|||
128797250|NCT04056624|463553284|FG000|Overall Study|Protocol Violation|1|||
128797251|NCT04056624|463553285|FG001|Overall Study|Protocol Violation|2|||
128797252|NCT04056624|463553286|FG002|Overall Study|Protocol Violation|0|||
128797253|NCT00703820|463553287|FG000|Overall Study|Adverse Event|12|||
128797254|NCT00703820|463553288|FG001|Overall Study|Adverse Event|17|||
128797255|NCT00703820|463553287|FG000|Overall Study|Death|5|||
128797256|NCT00703820|463553288|FG001|Overall Study|Death|0|||
128797257|NCT00703820|463553287|FG000|Overall Study|Lack of Efficacy|11|||
128797258|NCT00703820|463553288|FG001|Overall Study|Lack of Efficacy|11|||
128797259|NCT00703820|463553287|FG000|Overall Study|Received non-protocol therapy|1|||
128797260|NCT00703820|463553288|FG001|Overall Study|Received non-protocol therapy|0|||
128797261|NCT00703820|463553287|FG000|Overall Study|Physician Decision|4|||
128797262|NCT00703820|463553288|FG001|Overall Study|Physician Decision|5|||
128797263|NCT00703820|463553287|FG000|Overall Study|Withdrawal by Subject|2|||
128797264|NCT00703820|463553288|FG001|Overall Study|Withdrawal by Subject|1|||
128797265|NCT03531840|463553293|FG000|Overall Study|Death on study|3|||
128797266|NCT03531840|463553294|FG001|Overall Study|Death on study|2|||
128797267|NCT03531840|463553295|FG002|Overall Study|Death on study|1|||
128797268|NCT03531840|463553296|FG003|Overall Study|Death on study|2|||
128797269|NCT03531840|463553293|FG000|Overall Study|Death during follow up|2|||
128797270|NCT03531840|463553294|FG001|Overall Study|Death during follow up|3|||
128797271|NCT03531840|463553295|FG002|Overall Study|Death during follow up|4|||
128797272|NCT03531840|463553296|FG003|Overall Study|Death during follow up|1|||
128797273|NCT00761605|463553298|FG000|Overall Study|Adverse Event|26|||
128797274|NCT00761605|463553298|FG000|Overall Study|Death|2|||
128797275|NCT00761605|463553298|FG000|Overall Study|Lack of Efficacy|26|||
128797276|NCT00761605|463553298|FG000|Overall Study|Lost to Follow-up|29|||
128797277|NCT00761605|463553298|FG000|Overall Study|Withdrawal by Subject|37|||
128797278|NCT00761605|463553298|FG000|Overall Study|Other|21|||
128797279|NCT02267824|463553299|FG000|Overall Study|Pregnancy|1|||
128797280|NCT02267824|463553300|FG001|Overall Study|Pregnancy|1|||
128797281|NCT02267824|463553299|FG000|Overall Study|Lost to Follow-up|4|||
128797282|NCT02267824|463553300|FG001|Overall Study|Lost to Follow-up|0|||
128797283|NCT02267824|463553299|FG000|Overall Study|Protocol Violation|3|||
128797284|NCT02267824|463553300|FG001|Overall Study|Protocol Violation|0|||
128797285|NCT02267824|463553299|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
128797286|NCT02267824|463553300|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
128797287|NCT03451721|463553301|FG000|Overall Study|Death|1|||
128797288|NCT01985334|463553302|FG000|Overall Study|Administrative problems|1|||
128797289|NCT01985334|463553303|FG001|Overall Study|Administrative problems|1|||
128797290|NCT01985334|463553304|FG002|Overall Study|Administrative problems|0|||
128797291|NCT01985334|463553305|FG003|Overall Study|Administrative problems|2|||
128797292|NCT01985334|463553306|FG004|Overall Study|Administrative problems|0|||
128797293|NCT01985334|463553307|FG005|Overall Study|Administrative problems|1|||
128797294|NCT01985334|463553308|FG006|Overall Study|Administrative problems|1|||
128797295|NCT01985334|463553309|FG007|Overall Study|Administrative problems|3|||
128797296|NCT01985334|463553302|FG000|Overall Study|Death|1|||
128797297|NCT01985334|463553303|FG001|Overall Study|Death|0|||
128797298|NCT01985334|463553304|FG002|Overall Study|Death|0|||
128797299|NCT01985334|463553305|FG003|Overall Study|Death|3|||
128797300|NCT01985334|463553306|FG004|Overall Study|Death|0|||
128797301|NCT01985334|463553307|FG005|Overall Study|Death|0|||
128797302|NCT01985334|463553308|FG006|Overall Study|Death|1|||
128797303|NCT01985334|463553309|FG007|Overall Study|Death|2|||
128797304|NCT01985334|463553302|FG000|Overall Study|Worsening of disease|0|||
128797305|NCT01985334|463553303|FG001|Overall Study|Worsening of disease|0|||
128797306|NCT01985334|463553304|FG002|Overall Study|Worsening of disease|0|||
128797307|NCT01985334|463553305|FG003|Overall Study|Worsening of disease|1|||
128797308|NCT01985334|463553306|FG004|Overall Study|Worsening of disease|0|||
128797309|NCT01985334|463553307|FG005|Overall Study|Worsening of disease|3|||
128797310|NCT01985334|463553308|FG006|Overall Study|Worsening of disease|0|||
128797311|NCT01985334|463553309|FG007|Overall Study|Worsening of disease|1|||
128797312|NCT01985334|463553302|FG000|Overall Study|Other|2|||
128797313|NCT01985334|463553303|FG001|Overall Study|Other|9|||
128797314|NCT01985334|463553304|FG002|Overall Study|Other|7|||
128797315|NCT01985334|463553305|FG003|Overall Study|Other|17|||
128797316|NCT01985334|463553306|FG004|Overall Study|Other|4|||
128797317|NCT01985334|463553307|FG005|Overall Study|Other|8|||
128797318|NCT01985334|463553308|FG006|Overall Study|Other|4|||
128797319|NCT01985334|463553309|FG007|Overall Study|Other|7|||
128797320|NCT01985334|463553302|FG000|Overall Study|Protocol deviation|6|||
128797321|NCT01985334|463553303|FG001|Overall Study|Protocol deviation|31|||
128797322|NCT01985334|463553304|FG002|Overall Study|Protocol deviation|25|||
128797323|NCT01985334|463553305|FG003|Overall Study|Protocol deviation|84|||
128797324|NCT01985334|463553306|FG004|Overall Study|Protocol deviation|17|||
128797325|NCT01985334|463553307|FG005|Overall Study|Protocol deviation|47|||
128797326|NCT01985334|463553308|FG006|Overall Study|Protocol deviation|15|||
128797327|NCT01985334|463553309|FG007|Overall Study|Protocol deviation|42|||
128797328|NCT01985334|463553302|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
128797329|NCT01985334|463553303|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
128797330|NCT01985334|463553304|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
128797331|NCT01985334|463553305|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
128797332|NCT01985334|463553306|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
128797333|NCT01985334|463553307|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
128797334|NCT01985334|463553308|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
128797335|NCT01985334|463553309|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
128797336|NCT01985334|463553302|FG000|Overall Study|Subject withdrawal of consent|3|||
128797337|NCT01985334|463553303|FG001|Overall Study|Subject withdrawal of consent|6|||
128797338|NCT01985334|463553304|FG002|Overall Study|Subject withdrawal of consent|2|||
128797339|NCT01985334|463553305|FG003|Overall Study|Subject withdrawal of consent|28|||
128797340|NCT01985334|463553306|FG004|Overall Study|Subject withdrawal of consent|4|||
128797341|NCT01985334|463553307|FG005|Overall Study|Subject withdrawal of consent|19|||
128797342|NCT01985334|463553308|FG006|Overall Study|Subject withdrawal of consent|0|||
128797343|NCT01985334|463553309|FG007|Overall Study|Subject withdrawal of consent|20|||
128797344|NCT01985334|463553302|FG000|Overall Study|Adverse Event|0|||
128797345|NCT01985334|463553303|FG001|Overall Study|Adverse Event|8|||
128797346|NCT01985334|463553304|FG002|Overall Study|Adverse Event|2|||
128797347|NCT01985334|463553305|FG003|Overall Study|Adverse Event|26|||
128797348|NCT01985334|463553306|FG004|Overall Study|Adverse Event|3|||
128797349|NCT01985334|463553307|FG005|Overall Study|Adverse Event|18|||
128797350|NCT01985334|463553308|FG006|Overall Study|Adverse Event|3|||
128797351|NCT01985334|463553309|FG007|Overall Study|Adverse Event|15|||
128797352|NCT01985334|463553302|FG000|Overall Study|Other|4|||
128797353|NCT01985334|463553303|FG001|Overall Study|Other|2|||
128797354|NCT01985334|463553304|FG002|Overall Study|Other|3|||
128797355|NCT01985334|463553305|FG003|Overall Study|Other|10|||
128797356|NCT01985334|463553306|FG004|Overall Study|Other|1|||
128797357|NCT01985334|463553307|FG005|Overall Study|Other|6|||
128797358|NCT01985334|463553308|FG006|Overall Study|Other|2|||
128797359|NCT01985334|463553309|FG007|Overall Study|Other|2|||
128797360|NCT01985334|463553302|FG000|Overall Study|Medication non-compliance|0|||
128797361|NCT01985334|463553303|FG001|Overall Study|Medication non-compliance|4|||
128797362|NCT01985334|463553304|FG002|Overall Study|Medication non-compliance|1|||
128797363|NCT01985334|463553305|FG003|Overall Study|Medication non-compliance|6|||
128797364|NCT01985334|463553306|FG004|Overall Study|Medication non-compliance|2|||
128797365|NCT01985334|463553307|FG005|Overall Study|Medication non-compliance|3|||
128797366|NCT01985334|463553308|FG006|Overall Study|Medication non-compliance|1|||
128797367|NCT01985334|463553309|FG007|Overall Study|Medication non-compliance|3|||
128797368|NCT01985334|463553302|FG000|Overall Study|Use of prohibited treatment|1|||
128797369|NCT01985334|463553303|FG001|Overall Study|Use of prohibited treatment|4|||
128797370|NCT01985334|463553304|FG002|Overall Study|Use of prohibited treatment|1|||
128797371|NCT01985334|463553305|FG003|Overall Study|Use of prohibited treatment|2|||
128797372|NCT01985334|463553306|FG004|Overall Study|Use of prohibited treatment|1|||
128797373|NCT01985334|463553307|FG005|Overall Study|Use of prohibited treatment|6|||
128797374|NCT01985334|463553308|FG006|Overall Study|Use of prohibited treatment|2|||
128797375|NCT01985334|463553309|FG007|Overall Study|Use of prohibited treatment|0|||
128797376|NCT01985334|463553302|FG000|Overall Study|Investigator decision|0|||
128797377|NCT01985334|463553303|FG001|Overall Study|Investigator decision|3|||
128797378|NCT01985334|463553304|FG002|Overall Study|Investigator decision|0|||
128797379|NCT01985334|463553305|FG003|Overall Study|Investigator decision|7|||
128797380|NCT01985334|463553306|FG004|Overall Study|Investigator decision|1|||
128797381|NCT01985334|463553307|FG005|Overall Study|Investigator decision|1|||
128797382|NCT01985334|463553308|FG006|Overall Study|Investigator decision|0|||
128797383|NCT01985334|463553309|FG007|Overall Study|Investigator decision|4|||
128797384|NCT01985334|463553302|FG000|Overall Study|Lost to Follow-up|0|||
128797385|NCT01985334|463553303|FG001|Overall Study|Lost to Follow-up|2|||
128797386|NCT01985334|463553304|FG002|Overall Study|Lost to Follow-up|0|||
128797387|NCT01985334|463553305|FG003|Overall Study|Lost to Follow-up|3|||
128797388|NCT01985334|463553306|FG004|Overall Study|Lost to Follow-up|1|||
128797389|NCT01985334|463553307|FG005|Overall Study|Lost to Follow-up|4|||
128797390|NCT01985334|463553308|FG006|Overall Study|Lost to Follow-up|0|||
128797391|NCT01985334|463553309|FG007|Overall Study|Lost to Follow-up|3|||
128797392|NCT00914589|463553310|FG000|Overall Study|Adverse Event|1|||
128797393|NCT00914589|463553311|FG001|Overall Study|Adverse Event|0|||
128797394|NCT00914589|463553312|FG002|Overall Study|Adverse Event|1|||
128797395|NCT00914589|463553310|FG000|Overall Study|Protocol Violation|8|||
128797396|NCT00914589|463553311|FG001|Overall Study|Protocol Violation|6|||
128797397|NCT00914589|463553312|FG002|Overall Study|Protocol Violation|3|||
128797398|NCT00914589|463553310|FG000|Overall Study|unclassified|16|||
128797399|NCT00914589|463553311|FG001|Overall Study|unclassified|9|||
128797400|NCT00914589|463553312|FG002|Overall Study|unclassified|7|||
128797401|NCT00914589|463553310|FG000|Overall Study|Death|0|||
128797402|NCT00914589|463553311|FG001|Overall Study|Death|1|||
128797403|NCT00914589|463553312|FG002|Overall Study|Death|1|||
128797404|NCT01290341|463553313|FG000|Overall Study|Protocol Violation|7|||
128797405|NCT01290341|463553314|FG001|Overall Study|Protocol Violation|3|||
128797406|NCT01290341|463553313|FG000|Overall Study|Adverse Event|1|||
128797407|NCT01290341|463553314|FG001|Overall Study|Adverse Event|0|||
128797408|NCT01290341|463553313|FG000|Overall Study|Lost to Follow-up|21|||
128797409|NCT01290341|463553314|FG001|Overall Study|Lost to Follow-up|10|||
128797410|NCT01290341|463553313|FG000|Overall Study|Withdrawal by Subject|19|||
128797411|NCT01290341|463553314|FG001|Overall Study|Withdrawal by Subject|5|||
128797412|NCT01290341|463553313|FG000|Overall Study|Negative baseline culture and others|44|||
128797413|NCT01290341|463553314|FG001|Overall Study|Negative baseline culture and others|11|||
128797414|NCT03036813|463553319|FG000|Overall Study|Adverse Event|6|||
128797415|NCT03036813|463553320|FG001|Overall Study|Adverse Event|11|||
128797416|NCT03036813|463553321|FG002|Overall Study|Adverse Event|6|||
128797417|NCT03036813|463553319|FG000|Overall Study|Withdrawal by Subject|12|||
128797418|NCT03036813|463553320|FG001|Overall Study|Withdrawal by Subject|6|||
128797419|NCT03036813|463553321|FG002|Overall Study|Withdrawal by Subject|10|||
128797420|NCT03036813|463553319|FG000|Overall Study|Lost to Follow-up|1|||
128797421|NCT03036813|463553320|FG001|Overall Study|Lost to Follow-up|1|||
128797422|NCT03036813|463553321|FG002|Overall Study|Lost to Follow-up|0|||
128797423|NCT03036813|463553319|FG000|Overall Study|Physician Decision|2|||
128797424|NCT03036813|463553320|FG001|Overall Study|Physician Decision|1|||
128797425|NCT03036813|463553321|FG002|Overall Study|Physician Decision|1|||
128797426|NCT03036813|463553319|FG000|Overall Study|Non-Compliance|1|||
128797427|NCT03036813|463553320|FG001|Overall Study|Non-Compliance|5|||
128797428|NCT03036813|463553321|FG002|Overall Study|Non-Compliance|3|||
128797429|NCT03036813|463553319|FG000|Overall Study|Pregnancy|0|||
128797430|NCT03036813|463553320|FG001|Overall Study|Pregnancy|0|||
128797431|NCT03036813|463553321|FG002|Overall Study|Pregnancy|1|||
128797432|NCT03036813|463553319|FG000|Overall Study|Other|0|||
128797433|NCT03036813|463553320|FG001|Overall Study|Other|3|||
128797434|NCT03036813|463553321|FG002|Overall Study|Other|5|||
128797435|NCT01102231|463553322|FG000|Overall Study|Protocol Violation|3|||
128797436|NCT01102231|463553322|FG000|Overall Study|Lack of Efficacy|2|||
128797437|NCT01102231|463553322|FG000|Overall Study|Death|2|||
128797438|NCT01102231|463553322|FG000|Overall Study|Adverse Event|3|||
128797439|NCT01102231|463553322|FG000|Overall Study|Withdrawal by Subject|1|||
128797440|NCT01102231|463553322|FG000|Overall Study|Did not received the treatment|4|||
128797441|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
128797442|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
128797443|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
128797444|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
128797445|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
128797446|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
128797447|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
128797448|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
128797449|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
128797450|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
128797451|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
128797452|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
128797453|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
128797454|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
128797455|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
128797456|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
128797457|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
128797458|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
128797459|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
128797460|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
128797461|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
128797462|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
128797463|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
128797464|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
128797465|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
128797466|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
128797467|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
128797468|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
128797469|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
128797470|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
128797471|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
128797472|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
128797473|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
128797474|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
128797475|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
128797476|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
128797477|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
128797478|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
128797479|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
128797480|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
129204622|NCT05148234|465045841|FG006|Phase I|Ineligible|0|||
129204623|NCT05148234|465045842|FG007|Phase I|Ineligible|1|||
129204624|NCT05148234|465045835|FG000|Phase I|Company closed the trial.|0|||
129204625|NCT05148234|465045836|FG001|Phase I|Company closed the trial.|1|||
129204626|NCT05148234|465045837|FG002|Phase I|Company closed the trial.|0|||
129204627|NCT05148234|465045838|FG003|Phase I|Company closed the trial.|0|||
129204628|NCT05148234|465045839|FG004|Phase I|Company closed the trial.|0|||
129204629|NCT05148234|465045840|FG005|Phase I|Company closed the trial.|0|||
129204630|NCT05148234|465045841|FG006|Phase I|Company closed the trial.|0|||
128797481|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128797482|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128797483|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128797484|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
128797485|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128797486|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128797487|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128797488|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
128797489|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
128797490|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
128797491|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
128797492|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
128797493|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
128797494|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
128797495|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
128797496|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
128797497|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
128797498|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
128797499|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
128797500|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
128797501|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
128797502|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
128797503|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
128797504|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
128797505|NCT03903822|463553323|FG000|Treatment Phase (6 Weeks)|Other|2|||
128797506|NCT03903822|463553324|FG001|Treatment Phase (6 Weeks)|Other|1|||
128797507|NCT03903822|463553325|FG002|Treatment Phase (6 Weeks)|Other|0|||
128797508|NCT03903822|463553326|FG003|Treatment Phase (6 Weeks)|Other|0|||
128797509|NCT03903822|463553327|FG004|Treatment Phase (6 Weeks)|Other|1|||
128797510|NCT03903822|463553328|FG005|Treatment Phase (6 Weeks)|Other|1|||
128797511|NCT03903822|463553329|FG006|Treatment Phase (6 Weeks)|Other|0|||
128797512|NCT03903822|463553330|FG007|Treatment Phase (6 Weeks)|Other|0|||
128797513|NCT03903822|463553323|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
128797514|NCT03903822|463553324|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
128797515|NCT03903822|463553325|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
128797516|NCT03903822|463553326|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
128797517|NCT03903822|463553327|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
128797518|NCT03903822|463553328|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
128797519|NCT03903822|463553329|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
128797520|NCT03903822|463553330|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
128797521|NCT03903822|463553323|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
128797522|NCT03903822|463553324|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
128797523|NCT03903822|463553325|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
128797524|NCT03903822|463553326|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
128797525|NCT03903822|463553327|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
128797526|NCT03903822|463553328|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
128797527|NCT03903822|463553329|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
128797528|NCT03903822|463553330|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
128797529|NCT03903822|463553323|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
128797530|NCT03903822|463553324|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
128797531|NCT03903822|463553325|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
128797532|NCT03903822|463553326|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
128797533|NCT03903822|463553327|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
128797534|NCT03903822|463553328|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
128797535|NCT03903822|463553329|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
128797536|NCT03903822|463553330|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
128797537|NCT03903822|463553323|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
128797538|NCT03903822|463553324|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
128797539|NCT03903822|463553325|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
128797540|NCT03903822|463553326|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
128797541|NCT03903822|463553327|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
128797542|NCT03903822|463553328|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
128797543|NCT03903822|463553329|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
128797544|NCT03903822|463553330|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
128797545|NCT03903822|463553323|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
128797546|NCT03903822|463553324|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
128797547|NCT03903822|463553325|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
128797548|NCT03903822|463553326|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
128797549|NCT03903822|463553327|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
128797550|NCT03903822|463553328|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
128797551|NCT03903822|463553329|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
128797552|NCT03903822|463553330|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
128797553|NCT03903822|463553323|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128797554|NCT03903822|463553324|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128797555|NCT03903822|463553325|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128797556|NCT03903822|463553326|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128797557|NCT03903822|463553327|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128797558|NCT03903822|463553328|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
128797559|NCT03903822|463553329|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128797560|NCT03903822|463553330|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
128797561|NCT03903822|463553323|FG000|Follow up Phase (4 Weeks)|Other|1|||
128797562|NCT03903822|463553324|FG001|Follow up Phase (4 Weeks)|Other|1|||
128797563|NCT03903822|463553325|FG002|Follow up Phase (4 Weeks)|Other|0|||
128797564|NCT03903822|463553326|FG003|Follow up Phase (4 Weeks)|Other|0|||
128797565|NCT03903822|463553327|FG004|Follow up Phase (4 Weeks)|Other|0|||
128797566|NCT03903822|463553328|FG005|Follow up Phase (4 Weeks)|Other|0|||
128797567|NCT03903822|463553329|FG006|Follow up Phase (4 Weeks)|Other|0|||
128797568|NCT03903822|463553330|FG007|Follow up Phase (4 Weeks)|Other|0|||
128797569|NCT00529100|463553333|FG000|Overall Study|Adverse Event|0|||
128797570|NCT00529100|463553334|FG001|Overall Study|Adverse Event|5|||
128797571|NCT00529100|463553333|FG000|Overall Study|Protocol Violation|0|||
128797572|NCT00529100|463553334|FG001|Overall Study|Protocol Violation|1|||
128797573|NCT00529100|463553333|FG000|Overall Study|Progressive Disease|0|||
128797574|NCT00529100|463553334|FG001|Overall Study|Progressive Disease|1|||
128797575|NCT00529100|463553333|FG000|Overall Study|Withdrawal by Subject|0|||
128797576|NCT00529100|463553334|FG001|Overall Study|Withdrawal by Subject|1|||
128797577|NCT00529100|463553333|FG000|Overall Study|Participant Ineligibility|0|||
128797578|NCT00529100|463553334|FG001|Overall Study|Participant Ineligibility|1|||
128797579|NCT00807937|463553336|FG000|Overall Study|Adverse Event|12|||
128797580|NCT00807937|463553337|FG001|Overall Study|Adverse Event|12|||
128797581|NCT00807937|463553338|FG002|Overall Study|Adverse Event|5|||
128797582|NCT00807937|463553339|FG003|Overall Study|Adverse Event|4|||
128797583|NCT00807937|463553336|FG000|Overall Study|Protocol Violation|4|||
128797584|NCT00807937|463553337|FG001|Overall Study|Protocol Violation|5|||
128797585|NCT00807937|463553338|FG002|Overall Study|Protocol Violation|3|||
128797586|NCT00807937|463553339|FG003|Overall Study|Protocol Violation|3|||
128797587|NCT00807937|463553336|FG000|Overall Study|Withdrawal by Subject|5|||
128797588|NCT00807937|463553337|FG001|Overall Study|Withdrawal by Subject|4|||
128797589|NCT00807937|463553338|FG002|Overall Study|Withdrawal by Subject|1|||
128797590|NCT00807937|463553339|FG003|Overall Study|Withdrawal by Subject|4|||
128797591|NCT00807937|463553336|FG000|Overall Study|Lost to Follow-up|4|||
128797592|NCT00807937|463553337|FG001|Overall Study|Lost to Follow-up|0|||
128797593|NCT00807937|463553338|FG002|Overall Study|Lost to Follow-up|2|||
128797594|NCT00807937|463553339|FG003|Overall Study|Lost to Follow-up|1|||
128797595|NCT00807937|463553336|FG000|Overall Study|Lack of Efficacy|0|||
128797596|NCT00807937|463553337|FG001|Overall Study|Lack of Efficacy|0|||
128797597|NCT00807937|463553338|FG002|Overall Study|Lack of Efficacy|1|||
128797598|NCT00807937|463553339|FG003|Overall Study|Lack of Efficacy|2|||
128797599|NCT00807937|463553336|FG000|Overall Study|Intake of prohibited medicine|0|||
128797600|NCT00807937|463553337|FG001|Overall Study|Intake of prohibited medicine|0|||
128797601|NCT00807937|463553338|FG002|Overall Study|Intake of prohibited medicine|2|||
128797602|NCT00807937|463553339|FG003|Overall Study|Intake of prohibited medicine|0|||
128797603|NCT00807937|463553336|FG000|Overall Study|All other reasons (not provided)|2|||
128797604|NCT00807937|463553337|FG001|Overall Study|All other reasons (not provided)|4|||
128797605|NCT00807937|463553338|FG002|Overall Study|All other reasons (not provided)|0|||
128797606|NCT00807937|463553339|FG003|Overall Study|All other reasons (not provided)|1|||
128797607|NCT00390299|463553349|FG000|Overall Study|Cancellation|1|||
128797608|NCT00390299|463553350|FG001|Overall Study|Cancellation|0|||
128797609|NCT00390299|463553351|FG002|Overall Study|Cancellation|0|||
128797610|NCT00390299|463553352|FG003|Overall Study|Cancellation|0|||
128797611|NCT00390299|463553353|FG004|Overall Study|Cancellation|0|||
128797612|NCT00970359|463553354|FG000|Overall Study|Not Treated|4|||
128797613|NCT01565148|463553355|FG000|Overall Study|Withdrawal by Subject|1|||
128797614|NCT01565148|463553356|FG001|Overall Study|Withdrawal by Subject|1|||
128797615|NCT01565148|463553357|FG002|Overall Study|Withdrawal by Subject|1|||
128797616|NCT01565148|463553358|FG003|Overall Study|Withdrawal by Subject|2|||
128797617|NCT01565148|463553355|FG000|Overall Study|Lost to Follow-up|4|||
128797618|NCT01565148|463553356|FG001|Overall Study|Lost to Follow-up|4|||
128797619|NCT01565148|463553357|FG002|Overall Study|Lost to Follow-up|0|||
128797620|NCT01565148|463553358|FG003|Overall Study|Lost to Follow-up|3|||
128797621|NCT01565148|463553355|FG000|Overall Study|Rescue Therapy|8|||
128797622|NCT01565148|463553356|FG001|Overall Study|Rescue Therapy|5|||
128797623|NCT01565148|463553357|FG002|Overall Study|Rescue Therapy|5|||
128797624|NCT01565148|463553358|FG003|Overall Study|Rescue Therapy|8|||
128797625|NCT01565148|463553355|FG000|Overall Study|Death|0|||
128797626|NCT01565148|463553356|FG001|Overall Study|Death|0|||
128797627|NCT01565148|463553357|FG002|Overall Study|Death|1|||
128797628|NCT01565148|463553358|FG003|Overall Study|Death|0|||
128797629|NCT01565148|463553355|FG000|Overall Study|Physician Decision|2|||
128797630|NCT01565148|463553356|FG001|Overall Study|Physician Decision|5|||
128797631|NCT01565148|463553357|FG002|Overall Study|Physician Decision|0|||
128797632|NCT01565148|463553358|FG003|Overall Study|Physician Decision|0|||
128797633|NCT01061671|463553359|FG000|Overall Study|Withdrawal by Subject|16|||
128797634|NCT01061671|463553360|FG001|Overall Study|Withdrawal by Subject|20|||
128797635|NCT01061671|463553359|FG000|Overall Study|Lost to Follow-up|3|||
128797636|NCT01061671|463553360|FG001|Overall Study|Lost to Follow-up|5|||
128797637|NCT01061671|463553359|FG000|Overall Study|Death|28|||
128797638|NCT01061671|463553360|FG001|Overall Study|Death|30|||
128797639|NCT05368831|463553361|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
128797640|NCT01199575|463553362|FG000|Overall Study|Withdrawal by Subject|5|||
128797641|NCT00223795|463553363|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
128797642|NCT00223795|463553364|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
128797643|NCT00223795|463553363|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
128797644|NCT00223795|463553364|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
128797645|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
128797646|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
128797647|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
128797648|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
128797649|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
128797650|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
128797651|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
128797652|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
128797653|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
128797654|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
128797655|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
128797656|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
128797657|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
128797658|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
128797659|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
128797660|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
128797661|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
128797662|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
128797663|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
128797664|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
128797665|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
128797666|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
128797667|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
128797668|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
128797669|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
128797670|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
128797671|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
128797672|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
128797673|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
128797674|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
128797675|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
128797676|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
128797677|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
128797678|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
128797679|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
128797680|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
128797681|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
128797682|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
128797683|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
128797684|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
128797685|NCT02409667|463553369|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
128797686|NCT02409667|463553370|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
128797687|NCT02409667|463553371|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
128797688|NCT02409667|463553372|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
128797689|NCT02409667|463553373|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
128797690|NCT02409667|463553369|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
128797691|NCT02409667|463553370|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
128797692|NCT02409667|463553371|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
128797693|NCT02409667|463553372|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
128797694|NCT02409667|463553373|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
128797695|NCT02409667|463553369|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
128797696|NCT02409667|463553370|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
128797697|NCT02409667|463553371|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
128797698|NCT02409667|463553372|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
128797699|NCT02409667|463553373|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
128797700|NCT02409667|463553369|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
128797701|NCT02409667|463553370|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
128797702|NCT02409667|463553371|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
128797703|NCT02409667|463553372|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
128797704|NCT02409667|463553373|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
128797705|NCT02409667|463553369|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
128797706|NCT02409667|463553370|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
128797707|NCT02409667|463553371|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
128797708|NCT02409667|463553372|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
128797709|NCT02409667|463553373|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
128797710|NCT02409667|463553369|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
128797711|NCT02409667|463553370|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
128797712|NCT02409667|463553371|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
128797713|NCT02409667|463553372|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
128797714|NCT02409667|463553373|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
128797715|NCT02409667|463553369|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
128797716|NCT02409667|463553370|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
128797717|NCT02409667|463553371|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
128797718|NCT02409667|463553372|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
128797719|NCT02409667|463553373|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
128797720|NCT02409667|463553369|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
128797721|NCT02409667|463553370|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
128797722|NCT02409667|463553371|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
128797723|NCT02409667|463553372|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
128797724|NCT02409667|463553373|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
128797725|NCT03482635|463553376|FG000|Overall Study|Lack of Efficacy|0|||
128797726|NCT03482635|463553377|FG001|Overall Study|Lack of Efficacy|0|||
128797727|NCT03482635|463553378|FG002|Overall Study|Lack of Efficacy|1|||
128797728|NCT03482635|463553379|FG003|Overall Study|Lack of Efficacy|3|||
128797729|NCT03482635|463553376|FG000|Overall Study|Adverse Event|2|||
128797730|NCT03482635|463553377|FG001|Overall Study|Adverse Event|2|||
128797731|NCT03482635|463553378|FG002|Overall Study|Adverse Event|0|||
128797732|NCT03482635|463553379|FG003|Overall Study|Adverse Event|3|||
128797733|NCT03482635|463553376|FG000|Overall Study|Withdrawal by Subject|2|||
128797734|NCT03482635|463553377|FG001|Overall Study|Withdrawal by Subject|1|||
128797735|NCT03482635|463553378|FG002|Overall Study|Withdrawal by Subject|0|||
128797736|NCT03482635|463553379|FG003|Overall Study|Withdrawal by Subject|1|||
128797737|NCT03482635|463553376|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
128797738|NCT03482635|463553377|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
128797739|NCT03482635|463553378|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
128797740|NCT03482635|463553379|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
128797741|NCT03482635|463553376|FG000|Overall Study|Not treated|0|||
128797742|NCT03482635|463553377|FG001|Overall Study|Not treated|0|||
128797743|NCT03482635|463553378|FG002|Overall Study|Not treated|0|||
128797744|NCT03482635|463553379|FG003|Overall Study|Not treated|1|||
128797745|NCT03237481|463554474|FG000|Overall Study|Lost to Follow-up|1|||
128797746|NCT03237481|463554475|FG001|Overall Study|Lost to Follow-up|0|||
128797747|NCT03237481|463554476|FG002|Overall Study|Lost to Follow-up|0|||
128797748|NCT03237481|463554474|FG000|Overall Study|Protocol Violation|1|||
128797749|NCT03237481|463554475|FG001|Overall Study|Protocol Violation|0|||
128797750|NCT03237481|463554476|FG002|Overall Study|Protocol Violation|0|||
128797751|NCT03237481|463554474|FG000|Overall Study|Withdrawal by Subject|3|||
128797752|NCT03237481|463554475|FG001|Overall Study|Withdrawal by Subject|2|||
128797753|NCT03237481|463554476|FG002|Overall Study|Withdrawal by Subject|1|||
128797754|NCT01780298|463554480|FG000|Overall Study|Physician Decision|1|||
128797755|NCT01780298|463554481|FG001|Overall Study|Physician Decision|5|||
128797756|NCT01780298|463554482|FG002|Overall Study|Physician Decision|1|||
128797757|NCT01780298|463554483|FG003|Overall Study|Physician Decision|1|||
128797758|NCT01780298|463554480|FG000|Overall Study|Subject not matched|1|||
128797759|NCT01780298|463554481|FG001|Overall Study|Subject not matched|0|||
128797760|NCT01780298|463554482|FG002|Overall Study|Subject not matched|1|||
128797761|NCT01780298|463554483|FG003|Overall Study|Subject not matched|0|||
128797762|NCT01780298|463554480|FG000|Overall Study|Adverse Event|0|||
128797763|NCT01780298|463554481|FG001|Overall Study|Adverse Event|0|||
128797764|NCT01780298|463554482|FG002|Overall Study|Adverse Event|2|||
128797765|NCT01780298|463554483|FG003|Overall Study|Adverse Event|0|||
128797766|NCT02581215|463554484|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
128797767|NCT02581215|463554485|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
128797768|NCT02581215|463554484|FG000|Overall Study|Eligibility Criteria Not Met|0|||
128797769|NCT02581215|463554485|FG001|Overall Study|Eligibility Criteria Not Met|1|||
128797770|NCT04259450|463554493|FG000|Overall Study|Adverse event/ Toxicity|0|||
128797771|NCT04259450|463554494|FG001|Overall Study|Adverse event/ Toxicity|3|||
128797772|NCT04259450|463554495|FG002|Overall Study|Adverse event/ Toxicity|0|||
128797773|NCT04259450|463554496|FG003|Overall Study|Adverse event/ Toxicity|1|||
128797774|NCT04259450|463554497|FG004|Overall Study|Adverse event/ Toxicity|0|||
128797775|NCT04259450|463554498|FG005|Overall Study|Adverse event/ Toxicity|0|||
128797776|NCT04259450|463554499|FG006|Overall Study|Adverse event/ Toxicity|0|||
128797777|NCT04259450|463554500|FG007|Overall Study|Adverse event/ Toxicity|1|||
128797778|NCT04259450|463554501|FG008|Overall Study|Adverse event/ Toxicity|0|||
128797779|NCT04259450|463554502|FG009|Overall Study|Adverse event/ Toxicity|3|||
128797780|NCT04259450|463554493|FG000|Overall Study|Disease progression|2|||
128797781|NCT04259450|463554494|FG001|Overall Study|Disease progression|3|||
128797782|NCT04259450|463554495|FG002|Overall Study|Disease progression|4|||
128797783|NCT04259450|463554496|FG003|Overall Study|Disease progression|4|||
128797784|NCT04259450|463554497|FG004|Overall Study|Disease progression|6|||
128797785|NCT04259450|463554498|FG005|Overall Study|Disease progression|6|||
128797786|NCT04259450|463554499|FG006|Overall Study|Disease progression|6|||
128797787|NCT04259450|463554500|FG007|Overall Study|Disease progression|15|||
128797788|NCT04259450|463554501|FG008|Overall Study|Disease progression|6|||
128797789|NCT04259450|463554502|FG009|Overall Study|Disease progression|18|||
128797790|NCT04259450|463554493|FG000|Overall Study|Death|0|||
128797791|NCT04259450|463554494|FG001|Overall Study|Death|0|||
128797792|NCT04259450|463554495|FG002|Overall Study|Death|0|||
128797793|NCT04259450|463554496|FG003|Overall Study|Death|0|||
128797794|NCT04259450|463554497|FG004|Overall Study|Death|0|||
128797795|NCT04259450|463554498|FG005|Overall Study|Death|0|||
128797796|NCT04259450|463554499|FG006|Overall Study|Death|0|||
128797797|NCT04259450|463554500|FG007|Overall Study|Death|1|||
128797798|NCT04259450|463554501|FG008|Overall Study|Death|1|||
128797799|NCT04259450|463554502|FG009|Overall Study|Death|0|||
128797800|NCT04259450|463554493|FG000|Overall Study|Withdrawal by Subject|0|||
128797801|NCT04259450|463554494|FG001|Overall Study|Withdrawal by Subject|0|||
128797802|NCT04259450|463554495|FG002|Overall Study|Withdrawal by Subject|0|||
128797803|NCT04259450|463554496|FG003|Overall Study|Withdrawal by Subject|0|||
128797804|NCT04259450|463554497|FG004|Overall Study|Withdrawal by Subject|0|||
128797805|NCT04259450|463554498|FG005|Overall Study|Withdrawal by Subject|0|||
128797806|NCT04259450|463554499|FG006|Overall Study|Withdrawal by Subject|0|||
128797807|NCT04259450|463554500|FG007|Overall Study|Withdrawal by Subject|1|||
128797808|NCT04259450|463554501|FG008|Overall Study|Withdrawal by Subject|0|||
128797809|NCT04259450|463554502|FG009|Overall Study|Withdrawal by Subject|0|||
128797810|NCT04259450|463554493|FG000|Overall Study|Other than listed|0|||
128797811|NCT04259450|463554494|FG001|Overall Study|Other than listed|0|||
128797812|NCT04259450|463554495|FG002|Overall Study|Other than listed|0|||
128797813|NCT04259450|463554496|FG003|Overall Study|Other than listed|0|||
128797814|NCT04259450|463554497|FG004|Overall Study|Other than listed|0|||
128797815|NCT04259450|463554498|FG005|Overall Study|Other than listed|0|||
128797816|NCT04259450|463554499|FG006|Overall Study|Other than listed|0|||
128797817|NCT04259450|463554500|FG007|Overall Study|Other than listed|1|||
128797818|NCT04259450|463554501|FG008|Overall Study|Other than listed|1|||
128797819|NCT04259450|463554502|FG009|Overall Study|Other than listed|2|||
128797820|NCT05262738|463554508|FG000|Overall Study|Withdrawal by Subject|1|||
128797821|NCT05262738|463554509|FG001|Overall Study|Withdrawal by Subject|0|||
128797822|NCT01471691|463554510|FG000|Overall Study|Lack of Efficacy|0|||
128797823|NCT01471691|463554511|FG001|Overall Study|Lack of Efficacy|1|||
128797824|NCT00858117|463554512|FG000|Treatment on Study|Adverse Event|2|||
128797825|NCT00858117|463554512|FG000|Follow up for 5 Years|Death|4|||
128797826|NCT00858117|463554512|FG000|Follow up for 5 Years|No further data collected for study|9|||
128797827|NCT00277355|463554517|FG000|Overall Study|Withdrawal by Subject|3|||
128797828|NCT00277355|463554518|FG001|Overall Study|Withdrawal by Subject|3|||
128797829|NCT00277355|463554517|FG000|Overall Study|Lost to Follow-up|2|||
128797830|NCT00277355|463554518|FG001|Overall Study|Lost to Follow-up|2|||
128797831|NCT00277355|463554517|FG000|Overall Study|Adverse Event|5|||
128797832|NCT00277355|463554518|FG001|Overall Study|Adverse Event|0|||
128797833|NCT00277355|463554517|FG000|Overall Study|Death|3|||
128797834|NCT00277355|463554518|FG001|Overall Study|Death|0|||
128797835|NCT00277355|463554517|FG000|Overall Study|Physician Decision|1|||
128797836|NCT00277355|463554518|FG001|Overall Study|Physician Decision|0|||
128797837|NCT00350792|463554521|FG000|Overall Study|Adverse Event|11|||
128797838|NCT00350792|463554521|FG000|Overall Study|Death from Study Disease|1|||
128797839|NCT00350792|463554521|FG000|Overall Study|Death from Study Drug Toxicity|1|||
128797840|NCT00350792|463554521|FG000|Overall Study|Death Not Study Drug Related|2|||
128797841|NCT00350792|463554521|FG000|Overall Study|Protocol Violation|1|||
128797842|NCT00350792|463554521|FG000|Overall Study|Withdrawal by Subject|4|||
128797843|NCT00350792|463554521|FG000|Overall Study|Physician Decision|2|||
128797844|NCT00350792|463554521|FG000|Overall Study|Lack of Efficacy|11|||
128797845|NCT03988023|463554522|FG000|Overall Study|Non-compliance|3|||
128797846|NCT03988023|463554523|FG001|Overall Study|Non-compliance|0|||
128797847|NCT03988023|463554522|FG000|Overall Study|Withdrawal by Subject|39|||
128797848|NCT03988023|463554523|FG001|Overall Study|Withdrawal by Subject|37|||
128797849|NCT03988023|463554522|FG000|Overall Study|Adverse Event|0|||
128797850|NCT03988023|463554523|FG001|Overall Study|Adverse Event|2|||
128797851|NCT03988023|463554522|FG000|Overall Study|Physician Decision|0|||
128797852|NCT03988023|463554523|FG001|Overall Study|Physician Decision|1|||
128797853|NCT03988023|463554522|FG000|Overall Study|Lost to Follow-up|5|||
128797854|NCT03988023|463554523|FG001|Overall Study|Lost to Follow-up|8|||
128797855|NCT03988023|463554522|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
128797856|NCT03988023|463554523|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
128797857|NCT03988023|463554522|FG000|Overall Study|Lack of Efficacy|3|||
128797858|NCT03988023|463554523|FG001|Overall Study|Lack of Efficacy|1|||
128797859|NCT03988023|463554522|FG000|Overall Study|COVID-19 pandemic|225|||
128797860|NCT03988023|463554523|FG001|Overall Study|COVID-19 pandemic|227|||
128797861|NCT00785512|463554524|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
128797862|NCT00785512|463554525|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
128797863|NCT00785512|463554524|FG000|Overall Study|Adverse Event|0|||
128797864|NCT00785512|463554525|FG001|Overall Study|Adverse Event|0|||
128797865|NCT00785512|463554524|FG000|Overall Study|Lack of Efficacy|0|||
128797866|NCT00785512|463554525|FG001|Overall Study|Lack of Efficacy|2|||
128797867|NCT00785512|463554524|FG000|Overall Study|Withdrawal by Subject|0|||
128797868|NCT00785512|463554525|FG001|Overall Study|Withdrawal by Subject|1|||
128797869|NCT00785512|463554524|FG000|Overall Study|Lost to Follow-up|3|||
128797870|NCT00785512|463554525|FG001|Overall Study|Lost to Follow-up|0|||
128797871|NCT00785512|463554524|FG000|Overall Study|Precedure Refused|0|||
128797872|NCT00785512|463554525|FG001|Overall Study|Precedure Refused|0|||
128797873|NCT00785512|463554524|FG000|Overall Study|IVRS Programing Error|0|||
128797874|NCT00785512|463554525|FG001|Overall Study|IVRS Programing Error|0|||
128797875|NCT00785512|463554524|FG000|Overall Study|Physician Decision|0|||
128797876|NCT00785512|463554525|FG001|Overall Study|Physician Decision|0|||
128797877|NCT00785512|463554524|FG000|Overall Study|Lack of compliance|0|||
128797878|NCT00785512|463554525|FG001|Overall Study|Lack of compliance|1|||
128797879|NCT00396084|463554531|FG000|Overall Study|Adverse Event|0|||
128797880|NCT00396084|463554532|FG001|Overall Study|Adverse Event|0|||
128797881|NCT00396084|463554533|FG002|Overall Study|Adverse Event|0|||
128797882|NCT00396084|463554534|FG003|Overall Study|Adverse Event|0|||
128797883|NCT00396084|463554535|FG004|Overall Study|Adverse Event|1|||
128797884|NCT00396084|463554536|FG005|Overall Study|Adverse Event|2|||
128797885|NCT00396084|463554531|FG000|Overall Study|Withdrawal by Subject|0|||
128797886|NCT00396084|463554532|FG001|Overall Study|Withdrawal by Subject|0|||
128797887|NCT00396084|463554533|FG002|Overall Study|Withdrawal by Subject|0|||
128797888|NCT00396084|463554534|FG003|Overall Study|Withdrawal by Subject|1|||
128797889|NCT00396084|463554535|FG004|Overall Study|Withdrawal by Subject|0|||
128797890|NCT00396084|463554536|FG005|Overall Study|Withdrawal by Subject|0|||
128797891|NCT02708108|463554537|FG000|Overall Study|Death|1|||
128797892|NCT02708108|463554538|FG001|Overall Study|Death|2|||
128797893|NCT02708108|463554537|FG000|Overall Study|Regimen change|1|||
128797894|NCT02708108|463554538|FG001|Overall Study|Regimen change|0|||
128797895|NCT02708108|463554537|FG000|Overall Study|No MRD and no imaging available|0|||
128797896|NCT02708108|463554538|FG001|Overall Study|No MRD and no imaging available|1|||
128797897|NCT02568683|463554539|FG000|Overall Study|Death|0|||
128797898|NCT02568683|463554540|FG001|Overall Study|Death|2|||
128797899|NCT02568683|463554539|FG000|Overall Study|Withdrew Consent|1|||
128797900|NCT02568683|463554540|FG001|Overall Study|Withdrew Consent|0|||
128797901|NCT02568683|463554539|FG000|Overall Study|Study Terminated By Sponsor|5|||
128797902|NCT02568683|463554540|FG001|Overall Study|Study Terminated By Sponsor|2|||
128797903|NCT01736215|463554541|FG000|Overall Study|Early termination of erythropoietin use|1|||
128797904|NCT01736215|463554541|FG000|Overall Study|Adverse Event|4|||
128797905|NCT01736215|463554541|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
128797906|NCT01736215|463554541|FG000|Overall Study|Insufficient data to perform analysis|8|||
128797907|NCT01248936|463554547|FG000|Overall Study|Sponsor Decision|259|||
128797908|NCT01248936|463554547|FG000|Overall Study|Progression of Disease|50|||
128797909|NCT01248936|463554547|FG000|Overall Study|Death|26|||
128797910|NCT01248936|463554547|FG000|Overall Study|Withdrawal of Consent|20|||
128797911|NCT01248936|463554547|FG000|Overall Study|Adverse Event|8|||
128797912|NCT01248936|463554547|FG000|Overall Study|Lost to Follow-up|7|||
128797913|NCT01248936|463554547|FG000|Overall Study|Refused Treatment|1|||
128797914|NCT01248936|463554547|FG000|Overall Study|Other reason|3|||
128797915|NCT04556981|463554548|FG000|Overall Study|Death|0|||
128797916|NCT04556981|463554549|FG001|Overall Study|Death|1|||
128797917|NCT04556981|463554548|FG000|Overall Study|Lost to Follow-up|2|||
128797918|NCT04556981|463554549|FG001|Overall Study|Lost to Follow-up|11|||
128797919|NCT04556981|463554548|FG000|Overall Study|Moved from the study area|1|||
128797920|NCT04556981|463554549|FG001|Overall Study|Moved from the study area|4|||
128797921|NCT04556981|463554548|FG000|Overall Study|Withdrawal by Subject|2|||
128797922|NCT04556981|463554549|FG001|Overall Study|Withdrawal by Subject|2|||
128797923|NCT04556981|463554548|FG000|Overall Study|Other|2|||
128797924|NCT04556981|463554549|FG001|Overall Study|Other|1|||
128797925|NCT00068601|463554552|FG000|Overall Study|Ineligible|11|||
128797926|NCT00068601|463554553|FG001|Overall Study|Ineligible|13|||
128797927|NCT00068601|463554552|FG000|Overall Study|Not evaluable: withdrew consent|5|||
128797928|NCT00068601|463554553|FG001|Overall Study|Not evaluable: withdrew consent|4|||
128797929|NCT00068601|463554552|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
128797930|NCT00068601|463554553|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
128797931|NCT00068601|463554552|FG000|Overall Study|Death|11|||
128797932|NCT00068601|463554553|FG001|Overall Study|Death|3|||
128797933|NCT00068601|463554552|FG000|Overall Study|Lost to Follow-up|3|||
128797934|NCT00068601|463554553|FG001|Overall Study|Lost to Follow-up|2|||
128797935|NCT00068601|463554552|FG000|Overall Study|Missing primary outcome data|30|||
128797936|NCT00068601|463554553|FG001|Overall Study|Missing primary outcome data|34|||
128797937|NCT00440011|463554564|FG000|Overall Study|Adverse Event|2|||
128797938|NCT00440011|463554565|FG001|Overall Study|Adverse Event|0|||
128797939|NCT00440011|463554564|FG000|Overall Study|Lost to Follow-up|0|||
128797940|NCT00440011|463554565|FG001|Overall Study|Lost to Follow-up|2|||
128797941|NCT00440011|463554564|FG000|Overall Study|Protocol Violation|1|||
128797942|NCT00440011|463554565|FG001|Overall Study|Protocol Violation|1|||
128797943|NCT00440011|463554564|FG000|Overall Study|Withdrawal by Subject|1|||
128797944|NCT00440011|463554565|FG001|Overall Study|Withdrawal by Subject|0|||
128797945|NCT04732338|463554575|FG000|Overall Study|Lost to Follow-up|3|||
128797946|NCT04732338|463554576|FG001|Overall Study|Lost to Follow-up|3|||
128797947|NCT01803555|463554580|FG000|Overall Study|Adverse Event|3|||
128797948|NCT01803555|463554581|FG001|Overall Study|Adverse Event|2|||
128797949|NCT01803555|463554580|FG000|Overall Study|Withdrawal by Subject|3|||
128797950|NCT01803555|463554581|FG001|Overall Study|Withdrawal by Subject|3|||
128797951|NCT01803555|463554580|FG000|Overall Study|Non-compliance|1|||
128797952|NCT01803555|463554581|FG001|Overall Study|Non-compliance|1|||
128797953|NCT01803555|463554580|FG000|Overall Study|Protocol Violation|3|||
128797954|NCT01803555|463554581|FG001|Overall Study|Protocol Violation|5|||
128797955|NCT01803555|463554580|FG000|Overall Study|Lost to Follow-up|0|||
128797956|NCT01803555|463554581|FG001|Overall Study|Lost to Follow-up|2|||
128797957|NCT01803555|463554580|FG000|Overall Study|Other than specified|3|||
128797958|NCT01803555|463554581|FG001|Overall Study|Other than specified|5|||
128797959|NCT01551355|463554584|FG000|Overall Study|Lost to Follow-up|51|||
128797960|NCT01551355|463554585|FG001|Overall Study|Lost to Follow-up|49|||
128797961|NCT01551355|463554586|FG002|Overall Study|Lost to Follow-up|34|||
128797962|NCT01551355|463554587|FG003|Overall Study|Lost to Follow-up|24|||
128797963|NCT01551355|463554588|FG004|Overall Study|Lost to Follow-up|9|||
128797964|NCT01551355|463554589|FG005|Overall Study|Lost to Follow-up|6|||
128797965|NCT01925339|463554590|FG000|Overall Study|Adverse Event|2|||
128797966|NCT01925339|463554591|FG001|Overall Study|Adverse Event|0|||
128797967|NCT04766034|463554592|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
128797968|NCT04766034|463554593|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
128797969|NCT04766034|463554594|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
128797970|NCT04766034|463554595|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
128797971|NCT04766034|463554596|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
128797972|NCT04766034|463554592|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
128797973|NCT04766034|463554593|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
128797974|NCT04766034|463554594|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
128797975|NCT04766034|463554595|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
128797976|NCT04766034|463554596|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
128797977|NCT04766034|463554592|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
128797978|NCT04766034|463554593|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
128797979|NCT04766034|463554594|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
128797980|NCT04766034|463554595|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
128797981|NCT04766034|463554596|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
128797982|NCT04766034|463554592|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
128797983|NCT04766034|463554593|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
128797984|NCT04766034|463554594|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
128797985|NCT04766034|463554595|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
128797986|NCT04766034|463554596|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
128797987|NCT01538719|463554597|FG000|Overall Study|Lost to Follow-up|2|||
128797988|NCT01538719|463554598|FG001|Overall Study|Lost to Follow-up|0|||
128797989|NCT03664960|463554599|FG000|Overall Study|Adverse Event|0|||
128797990|NCT03664960|463554600|FG001|Overall Study|Adverse Event|3|||
128797991|NCT03664960|463554599|FG000|Overall Study|Lost to Follow-up|3|||
128797992|NCT03664960|463554600|FG001|Overall Study|Lost to Follow-up|2|||
128797993|NCT03664960|463554599|FG000|Overall Study|Physician Decision|1|||
128797994|NCT03664960|463554600|FG001|Overall Study|Physician Decision|0|||
128797995|NCT03664960|463554599|FG000|Overall Study|Withdrawal by Subject|3|||
128797996|NCT03664960|463554600|FG001|Overall Study|Withdrawal by Subject|14|||
128797997|NCT03664960|463554599|FG000|Overall Study|Sponsor Decision|1|||
128797998|NCT03664960|463554600|FG001|Overall Study|Sponsor Decision|1|||
128797999|NCT03664960|463554599|FG000|Overall Study|Other|1|||
128798000|NCT03664960|463554600|FG001|Overall Study|Other|2|||
128798001|NCT00774852|463554602|FG000|Overall Study|Adverse Event|9|||
128798002|NCT00774852|463554603|FG001|Overall Study|Adverse Event|6|||
128798003|NCT00774852|463554602|FG000|Overall Study|Death|2|||
128798004|NCT00774852|463554603|FG001|Overall Study|Death|1|||
128798005|NCT00774852|463554602|FG000|Overall Study|Lack of Efficacy|3|||
128798006|NCT00774852|463554603|FG001|Overall Study|Lack of Efficacy|7|||
128798007|NCT00774852|463554602|FG000|Overall Study|Lost to Follow-up|9|||
128798008|NCT00774852|463554603|FG001|Overall Study|Lost to Follow-up|5|||
128798009|NCT00774852|463554602|FG000|Overall Study|Physician Decision|2|||
128798010|NCT00774852|463554603|FG001|Overall Study|Physician Decision|6|||
128798011|NCT00774852|463554602|FG000|Overall Study|Pregnancy|1|||
128798012|NCT00774852|463554603|FG001|Overall Study|Pregnancy|2|||
128798013|NCT00774852|463554602|FG000|Overall Study|Withdrawal by Subject|2|||
128798014|NCT00774852|463554603|FG001|Overall Study|Withdrawal by Subject|2|||
128798015|NCT00774852|463554602|FG000|Overall Study|Non-responder|15|||
128798016|NCT00774852|463554603|FG001|Overall Study|Non-responder|11|||
128798017|NCT00774852|463554602|FG000|Overall Study|Subject non-compliance|0|||
128798018|NCT00774852|463554603|FG001|Overall Study|Subject non-compliance|1|||
128798019|NCT00774852|463554602|FG000|Overall Study|Protocol Violation|1|||
128798020|NCT00774852|463554603|FG001|Overall Study|Protocol Violation|0|||
128798021|NCT00774852|463554602|FG000|Overall Study|Subject received prohibited medication|1|||
128798022|NCT00774852|463554603|FG001|Overall Study|Subject received prohibited medication|0|||
128798023|NCT03997916|463554604|FG000|Overall Study|Protocol Violation|35|||
128798024|NCT03960463|463556938|FG000|Overall Study|Withdrawal by Subject|2|||
128798025|NCT03960463|463556939|FG001|Overall Study|Withdrawal by Subject|0|||
128798026|NCT05568615|463556940|FG000|Overall Study|Death|1|||
128798027|NCT05568615|463556940|FG000|Overall Study|Physician Decision|1|||
128798028|NCT03529110|463556941|FG000|Overall Study|Progressive Disease|66|||
128798029|NCT03529110|463556942|FG001|Overall Study|Progressive Disease|158|||
128798030|NCT03529110|463556941|FG000|Overall Study|Clinical Progression|4|||
128798031|NCT03529110|463556942|FG001|Overall Study|Clinical Progression|12|||
128798032|NCT03529110|463556941|FG000|Overall Study|Adverse Event|35|||
128798033|NCT03529110|463556942|FG001|Overall Study|Adverse Event|17|||
128798034|NCT03529110|463556941|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
128798035|NCT03529110|463556942|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
128798036|NCT03529110|463556941|FG000|Overall Study|Lack of Efficacy|3|||
128798037|NCT03529110|463556942|FG001|Overall Study|Lack of Efficacy|3|||
128798038|NCT03529110|463556941|FG000|Overall Study|Physician Decision|2|||
128798039|NCT03529110|463556942|FG001|Overall Study|Physician Decision|8|||
128798040|NCT03529110|463556941|FG000|Overall Study|Miscellaneous|2|||
128798041|NCT03529110|463556942|FG001|Overall Study|Miscellaneous|5|||
128798042|NCT04922021|463556945|FG000|Overall Study|Withdrawal by Subject|4|||
128798043|NCT04922021|463556946|FG001|Overall Study|Withdrawal by Subject|10|||
128798044|NCT04922021|463556945|FG000|Overall Study|Adverse Event|2|||
128798045|NCT04922021|463556946|FG001|Overall Study|Adverse Event|2|||
128798046|NCT04922021|463556945|FG000|Overall Study|Lack of Efficacy|0|||
128798047|NCT04922021|463556946|FG001|Overall Study|Lack of Efficacy|1|||
128798048|NCT04922021|463556945|FG000|Overall Study|Multiple reasons|1|||
128798049|NCT04922021|463556946|FG001|Overall Study|Multiple reasons|0|||
128798050|NCT04139668|463556956|FG000|Overall Study|Withdrawal by Subject|1|||
128798051|NCT03025789|463556961|FG000|Overall Study|Lack of Efficacy|6|||
128798052|NCT03025789|463556962|FG001|Overall Study|Lack of Efficacy|1|||
128798053|NCT03025789|463556961|FG000|Overall Study|Death|1|||
128798054|NCT03025789|463556962|FG001|Overall Study|Death|0|||
128798055|NCT03025789|463556961|FG000|Overall Study|Withdrawal by Subject|0|||
128798056|NCT03025789|463556962|FG001|Overall Study|Withdrawal by Subject|2|||
128798057|NCT02723955|463556964|FG000|Escalation Phase|Death|1|||
128798058|NCT02723955|463556965|FG001|Escalation Phase|Death|1|||
128798059|NCT02723955|463556966|FG002|Escalation Phase|Death|2|||
128798060|NCT02723955|463556967|FG003|Escalation Phase|Death|7|||
128798061|NCT02723955|463556968|FG004|Escalation Phase|Death|18|||
128798062|NCT02723955|463556969|FG005|Escalation Phase|Death|17|||
128798063|NCT02723955|463556970|FG006|Escalation Phase|Death|11|||
128798064|NCT02723955|463556971|FG007|Escalation Phase|Death|21|||
128798065|NCT02723955|463556972|FG008|Escalation Phase|Death|3|||
128798066|NCT02723955|463556973|FG009|Escalation Phase|Death|0|||
128798067|NCT02723955|463556974|FG010|Escalation Phase|Death|0|||
128798068|NCT02723955|463556975|FG011|Escalation Phase|Death|0|||
128798069|NCT02723955|463556976|FG012|Escalation Phase|Death|2|||
128798070|NCT02723955|463556977|FG013|Escalation Phase|Death|4|||
128798071|NCT02723955|463556978|FG014|Escalation Phase|Death|5|||
128798072|NCT02723955|463556979|FG015|Escalation Phase|Death|6|||
128798073|NCT02723955|463556980|FG016|Escalation Phase|Death|6|||
128798074|NCT02723955|463556981|FG017|Escalation Phase|Death|7|||
128798075|NCT02723955|463556982|FG018|Escalation Phase|Death|1|||
128798076|NCT02723955|463556983|FG019|Escalation Phase|Death|3|||
128798077|NCT02723955|463556984|FG020|Escalation Phase|Death|13|||
128798078|NCT02723955|463556985|FG021|Escalation Phase|Death|3|||
128798079|NCT02723955|463556986|FG022|Escalation Phase|Death|2|||
128798080|NCT02723955|463556987|FG023|Escalation Phase|Death|4|||
128798081|NCT02723955|463556988|FG024|Escalation Phase|Death|31|||
128798082|NCT02723955|463556989|FG025|Escalation Phase|Death|7|||
128798083|NCT02723955|463556990|FG026|Escalation Phase|Death|13|||
128798084|NCT02723955|463556991|FG027|Escalation Phase|Death|0|||
128798085|NCT02723955|463556992|FG028|Escalation Phase|Death|1|||
128798086|NCT02723955|463556993|FG029|Escalation Phase|Death|0|||
128798087|NCT02723955|463556994|FG030|Escalation Phase|Death|0|||
128798088|NCT02723955|463556995|FG031|Escalation Phase|Death|0|||
128798089|NCT02723955|463556996|FG032|Escalation Phase|Death|0|||
128798090|NCT02723955|463556997|FG033|Escalation Phase|Death|0|||
128798091|NCT02723955|463556998|FG034|Escalation Phase|Death|0|||
128798092|NCT02723955|463556999|FG035|Escalation Phase|Death|0|||
128798093|NCT02723955|463557000|FG036|Escalation Phase|Death|0|||
128798094|NCT02723955|463557001|FG037|Escalation Phase|Death|0|||
128798095|NCT02723955|463557002|FG038|Escalation Phase|Death|0|||
128798096|NCT02723955|463557003|FG039|Escalation Phase|Death|0|||
128798097|NCT02723955|463557004|FG040|Escalation Phase|Death|0|||
128798098|NCT02723955|463557005|FG041|Escalation Phase|Death|0|||
128798099|NCT02723955|463557006|FG042|Escalation Phase|Death|0|||
128798100|NCT02723955|463556964|FG000|Escalation Phase|Lost to Follow-up|0|||
128798101|NCT02723955|463556965|FG001|Escalation Phase|Lost to Follow-up|0|||
128798102|NCT02723955|463556966|FG002|Escalation Phase|Lost to Follow-up|0|||
128798103|NCT02723955|463556967|FG003|Escalation Phase|Lost to Follow-up|0|||
128798104|NCT02723955|463556968|FG004|Escalation Phase|Lost to Follow-up|0|||
128798105|NCT02723955|463556969|FG005|Escalation Phase|Lost to Follow-up|2|||
128798106|NCT02723955|463556970|FG006|Escalation Phase|Lost to Follow-up|1|||
128798107|NCT02723955|463556971|FG007|Escalation Phase|Lost to Follow-up|1|||
128798108|NCT02723955|463556972|FG008|Escalation Phase|Lost to Follow-up|1|||
128798109|NCT02723955|463556973|FG009|Escalation Phase|Lost to Follow-up|0|||
128798110|NCT02723955|463556974|FG010|Escalation Phase|Lost to Follow-up|0|||
128798111|NCT02723955|463556975|FG011|Escalation Phase|Lost to Follow-up|0|||
128798112|NCT02723955|463556976|FG012|Escalation Phase|Lost to Follow-up|1|||
128798113|NCT02723955|463556977|FG013|Escalation Phase|Lost to Follow-up|0|||
128798114|NCT02723955|463556978|FG014|Escalation Phase|Lost to Follow-up|0|||
128798115|NCT02723955|463556979|FG015|Escalation Phase|Lost to Follow-up|0|||
128798116|NCT02723955|463556980|FG016|Escalation Phase|Lost to Follow-up|1|||
128798117|NCT02723955|463556981|FG017|Escalation Phase|Lost to Follow-up|2|||
128798118|NCT02723955|463556982|FG018|Escalation Phase|Lost to Follow-up|0|||
128798119|NCT02723955|463556983|FG019|Escalation Phase|Lost to Follow-up|1|||
128798120|NCT02723955|463556984|FG020|Escalation Phase|Lost to Follow-up|2|||
128798121|NCT02723955|463556985|FG021|Escalation Phase|Lost to Follow-up|1|||
128798122|NCT02723955|463556986|FG022|Escalation Phase|Lost to Follow-up|0|||
128798123|NCT02723955|463556987|FG023|Escalation Phase|Lost to Follow-up|0|||
128798124|NCT02723955|463556988|FG024|Escalation Phase|Lost to Follow-up|1|||
128798125|NCT02723955|463556989|FG025|Escalation Phase|Lost to Follow-up|1|||
128798126|NCT02723955|463556990|FG026|Escalation Phase|Lost to Follow-up|3|||
128798127|NCT02723955|463556991|FG027|Escalation Phase|Lost to Follow-up|0|||
128798128|NCT02723955|463556992|FG028|Escalation Phase|Lost to Follow-up|1|||
128798129|NCT02723955|463556993|FG029|Escalation Phase|Lost to Follow-up|0|||
128798130|NCT02723955|463556994|FG030|Escalation Phase|Lost to Follow-up|0|||
128798131|NCT02723955|463556995|FG031|Escalation Phase|Lost to Follow-up|0|||
128798132|NCT02723955|463556996|FG032|Escalation Phase|Lost to Follow-up|0|||
128798133|NCT02723955|463556997|FG033|Escalation Phase|Lost to Follow-up|0|||
128798134|NCT02723955|463556998|FG034|Escalation Phase|Lost to Follow-up|0|||
128798135|NCT02723955|463556999|FG035|Escalation Phase|Lost to Follow-up|0|||
128798136|NCT02723955|463557000|FG036|Escalation Phase|Lost to Follow-up|0|||
128798137|NCT02723955|463557001|FG037|Escalation Phase|Lost to Follow-up|0|||
128798138|NCT02723955|463557002|FG038|Escalation Phase|Lost to Follow-up|0|||
128798139|NCT02723955|463557003|FG039|Escalation Phase|Lost to Follow-up|0|||
128798140|NCT02723955|463557004|FG040|Escalation Phase|Lost to Follow-up|0|||
128798141|NCT02723955|463557005|FG041|Escalation Phase|Lost to Follow-up|0|||
128798142|NCT02723955|463557006|FG042|Escalation Phase|Lost to Follow-up|0|||
128798143|NCT02723955|463556964|FG000|Escalation Phase|Physician Decision|0|||
128798144|NCT02723955|463556965|FG001|Escalation Phase|Physician Decision|0|||
128798145|NCT02723955|463556966|FG002|Escalation Phase|Physician Decision|0|||
128798146|NCT02723955|463556967|FG003|Escalation Phase|Physician Decision|0|||
128798147|NCT02723955|463556968|FG004|Escalation Phase|Physician Decision|0|||
128798148|NCT02723955|463556969|FG005|Escalation Phase|Physician Decision|2|||
128798149|NCT02723955|463556970|FG006|Escalation Phase|Physician Decision|0|||
128798150|NCT02723955|463556971|FG007|Escalation Phase|Physician Decision|0|||
128798151|NCT02723955|463556972|FG008|Escalation Phase|Physician Decision|0|||
128798152|NCT02723955|463556973|FG009|Escalation Phase|Physician Decision|0|||
128798153|NCT02723955|463556974|FG010|Escalation Phase|Physician Decision|0|||
128798154|NCT02723955|463556975|FG011|Escalation Phase|Physician Decision|0|||
128798155|NCT02723955|463556976|FG012|Escalation Phase|Physician Decision|0|||
128798156|NCT02723955|463556977|FG013|Escalation Phase|Physician Decision|0|||
128798157|NCT02723955|463556978|FG014|Escalation Phase|Physician Decision|0|||
128798158|NCT02723955|463556979|FG015|Escalation Phase|Physician Decision|0|||
128798159|NCT02723955|463556980|FG016|Escalation Phase|Physician Decision|0|||
128798160|NCT02723955|463556981|FG017|Escalation Phase|Physician Decision|0|||
128798161|NCT02723955|463556982|FG018|Escalation Phase|Physician Decision|0|||
128798162|NCT02723955|463556983|FG019|Escalation Phase|Physician Decision|0|||
128798163|NCT02723955|463556984|FG020|Escalation Phase|Physician Decision|0|||
128798164|NCT02723955|463556985|FG021|Escalation Phase|Physician Decision|0|||
128798165|NCT02723955|463556986|FG022|Escalation Phase|Physician Decision|0|||
128798166|NCT02723955|463556987|FG023|Escalation Phase|Physician Decision|0|||
128798167|NCT02723955|463556988|FG024|Escalation Phase|Physician Decision|0|||
128798168|NCT02723955|463556989|FG025|Escalation Phase|Physician Decision|0|||
128798169|NCT02723955|463556990|FG026|Escalation Phase|Physician Decision|2|||
128798170|NCT02723955|463556991|FG027|Escalation Phase|Physician Decision|0|||
128798171|NCT02723955|463556992|FG028|Escalation Phase|Physician Decision|0|||
128798172|NCT02723955|463556993|FG029|Escalation Phase|Physician Decision|0|||
128798173|NCT02723955|463556994|FG030|Escalation Phase|Physician Decision|0|||
128798174|NCT02723955|463556995|FG031|Escalation Phase|Physician Decision|0|||
128798175|NCT02723955|463556996|FG032|Escalation Phase|Physician Decision|0|||
128798176|NCT02723955|463556997|FG033|Escalation Phase|Physician Decision|0|||
128798177|NCT02723955|463556998|FG034|Escalation Phase|Physician Decision|0|||
128798178|NCT02723955|463556999|FG035|Escalation Phase|Physician Decision|0|||
128798179|NCT02723955|463557000|FG036|Escalation Phase|Physician Decision|0|||
128798180|NCT02723955|463557001|FG037|Escalation Phase|Physician Decision|0|||
128798181|NCT02723955|463557002|FG038|Escalation Phase|Physician Decision|0|||
128798182|NCT02723955|463557003|FG039|Escalation Phase|Physician Decision|0|||
128798183|NCT02723955|463557004|FG040|Escalation Phase|Physician Decision|0|||
128798184|NCT02723955|463557005|FG041|Escalation Phase|Physician Decision|0|||
128798185|NCT02723955|463557006|FG042|Escalation Phase|Physician Decision|0|||
128798186|NCT02723955|463556964|FG000|Escalation Phase|Withdrawal by Subject|0|||
128798187|NCT02723955|463556965|FG001|Escalation Phase|Withdrawal by Subject|0|||
128798188|NCT02723955|463556966|FG002|Escalation Phase|Withdrawal by Subject|0|||
128798189|NCT02723955|463556967|FG003|Escalation Phase|Withdrawal by Subject|0|||
128798190|NCT02723955|463556968|FG004|Escalation Phase|Withdrawal by Subject|1|||
128798191|NCT02723955|463556969|FG005|Escalation Phase|Withdrawal by Subject|1|||
128798192|NCT02723955|463556970|FG006|Escalation Phase|Withdrawal by Subject|1|||
128798193|NCT02723955|463556971|FG007|Escalation Phase|Withdrawal by Subject|1|||
128798194|NCT02723955|463556972|FG008|Escalation Phase|Withdrawal by Subject|0|||
128798195|NCT02723955|463556973|FG009|Escalation Phase|Withdrawal by Subject|0|||
128798196|NCT02723955|463556974|FG010|Escalation Phase|Withdrawal by Subject|0|||
128798197|NCT02723955|463556975|FG011|Escalation Phase|Withdrawal by Subject|0|||
128798198|NCT02723955|463556976|FG012|Escalation Phase|Withdrawal by Subject|1|||
128798199|NCT02723955|463556977|FG013|Escalation Phase|Withdrawal by Subject|0|||
128798200|NCT02723955|463556978|FG014|Escalation Phase|Withdrawal by Subject|0|||
128798201|NCT02723955|463556979|FG015|Escalation Phase|Withdrawal by Subject|0|||
128798202|NCT02723955|463556980|FG016|Escalation Phase|Withdrawal by Subject|1|||
128798203|NCT02723955|463556981|FG017|Escalation Phase|Withdrawal by Subject|0|||
128798204|NCT02723955|463556982|FG018|Escalation Phase|Withdrawal by Subject|0|||
128798205|NCT02723955|463556983|FG019|Escalation Phase|Withdrawal by Subject|0|||
128798206|NCT02723955|463556984|FG020|Escalation Phase|Withdrawal by Subject|0|||
128798207|NCT02723955|463556985|FG021|Escalation Phase|Withdrawal by Subject|0|||
128798208|NCT02723955|463556986|FG022|Escalation Phase|Withdrawal by Subject|0|||
128798209|NCT02723955|463556987|FG023|Escalation Phase|Withdrawal by Subject|2|||
128798210|NCT02723955|463556988|FG024|Escalation Phase|Withdrawal by Subject|0|||
128798211|NCT02723955|463556989|FG025|Escalation Phase|Withdrawal by Subject|1|||
128798212|NCT02723955|463556990|FG026|Escalation Phase|Withdrawal by Subject|0|||
128798213|NCT02723955|463556991|FG027|Escalation Phase|Withdrawal by Subject|0|||
128798214|NCT02723955|463556992|FG028|Escalation Phase|Withdrawal by Subject|1|||
128798215|NCT02723955|463556993|FG029|Escalation Phase|Withdrawal by Subject|0|||
128798216|NCT02723955|463556994|FG030|Escalation Phase|Withdrawal by Subject|0|||
128798217|NCT02723955|463556995|FG031|Escalation Phase|Withdrawal by Subject|0|||
128798218|NCT02723955|463556996|FG032|Escalation Phase|Withdrawal by Subject|0|||
128798219|NCT02723955|463556997|FG033|Escalation Phase|Withdrawal by Subject|0|||
128798220|NCT02723955|463556998|FG034|Escalation Phase|Withdrawal by Subject|0|||
128798221|NCT02723955|463556999|FG035|Escalation Phase|Withdrawal by Subject|0|||
128798222|NCT02723955|463557000|FG036|Escalation Phase|Withdrawal by Subject|0|||
128798223|NCT02723955|463557001|FG037|Escalation Phase|Withdrawal by Subject|0|||
128798224|NCT02723955|463557002|FG038|Escalation Phase|Withdrawal by Subject|0|||
128798225|NCT02723955|463557003|FG039|Escalation Phase|Withdrawal by Subject|0|||
128798226|NCT02723955|463557004|FG040|Escalation Phase|Withdrawal by Subject|0|||
128798227|NCT02723955|463557005|FG041|Escalation Phase|Withdrawal by Subject|0|||
128798228|NCT02723955|463557006|FG042|Escalation Phase|Withdrawal by Subject|0|||
128798229|NCT02723955|463556964|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798230|NCT02723955|463556965|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798231|NCT02723955|463556966|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798232|NCT02723955|463556967|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798233|NCT02723955|463556968|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
128798234|NCT02723955|463556969|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
128798235|NCT02723955|463556970|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
128798236|NCT02723955|463556971|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
128798237|NCT02723955|463556972|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
128798238|NCT02723955|463556973|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798239|NCT02723955|463556974|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798240|NCT02723955|463556975|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798241|NCT02723955|463556976|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798242|NCT02723955|463556977|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798243|NCT02723955|463556978|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798244|NCT02723955|463556979|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798245|NCT02723955|463556980|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798246|NCT02723955|463556981|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798247|NCT02723955|463556982|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798248|NCT02723955|463556983|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798249|NCT02723955|463556984|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798250|NCT02723955|463556985|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798251|NCT02723955|463556986|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798252|NCT02723955|463556987|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798253|NCT02723955|463556988|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798254|NCT02723955|463556989|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798255|NCT02723955|463556990|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798256|NCT02723955|463556991|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798257|NCT02723955|463556992|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798258|NCT02723955|463556993|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798259|NCT02723955|463556994|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798260|NCT02723955|463556995|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798261|NCT02723955|463556996|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798262|NCT02723955|463556997|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798263|NCT02723955|463556998|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798264|NCT02723955|463556999|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798265|NCT02723955|463557000|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798266|NCT02723955|463557001|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798267|NCT02723955|463557002|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798268|NCT02723955|463557003|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798269|NCT02723955|463557004|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798270|NCT02723955|463557005|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798271|NCT02723955|463557006|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
128798272|NCT02723955|463556964|FG000|Escalation Phase|Site Closed|0|||
128798273|NCT02723955|463556965|FG001|Escalation Phase|Site Closed|0|||
128798274|NCT02723955|463556966|FG002|Escalation Phase|Site Closed|0|||
128798275|NCT02723955|463556967|FG003|Escalation Phase|Site Closed|0|||
128798276|NCT02723955|463556968|FG004|Escalation Phase|Site Closed|0|||
128798277|NCT02723955|463556969|FG005|Escalation Phase|Site Closed|0|||
128798278|NCT02723955|463556970|FG006|Escalation Phase|Site Closed|0|||
128798279|NCT02723955|463556971|FG007|Escalation Phase|Site Closed|0|||
128798280|NCT02723955|463556972|FG008|Escalation Phase|Site Closed|0|||
128798281|NCT02723955|463556973|FG009|Escalation Phase|Site Closed|0|||
128798282|NCT02723955|463556974|FG010|Escalation Phase|Site Closed|0|||
128798283|NCT02723955|463556975|FG011|Escalation Phase|Site Closed|0|||
128798284|NCT02723955|463556976|FG012|Escalation Phase|Site Closed|0|||
128798285|NCT02723955|463556977|FG013|Escalation Phase|Site Closed|0|||
128798286|NCT02723955|463556978|FG014|Escalation Phase|Site Closed|0|||
128798287|NCT02723955|463556979|FG015|Escalation Phase|Site Closed|1|||
128798288|NCT02723955|463556980|FG016|Escalation Phase|Site Closed|0|||
128798289|NCT02723955|463556981|FG017|Escalation Phase|Site Closed|2|||
128798290|NCT02723955|463556982|FG018|Escalation Phase|Site Closed|0|||
128798291|NCT02723955|463556983|FG019|Escalation Phase|Site Closed|0|||
128798292|NCT02723955|463556984|FG020|Escalation Phase|Site Closed|1|||
128798293|NCT02723955|463556985|FG021|Escalation Phase|Site Closed|0|||
128798294|NCT02723955|463556986|FG022|Escalation Phase|Site Closed|0|||
128798295|NCT02723955|463556987|FG023|Escalation Phase|Site Closed|0|||
128798296|NCT02723955|463556988|FG024|Escalation Phase|Site Closed|3|||
128798297|NCT02723955|463556989|FG025|Escalation Phase|Site Closed|1|||
128798298|NCT02723955|463556990|FG026|Escalation Phase|Site Closed|3|||
128798299|NCT02723955|463556991|FG027|Escalation Phase|Site Closed|1|||
128798300|NCT02723955|463556992|FG028|Escalation Phase|Site Closed|1|||
128798301|NCT02723955|463556993|FG029|Escalation Phase|Site Closed|0|||
128798302|NCT02723955|463556994|FG030|Escalation Phase|Site Closed|0|||
128798303|NCT02723955|463556995|FG031|Escalation Phase|Site Closed|0|||
128798304|NCT02723955|463556996|FG032|Escalation Phase|Site Closed|0|||
128798305|NCT02723955|463556997|FG033|Escalation Phase|Site Closed|0|||
128798306|NCT02723955|463556998|FG034|Escalation Phase|Site Closed|0|||
128798307|NCT02723955|463556999|FG035|Escalation Phase|Site Closed|0|||
128798308|NCT02723955|463557000|FG036|Escalation Phase|Site Closed|0|||
128798309|NCT02723955|463557001|FG037|Escalation Phase|Site Closed|0|||
128798310|NCT02723955|463557002|FG038|Escalation Phase|Site Closed|0|||
128798311|NCT02723955|463557003|FG039|Escalation Phase|Site Closed|0|||
128798312|NCT02723955|463557004|FG040|Escalation Phase|Site Closed|0|||
128798313|NCT02723955|463557005|FG041|Escalation Phase|Site Closed|0|||
128798314|NCT02723955|463557006|FG042|Escalation Phase|Site Closed|0|||
128798315|NCT02723955|463556964|FG000|Expansion Phase|Death|0|||
128798316|NCT02723955|463556965|FG001|Expansion Phase|Death|0|||
128798317|NCT02723955|463556966|FG002|Expansion Phase|Death|0|||
128798318|NCT02723955|463556967|FG003|Expansion Phase|Death|0|||
128798319|NCT02723955|463556968|FG004|Expansion Phase|Death|0|||
128798320|NCT02723955|463556969|FG005|Expansion Phase|Death|0|||
128798321|NCT02723955|463556970|FG006|Expansion Phase|Death|0|||
128798322|NCT02723955|463556971|FG007|Expansion Phase|Death|0|||
128798323|NCT02723955|463556972|FG008|Expansion Phase|Death|0|||
128798324|NCT02723955|463556973|FG009|Expansion Phase|Death|25|||
128798325|NCT02723955|463556974|FG010|Expansion Phase|Death|69|||
128798326|NCT02723955|463556975|FG011|Expansion Phase|Death|48|||
128798327|NCT02723955|463556976|FG012|Expansion Phase|Death|0|||
128798328|NCT02723955|463556977|FG013|Expansion Phase|Death|0|||
128798329|NCT02723955|463556978|FG014|Expansion Phase|Death|0|||
128798330|NCT02723955|463556979|FG015|Expansion Phase|Death|0|||
128798331|NCT02723955|463556980|FG016|Expansion Phase|Death|0|||
128798332|NCT02723955|463556981|FG017|Expansion Phase|Death|0|||
128798333|NCT02723955|463556982|FG018|Expansion Phase|Death|0|||
128798334|NCT02723955|463556983|FG019|Expansion Phase|Death|0|||
128798335|NCT02723955|463556984|FG020|Expansion Phase|Death|0|||
128798336|NCT02723955|463556985|FG021|Expansion Phase|Death|0|||
128798337|NCT02723955|463556986|FG022|Expansion Phase|Death|0|||
128798338|NCT02723955|463556987|FG023|Expansion Phase|Death|0|||
128798339|NCT02723955|463556988|FG024|Expansion Phase|Death|0|||
128798340|NCT02723955|463556989|FG025|Expansion Phase|Death|0|||
128798341|NCT02723955|463556990|FG026|Expansion Phase|Death|0|||
128798342|NCT02723955|463556991|FG027|Expansion Phase|Death|0|||
128798343|NCT02723955|463556992|FG028|Expansion Phase|Death|0|||
128798344|NCT02723955|463556993|FG029|Expansion Phase|Death|12|||
128798345|NCT02723955|463556994|FG030|Expansion Phase|Death|202|||
128798346|NCT02723955|463556995|FG031|Expansion Phase|Death|31|||
128798347|NCT02723955|463556996|FG032|Expansion Phase|Death|17|||
128798348|NCT02723955|463556997|FG033|Expansion Phase|Death|2|||
128798349|NCT02723955|463556998|FG034|Expansion Phase|Death|3|||
128798350|NCT02723955|463556999|FG035|Expansion Phase|Death|3|||
128798351|NCT02723955|463557000|FG036|Expansion Phase|Death|1|||
128798352|NCT02723955|463557001|FG037|Expansion Phase|Death|0|||
128798353|NCT02723955|463557002|FG038|Expansion Phase|Death|0|||
128798354|NCT02723955|463557003|FG039|Expansion Phase|Death|0|||
128798355|NCT02723955|463557004|FG040|Expansion Phase|Death|0|||
128798356|NCT02723955|463557005|FG041|Expansion Phase|Death|0|||
128798357|NCT02723955|463557006|FG042|Expansion Phase|Death|0|||
128798358|NCT02723955|463556964|FG000|Expansion Phase|Lost to Follow-up|0|||
128798359|NCT02723955|463556965|FG001|Expansion Phase|Lost to Follow-up|0|||
128798360|NCT02723955|463556966|FG002|Expansion Phase|Lost to Follow-up|0|||
128798361|NCT02723955|463556967|FG003|Expansion Phase|Lost to Follow-up|0|||
128798362|NCT02723955|463556968|FG004|Expansion Phase|Lost to Follow-up|0|||
128798363|NCT02723955|463556969|FG005|Expansion Phase|Lost to Follow-up|0|||
128798364|NCT02723955|463556970|FG006|Expansion Phase|Lost to Follow-up|0|||
128798365|NCT02723955|463556971|FG007|Expansion Phase|Lost to Follow-up|0|||
128798366|NCT02723955|463556972|FG008|Expansion Phase|Lost to Follow-up|0|||
128798367|NCT02723955|463556973|FG009|Expansion Phase|Lost to Follow-up|0|||
128798368|NCT02723955|463556974|FG010|Expansion Phase|Lost to Follow-up|4|||
128798369|NCT02723955|463556975|FG011|Expansion Phase|Lost to Follow-up|1|||
128798370|NCT02723955|463556976|FG012|Expansion Phase|Lost to Follow-up|0|||
128798371|NCT02723955|463556977|FG013|Expansion Phase|Lost to Follow-up|0|||
128798372|NCT02723955|463556978|FG014|Expansion Phase|Lost to Follow-up|0|||
128798373|NCT02723955|463556979|FG015|Expansion Phase|Lost to Follow-up|0|||
128798374|NCT02723955|463556980|FG016|Expansion Phase|Lost to Follow-up|0|||
128798375|NCT02723955|463556981|FG017|Expansion Phase|Lost to Follow-up|0|||
128798376|NCT02723955|463556982|FG018|Expansion Phase|Lost to Follow-up|0|||
128798377|NCT02723955|463556983|FG019|Expansion Phase|Lost to Follow-up|0|||
128798378|NCT02723955|463556984|FG020|Expansion Phase|Lost to Follow-up|0|||
128798379|NCT02723955|463556985|FG021|Expansion Phase|Lost to Follow-up|0|||
128798380|NCT02723955|463556986|FG022|Expansion Phase|Lost to Follow-up|0|||
128798381|NCT02723955|463556987|FG023|Expansion Phase|Lost to Follow-up|0|||
128798382|NCT02723955|463556988|FG024|Expansion Phase|Lost to Follow-up|0|||
128798383|NCT02723955|463556989|FG025|Expansion Phase|Lost to Follow-up|0|||
128798384|NCT02723955|463556990|FG026|Expansion Phase|Lost to Follow-up|0|||
128798385|NCT02723955|463556991|FG027|Expansion Phase|Lost to Follow-up|0|||
128798386|NCT02723955|463556992|FG028|Expansion Phase|Lost to Follow-up|0|||
128798387|NCT02723955|463556993|FG029|Expansion Phase|Lost to Follow-up|1|||
128798388|NCT02723955|463556994|FG030|Expansion Phase|Lost to Follow-up|19|||
128798389|NCT02723955|463556995|FG031|Expansion Phase|Lost to Follow-up|2|||
128798390|NCT02723955|463556996|FG032|Expansion Phase|Lost to Follow-up|1|||
128798391|NCT02723955|463556997|FG033|Expansion Phase|Lost to Follow-up|0|||
128798392|NCT02723955|463556998|FG034|Expansion Phase|Lost to Follow-up|0|||
128798393|NCT02723955|463556999|FG035|Expansion Phase|Lost to Follow-up|0|||
128798394|NCT02723955|463557000|FG036|Expansion Phase|Lost to Follow-up|0|||
128798395|NCT02723955|463557001|FG037|Expansion Phase|Lost to Follow-up|0|||
128798396|NCT02723955|463557002|FG038|Expansion Phase|Lost to Follow-up|0|||
128798397|NCT02723955|463557003|FG039|Expansion Phase|Lost to Follow-up|0|||
128798398|NCT02723955|463557004|FG040|Expansion Phase|Lost to Follow-up|0|||
128798399|NCT02723955|463557005|FG041|Expansion Phase|Lost to Follow-up|0|||
128798400|NCT02723955|463557006|FG042|Expansion Phase|Lost to Follow-up|0|||
128798401|NCT02723955|463556964|FG000|Expansion Phase|Physician Decision|0|||
128798402|NCT02723955|463556965|FG001|Expansion Phase|Physician Decision|0|||
128798403|NCT02723955|463556966|FG002|Expansion Phase|Physician Decision|0|||
128798404|NCT02723955|463556967|FG003|Expansion Phase|Physician Decision|0|||
128798405|NCT02723955|463556968|FG004|Expansion Phase|Physician Decision|0|||
128798406|NCT02723955|463556969|FG005|Expansion Phase|Physician Decision|0|||
128798407|NCT02723955|463556970|FG006|Expansion Phase|Physician Decision|0|||
128798408|NCT02723955|463556971|FG007|Expansion Phase|Physician Decision|0|||
128798409|NCT02723955|463556972|FG008|Expansion Phase|Physician Decision|0|||
128798410|NCT02723955|463556973|FG009|Expansion Phase|Physician Decision|0|||
128798411|NCT02723955|463556974|FG010|Expansion Phase|Physician Decision|0|||
128798412|NCT02723955|463556975|FG011|Expansion Phase|Physician Decision|0|||
128798413|NCT02723955|463556976|FG012|Expansion Phase|Physician Decision|0|||
128798414|NCT02723955|463556977|FG013|Expansion Phase|Physician Decision|0|||
128798415|NCT02723955|463556978|FG014|Expansion Phase|Physician Decision|0|||
128798416|NCT02723955|463556979|FG015|Expansion Phase|Physician Decision|0|||
128798417|NCT02723955|463556980|FG016|Expansion Phase|Physician Decision|0|||
128798418|NCT02723955|463556981|FG017|Expansion Phase|Physician Decision|0|||
128798419|NCT02723955|463556982|FG018|Expansion Phase|Physician Decision|0|||
128798420|NCT02723955|463556983|FG019|Expansion Phase|Physician Decision|0|||
128798421|NCT02723955|463556984|FG020|Expansion Phase|Physician Decision|0|||
128798422|NCT02723955|463556985|FG021|Expansion Phase|Physician Decision|0|||
128798423|NCT02723955|463556986|FG022|Expansion Phase|Physician Decision|0|||
128798424|NCT02723955|463556987|FG023|Expansion Phase|Physician Decision|0|||
128798425|NCT02723955|463556988|FG024|Expansion Phase|Physician Decision|0|||
128798426|NCT02723955|463556989|FG025|Expansion Phase|Physician Decision|0|||
128798427|NCT02723955|463556990|FG026|Expansion Phase|Physician Decision|0|||
128798428|NCT02723955|463556991|FG027|Expansion Phase|Physician Decision|0|||
128798429|NCT02723955|463556992|FG028|Expansion Phase|Physician Decision|0|||
128798430|NCT02723955|463556993|FG029|Expansion Phase|Physician Decision|0|||
128798431|NCT02723955|463556994|FG030|Expansion Phase|Physician Decision|1|||
128798432|NCT02723955|463556995|FG031|Expansion Phase|Physician Decision|1|||
128798433|NCT02723955|463556996|FG032|Expansion Phase|Physician Decision|0|||
128798434|NCT02723955|463556997|FG033|Expansion Phase|Physician Decision|0|||
128798435|NCT02723955|463556998|FG034|Expansion Phase|Physician Decision|0|||
128798436|NCT02723955|463556999|FG035|Expansion Phase|Physician Decision|0|||
128798437|NCT02723955|463557000|FG036|Expansion Phase|Physician Decision|0|||
128798438|NCT02723955|463557001|FG037|Expansion Phase|Physician Decision|0|||
128798439|NCT02723955|463557002|FG038|Expansion Phase|Physician Decision|0|||
128798440|NCT02723955|463557003|FG039|Expansion Phase|Physician Decision|0|||
128798441|NCT02723955|463557004|FG040|Expansion Phase|Physician Decision|0|||
128798442|NCT02723955|463557005|FG041|Expansion Phase|Physician Decision|0|||
128798443|NCT02723955|463557006|FG042|Expansion Phase|Physician Decision|0|||
128798444|NCT02723955|463556964|FG000|Expansion Phase|Withdrawal by Subject|0|||
128798445|NCT02723955|463556965|FG001|Expansion Phase|Withdrawal by Subject|0|||
128798446|NCT02723955|463556966|FG002|Expansion Phase|Withdrawal by Subject|0|||
128798447|NCT02723955|463556967|FG003|Expansion Phase|Withdrawal by Subject|0|||
128798448|NCT02723955|463556968|FG004|Expansion Phase|Withdrawal by Subject|0|||
128798449|NCT02723955|463556969|FG005|Expansion Phase|Withdrawal by Subject|0|||
128798450|NCT02723955|463556970|FG006|Expansion Phase|Withdrawal by Subject|0|||
128798451|NCT02723955|463556971|FG007|Expansion Phase|Withdrawal by Subject|0|||
128798452|NCT02723955|463556972|FG008|Expansion Phase|Withdrawal by Subject|0|||
128798453|NCT02723955|463556973|FG009|Expansion Phase|Withdrawal by Subject|2|||
128798454|NCT02723955|463556974|FG010|Expansion Phase|Withdrawal by Subject|1|||
128798455|NCT02723955|463556975|FG011|Expansion Phase|Withdrawal by Subject|0|||
128798456|NCT02723955|463556976|FG012|Expansion Phase|Withdrawal by Subject|0|||
128798457|NCT02723955|463556977|FG013|Expansion Phase|Withdrawal by Subject|0|||
128798458|NCT02723955|463556978|FG014|Expansion Phase|Withdrawal by Subject|0|||
128798459|NCT02723955|463556979|FG015|Expansion Phase|Withdrawal by Subject|0|||
128798460|NCT02723955|463556980|FG016|Expansion Phase|Withdrawal by Subject|0|||
128798461|NCT02723955|463556981|FG017|Expansion Phase|Withdrawal by Subject|0|||
128798462|NCT02723955|463556982|FG018|Expansion Phase|Withdrawal by Subject|0|||
128798463|NCT02723955|463556983|FG019|Expansion Phase|Withdrawal by Subject|0|||
128798464|NCT02723955|463556984|FG020|Expansion Phase|Withdrawal by Subject|0|||
128798465|NCT02723955|463556985|FG021|Expansion Phase|Withdrawal by Subject|0|||
128798466|NCT02723955|463556986|FG022|Expansion Phase|Withdrawal by Subject|0|||
128798467|NCT02723955|463556987|FG023|Expansion Phase|Withdrawal by Subject|0|||
128798468|NCT02723955|463556988|FG024|Expansion Phase|Withdrawal by Subject|0|||
128798469|NCT02723955|463556989|FG025|Expansion Phase|Withdrawal by Subject|0|||
128798470|NCT02723955|463556990|FG026|Expansion Phase|Withdrawal by Subject|0|||
128798471|NCT02723955|463556991|FG027|Expansion Phase|Withdrawal by Subject|0|||
128798472|NCT02723955|463556992|FG028|Expansion Phase|Withdrawal by Subject|0|||
128798473|NCT02723955|463556993|FG029|Expansion Phase|Withdrawal by Subject|0|||
128798474|NCT02723955|463556994|FG030|Expansion Phase|Withdrawal by Subject|8|||
128798475|NCT02723955|463556995|FG031|Expansion Phase|Withdrawal by Subject|4|||
128798476|NCT02723955|463556996|FG032|Expansion Phase|Withdrawal by Subject|0|||
128798477|NCT02723955|463556997|FG033|Expansion Phase|Withdrawal by Subject|0|||
128798478|NCT02723955|463556998|FG034|Expansion Phase|Withdrawal by Subject|0|||
128798479|NCT02723955|463556999|FG035|Expansion Phase|Withdrawal by Subject|1|||
128798480|NCT02723955|463557000|FG036|Expansion Phase|Withdrawal by Subject|0|||
128798481|NCT02723955|463557001|FG037|Expansion Phase|Withdrawal by Subject|0|||
128798482|NCT02723955|463557002|FG038|Expansion Phase|Withdrawal by Subject|0|||
128798483|NCT02723955|463557003|FG039|Expansion Phase|Withdrawal by Subject|0|||
128798484|NCT02723955|463557004|FG040|Expansion Phase|Withdrawal by Subject|0|||
128798485|NCT02723955|463557005|FG041|Expansion Phase|Withdrawal by Subject|0|||
128798486|NCT02723955|463557006|FG042|Expansion Phase|Withdrawal by Subject|0|||
128798487|NCT02723955|463556964|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798488|NCT02723955|463556965|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798489|NCT02723955|463556966|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798490|NCT02723955|463556967|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798491|NCT02723955|463556968|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798492|NCT02723955|463556969|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798493|NCT02723955|463556970|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798494|NCT02723955|463556971|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798495|NCT02723955|463556972|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798496|NCT02723955|463556973|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
128798497|NCT02723955|463556974|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
128798498|NCT02723955|463556975|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
128798499|NCT02723955|463556976|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798500|NCT02723955|463556977|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798501|NCT02723955|463556978|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798502|NCT02723955|463556979|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798503|NCT02723955|463556980|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798504|NCT02723955|463556981|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798505|NCT02723955|463556982|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798506|NCT02723955|463556983|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798507|NCT02723955|463556984|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798508|NCT02723955|463556985|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798509|NCT02723955|463556986|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798510|NCT02723955|463556987|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798511|NCT02723955|463556988|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798512|NCT02723955|463556989|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798513|NCT02723955|463556990|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798514|NCT02723955|463556991|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798515|NCT02723955|463556992|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798516|NCT02723955|463556993|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798517|NCT02723955|463556994|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
128798518|NCT02723955|463556995|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798519|NCT02723955|463556996|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798520|NCT02723955|463556997|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798521|NCT02723955|463556998|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798522|NCT02723955|463556999|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798523|NCT02723955|463557000|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798524|NCT02723955|463557001|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798525|NCT02723955|463557002|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798526|NCT02723955|463557003|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798527|NCT02723955|463557004|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798528|NCT02723955|463557005|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798529|NCT02723955|463557006|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
128798530|NCT02723955|463556964|FG000|Expansion Phase|Site Closed|0|||
128798531|NCT02723955|463556965|FG001|Expansion Phase|Site Closed|0|||
128798532|NCT02723955|463556966|FG002|Expansion Phase|Site Closed|0|||
128798533|NCT02723955|463556967|FG003|Expansion Phase|Site Closed|0|||
128798534|NCT02723955|463556968|FG004|Expansion Phase|Site Closed|0|||
128798535|NCT02723955|463556969|FG005|Expansion Phase|Site Closed|0|||
128798536|NCT02723955|463556970|FG006|Expansion Phase|Site Closed|0|||
128798537|NCT02723955|463556971|FG007|Expansion Phase|Site Closed|0|||
128798538|NCT02723955|463556972|FG008|Expansion Phase|Site Closed|0|||
128798539|NCT02723955|463556973|FG009|Expansion Phase|Site Closed|1|||
128798540|NCT02723955|463556974|FG010|Expansion Phase|Site Closed|2|||
128798541|NCT02723955|463556975|FG011|Expansion Phase|Site Closed|6|||
128798542|NCT02723955|463556976|FG012|Expansion Phase|Site Closed|0|||
128798543|NCT02723955|463556977|FG013|Expansion Phase|Site Closed|0|||
128798544|NCT02723955|463556978|FG014|Expansion Phase|Site Closed|0|||
128798545|NCT02723955|463556979|FG015|Expansion Phase|Site Closed|0|||
128798546|NCT02723955|463556980|FG016|Expansion Phase|Site Closed|0|||
128798547|NCT02723955|463556981|FG017|Expansion Phase|Site Closed|0|||
128798548|NCT02723955|463556982|FG018|Expansion Phase|Site Closed|0|||
128798549|NCT02723955|463556983|FG019|Expansion Phase|Site Closed|0|||
128798550|NCT02723955|463556984|FG020|Expansion Phase|Site Closed|0|||
128798551|NCT02723955|463556985|FG021|Expansion Phase|Site Closed|0|||
128798552|NCT02723955|463556986|FG022|Expansion Phase|Site Closed|0|||
128798553|NCT02723955|463556987|FG023|Expansion Phase|Site Closed|0|||
128798554|NCT02723955|463556988|FG024|Expansion Phase|Site Closed|0|||
128798555|NCT02723955|463556989|FG025|Expansion Phase|Site Closed|0|||
128798556|NCT02723955|463556990|FG026|Expansion Phase|Site Closed|0|||
128798557|NCT02723955|463556991|FG027|Expansion Phase|Site Closed|0|||
128798558|NCT02723955|463556992|FG028|Expansion Phase|Site Closed|0|||
128798559|NCT02723955|463556993|FG029|Expansion Phase|Site Closed|0|||
128798560|NCT02723955|463556994|FG030|Expansion Phase|Site Closed|8|||
128798561|NCT02723955|463556995|FG031|Expansion Phase|Site Closed|4|||
128798562|NCT02723955|463556996|FG032|Expansion Phase|Site Closed|2|||
128798563|NCT02723955|463556997|FG033|Expansion Phase|Site Closed|2|||
128798564|NCT02723955|463556998|FG034|Expansion Phase|Site Closed|0|||
128798565|NCT02723955|463556999|FG035|Expansion Phase|Site Closed|0|||
128798566|NCT02723955|463557000|FG036|Expansion Phase|Site Closed|0|||
128798567|NCT02723955|463557001|FG037|Expansion Phase|Site Closed|0|||
128798568|NCT02723955|463557002|FG038|Expansion Phase|Site Closed|0|||
128798569|NCT02723955|463557003|FG039|Expansion Phase|Site Closed|0|||
128798570|NCT02723955|463557004|FG040|Expansion Phase|Site Closed|0|||
128798571|NCT02723955|463557005|FG041|Expansion Phase|Site Closed|0|||
128798572|NCT02723955|463557006|FG042|Expansion Phase|Site Closed|0|||
128798573|NCT02723955|463556964|FG000|Crossover/ Re-treatment Phase|Death|0|||
128798574|NCT02723955|463556965|FG001|Crossover/ Re-treatment Phase|Death|0|||
128798575|NCT02723955|463556966|FG002|Crossover/ Re-treatment Phase|Death|0|||
128798576|NCT02723955|463556967|FG003|Crossover/ Re-treatment Phase|Death|0|||
128798577|NCT02723955|463556968|FG004|Crossover/ Re-treatment Phase|Death|0|||
128798578|NCT02723955|463556969|FG005|Crossover/ Re-treatment Phase|Death|0|||
128798579|NCT02723955|463556970|FG006|Crossover/ Re-treatment Phase|Death|0|||
128798580|NCT02723955|463556971|FG007|Crossover/ Re-treatment Phase|Death|0|||
128798581|NCT02723955|463556972|FG008|Crossover/ Re-treatment Phase|Death|0|||
128798582|NCT02723955|463556973|FG009|Crossover/ Re-treatment Phase|Death|0|||
128798583|NCT02723955|463556974|FG010|Crossover/ Re-treatment Phase|Death|0|||
128798584|NCT02723955|463556975|FG011|Crossover/ Re-treatment Phase|Death|0|||
128798585|NCT02723955|463556976|FG012|Crossover/ Re-treatment Phase|Death|0|||
128798586|NCT02723955|463556977|FG013|Crossover/ Re-treatment Phase|Death|0|||
128798587|NCT02723955|463556978|FG014|Crossover/ Re-treatment Phase|Death|0|||
128798588|NCT02723955|463556979|FG015|Crossover/ Re-treatment Phase|Death|0|||
128798589|NCT02723955|463556980|FG016|Crossover/ Re-treatment Phase|Death|0|||
128798590|NCT02723955|463556981|FG017|Crossover/ Re-treatment Phase|Death|0|||
128798591|NCT02723955|463556982|FG018|Crossover/ Re-treatment Phase|Death|0|||
128798592|NCT02723955|463556983|FG019|Crossover/ Re-treatment Phase|Death|0|||
128798593|NCT02723955|463556984|FG020|Crossover/ Re-treatment Phase|Death|0|||
128798594|NCT02723955|463556985|FG021|Crossover/ Re-treatment Phase|Death|0|||
128798595|NCT02723955|463556986|FG022|Crossover/ Re-treatment Phase|Death|0|||
128798596|NCT02723955|463556987|FG023|Crossover/ Re-treatment Phase|Death|0|||
128798597|NCT02723955|463556988|FG024|Crossover/ Re-treatment Phase|Death|0|||
128798598|NCT02723955|463556989|FG025|Crossover/ Re-treatment Phase|Death|0|||
128798599|NCT02723955|463556990|FG026|Crossover/ Re-treatment Phase|Death|0|||
128798600|NCT02723955|463556991|FG027|Crossover/ Re-treatment Phase|Death|0|||
128798601|NCT02723955|463556992|FG028|Crossover/ Re-treatment Phase|Death|0|||
128798602|NCT02723955|463556993|FG029|Crossover/ Re-treatment Phase|Death|0|||
128798603|NCT02723955|463556994|FG030|Crossover/ Re-treatment Phase|Death|0|||
128798604|NCT02723955|463556995|FG031|Crossover/ Re-treatment Phase|Death|0|||
128798605|NCT02723955|463556996|FG032|Crossover/ Re-treatment Phase|Death|0|||
128798606|NCT02723955|463556997|FG033|Crossover/ Re-treatment Phase|Death|0|||
128798607|NCT02723955|463556998|FG034|Crossover/ Re-treatment Phase|Death|0|||
128798608|NCT02723955|463556999|FG035|Crossover/ Re-treatment Phase|Death|0|||
128798609|NCT02723955|463557000|FG036|Crossover/ Re-treatment Phase|Death|0|||
128798610|NCT02723955|463557001|FG037|Crossover/ Re-treatment Phase|Death|1|||
128798611|NCT02723955|463557002|FG038|Crossover/ Re-treatment Phase|Death|14|||
128798612|NCT02723955|463557003|FG039|Crossover/ Re-treatment Phase|Death|32|||
128798613|NCT02723955|463557004|FG040|Crossover/ Re-treatment Phase|Death|2|||
128798614|NCT02723955|463557005|FG041|Crossover/ Re-treatment Phase|Death|1|||
128798615|NCT02723955|463557006|FG042|Crossover/ Re-treatment Phase|Death|0|||
128798616|NCT02723955|463556964|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798617|NCT02723955|463556965|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798618|NCT02723955|463556966|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798619|NCT02723955|463556967|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798620|NCT02723955|463556968|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798621|NCT02723955|463556969|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798622|NCT02723955|463556970|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798623|NCT02723955|463556971|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798624|NCT02723955|463556972|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798625|NCT02723955|463556973|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798626|NCT02723955|463556974|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798627|NCT02723955|463556975|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798628|NCT02723955|463556976|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798629|NCT02723955|463556977|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798630|NCT02723955|463556978|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798631|NCT02723955|463556979|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798632|NCT02723955|463556980|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798633|NCT02723955|463556981|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798634|NCT02723955|463556982|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798635|NCT02723955|463556983|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798636|NCT02723955|463556984|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798637|NCT02723955|463556985|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798638|NCT02723955|463556986|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798639|NCT02723955|463556987|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798640|NCT02723955|463556988|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798641|NCT02723955|463556989|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798642|NCT02723955|463556990|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798643|NCT02723955|463556991|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798644|NCT02723955|463556992|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798645|NCT02723955|463556993|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798646|NCT02723955|463556994|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798647|NCT02723955|463556995|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798648|NCT02723955|463556996|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798649|NCT02723955|463556997|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798650|NCT02723955|463556998|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798651|NCT02723955|463556999|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798652|NCT02723955|463557000|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798653|NCT02723955|463557001|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798654|NCT02723955|463557002|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798655|NCT02723955|463557003|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
128798656|NCT02723955|463557004|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798657|NCT02723955|463557005|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798658|NCT02723955|463557006|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
128798659|NCT02723955|463556964|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798660|NCT02723955|463556965|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798661|NCT02723955|463556966|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798662|NCT02723955|463556967|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798663|NCT02723955|463556968|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798664|NCT02723955|463556969|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798665|NCT02723955|463556970|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798666|NCT02723955|463556971|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798667|NCT02723955|463556972|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798668|NCT02723955|463556973|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798669|NCT02723955|463556974|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798670|NCT02723955|463556975|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798671|NCT02723955|463556976|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798672|NCT02723955|463556977|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798673|NCT02723955|463556978|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798674|NCT02723955|463556979|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798675|NCT02723955|463556980|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798676|NCT02723955|463556981|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798677|NCT02723955|463556982|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798678|NCT02723955|463556983|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798679|NCT02723955|463556984|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798680|NCT02723955|463556985|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798681|NCT02723955|463556986|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798682|NCT02723955|463556987|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798683|NCT02723955|463556988|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798684|NCT02723955|463556989|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798685|NCT02723955|463556990|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798686|NCT02723955|463556991|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798687|NCT02723955|463556992|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798688|NCT02723955|463556993|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798689|NCT02723955|463556994|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798690|NCT02723955|463556995|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798691|NCT02723955|463556996|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798692|NCT02723955|463556997|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798693|NCT02723955|463556998|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798694|NCT02723955|463556999|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798695|NCT02723955|463557000|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798696|NCT02723955|463557001|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798697|NCT02723955|463557002|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
128798698|NCT02723955|463557003|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
128798699|NCT02723955|463557004|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798700|NCT02723955|463557005|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
128798701|NCT02723955|463557006|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
128798702|NCT02723955|463556964|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
128798703|NCT02723955|463556965|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
128798704|NCT02723955|463556966|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
128798705|NCT02723955|463556967|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
128798706|NCT02723955|463556968|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
128798707|NCT02723955|463556969|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
128798708|NCT02723955|463556970|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
128798709|NCT02723955|463556971|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
128798710|NCT02723955|463556972|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
128798711|NCT02723955|463556973|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
128798712|NCT02723955|463556974|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
128798713|NCT02723955|463556975|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
128798714|NCT02723955|463556976|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
128798715|NCT02723955|463556977|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
128798716|NCT02723955|463556978|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
128798717|NCT02723955|463556979|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
128798718|NCT02723955|463556980|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
128798719|NCT02723955|463556981|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
128798720|NCT02723955|463556982|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
128798721|NCT02723955|463556983|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
128798722|NCT02723955|463556984|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
128798723|NCT02723955|463556985|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
128798724|NCT02723955|463556986|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
128798725|NCT02723955|463556987|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
128798726|NCT02723955|463556988|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
128798727|NCT02723955|463556989|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
128798728|NCT02723955|463556990|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
128798729|NCT02723955|463556991|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
128798730|NCT02723955|463556992|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
128798731|NCT02723955|463556993|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
128798732|NCT02723955|463556994|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
128798733|NCT02723955|463556995|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
128798734|NCT02723955|463556996|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
128798735|NCT02723955|463556997|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
128798736|NCT02723955|463556998|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
128798737|NCT02723955|463556999|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
128798738|NCT02723955|463557000|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
128798739|NCT02723955|463557001|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
128798740|NCT02723955|463557002|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
128798741|NCT02723955|463557003|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
128798742|NCT02723955|463557004|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
128798743|NCT02723955|463557005|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
128798744|NCT02723955|463557006|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
128798745|NCT04999085|463557007|FG000|Overall Study|Death|1|||
128798746|NCT04907474|463557008|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
128798747|NCT04907474|463557009|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
128798748|NCT03873779|463557010|FG000|Overall Study|Withdrawal by Subject|1|||
128798749|NCT04279574|463557013|FG000|Overall Study|Death|1|||
128798750|NCT04279574|463557014|FG001|Overall Study|Death|0|||
128798751|NCT04279574|463557013|FG000|Overall Study|lost restoration, tooth fracture|1|||
128798752|NCT04279574|463557014|FG001|Overall Study|lost restoration, tooth fracture|0|||
128798753|NCT04279574|463557013|FG000|Overall Study|Lost to Follow-up|0|||
128798754|NCT04279574|463557014|FG001|Overall Study|Lost to Follow-up|1|||
128798755|NCT04188379|463557015|FG000|Overall Study|Withdrawal by Subject|10|||
128798756|NCT04188379|463557016|FG001|Overall Study|Withdrawal by Subject|3|||
128798757|NCT04188379|463557015|FG000|Overall Study|Physician Decision|0|||
128798758|NCT04188379|463557016|FG001|Overall Study|Physician Decision|1|||
128798759|NCT04188379|463557015|FG000|Overall Study|Adverse Event|3|||
128798760|NCT04188379|463557016|FG001|Overall Study|Adverse Event|1|||
128798761|NCT04188379|463557015|FG000|Overall Study|Pregnancy|1|||
128798762|NCT04188379|463557016|FG001|Overall Study|Pregnancy|0|||
128798763|NCT04188379|463557015|FG000|Overall Study|Lack of Efficacy|8|||
128798764|NCT04188379|463557016|FG001|Overall Study|Lack of Efficacy|5|||
128798765|NCT04188379|463557015|FG000|Overall Study|Other|0|||
128798766|NCT04188379|463557016|FG001|Overall Study|Other|3|||
128798767|NCT02566902|463557018|FG000|Overall Study|Protocol Violation|2|||
128798768|NCT02566902|463557019|FG001|Overall Study|Protocol Violation|1|||
128798769|NCT02411084|463557020|FG000|Overall Study|Lack of Efficacy|6|||
128798770|NCT02411084|463557021|FG001|Overall Study|Lack of Efficacy|3|||
128798771|NCT02411084|463557020|FG000|Overall Study|Death|5|||
128798772|NCT02411084|463557021|FG001|Overall Study|Death|4|||
128798773|NCT02411084|463557020|FG000|Overall Study|Adverse Event|2|||
128798774|NCT02411084|463557021|FG001|Overall Study|Adverse Event|1|||
128798775|NCT02411084|463557020|FG000|Overall Study|Other reasons|0|||
128798776|NCT02411084|463557021|FG001|Overall Study|Other reasons|5|||
128798777|NCT05773313|463557024|FG000|Overall Study|Lost to Follow-up|3|||
128798778|NCT02748317|463557025|FG000|Overall Study|Withdrawal by Subject|14|||
128798779|NCT02748317|463557025|FG000|Overall Study|Lost to Follow-up|8|||
128798780|NCT02748317|463557025|FG000|Overall Study|Death|1|||
128798781|NCT00332241|463557026|FG000|Overall Study|Lack of Efficacy|6|||
128798782|NCT00332241|463557027|FG001|Overall Study|Lack of Efficacy|1|||
128798783|NCT00332241|463557026|FG000|Overall Study|Adverse Event|3|||
128798784|NCT00332241|463557027|FG001|Overall Study|Adverse Event|5|||
128798785|NCT00332241|463557026|FG000|Overall Study|Withdrawal by Subject|2|||
128798786|NCT00332241|463557027|FG001|Overall Study|Withdrawal by Subject|1|||
128798787|NCT00332241|463557026|FG000|Overall Study|Lost to Follow-up|4|||
128798788|NCT00332241|463557027|FG001|Overall Study|Lost to Follow-up|1|||
128798789|NCT00802464|463557028|FG000|Month 0 - Month 8|Adverse Event|0|||
128798790|NCT00802464|463557029|FG001|Month 0 - Month 8|Adverse Event|1|||
128798791|NCT00802464|463557030|FG002|Month 0 - Month 8|Adverse Event|1|||
128798792|NCT00802464|463557031|FG003|Month 0 - Month 8|Adverse Event|2|||
128798793|NCT00802464|463557028|FG000|Month 0 - Month 8|Protocol Violation|0|||
128798794|NCT00802464|463557029|FG001|Month 0 - Month 8|Protocol Violation|0|||
128798795|NCT00802464|463557030|FG002|Month 0 - Month 8|Protocol Violation|1|||
128798796|NCT00802464|463557031|FG003|Month 0 - Month 8|Protocol Violation|0|||
128798797|NCT00802464|463557028|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
128798798|NCT00802464|463557029|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
128798799|NCT00802464|463557030|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
128798800|NCT00802464|463557031|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
128798801|NCT00802464|463557028|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
128798802|NCT00802464|463557029|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
128798803|NCT00802464|463557030|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
128798804|NCT00802464|463557031|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
128798805|NCT00802464|463557028|FG000|Month 0 - Month 8|Other|0|||
128798806|NCT00802464|463557029|FG001|Month 0 - Month 8|Other|0|||
128798807|NCT00802464|463557030|FG002|Month 0 - Month 8|Other|1|||
128798808|NCT00802464|463557031|FG003|Month 0 - Month 8|Other|0|||
128798809|NCT00802464|463557028|FG000|Month 8 - Month 14|Adverse Event|0|||
128798810|NCT00802464|463557029|FG001|Month 8 - Month 14|Adverse Event|1|||
128798811|NCT00802464|463557030|FG002|Month 8 - Month 14|Adverse Event|0|||
128798812|NCT00802464|463557031|FG003|Month 8 - Month 14|Adverse Event|0|||
128798813|NCT00802464|463557028|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
128798814|NCT00802464|463557029|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
128798815|NCT00802464|463557030|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
128798816|NCT00802464|463557031|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
128798817|NCT00802464|463557028|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
128798818|NCT00802464|463557029|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
128798819|NCT00802464|463557030|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
128798820|NCT00802464|463557031|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
128798821|NCT00402246|463557032|FG000|Overall Study|Death|62|||
128798822|NCT00402246|463557033|FG001|Overall Study|Death|58|||
128798823|NCT00402246|463557032|FG000|Overall Study|Lost to Follow-up|20|||
128798824|NCT00402246|463557033|FG001|Overall Study|Lost to Follow-up|28|||
128798825|NCT00402246|463557032|FG000|Overall Study|Withdrawal by Subject|72|||
128798826|NCT00402246|463557033|FG001|Overall Study|Withdrawal by Subject|87|||
128798827|NCT00402246|463557032|FG000|Overall Study|Physician Decision|24|||
128798828|NCT00402246|463557033|FG001|Overall Study|Physician Decision|26|||
128798829|NCT00402246|463557032|FG000|Overall Study|Protocol Violation|25|||
128798830|NCT00402246|463557033|FG001|Overall Study|Protocol Violation|24|||
128798831|NCT00402246|463557032|FG000|Overall Study|Missed Final Visit|1|||
128798832|NCT00402246|463557033|FG001|Overall Study|Missed Final Visit|2|||
128798833|NCT00402246|463557032|FG000|Overall Study|Insurance Issues|2|||
128798834|NCT00402246|463557033|FG001|Overall Study|Insurance Issues|1|||
128798835|NCT00402246|463557032|FG000|Overall Study|Heart Transplant|0|||
128798836|NCT00402246|463557033|FG001|Overall Study|Heart Transplant|1|||
128798837|NCT00402246|463557032|FG000|Overall Study|Patient's device explanted|6|||
128798838|NCT00402246|463557033|FG001|Overall Study|Patient's device explanted|2|||
128798839|NCT00402246|463557032|FG000|Overall Study|Center Closure|5|||
128798840|NCT00402246|463557033|FG001|Overall Study|Center Closure|3|||
128798841|NCT00402246|463557032|FG000|Overall Study|Deterioriating Condition|3|||
128798842|NCT00402246|463557033|FG001|Overall Study|Deterioriating Condition|2|||
128798843|NCT00434304|463557034|FG000|Overall Study|Adverse Event|14|||
128798844|NCT00434304|463557034|FG000|Overall Study|Lack of Efficacy|2|||
128798845|NCT00434304|463557034|FG000|Overall Study|Withdrawal by Subject|4|||
128798846|NCT01808339|463557038|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798847|NCT01808339|463557039|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798848|NCT01808339|463557040|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798849|NCT01808339|463557041|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
128798850|NCT01808339|463557042|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
128798851|NCT01808339|463557043|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
128798852|NCT01808339|463557038|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128798853|NCT01808339|463557039|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
128798854|NCT01808339|463557040|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128798855|NCT01808339|463557041|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
128798856|NCT01808339|463557042|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128798857|NCT01808339|463557043|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
128798858|NCT01808339|463557038|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798859|NCT01808339|463557039|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798860|NCT01808339|463557040|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
128798861|NCT01808339|463557041|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798862|NCT01808339|463557042|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798863|NCT01808339|463557043|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
128798864|NCT02622568|463557052|FG000|Overall Study|Lost to Follow-up|5|||
128798865|NCT02622568|463557053|FG001|Overall Study|Lost to Follow-up|5|||
128798866|NCT00371787|463557054|FG000|Overall Study|Withdrawal by Subject|3|||
128798867|NCT00371787|463557055|FG001|Overall Study|Withdrawal by Subject|1|||
128798868|NCT04425863|463557056|FG000|Overall Study|Death|0|||
128798869|NCT04425863|463557057|FG001|Overall Study|Death|0|||
128798870|NCT04425863|463557058|FG002|Overall Study|Death|1|||
128798871|NCT01854385|463557059|FG000|Pre-Treatment|Withdrawal by Subject|4|||
128798872|NCT01854385|463557059|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
128798873|NCT01854385|463557059|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
128798874|NCT01854385|463557059|FG000|Pre-Treatment|Unable to come for study visits|1|||
128798875|NCT01854385|463557059|FG000|Treatment|Lost to Follow-up|1|||
128798876|NCT02597920|463557063|FG000|Overall Study|Worsening of other pre-existing disease|0|||
128798877|NCT02597920|463557064|FG001|Overall Study|Worsening of other pre-existing disease|1|||
128798878|NCT02597920|463557065|FG002|Overall Study|Worsening of other pre-existing disease|0|||
128798879|NCT02597920|463557063|FG000|Overall Study|Other adverse event|20|||
128798880|NCT02597920|463557064|FG001|Overall Study|Other adverse event|30|||
128798881|NCT02597920|463557065|FG002|Overall Study|Other adverse event|0|||
128798882|NCT02597920|463557063|FG000|Overall Study|Lost to Follow-up|7|||
128798883|NCT02597920|463557064|FG001|Overall Study|Lost to Follow-up|9|||
128798884|NCT02597920|463557065|FG002|Overall Study|Lost to Follow-up|0|||
128798885|NCT02597920|463557063|FG000|Overall Study|Refuse to continue in the study|3|||
128798886|NCT02597920|463557064|FG001|Overall Study|Refuse to continue in the study|13|||
128798887|NCT02597920|463557065|FG002|Overall Study|Refuse to continue in the study|1|||
128798888|NCT02597920|463557063|FG000|Overall Study|Other than specified|10|||
128798889|NCT02597920|463557064|FG001|Overall Study|Other than specified|31|||
128798890|NCT02597920|463557065|FG002|Overall Study|Other than specified|5|||
128798891|NCT02597920|463557063|FG000|Overall Study|Other|1|||
128798892|NCT02597920|463557064|FG001|Overall Study|Other|0|||
128798893|NCT02597920|463557065|FG002|Overall Study|Other|0|||
128798894|NCT00642850|463557066|FG000|Overall Study|Death|7|||
128798895|NCT00642850|463557066|FG000|Overall Study|Adverse Event|2|||
128798896|NCT00642850|463557066|FG000|Overall Study|Lack of Efficacy|1|||
128798897|NCT00642850|463557066|FG000|Overall Study|Protocol Violation|2|||
128798898|NCT00642850|463557066|FG000|Overall Study|Kidney transplantation|8|||
128798899|NCT00642850|463557066|FG000|Overall Study|Blood transfusion|6|||
128798900|NCT00642850|463557066|FG000|Overall Study|Other reasons|7|||
128798901|NCT02549170|463557067|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
128798902|NCT02549170|463557068|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
128798903|NCT02549170|463557069|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
128798904|NCT02549170|463557070|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
128798905|NCT02549170|463557071|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
128798906|NCT02549170|463557067|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
128798907|NCT02549170|463557068|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
128798908|NCT02549170|463557069|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
128798909|NCT02549170|463557070|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
128798910|NCT02549170|463557071|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
128798911|NCT02549170|463557067|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
128798912|NCT02549170|463557068|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
128798913|NCT02549170|463557069|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
128798914|NCT02549170|463557070|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
128798915|NCT02549170|463557071|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
128798916|NCT01266122|463557073|FG000|Overall Study|Lost to Follow-up|6|||
128798917|NCT01266122|463557074|FG001|Overall Study|Lost to Follow-up|6|||
128798918|NCT00421889|463557075|FG000|Overall Study|Adverse Event|1|||
128798919|NCT00421889|463557076|FG001|Overall Study|Adverse Event|0|||
128798920|NCT00421889|463557077|FG002|Overall Study|Adverse Event|1|||
128798921|NCT00421889|463557078|FG003|Overall Study|Adverse Event|1|||
128798922|NCT00421889|463557079|FG004|Overall Study|Adverse Event|1|||
128798923|NCT00421889|463557080|FG005|Overall Study|Adverse Event|4|||
128798924|NCT00421889|463557081|FG006|Overall Study|Adverse Event|1|||
128798925|NCT00421889|463557082|FG007|Overall Study|Adverse Event|0|||
128798926|NCT00421889|463557083|FG008|Overall Study|Adverse Event|2|||
128798927|NCT00421889|463557075|FG000|Overall Study|Withdrawal by Subject|1|||
128798928|NCT00421889|463557076|FG001|Overall Study|Withdrawal by Subject|3|||
128798929|NCT00421889|463557077|FG002|Overall Study|Withdrawal by Subject|0|||
128798930|NCT00421889|463557078|FG003|Overall Study|Withdrawal by Subject|0|||
128798931|NCT00421889|463557079|FG004|Overall Study|Withdrawal by Subject|2|||
128798932|NCT00421889|463557080|FG005|Overall Study|Withdrawal by Subject|0|||
128798933|NCT00421889|463557081|FG006|Overall Study|Withdrawal by Subject|0|||
128798934|NCT00421889|463557082|FG007|Overall Study|Withdrawal by Subject|0|||
128798935|NCT00421889|463557083|FG008|Overall Study|Withdrawal by Subject|0|||
128798936|NCT00421889|463557075|FG000|Overall Study|Death|0|||
128798937|NCT00421889|463557076|FG001|Overall Study|Death|0|||
128798938|NCT00421889|463557077|FG002|Overall Study|Death|0|||
128798939|NCT00421889|463557078|FG003|Overall Study|Death|0|||
128798940|NCT00421889|463557079|FG004|Overall Study|Death|1|||
128798941|NCT00421889|463557080|FG005|Overall Study|Death|1|||
128798942|NCT00421889|463557081|FG006|Overall Study|Death|0|||
128798943|NCT00421889|463557082|FG007|Overall Study|Death|0|||
128798944|NCT00421889|463557083|FG008|Overall Study|Death|0|||
128798945|NCT00421889|463557075|FG000|Overall Study|Progressive disease|3|||
128798946|NCT00421889|463557076|FG001|Overall Study|Progressive disease|2|||
128798947|NCT00421889|463557077|FG002|Overall Study|Progressive disease|2|||
128798948|NCT00421889|463557078|FG003|Overall Study|Progressive disease|3|||
128798949|NCT00421889|463557079|FG004|Overall Study|Progressive disease|2|||
128798950|NCT00421889|463557080|FG005|Overall Study|Progressive disease|21|||
128798951|NCT00421889|463557081|FG006|Overall Study|Progressive disease|3|||
128798952|NCT00421889|463557082|FG007|Overall Study|Progressive disease|1|||
128798953|NCT00421889|463557083|FG008|Overall Study|Progressive disease|5|||
128798954|NCT00421889|463557075|FG000|Overall Study|Patient/Investigator request|0|||
128798955|NCT00421889|463557076|FG001|Overall Study|Patient/Investigator request|0|||
128798956|NCT00421889|463557077|FG002|Overall Study|Patient/Investigator request|0|||
128798957|NCT00421889|463557078|FG003|Overall Study|Patient/Investigator request|0|||
128798958|NCT00421889|463557079|FG004|Overall Study|Patient/Investigator request|0|||
128798959|NCT00421889|463557080|FG005|Overall Study|Patient/Investigator request|9|||
128798960|NCT00421889|463557081|FG006|Overall Study|Patient/Investigator request|0|||
128798961|NCT00421889|463557082|FG007|Overall Study|Patient/Investigator request|1|||
128798962|NCT00421889|463557083|FG008|Overall Study|Patient/Investigator request|3|||
128798963|NCT00421889|463557075|FG000|Overall Study|Lost to Follow-up|0|||
128798964|NCT00421889|463557076|FG001|Overall Study|Lost to Follow-up|0|||
128798965|NCT00421889|463557077|FG002|Overall Study|Lost to Follow-up|0|||
128798966|NCT00421889|463557078|FG003|Overall Study|Lost to Follow-up|0|||
128798967|NCT00421889|463557079|FG004|Overall Study|Lost to Follow-up|0|||
128798968|NCT00421889|463557080|FG005|Overall Study|Lost to Follow-up|0|||
128798969|NCT00421889|463557081|FG006|Overall Study|Lost to Follow-up|0|||
128798970|NCT00421889|463557082|FG007|Overall Study|Lost to Follow-up|0|||
128798971|NCT00421889|463557083|FG008|Overall Study|Lost to Follow-up|1|||
128798972|NCT03756571|463557084|FG000|Overall Study|Lost to Follow-up|1|||
128798973|NCT03756571|463557085|FG001|Overall Study|Lost to Follow-up|1|||
128798974|NCT00978042|463557086|FG000|Initial Treatment Period|Treated in Error|0|||
128798975|NCT00978042|463557087|FG001|Initial Treatment Period|Treated in Error|3|||
128798976|NCT00978042|463557086|FG000|Initial Treatment Period|Ineligibility|1|||
128798977|NCT00978042|463557087|FG001|Initial Treatment Period|Ineligibility|0|||
128798978|NCT00978042|463557086|FG000|Initial Treatment Period|Lost to Follow-up|21|||
128798979|NCT00978042|463557087|FG001|Initial Treatment Period|Lost to Follow-up|3|||
128798980|NCT00978042|463557086|FG000|Initial Treatment Period|Adverse Event|2|||
128798981|NCT00978042|463557087|FG001|Initial Treatment Period|Adverse Event|0|||
128798982|NCT00978042|463557086|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
128798983|NCT00978042|463557087|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
128798984|NCT00978042|463557086|FG000|Initial Treatment Period|Consent withdrawn|22|||
128798985|NCT00978042|463557087|FG001|Initial Treatment Period|Consent withdrawn|9|||
128798986|NCT00978042|463557086|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
128798987|NCT00978042|463557087|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
128798988|NCT02379819|463557088|FG000|Overall Study|Withdrawal by Subject|10|||
128798989|NCT02379819|463557088|FG000|Overall Study|Death|2|||
128798990|NCT02379819|463557088|FG000|Overall Study|Lack of Efficacy|1|||
128798991|NCT02379819|463557088|FG000|Overall Study|Lost to Follow-up|1|||
128798992|NCT04452318|463557091|FG000|Overall Study|Physician Decision|1|||
128798993|NCT04452318|463557092|FG001|Overall Study|Physician Decision|2|||
128798994|NCT04452318|463557093|FG002|Overall Study|Physician Decision|0|||
128798995|NCT04452318|463557094|FG003|Overall Study|Physician Decision|2|||
128798996|NCT04452318|463557095|FG004|Overall Study|Physician Decision|0|||
128798997|NCT04452318|463557096|FG005|Overall Study|Physician Decision|2|||
128798998|NCT04452318|463557097|FG006|Overall Study|Physician Decision|5|||
128798999|NCT04452318|463557091|FG000|Overall Study|Death|2|||
128799000|NCT04452318|463557092|FG001|Overall Study|Death|3|||
128799001|NCT04452318|463557093|FG002|Overall Study|Death|0|||
128799002|NCT04452318|463557094|FG003|Overall Study|Death|0|||
128799003|NCT04452318|463557095|FG004|Overall Study|Death|0|||
128799004|NCT04452318|463557096|FG005|Overall Study|Death|0|||
128799005|NCT04452318|463557097|FG006|Overall Study|Death|0|||
128799006|NCT04452318|463557091|FG000|Overall Study|Lost to Follow-up|38|||
128799007|NCT04452318|463557092|FG001|Overall Study|Lost to Follow-up|28|||
128799008|NCT04452318|463557093|FG002|Overall Study|Lost to Follow-up|0|||
128799009|NCT04452318|463557094|FG003|Overall Study|Lost to Follow-up|3|||
128799010|NCT04452318|463557095|FG004|Overall Study|Lost to Follow-up|3|||
128799011|NCT04452318|463557096|FG005|Overall Study|Lost to Follow-up|2|||
128799012|NCT04452318|463557097|FG006|Overall Study|Lost to Follow-up|1|||
128799013|NCT04452318|463557091|FG000|Overall Study|Withdrawal by Subject|46|||
128799014|NCT04452318|463557092|FG001|Overall Study|Withdrawal by Subject|40|||
128799015|NCT04452318|463557093|FG002|Overall Study|Withdrawal by Subject|0|||
128799016|NCT04452318|463557094|FG003|Overall Study|Withdrawal by Subject|18|||
128799017|NCT04452318|463557095|FG004|Overall Study|Withdrawal by Subject|6|||
128799018|NCT04452318|463557096|FG005|Overall Study|Withdrawal by Subject|8|||
128799019|NCT04452318|463557097|FG006|Overall Study|Withdrawal by Subject|6|||
128799020|NCT04629950|463557098|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
128799021|NCT04629950|463557099|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
128799022|NCT04629950|463557100|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
128799023|NCT04629950|463557101|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
128799024|NCT04629950|463557098|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
128799025|NCT04629950|463557099|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
128799026|NCT04629950|463557100|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
128799027|NCT04629950|463557101|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
128799028|NCT04629950|463557098|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
128799029|NCT04629950|463557099|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
128799030|NCT04629950|463557100|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
128799031|NCT04629950|463557101|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
128799032|NCT04629950|463557098|FG000|Extension Study|Withdrawal by Subject|0|||
128799033|NCT04629950|463557099|FG001|Extension Study|Withdrawal by Subject|0|||
128799034|NCT04629950|463557100|FG002|Extension Study|Withdrawal by Subject|1|||
128799035|NCT04629950|463557101|FG003|Extension Study|Withdrawal by Subject|0|||
128799036|NCT04629950|463557098|FG000|Extension Study|Adverse Event|0|||
128799037|NCT04629950|463557099|FG001|Extension Study|Adverse Event|0|||
128799038|NCT04629950|463557100|FG002|Extension Study|Adverse Event|0|||
128799039|NCT04629950|463557101|FG003|Extension Study|Adverse Event|1|||
128799040|NCT03233633|463557102|FG000|Overall Study|Adverse Event|2|||
128799041|NCT03233633|463557102|FG000|Overall Study|Less Than 3 Days of Data|6|||
128799042|NCT02088853|463557103|FG000|Overall Study|Pregnancy|1|||
128799043|NCT02088853|463557104|FG001|Overall Study|Pregnancy|0|||
128799044|NCT01697969|463557109|FG000|Overall Study|Did not meet inc/exc criteria|3|||
128799045|NCT01561989|463557110|FG000|Overall Study|accural target not met.|5|||
128799046|NCT01561989|463557111|FG001|Overall Study|accural target not met.|6|||
128799047|NCT03447249|463557114|FG000|Overall Study|Adverse Event|1|||
128799048|NCT03447249|463557115|FG001|Overall Study|Adverse Event|0|||
128799049|NCT03447249|463557114|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
128799050|NCT03447249|463557115|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
128799051|NCT03447249|463557114|FG000|Overall Study|Other|3|||
128799052|NCT03447249|463557115|FG001|Overall Study|Other|0|||
128799053|NCT03930420|463557116|FG000|Overall Study|Withdrawal by Subject|7|||
128799054|NCT03930420|463557117|FG001|Overall Study|Withdrawal by Subject|9|||
128799055|NCT01388361|463557118|FG000|Overall Study|Adverse Event|0|||
128799056|NCT01388361|463557119|FG001|Overall Study|Adverse Event|5|||
128799057|NCT01388361|463557120|FG002|Overall Study|Adverse Event|1|||
128799058|NCT01388361|463557118|FG000|Overall Study|Protocol Violation|0|||
128799059|NCT01388361|463557119|FG001|Overall Study|Protocol Violation|0|||
128799060|NCT01388361|463557120|FG002|Overall Study|Protocol Violation|2|||
128799061|NCT01388361|463557118|FG000|Overall Study|Withdrawal criteria|12|||
128799062|NCT01388361|463557119|FG001|Overall Study|Withdrawal criteria|7|||
128799063|NCT01388361|463557120|FG002|Overall Study|Withdrawal criteria|10|||
128799064|NCT01388361|463557118|FG000|Overall Study|Unclassified|0|||
128799065|NCT01388361|463557119|FG001|Overall Study|Unclassified|0|||
128799066|NCT01388361|463557120|FG002|Overall Study|Unclassified|1|||
128799067|NCT01070069|463557121|FG000|Overall Study|Death|1|||
128799068|NCT01070069|463557122|FG001|Overall Study|Death|0|||
128799069|NCT01070069|463557123|FG002|Overall Study|Death|2|||
128799070|NCT01070069|463557124|FG003|Overall Study|Death|0|||
128799071|NCT01070069|463557125|FG004|Overall Study|Death|1|||
128799072|NCT01070069|463557121|FG000|Overall Study|Withdrawal by Subject|1|||
128799073|NCT01070069|463557122|FG001|Overall Study|Withdrawal by Subject|1|||
128799074|NCT01070069|463557123|FG002|Overall Study|Withdrawal by Subject|4|||
128799075|NCT01070069|463557124|FG003|Overall Study|Withdrawal by Subject|0|||
128799076|NCT01070069|463557125|FG004|Overall Study|Withdrawal by Subject|0|||
128799077|NCT01070069|463557121|FG000|Overall Study|Lost to Follow-up|4|||
128799078|NCT01070069|463557122|FG001|Overall Study|Lost to Follow-up|1|||
128799079|NCT01070069|463557123|FG002|Overall Study|Lost to Follow-up|0|||
128799080|NCT01070069|463557124|FG003|Overall Study|Lost to Follow-up|0|||
128799081|NCT01070069|463557125|FG004|Overall Study|Lost to Follow-up|3|||
128799082|NCT00419341|463557126|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
128799083|NCT00419341|463557126|FG000|Wash in/Wash Out Period|Adverse Event|2|||
128799084|NCT00419341|463557126|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
128799085|NCT00419341|463557126|FG000|Efficacy Period|Withdrawal by Subject|6|||
128799086|NCT00419341|463557126|FG000|Efficacy Period|Protocol Violation|1|||
128799087|NCT00419341|463557126|FG000|Efficacy Period|Lost to Follow-up|1|||
128799088|NCT00419341|463557126|FG000|Efficacy Period|Non-compliance|1|||
128799089|NCT00419341|463557126|FG000|Efficacy Period|Termination of study site|1|||
128799090|NCT01499199|463557127|FG000|Overall Study|Adverse Event|1|||
128799091|NCT01499199|463557127|FG000|Overall Study|Lack of Efficacy|1|||
128799092|NCT02539225|463557134|FG000|Part A|Adverse Event|13|||
128799093|NCT02539225|463557135|FG001|Part A|Adverse Event|4|||
128799094|NCT02539225|463557134|FG000|Part A|Withdrawal by Subject|2|||
128799095|NCT02539225|463557135|FG001|Part A|Withdrawal by Subject|4|||
128799096|NCT02539225|463557134|FG000|Part A|Physician Decision|4|||
128799097|NCT02539225|463557135|FG001|Part A|Physician Decision|7|||
128799098|NCT02539225|463557134|FG000|Part A|Did Not Receive study Drug|1|||
128799099|NCT02539225|463557135|FG001|Part A|Did Not Receive study Drug|1|||
128799100|NCT02539225|463557134|FG000|Pre Treatment for Part B|Progressive disease|1|||
128799101|NCT02539225|463557135|FG001|Pre Treatment for Part B|Progressive disease|1|||
128799102|NCT02539225|463557134|FG000|Pre Treatment for Part B|Adverse Event|1|||
128799103|NCT02539225|463557135|FG001|Pre Treatment for Part B|Adverse Event|1|||
128799104|NCT02539225|463557134|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
128799105|NCT02539225|463557135|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
128799106|NCT02539225|463557134|FG000|Pre Treatment for Part B|Physician Decision|2|||
128799107|NCT02539225|463557135|FG001|Pre Treatment for Part B|Physician Decision|0|||
128799108|NCT02539225|463557134|FG000|Part B|Adverse Event|4|||
128799109|NCT02539225|463557135|FG001|Part B|Adverse Event|4|||
128799110|NCT02539225|463557134|FG000|Part B|Withdrawal by Subject|0|||
128799111|NCT02539225|463557135|FG001|Part B|Withdrawal by Subject|3|||
128799112|NCT02539225|463557134|FG000|Part B|Physician Decision|0|||
128799113|NCT02539225|463557135|FG001|Part B|Physician Decision|9|||
128799114|NCT04814186|463558566|FG000|Treatment Phase|Adverse Event|1|||
128799115|NCT04814186|463558566|FG000|Treatment Phase|Death|6|||
128799116|NCT04814186|463558566|FG000|Treatment Phase|Withdrawal by Subject|2|||
128799117|NCT04814186|463558566|FG000|Treatment Phase|Other|1|||
128799118|NCT04814186|463558566|FG000|Follow-Up Phase|Adverse Event|1|||
128799119|NCT04814186|463558566|FG000|Follow-Up Phase|Death|6|||
128799120|NCT04814186|463558566|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
128799121|NCT04814186|463558566|FG000|Follow-Up Phase|Other|1|||
128799122|NCT04043455|463558572|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
128799123|NCT04043455|463558573|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
128799124|NCT04043455|463558574|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
128799125|NCT04043455|463558575|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
128799126|NCT04043455|463558576|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
128799127|NCT04043455|463558577|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
128799128|NCT04043455|463558572|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
128799129|NCT04043455|463558573|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
128799130|NCT04043455|463558574|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
128799131|NCT04043455|463558575|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
128799132|NCT04043455|463558576|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
128799133|NCT04043455|463558577|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
128799134|NCT04043455|463558572|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
128799135|NCT04043455|463558573|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
128799136|NCT04043455|463558574|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
128799137|NCT04043455|463558575|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
128799138|NCT04043455|463558576|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
128799139|NCT04043455|463558577|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
128799140|NCT04043455|463558572|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
128799141|NCT04043455|463558573|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
128799142|NCT04043455|463558574|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
128799143|NCT04043455|463558575|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
128799144|NCT04043455|463558576|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
128799145|NCT04043455|463558577|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
128799146|NCT04043455|463558572|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
128799147|NCT04043455|463558573|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
128799148|NCT04043455|463558574|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
128799149|NCT04043455|463558575|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
128799150|NCT04043455|463558576|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
128799151|NCT04043455|463558577|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
128799152|NCT04043455|463558572|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
128799153|NCT04043455|463558573|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
128799154|NCT04043455|463558574|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
128799155|NCT04043455|463558575|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
128799156|NCT04043455|463558576|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
128799157|NCT04043455|463558577|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
128799158|NCT04043455|463558572|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
128799159|NCT04043455|463558573|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
128799160|NCT04043455|463558574|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
128799161|NCT04043455|463558575|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
128799162|NCT04043455|463558576|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
128799163|NCT04043455|463558577|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
128799164|NCT04043455|463558572|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
128799165|NCT04043455|463558573|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
128799166|NCT04043455|463558574|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
128799167|NCT04043455|463558575|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
128799168|NCT04043455|463558576|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
128799169|NCT04043455|463558577|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
128799170|NCT04043455|463558572|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
128799171|NCT04043455|463558573|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
128799172|NCT04043455|463558574|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
128799173|NCT04043455|463558575|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
128799174|NCT04043455|463558576|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
128799175|NCT04043455|463558577|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
128799176|NCT04043455|463558572|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
128799177|NCT04043455|463558573|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
128799178|NCT04043455|463558574|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
128799179|NCT04043455|463558575|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
128799180|NCT04043455|463558576|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
128799181|NCT04043455|463558577|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
128799182|NCT04043455|463558572|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
128799183|NCT04043455|463558573|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
128799184|NCT04043455|463558574|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
128799185|NCT04043455|463558575|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
128799186|NCT04043455|463558576|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
128799187|NCT04043455|463558577|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
128799188|NCT05194917|463558578|FG000|Overall Study|Lost to Follow-up|7|||
128799189|NCT05194917|463558579|FG001|Overall Study|Lost to Follow-up|5|||
128799190|NCT05194917|463558580|FG002|Overall Study|Lost to Follow-up|6|||
128799191|NCT05194917|463558581|FG003|Overall Study|Lost to Follow-up|5|||
128799192|NCT02544074|463558584|FG000|Overall Study|Withdrawal by Subject|0|||
128799193|NCT02544074|463558585|FG001|Overall Study|Withdrawal by Subject|1|||
128799194|NCT02544074|463558586|FG002|Overall Study|Withdrawal by Subject|0|||
128799195|NCT02544074|463558587|FG003|Overall Study|Withdrawal by Subject|0|||
128799196|NCT02544074|463558588|FG004|Overall Study|Withdrawal by Subject|0|||
128799197|NCT02544074|463558589|FG005|Overall Study|Withdrawal by Subject|0|||
128799198|NCT02544074|463558590|FG006|Overall Study|Withdrawal by Subject|0|||
128799199|NCT02544074|463558591|FG007|Overall Study|Withdrawal by Subject|0|||
128799200|NCT02544074|463558592|FG008|Overall Study|Withdrawal by Subject|0|||
128799201|NCT02544074|463558593|FG009|Overall Study|Withdrawal by Subject|0|||
128799202|NCT02544074|463558594|FG010|Overall Study|Withdrawal by Subject|0|||
128799203|NCT02544074|463558595|FG011|Overall Study|Withdrawal by Subject|0|||
128799204|NCT02544074|463558596|FG012|Overall Study|Withdrawal by Subject|0|||
128799205|NCT02544074|463558597|FG013|Overall Study|Withdrawal by Subject|0|||
128799206|NCT02544074|463558598|FG014|Overall Study|Withdrawal by Subject|0|||
128799207|NCT02544074|463558599|FG015|Overall Study|Withdrawal by Subject|0|||
128799208|NCT02544074|463558600|FG016|Overall Study|Withdrawal by Subject|0|||
128799209|NCT02544074|463558601|FG017|Overall Study|Withdrawal by Subject|0|||
128799210|NCT02544074|463558602|FG018|Overall Study|Withdrawal by Subject|0|||
128799211|NCT02544074|463558603|FG019|Overall Study|Withdrawal by Subject|0|||
128799212|NCT02544074|463558604|FG020|Overall Study|Withdrawal by Subject|0|||
128799213|NCT02544074|463558584|FG000|Overall Study|Tablet error|0|||
128799214|NCT02544074|463558585|FG001|Overall Study|Tablet error|0|||
128799215|NCT02544074|463558586|FG002|Overall Study|Tablet error|0|||
128799216|NCT02544074|463558587|FG003|Overall Study|Tablet error|0|||
128799217|NCT02544074|463558588|FG004|Overall Study|Tablet error|0|||
128799218|NCT02544074|463558589|FG005|Overall Study|Tablet error|1|||
128799219|NCT02544074|463558590|FG006|Overall Study|Tablet error|0|||
128799220|NCT02544074|463558591|FG007|Overall Study|Tablet error|0|||
128799221|NCT02544074|463558592|FG008|Overall Study|Tablet error|0|||
128799222|NCT02544074|463558593|FG009|Overall Study|Tablet error|1|||
128799223|NCT02544074|463558594|FG010|Overall Study|Tablet error|0|||
128799224|NCT02544074|463558595|FG011|Overall Study|Tablet error|0|||
128799225|NCT02544074|463558596|FG012|Overall Study|Tablet error|0|||
128799226|NCT02544074|463558597|FG013|Overall Study|Tablet error|0|||
128799227|NCT02544074|463558598|FG014|Overall Study|Tablet error|0|||
128799228|NCT02544074|463558599|FG015|Overall Study|Tablet error|0|||
128799229|NCT02544074|463558600|FG016|Overall Study|Tablet error|0|||
128799230|NCT02544074|463558601|FG017|Overall Study|Tablet error|0|||
128799231|NCT02544074|463558602|FG018|Overall Study|Tablet error|0|||
128799232|NCT02544074|463558603|FG019|Overall Study|Tablet error|0|||
128799233|NCT02544074|463558604|FG020|Overall Study|Tablet error|0|||
128799234|NCT03189524|463558605|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
128799235|NCT03189524|463558606|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
128799236|NCT03189524|463558607|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
128799237|NCT03189524|463558605|FG000|Overall Study|Death|2|||
128799238|NCT03189524|463558606|FG001|Overall Study|Death|2|||
128799239|NCT03189524|463558607|FG002|Overall Study|Death|1|||
128799240|NCT03189524|463558605|FG000|Overall Study|Lost to Follow-up|1|||
128799241|NCT03189524|463558606|FG001|Overall Study|Lost to Follow-up|0|||
128799242|NCT03189524|463558607|FG002|Overall Study|Lost to Follow-up|8|||
128799243|NCT03189524|463558605|FG000|Overall Study|Withdrawal by Subject|1|||
128799244|NCT03189524|463558606|FG001|Overall Study|Withdrawal by Subject|1|||
128799245|NCT03189524|463558607|FG002|Overall Study|Withdrawal by Subject|3|||
128799246|NCT03189524|463558605|FG000|Overall Study|Progressive Disease|0|||
128799247|NCT03189524|463558606|FG001|Overall Study|Progressive Disease|2|||
128799248|NCT03189524|463558607|FG002|Overall Study|Progressive Disease|0|||
128799249|NCT02980276|463558608|FG000|Overall Study|Withdrawal by Subject|4|||
128799250|NCT02980276|463558609|FG001|Overall Study|Withdrawal by Subject|4|||
128799251|NCT02980276|463558608|FG000|Overall Study|Physician Decision|0|||
128799252|NCT02980276|463558609|FG001|Overall Study|Physician Decision|1|||
128799253|NCT02980276|463558608|FG000|Overall Study|Lost to Follow-up|18|||
128799254|NCT02980276|463558609|FG001|Overall Study|Lost to Follow-up|18|||
128799255|NCT02980276|463558608|FG000|Overall Study|Death|1|||
128799256|NCT02980276|463558609|FG001|Overall Study|Death|0|||
128799257|NCT02980276|463558608|FG000|Overall Study|Miscellaneous other|10|||
128799258|NCT02980276|463558609|FG001|Overall Study|Miscellaneous other|4|||
128799259|NCT04300647|463558610|FG000|Pre-Crossover|Death|19|||
128799260|NCT04300647|463558611|FG001|Pre-Crossover|Death|58|||
128799261|NCT04300647|463558612|FG002|Pre-Crossover|Death|0|||
128799262|NCT04300647|463558610|FG000|Pre-Crossover|Lost to Follow-up|0|||
128799263|NCT04300647|463558611|FG001|Pre-Crossover|Lost to Follow-up|3|||
128799264|NCT04300647|463558612|FG002|Pre-Crossover|Lost to Follow-up|0|||
128799265|NCT04300647|463558610|FG000|Pre-Crossover|Withdrawal by Subject|2|||
128799266|NCT04300647|463558611|FG001|Pre-Crossover|Withdrawal by Subject|4|||
128799267|NCT04300647|463558612|FG002|Pre-Crossover|Withdrawal by Subject|0|||
128799268|NCT04300647|463558610|FG000|Pre-Crossover|On-going in Study|24|||
128799269|NCT04300647|463558611|FG001|Pre-Crossover|On-going in Study|61|||
128799270|NCT04300647|463558612|FG002|Pre-Crossover|On-going in Study|0|||
128799271|NCT04300647|463558610|FG000|Post-Crossover|Death|0|||
128799272|NCT04300647|463558611|FG001|Post-Crossover|Death|0|||
128799273|NCT04300647|463558612|FG002|Post-Crossover|Death|3|||
128799274|NCT04300647|463558610|FG000|Post-Crossover|Lost to Follow-up|0|||
128799275|NCT04300647|463558611|FG001|Post-Crossover|Lost to Follow-up|0|||
128799276|NCT04300647|463558612|FG002|Post-Crossover|Lost to Follow-up|1|||
128799277|NCT04300647|463558610|FG000|Post-Crossover|Withdrawal by Subject|0|||
128799278|NCT04300647|463558611|FG001|Post-Crossover|Withdrawal by Subject|0|||
128799279|NCT04300647|463558612|FG002|Post-Crossover|Withdrawal by Subject|1|||
128799280|NCT04300647|463558610|FG000|Post-Crossover|On-going in Study|0|||
128799281|NCT04300647|463558611|FG001|Post-Crossover|On-going in Study|0|||
128799282|NCT04300647|463558612|FG002|Post-Crossover|On-going in Study|8|||
128799283|NCT02824029|463558617|FG000|Overall Study|Didn't receive treatment|2|||
128799284|NCT02824029|463558617|FG000|Overall Study|Patient decision to discontinue treatment|3|||
128799285|NCT02824029|463558617|FG000|Overall Study|Non-compliant|5|||
128799286|NCT02824029|463558617|FG000|Overall Study|Progression of disease|15|||
128799287|NCT02824029|463558617|FG000|Overall Study|Inadequate response to therapy|2|||
128799288|NCT02824029|463558617|FG000|Overall Study|Possible progression per treating physician|1|||
128799289|NCT03613740|463558618|FG000|Overall Study|Lost to Follow-up|1|||
128799290|NCT03613740|463558619|FG001|Overall Study|Lost to Follow-up|1|||
128799291|NCT01443845|463558620|FG000|Overall Study|Protocol Violation|43|||
128799292|NCT01443845|463558621|FG001|Overall Study|Protocol Violation|45|||
128799293|NCT01443845|463558620|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
128799294|NCT01443845|463558621|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
128799295|NCT01443845|463558620|FG000|Overall Study|Deterioration in pulmonary function|1|||
128799296|NCT01443845|463558621|FG001|Overall Study|Deterioration in pulmonary function|4|||
128799297|NCT01443845|463558620|FG000|Overall Study|Lack of Efficacy|10|||
128799298|NCT01443845|463558621|FG001|Overall Study|Lack of Efficacy|5|||
128799299|NCT01443845|463558620|FG000|Overall Study|Adverse Event|64|||
128799300|NCT01443845|463558621|FG001|Overall Study|Adverse Event|138|||
128799301|NCT01443845|463558620|FG000|Overall Study|Withdrawal by Subject|63|||
128799302|NCT01443845|463558621|FG001|Overall Study|Withdrawal by Subject|67|||
128799303|NCT01443845|463558620|FG000|Overall Study|Military Conflict - Site Terminated|20|||
128799304|NCT01443845|463558621|FG001|Overall Study|Military Conflict - Site Terminated|21|||
128799305|NCT01443845|463558620|FG000|Overall Study|Lost to Follow-up|9|||
128799306|NCT01443845|463558621|FG001|Overall Study|Lost to Follow-up|13|||
128799307|NCT00520546|463558622|FG000|Overall Study|Withdrawal by Subject|1|||
128799308|NCT00520546|463558622|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
128799309|NCT02101281|463558626|FG000|Overall Study|Adverse Event|0|||
128799310|NCT02101281|463558627|FG001|Overall Study|Adverse Event|1|||
128799311|NCT00174382|463558628|FG000|Overall Study|Death|2|||
128799312|NCT00174382|463558628|FG000|Overall Study|Adverse Event|19|||
128799313|NCT00174382|463558628|FG000|Overall Study|Withdrawal by Subject|6|||
128799314|NCT00174382|463558628|FG000|Overall Study|Protocol Violation|3|||
128799315|NCT00174382|463558628|FG000|Overall Study|Arrived early for last visit in error|1|||
128799316|NCT00174382|463558628|FG000|Overall Study|Subject felt pill not effective enough|1|||
128799317|NCT00174382|463558628|FG000|Overall Study|Lost to Follow-up|1|||
128799318|NCT00296036|463558629|FG000|Overall Study|Withdrawal by Subject|1|||
128799319|NCT00296036|463558630|FG001|Overall Study|Withdrawal by Subject|0|||
128799320|NCT00296036|463558631|FG002|Overall Study|Withdrawal by Subject|2|||
128799321|NCT00296036|463558632|FG003|Overall Study|Withdrawal by Subject|1|||
128799322|NCT00296036|463558633|FG004|Overall Study|Withdrawal by Subject|2|||
128799323|NCT00296036|463558634|FG005|Overall Study|Withdrawal by Subject|1|||
128799324|NCT00296036|463558629|FG000|Overall Study|Protocol Violation|0|||
128799325|NCT00296036|463558630|FG001|Overall Study|Protocol Violation|0|||
128799326|NCT00296036|463558631|FG002|Overall Study|Protocol Violation|0|||
128799327|NCT00296036|463558632|FG003|Overall Study|Protocol Violation|0|||
128799328|NCT00296036|463558633|FG004|Overall Study|Protocol Violation|0|||
128799329|NCT00296036|463558634|FG005|Overall Study|Protocol Violation|3|||
128799330|NCT03403413|463558635|FG000|Overall Study|Lack of Efficacy|2|||
128799331|NCT03655262|463558636|FG000|Overall Study|Withdrawal by Subject|0|||
128799332|NCT03655262|463558637|FG001|Overall Study|Withdrawal by Subject|0|||
128799333|NCT03655262|463558638|FG002|Overall Study|Withdrawal by Subject|1|||
128799334|NCT03951805|463558642|FG000|Overall Study|Adverse Event|1|||
128799335|NCT03951805|463558643|FG001|Overall Study|Adverse Event|0|||
128799336|NCT03951805|463558644|FG002|Overall Study|Adverse Event|0|||
128799337|NCT03951805|463558645|FG003|Overall Study|Adverse Event|0|||
128799338|NCT00604669|463558646|FG000|Overall Study|lack of information in chart|7|||
128799339|NCT01695954|463558647|FG000|Overall Study|Withdrawal by Subject|4|||
128799340|NCT01695954|463558648|FG001|Overall Study|Withdrawal by Subject|0|||
128799341|NCT01695954|463558647|FG000|Overall Study|Adverse Event|0|||
128799342|NCT01695954|463558648|FG001|Overall Study|Adverse Event|2|||
128799343|NCT04328727|463558650|FG000|Overall Study|Guardian Decision|1|||
128799344|NCT04328727|463558650|FG000|Overall Study|Participant decision|4|||
128799345|NCT04328727|463558650|FG000|Overall Study|Death|3|||
128799346|NCT03684044|463558651|FG000|Overall Study|Adverse Event|3|||
128799347|NCT03684044|463558652|FG001|Overall Study|Adverse Event|0|||
128799348|NCT03684044|463558651|FG000|Overall Study|Death|4|||
128799349|NCT03684044|463558652|FG001|Overall Study|Death|7|||
128799350|NCT03684044|463558651|FG000|Overall Study|Lost to Follow-up|3|||
128799351|NCT03684044|463558652|FG001|Overall Study|Lost to Follow-up|2|||
128799352|NCT03684044|463558651|FG000|Overall Study|Patient Not Available|0|||
128799353|NCT03684044|463558652|FG001|Overall Study|Patient Not Available|2|||
128799354|NCT03684044|463558651|FG000|Overall Study|Physician Decision|1|||
128799355|NCT03684044|463558652|FG001|Overall Study|Physician Decision|0|||
128799356|NCT03684044|463558651|FG000|Overall Study|Withdrawal by Subject|11|||
128799357|NCT03684044|463558652|FG001|Overall Study|Withdrawal by Subject|9|||
128799358|NCT03703336|463558653|FG000|Overall Study|Parent withdrew consent|29|||
128799359|NCT03703336|463558654|FG001|Overall Study|Parent withdrew consent|8|||
128799360|NCT03703336|463558653|FG000|Overall Study|Migration|3|||
128799361|NCT03703336|463558654|FG001|Overall Study|Migration|3|||
128799362|NCT03703336|463558653|FG000|Overall Study|Protocol Violation|3|||
128799363|NCT03703336|463558654|FG001|Overall Study|Protocol Violation|1|||
128799364|NCT03703336|463558653|FG000|Overall Study|Physician Decision|2|||
128799365|NCT03703336|463558654|FG001|Overall Study|Physician Decision|0|||
128799366|NCT03703336|463558653|FG000|Overall Study|Adverse Event|0|||
128799367|NCT03703336|463558654|FG001|Overall Study|Adverse Event|2|||
128799368|NCT03703336|463558653|FG000|Overall Study|Lost to Follow-up|1|||
128799369|NCT03703336|463558654|FG001|Overall Study|Lost to Follow-up|0|||
128799370|NCT00595413|463558655|FG000|Overall Study|Adverse Event|0|||
128799371|NCT00595413|463558656|FG001|Overall Study|Adverse Event|2|||
128799372|NCT00595413|463558657|FG002|Overall Study|Adverse Event|1|||
128799373|NCT00595413|463558658|FG003|Overall Study|Adverse Event|1|||
128799374|NCT00595413|463558655|FG000|Overall Study|Lost to Follow-up|2|||
128799375|NCT00595413|463558656|FG001|Overall Study|Lost to Follow-up|2|||
128799376|NCT00595413|463558657|FG002|Overall Study|Lost to Follow-up|1|||
128799377|NCT00595413|463558658|FG003|Overall Study|Lost to Follow-up|3|||
128799378|NCT00595413|463558655|FG000|Overall Study|Death|0|||
128799379|NCT00595413|463558656|FG001|Overall Study|Death|0|||
128799380|NCT00595413|463558657|FG002|Overall Study|Death|1|||
128799381|NCT00595413|463558658|FG003|Overall Study|Death|0|||
128799382|NCT00595413|463558655|FG000|Overall Study|Other|5|||
128799383|NCT00595413|463558656|FG001|Overall Study|Other|1|||
128799384|NCT00595413|463558657|FG002|Overall Study|Other|5|||
128799385|NCT00595413|463558658|FG003|Overall Study|Other|0|||
128799386|NCT04149002|463558659|FG000|Overall Study|Lost to Follow-up|1|||
128799387|NCT04149002|463558660|FG001|Overall Study|Lost to Follow-up|0|||
128799388|NCT04149002|463558659|FG000|Overall Study|Withdrawal by Subject|1|||
128799389|NCT04149002|463558660|FG001|Overall Study|Withdrawal by Subject|0|||
128799390|NCT04583423|463558662|FG000|Overall Study|Lost to Follow-up|0|||
128799391|NCT04583423|463558663|FG001|Overall Study|Lost to Follow-up|1|||
128799392|NCT04583423|463558664|FG002|Overall Study|Lost to Follow-up|0|||
128799393|NCT04583423|463558665|FG003|Overall Study|Lost to Follow-up|2|||
128799394|NCT04583423|463558662|FG000|Overall Study|Study Terminated by Sponsor|32|||
128799395|NCT04583423|463558663|FG001|Overall Study|Study Terminated by Sponsor|35|||
128799396|NCT04583423|463558664|FG002|Overall Study|Study Terminated by Sponsor|36|||
128799397|NCT04583423|463558665|FG003|Overall Study|Study Terminated by Sponsor|33|||
128799398|NCT04583423|463558662|FG000|Overall Study|Withdrawal by Subject|3|||
128799399|NCT04583423|463558663|FG001|Overall Study|Withdrawal by Subject|1|||
128799400|NCT04583423|463558664|FG002|Overall Study|Withdrawal by Subject|2|||
128799401|NCT04583423|463558665|FG003|Overall Study|Withdrawal by Subject|1|||
128799402|NCT01198145|463558666|FG000|Overall Study|Withdrawal by Subject|1|||
128799403|NCT01198145|463558667|FG001|Overall Study|Withdrawal by Subject|1|||
128799404|NCT00603954|463558668|FG000|Overall Study|Protocol Violation|1|||
128799405|NCT00603954|463558669|FG001|Overall Study|Protocol Violation|2|||
128799406|NCT00580866|463558671|FG000|Overall Study|Lost to Follow-up|2|||
128799407|NCT00580866|463558672|FG001|Overall Study|Lost to Follow-up|2|||
128799408|NCT00609336|463558673|FG000|Overall Study|Protocol Violation|3|||
128799409|NCT00609336|463558673|FG000|Overall Study|Death|1|||
128799410|NCT00609336|463558673|FG000|Overall Study|LA or Met at Surgery|9|||
128799411|NCT02477605|463558674|FG000|Overall Study|Discontinued prior to treatment|1|||
128799412|NCT02477605|463558675|FG001|Overall Study|Discontinued prior to treatment|0|||
128799413|NCT02477605|463558674|FG000|Overall Study|Lost to Follow-up|0|||
128799414|NCT02477605|463558675|FG001|Overall Study|Lost to Follow-up|2|||
128799415|NCT02477605|463558674|FG000|Overall Study|Withdrawal by Subject|0|||
128799416|NCT02477605|463558675|FG001|Overall Study|Withdrawal by Subject|1|||
128799417|NCT02477605|463558674|FG000|Overall Study|Administered gas during surgery|0|||
128799418|NCT02477605|463558675|FG001|Overall Study|Administered gas during surgery|1|||
128799419|NCT02574455|463558676|FG000|Overall Study|Death|197|||
128799420|NCT02574455|463558677|FG001|Overall Study|Death|210|||
128799421|NCT02574455|463558676|FG000|Overall Study|Withdrawal of Consent|11|||
128799422|NCT02574455|463558677|FG001|Overall Study|Withdrawal of Consent|28|||
128799423|NCT02574455|463558676|FG000|Overall Study|Lost to Follow-up|4|||
128799424|NCT02574455|463558677|FG001|Overall Study|Lost to Follow-up|4|||
128799425|NCT02574455|463558676|FG000|Overall Study|Sponsor's Decision|55|||
128799426|NCT02574455|463558677|FG001|Overall Study|Sponsor's Decision|20|||
128799427|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Death|117|||
128799428|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Death|197|||
128799429|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
128799430|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
128799431|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
128799432|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
128799433|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
128799434|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
128799435|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
128799436|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
128799437|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
128799438|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
128799439|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
128799440|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
128799441|NCT02677896|463558678|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
128799442|NCT02677896|463558679|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
128799443|NCT02677896|463558678|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
128799444|NCT02677896|463558679|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
128799445|NCT02677896|463558678|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
128799446|NCT02677896|463558679|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
128799447|NCT02677896|463558678|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
128799448|NCT02677896|463558679|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
128799449|NCT02677896|463558678|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
128799450|NCT02677896|463558679|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
128799451|NCT02677896|463558678|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
128799452|NCT02677896|463558679|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
128799453|NCT02677896|463558678|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
128799454|NCT02677896|463558679|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
128799455|NCT01083316|463558683|FG000|Overall Study|Adverse Event|2|||
128799456|NCT01083316|463558683|FG000|Overall Study|Withdrawal by Subject|1|||
128799457|NCT04200365|463558684|FG000|Overall Study|Adverse Event|2|||
128799458|NCT04200365|463558684|FG000|Overall Study|Progressive Disease|4|||
128799459|NCT04200365|463558684|FG000|Overall Study|Lack of Efficacy|1|||
128799460|NCT04200365|463558684|FG000|Overall Study|Study Closure|4|||
128799461|NCT02318134|463558688|FG000|Overall Study|Withdrawal by Subject|2|||
128799462|NCT02318134|463558689|FG001|Overall Study|Withdrawal by Subject|1|||
128799463|NCT01976312|463558690|FG000|Overall Study|Pregnancy|0|||
128799464|NCT01976312|463558691|FG001|Overall Study|Pregnancy|1|||
128799465|NCT01976312|463558690|FG000|Overall Study|Lost to Follow-up|2|||
128799466|NCT01976312|463558691|FG001|Overall Study|Lost to Follow-up|0|||
128799467|NCT01976312|463558690|FG000|Overall Study|Withdrawal by Subject|7|||
128799468|NCT01976312|463558691|FG001|Overall Study|Withdrawal by Subject|2|||
128799469|NCT01976312|463558690|FG000|Overall Study|Adverse Event|6|||
128799470|NCT01976312|463558691|FG001|Overall Study|Adverse Event|6|||
128799471|NCT01976312|463558690|FG000|Overall Study|Protocol Violation|2|||
128799472|NCT01976312|463558691|FG001|Overall Study|Protocol Violation|0|||
128799473|NCT01609218|463558698|FG000|Period 1|Adverse Event|3|||
128799474|NCT01609218|463558699|FG001|Period 1|Adverse Event|5|||
128799475|NCT01609218|463558698|FG000|Period 1|Sponsor Decision|0|||
128799476|NCT01609218|463558699|FG001|Period 1|Sponsor Decision|1|||
128799477|NCT01609218|463558698|FG000|Period 2|Adverse Event|1|||
128799478|NCT01609218|463558699|FG001|Period 2|Adverse Event|0|||
128799479|NCT04428112|463558705|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
128799480|NCT04428112|463558706|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
128799481|NCT04428112|463558705|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
128799482|NCT04428112|463558706|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
128799483|NCT04428112|463558705|FG000|Overall Study|Withdrawal by Subject|9|||
128799484|NCT04428112|463558706|FG001|Overall Study|Withdrawal by Subject|4|||
128799485|NCT04428112|463558705|FG000|Overall Study|Lost to Follow-up|27|||
128799486|NCT04428112|463558706|FG001|Overall Study|Lost to Follow-up|7|||
128799487|NCT01207492|463558707|FG000|Overall Study|Still on study|1|||
128799488|NCT01207492|463558707|FG000|Overall Study|Withdrawal by Subject|9|||
128799489|NCT01207492|463558707|FG000|Overall Study|Physician Decision|1|||
128799490|NCT01207492|463558707|FG000|Overall Study|Progressive disease|3|||
128799491|NCT01207492|463558707|FG000|Overall Study|Toxicity|1|||
128799492|NCT02769858|463558708|FG000|Overall Study|Withdrawal by Subject|2|||
128799493|NCT03783026|463559762|FG000|Treatment Phase|Adverse Event|15|||
128799494|NCT03783026|463559762|FG000|Treatment Phase|Lack of Efficacy|11|||
128799495|NCT03783026|463559762|FG000|Treatment Phase|Withdrawal by Subject|6|||
128799496|NCT03783026|463559762|FG000|Treatment Phase|Lost to Follow-up|2|||
128799497|NCT03783026|463559762|FG000|Treatment Phase|Protocol Deviation|8|||
128799498|NCT03783026|463559762|FG000|Treatment Phase|Did Not Receive Treatment|1|||
128799499|NCT03783026|463559762|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
128799500|NCT01853748|463559763|FG000|Allocation|Withdrawal by Subject|1|||
128799501|NCT01853748|463559764|FG001|Allocation|Withdrawal by Subject|13|||
128799502|NCT01853748|463559763|FG000|Allocation|not sufficient to receive intervention|0|||
128799503|NCT01853748|463559764|FG001|Allocation|not sufficient to receive intervention|1|||
128799504|NCT01853748|463559763|FG000|Follow-Up|Withdrawal by Subject|7|||
128799505|NCT01853748|463559764|FG001|Follow-Up|Withdrawal by Subject|6|||
128799506|NCT01853748|463559763|FG000|Follow-Up|Adverse Event|67|||
128799507|NCT01853748|463559764|FG001|Follow-Up|Adverse Event|7|||
128799508|NCT01853748|463559763|FG000|Follow-Up|not available for data collection|16|||
128799509|NCT01853748|463559764|FG001|Follow-Up|not available for data collection|4|||
128799510|NCT04688450|463559773|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
128799511|NCT04688450|463559773|FG000|Overall Study|Withdrawal by Subject|1|||
128799512|NCT03346538|463559774|FG000|Overall Study|Physician Decision|0|||
128799513|NCT03346538|463559775|FG001|Overall Study|Physician Decision|1|||
128799514|NCT03346538|463559776|FG002|Overall Study|Physician Decision|0|||
128799515|NCT03346538|463559774|FG000|Overall Study|Withdrawal by Subject|3|||
128799516|NCT03346538|463559775|FG001|Overall Study|Withdrawal by Subject|2|||
128799517|NCT03346538|463559776|FG002|Overall Study|Withdrawal by Subject|0|||
128799518|NCT03346538|463559774|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
128799519|NCT03346538|463559775|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
128799520|NCT03346538|463559776|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
128799521|NCT01353313|463559777|FG000|Overall Study|Lost to Follow-up|22|||
128799522|NCT01353313|463559778|FG001|Overall Study|Lost to Follow-up|23|||
128799523|NCT01353313|463559777|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
128799524|NCT01353313|463559778|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
128799525|NCT04755660|463559779|FG000|Overall Study|Lost to Follow-up|1|||
128799526|NCT04755660|463559780|FG001|Overall Study|Lost to Follow-up|1|||
128799527|NCT04755660|463559781|FG002|Overall Study|Lost to Follow-up|0|||
128799528|NCT04755660|463559779|FG000|Overall Study|Withdrawal by Subject|0|||
128799529|NCT04755660|463559780|FG001|Overall Study|Withdrawal by Subject|1|||
128799530|NCT04755660|463559781|FG002|Overall Study|Withdrawal by Subject|1|||
128799531|NCT04755660|463559779|FG000|Overall Study|Physician Decision|0|||
128799532|NCT04755660|463559780|FG001|Overall Study|Physician Decision|0|||
128799533|NCT04755660|463559781|FG002|Overall Study|Physician Decision|1|||
128799534|NCT05672667|463559783|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
128799535|NCT04524390|463559784|FG000|Double Blind|Consent Withdrawal by subject|2|||
128799536|NCT04524390|463559785|FG001|Double Blind|Consent Withdrawal by subject|1|||
128799537|NCT04524390|463559786|FG002|Double Blind|Consent Withdrawal by subject|0|||
128799538|NCT04524390|463559784|FG000|Double Blind|Adverse Event|5|||
128799539|NCT04524390|463559785|FG001|Double Blind|Adverse Event|3|||
128799540|NCT04524390|463559786|FG002|Double Blind|Adverse Event|0|||
128799541|NCT04524390|463559784|FG000|Double Blind|Liver Transplant|5|||
128799542|NCT04524390|463559785|FG001|Double Blind|Liver Transplant|6|||
128799543|NCT04524390|463559786|FG002|Double Blind|Liver Transplant|0|||
128799544|NCT04524390|463559784|FG000|Double Blind|Disease Progression|0|||
128799545|NCT04524390|463559785|FG001|Double Blind|Disease Progression|1|||
128799546|NCT04524390|463559786|FG002|Double Blind|Disease Progression|0|||
128799547|NCT04524390|463559784|FG000|Open-Label|Drug interruption criteria|0|||
128799548|NCT04524390|463559785|FG001|Open-Label|Drug interruption criteria|0|||
128799549|NCT04524390|463559786|FG002|Open-Label|Drug interruption criteria|1|||
128799550|NCT04524390|463559784|FG000|Open-Label|Liver Transplant|0|||
128799551|NCT04524390|463559785|FG001|Open-Label|Liver Transplant|0|||
128799552|NCT04524390|463559786|FG002|Open-Label|Liver Transplant|1|||
128799553|NCT04524390|463559784|FG000|Open-Label|Disease Progression|0|||
128799554|NCT04524390|463559785|FG001|Open-Label|Disease Progression|0|||
128799555|NCT04524390|463559786|FG002|Open-Label|Disease Progression|1|||
128799556|NCT04524390|463559784|FG000|Open-Label|Adverse Event|0|||
128799557|NCT04524390|463559785|FG001|Open-Label|Adverse Event|0|||
128799558|NCT04524390|463559786|FG002|Open-Label|Adverse Event|3|||
128799559|NCT04524390|463559784|FG000|Open-Label|Study Termination by sponsor|0|||
128799560|NCT04524390|463559785|FG001|Open-Label|Study Termination by sponsor|0|||
128799561|NCT04524390|463559786|FG002|Open-Label|Study Termination by sponsor|45|||
128799562|NCT04540913|463559801|FG000|Overall Study|Withdrawal by Subject|14|||
128799563|NCT04540913|463559802|FG001|Overall Study|Withdrawal by Subject|3|||
128799564|NCT01693120|463559804|FG000|Enrollment|Lost to Follow-up|1|||
128799565|NCT01693120|463559804|FG000|Enrollment|Withdrawal by Subject|10|||
128799566|NCT01693120|463559804|FG000|Enrollment|Protocol Violation|46|||
128799567|NCT01693120|463559804|FG000|Enrollment|Physician Decision|3|||
128799568|NCT01693120|463559804|FG000|Enrollment|Adverse Event|1|||
128799569|NCT01693120|463559804|FG000|Enrollment|Study closed|8|||
128799570|NCT01693120|463559804|FG000|Enrollment|Other|1|||
128799571|NCT01693120|463559804|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
128799572|NCT01693120|463559804|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
128799573|NCT01693120|463559804|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
128799574|NCT01693120|463559804|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
128799575|NCT01693120|463559804|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
128799576|NCT04153565|463559805|FG000|Overall Study|Death|13|||
128799577|NCT02238483|463559813|FG000|Overall Study|Withdrawal by Subject|2|||
128799578|NCT02238483|463559814|FG001|Overall Study|Withdrawal by Subject|7|||
128799579|NCT02238483|463559813|FG000|Overall Study|Lost to Follow-up|1|||
128799580|NCT02238483|463559814|FG001|Overall Study|Lost to Follow-up|1|||
128799581|NCT02238483|463559813|FG000|Overall Study|Protocol Violation|1|||
128799582|NCT02238483|463559814|FG001|Overall Study|Protocol Violation|2|||
128799583|NCT02238483|463559813|FG000|Overall Study|Death|1|||
128799584|NCT02238483|463559814|FG001|Overall Study|Death|0|||
128799585|NCT02238483|463559813|FG000|Overall Study|Adverse Event|7|||
128799586|NCT02238483|463559814|FG001|Overall Study|Adverse Event|3|||
128799587|NCT02238483|463559813|FG000|Overall Study|Withdrawn due to physician decision|1|||
128799588|NCT02238483|463559814|FG001|Overall Study|Withdrawn due to physician decision|0|||
128799589|NCT02238483|463559813|FG000|Overall Study|Completion status not recorded|1|||
128799590|NCT02238483|463559814|FG001|Overall Study|Completion status not recorded|1|||
128799591|NCT02238483|463559813|FG000|Overall Study|Illness in family member|1|||
128799592|NCT02238483|463559814|FG001|Overall Study|Illness in family member|0|||
128799593|NCT00567489|463559815|FG000|Overall Study|Adverse Event|6|||
128799594|NCT00567489|463559816|FG001|Overall Study|Adverse Event|14|||
128799595|NCT00567489|463559815|FG000|Overall Study|Physician Decision|0|||
128799596|NCT00567489|463559816|FG001|Overall Study|Physician Decision|4|||
128799597|NCT00567489|463559815|FG000|Overall Study|Withdrawal by Subject|0|||
128799598|NCT00567489|463559816|FG001|Overall Study|Withdrawal by Subject|2|||
128799599|NCT00567489|463559815|FG000|Overall Study|Renal Transplantation|0|||
128799600|NCT00567489|463559816|FG001|Overall Study|Renal Transplantation|3|||
128799601|NCT00567489|463559815|FG000|Overall Study|Other|1|||
128799602|NCT00567489|463559816|FG001|Overall Study|Other|0|||
128799603|NCT00539734|463559817|FG000|Overall Study|Protocol Violation|1|||
128799604|NCT03565315|463559818|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
128799605|NCT03565315|463559819|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
128799606|NCT03565315|463559820|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
128799607|NCT03565315|463559821|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
128799608|NCT02692417|463559822|FG000|Overall Study|Withdrawal by Subject|5|||
128799609|NCT02692417|463559823|FG001|Overall Study|Withdrawal by Subject|1|||
128799610|NCT02692417|463559822|FG000|Overall Study|Adverse Event|1|||
128799611|NCT02692417|463559823|FG001|Overall Study|Adverse Event|0|||
128799612|NCT02372253|463559824|FG000|Overall Study|Non Compliance|2|||
128799613|NCT02372253|463559825|FG001|Overall Study|Non Compliance|0|||
128799614|NCT04048382|463559832|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
128799615|NCT04048382|463559833|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
128799616|NCT04048382|463559832|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
128799617|NCT04048382|463559833|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
128799618|NCT04048382|463559832|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
128799619|NCT04048382|463559833|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
128799620|NCT01205048|463559835|FG000|Overall Study|Withdrawal by Subject|14|||
128799621|NCT01205048|463559835|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
128799622|NCT01205048|463559835|FG000|Overall Study|Lost to Follow-up|4|||
128799623|NCT01205048|463559835|FG000|Overall Study|Other|2|||
128799624|NCT01255670|463559836|FG000|Overall Study|Adverse Event|10|||
128799625|NCT01255670|463559837|FG001|Overall Study|Adverse Event|10|||
128799626|NCT01255670|463559836|FG000|Overall Study|Lost to Follow-up|16|||
128799627|NCT01255670|463559837|FG001|Overall Study|Lost to Follow-up|10|||
128799628|NCT01037985|463559838|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
128799629|NCT01037985|463559839|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
128799630|NCT01037985|463559838|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
128799631|NCT01037985|463559839|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
128799632|NCT01037985|463559838|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
128799633|NCT01037985|463559839|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
128799634|NCT01037985|463559838|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
128799635|NCT01037985|463559839|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
128799636|NCT02269475|463559840|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
128799637|NCT02269475|463559841|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
128799638|NCT02269475|463559840|FG000|Overall Study|Withdrawal by Subject|0|||
128799639|NCT02269475|463559841|FG001|Overall Study|Withdrawal by Subject|1|||
128799640|NCT02730871|463559842|FG000|Overall Study|Adverse Event|6|||
128799641|NCT02730871|463559843|FG001|Overall Study|Adverse Event|0|||
128799642|NCT00823472|463559844|FG000|Overall Study|Physician Decision|24|||
128799643|NCT00823472|463559845|FG001|Overall Study|Physician Decision|28|||
128799644|NCT04992390|463559846|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
128799645|NCT04992390|463559847|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
128799646|NCT04992390|463559848|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
128799647|NCT04992390|463559846|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
128799648|NCT04992390|463559847|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
128799649|NCT04992390|463559848|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
128799650|NCT04992390|463559846|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
128799651|NCT04992390|463559847|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
128799652|NCT04992390|463559848|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
128799653|NCT04992390|463559846|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
128799654|NCT04992390|463559847|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
128799655|NCT04992390|463559848|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
128799656|NCT04992390|463559846|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
128799657|NCT04992390|463559847|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
128799658|NCT04992390|463559848|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
128799659|NCT04992390|463559846|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
128799660|NCT04992390|463559847|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
128799661|NCT04992390|463559848|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
128799662|NCT04992390|463559846|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
128799663|NCT04992390|463559847|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
128799664|NCT04992390|463559848|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
128799665|NCT04992390|463559846|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
128799666|NCT04992390|463559847|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
128799667|NCT04992390|463559848|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
128799668|NCT04992390|463559846|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
128799669|NCT04992390|463559847|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
128799670|NCT04992390|463559848|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
128799671|NCT04992390|463559846|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
128799672|NCT04992390|463559847|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
128799673|NCT04992390|463559848|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
128799674|NCT04992390|463559846|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
128799675|NCT04992390|463559847|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
128799676|NCT04992390|463559848|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
128799677|NCT04992390|463559846|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
128799678|NCT04992390|463559847|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
128799679|NCT04992390|463559848|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
128799680|NCT04992390|463559846|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
128799681|NCT04992390|463559847|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
128799682|NCT04992390|463559848|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
128799683|NCT04992390|463559846|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
128799684|NCT04992390|463559847|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
128799685|NCT04992390|463559848|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
128799686|NCT04992390|463559846|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
128799687|NCT04992390|463559847|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
128799688|NCT04992390|463559848|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
128799689|NCT04992390|463559846|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
128799690|NCT04992390|463559847|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
128799691|NCT04992390|463559848|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
128799692|NCT02807779|463559849|FG000|Overall Study|Lost to Follow-up|1|||
128799693|NCT02807779|463559850|FG001|Overall Study|Lost to Follow-up|0|||
128799694|NCT02807779|463559851|FG002|Overall Study|Lost to Follow-up|0|||
128799695|NCT02807779|463559849|FG000|Overall Study|Physician Decision|2|||
128799696|NCT02807779|463559850|FG001|Overall Study|Physician Decision|0|||
128799697|NCT02807779|463559851|FG002|Overall Study|Physician Decision|1|||
128799698|NCT02807779|463559849|FG000|Overall Study|Death|1|||
128799699|NCT02807779|463559850|FG001|Overall Study|Death|1|||
128799700|NCT02807779|463559851|FG002|Overall Study|Death|0|||
128799701|NCT04939246|463559852|FG000|After Treatment|Death|4|||
128799702|NCT04939246|463559852|FG000|After Treatment|Lost to Follow-up|1|||
128799703|NCT04939246|463559852|FG000|After Treatment|Discharged to hospice|2|||
128799704|NCT04994509|463559853|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
128799705|NCT04994509|463559854|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
128799706|NCT04994509|463559855|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
128799707|NCT04994509|463559853|FG000|Overall Study|Withdrew Consent|73|||
128799708|NCT04994509|463559854|FG001|Overall Study|Withdrew Consent|72|||
128799709|NCT04994509|463559855|FG002|Overall Study|Withdrew Consent|46|||
128799710|NCT04994509|463559853|FG000|Overall Study|Lost to Follow-up|39|||
128799711|NCT04994509|463559854|FG001|Overall Study|Lost to Follow-up|36|||
128799712|NCT04994509|463559855|FG002|Overall Study|Lost to Follow-up|26|||
128799713|NCT04994509|463559853|FG000|Overall Study|HIV-1 Infection|4|||
128799714|NCT04994509|463559854|FG001|Overall Study|HIV-1 Infection|20|||
128799715|NCT04994509|463559855|FG002|Overall Study|HIV-1 Infection|12|||
128799716|NCT04994509|463559853|FG000|Overall Study|Investigator's Discretion|9|||
128799717|NCT04994509|463559854|FG001|Overall Study|Investigator's Discretion|8|||
128799718|NCT04994509|463559855|FG002|Overall Study|Investigator's Discretion|11|||
128799719|NCT04994509|463559853|FG000|Overall Study|Randomized but Never Treated|10|||
128799720|NCT04994509|463559854|FG001|Overall Study|Randomized but Never Treated|10|||
128799721|NCT04994509|463559855|FG002|Overall Study|Randomized but Never Treated|3|||
128799722|NCT04994509|463559853|FG000|Overall Study|Pregnancy|5|||
128799723|NCT04994509|463559854|FG001|Overall Study|Pregnancy|5|||
128799724|NCT04994509|463559855|FG002|Overall Study|Pregnancy|0|||
128799725|NCT04994509|463559853|FG000|Overall Study|Death|0|||
128799726|NCT04994509|463559854|FG001|Overall Study|Death|5|||
128799727|NCT04994509|463559855|FG002|Overall Study|Death|0|||
128799728|NCT04994509|463559853|FG000|Overall Study|Adverse Event|2|||
128799729|NCT04994509|463559854|FG001|Overall Study|Adverse Event|1|||
128799730|NCT04994509|463559855|FG002|Overall Study|Adverse Event|0|||
128799731|NCT04994509|463559853|FG000|Overall Study|Non-compliance With Study Drug|1|||
128799732|NCT04994509|463559854|FG001|Overall Study|Non-compliance With Study Drug|1|||
128799733|NCT04994509|463559855|FG002|Overall Study|Non-compliance With Study Drug|1|||
128799734|NCT04994509|463559853|FG000|Overall Study|Withdrew Assent|3|||
128799735|NCT04994509|463559854|FG001|Overall Study|Withdrew Assent|0|||
128799736|NCT04994509|463559855|FG002|Overall Study|Withdrew Assent|0|||
128799737|NCT04994509|463559853|FG000|Overall Study|Protocol Violation|1|||
128799738|NCT04994509|463559854|FG001|Overall Study|Protocol Violation|0|||
128799739|NCT04994509|463559855|FG002|Overall Study|Protocol Violation|0|||
128799740|NCT02576509|463561627|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
128799741|NCT02576509|463561628|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
128799742|NCT02576509|463561627|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
128799743|NCT02576509|463561628|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
128799744|NCT02576509|463561627|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
128799745|NCT02576509|463561628|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
128799746|NCT02576509|463561627|FG000|Treatment Period|Disease progression|263|||
128799747|NCT02576509|463561628|FG001|Treatment Period|Disease progression|244|||
128799748|NCT02576509|463561627|FG000|Treatment Period|Study drug toxicity|37|||
128799749|NCT02576509|463561628|FG001|Treatment Period|Study drug toxicity|41|||
128799750|NCT02576509|463561627|FG000|Treatment Period|Death|1|||
128799751|NCT02576509|463561628|FG001|Treatment Period|Death|1|||
128799752|NCT02576509|463561627|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
128799753|NCT02576509|463561628|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
128799754|NCT02576509|463561627|FG000|Treatment Period|Participant request to stop treatment|8|||
128799755|NCT02576509|463561628|FG001|Treatment Period|Participant request to stop treatment|18|||
128799756|NCT02576509|463561627|FG000|Treatment Period|Participant withdrew consent|3|||
128799757|NCT02576509|463561628|FG001|Treatment Period|Participant withdrew consent|7|||
128799758|NCT02576509|463561627|FG000|Treatment Period|Lost to Follow-up|0|||
128799759|NCT02576509|463561628|FG001|Treatment Period|Lost to Follow-up|1|||
128799760|NCT02576509|463561627|FG000|Treatment Period|Maximum clinical benefit|1|||
128799761|NCT02576509|463561628|FG001|Treatment Period|Maximum clinical benefit|0|||
128799762|NCT02576509|463561627|FG000|Treatment Period|Poor/non-compliance|1|||
128799763|NCT02576509|463561628|FG001|Treatment Period|Poor/non-compliance|1|||
128799764|NCT02576509|463561627|FG000|Treatment Period|Participant no longer meets criteria|1|||
128799765|NCT02576509|463561628|FG001|Treatment Period|Participant no longer meets criteria|0|||
128799766|NCT02576509|463561627|FG000|Treatment Period|Other reason|12|||
128799767|NCT02576509|463561628|FG001|Treatment Period|Other reason|8|||
128799768|NCT02576509|463561627|FG000|Treatment Period|NOT REPORTED|1|||
128799769|NCT02576509|463561628|FG001|Treatment Period|NOT REPORTED|0|||
128799770|NCT02576509|463561627|FG000|Treatment Period|Administrative reason by sponsor|0|||
128799771|NCT02576509|463561628|FG001|Treatment Period|Administrative reason by sponsor|1|||
128799772|NCT04278586|463561629|FG000|Overall Study|Withdrawal by Subject|13|||
128799773|NCT04278586|463561630|FG001|Overall Study|Withdrawal by Subject|6|||
128799774|NCT04278586|463561629|FG000|Overall Study|Lost to Follow-up|37|||
128799775|NCT04278586|463561630|FG001|Overall Study|Lost to Follow-up|24|||
128799776|NCT04038957|463561633|FG000|Overall Study|Withdrawal by Subject|1|||
128799777|NCT04038957|463561633|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
128799778|NCT01998984|463561638|FG000|Overall Study|Adverse Event|0|||
128799779|NCT01998984|463561639|FG001|Overall Study|Adverse Event|0|||
128799780|NCT01998984|463561640|FG002|Overall Study|Adverse Event|0|||
128799781|NCT01998984|463561641|FG003|Overall Study|Adverse Event|1|||
128799782|NCT01998984|463561638|FG000|Overall Study|Lost to Follow-up|0|||
128799783|NCT01998984|463561639|FG001|Overall Study|Lost to Follow-up|1|||
128799784|NCT01998984|463561640|FG002|Overall Study|Lost to Follow-up|0|||
128799785|NCT01998984|463561641|FG003|Overall Study|Lost to Follow-up|1|||
128799786|NCT01998984|463561638|FG000|Overall Study|Withdrawal by Subject|0|||
128799787|NCT01998984|463561639|FG001|Overall Study|Withdrawal by Subject|0|||
128799788|NCT01998984|463561640|FG002|Overall Study|Withdrawal by Subject|1|||
128799789|NCT01998984|463561641|FG003|Overall Study|Withdrawal by Subject|0|||
128799790|NCT01998984|463561638|FG000|Overall Study|Other|0|||
128799791|NCT01998984|463561639|FG001|Overall Study|Other|0|||
128799792|NCT01998984|463561640|FG002|Overall Study|Other|0|||
128799793|NCT01998984|463561641|FG003|Overall Study|Other|1|||
128799794|NCT01843374|463561643|FG000|Overall Study|Death|155|||
128799795|NCT01843374|463561644|FG001|Overall Study|Death|313|||
128799796|NCT01843374|463561643|FG000|Overall Study|Withdrawal by Subject|14|||
128799797|NCT01843374|463561644|FG001|Overall Study|Withdrawal by Subject|20|||
128799798|NCT01843374|463561643|FG000|Overall Study|Withdrawing due to Other reason|20|||
128799799|NCT01843374|463561644|FG001|Overall Study|Withdrawing due to Other reason|46|||
128799800|NCT03397108|463561645|FG000|Overall Study|Lost to Follow-up|15|||
128799801|NCT03397108|463561646|FG001|Overall Study|Lost to Follow-up|0|||
128799802|NCT03397108|463561645|FG000|Overall Study|Insufficient milk production|3|||
128799803|NCT03397108|463561646|FG001|Overall Study|Insufficient milk production|2|||
128799804|NCT03397108|463561645|FG000|Overall Study|Withdrawal by Subject|2|||
128799805|NCT03397108|463561646|FG001|Overall Study|Withdrawal by Subject|0|||
128799806|NCT03624972|463561647|FG000|Overall Study|Lost to Follow-up|2|||
128799807|NCT03624972|463561648|FG001|Overall Study|Lost to Follow-up|0|||
128799808|NCT03624972|463561649|FG002|Overall Study|Lost to Follow-up|0|||
128799809|NCT03624972|463561647|FG000|Overall Study|Withdrawal by Subject|0|||
128799810|NCT03624972|463561648|FG001|Overall Study|Withdrawal by Subject|2|||
128799811|NCT03624972|463561649|FG002|Overall Study|Withdrawal by Subject|0|||
128799812|NCT03456076|463561650|FG000|Overall Study|Withdrawal by Subject|5|||
128799813|NCT03456076|463561651|FG001|Overall Study|Withdrawal by Subject|9|||
128799814|NCT03456076|463561650|FG000|Overall Study|Protocol deviation|0|||
128799815|NCT03456076|463561651|FG001|Overall Study|Protocol deviation|1|||
128799816|NCT03456076|463561650|FG000|Overall Study|Lost to Follow-up|0|||
128799817|NCT03456076|463561651|FG001|Overall Study|Lost to Follow-up|1|||
128799818|NCT03456076|463561650|FG000|Overall Study|Death|2|||
128799819|NCT03456076|463561651|FG001|Overall Study|Death|5|||
128799820|NCT03456076|463561650|FG000|Overall Study|Study ongoing|123|||
128799821|NCT03456076|463561651|FG001|Overall Study|Study ongoing|111|||
128799822|NCT03990649|463561655|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
128799823|NCT03990649|463561656|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
128799824|NCT03990649|463561657|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
128799825|NCT03990649|463561655|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
128799826|NCT03990649|463561656|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
128799827|NCT03990649|463561657|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
128799828|NCT03990649|463561655|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
128799829|NCT03990649|463561656|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
128799830|NCT03990649|463561657|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
128799831|NCT03990649|463561655|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
128799832|NCT03990649|463561656|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
128799833|NCT03990649|463561657|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
128799834|NCT03990649|463561655|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
128799835|NCT03990649|463561656|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
128799836|NCT03990649|463561657|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
128799837|NCT03990649|463561655|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
128799838|NCT03990649|463561656|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
128799839|NCT03990649|463561657|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
128799840|NCT03990649|463561655|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
128799841|NCT03990649|463561656|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
128799842|NCT03990649|463561657|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
128799843|NCT00505934|463561658|FG000|Overall Study|Adverse Event|1|||
128799844|NCT00505934|463561658|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
128799845|NCT00505934|463561658|FG000|Overall Study|Other: IV dose needed to be changed|1|||
128799846|NCT03050814|463561661|FG000|Overall Study|Screen failures|0|||
128799847|NCT03050814|463561662|FG001|Overall Study|Screen failures|0|||
128799848|NCT03050814|463561663|FG002|Overall Study|Screen failures|4|||
128799849|NCT05137236|463561667|FG000|Part A|Other than Specified|1|||
128799850|NCT05137236|463561668|FG001|Part A|Other than Specified|0|||
128799851|NCT05137236|463561669|FG002|Part A|Other than Specified|0|||
128799852|NCT05137236|463561670|FG003|Part A|Other than Specified|0|||
128799853|NCT05137236|463561671|FG004|Part A|Other than Specified|0|||
128799854|NCT05137236|463561672|FG005|Part A|Other than Specified|0|||
128799855|NCT05137236|463561673|FG006|Part A|Other than Specified|0|||
128799856|NCT05137236|463561674|FG007|Part A|Other than Specified|0|||
128799857|NCT05137236|463561667|FG000|Part A|Withdrawal by Subject|0|||
128799858|NCT05137236|463561668|FG001|Part A|Withdrawal by Subject|4|||
128799859|NCT05137236|463561669|FG002|Part A|Withdrawal by Subject|1|||
128799860|NCT05137236|463561670|FG003|Part A|Withdrawal by Subject|1|||
128799861|NCT05137236|463561671|FG004|Part A|Withdrawal by Subject|3|||
128799862|NCT05137236|463561672|FG005|Part A|Withdrawal by Subject|2|||
128799863|NCT05137236|463561673|FG006|Part A|Withdrawal by Subject|0|||
128799864|NCT05137236|463561674|FG007|Part A|Withdrawal by Subject|0|||
128799865|NCT05137236|463561667|FG000|Part A|Lost to Follow-up|5|||
128799866|NCT05137236|463561668|FG001|Part A|Lost to Follow-up|7|||
128799867|NCT05137236|463561669|FG002|Part A|Lost to Follow-up|1|||
128799868|NCT05137236|463561670|FG003|Part A|Lost to Follow-up|3|||
128799869|NCT05137236|463561671|FG004|Part A|Lost to Follow-up|3|||
128799870|NCT05137236|463561672|FG005|Part A|Lost to Follow-up|8|||
128799871|NCT05137236|463561673|FG006|Part A|Lost to Follow-up|0|||
128799872|NCT05137236|463561674|FG007|Part A|Lost to Follow-up|0|||
128799873|NCT05137236|463561667|FG000|Part B|Withdrawal by Subject|0|||
128799874|NCT05137236|463561668|FG001|Part B|Withdrawal by Subject|0|||
128799875|NCT05137236|463561669|FG002|Part B|Withdrawal by Subject|0|||
128799876|NCT05137236|463561670|FG003|Part B|Withdrawal by Subject|0|||
128799877|NCT05137236|463561671|FG004|Part B|Withdrawal by Subject|0|||
128799878|NCT05137236|463561672|FG005|Part B|Withdrawal by Subject|0|||
128799879|NCT05137236|463561673|FG006|Part B|Withdrawal by Subject|0|||
128799880|NCT05137236|463561674|FG007|Part B|Withdrawal by Subject|2|||
128799881|NCT05137236|463561667|FG000|Part B|Lost to Follow-up|0|||
128799882|NCT05137236|463561668|FG001|Part B|Lost to Follow-up|0|||
128799883|NCT05137236|463561669|FG002|Part B|Lost to Follow-up|0|||
128799884|NCT05137236|463561670|FG003|Part B|Lost to Follow-up|0|||
128799885|NCT05137236|463561671|FG004|Part B|Lost to Follow-up|0|||
128799886|NCT05137236|463561672|FG005|Part B|Lost to Follow-up|0|||
128799887|NCT05137236|463561673|FG006|Part B|Lost to Follow-up|5|||
128799888|NCT05137236|463561674|FG007|Part B|Lost to Follow-up|5|||
128799889|NCT05137236|463561667|FG000|Part B|Death|0|||
128799890|NCT05137236|463561668|FG001|Part B|Death|0|||
128799891|NCT05137236|463561669|FG002|Part B|Death|0|||
128799892|NCT05137236|463561670|FG003|Part B|Death|0|||
128799893|NCT05137236|463561671|FG004|Part B|Death|0|||
128799894|NCT05137236|463561672|FG005|Part B|Death|0|||
128799895|NCT05137236|463561673|FG006|Part B|Death|0|||
128799896|NCT05137236|463561674|FG007|Part B|Death|2|||
128799897|NCT02724956|463561675|FG000|Overall Study|Physician Decision|1|||
128799898|NCT02724956|463561676|FG001|Overall Study|Physician Decision|0|||
128799899|NCT02724956|463561675|FG000|Overall Study|Lack of Efficacy|0|||
128799900|NCT02724956|463561676|FG001|Overall Study|Lack of Efficacy|1|||
128799901|NCT02724956|463561675|FG000|Overall Study|Withdrawal by Subject|0|||
128799902|NCT02724956|463561676|FG001|Overall Study|Withdrawal by Subject|1|||
128799903|NCT02647905|463561683|FG000|Overall Study|Lost to Follow-up|1|||
128799904|NCT02647905|463561683|FG000|Overall Study|Withdrawal by Subject|2|||
128799905|NCT02015520|463561684|FG000|Overall Study|Lack of Efficacy|1|||
128799906|NCT02015520|463561685|FG001|Overall Study|Lack of Efficacy|0|||
128799907|NCT02015520|463561686|FG002|Overall Study|Lack of Efficacy|3|||
128799908|NCT02015520|463561687|FG003|Overall Study|Lack of Efficacy|2|||
128799909|NCT02015520|463561684|FG000|Overall Study|Adverse Event|0|||
128799910|NCT02015520|463561685|FG001|Overall Study|Adverse Event|0|||
128799911|NCT02015520|463561686|FG002|Overall Study|Adverse Event|0|||
128799912|NCT02015520|463561687|FG003|Overall Study|Adverse Event|1|||
128799913|NCT02015520|463561684|FG000|Overall Study|Withdrawal by Subject|2|||
128799914|NCT02015520|463561685|FG001|Overall Study|Withdrawal by Subject|2|||
128799915|NCT02015520|463561686|FG002|Overall Study|Withdrawal by Subject|1|||
128799916|NCT02015520|463561687|FG003|Overall Study|Withdrawal by Subject|0|||
128799917|NCT02015520|463561684|FG000|Overall Study|Death|1|||
128799918|NCT02015520|463561685|FG001|Overall Study|Death|0|||
128799919|NCT02015520|463561686|FG002|Overall Study|Death|0|||
128799920|NCT02015520|463561687|FG003|Overall Study|Death|0|||
128799921|NCT02015520|463561684|FG000|Overall Study|Lost to Follow-up|0|||
128799922|NCT02015520|463561685|FG001|Overall Study|Lost to Follow-up|0|||
128799923|NCT02015520|463561686|FG002|Overall Study|Lost to Follow-up|1|||
128799924|NCT02015520|463561687|FG003|Overall Study|Lost to Follow-up|0|||
128799925|NCT02015520|463561684|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
128799926|NCT02015520|463561685|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
128799927|NCT02015520|463561686|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
128799928|NCT02015520|463561687|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
128799929|NCT02015520|463561684|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
128799930|NCT02015520|463561685|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
128799931|NCT02015520|463561686|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
128799932|NCT02015520|463561687|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
128799933|NCT05119855|463561688|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
128799934|NCT05119855|463561689|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
128799935|NCT05119855|463561688|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
128799936|NCT05119855|463561689|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
128799937|NCT05119855|463561688|FG000|Overall Study|Lost to Follow-up|6|||
128799938|NCT05119855|463561689|FG001|Overall Study|Lost to Follow-up|8|||
128799939|NCT02932579|463561690|FG000|Overall Study|Withdrawal by Subject|4|||
128799940|NCT02932579|463561691|FG001|Overall Study|Withdrawal by Subject|1|||
128799941|NCT01972724|463561692|FG000|Double-Blind|Rescue Criteria Met|1|||
128799942|NCT01972724|463561693|FG001|Double-Blind|Rescue Criteria Met|0|||
128799943|NCT01972724|463561694|FG002|Double-Blind|Rescue Criteria Met|0|||
128799944|NCT01972724|463561692|FG000|Double-Blind|Adverse Event|1|||
128799945|NCT01972724|463561693|FG001|Double-Blind|Adverse Event|0|||
128799946|NCT01972724|463561694|FG002|Double-Blind|Adverse Event|0|||
128799947|NCT01972724|463561692|FG000|Double-Blind|Withdrawal of Consent|2|||
128799948|NCT01972724|463561693|FG001|Double-Blind|Withdrawal of Consent|1|||
128799949|NCT01972724|463561694|FG002|Double-Blind|Withdrawal of Consent|0|||
128799950|NCT01972724|463561692|FG000|Double-Blind|Significant Protocol Deviation|5|||
128799951|NCT01972724|463561693|FG001|Double-Blind|Significant Protocol Deviation|8|||
128799952|NCT01972724|463561694|FG002|Double-Blind|Significant Protocol Deviation|0|||
128799953|NCT01972724|463561692|FG000|Open-Label|Withdrew Consent|0|||
128799954|NCT01972724|463561693|FG001|Open-Label|Withdrew Consent|0|||
128799955|NCT01972724|463561694|FG002|Open-Label|Withdrew Consent|3|||
128799956|NCT01972724|463561692|FG000|Open-Label|Significant Protocol Deviation|0|||
128799957|NCT01972724|463561693|FG001|Open-Label|Significant Protocol Deviation|0|||
128799958|NCT01972724|463561694|FG002|Open-Label|Significant Protocol Deviation|2|||
128799959|NCT00111813|463561701|FG000|Overall Study|Adverse Event|1|||
128799960|NCT00111813|463561702|FG001|Overall Study|Adverse Event|2|||
128799961|NCT00111813|463561703|FG002|Overall Study|Adverse Event|4|||
128799962|NCT00111813|463561704|FG003|Overall Study|Adverse Event|2|||
128799963|NCT00111813|463561705|FG004|Overall Study|Adverse Event|2|||
128799964|NCT00111813|463561706|FG005|Overall Study|Adverse Event|2|||
128799965|NCT00111813|463561701|FG000|Overall Study|Progressive disease|2|||
128799966|NCT00111813|463561702|FG001|Overall Study|Progressive disease|1|||
128799967|NCT00111813|463561703|FG002|Overall Study|Progressive disease|5|||
128799968|NCT00111813|463561704|FG003|Overall Study|Progressive disease|3|||
128799969|NCT00111813|463561705|FG004|Overall Study|Progressive disease|4|||
128799970|NCT00111813|463561706|FG005|Overall Study|Progressive disease|3|||
128799971|NCT00111813|463561701|FG000|Overall Study|Lack of Efficacy|0|||
128799972|NCT00111813|463561702|FG001|Overall Study|Lack of Efficacy|0|||
128799973|NCT00111813|463561703|FG002|Overall Study|Lack of Efficacy|0|||
128799974|NCT00111813|463561704|FG003|Overall Study|Lack of Efficacy|0|||
128799975|NCT00111813|463561705|FG004|Overall Study|Lack of Efficacy|0|||
128799976|NCT00111813|463561706|FG005|Overall Study|Lack of Efficacy|1|||
128799977|NCT00111813|463561701|FG000|Overall Study|Other|0|||
128799978|NCT00111813|463561702|FG001|Overall Study|Other|0|||
128799979|NCT00111813|463561703|FG002|Overall Study|Other|1|||
128799980|NCT00111813|463561704|FG003|Overall Study|Other|0|||
128799981|NCT00111813|463561705|FG004|Overall Study|Other|0|||
128799982|NCT00111813|463561706|FG005|Overall Study|Other|0|||
128799983|NCT01610297|463561708|FG000|Overall Study|Lost to Follow-up|1|||
128799984|NCT02121002|463561713|FG000|Overall Study|Physician Decision|2|||
128799985|NCT02121002|463561714|FG001|Overall Study|Physician Decision|0|||
128799986|NCT02121002|463561715|FG002|Overall Study|Physician Decision|0|||
128799987|NCT02121002|463561713|FG000|Overall Study|Withdrawal by Subject|3|||
128799988|NCT02121002|463561714|FG001|Overall Study|Withdrawal by Subject|1|||
128799989|NCT02121002|463561715|FG002|Overall Study|Withdrawal by Subject|4|||
128799990|NCT02121002|463561713|FG000|Overall Study|Protocol Violation|1|||
128799991|NCT02121002|463561714|FG001|Overall Study|Protocol Violation|2|||
128799992|NCT02121002|463561715|FG002|Overall Study|Protocol Violation|4|||
128799993|NCT02121002|463561713|FG000|Overall Study|Concomitant therapy|0|||
128799994|NCT02121002|463561714|FG001|Overall Study|Concomitant therapy|1|||
128799995|NCT02121002|463561715|FG002|Overall Study|Concomitant therapy|1|||
128799996|NCT02121002|463561713|FG000|Overall Study|Others|1|||
128799997|NCT02121002|463561714|FG001|Overall Study|Others|0|||
128799998|NCT02121002|463561715|FG002|Overall Study|Others|1|||
128799999|NCT01007396|463561716|FG000|Overall Study|Lost to Follow-up|47|||
128800000|NCT02590432|463561720|FG000|Open-label Treatment Period|Adverse Event|97|||
128800001|NCT02590432|463561721|FG001|Open-label Treatment Period|Adverse Event|79|||
128800002|NCT02590432|463561722|FG002|Open-label Treatment Period|Adverse Event|0|||
128800003|NCT02590432|463561723|FG003|Open-label Treatment Period|Adverse Event|0|||
128800004|NCT02590432|463561724|FG004|Open-label Treatment Period|Adverse Event|0|||
128800005|NCT02590432|463561725|FG005|Open-label Treatment Period|Adverse Event|0|||
128800006|NCT02590432|463561726|FG006|Open-label Treatment Period|Adverse Event|0|||
128800007|NCT02590432|463561727|FG007|Open-label Treatment Period|Adverse Event|0|||
128800008|NCT02590432|463561728|FG008|Open-label Treatment Period|Adverse Event|0|||
128800009|NCT02590432|463561720|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
128800010|NCT02590432|463561721|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
128800011|NCT02590432|463561722|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
128800012|NCT02590432|463561723|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
128800013|NCT02590432|463561724|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
128800014|NCT02590432|463561725|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
128800015|NCT02590432|463561726|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
128800016|NCT02590432|463561727|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
128800017|NCT02590432|463561728|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
128800018|NCT02590432|463561720|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
128800019|NCT02590432|463561721|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
128800020|NCT02590432|463561722|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
128800021|NCT02590432|463561723|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
128800022|NCT02590432|463561724|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
128800023|NCT02590432|463561725|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
128800024|NCT02590432|463561726|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
128800025|NCT02590432|463561727|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
128800026|NCT02590432|463561728|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
128800027|NCT02590432|463561720|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
128800028|NCT02590432|463561721|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
128800029|NCT02590432|463561722|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
128800030|NCT02590432|463561723|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
128800031|NCT02590432|463561724|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
128800032|NCT02590432|463561725|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
128800033|NCT02590432|463561726|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
128800034|NCT02590432|463561727|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
128800035|NCT02590432|463561728|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
128800036|NCT02590432|463561720|FG000|Open-label Treatment Period|Protocol Violation|10|||
128800037|NCT02590432|463561721|FG001|Open-label Treatment Period|Protocol Violation|4|||
128800038|NCT02590432|463561722|FG002|Open-label Treatment Period|Protocol Violation|0|||
128800039|NCT02590432|463561723|FG003|Open-label Treatment Period|Protocol Violation|0|||
128800040|NCT02590432|463561724|FG004|Open-label Treatment Period|Protocol Violation|0|||
128800041|NCT02590432|463561725|FG005|Open-label Treatment Period|Protocol Violation|0|||
128800042|NCT02590432|463561726|FG006|Open-label Treatment Period|Protocol Violation|0|||
128800043|NCT02590432|463561727|FG007|Open-label Treatment Period|Protocol Violation|0|||
128800044|NCT02590432|463561728|FG008|Open-label Treatment Period|Protocol Violation|0|||
128800045|NCT02590432|463561720|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
128800046|NCT02590432|463561721|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
128800047|NCT02590432|463561722|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
128800048|NCT02590432|463561723|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
128800049|NCT02590432|463561724|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
128800050|NCT02590432|463561725|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
128800051|NCT02590432|463561726|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
128800052|NCT02590432|463561727|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
128800053|NCT02590432|463561728|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
128800054|NCT02590432|463561720|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
128800055|NCT02590432|463561721|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
128800056|NCT02590432|463561722|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
128800057|NCT02590432|463561723|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
128800058|NCT02590432|463561724|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
128800059|NCT02590432|463561725|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
128800060|NCT02590432|463561726|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
128800061|NCT02590432|463561727|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
128800062|NCT02590432|463561728|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
128800063|NCT02590432|463561720|FG000|Double-blind Treatment Period|Adverse Event|0|||
128800064|NCT02590432|463561721|FG001|Double-blind Treatment Period|Adverse Event|0|||
128800065|NCT02590432|463561722|FG002|Double-blind Treatment Period|Adverse Event|14|||
128800066|NCT02590432|463561723|FG003|Double-blind Treatment Period|Adverse Event|12|||
128800067|NCT02590432|463561724|FG004|Double-blind Treatment Period|Adverse Event|6|||
128800068|NCT02590432|463561725|FG005|Double-blind Treatment Period|Adverse Event|22|||
128800069|NCT02590432|463561726|FG006|Double-blind Treatment Period|Adverse Event|20|||
128800070|NCT02590432|463561727|FG007|Double-blind Treatment Period|Adverse Event|0|||
128800071|NCT02590432|463561728|FG008|Double-blind Treatment Period|Adverse Event|0|||
128800072|NCT02590432|463561720|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
128800073|NCT02590432|463561721|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
128800074|NCT02590432|463561722|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
128800075|NCT02590432|463561723|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
128800076|NCT02590432|463561724|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
128800077|NCT02590432|463561725|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
128800078|NCT02590432|463561726|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
128800079|NCT02590432|463561727|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
128800080|NCT02590432|463561728|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
128800081|NCT02590432|463561720|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
128800082|NCT02590432|463561721|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
128800083|NCT02590432|463561722|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
128800084|NCT02590432|463561723|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
128800085|NCT02590432|463561724|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
128800086|NCT02590432|463561725|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
128800087|NCT02590432|463561726|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
128800088|NCT02590432|463561727|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
128800089|NCT02590432|463561728|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
128800090|NCT02590432|463561720|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
128800091|NCT02590432|463561721|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
128800092|NCT02590432|463561722|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
128800093|NCT02590432|463561723|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
128800094|NCT02590432|463561724|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
128800095|NCT02590432|463561725|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
128800096|NCT02590432|463561726|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
128800097|NCT02590432|463561727|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
128800098|NCT02590432|463561728|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
128800099|NCT02590432|463561720|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800100|NCT02590432|463561721|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800101|NCT02590432|463561722|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800102|NCT02590432|463561723|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800103|NCT02590432|463561724|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800104|NCT02590432|463561725|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
128800105|NCT02590432|463561726|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800106|NCT02590432|463561727|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800107|NCT02590432|463561728|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
128800108|NCT02590432|463561720|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
128800109|NCT02590432|463561721|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
128800110|NCT02590432|463561722|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
128800111|NCT02590432|463561723|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
128800112|NCT02590432|463561724|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
128800113|NCT02590432|463561725|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
128800114|NCT02590432|463561726|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
128800115|NCT02590432|463561727|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
128800116|NCT02590432|463561728|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
128800117|NCT02590432|463561720|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800118|NCT02590432|463561721|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800119|NCT02590432|463561722|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800120|NCT02590432|463561723|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800121|NCT02590432|463561724|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800122|NCT02590432|463561725|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800123|NCT02590432|463561726|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800124|NCT02590432|463561727|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
128800125|NCT02590432|463561728|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
128800126|NCT02590432|463561720|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
128800127|NCT02590432|463561721|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
128800128|NCT02590432|463561722|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
128800129|NCT02590432|463561723|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
128800130|NCT02590432|463561724|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
128800131|NCT02590432|463561725|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
128800132|NCT02590432|463561726|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
128800133|NCT02590432|463561727|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
128800134|NCT02590432|463561728|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
128800135|NCT02590432|463561720|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800136|NCT02590432|463561721|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800137|NCT02590432|463561722|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800138|NCT02590432|463561723|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800139|NCT02590432|463561724|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800140|NCT02590432|463561725|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800141|NCT02590432|463561726|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800142|NCT02590432|463561727|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
128800143|NCT02590432|463561728|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
128800144|NCT02590432|463561720|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800145|NCT02590432|463561721|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800146|NCT02590432|463561722|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800147|NCT02590432|463561723|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800148|NCT02590432|463561724|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800149|NCT02590432|463561725|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800150|NCT02590432|463561726|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800151|NCT02590432|463561727|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
128800152|NCT02590432|463561728|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
128800153|NCT02590432|463561720|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800154|NCT02590432|463561721|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800155|NCT02590432|463561722|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800156|NCT02590432|463561723|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800157|NCT02590432|463561724|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800158|NCT02590432|463561725|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800159|NCT02590432|463561726|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800160|NCT02590432|463561727|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
128800161|NCT02590432|463561728|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
128800162|NCT02590432|463561720|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800163|NCT02590432|463561721|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800164|NCT02590432|463561722|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800165|NCT02590432|463561723|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800166|NCT02590432|463561724|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800167|NCT02590432|463561725|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800168|NCT02590432|463561726|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800169|NCT02590432|463561727|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
128800170|NCT02590432|463561728|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
128800171|NCT03283371|463561729|FG000|Placebo-controlled|Adverse Event|1|||
128800172|NCT03283371|463561730|FG001|Placebo-controlled|Adverse Event|1|||
128800173|NCT03283371|463561731|FG002|Placebo-controlled|Adverse Event|0|||
128800174|NCT03283371|463561732|FG003|Placebo-controlled|Adverse Event|0|||
128800175|NCT03283371|463561729|FG000|Placebo-controlled|Lack of Efficacy|1|||
128800176|NCT03283371|463561730|FG001|Placebo-controlled|Lack of Efficacy|0|||
128800177|NCT03283371|463561731|FG002|Placebo-controlled|Lack of Efficacy|0|||
128800178|NCT03283371|463561732|FG003|Placebo-controlled|Lack of Efficacy|0|||
128800179|NCT03283371|463561729|FG000|Placebo-controlled|Withdrawal by Subject|1|||
128800180|NCT03283371|463561730|FG001|Placebo-controlled|Withdrawal by Subject|1|||
128800181|NCT03283371|463561731|FG002|Placebo-controlled|Withdrawal by Subject|0|||
128800182|NCT03283371|463561732|FG003|Placebo-controlled|Withdrawal by Subject|0|||
128800183|NCT03283371|463561729|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
128800184|NCT03283371|463561730|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
128800185|NCT03283371|463561731|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
128800186|NCT03283371|463561732|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
128800187|NCT03283371|463561729|FG000|Open-label Phase|Adverse Event|0|||
128800188|NCT03283371|463561730|FG001|Open-label Phase|Adverse Event|0|||
128800189|NCT03283371|463561731|FG002|Open-label Phase|Adverse Event|2|||
128800190|NCT03283371|463561732|FG003|Open-label Phase|Adverse Event|0|||
128800191|NCT03283371|463561729|FG000|Open-label Phase|Withdrawal by Subject|0|||
128800192|NCT03283371|463561730|FG001|Open-label Phase|Withdrawal by Subject|0|||
128800193|NCT03283371|463561731|FG002|Open-label Phase|Withdrawal by Subject|1|||
128800194|NCT03283371|463561732|FG003|Open-label Phase|Withdrawal by Subject|0|||
128800195|NCT03283371|463561729|FG000|Open-label Phase|Other|0|||
128800196|NCT03283371|463561730|FG001|Open-label Phase|Other|0|||
128800197|NCT03283371|463561731|FG002|Open-label Phase|Other|1|||
128800198|NCT03283371|463561732|FG003|Open-label Phase|Other|1|||
128800199|NCT00243503|463561735|FG000|Overall Study|Adverse Event|11|||
128800200|NCT00243503|463561735|FG000|Overall Study|Withdrawal by Subject|1|||
128800201|NCT00243503|463561735|FG000|Overall Study|Lack of Efficacy|44|||
128800202|NCT00243503|463561735|FG000|Overall Study|Death|1|||
128800203|NCT00243503|463561735|FG000|Overall Study|Other|1|||
128800204|NCT04600752|463561738|FG000|Overall Study|Physician Decision|0|||
128800205|NCT04600752|463561739|FG001|Overall Study|Physician Decision|0|||
128800206|NCT04600752|463561740|FG002|Overall Study|Physician Decision|1|||
128800207|NCT04600752|463561738|FG000|Overall Study|Adverse Event|0|||
128800208|NCT04600752|463561739|FG001|Overall Study|Adverse Event|1|||
128800209|NCT04600752|463561740|FG002|Overall Study|Adverse Event|0|||
128800210|NCT04600752|463561738|FG000|Overall Study|Withdrawal by Subject|2|||
128800211|NCT04600752|463561739|FG001|Overall Study|Withdrawal by Subject|1|||
128800212|NCT04600752|463561740|FG002|Overall Study|Withdrawal by Subject|0|||
128800213|NCT04600752|463561738|FG000|Overall Study|Lack of Efficacy|1|||
128800214|NCT04600752|463561739|FG001|Overall Study|Lack of Efficacy|0|||
128800215|NCT04600752|463561740|FG002|Overall Study|Lack of Efficacy|0|||
128800216|NCT03076515|463561741|FG000|Overall Study|DMC decision based on interim analysis|25|||
128800217|NCT03076515|463561742|FG001|Overall Study|DMC decision based on interim analysis|29|||
128800218|NCT02374307|463561743|FG000|3-months Follow-up|Lost to Follow-up|1|||
128800219|NCT02374307|463561744|FG001|3-months Follow-up|Lost to Follow-up|2|||
128800220|NCT02374307|463561743|FG000|3-months Follow-up|Withdrawal by Subject|1|||
128800221|NCT02374307|463561744|FG001|3-months Follow-up|Withdrawal by Subject|4|||
128800222|NCT02374307|463561743|FG000|3-months Follow-up|Death|1|||
128800223|NCT02374307|463561744|FG001|3-months Follow-up|Death|2|||
128800224|NCT02374307|463561743|FG000|3-months Follow-up|Missed first follow-up|5|||
128800225|NCT02374307|463561744|FG001|3-months Follow-up|Missed first follow-up|1|||
128800226|NCT02374307|463561743|FG000|6-months Follow-up|Lost to Follow-up|1|||
128800227|NCT02374307|463561744|FG001|6-months Follow-up|Lost to Follow-up|2|||
128800228|NCT02374307|463561743|FG000|6-months Follow-up|Death|2|||
128800229|NCT02374307|463561744|FG001|6-months Follow-up|Death|1|||
128800230|NCT02374307|463561743|FG000|6-months Follow-up|Withdrawal by Subject|0|||
128800231|NCT02374307|463561744|FG001|6-months Follow-up|Withdrawal by Subject|3|||
128800232|NCT02554786|463561745|FG000|Overall Study|Subject/guardian decision|29|||
128800233|NCT02554786|463561746|FG001|Overall Study|Subject/guardian decision|17|||
128800234|NCT02554786|463561747|FG002|Overall Study|Subject/guardian decision|18|||
128800235|NCT02554786|463561748|FG003|Overall Study|Subject/guardian decision|30|||
128800236|NCT02554786|463561749|FG004|Overall Study|Subject/guardian decision|20|||
128800237|NCT02554786|463561745|FG000|Overall Study|Lost to Follow-up|4|||
128800238|NCT02554786|463561746|FG001|Overall Study|Lost to Follow-up|3|||
128800239|NCT02554786|463561747|FG002|Overall Study|Lost to Follow-up|4|||
128800240|NCT02554786|463561748|FG003|Overall Study|Lost to Follow-up|2|||
128800241|NCT02554786|463561749|FG004|Overall Study|Lost to Follow-up|2|||
128800242|NCT02554786|463561745|FG000|Overall Study|Protocol deviation|1|||
128800243|NCT02554786|463561746|FG001|Overall Study|Protocol deviation|3|||
128800244|NCT02554786|463561747|FG002|Overall Study|Protocol deviation|3|||
128800245|NCT02554786|463561748|FG003|Overall Study|Protocol deviation|4|||
128800246|NCT02554786|463561749|FG004|Overall Study|Protocol deviation|2|||
128800247|NCT02554786|463561745|FG000|Overall Study|Technical problems|1|||
128800248|NCT02554786|463561746|FG001|Overall Study|Technical problems|1|||
128800249|NCT02554786|463561747|FG002|Overall Study|Technical problems|0|||
128800250|NCT02554786|463561748|FG003|Overall Study|Technical problems|2|||
128800251|NCT02554786|463561749|FG004|Overall Study|Technical problems|1|||
128800252|NCT02554786|463561745|FG000|Overall Study|Adverse Event|0|||
128800253|NCT02554786|463561746|FG001|Overall Study|Adverse Event|0|||
128800254|NCT02554786|463561747|FG002|Overall Study|Adverse Event|0|||
128800255|NCT02554786|463561748|FG003|Overall Study|Adverse Event|0|||
128800256|NCT02554786|463561749|FG004|Overall Study|Adverse Event|2|||
128800257|NCT02554786|463561745|FG000|Overall Study|Death|0|||
128800258|NCT02554786|463561746|FG001|Overall Study|Death|0|||
128800259|NCT02554786|463561747|FG002|Overall Study|Death|0|||
128800260|NCT02554786|463561748|FG003|Overall Study|Death|1|||
128800261|NCT02554786|463561749|FG004|Overall Study|Death|0|||
128800262|NCT02554786|463561745|FG000|Overall Study|Non-compliance with study treatment|0|||
128800263|NCT02554786|463561746|FG001|Overall Study|Non-compliance with study treatment|1|||
128800264|NCT02554786|463561747|FG002|Overall Study|Non-compliance with study treatment|1|||
128800265|NCT02554786|463561748|FG003|Overall Study|Non-compliance with study treatment|0|||
128800266|NCT02554786|463561749|FG004|Overall Study|Non-compliance with study treatment|1|||
128800267|NCT02554786|463561745|FG000|Overall Study|Physician Decision|0|||
128800268|NCT02554786|463561746|FG001|Overall Study|Physician Decision|1|||
128800269|NCT02554786|463561747|FG002|Overall Study|Physician Decision|4|||
128800270|NCT02554786|463561748|FG003|Overall Study|Physician Decision|1|||
128800271|NCT02554786|463561749|FG004|Overall Study|Physician Decision|1|||
128800272|NCT02554786|463561745|FG000|Overall Study|Pregnancy|0|||
128800273|NCT02554786|463561746|FG001|Overall Study|Pregnancy|0|||
128800274|NCT02554786|463561747|FG002|Overall Study|Pregnancy|0|||
128800275|NCT02554786|463561748|FG003|Overall Study|Pregnancy|1|||
128800276|NCT02554786|463561749|FG004|Overall Study|Pregnancy|1|||
128800277|NCT04704284|463561755|FG000|Overall Study|Withdrawal by Subject|1|||
128800278|NCT00087139|463561761|FG000|Overall Study|Adverse Event|18|||
128800279|NCT00087139|463561762|FG001|Overall Study|Adverse Event|17|||
128800280|NCT00087139|463561763|FG002|Overall Study|Adverse Event|13|||
128800281|NCT00087139|463561761|FG000|Overall Study|Death|2|||
128800282|NCT00087139|463561762|FG001|Overall Study|Death|1|||
128800283|NCT00087139|463561763|FG002|Overall Study|Death|0|||
128800284|NCT00087139|463561761|FG000|Overall Study|Withdrawal by Subject|3|||
128800285|NCT00087139|463561762|FG001|Overall Study|Withdrawal by Subject|2|||
128800286|NCT00087139|463561763|FG002|Overall Study|Withdrawal by Subject|2|||
128800287|NCT00087139|463561761|FG000|Overall Study|Physician Decision|1|||
128800288|NCT00087139|463561762|FG001|Overall Study|Physician Decision|1|||
128800289|NCT00087139|463561763|FG002|Overall Study|Physician Decision|1|||
128800290|NCT00087139|463561761|FG000|Overall Study|Disease progression|9|||
128800291|NCT00087139|463561762|FG001|Overall Study|Disease progression|19|||
128800292|NCT00087139|463561763|FG002|Overall Study|Disease progression|12|||
128800293|NCT00087139|463561761|FG000|Overall Study|Ineligible|4|||
128800294|NCT00087139|463561762|FG001|Overall Study|Ineligible|7|||
128800295|NCT00087139|463561763|FG002|Overall Study|Ineligible|4|||
128800296|NCT00087139|463561761|FG000|Overall Study|Symptomatic deterioration|1|||
128800297|NCT00087139|463561762|FG001|Overall Study|Symptomatic deterioration|1|||
128800298|NCT00087139|463561763|FG002|Overall Study|Symptomatic deterioration|3|||
128800299|NCT00087139|463561761|FG000|Overall Study|Use of coumadin|1|||
128800300|NCT00087139|463561762|FG001|Overall Study|Use of coumadin|0|||
128800301|NCT00087139|463561763|FG002|Overall Study|Use of coumadin|0|||
128800302|NCT00087139|463561761|FG000|Overall Study|Response achieved|0|||
128800303|NCT00087139|463561762|FG001|Overall Study|Response achieved|1|||
128800304|NCT00087139|463561763|FG002|Overall Study|Response achieved|0|||
128800305|NCT00087139|463561761|FG000|Overall Study|Extradural disease|0|||
128800306|NCT00087139|463561762|FG001|Overall Study|Extradural disease|0|||
128800307|NCT00087139|463561763|FG002|Overall Study|Extradural disease|1|||
128800308|NCT00393484|463561767|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
128800309|NCT00393484|463561768|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
128800310|NCT00393484|463561767|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
128800311|NCT00393484|463561768|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
128800312|NCT00393484|463561767|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
128800313|NCT00393484|463561768|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
128800314|NCT00393484|463561767|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
128800315|NCT00393484|463561768|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
128800316|NCT00393484|463561767|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
128800317|NCT00393484|463561768|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
128800318|NCT00393484|463561767|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
128800319|NCT00393484|463561768|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
128800320|NCT00393484|463561767|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
128800321|NCT00393484|463561768|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
128800322|NCT00393484|463561767|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
128800323|NCT00393484|463561768|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
128800324|NCT00393484|463561767|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
128800325|NCT00393484|463561768|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
128800326|NCT00393484|463561767|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
128800327|NCT00393484|463561768|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
128800328|NCT03201562|463561771|FG000|Overall Study|Physician Decision|0|||
128800329|NCT03201562|463561772|FG001|Overall Study|Physician Decision|0|||
128800330|NCT03201562|463561773|FG002|Overall Study|Physician Decision|1|||
128800331|NCT03201562|463561771|FG000|Overall Study|Adverse Event|0|||
128800332|NCT03201562|463561772|FG001|Overall Study|Adverse Event|0|||
128800333|NCT03201562|463561773|FG002|Overall Study|Adverse Event|1|||
128800334|NCT03201562|463561771|FG000|Overall Study|Lost to Follow-up|0|||
128800335|NCT03201562|463561772|FG001|Overall Study|Lost to Follow-up|1|||
128800336|NCT03201562|463561773|FG002|Overall Study|Lost to Follow-up|2|||
128800337|NCT00001277|463561774|FG000|Overall Study|Adverse Event|0|||
128800338|NCT00001277|463561775|FG001|Overall Study|Adverse Event|0|||
128800339|NCT00001277|463561776|FG002|Overall Study|Adverse Event|1|||
128800340|NCT00001277|463561774|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
128800341|NCT00001277|463561775|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
128800342|NCT00001277|463561776|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
128800343|NCT00065260|463561777|FG000|Overall Study|Death|0|||
128800344|NCT00065260|463561778|FG001|Overall Study|Death|1|||
128800345|NCT02178098|463561780|FG000|Overall Study|Withdrawal by Subject|0|||
128800346|NCT02178098|463561781|FG001|Overall Study|Withdrawal by Subject|6|||
128800347|NCT02178098|463561780|FG000|Overall Study|Adverse Event|1|||
128800348|NCT02178098|463561781|FG001|Overall Study|Adverse Event|2|||
128800349|NCT02178098|463561780|FG000|Overall Study|Protocol Violation|1|||
128800350|NCT02178098|463561781|FG001|Overall Study|Protocol Violation|1|||
128800351|NCT02178098|463561780|FG000|Overall Study|Lost to Follow-up|0|||
128800352|NCT02178098|463561781|FG001|Overall Study|Lost to Follow-up|1|||
128800353|NCT02178098|463561780|FG000|Overall Study|Sponsor Request|1|||
128800354|NCT02178098|463561781|FG001|Overall Study|Sponsor Request|0|||
128800355|NCT02178098|463561780|FG000|Overall Study|Other|2|||
128800356|NCT02178098|463561781|FG001|Overall Study|Other|2|||
128800357|NCT01044303|463561784|FG000|Overall Study|Lost to Follow-up|2|||
128800358|NCT01109524|463561787|FG000|Overall Study|Disease Progression|29|||
128800359|NCT01109524|463561787|FG000|Overall Study|Study Drug toxicity|6|||
128800360|NCT01109524|463561787|FG000|Overall Study|Adverse Event|4|||
128800361|NCT01109524|463561787|FG000|Overall Study|Withdrawal by Subject|2|||
128800362|NCT01109524|463561787|FG000|Overall Study|Maximum clinical benefit|3|||
128800363|NCT01109524|463561787|FG000|Overall Study|Death|2|||
128800364|NCT01109524|463561787|FG000|Overall Study|No longer meets criteria|2|||
128800365|NCT01109524|463561787|FG000|Overall Study|Participant requested to end treatment|4|||
128800366|NCT01109524|463561787|FG000|Overall Study|Other|5|||
128800367|NCT03101371|463561788|FG000|Overall Study|Physician Decision|0|||
128800368|NCT03101371|463561789|FG001|Overall Study|Physician Decision|1|||
128800369|NCT03101371|463561788|FG000|Overall Study|Lost to Follow-up|1|||
128800370|NCT03101371|463561789|FG001|Overall Study|Lost to Follow-up|4|||
128800371|NCT03101371|463561788|FG000|Overall Study|Did not meet eligibility criteria|2|||
128800372|NCT03101371|463561789|FG001|Overall Study|Did not meet eligibility criteria|1|||
128800373|NCT00031694|463561805|FG000|Overall Study|Adverse Event|12|||
128800374|NCT00031694|463561805|FG000|Overall Study|Death|2|||
128800375|NCT00031694|463561805|FG000|Overall Study|Withdrawal by Subject|5|||
128800376|NCT02556138|463561809|FG000|Overall Study|Withdrawal by Subject|1|||
128800377|NCT04019444|463561811|FG000|Overall Study|Withdrawal by Subject|0|||
128800378|NCT04019444|463561812|FG001|Overall Study|Withdrawal by Subject|1|||
128800379|NCT04019444|463561813|FG002|Overall Study|Withdrawal by Subject|0|||
128800380|NCT04019444|463561814|FG003|Overall Study|Withdrawal by Subject|1|||
128800381|NCT04019444|463561811|FG000|Overall Study|Solicited Event|0|||
128800382|NCT04019444|463561812|FG001|Overall Study|Solicited Event|0|||
128800383|NCT04019444|463561813|FG002|Overall Study|Solicited Event|2|||
128800384|NCT04019444|463561814|FG003|Overall Study|Solicited Event|0|||
128800385|NCT01303445|463561826|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
128800386|NCT01303445|463561827|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
128800387|NCT01303445|463561826|FG000|Second Intervention (7 Days)|Adverse Event|0|||
128800388|NCT01303445|463561827|FG001|Second Intervention (7 Days)|Adverse Event|2|||
128800389|NCT01303445|463561826|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
128800390|NCT01303445|463561827|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
128800391|NCT01303445|463561826|FG000|Washout (14 Days)|Protocol Violation|1|||
128800392|NCT01303445|463561827|FG001|Washout (14 Days)|Protocol Violation|0|||
128800393|NCT01303445|463561826|FG000|Washout (14 Days)|Lost to Follow-up|0|||
128800394|NCT01303445|463561827|FG001|Washout (14 Days)|Lost to Follow-up|2|||
128800395|NCT01303445|463561826|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
128800396|NCT01303445|463561827|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
128800397|NCT01303445|463561826|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
128800398|NCT01303445|463561827|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
128800399|NCT03725722|463563455|FG000|Overall Study|Lack of Efficacy|2|||
128800400|NCT03725722|463563456|FG001|Overall Study|Lack of Efficacy|1|||
128800401|NCT03725722|463563457|FG002|Overall Study|Lack of Efficacy|2|||
128800402|NCT03725722|463563458|FG003|Overall Study|Lack of Efficacy|0|||
128800403|NCT03725722|463563459|FG004|Overall Study|Lack of Efficacy|2|||
128800404|NCT03725722|463563455|FG000|Overall Study|Adverse Event|2|||
128800405|NCT03725722|463563456|FG001|Overall Study|Adverse Event|2|||
128800406|NCT03725722|463563457|FG002|Overall Study|Adverse Event|1|||
128800407|NCT03725722|463563458|FG003|Overall Study|Adverse Event|0|||
128800408|NCT03725722|463563459|FG004|Overall Study|Adverse Event|6|||
128800409|NCT03725722|463563455|FG000|Overall Study|Withdrawal by Subject|4|||
128800410|NCT03725722|463563456|FG001|Overall Study|Withdrawal by Subject|1|||
128800411|NCT03725722|463563457|FG002|Overall Study|Withdrawal by Subject|0|||
128800412|NCT03725722|463563458|FG003|Overall Study|Withdrawal by Subject|4|||
128800413|NCT03725722|463563459|FG004|Overall Study|Withdrawal by Subject|4|||
128800414|NCT03725722|463563455|FG000|Overall Study|Lost to Follow-up|3|||
128800415|NCT03725722|463563456|FG001|Overall Study|Lost to Follow-up|1|||
128800416|NCT03725722|463563457|FG002|Overall Study|Lost to Follow-up|2|||
128800417|NCT03725722|463563458|FG003|Overall Study|Lost to Follow-up|2|||
128800418|NCT03725722|463563459|FG004|Overall Study|Lost to Follow-up|1|||
128800419|NCT03725722|463563455|FG000|Overall Study|Personal reasons|0|||
128800420|NCT03725722|463563456|FG001|Overall Study|Personal reasons|0|||
128800421|NCT03725722|463563457|FG002|Overall Study|Personal reasons|1|||
128800422|NCT03725722|463563458|FG003|Overall Study|Personal reasons|0|||
128800423|NCT03725722|463563459|FG004|Overall Study|Personal reasons|1|||
128800424|NCT03725722|463563455|FG000|Overall Study|COVID-19 situation|0|||
128800425|NCT03725722|463563456|FG001|Overall Study|COVID-19 situation|1|||
128800426|NCT03725722|463563457|FG002|Overall Study|COVID-19 situation|0|||
128800427|NCT03725722|463563458|FG003|Overall Study|COVID-19 situation|0|||
128800428|NCT03725722|463563459|FG004|Overall Study|COVID-19 situation|0|||
128800429|NCT05505045|463563460|FG000|Overall Study|Withdrawal by Subject|2|||
128800430|NCT05505045|463563461|FG001|Overall Study|Withdrawal by Subject|1|||
128800431|NCT01643070|463563462|FG000|Overall Study|Withdrawal by Subject|3|||
128800432|NCT01643070|463563463|FG001|Overall Study|Withdrawal by Subject|1|||
128800433|NCT01643070|463563462|FG000|Overall Study|Death|1|||
128800434|NCT01643070|463563463|FG001|Overall Study|Death|0|||
128800435|NCT01643070|463563462|FG000|Overall Study|Pregressive disease|0|||
128800436|NCT01643070|463563463|FG001|Overall Study|Pregressive disease|2|||
128800437|NCT01600014|463563464|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
128800438|NCT01600014|463563465|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
128800439|NCT01600014|463563464|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
128800440|NCT01600014|463563465|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
128800441|NCT01600014|463563464|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
128800442|NCT01600014|463563465|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
128800443|NCT01600014|463563464|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
128800444|NCT01600014|463563465|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
128800445|NCT01600014|463563464|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
128800446|NCT01600014|463563465|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
128800447|NCT01600014|463563464|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
128800448|NCT01600014|463563465|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
128800449|NCT01600014|463563464|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
128800450|NCT01600014|463563465|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
128800451|NCT01600014|463563464|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
128800452|NCT01600014|463563465|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
128800453|NCT01600014|463563464|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
128800454|NCT01600014|463563465|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
128800455|NCT01600014|463563464|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
128800456|NCT01600014|463563465|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
128800457|NCT01600014|463563464|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
128800458|NCT01600014|463563465|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
128800459|NCT01600014|463563464|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
128800460|NCT01600014|463563465|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
128800461|NCT01600014|463563464|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
128800462|NCT01600014|463563465|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
128800463|NCT01600014|463563464|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
128800464|NCT01600014|463563465|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
128800465|NCT01600014|463563464|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
128800466|NCT01600014|463563465|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
128800467|NCT01600014|463563464|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
128800468|NCT01600014|463563465|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
128800469|NCT01600014|463563464|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
128800470|NCT01600014|463563465|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
128800471|NCT04310735|463563469|FG000|Overall Study|Withdrawal by Subject|1|||
128800472|NCT04310735|463563470|FG001|Overall Study|Withdrawal by Subject|3|||
128800473|NCT04310735|463563471|FG002|Overall Study|Withdrawal by Subject|8|||
128800474|NCT04310735|463563469|FG000|Overall Study|Equipment malfunction|0|||
128800475|NCT04310735|463563470|FG001|Overall Study|Equipment malfunction|1|||
128800476|NCT04310735|463563471|FG002|Overall Study|Equipment malfunction|0|||
128800477|NCT03554265|463563474|FG000|Overall Study|Withdrawal by Subject|2|||
128800478|NCT03554265|463563475|FG001|Overall Study|Withdrawal by Subject|2|||
128800479|NCT03554265|463563476|FG002|Overall Study|Withdrawal by Subject|3|||
128800480|NCT03554265|463563474|FG000|Overall Study|Physician Decision|0|||
128800481|NCT03554265|463563475|FG001|Overall Study|Physician Decision|0|||
128800482|NCT03554265|463563476|FG002|Overall Study|Physician Decision|1|||
128800483|NCT05386238|463563477|FG000|Overall Study|Lost to Follow-up|3|||
128800484|NCT05386238|463563478|FG001|Overall Study|Lost to Follow-up|2|||
128800485|NCT05386238|463563477|FG000|Overall Study|Withdrawal by Subject|0|||
128800486|NCT05386238|463563478|FG001|Overall Study|Withdrawal by Subject|1|||
128800487|NCT04714320|463563479|FG000|Overall Study|Voluntary Withdrawal|4|||
128800488|NCT04714320|463563480|FG001|Overall Study|Voluntary Withdrawal|1|||
128800489|NCT04714320|463563481|FG002|Overall Study|Voluntary Withdrawal|2|||
128800490|NCT04714320|463563479|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
128800491|NCT04714320|463563480|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
128800492|NCT04714320|463563481|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
128800493|NCT04714320|463563479|FG000|Overall Study|Reason Not Specified|1|||
128800494|NCT04714320|463563480|FG001|Overall Study|Reason Not Specified|3|||
128800495|NCT04714320|463563481|FG002|Overall Study|Reason Not Specified|3|||
128800496|NCT05057897|463563482|FG000|Overall Study|Site closure|2|||
128800497|NCT05057897|463563483|FG001|Overall Study|Site closure|2|||
128800498|NCT05057897|463563482|FG000|Overall Study|Death|1|||
128800499|NCT05057897|463563483|FG001|Overall Study|Death|0|||
128800500|NCT03088813|463563484|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
128800501|NCT03088813|463563485|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
128800502|NCT03088813|463563486|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
128800503|NCT03088813|463563487|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
128800504|NCT03088813|463563484|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
128800505|NCT03088813|463563485|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
128800506|NCT03088813|463563486|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
128800507|NCT03088813|463563487|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
128800508|NCT03088813|463563484|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
128800509|NCT03088813|463563485|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
128800510|NCT03088813|463563486|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
128800511|NCT03088813|463563487|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
128800512|NCT03088813|463563484|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
128800513|NCT03088813|463563485|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
128800514|NCT03088813|463563486|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
128800515|NCT03088813|463563487|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
128800516|NCT03088813|463563484|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
128800517|NCT03088813|463563485|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
128800518|NCT03088813|463563486|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
128800519|NCT03088813|463563487|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
128800520|NCT03088813|463563484|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
128800521|NCT03088813|463563485|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
128800522|NCT03088813|463563486|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
128800523|NCT03088813|463563487|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
128800524|NCT03088813|463563484|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
128800525|NCT03088813|463563485|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
128800526|NCT03088813|463563486|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
128800527|NCT03088813|463563487|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
128800528|NCT01903811|463563496|FG000|Overall Study|No measurable disease|1|||
128800529|NCT01903811|463563497|FG001|Overall Study|No measurable disease|1|||
128800530|NCT01903811|463563496|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
128800531|NCT01903811|463563497|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
128800532|NCT01903811|463563496|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
128800533|NCT01903811|463563497|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
128800534|NCT01903811|463563496|FG000|Overall Study|Withdrawal by Subject|0|||
128800535|NCT01903811|463563497|FG001|Overall Study|Withdrawal by Subject|1|||
128800536|NCT03438188|463563498|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
128800537|NCT03438188|463563499|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
128800538|NCT03438188|463563500|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
128800539|NCT03438188|463563498|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
128800540|NCT03438188|463563499|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
128800541|NCT03438188|463563500|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
128800542|NCT03438188|463563498|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
128800543|NCT03438188|463563499|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
128800544|NCT03438188|463563500|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
128800545|NCT03438188|463563498|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
128800546|NCT03438188|463563499|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
128800547|NCT03438188|463563500|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
128800548|NCT03438188|463563498|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
128800549|NCT03438188|463563499|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
128800550|NCT03438188|463563500|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
128800551|NCT00670046|463563501|FG000|Overall Study|Lost to Follow-up|1|||
128800552|NCT00670046|463563502|FG001|Overall Study|Lost to Follow-up|1|||
128800553|NCT00670046|463563501|FG000|Overall Study|Withdrawal by Subject|0|||
128800554|NCT00670046|463563502|FG001|Overall Study|Withdrawal by Subject|1|||
128800555|NCT02300298|463563505|FG000|Disposition for Nintedanib|Progressive disease|10|||
128800556|NCT02300298|463563506|FG001|Disposition for Nintedanib|Progressive disease|0|||
128800557|NCT02300298|463563505|FG000|Disposition for Docetaxel|Progressive disease|0|||
128800558|NCT02300298|463563506|FG001|Disposition for Docetaxel|Progressive disease|6|||
128800559|NCT02300298|463563505|FG000|Disposition for Docetaxel|other adverse event|0|||
128800560|NCT02300298|463563506|FG001|Disposition for Docetaxel|other adverse event|4|||
128800561|NCT03285763|463563507|FG000|Overall Study|Death|470|||
128800562|NCT03285763|463563507|FG000|Overall Study|Lost to Follow-up|18|||
128800563|NCT03285763|463563507|FG000|Overall Study|Physician Decision|2|||
128800564|NCT03285763|463563507|FG000|Overall Study|Study Terminated By Sponsor|79|||
128800565|NCT03285763|463563507|FG000|Overall Study|Withdrawal by Subject|33|||
128800566|NCT00431834|463563512|FG000|Overall Study|Withdrawal by Subject|7|||
128800567|NCT00431834|463563512|FG000|Overall Study|Death|3|||
128800568|NCT00431834|463563512|FG000|Overall Study|Missed Endpoint Visit|2|||
128800569|NCT00431834|463563512|FG000|Overall Study|Lost to Follow-up|1|||
128800570|NCT02461628|463563516|FG000|Overall Study|Refused to complete survey|4|||
128800571|NCT02461628|463563517|FG001|Overall Study|Refused to complete survey|7|||
128800572|NCT02006758|463563525|FG000|Overall Study|Protocol Violation|1|||
128800573|NCT02006758|463563525|FG000|Overall Study|Death|1|||
128800574|NCT02006758|463563525|FG000|Overall Study|Lost to Follow-up|4|||
128800575|NCT02006758|463563525|FG000|Overall Study|Withdrawal by Subject|4|||
128800576|NCT02006758|463563525|FG000|Overall Study|Procedurally excluded|1|||
128800577|NCT02006758|463563525|FG000|Overall Study|Other|2|||
128800578|NCT04788641|463563526|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
128800579|NCT04788641|463563527|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
128800580|NCT04788641|463563528|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
128800581|NCT04788641|463563529|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
128800582|NCT04788641|463563526|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
128800583|NCT04788641|463563527|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
128800584|NCT04788641|463563528|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
128800585|NCT04788641|463563529|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
128800586|NCT04788641|463563526|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
128800587|NCT04788641|463563527|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
128800588|NCT04788641|463563528|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
128800589|NCT04788641|463563529|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
128800590|NCT02740231|463563534|FG000|Overall Study|Withdrawal by Subject|1|||
128800591|NCT02740231|463563535|FG001|Overall Study|Withdrawal by Subject|1|||
128800592|NCT02740231|463563536|FG002|Overall Study|Withdrawal by Subject|1|||
128800593|NCT02740231|463563537|FG003|Overall Study|Withdrawal by Subject|0|||
128800594|NCT02740231|463563534|FG000|Overall Study|Lack of Efficacy|0|||
128800595|NCT02740231|463563535|FG001|Overall Study|Lack of Efficacy|1|||
128800596|NCT02740231|463563536|FG002|Overall Study|Lack of Efficacy|0|||
128800597|NCT02740231|463563537|FG003|Overall Study|Lack of Efficacy|4|||
128800598|NCT02740231|463563534|FG000|Overall Study|Lost to Follow-up|1|||
128800599|NCT02740231|463563535|FG001|Overall Study|Lost to Follow-up|3|||
128800600|NCT02740231|463563536|FG002|Overall Study|Lost to Follow-up|0|||
128800601|NCT02740231|463563537|FG003|Overall Study|Lost to Follow-up|3|||
128800602|NCT02740231|463563534|FG000|Overall Study|Adverse Event|0|||
128800603|NCT02740231|463563535|FG001|Overall Study|Adverse Event|1|||
128800604|NCT02740231|463563536|FG002|Overall Study|Adverse Event|0|||
128800605|NCT02740231|463563537|FG003|Overall Study|Adverse Event|1|||
128800606|NCT02462759|463563538|FG000|Part 1: Double Blind|Death|1|||
128800607|NCT02462759|463563539|FG001|Part 1: Double Blind|Death|0|||
128800608|NCT02462759|463563540|FG002|Part 1: Double Blind|Death|0|||
128800609|NCT01000480|463563541|FG000|Induction Phase|Adverse Event|2|||
128800610|NCT01000480|463563541|FG000|Induction Phase|Lost to Follow-up|1|||
128800611|NCT01000480|463563541|FG000|Induction Phase|Physician Decision|1|||
128800612|NCT01000480|463563541|FG000|Induction Phase|Entry Criteria Not Met|3|||
128800613|NCT01000480|463563541|FG000|Concurrent Therapy Phase|Adverse Event|4|||
128800614|NCT01000480|463563541|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
128800615|NCT01000480|463563541|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
128800616|NCT01000480|463563541|FG000|Concurrent Therapy Phase|Physician Decision|1|||
128800617|NCT00999167|463563544|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
128800618|NCT00999167|463563545|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
128800619|NCT00999167|463563546|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
128800620|NCT00999167|463563544|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
128800621|NCT00999167|463563545|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
128800622|NCT00999167|463563546|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
128800623|NCT00999167|463563544|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
128800624|NCT00999167|463563545|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
128800625|NCT00999167|463563546|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
128800626|NCT00999167|463563544|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
128800627|NCT00999167|463563545|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
128800628|NCT00999167|463563546|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
128800629|NCT00999167|463563544|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
128800630|NCT00999167|463563545|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
128800631|NCT00999167|463563546|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
128800632|NCT00999167|463563544|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
128800633|NCT00999167|463563545|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
128800634|NCT00999167|463563546|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
128800635|NCT00999167|463563544|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
128800636|NCT00999167|463563545|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
128800637|NCT00999167|463563546|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
128800638|NCT00999167|463563544|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
128800639|NCT00999167|463563545|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
128800640|NCT00999167|463563546|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
128800641|NCT05052996|463563549|FG000|Overall Study|Still on study|0|||
128800642|NCT05052996|463563550|FG001|Overall Study|Still on study|0|||
128800643|NCT05052996|463563551|FG002|Overall Study|Still on study|47|||
128800644|NCT05052996|463563552|FG003|Overall Study|Still on study|44|||
128800645|NCT05052996|463563549|FG000|Overall Study|Cohort terminated by sponsor|21|||
128800646|NCT05052996|463563550|FG001|Overall Study|Cohort terminated by sponsor|12|||
128800647|NCT05052996|463563551|FG002|Overall Study|Cohort terminated by sponsor|0|||
128800648|NCT05052996|463563552|FG003|Overall Study|Cohort terminated by sponsor|0|||
128800649|NCT05052996|463563549|FG000|Overall Study|Withdrew consent|1|||
128800650|NCT05052996|463563550|FG001|Overall Study|Withdrew consent|0|||
128800651|NCT05052996|463563551|FG002|Overall Study|Withdrew consent|1|||
128800652|NCT05052996|463563552|FG003|Overall Study|Withdrew consent|2|||
128800653|NCT05052996|463563549|FG000|Overall Study|Lost to Follow-up|1|||
128800654|NCT05052996|463563550|FG001|Overall Study|Lost to Follow-up|0|||
128800655|NCT05052996|463563551|FG002|Overall Study|Lost to Follow-up|0|||
128800656|NCT05052996|463563552|FG003|Overall Study|Lost to Follow-up|2|||
128800657|NCT05052996|463563549|FG000|Overall Study|Adverse Event|0|||
128800658|NCT05052996|463563550|FG001|Overall Study|Adverse Event|0|||
128800659|NCT05052996|463563551|FG002|Overall Study|Adverse Event|2|||
128800660|NCT05052996|463563552|FG003|Overall Study|Adverse Event|0|||
128800661|NCT05052996|463563549|FG000|Overall Study|Randomized but never treated|0|||
128800662|NCT05052996|463563550|FG001|Overall Study|Randomized but never treated|0|||
128800663|NCT05052996|463563551|FG002|Overall Study|Randomized but never treated|1|||
128800664|NCT05052996|463563552|FG003|Overall Study|Randomized but never treated|1|||
128800665|NCT05052996|463563549|FG000|Overall Study|Protocol Violation|1|||
128800666|NCT05052996|463563550|FG001|Overall Study|Protocol Violation|0|||
128800667|NCT05052996|463563551|FG002|Overall Study|Protocol Violation|0|||
128800668|NCT05052996|463563552|FG003|Overall Study|Protocol Violation|0|||
128800669|NCT00522951|463563556|FG000|Period 1|body motion|0|||
128800670|NCT00522951|463563557|FG001|Period 1|body motion|1|||
128800671|NCT00522951|463563556|FG000|Washout Period|Adverse Event|0|||
128800672|NCT00522951|463563557|FG001|Washout Period|Adverse Event|1|||
128800673|NCT00522951|463563556|FG000|Washout Period|Death|0|||
128800674|NCT00522951|463563557|FG001|Washout Period|Death|1|||
128800675|NCT00522951|463563556|FG000|Period 2|Withdrawal by Subject|1|||
128800676|NCT00522951|463563557|FG001|Period 2|Withdrawal by Subject|0|||
128800677|NCT00522951|463563556|FG000|Period 2|residual contrast medium|1|||
128800678|NCT00522951|463563557|FG001|Period 2|residual contrast medium|1|||
128800679|NCT03101930|463563562|FG000|Overall Study|Withdrawal by Subject|2|||
128800680|NCT03101930|463563563|FG001|Overall Study|Withdrawal by Subject|1|||
128800681|NCT03101930|463563564|FG002|Overall Study|Withdrawal by Subject|2|||
128800682|NCT01747486|463563565|FG000|Stage 1|Physician Decision|3|||
128800683|NCT01747486|463563566|FG001|Stage 1|Physician Decision|0|||
128800684|NCT01747486|463563565|FG000|Stage 1|Withdrawal by Subject|4|||
128800685|NCT01747486|463563566|FG001|Stage 1|Withdrawal by Subject|3|||
128800686|NCT01747486|463563565|FG000|Stage 1|Disease progression|4|||
128800687|NCT01747486|463563566|FG001|Stage 1|Disease progression|9|||
128800688|NCT01747486|463563565|FG000|Stage 1|Death|1|||
128800689|NCT01747486|463563566|FG001|Stage 1|Death|1|||
128800690|NCT01747486|463563565|FG000|Stage 2|Physician Decision|2|||
128800691|NCT01747486|463563566|FG001|Stage 2|Physician Decision|0|||
128800692|NCT01747486|463563565|FG000|Stage 2|Withdrawal by Subject|1|||
128800693|NCT01747486|463563566|FG001|Stage 2|Withdrawal by Subject|0|||
128800694|NCT01747486|463563565|FG000|Stage 2|New Cancer Therapy|3|||
128800695|NCT01747486|463563566|FG001|Stage 2|New Cancer Therapy|0|||
128800696|NCT01747486|463563565|FG000|Stage 2|Disease Progression|3|||
128800697|NCT01747486|463563566|FG001|Stage 2|Disease Progression|0|||
128800698|NCT01771731|463563567|FG000|Overall Study|Physician Decision|1|||
128800699|NCT01771731|463563568|FG001|Overall Study|Physician Decision|0|||
128800700|NCT01771731|463563567|FG000|Overall Study|Protocol Violation|0|||
128800701|NCT01771731|463563568|FG001|Overall Study|Protocol Violation|1|||
128800702|NCT01771731|463563567|FG000|Overall Study|Adverse event: Pain Crisis|1|||
128800703|NCT01771731|463563568|FG001|Overall Study|Adverse event: Pain Crisis|1|||
128800704|NCT00976495|463563569|FG000|Overall Study|Withdrawal by Subject|0|||
128800705|NCT00976495|463563570|FG001|Overall Study|Withdrawal by Subject|1|||
128800706|NCT00976495|463563571|FG002|Overall Study|Withdrawal by Subject|0|||
128800707|NCT00331136|463563572|FG000|Overall Study|Adverse Event|3|||
128800708|NCT00331136|463563573|FG001|Overall Study|Adverse Event|5|||
128800709|NCT00331136|463563574|FG002|Overall Study|Adverse Event|0|||
128800710|NCT00331136|463563575|FG003|Overall Study|Adverse Event|1|||
128800711|NCT00331136|463563572|FG000|Overall Study|Withdrawal by Subject|0|||
128800712|NCT00331136|463563573|FG001|Overall Study|Withdrawal by Subject|1|||
128800713|NCT00331136|463563574|FG002|Overall Study|Withdrawal by Subject|0|||
128800714|NCT00331136|463563575|FG003|Overall Study|Withdrawal by Subject|0|||
128800715|NCT00331136|463563572|FG000|Overall Study|Lost to Follow-up|0|||
128800716|NCT00331136|463563573|FG001|Overall Study|Lost to Follow-up|1|||
128800717|NCT00331136|463563574|FG002|Overall Study|Lost to Follow-up|0|||
128800718|NCT00331136|463563575|FG003|Overall Study|Lost to Follow-up|0|||
128800719|NCT00331136|463563572|FG000|Overall Study|Protocol Violation|1|||
128800720|NCT00331136|463563573|FG001|Overall Study|Protocol Violation|0|||
128800721|NCT00331136|463563574|FG002|Overall Study|Protocol Violation|0|||
128800722|NCT00331136|463563575|FG003|Overall Study|Protocol Violation|0|||
128800723|NCT00331136|463563572|FG000|Overall Study|Not treated|1|||
128800724|NCT00331136|463563573|FG001|Overall Study|Not treated|0|||
128800725|NCT00331136|463563574|FG002|Overall Study|Not treated|0|||
128800726|NCT00331136|463563575|FG003|Overall Study|Not treated|0|||
128800727|NCT02321514|463563576|FG000|Overall Study|Death|15|||
128800728|NCT02321514|463563576|FG000|Overall Study|Missed Visit|7|||
128800729|NCT02321514|463563576|FG000|Overall Study|Study Exit|3|||
128800730|NCT04484935|463563579|FG000|Overall Study|Other|0|||
128800731|NCT04484935|463563580|FG001|Overall Study|Other|1|||
128800732|NCT04484935|463563579|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128800733|NCT04484935|463563580|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128800734|NCT04484935|463563579|FG000|Overall Study|Lost to Follow-up|1|||
128800735|NCT04484935|463563580|FG001|Overall Study|Lost to Follow-up|0|||
128800736|NCT04484935|463563579|FG000|Overall Study|Death|2|||
128800737|NCT04484935|463563580|FG001|Overall Study|Death|1|||
128800738|NCT01094184|463563584|FG000|Overall Study|Death|35|||
128800739|NCT01094184|463563585|FG001|Overall Study|Death|11|||
128800740|NCT03892564|463563586|FG000|Overall Study|Withdrawal by Subject|2|||
128800741|NCT02791230|463565443|FG000|Overall Study|Adverse Event|10|||
128800742|NCT02791230|463565444|FG001|Overall Study|Adverse Event|9|||
128800743|NCT02791230|463565445|FG002|Overall Study|Adverse Event|66|||
128800744|NCT02791230|463565443|FG000|Overall Study|Death|38|||
128800745|NCT02791230|463565444|FG001|Overall Study|Death|25|||
128800746|NCT02791230|463565445|FG002|Overall Study|Death|184|||
128800747|NCT02791230|463565443|FG000|Overall Study|Lack of Efficacy|1|||
128800748|NCT02791230|463565444|FG001|Overall Study|Lack of Efficacy|0|||
128800749|NCT02791230|463565445|FG002|Overall Study|Lack of Efficacy|3|||
128800750|NCT02791230|463565443|FG000|Overall Study|Lost to Follow-up|0|||
128800751|NCT02791230|463565444|FG001|Overall Study|Lost to Follow-up|0|||
128800752|NCT02791230|463565445|FG002|Overall Study|Lost to Follow-up|10|||
128800753|NCT02791230|463565443|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
128800754|NCT02791230|463565444|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
128800755|NCT02791230|463565445|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
128800756|NCT02791230|463565443|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
128800757|NCT02791230|463565444|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
128800758|NCT02791230|463565445|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
128800759|NCT02791230|463565443|FG000|Overall Study|Study sites terminated by sponsor|1|||
128800760|NCT02791230|463565444|FG001|Overall Study|Study sites terminated by sponsor|0|||
128800761|NCT02791230|463565445|FG002|Overall Study|Study sites terminated by sponsor|5|||
128800762|NCT02791230|463565443|FG000|Overall Study|Other|9|||
128800763|NCT02791230|463565444|FG001|Overall Study|Other|1|||
128800764|NCT02791230|463565445|FG002|Overall Study|Other|28|||
128800765|NCT02791230|463565443|FG000|Overall Study|Protocol Violation|0|||
128800766|NCT02791230|463565444|FG001|Overall Study|Protocol Violation|0|||
128800767|NCT02791230|463565445|FG002|Overall Study|Protocol Violation|4|||
128800768|NCT02791230|463565443|FG000|Overall Study|Withdrawal by Subject|24|||
128800769|NCT02791230|463565444|FG001|Overall Study|Withdrawal by Subject|13|||
128800770|NCT02791230|463565445|FG002|Overall Study|Withdrawal by Subject|172|||
128800771|NCT02791230|463565443|FG000|Overall Study|Enrolled but not treated|0|||
128800772|NCT02791230|463565444|FG001|Overall Study|Enrolled but not treated|0|||
128800773|NCT02791230|463565445|FG002|Overall Study|Enrolled but not treated|5|||
128800774|NCT01259401|463565446|FG000|4-month Follow-up|Death|0|||
128800775|NCT01259401|463565447|FG001|4-month Follow-up|Death|1|||
128800776|NCT01259401|463565446|FG000|4-month Follow-up|Lost to Follow-up|0|||
128800777|NCT01259401|463565447|FG001|4-month Follow-up|Lost to Follow-up|1|||
128800778|NCT04201834|463565455|FG000|Overall Study|Screen fail|1|||
128800779|NCT05696080|463565456|FG000|Overall Study|Lost to Follow-up|2|||
128800780|NCT05696080|463565457|FG001|Overall Study|Lost to Follow-up|1|||
128800781|NCT05696080|463565456|FG000|Overall Study|Physician Decision|1|||
128800782|NCT05696080|463565457|FG001|Overall Study|Physician Decision|0|||
128800783|NCT05696080|463565456|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
128800784|NCT05696080|463565457|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
128800785|NCT05696080|463565456|FG000|Overall Study|Withdrawal by Subject|12|||
128800786|NCT05696080|463565457|FG001|Overall Study|Withdrawal by Subject|0|||
128800787|NCT03954184|463565460|FG000|Overall Study|Lost to Follow-up|500|||
128800788|NCT03954184|463565461|FG001|Overall Study|Lost to Follow-up|0|||
128800789|NCT03398200|463565462|FG000|Overall Study|Withdrawal by Subject|0|||
128800790|NCT03398200|463565463|FG001|Overall Study|Withdrawal by Subject|1|||
128800791|NCT05478525|463565464|FG000|Overall Study|Withdrawal by Subject|0|||
128800792|NCT05478525|463565465|FG001|Overall Study|Withdrawal by Subject|1|||
128800793|NCT05478525|463565466|FG002|Overall Study|Withdrawal by Subject|2|||
128800794|NCT05478525|463565467|FG003|Overall Study|Withdrawal by Subject|0|||
128800795|NCT05478525|463565464|FG000|Overall Study|COVID-19 Infection|2|||
128800796|NCT05478525|463565465|FG001|Overall Study|COVID-19 Infection|0|||
128800797|NCT05478525|463565466|FG002|Overall Study|COVID-19 Infection|1|||
128800798|NCT05478525|463565467|FG003|Overall Study|COVID-19 Infection|1|||
128800799|NCT01649271|463565468|FG000|Overall Study|Progressive disease|4|||
128800800|NCT01649271|463565469|FG001|Overall Study|Progressive disease|5|||
128800801|NCT01649271|463565468|FG000|Overall Study|Other Adverse Event|0|||
128800802|NCT01649271|463565469|FG001|Overall Study|Other Adverse Event|2|||
128800803|NCT01649271|463565468|FG000|Overall Study|Withdrawal by Subject|1|||
128800804|NCT01649271|463565469|FG001|Overall Study|Withdrawal by Subject|0|||
128800805|NCT01649271|463565468|FG000|Overall Study|Other than stated above|1|||
128800806|NCT01649271|463565469|FG001|Overall Study|Other than stated above|0|||
128800807|NCT05644002|463565472|FG000|Overall Study|Lost to Follow-up|1|||
128800808|NCT05644002|463565473|FG001|Overall Study|Lost to Follow-up|2|||
128800809|NCT05644002|463565472|FG000|Overall Study|Withdrawal by Subject|0|||
128800810|NCT05644002|463565473|FG001|Overall Study|Withdrawal by Subject|1|||
128800811|NCT03821844|463565475|FG000|Overall Study|Death|37|||
128800812|NCT03821844|463565476|FG001|Overall Study|Death|31|||
128800813|NCT03821844|463565475|FG000|Overall Study|Discharged|10|||
128800814|NCT03821844|463565476|FG001|Overall Study|Discharged|14|||
128800815|NCT03821844|463565475|FG000|Overall Study|Not present in facility at followup|2|||
128800816|NCT03821844|463565476|FG001|Overall Study|Not present in facility at followup|3|||
128800817|NCT02605837|463565477|FG000|Overall Study|Adverse Event|3|||
128800818|NCT02605837|463565478|FG001|Overall Study|Adverse Event|1|||
128800819|NCT02605837|463565477|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128800820|NCT02605837|463565478|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128800821|NCT02605837|463565477|FG000|Overall Study|Withdrawal by Subject|8|||
128800822|NCT02605837|463565478|FG001|Overall Study|Withdrawal by Subject|8|||
128800823|NCT02605837|463565477|FG000|Overall Study|Physician Decision|0|||
128800824|NCT02605837|463565478|FG001|Overall Study|Physician Decision|1|||
128800825|NCT02652260|463565479|FG000|Base Study|Pregnancy|0|||
128800826|NCT02652260|463565480|FG001|Base Study|Pregnancy|1|||
128800827|NCT02652260|463565479|FG000|Base Study|Withdrawal by Subject|0|||
128800828|NCT02652260|463565480|FG001|Base Study|Withdrawal by Subject|1|||
128800829|NCT02652260|463565479|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
128800830|NCT02652260|463565480|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
128800831|NCT02652260|463565479|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
128800832|NCT02652260|463565480|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
128800833|NCT02652260|463565479|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
128800834|NCT02652260|463565480|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
128800835|NCT02652260|463565479|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
128800836|NCT02652260|463565480|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
128800837|NCT02652260|463565479|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
128800838|NCT02652260|463565480|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
128800839|NCT02652260|463565479|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
128800840|NCT02652260|463565480|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
128800841|NCT02652260|463565479|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
128800842|NCT02652260|463565480|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
128800843|NCT02652260|463565479|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
128800844|NCT02652260|463565480|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
128800845|NCT02652260|463565479|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
128800846|NCT02652260|463565480|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
128800847|NCT02652260|463565479|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
128800848|NCT02652260|463565480|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
128800849|NCT02652260|463565479|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
128800850|NCT02652260|463565480|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
128800851|NCT02652260|463565479|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
128800852|NCT02652260|463565480|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
128800853|NCT05056246|463565481|FG000|Overall Study|Adverse Event|0|||
128800854|NCT05056246|463565482|FG001|Overall Study|Adverse Event|0|||
128800855|NCT05056246|463565483|FG002|Overall Study|Adverse Event|0|||
128800856|NCT05056246|463565484|FG003|Overall Study|Adverse Event|0|||
128800857|NCT05056246|463565485|FG004|Overall Study|Adverse Event|1|||
128800858|NCT05056246|463565481|FG000|Overall Study|Lost to Follow-up|0|||
128800859|NCT05056246|463565482|FG001|Overall Study|Lost to Follow-up|0|||
128800860|NCT05056246|463565483|FG002|Overall Study|Lost to Follow-up|0|||
128800861|NCT05056246|463565484|FG003|Overall Study|Lost to Follow-up|2|||
128800862|NCT05056246|463565485|FG004|Overall Study|Lost to Follow-up|0|||
128800863|NCT05056246|463565481|FG000|Overall Study|Withdrawal by Subject|0|||
128800864|NCT05056246|463565482|FG001|Overall Study|Withdrawal by Subject|1|||
128800865|NCT05056246|463565483|FG002|Overall Study|Withdrawal by Subject|0|||
128800866|NCT05056246|463565484|FG003|Overall Study|Withdrawal by Subject|0|||
128800867|NCT05056246|463565485|FG004|Overall Study|Withdrawal by Subject|0|||
128800868|NCT03899961|463565491|FG000|Overall Study|-delivery prior to|2|||
128800869|NCT03899961|463565492|FG001|Overall Study|-delivery prior to|7|||
128800870|NCT03899961|463565491|FG000|Overall Study|req general anesth|1|||
128800871|NCT03899961|463565492|FG001|Overall Study|req general anesth|2|||
128800872|NCT03899961|463565491|FG000|Overall Study|capacity|5|||
128800873|NCT03899961|463565492|FG001|Overall Study|capacity|6|||
128800874|NCT03899961|463565491|FG000|Overall Study|Withdrawal by Subject|1|||
128800875|NCT03899961|463565492|FG001|Overall Study|Withdrawal by Subject|1|||
128800876|NCT05656911|463565493|FG000|Treatment Phase|Physician Decision|2|||
128800877|NCT05656911|463565494|FG001|Treatment Phase|Physician Decision|0|||
128800878|NCT05656911|463565493|FG000|Treatment Phase|Lack of Efficacy|6|||
128800879|NCT05656911|463565494|FG001|Treatment Phase|Lack of Efficacy|3|||
128800880|NCT05656911|463565493|FG000|Treatment Phase|Subject Decision|4|||
128800881|NCT05656911|463565494|FG001|Treatment Phase|Subject Decision|2|||
128800882|NCT05656911|463565493|FG000|Treatment Phase|Other Reasons|1|||
128800883|NCT05656911|463565494|FG001|Treatment Phase|Other Reasons|0|||
128800884|NCT05656911|463565493|FG000|Treatment Phase|Adverse Event|3|||
128800885|NCT05656911|463565494|FG001|Treatment Phase|Adverse Event|1|||
128800886|NCT05656911|463565493|FG000|Follow-up Phase|Subject Decision|0|||
128800887|NCT05656911|463565494|FG001|Follow-up Phase|Subject Decision|1|||
128800888|NCT05656911|463565493|FG000|Follow-up Phase|Missing|1|||
128800889|NCT05656911|463565494|FG001|Follow-up Phase|Missing|0|||
128800890|NCT02780388|463565495|FG000|Overall Study|Lost to Follow-up|0|||
128800891|NCT02780388|463565496|FG001|Overall Study|Lost to Follow-up|1|||
128800892|NCT02780388|463565497|FG002|Overall Study|Lost to Follow-up|0|||
128800893|NCT02780388|463565498|FG003|Overall Study|Lost to Follow-up|0|||
128800894|NCT02780388|463565499|FG004|Overall Study|Lost to Follow-up|0|||
128800895|NCT02780388|463565495|FG000|Overall Study|Withdrawal by Subject|1|||
128800896|NCT02780388|463565496|FG001|Overall Study|Withdrawal by Subject|1|||
128800897|NCT02780388|463565497|FG002|Overall Study|Withdrawal by Subject|0|||
128800898|NCT02780388|463565498|FG003|Overall Study|Withdrawal by Subject|0|||
128800899|NCT02780388|463565499|FG004|Overall Study|Withdrawal by Subject|0|||
128800900|NCT04527146|463565500|FG000|Overall Study|Withdrawal by Subject|12|||
128800901|NCT04527146|463565501|FG001|Overall Study|Withdrawal by Subject|15|||
128800902|NCT04527146|463565502|FG002|Overall Study|Withdrawal by Subject|7|||
128800903|NCT04527146|463565503|FG003|Overall Study|Withdrawal by Subject|16|||
128800904|NCT04527146|463565500|FG000|Overall Study|Lost to Follow-up|13|||
128800905|NCT04527146|463565501|FG001|Overall Study|Lost to Follow-up|9|||
128800906|NCT04527146|463565502|FG002|Overall Study|Lost to Follow-up|16|||
128800907|NCT04527146|463565503|FG003|Overall Study|Lost to Follow-up|13|||
128800908|NCT04527146|463565500|FG000|Overall Study|Death|0|||
128800909|NCT04527146|463565501|FG001|Overall Study|Death|1|||
128800910|NCT04527146|463565502|FG002|Overall Study|Death|1|||
128800911|NCT04527146|463565503|FG003|Overall Study|Death|0|||
128800912|NCT04527146|463565500|FG000|Overall Study|Adverse Event|0|||
128800913|NCT04527146|463565501|FG001|Overall Study|Adverse Event|0|||
128800914|NCT04527146|463565502|FG002|Overall Study|Adverse Event|1|||
128800915|NCT04527146|463565503|FG003|Overall Study|Adverse Event|0|||
128800916|NCT04527146|463565500|FG000|Overall Study|Ineligible after randomization|2|||
128800917|NCT04527146|463565501|FG001|Overall Study|Ineligible after randomization|0|||
128800918|NCT04527146|463565502|FG002|Overall Study|Ineligible after randomization|2|||
128800919|NCT04527146|463565503|FG003|Overall Study|Ineligible after randomization|2|||
128800920|NCT04527146|463565500|FG000|Overall Study|Moved to a different group|6|||
128800921|NCT04527146|463565501|FG001|Overall Study|Moved to a different group|3|||
128800922|NCT04527146|463565502|FG002|Overall Study|Moved to a different group|0|||
128800923|NCT04527146|463565503|FG003|Overall Study|Moved to a different group|2|||
128800924|NCT05107401|463565504|FG000|Overall Study|Lost to Follow-up|13|||
128800925|NCT05107401|463565505|FG001|Overall Study|Lost to Follow-up|12|||
128800926|NCT04468776|463565510|FG000|Overall Study|Lost to Follow-up|4|||
128800927|NCT04468776|463565511|FG001|Overall Study|Lost to Follow-up|3|||
128800928|NCT04468776|463565512|FG002|Overall Study|Lost to Follow-up|4|||
128800929|NCT04468776|463565510|FG000|Overall Study|Withdrawal by Subject|1|||
128800930|NCT04468776|463565511|FG001|Overall Study|Withdrawal by Subject|10|||
128800931|NCT04468776|463565512|FG002|Overall Study|Withdrawal by Subject|4|||
128800932|NCT04468776|463565510|FG000|Overall Study|Physician Decision|0|||
128800933|NCT04468776|463565511|FG001|Overall Study|Physician Decision|1|||
128800934|NCT04468776|463565512|FG002|Overall Study|Physician Decision|1|||
128800935|NCT04608045|463565516|FG000|Overall Study|Physician Decision|1|||
128800936|NCT03575052|463565517|FG000|Overall Study|Adverse Event|6|||
128800937|NCT03575052|463565518|FG001|Overall Study|Adverse Event|10|||
128800938|NCT03575052|463565517|FG000|Overall Study|Not further specified|5|||
128800939|NCT03575052|463565518|FG001|Overall Study|Not further specified|7|||
128800940|NCT03575052|463565517|FG000|Overall Study|Withdrawal by Subject|5|||
128800941|NCT03575052|463565518|FG001|Overall Study|Withdrawal by Subject|6|||
128800942|NCT03575052|463565517|FG000|Overall Study|Lost to Follow-up|3|||
128800943|NCT03575052|463565518|FG001|Overall Study|Lost to Follow-up|0|||
128800944|NCT03575052|463565517|FG000|Overall Study|Death|2|||
128800945|NCT03575052|463565518|FG001|Overall Study|Death|1|||
128800946|NCT03575052|463565517|FG000|Overall Study|Lack of Efficacy|2|||
128800947|NCT03575052|463565518|FG001|Overall Study|Lack of Efficacy|1|||
128800948|NCT03575052|463565517|FG000|Overall Study|Study drug noncompliance|1|||
128800949|NCT03575052|463565518|FG001|Overall Study|Study drug noncompliance|2|||
128800950|NCT03575052|463565517|FG000|Overall Study|Protocol Violation|0|||
128800951|NCT03575052|463565518|FG001|Overall Study|Protocol Violation|2|||
128800952|NCT03575052|463565517|FG000|Overall Study|Physician Decision|1|||
128800953|NCT03575052|463565518|FG001|Overall Study|Physician Decision|0|||
128800954|NCT03103321|463565519|FG000|Overall Study|Protocol Violation|1|||
128800955|NCT03103321|463565520|FG001|Overall Study|Protocol Violation|1|||
128800956|NCT03103321|463565521|FG002|Overall Study|Protocol Violation|1|||
128800957|NCT03103321|463565522|FG003|Overall Study|Protocol Violation|0|||
128800958|NCT04247542|463565523|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
128800959|NCT04247542|463565524|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
128800960|NCT04247542|463565525|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
128800961|NCT04247542|463565523|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
128800962|NCT04247542|463565524|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
128800963|NCT04247542|463565525|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
128800964|NCT04118452|463565526|FG000|Overall Study|Lost to Follow-up|5|||
128800965|NCT04118452|463565527|FG001|Overall Study|Lost to Follow-up|5|||
128800966|NCT04118452|463565526|FG000|Overall Study|Withdrawal by Subject|17|||
128800967|NCT04118452|463565527|FG001|Overall Study|Withdrawal by Subject|17|||
128800968|NCT05288283|463565528|FG000|Overall Study|Study Terminated Early|1|||
128800969|NCT05288283|463565529|FG001|Overall Study|Study Terminated Early|1|||
128800970|NCT05086744|463565530|FG000|Part A|Adverse Event|0|||
128800971|NCT05086744|463565531|FG001|Part A|Adverse Event|1|||
128800972|NCT05086744|463565530|FG000|Part A|Lack of Efficacy|3|||
128800973|NCT05086744|463565531|FG001|Part A|Lack of Efficacy|0|||
128800974|NCT05086744|463565530|FG000|Part A|Protocol deviation|1|||
128800975|NCT05086744|463565531|FG001|Part A|Protocol deviation|0|||
128800976|NCT05086744|463565530|FG000|Part A|Subject decision|1|||
128800977|NCT05086744|463565531|FG001|Part A|Subject decision|0|||
128800978|NCT05086744|463565530|FG000|Part B|Adverse Event|0|||
128800979|NCT05086744|463565531|FG001|Part B|Adverse Event|1|||
128800980|NCT05086744|463565530|FG000|Part B|Lack of Efficacy|0|||
128800981|NCT05086744|463565531|FG001|Part B|Lack of Efficacy|1|||
128800982|NCT05086744|463565530|FG000|Part B|Study terminated by sponsor|1|||
128800983|NCT05086744|463565531|FG001|Part B|Study terminated by sponsor|6|||
128800984|NCT01704079|463565532|FG000|Overall Study|Withdrawal by Subject|5|||
128800985|NCT01704079|463565533|FG001|Overall Study|Withdrawal by Subject|7|||
128800986|NCT01704079|463565532|FG000|Overall Study|Lost to Follow-up|2|||
128800987|NCT01704079|463565533|FG001|Overall Study|Lost to Follow-up|5|||
128800988|NCT01704079|463565532|FG000|Overall Study|Adverse Event|4|||
128800989|NCT01704079|463565533|FG001|Overall Study|Adverse Event|7|||
128800990|NCT01704079|463565532|FG000|Overall Study|Protocol Violation|1|||
128800991|NCT01704079|463565533|FG001|Overall Study|Protocol Violation|0|||
128800992|NCT01704079|463565532|FG000|Overall Study|Subject noncompliance|2|||
128800993|NCT01704079|463565533|FG001|Overall Study|Subject noncompliance|3|||
128800994|NCT01704079|463565532|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
128800995|NCT01704079|463565533|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
128800996|NCT04300231|463565534|FG000|Overall Study|Protocol Violation|4|||
128800997|NCT04300231|463565535|FG001|Overall Study|Protocol Violation|3|||
128800998|NCT04300231|463565536|FG002|Overall Study|Protocol Violation|0|||
128800999|NCT04300231|463565537|FG003|Overall Study|Protocol Violation|2|||
128801000|NCT05986565|463565543|FG000|Overall Study|Lost to Follow-up|8|||
128801001|NCT05986565|463565544|FG001|Overall Study|Lost to Follow-up|3|||
128801002|NCT05986565|463565543|FG000|Overall Study|Withdrawal by Subject|0|||
128801003|NCT05986565|463565544|FG001|Overall Study|Withdrawal by Subject|1|||
128801004|NCT02991807|463565547|FG000|Overall Study|Withdrawal by Subject|2|||
128801005|NCT02991807|463565548|FG001|Overall Study|Withdrawal by Subject|1|||
128801006|NCT02991807|463565547|FG000|Overall Study|Physician Decision|0|||
128801007|NCT02991807|463565548|FG001|Overall Study|Physician Decision|1|||
128801008|NCT02991807|463565547|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
128801009|NCT02991807|463565548|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
128801010|NCT00792636|463565550|FG000|Overall Study|Protocol Violation|17|||
128801011|NCT00792636|463565551|FG001|Overall Study|Protocol Violation|23|||
128801012|NCT00792636|463565552|FG002|Overall Study|Protocol Violation|20|||
128801013|NCT00792636|463565550|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
128801014|NCT00792636|463565551|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
128801015|NCT00792636|463565552|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
128801016|NCT00792636|463565550|FG000|Overall Study|Lost to Follow-up|13|||
128801017|NCT00792636|463565551|FG001|Overall Study|Lost to Follow-up|19|||
128801018|NCT00792636|463565552|FG002|Overall Study|Lost to Follow-up|14|||
128801019|NCT00792636|463565550|FG000|Overall Study|Withdrew Consent|10|||
128801020|NCT00792636|463565551|FG001|Overall Study|Withdrew Consent|13|||
128801021|NCT00792636|463565552|FG002|Overall Study|Withdrew Consent|9|||
128801022|NCT00792636|463565550|FG000|Overall Study|Lack of Efficacy|3|||
128801023|NCT00792636|463565551|FG001|Overall Study|Lack of Efficacy|4|||
128801024|NCT00792636|463565552|FG002|Overall Study|Lack of Efficacy|13|||
128801025|NCT00792636|463565550|FG000|Overall Study|Adverse Event|4|||
128801026|NCT00792636|463565551|FG001|Overall Study|Adverse Event|2|||
128801027|NCT00792636|463565552|FG002|Overall Study|Adverse Event|3|||
128801028|NCT00792636|463565550|FG000|Overall Study|Investigator Discretion|2|||
128801029|NCT00792636|463565551|FG001|Overall Study|Investigator Discretion|0|||
128801030|NCT00792636|463565552|FG002|Overall Study|Investigator Discretion|2|||
128801031|NCT04579250|463565553|FG000|Overall Study|Withdrawal by Subject|1|||
128801032|NCT04579250|463565554|FG001|Overall Study|Withdrawal by Subject|1|||
128801033|NCT04579250|463565555|FG002|Overall Study|Withdrawal by Subject|0|||
128801034|NCT04579250|463565553|FG000|Overall Study|Lost to Follow-up|1|||
128801035|NCT04579250|463565554|FG001|Overall Study|Lost to Follow-up|1|||
128801036|NCT04579250|463565555|FG002|Overall Study|Lost to Follow-up|0|||
128801037|NCT04579250|463565553|FG000|Overall Study|Moved from area|0|||
128801038|NCT04579250|463565554|FG001|Overall Study|Moved from area|1|||
128801039|NCT04579250|463565555|FG002|Overall Study|Moved from area|2|||
128801040|NCT02058108|463565556|FG000|Overall Study|Abnormal Laboratory Values|0|||
128801041|NCT02058108|463565557|FG001|Overall Study|Abnormal Laboratory Values|1|||
128801042|NCT02058108|463565556|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
128801043|NCT02058108|463565557|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
128801044|NCT02058108|463565556|FG000|Overall Study|No longer requires study drug|0|||
128801045|NCT02058108|463565557|FG001|Overall Study|No longer requires study drug|1|||
128801046|NCT02058108|463565556|FG000|Overall Study|Withdrawal by Subject|1|||
128801047|NCT02058108|463565557|FG001|Overall Study|Withdrawal by Subject|0|||
128801048|NCT02058108|463565556|FG000|Overall Study|Administrative problems|3|||
128801049|NCT02058108|463565557|FG001|Overall Study|Administrative problems|3|||
128801050|NCT02058108|463565556|FG000|Overall Study|Protocol Violation|0|||
128801051|NCT02058108|463565557|FG001|Overall Study|Protocol Violation|1|||
128801052|NCT04759833|463565561|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
128801053|NCT04759833|463565562|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
128801054|NCT04759833|463565563|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
128801055|NCT04759833|463565564|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
128801056|NCT04759833|463565565|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
128801057|NCT04759833|463565561|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
128801058|NCT04759833|463565562|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
128801059|NCT04759833|463565563|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
128801060|NCT04759833|463565564|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
128801061|NCT04759833|463565565|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
128801062|NCT04759833|463565561|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
128801063|NCT04759833|463565562|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
128801064|NCT04759833|463565563|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
128801065|NCT04759833|463565564|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
128801066|NCT04759833|463565565|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
128801067|NCT04759833|463565561|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
128801068|NCT04759833|463565562|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
128801069|NCT04759833|463565563|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
128801070|NCT04759833|463565564|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
128801071|NCT04759833|463565565|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
128801072|NCT04759833|463565561|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
128801073|NCT04759833|463565562|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
128801074|NCT04759833|463565563|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
128801075|NCT04759833|463565564|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
128801076|NCT04759833|463565565|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
128801077|NCT04759833|463565561|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
128801078|NCT04759833|463565562|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
128801079|NCT04759833|463565563|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
128801080|NCT04759833|463565564|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
128801081|NCT04759833|463565565|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
128801082|NCT04759833|463565561|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
128801083|NCT04759833|463565562|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
128801084|NCT04759833|463565563|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
128801085|NCT04759833|463565564|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
128801086|NCT04759833|463565565|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
128801087|NCT04759833|463565561|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
128801088|NCT04759833|463565562|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
128801089|NCT04759833|463565563|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
128801090|NCT04759833|463565564|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
128801091|NCT04759833|463565565|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
128801092|NCT04759833|463565561|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
128801093|NCT04759833|463565562|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
128801094|NCT04759833|463565563|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
128801095|NCT04759833|463565564|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
128801096|NCT04759833|463565565|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
128801097|NCT04759833|463565561|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
128801098|NCT04759833|463565562|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
128801099|NCT04759833|463565563|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
128801100|NCT04759833|463565564|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
128801101|NCT04759833|463565565|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
128801102|NCT04759833|463565561|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
128801103|NCT04759833|463565562|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
128801104|NCT04759833|463565563|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
128801105|NCT04759833|463565564|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
128801106|NCT04759833|463565565|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
128801107|NCT04759833|463565561|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
128801108|NCT04759833|463565562|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
128801109|NCT04759833|463565563|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
128801110|NCT04759833|463565564|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
128801111|NCT04759833|463565565|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
128801112|NCT04759833|463565561|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
128801113|NCT04759833|463565562|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
128801114|NCT04759833|463565563|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
128801115|NCT04759833|463565564|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
128801116|NCT04759833|463565565|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
128801117|NCT04711135|463565566|FG000|Overall Study|Physician Decision|0|||
128801118|NCT04711135|463565567|FG001|Overall Study|Physician Decision|1|||
128801119|NCT04711135|463565566|FG000|Overall Study|Ongoing treatment|0|||
128801120|NCT04711135|463565567|FG001|Overall Study|Ongoing treatment|1|||
128801121|NCT00998881|463565570|FG000|Overall Study|Adverse Event|2|||
128801122|NCT00998881|463565571|FG001|Overall Study|Adverse Event|2|||
128801123|NCT00998881|463565570|FG000|Overall Study|Lack of Efficacy|1|||
128801124|NCT00998881|463565571|FG001|Overall Study|Lack of Efficacy|0|||
128801125|NCT00998881|463565570|FG000|Overall Study|Physician Decision|3|||
128801126|NCT00998881|463565571|FG001|Overall Study|Physician Decision|0|||
128801127|NCT00998881|463565570|FG000|Overall Study|Withdrawal by Subject|1|||
128801128|NCT00998881|463565571|FG001|Overall Study|Withdrawal by Subject|0|||
128801129|NCT00998881|463565570|FG000|Overall Study|Personal matter|1|||
128801130|NCT00998881|463565571|FG001|Overall Study|Personal matter|0|||
128801131|NCT00818246|463565572|FG000|Overall Study|Impossible to match pictures|5|||
128801132|NCT01121991|463565573|FG000|Overall Study|Lack of Ovarian Response|2|||
128801133|NCT01121991|463565573|FG000|Overall Study|No Oocytes Retrieved|3|||
128801134|NCT01121991|463565573|FG000|Overall Study|No Fertilization|1|||
128801135|NCT00409838|463565574|FG000|Short-term Period|Adverse Event|0|||
128801136|NCT00409838|463565575|FG001|Short-term Period|Adverse Event|1|||
128801137|NCT00409838|463565574|FG000|Short-term Period|Lost to Follow-up|0|||
128801138|NCT00409838|463565575|FG001|Short-term Period|Lost to Follow-up|1|||
128801139|NCT00409838|463565574|FG000|Short-term Period|Withdrawal by Subject|2|||
128801140|NCT00409838|463565575|FG001|Short-term Period|Withdrawal by Subject|3|||
128801141|NCT00409838|463565574|FG000|Short-term Period|Never Treated|1|||
128801142|NCT00409838|463565575|FG001|Short-term Period|Never Treated|0|||
128801143|NCT00409838|463565574|FG000|Long-term Extension Period|Adverse Event|10|||
128801144|NCT00409838|463565575|FG001|Long-term Extension Period|Adverse Event|0|||
128801145|NCT00409838|463565574|FG000|Long-term Extension Period|Death|1|||
128801146|NCT00409838|463565575|FG001|Long-term Extension Period|Death|0|||
128801147|NCT00409838|463565574|FG000|Long-term Extension Period|Lack of Efficacy|2|||
128801148|NCT00409838|463565575|FG001|Long-term Extension Period|Lack of Efficacy|0|||
128801149|NCT00409838|463565574|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
128801150|NCT00409838|463565575|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
128801151|NCT00409838|463565574|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
128801152|NCT00409838|463565575|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
128801153|NCT00409838|463565574|FG000|Long-term Extension Period|Pregnancy|1|||
128801154|NCT00409838|463565575|FG001|Long-term Extension Period|Pregnancy|0|||
128801155|NCT01619410|463565576|FG000|Overall Study|Lost to Follow-up|7|||
128801156|NCT01619410|463565577|FG001|Overall Study|Lost to Follow-up|4|||
128801157|NCT01250769|463565579|FG000|Overall Study|Withdrawal by Subject|0|||
128801158|NCT01250769|463565580|FG001|Overall Study|Withdrawal by Subject|1|||
128801159|NCT01250769|463565581|FG002|Overall Study|Withdrawal by Subject|1|||
128801160|NCT01250769|463565582|FG003|Overall Study|Withdrawal by Subject|0|||
128801161|NCT01250769|463565579|FG000|Overall Study|Adverse Event|0|||
128801162|NCT01250769|463565580|FG001|Overall Study|Adverse Event|0|||
128801163|NCT01250769|463565581|FG002|Overall Study|Adverse Event|1|||
128801164|NCT01250769|463565582|FG003|Overall Study|Adverse Event|0|||
128801165|NCT02538341|463565586|FG000|Overall Study|Lost to Follow-up|51|||
128801166|NCT02538341|463565587|FG001|Overall Study|Lost to Follow-up|46|||
128801167|NCT02538341|463565586|FG000|Overall Study|Withdrawal by Subject|3|||
128801168|NCT02538341|463565587|FG001|Overall Study|Withdrawal by Subject|1|||
128801169|NCT02538341|463565586|FG000|Overall Study|Death|2|||
128801170|NCT02538341|463565587|FG001|Overall Study|Death|0|||
128801171|NCT03432858|463565590|FG000|Overall Study|Protocol Violation|2|||
128801172|NCT03432858|463565591|FG001|Overall Study|Protocol Violation|1|||
128801173|NCT03432858|463565592|FG002|Overall Study|Protocol Violation|9|||
128801174|NCT03432858|463565590|FG000|Overall Study|Withdrawal by Subject|0|||
128801175|NCT03432858|463565591|FG001|Overall Study|Withdrawal by Subject|1|||
128801176|NCT03432858|463565592|FG002|Overall Study|Withdrawal by Subject|1|||
128801177|NCT03432858|463565590|FG000|Overall Study|Procedure canceled/rescheduled|0|||
128801178|NCT03432858|463565591|FG001|Overall Study|Procedure canceled/rescheduled|9|||
128801179|NCT03432858|463565592|FG002|Overall Study|Procedure canceled/rescheduled|6|||
128801180|NCT03432858|463565590|FG000|Overall Study|Required postop mobilization with splinting|0|||
128801181|NCT03432858|463565591|FG001|Overall Study|Required postop mobilization with splinting|0|||
128801182|NCT03432858|463565592|FG002|Overall Study|Required postop mobilization with splinting|1|||
128801183|NCT04402294|463565593|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
128801184|NCT04402294|463565594|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
128801185|NCT04402294|463565593|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
128801186|NCT04402294|463565594|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
128801187|NCT01216176|463568320|FG000|Overall Study|Adverse Event|0|||
128801188|NCT01216176|463568321|FG001|Overall Study|Adverse Event|8|||
128801189|NCT01216176|463568322|FG002|Overall Study|Adverse Event|0|||
128801190|NCT01216176|463568320|FG000|Overall Study|Physician Decision|0|||
128801191|NCT01216176|463568321|FG001|Overall Study|Physician Decision|0|||
128801192|NCT01216176|463568322|FG002|Overall Study|Physician Decision|1|||
128801193|NCT03481660|463568325|FG000|Overall Study|Adverse Event|5|||
128801194|NCT03481660|463568326|FG001|Overall Study|Adverse Event|4|||
128801195|NCT03481660|463568325|FG000|Overall Study|Death|13|||
128801196|NCT03481660|463568326|FG001|Overall Study|Death|9|||
128801197|NCT03481660|463568325|FG000|Overall Study|Lost to Follow-up|2|||
128801198|NCT03481660|463568326|FG001|Overall Study|Lost to Follow-up|2|||
128801199|NCT03481660|463568325|FG000|Overall Study|Physician Decision|2|||
128801200|NCT03481660|463568326|FG001|Overall Study|Physician Decision|3|||
128801201|NCT03481660|463568325|FG000|Overall Study|Withdrawal by Subject|14|||
128801202|NCT03481660|463568326|FG001|Overall Study|Withdrawal by Subject|7|||
128801203|NCT03398148|463568327|FG000|Substudy 1 Period 1|Adverse Event|5|||
128801204|NCT03398148|463568328|FG001|Substudy 1 Period 1|Adverse Event|2|||
128801205|NCT03398148|463568329|FG002|Substudy 1 Period 1|Adverse Event|2|||
128801206|NCT03398148|463568330|FG003|Substudy 1 Period 1|Adverse Event|0|||
128801207|NCT03398148|463568331|FG004|Substudy 1 Period 1|Adverse Event|8|||
128801208|NCT03398148|463568332|FG005|Substudy 1 Period 1|Adverse Event|0|||
128801209|NCT03398148|463568333|FG006|Substudy 1 Period 1|Adverse Event|0|||
128801210|NCT03398148|463568334|FG007|Substudy 1 Period 1|Adverse Event|0|||
128801211|NCT03398148|463568335|FG008|Substudy 1 Period 1|Adverse Event|0|||
128801212|NCT03398148|463568336|FG009|Substudy 1 Period 1|Adverse Event|0|||
128801213|NCT03398148|463568337|FG010|Substudy 1 Period 1|Adverse Event|0|||
128801214|NCT03398148|463568338|FG011|Substudy 1 Period 1|Adverse Event|0|||
128801215|NCT03398148|463568339|FG012|Substudy 1 Period 1|Adverse Event|0|||
128801216|NCT03398148|463568340|FG013|Substudy 1 Period 1|Adverse Event|0|||
128801217|NCT03398148|463568341|FG014|Substudy 1 Period 1|Adverse Event|0|||
128801218|NCT03398148|463568327|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
128801219|NCT03398148|463568328|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
128801220|NCT03398148|463568329|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801221|NCT03398148|463568330|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
128801222|NCT03398148|463568331|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
128801223|NCT03398148|463568332|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801224|NCT03398148|463568333|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801225|NCT03398148|463568334|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801226|NCT03398148|463568335|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801227|NCT03398148|463568336|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801228|NCT03398148|463568337|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801229|NCT03398148|463568338|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801230|NCT03398148|463568339|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801231|NCT03398148|463568340|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801232|NCT03398148|463568341|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
128801233|NCT03398148|463568327|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
128801234|NCT03398148|463568328|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
128801235|NCT03398148|463568329|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
128801236|NCT03398148|463568330|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
128801237|NCT03398148|463568331|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
128801238|NCT03398148|463568332|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
128801239|NCT03398148|463568333|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
128801240|NCT03398148|463568334|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
128801241|NCT03398148|463568335|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
128801242|NCT03398148|463568336|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
128801243|NCT03398148|463568337|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
128801244|NCT03398148|463568338|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
128801245|NCT03398148|463568339|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
128801246|NCT03398148|463568340|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
128801247|NCT03398148|463568341|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
128801248|NCT03398148|463568327|FG000|Substudy 1 Period 1|Other|0|||
128801249|NCT03398148|463568328|FG001|Substudy 1 Period 1|Other|1|||
128801250|NCT03398148|463568329|FG002|Substudy 1 Period 1|Other|0|||
128801251|NCT03398148|463568330|FG003|Substudy 1 Period 1|Other|0|||
128801252|NCT03398148|463568331|FG004|Substudy 1 Period 1|Other|3|||
128801253|NCT03398148|463568332|FG005|Substudy 1 Period 1|Other|0|||
128801254|NCT03398148|463568333|FG006|Substudy 1 Period 1|Other|0|||
128801255|NCT03398148|463568334|FG007|Substudy 1 Period 1|Other|0|||
128801256|NCT03398148|463568335|FG008|Substudy 1 Period 1|Other|0|||
128801257|NCT03398148|463568336|FG009|Substudy 1 Period 1|Other|0|||
128801258|NCT03398148|463568337|FG010|Substudy 1 Period 1|Other|0|||
128801259|NCT03398148|463568338|FG011|Substudy 1 Period 1|Other|0|||
128801260|NCT03398148|463568339|FG012|Substudy 1 Period 1|Other|0|||
128801261|NCT03398148|463568340|FG013|Substudy 1 Period 1|Other|0|||
128801262|NCT03398148|463568341|FG014|Substudy 1 Period 1|Other|0|||
128801263|NCT03398148|463568327|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801264|NCT03398148|463568328|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801265|NCT03398148|463568329|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801266|NCT03398148|463568330|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801267|NCT03398148|463568331|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
128801268|NCT03398148|463568332|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801269|NCT03398148|463568333|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801270|NCT03398148|463568334|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801271|NCT03398148|463568335|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801272|NCT03398148|463568336|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801273|NCT03398148|463568337|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801274|NCT03398148|463568338|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801275|NCT03398148|463568339|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801276|NCT03398148|463568340|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801277|NCT03398148|463568341|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
128801278|NCT03398148|463568327|FG000|Substudy 1 Period 2|Adverse Event|0|||
128801279|NCT03398148|463568328|FG001|Substudy 1 Period 2|Adverse Event|0|||
128801280|NCT03398148|463568329|FG002|Substudy 1 Period 2|Adverse Event|0|||
128801281|NCT03398148|463568330|FG003|Substudy 1 Period 2|Adverse Event|0|||
128801282|NCT03398148|463568331|FG004|Substudy 1 Period 2|Adverse Event|0|||
128801283|NCT03398148|463568332|FG005|Substudy 1 Period 2|Adverse Event|2|||
128801284|NCT03398148|463568333|FG006|Substudy 1 Period 2|Adverse Event|4|||
128801285|NCT03398148|463568334|FG007|Substudy 1 Period 2|Adverse Event|0|||
128801286|NCT03398148|463568335|FG008|Substudy 1 Period 2|Adverse Event|0|||
128801287|NCT03398148|463568336|FG009|Substudy 1 Period 2|Adverse Event|0|||
128801288|NCT03398148|463568337|FG010|Substudy 1 Period 2|Adverse Event|0|||
128801289|NCT03398148|463568338|FG011|Substudy 1 Period 2|Adverse Event|0|||
128801290|NCT03398148|463568339|FG012|Substudy 1 Period 2|Adverse Event|0|||
128801291|NCT03398148|463568340|FG013|Substudy 1 Period 2|Adverse Event|0|||
128801292|NCT03398148|463568341|FG014|Substudy 1 Period 2|Adverse Event|0|||
128801293|NCT03398148|463568327|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801294|NCT03398148|463568328|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801295|NCT03398148|463568329|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801296|NCT03398148|463568330|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801297|NCT03398148|463568331|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801298|NCT03398148|463568332|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801299|NCT03398148|463568333|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
128801300|NCT03398148|463568334|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
128801301|NCT03398148|463568335|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801302|NCT03398148|463568336|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801303|NCT03398148|463568337|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801304|NCT03398148|463568338|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801305|NCT03398148|463568339|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801306|NCT03398148|463568340|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801307|NCT03398148|463568341|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
128801308|NCT03398148|463568327|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
128801309|NCT03398148|463568328|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
128801310|NCT03398148|463568329|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
128801311|NCT03398148|463568330|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
128801312|NCT03398148|463568331|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
128801313|NCT03398148|463568332|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
128801314|NCT03398148|463568333|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
128801315|NCT03398148|463568334|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
128801316|NCT03398148|463568335|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
128801317|NCT03398148|463568336|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
128801318|NCT03398148|463568337|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
128801319|NCT03398148|463568338|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
128801320|NCT03398148|463568339|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
128801321|NCT03398148|463568340|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
128801322|NCT03398148|463568341|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
128801323|NCT03398148|463568327|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801324|NCT03398148|463568328|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801325|NCT03398148|463568329|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801326|NCT03398148|463568330|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801327|NCT03398148|463568331|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801328|NCT03398148|463568332|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801329|NCT03398148|463568333|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
128801330|NCT03398148|463568334|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801331|NCT03398148|463568335|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801332|NCT03398148|463568336|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801333|NCT03398148|463568337|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801334|NCT03398148|463568338|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801335|NCT03398148|463568339|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129204631|NCT05148234|465045842|FG007|Phase I|Company closed the trial.|0|||
128801336|NCT03398148|463568340|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801337|NCT03398148|463568341|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801338|NCT03398148|463568327|FG000|Substudy 1 Period 2|Other|0|||
128801339|NCT03398148|463568328|FG001|Substudy 1 Period 2|Other|0|||
128801340|NCT03398148|463568329|FG002|Substudy 1 Period 2|Other|0|||
128801341|NCT03398148|463568330|FG003|Substudy 1 Period 2|Other|0|||
128801342|NCT03398148|463568331|FG004|Substudy 1 Period 2|Other|0|||
128801343|NCT03398148|463568332|FG005|Substudy 1 Period 2|Other|0|||
128801344|NCT03398148|463568333|FG006|Substudy 1 Period 2|Other|1|||
128801345|NCT03398148|463568334|FG007|Substudy 1 Period 2|Other|0|||
128801346|NCT03398148|463568335|FG008|Substudy 1 Period 2|Other|0|||
128801347|NCT03398148|463568336|FG009|Substudy 1 Period 2|Other|0|||
128801348|NCT03398148|463568337|FG010|Substudy 1 Period 2|Other|0|||
128801349|NCT03398148|463568338|FG011|Substudy 1 Period 2|Other|0|||
128801350|NCT03398148|463568339|FG012|Substudy 1 Period 2|Other|0|||
128801351|NCT03398148|463568340|FG013|Substudy 1 Period 2|Other|0|||
128801352|NCT03398148|463568341|FG014|Substudy 1 Period 2|Other|0|||
128801353|NCT03398148|463568327|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801354|NCT03398148|463568328|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801355|NCT03398148|463568329|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801356|NCT03398148|463568330|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801357|NCT03398148|463568331|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801358|NCT03398148|463568332|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801359|NCT03398148|463568333|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
128801360|NCT03398148|463568334|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801361|NCT03398148|463568335|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801362|NCT03398148|463568336|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801363|NCT03398148|463568337|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801364|NCT03398148|463568338|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801365|NCT03398148|463568339|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801366|NCT03398148|463568340|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801367|NCT03398148|463568341|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
128801368|NCT03398148|463568327|FG000|Substudy 2 Period 1|Adverse Event|0|||
128801369|NCT03398148|463568328|FG001|Substudy 2 Period 1|Adverse Event|0|||
128801370|NCT03398148|463568329|FG002|Substudy 2 Period 1|Adverse Event|0|||
128801371|NCT03398148|463568330|FG003|Substudy 2 Period 1|Adverse Event|0|||
128801372|NCT03398148|463568331|FG004|Substudy 2 Period 1|Adverse Event|0|||
128801373|NCT03398148|463568332|FG005|Substudy 2 Period 1|Adverse Event|0|||
128801374|NCT03398148|463568333|FG006|Substudy 2 Period 1|Adverse Event|0|||
128801375|NCT03398148|463568334|FG007|Substudy 2 Period 1|Adverse Event|0|||
128801376|NCT03398148|463568335|FG008|Substudy 2 Period 1|Adverse Event|0|||
128801377|NCT03398148|463568336|FG009|Substudy 2 Period 1|Adverse Event|12|||
128801378|NCT03398148|463568337|FG010|Substudy 2 Period 1|Adverse Event|2|||
128801379|NCT03398148|463568338|FG011|Substudy 2 Period 1|Adverse Event|0|||
128801380|NCT03398148|463568339|FG012|Substudy 2 Period 1|Adverse Event|0|||
128801381|NCT03398148|463568340|FG013|Substudy 2 Period 1|Adverse Event|0|||
128801382|NCT03398148|463568341|FG014|Substudy 2 Period 1|Adverse Event|0|||
128801383|NCT03398148|463568327|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801384|NCT03398148|463568328|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801385|NCT03398148|463568329|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801386|NCT03398148|463568330|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801387|NCT03398148|463568331|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801388|NCT03398148|463568332|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801389|NCT03398148|463568333|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801390|NCT03398148|463568334|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801391|NCT03398148|463568335|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801392|NCT03398148|463568336|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
128801393|NCT03398148|463568337|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
128801394|NCT03398148|463568338|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801395|NCT03398148|463568339|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801396|NCT03398148|463568340|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801397|NCT03398148|463568341|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
128801398|NCT03398148|463568327|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
128801399|NCT03398148|463568328|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
128801400|NCT03398148|463568329|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
128801401|NCT03398148|463568330|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
128801402|NCT03398148|463568331|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
128801403|NCT03398148|463568332|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
128801404|NCT03398148|463568333|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
128801405|NCT03398148|463568334|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
128801406|NCT03398148|463568335|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
128801407|NCT03398148|463568336|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
128801408|NCT03398148|463568337|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
128801409|NCT03398148|463568338|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
128801410|NCT03398148|463568339|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
128801411|NCT03398148|463568340|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
128801412|NCT03398148|463568341|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
128801413|NCT03398148|463568327|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801414|NCT03398148|463568328|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801415|NCT03398148|463568329|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801416|NCT03398148|463568330|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801417|NCT03398148|463568331|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801418|NCT03398148|463568332|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801419|NCT03398148|463568333|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801420|NCT03398148|463568334|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801421|NCT03398148|463568335|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801422|NCT03398148|463568336|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801423|NCT03398148|463568337|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
128801424|NCT03398148|463568338|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801425|NCT03398148|463568339|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801426|NCT03398148|463568340|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801427|NCT03398148|463568341|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
128801428|NCT03398148|463568327|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801429|NCT03398148|463568328|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801430|NCT03398148|463568329|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801431|NCT03398148|463568330|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801432|NCT03398148|463568331|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801433|NCT03398148|463568332|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801434|NCT03398148|463568333|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801435|NCT03398148|463568334|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801436|NCT03398148|463568335|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801437|NCT03398148|463568336|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801438|NCT03398148|463568337|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
128801439|NCT03398148|463568338|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801440|NCT03398148|463568339|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801441|NCT03398148|463568340|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801442|NCT03398148|463568341|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
128801443|NCT03398148|463568327|FG000|Substudy 2 Period 1|Other|0|||
128801444|NCT03398148|463568328|FG001|Substudy 2 Period 1|Other|0|||
128801445|NCT03398148|463568329|FG002|Substudy 2 Period 1|Other|0|||
128801446|NCT03398148|463568330|FG003|Substudy 2 Period 1|Other|0|||
128801447|NCT03398148|463568331|FG004|Substudy 2 Period 1|Other|0|||
128801448|NCT03398148|463568332|FG005|Substudy 2 Period 1|Other|0|||
128801449|NCT03398148|463568333|FG006|Substudy 2 Period 1|Other|0|||
128801450|NCT03398148|463568334|FG007|Substudy 2 Period 1|Other|0|||
128801451|NCT03398148|463568335|FG008|Substudy 2 Period 1|Other|0|||
128801452|NCT03398148|463568336|FG009|Substudy 2 Period 1|Other|4|||
128801453|NCT03398148|463568337|FG010|Substudy 2 Period 1|Other|4|||
128801454|NCT03398148|463568338|FG011|Substudy 2 Period 1|Other|0|||
128801455|NCT03398148|463568339|FG012|Substudy 2 Period 1|Other|0|||
128801456|NCT03398148|463568340|FG013|Substudy 2 Period 1|Other|0|||
128801457|NCT03398148|463568341|FG014|Substudy 2 Period 1|Other|0|||
128801458|NCT03398148|463568327|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801459|NCT03398148|463568328|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801460|NCT03398148|463568329|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801461|NCT03398148|463568330|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801462|NCT03398148|463568331|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801463|NCT03398148|463568332|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801464|NCT03398148|463568333|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801465|NCT03398148|463568334|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801466|NCT03398148|463568335|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801467|NCT03398148|463568336|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801468|NCT03398148|463568337|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
128801469|NCT03398148|463568338|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801470|NCT03398148|463568339|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801471|NCT03398148|463568340|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801472|NCT03398148|463568341|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
128801473|NCT03398148|463568327|FG000|Substudy 2 Period 2|Adverse Event|0|||
128801474|NCT03398148|463568328|FG001|Substudy 2 Period 2|Adverse Event|0|||
128801475|NCT03398148|463568329|FG002|Substudy 2 Period 2|Adverse Event|0|||
128801476|NCT03398148|463568330|FG003|Substudy 2 Period 2|Adverse Event|0|||
128801477|NCT03398148|463568331|FG004|Substudy 2 Period 2|Adverse Event|0|||
128801478|NCT03398148|463568332|FG005|Substudy 2 Period 2|Adverse Event|0|||
128801479|NCT03398148|463568333|FG006|Substudy 2 Period 2|Adverse Event|0|||
128801480|NCT03398148|463568334|FG007|Substudy 2 Period 2|Adverse Event|0|||
128801481|NCT03398148|463568335|FG008|Substudy 2 Period 2|Adverse Event|0|||
128801482|NCT03398148|463568336|FG009|Substudy 2 Period 2|Adverse Event|0|||
128801483|NCT03398148|463568337|FG010|Substudy 2 Period 2|Adverse Event|0|||
128801484|NCT03398148|463568338|FG011|Substudy 2 Period 2|Adverse Event|0|||
128801485|NCT03398148|463568339|FG012|Substudy 2 Period 2|Adverse Event|0|||
128801486|NCT03398148|463568340|FG013|Substudy 2 Period 2|Adverse Event|1|||
128801487|NCT03398148|463568341|FG014|Substudy 2 Period 2|Adverse Event|3|||
128801488|NCT03398148|463568327|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
128801489|NCT03398148|463568328|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
128801490|NCT03398148|463568329|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
128801491|NCT03398148|463568330|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
128801492|NCT03398148|463568331|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
128801493|NCT03398148|463568332|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
128801494|NCT03398148|463568333|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
128801495|NCT03398148|463568334|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
128801496|NCT03398148|463568335|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
128801497|NCT03398148|463568336|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
128801498|NCT03398148|463568337|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
128801499|NCT03398148|463568338|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
128801500|NCT03398148|463568339|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
128801501|NCT03398148|463568340|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
128801502|NCT03398148|463568341|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
128801503|NCT03398148|463568327|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801504|NCT03398148|463568328|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801505|NCT03398148|463568329|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801506|NCT03398148|463568330|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801507|NCT03398148|463568331|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801508|NCT03398148|463568332|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801509|NCT03398148|463568333|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801510|NCT03398148|463568334|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801511|NCT03398148|463568335|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801512|NCT03398148|463568336|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801513|NCT03398148|463568337|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801514|NCT03398148|463568338|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
128801515|NCT03398148|463568339|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
128801516|NCT03398148|463568340|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
128801517|NCT03398148|463568341|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
128801518|NCT03398148|463568327|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
128801519|NCT03398148|463568328|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
128801520|NCT03398148|463568329|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
128801521|NCT03398148|463568330|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
128801522|NCT03398148|463568331|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
128801523|NCT03398148|463568332|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
128801524|NCT03398148|463568333|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
128801525|NCT03398148|463568334|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
128801526|NCT03398148|463568335|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
128801527|NCT03398148|463568336|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
128801528|NCT03398148|463568337|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
128801529|NCT03398148|463568338|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
128801530|NCT03398148|463568339|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
128801531|NCT03398148|463568340|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
128801532|NCT03398148|463568341|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
128801533|NCT03398148|463568327|FG000|Substudy 2 Period 2|Other|0|||
128801534|NCT03398148|463568328|FG001|Substudy 2 Period 2|Other|0|||
128801535|NCT03398148|463568329|FG002|Substudy 2 Period 2|Other|0|||
128801536|NCT03398148|463568330|FG003|Substudy 2 Period 2|Other|0|||
128801537|NCT03398148|463568331|FG004|Substudy 2 Period 2|Other|0|||
128801538|NCT03398148|463568332|FG005|Substudy 2 Period 2|Other|0|||
128801539|NCT03398148|463568333|FG006|Substudy 2 Period 2|Other|0|||
128801540|NCT03398148|463568334|FG007|Substudy 2 Period 2|Other|0|||
128801541|NCT03398148|463568335|FG008|Substudy 2 Period 2|Other|0|||
128801542|NCT03398148|463568336|FG009|Substudy 2 Period 2|Other|0|||
128801543|NCT03398148|463568337|FG010|Substudy 2 Period 2|Other|0|||
128801544|NCT03398148|463568338|FG011|Substudy 2 Period 2|Other|0|||
128801545|NCT03398148|463568339|FG012|Substudy 2 Period 2|Other|0|||
128801546|NCT03398148|463568340|FG013|Substudy 2 Period 2|Other|1|||
128801547|NCT03398148|463568341|FG014|Substudy 2 Period 2|Other|1|||
128801548|NCT03398148|463568327|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801549|NCT03398148|463568328|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801550|NCT03398148|463568329|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801551|NCT03398148|463568330|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801552|NCT03398148|463568331|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801553|NCT03398148|463568332|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801554|NCT03398148|463568333|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801555|NCT03398148|463568334|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801556|NCT03398148|463568335|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801557|NCT03398148|463568336|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801558|NCT03398148|463568337|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801559|NCT03398148|463568338|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801560|NCT03398148|463568339|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
128801561|NCT03398148|463568340|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
128801562|NCT03398148|463568341|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
128801563|NCT00212355|463568342|FG000|Overall Study|Adverse Event|1|||
128801564|NCT00212355|463568342|FG000|Overall Study|Withdrawal by Subject|1|||
128801565|NCT00212355|463568342|FG000|Overall Study|A change of address|1|||
128801566|NCT04104321|463568346|FG000|Overall Study|didn't take the study drug|3|||
128801567|NCT03481777|463568347|FG000|Overall Study|Withdrawal by Subject|36|||
128801568|NCT03481777|463568348|FG001|Overall Study|Withdrawal by Subject|31|||
128801569|NCT03481777|463568347|FG000|Overall Study|Non stroke = non target population|277|||
128801570|NCT03481777|463568348|FG001|Overall Study|Non stroke = non target population|254|||
128801571|NCT04842500|463568349|FG000|Overall Study|Withdrawal by Subject|4|||
128801572|NCT04842500|463568350|FG001|Overall Study|Withdrawal by Subject|1|||
128801573|NCT04842500|463568351|FG002|Overall Study|Withdrawal by Subject|2|||
128801574|NCT04842500|463568352|FG003|Overall Study|Withdrawal by Subject|3|||
128801575|NCT04842500|463568349|FG000|Overall Study|Protocol Violation|1|||
128801576|NCT04842500|463568350|FG001|Overall Study|Protocol Violation|0|||
128801577|NCT04842500|463568351|FG002|Overall Study|Protocol Violation|0|||
128801578|NCT04842500|463568352|FG003|Overall Study|Protocol Violation|1|||
128801579|NCT05756075|463568355|FG000|Overall Study|Withdrawal by Subject|16|||
128801580|NCT05756075|463568356|FG001|Overall Study|Withdrawal by Subject|9|||
128801581|NCT04065048|463568357|FG000|Overall Study|Withdrawal by Subject|1|||
128801582|NCT04065048|463568358|FG001|Overall Study|Withdrawal by Subject|2|||
128801583|NCT04065048|463568359|FG002|Overall Study|Withdrawal by Subject|1|||
128801584|NCT04065048|463568360|FG003|Overall Study|Withdrawal by Subject|1|||
128801585|NCT04065048|463568357|FG000|Overall Study|Adverse Event|1|||
128801586|NCT04065048|463568358|FG001|Overall Study|Adverse Event|0|||
128801587|NCT04065048|463568359|FG002|Overall Study|Adverse Event|1|||
128801588|NCT04065048|463568360|FG003|Overall Study|Adverse Event|0|||
128801589|NCT05104697|463568362|FG000|Overall Study|Withdrawal by Subject|0|||
128801590|NCT05104697|463568363|FG001|Overall Study|Withdrawal by Subject|1|||
128801591|NCT03845465|463568364|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
128801592|NCT03845465|463568365|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
128801593|NCT03845465|463568364|FG000|6-month Data Collection|Withdrawal by Subject|0|||
128801594|NCT03845465|463568365|FG001|6-month Data Collection|Withdrawal by Subject|2|||
128801595|NCT03845465|463568364|FG000|12-month Data Collection|Withdrawal by Subject|0|||
128801596|NCT03845465|463568365|FG001|12-month Data Collection|Withdrawal by Subject|2|||
128801597|NCT05307978|463568373|FG000|Overall Study|Lost to Follow-up|0|||
128801598|NCT05307978|463568374|FG001|Overall Study|Lost to Follow-up|1|||
128801599|NCT05307978|463568375|FG002|Overall Study|Lost to Follow-up|0|||
128801600|NCT05307978|463568376|FG003|Overall Study|Lost to Follow-up|4|||
128801601|NCT05307978|463568377|FG004|Overall Study|Lost to Follow-up|0|||
128801602|NCT05307978|463568378|FG005|Overall Study|Lost to Follow-up|0|||
128801603|NCT05307978|463568379|FG006|Overall Study|Lost to Follow-up|1|||
128801604|NCT05075408|463568380|FG000|Overall Study|Withdrawal by Subject|5|||
128801605|NCT05075408|463568381|FG001|Overall Study|Withdrawal by Subject|3|||
128801606|NCT05075408|463568382|FG002|Overall Study|Withdrawal by Subject|4|||
128801607|NCT05075408|463568380|FG000|Overall Study|Adverse Event|5|||
128801608|NCT05075408|463568381|FG001|Overall Study|Adverse Event|7|||
128801609|NCT05075408|463568382|FG002|Overall Study|Adverse Event|8|||
128801610|NCT05075408|463568380|FG000|Overall Study|Protocol Violation|0|||
128801611|NCT05075408|463568381|FG001|Overall Study|Protocol Violation|1|||
128801612|NCT05075408|463568382|FG002|Overall Study|Protocol Violation|0|||
128801613|NCT05075408|463568380|FG000|Overall Study|Lost to Follow-up|2|||
128801614|NCT05075408|463568381|FG001|Overall Study|Lost to Follow-up|1|||
128801615|NCT05075408|463568382|FG002|Overall Study|Lost to Follow-up|1|||
128801616|NCT05075408|463568380|FG000|Overall Study|Physician Decision|1|||
128801617|NCT05075408|463568381|FG001|Overall Study|Physician Decision|0|||
128801618|NCT05075408|463568382|FG002|Overall Study|Physician Decision|0|||
128801619|NCT05075408|463568380|FG000|Overall Study|Other-unspecified|3|||
128801620|NCT05075408|463568381|FG001|Overall Study|Other-unspecified|2|||
128801621|NCT05075408|463568382|FG002|Overall Study|Other-unspecified|0|||
128801622|NCT02837510|463568383|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
128801623|NCT02837510|463568384|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
128801624|NCT02837510|463568383|FG000|Washout (2 Weeks)|Adverse Event|0|||
128801625|NCT02837510|463568384|FG001|Washout (2 Weeks)|Adverse Event|1|||
128801626|NCT02837510|463568383|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
128801627|NCT02837510|463568384|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
128801628|NCT02837510|463568383|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
128801629|NCT02837510|463568384|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
128801630|NCT02837510|463568383|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
128801631|NCT02837510|463568384|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
128801632|NCT02837510|463568383|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
128801633|NCT02837510|463568384|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
128801634|NCT05419505|463568385|FG000|Overall Study|Adverse Event|0|||
128801635|NCT05419505|463568386|FG001|Overall Study|Adverse Event|0|||
128801636|NCT05419505|463568387|FG002|Overall Study|Adverse Event|0|||
128801637|NCT05419505|463568388|FG003|Overall Study|Adverse Event|1|||
128801638|NCT05419505|463568389|FG004|Overall Study|Adverse Event|0|||
128801639|NCT05419505|463568390|FG005|Overall Study|Adverse Event|0|||
128801640|NCT05419505|463568391|FG006|Overall Study|Adverse Event|0|||
128801641|NCT05419505|463568392|FG007|Overall Study|Adverse Event|0|||
128801642|NCT05419505|463568385|FG000|Overall Study|Withdrawal by Subject|1|||
128801643|NCT05419505|463568386|FG001|Overall Study|Withdrawal by Subject|2|||
128801644|NCT05419505|463568387|FG002|Overall Study|Withdrawal by Subject|0|||
128801645|NCT05419505|463568388|FG003|Overall Study|Withdrawal by Subject|0|||
128801646|NCT05419505|463568389|FG004|Overall Study|Withdrawal by Subject|0|||
128801647|NCT05419505|463568390|FG005|Overall Study|Withdrawal by Subject|0|||
128801648|NCT05419505|463568391|FG006|Overall Study|Withdrawal by Subject|1|||
128801649|NCT05419505|463568392|FG007|Overall Study|Withdrawal by Subject|0|||
128801650|NCT05419505|463568385|FG000|Overall Study|Lost to Follow-up|2|||
128801651|NCT05419505|463568386|FG001|Overall Study|Lost to Follow-up|1|||
128801652|NCT05419505|463568387|FG002|Overall Study|Lost to Follow-up|0|||
128801653|NCT05419505|463568388|FG003|Overall Study|Lost to Follow-up|0|||
128801654|NCT05419505|463568389|FG004|Overall Study|Lost to Follow-up|1|||
128801655|NCT05419505|463568390|FG005|Overall Study|Lost to Follow-up|2|||
128801656|NCT05419505|463568391|FG006|Overall Study|Lost to Follow-up|0|||
128801657|NCT05419505|463568392|FG007|Overall Study|Lost to Follow-up|1|||
128801658|NCT04440176|463568399|FG000|Overall Study|Withdrawal by Subject|5|||
128801659|NCT04440176|463568400|FG001|Overall Study|Withdrawal by Subject|3|||
128801660|NCT04440176|463568399|FG000|Overall Study|Withdrawal by parent/guardian|4|||
128801661|NCT04440176|463568400|FG001|Overall Study|Withdrawal by parent/guardian|5|||
128801662|NCT04440176|463568399|FG000|Overall Study|Adverse Event|2|||
128801663|NCT04440176|463568400|FG001|Overall Study|Adverse Event|6|||
128801664|NCT04440176|463568399|FG000|Overall Study|Lost to Follow-up|22|||
128801665|NCT04440176|463568400|FG001|Overall Study|Lost to Follow-up|23|||
128801666|NCT04440176|463568399|FG000|Overall Study|Medication error without associated adverse event|0|||
128801667|NCT04440176|463568400|FG001|Overall Study|Medication error without associated adverse event|1|||
128801668|NCT04440176|463568399|FG000|Overall Study|No longer met eligibility criteria|7|||
128801669|NCT04440176|463568400|FG001|Overall Study|No longer met eligibility criteria|1|||
128801670|NCT04440176|463568399|FG000|Overall Study|Other|1|||
128801671|NCT04440176|463568400|FG001|Overall Study|Other|2|||
128801672|NCT04440176|463568399|FG000|Overall Study|Protocol deviation|6|||
128801673|NCT04440176|463568400|FG001|Overall Study|Protocol deviation|8|||
128801674|NCT04440176|463568399|FG000|Overall Study|Randomized but not vaccinated|6|||
128801675|NCT04440176|463568400|FG001|Overall Study|Randomized but not vaccinated|3|||
128801676|NCT04847999|463568405|FG000|Overall Study|Lost to Follow-up|0|||
128801677|NCT04847999|463568406|FG001|Overall Study|Lost to Follow-up|1|||
128801678|NCT02879448|463568407|FG000|Overall Study|Death|251|||
128801679|NCT02879448|463568408|FG001|Overall Study|Death|263|||
128801680|NCT02879448|463568407|FG000|Overall Study|Lost to Follow-up|23|||
128801681|NCT02879448|463568408|FG001|Overall Study|Lost to Follow-up|28|||
128801682|NCT02879448|463568407|FG000|Overall Study|Withdrawal by Subject|42|||
128801683|NCT02879448|463568408|FG001|Overall Study|Withdrawal by Subject|79|||
128801684|NCT02879448|463568407|FG000|Overall Study|Other Reasons|8|||
128801685|NCT02879448|463568408|FG001|Overall Study|Other Reasons|12|||
128801686|NCT05952076|463568409|FG000|Overall Study|Death|1|||
128801687|NCT05952076|463568410|FG001|Overall Study|Death|1|||
128801688|NCT05952076|463568409|FG000|Overall Study|Lost to Follow-up|0|||
128801689|NCT05952076|463568410|FG001|Overall Study|Lost to Follow-up|1|||
128801690|NCT01046136|463568411|FG000|Overall Study|Withdrawal by Subject|0|||
128801691|NCT01046136|463568412|FG001|Overall Study|Withdrawal by Subject|4|||
128801692|NCT01046136|463568411|FG000|Overall Study|Physician Decision|1|||
128801693|NCT01046136|463568412|FG001|Overall Study|Physician Decision|1|||
128801694|NCT01046136|463568411|FG000|Overall Study|Lost to Follow-up|3|||
128801695|NCT01046136|463568412|FG001|Overall Study|Lost to Follow-up|3|||
128801696|NCT00727909|463568413|FG000|Overall Study|Withdrawal by Subject|5|||
128801697|NCT00727909|463568414|FG001|Overall Study|Withdrawal by Subject|11|||
128801698|NCT00727909|463568415|FG002|Overall Study|Withdrawal by Subject|8|||
128801699|NCT00727909|463568416|FG003|Overall Study|Withdrawal by Subject|5|||
128801700|NCT00727909|463568413|FG000|Overall Study|Death|0|||
128801701|NCT00727909|463568414|FG001|Overall Study|Death|0|||
128801702|NCT00727909|463568415|FG002|Overall Study|Death|1|||
128801703|NCT00727909|463568416|FG003|Overall Study|Death|0|||
128801704|NCT03446157|463568417|FG000|Overall Study|Death|11|||
128801705|NCT03446157|463568418|FG001|Overall Study|Death|9|||
128801706|NCT03446157|463568417|FG000|Overall Study|Lost to Follow-up|0|||
128801707|NCT03446157|463568418|FG001|Overall Study|Lost to Follow-up|1|||
128801708|NCT03446157|463568417|FG000|Overall Study|Withdrawal by Subject|2|||
128801709|NCT03446157|463568418|FG001|Overall Study|Withdrawal by Subject|1|||
128801710|NCT00411151|463568419|FG000|Overall Study|Death|38|||
128801711|NCT00411151|463568419|FG000|Overall Study|Withdrawal by Subject|2|||
128801712|NCT00411151|463568419|FG000|Overall Study|Lost to Follow-up|2|||
128801713|NCT00411151|463568419|FG000|Overall Study|Protocol Violation|1|||
128801714|NCT00411151|463568419|FG000|Overall Study|Trial prematurely closed|4|||
128801715|NCT04110054|463568420|FG000|Overall Study|COVID-19 reason other than AE|0|||
128801716|NCT04110054|463568421|FG001|Overall Study|COVID-19 reason other than AE|0|||
128801717|NCT04110054|463568422|FG002|Overall Study|COVID-19 reason other than AE|2|||
128801718|NCT04110054|463568423|FG003|Overall Study|COVID-19 reason other than AE|0|||
128801719|NCT04110054|463568420|FG000|Overall Study|Withdrawal by Subject|0|||
128801720|NCT04110054|463568421|FG001|Overall Study|Withdrawal by Subject|3|||
128801721|NCT04110054|463568422|FG002|Overall Study|Withdrawal by Subject|2|||
128801722|NCT04110054|463568423|FG003|Overall Study|Withdrawal by Subject|0|||
128801723|NCT04110054|463568420|FG000|Overall Study|Adverse Event|1|||
128801724|NCT04110054|463568421|FG001|Overall Study|Adverse Event|1|||
128801725|NCT04110054|463568422|FG002|Overall Study|Adverse Event|4|||
128801726|NCT04110054|463568423|FG003|Overall Study|Adverse Event|3|||
128801727|NCT00093015|463568424|FG000|Overall Study|Withdrawal by Subject|194|||
128801728|NCT00093015|463568425|FG001|Overall Study|Withdrawal by Subject|171|||
128801729|NCT00093015|463568424|FG000|Overall Study|Lost to Follow-up|96|||
128801730|NCT00093015|463568425|FG001|Overall Study|Lost to Follow-up|108|||
128801731|NCT00093015|463568424|FG000|Overall Study|Death|375|||
128801732|NCT00093015|463568425|FG001|Overall Study|Death|385|||
128801733|NCT00632203|463568427|FG000|Overall Study|Did not start study treatment|1|||
128801734|NCT00632203|463568428|FG001|Overall Study|Did not start study treatment|0|||
128801735|NCT04287985|463568431|FG000|Overall Study|Adverse Event|1|||
128801736|NCT04287985|463568432|FG001|Overall Study|Adverse Event|0|||
128801737|NCT04287985|463568433|FG002|Overall Study|Adverse Event|0|||
128801738|NCT04287985|463568434|FG003|Overall Study|Adverse Event|0|||
128801739|NCT04287985|463568431|FG000|Overall Study|Protocol Violation|0|||
128801740|NCT04287985|463568432|FG001|Overall Study|Protocol Violation|1|||
128801741|NCT04287985|463568433|FG002|Overall Study|Protocol Violation|0|||
128801742|NCT04287985|463568434|FG003|Overall Study|Protocol Violation|0|||
128801743|NCT04287985|463568431|FG000|Overall Study|Physician Decision|0|||
128801744|NCT04287985|463568432|FG001|Overall Study|Physician Decision|0|||
128801745|NCT04287985|463568433|FG002|Overall Study|Physician Decision|0|||
128801746|NCT04287985|463568434|FG003|Overall Study|Physician Decision|1|||
128801747|NCT04287985|463568431|FG000|Overall Study|Withdrawal by Subject|2|||
128801748|NCT04287985|463568432|FG001|Overall Study|Withdrawal by Subject|1|||
128801749|NCT04287985|463568433|FG002|Overall Study|Withdrawal by Subject|1|||
128801750|NCT04287985|463568434|FG003|Overall Study|Withdrawal by Subject|2|||
128801751|NCT01340066|463568439|FG000|Placebo Run in Period|Screen Failures|27|||
128801752|NCT01340066|463568440|FG001|Placebo Run in Period|Screen Failures|0|||
128801753|NCT01340066|463568441|FG002|Placebo Run in Period|Screen Failures|0|||
128801754|NCT01340066|463568439|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
128801755|NCT01340066|463568440|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
128801756|NCT01340066|463568441|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
128801757|NCT01340066|463568439|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
128801758|NCT01340066|463568440|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
128801759|NCT01340066|463568441|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
128801760|NCT01340066|463568439|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
128801761|NCT01340066|463568440|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
128801762|NCT01340066|463568441|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
128801763|NCT02789020|463568442|FG000|Overall Study|Withdrawal by Subject|6|||
128801764|NCT02789020|463568443|FG001|Overall Study|Withdrawal by Subject|5|||
128801765|NCT04238247|463568452|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
128801766|NCT04238247|463568453|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
128801767|NCT04238247|463568454|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
128801768|NCT04238247|463568455|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
128801769|NCT04238247|463568452|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
128801770|NCT04238247|463568453|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
128801771|NCT04238247|463568454|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
128801772|NCT04238247|463568455|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
128801773|NCT04238247|463568452|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
128801774|NCT04238247|463568453|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
128801775|NCT04238247|463568454|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
128801776|NCT04238247|463568455|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
128801777|NCT04238247|463568452|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
128801778|NCT04238247|463568453|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
128801779|NCT04238247|463568454|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
128801780|NCT04238247|463568455|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
128801781|NCT04950127|463568456|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
128801782|NCT04950127|463568457|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
128801783|NCT04950127|463568458|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
128801784|NCT04950127|463568459|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
128801785|NCT04950127|463568460|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
128801786|NCT04950127|463568461|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
128801787|NCT04950127|463568456|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
128801788|NCT04950127|463568457|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
128801789|NCT04950127|463568458|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
128801790|NCT04950127|463568459|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
128801791|NCT04950127|463568460|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
128801792|NCT04950127|463568461|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
128801793|NCT04950127|463568456|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
128801794|NCT04950127|463568457|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
128801795|NCT04950127|463568458|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
128801796|NCT04950127|463568459|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
128801797|NCT04950127|463568460|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
128801798|NCT04950127|463568461|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
128801799|NCT04950127|463568456|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
128801800|NCT04950127|463568457|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
128801801|NCT04950127|463568458|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
128801802|NCT04950127|463568459|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
128801803|NCT04950127|463568460|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
128801804|NCT04950127|463568461|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
128801805|NCT04950127|463568456|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
128801806|NCT04950127|463568457|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
128801807|NCT04950127|463568458|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
128801808|NCT04950127|463568459|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
128801809|NCT04950127|463568460|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
128801810|NCT04950127|463568461|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
128801811|NCT03330795|463568462|FG000|Overall Study|Death|3|||
128801812|NCT03330795|463568462|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
128801813|NCT05064735|463568463|FG000|Overall Study|Withdrawal by Subject|7|||
128801814|NCT05064735|463568464|FG001|Overall Study|Withdrawal by Subject|8|||
128801815|NCT05064735|463568463|FG000|Overall Study|Lost to Follow-up|7|||
128801816|NCT05064735|463568464|FG001|Overall Study|Lost to Follow-up|2|||
128801817|NCT05064735|463568463|FG000|Overall Study|Physician Decision|2|||
128801818|NCT05064735|463568464|FG001|Overall Study|Physician Decision|1|||
128801819|NCT05064735|463568463|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
128801820|NCT05064735|463568464|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
128801821|NCT05064735|463568463|FG000|Overall Study|Site Closure|7|||
128801822|NCT05064735|463568464|FG001|Overall Study|Site Closure|2|||
128801823|NCT02376790|463568465|FG000|Overall Study|Withdrawal by Subject|43|||
128801824|NCT02376790|463568466|FG001|Overall Study|Withdrawal by Subject|36|||
128801825|NCT02376790|463568467|FG002|Overall Study|Withdrawal by Subject|37|||
128801826|NCT02376790|463568465|FG000|Overall Study|Decision by Sponsor|2|||
128801827|NCT02376790|463568466|FG001|Overall Study|Decision by Sponsor|1|||
128801828|NCT02376790|463568467|FG002|Overall Study|Decision by Sponsor|4|||
128801829|NCT02376790|463568465|FG000|Overall Study|Lost to Follow-up|15|||
128801830|NCT02376790|463568466|FG001|Overall Study|Lost to Follow-up|10|||
128801831|NCT02376790|463568467|FG002|Overall Study|Lost to Follow-up|12|||
128801832|NCT03014453|463568468|FG000|Overall Study|Lost to Follow-up|12|||
128801833|NCT03014453|463568468|FG000|Overall Study|Discontinued GER|3|||
128801834|NCT03014453|463568468|FG000|Overall Study|Excluded|19|||
128801835|NCT03014453|463568468|FG000|Overall Study|Refused to take part in|37|||
128801836|NCT05450458|463568469|FG000|Overall Study|Lost to Follow-up|4|||
128801837|NCT02794480|463568470|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
128801838|NCT02794480|463568471|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
128801839|NCT02794480|463568472|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
128801840|NCT02794480|463568473|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
128801841|NCT02794480|463568470|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
128801842|NCT02794480|463568471|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
128801843|NCT02794480|463568472|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
128801844|NCT02794480|463568473|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
128801845|NCT02794480|463568470|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128801846|NCT02794480|463568471|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128801847|NCT02794480|463568472|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128801848|NCT02794480|463568473|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
128801849|NCT02794480|463568470|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128801850|NCT02794480|463568471|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
128801851|NCT02794480|463568472|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128801852|NCT02794480|463568473|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
128801853|NCT02794480|463568470|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
128801854|NCT02794480|463568471|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128801855|NCT02794480|463568472|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128801856|NCT02794480|463568473|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
128801857|NCT00262301|463568474|FG000|Double-blind Phase|Lost to Follow-up|1|||
128801858|NCT00262301|463568475|FG001|Double-blind Phase|Lost to Follow-up|0|||
128801859|NCT00262301|463568476|FG002|Double-blind Phase|Lost to Follow-up|0|||
128801860|NCT00262301|463568474|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
128801861|NCT00262301|463568475|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
128801862|NCT00262301|463568476|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
128801863|NCT01017146|463568477|FG000|Overall Study|Adverse Event|11|||
128801864|NCT01017146|463568478|FG001|Overall Study|Adverse Event|1|||
128801865|NCT01017146|463568477|FG000|Overall Study|Lost to Follow-up|14|||
128801866|NCT01017146|463568478|FG001|Overall Study|Lost to Follow-up|14|||
128801867|NCT01017146|463568477|FG000|Overall Study|Noncompliance with Study Product|1|||
128801868|NCT01017146|463568478|FG001|Overall Study|Noncompliance with Study Product|1|||
128801869|NCT01017146|463568477|FG000|Overall Study|Withdrawal by Subject|32|||
128801870|NCT01017146|463568478|FG001|Overall Study|Withdrawal by Subject|16|||
128801871|NCT01017146|463568477|FG000|Overall Study|Relocation|0|||
128801872|NCT01017146|463568478|FG001|Overall Study|Relocation|4|||
128801873|NCT01017146|463568477|FG000|Overall Study|Pregnancy|2|||
128801874|NCT01017146|463568478|FG001|Overall Study|Pregnancy|1|||
128801875|NCT01017146|463568477|FG000|Overall Study|Protocol Violation|2|||
128801876|NCT01017146|463568478|FG001|Overall Study|Protocol Violation|0|||
128801877|NCT01017146|463568477|FG000|Overall Study|Took Excluded Medication|2|||
128801878|NCT01017146|463568478|FG001|Overall Study|Took Excluded Medication|0|||
128801879|NCT01017146|463568477|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
128801880|NCT01017146|463568478|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
128801881|NCT01017146|463568477|FG000|Overall Study|Change in Work Situation|1|||
128801882|NCT01017146|463568478|FG001|Overall Study|Change in Work Situation|0|||
128801883|NCT00901901|463568482|FG000|Treatment Period|Adverse Event|120|||
128801884|NCT00901901|463568483|FG001|Treatment Period|Adverse Event|128|||
128801885|NCT00901901|463568482|FG000|Treatment Period|Withdrawal by Subject|26|||
128801886|NCT00901901|463568483|FG001|Treatment Period|Withdrawal by Subject|24|||
128801887|NCT00901901|463568482|FG000|Treatment Period|Physician Decision|2|||
128801888|NCT00901901|463568483|FG001|Treatment Period|Physician Decision|2|||
128801889|NCT00901901|463568482|FG000|Treatment Period|Lost to Follow-up|3|||
128801890|NCT00901901|463568483|FG001|Treatment Period|Lost to Follow-up|5|||
128801891|NCT00901901|463568482|FG000|Treatment Period|Noncompliance with study medication|4|||
128801892|NCT00901901|463568483|FG001|Treatment Period|Noncompliance with study medication|1|||
128801893|NCT00901901|463568482|FG000|Treatment Period|Missing|1|||
128801894|NCT00901901|463568483|FG001|Treatment Period|Missing|0|||
128801895|NCT00901901|463568482|FG000|Treatment Period|Never treated|0|||
128801896|NCT00901901|463568483|FG001|Treatment Period|Never treated|3|||
128801897|NCT00901901|463568482|FG000|Treatment Period|Protocol driven decision point|0|||
128801898|NCT00901901|463568483|FG001|Treatment Period|Protocol driven decision point|2|||
128801899|NCT00901901|463568482|FG000|Treatment Period|Study terminated by sponsor|2|||
128801900|NCT00901901|463568483|FG001|Treatment Period|Study terminated by sponsor|0|||
128801901|NCT00901901|463568482|FG000|Treatment Period|Protocol Violation|5|||
128801902|NCT00901901|463568483|FG001|Treatment Period|Protocol Violation|9|||
128801903|NCT00901901|463568482|FG000|Treatment Period|Switch to commercial drug|1|||
128801904|NCT00901901|463568483|FG001|Treatment Period|Switch to commercial drug|1|||
128801905|NCT00901901|463568482|FG000|Treatment Period|Transfer to treatment continuation study|5|||
128801906|NCT00901901|463568483|FG001|Treatment Period|Transfer to treatment continuation study|2|||
128801907|NCT00901901|463568482|FG000|Follow-up Period|Death|181|||
128801908|NCT00901901|463568483|FG001|Follow-up Period|Death|208|||
128801909|NCT00901901|463568482|FG000|Follow-up Period|Protocol driven decision point|47|||
128801910|NCT00901901|463568483|FG001|Follow-up Period|Protocol driven decision point|36|||
128801911|NCT00901901|463568482|FG000|Follow-up Period|Withdrawal by Subject|6|||
128801912|NCT00901901|463568483|FG001|Follow-up Period|Withdrawal by Subject|9|||
128801913|NCT00901901|463568482|FG000|Follow-up Period|Lost to Follow-up|12|||
128801914|NCT00901901|463568483|FG001|Follow-up Period|Lost to Follow-up|8|||
128801915|NCT00901901|463568482|FG000|Follow-up Period|Missing|94|||
128801916|NCT00901901|463568483|FG001|Follow-up Period|Missing|80|||
128801917|NCT05171777|463568486|FG000|Treatment Crossover Period|Adverse Event|9|||
128801918|NCT05171777|463568487|FG001|Treatment Crossover Period|Adverse Event|6|||
128801919|NCT05171777|463568488|FG002|Treatment Crossover Period|Adverse Event|0|||
128801920|NCT05171777|463568489|FG003|Treatment Crossover Period|Adverse Event|0|||
128801921|NCT05171777|463568486|FG000|Treatment Crossover Period|Death|5|||
128801922|NCT05171777|463568487|FG001|Treatment Crossover Period|Death|5|||
128801923|NCT05171777|463568488|FG002|Treatment Crossover Period|Death|0|||
128801924|NCT05171777|463568489|FG003|Treatment Crossover Period|Death|0|||
128801925|NCT05171777|463568486|FG000|Treatment Crossover Period|Disease Relapse|0|||
128801926|NCT05171777|463568487|FG001|Treatment Crossover Period|Disease Relapse|1|||
128801927|NCT05171777|463568488|FG002|Treatment Crossover Period|Disease Relapse|0|||
128801928|NCT05171777|463568489|FG003|Treatment Crossover Period|Disease Relapse|0|||
128801929|NCT05171777|463568486|FG000|Treatment Crossover Period|Reason not Specified|2|||
128801930|NCT05171777|463568487|FG001|Treatment Crossover Period|Reason not Specified|1|||
128801931|NCT05171777|463568488|FG002|Treatment Crossover Period|Reason not Specified|0|||
128801932|NCT05171777|463568489|FG003|Treatment Crossover Period|Reason not Specified|0|||
128801933|NCT05171777|463568486|FG000|Treatment Crossover Period|Physician Decision|0|||
128801934|NCT05171777|463568487|FG001|Treatment Crossover Period|Physician Decision|1|||
128801935|NCT05171777|463568488|FG002|Treatment Crossover Period|Physician Decision|0|||
128801936|NCT05171777|463568489|FG003|Treatment Crossover Period|Physician Decision|0|||
128801937|NCT05171777|463568486|FG000|Treatment Crossover Period|Progressive Disease|13|||
128801938|NCT05171777|463568487|FG001|Treatment Crossover Period|Progressive Disease|9|||
128801939|NCT05171777|463568488|FG002|Treatment Crossover Period|Progressive Disease|0|||
128801940|NCT05171777|463568489|FG003|Treatment Crossover Period|Progressive Disease|0|||
128801941|NCT05171777|463568486|FG000|Treatment Crossover Period|Protocol Violation|0|||
128801942|NCT05171777|463568487|FG001|Treatment Crossover Period|Protocol Violation|2|||
128801943|NCT05171777|463568488|FG002|Treatment Crossover Period|Protocol Violation|0|||
128801944|NCT05171777|463568489|FG003|Treatment Crossover Period|Protocol Violation|0|||
128801945|NCT05171777|463568486|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
128801946|NCT05171777|463568487|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
128801947|NCT05171777|463568488|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
128801948|NCT05171777|463568489|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
128801949|NCT05171777|463568486|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
128801950|NCT05171777|463568487|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
128801951|NCT05171777|463568488|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
128801952|NCT05171777|463568489|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
128801953|NCT05171777|463568486|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
128801954|NCT05171777|463568487|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
128801955|NCT05171777|463568488|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
128801956|NCT05171777|463568489|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
128801957|NCT05171777|463568486|FG000|Treatment Continuation Period|Death|0|||
128801958|NCT05171777|463568487|FG001|Treatment Continuation Period|Death|0|||
128801959|NCT05171777|463568488|FG002|Treatment Continuation Period|Death|1|||
128801960|NCT05171777|463568489|FG003|Treatment Continuation Period|Death|6|||
128801961|NCT05171777|463568486|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
128801962|NCT05171777|463568487|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
128801963|NCT05171777|463568488|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
128801964|NCT05171777|463568489|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
128801965|NCT00632749|463568490|FG000|Overall Study|Progressive disease|3|||
128801966|NCT00632749|463568491|FG001|Overall Study|Progressive disease|2|||
128801967|NCT00632749|463568492|FG002|Overall Study|Progressive disease|2|||
128801968|NCT00632749|463568493|FG003|Overall Study|Progressive disease|2|||
128801969|NCT00632749|463568494|FG004|Overall Study|Progressive disease|4|||
128801970|NCT00632749|463568495|FG005|Overall Study|Progressive disease|4|||
128801971|NCT00632749|463568496|FG006|Overall Study|Progressive disease|3|||
128801972|NCT00632749|463568497|FG007|Overall Study|Progressive disease|2|||
128801973|NCT00632749|463568498|FG008|Overall Study|Progressive disease|3|||
128801974|NCT00632749|463568499|FG009|Overall Study|Progressive disease|2|||
128801975|NCT00632749|463568500|FG010|Overall Study|Progressive disease|4|||
128801976|NCT00632749|463568501|FG011|Overall Study|Progressive disease|3|||
128801977|NCT00632749|463568502|FG012|Overall Study|Progressive disease|2|||
128801978|NCT00632749|463568503|FG013|Overall Study|Progressive disease|4|||
128801979|NCT00632749|463568490|FG000|Overall Study|Other Adverse event|1|||
128801980|NCT00632749|463568491|FG001|Overall Study|Other Adverse event|1|||
128801981|NCT00632749|463568492|FG002|Overall Study|Other Adverse event|1|||
128801982|NCT00632749|463568493|FG003|Overall Study|Other Adverse event|1|||
128801983|NCT00632749|463568494|FG004|Overall Study|Other Adverse event|2|||
128801984|NCT00632749|463568495|FG005|Overall Study|Other Adverse event|4|||
128801985|NCT00632749|463568496|FG006|Overall Study|Other Adverse event|1|||
128801986|NCT00632749|463568497|FG007|Overall Study|Other Adverse event|2|||
128801987|NCT00632749|463568498|FG008|Overall Study|Other Adverse event|2|||
128801988|NCT00632749|463568499|FG009|Overall Study|Other Adverse event|0|||
128801989|NCT00632749|463568500|FG010|Overall Study|Other Adverse event|1|||
128801990|NCT00632749|463568501|FG011|Overall Study|Other Adverse event|0|||
128801991|NCT00632749|463568502|FG012|Overall Study|Other Adverse event|1|||
128801992|NCT00632749|463568503|FG013|Overall Study|Other Adverse event|0|||
128801993|NCT00632749|463568490|FG000|Overall Study|Refuse to continue medication|0|||
128801994|NCT00632749|463568491|FG001|Overall Study|Refuse to continue medication|0|||
128801995|NCT00632749|463568492|FG002|Overall Study|Refuse to continue medication|0|||
128801996|NCT00632749|463568493|FG003|Overall Study|Refuse to continue medication|1|||
128801997|NCT00632749|463568494|FG004|Overall Study|Refuse to continue medication|0|||
128801998|NCT00632749|463568495|FG005|Overall Study|Refuse to continue medication|0|||
128801999|NCT00632749|463568496|FG006|Overall Study|Refuse to continue medication|0|||
128802000|NCT00632749|463568497|FG007|Overall Study|Refuse to continue medication|0|||
128802001|NCT00632749|463568498|FG008|Overall Study|Refuse to continue medication|0|||
128802002|NCT00632749|463568499|FG009|Overall Study|Refuse to continue medication|1|||
128802003|NCT00632749|463568500|FG010|Overall Study|Refuse to continue medication|0|||
128802004|NCT00632749|463568501|FG011|Overall Study|Refuse to continue medication|0|||
128802005|NCT00632749|463568502|FG012|Overall Study|Refuse to continue medication|0|||
128802006|NCT00632749|463568503|FG013|Overall Study|Refuse to continue medication|0|||
128802007|NCT00632749|463568490|FG000|Overall Study|Reason other than those specified above|0|||
128802008|NCT00632749|463568491|FG001|Overall Study|Reason other than those specified above|2|||
128802009|NCT00632749|463568492|FG002|Overall Study|Reason other than those specified above|0|||
128802010|NCT00632749|463568493|FG003|Overall Study|Reason other than those specified above|0|||
128802011|NCT00632749|463568494|FG004|Overall Study|Reason other than those specified above|1|||
128802012|NCT00632749|463568495|FG005|Overall Study|Reason other than those specified above|0|||
128802013|NCT00632749|463568496|FG006|Overall Study|Reason other than those specified above|1|||
128802014|NCT00632749|463568497|FG007|Overall Study|Reason other than those specified above|0|||
128802015|NCT00632749|463568498|FG008|Overall Study|Reason other than those specified above|0|||
128802016|NCT00632749|463568499|FG009|Overall Study|Reason other than those specified above|0|||
128802017|NCT00632749|463568500|FG010|Overall Study|Reason other than those specified above|2|||
128802018|NCT00632749|463568501|FG011|Overall Study|Reason other than those specified above|1|||
128802019|NCT00632749|463568502|FG012|Overall Study|Reason other than those specified above|0|||
128802020|NCT00632749|463568503|FG013|Overall Study|Reason other than those specified above|2|||
129204632|NCT03061201|465045843|FG000|Overall Study|Participants Terminated at Month 36|0|||
129204633|NCT03061201|465045844|FG001|Overall Study|Participants Terminated at Month 36|1|||
129204634|NCT03061201|465045845|FG002|Overall Study|Participants Terminated at Month 36|0|||
129204635|NCT03061201|465045846|FG003|Overall Study|Participants Terminated at Month 36|1|||
129204636|NCT03061201|465045843|FG000|Overall Study|Lost to Follow-up|1|||
129204637|NCT03061201|465045844|FG001|Overall Study|Lost to Follow-up|0|||
129204638|NCT03061201|465045845|FG002|Overall Study|Lost to Follow-up|0|||
129204639|NCT03061201|465045846|FG003|Overall Study|Lost to Follow-up|0|||
129204640|NCT03062358|465045847|FG000|Overall Study|Death|269|||
129204641|NCT03062358|465045848|FG001|Overall Study|Death|145|||
129204642|NCT03062358|465045847|FG000|Overall Study|Withdrawal by Subject|2|||
129204643|NCT03062358|465045848|FG001|Overall Study|Withdrawal by Subject|1|||
128802033|NCT01136876|463568507|FG000|Overall Study|Lost to Follow-up|0|||
128802034|NCT01136876|463568508|FG001|Overall Study|Lost to Follow-up|1|||
128802035|NCT01136876|463568507|FG000|Overall Study|Physician Decision|3|||
128802036|NCT01136876|463568508|FG001|Overall Study|Physician Decision|5|||
128802037|NCT01136876|463568507|FG000|Overall Study|Missing NGAL measurement|2|||
128802038|NCT01136876|463568508|FG001|Overall Study|Missing NGAL measurement|5|||
128802039|NCT04128319|463568511|FG000|Overall Study|Death|3|||
128802040|NCT00976937|463568514|FG000|Overall Study|Adverse Event|4|||
128802041|NCT00976937|463568515|FG001|Overall Study|Adverse Event|5|||
128802042|NCT00976937|463568514|FG000|Overall Study|Lost to Follow-up|2|||
128802043|NCT00976937|463568515|FG001|Overall Study|Lost to Follow-up|1|||
128802044|NCT00976937|463568514|FG000|Overall Study|Withdrawal by Subject|5|||
128802045|NCT00976937|463568515|FG001|Overall Study|Withdrawal by Subject|3|||
128802046|NCT00976937|463568514|FG000|Overall Study|Poor compliance to protocol|3|||
128802047|NCT00976937|463568515|FG001|Overall Study|Poor compliance to protocol|0|||
128802048|NCT00976937|463568514|FG000|Overall Study|Personal and Familial Reason|2|||
128802049|NCT00976937|463568515|FG001|Overall Study|Personal and Familial Reason|2|||
128802050|NCT01011946|463568516|FG000|Overall Study|Transferred to another hospital|2|||
128802051|NCT01011946|463568516|FG000|Overall Study|No pathological lab value|1|||
128802052|NCT03988842|463568517|FG000|Overall Study|Death|1|||
128802053|NCT01227265|463568519|FG000|Overall Study|Did Not Receive Treatment|1|||
128802054|NCT01227265|463568520|FG001|Overall Study|Did Not Receive Treatment|2|||
128802055|NCT01227265|463568521|FG002|Overall Study|Did Not Receive Treatment|0|||
128802056|NCT01227265|463568519|FG000|Overall Study|Administrative|1|||
128802057|NCT01227265|463568520|FG001|Overall Study|Administrative|0|||
128802058|NCT01227265|463568521|FG002|Overall Study|Administrative|2|||
128802059|NCT01227265|463568519|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
128802060|NCT01227265|463568520|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
128802061|NCT01227265|463568521|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
128802062|NCT01227265|463568519|FG000|Overall Study|Protocol Violation|2|||
128802063|NCT01227265|463568520|FG001|Overall Study|Protocol Violation|1|||
128802064|NCT01227265|463568521|FG002|Overall Study|Protocol Violation|0|||
128802065|NCT01227265|463568519|FG000|Overall Study|Withdrawal by Subject|7|||
128802066|NCT01227265|463568520|FG001|Overall Study|Withdrawal by Subject|7|||
128802067|NCT01227265|463568521|FG002|Overall Study|Withdrawal by Subject|3|||
128802068|NCT01227265|463568519|FG000|Overall Study|Lost to Follow-up|2|||
128802069|NCT01227265|463568520|FG001|Overall Study|Lost to Follow-up|0|||
128802070|NCT01227265|463568521|FG002|Overall Study|Lost to Follow-up|3|||
128802071|NCT01227265|463568519|FG000|Overall Study|Adverse Event|6|||
128802072|NCT01227265|463568520|FG001|Overall Study|Adverse Event|10|||
128802073|NCT01227265|463568521|FG002|Overall Study|Adverse Event|5|||
128802074|NCT05028582|463568522|FG000|Overall Study|Lost to Follow-up|11|||
128802075|NCT05028582|463568523|FG001|Overall Study|Lost to Follow-up|9|||
128802076|NCT05028582|463568522|FG000|Overall Study|Withdrawal by Subject|9|||
128802077|NCT05028582|463568523|FG001|Overall Study|Withdrawal by Subject|10|||
128802078|NCT05028582|463568522|FG000|Overall Study|Adverse Event|5|||
128802079|NCT05028582|463568523|FG001|Overall Study|Adverse Event|2|||
128802080|NCT05028582|463568522|FG000|Overall Study|Miscellaneous|3|||
128802081|NCT05028582|463568523|FG001|Overall Study|Miscellaneous|2|||
128802082|NCT05028582|463568522|FG000|Overall Study|Lack of Efficacy|3|||
128802083|NCT05028582|463568523|FG001|Overall Study|Lack of Efficacy|1|||
128802084|NCT05028582|463568522|FG000|Overall Study|Physician Decision|0|||
128802085|NCT05028582|463568523|FG001|Overall Study|Physician Decision|1|||
128802086|NCT00186992|463570150|FG000|Overall Study|Withdrawal by Subject|5|||
128802087|NCT00186992|463570150|FG000|Overall Study|Physician's discretion|13|||
128802088|NCT00186992|463570150|FG000|Overall Study|PI Discretion|4|||
128802089|NCT00186992|463570150|FG000|Overall Study|Ineligible|2|||
128802090|NCT00186992|463570150|FG000|Overall Study|Lost to Follow-up|2|||
128802091|NCT00186992|463570150|FG000|Overall Study|Still on Study|9|||
128802092|NCT03683069|463570151|FG000|Overall Study|see limitations|12|||
128802093|NCT03683069|463570152|FG001|Overall Study|see limitations|13|||
128802094|NCT03769168|463570153|FG000|Overall Study|Adverse Event|0|||
128802095|NCT03769168|463570154|FG001|Overall Study|Adverse Event|1|||
128802096|NCT03769168|463570153|FG000|Overall Study|Lack of Efficacy|2|||
128802097|NCT03769168|463570154|FG001|Overall Study|Lack of Efficacy|4|||
128802098|NCT03769168|463570153|FG000|Overall Study|Post study access to treatment|3|||
128802099|NCT03769168|463570154|FG001|Overall Study|Post study access to treatment|11|||
128802100|NCT03769168|463570153|FG000|Overall Study|Physician Decision|1|||
128802101|NCT03769168|463570154|FG001|Overall Study|Physician Decision|4|||
128802102|NCT03769168|463570153|FG000|Overall Study|Subject Decision|2|||
128802103|NCT03769168|463570154|FG001|Overall Study|Subject Decision|4|||
128802104|NCT03769168|463570153|FG000|Overall Study|Guardian decision|1|||
128802105|NCT03769168|463570154|FG001|Overall Study|Guardian decision|0|||
128802106|NCT04941287|463570155|FG000|Overall Study|Rapid decline before starting treatment|3|||
128802107|NCT04941287|463570156|FG001|Overall Study|Rapid decline before starting treatment|1|||
128802108|NCT03324984|463570161|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
128802109|NCT03324984|463570162|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
128802110|NCT03547908|463570163|FG000|Blinded Phase|Lost to Follow-up|3|||
128802111|NCT03547908|463570164|FG001|Blinded Phase|Lost to Follow-up|3|||
128802112|NCT03547908|463570165|FG002|Blinded Phase|Lost to Follow-up|0|||
128802113|NCT03547908|463570166|FG003|Blinded Phase|Lost to Follow-up|0|||
128802114|NCT03547908|463570163|FG000|Blinded Phase|Withdrew Consent|2|||
128802115|NCT03547908|463570164|FG001|Blinded Phase|Withdrew Consent|3|||
128802116|NCT03547908|463570165|FG002|Blinded Phase|Withdrew Consent|0|||
128802117|NCT03547908|463570166|FG003|Blinded Phase|Withdrew Consent|0|||
128802118|NCT03547908|463570163|FG000|Blinded Phase|Investigator's Discretion|2|||
128802119|NCT03547908|463570164|FG001|Blinded Phase|Investigator's Discretion|1|||
128802120|NCT03547908|463570165|FG002|Blinded Phase|Investigator's Discretion|0|||
128802121|NCT03547908|463570166|FG003|Blinded Phase|Investigator's Discretion|0|||
128802122|NCT03547908|463570163|FG000|Blinded Phase|Death|2|||
128802123|NCT03547908|463570164|FG001|Blinded Phase|Death|0|||
128802124|NCT03547908|463570165|FG002|Blinded Phase|Death|0|||
128802125|NCT03547908|463570166|FG003|Blinded Phase|Death|0|||
128802126|NCT03547908|463570163|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
128802127|NCT03547908|463570164|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
128802128|NCT03547908|463570165|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
128802129|NCT03547908|463570166|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
128802130|NCT03547908|463570163|FG000|Blinded Phase|Adverse Event|1|||
128802131|NCT03547908|463570164|FG001|Blinded Phase|Adverse Event|0|||
128802132|NCT03547908|463570165|FG002|Blinded Phase|Adverse Event|0|||
128802133|NCT03547908|463570166|FG003|Blinded Phase|Adverse Event|0|||
128802134|NCT03547908|463570163|FG000|Blinded Phase|Randomized But Never Treated|1|||
128802135|NCT03547908|463570164|FG001|Blinded Phase|Randomized But Never Treated|0|||
128802136|NCT03547908|463570165|FG002|Blinded Phase|Randomized But Never Treated|0|||
128802137|NCT03547908|463570166|FG003|Blinded Phase|Randomized But Never Treated|0|||
128802138|NCT03547908|463570163|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
128802139|NCT03547908|463570164|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
128802140|NCT03547908|463570165|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
128802141|NCT03547908|463570166|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
128802142|NCT03547908|463570163|FG000|Open-label Extension Phase|Death|0|||
128802143|NCT03547908|463570164|FG001|Open-label Extension Phase|Death|0|||
128802144|NCT03547908|463570165|FG002|Open-label Extension Phase|Death|1|||
128802145|NCT03547908|463570166|FG003|Open-label Extension Phase|Death|0|||
128802146|NCT03416023|463570175|FG000|Overall Study|Exclusion criteria failure|1|||
128802147|NCT03416023|463570175|FG000|Overall Study|Withdrawal by Subject|6|||
128802148|NCT03416023|463570175|FG000|Overall Study|Explanted|7|||
128802149|NCT03416023|463570175|FG000|Overall Study|Physician Decision|1|||
128802150|NCT03416023|463570175|FG000|Overall Study|Lost to Follow-up|1|||
128802151|NCT03416023|463570175|FG000|Overall Study|Death|1|||
128802152|NCT02152137|463570177|FG000|Overall Study|Withdrawal by Subject|1|||
128802153|NCT02152137|463570177|FG000|Overall Study|Originally assigned to Arm B|3|||
128802154|NCT04878354|463570178|FG000|Overall Study|Adverse Event|4|||
128802155|NCT04878354|463570179|FG001|Overall Study|Adverse Event|13|||
128802156|NCT04878354|463570178|FG000|Overall Study|Withdrawal by Subject|14|||
128802157|NCT04878354|463570179|FG001|Overall Study|Withdrawal by Subject|12|||
128802158|NCT04878354|463570178|FG000|Overall Study|Lost to Follow-up|4|||
128802159|NCT04878354|463570179|FG001|Overall Study|Lost to Follow-up|1|||
128802160|NCT04878354|463570178|FG000|Overall Study|Lack of Efficacy|1|||
128802161|NCT04878354|463570179|FG001|Overall Study|Lack of Efficacy|0|||
128802162|NCT04878354|463570178|FG000|Overall Study|Protocol Violation|0|||
128802163|NCT04878354|463570179|FG001|Overall Study|Protocol Violation|1|||
128802164|NCT04878354|463570178|FG000|Overall Study|"Reason stated as other in CRF"|2|||
128802165|NCT04878354|463570179|FG001|Overall Study|"Reason stated as other in CRF"|3|||
128802166|NCT03358875|463570180|FG000|Overall Study|Death|409|||
128802167|NCT03358875|463570181|FG001|Overall Study|Death|223|||
128802168|NCT03358875|463570180|FG000|Overall Study|Study Closed by Sponsor|66|||
128802169|NCT03358875|463570181|FG001|Overall Study|Study Closed by Sponsor|29|||
128802170|NCT03358875|463570180|FG000|Overall Study|Withdrawal by Subject|13|||
128802171|NCT03358875|463570181|FG001|Overall Study|Withdrawal by Subject|16|||
128802172|NCT03358875|463570180|FG000|Overall Study|Lost to Follow-up|13|||
128802173|NCT03358875|463570181|FG001|Overall Study|Lost to Follow-up|2|||
128802174|NCT03358875|463570180|FG000|Overall Study|Miscellaneous|33|||
128802175|NCT03358875|463570181|FG001|Overall Study|Miscellaneous|0|||
128802176|NCT03358875|463570180|FG000|Overall Study|Remained on Study|1|||
128802177|NCT03358875|463570181|FG001|Overall Study|Remained on Study|0|||
128802178|NCT05510232|463570185|FG000|Overall Study|Withdrawal by Subject|2|||
128802179|NCT05510232|463570186|FG001|Overall Study|Withdrawal by Subject|7|||
128802180|NCT05510232|463570187|FG002|Overall Study|Withdrawal by Subject|6|||
128802181|NCT06194214|463570189|FG000|Overall Study|Adverse Event|1|||
128802182|NCT01631214|463570191|FG000|Overall Study|Withdrawal by Subject|276|||
128802183|NCT01631214|463570192|FG001|Overall Study|Withdrawal by Subject|290|||
128802184|NCT01631214|463570191|FG000|Overall Study|Death|113|||
128802185|NCT01631214|463570192|FG001|Overall Study|Death|106|||
128802186|NCT01631214|463570191|FG000|Overall Study|Lost to Follow-up|54|||
128802187|NCT01631214|463570192|FG001|Overall Study|Lost to Follow-up|40|||
128802188|NCT01631214|463570191|FG000|Overall Study|Adverse Event|45|||
128802189|NCT01631214|463570192|FG001|Overall Study|Adverse Event|45|||
128802190|NCT01631214|463570191|FG000|Overall Study|Other|22|||
128802191|NCT01631214|463570192|FG001|Overall Study|Other|19|||
128802192|NCT01631214|463570191|FG000|Overall Study|Noncompliance|16|||
128802193|NCT01631214|463570192|FG001|Overall Study|Noncompliance|15|||
128802194|NCT01631214|463570191|FG000|Overall Study|Requirement for Alternative Therapy|8|||
128802195|NCT01631214|463570192|FG001|Overall Study|Requirement for Alternative Therapy|3|||
128802196|NCT01631214|463570191|FG000|Overall Study|Protocol Deviation|4|||
128802197|NCT01631214|463570192|FG001|Overall Study|Protocol Deviation|3|||
128802198|NCT01631214|463570191|FG000|Overall Study|Ineligibility determined|5|||
128802199|NCT01631214|463570192|FG001|Overall Study|Ineligibility determined|2|||
128802200|NCT01631214|463570191|FG000|Overall Study|Administrative Decision|1|||
128802201|NCT01631214|463570192|FG001|Overall Study|Administrative Decision|0|||
128802202|NCT04112316|463570198|FG000|First Period (8 Weeks)|Protocol Violation|1|||
128802203|NCT04112316|463570199|FG001|First Period (8 Weeks)|Protocol Violation|0|||
128802204|NCT04112316|463570198|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
128802205|NCT04112316|463570199|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
128802206|NCT03857620|463570200|FG000|Overall Study|Death|4|||
128802207|NCT03857620|463570201|FG001|Overall Study|Death|5|||
128802208|NCT03857620|463570202|FG002|Overall Study|Death|7|||
128802209|NCT03857620|463570200|FG000|Overall Study|Lost to Follow-up|2|||
128802210|NCT03857620|463570201|FG001|Overall Study|Lost to Follow-up|5|||
128802211|NCT03857620|463570202|FG002|Overall Study|Lost to Follow-up|3|||
128802212|NCT03857620|463570200|FG000|Overall Study|Disease progression or relapse after study registration|1|||
128802213|NCT03857620|463570201|FG001|Overall Study|Disease progression or relapse after study registration|5|||
128802214|NCT03857620|463570202|FG002|Overall Study|Disease progression or relapse after study registration|1|||
128802215|NCT03857620|463570200|FG000|Overall Study|Ineligible|5|||
128802216|NCT03857620|463570201|FG001|Overall Study|Ineligible|0|||
128802217|NCT03857620|463570202|FG002|Overall Study|Ineligible|2|||
128802218|NCT03857620|463570200|FG000|Overall Study|No malignancy|1|||
128802219|NCT03857620|463570201|FG001|Overall Study|No malignancy|0|||
128802220|NCT03857620|463570202|FG002|Overall Study|No malignancy|1|||
128802221|NCT03857620|463570200|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
128802222|NCT03857620|463570201|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
128802223|NCT03857620|463570202|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
128802224|NCT03857620|463570200|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
128802225|NCT03857620|463570201|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
128802226|NCT03857620|463570202|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
128802227|NCT03857620|463570200|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
128802228|NCT03857620|463570201|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
128802229|NCT03857620|463570202|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
128802230|NCT03857620|463570200|FG000|Overall Study|Surgery not performed, patient decision|0|||
128802231|NCT03857620|463570201|FG001|Overall Study|Surgery not performed, patient decision|3|||
128802232|NCT03857620|463570202|FG002|Overall Study|Surgery not performed, patient decision|1|||
128802233|NCT03857620|463570200|FG000|Overall Study|Surgery not performed, other reason|3|||
128802234|NCT03857620|463570201|FG001|Overall Study|Surgery not performed, other reason|1|||
128802235|NCT03857620|463570202|FG002|Overall Study|Surgery not performed, other reason|4|||
128802236|NCT03857620|463570200|FG000|Overall Study|Worsening performance status after surgery performed|0|||
128802237|NCT03857620|463570201|FG001|Overall Study|Worsening performance status after surgery performed|1|||
128802238|NCT03857620|463570202|FG002|Overall Study|Worsening performance status after surgery performed|1|||
128802239|NCT02473250|463570203|FG000|Overall Study|Lost to Follow-up|10|||
128802240|NCT02473250|463570203|FG000|Overall Study|Physician Decision|5|||
128802241|NCT02473250|463570203|FG000|Overall Study|Did not tolerate medication washout|3|||
128802242|NCT02473250|463570203|FG000|Overall Study|Antidepressant effect of divalproex|2|||
128802243|NCT03517553|463570204|FG000|Overall Study|Withdrawal by Subject|2|||
128802244|NCT03271151|463570205|FG000|Overall Study|Lost to Follow-up|1|||
128802245|NCT03271151|463570206|FG001|Overall Study|Lost to Follow-up|3|||
128802246|NCT03271151|463570205|FG000|Overall Study|Withdrawal by Subject|1|||
128802247|NCT03271151|463570206|FG001|Overall Study|Withdrawal by Subject|0|||
128802248|NCT04093362|463570207|FG000|Overall Study|Study Termination|1|||
128802249|NCT04093362|463570208|FG001|Overall Study|Study Termination|1|||
128802250|NCT04093362|463570207|FG000|Overall Study|Withdrawal of Consent|1|||
128802251|NCT04093362|463570208|FG001|Overall Study|Withdrawal of Consent|0|||
128802252|NCT04093362|463570207|FG000|Overall Study|Death|1|||
128802253|NCT04093362|463570208|FG001|Overall Study|Death|3|||
128802254|NCT04093362|463570207|FG000|Overall Study|Reason not Specified|1|||
128802255|NCT04093362|463570208|FG001|Overall Study|Reason not Specified|2|||
128802256|NCT03433339|463570211|FG000|Overall Study|Lost to Follow-up|2|||
128802257|NCT03433339|463570212|FG001|Overall Study|Lost to Follow-up|0|||
128802258|NCT03433339|463570211|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
128802259|NCT03433339|463570212|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
128802260|NCT03433339|463570211|FG000|Overall Study|Withdrawal by Subject|0|||
128802261|NCT03433339|463570212|FG001|Overall Study|Withdrawal by Subject|2|||
128802262|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
128802263|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
128802264|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
128802265|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
128802266|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
128802267|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
128802268|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
128802269|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
128802270|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
128802271|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
128802272|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
128802273|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
128802274|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
128802275|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
128802276|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
128802277|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
128802278|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
128802279|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
128802280|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
128802281|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
128802282|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
128802283|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
128802284|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
128802285|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
128802286|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
128802287|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
128802288|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
128802289|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
128802290|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
128802291|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
128802292|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
128802293|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
128802294|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
128802295|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
128802296|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
128802297|NCT01898494|463570228|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
128802298|NCT01898494|463570229|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
128802299|NCT01898494|463570230|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
128802300|NCT01898494|463570231|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
128802301|NCT01898494|463570232|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
128802302|NCT01898494|463570228|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
128802303|NCT01898494|463570229|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
128802304|NCT01898494|463570230|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
128802305|NCT01898494|463570231|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
128802306|NCT01898494|463570232|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
128802307|NCT01898494|463570228|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
128802308|NCT01898494|463570229|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
128802309|NCT01898494|463570230|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
128802310|NCT01898494|463570231|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
128802311|NCT01898494|463570232|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
128802312|NCT01898494|463570228|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
128802313|NCT01898494|463570229|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
128802314|NCT01898494|463570230|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
128802315|NCT01898494|463570231|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
128802316|NCT01898494|463570232|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
128802317|NCT01898494|463570228|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
128802318|NCT01898494|463570229|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
128802319|NCT01898494|463570230|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
128802320|NCT01898494|463570231|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
128802321|NCT01898494|463570232|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
128802322|NCT01898494|463570228|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
128802323|NCT01898494|463570229|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
128802324|NCT01898494|463570230|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
128802325|NCT01898494|463570231|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
128802326|NCT01898494|463570232|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
128802327|NCT01898494|463570228|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
128802328|NCT01898494|463570229|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
128802329|NCT01898494|463570230|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
128802330|NCT01898494|463570231|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
128802331|NCT01898494|463570232|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
128802332|NCT03263026|463570233|FG000|Overall Study|Withdrawal by Subject|1|||
128802333|NCT03263026|463570234|FG001|Overall Study|Withdrawal by Subject|0|||
128802334|NCT03263026|463570233|FG000|Overall Study|Death|1|||
128802335|NCT03263026|463570234|FG001|Overall Study|Death|0|||
128802336|NCT03263026|463570233|FG000|Overall Study|Other/ Various|41|||
128802337|NCT03263026|463570234|FG001|Overall Study|Other/ Various|29|||
128802338|NCT03739996|463570237|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
128802339|NCT03739996|463570237|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
128802340|NCT03739996|463570237|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
128802341|NCT03739996|463570237|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
128802342|NCT03739996|463570237|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
128802343|NCT03739996|463570237|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
128802344|NCT03739996|463570237|FG000|Step 3 (SOC ART)|Death|1|||
128802345|NCT03739996|463570237|FG000|Step 3 (SOC ART)|Participant moved|1|||
128802346|NCT02553642|463570238|FG000|Overall Study|Withdrawal by Subject|0|||
128802347|NCT02553642|463570239|FG001|Overall Study|Withdrawal by Subject|3|||
128802348|NCT02553642|463570238|FG000|Overall Study|Physician Decision|0|||
128802349|NCT02553642|463570239|FG001|Overall Study|Physician Decision|1|||
128802350|NCT02553642|463570238|FG000|Overall Study|Additional cancer dx|0|||
128802351|NCT02553642|463570239|FG001|Overall Study|Additional cancer dx|1|||
128802352|NCT02553642|463570238|FG000|Overall Study|Never started treatment|0|||
128802353|NCT02553642|463570239|FG001|Overall Study|Never started treatment|1|||
128802354|NCT00448669|463570245|FG000|Overall Study|Lost to Follow-up|52|||
128802355|NCT00448669|463570246|FG001|Overall Study|Lost to Follow-up|63|||
128802356|NCT00448669|463570245|FG000|Overall Study|Withdrawal by Subject|90|||
128802357|NCT00448669|463570246|FG001|Overall Study|Withdrawal by Subject|74|||
128802358|NCT00448669|463570245|FG000|Overall Study|Relocated|49|||
128802359|NCT00448669|463570246|FG001|Overall Study|Relocated|36|||
128802360|NCT00448669|463570245|FG000|Overall Study|Were withdrawn by investigator|10|||
128802361|NCT00448669|463570246|FG001|Overall Study|Were withdrawn by investigator|6|||
128802362|NCT00448669|463570245|FG000|Overall Study|Death|2|||
128802363|NCT00448669|463570246|FG001|Overall Study|Death|4|||
128802364|NCT00448669|463570245|FG000|Overall Study|Had other reasons|5|||
128802365|NCT00448669|463570246|FG001|Overall Study|Had other reasons|6|||
128802366|NCT00448669|463570245|FG000|Overall Study|HIV-infected at enrollment|1|||
128802367|NCT00448669|463570246|FG001|Overall Study|HIV-infected at enrollment|2|||
128802368|NCT00448669|463570245|FG000|Overall Study|Never started drug|9|||
128802369|NCT00448669|463570246|FG001|Overall Study|Never started drug|7|||
128802370|NCT02638337|463570247|FG000|Overall Study|Adverse Event|6|||
128802371|NCT02638337|463570248|FG001|Overall Study|Adverse Event|10|||
128802372|NCT02638337|463570247|FG000|Overall Study|Protocol Violation|3|||
128802373|NCT02638337|463570248|FG001|Overall Study|Protocol Violation|0|||
128802374|NCT02638337|463570247|FG000|Overall Study|Withdrawal by Subject|13|||
128802375|NCT02638337|463570248|FG001|Overall Study|Withdrawal by Subject|16|||
128802376|NCT02638337|463570247|FG000|Overall Study|Lost to Follow-up|7|||
128802377|NCT02638337|463570248|FG001|Overall Study|Lost to Follow-up|7|||
128802378|NCT02638337|463570247|FG000|Overall Study|Other - Miscellaneous|4|||
128802379|NCT02638337|463570248|FG001|Overall Study|Other - Miscellaneous|3|||
128802380|NCT03771352|463570260|FG000|Overall Study|Screen failure|2|||
128802381|NCT03771352|463570260|FG000|Overall Study|Withdrawal by Subject|2|||
128802382|NCT03338816|463570266|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
128802383|NCT03338816|463570267|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
128802384|NCT03338816|463570268|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
128802385|NCT03338816|463570269|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
128802386|NCT03338816|463570266|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
128802387|NCT03338816|463570267|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
128802388|NCT03338816|463570268|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
128802389|NCT03338816|463570269|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
128802390|NCT03338816|463570266|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
128802391|NCT03338816|463570267|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
128802392|NCT03338816|463570268|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
128802393|NCT03338816|463570269|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
128802394|NCT03338816|463570266|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
128802395|NCT03338816|463570267|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
128802396|NCT03338816|463570268|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
128802397|NCT03338816|463570269|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
128802398|NCT03338816|463570266|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
128802399|NCT03338816|463570267|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
128802400|NCT03338816|463570268|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
128802401|NCT03338816|463570269|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
128802402|NCT03338816|463570266|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
128802403|NCT03338816|463570267|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
128802404|NCT03338816|463570268|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
128802405|NCT03338816|463570269|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
128802406|NCT03338816|463570266|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
128802407|NCT03338816|463570267|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
128802408|NCT03338816|463570268|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
128802409|NCT03338816|463570269|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
128802410|NCT03092726|463570270|FG000|Overall Study|Adverse Event|3|||
128802411|NCT03092726|463570271|FG001|Overall Study|Adverse Event|10|||
128802412|NCT03092726|463570270|FG000|Overall Study|Lack of Efficacy|0|||
128802413|NCT03092726|463570271|FG001|Overall Study|Lack of Efficacy|1|||
128802414|NCT03092726|463570270|FG000|Overall Study|Lost to Follow-up|1|||
128802415|NCT03092726|463570271|FG001|Overall Study|Lost to Follow-up|0|||
128802416|NCT03092726|463570270|FG000|Overall Study|Withdrawal by Subject|5|||
128802417|NCT03092726|463570271|FG001|Overall Study|Withdrawal by Subject|3|||
128802418|NCT03833167|463570276|FG000|Overall Study|Withdrawal by Subject|4|||
128802419|NCT03833167|463570277|FG001|Overall Study|Withdrawal by Subject|6|||
128802420|NCT03833167|463570276|FG000|Overall Study|Ongoing|186|||
128802421|NCT03833167|463570277|FG001|Overall Study|Ongoing|194|||
128802422|NCT03833167|463570276|FG000|Overall Study|Lost to Follow-up|1|||
128802423|NCT03833167|463570277|FG001|Overall Study|Lost to Follow-up|1|||
128802424|NCT03833167|463570276|FG000|Overall Study|Physician Decision|0|||
128802425|NCT03833167|463570277|FG001|Overall Study|Physician Decision|2|||
128802426|NCT03833167|463570276|FG000|Overall Study|Death|34|||
128802427|NCT03833167|463570277|FG001|Overall Study|Death|22|||
128802428|NCT01948661|463570279|FG000|Overall Study|Withdrawal by Subject|2|||
128802429|NCT01948661|463570280|FG001|Overall Study|Withdrawal by Subject|4|||
128802430|NCT03271489|463570281|FG000|Double-Blind (DB) Period|Adverse Event|4|||
128802431|NCT03271489|463570282|FG001|Double-Blind (DB) Period|Adverse Event|1|||
128802432|NCT03271489|463570281|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
128802433|NCT03271489|463570282|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
128802434|NCT03271489|463570281|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
128802435|NCT03271489|463570282|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
128802436|NCT03271489|463570281|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
128802437|NCT03271489|463570282|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
128802438|NCT03271489|463570281|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
128802439|NCT03271489|463570282|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
128802440|NCT03271489|463570281|FG000|Double-Blind (DB) Period|Other|6|||
128802441|NCT03271489|463570282|FG001|Double-Blind (DB) Period|Other|1|||
128802442|NCT03271489|463570281|FG000|Double-Blind (DB) Period|Missing|1|||
128802443|NCT03271489|463570282|FG001|Double-Blind (DB) Period|Missing|0|||
128802444|NCT03271489|463570281|FG000|Open-Label (OL) Period|Adverse Event|2|||
128802445|NCT03271489|463570282|FG001|Open-Label (OL) Period|Adverse Event|0|||
128802446|NCT03271489|463570281|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
128802447|NCT03271489|463570282|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
128802448|NCT03271489|463570281|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
128802449|NCT03271489|463570282|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
128802450|NCT03271489|463570281|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
128802451|NCT03271489|463570282|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
128802452|NCT03271489|463570281|FG000|Open-Label (OL) Period|No Specified|2|||
128802453|NCT03271489|463570282|FG001|Open-Label (OL) Period|No Specified|2|||
128802454|NCT03271489|463570281|FG000|Open-Label (OL) Period|Missing|2|||
128802455|NCT03271489|463570282|FG001|Open-Label (OL) Period|Missing|0|||
128802456|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
128802457|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
128802458|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
128802459|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
128802460|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
128802461|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
128802462|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
128802463|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
128802464|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
128802465|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
128802466|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
128802467|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
128802468|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
128802469|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
128802470|NCT03271489|463570281|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
128802471|NCT03271489|463570282|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
128802472|NCT02860130|463570283|FG000|Overall Study|Adverse Event|2|||
128802473|NCT02860130|463570284|FG001|Overall Study|Adverse Event|3|||
128802474|NCT02860130|463570283|FG000|Overall Study|Protocol Violation|1|||
128802475|NCT02860130|463570284|FG001|Overall Study|Protocol Violation|1|||
128802476|NCT02860130|463570283|FG000|Overall Study|Withdrawal by Subject|0|||
128802477|NCT02860130|463570284|FG001|Overall Study|Withdrawal by Subject|2|||
128802478|NCT02860130|463570283|FG000|Overall Study|Physician Decision|2|||
128802479|NCT02860130|463570284|FG001|Overall Study|Physician Decision|2|||
128802480|NCT02860130|463570283|FG000|Overall Study|Other|2|||
128802481|NCT02860130|463570284|FG001|Overall Study|Other|1|||
128802482|NCT03380390|463570285|FG000|Overall Study|Adverse Event|3|||
128802483|NCT02886286|463570286|FG000|Overall Study|pump motor stall|0|||
128802484|NCT02886286|463570287|FG001|Overall Study|pump motor stall|1|||
128802485|NCT02272816|463570288|FG000|Overall Study|Adverse Event|1|||
128802486|NCT00709098|463570293|FG000|Double-blind Period|Withdrawal of consent|3|||
128802487|NCT00709098|463570294|FG001|Double-blind Period|Withdrawal of consent|3|||
128802488|NCT00709098|463570295|FG002|Double-blind Period|Withdrawal of consent|0|||
128802489|NCT00709098|463570293|FG000|Double-blind Period|Administrative reason|1|||
128802490|NCT00709098|463570294|FG001|Double-blind Period|Administrative reason|3|||
128802491|NCT00709098|463570295|FG002|Double-blind Period|Administrative reason|0|||
128802492|NCT00709098|463570293|FG000|Double-blind Period|Death|1|||
128802493|NCT00709098|463570294|FG001|Double-blind Period|Death|1|||
128802494|NCT00709098|463570295|FG002|Double-blind Period|Death|0|||
128802495|NCT00709098|463570293|FG000|Double-blind Period|Lost to Follow-up|1|||
128802496|NCT00709098|463570294|FG001|Double-blind Period|Lost to Follow-up|1|||
128802497|NCT00709098|463570295|FG002|Double-blind Period|Lost to Follow-up|0|||
128802498|NCT00709098|463570293|FG000|Open-label Period|Withdrawal of consent|0|||
128802499|NCT00709098|463570294|FG001|Open-label Period|Withdrawal of consent|0|||
128802500|NCT00709098|463570295|FG002|Open-label Period|Withdrawal of consent|7|||
128802501|NCT00709098|463570293|FG000|Open-label Period|Administrative reason|0|||
128802502|NCT00709098|463570294|FG001|Open-label Period|Administrative reason|0|||
128802503|NCT00709098|463570295|FG002|Open-label Period|Administrative reason|5|||
128802504|NCT00709098|463570293|FG000|Open-label Period|Death|0|||
128802505|NCT00709098|463570294|FG001|Open-label Period|Death|0|||
128802506|NCT00709098|463570295|FG002|Open-label Period|Death|1|||
128802507|NCT00709098|463570293|FG000|Open-label Period|Lost to Follow-up|0|||
128802508|NCT00709098|463570294|FG001|Open-label Period|Lost to Follow-up|0|||
128802509|NCT00709098|463570295|FG002|Open-label Period|Lost to Follow-up|1|||
128802510|NCT03481816|463570297|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
128802511|NCT03481816|463570298|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
128802512|NCT03481816|463570297|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
128802513|NCT03481816|463570298|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
128802514|NCT03481816|463570297|FG000|Dose Expansion|Withdrawal by Subject|0|||
128802515|NCT03481816|463570298|FG001|Dose Expansion|Withdrawal by Subject|2|||
128802516|NCT03481816|463570297|FG000|Dose Expansion|Physician Decision|0|||
128802517|NCT03481816|463570298|FG001|Dose Expansion|Physician Decision|5|||
128802518|NCT03582722|463570304|FG000|Overall Study|Lost to Follow-up|1|||
128802519|NCT03582722|463570305|FG001|Overall Study|Lost to Follow-up|4|||
128802520|NCT03582722|463570304|FG000|Overall Study|Withdrawal by Subject|3|||
128802521|NCT03582722|463570305|FG001|Overall Study|Withdrawal by Subject|3|||
128802522|NCT03690206|463570306|FG000|Overall Study|Withdrawal by Subject|2|||
128802523|NCT03690206|463570307|FG001|Overall Study|Withdrawal by Subject|0|||
128802524|NCT03690206|463570308|FG002|Overall Study|Withdrawal by Subject|0|||
128802525|NCT03690206|463570306|FG000|Overall Study|ICF withdrawal|2|||
128802526|NCT03690206|463570307|FG001|Overall Study|ICF withdrawal|0|||
128802527|NCT03690206|463570308|FG002|Overall Study|ICF withdrawal|0|||
128802528|NCT06024174|463570309|FG000|Overall Study|Other Reasons|1|||
128802529|NCT06024174|463570309|FG000|Overall Study|Study terminated by Sponsor|4|||
128802530|NCT01959698|463570310|FG000|Overall Study|Adverse Event|0|||
128802531|NCT01959698|463570311|FG001|Overall Study|Adverse Event|0|||
128802532|NCT01959698|463570312|FG002|Overall Study|Adverse Event|0|||
128802533|NCT01959698|463570313|FG003|Overall Study|Adverse Event|0|||
128802534|NCT01959698|463570314|FG004|Overall Study|Adverse Event|0|||
128802535|NCT01959698|463570315|FG005|Overall Study|Adverse Event|0|||
128802536|NCT01959698|463570316|FG006|Overall Study|Adverse Event|1|||
128802537|NCT01959698|463570310|FG000|Overall Study|Physician Decision|1|||
128802538|NCT01959698|463570311|FG001|Overall Study|Physician Decision|0|||
128802539|NCT01959698|463570312|FG002|Overall Study|Physician Decision|1|||
128802540|NCT01959698|463570313|FG003|Overall Study|Physician Decision|2|||
128802541|NCT01959698|463570314|FG004|Overall Study|Physician Decision|0|||
128802542|NCT01959698|463570315|FG005|Overall Study|Physician Decision|3|||
128802543|NCT01959698|463570316|FG006|Overall Study|Physician Decision|3|||
128802544|NCT03012841|463572339|FG000|Overall Study|Protocol Violation|0|||
128802545|NCT03012841|463572340|FG001|Overall Study|Protocol Violation|10|||
128802546|NCT03012841|463572339|FG000|Overall Study|Lost to Follow-up|6|||
128802547|NCT03012841|463572340|FG001|Overall Study|Lost to Follow-up|1|||
128802548|NCT03012841|463572339|FG000|Overall Study|Withdrawal by Subject|6|||
128802549|NCT03012841|463572340|FG001|Overall Study|Withdrawal by Subject|0|||
128802550|NCT03012841|463572339|FG000|Overall Study|Unable to complete 12 month visit|6|||
128802551|NCT03012841|463572340|FG001|Overall Study|Unable to complete 12 month visit|0|||
128802552|NCT03012841|463572339|FG000|Overall Study|Subject relocation|1|||
128802553|NCT03012841|463572340|FG001|Overall Study|Subject relocation|0|||
128802554|NCT03012841|463572339|FG000|Overall Study|Seasonal winter travel|1|||
128802555|NCT03012841|463572340|FG001|Overall Study|Seasonal winter travel|0|||
128802556|NCT03012841|463572339|FG000|Overall Study|Physician Decision|0|||
128802557|NCT03012841|463572340|FG001|Overall Study|Physician Decision|2|||
128802558|NCT03012841|463572339|FG000|Overall Study|No ablation performed|0|||
128802559|NCT03012841|463572340|FG001|Overall Study|No ablation performed|2|||
128802560|NCT03012841|463572339|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
128802561|NCT03012841|463572340|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
128802562|NCT03012841|463572339|FG000|Overall Study|Insurance change|0|||
128802563|NCT03012841|463572340|FG001|Overall Study|Insurance change|1|||
128802564|NCT05096819|463572343|FG000|Overall Study|Withdrawal by Subject|3|||
128802565|NCT05096819|463572344|FG001|Overall Study|Withdrawal by Subject|0|||
128802566|NCT05687903|463572345|FG000|Overall Study|Protocol Deviation|1|||
128802567|NCT05687903|463572346|FG001|Overall Study|Protocol Deviation|1|||
128802568|NCT05687903|463572347|FG002|Overall Study|Protocol Deviation|0|||
128802569|NCT05687903|463572348|FG003|Overall Study|Protocol Deviation|1|||
128802570|NCT05687903|463572349|FG004|Overall Study|Protocol Deviation|0|||
128802571|NCT04855760|463572350|FG000|Overall Study|Adverse Event|21|||
128802572|NCT04855760|463572350|FG000|Overall Study|Withdrawal by Subject|116|||
128802573|NCT04855760|463572350|FG000|Overall Study|Lack of Efficacy|21|||
128802574|NCT04855760|463572350|FG000|Overall Study|Lost to Follow-up|49|||
128802575|NCT04855760|463572350|FG000|Overall Study|Protocol Violation|2|||
128802576|NCT04855760|463572350|FG000|Overall Study|Physician Decision|5|||
128802577|NCT04855760|463572350|FG000|Overall Study|Pregnancy|1|||
128802578|NCT04855760|463572350|FG000|Overall Study|Non-Compliance with Study Drug|11|||
128802579|NCT04855760|463572350|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
128802580|NCT04855760|463572350|FG000|Overall Study|Study Completed by Sponsor|202|||
128802581|NCT04855760|463572350|FG000|Overall Study|Other|13|||
128802582|NCT05613205|463572351|FG000|Overall Study|Lost to Follow-up|0|||
128802583|NCT05613205|463572352|FG001|Overall Study|Lost to Follow-up|0|||
128802584|NCT05613205|463572353|FG002|Overall Study|Lost to Follow-up|1|||
128802585|NCT05613205|463572354|FG003|Overall Study|Lost to Follow-up|1|||
128802586|NCT05613205|463572355|FG004|Overall Study|Lost to Follow-up|0|||
128802587|NCT05613205|463572351|FG000|Overall Study|Withdrawal by Subject|0|||
128802588|NCT05613205|463572352|FG001|Overall Study|Withdrawal by Subject|0|||
128802589|NCT05613205|463572353|FG002|Overall Study|Withdrawal by Subject|1|||
128802590|NCT05613205|463572354|FG003|Overall Study|Withdrawal by Subject|1|||
128802591|NCT05613205|463572355|FG004|Overall Study|Withdrawal by Subject|0|||
128802592|NCT04869982|463572363|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
128802593|NCT04869982|463572364|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
128802594|NCT04869982|463572363|FG000|Overall Study|Migrated / moved from the study area|1|||
128802595|NCT04869982|463572364|FG001|Overall Study|Migrated / moved from the study area|1|||
128802596|NCT04869982|463572363|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
128802597|NCT04869982|463572364|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
128802598|NCT04869982|463572363|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
128802599|NCT04869982|463572364|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
128802600|NCT04869982|463572363|FG000|Overall Study|Solicited adverse event|2|||
128802601|NCT04869982|463572364|FG001|Overall Study|Solicited adverse event|1|||
128802602|NCT02201108|463572367|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
128802603|NCT02201108|463572368|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
128802604|NCT02201108|463572369|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
128802605|NCT02201108|463572367|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
128802606|NCT02201108|463572368|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
128802607|NCT02201108|463572369|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
128802608|NCT02201108|463572367|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
128802609|NCT02201108|463572368|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
128802610|NCT02201108|463572369|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
128802611|NCT02201108|463572367|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
128802612|NCT02201108|463572368|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
128802613|NCT02201108|463572369|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
128802614|NCT02201108|463572367|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
128802615|NCT02201108|463572368|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
128802616|NCT02201108|463572369|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
128802617|NCT02201108|463572367|FG000|Open Label Period (up to Week 192)|Other reason|4|||
128802618|NCT02201108|463572368|FG001|Open Label Period (up to Week 192)|Other reason|7|||
128802619|NCT02201108|463572369|FG002|Open Label Period (up to Week 192)|Other reason|0|||
128802620|NCT02201108|463572367|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
128802621|NCT02201108|463572368|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
128802622|NCT02201108|463572369|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
128802623|NCT02201108|463572367|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
128802624|NCT02201108|463572368|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
128802625|NCT02201108|463572369|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
128802626|NCT02201108|463572367|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
128802627|NCT02201108|463572368|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
128802628|NCT02201108|463572369|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
128802629|NCT04143061|463572371|FG000|Overall Study|Protocol Deviation|0|||
128802630|NCT04143061|463572372|FG001|Overall Study|Protocol Deviation|0|||
128802631|NCT04143061|463572373|FG002|Overall Study|Protocol Deviation|0|||
128802632|NCT04143061|463572374|FG003|Overall Study|Protocol Deviation|0|||
128802633|NCT04143061|463572375|FG004|Overall Study|Protocol Deviation|0|||
128802634|NCT04143061|463572376|FG005|Overall Study|Protocol Deviation|0|||
128802635|NCT04143061|463572377|FG006|Overall Study|Protocol Deviation|5|||
128802636|NCT04143061|463572378|FG007|Overall Study|Protocol Deviation|5|||
128802637|NCT04143061|463572371|FG000|Overall Study|Withdrawal by Subject|2|||
128802638|NCT04143061|463572372|FG001|Overall Study|Withdrawal by Subject|0|||
128802639|NCT04143061|463572373|FG002|Overall Study|Withdrawal by Subject|0|||
128802640|NCT04143061|463572374|FG003|Overall Study|Withdrawal by Subject|0|||
128802641|NCT04143061|463572375|FG004|Overall Study|Withdrawal by Subject|0|||
128802642|NCT04143061|463572376|FG005|Overall Study|Withdrawal by Subject|1|||
128802643|NCT04143061|463572377|FG006|Overall Study|Withdrawal by Subject|0|||
128802644|NCT04143061|463572378|FG007|Overall Study|Withdrawal by Subject|0|||
128802645|NCT04143061|463572371|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128802646|NCT04143061|463572372|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128802647|NCT04143061|463572373|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128802648|NCT04143061|463572374|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
128802649|NCT04143061|463572375|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
128802650|NCT04143061|463572376|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
128802651|NCT04143061|463572377|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
128802652|NCT04143061|463572378|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
128802653|NCT03602014|463572379|FG000|Overall Study|Lost to Follow-up|2|||
128802654|NCT03602014|463572380|FG001|Overall Study|Lost to Follow-up|0|||
128802655|NCT03602014|463572381|FG002|Overall Study|Lost to Follow-up|0|||
128802656|NCT03289039|463572384|FG000|Overall Study|Withdrawal by Subject|0|||
128802657|NCT03289039|463572385|FG001|Overall Study|Withdrawal by Subject|1|||
128802658|NCT03289039|463572384|FG000|Overall Study|Became ineligible prior to treatment start|0|||
128802659|NCT03289039|463572385|FG001|Overall Study|Became ineligible prior to treatment start|1|||
128802660|NCT03289039|463572384|FG000|Overall Study|progressed before treatment start|1|||
128802661|NCT03289039|463572385|FG001|Overall Study|progressed before treatment start|0|||
128802662|NCT04732494|463572386|FG000|Overall Study|Death|39|||
128802663|NCT04732494|463572387|FG001|Overall Study|Death|36|||
128802664|NCT04732494|463572386|FG000|Overall Study|Study Closed by Sponsor|20|||
128802665|NCT04732494|463572387|FG001|Overall Study|Study Closed by Sponsor|15|||
128802666|NCT04732494|463572386|FG000|Overall Study|Withdrawal by Subject|2|||
128802667|NCT04732494|463572387|FG001|Overall Study|Withdrawal by Subject|7|||
128802668|NCT04732494|463572386|FG000|Overall Study|Lost to Follow-up|1|||
128802669|NCT04732494|463572387|FG001|Overall Study|Lost to Follow-up|5|||
128802670|NCT01673984|463572390|FG000|Overall Study|Adverse Event|1|||
128802671|NCT01673984|463572391|FG001|Overall Study|Adverse Event|0|||
128802672|NCT01673984|463572390|FG000|Overall Study|Study termination|9|||
128802673|NCT01673984|463572391|FG001|Overall Study|Study termination|6|||
128802674|NCT04437433|463572392|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
128802675|NCT04437433|463572393|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
128802676|NCT04437433|463572392|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
128802677|NCT04437433|463572393|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
128802678|NCT04437433|463572392|FG000|Overall Study|Adverse Event|9|||
128802679|NCT04437433|463572393|FG001|Overall Study|Adverse Event|0|||
128802680|NCT04437433|463572392|FG000|Overall Study|Lack of Efficacy|4|||
128802681|NCT04437433|463572393|FG001|Overall Study|Lack of Efficacy|0|||
128802682|NCT04437433|463572392|FG000|Overall Study|Withdrawal by Subject|4|||
128802683|NCT04437433|463572393|FG001|Overall Study|Withdrawal by Subject|1|||
128802684|NCT04437433|463572392|FG000|Overall Study|Protocol Deviation|0|||
128802685|NCT04437433|463572393|FG001|Overall Study|Protocol Deviation|1|||
128802686|NCT04437433|463572392|FG000|Overall Study|Other, not specified|0|||
128802687|NCT04437433|463572393|FG001|Overall Study|Other, not specified|1|||
128802688|NCT00894543|463572396|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
128802689|NCT00894543|463572397|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
128802690|NCT00894543|463572396|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
128802691|NCT00894543|463572397|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
128802692|NCT04048681|463572398|FG000|Overall Study|family emergency|0|||
128802693|NCT04048681|463572399|FG001|Overall Study|family emergency|0|||
128802694|NCT04048681|463572400|FG002|Overall Study|family emergency|0|||
128802695|NCT04048681|463572401|FG003|Overall Study|family emergency|1|||
128802696|NCT04048681|463572402|FG004|Overall Study|family emergency|0|||
128802697|NCT01532388|463572403|FG000|3-month Follow-up|Lost to Follow-up|68|||
128802698|NCT01532388|463572404|FG001|3-month Follow-up|Lost to Follow-up|68|||
128802699|NCT01532388|463572403|FG000|6-month Follow-up|Lost to Follow-up|74|||
128802700|NCT01532388|463572404|FG001|6-month Follow-up|Lost to Follow-up|66|||
128802701|NCT01532388|463572403|FG000|12-month Follow-up|Lost to Follow-up|69|||
128802702|NCT01532388|463572404|FG001|12-month Follow-up|Lost to Follow-up|67|||
128802703|NCT02919449|463572405|FG000|Overall Study|Withdrawal by Subject|1|||
128802704|NCT02919449|463572405|FG000|Overall Study|Investigator decision|1|||
128802705|NCT02697136|463572409|FG000|Overall Study|Adverse Event|3|||
128802706|NCT02697136|463572410|FG001|Overall Study|Adverse Event|0|||
128802707|NCT02538900|463572413|FG000|Overall Study|Death|2|||
128802708|NCT02538900|463572414|FG001|Overall Study|Death|2|||
128802709|NCT02538900|463572415|FG002|Overall Study|Death|2|||
128802710|NCT02538900|463572413|FG000|Overall Study|Withdrawal by Subject|18|||
128802711|NCT02538900|463572414|FG001|Overall Study|Withdrawal by Subject|16|||
128802712|NCT02538900|463572415|FG002|Overall Study|Withdrawal by Subject|15|||
128802713|NCT02874534|463572416|FG000|Overall Study|Withdrawal by Subject|5|||
128802714|NCT02874534|463572417|FG001|Overall Study|Withdrawal by Subject|8|||
128802715|NCT02874534|463572416|FG000|Overall Study|Lost to Follow-up|2|||
128802716|NCT02874534|463572417|FG001|Overall Study|Lost to Follow-up|2|||
128802717|NCT02874534|463572416|FG000|Overall Study|Ongoing in study|1|||
128802718|NCT02874534|463572417|FG001|Overall Study|Ongoing in study|1|||
128802719|NCT02923180|463572418|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
128802720|NCT02923180|463572418|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
128802721|NCT05198310|463572419|FG000|Overall Study|Lost to Follow-up|0|||
128802722|NCT05198310|463572420|FG001|Overall Study|Lost to Follow-up|1|||
128802723|NCT05198310|463572421|FG002|Overall Study|Lost to Follow-up|0|||
128802724|NCT05198310|463572422|FG003|Overall Study|Lost to Follow-up|0|||
128802725|NCT05198310|463572423|FG004|Overall Study|Lost to Follow-up|0|||
128802726|NCT05198310|463572424|FG005|Overall Study|Lost to Follow-up|0|||
128802727|NCT05198310|463572425|FG006|Overall Study|Lost to Follow-up|0|||
128802728|NCT05198310|463572426|FG007|Overall Study|Lost to Follow-up|0|||
128802729|NCT05198310|463572419|FG000|Overall Study|Withdrawal by Subject|0|||
128802730|NCT05198310|463572420|FG001|Overall Study|Withdrawal by Subject|0|||
128802731|NCT05198310|463572421|FG002|Overall Study|Withdrawal by Subject|0|||
128802732|NCT05198310|463572422|FG003|Overall Study|Withdrawal by Subject|2|||
128802733|NCT05198310|463572423|FG004|Overall Study|Withdrawal by Subject|0|||
128802734|NCT05198310|463572424|FG005|Overall Study|Withdrawal by Subject|2|||
128802735|NCT05198310|463572425|FG006|Overall Study|Withdrawal by Subject|1|||
128802736|NCT05198310|463572426|FG007|Overall Study|Withdrawal by Subject|3|||
128802737|NCT04436107|463572427|FG000|Overall Study|Sponsor Ended Study|2|||
128802738|NCT04436107|463572428|FG001|Overall Study|Sponsor Ended Study|4|||
128802739|NCT04436107|463572429|FG002|Overall Study|Sponsor Ended Study|8|||
128802740|NCT04436107|463572430|FG003|Overall Study|Sponsor Ended Study|20|||
128802741|NCT04436107|463572427|FG000|Overall Study|Death|3|||
128802742|NCT04436107|463572428|FG001|Overall Study|Death|5|||
128802743|NCT04436107|463572429|FG002|Overall Study|Death|3|||
128802744|NCT04436107|463572430|FG003|Overall Study|Death|18|||
128802745|NCT04436107|463572427|FG000|Overall Study|Withdrawal by Subject|1|||
128802746|NCT04436107|463572428|FG001|Overall Study|Withdrawal by Subject|1|||
128802747|NCT04436107|463572429|FG002|Overall Study|Withdrawal by Subject|0|||
128802748|NCT04436107|463572430|FG003|Overall Study|Withdrawal by Subject|1|||
128802749|NCT01095796|463572431|FG000|Overall Study|Randomized but Not Treated|5|||
128802750|NCT01095796|463572432|FG001|Overall Study|Randomized but Not Treated|2|||
128802751|NCT01095796|463572431|FG000|Overall Study|Adverse Event|9|||
128802752|NCT01095796|463572432|FG001|Overall Study|Adverse Event|19|||
128802753|NCT01095796|463572431|FG000|Overall Study|Death|3|||
128802754|NCT01095796|463572432|FG001|Overall Study|Death|2|||
128802755|NCT01095796|463572431|FG000|Overall Study|Pregnancy|2|||
128802756|NCT01095796|463572432|FG001|Overall Study|Pregnancy|0|||
128802757|NCT01095796|463572431|FG000|Overall Study|Lack of Efficacy|5|||
128802758|NCT01095796|463572432|FG001|Overall Study|Lack of Efficacy|3|||
128802759|NCT01095796|463572431|FG000|Overall Study|Investigator's Discretion|7|||
128802760|NCT01095796|463572432|FG001|Overall Study|Investigator's Discretion|2|||
128802761|NCT01095796|463572431|FG000|Overall Study|Withdrew Consent|16|||
128802762|NCT01095796|463572432|FG001|Overall Study|Withdrew Consent|22|||
128802763|NCT01095796|463572431|FG000|Overall Study|Lost to Follow-up|27|||
128802764|NCT01095796|463572432|FG001|Overall Study|Lost to Follow-up|29|||
128802765|NCT01095796|463572431|FG000|Overall Study|Participant Noncompliance|5|||
128802766|NCT01095796|463572432|FG001|Overall Study|Participant Noncompliance|10|||
128802767|NCT01095796|463572431|FG000|Overall Study|Protocol Violation|1|||
128802768|NCT01095796|463572432|FG001|Overall Study|Protocol Violation|0|||
128802769|NCT01095796|463572431|FG000|Overall Study|Participant Transferred to Another Study|215|||
128802770|NCT01095796|463572432|FG001|Overall Study|Participant Transferred to Another Study|200|||
128802771|NCT01989455|463572437|FG000|Overall Study|Adverse Event|0|||
128802772|NCT01989455|463572438|FG001|Overall Study|Adverse Event|1|||
128802773|NCT01989455|463572439|FG002|Overall Study|Adverse Event|0|||
128802774|NCT01989455|463572440|FG003|Overall Study|Adverse Event|0|||
128802775|NCT01989455|463572441|FG004|Overall Study|Adverse Event|0|||
128802776|NCT01989455|463572437|FG000|Overall Study|Withdrawal by Subject|0|||
128802777|NCT01989455|463572438|FG001|Overall Study|Withdrawal by Subject|1|||
128802778|NCT01989455|463572439|FG002|Overall Study|Withdrawal by Subject|0|||
128802779|NCT01989455|463572440|FG003|Overall Study|Withdrawal by Subject|0|||
128802780|NCT01989455|463572441|FG004|Overall Study|Withdrawal by Subject|0|||
128802781|NCT01989455|463572437|FG000|Overall Study|Technical problems with infusion|0|||
128802782|NCT01989455|463572438|FG001|Overall Study|Technical problems with infusion|0|||
128802783|NCT01989455|463572439|FG002|Overall Study|Technical problems with infusion|1|||
128802784|NCT01989455|463572440|FG003|Overall Study|Technical problems with infusion|0|||
128802785|NCT01989455|463572441|FG004|Overall Study|Technical problems with infusion|1|||
128802786|NCT05512962|463572442|FG000|Overall Study|Withdrawal by Subject|1|||
128802787|NCT05512962|463572443|FG001|Overall Study|Withdrawal by Subject|0|||
128802788|NCT05575076|463572445|FG000|Overall Study|Adverse Event|24|||
128802789|NCT05575076|463572445|FG000|Overall Study|Death|7|||
128802790|NCT05575076|463572445|FG000|Overall Study|Lost to Follow-up|16|||
128802791|NCT05575076|463572445|FG000|Overall Study|Non-Compliance|3|||
128802792|NCT05575076|463572445|FG000|Overall Study|Physician Decision|6|||
128802793|NCT05575076|463572445|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
128802794|NCT05575076|463572445|FG000|Overall Study|Withdrawal by Subject|71|||
128802795|NCT05575076|463572445|FG000|Overall Study|Study Terminated by Sponsor|630|||
128802796|NCT05575076|463572445|FG000|Overall Study|Other|17|||
128802797|NCT01127373|463572446|FG000|Overall Study|Not Treated|3|||
128802798|NCT01127373|463572446|FG000|Overall Study|Lost to Follow-up|7|||
128802799|NCT01127373|463572446|FG000|Overall Study|Withdrawal by Subject|1|||
128802800|NCT01127373|463572446|FG000|Overall Study|Disease progression|1|||
128802801|NCT01426412|463572453|FG000|Overall Study|Withdrawal by Subject|1|||
128802802|NCT01426412|463572454|FG001|Overall Study|Withdrawal by Subject|0|||
128802803|NCT01426412|463572455|FG002|Overall Study|Withdrawal by Subject|0|||
128802804|NCT01426412|463572456|FG003|Overall Study|Withdrawal by Subject|0|||
128802805|NCT01426412|463572457|FG004|Overall Study|Withdrawal by Subject|1|||
128802806|NCT01426412|463572458|FG005|Overall Study|Withdrawal by Subject|0|||
128802807|NCT01426412|463572459|FG006|Overall Study|Withdrawal by Subject|0|||
128802808|NCT01426412|463572460|FG007|Overall Study|Withdrawal by Subject|3|||
128802809|NCT01426412|463572461|FG008|Overall Study|Withdrawal by Subject|1|||
128802810|NCT01084707|463572463|FG000|Overall Study|Withdrawal by Subject|6|||
128802811|NCT02671435|463572468|FG000|Overall Study|Death|1|||
128802812|NCT02671435|463572469|FG001|Overall Study|Death|3|||
128802813|NCT02671435|463572470|FG002|Overall Study|Death|0|||
128802814|NCT02671435|463572471|FG003|Overall Study|Death|16|||
128802815|NCT02671435|463572472|FG004|Overall Study|Death|14|||
128802816|NCT02671435|463572473|FG005|Overall Study|Death|29|||
128802817|NCT02671435|463572474|FG006|Overall Study|Death|34|||
128802818|NCT02671435|463572475|FG007|Overall Study|Death|28|||
128802819|NCT02671435|463572476|FG008|Overall Study|Death|19|||
128802820|NCT02671435|463572477|FG009|Overall Study|Death|10|||
128802821|NCT02671435|463572478|FG010|Overall Study|Death|8|||
128802822|NCT02671435|463572479|FG011|Overall Study|Death|29|||
128802823|NCT02671435|463572480|FG012|Overall Study|Death|29|||
128802824|NCT02671435|463572481|FG013|Overall Study|Death|29|||
128802825|NCT02671435|463572482|FG014|Overall Study|Death|27|||
128802826|NCT02671435|463572468|FG000|Overall Study|Lost to Follow-up|0|||
128802827|NCT02671435|463572469|FG001|Overall Study|Lost to Follow-up|0|||
128802828|NCT02671435|463572470|FG002|Overall Study|Lost to Follow-up|1|||
128802829|NCT02671435|463572471|FG003|Overall Study|Lost to Follow-up|0|||
128802830|NCT02671435|463572472|FG004|Overall Study|Lost to Follow-up|1|||
128802831|NCT02671435|463572473|FG005|Overall Study|Lost to Follow-up|1|||
128802832|NCT02671435|463572474|FG006|Overall Study|Lost to Follow-up|2|||
128802833|NCT02671435|463572475|FG007|Overall Study|Lost to Follow-up|2|||
128802834|NCT02671435|463572476|FG008|Overall Study|Lost to Follow-up|0|||
128802835|NCT02671435|463572477|FG009|Overall Study|Lost to Follow-up|2|||
128802836|NCT02671435|463572478|FG010|Overall Study|Lost to Follow-up|0|||
128802837|NCT02671435|463572479|FG011|Overall Study|Lost to Follow-up|3|||
128802838|NCT02671435|463572480|FG012|Overall Study|Lost to Follow-up|3|||
128802839|NCT02671435|463572481|FG013|Overall Study|Lost to Follow-up|2|||
128802840|NCT02671435|463572482|FG014|Overall Study|Lost to Follow-up|0|||
128802841|NCT02671435|463572468|FG000|Overall Study|Withdrawal by Subject|2|||
128802842|NCT02671435|463572469|FG001|Overall Study|Withdrawal by Subject|0|||
128802843|NCT02671435|463572470|FG002|Overall Study|Withdrawal by Subject|2|||
128802844|NCT02671435|463572471|FG003|Overall Study|Withdrawal by Subject|2|||
128802845|NCT02671435|463572472|FG004|Overall Study|Withdrawal by Subject|2|||
128802846|NCT02671435|463572473|FG005|Overall Study|Withdrawal by Subject|7|||
128802847|NCT02671435|463572474|FG006|Overall Study|Withdrawal by Subject|2|||
128802848|NCT02671435|463572475|FG007|Overall Study|Withdrawal by Subject|7|||
128802849|NCT02671435|463572476|FG008|Overall Study|Withdrawal by Subject|1|||
128802850|NCT02671435|463572477|FG009|Overall Study|Withdrawal by Subject|1|||
128802851|NCT02671435|463572478|FG010|Overall Study|Withdrawal by Subject|2|||
128802852|NCT02671435|463572479|FG011|Overall Study|Withdrawal by Subject|4|||
128802853|NCT02671435|463572480|FG012|Overall Study|Withdrawal by Subject|4|||
128802854|NCT02671435|463572481|FG013|Overall Study|Withdrawal by Subject|4|||
128802855|NCT02671435|463572482|FG014|Overall Study|Withdrawal by Subject|2|||
128802856|NCT02671435|463572468|FG000|Overall Study|Un-specified|0|||
128802857|NCT02671435|463572469|FG001|Overall Study|Un-specified|0|||
128802858|NCT02671435|463572470|FG002|Overall Study|Un-specified|0|||
128802859|NCT02671435|463572471|FG003|Overall Study|Un-specified|0|||
128802860|NCT02671435|463572472|FG004|Overall Study|Un-specified|1|||
128802861|NCT02671435|463572473|FG005|Overall Study|Un-specified|3|||
128802862|NCT02671435|463572474|FG006|Overall Study|Un-specified|2|||
128802863|NCT02671435|463572475|FG007|Overall Study|Un-specified|3|||
128802864|NCT02671435|463572476|FG008|Overall Study|Un-specified|0|||
128802865|NCT02671435|463572477|FG009|Overall Study|Un-specified|5|||
128802866|NCT02671435|463572478|FG010|Overall Study|Un-specified|8|||
128802867|NCT02671435|463572479|FG011|Overall Study|Un-specified|4|||
128802868|NCT02671435|463572480|FG012|Overall Study|Un-specified|5|||
128802869|NCT02671435|463572481|FG013|Overall Study|Un-specified|9|||
128802870|NCT02671435|463572482|FG014|Overall Study|Un-specified|8|||
128802871|NCT02412748|463572485|FG000|Overall Study|Lost to Follow-up|38|||
128802872|NCT02412748|463572486|FG001|Overall Study|Lost to Follow-up|39|||
128802873|NCT03069313|463572487|FG000|Overall Study|Adverse Event|5|||
128802874|NCT04820686|463572491|FG000|Overall Study|Withdrawal by Subject|5|||
128802875|NCT04820686|463572492|FG001|Overall Study|Withdrawal by Subject|2|||
128802876|NCT04820686|463572493|FG002|Overall Study|Withdrawal by Subject|3|||
128802877|NCT04820686|463572491|FG000|Overall Study|Study Termination|25|||
128802878|NCT04820686|463572492|FG001|Overall Study|Study Termination|13|||
128802879|NCT04820686|463572493|FG002|Overall Study|Study Termination|14|||
128802880|NCT04820686|463572491|FG000|Overall Study|Adverse Event|0|||
128802881|NCT04820686|463572492|FG001|Overall Study|Adverse Event|1|||
128802882|NCT04820686|463572493|FG002|Overall Study|Adverse Event|0|||
128802883|NCT01872078|463572494|FG000|Overall Study|Adverse Event|0|||
128802884|NCT01872078|463572495|FG001|Overall Study|Adverse Event|0|||
128802885|NCT01872078|463572496|FG002|Overall Study|Adverse Event|1|||
128802886|NCT01872078|463572497|FG003|Overall Study|Adverse Event|0|||
128802887|NCT01872078|463572494|FG000|Overall Study|Dose administration non-compliance|0|||
128802888|NCT01872078|463572495|FG001|Overall Study|Dose administration non-compliance|0|||
128802889|NCT01872078|463572496|FG002|Overall Study|Dose administration non-compliance|0|||
128802890|NCT01872078|463572497|FG003|Overall Study|Dose administration non-compliance|1|||
128802891|NCT01872078|463572494|FG000|Overall Study|Protocol Violation|0|||
128802892|NCT01872078|463572495|FG001|Overall Study|Protocol Violation|0|||
128802893|NCT01872078|463572496|FG002|Overall Study|Protocol Violation|1|||
128802894|NCT01872078|463572497|FG003|Overall Study|Protocol Violation|0|||
128802895|NCT01872078|463572494|FG000|Overall Study|Withdrawal by Subject|0|||
128802896|NCT01872078|463572495|FG001|Overall Study|Withdrawal by Subject|0|||
128802897|NCT01872078|463572496|FG002|Overall Study|Withdrawal by Subject|1|||
128802898|NCT01872078|463572497|FG003|Overall Study|Withdrawal by Subject|0|||
128802899|NCT01872078|463572494|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
128802900|NCT01872078|463572495|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
128802901|NCT01872078|463572496|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
128802902|NCT01872078|463572497|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
128802903|NCT01424670|463572498|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
128802904|NCT01424670|463572499|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
128802905|NCT01424670|463572498|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
128802906|NCT01424670|463572499|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
128802907|NCT01424670|463572498|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
128802908|NCT01424670|463572499|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
128802909|NCT01424670|463572498|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
128802910|NCT01424670|463572499|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
128802911|NCT01424670|463572498|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
128802912|NCT01424670|463572499|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
128802913|NCT01424670|463572498|FG000|Continuation Period|Adverse Event|13|||
128802914|NCT01424670|463572499|FG001|Continuation Period|Adverse Event|5|||
128802915|NCT01424670|463572498|FG000|Continuation Period|Lost to Follow-up|2|||
128802916|NCT01424670|463572499|FG001|Continuation Period|Lost to Follow-up|0|||
128802917|NCT01424670|463572498|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
128802918|NCT01424670|463572499|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
128802919|NCT01424670|463572498|FG000|Continuation Period|Physician Decision|5|||
128802920|NCT01424670|463572499|FG001|Continuation Period|Physician Decision|4|||
128802921|NCT01424670|463572498|FG000|Continuation Period|Withdrawal by Subject|13|||
128802922|NCT01424670|463572499|FG001|Continuation Period|Withdrawal by Subject|4|||
128802923|NCT00761189|463572500|FG000|Overall Study|Adverse Event|42|||
128802924|NCT00761189|463572500|FG000|Overall Study|Lack of Efficacy|45|||
128802925|NCT00761189|463572500|FG000|Overall Study|Lost to Follow-up|36|||
128802926|NCT00761189|463572500|FG000|Overall Study|Withdrawal by Subject|49|||
128802927|NCT00761189|463572500|FG000|Overall Study|Other|13|||
128802928|NCT01494922|463572501|FG000|Overall Study|Adverse Event|1|||
128802929|NCT02891915|463572502|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
128802930|NCT02891915|463572503|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
128802931|NCT02891915|463572502|FG000|Overall Study|Withdrawal by Subject|3|||
128802932|NCT02891915|463572503|FG001|Overall Study|Withdrawal by Subject|3|||
128802933|NCT02891915|463572502|FG000|Overall Study|Became Ineligible After Enrollment|2|||
128802934|NCT02891915|463572503|FG001|Overall Study|Became Ineligible After Enrollment|1|||
128802935|NCT02891915|463572502|FG000|Overall Study|Lost to Follow-up|1|||
128802936|NCT02891915|463572503|FG001|Overall Study|Lost to Follow-up|4|||
128802937|NCT02891915|463572502|FG000|Overall Study|Physician Decision|1|||
128802938|NCT02891915|463572503|FG001|Overall Study|Physician Decision|0|||
128802939|NCT01091168|463572504|FG000|Overall Study|Progressive disease|250|||
128802940|NCT01091168|463572505|FG001|Overall Study|Progressive disease|234|||
128802941|NCT01091168|463572504|FG000|Overall Study|Adverse Event|21|||
128802942|NCT01091168|463572505|FG001|Overall Study|Adverse Event|24|||
128802943|NCT01091168|463572504|FG000|Overall Study|Lost to Follow-up|0|||
128802944|NCT01091168|463572505|FG001|Overall Study|Lost to Follow-up|1|||
128802945|NCT01091168|463572504|FG000|Overall Study|Physician, patient's decision, other|27|||
128802946|NCT01091168|463572505|FG001|Overall Study|Physician, patient's decision, other|37|||
128802947|NCT04567615|463572508|FG000|Randomization|Participant withdrew consent|1|||
128802948|NCT04567615|463572509|FG001|Randomization|Participant withdrew consent|0|||
128802949|NCT04567615|463572510|FG002|Randomization|Participant withdrew consent|0|||
128802950|NCT04567615|463572508|FG000|Randomization|Adverse event unrelated to study drug|0|||
128802951|NCT04567615|463572509|FG001|Randomization|Adverse event unrelated to study drug|1|||
128802952|NCT04567615|463572510|FG002|Randomization|Adverse event unrelated to study drug|0|||
128802953|NCT04567615|463572508|FG000|Treatment Period|Participant Withdrew Consent|2|||
128802954|NCT04567615|463572509|FG001|Treatment Period|Participant Withdrew Consent|5|||
128802955|NCT04567615|463572510|FG002|Treatment Period|Participant Withdrew Consent|1|||
128802956|NCT04567615|463572508|FG000|Treatment Period|Death|1|||
128802957|NCT04567615|463572509|FG001|Treatment Period|Death|2|||
128802958|NCT04567615|463572510|FG002|Treatment Period|Death|0|||
128802959|NCT04567615|463572508|FG000|Treatment Period|Lost to Follow-up|0|||
128802960|NCT04567615|463572509|FG001|Treatment Period|Lost to Follow-up|1|||
128802961|NCT04567615|463572510|FG002|Treatment Period|Lost to Follow-up|0|||
128802962|NCT04567615|463572508|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
128802963|NCT04567615|463572509|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
128802964|NCT04567615|463572510|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
128802965|NCT04567615|463572508|FG000|Treatment Period|Disease Progression|85|||
128802966|NCT04567615|463572509|FG001|Treatment Period|Disease Progression|63|||
128802967|NCT04567615|463572510|FG002|Treatment Period|Disease Progression|16|||
128802968|NCT04567615|463572508|FG000|Treatment Period|Study Drug Toxicity|3|||
128802969|NCT04567615|463572509|FG001|Treatment Period|Study Drug Toxicity|10|||
128802970|NCT04567615|463572510|FG002|Treatment Period|Study Drug Toxicity|4|||
128802971|NCT04567615|463572508|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
128802972|NCT04567615|463572509|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
128802973|NCT04567615|463572510|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
128802974|NCT04567615|463572508|FG000|Treatment Period|Other Reasons|1|||
128802975|NCT04567615|463572509|FG001|Treatment Period|Other Reasons|2|||
128802976|NCT04567615|463572510|FG002|Treatment Period|Other Reasons|0|||
128802977|NCT04567615|463572508|FG000|Treatment Period|Still On-going Treatment|21|||
128802978|NCT04567615|463572509|FG001|Treatment Period|Still On-going Treatment|22|||
128802979|NCT04567615|463572510|FG002|Treatment Period|Still On-going Treatment|2|||
128802980|NCT03744312|463573641|FG000|Overall Study|Withdrawal by Subject|0|||
128802981|NCT03744312|463573642|FG001|Overall Study|Withdrawal by Subject|1|||
128802982|NCT03744312|463573641|FG000|Overall Study|Screen fail|0|||
128802983|NCT03744312|463573642|FG001|Overall Study|Screen fail|1|||
128802984|NCT04924062|463573643|FG000|Overall Study|Death|49|||
128802985|NCT04924062|463573644|FG001|Overall Study|Death|63|||
128802986|NCT04924062|463573643|FG000|Overall Study|Participant On-going|26|||
128802987|NCT04924062|463573644|FG001|Overall Study|Participant On-going|20|||
128802988|NCT04607044|463573647|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
128802989|NCT04607044|463573647|FG000|Overall Study|Adverse Event|1|||
128802990|NCT04607044|463573647|FG000|Overall Study|Did not receive study device|3|||
128802991|NCT04607044|463573647|FG000|Overall Study|Death|1|||
128802992|NCT04059354|463573650|FG000|Overall Study|COVID-19 pandemic|3|||
128802993|NCT05403801|463573651|FG000|Overall Study|Withdrawal by Subject|2|||
128802994|NCT03651895|463573653|FG000|First Drug Assignment|Adverse Event|4|||
128802995|NCT03651895|463573654|FG001|First Drug Assignment|Adverse Event|5|||
128802996|NCT03651895|463573653|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
128802997|NCT03651895|463573654|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
128802998|NCT02525692|463573655|FG000|Overall Study|Withdrawal by Subject|1|||
128802999|NCT02525692|463573656|FG001|Overall Study|Withdrawal by Subject|1|||
128803000|NCT02525692|463573657|FG002|Overall Study|Withdrawal by Subject|0|||
128803001|NCT02525692|463573658|FG003|Overall Study|Withdrawal by Subject|5|||
128803002|NCT02525692|463573659|FG004|Overall Study|Withdrawal by Subject|0|||
128803003|NCT02525692|463573660|FG005|Overall Study|Withdrawal by Subject|1|||
128803004|NCT02525692|463573655|FG000|Overall Study|Death|16|||
128803005|NCT02525692|463573656|FG001|Overall Study|Death|18|||
128803006|NCT02525692|463573657|FG002|Overall Study|Death|7|||
128803007|NCT02525692|463573658|FG003|Overall Study|Death|20|||
128803008|NCT02525692|463573659|FG004|Overall Study|Death|3|||
128803009|NCT02525692|463573660|FG005|Overall Study|Death|6|||
128803010|NCT02525692|463573655|FG000|Overall Study|Lost to Follow-up|0|||
128803011|NCT02525692|463573656|FG001|Overall Study|Lost to Follow-up|0|||
128803012|NCT02525692|463573657|FG002|Overall Study|Lost to Follow-up|1|||
128803013|NCT02525692|463573658|FG003|Overall Study|Lost to Follow-up|5|||
128803014|NCT02525692|463573659|FG004|Overall Study|Lost to Follow-up|0|||
128803015|NCT02525692|463573660|FG005|Overall Study|Lost to Follow-up|0|||
128803016|NCT02396199|463573661|FG000|Overall Study|Lost to Follow-up|1|||
128803017|NCT02396199|463573661|FG000|Overall Study|Death|4|||
128803018|NCT04337372|463573671|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
128803019|NCT04337372|463573672|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
128803020|NCT04337372|463573673|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
128803021|NCT04337372|463573674|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
128803022|NCT04337372|463573671|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
128803023|NCT04337372|463573672|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
128803024|NCT04337372|463573673|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
128803025|NCT04337372|463573674|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
128803026|NCT04337372|463573671|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
128803027|NCT04337372|463573672|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
128803028|NCT04337372|463573673|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
128803029|NCT04337372|463573674|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
128803030|NCT04337372|463573671|FG000|Day 2: EEG Measures|Protocol Violation|6|||
128803031|NCT04337372|463573672|FG001|Day 2: EEG Measures|Protocol Violation|6|||
128803032|NCT04337372|463573673|FG002|Day 2: EEG Measures|Protocol Violation|5|||
128803033|NCT04337372|463573674|FG003|Day 2: EEG Measures|Protocol Violation|17|||
128803034|NCT05307783|463573675|FG000|Overall Study|Death|7|||
128803035|NCT05307783|463573675|FG000|Overall Study|Lost to Follow-up|4|||
128803036|NCT04883645|463573676|FG000|Overall Study|Death|1|||
128803037|NCT00567398|463573677|FG000|Overall Study|Adverse Event|6|||
128803038|NCT00567398|463573678|FG001|Overall Study|Adverse Event|14|||
128803039|NCT00567398|463573677|FG000|Overall Study|Physician Decision|0|||
128803040|NCT00567398|463573678|FG001|Overall Study|Physician Decision|4|||
128803041|NCT00567398|463573677|FG000|Overall Study|Withdrawal by Subject|0|||
128803042|NCT00567398|463573678|FG001|Overall Study|Withdrawal by Subject|2|||
128803043|NCT00567398|463573677|FG000|Overall Study|Renal Transplantation|0|||
128803044|NCT00567398|463573678|FG001|Overall Study|Renal Transplantation|3|||
128803045|NCT00567398|463573677|FG000|Overall Study|Other|1|||
128803046|NCT00567398|463573678|FG001|Overall Study|Other|0|||
128803047|NCT03055377|463573688|FG000|Treatment Phase|Lost to Follow-up|28|||
128803048|NCT03055377|463573689|FG001|Treatment Phase|Lost to Follow-up|24|||
128803049|NCT03055377|463573688|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
128803050|NCT03055377|463573689|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
128803051|NCT01718743|463573690|FG000|Overall Study|Physician Decision|7|||
128803052|NCT01718743|463573690|FG000|Overall Study|Withdrawal by Subject|14|||
128803053|NCT01718743|463573690|FG000|Overall Study|Progressive Disease|22|||
128803054|NCT01718743|463573690|FG000|Overall Study|Toxicity|1|||
128803055|NCT01718743|463573690|FG000|Overall Study|Malignancy|1|||
128803056|NCT03157167|463573694|FG000|Overall Study|Withdrawal by Subject|1|||
128803057|NCT03157167|463573695|FG001|Overall Study|Withdrawal by Subject|0|||
128803058|NCT03157167|463573696|FG002|Overall Study|Withdrawal by Subject|0|||
128803059|NCT04905407|463573698|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
128803060|NCT04905407|463573699|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
128803061|NCT04905407|463573700|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
128803062|NCT04905407|463573701|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
128803063|NCT04905407|463573698|FG000|Part 1 and Part 2|Death|7|||
128803064|NCT04905407|463573699|FG001|Part 1 and Part 2|Death|7|||
128803065|NCT04905407|463573700|FG002|Part 1 and Part 2|Death|7|||
128803066|NCT04905407|463573701|FG003|Part 1 and Part 2|Death|0|||
128803067|NCT04905407|463573698|FG000|Part 1 and Part 2|Other than specified|0|||
128803068|NCT04905407|463573699|FG001|Part 1 and Part 2|Other than specified|0|||
128803069|NCT04905407|463573700|FG002|Part 1 and Part 2|Other than specified|1|||
128803070|NCT04905407|463573701|FG003|Part 1 and Part 2|Other than specified|0|||
128803071|NCT04905407|463573698|FG000|Part 3|Death|0|||
128803072|NCT04905407|463573699|FG001|Part 3|Death|0|||
128803073|NCT04905407|463573700|FG002|Part 3|Death|0|||
128803074|NCT04905407|463573701|FG003|Part 3|Death|2|||
128803075|NCT05136404|463573702|FG000|Period 1|Adverse Event|0|||
128803076|NCT05136404|463573703|FG001|Period 1|Adverse Event|1|||
128803077|NCT05136404|463573704|FG002|Period 1|Adverse Event|1|||
128803078|NCT05136404|463573702|FG000|Period 2|Inappropriate Behavior|0|||
128803079|NCT05136404|463573703|FG001|Period 2|Inappropriate Behavior|0|||
128803080|NCT05136404|463573704|FG002|Period 2|Inappropriate Behavior|1|||
128803081|NCT05136404|463573702|FG000|Period 3|Adverse Event|0|||
128803082|NCT05136404|463573703|FG001|Period 3|Adverse Event|0|||
128803083|NCT05136404|463573704|FG002|Period 3|Adverse Event|1|||
128803084|NCT01894061|463573707|FG000|Overall Study|Screen failure|1|||
128803085|NCT01894061|463573707|FG000|Overall Study|Withdrawal by Subject|1|||
128803086|NCT05444192|463573708|FG000|Overall Study|Lost to Follow-up|1|||
128803087|NCT05444192|463573709|FG001|Overall Study|Lost to Follow-up|0|||
128803088|NCT05623345|463573711|FG000|Overall Study|Withdrawal by Subject|14|||
128803089|NCT05623345|463573712|FG001|Overall Study|Withdrawal by Subject|0|||
128803090|NCT05623345|463573713|FG002|Overall Study|Withdrawal by Subject|9|||
128803091|NCT05623345|463573714|FG003|Overall Study|Withdrawal by Subject|20|||
128803092|NCT05623345|463573711|FG000|Overall Study|Lost to Follow-up|3|||
128803093|NCT05623345|463573712|FG001|Overall Study|Lost to Follow-up|0|||
128803094|NCT05623345|463573713|FG002|Overall Study|Lost to Follow-up|7|||
128803095|NCT05623345|463573714|FG003|Overall Study|Lost to Follow-up|2|||
128803096|NCT05623345|463573711|FG000|Overall Study|Termination of Study By Sponsor|37|||
128803097|NCT05623345|463573712|FG001|Overall Study|Termination of Study By Sponsor|4|||
128803098|NCT05623345|463573713|FG002|Overall Study|Termination of Study By Sponsor|40|||
128803099|NCT05623345|463573714|FG003|Overall Study|Termination of Study By Sponsor|38|||
128803100|NCT05384730|463573715|FG000|Overall Study|Adverse Event|1|||
128803101|NCT05384730|463573716|FG001|Overall Study|Adverse Event|0|||
128803102|NCT05384730|463573715|FG000|Overall Study|Lack of social support|2|||
128803103|NCT05384730|463573716|FG001|Overall Study|Lack of social support|0|||
128803104|NCT05384730|463573715|FG000|Overall Study|Hospital readmission|2|||
128803105|NCT05384730|463573716|FG001|Overall Study|Hospital readmission|0|||
128803106|NCT05384730|463573715|FG000|Overall Study|Disease progression|5|||
128803107|NCT05384730|463573716|FG001|Overall Study|Disease progression|0|||
128803108|NCT05384730|463573715|FG000|Overall Study|Overwhelmed with College commitments|0|||
128803109|NCT05384730|463573716|FG001|Overall Study|Overwhelmed with College commitments|2|||
128803110|NCT01772472|463573717|FG000|Overall Study|Death|126|||
128803111|NCT01772472|463573718|FG001|Overall Study|Death|94|||
128803112|NCT01772472|463573717|FG000|Overall Study|Lost to Follow-up|51|||
128803113|NCT01772472|463573718|FG001|Overall Study|Lost to Follow-up|50|||
128803114|NCT01772472|463573717|FG000|Overall Study|Other|9|||
128803115|NCT01772472|463573718|FG001|Overall Study|Other|7|||
128803116|NCT01772472|463573717|FG000|Overall Study|Physician Decision|1|||
128803117|NCT01772472|463573718|FG001|Overall Study|Physician Decision|7|||
128803118|NCT01772472|463573717|FG000|Overall Study|Withdrawal by Subject|115|||
128803119|NCT01772472|463573718|FG001|Overall Study|Withdrawal by Subject|90|||
128803120|NCT01772472|463573717|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
128803121|NCT01772472|463573718|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
128803122|NCT03578536|463573727|FG000|Overall Study|Lost to Follow-up|1|||
128803123|NCT04431726|463573728|FG000|Overall Study|Ongoing in the Study|55|||
128803124|NCT04116736|463573729|FG000|Overall Study|Withdrew consent during study|3|||
128803125|NCT04116736|463573730|FG001|Overall Study|Withdrew consent during study|1|||
128803126|NCT04116736|463573729|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
128803127|NCT04116736|463573730|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
128803128|NCT04116736|463573729|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
128803129|NCT04116736|463573730|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
128803130|NCT04116736|463573729|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
128803131|NCT04116736|463573730|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
128803132|NCT04116736|463573729|FG000|Overall Study|Subject was enrolled in error|2|||
128803133|NCT04116736|463573730|FG001|Overall Study|Subject was enrolled in error|0|||
128803134|NCT04116736|463573729|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
128803135|NCT04116736|463573730|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
128803136|NCT04116736|463573729|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
128803137|NCT04116736|463573730|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
128803138|NCT04116736|463573729|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
128803139|NCT04116736|463573730|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
128803140|NCT04157348|463573734|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
128803141|NCT04157348|463573735|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
128803142|NCT04157348|463573734|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
128803143|NCT04157348|463573735|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
128803144|NCT04157348|463573734|FG000|Double-blind Treatment Period|Adverse Event|0|||
128803145|NCT04157348|463573735|FG001|Double-blind Treatment Period|Adverse Event|1|||
128803146|NCT04157348|463573734|FG000|Open-label Extension Period|Adverse Event|1|||
128803147|NCT04157348|463573735|FG001|Open-label Extension Period|Adverse Event|1|||
128803148|NCT04157348|463573734|FG000|Open-label Extension Period|Death|0|||
128803149|NCT04157348|463573735|FG001|Open-label Extension Period|Death|1|||
128803150|NCT04157348|463573734|FG000|Open-label Extension Period|Lack of Efficacy|2|||
128803151|NCT04157348|463573735|FG001|Open-label Extension Period|Lack of Efficacy|2|||
128803152|NCT04157348|463573734|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
128803153|NCT04157348|463573735|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
128803154|NCT04157348|463573734|FG000|Open-label Extension Period|Ongoing|60|||
128803155|NCT04157348|463573735|FG001|Open-label Extension Period|Ongoing|57|||
128803156|NCT04157348|463573734|FG000|Open-label Extension Period|other reasons|1|||
128803157|NCT04157348|463573735|FG001|Open-label Extension Period|other reasons|1|||
128803158|NCT04854096|463573736|FG000|Overall Study|Adverse Event|1|||
128803159|NCT04854096|463573737|FG001|Overall Study|Adverse Event|0|||
128803160|NCT04854096|463573736|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
128803161|NCT04854096|463573737|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
128803162|NCT04854096|463573736|FG000|Overall Study|Withdrawal by Subject|1|||
128803163|NCT04854096|463573737|FG001|Overall Study|Withdrawal by Subject|0|||
128803164|NCT04854096|463573736|FG000|Overall Study|Other reasons|1|||
128803165|NCT04854096|463573737|FG001|Overall Study|Other reasons|0|||
128803166|NCT04757610|463573738|FG000|Overall Study|Adverse Event|13|||
128803167|NCT04757610|463573739|FG001|Overall Study|Adverse Event|10|||
128803168|NCT04757610|463573740|FG002|Overall Study|Adverse Event|5|||
128803169|NCT04757610|463573738|FG000|Overall Study|Death|5|||
128803170|NCT04757610|463573739|FG001|Overall Study|Death|13|||
128803171|NCT04757610|463573740|FG002|Overall Study|Death|8|||
128803172|NCT04757610|463573738|FG000|Overall Study|Lack of Efficacy|1|||
128803173|NCT04757610|463573739|FG001|Overall Study|Lack of Efficacy|2|||
128803174|NCT04757610|463573740|FG002|Overall Study|Lack of Efficacy|3|||
128803175|NCT04757610|463573738|FG000|Overall Study|Lost to Follow-up|7|||
128803176|NCT04757610|463573739|FG001|Overall Study|Lost to Follow-up|2|||
128803177|NCT04757610|463573740|FG002|Overall Study|Lost to Follow-up|7|||
128803178|NCT04757610|463573738|FG000|Overall Study|Physician Decision|4|||
128803179|NCT04757610|463573739|FG001|Overall Study|Physician Decision|1|||
128803180|NCT04757610|463573740|FG002|Overall Study|Physician Decision|2|||
128803181|NCT04757610|463573738|FG000|Overall Study|Withdrawal by Subject|26|||
128803182|NCT04757610|463573739|FG001|Overall Study|Withdrawal by Subject|25|||
128803183|NCT04757610|463573740|FG002|Overall Study|Withdrawal by Subject|25|||
128803184|NCT04757610|463573738|FG000|Overall Study|Study Terminated by Sponsor|105|||
128803185|NCT04757610|463573739|FG001|Overall Study|Study Terminated by Sponsor|105|||
128803186|NCT04757610|463573740|FG002|Overall Study|Study Terminated by Sponsor|110|||
128803187|NCT04757610|463573738|FG000|Overall Study|Randomized in Error|1|||
128803188|NCT04757610|463573739|FG001|Overall Study|Randomized in Error|0|||
128803189|NCT04757610|463573740|FG002|Overall Study|Randomized in Error|0|||
128803190|NCT02965846|463573741|FG000|Overall Study|Lost to Follow-up|1|||
128803191|NCT02965846|463573742|FG001|Overall Study|Lost to Follow-up|0|||
128803192|NCT02965846|463573743|FG002|Overall Study|Lost to Follow-up|0|||
128803193|NCT02965846|463573741|FG000|Overall Study|Withdrawal by Subject|0|||
128803194|NCT02965846|463573742|FG001|Overall Study|Withdrawal by Subject|1|||
128803195|NCT02965846|463573743|FG002|Overall Study|Withdrawal by Subject|0|||
128803196|NCT02965846|463573741|FG000|Overall Study|Study Terminated By Sponsor|4|||
128803197|NCT02965846|463573742|FG001|Overall Study|Study Terminated By Sponsor|4|||
128803198|NCT02965846|463573743|FG002|Overall Study|Study Terminated By Sponsor|0|||
128803199|NCT02965846|463573741|FG000|Overall Study|Participants not randomized|0|||
128803200|NCT02965846|463573742|FG001|Overall Study|Participants not randomized|0|||
128803201|NCT02965846|463573743|FG002|Overall Study|Participants not randomized|33|||
128803202|NCT00879333|463573744|FG000|Overall Study|Adverse Event|94|||
128803203|NCT00879333|463573745|FG001|Overall Study|Adverse Event|34|||
128803204|NCT00879333|463573744|FG000|Overall Study|Abnormal Laboratory Value|1|||
128803205|NCT00879333|463573745|FG001|Overall Study|Abnormal Laboratory Value|0|||
128803206|NCT00879333|463573744|FG000|Overall Study|Withdrawal by Subject|20|||
128803207|NCT00879333|463573745|FG001|Overall Study|Withdrawal by Subject|7|||
128803208|NCT00879333|463573744|FG000|Overall Study|Lost to Follow-up|2|||
128803209|NCT00879333|463573745|FG001|Overall Study|Lost to Follow-up|1|||
128803210|NCT00879333|463573744|FG000|Overall Study|Administrative Problems|2|||
128803211|NCT00879333|463573745|FG001|Overall Study|Administrative Problems|0|||
128803212|NCT00879333|463573744|FG000|Overall Study|Death|16|||
128803213|NCT00879333|463573745|FG001|Overall Study|Death|5|||
128803214|NCT00879333|463573744|FG000|Overall Study|Disease Progression|292|||
128803215|NCT00879333|463573745|FG001|Overall Study|Disease Progression|169|||
128803216|NCT00879333|463573744|FG000|Overall Study|Protocol Violation|1|||
128803217|NCT00879333|463573745|FG001|Overall Study|Protocol Violation|1|||
128803218|NCT04154384|463573746|FG000|Overall Study|Lost to Follow-up|24|||
128803219|NCT04154384|463573747|FG001|Overall Study|Lost to Follow-up|33|||
128803220|NCT04154384|463573748|FG002|Overall Study|Lost to Follow-up|0|||
128803221|NCT04154384|463573746|FG000|Overall Study|Withdrawal by Subject|7|||
128803222|NCT04154384|463573747|FG001|Overall Study|Withdrawal by Subject|18|||
128803223|NCT04154384|463573748|FG002|Overall Study|Withdrawal by Subject|0|||
128803224|NCT04154384|463573746|FG000|Overall Study|Missing outcome data|1|||
128803225|NCT04154384|463573747|FG001|Overall Study|Missing outcome data|0|||
128803226|NCT04154384|463573748|FG002|Overall Study|Missing outcome data|0|||
128803227|NCT05048186|463573749|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
128803228|NCT05048186|463573750|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
128803229|NCT05048186|463573749|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
128803230|NCT05048186|463573750|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
128803231|NCT00951379|463573751|FG000|Overall Study|Adverse Event|4|||
128803232|NCT00951379|463573752|FG001|Overall Study|Adverse Event|1|||
128803233|NCT00951379|463573751|FG000|Overall Study|Withdrawal by Subject|1|||
128803234|NCT00951379|463573752|FG001|Overall Study|Withdrawal by Subject|0|||
128803235|NCT00951379|463573751|FG000|Overall Study|Noncompliance|1|||
128803236|NCT00951379|463573752|FG001|Overall Study|Noncompliance|0|||
128803237|NCT00951379|463573751|FG000|Overall Study|Disease Progression|0|||
128803238|NCT00951379|463573752|FG001|Overall Study|Disease Progression|1|||
128803239|NCT02742519|463573754|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
128803240|NCT02742519|463573755|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
128803241|NCT02742519|463573756|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
128803242|NCT02742519|463573754|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
128803243|NCT02742519|463573755|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
128803244|NCT02742519|463573756|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
128803245|NCT02742519|463573754|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
128803246|NCT02742519|463573755|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
128803247|NCT02742519|463573756|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
128803248|NCT04377308|463573757|FG000|Overall Study|Withdrawal by Subject|0|||
128803249|NCT04377308|463573758|FG001|Overall Study|Withdrawal by Subject|1|||
128803250|NCT02759016|463573759|FG000|Overall Study|Not treated with BI 836826|1|||
128803251|NCT02759016|463573760|FG001|Overall Study|Not treated with BI 836826|0|||
128803252|NCT02759016|463573759|FG000|Overall Study|Progressive disease|1|||
128803253|NCT02759016|463573760|FG001|Overall Study|Progressive disease|0|||
128803254|NCT02759016|463573759|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
128803255|NCT02759016|463573760|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
128803256|NCT02759016|463573759|FG000|Overall Study|Other not defined above|2|||
128803257|NCT02759016|463573760|FG001|Overall Study|Other not defined above|1|||
128803258|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
128803259|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
128803260|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
128803261|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
128803262|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
128803263|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
128803264|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
128803265|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
128803266|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
128803267|NCT03939312|463573761|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
128803268|NCT03939312|463573761|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
128803269|NCT03939312|463573761|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
128803270|NCT02119650|463573762|FG000|Overall Study|Adverse Event|3|||
128803271|NCT02119650|463573763|FG001|Overall Study|Adverse Event|4|||
128803272|NCT02119650|463573762|FG000|Overall Study|Subject decision|2|||
128803273|NCT02119650|463573763|FG001|Overall Study|Subject decision|3|||
128803274|NCT02119650|463573762|FG000|Overall Study|Disease progression|11|||
128803275|NCT02119650|463573763|FG001|Overall Study|Disease progression|14|||
128803276|NCT02119650|463573762|FG000|Overall Study|Death|5|||
128803277|NCT02119650|463573763|FG001|Overall Study|Death|1|||
128803278|NCT02119650|463573762|FG000|Overall Study|Noncompliance with study treatment|1|||
128803279|NCT02119650|463573763|FG001|Overall Study|Noncompliance with study treatment|1|||
128803280|NCT02119650|463573762|FG000|Overall Study|Study terminated by the sponsor|1|||
128803281|NCT02119650|463573763|FG001|Overall Study|Study terminated by the sponsor|0|||
128803282|NCT02119650|463573762|FG000|Overall Study|Physician Decision|0|||
128803283|NCT02119650|463573763|FG001|Overall Study|Physician Decision|2|||
128803284|NCT02119650|463573762|FG000|Overall Study|Multiple reasons for termination|2|||
128803285|NCT02119650|463573763|FG001|Overall Study|Multiple reasons for termination|1|||
128803286|NCT01721291|463573764|FG000|Overall Study|Withdrawal by Subject|1|||
128803287|NCT01721291|463573765|FG001|Overall Study|Withdrawal by Subject|0|||
128803288|NCT01721291|463573764|FG000|Overall Study|did not like the treatment|1|||
128803289|NCT01721291|463573765|FG001|Overall Study|did not like the treatment|0|||
128803290|NCT05134337|463575082|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
128803291|NCT05134337|463575083|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
128803292|NCT02349412|463575086|FG000|Overall Study|Withdrawal by Subject|7|||
128803293|NCT02349412|463575087|FG001|Overall Study|Withdrawal by Subject|7|||
128803294|NCT03460236|463575088|FG000|Overall Study|failed radiographic screening|16|||
128803295|NCT03460236|463575088|FG000|Overall Study|Withdrawal by Subject|11|||
128803296|NCT00979576|463575091|FG000|Combination Treatment Phase|Progressive disease|3|||
128803297|NCT00979576|463575092|FG001|Combination Treatment Phase|Progressive disease|1|||
128803298|NCT00979576|463575093|FG002|Combination Treatment Phase|Progressive disease|5|||
128803299|NCT00979576|463575091|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
128803300|NCT00979576|463575092|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
128803301|NCT00979576|463575093|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
128803302|NCT00979576|463575091|FG000|Combination Treatment Phase|Adverse Event|0|||
128803303|NCT00979576|463575092|FG001|Combination Treatment Phase|Adverse Event|2|||
128803304|NCT00979576|463575093|FG002|Combination Treatment Phase|Adverse Event|2|||
128803305|NCT00979576|463575091|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
128803306|NCT00979576|463575092|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
128803307|NCT00979576|463575093|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
128803308|NCT04840199|463575094|FG000|Overall Study|Study Terminated by Sponsor|8|||
128803309|NCT04840199|463575095|FG001|Overall Study|Study Terminated by Sponsor|9|||
128803310|NCT04840199|463575094|FG000|Overall Study|Lost to Follow-up|0|||
128803311|NCT04840199|463575095|FG001|Overall Study|Lost to Follow-up|2|||
128803312|NCT04840199|463575094|FG000|Overall Study|Withdrawal by Subject|2|||
128803313|NCT04840199|463575095|FG001|Overall Study|Withdrawal by Subject|0|||
128803314|NCT04840199|463575094|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
128803315|NCT04840199|463575095|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
128803316|NCT05415436|463575099|FG000|Overall Study|Surgeon cancelled procedure|1|||
128803317|NCT05415436|463575100|FG001|Overall Study|Surgeon cancelled procedure|0|||
128803318|NCT05415436|463575099|FG000|Overall Study|Death|1|||
128803319|NCT05415436|463575100|FG001|Overall Study|Death|0|||
128803320|NCT03819686|463575101|FG000|Overall Study|Lost to Follow-up|2|||
128803321|NCT03819686|463575102|FG001|Overall Study|Lost to Follow-up|3|||
128803322|NCT06023082|463575114|FG000|Overall Study|Withdrawal by Subject|2|||
128803323|NCT06023082|463575114|FG000|Overall Study|Lost to Follow-up|15|||
128803324|NCT06023082|463575114|FG000|Overall Study|Side effects|5|||
128803325|NCT03584516|463575115|FG000|Part 1|Death|2|||
128803326|NCT03584516|463575116|FG001|Part 1|Death|3|||
128803327|NCT03584516|463575117|FG002|Part 1|Death|0|||
128803328|NCT03584516|463575118|FG003|Part 1|Death|0|||
128803329|NCT03584516|463575119|FG004|Part 1|Death|0|||
128803330|NCT03584516|463575120|FG005|Part 1|Death|0|||
128803331|NCT03584516|463575115|FG000|Part 1|Withdrawal by Subject|2|||
128803332|NCT03584516|463575116|FG001|Part 1|Withdrawal by Subject|0|||
128803333|NCT03584516|463575117|FG002|Part 1|Withdrawal by Subject|0|||
128803334|NCT03584516|463575118|FG003|Part 1|Withdrawal by Subject|0|||
128803335|NCT03584516|463575119|FG004|Part 1|Withdrawal by Subject|0|||
128803336|NCT03584516|463575120|FG005|Part 1|Withdrawal by Subject|0|||
128803337|NCT03584516|463575115|FG000|Part 1|Lost to Follow-up|1|||
128803338|NCT03584516|463575116|FG001|Part 1|Lost to Follow-up|0|||
128803339|NCT03584516|463575117|FG002|Part 1|Lost to Follow-up|0|||
128803340|NCT03584516|463575118|FG003|Part 1|Lost to Follow-up|0|||
128803341|NCT03584516|463575119|FG004|Part 1|Lost to Follow-up|0|||
128803342|NCT03584516|463575120|FG005|Part 1|Lost to Follow-up|0|||
128803343|NCT03584516|463575115|FG000|Part 1|Study Terminated by Sponsor|0|||
128803344|NCT03584516|463575116|FG001|Part 1|Study Terminated by Sponsor|2|||
128803345|NCT03584516|463575117|FG002|Part 1|Study Terminated by Sponsor|0|||
128803346|NCT03584516|463575118|FG003|Part 1|Study Terminated by Sponsor|0|||
128803347|NCT03584516|463575119|FG004|Part 1|Study Terminated by Sponsor|0|||
128803348|NCT03584516|463575120|FG005|Part 1|Study Terminated by Sponsor|0|||
128803349|NCT03584516|463575115|FG000|Part 1 Expansion|Death|0|||
128803350|NCT03584516|463575116|FG001|Part 1 Expansion|Death|0|||
128803351|NCT03584516|463575117|FG002|Part 1 Expansion|Death|9|||
128803352|NCT03584516|463575118|FG003|Part 1 Expansion|Death|8|||
128803353|NCT03584516|463575119|FG004|Part 1 Expansion|Death|4|||
128803354|NCT03584516|463575120|FG005|Part 1 Expansion|Death|5|||
128803355|NCT03584516|463575115|FG000|Part 1 Expansion|Lost to Follow-up|0|||
128803356|NCT03584516|463575116|FG001|Part 1 Expansion|Lost to Follow-up|0|||
128803357|NCT03584516|463575117|FG002|Part 1 Expansion|Lost to Follow-up|0|||
128803358|NCT03584516|463575118|FG003|Part 1 Expansion|Lost to Follow-up|1|||
128803359|NCT03584516|463575119|FG004|Part 1 Expansion|Lost to Follow-up|0|||
128803360|NCT03584516|463575120|FG005|Part 1 Expansion|Lost to Follow-up|0|||
128803361|NCT03584516|463575115|FG000|Part 1 Expansion|Physician Decision|0|||
128803362|NCT03584516|463575116|FG001|Part 1 Expansion|Physician Decision|0|||
128803363|NCT03584516|463575117|FG002|Part 1 Expansion|Physician Decision|4|||
128803364|NCT03584516|463575118|FG003|Part 1 Expansion|Physician Decision|3|||
128803365|NCT03584516|463575119|FG004|Part 1 Expansion|Physician Decision|2|||
128803366|NCT03584516|463575120|FG005|Part 1 Expansion|Physician Decision|3|||
128803367|NCT03584516|463575115|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
128803368|NCT03584516|463575116|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
128803369|NCT03584516|463575117|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
128803370|NCT03584516|463575118|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
128803371|NCT03584516|463575119|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
128803372|NCT03584516|463575120|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
128803373|NCT03584516|463575115|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
128803374|NCT03584516|463575116|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
128803375|NCT03584516|463575117|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
128803376|NCT03584516|463575118|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
128803377|NCT03584516|463575119|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
128803378|NCT03584516|463575120|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
128803379|NCT03584516|463575115|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
128803380|NCT03584516|463575116|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
128803381|NCT03584516|463575117|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
128803382|NCT03584516|463575118|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
128803383|NCT03584516|463575119|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
128803384|NCT03584516|463575120|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
128803385|NCT03584516|463575115|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
128803386|NCT03584516|463575116|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
128803387|NCT03584516|463575117|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
128803388|NCT03584516|463575118|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
128803389|NCT03584516|463575119|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
128803390|NCT03584516|463575120|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
128803391|NCT04868110|463575121|FG000|Overall Study|Withdrawal by Subject|3|||
128803392|NCT04868110|463575122|FG001|Overall Study|Withdrawal by Subject|4|||
128803393|NCT04823611|463575123|FG000|Overall Study|Adverse Event|2|||
128803394|NCT04823611|463575124|FG001|Overall Study|Adverse Event|0|||
128803395|NCT04823611|463575125|FG002|Overall Study|Adverse Event|1|||
128803396|NCT04823611|463575126|FG003|Overall Study|Adverse Event|0|||
128803397|NCT04823611|463575127|FG004|Overall Study|Adverse Event|0|||
128803398|NCT04823611|463575128|FG005|Overall Study|Adverse Event|0|||
128803399|NCT04823611|463575129|FG006|Overall Study|Adverse Event|0|||
128803400|NCT04511702|463575134|FG000|Overall Study|Lost to Follow-up|3|||
128803401|NCT04511702|463575135|FG001|Overall Study|Lost to Follow-up|0|||
128803402|NCT04511702|463575136|FG002|Overall Study|Lost to Follow-up|4|||
128803403|NCT04511702|463575134|FG000|Overall Study|Withdrawal by Subject|17|||
128803404|NCT04511702|463575135|FG001|Overall Study|Withdrawal by Subject|1|||
128803405|NCT04511702|463575136|FG002|Overall Study|Withdrawal by Subject|8|||
128803406|NCT02840474|463575139|FG000|Overall Study|Lost to Follow-up|1|||
128803407|NCT02840474|463575140|FG001|Overall Study|Lost to Follow-up|0|||
128803408|NCT03192891|463575141|FG000|Overall Study|Lost to Follow-up|55|||
128803409|NCT05141903|463575142|FG000|Overall Study|Withdrawal by Subject|0|||
128803410|NCT05141903|463575143|FG001|Overall Study|Withdrawal by Subject|1|||
128803411|NCT05141903|463575144|FG002|Overall Study|Withdrawal by Subject|1|||
128803412|NCT05141903|463575145|FG003|Overall Study|Withdrawal by Subject|0|||
128803413|NCT05141903|463575146|FG004|Overall Study|Withdrawal by Subject|0|||
128803414|NCT05141903|463575142|FG000|Overall Study|Other|1|||
128803415|NCT05141903|463575143|FG001|Overall Study|Other|1|||
128803416|NCT05141903|463575144|FG002|Overall Study|Other|0|||
128803417|NCT05141903|463575145|FG003|Overall Study|Other|0|||
128803418|NCT05141903|463575146|FG004|Overall Study|Other|0|||
128803419|NCT05387447|463575149|FG000|Overall Study|Participants changed their minds about study participation.|3|||
128803420|NCT05387447|463575150|FG001|Overall Study|Participants changed their minds about study participation.|5|||
128803421|NCT01707030|463575157|FG000|Overall Study|Death|1|||
128803422|NCT01707030|463575158|FG001|Overall Study|Death|1|||
128803423|NCT01707030|463575157|FG000|Overall Study|Withdrawal by Subject|2|||
128803424|NCT01707030|463575158|FG001|Overall Study|Withdrawal by Subject|3|||
128803425|NCT01707030|463575157|FG000|Overall Study|Lost to Follow-up|8|||
128803426|NCT01707030|463575158|FG001|Overall Study|Lost to Follow-up|13|||
128803427|NCT04820855|463575159|FG000|Overall Study|Lost to Follow-up|6|||
128803428|NCT04820855|463575160|FG001|Overall Study|Lost to Follow-up|9|||
128803429|NCT04093752|463575162|FG000|Overall Study|Adverse Event|7|||
128803430|NCT04093752|463575163|FG001|Overall Study|Adverse Event|19|||
128803431|NCT04093752|463575164|FG002|Overall Study|Adverse Event|18|||
128803432|NCT04093752|463575165|FG003|Overall Study|Adverse Event|4|||
128803433|NCT04093752|463575162|FG000|Overall Study|Withdrawal by Subject|6|||
128803434|NCT04093752|463575163|FG001|Overall Study|Withdrawal by Subject|6|||
128803435|NCT04093752|463575164|FG002|Overall Study|Withdrawal by Subject|8|||
128803436|NCT04093752|463575165|FG003|Overall Study|Withdrawal by Subject|20|||
128803437|NCT04093752|463575162|FG000|Overall Study|Lost to Follow-up|2|||
128803438|NCT04093752|463575163|FG001|Overall Study|Lost to Follow-up|1|||
128803439|NCT04093752|463575164|FG002|Overall Study|Lost to Follow-up|1|||
128803440|NCT04093752|463575165|FG003|Overall Study|Lost to Follow-up|1|||
128803441|NCT04093752|463575162|FG000|Overall Study|Death|0|||
128803442|NCT04093752|463575163|FG001|Overall Study|Death|0|||
128803443|NCT04093752|463575164|FG002|Overall Study|Death|1|||
128803444|NCT04093752|463575165|FG003|Overall Study|Death|2|||
128803445|NCT04093752|463575162|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
128803446|NCT04093752|463575163|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
128803447|NCT04093752|463575164|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
128803448|NCT04093752|463575165|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
128803449|NCT04093752|463575162|FG000|Overall Study|Covid 19|0|||
128803450|NCT04093752|463575163|FG001|Overall Study|Covid 19|0|||
128803451|NCT04093752|463575164|FG002|Overall Study|Covid 19|0|||
128803452|NCT04093752|463575165|FG003|Overall Study|Covid 19|1|||
128803453|NCT04093752|463575162|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
128803454|NCT04093752|463575163|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
128803455|NCT04093752|463575164|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
128803456|NCT04093752|463575165|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
128803457|NCT04093752|463575162|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
128803458|NCT04093752|463575163|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
128803459|NCT04093752|463575164|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
128803460|NCT04093752|463575165|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
128803461|NCT04093752|463575162|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
128803462|NCT04093752|463575163|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
128803463|NCT04093752|463575164|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
128803464|NCT04093752|463575165|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
128803465|NCT01101451|463575167|FG000|Overall Study|Eligible and never treated|0|||
128803466|NCT01101451|463575168|FG001|Overall Study|Eligible and never treated|5|||
128803467|NCT01101451|463575167|FG000|Overall Study|Ineligible and treated|12|||
128803468|NCT01101451|463575168|FG001|Overall Study|Ineligible and treated|8|||
128803469|NCT01101451|463575167|FG000|Overall Study|Ineligible and never treated|2|||
128803470|NCT01101451|463575168|FG001|Overall Study|Ineligible and never treated|2|||
128803471|NCT00073749|463575169|FG000|Overall Study|Disease Progression|2|||
128803472|NCT00073749|463575170|FG001|Overall Study|Disease Progression|0|||
128803473|NCT00073749|463575171|FG002|Overall Study|Disease Progression|3|||
128803474|NCT00073749|463575172|FG003|Overall Study|Disease Progression|2|||
128803475|NCT00073749|463575173|FG004|Overall Study|Disease Progression|3|||
128803476|NCT00073749|463575174|FG005|Overall Study|Disease Progression|1|||
128803477|NCT00073749|463575175|FG006|Overall Study|Disease Progression|3|||
128803478|NCT00073749|463575169|FG000|Overall Study|Death|0|||
128803479|NCT00073749|463575170|FG001|Overall Study|Death|1|||
128803480|NCT00073749|463575171|FG002|Overall Study|Death|1|||
128803481|NCT00073749|463575172|FG003|Overall Study|Death|0|||
128803482|NCT00073749|463575173|FG004|Overall Study|Death|0|||
128803483|NCT00073749|463575174|FG005|Overall Study|Death|0|||
128803484|NCT00073749|463575175|FG006|Overall Study|Death|29|||
128803485|NCT00073749|463575169|FG000|Overall Study|Adverse Event|0|||
128803486|NCT00073749|463575170|FG001|Overall Study|Adverse Event|3|||
128803487|NCT00073749|463575171|FG002|Overall Study|Adverse Event|6|||
128803488|NCT00073749|463575172|FG003|Overall Study|Adverse Event|4|||
128803489|NCT00073749|463575173|FG004|Overall Study|Adverse Event|2|||
128803490|NCT00073749|463575174|FG005|Overall Study|Adverse Event|1|||
128803491|NCT00073749|463575175|FG006|Overall Study|Adverse Event|0|||
128803492|NCT00073749|463575169|FG000|Overall Study|Physician Decision|0|||
128803493|NCT00073749|463575170|FG001|Overall Study|Physician Decision|0|||
128803494|NCT00073749|463575171|FG002|Overall Study|Physician Decision|1|||
128803495|NCT00073749|463575172|FG003|Overall Study|Physician Decision|0|||
128803496|NCT00073749|463575173|FG004|Overall Study|Physician Decision|0|||
128803497|NCT00073749|463575174|FG005|Overall Study|Physician Decision|2|||
128803498|NCT00073749|463575175|FG006|Overall Study|Physician Decision|0|||
128803499|NCT00073749|463575169|FG000|Overall Study|Withdrawal by Subject|0|||
128803500|NCT00073749|463575170|FG001|Overall Study|Withdrawal by Subject|1|||
128803501|NCT00073749|463575171|FG002|Overall Study|Withdrawal by Subject|0|||
128803502|NCT00073749|463575172|FG003|Overall Study|Withdrawal by Subject|0|||
128803503|NCT00073749|463575173|FG004|Overall Study|Withdrawal by Subject|1|||
128803504|NCT00073749|463575174|FG005|Overall Study|Withdrawal by Subject|0|||
128803505|NCT00073749|463575175|FG006|Overall Study|Withdrawal by Subject|2|||
128803506|NCT00073749|463575169|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
128803507|NCT00073749|463575170|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
128803508|NCT00073749|463575171|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
128803509|NCT00073749|463575172|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
128803510|NCT00073749|463575173|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
128803511|NCT00073749|463575174|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
128803512|NCT00073749|463575175|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
128803513|NCT00073749|463575169|FG000|Overall Study|Lost to Follow-up|0|||
128803514|NCT00073749|463575170|FG001|Overall Study|Lost to Follow-up|0|||
128803515|NCT00073749|463575171|FG002|Overall Study|Lost to Follow-up|0|||
128803516|NCT00073749|463575172|FG003|Overall Study|Lost to Follow-up|0|||
128803517|NCT00073749|463575173|FG004|Overall Study|Lost to Follow-up|0|||
128803518|NCT00073749|463575174|FG005|Overall Study|Lost to Follow-up|0|||
128803519|NCT00073749|463575175|FG006|Overall Study|Lost to Follow-up|2|||
128803520|NCT00073749|463575169|FG000|Overall Study|Other|0|||
128803521|NCT00073749|463575170|FG001|Overall Study|Other|0|||
128803522|NCT00073749|463575171|FG002|Overall Study|Other|0|||
128803523|NCT00073749|463575172|FG003|Overall Study|Other|0|||
128803524|NCT00073749|463575173|FG004|Overall Study|Other|0|||
128803525|NCT00073749|463575174|FG005|Overall Study|Other|2|||
128803526|NCT00073749|463575175|FG006|Overall Study|Other|0|||
128803527|NCT04218266|463575176|FG000|Overall Study|Death|1|||
128803528|NCT04218266|463575177|FG001|Overall Study|Death|2|||
128803529|NCT04218266|463575178|FG002|Overall Study|Death|3|||
128803530|NCT04218266|463575176|FG000|Overall Study|Adverse Event|13|||
128803531|NCT04218266|463575177|FG001|Overall Study|Adverse Event|14|||
128803532|NCT04218266|463575178|FG002|Overall Study|Adverse Event|11|||
128803533|NCT04218266|463575176|FG000|Overall Study|Other|7|||
128803534|NCT04218266|463575177|FG001|Overall Study|Other|5|||
128803535|NCT04218266|463575178|FG002|Overall Study|Other|14|||
128803536|NCT04218266|463575176|FG000|Overall Study|Physician Decision|1|||
128803537|NCT04218266|463575177|FG001|Overall Study|Physician Decision|3|||
128803538|NCT04218266|463575178|FG002|Overall Study|Physician Decision|2|||
128803539|NCT04218266|463575176|FG000|Overall Study|Non-compliance with study drug|0|||
128803540|NCT04218266|463575177|FG001|Overall Study|Non-compliance with study drug|0|||
128803541|NCT04218266|463575178|FG002|Overall Study|Non-compliance with study drug|1|||
128803542|NCT04218266|463575176|FG000|Overall Study|Withdrawal by Subject|1|||
128803543|NCT04218266|463575177|FG001|Overall Study|Withdrawal by Subject|3|||
128803544|NCT04218266|463575178|FG002|Overall Study|Withdrawal by Subject|1|||
128803545|NCT04218266|463575176|FG000|Overall Study|Study drug never administered|2|||
128803546|NCT04218266|463575177|FG001|Overall Study|Study drug never administered|0|||
128803547|NCT04218266|463575178|FG002|Overall Study|Study drug never administered|0|||
128803548|NCT03912831|463575179|FG000|Overall Study|Death|1|||
128803549|NCT03912831|463575180|FG001|Overall Study|Death|1|||
128803550|NCT03912831|463575181|FG002|Overall Study|Death|1|||
128803551|NCT03912831|463575182|FG003|Overall Study|Death|1|||
128803552|NCT03912831|463575183|FG004|Overall Study|Death|1|||
128803553|NCT03912831|463575184|FG005|Overall Study|Death|1|||
128803554|NCT03912831|463575179|FG000|Overall Study|Reason not Specified|0|||
128803555|NCT03912831|463575180|FG001|Overall Study|Reason not Specified|0|||
128803556|NCT03912831|463575181|FG002|Overall Study|Reason not Specified|0|||
128803557|NCT03912831|463575182|FG003|Overall Study|Reason not Specified|0|||
128803558|NCT03912831|463575183|FG004|Overall Study|Reason not Specified|1|||
128803559|NCT03912831|463575184|FG005|Overall Study|Reason not Specified|0|||
128803560|NCT03912831|463575179|FG000|Overall Study|Withdrawal by Participant|0|||
128803561|NCT03912831|463575180|FG001|Overall Study|Withdrawal by Participant|0|||
128803562|NCT03912831|463575181|FG002|Overall Study|Withdrawal by Participant|0|||
128803563|NCT03912831|463575182|FG003|Overall Study|Withdrawal by Participant|0|||
128803564|NCT03912831|463575183|FG004|Overall Study|Withdrawal by Participant|1|||
128803565|NCT03912831|463575184|FG005|Overall Study|Withdrawal by Participant|0|||
128803566|NCT03580369|463575185|FG000|Overall Study|No treatment due to mis-randomization|1|||
128803567|NCT03580369|463575186|FG001|Overall Study|No treatment due to mis-randomization|0|||
128803568|NCT03580369|463575187|FG002|Overall Study|No treatment due to mis-randomization|0|||
128803569|NCT03580369|463575188|FG003|Overall Study|No treatment due to mis-randomization|0|||
128803570|NCT03580369|463575189|FG004|Overall Study|No treatment due to mis-randomization|3|||
128803571|NCT03580369|463575190|FG005|Overall Study|No treatment due to mis-randomization|0|||
128803572|NCT03580369|463575191|FG006|Overall Study|No treatment due to mis-randomization|0|||
128803573|NCT03580369|463575192|FG007|Overall Study|No treatment due to mis-randomization|0|||
128803574|NCT03580369|463575185|FG000|Overall Study|Reason unknown|0|||
128803575|NCT03580369|463575186|FG001|Overall Study|Reason unknown|0|||
128803576|NCT03580369|463575187|FG002|Overall Study|Reason unknown|1|||
128803577|NCT03580369|463575188|FG003|Overall Study|Reason unknown|0|||
128803578|NCT03580369|463575189|FG004|Overall Study|Reason unknown|0|||
128803579|NCT03580369|463575190|FG005|Overall Study|Reason unknown|0|||
128803580|NCT03580369|463575191|FG006|Overall Study|Reason unknown|0|||
128803581|NCT03580369|463575192|FG007|Overall Study|Reason unknown|0|||
128803582|NCT03580369|463575185|FG000|Overall Study|Technical problems|0|||
128803583|NCT03580369|463575186|FG001|Overall Study|Technical problems|0|||
128803584|NCT03580369|463575187|FG002|Overall Study|Technical problems|0|||
128803585|NCT03580369|463575188|FG003|Overall Study|Technical problems|0|||
128803586|NCT03580369|463575189|FG004|Overall Study|Technical problems|1|||
128803587|NCT03580369|463575190|FG005|Overall Study|Technical problems|0|||
128803588|NCT03580369|463575191|FG006|Overall Study|Technical problems|2|||
128803589|NCT03580369|463575192|FG007|Overall Study|Technical problems|0|||
128803590|NCT03580369|463575185|FG000|Overall Study|Pregnancy|2|||
128803591|NCT03580369|463575186|FG001|Overall Study|Pregnancy|0|||
128803592|NCT03580369|463575187|FG002|Overall Study|Pregnancy|3|||
128803593|NCT03580369|463575188|FG003|Overall Study|Pregnancy|0|||
128803594|NCT03580369|463575189|FG004|Overall Study|Pregnancy|2|||
128803595|NCT03580369|463575190|FG005|Overall Study|Pregnancy|0|||
128803596|NCT03580369|463575191|FG006|Overall Study|Pregnancy|0|||
128803597|NCT03580369|463575192|FG007|Overall Study|Pregnancy|0|||
128803598|NCT03580369|463575185|FG000|Overall Study|Lost to Follow-up|2|||
128803599|NCT03580369|463575186|FG001|Overall Study|Lost to Follow-up|0|||
128803600|NCT03580369|463575187|FG002|Overall Study|Lost to Follow-up|2|||
128803601|NCT03580369|463575188|FG003|Overall Study|Lost to Follow-up|0|||
128803602|NCT03580369|463575189|FG004|Overall Study|Lost to Follow-up|3|||
128803603|NCT03580369|463575190|FG005|Overall Study|Lost to Follow-up|0|||
128803604|NCT03580369|463575191|FG006|Overall Study|Lost to Follow-up|1|||
128803605|NCT03580369|463575192|FG007|Overall Study|Lost to Follow-up|0|||
128803606|NCT03580369|463575185|FG000|Overall Study|Physician Decision|4|||
128803607|NCT03580369|463575186|FG001|Overall Study|Physician Decision|0|||
128803608|NCT03580369|463575187|FG002|Overall Study|Physician Decision|4|||
128803609|NCT03580369|463575188|FG003|Overall Study|Physician Decision|1|||
128803610|NCT03580369|463575189|FG004|Overall Study|Physician Decision|1|||
128803611|NCT03580369|463575190|FG005|Overall Study|Physician Decision|0|||
128803612|NCT03580369|463575191|FG006|Overall Study|Physician Decision|0|||
128803613|NCT03580369|463575192|FG007|Overall Study|Physician Decision|0|||
128803614|NCT03580369|463575185|FG000|Overall Study|Lack of Efficacy|3|||
128803615|NCT03580369|463575186|FG001|Overall Study|Lack of Efficacy|0|||
128803616|NCT03580369|463575187|FG002|Overall Study|Lack of Efficacy|7|||
128803617|NCT03580369|463575188|FG003|Overall Study|Lack of Efficacy|0|||
128803618|NCT03580369|463575189|FG004|Overall Study|Lack of Efficacy|2|||
128803619|NCT03580369|463575190|FG005|Overall Study|Lack of Efficacy|0|||
128803620|NCT03580369|463575191|FG006|Overall Study|Lack of Efficacy|3|||
128803621|NCT03580369|463575192|FG007|Overall Study|Lack of Efficacy|0|||
128803622|NCT03580369|463575185|FG000|Overall Study|Protocol Violation|6|||
128803623|NCT03580369|463575186|FG001|Overall Study|Protocol Violation|0|||
128803624|NCT03580369|463575187|FG002|Overall Study|Protocol Violation|6|||
128803625|NCT03580369|463575188|FG003|Overall Study|Protocol Violation|1|||
128803626|NCT03580369|463575189|FG004|Overall Study|Protocol Violation|8|||
128803627|NCT03580369|463575190|FG005|Overall Study|Protocol Violation|2|||
128803628|NCT03580369|463575191|FG006|Overall Study|Protocol Violation|1|||
128803629|NCT03580369|463575192|FG007|Overall Study|Protocol Violation|0|||
128803630|NCT03580369|463575185|FG000|Overall Study|Adverse Event|7|||
128803631|NCT03580369|463575186|FG001|Overall Study|Adverse Event|0|||
128803632|NCT03580369|463575187|FG002|Overall Study|Adverse Event|14|||
128803633|NCT03580369|463575188|FG003|Overall Study|Adverse Event|1|||
128803634|NCT03580369|463575189|FG004|Overall Study|Adverse Event|6|||
128803635|NCT03580369|463575190|FG005|Overall Study|Adverse Event|0|||
128803636|NCT03580369|463575191|FG006|Overall Study|Adverse Event|1|||
128803637|NCT03580369|463575192|FG007|Overall Study|Adverse Event|0|||
128803638|NCT03580369|463575185|FG000|Overall Study|Withdrawal by Subject|19|||
128803639|NCT03580369|463575186|FG001|Overall Study|Withdrawal by Subject|0|||
128803640|NCT03580369|463575187|FG002|Overall Study|Withdrawal by Subject|17|||
128803641|NCT03580369|463575188|FG003|Overall Study|Withdrawal by Subject|0|||
128803642|NCT03580369|463575189|FG004|Overall Study|Withdrawal by Subject|16|||
128803643|NCT03580369|463575190|FG005|Overall Study|Withdrawal by Subject|1|||
128803644|NCT03580369|463575191|FG006|Overall Study|Withdrawal by Subject|7|||
128803645|NCT03580369|463575192|FG007|Overall Study|Withdrawal by Subject|0|||
128803646|NCT04442126|463575205|FG000|Overall Study|Withdrawal by Subject|0|||
128803647|NCT04442126|463575206|FG001|Overall Study|Withdrawal by Subject|0|||
128803648|NCT04442126|463575207|FG002|Overall Study|Withdrawal by Subject|0|||
128803649|NCT04442126|463575208|FG003|Overall Study|Withdrawal by Subject|2|||
128803650|NCT04442126|463575209|FG004|Overall Study|Withdrawal by Subject|1|||
128803651|NCT04442126|463575210|FG005|Overall Study|Withdrawal by Subject|0|||
128803652|NCT04442126|463575211|FG006|Overall Study|Withdrawal by Subject|1|||
128803653|NCT04442126|463575212|FG007|Overall Study|Withdrawal by Subject|1|||
128803654|NCT04442126|463575213|FG008|Overall Study|Withdrawal by Subject|3|||
128803655|NCT04442126|463575205|FG000|Overall Study|Death|1|||
128803656|NCT04442126|463575206|FG001|Overall Study|Death|0|||
128803657|NCT04442126|463575207|FG002|Overall Study|Death|0|||
128803658|NCT04442126|463575208|FG003|Overall Study|Death|1|||
128803659|NCT04442126|463575209|FG004|Overall Study|Death|2|||
128803660|NCT04442126|463575210|FG005|Overall Study|Death|2|||
128803661|NCT04442126|463575211|FG006|Overall Study|Death|4|||
128803662|NCT04442126|463575212|FG007|Overall Study|Death|1|||
128803663|NCT04442126|463575213|FG008|Overall Study|Death|5|||
128803664|NCT04442126|463575205|FG000|Overall Study|Study Terminated by Sponsor|0|||
128803665|NCT04442126|463575206|FG001|Overall Study|Study Terminated by Sponsor|0|||
128803666|NCT04442126|463575207|FG002|Overall Study|Study Terminated by Sponsor|0|||
128803667|NCT04442126|463575208|FG003|Overall Study|Study Terminated by Sponsor|0|||
128803668|NCT04442126|463575209|FG004|Overall Study|Study Terminated by Sponsor|0|||
128803669|NCT04442126|463575210|FG005|Overall Study|Study Terminated by Sponsor|1|||
128803670|NCT04442126|463575211|FG006|Overall Study|Study Terminated by Sponsor|4|||
128803671|NCT04442126|463575212|FG007|Overall Study|Study Terminated by Sponsor|2|||
128803672|NCT04442126|463575213|FG008|Overall Study|Study Terminated by Sponsor|10|||
128803673|NCT04442126|463575205|FG000|Overall Study|Lost to Follow-up|0|||
128803674|NCT04442126|463575206|FG001|Overall Study|Lost to Follow-up|0|||
128803675|NCT04442126|463575207|FG002|Overall Study|Lost to Follow-up|0|||
128803676|NCT04442126|463575208|FG003|Overall Study|Lost to Follow-up|0|||
128803677|NCT04442126|463575209|FG004|Overall Study|Lost to Follow-up|0|||
128803678|NCT04442126|463575210|FG005|Overall Study|Lost to Follow-up|0|||
128803679|NCT04442126|463575211|FG006|Overall Study|Lost to Follow-up|0|||
128803680|NCT04442126|463575212|FG007|Overall Study|Lost to Follow-up|1|||
128803681|NCT04442126|463575213|FG008|Overall Study|Lost to Follow-up|2|||
128803682|NCT04442126|463575205|FG000|Overall Study|Progressive Disease|0|||
128803683|NCT04442126|463575206|FG001|Overall Study|Progressive Disease|1|||
128803684|NCT04442126|463575207|FG002|Overall Study|Progressive Disease|3|||
128803685|NCT04442126|463575208|FG003|Overall Study|Progressive Disease|0|||
128803686|NCT04442126|463575209|FG004|Overall Study|Progressive Disease|3|||
128803687|NCT04442126|463575210|FG005|Overall Study|Progressive Disease|0|||
128803688|NCT04442126|463575211|FG006|Overall Study|Progressive Disease|0|||
128803689|NCT04442126|463575212|FG007|Overall Study|Progressive Disease|0|||
128803690|NCT04442126|463575213|FG008|Overall Study|Progressive Disease|0|||
128803691|NCT04442126|463575205|FG000|Overall Study|Other|0|||
128803692|NCT04442126|463575206|FG001|Overall Study|Other|0|||
128803693|NCT04442126|463575207|FG002|Overall Study|Other|0|||
128803694|NCT04442126|463575208|FG003|Overall Study|Other|0|||
128803695|NCT04442126|463575209|FG004|Overall Study|Other|0|||
128803696|NCT04442126|463575210|FG005|Overall Study|Other|0|||
128803697|NCT04442126|463575211|FG006|Overall Study|Other|0|||
128803698|NCT04442126|463575212|FG007|Overall Study|Other|0|||
128803699|NCT04442126|463575213|FG008|Overall Study|Other|1|||
128803700|NCT04774237|463575215|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
128803701|NCT04774237|463575216|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
128803702|NCT04774237|463575217|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
128803703|NCT04774237|463575218|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
128803704|NCT04774237|463575219|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
128803705|NCT04774237|463575220|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
129204644|NCT03062358|465045847|FG000|Overall Study|Sponsor Decision|29|||
129204645|NCT03062358|465045848|FG001|Overall Study|Sponsor Decision|7|||
129204646|NCT03861273|465045849|FG000|Screening Phase (3 Weeks)|Other|1|||
129204647|NCT03861273|465045849|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
129204648|NCT03861273|465045849|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
129204649|NCT03861273|465045849|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
129204650|NCT03861273|465045849|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
129204651|NCT03799341|465045850|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
129204652|NCT03799341|465045851|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
129204653|NCT03799341|465045852|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
128803716|NCT04923347|463576871|FG000|Overall Study|Withdrawal by Subject|14|||
128803717|NCT03424811|463576872|FG000|Overall Study|Lost to Follow-up|9|||
128803718|NCT03424811|463576873|FG001|Overall Study|Lost to Follow-up|0|||
128803719|NCT00753090|463576885|FG000|Overall Study|Withdrawal by Subject|10|||
128803720|NCT00753090|463576886|FG001|Overall Study|Withdrawal by Subject|10|||
128803721|NCT00753090|463576885|FG000|Overall Study|Death|17|||
128803722|NCT00753090|463576886|FG001|Overall Study|Death|6|||
128803723|NCT00753090|463576885|FG000|Overall Study|Study Prosthesis Removed|12|||
128803724|NCT00753090|463576886|FG001|Overall Study|Study Prosthesis Removed|3|||
128803725|NCT00753090|463576885|FG000|Overall Study|Lost to Follow-up|2|||
128803726|NCT00753090|463576886|FG001|Overall Study|Lost to Follow-up|2|||
128803727|NCT00753090|463576885|FG000|Overall Study|Other|127|||
128803728|NCT00753090|463576886|FG001|Overall Study|Other|75|||
128803729|NCT05215847|463576887|FG000|Overall Study|Lost to Follow-up|1|||
128803730|NCT06066541|463576894|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
128803731|NCT06066541|463576895|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
128803732|NCT06066541|463576896|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
128803733|NCT06066541|463576897|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
128803734|NCT06066541|463576898|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
128803735|NCT06066541|463576899|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
128803736|NCT06066541|463576900|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
128803737|NCT06066541|463576894|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
128803738|NCT06066541|463576895|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
128803739|NCT06066541|463576896|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
128803740|NCT06066541|463576897|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
128803741|NCT06066541|463576898|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
128803742|NCT06066541|463576899|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
128803743|NCT06066541|463576900|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
128803744|NCT02819843|463576901|FG000|Overall Study|Disease progression before RT|0|||
128803745|NCT02819843|463576902|FG001|Overall Study|Disease progression before RT|1|||
128803746|NCT03055858|463576904|FG000|Overall Study|Death|9|||
128803747|NCT03055858|463576904|FG000|Overall Study|Withdrawal by Subject|11|||
128803748|NCT03055858|463576904|FG000|Overall Study|Lost to Follow-up|6|||
128803749|NCT03055858|463576904|FG000|Overall Study|Missed Follow-Up Visits|18|||
128803750|NCT04586920|463576905|FG000|Overall Study|Lost to Follow-up|0|||
128803751|NCT04586920|463576906|FG001|Overall Study|Lost to Follow-up|0|||
128803752|NCT04586920|463576907|FG002|Overall Study|Lost to Follow-up|0|||
128803753|NCT04586920|463576908|FG003|Overall Study|Lost to Follow-up|0|||
128803754|NCT04586920|463576909|FG004|Overall Study|Lost to Follow-up|0|||
128803755|NCT04586920|463576910|FG005|Overall Study|Lost to Follow-up|0|||
128803756|NCT04586920|463576911|FG006|Overall Study|Lost to Follow-up|1|||
128803757|NCT04586920|463576912|FG007|Overall Study|Lost to Follow-up|1|||
128803758|NCT04586920|463576913|FG008|Overall Study|Lost to Follow-up|0|||
128803759|NCT04586920|463576914|FG009|Overall Study|Lost to Follow-up|1|||
128803760|NCT04586920|463576915|FG010|Overall Study|Lost to Follow-up|0|||
128803761|NCT04586920|463576916|FG011|Overall Study|Lost to Follow-up|0|||
128803762|NCT04586920|463576917|FG012|Overall Study|Lost to Follow-up|0|||
128803763|NCT04586920|463576918|FG013|Overall Study|Lost to Follow-up|1|||
128803764|NCT04586920|463576919|FG014|Overall Study|Lost to Follow-up|0|||
128803765|NCT04586920|463576920|FG015|Overall Study|Lost to Follow-up|0|||
128803766|NCT04586920|463576921|FG016|Overall Study|Lost to Follow-up|0|||
128803767|NCT04586920|463576922|FG017|Overall Study|Lost to Follow-up|0|||
128803768|NCT04586920|463576905|FG000|Overall Study|Withdrawal by Subject|0|||
128803769|NCT04586920|463576906|FG001|Overall Study|Withdrawal by Subject|0|||
128803770|NCT04586920|463576907|FG002|Overall Study|Withdrawal by Subject|0|||
128803771|NCT04586920|463576908|FG003|Overall Study|Withdrawal by Subject|0|||
128803772|NCT04586920|463576909|FG004|Overall Study|Withdrawal by Subject|0|||
128803773|NCT04586920|463576910|FG005|Overall Study|Withdrawal by Subject|0|||
128803774|NCT04586920|463576911|FG006|Overall Study|Withdrawal by Subject|0|||
128803775|NCT04586920|463576912|FG007|Overall Study|Withdrawal by Subject|1|||
128803776|NCT04586920|463576913|FG008|Overall Study|Withdrawal by Subject|0|||
128803777|NCT04586920|463576914|FG009|Overall Study|Withdrawal by Subject|1|||
128803778|NCT04586920|463576915|FG010|Overall Study|Withdrawal by Subject|0|||
128803779|NCT04586920|463576916|FG011|Overall Study|Withdrawal by Subject|1|||
128803780|NCT04586920|463576917|FG012|Overall Study|Withdrawal by Subject|0|||
128803781|NCT04586920|463576918|FG013|Overall Study|Withdrawal by Subject|0|||
128803782|NCT04586920|463576919|FG014|Overall Study|Withdrawal by Subject|0|||
128803783|NCT04586920|463576920|FG015|Overall Study|Withdrawal by Subject|0|||
128803784|NCT04586920|463576921|FG016|Overall Study|Withdrawal by Subject|0|||
128803785|NCT04586920|463576922|FG017|Overall Study|Withdrawal by Subject|0|||
128803786|NCT02728557|463576927|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
128803787|NCT02728557|463576928|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
128803788|NCT02728557|463576927|FG000|Overall Study|Dissatisfaction with research tasks|0|||
128803789|NCT02728557|463576928|FG001|Overall Study|Dissatisfaction with research tasks|1|||
128803790|NCT02728557|463576927|FG000|Overall Study|Scheduling or change in availability|1|||
128803791|NCT02728557|463576928|FG001|Overall Study|Scheduling or change in availability|1|||
128803792|NCT03897686|463576929|FG000|Overall Study|Protocol Violation|1|||
128803793|NCT03897686|463576930|FG001|Overall Study|Protocol Violation|1|||
128803794|NCT03897686|463576929|FG000|Overall Study|Withdrawal by Subject|1|||
128803795|NCT03897686|463576930|FG001|Overall Study|Withdrawal by Subject|1|||
128803796|NCT04052516|463576931|FG000|Overall Study|Withdrawal by Subject|4|||
128803797|NCT04052516|463576932|FG001|Overall Study|Withdrawal by Subject|5|||
128803798|NCT04052516|463576933|FG002|Overall Study|Withdrawal by Subject|6|||
128803799|NCT04052516|463576931|FG000|Overall Study|Adverse Event|3|||
128803800|NCT04052516|463576932|FG001|Overall Study|Adverse Event|2|||
128803801|NCT04052516|463576933|FG002|Overall Study|Adverse Event|8|||
128803802|NCT04052516|463576931|FG000|Overall Study|Lost to Follow-up|2|||
128803803|NCT04052516|463576932|FG001|Overall Study|Lost to Follow-up|5|||
128803804|NCT04052516|463576933|FG002|Overall Study|Lost to Follow-up|3|||
128803805|NCT04052516|463576931|FG000|Overall Study|Protocol Violation|1|||
128803806|NCT04052516|463576932|FG001|Overall Study|Protocol Violation|1|||
128803807|NCT04052516|463576933|FG002|Overall Study|Protocol Violation|0|||
128803808|NCT04052516|463576931|FG000|Overall Study|Death|1|||
128803809|NCT04052516|463576932|FG001|Overall Study|Death|0|||
128803810|NCT04052516|463576933|FG002|Overall Study|Death|0|||
128803811|NCT04052516|463576931|FG000|Overall Study|Physician Decision|0|||
128803812|NCT04052516|463576932|FG001|Overall Study|Physician Decision|1|||
128803813|NCT04052516|463576933|FG002|Overall Study|Physician Decision|0|||
128803814|NCT04052516|463576931|FG000|Overall Study|Pregnancy|1|||
128803815|NCT04052516|463576932|FG001|Overall Study|Pregnancy|0|||
128803816|NCT04052516|463576933|FG002|Overall Study|Pregnancy|0|||
128803817|NCT04052516|463576931|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
128803818|NCT04052516|463576932|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
128803819|NCT04052516|463576933|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
128803820|NCT04052516|463576931|FG000|Overall Study|Reason not recorded|0|||
128803821|NCT04052516|463576932|FG001|Overall Study|Reason not recorded|1|||
128803822|NCT04052516|463576933|FG002|Overall Study|Reason not recorded|0|||
128803823|NCT03416010|463576934|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
128803824|NCT03416010|463576935|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
128803825|NCT03416010|463576934|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
128803826|NCT03416010|463576935|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
128803827|NCT03416010|463576934|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
128803828|NCT03416010|463576935|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
128803829|NCT03416010|463576934|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
128803830|NCT03416010|463576935|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
128803831|NCT03416010|463576934|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
128803832|NCT03416010|463576935|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
128803833|NCT03416010|463576934|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
128803834|NCT03416010|463576935|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
128803835|NCT03416010|463576934|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
128803836|NCT03416010|463576935|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
128803837|NCT03948763|463576936|FG000|Overall Study|Sponsor's decision|0|||
128803838|NCT03948763|463576937|FG001|Overall Study|Sponsor's decision|2|||
128803839|NCT03948763|463576938|FG002|Overall Study|Sponsor's decision|6|||
128803840|NCT03948763|463576939|FG003|Overall Study|Sponsor's decision|4|||
128803841|NCT03948763|463576940|FG004|Overall Study|Sponsor's decision|0|||
128803842|NCT03948763|463576936|FG000|Overall Study|Physician Decision|0|||
128803843|NCT03948763|463576937|FG001|Overall Study|Physician Decision|0|||
128803844|NCT03948763|463576938|FG002|Overall Study|Physician Decision|1|||
128803845|NCT03948763|463576939|FG003|Overall Study|Physician Decision|0|||
128803846|NCT03948763|463576940|FG004|Overall Study|Physician Decision|0|||
128803847|NCT03948763|463576936|FG000|Overall Study|Lost to Follow-up|0|||
128803848|NCT03948763|463576937|FG001|Overall Study|Lost to Follow-up|0|||
128803849|NCT03948763|463576938|FG002|Overall Study|Lost to Follow-up|0|||
128803850|NCT03948763|463576939|FG003|Overall Study|Lost to Follow-up|0|||
128803851|NCT03948763|463576940|FG004|Overall Study|Lost to Follow-up|1|||
128803852|NCT03948763|463576936|FG000|Overall Study|Death|2|||
128803853|NCT03948763|463576937|FG001|Overall Study|Death|12|||
128803854|NCT03948763|463576938|FG002|Overall Study|Death|13|||
128803855|NCT03948763|463576939|FG003|Overall Study|Death|10|||
128803856|NCT03948763|463576940|FG004|Overall Study|Death|11|||
128803857|NCT03948763|463576936|FG000|Overall Study|Withdrawal by Subject|1|||
128803858|NCT03948763|463576937|FG001|Overall Study|Withdrawal by Subject|1|||
128803859|NCT03948763|463576938|FG002|Overall Study|Withdrawal by Subject|0|||
128803860|NCT03948763|463576939|FG003|Overall Study|Withdrawal by Subject|2|||
128803861|NCT03948763|463576940|FG004|Overall Study|Withdrawal by Subject|4|||
128803862|NCT05038566|463576953|FG000|Overall Study|Technical Difficulties with the Device|0|||
128803863|NCT05038566|463576954|FG001|Overall Study|Technical Difficulties with the Device|1|||
128803864|NCT04716634|463576956|FG000|Overall Study|Death|24|||
128803865|NCT04716634|463576957|FG001|Overall Study|Death|24|||
128803866|NCT04716634|463576958|FG002|Overall Study|Death|8|||
128803867|NCT04716634|463576956|FG000|Overall Study|Closed by Sponsor|4|||
128803868|NCT04716634|463576957|FG001|Overall Study|Closed by Sponsor|4|||
128803869|NCT04716634|463576958|FG002|Overall Study|Closed by Sponsor|5|||
128803870|NCT04716634|463576956|FG000|Overall Study|Lost to Follow-up|1|||
128803871|NCT04716634|463576957|FG001|Overall Study|Lost to Follow-up|0|||
128803872|NCT04716634|463576958|FG002|Overall Study|Lost to Follow-up|1|||
128803873|NCT04716634|463576956|FG000|Overall Study|Withdrawal by Subject|0|||
128803874|NCT04716634|463576957|FG001|Overall Study|Withdrawal by Subject|0|||
128803875|NCT04716634|463576958|FG002|Overall Study|Withdrawal by Subject|1|||
128803876|NCT03089398|463576963|FG000|Overall Study|Death|4|||
128803877|NCT03089398|463576964|FG001|Overall Study|Death|9|||
128803878|NCT03089398|463576963|FG000|Overall Study|Lost to Follow-up|21|||
128803879|NCT03089398|463576964|FG001|Overall Study|Lost to Follow-up|30|||
128803880|NCT03089398|463576963|FG000|Overall Study|Withdrawal by Subject|2|||
128803881|NCT03089398|463576964|FG001|Overall Study|Withdrawal by Subject|2|||
128803882|NCT05062265|463576965|FG000|Overall Study|Withdrawal by Subject|1|||
128803883|NCT05062265|463576966|FG001|Overall Study|Withdrawal by Subject|0|||
128803884|NCT05439603|463576967|FG000|Overall Study|met withdrawal criteria|2|||
128803885|NCT02682316|463576972|FG000|Overall Study|Benign Final Pathology|27|||
128803886|NCT02682316|463576973|FG001|Overall Study|Benign Final Pathology|26|||
128803887|NCT02682316|463576972|FG000|Overall Study|Reoperation before 30 days|7|||
128803888|NCT02682316|463576973|FG001|Overall Study|Reoperation before 30 days|6|||
128803889|NCT02682316|463576972|FG000|Overall Study|Ineligible|1|||
128803890|NCT02682316|463576973|FG001|Overall Study|Ineligible|0|||
128803891|NCT02682316|463576972|FG000|Overall Study|Death|1|||
128803892|NCT02682316|463576973|FG001|Overall Study|Death|0|||
128803893|NCT02682316|463576972|FG000|Overall Study|Lost to Follow-up|7|||
128803894|NCT02682316|463576973|FG001|Overall Study|Lost to Follow-up|3|||
128803895|NCT00150813|463576975|FG000|Overall Study|Adverse Event|1|||
128803896|NCT00150813|463576975|FG000|Overall Study|Lack of Efficacy|1|||
128803897|NCT00150813|463576975|FG000|Overall Study|Lost to Follow-up|5|||
128803898|NCT00150813|463576975|FG000|Overall Study|Withdrawal by Subject|5|||
128803899|NCT00150813|463576975|FG000|Overall Study|Remission|3|||
128803900|NCT00150813|463576975|FG000|Overall Study|Planned pregancy|1|||
128803901|NCT00150813|463576975|FG000|Overall Study|Switch to commercially available LEV|2|||
128803902|NCT03052608|463576977|FG000|Treatment Phase|Adverse Event|10|||
128803903|NCT03052608|463576978|FG001|Treatment Phase|Adverse Event|12|||
128803904|NCT03052608|463576977|FG000|Treatment Phase|Death|6|||
128803905|NCT03052608|463576978|FG001|Treatment Phase|Death|4|||
128803906|NCT03052608|463576977|FG000|Treatment Phase|Withdrawal by Subject|4|||
128803907|NCT03052608|463576978|FG001|Treatment Phase|Withdrawal by Subject|12|||
128803908|NCT03052608|463576977|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
128803909|NCT03052608|463576978|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
128803910|NCT03052608|463576977|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
128803911|NCT03052608|463576978|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
128803912|NCT03052608|463576977|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
128803913|NCT03052608|463576978|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
128803914|NCT03052608|463576977|FG000|Treatment Phase|Ongoing|103|||
128803915|NCT03052608|463576978|FG001|Treatment Phase|Ongoing|31|||
128803916|NCT03052608|463576977|FG000|Long-Term Follow-up Phase|Death|23|||
128803917|NCT03052608|463576978|FG001|Long-Term Follow-up Phase|Death|28|||
128803918|NCT03052608|463576977|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
128803919|NCT03052608|463576978|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
128803920|NCT03052608|463576977|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
128803921|NCT03052608|463576978|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
128803922|NCT03052608|463576977|FG000|Long-Term Follow-up Phase|Ongoing|122|||
128803923|NCT03052608|463576978|FG001|Long-Term Follow-up Phase|Ongoing|99|||
128803924|NCT03113500|463576979|FG000|Overall Study|Withdrawal by Subject|1|||
128803925|NCT05249439|463576981|FG000|Overall Study|Withdrawal by Subject|2|||
128803926|NCT05249439|463576982|FG001|Overall Study|Withdrawal by Subject|5|||
128803927|NCT05249439|463576981|FG000|Overall Study|Physician Decision|3|||
128803928|NCT05249439|463576982|FG001|Overall Study|Physician Decision|1|||
128803929|NCT01376700|463576985|FG000|Overall Study|Sponsor terminated study early|8|||
128803930|NCT01376700|463576985|FG000|Overall Study|Low or high titer inhibitor|8|||
128803931|NCT00601900|463576997|FG000|Overall Study|Withdrawal by Subject|0|||
128803932|NCT00601900|463576998|FG001|Overall Study|Withdrawal by Subject|3|||
128803933|NCT02500758|463577002|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
128803934|NCT02500758|463577003|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
128803935|NCT02500758|463577002|FG000|Washout (1 Week)|Lost to Follow-up|2|||
128803936|NCT02500758|463577003|FG001|Washout (1 Week)|Lost to Follow-up|2|||
128803937|NCT02500758|463577002|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
128803938|NCT02500758|463577003|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
128803939|NCT02500758|463577002|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
128803940|NCT02500758|463577003|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
128803941|NCT02500758|463577002|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
128803942|NCT02500758|463577003|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
128803943|NCT00274469|463577005|FG000|Overall Study|Death|63|||
128803944|NCT00274469|463577006|FG001|Overall Study|Death|74|||
128803945|NCT00274469|463577005|FG000|Overall Study|Did not consent to OS follow-up|16|||
128803946|NCT00274469|463577006|FG001|Overall Study|Did not consent to OS follow-up|19|||
128803947|NCT02140645|463577008|FG000|Overall Study|Not linked|5489|||
128803948|NCT02140645|463577009|FG001|Overall Study|Not linked|61654|||
128803949|NCT02140645|463577010|FG002|Overall Study|Not linked|4236|||
128803950|NCT02140645|463577011|FG003|Overall Study|Not linked|13833|||
128803951|NCT02140645|463577012|FG004|Overall Study|Not linked|3286|||
128803952|NCT02140645|463577013|FG005|Overall Study|Not linked|70896|||
128803953|NCT00593489|463577017|FG000|Allocation|did not attend workshop; allocation not|2|||
128803954|NCT00593489|463577018|FG001|Allocation|did not attend workshop; allocation not|1|||
128803955|NCT00611559|463577019|FG000|Overall Study|Lost to Follow-up|0|||
128803956|NCT00611559|463577020|FG001|Overall Study|Lost to Follow-up|1|||
128803957|NCT00611559|463577021|FG002|Overall Study|Lost to Follow-up|0|||
128803958|NCT00611559|463577019|FG000|Overall Study|Protocol Violation|1|||
128803959|NCT00611559|463577020|FG001|Overall Study|Protocol Violation|0|||
128803960|NCT00611559|463577021|FG002|Overall Study|Protocol Violation|1|||
128803961|NCT04095104|463577022|FG000|Overall Study|Withdrawal by Subject|0|||
128803962|NCT04095104|463577023|FG001|Overall Study|Withdrawal by Subject|1|||
128803963|NCT06450405|463577028|FG000|Overall Study|Study funding terminated.|0|||
128803964|NCT06450405|463577029|FG001|Overall Study|Study funding terminated.|2|||
128803965|NCT03152786|463578073|FG000|Overall Study|Withdrawal by Subject|2|||
128803966|NCT03152786|463578074|FG001|Overall Study|Withdrawal by Subject|1|||
128803967|NCT04533022|463578075|FG000|Overall Study|Withdrawal by Subject|15|||
128803968|NCT04533022|463578075|FG000|Overall Study|Adverse Event|6|||
128803969|NCT04533022|463578075|FG000|Overall Study|Death|1|||
128803970|NCT04533022|463578075|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
128803971|NCT04533022|463578075|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
128803972|NCT05113966|463578077|FG000|Overall Study|Death|21|||
128803973|NCT05113966|463578077|FG000|Overall Study|Study Terminated by Sponsor|9|||
128803974|NCT03747484|463578078|FG000|Overall Study|Lack of Efficacy|0|||
128803975|NCT03747484|463578079|FG001|Overall Study|Lack of Efficacy|1|||
128803976|NCT03747484|463578080|FG002|Overall Study|Lack of Efficacy|1|||
128803977|NCT03747484|463578081|FG003|Overall Study|Lack of Efficacy|2|||
128803978|NCT03747484|463578082|FG004|Overall Study|Lack of Efficacy|2|||
128803979|NCT02597946|463578084|FG000|Overall Study|Withdrawal by Subject|1|||
128803980|NCT02597946|463578084|FG000|Overall Study|Progressive disease|16|||
128803981|NCT02597946|463578084|FG000|Overall Study|Other than above|1|||
128803982|NCT05058391|463578089|FG000|Overall Study|Adverse Event|1|||
128803983|NCT03833245|463578093|FG000|Overall Study|Death|0|||
128803984|NCT03833245|463578094|FG001|Overall Study|Death|1|||
128803985|NCT03775109|463578095|FG000|Overall Study|Adverse Event|1|||
128803986|NCT03775109|463578096|FG001|Overall Study|Adverse Event|0|||
128803987|NCT03775109|463578095|FG000|Overall Study|COVID-19 outbreak|2|||
128803988|NCT03775109|463578096|FG001|Overall Study|COVID-19 outbreak|0|||
128803989|NCT03775109|463578095|FG000|Overall Study|Lost to Follow-up|0|||
128803990|NCT03775109|463578096|FG001|Overall Study|Lost to Follow-up|2|||
128803991|NCT03775109|463578095|FG000|Overall Study|Withdrawal by Subject|1|||
128803992|NCT03775109|463578096|FG001|Overall Study|Withdrawal by Subject|1|||
128803993|NCT03775109|463578095|FG000|Overall Study|Death|0|||
128803994|NCT03775109|463578096|FG001|Overall Study|Death|1|||
128803995|NCT03775109|463578095|FG000|Overall Study|Lack of Efficacy|1|||
128803996|NCT03775109|463578096|FG001|Overall Study|Lack of Efficacy|0|||
128803997|NCT03347383|463578097|FG000|Overall Study|Death|39|||
128803998|NCT03347383|463578097|FG000|Overall Study|Withdrawal by Subject|3|||
128803999|NCT03347383|463578097|FG000|Overall Study|Lost to Follow-up|9|||
128804000|NCT01938547|463578105|FG000|Overall Study|Physician Decision|1|||
128804001|NCT00739648|463578110|FG000|Overall Study|Adverse Event|3|||
128804002|NCT00739648|463578111|FG001|Overall Study|Adverse Event|15|||
128804003|NCT00739648|463578110|FG000|Overall Study|Withdrawal by Subject|13|||
128804004|NCT00739648|463578111|FG001|Overall Study|Withdrawal by Subject|25|||
128804005|NCT00739648|463578110|FG000|Overall Study|Lost to Follow-up|4|||
128804006|NCT00739648|463578111|FG001|Overall Study|Lost to Follow-up|7|||
128804007|NCT00739648|463578110|FG000|Overall Study|Death|2|||
128804008|NCT00739648|463578111|FG001|Overall Study|Death|0|||
128804009|NCT00739648|463578110|FG000|Overall Study|Do not know|4|||
128804010|NCT00739648|463578111|FG001|Overall Study|Do not know|6|||
128804011|NCT05110495|463578112|FG000|Overall Study|Lost to Follow-up|1|||
128804012|NCT05110495|463578112|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
128804013|NCT04173663|463578113|FG000|Overall Study|Withdrawal by Subject|1|||
128804014|NCT04173663|463578114|FG001|Overall Study|Withdrawal by Subject|6|||
128804015|NCT04173663|463578113|FG000|Overall Study|Lost to Follow-up|17|||
128804016|NCT04173663|463578114|FG001|Overall Study|Lost to Follow-up|24|||
128804017|NCT02630823|463578120|FG000|Overall Study|Withdrawal by Subject|1|||
128804018|NCT02630823|463578120|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
128804019|NCT03391466|463578121|FG000|Overall Study|Death|82|||
128804020|NCT03391466|463578122|FG001|Overall Study|Death|85|||
128804021|NCT03391466|463578121|FG000|Overall Study|Still on study|93|||
128804022|NCT03391466|463578122|FG001|Overall Study|Still on study|74|||
128804023|NCT03391466|463578121|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
128804024|NCT03391466|463578122|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
128804025|NCT03391466|463578121|FG000|Overall Study|Lost to Follow-up|5|||
128804026|NCT03391466|463578122|FG001|Overall Study|Lost to Follow-up|5|||
128804027|NCT03391466|463578121|FG000|Overall Study|Investigator decision|0|||
128804028|NCT03391466|463578122|FG001|Overall Study|Investigator decision|1|||
128804029|NCT03391466|463578121|FG000|Overall Study|Other|0|||
128804030|NCT03391466|463578122|FG001|Overall Study|Other|1|||
128804031|NCT03655132|463578125|FG000|Overall Study|Lost to Follow-up|2|||
128804032|NCT03655132|463578126|FG001|Overall Study|Lost to Follow-up|1|||
128804033|NCT03655132|463578125|FG000|Overall Study|Withdrawal by Subject|0|||
128804034|NCT03655132|463578126|FG001|Overall Study|Withdrawal by Subject|1|||
128804035|NCT03655132|463578125|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
128804036|NCT03655132|463578126|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
128804037|NCT05919082|463578131|FG000|Overall Study|Adverse Event|3|||
128804038|NCT05919082|463578132|FG001|Overall Study|Adverse Event|0|||
128804039|NCT05919082|463578131|FG000|Overall Study|Lost to Follow-up|0|||
128804040|NCT05919082|463578132|FG001|Overall Study|Lost to Follow-up|1|||
128804041|NCT05919082|463578131|FG000|Overall Study|Withdrawal by Subject|8|||
128804042|NCT05919082|463578132|FG001|Overall Study|Withdrawal by Subject|9|||
128804043|NCT05919082|463578131|FG000|Overall Study|Lack of Efficacy|0|||
128804044|NCT05919082|463578132|FG001|Overall Study|Lack of Efficacy|1|||
128804045|NCT05919082|463578131|FG000|Overall Study|Investigator Decision|1|||
128804046|NCT05919082|463578132|FG001|Overall Study|Investigator Decision|0|||
128804047|NCT03526861|463578142|FG000|Initial Treatment Period|Not dosed|1|||
128804048|NCT03526861|463578143|FG001|Initial Treatment Period|Not dosed|1|||
128804049|NCT03526861|463578144|FG002|Initial Treatment Period|Not dosed|1|||
128804050|NCT03526861|463578145|FG003|Initial Treatment Period|Not dosed|0|||
128804051|NCT03526861|463578146|FG004|Initial Treatment Period|Not dosed|0|||
128804052|NCT03526861|463578147|FG005|Initial Treatment Period|Not dosed|0|||
128804053|NCT03526861|463578148|FG006|Initial Treatment Period|Not dosed|0|||
128804054|NCT03526861|463578149|FG007|Initial Treatment Period|Not dosed|0|||
128804055|NCT03526861|463578150|FG008|Initial Treatment Period|Not dosed|0|||
128804056|NCT03526861|463578142|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
128804057|NCT03526861|463578143|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
128804058|NCT03526861|463578144|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
128804059|NCT03526861|463578145|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804060|NCT03526861|463578146|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804061|NCT03526861|463578147|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804062|NCT03526861|463578148|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804063|NCT03526861|463578149|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804064|NCT03526861|463578150|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804065|NCT03526861|463578142|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
128804066|NCT03526861|463578143|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
128804067|NCT03526861|463578144|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
128804068|NCT03526861|463578145|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
128804069|NCT03526861|463578146|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
128804070|NCT03526861|463578147|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
128804071|NCT03526861|463578148|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
128804072|NCT03526861|463578149|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
128804073|NCT03526861|463578150|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
128804074|NCT03526861|463578142|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804075|NCT03526861|463578143|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804076|NCT03526861|463578144|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804077|NCT03526861|463578145|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
128804078|NCT03526861|463578146|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
128804079|NCT03526861|463578147|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804080|NCT03526861|463578148|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
128804081|NCT03526861|463578149|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804082|NCT03526861|463578150|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804083|NCT03526861|463578142|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
128804084|NCT03526861|463578143|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
128804085|NCT03526861|463578144|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
128804086|NCT03526861|463578145|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
128804087|NCT03526861|463578146|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
128804088|NCT03526861|463578147|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
128804089|NCT03526861|463578148|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
128804090|NCT03526861|463578149|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
128804091|NCT03526861|463578150|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
128804092|NCT03526861|463578142|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804093|NCT03526861|463578143|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804094|NCT03526861|463578144|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804095|NCT03526861|463578145|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
128804096|NCT03526861|463578146|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804097|NCT03526861|463578147|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804098|NCT03526861|463578148|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804099|NCT03526861|463578149|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804100|NCT03526861|463578150|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804101|NCT03526861|463578142|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804102|NCT03526861|463578143|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804103|NCT03526861|463578144|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804104|NCT03526861|463578145|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804105|NCT03526861|463578146|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804106|NCT03526861|463578147|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804107|NCT03526861|463578148|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804108|NCT03526861|463578149|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
128804109|NCT03526861|463578150|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
128804110|NCT03526861|463578142|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804111|NCT03526861|463578143|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804112|NCT03526861|463578144|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804113|NCT03526861|463578145|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804114|NCT03526861|463578146|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804115|NCT03526861|463578147|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804116|NCT03526861|463578148|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804117|NCT03526861|463578149|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
128804118|NCT03526861|463578150|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
128804119|NCT03526861|463578142|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804120|NCT03526861|463578143|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804121|NCT03526861|463578144|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804122|NCT03526861|463578145|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804123|NCT03526861|463578146|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804124|NCT03526861|463578147|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804125|NCT03526861|463578148|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804126|NCT03526861|463578149|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
128804127|NCT03526861|463578150|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
128804128|NCT00650104|463578152|FG000|Overall Study|Adverse Event|17|||
128804129|NCT00650104|463578152|FG000|Overall Study|Death|2|||
128804130|NCT00650104|463578152|FG000|Overall Study|Withdrawal by Subject|11|||
128804131|NCT00650104|463578152|FG000|Overall Study|Physician Decision|7|||
128804132|NCT00650104|463578152|FG000|Overall Study|Lost to Follow-up|1|||
128804133|NCT00650104|463578152|FG000|Overall Study|Non-compliance|2|||
128804134|NCT00650104|463578152|FG000|Overall Study|Sponsor Terminated Dosing|1|||
128804135|NCT04999592|463578160|FG000|Overall Study|Withdrawal by Subject|1|||
128804136|NCT04999592|463578161|FG001|Overall Study|Withdrawal by Subject|0|||
128804137|NCT03527160|463578163|FG000|Overall Study|No urine collected|13|||
128804138|NCT03527160|463578163|FG000|Overall Study|No clinical serum creatinine collected|6|||
128804139|NCT03527160|463578163|FG000|Overall Study|Did not meet inclusion|2|||
128804140|NCT02910713|463578164|FG000|Overall Study|Protocol Violation|2|||
128804141|NCT02910713|463578164|FG000|Overall Study|Subject Choice|4|||
128804142|NCT02910713|463578164|FG000|Overall Study|Received One Application|10|||
128804143|NCT02910713|463578164|FG000|Overall Study|Received Neither Application|18|||
128804144|NCT02910713|463578164|FG000|Overall Study|Enrollment cap|7|||
128804145|NCT02910713|463578164|FG000|Overall Study|Investigator Discretion|1|||
128804146|NCT03767517|463578165|FG000|Overall Study|Lost to Follow-up|16|||
128804147|NCT03767517|463578166|FG001|Overall Study|Lost to Follow-up|10|||
128804148|NCT03767517|463578165|FG000|Overall Study|Death|2|||
128804149|NCT03767517|463578166|FG001|Overall Study|Death|3|||
128804150|NCT02163447|463579201|FG000|Overall Study|Withdrawal by Subject|2|||
128804151|NCT02163447|463579202|FG001|Overall Study|Withdrawal by Subject|0|||
128804152|NCT02163447|463579203|FG002|Overall Study|Withdrawal by Subject|1|||
128804153|NCT02163447|463579201|FG000|Overall Study|Lost to Follow-up|1|||
128804154|NCT02163447|463579202|FG001|Overall Study|Lost to Follow-up|3|||
128804155|NCT02163447|463579203|FG002|Overall Study|Lost to Follow-up|0|||
128804156|NCT02163447|463579201|FG000|Overall Study|Moved out of study area|2|||
128804157|NCT02163447|463579202|FG001|Overall Study|Moved out of study area|3|||
128804158|NCT02163447|463579203|FG002|Overall Study|Moved out of study area|2|||
128804159|NCT02163447|463579201|FG000|Overall Study|Became HIV infected at time of delivery|1|||
128804160|NCT02163447|463579202|FG001|Overall Study|Became HIV infected at time of delivery|0|||
128804161|NCT02163447|463579203|FG002|Overall Study|Became HIV infected at time of delivery|0|||
128804162|NCT05386355|463579204|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
128804163|NCT05386355|463579205|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
128804164|NCT05386355|463579206|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
128804165|NCT05386355|463579207|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
128804166|NCT06143670|463579208|FG000|Overall Study|Lost to Follow-up|0|||
128804167|NCT06143670|463579209|FG001|Overall Study|Lost to Follow-up|1|||
128804168|NCT06143670|463579208|FG000|Overall Study|Withdrawal by Subject|3|||
128804169|NCT06143670|463579209|FG001|Overall Study|Withdrawal by Subject|0|||
128804170|NCT03625882|463579211|FG000|Overall Study|Protocol Violation|3|||
128804171|NCT05691452|463579217|FG000|Overall Study|Withdrawal by Subject|1|||
128804172|NCT05691452|463579218|FG001|Overall Study|Withdrawal by Subject|1|||
128804173|NCT05691452|463579219|FG002|Overall Study|Withdrawal by Subject|0|||
128804174|NCT05691452|463579217|FG000|Overall Study|Physician Decision|1|||
128804175|NCT05691452|463579218|FG001|Overall Study|Physician Decision|0|||
128804176|NCT05691452|463579219|FG002|Overall Study|Physician Decision|0|||
128804177|NCT05691452|463579217|FG000|Overall Study|Lost to Follow-up|0|||
128804178|NCT05691452|463579218|FG001|Overall Study|Lost to Follow-up|0|||
128804179|NCT05691452|463579219|FG002|Overall Study|Lost to Follow-up|1|||
128804180|NCT05691452|463579217|FG000|Overall Study|Adverse Event|0|||
128804181|NCT05691452|463579218|FG001|Overall Study|Adverse Event|0|||
128804182|NCT05691452|463579219|FG002|Overall Study|Adverse Event|1|||
128804183|NCT05320432|463579220|FG000|Overall Study|Withdrawal by Subject|0|||
128804184|NCT05320432|463579221|FG001|Overall Study|Withdrawal by Subject|2|||
128804185|NCT04842643|463579222|FG000|Overall Study|Physician Decision|1|||
128804186|NCT04842643|463579222|FG000|Overall Study|Other|1|||
128804187|NCT03484702|463579223|FG000|Treatment Period|Death|3|||
128804188|NCT03484702|463579224|FG001|Treatment Period|Death|1|||
128804189|NCT03484702|463579225|FG002|Treatment Period|Death|0|||
128804190|NCT03484702|463579226|FG003|Treatment Period|Death|0|||
128804191|NCT03484702|463579227|FG004|Treatment Period|Death|0|||
128804192|NCT03484702|463579228|FG005|Treatment Period|Death|0|||
128804193|NCT03484702|463579223|FG000|Treatment Period|Adverse Event|1|||
128804194|NCT03484702|463579224|FG001|Treatment Period|Adverse Event|0|||
128804195|NCT03484702|463579225|FG002|Treatment Period|Adverse Event|0|||
128804196|NCT03484702|463579226|FG003|Treatment Period|Adverse Event|0|||
128804197|NCT03484702|463579227|FG004|Treatment Period|Adverse Event|0|||
128804198|NCT03484702|463579228|FG005|Treatment Period|Adverse Event|0|||
128804199|NCT03484702|463579223|FG000|Treatment Period|Participant Withdrew from Study|0|||
128804200|NCT03484702|463579224|FG001|Treatment Period|Participant Withdrew from Study|1|||
128804201|NCT03484702|463579225|FG002|Treatment Period|Participant Withdrew from Study|0|||
128804202|NCT03484702|463579226|FG003|Treatment Period|Participant Withdrew from Study|0|||
128804203|NCT03484702|463579227|FG004|Treatment Period|Participant Withdrew from Study|0|||
128804204|NCT03484702|463579228|FG005|Treatment Period|Participant Withdrew from Study|0|||
128804205|NCT03484702|463579223|FG000|Treatment Period|Physician Decision|0|||
128804206|NCT03484702|463579224|FG001|Treatment Period|Physician Decision|1|||
128804207|NCT03484702|463579225|FG002|Treatment Period|Physician Decision|0|||
128804208|NCT03484702|463579226|FG003|Treatment Period|Physician Decision|0|||
128804209|NCT03484702|463579227|FG004|Treatment Period|Physician Decision|0|||
128804210|NCT03484702|463579228|FG005|Treatment Period|Physician Decision|1|||
128804211|NCT01757665|463579236|FG000|Overall Study|Still on Study - Visit Completed|240|||
128804212|NCT01757665|463579237|FG001|Overall Study|Still on Study - Visit Completed|30|||
128804213|NCT01757665|463579236|FG000|Overall Study|Still on Study - Visit Pending|398|||
128804214|NCT01757665|463579237|FG001|Overall Study|Still on Study - Visit Pending|40|||
128804215|NCT01757665|463579236|FG000|Overall Study|Still on Study - Missed Visit|14|||
128804216|NCT01757665|463579237|FG001|Overall Study|Still on Study - Missed Visit|1|||
128804217|NCT01757665|463579236|FG000|Overall Study|Death|25|||
128804218|NCT01757665|463579237|FG001|Overall Study|Death|8|||
128804219|NCT01757665|463579236|FG000|Overall Study|Explant|1|||
128804220|NCT01757665|463579237|FG001|Overall Study|Explant|2|||
128804221|NCT01757665|463579236|FG000|Overall Study|Withdrawal by Subject|10|||
128804222|NCT01757665|463579237|FG001|Overall Study|Withdrawal by Subject|0|||
128804223|NCT01757665|463579236|FG000|Overall Study|Lost to Follow-up|1|||
128804224|NCT01757665|463579237|FG001|Overall Study|Lost to Follow-up|1|||
128804225|NCT01757665|463579236|FG000|Overall Study|Not Implanted with Device|5|||
128804226|NCT01757665|463579237|FG001|Overall Study|Not Implanted with Device|1|||
128804227|NCT05816551|463579238|FG000|Overall Study|Withdrawal by Subject|0|||
128804228|NCT05816551|463579239|FG001|Overall Study|Withdrawal by Subject|1|||
128804229|NCT05816551|463579238|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
128804230|NCT05816551|463579239|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
128804231|NCT02651324|463579248|FG000|Overall Study|drug not administered, due dispensing issue|1|||
128804232|NCT02651324|463579249|FG001|Overall Study|drug not administered, due dispensing issue|0|||
128804233|NCT05461131|463579250|FG000|Overall Study|Lost to Follow-up|0|||
128804234|NCT05461131|463579251|FG001|Overall Study|Lost to Follow-up|2|||
128804235|NCT03101904|463579253|FG000|Wash Out (10 Days)|Adverse Event|1|||
128804236|NCT03101904|463579254|FG001|Wash Out (10 Days)|Adverse Event|0|||
128804237|NCT03101904|463579253|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
128804238|NCT03101904|463579254|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
128804239|NCT04538417|463579255|FG000|Overall Study|Withdrawal by Subject|2|||
128804240|NCT04549168|463579256|FG000|Randomization Phase|Adverse Event|0|||
128804241|NCT04549168|463579257|FG001|Randomization Phase|Adverse Event|0|||
128804242|NCT04549168|463579258|FG002|Randomization Phase|Adverse Event|1|||
128804243|NCT04549168|463579256|FG000|Randomization Phase|Other|0|||
128804244|NCT04549168|463579257|FG001|Randomization Phase|Other|2|||
128804245|NCT04549168|463579258|FG002|Randomization Phase|Other|0|||
128804246|NCT04549168|463579256|FG000|Randomization Phase|Withdrawal by Subject|0|||
128804247|NCT04549168|463579257|FG001|Randomization Phase|Withdrawal by Subject|2|||
128804248|NCT04549168|463579258|FG002|Randomization Phase|Withdrawal by Subject|1|||
128804249|NCT02662062|463579262|FG000|Overall Study|Withdrawal by Subject|1|||
128804250|NCT06311084|463579263|FG000|Overall Study|Lost to Follow-up|14|||
128804251|NCT03988634|463579264|FG000|Double-Blind|Adverse Event|4|||
128804252|NCT03988634|463579265|FG001|Double-Blind|Adverse Event|0|||
128804253|NCT03988634|463579266|FG002|Double-Blind|Adverse Event|0|||
128804254|NCT03988634|463579264|FG000|Double-Blind|Death|18|||
128804255|NCT03988634|463579265|FG001|Double-Blind|Death|26|||
128804256|NCT03988634|463579266|FG002|Double-Blind|Death|0|||
128804257|NCT03988634|463579264|FG000|Double-Blind|Lost to Follow-up|6|||
128804258|NCT03988634|463579265|FG001|Double-Blind|Lost to Follow-up|7|||
128804259|NCT03988634|463579266|FG002|Double-Blind|Lost to Follow-up|0|||
128804260|NCT03988634|463579264|FG000|Double-Blind|Physician Decision|9|||
128804261|NCT03988634|463579265|FG001|Double-Blind|Physician Decision|5|||
128804262|NCT03988634|463579266|FG002|Double-Blind|Physician Decision|0|||
128804263|NCT03988634|463579264|FG000|Double-Blind|Subject decision|24|||
128804264|NCT03988634|463579265|FG001|Double-Blind|Subject decision|13|||
128804265|NCT03988634|463579266|FG002|Double-Blind|Subject decision|0|||
128804266|NCT03988634|463579264|FG000|Open-Label|Adverse Event|0|||
128804267|NCT03988634|463579265|FG001|Open-Label|Adverse Event|0|||
128804268|NCT03988634|463579266|FG002|Open-Label|Adverse Event|7|||
128804269|NCT03988634|463579264|FG000|Open-Label|Physician Decision|0|||
128804270|NCT03988634|463579265|FG001|Open-Label|Physician Decision|0|||
128804271|NCT03988634|463579266|FG002|Open-Label|Physician Decision|1|||
128804272|NCT03988634|463579264|FG000|Open-Label|Technical problems|0|||
128804273|NCT03988634|463579265|FG001|Open-Label|Technical problems|0|||
128804274|NCT03988634|463579266|FG002|Open-Label|Technical problems|1|||
128804275|NCT04725240|463579267|FG000|Overall Study|Adverse Event|2|||
128804276|NCT02249949|463579268|FG000|Overall Study|Cancelled prior to treatment|2|||
128804277|NCT02097420|463579269|FG000|Overall Study|Death|6|||
128804278|NCT02097420|463579269|FG000|Overall Study|Valve explanted|13|||
128804279|NCT02097420|463579269|FG000|Overall Study|Other Reason|1|||
128804280|NCT03161379|463579272|FG000|Overall Study|Withdrawal by Subject|4|||
128804281|NCT03161379|463579272|FG000|Overall Study|disease progression during chemotherapy|5|||
128804282|NCT03161379|463579272|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
128804283|NCT03161379|463579272|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
128804284|NCT00931710|463579278|FG000|Overall Study|Adverse Event|16|||
128804285|NCT00931710|463579279|FG001|Overall Study|Adverse Event|10|||
128804286|NCT00931710|463579278|FG000|Overall Study|Abnormal test procedure results|2|||
128804287|NCT00931710|463579279|FG001|Overall Study|Abnormal test procedure results|0|||
128804288|NCT00931710|463579278|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
128804289|NCT00931710|463579279|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
128804290|NCT00931710|463579278|FG000|Overall Study|Patient withdrew consent|4|||
128804291|NCT00931710|463579279|FG001|Overall Study|Patient withdrew consent|9|||
128804292|NCT00931710|463579278|FG000|Overall Study|Lost to Follow-up|6|||
128804293|NCT00931710|463579279|FG001|Overall Study|Lost to Follow-up|5|||
128804294|NCT00931710|463579278|FG000|Overall Study|Protocol deviation|1|||
128804295|NCT00931710|463579279|FG001|Overall Study|Protocol deviation|2|||
128804296|NCT03385629|463579280|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
128804297|NCT03385629|463579281|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
128804298|NCT03385629|463579280|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
128804299|NCT03385629|463579281|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
128804300|NCT03385629|463579280|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
128804301|NCT03385629|463579281|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
128804302|NCT05633407|463579282|FG000|Overall Study|Physician Decision|2|||
128804303|NCT05633407|463579283|FG001|Overall Study|Physician Decision|0|||
128804304|NCT05633407|463579282|FG000|Overall Study|Adverse Event|1|||
128804305|NCT05633407|463579283|FG001|Overall Study|Adverse Event|0|||
128804306|NCT05633407|463579282|FG000|Overall Study|Withdrawal by Subject|1|||
128804307|NCT05633407|463579283|FG001|Overall Study|Withdrawal by Subject|0|||
128804308|NCT05633407|463579282|FG000|Overall Study|Other|1|||
128804309|NCT05633407|463579283|FG001|Overall Study|Other|1|||
128804310|NCT05792423|463579287|FG000|Overall Study|Withdrawal by Subject|2|||
128804311|NCT05338086|463580730|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
128804312|NCT05338086|463580731|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
128804313|NCT05338086|463580732|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
128804314|NCT05338086|463580733|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
128804315|NCT05338086|463580734|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
128804316|NCT05338086|463580730|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
128804317|NCT05338086|463580731|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
128804318|NCT05338086|463580732|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
128804319|NCT05338086|463580733|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
128804320|NCT05338086|463580734|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
128804321|NCT05338086|463580730|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
128804322|NCT05338086|463580731|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
128804323|NCT05338086|463580732|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
128804324|NCT05338086|463580733|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
128804325|NCT05338086|463580734|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
128804326|NCT05338086|463580730|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
128804327|NCT05338086|463580731|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
128804328|NCT05338086|463580732|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
128804329|NCT05338086|463580733|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
128804330|NCT05338086|463580734|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
128804331|NCT05338086|463580730|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
128804332|NCT05338086|463580731|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
128804333|NCT05338086|463580732|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
128804334|NCT05338086|463580733|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
128804335|NCT05338086|463580734|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
128804336|NCT05338086|463580730|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
128804337|NCT05338086|463580731|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
128804338|NCT05338086|463580732|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
128804339|NCT05338086|463580733|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
128804340|NCT05338086|463580734|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
128804341|NCT05338086|463580730|FG000|Transition Period (M12 to M18)|Death|0|||
128804342|NCT05338086|463580731|FG001|Transition Period (M12 to M18)|Death|0|||
128804343|NCT05338086|463580732|FG002|Transition Period (M12 to M18)|Death|1|||
128804344|NCT05338086|463580733|FG003|Transition Period (M12 to M18)|Death|0|||
128804345|NCT05338086|463580734|FG004|Transition Period (M12 to M18)|Death|0|||
128804346|NCT05338086|463580730|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
128804347|NCT05338086|463580731|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
128804348|NCT05338086|463580732|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
128804349|NCT05338086|463580733|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
128804350|NCT05338086|463580734|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
128804351|NCT05338086|463580730|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
128804352|NCT05338086|463580731|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
128804353|NCT05338086|463580732|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
128804354|NCT05338086|463580733|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
128804355|NCT05338086|463580734|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
128804356|NCT05338086|463580730|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
128804357|NCT05338086|463580731|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
128804358|NCT05338086|463580732|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
128804359|NCT05338086|463580733|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
128804360|NCT05338086|463580734|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
128804361|NCT03940703|463580735|FG000|Overall Study|Still under treatment|31|||
128804362|NCT03940703|463580736|FG001|Overall Study|Still under treatment|0|||
128804363|NCT04521478|463580737|FG000|Overall Study|Protocol Violation|2|||
128804364|NCT04521478|463580738|FG001|Overall Study|Protocol Violation|0|||
128804365|NCT04521478|463580739|FG002|Overall Study|Protocol Violation|1|||
128804366|NCT04521478|463580740|FG003|Overall Study|Protocol Violation|0|||
128804367|NCT04521478|463580741|FG004|Overall Study|Protocol Violation|0|||
128804368|NCT04521478|463580742|FG005|Overall Study|Protocol Violation|0|||
128804369|NCT04521478|463580737|FG000|Overall Study|Technical Problems|0|||
128804370|NCT04521478|463580738|FG001|Overall Study|Technical Problems|0|||
128804371|NCT04521478|463580739|FG002|Overall Study|Technical Problems|0|||
128804372|NCT04521478|463580740|FG003|Overall Study|Technical Problems|1|||
128804373|NCT04521478|463580741|FG004|Overall Study|Technical Problems|0|||
128804374|NCT04521478|463580742|FG005|Overall Study|Technical Problems|0|||
128804375|NCT04521478|463580737|FG000|Overall Study|Burden of Study Procedures|1|||
128804376|NCT04521478|463580738|FG001|Overall Study|Burden of Study Procedures|0|||
128804377|NCT04521478|463580739|FG002|Overall Study|Burden of Study Procedures|0|||
128804378|NCT04521478|463580740|FG003|Overall Study|Burden of Study Procedures|1|||
128804379|NCT04521478|463580741|FG004|Overall Study|Burden of Study Procedures|0|||
128804380|NCT04521478|463580742|FG005|Overall Study|Burden of Study Procedures|1|||
128804381|NCT04521478|463580737|FG000|Overall Study|Lack of Efficacy|0|||
128804382|NCT04521478|463580738|FG001|Overall Study|Lack of Efficacy|0|||
128804383|NCT04521478|463580739|FG002|Overall Study|Lack of Efficacy|0|||
128804384|NCT04521478|463580740|FG003|Overall Study|Lack of Efficacy|0|||
128804385|NCT04521478|463580741|FG004|Overall Study|Lack of Efficacy|1|||
128804386|NCT04521478|463580742|FG005|Overall Study|Lack of Efficacy|1|||
128804387|NCT04521478|463580737|FG000|Overall Study|Adverse Event|7|||
128804388|NCT04521478|463580738|FG001|Overall Study|Adverse Event|0|||
128804389|NCT04521478|463580739|FG002|Overall Study|Adverse Event|2|||
128804390|NCT04521478|463580740|FG003|Overall Study|Adverse Event|1|||
128804391|NCT04521478|463580741|FG004|Overall Study|Adverse Event|2|||
128804392|NCT04521478|463580742|FG005|Overall Study|Adverse Event|7|||
128804393|NCT04521478|463580737|FG000|Overall Study|No Reason Available|0|||
128804394|NCT04521478|463580738|FG001|Overall Study|No Reason Available|2|||
128804395|NCT04521478|463580739|FG002|Overall Study|No Reason Available|0|||
128804396|NCT04521478|463580740|FG003|Overall Study|No Reason Available|0|||
128804397|NCT04521478|463580741|FG004|Overall Study|No Reason Available|1|||
128804398|NCT04521478|463580742|FG005|Overall Study|No Reason Available|0|||
128804399|NCT04521478|463580737|FG000|Overall Study|Other than listed|3|||
128804400|NCT04521478|463580738|FG001|Overall Study|Other than listed|3|||
128804401|NCT04521478|463580739|FG002|Overall Study|Other than listed|3|||
128804402|NCT04521478|463580740|FG003|Overall Study|Other than listed|2|||
128804403|NCT04521478|463580741|FG004|Overall Study|Other than listed|3|||
128804404|NCT04521478|463580742|FG005|Overall Study|Other than listed|3|||
128804405|NCT04521478|463580737|FG000|Overall Study|Not treated|0|||
128804406|NCT04521478|463580738|FG001|Overall Study|Not treated|0|||
128804407|NCT04521478|463580739|FG002|Overall Study|Not treated|0|||
128804408|NCT04521478|463580740|FG003|Overall Study|Not treated|0|||
128804409|NCT04521478|463580741|FG004|Overall Study|Not treated|0|||
128804410|NCT04521478|463580742|FG005|Overall Study|Not treated|1|||
128804411|NCT04850807|463580750|FG000|Overall Study|Death|50|||
128804412|NCT04850807|463580751|FG001|Overall Study|Death|55|||
128804413|NCT04850807|463580750|FG000|Overall Study|Discharged|17|||
128804414|NCT04850807|463580751|FG001|Overall Study|Discharged|13|||
128804415|NCT04850807|463580750|FG000|Overall Study|Incomplete baseline data|3|||
128804416|NCT04850807|463580751|FG001|Overall Study|Incomplete baseline data|2|||
128804417|NCT02187003|463580752|FG000|Overall Study|Adverse Event|2|||
128804418|NCT02187003|463580753|FG001|Overall Study|Adverse Event|0|||
128804419|NCT02187003|463580752|FG000|Overall Study|Lost to Follow-up|14|||
128804420|NCT02187003|463580753|FG001|Overall Study|Lost to Follow-up|10|||
128804421|NCT02187003|463580752|FG000|Overall Study|Withdrawal by Subject|3|||
128804422|NCT02187003|463580753|FG001|Overall Study|Withdrawal by Subject|7|||
128804423|NCT02187003|463580752|FG000|Overall Study|Protocol Violation|2|||
128804424|NCT02187003|463580753|FG001|Overall Study|Protocol Violation|4|||
128804425|NCT02187003|463580752|FG000|Overall Study|Other|5|||
128804426|NCT02187003|463580753|FG001|Overall Study|Other|5|||
128804427|NCT02187003|463580752|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
128804428|NCT02187003|463580753|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
128804429|NCT04593472|463580754|FG000|Overall Study|Death|31|||
128804430|NCT04593472|463580755|FG001|Overall Study|Death|27|||
128804431|NCT04593472|463580754|FG000|Overall Study|Withdrawal by Subject|12|||
128804432|NCT04593472|463580755|FG001|Overall Study|Withdrawal by Subject|12|||
128804433|NCT04593472|463580754|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
128804434|NCT04593472|463580755|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
128804435|NCT04593472|463580754|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
128804436|NCT04593472|463580755|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
128804437|NCT04593472|463580754|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
128804438|NCT04593472|463580755|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
128804439|NCT04593472|463580754|FG000|Overall Study|Lost to Follow-up|0|||
128804440|NCT04593472|463580755|FG001|Overall Study|Lost to Follow-up|2|||
128804441|NCT04593472|463580754|FG000|Overall Study|Still collecting 24-month assessment|17|||
128804442|NCT04593472|463580755|FG001|Overall Study|Still collecting 24-month assessment|10|||
128804443|NCT03896516|463580756|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
128804444|NCT03896516|463580757|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
128804445|NCT03896516|463580756|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
128804446|NCT03896516|463580757|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
128804447|NCT03896516|463580756|FG000|Washout Period|Physician Decision|3|||
128804448|NCT03896516|463580757|FG001|Washout Period|Physician Decision|1|||
128804449|NCT03896516|463580756|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
128804450|NCT03896516|463580757|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
128804451|NCT03713086|463580767|FG000|Overall Study|Withdrawal by Subject|0|||
128804452|NCT03713086|463580768|FG001|Overall Study|Withdrawal by Subject|2|||
128804453|NCT03713086|463580769|FG002|Overall Study|Withdrawal by Subject|1|||
128804454|NCT03713086|463580770|FG003|Overall Study|Withdrawal by Subject|0|||
128804455|NCT03713086|463580767|FG000|Overall Study|Lost to Follow-up|0|||
128804456|NCT03713086|463580768|FG001|Overall Study|Lost to Follow-up|1|||
128804457|NCT03713086|463580769|FG002|Overall Study|Lost to Follow-up|0|||
128804458|NCT03713086|463580770|FG003|Overall Study|Lost to Follow-up|1|||
128804459|NCT00676715|463580781|FG000|Treatment Period (TP)|Adverse Event|0|||
128804460|NCT00676715|463580782|FG001|Treatment Period (TP)|Adverse Event|3|||
128804461|NCT00676715|463580783|FG002|Treatment Period (TP)|Adverse Event|2|||
128804462|NCT00676715|463580784|FG003|Treatment Period (TP)|Adverse Event|2|||
128804463|NCT00676715|463580781|FG000|Treatment Period (TP)|Death|0|||
128804464|NCT00676715|463580782|FG001|Treatment Period (TP)|Death|0|||
128804465|NCT00676715|463580783|FG002|Treatment Period (TP)|Death|1|||
128804466|NCT00676715|463580784|FG003|Treatment Period (TP)|Death|0|||
128804467|NCT00676715|463580781|FG000|Treatment Period (TP)|Failure to return|1|||
128804468|NCT00676715|463580782|FG001|Treatment Period (TP)|Failure to return|0|||
128804469|NCT00676715|463580783|FG002|Treatment Period (TP)|Failure to return|0|||
128804470|NCT00676715|463580784|FG003|Treatment Period (TP)|Failure to return|0|||
128804471|NCT00676715|463580781|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
128804472|NCT00676715|463580782|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
128804473|NCT00676715|463580783|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
128804474|NCT00676715|463580784|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
128804475|NCT00676715|463580781|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
128804476|NCT00676715|463580782|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
128804477|NCT00676715|463580783|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
128804478|NCT00676715|463580784|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
128804479|NCT00676715|463580781|FG000|Treatment Period (TP)|Withdrew consent|3|||
128804480|NCT00676715|463580782|FG001|Treatment Period (TP)|Withdrew consent|3|||
128804481|NCT00676715|463580783|FG002|Treatment Period (TP)|Withdrew consent|3|||
128804482|NCT00676715|463580784|FG003|Treatment Period (TP)|Withdrew consent|3|||
128804483|NCT00676715|463580781|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
128804484|NCT00676715|463580782|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
128804485|NCT00676715|463580783|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
128804486|NCT00676715|463580784|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
128804487|NCT00676715|463580781|FG000|Treatment Period (TP)|Administrative|0|||
128804488|NCT00676715|463580782|FG001|Treatment Period (TP)|Administrative|0|||
128804489|NCT00676715|463580783|FG002|Treatment Period (TP)|Administrative|0|||
128804490|NCT00676715|463580784|FG003|Treatment Period (TP)|Administrative|1|||
128804491|NCT00676715|463580781|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
128804492|NCT00676715|463580782|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
128804493|NCT00676715|463580783|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
128804494|NCT00676715|463580784|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
128804495|NCT00676715|463580781|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
128804496|NCT00676715|463580782|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
128804497|NCT00676715|463580783|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
128804498|NCT00676715|463580784|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
128804499|NCT00676715|463580781|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
128804500|NCT00676715|463580782|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
128804501|NCT00676715|463580783|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
128804502|NCT00676715|463580784|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
128804503|NCT00676715|463580781|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
128804504|NCT00676715|463580782|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
128804505|NCT00676715|463580783|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
128804506|NCT00676715|463580784|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
128804507|NCT00676715|463580781|FG000|Treatment-free Period (TFP)|Death|1|||
128804508|NCT00676715|463580782|FG001|Treatment-free Period (TFP)|Death|1|||
128804509|NCT00676715|463580783|FG002|Treatment-free Period (TFP)|Death|1|||
128804510|NCT00676715|463580784|FG003|Treatment-free Period (TFP)|Death|0|||
128804511|NCT00676715|463580781|FG000|Open Label Extension (OLE)|Reason not provided|3|||
128804512|NCT00676715|463580782|FG001|Open Label Extension (OLE)|Reason not provided|4|||
128804513|NCT00676715|463580783|FG002|Open Label Extension (OLE)|Reason not provided|1|||
128804514|NCT00676715|463580784|FG003|Open Label Extension (OLE)|Reason not provided|4|||
128804515|NCT00676715|463580781|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
128804516|NCT00676715|463580782|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
128804517|NCT00676715|463580783|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
128804518|NCT00676715|463580784|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
128804519|NCT00676715|463580781|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
128804520|NCT00676715|463580782|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
128804521|NCT00676715|463580783|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
128804522|NCT00676715|463580784|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
128804523|NCT00676715|463580781|FG000|Open Label Extension (OLE)|Adverse Event|0|||
128804524|NCT00676715|463580782|FG001|Open Label Extension (OLE)|Adverse Event|3|||
128804525|NCT00676715|463580783|FG002|Open Label Extension (OLE)|Adverse Event|1|||
128804526|NCT00676715|463580784|FG003|Open Label Extension (OLE)|Adverse Event|0|||
128804527|NCT00676715|463580781|FG000|Open Label Extension (OLE)|Death|2|||
128804528|NCT00676715|463580782|FG001|Open Label Extension (OLE)|Death|0|||
128804529|NCT00676715|463580783|FG002|Open Label Extension (OLE)|Death|2|||
128804530|NCT00676715|463580784|FG003|Open Label Extension (OLE)|Death|2|||
128804531|NCT01820260|463580785|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804532|NCT01820260|463580786|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804533|NCT01820260|463580787|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804534|NCT01820260|463580788|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804535|NCT01820260|463580789|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804536|NCT01820260|463580790|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804537|NCT01820260|463580791|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
128804538|NCT01820260|463580792|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804539|NCT01820260|463580793|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804540|NCT01820260|463580794|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804541|NCT01820260|463580795|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804542|NCT01820260|463580796|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804543|NCT01820260|463580797|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804544|NCT01820260|463580798|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
128804545|NCT01820260|463580785|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804546|NCT01820260|463580786|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804547|NCT01820260|463580787|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804548|NCT01820260|463580788|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804549|NCT01820260|463580789|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804550|NCT01820260|463580790|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804551|NCT01820260|463580791|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804552|NCT01820260|463580792|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804553|NCT01820260|463580793|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804554|NCT01820260|463580794|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
128804555|NCT01820260|463580795|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804556|NCT01820260|463580796|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804557|NCT01820260|463580797|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804558|NCT01820260|463580798|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
128804559|NCT04831281|463580800|FG000|Overall Study|Adverse Event|1|||
128804560|NCT04831281|463580801|FG001|Overall Study|Adverse Event|0|||
128804561|NCT04831281|463580802|FG002|Overall Study|Adverse Event|3|||
128804562|NCT04831281|463580800|FG000|Overall Study|Withdrawal by Subject|0|||
128804563|NCT04831281|463580801|FG001|Overall Study|Withdrawal by Subject|1|||
128804564|NCT04831281|463580802|FG002|Overall Study|Withdrawal by Subject|2|||
128804565|NCT04831281|463580800|FG000|Overall Study|Undetermined|1|||
128804566|NCT04831281|463580801|FG001|Overall Study|Undetermined|1|||
128804567|NCT04831281|463580802|FG002|Overall Study|Undetermined|0|||
128804568|NCT02728076|463580803|FG000|Overall Study|Physician Decision|4|||
128804569|NCT05054374|463580804|FG000|Overall Study|Withdrawal by Subject|1|||
128804570|NCT05054374|463580805|FG001|Overall Study|Withdrawal by Subject|0|||
128804571|NCT05054374|463580806|FG002|Overall Study|Withdrawal by Subject|0|||
128804572|NCT05054374|463580807|FG003|Overall Study|Withdrawal by Subject|0|||
128804573|NCT05054374|463580804|FG000|Overall Study|Progressive Disease|5|||
128804574|NCT05054374|463580805|FG001|Overall Study|Progressive Disease|0|||
128804575|NCT05054374|463580806|FG002|Overall Study|Progressive Disease|0|||
128804576|NCT05054374|463580807|FG003|Overall Study|Progressive Disease|0|||
128804577|NCT04089371|463580808|FG000|Overall Study|Withdrawal by Subject|0|||
128804578|NCT04089371|463580809|FG001|Overall Study|Withdrawal by Subject|1|||
128804579|NCT04089371|463580808|FG000|Overall Study|Study terminated early|0|||
128804580|NCT04089371|463580809|FG001|Overall Study|Study terminated early|9|||
128804581|NCT03453619|463580810|FG000|Core Study (Part A)|Physician Decision|0|||
128804582|NCT03453619|463580811|FG001|Core Study (Part A)|Physician Decision|0|||
128804583|NCT03453619|463580812|FG002|Core Study (Part A)|Physician Decision|2|||
128804584|NCT03453619|463580813|FG003|Core Study (Part A)|Physician Decision|0|||
128804585|NCT03453619|463580810|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
128804586|NCT03453619|463580811|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
128804587|NCT03453619|463580812|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
128804588|NCT03453619|463580813|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
128804589|NCT03453619|463580810|FG000|Core Study (Part A)|Other|0|||
128804590|NCT03453619|463580811|FG001|Core Study (Part A)|Other|1|||
128804591|NCT03453619|463580812|FG002|Core Study (Part A)|Other|0|||
128804592|NCT03453619|463580813|FG003|Core Study (Part A)|Other|0|||
128804593|NCT03453619|463580810|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
128804594|NCT03453619|463580811|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
128804595|NCT03453619|463580812|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
128804596|NCT03453619|463580813|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
128804597|NCT03453619|463580810|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
128804598|NCT03453619|463580811|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
128804599|NCT03453619|463580812|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
128804600|NCT03453619|463580813|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
128804601|NCT03453619|463580810|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
128804602|NCT03453619|463580811|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
128804603|NCT03453619|463580812|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
128804604|NCT03453619|463580813|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
128804605|NCT03453619|463580810|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
128804606|NCT03453619|463580811|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
128804607|NCT03453619|463580812|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
128804608|NCT03453619|463580813|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
128804609|NCT05862870|463580814|FG000|Overall Study|Lost to Follow-up|3|||
128804610|NCT02365766|463580815|FG000|Overall Study|Withdrawal by Subject|0|||
128804611|NCT02365766|463580816|FG001|Overall Study|Withdrawal by Subject|0|||
128804612|NCT02365766|463580817|FG002|Overall Study|Withdrawal by Subject|1|||
128804613|NCT02365766|463580815|FG000|Overall Study|Eligibility Criteria Not Met|0|||
128804614|NCT02365766|463580816|FG001|Overall Study|Eligibility Criteria Not Met|0|||
128804615|NCT02365766|463580817|FG002|Overall Study|Eligibility Criteria Not Met|1|||
128804616|NCT02307565|463580821|FG000|Overall Study|Adverse Event|3|||
128804617|NCT02307565|463580822|FG001|Overall Study|Adverse Event|2|||
128804618|NCT02307565|463580821|FG000|Overall Study|Withdrawal by Subject|2|||
128804619|NCT02307565|463580822|FG001|Overall Study|Withdrawal by Subject|2|||
128804620|NCT04936035|463580829|FG000|Overall Study|Adverse Event|0|||
128804621|NCT04936035|463580830|FG001|Overall Study|Adverse Event|1|||
128804622|NCT04936035|463580831|FG002|Overall Study|Adverse Event|0|||
128804623|NCT04936035|463580832|FG003|Overall Study|Adverse Event|0|||
128804624|NCT04936035|463580833|FG004|Overall Study|Adverse Event|0|||
128804625|NCT04936035|463580829|FG000|Overall Study|Death|0|||
128804626|NCT04936035|463580830|FG001|Overall Study|Death|0|||
128804627|NCT04936035|463580831|FG002|Overall Study|Death|0|||
128804628|NCT04936035|463580832|FG003|Overall Study|Death|1|||
128804629|NCT04936035|463580833|FG004|Overall Study|Death|0|||
128804630|NCT04936035|463580829|FG000|Overall Study|Lost to Follow-up|0|||
128804631|NCT04936035|463580830|FG001|Overall Study|Lost to Follow-up|1|||
128804632|NCT04936035|463580831|FG002|Overall Study|Lost to Follow-up|1|||
128804633|NCT04936035|463580832|FG003|Overall Study|Lost to Follow-up|2|||
128804634|NCT04936035|463580833|FG004|Overall Study|Lost to Follow-up|1|||
128804635|NCT04936035|463580829|FG000|Overall Study|Physician Decision|0|||
128804636|NCT04936035|463580830|FG001|Overall Study|Physician Decision|1|||
128804637|NCT04936035|463580831|FG002|Overall Study|Physician Decision|0|||
128804638|NCT04936035|463580832|FG003|Overall Study|Physician Decision|0|||
128804639|NCT04936035|463580833|FG004|Overall Study|Physician Decision|0|||
128804640|NCT04936035|463580829|FG000|Overall Study|Protocol Deviation|0|||
128804641|NCT04936035|463580830|FG001|Overall Study|Protocol Deviation|0|||
128804642|NCT04936035|463580831|FG002|Overall Study|Protocol Deviation|1|||
128804643|NCT04936035|463580832|FG003|Overall Study|Protocol Deviation|0|||
128804644|NCT04936035|463580833|FG004|Overall Study|Protocol Deviation|0|||
128804645|NCT04936035|463580829|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
128804646|NCT04936035|463580830|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
128804647|NCT04936035|463580831|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
128804648|NCT04936035|463580832|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
128804649|NCT04936035|463580833|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
128804650|NCT04936035|463580829|FG000|Overall Study|Reason Unknown|0|||
128804651|NCT04936035|463580830|FG001|Overall Study|Reason Unknown|0|||
128804652|NCT04936035|463580831|FG002|Overall Study|Reason Unknown|0|||
128804653|NCT04936035|463580832|FG003|Overall Study|Reason Unknown|0|||
128804654|NCT04936035|463580833|FG004|Overall Study|Reason Unknown|1|||
128804655|NCT04936035|463580829|FG000|Overall Study|Withdrawal by Subject|1|||
128804656|NCT04936035|463580830|FG001|Overall Study|Withdrawal by Subject|0|||
128804657|NCT04936035|463580831|FG002|Overall Study|Withdrawal by Subject|0|||
128804658|NCT04936035|463580832|FG003|Overall Study|Withdrawal by Subject|0|||
128804659|NCT04936035|463580833|FG004|Overall Study|Withdrawal by Subject|0|||
128804660|NCT04936035|463580829|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
128804661|NCT04936035|463580830|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
128804662|NCT04936035|463580831|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
128804663|NCT04936035|463580832|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
128804664|NCT04936035|463580833|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
128804665|NCT04936035|463580829|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
128804666|NCT04936035|463580830|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
128804667|NCT04936035|463580831|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
128804668|NCT04936035|463580832|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
128804669|NCT04936035|463580833|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
128804670|NCT04936035|463580829|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
128804671|NCT04936035|463580830|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
128804672|NCT04936035|463580831|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
128804673|NCT04936035|463580832|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
128804674|NCT04936035|463580833|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
128804675|NCT02913872|463580843|FG000|Overall Study|Withdrawal by Subject|1|||
128804676|NCT03361748|463580853|FG000|Overall Study|Death|77|||
128804677|NCT03361748|463580853|FG000|Overall Study|Lost to Follow-up|4|||
128804678|NCT03361748|463580853|FG000|Overall Study|Withdrawal by Subject|20|||
128804679|NCT02814838|463580856|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
128804680|NCT02814838|463580857|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
128804681|NCT02814838|463580856|FG000|Overall Study|Consent withdrawal|1|||
128804682|NCT02814838|463580857|FG001|Overall Study|Consent withdrawal|1|||
128804683|NCT01361711|463580859|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
128804684|NCT01361711|463580859|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
128804685|NCT01361711|463580859|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
128804686|NCT01361711|463580859|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
128804687|NCT01361711|463580859|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
128804688|NCT01361711|463580859|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
128804689|NCT01361711|463580859|FG000|Completed Week 18 of Treatment|Other|9|||
128804690|NCT01361711|463580859|FG000|10 Year Follow-up|Still in follow-up|22|||
128804691|NCT01361711|463580859|FG000|10 Year Follow-up|Death|7|||
128804692|NCT01361711|463580859|FG000|10 Year Follow-up|Developed new cancer|1|||
128804693|NCT01361711|463580859|FG000|10 Year Follow-up|Lost to Follow-up|2|||
128804694|NCT01361711|463580859|FG000|10 Year Follow-up|New treatment started|6|||
128804695|NCT01361711|463580859|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
128804696|NCT01361711|463580859|FG000|10 Year Follow-up|Progressive Disease|1|||
128804697|NCT02596126|463580860|FG000|Overall Study|Lost to Follow-up|12|||
128804698|NCT02596126|463580861|FG001|Overall Study|Lost to Follow-up|21|||
128804699|NCT02596126|463580860|FG000|Overall Study|Protocol Violation|7|||
128804700|NCT02596126|463580861|FG001|Overall Study|Protocol Violation|9|||
128804701|NCT03396588|463580862|FG000|Overall Study|Physician Decision|2|||
128804702|NCT03396588|463580863|FG001|Overall Study|Physician Decision|3|||
128804703|NCT05179395|463580864|FG000|Overall Study|Lack of Efficacy|1|||
128804704|NCT00812461|463580865|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
128804705|NCT00812461|463580866|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
128804706|NCT00812461|463580865|FG000|All Treated Patients|Adverse Event|8|||
128804707|NCT00812461|463580866|FG001|All Treated Patients|Adverse Event|15|||
128804708|NCT00812461|463580865|FG000|All Treated Patients|Lack of Efficacy|13|||
128804709|NCT00812461|463580866|FG001|All Treated Patients|Lack of Efficacy|7|||
128804710|NCT00812461|463580865|FG000|All Treated Patients|Non-compliance|6|||
128804711|NCT00812461|463580866|FG001|All Treated Patients|Non-compliance|9|||
128804712|NCT00812461|463580865|FG000|All Treated Patients|Protocol Violation|36|||
128804713|NCT00812461|463580866|FG001|All Treated Patients|Protocol Violation|27|||
128804714|NCT00812461|463580865|FG000|All Treated Patients|Withdrawal by Subject|45|||
128804715|NCT00812461|463580866|FG001|All Treated Patients|Withdrawal by Subject|54|||
128804716|NCT00812461|463580865|FG000|All Treated Patients|Lost to Follow-up|11|||
128804717|NCT00812461|463580866|FG001|All Treated Patients|Lost to Follow-up|14|||
128804718|NCT00812461|463580865|FG000|All Treated Patients|Other Reason|13|||
128804719|NCT00812461|463580866|FG001|All Treated Patients|Other Reason|21|||
128804720|NCT02471638|463580870|FG000|Overall Study|Early Term Withdrawal|10|||
128804721|NCT04833777|463582330|FG000|Overall Study|Lost to Follow-up|1|||
128804722|NCT04833777|463582331|FG001|Overall Study|Lost to Follow-up|0|||
128804723|NCT02287311|463582332|FG000|Cohort 1: Dose Level 1|Death|2|||
128804724|NCT02287311|463582333|FG001|Cohort 1: Dose Level 1|Death|0|||
128804725|NCT02287311|463582334|FG002|Cohort 1: Dose Level 1|Death|0|||
128804726|NCT02287311|463582335|FG003|Cohort 1: Dose Level 1|Death|3|||
128804727|NCT02287311|463582336|FG004|Cohort 1: Dose Level 1|Death|0|||
128804728|NCT02287311|463582337|FG005|Cohort 1: Dose Level 1|Death|0|||
128804729|NCT02287311|463582338|FG006|Cohort 1: Dose Level 1|Death|1|||
128804730|NCT02287311|463582339|FG007|Cohort 1: Dose Level 1|Death|0|||
128804731|NCT02287311|463582340|FG008|Cohort 1: Dose Level 1|Death|0|||
128804732|NCT02287311|463582332|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
128804733|NCT02287311|463582333|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
128804734|NCT02287311|463582334|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
128804735|NCT02287311|463582335|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
128804736|NCT02287311|463582336|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
128804737|NCT02287311|463582337|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
128804738|NCT02287311|463582338|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
128804739|NCT02287311|463582339|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
128804740|NCT02287311|463582340|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
128804741|NCT02287311|463582332|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
128804742|NCT02287311|463582333|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
128804743|NCT02287311|463582334|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
128804744|NCT02287311|463582335|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
128804745|NCT02287311|463582336|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
128804746|NCT02287311|463582337|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
128804747|NCT02287311|463582338|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
128804748|NCT02287311|463582339|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
128804749|NCT02287311|463582340|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
128804750|NCT02287311|463582332|FG000|Cohort 2: Dose Level 2|Death|0|||
128804751|NCT02287311|463582333|FG001|Cohort 2: Dose Level 2|Death|2|||
128804752|NCT02287311|463582334|FG002|Cohort 2: Dose Level 2|Death|0|||
128804753|NCT02287311|463582335|FG003|Cohort 2: Dose Level 2|Death|0|||
128804754|NCT02287311|463582336|FG004|Cohort 2: Dose Level 2|Death|2|||
128804755|NCT02287311|463582337|FG005|Cohort 2: Dose Level 2|Death|0|||
128804756|NCT02287311|463582338|FG006|Cohort 2: Dose Level 2|Death|0|||
128804757|NCT02287311|463582339|FG007|Cohort 2: Dose Level 2|Death|2|||
128804758|NCT02287311|463582340|FG008|Cohort 2: Dose Level 2|Death|0|||
128804759|NCT02287311|463582332|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804760|NCT02287311|463582333|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804761|NCT02287311|463582334|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804762|NCT02287311|463582335|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804763|NCT02287311|463582336|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
128804764|NCT02287311|463582337|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804765|NCT02287311|463582338|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804766|NCT02287311|463582339|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804767|NCT02287311|463582340|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
128804768|NCT02287311|463582332|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804769|NCT02287311|463582333|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
128804770|NCT02287311|463582334|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804771|NCT02287311|463582335|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804772|NCT02287311|463582336|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804773|NCT02287311|463582337|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804774|NCT02287311|463582338|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804775|NCT02287311|463582339|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804776|NCT02287311|463582340|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
128804777|NCT02287311|463582332|FG000|Cohort 3: Dose Level 3|Death|0|||
128804778|NCT02287311|463582333|FG001|Cohort 3: Dose Level 3|Death|0|||
128804779|NCT02287311|463582334|FG002|Cohort 3: Dose Level 3|Death|4|||
128804780|NCT02287311|463582335|FG003|Cohort 3: Dose Level 3|Death|0|||
128804781|NCT02287311|463582336|FG004|Cohort 3: Dose Level 3|Death|0|||
128804782|NCT02287311|463582337|FG005|Cohort 3: Dose Level 3|Death|4|||
128804783|NCT02287311|463582338|FG006|Cohort 3: Dose Level 3|Death|0|||
128804784|NCT02287311|463582339|FG007|Cohort 3: Dose Level 3|Death|0|||
128804785|NCT02287311|463582340|FG008|Cohort 3: Dose Level 3|Death|2|||
128804786|NCT02287311|463582332|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
128804787|NCT02287311|463582333|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
128804788|NCT02287311|463582334|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
128804789|NCT02287311|463582335|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
128804790|NCT02287311|463582336|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
128804791|NCT02287311|463582337|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
128804792|NCT02287311|463582338|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
128804793|NCT02287311|463582339|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
128804794|NCT02287311|463582340|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
128804795|NCT02287311|463582332|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
128804796|NCT02287311|463582333|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
128804797|NCT02287311|463582334|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
128804798|NCT02287311|463582335|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
128804799|NCT02287311|463582336|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
128804800|NCT02287311|463582337|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
128804801|NCT02287311|463582338|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
128804802|NCT02287311|463582339|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
128804803|NCT02287311|463582340|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
128804804|NCT03648840|463582341|FG000|First IV Infusion Session|Adverse Event|0|||
128804805|NCT03648840|463582342|FG001|First IV Infusion Session|Adverse Event|2|||
128804806|NCT03648840|463582341|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
128804807|NCT03648840|463582342|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
128804808|NCT03648840|463582341|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
128804809|NCT03648840|463582342|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
128804810|NCT03648840|463582341|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
128804811|NCT03648840|463582342|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
128804812|NCT05418296|463582343|FG000|Overall Study|Withdrawal by Subject|4|||
128804813|NCT05418296|463582344|FG001|Overall Study|Withdrawal by Subject|1|||
128804814|NCT05382936|463582345|FG000|Overall Study|Progressive Disease|3|||
128804815|NCT05382936|463582346|FG001|Overall Study|Progressive Disease|5|||
128804816|NCT05382936|463582347|FG002|Overall Study|Progressive Disease|2|||
128804817|NCT05382936|463582348|FG003|Overall Study|Progressive Disease|5|||
128804818|NCT05382936|463582345|FG000|Overall Study|Adverse Event|0|||
128804819|NCT05382936|463582346|FG001|Overall Study|Adverse Event|1|||
128804820|NCT05382936|463582347|FG002|Overall Study|Adverse Event|1|||
128804821|NCT05382936|463582348|FG003|Overall Study|Adverse Event|0|||
128804822|NCT05382936|463582345|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
128804823|NCT05382936|463582346|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
128804824|NCT05382936|463582347|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
128804825|NCT05382936|463582348|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
128804826|NCT05382936|463582345|FG000|Overall Study|Withdrawal by Subject|0|||
128804827|NCT05382936|463582346|FG001|Overall Study|Withdrawal by Subject|0|||
128804828|NCT05382936|463582347|FG002|Overall Study|Withdrawal by Subject|1|||
128804829|NCT05382936|463582348|FG003|Overall Study|Withdrawal by Subject|1|||
128804830|NCT04630262|463582353|FG000|Overall Study|Intraoperative Screen Failure|5|||
128804831|NCT04630262|463582353|FG000|Overall Study|Study terminated prematurely|71|||
128804832|NCT04630262|463582353|FG000|Overall Study|Withdrawal by Subject|2|||
128804833|NCT04630262|463582353|FG000|Overall Study|Physician Decision|2|||
128804834|NCT01195831|463582355|FG000|Overall Study|Lost to Follow-up|2|||
128804835|NCT01195831|463582356|FG001|Overall Study|Lost to Follow-up|4|||
128804836|NCT01195831|463582355|FG000|Overall Study|Withdrawal by Subject|2|||
128804837|NCT01195831|463582356|FG001|Overall Study|Withdrawal by Subject|2|||
128804838|NCT01195831|463582355|FG000|Overall Study|Adverse Event|4|||
128804839|NCT01195831|463582356|FG001|Overall Study|Adverse Event|2|||
128804840|NCT01195831|463582355|FG000|Overall Study|Protocol Violation|0|||
128804841|NCT01195831|463582356|FG001|Overall Study|Protocol Violation|2|||
128804842|NCT01857934|463582357|FG000|Overall Study|Relapse or progression|2|||
128804843|NCT01857934|463582357|FG000|Overall Study|Unacceptable toxicity|3|||
128804844|NCT01857934|463582357|FG000|Overall Study|Unwillingness or inability to comply|2|||
128804845|NCT01857934|463582357|FG000|Overall Study|Physician Decision|3|||
128804846|NCT04703322|463582359|FG000|Overall Study|Ongoing|8|||
128804847|NCT04703322|463582359|FG000|Overall Study|Withdrawal by Subject|1|||
128804848|NCT04638998|463582363|FG000|Overall Study|Withdrawal by Subject|1|||
128804849|NCT04638998|463582364|FG001|Overall Study|Withdrawal by Subject|3|||
128804850|NCT03692676|463582365|FG000|Overall Study|exclude patients with prior use|4424|||
128804851|NCT03692676|463582366|FG001|Overall Study|exclude patients with prior use|24726|||
128804852|NCT03692676|463582367|FG002|Overall Study|exclude patients with prior use|0|||
128804853|NCT03692676|463582368|FG003|Overall Study|exclude patients with prior use|0|||
128804854|NCT03692676|463582365|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
128804855|NCT03692676|463582366|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
128804856|NCT03692676|463582367|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
128804857|NCT03692676|463582368|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
128804858|NCT03692676|463582365|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
128804859|NCT03692676|463582366|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
128804860|NCT03692676|463582367|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
128804861|NCT03692676|463582368|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
128804862|NCT03692676|463582365|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
128804863|NCT03692676|463582366|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
128804864|NCT03692676|463582367|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
128804865|NCT03692676|463582368|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
128804866|NCT03692676|463582365|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
128804867|NCT03692676|463582366|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
128804868|NCT03692676|463582367|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
128804869|NCT03692676|463582368|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
128804870|NCT03692676|463582365|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
128804871|NCT03692676|463582366|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
128804872|NCT03692676|463582367|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
128804873|NCT03692676|463582368|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
128804874|NCT03692676|463582365|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
128804875|NCT03692676|463582366|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
128804876|NCT03692676|463582367|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
128804877|NCT03692676|463582368|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
128804878|NCT03692676|463582365|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
128804879|NCT03692676|463582366|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
128804880|NCT03692676|463582367|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
128804881|NCT03692676|463582368|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
128804882|NCT03692676|463582365|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
128804883|NCT03692676|463582366|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
128804884|NCT03692676|463582367|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
128804885|NCT03692676|463582368|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
128804886|NCT03692676|463582365|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
128804887|NCT03692676|463582366|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
128804888|NCT03692676|463582367|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
128804889|NCT03692676|463582368|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
128804890|NCT03692676|463582365|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
128804891|NCT03692676|463582366|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
128804892|NCT03692676|463582367|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
128804893|NCT03692676|463582368|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
128804894|NCT03692676|463582365|FG000|Overall Study|Other|0|||
128804895|NCT03692676|463582366|FG001|Overall Study|Other|805|||
128804896|NCT03692676|463582367|FG002|Overall Study|Other|758|||
128804897|NCT03692676|463582368|FG003|Overall Study|Other|277|||
128804898|NCT03692676|463582365|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
128804899|NCT03692676|463582366|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
128804900|NCT03692676|463582367|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
128804901|NCT03692676|463582368|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
128804902|NCT05374837|463582371|FG000|Overall Study|Lost to Follow-up|17|||
128804903|NCT05374837|463582372|FG001|Overall Study|Lost to Follow-up|18|||
128804904|NCT02312960|463582378|FG000|Overall Study|Death|24|||
128804905|NCT02312960|463582379|FG001|Overall Study|Death|32|||
128804906|NCT02312960|463582380|FG002|Overall Study|Death|25|||
128804907|NCT02312960|463582381|FG003|Overall Study|Death|11|||
128804908|NCT02312960|463582382|FG004|Overall Study|Death|5|||
128804909|NCT02312960|463582383|FG005|Overall Study|Death|5|||
128804910|NCT02312960|463582384|FG006|Overall Study|Death|8|||
128804911|NCT02312960|463582385|FG007|Overall Study|Death|5|||
128804912|NCT02312960|463582386|FG008|Overall Study|Death|7|||
128804913|NCT02312960|463582387|FG009|Overall Study|Death|3|||
128804914|NCT02312960|463582388|FG010|Overall Study|Death|3|||
128804915|NCT02312960|463582389|FG011|Overall Study|Death|1|||
128804916|NCT02312960|463582390|FG012|Overall Study|Death|25|||
128804917|NCT02312960|463582391|FG013|Overall Study|Death|19|||
128804918|NCT02312960|463582378|FG000|Overall Study|Missing|0|||
128804919|NCT02312960|463582379|FG001|Overall Study|Missing|0|||
128804920|NCT02312960|463582380|FG002|Overall Study|Missing|2|||
128804921|NCT02312960|463582381|FG003|Overall Study|Missing|0|||
128804922|NCT02312960|463582382|FG004|Overall Study|Missing|0|||
128804923|NCT02312960|463582383|FG005|Overall Study|Missing|0|||
128804924|NCT02312960|463582384|FG006|Overall Study|Missing|0|||
128804925|NCT02312960|463582385|FG007|Overall Study|Missing|0|||
128804926|NCT02312960|463582386|FG008|Overall Study|Missing|0|||
128804927|NCT02312960|463582387|FG009|Overall Study|Missing|0|||
128804928|NCT02312960|463582388|FG010|Overall Study|Missing|0|||
128804929|NCT02312960|463582389|FG011|Overall Study|Missing|0|||
128804930|NCT02312960|463582390|FG012|Overall Study|Missing|0|||
128804931|NCT02312960|463582391|FG013|Overall Study|Missing|0|||
128804932|NCT02312960|463582378|FG000|Overall Study|Lost to Follow-up|0|||
128804933|NCT02312960|463582379|FG001|Overall Study|Lost to Follow-up|0|||
128804934|NCT02312960|463582380|FG002|Overall Study|Lost to Follow-up|1|||
128804935|NCT02312960|463582381|FG003|Overall Study|Lost to Follow-up|0|||
128804936|NCT02312960|463582382|FG004|Overall Study|Lost to Follow-up|0|||
128804937|NCT02312960|463582383|FG005|Overall Study|Lost to Follow-up|0|||
128804938|NCT02312960|463582384|FG006|Overall Study|Lost to Follow-up|1|||
128804939|NCT02312960|463582385|FG007|Overall Study|Lost to Follow-up|1|||
128804940|NCT02312960|463582386|FG008|Overall Study|Lost to Follow-up|0|||
128804941|NCT02312960|463582387|FG009|Overall Study|Lost to Follow-up|1|||
128804942|NCT02312960|463582388|FG010|Overall Study|Lost to Follow-up|0|||
128804943|NCT02312960|463582389|FG011|Overall Study|Lost to Follow-up|0|||
128804944|NCT02312960|463582390|FG012|Overall Study|Lost to Follow-up|1|||
128804945|NCT02312960|463582391|FG013|Overall Study|Lost to Follow-up|0|||
128804946|NCT02312960|463582378|FG000|Overall Study|Withdrawal by Subject|1|||
128804947|NCT02312960|463582379|FG001|Overall Study|Withdrawal by Subject|2|||
128804948|NCT02312960|463582380|FG002|Overall Study|Withdrawal by Subject|0|||
128804949|NCT02312960|463582381|FG003|Overall Study|Withdrawal by Subject|0|||
128804950|NCT02312960|463582382|FG004|Overall Study|Withdrawal by Subject|1|||
128804951|NCT02312960|463582383|FG005|Overall Study|Withdrawal by Subject|0|||
128804952|NCT02312960|463582384|FG006|Overall Study|Withdrawal by Subject|1|||
128804953|NCT02312960|463582385|FG007|Overall Study|Withdrawal by Subject|2|||
128804954|NCT02312960|463582386|FG008|Overall Study|Withdrawal by Subject|2|||
128804955|NCT02312960|463582387|FG009|Overall Study|Withdrawal by Subject|3|||
128804956|NCT02312960|463582388|FG010|Overall Study|Withdrawal by Subject|0|||
128804957|NCT02312960|463582389|FG011|Overall Study|Withdrawal by Subject|0|||
128804958|NCT02312960|463582390|FG012|Overall Study|Withdrawal by Subject|2|||
128804959|NCT02312960|463582391|FG013|Overall Study|Withdrawal by Subject|0|||
128804960|NCT05458011|463582392|FG000|DB Period (12 Weeks)|Adverse Event|2|||
128804961|NCT05458011|463582393|FG001|DB Period (12 Weeks)|Adverse Event|1|||
128804962|NCT05458011|463582394|FG002|DB Period (12 Weeks)|Adverse Event|1|||
128804963|NCT05458011|463582392|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
128804964|NCT05458011|463582393|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
128804965|NCT05458011|463582394|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
128804966|NCT05458011|463582392|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
128804967|NCT05458011|463582393|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
128804968|NCT05458011|463582394|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
128804969|NCT05458011|463582392|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
128804970|NCT05458011|463582393|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
128804971|NCT05458011|463582394|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
128804972|NCT05458011|463582392|FG000|OL Period (12 Weeks)|Adverse Event|1|||
128804973|NCT05458011|463582393|FG001|OL Period (12 Weeks)|Adverse Event|2|||
128804974|NCT05458011|463582394|FG002|OL Period (12 Weeks)|Adverse Event|1|||
128804975|NCT05458011|463582392|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
128804976|NCT05458011|463582393|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
128804977|NCT05458011|463582394|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
128804978|NCT02900924|463582414|FG000|Overall Study|Death|52|||
128804979|NCT02900924|463582414|FG000|Overall Study|Lost to Follow-up|4|||
128804980|NCT02900924|463582414|FG000|Overall Study|Withdrawal by Subject|20|||
128804981|NCT02900924|463582414|FG000|Overall Study|Missed Visit|33|||
128804982|NCT05956002|463582435|FG000|Treatment Period 3|Adverse Event|0|||
128804983|NCT05956002|463582436|FG001|Treatment Period 3|Adverse Event|0|||
128804984|NCT05956002|463582437|FG002|Treatment Period 3|Adverse Event|1|||
128804985|NCT05956002|463582438|FG003|Treatment Period 3|Adverse Event|0|||
128804986|NCT03978871|463582440|FG000|Overall Study|Lost to Follow-up|11|||
128804987|NCT03978871|463582441|FG001|Overall Study|Lost to Follow-up|12|||
128804988|NCT04072822|463582442|FG000|Treatment|Adverse Event|9|||
128804989|NCT04072822|463582443|FG001|Treatment|Adverse Event|5|||
128804990|NCT04072822|463582442|FG000|Treatment|Met Stopping Criteria|13|||
128804991|NCT04072822|463582443|FG001|Treatment|Met Stopping Criteria|24|||
128804992|NCT04072822|463582442|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
128804993|NCT04072822|463582443|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
128804994|NCT04072822|463582442|FG000|Treatment|Withdrawal by Subject|0|||
128804995|NCT04072822|463582443|FG001|Treatment|Withdrawal by Subject|2|||
128804996|NCT04072822|463582442|FG000|Treatment|Death|0|||
128804997|NCT04072822|463582443|FG001|Treatment|Death|2|||
128804998|NCT04072822|463582442|FG000|Treatment|Lost to Follow-up|11|||
128804999|NCT04072822|463582443|FG001|Treatment|Lost to Follow-up|3|||
128805000|NCT04072822|463582442|FG000|Treatment|Physician Decision|1|||
128805001|NCT04072822|463582443|FG001|Treatment|Physician Decision|0|||
128805002|NCT04072822|463582442|FG000|Treatment|Other|7|||
128805003|NCT04072822|463582443|FG001|Treatment|Other|9|||
128805004|NCT04072822|463582442|FG000|Follow-up|Withdrawal by Subject|1|||
128805005|NCT04072822|463582443|FG001|Follow-up|Withdrawal by Subject|0|||
128805006|NCT04072822|463582442|FG000|Follow-up|Lost to Follow-up|5|||
128805007|NCT04072822|463582443|FG001|Follow-up|Lost to Follow-up|4|||
128805008|NCT04391894|463582444|FG000|Overall Study|Adverse Event|1|||
128805009|NCT04391894|463582445|FG001|Overall Study|Adverse Event|1|||
128805010|NCT04391894|463582446|FG002|Overall Study|Adverse Event|1|||
128805011|NCT04391894|463582447|FG003|Overall Study|Adverse Event|1|||
128805012|NCT04391894|463582448|FG004|Overall Study|Adverse Event|1|||
128805013|NCT04391894|463582444|FG000|Overall Study|Lost to Follow-up|1|||
128805014|NCT04391894|463582445|FG001|Overall Study|Lost to Follow-up|0|||
128805015|NCT04391894|463582446|FG002|Overall Study|Lost to Follow-up|0|||
128805016|NCT04391894|463582447|FG003|Overall Study|Lost to Follow-up|0|||
128805017|NCT04391894|463582448|FG004|Overall Study|Lost to Follow-up|0|||
128805018|NCT04391894|463582444|FG000|Overall Study|Protocol Violation|0|||
128805019|NCT04391894|463582445|FG001|Overall Study|Protocol Violation|0|||
128805020|NCT04391894|463582446|FG002|Overall Study|Protocol Violation|0|||
128805021|NCT04391894|463582447|FG003|Overall Study|Protocol Violation|1|||
128805022|NCT04391894|463582448|FG004|Overall Study|Protocol Violation|0|||
128805023|NCT04391894|463582444|FG000|Overall Study|Withdrawal by Subject|2|||
128805024|NCT04391894|463582445|FG001|Overall Study|Withdrawal by Subject|0|||
128805025|NCT04391894|463582446|FG002|Overall Study|Withdrawal by Subject|3|||
128805026|NCT04391894|463582447|FG003|Overall Study|Withdrawal by Subject|0|||
128805027|NCT04391894|463582448|FG004|Overall Study|Withdrawal by Subject|1|||
128805028|NCT04391894|463582444|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
128805029|NCT04391894|463582445|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
128805030|NCT04391894|463582446|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
128805031|NCT04391894|463582447|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
128805032|NCT04391894|463582448|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
128805033|NCT02323321|463582449|FG000|Overall Study|Re-Transplant|1|||
128805034|NCT02323321|463582449|FG000|Overall Study|Death|12|||
128805035|NCT00446225|463582450|FG000|Overall Study|Protocol Violation|1|||
128805036|NCT00446225|463582451|FG001|Overall Study|Protocol Violation|0|||
128805037|NCT04450342|463582452|FG000|Overall Study|Adverse Event|1|||
128805038|NCT04450342|463582453|FG001|Overall Study|Adverse Event|1|||
128805039|NCT04450342|463582454|FG002|Overall Study|Adverse Event|0|||
128805040|NCT04450342|463582452|FG000|Overall Study|Device not used|1|||
128805041|NCT04450342|463582453|FG001|Overall Study|Device not used|0|||
128805042|NCT04450342|463582454|FG002|Overall Study|Device not used|0|||
128805043|NCT04450342|463582452|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
128805044|NCT04450342|463582453|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
128805045|NCT04450342|463582454|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
128805046|NCT04450342|463582452|FG000|Overall Study|Physician Decision|1|||
128805047|NCT04450342|463582453|FG001|Overall Study|Physician Decision|0|||
128805048|NCT04450342|463582454|FG002|Overall Study|Physician Decision|1|||
128805049|NCT04450342|463582452|FG000|Overall Study|Protocol Deviation|0|||
128805050|NCT04450342|463582453|FG001|Overall Study|Protocol Deviation|1|||
128805051|NCT04450342|463582454|FG002|Overall Study|Protocol Deviation|0|||
128805052|NCT04450342|463582452|FG000|Overall Study|Reoperation|1|||
128805053|NCT04450342|463582453|FG001|Overall Study|Reoperation|1|||
128805054|NCT04450342|463582454|FG002|Overall Study|Reoperation|0|||
128805055|NCT04450342|463582452|FG000|Overall Study|Screen Failures|0|||
128805056|NCT04450342|463582453|FG001|Overall Study|Screen Failures|0|||
128805057|NCT04450342|463582454|FG002|Overall Study|Screen Failures|2|||
128805058|NCT04450342|463582452|FG000|Overall Study|Site Terminated by Sponsor|1|||
128805059|NCT04450342|463582453|FG001|Overall Study|Site Terminated by Sponsor|1|||
128805060|NCT04450342|463582454|FG002|Overall Study|Site Terminated by Sponsor|1|||
128805061|NCT04450342|463582452|FG000|Overall Study|Study Terminated by Sponsor|31|||
128805062|NCT04450342|463582453|FG001|Overall Study|Study Terminated by Sponsor|29|||
128805063|NCT04450342|463582454|FG002|Overall Study|Study Terminated by Sponsor|6|||
128805064|NCT04450342|463582452|FG000|Overall Study|Withdrawal by Subject|0|||
128805065|NCT04450342|463582453|FG001|Overall Study|Withdrawal by Subject|1|||
128805066|NCT04450342|463582454|FG002|Overall Study|Withdrawal by Subject|2|||
128805067|NCT00220740|463582459|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
128805068|NCT00220740|463582460|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
128805069|NCT00220740|463582459|FG000|Efficacy Period|Adverse Event|1|||
128805070|NCT00220740|463582460|FG001|Efficacy Period|Adverse Event|1|||
128805071|NCT00220740|463582459|FG000|Efficacy Period|Withdrawal by Subject|1|||
128805072|NCT00220740|463582460|FG001|Efficacy Period|Withdrawal by Subject|0|||
128805073|NCT00220740|463582459|FG000|Efficacy Period|Protocol Violation|1|||
128805074|NCT00220740|463582460|FG001|Efficacy Period|Protocol Violation|0|||
128805075|NCT00220740|463582459|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
128805076|NCT00220740|463582460|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
128805077|NCT01057433|463582461|FG000|Overall Study|Adverse Event|1|||
128805078|NCT05268302|463582462|FG000|Overall Study|Death|0|||
128805079|NCT05268302|463582463|FG001|Overall Study|Death|1|||
128805080|NCT02811679|463582464|FG000|Overall Study|Adverse Event|1|||
128805081|NCT02811679|463582464|FG000|Overall Study|Lack of Efficacy|6|||
128805082|NCT02811679|463582464|FG000|Overall Study|Early study closure due to slow accrual|3|||
128805083|NCT05319860|463582466|FG000|Overall Study|Death|1|||
128805084|NCT05319860|463582467|FG001|Overall Study|Death|1|||
128805085|NCT05319860|463582466|FG000|Overall Study|Lost to Follow-up|3|||
128805086|NCT05319860|463582467|FG001|Overall Study|Lost to Follow-up|1|||
128805087|NCT05319860|463582466|FG000|Overall Study|Withdrawal by Subject|1|||
128805088|NCT05319860|463582467|FG001|Overall Study|Withdrawal by Subject|7|||
128805089|NCT04314895|463582468|FG000|Overall Study|Lost to Follow-up|1|||
128805090|NCT04314895|463582468|FG000|Overall Study|Death|10|||
128805091|NCT04314895|463582468|FG000|Overall Study|Physician Decision|2|||
128805092|NCT03941860|463582469|FG000|Overall Study|Withdrawal by Subject|0|||
128805093|NCT03941860|463582470|FG001|Overall Study|Withdrawal by Subject|1|||
128805094|NCT04402489|463584173|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
128805095|NCT04402489|463584174|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
128805096|NCT04402489|463584175|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
128805097|NCT04402489|463584176|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
128805098|NCT04402489|463584177|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
128805099|NCT04402489|463584173|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
128805100|NCT04402489|463584174|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
128805101|NCT04402489|463584175|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
128805102|NCT04402489|463584176|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
128805103|NCT04402489|463584177|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
128805104|NCT04402489|463584173|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
128805105|NCT04402489|463584174|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
128805106|NCT04402489|463584175|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
128805107|NCT04402489|463584176|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
128805108|NCT04402489|463584177|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
128805109|NCT04402489|463584173|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
128805110|NCT04402489|463584174|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
128805111|NCT04402489|463584175|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
128805112|NCT04402489|463584176|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
128805113|NCT04402489|463584177|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
128805114|NCT04402489|463584173|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
128805115|NCT04402489|463584174|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
128805116|NCT04402489|463584175|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
128805117|NCT04402489|463584176|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
128805118|NCT04402489|463584177|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
128805119|NCT04402489|463584173|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
128805120|NCT04402489|463584174|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
128805121|NCT04402489|463584175|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
128805122|NCT04402489|463584176|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
128805123|NCT04402489|463584177|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
128805124|NCT04178733|463584183|FG000|Overall Study|Investigator Decision|0|||
128805125|NCT04178733|463584184|FG001|Overall Study|Investigator Decision|0|||
128805126|NCT04178733|463584185|FG002|Overall Study|Investigator Decision|0|||
128805127|NCT04178733|463584186|FG003|Overall Study|Investigator Decision|1|||
128805128|NCT04178733|463584187|FG004|Overall Study|Investigator Decision|2|||
128805129|NCT05063994|463584202|FG000|Cortef Run-In|Withdrawal of Consent|1|||
128805130|NCT05063994|463584203|FG001|Cortef Run-In|Withdrawal of Consent|0|||
128805131|NCT05063994|463584204|FG002|Cortef Run-In|Withdrawal of Consent|0|||
128805132|NCT05063994|463584202|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
128805133|NCT05063994|463584203|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
128805134|NCT05063994|463584204|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
128805135|NCT05063994|463584202|FG000|Treatment|Physician Decision|0|||
128805136|NCT05063994|463584203|FG001|Treatment|Physician Decision|0|||
128805137|NCT05063994|463584204|FG002|Treatment|Physician Decision|1|||
128805138|NCT05063994|463584202|FG000|Treatment|Withdrawal by Subject|0|||
128805139|NCT05063994|463584203|FG001|Treatment|Withdrawal by Subject|0|||
128805140|NCT05063994|463584204|FG002|Treatment|Withdrawal by Subject|1|||
128805141|NCT05063994|463584202|FG000|Treatment|Withdrawal of Consent|0|||
128805142|NCT05063994|463584203|FG001|Treatment|Withdrawal of Consent|0|||
128805143|NCT05063994|463584204|FG002|Treatment|Withdrawal of Consent|1|||
128805144|NCT01180634|463584206|FG000|Overall Study|Adverse Event|4|||
128805145|NCT01180634|463584207|FG001|Overall Study|Adverse Event|1|||
128805146|NCT01180634|463584206|FG000|Overall Study|Miscellaneous|2|||
128805147|NCT01180634|463584207|FG001|Overall Study|Miscellaneous|0|||
128805148|NCT01180634|463584206|FG000|Overall Study|Withdrawal by Subject|4|||
128805149|NCT01180634|463584207|FG001|Overall Study|Withdrawal by Subject|0|||
128805150|NCT03692611|463584208|FG000|Overall Study|Found to be ineligible postrandomization|3|||
128805151|NCT03692611|463584209|FG001|Overall Study|Found to be ineligible postrandomization|0|||
128805152|NCT04419168|463584210|FG000|Overall Study|Protocol Violation|1|||
128805153|NCT04419168|463584211|FG001|Overall Study|Protocol Violation|1|||
128805154|NCT04419168|463584210|FG000|Overall Study|Lost to Follow-up|7|||
128805155|NCT04419168|463584211|FG001|Overall Study|Lost to Follow-up|7|||
128805156|NCT04419168|463584210|FG000|Overall Study|Missed 6-month Visit|48|||
128805157|NCT04419168|463584211|FG001|Overall Study|Missed 6-month Visit|45|||
128805158|NCT04490915|463584212|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
128805159|NCT04490915|463584213|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
128805160|NCT04490915|463584212|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
128805161|NCT04490915|463584213|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
128805162|NCT04490915|463584212|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
128805163|NCT04490915|463584213|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
128805164|NCT04490915|463584212|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
128805165|NCT04490915|463584213|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
128805166|NCT04490915|463584212|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
128805167|NCT04490915|463584213|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
128805168|NCT04490915|463584212|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
128805169|NCT04490915|463584213|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
128805170|NCT04490915|463584212|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
128805171|NCT04490915|463584213|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
128805172|NCT05009251|463584214|FG000|Overall Study|Protocol Violation|100|||
128805173|NCT05009251|463584215|FG001|Overall Study|Protocol Violation|105|||
128805174|NCT05009251|463584216|FG002|Overall Study|Protocol Violation|119|||
128805175|NCT05009251|463584217|FG003|Overall Study|Protocol Violation|120|||
128805176|NCT05009251|463584218|FG004|Overall Study|Protocol Violation|119|||
128805177|NCT05009251|463584214|FG000|Overall Study|Death|25|||
128805178|NCT05009251|463584215|FG001|Overall Study|Death|22|||
128805179|NCT05009251|463584216|FG002|Overall Study|Death|24|||
128805180|NCT05009251|463584217|FG003|Overall Study|Death|19|||
128805181|NCT05009251|463584218|FG004|Overall Study|Death|15|||
128805182|NCT05406921|463584224|FG000|Overall Study|Withdrawal by Subject|25|||
128805183|NCT05406921|463584225|FG001|Overall Study|Withdrawal by Subject|0|||
128805184|NCT05406921|463584226|FG002|Overall Study|Withdrawal by Subject|25|||
128805185|NCT05406921|463584224|FG000|Overall Study|Protocol Violation|0|||
128805186|NCT05406921|463584225|FG001|Overall Study|Protocol Violation|12|||
128805187|NCT05406921|463584226|FG002|Overall Study|Protocol Violation|0|||
128805188|NCT00616967|463584231|FG000|Overall Study|Withdrawal by Subject|0|||
128805189|NCT00616967|463584232|FG001|Overall Study|Withdrawal by Subject|0|||
128805190|NCT00616967|463584233|FG002|Overall Study|Withdrawal by Subject|1|||
128805191|NCT02910583|463584234|FG000|Overall Study|Death|7|||
128805192|NCT02910583|463584235|FG001|Overall Study|Death|3|||
128805193|NCT02910583|463584234|FG000|Overall Study|Lost to Follow-up|1|||
128805194|NCT02910583|463584235|FG001|Overall Study|Lost to Follow-up|0|||
128805195|NCT02910583|463584234|FG000|Overall Study|Withdrawal by Subject|12|||
128805196|NCT02910583|463584235|FG001|Overall Study|Withdrawal by Subject|8|||
128805197|NCT02910583|463584234|FG000|Overall Study|Other, Not Specified|6|||
128805198|NCT02910583|463584235|FG001|Overall Study|Other, Not Specified|3|||
128805199|NCT01331005|463584237|FG000|Overall Study|Lost to Follow-up|2|||
128805200|NCT01331005|463584238|FG001|Overall Study|Lost to Follow-up|1|||
128805201|NCT01331005|463584237|FG000|Overall Study|Withdrawal by Subject|2|||
128805202|NCT01331005|463584238|FG001|Overall Study|Withdrawal by Subject|3|||
128805203|NCT02029443|463584239|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
128805204|NCT02029443|463584240|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
128805205|NCT02029443|463584241|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
128805206|NCT02029443|463584242|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
128805207|NCT02029443|463584243|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
128805208|NCT02029443|463584239|FG000|Overall Study|Death|13|||
128805209|NCT02029443|463584240|FG001|Overall Study|Death|2|||
128805210|NCT02029443|463584241|FG002|Overall Study|Death|2|||
128805211|NCT02029443|463584242|FG003|Overall Study|Death|11|||
128805212|NCT02029443|463584243|FG004|Overall Study|Death|2|||
128805213|NCT02029443|463584239|FG000|Overall Study|Lost to Follow-up|1|||
128805214|NCT02029443|463584240|FG001|Overall Study|Lost to Follow-up|0|||
128805215|NCT02029443|463584241|FG002|Overall Study|Lost to Follow-up|1|||
128805216|NCT02029443|463584242|FG003|Overall Study|Lost to Follow-up|1|||
128805217|NCT02029443|463584243|FG004|Overall Study|Lost to Follow-up|0|||
128805218|NCT02029443|463584239|FG000|Overall Study|Started other anti-cancer therapy|17|||
128805219|NCT02029443|463584240|FG001|Overall Study|Started other anti-cancer therapy|4|||
128805220|NCT02029443|463584241|FG002|Overall Study|Started other anti-cancer therapy|7|||
128805221|NCT02029443|463584242|FG003|Overall Study|Started other anti-cancer therapy|9|||
128805222|NCT02029443|463584243|FG004|Overall Study|Started other anti-cancer therapy|3|||
128805223|NCT02029443|463584239|FG000|Overall Study|Withdrawal by Subject|3|||
128805224|NCT02029443|463584240|FG001|Overall Study|Withdrawal by Subject|1|||
128805225|NCT02029443|463584241|FG002|Overall Study|Withdrawal by Subject|1|||
128805226|NCT02029443|463584242|FG003|Overall Study|Withdrawal by Subject|1|||
128805227|NCT02029443|463584243|FG004|Overall Study|Withdrawal by Subject|0|||
128805228|NCT02029443|463584239|FG000|Overall Study|Other|6|||
128805229|NCT02029443|463584240|FG001|Overall Study|Other|6|||
128805230|NCT02029443|463584241|FG002|Overall Study|Other|4|||
128805231|NCT02029443|463584242|FG003|Overall Study|Other|2|||
128805232|NCT02029443|463584243|FG004|Overall Study|Other|0|||
128805233|NCT03393975|463584247|FG000|Urgent Treatment Period|Physician Decision|0|||
128805234|NCT03393975|463584248|FG001|Urgent Treatment Period|Physician Decision|0|||
128805235|NCT03393975|463584249|FG002|Urgent Treatment Period|Physician Decision|0|||
128805236|NCT03393975|463584250|FG003|Urgent Treatment Period|Physician Decision|1|||
128805237|NCT03393975|463584247|FG000|Prophylaxis Period 1|Reason not Specified|0|||
128805238|NCT03393975|463584248|FG001|Prophylaxis Period 1|Reason not Specified|1|||
128805239|NCT03393975|463584249|FG002|Prophylaxis Period 1|Reason not Specified|0|||
128805240|NCT03393975|463584250|FG003|Prophylaxis Period 1|Reason not Specified|0|||
128805241|NCT03393975|463584247|FG000|Prophylaxis Period 2|Reason not Specified|0|||
128805242|NCT03393975|463584248|FG001|Prophylaxis Period 2|Reason not Specified|1|||
128805243|NCT03393975|463584249|FG002|Prophylaxis Period 2|Reason not Specified|0|||
128805244|NCT03393975|463584250|FG003|Prophylaxis Period 2|Reason not Specified|0|||
128805245|NCT02549339|463584257|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
128805246|NCT02549339|463584258|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
128805247|NCT02549339|463584257|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
128805248|NCT02549339|463584258|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
128805249|NCT02549339|463584257|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
128805250|NCT02549339|463584258|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
128805251|NCT02549339|463584257|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
128805252|NCT02549339|463584258|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
128805253|NCT02549339|463584257|FG000|12-month Follow-up|Lack of Efficacy|0|||
128805254|NCT02549339|463584258|FG001|12-month Follow-up|Lack of Efficacy|2|||
128805255|NCT02549339|463584257|FG000|12-month Follow-up|Withdrawal by Subject|8|||
128805256|NCT02549339|463584258|FG001|12-month Follow-up|Withdrawal by Subject|3|||
128805257|NCT02549339|463584257|FG000|12-month Follow-up|Lost to Follow-up|1|||
128805258|NCT02549339|463584258|FG001|12-month Follow-up|Lost to Follow-up|3|||
128805259|NCT02549339|463584257|FG000|12-month Follow-up|Other|0|||
128805260|NCT02549339|463584258|FG001|12-month Follow-up|Other|3|||
128805261|NCT03016169|463584259|FG000|Overall Study|Lost to Follow-up|4|||
128805262|NCT03016169|463584259|FG000|Overall Study|Death|54|||
128805263|NCT03016169|463584259|FG000|Overall Study|Device Explant|11|||
128805264|NCT03016169|463584259|FG000|Overall Study|Withdrawal by Subject|19|||
128805265|NCT03016169|463584259|FG000|Overall Study|Other Reasons|1|||
128805266|NCT02724878|463584260|FG000|Overall Study|Still on Active Therapy|15|||
128805267|NCT02724878|463584260|FG000|Overall Study|Disease Progression|31|||
128805268|NCT02724878|463584260|FG000|Overall Study|Toxicity|5|||
128805269|NCT02724878|463584260|FG000|Overall Study|Death|1|||
128805270|NCT02724878|463584260|FG000|Overall Study|Withdrawal by Subject|4|||
128805271|NCT02724878|463584260|FG000|Overall Study|Lost to Follow-up|2|||
128805272|NCT02724878|463584260|FG000|Overall Study|Protocol Violation|1|||
128805273|NCT02724878|463584260|FG000|Overall Study|Ineligible for Study Drug|5|||
128805274|NCT02724878|463584260|FG000|Overall Study|not started|1|||
128805275|NCT04838262|463584262|FG000|Overall Study|Withdrawal by Subject|9|||
128805276|NCT04838262|463584263|FG001|Overall Study|Withdrawal by Subject|4|||
128805277|NCT03175029|463584266|FG000|Overall Study|Withdrawal by Subject|2|||
128805278|NCT03175029|463584267|FG001|Overall Study|Withdrawal by Subject|1|||
128805279|NCT03175029|463584266|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
128805280|NCT03175029|463584267|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
128805281|NCT05524233|463584268|FG000|Overall Study|Lost to Follow-up|2|||
128805282|NCT05524233|463584268|FG000|Overall Study|Adverse Event|2|||
128805283|NCT05524233|463584268|FG000|Overall Study|Withdrawal by Subject|1|||
128805284|NCT02506959|463584269|FG000|Overall Study|Physician Decision|2|||
128805285|NCT02506959|463584270|FG001|Overall Study|Physician Decision|1|||
128805286|NCT04382898|463584272|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
128805287|NCT04382898|463584273|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
128805288|NCT04382898|463584274|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
128805289|NCT04382898|463584275|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
128805290|NCT04382898|463584276|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
128805291|NCT04382898|463584272|FG000|Part 1: Dose Titration|Death|6|||
128805292|NCT04382898|463584273|FG001|Part 1: Dose Titration|Death|0|||
128805293|NCT04382898|463584274|FG002|Part 1: Dose Titration|Death|0|||
128805294|NCT04382898|463584275|FG003|Part 1: Dose Titration|Death|0|||
128805295|NCT04382898|463584276|FG004|Part 1: Dose Titration|Death|0|||
128805296|NCT04382898|463584272|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
128805297|NCT04382898|463584273|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
128805298|NCT04382898|463584274|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
128805299|NCT04382898|463584275|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
128805300|NCT04382898|463584276|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
128805301|NCT04382898|463584272|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
128805302|NCT04382898|463584273|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
128805303|NCT04382898|463584274|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
128805304|NCT04382898|463584275|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
128805305|NCT04382898|463584276|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
128805306|NCT04382898|463584272|FG000|Part 2: Dose Expansion|Death|0|||
128805307|NCT04382898|463584273|FG001|Part 2: Dose Expansion|Death|17|||
128805308|NCT04382898|463584274|FG002|Part 2: Dose Expansion|Death|13|||
128805309|NCT04382898|463584275|FG003|Part 2: Dose Expansion|Death|1|||
128805310|NCT04382898|463584276|FG004|Part 2: Dose Expansion|Death|0|||
128805311|NCT04382898|463584272|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
128805312|NCT04382898|463584273|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
128805313|NCT04382898|463584274|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
128805314|NCT04382898|463584275|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
128805315|NCT04382898|463584276|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
128805316|NCT04382898|463584272|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
128805317|NCT04382898|463584273|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
128805318|NCT04382898|463584274|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
128805319|NCT04382898|463584275|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
128805320|NCT04382898|463584276|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
128805321|NCT04382898|463584272|FG000|Part 2: Dose Expansion|Other|0|||
128805322|NCT04382898|463584273|FG001|Part 2: Dose Expansion|Other|0|||
128805323|NCT04382898|463584274|FG002|Part 2: Dose Expansion|Other|1|||
128805324|NCT04382898|463584275|FG003|Part 2: Dose Expansion|Other|0|||
128805325|NCT04382898|463584276|FG004|Part 2: Dose Expansion|Other|0|||
128805326|NCT05229120|463584277|FG000|Overall Study|Withdrawal by Subject|8|||
128805327|NCT01566695|463584280|FG000|Overall Study|Lack of Efficacy|1|||
128805328|NCT01566695|463584281|FG001|Overall Study|Lack of Efficacy|0|||
128805329|NCT01566695|463584280|FG000|Overall Study|Adverse Event|3|||
128805330|NCT01566695|463584281|FG001|Overall Study|Adverse Event|0|||
128805331|NCT01566695|463584280|FG000|Overall Study|Death|79|||
128805332|NCT01566695|463584281|FG001|Overall Study|Death|86|||
128805333|NCT01566695|463584280|FG000|Overall Study|Withdrawal by Subject|13|||
128805334|NCT01566695|463584281|FG001|Overall Study|Withdrawal by Subject|12|||
128805335|NCT01566695|463584280|FG000|Overall Study|Lost to Follow-up|0|||
128805336|NCT01566695|463584281|FG001|Overall Study|Lost to Follow-up|3|||
128805337|NCT01566695|463584280|FG000|Overall Study|Other reasons|11|||
128805338|NCT01566695|463584281|FG001|Overall Study|Other reasons|8|||
128805339|NCT03763708|463584282|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
128805340|NCT03763708|463584283|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805341|NCT03763708|463584284|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805342|NCT03763708|463584285|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805343|NCT03763708|463584286|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805344|NCT03763708|463584287|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805345|NCT03763708|463584288|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805346|NCT03763708|463584289|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805347|NCT03763708|463584290|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
128805348|NCT03763708|463584282|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805349|NCT03763708|463584283|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805350|NCT03763708|463584284|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
128805351|NCT03763708|463584285|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805352|NCT03763708|463584286|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805353|NCT03763708|463584287|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805354|NCT03763708|463584288|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805355|NCT03763708|463584289|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805356|NCT03763708|463584290|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
128805357|NCT03763708|463584282|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805358|NCT03763708|463584283|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805359|NCT03763708|463584284|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805360|NCT03763708|463584285|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
128805361|NCT03763708|463584286|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805362|NCT03763708|463584287|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805363|NCT03763708|463584288|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805364|NCT03763708|463584289|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805365|NCT03763708|463584290|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
128805366|NCT03763708|463584282|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805367|NCT03763708|463584283|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805368|NCT03763708|463584284|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805369|NCT03763708|463584285|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805370|NCT03763708|463584286|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
128805371|NCT03763708|463584287|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805372|NCT03763708|463584288|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805373|NCT03763708|463584289|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805374|NCT03763708|463584290|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
128805375|NCT03763708|463584282|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805376|NCT03763708|463584283|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805377|NCT03763708|463584284|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805378|NCT03763708|463584285|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805379|NCT03763708|463584286|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805380|NCT03763708|463584287|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
128805381|NCT03763708|463584288|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805382|NCT03763708|463584289|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805383|NCT03763708|463584290|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
128805384|NCT03763708|463584282|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805385|NCT03763708|463584283|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805386|NCT03763708|463584284|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805387|NCT03763708|463584285|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805388|NCT03763708|463584286|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805389|NCT03763708|463584287|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805390|NCT03763708|463584288|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
128805391|NCT03763708|463584289|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805392|NCT03763708|463584290|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
128805393|NCT03763708|463584282|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
128805394|NCT03763708|463584283|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
128805395|NCT03763708|463584284|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
128805396|NCT03763708|463584285|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
128805397|NCT03763708|463584286|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
128805398|NCT03763708|463584287|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
128805399|NCT03763708|463584288|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
128805400|NCT03763708|463584289|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
128805401|NCT03763708|463584290|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
128805402|NCT03763708|463584282|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
128805403|NCT03763708|463584283|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
128805404|NCT03763708|463584284|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
128805405|NCT03763708|463584285|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
128805406|NCT03763708|463584286|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
128805407|NCT03763708|463584287|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
128805408|NCT03763708|463584288|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
128805409|NCT03763708|463584289|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
128805410|NCT03763708|463584290|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
128805411|NCT03763708|463584282|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
128805412|NCT03763708|463584283|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
128805413|NCT03763708|463584284|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
128805414|NCT03763708|463584285|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
128805415|NCT03763708|463584286|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
128805416|NCT03763708|463584287|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
128805417|NCT03763708|463584288|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
128805418|NCT03763708|463584289|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
128805419|NCT03763708|463584290|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
128805420|NCT02281955|463584297|FG000|Overall Study|Death|1|||
128805421|NCT00378105|463584303|FG000|Overall Study|Adverse Event|3|||
128805422|NCT00378105|463584304|FG001|Overall Study|Adverse Event|1|||
128805423|NCT00378105|463584303|FG000|Overall Study|Withdrawal by Subject|3|||
128805424|NCT00378105|463584304|FG001|Overall Study|Withdrawal by Subject|3|||
128805425|NCT00378105|463584303|FG000|Overall Study|Death|1|||
128805426|NCT00378105|463584304|FG001|Overall Study|Death|0|||
128805427|NCT00378105|463584303|FG000|Overall Study|Going to transplant|7|||
128805428|NCT00378105|463584304|FG001|Overall Study|Going to transplant|8|||
128805429|NCT00378105|463584303|FG000|Overall Study|Progressive disease|3|||
128805430|NCT00378105|463584304|FG001|Overall Study|Progressive disease|3|||
128805431|NCT00378105|463584303|FG000|Overall Study|remain on study|3|||
128805432|NCT00378105|463584304|FG001|Overall Study|remain on study|11|||
128805433|NCT00378105|463584303|FG000|Overall Study|Physician Decision|0|||
128805434|NCT00378105|463584304|FG001|Overall Study|Physician Decision|2|||
128805435|NCT00378105|463584303|FG000|Overall Study|Going non-protocol therapy|0|||
128805436|NCT00378105|463584304|FG001|Overall Study|Going non-protocol therapy|1|||
128805437|NCT00378105|463584303|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
128805438|NCT00378105|463584304|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
128805439|NCT05192200|463584305|FG000|Treatment Period|Other|1|||
128805440|NCT05192200|463584305|FG000|Treatment Period|Lack of Efficacy|1|||
128805441|NCT05192200|463584305|FG000|Treatment Period|Withdrawal by Subject|1|||
128805442|NCT05192200|463584305|FG000|Follow-up|Withdrawal by Subject|1|||
128805443|NCT04533347|463584308|FG000|Overall Study|Adverse Event|1|||
128805444|NCT04533347|463584309|FG001|Overall Study|Adverse Event|2|||
128805445|NCT04533347|463584308|FG000|Overall Study|Lost to Follow-up|2|||
128805446|NCT04533347|463584309|FG001|Overall Study|Lost to Follow-up|0|||
128805447|NCT04533347|463584308|FG000|Overall Study|Withdrawal by Subject|1|||
128805448|NCT04533347|463584309|FG001|Overall Study|Withdrawal by Subject|0|||
128805449|NCT03907397|463584310|FG000|Overall Study|Lost to Follow-up|0|||
128805450|NCT03907397|463584311|FG001|Overall Study|Lost to Follow-up|1|||
128805451|NCT03907397|463584310|FG000|Overall Study|Physician Decision|2|||
128805452|NCT03907397|463584311|FG001|Overall Study|Physician Decision|1|||
128805453|NCT03907397|463584310|FG000|Overall Study|Withdrawal by Subject|5|||
128805454|NCT03907397|463584311|FG001|Overall Study|Withdrawal by Subject|4|||
128805455|NCT03907397|463584310|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
128805456|NCT03907397|463584311|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
128805457|NCT05059262|463586342|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
128805458|NCT05059262|463586343|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
128805459|NCT05059262|463586342|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
128805460|NCT05059262|463586343|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
128805461|NCT05059262|463586342|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
128805462|NCT05059262|463586343|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
128805463|NCT05059262|463586342|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
128805464|NCT05059262|463586343|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
128805465|NCT05059262|463586342|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
128805466|NCT05059262|463586343|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
128805467|NCT05059262|463586342|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
128805468|NCT05059262|463586343|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
128805469|NCT05059262|463586342|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
128805470|NCT05059262|463586343|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
128805471|NCT05059262|463586342|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
128805472|NCT05059262|463586343|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
128805473|NCT05059262|463586342|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
128805474|NCT05059262|463586343|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
128805475|NCT04083235|463586356|FG000|Overall Study|Death|252|||
128805476|NCT04083235|463586357|FG001|Overall Study|Death|277|||
128805477|NCT04083235|463586356|FG000|Overall Study|Withdrawal by Subject|13|||
128805478|NCT04083235|463586357|FG001|Overall Study|Withdrawal by Subject|17|||
128805479|NCT04083235|463586356|FG000|Overall Study|Lost to Follow-up|1|||
128805480|NCT04083235|463586357|FG001|Overall Study|Lost to Follow-up|1|||
128805481|NCT04083235|463586356|FG000|Overall Study|Does not meet entry criteria|1|||
128805482|NCT04083235|463586357|FG001|Overall Study|Does not meet entry criteria|0|||
128805483|NCT04083235|463586356|FG000|Overall Study|Did not receive treatment|13|||
128805484|NCT04083235|463586357|FG001|Overall Study|Did not receive treatment|8|||
128805485|NCT04083235|463586356|FG000|Overall Study|Ongoing at the time of DCO|44|||
128805486|NCT04083235|463586357|FG001|Overall Study|Ongoing at the time of DCO|7|||
128805487|NCT03958955|463586358|FG000|Overall Study|Adverse Event|1|||
128805488|NCT02927769|463586360|FG000|Induction Phase|Study drug toxicity|1|||
128805489|NCT02927769|463586361|FG001|Induction Phase|Study drug toxicity|1|||
128805490|NCT02927769|463586360|FG000|Induction Phase|Disease progression|0|||
128805491|NCT02927769|463586361|FG001|Induction Phase|Disease progression|1|||
128805492|NCT02927769|463586360|FG000|Intensification Phase|Study drug toxicity|1|||
128805493|NCT02927769|463586361|FG001|Intensification Phase|Study drug toxicity|0|||
128805494|NCT05082909|463586362|FG000|Overall Study|Protocol Violation|0|||
128805495|NCT05082909|463586363|FG001|Overall Study|Protocol Violation|0|||
128805496|NCT05082909|463586364|FG002|Overall Study|Protocol Violation|1|||
128805497|NCT05082909|463586365|FG003|Overall Study|Protocol Violation|0|||
128805498|NCT05082909|463586366|FG004|Overall Study|Protocol Violation|0|||
128805499|NCT05082909|463586367|FG005|Overall Study|Protocol Violation|0|||
128805500|NCT03315754|463586370|FG000|Overall Study|COVID-19 complications leading to death|1|||
128805501|NCT03315754|463586370|FG000|Overall Study|insurance coverage issue|1|||
128805502|NCT05227209|463586374|FG000|Overall Study|Adverse Event|11|||
128805503|NCT05227209|463586374|FG000|Overall Study|Lost to Follow-up|1|||
128805504|NCT05227209|463586374|FG000|Overall Study|Withdrawal by Subject|7|||
128805505|NCT05227209|463586374|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
128805506|NCT04245501|463586379|FG000|Overall Study|Adverse Event|2|||
128805507|NCT04245501|463586380|FG001|Overall Study|Adverse Event|0|||
128805508|NCT04245501|463586379|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
128805509|NCT04245501|463586380|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
128805510|NCT01426425|463586381|FG000|Overall Study|Exited prior to EP study|22|||
128805511|NCT01426425|463586381|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
128805512|NCT01426425|463586381|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
128805513|NCT03281291|463586387|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
128805514|NCT03281291|463586388|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
128805515|NCT03281291|463586389|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
128805516|NCT03281291|463586390|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
128805517|NCT03281291|463586391|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
128805518|NCT03281291|463586387|FG000|Overall Study|Protocol Deviation|2|||
128805519|NCT03281291|463586388|FG001|Overall Study|Protocol Deviation|0|||
128805520|NCT03281291|463586389|FG002|Overall Study|Protocol Deviation|1|||
128805521|NCT03281291|463586390|FG003|Overall Study|Protocol Deviation|2|||
128805522|NCT03281291|463586391|FG004|Overall Study|Protocol Deviation|1|||
128805523|NCT03281291|463586387|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
128805524|NCT03281291|463586388|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
128805525|NCT03281291|463586389|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
128805526|NCT03281291|463586390|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
128805527|NCT03281291|463586391|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
128805528|NCT03281291|463586387|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
128805529|NCT03281291|463586388|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
128805530|NCT03281291|463586389|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
128805531|NCT03281291|463586390|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
128805532|NCT03281291|463586391|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
128805533|NCT03281291|463586387|FG000|Overall Study|Lost to Follow-up|10|||
128805534|NCT03281291|463586388|FG001|Overall Study|Lost to Follow-up|10|||
128805535|NCT03281291|463586389|FG002|Overall Study|Lost to Follow-up|4|||
128805536|NCT03281291|463586390|FG003|Overall Study|Lost to Follow-up|6|||
128805537|NCT03281291|463586391|FG004|Overall Study|Lost to Follow-up|10|||
128805538|NCT03281291|463586387|FG000|Overall Study|Other|0|||
128805539|NCT03281291|463586388|FG001|Overall Study|Other|2|||
128805540|NCT03281291|463586389|FG002|Overall Study|Other|0|||
128805541|NCT03281291|463586390|FG003|Overall Study|Other|2|||
128805542|NCT03281291|463586391|FG004|Overall Study|Other|1|||
128805543|NCT00512070|463586394|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
128805544|NCT00512070|463586395|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
128805545|NCT00512070|463586396|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
128805546|NCT00512070|463586394|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
128805547|NCT00512070|463586395|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
128805548|NCT00512070|463586396|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
128805549|NCT00961571|463586397|FG000|Overall Study|Physician Decision|39|||
128805550|NCT03932682|463586401|FG000|Overall Study|Death|1|||
128805551|NCT03932682|463586402|FG001|Overall Study|Death|2|||
128805552|NCT03932682|463586401|FG000|Overall Study|Withdrawal by Subject|37|||
128805553|NCT03932682|463586402|FG001|Overall Study|Withdrawal by Subject|45|||
128805554|NCT03932682|463586401|FG000|Overall Study|Lost to Follow-up|19|||
128805555|NCT03932682|463586402|FG001|Overall Study|Lost to Follow-up|25|||
128805556|NCT03932682|463586401|FG000|Overall Study|Protocol Violation|0|||
128805557|NCT03932682|463586402|FG001|Overall Study|Protocol Violation|2|||
128805558|NCT03932682|463586401|FG000|Overall Study|Other|9|||
128805559|NCT03932682|463586402|FG001|Overall Study|Other|23|||
128805560|NCT04390048|463586408|FG000|Overall Study|Withdrawal by Subject|1|||
128805561|NCT04390048|463586409|FG001|Overall Study|Withdrawal by Subject|3|||
128805562|NCT03126019|463586410|FG000|Overall Study|Death|5|||
128805563|NCT03126019|463586411|FG001|Overall Study|Death|27|||
128805564|NCT03126019|463586410|FG000|Overall Study|Lost to Follow-up|2|||
128805565|NCT03126019|463586411|FG001|Overall Study|Lost to Follow-up|4|||
128805566|NCT03126019|463586410|FG000|Overall Study|Withdrawal by Subject|1|||
128805567|NCT03126019|463586411|FG001|Overall Study|Withdrawal by Subject|9|||
128805568|NCT03126019|463586410|FG000|Overall Study|Physician Decision|1|||
128805569|NCT03126019|463586411|FG001|Overall Study|Physician Decision|0|||
128805570|NCT03126019|463586410|FG000|Overall Study|Transitioned to Rollover Study|0|||
128805571|NCT03126019|463586411|FG001|Overall Study|Transitioned to Rollover Study|11|||
128805572|NCT03126019|463586410|FG000|Overall Study|Did Not Return to Site for Care|0|||
128805573|NCT03126019|463586411|FG001|Overall Study|Did Not Return to Site for Care|1|||
128805574|NCT03126019|463586410|FG000|Overall Study|Site Closed|0|||
128805575|NCT03126019|463586411|FG001|Overall Study|Site Closed|1|||
128805576|NCT04556656|463586413|FG000|Overall Study|Withdrawal by Subject|14|||
128805577|NCT04556656|463586414|FG001|Overall Study|Withdrawal by Subject|12|||
128805578|NCT04556656|463586413|FG000|Overall Study|Physician Decision|1|||
128805579|NCT04556656|463586414|FG001|Overall Study|Physician Decision|0|||
128805580|NCT04556656|463586413|FG000|Overall Study|Adverse Event|4|||
128805581|NCT04556656|463586414|FG001|Overall Study|Adverse Event|7|||
128805582|NCT04556656|463586413|FG000|Overall Study|Death|4|||
128805583|NCT04556656|463586414|FG001|Overall Study|Death|0|||
128805584|NCT04556656|463586413|FG000|Overall Study|Lost to Follow-up|3|||
128805585|NCT04556656|463586414|FG001|Overall Study|Lost to Follow-up|2|||
128805586|NCT04556656|463586413|FG000|Overall Study|Not further specified|2|||
128805587|NCT04556656|463586414|FG001|Overall Study|Not further specified|1|||
128805588|NCT05470400|463586424|FG000|Overall Study|Lost to Follow-up|0|||
128805589|NCT05470400|463586425|FG001|Overall Study|Lost to Follow-up|0|||
128805590|NCT05470400|463586426|FG002|Overall Study|Lost to Follow-up|0|||
128805591|NCT05470400|463586427|FG003|Overall Study|Lost to Follow-up|0|||
128805592|NCT05470400|463586428|FG004|Overall Study|Lost to Follow-up|0|||
128805593|NCT05470400|463586429|FG005|Overall Study|Lost to Follow-up|0|||
128805594|NCT05470400|463586430|FG006|Overall Study|Lost to Follow-up|0|||
128805595|NCT05470400|463586431|FG007|Overall Study|Lost to Follow-up|1|||
128805596|NCT05470400|463586424|FG000|Overall Study|Withdrawal by Subject|1|||
128805597|NCT05470400|463586425|FG001|Overall Study|Withdrawal by Subject|0|||
128805598|NCT05470400|463586426|FG002|Overall Study|Withdrawal by Subject|0|||
128805599|NCT05470400|463586427|FG003|Overall Study|Withdrawal by Subject|0|||
128805600|NCT05470400|463586428|FG004|Overall Study|Withdrawal by Subject|0|||
128805601|NCT05470400|463586429|FG005|Overall Study|Withdrawal by Subject|1|||
128805602|NCT05470400|463586430|FG006|Overall Study|Withdrawal by Subject|0|||
128805603|NCT05470400|463586431|FG007|Overall Study|Withdrawal by Subject|2|||
128805604|NCT03138512|463586432|FG000|Randomization|Participants withdrew consent|0|||
128805605|NCT03138512|463586433|FG001|Randomization|Participants withdrew consent|1|||
128805606|NCT03138512|463586434|FG002|Randomization|Participants withdrew consent|1|||
128805607|NCT03138512|463586435|FG003|Randomization|Participants withdrew consent|0|||
128805608|NCT03138512|463586436|FG004|Randomization|Participants withdrew consent|0|||
128805609|NCT03138512|463586432|FG000|Randomization|Participant no longer meets study criteria|0|||
128805610|NCT03138512|463586433|FG001|Randomization|Participant no longer meets study criteria|3|||
128805611|NCT03138512|463586434|FG002|Randomization|Participant no longer meets study criteria|1|||
128805612|NCT03138512|463586435|FG003|Randomization|Participant no longer meets study criteria|1|||
128805613|NCT03138512|463586436|FG004|Randomization|Participant no longer meets study criteria|3|||
128805614|NCT03138512|463586432|FG000|Randomization|Other reasons|1|||
128805615|NCT03138512|463586433|FG001|Randomization|Other reasons|0|||
128805616|NCT03138512|463586434|FG002|Randomization|Other reasons|0|||
128805617|NCT03138512|463586435|FG003|Randomization|Other reasons|0|||
128805618|NCT03138512|463586436|FG004|Randomization|Other reasons|0|||
128805619|NCT03138512|463586432|FG000|Treatment Part A|Disease recurrence|10|||
128805620|NCT03138512|463586433|FG001|Treatment Part A|Disease recurrence|20|||
128805621|NCT03138512|463586434|FG002|Treatment Part A|Disease recurrence|0|||
128805622|NCT03138512|463586435|FG003|Treatment Part A|Disease recurrence|0|||
128805623|NCT03138512|463586436|FG004|Treatment Part A|Disease recurrence|0|||
128805624|NCT03138512|463586432|FG000|Treatment Part A|Study Drug Toxicity|132|||
128805625|NCT03138512|463586433|FG001|Treatment Part A|Study Drug Toxicity|5|||
128805626|NCT03138512|463586434|FG002|Treatment Part A|Study Drug Toxicity|0|||
128805627|NCT03138512|463586435|FG003|Treatment Part A|Study Drug Toxicity|0|||
128805628|NCT03138512|463586436|FG004|Treatment Part A|Study Drug Toxicity|0|||
128805629|NCT03138512|463586432|FG000|Treatment Part A|Death|1|||
128805630|NCT03138512|463586433|FG001|Treatment Part A|Death|0|||
128805631|NCT03138512|463586434|FG002|Treatment Part A|Death|0|||
128805632|NCT03138512|463586435|FG003|Treatment Part A|Death|0|||
128805633|NCT03138512|463586436|FG004|Treatment Part A|Death|0|||
128805634|NCT03138512|463586432|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
128805635|NCT03138512|463586433|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
128805636|NCT03138512|463586434|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
128805637|NCT03138512|463586435|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
128805638|NCT03138512|463586436|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
128805639|NCT03138512|463586432|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
128805640|NCT03138512|463586433|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
128805641|NCT03138512|463586434|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
128805642|NCT03138512|463586435|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
128805643|NCT03138512|463586436|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
128805644|NCT03138512|463586432|FG000|Treatment Part A|Participant withdrew consent|2|||
128805645|NCT03138512|463586433|FG001|Treatment Part A|Participant withdrew consent|4|||
128805646|NCT03138512|463586434|FG002|Treatment Part A|Participant withdrew consent|0|||
128805647|NCT03138512|463586435|FG003|Treatment Part A|Participant withdrew consent|0|||
128805648|NCT03138512|463586436|FG004|Treatment Part A|Participant withdrew consent|0|||
128805649|NCT03138512|463586432|FG000|Treatment Part A|Lost to Follow-up|0|||
128805650|NCT03138512|463586433|FG001|Treatment Part A|Lost to Follow-up|1|||
128805651|NCT03138512|463586434|FG002|Treatment Part A|Lost to Follow-up|0|||
128805652|NCT03138512|463586435|FG003|Treatment Part A|Lost to Follow-up|0|||
128805653|NCT03138512|463586436|FG004|Treatment Part A|Lost to Follow-up|0|||
128805654|NCT03138512|463586432|FG000|Treatment Part A|Poor/non-compliance|1|||
128805655|NCT03138512|463586433|FG001|Treatment Part A|Poor/non-compliance|0|||
128805656|NCT03138512|463586434|FG002|Treatment Part A|Poor/non-compliance|0|||
128805657|NCT03138512|463586435|FG003|Treatment Part A|Poor/non-compliance|0|||
128805658|NCT03138512|463586436|FG004|Treatment Part A|Poor/non-compliance|0|||
128805659|NCT03138512|463586432|FG000|Treatment Part A|Pregnancy|0|||
128805660|NCT03138512|463586433|FG001|Treatment Part A|Pregnancy|1|||
128805661|NCT03138512|463586434|FG002|Treatment Part A|Pregnancy|0|||
128805662|NCT03138512|463586435|FG003|Treatment Part A|Pregnancy|0|||
128805663|NCT03138512|463586436|FG004|Treatment Part A|Pregnancy|0|||
128805664|NCT03138512|463586432|FG000|Treatment Part A|Other reasons|11|||
128805665|NCT03138512|463586433|FG001|Treatment Part A|Other reasons|8|||
128805666|NCT03138512|463586434|FG002|Treatment Part A|Other reasons|0|||
128805667|NCT03138512|463586435|FG003|Treatment Part A|Other reasons|0|||
128805668|NCT03138512|463586436|FG004|Treatment Part A|Other reasons|0|||
128805669|NCT03138512|463586432|FG000|Treatment Part B|Disease recurrence|0|||
128805670|NCT03138512|463586433|FG001|Treatment Part B|Disease recurrence|0|||
128805671|NCT03138512|463586434|FG002|Treatment Part B|Disease recurrence|6|||
128805672|NCT03138512|463586435|FG003|Treatment Part B|Disease recurrence|12|||
128805673|NCT03138512|463586436|FG004|Treatment Part B|Disease recurrence|10|||
128805674|NCT03138512|463586432|FG000|Treatment Part B|Study drug toxicity|0|||
128805675|NCT03138512|463586433|FG001|Treatment Part B|Study drug toxicity|0|||
128805676|NCT03138512|463586434|FG002|Treatment Part B|Study drug toxicity|63|||
128805677|NCT03138512|463586435|FG003|Treatment Part B|Study drug toxicity|3|||
128805678|NCT03138512|463586436|FG004|Treatment Part B|Study drug toxicity|45|||
128805679|NCT03138512|463586432|FG000|Treatment Part B|Death|0|||
128805680|NCT03138512|463586433|FG001|Treatment Part B|Death|0|||
128805681|NCT03138512|463586434|FG002|Treatment Part B|Death|1|||
128805682|NCT03138512|463586435|FG003|Treatment Part B|Death|0|||
128805683|NCT03138512|463586436|FG004|Treatment Part B|Death|0|||
128805684|NCT03138512|463586432|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
128805685|NCT03138512|463586433|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
128805686|NCT03138512|463586434|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
128805687|NCT03138512|463586435|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
128805688|NCT03138512|463586436|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
128805689|NCT03138512|463586432|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
128805690|NCT03138512|463586433|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
128805691|NCT03138512|463586434|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
128805692|NCT03138512|463586435|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
128805693|NCT03138512|463586436|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
128805694|NCT03138512|463586432|FG000|Treatment Part B|Participant withdrew consent|0|||
128805695|NCT03138512|463586433|FG001|Treatment Part B|Participant withdrew consent|0|||
128805696|NCT03138512|463586434|FG002|Treatment Part B|Participant withdrew consent|1|||
128805697|NCT03138512|463586435|FG003|Treatment Part B|Participant withdrew consent|1|||
128805698|NCT03138512|463586436|FG004|Treatment Part B|Participant withdrew consent|2|||
128805699|NCT03138512|463586432|FG000|Treatment Part B|Lost to Follow-up|0|||
128805700|NCT03138512|463586433|FG001|Treatment Part B|Lost to Follow-up|0|||
128805701|NCT03138512|463586434|FG002|Treatment Part B|Lost to Follow-up|0|||
128805702|NCT03138512|463586435|FG003|Treatment Part B|Lost to Follow-up|1|||
128805703|NCT03138512|463586436|FG004|Treatment Part B|Lost to Follow-up|0|||
128805704|NCT03138512|463586432|FG000|Treatment Part B|Poor/non-compliance|0|||
128805705|NCT03138512|463586433|FG001|Treatment Part B|Poor/non-compliance|0|||
128805706|NCT03138512|463586434|FG002|Treatment Part B|Poor/non-compliance|1|||
128805707|NCT03138512|463586435|FG003|Treatment Part B|Poor/non-compliance|1|||
128805708|NCT03138512|463586436|FG004|Treatment Part B|Poor/non-compliance|1|||
128805709|NCT03138512|463586432|FG000|Treatment Part B|Other reasons|0|||
128805710|NCT03138512|463586433|FG001|Treatment Part B|Other reasons|0|||
128805711|NCT03138512|463586434|FG002|Treatment Part B|Other reasons|3|||
128805712|NCT03138512|463586435|FG003|Treatment Part B|Other reasons|1|||
128805713|NCT03138512|463586436|FG004|Treatment Part B|Other reasons|5|||
128805714|NCT05323084|463586437|FG000|Period 2 - Washout|Lost to Follow-up|0|||
128805715|NCT05323084|463586438|FG001|Period 2 - Washout|Lost to Follow-up|1|||
128805716|NCT04382404|463586439|FG000|Overall Study|Adverse Event|1|||
128805717|NCT04382404|463586439|FG000|Overall Study|Lost to Follow-up|2|||
128805718|NCT05687916|463586441|FG000|Overall Study|Adverse Event|1|||
128805719|NCT05687916|463586442|FG001|Overall Study|Adverse Event|2|||
128805720|NCT05687916|463586443|FG002|Overall Study|Adverse Event|0|||
128805721|NCT05687916|463586441|FG000|Overall Study|Withdrawal by Subject|1|||
128805722|NCT05687916|463586442|FG001|Overall Study|Withdrawal by Subject|0|||
128805723|NCT05687916|463586443|FG002|Overall Study|Withdrawal by Subject|1|||
128805724|NCT05687916|463586441|FG000|Overall Study|Protocol Violation|0|||
128805725|NCT05687916|463586442|FG001|Overall Study|Protocol Violation|2|||
128805726|NCT05687916|463586443|FG002|Overall Study|Protocol Violation|1|||
128805727|NCT05687916|463586441|FG000|Overall Study|Reason not Specified|1|||
128805728|NCT05687916|463586442|FG001|Overall Study|Reason not Specified|0|||
128805729|NCT05687916|463586443|FG002|Overall Study|Reason not Specified|0|||
128805730|NCT03332017|463586444|FG000|Overall Study|Lost to Follow-up|1|||
128805731|NCT03332017|463586445|FG001|Overall Study|Lost to Follow-up|2|||
128805732|NCT03332017|463586444|FG000|Overall Study|Death|17|||
128805733|NCT03332017|463586445|FG001|Overall Study|Death|16|||
128805734|NCT03332017|463586444|FG000|Overall Study|Withdrawal by Subject|6|||
128805735|NCT03332017|463586445|FG001|Overall Study|Withdrawal by Subject|14|||
128805736|NCT03332017|463586444|FG000|Overall Study|Other|1|||
128805737|NCT03332017|463586445|FG001|Overall Study|Other|3|||
128805738|NCT03332017|463586444|FG000|Overall Study|Remained in Study (Ongoing)|47|||
128805739|NCT03332017|463586445|FG001|Overall Study|Remained in Study (Ongoing)|110|||
128805740|NCT01261312|463586446|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
128805741|NCT01261312|463586447|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
128805742|NCT01261312|463586448|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
128805743|NCT01261312|463586449|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805744|NCT01261312|463586450|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805745|NCT01261312|463586451|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805746|NCT01261312|463586452|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805747|NCT01261312|463586453|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805748|NCT01261312|463586454|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805749|NCT01261312|463586455|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805750|NCT01261312|463586456|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805751|NCT01261312|463586457|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805752|NCT01261312|463586458|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
128805753|NCT01261312|463586446|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
128805754|NCT01261312|463586447|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
128805755|NCT01261312|463586448|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805756|NCT01261312|463586449|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805757|NCT01261312|463586450|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805758|NCT01261312|463586451|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805759|NCT01261312|463586452|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805760|NCT01261312|463586453|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805761|NCT01261312|463586454|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805762|NCT01261312|463586455|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805763|NCT01261312|463586456|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805764|NCT01261312|463586457|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805765|NCT01261312|463586458|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
128805766|NCT01261312|463586446|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
128805767|NCT01261312|463586447|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
128805768|NCT01261312|463586448|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805769|NCT01261312|463586449|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805770|NCT01261312|463586450|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805771|NCT01261312|463586451|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805772|NCT01261312|463586452|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805773|NCT01261312|463586453|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805774|NCT01261312|463586454|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805775|NCT01261312|463586455|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805776|NCT01261312|463586456|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805777|NCT01261312|463586457|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805778|NCT01261312|463586458|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
128805779|NCT01261312|463586446|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
128805780|NCT01261312|463586447|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
128805781|NCT01261312|463586448|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805782|NCT01261312|463586449|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805783|NCT01261312|463586450|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805784|NCT01261312|463586451|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805785|NCT01261312|463586452|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805786|NCT01261312|463586453|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805787|NCT01261312|463586454|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805788|NCT01261312|463586455|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805789|NCT01261312|463586456|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805790|NCT01261312|463586457|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805791|NCT01261312|463586458|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
128805792|NCT01261312|463586446|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
128805793|NCT01261312|463586447|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
128805794|NCT01261312|463586448|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
128805795|NCT01261312|463586449|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805796|NCT01261312|463586450|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805797|NCT01261312|463586451|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805798|NCT01261312|463586452|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805799|NCT01261312|463586453|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805800|NCT01261312|463586454|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805801|NCT01261312|463586455|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805802|NCT01261312|463586456|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805803|NCT01261312|463586457|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805804|NCT01261312|463586458|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
128805805|NCT01261312|463586446|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
128805806|NCT01261312|463586447|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
128805807|NCT01261312|463586448|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
128805808|NCT01261312|463586449|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805809|NCT01261312|463586450|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805810|NCT01261312|463586451|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805811|NCT01261312|463586452|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805812|NCT01261312|463586453|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805813|NCT01261312|463586454|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805814|NCT01261312|463586455|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805815|NCT01261312|463586456|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805816|NCT01261312|463586457|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805817|NCT01261312|463586458|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
128805818|NCT01261312|463586446|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
128805819|NCT01261312|463586447|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805820|NCT01261312|463586448|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
128805821|NCT01261312|463586449|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805822|NCT01261312|463586450|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805823|NCT01261312|463586451|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805824|NCT01261312|463586452|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805825|NCT01261312|463586453|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805826|NCT01261312|463586454|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805827|NCT01261312|463586455|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805828|NCT01261312|463586456|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805829|NCT01261312|463586457|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805830|NCT01261312|463586458|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
128805831|NCT01261312|463586446|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805832|NCT01261312|463586447|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805833|NCT01261312|463586448|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805834|NCT01261312|463586449|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
128805835|NCT01261312|463586450|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
128805836|NCT01261312|463586451|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
128805837|NCT01261312|463586452|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805838|NCT01261312|463586453|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805839|NCT01261312|463586454|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805840|NCT01261312|463586455|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805841|NCT01261312|463586456|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805842|NCT01261312|463586457|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805843|NCT01261312|463586458|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
128805844|NCT01261312|463586446|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805845|NCT01261312|463586447|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805846|NCT01261312|463586448|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805847|NCT01261312|463586449|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805848|NCT01261312|463586450|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
128805849|NCT01261312|463586451|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
128805850|NCT01261312|463586452|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805851|NCT01261312|463586453|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805852|NCT01261312|463586454|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805853|NCT01261312|463586455|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805854|NCT01261312|463586456|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805855|NCT01261312|463586457|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805856|NCT01261312|463586458|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
128805857|NCT01261312|463586446|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805858|NCT01261312|463586447|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805859|NCT01261312|463586448|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805860|NCT01261312|463586449|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805861|NCT01261312|463586450|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
128805862|NCT01261312|463586451|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
128805863|NCT01261312|463586452|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805864|NCT01261312|463586453|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805865|NCT01261312|463586454|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805866|NCT01261312|463586455|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805867|NCT01261312|463586456|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805868|NCT01261312|463586457|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805869|NCT01261312|463586458|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
128805870|NCT01261312|463586446|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805871|NCT01261312|463586447|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805872|NCT01261312|463586448|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805873|NCT01261312|463586449|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
128805874|NCT01261312|463586450|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
128805875|NCT01261312|463586451|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
128805876|NCT01261312|463586452|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805877|NCT01261312|463586453|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805878|NCT01261312|463586454|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805879|NCT01261312|463586455|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805880|NCT01261312|463586456|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805881|NCT01261312|463586457|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805882|NCT01261312|463586458|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
128805883|NCT01261312|463586446|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805884|NCT01261312|463586447|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805885|NCT01261312|463586448|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805886|NCT01261312|463586449|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805887|NCT01261312|463586450|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805888|NCT01261312|463586451|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
128805889|NCT01261312|463586452|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805890|NCT01261312|463586453|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805891|NCT01261312|463586454|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805892|NCT01261312|463586455|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805893|NCT01261312|463586456|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805894|NCT01261312|463586457|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805895|NCT01261312|463586458|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
128805896|NCT01261312|463586446|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805897|NCT01261312|463586447|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805898|NCT01261312|463586448|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805899|NCT01261312|463586449|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
128805900|NCT01261312|463586450|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
128805901|NCT01261312|463586451|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
128805902|NCT01261312|463586452|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805903|NCT01261312|463586453|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805904|NCT01261312|463586454|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805905|NCT01261312|463586455|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805906|NCT01261312|463586456|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805907|NCT01261312|463586457|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805908|NCT01261312|463586458|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
128805909|NCT01261312|463586446|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805910|NCT01261312|463586447|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805911|NCT01261312|463586448|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805912|NCT01261312|463586449|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
128805913|NCT01261312|463586450|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
128805914|NCT01261312|463586451|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
128805915|NCT01261312|463586452|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805916|NCT01261312|463586453|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805917|NCT01261312|463586454|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805918|NCT01261312|463586455|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805919|NCT01261312|463586456|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805920|NCT01261312|463586457|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805921|NCT01261312|463586458|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
128805922|NCT01261312|463586446|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805923|NCT01261312|463586447|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805924|NCT01261312|463586448|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805925|NCT01261312|463586449|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805926|NCT01261312|463586450|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805927|NCT01261312|463586451|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805928|NCT01261312|463586452|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
128805929|NCT01261312|463586453|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
128805930|NCT01261312|463586454|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
128805931|NCT01261312|463586455|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805932|NCT01261312|463586456|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805933|NCT01261312|463586457|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805934|NCT01261312|463586458|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
128805935|NCT01261312|463586446|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805936|NCT01261312|463586447|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805937|NCT01261312|463586448|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805938|NCT01261312|463586449|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805939|NCT01261312|463586450|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805940|NCT01261312|463586451|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805941|NCT01261312|463586452|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805942|NCT01261312|463586453|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
128805943|NCT01261312|463586454|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
128805944|NCT01261312|463586455|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805945|NCT01261312|463586456|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805946|NCT01261312|463586457|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805947|NCT01261312|463586458|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
128805948|NCT01261312|463586446|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805949|NCT01261312|463586447|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805950|NCT01261312|463586448|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805951|NCT01261312|463586449|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805952|NCT01261312|463586450|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805953|NCT01261312|463586451|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805954|NCT01261312|463586452|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
128805955|NCT01261312|463586453|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
128805956|NCT01261312|463586454|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
128805957|NCT01261312|463586455|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805958|NCT01261312|463586456|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805959|NCT01261312|463586457|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805960|NCT01261312|463586458|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
128805961|NCT01261312|463586446|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
128805962|NCT01261312|463586447|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
128805963|NCT01261312|463586448|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
128805964|NCT01261312|463586449|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
128805965|NCT01261312|463586450|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
128805966|NCT01261312|463586451|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
128805967|NCT01261312|463586452|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
128805968|NCT01261312|463586453|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
128805969|NCT01261312|463586454|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
128805970|NCT01261312|463586455|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
128805971|NCT01261312|463586456|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
128805972|NCT01261312|463586457|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
128805973|NCT01261312|463586458|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
128805974|NCT01261312|463586446|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805975|NCT01261312|463586447|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805976|NCT01261312|463586448|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805977|NCT01261312|463586449|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805978|NCT01261312|463586450|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805979|NCT01261312|463586451|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805980|NCT01261312|463586452|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
128805981|NCT01261312|463586453|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
128805982|NCT01261312|463586454|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
128805983|NCT01261312|463586455|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805984|NCT01261312|463586456|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805985|NCT01261312|463586457|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805986|NCT01261312|463586458|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
128805987|NCT01261312|463586446|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805988|NCT01261312|463586447|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805989|NCT01261312|463586448|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805990|NCT01261312|463586449|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805991|NCT01261312|463586450|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805992|NCT01261312|463586451|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805993|NCT01261312|463586452|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
128805994|NCT01261312|463586453|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
128805995|NCT01261312|463586454|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
128805996|NCT01261312|463586455|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805997|NCT01261312|463586456|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805998|NCT01261312|463586457|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128805999|NCT01261312|463586458|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
128806000|NCT01261312|463586446|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806001|NCT01261312|463586447|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806002|NCT01261312|463586448|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806003|NCT01261312|463586449|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806004|NCT01261312|463586450|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806005|NCT01261312|463586451|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806006|NCT01261312|463586452|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
128806007|NCT01261312|463586453|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
128806008|NCT01261312|463586454|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
128806009|NCT01261312|463586455|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806010|NCT01261312|463586456|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806011|NCT01261312|463586457|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806012|NCT01261312|463586458|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
128806013|NCT01261312|463586446|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806014|NCT01261312|463586447|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806015|NCT01261312|463586448|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806016|NCT01261312|463586449|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806017|NCT01261312|463586450|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806018|NCT01261312|463586451|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806019|NCT01261312|463586452|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806020|NCT01261312|463586453|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806021|NCT01261312|463586454|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
128806022|NCT01261312|463586455|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
128806023|NCT01261312|463586456|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
128806024|NCT01261312|463586457|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
128806025|NCT01261312|463586458|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
128806026|NCT01261312|463586446|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806027|NCT01261312|463586447|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806028|NCT01261312|463586448|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806029|NCT01261312|463586449|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806030|NCT01261312|463586450|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806031|NCT01261312|463586451|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806032|NCT01261312|463586452|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806033|NCT01261312|463586453|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806034|NCT01261312|463586454|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806035|NCT01261312|463586455|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
128806036|NCT01261312|463586456|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
128806037|NCT01261312|463586457|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
128806038|NCT01261312|463586458|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
128806039|NCT01261312|463586446|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806040|NCT01261312|463586447|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806041|NCT01261312|463586448|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806042|NCT01261312|463586449|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806043|NCT01261312|463586450|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806044|NCT01261312|463586451|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806045|NCT01261312|463586452|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806046|NCT01261312|463586453|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806047|NCT01261312|463586454|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
128806048|NCT01261312|463586455|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
128806049|NCT01261312|463586456|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
128806050|NCT01261312|463586457|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
128806051|NCT01261312|463586458|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
128806052|NCT01261312|463586446|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806053|NCT01261312|463586447|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806054|NCT01261312|463586448|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806055|NCT01261312|463586449|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806056|NCT01261312|463586450|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806057|NCT01261312|463586451|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806058|NCT01261312|463586452|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806059|NCT01261312|463586453|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806060|NCT01261312|463586454|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
128806061|NCT01261312|463586455|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
128806062|NCT01261312|463586456|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
128806063|NCT01261312|463586457|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
128806064|NCT01261312|463586458|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
128806065|NCT01261312|463586446|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806066|NCT01261312|463586447|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806067|NCT01261312|463586448|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806068|NCT01261312|463586449|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806069|NCT01261312|463586450|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806070|NCT01261312|463586451|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806071|NCT01261312|463586452|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806072|NCT01261312|463586453|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806073|NCT01261312|463586454|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
128806074|NCT01261312|463586455|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
128806075|NCT01261312|463586456|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
128806076|NCT01261312|463586457|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
128806077|NCT01261312|463586458|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
128806078|NCT01261312|463586446|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806079|NCT01261312|463586447|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806080|NCT01261312|463586448|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806081|NCT01261312|463586449|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806082|NCT01261312|463586450|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806083|NCT01261312|463586451|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806084|NCT01261312|463586452|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806085|NCT01261312|463586453|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806086|NCT01261312|463586454|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
128806087|NCT01261312|463586455|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
128806088|NCT01261312|463586456|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
128806089|NCT01261312|463586457|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
128806090|NCT01261312|463586458|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
128806091|NCT01261312|463586446|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806092|NCT01261312|463586447|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806093|NCT01261312|463586448|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806094|NCT01261312|463586449|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806095|NCT01261312|463586450|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806096|NCT01261312|463586451|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806097|NCT01261312|463586452|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806098|NCT01261312|463586453|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806099|NCT01261312|463586454|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
128806100|NCT01261312|463586455|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
128806101|NCT01261312|463586456|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
128806102|NCT01261312|463586457|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
128806103|NCT01261312|463586458|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
128806104|NCT01809691|463586461|FG000|Overall Study|Currently on Treatment|192|||
128806105|NCT01809691|463586462|FG001|Overall Study|Currently on Treatment|100|||
128806106|NCT01809691|463586461|FG000|Overall Study|No Protocol Treatment|10|||
128806107|NCT01809691|463586462|FG001|Overall Study|No Protocol Treatment|11|||
128806108|NCT01809691|463586461|FG000|Overall Study|Adverse Event|80|||
128806109|NCT01809691|463586462|FG001|Overall Study|Adverse Event|21|||
128806110|NCT01809691|463586461|FG000|Overall Study|Disease Progression|226|||
128806111|NCT01809691|463586462|FG001|Overall Study|Disease Progression|372|||
128806112|NCT01809691|463586461|FG000|Overall Study|Death|26|||
128806113|NCT01809691|463586462|FG001|Overall Study|Death|13|||
128806114|NCT01809691|463586461|FG000|Overall Study|Participant Refusal|70|||
128806115|NCT01809691|463586462|FG001|Overall Study|Participant Refusal|72|||
128806116|NCT01809691|463586461|FG000|Overall Study|Other, Not Specified|34|||
128806117|NCT01809691|463586462|FG001|Overall Study|Other, Not Specified|52|||
128806118|NCT02783300|463586469|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806119|NCT02783300|463586470|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806120|NCT02783300|463586471|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806121|NCT02783300|463586472|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806122|NCT02783300|463586473|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806123|NCT02783300|463586474|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806124|NCT02783300|463586475|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
128806125|NCT02783300|463586476|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806126|NCT02783300|463586477|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806127|NCT02783300|463586478|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806128|NCT02783300|463586479|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806129|NCT02783300|463586480|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806130|NCT02783300|463586481|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806131|NCT02783300|463586482|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806132|NCT02783300|463586483|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806133|NCT02783300|463586484|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806134|NCT02783300|463586485|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806135|NCT02783300|463586486|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806136|NCT02783300|463586487|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806137|NCT02783300|463586488|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806138|NCT02783300|463586489|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806139|NCT02783300|463586490|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806140|NCT02783300|463586491|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806141|NCT02783300|463586492|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806142|NCT02783300|463586493|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806143|NCT02783300|463586494|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806144|NCT02783300|463586495|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
128806145|NCT02783300|463586469|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806146|NCT02783300|463586470|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806147|NCT02783300|463586471|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806148|NCT02783300|463586472|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
128806149|NCT02783300|463586473|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806150|NCT02783300|463586474|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806151|NCT02783300|463586475|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806152|NCT02783300|463586476|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806153|NCT02783300|463586477|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806154|NCT02783300|463586478|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806155|NCT02783300|463586479|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806156|NCT02783300|463586480|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806157|NCT02783300|463586481|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806158|NCT02783300|463586482|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806159|NCT02783300|463586483|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806160|NCT02783300|463586484|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806161|NCT02783300|463586485|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806162|NCT02783300|463586486|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806163|NCT02783300|463586487|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806164|NCT02783300|463586488|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806165|NCT02783300|463586489|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806166|NCT02783300|463586490|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806167|NCT02783300|463586491|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806168|NCT02783300|463586492|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806169|NCT02783300|463586493|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806170|NCT02783300|463586494|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806171|NCT02783300|463586495|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
128806172|NCT02783300|463586469|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
128806173|NCT02783300|463586470|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
128806174|NCT02783300|463586471|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
128806175|NCT02783300|463586472|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
128806176|NCT02783300|463586473|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
128806177|NCT02783300|463586474|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
128806178|NCT02783300|463586475|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
128806179|NCT02783300|463586476|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
128806180|NCT02783300|463586477|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
128806181|NCT02783300|463586478|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
128806182|NCT02783300|463586479|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
128806183|NCT02783300|463586480|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
128806184|NCT02783300|463586481|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
128806185|NCT02783300|463586482|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
128806186|NCT02783300|463586483|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
128806187|NCT02783300|463586484|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
128806188|NCT02783300|463586485|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
128806189|NCT02783300|463586486|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
128806190|NCT02783300|463586487|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
128806191|NCT02783300|463586488|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
128806192|NCT02783300|463586489|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
128806193|NCT02783300|463586490|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
128806194|NCT02783300|463586491|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
128806195|NCT02783300|463586492|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
128806196|NCT02783300|463586493|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
128806197|NCT02783300|463586494|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
128806198|NCT02783300|463586495|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
128806199|NCT02783300|463586469|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806200|NCT02783300|463586470|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806201|NCT02783300|463586471|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806202|NCT02783300|463586472|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806203|NCT02783300|463586473|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806204|NCT02783300|463586474|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806205|NCT02783300|463586475|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
128806206|NCT02783300|463586476|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806207|NCT02783300|463586477|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806208|NCT02783300|463586478|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806209|NCT02783300|463586479|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806210|NCT02783300|463586480|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806211|NCT02783300|463586481|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
128806212|NCT02783300|463586482|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806213|NCT02783300|463586483|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806214|NCT02783300|463586484|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806215|NCT02783300|463586485|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806216|NCT02783300|463586486|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806217|NCT02783300|463586487|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806218|NCT02783300|463586488|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806219|NCT02783300|463586489|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806220|NCT02783300|463586490|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806221|NCT02783300|463586491|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806222|NCT02783300|463586492|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806223|NCT02783300|463586493|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806224|NCT02783300|463586494|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806225|NCT02783300|463586495|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
128806226|NCT02783300|463586469|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806227|NCT02783300|463586470|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806228|NCT02783300|463586471|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806229|NCT02783300|463586472|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806230|NCT02783300|463586473|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
128806231|NCT02783300|463586474|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806232|NCT02783300|463586475|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
128806233|NCT02783300|463586476|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806234|NCT02783300|463586477|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806235|NCT02783300|463586478|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
128806236|NCT02783300|463586479|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806237|NCT02783300|463586480|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806238|NCT02783300|463586481|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
128806239|NCT02783300|463586482|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806240|NCT02783300|463586483|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806241|NCT02783300|463586484|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806242|NCT02783300|463586485|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806243|NCT02783300|463586486|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806244|NCT02783300|463586487|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806245|NCT02783300|463586488|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806246|NCT02783300|463586489|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806247|NCT02783300|463586490|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806248|NCT02783300|463586491|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806249|NCT02783300|463586492|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806250|NCT02783300|463586493|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806251|NCT02783300|463586494|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806252|NCT02783300|463586495|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
128806253|NCT02783300|463586469|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806254|NCT02783300|463586470|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806255|NCT02783300|463586471|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806256|NCT02783300|463586472|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806257|NCT02783300|463586473|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806258|NCT02783300|463586474|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806259|NCT02783300|463586475|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806260|NCT02783300|463586476|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806261|NCT02783300|463586477|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806262|NCT02783300|463586478|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806263|NCT02783300|463586479|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806264|NCT02783300|463586480|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806265|NCT02783300|463586481|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806266|NCT02783300|463586482|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806267|NCT02783300|463586483|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806268|NCT02783300|463586484|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
128806269|NCT02783300|463586485|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806270|NCT02783300|463586486|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
128806271|NCT02783300|463586487|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
128806272|NCT02783300|463586488|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
128806273|NCT02783300|463586489|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806274|NCT02783300|463586490|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806275|NCT02783300|463586491|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806276|NCT02783300|463586492|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806277|NCT02783300|463586493|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
128806278|NCT02783300|463586494|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806279|NCT02783300|463586495|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
128806280|NCT02783300|463586469|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806281|NCT02783300|463586470|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806282|NCT02783300|463586471|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806283|NCT02783300|463586472|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806284|NCT02783300|463586473|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806285|NCT02783300|463586474|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806286|NCT02783300|463586475|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806287|NCT02783300|463586476|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806288|NCT02783300|463586477|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806289|NCT02783300|463586478|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806290|NCT02783300|463586479|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806291|NCT02783300|463586480|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806292|NCT02783300|463586481|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806293|NCT02783300|463586482|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806294|NCT02783300|463586483|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806295|NCT02783300|463586484|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806296|NCT02783300|463586485|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
128806297|NCT02783300|463586486|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806298|NCT02783300|463586487|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
128806299|NCT02783300|463586488|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
128806300|NCT02783300|463586489|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806301|NCT02783300|463586490|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806302|NCT02783300|463586491|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806303|NCT02783300|463586492|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806304|NCT02783300|463586493|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806305|NCT02783300|463586494|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806306|NCT02783300|463586495|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
128806307|NCT02783300|463586469|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806308|NCT02783300|463586470|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806309|NCT02783300|463586471|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806310|NCT02783300|463586472|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806311|NCT02783300|463586473|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806312|NCT02783300|463586474|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806313|NCT02783300|463586475|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806314|NCT02783300|463586476|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806315|NCT02783300|463586477|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806316|NCT02783300|463586478|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806317|NCT02783300|463586479|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806318|NCT02783300|463586480|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806319|NCT02783300|463586481|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806320|NCT02783300|463586482|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806321|NCT02783300|463586483|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806322|NCT02783300|463586484|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806323|NCT02783300|463586485|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
128806324|NCT02783300|463586486|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806325|NCT02783300|463586487|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
128806326|NCT02783300|463586488|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
128806327|NCT02783300|463586489|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
128806328|NCT02783300|463586490|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806329|NCT02783300|463586491|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806330|NCT02783300|463586492|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806331|NCT02783300|463586493|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806332|NCT02783300|463586494|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806333|NCT02783300|463586495|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
128806334|NCT02783300|463586469|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806335|NCT02783300|463586470|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806336|NCT02783300|463586471|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806337|NCT02783300|463586472|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806338|NCT02783300|463586473|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806339|NCT02783300|463586474|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806340|NCT02783300|463586475|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806341|NCT02783300|463586476|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806342|NCT02783300|463586477|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806343|NCT02783300|463586478|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806344|NCT02783300|463586479|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806345|NCT02783300|463586480|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806346|NCT02783300|463586481|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806347|NCT02783300|463586482|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806348|NCT02783300|463586483|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806349|NCT02783300|463586484|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
128806350|NCT02783300|463586485|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806351|NCT02783300|463586486|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806352|NCT02783300|463586487|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806353|NCT02783300|463586488|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806354|NCT02783300|463586489|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806355|NCT02783300|463586490|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806356|NCT02783300|463586491|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
128806357|NCT02783300|463586492|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806358|NCT02783300|463586493|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806359|NCT02783300|463586494|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806360|NCT02783300|463586495|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
128806361|NCT02783300|463586469|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806362|NCT02783300|463586470|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806363|NCT02783300|463586471|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806364|NCT02783300|463586472|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806365|NCT02783300|463586473|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806366|NCT02783300|463586474|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806367|NCT02783300|463586475|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806368|NCT02783300|463586476|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806369|NCT02783300|463586477|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806370|NCT02783300|463586478|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806371|NCT02783300|463586479|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806372|NCT02783300|463586480|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806373|NCT02783300|463586481|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806374|NCT02783300|463586482|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
128806375|NCT02783300|463586483|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
128806376|NCT02783300|463586484|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
128806377|NCT02783300|463586485|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
128806378|NCT02783300|463586486|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806379|NCT02783300|463586487|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
128806380|NCT02783300|463586488|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
128806381|NCT02783300|463586489|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806382|NCT02783300|463586490|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806383|NCT02783300|463586491|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806384|NCT02783300|463586492|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806385|NCT02783300|463586493|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806386|NCT02783300|463586494|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806387|NCT02783300|463586495|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
128806388|NCT02783300|463586469|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806389|NCT02783300|463586470|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806390|NCT02783300|463586471|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806391|NCT02783300|463586472|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806392|NCT02783300|463586473|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806393|NCT02783300|463586474|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806394|NCT02783300|463586475|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806395|NCT02783300|463586476|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806396|NCT02783300|463586477|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806397|NCT02783300|463586478|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806398|NCT02783300|463586479|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806399|NCT02783300|463586480|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806400|NCT02783300|463586481|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806401|NCT02783300|463586482|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
128806402|NCT02783300|463586483|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
128806403|NCT02783300|463586484|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
128806404|NCT02783300|463586485|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
128806405|NCT02783300|463586486|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
128806406|NCT02783300|463586487|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
128806407|NCT02783300|463586488|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
128806408|NCT02783300|463586489|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
128806409|NCT02783300|463586490|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
128806410|NCT02783300|463586491|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
128806411|NCT02783300|463586492|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
128806412|NCT02783300|463586493|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
128806413|NCT02783300|463586494|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
128806414|NCT02783300|463586495|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
128806415|NCT02783300|463586469|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806416|NCT02783300|463586470|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806417|NCT02783300|463586471|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806418|NCT02783300|463586472|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806419|NCT02783300|463586473|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806420|NCT02783300|463586474|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806421|NCT02783300|463586475|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806422|NCT02783300|463586476|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806423|NCT02783300|463586477|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806424|NCT02783300|463586478|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806425|NCT02783300|463586479|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806426|NCT02783300|463586480|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806427|NCT02783300|463586481|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806428|NCT02783300|463586482|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806429|NCT02783300|463586483|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806430|NCT02783300|463586484|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806431|NCT02783300|463586485|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806432|NCT02783300|463586486|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806433|NCT02783300|463586487|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806434|NCT02783300|463586488|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806435|NCT02783300|463586489|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806436|NCT02783300|463586490|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806437|NCT02783300|463586491|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806438|NCT02783300|463586492|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806439|NCT02783300|463586493|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806440|NCT02783300|463586494|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
128806441|NCT02783300|463586495|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
128806442|NCT02783300|463586469|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806443|NCT02783300|463586470|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806444|NCT02783300|463586471|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806445|NCT02783300|463586472|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806446|NCT02783300|463586473|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806447|NCT02783300|463586474|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806448|NCT02783300|463586475|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806449|NCT02783300|463586476|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806450|NCT02783300|463586477|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806451|NCT02783300|463586478|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806452|NCT02783300|463586479|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806453|NCT02783300|463586480|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806454|NCT02783300|463586481|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806455|NCT02783300|463586482|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806456|NCT02783300|463586483|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806457|NCT02783300|463586484|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806458|NCT02783300|463586485|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806459|NCT02783300|463586486|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806460|NCT02783300|463586487|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806461|NCT02783300|463586488|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806462|NCT02783300|463586489|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806463|NCT02783300|463586490|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806464|NCT02783300|463586491|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806465|NCT02783300|463586492|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806466|NCT02783300|463586493|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806467|NCT02783300|463586494|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
128806468|NCT02783300|463586495|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
128806469|NCT03535272|463586496|FG000|Overall Study|Lost to Follow-up|71|||
128806470|NCT03535272|463586497|FG001|Overall Study|Lost to Follow-up|73|||
128806471|NCT03892616|463586498|FG000|Washout Period 2|Met discontinuation criterion|0|||
128806472|NCT03892616|463586499|FG001|Washout Period 2|Met discontinuation criterion|0|||
128806473|NCT03892616|463586500|FG002|Washout Period 2|Met discontinuation criterion|0|||
128806474|NCT03892616|463586501|FG003|Washout Period 2|Met discontinuation criterion|0|||
128806475|NCT03892616|463586502|FG004|Washout Period 2|Met discontinuation criterion|0|||
128806476|NCT03892616|463586503|FG005|Washout Period 2|Met discontinuation criterion|0|||
128806477|NCT03892616|463586504|FG006|Washout Period 2|Met discontinuation criterion|0|||
128806478|NCT03892616|463586505|FG007|Washout Period 2|Met discontinuation criterion|0|||
128806479|NCT03892616|463586506|FG008|Washout Period 2|Met discontinuation criterion|1|||
128806480|NCT03892616|463586507|FG009|Washout Period 2|Met discontinuation criterion|0|||
128806481|NCT03892616|463586508|FG010|Washout Period 2|Met discontinuation criterion|0|||
128806482|NCT03892616|463586509|FG011|Washout Period 2|Met discontinuation criterion|0|||
128806483|NCT04831216|463586514|FG000|Overall Study|Lost to Follow-up|32|||
128806484|NCT03930342|463586521|FG000|Overall Study|Lost to Follow-up|70|||
128806485|NCT03930342|463586522|FG001|Overall Study|Lost to Follow-up|77|||
128806486|NCT05021640|463588320|FG000|Overall Study|Lost to Follow-up|0|||
128806487|NCT05021640|463588321|FG001|Overall Study|Lost to Follow-up|0|||
128806488|NCT05021640|463588322|FG002|Overall Study|Lost to Follow-up|0|||
128806489|NCT05021640|463588323|FG003|Overall Study|Lost to Follow-up|0|||
128806490|NCT05021640|463588324|FG004|Overall Study|Lost to Follow-up|1|||
128806491|NCT04737772|463588325|FG000|Phase 2 Study|Lost to Follow-up|15|||
128806492|NCT04737772|463588326|FG001|Phase 2 Study|Lost to Follow-up|15|||
128806493|NCT04737772|463588325|FG000|Phase 2 Study|Withdrawal by Subject|0|||
128806494|NCT04737772|463588326|FG001|Phase 2 Study|Withdrawal by Subject|1|||
128806495|NCT04737772|463588325|FG000|Phase 2 Study|Did not take any coaching calls|4|||
128806496|NCT04737772|463588326|FG001|Phase 2 Study|Did not take any coaching calls|0|||
128806497|NCT04737772|463588325|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
128806498|NCT04737772|463588326|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
128806499|NCT04737772|463588325|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
128806500|NCT04737772|463588326|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
128806501|NCT05691309|463588328|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
128806502|NCT05691309|463588328|FG000|Overall Study|vancomycin levels not evaluable|2|||
128806503|NCT01804816|463588329|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
128806504|NCT01804816|463588329|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
128806505|NCT04421378|463588335|FG000|Overall Study|Adverse Event|2|||
128806506|NCT04421378|463588336|FG001|Overall Study|Adverse Event|7|||
128806507|NCT04421378|463588337|FG002|Overall Study|Adverse Event|0|||
128806508|NCT04421378|463588338|FG003|Overall Study|Adverse Event|1|||
128806509|NCT04421378|463588339|FG004|Overall Study|Adverse Event|0|||
128806510|NCT04421378|463588335|FG000|Overall Study|Physician Decision|1|||
128806511|NCT04421378|463588336|FG001|Overall Study|Physician Decision|2|||
128806512|NCT04421378|463588337|FG002|Overall Study|Physician Decision|0|||
128806513|NCT04421378|463588338|FG003|Overall Study|Physician Decision|0|||
128806514|NCT04421378|463588339|FG004|Overall Study|Physician Decision|0|||
128806515|NCT04421378|463588335|FG000|Overall Study|Progressive Disease|16|||
128806516|NCT04421378|463588336|FG001|Overall Study|Progressive Disease|4|||
128806517|NCT04421378|463588337|FG002|Overall Study|Progressive Disease|18|||
128806518|NCT04421378|463588338|FG003|Overall Study|Progressive Disease|11|||
128806519|NCT04421378|463588339|FG004|Overall Study|Progressive Disease|3|||
128806520|NCT04421378|463588335|FG000|Overall Study|Study Terminated by Sponsor|0|||
128806521|NCT04421378|463588336|FG001|Overall Study|Study Terminated by Sponsor|1|||
128806522|NCT04421378|463588337|FG002|Overall Study|Study Terminated by Sponsor|1|||
128806523|NCT04421378|463588338|FG003|Overall Study|Study Terminated by Sponsor|0|||
128806524|NCT04421378|463588339|FG004|Overall Study|Study Terminated by Sponsor|0|||
128806525|NCT04421378|463588335|FG000|Overall Study|Withdrawal by Subject|3|||
128806526|NCT04421378|463588336|FG001|Overall Study|Withdrawal by Subject|1|||
128806527|NCT04421378|463588337|FG002|Overall Study|Withdrawal by Subject|0|||
128806528|NCT04421378|463588338|FG003|Overall Study|Withdrawal by Subject|2|||
128806529|NCT04421378|463588339|FG004|Overall Study|Withdrawal by Subject|0|||
128806530|NCT04421378|463588335|FG000|Overall Study|Other|1|||
128806531|NCT04421378|463588336|FG001|Overall Study|Other|0|||
128806532|NCT04421378|463588337|FG002|Overall Study|Other|0|||
128806533|NCT04421378|463588338|FG003|Overall Study|Other|0|||
128806534|NCT04421378|463588339|FG004|Overall Study|Other|0|||
128806535|NCT04263311|463588340|FG000|Overall Study|Lost to Follow-up|1|||
128806536|NCT04263311|463588341|FG001|Overall Study|Lost to Follow-up|2|||
128806537|NCT04263311|463588342|FG002|Overall Study|Lost to Follow-up|0|||
128806538|NCT04263311|463588340|FG000|Overall Study|Health Issues|1|||
128806539|NCT04263311|463588341|FG001|Overall Study|Health Issues|0|||
128806540|NCT04263311|463588342|FG002|Overall Study|Health Issues|0|||
128806541|NCT04263311|463588340|FG000|Overall Study|Left the country|1|||
128806542|NCT04263311|463588341|FG001|Overall Study|Left the country|0|||
128806543|NCT04263311|463588342|FG002|Overall Study|Left the country|0|||
128806544|NCT04263311|463588340|FG000|Overall Study|Unable to maintain time commitment|1|||
128806545|NCT04263311|463588341|FG001|Overall Study|Unable to maintain time commitment|0|||
128806546|NCT04263311|463588342|FG002|Overall Study|Unable to maintain time commitment|0|||
128806547|NCT04263311|463588340|FG000|Overall Study|No longer interested|1|||
128806548|NCT04263311|463588341|FG001|Overall Study|No longer interested|0|||
128806549|NCT04263311|463588342|FG002|Overall Study|No longer interested|0|||
128806550|NCT04263311|463588340|FG000|Overall Study|Ineligible post consent|0|||
128806551|NCT04263311|463588341|FG001|Overall Study|Ineligible post consent|0|||
128806552|NCT04263311|463588342|FG002|Overall Study|Ineligible post consent|5|||
128806553|NCT02592330|463588343|FG000|Overall Study|Withdrawal by Subject|1|||
128806554|NCT02592330|463588344|FG001|Overall Study|Withdrawal by Subject|0|||
128806555|NCT02592330|463588343|FG000|Overall Study|Failed Biopsy|1|||
128806556|NCT02592330|463588344|FG001|Overall Study|Failed Biopsy|0|||
128806557|NCT04673929|463588345|FG000|Overall Study|Death|73|||
128806558|NCT04673929|463588345|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
128806559|NCT02807636|463588348|FG000|Overall Study|Lost to Follow-up|10|||
128806560|NCT02807636|463588349|FG001|Overall Study|Lost to Follow-up|13|||
128806561|NCT02807636|463588350|FG002|Overall Study|Lost to Follow-up|6|||
128806562|NCT02807636|463588348|FG000|Overall Study|Protocol Deviation|1|||
128806563|NCT02807636|463588349|FG001|Overall Study|Protocol Deviation|0|||
128806564|NCT02807636|463588350|FG002|Overall Study|Protocol Deviation|0|||
128806565|NCT02807636|463588348|FG000|Overall Study|Symptomatic Deterioration|0|||
128806566|NCT02807636|463588349|FG001|Overall Study|Symptomatic Deterioration|1|||
128806567|NCT02807636|463588350|FG002|Overall Study|Symptomatic Deterioration|0|||
128806568|NCT02807636|463588348|FG000|Overall Study|Withdrawal by Subject|39|||
128806569|NCT02807636|463588349|FG001|Overall Study|Withdrawal by Subject|28|||
128806570|NCT02807636|463588350|FG002|Overall Study|Withdrawal by Subject|24|||
128806571|NCT02807636|463588348|FG000|Overall Study|Death|303|||
128806572|NCT02807636|463588349|FG001|Overall Study|Death|332|||
128806573|NCT02807636|463588350|FG002|Overall Study|Death|272|||
128806574|NCT02807636|463588348|FG000|Overall Study|Study Terminated By Sponsor|47|||
128806575|NCT02807636|463588349|FG001|Overall Study|Study Terminated By Sponsor|76|||
128806576|NCT02807636|463588350|FG002|Overall Study|Study Terminated By Sponsor|60|||
128806577|NCT02807636|463588348|FG000|Overall Study|Physician Decision|0|||
128806578|NCT02807636|463588349|FG001|Overall Study|Physician Decision|1|||
128806579|NCT02807636|463588350|FG002|Overall Study|Physician Decision|0|||
128806580|NCT04088630|463588351|FG000|Overall Study|Lost to Follow-up|3|||
128806581|NCT04088630|463588352|FG001|Overall Study|Lost to Follow-up|2|||
128806582|NCT04088630|463588353|FG002|Overall Study|Lost to Follow-up|6|||
128806583|NCT04088630|463588351|FG000|Overall Study|Death|3|||
128806584|NCT04088630|463588352|FG001|Overall Study|Death|1|||
128806585|NCT04088630|463588353|FG002|Overall Study|Death|1|||
128806586|NCT04088630|463588351|FG000|Overall Study|Physician Decision|0|||
128806587|NCT04088630|463588352|FG001|Overall Study|Physician Decision|1|||
128806588|NCT04088630|463588353|FG002|Overall Study|Physician Decision|1|||
128806589|NCT02954341|463588354|FG000|Overall Study|Attempted Implant unsuccessful|5|||
128806590|NCT02954341|463588354|FG000|Overall Study|Death|90|||
128806591|NCT02954341|463588354|FG000|Overall Study|Withdrawal by Subject|4|||
128806592|NCT02954341|463588354|FG000|Overall Study|Physician Decision|13|||
128806593|NCT02954341|463588354|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
128806594|NCT02954341|463588354|FG000|Overall Study|Not implanted due to physician's decision|1|||
128806595|NCT02954341|463588354|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
128806596|NCT04024813|463588355|FG000|Overall Study|Study terminated by Sponsor|1|||
128806597|NCT05034952|463588356|FG000|Overall Study|Adverse Event|1|||
128806598|NCT05034952|463588357|FG001|Overall Study|Adverse Event|0|||
128806599|NCT05034952|463588358|FG002|Overall Study|Adverse Event|0|||
128806600|NCT05034952|463588359|FG003|Overall Study|Adverse Event|0|||
128806601|NCT05034952|463588356|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
128806602|NCT05034952|463588357|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
128806603|NCT05034952|463588358|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
128806604|NCT05034952|463588359|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
128806605|NCT05034952|463588356|FG000|Overall Study|Lost to Follow-up|1|||
128806606|NCT05034952|463588357|FG001|Overall Study|Lost to Follow-up|4|||
128806607|NCT05034952|463588358|FG002|Overall Study|Lost to Follow-up|3|||
128806608|NCT05034952|463588359|FG003|Overall Study|Lost to Follow-up|3|||
128806609|NCT05034952|463588356|FG000|Overall Study|Other|0|||
128806610|NCT05034952|463588357|FG001|Overall Study|Other|0|||
128806611|NCT05034952|463588358|FG002|Overall Study|Other|0|||
128806612|NCT05034952|463588359|FG003|Overall Study|Other|1|||
128806613|NCT04950660|463588364|FG000|Overall Study|Protocol Violation|4|||
128806614|NCT04950660|463588365|FG001|Overall Study|Protocol Violation|2|||
128806615|NCT04950660|463588364|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
128806616|NCT04950660|463588365|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
128806617|NCT04950660|463588364|FG000|Overall Study|Withdrawal by Subject|0|||
128806618|NCT04950660|463588365|FG001|Overall Study|Withdrawal by Subject|1|||
128806619|NCT04950660|463588364|FG000|Overall Study|Hypotension|1|||
128806620|NCT04950660|463588365|FG001|Overall Study|Hypotension|0|||
128806621|NCT02437318|463588366|FG000|Overall Study|Progressive disease|207|||
128806622|NCT02437318|463588367|FG001|Overall Study|Progressive disease|240|||
128806623|NCT02437318|463588366|FG000|Overall Study|Subject/guardian decision|24|||
128806624|NCT02437318|463588367|FG001|Overall Study|Subject/guardian decision|11|||
128806625|NCT02437318|463588366|FG000|Overall Study|Physician Decision|29|||
128806626|NCT02437318|463588367|FG001|Overall Study|Physician Decision|22|||
128806627|NCT02437318|463588366|FG000|Overall Study|Adverse Event|14|||
128806628|NCT02437318|463588367|FG001|Overall Study|Adverse Event|4|||
128806629|NCT02437318|463588366|FG000|Overall Study|Death|4|||
128806630|NCT02437318|463588367|FG001|Overall Study|Death|4|||
128806631|NCT02437318|463588366|FG000|Overall Study|Protocol deviation|5|||
128806632|NCT02437318|463588367|FG001|Overall Study|Protocol deviation|7|||
128806633|NCT02437318|463588366|FG000|Overall Study|Sponsor decision|1|||
128806634|NCT02437318|463588367|FG001|Overall Study|Sponsor decision|0|||
128806635|NCT00920621|463588368|FG000|Overall Study|Lost to Follow-up|16|||
128806636|NCT00920621|463588369|FG001|Overall Study|Lost to Follow-up|17|||
128806637|NCT00920621|463588370|FG002|Overall Study|Lost to Follow-up|19|||
128806638|NCT00920621|463588371|FG003|Overall Study|Lost to Follow-up|21|||
128806639|NCT00920621|463588368|FG000|Overall Study|Fetal/neonatal deaths|16|||
128806640|NCT00920621|463588369|FG001|Overall Study|Fetal/neonatal deaths|14|||
128806641|NCT00920621|463588370|FG002|Overall Study|Fetal/neonatal deaths|16|||
128806642|NCT00920621|463588371|FG003|Overall Study|Fetal/neonatal deaths|14|||
128806643|NCT00920621|463588368|FG000|Overall Study|Blood sample not collected|22|||
128806644|NCT00920621|463588369|FG001|Overall Study|Blood sample not collected|14|||
128806645|NCT00920621|463588370|FG002|Overall Study|Blood sample not collected|0|||
128806646|NCT00920621|463588371|FG003|Overall Study|Blood sample not collected|0|||
128806647|NCT04321031|463588374|FG000|Overall Study|Adverse Event|0|||
128806648|NCT04321031|463588375|FG001|Overall Study|Adverse Event|2|||
128806649|NCT04321031|463588376|FG002|Overall Study|Adverse Event|2|||
128806650|NCT04321031|463588377|FG003|Overall Study|Adverse Event|2|||
128806651|NCT04321031|463588378|FG004|Overall Study|Adverse Event|2|||
128806652|NCT04321031|463588379|FG005|Overall Study|Adverse Event|2|||
128806653|NCT04321031|463588380|FG006|Overall Study|Adverse Event|0|||
128806654|NCT04321031|463588374|FG000|Overall Study|Lost to Follow-up|0|||
128806655|NCT04321031|463588375|FG001|Overall Study|Lost to Follow-up|0|||
128806656|NCT04321031|463588376|FG002|Overall Study|Lost to Follow-up|0|||
128806657|NCT04321031|463588377|FG003|Overall Study|Lost to Follow-up|1|||
128806658|NCT04321031|463588378|FG004|Overall Study|Lost to Follow-up|0|||
128806659|NCT04321031|463588379|FG005|Overall Study|Lost to Follow-up|2|||
128806660|NCT04321031|463588380|FG006|Overall Study|Lost to Follow-up|1|||
128806661|NCT04321031|463588374|FG000|Overall Study|Withdrawal by Subject|2|||
128806662|NCT04321031|463588375|FG001|Overall Study|Withdrawal by Subject|2|||
128806663|NCT04321031|463588376|FG002|Overall Study|Withdrawal by Subject|1|||
128806664|NCT04321031|463588377|FG003|Overall Study|Withdrawal by Subject|3|||
128806665|NCT04321031|463588378|FG004|Overall Study|Withdrawal by Subject|1|||
128806666|NCT04321031|463588379|FG005|Overall Study|Withdrawal by Subject|0|||
128806667|NCT04321031|463588380|FG006|Overall Study|Withdrawal by Subject|1|||
128806668|NCT04321031|463588374|FG000|Overall Study|Non-compliance with study drug|0|||
128806669|NCT04321031|463588375|FG001|Overall Study|Non-compliance with study drug|0|||
128806670|NCT04321031|463588376|FG002|Overall Study|Non-compliance with study drug|0|||
128806671|NCT04321031|463588377|FG003|Overall Study|Non-compliance with study drug|0|||
128806672|NCT04321031|463588378|FG004|Overall Study|Non-compliance with study drug|0|||
128806673|NCT04321031|463588379|FG005|Overall Study|Non-compliance with study drug|1|||
128806674|NCT04321031|463588380|FG006|Overall Study|Non-compliance with study drug|0|||
128806675|NCT04321031|463588374|FG000|Overall Study|Other|0|||
128806676|NCT04321031|463588375|FG001|Overall Study|Other|0|||
128806677|NCT04321031|463588376|FG002|Overall Study|Other|0|||
128806678|NCT04321031|463588377|FG003|Overall Study|Other|1|||
128806679|NCT04321031|463588378|FG004|Overall Study|Other|0|||
128806680|NCT04321031|463588379|FG005|Overall Study|Other|0|||
128806681|NCT04321031|463588380|FG006|Overall Study|Other|0|||
128806682|NCT04237298|463588383|FG000|Overall Study|Lost to Follow-up|4|||
128806683|NCT04237298|463588384|FG001|Overall Study|Lost to Follow-up|5|||
128806684|NCT02530671|463588385|FG000|Overall Study|Lost to Follow-up|2|||
128806685|NCT02530671|463588386|FG001|Overall Study|Lost to Follow-up|0|||
128806686|NCT02530671|463588385|FG000|Overall Study|Withdrawal by Subject|1|||
128806687|NCT02530671|463588386|FG001|Overall Study|Withdrawal by Subject|0|||
128806688|NCT02736409|463588387|FG000|Overall Study|Withdrawal by Subject|4|||
128806689|NCT02736409|463588388|FG001|Overall Study|Withdrawal by Subject|2|||
128806690|NCT02736409|463588389|FG002|Overall Study|Withdrawal by Subject|17|||
128806691|NCT02736409|463588390|FG003|Overall Study|Withdrawal by Subject|3|||
128806692|NCT02736409|463588387|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128806693|NCT02736409|463588388|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128806694|NCT02736409|463588389|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128806695|NCT02736409|463588390|FG003|Overall Study|Non-Compliance with Study Drug|1|||
128806696|NCT02736409|463588387|FG000|Overall Study|Adverse Event|0|||
128806697|NCT02736409|463588388|FG001|Overall Study|Adverse Event|1|||
128806698|NCT02736409|463588389|FG002|Overall Study|Adverse Event|5|||
128806699|NCT02736409|463588390|FG003|Overall Study|Adverse Event|4|||
128806700|NCT02736409|463588387|FG000|Overall Study|Other|0|||
128806701|NCT02736409|463588388|FG001|Overall Study|Other|0|||
128806702|NCT02736409|463588389|FG002|Overall Study|Other|1|||
128806703|NCT02736409|463588390|FG003|Overall Study|Other|1|||
128806704|NCT02736409|463588387|FG000|Overall Study|Pregnancy|0|||
128806705|NCT02736409|463588388|FG001|Overall Study|Pregnancy|0|||
128806706|NCT02736409|463588389|FG002|Overall Study|Pregnancy|1|||
128806707|NCT02736409|463588390|FG003|Overall Study|Pregnancy|0|||
128806708|NCT02736409|463588387|FG000|Overall Study|Lost to Follow-up|0|||
128806709|NCT02736409|463588388|FG001|Overall Study|Lost to Follow-up|0|||
128806710|NCT02736409|463588389|FG002|Overall Study|Lost to Follow-up|2|||
128806711|NCT02736409|463588390|FG003|Overall Study|Lost to Follow-up|1|||
128806712|NCT02736409|463588387|FG000|Overall Study|Physician Decision|0|||
128806713|NCT02736409|463588388|FG001|Overall Study|Physician Decision|0|||
128806714|NCT02736409|463588389|FG002|Overall Study|Physician Decision|0|||
128806715|NCT02736409|463588390|FG003|Overall Study|Physician Decision|2|||
128806716|NCT01415154|463588391|FG000|Overall Study|Lack of Efficacy|4|||
128806717|NCT01415154|463588392|FG001|Overall Study|Lack of Efficacy|5|||
128806718|NCT01415154|463588391|FG000|Overall Study|Withdrawal by Subject|7|||
128806719|NCT01415154|463588392|FG001|Overall Study|Withdrawal by Subject|8|||
128806720|NCT01415154|463588391|FG000|Overall Study|Lost to Follow-up|1|||
128806721|NCT01415154|463588392|FG001|Overall Study|Lost to Follow-up|4|||
128806722|NCT01415154|463588391|FG000|Overall Study|Protocol Violation|0|||
128806723|NCT01415154|463588392|FG001|Overall Study|Protocol Violation|1|||
128806724|NCT01415154|463588391|FG000|Overall Study|Satisfactory Response|0|||
128806725|NCT01415154|463588392|FG001|Overall Study|Satisfactory Response|1|||
128806726|NCT01415154|463588391|FG000|Overall Study|Adverse Event|1|||
128806727|NCT01415154|463588392|FG001|Overall Study|Adverse Event|1|||
128806728|NCT00170573|463588397|FG000|Overall Study|Violation of inclusion criteria|13|||
128806729|NCT05536440|463588412|FG000|Overall Study|Adverse Event|0|||
128806730|NCT05536440|463588413|FG001|Overall Study|Adverse Event|0|||
128806731|NCT05536440|463588414|FG002|Overall Study|Adverse Event|0|||
128806732|NCT05536440|463588415|FG003|Overall Study|Adverse Event|0|||
128806733|NCT05536440|463588416|FG004|Overall Study|Adverse Event|0|||
128806734|NCT05536440|463588417|FG005|Overall Study|Adverse Event|0|||
128806735|NCT05536440|463588418|FG006|Overall Study|Adverse Event|0|||
128806736|NCT05536440|463588419|FG007|Overall Study|Adverse Event|0|||
128806737|NCT05536440|463588420|FG008|Overall Study|Adverse Event|1|||
128806738|NCT06283173|463588421|FG000|Overall Study|Did not show for first visit|10|||
128806739|NCT06283173|463588421|FG000|Overall Study|Lost to Follow-up|12|||
128806740|NCT06283173|463588421|FG000|Overall Study|Physician Decision|7|||
128806741|NCT01580488|463588432|FG000|Overall Study|Withdrawal by Subject|1|||
128806742|NCT04401800|463588435|FG000|Overall Study|Death|17|||
128806743|NCT04401800|463588435|FG000|Overall Study|Lost to Follow-up|5|||
128806744|NCT04401800|463588435|FG000|Overall Study|Withdrawal by Subject|4|||
128806745|NCT03338790|463588441|FG000|Overall Study|Disease Progression|65|||
128806746|NCT03338790|463588442|FG001|Overall Study|Disease Progression|43|||
128806747|NCT03338790|463588443|FG002|Overall Study|Disease Progression|50|||
128806748|NCT03338790|463588444|FG003|Overall Study|Disease Progression|37|||
128806749|NCT03338790|463588441|FG000|Overall Study|Study Drug Toxicity|9|||
128806750|NCT03338790|463588442|FG001|Overall Study|Study Drug Toxicity|8|||
128806751|NCT03338790|463588443|FG002|Overall Study|Study Drug Toxicity|15|||
128806752|NCT03338790|463588444|FG003|Overall Study|Study Drug Toxicity|0|||
128806753|NCT03338790|463588441|FG000|Overall Study|Death|1|||
128806754|NCT03338790|463588442|FG001|Overall Study|Death|1|||
128806755|NCT03338790|463588443|FG002|Overall Study|Death|1|||
128806756|NCT03338790|463588444|FG003|Overall Study|Death|0|||
128806757|NCT03338790|463588441|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
128806758|NCT03338790|463588442|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
128806759|NCT03338790|463588443|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
128806760|NCT03338790|463588444|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
128806761|NCT03338790|463588441|FG000|Overall Study|Participant request to discontinue study treatment|3|||
128806762|NCT03338790|463588442|FG001|Overall Study|Participant request to discontinue study treatment|3|||
128806763|NCT03338790|463588443|FG002|Overall Study|Participant request to discontinue study treatment|2|||
128806764|NCT03338790|463588444|FG003|Overall Study|Participant request to discontinue study treatment|1|||
128806765|NCT03338790|463588441|FG000|Overall Study|Poor/non-compliance|0|||
128806766|NCT03338790|463588442|FG001|Overall Study|Poor/non-compliance|1|||
128806767|NCT03338790|463588443|FG002|Overall Study|Poor/non-compliance|0|||
128806768|NCT03338790|463588444|FG003|Overall Study|Poor/non-compliance|0|||
128806769|NCT03338790|463588441|FG000|Overall Study|Participant withdrew consent|1|||
128806770|NCT03338790|463588442|FG001|Overall Study|Participant withdrew consent|0|||
128806771|NCT03338790|463588443|FG002|Overall Study|Participant withdrew consent|1|||
128806772|NCT03338790|463588444|FG003|Overall Study|Participant withdrew consent|1|||
128806773|NCT03338790|463588441|FG000|Overall Study|Other reasons|0|||
128806774|NCT03338790|463588442|FG001|Overall Study|Other reasons|5|||
128806775|NCT03338790|463588443|FG002|Overall Study|Other reasons|0|||
128806776|NCT03338790|463588444|FG003|Overall Study|Other reasons|2|||
128806777|NCT03338790|463588441|FG000|Overall Study|Not reported|0|||
128806778|NCT03338790|463588442|FG001|Overall Study|Not reported|0|||
128806779|NCT03338790|463588443|FG002|Overall Study|Not reported|1|||
128806780|NCT03338790|463588444|FG003|Overall Study|Not reported|0|||
128806781|NCT03338790|463588441|FG000|Overall Study|Completed treatment period|1|||
128806782|NCT03338790|463588442|FG001|Overall Study|Completed treatment period|2|||
128806783|NCT03338790|463588443|FG002|Overall Study|Completed treatment period|0|||
128806784|NCT03338790|463588444|FG003|Overall Study|Completed treatment period|0|||
128806785|NCT04588298|463588449|FG000|Overall Study|Adverse Event|0|||
128806786|NCT04588298|463588450|FG001|Overall Study|Adverse Event|0|||
128806787|NCT04588298|463588451|FG002|Overall Study|Adverse Event|1|||
128806788|NCT04588298|463588452|FG003|Overall Study|Adverse Event|0|||
128806789|NCT04588298|463588453|FG004|Overall Study|Adverse Event|2|||
128806790|NCT04588298|463588449|FG000|Overall Study|Withdrawal by Subject|1|||
128806791|NCT04588298|463588450|FG001|Overall Study|Withdrawal by Subject|0|||
128806792|NCT04588298|463588451|FG002|Overall Study|Withdrawal by Subject|0|||
128806793|NCT04588298|463588452|FG003|Overall Study|Withdrawal by Subject|1|||
128806794|NCT04588298|463588453|FG004|Overall Study|Withdrawal by Subject|0|||
128806795|NCT03846505|463588454|FG000|Treatment Phase|Withdrawal by Subject|9|||
128806796|NCT03846505|463588455|FG001|Treatment Phase|Withdrawal by Subject|11|||
128806797|NCT03846505|463588454|FG000|Treatment Phase|Lost to Follow-up|6|||
128806798|NCT03846505|463588455|FG001|Treatment Phase|Lost to Follow-up|2|||
128806799|NCT03846505|463588454|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
128806800|NCT03846505|463588455|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
128806801|NCT03846505|463588454|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
128806802|NCT03846505|463588455|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
128806803|NCT04485039|463588456|FG000|TPOXX Only|Adverse Event|2|||
128806804|NCT04485039|463588456|FG000|TPOXX Only|Physician Decision|1|||
128806805|NCT04485039|463588456|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
128806806|NCT04485039|463588456|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
128806807|NCT04005716|463588460|FG000|Overall Study|Death|175|||
128806808|NCT04005716|463588461|FG001|Overall Study|Death|196|||
128806809|NCT04005716|463588460|FG000|Overall Study|Withdrawal by Subject|1|||
128806810|NCT04005716|463588461|FG001|Overall Study|Withdrawal by Subject|6|||
128806811|NCT04005716|463588460|FG000|Overall Study|Lost to Follow-up|2|||
128806812|NCT04005716|463588461|FG001|Overall Study|Lost to Follow-up|2|||
128806813|NCT03135548|463588465|FG000|Overall Study|Lost to Follow-up|3|||
128806814|NCT03135548|463588466|FG001|Overall Study|Lost to Follow-up|0|||
128806815|NCT03135548|463588467|FG002|Overall Study|Lost to Follow-up|0|||
128806816|NCT03135548|463588465|FG000|Overall Study|Withdrawal by Subject|2|||
128806817|NCT03135548|463588466|FG001|Overall Study|Withdrawal by Subject|2|||
128806818|NCT03135548|463588467|FG002|Overall Study|Withdrawal by Subject|1|||
128806819|NCT03135548|463588465|FG000|Overall Study|Other than listed|0|||
128806820|NCT03135548|463588466|FG001|Overall Study|Other than listed|2|||
128806821|NCT03135548|463588467|FG002|Overall Study|Other than listed|2|||
128806822|NCT03445988|463588470|FG000|Overall Study|Lost to Follow-up|14|||
128806823|NCT03445988|463588471|FG001|Overall Study|Lost to Follow-up|26|||
128806824|NCT03445988|463588472|FG002|Overall Study|Lost to Follow-up|27|||
128806825|NCT03445988|463588473|FG003|Overall Study|Lost to Follow-up|66|||
128806826|NCT03445988|463588470|FG000|Overall Study|Withdrawal by Subject|7|||
128806827|NCT03445988|463588471|FG001|Overall Study|Withdrawal by Subject|4|||
128806828|NCT03445988|463588472|FG002|Overall Study|Withdrawal by Subject|3|||
128806829|NCT03445988|463588473|FG003|Overall Study|Withdrawal by Subject|5|||
128806830|NCT03445988|463588470|FG000|Overall Study|Death (unrelated to study)|5|||
128806831|NCT03445988|463588471|FG001|Overall Study|Death (unrelated to study)|1|||
128806832|NCT03445988|463588472|FG002|Overall Study|Death (unrelated to study)|2|||
128806833|NCT03445988|463588473|FG003|Overall Study|Death (unrelated to study)|4|||
128806834|NCT03988608|463588474|FG000|Overall Study|Adverse Event|1|||
128806835|NCT03988608|463588474|FG000|Overall Study|Lost to Follow-up|1|||
128806836|NCT03988608|463588474|FG000|Overall Study|Withdrawal by Subject|3|||
128806837|NCT03988608|463588474|FG000|Overall Study|Death|1|||
128806838|NCT05592418|463588475|FG000|Overall Study|Adverse Event|1|||
128806839|NCT05592418|463588476|FG001|Overall Study|Adverse Event|0|||
128806840|NCT05592418|463588475|FG000|Overall Study|Lost to Follow-up|1|||
128806841|NCT05592418|463588476|FG001|Overall Study|Lost to Follow-up|3|||
128806842|NCT05592418|463588475|FG000|Overall Study|Withdrawal by Subject|2|||
128806843|NCT05592418|463588476|FG001|Overall Study|Withdrawal by Subject|7|||
128806844|NCT04727554|463588477|FG000|Overall Study|Lost to Follow-up|0|||
128806845|NCT04727554|463588478|FG001|Overall Study|Lost to Follow-up|1|||
128806846|NCT04727554|463588477|FG000|Overall Study|Death|2|||
128806847|NCT04727554|463588478|FG001|Overall Study|Death|6|||
128806848|NCT04727554|463588477|FG000|Overall Study|Withdrawal by Subject|1|||
128806849|NCT04727554|463588478|FG001|Overall Study|Withdrawal by Subject|0|||
128806850|NCT03090152|463589641|FG000|Overall Study|Withdrawal by Subject|0|||
128806851|NCT03090152|463589642|FG001|Overall Study|Withdrawal by Subject|2|||
128806852|NCT03090152|463589643|FG002|Overall Study|Withdrawal by Subject|1|||
128806853|NCT03090152|463589641|FG000|Overall Study|Surgery Canceled|1|||
128806854|NCT03090152|463589642|FG001|Overall Study|Surgery Canceled|0|||
128806855|NCT03090152|463589643|FG002|Overall Study|Surgery Canceled|0|||
128806856|NCT03090152|463589641|FG000|Overall Study|Epidural catheter could not be placed|0|||
128806857|NCT03090152|463589642|FG001|Overall Study|Epidural catheter could not be placed|2|||
128806858|NCT03090152|463589643|FG002|Overall Study|Epidural catheter could not be placed|0|||
128806859|NCT02729311|463589644|FG000|Overall Study|Withdrawal by Subject|8|||
128806860|NCT02729311|463589645|FG001|Overall Study|Withdrawal by Subject|2|||
128806861|NCT04783935|463589658|FG000|Overall Study|Withdrawal by Subject|6|||
128806862|NCT04783935|463589658|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
128806863|NCT04783935|463589658|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
128806864|NCT04783935|463589658|FG000|Overall Study|Lost to Follow-up|3|||
128806865|NCT04783935|463589658|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
128806866|NCT04956861|463589663|FG000|Overall Study|Withdrawal by Subject|4|||
128806867|NCT04956861|463589664|FG001|Overall Study|Withdrawal by Subject|4|||
128806868|NCT04956861|463589665|FG002|Overall Study|Withdrawal by Subject|2|||
128806869|NCT04956861|463589663|FG000|Overall Study|Physician Decision|4|||
128806870|NCT04956861|463589664|FG001|Overall Study|Physician Decision|5|||
128806871|NCT04956861|463589665|FG002|Overall Study|Physician Decision|1|||
128806872|NCT05337748|463589669|FG000|Overall Study|Withdrawal by Subject|1|||
128806873|NCT05337748|463589670|FG001|Overall Study|Withdrawal by Subject|0|||
128806874|NCT05337748|463589669|FG000|Overall Study|Death|1|||
128806875|NCT05337748|463589670|FG001|Overall Study|Death|0|||
128806876|NCT04806594|463589671|FG000|Overall Study|Withdrawal by Subject|2|||
128806877|NCT04806594|463589671|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
128806878|NCT02543281|463589672|FG000|Overall Study|Lost to Follow-up|0|||
128806879|NCT02543281|463589673|FG001|Overall Study|Lost to Follow-up|0|||
128806880|NCT02543281|463589674|FG002|Overall Study|Lost to Follow-up|1|||
128806881|NCT03143153|463589675|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
128806882|NCT03143153|463589676|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
128806883|NCT03143153|463589677|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
128806884|NCT03143153|463589675|FG000|Pre-Treatment|Participant withdrew consent|0|||
128806885|NCT03143153|463589676|FG001|Pre-Treatment|Participant withdrew consent|1|||
128806886|NCT03143153|463589677|FG002|Pre-Treatment|Participant withdrew consent|12|||
128806887|NCT03143153|463589675|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
128806888|NCT03143153|463589676|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
128806889|NCT03143153|463589677|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
128806890|NCT03143153|463589675|FG000|Pre-Treatment|Other Reasons|1|||
128806891|NCT03143153|463589676|FG001|Pre-Treatment|Other Reasons|2|||
128806892|NCT03143153|463589677|FG002|Pre-Treatment|Other Reasons|1|||
128806893|NCT03143153|463589675|FG000|Pre-Treatment|Disease Progression|1|||
128806894|NCT03143153|463589676|FG001|Pre-Treatment|Disease Progression|1|||
128806895|NCT03143153|463589677|FG002|Pre-Treatment|Disease Progression|2|||
128806896|NCT03143153|463589675|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
128806897|NCT03143153|463589676|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
128806898|NCT03143153|463589677|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
128806899|NCT03143153|463589675|FG000|Treatment|Disease progression|174|||
128806900|NCT03143153|463589676|FG001|Treatment|Disease progression|184|||
128806901|NCT03143153|463589677|FG002|Treatment|Disease progression|193|||
128806902|NCT03143153|463589675|FG000|Treatment|Study drug toxicity|59|||
128806903|NCT03143153|463589676|FG001|Treatment|Study drug toxicity|33|||
128806904|NCT03143153|463589677|FG002|Treatment|Study drug toxicity|40|||
128806905|NCT03143153|463589675|FG000|Treatment|Death|5|||
128806906|NCT03143153|463589676|FG001|Treatment|Death|3|||
128806907|NCT03143153|463589677|FG002|Treatment|Death|4|||
128806908|NCT03143153|463589675|FG000|Treatment|Adverse event unrelated to study drug|19|||
128806909|NCT03143153|463589676|FG001|Treatment|Adverse event unrelated to study drug|28|||
128806910|NCT03143153|463589677|FG002|Treatment|Adverse event unrelated to study drug|12|||
128806911|NCT03143153|463589675|FG000|Treatment|Participant request to discontinue study treatment|13|||
128806912|NCT03143153|463589676|FG001|Treatment|Participant request to discontinue study treatment|15|||
128806913|NCT03143153|463589677|FG002|Treatment|Participant request to discontinue study treatment|20|||
128806914|NCT03143153|463589675|FG000|Treatment|Participant withdrew consent|3|||
128806915|NCT03143153|463589676|FG001|Treatment|Participant withdrew consent|4|||
128806916|NCT03143153|463589677|FG002|Treatment|Participant withdrew consent|12|||
128806917|NCT03143153|463589675|FG000|Treatment|Pregnancy|1|||
128806918|NCT03143153|463589676|FG001|Treatment|Pregnancy|0|||
128806919|NCT03143153|463589677|FG002|Treatment|Pregnancy|0|||
128806920|NCT03143153|463589675|FG000|Treatment|Maximum clinical benefit|1|||
128806921|NCT03143153|463589676|FG001|Treatment|Maximum clinical benefit|3|||
128806922|NCT03143153|463589677|FG002|Treatment|Maximum clinical benefit|4|||
128806923|NCT03143153|463589675|FG000|Treatment|Completed treatment as per Protocol|13|||
128806924|NCT03143153|463589676|FG001|Treatment|Completed treatment as per Protocol|8|||
128806925|NCT03143153|463589677|FG002|Treatment|Completed treatment as per Protocol|0|||
128806926|NCT03143153|463589675|FG000|Treatment|Other reasons|12|||
128806927|NCT03143153|463589676|FG001|Treatment|Other reasons|7|||
128806928|NCT03143153|463589677|FG002|Treatment|Other reasons|15|||
128806929|NCT03143153|463589675|FG000|Treatment|Not reported|1|||
128806930|NCT03143153|463589676|FG001|Treatment|Not reported|0|||
128806931|NCT03143153|463589677|FG002|Treatment|Not reported|0|||
128806932|NCT02312557|463589678|FG000|Overall Study|Survival follow-up|4|||
128806933|NCT04784559|463589680|FG000|Overall Study|Withdrawal by Subject|3|||
128806934|NCT04784559|463589681|FG001|Overall Study|Withdrawal by Subject|2|||
128806935|NCT04784559|463589682|FG002|Overall Study|Withdrawal by Subject|1|||
128806936|NCT04784559|463589680|FG000|Overall Study|Death|2|||
128806937|NCT04784559|463589681|FG001|Overall Study|Death|1|||
128806938|NCT04784559|463589682|FG002|Overall Study|Death|2|||
128806939|NCT04784559|463589680|FG000|Overall Study|Lost to Follow-up|0|||
128806940|NCT04784559|463589681|FG001|Overall Study|Lost to Follow-up|0|||
128806941|NCT04784559|463589682|FG002|Overall Study|Lost to Follow-up|2|||
128806942|NCT04784559|463589680|FG000|Overall Study|Participant worsened, PI decision|1|||
128806943|NCT04784559|463589681|FG001|Overall Study|Participant worsened, PI decision|0|||
128806944|NCT04784559|463589682|FG002|Overall Study|Participant worsened, PI decision|0|||
128806945|NCT04784559|463589680|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
128806946|NCT04784559|463589681|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
128806947|NCT04784559|463589682|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
128806948|NCT04784559|463589680|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
128806949|NCT04784559|463589681|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
128806950|NCT04784559|463589682|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
128806951|NCT04784559|463589680|FG000|Overall Study|Did not meet all inclusion criteria|0|||
128806952|NCT04784559|463589681|FG001|Overall Study|Did not meet all inclusion criteria|1|||
128806953|NCT04784559|463589682|FG002|Overall Study|Did not meet all inclusion criteria|0|||
128806954|NCT04784559|463589680|FG000|Overall Study|The participant was transferred to IRCU|0|||
128806955|NCT04784559|463589681|FG001|Overall Study|The participant was transferred to IRCU|1|||
128806956|NCT04784559|463589682|FG002|Overall Study|The participant was transferred to IRCU|0|||
128806957|NCT04784559|463589680|FG000|Overall Study|SAE|0|||
128806958|NCT04784559|463589681|FG001|Overall Study|SAE|1|||
128806959|NCT04784559|463589682|FG002|Overall Study|SAE|0|||
128806960|NCT04784559|463589680|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
128806961|NCT04784559|463589681|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
128806962|NCT04784559|463589682|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
128806963|NCT04021602|463589688|FG000|Overall Study|Lost to Follow-up|3|||
128806964|NCT04021602|463589689|FG001|Overall Study|Lost to Follow-up|3|||
128806965|NCT04021602|463589690|FG002|Overall Study|Lost to Follow-up|1|||
128806966|NCT04021602|463589688|FG000|Overall Study|Adverse Event|1|||
128806967|NCT04021602|463589689|FG001|Overall Study|Adverse Event|0|||
128806968|NCT04021602|463589690|FG002|Overall Study|Adverse Event|1|||
128806969|NCT02120456|463589691|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806970|NCT02120456|463589692|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806971|NCT02120456|463589693|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806972|NCT02120456|463589694|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806973|NCT02120456|463589695|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806974|NCT02120456|463589696|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806975|NCT02120456|463589697|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
128806976|NCT02120456|463589698|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806977|NCT02120456|463589699|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
128806978|NCT02120456|463589691|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806979|NCT02120456|463589692|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806980|NCT02120456|463589693|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806981|NCT02120456|463589694|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806982|NCT02120456|463589695|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806983|NCT02120456|463589696|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806984|NCT02120456|463589697|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
128806985|NCT02120456|463589698|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806986|NCT02120456|463589699|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
128806987|NCT02120456|463589691|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806988|NCT02120456|463589692|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806989|NCT02120456|463589693|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806990|NCT02120456|463589694|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806991|NCT02120456|463589695|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806992|NCT02120456|463589696|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806993|NCT02120456|463589697|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806994|NCT02120456|463589698|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
128806995|NCT02120456|463589699|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
128806996|NCT02689284|463589706|FG000|Overall Study|Adverse Event|1|||
128806997|NCT02689284|463589707|FG001|Overall Study|Adverse Event|8|||
128806998|NCT02689284|463589706|FG000|Overall Study|Death|0|||
128806999|NCT02689284|463589707|FG001|Overall Study|Death|1|||
128807000|NCT02689284|463589706|FG000|Overall Study|Physician Decision|1|||
128807001|NCT02689284|463589707|FG001|Overall Study|Physician Decision|2|||
128807002|NCT02689284|463589706|FG000|Overall Study|Withdrawal by Subject|0|||
128807003|NCT02689284|463589707|FG001|Overall Study|Withdrawal by Subject|1|||
128807004|NCT02689284|463589706|FG000|Overall Study|progression of cancer|1|||
128807005|NCT02689284|463589707|FG001|Overall Study|progression of cancer|72|||
128807006|NCT02689284|463589706|FG000|Overall Study|decreased heart function|0|||
128807007|NCT02689284|463589707|FG001|Overall Study|decreased heart function|1|||
128807008|NCT02689284|463589706|FG000|Overall Study|concern for anemia|0|||
128807009|NCT02689284|463589707|FG001|Overall Study|concern for anemia|1|||
128807010|NCT02689284|463589706|FG000|Overall Study|no measurable cancer for evaluation|0|||
128807011|NCT02689284|463589707|FG001|Overall Study|no measurable cancer for evaluation|1|||
128807012|NCT05569252|463589710|FG000|Overall Study|Adverse event (central vision loss)|1|||
128807013|NCT05569252|463589711|FG001|Overall Study|Adverse event (central vision loss)|0|||
128807014|NCT05569252|463589712|FG002|Overall Study|Adverse event (central vision loss)|0|||
128807015|NCT05569252|463589713|FG003|Overall Study|Adverse event (central vision loss)|0|||
128807016|NCT03665597|463589714|FG000|Period 1|Adverse Event|1|||
128807017|NCT03665597|463589715|FG001|Period 1|Adverse Event|0|||
128807018|NCT03665597|463589716|FG002|Period 1|Adverse Event|0|||
128807019|NCT03665597|463589717|FG003|Period 1|Adverse Event|1|||
128807020|NCT03665597|463589718|FG004|Period 1|Adverse Event|0|||
128807021|NCT03665597|463589719|FG005|Period 1|Adverse Event|0|||
128807022|NCT03665597|463589720|FG006|Period 1|Adverse Event|0|||
128807023|NCT03665597|463589714|FG000|Period 1|Screen Failure|0|||
128807024|NCT03665597|463589715|FG001|Period 1|Screen Failure|0|||
128807025|NCT03665597|463589716|FG002|Period 1|Screen Failure|0|||
128807026|NCT03665597|463589717|FG003|Period 1|Screen Failure|1|||
128807027|NCT03665597|463589718|FG004|Period 1|Screen Failure|0|||
128807028|NCT03665597|463589719|FG005|Period 1|Screen Failure|0|||
128807029|NCT03665597|463589720|FG006|Period 1|Screen Failure|0|||
128807030|NCT03665597|463589714|FG000|Period 1|Death|0|||
128807031|NCT03665597|463589715|FG001|Period 1|Death|0|||
128807032|NCT03665597|463589716|FG002|Period 1|Death|0|||
128807033|NCT03665597|463589717|FG003|Period 1|Death|0|||
128807034|NCT03665597|463589718|FG004|Period 1|Death|0|||
128807035|NCT03665597|463589719|FG005|Period 1|Death|0|||
128807036|NCT03665597|463589720|FG006|Period 1|Death|45|||
128807037|NCT03665597|463589714|FG000|Period 1|Withdrawal by Subject|0|||
128807038|NCT03665597|463589715|FG001|Period 1|Withdrawal by Subject|0|||
128807039|NCT03665597|463589716|FG002|Period 1|Withdrawal by Subject|0|||
128807040|NCT03665597|463589717|FG003|Period 1|Withdrawal by Subject|0|||
128807041|NCT03665597|463589718|FG004|Period 1|Withdrawal by Subject|0|||
128807042|NCT03665597|463589719|FG005|Period 1|Withdrawal by Subject|0|||
128807043|NCT03665597|463589720|FG006|Period 1|Withdrawal by Subject|5|||
128807044|NCT03665597|463589714|FG000|Period 2|Adverse Event|0|||
128807045|NCT03665597|463589715|FG001|Period 2|Adverse Event|0|||
128807046|NCT03665597|463589716|FG002|Period 2|Adverse Event|0|||
128807047|NCT03665597|463589717|FG003|Period 2|Adverse Event|0|||
128807048|NCT03665597|463589718|FG004|Period 2|Adverse Event|0|||
128807049|NCT03665597|463589719|FG005|Period 2|Adverse Event|1|||
128807050|NCT03665597|463589720|FG006|Period 2|Adverse Event|0|||
128807051|NCT03665597|463589714|FG000|Period 3|Adverse Event|0|||
128807052|NCT03665597|463589715|FG001|Period 3|Adverse Event|1|||
128807053|NCT03665597|463589716|FG002|Period 3|Adverse Event|0|||
128807054|NCT03665597|463589717|FG003|Period 3|Adverse Event|0|||
128807055|NCT03665597|463589718|FG004|Period 3|Adverse Event|0|||
128807056|NCT03665597|463589719|FG005|Period 3|Adverse Event|0|||
128807057|NCT03665597|463589720|FG006|Period 3|Adverse Event|0|||
128807058|NCT03665597|463589714|FG000|Period 3|Death|0|||
128807059|NCT03665597|463589715|FG001|Period 3|Death|0|||
128807060|NCT03665597|463589716|FG002|Period 3|Death|0|||
128807061|NCT03665597|463589717|FG003|Period 3|Death|0|||
128807062|NCT03665597|463589718|FG004|Period 3|Death|1|||
128807063|NCT03665597|463589719|FG005|Period 3|Death|0|||
128807064|NCT03665597|463589720|FG006|Period 3|Death|0|||
128807065|NCT03665597|463589714|FG000|Period 4|Adverse Event|2|||
128807066|NCT03665597|463589715|FG001|Period 4|Adverse Event|2|||
128807067|NCT03665597|463589716|FG002|Period 4|Adverse Event|2|||
128807068|NCT03665597|463589717|FG003|Period 4|Adverse Event|2|||
128807069|NCT03665597|463589718|FG004|Period 4|Adverse Event|1|||
128807070|NCT03665597|463589719|FG005|Period 4|Adverse Event|0|||
128807071|NCT03665597|463589720|FG006|Period 4|Adverse Event|0|||
128807072|NCT03665597|463589714|FG000|Period 4|Death|0|||
128807073|NCT03665597|463589715|FG001|Period 4|Death|0|||
128807074|NCT03665597|463589716|FG002|Period 4|Death|2|||
128807075|NCT03665597|463589717|FG003|Period 4|Death|0|||
128807076|NCT03665597|463589718|FG004|Period 4|Death|0|||
128807077|NCT03665597|463589719|FG005|Period 4|Death|0|||
128807078|NCT03665597|463589720|FG006|Period 4|Death|0|||
128807079|NCT03665597|463589714|FG000|Period 4|Physician Decision|1|||
128807080|NCT03665597|463589715|FG001|Period 4|Physician Decision|2|||
128807081|NCT03665597|463589716|FG002|Period 4|Physician Decision|0|||
128807082|NCT03665597|463589717|FG003|Period 4|Physician Decision|0|||
128807083|NCT03665597|463589718|FG004|Period 4|Physician Decision|0|||
128807084|NCT03665597|463589719|FG005|Period 4|Physician Decision|0|||
128807085|NCT03665597|463589720|FG006|Period 4|Physician Decision|0|||
128807086|NCT03110315|463589723|FG000|Overall Study|Withdrawal by Subject|1|||
128807087|NCT03110315|463589724|FG001|Overall Study|Withdrawal by Subject|0|||
128807088|NCT05371652|463589728|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
128807089|NCT05371652|463589728|FG000|Overall Study|Withdrawal by Subject|12|||
128807090|NCT05371652|463589728|FG000|Overall Study|Adverse Event|1|||
128807091|NCT05371652|463589728|FG000|Overall Study|Other|11|||
128807092|NCT04410042|463589729|FG000|Overall Study|Not Eligible|1|||
128807093|NCT04410042|463589730|FG001|Overall Study|Not Eligible|1|||
128807094|NCT03720795|463589733|FG000|Phase 1|Lost to Follow-up|4|||
128807095|NCT03720795|463589733|FG000|Phase 1|Withdrawal by Subject|6|||
128807096|NCT03720795|463589733|FG000|Phase 1|Protocol Violation|1|||
128807097|NCT03720795|463589733|FG000|Phase 1|Other|1|||
128807098|NCT03720795|463589733|FG000|Phase 2|Lost to Follow-up|5|||
128807099|NCT03720795|463589733|FG000|Phase 2|Withdrawal by Subject|10|||
128807100|NCT03720795|463589733|FG000|Phase 2|Protocol Violation|2|||
128807101|NCT03720795|463589733|FG000|3 Month Follow Up|Lost to Follow-up|2|||
128807102|NCT05134233|463589734|FG000|Overall Study|Pregnancy|1|||
128807103|NCT05134233|463589734|FG000|Overall Study|MEP value too low|2|||
128807104|NCT05134233|463589734|FG000|Overall Study|Lost to Follow-up|1|||
128807105|NCT02724631|463589737|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
128807106|NCT04763265|463589738|FG000|Overall Study|Adverse Event|1|||
128807107|NCT04763265|463589739|FG001|Overall Study|Adverse Event|0|||
128807108|NCT04763265|463589738|FG000|Overall Study|Lost to Follow-up|2|||
128807109|NCT04763265|463589739|FG001|Overall Study|Lost to Follow-up|4|||
128807110|NCT04763265|463589738|FG000|Overall Study|Withdrawal by Subject|0|||
128807111|NCT04763265|463589739|FG001|Overall Study|Withdrawal by Subject|1|||
128807112|NCT05609760|463589755|FG000|Overall Study|Lost to Follow-up|0|||
128807113|NCT05609760|463589756|FG001|Overall Study|Lost to Follow-up|1|||
128807114|NCT05609760|463589755|FG000|Overall Study|Withdrawal by Subject|1|||
128807115|NCT05609760|463589756|FG001|Overall Study|Withdrawal by Subject|0|||
128807116|NCT04049643|463589757|FG000|Overall Study|Lack of Efficacy|1|||
128807117|NCT04049643|463589758|FG001|Overall Study|Lack of Efficacy|1|||
128807118|NCT04049643|463589759|FG002|Overall Study|Lack of Efficacy|0|||
128807119|NCT04049643|463589757|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
128807120|NCT04049643|463589758|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
128807121|NCT04049643|463589759|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
128807122|NCT05089734|463589760|FG000|Overall Study|Still on study|122|||
128807123|NCT05089734|463589761|FG001|Overall Study|Still on study|101|||
128807124|NCT05089734|463589760|FG000|Overall Study|Death|161|||
128807125|NCT05089734|463589761|FG001|Overall Study|Death|179|||
128807126|NCT05089734|463589760|FG000|Overall Study|Withdrew consent|11|||
128807127|NCT05089734|463589761|FG001|Overall Study|Withdrew consent|24|||
128807128|NCT05089734|463589760|FG000|Overall Study|Lost to Follow-up|5|||
128807129|NCT05089734|463589761|FG001|Overall Study|Lost to Follow-up|0|||
128807130|NCT05302596|463589762|FG000|Overall Study|Withdrawal by Subject|1|||
128807131|NCT05302596|463589763|FG001|Overall Study|Withdrawal by Subject|1|||
128807132|NCT04060355|463591285|FG000|Overall Study|Lost to Follow-up|41|||
128807133|NCT01140880|463591286|FG000|Overall Study|Death|0|||
128807134|NCT01140880|463591287|FG001|Overall Study|Death|1|||
128807135|NCT01140880|463591286|FG000|Overall Study|Withdrawal by Subject|6|||
128807136|NCT01140880|463591287|FG001|Overall Study|Withdrawal by Subject|3|||
128807137|NCT01140880|463591286|FG000|Overall Study|Lost to Follow-up|8|||
128807138|NCT01140880|463591287|FG001|Overall Study|Lost to Follow-up|10|||
128807139|NCT01140880|463591286|FG000|Overall Study|Protocol Violation|0|||
128807140|NCT01140880|463591287|FG001|Overall Study|Protocol Violation|30|||
128807141|NCT03376321|463591290|FG000|Overall Study|Other|5|||
128807142|NCT03376321|463591291|FG001|Overall Study|Other|1|||
128807143|NCT03376321|463591290|FG000|Overall Study|Withdrawal by Subject|8|||
128807144|NCT03376321|463591291|FG001|Overall Study|Withdrawal by Subject|14|||
128807145|NCT03376321|463591290|FG000|Overall Study|Lost to Follow-up|1|||
128807146|NCT03376321|463591291|FG001|Overall Study|Lost to Follow-up|7|||
128807147|NCT03376321|463591290|FG000|Overall Study|Death|4|||
128807148|NCT03376321|463591291|FG001|Overall Study|Death|0|||
128807149|NCT03376321|463591290|FG000|Overall Study|Randomized, not treated|5|||
128807150|NCT03376321|463591291|FG001|Overall Study|Randomized, not treated|3|||
128807151|NCT02671903|463591292|FG000|Period 0 (Run-In)|Death|0|||
128807152|NCT02671903|463591293|FG001|Period 0 (Run-In)|Death|0|||
128807153|NCT02671903|463591294|FG002|Period 0 (Run-In)|Death|3|||
128807154|NCT02671903|463591292|FG000|Period 0 (Run-In)|Physician Decision|0|||
128807155|NCT02671903|463591293|FG001|Period 0 (Run-In)|Physician Decision|0|||
128807156|NCT02671903|463591294|FG002|Period 0 (Run-In)|Physician Decision|4|||
128807157|NCT02671903|463591292|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
128807158|NCT02671903|463591293|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
128807159|NCT02671903|463591294|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
128807160|NCT02671903|463591292|FG000|Period 0 (Run-In)|Protocol Violation|0|||
128807161|NCT02671903|463591293|FG001|Period 0 (Run-In)|Protocol Violation|0|||
128807162|NCT02671903|463591294|FG002|Period 0 (Run-In)|Protocol Violation|1|||
128807163|NCT02671903|463591292|FG000|Period 0 (Run-In)|Adverse Event|0|||
128807164|NCT02671903|463591293|FG001|Period 0 (Run-In)|Adverse Event|0|||
128807165|NCT02671903|463591294|FG002|Period 0 (Run-In)|Adverse Event|1|||
128807166|NCT02671903|463591292|FG000|Period 0 (Run-In)|Implantation Failure|0|||
128807167|NCT02671903|463591293|FG001|Period 0 (Run-In)|Implantation Failure|0|||
128807168|NCT02671903|463591294|FG002|Period 0 (Run-In)|Implantation Failure|2|||
128807169|NCT02671903|463591292|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
128807170|NCT02671903|463591293|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
128807171|NCT02671903|463591294|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
128807172|NCT02992925|463591299|FG000|Cohort 2|Physician Decision|0|||
128807173|NCT02992925|463591300|FG001|Cohort 2|Physician Decision|0|||
128807174|NCT02992925|463591301|FG002|Cohort 2|Physician Decision|1|||
128807175|NCT02992925|463591302|FG003|Cohort 2|Physician Decision|0|||
128807176|NCT02992925|463591299|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
128807177|NCT02992925|463591300|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
128807178|NCT02992925|463591301|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
128807179|NCT02992925|463591302|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
128807180|NCT03779204|463591303|FG000|Overall Study|Lost to Follow-up|2|||
128807181|NCT03779204|463591304|FG001|Overall Study|Lost to Follow-up|0|||
128807182|NCT04150718|463591305|FG000|Overall Study|Withdrawal by Subject|2|||
128807183|NCT04150718|463591306|FG001|Overall Study|Withdrawal by Subject|7|||
128807184|NCT04150718|463591307|FG002|Overall Study|Withdrawal by Subject|1|||
128807185|NCT04150718|463591305|FG000|Overall Study|Lost to Follow-up|1|||
128807186|NCT04150718|463591306|FG001|Overall Study|Lost to Follow-up|2|||
128807187|NCT04150718|463591307|FG002|Overall Study|Lost to Follow-up|0|||
128807188|NCT04150718|463591305|FG000|Overall Study|Ineligible|1|||
128807189|NCT04150718|463591306|FG001|Overall Study|Ineligible|0|||
128807190|NCT04150718|463591307|FG002|Overall Study|Ineligible|10|||
128807191|NCT04258709|463591308|FG000|Overall Study|Lost to Follow-up|10|||
128807192|NCT04258709|463591309|FG001|Overall Study|Lost to Follow-up|4|||
128807193|NCT04258709|463591308|FG000|Overall Study|Withdrawal by Subject|1|||
128807194|NCT04258709|463591309|FG001|Overall Study|Withdrawal by Subject|0|||
128807195|NCT04258709|463591308|FG000|Overall Study|Fetal demise|0|||
128807196|NCT04258709|463591309|FG001|Overall Study|Fetal demise|1|||
128807197|NCT04258709|463591308|FG000|Overall Study|Protocol Violation|1|||
128807198|NCT04258709|463591309|FG001|Overall Study|Protocol Violation|1|||
128807199|NCT04034251|463591310|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
128807200|NCT04034251|463591311|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
128807201|NCT04034251|463591312|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
128807202|NCT06074523|463591313|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
128807203|NCT06074523|463591313|FG000|Overall Study|Withdrawal by Subject|1|||
128807204|NCT05273749|463591314|FG000|Overall Study|Adverse Event|14|||
128807205|NCT05273749|463591315|FG001|Overall Study|Adverse Event|8|||
128807206|NCT05273749|463591314|FG000|Overall Study|Lack of Efficacy|2|||
128807207|NCT05273749|463591315|FG001|Overall Study|Lack of Efficacy|8|||
128807208|NCT05273749|463591314|FG000|Overall Study|Physician Decision|0|||
128807209|NCT05273749|463591315|FG001|Overall Study|Physician Decision|2|||
128807210|NCT05273749|463591314|FG000|Overall Study|Withdrawal by Subject|14|||
128807211|NCT05273749|463591315|FG001|Overall Study|Withdrawal by Subject|16|||
128807212|NCT05273749|463591314|FG000|Overall Study|Lost to Follow-up|10|||
128807213|NCT05273749|463591315|FG001|Overall Study|Lost to Follow-up|10|||
128807214|NCT05273749|463591314|FG000|Overall Study|Pregnancy|1|||
128807215|NCT05273749|463591315|FG001|Overall Study|Pregnancy|0|||
128807216|NCT05273749|463591314|FG000|Overall Study|Non-Compliance|3|||
128807217|NCT05273749|463591315|FG001|Overall Study|Non-Compliance|2|||
128807218|NCT05273749|463591314|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
128807219|NCT05273749|463591315|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
128807220|NCT05563246|463591322|FG000|Overall Study|Withdrawal by Subject|1|||
128807221|NCT05563246|463591323|FG001|Overall Study|Withdrawal by Subject|2|||
128807222|NCT05563246|463591324|FG002|Overall Study|Withdrawal by Subject|0|||
128807223|NCT05563246|463591325|FG003|Overall Study|Withdrawal by Subject|0|||
128807224|NCT05563246|463591322|FG000|Overall Study|Protocol Deviation|0|||
128807225|NCT05563246|463591323|FG001|Overall Study|Protocol Deviation|1|||
128807226|NCT05563246|463591324|FG002|Overall Study|Protocol Deviation|0|||
128807227|NCT05563246|463591325|FG003|Overall Study|Protocol Deviation|0|||
128807228|NCT05563246|463591322|FG000|Overall Study|Physician Decision|0|||
128807229|NCT05563246|463591323|FG001|Overall Study|Physician Decision|1|||
128807230|NCT05563246|463591324|FG002|Overall Study|Physician Decision|0|||
128807231|NCT05563246|463591325|FG003|Overall Study|Physician Decision|0|||
128807232|NCT05563246|463591322|FG000|Overall Study|Adverse Event|0|||
128807233|NCT05563246|463591323|FG001|Overall Study|Adverse Event|0|||
128807234|NCT05563246|463591324|FG002|Overall Study|Adverse Event|2|||
128807235|NCT05563246|463591325|FG003|Overall Study|Adverse Event|0|||
128807236|NCT05563246|463591322|FG000|Overall Study|Lost to Follow-up|0|||
128807237|NCT05563246|463591323|FG001|Overall Study|Lost to Follow-up|0|||
128807238|NCT05563246|463591324|FG002|Overall Study|Lost to Follow-up|1|||
128807239|NCT05563246|463591325|FG003|Overall Study|Lost to Follow-up|0|||
128807240|NCT01416831|463591327|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
128807241|NCT01416831|463591328|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
128807242|NCT05215314|463591329|FG000|Overall Study|Lost to Follow-up|2|||
128807243|NCT05215314|463591330|FG001|Overall Study|Lost to Follow-up|2|||
128807244|NCT05215314|463591329|FG000|Overall Study|Withdrawal by Subject|2|||
128807245|NCT05215314|463591330|FG001|Overall Study|Withdrawal by Subject|0|||
128807246|NCT05215314|463591329|FG000|Overall Study|Physician Decision|1|||
128807247|NCT05215314|463591330|FG001|Overall Study|Physician Decision|0|||
128807248|NCT04294225|463591331|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
128807249|NCT04294225|463591331|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
128807250|NCT04294225|463591331|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
128807251|NCT04294225|463591331|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
128807252|NCT04294225|463591331|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
128807253|NCT04812535|463591333|FG000|Overall Study|Withdrawal by Subject|0|||
128807254|NCT04812535|463591334|FG001|Overall Study|Withdrawal by Subject|0|||
128807255|NCT04812535|463591335|FG002|Overall Study|Withdrawal by Subject|0|||
128807256|NCT04812535|463591336|FG003|Overall Study|Withdrawal by Subject|1|||
128807257|NCT04812535|463591333|FG000|Overall Study|Death|7|||
128807258|NCT04812535|463591334|FG001|Overall Study|Death|2|||
128807259|NCT04812535|463591335|FG002|Overall Study|Death|4|||
128807260|NCT04812535|463591336|FG003|Overall Study|Death|1|||
128807261|NCT04812535|463591333|FG000|Overall Study|Due to premature study termination by sponsor|2|||
128807262|NCT04812535|463591334|FG001|Overall Study|Due to premature study termination by sponsor|0|||
128807263|NCT04812535|463591335|FG002|Overall Study|Due to premature study termination by sponsor|1|||
128807264|NCT04812535|463591336|FG003|Overall Study|Due to premature study termination by sponsor|3|||
128807265|NCT03436745|463591337|FG000|Overall Study|Ineligible|0|||
128807266|NCT03436745|463591338|FG001|Overall Study|Ineligible|0|||
128807267|NCT03436745|463591339|FG002|Overall Study|Ineligible|1|||
128807268|NCT03336333|463591340|FG000|Overall Study|Remained on study at time of data cut-off|202|||
128807269|NCT03336333|463591341|FG001|Overall Study|Remained on study at time of data cut-off|219|||
128807270|NCT03336333|463591342|FG002|Overall Study|Remained on study at time of data cut-off|102|||
128807271|NCT03336333|463591340|FG000|Overall Study|Death|14|||
128807272|NCT03336333|463591341|FG001|Overall Study|Death|16|||
128807273|NCT03336333|463591342|FG002|Overall Study|Death|8|||
128807274|NCT03336333|463591340|FG000|Overall Study|Withdrawal by Subject|16|||
128807275|NCT03336333|463591341|FG001|Overall Study|Withdrawal by Subject|5|||
128807276|NCT03336333|463591342|FG002|Overall Study|Withdrawal by Subject|1|||
128807277|NCT03336333|463591340|FG000|Overall Study|Physician Decision|5|||
128807278|NCT03336333|463591341|FG001|Overall Study|Physician Decision|1|||
128807279|NCT03336333|463591342|FG002|Overall Study|Physician Decision|0|||
128807280|NCT03336333|463591340|FG000|Overall Study|Lost to Follow-up|1|||
128807281|NCT03336333|463591341|FG001|Overall Study|Lost to Follow-up|0|||
128807282|NCT03336333|463591342|FG002|Overall Study|Lost to Follow-up|0|||
128807283|NCT03673111|463591347|FG000|Overall Study|Protocol Violation|0|||
128807284|NCT03673111|463591348|FG001|Overall Study|Protocol Violation|0|||
128807285|NCT03673111|463591349|FG002|Overall Study|Protocol Violation|0|||
128807286|NCT03673111|463591350|FG003|Overall Study|Protocol Violation|0|||
128807287|NCT03673111|463591351|FG004|Overall Study|Protocol Violation|0|||
128807288|NCT03673111|463591352|FG005|Overall Study|Protocol Violation|0|||
128807289|NCT03673111|463591353|FG006|Overall Study|Protocol Violation|0|||
128807290|NCT03673111|463591354|FG007|Overall Study|Protocol Violation|0|||
128807291|NCT03673111|463591355|FG008|Overall Study|Protocol Violation|0|||
128807292|NCT03673111|463591356|FG009|Overall Study|Protocol Violation|0|||
128807293|NCT03673111|463591357|FG010|Overall Study|Protocol Violation|1|||
128807294|NCT03673111|463591358|FG011|Overall Study|Protocol Violation|0|||
128807295|NCT03673111|463591359|FG012|Overall Study|Protocol Violation|0|||
128807296|NCT03673111|463591360|FG013|Overall Study|Protocol Violation|0|||
128807297|NCT03673111|463591347|FG000|Overall Study|Adverse Event|1|||
128807298|NCT03673111|463591348|FG001|Overall Study|Adverse Event|0|||
128807299|NCT03673111|463591349|FG002|Overall Study|Adverse Event|0|||
128807300|NCT03673111|463591350|FG003|Overall Study|Adverse Event|0|||
128807301|NCT03673111|463591351|FG004|Overall Study|Adverse Event|0|||
128807302|NCT03673111|463591352|FG005|Overall Study|Adverse Event|0|||
128807303|NCT03673111|463591353|FG006|Overall Study|Adverse Event|0|||
128807304|NCT03673111|463591354|FG007|Overall Study|Adverse Event|0|||
128807305|NCT03673111|463591355|FG008|Overall Study|Adverse Event|0|||
128807306|NCT03673111|463591356|FG009|Overall Study|Adverse Event|0|||
128807307|NCT03673111|463591357|FG010|Overall Study|Adverse Event|0|||
128807308|NCT03673111|463591358|FG011|Overall Study|Adverse Event|0|||
128807309|NCT03673111|463591359|FG012|Overall Study|Adverse Event|0|||
128807310|NCT03673111|463591360|FG013|Overall Study|Adverse Event|0|||
128807311|NCT03792555|463591363|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
128807312|NCT03792555|463591364|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
128807313|NCT03792555|463591365|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
128807314|NCT03792555|463591363|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
128807315|NCT03792555|463591364|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
128807316|NCT03792555|463591365|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
128807317|NCT03792555|463591363|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
128807318|NCT03792555|463591364|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
128807319|NCT03792555|463591365|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
128807320|NCT03623321|463591366|FG000|Overall Study|Adverse Event|32|||
128807321|NCT03623321|463591366|FG000|Overall Study|Death|9|||
128807322|NCT03623321|463591366|FG000|Overall Study|Lack of Efficacy|9|||
128807323|NCT03623321|463591366|FG000|Overall Study|Lost to Follow-up|6|||
128807324|NCT03623321|463591366|FG000|Overall Study|Noncompliance with study drug|6|||
128807325|NCT03623321|463591366|FG000|Overall Study|Use of prohibited medication|3|||
128807326|NCT03623321|463591366|FG000|Overall Study|Physician Decision|5|||
128807327|NCT03623321|463591366|FG000|Overall Study|Protocol Violation|1|||
128807328|NCT03623321|463591366|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
128807329|NCT03623321|463591366|FG000|Overall Study|Not further specified|43|||
128807330|NCT02243709|463591368|FG000|Phase 1|Lost to Follow-up|0|||
128807331|NCT02243709|463591369|FG001|Phase 1|Lost to Follow-up|1|||
128807332|NCT02243709|463591368|FG000|Phase 1|Withdrawal by Subject|1|||
128807333|NCT02243709|463591369|FG001|Phase 1|Withdrawal by Subject|0|||
128807334|NCT02243709|463591368|FG000|Phase 1|Protocol Violation|0|||
128807335|NCT02243709|463591369|FG001|Phase 1|Protocol Violation|1|||
128807336|NCT02243709|463591368|FG000|Phase 1|Adverse Event|0|||
128807337|NCT02243709|463591369|FG001|Phase 1|Adverse Event|1|||
128807338|NCT01785719|463591372|FG000|4-week Baseline Evaluation|Physician Decision|1|||
128807339|NCT01785719|463591373|FG001|4-week Baseline Evaluation|Physician Decision|0|||
128807340|NCT01785719|463591372|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
128807341|NCT01785719|463591373|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
128807342|NCT01785719|463591372|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
128807343|NCT01785719|463591373|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
128807344|NCT01785719|463591372|FG000|4-week Baseline Evaluation|Pregnancy|0|||
128807345|NCT01785719|463591373|FG001|4-week Baseline Evaluation|Pregnancy|2|||
128807346|NCT01785719|463591372|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
128807347|NCT01785719|463591373|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
128807348|NCT01785719|463591372|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
128807349|NCT01785719|463591373|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
128807350|NCT01785719|463591372|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
128807351|NCT01785719|463591373|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
128807352|NCT01785719|463591372|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
128807353|NCT01785719|463591373|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
128807354|NCT01785719|463591372|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
128807355|NCT01785719|463591373|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
128807356|NCT01785719|463591372|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
128807357|NCT01785719|463591373|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
128807358|NCT01785719|463591372|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
128807359|NCT01785719|463591373|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
128807360|NCT01785719|463591372|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
128807361|NCT01785719|463591373|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
128807362|NCT01785719|463591372|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
128807363|NCT01785719|463591373|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
128807364|NCT01785719|463591372|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
128807365|NCT01785719|463591373|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
128807366|NCT01785719|463591372|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
128807367|NCT01785719|463591373|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
128807368|NCT03443323|463591374|FG000|Overall Study|Lost to Follow-up|2|||
128807369|NCT03443323|463591375|FG001|Overall Study|Lost to Follow-up|2|||
128807370|NCT03443323|463591374|FG000|Overall Study|PI withdrawal|1|||
128807371|NCT03443323|463591375|FG001|Overall Study|PI withdrawal|0|||
128807372|NCT04347161|463591382|FG000|Overall Study|Death|0|||
128807373|NCT04347161|463591383|FG001|Overall Study|Death|2|||
128807374|NCT04347161|463591382|FG000|Overall Study|Withdrawal by Subject|1|||
128807375|NCT04347161|463591383|FG001|Overall Study|Withdrawal by Subject|0|||
128807376|NCT04347161|463591382|FG000|Overall Study|Lost to Follow-up|0|||
128807377|NCT04347161|463591383|FG001|Overall Study|Lost to Follow-up|1|||
128807378|NCT04347161|463591382|FG000|Overall Study|No longer on study medication|1|||
128807379|NCT04347161|463591383|FG001|Overall Study|No longer on study medication|1|||
128807380|NCT04169373|463591384|FG000|Week 1 to Week 14|Adverse Event|1|||
128807381|NCT04169373|463591385|FG001|Week 1 to Week 14|Adverse Event|0|||
128807382|NCT04169373|463591386|FG002|Week 1 to Week 14|Adverse Event|1|||
128807383|NCT04169373|463591387|FG003|Week 1 to Week 14|Adverse Event|2|||
128807384|NCT04169373|463591384|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
128807385|NCT04169373|463591385|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
128807386|NCT04169373|463591386|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
128807387|NCT04169373|463591387|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
128807388|NCT04169373|463591384|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
128807389|NCT04169373|463591385|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
128807390|NCT04169373|463591386|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
128807391|NCT04169373|463591387|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
128807392|NCT04169373|463591384|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
128807393|NCT04169373|463591385|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
128807394|NCT04169373|463591386|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
128807395|NCT04169373|463591387|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
128807396|NCT04169373|463591384|FG000|Week 1 to Week 14|Other|1|||
128807397|NCT04169373|463591385|FG001|Week 1 to Week 14|Other|3|||
128807398|NCT04169373|463591386|FG002|Week 1 to Week 14|Other|3|||
128807399|NCT04169373|463591387|FG003|Week 1 to Week 14|Other|5|||
128807400|NCT04169373|463591384|FG000|Week 14 to Week 52|Adverse Event|1|||
128807401|NCT04169373|463591385|FG001|Week 14 to Week 52|Adverse Event|0|||
128807402|NCT04169373|463591386|FG002|Week 14 to Week 52|Adverse Event|0|||
128807403|NCT04169373|463591387|FG003|Week 14 to Week 52|Adverse Event|1|||
128807404|NCT04169373|463591384|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
128807405|NCT04169373|463591385|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
128807406|NCT04169373|463591386|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
128807407|NCT04169373|463591387|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
128807408|NCT04169373|463591384|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
128807409|NCT04169373|463591385|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
128807410|NCT04169373|463591386|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
128807411|NCT04169373|463591387|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
128807412|NCT04169373|463591384|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
128807413|NCT04169373|463591385|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
128807414|NCT04169373|463591386|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
128807415|NCT04169373|463591387|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
128807416|NCT04169373|463591384|FG000|Week 14 to Week 52|Other|4|||
128807417|NCT04169373|463591385|FG001|Week 14 to Week 52|Other|5|||
128807418|NCT04169373|463591386|FG002|Week 14 to Week 52|Other|4|||
128807419|NCT04169373|463591387|FG003|Week 14 to Week 52|Other|5|||
128807420|NCT04169373|463591384|FG000|Week 14 to Week 52|Ongoing|0|||
128807421|NCT04169373|463591385|FG001|Week 14 to Week 52|Ongoing|1|||
128807422|NCT04169373|463591386|FG002|Week 14 to Week 52|Ongoing|0|||
128807423|NCT04169373|463591387|FG003|Week 14 to Week 52|Ongoing|0|||
128807424|NCT04610892|463591388|FG000|Overall Study|Adverse Event|1|||
128807425|NCT04610892|463591389|FG001|Overall Study|Adverse Event|0|||
128807426|NCT04610892|463591390|FG002|Overall Study|Adverse Event|0|||
128807427|NCT04610892|463591391|FG003|Overall Study|Adverse Event|1|||
128807428|NCT04610892|463591392|FG004|Overall Study|Adverse Event|3|||
128807429|NCT04610892|463591388|FG000|Overall Study|Death|0|||
128807430|NCT04610892|463591389|FG001|Overall Study|Death|1|||
128807431|NCT04610892|463591390|FG002|Overall Study|Death|0|||
128807432|NCT04610892|463591391|FG003|Overall Study|Death|1|||
128807433|NCT04610892|463591392|FG004|Overall Study|Death|0|||
128807434|NCT04610892|463591388|FG000|Overall Study|Withdrawal by Subject|3|||
128807435|NCT04610892|463591389|FG001|Overall Study|Withdrawal by Subject|2|||
128807436|NCT04610892|463591390|FG002|Overall Study|Withdrawal by Subject|0|||
128807437|NCT04610892|463591391|FG003|Overall Study|Withdrawal by Subject|6|||
128807438|NCT04610892|463591392|FG004|Overall Study|Withdrawal by Subject|6|||
128807439|NCT04610892|463591388|FG000|Overall Study|Subjects who did not receive treatment|1|||
128807440|NCT04610892|463591389|FG001|Overall Study|Subjects who did not receive treatment|0|||
128807441|NCT04610892|463591390|FG002|Overall Study|Subjects who did not receive treatment|0|||
128807442|NCT04610892|463591391|FG003|Overall Study|Subjects who did not receive treatment|0|||
128807443|NCT04610892|463591392|FG004|Overall Study|Subjects who did not receive treatment|2|||
128807444|NCT05520190|463591393|FG000|Overall Study|Lost to Follow-up|7|||
128807445|NCT05520190|463591393|FG000|Overall Study|Withdrawal by Subject|2|||
128807446|NCT01999075|463591394|FG000|Overall Study|Lost to Follow-up|0|||
128807447|NCT01999075|463591395|FG001|Overall Study|Lost to Follow-up|2|||
128807448|NCT01999075|463591394|FG000|Overall Study|Withdrawal by Subject|2|||
128807449|NCT01999075|463591395|FG001|Overall Study|Withdrawal by Subject|7|||
128807450|NCT01999075|463591394|FG000|Overall Study|Enrolled in drug trial|3|||
128807451|NCT01999075|463591395|FG001|Overall Study|Enrolled in drug trial|1|||
128807452|NCT01999075|463591394|FG000|Overall Study|Became ineligible|0|||
128807453|NCT01999075|463591395|FG001|Overall Study|Became ineligible|2|||
128807454|NCT03683719|463591396|FG000|Overall Study|Lack of Efficacy|1|||
128807455|NCT03683719|463591397|FG001|Overall Study|Lack of Efficacy|3|||
128807456|NCT03683719|463591398|FG002|Overall Study|Lack of Efficacy|4|||
128807457|NCT03683719|463591399|FG003|Overall Study|Lack of Efficacy|0|||
128807458|NCT03683719|463591400|FG004|Overall Study|Lack of Efficacy|4|||
128807459|NCT03683719|463591396|FG000|Overall Study|Adverse Event|6|||
128807460|NCT03683719|463591397|FG001|Overall Study|Adverse Event|6|||
128807461|NCT03683719|463591398|FG002|Overall Study|Adverse Event|0|||
128807462|NCT03683719|463591399|FG003|Overall Study|Adverse Event|1|||
128807463|NCT03683719|463591400|FG004|Overall Study|Adverse Event|3|||
128807464|NCT03683719|463591396|FG000|Overall Study|Withdrawal by Subject|4|||
128807465|NCT03683719|463591397|FG001|Overall Study|Withdrawal by Subject|4|||
128807466|NCT03683719|463591398|FG002|Overall Study|Withdrawal by Subject|3|||
128807467|NCT03683719|463591399|FG003|Overall Study|Withdrawal by Subject|5|||
128807468|NCT03683719|463591400|FG004|Overall Study|Withdrawal by Subject|5|||
128807469|NCT03683719|463591396|FG000|Overall Study|Lost to Follow-up|1|||
128807470|NCT03683719|463591397|FG001|Overall Study|Lost to Follow-up|0|||
128807471|NCT03683719|463591398|FG002|Overall Study|Lost to Follow-up|0|||
128807472|NCT03683719|463591399|FG003|Overall Study|Lost to Follow-up|1|||
128807473|NCT03683719|463591400|FG004|Overall Study|Lost to Follow-up|1|||
128807474|NCT03683719|463591396|FG000|Overall Study|Other personal reasons|0|||
128807475|NCT03683719|463591397|FG001|Overall Study|Other personal reasons|0|||
128807476|NCT03683719|463591398|FG002|Overall Study|Other personal reasons|1|||
128807477|NCT03683719|463591399|FG003|Overall Study|Other personal reasons|0|||
128807478|NCT03683719|463591400|FG004|Overall Study|Other personal reasons|1|||
128807479|NCT03476187|463591407|FG000|Overall Study|Protocol Violation|7|||
128807480|NCT03476187|463591407|FG000|Overall Study|Physician Decision|5|||
128807481|NCT03924986|463591408|FG000|Overall Study|Death|57|||
128807482|NCT03924986|463591409|FG001|Overall Study|Death|66|||
128807483|NCT03924986|463591408|FG000|Overall Study|Study Concluded by Sponsor|51|||
128807484|NCT03924986|463591409|FG001|Overall Study|Study Concluded by Sponsor|41|||
128807485|NCT03924986|463591408|FG000|Overall Study|Withdrawal by Subject|15|||
128807486|NCT03924986|463591409|FG001|Overall Study|Withdrawal by Subject|20|||
128807487|NCT03924986|463591408|FG000|Overall Study|Lost to Follow-up|7|||
128807488|NCT03924986|463591409|FG001|Overall Study|Lost to Follow-up|5|||
128807489|NCT03924986|463591408|FG000|Overall Study|Miscellaneous|1|||
128807490|NCT03924986|463591409|FG001|Overall Study|Miscellaneous|0|||
128807491|NCT05948670|463591411|FG000|Overall Study|Protocol Violation|6|||
128807492|NCT05948670|463591412|FG001|Overall Study|Protocol Violation|8|||
128807493|NCT05948670|463591411|FG000|Overall Study|Withdrawal by Subject|0|||
128807494|NCT05948670|463591412|FG001|Overall Study|Withdrawal by Subject|1|||
128807495|NCT04562649|463591414|FG000|Overall Study|Withdrawal by Subject|11|||
128807496|NCT04562649|463591415|FG001|Overall Study|Withdrawal by Subject|8|||
128807497|NCT04562649|463591414|FG000|Overall Study|Lost to Follow-up|26|||
128807498|NCT04562649|463591415|FG001|Overall Study|Lost to Follow-up|20|||
128807499|NCT03519581|463591423|FG000|Overall Study|Lost to Follow-up|3|||
128807500|NCT03519581|463591424|FG001|Overall Study|Lost to Follow-up|2|||
128807501|NCT03519581|463591423|FG000|Overall Study|Adverse Event|5|||
128807502|NCT03519581|463591424|FG001|Overall Study|Adverse Event|2|||
128807503|NCT03519581|463591423|FG000|Overall Study|Withdrawal by Subject|2|||
128807504|NCT03519581|463591424|FG001|Overall Study|Withdrawal by Subject|0|||
128807505|NCT03519581|463591423|FG000|Overall Study|Change to insurance|2|||
128807506|NCT03519581|463591424|FG001|Overall Study|Change to insurance|1|||
128807507|NCT03519581|463591423|FG000|Overall Study|Other|2|||
128807508|NCT03519581|463591424|FG001|Overall Study|Other|4|||
128807509|NCT05268393|463591425|FG000|Overall Study|Withdrawal by Subject|2|||
128807510|NCT05268393|463591426|FG001|Overall Study|Withdrawal by Subject|1|||
128807511|NCT00450658|463591427|FG000|Overall Study|Adverse Event|24|||
128807512|NCT00450658|463591428|FG001|Overall Study|Adverse Event|15|||
128807513|NCT00450658|463591427|FG000|Overall Study|Withdrawal by Subject|43|||
128807514|NCT00450658|463591428|FG001|Overall Study|Withdrawal by Subject|26|||
128807515|NCT00450658|463591427|FG000|Overall Study|Lost to Follow-up|22|||
128807516|NCT00450658|463591428|FG001|Overall Study|Lost to Follow-up|5|||
128807517|NCT00450658|463591427|FG000|Overall Study|UGI ulcer|33|||
128807518|NCT00450658|463591428|FG001|Overall Study|UGI ulcer|34|||
128807519|NCT00450658|463591427|FG000|Overall Study|misc|21|||
128807520|NCT00450658|463591428|FG001|Overall Study|misc|10|||
128807521|NCT05763823|463591429|FG000|Overall Study|Death|6|||
128807522|NCT05763823|463591429|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
128807523|NCT05763823|463591429|FG000|Overall Study|Withdrawal by Subject|6|||
128807524|NCT01494662|463591436|FG000|Overall Study|Withdrawal by Subject|0|||
128807525|NCT01494662|463591437|FG001|Overall Study|Withdrawal by Subject|0|||
128807526|NCT01494662|463591438|FG002|Overall Study|Withdrawal by Subject|1|||
128807527|NCT01494662|463591439|FG003|Overall Study|Withdrawal by Subject|0|||
128807528|NCT01494662|463591440|FG004|Overall Study|Withdrawal by Subject|0|||
128807529|NCT01494662|463591441|FG005|Overall Study|Withdrawal by Subject|0|||
128807530|NCT01494662|463591442|FG006|Overall Study|Withdrawal by Subject|0|||
128807531|NCT01494662|463591436|FG000|Overall Study|Physician Decision|0|||
128807532|NCT01494662|463591437|FG001|Overall Study|Physician Decision|0|||
128807533|NCT01494662|463591438|FG002|Overall Study|Physician Decision|1|||
128807534|NCT01494662|463591439|FG003|Overall Study|Physician Decision|0|||
128807535|NCT01494662|463591440|FG004|Overall Study|Physician Decision|0|||
128807536|NCT01494662|463591441|FG005|Overall Study|Physician Decision|0|||
128807537|NCT01494662|463591442|FG006|Overall Study|Physician Decision|0|||
128807538|NCT05311384|463591443|FG000|Overall Study|Uncontrolled health conditions|2|||
128807539|NCT05311384|463591443|FG000|Overall Study|Withdrawal by Subject|1|||
128807540|NCT03302494|463591444|FG000|Overall Study|Other|7|||
128807541|NCT03302494|463591445|FG001|Overall Study|Other|4|||
128807542|NCT03302494|463591446|FG002|Overall Study|Other|6|||
128807543|NCT03302494|463591444|FG000|Overall Study|Withdrawal by Subject|10|||
128807544|NCT03302494|463591445|FG001|Overall Study|Withdrawal by Subject|2|||
128807545|NCT03302494|463591446|FG002|Overall Study|Withdrawal by Subject|9|||
128807546|NCT03302494|463591444|FG000|Overall Study|Study Terminated by Sponsor|32|||
128807547|NCT03302494|463591445|FG001|Overall Study|Study Terminated by Sponsor|29|||
128807548|NCT03302494|463591446|FG002|Overall Study|Study Terminated by Sponsor|30|||
128807549|NCT03302494|463591444|FG000|Overall Study|Physician Decision|1|||
128807550|NCT03302494|463591445|FG001|Overall Study|Physician Decision|0|||
128807551|NCT03302494|463591446|FG002|Overall Study|Physician Decision|1|||
128807552|NCT03302494|463591444|FG000|Overall Study|Lost to Follow-up|1|||
128807553|NCT03302494|463591445|FG001|Overall Study|Lost to Follow-up|3|||
128807554|NCT03302494|463591446|FG002|Overall Study|Lost to Follow-up|3|||
128807555|NCT03302494|463591444|FG000|Overall Study|Death|13|||
128807556|NCT03302494|463591445|FG001|Overall Study|Death|11|||
128807557|NCT03302494|463591446|FG002|Overall Study|Death|4|||
128807558|NCT03302494|463591444|FG000|Overall Study|Adverse Event|1|||
128807559|NCT03302494|463591445|FG001|Overall Study|Adverse Event|2|||
128807560|NCT03302494|463591446|FG002|Overall Study|Adverse Event|0|||
128807561|NCT03302494|463591444|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
128807562|NCT03302494|463591445|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
128807563|NCT03302494|463591446|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
128807564|NCT01573442|463591447|FG000|Overall Study|Cancels|9|||
128807565|NCT01573442|463591448|FG001|Overall Study|Cancels|10|||
128807566|NCT05710107|463591449|FG000|Overall Study|Withdrawal by Subject|1|||
128807567|NCT05710107|463591450|FG001|Overall Study|Withdrawal by Subject|1|||
128807568|NCT05710107|463591449|FG000|Overall Study|Lost to Follow-up|8|||
128807569|NCT05710107|463591450|FG001|Overall Study|Lost to Follow-up|9|||
128807570|NCT05710107|463591449|FG000|Overall Study|Unable to place assigned block|2|||
128807571|NCT05710107|463591450|FG001|Overall Study|Unable to place assigned block|0|||
128807572|NCT05710107|463591449|FG000|Overall Study|Withdrawn by study team|0|||
128807573|NCT05710107|463591450|FG001|Overall Study|Withdrawn by study team|1|||
128807574|NCT05071807|463591451|FG000|Overall Study|Withdrawal by Subject|4|||
128807575|NCT05071807|463591452|FG001|Overall Study|Withdrawal by Subject|0|||
128807576|NCT05071807|463591451|FG000|Overall Study|Unrelated medical issues|3|||
128807577|NCT05071807|463591452|FG001|Overall Study|Unrelated medical issues|0|||
128807578|NCT05071807|463591451|FG000|Overall Study|Relocated|0|||
128807579|NCT05071807|463591452|FG001|Overall Study|Relocated|1|||
128807580|NCT05551637|463591453|FG000|Overall Study|Lack of Efficacy|0|||
128807581|NCT05551637|463591454|FG001|Overall Study|Lack of Efficacy|6|||
128807582|NCT05551637|463591453|FG000|Overall Study|Lost to Follow-up|1|||
128807583|NCT05551637|463591454|FG001|Overall Study|Lost to Follow-up|1|||
128807584|NCT03131648|463593041|FG000|Initial Treatment Period|Not dosed|2|||
128807585|NCT03131648|463593042|FG001|Initial Treatment Period|Not dosed|2|||
128807586|NCT03131648|463593043|FG002|Initial Treatment Period|Not dosed|0|||
128807587|NCT03131648|463593044|FG003|Initial Treatment Period|Not dosed|0|||
128807588|NCT03131648|463593045|FG004|Initial Treatment Period|Not dosed|0|||
128807589|NCT03131648|463593046|FG005|Initial Treatment Period|Not dosed|0|||
128807590|NCT03131648|463593047|FG006|Initial Treatment Period|Not dosed|0|||
128807591|NCT03131648|463593048|FG007|Initial Treatment Period|Not dosed|0|||
128807592|NCT03131648|463593041|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
128807593|NCT03131648|463593042|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
128807594|NCT03131648|463593043|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128807595|NCT03131648|463593044|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128807596|NCT03131648|463593045|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128807597|NCT03131648|463593046|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128807598|NCT03131648|463593047|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128807599|NCT03131648|463593048|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128807600|NCT03131648|463593041|FG000|Open-label Treatment|Discontinued IMP|0|||
128807601|NCT03131648|463593042|FG001|Open-label Treatment|Discontinued IMP|0|||
128807602|NCT03131648|463593043|FG002|Open-label Treatment|Discontinued IMP|0|||
128807603|NCT03131648|463593044|FG003|Open-label Treatment|Discontinued IMP|0|||
128807604|NCT03131648|463593045|FG004|Open-label Treatment|Discontinued IMP|0|||
128807605|NCT03131648|463593046|FG005|Open-label Treatment|Discontinued IMP|0|||
128807606|NCT03131648|463593047|FG006|Open-label Treatment|Discontinued IMP|112|||
128807607|NCT03131648|463593048|FG007|Open-label Treatment|Discontinued IMP|0|||
128807608|NCT03131648|463593041|FG000|Open-label Treatment|Completed Week 50|0|||
128807609|NCT03131648|463593042|FG001|Open-label Treatment|Completed Week 50|0|||
128807610|NCT03131648|463593043|FG002|Open-label Treatment|Completed Week 50|0|||
128807611|NCT03131648|463593044|FG003|Open-label Treatment|Completed Week 50|0|||
128807612|NCT03131648|463593045|FG004|Open-label Treatment|Completed Week 50|0|||
128807613|NCT03131648|463593046|FG005|Open-label Treatment|Completed Week 50|0|||
128807614|NCT03131648|463593047|FG006|Open-label Treatment|Completed Week 50|6|||
128807615|NCT03131648|463593048|FG007|Open-label Treatment|Completed Week 50|0|||
128807616|NCT03131648|463593041|FG000|Maintenance Treatment Period|Not dosed|0|||
128807617|NCT03131648|463593042|FG001|Maintenance Treatment Period|Not dosed|0|||
128807618|NCT03131648|463593043|FG002|Maintenance Treatment Period|Not dosed|3|||
128807619|NCT03131648|463593044|FG003|Maintenance Treatment Period|Not dosed|2|||
128807620|NCT03131648|463593045|FG004|Maintenance Treatment Period|Not dosed|1|||
128807621|NCT03131648|463593046|FG005|Maintenance Treatment Period|Not dosed|0|||
128807622|NCT03131648|463593047|FG006|Maintenance Treatment Period|Not dosed|0|||
128807623|NCT03131648|463593048|FG007|Maintenance Treatment Period|Not dosed|0|||
128807624|NCT03131648|463593041|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
128807625|NCT03131648|463593042|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
128807626|NCT03131648|463593043|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
128807627|NCT03131648|463593044|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
128807628|NCT03131648|463593045|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
128807629|NCT03131648|463593046|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
128807630|NCT03131648|463593047|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
128807631|NCT03131648|463593048|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
128807632|NCT03131648|463593041|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
128807633|NCT03131648|463593042|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
128807634|NCT03131648|463593043|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
128807635|NCT03131648|463593044|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
128807636|NCT03131648|463593045|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
128807637|NCT03131648|463593046|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
128807638|NCT03131648|463593047|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
128807639|NCT03131648|463593048|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
128807640|NCT03131648|463593041|FG000|Maintenance Treatment Period|Completed Week 50|0|||
128807641|NCT03131648|463593042|FG001|Maintenance Treatment Period|Completed Week 50|0|||
128807642|NCT03131648|463593043|FG002|Maintenance Treatment Period|Completed Week 50|0|||
128807643|NCT03131648|463593044|FG003|Maintenance Treatment Period|Completed Week 50|0|||
128807644|NCT03131648|463593045|FG004|Maintenance Treatment Period|Completed Week 50|1|||
128807645|NCT03131648|463593046|FG005|Maintenance Treatment Period|Completed Week 50|0|||
128807646|NCT03131648|463593047|FG006|Maintenance Treatment Period|Completed Week 50|0|||
128807647|NCT03131648|463593048|FG007|Maintenance Treatment Period|Completed Week 50|0|||
128807648|NCT03131648|463593041|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
128807649|NCT03131648|463593042|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
128807650|NCT03131648|463593043|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
128807651|NCT03131648|463593044|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
128807652|NCT03131648|463593045|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
128807653|NCT03131648|463593046|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
128807654|NCT03131648|463593047|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
128807655|NCT03131648|463593048|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
128807656|NCT05633953|463593049|FG000|Overall Study|Adverse Event|7|||
128807657|NCT05633953|463593049|FG000|Overall Study|Death|30|||
128807658|NCT05633953|463593049|FG000|Overall Study|Lost to Follow-up|1|||
128807659|NCT05633953|463593049|FG000|Overall Study|Osilodrostat discontinued|4|||
128807660|NCT05633953|463593049|FG000|Overall Study|Physician Decision|1|||
128807661|NCT05633953|463593049|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
128807662|NCT05633953|463593049|FG000|Overall Study|Progressive disease|2|||
128807663|NCT05324124|463593050|FG000|Period 1|Withdrawal by Subject|1|||
128807664|NCT05324124|463593051|FG001|Period 1|Withdrawal by Subject|0|||
128807665|NCT05324124|463593050|FG000|Period 1|Physician Decision|0|||
128807666|NCT05324124|463593051|FG001|Period 1|Physician Decision|1|||
128807667|NCT02287610|463593052|FG000|Overall Study|Lost to Follow-up|3|||
128807668|NCT02287610|463593052|FG000|Overall Study|Withdrawal by Subject|8|||
128807669|NCT02287610|463593052|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
128807670|NCT05247489|463593058|FG000|Overall Study|Lost to Follow-up|5|||
128807671|NCT05247489|463593059|FG001|Overall Study|Lost to Follow-up|1|||
128807672|NCT05247489|463593058|FG000|Overall Study|Withdrawal by Subject|6|||
128807673|NCT05247489|463593059|FG001|Overall Study|Withdrawal by Subject|7|||
128807674|NCT05247489|463593058|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
128807675|NCT05247489|463593059|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
128807676|NCT05247489|463593058|FG000|Overall Study|Left Country|1|||
128807677|NCT05247489|463593059|FG001|Overall Study|Left Country|0|||
128807678|NCT05247489|463593058|FG000|Overall Study|Noncompliance with Investigational Product|1|||
128807679|NCT05247489|463593059|FG001|Overall Study|Noncompliance with Investigational Product|0|||
128807680|NCT05247489|463593058|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
128807681|NCT05247489|463593059|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
128807682|NCT03771898|463593060|FG000|Overall Study|Adverse Event|1|||
128807683|NCT03771898|463593061|FG001|Overall Study|Adverse Event|0|||
128807684|NCT03771898|463593062|FG002|Overall Study|Adverse Event|0|||
128807685|NCT03771898|463593063|FG003|Overall Study|Adverse Event|0|||
128807686|NCT03771898|463593064|FG004|Overall Study|Adverse Event|0|||
128807687|NCT03771898|463593060|FG000|Overall Study|Lost to Follow-up|1|||
128807688|NCT03771898|463593061|FG001|Overall Study|Lost to Follow-up|1|||
128807689|NCT03771898|463593062|FG002|Overall Study|Lost to Follow-up|1|||
128807690|NCT03771898|463593063|FG003|Overall Study|Lost to Follow-up|0|||
128807691|NCT03771898|463593064|FG004|Overall Study|Lost to Follow-up|0|||
128807692|NCT03771898|463593060|FG000|Overall Study|Withdrawal by parent/guardian|1|||
128807693|NCT03771898|463593061|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128807694|NCT03771898|463593062|FG002|Overall Study|Withdrawal by parent/guardian|0|||
128807695|NCT03771898|463593063|FG003|Overall Study|Withdrawal by parent/guardian|0|||
128807696|NCT03771898|463593064|FG004|Overall Study|Withdrawal by parent/guardian|0|||
128807697|NCT03771898|463593060|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
128807698|NCT03771898|463593061|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
128807699|NCT03771898|463593062|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
128807700|NCT03771898|463593063|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
128807701|NCT03771898|463593064|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
128807702|NCT04541706|463593065|FG000|Overall Study|Withdrawal by Subject|3|||
128807703|NCT04541706|463593065|FG000|Overall Study|Progressive disease|33|||
128807704|NCT04541706|463593065|FG000|Overall Study|Physician Decision|1|||
128807705|NCT04541706|463593065|FG000|Overall Study|Lost to Follow-up|2|||
128807706|NCT04541706|463593065|FG000|Overall Study|Death|5|||
128807707|NCT04541706|463593065|FG000|Overall Study|Adverse Event|1|||
128807708|NCT04927065|463593072|FG000|First Booster|Adverse Event|1|||
128807709|NCT04927065|463593073|FG001|First Booster|Adverse Event|0|||
128807710|NCT04927065|463593074|FG002|First Booster|Adverse Event|0|||
128807711|NCT04927065|463593075|FG003|First Booster|Adverse Event|0|||
128807712|NCT04927065|463593076|FG004|First Booster|Adverse Event|0|||
128807713|NCT04927065|463593077|FG005|First Booster|Adverse Event|0|||
128807714|NCT04927065|463593078|FG006|First Booster|Adverse Event|0|||
128807715|NCT04927065|463593079|FG007|First Booster|Adverse Event|1|||
128807716|NCT04927065|463593080|FG008|First Booster|Adverse Event|0|||
128807717|NCT04927065|463593081|FG009|First Booster|Adverse Event|0|||
128807718|NCT04927065|463593082|FG010|First Booster|Adverse Event|0|||
128807719|NCT04927065|463593083|FG011|First Booster|Adverse Event|0|||
128807720|NCT04927065|463593084|FG012|First Booster|Adverse Event|0|||
128807721|NCT04927065|463593085|FG013|First Booster|Adverse Event|0|||
128807722|NCT04927065|463593086|FG014|First Booster|Adverse Event|0|||
128807723|NCT04927065|463593087|FG015|First Booster|Adverse Event|0|||
128807724|NCT04927065|463593072|FG000|First Booster|Death|1|||
128807725|NCT04927065|463593073|FG001|First Booster|Death|0|||
128807726|NCT04927065|463593074|FG002|First Booster|Death|0|||
128807727|NCT04927065|463593075|FG003|First Booster|Death|1|||
128807728|NCT04927065|463593076|FG004|First Booster|Death|0|||
128807729|NCT04927065|463593077|FG005|First Booster|Death|1|||
128807730|NCT04927065|463593078|FG006|First Booster|Death|0|||
128807731|NCT04927065|463593079|FG007|First Booster|Death|0|||
128807732|NCT04927065|463593080|FG008|First Booster|Death|0|||
128807733|NCT04927065|463593081|FG009|First Booster|Death|0|||
128807734|NCT04927065|463593082|FG010|First Booster|Death|0|||
128807735|NCT04927065|463593083|FG011|First Booster|Death|0|||
128807736|NCT04927065|463593084|FG012|First Booster|Death|0|||
128807737|NCT04927065|463593085|FG013|First Booster|Death|0|||
128807738|NCT04927065|463593086|FG014|First Booster|Death|0|||
128807739|NCT04927065|463593087|FG015|First Booster|Death|0|||
128807740|NCT04927065|463593072|FG000|First Booster|Lost to Follow-up|8|||
128807741|NCT04927065|463593073|FG001|First Booster|Lost to Follow-up|20|||
128807742|NCT04927065|463593074|FG002|First Booster|Lost to Follow-up|0|||
128807743|NCT04927065|463593075|FG003|First Booster|Lost to Follow-up|11|||
128807744|NCT04927065|463593076|FG004|First Booster|Lost to Follow-up|43|||
128807745|NCT04927065|463593077|FG005|First Booster|Lost to Follow-up|30|||
128807746|NCT04927065|463593078|FG006|First Booster|Lost to Follow-up|28|||
128807747|NCT04927065|463593079|FG007|First Booster|Lost to Follow-up|23|||
128807748|NCT04927065|463593080|FG008|First Booster|Lost to Follow-up|4|||
128807749|NCT04927065|463593081|FG009|First Booster|Lost to Follow-up|15|||
128807750|NCT04927065|463593082|FG010|First Booster|Lost to Follow-up|0|||
128807751|NCT04927065|463593083|FG011|First Booster|Lost to Follow-up|0|||
128807752|NCT04927065|463593084|FG012|First Booster|Lost to Follow-up|0|||
128807753|NCT04927065|463593085|FG013|First Booster|Lost to Follow-up|0|||
128807754|NCT04927065|463593086|FG014|First Booster|Lost to Follow-up|0|||
128807755|NCT04927065|463593087|FG015|First Booster|Lost to Follow-up|0|||
128807756|NCT04927065|463593072|FG000|First Booster|Physician Decision|1|||
128807757|NCT04927065|463593073|FG001|First Booster|Physician Decision|0|||
128807758|NCT04927065|463593074|FG002|First Booster|Physician Decision|0|||
128807759|NCT04927065|463593075|FG003|First Booster|Physician Decision|3|||
128807760|NCT04927065|463593076|FG004|First Booster|Physician Decision|1|||
128807761|NCT04927065|463593077|FG005|First Booster|Physician Decision|1|||
128807762|NCT04927065|463593078|FG006|First Booster|Physician Decision|0|||
128807763|NCT04927065|463593079|FG007|First Booster|Physician Decision|3|||
128807764|NCT04927065|463593080|FG008|First Booster|Physician Decision|0|||
128807765|NCT04927065|463593081|FG009|First Booster|Physician Decision|0|||
128807766|NCT04927065|463593082|FG010|First Booster|Physician Decision|0|||
128807767|NCT04927065|463593083|FG011|First Booster|Physician Decision|0|||
128807768|NCT04927065|463593084|FG012|First Booster|Physician Decision|0|||
128807769|NCT04927065|463593085|FG013|First Booster|Physician Decision|0|||
128807770|NCT04927065|463593086|FG014|First Booster|Physician Decision|0|||
128807771|NCT04927065|463593087|FG015|First Booster|Physician Decision|0|||
128807772|NCT04927065|463593072|FG000|First Booster|Protocol Violation|4|||
128807773|NCT04927065|463593073|FG001|First Booster|Protocol Violation|4|||
128807774|NCT04927065|463593074|FG002|First Booster|Protocol Violation|0|||
128807775|NCT04927065|463593075|FG003|First Booster|Protocol Violation|3|||
128807776|NCT04927065|463593076|FG004|First Booster|Protocol Violation|0|||
128807777|NCT04927065|463593077|FG005|First Booster|Protocol Violation|0|||
128807778|NCT04927065|463593078|FG006|First Booster|Protocol Violation|0|||
128807779|NCT04927065|463593079|FG007|First Booster|Protocol Violation|2|||
128807780|NCT04927065|463593080|FG008|First Booster|Protocol Violation|0|||
128807781|NCT04927065|463593081|FG009|First Booster|Protocol Violation|0|||
128807782|NCT04927065|463593082|FG010|First Booster|Protocol Violation|0|||
128807783|NCT04927065|463593083|FG011|First Booster|Protocol Violation|0|||
128807784|NCT04927065|463593084|FG012|First Booster|Protocol Violation|0|||
128807785|NCT04927065|463593085|FG013|First Booster|Protocol Violation|0|||
128807786|NCT04927065|463593086|FG014|First Booster|Protocol Violation|0|||
128807787|NCT04927065|463593087|FG015|First Booster|Protocol Violation|0|||
128807788|NCT04927065|463593072|FG000|First Booster|Withdrawal by Subject|8|||
128807789|NCT04927065|463593073|FG001|First Booster|Withdrawal by Subject|23|||
128807790|NCT04927065|463593074|FG002|First Booster|Withdrawal by Subject|0|||
128807791|NCT04927065|463593075|FG003|First Booster|Withdrawal by Subject|19|||
128807792|NCT04927065|463593076|FG004|First Booster|Withdrawal by Subject|20|||
128807793|NCT04927065|463593077|FG005|First Booster|Withdrawal by Subject|15|||
128807794|NCT04927065|463593078|FG006|First Booster|Withdrawal by Subject|6|||
128807795|NCT04927065|463593079|FG007|First Booster|Withdrawal by Subject|24|||
128807796|NCT04927065|463593080|FG008|First Booster|Withdrawal by Subject|0|||
128807797|NCT04927065|463593081|FG009|First Booster|Withdrawal by Subject|4|||
128807798|NCT04927065|463593082|FG010|First Booster|Withdrawal by Subject|0|||
128807799|NCT04927065|463593083|FG011|First Booster|Withdrawal by Subject|0|||
128807800|NCT04927065|463593084|FG012|First Booster|Withdrawal by Subject|0|||
128807801|NCT04927065|463593085|FG013|First Booster|Withdrawal by Subject|0|||
128807802|NCT04927065|463593086|FG014|First Booster|Withdrawal by Subject|0|||
128807803|NCT04927065|463593087|FG015|First Booster|Withdrawal by Subject|0|||
128807804|NCT04927065|463593072|FG000|First Booster|Other Than Specified|1|||
128807805|NCT04927065|463593073|FG001|First Booster|Other Than Specified|1|||
128807806|NCT04927065|463593074|FG002|First Booster|Other Than Specified|0|||
128807807|NCT04927065|463593075|FG003|First Booster|Other Than Specified|1|||
128807808|NCT04927065|463593076|FG004|First Booster|Other Than Specified|2|||
128807809|NCT04927065|463593077|FG005|First Booster|Other Than Specified|3|||
128807810|NCT04927065|463593078|FG006|First Booster|Other Than Specified|2|||
128807811|NCT04927065|463593079|FG007|First Booster|Other Than Specified|6|||
128807812|NCT04927065|463593080|FG008|First Booster|Other Than Specified|0|||
128807813|NCT04927065|463593081|FG009|First Booster|Other Than Specified|4|||
128807814|NCT04927065|463593082|FG010|First Booster|Other Than Specified|0|||
128807815|NCT04927065|463593083|FG011|First Booster|Other Than Specified|0|||
128807816|NCT04927065|463593084|FG012|First Booster|Other Than Specified|0|||
128807817|NCT04927065|463593085|FG013|First Booster|Other Than Specified|0|||
128807818|NCT04927065|463593086|FG014|First Booster|Other Than Specified|0|||
128807819|NCT04927065|463593087|FG015|First Booster|Other Than Specified|0|||
128807820|NCT04927065|463593072|FG000|Second Booster|Death|0|||
128807821|NCT04927065|463593073|FG001|Second Booster|Death|0|||
128807822|NCT04927065|463593074|FG002|Second Booster|Death|0|||
128807823|NCT04927065|463593075|FG003|Second Booster|Death|0|||
128807824|NCT04927065|463593076|FG004|Second Booster|Death|0|||
128807825|NCT04927065|463593077|FG005|Second Booster|Death|0|||
128807826|NCT04927065|463593078|FG006|Second Booster|Death|0|||
128807827|NCT04927065|463593079|FG007|Second Booster|Death|0|||
128807828|NCT04927065|463593080|FG008|Second Booster|Death|0|||
128807829|NCT04927065|463593081|FG009|Second Booster|Death|0|||
128807830|NCT04927065|463593082|FG010|Second Booster|Death|2|||
128807831|NCT04927065|463593083|FG011|Second Booster|Death|0|||
128807832|NCT04927065|463593084|FG012|Second Booster|Death|2|||
128807833|NCT04927065|463593085|FG013|Second Booster|Death|2|||
128807834|NCT04927065|463593086|FG014|Second Booster|Death|0|||
128807835|NCT04927065|463593087|FG015|Second Booster|Death|0|||
128807836|NCT04927065|463593072|FG000|Second Booster|Lost to Follow-up|0|||
128807837|NCT04927065|463593073|FG001|Second Booster|Lost to Follow-up|0|||
128807838|NCT04927065|463593074|FG002|Second Booster|Lost to Follow-up|3|||
128807839|NCT04927065|463593075|FG003|Second Booster|Lost to Follow-up|0|||
128807840|NCT04927065|463593076|FG004|Second Booster|Lost to Follow-up|0|||
128807841|NCT04927065|463593077|FG005|Second Booster|Lost to Follow-up|0|||
128807842|NCT04927065|463593078|FG006|Second Booster|Lost to Follow-up|0|||
128807843|NCT04927065|463593079|FG007|Second Booster|Lost to Follow-up|0|||
128807844|NCT04927065|463593080|FG008|Second Booster|Lost to Follow-up|0|||
128807845|NCT04927065|463593081|FG009|Second Booster|Lost to Follow-up|0|||
128807846|NCT04927065|463593082|FG010|Second Booster|Lost to Follow-up|14|||
128807847|NCT04927065|463593083|FG011|Second Booster|Lost to Follow-up|10|||
128807848|NCT04927065|463593084|FG012|Second Booster|Lost to Follow-up|13|||
128807849|NCT04927065|463593085|FG013|Second Booster|Lost to Follow-up|16|||
128807850|NCT04927065|463593086|FG014|Second Booster|Lost to Follow-up|0|||
128807851|NCT04927065|463593087|FG015|Second Booster|Lost to Follow-up|0|||
128807852|NCT04927065|463593072|FG000|Second Booster|Physician Decision|0|||
128807853|NCT04927065|463593073|FG001|Second Booster|Physician Decision|0|||
128807854|NCT04927065|463593074|FG002|Second Booster|Physician Decision|0|||
128807855|NCT04927065|463593075|FG003|Second Booster|Physician Decision|0|||
128807856|NCT04927065|463593076|FG004|Second Booster|Physician Decision|0|||
128807857|NCT04927065|463593077|FG005|Second Booster|Physician Decision|0|||
128807858|NCT04927065|463593078|FG006|Second Booster|Physician Decision|0|||
128807859|NCT04927065|463593079|FG007|Second Booster|Physician Decision|0|||
128807860|NCT04927065|463593080|FG008|Second Booster|Physician Decision|0|||
128807861|NCT04927065|463593081|FG009|Second Booster|Physician Decision|0|||
128807862|NCT04927065|463593082|FG010|Second Booster|Physician Decision|0|||
128807863|NCT04927065|463593083|FG011|Second Booster|Physician Decision|3|||
128807864|NCT04927065|463593084|FG012|Second Booster|Physician Decision|0|||
128807865|NCT04927065|463593085|FG013|Second Booster|Physician Decision|1|||
128807866|NCT04927065|463593086|FG014|Second Booster|Physician Decision|0|||
128807867|NCT04927065|463593087|FG015|Second Booster|Physician Decision|0|||
128807868|NCT04927065|463593072|FG000|Second Booster|Withdrawal by Subject|0|||
128807869|NCT04927065|463593073|FG001|Second Booster|Withdrawal by Subject|0|||
128807870|NCT04927065|463593074|FG002|Second Booster|Withdrawal by Subject|4|||
128807871|NCT04927065|463593075|FG003|Second Booster|Withdrawal by Subject|0|||
128807872|NCT04927065|463593076|FG004|Second Booster|Withdrawal by Subject|0|||
128807873|NCT04927065|463593077|FG005|Second Booster|Withdrawal by Subject|0|||
128807874|NCT04927065|463593078|FG006|Second Booster|Withdrawal by Subject|0|||
128807875|NCT04927065|463593079|FG007|Second Booster|Withdrawal by Subject|0|||
128807876|NCT04927065|463593080|FG008|Second Booster|Withdrawal by Subject|0|||
128807877|NCT04927065|463593081|FG009|Second Booster|Withdrawal by Subject|0|||
128807878|NCT04927065|463593082|FG010|Second Booster|Withdrawal by Subject|3|||
128807879|NCT04927065|463593083|FG011|Second Booster|Withdrawal by Subject|16|||
128807880|NCT04927065|463593084|FG012|Second Booster|Withdrawal by Subject|13|||
128807881|NCT04927065|463593085|FG013|Second Booster|Withdrawal by Subject|9|||
128807882|NCT04927065|463593086|FG014|Second Booster|Withdrawal by Subject|0|||
128807883|NCT04927065|463593087|FG015|Second Booster|Withdrawal by Subject|0|||
128807884|NCT04927065|463593072|FG000|Second Booster|Other Than Specified|0|||
128807885|NCT04927065|463593073|FG001|Second Booster|Other Than Specified|0|||
128807886|NCT04927065|463593074|FG002|Second Booster|Other Than Specified|0|||
128807887|NCT04927065|463593075|FG003|Second Booster|Other Than Specified|0|||
128807888|NCT04927065|463593076|FG004|Second Booster|Other Than Specified|0|||
128807889|NCT04927065|463593077|FG005|Second Booster|Other Than Specified|0|||
128807890|NCT04927065|463593078|FG006|Second Booster|Other Than Specified|0|||
128807891|NCT04927065|463593079|FG007|Second Booster|Other Than Specified|0|||
128807892|NCT04927065|463593080|FG008|Second Booster|Other Than Specified|0|||
128807893|NCT04927065|463593081|FG009|Second Booster|Other Than Specified|0|||
128807894|NCT04927065|463593082|FG010|Second Booster|Other Than Specified|1|||
128807895|NCT04927065|463593083|FG011|Second Booster|Other Than Specified|1|||
128807896|NCT04927065|463593084|FG012|Second Booster|Other Than Specified|4|||
128807897|NCT04927065|463593085|FG013|Second Booster|Other Than Specified|0|||
128807898|NCT04927065|463593086|FG014|Second Booster|Other Than Specified|0|||
128807899|NCT04927065|463593087|FG015|Second Booster|Other Than Specified|0|||
128807900|NCT04927065|463593072|FG000|Third Booster|Lost to Follow-up|0|||
128807901|NCT04927065|463593073|FG001|Third Booster|Lost to Follow-up|0|||
128807902|NCT04927065|463593074|FG002|Third Booster|Lost to Follow-up|0|||
128807903|NCT04927065|463593075|FG003|Third Booster|Lost to Follow-up|0|||
128807904|NCT04927065|463593076|FG004|Third Booster|Lost to Follow-up|0|||
128807905|NCT04927065|463593077|FG005|Third Booster|Lost to Follow-up|0|||
128807906|NCT04927065|463593078|FG006|Third Booster|Lost to Follow-up|0|||
128807907|NCT04927065|463593079|FG007|Third Booster|Lost to Follow-up|0|||
128807908|NCT04927065|463593080|FG008|Third Booster|Lost to Follow-up|0|||
128807909|NCT04927065|463593081|FG009|Third Booster|Lost to Follow-up|0|||
128807910|NCT04927065|463593082|FG010|Third Booster|Lost to Follow-up|0|||
128807911|NCT04927065|463593083|FG011|Third Booster|Lost to Follow-up|0|||
128807912|NCT04927065|463593084|FG012|Third Booster|Lost to Follow-up|0|||
128807913|NCT04927065|463593085|FG013|Third Booster|Lost to Follow-up|0|||
128807914|NCT04927065|463593086|FG014|Third Booster|Lost to Follow-up|0|||
128807915|NCT04927065|463593087|FG015|Third Booster|Lost to Follow-up|1|||
128807916|NCT04927065|463593072|FG000|Third Booster|Withdrawal by Subject|0|||
128807917|NCT04927065|463593073|FG001|Third Booster|Withdrawal by Subject|0|||
128807918|NCT04927065|463593074|FG002|Third Booster|Withdrawal by Subject|0|||
128807919|NCT04927065|463593075|FG003|Third Booster|Withdrawal by Subject|0|||
128807920|NCT04927065|463593076|FG004|Third Booster|Withdrawal by Subject|0|||
128807921|NCT04927065|463593077|FG005|Third Booster|Withdrawal by Subject|0|||
128807922|NCT04927065|463593078|FG006|Third Booster|Withdrawal by Subject|0|||
128807923|NCT04927065|463593079|FG007|Third Booster|Withdrawal by Subject|0|||
128807924|NCT04927065|463593080|FG008|Third Booster|Withdrawal by Subject|0|||
128807925|NCT04927065|463593081|FG009|Third Booster|Withdrawal by Subject|0|||
128807926|NCT04927065|463593082|FG010|Third Booster|Withdrawal by Subject|0|||
128807927|NCT04927065|463593083|FG011|Third Booster|Withdrawal by Subject|0|||
128807928|NCT04927065|463593084|FG012|Third Booster|Withdrawal by Subject|0|||
128807929|NCT04927065|463593085|FG013|Third Booster|Withdrawal by Subject|0|||
128807930|NCT04927065|463593086|FG014|Third Booster|Withdrawal by Subject|0|||
128807931|NCT04927065|463593087|FG015|Third Booster|Withdrawal by Subject|1|||
128807932|NCT03406871|463593088|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
128807933|NCT03406871|463593089|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
128807934|NCT03406871|463593090|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
128807935|NCT03406871|463593088|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
128807936|NCT03406871|463593089|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
128807937|NCT03406871|463593090|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
128807938|NCT03406871|463593088|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
128807939|NCT03406871|463593089|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
128807940|NCT03406871|463593090|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
128807941|NCT03406871|463593088|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
128807942|NCT03406871|463593089|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
128807943|NCT03406871|463593090|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
128807944|NCT03406871|463593088|FG000|Expansion Cohort(Final Analysis)|Death|0|||
128807945|NCT03406871|463593089|FG001|Expansion Cohort(Final Analysis)|Death|1|||
128807946|NCT03406871|463593090|FG002|Expansion Cohort(Final Analysis)|Death|0|||
128807947|NCT03406871|463593088|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
128807948|NCT03406871|463593089|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
128807949|NCT03406871|463593090|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
128807950|NCT03366649|463593091|FG000|Overall Study|Failed preoperative screening|4|||
128807951|NCT03366649|463593092|FG001|Overall Study|Failed preoperative screening|0|||
128807952|NCT03366649|463593093|FG002|Overall Study|Failed preoperative screening|0|||
128807953|NCT03366649|463593091|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
128807954|NCT03366649|463593092|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
128807955|NCT03366649|463593093|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
128807956|NCT01744782|463593099|FG000|Overall Study|Death|1|||
128807957|NCT01413100|463593102|FG000|Overall Study|Withdrawal by Subject|1|||
128807958|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
128807959|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
128807960|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
128807961|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
128807962|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
128807963|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
128807964|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
128807965|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
128807966|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
128807967|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
128807968|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
128807969|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
128807970|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
128807971|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
128807972|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
128807973|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
128807974|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
128807975|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
128807976|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
128807977|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
128807978|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
128807979|NCT05369403|463593103|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
128807980|NCT05369403|463593104|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
128807981|NCT05369403|463593105|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
128807982|NCT05369403|463593103|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
128807983|NCT05369403|463593104|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
128807984|NCT05369403|463593105|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
128807985|NCT05369403|463593103|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
128807986|NCT05369403|463593104|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
128807987|NCT05369403|463593105|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
128807988|NCT05369403|463593103|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
128807989|NCT05369403|463593104|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
128807990|NCT05369403|463593105|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
128807991|NCT04896476|463593114|FG000|Overall Study|Withdrawal by Subject|1|||
128807992|NCT04896476|463593114|FG000|Overall Study|Lost to Follow-up|2|||
128807993|NCT03699709|463593115|FG000|Overall Study|Death|1|||
128807994|NCT03699709|463593116|FG001|Overall Study|Death|2|||
128807995|NCT03699709|463593115|FG000|Overall Study|Lost to Follow-up|10|||
128807996|NCT03699709|463593116|FG001|Overall Study|Lost to Follow-up|3|||
128807997|NCT03699709|463593115|FG000|Overall Study|Withdrawal by Subject|5|||
128807998|NCT03699709|463593116|FG001|Overall Study|Withdrawal by Subject|0|||
128807999|NCT03699709|463593115|FG000|Overall Study|incarcerated|1|||
128808000|NCT03699709|463593116|FG001|Overall Study|incarcerated|0|||
128808001|NCT03699709|463593115|FG000|Overall Study|scheduled, but no show|0|||
128808002|NCT03699709|463593116|FG001|Overall Study|scheduled, but no show|1|||
128808003|NCT03056040|463593120|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
128808004|NCT03056040|463593121|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
128808005|NCT03056040|463593120|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
128808006|NCT03056040|463593121|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
128808007|NCT03056040|463593120|FG000|Primary Evaluation Period|Pregnancy|0|||
128808008|NCT03056040|463593121|FG001|Primary Evaluation Period|Pregnancy|1|||
128808009|NCT03056040|463593120|FG000|Primary Evaluation Period|Randomized, not treated|1|||
128808010|NCT03056040|463593121|FG001|Primary Evaluation Period|Randomized, not treated|1|||
128808011|NCT03056040|463593120|FG000|Extension Period|Physician Decision|3|||
128808012|NCT03056040|463593121|FG001|Extension Period|Physician Decision|3|||
128808013|NCT03056040|463593120|FG000|Extension Period|Lost to Follow-up|0|||
128808014|NCT03056040|463593121|FG001|Extension Period|Lost to Follow-up|1|||
128808015|NCT03056040|463593120|FG000|Extension Period|Death|0|||
128808016|NCT03056040|463593121|FG001|Extension Period|Death|3|||
128808017|NCT03056040|463593120|FG000|Extension Period|Withdrawal by Subject|1|||
128808018|NCT03056040|463593121|FG001|Extension Period|Withdrawal by Subject|0|||
128808019|NCT04029688|463593122|FG000|Overall Study|Death|8|||
128808020|NCT04029688|463593123|FG001|Overall Study|Death|3|||
128808021|NCT04029688|463593124|FG002|Overall Study|Death|6|||
128808022|NCT04029688|463593125|FG003|Overall Study|Death|2|||
128808023|NCT04029688|463593126|FG004|Overall Study|Death|5|||
128808024|NCT04029688|463593127|FG005|Overall Study|Death|0|||
128808025|NCT04029688|463593128|FG006|Overall Study|Death|2|||
128808026|NCT04029688|463593129|FG007|Overall Study|Death|3|||
128808027|NCT04029688|463593122|FG000|Overall Study|Study Terminated by Sponsor|0|||
128808028|NCT04029688|463593123|FG001|Overall Study|Study Terminated by Sponsor|0|||
128808029|NCT04029688|463593124|FG002|Overall Study|Study Terminated by Sponsor|0|||
128808030|NCT04029688|463593125|FG003|Overall Study|Study Terminated by Sponsor|0|||
128808031|NCT04029688|463593126|FG004|Overall Study|Study Terminated by Sponsor|1|||
128808032|NCT04029688|463593127|FG005|Overall Study|Study Terminated by Sponsor|3|||
128808033|NCT04029688|463593128|FG006|Overall Study|Study Terminated by Sponsor|1|||
128808034|NCT04029688|463593129|FG007|Overall Study|Study Terminated by Sponsor|3|||
128808035|NCT04029688|463593122|FG000|Overall Study|Withdrawal by Subject|0|||
128808036|NCT04029688|463593123|FG001|Overall Study|Withdrawal by Subject|0|||
128808037|NCT04029688|463593124|FG002|Overall Study|Withdrawal by Subject|0|||
128808038|NCT04029688|463593125|FG003|Overall Study|Withdrawal by Subject|1|||
128808039|NCT04029688|463593126|FG004|Overall Study|Withdrawal by Subject|0|||
128808040|NCT04029688|463593127|FG005|Overall Study|Withdrawal by Subject|0|||
128808041|NCT04029688|463593128|FG006|Overall Study|Withdrawal by Subject|0|||
128808042|NCT04029688|463593129|FG007|Overall Study|Withdrawal by Subject|0|||
128808043|NCT05875142|463593130|FG000|Overall Study|Lost to Follow-up|0|||
128808044|NCT05875142|463593131|FG001|Overall Study|Lost to Follow-up|1|||
128808045|NCT05875142|463593132|FG002|Overall Study|Lost to Follow-up|1|||
128808046|NCT05784662|463593133|FG000|Overall Study|Lost to Follow-up|21|||
128808047|NCT05784662|463593134|FG001|Overall Study|Lost to Follow-up|17|||
128808048|NCT04739956|463593145|FG000|Overall Study|Withdrawal by Subject|1|||
128808049|NCT04739956|463593146|FG001|Overall Study|Withdrawal by Subject|1|||
128808050|NCT03920111|463593147|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
128808051|NCT03920111|463593148|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
128808052|NCT03920111|463593149|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
128808053|NCT03396926|463593152|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
128808054|NCT03396926|463593153|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
128808055|NCT00999804|463593154|FG000|Overall Study|Lack of Efficacy|9|||
128808056|NCT00999804|463593155|FG001|Overall Study|Lack of Efficacy|2|||
128808057|NCT00999804|463593154|FG000|Overall Study|Adverse Event|4|||
128808058|NCT00999804|463593155|FG001|Overall Study|Adverse Event|3|||
128808059|NCT00999804|463593154|FG000|Overall Study|Withdrawal by Subject|4|||
128808060|NCT00999804|463593155|FG001|Overall Study|Withdrawal by Subject|0|||
128808061|NCT00999804|463593154|FG000|Overall Study|Death|1|||
128808062|NCT00999804|463593155|FG001|Overall Study|Death|0|||
128808063|NCT00999804|463593154|FG000|Overall Study|Ineligible|3|||
128808064|NCT00999804|463593155|FG001|Overall Study|Ineligible|0|||
128808065|NCT05256706|463593157|FG000|Overall Study|Lost to Follow-up|9|||
128808066|NCT05256706|463593158|FG001|Overall Study|Lost to Follow-up|3|||
128808067|NCT05256706|463593157|FG000|Overall Study|Withdrawal by Subject|7|||
128808068|NCT05256706|463593158|FG001|Overall Study|Withdrawal by Subject|11|||
128808069|NCT05256706|463593157|FG000|Overall Study|Screen Failures|3|||
128808070|NCT05256706|463593158|FG001|Overall Study|Screen Failures|0|||
128808071|NCT01997840|463593159|FG000|Overall Study|Lost to Follow-up|0|||
128808072|NCT01997840|463593160|FG001|Overall Study|Lost to Follow-up|0|||
128808073|NCT01997840|463593161|FG002|Overall Study|Lost to Follow-up|1|||
128808074|NCT01997840|463593162|FG003|Overall Study|Lost to Follow-up|0|||
128808075|NCT01997840|463593159|FG000|Overall Study|Withdrawal by participant|0|||
128808076|NCT01997840|463593160|FG001|Overall Study|Withdrawal by participant|0|||
128808077|NCT01997840|463593161|FG002|Overall Study|Withdrawal by participant|8|||
128808078|NCT01997840|463593162|FG003|Overall Study|Withdrawal by participant|1|||
128808079|NCT01997840|463593159|FG000|Overall Study|Physician Decision|0|||
128808080|NCT01997840|463593160|FG001|Overall Study|Physician Decision|0|||
128808081|NCT01997840|463593161|FG002|Overall Study|Physician Decision|3|||
128808082|NCT01997840|463593162|FG003|Overall Study|Physician Decision|0|||
128808083|NCT01997840|463593159|FG000|Overall Study|Progressive disease|3|||
128808084|NCT01997840|463593160|FG001|Overall Study|Progressive disease|4|||
128808085|NCT01997840|463593161|FG002|Overall Study|Progressive disease|57|||
128808086|NCT01997840|463593162|FG003|Overall Study|Progressive disease|8|||
128808087|NCT01997840|463593159|FG000|Overall Study|Other reasons|0|||
128808088|NCT01997840|463593160|FG001|Overall Study|Other reasons|0|||
128808089|NCT01997840|463593161|FG002|Overall Study|Other reasons|1|||
128808090|NCT01997840|463593162|FG003|Overall Study|Other reasons|0|||
128808091|NCT01997840|463593159|FG000|Overall Study|Adverse Event|0|||
128808092|NCT01997840|463593160|FG001|Overall Study|Adverse Event|0|||
128808093|NCT01997840|463593161|FG002|Overall Study|Adverse Event|15|||
128808094|NCT01997840|463593162|FG003|Overall Study|Adverse Event|2|||
128808095|NCT03850678|463593163|FG000|Overall Study|Withdrawal by Subject|3|||
128808096|NCT03850678|463593164|FG001|Overall Study|Withdrawal by Subject|0|||
128808097|NCT03850678|463593163|FG000|Overall Study|Experimenter Error|1|||
128808098|NCT03850678|463593164|FG001|Overall Study|Experimenter Error|1|||
128808099|NCT03850678|463593163|FG000|Overall Study|Did Not Condition To Experiment|7|||
128808100|NCT03850678|463593164|FG001|Overall Study|Did Not Condition To Experiment|2|||
128808101|NCT04322643|463593174|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
128808102|NCT03891667|463593175|FG000|Overall Study|Physician Decision|1|||
128808103|NCT03891667|463593176|FG001|Overall Study|Physician Decision|1|||
128808104|NCT03891667|463593175|FG000|Overall Study|COVID related pause|1|||
128808105|NCT03891667|463593176|FG001|Overall Study|COVID related pause|0|||
128808106|NCT03891667|463593175|FG000|Overall Study|Withdrawal by Subject|0|||
128808107|NCT03891667|463593176|FG001|Overall Study|Withdrawal by Subject|1|||
128808108|NCT03891667|463593175|FG000|Overall Study|Adverse Event|0|||
128808109|NCT03891667|463593176|FG001|Overall Study|Adverse Event|1|||
128808110|NCT04166773|463593187|FG000|Overall Study|Adverse Event|2|||
128808111|NCT04166773|463593188|FG001|Overall Study|Adverse Event|0|||
128808112|NCT04166773|463593189|FG002|Overall Study|Adverse Event|2|||
128808113|NCT04166773|463593190|FG003|Overall Study|Adverse Event|1|||
128808114|NCT04166773|463593187|FG000|Overall Study|Lost to Follow-up|4|||
128808115|NCT04166773|463593188|FG001|Overall Study|Lost to Follow-up|2|||
128808116|NCT04166773|463593189|FG002|Overall Study|Lost to Follow-up|1|||
128808117|NCT04166773|463593190|FG003|Overall Study|Lost to Follow-up|3|||
128808118|NCT04166773|463593187|FG000|Overall Study|Physician Decision|0|||
128808119|NCT04166773|463593188|FG001|Overall Study|Physician Decision|0|||
128808120|NCT04166773|463593189|FG002|Overall Study|Physician Decision|0|||
128808121|NCT04166773|463593190|FG003|Overall Study|Physician Decision|1|||
128808122|NCT04166773|463593187|FG000|Overall Study|Withdrawal by Subject|1|||
128808123|NCT04166773|463593188|FG001|Overall Study|Withdrawal by Subject|1|||
128808124|NCT04166773|463593189|FG002|Overall Study|Withdrawal by Subject|2|||
128808125|NCT04166773|463593190|FG003|Overall Study|Withdrawal by Subject|5|||
128808126|NCT05076708|463593191|FG000|Overall Study|Withdrawal by Subject|4|||
128808127|NCT05076708|463593191|FG000|Overall Study|Lost to study during switch phase|8|||
128808128|NCT04717492|463593195|FG000|Overall Study|Withdrawal by Subject|2|||
128808129|NCT04717492|463593196|FG001|Overall Study|Withdrawal by Subject|13|||
128808130|NCT04717492|463593195|FG000|Overall Study|Lost to Follow-up|2|||
128808131|NCT04717492|463593196|FG001|Overall Study|Lost to Follow-up|9|||
128808132|NCT04456517|463593197|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
128808133|NCT04456517|463593198|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
128808134|NCT05282173|463593200|FG000|Overall Study|Missed|3|||
128808135|NCT05282173|463593201|FG001|Overall Study|Missed|2|||
128808136|NCT05282173|463593202|FG002|Overall Study|Missed|4|||
128808137|NCT03476460|463593203|FG000|Overall Study|Withdrawal by Subject|3|||
128808138|NCT03476460|463593204|FG001|Overall Study|Withdrawal by Subject|2|||
128808139|NCT03476460|463593203|FG000|Overall Study|Non-compliance with treatment|3|||
128808140|NCT03476460|463593204|FG001|Overall Study|Non-compliance with treatment|0|||
128808141|NCT03476460|463593203|FG000|Overall Study|Missing laboratory tests|5|||
128808142|NCT03476460|463593204|FG001|Overall Study|Missing laboratory tests|5|||
128808143|NCT03476460|463593203|FG000|Overall Study|Adverse Event|0|||
128808144|NCT03476460|463593204|FG001|Overall Study|Adverse Event|1|||
128808145|NCT05351554|463593205|FG000|Overall Study|Study terminated by sponsor|1|||
128808146|NCT03774082|463593206|FG000|Overall Study|Death|6|||
128808147|NCT03774082|463593207|FG001|Overall Study|Death|3|||
128808148|NCT03774082|463593208|FG002|Overall Study|Death|2|||
128808149|NCT03774082|463593206|FG000|Overall Study|Subject decision|0|||
128808150|NCT03774082|463593207|FG001|Overall Study|Subject decision|3|||
128808151|NCT03774082|463593208|FG002|Overall Study|Subject decision|0|||
128808152|NCT03774082|463593206|FG000|Overall Study|Lost to Follow-up|2|||
128808153|NCT03774082|463593207|FG001|Overall Study|Lost to Follow-up|0|||
128808154|NCT03774082|463593208|FG002|Overall Study|Lost to Follow-up|0|||
128808155|NCT03774082|463593206|FG000|Overall Study|Guardian decision|0|||
128808156|NCT03774082|463593207|FG001|Overall Study|Guardian decision|0|||
128808157|NCT03774082|463593208|FG002|Overall Study|Guardian decision|1|||
128808158|NCT03774082|463593206|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
128808159|NCT03774082|463593207|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
128808160|NCT03774082|463593208|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
128808161|NCT02727699|463595402|FG000|Overall Study|Adverse Event|2|||
128808162|NCT02727699|463595403|FG001|Overall Study|Adverse Event|0|||
128808163|NCT02727699|463595402|FG000|Overall Study|Withdrawal by Subject|5|||
128808164|NCT02727699|463595403|FG001|Overall Study|Withdrawal by Subject|3|||
128808165|NCT02727699|463595402|FG000|Overall Study|Protocol Violation|0|||
128808166|NCT02727699|463595403|FG001|Overall Study|Protocol Violation|1|||
128808167|NCT02727699|463595402|FG000|Overall Study|Physician Decision|0|||
128808168|NCT02727699|463595403|FG001|Overall Study|Physician Decision|1|||
128808169|NCT02727699|463595402|FG000|Overall Study|Lost to Follow-up|1|||
128808170|NCT02727699|463595403|FG001|Overall Study|Lost to Follow-up|0|||
128808171|NCT02727699|463595402|FG000|Overall Study|Sponsor Decision|1|||
128808172|NCT02727699|463595403|FG001|Overall Study|Sponsor Decision|0|||
128808173|NCT04318548|463595404|FG000|Overall Study|Adverse Event|0|||
128808174|NCT04318548|463595405|FG001|Overall Study|Adverse Event|0|||
128808175|NCT04318548|463595406|FG002|Overall Study|Adverse Event|1|||
128808176|NCT04318548|463595404|FG000|Overall Study|Lost to Follow-up|6|||
128808177|NCT04318548|463595405|FG001|Overall Study|Lost to Follow-up|13|||
128808178|NCT04318548|463595406|FG002|Overall Study|Lost to Follow-up|9|||
128808179|NCT04318548|463595404|FG000|Overall Study|Protocol Violation|1|||
128808180|NCT04318548|463595405|FG001|Overall Study|Protocol Violation|0|||
128808181|NCT04318548|463595406|FG002|Overall Study|Protocol Violation|2|||
128808182|NCT04318548|463595404|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
128808183|NCT04318548|463595405|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
128808184|NCT04318548|463595406|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
128808185|NCT04318548|463595404|FG000|Overall Study|Migrated / moved from the study area|0|||
128808186|NCT04318548|463595405|FG001|Overall Study|Migrated / moved from the study area|0|||
128808187|NCT04318548|463595406|FG002|Overall Study|Migrated / moved from the study area|1|||
128808188|NCT04318548|463595404|FG000|Overall Study|Other|1|||
128808189|NCT04318548|463595405|FG001|Overall Study|Other|2|||
128808190|NCT04318548|463595406|FG002|Overall Study|Other|3|||
128808191|NCT04179500|463595407|FG000|Treatment|Withdrawal by Subject|1|||
128808192|NCT04179500|463595407|FG000|Treatment|Adverse Event|2|||
128808193|NCT04179500|463595407|FG000|Treatment|pyrazinamide resistance|1|||
128808194|NCT04241068|463595408|FG000|Core Treatment Period|Adverse Event|91|||
128808195|NCT04241068|463595408|FG000|Core Treatment Period|Change of Treatment|4|||
128808196|NCT04241068|463595408|FG000|Core Treatment Period|Consent Withdrawn|143|||
128808197|NCT04241068|463595408|FG000|Core Treatment Period|Death|26|||
128808198|NCT04241068|463595408|FG000|Core Treatment Period|Disease Progression|67|||
128808199|NCT04241068|463595408|FG000|Core Treatment Period|Investigator Decision|40|||
128808200|NCT04241068|463595408|FG000|Core Treatment Period|Loss of Capacity|9|||
128808201|NCT04241068|463595408|FG000|Core Treatment Period|Lost to Follow-up|11|||
128808202|NCT04241068|463595408|FG000|Core Treatment Period|Relocation|4|||
128808203|NCT04241068|463595408|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
128808204|NCT04241068|463595408|FG000|Core Treatment Period|Study Visit Burden|40|||
128808205|NCT04241068|463595408|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
128808206|NCT04241068|463595408|FG000|Core Treatment Period|Missing|2|||
128808207|NCT04241068|463595408|FG000|Core Treatment Period|Reason Not Specified|41|||
128808208|NCT04241068|463595408|FG000|LTE Period|Adverse Event|19|||
128808209|NCT04241068|463595408|FG000|LTE Period|Change of Treatment|1|||
128808210|NCT04241068|463595408|FG000|LTE Period|Consent Withdrawn|71|||
128808211|NCT04241068|463595408|FG000|LTE Period|Death|8|||
128808212|NCT04241068|463595408|FG000|LTE Period|Disease Progression|11|||
128808213|NCT04241068|463595408|FG000|LTE Period|Investigator Decision|12|||
128808214|NCT04241068|463595408|FG000|LTE Period|Loss of Capacity|2|||
128808215|NCT04241068|463595408|FG000|LTE Period|Lost to Follow-up|7|||
128808216|NCT04241068|463595408|FG000|LTE Period|Relocation|6|||
128808217|NCT04241068|463595408|FG000|LTE Period|Site Terminated by Sponsor|26|||
128808218|NCT04241068|463595408|FG000|LTE Period|Study Terminated by Sponsor|276|||
128808219|NCT04241068|463595408|FG000|LTE Period|Study Visit Burden|10|||
128808220|NCT04241068|463595408|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
128808221|NCT04241068|463595408|FG000|LTE Period|Reason Not Specified|65|||
128808222|NCT04177823|463595409|FG000|Overall Study|Physician Decision|1|||
128808223|NCT04177823|463595409|FG000|Overall Study|Withdrawal by Subject|1|||
128808224|NCT05368103|463595410|FG000|Overall Study|Withdrawal by Subject|4|||
128808225|NCT05368103|463595410|FG000|Overall Study|Lost to Follow-up|1|||
128808226|NCT05368103|463595410|FG000|Overall Study|Lack of Efficacy|3|||
128808227|NCT03675282|463595411|FG000|Overall Study|Lost to Follow-up|4|||
128808228|NCT03675282|463595412|FG001|Overall Study|Lost to Follow-up|8|||
128808229|NCT03675282|463595413|FG002|Overall Study|Lost to Follow-up|1|||
128808230|NCT03675282|463595414|FG003|Overall Study|Lost to Follow-up|0|||
128808231|NCT03675282|463595415|FG004|Overall Study|Lost to Follow-up|2|||
128808232|NCT03675282|463595416|FG005|Overall Study|Lost to Follow-up|7|||
128808233|NCT03675282|463595411|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
128808234|NCT03675282|463595412|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
128808235|NCT03675282|463595413|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
128808236|NCT03675282|463595414|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
128808237|NCT03675282|463595415|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
128808238|NCT03675282|463595416|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
128808239|NCT03675282|463595411|FG000|Overall Study|Physician Decision|1|||
128808240|NCT03675282|463595412|FG001|Overall Study|Physician Decision|0|||
128808241|NCT03675282|463595413|FG002|Overall Study|Physician Decision|0|||
128808242|NCT03675282|463595414|FG003|Overall Study|Physician Decision|0|||
128808243|NCT03675282|463595415|FG004|Overall Study|Physician Decision|0|||
128808244|NCT03675282|463595416|FG005|Overall Study|Physician Decision|0|||
128808245|NCT04977947|463595417|FG000|Overall Study|Lost to Follow-up|1|||
128808246|NCT04977947|463595418|FG001|Overall Study|Lost to Follow-up|1|||
128808247|NCT04274764|463595419|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
128808248|NCT04274764|463595420|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
128808249|NCT02677298|463595421|FG000|Double Blind Phase|Adverse Event|2|||
128808250|NCT02677298|463595422|FG001|Double Blind Phase|Adverse Event|1|||
128808251|NCT02677298|463595423|FG002|Double Blind Phase|Adverse Event|0|||
128808252|NCT02677298|463595421|FG000|Double Blind Phase|Physician Decision|5|||
128808253|NCT02677298|463595422|FG001|Double Blind Phase|Physician Decision|0|||
128808254|NCT02677298|463595423|FG002|Double Blind Phase|Physician Decision|0|||
128808255|NCT02677298|463595421|FG000|Double Blind Phase|Lost to Follow-up|11|||
128808256|NCT02677298|463595422|FG001|Double Blind Phase|Lost to Follow-up|7|||
128808257|NCT02677298|463595423|FG002|Double Blind Phase|Lost to Follow-up|0|||
128808258|NCT02677298|463595421|FG000|Double Blind Phase|Withdrawal by Subject|11|||
128808259|NCT02677298|463595422|FG001|Double Blind Phase|Withdrawal by Subject|8|||
128808260|NCT02677298|463595423|FG002|Double Blind Phase|Withdrawal by Subject|0|||
128808261|NCT02677298|463595421|FG000|Double Blind Phase|No study drug available at site|0|||
128808262|NCT02677298|463595422|FG001|Double Blind Phase|No study drug available at site|1|||
128808263|NCT02677298|463595423|FG002|Double Blind Phase|No study drug available at site|0|||
128808264|NCT02677298|463595421|FG000|Open Label Phase|Adverse Event|0|||
128808265|NCT02677298|463595422|FG001|Open Label Phase|Adverse Event|0|||
128808266|NCT02677298|463595423|FG002|Open Label Phase|Adverse Event|4|||
128808267|NCT02677298|463595421|FG000|Open Label Phase|Physician Decision|0|||
128808268|NCT02677298|463595422|FG001|Open Label Phase|Physician Decision|0|||
128808269|NCT02677298|463595423|FG002|Open Label Phase|Physician Decision|1|||
128808270|NCT02677298|463595421|FG000|Open Label Phase|Lost to Follow-up|0|||
128808271|NCT02677298|463595422|FG001|Open Label Phase|Lost to Follow-up|0|||
128808272|NCT02677298|463595423|FG002|Open Label Phase|Lost to Follow-up|17|||
128808273|NCT02677298|463595421|FG000|Open Label Phase|Withdrawal by Subject|0|||
128808274|NCT02677298|463595422|FG001|Open Label Phase|Withdrawal by Subject|0|||
128808275|NCT02677298|463595423|FG002|Open Label Phase|Withdrawal by Subject|38|||
128808276|NCT03611621|463595424|FG000|Overall Study|Graft loss|3|||
128808277|NCT03611621|463595424|FG000|Overall Study|Death|3|||
128808278|NCT03611621|463595424|FG000|Overall Study|Lost to Follow-up|1|||
128808279|NCT03039023|463595438|FG000|Overall Study|Withdrawal by Subject|1|||
128808280|NCT03039023|463595439|FG001|Overall Study|Withdrawal by Subject|0|||
128808281|NCT03039023|463595440|FG002|Overall Study|Withdrawal by Subject|1|||
128808282|NCT03039023|463595441|FG003|Overall Study|Withdrawal by Subject|1|||
128808283|NCT03039023|463595442|FG004|Overall Study|Withdrawal by Subject|0|||
128808284|NCT03039023|463595438|FG000|Overall Study|Physician Decision|0|||
128808285|NCT03039023|463595439|FG001|Overall Study|Physician Decision|0|||
128808286|NCT03039023|463595440|FG002|Overall Study|Physician Decision|0|||
128808287|NCT03039023|463595441|FG003|Overall Study|Physician Decision|1|||
128808288|NCT03039023|463595442|FG004|Overall Study|Physician Decision|0|||
128808289|NCT04130438|463595443|FG000|Overall Study|Lost to Follow-up|0|||
128808290|NCT04130438|463595444|FG001|Overall Study|Lost to Follow-up|0|||
128808291|NCT04130438|463595445|FG002|Overall Study|Lost to Follow-up|1|||
128808292|NCT03232138|463595448|FG000|Overall Study|Physician Decision|1|||
128808293|NCT03232138|463595449|FG001|Overall Study|Physician Decision|0|||
128808294|NCT03232138|463595448|FG000|Overall Study|Adverse Event|2|||
128808295|NCT03232138|463595449|FG001|Overall Study|Adverse Event|0|||
128808296|NCT03232138|463595448|FG000|Overall Study|Withdrawal by Subject|1|||
128808297|NCT03232138|463595449|FG001|Overall Study|Withdrawal by Subject|2|||
128808298|NCT04142788|463595450|FG000|Overall Study|Trial terminated prematurely|2|||
128808299|NCT04142788|463595451|FG001|Overall Study|Trial terminated prematurely|2|||
128808300|NCT03853746|463595456|FG000|Overall Study|Withdrawal by Subject|1|||
128808301|NCT04764448|463595457|FG000|Overall Study|Study terminated by sponsor|2|||
128808302|NCT04764448|463595458|FG001|Overall Study|Study terminated by sponsor|2|||
128808303|NCT04764448|463595459|FG002|Overall Study|Study terminated by sponsor|5|||
128808304|NCT04764448|463595457|FG000|Overall Study|Withdrawal by Subject|3|||
128808305|NCT04764448|463595458|FG001|Overall Study|Withdrawal by Subject|3|||
128808306|NCT04764448|463595459|FG002|Overall Study|Withdrawal by Subject|1|||
128808307|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Other|0|||
128808308|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Other|0|||
128808309|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Other|0|||
128808310|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Other|0|||
128808311|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Other|0|||
128808312|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Other|0|||
128808313|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Other|0|||
128808314|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Other|0|||
128808315|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Other|0|||
128808316|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Other|0|||
128808317|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Other|1|||
128808318|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Other|1|||
128808319|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Other|1|||
128808320|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Other|0|||
128808321|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Other|3|||
128808322|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Other|1|||
128808323|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Other|1|||
128808324|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Other|0|||
128808325|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808326|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808327|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808328|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808329|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808330|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808331|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
128808332|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808333|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
128808334|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808335|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808336|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808337|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
128808338|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808339|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808340|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808341|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808342|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
128808343|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808344|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808345|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808346|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808347|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808348|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808349|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808350|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
128808351|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808352|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808353|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808354|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808355|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808356|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808357|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808358|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808359|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808360|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
128808361|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808362|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808363|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808364|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808365|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808366|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808367|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808368|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808369|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808370|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
128808371|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808372|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808373|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808374|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808375|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808376|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808377|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808378|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
128808379|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Death|0|||
128808380|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Death|0|||
128808381|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Death|0|||
128808382|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Death|0|||
128808383|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Death|0|||
128808384|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Death|0|||
128808385|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Death|0|||
128808386|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Death|0|||
128808387|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Death|0|||
128808388|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Death|1|||
128808389|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Death|0|||
128808390|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Death|1|||
128808391|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Death|0|||
128808392|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Death|1|||
128808393|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Death|0|||
128808394|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Death|0|||
128808395|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Death|2|||
128808396|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Death|0|||
128808397|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
128808398|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
128808399|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
128808400|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
128808401|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
128808402|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
128808403|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
128808404|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
128808405|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
128808406|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
128808407|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
128808408|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
128808409|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
128808410|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
128808411|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
128808412|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
128808413|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
128808414|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
128808415|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Adverse Event|0|||
128808416|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Adverse Event|0|||
128808417|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Adverse Event|0|||
128808418|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Adverse Event|0|||
128808419|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Adverse Event|0|||
128808420|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Adverse Event|0|||
128808421|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Adverse Event|2|||
128808422|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Adverse Event|0|||
128808423|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Adverse Event|0|||
128808424|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Adverse Event|0|||
128808425|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Adverse Event|1|||
128808426|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Adverse Event|2|||
128808427|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Adverse Event|0|||
128808428|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Adverse Event|1|||
128808429|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Adverse Event|0|||
128808430|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Adverse Event|0|||
128808431|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Adverse Event|1|||
128808432|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Adverse Event|0|||
128808433|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
128808434|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
128808435|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
128808436|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
128808437|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
128808438|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
128808439|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
128808440|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
128808441|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
128808442|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
128808443|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
128808444|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
128808445|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
128808446|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
128808447|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
128808448|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
128808449|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
128808450|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
128808451|NCT03269136|463595466|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808452|NCT03269136|463595467|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808453|NCT03269136|463595468|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808454|NCT03269136|463595469|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808455|NCT03269136|463595470|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808456|NCT03269136|463595471|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808457|NCT03269136|463595472|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808458|NCT03269136|463595473|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808459|NCT03269136|463595474|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808460|NCT03269136|463595475|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808461|NCT03269136|463595476|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808462|NCT03269136|463595477|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808463|NCT03269136|463595478|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
128808464|NCT03269136|463595479|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
128808465|NCT03269136|463595480|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
128808466|NCT03269136|463595481|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808467|NCT03269136|463595482|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
128808468|NCT03269136|463595483|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
128808469|NCT03269136|463595466|FG000|Part 2A: Dose Expansion|Other|0|||
128808470|NCT03269136|463595467|FG001|Part 2A: Dose Expansion|Other|0|||
128808471|NCT03269136|463595468|FG002|Part 2A: Dose Expansion|Other|0|||
128808472|NCT03269136|463595469|FG003|Part 2A: Dose Expansion|Other|0|||
128808473|NCT03269136|463595470|FG004|Part 2A: Dose Expansion|Other|0|||
128808474|NCT03269136|463595471|FG005|Part 2A: Dose Expansion|Other|0|||
128808475|NCT03269136|463595472|FG006|Part 2A: Dose Expansion|Other|0|||
128808476|NCT03269136|463595473|FG007|Part 2A: Dose Expansion|Other|0|||
128808477|NCT03269136|463595474|FG008|Part 2A: Dose Expansion|Other|0|||
128808478|NCT03269136|463595475|FG009|Part 2A: Dose Expansion|Other|0|||
128808479|NCT03269136|463595476|FG010|Part 2A: Dose Expansion|Other|0|||
128808480|NCT03269136|463595477|FG011|Part 2A: Dose Expansion|Other|0|||
128808481|NCT03269136|463595478|FG012|Part 2A: Dose Expansion|Other|0|||
128808482|NCT03269136|463595479|FG013|Part 2A: Dose Expansion|Other|0|||
128808483|NCT03269136|463595480|FG014|Part 2A: Dose Expansion|Other|0|||
128808484|NCT03269136|463595481|FG015|Part 2A: Dose Expansion|Other|0|||
128808485|NCT03269136|463595482|FG016|Part 2A: Dose Expansion|Other|0|||
128808486|NCT03269136|463595483|FG017|Part 2A: Dose Expansion|Other|1|||
128808487|NCT03269136|463595466|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808488|NCT03269136|463595467|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808489|NCT03269136|463595468|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808490|NCT03269136|463595469|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808491|NCT03269136|463595470|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808492|NCT03269136|463595471|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808493|NCT03269136|463595472|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808494|NCT03269136|463595473|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808495|NCT03269136|463595474|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808496|NCT03269136|463595475|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808497|NCT03269136|463595476|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808498|NCT03269136|463595477|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808499|NCT03269136|463595478|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808500|NCT03269136|463595479|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808501|NCT03269136|463595480|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808502|NCT03269136|463595481|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808503|NCT03269136|463595482|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
128808504|NCT03269136|463595483|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
128808505|NCT03269136|463595466|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
128808506|NCT03269136|463595467|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
128808507|NCT03269136|463595468|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
128808508|NCT03269136|463595469|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
128808509|NCT03269136|463595470|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
128808510|NCT03269136|463595471|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
128808511|NCT03269136|463595472|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
128808512|NCT03269136|463595473|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
128808513|NCT03269136|463595474|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
128808514|NCT03269136|463595475|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
128808515|NCT03269136|463595476|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
128808516|NCT03269136|463595477|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
128808517|NCT03269136|463595478|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
128808518|NCT03269136|463595479|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
128808519|NCT03269136|463595480|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
128808520|NCT03269136|463595481|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
128808521|NCT03269136|463595482|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
128808522|NCT03269136|463595483|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
128808523|NCT03269136|463595466|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
128808524|NCT03269136|463595467|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
128808525|NCT03269136|463595468|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
128808526|NCT03269136|463595469|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
128808527|NCT03269136|463595470|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
128808528|NCT03269136|463595471|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
128808529|NCT03269136|463595472|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
128808530|NCT03269136|463595473|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
128808531|NCT03269136|463595474|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
128808532|NCT03269136|463595475|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
128808533|NCT03269136|463595476|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
128808534|NCT03269136|463595477|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
128808535|NCT03269136|463595478|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
128808536|NCT03269136|463595479|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
128808537|NCT03269136|463595480|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
128808538|NCT03269136|463595481|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
128808539|NCT03269136|463595482|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
128808540|NCT03269136|463595483|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
128808541|NCT03269136|463595466|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
128808542|NCT03269136|463595467|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
128808543|NCT03269136|463595468|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
128808544|NCT03269136|463595469|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
128808545|NCT03269136|463595470|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
128808546|NCT03269136|463595471|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
128808547|NCT03269136|463595472|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
128808548|NCT03269136|463595473|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
128808549|NCT03269136|463595474|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
128808550|NCT03269136|463595475|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
128808551|NCT03269136|463595476|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
128808552|NCT03269136|463595477|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
128808553|NCT03269136|463595478|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
128808554|NCT03269136|463595479|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
128808555|NCT03269136|463595480|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
128808556|NCT03269136|463595481|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
128808557|NCT03269136|463595482|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
128808558|NCT03269136|463595483|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
128808559|NCT03150810|463595492|FG000|Overall Study|Death|4|||
128808560|NCT03150810|463595493|FG001|Overall Study|Death|8|||
128808561|NCT03150810|463595494|FG002|Overall Study|Death|7|||
128808562|NCT03150810|463595495|FG003|Overall Study|Death|2|||
128808563|NCT03150810|463595496|FG004|Overall Study|Death|2|||
128808564|NCT03150810|463595497|FG005|Overall Study|Death|10|||
128808565|NCT03150810|463595498|FG006|Overall Study|Death|8|||
128808566|NCT03150810|463595499|FG007|Overall Study|Death|6|||
128808567|NCT03150810|463595500|FG008|Overall Study|Death|18|||
128808568|NCT03150810|463595501|FG009|Overall Study|Death|3|||
128808569|NCT03150810|463595502|FG010|Overall Study|Death|19|||
128808570|NCT03150810|463595503|FG011|Overall Study|Death|1|||
128808571|NCT03150810|463595504|FG012|Overall Study|Death|19|||
128808572|NCT03150810|463595492|FG000|Overall Study|Withdrawal by Subject|0|||
128808573|NCT03150810|463595493|FG001|Overall Study|Withdrawal by Subject|1|||
128808574|NCT03150810|463595494|FG002|Overall Study|Withdrawal by Subject|1|||
128808575|NCT03150810|463595495|FG003|Overall Study|Withdrawal by Subject|1|||
128808576|NCT03150810|463595496|FG004|Overall Study|Withdrawal by Subject|0|||
128808577|NCT03150810|463595497|FG005|Overall Study|Withdrawal by Subject|0|||
128808578|NCT03150810|463595498|FG006|Overall Study|Withdrawal by Subject|2|||
128808579|NCT03150810|463595499|FG007|Overall Study|Withdrawal by Subject|0|||
128808580|NCT03150810|463595500|FG008|Overall Study|Withdrawal by Subject|2|||
128808581|NCT03150810|463595501|FG009|Overall Study|Withdrawal by Subject|0|||
128808582|NCT03150810|463595502|FG010|Overall Study|Withdrawal by Subject|1|||
128808583|NCT03150810|463595503|FG011|Overall Study|Withdrawal by Subject|0|||
128808584|NCT03150810|463595504|FG012|Overall Study|Withdrawal by Subject|1|||
128808585|NCT03150810|463595492|FG000|Overall Study|Sponsor Decision|0|||
128808586|NCT03150810|463595493|FG001|Overall Study|Sponsor Decision|2|||
128808587|NCT03150810|463595494|FG002|Overall Study|Sponsor Decision|0|||
128808588|NCT03150810|463595495|FG003|Overall Study|Sponsor Decision|0|||
128808589|NCT03150810|463595496|FG004|Overall Study|Sponsor Decision|1|||
128808590|NCT03150810|463595497|FG005|Overall Study|Sponsor Decision|1|||
128808591|NCT03150810|463595498|FG006|Overall Study|Sponsor Decision|0|||
128808592|NCT03150810|463595499|FG007|Overall Study|Sponsor Decision|0|||
128808593|NCT03150810|463595500|FG008|Overall Study|Sponsor Decision|1|||
128808594|NCT03150810|463595501|FG009|Overall Study|Sponsor Decision|0|||
128808595|NCT03150810|463595502|FG010|Overall Study|Sponsor Decision|0|||
128808596|NCT03150810|463595503|FG011|Overall Study|Sponsor Decision|0|||
128808597|NCT03150810|463595504|FG012|Overall Study|Sponsor Decision|5|||
128808598|NCT03150810|463595492|FG000|Overall Study|Lost to Follow-up|0|||
128808599|NCT03150810|463595493|FG001|Overall Study|Lost to Follow-up|1|||
128808600|NCT03150810|463595494|FG002|Overall Study|Lost to Follow-up|1|||
128808601|NCT03150810|463595495|FG003|Overall Study|Lost to Follow-up|0|||
128808602|NCT03150810|463595496|FG004|Overall Study|Lost to Follow-up|0|||
128808603|NCT03150810|463595497|FG005|Overall Study|Lost to Follow-up|0|||
128808604|NCT03150810|463595498|FG006|Overall Study|Lost to Follow-up|1|||
128808605|NCT03150810|463595499|FG007|Overall Study|Lost to Follow-up|0|||
128808606|NCT03150810|463595500|FG008|Overall Study|Lost to Follow-up|0|||
128808607|NCT03150810|463595501|FG009|Overall Study|Lost to Follow-up|0|||
128808608|NCT03150810|463595502|FG010|Overall Study|Lost to Follow-up|1|||
128808609|NCT03150810|463595503|FG011|Overall Study|Lost to Follow-up|0|||
128808610|NCT03150810|463595504|FG012|Overall Study|Lost to Follow-up|0|||
128808611|NCT03150810|463595492|FG000|Overall Study|Physician Decision|0|||
128808612|NCT03150810|463595493|FG001|Overall Study|Physician Decision|0|||
128808613|NCT03150810|463595494|FG002|Overall Study|Physician Decision|0|||
128808614|NCT03150810|463595495|FG003|Overall Study|Physician Decision|0|||
128808615|NCT03150810|463595496|FG004|Overall Study|Physician Decision|0|||
128808616|NCT03150810|463595497|FG005|Overall Study|Physician Decision|1|||
128808617|NCT03150810|463595498|FG006|Overall Study|Physician Decision|1|||
128808618|NCT03150810|463595499|FG007|Overall Study|Physician Decision|0|||
128808619|NCT03150810|463595500|FG008|Overall Study|Physician Decision|0|||
128808620|NCT03150810|463595501|FG009|Overall Study|Physician Decision|0|||
128808621|NCT03150810|463595502|FG010|Overall Study|Physician Decision|0|||
128808622|NCT03150810|463595503|FG011|Overall Study|Physician Decision|0|||
128808623|NCT03150810|463595504|FG012|Overall Study|Physician Decision|0|||
128808624|NCT03150810|463595492|FG000|Overall Study|Site withdrawal from study|0|||
128808625|NCT03150810|463595493|FG001|Overall Study|Site withdrawal from study|1|||
128808626|NCT03150810|463595494|FG002|Overall Study|Site withdrawal from study|0|||
128808627|NCT03150810|463595495|FG003|Overall Study|Site withdrawal from study|0|||
128808628|NCT03150810|463595496|FG004|Overall Study|Site withdrawal from study|0|||
128808629|NCT03150810|463595497|FG005|Overall Study|Site withdrawal from study|0|||
128808630|NCT03150810|463595498|FG006|Overall Study|Site withdrawal from study|0|||
128808631|NCT03150810|463595499|FG007|Overall Study|Site withdrawal from study|0|||
128808632|NCT03150810|463595500|FG008|Overall Study|Site withdrawal from study|0|||
128808633|NCT03150810|463595501|FG009|Overall Study|Site withdrawal from study|1|||
128808634|NCT03150810|463595502|FG010|Overall Study|Site withdrawal from study|1|||
128808635|NCT03150810|463595503|FG011|Overall Study|Site withdrawal from study|0|||
128808636|NCT03150810|463595504|FG012|Overall Study|Site withdrawal from study|0|||
128808637|NCT03150810|463595492|FG000|Overall Study|Hospice|0|||
128808638|NCT03150810|463595493|FG001|Overall Study|Hospice|0|||
128808639|NCT03150810|463595494|FG002|Overall Study|Hospice|0|||
128808640|NCT03150810|463595495|FG003|Overall Study|Hospice|0|||
128808641|NCT03150810|463595496|FG004|Overall Study|Hospice|0|||
128808642|NCT03150810|463595497|FG005|Overall Study|Hospice|1|||
128808643|NCT03150810|463595498|FG006|Overall Study|Hospice|0|||
128808644|NCT03150810|463595499|FG007|Overall Study|Hospice|0|||
128808645|NCT03150810|463595500|FG008|Overall Study|Hospice|0|||
128808646|NCT03150810|463595501|FG009|Overall Study|Hospice|0|||
128808647|NCT03150810|463595502|FG010|Overall Study|Hospice|0|||
128808648|NCT03150810|463595503|FG011|Overall Study|Hospice|0|||
128808649|NCT03150810|463595504|FG012|Overall Study|Hospice|0|||
128808650|NCT03150810|463595492|FG000|Overall Study|Participant relocated abroad.|0|||
128808651|NCT03150810|463595493|FG001|Overall Study|Participant relocated abroad.|0|||
128808652|NCT03150810|463595494|FG002|Overall Study|Participant relocated abroad.|0|||
128808653|NCT03150810|463595495|FG003|Overall Study|Participant relocated abroad.|0|||
128808654|NCT03150810|463595496|FG004|Overall Study|Participant relocated abroad.|0|||
128808655|NCT03150810|463595497|FG005|Overall Study|Participant relocated abroad.|1|||
128808656|NCT03150810|463595498|FG006|Overall Study|Participant relocated abroad.|0|||
128808657|NCT03150810|463595499|FG007|Overall Study|Participant relocated abroad.|0|||
128808658|NCT03150810|463595500|FG008|Overall Study|Participant relocated abroad.|0|||
128808659|NCT03150810|463595501|FG009|Overall Study|Participant relocated abroad.|0|||
128808660|NCT03150810|463595502|FG010|Overall Study|Participant relocated abroad.|0|||
128808661|NCT03150810|463595503|FG011|Overall Study|Participant relocated abroad.|0|||
128808662|NCT03150810|463595504|FG012|Overall Study|Participant relocated abroad.|0|||
128808663|NCT03150810|463595492|FG000|Overall Study|Transferred care to oncologist|0|||
128808664|NCT03150810|463595493|FG001|Overall Study|Transferred care to oncologist|0|||
128808665|NCT03150810|463595494|FG002|Overall Study|Transferred care to oncologist|0|||
128808666|NCT03150810|463595495|FG003|Overall Study|Transferred care to oncologist|0|||
128808667|NCT03150810|463595496|FG004|Overall Study|Transferred care to oncologist|0|||
128808668|NCT03150810|463595497|FG005|Overall Study|Transferred care to oncologist|0|||
128808669|NCT03150810|463595498|FG006|Overall Study|Transferred care to oncologist|2|||
128808670|NCT03150810|463595499|FG007|Overall Study|Transferred care to oncologist|0|||
128808671|NCT03150810|463595500|FG008|Overall Study|Transferred care to oncologist|0|||
128808672|NCT03150810|463595501|FG009|Overall Study|Transferred care to oncologist|0|||
128808673|NCT03150810|463595502|FG010|Overall Study|Transferred care to oncologist|0|||
128808674|NCT03150810|463595503|FG011|Overall Study|Transferred care to oncologist|0|||
128808675|NCT03150810|463595504|FG012|Overall Study|Transferred care to oncologist|0|||
128808676|NCT05116787|463595505|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
128808677|NCT05116787|463595506|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
128808678|NCT05116787|463595505|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
128808679|NCT05116787|463595506|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
128808680|NCT05116787|463595505|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
128808681|NCT05116787|463595506|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
128808682|NCT05116787|463595505|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
128808683|NCT05116787|463595506|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
128808684|NCT06393088|463595508|FG000|Overall Study|Withdrawal by Subject|0|||
128808685|NCT06393088|463595509|FG001|Overall Study|Withdrawal by Subject|2|||
128808686|NCT03903146|463595510|FG000|Overall Study|Lost to Follow-up|6|||
128808687|NCT03903146|463595511|FG001|Overall Study|Lost to Follow-up|4|||
128808688|NCT03903146|463595510|FG000|Overall Study|Withdrawal by Subject|0|||
128808689|NCT03903146|463595511|FG001|Overall Study|Withdrawal by Subject|1|||
128808690|NCT04176965|463595512|FG000|Overall Study|Death|1|||
128808691|NCT04176965|463595513|FG001|Overall Study|Death|2|||
128808692|NCT04176965|463595512|FG000|Overall Study|Lost to Follow-up|10|||
128808693|NCT04176965|463595513|FG001|Overall Study|Lost to Follow-up|2|||
128808694|NCT04176965|463595512|FG000|Overall Study|Withdrawal by Subject|6|||
128808695|NCT04176965|463595513|FG001|Overall Study|Withdrawal by Subject|1|||
128808696|NCT02919683|463595514|FG000|Post-Surgery Follow-Up|Death|2|||
128808697|NCT02919683|463595515|FG001|Post-Surgery Follow-Up|Death|2|||
128808698|NCT02919683|463595514|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
128808699|NCT02919683|463595515|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
128808700|NCT04072380|463595516|FG000|Overall Study|Adverse Event|4|||
128808701|NCT04072380|463595517|FG001|Overall Study|Adverse Event|6|||
128808702|NCT04072380|463595518|FG002|Overall Study|Adverse Event|0|||
128808703|NCT04072380|463595516|FG000|Overall Study|Withdrawal by Subject|3|||
128808704|NCT04072380|463595517|FG001|Overall Study|Withdrawal by Subject|1|||
128808705|NCT04072380|463595518|FG002|Overall Study|Withdrawal by Subject|1|||
128808706|NCT04072380|463595516|FG000|Overall Study|Physician Decision|2|||
128808707|NCT04072380|463595517|FG001|Overall Study|Physician Decision|0|||
128808708|NCT04072380|463595518|FG002|Overall Study|Physician Decision|0|||
128808709|NCT04072380|463595516|FG000|Overall Study|Protocol Violation|0|||
128808710|NCT04072380|463595517|FG001|Overall Study|Protocol Violation|2|||
128808711|NCT04072380|463595518|FG002|Overall Study|Protocol Violation|3|||
128808712|NCT04072380|463595516|FG000|Overall Study|Intercurrent Illness and Others|3|||
128808713|NCT04072380|463595517|FG001|Overall Study|Intercurrent Illness and Others|5|||
128808714|NCT04072380|463595518|FG002|Overall Study|Intercurrent Illness and Others|6|||
128808715|NCT03033576|463595521|FG000|Overall Study|Ineligible|1|||
128808716|NCT03033576|463595522|FG001|Overall Study|Ineligible|1|||
128808717|NCT03033576|463595521|FG000|Overall Study|Adverse Event|4|||
128808718|NCT03033576|463595522|FG001|Overall Study|Adverse Event|20|||
128808719|NCT03033576|463595521|FG000|Overall Study|Progression/relapse|9|||
128808720|NCT03033576|463595522|FG001|Overall Study|Progression/relapse|36|||
128808721|NCT03033576|463595521|FG000|Overall Study|Death|1|||
128808722|NCT03033576|463595522|FG001|Overall Study|Death|1|||
128808723|NCT03033576|463595521|FG000|Overall Study|Patient refusal|1|||
128808724|NCT03033576|463595522|FG001|Overall Study|Patient refusal|6|||
128808725|NCT03033576|463595521|FG000|Overall Study|Other, unspecified reasons|0|||
128808726|NCT03033576|463595522|FG001|Overall Study|Other, unspecified reasons|4|||
128808727|NCT03033576|463595521|FG000|Overall Study|Currently on protocol therapy|0|||
128808728|NCT03033576|463595522|FG001|Overall Study|Currently on protocol therapy|2|||
128808729|NCT05179837|463595523|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
128808730|NCT05179837|463595523|FG000|Overall Study|Device malfunctioned|1|||
128808731|NCT05179837|463595523|FG000|Overall Study|Image quality too low|2|||
128808732|NCT05051124|463595524|FG000|Overall Study|Lost to Follow-up|2|||
128808733|NCT05051124|463595524|FG000|Overall Study|Withdrawal by Subject|1|||
128808734|NCT05051124|463595524|FG000|Overall Study|Residential relocation|2|||
128808735|NCT05051124|463595524|FG000|Overall Study|Death|1|||
128808736|NCT04782973|463595525|FG000|Overall Study|Withdrawal by Subject|5|||
128808737|NCT04782973|463595525|FG000|Overall Study|Protocol Violation|6|||
128808738|NCT04782973|463595525|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
128808739|NCT06491433|463595526|FG000|Overall Study|Protocol Violation|51|||
128808740|NCT06491433|463595526|FG000|Overall Study|consent withdrawal|2|||
128808741|NCT06491433|463595526|FG000|Overall Study|screen failure|1|||
128808742|NCT05478499|463595532|FG000|Overall Study|Adverse Event|4|||
128808743|NCT05478499|463595533|FG001|Overall Study|Adverse Event|2|||
128808744|NCT05478499|463595532|FG000|Overall Study|Withdrawal by Subject|3|||
128808745|NCT05478499|463595533|FG001|Overall Study|Withdrawal by Subject|2|||
128808746|NCT05478499|463595532|FG000|Overall Study|Lack of Efficacy|1|||
128808747|NCT05478499|463595533|FG001|Overall Study|Lack of Efficacy|0|||
128808748|NCT05478499|463595532|FG000|Overall Study|Lost to Follow-up|1|||
128808749|NCT05478499|463595533|FG001|Overall Study|Lost to Follow-up|0|||
128808750|NCT05478499|463595532|FG000|Overall Study|Other reasons|0|||
128808751|NCT05478499|463595533|FG001|Overall Study|Other reasons|1|||
128808752|NCT02962895|463595534|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
128808753|NCT02962895|463595535|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
128808754|NCT02962895|463595536|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
128808755|NCT02962895|463595537|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
128808756|NCT02962895|463595538|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
128808757|NCT02962895|463595539|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
128808758|NCT02962895|463595540|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
128808759|NCT02962895|463595534|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
128808760|NCT02962895|463595535|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
128808761|NCT02962895|463595536|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
128808762|NCT02962895|463595537|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
128808763|NCT02962895|463595538|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
128808764|NCT02962895|463595539|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
128808765|NCT02962895|463595540|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
128808766|NCT02962895|463595534|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
128808767|NCT02962895|463595535|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
128808768|NCT02962895|463595536|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
128808769|NCT02962895|463595537|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
128808770|NCT02962895|463595538|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
128808771|NCT02962895|463595539|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
128808772|NCT02962895|463595540|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
128808773|NCT02962895|463595534|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
128808774|NCT02962895|463595535|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
128808775|NCT02962895|463595536|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
128808776|NCT02962895|463595537|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
128808777|NCT02962895|463595538|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
128808778|NCT02962895|463595539|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
128808779|NCT02962895|463595540|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
128808780|NCT02962895|463595534|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
128808781|NCT02962895|463595535|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
128808782|NCT02962895|463595536|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
128808783|NCT02962895|463595537|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
128808784|NCT02962895|463595538|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
128808785|NCT02962895|463595539|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
128808786|NCT02962895|463595540|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
128808787|NCT02962895|463595534|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
128808788|NCT02962895|463595535|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
128808789|NCT02962895|463595536|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
128808790|NCT02962895|463595537|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
128808791|NCT02962895|463595538|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
128808792|NCT02962895|463595539|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
128808793|NCT02962895|463595540|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
128808794|NCT02962895|463595534|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
128808795|NCT02962895|463595535|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
128808796|NCT02962895|463595536|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
128808797|NCT02962895|463595537|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
128808798|NCT02962895|463595538|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
128808799|NCT02962895|463595539|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
128808800|NCT02962895|463595540|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
128808801|NCT02962895|463595534|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
128808802|NCT02962895|463595535|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
128808803|NCT02962895|463595536|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
128808804|NCT02962895|463595537|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
128808805|NCT02962895|463595538|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
128808806|NCT02962895|463595539|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
128808807|NCT02962895|463595540|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
128808808|NCT02962895|463595534|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
128808809|NCT02962895|463595535|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
128808810|NCT02962895|463595536|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
128808811|NCT02962895|463595537|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
128808812|NCT02962895|463595538|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
128808813|NCT02962895|463595539|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
128808814|NCT02962895|463595540|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
128808815|NCT02962895|463595534|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
128808816|NCT02962895|463595535|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
128808817|NCT02962895|463595536|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
128808818|NCT02962895|463595537|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
128808819|NCT02962895|463595538|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
128808820|NCT02962895|463595539|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
128808821|NCT02962895|463595540|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
128808822|NCT02962895|463595534|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
128808823|NCT02962895|463595535|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
128808824|NCT02962895|463595536|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
128808825|NCT02962895|463595537|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
128808826|NCT02962895|463595538|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
128808827|NCT02962895|463595539|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
128808828|NCT02962895|463595540|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
128808829|NCT02962895|463595534|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
128808830|NCT02962895|463595535|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
128808831|NCT02962895|463595536|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
128808832|NCT02962895|463595537|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
128808833|NCT02962895|463595538|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
128808834|NCT02962895|463595539|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
128808835|NCT02962895|463595540|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
128808836|NCT02962895|463595534|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
128808837|NCT02962895|463595535|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
128808838|NCT02962895|463595536|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
128808839|NCT02962895|463595537|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
128808840|NCT02962895|463595538|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
128808841|NCT02962895|463595539|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
128808842|NCT02962895|463595540|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
128808843|NCT02962895|463595534|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
128808844|NCT02962895|463595535|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
128808845|NCT02962895|463595536|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
128808846|NCT02962895|463595537|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
128808847|NCT02962895|463595538|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
128808848|NCT02962895|463595539|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
128808849|NCT02962895|463595540|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
128808850|NCT03364647|463595543|FG000|Overall Study|Withdrawal by Subject|3|||
128808851|NCT03364647|463595544|FG001|Overall Study|Withdrawal by Subject|1|||
128808852|NCT01606215|463595551|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
128808853|NCT01606215|463595552|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
128808854|NCT04592549|463595553|FG000|Overall Study|Withdrawal by Subject|0|||
128808855|NCT04592549|463595554|FG001|Overall Study|Withdrawal by Subject|1|||
128808856|NCT04592549|463595555|FG002|Overall Study|Withdrawal by Subject|0|||
128808857|NCT04592549|463595556|FG003|Overall Study|Withdrawal by Subject|1|||
128808858|NCT04592549|463595557|FG004|Overall Study|Withdrawal by Subject|1|||
128808859|NCT04592549|463595558|FG005|Overall Study|Withdrawal by Subject|0|||
128808860|NCT04592549|463595553|FG000|Overall Study|Lost to Follow-up|2|||
128808861|NCT04592549|463595554|FG001|Overall Study|Lost to Follow-up|0|||
128808862|NCT04592549|463595555|FG002|Overall Study|Lost to Follow-up|0|||
128808863|NCT04592549|463595556|FG003|Overall Study|Lost to Follow-up|1|||
128808864|NCT04592549|463595557|FG004|Overall Study|Lost to Follow-up|1|||
128808865|NCT04592549|463595558|FG005|Overall Study|Lost to Follow-up|1|||
128808866|NCT05184192|463595559|FG000|Overall Study|Lost to Follow-up|4|||
128808867|NCT05184192|463595560|FG001|Overall Study|Lost to Follow-up|7|||
128808868|NCT05184192|463595559|FG000|Overall Study|Adverse Event|1|||
128808869|NCT05184192|463595560|FG001|Overall Study|Adverse Event|4|||
128808870|NCT05184192|463595559|FG000|Overall Study|PI withdrawal|1|||
128808871|NCT05184192|463595560|FG001|Overall Study|PI withdrawal|2|||
128808872|NCT05184192|463595559|FG000|Overall Study|Withdrew due to adverse effect|1|||
128808873|NCT05184192|463595560|FG001|Overall Study|Withdrew due to adverse effect|0|||
128808874|NCT05184192|463595559|FG000|Overall Study|Medication schedule|1|||
128808875|NCT05184192|463595560|FG001|Overall Study|Medication schedule|0|||
128808876|NCT05184192|463595559|FG000|Overall Study|Concern for adverse effects|0|||
128808877|NCT05184192|463595560|FG001|Overall Study|Concern for adverse effects|4|||
128808878|NCT05093829|463595567|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
128808879|NCT05093829|463595568|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
128808880|NCT05093829|463595569|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
128808881|NCT05093829|463595570|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
128808882|NCT05093829|463595571|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
128808883|NCT04353661|463597503|FG000|Overall Study|Protocol Violation|0|||
128808884|NCT04353661|463597504|FG001|Overall Study|Protocol Violation|0|||
128808885|NCT04353661|463597505|FG002|Overall Study|Protocol Violation|1|||
128808886|NCT04353661|463597503|FG000|Overall Study|Study termination by the Sponsor|1|||
128808887|NCT04353661|463597504|FG001|Overall Study|Study termination by the Sponsor|1|||
128808888|NCT04353661|463597505|FG002|Overall Study|Study termination by the Sponsor|1|||
128808889|NCT00667251|463597506|FG000|Overall Study|Disease progression|232|||
128808890|NCT00667251|463597507|FG001|Overall Study|Disease progression|203|||
128808891|NCT00667251|463597506|FG000|Overall Study|Toxicity|44|||
128808892|NCT00667251|463597507|FG001|Overall Study|Toxicity|23|||
128808893|NCT00667251|463597506|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
128808894|NCT00667251|463597507|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
128808895|NCT00667251|463597506|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
128808896|NCT00667251|463597507|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
128808897|NCT00667251|463597506|FG000|Overall Study|Symptomatic progression|8|||
128808898|NCT00667251|463597507|FG001|Overall Study|Symptomatic progression|4|||
128808899|NCT00667251|463597506|FG000|Overall Study|Death|6|||
128808900|NCT00667251|463597507|FG001|Overall Study|Death|11|||
128808901|NCT00667251|463597506|FG000|Overall Study|Intercurrent illness|5|||
128808902|NCT00667251|463597507|FG001|Overall Study|Intercurrent illness|6|||
128808903|NCT00667251|463597506|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
128808904|NCT00667251|463597507|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
128808905|NCT00667251|463597506|FG000|Overall Study|Randomized not Treated|4|||
128808906|NCT00667251|463597507|FG001|Overall Study|Randomized not Treated|1|||
128808907|NCT02995434|463597512|FG000|Overall Study|Adverse Event|1|||
128808908|NCT02995434|463597513|FG001|Overall Study|Adverse Event|0|||
128808909|NCT02995434|463597512|FG000|Overall Study|Withdrawal by Subject|6|||
128808910|NCT02995434|463597513|FG001|Overall Study|Withdrawal by Subject|3|||
128808911|NCT03047928|463597514|FG000|Overall Study|Adverse Event|0|||
128808912|NCT03047928|463597515|FG001|Overall Study|Adverse Event|2|||
128808913|NCT03047928|463597516|FG002|Overall Study|Adverse Event|0|||
128808914|NCT03047928|463597514|FG000|Overall Study|Protocol Violation|0|||
128808915|NCT03047928|463597515|FG001|Overall Study|Protocol Violation|1|||
128808916|NCT03047928|463597516|FG002|Overall Study|Protocol Violation|0|||
128808917|NCT03047928|463597514|FG000|Overall Study|included in another protocol|0|||
128808918|NCT03047928|463597515|FG001|Overall Study|included in another protocol|1|||
128808919|NCT03047928|463597516|FG002|Overall Study|included in another protocol|0|||
128808920|NCT04492007|463597517|FG000|Overall Study|Lost to Follow-up|1|||
128808921|NCT04492007|463597518|FG001|Overall Study|Lost to Follow-up|1|||
128808922|NCT04492007|463597519|FG002|Overall Study|Lost to Follow-up|2|||
128808923|NCT04492007|463597520|FG003|Overall Study|Lost to Follow-up|2|||
128808924|NCT04492007|463597517|FG000|Overall Study|Protocol Violation|1|||
128808925|NCT04492007|463597518|FG001|Overall Study|Protocol Violation|1|||
128808926|NCT04492007|463597519|FG002|Overall Study|Protocol Violation|1|||
128808927|NCT04492007|463597520|FG003|Overall Study|Protocol Violation|1|||
128808928|NCT04492007|463597517|FG000|Overall Study|Withdrawal by Subject|0|||
128808929|NCT04492007|463597518|FG001|Overall Study|Withdrawal by Subject|0|||
128808930|NCT04492007|463597519|FG002|Overall Study|Withdrawal by Subject|1|||
128808931|NCT04492007|463597520|FG003|Overall Study|Withdrawal by Subject|1|||
128808932|NCT05178316|463597525|FG000|Overall Study|Adverse Event|5|||
128808933|NCT05178316|463597526|FG001|Overall Study|Adverse Event|4|||
128808934|NCT05178316|463597527|FG002|Overall Study|Adverse Event|9|||
128808935|NCT05178316|463597525|FG000|Overall Study|Enrolled in Error|1|||
128808936|NCT05178316|463597526|FG001|Overall Study|Enrolled in Error|2|||
128808937|NCT05178316|463597527|FG002|Overall Study|Enrolled in Error|1|||
128808938|NCT05178316|463597525|FG000|Overall Study|Lost to Follow-up|3|||
128808939|NCT05178316|463597526|FG001|Overall Study|Lost to Follow-up|15|||
128808940|NCT05178316|463597527|FG002|Overall Study|Lost to Follow-up|11|||
128808941|NCT05178316|463597525|FG000|Overall Study|Noncompliance|1|||
128808942|NCT05178316|463597526|FG001|Overall Study|Noncompliance|3|||
128808943|NCT05178316|463597527|FG002|Overall Study|Noncompliance|1|||
128808944|NCT05178316|463597525|FG000|Overall Study|Other|0|||
128808945|NCT05178316|463597526|FG001|Overall Study|Other|1|||
128808946|NCT05178316|463597527|FG002|Overall Study|Other|0|||
128808947|NCT05178316|463597525|FG000|Overall Study|Physician Decision|0|||
128808948|NCT05178316|463597526|FG001|Overall Study|Physician Decision|3|||
128808949|NCT05178316|463597527|FG002|Overall Study|Physician Decision|2|||
128808950|NCT05178316|463597525|FG000|Overall Study|Protocol deviation|1|||
128808951|NCT05178316|463597526|FG001|Overall Study|Protocol deviation|0|||
128808952|NCT05178316|463597527|FG002|Overall Study|Protocol deviation|1|||
128808953|NCT05178316|463597525|FG000|Overall Study|Sponsor decision|1|||
128808954|NCT05178316|463597526|FG001|Overall Study|Sponsor decision|0|||
128808955|NCT05178316|463597527|FG002|Overall Study|Sponsor decision|1|||
128808956|NCT05178316|463597525|FG000|Overall Study|Withdrawal by Subject|5|||
128808957|NCT05178316|463597526|FG001|Overall Study|Withdrawal by Subject|11|||
128808958|NCT05178316|463597527|FG002|Overall Study|Withdrawal by Subject|5|||
128808959|NCT03457142|463597528|FG000|Overall Study|Death|1|||
128808960|NCT03792256|463597531|FG000|Overall Study|Death|0|||
128808961|NCT03792256|463597532|FG001|Overall Study|Death|1|||
128808962|NCT03792256|463597531|FG000|Overall Study|Lack of Efficacy|0|||
128808963|NCT03792256|463597532|FG001|Overall Study|Lack of Efficacy|1|||
128808964|NCT03792256|463597531|FG000|Overall Study|Withdrawal by Subject|0|||
128808965|NCT03792256|463597532|FG001|Overall Study|Withdrawal by Subject|1|||
128808966|NCT04760678|463597535|FG000|Overall Study|Death|13|||
128808967|NCT04760678|463597535|FG000|Overall Study|Lost to Follow-up|48|||
128808968|NCT04760678|463597535|FG000|Overall Study|Withdrawal by Subject|1|||
128808969|NCT01748448|463597538|FG000|Treatment Period|Consent withdrawn by subject|1|||
128808970|NCT01748448|463597539|FG001|Treatment Period|Consent withdrawn by subject|0|||
128808971|NCT01748448|463597538|FG000|Treatment Period|Adverse Event|1|||
128808972|NCT01748448|463597539|FG001|Treatment Period|Adverse Event|0|||
128808973|NCT01748448|463597538|FG000|Treatment Period|Personal|0|||
128808974|NCT01748448|463597539|FG001|Treatment Period|Personal|1|||
128808975|NCT02907099|463597540|FG000|Overall Study|Adverse Event|1|||
128808976|NCT02907099|463597540|FG000|Overall Study|Withdrawal by Subject|2|||
128808977|NCT02907099|463597540|FG000|Overall Study|Screen Fail|2|||
128808978|NCT03436290|463597541|FG000|Overall Study|Post-randomization Exclusion|1|||
128808979|NCT03436290|463597542|FG001|Overall Study|Post-randomization Exclusion|0|||
128808980|NCT03436290|463597541|FG000|Overall Study|Death|6|||
128808981|NCT03436290|463597542|FG001|Overall Study|Death|0|||
128808982|NCT03436290|463597541|FG000|Overall Study|Withdrawal by Subject|4|||
128808983|NCT03436290|463597542|FG001|Overall Study|Withdrawal by Subject|0|||
128808984|NCT03436290|463597541|FG000|Overall Study|Protocol Violation|30|||
128808985|NCT03436290|463597542|FG001|Overall Study|Protocol Violation|0|||
128808986|NCT05516147|463597545|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
128808987|NCT04952909|463597551|FG000|Overall Study|Death|3|||
128808988|NCT02515773|463597552|FG000|Overall Study|Withdrawal by Subject|12|||
128808989|NCT02515773|463597553|FG001|Overall Study|Withdrawal by Subject|2|||
128808990|NCT02515773|463597552|FG000|Overall Study|Lost to Follow-up|119|||
128808991|NCT02515773|463597553|FG001|Overall Study|Lost to Follow-up|126|||
128808992|NCT02515773|463597552|FG000|Overall Study|Discharged from Clinic Services|53|||
128808993|NCT02515773|463597553|FG001|Overall Study|Discharged from Clinic Services|84|||
128808994|NCT02515773|463597552|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
128808995|NCT02515773|463597553|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
128808996|NCT02515773|463597552|FG000|Overall Study|Follow-up at non-study site|8|||
128808997|NCT02515773|463597553|FG001|Overall Study|Follow-up at non-study site|16|||
128808998|NCT02515773|463597552|FG000|Overall Study|Moved from area|9|||
128808999|NCT02515773|463597553|FG001|Overall Study|Moved from area|14|||
128809000|NCT03468218|463597554|FG000|Overall Study|Adverse Event|5|||
128809001|NCT03468218|463597554|FG000|Overall Study|Progressive Disease|16|||
128809002|NCT03468218|463597554|FG000|Overall Study|Death|1|||
128809003|NCT03468218|463597554|FG000|Overall Study|Alternate therapy|1|||
128809004|NCT03468218|463597554|FG000|Overall Study|Withdrawal by Subject|2|||
128809005|NCT03829410|463597556|FG000|Overall Study|Adverse Event|1|||
128809006|NCT03829410|463597557|FG001|Overall Study|Adverse Event|0|||
128809007|NCT03829410|463597558|FG002|Overall Study|Adverse Event|1|||
128809008|NCT03829410|463597559|FG003|Overall Study|Adverse Event|4|||
128809009|NCT03829410|463597556|FG000|Overall Study|Physician Decision|0|||
128809010|NCT03829410|463597557|FG001|Overall Study|Physician Decision|0|||
128809011|NCT03829410|463597558|FG002|Overall Study|Physician Decision|0|||
128809012|NCT03829410|463597559|FG003|Overall Study|Physician Decision|2|||
128809013|NCT03829410|463597556|FG000|Overall Study|Disease Progressing|3|||
128809014|NCT03829410|463597557|FG001|Overall Study|Disease Progressing|4|||
128809015|NCT03829410|463597558|FG002|Overall Study|Disease Progressing|2|||
128809016|NCT03829410|463597559|FG003|Overall Study|Disease Progressing|31|||
128809017|NCT03829410|463597556|FG000|Overall Study|Miscellaneous|2|||
128809018|NCT03829410|463597557|FG001|Overall Study|Miscellaneous|4|||
128809019|NCT03829410|463597558|FG002|Overall Study|Miscellaneous|3|||
128809020|NCT03829410|463597559|FG003|Overall Study|Miscellaneous|10|||
128809021|NCT03719443|463597560|FG000|Overall Study|Lost to Follow-up|0|||
128809022|NCT03719443|463597561|FG001|Overall Study|Lost to Follow-up|0|||
128809023|NCT03719443|463597562|FG002|Overall Study|Lost to Follow-up|1|||
128809024|NCT03719443|463597563|FG003|Overall Study|Lost to Follow-up|0|||
128809025|NCT03719443|463597564|FG004|Overall Study|Lost to Follow-up|1|||
128809026|NCT03719443|463597565|FG005|Overall Study|Lost to Follow-up|0|||
128809027|NCT03719443|463597566|FG006|Overall Study|Lost to Follow-up|1|||
128809028|NCT03719443|463597560|FG000|Overall Study|Withdrawal by Subject|0|||
128809029|NCT03719443|463597561|FG001|Overall Study|Withdrawal by Subject|0|||
128809030|NCT03719443|463597562|FG002|Overall Study|Withdrawal by Subject|1|||
128809031|NCT03719443|463597563|FG003|Overall Study|Withdrawal by Subject|0|||
128809032|NCT03719443|463597564|FG004|Overall Study|Withdrawal by Subject|0|||
128809033|NCT03719443|463597565|FG005|Overall Study|Withdrawal by Subject|0|||
128809034|NCT03719443|463597566|FG006|Overall Study|Withdrawal by Subject|0|||
128809035|NCT04924660|463597567|FG000|United States|Death|29|||
128809036|NCT04924660|463597568|FG001|United States|Death|32|||
128809037|NCT04924660|463597569|FG002|United States|Death|34|||
128809038|NCT04924660|463597570|FG003|United States|Death|25|||
128809039|NCT04924660|463597571|FG004|United States|Death|26|||
128809040|NCT04924660|463597572|FG005|United States|Death|23|||
128809041|NCT04924660|463597567|FG000|United States|Lost to Follow-up|15|||
128809042|NCT04924660|463597568|FG001|United States|Lost to Follow-up|10|||
128809043|NCT04924660|463597569|FG002|United States|Lost to Follow-up|13|||
128809044|NCT04924660|463597570|FG003|United States|Lost to Follow-up|5|||
128809045|NCT04924660|463597571|FG004|United States|Lost to Follow-up|19|||
128809046|NCT04924660|463597572|FG005|United States|Lost to Follow-up|20|||
128809047|NCT04924660|463597567|FG000|United States|Withdrawal by Subject|8|||
128809048|NCT04924660|463597568|FG001|United States|Withdrawal by Subject|3|||
128809049|NCT04924660|463597569|FG002|United States|Withdrawal by Subject|3|||
128809050|NCT04924660|463597570|FG003|United States|Withdrawal by Subject|3|||
128809051|NCT04924660|463597571|FG004|United States|Withdrawal by Subject|8|||
128809052|NCT04924660|463597572|FG005|United States|Withdrawal by Subject|4|||
128809053|NCT04924660|463597567|FG000|Spain|Death|0|||
128809054|NCT04924660|463597568|FG001|Spain|Death|0|||
128809055|NCT04924660|463597569|FG002|Spain|Death|0|||
128809056|NCT04924660|463597570|FG003|Spain|Death|0|||
128809057|NCT04924660|463597571|FG004|Spain|Death|0|||
128809058|NCT04924660|463597572|FG005|Spain|Death|2|||
128809059|NCT04924660|463597567|FG000|Spain|Lost to Follow-up|0|||
128809060|NCT04924660|463597568|FG001|Spain|Lost to Follow-up|0|||
128809061|NCT04924660|463597569|FG002|Spain|Lost to Follow-up|0|||
128809062|NCT04924660|463597570|FG003|Spain|Lost to Follow-up|0|||
128809063|NCT04924660|463597571|FG004|Spain|Lost to Follow-up|1|||
128809064|NCT04924660|463597572|FG005|Spain|Lost to Follow-up|0|||
128809065|NCT04924660|463597567|FG000|Brazil|Death|0|||
128809066|NCT04924660|463597568|FG001|Brazil|Death|0|||
128809067|NCT04924660|463597569|FG002|Brazil|Death|0|||
128809068|NCT04924660|463597570|FG003|Brazil|Death|0|||
128809069|NCT04924660|463597571|FG004|Brazil|Death|1|||
128809070|NCT04924660|463597572|FG005|Brazil|Death|0|||
128809071|NCT04924660|463597567|FG000|Italy|Lost to Follow-up|0|||
128809072|NCT04924660|463597568|FG001|Italy|Lost to Follow-up|0|||
128809073|NCT04924660|463597569|FG002|Italy|Lost to Follow-up|0|||
128809074|NCT04924660|463597570|FG003|Italy|Lost to Follow-up|0|||
128809075|NCT04924660|463597571|FG004|Italy|Lost to Follow-up|0|||
128809076|NCT04924660|463597572|FG005|Italy|Lost to Follow-up|1|||
128809077|NCT04924660|463597567|FG000|South Africa|Death|0|||
128809078|NCT04924660|463597568|FG001|South Africa|Death|0|||
128809079|NCT04924660|463597569|FG002|South Africa|Death|0|||
128809080|NCT04924660|463597570|FG003|South Africa|Death|0|||
128809081|NCT04924660|463597571|FG004|South Africa|Death|0|||
128809082|NCT04924660|463597572|FG005|South Africa|Death|1|||
128809083|NCT04924660|463597567|FG000|South Africa|Lost to Follow-up|0|||
128809084|NCT04924660|463597568|FG001|South Africa|Lost to Follow-up|0|||
128809085|NCT04924660|463597569|FG002|South Africa|Lost to Follow-up|0|||
128809086|NCT04924660|463597570|FG003|South Africa|Lost to Follow-up|0|||
128809087|NCT04924660|463597571|FG004|South Africa|Lost to Follow-up|0|||
128809088|NCT04924660|463597572|FG005|South Africa|Lost to Follow-up|1|||
128809089|NCT03557697|463597573|FG000|Overall Study|Withdrawal by Subject|2|||
128809090|NCT03557697|463597574|FG001|Overall Study|Withdrawal by Subject|4|||
128809091|NCT04749615|463597576|FG000|Overall Study|Lost to Follow-up|6|||
128809092|NCT04749615|463597577|FG001|Overall Study|Lost to Follow-up|10|||
128809093|NCT03611491|463597578|FG000|Overall Study|Lost to Follow-up|1|||
128809094|NCT05894577|463597592|FG000|Overall Study|No receipt of study drug|14|||
128809095|NCT05894577|463597593|FG001|Overall Study|No receipt of study drug|13|||
128809096|NCT05894577|463597592|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
128809097|NCT05894577|463597593|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
128809098|NCT05894577|463597592|FG000|Overall Study|Screen Fail|2|||
128809099|NCT05894577|463597593|FG001|Overall Study|Screen Fail|0|||
128809100|NCT05894577|463597592|FG000|Overall Study|Study drug recall|86|||
128809101|NCT05894577|463597593|FG001|Overall Study|Study drug recall|63|||
128809102|NCT05481320|463597594|FG000|Overall Study|Withdrawal by Subject|1|||
128809103|NCT05481320|463597595|FG001|Overall Study|Withdrawal by Subject|1|||
128809104|NCT05481320|463597594|FG000|Overall Study|Care recipent passed away|0|||
128809105|NCT05481320|463597595|FG001|Overall Study|Care recipent passed away|1|||
128809106|NCT05481320|463597594|FG000|Overall Study|Out-of-window assessment|0|||
128809107|NCT05481320|463597595|FG001|Overall Study|Out-of-window assessment|1|||
128809108|NCT05481320|463597594|FG000|Overall Study|No longer a primary caregiver|3|||
128809109|NCT05481320|463597595|FG001|Overall Study|No longer a primary caregiver|0|||
128809110|NCT05481320|463597594|FG000|Overall Study|Unable to contact|1|||
128809111|NCT05481320|463597595|FG001|Overall Study|Unable to contact|0|||
128809112|NCT04509674|463597597|FG000|Overall Study|Not treated|33|||
128809113|NCT04509674|463597598|FG001|Overall Study|Not treated|26|||
128809114|NCT04509674|463597597|FG000|Overall Study|Protocol Violation|9|||
128809115|NCT04509674|463597598|FG001|Overall Study|Protocol Violation|10|||
128809116|NCT04509674|463597597|FG000|Overall Study|Lost to Follow-up|31|||
128809117|NCT04509674|463597598|FG001|Overall Study|Lost to Follow-up|39|||
128809118|NCT04509674|463597597|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
128809119|NCT04509674|463597598|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
128809120|NCT04509674|463597597|FG000|Overall Study|Adverse event, serious fatal event|11|||
128809121|NCT04509674|463597598|FG001|Overall Study|Adverse event, serious fatal event|4|||
128809122|NCT04509674|463597597|FG000|Overall Study|Adverse event, non-fatal event|107|||
128809123|NCT04509674|463597598|FG001|Overall Study|Adverse event, non-fatal event|118|||
128809124|NCT04509674|463597597|FG000|Overall Study|Other reason than listed|106|||
128809125|NCT04509674|463597598|FG001|Overall Study|Other reason than listed|95|||
128809126|NCT01214616|463597599|FG000|Overall Study|Progressive disease|2|||
128809127|NCT01214616|463597600|FG001|Overall Study|Progressive disease|2|||
128809128|NCT01214616|463597601|FG002|Overall Study|Progressive disease|2|||
128809129|NCT01214616|463597602|FG003|Overall Study|Progressive disease|4|||
128809130|NCT01214616|463597599|FG000|Overall Study|Dose limiting toxicity|0|||
128809131|NCT01214616|463597600|FG001|Overall Study|Dose limiting toxicity|2|||
128809132|NCT01214616|463597601|FG002|Overall Study|Dose limiting toxicity|0|||
128809133|NCT01214616|463597602|FG003|Overall Study|Dose limiting toxicity|0|||
128809134|NCT01214616|463597599|FG000|Overall Study|Other adverse events|0|||
128809135|NCT01214616|463597600|FG001|Overall Study|Other adverse events|1|||
128809136|NCT01214616|463597601|FG002|Overall Study|Other adverse events|1|||
128809137|NCT01214616|463597602|FG003|Overall Study|Other adverse events|1|||
128809138|NCT01214616|463597599|FG000|Overall Study|Withdrawal by Subject|1|||
128809139|NCT01214616|463597600|FG001|Overall Study|Withdrawal by Subject|0|||
128809140|NCT01214616|463597601|FG002|Overall Study|Withdrawal by Subject|0|||
128809141|NCT01214616|463597602|FG003|Overall Study|Withdrawal by Subject|1|||
128809142|NCT03721952|463597603|FG000|Overall Study|Lost to Follow-up|0|||
128809143|NCT03721952|463597604|FG001|Overall Study|Lost to Follow-up|0|||
128809144|NCT03721952|463597605|FG002|Overall Study|Lost to Follow-up|2|||
128809145|NCT03721952|463597606|FG003|Overall Study|Lost to Follow-up|0|||
128809146|NCT03721952|463597607|FG004|Overall Study|Lost to Follow-up|0|||
128809147|NCT03721952|463597603|FG000|Overall Study|Protocol Violation|0|||
128809148|NCT03721952|463597604|FG001|Overall Study|Protocol Violation|1|||
128809149|NCT03721952|463597605|FG002|Overall Study|Protocol Violation|0|||
128809150|NCT03721952|463597606|FG003|Overall Study|Protocol Violation|0|||
128809151|NCT03721952|463597607|FG004|Overall Study|Protocol Violation|0|||
128809152|NCT03721952|463597603|FG000|Overall Study|Withdrawal by Subject|1|||
128809153|NCT03721952|463597604|FG001|Overall Study|Withdrawal by Subject|0|||
128809154|NCT03721952|463597605|FG002|Overall Study|Withdrawal by Subject|40|||
128809155|NCT03721952|463597606|FG003|Overall Study|Withdrawal by Subject|28|||
128809156|NCT03721952|463597607|FG004|Overall Study|Withdrawal by Subject|0|||
128809157|NCT05292365|463597608|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
128809158|NCT05292365|463597609|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
128809159|NCT05292365|463597610|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
128809160|NCT05292365|463597611|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
128809161|NCT04495894|463597615|FG000|Overall Study|Withdrawal by Subject|2|||
128809162|NCT04495894|463597616|FG001|Overall Study|Withdrawal by Subject|0|||
128809163|NCT04495894|463597617|FG002|Overall Study|Withdrawal by Subject|2|||
128809164|NCT04495894|463597618|FG003|Overall Study|Withdrawal by Subject|3|||
128809165|NCT04495894|463597615|FG000|Overall Study|Early termination|0|||
128809166|NCT04495894|463597616|FG001|Overall Study|Early termination|0|||
128809167|NCT04495894|463597617|FG002|Overall Study|Early termination|3|||
128809168|NCT04495894|463597618|FG003|Overall Study|Early termination|0|||
128809169|NCT05579899|463597620|FG000|Overall Study|Lost to Follow-up|3|||
128809170|NCT05579899|463597621|FG001|Overall Study|Lost to Follow-up|1|||
128809171|NCT05579899|463597620|FG000|Overall Study|Adverse Event|0|||
128809172|NCT05579899|463597621|FG001|Overall Study|Adverse Event|3|||
128809173|NCT05579899|463597620|FG000|Overall Study|Pregnancy|0|||
128809174|NCT05579899|463597621|FG001|Overall Study|Pregnancy|1|||
128809175|NCT05579899|463597620|FG000|Overall Study|Withdrawal by Subject|0|||
128809176|NCT05579899|463597621|FG001|Overall Study|Withdrawal by Subject|3|||
128809177|NCT01000961|463597623|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
128809178|NCT01000961|463597624|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
128809179|NCT01000961|463597623|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
128809180|NCT01000961|463597624|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
128809181|NCT04185298|463597628|FG000|Overall Study|Lost to Follow-up|1|||
128809182|NCT04185298|463597629|FG001|Overall Study|Lost to Follow-up|3|||
128809183|NCT04185298|463597628|FG000|Overall Study|Withdrawal by Subject|0|||
128809184|NCT04185298|463597629|FG001|Overall Study|Withdrawal by Subject|3|||
128809185|NCT04015167|463597641|FG000|Overall Study|Lost to Follow-up|40|||
128809186|NCT04015167|463597641|FG000|Overall Study|Adverse Event|5|||
128809187|NCT04015167|463597641|FG000|Overall Study|Withdrawal by Subject|2|||
128809188|NCT04015167|463597641|FG000|Overall Study|Subject went to jail|1|||
128809189|NCT03640312|463597642|FG000|Overall Study|Lost to Follow-up|3|||
128809190|NCT03640312|463597643|FG001|Overall Study|Lost to Follow-up|6|||
128809191|NCT03382652|463597644|FG000|Overall Study|Lost to Follow-up|6|||
128809192|NCT03382652|463597644|FG000|Overall Study|Death|4|||
128809193|NCT03382652|463597644|FG000|Overall Study|Revision|5|||
128809194|NCT03382652|463597644|FG000|Overall Study|Patient withdrew|3|||
128809195|NCT03382652|463597644|FG000|Overall Study|Other reasons|21|||
128809196|NCT04810650|463597648|FG000|Overall Study|Disenrolled in error|0|||
128809197|NCT04810650|463597649|FG001|Overall Study|Disenrolled in error|0|||
128809198|NCT04810650|463597650|FG002|Overall Study|Disenrolled in error|0|||
128809199|NCT04810650|463597651|FG003|Overall Study|Disenrolled in error|0|||
128809200|NCT04810650|463597652|FG004|Overall Study|Disenrolled in error|0|||
128809201|NCT04810650|463597653|FG005|Overall Study|Disenrolled in error|0|||
128809202|NCT04810650|463597654|FG006|Overall Study|Disenrolled in error|0|||
128809203|NCT04810650|463597655|FG007|Overall Study|Disenrolled in error|0|||
128809204|NCT04810650|463597656|FG008|Overall Study|Disenrolled in error|1|||
128809205|NCT04810650|463597657|FG009|Overall Study|Disenrolled in error|0|||
128809206|NCT04810650|463597658|FG010|Overall Study|Disenrolled in error|0|||
128809207|NCT04810650|463597659|FG011|Overall Study|Disenrolled in error|0|||
128809208|NCT04810650|463597660|FG012|Overall Study|Disenrolled in error|0|||
128809209|NCT04810650|463597661|FG013|Overall Study|Disenrolled in error|0|||
128809210|NCT04810650|463597648|FG000|Overall Study|Death|0|||
128809211|NCT04810650|463597649|FG001|Overall Study|Death|0|||
128809212|NCT04810650|463597650|FG002|Overall Study|Death|0|||
128809213|NCT04810650|463597651|FG003|Overall Study|Death|0|||
128809214|NCT04810650|463597652|FG004|Overall Study|Death|0|||
128809215|NCT04810650|463597653|FG005|Overall Study|Death|0|||
128809216|NCT04810650|463597654|FG006|Overall Study|Death|2|||
128809217|NCT04810650|463597655|FG007|Overall Study|Death|2|||
128809218|NCT04810650|463597656|FG008|Overall Study|Death|0|||
128809219|NCT04810650|463597657|FG009|Overall Study|Death|1|||
128809220|NCT04810650|463597658|FG010|Overall Study|Death|0|||
128809221|NCT04810650|463597659|FG011|Overall Study|Death|0|||
128809222|NCT04810650|463597660|FG012|Overall Study|Death|2|||
128809223|NCT04810650|463597661|FG013|Overall Study|Death|1|||
128809224|NCT04810650|463597648|FG000|Overall Study|Moved/transferred care|0|||
128809225|NCT04810650|463597649|FG001|Overall Study|Moved/transferred care|0|||
128809226|NCT04810650|463597650|FG002|Overall Study|Moved/transferred care|0|||
128809227|NCT04810650|463597651|FG003|Overall Study|Moved/transferred care|0|||
128809228|NCT04810650|463597652|FG004|Overall Study|Moved/transferred care|0|||
128809229|NCT04810650|463597653|FG005|Overall Study|Moved/transferred care|0|||
128809230|NCT04810650|463597654|FG006|Overall Study|Moved/transferred care|0|||
128809231|NCT04810650|463597655|FG007|Overall Study|Moved/transferred care|1|||
128809232|NCT04810650|463597656|FG008|Overall Study|Moved/transferred care|12|||
128809233|NCT04810650|463597657|FG009|Overall Study|Moved/transferred care|10|||
128809234|NCT04810650|463597658|FG010|Overall Study|Moved/transferred care|0|||
128809235|NCT04810650|463597659|FG011|Overall Study|Moved/transferred care|0|||
128809236|NCT04810650|463597660|FG012|Overall Study|Moved/transferred care|0|||
128809237|NCT04810650|463597661|FG013|Overall Study|Moved/transferred care|0|||
128809238|NCT04810650|463597648|FG000|Overall Study|Lost to Follow-up|15|||
128809239|NCT04810650|463597649|FG001|Overall Study|Lost to Follow-up|12|||
128809240|NCT04810650|463597650|FG002|Overall Study|Lost to Follow-up|7|||
128809241|NCT04810650|463597651|FG003|Overall Study|Lost to Follow-up|9|||
128809242|NCT04810650|463597652|FG004|Overall Study|Lost to Follow-up|10|||
128809243|NCT04810650|463597653|FG005|Overall Study|Lost to Follow-up|6|||
128809244|NCT04810650|463597654|FG006|Overall Study|Lost to Follow-up|0|||
128809245|NCT04810650|463597655|FG007|Overall Study|Lost to Follow-up|0|||
128809246|NCT04810650|463597656|FG008|Overall Study|Lost to Follow-up|0|||
128809247|NCT04810650|463597657|FG009|Overall Study|Lost to Follow-up|0|||
128809248|NCT04810650|463597658|FG010|Overall Study|Lost to Follow-up|1|||
128809249|NCT04810650|463597659|FG011|Overall Study|Lost to Follow-up|0|||
128809250|NCT04810650|463597660|FG012|Overall Study|Lost to Follow-up|3|||
128809251|NCT04810650|463597661|FG013|Overall Study|Lost to Follow-up|9|||
128809252|NCT04810650|463597648|FG000|Overall Study|Participant declined|0|||
128809253|NCT04810650|463597649|FG001|Overall Study|Participant declined|0|||
128809254|NCT04810650|463597650|FG002|Overall Study|Participant declined|0|||
128809255|NCT04810650|463597651|FG003|Overall Study|Participant declined|0|||
128809256|NCT04810650|463597652|FG004|Overall Study|Participant declined|0|||
128809257|NCT04810650|463597653|FG005|Overall Study|Participant declined|0|||
128809258|NCT04810650|463597654|FG006|Overall Study|Participant declined|0|||
128809259|NCT04810650|463597655|FG007|Overall Study|Participant declined|0|||
128809260|NCT04810650|463597656|FG008|Overall Study|Participant declined|0|||
128809261|NCT04810650|463597657|FG009|Overall Study|Participant declined|0|||
128809262|NCT04810650|463597658|FG010|Overall Study|Participant declined|2|||
128809263|NCT04810650|463597659|FG011|Overall Study|Participant declined|0|||
128809264|NCT04810650|463597660|FG012|Overall Study|Participant declined|0|||
128809265|NCT04810650|463597661|FG013|Overall Study|Participant declined|0|||
128809266|NCT02761057|463597665|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
128809267|NCT02761057|463597666|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
128809268|NCT02761057|463597667|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
128809269|NCT02761057|463597668|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
128809270|NCT02761057|463597665|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
128809271|NCT02761057|463597666|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
128809272|NCT02761057|463597667|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
128809273|NCT02761057|463597668|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
128809274|NCT02761057|463597665|FG000|Overall Study|Currently On Study Treatment|0|||
128809275|NCT02761057|463597666|FG001|Overall Study|Currently On Study Treatment|3|||
128809276|NCT02761057|463597667|FG002|Overall Study|Currently On Study Treatment|0|||
128809277|NCT02761057|463597668|FG003|Overall Study|Currently On Study Treatment|0|||
128809278|NCT02761057|463597665|FG000|Overall Study|Adverse Event|11|||
128809279|NCT02761057|463597666|FG001|Overall Study|Adverse Event|9|||
128809280|NCT02761057|463597667|FG002|Overall Study|Adverse Event|5|||
128809281|NCT02761057|463597668|FG003|Overall Study|Adverse Event|3|||
128809282|NCT02761057|463597665|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
128809283|NCT02761057|463597666|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
128809284|NCT02761057|463597667|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
128809285|NCT02761057|463597668|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
128809286|NCT02761057|463597665|FG000|Overall Study|Progression/Relapse|29|||
128809287|NCT02761057|463597666|FG001|Overall Study|Progression/Relapse|27|||
128809288|NCT02761057|463597667|FG002|Overall Study|Progression/Relapse|20|||
128809289|NCT02761057|463597668|FG003|Overall Study|Progression/Relapse|23|||
128809290|NCT02761057|463597665|FG000|Overall Study|Death|2|||
128809291|NCT02761057|463597666|FG001|Overall Study|Death|2|||
128809292|NCT02761057|463597667|FG002|Overall Study|Death|1|||
128809293|NCT02761057|463597668|FG003|Overall Study|Death|1|||
128809294|NCT02761057|463597665|FG000|Overall Study|Other - Not Protocol Specified|2|||
128809295|NCT02761057|463597666|FG001|Overall Study|Other - Not Protocol Specified|1|||
128809296|NCT02761057|463597667|FG002|Overall Study|Other - Not Protocol Specified|2|||
128809297|NCT02761057|463597668|FG003|Overall Study|Other - Not Protocol Specified|0|||
128809298|NCT06037369|463597671|FG000|Overall Study|Lost to Follow-up|0|||
128809299|NCT06037369|463597672|FG001|Overall Study|Lost to Follow-up|1|||
128809300|NCT05008835|463597674|FG000|Overall Study|Adverse Event|5|||
128809301|NCT05008835|463597675|FG001|Overall Study|Adverse Event|2|||
128809302|NCT05008835|463597676|FG002|Overall Study|Adverse Event|1|||
128809303|NCT05008835|463597674|FG000|Overall Study|Lack of Efficacy|0|||
128809304|NCT05008835|463597675|FG001|Overall Study|Lack of Efficacy|0|||
128809305|NCT05008835|463597676|FG002|Overall Study|Lack of Efficacy|1|||
128809306|NCT05008835|463597674|FG000|Overall Study|Study terminated by sponsor|0|||
128809307|NCT05008835|463597675|FG001|Overall Study|Study terminated by sponsor|0|||
128809308|NCT05008835|463597676|FG002|Overall Study|Study terminated by sponsor|1|||
128809309|NCT05008835|463597674|FG000|Overall Study|Not further specified|3|||
128809310|NCT05008835|463597675|FG001|Overall Study|Not further specified|2|||
128809311|NCT05008835|463597676|FG002|Overall Study|Not further specified|1|||
128809312|NCT04171999|463597677|FG000|Overall Study|deemed ineligible after randomization|2|||
128809313|NCT04171999|463597678|FG001|Overall Study|deemed ineligible after randomization|1|||
128809314|NCT04876118|463597683|FG000|Overall Study|Pregnancy|1|||
128809315|NCT04876118|463597683|FG000|Overall Study|Withdrawal by Subject|14|||
128809316|NCT04948697|463597686|FG000|Overall Study|Progressive disease|27|||
128809317|NCT04948697|463597687|FG001|Overall Study|Progressive disease|18|||
128809318|NCT04948697|463597686|FG000|Overall Study|Adverse Event|14|||
128809319|NCT04948697|463597687|FG001|Overall Study|Adverse Event|4|||
128809320|NCT04948697|463597686|FG000|Overall Study|Participant moved to long term extension study|7|||
128809321|NCT04948697|463597687|FG001|Overall Study|Participant moved to long term extension study|4|||
128809322|NCT04948697|463597686|FG000|Overall Study|Withdrawal by Subject|10|||
128809323|NCT04948697|463597687|FG001|Overall Study|Withdrawal by Subject|0|||
128809324|NCT04948697|463597686|FG000|Overall Study|Closed by Sponsor|3|||
128809325|NCT04948697|463597687|FG001|Overall Study|Closed by Sponsor|2|||
128809326|NCT04948697|463597686|FG000|Overall Study|Physician Decision|0|||
128809327|NCT04948697|463597687|FG001|Overall Study|Physician Decision|2|||
128809328|NCT04948697|463597686|FG000|Overall Study|Lost to Follow-up|0|||
128809329|NCT04948697|463597687|FG001|Overall Study|Lost to Follow-up|1|||
128809330|NCT04948697|463597686|FG000|Overall Study|Other-Miscellaneous|1|||
128809331|NCT04948697|463597687|FG001|Overall Study|Other-Miscellaneous|0|||
128809332|NCT04948697|463597686|FG000|Overall Study|Randomized but not treated|0|||
128809333|NCT04948697|463597687|FG001|Overall Study|Randomized but not treated|1|||
128809334|NCT04338061|463597688|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
128809335|NCT04338061|463597689|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
128809336|NCT04338061|463597688|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
128809337|NCT04338061|463597689|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
128809338|NCT04338061|463597688|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
128809339|NCT04338061|463597689|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
128809340|NCT04338061|463597688|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
128809341|NCT04338061|463597689|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
128809342|NCT04338061|463597688|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
128809343|NCT04338061|463597689|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
128809344|NCT04338061|463597688|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
128809345|NCT04338061|463597689|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
128809346|NCT04338061|463597688|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
128809347|NCT04338061|463597689|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
128809348|NCT04338061|463597688|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
128809349|NCT04338061|463597689|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
128809350|NCT04338061|463597688|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
128809351|NCT04338061|463597689|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
128809352|NCT04338061|463597688|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
128809353|NCT04338061|463597689|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
128809354|NCT04338061|463597688|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
128809355|NCT04338061|463597689|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
128809356|NCT04338061|463597688|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
128809357|NCT04338061|463597689|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
128809358|NCT03365882|463597690|FG000|Randomization|Still Receiving Protocol Treatment|2|||
128809359|NCT03365882|463597691|FG001|Randomization|Still Receiving Protocol Treatment|0|||
128809360|NCT03365882|463597690|FG000|Randomization|Adverse Event|1|||
128809361|NCT03365882|463597691|FG001|Randomization|Adverse Event|2|||
128809362|NCT03365882|463597690|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
128809363|NCT03365882|463597691|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
128809364|NCT03365882|463597690|FG000|Randomization|Progression/Relapse|21|||
128809365|NCT03365882|463597691|FG001|Randomization|Progression/Relapse|3|||
128809366|NCT03365882|463597690|FG000|Randomization|Death|1|||
128809367|NCT03365882|463597691|FG001|Randomization|Death|0|||
128809368|NCT03365882|463597690|FG000|Randomization|Other - Not Protocol Specified|1|||
128809369|NCT03365882|463597691|FG001|Randomization|Other - Not Protocol Specified|1|||
128809370|NCT03365882|463597690|FG000|Randomization|Major Protocol Deviation|0|||
128809371|NCT03365882|463597691|FG001|Randomization|Major Protocol Deviation|1|||
128809372|NCT03365882|463597690|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
128809373|NCT03365882|463597691|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
128809374|NCT03365882|463597690|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
128809375|NCT03365882|463597691|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
128809376|NCT03365882|463597690|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
128809377|NCT03365882|463597691|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
128809378|NCT03365882|463597690|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
128809379|NCT03365882|463597691|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
128809380|NCT03338933|463599745|FG000|Screening Visit|Lost to Follow-up|1|||
128809381|NCT03338933|463599746|FG001|Screening Visit|Lost to Follow-up|3|||
128809382|NCT03338933|463599747|FG002|Screening Visit|Lost to Follow-up|1|||
128809383|NCT03338933|463599748|FG003|Screening Visit|Lost to Follow-up|4|||
128809384|NCT03338933|463599745|FG000|Screening Visit|Screen fail after consent|2|||
128809385|NCT03338933|463599746|FG001|Screening Visit|Screen fail after consent|7|||
128809386|NCT03338933|463599747|FG002|Screening Visit|Screen fail after consent|1|||
128809387|NCT03338933|463599748|FG003|Screening Visit|Screen fail after consent|4|||
128809388|NCT03338933|463599745|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
128809389|NCT03338933|463599746|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
128809390|NCT03338933|463599747|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
128809391|NCT03338933|463599748|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
128809392|NCT03338933|463599745|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
128809393|NCT03338933|463599746|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
128809394|NCT03338933|463599747|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
128809395|NCT03338933|463599748|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
128809396|NCT03338933|463599745|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
128809397|NCT03338933|463599746|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
128809398|NCT03338933|463599747|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
128809399|NCT03338933|463599748|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
128809400|NCT01084876|463599750|FG000|Main Study Treatment Period|Adverse Event|12|||
128809401|NCT01084876|463599751|FG001|Main Study Treatment Period|Adverse Event|7|||
128809402|NCT01084876|463599750|FG000|Main Study Treatment Period|Disease Progression|41|||
128809403|NCT01084876|463599751|FG001|Main Study Treatment Period|Disease Progression|24|||
128809404|NCT01084876|463599750|FG000|Main Study Treatment Period|Physician Decision|2|||
128809405|NCT01084876|463599751|FG001|Main Study Treatment Period|Physician Decision|0|||
128809406|NCT01084876|463599750|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
128809407|NCT01084876|463599751|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
128809408|NCT01084876|463599750|FG000|Main Study Treatment Period|Other Reason|0|||
128809409|NCT01084876|463599751|FG001|Main Study Treatment Period|Other Reason|1|||
128809410|NCT01084876|463599750|FG000|Main Study Treatment Period|Other|0|||
128809411|NCT01084876|463599751|FG001|Main Study Treatment Period|Other|1|||
128809412|NCT01084876|463599750|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
128809413|NCT01084876|463599751|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
128809414|NCT01084876|463599750|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
128809415|NCT01084876|463599751|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
128809416|NCT01084876|463599750|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
128809417|NCT01084876|463599751|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
128809418|NCT01084876|463599750|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
128809419|NCT01084876|463599751|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
128809420|NCT01084876|463599750|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
128809421|NCT01084876|463599751|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
128809422|NCT01084876|463599750|FG000|Treatment Period Beyond Cycle 8|Other|6|||
128809423|NCT01084876|463599751|FG001|Treatment Period Beyond Cycle 8|Other|9|||
128809424|NCT05308004|463599758|FG000|Overall Study|Not seen by Palliative Care NP|0|||
128809425|NCT05308004|463599759|FG001|Overall Study|Not seen by Palliative Care NP|1|||
128809426|NCT03575897|463599760|FG000|Overall Study|Lost to Follow-up|12|||
128809427|NCT03575897|463599761|FG001|Overall Study|Lost to Follow-up|13|||
128809428|NCT04359108|463599762|FG000|Overall Study|Withdrawal by Subject|1|||
128809429|NCT04359108|463599763|FG001|Overall Study|Withdrawal by Subject|0|||
128809430|NCT04359108|463599762|FG000|Overall Study|Unable or too feeble to walk independently|0|||
128809431|NCT04359108|463599763|FG001|Overall Study|Unable or too feeble to walk independently|2|||
128809432|NCT04359108|463599762|FG000|Overall Study|Argus II system stopped functioning|0|||
128809433|NCT04359108|463599763|FG001|Overall Study|Argus II system stopped functioning|1|||
128809434|NCT04359108|463599762|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
128809435|NCT04359108|463599763|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
128809436|NCT03652688|463599764|FG000|Baseline|Withdrawal by Subject|0|||
128809437|NCT03652688|463599765|FG001|Baseline|Withdrawal by Subject|3|||
128809438|NCT03652688|463599764|FG000|Follow-up|Lost to Follow-up|56|||
128809439|NCT03652688|463599765|FG001|Follow-up|Lost to Follow-up|54|||
128809440|NCT06205407|463599766|FG000|Period 2|Withdrawal by Subject|0|||
128809441|NCT06205407|463599767|FG001|Period 2|Withdrawal by Subject|1|||
128809442|NCT06205407|463599766|FG000|Period 2|Adverse Event|2|||
128809443|NCT06205407|463599767|FG001|Period 2|Adverse Event|1|||
128809444|NCT04676022|463599768|FG000|Overall Study|Screen Failure/|1|||
128809445|NCT04676022|463599769|FG001|Overall Study|Screen Failure/|1|||
128809446|NCT04676022|463599770|FG002|Overall Study|Screen Failure/|85|||
128809447|NCT04676022|463599768|FG000|Overall Study|Lost to Follow-up|1|||
128809448|NCT04676022|463599769|FG001|Overall Study|Lost to Follow-up|1|||
128809449|NCT04676022|463599770|FG002|Overall Study|Lost to Follow-up|0|||
128809450|NCT04676022|463599768|FG000|Overall Study|Adverse Event|2|||
128809451|NCT04676022|463599769|FG001|Overall Study|Adverse Event|0|||
128809452|NCT04676022|463599770|FG002|Overall Study|Adverse Event|1|||
128809453|NCT04676022|463599768|FG000|Overall Study|Physician Decision|2|||
128809454|NCT04676022|463599769|FG001|Overall Study|Physician Decision|0|||
128809455|NCT04676022|463599770|FG002|Overall Study|Physician Decision|1|||
128809456|NCT04676022|463599768|FG000|Overall Study|Withdrawal by Subject|3|||
128809457|NCT04676022|463599769|FG001|Overall Study|Withdrawal by Subject|1|||
128809458|NCT04676022|463599770|FG002|Overall Study|Withdrawal by Subject|6|||
128809459|NCT04676022|463599768|FG000|Overall Study|Will not move forward with permanent implant|6|||
128809460|NCT04676022|463599769|FG001|Overall Study|Will not move forward with permanent implant|0|||
128809461|NCT04676022|463599770|FG002|Overall Study|Will not move forward with permanent implant|0|||
128809462|NCT04676022|463599768|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
128809463|NCT04676022|463599769|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
128809464|NCT04676022|463599770|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
128809465|NCT05409183|463599774|FG000|Complete Study|Adverse Event|1|||
128809466|NCT05409183|463599775|FG001|Complete Study|Adverse Event|2|||
128809467|NCT05409183|463599774|FG000|Complete Study|Withdrawal by Subject|3|||
128809468|NCT05409183|463599775|FG001|Complete Study|Withdrawal by Subject|0|||
128809469|NCT02274662|463599776|FG000|Overall Study|Death|1|||
128809470|NCT02274662|463599776|FG000|Overall Study|Lost to Follow-up|3|||
128809471|NCT03194217|463599777|FG000|Overall Study|Adverse Event|0|||
128809472|NCT03194217|463599778|FG001|Overall Study|Adverse Event|2|||
128809473|NCT03194217|463599779|FG002|Overall Study|Adverse Event|3|||
128809474|NCT03194217|463599780|FG003|Overall Study|Adverse Event|3|||
128809475|NCT03194217|463599777|FG000|Overall Study|Failure to meet randomisation criteria|0|||
128809476|NCT03194217|463599778|FG001|Overall Study|Failure to meet randomisation criteria|0|||
128809477|NCT03194217|463599779|FG002|Overall Study|Failure to meet randomisation criteria|0|||
128809478|NCT03194217|463599780|FG003|Overall Study|Failure to meet randomisation criteria|1|||
128809479|NCT03194217|463599777|FG000|Overall Study|Other|0|||
128809480|NCT03194217|463599778|FG001|Overall Study|Other|1|||
128809481|NCT03194217|463599779|FG002|Overall Study|Other|1|||
128809482|NCT03194217|463599780|FG003|Overall Study|Other|0|||
128809483|NCT02936752|463599781|FG000|Overall Study|Death|2|||
128809484|NCT02936752|463599782|FG001|Overall Study|Death|1|||
128809485|NCT02936752|463599781|FG000|Overall Study|Physician Decision|4|||
128809486|NCT02936752|463599782|FG001|Overall Study|Physician Decision|0|||
128809487|NCT02936752|463599781|FG000|Overall Study|Withdrawal by Subject|0|||
128809488|NCT02936752|463599782|FG001|Overall Study|Withdrawal by Subject|2|||
128809489|NCT04489771|463599785|FG000|Overall Study|Death|27|||
128809490|NCT04489771|463599786|FG001|Overall Study|Death|25|||
128809491|NCT04489771|463599785|FG000|Overall Study|Withdrawal by Subject|1|||
128809492|NCT04489771|463599786|FG001|Overall Study|Withdrawal by Subject|0|||
128809493|NCT04489771|463599785|FG000|Overall Study|Participants Ongoing in Study|50|||
128809494|NCT04489771|463599786|FG001|Overall Study|Participants Ongoing in Study|51|||
128809495|NCT03197662|463599791|FG000|Overall Study|Withdrawn by family|0|||
128809496|NCT03197662|463599792|FG001|Overall Study|Withdrawn by family|2|||
128809497|NCT04064164|463599802|FG000|Overall Study|Withdrawal by Subject|8|||
128809498|NCT04064164|463599803|FG001|Overall Study|Withdrawal by Subject|8|||
128809499|NCT04059484|463599804|FG000|Overall Study|Adverse Event|2|||
128809500|NCT04059484|463599805|FG001|Overall Study|Adverse Event|5|||
128809501|NCT04059484|463599804|FG000|Overall Study|Withdrawal by Subject|5|||
128809502|NCT04059484|463599805|FG001|Overall Study|Withdrawal by Subject|3|||
128809503|NCT04059484|463599804|FG000|Overall Study|Progressive disease|112|||
128809504|NCT04059484|463599805|FG001|Overall Study|Progressive disease|112|||
128809505|NCT04059484|463599804|FG000|Overall Study|Other|8|||
128809506|NCT04059484|463599805|FG001|Overall Study|Other|3|||
128809507|NCT04059484|463599804|FG000|Overall Study|Ongoing|20|||
128809508|NCT04059484|463599805|FG001|Overall Study|Ongoing|20|||
128809509|NCT02949362|463599806|FG000|Retrospective Period|Inform consent not signed by participant|4|||
128809510|NCT02949362|463599807|FG001|Retrospective Period|Inform consent not signed by participant|1|||
128809511|NCT02949362|463599808|FG002|Retrospective Period|Inform consent not signed by participant|0|||
128809512|NCT02949362|463599809|FG003|Retrospective Period|Inform consent not signed by participant|0|||
128809513|NCT02949362|463599806|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
128809514|NCT02949362|463599807|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
128809515|NCT02949362|463599808|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
128809516|NCT02949362|463599809|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
128809517|NCT02949362|463599806|FG000|Prospective Period|Other|0|||
128809518|NCT02949362|463599807|FG001|Prospective Period|Other|0|||
128809519|NCT02949362|463599808|FG002|Prospective Period|Other|0|||
128809520|NCT02949362|463599809|FG003|Prospective Period|Other|4|||
128809521|NCT04633122|463599813|FG000|Overall Study|Remained on treatment|19|||
128809522|NCT04633122|463599814|FG001|Overall Study|Remained on treatment|14|||
128809523|NCT04633122|463599813|FG000|Overall Study|Survival follow-up stopped|22|||
128809524|NCT04633122|463599814|FG001|Overall Study|Survival follow-up stopped|25|||
128809525|NCT03307343|463599815|FG000|Overall Study|Withdrawal by Subject|1|||
128809526|NCT03307343|463599816|FG001|Overall Study|Withdrawal by Subject|2|||
128809527|NCT03307343|463599815|FG000|Overall Study|Pregnancy|0|||
128809528|NCT03307343|463599816|FG001|Overall Study|Pregnancy|2|||
128809529|NCT03307343|463599815|FG000|Overall Study|Physician Decision|1|||
128809530|NCT03307343|463599816|FG001|Overall Study|Physician Decision|0|||
128809531|NCT03307343|463599815|FG000|Overall Study|Lost to Follow-up|0|||
128809532|NCT03307343|463599816|FG001|Overall Study|Lost to Follow-up|2|||
128809533|NCT01798498|463599817|FG000|Overall Study|Lost to Follow-up|1|||
128809534|NCT03896789|463599818|FG000|Baseline|Lost to Follow-up|1|||
128809535|NCT03896789|463599819|FG001|Baseline|Lost to Follow-up|2|||
128809536|NCT03896789|463599818|FG000|Baseline|Death|3|||
128809537|NCT03896789|463599819|FG001|Baseline|Death|6|||
128809538|NCT03896789|463599818|FG000|Post-Randomization|Lost to Follow-up|12|||
128809539|NCT03896789|463599819|FG001|Post-Randomization|Lost to Follow-up|11|||
128809540|NCT03896789|463599818|FG000|Post-Randomization|Death|12|||
128809541|NCT03896789|463599819|FG001|Post-Randomization|Death|13|||
128809542|NCT03447470|463599820|FG000|Overall Study|Death|0|||
128809543|NCT03447470|463599821|FG001|Overall Study|Death|1|||
128809544|NCT03447470|463599822|FG002|Overall Study|Death|3|||
128809545|NCT03447470|463599823|FG003|Overall Study|Death|0|||
128809546|NCT03447470|463599824|FG004|Overall Study|Death|1|||
128809547|NCT03447470|463599825|FG005|Overall Study|Death|0|||
128809548|NCT03447470|463599826|FG006|Overall Study|Death|3|||
128809549|NCT03447470|463599827|FG007|Overall Study|Death|3|||
128809550|NCT03447470|463599828|FG008|Overall Study|Death|1|||
128809551|NCT03447470|463599820|FG000|Overall Study|Withdrawal by Subject|1|||
128809552|NCT03447470|463599821|FG001|Overall Study|Withdrawal by Subject|0|||
128809553|NCT03447470|463599822|FG002|Overall Study|Withdrawal by Subject|0|||
128809554|NCT03447470|463599823|FG003|Overall Study|Withdrawal by Subject|0|||
128809555|NCT03447470|463599824|FG004|Overall Study|Withdrawal by Subject|1|||
128809556|NCT03447470|463599825|FG005|Overall Study|Withdrawal by Subject|0|||
128809557|NCT03447470|463599826|FG006|Overall Study|Withdrawal by Subject|1|||
128809558|NCT03447470|463599827|FG007|Overall Study|Withdrawal by Subject|1|||
128809559|NCT03447470|463599828|FG008|Overall Study|Withdrawal by Subject|3|||
128809560|NCT03447470|463599820|FG000|Overall Study|Treatment discontinued|3|||
128809561|NCT03447470|463599821|FG001|Overall Study|Treatment discontinued|2|||
128809562|NCT03447470|463599822|FG002|Overall Study|Treatment discontinued|4|||
128809563|NCT03447470|463599823|FG003|Overall Study|Treatment discontinued|6|||
128809564|NCT03447470|463599824|FG004|Overall Study|Treatment discontinued|2|||
128809565|NCT03447470|463599825|FG005|Overall Study|Treatment discontinued|1|||
128809566|NCT03447470|463599826|FG006|Overall Study|Treatment discontinued|2|||
128809567|NCT03447470|463599827|FG007|Overall Study|Treatment discontinued|4|||
128809568|NCT03447470|463599828|FG008|Overall Study|Treatment discontinued|3|||
128809569|NCT05780437|463599829|FG000|Overall Study|Withdrawal by Subject|22|||
128809570|NCT05780437|463599830|FG001|Overall Study|Withdrawal by Subject|16|||
128809571|NCT03452579|463599831|FG000|Overall Study|Death|0|||
128809572|NCT03452579|463599832|FG001|Overall Study|Death|1|||
128809573|NCT03452579|463599831|FG000|Overall Study|Withdrawal by Subject|2|||
128809574|NCT03452579|463599832|FG001|Overall Study|Withdrawal by Subject|0|||
128809575|NCT03452579|463599831|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
128809576|NCT03452579|463599832|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
128809577|NCT03452579|463599831|FG000|Overall Study|Physician Decision|1|||
128809578|NCT03452579|463599832|FG001|Overall Study|Physician Decision|1|||
128809579|NCT03452579|463599831|FG000|Overall Study|Adverse Event|1|||
128809580|NCT03452579|463599832|FG001|Overall Study|Adverse Event|4|||
128809581|NCT05794243|463599835|FG000|Overall Study|Withdrawal by Subject|1|||
128809582|NCT05794243|463599836|FG001|Overall Study|Withdrawal by Subject|0|||
128809583|NCT05794243|463599837|FG002|Overall Study|Withdrawal by Subject|1|||
128809584|NCT05794243|463599835|FG000|Overall Study|Physician Decision|0|||
128809585|NCT05794243|463599836|FG001|Overall Study|Physician Decision|3|||
128809586|NCT05794243|463599837|FG002|Overall Study|Physician Decision|1|||
128809587|NCT04788511|463599838|FG000|Overall Study|Withdrawal by Subject|2|||
128809588|NCT04788511|463599839|FG001|Overall Study|Withdrawal by Subject|1|||
128809589|NCT04788511|463599838|FG000|Overall Study|Lost to Follow-up|2|||
128809590|NCT04788511|463599839|FG001|Overall Study|Lost to Follow-up|7|||
128809591|NCT04788511|463599838|FG000|Overall Study|Death|3|||
128809592|NCT04788511|463599839|FG001|Overall Study|Death|4|||
128809593|NCT04652700|463599842|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
128809594|NCT04652700|463599843|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
128809595|NCT04652700|463599842|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
128809596|NCT04652700|463599843|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
128809597|NCT04652700|463599842|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
128809598|NCT04652700|463599843|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
128809599|NCT04652700|463599842|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
128809600|NCT04652700|463599843|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
128809601|NCT04652700|463599842|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
128809602|NCT04652700|463599843|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
128809603|NCT04652700|463599842|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
128809604|NCT04652700|463599843|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
128809605|NCT04652700|463599842|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
128809606|NCT04652700|463599843|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
128809607|NCT04652700|463599842|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
128809608|NCT04652700|463599843|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
128809609|NCT04652700|463599842|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
128809610|NCT04652700|463599843|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
128809611|NCT04187833|463599844|FG000|Overall Study|Withdrawal by Subject|1|||
128809612|NCT04209465|463599845|FG000|Overall Study|Adverse Event|0|||
128809613|NCT04209465|463599846|FG001|Overall Study|Adverse Event|0|||
128809614|NCT04209465|463599847|FG002|Overall Study|Adverse Event|0|||
128809615|NCT04209465|463599848|FG003|Overall Study|Adverse Event|0|||
128809616|NCT04209465|463599849|FG004|Overall Study|Adverse Event|0|||
128809617|NCT04209465|463599850|FG005|Overall Study|Adverse Event|1|||
128809618|NCT04209465|463599851|FG006|Overall Study|Adverse Event|0|||
128809619|NCT04209465|463599852|FG007|Overall Study|Adverse Event|0|||
128809620|NCT04209465|463599853|FG008|Overall Study|Adverse Event|1|||
128809621|NCT04209465|463599854|FG009|Overall Study|Adverse Event|0|||
128809622|NCT04209465|463599855|FG010|Overall Study|Adverse Event|2|||
128809623|NCT04209465|463599856|FG011|Overall Study|Adverse Event|1|||
128809624|NCT04209465|463599857|FG012|Overall Study|Adverse Event|1|||
128809625|NCT04209465|463599845|FG000|Overall Study|Death|1|||
128809626|NCT04209465|463599846|FG001|Overall Study|Death|0|||
128809627|NCT04209465|463599847|FG002|Overall Study|Death|0|||
128809628|NCT04209465|463599848|FG003|Overall Study|Death|0|||
128809629|NCT04209465|463599849|FG004|Overall Study|Death|2|||
128809630|NCT04209465|463599850|FG005|Overall Study|Death|7|||
128809631|NCT04209465|463599851|FG006|Overall Study|Death|2|||
128809632|NCT04209465|463599852|FG007|Overall Study|Death|2|||
128809633|NCT04209465|463599853|FG008|Overall Study|Death|1|||
128809634|NCT04209465|463599854|FG009|Overall Study|Death|1|||
128809635|NCT04209465|463599855|FG010|Overall Study|Death|1|||
128809636|NCT04209465|463599856|FG011|Overall Study|Death|0|||
128809637|NCT04209465|463599857|FG012|Overall Study|Death|10|||
128809638|NCT04209465|463599845|FG000|Overall Study|Physician Decision|0|||
128809639|NCT04209465|463599846|FG001|Overall Study|Physician Decision|1|||
128809640|NCT04209465|463599847|FG002|Overall Study|Physician Decision|0|||
128809641|NCT04209465|463599848|FG003|Overall Study|Physician Decision|0|||
128809642|NCT04209465|463599849|FG004|Overall Study|Physician Decision|0|||
128809643|NCT04209465|463599850|FG005|Overall Study|Physician Decision|0|||
128809644|NCT04209465|463599851|FG006|Overall Study|Physician Decision|0|||
128809645|NCT04209465|463599852|FG007|Overall Study|Physician Decision|0|||
128809646|NCT04209465|463599853|FG008|Overall Study|Physician Decision|0|||
128809647|NCT04209465|463599854|FG009|Overall Study|Physician Decision|0|||
128809648|NCT04209465|463599855|FG010|Overall Study|Physician Decision|0|||
128809649|NCT04209465|463599856|FG011|Overall Study|Physician Decision|0|||
128809650|NCT04209465|463599857|FG012|Overall Study|Physician Decision|0|||
128809651|NCT04209465|463599845|FG000|Overall Study|Progressive Disease|0|||
128809652|NCT04209465|463599846|FG001|Overall Study|Progressive Disease|0|||
128809653|NCT04209465|463599847|FG002|Overall Study|Progressive Disease|1|||
128809654|NCT04209465|463599848|FG003|Overall Study|Progressive Disease|2|||
128809655|NCT04209465|463599849|FG004|Overall Study|Progressive Disease|8|||
128809656|NCT04209465|463599850|FG005|Overall Study|Progressive Disease|5|||
128809657|NCT04209465|463599851|FG006|Overall Study|Progressive Disease|3|||
128809658|NCT04209465|463599852|FG007|Overall Study|Progressive Disease|4|||
128809659|NCT04209465|463599853|FG008|Overall Study|Progressive Disease|1|||
128809660|NCT04209465|463599854|FG009|Overall Study|Progressive Disease|3|||
128809661|NCT04209465|463599855|FG010|Overall Study|Progressive Disease|2|||
128809662|NCT04209465|463599856|FG011|Overall Study|Progressive Disease|1|||
128809663|NCT04209465|463599857|FG012|Overall Study|Progressive Disease|0|||
128809664|NCT04209465|463599845|FG000|Overall Study|Withdrawal by Subject|0|||
128809665|NCT04209465|463599846|FG001|Overall Study|Withdrawal by Subject|0|||
128809666|NCT04209465|463599847|FG002|Overall Study|Withdrawal by Subject|0|||
128809667|NCT04209465|463599848|FG003|Overall Study|Withdrawal by Subject|0|||
128809668|NCT04209465|463599849|FG004|Overall Study|Withdrawal by Subject|0|||
128809669|NCT04209465|463599850|FG005|Overall Study|Withdrawal by Subject|1|||
128809670|NCT04209465|463599851|FG006|Overall Study|Withdrawal by Subject|2|||
128809671|NCT04209465|463599852|FG007|Overall Study|Withdrawal by Subject|0|||
128809672|NCT04209465|463599853|FG008|Overall Study|Withdrawal by Subject|1|||
128809673|NCT04209465|463599854|FG009|Overall Study|Withdrawal by Subject|0|||
128809674|NCT04209465|463599855|FG010|Overall Study|Withdrawal by Subject|0|||
128809675|NCT04209465|463599856|FG011|Overall Study|Withdrawal by Subject|2|||
128809676|NCT04209465|463599857|FG012|Overall Study|Withdrawal by Subject|2|||
128809677|NCT04209465|463599845|FG000|Overall Study|Lost to Follow-up|0|||
128809678|NCT04209465|463599846|FG001|Overall Study|Lost to Follow-up|0|||
128809679|NCT04209465|463599847|FG002|Overall Study|Lost to Follow-up|0|||
128809680|NCT04209465|463599848|FG003|Overall Study|Lost to Follow-up|0|||
128809681|NCT04209465|463599849|FG004|Overall Study|Lost to Follow-up|0|||
128809682|NCT04209465|463599850|FG005|Overall Study|Lost to Follow-up|1|||
128809683|NCT04209465|463599851|FG006|Overall Study|Lost to Follow-up|0|||
128809684|NCT04209465|463599852|FG007|Overall Study|Lost to Follow-up|0|||
128809685|NCT04209465|463599853|FG008|Overall Study|Lost to Follow-up|1|||
128809686|NCT04209465|463599854|FG009|Overall Study|Lost to Follow-up|0|||
128809687|NCT04209465|463599855|FG010|Overall Study|Lost to Follow-up|0|||
128809688|NCT04209465|463599856|FG011|Overall Study|Lost to Follow-up|1|||
128809689|NCT04209465|463599857|FG012|Overall Study|Lost to Follow-up|0|||
128809690|NCT04209465|463599845|FG000|Overall Study|Started new therapy|0|||
128809691|NCT04209465|463599846|FG001|Overall Study|Started new therapy|0|||
128809692|NCT04209465|463599847|FG002|Overall Study|Started new therapy|0|||
128809693|NCT04209465|463599848|FG003|Overall Study|Started new therapy|0|||
128809694|NCT04209465|463599849|FG004|Overall Study|Started new therapy|0|||
128809695|NCT04209465|463599850|FG005|Overall Study|Started new therapy|1|||
128809696|NCT04209465|463599851|FG006|Overall Study|Started new therapy|0|||
128809697|NCT04209465|463599852|FG007|Overall Study|Started new therapy|0|||
128809698|NCT04209465|463599853|FG008|Overall Study|Started new therapy|0|||
128809699|NCT04209465|463599854|FG009|Overall Study|Started new therapy|0|||
128809700|NCT04209465|463599855|FG010|Overall Study|Started new therapy|0|||
128809701|NCT04209465|463599856|FG011|Overall Study|Started new therapy|0|||
128809702|NCT04209465|463599857|FG012|Overall Study|Started new therapy|0|||
128809703|NCT04209465|463599845|FG000|Overall Study|Study terminated early by sponsor|0|||
128809704|NCT04209465|463599846|FG001|Overall Study|Study terminated early by sponsor|0|||
128809705|NCT04209465|463599847|FG002|Overall Study|Study terminated early by sponsor|0|||
128809706|NCT04209465|463599848|FG003|Overall Study|Study terminated early by sponsor|0|||
128809707|NCT04209465|463599849|FG004|Overall Study|Study terminated early by sponsor|0|||
128809708|NCT04209465|463599850|FG005|Overall Study|Study terminated early by sponsor|0|||
128809709|NCT04209465|463599851|FG006|Overall Study|Study terminated early by sponsor|3|||
128809710|NCT04209465|463599852|FG007|Overall Study|Study terminated early by sponsor|0|||
128809711|NCT04209465|463599853|FG008|Overall Study|Study terminated early by sponsor|0|||
128809712|NCT04209465|463599854|FG009|Overall Study|Study terminated early by sponsor|0|||
128809713|NCT04209465|463599855|FG010|Overall Study|Study terminated early by sponsor|0|||
128809714|NCT04209465|463599856|FG011|Overall Study|Study terminated early by sponsor|0|||
128809715|NCT04209465|463599857|FG012|Overall Study|Study terminated early by sponsor|3|||
128809716|NCT04209465|463599845|FG000|Overall Study|Other|0|||
128809717|NCT04209465|463599846|FG001|Overall Study|Other|0|||
128809718|NCT04209465|463599847|FG002|Overall Study|Other|0|||
128809719|NCT04209465|463599848|FG003|Overall Study|Other|0|||
128809720|NCT04209465|463599849|FG004|Overall Study|Other|0|||
128809721|NCT04209465|463599850|FG005|Overall Study|Other|0|||
128809722|NCT04209465|463599851|FG006|Overall Study|Other|0|||
128809723|NCT04209465|463599852|FG007|Overall Study|Other|0|||
128809724|NCT04209465|463599853|FG008|Overall Study|Other|1|||
128809725|NCT04209465|463599854|FG009|Overall Study|Other|0|||
128809726|NCT04209465|463599855|FG010|Overall Study|Other|0|||
128809727|NCT04209465|463599856|FG011|Overall Study|Other|0|||
128809728|NCT04209465|463599857|FG012|Overall Study|Other|0|||
128809729|NCT05603143|463599858|FG000|Overall Study|Withdrew consent|6|||
128809730|NCT05603143|463599859|FG001|Overall Study|Withdrew consent|2|||
128809731|NCT05603143|463599858|FG000|Overall Study|Randomized but never treated|0|||
128809732|NCT05603143|463599859|FG001|Overall Study|Randomized but never treated|3|||
128809733|NCT05603143|463599858|FG000|Overall Study|Adverse Event|2|||
128809734|NCT05603143|463599859|FG001|Overall Study|Adverse Event|0|||
128809735|NCT05603143|463599858|FG000|Overall Study|Death|0|||
128809736|NCT05603143|463599859|FG001|Overall Study|Death|1|||
128809737|NCT05603143|463599858|FG000|Overall Study|Investigator's discretion|1|||
128809738|NCT05603143|463599859|FG001|Overall Study|Investigator's discretion|0|||
128809739|NCT05603143|463599858|FG000|Overall Study|Lost to Follow-up|0|||
128809740|NCT05603143|463599859|FG001|Overall Study|Lost to Follow-up|1|||
128809741|NCT05603143|463599858|FG000|Overall Study|Protocol Violation|0|||
128809742|NCT05603143|463599859|FG001|Overall Study|Protocol Violation|1|||
128809743|NCT03097549|463599860|FG000|Overall Study|Withdrawal by Subject|1|||
128809744|NCT03097549|463599861|FG001|Overall Study|Withdrawal by Subject|0|||
128809745|NCT03097549|463599860|FG000|Overall Study|Lost to Follow-up|1|||
128809746|NCT03097549|463599861|FG001|Overall Study|Lost to Follow-up|0|||
128809747|NCT05783102|463599862|FG000|Overall Study|Lost to Follow-up|1|||
128809748|NCT05783102|463599862|FG000|Overall Study|Withdrawal by Subject|2|||
128809749|NCT04505904|463599863|FG000|Overall Study|Withdrawal by Subject|1|||
128809750|NCT04505904|463599864|FG001|Overall Study|Withdrawal by Subject|2|||
128809751|NCT04505904|463599865|FG002|Overall Study|Withdrawal by Subject|0|||
128809752|NCT04505904|463599866|FG003|Overall Study|Withdrawal by Subject|0|||
128809753|NCT04505904|463599863|FG000|Overall Study|Physician Decision|1|||
128809754|NCT04505904|463599864|FG001|Overall Study|Physician Decision|0|||
128809755|NCT04505904|463599865|FG002|Overall Study|Physician Decision|0|||
128809756|NCT04505904|463599866|FG003|Overall Study|Physician Decision|0|||
128809757|NCT04505904|463599863|FG000|Overall Study|Adverse Event|0|||
128809758|NCT04505904|463599864|FG001|Overall Study|Adverse Event|1|||
128809759|NCT04505904|463599865|FG002|Overall Study|Adverse Event|0|||
128809760|NCT04505904|463599866|FG003|Overall Study|Adverse Event|0|||
128809761|NCT04277442|463599869|FG000|Overall Study|Death|1|||
128809762|NCT03544281|463599870|FG000|Main Study Phase|Death|3|||
128809763|NCT03544281|463599871|FG001|Main Study Phase|Death|2|||
128809764|NCT03544281|463599872|FG002|Main Study Phase|Death|6|||
128809765|NCT03544281|463599873|FG003|Main Study Phase|Death|8|||
128809766|NCT03544281|463599874|FG004|Main Study Phase|Death|4|||
128809767|NCT03544281|463599875|FG005|Main Study Phase|Death|2|||
128809768|NCT03544281|463599876|FG006|Main Study Phase|Death|4|||
128809769|NCT03544281|463599877|FG007|Main Study Phase|Death|5|||
128809770|NCT03544281|463599878|FG008|Main Study Phase|Death|5|||
128809771|NCT03544281|463599879|FG009|Main Study Phase|Death|8|||
128809772|NCT03544281|463599880|FG010|Main Study Phase|Death|6|||
128809773|NCT03544281|463599881|FG011|Main Study Phase|Death|4|||
128809774|NCT03544281|463599882|FG012|Main Study Phase|Death|0|||
128809775|NCT03544281|463599883|FG013|Main Study Phase|Death|0|||
128809776|NCT03544281|463599884|FG014|Main Study Phase|Death|0|||
128809777|NCT03544281|463599885|FG015|Main Study Phase|Death|0|||
128809778|NCT03544281|463599886|FG016|Main Study Phase|Death|0|||
128809779|NCT03544281|463599887|FG017|Main Study Phase|Death|0|||
128809780|NCT03544281|463599888|FG018|Main Study Phase|Death|0|||
128809781|NCT03544281|463599889|FG019|Main Study Phase|Death|0|||
128809782|NCT03544281|463599890|FG020|Main Study Phase|Death|0|||
128809783|NCT03544281|463599891|FG021|Main Study Phase|Death|0|||
128809784|NCT03544281|463599870|FG000|Main Study Phase|Lost to Follow-up|0|||
128809785|NCT03544281|463599871|FG001|Main Study Phase|Lost to Follow-up|0|||
128809786|NCT03544281|463599872|FG002|Main Study Phase|Lost to Follow-up|0|||
128809787|NCT03544281|463599873|FG003|Main Study Phase|Lost to Follow-up|0|||
128809788|NCT03544281|463599874|FG004|Main Study Phase|Lost to Follow-up|0|||
128809789|NCT03544281|463599875|FG005|Main Study Phase|Lost to Follow-up|0|||
128809790|NCT03544281|463599876|FG006|Main Study Phase|Lost to Follow-up|0|||
128809791|NCT03544281|463599877|FG007|Main Study Phase|Lost to Follow-up|0|||
128809792|NCT03544281|463599878|FG008|Main Study Phase|Lost to Follow-up|0|||
128809793|NCT03544281|463599879|FG009|Main Study Phase|Lost to Follow-up|0|||
128809794|NCT03544281|463599880|FG010|Main Study Phase|Lost to Follow-up|1|||
128809795|NCT03544281|463599881|FG011|Main Study Phase|Lost to Follow-up|0|||
128809796|NCT03544281|463599882|FG012|Main Study Phase|Lost to Follow-up|0|||
128809797|NCT03544281|463599883|FG013|Main Study Phase|Lost to Follow-up|0|||
128809798|NCT03544281|463599884|FG014|Main Study Phase|Lost to Follow-up|0|||
128809799|NCT03544281|463599885|FG015|Main Study Phase|Lost to Follow-up|0|||
128809800|NCT03544281|463599886|FG016|Main Study Phase|Lost to Follow-up|0|||
128809801|NCT03544281|463599887|FG017|Main Study Phase|Lost to Follow-up|0|||
128809802|NCT03544281|463599888|FG018|Main Study Phase|Lost to Follow-up|0|||
128809803|NCT03544281|463599889|FG019|Main Study Phase|Lost to Follow-up|0|||
128809804|NCT03544281|463599890|FG020|Main Study Phase|Lost to Follow-up|0|||
128809805|NCT03544281|463599891|FG021|Main Study Phase|Lost to Follow-up|0|||
128809806|NCT03544281|463599870|FG000|Main Study Phase|Physician Decision|0|||
128809807|NCT03544281|463599871|FG001|Main Study Phase|Physician Decision|0|||
128809808|NCT03544281|463599872|FG002|Main Study Phase|Physician Decision|0|||
128809809|NCT03544281|463599873|FG003|Main Study Phase|Physician Decision|0|||
128809810|NCT03544281|463599874|FG004|Main Study Phase|Physician Decision|0|||
128809811|NCT03544281|463599875|FG005|Main Study Phase|Physician Decision|0|||
128809812|NCT03544281|463599876|FG006|Main Study Phase|Physician Decision|0|||
128809813|NCT03544281|463599877|FG007|Main Study Phase|Physician Decision|1|||
128809814|NCT03544281|463599878|FG008|Main Study Phase|Physician Decision|0|||
128809815|NCT03544281|463599879|FG009|Main Study Phase|Physician Decision|0|||
128809816|NCT03544281|463599880|FG010|Main Study Phase|Physician Decision|0|||
128809817|NCT03544281|463599881|FG011|Main Study Phase|Physician Decision|0|||
128809818|NCT03544281|463599882|FG012|Main Study Phase|Physician Decision|0|||
128809819|NCT03544281|463599883|FG013|Main Study Phase|Physician Decision|0|||
128809820|NCT03544281|463599884|FG014|Main Study Phase|Physician Decision|0|||
128809821|NCT03544281|463599885|FG015|Main Study Phase|Physician Decision|0|||
128809822|NCT03544281|463599886|FG016|Main Study Phase|Physician Decision|0|||
128809823|NCT03544281|463599887|FG017|Main Study Phase|Physician Decision|0|||
128809824|NCT03544281|463599888|FG018|Main Study Phase|Physician Decision|0|||
128809825|NCT03544281|463599889|FG019|Main Study Phase|Physician Decision|0|||
128809826|NCT03544281|463599890|FG020|Main Study Phase|Physician Decision|0|||
128809827|NCT03544281|463599891|FG021|Main Study Phase|Physician Decision|0|||
128809828|NCT03544281|463599870|FG000|Main Study Phase|Withdrawal by Subject|2|||
128809829|NCT03544281|463599871|FG001|Main Study Phase|Withdrawal by Subject|0|||
128809830|NCT03544281|463599872|FG002|Main Study Phase|Withdrawal by Subject|1|||
128809831|NCT03544281|463599873|FG003|Main Study Phase|Withdrawal by Subject|2|||
128809832|NCT03544281|463599874|FG004|Main Study Phase|Withdrawal by Subject|0|||
128809833|NCT03544281|463599875|FG005|Main Study Phase|Withdrawal by Subject|0|||
128809834|NCT03544281|463599876|FG006|Main Study Phase|Withdrawal by Subject|0|||
128809835|NCT03544281|463599877|FG007|Main Study Phase|Withdrawal by Subject|0|||
128809836|NCT03544281|463599878|FG008|Main Study Phase|Withdrawal by Subject|2|||
128809837|NCT03544281|463599879|FG009|Main Study Phase|Withdrawal by Subject|3|||
128809838|NCT03544281|463599880|FG010|Main Study Phase|Withdrawal by Subject|0|||
128809839|NCT03544281|463599881|FG011|Main Study Phase|Withdrawal by Subject|4|||
128809840|NCT03544281|463599882|FG012|Main Study Phase|Withdrawal by Subject|0|||
128809841|NCT03544281|463599883|FG013|Main Study Phase|Withdrawal by Subject|0|||
128809842|NCT03544281|463599884|FG014|Main Study Phase|Withdrawal by Subject|0|||
128809843|NCT03544281|463599885|FG015|Main Study Phase|Withdrawal by Subject|0|||
128809844|NCT03544281|463599886|FG016|Main Study Phase|Withdrawal by Subject|0|||
128809845|NCT03544281|463599887|FG017|Main Study Phase|Withdrawal by Subject|0|||
128809846|NCT03544281|463599888|FG018|Main Study Phase|Withdrawal by Subject|0|||
128809847|NCT03544281|463599889|FG019|Main Study Phase|Withdrawal by Subject|0|||
128809848|NCT03544281|463599890|FG020|Main Study Phase|Withdrawal by Subject|0|||
128809849|NCT03544281|463599891|FG021|Main Study Phase|Withdrawal by Subject|0|||
128809850|NCT03544281|463599870|FG000|Main Study Phase|Ongoing|3|||
128809851|NCT03544281|463599871|FG001|Main Study Phase|Ongoing|1|||
128809852|NCT03544281|463599872|FG002|Main Study Phase|Ongoing|2|||
128809853|NCT03544281|463599873|FG003|Main Study Phase|Ongoing|4|||
128809854|NCT03544281|463599874|FG004|Main Study Phase|Ongoing|2|||
128809855|NCT03544281|463599875|FG005|Main Study Phase|Ongoing|4|||
128809856|NCT03544281|463599876|FG006|Main Study Phase|Ongoing|4|||
128809857|NCT03544281|463599877|FG007|Main Study Phase|Ongoing|0|||
128809858|NCT03544281|463599878|FG008|Main Study Phase|Ongoing|2|||
128809859|NCT03544281|463599879|FG009|Main Study Phase|Ongoing|2|||
128809860|NCT03544281|463599880|FG010|Main Study Phase|Ongoing|1|||
128809861|NCT03544281|463599881|FG011|Main Study Phase|Ongoing|0|||
128809862|NCT03544281|463599882|FG012|Main Study Phase|Ongoing|0|||
128809863|NCT03544281|463599883|FG013|Main Study Phase|Ongoing|0|||
128809864|NCT03544281|463599884|FG014|Main Study Phase|Ongoing|0|||
128809865|NCT03544281|463599885|FG015|Main Study Phase|Ongoing|0|||
128809866|NCT03544281|463599886|FG016|Main Study Phase|Ongoing|0|||
128809867|NCT03544281|463599887|FG017|Main Study Phase|Ongoing|0|||
128809868|NCT03544281|463599888|FG018|Main Study Phase|Ongoing|0|||
128809869|NCT03544281|463599889|FG019|Main Study Phase|Ongoing|0|||
128809870|NCT03544281|463599890|FG020|Main Study Phase|Ongoing|0|||
128809871|NCT03544281|463599891|FG021|Main Study Phase|Ongoing|0|||
128809872|NCT03544281|463599870|FG000|Main Study Phase|Investigator Site Closed|0|||
128809873|NCT03544281|463599871|FG001|Main Study Phase|Investigator Site Closed|0|||
128809874|NCT03544281|463599872|FG002|Main Study Phase|Investigator Site Closed|0|||
128809875|NCT03544281|463599873|FG003|Main Study Phase|Investigator Site Closed|0|||
128809876|NCT03544281|463599874|FG004|Main Study Phase|Investigator Site Closed|0|||
128809877|NCT03544281|463599875|FG005|Main Study Phase|Investigator Site Closed|0|||
128809878|NCT03544281|463599876|FG006|Main Study Phase|Investigator Site Closed|0|||
128809879|NCT03544281|463599877|FG007|Main Study Phase|Investigator Site Closed|0|||
128809880|NCT03544281|463599878|FG008|Main Study Phase|Investigator Site Closed|0|||
128809881|NCT03544281|463599879|FG009|Main Study Phase|Investigator Site Closed|1|||
128809882|NCT03544281|463599880|FG010|Main Study Phase|Investigator Site Closed|0|||
128809883|NCT03544281|463599881|FG011|Main Study Phase|Investigator Site Closed|0|||
128809884|NCT03544281|463599882|FG012|Main Study Phase|Investigator Site Closed|0|||
128809885|NCT03544281|463599883|FG013|Main Study Phase|Investigator Site Closed|0|||
128809886|NCT03544281|463599884|FG014|Main Study Phase|Investigator Site Closed|0|||
128809887|NCT03544281|463599885|FG015|Main Study Phase|Investigator Site Closed|0|||
128809888|NCT03544281|463599886|FG016|Main Study Phase|Investigator Site Closed|0|||
128809889|NCT03544281|463599887|FG017|Main Study Phase|Investigator Site Closed|0|||
128809890|NCT03544281|463599888|FG018|Main Study Phase|Investigator Site Closed|0|||
128809891|NCT03544281|463599889|FG019|Main Study Phase|Investigator Site Closed|0|||
128809892|NCT03544281|463599890|FG020|Main Study Phase|Investigator Site Closed|0|||
128809893|NCT03544281|463599891|FG021|Main Study Phase|Investigator Site Closed|0|||
128809894|NCT03544281|463599870|FG000|Main Study Phase|Did not receive study treatment|0|||
128809895|NCT03544281|463599871|FG001|Main Study Phase|Did not receive study treatment|0|||
128809896|NCT03544281|463599872|FG002|Main Study Phase|Did not receive study treatment|0|||
128809897|NCT03544281|463599873|FG003|Main Study Phase|Did not receive study treatment|0|||
128809898|NCT03544281|463599874|FG004|Main Study Phase|Did not receive study treatment|0|||
128809899|NCT03544281|463599875|FG005|Main Study Phase|Did not receive study treatment|0|||
128809900|NCT03544281|463599876|FG006|Main Study Phase|Did not receive study treatment|1|||
128809901|NCT03544281|463599877|FG007|Main Study Phase|Did not receive study treatment|0|||
128809902|NCT03544281|463599878|FG008|Main Study Phase|Did not receive study treatment|0|||
128809903|NCT03544281|463599879|FG009|Main Study Phase|Did not receive study treatment|0|||
128809904|NCT03544281|463599880|FG010|Main Study Phase|Did not receive study treatment|0|||
128809905|NCT03544281|463599881|FG011|Main Study Phase|Did not receive study treatment|0|||
128809906|NCT03544281|463599882|FG012|Main Study Phase|Did not receive study treatment|0|||
128809907|NCT03544281|463599883|FG013|Main Study Phase|Did not receive study treatment|0|||
128809908|NCT03544281|463599884|FG014|Main Study Phase|Did not receive study treatment|0|||
128809909|NCT03544281|463599885|FG015|Main Study Phase|Did not receive study treatment|0|||
128809910|NCT03544281|463599886|FG016|Main Study Phase|Did not receive study treatment|0|||
128809911|NCT03544281|463599887|FG017|Main Study Phase|Did not receive study treatment|0|||
128809912|NCT03544281|463599888|FG018|Main Study Phase|Did not receive study treatment|0|||
128809913|NCT03544281|463599889|FG019|Main Study Phase|Did not receive study treatment|0|||
128809914|NCT03544281|463599890|FG020|Main Study Phase|Did not receive study treatment|0|||
128809915|NCT03544281|463599891|FG021|Main Study Phase|Did not receive study treatment|0|||
128809916|NCT03544281|463599870|FG000|PACT Phase|Adverse Event|0|||
128809917|NCT03544281|463599871|FG001|PACT Phase|Adverse Event|0|||
128809918|NCT03544281|463599872|FG002|PACT Phase|Adverse Event|0|||
128809919|NCT03544281|463599873|FG003|PACT Phase|Adverse Event|0|||
128809920|NCT03544281|463599874|FG004|PACT Phase|Adverse Event|0|||
128809921|NCT03544281|463599875|FG005|PACT Phase|Adverse Event|0|||
128809922|NCT03544281|463599876|FG006|PACT Phase|Adverse Event|0|||
128809923|NCT03544281|463599877|FG007|PACT Phase|Adverse Event|0|||
128809924|NCT03544281|463599878|FG008|PACT Phase|Adverse Event|0|||
128809925|NCT03544281|463599879|FG009|PACT Phase|Adverse Event|0|||
128809926|NCT03544281|463599880|FG010|PACT Phase|Adverse Event|0|||
128809927|NCT03544281|463599881|FG011|PACT Phase|Adverse Event|0|||
128809928|NCT03544281|463599882|FG012|PACT Phase|Adverse Event|1|||
128809929|NCT03544281|463599883|FG013|PACT Phase|Adverse Event|0|||
128809930|NCT03544281|463599884|FG014|PACT Phase|Adverse Event|0|||
128809931|NCT03544281|463599885|FG015|PACT Phase|Adverse Event|0|||
128809932|NCT03544281|463599886|FG016|PACT Phase|Adverse Event|0|||
128809933|NCT03544281|463599887|FG017|PACT Phase|Adverse Event|1|||
128809934|NCT03544281|463599888|FG018|PACT Phase|Adverse Event|1|||
128809935|NCT03544281|463599889|FG019|PACT Phase|Adverse Event|0|||
128809936|NCT03544281|463599890|FG020|PACT Phase|Adverse Event|0|||
128809937|NCT03544281|463599891|FG021|PACT Phase|Adverse Event|0|||
128809938|NCT03092518|463599893|FG000|Overall Study|Ineligible|2|||
128809939|NCT02547987|463599896|FG000|Overall Study|Withdrawal by Subject|1|||
128809940|NCT02547987|463599896|FG000|Overall Study|Adverse Event|2|||
128809941|NCT04282148|463599897|FG000|Overall Study|Death|7|||
128809942|NCT04282148|463599897|FG000|Overall Study|Withdrawal by Subject|1|||
128809943|NCT04282148|463599897|FG000|Overall Study|Physician Decision|1|||
128809944|NCT04925986|463599898|FG000|Overall Study|Death|0|||
128809945|NCT04925986|463599899|FG001|Overall Study|Death|0|||
128809946|NCT04925986|463599900|FG002|Overall Study|Death|2|||
128809947|NCT04925986|463599901|FG003|Overall Study|Death|0|||
128809948|NCT04925986|463599898|FG000|Overall Study|Lack of Efficacy|1|||
128809949|NCT04925986|463599899|FG001|Overall Study|Lack of Efficacy|2|||
128809950|NCT04925986|463599900|FG002|Overall Study|Lack of Efficacy|0|||
128809951|NCT04925986|463599901|FG003|Overall Study|Lack of Efficacy|1|||
128809952|NCT04925986|463599898|FG000|Overall Study|Withdrawal by Subject|0|||
128809953|NCT04925986|463599899|FG001|Overall Study|Withdrawal by Subject|0|||
128809954|NCT04925986|463599900|FG002|Overall Study|Withdrawal by Subject|1|||
128809955|NCT04925986|463599901|FG003|Overall Study|Withdrawal by Subject|2|||
128809956|NCT06181760|463599902|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
128809957|NCT06181760|463599903|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
128809958|NCT06181760|463599904|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
128809959|NCT06181760|463599905|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
128809960|NCT04770532|463599906|FG000|Overall Study|Withdrawal by Subject|0|||
128809961|NCT04770532|463599907|FG001|Overall Study|Withdrawal by Subject|3|||
128809962|NCT04770532|463599906|FG000|Overall Study|Physician Decision|1|||
128809963|NCT04770532|463599907|FG001|Overall Study|Physician Decision|0|||
128809964|NCT04770532|463599906|FG000|Overall Study|Death|2|||
128809965|NCT04770532|463599907|FG001|Overall Study|Death|2|||
128809966|NCT04938492|463599908|FG000|Overall Study|Lost to Follow-up|17|||
128809967|NCT04938492|463599909|FG001|Overall Study|Lost to Follow-up|18|||
128809968|NCT05084508|463599910|FG000|Overall Study|Lost to Follow-up|6|||
128809969|NCT05084508|463599911|FG001|Overall Study|Lost to Follow-up|3|||
128809970|NCT05084508|463599912|FG002|Overall Study|Lost to Follow-up|7|||
128809971|NCT05084508|463599913|FG003|Overall Study|Lost to Follow-up|3|||
128809972|NCT05084508|463599910|FG000|Overall Study|Withdrawal by Subject|0|||
128809973|NCT05084508|463599911|FG001|Overall Study|Withdrawal by Subject|2|||
128809974|NCT05084508|463599912|FG002|Overall Study|Withdrawal by Subject|3|||
128809975|NCT05084508|463599913|FG003|Overall Study|Withdrawal by Subject|1|||
128809976|NCT05084508|463599910|FG000|Overall Study|Other|0|||
128809977|NCT05084508|463599911|FG001|Overall Study|Other|0|||
128809978|NCT05084508|463599912|FG002|Overall Study|Other|0|||
128809979|NCT05084508|463599913|FG003|Overall Study|Other|1|||
128809980|NCT03631784|463599916|FG000|Overall Study|Participants Ongoing|1|||
128809981|NCT03631784|463599917|FG001|Overall Study|Participants Ongoing|0|||
128809982|NCT03631784|463599916|FG000|Overall Study|Withdrawal by Subject|3|||
128809983|NCT03631784|463599917|FG001|Overall Study|Withdrawal by Subject|3|||
128809984|NCT03631784|463599916|FG000|Overall Study|Sponsor's Decision|36|||
128809985|NCT03631784|463599917|FG001|Overall Study|Sponsor's Decision|52|||
128809986|NCT03631784|463599916|FG000|Overall Study|Lost to Follow-up|1|||
128809987|NCT03631784|463599917|FG001|Overall Study|Lost to Follow-up|0|||
128809988|NCT03631784|463599916|FG000|Overall Study|Death|71|||
128809989|NCT03631784|463599917|FG001|Overall Study|Death|49|||
128809990|NCT04437615|463599921|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
128809991|NCT04229992|463602265|FG000|Overall Study|Withdrawal by Subject|0|||
128809992|NCT04229992|463602266|FG001|Overall Study|Withdrawal by Subject|2|||
128809993|NCT04229992|463602267|FG002|Overall Study|Withdrawal by Subject|1|||
128809994|NCT04229992|463602268|FG003|Overall Study|Withdrawal by Subject|1|||
128809995|NCT04229992|463602265|FG000|Overall Study|Adverse Event|1|||
128809996|NCT04229992|463602266|FG001|Overall Study|Adverse Event|1|||
128809997|NCT04229992|463602267|FG002|Overall Study|Adverse Event|3|||
128809998|NCT04229992|463602268|FG003|Overall Study|Adverse Event|1|||
128809999|NCT04229992|463602265|FG000|Overall Study|Lost to Follow-up|0|||
128810000|NCT04229992|463602266|FG001|Overall Study|Lost to Follow-up|0|||
128810001|NCT04229992|463602267|FG002|Overall Study|Lost to Follow-up|0|||
128810002|NCT04229992|463602268|FG003|Overall Study|Lost to Follow-up|1|||
128810003|NCT03770273|463602269|FG000|Overall Study|Adverse Event|2|||
128810004|NCT03770273|463602270|FG001|Overall Study|Adverse Event|0|||
128810005|NCT03770273|463602269|FG000|Overall Study|Lost to Follow-up|1|||
128810006|NCT03770273|463602270|FG001|Overall Study|Lost to Follow-up|1|||
128810007|NCT00418886|463602271|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
128810008|NCT00418886|463602272|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
128810009|NCT00418886|463602271|FG000|Randomized Period|Death|122|||
128810010|NCT00418886|463602272|FG001|Randomized Period|Death|147|||
128810011|NCT00418886|463602271|FG000|Randomized Period|Withdrawal by Subject|9|||
128810012|NCT00418886|463602272|FG001|Randomized Period|Withdrawal by Subject|10|||
128810013|NCT00418886|463602271|FG000|Randomized Period|Lost to Follow-up|4|||
128810014|NCT00418886|463602272|FG001|Randomized Period|Lost to Follow-up|6|||
128810015|NCT00418886|463602271|FG000|Randomized Period|withdrawn due to other reason|1|||
128810016|NCT00418886|463602272|FG001|Randomized Period|withdrawn due to other reason|0|||
128810017|NCT00418886|463602271|FG000|Randomized Period|randomised but no treatment received|0|||
128810018|NCT00418886|463602272|FG001|Randomized Period|randomised but no treatment received|1|||
128810019|NCT04060654|463602273|FG000|Overall Study|Withdrawal by Subject|1|||
128810020|NCT04060654|463602273|FG000|Overall Study|Lost to Follow-up|5|||
128810021|NCT03707951|463602274|FG000|Overall Study|Lost to Follow-up|8|||
128810022|NCT03707951|463602275|FG001|Overall Study|Lost to Follow-up|17|||
128810023|NCT03707951|463602274|FG000|Overall Study|Withdrawal by Subject|6|||
128810024|NCT03707951|463602275|FG001|Overall Study|Withdrawal by Subject|6|||
128810025|NCT04887129|463602276|FG000|Overall Study|Lost to Follow-up|0|||
128810026|NCT04887129|463602277|FG001|Overall Study|Lost to Follow-up|24|||
128810027|NCT04887129|463602276|FG000|Overall Study|Withdrawal by Subject|9|||
128810028|NCT04887129|463602277|FG001|Overall Study|Withdrawal by Subject|57|||
128810029|NCT04887129|463602276|FG000|Overall Study|Other|2|||
128810030|NCT04887129|463602277|FG001|Overall Study|Other|9|||
128810031|NCT02921230|463602280|FG000|Overall Study|Withdrawal by Subject|20|||
128810032|NCT02921230|463602281|FG001|Overall Study|Withdrawal by Subject|8|||
128810033|NCT02921230|463602280|FG000|Overall Study|Death|12|||
128810034|NCT02921230|463602281|FG001|Overall Study|Death|3|||
128810035|NCT02921230|463602280|FG000|Overall Study|Protocol Violation|17|||
128810036|NCT02921230|463602281|FG001|Overall Study|Protocol Violation|6|||
128810037|NCT02921230|463602280|FG000|Overall Study|Early completion|5|||
128810038|NCT02921230|463602281|FG001|Overall Study|Early completion|1|||
128810039|NCT02921230|463602280|FG000|Overall Study|Pending data entry|1|||
128810040|NCT02921230|463602281|FG001|Overall Study|Pending data entry|0|||
128810041|NCT05177848|463602286|FG000|Overall Study|Lost to Follow-up|1|||
128810042|NCT05177848|463602287|FG001|Overall Study|Lost to Follow-up|4|||
128810043|NCT05177848|463602286|FG000|Overall Study|Discontinued|2|||
128810044|NCT05177848|463602287|FG001|Overall Study|Discontinued|1|||
128810045|NCT02035787|463602288|FG000|Overall Study- 12 Months|Adverse Event|3|||
128810046|NCT02035787|463602289|FG001|Overall Study- 12 Months|Adverse Event|0|||
128810047|NCT02035787|463602288|FG000|Overall Study- 12 Months|Complete response|4|||
128810048|NCT02035787|463602289|FG001|Overall Study- 12 Months|Complete response|1|||
128810049|NCT02035787|463602288|FG000|Overall Study- 12 Months|Protocol Violation|1|||
128810050|NCT02035787|463602289|FG001|Overall Study- 12 Months|Protocol Violation|1|||
128810051|NCT06414213|463602290|FG000|Overall Study|Lost to Follow-up|1|||
128810052|NCT06414213|463602291|FG001|Overall Study|Lost to Follow-up|1|||
128810053|NCT06414213|463602292|FG002|Overall Study|Lost to Follow-up|3|||
128810054|NCT04971395|463602293|FG000|Overall Study|Withdrawal by Subject|0|||
128810055|NCT04971395|463602294|FG001|Overall Study|Withdrawal by Subject|1|||
128810056|NCT04971395|463602295|FG002|Overall Study|Withdrawal by Subject|0|||
128810057|NCT03953508|463602296|FG000|Baseline|Lost to Follow-up|3|||
128810058|NCT03953508|463602297|FG001|Baseline|Lost to Follow-up|2|||
128810059|NCT03953508|463602296|FG000|6-month Follow-up|Lost to Follow-up|62|||
128810060|NCT03953508|463602297|FG001|6-month Follow-up|Lost to Follow-up|70|||
128810061|NCT03771417|463602298|FG000|Overall Study|Withdrawal by Subject|1|||
128810062|NCT03771417|463602299|FG001|Overall Study|Withdrawal by Subject|0|||
128810063|NCT03771417|463602300|FG002|Overall Study|Withdrawal by Subject|0|||
128810064|NCT03771417|463602298|FG000|Overall Study|Covid-19 Shutdown|0|||
128810065|NCT03771417|463602299|FG001|Overall Study|Covid-19 Shutdown|1|||
128810066|NCT03771417|463602300|FG002|Overall Study|Covid-19 Shutdown|0|||
128810067|NCT02924272|463602305|FG000|Overall Study|Site Terminated by Sponsor|4|||
128810068|NCT02924272|463602306|FG001|Overall Study|Site Terminated by Sponsor|1|||
128810069|NCT02924272|463602305|FG000|Overall Study|Withdrawal by Subject|2|||
128810070|NCT02924272|463602306|FG001|Overall Study|Withdrawal by Subject|0|||
128810071|NCT02924272|463602305|FG000|Overall Study|Adverse Event|3|||
128810072|NCT02924272|463602306|FG001|Overall Study|Adverse Event|0|||
128810073|NCT02924272|463602305|FG000|Overall Study|Progressive Disease|11|||
128810074|NCT02924272|463602306|FG001|Overall Study|Progressive Disease|8|||
128810075|NCT02924272|463602305|FG000|Overall Study|Clinical Deterioration|1|||
128810076|NCT02924272|463602306|FG001|Overall Study|Clinical Deterioration|0|||
128810077|NCT02924272|463602305|FG000|Overall Study|Death|1|||
128810078|NCT02924272|463602306|FG001|Overall Study|Death|0|||
128810079|NCT02924272|463602305|FG000|Overall Study|Reason Not Specified|1|||
128810080|NCT02924272|463602306|FG001|Overall Study|Reason Not Specified|0|||
128810081|NCT02100813|463602311|FG000|Overall Study|Adverse Event|0|||
128810082|NCT02100813|463602312|FG001|Overall Study|Adverse Event|0|||
128810083|NCT02100813|463602313|FG002|Overall Study|Adverse Event|0|||
128810084|NCT02100813|463602314|FG003|Overall Study|Adverse Event|0|||
128810085|NCT02100813|463602315|FG004|Overall Study|Adverse Event|0|||
128810086|NCT02100813|463602316|FG005|Overall Study|Adverse Event|0|||
128810087|NCT02100813|463602317|FG006|Overall Study|Adverse Event|0|||
128810088|NCT02100813|463602318|FG007|Overall Study|Adverse Event|1|||
128810089|NCT04856163|463602319|FG000|Overall Study|Lost to Follow-up|97|||
128810090|NCT04856163|463602320|FG001|Overall Study|Lost to Follow-up|100|||
128810091|NCT00881621|463602328|FG000|Overall Study|Physician Decision|34|||
128810092|NCT03936322|463602333|FG000|Overall Study|Lost to Follow-up|1|||
128810093|NCT03936322|463602333|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
128810094|NCT05434078|463602335|FG000|Overall Study|Lost to Follow-up|2|||
128810095|NCT05434078|463602336|FG001|Overall Study|Lost to Follow-up|1|||
128810096|NCT05434078|463602335|FG000|Overall Study|Withdrawal by Subject|1|||
128810097|NCT05434078|463602336|FG001|Overall Study|Withdrawal by Subject|0|||
128810098|NCT01160211|463602337|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
128810099|NCT01160211|463602338|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
128810100|NCT01160211|463602339|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
128810101|NCT01160211|463602337|FG000|Overall Study|Lost to Follow-up|4|||
128810102|NCT01160211|463602338|FG001|Overall Study|Lost to Follow-up|8|||
128810103|NCT01160211|463602339|FG002|Overall Study|Lost to Follow-up|4|||
128810104|NCT01160211|463602337|FG000|Overall Study|Physician Decision|1|||
128810105|NCT01160211|463602338|FG001|Overall Study|Physician Decision|0|||
128810106|NCT01160211|463602339|FG002|Overall Study|Physician Decision|0|||
128810107|NCT01160211|463602337|FG000|Overall Study|Withdrawal by Subject|4|||
128810108|NCT01160211|463602338|FG001|Overall Study|Withdrawal by Subject|2|||
128810109|NCT01160211|463602339|FG002|Overall Study|Withdrawal by Subject|2|||
128810110|NCT01160211|463602337|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
128810111|NCT01160211|463602338|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
128810112|NCT01160211|463602339|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
128810113|NCT02734290|463602343|FG000|Overall Study|Adverse Event|1|||
128810114|NCT02734290|463602344|FG001|Overall Study|Adverse Event|0|||
128810115|NCT02734290|463602343|FG000|Overall Study|Death|1|||
128810116|NCT02734290|463602344|FG001|Overall Study|Death|0|||
128810117|NCT03158129|463602345|FG000|Overall Study|Adverse Event|0|||
128810118|NCT03158129|463602346|FG001|Overall Study|Adverse Event|1|||
128810119|NCT03158129|463602347|FG002|Overall Study|Adverse Event|0|||
128810120|NCT03158129|463602348|FG003|Overall Study|Adverse Event|0|||
128810121|NCT03158129|463602345|FG000|Overall Study|Death|0|||
128810122|NCT03158129|463602346|FG001|Overall Study|Death|0|||
128810123|NCT03158129|463602347|FG002|Overall Study|Death|0|||
128810124|NCT03158129|463602348|FG003|Overall Study|Death|1|||
128810125|NCT03158129|463602345|FG000|Overall Study|High surgical risk|1|||
128810126|NCT03158129|463602346|FG001|Overall Study|High surgical risk|1|||
128810127|NCT03158129|463602347|FG002|Overall Study|High surgical risk|0|||
128810128|NCT03158129|463602348|FG003|Overall Study|High surgical risk|0|||
128810129|NCT03158129|463602345|FG000|Overall Study|Progression|1|||
128810130|NCT03158129|463602346|FG001|Overall Study|Progression|1|||
128810131|NCT03158129|463602347|FG002|Overall Study|Progression|0|||
128810132|NCT03158129|463602348|FG003|Overall Study|Progression|0|||
128810133|NCT03158129|463602345|FG000|Overall Study|Lack of resectability|0|||
128810134|NCT03158129|463602346|FG001|Overall Study|Lack of resectability|1|||
128810135|NCT03158129|463602347|FG002|Overall Study|Lack of resectability|0|||
128810136|NCT03158129|463602348|FG003|Overall Study|Lack of resectability|0|||
128810137|NCT03158129|463602345|FG000|Overall Study|Declined surgery|0|||
128810138|NCT03158129|463602346|FG001|Overall Study|Declined surgery|1|||
128810139|NCT03158129|463602347|FG002|Overall Study|Declined surgery|0|||
128810140|NCT03158129|463602348|FG003|Overall Study|Declined surgery|0|||
129204654|NCT03799341|465045850|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
129204655|NCT03799341|465045851|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
129204656|NCT03799341|465045852|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
129204657|NCT03799341|465045850|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
128810141|NCT03158129|463602345|FG000|Overall Study|No longer surgical candidate|0|||
128810142|NCT03158129|463602346|FG001|Overall Study|No longer surgical candidate|0|||
128810143|NCT03158129|463602347|FG002|Overall Study|No longer surgical candidate|0|||
128810144|NCT03158129|463602348|FG003|Overall Study|No longer surgical candidate|1|||
128810145|NCT02577835|463602349|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
128810146|NCT04342494|463602350|FG000|Overall Study|Questionnaire partially completed|1|||
128810147|NCT04342494|463602351|FG001|Overall Study|Questionnaire partially completed|0|||
128810148|NCT04342494|463602352|FG002|Overall Study|Questionnaire partially completed|2|||
128810149|NCT04342494|463602353|FG003|Overall Study|Questionnaire partially completed|0|||
128810150|NCT04342494|463602354|FG004|Overall Study|Questionnaire partially completed|1|||
128810151|NCT04342494|463602350|FG000|Overall Study|Lost to Follow-up|49|||
128810152|NCT04342494|463602351|FG001|Overall Study|Lost to Follow-up|38|||
128810153|NCT04342494|463602352|FG002|Overall Study|Lost to Follow-up|34|||
128810154|NCT04342494|463602353|FG003|Overall Study|Lost to Follow-up|34|||
128810155|NCT04342494|463602354|FG004|Overall Study|Lost to Follow-up|35|||
128810156|NCT04806451|463602355|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
128810157|NCT04806451|463602356|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
128810158|NCT04806451|463602355|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
128810159|NCT04806451|463602356|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
128810160|NCT04806451|463602355|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
128810161|NCT04806451|463602356|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
128810162|NCT05835336|463602357|FG000|Overall Study|Withdrawal by Subject|5|||
128810163|NCT05835336|463602357|FG000|Overall Study|Did not complete the personalization process|3|||
128810164|NCT02979522|463602358|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
128810165|NCT02979522|463602359|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
128810166|NCT02979522|463602358|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
128810167|NCT02979522|463602359|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
128810168|NCT03199469|463602361|FG000|Overall Study|Randomized, not treated|0|||
128810169|NCT03199469|463602362|FG001|Overall Study|Randomized, not treated|3|||
128810170|NCT03199469|463602361|FG000|Overall Study|Withdrawal by Subject|1|||
128810171|NCT03199469|463602362|FG001|Overall Study|Withdrawal by Subject|0|||
128810172|NCT03199469|463602361|FG000|Overall Study|Death|1|||
128810173|NCT03199469|463602362|FG001|Overall Study|Death|3|||
128810174|NCT03199469|463602361|FG000|Overall Study|Ongoing|5|||
128810175|NCT03199469|463602362|FG001|Overall Study|Ongoing|14|||
128810176|NCT04963270|463602364|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
128810177|NCT04963270|463602365|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
128810178|NCT04963270|463602366|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
128810179|NCT04963270|463602367|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
128810180|NCT04963270|463602364|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
128810181|NCT04963270|463602365|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
128810182|NCT04963270|463602366|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
128810183|NCT04963270|463602367|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
128810184|NCT04963270|463602364|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
128810185|NCT04963270|463602365|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
128810186|NCT04963270|463602366|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
128810187|NCT04963270|463602367|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
128810188|NCT04963270|463602364|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
128810189|NCT04963270|463602365|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
128810190|NCT04963270|463602366|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
128810191|NCT04963270|463602367|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
128810192|NCT04963270|463602364|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
128810193|NCT04963270|463602365|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
128810194|NCT04963270|463602366|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
128810195|NCT04963270|463602367|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
128810196|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
129204658|NCT03799341|465045851|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
129204659|NCT03799341|465045852|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
128810197|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
128810198|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
128810199|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
128810200|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
128810201|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
128810202|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
128810203|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
128810204|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
128810205|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
128810206|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
128810207|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
128810208|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
128810209|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
128810210|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
128810211|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
128810212|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
128810213|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
128810214|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
128810215|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
128810216|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
128810217|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
128810218|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
128810219|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
128810220|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
128810221|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
128810222|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
128810223|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
128810224|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
128810225|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
128810226|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
128810227|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
128810228|NCT04963270|463602364|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
128810229|NCT04963270|463602365|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
128810230|NCT04963270|463602366|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
128810231|NCT04963270|463602367|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
128810232|NCT04624633|463602370|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
128810233|NCT04624633|463602371|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
128810234|NCT04624633|463602370|FG000|Overall Study|Death|1|||
128810235|NCT04624633|463602371|FG001|Overall Study|Death|0|||
128810236|NCT04316871|463602372|FG000|Overall Study|Protocol Violation|2|||
128810237|NCT04316871|463602373|FG001|Overall Study|Protocol Violation|2|||
128810238|NCT04316871|463602374|FG002|Overall Study|Protocol Violation|2|||
128810239|NCT04316871|463602375|FG003|Overall Study|Protocol Violation|2|||
128810240|NCT05087992|463602376|FG000|Overall Study|Adverse Event|0|||
128810241|NCT05087992|463602377|FG001|Overall Study|Adverse Event|1|||
128810242|NCT05087992|463602378|FG002|Overall Study|Adverse Event|0|||
128810243|NCT05087992|463602376|FG000|Overall Study|Withdrawal by Subject|2|||
128810244|NCT05087992|463602377|FG001|Overall Study|Withdrawal by Subject|0|||
128810245|NCT05087992|463602378|FG002|Overall Study|Withdrawal by Subject|0|||
128810246|NCT05087992|463602376|FG000|Overall Study|clinical disease progression|3|||
128810247|NCT05087992|463602377|FG001|Overall Study|clinical disease progression|1|||
128810248|NCT05087992|463602378|FG002|Overall Study|clinical disease progression|0|||
128810249|NCT05087992|463602376|FG000|Overall Study|objective disease progression|4|||
128810250|NCT05087992|463602377|FG001|Overall Study|objective disease progression|1|||
128810251|NCT05087992|463602378|FG002|Overall Study|objective disease progression|0|||
128810252|NCT01842542|463602379|FG000|Overall Study|Withdrawal by Subject|2|||
128810253|NCT01842542|463602379|FG000|Overall Study|Lack of Efficacy|1|||
128810254|NCT01842542|463602379|FG000|Overall Study|Protocol Non-compliance|2|||
128810255|NCT01842542|463602379|FG000|Overall Study|Lost to Follow-up|1|||
128810256|NCT01824394|463602385|FG000|Overall Study|Early Termination|1|||
128810257|NCT01824394|463602386|FG001|Overall Study|Early Termination|1|||
128810258|NCT01824394|463602387|FG002|Overall Study|Early Termination|3|||
128810259|NCT01824394|463602385|FG000|Overall Study|Withdrawn due to Study Termination|91|||
128810260|NCT01824394|463602386|FG001|Overall Study|Withdrawn due to Study Termination|83|||
128810261|NCT01824394|463602387|FG002|Overall Study|Withdrawn due to Study Termination|41|||
128810262|NCT01824394|463602385|FG000|Overall Study|Lost to Follow-up|0|||
128810263|NCT01824394|463602386|FG001|Overall Study|Lost to Follow-up|9|||
128810264|NCT01824394|463602387|FG002|Overall Study|Lost to Follow-up|3|||
128810265|NCT01824394|463602385|FG000|Overall Study|Death|3|||
128810266|NCT01824394|463602386|FG001|Overall Study|Death|2|||
128810267|NCT01824394|463602387|FG002|Overall Study|Death|4|||
128810268|NCT01824394|463602385|FG000|Overall Study|Discontinued Subjects|1|||
128810269|NCT01824394|463602386|FG001|Overall Study|Discontinued Subjects|1|||
128810270|NCT01824394|463602387|FG002|Overall Study|Discontinued Subjects|2|||
128810271|NCT01824394|463602385|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
128810272|NCT01824394|463602386|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
128810273|NCT01824394|463602387|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
128810274|NCT00227344|463602390|FG000|Overall Study|study terminated early|12|||
128810275|NCT00227344|463602391|FG001|Overall Study|study terminated early|5|||
128810276|NCT01987895|463602392|FG000|Overall Study|Withdrawal by Subject|12|||
128810277|NCT01987895|463602393|FG001|Overall Study|Withdrawal by Subject|7|||
128810278|NCT01987895|463602392|FG000|Overall Study|Physician Decision|8|||
128810279|NCT01987895|463602393|FG001|Overall Study|Physician Decision|10|||
128810280|NCT01987895|463602392|FG000|Overall Study|Death|7|||
128810281|NCT01987895|463602393|FG001|Overall Study|Death|7|||
128810282|NCT01987895|463602392|FG000|Overall Study|Lost to Follow-up|3|||
128810283|NCT01987895|463602393|FG001|Overall Study|Lost to Follow-up|5|||
128810284|NCT01987895|463602392|FG000|Overall Study|randomized before giving IC|0|||
128810285|NCT01987895|463602393|FG001|Overall Study|randomized before giving IC|1|||
128810286|NCT05364671|463602394|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
128810287|NCT05364671|463602395|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
128810288|NCT05364671|463602394|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
128810289|NCT05364671|463602395|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
128810290|NCT05364671|463602394|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
128810291|NCT05364671|463602395|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
128810292|NCT05364671|463602394|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
128810293|NCT05364671|463602395|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
128810294|NCT05364671|463602394|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
128810295|NCT05364671|463602395|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
128810296|NCT05256017|463602396|FG000|Treatment Period|Withdrawal by Subject|1|||
128810297|NCT05256017|463602397|FG001|Treatment Period|Withdrawal by Subject|1|||
128810298|NCT05256017|463602396|FG000|Follow-up|Lost to Follow-up|7|||
128810299|NCT05256017|463602397|FG001|Follow-up|Lost to Follow-up|1|||
128810300|NCT05256017|463602396|FG000|Follow-up|Withdrawal by Subject|1|||
128810301|NCT05256017|463602397|FG001|Follow-up|Withdrawal by Subject|0|||
128810302|NCT05256017|463602396|FG000|Follow-up|Death|0|||
128810303|NCT05256017|463602397|FG001|Follow-up|Death|1|||
128810304|NCT03536754|463602402|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
128810305|NCT03536754|463602403|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
128810306|NCT03536754|463602404|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
128810307|NCT03536754|463602405|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
128810308|NCT03536754|463602406|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
128810309|NCT03536754|463602402|FG000|Open Label Extension|Other|0|||
128810310|NCT03536754|463602403|FG001|Open Label Extension|Other|0|||
128810311|NCT03536754|463602404|FG002|Open Label Extension|Other|0|||
128810312|NCT03536754|463602405|FG003|Open Label Extension|Other|0|||
128810313|NCT03536754|463602406|FG004|Open Label Extension|Other|1|||
128810314|NCT04858321|463602407|FG000|Overall Study|Withdrawal by Subject|3|||
128810315|NCT05057247|463602408|FG000|Overall Study|Death|4|||
128810316|NCT05057247|463602408|FG000|Overall Study|Physician Decision|3|||
128810317|NCT05057247|463602408|FG000|Overall Study|Progressive Disease|7|||
128810318|NCT05057247|463602408|FG000|Overall Study|Withdrawal by Subject|3|||
128810319|NCT05057247|463602408|FG000|Overall Study|Adverse Event|6|||
128810320|NCT05057247|463602408|FG000|Overall Study|Subject Non-Compliance|1|||
128810321|NCT05057247|463602408|FG000|Overall Study|On treatment|2|||
128810322|NCT05647304|463602419|FG000|Overall Study|Withdrawal by Subject|1|||
128810323|NCT05647304|463602420|FG001|Overall Study|Withdrawal by Subject|0|||
128810324|NCT02146378|463602421|FG000|Overall Study|No information of administration|2|||
128810325|NCT02683447|463602422|FG000|Overall Study|Lost to Follow-up|2|||
128810326|NCT03448107|463602423|FG000|Overall Study|Lost to Follow-up|229|||
128810327|NCT03448107|463602424|FG001|Overall Study|Lost to Follow-up|258|||
128810328|NCT04025554|463602425|FG000|Overall Study|Adverse Event|3|||
128810329|NCT03115476|463602426|FG000|LP0084-1369|Death|1|||
128810330|NCT03115476|463602427|FG001|LP0084-1369|Death|0|||
128810331|NCT03115476|463602428|FG002|LP0084-1369|Death|2|||
128810332|NCT03115476|463602426|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
128810333|NCT03115476|463602427|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
128810334|NCT03115476|463602428|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
128810335|NCT00613106|463602432|FG000|Overall Study|Adverse Event|3|||
128810336|NCT00613106|463602433|FG001|Overall Study|Adverse Event|1|||
128810337|NCT00613106|463602432|FG000|Overall Study|Withdrawal by Subject|6|||
128810338|NCT00613106|463602433|FG001|Overall Study|Withdrawal by Subject|3|||
128810339|NCT00613106|463602432|FG000|Overall Study|Lost to Follow-up|7|||
128810340|NCT00613106|463602433|FG001|Overall Study|Lost to Follow-up|2|||
128810341|NCT00613106|463602432|FG000|Overall Study|misc|4|||
128810342|NCT00613106|463602433|FG001|Overall Study|misc|3|||
128810343|NCT05296525|463602442|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
128810344|NCT05296525|463602443|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
128810345|NCT05296525|463602444|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
128810346|NCT05296525|463602445|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
128810347|NCT04065841|463602448|FG000|Overall Study|Adverse Event|4|||
128810348|NCT04065841|463602449|FG001|Overall Study|Adverse Event|2|||
128810349|NCT04065841|463602450|FG002|Overall Study|Adverse Event|10|||
128810350|NCT04065841|463602451|FG003|Overall Study|Adverse Event|1|||
128810351|NCT04065841|463602448|FG000|Overall Study|Lost to Follow-up|1|||
128810352|NCT04065841|463602449|FG001|Overall Study|Lost to Follow-up|2|||
128810353|NCT04065841|463602450|FG002|Overall Study|Lost to Follow-up|2|||
128810354|NCT04065841|463602451|FG003|Overall Study|Lost to Follow-up|2|||
128810355|NCT04065841|463602448|FG000|Overall Study|Physician Decision|1|||
128810356|NCT04065841|463602449|FG001|Overall Study|Physician Decision|0|||
128810357|NCT04065841|463602450|FG002|Overall Study|Physician Decision|0|||
128810358|NCT04065841|463602451|FG003|Overall Study|Physician Decision|0|||
128810359|NCT04065841|463602448|FG000|Overall Study|Protocol Violation|0|||
128810360|NCT04065841|463602449|FG001|Overall Study|Protocol Violation|1|||
128810361|NCT04065841|463602450|FG002|Overall Study|Protocol Violation|0|||
128810362|NCT04065841|463602451|FG003|Overall Study|Protocol Violation|0|||
128810363|NCT04065841|463602448|FG000|Overall Study|Study terminated by Sponsor|22|||
128810364|NCT04065841|463602449|FG001|Overall Study|Study terminated by Sponsor|16|||
128810365|NCT04065841|463602450|FG002|Overall Study|Study terminated by Sponsor|28|||
128810366|NCT04065841|463602451|FG003|Overall Study|Study terminated by Sponsor|17|||
128810367|NCT04065841|463602448|FG000|Overall Study|Withdrawal by Subject|1|||
128810368|NCT04065841|463602449|FG001|Overall Study|Withdrawal by Subject|1|||
128810369|NCT04065841|463602450|FG002|Overall Study|Withdrawal by Subject|2|||
128810370|NCT04065841|463602451|FG003|Overall Study|Withdrawal by Subject|0|||
128810371|NCT01420237|463602452|FG000|Overall Study|Death|13|||
128810372|NCT01420237|463602452|FG000|Overall Study|Withdrawal by Subject|41|||
128810373|NCT01420237|463602452|FG000|Overall Study|Lost to Follow-up|32|||
128810374|NCT01420237|463602452|FG000|Overall Study|Adverse Event|10|||
128810375|NCT01420237|463602452|FG000|Overall Study|Investigative Site Termination|43|||
128810376|NCT01420237|463602452|FG000|Overall Study|Censored because study device not implanted|21|||
128810377|NCT01420237|463602452|FG000|Overall Study|Censored because surgery not performed|2|||
128810378|NCT01420237|463602452|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
128810379|NCT01420237|463602452|FG000|Overall Study|Sponsor terminated study early|127|||
128810380|NCT04492722|463602453|FG000|Overall Study|Adverse Event|7|||
128810381|NCT04492722|463602454|FG001|Overall Study|Adverse Event|2|||
128810382|NCT04492722|463602455|FG002|Overall Study|Adverse Event|3|||
128810383|NCT04492722|463602456|FG003|Overall Study|Adverse Event|0|||
128810384|NCT04492722|463602453|FG000|Overall Study|Death|0|||
128810385|NCT04492722|463602454|FG001|Overall Study|Death|0|||
128810386|NCT04492722|463602455|FG002|Overall Study|Death|0|||
128810387|NCT04492722|463602456|FG003|Overall Study|Death|1|||
128810388|NCT04492722|463602453|FG000|Overall Study|Lost to Follow-up|0|||
128810389|NCT04492722|463602454|FG001|Overall Study|Lost to Follow-up|1|||
128810390|NCT04492722|463602455|FG002|Overall Study|Lost to Follow-up|0|||
128810391|NCT04492722|463602456|FG003|Overall Study|Lost to Follow-up|1|||
128810392|NCT04492722|463602453|FG000|Overall Study|Physician Decision|0|||
128810393|NCT04492722|463602454|FG001|Overall Study|Physician Decision|3|||
128810394|NCT04492722|463602455|FG002|Overall Study|Physician Decision|1|||
128810395|NCT04492722|463602456|FG003|Overall Study|Physician Decision|1|||
128810396|NCT04492722|463602453|FG000|Overall Study|Withdrawal by Subject|6|||
128810397|NCT04492722|463602454|FG001|Overall Study|Withdrawal by Subject|6|||
128810398|NCT04492722|463602455|FG002|Overall Study|Withdrawal by Subject|0|||
128810399|NCT04492722|463602456|FG003|Overall Study|Withdrawal by Subject|3|||
128810400|NCT04492722|463602453|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
128810401|NCT04492722|463602454|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
128810402|NCT04492722|463602455|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
128810403|NCT04492722|463602456|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
128810404|NCT04492722|463602453|FG000|Overall Study|Due to Covid-19 pandemic|7|||
128810405|NCT04492722|463602454|FG001|Overall Study|Due to Covid-19 pandemic|3|||
128810406|NCT04492722|463602455|FG002|Overall Study|Due to Covid-19 pandemic|7|||
128810407|NCT04492722|463602456|FG003|Overall Study|Due to Covid-19 pandemic|6|||
128810408|NCT04492722|463602453|FG000|Overall Study|Failure to meet randomisation criteria|2|||
128810409|NCT04492722|463602454|FG001|Overall Study|Failure to meet randomisation criteria|3|||
128810410|NCT04492722|463602455|FG002|Overall Study|Failure to meet randomisation criteria|4|||
128810411|NCT04492722|463602456|FG003|Overall Study|Failure to meet randomisation criteria|2|||
128810412|NCT04492722|463602453|FG000|Overall Study|Early termination from the study|54|||
128810413|NCT04492722|463602454|FG001|Overall Study|Early termination from the study|51|||
128810414|NCT04492722|463602455|FG002|Overall Study|Early termination from the study|50|||
128810415|NCT04492722|463602456|FG003|Overall Study|Early termination from the study|50|||
128810416|NCT04492722|463602453|FG000|Overall Study|Missing|3|||
128810417|NCT04492722|463602454|FG001|Overall Study|Missing|0|||
128810418|NCT04492722|463602455|FG002|Overall Study|Missing|0|||
128810419|NCT04492722|463602456|FG003|Overall Study|Missing|5|||
128810420|NCT04492722|463602453|FG000|Overall Study|Participants who did not receive treatment|0|||
128810421|NCT04492722|463602454|FG001|Overall Study|Participants who did not receive treatment|1|||
128810422|NCT04492722|463602455|FG002|Overall Study|Participants who did not receive treatment|4|||
128810423|NCT04492722|463602456|FG003|Overall Study|Participants who did not receive treatment|0|||
128810424|NCT05030233|463602460|FG000|Overall Study|withdrawn for transfer|1|||
128810425|NCT05030233|463602461|FG001|Overall Study|withdrawn for transfer|0|||
128810426|NCT01396278|463604377|FG000|Overall Study|Adverse Event|0|||
128810427|NCT01396278|463604378|FG001|Overall Study|Adverse Event|0|||
128810428|NCT01396278|463604379|FG002|Overall Study|Adverse Event|0|||
128810429|NCT01396278|463604380|FG003|Overall Study|Adverse Event|2|||
128810430|NCT01396278|463604381|FG004|Overall Study|Adverse Event|0|||
128810431|NCT01396278|463604377|FG000|Overall Study|Withdraw due to trial termination|2|||
128810432|NCT01396278|463604378|FG001|Overall Study|Withdraw due to trial termination|1|||
128810433|NCT01396278|463604379|FG002|Overall Study|Withdraw due to trial termination|1|||
128810434|NCT01396278|463604380|FG003|Overall Study|Withdraw due to trial termination|0|||
128810435|NCT01396278|463604381|FG004|Overall Study|Withdraw due to trial termination|2|||
128810436|NCT04515576|463604384|FG000|Overall Study|Withdrawal by Subject|0|||
128810437|NCT04515576|463604385|FG001|Overall Study|Withdrawal by Subject|0|||
128810438|NCT04515576|463604386|FG002|Overall Study|Withdrawal by Subject|0|||
128810439|NCT04515576|463604387|FG003|Overall Study|Withdrawal by Subject|0|||
128810440|NCT04515576|463604388|FG004|Overall Study|Withdrawal by Subject|0|||
128810441|NCT04515576|463604389|FG005|Overall Study|Withdrawal by Subject|1|||
128810442|NCT05028634|463604390|FG000|Overall Study|Withdrawal by Subject|0|||
128810443|NCT05028634|463604391|FG001|Overall Study|Withdrawal by Subject|1|||
128810444|NCT05653427|463604392|FG000|Overall Study|Study Terminated by Sponsor|13|||
128810445|NCT04256941|463604400|FG000|Overall Study|Withdrawal by Subject|0|||
128810446|NCT04256941|463604401|FG001|Overall Study|Withdrawal by Subject|1|||
128810447|NCT04256941|463604400|FG000|Overall Study|Death|1|||
128810448|NCT04256941|463604401|FG001|Overall Study|Death|0|||
128810449|NCT04256941|463604400|FG000|Overall Study|Disease Progession|0|||
128810450|NCT04256941|463604401|FG001|Overall Study|Disease Progession|2|||
128810451|NCT02908477|463604408|FG000|Overall Study|Withdrawal by Subject|8|||
128810452|NCT02908477|463604409|FG001|Overall Study|Withdrawal by Subject|28|||
128810453|NCT02140554|463604410|FG000|Overall Study|Withdrawal of consent|1|||
128810454|NCT02140554|463604411|FG001|Overall Study|Withdrawal of consent|0|||
128810455|NCT02140554|463604412|FG002|Overall Study|Withdrawal of consent|4|||
128810456|NCT02140554|463604410|FG000|Overall Study|Physician Decision|1|||
128810457|NCT02140554|463604411|FG001|Overall Study|Physician Decision|0|||
128810458|NCT02140554|463604412|FG002|Overall Study|Physician Decision|2|||
128810459|NCT02140554|463604410|FG000|Overall Study|Death|0|||
128810460|NCT02140554|463604411|FG001|Overall Study|Death|0|||
128810461|NCT02140554|463604412|FG002|Overall Study|Death|1|||
128810462|NCT02140554|463604410|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
128810463|NCT02140554|463604411|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
128810464|NCT02140554|463604412|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
128810465|NCT05659537|463604413|FG000|Overall Study|Adverse Event|5|||
128810466|NCT05659537|463604413|FG000|Overall Study|Lost to Follow-up|4|||
128810467|NCT05659537|463604413|FG000|Overall Study|Withdrawal by Subject|13|||
128810468|NCT05659537|463604413|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
128810469|NCT05659537|463604413|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
128810470|NCT05659537|463604413|FG000|Overall Study|Participant was suffering from anaemia|1|||
128810471|NCT04728347|463604414|FG000|Overall Study|Sponsor decision|0|||
128810472|NCT04728347|463604415|FG001|Overall Study|Sponsor decision|0|||
128810473|NCT04728347|463604416|FG002|Overall Study|Sponsor decision|1|||
128810474|NCT04728347|463604417|FG003|Overall Study|Sponsor decision|0|||
128810475|NCT02105766|463604427|FG000|Overall Study|Physician Decision|1|||
128810476|NCT02105766|463604428|FG001|Overall Study|Physician Decision|1|||
128810477|NCT02105766|463604429|FG002|Overall Study|Physician Decision|0|||
128810478|NCT02105766|463604427|FG000|Overall Study|Lost to Follow-up|2|||
128810479|NCT02105766|463604428|FG001|Overall Study|Lost to Follow-up|0|||
128810480|NCT02105766|463604429|FG002|Overall Study|Lost to Follow-up|0|||
128810481|NCT02105766|463604427|FG000|Overall Study|Death|1|||
128810482|NCT02105766|463604428|FG001|Overall Study|Death|1|||
128810483|NCT02105766|463604429|FG002|Overall Study|Death|0|||
128810484|NCT03897465|463604430|FG000|Overall Study|Lost to Follow-up|2|||
128810485|NCT03897465|463604431|FG001|Overall Study|Lost to Follow-up|1|||
128810486|NCT03897465|463604430|FG000|Overall Study|Adverse Event|2|||
128810487|NCT03897465|463604431|FG001|Overall Study|Adverse Event|0|||
128810488|NCT03897465|463604430|FG000|Overall Study|complete healing by V2|1|||
128810489|NCT03897465|463604431|FG001|Overall Study|complete healing by V2|0|||
128810490|NCT03897465|463604430|FG000|Overall Study|occurence of exclusion criterion|1|||
128810491|NCT03897465|463604431|FG001|Overall Study|occurence of exclusion criterion|1|||
128810492|NCT03897465|463604430|FG000|Overall Study|Other|1|||
128810493|NCT03897465|463604431|FG001|Overall Study|Other|0|||
128810494|NCT05119023|463604432|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
128810495|NCT05119023|463604432|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
128810496|NCT05119023|463604432|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
128810497|NCT06516705|463604452|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
128810498|NCT06516705|463604453|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
128810499|NCT06516705|463604452|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
128810500|NCT06516705|463604453|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
128810501|NCT06516705|463604452|FG000|T3 ( 3 Month After Education)|covid-19|1|||
128810502|NCT06516705|463604453|FG001|T3 ( 3 Month After Education)|covid-19|2|||
128810503|NCT06516705|463604452|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
128810504|NCT06516705|463604453|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
128810505|NCT06516705|463604452|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
128810506|NCT06516705|463604453|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
128810507|NCT06516705|463604452|FG000|T4 ( 6 Month After Education)|covid-19|3|||
128810508|NCT06516705|463604453|FG001|T4 ( 6 Month After Education)|covid-19|2|||
128810509|NCT06516705|463604452|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
128810510|NCT06516705|463604453|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
128810511|NCT04292223|463604457|FG000|Overall Study|Adverse Event|1|||
128810512|NCT04292223|463604457|FG000|Overall Study|Lost to Follow-up|1|||
128810513|NCT04292223|463604457|FG000|Overall Study|Noncompliance with study drug|2|||
128810514|NCT04292223|463604457|FG000|Overall Study|Patient moved out of the state|1|||
128810515|NCT05453773|463604458|FG000|Overall Study|Withdrawal by Subject|3|||
128810516|NCT05453773|463604458|FG000|Overall Study|Lost to Follow-up|3|||
128810517|NCT05453773|463604458|FG000|Overall Study|Difficult Blood Draw|3|||
128810518|NCT02023866|463604461|FG000|Overall Study|Non-compliance|2|||
128810519|NCT02023866|463604461|FG000|Overall Study|Adverse Event|3|||
128810520|NCT02023866|463604461|FG000|Overall Study|Withdrawal by Subject|1|||
128810521|NCT03023410|463604462|FG000|Overall Study|study termination|0|||
128810522|NCT03023410|463604463|FG001|Overall Study|study termination|1|||
128810523|NCT04799899|463604464|FG000|Overall Study|Lost to Follow-up|2|||
128810524|NCT04799899|463604465|FG001|Overall Study|Lost to Follow-up|4|||
128810525|NCT04019873|463604466|FG000|Overall Study|Discontinued from the treatment|1|||
128810526|NCT04019873|463604467|FG001|Overall Study|Discontinued from the treatment|39|||
128810527|NCT04019873|463604468|FG002|Overall Study|Discontinued from the treatment|2|||
128810528|NCT04683744|463604475|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
128810529|NCT04683744|463604476|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
128810530|NCT04683744|463604477|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
128810531|NCT04927364|463604483|FG000|Overall Study|Withdrawal by Subject|3|||
128810532|NCT04927364|463604483|FG000|Overall Study|Unable to complete preassessment MRI|1|||
128810533|NCT04091750|463604486|FG000|Overall Study|Adverse Event|4|||
128810534|NCT04091750|463604486|FG000|Overall Study|Withdrawal by Subject|1|||
128810535|NCT02919306|463604487|FG000|Overall Study|Withdrawal by Subject|1|||
128810536|NCT02919306|463604488|FG001|Overall Study|Withdrawal by Subject|0|||
128810537|NCT02919306|463604487|FG000|Overall Study|Protocol Violation|1|||
128810538|NCT02919306|463604488|FG001|Overall Study|Protocol Violation|0|||
128810539|NCT04473222|463604489|FG000|Overall Study|Lost to Follow-up|13|||
128810540|NCT04473222|463604490|FG001|Overall Study|Lost to Follow-up|13|||
128810541|NCT04473222|463604489|FG000|Overall Study|Withdrawal by Subject|0|||
128810542|NCT04473222|463604490|FG001|Overall Study|Withdrawal by Subject|1|||
128810543|NCT04473222|463604489|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
128810544|NCT04473222|463604490|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
128810545|NCT04293055|463604491|FG000|Overall Study|Lost to Follow-up|1|||
128810546|NCT04293055|463604492|FG001|Overall Study|Lost to Follow-up|1|||
128810547|NCT04293055|463604491|FG000|Overall Study|Did not trigger randomization|6|||
128810548|NCT04293055|463604492|FG001|Overall Study|Did not trigger randomization|5|||
128810549|NCT03560609|463604493|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
128810550|NCT03560609|463604494|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
128810551|NCT04195698|463604505|FG000|Overall Study|Adverse Event|4|||
128810552|NCT04195698|463604506|FG001|Overall Study|Adverse Event|11|||
128810553|NCT04195698|463604505|FG000|Overall Study|Withdrawal by Subject|9|||
128810554|NCT04195698|463604506|FG001|Overall Study|Withdrawal by Subject|10|||
128810555|NCT04195698|463604505|FG000|Overall Study|Lost to Follow-up|5|||
128810556|NCT04195698|463604506|FG001|Overall Study|Lost to Follow-up|4|||
128810557|NCT04195698|463604505|FG000|Overall Study|Lack of Efficacy|2|||
128810558|NCT04195698|463604506|FG001|Overall Study|Lack of Efficacy|10|||
128810559|NCT04195698|463604505|FG000|Overall Study|Other|5|||
128810560|NCT04195698|463604506|FG001|Overall Study|Other|4|||
128810561|NCT01369355|463604508|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
128810562|NCT01369355|463604509|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
128810563|NCT01369355|463604510|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
128810564|NCT01369355|463604511|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
128810565|NCT01369355|463604512|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
128810566|NCT01369355|463604513|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
128810567|NCT01369355|463604514|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
128810568|NCT01369355|463604515|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
128810569|NCT01369355|463604516|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
128810570|NCT01369355|463604508|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
128810571|NCT01369355|463604509|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
128810572|NCT01369355|463604510|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
128810573|NCT01369355|463604511|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
128810574|NCT01369355|463604512|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
128810575|NCT01369355|463604513|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
128810576|NCT01369355|463604514|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
128810577|NCT01369355|463604515|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
128810578|NCT01369355|463604516|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
128810579|NCT01369355|463604508|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
128810580|NCT01369355|463604509|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
128810581|NCT01369355|463604510|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
128810582|NCT01369355|463604511|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
128810583|NCT01369355|463604512|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
128810584|NCT01369355|463604513|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
128810585|NCT01369355|463604514|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
128810586|NCT01369355|463604515|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
128810587|NCT01369355|463604516|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
128810588|NCT01369355|463604508|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
128810589|NCT01369355|463604509|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
128810590|NCT01369355|463604510|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
128810591|NCT01369355|463604511|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
128810592|NCT01369355|463604512|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
128810593|NCT01369355|463604513|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
128810594|NCT01369355|463604514|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
128810595|NCT01369355|463604515|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
128810596|NCT01369355|463604516|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
128810597|NCT01369355|463604508|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
128810598|NCT01369355|463604509|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
128810599|NCT01369355|463604510|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
128810600|NCT01369355|463604511|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
128810601|NCT01369355|463604512|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
128810602|NCT01369355|463604513|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
128810603|NCT01369355|463604514|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
128810604|NCT01369355|463604515|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
128810605|NCT01369355|463604516|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
128810606|NCT01369355|463604508|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
128810607|NCT01369355|463604509|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
128810608|NCT01369355|463604510|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
128810609|NCT01369355|463604511|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
128810610|NCT01369355|463604512|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
128810611|NCT01369355|463604513|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
128810612|NCT01369355|463604514|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
128810613|NCT01369355|463604515|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
128810614|NCT01369355|463604516|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
128810615|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
128810616|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
128810617|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
128810618|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
128810619|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
128810620|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
128810621|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
128810622|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
128810623|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
128810624|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Death|0|||
128810625|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Death|0|||
128810626|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Death|0|||
128810627|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Death|0|||
128810628|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Death|0|||
128810629|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Death|0|||
128810630|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Death|0|||
128810631|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Death|1|||
128810632|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Death|3|||
128810633|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
128810634|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
128810635|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
128810636|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
128810637|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
128810638|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
128810639|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
128810640|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
128810641|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
128810642|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
128810643|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
128810644|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
128810645|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
128810646|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
128810647|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
128810648|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
128810649|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
128810650|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
128810651|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
128810652|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
128810653|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
128810654|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
128810655|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
128810656|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
128810657|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
128810658|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
128810659|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
128810660|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
128810661|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
128810662|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
128810663|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
128810664|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
128810665|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
128810666|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
128810667|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
128810668|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
128810669|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
128810670|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
128810671|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
128810672|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
128810673|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
128810674|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
128810675|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
128810676|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
128810677|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
128810678|NCT01369355|463604508|FG000|Long-term Extension (Week 44-272)|Other|0|||
128810679|NCT01369355|463604509|FG001|Long-term Extension (Week 44-272)|Other|0|||
128810680|NCT01369355|463604510|FG002|Long-term Extension (Week 44-272)|Other|0|||
128810681|NCT01369355|463604511|FG003|Long-term Extension (Week 44-272)|Other|0|||
128810682|NCT01369355|463604512|FG004|Long-term Extension (Week 44-272)|Other|0|||
128810683|NCT01369355|463604513|FG005|Long-term Extension (Week 44-272)|Other|0|||
128810684|NCT01369355|463604514|FG006|Long-term Extension (Week 44-272)|Other|110|||
128810685|NCT01369355|463604515|FG007|Long-term Extension (Week 44-272)|Other|9|||
128810686|NCT01369355|463604516|FG008|Long-term Extension (Week 44-272)|Other|17|||
128810687|NCT01902173|463604517|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
128810688|NCT01902173|463604518|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
128810689|NCT01902173|463604519|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
128810690|NCT01902173|463604520|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
128810691|NCT01902173|463604521|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
128810692|NCT01902173|463604522|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
128810693|NCT01902173|463604517|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
128810694|NCT01902173|463604518|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
128810695|NCT01902173|463604519|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
128810696|NCT01902173|463604520|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
128810697|NCT01902173|463604521|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
128810698|NCT01902173|463604522|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
128810699|NCT01902173|463604517|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
128810700|NCT01902173|463604518|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
128810701|NCT01902173|463604519|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
128810702|NCT01902173|463604520|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
128810703|NCT01902173|463604521|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
128810704|NCT01902173|463604522|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
128810705|NCT01902173|463604517|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
128810706|NCT01902173|463604518|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
128810707|NCT01902173|463604519|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
128810708|NCT01902173|463604520|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
128810709|NCT01902173|463604521|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
128810710|NCT01902173|463604522|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
128810711|NCT01902173|463604517|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
128810712|NCT01902173|463604518|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
128810713|NCT01902173|463604519|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
128810714|NCT01902173|463604520|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
128810715|NCT01902173|463604521|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
128810716|NCT01902173|463604522|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
128810717|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
128810718|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
128810719|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
128810720|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
128810721|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
128810722|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
128810723|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
128810724|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
128810725|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
128810726|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
128810727|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
128810728|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
128810729|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
128810730|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
128810731|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
128810732|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
128810733|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
128810734|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
128810735|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
128810736|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
128810737|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
128810738|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
128810739|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
128810740|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
128810741|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
128810742|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
128810743|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
128810744|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
128810745|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
128810746|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
128810747|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
128810748|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
128810749|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
128810750|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
128810751|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
128810752|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
128810753|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
128810754|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
128810755|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
128810756|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
128810757|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
128810758|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
128810759|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
128810760|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
128810761|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
128810762|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
128810763|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
128810764|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
128810765|NCT01902173|463604517|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
128810766|NCT01902173|463604518|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
128810767|NCT01902173|463604519|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
128810768|NCT01902173|463604520|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
128810769|NCT01902173|463604521|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
128810770|NCT01902173|463604522|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
128810771|NCT02262728|463604524|FG000|Follow-up Phase (3 Years)|Death|0|||
128810772|NCT02262728|463604525|FG001|Follow-up Phase (3 Years)|Death|1|||
128810773|NCT02262728|463604524|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
128810774|NCT02262728|463604525|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
128810775|NCT02262728|463604524|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
128810776|NCT02262728|463604525|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
128810777|NCT05540665|463604526|FG000|Overall Study|Study terminated by sponsor|6|||
128810778|NCT05540665|463604527|FG001|Overall Study|Study terminated by sponsor|6|||
128810779|NCT05540665|463604528|FG002|Overall Study|Study terminated by sponsor|7|||
128810780|NCT04632992|463604530|FG000|Overall Study|Adverse Event|0|||
128810781|NCT04632992|463604531|FG001|Overall Study|Adverse Event|0|||
128810782|NCT04632992|463604532|FG002|Overall Study|Adverse Event|0|||
128810783|NCT04632992|463604533|FG003|Overall Study|Adverse Event|0|||
128810784|NCT04632992|463604534|FG004|Overall Study|Adverse Event|0|||
128810785|NCT04632992|463604535|FG005|Overall Study|Adverse Event|0|||
128810786|NCT04632992|463604536|FG006|Overall Study|Adverse Event|0|||
128810787|NCT04632992|463604537|FG007|Overall Study|Adverse Event|0|||
128810788|NCT04632992|463604538|FG008|Overall Study|Adverse Event|0|||
128810789|NCT04632992|463604539|FG009|Overall Study|Adverse Event|0|||
128810790|NCT04632992|463604540|FG010|Overall Study|Adverse Event|0|||
128810791|NCT04632992|463604541|FG011|Overall Study|Adverse Event|0|||
128810792|NCT04632992|463604542|FG012|Overall Study|Adverse Event|1|||
128810793|NCT04632992|463604543|FG013|Overall Study|Adverse Event|0|||
128810794|NCT04632992|463604530|FG000|Overall Study|Death|17|||
128810795|NCT04632992|463604531|FG001|Overall Study|Death|1|||
128810796|NCT04632992|463604532|FG002|Overall Study|Death|14|||
128810797|NCT04632992|463604533|FG003|Overall Study|Death|14|||
128810798|NCT04632992|463604534|FG004|Overall Study|Death|13|||
128810799|NCT04632992|463604535|FG005|Overall Study|Death|6|||
128810800|NCT04632992|463604536|FG006|Overall Study|Death|7|||
128810801|NCT04632992|463604537|FG007|Overall Study|Death|12|||
128810802|NCT04632992|463604538|FG008|Overall Study|Death|15|||
128810803|NCT04632992|463604539|FG009|Overall Study|Death|20|||
128810804|NCT04632992|463604540|FG010|Overall Study|Death|8|||
128810805|NCT04632992|463604541|FG011|Overall Study|Death|2|||
128810806|NCT04632992|463604542|FG012|Overall Study|Death|10|||
128810807|NCT04632992|463604543|FG013|Overall Study|Death|1|||
128810808|NCT04632992|463604530|FG000|Overall Study|Lost to Follow-up|1|||
128810809|NCT04632992|463604531|FG001|Overall Study|Lost to Follow-up|0|||
128810810|NCT04632992|463604532|FG002|Overall Study|Lost to Follow-up|1|||
128810811|NCT04632992|463604533|FG003|Overall Study|Lost to Follow-up|0|||
128810812|NCT04632992|463604534|FG004|Overall Study|Lost to Follow-up|2|||
128810813|NCT04632992|463604535|FG005|Overall Study|Lost to Follow-up|0|||
128810814|NCT04632992|463604536|FG006|Overall Study|Lost to Follow-up|1|||
128810815|NCT04632992|463604537|FG007|Overall Study|Lost to Follow-up|1|||
128810816|NCT04632992|463604538|FG008|Overall Study|Lost to Follow-up|1|||
128810817|NCT04632992|463604539|FG009|Overall Study|Lost to Follow-up|1|||
128810818|NCT04632992|463604540|FG010|Overall Study|Lost to Follow-up|2|||
128810819|NCT04632992|463604541|FG011|Overall Study|Lost to Follow-up|0|||
128810820|NCT04632992|463604542|FG012|Overall Study|Lost to Follow-up|0|||
128810821|NCT04632992|463604543|FG013|Overall Study|Lost to Follow-up|0|||
128810822|NCT04632992|463604530|FG000|Overall Study|Reason not Specified|2|||
128810823|NCT04632992|463604531|FG001|Overall Study|Reason not Specified|0|||
128810824|NCT04632992|463604532|FG002|Overall Study|Reason not Specified|1|||
128810825|NCT04632992|463604533|FG003|Overall Study|Reason not Specified|1|||
128810826|NCT04632992|463604534|FG004|Overall Study|Reason not Specified|0|||
128810827|NCT04632992|463604535|FG005|Overall Study|Reason not Specified|0|||
128810828|NCT04632992|463604536|FG006|Overall Study|Reason not Specified|0|||
128810829|NCT04632992|463604537|FG007|Overall Study|Reason not Specified|0|||
128810830|NCT04632992|463604538|FG008|Overall Study|Reason not Specified|0|||
128810831|NCT04632992|463604539|FG009|Overall Study|Reason not Specified|0|||
128810832|NCT04632992|463604540|FG010|Overall Study|Reason not Specified|1|||
128810833|NCT04632992|463604541|FG011|Overall Study|Reason not Specified|0|||
128810834|NCT04632992|463604542|FG012|Overall Study|Reason not Specified|0|||
128810835|NCT04632992|463604543|FG013|Overall Study|Reason not Specified|0|||
128810836|NCT04632992|463604530|FG000|Overall Study|Physician Decision|0|||
128810837|NCT04632992|463604531|FG001|Overall Study|Physician Decision|0|||
128810838|NCT04632992|463604532|FG002|Overall Study|Physician Decision|0|||
128810839|NCT04632992|463604533|FG003|Overall Study|Physician Decision|2|||
128810840|NCT04632992|463604534|FG004|Overall Study|Physician Decision|1|||
128810841|NCT04632992|463604535|FG005|Overall Study|Physician Decision|0|||
128810842|NCT04632992|463604536|FG006|Overall Study|Physician Decision|0|||
128810843|NCT04632992|463604537|FG007|Overall Study|Physician Decision|0|||
128810844|NCT04632992|463604538|FG008|Overall Study|Physician Decision|0|||
128810845|NCT04632992|463604539|FG009|Overall Study|Physician Decision|0|||
128810846|NCT04632992|463604540|FG010|Overall Study|Physician Decision|0|||
128810847|NCT04632992|463604541|FG011|Overall Study|Physician Decision|0|||
128810848|NCT04632992|463604542|FG012|Overall Study|Physician Decision|3|||
128810849|NCT04632992|463604543|FG013|Overall Study|Physician Decision|0|||
128810850|NCT04632992|463604530|FG000|Overall Study|Progressive Disease|0|||
128810851|NCT04632992|463604531|FG001|Overall Study|Progressive Disease|0|||
128810852|NCT04632992|463604532|FG002|Overall Study|Progressive Disease|0|||
128810853|NCT04632992|463604533|FG003|Overall Study|Progressive Disease|0|||
128810854|NCT04632992|463604534|FG004|Overall Study|Progressive Disease|1|||
128810855|NCT04632992|463604535|FG005|Overall Study|Progressive Disease|0|||
128810856|NCT04632992|463604536|FG006|Overall Study|Progressive Disease|0|||
128810857|NCT04632992|463604537|FG007|Overall Study|Progressive Disease|0|||
128810858|NCT04632992|463604538|FG008|Overall Study|Progressive Disease|0|||
128810859|NCT04632992|463604539|FG009|Overall Study|Progressive Disease|1|||
128810860|NCT04632992|463604540|FG010|Overall Study|Progressive Disease|1|||
128810861|NCT04632992|463604541|FG011|Overall Study|Progressive Disease|0|||
128810862|NCT04632992|463604542|FG012|Overall Study|Progressive Disease|2|||
128810863|NCT04632992|463604543|FG013|Overall Study|Progressive Disease|0|||
128810864|NCT04632992|463604530|FG000|Overall Study|Withdrawal by Subject|4|||
128810865|NCT04632992|463604531|FG001|Overall Study|Withdrawal by Subject|1|||
128810866|NCT04632992|463604532|FG002|Overall Study|Withdrawal by Subject|5|||
128810867|NCT04632992|463604533|FG003|Overall Study|Withdrawal by Subject|4|||
128810868|NCT04632992|463604534|FG004|Overall Study|Withdrawal by Subject|3|||
128810869|NCT04632992|463604535|FG005|Overall Study|Withdrawal by Subject|3|||
128810870|NCT04632992|463604536|FG006|Overall Study|Withdrawal by Subject|0|||
128810871|NCT04632992|463604537|FG007|Overall Study|Withdrawal by Subject|5|||
128810872|NCT04632992|463604538|FG008|Overall Study|Withdrawal by Subject|0|||
128810873|NCT04632992|463604539|FG009|Overall Study|Withdrawal by Subject|2|||
128810874|NCT04632992|463604540|FG010|Overall Study|Withdrawal by Subject|8|||
128810875|NCT04632992|463604541|FG011|Overall Study|Withdrawal by Subject|0|||
128810876|NCT04632992|463604542|FG012|Overall Study|Withdrawal by Subject|1|||
128810877|NCT04632992|463604543|FG013|Overall Study|Withdrawal by Subject|1|||
128810878|NCT03603600|463604544|FG000|Overall Study|Withdrawal by Subject|5|||
128810879|NCT03603600|463604545|FG001|Overall Study|Withdrawal by Subject|7|||
128810880|NCT03603600|463604544|FG000|Overall Study|Lost to Follow-up|2|||
128810881|NCT03603600|463604545|FG001|Overall Study|Lost to Follow-up|3|||
128810882|NCT03603600|463604544|FG000|Overall Study|Death|3|||
128810883|NCT03603600|463604545|FG001|Overall Study|Death|1|||
128810884|NCT03603600|463604544|FG000|Overall Study|Physician Decision|2|||
128810885|NCT03603600|463604545|FG001|Overall Study|Physician Decision|1|||
128810886|NCT03603600|463604544|FG000|Overall Study|Other reason|1|||
128810887|NCT03603600|463604545|FG001|Overall Study|Other reason|0|||
128810888|NCT03524612|463604549|FG000|Overall Study|Lack of Efficacy|10|||
128810889|NCT03524612|463604549|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
128810890|NCT03524612|463604549|FG000|Overall Study|Adverse Event|10|||
128810891|NCT03524612|463604549|FG000|Overall Study|Withdrawal by Subject|7|||
128810892|NCT03524612|463604549|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
128810893|NCT03524612|463604549|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
128810894|NCT03524612|463604549|FG000|Overall Study|New therapy for study indication|6|||
128810895|NCT03524612|463604549|FG000|Overall Study|Death|3|||
128810896|NCT03524612|463604549|FG000|Overall Study|Lost to Follow-up|2|||
128810897|NCT03524612|463604549|FG000|Overall Study|Protocol Violation|1|||
128810898|NCT05457647|463604551|FG000|Overall Study|Lost to Follow-up|3|||
128810899|NCT02489903|463604552|FG000|Screening|Screen Failure|24|||
128810900|NCT02489903|463604553|FG001|Screening|Screen Failure|0|||
128810901|NCT02489903|463604554|FG002|Screening|Screen Failure|0|||
128810902|NCT02489903|463604555|FG003|Screening|Screen Failure|8|||
128810903|NCT02489903|463604552|FG000|Randomized and Received Treatment|Protocol Violation|0|||
128810904|NCT02489903|463604553|FG001|Randomized and Received Treatment|Protocol Violation|1|||
128810905|NCT02489903|463604554|FG002|Randomized and Received Treatment|Protocol Violation|0|||
128810906|NCT02489903|463604555|FG003|Randomized and Received Treatment|Protocol Violation|0|||
128810907|NCT02489903|463604552|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
128810908|NCT02489903|463604553|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
128810909|NCT02489903|463604554|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
128810910|NCT02489903|463604555|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
128810911|NCT02489903|463604552|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
128810912|NCT02489903|463604553|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
128810913|NCT02489903|463604554|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
128810914|NCT02489903|463604555|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
128810915|NCT02489903|463604552|FG000|Randomized and Received Treatment|Death|10|||
128810916|NCT02489903|463604553|FG001|Randomized and Received Treatment|Death|1|||
128810917|NCT02489903|463604554|FG002|Randomized and Received Treatment|Death|0|||
128810918|NCT02489903|463604555|FG003|Randomized and Received Treatment|Death|0|||
128810919|NCT05257486|463604556|FG000|Overall Study|Protocol Violation|3|||
128810920|NCT03976362|463604557|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
128810921|NCT03976362|463604558|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
128810922|NCT03976362|463604559|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
128810923|NCT03976362|463604557|FG000|Induction Phase|Death|62|||
128810924|NCT03976362|463604558|FG001|Induction Phase|Death|0|||
128810925|NCT03976362|463604559|FG002|Induction Phase|Death|0|||
128810926|NCT03976362|463604557|FG000|Maintenance Phase|Participants Ongoing|0|||
128810927|NCT03976362|463604558|FG001|Maintenance Phase|Participants Ongoing|106|||
128810928|NCT03976362|463604559|FG002|Maintenance Phase|Participants Ongoing|103|||
128810929|NCT03976362|463604557|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128810930|NCT03976362|463604558|FG001|Maintenance Phase|Withdrawal by Subject|4|||
128810931|NCT03976362|463604559|FG002|Maintenance Phase|Withdrawal by Subject|4|||
128810932|NCT03976362|463604557|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
128810933|NCT03976362|463604558|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
128810934|NCT03976362|463604559|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
128810935|NCT03976362|463604557|FG000|Maintenance Phase|Death|0|||
128810936|NCT03976362|463604558|FG001|Maintenance Phase|Death|186|||
128810937|NCT03976362|463604559|FG002|Maintenance Phase|Death|187|||
128810938|NCT05126433|463604560|FG000|Overall Study|Withdrawal by Subject|3|||
128810939|NCT05126433|463604561|FG001|Overall Study|Withdrawal by Subject|0|||
128810940|NCT05126433|463604562|FG002|Overall Study|Withdrawal by Subject|4|||
128810941|NCT05126433|463604560|FG000|Overall Study|Death|9|||
128810942|NCT05126433|463604561|FG001|Overall Study|Death|3|||
128810943|NCT05126433|463604562|FG002|Overall Study|Death|5|||
128810944|NCT05126433|463604560|FG000|Overall Study|Study Terminated by sponsor|0|||
128810945|NCT05126433|463604561|FG001|Overall Study|Study Terminated by sponsor|1|||
128810946|NCT05126433|463604562|FG002|Overall Study|Study Terminated by sponsor|2|||
128810947|NCT05126433|463604560|FG000|Overall Study|Progressive Disease|1|||
128810948|NCT05126433|463604561|FG001|Overall Study|Progressive Disease|4|||
128810949|NCT05126433|463604562|FG002|Overall Study|Progressive Disease|3|||
128810950|NCT05126433|463604560|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
128810951|NCT05126433|463604561|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
128810952|NCT05126433|463604562|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
128810953|NCT04137289|463604563|FG000|Overall Study|Death|0|||
128810954|NCT04137289|463604564|FG001|Overall Study|Death|0|||
128810955|NCT04137289|463604565|FG002|Overall Study|Death|0|||
128810956|NCT04137289|463604566|FG003|Overall Study|Death|0|||
128810957|NCT04137289|463604567|FG004|Overall Study|Death|0|||
128810958|NCT04137289|463604568|FG005|Overall Study|Death|0|||
128810959|NCT04137289|463604569|FG006|Overall Study|Death|1|||
128810960|NCT04137289|463604570|FG007|Overall Study|Death|0|||
128810961|NCT04137289|463604571|FG008|Overall Study|Death|0|||
128810962|NCT04137289|463604563|FG000|Overall Study|Clinical disease progression|0|||
128810963|NCT04137289|463604564|FG001|Overall Study|Clinical disease progression|0|||
128810964|NCT04137289|463604565|FG002|Overall Study|Clinical disease progression|0|||
128810965|NCT04137289|463604566|FG003|Overall Study|Clinical disease progression|4|||
128810966|NCT04137289|463604567|FG004|Overall Study|Clinical disease progression|4|||
128810967|NCT04137289|463604568|FG005|Overall Study|Clinical disease progression|2|||
128810968|NCT04137289|463604569|FG006|Overall Study|Clinical disease progression|5|||
128810969|NCT04137289|463604570|FG007|Overall Study|Clinical disease progression|1|||
128810970|NCT04137289|463604571|FG008|Overall Study|Clinical disease progression|0|||
128810971|NCT04137289|463604563|FG000|Overall Study|Lost to Follow-up|0|||
128810972|NCT04137289|463604564|FG001|Overall Study|Lost to Follow-up|0|||
128810973|NCT04137289|463604565|FG002|Overall Study|Lost to Follow-up|0|||
128810974|NCT04137289|463604566|FG003|Overall Study|Lost to Follow-up|1|||
128810975|NCT04137289|463604567|FG004|Overall Study|Lost to Follow-up|0|||
128810976|NCT04137289|463604568|FG005|Overall Study|Lost to Follow-up|0|||
128810977|NCT04137289|463604569|FG006|Overall Study|Lost to Follow-up|0|||
128810978|NCT04137289|463604570|FG007|Overall Study|Lost to Follow-up|0|||
128810979|NCT04137289|463604571|FG008|Overall Study|Lost to Follow-up|0|||
128810980|NCT04137289|463604563|FG000|Overall Study|Adverse Event|0|||
128810981|NCT04137289|463604564|FG001|Overall Study|Adverse Event|0|||
128810982|NCT04137289|463604565|FG002|Overall Study|Adverse Event|1|||
128810983|NCT04137289|463604566|FG003|Overall Study|Adverse Event|0|||
128810984|NCT04137289|463604567|FG004|Overall Study|Adverse Event|0|||
128810985|NCT04137289|463604568|FG005|Overall Study|Adverse Event|1|||
128810986|NCT04137289|463604569|FG006|Overall Study|Adverse Event|0|||
128810987|NCT04137289|463604570|FG007|Overall Study|Adverse Event|0|||
128810988|NCT04137289|463604571|FG008|Overall Study|Adverse Event|0|||
128810989|NCT04137289|463604563|FG000|Overall Study|Lack of clinical benefit|0|||
128810990|NCT04137289|463604564|FG001|Overall Study|Lack of clinical benefit|0|||
128810991|NCT04137289|463604565|FG002|Overall Study|Lack of clinical benefit|0|||
128810992|NCT04137289|463604566|FG003|Overall Study|Lack of clinical benefit|0|||
128810993|NCT04137289|463604567|FG004|Overall Study|Lack of clinical benefit|0|||
128810994|NCT04137289|463604568|FG005|Overall Study|Lack of clinical benefit|0|||
128810995|NCT04137289|463604569|FG006|Overall Study|Lack of clinical benefit|0|||
128810996|NCT04137289|463604570|FG007|Overall Study|Lack of clinical benefit|0|||
128810997|NCT04137289|463604571|FG008|Overall Study|Lack of clinical benefit|1|||
128810998|NCT04137289|463604563|FG000|Overall Study|Objective disease progression|1|||
128810999|NCT04137289|463604564|FG001|Overall Study|Objective disease progression|1|||
128811000|NCT04137289|463604565|FG002|Overall Study|Objective disease progression|6|||
128811001|NCT04137289|463604566|FG003|Overall Study|Objective disease progression|18|||
128811002|NCT04137289|463604567|FG004|Overall Study|Objective disease progression|12|||
128811003|NCT04137289|463604568|FG005|Overall Study|Objective disease progression|20|||
128811004|NCT04137289|463604569|FG006|Overall Study|Objective disease progression|18|||
128811005|NCT04137289|463604570|FG007|Overall Study|Objective disease progression|7|||
128811006|NCT04137289|463604571|FG008|Overall Study|Objective disease progression|6|||
128811007|NCT03812679|463606377|FG000|Overall Study|Adverse Event|2|||
128811008|NCT03812679|463606377|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
128811009|NCT03812679|463606377|FG000|Overall Study|Renal transplant|1|||
128811010|NCT03812679|463606377|FG000|Overall Study|Withdrawal by Subject|1|||
128811011|NCT03812679|463606377|FG000|Overall Study|Termination of study|2|||
128811012|NCT03812679|463606377|FG000|Overall Study|Water device replacement|1|||
128811013|NCT05486078|463606378|FG000|Overall Study|4 drop out and one withdrawn|5|||
128811014|NCT05590403|463606379|FG000|Overall Study|Lost to Follow-up|13|||
128811015|NCT05590403|463606380|FG001|Overall Study|Lost to Follow-up|1|||
128811016|NCT05590403|463606381|FG002|Overall Study|Lost to Follow-up|7|||
128811017|NCT05590403|463606382|FG003|Overall Study|Lost to Follow-up|3|||
128811018|NCT05590403|463606383|FG004|Overall Study|Lost to Follow-up|4|||
128811019|NCT05590403|463606379|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
128811020|NCT05590403|463606380|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
128811021|NCT05590403|463606381|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
128811022|NCT05590403|463606382|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
128811023|NCT05590403|463606383|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
128811024|NCT05590403|463606379|FG000|Overall Study|Other|2|||
128811025|NCT05590403|463606380|FG001|Overall Study|Other|0|||
128811026|NCT05590403|463606381|FG002|Overall Study|Other|2|||
128811027|NCT05590403|463606382|FG003|Overall Study|Other|2|||
128811028|NCT05590403|463606383|FG004|Overall Study|Other|0|||
128811029|NCT05590403|463606379|FG000|Overall Study|Migrated / moved from the study area|1|||
128811030|NCT05590403|463606380|FG001|Overall Study|Migrated / moved from the study area|1|||
128811031|NCT05590403|463606381|FG002|Overall Study|Migrated / moved from the study area|0|||
128811032|NCT05590403|463606382|FG003|Overall Study|Migrated / moved from the study area|3|||
128811033|NCT05590403|463606383|FG004|Overall Study|Migrated / moved from the study area|1|||
128811034|NCT05590403|463606379|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
128811035|NCT05590403|463606380|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
128811036|NCT05590403|463606381|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
128811037|NCT05590403|463606382|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
128811038|NCT05590403|463606383|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
128811039|NCT04552223|463606384|FG000|Overall Study|Withdrawal by Subject|1|||
128811040|NCT04526704|463606385|FG000|Overall Study|Adverse Event|1|||
128811041|NCT04526704|463606386|FG001|Overall Study|Adverse Event|0|||
128811042|NCT04526704|463606385|FG000|Overall Study|Physician Decision|1|||
128811043|NCT04526704|463606386|FG001|Overall Study|Physician Decision|0|||
128811044|NCT04526704|463606385|FG000|Overall Study|Withdrawal by Subject|2|||
128811045|NCT04526704|463606386|FG001|Overall Study|Withdrawal by Subject|0|||
128811046|NCT02737436|463606387|FG000|Washout Period|Lost to Follow-up|5|||
128811047|NCT02737436|463606388|FG001|Washout Period|Lost to Follow-up|11|||
128811048|NCT02737436|463606387|FG000|Data Analysis|Scanning data problems|5|||
128811049|NCT02737436|463606388|FG001|Data Analysis|Scanning data problems|8|||
128811050|NCT03701399|463606389|FG000|Overall Study|Adverse Event|3|||
128811051|NCT03701399|463606390|FG001|Overall Study|Adverse Event|5|||
128811052|NCT03701399|463606389|FG000|Overall Study|Withdrawal by Subject|6|||
128811053|NCT03701399|463606390|FG001|Overall Study|Withdrawal by Subject|3|||
128811054|NCT03701399|463606389|FG000|Overall Study|Investigators decision|1|||
128811055|NCT03701399|463606390|FG001|Overall Study|Investigators decision|2|||
128811056|NCT03701399|463606389|FG000|Overall Study|Lost to Follow-up|1|||
128811057|NCT03701399|463606390|FG001|Overall Study|Lost to Follow-up|2|||
128811058|NCT03701399|463606389|FG000|Overall Study|Death|1|||
128811059|NCT03701399|463606390|FG001|Overall Study|Death|1|||
128811060|NCT03701399|463606389|FG000|Overall Study|Randomized but not treated|1|||
128811061|NCT03701399|463606390|FG001|Overall Study|Randomized but not treated|0|||
128811062|NCT00554788|463606391|FG000|Overall Study|Adverse Event|0|||
128811063|NCT00554788|463606392|FG001|Overall Study|Adverse Event|1|||
128811064|NCT00554788|463606393|FG002|Overall Study|Adverse Event|2|||
128811065|NCT00554788|463606391|FG000|Overall Study|Lost to Follow-up|4|||
128811066|NCT00554788|463606392|FG001|Overall Study|Lost to Follow-up|3|||
128811067|NCT00554788|463606393|FG002|Overall Study|Lost to Follow-up|3|||
128811068|NCT00554788|463606391|FG000|Overall Study|Physician Decision|1|||
128811069|NCT00554788|463606392|FG001|Overall Study|Physician Decision|1|||
128811070|NCT00554788|463606393|FG002|Overall Study|Physician Decision|3|||
128811071|NCT00554788|463606391|FG000|Overall Study|Withdrawal by Subject|0|||
128811072|NCT00554788|463606392|FG001|Overall Study|Withdrawal by Subject|0|||
128811073|NCT00554788|463606393|FG002|Overall Study|Withdrawal by Subject|1|||
128811074|NCT00554788|463606391|FG000|Overall Study|Refusal of further protocol therapy|0|||
128811075|NCT00554788|463606392|FG001|Overall Study|Refusal of further protocol therapy|1|||
128811076|NCT00554788|463606393|FG002|Overall Study|Refusal of further protocol therapy|1|||
128811077|NCT00554788|463606391|FG000|Overall Study|Progressive disease|0|||
128811078|NCT00554788|463606392|FG001|Overall Study|Progressive disease|0|||
128811079|NCT00554788|463606393|FG002|Overall Study|Progressive disease|3|||
128811080|NCT00554788|463606391|FG000|Overall Study|Ineligible|2|||
128811081|NCT00554788|463606392|FG001|Overall Study|Ineligible|0|||
128811082|NCT00554788|463606393|FG002|Overall Study|Ineligible|1|||
128811083|NCT03134196|463606402|FG000|Overall Study|Death|2|||
128811084|NCT03134196|463606403|FG001|Overall Study|Death|1|||
128811085|NCT03134196|463606402|FG000|Overall Study|Lost to Follow-up|13|||
128811086|NCT03134196|463606403|FG001|Overall Study|Lost to Follow-up|15|||
128811087|NCT03134196|463606402|FG000|Overall Study|Physician Decision|0|||
128811088|NCT03134196|463606403|FG001|Overall Study|Physician Decision|1|||
128811089|NCT03134196|463606402|FG000|Overall Study|Withdrawal by Subject|19|||
128811090|NCT03134196|463606403|FG001|Overall Study|Withdrawal by Subject|12|||
128811091|NCT03134196|463606402|FG000|Overall Study|Site Unable to Contact Participant|2|||
128811092|NCT03134196|463606403|FG001|Overall Study|Site Unable to Contact Participant|0|||
128811093|NCT03134196|463606402|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
128811094|NCT03134196|463606403|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
128811095|NCT03134196|463606402|FG000|Overall Study|Scheduling Conflict|1|||
128811096|NCT03134196|463606403|FG001|Overall Study|Scheduling Conflict|0|||
128811097|NCT04719390|463606406|FG000|Overall Study|Withdrawal by Subject|1|||
128811098|NCT00753545|463606407|FG000|Overall Study|Death|98|||
128811099|NCT00753545|463606408|FG001|Overall Study|Death|112|||
128811100|NCT00753545|463606407|FG000|Overall Study|Lost to Follow-up|2|||
128811101|NCT00753545|463606408|FG001|Overall Study|Lost to Follow-up|3|||
128811102|NCT00753545|463606407|FG000|Overall Study|Protocol Violation|1|||
128811103|NCT00753545|463606408|FG001|Overall Study|Protocol Violation|0|||
128811104|NCT00753545|463606407|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
128811105|NCT00753545|463606408|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
128811106|NCT06190691|463606409|FG000|Overall Study|Adverse Event|2|||
128811107|NCT06190691|463606410|FG001|Overall Study|Adverse Event|0|||
128811108|NCT06190691|463606411|FG002|Overall Study|Adverse Event|0|||
128811109|NCT06190691|463606412|FG003|Overall Study|Adverse Event|0|||
128811110|NCT05746455|463606413|FG000|Overall Study|Discharged from Clinical Service|1|||
128811111|NCT05746455|463606413|FG000|Overall Study|Lost to Follow-up|1|||
128811112|NCT02485938|463606415|FG000|Overall Study|Withdrawal of consent|2|||
128811113|NCT02485938|463606416|FG001|Overall Study|Withdrawal of consent|0|||
128811114|NCT03016754|463606419|FG000|Overall Study|Death|5|||
128811115|NCT03016754|463606420|FG001|Overall Study|Death|4|||
128811116|NCT03016754|463606421|FG002|Overall Study|Death|5|||
128811117|NCT03016754|463606422|FG003|Overall Study|Death|1|||
128811118|NCT03016754|463606419|FG000|Overall Study|Lost to Follow-up|23|||
128811119|NCT03016754|463606420|FG001|Overall Study|Lost to Follow-up|17|||
128811120|NCT03016754|463606421|FG002|Overall Study|Lost to Follow-up|4|||
128811121|NCT03016754|463606422|FG003|Overall Study|Lost to Follow-up|2|||
128811122|NCT03016754|463606419|FG000|Overall Study|Withdrawal by Subject|6|||
128811123|NCT03016754|463606420|FG001|Overall Study|Withdrawal by Subject|6|||
128811124|NCT03016754|463606421|FG002|Overall Study|Withdrawal by Subject|2|||
128811125|NCT03016754|463606422|FG003|Overall Study|Withdrawal by Subject|2|||
128811126|NCT03016754|463606419|FG000|Overall Study|Other/Unknown|2|||
128811127|NCT03016754|463606420|FG001|Overall Study|Other/Unknown|4|||
128811128|NCT03016754|463606421|FG002|Overall Study|Other/Unknown|2|||
128811129|NCT03016754|463606422|FG003|Overall Study|Other/Unknown|1|||
128811130|NCT03016754|463606419|FG000|Overall Study|Protocol Violation|0|||
128811131|NCT03016754|463606420|FG001|Overall Study|Protocol Violation|0|||
128811132|NCT03016754|463606421|FG002|Overall Study|Protocol Violation|0|||
128811133|NCT03016754|463606422|FG003|Overall Study|Protocol Violation|4|||
128811134|NCT03839940|463606423|FG000|Overall Study|Withdrawal by Subject|3|||
128811135|NCT03839940|463606424|FG001|Overall Study|Withdrawal by Subject|0|||
128811136|NCT03839940|463606423|FG000|Overall Study|Protocol Violation|0|||
128811137|NCT03839940|463606424|FG001|Overall Study|Protocol Violation|1|||
128811138|NCT03839940|463606423|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
128811139|NCT03839940|463606424|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
128811140|NCT03241745|463606425|FG000|Overall Study|Adverse Event|7|||
128811141|NCT03241745|463606425|FG000|Overall Study|Death|1|||
128811142|NCT03241745|463606425|FG000|Overall Study|Withdrawal by Subject|5|||
128811143|NCT03241745|463606425|FG000|Overall Study|Treatment delay >28 days|2|||
128811144|NCT03241745|463606425|FG000|Overall Study|Lack of Efficacy|14|||
128811145|NCT00470704|463606427|FG000|Overall Study|Withdrawal by Subject|4|||
128811146|NCT00470704|463606428|FG001|Overall Study|Withdrawal by Subject|3|||
128811147|NCT00470704|463606427|FG000|Overall Study|Relapse/Progression|37|||
128811148|NCT00470704|463606428|FG001|Overall Study|Relapse/Progression|42|||
128811149|NCT00470704|463606427|FG000|Overall Study|toxicity|0|||
128811150|NCT00470704|463606428|FG001|Overall Study|toxicity|1|||
128811151|NCT04295798|463606435|FG000|Overall Study|Lost to Follow-up|1|||
128811152|NCT04650269|463606441|FG000|Overall Study|Death|3|||
128811153|NCT04650269|463606441|FG000|Overall Study|Lost to Follow-up|6|||
128811154|NCT01437709|463606442|FG000|Overall Study|Adverse Event|0|||
128811155|NCT01437709|463606443|FG001|Overall Study|Adverse Event|1|||
128811156|NCT01437709|463606444|FG002|Overall Study|Adverse Event|0|||
128811157|NCT01437709|463606442|FG000|Overall Study|Pt trasnferred care|0|||
128811158|NCT01437709|463606443|FG001|Overall Study|Pt trasnferred care|1|||
128811159|NCT01437709|463606444|FG002|Overall Study|Pt trasnferred care|0|||
128811160|NCT00085735|463606445|FG000|Overall Study|Adverse Event|1|||
128811161|NCT00085735|463606446|FG001|Overall Study|Adverse Event|0|||
128811162|NCT00085735|463606447|FG002|Overall Study|Adverse Event|0|||
128811163|NCT00085735|463606448|FG003|Overall Study|Adverse Event|0|||
128811164|NCT00085735|463606449|FG004|Overall Study|Adverse Event|0|||
128811165|NCT00085735|463606450|FG005|Overall Study|Adverse Event|0|||
128811166|NCT00085735|463606445|FG000|Overall Study|Lack of Efficacy|2|||
128811167|NCT00085735|463606446|FG001|Overall Study|Lack of Efficacy|4|||
128811168|NCT00085735|463606447|FG002|Overall Study|Lack of Efficacy|6|||
128811169|NCT00085735|463606448|FG003|Overall Study|Lack of Efficacy|3|||
128811170|NCT00085735|463606449|FG004|Overall Study|Lack of Efficacy|4|||
128811171|NCT00085735|463606450|FG005|Overall Study|Lack of Efficacy|3|||
128811172|NCT00085735|463606445|FG000|Overall Study|Lost to Follow-up|0|||
128811173|NCT00085735|463606446|FG001|Overall Study|Lost to Follow-up|1|||
128811174|NCT00085735|463606447|FG002|Overall Study|Lost to Follow-up|0|||
128811175|NCT00085735|463606448|FG003|Overall Study|Lost to Follow-up|0|||
128811176|NCT00085735|463606449|FG004|Overall Study|Lost to Follow-up|1|||
128811177|NCT00085735|463606450|FG005|Overall Study|Lost to Follow-up|0|||
128811178|NCT00085735|463606445|FG000|Overall Study|Physician Decision|2|||
128811179|NCT00085735|463606446|FG001|Overall Study|Physician Decision|3|||
128811180|NCT00085735|463606447|FG002|Overall Study|Physician Decision|2|||
128811181|NCT00085735|463606448|FG003|Overall Study|Physician Decision|3|||
128811182|NCT00085735|463606449|FG004|Overall Study|Physician Decision|11|||
128811183|NCT00085735|463606450|FG005|Overall Study|Physician Decision|8|||
128811184|NCT00085735|463606445|FG000|Overall Study|Protocol Violation|1|||
128811185|NCT00085735|463606446|FG001|Overall Study|Protocol Violation|0|||
128811186|NCT00085735|463606447|FG002|Overall Study|Protocol Violation|0|||
128811187|NCT00085735|463606448|FG003|Overall Study|Protocol Violation|0|||
128811188|NCT00085735|463606449|FG004|Overall Study|Protocol Violation|0|||
128811189|NCT00085735|463606450|FG005|Overall Study|Protocol Violation|0|||
128811190|NCT00085735|463606445|FG000|Overall Study|Withdrawal by Subject|1|||
128811191|NCT00085735|463606446|FG001|Overall Study|Withdrawal by Subject|0|||
128811192|NCT00085735|463606447|FG002|Overall Study|Withdrawal by Subject|4|||
128811193|NCT00085735|463606448|FG003|Overall Study|Withdrawal by Subject|5|||
128811194|NCT00085735|463606449|FG004|Overall Study|Withdrawal by Subject|7|||
128811195|NCT00085735|463606450|FG005|Overall Study|Withdrawal by Subject|8|||
128811196|NCT00085735|463606445|FG000|Overall Study|Patient ineligible|1|||
128811197|NCT00085735|463606446|FG001|Overall Study|Patient ineligible|0|||
128811198|NCT00085735|463606447|FG002|Overall Study|Patient ineligible|3|||
128811199|NCT00085735|463606448|FG003|Overall Study|Patient ineligible|7|||
128811200|NCT00085735|463606449|FG004|Overall Study|Patient ineligible|17|||
128811201|NCT00085735|463606450|FG005|Overall Study|Patient ineligible|8|||
128811202|NCT00085735|463606445|FG000|Overall Study|Excess residual disease|2|||
128811203|NCT00085735|463606446|FG001|Overall Study|Excess residual disease|2|||
128811204|NCT00085735|463606447|FG002|Overall Study|Excess residual disease|1|||
128811205|NCT00085735|463606448|FG003|Overall Study|Excess residual disease|1|||
128811206|NCT00085735|463606449|FG004|Overall Study|Excess residual disease|1|||
128811207|NCT00085735|463606450|FG005|Overall Study|Excess residual disease|4|||
128811208|NCT00085735|463606445|FG000|Overall Study|Reason not documented|1|||
128811209|NCT00085735|463606446|FG001|Overall Study|Reason not documented|0|||
128811210|NCT00085735|463606447|FG002|Overall Study|Reason not documented|1|||
128811211|NCT00085735|463606448|FG003|Overall Study|Reason not documented|0|||
128811212|NCT00085735|463606449|FG004|Overall Study|Reason not documented|1|||
128811213|NCT00085735|463606450|FG005|Overall Study|Reason not documented|0|||
128811214|NCT00085735|463606445|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
128811215|NCT00085735|463606446|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
128811216|NCT00085735|463606447|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
128811217|NCT00085735|463606448|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
128811218|NCT00085735|463606449|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
128811219|NCT00085735|463606450|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
128811220|NCT05459688|463606451|FG000|Overall Study|Lost to Follow-up|6|||
128811221|NCT05459688|463606451|FG000|Overall Study|Physician Decision|1|||
128811222|NCT05459688|463606451|FG000|Overall Study|Withdrawal by Subject|19|||
128811223|NCT05459688|463606451|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
128811224|NCT04908722|463606452|FG000|Overall Study|Protocol deviation|1|||
128811225|NCT04908722|463606453|FG001|Overall Study|Protocol deviation|0|||
128811226|NCT04908722|463606454|FG002|Overall Study|Protocol deviation|0|||
128811227|NCT04908722|463606455|FG003|Overall Study|Protocol deviation|0|||
128811228|NCT04908722|463606456|FG004|Overall Study|Protocol deviation|0|||
128811229|NCT04908722|463606457|FG005|Overall Study|Protocol deviation|1|||
128811230|NCT04908722|463606452|FG000|Overall Study|Lost to Follow-up|33|||
128811231|NCT04908722|463606453|FG001|Overall Study|Lost to Follow-up|33|||
128811232|NCT04908722|463606454|FG002|Overall Study|Lost to Follow-up|36|||
128811233|NCT04908722|463606455|FG003|Overall Study|Lost to Follow-up|30|||
128811234|NCT04908722|463606456|FG004|Overall Study|Lost to Follow-up|32|||
128811235|NCT04908722|463606457|FG005|Overall Study|Lost to Follow-up|34|||
128811236|NCT04908722|463606452|FG000|Overall Study|Physician Decision|1|||
128811237|NCT04908722|463606453|FG001|Overall Study|Physician Decision|1|||
128811238|NCT04908722|463606454|FG002|Overall Study|Physician Decision|1|||
128811239|NCT04908722|463606455|FG003|Overall Study|Physician Decision|2|||
128811240|NCT04908722|463606456|FG004|Overall Study|Physician Decision|0|||
128811241|NCT04908722|463606457|FG005|Overall Study|Physician Decision|0|||
128811242|NCT04908722|463606452|FG000|Overall Study|Death|1|||
128811243|NCT04908722|463606453|FG001|Overall Study|Death|0|||
128811244|NCT04908722|463606454|FG002|Overall Study|Death|0|||
128811245|NCT04908722|463606455|FG003|Overall Study|Death|0|||
128811246|NCT04908722|463606456|FG004|Overall Study|Death|0|||
128811247|NCT04908722|463606457|FG005|Overall Study|Death|1|||
128811248|NCT04908722|463606452|FG000|Overall Study|Withdrawal by Subject|12|||
128811249|NCT04908722|463606453|FG001|Overall Study|Withdrawal by Subject|8|||
128811250|NCT04908722|463606454|FG002|Overall Study|Withdrawal by Subject|7|||
128811251|NCT04908722|463606455|FG003|Overall Study|Withdrawal by Subject|6|||
128811252|NCT04908722|463606456|FG004|Overall Study|Withdrawal by Subject|12|||
128811253|NCT04908722|463606457|FG005|Overall Study|Withdrawal by Subject|14|||
128811254|NCT04908722|463606452|FG000|Overall Study|Other|3|||
128811255|NCT04908722|463606453|FG001|Overall Study|Other|1|||
128811256|NCT04908722|463606454|FG002|Overall Study|Other|3|||
128811257|NCT04908722|463606455|FG003|Overall Study|Other|2|||
128811258|NCT04908722|463606456|FG004|Overall Study|Other|4|||
128811259|NCT04908722|463606457|FG005|Overall Study|Other|1|||
128811260|NCT04908722|463606452|FG000|Overall Study|Initiated prohibited medication|0|||
128811261|NCT04908722|463606453|FG001|Overall Study|Initiated prohibited medication|0|||
128811262|NCT04908722|463606454|FG002|Overall Study|Initiated prohibited medication|0|||
128811263|NCT04908722|463606455|FG003|Overall Study|Initiated prohibited medication|1|||
128811264|NCT04908722|463606456|FG004|Overall Study|Initiated prohibited medication|0|||
128811265|NCT04908722|463606457|FG005|Overall Study|Initiated prohibited medication|1|||
128811266|NCT04908722|463606452|FG000|Overall Study|Randomized but not vaccinated|3|||
128811267|NCT04908722|463606453|FG001|Overall Study|Randomized but not vaccinated|1|||
128811268|NCT04908722|463606454|FG002|Overall Study|Randomized but not vaccinated|2|||
128811269|NCT04908722|463606455|FG003|Overall Study|Randomized but not vaccinated|2|||
128811270|NCT04908722|463606456|FG004|Overall Study|Randomized but not vaccinated|3|||
128811271|NCT04908722|463606457|FG005|Overall Study|Randomized but not vaccinated|4|||
128811272|NCT02319759|463606458|FG000|Week 0 - 16|Lack of Efficacy|1|||
128811273|NCT02319759|463606459|FG001|Week 0 - 16|Lack of Efficacy|0|||
128811274|NCT02319759|463606460|FG002|Week 0 - 16|Lack of Efficacy|0|||
128811275|NCT02319759|463606461|FG003|Week 0 - 16|Lack of Efficacy|0|||
128811276|NCT02319759|463606462|FG004|Week 0 - 16|Lack of Efficacy|0|||
128811277|NCT02319759|463606458|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
128811278|NCT02319759|463606459|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
128811279|NCT02319759|463606460|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
128811280|NCT02319759|463606461|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
128811281|NCT02319759|463606462|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
128811282|NCT02319759|463606458|FG000|Week 16 - 24|Lack of Efficacy|1|||
128811283|NCT02319759|463606459|FG001|Week 16 - 24|Lack of Efficacy|0|||
128811284|NCT02319759|463606460|FG002|Week 16 - 24|Lack of Efficacy|1|||
128811285|NCT02319759|463606461|FG003|Week 16 - 24|Lack of Efficacy|0|||
128811286|NCT02319759|463606462|FG004|Week 16 - 24|Lack of Efficacy|0|||
128811287|NCT02319759|463606458|FG000|Week 16 - 24|Lost to Follow-up|1|||
128811288|NCT02319759|463606459|FG001|Week 16 - 24|Lost to Follow-up|0|||
128811289|NCT02319759|463606460|FG002|Week 16 - 24|Lost to Follow-up|0|||
128811290|NCT02319759|463606461|FG003|Week 16 - 24|Lost to Follow-up|0|||
128811291|NCT02319759|463606462|FG004|Week 16 - 24|Lost to Follow-up|0|||
128811292|NCT02319759|463606458|FG000|Week 16 - 24|Withdrawal by Subject|0|||
128811293|NCT02319759|463606459|FG001|Week 16 - 24|Withdrawal by Subject|0|||
128811294|NCT02319759|463606460|FG002|Week 16 - 24|Withdrawal by Subject|2|||
128811295|NCT02319759|463606461|FG003|Week 16 - 24|Withdrawal by Subject|0|||
128811296|NCT02319759|463606462|FG004|Week 16 - 24|Withdrawal by Subject|0|||
128811297|NCT02319759|463606458|FG000|Week 24 - 56|Adverse Event|0|||
128811298|NCT02319759|463606459|FG001|Week 24 - 56|Adverse Event|0|||
128811299|NCT02319759|463606460|FG002|Week 24 - 56|Adverse Event|2|||
128811300|NCT02319759|463606461|FG003|Week 24 - 56|Adverse Event|0|||
128811301|NCT02319759|463606462|FG004|Week 24 - 56|Adverse Event|0|||
128811302|NCT02319759|463606458|FG000|Week 24 - 56|Lack of Efficacy|0|||
128811303|NCT02319759|463606459|FG001|Week 24 - 56|Lack of Efficacy|0|||
128811304|NCT02319759|463606460|FG002|Week 24 - 56|Lack of Efficacy|0|||
128811305|NCT02319759|463606461|FG003|Week 24 - 56|Lack of Efficacy|2|||
128811306|NCT02319759|463606462|FG004|Week 24 - 56|Lack of Efficacy|1|||
128811307|NCT02319759|463606458|FG000|Week 24 - 56|Withdrawal by Subject|0|||
128811308|NCT02319759|463606459|FG001|Week 24 - 56|Withdrawal by Subject|1|||
128811309|NCT02319759|463606460|FG002|Week 24 - 56|Withdrawal by Subject|0|||
128811310|NCT02319759|463606461|FG003|Week 24 - 56|Withdrawal by Subject|0|||
128811311|NCT02319759|463606462|FG004|Week 24 - 56|Withdrawal by Subject|0|||
128811312|NCT02319759|463606458|FG000|Week 24 - 56|Lost to Follow-up|0|||
128811313|NCT02319759|463606459|FG001|Week 24 - 56|Lost to Follow-up|0|||
128811314|NCT02319759|463606460|FG002|Week 24 - 56|Lost to Follow-up|0|||
128811315|NCT02319759|463606461|FG003|Week 24 - 56|Lost to Follow-up|0|||
128811316|NCT02319759|463606462|FG004|Week 24 - 56|Lost to Follow-up|1|||
128811317|NCT06424236|463606465|FG000|Overall Study|Adverse Event|0|||
128811318|NCT06424236|463606466|FG001|Overall Study|Adverse Event|1|||
128811319|NCT06424236|463606467|FG002|Overall Study|Adverse Event|0|||
128811320|NCT06424236|463606465|FG000|Overall Study|Withdrawal by Subject|3|||
128811321|NCT06424236|463606466|FG001|Overall Study|Withdrawal by Subject|1|||
128811322|NCT06424236|463606467|FG002|Overall Study|Withdrawal by Subject|2|||
128811323|NCT06424236|463606465|FG000|Overall Study|Physician Decision|0|||
128811324|NCT06424236|463606466|FG001|Overall Study|Physician Decision|1|||
128811325|NCT06424236|463606467|FG002|Overall Study|Physician Decision|0|||
128811326|NCT06424236|463606465|FG000|Overall Study|Study Terminated by Sponsor|11|||
128811327|NCT06424236|463606466|FG001|Overall Study|Study Terminated by Sponsor|20|||
128811328|NCT06424236|463606467|FG002|Overall Study|Study Terminated by Sponsor|16|||
128811329|NCT06424236|463606465|FG000|Overall Study|Lost to Follow-up|0|||
128811330|NCT06424236|463606466|FG001|Overall Study|Lost to Follow-up|1|||
128811331|NCT06424236|463606467|FG002|Overall Study|Lost to Follow-up|0|||
128811332|NCT06424236|463606465|FG000|Overall Study|Disease Progression|0|||
128811333|NCT06424236|463606466|FG001|Overall Study|Disease Progression|1|||
128811334|NCT06424236|463606467|FG002|Overall Study|Disease Progression|2|||
128811335|NCT06424236|463606465|FG000|Overall Study|Other|0|||
128811336|NCT06424236|463606466|FG001|Overall Study|Other|0|||
128811337|NCT06424236|463606467|FG002|Overall Study|Other|1|||
128811338|NCT03339713|463606469|FG000|Overall Study|Lost to Follow-up|2|||
128811339|NCT03339713|463606470|FG001|Overall Study|Lost to Follow-up|1|||
128811340|NCT03339713|463606469|FG000|Overall Study|Protocol Violation|1|||
128811341|NCT03339713|463606470|FG001|Overall Study|Protocol Violation|0|||
128811342|NCT03339713|463606469|FG000|Overall Study|Withdrawal by Subject|1|||
128811343|NCT03339713|463606470|FG001|Overall Study|Withdrawal by Subject|1|||
128811344|NCT01959425|463606471|FG000|Overall Study|Withdrawal by Subject|5|||
128811345|NCT01959425|463606472|FG001|Overall Study|Withdrawal by Subject|4|||
128811346|NCT01959425|463606471|FG000|Overall Study|Lost to Follow-up|1|||
128811347|NCT01959425|463606472|FG001|Overall Study|Lost to Follow-up|0|||
128811348|NCT01959425|463606471|FG000|Overall Study|Discontinued Subjects|6|||
128811349|NCT01959425|463606472|FG001|Overall Study|Discontinued Subjects|4|||
128811350|NCT02619838|463606473|FG000|Overall Study|Lost to Follow-up|9|||
128811351|NCT02619838|463606473|FG000|Overall Study|Withdrawal by Subject|15|||
128811352|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
128811353|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
128811354|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
128811355|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
128811356|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
128811357|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
128811358|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
128811359|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
128811360|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
128811361|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
128811362|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
128811363|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
128811364|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
128811365|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
128811366|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
128811367|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
128811368|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
128811369|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
128811370|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
128811371|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
128811372|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
128811373|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
128811374|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
128811375|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
128811376|NCT01715285|463606474|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
128811377|NCT01715285|463606475|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
128811378|NCT01715285|463606476|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
128811379|NCT01715285|463606474|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
128811380|NCT01715285|463606475|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
128811381|NCT01715285|463606476|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
128811382|NCT01715285|463606474|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
128811383|NCT01715285|463606475|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
128811384|NCT01715285|463606476|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
128811385|NCT01715285|463606474|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
128811386|NCT01715285|463606475|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
128811387|NCT01715285|463606476|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
128811388|NCT01715285|463606474|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
128811389|NCT01715285|463606475|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
128811390|NCT01715285|463606476|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
128811391|NCT01715285|463606474|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
128811392|NCT01715285|463606475|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
128811393|NCT01715285|463606476|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
128811394|NCT02359890|463606479|FG000|Overall Study|Not meeting eligibility|4|||
128811395|NCT02359890|463606479|FG000|Overall Study|Never treated with study catheter|6|||
128811396|NCT04066244|463606480|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
128811397|NCT04066244|463606481|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
128811398|NCT04066244|463606482|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
128811399|NCT04066244|463606483|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
128811400|NCT04066244|463606484|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
128811401|NCT04066244|463606485|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
128811402|NCT04066244|463606480|FG000|Part 2 (Cohort 5)|Death|0|||
128811403|NCT04066244|463606481|FG001|Part 2 (Cohort 5)|Death|0|||
128811404|NCT04066244|463606482|FG002|Part 2 (Cohort 5)|Death|0|||
128811405|NCT04066244|463606483|FG003|Part 2 (Cohort 5)|Death|0|||
128811406|NCT04066244|463606484|FG004|Part 2 (Cohort 5)|Death|0|||
128811407|NCT04066244|463606485|FG005|Part 2 (Cohort 5)|Death|2|||
128811408|NCT04066244|463606480|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
128811409|NCT04066244|463606481|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
128811410|NCT04066244|463606482|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
128811411|NCT04066244|463606483|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
128811412|NCT04066244|463606484|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
128811413|NCT04066244|463606485|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
128811414|NCT04066244|463606480|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
128811415|NCT04066244|463606481|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
128811416|NCT04066244|463606482|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
128811417|NCT04066244|463606483|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
128811418|NCT04066244|463606484|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
128811419|NCT04066244|463606485|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
128811420|NCT01073566|463606486|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
128811421|NCT01073566|463606487|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
128811422|NCT05006872|463606498|FG000|Overall Study|Lost to Follow-up|37|||
128811423|NCT05006872|463606499|FG001|Overall Study|Lost to Follow-up|31|||
128811424|NCT02547233|463606501|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
128811425|NCT02547233|463606502|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
128811426|NCT02547233|463606501|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
128811427|NCT02547233|463606502|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
128811428|NCT02547233|463606501|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
128811429|NCT02547233|463606502|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
128811430|NCT02547233|463606501|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
128811431|NCT02547233|463606502|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
128811432|NCT02547233|463606501|FG000|12-month Follow-up|Withdrawal by Subject|10|||
128811433|NCT02547233|463606502|FG001|12-month Follow-up|Withdrawal by Subject|10|||
128811434|NCT02547233|463606501|FG000|12-month Follow-up|Lost to Follow-up|3|||
128811435|NCT02547233|463606502|FG001|12-month Follow-up|Lost to Follow-up|3|||
128811436|NCT02547233|463606501|FG000|12-month Follow-up|Lack of Efficacy|1|||
128811437|NCT02547233|463606502|FG001|12-month Follow-up|Lack of Efficacy|2|||
128811438|NCT02547233|463606501|FG000|12-month Follow-up|Protocol Violation|0|||
128811439|NCT02547233|463606502|FG001|12-month Follow-up|Protocol Violation|1|||
128811440|NCT02547233|463606501|FG000|12-month Follow-up|Other|0|||
128811441|NCT02547233|463606502|FG001|12-month Follow-up|Other|1|||
128811442|NCT04096040|463606503|FG000|Overall Study|Protocol Violation|12|||
128811443|NCT04096040|463606503|FG000|Overall Study|Non-compliant site|4|||
128811444|NCT04973254|463606504|FG000|Overall Study|Not adherent|0|||
128811445|NCT04973254|463606505|FG001|Overall Study|Not adherent|1|||
128811446|NCT04973254|463606506|FG002|Overall Study|Not adherent|0|||
128811447|NCT05170009|463606507|FG000|Overall Study|Physician Decision|0|||
128811448|NCT05170009|463606508|FG001|Overall Study|Physician Decision|1|||
128811449|NCT04629716|463606511|FG000|Overall Study|Lost to Follow-up|7|||
128811450|NCT04629716|463606512|FG001|Overall Study|Lost to Follow-up|3|||
128811451|NCT04542317|463606513|FG000|Overall Study|Care recipients passed away|18|||
128811452|NCT04542317|463606514|FG001|Overall Study|Care recipients passed away|13|||
128811453|NCT04542317|463606513|FG000|Overall Study|No longer a primary caregiver|5|||
128811454|NCT04542317|463606514|FG001|Overall Study|No longer a primary caregiver|1|||
128811455|NCT04542317|463606513|FG000|Overall Study|Withdrawal by Subject|4|||
128811456|NCT04542317|463606514|FG001|Overall Study|Withdrawal by Subject|2|||
128811457|NCT04542317|463606513|FG000|Overall Study|Caregivers passed away|0|||
128811458|NCT04542317|463606514|FG001|Overall Study|Caregivers passed away|2|||
128811459|NCT03270501|463606523|FG000|Overall Study|Screen failure|6|||
128811460|NCT03270501|463606523|FG000|Overall Study|Lost to Follow-up|2|||
128811461|NCT03270501|463606523|FG000|Overall Study|Adverse Event|1|||
128811462|NCT03766009|463608576|FG000|Usual Care|Death|0|||
128811463|NCT03766009|463608577|FG001|Usual Care|Death|0|||
128811464|NCT03766009|463608578|FG002|Usual Care|Death|0|||
128811465|NCT03766009|463608579|FG003|Usual Care|Death|1|||
128811466|NCT03766009|463608580|FG004|Usual Care|Death|0|||
128811467|NCT03766009|463608581|FG005|Usual Care|Death|0|||
128811468|NCT03766009|463608576|FG000|Usual Care|Lost to Follow-up|0|||
128811469|NCT03766009|463608577|FG001|Usual Care|Lost to Follow-up|0|||
128811470|NCT03766009|463608578|FG002|Usual Care|Lost to Follow-up|0|||
128811471|NCT03766009|463608579|FG003|Usual Care|Lost to Follow-up|1|||
128811472|NCT03766009|463608580|FG004|Usual Care|Lost to Follow-up|0|||
128811473|NCT03766009|463608581|FG005|Usual Care|Lost to Follow-up|0|||
128811474|NCT03766009|463608576|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
128811475|NCT03766009|463608577|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
128811476|NCT03766009|463608578|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
128811477|NCT03766009|463608579|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
128811478|NCT03766009|463608580|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
128811479|NCT03766009|463608581|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
128811480|NCT03766009|463608576|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
128811481|NCT03766009|463608577|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
128811482|NCT03766009|463608578|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
128811483|NCT03766009|463608579|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
128811484|NCT03766009|463608580|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
128811485|NCT03766009|463608581|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
128811486|NCT03766009|463608576|FG000|Usual Care|No treatment or declined surgery|0|||
128811487|NCT03766009|463608577|FG001|Usual Care|No treatment or declined surgery|0|||
128811488|NCT03766009|463608578|FG002|Usual Care|No treatment or declined surgery|0|||
128811489|NCT03766009|463608579|FG003|Usual Care|No treatment or declined surgery|2|||
128811490|NCT03766009|463608580|FG004|Usual Care|No treatment or declined surgery|0|||
128811491|NCT03766009|463608581|FG005|Usual Care|No treatment or declined surgery|0|||
128811492|NCT03766009|463608576|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
128811493|NCT03766009|463608577|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
128811494|NCT03766009|463608578|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
128811495|NCT03766009|463608579|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
128811496|NCT03766009|463608580|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
128811497|NCT03766009|463608581|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
128811498|NCT03766009|463608576|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
128811499|NCT03766009|463608577|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
128811500|NCT03766009|463608578|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
128811501|NCT03766009|463608579|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
128811502|NCT03766009|463608580|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
128811503|NCT03766009|463608581|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
128811504|NCT03766009|463608576|FG000|Usual Care|Ineligible|0|||
128811505|NCT03766009|463608577|FG001|Usual Care|Ineligible|1|||
128811506|NCT03766009|463608578|FG002|Usual Care|Ineligible|0|||
128811507|NCT03766009|463608579|FG003|Usual Care|Ineligible|0|||
128811508|NCT03766009|463608580|FG004|Usual Care|Ineligible|0|||
128811509|NCT03766009|463608581|FG005|Usual Care|Ineligible|0|||
128811510|NCT03766009|463608576|FG000|Usual Care|Other: Staff turnover|0|||
128811511|NCT03766009|463608577|FG001|Usual Care|Other: Staff turnover|0|||
128811512|NCT03766009|463608578|FG002|Usual Care|Other: Staff turnover|0|||
128811513|NCT03766009|463608579|FG003|Usual Care|Other: Staff turnover|0|||
128811514|NCT03766009|463608580|FG004|Usual Care|Other: Staff turnover|0|||
128811515|NCT03766009|463608581|FG005|Usual Care|Other: Staff turnover|2|||
128811516|NCT03869866|463608582|FG000|Overall Study|Protocol Violation|1|||
128811517|NCT03869866|463608582|FG000|Overall Study|Withdrawal by Subject|3|||
128811518|NCT03867500|463608583|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
128811519|NCT02985957|463608584|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
128811520|NCT02985957|463608585|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
128811521|NCT02985957|463608586|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
128811522|NCT02985957|463608587|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
128811523|NCT02985957|463608588|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
128811524|NCT02985957|463608589|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
128811525|NCT02985957|463608590|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
128811526|NCT02985957|463608584|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
128811527|NCT02985957|463608585|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
128811528|NCT02985957|463608586|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
128811529|NCT02985957|463608587|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
128811530|NCT02985957|463608588|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
128811531|NCT02985957|463608589|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
128811532|NCT02985957|463608590|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
128811533|NCT02985957|463608584|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
128811534|NCT02985957|463608585|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
128811535|NCT02985957|463608586|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
128811536|NCT02985957|463608587|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
128811537|NCT02985957|463608588|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
128811538|NCT02985957|463608589|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
128811539|NCT02985957|463608590|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
128811540|NCT02985957|463608584|FG000|Treatment Period|Death|0|||
128811541|NCT02985957|463608585|FG001|Treatment Period|Death|0|||
128811542|NCT02985957|463608586|FG002|Treatment Period|Death|0|||
128811543|NCT02985957|463608587|FG003|Treatment Period|Death|0|||
128811544|NCT02985957|463608588|FG004|Treatment Period|Death|1|||
128811545|NCT02985957|463608589|FG005|Treatment Period|Death|0|||
128811546|NCT02985957|463608590|FG006|Treatment Period|Death|0|||
128811547|NCT02985957|463608584|FG000|Treatment Period|Participant withdrew consent|0|||
128811548|NCT02985957|463608585|FG001|Treatment Period|Participant withdrew consent|0|||
128811549|NCT02985957|463608586|FG002|Treatment Period|Participant withdrew consent|0|||
128811550|NCT02985957|463608587|FG003|Treatment Period|Participant withdrew consent|1|||
128811551|NCT02985957|463608588|FG004|Treatment Period|Participant withdrew consent|3|||
128811552|NCT02985957|463608589|FG005|Treatment Period|Participant withdrew consent|0|||
128811553|NCT02985957|463608590|FG006|Treatment Period|Participant withdrew consent|1|||
128811554|NCT02985957|463608584|FG000|Treatment Period|Lost to Follow-up|0|||
128811555|NCT02985957|463608585|FG001|Treatment Period|Lost to Follow-up|0|||
128811556|NCT02985957|463608586|FG002|Treatment Period|Lost to Follow-up|0|||
128811557|NCT02985957|463608587|FG003|Treatment Period|Lost to Follow-up|0|||
128811558|NCT02985957|463608588|FG004|Treatment Period|Lost to Follow-up|1|||
128811559|NCT02985957|463608589|FG005|Treatment Period|Lost to Follow-up|0|||
128811560|NCT02985957|463608590|FG006|Treatment Period|Lost to Follow-up|0|||
128811561|NCT02985957|463608584|FG000|Treatment Period|Other reasons|0|||
128811562|NCT02985957|463608585|FG001|Treatment Period|Other reasons|0|||
128811563|NCT02985957|463608586|FG002|Treatment Period|Other reasons|1|||
128811564|NCT02985957|463608587|FG003|Treatment Period|Other reasons|3|||
128811565|NCT02985957|463608588|FG004|Treatment Period|Other reasons|6|||
128811566|NCT02985957|463608589|FG005|Treatment Period|Other reasons|0|||
128811567|NCT02985957|463608590|FG006|Treatment Period|Other reasons|1|||
128811568|NCT02985957|463608584|FG000|Treatment Period|Not reported|0|||
128811569|NCT02985957|463608585|FG001|Treatment Period|Not reported|1|||
128811570|NCT02985957|463608586|FG002|Treatment Period|Not reported|2|||
128811571|NCT02985957|463608587|FG003|Treatment Period|Not reported|5|||
128811572|NCT02985957|463608588|FG004|Treatment Period|Not reported|0|||
128811573|NCT02985957|463608589|FG005|Treatment Period|Not reported|0|||
128811574|NCT02985957|463608590|FG006|Treatment Period|Not reported|0|||
128811575|NCT02985957|463608584|FG000|Treatment Period|Maximum clinical benefit|0|||
128811576|NCT02985957|463608585|FG001|Treatment Period|Maximum clinical benefit|0|||
128811577|NCT02985957|463608586|FG002|Treatment Period|Maximum clinical benefit|1|||
128811578|NCT02985957|463608587|FG003|Treatment Period|Maximum clinical benefit|1|||
128811579|NCT02985957|463608588|FG004|Treatment Period|Maximum clinical benefit|0|||
128811580|NCT02985957|463608589|FG005|Treatment Period|Maximum clinical benefit|0|||
128811581|NCT02985957|463608590|FG006|Treatment Period|Maximum clinical benefit|2|||
128811582|NCT02985957|463608584|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
128811583|NCT02985957|463608585|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
128811584|NCT02985957|463608586|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
128811585|NCT02985957|463608587|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
128811586|NCT02985957|463608588|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
128811587|NCT02985957|463608589|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
128811588|NCT02985957|463608590|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
128811589|NCT02985957|463608584|FG000|Treatment Period|Study drug toxicity|1|||
128811590|NCT02985957|463608585|FG001|Treatment Period|Study drug toxicity|23|||
128811591|NCT02985957|463608586|FG002|Treatment Period|Study drug toxicity|20|||
128811592|NCT02985957|463608587|FG003|Treatment Period|Study drug toxicity|11|||
128811593|NCT02985957|463608588|FG004|Treatment Period|Study drug toxicity|19|||
128811594|NCT02985957|463608589|FG005|Treatment Period|Study drug toxicity|3|||
128811595|NCT02985957|463608590|FG006|Treatment Period|Study drug toxicity|5|||
128811596|NCT02985957|463608584|FG000|Treatment Period|Disease progression|0|||
128811597|NCT02985957|463608585|FG001|Treatment Period|Disease progression|16|||
128811598|NCT02985957|463608586|FG002|Treatment Period|Disease progression|20|||
128811599|NCT02985957|463608587|FG003|Treatment Period|Disease progression|39|||
128811600|NCT02985957|463608588|FG004|Treatment Period|Disease progression|29|||
128811601|NCT02985957|463608589|FG005|Treatment Period|Disease progression|11|||
128811602|NCT02985957|463608590|FG006|Treatment Period|Disease progression|28|||
128811603|NCT02985957|463608584|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
128811604|NCT02985957|463608585|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
128811605|NCT02985957|463608586|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
128811606|NCT02985957|463608587|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
128811607|NCT02985957|463608588|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
128811608|NCT02985957|463608589|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
128811609|NCT02985957|463608590|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
128811610|NCT02985957|463608584|FG000|Treatment Period|Poor/Non-Compliance|0|||
128811611|NCT02985957|463608585|FG001|Treatment Period|Poor/Non-Compliance|0|||
128811612|NCT02985957|463608586|FG002|Treatment Period|Poor/Non-Compliance|0|||
128811613|NCT02985957|463608587|FG003|Treatment Period|Poor/Non-Compliance|0|||
128811614|NCT02985957|463608588|FG004|Treatment Period|Poor/Non-Compliance|1|||
128811615|NCT02985957|463608589|FG005|Treatment Period|Poor/Non-Compliance|1|||
128811616|NCT02985957|463608590|FG006|Treatment Period|Poor/Non-Compliance|0|||
128811617|NCT02985957|463608584|FG000|Treatment Period|Continuing in Treatment Period|0|||
128811618|NCT02985957|463608585|FG001|Treatment Period|Continuing in Treatment Period|1|||
128811619|NCT02985957|463608586|FG002|Treatment Period|Continuing in Treatment Period|0|||
128811620|NCT02985957|463608587|FG003|Treatment Period|Continuing in Treatment Period|4|||
128811621|NCT02985957|463608588|FG004|Treatment Period|Continuing in Treatment Period|4|||
128811622|NCT02985957|463608589|FG005|Treatment Period|Continuing in Treatment Period|0|||
128811623|NCT02985957|463608590|FG006|Treatment Period|Continuing in Treatment Period|0|||
128811624|NCT04802967|463608597|FG000|Part B|Withdrawal by Subject|0|||
128811625|NCT04802967|463608598|FG001|Part B|Withdrawal by Subject|0|||
128811626|NCT04802967|463608599|FG002|Part B|Withdrawal by Subject|0|||
128811627|NCT04802967|463608600|FG003|Part B|Withdrawal by Subject|0|||
128811628|NCT04802967|463608601|FG004|Part B|Withdrawal by Subject|0|||
128811629|NCT04802967|463608602|FG005|Part B|Withdrawal by Subject|1|||
128811630|NCT04802967|463608603|FG006|Part B|Withdrawal by Subject|0|||
128811631|NCT04802967|463608604|FG007|Part B|Withdrawal by Subject|0|||
128811632|NCT04802967|463608605|FG008|Part B|Withdrawal by Subject|0|||
128811633|NCT04802967|463608606|FG009|Part B|Withdrawal by Subject|0|||
128811634|NCT04625283|463608607|FG000|Overall Study|post randomization exclusion|28|||
128811635|NCT04625283|463608608|FG001|Overall Study|post randomization exclusion|20|||
128811636|NCT02817776|463608609|FG000|Overall Study|Excluded|33|||
128811637|NCT02817776|463608609|FG000|Overall Study|Lost to Follow-up|20|||
128811638|NCT02817776|463608609|FG000|Overall Study|Withdrawal by Subject|33|||
128811639|NCT02817776|463608609|FG000|Overall Study|Death|2|||
128811640|NCT02598388|463608612|FG000|Overall Study|Lost to Follow-up|1|||
128811641|NCT02598388|463608613|FG001|Overall Study|Lost to Follow-up|0|||
128811642|NCT02598388|463608614|FG002|Overall Study|Lost to Follow-up|1|||
128811643|NCT02598388|463608615|FG003|Overall Study|Lost to Follow-up|0|||
128811644|NCT02598388|463608616|FG004|Overall Study|Lost to Follow-up|5|||
128811645|NCT02598388|463608617|FG005|Overall Study|Lost to Follow-up|1|||
128811646|NCT02598388|463608618|FG006|Overall Study|Lost to Follow-up|2|||
128811647|NCT02598388|463608619|FG007|Overall Study|Lost to Follow-up|1|||
128811648|NCT02598388|463608620|FG008|Overall Study|Lost to Follow-up|0|||
128811649|NCT02598388|463608621|FG009|Overall Study|Lost to Follow-up|0|||
128811650|NCT02598388|463608622|FG010|Overall Study|Lost to Follow-up|1|||
128811651|NCT02598388|463608623|FG011|Overall Study|Lost to Follow-up|0|||
128811652|NCT02598388|463608612|FG000|Overall Study|Withdrawal by Subject|0|||
128811653|NCT02598388|463608613|FG001|Overall Study|Withdrawal by Subject|0|||
128811654|NCT02598388|463608614|FG002|Overall Study|Withdrawal by Subject|0|||
128811655|NCT02598388|463608615|FG003|Overall Study|Withdrawal by Subject|0|||
128811656|NCT02598388|463608616|FG004|Overall Study|Withdrawal by Subject|2|||
128811657|NCT02598388|463608617|FG005|Overall Study|Withdrawal by Subject|0|||
128811658|NCT02598388|463608618|FG006|Overall Study|Withdrawal by Subject|2|||
128811659|NCT02598388|463608619|FG007|Overall Study|Withdrawal by Subject|0|||
128811660|NCT02598388|463608620|FG008|Overall Study|Withdrawal by Subject|0|||
128811661|NCT02598388|463608621|FG009|Overall Study|Withdrawal by Subject|1|||
128811662|NCT02598388|463608622|FG010|Overall Study|Withdrawal by Subject|0|||
128811663|NCT02598388|463608623|FG011|Overall Study|Withdrawal by Subject|0|||
128811664|NCT02598388|463608612|FG000|Overall Study|Other|0|||
128811665|NCT02598388|463608613|FG001|Overall Study|Other|0|||
128811666|NCT02598388|463608614|FG002|Overall Study|Other|1|||
128811667|NCT02598388|463608615|FG003|Overall Study|Other|0|||
128811668|NCT02598388|463608616|FG004|Overall Study|Other|3|||
128811669|NCT02598388|463608617|FG005|Overall Study|Other|0|||
128811670|NCT02598388|463608618|FG006|Overall Study|Other|1|||
128811671|NCT02598388|463608619|FG007|Overall Study|Other|0|||
128811672|NCT02598388|463608620|FG008|Overall Study|Other|0|||
128811673|NCT02598388|463608621|FG009|Overall Study|Other|0|||
128811674|NCT02598388|463608622|FG010|Overall Study|Other|0|||
128811675|NCT02598388|463608623|FG011|Overall Study|Other|0|||
128811676|NCT05020249|463608624|FG000|Overall Study|Protocol Violation|1|||
128811677|NCT05020249|463608625|FG001|Overall Study|Protocol Violation|0|||
128811678|NCT05499377|463608649|FG000|Overall Study|Withdrawal by Subject|2|||
128811679|NCT05499377|463608650|FG001|Overall Study|Withdrawal by Subject|0|||
128811680|NCT05499377|463608649|FG000|Overall Study|Physician Decision|1|||
128811681|NCT05499377|463608650|FG001|Overall Study|Physician Decision|0|||
128811682|NCT04971681|463608652|FG000|Followup|Lost to Follow-up|1|||
128811683|NCT04971681|463608653|FG001|Followup|Lost to Follow-up|0|||
128811684|NCT00686335|463608654|FG000|Run-in Period|Adverse Event|1|||
128811685|NCT00686335|463608654|FG000|Run-in Period|asthma exacerbation|1|||
128811686|NCT00686335|463608654|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
128811687|NCT04149704|463608655|FG000|Three Month Follow-up|Death|2|||
128811688|NCT04149704|463608656|FG001|Three Month Follow-up|Death|0|||
128811689|NCT04149704|463608657|FG002|Three Month Follow-up|Death|0|||
128811690|NCT04149704|463608658|FG003|Three Month Follow-up|Death|0|||
128811691|NCT04149704|463608655|FG000|Three Month Follow-up|Lost to Follow-up|1|||
128811692|NCT04149704|463608656|FG001|Three Month Follow-up|Lost to Follow-up|4|||
128811693|NCT04149704|463608657|FG002|Three Month Follow-up|Lost to Follow-up|5|||
128811694|NCT04149704|463608658|FG003|Three Month Follow-up|Lost to Follow-up|5|||
128811695|NCT04149704|463608655|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
128811696|NCT04149704|463608656|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
128811697|NCT04149704|463608657|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
128811698|NCT04149704|463608658|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
128811699|NCT04149704|463608655|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
128811700|NCT04149704|463608656|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
128811701|NCT04149704|463608657|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
128811702|NCT04149704|463608658|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
128811703|NCT04350463|463608663|FG000|Overall Study|Other reason|0|||
128811704|NCT04350463|463608664|FG001|Overall Study|Other reason|0|||
128811705|NCT04350463|463608665|FG002|Overall Study|Other reason|0|||
128811706|NCT04350463|463608666|FG003|Overall Study|Other reason|1|||
128811707|NCT04350463|463608663|FG000|Overall Study|Lost to Follow-up|0|||
128811708|NCT04350463|463608664|FG001|Overall Study|Lost to Follow-up|0|||
128811709|NCT04350463|463608665|FG002|Overall Study|Lost to Follow-up|0|||
128811710|NCT04350463|463608666|FG003|Overall Study|Lost to Follow-up|2|||
128811711|NCT04350463|463608663|FG000|Overall Study|Withdrawal by Subject|4|||
128811712|NCT04350463|463608664|FG001|Overall Study|Withdrawal by Subject|0|||
128811713|NCT04350463|463608665|FG002|Overall Study|Withdrawal by Subject|1|||
128811714|NCT04350463|463608666|FG003|Overall Study|Withdrawal by Subject|4|||
128811715|NCT04350463|463608663|FG000|Overall Study|Adverse Event|0|||
128811716|NCT04350463|463608664|FG001|Overall Study|Adverse Event|0|||
128811717|NCT04350463|463608665|FG002|Overall Study|Adverse Event|0|||
128811718|NCT04350463|463608666|FG003|Overall Study|Adverse Event|2|||
128811719|NCT04350463|463608663|FG000|Overall Study|Death|27|||
128811720|NCT04350463|463608664|FG001|Overall Study|Death|2|||
128811721|NCT04350463|463608665|FG002|Overall Study|Death|13|||
128811722|NCT04350463|463608666|FG003|Overall Study|Death|26|||
128811723|NCT04111536|463608667|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
128811724|NCT04111536|463608668|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
128811725|NCT04111536|463608667|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
128811726|NCT04111536|463608668|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
128811727|NCT04111536|463608667|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
128811728|NCT04111536|463608668|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
128811729|NCT04111536|463608667|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
128811730|NCT04111536|463608668|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
128811731|NCT05714761|463608669|FG000|Overall Study|Lost to Follow-up|3|||
128811732|NCT05714761|463608669|FG000|Overall Study|Withdrawal by Subject|3|||
128811733|NCT05714761|463608669|FG000|Overall Study|unblinding of sensor data|1|||
128811734|NCT05714761|463608669|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
128811735|NCT05714761|463608669|FG000|Overall Study|did not return second CGM sensor|4|||
128811736|NCT05949788|463608671|FG000|Overall Study|severe birth deformity|2|||
128811737|NCT05949788|463608672|FG001|Overall Study|severe birth deformity|7|||
128811738|NCT05949788|463608671|FG000|Overall Study|twin-twin transfusion syndrome|2|||
128811739|NCT05949788|463608672|FG001|Overall Study|twin-twin transfusion syndrome|7|||
128811740|NCT05949788|463608671|FG000|Overall Study|neonatal hemolytic disease|3|||
128811741|NCT05949788|463608672|FG001|Overall Study|neonatal hemolytic disease|8|||
128811742|NCT05949788|463608671|FG000|Overall Study|death within 14 days after birth|2|||
128811743|NCT05949788|463608672|FG001|Overall Study|death within 14 days after birth|6|||
128811744|NCT05949788|463608671|FG000|Overall Study|transfer to another hospital|2|||
128811745|NCT05949788|463608672|FG001|Overall Study|transfer to another hospital|6|||
128811746|NCT05362487|463608673|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
128811747|NCT05415722|463608688|FG000|Overall Study|Lost to Follow-up|0|||
128811748|NCT05415722|463608689|FG001|Overall Study|Lost to Follow-up|2|||
128811749|NCT05415722|463608690|FG002|Overall Study|Lost to Follow-up|0|||
128811750|NCT05415722|463608691|FG003|Overall Study|Lost to Follow-up|1|||
128811751|NCT05415722|463608692|FG004|Overall Study|Lost to Follow-up|0|||
128811752|NCT05415722|463608693|FG005|Overall Study|Lost to Follow-up|0|||
128811753|NCT05415722|463608694|FG006|Overall Study|Lost to Follow-up|1|||
128811754|NCT05415722|463608688|FG000|Overall Study|Physician Decision|0|||
128811755|NCT05415722|463608689|FG001|Overall Study|Physician Decision|0|||
128811756|NCT05415722|463608690|FG002|Overall Study|Physician Decision|0|||
128811757|NCT05415722|463608691|FG003|Overall Study|Physician Decision|1|||
128811758|NCT05415722|463608692|FG004|Overall Study|Physician Decision|0|||
128811759|NCT05415722|463608693|FG005|Overall Study|Physician Decision|0|||
128811760|NCT05415722|463608694|FG006|Overall Study|Physician Decision|1|||
128811761|NCT05415722|463608688|FG000|Overall Study|Protocol Violation|0|||
128811762|NCT05415722|463608689|FG001|Overall Study|Protocol Violation|0|||
128811763|NCT05415722|463608690|FG002|Overall Study|Protocol Violation|0|||
128811764|NCT05415722|463608691|FG003|Overall Study|Protocol Violation|1|||
128811765|NCT05415722|463608692|FG004|Overall Study|Protocol Violation|0|||
128811766|NCT05415722|463608693|FG005|Overall Study|Protocol Violation|0|||
128811767|NCT05415722|463608694|FG006|Overall Study|Protocol Violation|0|||
128811768|NCT05415722|463608688|FG000|Overall Study|Sponsor Discretion|0|||
128811769|NCT05415722|463608689|FG001|Overall Study|Sponsor Discretion|0|||
128811770|NCT05415722|463608690|FG002|Overall Study|Sponsor Discretion|0|||
128811771|NCT05415722|463608691|FG003|Overall Study|Sponsor Discretion|0|||
128811772|NCT05415722|463608692|FG004|Overall Study|Sponsor Discretion|1|||
128811773|NCT05415722|463608693|FG005|Overall Study|Sponsor Discretion|1|||
128811774|NCT05415722|463608694|FG006|Overall Study|Sponsor Discretion|0|||
128811775|NCT05415722|463608688|FG000|Overall Study|Withdrawal by Subject|0|||
128811776|NCT05415722|463608689|FG001|Overall Study|Withdrawal by Subject|1|||
128811777|NCT05415722|463608690|FG002|Overall Study|Withdrawal by Subject|0|||
128811778|NCT05415722|463608691|FG003|Overall Study|Withdrawal by Subject|1|||
128811779|NCT05415722|463608692|FG004|Overall Study|Withdrawal by Subject|1|||
128811780|NCT05415722|463608693|FG005|Overall Study|Withdrawal by Subject|0|||
128811781|NCT05415722|463608694|FG006|Overall Study|Withdrawal by Subject|1|||
128811782|NCT04537715|463608696|FG000|Overall Study|Death|3|||
128811783|NCT04537715|463608697|FG001|Overall Study|Death|1|||
128811784|NCT04537715|463608696|FG000|Overall Study|Withdrawal by Subject|3|||
128811785|NCT04537715|463608697|FG001|Overall Study|Withdrawal by Subject|1|||
128811786|NCT04537715|463608696|FG000|Overall Study|Other|4|||
128811787|NCT04537715|463608697|FG001|Overall Study|Other|3|||
128811788|NCT04537715|463608696|FG000|Overall Study|Progressive disease|1|||
128811789|NCT04537715|463608697|FG001|Overall Study|Progressive disease|0|||
128811790|NCT02191618|463608698|FG000|Overall Study|Withdrawal by Subject|3|||
128811791|NCT02191618|463608698|FG000|Overall Study|Missed Visit|4|||
128811792|NCT03461276|463608700|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
128811793|NCT03461276|463608701|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
128811794|NCT03461276|463608700|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
128811795|NCT03461276|463608701|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
128811796|NCT03461276|463608700|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
128811797|NCT03461276|463608701|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
128811798|NCT03461276|463608700|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
128811799|NCT03461276|463608701|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
128811800|NCT03461276|463608700|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
128811801|NCT03461276|463608701|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
128811802|NCT03461276|463608700|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
128811803|NCT03461276|463608701|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
128811804|NCT03461276|463608700|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
128811805|NCT03461276|463608701|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
128811806|NCT03461276|463608700|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
128811807|NCT03461276|463608701|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
128811808|NCT03461276|463608700|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
128811809|NCT03461276|463608701|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
128811810|NCT03461276|463608700|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
128811811|NCT03461276|463608701|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
128811812|NCT04623671|463608702|FG000|Overall Study|Adverse Event|0|||
128811813|NCT04623671|463608703|FG001|Overall Study|Adverse Event|1|||
128811814|NCT04623671|463608702|FG000|Overall Study|Lost to Follow-up|2|||
128811815|NCT04623671|463608703|FG001|Overall Study|Lost to Follow-up|1|||
128811816|NCT04623671|463608702|FG000|Overall Study|Death|5|||
128811817|NCT04623671|463608703|FG001|Overall Study|Death|5|||
128811818|NCT04663737|463608704|FG000|Overall Study|Withdrawal by Subject|2|||
128811819|NCT04663737|463608705|FG001|Overall Study|Withdrawal by Subject|0|||
128811820|NCT04700163|463608709|FG000|Overall Study|Lost to Follow-up|0|||
128811821|NCT04700163|463608710|FG001|Overall Study|Lost to Follow-up|0|||
128811822|NCT04700163|463608711|FG002|Overall Study|Lost to Follow-up|0|||
128811823|NCT04700163|463608712|FG003|Overall Study|Lost to Follow-up|0|||
128811824|NCT04700163|463608713|FG004|Overall Study|Lost to Follow-up|0|||
128811825|NCT04700163|463608714|FG005|Overall Study|Lost to Follow-up|1|||
128811826|NCT03848065|463608715|FG000|Overall Study|Death|0|||
128811827|NCT03848065|463608716|FG001|Overall Study|Death|1|||
128811828|NCT03848065|463608717|FG002|Overall Study|Death|0|||
128811829|NCT03848065|463608715|FG000|Overall Study|Lost to Follow-up|0|||
128811830|NCT03848065|463608716|FG001|Overall Study|Lost to Follow-up|0|||
128811831|NCT03848065|463608717|FG002|Overall Study|Lost to Follow-up|1|||
128811832|NCT03848065|463608715|FG000|Overall Study|Physician Decision|0|||
128811833|NCT03848065|463608716|FG001|Overall Study|Physician Decision|0|||
128811834|NCT03848065|463608717|FG002|Overall Study|Physician Decision|1|||
128811835|NCT03496168|463608724|FG000|Overall Study|Other Reasons|1|||
128811836|NCT03496168|463608724|FG000|Overall Study|Adverse Event|1|||
128811837|NCT03865498|463608725|FG000|Overall Study|Lack of Efficacy|12|||
128811838|NCT03865498|463608726|FG001|Overall Study|Lack of Efficacy|11|||
128811839|NCT03865498|463608725|FG000|Overall Study|Lost to Follow-up|125|||
128811840|NCT03865498|463608726|FG001|Overall Study|Lost to Follow-up|133|||
128811841|NCT03865498|463608725|FG000|Overall Study|Withdrawal by Subject|2|||
128811842|NCT03865498|463608726|FG001|Overall Study|Withdrawal by Subject|4|||
128811843|NCT05869383|463608727|FG000|Overall Study|Withdrawal by Subject|2|||
128811844|NCT05869383|463608728|FG001|Overall Study|Withdrawal by Subject|0|||
128811845|NCT04137367|463608729|FG000|Overall Study|Lost to Follow-up|8|||
128811846|NCT04137367|463608730|FG001|Overall Study|Lost to Follow-up|6|||
128811847|NCT04137367|463608731|FG002|Overall Study|Lost to Follow-up|4|||
128811848|NCT03907878|463608732|FG000|Treatment Period|Withdrawal by Subject|5|||
128811849|NCT03907878|463608732|FG000|Treatment Period|Adverse Event|4|||
128811850|NCT03907878|463608732|FG000|Treatment Period|Lack of Efficacy|1|||
128811851|NCT03907878|463608732|FG000|Treatment Period|Protocol Violation|1|||
128811852|NCT03907878|463608732|FG000|Follow-up Period|Adverse Event|3|||
128811853|NCT03907878|463608732|FG000|Follow-up Period|Withdrawal by Subject|3|||
128811854|NCT05144009|463608733|FG000|Overall Study|Lost to Follow-up|0|||
128811855|NCT05144009|463608734|FG001|Overall Study|Lost to Follow-up|1|||
128811856|NCT05144009|463608733|FG000|Overall Study|Study Termination by the Sponsor|11|||
128811857|NCT05144009|463608734|FG001|Overall Study|Study Termination by the Sponsor|11|||
128811858|NCT05144009|463608733|FG000|Overall Study|Disease Progression|1|||
128811859|NCT05144009|463608734|FG001|Overall Study|Disease Progression|0|||
128811860|NCT05144009|463608733|FG000|Overall Study|Participant Decision|0|||
128811861|NCT05144009|463608734|FG001|Overall Study|Participant Decision|2|||
128811862|NCT05144009|463608733|FG000|Overall Study|Death|5|||
128811863|NCT05144009|463608734|FG001|Overall Study|Death|10|||
128811864|NCT04499924|463608735|FG000|Overall Study|Study termination by sponsor|4|||
128811865|NCT04499924|463608736|FG001|Overall Study|Study termination by sponsor|6|||
128811866|NCT04499924|463608735|FG000|Overall Study|Withdrawal by Subject|1|||
128811867|NCT04499924|463608736|FG001|Overall Study|Withdrawal by Subject|3|||
128811868|NCT01648023|463608741|FG000|Overall Study|Screen Fail Post Randomization|1|||
128811869|NCT01648023|463608742|FG001|Overall Study|Screen Fail Post Randomization|2|||
128811870|NCT04599062|463608750|FG000|Overall Study|Physician Decision|1|||
128811871|NCT04599062|463608751|FG001|Overall Study|Physician Decision|0|||
128811872|NCT04074759|463608753|FG000|Overall Study|Withdrawal by Subject|0|||
128811873|NCT04074759|463608754|FG001|Overall Study|Withdrawal by Subject|0|||
128811874|NCT04074759|463608755|FG002|Overall Study|Withdrawal by Subject|0|||
128811875|NCT04074759|463608756|FG003|Overall Study|Withdrawal by Subject|0|||
128811876|NCT04074759|463608757|FG004|Overall Study|Withdrawal by Subject|0|||
128811877|NCT04074759|463608758|FG005|Overall Study|Withdrawal by Subject|2|||
128811878|NCT04074759|463608759|FG006|Overall Study|Withdrawal by Subject|0|||
128811879|NCT04074759|463608760|FG007|Overall Study|Withdrawal by Subject|2|||
128811880|NCT04074759|463608761|FG008|Overall Study|Withdrawal by Subject|1|||
128811881|NCT04074759|463608762|FG009|Overall Study|Withdrawal by Subject|2|||
128811882|NCT04074759|463608763|FG010|Overall Study|Withdrawal by Subject|9|||
128811883|NCT04074759|463608764|FG011|Overall Study|Withdrawal by Subject|2|||
128811884|NCT04074759|463608765|FG012|Overall Study|Withdrawal by Subject|1|||
128811885|NCT04074759|463608766|FG013|Overall Study|Withdrawal by Subject|3|||
128811886|NCT04074759|463608767|FG014|Overall Study|Withdrawal by Subject|2|||
128811887|NCT04074759|463608768|FG015|Overall Study|Withdrawal by Subject|0|||
128811888|NCT04074759|463608769|FG016|Overall Study|Withdrawal by Subject|0|||
128811889|NCT04074759|463608770|FG017|Overall Study|Withdrawal by Subject|3|||
128811890|NCT04074759|463608771|FG018|Overall Study|Withdrawal by Subject|1|||
128811891|NCT04074759|463608753|FG000|Overall Study|Death|1|||
128811892|NCT04074759|463608754|FG001|Overall Study|Death|0|||
128811893|NCT04074759|463608755|FG002|Overall Study|Death|1|||
128811894|NCT04074759|463608756|FG003|Overall Study|Death|1|||
128811895|NCT04074759|463608757|FG004|Overall Study|Death|2|||
128811896|NCT04074759|463608758|FG005|Overall Study|Death|0|||
128811897|NCT04074759|463608759|FG006|Overall Study|Death|1|||
128811898|NCT04074759|463608760|FG007|Overall Study|Death|0|||
128811899|NCT04074759|463608761|FG008|Overall Study|Death|3|||
128811900|NCT04074759|463608762|FG009|Overall Study|Death|2|||
128811901|NCT04074759|463608763|FG010|Overall Study|Death|4|||
128811902|NCT04074759|463608764|FG011|Overall Study|Death|1|||
128811903|NCT04074759|463608765|FG012|Overall Study|Death|0|||
128811904|NCT04074759|463608766|FG013|Overall Study|Death|2|||
128811905|NCT04074759|463608767|FG014|Overall Study|Death|1|||
128811906|NCT04074759|463608768|FG015|Overall Study|Death|0|||
128811907|NCT04074759|463608769|FG016|Overall Study|Death|1|||
128811908|NCT04074759|463608770|FG017|Overall Study|Death|0|||
128811909|NCT04074759|463608771|FG018|Overall Study|Death|1|||
128811910|NCT04074759|463608753|FG000|Overall Study|Lost to Follow-up|0|||
128811911|NCT04074759|463608754|FG001|Overall Study|Lost to Follow-up|0|||
128811912|NCT04074759|463608755|FG002|Overall Study|Lost to Follow-up|0|||
128811913|NCT04074759|463608756|FG003|Overall Study|Lost to Follow-up|0|||
128811914|NCT04074759|463608757|FG004|Overall Study|Lost to Follow-up|0|||
128811915|NCT04074759|463608758|FG005|Overall Study|Lost to Follow-up|0|||
128811916|NCT04074759|463608759|FG006|Overall Study|Lost to Follow-up|0|||
128811917|NCT04074759|463608760|FG007|Overall Study|Lost to Follow-up|0|||
128811918|NCT04074759|463608761|FG008|Overall Study|Lost to Follow-up|0|||
128811919|NCT04074759|463608762|FG009|Overall Study|Lost to Follow-up|0|||
128811920|NCT04074759|463608763|FG010|Overall Study|Lost to Follow-up|1|||
128811921|NCT04074759|463608764|FG011|Overall Study|Lost to Follow-up|0|||
128811922|NCT04074759|463608765|FG012|Overall Study|Lost to Follow-up|0|||
128811923|NCT04074759|463608766|FG013|Overall Study|Lost to Follow-up|0|||
128811924|NCT04074759|463608767|FG014|Overall Study|Lost to Follow-up|0|||
128811925|NCT04074759|463608768|FG015|Overall Study|Lost to Follow-up|0|||
128811926|NCT04074759|463608769|FG016|Overall Study|Lost to Follow-up|1|||
128811927|NCT04074759|463608770|FG017|Overall Study|Lost to Follow-up|0|||
128811928|NCT04074759|463608771|FG018|Overall Study|Lost to Follow-up|1|||
128811929|NCT04074759|463608753|FG000|Overall Study|Other|0|||
128811930|NCT04074759|463608754|FG001|Overall Study|Other|1|||
128811931|NCT04074759|463608755|FG002|Overall Study|Other|1|||
128811932|NCT04074759|463608756|FG003|Overall Study|Other|0|||
128811933|NCT04074759|463608757|FG004|Overall Study|Other|2|||
128811934|NCT04074759|463608758|FG005|Overall Study|Other|1|||
128811935|NCT04074759|463608759|FG006|Overall Study|Other|2|||
128811936|NCT04074759|463608760|FG007|Overall Study|Other|1|||
128811937|NCT04074759|463608761|FG008|Overall Study|Other|1|||
128811938|NCT04074759|463608762|FG009|Overall Study|Other|4|||
128811939|NCT04074759|463608763|FG010|Overall Study|Other|4|||
128811940|NCT04074759|463608764|FG011|Overall Study|Other|2|||
128811941|NCT04074759|463608765|FG012|Overall Study|Other|0|||
128811942|NCT04074759|463608766|FG013|Overall Study|Other|0|||
128811943|NCT04074759|463608767|FG014|Overall Study|Other|0|||
128811944|NCT04074759|463608768|FG015|Overall Study|Other|1|||
128811945|NCT04074759|463608769|FG016|Overall Study|Other|0|||
128811946|NCT04074759|463608770|FG017|Overall Study|Other|0|||
128811947|NCT04074759|463608771|FG018|Overall Study|Other|0|||
128811948|NCT04074759|463608753|FG000|Overall Study|Missing end of study status|0|||
128811949|NCT04074759|463608754|FG001|Overall Study|Missing end of study status|0|||
128811950|NCT04074759|463608755|FG002|Overall Study|Missing end of study status|0|||
128811951|NCT04074759|463608756|FG003|Overall Study|Missing end of study status|0|||
128811952|NCT04074759|463608757|FG004|Overall Study|Missing end of study status|0|||
128811953|NCT04074759|463608758|FG005|Overall Study|Missing end of study status|0|||
128811954|NCT04074759|463608759|FG006|Overall Study|Missing end of study status|0|||
128811955|NCT04074759|463608760|FG007|Overall Study|Missing end of study status|0|||
128811956|NCT04074759|463608761|FG008|Overall Study|Missing end of study status|0|||
128811957|NCT04074759|463608762|FG009|Overall Study|Missing end of study status|0|||
128811958|NCT04074759|463608763|FG010|Overall Study|Missing end of study status|2|||
128811959|NCT04074759|463608764|FG011|Overall Study|Missing end of study status|0|||
128811960|NCT04074759|463608765|FG012|Overall Study|Missing end of study status|0|||
128811961|NCT04074759|463608766|FG013|Overall Study|Missing end of study status|0|||
128811962|NCT04074759|463608767|FG014|Overall Study|Missing end of study status|0|||
128811963|NCT04074759|463608768|FG015|Overall Study|Missing end of study status|0|||
128811964|NCT04074759|463608769|FG016|Overall Study|Missing end of study status|1|||
128811965|NCT04074759|463608770|FG017|Overall Study|Missing end of study status|0|||
128811966|NCT04074759|463608771|FG018|Overall Study|Missing end of study status|0|||
128811967|NCT05329220|463608772|FG000|Active Trial Period|Adverse Event|0|||
128811968|NCT05329220|463608773|FG001|Active Trial Period|Adverse Event|0|||
128811969|NCT05329220|463608774|FG002|Active Trial Period|Adverse Event|0|||
128811970|NCT05329220|463608775|FG003|Active Trial Period|Adverse Event|0|||
128811971|NCT05329220|463608776|FG004|Active Trial Period|Adverse Event|1|||
128811972|NCT05329220|463608777|FG005|Active Trial Period|Adverse Event|0|||
128811973|NCT05329220|463608772|FG000|Active Trial Period|Lost to Follow-up|0|||
128811974|NCT05329220|463608773|FG001|Active Trial Period|Lost to Follow-up|0|||
128811975|NCT05329220|463608774|FG002|Active Trial Period|Lost to Follow-up|0|||
128811976|NCT05329220|463608775|FG003|Active Trial Period|Lost to Follow-up|0|||
128811977|NCT05329220|463608776|FG004|Active Trial Period|Lost to Follow-up|32|||
128811978|NCT05329220|463608777|FG005|Active Trial Period|Lost to Follow-up|28|||
128811979|NCT05329220|463608772|FG000|Active Trial Period|Physician Decision|0|||
128811980|NCT05329220|463608773|FG001|Active Trial Period|Physician Decision|0|||
128811981|NCT05329220|463608774|FG002|Active Trial Period|Physician Decision|0|||
128811982|NCT05329220|463608775|FG003|Active Trial Period|Physician Decision|0|||
128811983|NCT05329220|463608776|FG004|Active Trial Period|Physician Decision|2|||
128811984|NCT05329220|463608777|FG005|Active Trial Period|Physician Decision|0|||
128811985|NCT05329220|463608772|FG000|Active Trial Period|Protocol Violation|0|||
128811986|NCT05329220|463608773|FG001|Active Trial Period|Protocol Violation|0|||
128811987|NCT05329220|463608774|FG002|Active Trial Period|Protocol Violation|0|||
128811988|NCT05329220|463608775|FG003|Active Trial Period|Protocol Violation|0|||
128811989|NCT05329220|463608776|FG004|Active Trial Period|Protocol Violation|1|||
128811990|NCT05329220|463608777|FG005|Active Trial Period|Protocol Violation|3|||
128811991|NCT05329220|463608772|FG000|Active Trial Period|Withdrawal by Subject|0|||
128811992|NCT05329220|463608773|FG001|Active Trial Period|Withdrawal by Subject|0|||
128811993|NCT05329220|463608774|FG002|Active Trial Period|Withdrawal by Subject|0|||
128811994|NCT05329220|463608775|FG003|Active Trial Period|Withdrawal by Subject|1|||
128811995|NCT05329220|463608776|FG004|Active Trial Period|Withdrawal by Subject|12|||
128811996|NCT05329220|463608777|FG005|Active Trial Period|Withdrawal by Subject|13|||
128811997|NCT05329220|463608772|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
128811998|NCT05329220|463608773|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
128811999|NCT05329220|463608774|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
128812000|NCT05329220|463608775|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
128812001|NCT05329220|463608776|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
128812002|NCT05329220|463608777|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
128812003|NCT05329220|463608772|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
128812004|NCT05329220|463608773|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
128812005|NCT05329220|463608774|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
128812006|NCT05329220|463608775|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
128812007|NCT05329220|463608776|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
128812008|NCT05329220|463608777|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
128812009|NCT05329220|463608772|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
128812010|NCT05329220|463608773|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
128812011|NCT05329220|463608774|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
128812012|NCT05329220|463608775|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
128812013|NCT05329220|463608776|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
128812014|NCT05329220|463608777|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
128812015|NCT05329220|463608772|FG000|Follow-up Period|Adverse Event|0|||
128812016|NCT05329220|463608773|FG001|Follow-up Period|Adverse Event|0|||
128812017|NCT05329220|463608774|FG002|Follow-up Period|Adverse Event|0|||
128812018|NCT05329220|463608775|FG003|Follow-up Period|Adverse Event|0|||
128812019|NCT05329220|463608776|FG004|Follow-up Period|Adverse Event|2|||
128812020|NCT05329220|463608777|FG005|Follow-up Period|Adverse Event|1|||
128812021|NCT05329220|463608772|FG000|Follow-up Period|Death|0|||
128812022|NCT05329220|463608773|FG001|Follow-up Period|Death|0|||
128812023|NCT05329220|463608774|FG002|Follow-up Period|Death|1|||
128812024|NCT05329220|463608775|FG003|Follow-up Period|Death|1|||
128812025|NCT05329220|463608776|FG004|Follow-up Period|Death|0|||
128812026|NCT05329220|463608777|FG005|Follow-up Period|Death|1|||
128812027|NCT05329220|463608772|FG000|Follow-up Period|Lost to Follow-up|0|||
128812028|NCT05329220|463608773|FG001|Follow-up Period|Lost to Follow-up|1|||
128812029|NCT05329220|463608774|FG002|Follow-up Period|Lost to Follow-up|2|||
128812030|NCT05329220|463608775|FG003|Follow-up Period|Lost to Follow-up|2|||
128812031|NCT05329220|463608776|FG004|Follow-up Period|Lost to Follow-up|113|||
128812032|NCT05329220|463608777|FG005|Follow-up Period|Lost to Follow-up|89|||
128812033|NCT05329220|463608772|FG000|Follow-up Period|Physician Decision|0|||
128812034|NCT05329220|463608773|FG001|Follow-up Period|Physician Decision|0|||
128812035|NCT05329220|463608774|FG002|Follow-up Period|Physician Decision|0|||
128812036|NCT05329220|463608775|FG003|Follow-up Period|Physician Decision|0|||
128812037|NCT05329220|463608776|FG004|Follow-up Period|Physician Decision|2|||
128812038|NCT05329220|463608777|FG005|Follow-up Period|Physician Decision|2|||
128812039|NCT05329220|463608772|FG000|Follow-up Period|Protocol Violation|0|||
128812040|NCT05329220|463608773|FG001|Follow-up Period|Protocol Violation|0|||
128812041|NCT05329220|463608774|FG002|Follow-up Period|Protocol Violation|0|||
128812042|NCT05329220|463608775|FG003|Follow-up Period|Protocol Violation|0|||
128812043|NCT05329220|463608776|FG004|Follow-up Period|Protocol Violation|0|||
128812044|NCT05329220|463608777|FG005|Follow-up Period|Protocol Violation|1|||
128812045|NCT05329220|463608772|FG000|Follow-up Period|Withdrawal by Subject|0|||
128812046|NCT05329220|463608773|FG001|Follow-up Period|Withdrawal by Subject|0|||
128812047|NCT05329220|463608774|FG002|Follow-up Period|Withdrawal by Subject|1|||
128812048|NCT05329220|463608775|FG003|Follow-up Period|Withdrawal by Subject|1|||
128812049|NCT05329220|463608776|FG004|Follow-up Period|Withdrawal by Subject|34|||
128812050|NCT05329220|463608777|FG005|Follow-up Period|Withdrawal by Subject|35|||
128812051|NCT05329220|463608772|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
128812052|NCT05329220|463608773|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
128812053|NCT05329220|463608774|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
128812054|NCT05329220|463608775|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
128812055|NCT05329220|463608776|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
128812056|NCT05329220|463608777|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
128812057|NCT05329220|463608772|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
128812058|NCT05329220|463608773|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
128812059|NCT05329220|463608774|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
128812060|NCT05329220|463608775|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
128812061|NCT05329220|463608776|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
128812062|NCT05329220|463608777|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
128812063|NCT05329220|463608772|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
128812064|NCT05329220|463608773|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
128812065|NCT05329220|463608774|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
128812066|NCT05329220|463608775|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
128812067|NCT05329220|463608776|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
128812068|NCT05329220|463608777|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
128812069|NCT05329220|463608772|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
128812070|NCT05329220|463608773|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
128812071|NCT05329220|463608774|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
128812072|NCT05329220|463608775|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
128812073|NCT05329220|463608776|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
128812074|NCT05329220|463608777|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
128812075|NCT05329220|463608772|FG000|Follow-up Period|EARLY TERMINATION|0|||
128812076|NCT05329220|463608773|FG001|Follow-up Period|EARLY TERMINATION|0|||
128812077|NCT05329220|463608774|FG002|Follow-up Period|EARLY TERMINATION|0|||
128812078|NCT05329220|463608775|FG003|Follow-up Period|EARLY TERMINATION|0|||
128812079|NCT05329220|463608776|FG004|Follow-up Period|EARLY TERMINATION|0|||
128812080|NCT05329220|463608777|FG005|Follow-up Period|EARLY TERMINATION|1|||
128812081|NCT05329220|463608772|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
128812082|NCT05329220|463608773|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
128812083|NCT05329220|463608774|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
128812084|NCT05329220|463608775|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
128812085|NCT05329220|463608776|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
128812086|NCT05329220|463608777|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
128812087|NCT05329220|463608772|FG000|Follow-up Period|DROPPED|0|||
128812088|NCT05329220|463608773|FG001|Follow-up Period|DROPPED|0|||
128812089|NCT05329220|463608774|FG002|Follow-up Period|DROPPED|0|||
128812090|NCT05329220|463608775|FG003|Follow-up Period|DROPPED|0|||
128812091|NCT05329220|463608776|FG004|Follow-up Period|DROPPED|0|||
128812092|NCT05329220|463608777|FG005|Follow-up Period|DROPPED|1|||
128812093|NCT05329220|463608772|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
128812094|NCT05329220|463608773|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
128812095|NCT05329220|463608774|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
128812096|NCT05329220|463608775|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
128812097|NCT05329220|463608776|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
128812098|NCT05329220|463608777|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
128812099|NCT03931174|463608780|FG000|Providers|Staff left organization|26|||
128812100|NCT03931174|463608781|FG001|Providers|Staff left organization|25|||
128812101|NCT03931174|463608780|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
128812102|NCT03931174|463608781|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
128812103|NCT03931174|463608780|FG000|Providers|Lost to Follow-up|4|||
128812104|NCT03931174|463608781|FG001|Providers|Lost to Follow-up|4|||
128812105|NCT03931174|463608780|FG000|Patients|Post-consent screening failure|1|||
128812106|NCT03931174|463608781|FG001|Patients|Post-consent screening failure|1|||
128812107|NCT03931174|463608780|FG000|Patients|Death|1|||
128812108|NCT03931174|463608781|FG001|Patients|Death|1|||
128812109|NCT03931174|463608780|FG000|Patients|Lost to Follow-up|60|||
128812110|NCT03931174|463608781|FG001|Patients|Lost to Follow-up|89|||
128812111|NCT03322267|463608782|FG000|Overall Study|Lack of Efficacy|11|||
128812112|NCT03322267|463608782|FG000|Overall Study|Adverse Event|1|||
128812113|NCT03322267|463608782|FG000|Overall Study|Withdrawal by Subject|2|||
128812114|NCT03852472|463608792|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
128812115|NCT03852472|463608793|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
128812116|NCT03852472|463608794|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
128812117|NCT03852472|463608795|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
128812118|NCT03852472|463608796|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
128812119|NCT03852472|463608792|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
128812120|NCT03852472|463608793|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
128812121|NCT03852472|463608794|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
128812122|NCT03852472|463608795|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
128812123|NCT03852472|463608796|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
128812124|NCT03852472|463608792|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
128812125|NCT03852472|463608793|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
128812126|NCT03852472|463608794|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
128812127|NCT03852472|463608795|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
128812128|NCT03852472|463608796|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
128812129|NCT03852472|463608792|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
128812130|NCT03852472|463608793|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
128812131|NCT03852472|463608794|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
128812132|NCT03852472|463608795|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
128812133|NCT03852472|463608796|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
128812134|NCT03852472|463608792|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
128812135|NCT03852472|463608793|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
128812136|NCT03852472|463608794|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
128812137|NCT03852472|463608795|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
128812138|NCT03852472|463608796|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
128812139|NCT03852472|463608792|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
128812140|NCT03852472|463608793|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
128812141|NCT03852472|463608794|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
128812142|NCT03852472|463608795|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
128812143|NCT03852472|463608796|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
128812144|NCT03852472|463608792|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
128812145|NCT03852472|463608793|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
128812146|NCT03852472|463608794|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
128812147|NCT03852472|463608795|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
128812148|NCT03852472|463608796|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
128812149|NCT03852472|463608792|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
128812150|NCT03852472|463608793|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
128812151|NCT03852472|463608794|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
128812152|NCT03852472|463608795|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
128812153|NCT03852472|463608796|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
128812154|NCT03852472|463608792|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
128812155|NCT03852472|463608793|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
128812156|NCT03852472|463608794|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
128812157|NCT03852472|463608795|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
128812158|NCT03852472|463608796|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
128812159|NCT03852472|463608792|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
128812160|NCT03852472|463608793|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
128812161|NCT03852472|463608794|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
128812162|NCT03852472|463608795|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
128812163|NCT03852472|463608796|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
128812164|NCT03852472|463608792|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
128812165|NCT03852472|463608793|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
128812166|NCT03852472|463608794|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
128812167|NCT03852472|463608795|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
128812168|NCT03852472|463608796|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
128812169|NCT03852472|463608792|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
128812170|NCT03852472|463608793|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
128812171|NCT03852472|463608794|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
128812172|NCT03852472|463608795|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
128812173|NCT03852472|463608796|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
128812174|NCT03852472|463608792|FG000|Period 2 - Week 44|Adverse Event|0|||
128812175|NCT03852472|463608793|FG001|Period 2 - Week 44|Adverse Event|3|||
128812176|NCT03852472|463608794|FG002|Period 2 - Week 44|Adverse Event|1|||
128812177|NCT03852472|463608795|FG003|Period 2 - Week 44|Adverse Event|2|||
128812178|NCT03852472|463608796|FG004|Period 2 - Week 44|Adverse Event|2|||
128812179|NCT03852472|463608792|FG000|Period 2 - Week 44|COVID-19 Related|0|||
128812180|NCT03852472|463608793|FG001|Period 2 - Week 44|COVID-19 Related|0|||
128812181|NCT03852472|463608794|FG002|Period 2 - Week 44|COVID-19 Related|0|||
128812182|NCT03852472|463608795|FG003|Period 2 - Week 44|COVID-19 Related|1|||
128812183|NCT03852472|463608796|FG004|Period 2 - Week 44|COVID-19 Related|0|||
128812184|NCT03852472|463608792|FG000|Period 2 - Week 44|Reason not stated|0|||
128812185|NCT03852472|463608793|FG001|Period 2 - Week 44|Reason not stated|0|||
128812186|NCT03852472|463608794|FG002|Period 2 - Week 44|Reason not stated|0|||
128812187|NCT03852472|463608795|FG003|Period 2 - Week 44|Reason not stated|0|||
128812188|NCT03852472|463608796|FG004|Period 2 - Week 44|Reason not stated|1|||
128812189|NCT06457802|463608797|FG000|Overall Study|Early termination of study prior to participant completion|2|||
128812190|NCT06457802|463608798|FG001|Overall Study|Early termination of study prior to participant completion|2|||
128812191|NCT01467427|463608799|FG000|Overall Study|Withdrawal by Subject|1|||
128812192|NCT01467427|463608800|FG001|Overall Study|Withdrawal by Subject|0|||
128812193|NCT01467427|463608799|FG000|Overall Study|Not continuing in extension phase|0|||
128812194|NCT01467427|463608800|FG001|Overall Study|Not continuing in extension phase|2|||
128812195|NCT01467427|463608799|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
128812196|NCT01467427|463608800|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
128812197|NCT01467427|463608799|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
128812198|NCT01467427|463608800|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
128812199|NCT01467427|463608799|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
128812200|NCT01467427|463608800|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
128812201|NCT01467427|463608799|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
128812202|NCT01467427|463608800|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
128812203|NCT03161028|463608801|FG000|Overall Study|Withdrawal by Subject|6|||
128812204|NCT03161028|463608802|FG001|Overall Study|Withdrawal by Subject|4|||
128812205|NCT03161028|463608801|FG000|Overall Study|Adverse Event|5|||
128812206|NCT03161028|463608802|FG001|Overall Study|Adverse Event|1|||
128812207|NCT03161028|463608801|FG000|Overall Study|Study drug side effects|2|||
128812208|NCT03161028|463608802|FG001|Overall Study|Study drug side effects|2|||
128812209|NCT03161028|463608801|FG000|Overall Study|Administrative PD/UP|4|||
128812210|NCT03161028|463608802|FG001|Overall Study|Administrative PD/UP|2|||
128812211|NCT03161028|463608801|FG000|Overall Study|Lost to Follow-up|2|||
128812212|NCT03161028|463608802|FG001|Overall Study|Lost to Follow-up|0|||
128812213|NCT03161028|463608801|FG000|Overall Study|Unable to comply with procedures|1|||
128812214|NCT03161028|463608802|FG001|Overall Study|Unable to comply with procedures|1|||
128812215|NCT03492216|463608803|FG000|Overall Study|Death|1|||
128812216|NCT03492216|463608804|FG001|Overall Study|Death|0|||
128812217|NCT03492216|463608805|FG002|Overall Study|Death|4|||
128812218|NCT03492216|463608806|FG003|Overall Study|Death|0|||
128812219|NCT03492216|463608803|FG000|Overall Study|Withdrawal by Subject|5|||
128812220|NCT03492216|463608804|FG001|Overall Study|Withdrawal by Subject|3|||
128812221|NCT03492216|463608805|FG002|Overall Study|Withdrawal by Subject|1|||
128812222|NCT03492216|463608806|FG003|Overall Study|Withdrawal by Subject|1|||
128812223|NCT03492216|463608803|FG000|Overall Study|Lost to Follow-up|9|||
128812224|NCT03492216|463608804|FG001|Overall Study|Lost to Follow-up|2|||
128812225|NCT03492216|463608805|FG002|Overall Study|Lost to Follow-up|7|||
128812226|NCT03492216|463608806|FG003|Overall Study|Lost to Follow-up|8|||
128812227|NCT03492216|463608803|FG000|Overall Study|Moved|5|||
128812228|NCT03492216|463608804|FG001|Overall Study|Moved|3|||
128812229|NCT03492216|463608805|FG002|Overall Study|Moved|3|||
128812230|NCT03492216|463608806|FG003|Overall Study|Moved|5|||
128812231|NCT03492216|463608803|FG000|Overall Study|Too ill|0|||
128812232|NCT03492216|463608804|FG001|Overall Study|Too ill|1|||
128812233|NCT03492216|463608805|FG002|Overall Study|Too ill|0|||
128812234|NCT03492216|463608806|FG003|Overall Study|Too ill|0|||
128812235|NCT03492216|463608803|FG000|Overall Study|Incarcerated|0|||
128812236|NCT03492216|463608804|FG001|Overall Study|Incarcerated|0|||
128812237|NCT03492216|463608805|FG002|Overall Study|Incarcerated|2|||
128812238|NCT03492216|463608806|FG003|Overall Study|Incarcerated|0|||
128812239|NCT00736723|463608807|FG000|Overall Study|Withdrawal by Subject|4|||
128812240|NCT00736723|463608808|FG001|Overall Study|Withdrawal by Subject|3|||
128812241|NCT02601313|463608810|FG000|Overall Study|Death|2|||
128812242|NCT02601313|463608811|FG001|Overall Study|Death|41|||
128812243|NCT02601313|463608812|FG002|Overall Study|Death|6|||
128812244|NCT02601313|463608810|FG000|Overall Study|Enrolled but never treated|0|||
128812245|NCT02601313|463608811|FG001|Overall Study|Enrolled but never treated|6|||
128812246|NCT02601313|463608812|FG002|Overall Study|Enrolled but never treated|3|||
128812247|NCT02601313|463608810|FG000|Overall Study|Enrolled, did not initiate AC|4|||
128812248|NCT02601313|463608811|FG001|Overall Study|Enrolled, did not initiate AC|0|||
128812249|NCT02601313|463608812|FG002|Overall Study|Enrolled, did not initiate AC|0|||
128812250|NCT02601313|463608810|FG000|Overall Study|Full consent withdrawal|0|||
128812251|NCT02601313|463608811|FG001|Overall Study|Full consent withdrawal|3|||
128812252|NCT02601313|463608812|FG002|Overall Study|Full consent withdrawal|2|||
128812253|NCT02601313|463608810|FG000|Overall Study|Lost to Follow-up|0|||
128812254|NCT02601313|463608811|FG001|Overall Study|Lost to Follow-up|1|||
128812255|NCT02601313|463608812|FG002|Overall Study|Lost to Follow-up|1|||
128812256|NCT02975882|463610511|FG000|Overall Study|Adverse Event|1|||
128812257|NCT02975882|463610512|FG001|Overall Study|Adverse Event|2|||
128812258|NCT02975882|463610513|FG002|Overall Study|Adverse Event|1|||
128812259|NCT02975882|463610514|FG003|Overall Study|Adverse Event|1|||
128812260|NCT02975882|463610511|FG000|Overall Study|Death|0|||
128812261|NCT02975882|463610512|FG001|Overall Study|Death|1|||
128812262|NCT02975882|463610513|FG002|Overall Study|Death|0|||
128812263|NCT02975882|463610514|FG003|Overall Study|Death|0|||
128812264|NCT02975882|463610511|FG000|Overall Study|Lack of Efficacy|3|||
128812265|NCT02975882|463610512|FG001|Overall Study|Lack of Efficacy|7|||
128812266|NCT02975882|463610513|FG002|Overall Study|Lack of Efficacy|4|||
128812267|NCT02975882|463610514|FG003|Overall Study|Lack of Efficacy|3|||
128812268|NCT02975882|463610511|FG000|Overall Study|Physician Decision|0|||
128812269|NCT02975882|463610512|FG001|Overall Study|Physician Decision|2|||
128812270|NCT02975882|463610513|FG002|Overall Study|Physician Decision|4|||
128812271|NCT02975882|463610514|FG003|Overall Study|Physician Decision|2|||
128812272|NCT02975882|463610511|FG000|Overall Study|Ineligible|0|||
128812273|NCT02975882|463610512|FG001|Overall Study|Ineligible|1|||
128812274|NCT02975882|463610513|FG002|Overall Study|Ineligible|0|||
128812275|NCT02975882|463610514|FG003|Overall Study|Ineligible|0|||
128812276|NCT03524118|463610518|FG000|Overall Study|Lost to Follow-up|0|||
128812277|NCT03524118|463610519|FG001|Overall Study|Lost to Follow-up|0|||
128812278|NCT03524118|463610520|FG002|Overall Study|Lost to Follow-up|0|||
128812279|NCT03524118|463610521|FG003|Overall Study|Lost to Follow-up|0|||
128812280|NCT03524118|463610522|FG004|Overall Study|Lost to Follow-up|1|||
128812281|NCT03524118|463610523|FG005|Overall Study|Lost to Follow-up|0|||
128812282|NCT03524118|463610518|FG000|Overall Study|Other|0|||
128812283|NCT03524118|463610519|FG001|Overall Study|Other|1|||
128812284|NCT03524118|463610520|FG002|Overall Study|Other|0|||
128812285|NCT03524118|463610521|FG003|Overall Study|Other|0|||
128812286|NCT03524118|463610522|FG004|Overall Study|Other|1|||
128812287|NCT03524118|463610523|FG005|Overall Study|Other|1|||
128812288|NCT03524118|463610518|FG000|Overall Study|Physician Decision|0|||
128812289|NCT03524118|463610519|FG001|Overall Study|Physician Decision|0|||
128812290|NCT03524118|463610520|FG002|Overall Study|Physician Decision|0|||
128812291|NCT03524118|463610521|FG003|Overall Study|Physician Decision|0|||
128812292|NCT03524118|463610522|FG004|Overall Study|Physician Decision|1|||
128812293|NCT03524118|463610523|FG005|Overall Study|Physician Decision|0|||
128812294|NCT03524118|463610518|FG000|Overall Study|Protocol Violation|0|||
128812295|NCT03524118|463610519|FG001|Overall Study|Protocol Violation|0|||
128812296|NCT03524118|463610520|FG002|Overall Study|Protocol Violation|1|||
128812297|NCT03524118|463610521|FG003|Overall Study|Protocol Violation|0|||
128812298|NCT03524118|463610522|FG004|Overall Study|Protocol Violation|1|||
128812299|NCT03524118|463610523|FG005|Overall Study|Protocol Violation|0|||
128812300|NCT03524118|463610518|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128812301|NCT03524118|463610519|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
128812302|NCT03524118|463610520|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
128812303|NCT03524118|463610521|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
128812304|NCT03524118|463610522|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
128812305|NCT03524118|463610523|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
128812306|NCT01824875|463610524|FG000|Overall Study|Disease progression|22|||
128812307|NCT01824875|463610525|FG001|Overall Study|Disease progression|15|||
128812308|NCT01824875|463610524|FG000|Overall Study|Withdrawal by Subject|5|||
128812309|NCT01824875|463610525|FG001|Overall Study|Withdrawal by Subject|4|||
128812310|NCT01824875|463610524|FG000|Overall Study|Adverse Event|4|||
128812311|NCT01824875|463610525|FG001|Overall Study|Adverse Event|10|||
128812312|NCT01824875|463610524|FG000|Overall Study|Alternative therapy|3|||
128812313|NCT01824875|463610525|FG001|Overall Study|Alternative therapy|0|||
128812314|NCT01824875|463610524|FG000|Overall Study|Complicating disease|1|||
128812315|NCT01824875|463610525|FG001|Overall Study|Complicating disease|0|||
128812316|NCT01824875|463610524|FG000|Overall Study|Physician Decision|0|||
128812317|NCT01824875|463610525|FG001|Overall Study|Physician Decision|1|||
128812318|NCT01824875|463610524|FG000|Overall Study|Non-compliance|1|||
128812319|NCT01824875|463610525|FG001|Overall Study|Non-compliance|1|||
128812320|NCT01824875|463610524|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
128812321|NCT01824875|463610525|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
128812322|NCT01824875|463610524|FG000|Overall Study|Administrative issues|0|||
128812323|NCT01824875|463610525|FG001|Overall Study|Administrative issues|2|||
128812324|NCT01824875|463610524|FG000|Overall Study|Ineligible or never started treatment|9|||
128812325|NCT01824875|463610525|FG001|Overall Study|Ineligible or never started treatment|5|||
128812326|NCT01824875|463610524|FG000|Overall Study|Other|0|||
128812327|NCT01824875|463610525|FG001|Overall Study|Other|2|||
128812328|NCT01098812|463610528|FG000|Overall Study|Death|2|||
128812329|NCT01098812|463610529|FG001|Overall Study|Death|0|||
128812330|NCT01098812|463610530|FG002|Overall Study|Death|1|||
128812331|NCT01098812|463610528|FG000|Overall Study|Lost to Follow-up|0|||
128812332|NCT01098812|463610529|FG001|Overall Study|Lost to Follow-up|1|||
128812333|NCT01098812|463610530|FG002|Overall Study|Lost to Follow-up|0|||
128812334|NCT03462030|463610533|FG000|Overall Study|Withdrawal by Subject|1|||
128812335|NCT03462030|463610534|FG001|Overall Study|Withdrawal by Subject|1|||
128812336|NCT02979327|463610535|FG000|First Intervention|Protocol Violation|1|||
128812337|NCT02979327|463610536|FG001|First Intervention|Protocol Violation|0|||
128812338|NCT03474679|463610545|FG000|Overall Study|Death|7|||
128812339|NCT03474679|463610545|FG000|Overall Study|Withdrawal by Subject|1|||
128812340|NCT01539083|463610548|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
128812341|NCT01539083|463610549|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
128812342|NCT01539083|463610550|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
128812343|NCT01539083|463610548|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
128812344|NCT01539083|463610549|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
128812345|NCT01539083|463610550|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
128812346|NCT01539083|463610548|FG000|Before Randomization (VCD Induction)|Death|6|||
128812347|NCT01539083|463610549|FG001|Before Randomization (VCD Induction)|Death|0|||
128812348|NCT01539083|463610550|FG002|Before Randomization (VCD Induction)|Death|0|||
128812349|NCT01539083|463610548|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
128812350|NCT01539083|463610549|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
128812351|NCT01539083|463610550|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
128812352|NCT01539083|463610548|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
128812353|NCT01539083|463610549|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
128812354|NCT01539083|463610550|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
128812355|NCT01539083|463610548|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
128812356|NCT01539083|463610549|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
128812357|NCT01539083|463610550|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
128812358|NCT01539083|463610548|FG000|Before Randomization (VCD Induction)|Other|5|||
128812359|NCT01539083|463610549|FG001|Before Randomization (VCD Induction)|Other|0|||
128812360|NCT01539083|463610550|FG002|Before Randomization (VCD Induction)|Other|0|||
128812361|NCT01539083|463610548|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
128812362|NCT01539083|463610549|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
128812363|NCT01539083|463610550|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
128812364|NCT01539083|463610548|FG000|After Randomization (TP and VTP)|Other|0|||
128812365|NCT01539083|463610549|FG001|After Randomization (TP and VTP)|Other|1|||
128812366|NCT01539083|463610550|FG002|After Randomization (TP and VTP)|Other|1|||
128812367|NCT01539083|463610548|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
128812368|NCT01539083|463610549|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
128812369|NCT01539083|463610550|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
128812370|NCT01539083|463610548|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
128812371|NCT01539083|463610549|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
128812372|NCT01539083|463610550|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
128812373|NCT01539083|463610548|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
128812374|NCT01539083|463610549|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
128812375|NCT01539083|463610550|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
128812376|NCT01539083|463610548|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
128812377|NCT01539083|463610549|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
128812378|NCT01539083|463610550|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
128812379|NCT01539083|463610548|FG000|After Randomization (TP and VTP)|Death|0|||
128812380|NCT01539083|463610549|FG001|After Randomization (TP and VTP)|Death|6|||
128812381|NCT01539083|463610550|FG002|After Randomization (TP and VTP)|Death|11|||
128812382|NCT02573493|463610551|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
128812383|NCT02573493|463610552|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
128812384|NCT02573493|463610553|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
128812385|NCT02573493|463610554|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
128812386|NCT04332926|463610555|FG000|Overall Study|Withdrawal by Subject|6|||
128812387|NCT04332926|463610555|FG000|Overall Study|Physician Decision|6|||
128812388|NCT02677805|463610563|FG000|Double Blind Phase|Lost to Follow-up|8|||
128812389|NCT02677805|463610564|FG001|Double Blind Phase|Lost to Follow-up|3|||
128812390|NCT02677805|463610565|FG002|Double Blind Phase|Lost to Follow-up|0|||
128812391|NCT02677805|463610563|FG000|Double Blind Phase|Withdrawal by Subject|5|||
128812392|NCT02677805|463610564|FG001|Double Blind Phase|Withdrawal by Subject|2|||
128812393|NCT02677805|463610565|FG002|Double Blind Phase|Withdrawal by Subject|0|||
128812394|NCT02677805|463610563|FG000|Open Label Phase|Lost to Follow-up|0|||
128812395|NCT02677805|463610564|FG001|Open Label Phase|Lost to Follow-up|0|||
128812396|NCT02677805|463610565|FG002|Open Label Phase|Lost to Follow-up|10|||
128812397|NCT02677805|463610563|FG000|Open Label Phase|Withdrawal by Subject|0|||
128812398|NCT02677805|463610564|FG001|Open Label Phase|Withdrawal by Subject|0|||
128812399|NCT02677805|463610565|FG002|Open Label Phase|Withdrawal by Subject|6|||
128812400|NCT02268253|463610566|FG000|Stage 1|Withdrawal by Subject|1|||
128812401|NCT02268253|463610567|FG001|Stage 1|Withdrawal by Subject|0|||
128812402|NCT02268253|463610568|FG002|Stage 1|Withdrawal by Subject|0|||
128812403|NCT02268253|463610569|FG003|Stage 1|Withdrawal by Subject|0|||
128812404|NCT02268253|463610570|FG004|Stage 1|Withdrawal by Subject|0|||
128812405|NCT02268253|463610571|FG005|Stage 1|Withdrawal by Subject|0|||
128812406|NCT02268253|463610572|FG006|Stage 1|Withdrawal by Subject|0|||
128812407|NCT02268253|463610566|FG000|Stage 1|Death|0|||
128812408|NCT02268253|463610567|FG001|Stage 1|Death|2|||
128812409|NCT02268253|463610568|FG002|Stage 1|Death|2|||
128812410|NCT02268253|463610569|FG003|Stage 1|Death|2|||
128812411|NCT02268253|463610570|FG004|Stage 1|Death|1|||
128812412|NCT02268253|463610571|FG005|Stage 1|Death|1|||
128812413|NCT02268253|463610572|FG006|Stage 1|Death|0|||
128812414|NCT02268253|463610566|FG000|Stage 2|Disease Recurrence/ Progression|0|||
128812415|NCT02268253|463610567|FG001|Stage 2|Disease Recurrence/ Progression|0|||
128812416|NCT02268253|463610568|FG002|Stage 2|Disease Recurrence/ Progression|1|||
128812417|NCT02268253|463610569|FG003|Stage 2|Disease Recurrence/ Progression|0|||
128812418|NCT02268253|463610570|FG004|Stage 2|Disease Recurrence/ Progression|0|||
128812419|NCT02268253|463610571|FG005|Stage 2|Disease Recurrence/ Progression|0|||
128812420|NCT02268253|463610572|FG006|Stage 2|Disease Recurrence/ Progression|0|||
128812421|NCT02268253|463610566|FG000|Stage 2|Withdrawal by Subject|0|||
128812422|NCT02268253|463610567|FG001|Stage 2|Withdrawal by Subject|0|||
128812423|NCT02268253|463610568|FG002|Stage 2|Withdrawal by Subject|2|||
128812424|NCT02268253|463610569|FG003|Stage 2|Withdrawal by Subject|0|||
128812425|NCT02268253|463610570|FG004|Stage 2|Withdrawal by Subject|0|||
128812426|NCT02268253|463610571|FG005|Stage 2|Withdrawal by Subject|2|||
128812427|NCT02268253|463610572|FG006|Stage 2|Withdrawal by Subject|0|||
128812428|NCT02268253|463610566|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
128812429|NCT02268253|463610567|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
128812430|NCT02268253|463610568|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
128812431|NCT02268253|463610569|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
128812432|NCT02268253|463610570|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
128812433|NCT02268253|463610571|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
128812434|NCT02268253|463610572|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
128812435|NCT02268253|463610566|FG000|Stage 2|Death|0|||
128812436|NCT02268253|463610567|FG001|Stage 2|Death|0|||
128812437|NCT02268253|463610568|FG002|Stage 2|Death|19|||
128812438|NCT02268253|463610569|FG003|Stage 2|Death|0|||
128812439|NCT02268253|463610570|FG004|Stage 2|Death|0|||
128812440|NCT02268253|463610571|FG005|Stage 2|Death|20|||
128812441|NCT02268253|463610572|FG006|Stage 2|Death|1|||
128812442|NCT02268253|463610566|FG000|Stage 2|Lost to Follow-up|0|||
128812443|NCT02268253|463610567|FG001|Stage 2|Lost to Follow-up|0|||
128812444|NCT02268253|463610568|FG002|Stage 2|Lost to Follow-up|0|||
128812445|NCT02268253|463610569|FG003|Stage 2|Lost to Follow-up|0|||
128812446|NCT02268253|463610570|FG004|Stage 2|Lost to Follow-up|0|||
128812447|NCT02268253|463610571|FG005|Stage 2|Lost to Follow-up|4|||
128812448|NCT02268253|463610572|FG006|Stage 2|Lost to Follow-up|0|||
128812449|NCT02268253|463610566|FG000|Stage 2|Transferred to Hospice|0|||
128812450|NCT02268253|463610567|FG001|Stage 2|Transferred to Hospice|0|||
128812451|NCT02268253|463610568|FG002|Stage 2|Transferred to Hospice|0|||
128812452|NCT02268253|463610569|FG003|Stage 2|Transferred to Hospice|0|||
128812453|NCT02268253|463610570|FG004|Stage 2|Transferred to Hospice|0|||
128812454|NCT02268253|463610571|FG005|Stage 2|Transferred to Hospice|2|||
128812455|NCT02268253|463610572|FG006|Stage 2|Transferred to Hospice|0|||
128812456|NCT02268253|463610566|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
128812457|NCT02268253|463610567|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
128812458|NCT02268253|463610568|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
128812459|NCT02268253|463610569|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
128812460|NCT02268253|463610570|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
128812461|NCT02268253|463610571|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
128812462|NCT02268253|463610572|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
128812463|NCT02268253|463610566|FG000|Stage 3A|Withdrawal by Subject|0|||
128812464|NCT02268253|463610567|FG001|Stage 3A|Withdrawal by Subject|0|||
128812465|NCT02268253|463610568|FG002|Stage 3A|Withdrawal by Subject|2|||
128812466|NCT02268253|463610569|FG003|Stage 3A|Withdrawal by Subject|0|||
128812467|NCT02268253|463610570|FG004|Stage 3A|Withdrawal by Subject|0|||
128812468|NCT02268253|463610571|FG005|Stage 3A|Withdrawal by Subject|0|||
128812469|NCT02268253|463610572|FG006|Stage 3A|Withdrawal by Subject|0|||
128812470|NCT02268253|463610566|FG000|Stage 3A|Physician Decision|0|||
128812471|NCT02268253|463610567|FG001|Stage 3A|Physician Decision|0|||
128812472|NCT02268253|463610568|FG002|Stage 3A|Physician Decision|2|||
128812473|NCT02268253|463610569|FG003|Stage 3A|Physician Decision|0|||
128812474|NCT02268253|463610570|FG004|Stage 3A|Physician Decision|0|||
128812475|NCT02268253|463610571|FG005|Stage 3A|Physician Decision|0|||
128812476|NCT02268253|463610572|FG006|Stage 3A|Physician Decision|0|||
128812477|NCT02268253|463610566|FG000|Stage 3A|Study Terminated by Sponsor|0|||
128812478|NCT02268253|463610567|FG001|Stage 3A|Study Terminated by Sponsor|0|||
128812479|NCT02268253|463610568|FG002|Stage 3A|Study Terminated by Sponsor|2|||
128812480|NCT02268253|463610569|FG003|Stage 3A|Study Terminated by Sponsor|0|||
128812481|NCT02268253|463610570|FG004|Stage 3A|Study Terminated by Sponsor|0|||
128812482|NCT02268253|463610571|FG005|Stage 3A|Study Terminated by Sponsor|0|||
128812483|NCT02268253|463610572|FG006|Stage 3A|Study Terminated by Sponsor|0|||
128812484|NCT02268253|463610566|FG000|Stage 3A|Lost to Follow-up|0|||
128812485|NCT02268253|463610567|FG001|Stage 3A|Lost to Follow-up|0|||
128812486|NCT02268253|463610568|FG002|Stage 3A|Lost to Follow-up|1|||
128812487|NCT02268253|463610569|FG003|Stage 3A|Lost to Follow-up|0|||
128812488|NCT02268253|463610570|FG004|Stage 3A|Lost to Follow-up|0|||
128812489|NCT02268253|463610571|FG005|Stage 3A|Lost to Follow-up|0|||
128812490|NCT02268253|463610572|FG006|Stage 3A|Lost to Follow-up|0|||
128812491|NCT02268253|463610566|FG000|Stage 3A|Death|0|||
128812492|NCT02268253|463610567|FG001|Stage 3A|Death|0|||
128812493|NCT02268253|463610568|FG002|Stage 3A|Death|5|||
128812494|NCT02268253|463610569|FG003|Stage 3A|Death|0|||
128812495|NCT02268253|463610570|FG004|Stage 3A|Death|0|||
128812496|NCT02268253|463610571|FG005|Stage 3A|Death|0|||
128812497|NCT02268253|463610572|FG006|Stage 3A|Death|0|||
128812498|NCT05672069|463610573|FG000|Overall Study|Implant removal|1|||
128812499|NCT05672069|463610573|FG000|Overall Study|Lost to Follow-up|2|||
128812500|NCT05213390|463610576|FG000|Overall Study|Withdrawal by Subject|2|||
128812501|NCT05213390|463610576|FG000|Overall Study|Lost to Follow-up|12|||
128812502|NCT05213390|463610576|FG000|Overall Study|Protocol Violation|9|||
128812503|NCT01824537|463610577|FG000|Overall Study|Lost to Follow-up|78|||
128812504|NCT01824537|463610578|FG001|Overall Study|Lost to Follow-up|87|||
128812505|NCT03808818|463610579|FG000|Overall Study|Death|6|||
128812506|NCT03808818|463610580|FG001|Overall Study|Death|6|||
128812507|NCT03808818|463610579|FG000|Overall Study|Withdrawal by Subject|7|||
128812508|NCT03808818|463610580|FG001|Overall Study|Withdrawal by Subject|18|||
128812509|NCT03808818|463610579|FG000|Overall Study|Lost to Follow-up|31|||
128812510|NCT03808818|463610580|FG001|Overall Study|Lost to Follow-up|33|||
128812511|NCT03031470|463610588|FG000|Overall Study|Adverse Event|3|||
128812512|NCT03031470|463610589|FG001|Overall Study|Adverse Event|0|||
128812513|NCT03031470|463610588|FG000|Overall Study|Death|3|||
128812514|NCT03031470|463610589|FG001|Overall Study|Death|1|||
128812515|NCT03031470|463610588|FG000|Overall Study|Lost to Follow-up|1|||
128812516|NCT03031470|463610589|FG001|Overall Study|Lost to Follow-up|1|||
128812517|NCT03031470|463610588|FG000|Overall Study|Withdrawal by Subject|1|||
128812518|NCT03031470|463610589|FG001|Overall Study|Withdrawal by Subject|0|||
128812519|NCT03031470|463610588|FG000|Overall Study|Protocol entry criteria not met|0|||
128812520|NCT03031470|463610589|FG001|Overall Study|Protocol entry criteria not met|1|||
128812521|NCT03031470|463610588|FG000|Overall Study|Cancel the operation|0|||
128812522|NCT03031470|463610589|FG001|Overall Study|Cancel the operation|1|||
128812523|NCT01943409|463610592|FG000|Overall Study|resumed oral/entral|24|||
128812524|NCT01943409|463610593|FG001|Overall Study|resumed oral/entral|20|||
128812525|NCT01943409|463610592|FG000|Overall Study|Protocol Violation|14|||
128812526|NCT01943409|463610593|FG001|Overall Study|Protocol Violation|24|||
128812527|NCT01943409|463610592|FG000|Overall Study|Death|3|||
128812528|NCT01943409|463610593|FG001|Overall Study|Death|1|||
128812529|NCT01943409|463610592|FG000|Overall Study|Withdrawal by Subject|4|||
128812530|NCT01943409|463610593|FG001|Overall Study|Withdrawal by Subject|3|||
128812531|NCT02310646|463610594|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
128812532|NCT02310646|463610595|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
128812533|NCT02310646|463610594|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
128812534|NCT02310646|463610595|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
128812535|NCT02231164|463610600|FG000|Overall Study|Adverse Event|1|||
128812536|NCT02231164|463610601|FG001|Overall Study|Adverse Event|1|||
128812537|NCT02231164|463610600|FG000|Overall Study|Lack of Efficacy|4|||
128812538|NCT02231164|463610601|FG001|Overall Study|Lack of Efficacy|3|||
128812539|NCT02231164|463610600|FG000|Overall Study|Withdrawal by Subject|1|||
128812540|NCT02231164|463610601|FG001|Overall Study|Withdrawal by Subject|2|||
128812541|NCT02547363|463610602|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
128812542|NCT02547363|463610603|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
128812543|NCT02547363|463610602|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
128812544|NCT02547363|463610603|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
128812545|NCT02547363|463610602|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
128812546|NCT02547363|463610603|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
128812547|NCT02547363|463610602|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
128812548|NCT02547363|463610603|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
128812549|NCT02547363|463610602|FG000|12-month Follow-up|Withdrawal by Subject|4|||
128812550|NCT02547363|463610603|FG001|12-month Follow-up|Withdrawal by Subject|3|||
128812551|NCT02547363|463610602|FG000|12-month Follow-up|Lost to Follow-up|4|||
128812552|NCT02547363|463610603|FG001|12-month Follow-up|Lost to Follow-up|1|||
128812553|NCT02547363|463610602|FG000|12-month Follow-up|Lack of Efficacy|1|||
128812554|NCT02547363|463610603|FG001|12-month Follow-up|Lack of Efficacy|1|||
128812555|NCT02547363|463610602|FG000|12-month Follow-up|Other|1|||
128812556|NCT02547363|463610603|FG001|12-month Follow-up|Other|0|||
128812557|NCT05281562|463610606|FG000|Overall Study|Ineligible patient|1|||
128812558|NCT05281562|463610607|FG001|Overall Study|Ineligible patient|0|||
128812559|NCT04436276|463610608|FG000|Overall Study|Adverse Event|0|||
128812560|NCT04436276|463610609|FG001|Overall Study|Adverse Event|0|||
128812561|NCT04436276|463610610|FG002|Overall Study|Adverse Event|0|||
128812562|NCT04436276|463610611|FG003|Overall Study|Adverse Event|0|||
128812563|NCT04436276|463610612|FG004|Overall Study|Adverse Event|0|||
128812564|NCT04436276|463610613|FG005|Overall Study|Adverse Event|0|||
128812565|NCT04436276|463610614|FG006|Overall Study|Adverse Event|0|||
128812566|NCT04436276|463610615|FG007|Overall Study|Adverse Event|0|||
128812567|NCT04436276|463610616|FG008|Overall Study|Adverse Event|0|||
128812568|NCT04436276|463610617|FG009|Overall Study|Adverse Event|0|||
128812569|NCT04436276|463610618|FG010|Overall Study|Adverse Event|0|||
128812570|NCT04436276|463610619|FG011|Overall Study|Adverse Event|0|||
128812571|NCT04436276|463610620|FG012|Overall Study|Adverse Event|0|||
128812572|NCT04436276|463610621|FG013|Overall Study|Adverse Event|0|||
128812573|NCT04436276|463610622|FG014|Overall Study|Adverse Event|0|||
128812574|NCT04436276|463610623|FG015|Overall Study|Adverse Event|0|||
128812575|NCT04436276|463610624|FG016|Overall Study|Adverse Event|1|||
128812576|NCT04436276|463610625|FG017|Overall Study|Adverse Event|0|||
128812577|NCT04436276|463610626|FG018|Overall Study|Adverse Event|0|||
128812578|NCT04436276|463610627|FG019|Overall Study|Adverse Event|0|||
128812579|NCT04436276|463610628|FG020|Overall Study|Adverse Event|0|||
128812580|NCT04436276|463610629|FG021|Overall Study|Adverse Event|0|||
128812581|NCT04436276|463610630|FG022|Overall Study|Adverse Event|0|||
128812582|NCT04436276|463610608|FG000|Overall Study|Death|0|||
128812583|NCT04436276|463610609|FG001|Overall Study|Death|0|||
128812584|NCT04436276|463610610|FG002|Overall Study|Death|0|||
128812585|NCT04436276|463610611|FG003|Overall Study|Death|0|||
128812586|NCT04436276|463610612|FG004|Overall Study|Death|0|||
128812587|NCT04436276|463610613|FG005|Overall Study|Death|0|||
128812588|NCT04436276|463610614|FG006|Overall Study|Death|0|||
128812589|NCT04436276|463610615|FG007|Overall Study|Death|0|||
128812590|NCT04436276|463610616|FG008|Overall Study|Death|0|||
128812591|NCT04436276|463610617|FG009|Overall Study|Death|0|||
128812592|NCT04436276|463610618|FG010|Overall Study|Death|0|||
128812593|NCT04436276|463610619|FG011|Overall Study|Death|0|||
128812594|NCT04436276|463610620|FG012|Overall Study|Death|1|||
128812595|NCT04436276|463610621|FG013|Overall Study|Death|0|||
128812596|NCT04436276|463610622|FG014|Overall Study|Death|1|||
128812597|NCT04436276|463610623|FG015|Overall Study|Death|0|||
128812598|NCT04436276|463610624|FG016|Overall Study|Death|0|||
128812599|NCT04436276|463610625|FG017|Overall Study|Death|0|||
128812600|NCT04436276|463610626|FG018|Overall Study|Death|0|||
128812601|NCT04436276|463610627|FG019|Overall Study|Death|2|||
128812602|NCT04436276|463610628|FG020|Overall Study|Death|0|||
128812603|NCT04436276|463610629|FG021|Overall Study|Death|1|||
128812604|NCT04436276|463610630|FG022|Overall Study|Death|0|||
128812605|NCT04436276|463610608|FG000|Overall Study|Lost to Follow-up|0|||
128812606|NCT04436276|463610609|FG001|Overall Study|Lost to Follow-up|2|||
128812607|NCT04436276|463610610|FG002|Overall Study|Lost to Follow-up|2|||
128812608|NCT04436276|463610611|FG003|Overall Study|Lost to Follow-up|1|||
128812609|NCT04436276|463610612|FG004|Overall Study|Lost to Follow-up|4|||
128812610|NCT04436276|463610613|FG005|Overall Study|Lost to Follow-up|1|||
128812611|NCT04436276|463610614|FG006|Overall Study|Lost to Follow-up|0|||
128812612|NCT04436276|463610615|FG007|Overall Study|Lost to Follow-up|0|||
128812613|NCT04436276|463610616|FG008|Overall Study|Lost to Follow-up|1|||
128812614|NCT04436276|463610617|FG009|Overall Study|Lost to Follow-up|0|||
128812615|NCT04436276|463610618|FG010|Overall Study|Lost to Follow-up|5|||
128812616|NCT04436276|463610619|FG011|Overall Study|Lost to Follow-up|5|||
128812617|NCT04436276|463610620|FG012|Overall Study|Lost to Follow-up|4|||
128812618|NCT04436276|463610621|FG013|Overall Study|Lost to Follow-up|1|||
128812619|NCT04436276|463610622|FG014|Overall Study|Lost to Follow-up|7|||
128812620|NCT04436276|463610623|FG015|Overall Study|Lost to Follow-up|7|||
128812621|NCT04436276|463610624|FG016|Overall Study|Lost to Follow-up|1|||
128812622|NCT04436276|463610625|FG017|Overall Study|Lost to Follow-up|0|||
128812623|NCT04436276|463610626|FG018|Overall Study|Lost to Follow-up|1|||
128812624|NCT04436276|463610627|FG019|Overall Study|Lost to Follow-up|1|||
128812625|NCT04436276|463610628|FG020|Overall Study|Lost to Follow-up|2|||
128812626|NCT04436276|463610629|FG021|Overall Study|Lost to Follow-up|1|||
128812627|NCT04436276|463610630|FG022|Overall Study|Lost to Follow-up|1|||
128812628|NCT04436276|463610608|FG000|Overall Study|Physician Decision|1|||
128812629|NCT04436276|463610609|FG001|Overall Study|Physician Decision|0|||
128812630|NCT04436276|463610610|FG002|Overall Study|Physician Decision|2|||
128812631|NCT04436276|463610611|FG003|Overall Study|Physician Decision|1|||
128812632|NCT04436276|463610612|FG004|Overall Study|Physician Decision|0|||
128812633|NCT04436276|463610613|FG005|Overall Study|Physician Decision|0|||
128812634|NCT04436276|463610614|FG006|Overall Study|Physician Decision|0|||
128812635|NCT04436276|463610615|FG007|Overall Study|Physician Decision|0|||
128812636|NCT04436276|463610616|FG008|Overall Study|Physician Decision|0|||
128812637|NCT04436276|463610617|FG009|Overall Study|Physician Decision|0|||
128812638|NCT04436276|463610618|FG010|Overall Study|Physician Decision|0|||
128812639|NCT04436276|463610619|FG011|Overall Study|Physician Decision|1|||
128812640|NCT04436276|463610620|FG012|Overall Study|Physician Decision|2|||
128812641|NCT04436276|463610621|FG013|Overall Study|Physician Decision|0|||
128812642|NCT04436276|463610622|FG014|Overall Study|Physician Decision|0|||
128812643|NCT04436276|463610623|FG015|Overall Study|Physician Decision|0|||
128812644|NCT04436276|463610624|FG016|Overall Study|Physician Decision|0|||
128812645|NCT04436276|463610625|FG017|Overall Study|Physician Decision|0|||
128812646|NCT04436276|463610626|FG018|Overall Study|Physician Decision|0|||
128812647|NCT04436276|463610627|FG019|Overall Study|Physician Decision|0|||
128812648|NCT04436276|463610628|FG020|Overall Study|Physician Decision|1|||
128812649|NCT04436276|463610629|FG021|Overall Study|Physician Decision|2|||
128812650|NCT04436276|463610630|FG022|Overall Study|Physician Decision|0|||
128812651|NCT04436276|463610608|FG000|Overall Study|Protocol Violation|0|||
128812652|NCT04436276|463610609|FG001|Overall Study|Protocol Violation|0|||
128812653|NCT04436276|463610610|FG002|Overall Study|Protocol Violation|0|||
128812654|NCT04436276|463610611|FG003|Overall Study|Protocol Violation|0|||
128812655|NCT04436276|463610612|FG004|Overall Study|Protocol Violation|0|||
128812656|NCT04436276|463610613|FG005|Overall Study|Protocol Violation|0|||
128812657|NCT04436276|463610614|FG006|Overall Study|Protocol Violation|0|||
128812658|NCT04436276|463610615|FG007|Overall Study|Protocol Violation|0|||
128812659|NCT04436276|463610616|FG008|Overall Study|Protocol Violation|0|||
128812660|NCT04436276|463610617|FG009|Overall Study|Protocol Violation|0|||
128812661|NCT04436276|463610618|FG010|Overall Study|Protocol Violation|0|||
128812662|NCT04436276|463610619|FG011|Overall Study|Protocol Violation|0|||
128812663|NCT04436276|463610620|FG012|Overall Study|Protocol Violation|0|||
128812664|NCT04436276|463610621|FG013|Overall Study|Protocol Violation|1|||
128812665|NCT04436276|463610622|FG014|Overall Study|Protocol Violation|0|||
128812666|NCT04436276|463610623|FG015|Overall Study|Protocol Violation|1|||
128812667|NCT04436276|463610624|FG016|Overall Study|Protocol Violation|0|||
128812668|NCT04436276|463610625|FG017|Overall Study|Protocol Violation|0|||
128812669|NCT04436276|463610626|FG018|Overall Study|Protocol Violation|0|||
128812670|NCT04436276|463610627|FG019|Overall Study|Protocol Violation|0|||
128812671|NCT04436276|463610628|FG020|Overall Study|Protocol Violation|0|||
128812672|NCT04436276|463610629|FG021|Overall Study|Protocol Violation|0|||
128812673|NCT04436276|463610630|FG022|Overall Study|Protocol Violation|0|||
128812674|NCT04436276|463610608|FG000|Overall Study|Withdrawal by Subject|25|||
128812675|NCT04436276|463610609|FG001|Overall Study|Withdrawal by Subject|22|||
128812676|NCT04436276|463610610|FG002|Overall Study|Withdrawal by Subject|24|||
128812677|NCT04436276|463610611|FG003|Overall Study|Withdrawal by Subject|23|||
128812678|NCT04436276|463610612|FG004|Overall Study|Withdrawal by Subject|14|||
128812679|NCT04436276|463610613|FG005|Overall Study|Withdrawal by Subject|0|||
128812680|NCT04436276|463610614|FG006|Overall Study|Withdrawal by Subject|0|||
128812681|NCT04436276|463610615|FG007|Overall Study|Withdrawal by Subject|1|||
128812682|NCT04436276|463610616|FG008|Overall Study|Withdrawal by Subject|0|||
128812683|NCT04436276|463610617|FG009|Overall Study|Withdrawal by Subject|1|||
128812684|NCT04436276|463610618|FG010|Overall Study|Withdrawal by Subject|17|||
128812685|NCT04436276|463610619|FG011|Overall Study|Withdrawal by Subject|7|||
128812686|NCT04436276|463610620|FG012|Overall Study|Withdrawal by Subject|10|||
128812687|NCT04436276|463610621|FG013|Overall Study|Withdrawal by Subject|6|||
128812688|NCT04436276|463610622|FG014|Overall Study|Withdrawal by Subject|20|||
128812689|NCT04436276|463610623|FG015|Overall Study|Withdrawal by Subject|6|||
128812690|NCT04436276|463610624|FG016|Overall Study|Withdrawal by Subject|11|||
128812691|NCT04436276|463610625|FG017|Overall Study|Withdrawal by Subject|4|||
128812692|NCT04436276|463610626|FG018|Overall Study|Withdrawal by Subject|14|||
128812693|NCT04436276|463610627|FG019|Overall Study|Withdrawal by Subject|24|||
128812694|NCT04436276|463610628|FG020|Overall Study|Withdrawal by Subject|24|||
128812695|NCT04436276|463610629|FG021|Overall Study|Withdrawal by Subject|16|||
128812696|NCT04436276|463610630|FG022|Overall Study|Withdrawal by Subject|14|||
128812697|NCT04436276|463610608|FG000|Overall Study|Other|3|||
128812698|NCT04436276|463610609|FG001|Overall Study|Other|2|||
128812699|NCT04436276|463610610|FG002|Overall Study|Other|5|||
128812700|NCT04436276|463610611|FG003|Overall Study|Other|9|||
128812701|NCT04436276|463610612|FG004|Overall Study|Other|23|||
128812702|NCT04436276|463610613|FG005|Overall Study|Other|1|||
128812703|NCT04436276|463610614|FG006|Overall Study|Other|0|||
128812704|NCT04436276|463610615|FG007|Overall Study|Other|0|||
128812705|NCT04436276|463610616|FG008|Overall Study|Other|0|||
128812706|NCT04436276|463610617|FG009|Overall Study|Other|0|||
128812707|NCT04436276|463610618|FG010|Overall Study|Other|3|||
128812708|NCT04436276|463610619|FG011|Overall Study|Other|1|||
128812709|NCT04436276|463610620|FG012|Overall Study|Other|1|||
128812710|NCT04436276|463610621|FG013|Overall Study|Other|2|||
128812711|NCT04436276|463610622|FG014|Overall Study|Other|3|||
128812712|NCT04436276|463610623|FG015|Overall Study|Other|0|||
128812713|NCT04436276|463610624|FG016|Overall Study|Other|0|||
128812714|NCT04436276|463610625|FG017|Overall Study|Other|6|||
128812715|NCT04436276|463610626|FG018|Overall Study|Other|1|||
128812716|NCT04436276|463610627|FG019|Overall Study|Other|0|||
128812717|NCT04436276|463610628|FG020|Overall Study|Other|2|||
128812718|NCT04436276|463610629|FG021|Overall Study|Other|2|||
128812719|NCT04436276|463610630|FG022|Overall Study|Other|60|||
128812720|NCT05977530|463610632|FG000|Overall Study|Withdrawal by Subject|1|||
128812721|NCT05977530|463610632|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
128812722|NCT04797897|463610637|FG000|Overall Study|Study Termination by Sponsor|1|||
128812723|NCT04797897|463610638|FG001|Overall Study|Study Termination by Sponsor|1|||
128812724|NCT03024437|463610643|FG000|Overall Study|Adverse Event|0|||
128812725|NCT03024437|463610644|FG001|Overall Study|Adverse Event|1|||
128812726|NCT03024437|463610645|FG002|Overall Study|Adverse Event|3|||
128812727|NCT03024437|463610646|FG003|Overall Study|Adverse Event|5|||
128812728|NCT03024437|463610647|FG004|Overall Study|Adverse Event|0|||
128812729|NCT03024437|463610643|FG000|Overall Study|Physician Decision|1|||
128812730|NCT03024437|463610644|FG001|Overall Study|Physician Decision|0|||
128812731|NCT03024437|463610645|FG002|Overall Study|Physician Decision|0|||
128812732|NCT03024437|463610646|FG003|Overall Study|Physician Decision|1|||
128812733|NCT03024437|463610647|FG004|Overall Study|Physician Decision|0|||
128812734|NCT03024437|463610643|FG000|Overall Study|Disease progression, relapse|1|||
128812735|NCT03024437|463610644|FG001|Overall Study|Disease progression, relapse|0|||
128812736|NCT03024437|463610645|FG002|Overall Study|Disease progression, relapse|0|||
128812737|NCT03024437|463610646|FG003|Overall Study|Disease progression, relapse|3|||
128812738|NCT03024437|463610647|FG004|Overall Study|Disease progression, relapse|0|||
128812739|NCT03024437|463610643|FG000|Overall Study|Disease progression, refractory disease|4|||
128812740|NCT03024437|463610644|FG001|Overall Study|Disease progression, refractory disease|4|||
128812741|NCT03024437|463610645|FG002|Overall Study|Disease progression, refractory disease|2|||
128812742|NCT03024437|463610646|FG003|Overall Study|Disease progression, refractory disease|2|||
128812743|NCT03024437|463610647|FG004|Overall Study|Disease progression, refractory disease|1|||
128812744|NCT03024437|463610643|FG000|Overall Study|Newly diagnosed cancer|0|||
128812745|NCT03024437|463610644|FG001|Overall Study|Newly diagnosed cancer|0|||
128812746|NCT03024437|463610645|FG002|Overall Study|Newly diagnosed cancer|0|||
128812747|NCT03024437|463610646|FG003|Overall Study|Newly diagnosed cancer|1|||
128812748|NCT03024437|463610647|FG004|Overall Study|Newly diagnosed cancer|0|||
128812749|NCT03024437|463610643|FG000|Overall Study|Moved out of state|0|||
128812750|NCT03024437|463610644|FG001|Overall Study|Moved out of state|1|||
128812751|NCT03024437|463610645|FG002|Overall Study|Moved out of state|0|||
128812752|NCT03024437|463610646|FG003|Overall Study|Moved out of state|0|||
128812753|NCT03024437|463610647|FG004|Overall Study|Moved out of state|0|||
128812754|NCT03024437|463610643|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
128812755|NCT03024437|463610644|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
128812756|NCT03024437|463610645|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
128812757|NCT03024437|463610646|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
128812758|NCT03024437|463610647|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
128812759|NCT05239455|463610649|FG000|Overall Study|Adverse Event|1|||
128812760|NCT05239455|463610649|FG000|Overall Study|Sponsor Decision|5|||
128812761|NCT05239455|463610649|FG000|Overall Study|Incomplete Blood Collection|1|||
128812762|NCT01799265|463610650|FG000|Overall Study|Lost to Follow-up|1|||
128812763|NCT01799265|463610651|FG001|Overall Study|Lost to Follow-up|0|||
128812764|NCT01799265|463610650|FG000|Overall Study|Protocol Violation|2|||
128812765|NCT01799265|463610651|FG001|Overall Study|Protocol Violation|1|||
128812766|NCT01799265|463610650|FG000|Overall Study|inadequate sleep study|0|||
128812767|NCT01799265|463610651|FG001|Overall Study|inadequate sleep study|2|||
128812768|NCT03459729|463610652|FG000|Overall Study|Physician Decision|2|||
128812769|NCT02364557|463610653|FG000|Overall Study|Protocol Violation|3|||
128812770|NCT02364557|463610654|FG001|Overall Study|Protocol Violation|1|||
128812771|NCT04200456|463610659|FG000|Overall Study|Physician Decision|0|||
128812772|NCT04200456|463610660|FG001|Overall Study|Physician Decision|1|||
128812773|NCT04200456|463610659|FG000|Overall Study|Withdrawal by Subject|2|||
128812774|NCT04200456|463610660|FG001|Overall Study|Withdrawal by Subject|2|||
128812775|NCT04200456|463610659|FG000|Overall Study|Lack of Efficacy|1|||
128812776|NCT04200456|463610660|FG001|Overall Study|Lack of Efficacy|1|||
128812777|NCT04200456|463610659|FG000|Overall Study|Adverse event, non-fatal|0|||
128812778|NCT04200456|463610660|FG001|Overall Study|Adverse event, non-fatal|1|||
128812779|NCT04200456|463610659|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
128812780|NCT04200456|463610660|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
128812781|NCT04828005|463610661|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
128812782|NCT04828005|463610662|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
128812783|NCT04828005|463610663|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
128812784|NCT04828005|463610664|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
128812785|NCT04828005|463610661|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
128812786|NCT04828005|463610662|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
128812787|NCT04828005|463610663|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
128812788|NCT04828005|463610664|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
128812789|NCT04828005|463610661|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
128812790|NCT04828005|463610662|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
128812791|NCT04828005|463610663|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
128812792|NCT04828005|463610664|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
128812793|NCT04828005|463610661|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
128812794|NCT04828005|463610662|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
128812795|NCT04828005|463610663|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
128812796|NCT04828005|463610664|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
128812797|NCT04828005|463610661|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
128812798|NCT04828005|463610662|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
128812799|NCT04828005|463610663|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
128812800|NCT04828005|463610664|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
128812801|NCT04828005|463610661|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
128812802|NCT04828005|463610662|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
128812803|NCT04828005|463610663|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
128812804|NCT04828005|463610664|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
128812805|NCT04828005|463610661|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
128812806|NCT04828005|463610662|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
128812807|NCT04828005|463610663|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
128812808|NCT04828005|463610664|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
128812809|NCT04828005|463610661|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
128812810|NCT04828005|463610662|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
128812811|NCT04828005|463610663|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
128812812|NCT04828005|463610664|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
128812813|NCT04828005|463610661|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
128812814|NCT04828005|463610662|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
128812815|NCT04828005|463610663|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
128812816|NCT04828005|463610664|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
128812817|NCT00506519|463612574|FG000|Overall Study|Death|4|||
128812818|NCT00506519|463612575|FG001|Overall Study|Death|6|||
128812819|NCT00506519|463612576|FG002|Overall Study|Death|0|||
128812820|NCT00506519|463612574|FG000|Overall Study|Adverse Event|1|||
128812821|NCT00506519|463612575|FG001|Overall Study|Adverse Event|0|||
128812822|NCT00506519|463612576|FG002|Overall Study|Adverse Event|0|||
128812823|NCT01186367|463612577|FG000|Overall Study|Lost to Follow-up|7|||
128812824|NCT01186367|463612578|FG001|Overall Study|Lost to Follow-up|4|||
128812825|NCT01186367|463612579|FG002|Overall Study|Lost to Follow-up|7|||
128812826|NCT01186367|463612577|FG000|Overall Study|Did not receive study treatment|0|||
128812827|NCT01186367|463612578|FG001|Overall Study|Did not receive study treatment|1|||
128812828|NCT01186367|463612579|FG002|Overall Study|Did not receive study treatment|0|||
128812829|NCT03945292|463612580|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
128812830|NCT03945292|463612581|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
128812831|NCT03945292|463612582|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
128812832|NCT03945292|463612583|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
128812833|NCT03945292|463612584|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
128812834|NCT03945292|463612585|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
128812835|NCT03945292|463612586|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
128812836|NCT03945292|463612587|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
128812837|NCT03945292|463612580|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
128812838|NCT03945292|463612581|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
128812839|NCT03945292|463612582|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
128812840|NCT03945292|463612583|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
128812841|NCT03945292|463612584|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
128812842|NCT03945292|463612585|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
128812843|NCT03945292|463612586|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
128812844|NCT03945292|463612587|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
128812845|NCT03945292|463612580|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
128812846|NCT03945292|463612581|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
128812847|NCT03945292|463612582|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
128812848|NCT03945292|463612583|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
128812849|NCT03945292|463612584|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
128812850|NCT03945292|463612585|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
128812851|NCT03945292|463612586|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
128812852|NCT03945292|463612587|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
128812853|NCT04987320|463612589|FG000|Overall Study|Withdrawal by Subject|0|||
128812854|NCT04987320|463612590|FG001|Overall Study|Withdrawal by Subject|1|||
128812855|NCT01129102|463612591|FG000|Overall Study|No study drug treatment|2|||
128812856|NCT01129102|463612592|FG001|Overall Study|No study drug treatment|3|||
128812857|NCT01129102|463612593|FG002|Overall Study|No study drug treatment|1|||
128812858|NCT01129102|463612591|FG000|Overall Study|Withdrawal by Subject|2|||
128812859|NCT01129102|463612592|FG001|Overall Study|Withdrawal by Subject|0|||
128812860|NCT01129102|463612593|FG002|Overall Study|Withdrawal by Subject|3|||
128812861|NCT01129102|463612591|FG000|Overall Study|Protocol Violation|0|||
128812862|NCT01129102|463612592|FG001|Overall Study|Protocol Violation|1|||
128812863|NCT01129102|463612593|FG002|Overall Study|Protocol Violation|1|||
128812864|NCT01129102|463612591|FG000|Overall Study|Pregnancy|0|||
128812865|NCT01129102|463612592|FG001|Overall Study|Pregnancy|0|||
128812866|NCT01129102|463612593|FG002|Overall Study|Pregnancy|1|||
128812867|NCT01129102|463612591|FG000|Overall Study|Adverse Event|2|||
128812868|NCT01129102|463612592|FG001|Overall Study|Adverse Event|2|||
128812869|NCT01129102|463612593|FG002|Overall Study|Adverse Event|1|||
128812870|NCT01129102|463612591|FG000|Overall Study|Lost to Follow-up|2|||
128812871|NCT01129102|463612592|FG001|Overall Study|Lost to Follow-up|0|||
128812872|NCT01129102|463612593|FG002|Overall Study|Lost to Follow-up|0|||
128812873|NCT03379675|463612596|FG000|Overall Study|Lost to Follow-up|0|||
128812874|NCT03379675|463612597|FG001|Overall Study|Lost to Follow-up|1|||
128812875|NCT03379675|463612598|FG002|Overall Study|Lost to Follow-up|0|||
128812876|NCT03379675|463612596|FG000|Overall Study|Adverse Event|2|||
128812877|NCT03379675|463612597|FG001|Overall Study|Adverse Event|0|||
128812878|NCT03379675|463612598|FG002|Overall Study|Adverse Event|0|||
128812879|NCT03379675|463612596|FG000|Overall Study|Withdrawal by Subject|2|||
128812880|NCT03379675|463612597|FG001|Overall Study|Withdrawal by Subject|1|||
128812881|NCT03379675|463612598|FG002|Overall Study|Withdrawal by Subject|2|||
128812882|NCT02675751|463612600|FG000|Overall Study|Lost to Follow-up|16|||
128812883|NCT03371381|463612601|FG000|Overall Study|Death|5|||
128812884|NCT03371381|463612601|FG000|Overall Study|Study terminated by sponsor|3|||
128812885|NCT03371381|463612601|FG000|Overall Study|Other|4|||
128812886|NCT03628924|463612602|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
128812887|NCT03628924|463612603|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
128812888|NCT03628924|463612604|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
128812889|NCT03628924|463612605|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
128812890|NCT03628924|463612606|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
128812891|NCT03628924|463612607|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
128812892|NCT03628924|463612608|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
128812893|NCT03628924|463612602|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128812894|NCT03628924|463612603|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128812895|NCT03628924|463612604|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
128812896|NCT03628924|463612605|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128812897|NCT03628924|463612606|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128812898|NCT03628924|463612607|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128812899|NCT03628924|463612608|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
128812900|NCT03628924|463612602|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
128812901|NCT03628924|463612603|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
128812902|NCT03628924|463612604|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
128812903|NCT03628924|463612605|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
128812904|NCT03628924|463612606|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
128812905|NCT03628924|463612607|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
128812906|NCT03628924|463612608|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
128812907|NCT03628924|463612602|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128812908|NCT03628924|463612603|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
128812909|NCT03628924|463612604|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128812910|NCT03628924|463612605|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128812911|NCT03628924|463612606|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128812912|NCT03628924|463612607|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128812913|NCT03628924|463612608|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128812914|NCT03628924|463612602|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
128812915|NCT03628924|463612603|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
128812916|NCT03628924|463612604|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
128812917|NCT03628924|463612605|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
128812918|NCT03628924|463612606|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
128812919|NCT03628924|463612607|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
128812920|NCT03628924|463612608|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
128812921|NCT03628924|463612602|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
128812922|NCT03628924|463612603|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
128812923|NCT03628924|463612604|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
128812924|NCT03628924|463612605|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
128812925|NCT03628924|463612606|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
128812926|NCT03628924|463612607|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
128812927|NCT03628924|463612608|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
128812928|NCT03628924|463612602|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
128812929|NCT03628924|463612603|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
128812930|NCT03628924|463612604|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
128812931|NCT03628924|463612605|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
128812932|NCT03628924|463612606|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
128812933|NCT03628924|463612607|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
128812934|NCT03628924|463612608|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
128812935|NCT03628924|463612602|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
128812936|NCT03628924|463612603|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
128812937|NCT03628924|463612604|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
128812938|NCT03628924|463612605|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
128812939|NCT03628924|463612606|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
128812940|NCT03628924|463612607|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
128812941|NCT03628924|463612608|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
128812942|NCT03628924|463612602|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
128812943|NCT03628924|463612603|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
128812944|NCT03628924|463612604|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
128812945|NCT03628924|463612605|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
128812946|NCT03628924|463612606|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
128812947|NCT03628924|463612607|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
128812948|NCT03628924|463612608|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
128812949|NCT03628924|463612602|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
128812950|NCT03628924|463612603|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
128812951|NCT03628924|463612604|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
128812952|NCT03628924|463612605|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
128812953|NCT03628924|463612606|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
128812954|NCT03628924|463612607|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
128812955|NCT03628924|463612608|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
128812956|NCT06019559|463612609|FG000|Overall Study|Withdrawal by Subject|7|||
128812957|NCT06019559|463612610|FG001|Overall Study|Withdrawal by Subject|6|||
128812958|NCT06019559|463612611|FG002|Overall Study|Withdrawal by Subject|5|||
128812959|NCT06019559|463612609|FG000|Overall Study|Lost to Follow-up|2|||
128812960|NCT06019559|463612610|FG001|Overall Study|Lost to Follow-up|0|||
128812961|NCT06019559|463612611|FG002|Overall Study|Lost to Follow-up|3|||
128812962|NCT06215521|463612612|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
128812963|NCT06215521|463612613|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
128812964|NCT06215521|463612614|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
128812965|NCT06215521|463612615|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
128812966|NCT06215521|463612616|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
128812967|NCT06215521|463612617|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
128812968|NCT03858634|463612621|FG000|Overall Study|Withdrawal by Subject|1|||
128812969|NCT03858634|463612622|FG001|Overall Study|Withdrawal by Subject|0|||
128812970|NCT03858634|463612621|FG000|Overall Study|Adverse Event|1|||
128812971|NCT03858634|463612622|FG001|Overall Study|Adverse Event|0|||
128812972|NCT03858634|463612621|FG000|Overall Study|Lost to Follow-up|0|||
128812973|NCT03858634|463612622|FG001|Overall Study|Lost to Follow-up|1|||
128812974|NCT03858634|463612621|FG000|Overall Study|Other, Not Specified|1|||
128812975|NCT03858634|463612622|FG001|Overall Study|Other, Not Specified|1|||
128812976|NCT04676763|463612623|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
128812977|NCT04676763|463612624|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
128812978|NCT04676763|463612625|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
128812979|NCT04676763|463612623|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
128812980|NCT04676763|463612624|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
128812981|NCT04676763|463612625|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
128812982|NCT04676763|463612623|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
128812983|NCT04676763|463612624|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
128812984|NCT04676763|463612625|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
128812985|NCT03150173|463612626|FG000|Overall Study|Lost to Follow-up|13|||
128812986|NCT03150173|463612627|FG001|Overall Study|Lost to Follow-up|5|||
128812987|NCT04016662|463612629|FG000|Run-In Phase|Death|1|||
128812988|NCT04016662|463612629|FG000|Run-In Phase|Withdrawal by Subject|11|||
128812989|NCT04016662|463612629|FG000|Run-In Phase|Not meeting screening eligibility|9|||
128812990|NCT04016662|463612629|FG000|Run-In Phase|Physician Decision|3|||
128812991|NCT04016662|463612629|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
128812992|NCT04016662|463612629|FG000|PLGS (12 Weeks)|Death|1|||
128812993|NCT04016662|463612629|FG000|SAP (12 Weeks)|Death|1|||
128812994|NCT01802788|463612630|FG000|Overall Study|Withdrawal by Subject|102|||
128812995|NCT01802788|463612631|FG001|Overall Study|Withdrawal by Subject|5|||
128812996|NCT01802788|463612630|FG000|Overall Study|Death|382|||
128812997|NCT01802788|463612631|FG001|Overall Study|Death|18|||
128812998|NCT01802788|463612630|FG000|Overall Study|Lost to Follow-up|31|||
128812999|NCT01802788|463612631|FG001|Overall Study|Lost to Follow-up|2|||
128813000|NCT01802788|463612630|FG000|Overall Study|Physician Decision|3|||
128813001|NCT01802788|463612631|FG001|Overall Study|Physician Decision|0|||
128813002|NCT01802788|463612630|FG000|Overall Study|Patient Non-Compliance|1|||
128813003|NCT01802788|463612631|FG001|Overall Study|Patient Non-Compliance|0|||
128813004|NCT01802788|463612630|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
128813005|NCT01802788|463612631|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
128813006|NCT01802788|463612630|FG000|Overall Study|Other Reasons|19|||
128813007|NCT01802788|463612631|FG001|Overall Study|Other Reasons|0|||
128813008|NCT03021096|463612632|FG000|Overall Study|Lost to Follow-up|4|||
128813009|NCT03021096|463612632|FG000|Overall Study|Protocol Violation|2|||
128813010|NCT03904147|463612637|FG000|Overall Study|Death|15|||
128813011|NCT03904147|463612638|FG001|Overall Study|Death|13|||
128813012|NCT03904147|463612639|FG002|Overall Study|Death|15|||
128813013|NCT03904147|463612637|FG000|Overall Study|Withdrawal by Subject|7|||
128813014|NCT03904147|463612638|FG001|Overall Study|Withdrawal by Subject|12|||
128813015|NCT03904147|463612639|FG002|Overall Study|Withdrawal by Subject|1|||
128813016|NCT03904147|463612637|FG000|Overall Study|1Y visit completed after 365 days|1|||
128813017|NCT03904147|463612638|FG001|Overall Study|1Y visit completed after 365 days|1|||
128813018|NCT03904147|463612639|FG002|Overall Study|1Y visit completed after 365 days|0|||
128813019|NCT00764751|463612647|FG000|Overall Study|Adverse Event|1|||
128813020|NCT00764751|463612648|FG001|Overall Study|Adverse Event|1|||
128813021|NCT00764751|463612647|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
128813022|NCT00764751|463612648|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
128813023|NCT03011333|463612654|FG000|Overall Study|Lost to Follow-up|0|||
128813024|NCT03011333|463612655|FG001|Overall Study|Lost to Follow-up|1|||
128813025|NCT03011333|463612656|FG002|Overall Study|Lost to Follow-up|0|||
128813026|NCT03011333|463612657|FG003|Overall Study|Lost to Follow-up|1|||
128813027|NCT03011333|463612658|FG004|Overall Study|Lost to Follow-up|4|||
128813028|NCT03011333|463612659|FG005|Overall Study|Lost to Follow-up|4|||
128813029|NCT03011333|463612660|FG006|Overall Study|Lost to Follow-up|5|||
128813030|NCT02998268|463612664|FG000|Overall Study|Adverse Event|0|||
128813031|NCT02998268|463612665|FG001|Overall Study|Adverse Event|2|||
128813032|NCT02998268|463612664|FG000|Overall Study|Withdrawal by Subject|0|||
128813033|NCT02998268|463612665|FG001|Overall Study|Withdrawal by Subject|1|||
128813034|NCT05269667|463612666|FG000|Overall Study|Study Terminated by Sponsor|4|||
128813035|NCT04413708|463612667|FG000|Overall Study|Lost to Follow-up|1|||
128813036|NCT04413708|463612668|FG001|Overall Study|Lost to Follow-up|2|||
128813037|NCT05399459|463612675|FG000|Overall Study|Randomized but not treated|29|||
128813038|NCT05399459|463612676|FG001|Overall Study|Randomized but not treated|30|||
128813039|NCT05399459|463612677|FG002|Overall Study|Randomized but not treated|38|||
128813040|NCT05399459|463612675|FG000|Overall Study|Lost to Follow-up|1|||
128813041|NCT05399459|463612676|FG001|Overall Study|Lost to Follow-up|0|||
128813042|NCT05399459|463612677|FG002|Overall Study|Lost to Follow-up|0|||
128813043|NCT03020199|463612680|FG000|Treatment Period|Adverse Event|0|||
128813044|NCT03020199|463612681|FG001|Treatment Period|Adverse Event|2|||
128813045|NCT03020199|463612680|FG000|Treatment Period|Lack of Efficacy|1|||
128813046|NCT03020199|463612681|FG001|Treatment Period|Lack of Efficacy|6|||
128813047|NCT03020199|463612680|FG000|Treatment Period|Lost to Follow-up|1|||
128813048|NCT03020199|463612681|FG001|Treatment Period|Lost to Follow-up|6|||
128813049|NCT03020199|463612680|FG000|Treatment Period|Physician Decision|0|||
128813050|NCT03020199|463612681|FG001|Treatment Period|Physician Decision|1|||
128813051|NCT03020199|463612680|FG000|Treatment Period|Subject/guardian decision|8|||
128813052|NCT03020199|463612681|FG001|Treatment Period|Subject/guardian decision|15|||
128813053|NCT03020199|463612680|FG000|Treatment Period|Subjects not treated|3|||
128813054|NCT03020199|463612681|FG001|Treatment Period|Subjects not treated|4|||
128813055|NCT03020199|463612680|FG000|Follow-up Period|Disease relapse|32|||
128813056|NCT03020199|463612681|FG001|Follow-up Period|Disease relapse|7|||
128813057|NCT03020199|463612680|FG000|Follow-up Period|Lack of Efficacy|1|||
128813058|NCT03020199|463612681|FG001|Follow-up Period|Lack of Efficacy|2|||
128813059|NCT03020199|463612680|FG000|Follow-up Period|Lost to Follow-up|4|||
128813060|NCT03020199|463612681|FG001|Follow-up Period|Lost to Follow-up|6|||
128813061|NCT03020199|463612680|FG000|Follow-up Period|Physician Decision|2|||
128813062|NCT03020199|463612681|FG001|Follow-up Period|Physician Decision|2|||
128813063|NCT03020199|463612680|FG000|Follow-up Period|Protocol Violation|1|||
128813064|NCT03020199|463612681|FG001|Follow-up Period|Protocol Violation|2|||
128813065|NCT03020199|463612680|FG000|Follow-up Period|Study terminated by Sponsor|6|||
128813066|NCT03020199|463612681|FG001|Follow-up Period|Study terminated by Sponsor|3|||
128813067|NCT03020199|463612680|FG000|Follow-up Period|Subject/guardian decision|14|||
128813068|NCT03020199|463612681|FG001|Follow-up Period|Subject/guardian decision|9|||
128813069|NCT05583578|463612682|FG000|Overall Study|Withdrawal by Subject|2|||
128813070|NCT05583578|463612683|FG001|Overall Study|Withdrawal by Subject|0|||
128813071|NCT05201079|463612684|FG000|Overall Study|Adverse Event|7|||
128813072|NCT05201079|463612685|FG001|Overall Study|Adverse Event|11|||
128813073|NCT05201079|463612684|FG000|Overall Study|Death|1|||
128813074|NCT05201079|463612685|FG001|Overall Study|Death|1|||
128813075|NCT05201079|463612684|FG000|Overall Study|Lack of Efficacy|0|||
128813076|NCT05201079|463612685|FG001|Overall Study|Lack of Efficacy|2|||
128813077|NCT05201079|463612684|FG000|Overall Study|Lost to Follow-up|0|||
128813078|NCT05201079|463612685|FG001|Overall Study|Lost to Follow-up|1|||
128813079|NCT05201079|463612684|FG000|Overall Study|Physician Decision|1|||
128813080|NCT05201079|463612685|FG001|Overall Study|Physician Decision|1|||
128813081|NCT05201079|463612684|FG000|Overall Study|Protocol Violation|1|||
128813082|NCT05201079|463612685|FG001|Overall Study|Protocol Violation|0|||
128813083|NCT05201079|463612684|FG000|Overall Study|Withdrawal by Subject|1|||
128813084|NCT05201079|463612685|FG001|Overall Study|Withdrawal by Subject|0|||
128813085|NCT05201079|463612684|FG000|Overall Study|Forbidden medication|9|||
128813086|NCT05201079|463612685|FG001|Overall Study|Forbidden medication|5|||
128813087|NCT05201079|463612684|FG000|Overall Study|Transfer to another hospital|0|||
128813088|NCT05201079|463612685|FG001|Overall Study|Transfer to another hospital|1|||
128813089|NCT05201079|463612684|FG000|Overall Study|Clinical condition|1|||
128813090|NCT05201079|463612685|FG001|Overall Study|Clinical condition|0|||
128813091|NCT05201079|463612684|FG000|Overall Study|SAE and sepsis|1|||
128813092|NCT05201079|463612685|FG001|Overall Study|SAE and sepsis|0|||
128813093|NCT04907851|463612686|FG000|Overall Study|Consent withdrawn|1|||
128813094|NCT04907851|463612687|FG001|Overall Study|Consent withdrawn|2|||
128813095|NCT04907851|463612688|FG002|Overall Study|Consent withdrawn|0|||
128813096|NCT04907851|463612686|FG000|Overall Study|Death|5|||
128813097|NCT04907851|463612687|FG001|Overall Study|Death|15|||
128813098|NCT04907851|463612688|FG002|Overall Study|Death|10|||
128813099|NCT01210807|463612695|FG000|Overall Study|Lost to Follow-up|1|||
128813100|NCT01210807|463612696|FG001|Overall Study|Lost to Follow-up|2|||
128813101|NCT01210807|463612695|FG000|Overall Study|Not implanted bilaterally|2|||
128813102|NCT01210807|463612696|FG001|Overall Study|Not implanted bilaterally|1|||
128813103|NCT05477186|463612701|FG000|Overall Study|Vaccine not administered|0|||
128813104|NCT05477186|463612702|FG001|Overall Study|Vaccine not administered|2|||
128813105|NCT05477186|463612703|FG002|Overall Study|Vaccine not administered|1|||
128813106|NCT05477186|463612704|FG003|Overall Study|Vaccine not administered|0|||
128813107|NCT05477186|463612705|FG004|Overall Study|Vaccine not administered|1|||
128813108|NCT05477186|463612706|FG005|Overall Study|Vaccine not administered|0|||
128813109|NCT05477186|463612707|FG006|Overall Study|Vaccine not administered|0|||
128813110|NCT05477186|463612701|FG000|Overall Study|Withdrawal by Subject|1|||
128813111|NCT05477186|463612702|FG001|Overall Study|Withdrawal by Subject|0|||
128813112|NCT05477186|463612703|FG002|Overall Study|Withdrawal by Subject|0|||
128813113|NCT05477186|463612704|FG003|Overall Study|Withdrawal by Subject|0|||
128813114|NCT05477186|463612705|FG004|Overall Study|Withdrawal by Subject|0|||
128813115|NCT05477186|463612706|FG005|Overall Study|Withdrawal by Subject|1|||
128813116|NCT05477186|463612707|FG006|Overall Study|Withdrawal by Subject|0|||
128813117|NCT05477186|463612701|FG000|Overall Study|Lost to Follow-up|1|||
128813118|NCT05477186|463612702|FG001|Overall Study|Lost to Follow-up|0|||
128813119|NCT05477186|463612703|FG002|Overall Study|Lost to Follow-up|2|||
128813120|NCT05477186|463612704|FG003|Overall Study|Lost to Follow-up|1|||
128813121|NCT05477186|463612705|FG004|Overall Study|Lost to Follow-up|1|||
128813122|NCT05477186|463612706|FG005|Overall Study|Lost to Follow-up|0|||
128813123|NCT05477186|463612707|FG006|Overall Study|Lost to Follow-up|2|||
128813124|NCT00324805|463612708|FG000|Overall Study|Adverse Event|62|||
128813125|NCT00324805|463612709|FG001|Overall Study|Adverse Event|203|||
128813126|NCT00324805|463612708|FG000|Overall Study|Progression|7|||
128813127|NCT00324805|463612709|FG001|Overall Study|Progression|35|||
128813128|NCT00324805|463612708|FG000|Overall Study|Withdrawal by Subject|51|||
128813129|NCT00324805|463612709|FG001|Overall Study|Withdrawal by Subject|174|||
128813130|NCT00324805|463612708|FG000|Overall Study|Death|6|||
128813131|NCT00324805|463612709|FG001|Overall Study|Death|9|||
128813132|NCT00324805|463612708|FG000|Overall Study|Alternative therapy|4|||
128813133|NCT00324805|463612709|FG001|Overall Study|Alternative therapy|8|||
128813134|NCT00324805|463612708|FG000|Overall Study|Other complicating disease|1|||
128813135|NCT00324805|463612709|FG001|Overall Study|Other complicating disease|9|||
128813136|NCT00324805|463612708|FG000|Overall Study|Other reasons|7|||
128813137|NCT00324805|463612709|FG001|Overall Study|Other reasons|26|||
128813138|NCT00324805|463612708|FG000|Overall Study|Other|0|||
128813139|NCT00324805|463612709|FG001|Overall Study|Other|2|||
128813140|NCT00324805|463612708|FG000|Overall Study|Did not start therapy|12|||
128813141|NCT00324805|463612709|FG001|Overall Study|Did not start therapy|17|||
128813142|NCT05792085|463612711|FG000|Overall Study|Death|0|||
128813143|NCT05792085|463612712|FG001|Overall Study|Death|0|||
128813144|NCT05792085|463612713|FG002|Overall Study|Death|0|||
128813145|NCT05792085|463612714|FG003|Overall Study|Death|0|||
128813146|NCT05792085|463612715|FG004|Overall Study|Death|1|||
128813147|NCT01919554|463612716|FG000|Overall Study|Withdrawal by Subject|0|||
128813148|NCT01919554|463612717|FG001|Overall Study|Withdrawal by Subject|0|||
128813149|NCT01919554|463612718|FG002|Overall Study|Withdrawal by Subject|1|||
128813150|NCT01919554|463612719|FG003|Overall Study|Withdrawal by Subject|1|||
128813151|NCT01544114|463612724|FG000|Overall Study|Withdrawal by Subject|0|||
128813152|NCT01544114|463612725|FG001|Overall Study|Withdrawal by Subject|0|||
128813153|NCT01544114|463612726|FG002|Overall Study|Withdrawal by Subject|3|||
128813154|NCT01544114|463612724|FG000|Overall Study|Lost to Follow-up|0|||
128813155|NCT01544114|463612725|FG001|Overall Study|Lost to Follow-up|2|||
128813156|NCT01544114|463612726|FG002|Overall Study|Lost to Follow-up|0|||
128813157|NCT01544114|463612724|FG000|Overall Study|Adverse Event|1|||
128813158|NCT01544114|463612725|FG001|Overall Study|Adverse Event|1|||
128813159|NCT01544114|463612726|FG002|Overall Study|Adverse Event|2|||
128813160|NCT01544114|463612724|FG000|Overall Study|Protocol Violation|0|||
128813161|NCT01544114|463612725|FG001|Overall Study|Protocol Violation|1|||
128813162|NCT01544114|463612726|FG002|Overall Study|Protocol Violation|0|||
128813163|NCT01733316|463612729|FG000|RP103 Phase|Non-compliance|1|||
128813164|NCT01733316|463612729|FG000|Long Term Extension Phase|Adverse Event|1|||
128813165|NCT01733316|463612729|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
128813166|NCT01733316|463612729|FG000|Long Term Extension Phase|Sponsor Decision|2|||
128813167|NCT00433329|463614245|FG000|Overall Study|Adverse Event|9|||
128813168|NCT00433329|463614245|FG000|Overall Study|Death|4|||
128813169|NCT00433329|463614245|FG000|Overall Study|Withdrew consent|3|||
128813170|NCT00433329|463614245|FG000|Overall Study|Discontinued sildenafil|2|||
128813171|NCT00433329|463614245|FG000|Overall Study|Moved out of state|1|||
128813172|NCT00433329|463614245|FG000|Overall Study|Lost to Follow-up|1|||
128813173|NCT00433329|463614245|FG000|Overall Study|Physician Decision|1|||
128813174|NCT03381196|463614246|FG000|Overall Study|Withdrawal by Subject|7|||
128813175|NCT03381196|463614247|FG001|Overall Study|Withdrawal by Subject|7|||
128813176|NCT03381196|463614246|FG000|Overall Study|Other|0|||
128813177|NCT03381196|463614247|FG001|Overall Study|Other|1|||
128813178|NCT03381196|463614246|FG000|Overall Study|Lost to Follow-up|5|||
128813179|NCT03381196|463614247|FG001|Overall Study|Lost to Follow-up|4|||
128813180|NCT03381196|463614246|FG000|Overall Study|Death|0|||
128813181|NCT03381196|463614247|FG001|Overall Study|Death|1|||
128813182|NCT03381196|463614246|FG000|Overall Study|Adverse Event|1|||
128813183|NCT03381196|463614247|FG001|Overall Study|Adverse Event|0|||
128813184|NCT03381196|463614246|FG000|Overall Study|Randomized, not treated|3|||
128813185|NCT03381196|463614247|FG001|Overall Study|Randomized, not treated|6|||
128813186|NCT04044768|463614249|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
128813187|NCT04044768|463614250|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
128813188|NCT01574274|463614251|FG000|Overall Study|Ineligible|0|||
128813189|NCT01574274|463614252|FG001|Overall Study|Ineligible|1|||
128813190|NCT01574274|463614251|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
128813191|NCT01574274|463614252|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
128813192|NCT01574274|463614251|FG000|Overall Study|Ph+ B-ALL|3|||
128813193|NCT01574274|463614252|FG001|Overall Study|Ph+ B-ALL|4|||
128813194|NCT01574274|463614251|FG000|Overall Study|Induction Death|2|||
128813195|NCT01574274|463614252|FG001|Overall Study|Induction Death|0|||
128813196|NCT01574274|463614251|FG000|Overall Study|Induction Failure|4|||
128813197|NCT01574274|463614252|FG001|Overall Study|Induction Failure|1|||
128813198|NCT01574274|463614251|FG000|Overall Study|Adverse Event|16|||
128813199|NCT01574274|463614252|FG001|Overall Study|Adverse Event|13|||
128813200|NCT01574274|463614251|FG000|Overall Study|Remission Death|1|||
128813201|NCT01574274|463614252|FG001|Overall Study|Remission Death|0|||
128813202|NCT01574274|463614251|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
128813203|NCT01574274|463614252|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
128813204|NCT01574274|463614251|FG000|Overall Study|Other, unknown|3|||
128813205|NCT01574274|463614252|FG001|Overall Study|Other, unknown|2|||
128813206|NCT05089019|463614253|FG000|Period 1|Withdrawal by Subject|0|||
128813207|NCT05089019|463614254|FG001|Period 1|Withdrawal by Subject|1|||
128813208|NCT05089019|463614253|FG000|Washout Period|Adverse Event|3|||
128813209|NCT05089019|463614254|FG001|Washout Period|Adverse Event|4|||
128813210|NCT05089019|463614253|FG000|Washout Period|Lost to Follow-up|1|||
128813211|NCT05089019|463614254|FG001|Washout Period|Lost to Follow-up|0|||
128813212|NCT05089019|463614253|FG000|Washout Period|Physician Decision|2|||
128813213|NCT05089019|463614254|FG001|Washout Period|Physician Decision|0|||
128813214|NCT05089019|463614253|FG000|Washout Period|Withdrawal by Subject|6|||
128813215|NCT05089019|463614254|FG001|Washout Period|Withdrawal by Subject|3|||
128813216|NCT05089019|463614253|FG000|Period 2|Adverse Event|4|||
128813217|NCT05089019|463614254|FG001|Period 2|Adverse Event|2|||
128813218|NCT05089019|463614253|FG000|Period 2|Lost to Follow-up|1|||
128813219|NCT05089019|463614254|FG001|Period 2|Lost to Follow-up|0|||
128813220|NCT05089019|463614253|FG000|Period 2|Withdrawal by Subject|0|||
128813221|NCT05089019|463614254|FG001|Period 2|Withdrawal by Subject|1|||
128813222|NCT01593917|463614255|FG000|Overall Study|Death|67|||
128813223|NCT01593917|463614255|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
128813224|NCT01593917|463614255|FG000|Overall Study|Withdrawal by Subject|23|||
128813225|NCT01593917|463614255|FG000|Overall Study|Lost to Follow-up|12|||
128813226|NCT01593917|463614255|FG000|Overall Study|Protocol Violation|5|||
128813227|NCT01593917|463614255|FG000|Overall Study|Physician Decision|3|||
128813228|NCT02043678|463614260|FG000|Overall Study|Never treated|11|||
128813229|NCT02043678|463614261|FG001|Overall Study|Never treated|9|||
128813230|NCT02043678|463614260|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
128813231|NCT02043678|463614261|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
128813232|NCT02043678|463614260|FG000|Overall Study|AE without clinical PD|54|||
128813233|NCT02043678|463614261|FG001|Overall Study|AE without clinical PD|36|||
128813234|NCT02043678|463614260|FG000|Overall Study|Lost to Follow-up|1|||
128813235|NCT02043678|463614261|FG001|Overall Study|Lost to Follow-up|1|||
128813236|NCT02043678|463614260|FG000|Overall Study|Other|10|||
128813237|NCT02043678|463614261|FG001|Overall Study|Other|14|||
128813238|NCT02043678|463614260|FG000|Overall Study|Clinical PD|114|||
128813239|NCT02043678|463614261|FG001|Overall Study|Clinical PD|148|||
128813240|NCT02043678|463614260|FG000|Overall Study|Radiological PD|100|||
128813241|NCT02043678|463614261|FG001|Overall Study|Radiological PD|90|||
128813242|NCT02043678|463614260|FG000|Overall Study|Protocol-driven decision point|59|||
128813243|NCT02043678|463614261|FG001|Overall Study|Protocol-driven decision point|58|||
128813244|NCT02043678|463614260|FG000|Overall Study|Withdrawal by Subject|16|||
128813245|NCT02043678|463614261|FG001|Overall Study|Withdrawal by Subject|20|||
128813246|NCT02043678|463614260|FG000|Overall Study|Protocol Violation|1|||
128813247|NCT02043678|463614261|FG001|Overall Study|Protocol Violation|0|||
128813248|NCT02043678|463614260|FG000|Overall Study|Deterioration of general conditions|1|||
128813249|NCT02043678|463614261|FG001|Overall Study|Deterioration of general conditions|1|||
128813250|NCT02043678|463614260|FG000|Overall Study|Logistical difficulties|2|||
128813251|NCT02043678|463614261|FG001|Overall Study|Logistical difficulties|0|||
128813252|NCT02043678|463614260|FG000|Overall Study|Non-compliance with study drug|3|||
128813253|NCT02043678|463614261|FG001|Overall Study|Non-compliance with study drug|1|||
128813254|NCT02043678|463614260|FG000|Overall Study|Physician Decision|4|||
128813255|NCT02043678|463614261|FG001|Overall Study|Physician Decision|3|||
128813256|NCT02043678|463614260|FG000|Overall Study|Subject decision|0|||
128813257|NCT02043678|463614261|FG001|Overall Study|Subject decision|1|||
128813258|NCT02043678|463614260|FG000|Overall Study|Switching to other therapy|3|||
128813259|NCT02043678|463614261|FG001|Overall Study|Switching to other therapy|2|||
128813260|NCT02043678|463614260|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
128813261|NCT02043678|463614261|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
128813262|NCT02043678|463614260|FG000|Overall Study|Missing|1|||
128813263|NCT02043678|463614261|FG001|Overall Study|Missing|0|||
128813264|NCT02043678|463614260|FG000|Overall Study|Adverse Event|0|||
128813265|NCT02043678|463614261|FG001|Overall Study|Adverse Event|1|||
128813266|NCT05543629|463614262|FG000|Overall Study|Death|1|||
128813267|NCT05543629|463614263|FG001|Overall Study|Death|0|||
128813268|NCT05543629|463614264|FG002|Overall Study|Death|1|||
128813269|NCT05543629|463614265|FG003|Overall Study|Death|0|||
128813270|NCT05543629|463614266|FG004|Overall Study|Death|0|||
128813271|NCT05543629|463614267|FG005|Overall Study|Death|1|||
128813272|NCT05543629|463614268|FG006|Overall Study|Death|2|||
128813273|NCT05543629|463614269|FG007|Overall Study|Death|2|||
128813274|NCT05543629|463614262|FG000|Overall Study|Other Reasons|0|||
128813275|NCT05543629|463614263|FG001|Overall Study|Other Reasons|0|||
128813276|NCT05543629|463614264|FG002|Overall Study|Other Reasons|0|||
128813277|NCT05543629|463614265|FG003|Overall Study|Other Reasons|0|||
128813278|NCT05543629|463614266|FG004|Overall Study|Other Reasons|1|||
128813279|NCT05543629|463614267|FG005|Overall Study|Other Reasons|0|||
128813280|NCT05543629|463614268|FG006|Overall Study|Other Reasons|0|||
128813281|NCT05543629|463614269|FG007|Overall Study|Other Reasons|0|||
128813282|NCT05543629|463614262|FG000|Overall Study|Physician Decision|0|||
128813283|NCT05543629|463614263|FG001|Overall Study|Physician Decision|0|||
128813284|NCT05543629|463614264|FG002|Overall Study|Physician Decision|3|||
128813285|NCT05543629|463614265|FG003|Overall Study|Physician Decision|0|||
128813286|NCT05543629|463614266|FG004|Overall Study|Physician Decision|0|||
128813287|NCT05543629|463614267|FG005|Overall Study|Physician Decision|0|||
128813288|NCT05543629|463614268|FG006|Overall Study|Physician Decision|1|||
128813289|NCT05543629|463614269|FG007|Overall Study|Physician Decision|0|||
128813290|NCT05543629|463614262|FG000|Overall Study|Study terminated by Sponsor|1|||
128813291|NCT05543629|463614263|FG001|Overall Study|Study terminated by Sponsor|0|||
128813292|NCT05543629|463614264|FG002|Overall Study|Study terminated by Sponsor|0|||
128813293|NCT05543629|463614265|FG003|Overall Study|Study terminated by Sponsor|1|||
128813294|NCT05543629|463614266|FG004|Overall Study|Study terminated by Sponsor|0|||
128813295|NCT05543629|463614267|FG005|Overall Study|Study terminated by Sponsor|4|||
128813296|NCT05543629|463614268|FG006|Overall Study|Study terminated by Sponsor|1|||
128813297|NCT05543629|463614269|FG007|Overall Study|Study terminated by Sponsor|0|||
128813298|NCT05543629|463614262|FG000|Overall Study|Withdrawal by Subject|1|||
128813299|NCT05543629|463614263|FG001|Overall Study|Withdrawal by Subject|1|||
128813300|NCT05543629|463614264|FG002|Overall Study|Withdrawal by Subject|0|||
128813301|NCT05543629|463614265|FG003|Overall Study|Withdrawal by Subject|2|||
128813302|NCT05543629|463614266|FG004|Overall Study|Withdrawal by Subject|1|||
128813303|NCT05543629|463614267|FG005|Overall Study|Withdrawal by Subject|1|||
128813304|NCT05543629|463614268|FG006|Overall Study|Withdrawal by Subject|1|||
128813305|NCT05543629|463614269|FG007|Overall Study|Withdrawal by Subject|1|||
128813306|NCT05543629|463614262|FG000|Overall Study|Not Reported|2|||
128813307|NCT05543629|463614263|FG001|Overall Study|Not Reported|2|||
128813308|NCT05543629|463614264|FG002|Overall Study|Not Reported|0|||
128813309|NCT05543629|463614265|FG003|Overall Study|Not Reported|0|||
128813310|NCT05543629|463614266|FG004|Overall Study|Not Reported|1|||
128813311|NCT05543629|463614267|FG005|Overall Study|Not Reported|1|||
128813312|NCT05543629|463614268|FG006|Overall Study|Not Reported|3|||
128813313|NCT05543629|463614269|FG007|Overall Study|Not Reported|0|||
128813314|NCT03216057|463614270|FG000|Overall Study|Lost to Follow-up|2|||
128813315|NCT03216057|463614271|FG001|Overall Study|Lost to Follow-up|2|||
128813316|NCT04568603|463614272|FG000|Overall Study|Physician Decision|1|||
128813317|NCT04564742|463614273|FG000|Overall Study|Lost to Follow-up|1|||
128813318|NCT04564742|463614274|FG001|Overall Study|Lost to Follow-up|0|||
128813319|NCT04564742|463614273|FG000|Overall Study|Consent Withdrawal|4|||
128813320|NCT04564742|463614274|FG001|Overall Study|Consent Withdrawal|4|||
128813321|NCT03313076|463614278|FG000|Overall Study|Withdrawal by Subject|2|||
128813322|NCT03313076|463614279|FG001|Overall Study|Withdrawal by Subject|0|||
128813323|NCT03313076|463614280|FG002|Overall Study|Withdrawal by Subject|0|||
128813324|NCT03313076|463614281|FG003|Overall Study|Withdrawal by Subject|0|||
128813325|NCT03313076|463614278|FG000|Overall Study|Lost to Follow-up|0|||
128813326|NCT03313076|463614279|FG001|Overall Study|Lost to Follow-up|2|||
128813327|NCT03313076|463614280|FG002|Overall Study|Lost to Follow-up|2|||
128813328|NCT03313076|463614281|FG003|Overall Study|Lost to Follow-up|2|||
128813329|NCT04307355|463614287|FG000|Overall Study|Non-Compliance|3|||
128813330|NCT04307355|463614288|FG001|Overall Study|Non-Compliance|3|||
128813331|NCT04307355|463614289|FG002|Overall Study|Non-Compliance|0|||
128813332|NCT04225273|463614291|FG000|Overall Study|Lost to Follow-up|3|||
128813333|NCT05270408|463614293|FG000|Started Treatment|Withdrawal by Subject|0|||
128813334|NCT05270408|463614294|FG001|Started Treatment|Withdrawal by Subject|0|||
128813335|NCT05270408|463614295|FG002|Started Treatment|Withdrawal by Subject|3|||
128813336|NCT05270408|463614293|FG000|Started Treatment|Adverse Event|0|||
128813337|NCT05270408|463614294|FG001|Started Treatment|Adverse Event|0|||
128813338|NCT05270408|463614295|FG002|Started Treatment|Adverse Event|1|||
128813339|NCT05270408|463614293|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
128813340|NCT05270408|463614294|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
128813341|NCT05270408|463614295|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
128813342|NCT02465268|463614297|FG000|Overall Study|Withdrawal by Subject|4|||
128813343|NCT02465268|463614298|FG001|Overall Study|Withdrawal by Subject|3|||
128813344|NCT02465268|463614299|FG002|Overall Study|Withdrawal by Subject|1|||
128813345|NCT02465268|463614297|FG000|Overall Study|Not evaluable per protocol criteria|3|||
128813346|NCT02465268|463614298|FG001|Overall Study|Not evaluable per protocol criteria|2|||
128813347|NCT02465268|463614299|FG002|Overall Study|Not evaluable per protocol criteria|1|||
128813348|NCT02465268|463614297|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
128813349|NCT02465268|463614298|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
128813350|NCT02465268|463614299|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
128813351|NCT02465268|463614297|FG000|Overall Study|Study drug did not pass QA/QC|1|||
128813352|NCT02465268|463614298|FG001|Overall Study|Study drug did not pass QA/QC|0|||
128813353|NCT02465268|463614299|FG002|Overall Study|Study drug did not pass QA/QC|0|||
128813354|NCT02465268|463614297|FG000|Overall Study|Adverse Event|0|||
128813355|NCT02465268|463614298|FG001|Overall Study|Adverse Event|1|||
128813356|NCT02465268|463614299|FG002|Overall Study|Adverse Event|0|||
128813357|NCT02465268|463614297|FG000|Overall Study|Physician Decision|0|||
128813358|NCT02465268|463614298|FG001|Overall Study|Physician Decision|1|||
128813359|NCT02465268|463614299|FG002|Overall Study|Physician Decision|0|||
128813360|NCT03133546|463614300|FG000|Overall Study|Death|46|||
128813361|NCT03133546|463614301|FG001|Overall Study|Death|43|||
128813362|NCT03133546|463614300|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
128813363|NCT03133546|463614301|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
128813364|NCT06103188|463614304|FG000|Overall Study|Lost to Follow-up|1|||
128813365|NCT06103188|463614305|FG001|Overall Study|Lost to Follow-up|6|||
128813366|NCT06103188|463614306|FG002|Overall Study|Lost to Follow-up|4|||
128813367|NCT01175356|463614309|FG000|Overall Study|Death|1|||
128813368|NCT01175356|463614309|FG000|Overall Study|Lack of Efficacy|12|||
128813369|NCT01175356|463614309|FG000|Overall Study|Lost to Follow-up|1|||
128813370|NCT01175356|463614309|FG000|Overall Study|Physician Decision|23|||
128813371|NCT01175356|463614309|FG000|Overall Study|Ineligible|1|||
128813372|NCT01175356|463614309|FG000|Overall Study|Treatment Slot Not Available|18|||
128813373|NCT01175356|463614309|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
128813374|NCT01175356|463614309|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
128813375|NCT01175356|463614309|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
128813376|NCT01175356|463614309|FG000|Overall Study|Inadequate stem cell for transplant|1|||
128813377|NCT01175356|463614309|FG000|Overall Study|Initiation other tx prior to completion|9|||
128813378|NCT04005794|463614314|FG000|Overall Study|Lost to Follow-up|0|||
128813379|NCT04005794|463614315|FG001|Overall Study|Lost to Follow-up|4|||
128813380|NCT04005794|463614316|FG002|Overall Study|Lost to Follow-up|0|||
128813381|NCT04313972|463614319|FG000|Overall Study|Withdrawal by Subject|0|||
128813382|NCT04313972|463614320|FG001|Overall Study|Withdrawal by Subject|1|||
128813383|NCT05386030|463614334|FG000|Overall Study|Death|1|||
128813384|NCT05386030|463614335|FG001|Overall Study|Death|0|||
128813385|NCT05386030|463614334|FG000|Overall Study|Physician Decision|2|||
128813386|NCT05386030|463614335|FG001|Overall Study|Physician Decision|1|||
128813387|NCT05386030|463614334|FG000|Overall Study|Lost to Follow-up|19|||
128813388|NCT05386030|463614335|FG001|Overall Study|Lost to Follow-up|7|||
128813389|NCT05386030|463614334|FG000|Overall Study|Withdrawal by Subject|20|||
128813390|NCT05386030|463614335|FG001|Overall Study|Withdrawal by Subject|10|||
128813391|NCT05386030|463614334|FG000|Overall Study|Eligibility criteria violation|1|||
128813392|NCT05386030|463614335|FG001|Overall Study|Eligibility criteria violation|1|||
128813393|NCT05386030|463614334|FG000|Overall Study|Personal Reasons|1|||
128813394|NCT05386030|463614335|FG001|Overall Study|Personal Reasons|0|||
128813395|NCT04524442|463614336|FG000|Overall Study|Subject Decision|1|||
128813396|NCT04719832|463614337|FG000|Overall Study|Adverse Event|2|||
128813397|NCT04719832|463614338|FG001|Overall Study|Adverse Event|0|||
128813398|NCT04719832|463614337|FG000|Overall Study|Lack of Efficacy|2|||
128813399|NCT04719832|463614338|FG001|Overall Study|Lack of Efficacy|4|||
128813400|NCT04719832|463614337|FG000|Overall Study|Lost to Follow-up|0|||
128813401|NCT04719832|463614338|FG001|Overall Study|Lost to Follow-up|2|||
128813402|NCT04719832|463614337|FG000|Overall Study|Physician Decision|0|||
128813403|NCT04719832|463614338|FG001|Overall Study|Physician Decision|1|||
128813404|NCT04719832|463614337|FG000|Overall Study|Pregnancy|1|||
128813405|NCT04719832|463614338|FG001|Overall Study|Pregnancy|1|||
128813406|NCT04719832|463614337|FG000|Overall Study|Withdrawal by Subject|5|||
128813407|NCT04719832|463614338|FG001|Overall Study|Withdrawal by Subject|5|||
128813408|NCT04719832|463614337|FG000|Overall Study|Randomized, not treated|0|||
128813409|NCT04719832|463614338|FG001|Overall Study|Randomized, not treated|2|||
128813410|NCT04719832|463614337|FG000|Overall Study|GCP violations|4|||
128813411|NCT04719832|463614338|FG001|Overall Study|GCP violations|7|||
128813412|NCT05228457|463614339|FG000|Overall Study|Withdrawal by Subject|1|||
128813413|NCT05228457|463614340|FG001|Overall Study|Withdrawal by Subject|1|||
128813414|NCT04880863|463614343|FG000|Overall Study|Adverse Event|1|||
128813415|NCT04880863|463614343|FG000|Overall Study|Patient decision|2|||
128813416|NCT04880863|463614343|FG000|Overall Study|Confirmed Disease Progression|15|||
128813417|NCT04880863|463614343|FG000|Overall Study|Death|3|||
128813418|NCT04880863|463614343|FG000|Overall Study|Physician Decision|4|||
128813419|NCT04880863|463614343|FG000|Overall Study|Unconfirmed Disease Progression|4|||
128813420|NCT04880863|463614343|FG000|Overall Study|Withdrawal by Subject|2|||
128813421|NCT04880863|463614343|FG000|Overall Study|Study discontinuation by the sponsor|4|||
128813422|NCT04880863|463614343|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
128813423|NCT04880863|463614343|FG000|Overall Study|Not received study drug NAP|2|||
128813424|NCT03213691|463614344|FG000|Overall Study|Adverse Event|2|||
128813425|NCT03213691|463614344|FG000|Overall Study|Death|3|||
128813426|NCT03213691|463614344|FG000|Overall Study|Physician Decision|1|||
128813427|NCT03213691|463614344|FG000|Overall Study|Progressive Disease|14|||
128813428|NCT03213691|463614344|FG000|Overall Study|Ineligible|1|||
128813429|NCT04898673|463614345|FG000|Overall Study|Screenfail|1|||
128813430|NCT04898673|463614346|FG001|Overall Study|Screenfail|0|||
128813431|NCT01152450|463614351|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
128813432|NCT01152450|463614352|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
128813433|NCT01152450|463614353|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
128813434|NCT01152450|463614354|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
128813435|NCT01152450|463614355|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
128813436|NCT01152450|463614356|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
128813437|NCT01152450|463614351|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
128813438|NCT01152450|463614352|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
128813439|NCT01152450|463614353|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
128813440|NCT01152450|463614354|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
128813441|NCT01152450|463614355|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
128813442|NCT01152450|463614356|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
128813443|NCT01152450|463614351|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128813444|NCT01152450|463614352|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
128813445|NCT01152450|463614353|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
128813446|NCT01152450|463614354|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128813447|NCT01152450|463614355|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128813448|NCT01152450|463614356|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
128813449|NCT03058289|463614360|FG000|Overall Study|Radiographic Deterioration|0|||
128813450|NCT03058289|463614361|FG001|Overall Study|Radiographic Deterioration|3|||
128813451|NCT03058289|463614362|FG002|Overall Study|Radiographic Deterioration|1|||
128813452|NCT03058289|463614363|FG003|Overall Study|Radiographic Deterioration|2|||
128813453|NCT03058289|463614364|FG004|Overall Study|Radiographic Deterioration|6|||
128813454|NCT03058289|463614365|FG005|Overall Study|Radiographic Deterioration|3|||
128813455|NCT03058289|463614366|FG006|Overall Study|Radiographic Deterioration|0|||
128813456|NCT03058289|463614367|FG007|Overall Study|Radiographic Deterioration|4|||
128813457|NCT03058289|463614368|FG008|Overall Study|Radiographic Deterioration|2|||
128813458|NCT03058289|463614360|FG000|Overall Study|Adverse Event|2|||
128813459|NCT03058289|463614361|FG001|Overall Study|Adverse Event|0|||
128813460|NCT03058289|463614362|FG002|Overall Study|Adverse Event|1|||
128813461|NCT03058289|463614363|FG003|Overall Study|Adverse Event|3|||
128813462|NCT03058289|463614364|FG004|Overall Study|Adverse Event|1|||
128813463|NCT03058289|463614365|FG005|Overall Study|Adverse Event|0|||
128813464|NCT03058289|463614366|FG006|Overall Study|Adverse Event|1|||
128813465|NCT03058289|463614367|FG007|Overall Study|Adverse Event|3|||
128813466|NCT03058289|463614368|FG008|Overall Study|Adverse Event|0|||
128813467|NCT03058289|463614360|FG000|Overall Study|Withdrawal by Subject|0|||
128813468|NCT03058289|463614361|FG001|Overall Study|Withdrawal by Subject|0|||
128813469|NCT03058289|463614362|FG002|Overall Study|Withdrawal by Subject|0|||
128813470|NCT03058289|463614363|FG003|Overall Study|Withdrawal by Subject|2|||
128813471|NCT03058289|463614364|FG004|Overall Study|Withdrawal by Subject|0|||
128813472|NCT03058289|463614365|FG005|Overall Study|Withdrawal by Subject|2|||
128813473|NCT03058289|463614366|FG006|Overall Study|Withdrawal by Subject|0|||
128813474|NCT03058289|463614367|FG007|Overall Study|Withdrawal by Subject|4|||
128813475|NCT03058289|463614368|FG008|Overall Study|Withdrawal by Subject|1|||
128813476|NCT03058289|463614360|FG000|Overall Study|Physician Decision|1|||
128813477|NCT03058289|463614361|FG001|Overall Study|Physician Decision|0|||
128813478|NCT03058289|463614362|FG002|Overall Study|Physician Decision|0|||
128813479|NCT03058289|463614363|FG003|Overall Study|Physician Decision|2|||
128813480|NCT03058289|463614364|FG004|Overall Study|Physician Decision|1|||
128813481|NCT03058289|463614365|FG005|Overall Study|Physician Decision|0|||
128813482|NCT03058289|463614366|FG006|Overall Study|Physician Decision|2|||
128813483|NCT03058289|463614367|FG007|Overall Study|Physician Decision|3|||
128813484|NCT03058289|463614368|FG008|Overall Study|Physician Decision|0|||
128813485|NCT03058289|463614360|FG000|Overall Study|Clinical Deterioration|2|||
128813486|NCT03058289|463614361|FG001|Overall Study|Clinical Deterioration|0|||
128813487|NCT03058289|463614362|FG002|Overall Study|Clinical Deterioration|0|||
128813488|NCT03058289|463614363|FG003|Overall Study|Clinical Deterioration|2|||
128813489|NCT03058289|463614364|FG004|Overall Study|Clinical Deterioration|1|||
128813490|NCT03058289|463614365|FG005|Overall Study|Clinical Deterioration|1|||
128813491|NCT03058289|463614366|FG006|Overall Study|Clinical Deterioration|0|||
128813492|NCT03058289|463614367|FG007|Overall Study|Clinical Deterioration|3|||
128813493|NCT03058289|463614368|FG008|Overall Study|Clinical Deterioration|2|||
128813494|NCT03058289|463614360|FG000|Overall Study|Lost to Follow-up|0|||
128813495|NCT03058289|463614361|FG001|Overall Study|Lost to Follow-up|0|||
128813496|NCT03058289|463614362|FG002|Overall Study|Lost to Follow-up|0|||
128813497|NCT03058289|463614363|FG003|Overall Study|Lost to Follow-up|0|||
128813498|NCT03058289|463614364|FG004|Overall Study|Lost to Follow-up|1|||
128813499|NCT03058289|463614365|FG005|Overall Study|Lost to Follow-up|0|||
128813500|NCT03058289|463614366|FG006|Overall Study|Lost to Follow-up|0|||
128813501|NCT03058289|463614367|FG007|Overall Study|Lost to Follow-up|0|||
128813502|NCT03058289|463614368|FG008|Overall Study|Lost to Follow-up|0|||
128813503|NCT03058289|463614360|FG000|Overall Study|Refused Further Treatment|0|||
128813504|NCT03058289|463614361|FG001|Overall Study|Refused Further Treatment|0|||
128813505|NCT03058289|463614362|FG002|Overall Study|Refused Further Treatment|1|||
128813506|NCT03058289|463614363|FG003|Overall Study|Refused Further Treatment|0|||
128813507|NCT03058289|463614364|FG004|Overall Study|Refused Further Treatment|1|||
128813508|NCT03058289|463614365|FG005|Overall Study|Refused Further Treatment|0|||
128813509|NCT03058289|463614366|FG006|Overall Study|Refused Further Treatment|0|||
128813510|NCT03058289|463614367|FG007|Overall Study|Refused Further Treatment|0|||
128813511|NCT03058289|463614368|FG008|Overall Study|Refused Further Treatment|0|||
128813512|NCT03058289|463614360|FG000|Overall Study|Rapid Progression of Disease|0|||
128813513|NCT03058289|463614361|FG001|Overall Study|Rapid Progression of Disease|0|||
128813514|NCT03058289|463614362|FG002|Overall Study|Rapid Progression of Disease|0|||
128813515|NCT03058289|463614363|FG003|Overall Study|Rapid Progression of Disease|1|||
128813516|NCT03058289|463614364|FG004|Overall Study|Rapid Progression of Disease|0|||
128813517|NCT03058289|463614365|FG005|Overall Study|Rapid Progression of Disease|0|||
128813518|NCT03058289|463614366|FG006|Overall Study|Rapid Progression of Disease|0|||
128813519|NCT03058289|463614367|FG007|Overall Study|Rapid Progression of Disease|0|||
128813520|NCT03058289|463614368|FG008|Overall Study|Rapid Progression of Disease|0|||
128813521|NCT05546411|463614369|FG000|Overall Study|Progressive Disease|1|||
128813522|NCT05546411|463614370|FG001|Overall Study|Progressive Disease|0|||
128813523|NCT05546411|463614369|FG000|Overall Study|Adverse Event|0|||
128813524|NCT05546411|463614370|FG001|Overall Study|Adverse Event|1|||
128813525|NCT05546411|463614369|FG000|Overall Study|Metastatic disease|1|||
128813526|NCT05546411|463614370|FG001|Overall Study|Metastatic disease|0|||
128813527|NCT02606422|463614371|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
128813528|NCT02606422|463614372|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
128813529|NCT02606422|463614371|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
128813530|NCT02606422|463614372|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
128813531|NCT02606422|463614371|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
128813532|NCT02606422|463614372|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
128813533|NCT02606422|463614371|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
128813534|NCT02606422|463614372|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
128813535|NCT04625465|463614373|FG000|Overall Study|Lost to Follow-up|2|||
128813536|NCT04625465|463614374|FG001|Overall Study|Lost to Follow-up|2|||
128813537|NCT04625465|463614375|FG002|Overall Study|Lost to Follow-up|1|||
128813538|NCT04625465|463614376|FG003|Overall Study|Lost to Follow-up|0|||
128813539|NCT04625465|463614377|FG004|Overall Study|Lost to Follow-up|0|||
128813540|NCT04625465|463614378|FG005|Overall Study|Lost to Follow-up|2|||
128813541|NCT04625465|463614379|FG006|Overall Study|Lost to Follow-up|0|||
128813542|NCT04625465|463614380|FG007|Overall Study|Lost to Follow-up|0|||
128813543|NCT04625465|463614373|FG000|Overall Study|Death|1|||
128813544|NCT04625465|463614374|FG001|Overall Study|Death|0|||
128813545|NCT04625465|463614375|FG002|Overall Study|Death|0|||
128813546|NCT04625465|463614376|FG003|Overall Study|Death|0|||
128813547|NCT04625465|463614377|FG004|Overall Study|Death|0|||
128813548|NCT04625465|463614378|FG005|Overall Study|Death|0|||
128813549|NCT04625465|463614379|FG006|Overall Study|Death|0|||
128813550|NCT04625465|463614380|FG007|Overall Study|Death|0|||
128813551|NCT04625465|463614373|FG000|Overall Study|Withdrawal by Subject|1|||
128813552|NCT04625465|463614374|FG001|Overall Study|Withdrawal by Subject|0|||
128813553|NCT04625465|463614375|FG002|Overall Study|Withdrawal by Subject|4|||
128813554|NCT04625465|463614376|FG003|Overall Study|Withdrawal by Subject|4|||
128813555|NCT04625465|463614377|FG004|Overall Study|Withdrawal by Subject|4|||
128813556|NCT04625465|463614378|FG005|Overall Study|Withdrawal by Subject|0|||
128813557|NCT04625465|463614379|FG006|Overall Study|Withdrawal by Subject|0|||
128813558|NCT04625465|463614380|FG007|Overall Study|Withdrawal by Subject|0|||
128813559|NCT05566639|463614383|FG000|Overall Study|Adverse Event|1|||
128813560|NCT05566639|463614384|FG001|Overall Study|Adverse Event|1|||
128813561|NCT05566639|463614383|FG000|Overall Study|Serious Adverse Event|1|||
128813562|NCT05566639|463614384|FG001|Overall Study|Serious Adverse Event|3|||
128813563|NCT05566639|463614383|FG000|Overall Study|Death|44|||
128813564|NCT05566639|463614384|FG001|Overall Study|Death|45|||
128813565|NCT05566639|463614383|FG000|Overall Study|Lost to Follow-up|467|||
128813566|NCT05566639|463614384|FG001|Overall Study|Lost to Follow-up|461|||
128813567|NCT05566639|463614383|FG000|Overall Study|Physician Decision|45|||
128813568|NCT05566639|463614384|FG001|Overall Study|Physician Decision|44|||
128813569|NCT05566639|463614383|FG000|Overall Study|Protocol Deviation|4|||
128813570|NCT05566639|463614384|FG001|Overall Study|Protocol Deviation|4|||
128813571|NCT05566639|463614383|FG000|Overall Study|Withdrawal by Subject|277|||
128813572|NCT05566639|463614384|FG001|Overall Study|Withdrawal by Subject|271|||
128813573|NCT05566639|463614383|FG000|Overall Study|Other Than Specified|52|||
128813574|NCT05566639|463614384|FG001|Overall Study|Other Than Specified|64|||
128813575|NCT04159415|463614386|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
128813576|NCT04159415|463614387|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
128813577|NCT04159415|463614388|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
128813578|NCT04159415|463614389|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
128813579|NCT04159415|463614390|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
128813580|NCT04159415|463614391|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
128813581|NCT04159415|463614392|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
128813582|NCT04159415|463614393|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
128813583|NCT03800654|463614394|FG000|Overall Study|Time constraints|3|||
128813584|NCT03800654|463614395|FG001|Overall Study|Time constraints|3|||
128813585|NCT03800654|463614396|FG002|Overall Study|Time constraints|3|||
128813586|NCT03800654|463614394|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
128813587|NCT03800654|463614395|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
128813588|NCT03800654|463614396|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
128813589|NCT03800654|463614394|FG000|Overall Study|Lost to Follow-up|2|||
128813590|NCT03800654|463614395|FG001|Overall Study|Lost to Follow-up|1|||
128813591|NCT03800654|463614396|FG002|Overall Study|Lost to Follow-up|6|||
128813592|NCT03800654|463614394|FG000|Overall Study|Medical Health Issue|0|||
128813593|NCT03800654|463614395|FG001|Overall Study|Medical Health Issue|0|||
128813594|NCT03800654|463614396|FG002|Overall Study|Medical Health Issue|1|||
128813595|NCT03800654|463614394|FG000|Overall Study|Personal Issues|0|||
128813596|NCT03800654|463614395|FG001|Overall Study|Personal Issues|2|||
128813597|NCT03800654|463614396|FG002|Overall Study|Personal Issues|0|||
128813598|NCT03800654|463614394|FG000|Overall Study|Protocol Violation|0|||
128813599|NCT03800654|463614395|FG001|Overall Study|Protocol Violation|1|||
128813600|NCT03800654|463614396|FG002|Overall Study|Protocol Violation|0|||
128813601|NCT03691935|463614397|FG000|Overall Study|Physician Decision|2|||
128813602|NCT03691935|463614398|FG001|Overall Study|Physician Decision|1|||
128813603|NCT03691935|463614397|FG000|Overall Study|Adverse Event|3|||
128813604|NCT03691935|463614398|FG001|Overall Study|Adverse Event|0|||
128813605|NCT01946789|463614404|FG000|Overall Study|Death|0|||
128813606|NCT01946789|463614405|FG001|Overall Study|Death|2|||
128813607|NCT01946789|463614406|FG002|Overall Study|Death|1|||
128813608|NCT01946789|463614407|FG003|Overall Study|Death|1|||
128813609|NCT01946789|463614408|FG004|Overall Study|Death|1|||
128813610|NCT01946789|463614409|FG005|Overall Study|Death|1|||
128813611|NCT01946789|463614410|FG006|Overall Study|Death|3|||
128813612|NCT01946789|463614411|FG007|Overall Study|Death|1|||
128813613|NCT01946789|463614412|FG008|Overall Study|Death|2|||
128813614|NCT01946789|463614404|FG000|Overall Study|Progressive Disease|0|||
128813615|NCT01946789|463614405|FG001|Overall Study|Progressive Disease|0|||
128813616|NCT01946789|463614406|FG002|Overall Study|Progressive Disease|1|||
128813617|NCT01946789|463614407|FG003|Overall Study|Progressive Disease|0|||
128813618|NCT01946789|463614408|FG004|Overall Study|Progressive Disease|0|||
128813619|NCT01946789|463614409|FG005|Overall Study|Progressive Disease|2|||
128813620|NCT01946789|463614410|FG006|Overall Study|Progressive Disease|0|||
128813621|NCT01946789|463614411|FG007|Overall Study|Progressive Disease|0|||
128813622|NCT01946789|463614412|FG008|Overall Study|Progressive Disease|0|||
128813623|NCT01946789|463614404|FG000|Overall Study|Withdrawal by Subject|0|||
128813624|NCT01946789|463614405|FG001|Overall Study|Withdrawal by Subject|0|||
128813625|NCT01946789|463614406|FG002|Overall Study|Withdrawal by Subject|0|||
128813626|NCT01946789|463614407|FG003|Overall Study|Withdrawal by Subject|2|||
128813627|NCT01946789|463614408|FG004|Overall Study|Withdrawal by Subject|1|||
128813628|NCT01946789|463614409|FG005|Overall Study|Withdrawal by Subject|0|||
128813629|NCT01946789|463614410|FG006|Overall Study|Withdrawal by Subject|1|||
128813630|NCT01946789|463614411|FG007|Overall Study|Withdrawal by Subject|0|||
128813631|NCT01946789|463614412|FG008|Overall Study|Withdrawal by Subject|0|||
128813632|NCT05374798|463614413|FG000|Overall Study|Lost to Follow-up|2|||
128813633|NCT05374798|463614413|FG000|Overall Study|Withdrawal by Subject|2|||
128813634|NCT05374798|463614413|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
128813635|NCT05576155|463614414|FG000|Overall Study|Withdrawal by Subject|1|||
128813636|NCT05576155|463614415|FG001|Overall Study|Withdrawal by Subject|1|||
128813637|NCT02696707|463616227|FG000|Per Protocol Population|Physician Decision|2|||
128813638|NCT02696707|463616228|FG001|Per Protocol Population|Physician Decision|1|||
128813639|NCT02696707|463616227|FG000|Per Protocol Population|Participant Decision|0|||
128813640|NCT02696707|463616228|FG001|Per Protocol Population|Participant Decision|2|||
128813641|NCT02696707|463616227|FG000|Completed Study as Planned|Reason = LVEF|2|||
128813642|NCT02696707|463616228|FG001|Completed Study as Planned|Reason = LVEF|2|||
128813643|NCT02696707|463616227|FG000|Completed Study as Planned|Protocol Violation|2|||
128813644|NCT02696707|463616228|FG001|Completed Study as Planned|Protocol Violation|6|||
128813645|NCT02696707|463616227|FG000|Completed Study as Planned|Metastatic disease|3|||
128813646|NCT02696707|463616228|FG001|Completed Study as Planned|Metastatic disease|0|||
128813647|NCT02696707|463616227|FG000|Completed Study as Planned|Location|1|||
128813648|NCT02696707|463616228|FG001|Completed Study as Planned|Location|1|||
128813649|NCT05251909|463616233|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
128813650|NCT05251909|463616234|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
128813651|NCT06181227|463616235|FG000|Overall Study|Study terminated by sponsor|7|||
128813652|NCT06181227|463616236|FG001|Overall Study|Study terminated by sponsor|9|||
128813653|NCT05543915|463616237|FG000|Overall Study|Lost to Follow-up|0|||
128813654|NCT05543915|463616238|FG001|Overall Study|Lost to Follow-up|1|||
128813655|NCT03854227|463616242|FG000|Overall Study|Adverse Event|0|||
128813656|NCT03854227|463616243|FG001|Overall Study|Adverse Event|0|||
128813657|NCT03854227|463616244|FG002|Overall Study|Adverse Event|0|||
128813658|NCT03854227|463616245|FG003|Overall Study|Adverse Event|1|||
128813659|NCT03854227|463616246|FG004|Overall Study|Adverse Event|0|||
128813660|NCT03854227|463616247|FG005|Overall Study|Adverse Event|0|||
128813661|NCT03854227|463616248|FG006|Overall Study|Adverse Event|1|||
128813662|NCT03854227|463616249|FG007|Overall Study|Adverse Event|0|||
128813663|NCT03854227|463616250|FG008|Overall Study|Adverse Event|0|||
128813664|NCT03854227|463616251|FG009|Overall Study|Adverse Event|3|||
128813665|NCT03854227|463616252|FG010|Overall Study|Adverse Event|0|||
128813666|NCT03854227|463616253|FG011|Overall Study|Adverse Event|1|||
128813667|NCT03854227|463616242|FG000|Overall Study|Death|0|||
128813668|NCT03854227|463616243|FG001|Overall Study|Death|0|||
128813669|NCT03854227|463616244|FG002|Overall Study|Death|0|||
128813670|NCT03854227|463616245|FG003|Overall Study|Death|0|||
128813671|NCT03854227|463616246|FG004|Overall Study|Death|0|||
128813672|NCT03854227|463616247|FG005|Overall Study|Death|1|||
128813673|NCT03854227|463616248|FG006|Overall Study|Death|0|||
128813674|NCT03854227|463616249|FG007|Overall Study|Death|0|||
128813675|NCT03854227|463616250|FG008|Overall Study|Death|0|||
128813676|NCT03854227|463616251|FG009|Overall Study|Death|1|||
128813677|NCT03854227|463616252|FG010|Overall Study|Death|0|||
128813678|NCT03854227|463616253|FG011|Overall Study|Death|1|||
128813679|NCT03854227|463616242|FG000|Overall Study|Physician Decision|0|||
128813680|NCT03854227|463616243|FG001|Overall Study|Physician Decision|0|||
128813681|NCT03854227|463616244|FG002|Overall Study|Physician Decision|0|||
128813682|NCT03854227|463616245|FG003|Overall Study|Physician Decision|0|||
128813683|NCT03854227|463616246|FG004|Overall Study|Physician Decision|0|||
128813684|NCT03854227|463616247|FG005|Overall Study|Physician Decision|1|||
128813685|NCT03854227|463616248|FG006|Overall Study|Physician Decision|0|||
128813686|NCT03854227|463616249|FG007|Overall Study|Physician Decision|0|||
128813687|NCT03854227|463616250|FG008|Overall Study|Physician Decision|1|||
128813688|NCT03854227|463616251|FG009|Overall Study|Physician Decision|1|||
128813689|NCT03854227|463616252|FG010|Overall Study|Physician Decision|0|||
128813690|NCT03854227|463616253|FG011|Overall Study|Physician Decision|1|||
128813691|NCT03854227|463616242|FG000|Overall Study|Progressive disease|1|||
128813692|NCT03854227|463616243|FG001|Overall Study|Progressive disease|1|||
128813693|NCT03854227|463616244|FG002|Overall Study|Progressive disease|1|||
128813694|NCT03854227|463616245|FG003|Overall Study|Progressive disease|2|||
128813695|NCT03854227|463616246|FG004|Overall Study|Progressive disease|3|||
128813696|NCT03854227|463616247|FG005|Overall Study|Progressive disease|1|||
128813697|NCT03854227|463616248|FG006|Overall Study|Progressive disease|2|||
128813698|NCT03854227|463616249|FG007|Overall Study|Progressive disease|5|||
128813699|NCT03854227|463616250|FG008|Overall Study|Progressive disease|2|||
128813700|NCT03854227|463616251|FG009|Overall Study|Progressive disease|5|||
128813701|NCT03854227|463616252|FG010|Overall Study|Progressive disease|1|||
128813702|NCT03854227|463616253|FG011|Overall Study|Progressive disease|6|||
128813703|NCT03854227|463616242|FG000|Overall Study|Study terminated by sponsor|0|||
128813704|NCT03854227|463616243|FG001|Overall Study|Study terminated by sponsor|0|||
128813705|NCT03854227|463616244|FG002|Overall Study|Study terminated by sponsor|0|||
128813706|NCT03854227|463616245|FG003|Overall Study|Study terminated by sponsor|0|||
128813707|NCT03854227|463616246|FG004|Overall Study|Study terminated by sponsor|0|||
128813708|NCT03854227|463616247|FG005|Overall Study|Study terminated by sponsor|0|||
128813709|NCT03854227|463616248|FG006|Overall Study|Study terminated by sponsor|0|||
128813710|NCT03854227|463616249|FG007|Overall Study|Study terminated by sponsor|0|||
128813711|NCT03854227|463616250|FG008|Overall Study|Study terminated by sponsor|0|||
128813712|NCT03854227|463616251|FG009|Overall Study|Study terminated by sponsor|1|||
128813713|NCT03854227|463616252|FG010|Overall Study|Study terminated by sponsor|0|||
128813714|NCT03854227|463616253|FG011|Overall Study|Study terminated by sponsor|0|||
128813715|NCT03854227|463616242|FG000|Overall Study|Withdrawal by Subject|0|||
128813716|NCT03854227|463616243|FG001|Overall Study|Withdrawal by Subject|0|||
128813717|NCT03854227|463616244|FG002|Overall Study|Withdrawal by Subject|1|||
128813718|NCT03854227|463616245|FG003|Overall Study|Withdrawal by Subject|0|||
128813719|NCT03854227|463616246|FG004|Overall Study|Withdrawal by Subject|0|||
128813720|NCT03854227|463616247|FG005|Overall Study|Withdrawal by Subject|0|||
128813721|NCT03854227|463616248|FG006|Overall Study|Withdrawal by Subject|0|||
128813722|NCT03854227|463616249|FG007|Overall Study|Withdrawal by Subject|0|||
128813723|NCT03854227|463616250|FG008|Overall Study|Withdrawal by Subject|0|||
128813724|NCT03854227|463616251|FG009|Overall Study|Withdrawal by Subject|1|||
128813725|NCT03854227|463616252|FG010|Overall Study|Withdrawal by Subject|1|||
128813726|NCT03854227|463616253|FG011|Overall Study|Withdrawal by Subject|0|||
128813727|NCT03854227|463616242|FG000|Overall Study|Disease relapse|0|||
128813728|NCT03854227|463616243|FG001|Overall Study|Disease relapse|0|||
128813729|NCT03854227|463616244|FG002|Overall Study|Disease relapse|0|||
128813730|NCT03854227|463616245|FG003|Overall Study|Disease relapse|0|||
128813731|NCT03854227|463616246|FG004|Overall Study|Disease relapse|0|||
128813732|NCT03854227|463616247|FG005|Overall Study|Disease relapse|0|||
128813733|NCT03854227|463616248|FG006|Overall Study|Disease relapse|0|||
128813734|NCT03854227|463616249|FG007|Overall Study|Disease relapse|0|||
128813735|NCT03854227|463616250|FG008|Overall Study|Disease relapse|1|||
128813736|NCT03854227|463616251|FG009|Overall Study|Disease relapse|0|||
128813737|NCT03854227|463616252|FG010|Overall Study|Disease relapse|0|||
128813738|NCT03854227|463616253|FG011|Overall Study|Disease relapse|0|||
128813739|NCT03854227|463616242|FG000|Overall Study|Global deterioration of health status|0|||
128813740|NCT03854227|463616243|FG001|Overall Study|Global deterioration of health status|0|||
128813741|NCT03854227|463616244|FG002|Overall Study|Global deterioration of health status|0|||
128813742|NCT03854227|463616245|FG003|Overall Study|Global deterioration of health status|0|||
128813743|NCT03854227|463616246|FG004|Overall Study|Global deterioration of health status|0|||
128813744|NCT03854227|463616247|FG005|Overall Study|Global deterioration of health status|1|||
128813745|NCT03854227|463616248|FG006|Overall Study|Global deterioration of health status|0|||
128813746|NCT03854227|463616249|FG007|Overall Study|Global deterioration of health status|1|||
128813747|NCT03854227|463616250|FG008|Overall Study|Global deterioration of health status|0|||
128813748|NCT03854227|463616251|FG009|Overall Study|Global deterioration of health status|0|||
128813749|NCT03854227|463616252|FG010|Overall Study|Global deterioration of health status|0|||
128813750|NCT03854227|463616253|FG011|Overall Study|Global deterioration of health status|0|||
128813751|NCT03854227|463616242|FG000|Overall Study|Refused further treatment|0|||
128813752|NCT03854227|463616243|FG001|Overall Study|Refused further treatment|0|||
128813753|NCT03854227|463616244|FG002|Overall Study|Refused further treatment|0|||
128813754|NCT03854227|463616245|FG003|Overall Study|Refused further treatment|0|||
128813755|NCT03854227|463616246|FG004|Overall Study|Refused further treatment|0|||
128813756|NCT03854227|463616247|FG005|Overall Study|Refused further treatment|0|||
128813757|NCT03854227|463616248|FG006|Overall Study|Refused further treatment|0|||
128813758|NCT03854227|463616249|FG007|Overall Study|Refused further treatment|0|||
128813759|NCT03854227|463616250|FG008|Overall Study|Refused further treatment|0|||
128813760|NCT03854227|463616251|FG009|Overall Study|Refused further treatment|1|||
128813761|NCT03854227|463616252|FG010|Overall Study|Refused further treatment|0|||
128813762|NCT03854227|463616253|FG011|Overall Study|Refused further treatment|1|||
128813763|NCT03854227|463616242|FG000|Overall Study|Other|0|||
128813764|NCT03854227|463616243|FG001|Overall Study|Other|0|||
128813765|NCT03854227|463616244|FG002|Overall Study|Other|0|||
128813766|NCT03854227|463616245|FG003|Overall Study|Other|0|||
128813767|NCT03854227|463616246|FG004|Overall Study|Other|0|||
128813768|NCT03854227|463616247|FG005|Overall Study|Other|0|||
128813769|NCT03854227|463616248|FG006|Overall Study|Other|0|||
128813770|NCT03854227|463616249|FG007|Overall Study|Other|0|||
128813771|NCT03854227|463616250|FG008|Overall Study|Other|1|||
128813772|NCT03854227|463616251|FG009|Overall Study|Other|1|||
128813773|NCT03854227|463616252|FG010|Overall Study|Other|0|||
128813774|NCT03854227|463616253|FG011|Overall Study|Other|0|||
128813775|NCT03668236|463616254|FG000|90-day Follow-up|Withdrawal by Subject|3|||
128813776|NCT03668236|463616255|FG001|90-day Follow-up|Withdrawal by Subject|2|||
128813777|NCT03668236|463616254|FG000|90-day Follow-up|Lost to Follow-up|3|||
128813778|NCT03668236|463616255|FG001|90-day Follow-up|Lost to Follow-up|1|||
128813779|NCT03668236|463616254|FG000|Baseline Characteristics|Lost to Follow-up|9|||
128813780|NCT03668236|463616255|FG001|Baseline Characteristics|Lost to Follow-up|5|||
128813781|NCT03668236|463616254|FG000|1-year Follow-up|Withdrawal by Subject|17|||
128813782|NCT03668236|463616255|FG001|1-year Follow-up|Withdrawal by Subject|15|||
128813783|NCT06132282|463616261|FG000|Overall Study|Lost to Follow-up|31|||
128813784|NCT04376502|463616267|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
128813785|NCT03748953|463616268|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
128813786|NCT03748953|463616269|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
128813787|NCT03748953|463616268|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
128813788|NCT03748953|463616269|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
128813789|NCT03748953|463616268|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
128813790|NCT03748953|463616269|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
128813791|NCT03748953|463616268|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
128813792|NCT03748953|463616269|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
128813793|NCT03748953|463616268|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
128813794|NCT03748953|463616269|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
128813795|NCT04119843|463616274|FG000|Overall Study|Adverse Event|3|||
128813796|NCT04119843|463616274|FG000|Overall Study|Death|1|||
128813797|NCT02841579|463616275|FG000|Overall Study|Death|1|||
128813798|NCT02841579|463616275|FG000|Overall Study|Adverse Event|1|||
128813799|NCT02841579|463616275|FG000|Overall Study|Lack of Efficacy|9|||
128813800|NCT03768505|463616278|FG000|Overall Study|sponsor decision|76|||
128813801|NCT03768505|463616278|FG000|Overall Study|Death|35|||
128813802|NCT03768505|463616278|FG000|Overall Study|Other -Various|30|||
128813803|NCT03768505|463616278|FG000|Overall Study|Withdrawal by Subject|22|||
128813804|NCT03768505|463616278|FG000|Overall Study|Lost to Follow-up|6|||
128813805|NCT02815566|463616279|FG000|Overall Study|Adverse Event|1|||
128813806|NCT02815566|463616280|FG001|Overall Study|Adverse Event|1|||
128813807|NCT02815566|463616279|FG000|Overall Study|Withdrawal by Subject|1|||
128813808|NCT02815566|463616280|FG001|Overall Study|Withdrawal by Subject|0|||
128813809|NCT02815566|463616279|FG000|Overall Study|Lost to Follow-up|0|||
128813810|NCT02815566|463616280|FG001|Overall Study|Lost to Follow-up|1|||
128813811|NCT04032704|463616283|FG000|Part A|Withdrawal by Subject|0|||
128813812|NCT04032704|463616284|FG001|Part A|Withdrawal by Subject|0|||
128813813|NCT04032704|463616285|FG002|Part A|Withdrawal by Subject|3|||
128813814|NCT04032704|463616286|FG003|Part A|Withdrawal by Subject|0|||
128813815|NCT04032704|463616287|FG004|Part A|Withdrawal by Subject|1|||
128813816|NCT04032704|463616288|FG005|Part A|Withdrawal by Subject|7|||
128813817|NCT04032704|463616289|FG006|Part A|Withdrawal by Subject|0|||
128813818|NCT04032704|463616290|FG007|Part A|Withdrawal by Subject|0|||
128813819|NCT04032704|463616291|FG008|Part A|Withdrawal by Subject|0|||
128813820|NCT04032704|463616292|FG009|Part A|Withdrawal by Subject|0|||
128813821|NCT04032704|463616293|FG010|Part A|Withdrawal by Subject|0|||
128813822|NCT04032704|463616294|FG011|Part A|Withdrawal by Subject|0|||
128813823|NCT04032704|463616295|FG012|Part A|Withdrawal by Subject|0|||
128813824|NCT04032704|463616296|FG013|Part A|Withdrawal by Subject|0|||
128813825|NCT04032704|463616297|FG014|Part A|Withdrawal by Subject|0|||
128813826|NCT04032704|463616298|FG015|Part A|Withdrawal by Subject|0|||
128813827|NCT04032704|463616299|FG016|Part A|Withdrawal by Subject|0|||
128813828|NCT04032704|463616300|FG017|Part A|Withdrawal by Subject|0|||
128813829|NCT04032704|463616283|FG000|Part A|Lost to Follow-up|1|||
128813830|NCT04032704|463616284|FG001|Part A|Lost to Follow-up|0|||
128813831|NCT04032704|463616285|FG002|Part A|Lost to Follow-up|0|||
128813832|NCT04032704|463616286|FG003|Part A|Lost to Follow-up|0|||
128813833|NCT04032704|463616287|FG004|Part A|Lost to Follow-up|0|||
128813834|NCT04032704|463616288|FG005|Part A|Lost to Follow-up|0|||
128813835|NCT04032704|463616289|FG006|Part A|Lost to Follow-up|0|||
128813836|NCT04032704|463616290|FG007|Part A|Lost to Follow-up|0|||
128813837|NCT04032704|463616291|FG008|Part A|Lost to Follow-up|0|||
128813838|NCT04032704|463616292|FG009|Part A|Lost to Follow-up|0|||
128813839|NCT04032704|463616293|FG010|Part A|Lost to Follow-up|0|||
128813840|NCT04032704|463616294|FG011|Part A|Lost to Follow-up|0|||
128813841|NCT04032704|463616295|FG012|Part A|Lost to Follow-up|0|||
128813842|NCT04032704|463616296|FG013|Part A|Lost to Follow-up|0|||
128813843|NCT04032704|463616297|FG014|Part A|Lost to Follow-up|0|||
128813844|NCT04032704|463616298|FG015|Part A|Lost to Follow-up|0|||
128813845|NCT04032704|463616299|FG016|Part A|Lost to Follow-up|0|||
128813846|NCT04032704|463616300|FG017|Part A|Lost to Follow-up|0|||
128813847|NCT04032704|463616283|FG000|Part A|Death|9|||
128813848|NCT04032704|463616284|FG001|Part A|Death|2|||
128813849|NCT04032704|463616285|FG002|Part A|Death|10|||
128813850|NCT04032704|463616286|FG003|Part A|Death|7|||
128813851|NCT04032704|463616287|FG004|Part A|Death|4|||
128813852|NCT04032704|463616288|FG005|Part A|Death|5|||
128813853|NCT04032704|463616289|FG006|Part A|Death|0|||
128813854|NCT04032704|463616290|FG007|Part A|Death|0|||
128813855|NCT04032704|463616291|FG008|Part A|Death|0|||
128813856|NCT04032704|463616292|FG009|Part A|Death|0|||
128813857|NCT04032704|463616293|FG010|Part A|Death|0|||
128813858|NCT04032704|463616294|FG011|Part A|Death|0|||
128813859|NCT04032704|463616295|FG012|Part A|Death|0|||
128813860|NCT04032704|463616296|FG013|Part A|Death|0|||
128813861|NCT04032704|463616297|FG014|Part A|Death|0|||
128813862|NCT04032704|463616298|FG015|Part A|Death|0|||
128813863|NCT04032704|463616299|FG016|Part A|Death|0|||
128813864|NCT04032704|463616300|FG017|Part A|Death|0|||
128813865|NCT04032704|463616283|FG000|Part B|Other|0|||
128813866|NCT04032704|463616284|FG001|Part B|Other|0|||
128813867|NCT04032704|463616285|FG002|Part B|Other|0|||
128813868|NCT04032704|463616286|FG003|Part B|Other|0|||
128813869|NCT04032704|463616287|FG004|Part B|Other|0|||
128813870|NCT04032704|463616288|FG005|Part B|Other|0|||
128813871|NCT04032704|463616289|FG006|Part B|Other|0|||
128813872|NCT04032704|463616290|FG007|Part B|Other|1|||
128813873|NCT04032704|463616291|FG008|Part B|Other|2|||
128813874|NCT04032704|463616292|FG009|Part B|Other|1|||
128813875|NCT04032704|463616293|FG010|Part B|Other|1|||
128813876|NCT04032704|463616294|FG011|Part B|Other|1|||
128813877|NCT04032704|463616295|FG012|Part B|Other|5|||
128813878|NCT04032704|463616296|FG013|Part B|Other|13|||
128813879|NCT04032704|463616297|FG014|Part B|Other|0|||
128813880|NCT04032704|463616298|FG015|Part B|Other|0|||
128813881|NCT04032704|463616299|FG016|Part B|Other|0|||
128813882|NCT04032704|463616300|FG017|Part B|Other|0|||
128813883|NCT04032704|463616283|FG000|Part B|Study termination by Sponsor|0|||
128813884|NCT04032704|463616284|FG001|Part B|Study termination by Sponsor|0|||
128813885|NCT04032704|463616285|FG002|Part B|Study termination by Sponsor|0|||
128813886|NCT04032704|463616286|FG003|Part B|Study termination by Sponsor|0|||
128813887|NCT04032704|463616287|FG004|Part B|Study termination by Sponsor|0|||
128813888|NCT04032704|463616288|FG005|Part B|Study termination by Sponsor|0|||
128813889|NCT04032704|463616289|FG006|Part B|Study termination by Sponsor|0|||
128813890|NCT04032704|463616290|FG007|Part B|Study termination by Sponsor|0|||
128813891|NCT04032704|463616291|FG008|Part B|Study termination by Sponsor|1|||
128813892|NCT04032704|463616292|FG009|Part B|Study termination by Sponsor|0|||
128813893|NCT04032704|463616293|FG010|Part B|Study termination by Sponsor|0|||
128813894|NCT04032704|463616294|FG011|Part B|Study termination by Sponsor|0|||
128813895|NCT04032704|463616295|FG012|Part B|Study termination by Sponsor|0|||
128813896|NCT04032704|463616296|FG013|Part B|Study termination by Sponsor|0|||
128813897|NCT04032704|463616297|FG014|Part B|Study termination by Sponsor|0|||
128813898|NCT04032704|463616298|FG015|Part B|Study termination by Sponsor|0|||
128813899|NCT04032704|463616299|FG016|Part B|Study termination by Sponsor|0|||
128813900|NCT04032704|463616300|FG017|Part B|Study termination by Sponsor|0|||
128813901|NCT04032704|463616283|FG000|Part B|Withdrawal by Subject|0|||
128813902|NCT04032704|463616284|FG001|Part B|Withdrawal by Subject|0|||
128813903|NCT04032704|463616285|FG002|Part B|Withdrawal by Subject|0|||
128813904|NCT04032704|463616286|FG003|Part B|Withdrawal by Subject|0|||
128813905|NCT04032704|463616287|FG004|Part B|Withdrawal by Subject|0|||
128813906|NCT04032704|463616288|FG005|Part B|Withdrawal by Subject|0|||
128813907|NCT04032704|463616289|FG006|Part B|Withdrawal by Subject|3|||
128813908|NCT04032704|463616290|FG007|Part B|Withdrawal by Subject|2|||
128813909|NCT04032704|463616291|FG008|Part B|Withdrawal by Subject|2|||
128813910|NCT04032704|463616292|FG009|Part B|Withdrawal by Subject|1|||
128813911|NCT04032704|463616293|FG010|Part B|Withdrawal by Subject|4|||
128813912|NCT04032704|463616294|FG011|Part B|Withdrawal by Subject|6|||
128813913|NCT04032704|463616295|FG012|Part B|Withdrawal by Subject|2|||
128813914|NCT04032704|463616296|FG013|Part B|Withdrawal by Subject|1|||
128813915|NCT04032704|463616297|FG014|Part B|Withdrawal by Subject|0|||
128813916|NCT04032704|463616298|FG015|Part B|Withdrawal by Subject|1|||
128813917|NCT04032704|463616299|FG016|Part B|Withdrawal by Subject|0|||
128813918|NCT04032704|463616300|FG017|Part B|Withdrawal by Subject|0|||
128813919|NCT04032704|463616283|FG000|Part B|Lost to Follow-up|0|||
128813920|NCT04032704|463616284|FG001|Part B|Lost to Follow-up|0|||
128813921|NCT04032704|463616285|FG002|Part B|Lost to Follow-up|0|||
128813922|NCT04032704|463616286|FG003|Part B|Lost to Follow-up|0|||
128813923|NCT04032704|463616287|FG004|Part B|Lost to Follow-up|0|||
128813924|NCT04032704|463616288|FG005|Part B|Lost to Follow-up|0|||
128813925|NCT04032704|463616289|FG006|Part B|Lost to Follow-up|0|||
128813926|NCT04032704|463616290|FG007|Part B|Lost to Follow-up|0|||
128813927|NCT04032704|463616291|FG008|Part B|Lost to Follow-up|0|||
128813928|NCT04032704|463616292|FG009|Part B|Lost to Follow-up|0|||
128813929|NCT04032704|463616293|FG010|Part B|Lost to Follow-up|0|||
128813930|NCT04032704|463616294|FG011|Part B|Lost to Follow-up|1|||
128813931|NCT04032704|463616295|FG012|Part B|Lost to Follow-up|0|||
128813932|NCT04032704|463616296|FG013|Part B|Lost to Follow-up|0|||
128813933|NCT04032704|463616297|FG014|Part B|Lost to Follow-up|0|||
128813934|NCT04032704|463616298|FG015|Part B|Lost to Follow-up|0|||
128813935|NCT04032704|463616299|FG016|Part B|Lost to Follow-up|0|||
128813936|NCT04032704|463616300|FG017|Part B|Lost to Follow-up|0|||
128813937|NCT04032704|463616283|FG000|Part B|Death|0|||
128813938|NCT04032704|463616284|FG001|Part B|Death|0|||
128813939|NCT04032704|463616285|FG002|Part B|Death|0|||
128813940|NCT04032704|463616286|FG003|Part B|Death|0|||
128813941|NCT04032704|463616287|FG004|Part B|Death|0|||
128813942|NCT04032704|463616288|FG005|Part B|Death|0|||
128813943|NCT04032704|463616289|FG006|Part B|Death|13|||
128813944|NCT04032704|463616290|FG007|Part B|Death|13|||
128813945|NCT04032704|463616291|FG008|Part B|Death|14|||
128813946|NCT04032704|463616292|FG009|Part B|Death|12|||
128813947|NCT04032704|463616293|FG010|Part B|Death|12|||
128813948|NCT04032704|463616294|FG011|Part B|Death|13|||
128813949|NCT04032704|463616295|FG012|Part B|Death|7|||
128813950|NCT04032704|463616296|FG013|Part B|Death|17|||
128813951|NCT04032704|463616297|FG014|Part B|Death|2|||
128813952|NCT04032704|463616298|FG015|Part B|Death|1|||
128813953|NCT04032704|463616299|FG016|Part B|Death|2|||
128813954|NCT04032704|463616300|FG017|Part B|Death|2|||
128813955|NCT02861300|463616301|FG000|Overall Study|Death|0|||
128813956|NCT02861300|463616302|FG001|Overall Study|Death|0|||
128813957|NCT02861300|463616303|FG002|Overall Study|Death|0|||
128813958|NCT02861300|463616304|FG003|Overall Study|Death|0|||
128813959|NCT02861300|463616305|FG004|Overall Study|Death|0|||
128813960|NCT02861300|463616306|FG005|Overall Study|Death|0|||
128813961|NCT02861300|463616307|FG006|Overall Study|Death|24|||
128813962|NCT02861300|463616301|FG000|Overall Study|Delay in treatment|0|||
128813963|NCT02861300|463616302|FG001|Overall Study|Delay in treatment|0|||
128813964|NCT02861300|463616303|FG002|Overall Study|Delay in treatment|0|||
128813965|NCT02861300|463616304|FG003|Overall Study|Delay in treatment|0|||
128813966|NCT02861300|463616305|FG004|Overall Study|Delay in treatment|0|||
128813967|NCT02861300|463616306|FG005|Overall Study|Delay in treatment|1|||
128813968|NCT02861300|463616307|FG006|Overall Study|Delay in treatment|0|||
128813969|NCT02861300|463616301|FG000|Overall Study|Disease Progression|0|||
128813970|NCT02861300|463616302|FG001|Overall Study|Disease Progression|1|||
128813971|NCT02861300|463616303|FG002|Overall Study|Disease Progression|0|||
128813972|NCT02861300|463616304|FG003|Overall Study|Disease Progression|0|||
128813973|NCT02861300|463616305|FG004|Overall Study|Disease Progression|0|||
128813974|NCT02861300|463616306|FG005|Overall Study|Disease Progression|0|||
128813975|NCT02861300|463616307|FG006|Overall Study|Disease Progression|2|||
128813976|NCT02861300|463616301|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
128813977|NCT02861300|463616302|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
128813978|NCT02861300|463616303|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
128813979|NCT02861300|463616304|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
128813980|NCT02861300|463616305|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
128813981|NCT02861300|463616306|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
128813982|NCT02861300|463616307|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
128813983|NCT02861300|463616301|FG000|Overall Study|Clinical Complications|0|||
128813984|NCT02861300|463616302|FG001|Overall Study|Clinical Complications|0|||
128813985|NCT02861300|463616303|FG002|Overall Study|Clinical Complications|0|||
128813986|NCT02861300|463616304|FG003|Overall Study|Clinical Complications|0|||
128813987|NCT02861300|463616305|FG004|Overall Study|Clinical Complications|0|||
128813988|NCT02861300|463616306|FG005|Overall Study|Clinical Complications|0|||
128813989|NCT02861300|463616307|FG006|Overall Study|Clinical Complications|1|||
128813990|NCT03252847|463616308|FG000|Overall Study|Withdrawal by Subject|0|||
128813991|NCT03252847|463616309|FG001|Overall Study|Withdrawal by Subject|0|||
128813992|NCT03252847|463616310|FG002|Overall Study|Withdrawal by Subject|1|||
128813993|NCT03252847|463616311|FG003|Overall Study|Withdrawal by Subject|0|||
128813994|NCT03252847|463616312|FG004|Overall Study|Withdrawal by Subject|0|||
128813995|NCT03252847|463616313|FG005|Overall Study|Withdrawal by Subject|0|||
128813996|NCT03252847|463616314|FG006|Overall Study|Withdrawal by Subject|0|||
128813997|NCT03252847|463616308|FG000|Overall Study|Other: Patient decision|0|||
128813998|NCT03252847|463616309|FG001|Overall Study|Other: Patient decision|0|||
128813999|NCT03252847|463616310|FG002|Overall Study|Other: Patient decision|0|||
128814000|NCT03252847|463616311|FG003|Overall Study|Other: Patient decision|0|||
128814001|NCT03252847|463616312|FG004|Overall Study|Other: Patient decision|1|||
128814002|NCT03252847|463616313|FG005|Overall Study|Other: Patient decision|0|||
128814003|NCT03252847|463616314|FG006|Overall Study|Other: Patient decision|0|||
128814004|NCT01501955|463616315|FG000|Overall Study|Withdrawal by Subject|1|||
128814005|NCT01501955|463616316|FG001|Overall Study|Withdrawal by Subject|0|||
128814006|NCT01501955|463616315|FG000|Overall Study|Adverse Event|1|||
128814007|NCT01501955|463616316|FG001|Overall Study|Adverse Event|3|||
128814008|NCT04992520|463616318|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
128814009|NCT04992520|463616319|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
128814010|NCT04992520|463616320|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
128814011|NCT04992520|463616321|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
128814012|NCT04992520|463616322|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
128814013|NCT04992520|463616323|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
128814014|NCT04992520|463616318|FG000|Part A: First Challenge|Non-compliance|0|||
128814015|NCT04992520|463616319|FG001|Part A: First Challenge|Non-compliance|0|||
128814016|NCT04992520|463616320|FG002|Part A: First Challenge|Non-compliance|0|||
128814017|NCT04992520|463616321|FG003|Part A: First Challenge|Non-compliance|1|||
128814018|NCT04992520|463616322|FG004|Part A: First Challenge|Non-compliance|0|||
128814019|NCT04992520|463616323|FG005|Part A: First Challenge|Non-compliance|0|||
128814020|NCT04992520|463616318|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
128814021|NCT04992520|463616319|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
128814022|NCT04992520|463616320|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
128814023|NCT04992520|463616321|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
128814024|NCT04992520|463616322|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
128814025|NCT04992520|463616323|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
128814026|NCT04992520|463616318|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
128814027|NCT04992520|463616319|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
128814028|NCT04992520|463616320|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
128814029|NCT04992520|463616321|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
128814030|NCT04992520|463616322|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
128814031|NCT04992520|463616323|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
128814032|NCT02714257|463616327|FG000|Overall Study|Withdrawal by Subject|6|||
128814033|NCT02714257|463616328|FG001|Overall Study|Withdrawal by Subject|11|||
128814034|NCT02714257|463616327|FG000|Overall Study|Death|3|||
128814035|NCT02714257|463616328|FG001|Overall Study|Death|4|||
128814036|NCT02714257|463616327|FG000|Overall Study|Lost to Follow-up|1|||
128814037|NCT02714257|463616328|FG001|Overall Study|Lost to Follow-up|6|||
128814038|NCT00104676|463616329|FG000|Overall Study|Death|3|||
128814039|NCT00104676|463616330|FG001|Overall Study|Death|2|||
128814040|NCT00104676|463616329|FG000|Overall Study|Withdrawal by Subject|0|||
128814041|NCT00104676|463616330|FG001|Overall Study|Withdrawal by Subject|2|||
128814042|NCT00104676|463616329|FG000|Overall Study|treatment interruption|4|||
128814043|NCT00104676|463616330|FG001|Overall Study|treatment interruption|10|||
128814044|NCT05808257|463616331|FG000|Overall Study|Lost to Follow-up|8|||
128814045|NCT05808257|463616332|FG001|Overall Study|Lost to Follow-up|8|||
128814046|NCT04042233|463616333|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
128814047|NCT04042233|463616334|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
128814048|NCT04042233|463616333|FG000|Overall Study|Protocol Violation|0|||
128814049|NCT04042233|463616334|FG001|Overall Study|Protocol Violation|2|||
128814050|NCT03899259|463616341|FG000|Overall Study|Adverse Event|5|||
128814051|NCT03899259|463616342|FG001|Overall Study|Adverse Event|4|||
128814052|NCT03899259|463616343|FG002|Overall Study|Adverse Event|6|||
128814053|NCT03899259|463616341|FG000|Overall Study|Lack of Efficacy|5|||
128814054|NCT03899259|463616342|FG001|Overall Study|Lack of Efficacy|0|||
128814055|NCT03899259|463616343|FG002|Overall Study|Lack of Efficacy|2|||
128814056|NCT03899259|463616341|FG000|Overall Study|Pregnancy|3|||
128814057|NCT03899259|463616342|FG001|Overall Study|Pregnancy|0|||
128814058|NCT03899259|463616343|FG002|Overall Study|Pregnancy|1|||
128814059|NCT03899259|463616341|FG000|Overall Study|Physician Decision|0|||
128814060|NCT03899259|463616342|FG001|Overall Study|Physician Decision|1|||
128814061|NCT03899259|463616343|FG002|Overall Study|Physician Decision|0|||
128814062|NCT03899259|463616341|FG000|Overall Study|Protocol Deviation|1|||
128814063|NCT03899259|463616342|FG001|Overall Study|Protocol Deviation|1|||
128814064|NCT03899259|463616343|FG002|Overall Study|Protocol Deviation|1|||
128814065|NCT03899259|463616341|FG000|Overall Study|Withdrawal by Subject|8|||
128814066|NCT03899259|463616342|FG001|Overall Study|Withdrawal by Subject|10|||
128814067|NCT03899259|463616343|FG002|Overall Study|Withdrawal by Subject|12|||
128814068|NCT03899259|463616341|FG000|Overall Study|Lost to Follow-up|5|||
128814069|NCT03899259|463616342|FG001|Overall Study|Lost to Follow-up|6|||
128814070|NCT03899259|463616343|FG002|Overall Study|Lost to Follow-up|2|||
128814071|NCT03899259|463616341|FG000|Overall Study|Lack of Adherence|1|||
128814072|NCT03899259|463616342|FG001|Overall Study|Lack of Adherence|0|||
128814073|NCT03899259|463616343|FG002|Overall Study|Lack of Adherence|0|||
128814074|NCT03899259|463616341|FG000|Overall Study|Screen Failure|1|||
128814075|NCT03899259|463616342|FG001|Overall Study|Screen Failure|0|||
128814076|NCT03899259|463616343|FG002|Overall Study|Screen Failure|0|||
128814077|NCT03899259|463616341|FG000|Overall Study|Ongoing Study Participation|127|||
128814078|NCT03899259|463616342|FG001|Overall Study|Ongoing Study Participation|134|||
128814079|NCT03899259|463616343|FG002|Overall Study|Ongoing Study Participation|210|||
128814080|NCT01197378|463616344|FG000|Overall Study|Adverse Event|3|||
128814081|NCT01197378|463616344|FG000|Overall Study|Withdrawal by Subject|1|||
128814082|NCT01197378|463616344|FG000|Overall Study|Physician Decision|1|||
128814083|NCT01197378|463616344|FG000|Overall Study|Other|2|||
128814084|NCT05139810|463616345|FG000|Overall Study|Voluntary Withdrawal|2|||
128814085|NCT05139810|463616346|FG001|Overall Study|Voluntary Withdrawal|1|||
128814086|NCT05139810|463616347|FG002|Overall Study|Voluntary Withdrawal|0|||
128814087|NCT05139810|463616345|FG000|Overall Study|Pregnancy|1|||
128814088|NCT05139810|463616346|FG001|Overall Study|Pregnancy|0|||
128814089|NCT05139810|463616347|FG002|Overall Study|Pregnancy|0|||
128814090|NCT05139810|463616345|FG000|Overall Study|Roll Over to CS7|19|||
128814091|NCT05139810|463616346|FG001|Overall Study|Roll Over to CS7|44|||
128814092|NCT05139810|463616347|FG002|Overall Study|Roll Over to CS7|20|||
128814093|NCT06182033|463616348|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
128814094|NCT06182033|463616349|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
128814095|NCT06182033|463616348|FG000|Overall Study|Target child relocation|1|||
128814096|NCT06182033|463616349|FG001|Overall Study|Target child relocation|1|||
128814097|NCT06182033|463616348|FG000|Overall Study|Withdrawal by Subject|1|||
128814098|NCT06182033|463616349|FG001|Overall Study|Withdrawal by Subject|0|||
128814099|NCT05704543|463616350|FG000|Overall Study|Withdrawal by Subject|1|||
128814100|NCT05704543|463616351|FG001|Overall Study|Withdrawal by Subject|1|||
128814101|NCT05704543|463616352|FG002|Overall Study|Withdrawal by Subject|0|||
128814102|NCT05704543|463616353|FG003|Overall Study|Withdrawal by Subject|2|||
128814103|NCT05704543|463616350|FG000|Overall Study|Lost to Follow-up|1|||
128814104|NCT05704543|463616351|FG001|Overall Study|Lost to Follow-up|2|||
128814105|NCT05704543|463616352|FG002|Overall Study|Lost to Follow-up|0|||
128814106|NCT05704543|463616353|FG003|Overall Study|Lost to Follow-up|0|||
128814107|NCT02723591|463616355|FG000|Overall Study|Adverse Event|48|||
128814108|NCT02723591|463616356|FG001|Overall Study|Adverse Event|40|||
128814109|NCT02723591|463616355|FG000|Overall Study|Death|2|||
128814110|NCT02723591|463616356|FG001|Overall Study|Death|2|||
128814111|NCT02723591|463616355|FG000|Overall Study|Lack of Efficacy|4|||
128814112|NCT02723591|463616356|FG001|Overall Study|Lack of Efficacy|3|||
128814113|NCT02723591|463616355|FG000|Overall Study|Lost to Follow-up|1|||
128814114|NCT02723591|463616356|FG001|Overall Study|Lost to Follow-up|7|||
128814115|NCT02723591|463616355|FG000|Overall Study|Protocol Violation|20|||
128814116|NCT02723591|463616356|FG001|Overall Study|Protocol Violation|23|||
128814117|NCT02723591|463616355|FG000|Overall Study|Withdrawal by Subject|4|||
128814118|NCT02723591|463616356|FG001|Overall Study|Withdrawal by Subject|8|||
128814119|NCT02723591|463616355|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
128814120|NCT02723591|463616356|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
128814121|NCT02723591|463616355|FG000|Overall Study|Miscellaneous|5|||
128814122|NCT02723591|463616356|FG001|Overall Study|Miscellaneous|6|||
128814123|NCT02151981|463616359|FG000|Overall Study|Death|184|||
128814124|NCT02151981|463616360|FG001|Overall Study|Death|88|||
128814125|NCT02151981|463616359|FG000|Overall Study|Lost to Follow-up|7|||
128814126|NCT02151981|463616360|FG001|Overall Study|Lost to Follow-up|1|||
128814127|NCT02151981|463616359|FG000|Overall Study|Withdrawal by Subject|27|||
128814128|NCT02151981|463616360|FG001|Overall Study|Withdrawal by Subject|21|||
128814129|NCT02151981|463616359|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128814130|NCT02151981|463616360|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
128814131|NCT02151981|463616359|FG000|Overall Study|Other reasons|1|||
128814132|NCT02151981|463616360|FG001|Overall Study|Other reasons|2|||
128814133|NCT01275677|463616369|FG000|Overall Study|Not at risk for recurrence.|1|||
128814134|NCT01275677|463616370|FG001|Overall Study|Not at risk for recurrence.|1|||
128814135|NCT01275677|463616369|FG000|Overall Study|No follow-up|26|||
128814136|NCT01275677|463616370|FG001|Overall Study|No follow-up|37|||
128814137|NCT01275677|463616369|FG000|Overall Study|No clinical follow up.|1|||
128814138|NCT01275677|463616370|FG001|Overall Study|No clinical follow up.|4|||
128814139|NCT04409353|463616378|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
128814140|NCT04409353|463616379|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
128814141|NCT04409353|463616380|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
128814142|NCT04409353|463616378|FG000|Overall Study|Lost to Follow-up|6|||
128814143|NCT04409353|463616379|FG001|Overall Study|Lost to Follow-up|8|||
128814144|NCT04409353|463616380|FG002|Overall Study|Lost to Follow-up|7|||
128814145|NCT04409353|463616378|FG000|Overall Study|Major surgery during participation window|4|||
128814146|NCT04409353|463616379|FG001|Overall Study|Major surgery during participation window|3|||
128814147|NCT04409353|463616380|FG002|Overall Study|Major surgery during participation window|3|||
128814148|NCT04409353|463616378|FG000|Overall Study|Life event occurred during participation window|3|||
128814149|NCT04409353|463616379|FG001|Overall Study|Life event occurred during participation window|2|||
128814150|NCT04409353|463616380|FG002|Overall Study|Life event occurred during participation window|4|||
128814151|NCT04409353|463616378|FG000|Overall Study|Lack of Efficacy|4|||
128814152|NCT04409353|463616379|FG001|Overall Study|Lack of Efficacy|1|||
128814153|NCT04409353|463616380|FG002|Overall Study|Lack of Efficacy|3|||
128814154|NCT04409353|463616378|FG000|Overall Study|Adverse Event|2|||
128814155|NCT04409353|463616379|FG001|Overall Study|Adverse Event|1|||
128814156|NCT04409353|463616380|FG002|Overall Study|Adverse Event|1|||
128814157|NCT04409353|463616378|FG000|Overall Study|Disease burden - unable to participate|0|||
128814158|NCT04409353|463616379|FG001|Overall Study|Disease burden - unable to participate|1|||
128814159|NCT04409353|463616380|FG002|Overall Study|Disease burden - unable to participate|1|||
128814160|NCT04409353|463616378|FG000|Overall Study|Intervention too complicated|1|||
128814161|NCT04409353|463616379|FG001|Overall Study|Intervention too complicated|0|||
128814162|NCT04409353|463616380|FG002|Overall Study|Intervention too complicated|1|||
128814163|NCT04081103|463616381|FG000|Overall Study|Adverse Event|1|||
128814164|NCT04081103|463616382|FG001|Overall Study|Adverse Event|1|||
128814165|NCT04081103|463616383|FG002|Overall Study|Adverse Event|1|||
128814166|NCT04081103|463616381|FG000|Overall Study|Physician Decision|0|||
128814167|NCT04081103|463616382|FG001|Overall Study|Physician Decision|0|||
128814168|NCT04081103|463616383|FG002|Overall Study|Physician Decision|1|||
128814169|NCT03034356|463616384|FG000|Baseline|Lost to Follow-up|2|||
128814170|NCT03034356|463616385|FG001|Baseline|Lost to Follow-up|4|||
128814171|NCT03034356|463616384|FG000|Baseline|Withdrawal by Subject|2|||
128814172|NCT03034356|463616385|FG001|Baseline|Withdrawal by Subject|0|||
128814173|NCT03034356|463616384|FG000|Baseline|Physician Decision|0|||
128814174|NCT03034356|463616385|FG001|Baseline|Physician Decision|1|||
128814175|NCT03034356|463616384|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
128814176|NCT03034356|463616385|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
128814177|NCT03034356|463616384|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
128814178|NCT03034356|463616385|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
128814179|NCT03034356|463616384|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
128814180|NCT03034356|463616385|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
128814181|NCT03034356|463616384|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
128814182|NCT03034356|463616385|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
128814183|NCT05309291|463616386|FG000|Overall Study|Adverse Event|0|||
128814184|NCT05309291|463616387|FG001|Overall Study|Adverse Event|1|||
128814185|NCT05209152|463616390|FG000|Overall Study|Sponsor decision|1|||
128814186|NCT05209152|463616391|FG001|Overall Study|Sponsor decision|2|||
128814187|NCT05209152|463616390|FG000|Overall Study|Death|3|||
128814188|NCT05209152|463616391|FG001|Overall Study|Death|1|||
128814189|NCT05809453|463618170|FG000|Overall Study|Withdrawal by Subject|1|||
128814190|NCT05809453|463618171|FG001|Overall Study|Withdrawal by Subject|0|||
128814191|NCT05809453|463618172|FG002|Overall Study|Withdrawal by Subject|0|||
128814192|NCT05809453|463618173|FG003|Overall Study|Withdrawal by Subject|0|||
128814193|NCT03287817|463618174|FG000|Overall Study|Progressive disease|4|||
128814194|NCT03287817|463618175|FG001|Overall Study|Progressive disease|2|||
128814195|NCT03287817|463618176|FG002|Overall Study|Progressive disease|3|||
128814196|NCT03287817|463618177|FG003|Overall Study|Progressive disease|10|||
128814197|NCT03287817|463618178|FG004|Overall Study|Progressive disease|8|||
128814198|NCT03287817|463618174|FG000|Overall Study|Death|0|||
128814199|NCT03287817|463618175|FG001|Overall Study|Death|0|||
128814200|NCT03287817|463618176|FG002|Overall Study|Death|2|||
128814201|NCT03287817|463618177|FG003|Overall Study|Death|3|||
128814202|NCT03287817|463618178|FG004|Overall Study|Death|4|||
128814203|NCT03287817|463618174|FG000|Overall Study|Physician Decision|0|||
128814204|NCT03287817|463618175|FG001|Overall Study|Physician Decision|0|||
128814205|NCT03287817|463618176|FG002|Overall Study|Physician Decision|0|||
128814206|NCT03287817|463618177|FG003|Overall Study|Physician Decision|1|||
128814207|NCT03287817|463618178|FG004|Overall Study|Physician Decision|0|||
128814208|NCT03287817|463618174|FG000|Overall Study|Withdrawal by Subject|0|||
128814209|NCT03287817|463618175|FG001|Overall Study|Withdrawal by Subject|0|||
128814210|NCT03287817|463618176|FG002|Overall Study|Withdrawal by Subject|0|||
128814211|NCT03287817|463618177|FG003|Overall Study|Withdrawal by Subject|0|||
128814212|NCT03287817|463618178|FG004|Overall Study|Withdrawal by Subject|4|||
128814213|NCT02993159|463618181|FG000|Overall Study|Withdrawal by Subject|1|||
128814214|NCT02993159|463618182|FG001|Overall Study|Withdrawal by Subject|3|||
128814215|NCT02993159|463618181|FG000|Overall Study|Protocol Violation|1|||
128814216|NCT02993159|463618182|FG001|Overall Study|Protocol Violation|0|||
128814217|NCT02993159|463618181|FG000|Overall Study|Opted out of surgery|2|||
128814218|NCT02993159|463618182|FG001|Overall Study|Opted out of surgery|0|||
128814219|NCT02993159|463618181|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
128814220|NCT02993159|463618182|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
128814221|NCT02993159|463618181|FG000|Overall Study|Physician Decision|0|||
128814222|NCT02993159|463618182|FG001|Overall Study|Physician Decision|1|||
128814223|NCT03625167|463618185|FG000|Overall Study|Protocol Violation|5|||
128814224|NCT04314713|463618188|FG000|Overall Study|Lost to Follow-up|0|||
128814225|NCT04314713|463618189|FG001|Overall Study|Lost to Follow-up|0|||
128814226|NCT04314713|463618190|FG002|Overall Study|Lost to Follow-up|0|||
128814227|NCT04314713|463618191|FG003|Overall Study|Lost to Follow-up|1|||
128814228|NCT04314713|463618192|FG004|Overall Study|Lost to Follow-up|0|||
128814229|NCT04314713|463618193|FG005|Overall Study|Lost to Follow-up|0|||
128814230|NCT00248287|463618198|FG000|Overall Study|Adverse Event|11|||
128814231|NCT00248287|463618199|FG001|Overall Study|Adverse Event|10|||
128814232|NCT00248287|463618198|FG000|Overall Study|Death|1|||
128814233|NCT00248287|463618199|FG001|Overall Study|Death|0|||
128814234|NCT00248287|463618198|FG000|Overall Study|Lost to Follow-up|0|||
128814235|NCT00248287|463618199|FG001|Overall Study|Lost to Follow-up|1|||
128814236|NCT00248287|463618198|FG000|Overall Study|Investigator Request|4|||
128814237|NCT00248287|463618199|FG001|Overall Study|Investigator Request|3|||
128814238|NCT00248287|463618198|FG000|Overall Study|Patient Request|5|||
128814239|NCT00248287|463618199|FG001|Overall Study|Patient Request|3|||
128814240|NCT00248287|463618198|FG000|Overall Study|Other|3|||
128814241|NCT00248287|463618199|FG001|Overall Study|Other|2|||
128814242|NCT04103580|463618202|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
128814243|NCT04103580|463618203|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
128814244|NCT04103580|463618202|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
128814245|NCT04103580|463618203|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
128814246|NCT04103580|463618202|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
128814247|NCT04103580|463618203|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
128814248|NCT04103580|463618202|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
128814249|NCT04103580|463618203|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
128814250|NCT04103580|463618202|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
128814251|NCT04103580|463618203|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
128814252|NCT04103580|463618202|FG000|Phase 1 Active Caregiving|Other|3|||
128814253|NCT04103580|463618203|FG001|Phase 1 Active Caregiving|Other|3|||
128814254|NCT04103580|463618202|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
128814255|NCT04103580|463618203|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
128814256|NCT04103580|463618202|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
128814257|NCT04103580|463618203|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
128814258|NCT04103580|463618202|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
128814259|NCT04103580|463618203|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
128814260|NCT04103580|463618202|FG000|Phase 2 Bereavement|Other|8|||
128814261|NCT04103580|463618203|FG001|Phase 2 Bereavement|Other|6|||
128814262|NCT04145440|463618204|FG000|Overall Study|Physician Decision|3|||
128814263|NCT04145440|463618205|FG001|Overall Study|Physician Decision|0|||
128814264|NCT04145440|463618204|FG000|Overall Study|Use of prohibited therapy|2|||
128814265|NCT04145440|463618205|FG001|Overall Study|Use of prohibited therapy|3|||
128814266|NCT04568486|463618208|FG000|Overall Study|Withdrawal by Subject|26|||
128814267|NCT04568486|463618208|FG000|Overall Study|Lost to Follow-up|7|||
128814268|NCT05297565|463618211|FG000|Overall Study|Other Reasons|0|||
128814269|NCT05297565|463618212|FG001|Overall Study|Other Reasons|1|||
128814270|NCT05297565|463618211|FG000|Overall Study|Physician Decision|0|||
128814271|NCT05297565|463618212|FG001|Overall Study|Physician Decision|1|||
128814272|NCT05297565|463618211|FG000|Overall Study|Disease recurrence|1|||
128814273|NCT05297565|463618212|FG001|Overall Study|Disease recurrence|0|||
128814274|NCT05670587|463618225|FG000|Overall Study|Withdrawal by Subject|3|||
128814275|NCT05940194|463618227|FG000|Overall Study|Adverse Event|0|||
128814276|NCT05940194|463618228|FG001|Overall Study|Adverse Event|1|||
128814277|NCT05940194|463618229|FG002|Overall Study|Adverse Event|0|||
128814278|NCT05940194|463618227|FG000|Overall Study|Migrated/Moved from the study area|2|||
128814279|NCT05940194|463618228|FG001|Overall Study|Migrated/Moved from the study area|2|||
128814280|NCT05940194|463618229|FG002|Overall Study|Migrated/Moved from the study area|4|||
128814281|NCT01959607|463618230|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
128814282|NCT01959607|463618231|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
128814283|NCT01959607|463618232|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
128814284|NCT01959607|463618233|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
128814285|NCT04054193|463618245|FG000|Cycle 1|Physician Decision|1|||
128814286|NCT04054193|463618245|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
128814287|NCT04054193|463618245|FG000|Cycle 1|Allocated but not treated|3|||
128814288|NCT04054193|463618245|FG000|Cycles 2-3|Physician Decision|2|||
128814289|NCT04054193|463618245|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
128814290|NCT04054193|463618245|FG000|Cycles 2-3|Various reasons|17|||
128814291|NCT02966873|463618246|FG000|Overall Study|Lost to Follow-up|16|||
128814292|NCT02966873|463618247|FG001|Overall Study|Lost to Follow-up|15|||
128814293|NCT03084536|463618248|FG000|Overall Study|Determined to be ineligible|0|||
128814294|NCT03084536|463618249|FG001|Overall Study|Determined to be ineligible|0|||
128814295|NCT03084536|463618250|FG002|Overall Study|Determined to be ineligible|16|||
128814296|NCT03084536|463618248|FG000|Overall Study|Withdrawal by Subject|0|||
128814297|NCT03084536|463618249|FG001|Overall Study|Withdrawal by Subject|0|||
128814298|NCT03084536|463618250|FG002|Overall Study|Withdrawal by Subject|4|||
128814299|NCT03084536|463618248|FG000|Overall Study|Physician Decision|0|||
128814300|NCT03084536|463618249|FG001|Overall Study|Physician Decision|0|||
128814301|NCT03084536|463618250|FG002|Overall Study|Physician Decision|3|||
128814302|NCT03084536|463618248|FG000|Overall Study|Death|0|||
128814303|NCT03084536|463618249|FG001|Overall Study|Death|0|||
128814304|NCT03084536|463618250|FG002|Overall Study|Death|1|||
128814305|NCT03084536|463618248|FG000|Overall Study|Lost to Follow-up|0|||
128814306|NCT03084536|463618249|FG001|Overall Study|Lost to Follow-up|0|||
128814307|NCT03084536|463618250|FG002|Overall Study|Lost to Follow-up|1|||
128814308|NCT03084536|463618248|FG000|Overall Study|Protocol Violation|0|||
128814309|NCT03084536|463618249|FG001|Overall Study|Protocol Violation|0|||
128814310|NCT03084536|463618250|FG002|Overall Study|Protocol Violation|1|||
128814311|NCT03084536|463618248|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
128814312|NCT03084536|463618249|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
128814313|NCT03084536|463618250|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
128814314|NCT03235544|463618256|FG000|Overall Study|Death|11|||
128814315|NCT03235544|463618257|FG001|Overall Study|Death|31|||
128814316|NCT03235544|463618258|FG002|Overall Study|Death|19|||
128814317|NCT03235544|463618259|FG003|Overall Study|Death|34|||
128814318|NCT03235544|463618256|FG000|Overall Study|Lost to Follow-up|0|||
128814319|NCT03235544|463618257|FG001|Overall Study|Lost to Follow-up|1|||
128814320|NCT03235544|463618258|FG002|Overall Study|Lost to Follow-up|1|||
128814321|NCT03235544|463618259|FG003|Overall Study|Lost to Follow-up|1|||
128814322|NCT03235544|463618256|FG000|Overall Study|Withdrawal by Subject|0|||
128814323|NCT03235544|463618257|FG001|Overall Study|Withdrawal by Subject|3|||
128814324|NCT03235544|463618258|FG002|Overall Study|Withdrawal by Subject|1|||
128814325|NCT03235544|463618259|FG003|Overall Study|Withdrawal by Subject|5|||
128814326|NCT03235544|463618256|FG000|Overall Study|Disease Progression|0|||
128814327|NCT03235544|463618257|FG001|Overall Study|Disease Progression|1|||
128814328|NCT03235544|463618258|FG002|Overall Study|Disease Progression|0|||
128814329|NCT03235544|463618259|FG003|Overall Study|Disease Progression|2|||
128814330|NCT03235544|463618256|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
128814331|NCT03235544|463618257|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
128814332|NCT03235544|463618258|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
128814333|NCT03235544|463618259|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
128814334|NCT03235544|463618256|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
128814335|NCT03235544|463618257|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
128814336|NCT03235544|463618258|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
128814337|NCT03235544|463618259|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
128814338|NCT04830800|463618260|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
128814339|NCT04830800|463618261|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
128814340|NCT04830800|463618262|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
128814341|NCT04830800|463618263|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
128814342|NCT04830800|463618264|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
128814343|NCT01456949|463618267|FG000|Enrollment|PI death- incomplete data|6|||
128814344|NCT01456949|463618267|FG000|Enrollment|Death|1|||
128814345|NCT01456949|463618267|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
128814346|NCT01456949|463618267|FG000|Enrollment|Physician Decision|10|||
128814347|NCT01456949|463618267|FG000|Enrollment|Withdrawal by Subject|7|||
128814348|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
128814349|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
128814350|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
128814351|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
128814352|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
128814353|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
128814354|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
128814355|NCT01456949|463618267|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
128814356|NCT03710603|463618268|FG000|Overall Study|Adverse Event|1|||
128814357|NCT03710603|463618269|FG001|Overall Study|Adverse Event|0|||
128814358|NCT03710603|463618268|FG000|Overall Study|Death|44|||
128814359|NCT03710603|463618269|FG001|Overall Study|Death|34|||
128814360|NCT03710603|463618268|FG000|Overall Study|Lost to Follow-up|3|||
128814361|NCT03710603|463618269|FG001|Overall Study|Lost to Follow-up|5|||
128814362|NCT03710603|463618268|FG000|Overall Study|Withdrawal by Subject|11|||
128814363|NCT03710603|463618269|FG001|Overall Study|Withdrawal by Subject|10|||
128814364|NCT02626533|463618270|FG000|Overall Study|Protocol Violation|14|||
128814365|NCT02626533|463618270|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
128814366|NCT02626533|463618270|FG000|Overall Study|Withdrawal by Subject|1|||
128814367|NCT04753697|463618271|FG000|Induction Phase|Withdrawal by Subject|12|||
128814368|NCT04753697|463618272|FG001|Induction Phase|Withdrawal by Subject|5|||
128814369|NCT04753697|463618273|FG002|Induction Phase|Withdrawal by Subject|6|||
128814370|NCT04753697|463618271|FG000|Induction Phase|Physician Decision|1|||
128814371|NCT04753697|463618272|FG001|Induction Phase|Physician Decision|0|||
128814372|NCT04753697|463618273|FG002|Induction Phase|Physician Decision|0|||
128814373|NCT04753697|463618271|FG000|Induction Phase|Lost to Follow-up|2|||
128814374|NCT04753697|463618272|FG001|Induction Phase|Lost to Follow-up|2|||
128814375|NCT04753697|463618273|FG002|Induction Phase|Lost to Follow-up|1|||
128814376|NCT04753697|463618271|FG000|Induction Phase|Lack of Efficacy|1|||
128814377|NCT04753697|463618272|FG001|Induction Phase|Lack of Efficacy|0|||
128814378|NCT04753697|463618273|FG002|Induction Phase|Lack of Efficacy|0|||
128814379|NCT04753697|463618271|FG000|Maintenance Phase|Physician Decision|0|||
128814380|NCT04753697|463618272|FG001|Maintenance Phase|Physician Decision|0|||
128814381|NCT04753697|463618273|FG002|Maintenance Phase|Physician Decision|1|||
128814382|NCT04753697|463618271|FG000|Maintenance Phase|Withdrawal by Subject|3|||
128814383|NCT04753697|463618272|FG001|Maintenance Phase|Withdrawal by Subject|4|||
128814384|NCT04753697|463618273|FG002|Maintenance Phase|Withdrawal by Subject|6|||
128814385|NCT04753697|463618271|FG000|Maintenance Phase|Lost to Follow-up|2|||
128814386|NCT04753697|463618272|FG001|Maintenance Phase|Lost to Follow-up|2|||
128814387|NCT04753697|463618273|FG002|Maintenance Phase|Lost to Follow-up|0|||
128814388|NCT04753697|463618271|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
128814389|NCT04753697|463618272|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
128814390|NCT04753697|463618273|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
128814391|NCT04753697|463618271|FG000|Maintenance Phase|Adverse Event|0|||
128814392|NCT04753697|463618272|FG001|Maintenance Phase|Adverse Event|1|||
128814393|NCT04753697|463618273|FG002|Maintenance Phase|Adverse Event|1|||
128814394|NCT04753697|463618271|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
128814395|NCT04753697|463618272|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
128814396|NCT04753697|463618273|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
128814397|NCT03701763|463618274|FG000|Placebo-controlled Phase|Adverse Event|1|||
128814398|NCT03701763|463618275|FG001|Placebo-controlled Phase|Adverse Event|5|||
128814399|NCT03701763|463618276|FG002|Placebo-controlled Phase|Adverse Event|0|||
128814400|NCT03701763|463618277|FG003|Placebo-controlled Phase|Adverse Event|0|||
128814401|NCT03701763|463618274|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
128814402|NCT03701763|463618275|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
128814403|NCT03701763|463618276|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
128814404|NCT03701763|463618277|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
128814405|NCT03701763|463618274|FG000|Placebo-controlled Phase|Miscellaneous|2|||
128814406|NCT03701763|463618275|FG001|Placebo-controlled Phase|Miscellaneous|0|||
128814407|NCT03701763|463618276|FG002|Placebo-controlled Phase|Miscellaneous|0|||
128814408|NCT03701763|463618277|FG003|Placebo-controlled Phase|Miscellaneous|0|||
128814409|NCT03701763|463618274|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
128814410|NCT03701763|463618275|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
128814411|NCT03701763|463618276|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
128814412|NCT03701763|463618277|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
128814413|NCT03701763|463618274|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
128814414|NCT03701763|463618275|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
128814415|NCT03701763|463618276|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
128814416|NCT03701763|463618277|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
128814417|NCT03701763|463618274|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
128814418|NCT03701763|463618275|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
128814419|NCT03701763|463618276|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
128814420|NCT03701763|463618277|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
128814421|NCT03701763|463618274|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
128814422|NCT03701763|463618275|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
128814423|NCT03701763|463618276|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
128814424|NCT03701763|463618277|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
128814425|NCT03701763|463618274|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
128814426|NCT03701763|463618275|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
128814427|NCT03701763|463618276|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
128814428|NCT03701763|463618277|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
128814429|NCT03701763|463618274|FG000|Apremilast Extension Phase|Adverse Event|0|||
128814430|NCT03701763|463618275|FG001|Apremilast Extension Phase|Adverse Event|0|||
128814431|NCT03701763|463618276|FG002|Apremilast Extension Phase|Adverse Event|3|||
128814432|NCT03701763|463618277|FG003|Apremilast Extension Phase|Adverse Event|1|||
128814433|NCT03701763|463618274|FG000|Apremilast Extension Phase|Miscellaneous|0|||
128814434|NCT03701763|463618275|FG001|Apremilast Extension Phase|Miscellaneous|0|||
128814435|NCT03701763|463618276|FG002|Apremilast Extension Phase|Miscellaneous|2|||
128814436|NCT03701763|463618277|FG003|Apremilast Extension Phase|Miscellaneous|1|||
128814437|NCT03701763|463618274|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
128814438|NCT03701763|463618275|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
128814439|NCT03701763|463618276|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
128814440|NCT03701763|463618277|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
128814441|NCT03701763|463618274|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
128814442|NCT03701763|463618275|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
128814443|NCT03701763|463618276|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
128814444|NCT03701763|463618277|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
128814445|NCT03701763|463618274|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
128814446|NCT03701763|463618275|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
128814447|NCT03701763|463618276|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
128814448|NCT03701763|463618277|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
128814449|NCT03701763|463618274|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
128814450|NCT03701763|463618275|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
128814451|NCT03701763|463618276|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
128814452|NCT03701763|463618277|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
128814453|NCT03701763|463618274|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
128814454|NCT03701763|463618275|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
128814455|NCT03701763|463618276|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
128814456|NCT03701763|463618277|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
128814457|NCT03701763|463618274|FG000|14-Week Observational Follow-up Phase|Other|0|||
128814458|NCT03701763|463618275|FG001|14-Week Observational Follow-up Phase|Other|0|||
128814459|NCT03701763|463618276|FG002|14-Week Observational Follow-up Phase|Other|1|||
128814460|NCT03701763|463618277|FG003|14-Week Observational Follow-up Phase|Other|0|||
128814461|NCT03701763|463618274|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
128814462|NCT03701763|463618275|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
128814463|NCT03701763|463618276|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
128814464|NCT03701763|463618277|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
128814465|NCT03701763|463618274|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
128814466|NCT03701763|463618275|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
128814467|NCT03701763|463618276|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
128814468|NCT03701763|463618277|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
128814469|NCT03785964|463618279|FG000|Overall Study|Adverse Event|14|||
128814470|NCT03785964|463618280|FG001|Overall Study|Adverse Event|1|||
128814471|NCT03785964|463618279|FG000|Overall Study|Unqualified Clinical Progression|1|||
128814472|NCT03785964|463618280|FG001|Overall Study|Unqualified Clinical Progression|1|||
128814473|NCT03785964|463618279|FG000|Overall Study|Participant non-compliance|1|||
128814474|NCT03785964|463618280|FG001|Overall Study|Participant non-compliance|1|||
128814475|NCT03785964|463618279|FG000|Overall Study|Not treated|1|||
128814476|NCT03785964|463618280|FG001|Overall Study|Not treated|0|||
128814477|NCT03785964|463618279|FG000|Overall Study|Other reason|5|||
128814478|NCT03785964|463618280|FG001|Overall Study|Other reason|11|||
128814479|NCT03785964|463618279|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
128814480|NCT03785964|463618280|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
128814481|NCT04117347|463618287|FG000|Overall Study|Adverse Event|0|||
128814482|NCT04117347|463618288|FG001|Overall Study|Adverse Event|0|||
128814483|NCT04117347|463618289|FG002|Overall Study|Adverse Event|1|||
128814484|NCT04117347|463618287|FG000|Overall Study|No time for study|0|||
128814485|NCT04117347|463618288|FG001|Overall Study|No time for study|2|||
128814486|NCT04117347|463618289|FG002|Overall Study|No time for study|0|||
128814487|NCT04117347|463618287|FG000|Overall Study|Family emergency|1|||
128814488|NCT04117347|463618288|FG001|Overall Study|Family emergency|0|||
128814489|NCT04117347|463618289|FG002|Overall Study|Family emergency|0|||
128814490|NCT02505984|463618290|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
128814491|NCT02505984|463618291|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
128814492|NCT02505984|463618290|FG000|Overall Study|Unreliable self-report data|1|||
128814493|NCT02505984|463618291|FG001|Overall Study|Unreliable self-report data|0|||
128814494|NCT02505984|463618290|FG000|Overall Study|Study blind opened during assessment|0|||
128814495|NCT02505984|463618291|FG001|Overall Study|Study blind opened during assessment|1|||
128814496|NCT02505984|463618290|FG000|Overall Study|Noncompliance with study protocol|0|||
128814497|NCT02505984|463618291|FG001|Overall Study|Noncompliance with study protocol|1|||
128814498|NCT03687086|463618292|FG000|Overall Study|Withdrawal by Subject|3|||
128814499|NCT03687086|463618293|FG001|Overall Study|Withdrawal by Subject|4|||
128814500|NCT03687086|463618292|FG000|Overall Study|Lost to Follow-up|1|||
128814501|NCT03687086|463618293|FG001|Overall Study|Lost to Follow-up|1|||
128814502|NCT03687086|463618292|FG000|Overall Study|Death|1|||
128814503|NCT03687086|463618293|FG001|Overall Study|Death|0|||
128814504|NCT03687086|463618292|FG000|Overall Study|Incomplete assessment|0|||
128814505|NCT03687086|463618293|FG001|Overall Study|Incomplete assessment|2|||
128814506|NCT04201262|463618298|FG000|Overall Study|Adverse Event|1|||
128814507|NCT04201262|463618299|FG001|Overall Study|Adverse Event|2|||
128814508|NCT04201262|463618298|FG000|Overall Study|Continuing in the study|57|||
128814509|NCT04201262|463618299|FG001|Overall Study|Continuing in the study|0|||
128814510|NCT04201262|463618298|FG000|Overall Study|Withdrawal by Subject|0|||
128814511|NCT04201262|463618299|FG001|Overall Study|Withdrawal by Subject|1|||
128814512|NCT05446168|463618300|FG000|Overall Study|Physician Decision|0|||
128814513|NCT05446168|463618301|FG001|Overall Study|Physician Decision|1|||
128814514|NCT03511664|463618303|FG000|Overall Study|Death|457|||
128814515|NCT03511664|463618304|FG001|Overall Study|Death|201|||
128814516|NCT03511664|463618305|FG002|Overall Study|Death|21|||
128814517|NCT03511664|463618303|FG000|Overall Study|Withdrew consent|40|||
128814518|NCT03511664|463618304|FG001|Overall Study|Withdrew consent|63|||
128814519|NCT03511664|463618305|FG002|Overall Study|Withdrew consent|3|||
128814520|NCT03511664|463618303|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
128814521|NCT03511664|463618304|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
128814522|NCT03511664|463618305|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
128814523|NCT03511664|463618303|FG000|Overall Study|Lost to Follow-up|8|||
128814524|NCT03511664|463618304|FG001|Overall Study|Lost to Follow-up|5|||
128814525|NCT03511664|463618305|FG002|Overall Study|Lost to Follow-up|0|||
128814526|NCT03511664|463618303|FG000|Overall Study|Physician Decision|2|||
128814527|NCT03511664|463618304|FG001|Overall Study|Physician Decision|1|||
128814528|NCT03511664|463618305|FG002|Overall Study|Physician Decision|0|||
128814529|NCT03511664|463618303|FG000|Overall Study|Patient non-compliance|1|||
128814530|NCT03511664|463618304|FG001|Overall Study|Patient non-compliance|0|||
128814531|NCT03511664|463618305|FG002|Overall Study|Patient non-compliance|0|||
128814532|NCT02823145|463618310|FG000|Enrollment|Other|1|||
128814533|NCT02823145|463618311|FG001|Enrollment|Other|0|||
128814534|NCT02823145|463618310|FG000|Treatment|Adverse Event|0|||
128814535|NCT02823145|463618311|FG001|Treatment|Adverse Event|11|||
128814536|NCT02823145|463618310|FG000|Treatment|Death|0|||
128814537|NCT02823145|463618311|FG001|Treatment|Death|3|||
128814538|NCT02823145|463618310|FG000|Treatment|Family Decision|0|||
128814539|NCT02823145|463618311|FG001|Treatment|Family Decision|1|||
128814540|NCT02823145|463618310|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
128814541|NCT02823145|463618311|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
128814542|NCT02823145|463618310|FG000|Treatment|Lack of Efficacy|0|||
128814543|NCT02823145|463618311|FG001|Treatment|Lack of Efficacy|48|||
128814544|NCT02823145|463618310|FG000|Treatment|Non-Compliance With E-Diary|0|||
128814545|NCT02823145|463618311|FG001|Treatment|Non-Compliance With E-Diary|1|||
128814546|NCT02823145|463618310|FG000|Treatment|Physician Decision|0|||
128814547|NCT02823145|463618311|FG001|Treatment|Physician Decision|2|||
128814548|NCT02823145|463618310|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
128814549|NCT02823145|463618311|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
128814550|NCT02823145|463618310|FG000|Treatment|Subject needed to take prohibited medication|0|||
128814551|NCT02823145|463618311|FG001|Treatment|Subject needed to take prohibited medication|1|||
128814552|NCT02823145|463618310|FG000|Treatment|Subject transferred to direct access programme|0|||
128814553|NCT02823145|463618311|FG001|Treatment|Subject transferred to direct access programme|1|||
128814554|NCT02823145|463618310|FG000|Treatment|Switching to commercially available drug|0|||
128814555|NCT02823145|463618311|FG001|Treatment|Switching to commercially available drug|11|||
128814556|NCT02823145|463618310|FG000|Treatment|Transitioned to commercial supply of medication|0|||
128814557|NCT02823145|463618311|FG001|Treatment|Transitioned to commercial supply of medication|1|||
128814558|NCT02823145|463618310|FG000|Treatment|Withdrawal By Caregiver|0|||
128814559|NCT02823145|463618311|FG001|Treatment|Withdrawal By Caregiver|1|||
128814560|NCT02823145|463618310|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
128814561|NCT02823145|463618311|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
128814562|NCT02823145|463618310|FG000|Treatment|Withdrawal by Subject|0|||
128814563|NCT02823145|463618311|FG001|Treatment|Withdrawal by Subject|16|||
128814564|NCT02823145|463618310|FG000|Treatment|Reason unknown|0|||
128814565|NCT02823145|463618311|FG001|Treatment|Reason unknown|1|||
128814566|NCT05292391|463618312|FG000|Overall Study|Lost to Follow-up|0|||
128814567|NCT05292391|463618313|FG001|Overall Study|Lost to Follow-up|0|||
128814568|NCT05292391|463618314|FG002|Overall Study|Lost to Follow-up|0|||
128814569|NCT05292391|463618315|FG003|Overall Study|Lost to Follow-up|1|||
128814570|NCT05292391|463618316|FG004|Overall Study|Lost to Follow-up|0|||
128814571|NCT04857723|463618317|FG000|Overall Study|Withdrawal by Subject|2|||
128814572|NCT03221426|463618318|FG000|Overall Study|Ongoing in study|212|||
128814573|NCT03221426|463618319|FG001|Overall Study|Ongoing in study|193|||
128814574|NCT03221426|463618320|FG002|Overall Study|Ongoing in study|61|||
128814575|NCT03221426|463618321|FG003|Overall Study|Ongoing in study|55|||
128814576|NCT03221426|463618318|FG000|Overall Study|Withdrawal by Subject|12|||
128814577|NCT03221426|463618319|FG001|Overall Study|Withdrawal by Subject|4|||
128814578|NCT03221426|463618320|FG002|Overall Study|Withdrawal by Subject|2|||
128814579|NCT03221426|463618321|FG003|Overall Study|Withdrawal by Subject|3|||
128814580|NCT03221426|463618318|FG000|Overall Study|Lost to Follow-up|4|||
128814581|NCT03221426|463618319|FG001|Overall Study|Lost to Follow-up|1|||
128814582|NCT03221426|463618320|FG002|Overall Study|Lost to Follow-up|1|||
128814583|NCT03221426|463618321|FG003|Overall Study|Lost to Follow-up|0|||
128814584|NCT03221426|463618318|FG000|Overall Study|Death|174|||
128814585|NCT03221426|463618319|FG001|Overall Study|Death|204|||
128814586|NCT03221426|463618320|FG002|Overall Study|Death|36|||
128814587|NCT03221426|463618321|FG003|Overall Study|Death|45|||
128814588|NCT02276885|463620021|FG000|Overall Study|Withdrawal by Subject|2|||
128814589|NCT02276885|463620022|FG001|Overall Study|Withdrawal by Subject|0|||
128814590|NCT02276885|463620021|FG000|Overall Study|Lost to Follow-up|5|||
128814591|NCT02276885|463620022|FG001|Overall Study|Lost to Follow-up|2|||
128814592|NCT04171141|463620026|FG000|Overall Study|Adverse Event|0|||
128814593|NCT04171141|463620027|FG001|Overall Study|Adverse Event|0|||
128814594|NCT04171141|463620028|FG002|Overall Study|Adverse Event|2|||
128814595|NCT04171141|463620029|FG003|Overall Study|Adverse Event|0|||
128814596|NCT04171141|463620030|FG004|Overall Study|Adverse Event|0|||
128814597|NCT04171141|463620031|FG005|Overall Study|Adverse Event|0|||
128814598|NCT04171141|463620032|FG006|Overall Study|Adverse Event|0|||
128814599|NCT04171141|463620033|FG007|Overall Study|Adverse Event|0|||
128814600|NCT04171141|463620034|FG008|Overall Study|Adverse Event|0|||
128814601|NCT04171141|463620035|FG009|Overall Study|Adverse Event|0|||
128814602|NCT04171141|463620036|FG010|Overall Study|Adverse Event|0|||
128814603|NCT04171141|463620037|FG011|Overall Study|Adverse Event|0|||
128814604|NCT04171141|463620038|FG012|Overall Study|Adverse Event|0|||
128814605|NCT04171141|463620039|FG013|Overall Study|Adverse Event|2|||
128814606|NCT04171141|463620040|FG014|Overall Study|Adverse Event|0|||
128814607|NCT04171141|463620041|FG015|Overall Study|Adverse Event|0|||
128814608|NCT04171141|463620026|FG000|Overall Study|Physician Decision|0|||
128814609|NCT04171141|463620027|FG001|Overall Study|Physician Decision|0|||
128814610|NCT04171141|463620028|FG002|Overall Study|Physician Decision|0|||
128814611|NCT04171141|463620029|FG003|Overall Study|Physician Decision|0|||
128814612|NCT04171141|463620030|FG004|Overall Study|Physician Decision|1|||
128814613|NCT04171141|463620031|FG005|Overall Study|Physician Decision|0|||
128814614|NCT04171141|463620032|FG006|Overall Study|Physician Decision|0|||
128814615|NCT04171141|463620033|FG007|Overall Study|Physician Decision|0|||
128814616|NCT04171141|463620034|FG008|Overall Study|Physician Decision|0|||
128814617|NCT04171141|463620035|FG009|Overall Study|Physician Decision|0|||
128814618|NCT04171141|463620036|FG010|Overall Study|Physician Decision|0|||
128814619|NCT04171141|463620037|FG011|Overall Study|Physician Decision|0|||
128814620|NCT04171141|463620038|FG012|Overall Study|Physician Decision|0|||
128814621|NCT04171141|463620039|FG013|Overall Study|Physician Decision|0|||
128814622|NCT04171141|463620040|FG014|Overall Study|Physician Decision|0|||
128814623|NCT04171141|463620041|FG015|Overall Study|Physician Decision|1|||
128814624|NCT04171141|463620026|FG000|Overall Study|Progressive disease|2|||
128814625|NCT04171141|463620027|FG001|Overall Study|Progressive disease|3|||
128814626|NCT04171141|463620028|FG002|Overall Study|Progressive disease|4|||
128814627|NCT04171141|463620029|FG003|Overall Study|Progressive disease|7|||
128814628|NCT04171141|463620030|FG004|Overall Study|Progressive disease|1|||
128814629|NCT04171141|463620031|FG005|Overall Study|Progressive disease|8|||
128814630|NCT04171141|463620032|FG006|Overall Study|Progressive disease|4|||
128814631|NCT04171141|463620033|FG007|Overall Study|Progressive disease|6|||
128814632|NCT04171141|463620034|FG008|Overall Study|Progressive disease|7|||
128814633|NCT04171141|463620035|FG009|Overall Study|Progressive disease|3|||
128814634|NCT04171141|463620036|FG010|Overall Study|Progressive disease|4|||
128814635|NCT04171141|463620037|FG011|Overall Study|Progressive disease|3|||
128814636|NCT04171141|463620038|FG012|Overall Study|Progressive disease|4|||
128814637|NCT04171141|463620039|FG013|Overall Study|Progressive disease|2|||
128814638|NCT04171141|463620040|FG014|Overall Study|Progressive disease|4|||
128814639|NCT04171141|463620041|FG015|Overall Study|Progressive disease|1|||
128814640|NCT04171141|463620026|FG000|Overall Study|Withdrawal by Subject|0|||
128814641|NCT04171141|463620027|FG001|Overall Study|Withdrawal by Subject|0|||
128814642|NCT04171141|463620028|FG002|Overall Study|Withdrawal by Subject|0|||
128814643|NCT04171141|463620029|FG003|Overall Study|Withdrawal by Subject|1|||
128814644|NCT04171141|463620030|FG004|Overall Study|Withdrawal by Subject|0|||
128814645|NCT04171141|463620031|FG005|Overall Study|Withdrawal by Subject|0|||
128814646|NCT04171141|463620032|FG006|Overall Study|Withdrawal by Subject|1|||
128814647|NCT04171141|463620033|FG007|Overall Study|Withdrawal by Subject|0|||
128814648|NCT04171141|463620034|FG008|Overall Study|Withdrawal by Subject|0|||
128814649|NCT04171141|463620035|FG009|Overall Study|Withdrawal by Subject|1|||
128814650|NCT04171141|463620036|FG010|Overall Study|Withdrawal by Subject|0|||
128814651|NCT04171141|463620037|FG011|Overall Study|Withdrawal by Subject|0|||
128814652|NCT04171141|463620038|FG012|Overall Study|Withdrawal by Subject|0|||
128814653|NCT04171141|463620039|FG013|Overall Study|Withdrawal by Subject|0|||
128814654|NCT04171141|463620040|FG014|Overall Study|Withdrawal by Subject|0|||
128814655|NCT04171141|463620041|FG015|Overall Study|Withdrawal by Subject|0|||
128814656|NCT04171141|463620026|FG000|Overall Study|Global deterioration of health status|0|||
128814657|NCT04171141|463620027|FG001|Overall Study|Global deterioration of health status|0|||
128814658|NCT04171141|463620028|FG002|Overall Study|Global deterioration of health status|0|||
128814659|NCT04171141|463620029|FG003|Overall Study|Global deterioration of health status|1|||
128814660|NCT04171141|463620030|FG004|Overall Study|Global deterioration of health status|0|||
128814661|NCT04171141|463620031|FG005|Overall Study|Global deterioration of health status|2|||
128814662|NCT04171141|463620032|FG006|Overall Study|Global deterioration of health status|1|||
128814663|NCT04171141|463620033|FG007|Overall Study|Global deterioration of health status|0|||
128814664|NCT04171141|463620034|FG008|Overall Study|Global deterioration of health status|1|||
128814665|NCT04171141|463620035|FG009|Overall Study|Global deterioration of health status|0|||
128814666|NCT04171141|463620036|FG010|Overall Study|Global deterioration of health status|0|||
128814667|NCT04171141|463620037|FG011|Overall Study|Global deterioration of health status|0|||
128814668|NCT04171141|463620038|FG012|Overall Study|Global deterioration of health status|0|||
128814669|NCT04171141|463620039|FG013|Overall Study|Global deterioration of health status|0|||
128814670|NCT04171141|463620040|FG014|Overall Study|Global deterioration of health status|1|||
128814671|NCT04171141|463620041|FG015|Overall Study|Global deterioration of health status|1|||
128814672|NCT04233216|463620045|FG000|Overall Study|Lost to Follow-up|1|||
128814673|NCT04233216|463620046|FG001|Overall Study|Lost to Follow-up|0|||
128814674|NCT04233216|463620047|FG002|Overall Study|Lost to Follow-up|2|||
128814675|NCT04233216|463620048|FG003|Overall Study|Lost to Follow-up|0|||
128814676|NCT04233216|463620045|FG000|Overall Study|Physician Decision|0|||
128814677|NCT04233216|463620046|FG001|Overall Study|Physician Decision|3|||
128814678|NCT04233216|463620047|FG002|Overall Study|Physician Decision|0|||
128814679|NCT04233216|463620048|FG003|Overall Study|Physician Decision|2|||
128814680|NCT04233216|463620045|FG000|Overall Study|Withdrawal by Subject|0|||
128814681|NCT04233216|463620046|FG001|Overall Study|Withdrawal by Subject|2|||
128814682|NCT04233216|463620047|FG002|Overall Study|Withdrawal by Subject|1|||
128814683|NCT04233216|463620048|FG003|Overall Study|Withdrawal by Subject|0|||
128814684|NCT05034328|463620053|FG000|Overall Study|Protocol Violation|1|||
128814685|NCT05034328|463620054|FG001|Overall Study|Protocol Violation|0|||
128814686|NCT05034328|463620053|FG000|Overall Study|Lost to Follow-up|0|||
128814687|NCT05034328|463620054|FG001|Overall Study|Lost to Follow-up|10|||
128814688|NCT02969707|463620055|FG000|Overall Study|Withdrawal by Subject|6|||
128814689|NCT02969707|463620056|FG001|Overall Study|Withdrawal by Subject|5|||
128814690|NCT02969707|463620055|FG000|Overall Study|Severe anxiety|0|||
128814691|NCT02969707|463620056|FG001|Overall Study|Severe anxiety|1|||
128814692|NCT02969707|463620055|FG000|Overall Study|Positive toxicology screen|0|||
128814693|NCT02969707|463620056|FG001|Overall Study|Positive toxicology screen|2|||
128814694|NCT02969707|463620055|FG000|Overall Study|Claustrophobia|2|||
128814695|NCT02969707|463620056|FG001|Overall Study|Claustrophobia|2|||
128814696|NCT02969707|463620055|FG000|Overall Study|Non-compliance|1|||
128814697|NCT02969707|463620056|FG001|Overall Study|Non-compliance|2|||
128814698|NCT04979442|463620057|FG000|Overall Study|Death|43|||
128814699|NCT04979442|463620058|FG001|Overall Study|Death|30|||
128814700|NCT04979442|463620057|FG000|Overall Study|Withdrawal by Subject|8|||
128814701|NCT04979442|463620058|FG001|Overall Study|Withdrawal by Subject|13|||
128814702|NCT04979442|463620057|FG000|Overall Study|Physician Decision|1|||
128814703|NCT04979442|463620058|FG001|Overall Study|Physician Decision|1|||
128814704|NCT04979442|463620057|FG000|Overall Study|Lost to Follow-up|0|||
128814705|NCT04979442|463620058|FG001|Overall Study|Lost to Follow-up|2|||
128814706|NCT04979442|463620057|FG000|Overall Study|do not want to continue|0|||
128814707|NCT04979442|463620058|FG001|Overall Study|do not want to continue|1|||
128814708|NCT03766685|463620076|FG000|Overall Study|Lost to Follow-up|1|||
128814709|NCT03766685|463620077|FG001|Overall Study|Lost to Follow-up|1|||
128814710|NCT03766685|463620078|FG002|Overall Study|Lost to Follow-up|0|||
128814711|NCT03766685|463620079|FG003|Overall Study|Lost to Follow-up|0|||
128814712|NCT03766685|463620076|FG000|Overall Study|Adverse Event, not fatal|0|||
128814713|NCT03766685|463620077|FG001|Overall Study|Adverse Event, not fatal|1|||
128814714|NCT03766685|463620078|FG002|Overall Study|Adverse Event, not fatal|0|||
128814715|NCT03766685|463620079|FG003|Overall Study|Adverse Event, not fatal|1|||
128814716|NCT03766685|463620076|FG000|Overall Study|Withdrawal by Subject|0|||
128814717|NCT03766685|463620077|FG001|Overall Study|Withdrawal by Subject|2|||
128814718|NCT03766685|463620078|FG002|Overall Study|Withdrawal by Subject|0|||
128814719|NCT03766685|463620079|FG003|Overall Study|Withdrawal by Subject|0|||
128814720|NCT03766685|463620076|FG000|Overall Study|Protocol Violation|0|||
128814721|NCT03766685|463620077|FG001|Overall Study|Protocol Violation|1|||
128814722|NCT03766685|463620078|FG002|Overall Study|Protocol Violation|0|||
128814723|NCT03766685|463620079|FG003|Overall Study|Protocol Violation|0|||
128814724|NCT03766685|463620076|FG000|Overall Study|Non-compliance|0|||
128814725|NCT03766685|463620077|FG001|Overall Study|Non-compliance|2|||
128814726|NCT03766685|463620078|FG002|Overall Study|Non-compliance|0|||
128814727|NCT03766685|463620079|FG003|Overall Study|Non-compliance|0|||
128814728|NCT02927236|463620084|FG000|Characterization Phase|Physician Decision|0|||
128814729|NCT02927236|463620085|FG001|Characterization Phase|Physician Decision|3|||
128814730|NCT02927236|463620086|FG002|Characterization Phase|Physician Decision|0|||
128814731|NCT02927236|463620087|FG003|Characterization Phase|Physician Decision|2|||
128814732|NCT02927236|463620084|FG000|Characterization Phase|Lost to Follow-up|0|||
128814733|NCT02927236|463620085|FG001|Characterization Phase|Lost to Follow-up|0|||
128814734|NCT02927236|463620086|FG002|Characterization Phase|Lost to Follow-up|0|||
128814735|NCT02927236|463620087|FG003|Characterization Phase|Lost to Follow-up|3|||
128814736|NCT02927236|463620084|FG000|Characterization Phase|Withdrawal by Subject|1|||
128814737|NCT02927236|463620085|FG001|Characterization Phase|Withdrawal by Subject|0|||
128814738|NCT02927236|463620086|FG002|Characterization Phase|Withdrawal by Subject|0|||
128814739|NCT02927236|463620087|FG003|Characterization Phase|Withdrawal by Subject|1|||
128814740|NCT02927236|463620084|FG000|Treatment Phase|Adverse Event|1|||
128814741|NCT02927236|463620085|FG001|Treatment Phase|Adverse Event|0|||
128814742|NCT02927236|463620086|FG002|Treatment Phase|Adverse Event|1|||
128814743|NCT02927236|463620087|FG003|Treatment Phase|Adverse Event|1|||
128814744|NCT02927236|463620084|FG000|Treatment Phase|Protocol Violation|3|||
128814745|NCT02927236|463620085|FG001|Treatment Phase|Protocol Violation|0|||
128814746|NCT02927236|463620086|FG002|Treatment Phase|Protocol Violation|0|||
128814747|NCT02927236|463620087|FG003|Treatment Phase|Protocol Violation|1|||
128814748|NCT02927236|463620084|FG000|Treatment Phase|Lost to Follow-up|1|||
128814749|NCT02927236|463620085|FG001|Treatment Phase|Lost to Follow-up|0|||
128814750|NCT02927236|463620086|FG002|Treatment Phase|Lost to Follow-up|0|||
128814751|NCT02927236|463620087|FG003|Treatment Phase|Lost to Follow-up|0|||
128814752|NCT02927236|463620084|FG000|Follow-up Phase|Lost to Follow-up|1|||
128814753|NCT02927236|463620085|FG001|Follow-up Phase|Lost to Follow-up|0|||
128814754|NCT02927236|463620086|FG002|Follow-up Phase|Lost to Follow-up|1|||
128814755|NCT02927236|463620087|FG003|Follow-up Phase|Lost to Follow-up|0|||
128814756|NCT05496231|463620091|FG000|Overall Study|Adverse Event|1|||
128814757|NCT05496231|463620092|FG001|Overall Study|Adverse Event|1|||
128814758|NCT05496231|463620093|FG002|Overall Study|Adverse Event|0|||
128814759|NCT05496231|463620094|FG003|Overall Study|Adverse Event|4|||
128814760|NCT05496231|463620091|FG000|Overall Study|Withdrawal by Subject|5|||
128814761|NCT05496231|463620092|FG001|Overall Study|Withdrawal by Subject|5|||
128814762|NCT05496231|463620093|FG002|Overall Study|Withdrawal by Subject|4|||
128814763|NCT05496231|463620094|FG003|Overall Study|Withdrawal by Subject|11|||
128814764|NCT05496231|463620091|FG000|Overall Study|Migrated/moved from the study area|3|||
128814765|NCT05496231|463620092|FG001|Overall Study|Migrated/moved from the study area|5|||
128814766|NCT05496231|463620093|FG002|Overall Study|Migrated/moved from the study area|3|||
128814767|NCT05496231|463620094|FG003|Overall Study|Migrated/moved from the study area|3|||
128814768|NCT05496231|463620091|FG000|Overall Study|Lost to Follow-up|13|||
128814769|NCT05496231|463620092|FG001|Overall Study|Lost to Follow-up|6|||
128814770|NCT05496231|463620093|FG002|Overall Study|Lost to Follow-up|11|||
128814771|NCT05496231|463620094|FG003|Overall Study|Lost to Follow-up|6|||
128814772|NCT05496231|463620091|FG000|Overall Study|Other|9|||
128814773|NCT05496231|463620092|FG001|Overall Study|Other|7|||
128814774|NCT05496231|463620093|FG002|Overall Study|Other|7|||
128814775|NCT05496231|463620094|FG003|Overall Study|Other|8|||
128814776|NCT05029622|463620099|FG000|Overall Study|Lost to Follow-up|1|||
128814777|NCT03974178|463620101|FG000|Overall Study|Death|0|||
128814778|NCT03974178|463620102|FG001|Overall Study|Death|1|||
128814779|NCT04508309|463620106|FG000|Overall Study|Death|0|||
128814780|NCT04508309|463620107|FG001|Overall Study|Death|0|||
128814781|NCT04508309|463620108|FG002|Overall Study|Death|0|||
128814782|NCT04508309|463620109|FG003|Overall Study|Death|0|||
128814783|NCT04508309|463620110|FG004|Overall Study|Death|1|||
128814784|NCT04508309|463620106|FG000|Overall Study|Lost to Follow-up|0|||
128814785|NCT04508309|463620107|FG001|Overall Study|Lost to Follow-up|0|||
128814786|NCT04508309|463620108|FG002|Overall Study|Lost to Follow-up|1|||
128814787|NCT04508309|463620109|FG003|Overall Study|Lost to Follow-up|1|||
128814788|NCT04508309|463620110|FG004|Overall Study|Lost to Follow-up|0|||
128814789|NCT04508309|463620106|FG000|Overall Study|Withdrawal by Subject|0|||
128814790|NCT04508309|463620107|FG001|Overall Study|Withdrawal by Subject|0|||
128814791|NCT04508309|463620108|FG002|Overall Study|Withdrawal by Subject|0|||
128814792|NCT04508309|463620109|FG003|Overall Study|Withdrawal by Subject|0|||
128814793|NCT04508309|463620110|FG004|Overall Study|Withdrawal by Subject|1|||
128814794|NCT05526430|463620111|FG000|Overall Study|Withdrawal by Subject|0|||
128814795|NCT05526430|463620112|FG001|Overall Study|Withdrawal by Subject|2|||
128814796|NCT05526430|463620113|FG002|Overall Study|Withdrawal by Subject|0|||
128814797|NCT05526430|463620114|FG003|Overall Study|Withdrawal by Subject|0|||
128814798|NCT03085810|463620118|FG000|Main Study|Withdrawal by Subject|77|||
128814799|NCT03085810|463620119|FG001|Main Study|Withdrawal by Subject|0|||
128814800|NCT03085810|463620120|FG002|Main Study|Withdrawal by Subject|0|||
128814801|NCT03085810|463620118|FG000|Main Study|Terminated By Sponsor|14|||
128814802|NCT03085810|463620119|FG001|Main Study|Terminated By Sponsor|0|||
128814803|NCT03085810|463620120|FG002|Main Study|Terminated By Sponsor|0|||
128814804|NCT03085810|463620118|FG000|Main Study|Protocol Violation|15|||
128814805|NCT03085810|463620119|FG001|Main Study|Protocol Violation|0|||
128814806|NCT03085810|463620120|FG002|Main Study|Protocol Violation|0|||
128814807|NCT03085810|463620118|FG000|Main Study|Physician Decision|13|||
128814808|NCT03085810|463620119|FG001|Main Study|Physician Decision|0|||
128814809|NCT03085810|463620120|FG002|Main Study|Physician Decision|0|||
128814810|NCT03085810|463620118|FG000|Main Study|Lost to Follow-up|17|||
128814811|NCT03085810|463620119|FG001|Main Study|Lost to Follow-up|0|||
128814812|NCT03085810|463620120|FG002|Main Study|Lost to Follow-up|0|||
128814813|NCT03085810|463620118|FG000|Main Study|Adverse Event|25|||
128814814|NCT03085810|463620119|FG001|Main Study|Adverse Event|0|||
128814815|NCT03085810|463620120|FG002|Main Study|Adverse Event|0|||
128814816|NCT03085810|463620118|FG000|Main Study|Pregnancy|7|||
128814817|NCT03085810|463620119|FG001|Main Study|Pregnancy|0|||
128814818|NCT03085810|463620120|FG002|Main Study|Pregnancy|0|||
128814819|NCT03085810|463620118|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
128814820|NCT03085810|463620119|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
128814821|NCT03085810|463620120|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
128814822|NCT03085810|463620118|FG000|Main Study|Lack of Efficacy|10|||
128814823|NCT03085810|463620119|FG001|Main Study|Lack of Efficacy|0|||
128814824|NCT03085810|463620120|FG002|Main Study|Lack of Efficacy|0|||
128814825|NCT03085810|463620118|FG000|Main Study|Death|12|||
128814826|NCT03085810|463620119|FG001|Main Study|Death|0|||
128814827|NCT03085810|463620120|FG002|Main Study|Death|0|||
128814828|NCT03085810|463620118|FG000|Main Study|Disease progression|1|||
128814829|NCT03085810|463620119|FG001|Main Study|Disease progression|0|||
128814830|NCT03085810|463620120|FG002|Main Study|Disease progression|0|||
128814831|NCT03085810|463620118|FG000|Main Study|Site Closure|3|||
128814832|NCT03085810|463620119|FG001|Main Study|Site Closure|0|||
128814833|NCT03085810|463620120|FG002|Main Study|Site Closure|0|||
128814834|NCT03085810|463620118|FG000|Main Study|Planned pregnancy|17|||
128814835|NCT03085810|463620119|FG001|Main Study|Planned pregnancy|0|||
128814836|NCT03085810|463620120|FG002|Main Study|Planned pregnancy|0|||
128814837|NCT03085810|463620118|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
128814838|NCT03085810|463620119|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
128814839|NCT03085810|463620120|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
128814840|NCT03085810|463620118|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
128814841|NCT03085810|463620119|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
128814842|NCT03085810|463620120|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
128814843|NCT03085810|463620118|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
128814844|NCT03085810|463620119|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
128814845|NCT03085810|463620120|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
128814846|NCT03085810|463620118|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
128814847|NCT03085810|463620119|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
128814848|NCT03085810|463620120|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
128814849|NCT05200403|463620123|FG000|Overall Study|Withdrawal by Subject|4|||
128814850|NCT05200403|463620124|FG001|Overall Study|Withdrawal by Subject|2|||
128814851|NCT05200403|463620125|FG002|Overall Study|Withdrawal by Subject|6|||
128814852|NCT05073458|463620127|FG000|24-week Double-blind Period|Adverse Event|1|||
128814853|NCT05073458|463620128|FG001|24-week Double-blind Period|Adverse Event|0|||
128814854|NCT05073458|463620127|FG000|24-week Double-blind Period|Physician Decision|1|||
128814855|NCT05073458|463620128|FG001|24-week Double-blind Period|Physician Decision|0|||
128814856|NCT05073458|463620127|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
128814857|NCT05073458|463620128|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
128814858|NCT05073458|463620127|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
128814859|NCT05073458|463620128|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
128814860|NCT05073458|463620127|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
128814861|NCT05073458|463620128|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
128814862|NCT05073458|463620127|FG000|24-week Open-label Period|Adverse Event|1|||
128814863|NCT05073458|463620128|FG001|24-week Open-label Period|Adverse Event|2|||
128814864|NCT00950742|463620134|FG000|Overall Study|Other Adverse Event|1|||
128814865|NCT00950742|463620135|FG001|Overall Study|Other Adverse Event|0|||
128814866|NCT00950742|463620134|FG000|Overall Study|Withdrawal by Subject|3|||
128814867|NCT00950742|463620135|FG001|Overall Study|Withdrawal by Subject|0|||
128814868|NCT00950742|463620134|FG000|Overall Study|Progressive Disease|6|||
128814869|NCT00950742|463620135|FG001|Overall Study|Progressive Disease|2|||
128814870|NCT00950742|463620134|FG000|Overall Study|Dose limiting toxicity|6|||
128814871|NCT00950742|463620135|FG001|Overall Study|Dose limiting toxicity|0|||
128814872|NCT04850898|463620139|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
128814873|NCT04850898|463620140|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
128814874|NCT00592852|463620141|FG000|Overall Study|Non-compliance|1|||
128814875|NCT00592852|463620141|FG000|Overall Study|Adverse Event|3|||
128814876|NCT00592852|463620141|FG000|Overall Study|Found ineligible|1|||
128814877|NCT00592852|463620141|FG000|Overall Study|Withdrawal by Subject|1|||
128814878|NCT05002088|463620143|FG000|Overall Study|Withdrawal by Subject|9|||
128814879|NCT05002088|463620144|FG001|Overall Study|Withdrawal by Subject|0|||
128814880|NCT05002088|463620143|FG000|Overall Study|Lost to Follow-up|0|||
128814881|NCT05002088|463620144|FG001|Overall Study|Lost to Follow-up|1|||
128814882|NCT05002088|463620143|FG000|Overall Study|Death|16|||
128814883|NCT05002088|463620144|FG001|Overall Study|Death|2|||
128814884|NCT05002088|463620143|FG000|Overall Study|Protocol Violation|25|||
128814885|NCT05002088|463620144|FG001|Overall Study|Protocol Violation|7|||
128814886|NCT04068181|463620145|FG000|Overall Study|Death|17|||
128814887|NCT04068181|463620146|FG001|Overall Study|Death|12|||
128814888|NCT04068181|463620147|FG002|Overall Study|Death|4|||
128814889|NCT04068181|463620148|FG003|Overall Study|Death|7|||
128814890|NCT04068181|463620145|FG000|Overall Study|Lost to Follow-up|1|||
128814891|NCT04068181|463620146|FG001|Overall Study|Lost to Follow-up|0|||
128814892|NCT04068181|463620147|FG002|Overall Study|Lost to Follow-up|0|||
128814893|NCT04068181|463620148|FG003|Overall Study|Lost to Follow-up|0|||
128814894|NCT04068181|463620145|FG000|Overall Study|Withdrawal of consent from study|3|||
128814895|NCT04068181|463620146|FG001|Overall Study|Withdrawal of consent from study|0|||
128814896|NCT04068181|463620147|FG002|Overall Study|Withdrawal of consent from study|0|||
128814897|NCT04068181|463620148|FG003|Overall Study|Withdrawal of consent from study|0|||
128814898|NCT05194956|463620149|FG000|Washout Period|Withdrawal by Subject|0|||
128814899|NCT05194956|463620150|FG001|Washout Period|Withdrawal by Subject|2|||
128814900|NCT04515849|463620154|FG000|Overall Study|Adverse Event|0|||
128814901|NCT04515849|463620155|FG001|Overall Study|Adverse Event|0|||
128814902|NCT04515849|463620156|FG002|Overall Study|Adverse Event|0|||
128814903|NCT04515849|463620157|FG003|Overall Study|Adverse Event|1|||
128814904|NCT04515849|463620158|FG004|Overall Study|Adverse Event|2|||
128814905|NCT04515849|463620154|FG000|Overall Study|Death|2|||
128814906|NCT04515849|463620155|FG001|Overall Study|Death|0|||
128814907|NCT04515849|463620156|FG002|Overall Study|Death|0|||
128814908|NCT04515849|463620157|FG003|Overall Study|Death|0|||
128814909|NCT04515849|463620158|FG004|Overall Study|Death|0|||
128814910|NCT04515849|463620154|FG000|Overall Study|Other:family emergency|0|||
128814911|NCT04515849|463620155|FG001|Overall Study|Other:family emergency|0|||
128814912|NCT04515849|463620156|FG002|Overall Study|Other:family emergency|0|||
128814913|NCT04515849|463620157|FG003|Overall Study|Other:family emergency|1|||
128814914|NCT04515849|463620158|FG004|Overall Study|Other:family emergency|0|||
128814915|NCT04515849|463620154|FG000|Overall Study|Other:randomised by error|0|||
128814916|NCT04515849|463620155|FG001|Overall Study|Other:randomised by error|1|||
128814917|NCT04515849|463620156|FG002|Overall Study|Other:randomised by error|0|||
128814918|NCT04515849|463620157|FG003|Overall Study|Other:randomised by error|0|||
128814919|NCT04515849|463620158|FG004|Overall Study|Other:randomised by error|0|||
128814920|NCT04515849|463620154|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
128814921|NCT04515849|463620155|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
128814922|NCT04515849|463620156|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
128814923|NCT04515849|463620157|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
128814924|NCT04515849|463620158|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
128814925|NCT04515849|463620154|FG000|Overall Study|Physician Decision|0|||
128814926|NCT04515849|463620155|FG001|Overall Study|Physician Decision|1|||
128814927|NCT04515849|463620156|FG002|Overall Study|Physician Decision|0|||
128814928|NCT04515849|463620157|FG003|Overall Study|Physician Decision|0|||
128814929|NCT04515849|463620158|FG004|Overall Study|Physician Decision|0|||
128814930|NCT04515849|463620154|FG000|Overall Study|Withdrawal by Subject|1|||
128814931|NCT04515849|463620155|FG001|Overall Study|Withdrawal by Subject|2|||
128814932|NCT04515849|463620156|FG002|Overall Study|Withdrawal by Subject|1|||
128814933|NCT04515849|463620157|FG003|Overall Study|Withdrawal by Subject|0|||
128814934|NCT04515849|463620158|FG004|Overall Study|Withdrawal by Subject|0|||
128814935|NCT04577963|463620164|FG000|Part 2|Death|0|||
128814936|NCT04577963|463620165|FG001|Part 2|Death|1|||
128814937|NCT04577963|463620166|FG002|Part 2|Death|8|||
128814938|NCT04577963|463620167|FG003|Part 2|Death|0|||
128814939|NCT04577963|463620168|FG004|Part 2|Death|20|||
128814940|NCT04577963|463620164|FG000|Part 2|Lost to Follow-up|0|||
128814941|NCT04577963|463620165|FG001|Part 2|Lost to Follow-up|0|||
128814942|NCT04577963|463620166|FG002|Part 2|Lost to Follow-up|0|||
128814943|NCT04577963|463620167|FG003|Part 2|Lost to Follow-up|0|||
128814944|NCT04577963|463620168|FG004|Part 2|Lost to Follow-up|2|||
128814945|NCT04577963|463620164|FG000|Part 2|Withdrawal by Subject|0|||
128814946|NCT04577963|463620165|FG001|Part 2|Withdrawal by Subject|0|||
128814947|NCT04577963|463620166|FG002|Part 2|Withdrawal by Subject|0|||
128814948|NCT04577963|463620167|FG003|Part 2|Withdrawal by Subject|0|||
128814949|NCT04577963|463620168|FG004|Part 2|Withdrawal by Subject|10|||
128814950|NCT04577963|463620164|FG000|Part 2|Progressive disease|0|||
128814951|NCT04577963|463620165|FG001|Part 2|Progressive disease|0|||
128814952|NCT04577963|463620166|FG002|Part 2|Progressive disease|0|||
128814953|NCT04577963|463620167|FG003|Part 2|Progressive disease|0|||
128814954|NCT04577963|463620168|FG004|Part 2|Progressive disease|2|||
128814955|NCT04577963|463620164|FG000|Part 2|Investigator decision|0|||
128814956|NCT04577963|463620165|FG001|Part 2|Investigator decision|0|||
128814957|NCT04577963|463620166|FG002|Part 2|Investigator decision|0|||
128814958|NCT04577963|463620167|FG003|Part 2|Investigator decision|0|||
128814959|NCT04577963|463620168|FG004|Part 2|Investigator decision|1|||
128814960|NCT04577963|463620164|FG000|Part 2|Sponsor terminated study|0|||
128814961|NCT04577963|463620165|FG001|Part 2|Sponsor terminated study|0|||
128814962|NCT04577963|463620166|FG002|Part 2|Sponsor terminated study|3|||
128814963|NCT04577963|463620167|FG003|Part 2|Sponsor terminated study|1|||
128814964|NCT04577963|463620168|FG004|Part 2|Sponsor terminated study|4|||
128814965|NCT03257410|463622272|FG000|Overall Study|Adverse Event|2|||
128814966|NCT03257410|463622273|FG001|Overall Study|Adverse Event|3|||
128814967|NCT03257410|463622272|FG000|Overall Study|Protocol Violation|1|||
128814968|NCT03257410|463622273|FG001|Overall Study|Protocol Violation|2|||
128814969|NCT03257410|463622272|FG000|Overall Study|Lost to Follow-up|1|||
128814970|NCT03257410|463622273|FG001|Overall Study|Lost to Follow-up|0|||
128814971|NCT03257410|463622272|FG000|Overall Study|Withdrawal by Subject|1|||
128814972|NCT03257410|463622273|FG001|Overall Study|Withdrawal by Subject|2|||
128814973|NCT03257410|463622272|FG000|Overall Study|Physician Decision|1|||
128814974|NCT03257410|463622273|FG001|Overall Study|Physician Decision|1|||
128814975|NCT03257410|463622272|FG000|Overall Study|Renal transplantation|2|||
128814976|NCT03257410|463622273|FG001|Overall Study|Renal transplantation|0|||
128814977|NCT03257410|463622272|FG000|Overall Study|Switch to peritoneal dialysis|1|||
128814978|NCT03257410|463622273|FG001|Overall Study|Switch to peritoneal dialysis|0|||
128814979|NCT03257410|463622272|FG000|Overall Study|Death|3|||
128814980|NCT03257410|463622273|FG001|Overall Study|Death|2|||
128814981|NCT03257410|463622272|FG000|Overall Study|Change to another dialysis center|2|||
128814982|NCT03257410|463622273|FG001|Overall Study|Change to another dialysis center|2|||
128814983|NCT03257410|463622272|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
128814984|NCT03257410|463622273|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
128814985|NCT03257410|463622272|FG000|Overall Study|Miscellaneous|2|||
128814986|NCT03257410|463622273|FG001|Overall Study|Miscellaneous|2|||
128814987|NCT03257410|463622272|FG000|Overall Study|Other|0|||
128814988|NCT03257410|463622273|FG001|Overall Study|Other|1|||
128814989|NCT04858451|463622274|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
128814990|NCT04858451|463622275|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814991|NCT04858451|463622276|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814992|NCT04858451|463622277|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814993|NCT04858451|463622278|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814994|NCT04858451|463622279|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814995|NCT04858451|463622280|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814996|NCT04858451|463622281|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814997|NCT04858451|463622282|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
128814998|NCT04858451|463622274|FG000|Part 2|Discontinued|0|||
128814999|NCT04858451|463622275|FG001|Part 2|Discontinued|0|||
128815000|NCT04858451|463622276|FG002|Part 2|Discontinued|0|||
128815001|NCT04858451|463622277|FG003|Part 2|Discontinued|0|||
128815002|NCT04858451|463622278|FG004|Part 2|Discontinued|0|||
128815003|NCT04858451|463622279|FG005|Part 2|Discontinued|0|||
128815004|NCT04858451|463622280|FG006|Part 2|Discontinued|0|||
128815005|NCT04858451|463622281|FG007|Part 2|Discontinued|0|||
128815006|NCT04858451|463622282|FG008|Part 2|Discontinued|63|||
128815007|NCT03314454|463622283|FG000|Overall Study|Protocol Violation|1|||
128815008|NCT03652389|463622284|FG000|Overall Study|Lost to Follow-up|1|||
128815009|NCT03652389|463622285|FG001|Overall Study|Lost to Follow-up|5|||
128815010|NCT03652389|463622284|FG000|Overall Study|Withdrawal by Subject|5|||
128815011|NCT03652389|463622285|FG001|Overall Study|Withdrawal by Subject|1|||
128815012|NCT03652389|463622284|FG000|Overall Study|New diagnosis|2|||
128815013|NCT03652389|463622285|FG001|Overall Study|New diagnosis|0|||
128815014|NCT04298983|463622287|FG000|Overall Study|Adverse Event|4|||
128815015|NCT04298983|463622287|FG000|Overall Study|Lack of Efficacy|3|||
128815016|NCT04248725|463622288|FG000|Post-Treatment|Lost to Follow-up|6|||
128815017|NCT04248725|463622289|FG001|Post-Treatment|Lost to Follow-up|5|||
128815018|NCT04248725|463622288|FG000|6-Month Follow Up|Lost to Follow-up|9|||
128815019|NCT04248725|463622289|FG001|6-Month Follow Up|Lost to Follow-up|8|||
128815020|NCT02116530|463622290|FG000|Overall Study|Withdrawal by Subject|1|||
128815021|NCT02116530|463622291|FG001|Overall Study|Withdrawal by Subject|2|||
128815022|NCT02116530|463622290|FG000|Overall Study|Adverse Event|4|||
128815023|NCT02116530|463622291|FG001|Overall Study|Adverse Event|0|||
128815024|NCT02116530|463622290|FG000|Overall Study|Physician Decision|1|||
128815025|NCT02116530|463622291|FG001|Overall Study|Physician Decision|0|||
128815026|NCT02116530|463622290|FG000|Overall Study|Lost to Follow-up|1|||
128815027|NCT02116530|463622291|FG001|Overall Study|Lost to Follow-up|0|||
128815028|NCT02116530|463622290|FG000|Overall Study|Other Medical Problems|2|||
128815029|NCT02116530|463622291|FG001|Overall Study|Other Medical Problems|2|||
128815030|NCT03656510|463622293|FG000|Overall Study|Lost to Follow-up|1|||
128815031|NCT03656510|463622294|FG001|Overall Study|Lost to Follow-up|0|||
128815032|NCT03656510|463622295|FG002|Overall Study|Lost to Follow-up|0|||
128815033|NCT03656510|463622296|FG003|Overall Study|Lost to Follow-up|0|||
128815034|NCT03656510|463622297|FG004|Overall Study|Lost to Follow-up|0|||
128815035|NCT03656510|463622298|FG005|Overall Study|Lost to Follow-up|0|||
128815036|NCT03656510|463622293|FG000|Overall Study|Withdrawal by Subject|1|||
128815037|NCT03656510|463622294|FG001|Overall Study|Withdrawal by Subject|1|||
128815038|NCT03656510|463622295|FG002|Overall Study|Withdrawal by Subject|0|||
128815039|NCT03656510|463622296|FG003|Overall Study|Withdrawal by Subject|1|||
128815040|NCT03656510|463622297|FG004|Overall Study|Withdrawal by Subject|0|||
128815041|NCT03656510|463622298|FG005|Overall Study|Withdrawal by Subject|0|||
128815042|NCT05671653|463622303|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
128815043|NCT05671653|463622304|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
128815044|NCT05671653|463622305|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
128815045|NCT05671653|463622306|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
128815046|NCT05671653|463622307|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
128815047|NCT05671653|463622308|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
128815048|NCT05671653|463622309|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
128815049|NCT05671653|463622310|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
128815050|NCT05671653|463622311|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
128815051|NCT05671653|463622312|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
128815052|NCT05671653|463622313|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
128815053|NCT05671653|463622314|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
128815054|NCT05671653|463622315|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
128815055|NCT05671653|463622303|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815056|NCT05671653|463622304|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815057|NCT05671653|463622305|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815058|NCT05671653|463622306|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815059|NCT05671653|463622307|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815060|NCT05671653|463622308|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
128815061|NCT05671653|463622309|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815062|NCT05671653|463622310|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815063|NCT05671653|463622311|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815064|NCT05671653|463622312|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815065|NCT05671653|463622313|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815066|NCT05671653|463622314|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815067|NCT05671653|463622315|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
128815068|NCT05671653|463622303|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815069|NCT05671653|463622304|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815070|NCT05671653|463622305|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815071|NCT05671653|463622306|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815072|NCT05671653|463622307|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815073|NCT05671653|463622308|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
128815074|NCT05671653|463622309|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815075|NCT05671653|463622310|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815076|NCT05671653|463622311|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815077|NCT05671653|463622312|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815078|NCT05671653|463622313|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815079|NCT05671653|463622314|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815080|NCT05671653|463622315|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
128815081|NCT05671653|463622303|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815082|NCT05671653|463622304|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815083|NCT05671653|463622305|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815084|NCT05671653|463622306|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815085|NCT05671653|463622307|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815086|NCT05671653|463622308|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815087|NCT05671653|463622309|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815088|NCT05671653|463622310|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815089|NCT05671653|463622311|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
128815090|NCT05671653|463622312|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815091|NCT05671653|463622313|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815092|NCT05671653|463622314|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815093|NCT05671653|463622315|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
128815094|NCT05671653|463622303|FG000|Cohort 2 Period 2|Adverse Event|0|||
128815095|NCT05671653|463622304|FG001|Cohort 2 Period 2|Adverse Event|0|||
128815096|NCT05671653|463622305|FG002|Cohort 2 Period 2|Adverse Event|0|||
128815097|NCT05671653|463622306|FG003|Cohort 2 Period 2|Adverse Event|0|||
128815098|NCT05671653|463622307|FG004|Cohort 2 Period 2|Adverse Event|0|||
128815099|NCT05671653|463622308|FG005|Cohort 2 Period 2|Adverse Event|0|||
128815100|NCT05671653|463622309|FG006|Cohort 2 Period 2|Adverse Event|0|||
128815101|NCT05671653|463622310|FG007|Cohort 2 Period 2|Adverse Event|0|||
128815102|NCT05671653|463622311|FG008|Cohort 2 Period 2|Adverse Event|0|||
128815103|NCT05671653|463622312|FG009|Cohort 2 Period 2|Adverse Event|0|||
128815104|NCT05671653|463622313|FG010|Cohort 2 Period 2|Adverse Event|1|||
128815105|NCT05671653|463622314|FG011|Cohort 2 Period 2|Adverse Event|0|||
128815106|NCT05671653|463622315|FG012|Cohort 2 Period 2|Adverse Event|0|||
128815107|NCT05671653|463622303|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
128815108|NCT05671653|463622304|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
128815109|NCT05671653|463622305|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
128815110|NCT05671653|463622306|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
128815111|NCT05671653|463622307|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
128815112|NCT05671653|463622308|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
128815113|NCT05671653|463622309|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
128815114|NCT05671653|463622310|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
128815115|NCT05671653|463622311|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
128815116|NCT05671653|463622312|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
128815117|NCT05671653|463622313|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
128815118|NCT05671653|463622314|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
128815119|NCT05671653|463622315|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
128815120|NCT05671653|463622303|FG000|Cohort 2 Period 2|Pregnancy|0|||
128815121|NCT05671653|463622304|FG001|Cohort 2 Period 2|Pregnancy|0|||
128815122|NCT05671653|463622305|FG002|Cohort 2 Period 2|Pregnancy|0|||
128815123|NCT05671653|463622306|FG003|Cohort 2 Period 2|Pregnancy|0|||
128815124|NCT05671653|463622307|FG004|Cohort 2 Period 2|Pregnancy|0|||
128815125|NCT05671653|463622308|FG005|Cohort 2 Period 2|Pregnancy|0|||
128815126|NCT05671653|463622309|FG006|Cohort 2 Period 2|Pregnancy|0|||
128815127|NCT05671653|463622310|FG007|Cohort 2 Period 2|Pregnancy|0|||
128815128|NCT05671653|463622311|FG008|Cohort 2 Period 2|Pregnancy|0|||
128815129|NCT05671653|463622312|FG009|Cohort 2 Period 2|Pregnancy|0|||
128815130|NCT05671653|463622313|FG010|Cohort 2 Period 2|Pregnancy|1|||
128815131|NCT05671653|463622314|FG011|Cohort 2 Period 2|Pregnancy|0|||
128815132|NCT05671653|463622315|FG012|Cohort 2 Period 2|Pregnancy|0|||
128815133|NCT05671653|463622303|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815134|NCT05671653|463622304|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815135|NCT05671653|463622305|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815136|NCT05671653|463622306|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815137|NCT05671653|463622307|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815138|NCT05671653|463622308|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815139|NCT05671653|463622309|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815140|NCT05671653|463622310|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815141|NCT05671653|463622311|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815142|NCT05671653|463622312|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815143|NCT05671653|463622313|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
128815144|NCT05671653|463622314|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815145|NCT05671653|463622315|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
128815146|NCT05671653|463622303|FG000|Cohort 2 Period 2|Other|0|||
128815147|NCT05671653|463622304|FG001|Cohort 2 Period 2|Other|0|||
128815148|NCT05671653|463622305|FG002|Cohort 2 Period 2|Other|0|||
128815149|NCT05671653|463622306|FG003|Cohort 2 Period 2|Other|0|||
128815150|NCT05671653|463622307|FG004|Cohort 2 Period 2|Other|0|||
128815151|NCT05671653|463622308|FG005|Cohort 2 Period 2|Other|0|||
128815152|NCT05671653|463622309|FG006|Cohort 2 Period 2|Other|0|||
128815153|NCT05671653|463622310|FG007|Cohort 2 Period 2|Other|0|||
128815154|NCT05671653|463622311|FG008|Cohort 2 Period 2|Other|0|||
128815155|NCT05671653|463622312|FG009|Cohort 2 Period 2|Other|0|||
128815156|NCT05671653|463622313|FG010|Cohort 2 Period 2|Other|1|||
128815157|NCT05671653|463622314|FG011|Cohort 2 Period 2|Other|0|||
128815158|NCT05671653|463622315|FG012|Cohort 2 Period 2|Other|0|||
128815159|NCT05671653|463622303|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815160|NCT05671653|463622304|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815161|NCT05671653|463622305|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815162|NCT05671653|463622306|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815163|NCT05671653|463622307|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815164|NCT05671653|463622308|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815165|NCT05671653|463622309|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815166|NCT05671653|463622310|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815167|NCT05671653|463622311|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815168|NCT05671653|463622312|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815169|NCT05671653|463622313|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815170|NCT05671653|463622314|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
128815171|NCT05671653|463622315|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
128815172|NCT02305888|463622316|FG000|Overall Study|Lost to Follow-up|0|||
128815173|NCT02305888|463622317|FG001|Overall Study|Lost to Follow-up|0|||
128815174|NCT02305888|463622318|FG002|Overall Study|Lost to Follow-up|1|||
128815175|NCT02305888|463622316|FG000|Overall Study|Adverse Event|0|||
128815176|NCT02305888|463622317|FG001|Overall Study|Adverse Event|1|||
128815177|NCT02305888|463622318|FG002|Overall Study|Adverse Event|0|||
128815178|NCT06232590|463622319|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
128815179|NCT06232590|463622320|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
128815180|NCT04914676|463622321|FG000|Overall Study|Study termination|3|||
128815181|NCT04914676|463622322|FG001|Overall Study|Study termination|0|||
128815182|NCT05436262|463622324|FG000|Pre-Randomization|Withdrawal by Subject|1|||
128815183|NCT05436262|463622325|FG001|Pre-Randomization|Withdrawal by Subject|0|||
128815184|NCT05436262|463622326|FG002|Pre-Randomization|Withdrawal by Subject|0|||
128815185|NCT05436262|463622324|FG000|Randomization|Withdrawal by Subject|0|||
128815186|NCT05436262|463622325|FG001|Randomization|Withdrawal by Subject|1|||
128815187|NCT05436262|463622326|FG002|Randomization|Withdrawal by Subject|0|||
128815188|NCT05299073|463622327|FG000|Overall Study|Withdrawal by Subject|0|||
128815189|NCT05299073|463622328|FG001|Overall Study|Withdrawal by Subject|0|||
128815190|NCT05299073|463622329|FG002|Overall Study|Withdrawal by Subject|1|||
128815191|NCT05299073|463622327|FG000|Overall Study|Adverse Event|0|||
128815192|NCT05299073|463622328|FG001|Overall Study|Adverse Event|1|||
128815193|NCT05299073|463622329|FG002|Overall Study|Adverse Event|0|||
128815194|NCT05299073|463622327|FG000|Overall Study|Lost to Follow-up|0|||
128815195|NCT05299073|463622328|FG001|Overall Study|Lost to Follow-up|1|||
128815196|NCT05299073|463622329|FG002|Overall Study|Lost to Follow-up|0|||
128815197|NCT04770402|463622336|FG000|Overall Study|Lost to Follow-up|1|||
128815198|NCT04770402|463622337|FG001|Overall Study|Lost to Follow-up|2|||
128815199|NCT04770402|463622336|FG000|Overall Study|Non-compliance|1|||
128815200|NCT04770402|463622337|FG001|Overall Study|Non-compliance|0|||
128815201|NCT04770402|463622336|FG000|Overall Study|Withdrawal by Subject|0|||
128815202|NCT04770402|463622337|FG001|Overall Study|Withdrawal by Subject|1|||
128815203|NCT03599661|463622339|FG000|Overall Study|Lost to Follow-up|9|||
128815204|NCT04909801|463622340|FG000|Overall Study|Lack of Efficacy|2|||
128815205|NCT04909801|463622341|FG001|Overall Study|Lack of Efficacy|1|||
128815206|NCT04909801|463622340|FG000|Overall Study|Adverse Event|1|||
128815207|NCT04909801|463622341|FG001|Overall Study|Adverse Event|2|||
128815208|NCT04909801|463622340|FG000|Overall Study|Participant request to discontinue study treatment|1|||
128815209|NCT04909801|463622341|FG001|Overall Study|Participant request to discontinue study treatment|2|||
128815210|NCT04909801|463622340|FG000|Overall Study|Withdrawal by Subject|2|||
128815211|NCT04909801|463622341|FG001|Overall Study|Withdrawal by Subject|1|||
128815212|NCT04909801|463622340|FG000|Overall Study|other reasons|1|||
128815213|NCT04909801|463622341|FG001|Overall Study|other reasons|1|||
128815214|NCT04550221|463622344|FG000|Overall Study|Lost to Follow-up|0|||
128815215|NCT04550221|463622345|FG001|Overall Study|Lost to Follow-up|4|||
128815216|NCT04550221|463622344|FG000|Overall Study|Withdrawn|3|||
128815217|NCT04550221|463622345|FG001|Overall Study|Withdrawn|0|||
128815218|NCT04550221|463622344|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
128815219|NCT04550221|463622345|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
128815220|NCT04811040|463622346|FG000|Overall Study|Lost to Follow-up|2|||
128815221|NCT04811040|463622347|FG001|Overall Study|Lost to Follow-up|0|||
128815222|NCT04811040|463622348|FG002|Overall Study|Lost to Follow-up|0|||
128815223|NCT04811040|463622349|FG003|Overall Study|Lost to Follow-up|0|||
128815224|NCT04811040|463622346|FG000|Overall Study|Withdrew consent|1|||
128815225|NCT04811040|463622347|FG001|Overall Study|Withdrew consent|1|||
128815226|NCT04811040|463622348|FG002|Overall Study|Withdrew consent|0|||
128815227|NCT04811040|463622349|FG003|Overall Study|Withdrew consent|0|||
128815228|NCT05274074|463622350|FG000|Overall Study|Lost to Follow-up|2|||
128815229|NCT05274074|463622351|FG001|Overall Study|Lost to Follow-up|3|||
128815230|NCT05274074|463622350|FG000|Overall Study|Withdrawal by Subject|1|||
128815231|NCT05274074|463622351|FG001|Overall Study|Withdrawal by Subject|2|||
128815232|NCT04568434|463622372|FG000|Overall Study|Voluntary Withdrawal|0|||
128815233|NCT04568434|463622373|FG001|Overall Study|Voluntary Withdrawal|1|||
128815234|NCT04568434|463622374|FG002|Overall Study|Voluntary Withdrawal|1|||
128815235|NCT04568434|463622372|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
128815236|NCT04568434|463622373|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
128815237|NCT04568434|463622374|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
128815238|NCT04568434|463622372|FG000|Overall Study|Investigator Judgement|1|||
128815239|NCT04568434|463622373|FG001|Overall Study|Investigator Judgement|0|||
128815240|NCT04568434|463622374|FG002|Overall Study|Investigator Judgement|0|||
128815241|NCT05469464|463622375|FG000|Overall Study|Withdrawal by Subject|8|||
128815242|NCT05469464|463622376|FG001|Overall Study|Withdrawal by Subject|7|||
128815243|NCT05469464|463622377|FG002|Overall Study|Withdrawal by Subject|4|||
128815244|NCT05469464|463622378|FG003|Overall Study|Withdrawal by Subject|5|||
128815245|NCT05469464|463622375|FG000|Overall Study|Adverse Event|8|||
128815246|NCT05469464|463622376|FG001|Overall Study|Adverse Event|14|||
128815247|NCT05469464|463622377|FG002|Overall Study|Adverse Event|13|||
128815248|NCT05469464|463622378|FG003|Overall Study|Adverse Event|2|||
128815249|NCT05469464|463622375|FG000|Overall Study|Lost to Follow-up|2|||
128815250|NCT05469464|463622376|FG001|Overall Study|Lost to Follow-up|5|||
128815251|NCT05469464|463622377|FG002|Overall Study|Lost to Follow-up|3|||
128815252|NCT05469464|463622378|FG003|Overall Study|Lost to Follow-up|3|||
128815253|NCT05469464|463622375|FG000|Overall Study|Lack of Efficacy|4|||
128815254|NCT05469464|463622376|FG001|Overall Study|Lack of Efficacy|1|||
128815255|NCT05469464|463622377|FG002|Overall Study|Lack of Efficacy|2|||
128815256|NCT05469464|463622378|FG003|Overall Study|Lack of Efficacy|2|||
128815257|NCT05469464|463622375|FG000|Overall Study|Physician Decision|0|||
128815258|NCT05469464|463622376|FG001|Overall Study|Physician Decision|0|||
128815259|NCT05469464|463622377|FG002|Overall Study|Physician Decision|0|||
128815260|NCT05469464|463622378|FG003|Overall Study|Physician Decision|1|||
128815261|NCT03905798|463622379|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
128815262|NCT06473662|463622380|FG000|Overall Study|Withdrawal by Subject|1|||
128815263|NCT06473662|463622381|FG001|Overall Study|Withdrawal by Subject|6|||
128815264|NCT06473662|463622382|FG002|Overall Study|Withdrawal by Subject|5|||
128815265|NCT06473662|463622380|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
128815266|NCT06473662|463622381|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
128815267|NCT06473662|463622382|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
128815268|NCT06473662|463622380|FG000|Overall Study|Starting HbA1c below 7%|0|||
128815269|NCT06473662|463622381|FG001|Overall Study|Starting HbA1c below 7%|1|||
128815270|NCT06473662|463622382|FG002|Overall Study|Starting HbA1c below 7%|1|||
128815271|NCT06473662|463622380|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
128815272|NCT06473662|463622381|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
128815273|NCT06473662|463622382|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
128815274|NCT06473662|463622380|FG000|Overall Study|Did not take medication|2|||
128815275|NCT06473662|463622381|FG001|Overall Study|Did not take medication|3|||
128815276|NCT06473662|463622382|FG002|Overall Study|Did not take medication|2|||
128815277|NCT05485779|463622383|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815278|NCT05485779|463622384|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815279|NCT05485779|463622385|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815280|NCT05485779|463622386|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815281|NCT05485779|463622387|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815282|NCT05485779|463622388|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815283|NCT05485779|463622389|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815284|NCT05485779|463622390|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
128815285|NCT05485779|463622391|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
128815286|NCT05485779|463622392|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815287|NCT05485779|463622393|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
128815288|NCT05485779|463622383|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815289|NCT05485779|463622384|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815290|NCT05485779|463622385|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815291|NCT05485779|463622386|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815292|NCT05485779|463622387|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815293|NCT05485779|463622388|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815294|NCT05485779|463622389|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815295|NCT05485779|463622390|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815296|NCT05485779|463622391|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815297|NCT05485779|463622392|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
128815298|NCT05485779|463622393|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
128815299|NCT05485779|463622383|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815300|NCT05485779|463622384|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815301|NCT05485779|463622385|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815302|NCT05485779|463622386|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
128815303|NCT05485779|463622387|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815304|NCT05485779|463622388|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815305|NCT05485779|463622389|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815306|NCT05485779|463622390|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815307|NCT05485779|463622391|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815308|NCT05485779|463622392|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815309|NCT05485779|463622393|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
128815310|NCT03463044|463622396|FG000|Overall Study|Lost to Follow-up|0|||
128815311|NCT03463044|463622397|FG001|Overall Study|Lost to Follow-up|0|||
128815312|NCT03463044|463622398|FG002|Overall Study|Lost to Follow-up|0|||
128815313|NCT03463044|463622399|FG003|Overall Study|Lost to Follow-up|0|||
128815314|NCT03463044|463622400|FG004|Overall Study|Lost to Follow-up|0|||
128815315|NCT03463044|463622401|FG005|Overall Study|Lost to Follow-up|0|||
128815316|NCT03463044|463622402|FG006|Overall Study|Lost to Follow-up|0|||
128815317|NCT03463044|463622403|FG007|Overall Study|Lost to Follow-up|1|||
128815318|NCT03463044|463622404|FG008|Overall Study|Lost to Follow-up|0|||
128815319|NCT05192109|463622407|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
128815320|NCT05192109|463622408|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
128815321|NCT05192109|463622409|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
128815322|NCT05192109|463622410|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
128815323|NCT05192109|463622407|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
128815324|NCT05192109|463622408|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
128815325|NCT05192109|463622409|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
128815326|NCT05192109|463622410|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
128815327|NCT04498390|463622411|FG000|Overall Study|Adverse Event|0|||
128815328|NCT04498390|463622412|FG001|Overall Study|Adverse Event|0|||
128815329|NCT04498390|463622413|FG002|Overall Study|Adverse Event|1|||
128815330|NCT04498390|463622414|FG003|Overall Study|Adverse Event|0|||
128815331|NCT04498390|463622415|FG004|Overall Study|Adverse Event|0|||
128815332|NCT04498390|463622411|FG000|Overall Study|Withdrawal by Subject|0|||
128815333|NCT04498390|463622412|FG001|Overall Study|Withdrawal by Subject|0|||
128815334|NCT04498390|463622413|FG002|Overall Study|Withdrawal by Subject|0|||
128815335|NCT04498390|463622414|FG003|Overall Study|Withdrawal by Subject|1|||
128815336|NCT04498390|463622415|FG004|Overall Study|Withdrawal by Subject|0|||
128815337|NCT05170841|463622420|FG000|Single Dose Phase|Adverse Event|1|||
128815338|NCT05170841|463622421|FG001|Single Dose Phase|Adverse Event|2|||
128815339|NCT05170841|463622422|FG002|Single Dose Phase|Adverse Event|0|||
128815340|NCT05170841|463622423|FG003|Single Dose Phase|Adverse Event|2|||
128815341|NCT05170841|463622420|FG000|Multiple Dose Phase|Adverse Event|1|||
128815342|NCT05170841|463622421|FG001|Multiple Dose Phase|Adverse Event|2|||
128815343|NCT05170841|463622422|FG002|Multiple Dose Phase|Adverse Event|1|||
128815344|NCT05170841|463622423|FG003|Multiple Dose Phase|Adverse Event|4|||
128815345|NCT05170841|463622420|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
128815346|NCT05170841|463622421|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
128815347|NCT05170841|463622422|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
128815348|NCT05170841|463622423|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
128815349|NCT04865289|463622424|FG000|Overall Study|Participant ongoing in study|47|||
128815350|NCT04865289|463622425|FG001|Overall Study|Participant ongoing in study|35|||
128815351|NCT04865289|463622424|FG000|Overall Study|Death|27|||
128815352|NCT04865289|463622425|FG001|Overall Study|Death|21|||
128815353|NCT02733159|463622428|FG000|Overall Study|Adverse Event|1|||
128815354|NCT02733159|463622428|FG000|Overall Study|Lack of disease progression|1|||
128815355|NCT06122194|463622429|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
128815356|NCT06122194|463622430|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
128815357|NCT06122194|463622431|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
128815358|NCT06122194|463622432|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
128815359|NCT02709161|463622441|FG000|Overall Study|Withdrawal by Subject|1|||
128815360|NCT02709161|463622442|FG001|Overall Study|Withdrawal by Subject|0|||
128815361|NCT03626220|463622443|FG000|Overall Study|Withdrawal by Subject|2|||
128815362|NCT03626220|463622444|FG001|Overall Study|Withdrawal by Subject|0|||
128815363|NCT02561247|463623753|FG000|Overall Study|Protocol Violation|1|||
128815364|NCT02561247|463623753|FG000|Overall Study|Withdrawal by Subject|1|||
128815365|NCT02561247|463623753|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
128815366|NCT03663569|463623754|FG000|Overall Study|Discontinuation of study|11|||
128815367|NCT03663569|463623754|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
128815368|NCT03663569|463623754|FG000|Overall Study|Deceased patient|6|||
128815369|NCT03663569|463623754|FG000|Overall Study|Lost to Follow-up|18|||
128815370|NCT03663569|463623754|FG000|Overall Study|Withdrawal of consent|5|||
128815371|NCT03663569|463623754|FG000|Overall Study|Patient's request|11|||
128815372|NCT03663569|463623754|FG000|Overall Study|Adverse Event|4|||
128815373|NCT03663569|463623754|FG000|Overall Study|Not come to second visit|3|||
128815374|NCT03663569|463623754|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
128815375|NCT03663569|463623754|FG000|Overall Study|Serious adverse event|1|||
128815376|NCT04231149|463623755|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
128815377|NCT04231149|463623756|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
128815378|NCT04231149|463623757|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
128815379|NCT04231149|463623758|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
128815380|NCT04231149|463623759|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
128815381|NCT05877976|463623760|FG000|Overall Study|Lost to Follow-up|31|||
128815382|NCT05622812|463623761|FG000|Overall Study|Withdrawal by Subject|1|||
128815383|NCT05622812|463623762|FG001|Overall Study|Withdrawal by Subject|4|||
128815384|NCT05622812|463623761|FG000|Overall Study|Lost to Follow-up|2|||
128815385|NCT05622812|463623762|FG001|Overall Study|Lost to Follow-up|1|||
128815386|NCT02844465|463623763|FG000|Overall Study|Screen Failure|36|||
128815387|NCT02844465|463623763|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
128815388|NCT02844465|463623763|FG000|Overall Study|Withdrawal by Subject|5|||
128815389|NCT02844465|463623763|FG000|Overall Study|Lost to Follow-up|1|||
128815390|NCT02844465|463623763|FG000|Overall Study|Retreatment|1|||
128815391|NCT03819153|463623764|FG000|Overall Study|Withdrawal by Subject|20|||
128815392|NCT03819153|463623765|FG001|Overall Study|Withdrawal by Subject|28|||
128815393|NCT03819153|463623764|FG000|Overall Study|Lost to Follow-up|23|||
128815394|NCT03819153|463623765|FG001|Overall Study|Lost to Follow-up|30|||
128815395|NCT03240016|463623772|FG000|Overall Study|Adverse Event|9|||
128815396|NCT03240016|463623772|FG000|Overall Study|Withdrawal by Subject|7|||
128815397|NCT03240016|463623772|FG000|Overall Study|Death|1|||
128815398|NCT03240016|463623772|FG000|Overall Study|Physician Decision|2|||
128815399|NCT03913442|463623773|FG000|Overall Study|Adverse Event|0|||
128815400|NCT03913442|463623774|FG001|Overall Study|Adverse Event|3|||
128815401|NCT03913442|463623773|FG000|Overall Study|Withdrawal by Subject|5|||
128815402|NCT03913442|463623774|FG001|Overall Study|Withdrawal by Subject|5|||
128815403|NCT03913442|463623773|FG000|Overall Study|Terminations|2|||
128815404|NCT03913442|463623774|FG001|Overall Study|Terminations|1|||
128815405|NCT03913442|463623773|FG000|Overall Study|Lost to Follow-up|2|||
128815406|NCT03913442|463623774|FG001|Overall Study|Lost to Follow-up|2|||
128815407|NCT05070728|463623775|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
128815408|NCT05070728|463623776|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
128815409|NCT02589795|463623778|FG000|Overall Study|Lost to Follow-up|1|||
128815410|NCT02589795|463623779|FG001|Overall Study|Lost to Follow-up|0|||
128815411|NCT02589795|463623780|FG002|Overall Study|Lost to Follow-up|0|||
128815412|NCT02589795|463623778|FG000|Overall Study|Withdrawal by Subject|0|||
128815413|NCT02589795|463623779|FG001|Overall Study|Withdrawal by Subject|0|||
128815414|NCT02589795|463623780|FG002|Overall Study|Withdrawal by Subject|2|||
128815415|NCT02589795|463623778|FG000|Overall Study|Protocol Violation|0|||
128815416|NCT02589795|463623779|FG001|Overall Study|Protocol Violation|0|||
128815417|NCT02589795|463623780|FG002|Overall Study|Protocol Violation|1|||
128815418|NCT01828099|463623791|FG000|Treatment Period|Adverse Event|24|||
128815419|NCT01828099|463623792|FG001|Treatment Period|Adverse Event|23|||
128815420|NCT01828099|463623791|FG000|Treatment Period|Death|10|||
128815421|NCT01828099|463623792|FG001|Treatment Period|Death|12|||
128815422|NCT01828099|463623791|FG000|Treatment Period|Lost to Follow-up|2|||
128815423|NCT01828099|463623792|FG001|Treatment Period|Lost to Follow-up|1|||
128815424|NCT01828099|463623791|FG000|Treatment Period|Non-compliance with study treatment|1|||
128815425|NCT01828099|463623792|FG001|Treatment Period|Non-compliance with study treatment|0|||
128815426|NCT01828099|463623791|FG000|Treatment Period|Physician Decision|17|||
128815427|NCT01828099|463623792|FG001|Treatment Period|Physician Decision|16|||
128815428|NCT01828099|463623791|FG000|Treatment Period|Progressive disease|99|||
128815429|NCT01828099|463623792|FG001|Treatment Period|Progressive disease|107|||
128815430|NCT01828099|463623791|FG000|Treatment Period|Subject/guardian decision|22|||
128815431|NCT01828099|463623792|FG001|Treatment Period|Subject/guardian decision|26|||
128815432|NCT01828099|463623791|FG000|Treatment Period|Study terminated by Sponsor|13|||
128815433|NCT01828099|463623792|FG001|Treatment Period|Study terminated by Sponsor|1|||
128815434|NCT01828099|463623791|FG000|Treatment Period|Protocol deviation|1|||
128815435|NCT01828099|463623792|FG001|Treatment Period|Protocol deviation|0|||
128815436|NCT01828099|463623791|FG000|Treatment Period|No longer requires treatment|0|||
128815437|NCT01828099|463623792|FG001|Treatment Period|No longer requires treatment|1|||
128815438|NCT01828099|463623791|FG000|Extension-treatment Phase|Adverse Event|0|||
128815439|NCT01828099|463623792|FG001|Extension-treatment Phase|Adverse Event|17|||
128815440|NCT01828099|463623791|FG000|Extension-treatment Phase|Death|0|||
128815441|NCT01828099|463623792|FG001|Extension-treatment Phase|Death|11|||
128815442|NCT01828099|463623791|FG000|Extension-treatment Phase|Physician Decision|0|||
128815443|NCT01828099|463623792|FG001|Extension-treatment Phase|Physician Decision|5|||
128815444|NCT01828099|463623791|FG000|Extension-treatment Phase|Progressive disease|0|||
128815445|NCT01828099|463623792|FG001|Extension-treatment Phase|Progressive disease|54|||
128815446|NCT01828099|463623791|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
128815447|NCT01828099|463623792|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
128815448|NCT01828099|463623791|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
128815449|NCT01828099|463623792|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
128815450|NCT05934942|463623796|FG000|Run-in Period|Not treated|1|||
128815451|NCT05934942|463623796|FG000|Run-in Period|Withdrawal by Subject|1|||
128815452|NCT04362254|463623797|FG000|Overall Study|Adverse Event|1|||
128815453|NCT04362254|463623797|FG000|Overall Study|Protocol Violation|1|||
128815454|NCT04362254|463623797|FG000|Overall Study|Due to early termination of the trial|10|||
128815455|NCT00321048|463623798|FG000|Overall Study|Withdrawal by Subject|6|||
128815456|NCT00321048|463623799|FG001|Overall Study|Withdrawal by Subject|8|||
128815457|NCT04707625|463623800|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
128815458|NCT04471246|463623803|FG000|Overall Study|Lost to Follow-up|2|||
128815459|NCT04471246|463623804|FG001|Overall Study|Lost to Follow-up|2|||
128815460|NCT05764525|463623805|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
128815461|NCT05764525|463623806|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
128815462|NCT05764525|463623805|FG000|Overall Study|Withdrawal by Subject|4|||
128815463|NCT05764525|463623806|FG001|Overall Study|Withdrawal by Subject|8|||
128815464|NCT05764525|463623805|FG000|Overall Study|Physician Decision|1|||
128815465|NCT05764525|463623806|FG001|Overall Study|Physician Decision|0|||
128815466|NCT03334630|463623807|FG000|Overall Study|Withdrawal by Subject|7|||
128815467|NCT03334630|463623808|FG001|Overall Study|Withdrawal by Subject|7|||
128815468|NCT03334630|463623807|FG000|Overall Study|Lost to Follow-up|3|||
128815469|NCT03334630|463623808|FG001|Overall Study|Lost to Follow-up|1|||
128815470|NCT03334630|463623807|FG000|Overall Study|Adverse Event|0|||
128815471|NCT03334630|463623808|FG001|Overall Study|Adverse Event|1|||
128815472|NCT03334630|463623807|FG000|Overall Study|Physician Decision|1|||
128815473|NCT03334630|463623808|FG001|Overall Study|Physician Decision|1|||
128815474|NCT03334630|463623807|FG000|Overall Study|Enrollment closed|2|||
128815475|NCT03334630|463623808|FG001|Overall Study|Enrollment closed|1|||
128815476|NCT03334630|463623807|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
128815477|NCT03334630|463623808|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
128815478|NCT03334630|463623807|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
128815479|NCT03334630|463623808|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
128815480|NCT03030261|463623810|FG000|Overall Study|Still receiving continuation therapy|5|||
128815481|NCT05370040|463623814|FG000|Overall Study|Lost to Follow-up|0|||
128815482|NCT05370040|463623815|FG001|Overall Study|Lost to Follow-up|0|||
128815483|NCT05370040|463623816|FG002|Overall Study|Lost to Follow-up|1|||
128815484|NCT05370040|463623817|FG003|Overall Study|Lost to Follow-up|0|||
128815485|NCT05370040|463623818|FG004|Overall Study|Lost to Follow-up|1|||
128815486|NCT05370040|463623819|FG005|Overall Study|Lost to Follow-up|0|||
128815487|NCT04971109|463623820|FG000|Overall Study|Adverse Event|4|||
128815488|NCT04971109|463623821|FG001|Overall Study|Adverse Event|3|||
128815489|NCT04971109|463623820|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
128815490|NCT04971109|463623821|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
128815491|NCT04971109|463623820|FG000|Overall Study|Lost to Follow-up|8|||
128815492|NCT04971109|463623821|FG001|Overall Study|Lost to Follow-up|2|||
128815493|NCT04971109|463623820|FG000|Overall Study|Physician Decision|5|||
128815494|NCT04971109|463623821|FG001|Overall Study|Physician Decision|0|||
128815495|NCT04971109|463623820|FG000|Overall Study|Protocol Violation|0|||
128815496|NCT04971109|463623821|FG001|Overall Study|Protocol Violation|1|||
128815497|NCT04971109|463623820|FG000|Overall Study|Withdrawal by Subject|18|||
128815498|NCT04971109|463623821|FG001|Overall Study|Withdrawal by Subject|3|||
128815499|NCT04971109|463623820|FG000|Overall Study|Subject was randomized in error|1|||
128815500|NCT04971109|463623821|FG001|Overall Study|Subject was randomized in error|0|||
128815501|NCT03910478|463623822|FG000|Overall Study|Death|13|||
128815502|NCT03910478|463623823|FG001|Overall Study|Death|6|||
128815503|NCT03910478|463623822|FG000|Overall Study|Withdrawal by Subject|23|||
128815504|NCT03910478|463623823|FG001|Overall Study|Withdrawal by Subject|2|||
128815505|NCT03910478|463623822|FG000|Overall Study|Physician Decision|5|||
128815506|NCT03910478|463623823|FG001|Overall Study|Physician Decision|0|||
128815507|NCT03910478|463623822|FG000|Overall Study|Protocol Violation|1|||
128815508|NCT03910478|463623823|FG001|Overall Study|Protocol Violation|0|||
128815509|NCT03910478|463623822|FG000|Overall Study|Failure to meet continuation criteria|2|||
128815510|NCT03910478|463623823|FG001|Overall Study|Failure to meet continuation criteria|0|||
128815511|NCT03910478|463623822|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
128815512|NCT03910478|463623823|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
128815513|NCT05293171|463623825|FG000|Washout 5 to 7 Days|Adverse Event|1|||
128815514|NCT05293171|463623826|FG001|Washout 5 to 7 Days|Adverse Event|1|||
128815515|NCT05293171|463623827|FG002|Washout 5 to 7 Days|Adverse Event|0|||
128815516|NCT05293171|463623828|FG003|Washout 5 to 7 Days|Adverse Event|0|||
128815517|NCT05293171|463623829|FG004|Washout 5 to 7 Days|Adverse Event|0|||
128815518|NCT05293171|463623830|FG005|Washout 5 to 7 Days|Adverse Event|0|||
128815519|NCT05293171|463623831|FG006|Washout 5 to 7 Days|Adverse Event|0|||
128815520|NCT05293171|463623832|FG007|Washout 5 to 7 Days|Adverse Event|0|||
128815521|NCT05293171|463623833|FG008|Washout 5 to 7 Days|Adverse Event|0|||
128815522|NCT05293171|463623834|FG009|Washout 5 to 7 Days|Adverse Event|0|||
128815523|NCT05293171|463623835|FG010|Washout 5 to 7 Days|Adverse Event|0|||
128815524|NCT05293171|463623836|FG011|Washout 5 to 7 Days|Adverse Event|0|||
128815525|NCT05293171|463623825|FG000|Washout 5 to 7 Days|Adverse Event|0|||
128815526|NCT05293171|463623826|FG001|Washout 5 to 7 Days|Adverse Event|0|||
128815527|NCT05293171|463623827|FG002|Washout 5 to 7 Days|Adverse Event|0|||
128815528|NCT05293171|463623828|FG003|Washout 5 to 7 Days|Adverse Event|0|||
128815529|NCT05293171|463623829|FG004|Washout 5 to 7 Days|Adverse Event|0|||
128815530|NCT05293171|463623830|FG005|Washout 5 to 7 Days|Adverse Event|1|||
128815531|NCT05293171|463623831|FG006|Washout 5 to 7 Days|Adverse Event|0|||
128815532|NCT05293171|463623832|FG007|Washout 5 to 7 Days|Adverse Event|0|||
128815533|NCT05293171|463623833|FG008|Washout 5 to 7 Days|Adverse Event|0|||
128815534|NCT05293171|463623834|FG009|Washout 5 to 7 Days|Adverse Event|0|||
128815535|NCT05293171|463623835|FG010|Washout 5 to 7 Days|Adverse Event|0|||
128815536|NCT05293171|463623836|FG011|Washout 5 to 7 Days|Adverse Event|0|||
128815537|NCT03987022|463623844|FG000|Overall Study|Lost to Follow-up|2|||
128815538|NCT03987022|463623845|FG001|Overall Study|Lost to Follow-up|2|||
128815539|NCT03987022|463623844|FG000|Overall Study|Withdrawal by Subject|1|||
128815540|NCT03987022|463623845|FG001|Overall Study|Withdrawal by Subject|0|||
128815541|NCT03478956|463623846|FG000|Randomized Treatment Period|Adverse Event|1|||
128815542|NCT03478956|463623847|FG001|Randomized Treatment Period|Adverse Event|0|||
128815543|NCT03478956|463623848|FG002|Randomized Treatment Period|Adverse Event|0|||
128815544|NCT03478956|463623849|FG003|Randomized Treatment Period|Adverse Event|0|||
128815545|NCT03478956|463623846|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
128815546|NCT03478956|463623847|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
128815547|NCT03478956|463623848|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
128815548|NCT03478956|463623849|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
128815549|NCT03478956|463623846|FG000|Open Label Extension Period|Adverse Event|0|||
128815550|NCT03478956|463623847|FG001|Open Label Extension Period|Adverse Event|0|||
128815551|NCT03478956|463623848|FG002|Open Label Extension Period|Adverse Event|4|||
128815552|NCT03478956|463623849|FG003|Open Label Extension Period|Adverse Event|0|||
128815553|NCT03478956|463623846|FG000|Open Label Extension Period|Lack of Efficacy|0|||
128815554|NCT03478956|463623847|FG001|Open Label Extension Period|Lack of Efficacy|0|||
128815555|NCT03478956|463623848|FG002|Open Label Extension Period|Lack of Efficacy|8|||
128815556|NCT03478956|463623849|FG003|Open Label Extension Period|Lack of Efficacy|0|||
128815557|NCT03478956|463623846|FG000|Open Label Extension Period|Reason Not Provided|0|||
128815558|NCT03478956|463623847|FG001|Open Label Extension Period|Reason Not Provided|0|||
128815559|NCT03478956|463623848|FG002|Open Label Extension Period|Reason Not Provided|1|||
128815560|NCT03478956|463623849|FG003|Open Label Extension Period|Reason Not Provided|0|||
128815561|NCT03478956|463623846|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
128815562|NCT03478956|463623847|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
128815563|NCT03478956|463623848|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
128815564|NCT03478956|463623849|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
128815565|NCT03478956|463623846|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
128815566|NCT03478956|463623847|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
128815567|NCT03478956|463623848|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
128815568|NCT03478956|463623849|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
128815569|NCT03478956|463623846|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
128815570|NCT03478956|463623847|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
128815571|NCT03478956|463623848|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
128815572|NCT03478956|463623849|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
128815573|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
128815574|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
128815575|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
128815576|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
128815577|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
128815578|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
128815579|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
128815580|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
128815581|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
128815582|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
128815583|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
128815584|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
128815585|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
128815586|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
128815587|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
128815588|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
128815589|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
128815590|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
128815591|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
128815592|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
128815593|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
128815594|NCT04800211|463623850|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
128815595|NCT04800211|463623851|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
128815596|NCT04800211|463623852|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
128815597|NCT04800211|463623850|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
128815598|NCT04800211|463623851|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
128815599|NCT04800211|463623852|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
128815600|NCT04800211|463623850|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
128815601|NCT04800211|463623851|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
128815602|NCT04800211|463623852|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
128815603|NCT04800211|463623850|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
128815604|NCT04800211|463623851|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
128815605|NCT04800211|463623852|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
128815606|NCT05123586|463623855|FG000|Overall Study|Physician Decision|1|||
128815607|NCT05123586|463623856|FG001|Overall Study|Physician Decision|1|||
128815608|NCT05123586|463623855|FG000|Overall Study|Withdrawal by Subject|0|||
128815609|NCT05123586|463623856|FG001|Overall Study|Withdrawal by Subject|3|||
128815610|NCT03734679|463623862|FG000|Overall Study|Missed Visit|1|||
128815611|NCT02887521|463623872|FG000|Overall Study|Withdrawal by Subject|0|||
128815612|NCT02887521|463623873|FG001|Overall Study|Withdrawal by Subject|3|||
128815613|NCT03916185|463625105|FG000|Overall Study|Lost to Follow-up|0|||
128815614|NCT03916185|463625106|FG001|Overall Study|Lost to Follow-up|1|||
128815615|NCT03916185|463625107|FG002|Overall Study|Lost to Follow-up|0|||
128815616|NCT03916185|463625108|FG003|Overall Study|Lost to Follow-up|0|||
128815617|NCT03916185|463625105|FG000|Overall Study|Moved|1|||
128815618|NCT03916185|463625106|FG001|Overall Study|Moved|0|||
128815619|NCT03916185|463625107|FG002|Overall Study|Moved|0|||
128815620|NCT03916185|463625108|FG003|Overall Study|Moved|1|||
128815621|NCT03916185|463625105|FG000|Overall Study|Not Able to Get to Clinic|1|||
128815622|NCT03916185|463625106|FG001|Overall Study|Not Able to Get to Clinic|0|||
128815623|NCT03916185|463625107|FG002|Overall Study|Not Able to Get to Clinic|0|||
128815624|NCT03916185|463625108|FG003|Overall Study|Not Able to Get to Clinic|0|||
128815625|NCT05299723|463625116|FG000|Overall Study|Withdrawal by Subject|0|||
128815626|NCT05299723|463625117|FG001|Overall Study|Withdrawal by Subject|2|||
128815627|NCT05299723|463625118|FG002|Overall Study|Withdrawal by Subject|0|||
128815628|NCT02460458|463625119|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
128815629|NCT02460458|463625119|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
128815630|NCT02460458|463625119|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
128815631|NCT02460458|463625119|FG000|First Prospective Phase|Lost to Follow-up|84|||
128815632|NCT02460458|463625119|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
128815633|NCT03220035|463625120|FG000|Overall Study|Adverse Event|1|||
128815634|NCT03220035|463625120|FG000|Overall Study|Protocol Violation|1|||
128815635|NCT03220035|463625120|FG000|Overall Study|Progressive Disease|2|||
128815636|NCT02433379|463625124|FG000|Overall Study|Screen Failures|55|||
128815637|NCT02433379|463625124|FG000|Overall Study|Death|57|||
128815638|NCT02433379|463625124|FG000|Overall Study|Total Withdrawals|209|||
128815639|NCT03952338|463625125|FG000|Overall Study|Lost to Follow-up|11|||
128815640|NCT03952338|463625126|FG001|Overall Study|Lost to Follow-up|17|||
128815641|NCT03952338|463625125|FG000|Overall Study|Withdrawal by Subject|1|||
128815642|NCT03952338|463625126|FG001|Overall Study|Withdrawal by Subject|1|||
128815643|NCT03952338|463625125|FG000|Overall Study|Protocol Violation|1|||
128815644|NCT03952338|463625126|FG001|Overall Study|Protocol Violation|0|||
128815645|NCT02593773|463625131|FG000|Overall Study|Voluntary Withdrawal|3|||
128815646|NCT02593773|463625131|FG000|Overall Study|Study Terminated by Sponsor|31|||
128815647|NCT02593773|463625131|FG000|Overall Study|Death|1|||
128815648|NCT05452460|463625133|FG000|Overall Study|Lost to Follow-up|3|||
128815649|NCT05452460|463625134|FG001|Overall Study|Lost to Follow-up|3|||
128815650|NCT05452460|463625133|FG000|Overall Study|Did not receive intervention|1|||
128815651|NCT05452460|463625134|FG001|Overall Study|Did not receive intervention|0|||
128815652|NCT04447040|463625137|FG000|Overall Study|Lost to Follow-up|2|||
128815653|NCT04447040|463625138|FG001|Overall Study|Lost to Follow-up|1|||
128815654|NCT04447040|463625139|FG002|Overall Study|Lost to Follow-up|3|||
128815655|NCT04447040|463625140|FG003|Overall Study|Lost to Follow-up|3|||
128815656|NCT04447040|463625141|FG004|Overall Study|Lost to Follow-up|1|||
128815657|NCT04447040|463625142|FG005|Overall Study|Lost to Follow-up|3|||
128815658|NCT04447040|463625137|FG000|Overall Study|Withdrawal by Subject|0|||
128815659|NCT04447040|463625138|FG001|Overall Study|Withdrawal by Subject|1|||
128815660|NCT04447040|463625139|FG002|Overall Study|Withdrawal by Subject|1|||
128815661|NCT04447040|463625140|FG003|Overall Study|Withdrawal by Subject|1|||
128815662|NCT04447040|463625141|FG004|Overall Study|Withdrawal by Subject|0|||
128815663|NCT04447040|463625142|FG005|Overall Study|Withdrawal by Subject|0|||
128815664|NCT01208662|463625143|FG000|Induction and Consolidation|Disease Progression|23|||
128815665|NCT01208662|463625144|FG001|Induction and Consolidation|Disease Progression|13|||
128815666|NCT01208662|463625145|FG002|Induction and Consolidation|Disease Progression|0|||
128815667|NCT01208662|463625143|FG000|Induction and Consolidation|Adverse Event|16|||
128815668|NCT01208662|463625144|FG001|Induction and Consolidation|Adverse Event|18|||
128815669|NCT01208662|463625145|FG002|Induction and Consolidation|Adverse Event|2|||
128815670|NCT01208662|463625143|FG000|Induction and Consolidation|MD or Participant Decision|16|||
128815671|NCT01208662|463625144|FG001|Induction and Consolidation|MD or Participant Decision|34|||
128815672|NCT01208662|463625145|FG002|Induction and Consolidation|MD or Participant Decision|4|||
128815673|NCT01208662|463625143|FG000|Induction and Consolidation|Death|1|||
128815674|NCT01208662|463625144|FG001|Induction and Consolidation|Death|3|||
128815675|NCT01208662|463625145|FG002|Induction and Consolidation|Death|1|||
128815676|NCT01208662|463625143|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
128815677|NCT01208662|463625144|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
128815678|NCT01208662|463625145|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
128815679|NCT01208662|463625143|FG000|Maintenance|Disease Progression|156|||
128815680|NCT01208662|463625144|FG001|Maintenance|Disease Progression|102|||
128815681|NCT01208662|463625145|FG002|Maintenance|Disease Progression|0|||
128815682|NCT01208662|463625143|FG000|Maintenance|Adverse Event|12|||
128815683|NCT01208662|463625144|FG001|Maintenance|Adverse Event|28|||
128815684|NCT01208662|463625145|FG002|Maintenance|Adverse Event|0|||
128815685|NCT01208662|463625143|FG000|Maintenance|MD or Participant Decision|24|||
128815686|NCT01208662|463625144|FG001|Maintenance|MD or Participant Decision|36|||
128815687|NCT01208662|463625145|FG002|Maintenance|MD or Participant Decision|0|||
128815688|NCT01208662|463625143|FG000|Maintenance|Death|0|||
128815689|NCT01208662|463625144|FG001|Maintenance|Death|3|||
128815690|NCT01208662|463625145|FG002|Maintenance|Death|0|||
128815691|NCT01208662|463625143|FG000|Maintenance|Discontinued for other reasons|21|||
128815692|NCT01208662|463625144|FG001|Maintenance|Discontinued for other reasons|31|||
128815693|NCT01208662|463625145|FG002|Maintenance|Discontinued for other reasons|0|||
128815694|NCT01208662|463625143|FG000|Maintenance|Still on Treatment|78|||
128815695|NCT01208662|463625144|FG001|Maintenance|Still on Treatment|89|||
128815696|NCT01208662|463625145|FG002|Maintenance|Still on Treatment|0|||
128815697|NCT04076618|463625146|FG000|Overall Study|Lost to Follow-up|2|||
128815698|NCT04076618|463625147|FG001|Overall Study|Lost to Follow-up|1|||
128815699|NCT04076618|463625148|FG002|Overall Study|Lost to Follow-up|3|||
128815700|NCT04076618|463625146|FG000|Overall Study|Withdrawal by Subject|3|||
128815701|NCT04076618|463625147|FG001|Overall Study|Withdrawal by Subject|1|||
128815702|NCT04076618|463625148|FG002|Overall Study|Withdrawal by Subject|2|||
128815703|NCT04076618|463625146|FG000|Overall Study|Relocated out of state|0|||
128815704|NCT04076618|463625147|FG001|Overall Study|Relocated out of state|2|||
128815705|NCT04076618|463625148|FG002|Overall Study|Relocated out of state|0|||
128815706|NCT04076618|463625146|FG000|Overall Study|COVID concerns|0|||
128815707|NCT04076618|463625147|FG001|Overall Study|COVID concerns|1|||
128815708|NCT04076618|463625148|FG002|Overall Study|COVID concerns|0|||
128815709|NCT04076618|463625146|FG000|Overall Study|Adverse Event|0|||
128815710|NCT04076618|463625147|FG001|Overall Study|Adverse Event|0|||
128815711|NCT04076618|463625148|FG002|Overall Study|Adverse Event|2|||
128815712|NCT01928394|463625149|FG000|Treatment Period|Disease progression|17|||
128815713|NCT01928394|463625150|FG001|Treatment Period|Disease progression|2|||
128815714|NCT01928394|463625151|FG002|Treatment Period|Disease progression|12|||
128815715|NCT01928394|463625152|FG003|Treatment Period|Disease progression|48|||
128815716|NCT01928394|463625153|FG004|Treatment Period|Disease progression|3|||
128815717|NCT01928394|463625154|FG005|Treatment Period|Disease progression|25|||
128815718|NCT01928394|463625155|FG006|Treatment Period|Disease progression|38|||
128815719|NCT01928394|463625156|FG007|Treatment Period|Disease progression|16|||
128815720|NCT01928394|463625157|FG008|Treatment Period|Disease progression|3|||
128815721|NCT01928394|463625158|FG009|Treatment Period|Disease progression|11|||
128815722|NCT01928394|463625159|FG010|Treatment Period|Disease progression|22|||
128815723|NCT01928394|463625160|FG011|Treatment Period|Disease progression|73|||
128815724|NCT01928394|463625161|FG012|Treatment Period|Disease progression|38|||
128815725|NCT01928394|463625162|FG013|Treatment Period|Disease progression|118|||
128815726|NCT01928394|463625163|FG014|Treatment Period|Disease progression|59|||
128815727|NCT01928394|463625164|FG015|Treatment Period|Disease progression|1|||
128815728|NCT01928394|463625165|FG016|Treatment Period|Disease progression|43|||
128815729|NCT01928394|463625166|FG017|Treatment Period|Disease progression|56|||
128815730|NCT01928394|463625167|FG018|Treatment Period|Disease progression|50|||
128815731|NCT01928394|463625168|FG019|Treatment Period|Disease progression|71|||
128815732|NCT01928394|463625169|FG020|Treatment Period|Disease progression|30|||
128815733|NCT01928394|463625170|FG021|Treatment Period|Disease progression|31|||
128815734|NCT01928394|463625171|FG022|Treatment Period|Disease progression|31|||
128815735|NCT01928394|463625149|FG000|Treatment Period|Study drug toxicity|1|||
128815736|NCT01928394|463625150|FG001|Treatment Period|Study drug toxicity|1|||
128815737|NCT01928394|463625151|FG002|Treatment Period|Study drug toxicity|3|||
128815738|NCT01928394|463625152|FG003|Treatment Period|Study drug toxicity|3|||
128815739|NCT01928394|463625153|FG004|Treatment Period|Study drug toxicity|0|||
128815740|NCT01928394|463625154|FG005|Treatment Period|Study drug toxicity|9|||
128815741|NCT01928394|463625155|FG006|Treatment Period|Study drug toxicity|7|||
128815742|NCT01928394|463625156|FG007|Treatment Period|Study drug toxicity|1|||
128815743|NCT01928394|463625157|FG008|Treatment Period|Study drug toxicity|0|||
128815744|NCT01928394|463625158|FG009|Treatment Period|Study drug toxicity|5|||
128815745|NCT01928394|463625159|FG010|Treatment Period|Study drug toxicity|2|||
128815746|NCT01928394|463625160|FG011|Treatment Period|Study drug toxicity|3|||
128815747|NCT01928394|463625161|FG012|Treatment Period|Study drug toxicity|7|||
128815748|NCT01928394|463625162|FG013|Treatment Period|Study drug toxicity|5|||
128815749|NCT01928394|463625163|FG014|Treatment Period|Study drug toxicity|12|||
128815750|NCT01928394|463625164|FG015|Treatment Period|Study drug toxicity|0|||
128815751|NCT01928394|463625165|FG016|Treatment Period|Study drug toxicity|3|||
128815752|NCT01928394|463625166|FG017|Treatment Period|Study drug toxicity|3|||
128815753|NCT01928394|463625167|FG018|Treatment Period|Study drug toxicity|12|||
128815754|NCT01928394|463625168|FG019|Treatment Period|Study drug toxicity|15|||
128815755|NCT01928394|463625169|FG020|Treatment Period|Study drug toxicity|4|||
128815756|NCT01928394|463625170|FG021|Treatment Period|Study drug toxicity|7|||
128815757|NCT01928394|463625171|FG022|Treatment Period|Study drug toxicity|4|||
128815758|NCT01928394|463625149|FG000|Treatment Period|AE unrelated to study drug|0|||
128815759|NCT01928394|463625150|FG001|Treatment Period|AE unrelated to study drug|0|||
128815760|NCT01928394|463625151|FG002|Treatment Period|AE unrelated to study drug|2|||
128815761|NCT01928394|463625152|FG003|Treatment Period|AE unrelated to study drug|3|||
128815762|NCT01928394|463625153|FG004|Treatment Period|AE unrelated to study drug|0|||
128815763|NCT01928394|463625154|FG005|Treatment Period|AE unrelated to study drug|5|||
128815764|NCT01928394|463625155|FG006|Treatment Period|AE unrelated to study drug|1|||
128815765|NCT01928394|463625156|FG007|Treatment Period|AE unrelated to study drug|0|||
128815766|NCT01928394|463625157|FG008|Treatment Period|AE unrelated to study drug|0|||
128815767|NCT01928394|463625158|FG009|Treatment Period|AE unrelated to study drug|2|||
128815768|NCT01928394|463625159|FG010|Treatment Period|AE unrelated to study drug|0|||
128815769|NCT01928394|463625160|FG011|Treatment Period|AE unrelated to study drug|12|||
128815770|NCT01928394|463625161|FG012|Treatment Period|AE unrelated to study drug|6|||
128815771|NCT01928394|463625162|FG013|Treatment Period|AE unrelated to study drug|13|||
128815772|NCT01928394|463625163|FG014|Treatment Period|AE unrelated to study drug|6|||
128815773|NCT01928394|463625164|FG015|Treatment Period|AE unrelated to study drug|1|||
128815774|NCT01928394|463625165|FG016|Treatment Period|AE unrelated to study drug|1|||
128815775|NCT01928394|463625166|FG017|Treatment Period|AE unrelated to study drug|6|||
128815776|NCT01928394|463625167|FG018|Treatment Period|AE unrelated to study drug|3|||
128815777|NCT01928394|463625168|FG019|Treatment Period|AE unrelated to study drug|5|||
128815778|NCT01928394|463625169|FG020|Treatment Period|AE unrelated to study drug|1|||
128815779|NCT01928394|463625170|FG021|Treatment Period|AE unrelated to study drug|1|||
128815780|NCT01928394|463625171|FG022|Treatment Period|AE unrelated to study drug|0|||
128815781|NCT01928394|463625149|FG000|Treatment Period|Participant request to stop therapy|0|||
128815782|NCT01928394|463625150|FG001|Treatment Period|Participant request to stop therapy|0|||
128815783|NCT01928394|463625151|FG002|Treatment Period|Participant request to stop therapy|0|||
128815784|NCT01928394|463625152|FG003|Treatment Period|Participant request to stop therapy|0|||
128815785|NCT01928394|463625153|FG004|Treatment Period|Participant request to stop therapy|0|||
128815786|NCT01928394|463625154|FG005|Treatment Period|Participant request to stop therapy|3|||
128815787|NCT01928394|463625155|FG006|Treatment Period|Participant request to stop therapy|3|||
128815788|NCT01928394|463625156|FG007|Treatment Period|Participant request to stop therapy|0|||
128815789|NCT01928394|463625157|FG008|Treatment Period|Participant request to stop therapy|0|||
128815790|NCT01928394|463625158|FG009|Treatment Period|Participant request to stop therapy|0|||
128815791|NCT01928394|463625159|FG010|Treatment Period|Participant request to stop therapy|3|||
128815792|NCT01928394|463625160|FG011|Treatment Period|Participant request to stop therapy|2|||
128815793|NCT01928394|463625161|FG012|Treatment Period|Participant request to stop therapy|1|||
128815794|NCT01928394|463625162|FG013|Treatment Period|Participant request to stop therapy|2|||
128815795|NCT01928394|463625163|FG014|Treatment Period|Participant request to stop therapy|4|||
128815796|NCT01928394|463625164|FG015|Treatment Period|Participant request to stop therapy|0|||
128815797|NCT01928394|463625165|FG016|Treatment Period|Participant request to stop therapy|1|||
128815798|NCT01928394|463625166|FG017|Treatment Period|Participant request to stop therapy|3|||
128815799|NCT01928394|463625167|FG018|Treatment Period|Participant request to stop therapy|1|||
128815800|NCT01928394|463625168|FG019|Treatment Period|Participant request to stop therapy|1|||
128815801|NCT01928394|463625169|FG020|Treatment Period|Participant request to stop therapy|3|||
128815802|NCT01928394|463625170|FG021|Treatment Period|Participant request to stop therapy|1|||
128815803|NCT01928394|463625171|FG022|Treatment Period|Participant request to stop therapy|3|||
128815804|NCT01928394|463625149|FG000|Treatment Period|Participant withdrew consent|0|||
128815805|NCT01928394|463625150|FG001|Treatment Period|Participant withdrew consent|0|||
128815806|NCT01928394|463625151|FG002|Treatment Period|Participant withdrew consent|1|||
128815807|NCT01928394|463625152|FG003|Treatment Period|Participant withdrew consent|1|||
128815808|NCT01928394|463625153|FG004|Treatment Period|Participant withdrew consent|0|||
128815809|NCT01928394|463625154|FG005|Treatment Period|Participant withdrew consent|1|||
128815810|NCT01928394|463625155|FG006|Treatment Period|Participant withdrew consent|0|||
128815811|NCT01928394|463625156|FG007|Treatment Period|Participant withdrew consent|1|||
128815812|NCT01928394|463625157|FG008|Treatment Period|Participant withdrew consent|0|||
128815813|NCT01928394|463625158|FG009|Treatment Period|Participant withdrew consent|0|||
128815814|NCT01928394|463625159|FG010|Treatment Period|Participant withdrew consent|1|||
128815815|NCT01928394|463625160|FG011|Treatment Period|Participant withdrew consent|1|||
128815816|NCT01928394|463625161|FG012|Treatment Period|Participant withdrew consent|1|||
128815817|NCT01928394|463625162|FG013|Treatment Period|Participant withdrew consent|0|||
128815818|NCT01928394|463625163|FG014|Treatment Period|Participant withdrew consent|2|||
128815819|NCT01928394|463625164|FG015|Treatment Period|Participant withdrew consent|0|||
128815820|NCT01928394|463625165|FG016|Treatment Period|Participant withdrew consent|2|||
128815821|NCT01928394|463625166|FG017|Treatment Period|Participant withdrew consent|1|||
128815822|NCT01928394|463625167|FG018|Treatment Period|Participant withdrew consent|1|||
128815823|NCT01928394|463625168|FG019|Treatment Period|Participant withdrew consent|1|||
128815824|NCT01928394|463625169|FG020|Treatment Period|Participant withdrew consent|0|||
128815825|NCT01928394|463625170|FG021|Treatment Period|Participant withdrew consent|2|||
128815826|NCT01928394|463625171|FG022|Treatment Period|Participant withdrew consent|0|||
128815827|NCT01928394|463625149|FG000|Treatment Period|Poor/non-compliance|0|||
128815828|NCT01928394|463625150|FG001|Treatment Period|Poor/non-compliance|0|||
128815829|NCT01928394|463625151|FG002|Treatment Period|Poor/non-compliance|0|||
128815830|NCT01928394|463625152|FG003|Treatment Period|Poor/non-compliance|1|||
128815831|NCT01928394|463625153|FG004|Treatment Period|Poor/non-compliance|0|||
128815832|NCT01928394|463625154|FG005|Treatment Period|Poor/non-compliance|0|||
128815833|NCT01928394|463625155|FG006|Treatment Period|Poor/non-compliance|0|||
128815834|NCT01928394|463625156|FG007|Treatment Period|Poor/non-compliance|0|||
128815835|NCT01928394|463625157|FG008|Treatment Period|Poor/non-compliance|0|||
128815836|NCT01928394|463625158|FG009|Treatment Period|Poor/non-compliance|0|||
128815837|NCT01928394|463625159|FG010|Treatment Period|Poor/non-compliance|0|||
128815838|NCT01928394|463625160|FG011|Treatment Period|Poor/non-compliance|0|||
128815839|NCT01928394|463625161|FG012|Treatment Period|Poor/non-compliance|1|||
128815840|NCT01928394|463625162|FG013|Treatment Period|Poor/non-compliance|0|||
128815841|NCT01928394|463625163|FG014|Treatment Period|Poor/non-compliance|1|||
128815842|NCT01928394|463625164|FG015|Treatment Period|Poor/non-compliance|0|||
128815843|NCT01928394|463625165|FG016|Treatment Period|Poor/non-compliance|0|||
128815844|NCT01928394|463625166|FG017|Treatment Period|Poor/non-compliance|1|||
128815845|NCT01928394|463625167|FG018|Treatment Period|Poor/non-compliance|0|||
128815846|NCT01928394|463625168|FG019|Treatment Period|Poor/non-compliance|1|||
128815847|NCT01928394|463625169|FG020|Treatment Period|Poor/non-compliance|0|||
128815848|NCT01928394|463625170|FG021|Treatment Period|Poor/non-compliance|0|||
128815849|NCT01928394|463625171|FG022|Treatment Period|Poor/non-compliance|0|||
128815850|NCT01928394|463625149|FG000|Treatment Period|other reason|0|||
128815851|NCT01928394|463625150|FG001|Treatment Period|other reason|0|||
128815852|NCT01928394|463625151|FG002|Treatment Period|other reason|0|||
128815853|NCT01928394|463625152|FG003|Treatment Period|other reason|0|||
128815854|NCT01928394|463625153|FG004|Treatment Period|other reason|0|||
128815855|NCT01928394|463625154|FG005|Treatment Period|other reason|0|||
128815856|NCT01928394|463625155|FG006|Treatment Period|other reason|0|||
128815857|NCT01928394|463625156|FG007|Treatment Period|other reason|0|||
128815858|NCT01928394|463625157|FG008|Treatment Period|other reason|0|||
128815859|NCT01928394|463625158|FG009|Treatment Period|other reason|0|||
128815860|NCT01928394|463625159|FG010|Treatment Period|other reason|1|||
128815861|NCT01928394|463625160|FG011|Treatment Period|other reason|1|||
128815862|NCT01928394|463625161|FG012|Treatment Period|other reason|1|||
128815863|NCT01928394|463625162|FG013|Treatment Period|other reason|0|||
128815864|NCT01928394|463625163|FG014|Treatment Period|other reason|1|||
128815865|NCT01928394|463625164|FG015|Treatment Period|other reason|0|||
128815866|NCT01928394|463625165|FG016|Treatment Period|other reason|0|||
128815867|NCT01928394|463625166|FG017|Treatment Period|other reason|0|||
128815868|NCT01928394|463625167|FG018|Treatment Period|other reason|2|||
128815869|NCT01928394|463625168|FG019|Treatment Period|other reason|2|||
128815870|NCT01928394|463625169|FG020|Treatment Period|other reason|0|||
128815871|NCT01928394|463625170|FG021|Treatment Period|other reason|0|||
128815872|NCT01928394|463625171|FG022|Treatment Period|other reason|0|||
128815873|NCT01928394|463625149|FG000|Treatment Period|Maximum clinical benefit|0|||
128815874|NCT01928394|463625150|FG001|Treatment Period|Maximum clinical benefit|0|||
128815875|NCT01928394|463625151|FG002|Treatment Period|Maximum clinical benefit|0|||
128815876|NCT01928394|463625152|FG003|Treatment Period|Maximum clinical benefit|0|||
128815877|NCT01928394|463625153|FG004|Treatment Period|Maximum clinical benefit|0|||
128815878|NCT01928394|463625154|FG005|Treatment Period|Maximum clinical benefit|0|||
128815879|NCT01928394|463625155|FG006|Treatment Period|Maximum clinical benefit|0|||
128815880|NCT01928394|463625156|FG007|Treatment Period|Maximum clinical benefit|0|||
128815881|NCT01928394|463625157|FG008|Treatment Period|Maximum clinical benefit|0|||
128815882|NCT01928394|463625158|FG009|Treatment Period|Maximum clinical benefit|0|||
128815883|NCT01928394|463625159|FG010|Treatment Period|Maximum clinical benefit|1|||
128815884|NCT01928394|463625160|FG011|Treatment Period|Maximum clinical benefit|1|||
128815885|NCT01928394|463625161|FG012|Treatment Period|Maximum clinical benefit|0|||
128815886|NCT01928394|463625162|FG013|Treatment Period|Maximum clinical benefit|0|||
128815887|NCT01928394|463625163|FG014|Treatment Period|Maximum clinical benefit|1|||
128815888|NCT01928394|463625164|FG015|Treatment Period|Maximum clinical benefit|0|||
128815889|NCT01928394|463625165|FG016|Treatment Period|Maximum clinical benefit|0|||
128815890|NCT01928394|463625166|FG017|Treatment Period|Maximum clinical benefit|1|||
128815891|NCT01928394|463625167|FG018|Treatment Period|Maximum clinical benefit|1|||
128815892|NCT01928394|463625168|FG019|Treatment Period|Maximum clinical benefit|0|||
128815893|NCT01928394|463625169|FG020|Treatment Period|Maximum clinical benefit|2|||
128815894|NCT01928394|463625170|FG021|Treatment Period|Maximum clinical benefit|0|||
128815895|NCT01928394|463625171|FG022|Treatment Period|Maximum clinical benefit|0|||
128815896|NCT01928394|463625149|FG000|Treatment Period|Lost to Follow-up|0|||
128815897|NCT01928394|463625150|FG001|Treatment Period|Lost to Follow-up|0|||
128815898|NCT01928394|463625151|FG002|Treatment Period|Lost to Follow-up|0|||
128815899|NCT01928394|463625152|FG003|Treatment Period|Lost to Follow-up|0|||
128815900|NCT01928394|463625153|FG004|Treatment Period|Lost to Follow-up|0|||
128815901|NCT01928394|463625154|FG005|Treatment Period|Lost to Follow-up|0|||
128815902|NCT01928394|463625155|FG006|Treatment Period|Lost to Follow-up|0|||
128815903|NCT01928394|463625156|FG007|Treatment Period|Lost to Follow-up|0|||
128815904|NCT01928394|463625157|FG008|Treatment Period|Lost to Follow-up|0|||
128815905|NCT01928394|463625158|FG009|Treatment Period|Lost to Follow-up|0|||
128815906|NCT01928394|463625159|FG010|Treatment Period|Lost to Follow-up|0|||
128815907|NCT01928394|463625160|FG011|Treatment Period|Lost to Follow-up|0|||
128815908|NCT01928394|463625161|FG012|Treatment Period|Lost to Follow-up|0|||
128815909|NCT01928394|463625162|FG013|Treatment Period|Lost to Follow-up|0|||
128815910|NCT01928394|463625163|FG014|Treatment Period|Lost to Follow-up|0|||
128815911|NCT01928394|463625164|FG015|Treatment Period|Lost to Follow-up|0|||
128815912|NCT01928394|463625165|FG016|Treatment Period|Lost to Follow-up|0|||
128815913|NCT01928394|463625166|FG017|Treatment Period|Lost to Follow-up|0|||
128815914|NCT01928394|463625167|FG018|Treatment Period|Lost to Follow-up|0|||
128815915|NCT01928394|463625168|FG019|Treatment Period|Lost to Follow-up|0|||
128815916|NCT01928394|463625169|FG020|Treatment Period|Lost to Follow-up|0|||
128815917|NCT01928394|463625170|FG021|Treatment Period|Lost to Follow-up|0|||
128815918|NCT01928394|463625171|FG022|Treatment Period|Lost to Follow-up|1|||
128815919|NCT01928394|463625149|FG000|Treatment Period|Death|0|||
128815920|NCT01928394|463625150|FG001|Treatment Period|Death|0|||
128815921|NCT01928394|463625151|FG002|Treatment Period|Death|0|||
128815922|NCT01928394|463625152|FG003|Treatment Period|Death|0|||
128815923|NCT01928394|463625153|FG004|Treatment Period|Death|0|||
128815924|NCT01928394|463625154|FG005|Treatment Period|Death|0|||
128815925|NCT01928394|463625155|FG006|Treatment Period|Death|0|||
128815926|NCT01928394|463625156|FG007|Treatment Period|Death|0|||
128815927|NCT01928394|463625157|FG008|Treatment Period|Death|0|||
128815928|NCT01928394|463625158|FG009|Treatment Period|Death|0|||
128815929|NCT01928394|463625159|FG010|Treatment Period|Death|0|||
128815930|NCT01928394|463625160|FG011|Treatment Period|Death|0|||
128815931|NCT01928394|463625161|FG012|Treatment Period|Death|0|||
128815932|NCT01928394|463625162|FG013|Treatment Period|Death|1|||
128815933|NCT01928394|463625163|FG014|Treatment Period|Death|2|||
128815934|NCT01928394|463625164|FG015|Treatment Period|Death|0|||
128815935|NCT01928394|463625165|FG016|Treatment Period|Death|0|||
128815936|NCT01928394|463625166|FG017|Treatment Period|Death|0|||
128815937|NCT01928394|463625167|FG018|Treatment Period|Death|0|||
128815938|NCT01928394|463625168|FG019|Treatment Period|Death|0|||
128815939|NCT01928394|463625169|FG020|Treatment Period|Death|0|||
128815940|NCT01928394|463625170|FG021|Treatment Period|Death|0|||
128815941|NCT01928394|463625171|FG022|Treatment Period|Death|0|||
128815942|NCT01928394|463625149|FG000|Follow-up Period|Participant withdrew consent|3|||
128815943|NCT01928394|463625150|FG001|Follow-up Period|Participant withdrew consent|0|||
128815944|NCT01928394|463625151|FG002|Follow-up Period|Participant withdrew consent|1|||
128815945|NCT01928394|463625152|FG003|Follow-up Period|Participant withdrew consent|4|||
128815946|NCT01928394|463625153|FG004|Follow-up Period|Participant withdrew consent|0|||
128815947|NCT01928394|463625154|FG005|Follow-up Period|Participant withdrew consent|2|||
128815948|NCT01928394|463625155|FG006|Follow-up Period|Participant withdrew consent|5|||
128815949|NCT01928394|463625156|FG007|Follow-up Period|Participant withdrew consent|1|||
128815950|NCT01928394|463625157|FG008|Follow-up Period|Participant withdrew consent|0|||
128815951|NCT01928394|463625158|FG009|Follow-up Period|Participant withdrew consent|0|||
128815952|NCT01928394|463625159|FG010|Follow-up Period|Participant withdrew consent|5|||
128815953|NCT01928394|463625160|FG011|Follow-up Period|Participant withdrew consent|8|||
128815954|NCT01928394|463625161|FG012|Follow-up Period|Participant withdrew consent|2|||
128815955|NCT01928394|463625162|FG013|Follow-up Period|Participant withdrew consent|12|||
128815956|NCT01928394|463625163|FG014|Follow-up Period|Participant withdrew consent|7|||
128815957|NCT01928394|463625164|FG015|Follow-up Period|Participant withdrew consent|0|||
128815958|NCT01928394|463625165|FG016|Follow-up Period|Participant withdrew consent|5|||
128815959|NCT01928394|463625166|FG017|Follow-up Period|Participant withdrew consent|3|||
128815960|NCT01928394|463625167|FG018|Follow-up Period|Participant withdrew consent|2|||
128815961|NCT01928394|463625168|FG019|Follow-up Period|Participant withdrew consent|7|||
128815962|NCT01928394|463625169|FG020|Follow-up Period|Participant withdrew consent|4|||
128815963|NCT01928394|463625170|FG021|Follow-up Period|Participant withdrew consent|6|||
128815964|NCT01928394|463625171|FG022|Follow-up Period|Participant withdrew consent|2|||
128815965|NCT01928394|463625149|FG000|Follow-up Period|Death|0|||
128815966|NCT01928394|463625150|FG001|Follow-up Period|Death|0|||
128815967|NCT01928394|463625151|FG002|Follow-up Period|Death|2|||
128815968|NCT01928394|463625152|FG003|Follow-up Period|Death|6|||
128815969|NCT01928394|463625153|FG004|Follow-up Period|Death|0|||
128815970|NCT01928394|463625154|FG005|Follow-up Period|Death|6|||
128815971|NCT01928394|463625155|FG006|Follow-up Period|Death|6|||
128815972|NCT01928394|463625156|FG007|Follow-up Period|Death|2|||
128815973|NCT01928394|463625157|FG008|Follow-up Period|Death|1|||
128815974|NCT01928394|463625158|FG009|Follow-up Period|Death|2|||
128815975|NCT01928394|463625159|FG010|Follow-up Period|Death|4|||
128815976|NCT01928394|463625160|FG011|Follow-up Period|Death|12|||
128815977|NCT01928394|463625161|FG012|Follow-up Period|Death|11|||
128815978|NCT01928394|463625162|FG013|Follow-up Period|Death|25|||
128815979|NCT01928394|463625163|FG014|Follow-up Period|Death|18|||
128815980|NCT01928394|463625164|FG015|Follow-up Period|Death|0|||
128815981|NCT01928394|463625165|FG016|Follow-up Period|Death|6|||
128815982|NCT01928394|463625166|FG017|Follow-up Period|Death|5|||
128815983|NCT01928394|463625167|FG018|Follow-up Period|Death|13|||
128815984|NCT01928394|463625168|FG019|Follow-up Period|Death|13|||
128815985|NCT01928394|463625169|FG020|Follow-up Period|Death|5|||
128815986|NCT01928394|463625170|FG021|Follow-up Period|Death|3|||
128815987|NCT01928394|463625171|FG022|Follow-up Period|Death|2|||
128815988|NCT01928394|463625149|FG000|Follow-up Period|other reason|0|||
128815989|NCT01928394|463625150|FG001|Follow-up Period|other reason|0|||
128815990|NCT01928394|463625151|FG002|Follow-up Period|other reason|0|||
128815991|NCT01928394|463625152|FG003|Follow-up Period|other reason|0|||
128815992|NCT01928394|463625153|FG004|Follow-up Period|other reason|0|||
128815993|NCT01928394|463625154|FG005|Follow-up Period|other reason|0|||
128815994|NCT01928394|463625155|FG006|Follow-up Period|other reason|1|||
128815995|NCT01928394|463625156|FG007|Follow-up Period|other reason|3|||
128815996|NCT01928394|463625157|FG008|Follow-up Period|other reason|0|||
128815997|NCT01928394|463625158|FG009|Follow-up Period|other reason|0|||
128815998|NCT01928394|463625159|FG010|Follow-up Period|other reason|2|||
128815999|NCT01928394|463625160|FG011|Follow-up Period|other reason|1|||
128816000|NCT01928394|463625161|FG012|Follow-up Period|other reason|0|||
128816001|NCT01928394|463625162|FG013|Follow-up Period|other reason|1|||
128816002|NCT01928394|463625163|FG014|Follow-up Period|other reason|4|||
128816003|NCT01928394|463625164|FG015|Follow-up Period|other reason|0|||
128816004|NCT01928394|463625165|FG016|Follow-up Period|other reason|2|||
128816005|NCT01928394|463625166|FG017|Follow-up Period|other reason|0|||
128816006|NCT01928394|463625167|FG018|Follow-up Period|other reason|1|||
128816007|NCT01928394|463625168|FG019|Follow-up Period|other reason|1|||
128816008|NCT01928394|463625169|FG020|Follow-up Period|other reason|0|||
128816009|NCT01928394|463625170|FG021|Follow-up Period|other reason|0|||
128816010|NCT01928394|463625171|FG022|Follow-up Period|other reason|1|||
128816011|NCT01928394|463625149|FG000|Follow-up Period|Lost to Follow-up|0|||
128816012|NCT01928394|463625150|FG001|Follow-up Period|Lost to Follow-up|0|||
128816013|NCT01928394|463625151|FG002|Follow-up Period|Lost to Follow-up|0|||
128816014|NCT01928394|463625152|FG003|Follow-up Period|Lost to Follow-up|0|||
128816015|NCT01928394|463625153|FG004|Follow-up Period|Lost to Follow-up|0|||
128816016|NCT01928394|463625154|FG005|Follow-up Period|Lost to Follow-up|0|||
128816017|NCT01928394|463625155|FG006|Follow-up Period|Lost to Follow-up|0|||
128816018|NCT01928394|463625156|FG007|Follow-up Period|Lost to Follow-up|0|||
128816019|NCT01928394|463625157|FG008|Follow-up Period|Lost to Follow-up|0|||
128816020|NCT01928394|463625158|FG009|Follow-up Period|Lost to Follow-up|0|||
128816021|NCT01928394|463625159|FG010|Follow-up Period|Lost to Follow-up|0|||
128816022|NCT01928394|463625160|FG011|Follow-up Period|Lost to Follow-up|1|||
128816023|NCT01928394|463625161|FG012|Follow-up Period|Lost to Follow-up|1|||
128816024|NCT01928394|463625162|FG013|Follow-up Period|Lost to Follow-up|0|||
128816025|NCT01928394|463625163|FG014|Follow-up Period|Lost to Follow-up|1|||
128816026|NCT01928394|463625164|FG015|Follow-up Period|Lost to Follow-up|0|||
128816027|NCT01928394|463625165|FG016|Follow-up Period|Lost to Follow-up|1|||
128816028|NCT01928394|463625166|FG017|Follow-up Period|Lost to Follow-up|0|||
128816029|NCT01928394|463625167|FG018|Follow-up Period|Lost to Follow-up|0|||
128816030|NCT01928394|463625168|FG019|Follow-up Period|Lost to Follow-up|0|||
128816031|NCT01928394|463625169|FG020|Follow-up Period|Lost to Follow-up|0|||
128816032|NCT01928394|463625170|FG021|Follow-up Period|Lost to Follow-up|0|||
128816033|NCT01928394|463625171|FG022|Follow-up Period|Lost to Follow-up|1|||
128816034|NCT04433208|463625172|FG000|Overall Study|Withdrawal by Subject|0|||
128816035|NCT04433208|463625173|FG001|Overall Study|Withdrawal by Subject|1|||
128816036|NCT04433208|463625174|FG002|Overall Study|Withdrawal by Subject|1|||
128816037|NCT04433208|463625175|FG003|Overall Study|Withdrawal by Subject|0|||
128816038|NCT04433208|463625176|FG004|Overall Study|Withdrawal by Subject|2|||
128816039|NCT04433208|463625177|FG005|Overall Study|Withdrawal by Subject|1|||
128816040|NCT04433208|463625172|FG000|Overall Study|Lost to Follow-up|0|||
128816041|NCT04433208|463625173|FG001|Overall Study|Lost to Follow-up|0|||
128816042|NCT04433208|463625174|FG002|Overall Study|Lost to Follow-up|0|||
128816043|NCT04433208|463625175|FG003|Overall Study|Lost to Follow-up|0|||
128816044|NCT04433208|463625176|FG004|Overall Study|Lost to Follow-up|0|||
128816045|NCT04433208|463625177|FG005|Overall Study|Lost to Follow-up|1|||
128816046|NCT03386578|463625182|FG000|PK Component|Lost to Follow-up|0|||
128816047|NCT03386578|463625183|FG001|PK Component|Lost to Follow-up|1|||
128816048|NCT03386578|463625184|FG002|PK Component|Lost to Follow-up|0|||
128816049|NCT03386578|463625185|FG003|PK Component|Lost to Follow-up|0|||
128816050|NCT03386578|463625186|FG004|PK Component|Lost to Follow-up|0|||
128816051|NCT03386578|463625187|FG005|PK Component|Lost to Follow-up|0|||
128816052|NCT03386578|463625188|FG006|PK Component|Lost to Follow-up|1|||
128816053|NCT03386578|463625189|FG007|PK Component|Lost to Follow-up|0|||
128816054|NCT03386578|463625190|FG008|PK Component|Lost to Follow-up|0|||
128816055|NCT03386578|463625191|FG009|PK Component|Lost to Follow-up|0|||
128816056|NCT03386578|463625182|FG000|PK Component|Stillbirth/Abortion|0|||
128816057|NCT03386578|463625183|FG001|PK Component|Stillbirth/Abortion|0|||
128816058|NCT03386578|463625184|FG002|PK Component|Stillbirth/Abortion|0|||
128816059|NCT03386578|463625185|FG003|PK Component|Stillbirth/Abortion|0|||
128816060|NCT03386578|463625186|FG004|PK Component|Stillbirth/Abortion|0|||
128816061|NCT03386578|463625187|FG005|PK Component|Stillbirth/Abortion|2|||
128816062|NCT03386578|463625188|FG006|PK Component|Stillbirth/Abortion|0|||
128816063|NCT03386578|463625189|FG007|PK Component|Stillbirth/Abortion|0|||
128816064|NCT03386578|463625190|FG008|PK Component|Stillbirth/Abortion|0|||
128816065|NCT03386578|463625191|FG009|PK Component|Stillbirth/Abortion|0|||
128816066|NCT03386578|463625182|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
128816067|NCT03386578|463625183|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
128816068|NCT03386578|463625184|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
128816069|NCT03386578|463625185|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
128816070|NCT03386578|463625186|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
128816071|NCT03386578|463625187|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
128816072|NCT03386578|463625188|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
128816073|NCT03386578|463625189|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
128816074|NCT03386578|463625190|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
128816075|NCT03386578|463625191|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
128816076|NCT03386578|463625182|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
128816077|NCT03386578|463625183|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
128816078|NCT03386578|463625184|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
128816079|NCT03386578|463625185|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
128816080|NCT03386578|463625186|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
128816081|NCT03386578|463625187|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
128816082|NCT03386578|463625188|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
128816083|NCT03386578|463625189|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
128816084|NCT03386578|463625190|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
128816085|NCT03386578|463625191|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
128816086|NCT03386578|463625182|FG000|PrEP Comparison Component Step 1|Death|0|||
128816087|NCT03386578|463625183|FG001|PrEP Comparison Component Step 1|Death|0|||
128816088|NCT03386578|463625184|FG002|PrEP Comparison Component Step 1|Death|1|||
128816089|NCT03386578|463625185|FG003|PrEP Comparison Component Step 1|Death|0|||
128816090|NCT03386578|463625186|FG004|PrEP Comparison Component Step 1|Death|0|||
128816091|NCT03386578|463625187|FG005|PrEP Comparison Component Step 1|Death|0|||
128816092|NCT03386578|463625188|FG006|PrEP Comparison Component Step 1|Death|0|||
128816093|NCT03386578|463625189|FG007|PrEP Comparison Component Step 1|Death|9|||
128816094|NCT03386578|463625190|FG008|PrEP Comparison Component Step 1|Death|5|||
128816095|NCT03386578|463625191|FG009|PrEP Comparison Component Step 1|Death|0|||
128816096|NCT03386578|463625182|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816097|NCT03386578|463625183|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816098|NCT03386578|463625184|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816099|NCT03386578|463625185|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
128816100|NCT03386578|463625186|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816101|NCT03386578|463625187|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816102|NCT03386578|463625188|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816103|NCT03386578|463625189|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816104|NCT03386578|463625190|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
128816105|NCT03386578|463625191|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
128816106|NCT03386578|463625182|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816107|NCT03386578|463625183|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816108|NCT03386578|463625184|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816109|NCT03386578|463625185|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816110|NCT03386578|463625186|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816111|NCT03386578|463625187|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816112|NCT03386578|463625188|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816113|NCT03386578|463625189|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
128816114|NCT03386578|463625190|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
128816115|NCT03386578|463625191|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
128816116|NCT03386578|463625182|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816117|NCT03386578|463625183|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816118|NCT03386578|463625184|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816119|NCT03386578|463625185|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816120|NCT03386578|463625186|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816121|NCT03386578|463625187|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816122|NCT03386578|463625188|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816123|NCT03386578|463625189|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
128816124|NCT03386578|463625190|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
128816125|NCT03386578|463625191|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
128816126|NCT05093842|463625194|FG000|Overall Study|Pregnancy loss|1|||
128816127|NCT05093842|463625195|FG001|Overall Study|Pregnancy loss|1|||
128816128|NCT05093842|463625194|FG000|Overall Study|Lost to Follow-up|6|||
128816129|NCT05093842|463625195|FG001|Overall Study|Lost to Follow-up|0|||
128816130|NCT05093842|463625194|FG000|Overall Study|Physician Decision|0|||
128816131|NCT05093842|463625195|FG001|Overall Study|Physician Decision|1|||
128816132|NCT04066205|463625196|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
128816133|NCT04066205|463625197|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
128816134|NCT04066205|463625196|FG000|T2 Immediate Post-Intervention|did not respond|5|||
128816135|NCT04066205|463625197|FG001|T2 Immediate Post-Intervention|did not respond|3|||
128816136|NCT01712490|463625198|FG000|Overall Study|Ongoing|601|||
128816137|NCT01712490|463625199|FG001|Overall Study|Ongoing|586|||
128816138|NCT01712490|463625198|FG000|Overall Study|Other|11|||
128816139|NCT01712490|463625199|FG001|Overall Study|Other|11|||
128816140|NCT01712490|463625198|FG000|Overall Study|Withdrawal by Subject|36|||
128816141|NCT01712490|463625199|FG001|Overall Study|Withdrawal by Subject|44|||
128816142|NCT01712490|463625198|FG000|Overall Study|Lost to Follow-up|16|||
128816143|NCT01712490|463625199|FG001|Overall Study|Lost to Follow-up|29|||
128816144|NCT02724969|463625200|FG000|Overall Study|Lost to Follow-up|12|||
128816145|NCT02724969|463625201|FG001|Overall Study|Lost to Follow-up|6|||
128816146|NCT02724969|463625200|FG000|Overall Study|Withdrawal by Subject|3|||
128816147|NCT02724969|463625201|FG001|Overall Study|Withdrawal by Subject|3|||
128816148|NCT02724969|463625200|FG000|Overall Study|Infant demise|0|||
128816149|NCT02724969|463625201|FG001|Overall Study|Infant demise|2|||
128816150|NCT05147116|463625202|FG000|Overall Study|Withdrawal by Subject|0|||
128816151|NCT05147116|463625203|FG001|Overall Study|Withdrawal by Subject|1|||
128816152|NCT03672916|463625204|FG000|Overall Study|Death|6|||
128816153|NCT03672916|463625204|FG000|Overall Study|Lost to Follow-up|29|||
128816154|NCT03672916|463625204|FG000|Overall Study|Adverse Event|6|||
128816155|NCT03672916|463625204|FG000|Overall Study|Withdrawal by Subject|11|||
128816156|NCT04197336|463625205|FG000|Overall Study|Withdrawal by Subject|1|||
128816157|NCT04585815|463625206|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
128816158|NCT04585815|463625207|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
128816159|NCT04585815|463625208|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
128816160|NCT04585815|463625209|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
128816161|NCT04585815|463625210|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
128816162|NCT04585815|463625211|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
128816163|NCT04585815|463625212|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
128816164|NCT04585815|463625206|FG000|Sub-study A- Treatment Phase|Death|0|||
128816165|NCT04585815|463625207|FG001|Sub-study A- Treatment Phase|Death|1|||
128816166|NCT04585815|463625208|FG002|Sub-study A- Treatment Phase|Death|0|||
128816167|NCT04585815|463625209|FG003|Sub-study A- Treatment Phase|Death|0|||
128816168|NCT04585815|463625210|FG004|Sub-study A- Treatment Phase|Death|0|||
128816169|NCT04585815|463625211|FG005|Sub-study A- Treatment Phase|Death|0|||
128816170|NCT04585815|463625212|FG006|Sub-study A- Treatment Phase|Death|0|||
128816171|NCT04585815|463625206|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
128816172|NCT04585815|463625207|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
128816173|NCT04585815|463625208|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
128816174|NCT04585815|463625209|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
128816175|NCT04585815|463625210|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
128816176|NCT04585815|463625211|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
128816177|NCT04585815|463625212|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
128816178|NCT04585815|463625206|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
128816179|NCT04585815|463625207|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
128816180|NCT04585815|463625208|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
128816181|NCT04585815|463625209|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
128816182|NCT04585815|463625210|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
128816183|NCT04585815|463625211|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
128816184|NCT04585815|463625212|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
128816185|NCT04585815|463625206|FG000|Sub-study A- Treatment Phase|Other|1|||
128816186|NCT04585815|463625207|FG001|Sub-study A- Treatment Phase|Other|0|||
128816187|NCT04585815|463625208|FG002|Sub-study A- Treatment Phase|Other|0|||
128816188|NCT04585815|463625209|FG003|Sub-study A- Treatment Phase|Other|0|||
128816189|NCT04585815|463625210|FG004|Sub-study A- Treatment Phase|Other|0|||
128816190|NCT04585815|463625211|FG005|Sub-study A- Treatment Phase|Other|0|||
128816191|NCT04585815|463625212|FG006|Sub-study A- Treatment Phase|Other|0|||
128816192|NCT04585815|463625206|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
128816193|NCT04585815|463625207|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
128816194|NCT04585815|463625208|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
128816195|NCT04585815|463625209|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
128816196|NCT04585815|463625210|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
128816197|NCT04585815|463625211|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
128816198|NCT04585815|463625212|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
128816199|NCT04585815|463625206|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
128816200|NCT04585815|463625207|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
128816201|NCT04585815|463625208|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
128816202|NCT04585815|463625209|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
128816203|NCT04585815|463625210|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
128816204|NCT04585815|463625211|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
128816205|NCT04585815|463625212|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
128816206|NCT04585815|463625206|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
128816207|NCT04585815|463625207|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
128816208|NCT04585815|463625208|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
128816209|NCT04585815|463625209|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
128816210|NCT04585815|463625210|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
128816211|NCT04585815|463625211|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
128816212|NCT04585815|463625212|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
128816213|NCT04585815|463625206|FG000|Sub-study B- Treatment Phase|Death|0|||
128816214|NCT04585815|463625207|FG001|Sub-study B- Treatment Phase|Death|0|||
128816215|NCT04585815|463625208|FG002|Sub-study B- Treatment Phase|Death|0|||
128816216|NCT04585815|463625209|FG003|Sub-study B- Treatment Phase|Death|1|||
128816217|NCT04585815|463625210|FG004|Sub-study B- Treatment Phase|Death|0|||
128816218|NCT04585815|463625211|FG005|Sub-study B- Treatment Phase|Death|0|||
128816219|NCT04585815|463625212|FG006|Sub-study B- Treatment Phase|Death|0|||
128816220|NCT04585815|463625206|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
128816221|NCT04585815|463625207|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
128816222|NCT04585815|463625208|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
128816223|NCT04585815|463625209|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
128816224|NCT04585815|463625210|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
128816225|NCT04585815|463625211|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
128816226|NCT04585815|463625212|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
128816227|NCT04585815|463625206|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
128816228|NCT04585815|463625207|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
128816229|NCT04585815|463625208|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
128816230|NCT04585815|463625209|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
128816231|NCT04585815|463625210|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
128816232|NCT04585815|463625211|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
128816233|NCT04585815|463625212|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
128816234|NCT04585815|463625206|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
128816235|NCT04585815|463625207|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
128816236|NCT04585815|463625208|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
128816237|NCT04585815|463625209|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
128816238|NCT04585815|463625210|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
128816239|NCT04585815|463625211|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
128816240|NCT04585815|463625212|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
128816241|NCT04585815|463625206|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
128816242|NCT04585815|463625207|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
128816243|NCT04585815|463625208|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
128816244|NCT04585815|463625209|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
128816245|NCT04585815|463625210|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
128816246|NCT04585815|463625211|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
128816247|NCT04585815|463625212|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
128816248|NCT04585815|463625206|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
128816249|NCT04585815|463625207|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
128816250|NCT04585815|463625208|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
128816251|NCT04585815|463625209|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
128816252|NCT04585815|463625210|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
128816253|NCT04585815|463625211|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
128816254|NCT04585815|463625212|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
128816255|NCT04585815|463625206|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
128816256|NCT04585815|463625207|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
128816257|NCT04585815|463625208|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
128816258|NCT04585815|463625209|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
128816259|NCT04585815|463625210|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
128816260|NCT04585815|463625211|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
128816261|NCT04585815|463625212|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
128816262|NCT04585815|463625206|FG000|Sub-study B- Follow-up Phase|Death|0|||
128816263|NCT04585815|463625207|FG001|Sub-study B- Follow-up Phase|Death|0|||
128816264|NCT04585815|463625208|FG002|Sub-study B- Follow-up Phase|Death|1|||
128816265|NCT04585815|463625209|FG003|Sub-study B- Follow-up Phase|Death|3|||
128816266|NCT04585815|463625210|FG004|Sub-study B- Follow-up Phase|Death|0|||
128816267|NCT04585815|463625211|FG005|Sub-study B- Follow-up Phase|Death|0|||
128816268|NCT04585815|463625212|FG006|Sub-study B- Follow-up Phase|Death|1|||
128816269|NCT04295512|463625220|FG000|Overall Study|Lack of family response to schedule assessment|0|||
128816270|NCT04295512|463625221|FG001|Overall Study|Lack of family response to schedule assessment|0|||
128816271|NCT04295512|463625222|FG002|Overall Study|Lack of family response to schedule assessment|0|||
128816272|NCT04295512|463625223|FG003|Overall Study|Lack of family response to schedule assessment|2|||
128816273|NCT04295512|463625220|FG000|Overall Study|Therapist did not refer eligible family|7|||
128816274|NCT04295512|463625221|FG001|Overall Study|Therapist did not refer eligible family|7|||
128816275|NCT04295512|463625222|FG002|Overall Study|Therapist did not refer eligible family|0|||
128816276|NCT04295512|463625223|FG003|Overall Study|Therapist did not refer eligible family|0|||
128816277|NCT04587453|463625228|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
128816278|NCT04587453|463625229|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
128816279|NCT03571581|463625232|FG000|Overall Study|Death|2|||
128816280|NCT03571581|463625232|FG000|Overall Study|Withdrawal by Subject|2|||
128816281|NCT01309672|463625234|FG000|Overall Study|Lack of Efficacy|20|||
128816282|NCT01309672|463625234|FG000|Overall Study|Other|9|||
128816283|NCT01309672|463625234|FG000|Overall Study|Adverse Event|5|||
128816284|NCT01309672|463625234|FG000|Overall Study|Withdrawal by Subject|3|||
128816285|NCT05623228|463625235|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
128816286|NCT05623228|463625236|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
128816287|NCT05623228|463625237|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
128816288|NCT05623228|463625238|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
128816289|NCT05623228|463625239|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
128816290|NCT05623228|463625240|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
128816291|NCT05623228|463625241|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
128816292|NCT05623228|463625242|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
128816293|NCT05623228|463625235|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
128816294|NCT05623228|463625236|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
128816295|NCT05623228|463625237|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
128816296|NCT05623228|463625238|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
128816297|NCT05623228|463625239|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
128816298|NCT05623228|463625240|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
128816299|NCT05623228|463625241|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
128816300|NCT05623228|463625242|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
128816301|NCT04141891|463625244|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
128816302|NCT04141891|463625245|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
128816303|NCT04141891|463625244|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
128816304|NCT04141891|463625245|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
128816305|NCT04141891|463625244|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
128816306|NCT04141891|463625245|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
128816307|NCT04141891|463625244|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
128816308|NCT04141891|463625245|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
128816309|NCT04141891|463625244|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
128816310|NCT04141891|463625245|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
128816311|NCT04141891|463625244|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
128816312|NCT04141891|463625245|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
128816313|NCT04141891|463625244|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
128816314|NCT04141891|463625245|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
128816315|NCT04141891|463625244|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
128816316|NCT04141891|463625245|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
128816317|NCT04141891|463625244|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
128816318|NCT04141891|463625245|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
128816319|NCT04141891|463625244|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
128816320|NCT04141891|463625245|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
128816321|NCT04141891|463625244|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
128816322|NCT04141891|463625245|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
128816323|NCT04141891|463625244|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
128816324|NCT04141891|463625245|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
128816325|NCT04141891|463625244|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
128816326|NCT04141891|463625245|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
128816327|NCT04141891|463625244|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
128816328|NCT04141891|463625245|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
128816329|NCT04625725|463625246|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
128816330|NCT04625725|463625247|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
128816331|NCT04625725|463625248|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
128816332|NCT04625725|463625249|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
128816333|NCT04625725|463625250|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
128816334|NCT04625725|463625251|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
128816335|NCT04625725|463625246|FG000|Provent Main Study|Withdrawal by Subject|242|||
128816336|NCT04625725|463625247|FG001|Provent Main Study|Withdrawal by Subject|144|||
128816337|NCT04625725|463625248|FG002|Provent Main Study|Withdrawal by Subject|0|||
128816338|NCT04625725|463625249|FG003|Provent Main Study|Withdrawal by Subject|0|||
128816339|NCT04625725|463625250|FG004|Provent Main Study|Withdrawal by Subject|0|||
128816340|NCT04625725|463625251|FG005|Provent Main Study|Withdrawal by Subject|0|||
128816341|NCT04625725|463625246|FG000|Provent Main Study|Physician Decision|5|||
128816342|NCT04625725|463625247|FG001|Provent Main Study|Physician Decision|0|||
128816343|NCT04625725|463625248|FG002|Provent Main Study|Physician Decision|0|||
128816344|NCT04625725|463625249|FG003|Provent Main Study|Physician Decision|0|||
128816345|NCT04625725|463625250|FG004|Provent Main Study|Physician Decision|0|||
128816346|NCT04625725|463625251|FG005|Provent Main Study|Physician Decision|0|||
128816347|NCT04625725|463625246|FG000|Provent Main Study|Protocol Violation|1|||
128816348|NCT04625725|463625247|FG001|Provent Main Study|Protocol Violation|0|||
128816349|NCT04625725|463625248|FG002|Provent Main Study|Protocol Violation|0|||
128816350|NCT04625725|463625249|FG003|Provent Main Study|Protocol Violation|0|||
128816351|NCT04625725|463625250|FG004|Provent Main Study|Protocol Violation|0|||
128816352|NCT04625725|463625251|FG005|Provent Main Study|Protocol Violation|0|||
128816353|NCT04625725|463625246|FG000|Provent Main Study|Lost to Follow-up|357|||
128816354|NCT04625725|463625247|FG001|Provent Main Study|Lost to Follow-up|200|||
128816355|NCT04625725|463625248|FG002|Provent Main Study|Lost to Follow-up|0|||
128816356|NCT04625725|463625249|FG003|Provent Main Study|Lost to Follow-up|0|||
128816357|NCT04625725|463625250|FG004|Provent Main Study|Lost to Follow-up|0|||
128816358|NCT04625725|463625251|FG005|Provent Main Study|Lost to Follow-up|0|||
128816359|NCT04625725|463625246|FG000|Provent Main Study|Death|22|||
128816360|NCT04625725|463625247|FG001|Provent Main Study|Death|10|||
128816361|NCT04625725|463625248|FG002|Provent Main Study|Death|0|||
128816362|NCT04625725|463625249|FG003|Provent Main Study|Death|0|||
128816363|NCT04625725|463625250|FG004|Provent Main Study|Death|0|||
128816364|NCT04625725|463625251|FG005|Provent Main Study|Death|0|||
128816365|NCT04625725|463625246|FG000|Provent Main Study|Adverse Event|2|||
128816366|NCT04625725|463625247|FG001|Provent Main Study|Adverse Event|1|||
128816367|NCT04625725|463625248|FG002|Provent Main Study|Adverse Event|0|||
128816368|NCT04625725|463625249|FG003|Provent Main Study|Adverse Event|0|||
128816369|NCT04625725|463625250|FG004|Provent Main Study|Adverse Event|0|||
128816370|NCT04625725|463625251|FG005|Provent Main Study|Adverse Event|0|||
128816371|NCT04625725|463625246|FG000|Provent Main Study|Participants dosed in sub-study|310|||
128816372|NCT04625725|463625247|FG001|Provent Main Study|Participants dosed in sub-study|193|||
128816373|NCT04625725|463625248|FG002|Provent Main Study|Participants dosed in sub-study|0|||
128816374|NCT04625725|463625249|FG003|Provent Main Study|Participants dosed in sub-study|0|||
128816375|NCT04625725|463625250|FG004|Provent Main Study|Participants dosed in sub-study|0|||
128816376|NCT04625725|463625251|FG005|Provent Main Study|Participants dosed in sub-study|0|||
128816377|NCT04625725|463625246|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
128816378|NCT04625725|463625247|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
128816379|NCT04625725|463625248|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
128816380|NCT04625725|463625249|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
128816381|NCT04625725|463625250|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
128816382|NCT04625725|463625251|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
128816383|NCT04625725|463625246|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
128816384|NCT04625725|463625247|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
128816385|NCT04625725|463625248|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
128816386|NCT04625725|463625249|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
128816387|NCT04625725|463625250|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
128816388|NCT04625725|463625251|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
128816389|NCT04625725|463625246|FG000|Provent Main Study|INCARCERATION|3|||
128816390|NCT04625725|463625247|FG001|Provent Main Study|INCARCERATION|0|||
128816391|NCT04625725|463625248|FG002|Provent Main Study|INCARCERATION|0|||
128816392|NCT04625725|463625249|FG003|Provent Main Study|INCARCERATION|0|||
128816393|NCT04625725|463625250|FG004|Provent Main Study|INCARCERATION|0|||
128816394|NCT04625725|463625251|FG005|Provent Main Study|INCARCERATION|0|||
128816395|NCT04625725|463625246|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
128816396|NCT04625725|463625247|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
128816397|NCT04625725|463625248|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
128816398|NCT04625725|463625249|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
128816399|NCT04625725|463625250|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
128816400|NCT04625725|463625251|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
128816401|NCT04625725|463625246|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
128816402|NCT04625725|463625247|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
128816403|NCT04625725|463625248|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
128816404|NCT04625725|463625249|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
128816405|NCT04625725|463625250|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
128816406|NCT04625725|463625251|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
128816407|NCT04625725|463625246|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
128816408|NCT04625725|463625247|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
128816409|NCT04625725|463625248|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
128816410|NCT04625725|463625249|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
128816411|NCT04625725|463625250|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
128816412|NCT04625725|463625251|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
128816413|NCT04625725|463625246|FG000|Provent Main Study|MISSING REASON|0|||
128816414|NCT04625725|463625247|FG001|Provent Main Study|MISSING REASON|1|||
128816415|NCT04625725|463625248|FG002|Provent Main Study|MISSING REASON|0|||
128816416|NCT04625725|463625249|FG003|Provent Main Study|MISSING REASON|0|||
128816417|NCT04625725|463625250|FG004|Provent Main Study|MISSING REASON|0|||
128816418|NCT04625725|463625251|FG005|Provent Main Study|MISSING REASON|0|||
128816419|NCT04625725|463625246|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
128816420|NCT04625725|463625247|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
128816421|NCT04625725|463625248|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
128816422|NCT04625725|463625249|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
128816423|NCT04625725|463625250|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
128816424|NCT04625725|463625251|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
128816425|NCT04625725|463625246|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
128816426|NCT04625725|463625247|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
128816427|NCT04625725|463625248|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
128816428|NCT04625725|463625249|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
128816429|NCT04625725|463625250|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
128816430|NCT04625725|463625251|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
128816431|NCT04625725|463625246|FG000|Provent Sub Study|Lost to Follow-up|0|||
128816432|NCT04625725|463625247|FG001|Provent Sub Study|Lost to Follow-up|0|||
128816433|NCT04625725|463625248|FG002|Provent Sub Study|Lost to Follow-up|20|||
128816434|NCT04625725|463625249|FG003|Provent Sub Study|Lost to Follow-up|10|||
128816435|NCT04625725|463625250|FG004|Provent Sub Study|Lost to Follow-up|6|||
128816436|NCT04625725|463625251|FG005|Provent Sub Study|Lost to Follow-up|4|||
128816437|NCT04625725|463625246|FG000|Provent Sub Study|Death|0|||
128816438|NCT04625725|463625247|FG001|Provent Sub Study|Death|0|||
128816439|NCT04625725|463625248|FG002|Provent Sub Study|Death|8|||
128816440|NCT04625725|463625249|FG003|Provent Sub Study|Death|5|||
128816441|NCT04625725|463625250|FG004|Provent Sub Study|Death|0|||
128816442|NCT04625725|463625251|FG005|Provent Sub Study|Death|1|||
128816443|NCT04625725|463625246|FG000|Provent Sub Study|Adverse Event|0|||
128816444|NCT04625725|463625247|FG001|Provent Sub Study|Adverse Event|0|||
128816445|NCT04625725|463625248|FG002|Provent Sub Study|Adverse Event|0|||
128816446|NCT04625725|463625249|FG003|Provent Sub Study|Adverse Event|0|||
128816447|NCT04625725|463625250|FG004|Provent Sub Study|Adverse Event|0|||
128816448|NCT04625725|463625251|FG005|Provent Sub Study|Adverse Event|1|||
128816449|NCT04625725|463625246|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
128816450|NCT04625725|463625247|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
128816451|NCT04625725|463625248|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
128816452|NCT04625725|463625249|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
128816453|NCT04625725|463625250|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
128816454|NCT04625725|463625251|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
128816455|NCT04625725|463625246|FG000|Provent Sub Study|Withdrawal by Subject|0|||
128816456|NCT04625725|463625247|FG001|Provent Sub Study|Withdrawal by Subject|0|||
128816457|NCT04625725|463625248|FG002|Provent Sub Study|Withdrawal by Subject|11|||
128816458|NCT04625725|463625249|FG003|Provent Sub Study|Withdrawal by Subject|13|||
128816459|NCT04625725|463625250|FG004|Provent Sub Study|Withdrawal by Subject|5|||
128816460|NCT04625725|463625251|FG005|Provent Sub Study|Withdrawal by Subject|6|||
128816461|NCT04625725|463625246|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
128816462|NCT04625725|463625247|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
128816463|NCT04625725|463625248|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
128816464|NCT04625725|463625249|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
128816465|NCT04625725|463625250|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
128816466|NCT04625725|463625251|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
128816467|NCT04737330|463625252|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
128816468|NCT04737330|463625253|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
128816469|NCT04737330|463625252|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
128816470|NCT04737330|463625253|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
128816471|NCT04737330|463625252|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
128816472|NCT04737330|463625253|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
128816473|NCT04737330|463625252|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
128816474|NCT04737330|463625253|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
128816475|NCT04737330|463625252|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
128816476|NCT04737330|463625253|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
128816477|NCT04737330|463625252|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
128816478|NCT04737330|463625253|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
128816479|NCT05873556|463625256|FG000|Overall Study|Lost to Follow-up|4|||
128816480|NCT05873556|463625257|FG001|Overall Study|Lost to Follow-up|1|||
128816481|NCT04689256|463625258|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
128816482|NCT04689256|463625259|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
128816483|NCT00696111|463626609|FG000|Overall Study|Withdrawal by Subject|17|||
128816484|NCT02038777|463626614|FG000|Overall Study|Death|0|||
128816485|NCT02038777|463626615|FG001|Overall Study|Death|2|||
128816486|NCT02038777|463626616|FG002|Overall Study|Death|0|||
128816487|NCT02038777|463626617|FG003|Overall Study|Death|1|||
128816488|NCT02038777|463626618|FG004|Overall Study|Death|2|||
128816489|NCT02038777|463626619|FG005|Overall Study|Death|4|||
128816490|NCT02038777|463626620|FG006|Overall Study|Death|0|||
128816491|NCT02038777|463626621|FG007|Overall Study|Death|11|||
128816492|NCT02038777|463626614|FG000|Overall Study|Lost to Follow-up|0|||
128816493|NCT02038777|463626615|FG001|Overall Study|Lost to Follow-up|0|||
128816494|NCT02038777|463626616|FG002|Overall Study|Lost to Follow-up|0|||
128816495|NCT02038777|463626617|FG003|Overall Study|Lost to Follow-up|1|||
128816496|NCT02038777|463626618|FG004|Overall Study|Lost to Follow-up|0|||
128816497|NCT02038777|463626619|FG005|Overall Study|Lost to Follow-up|0|||
128816498|NCT02038777|463626620|FG006|Overall Study|Lost to Follow-up|0|||
128816499|NCT02038777|463626621|FG007|Overall Study|Lost to Follow-up|0|||
128816500|NCT02038777|463626614|FG000|Overall Study|Other|0|||
128816501|NCT02038777|463626615|FG001|Overall Study|Other|1|||
128816502|NCT02038777|463626616|FG002|Overall Study|Other|0|||
128816503|NCT02038777|463626617|FG003|Overall Study|Other|2|||
128816504|NCT02038777|463626618|FG004|Overall Study|Other|1|||
128816505|NCT02038777|463626619|FG005|Overall Study|Other|0|||
128816506|NCT02038777|463626620|FG006|Overall Study|Other|0|||
128816507|NCT02038777|463626621|FG007|Overall Study|Other|0|||
128816508|NCT02038777|463626614|FG000|Overall Study|Randomized but not treated|0|||
128816509|NCT02038777|463626615|FG001|Overall Study|Randomized but not treated|1|||
128816510|NCT02038777|463626616|FG002|Overall Study|Randomized but not treated|0|||
128816511|NCT02038777|463626617|FG003|Overall Study|Randomized but not treated|0|||
128816512|NCT02038777|463626618|FG004|Overall Study|Randomized but not treated|0|||
128816513|NCT02038777|463626619|FG005|Overall Study|Randomized but not treated|0|||
128816514|NCT02038777|463626620|FG006|Overall Study|Randomized but not treated|0|||
128816515|NCT02038777|463626621|FG007|Overall Study|Randomized but not treated|0|||
128816516|NCT02038777|463626614|FG000|Overall Study|Started Chemotherapy|1|||
128816517|NCT02038777|463626615|FG001|Overall Study|Started Chemotherapy|0|||
128816518|NCT02038777|463626616|FG002|Overall Study|Started Chemotherapy|3|||
128816519|NCT02038777|463626617|FG003|Overall Study|Started Chemotherapy|0|||
128816520|NCT02038777|463626618|FG004|Overall Study|Started Chemotherapy|0|||
128816521|NCT02038777|463626619|FG005|Overall Study|Started Chemotherapy|0|||
128816522|NCT02038777|463626620|FG006|Overall Study|Started Chemotherapy|0|||
128816523|NCT02038777|463626621|FG007|Overall Study|Started Chemotherapy|0|||
128816524|NCT02038777|463626614|FG000|Overall Study|participation terminated by sponsor|0|||
128816525|NCT02038777|463626615|FG001|Overall Study|participation terminated by sponsor|0|||
128816526|NCT02038777|463626616|FG002|Overall Study|participation terminated by sponsor|0|||
128816527|NCT02038777|463626617|FG003|Overall Study|participation terminated by sponsor|0|||
128816528|NCT02038777|463626618|FG004|Overall Study|participation terminated by sponsor|0|||
128816529|NCT02038777|463626619|FG005|Overall Study|participation terminated by sponsor|0|||
128816530|NCT02038777|463626620|FG006|Overall Study|participation terminated by sponsor|1|||
128816531|NCT02038777|463626621|FG007|Overall Study|participation terminated by sponsor|1|||
128816532|NCT04299464|463626622|FG000|Overall Study|Adverse Event|1|||
128816533|NCT04299464|463626623|FG001|Overall Study|Adverse Event|0|||
128816534|NCT04299464|463626624|FG002|Overall Study|Adverse Event|2|||
128816535|NCT04299464|463626622|FG000|Overall Study|Non-compliance with Study Drug|1|||
128816536|NCT04299464|463626623|FG001|Overall Study|Non-compliance with Study Drug|0|||
128816537|NCT04299464|463626624|FG002|Overall Study|Non-compliance with Study Drug|0|||
128816538|NCT04299464|463626622|FG000|Overall Study|Reason not Specified|0|||
128816539|NCT04299464|463626623|FG001|Overall Study|Reason not Specified|1|||
128816540|NCT04299464|463626624|FG002|Overall Study|Reason not Specified|3|||
128816541|NCT04299464|463626622|FG000|Overall Study|Physician Decision|0|||
128816542|NCT04299464|463626623|FG001|Overall Study|Physician Decision|1|||
128816543|NCT04299464|463626624|FG002|Overall Study|Physician Decision|1|||
128816544|NCT04299464|463626622|FG000|Overall Study|Withdrawal by Subject|0|||
128816545|NCT04299464|463626623|FG001|Overall Study|Withdrawal by Subject|2|||
128816546|NCT04299464|463626624|FG002|Overall Study|Withdrawal by Subject|1|||
129204660|NCT03799341|465045850|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
129204661|NCT03799341|465045851|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
129204662|NCT03799341|465045852|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
129204663|NCT03799341|465045850|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
129204664|NCT03799341|465045851|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
129204665|NCT03799341|465045852|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
129204666|NCT03799341|465045850|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
129204667|NCT03799341|465045851|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
129204668|NCT03799341|465045852|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
129204669|NCT01116648|465045853|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
129204670|NCT01116648|465045854|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
129204671|NCT01116648|465045855|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
129204672|NCT01116648|465045856|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
129204673|NCT01116648|465045857|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
129204674|NCT01116648|465045858|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
129204675|NCT01116648|465045859|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
129204676|NCT01116648|465045860|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
129204677|NCT01116648|465045861|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
129204678|NCT01116648|465045862|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
129204679|NCT01116648|465045863|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
128816547|NCT05907174|463626625|FG000|3-Month Assessment|Withdrawal by Subject|0|||
128816548|NCT05907174|463626626|FG001|3-Month Assessment|Withdrawal by Subject|0|||
128816549|NCT05907174|463626627|FG002|3-Month Assessment|Withdrawal by Subject|0|||
128816550|NCT05907174|463626628|FG003|3-Month Assessment|Withdrawal by Subject|1|||
128816551|NCT05907174|463626625|FG000|3-Month Assessment|Lost to Follow-up|1|||
128816552|NCT05907174|463626626|FG001|3-Month Assessment|Lost to Follow-up|1|||
128816553|NCT05907174|463626627|FG002|3-Month Assessment|Lost to Follow-up|1|||
128816554|NCT05907174|463626628|FG003|3-Month Assessment|Lost to Follow-up|1|||
128816555|NCT05907174|463626625|FG000|6-Month Assessment|Death|0|||
128816556|NCT05907174|463626626|FG001|6-Month Assessment|Death|0|||
128816557|NCT05907174|463626627|FG002|6-Month Assessment|Death|3|||
128816558|NCT05907174|463626628|FG003|6-Month Assessment|Death|0|||
128816559|NCT05907174|463626625|FG000|6-Month Assessment|Withdrawal by Subject|0|||
128816560|NCT05907174|463626626|FG001|6-Month Assessment|Withdrawal by Subject|0|||
128816561|NCT05907174|463626627|FG002|6-Month Assessment|Withdrawal by Subject|1|||
128816562|NCT05907174|463626628|FG003|6-Month Assessment|Withdrawal by Subject|1|||
128816563|NCT05907174|463626625|FG000|6-Month Assessment|Lost to Follow-up|0|||
128816564|NCT05907174|463626626|FG001|6-Month Assessment|Lost to Follow-up|1|||
128816565|NCT05907174|463626627|FG002|6-Month Assessment|Lost to Follow-up|1|||
128816566|NCT05907174|463626628|FG003|6-Month Assessment|Lost to Follow-up|1|||
128816567|NCT04685135|463626635|FG000|Overall Study|Death|126|||
128816568|NCT04685135|463626636|FG001|Overall Study|Death|53|||
128816569|NCT04685135|463626635|FG000|Overall Study|Withdrawal by Subject|12|||
128816570|NCT04685135|463626636|FG001|Overall Study|Withdrawal by Subject|16|||
128816571|NCT01346540|463626650|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
128816572|NCT01346540|463626651|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
128816573|NCT01346540|463626650|FG000|Overall Study|Adverse Event|0|||
128816574|NCT01346540|463626651|FG001|Overall Study|Adverse Event|4|||
128816575|NCT03362476|463626656|FG000|Overall Study|Withdrawal by Subject|0|||
128816576|NCT03362476|463626657|FG001|Overall Study|Withdrawal by Subject|1|||
128816577|NCT05974501|463626658|FG000|Overall Study|Physician Decision|0|||
128816578|NCT05974501|463626659|FG001|Overall Study|Physician Decision|1|||
128816579|NCT04270942|463626662|FG000|Overall Study|Death|1|||
128816580|NCT01221948|463626675|FG000|Overall Study|Physician Decision|5|||
128816581|NCT01221948|463626675|FG000|Overall Study|Withdrawal by Subject|2|||
128816582|NCT01221948|463626675|FG000|Overall Study|not disclosed|2|||
128816583|NCT01221948|463626675|FG000|Overall Study|Death|1|||
128816584|NCT01221948|463626675|FG000|Overall Study|Protocol Violation|4|||
128816585|NCT00746096|463626676|FG000|Overall Study|Adverse Event|1|||
128816586|NCT00746096|463626677|FG001|Overall Study|Adverse Event|0|||
128816587|NCT00746096|463626676|FG000|Overall Study|Withdrawal by Subject|5|||
128816588|NCT00746096|463626677|FG001|Overall Study|Withdrawal by Subject|1|||
128816589|NCT00746096|463626676|FG000|Overall Study|Lost to Follow-up|2|||
128816590|NCT00746096|463626677|FG001|Overall Study|Lost to Follow-up|1|||
128816591|NCT00746096|463626676|FG000|Overall Study|Protocol Violation|1|||
128816592|NCT00746096|463626677|FG001|Overall Study|Protocol Violation|0|||
128816593|NCT00746096|463626676|FG000|Overall Study|No study drug treatment|1|||
128816594|NCT00746096|463626677|FG001|Overall Study|No study drug treatment|1|||
128816595|NCT04059185|463626678|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
128816596|NCT04059185|463626679|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
129204680|NCT01116648|465045864|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
129204681|NCT01116648|465045865|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
128816597|NCT04059185|463626680|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
128816598|NCT04059185|463626678|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
128816599|NCT04059185|463626679|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
128816600|NCT04059185|463626680|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
128816601|NCT04059185|463626678|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
128816602|NCT04059185|463626679|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
128816603|NCT04059185|463626680|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
129204682|NCT01116648|465045866|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
129204683|NCT01116648|465045867|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
129204684|NCT04539938|465045868|FG000|Overall Study|Death|30|||
129204685|NCT04539938|465045868|FG000|Overall Study|Withdrawal by Subject|4|||
129204686|NCT00410956|465045869|FG000|Overall Study|Adverse Event|1|||
129204687|NCT00410956|465045869|FG000|Overall Study|Death|2|||
129204688|NCT00410956|465045869|FG000|Overall Study|Lack of Efficacy|10|||
129204689|NCT00410956|465045869|FG000|Overall Study|Physician Decision|6|||
129204690|NCT01650194|465045870|FG000|Overall Study|Progressive Disease (PD)|35|||
129204691|NCT01650194|465045870|FG000|Overall Study|Withdrawal by Subject|2|||
129204692|NCT01650194|465045870|FG000|Overall Study|Miscellaneous|10|||
129204693|NCT00880698|465045873|FG000|Overall Study|Death|0|||
129204694|NCT00880698|465045874|FG001|Overall Study|Death|0|||
129204695|NCT00880698|465045875|FG002|Overall Study|Death|1|||
129204696|NCT00880698|465045876|FG003|Overall Study|Death|2|||
129204697|NCT00880698|465045873|FG000|Overall Study|Lost to Follow-up|1|||
129204698|NCT00880698|465045874|FG001|Overall Study|Lost to Follow-up|3|||
129204699|NCT00880698|465045875|FG002|Overall Study|Lost to Follow-up|0|||
129204700|NCT00880698|465045876|FG003|Overall Study|Lost to Follow-up|1|||
129204701|NCT00794950|465045877|FG000|BCG Induction|Withdrawal by Subject|2|||
129204702|NCT00794950|465045877|FG000|BCG Induction|ineligible|3|||
129204703|NCT00794950|465045877|FG000|BCG Induction|noncompliant w. BCG|1|||
129204704|NCT00794950|465045877|FG000|BCG Induction|Adverse Event|1|||
129204705|NCT00794950|465045877|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
129204706|NCT00794950|465045877|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
129204707|NCT00794950|465045877|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
129204708|NCT00794950|465045877|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
129204709|NCT00445549|465046917|FG000|Overall Study|progressive disease|12|||
128816604|NCT04059185|463626678|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
128816605|NCT04059185|463626679|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
128816606|NCT04059185|463626680|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
128816607|NCT04059185|463626678|FG000|Longitudinal Assessment-Adults Only|Death|4|||
128816608|NCT04059185|463626679|FG001|Longitudinal Assessment-Adults Only|Death|4|||
128816609|NCT04059185|463626680|FG002|Longitudinal Assessment-Adults Only|Death|3|||
128816610|NCT03756662|463626681|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
128816611|NCT03298451|463626688|FG000|Overall Study|Death|275|||
128816612|NCT03298451|463626689|FG001|Overall Study|Death|260|||
128816613|NCT03298451|463626690|FG002|Overall Study|Death|122|||
128816614|NCT03298451|463626691|FG003|Overall Study|Death|280|||
128816615|NCT03298451|463626688|FG000|Overall Study|Lost to Follow-up|1|||
128816616|NCT03298451|463626689|FG001|Overall Study|Lost to Follow-up|1|||
128816617|NCT03298451|463626690|FG002|Overall Study|Lost to Follow-up|0|||
128816618|NCT03298451|463626691|FG003|Overall Study|Lost to Follow-up|7|||
128816619|NCT03298451|463626688|FG000|Overall Study|Withdrawal by Subject|9|||
128816620|NCT03298451|463626689|FG001|Overall Study|Withdrawal by Subject|7|||
128816621|NCT03298451|463626690|FG002|Overall Study|Withdrawal by Subject|1|||
128816622|NCT03298451|463626691|FG003|Overall Study|Withdrawal by Subject|20|||
128816623|NCT03295721|463626696|FG000|Overall Study|Adverse Event|1|||
128816624|NCT03295721|463626697|FG001|Overall Study|Adverse Event|0|||
128816625|NCT03295721|463626698|FG002|Overall Study|Adverse Event|0|||
128816626|NCT03295721|463626696|FG000|Overall Study|Lost to Follow-up|1|||
128816627|NCT03295721|463626697|FG001|Overall Study|Lost to Follow-up|1|||
128816628|NCT03295721|463626698|FG002|Overall Study|Lost to Follow-up|1|||
128816629|NCT03295721|463626696|FG000|Overall Study|Withdrawal by Subject|1|||
128816630|NCT03295721|463626697|FG001|Overall Study|Withdrawal by Subject|0|||
128816631|NCT03295721|463626698|FG002|Overall Study|Withdrawal by Subject|1|||
128816632|NCT03295721|463626696|FG000|Overall Study|Death|0|||
128816633|NCT03295721|463626697|FG001|Overall Study|Death|0|||
128816634|NCT03295721|463626698|FG002|Overall Study|Death|1|||
128816635|NCT01651403|463626704|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
128816636|NCT01651403|463626705|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
128816637|NCT01651403|463626704|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
128816638|NCT01651403|463626705|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
128816639|NCT01651403|463626704|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
129204710|NCT02079740|465046922|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
129204711|NCT02079740|465046923|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
129204712|NCT02079740|465046924|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
129204713|NCT02079740|465046925|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
128816640|NCT01651403|463626705|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
128816641|NCT01651403|463626704|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
128816642|NCT01651403|463626705|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
128816643|NCT01651403|463626704|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
128816644|NCT01651403|463626705|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
128816645|NCT01651403|463626704|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
128816646|NCT01651403|463626705|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
128816647|NCT05090683|463626708|FG000|Overall Study|Lost to Follow-up|10|||
128816648|NCT05090683|463626709|FG001|Overall Study|Lost to Follow-up|2|||
128816649|NCT05090683|463626708|FG000|Overall Study|Withdrawal by Subject|15|||
128816650|NCT05090683|463626709|FG001|Overall Study|Withdrawal by Subject|0|||
128816651|NCT04032847|463626712|FG000|Overall Study|Study termination by sponsor|8|||
128816652|NCT04032847|463626713|FG001|Overall Study|Study termination by sponsor|0|||
128816653|NCT04032847|463626714|FG002|Overall Study|Study termination by sponsor|4|||
128816654|NCT04032847|463626712|FG000|Overall Study|Death|12|||
128816655|NCT04032847|463626713|FG001|Overall Study|Death|0|||
128816656|NCT04032847|463626714|FG002|Overall Study|Death|0|||
128816657|NCT04032847|463626712|FG000|Overall Study|Progressive disease|2|||
128816658|NCT04032847|463626713|FG001|Overall Study|Progressive disease|0|||
128816659|NCT04032847|463626714|FG002|Overall Study|Progressive disease|1|||
128816660|NCT03325985|463626715|FG000|Overall Study|Lost to Follow-up|122|||
128816661|NCT03325985|463626716|FG001|Overall Study|Lost to Follow-up|26|||
128816662|NCT03325985|463626717|FG002|Overall Study|Lost to Follow-up|141|||
128816663|NCT03325985|463626718|FG003|Overall Study|Lost to Follow-up|28|||
128816664|NCT03325985|463626715|FG000|Overall Study|Death|99|||
128816665|NCT03325985|463626716|FG001|Overall Study|Death|36|||
128816666|NCT03325985|463626717|FG002|Overall Study|Death|94|||
128816667|NCT03325985|463626718|FG003|Overall Study|Death|32|||
128816668|NCT03056573|463626719|FG000|Overall Study|Death|2|||
128816669|NCT03056573|463626720|FG001|Overall Study|Death|4|||
128816670|NCT03056573|463626719|FG000|Overall Study|Withdrawal by Subject|2|||
128816671|NCT03056573|463626720|FG001|Overall Study|Withdrawal by Subject|0|||
128816672|NCT03056573|463626719|FG000|Overall Study|Lost to Follow-up|1|||
128816673|NCT03056573|463626720|FG001|Overall Study|Lost to Follow-up|1|||
128816674|NCT05104463|463626721|FG000|Overall Study|Adverse Event|1|||
128816675|NCT05104463|463626722|FG001|Overall Study|Adverse Event|1|||
128816676|NCT05104463|463626721|FG000|Overall Study|Lost to Follow-up|1|||
128816677|NCT05104463|463626722|FG001|Overall Study|Lost to Follow-up|1|||
128816678|NCT05104463|463626721|FG000|Overall Study|Physician Decision|1|||
128816679|NCT05104463|463626722|FG001|Overall Study|Physician Decision|0|||
128816680|NCT05104463|463626721|FG000|Overall Study|Protocol Violation|0|||
128816681|NCT05104463|463626722|FG001|Overall Study|Protocol Violation|2|||
128816682|NCT05104463|463626721|FG000|Overall Study|Withdrawal by Subject|1|||
128816683|NCT05104463|463626722|FG001|Overall Study|Withdrawal by Subject|1|||
128816684|NCT05267470|463626724|FG000|Overall Study|Decision by sponsor|0|||
128816685|NCT05267470|463626725|FG001|Overall Study|Decision by sponsor|3|||
128816686|NCT05267470|463626726|FG002|Overall Study|Decision by sponsor|19|||
128816687|NCT05267470|463626727|FG003|Overall Study|Decision by sponsor|7|||
128816688|NCT05267470|463626728|FG004|Overall Study|Decision by sponsor|3|||
128816689|NCT05267470|463626724|FG000|Overall Study|Withdrawal by Subject|1|||
128816690|NCT05267470|463626725|FG001|Overall Study|Withdrawal by Subject|1|||
128816691|NCT05267470|463626726|FG002|Overall Study|Withdrawal by Subject|2|||
128816692|NCT05267470|463626727|FG003|Overall Study|Withdrawal by Subject|2|||
128816693|NCT05267470|463626728|FG004|Overall Study|Withdrawal by Subject|0|||
128816694|NCT05267470|463626724|FG000|Overall Study|Death|3|||
128816695|NCT05267470|463626725|FG001|Overall Study|Death|5|||
128816696|NCT05267470|463626726|FG002|Overall Study|Death|8|||
128816697|NCT05267470|463626727|FG003|Overall Study|Death|18|||
128816698|NCT05267470|463626728|FG004|Overall Study|Death|1|||
128816699|NCT05267470|463626724|FG000|Overall Study|Lost to Follow-up|0|||
128816700|NCT05267470|463626725|FG001|Overall Study|Lost to Follow-up|0|||
128816701|NCT05267470|463626726|FG002|Overall Study|Lost to Follow-up|0|||
128816702|NCT05267470|463626727|FG003|Overall Study|Lost to Follow-up|1|||
128816703|NCT05267470|463626728|FG004|Overall Study|Lost to Follow-up|0|||
128816704|NCT03381586|463626731|FG000|Overall Study|Adverse Event|1|||
128816705|NCT03381586|463626732|FG001|Overall Study|Adverse Event|1|||
128816706|NCT03381586|463626731|FG000|Overall Study|Protocol Violation|1|||
128816707|NCT03381586|463626732|FG001|Overall Study|Protocol Violation|0|||
128816708|NCT03381586|463626731|FG000|Overall Study|Withdrawal by Subject|1|||
128816709|NCT03381586|463626732|FG001|Overall Study|Withdrawal by Subject|2|||
128816710|NCT04230681|463626737|FG000|Overall Study|Physician Decision|2|||
128816711|NCT04230681|463626738|FG001|Overall Study|Physician Decision|3|||
128816712|NCT04230681|463626737|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
128816713|NCT04230681|463626738|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
128816714|NCT04230681|463626737|FG000|Overall Study|IV inadvertently removed|0|||
128816715|NCT04230681|463626738|FG001|Overall Study|IV inadvertently removed|1|||
128816716|NCT03676192|463628853|FG000|Induction Study Period|Adverse Event|21|||
128816717|NCT03676192|463628854|FG001|Induction Study Period|Adverse Event|20|||
128816718|NCT03676192|463628853|FG000|Induction Study Period|Death|23|||
128816719|NCT03676192|463628854|FG001|Induction Study Period|Death|20|||
128816720|NCT03676192|463628853|FG000|Induction Study Period|Lost to Follow-up|3|||
128816721|NCT03676192|463628854|FG001|Induction Study Period|Lost to Follow-up|3|||
128816722|NCT03676192|463628853|FG000|Induction Study Period|Physician Decision|6|||
128816723|NCT03676192|463628854|FG001|Induction Study Period|Physician Decision|3|||
128816724|NCT03676192|463628853|FG000|Induction Study Period|Progressive Disease|32|||
128816725|NCT03676192|463628854|FG001|Induction Study Period|Progressive Disease|21|||
128816726|NCT03676192|463628853|FG000|Induction Study Period|Protocol Violation|1|||
128816727|NCT03676192|463628854|FG001|Induction Study Period|Protocol Violation|2|||
128816728|NCT03676192|463628853|FG000|Induction Study Period|Withdrawal by Subject|20|||
128816729|NCT03676192|463628854|FG001|Induction Study Period|Withdrawal by Subject|15|||
128816730|NCT04079218|463628855|FG000|Overall Study|Death|1|||
128816731|NCT04079218|463628856|FG001|Overall Study|Death|0|||
128816732|NCT04079218|463628855|FG000|Overall Study|Withdrawal by Subject|3|||
128816733|NCT04079218|463628856|FG001|Overall Study|Withdrawal by Subject|0|||
128816734|NCT04079218|463628855|FG000|Overall Study|Physician Decision|4|||
128816735|NCT04079218|463628856|FG001|Overall Study|Physician Decision|0|||
128816736|NCT04079218|463628855|FG000|Overall Study|Lost to Follow-up|0|||
128816737|NCT04079218|463628856|FG001|Overall Study|Lost to Follow-up|1|||
128816738|NCT02424617|463628859|FG000|Overall Study|Adverse Event|0|||
128816739|NCT02424617|463628860|FG001|Overall Study|Adverse Event|1|||
128816740|NCT02424617|463628861|FG002|Overall Study|Adverse Event|0|||
128816741|NCT02424617|463628862|FG003|Overall Study|Adverse Event|0|||
128816742|NCT02424617|463628859|FG000|Overall Study|Investigator Decision|0|||
128816743|NCT02424617|463628860|FG001|Overall Study|Investigator Decision|0|||
128816744|NCT02424617|463628861|FG002|Overall Study|Investigator Decision|0|||
128816745|NCT02424617|463628862|FG003|Overall Study|Investigator Decision|1|||
128816746|NCT02424617|463628859|FG000|Overall Study|Withdrawal by Subject|1|||
128816747|NCT02424617|463628860|FG001|Overall Study|Withdrawal by Subject|1|||
128816748|NCT02424617|463628861|FG002|Overall Study|Withdrawal by Subject|0|||
128816749|NCT02424617|463628862|FG003|Overall Study|Withdrawal by Subject|1|||
128816750|NCT02424617|463628859|FG000|Overall Study|Progressive Disease|7|||
128816751|NCT02424617|463628860|FG001|Overall Study|Progressive Disease|6|||
128816752|NCT02424617|463628861|FG002|Overall Study|Progressive Disease|11|||
128816753|NCT02424617|463628862|FG003|Overall Study|Progressive Disease|10|||
128816754|NCT02424617|463628859|FG000|Overall Study|Other|0|||
128816755|NCT02424617|463628860|FG001|Overall Study|Other|0|||
128816756|NCT02424617|463628861|FG002|Overall Study|Other|0|||
128816757|NCT02424617|463628862|FG003|Overall Study|Other|1|||
128816758|NCT02694822|463628863|FG000|Phase 1|Death|2|||
128816759|NCT02694822|463628864|FG001|Phase 1|Death|1|||
128816760|NCT02694822|463628865|FG002|Phase 1|Death|6|||
128816761|NCT02694822|463628866|FG003|Phase 1|Death|6|||
128816762|NCT02694822|463628867|FG004|Phase 1|Death|3|||
128816763|NCT02694822|463628868|FG005|Phase 1|Death|0|||
128816764|NCT02694822|463628863|FG000|Phase 1|Withdrawal by Subject|2|||
128816765|NCT02694822|463628864|FG001|Phase 1|Withdrawal by Subject|2|||
128816766|NCT02694822|463628865|FG002|Phase 1|Withdrawal by Subject|4|||
128816767|NCT02694822|463628866|FG003|Phase 1|Withdrawal by Subject|8|||
128816768|NCT02694822|463628867|FG004|Phase 1|Withdrawal by Subject|1|||
128816769|NCT02694822|463628868|FG005|Phase 1|Withdrawal by Subject|0|||
128816770|NCT02694822|463628863|FG000|Phase 2|Death|0|||
128816771|NCT02694822|463628864|FG001|Phase 2|Death|0|||
128816772|NCT02694822|463628865|FG002|Phase 2|Death|0|||
128816773|NCT02694822|463628866|FG003|Phase 2|Death|0|||
128816774|NCT02694822|463628867|FG004|Phase 2|Death|0|||
128816775|NCT02694822|463628868|FG005|Phase 2|Death|26|||
128816776|NCT02694822|463628863|FG000|Phase 2|Withdrawal by Subject|0|||
128816777|NCT02694822|463628864|FG001|Phase 2|Withdrawal by Subject|0|||
128816778|NCT02694822|463628865|FG002|Phase 2|Withdrawal by Subject|0|||
128816779|NCT02694822|463628866|FG003|Phase 2|Withdrawal by Subject|0|||
128816780|NCT02694822|463628867|FG004|Phase 2|Withdrawal by Subject|0|||
128816781|NCT02694822|463628868|FG005|Phase 2|Withdrawal by Subject|13|||
128816782|NCT02694822|463628863|FG000|Phase 2|Administrative Study Closure|0|||
128816783|NCT02694822|463628864|FG001|Phase 2|Administrative Study Closure|0|||
128816784|NCT02694822|463628865|FG002|Phase 2|Administrative Study Closure|0|||
128816785|NCT02694822|463628866|FG003|Phase 2|Administrative Study Closure|0|||
128816786|NCT02694822|463628867|FG004|Phase 2|Administrative Study Closure|0|||
128816787|NCT02694822|463628868|FG005|Phase 2|Administrative Study Closure|2|||
128816788|NCT02694822|463628863|FG000|Phase 2|Lost to Follow-up|0|||
128816789|NCT02694822|463628864|FG001|Phase 2|Lost to Follow-up|0|||
128816790|NCT02694822|463628865|FG002|Phase 2|Lost to Follow-up|0|||
128816791|NCT02694822|463628866|FG003|Phase 2|Lost to Follow-up|0|||
128816792|NCT02694822|463628867|FG004|Phase 2|Lost to Follow-up|0|||
128816793|NCT02694822|463628868|FG005|Phase 2|Lost to Follow-up|1|||
128816794|NCT02694822|463628863|FG000|Phase 2|Participant Transferred to Another Site|0|||
128816795|NCT02694822|463628864|FG001|Phase 2|Participant Transferred to Another Site|0|||
128816796|NCT02694822|463628865|FG002|Phase 2|Participant Transferred to Another Site|0|||
128816797|NCT02694822|463628866|FG003|Phase 2|Participant Transferred to Another Site|0|||
128816798|NCT02694822|463628867|FG004|Phase 2|Participant Transferred to Another Site|0|||
128816799|NCT02694822|463628868|FG005|Phase 2|Participant Transferred to Another Site|1|||
128816800|NCT01868997|463628871|FG000|Overall Study|Adverse Event|2|||
128816801|NCT01868997|463628872|FG001|Overall Study|Adverse Event|5|||
128816802|NCT01868997|463628871|FG000|Overall Study|Lack of Efficacy|2|||
128816803|NCT01868997|463628872|FG001|Overall Study|Lack of Efficacy|0|||
128816804|NCT01868997|463628871|FG000|Overall Study|Other|3|||
128816805|NCT01868997|463628872|FG001|Overall Study|Other|1|||
128816806|NCT02052882|463628878|FG000|Overall Study|Not treated|11|||
128816807|NCT02052882|463628878|FG000|Overall Study|Protocol Violation|1|||
128816808|NCT02052882|463628878|FG000|Overall Study|Inadequate testing|1|||
128816809|NCT04766892|463628879|FG000|Overall Study|Withdrawal by Subject|1|||
128816810|NCT04766892|463628879|FG000|Overall Study|Lost to Follow-up|1|||
128816811|NCT04766892|463628879|FG000|Overall Study|Adverse Event|3|||
128816812|NCT04766892|463628879|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
128816813|NCT04778397|463628880|FG000|Overall Study|Death|59|||
128816814|NCT04778397|463628881|FG001|Overall Study|Death|54|||
128816815|NCT04778397|463628882|FG002|Overall Study|Death|11|||
128816816|NCT04778397|463628883|FG003|Overall Study|Death|9|||
128816817|NCT04778397|463628880|FG000|Overall Study|Study Terminated by Sponsor|34|||
128816818|NCT04778397|463628881|FG001|Overall Study|Study Terminated by Sponsor|42|||
128816819|NCT04778397|463628882|FG002|Overall Study|Study Terminated by Sponsor|15|||
128816820|NCT04778397|463628883|FG003|Overall Study|Study Terminated by Sponsor|12|||
128816821|NCT04778397|463628880|FG000|Overall Study|Withdrew Consent|5|||
128816822|NCT04778397|463628881|FG001|Overall Study|Withdrew Consent|4|||
128816823|NCT04778397|463628882|FG002|Overall Study|Withdrew Consent|1|||
128816824|NCT04778397|463628883|FG003|Overall Study|Withdrew Consent|1|||
128816825|NCT04778397|463628880|FG000|Overall Study|Reason Not Specified|1|||
128816826|NCT04778397|463628881|FG001|Overall Study|Reason Not Specified|3|||
128816827|NCT04778397|463628882|FG002|Overall Study|Reason Not Specified|0|||
128816828|NCT04778397|463628883|FG003|Overall Study|Reason Not Specified|2|||
128816829|NCT04778397|463628880|FG000|Overall Study|Lost to Follow-up|2|||
128816830|NCT04778397|463628881|FG001|Overall Study|Lost to Follow-up|1|||
128816831|NCT04778397|463628882|FG002|Overall Study|Lost to Follow-up|0|||
128816832|NCT04778397|463628883|FG003|Overall Study|Lost to Follow-up|1|||
128816833|NCT05906784|463628884|FG000|Overall Study|Lost to Follow-up|2|||
128816834|NCT05906784|463628885|FG001|Overall Study|Lost to Follow-up|1|||
128816835|NCT05906784|463628886|FG002|Overall Study|Lost to Follow-up|1|||
128816836|NCT05906784|463628887|FG003|Overall Study|Lost to Follow-up|1|||
128816837|NCT02668692|463628888|FG000|Overall Study|Adverse Event|1|||
128816838|NCT02668692|463628889|FG001|Overall Study|Adverse Event|0|||
128816839|NCT03308877|463628894|FG000|Overall Study|Lost to Follow-up|32|||
128816840|NCT03308877|463628895|FG001|Overall Study|Lost to Follow-up|28|||
128816841|NCT04677738|463628905|FG000|Overall Study|Withdrawal by Subject|4|||
128816842|NCT04677738|463628906|FG001|Overall Study|Withdrawal by Subject|2|||
128816843|NCT03249090|463628907|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
128816844|NCT03249090|463628908|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
128816845|NCT03249090|463628907|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
128816846|NCT03249090|463628908|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
128816847|NCT03249090|463628907|FG000|3 Month Time Point|Voluntary withdrawal|6|||
128816848|NCT03249090|463628908|FG001|3 Month Time Point|Voluntary withdrawal|3|||
128816849|NCT03249090|463628907|FG000|3 Month Time Point|Changed oncology practice|4|||
128816850|NCT03249090|463628908|FG001|3 Month Time Point|Changed oncology practice|2|||
128816851|NCT03249090|463628907|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
128816852|NCT03249090|463628908|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
128816853|NCT03249090|463628907|FG000|12 Month Time Point|Voluntary withdrawal|35|||
128816854|NCT03249090|463628908|FG001|12 Month Time Point|Voluntary withdrawal|4|||
128816855|NCT03249090|463628907|FG000|12 Month Time Point|Changed oncology practice|20|||
128816856|NCT03249090|463628908|FG001|12 Month Time Point|Changed oncology practice|9|||
128759313|NCT03518125|463408843|FG005|Overall Study|Missed Day 394 Visit|0|||
128759314|NCT01078155|463408848|FG000|Overall Study|Adverse Event|7|||
128759315|NCT01078155|463408848|FG000|Overall Study|Lack of Efficacy|16|||
128759316|NCT01078155|463408848|FG000|Overall Study|Participant's Decision|6|||
128759317|NCT01078155|463408848|FG000|Overall Study|Lost to Follow-up|15|||
128759318|NCT03286751|463408849|FG000|Washout Period 1|Withdrawal by Subject|0|||
128759319|NCT03286751|463408850|FG001|Washout Period 1|Withdrawal by Subject|0|||
128759320|NCT03286751|463408851|FG002|Washout Period 1|Withdrawal by Subject|0|||
128759321|NCT03286751|463408852|FG003|Washout Period 1|Withdrawal by Subject|0|||
128759322|NCT03286751|463408853|FG004|Washout Period 1|Withdrawal by Subject|1|||
128759323|NCT03286751|463408854|FG005|Washout Period 1|Withdrawal by Subject|0|||
128759324|NCT03286751|463408849|FG000|Washout Period 2|Personal Reasons|0|||
128759325|NCT03286751|463408850|FG001|Washout Period 2|Personal Reasons|1|||
128759326|NCT03286751|463408851|FG002|Washout Period 2|Personal Reasons|0|||
128759327|NCT03286751|463408852|FG003|Washout Period 2|Personal Reasons|0|||
128759328|NCT03286751|463408853|FG004|Washout Period 2|Personal Reasons|0|||
128759329|NCT03286751|463408854|FG005|Washout Period 2|Personal Reasons|0|||
128759330|NCT03286751|463408849|FG000|Washout Period 5|Adverse Event|0|||
128759331|NCT03286751|463408850|FG001|Washout Period 5|Adverse Event|0|||
128759332|NCT03286751|463408851|FG002|Washout Period 5|Adverse Event|0|||
128759333|NCT03286751|463408852|FG003|Washout Period 5|Adverse Event|0|||
128759334|NCT03286751|463408853|FG004|Washout Period 5|Adverse Event|1|||
128759335|NCT03286751|463408854|FG005|Washout Period 5|Adverse Event|0|||
128759336|NCT01621880|463408855|FG000|Overall Study|Adverse Event|5|||
128759337|NCT01621880|463408856|FG001|Overall Study|Adverse Event|1|||
128759338|NCT01621880|463408855|FG000|Overall Study|Withdrawal by Subject|5|||
128759339|NCT01621880|463408856|FG001|Overall Study|Withdrawal by Subject|4|||
128759340|NCT01127646|463408857|FG000|Overall Study|Entry Criteria Not Met|1|||
128759341|NCT01127646|463408858|FG001|Overall Study|Entry Criteria Not Met|0|||
128759342|NCT01127646|463408857|FG000|Overall Study|Protocol Violation|0|||
128759343|NCT01127646|463408858|FG001|Overall Study|Protocol Violation|1|||
128759344|NCT04067401|463408859|FG000|Overall Study|Withdrawal by Subject|7|||
128759345|NCT04067401|463408860|FG001|Overall Study|Withdrawal by Subject|0|||
128759346|NCT04067401|463408859|FG000|Overall Study|no data provided|1|||
128759347|NCT04067401|463408860|FG001|Overall Study|no data provided|0|||
128759348|NCT01662063|463408863|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
128759349|NCT01662063|463408864|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
128759350|NCT01662063|463408865|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
128759351|NCT01662063|463408863|FG000|Overall Study|Lack of Efficacy|1|||
128759352|NCT01662063|463408864|FG001|Overall Study|Lack of Efficacy|6|||
128816857|NCT04359654|463628912|FG000|Overall Study|Withdrawal by Subject|1|||
128816858|NCT04359654|463628913|FG001|Overall Study|Withdrawal by Subject|0|||
128816859|NCT04359654|463628912|FG000|Overall Study|Adverse Event|0|||
128816860|NCT04359654|463628913|FG001|Overall Study|Adverse Event|1|||
128816861|NCT04314778|463628914|FG000|Overall Study|Lost to Follow-up|5|||
128816862|NCT04314778|463628915|FG001|Overall Study|Lost to Follow-up|3|||
128816863|NCT03523572|463628916|FG000|Dose Escalation|Progressive disease|1|||
128816864|NCT03523572|463628917|FG001|Dose Escalation|Progressive disease|0|||
128816865|NCT03523572|463628918|FG002|Dose Escalation|Progressive disease|0|||
128816866|NCT03523572|463628919|FG003|Dose Escalation|Progressive disease|0|||
128816867|NCT03523572|463628920|FG004|Dose Escalation|Progressive disease|0|||
128816868|NCT03523572|463628921|FG005|Dose Escalation|Progressive disease|0|||
128816869|NCT03523572|463628916|FG000|Dose Escalation|Clinical Progression|0|||
128816870|NCT03523572|463628917|FG001|Dose Escalation|Clinical Progression|1|||
128816871|NCT03523572|463628918|FG002|Dose Escalation|Clinical Progression|0|||
128816872|NCT03523572|463628919|FG003|Dose Escalation|Clinical Progression|0|||
128816873|NCT03523572|463628920|FG004|Dose Escalation|Clinical Progression|0|||
128816874|NCT03523572|463628921|FG005|Dose Escalation|Clinical Progression|0|||
128816875|NCT03523572|463628916|FG000|Dose Escalation|Adverse Event|2|||
128816876|NCT03523572|463628917|FG001|Dose Escalation|Adverse Event|0|||
128816877|NCT03523572|463628918|FG002|Dose Escalation|Adverse Event|0|||
128816878|NCT03523572|463628919|FG003|Dose Escalation|Adverse Event|0|||
128816879|NCT03523572|463628920|FG004|Dose Escalation|Adverse Event|0|||
128816880|NCT03523572|463628921|FG005|Dose Escalation|Adverse Event|0|||
128816881|NCT03523572|463628916|FG000|Dose Escalation|Physician Decision|1|||
128816882|NCT03523572|463628917|FG001|Dose Escalation|Physician Decision|1|||
128816883|NCT03523572|463628918|FG002|Dose Escalation|Physician Decision|0|||
128816884|NCT03523572|463628919|FG003|Dose Escalation|Physician Decision|0|||
128816885|NCT03523572|463628920|FG004|Dose Escalation|Physician Decision|0|||
128816886|NCT03523572|463628921|FG005|Dose Escalation|Physician Decision|0|||
128816887|NCT03523572|463628916|FG000|Dose Expansion|Progressive Disease|0|||
128816888|NCT03523572|463628917|FG001|Dose Expansion|Progressive Disease|0|||
128816889|NCT03523572|463628918|FG002|Dose Expansion|Progressive Disease|9|||
128816890|NCT03523572|463628919|FG003|Dose Expansion|Progressive Disease|11|||
128816891|NCT03523572|463628920|FG004|Dose Expansion|Progressive Disease|15|||
128816892|NCT03523572|463628921|FG005|Dose Expansion|Progressive Disease|2|||
128816893|NCT03523572|463628916|FG000|Dose Expansion|Clinical Progression|0|||
128816894|NCT03523572|463628917|FG001|Dose Expansion|Clinical Progression|0|||
128816895|NCT03523572|463628918|FG002|Dose Expansion|Clinical Progression|2|||
128816896|NCT03523572|463628919|FG003|Dose Expansion|Clinical Progression|2|||
128816897|NCT03523572|463628920|FG004|Dose Expansion|Clinical Progression|2|||
128816898|NCT03523572|463628921|FG005|Dose Expansion|Clinical Progression|0|||
128816899|NCT03523572|463628916|FG000|Dose Expansion|Adverse Event|0|||
128816900|NCT03523572|463628917|FG001|Dose Expansion|Adverse Event|0|||
128816901|NCT03523572|463628918|FG002|Dose Expansion|Adverse Event|10|||
128816902|NCT03523572|463628919|FG003|Dose Expansion|Adverse Event|1|||
128816903|NCT03523572|463628920|FG004|Dose Expansion|Adverse Event|5|||
128816904|NCT03523572|463628921|FG005|Dose Expansion|Adverse Event|2|||
128816905|NCT03523572|463628916|FG000|Dose Expansion|Withdrawal by Subject|0|||
128816906|NCT03523572|463628917|FG001|Dose Expansion|Withdrawal by Subject|0|||
128816907|NCT03523572|463628918|FG002|Dose Expansion|Withdrawal by Subject|1|||
128816908|NCT03523572|463628919|FG003|Dose Expansion|Withdrawal by Subject|1|||
128816909|NCT03523572|463628920|FG004|Dose Expansion|Withdrawal by Subject|0|||
128816910|NCT03523572|463628921|FG005|Dose Expansion|Withdrawal by Subject|0|||
128816911|NCT03523572|463628916|FG000|Dose Expansion|Physician Decision|0|||
128816912|NCT03523572|463628917|FG001|Dose Expansion|Physician Decision|0|||
128816913|NCT03523572|463628918|FG002|Dose Expansion|Physician Decision|1|||
128816914|NCT03523572|463628919|FG003|Dose Expansion|Physician Decision|0|||
128816915|NCT03523572|463628920|FG004|Dose Expansion|Physician Decision|1|||
128816916|NCT03523572|463628921|FG005|Dose Expansion|Physician Decision|0|||
128816917|NCT03523572|463628916|FG000|Dose Expansion|Miscellaneous|0|||
128816918|NCT03523572|463628917|FG001|Dose Expansion|Miscellaneous|0|||
128816919|NCT03523572|463628918|FG002|Dose Expansion|Miscellaneous|0|||
128816920|NCT03523572|463628919|FG003|Dose Expansion|Miscellaneous|0|||
128816921|NCT03523572|463628920|FG004|Dose Expansion|Miscellaneous|3|||
128816922|NCT03523572|463628921|FG005|Dose Expansion|Miscellaneous|0|||
128816923|NCT03519178|463628925|FG000|PF-06873600 Treatment|Adverse Event|0|||
128816924|NCT03519178|463628926|FG001|PF-06873600 Treatment|Adverse Event|0|||
128816925|NCT03519178|463628927|FG002|PF-06873600 Treatment|Adverse Event|0|||
128816926|NCT03519178|463628928|FG003|PF-06873600 Treatment|Adverse Event|0|||
128816927|NCT03519178|463628929|FG004|PF-06873600 Treatment|Adverse Event|0|||
128816928|NCT03519178|463628930|FG005|PF-06873600 Treatment|Adverse Event|0|||
128816929|NCT03519178|463628931|FG006|PF-06873600 Treatment|Adverse Event|0|||
128816930|NCT03519178|463628932|FG007|PF-06873600 Treatment|Adverse Event|2|||
128816931|NCT03519178|463628933|FG008|PF-06873600 Treatment|Adverse Event|1|||
128816932|NCT03519178|463628934|FG009|PF-06873600 Treatment|Adverse Event|0|||
128816933|NCT03519178|463628935|FG010|PF-06873600 Treatment|Adverse Event|0|||
128816934|NCT03519178|463628936|FG011|PF-06873600 Treatment|Adverse Event|0|||
128816935|NCT03519178|463628937|FG012|PF-06873600 Treatment|Adverse Event|1|||
128816936|NCT03519178|463628938|FG013|PF-06873600 Treatment|Adverse Event|3|||
128816937|NCT03519178|463628939|FG014|PF-06873600 Treatment|Adverse Event|2|||
128816938|NCT03519178|463628925|FG000|PF-06873600 Treatment|Death|0|||
128816939|NCT03519178|463628926|FG001|PF-06873600 Treatment|Death|0|||
128816940|NCT03519178|463628927|FG002|PF-06873600 Treatment|Death|0|||
128816941|NCT03519178|463628928|FG003|PF-06873600 Treatment|Death|0|||
128816942|NCT03519178|463628929|FG004|PF-06873600 Treatment|Death|0|||
128816943|NCT03519178|463628930|FG005|PF-06873600 Treatment|Death|0|||
128816944|NCT03519178|463628931|FG006|PF-06873600 Treatment|Death|0|||
128816945|NCT03519178|463628932|FG007|PF-06873600 Treatment|Death|0|||
128816946|NCT03519178|463628933|FG008|PF-06873600 Treatment|Death|1|||
128816947|NCT03519178|463628934|FG009|PF-06873600 Treatment|Death|1|||
128816948|NCT03519178|463628935|FG010|PF-06873600 Treatment|Death|0|||
128816949|NCT03519178|463628936|FG011|PF-06873600 Treatment|Death|0|||
128816950|NCT03519178|463628937|FG012|PF-06873600 Treatment|Death|0|||
128816951|NCT03519178|463628938|FG013|PF-06873600 Treatment|Death|0|||
128816952|NCT03519178|463628939|FG014|PF-06873600 Treatment|Death|1|||
128816953|NCT03519178|463628925|FG000|PF-06873600 Treatment|Physician Decision|0|||
128816954|NCT03519178|463628926|FG001|PF-06873600 Treatment|Physician Decision|0|||
128816955|NCT03519178|463628927|FG002|PF-06873600 Treatment|Physician Decision|0|||
128816956|NCT03519178|463628928|FG003|PF-06873600 Treatment|Physician Decision|0|||
128816957|NCT03519178|463628929|FG004|PF-06873600 Treatment|Physician Decision|0|||
128816958|NCT03519178|463628930|FG005|PF-06873600 Treatment|Physician Decision|0|||
128816959|NCT03519178|463628931|FG006|PF-06873600 Treatment|Physician Decision|0|||
128816960|NCT03519178|463628932|FG007|PF-06873600 Treatment|Physician Decision|1|||
128816961|NCT03519178|463628933|FG008|PF-06873600 Treatment|Physician Decision|0|||
128816962|NCT03519178|463628934|FG009|PF-06873600 Treatment|Physician Decision|0|||
128816963|NCT03519178|463628935|FG010|PF-06873600 Treatment|Physician Decision|1|||
128816964|NCT03519178|463628936|FG011|PF-06873600 Treatment|Physician Decision|0|||
128816965|NCT03519178|463628937|FG012|PF-06873600 Treatment|Physician Decision|0|||
128816966|NCT03519178|463628938|FG013|PF-06873600 Treatment|Physician Decision|4|||
128816967|NCT03519178|463628939|FG014|PF-06873600 Treatment|Physician Decision|1|||
128816968|NCT03519178|463628925|FG000|PF-06873600 Treatment|Progressive disease|1|||
128816969|NCT03519178|463628926|FG001|PF-06873600 Treatment|Progressive disease|1|||
128816970|NCT03519178|463628927|FG002|PF-06873600 Treatment|Progressive disease|1|||
128816971|NCT03519178|463628928|FG003|PF-06873600 Treatment|Progressive disease|1|||
128816972|NCT03519178|463628929|FG004|PF-06873600 Treatment|Progressive disease|6|||
128816973|NCT03519178|463628930|FG005|PF-06873600 Treatment|Progressive disease|7|||
128816974|NCT03519178|463628931|FG006|PF-06873600 Treatment|Progressive disease|3|||
128816975|NCT03519178|463628932|FG007|PF-06873600 Treatment|Progressive disease|7|||
128816976|NCT03519178|463628933|FG008|PF-06873600 Treatment|Progressive disease|3|||
128816977|NCT03519178|463628934|FG009|PF-06873600 Treatment|Progressive disease|5|||
128816978|NCT03519178|463628935|FG010|PF-06873600 Treatment|Progressive disease|4|||
128816979|NCT03519178|463628936|FG011|PF-06873600 Treatment|Progressive disease|3|||
128816980|NCT03519178|463628937|FG012|PF-06873600 Treatment|Progressive disease|4|||
128816981|NCT03519178|463628938|FG013|PF-06873600 Treatment|Progressive disease|28|||
128816982|NCT03519178|463628939|FG014|PF-06873600 Treatment|Progressive disease|7|||
128816983|NCT03519178|463628925|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
128816984|NCT03519178|463628926|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
128816985|NCT03519178|463628927|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
128816986|NCT03519178|463628928|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
128816987|NCT03519178|463628929|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
128816988|NCT03519178|463628930|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
128816989|NCT03519178|463628931|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
128816990|NCT03519178|463628932|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
128816991|NCT03519178|463628933|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
128816992|NCT03519178|463628934|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
128816993|NCT03519178|463628935|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
128816994|NCT03519178|463628936|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
128816995|NCT03519178|463628937|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
128816996|NCT03519178|463628938|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
128816997|NCT03519178|463628939|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
128816998|NCT03519178|463628925|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
128816999|NCT03519178|463628926|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
128817000|NCT03519178|463628927|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
128817001|NCT03519178|463628928|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
128817002|NCT03519178|463628929|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
128817003|NCT03519178|463628930|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
128817004|NCT03519178|463628931|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
128817005|NCT03519178|463628932|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
128817006|NCT03519178|463628933|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
128817007|NCT03519178|463628934|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
128817008|NCT03519178|463628935|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
128817009|NCT03519178|463628936|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
128817010|NCT03519178|463628937|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
128817011|NCT03519178|463628938|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
128817012|NCT03519178|463628939|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
128817013|NCT03519178|463628925|FG000|PF-06873600 Treatment|Refused further treatment|0|||
128817014|NCT03519178|463628926|FG001|PF-06873600 Treatment|Refused further treatment|1|||
128817015|NCT03519178|463628927|FG002|PF-06873600 Treatment|Refused further treatment|0|||
128817016|NCT03519178|463628928|FG003|PF-06873600 Treatment|Refused further treatment|0|||
128817017|NCT03519178|463628929|FG004|PF-06873600 Treatment|Refused further treatment|1|||
128817018|NCT03519178|463628930|FG005|PF-06873600 Treatment|Refused further treatment|0|||
128817019|NCT03519178|463628931|FG006|PF-06873600 Treatment|Refused further treatment|0|||
128817020|NCT03519178|463628932|FG007|PF-06873600 Treatment|Refused further treatment|0|||
128817021|NCT03519178|463628933|FG008|PF-06873600 Treatment|Refused further treatment|0|||
128817022|NCT03519178|463628934|FG009|PF-06873600 Treatment|Refused further treatment|0|||
128817023|NCT03519178|463628935|FG010|PF-06873600 Treatment|Refused further treatment|0|||
128817024|NCT03519178|463628936|FG011|PF-06873600 Treatment|Refused further treatment|0|||
128817025|NCT03519178|463628937|FG012|PF-06873600 Treatment|Refused further treatment|0|||
128817026|NCT03519178|463628938|FG013|PF-06873600 Treatment|Refused further treatment|0|||
128817027|NCT03519178|463628939|FG014|PF-06873600 Treatment|Refused further treatment|1|||
128817028|NCT03519178|463628925|FG000|PF-06873600 Treatment|Other|0|||
128817029|NCT03519178|463628926|FG001|PF-06873600 Treatment|Other|0|||
128817030|NCT03519178|463628927|FG002|PF-06873600 Treatment|Other|0|||
128817031|NCT03519178|463628928|FG003|PF-06873600 Treatment|Other|0|||
128817032|NCT03519178|463628929|FG004|PF-06873600 Treatment|Other|0|||
128817033|NCT03519178|463628930|FG005|PF-06873600 Treatment|Other|0|||
128817034|NCT03519178|463628931|FG006|PF-06873600 Treatment|Other|0|||
128817035|NCT03519178|463628932|FG007|PF-06873600 Treatment|Other|0|||
128817036|NCT03519178|463628933|FG008|PF-06873600 Treatment|Other|1|||
128817037|NCT03519178|463628934|FG009|PF-06873600 Treatment|Other|0|||
128817038|NCT03519178|463628935|FG010|PF-06873600 Treatment|Other|0|||
128817039|NCT03519178|463628936|FG011|PF-06873600 Treatment|Other|0|||
128817040|NCT03519178|463628937|FG012|PF-06873600 Treatment|Other|0|||
128817041|NCT03519178|463628938|FG013|PF-06873600 Treatment|Other|1|||
128817042|NCT03519178|463628939|FG014|PF-06873600 Treatment|Other|3|||
128817043|NCT03519178|463628925|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
128817044|NCT03519178|463628926|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
128817045|NCT03519178|463628927|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
128817046|NCT03519178|463628928|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
128817047|NCT03519178|463628929|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
128817048|NCT03519178|463628930|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
128817049|NCT03519178|463628931|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
128817050|NCT03519178|463628932|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
128817051|NCT03519178|463628933|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
128817052|NCT03519178|463628934|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
128817053|NCT03519178|463628935|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
128817054|NCT03519178|463628936|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
128817055|NCT03519178|463628937|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
128817056|NCT03519178|463628938|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
128817057|NCT03519178|463628939|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
128817058|NCT03519178|463628925|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817059|NCT03519178|463628926|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817060|NCT03519178|463628927|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817061|NCT03519178|463628928|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817062|NCT03519178|463628929|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817063|NCT03519178|463628930|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817064|NCT03519178|463628931|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817065|NCT03519178|463628932|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817066|NCT03519178|463628933|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817067|NCT03519178|463628934|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817068|NCT03519178|463628935|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817069|NCT03519178|463628936|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817070|NCT03519178|463628937|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
128817071|NCT03519178|463628938|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
128817072|NCT03519178|463628939|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
128817073|NCT03519178|463628925|FG000|PF-06873600 Treatment|Ongoing|0|||
128817074|NCT03519178|463628926|FG001|PF-06873600 Treatment|Ongoing|0|||
128817075|NCT03519178|463628927|FG002|PF-06873600 Treatment|Ongoing|0|||
128817076|NCT03519178|463628928|FG003|PF-06873600 Treatment|Ongoing|0|||
128817077|NCT03519178|463628929|FG004|PF-06873600 Treatment|Ongoing|0|||
128817078|NCT03519178|463628930|FG005|PF-06873600 Treatment|Ongoing|0|||
128817079|NCT03519178|463628931|FG006|PF-06873600 Treatment|Ongoing|0|||
128817080|NCT03519178|463628932|FG007|PF-06873600 Treatment|Ongoing|0|||
128817081|NCT03519178|463628933|FG008|PF-06873600 Treatment|Ongoing|0|||
128817082|NCT03519178|463628934|FG009|PF-06873600 Treatment|Ongoing|0|||
128817083|NCT03519178|463628935|FG010|PF-06873600 Treatment|Ongoing|0|||
128817084|NCT03519178|463628936|FG011|PF-06873600 Treatment|Ongoing|0|||
128817085|NCT03519178|463628937|FG012|PF-06873600 Treatment|Ongoing|0|||
128817086|NCT03519178|463628938|FG013|PF-06873600 Treatment|Ongoing|1|||
128817087|NCT03519178|463628939|FG014|PF-06873600 Treatment|Ongoing|6|||
128817088|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817089|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817090|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817091|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817092|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817093|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817094|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817095|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817096|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817097|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817098|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817099|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817100|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817101|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
128817102|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
128817103|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Death|0|||
128817104|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Death|0|||
128817105|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Death|0|||
128817106|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Death|0|||
128817107|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Death|0|||
128817108|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Death|0|||
128817109|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Death|0|||
128817110|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Death|0|||
128817111|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Death|0|||
128817112|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Death|1|||
128817113|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Death|0|||
128817114|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Death|0|||
128817115|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Death|0|||
128817116|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Death|0|||
128817117|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Death|1|||
128817118|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817119|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817120|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817121|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817122|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817123|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817124|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817125|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817126|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817127|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817128|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817129|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817130|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817131|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
128817132|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
128817133|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817134|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817135|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817136|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817137|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817138|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817139|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817140|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817141|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817142|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817143|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817144|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817145|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
128817146|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
128817147|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
128817148|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817149|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817150|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817151|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817152|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817153|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817154|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817155|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817156|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817157|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
128817158|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817159|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817160|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
128817161|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
128817162|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
128817163|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817164|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817165|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817166|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817167|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817168|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817169|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817170|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817171|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817172|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817173|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817174|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817175|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
128817176|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
128817177|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
128817178|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817179|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817180|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817181|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817182|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817183|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817184|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817185|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817186|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817187|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
128817188|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817189|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817190|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
128817191|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
128817192|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
128817193|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817194|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817195|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817196|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817197|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817198|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817199|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817200|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817201|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817202|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
128817203|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817204|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817205|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817206|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
128817207|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
128817208|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817209|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817210|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817211|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817212|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817213|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817214|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817215|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817216|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817217|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817218|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817219|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817220|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817221|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
128817222|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
128817223|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Other|0|||
128817224|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Other|0|||
128817225|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Other|0|||
128817226|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Other|0|||
128817227|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Other|0|||
128817228|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Other|0|||
128817229|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Other|0|||
128817230|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Other|0|||
128817231|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Other|0|||
128817232|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Other|0|||
128817233|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Other|0|||
128817234|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Other|0|||
128817235|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Other|0|||
128817236|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Other|1|||
128817237|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Other|3|||
128817238|NCT03519178|463628925|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817239|NCT03519178|463628926|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817240|NCT03519178|463628927|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817241|NCT03519178|463628928|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817242|NCT03519178|463628929|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817243|NCT03519178|463628930|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817244|NCT03519178|463628931|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817245|NCT03519178|463628932|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817246|NCT03519178|463628933|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817247|NCT03519178|463628934|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817248|NCT03519178|463628935|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817249|NCT03519178|463628936|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817250|NCT03519178|463628937|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
128817251|NCT03519178|463628938|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
128817252|NCT03519178|463628939|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
128817253|NCT03519178|463628925|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
128817254|NCT03519178|463628926|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
128817255|NCT03519178|463628927|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
128817256|NCT03519178|463628928|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
128817257|NCT03519178|463628929|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
128817258|NCT03519178|463628930|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
128817259|NCT03519178|463628931|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
128817260|NCT03519178|463628932|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
128817261|NCT03519178|463628933|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
128817262|NCT03519178|463628934|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
128817263|NCT03519178|463628935|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
128817264|NCT03519178|463628936|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
128817265|NCT03519178|463628937|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
128817266|NCT03519178|463628938|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
128817267|NCT03519178|463628939|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
128817268|NCT03519178|463628925|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
128817269|NCT03519178|463628926|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
128817270|NCT03519178|463628927|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
128817271|NCT03519178|463628928|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
128817272|NCT03519178|463628929|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
128817273|NCT03519178|463628930|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
128817274|NCT03519178|463628931|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
128817275|NCT03519178|463628932|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
128817276|NCT03519178|463628933|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
128817277|NCT03519178|463628934|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
128817278|NCT03519178|463628935|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
128817279|NCT03519178|463628936|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
128817280|NCT03519178|463628937|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
128817281|NCT03519178|463628938|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
128817282|NCT03519178|463628939|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
128817283|NCT03519178|463628925|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817284|NCT03519178|463628926|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817285|NCT03519178|463628927|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817286|NCT03519178|463628928|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817287|NCT03519178|463628929|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817288|NCT03519178|463628930|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817289|NCT03519178|463628931|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817290|NCT03519178|463628932|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817291|NCT03519178|463628933|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817292|NCT03519178|463628934|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817293|NCT03519178|463628935|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
128817294|NCT03519178|463628936|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817295|NCT03519178|463628937|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817296|NCT03519178|463628938|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817297|NCT03519178|463628939|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
128817298|NCT03519178|463628925|FG000|Follow-Up|Death|0|||
128817299|NCT03519178|463628926|FG001|Follow-Up|Death|0|||
128817300|NCT03519178|463628927|FG002|Follow-Up|Death|1|||
128817301|NCT03519178|463628928|FG003|Follow-Up|Death|0|||
128817302|NCT03519178|463628929|FG004|Follow-Up|Death|0|||
128817303|NCT03519178|463628930|FG005|Follow-Up|Death|0|||
128817304|NCT03519178|463628931|FG006|Follow-Up|Death|0|||
128817305|NCT03519178|463628932|FG007|Follow-Up|Death|0|||
128817306|NCT03519178|463628933|FG008|Follow-Up|Death|3|||
128817307|NCT03519178|463628934|FG009|Follow-Up|Death|1|||
128817308|NCT03519178|463628935|FG010|Follow-Up|Death|0|||
128817309|NCT03519178|463628936|FG011|Follow-Up|Death|0|||
128817310|NCT03519178|463628937|FG012|Follow-Up|Death|2|||
128817311|NCT03519178|463628938|FG013|Follow-Up|Death|0|||
128817312|NCT03519178|463628939|FG014|Follow-Up|Death|0|||
128817313|NCT03519178|463628925|FG000|Follow-Up|Lost to Follow-up|0|||
128817314|NCT03519178|463628926|FG001|Follow-Up|Lost to Follow-up|0|||
128817315|NCT03519178|463628927|FG002|Follow-Up|Lost to Follow-up|0|||
128817316|NCT03519178|463628928|FG003|Follow-Up|Lost to Follow-up|0|||
128817317|NCT03519178|463628929|FG004|Follow-Up|Lost to Follow-up|0|||
128817318|NCT03519178|463628930|FG005|Follow-Up|Lost to Follow-up|3|||
128817319|NCT03519178|463628931|FG006|Follow-Up|Lost to Follow-up|1|||
128817320|NCT03519178|463628932|FG007|Follow-Up|Lost to Follow-up|4|||
128817321|NCT03519178|463628933|FG008|Follow-Up|Lost to Follow-up|1|||
128817322|NCT03519178|463628934|FG009|Follow-Up|Lost to Follow-up|0|||
128817323|NCT03519178|463628935|FG010|Follow-Up|Lost to Follow-up|0|||
128817324|NCT03519178|463628936|FG011|Follow-Up|Lost to Follow-up|0|||
128817325|NCT03519178|463628937|FG012|Follow-Up|Lost to Follow-up|0|||
128817326|NCT03519178|463628938|FG013|Follow-Up|Lost to Follow-up|0|||
128817327|NCT03519178|463628939|FG014|Follow-Up|Lost to Follow-up|0|||
128817328|NCT03519178|463628925|FG000|Follow-Up|Withdrawal by Subject|1|||
128817329|NCT03519178|463628926|FG001|Follow-Up|Withdrawal by Subject|2|||
128817330|NCT03519178|463628927|FG002|Follow-Up|Withdrawal by Subject|2|||
128817331|NCT03519178|463628928|FG003|Follow-Up|Withdrawal by Subject|3|||
128817332|NCT03519178|463628929|FG004|Follow-Up|Withdrawal by Subject|5|||
128817333|NCT03519178|463628930|FG005|Follow-Up|Withdrawal by Subject|1|||
128817334|NCT03519178|463628931|FG006|Follow-Up|Withdrawal by Subject|2|||
128817335|NCT03519178|463628932|FG007|Follow-Up|Withdrawal by Subject|6|||
128817336|NCT03519178|463628933|FG008|Follow-Up|Withdrawal by Subject|5|||
128817337|NCT03519178|463628934|FG009|Follow-Up|Withdrawal by Subject|2|||
128817338|NCT03519178|463628935|FG010|Follow-Up|Withdrawal by Subject|3|||
128817339|NCT03519178|463628936|FG011|Follow-Up|Withdrawal by Subject|5|||
128817340|NCT03519178|463628937|FG012|Follow-Up|Withdrawal by Subject|2|||
128817341|NCT03519178|463628938|FG013|Follow-Up|Withdrawal by Subject|0|||
128817342|NCT03519178|463628939|FG014|Follow-Up|Withdrawal by Subject|0|||
128817343|NCT03519178|463628925|FG000|Follow-Up|Other|0|||
128817344|NCT03519178|463628926|FG001|Follow-Up|Other|0|||
128817345|NCT03519178|463628927|FG002|Follow-Up|Other|0|||
128817346|NCT03519178|463628928|FG003|Follow-Up|Other|0|||
128817347|NCT03519178|463628929|FG004|Follow-Up|Other|0|||
128817348|NCT03519178|463628930|FG005|Follow-Up|Other|0|||
128817349|NCT03519178|463628931|FG006|Follow-Up|Other|0|||
128817350|NCT03519178|463628932|FG007|Follow-Up|Other|1|||
128817351|NCT03519178|463628933|FG008|Follow-Up|Other|0|||
128817352|NCT03519178|463628934|FG009|Follow-Up|Other|0|||
128817353|NCT03519178|463628935|FG010|Follow-Up|Other|0|||
128817354|NCT03519178|463628936|FG011|Follow-Up|Other|0|||
128817355|NCT03519178|463628937|FG012|Follow-Up|Other|0|||
128817356|NCT03519178|463628938|FG013|Follow-Up|Other|0|||
128817357|NCT03519178|463628939|FG014|Follow-Up|Other|0|||
128817358|NCT03519178|463628925|FG000|Long-term Follow-up|Death|0|||
128817359|NCT03519178|463628926|FG001|Long-term Follow-up|Death|0|||
128817360|NCT03519178|463628927|FG002|Long-term Follow-up|Death|0|||
128817361|NCT03519178|463628928|FG003|Long-term Follow-up|Death|0|||
128817362|NCT03519178|463628929|FG004|Long-term Follow-up|Death|0|||
128817363|NCT03519178|463628930|FG005|Long-term Follow-up|Death|0|||
128817364|NCT03519178|463628931|FG006|Long-term Follow-up|Death|0|||
128817365|NCT03519178|463628932|FG007|Long-term Follow-up|Death|0|||
128817366|NCT03519178|463628933|FG008|Long-term Follow-up|Death|0|||
128817367|NCT03519178|463628934|FG009|Long-term Follow-up|Death|0|||
128817368|NCT03519178|463628935|FG010|Long-term Follow-up|Death|0|||
128817369|NCT03519178|463628936|FG011|Long-term Follow-up|Death|0|||
128817370|NCT03519178|463628937|FG012|Long-term Follow-up|Death|0|||
128817371|NCT03519178|463628938|FG013|Long-term Follow-up|Death|4|||
128817372|NCT03519178|463628939|FG014|Long-term Follow-up|Death|4|||
128817373|NCT03519178|463628925|FG000|Long-term Follow-up|Lost to Follow-up|0|||
128817374|NCT03519178|463628926|FG001|Long-term Follow-up|Lost to Follow-up|0|||
128817375|NCT03519178|463628927|FG002|Long-term Follow-up|Lost to Follow-up|0|||
128817376|NCT03519178|463628928|FG003|Long-term Follow-up|Lost to Follow-up|0|||
128817377|NCT03519178|463628929|FG004|Long-term Follow-up|Lost to Follow-up|0|||
128817378|NCT03519178|463628930|FG005|Long-term Follow-up|Lost to Follow-up|0|||
128817379|NCT03519178|463628931|FG006|Long-term Follow-up|Lost to Follow-up|0|||
128817380|NCT03519178|463628932|FG007|Long-term Follow-up|Lost to Follow-up|0|||
128817381|NCT03519178|463628933|FG008|Long-term Follow-up|Lost to Follow-up|0|||
128817382|NCT03519178|463628934|FG009|Long-term Follow-up|Lost to Follow-up|0|||
128817383|NCT03519178|463628935|FG010|Long-term Follow-up|Lost to Follow-up|0|||
128817384|NCT03519178|463628936|FG011|Long-term Follow-up|Lost to Follow-up|0|||
128817385|NCT03519178|463628937|FG012|Long-term Follow-up|Lost to Follow-up|0|||
128817386|NCT03519178|463628938|FG013|Long-term Follow-up|Lost to Follow-up|1|||
128817387|NCT03519178|463628939|FG014|Long-term Follow-up|Lost to Follow-up|1|||
128817388|NCT03519178|463628925|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
128817389|NCT03519178|463628926|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
128817390|NCT03519178|463628927|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
128817391|NCT03519178|463628928|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
128817392|NCT03519178|463628929|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
128817393|NCT03519178|463628930|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
128817394|NCT03519178|463628931|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
128817395|NCT03519178|463628932|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
128817396|NCT03519178|463628933|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
128817397|NCT03519178|463628934|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
128817398|NCT03519178|463628935|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
128817399|NCT03519178|463628936|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
128817400|NCT03519178|463628937|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
128817401|NCT03519178|463628938|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
128817402|NCT03519178|463628939|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
128817403|NCT03519178|463628925|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
128817404|NCT03519178|463628926|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
128817405|NCT03519178|463628927|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
128817406|NCT03519178|463628928|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
128817407|NCT03519178|463628929|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
128817408|NCT03519178|463628930|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
128817409|NCT03519178|463628931|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
128817410|NCT03519178|463628932|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
128817411|NCT03519178|463628933|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
128817412|NCT03519178|463628934|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
128817413|NCT03519178|463628935|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
128817414|NCT03519178|463628936|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
128817415|NCT03519178|463628937|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
128817416|NCT03519178|463628938|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
128817417|NCT03519178|463628939|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
128817418|NCT03519178|463628925|FG000|Long-term Follow-up|Other|0|||
128817419|NCT03519178|463628926|FG001|Long-term Follow-up|Other|0|||
128817420|NCT03519178|463628927|FG002|Long-term Follow-up|Other|0|||
128817421|NCT03519178|463628928|FG003|Long-term Follow-up|Other|0|||
128817422|NCT03519178|463628929|FG004|Long-term Follow-up|Other|0|||
128817423|NCT03519178|463628930|FG005|Long-term Follow-up|Other|0|||
128817424|NCT03519178|463628931|FG006|Long-term Follow-up|Other|0|||
128817425|NCT03519178|463628932|FG007|Long-term Follow-up|Other|0|||
128817426|NCT03519178|463628933|FG008|Long-term Follow-up|Other|0|||
128817427|NCT03519178|463628934|FG009|Long-term Follow-up|Other|0|||
128817428|NCT03519178|463628935|FG010|Long-term Follow-up|Other|0|||
128817429|NCT03519178|463628936|FG011|Long-term Follow-up|Other|0|||
128817430|NCT03519178|463628937|FG012|Long-term Follow-up|Other|0|||
128817431|NCT03519178|463628938|FG013|Long-term Follow-up|Other|0|||
128817432|NCT03519178|463628939|FG014|Long-term Follow-up|Other|1|||
128817433|NCT03519178|463628925|FG000|Long-term Follow-up|Ongoing|0|||
128817434|NCT03519178|463628926|FG001|Long-term Follow-up|Ongoing|0|||
128817435|NCT03519178|463628927|FG002|Long-term Follow-up|Ongoing|0|||
128817436|NCT03519178|463628928|FG003|Long-term Follow-up|Ongoing|0|||
128817437|NCT03519178|463628929|FG004|Long-term Follow-up|Ongoing|0|||
128817438|NCT03519178|463628930|FG005|Long-term Follow-up|Ongoing|0|||
128817439|NCT03519178|463628931|FG006|Long-term Follow-up|Ongoing|0|||
128817440|NCT03519178|463628932|FG007|Long-term Follow-up|Ongoing|0|||
128817441|NCT03519178|463628933|FG008|Long-term Follow-up|Ongoing|0|||
128817442|NCT03519178|463628934|FG009|Long-term Follow-up|Ongoing|0|||
128817443|NCT03519178|463628935|FG010|Long-term Follow-up|Ongoing|0|||
128817444|NCT03519178|463628936|FG011|Long-term Follow-up|Ongoing|0|||
128817445|NCT03519178|463628937|FG012|Long-term Follow-up|Ongoing|0|||
128817446|NCT03519178|463628938|FG013|Long-term Follow-up|Ongoing|1|||
128817447|NCT03519178|463628939|FG014|Long-term Follow-up|Ongoing|0|||
128817448|NCT02315703|463628940|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
128817449|NCT02315703|463628941|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
128817450|NCT02315703|463628942|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
128817451|NCT02315703|463628943|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
128817452|NCT02315703|463628944|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
128817453|NCT02315703|463628945|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
128817454|NCT02315703|463628946|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
128817455|NCT02315703|463628947|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
128817456|NCT02315703|463628940|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
128817457|NCT02315703|463628941|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
128817458|NCT02315703|463628942|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
128817459|NCT02315703|463628943|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
128817460|NCT02315703|463628944|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
128817461|NCT02315703|463628945|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
128817462|NCT02315703|463628946|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
128817463|NCT02315703|463628947|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
128817464|NCT02315703|463628940|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
128817465|NCT02315703|463628941|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
128817466|NCT02315703|463628942|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
128817467|NCT02315703|463628943|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
128817468|NCT02315703|463628944|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
128817469|NCT02315703|463628945|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
128817470|NCT02315703|463628946|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
128817471|NCT02315703|463628947|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
128817472|NCT02315703|463628940|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
128817473|NCT02315703|463628941|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
128817474|NCT02315703|463628942|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
128817475|NCT02315703|463628943|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
128817476|NCT02315703|463628944|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
128817477|NCT02315703|463628945|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
128817478|NCT02315703|463628946|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
128817479|NCT02315703|463628947|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
128817480|NCT02315703|463628940|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
128817481|NCT02315703|463628941|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
128817482|NCT02315703|463628942|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
128817483|NCT02315703|463628943|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
128817484|NCT02315703|463628944|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
128817485|NCT02315703|463628945|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
128817486|NCT02315703|463628946|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
128817487|NCT02315703|463628947|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
128817488|NCT02315703|463628940|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
128817489|NCT02315703|463628941|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
128817490|NCT02315703|463628942|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
128817491|NCT02315703|463628943|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
128817492|NCT02315703|463628944|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
128817493|NCT02315703|463628945|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
128817494|NCT02315703|463628946|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
128817495|NCT02315703|463628947|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
128817496|NCT02315703|463628940|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
128817497|NCT02315703|463628941|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
128817498|NCT02315703|463628942|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
128817499|NCT02315703|463628943|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
128817500|NCT02315703|463628944|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
128817501|NCT02315703|463628945|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
128817502|NCT02315703|463628946|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
128817503|NCT02315703|463628947|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
128817504|NCT02315703|463628940|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
128817505|NCT02315703|463628941|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
128817506|NCT02315703|463628942|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
128817507|NCT02315703|463628943|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
128817508|NCT02315703|463628944|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
128817509|NCT02315703|463628945|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
128817510|NCT02315703|463628946|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
128817511|NCT02315703|463628947|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
128817512|NCT02315703|463628940|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
128817513|NCT02315703|463628941|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
128817514|NCT02315703|463628942|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
128817515|NCT02315703|463628943|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
128817516|NCT02315703|463628944|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
128817517|NCT02315703|463628945|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
128817518|NCT02315703|463628946|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
128817519|NCT02315703|463628947|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
128817520|NCT02240238|463628948|FG000|Phase 1|Adverse Event|0|||
128817521|NCT02240238|463628949|FG001|Phase 1|Adverse Event|0|||
128817522|NCT02240238|463628950|FG002|Phase 1|Adverse Event|0|||
128817523|NCT02240238|463628951|FG003|Phase 1|Adverse Event|0|||
128817524|NCT02240238|463628952|FG004|Phase 1|Adverse Event|0|||
128817525|NCT02240238|463628953|FG005|Phase 1|Adverse Event|0|||
128817526|NCT02240238|463628954|FG006|Phase 1|Adverse Event|3|||
128817527|NCT02240238|463628955|FG007|Phase 1|Adverse Event|1|||
128817528|NCT02240238|463628956|FG008|Phase 1|Adverse Event|0|||
128817529|NCT02240238|463628957|FG009|Phase 1|Adverse Event|0|||
128817530|NCT02240238|463628958|FG010|Phase 1|Adverse Event|0|||
128817531|NCT02240238|463628959|FG011|Phase 1|Adverse Event|0|||
128817532|NCT02240238|463628948|FG000|Phase 1|Death|0|||
128817533|NCT02240238|463628949|FG001|Phase 1|Death|0|||
128817534|NCT02240238|463628950|FG002|Phase 1|Death|0|||
128817535|NCT02240238|463628951|FG003|Phase 1|Death|0|||
128817536|NCT02240238|463628952|FG004|Phase 1|Death|0|||
128817537|NCT02240238|463628953|FG005|Phase 1|Death|1|||
128817538|NCT02240238|463628954|FG006|Phase 1|Death|0|||
128817539|NCT02240238|463628955|FG007|Phase 1|Death|0|||
128817540|NCT02240238|463628956|FG008|Phase 1|Death|0|||
128817541|NCT02240238|463628957|FG009|Phase 1|Death|0|||
128817542|NCT02240238|463628958|FG010|Phase 1|Death|0|||
128817543|NCT02240238|463628959|FG011|Phase 1|Death|0|||
128817544|NCT02240238|463628948|FG000|Phase 1|Sponsor termination|0|||
128817545|NCT02240238|463628949|FG001|Phase 1|Sponsor termination|0|||
128817546|NCT02240238|463628950|FG002|Phase 1|Sponsor termination|0|||
128817547|NCT02240238|463628951|FG003|Phase 1|Sponsor termination|0|||
128817548|NCT02240238|463628952|FG004|Phase 1|Sponsor termination|0|||
128817549|NCT02240238|463628953|FG005|Phase 1|Sponsor termination|1|||
128817550|NCT02240238|463628954|FG006|Phase 1|Sponsor termination|0|||
128817551|NCT02240238|463628955|FG007|Phase 1|Sponsor termination|0|||
128817552|NCT02240238|463628956|FG008|Phase 1|Sponsor termination|0|||
128817553|NCT02240238|463628957|FG009|Phase 1|Sponsor termination|0|||
128817554|NCT02240238|463628958|FG010|Phase 1|Sponsor termination|0|||
128817555|NCT02240238|463628959|FG011|Phase 1|Sponsor termination|0|||
128817556|NCT02240238|463628948|FG000|Phase 1|Withdrawal by Subject|0|||
128817557|NCT02240238|463628949|FG001|Phase 1|Withdrawal by Subject|0|||
128817558|NCT02240238|463628950|FG002|Phase 1|Withdrawal by Subject|0|||
128817559|NCT02240238|463628951|FG003|Phase 1|Withdrawal by Subject|0|||
128817560|NCT02240238|463628952|FG004|Phase 1|Withdrawal by Subject|0|||
128817561|NCT02240238|463628953|FG005|Phase 1|Withdrawal by Subject|2|||
128817562|NCT02240238|463628954|FG006|Phase 1|Withdrawal by Subject|0|||
128817563|NCT02240238|463628955|FG007|Phase 1|Withdrawal by Subject|0|||
128817564|NCT02240238|463628956|FG008|Phase 1|Withdrawal by Subject|0|||
128817565|NCT02240238|463628957|FG009|Phase 1|Withdrawal by Subject|0|||
128817566|NCT02240238|463628958|FG010|Phase 1|Withdrawal by Subject|0|||
128817567|NCT02240238|463628959|FG011|Phase 1|Withdrawal by Subject|0|||
128817568|NCT02240238|463628948|FG000|Phase 1|Physician Decision|0|||
128817569|NCT02240238|463628949|FG001|Phase 1|Physician Decision|0|||
128817570|NCT02240238|463628950|FG002|Phase 1|Physician Decision|0|||
128817571|NCT02240238|463628951|FG003|Phase 1|Physician Decision|0|||
128817572|NCT02240238|463628952|FG004|Phase 1|Physician Decision|0|||
128817573|NCT02240238|463628953|FG005|Phase 1|Physician Decision|2|||
128817574|NCT02240238|463628954|FG006|Phase 1|Physician Decision|0|||
128817575|NCT02240238|463628955|FG007|Phase 1|Physician Decision|0|||
128817576|NCT02240238|463628956|FG008|Phase 1|Physician Decision|0|||
128817577|NCT02240238|463628957|FG009|Phase 1|Physician Decision|0|||
128817578|NCT02240238|463628958|FG010|Phase 1|Physician Decision|0|||
128817579|NCT02240238|463628959|FG011|Phase 1|Physician Decision|0|||
128817580|NCT02240238|463628948|FG000|Phase 2|Adverse Event|0|||
128817581|NCT02240238|463628949|FG001|Phase 2|Adverse Event|0|||
128817582|NCT02240238|463628950|FG002|Phase 2|Adverse Event|0|||
128817583|NCT02240238|463628951|FG003|Phase 2|Adverse Event|0|||
128817584|NCT02240238|463628952|FG004|Phase 2|Adverse Event|0|||
128817585|NCT02240238|463628953|FG005|Phase 2|Adverse Event|0|||
128817586|NCT02240238|463628954|FG006|Phase 2|Adverse Event|0|||
128817587|NCT02240238|463628955|FG007|Phase 2|Adverse Event|0|||
128817588|NCT02240238|463628956|FG008|Phase 2|Adverse Event|0|||
128817589|NCT02240238|463628957|FG009|Phase 2|Adverse Event|7|||
128817590|NCT02240238|463628958|FG010|Phase 2|Adverse Event|14|||
128817591|NCT02240238|463628959|FG011|Phase 2|Adverse Event|2|||
128817592|NCT02240238|463628948|FG000|Phase 2|Death|0|||
128817593|NCT02240238|463628949|FG001|Phase 2|Death|0|||
128817594|NCT02240238|463628950|FG002|Phase 2|Death|0|||
128817595|NCT02240238|463628951|FG003|Phase 2|Death|0|||
128817596|NCT02240238|463628952|FG004|Phase 2|Death|0|||
128817597|NCT02240238|463628953|FG005|Phase 2|Death|0|||
128817598|NCT02240238|463628954|FG006|Phase 2|Death|0|||
128817599|NCT02240238|463628955|FG007|Phase 2|Death|0|||
128817600|NCT02240238|463628956|FG008|Phase 2|Death|0|||
128817601|NCT02240238|463628957|FG009|Phase 2|Death|3|||
128817602|NCT02240238|463628958|FG010|Phase 2|Death|2|||
128817603|NCT02240238|463628959|FG011|Phase 2|Death|1|||
128817604|NCT02240238|463628948|FG000|Phase 2|Disease progression|0|||
128817605|NCT02240238|463628949|FG001|Phase 2|Disease progression|0|||
128817606|NCT02240238|463628950|FG002|Phase 2|Disease progression|0|||
128817607|NCT02240238|463628951|FG003|Phase 2|Disease progression|0|||
128817608|NCT02240238|463628952|FG004|Phase 2|Disease progression|0|||
128817609|NCT02240238|463628953|FG005|Phase 2|Disease progression|0|||
128817610|NCT02240238|463628954|FG006|Phase 2|Disease progression|0|||
128817611|NCT02240238|463628955|FG007|Phase 2|Disease progression|0|||
128817612|NCT02240238|463628956|FG008|Phase 2|Disease progression|0|||
128817613|NCT02240238|463628957|FG009|Phase 2|Disease progression|5|||
128817614|NCT02240238|463628958|FG010|Phase 2|Disease progression|11|||
128817615|NCT02240238|463628959|FG011|Phase 2|Disease progression|1|||
128817616|NCT02240238|463628948|FG000|Phase 2|Withdrawal by Subject|0|||
128817617|NCT02240238|463628949|FG001|Phase 2|Withdrawal by Subject|0|||
128817618|NCT02240238|463628950|FG002|Phase 2|Withdrawal by Subject|0|||
128817619|NCT02240238|463628951|FG003|Phase 2|Withdrawal by Subject|0|||
128817620|NCT02240238|463628952|FG004|Phase 2|Withdrawal by Subject|0|||
128817621|NCT02240238|463628953|FG005|Phase 2|Withdrawal by Subject|0|||
128817622|NCT02240238|463628954|FG006|Phase 2|Withdrawal by Subject|0|||
128817623|NCT02240238|463628955|FG007|Phase 2|Withdrawal by Subject|0|||
128817624|NCT02240238|463628956|FG008|Phase 2|Withdrawal by Subject|0|||
128817625|NCT02240238|463628957|FG009|Phase 2|Withdrawal by Subject|1|||
128817626|NCT02240238|463628958|FG010|Phase 2|Withdrawal by Subject|1|||
128817627|NCT02240238|463628959|FG011|Phase 2|Withdrawal by Subject|0|||
128817628|NCT02240238|463628948|FG000|Phase 2|Physician Decision|0|||
128817629|NCT02240238|463628949|FG001|Phase 2|Physician Decision|0|||
128817630|NCT02240238|463628950|FG002|Phase 2|Physician Decision|0|||
128817631|NCT02240238|463628951|FG003|Phase 2|Physician Decision|0|||
128817632|NCT02240238|463628952|FG004|Phase 2|Physician Decision|0|||
128817633|NCT02240238|463628953|FG005|Phase 2|Physician Decision|0|||
128817634|NCT02240238|463628954|FG006|Phase 2|Physician Decision|0|||
128817635|NCT02240238|463628955|FG007|Phase 2|Physician Decision|0|||
128817636|NCT02240238|463628956|FG008|Phase 2|Physician Decision|0|||
128817637|NCT02240238|463628957|FG009|Phase 2|Physician Decision|1|||
128817638|NCT02240238|463628958|FG010|Phase 2|Physician Decision|3|||
128817639|NCT02240238|463628959|FG011|Phase 2|Physician Decision|0|||
128817640|NCT02240238|463628948|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817641|NCT02240238|463628949|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817642|NCT02240238|463628950|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817643|NCT02240238|463628951|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817644|NCT02240238|463628952|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817645|NCT02240238|463628953|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817646|NCT02240238|463628954|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817647|NCT02240238|463628955|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817648|NCT02240238|463628956|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817649|NCT02240238|463628957|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
128817650|NCT02240238|463628958|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817651|NCT02240238|463628959|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
128817652|NCT02240238|463628948|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817653|NCT02240238|463628949|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817654|NCT02240238|463628950|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817655|NCT02240238|463628951|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817656|NCT02240238|463628952|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817657|NCT02240238|463628953|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817658|NCT02240238|463628954|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817659|NCT02240238|463628955|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817660|NCT02240238|463628956|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817661|NCT02240238|463628957|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
128817662|NCT02240238|463628958|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817663|NCT02240238|463628959|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
128817664|NCT02240238|463628948|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817665|NCT02240238|463628949|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817666|NCT02240238|463628950|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817667|NCT02240238|463628951|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817668|NCT02240238|463628952|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817669|NCT02240238|463628953|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817670|NCT02240238|463628954|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817671|NCT02240238|463628955|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817672|NCT02240238|463628956|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817673|NCT02240238|463628957|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817674|NCT02240238|463628958|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
128817675|NCT02240238|463628959|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
128817676|NCT02240238|463628948|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817677|NCT02240238|463628949|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817678|NCT02240238|463628950|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817679|NCT02240238|463628951|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817680|NCT02240238|463628952|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817681|NCT02240238|463628953|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817682|NCT02240238|463628954|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817683|NCT02240238|463628955|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817684|NCT02240238|463628956|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817685|NCT02240238|463628957|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817686|NCT02240238|463628958|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
128817687|NCT02240238|463628959|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
128817688|NCT02240238|463628948|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817689|NCT02240238|463628949|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817690|NCT02240238|463628950|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817691|NCT02240238|463628951|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817692|NCT02240238|463628952|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817693|NCT02240238|463628953|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817694|NCT02240238|463628954|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817695|NCT02240238|463628955|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817696|NCT02240238|463628956|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817697|NCT02240238|463628957|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817698|NCT02240238|463628958|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
128817699|NCT02240238|463628959|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
128817700|NCT02240238|463628948|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817701|NCT02240238|463628949|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817702|NCT02240238|463628950|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817703|NCT02240238|463628951|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817704|NCT02240238|463628952|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817705|NCT02240238|463628953|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817706|NCT02240238|463628954|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817707|NCT02240238|463628955|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817708|NCT02240238|463628956|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817709|NCT02240238|463628957|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817710|NCT02240238|463628958|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
128817711|NCT02240238|463628959|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
128817712|NCT02240238|463628948|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817713|NCT02240238|463628949|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817714|NCT02240238|463628950|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817715|NCT02240238|463628951|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817716|NCT02240238|463628952|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817717|NCT02240238|463628953|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817718|NCT02240238|463628954|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817719|NCT02240238|463628955|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817720|NCT02240238|463628956|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817721|NCT02240238|463628957|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817722|NCT02240238|463628958|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
128817723|NCT02240238|463628959|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
128817724|NCT02240238|463628948|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817725|NCT02240238|463628949|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817726|NCT02240238|463628950|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817727|NCT02240238|463628951|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817728|NCT02240238|463628952|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817729|NCT02240238|463628953|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817730|NCT02240238|463628954|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817731|NCT02240238|463628955|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817732|NCT02240238|463628956|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817733|NCT02240238|463628957|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817734|NCT02240238|463628958|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
128817735|NCT02240238|463628959|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
128817736|NCT03476343|463628982|FG000|Overall Study|Clinical exam moved to another scanner|7|||
128817737|NCT03476343|463628982|FG000|Overall Study|Clinical order cancelled|4|||
128817738|NCT03476343|463628982|FG000|Overall Study|Neonate did not settle down for the scan|1|||
128817739|NCT03088878|463628983|FG000|Overall Study|Adverse Event|0|||
128817740|NCT03088878|463628984|FG001|Overall Study|Adverse Event|0|||
128817741|NCT03088878|463628985|FG002|Overall Study|Adverse Event|0|||
128817742|NCT03088878|463628986|FG003|Overall Study|Adverse Event|0|||
128817743|NCT03088878|463628987|FG004|Overall Study|Adverse Event|4|||
128817744|NCT03088878|463628988|FG005|Overall Study|Adverse Event|2|||
128817745|NCT03088878|463628989|FG006|Overall Study|Adverse Event|1|||
128817746|NCT03088878|463628990|FG007|Overall Study|Adverse Event|0|||
128817747|NCT03088878|463628991|FG008|Overall Study|Adverse Event|0|||
128817748|NCT03088878|463628992|FG009|Overall Study|Adverse Event|0|||
128817749|NCT03088878|463628993|FG010|Overall Study|Adverse Event|0|||
128817750|NCT03088878|463628994|FG011|Overall Study|Adverse Event|0|||
128817751|NCT03088878|463628995|FG012|Overall Study|Adverse Event|5|||
128817752|NCT03088878|463628996|FG013|Overall Study|Adverse Event|3|||
128817753|NCT03088878|463628983|FG000|Overall Study|Clinical Progression|0|||
128817754|NCT03088878|463628984|FG001|Overall Study|Clinical Progression|0|||
128817755|NCT03088878|463628985|FG002|Overall Study|Clinical Progression|0|||
128817756|NCT03088878|463628986|FG003|Overall Study|Clinical Progression|0|||
128817757|NCT03088878|463628987|FG004|Overall Study|Clinical Progression|2|||
128817758|NCT03088878|463628988|FG005|Overall Study|Clinical Progression|0|||
128817759|NCT03088878|463628989|FG006|Overall Study|Clinical Progression|0|||
128817760|NCT03088878|463628990|FG007|Overall Study|Clinical Progression|0|||
128817761|NCT03088878|463628991|FG008|Overall Study|Clinical Progression|0|||
128817762|NCT03088878|463628992|FG009|Overall Study|Clinical Progression|0|||
128817763|NCT03088878|463628993|FG010|Overall Study|Clinical Progression|0|||
128817764|NCT03088878|463628994|FG011|Overall Study|Clinical Progression|0|||
128817765|NCT03088878|463628995|FG012|Overall Study|Clinical Progression|0|||
128817766|NCT03088878|463628996|FG013|Overall Study|Clinical Progression|0|||
128817767|NCT03088878|463628983|FG000|Overall Study|Death|0|||
128817768|NCT03088878|463628984|FG001|Overall Study|Death|0|||
128817769|NCT03088878|463628985|FG002|Overall Study|Death|0|||
128817770|NCT03088878|463628986|FG003|Overall Study|Death|0|||
128817771|NCT03088878|463628987|FG004|Overall Study|Death|2|||
128817772|NCT03088878|463628988|FG005|Overall Study|Death|0|||
128817773|NCT03088878|463628989|FG006|Overall Study|Death|0|||
128817774|NCT03088878|463628990|FG007|Overall Study|Death|0|||
128817775|NCT03088878|463628991|FG008|Overall Study|Death|0|||
128817776|NCT03088878|463628992|FG009|Overall Study|Death|0|||
128817777|NCT03088878|463628993|FG010|Overall Study|Death|0|||
128817778|NCT03088878|463628994|FG011|Overall Study|Death|1|||
128817779|NCT03088878|463628995|FG012|Overall Study|Death|0|||
128817780|NCT03088878|463628996|FG013|Overall Study|Death|0|||
128817781|NCT03088878|463628983|FG000|Overall Study|Disease Progression|1|||
128817782|NCT03088878|463628984|FG001|Overall Study|Disease Progression|2|||
128817783|NCT03088878|463628985|FG002|Overall Study|Disease Progression|3|||
128817784|NCT03088878|463628986|FG003|Overall Study|Disease Progression|0|||
128817785|NCT03088878|463628987|FG004|Overall Study|Disease Progression|3|||
128817786|NCT03088878|463628988|FG005|Overall Study|Disease Progression|0|||
128817787|NCT03088878|463628989|FG006|Overall Study|Disease Progression|0|||
128817788|NCT03088878|463628990|FG007|Overall Study|Disease Progression|0|||
128817789|NCT03088878|463628991|FG008|Overall Study|Disease Progression|0|||
128817790|NCT03088878|463628992|FG009|Overall Study|Disease Progression|0|||
128817791|NCT03088878|463628993|FG010|Overall Study|Disease Progression|0|||
128817792|NCT03088878|463628994|FG011|Overall Study|Disease Progression|0|||
128817793|NCT03088878|463628995|FG012|Overall Study|Disease Progression|1|||
128817794|NCT03088878|463628996|FG013|Overall Study|Disease Progression|1|||
128817795|NCT03088878|463628983|FG000|Overall Study|Initiation of Alternative Treatment|0|||
128817796|NCT03088878|463628984|FG001|Overall Study|Initiation of Alternative Treatment|0|||
128817797|NCT03088878|463628985|FG002|Overall Study|Initiation of Alternative Treatment|0|||
128817798|NCT03088878|463628986|FG003|Overall Study|Initiation of Alternative Treatment|1|||
128817799|NCT03088878|463628987|FG004|Overall Study|Initiation of Alternative Treatment|0|||
128817800|NCT03088878|463628988|FG005|Overall Study|Initiation of Alternative Treatment|0|||
128817801|NCT03088878|463628989|FG006|Overall Study|Initiation of Alternative Treatment|0|||
128817802|NCT03088878|463628990|FG007|Overall Study|Initiation of Alternative Treatment|1|||
128817803|NCT03088878|463628991|FG008|Overall Study|Initiation of Alternative Treatment|1|||
128817804|NCT03088878|463628992|FG009|Overall Study|Initiation of Alternative Treatment|0|||
128817805|NCT03088878|463628993|FG010|Overall Study|Initiation of Alternative Treatment|0|||
128817806|NCT03088878|463628994|FG011|Overall Study|Initiation of Alternative Treatment|0|||
128817807|NCT03088878|463628995|FG012|Overall Study|Initiation of Alternative Treatment|0|||
128817808|NCT03088878|463628996|FG013|Overall Study|Initiation of Alternative Treatment|0|||
128817809|NCT03088878|463628983|FG000|Overall Study|Withdrawal by Subject|0|||
128817810|NCT03088878|463628984|FG001|Overall Study|Withdrawal by Subject|0|||
128817811|NCT03088878|463628985|FG002|Overall Study|Withdrawal by Subject|0|||
128817812|NCT03088878|463628986|FG003|Overall Study|Withdrawal by Subject|1|||
128817813|NCT03088878|463628987|FG004|Overall Study|Withdrawal by Subject|4|||
128817814|NCT03088878|463628988|FG005|Overall Study|Withdrawal by Subject|1|||
128817815|NCT03088878|463628989|FG006|Overall Study|Withdrawal by Subject|1|||
128817816|NCT03088878|463628990|FG007|Overall Study|Withdrawal by Subject|0|||
128817817|NCT03088878|463628991|FG008|Overall Study|Withdrawal by Subject|1|||
128817818|NCT03088878|463628992|FG009|Overall Study|Withdrawal by Subject|2|||
128817819|NCT03088878|463628993|FG010|Overall Study|Withdrawal by Subject|0|||
128817820|NCT03088878|463628994|FG011|Overall Study|Withdrawal by Subject|2|||
128817821|NCT03088878|463628995|FG012|Overall Study|Withdrawal by Subject|1|||
128817822|NCT03088878|463628996|FG013|Overall Study|Withdrawal by Subject|0|||
128817823|NCT03088878|463628983|FG000|Overall Study|Terminated by Sponsor|2|||
128817824|NCT03088878|463628984|FG001|Overall Study|Terminated by Sponsor|1|||
128817825|NCT03088878|463628985|FG002|Overall Study|Terminated by Sponsor|0|||
128817826|NCT03088878|463628986|FG003|Overall Study|Terminated by Sponsor|1|||
128817827|NCT03088878|463628987|FG004|Overall Study|Terminated by Sponsor|6|||
128817828|NCT03088878|463628988|FG005|Overall Study|Terminated by Sponsor|0|||
128817829|NCT03088878|463628989|FG006|Overall Study|Terminated by Sponsor|0|||
128817830|NCT03088878|463628990|FG007|Overall Study|Terminated by Sponsor|0|||
128817831|NCT03088878|463628991|FG008|Overall Study|Terminated by Sponsor|0|||
128817832|NCT03088878|463628992|FG009|Overall Study|Terminated by Sponsor|0|||
128817833|NCT03088878|463628993|FG010|Overall Study|Terminated by Sponsor|3|||
128817834|NCT03088878|463628994|FG011|Overall Study|Terminated by Sponsor|13|||
128817835|NCT03088878|463628995|FG012|Overall Study|Terminated by Sponsor|2|||
128817836|NCT03088878|463628996|FG013|Overall Study|Terminated by Sponsor|1|||
128817837|NCT03088878|463628983|FG000|Overall Study|Completed 2 years of Treatment|0|||
128817838|NCT03088878|463628984|FG001|Overall Study|Completed 2 years of Treatment|0|||
128817839|NCT03088878|463628985|FG002|Overall Study|Completed 2 years of Treatment|0|||
128817840|NCT03088878|463628986|FG003|Overall Study|Completed 2 years of Treatment|0|||
128817841|NCT03088878|463628987|FG004|Overall Study|Completed 2 years of Treatment|0|||
128817842|NCT03088878|463628988|FG005|Overall Study|Completed 2 years of Treatment|0|||
128817843|NCT03088878|463628989|FG006|Overall Study|Completed 2 years of Treatment|1|||
128817844|NCT03088878|463628990|FG007|Overall Study|Completed 2 years of Treatment|0|||
128817845|NCT03088878|463628991|FG008|Overall Study|Completed 2 years of Treatment|0|||
128817846|NCT03088878|463628992|FG009|Overall Study|Completed 2 years of Treatment|1|||
128817847|NCT03088878|463628993|FG010|Overall Study|Completed 2 years of Treatment|0|||
128817848|NCT03088878|463628994|FG011|Overall Study|Completed 2 years of Treatment|0|||
128817849|NCT03088878|463628995|FG012|Overall Study|Completed 2 years of Treatment|8|||
128817850|NCT03088878|463628996|FG013|Overall Study|Completed 2 years of Treatment|3|||
128817851|NCT03088878|463628983|FG000|Overall Study|Physician Decision|0|||
128817852|NCT03088878|463628984|FG001|Overall Study|Physician Decision|0|||
128817853|NCT03088878|463628985|FG002|Overall Study|Physician Decision|0|||
128817854|NCT03088878|463628986|FG003|Overall Study|Physician Decision|0|||
128817855|NCT03088878|463628987|FG004|Overall Study|Physician Decision|0|||
128817856|NCT03088878|463628988|FG005|Overall Study|Physician Decision|0|||
128817857|NCT03088878|463628989|FG006|Overall Study|Physician Decision|0|||
128817858|NCT03088878|463628990|FG007|Overall Study|Physician Decision|2|||
128817859|NCT03088878|463628991|FG008|Overall Study|Physician Decision|1|||
128817860|NCT03088878|463628992|FG009|Overall Study|Physician Decision|0|||
128817861|NCT03088878|463628993|FG010|Overall Study|Physician Decision|0|||
128817862|NCT03088878|463628994|FG011|Overall Study|Physician Decision|0|||
128817863|NCT03088878|463628995|FG012|Overall Study|Physician Decision|0|||
128817864|NCT03088878|463628996|FG013|Overall Study|Physician Decision|1|||
128817865|NCT03088878|463628983|FG000|Overall Study|COVID Related noncompliance|0|||
128817866|NCT03088878|463628984|FG001|Overall Study|COVID Related noncompliance|0|||
128817867|NCT03088878|463628985|FG002|Overall Study|COVID Related noncompliance|0|||
128817868|NCT03088878|463628986|FG003|Overall Study|COVID Related noncompliance|0|||
128817869|NCT03088878|463628987|FG004|Overall Study|COVID Related noncompliance|0|||
128817870|NCT03088878|463628988|FG005|Overall Study|COVID Related noncompliance|0|||
128817871|NCT03088878|463628989|FG006|Overall Study|COVID Related noncompliance|0|||
128817872|NCT03088878|463628990|FG007|Overall Study|COVID Related noncompliance|0|||
128817873|NCT03088878|463628991|FG008|Overall Study|COVID Related noncompliance|0|||
128817874|NCT03088878|463628992|FG009|Overall Study|COVID Related noncompliance|0|||
128817875|NCT03088878|463628993|FG010|Overall Study|COVID Related noncompliance|0|||
128817876|NCT03088878|463628994|FG011|Overall Study|COVID Related noncompliance|0|||
128817877|NCT03088878|463628995|FG012|Overall Study|COVID Related noncompliance|0|||
128817878|NCT03088878|463628996|FG013|Overall Study|COVID Related noncompliance|1|||
128817879|NCT03088878|463628983|FG000|Overall Study|Drug or Study Noncompliance|0|||
128817880|NCT03088878|463628984|FG001|Overall Study|Drug or Study Noncompliance|0|||
128817881|NCT03088878|463628985|FG002|Overall Study|Drug or Study Noncompliance|0|||
128817882|NCT03088878|463628986|FG003|Overall Study|Drug or Study Noncompliance|0|||
128817883|NCT03088878|463628987|FG004|Overall Study|Drug or Study Noncompliance|0|||
128817884|NCT03088878|463628988|FG005|Overall Study|Drug or Study Noncompliance|0|||
128817885|NCT03088878|463628989|FG006|Overall Study|Drug or Study Noncompliance|0|||
128817886|NCT03088878|463628990|FG007|Overall Study|Drug or Study Noncompliance|0|||
128817887|NCT03088878|463628991|FG008|Overall Study|Drug or Study Noncompliance|0|||
128817888|NCT03088878|463628992|FG009|Overall Study|Drug or Study Noncompliance|0|||
128817889|NCT03088878|463628993|FG010|Overall Study|Drug or Study Noncompliance|0|||
128817890|NCT03088878|463628994|FG011|Overall Study|Drug or Study Noncompliance|0|||
128817891|NCT03088878|463628995|FG012|Overall Study|Drug or Study Noncompliance|1|||
128817892|NCT03088878|463628996|FG013|Overall Study|Drug or Study Noncompliance|0|||
128817893|NCT05216406|463628997|FG000|Overall Study|Lost to Follow-up|8|||
128817894|NCT05216406|463628998|FG001|Overall Study|Lost to Follow-up|9|||
128817895|NCT04690582|463629001|FG000|Overall Study|Withdrawal by Subject|6|||
128817896|NCT04690582|463629002|FG001|Overall Study|Withdrawal by Subject|4|||
128817897|NCT03711474|463629003|FG000|Overall Study|Physician Decision|2|||
128817898|NCT03711474|463629004|FG001|Overall Study|Physician Decision|0|||
128817899|NCT03625115|463629007|FG000|Overall Study|Withdrawal by Subject|4|||
128817900|NCT03625115|463629008|FG001|Overall Study|Withdrawal by Subject|7|||
128817901|NCT03625115|463629007|FG000|Overall Study|Lost to Follow-up|17|||
128817902|NCT03625115|463629008|FG001|Overall Study|Lost to Follow-up|24|||
128817903|NCT05868382|463629010|FG000|Overall Study|Lost to Follow-up|5|||
128817904|NCT05868382|463629011|FG001|Overall Study|Lost to Follow-up|0|||
128817905|NCT05868382|463629012|FG002|Overall Study|Lost to Follow-up|6|||
128817906|NCT05868382|463629013|FG003|Overall Study|Lost to Follow-up|4|||
128817907|NCT05868382|463629014|FG004|Overall Study|Lost to Follow-up|2|||
128817908|NCT05868382|463629015|FG005|Overall Study|Lost to Follow-up|6|||
128817909|NCT05868382|463629010|FG000|Overall Study|Withdrawal by Subject|1|||
128817910|NCT05868382|463629011|FG001|Overall Study|Withdrawal by Subject|0|||
128817911|NCT05868382|463629012|FG002|Overall Study|Withdrawal by Subject|0|||
128817912|NCT05868382|463629013|FG003|Overall Study|Withdrawal by Subject|0|||
128817913|NCT05868382|463629014|FG004|Overall Study|Withdrawal by Subject|1|||
128817914|NCT05868382|463629015|FG005|Overall Study|Withdrawal by Subject|0|||
128817915|NCT02497950|463629016|FG000|Overall Study|Death|209|||
128817916|NCT02497950|463629016|FG000|Overall Study|Transplanted|85|||
128817917|NCT02497950|463629016|FG000|Overall Study|Explanted|8|||
128817918|NCT02497950|463629016|FG000|Overall Study|Device Permanently Deactivated|4|||
128817919|NCT02497950|463629016|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
128817920|NCT02497950|463629016|FG000|Overall Study|Lost to Follow-up|6|||
128817921|NCT02497950|463629016|FG000|Overall Study|Withdrawal by Subject|2|||
128817922|NCT02497950|463629016|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
128817923|NCT02497950|463629016|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
128817924|NCT01236781|463629017|FG000|Overall Study|Ineligible|2|||
128817925|NCT01236781|463629018|FG001|Overall Study|Ineligible|1|||
128817926|NCT01236781|463629017|FG000|Overall Study|Did not complete study imaging|5|||
128817927|NCT01236781|463629018|FG001|Overall Study|Did not complete study imaging|0|||
128817928|NCT01009788|463629031|FG000|Overall Study|Withdrawal by Subject|1|||
128817929|NCT01009788|463629032|FG001|Overall Study|Withdrawal by Subject|0|||
128817930|NCT04308681|463629033|FG000|Pre-Treatment|Not reported|1|||
128817931|NCT04308681|463629034|FG001|Pre-Treatment|Not reported|1|||
128817932|NCT04308681|463629035|FG002|Pre-Treatment|Not reported|0|||
128817933|NCT04308681|463629036|FG003|Pre-Treatment|Not reported|0|||
128817934|NCT04308681|463629037|FG004|Pre-Treatment|Not reported|0|||
128817935|NCT04308681|463629038|FG005|Pre-Treatment|Not reported|2|||
128817936|NCT04308681|463629039|FG006|Pre-Treatment|Not reported|0|||
128817937|NCT04308681|463629040|FG007|Pre-Treatment|Not reported|0|||
128817938|NCT04308681|463629033|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
128817939|NCT04308681|463629034|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
128817940|NCT04308681|463629035|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
128817941|NCT04308681|463629036|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
128817942|NCT04308681|463629037|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
128817943|NCT04308681|463629038|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
128817944|NCT04308681|463629039|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
128817945|NCT04308681|463629040|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
128817946|NCT04308681|463629033|FG000|Treatment up to Week 26|Other reasons|2|||
128817947|NCT04308681|463629034|FG001|Treatment up to Week 26|Other reasons|0|||
128817948|NCT04308681|463629035|FG002|Treatment up to Week 26|Other reasons|0|||
128817949|NCT04308681|463629036|FG003|Treatment up to Week 26|Other reasons|0|||
128817950|NCT04308681|463629037|FG004|Treatment up to Week 26|Other reasons|1|||
128817951|NCT04308681|463629038|FG005|Treatment up to Week 26|Other reasons|1|||
128817952|NCT04308681|463629039|FG006|Treatment up to Week 26|Other reasons|0|||
128817953|NCT04308681|463629040|FG007|Treatment up to Week 26|Other reasons|0|||
128817954|NCT04308681|463629033|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
128817955|NCT04308681|463629034|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
128817956|NCT04308681|463629035|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
128817957|NCT04308681|463629036|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
128817958|NCT04308681|463629037|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
128817959|NCT04308681|463629038|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
128817960|NCT04308681|463629039|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
128817961|NCT04308681|463629040|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
128817962|NCT04308681|463629033|FG000|Treatment up to Week 26|Adverse Event|6|||
128817963|NCT04308681|463629034|FG001|Treatment up to Week 26|Adverse Event|5|||
128817964|NCT04308681|463629035|FG002|Treatment up to Week 26|Adverse Event|5|||
128817965|NCT04308681|463629036|FG003|Treatment up to Week 26|Adverse Event|0|||
128817966|NCT04308681|463629037|FG004|Treatment up to Week 26|Adverse Event|6|||
128817967|NCT04308681|463629038|FG005|Treatment up to Week 26|Adverse Event|1|||
128817968|NCT04308681|463629039|FG006|Treatment up to Week 26|Adverse Event|0|||
128817969|NCT04308681|463629040|FG007|Treatment up to Week 26|Adverse Event|0|||
128817970|NCT04308681|463629033|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
128817971|NCT04308681|463629034|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
128817972|NCT04308681|463629035|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
128817973|NCT04308681|463629036|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
128817974|NCT04308681|463629037|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
128817975|NCT04308681|463629038|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
128817976|NCT04308681|463629039|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
128817977|NCT04308681|463629040|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
128817978|NCT04308681|463629033|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
128817979|NCT04308681|463629034|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
128817980|NCT04308681|463629035|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
128817981|NCT04308681|463629036|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
128817982|NCT04308681|463629037|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
128817983|NCT04308681|463629038|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
128817984|NCT04308681|463629039|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
128817985|NCT04308681|463629040|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
128817986|NCT04308681|463629033|FG000|OTE - 26 Weeks|Death|0|||
128817987|NCT04308681|463629034|FG001|OTE - 26 Weeks|Death|1|||
128817988|NCT04308681|463629035|FG002|OTE - 26 Weeks|Death|0|||
128817989|NCT04308681|463629036|FG003|OTE - 26 Weeks|Death|0|||
128817990|NCT04308681|463629037|FG004|OTE - 26 Weeks|Death|0|||
128817991|NCT04308681|463629038|FG005|OTE - 26 Weeks|Death|0|||
128817992|NCT04308681|463629039|FG006|OTE - 26 Weeks|Death|1|||
128817993|NCT04308681|463629040|FG007|OTE - 26 Weeks|Death|0|||
128817994|NCT04308681|463629033|FG000|OTE - 26 Weeks|Adverse Event|0|||
128817995|NCT04308681|463629034|FG001|OTE - 26 Weeks|Adverse Event|2|||
128817996|NCT04308681|463629035|FG002|OTE - 26 Weeks|Adverse Event|8|||
128817997|NCT04308681|463629036|FG003|OTE - 26 Weeks|Adverse Event|3|||
128817998|NCT04308681|463629037|FG004|OTE - 26 Weeks|Adverse Event|0|||
128817999|NCT04308681|463629038|FG005|OTE - 26 Weeks|Adverse Event|1|||
128818000|NCT04308681|463629039|FG006|OTE - 26 Weeks|Adverse Event|2|||
128818001|NCT04308681|463629040|FG007|OTE - 26 Weeks|Adverse Event|0|||
128818002|NCT04308681|463629033|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
128818003|NCT04308681|463629034|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
128818004|NCT04308681|463629035|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
128818005|NCT04308681|463629036|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
128818006|NCT04308681|463629037|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
128818007|NCT04308681|463629038|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
128818008|NCT04308681|463629039|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
128818009|NCT04308681|463629040|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
128818010|NCT05565820|463629041|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
128818011|NCT05565820|463629042|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
128818012|NCT05565820|463629041|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
128818013|NCT05565820|463629042|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
128818014|NCT03213665|463629046|FG000|Overall Study|Adverse Event|1|||
128818015|NCT03213665|463629046|FG000|Overall Study|Physician Decision|2|||
128818016|NCT03213665|463629046|FG000|Overall Study|Withdrawal by Subject|3|||
128818017|NCT03213665|463629046|FG000|Overall Study|Progressive Disease|13|||
128818018|NCT02684227|463629048|FG000|Overall Study|Adverse Event|1|||
128818019|NCT02684227|463629049|FG001|Overall Study|Adverse Event|7|||
128818020|NCT02684227|463629048|FG000|Overall Study|Death|0|||
128818021|NCT02684227|463629049|FG001|Overall Study|Death|2|||
128818022|NCT02684227|463629048|FG000|Overall Study|Withdrawal by Subject|0|||
128818023|NCT02684227|463629049|FG001|Overall Study|Withdrawal by Subject|1|||
128818024|NCT02684227|463629048|FG000|Overall Study|Progressive Disease|0|||
128818025|NCT02684227|463629049|FG001|Overall Study|Progressive Disease|2|||
128818026|NCT03606408|463629050|FG000|Overall Study|Adverse Event|13|||
128818027|NCT03606408|463629050|FG000|Overall Study|Withdrawal by Subject|7|||
128818028|NCT03606408|463629050|FG000|Overall Study|Physician Decision|4|||
128818029|NCT03606408|463629050|FG000|Overall Study|Lack of Efficacy|2|||
128818030|NCT03606408|463629050|FG000|Overall Study|Death|1|||
128818031|NCT03606408|463629050|FG000|Overall Study|new therapy for study indication|1|||
128818032|NCT03556293|463629051|FG000|Overall Study|Ineligible for analysis|1904|||
128818033|NCT03556293|463629052|FG001|Overall Study|Ineligible for analysis|1471|||
128818034|NCT03556293|463629053|FG002|Overall Study|Ineligible for analysis|1091|||
128818035|NCT03556293|463629054|FG003|Overall Study|Ineligible for analysis|1269|||
128818036|NCT05645757|463630743|FG000|Overall Study|Enrolled but treatment not administered|0|||
128818037|NCT05645757|463630744|FG001|Overall Study|Enrolled but treatment not administered|0|||
128818038|NCT05645757|463630745|FG002|Overall Study|Enrolled but treatment not administered|0|||
128818039|NCT05645757|463630746|FG003|Overall Study|Enrolled but treatment not administered|0|||
128818040|NCT05645757|463630747|FG004|Overall Study|Enrolled but treatment not administered|1|||
128818041|NCT05645757|463630748|FG005|Overall Study|Enrolled but treatment not administered|1|||
128818042|NCT05645757|463630749|FG006|Overall Study|Enrolled but treatment not administered|0|||
128818043|NCT05645757|463630750|FG007|Overall Study|Enrolled but treatment not administered|0|||
128818044|NCT00539591|463630751|FG000|Overall Study|Toxicity|3|||
128818045|NCT00539591|463630752|FG001|Overall Study|Toxicity|0|||
128818046|NCT00539591|463630753|FG002|Overall Study|Toxicity|0|||
128818047|NCT00539591|463630751|FG000|Overall Study|Disease progression|2|||
128818048|NCT00539591|463630752|FG001|Overall Study|Disease progression|2|||
128818049|NCT00539591|463630753|FG002|Overall Study|Disease progression|3|||
128818050|NCT03924635|463630754|FG000|Overall Study|Withdrawal by Subject|2|||
128818051|NCT03924635|463630755|FG001|Overall Study|Withdrawal by Subject|4|||
128818052|NCT01960452|463630756|FG000|Overall Study|Withdrawal by Subject|2|||
128818053|NCT01960452|463630757|FG001|Overall Study|Withdrawal by Subject|1|||
128818054|NCT01960452|463630756|FG000|Overall Study|Sleep apnea in Night 1|1|||
128818055|NCT01960452|463630757|FG001|Overall Study|Sleep apnea in Night 1|0|||
128818056|NCT01960452|463630756|FG000|Overall Study|Poor Sleep in Night 1|0|||
128818057|NCT01960452|463630757|FG001|Overall Study|Poor Sleep in Night 1|2|||
128818058|NCT01960452|463630756|FG000|Overall Study|No Sex/Age Match Night 1|1|||
128818059|NCT01960452|463630757|FG001|Overall Study|No Sex/Age Match Night 1|0|||
128818060|NCT01960452|463630756|FG000|Overall Study|No Sex/Age Match Night 2|0|||
128818061|NCT01960452|463630757|FG001|Overall Study|No Sex/Age Match Night 2|2|||
128818062|NCT01960452|463630756|FG000|Overall Study|Technical Difficulties Night 2|2|||
128818063|NCT01960452|463630757|FG001|Overall Study|Technical Difficulties Night 2|0|||
128818064|NCT03209973|463630763|FG000|Overall Study|Withdrawal by Subject|7|||
128818065|NCT03209973|463630763|FG000|Overall Study|Lost to Follow-up|2|||
128818066|NCT03209973|463630763|FG000|Overall Study|Death|8|||
128818067|NCT03209973|463630763|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
128818068|NCT03209973|463630763|FG000|Overall Study|Sponsor Decision|18|||
128818069|NCT03209973|463630763|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
128818070|NCT03209973|463630763|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
128818071|NCT04294641|463630764|FG000|Overall Study|Screen failure|4|||
128818072|NCT01627574|463630766|FG000|Overall Study|Withdrawal by Subject|8|||
128818073|NCT01627574|463630767|FG001|Overall Study|Withdrawal by Subject|5|||
128818074|NCT01627574|463630766|FG000|Overall Study|Lost to Follow-up|13|||
128818075|NCT01627574|463630767|FG001|Overall Study|Lost to Follow-up|13|||
128818076|NCT04730739|463630768|FG000|Overall Study|Death|1|||
128818077|NCT04707469|463630771|FG000|Overall Study|Site closure|0|||
128818078|NCT04707469|463630772|FG001|Overall Study|Site closure|2|||
128818079|NCT04707469|463630773|FG002|Overall Study|Site closure|0|||
128818080|NCT04707469|463630771|FG000|Overall Study|Physician Decision|2|||
128818081|NCT04707469|463630772|FG001|Overall Study|Physician Decision|2|||
128818082|NCT04707469|463630773|FG002|Overall Study|Physician Decision|2|||
128818083|NCT04707469|463630771|FG000|Overall Study|Death|1|||
128818084|NCT04707469|463630772|FG001|Overall Study|Death|6|||
128818085|NCT04707469|463630773|FG002|Overall Study|Death|2|||
128818086|NCT04707469|463630771|FG000|Overall Study|Lost to Follow-up|9|||
128818087|NCT04707469|463630772|FG001|Overall Study|Lost to Follow-up|19|||
128818088|NCT04707469|463630773|FG002|Overall Study|Lost to Follow-up|14|||
128818089|NCT04707469|463630771|FG000|Overall Study|Withdrawal by Subject|17|||
128818090|NCT04707469|463630772|FG001|Overall Study|Withdrawal by Subject|16|||
128818091|NCT04707469|463630773|FG002|Overall Study|Withdrawal by Subject|12|||
128818092|NCT04024020|463630786|FG000|Overall Study|Withdrawal by Subject|2|||
128818093|NCT04024020|463630787|FG001|Overall Study|Withdrawal by Subject|2|||
128818094|NCT05646355|463630788|FG000|Overall Study|Lost to Follow-up|1|||
128818095|NCT05646355|463630789|FG001|Overall Study|Lost to Follow-up|0|||
128818096|NCT05646355|463630788|FG000|Overall Study|translated materials not available for pilot|2|||
128818097|NCT05646355|463630789|FG001|Overall Study|translated materials not available for pilot|0|||
128818098|NCT05646355|463630788|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
128818099|NCT05646355|463630789|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
128818100|NCT05269966|463630792|FG000|Overall Study|Adverse Event|4|||
128818101|NCT05269966|463630792|FG000|Overall Study|Withdrawal by Subject|1|||
128818102|NCT05269966|463630792|FG000|Overall Study|Lost to Follow-up|4|||
128818103|NCT05269966|463630792|FG000|Overall Study|Physician Decision|1|||
128818104|NCT05863156|463630793|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
128818105|NCT05863156|463630794|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
128818106|NCT05863156|463630795|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
128818107|NCT04797195|463630796|FG000|Overall Study|Death|8|||
128818108|NCT04797195|463630797|FG001|Overall Study|Death|15|||
128818109|NCT04797195|463630796|FG000|Overall Study|Change from PD|15|||
128818110|NCT04797195|463630797|FG001|Overall Study|Change from PD|15|||
128818111|NCT04797195|463630796|FG000|Overall Study|Withdrawal by Subject|3|||
128818112|NCT04797195|463630797|FG001|Overall Study|Withdrawal by Subject|2|||
128818113|NCT04101357|463630798|FG000|Overall Study|Death|1|||
128818114|NCT04101357|463630799|FG001|Overall Study|Death|1|||
128818115|NCT04101357|463630800|FG002|Overall Study|Death|1|||
128818116|NCT04101357|463630801|FG003|Overall Study|Death|2|||
128818117|NCT04101357|463630802|FG004|Overall Study|Death|4|||
128818118|NCT04101357|463630803|FG005|Overall Study|Death|11|||
128818119|NCT04101357|463630804|FG006|Overall Study|Death|4|||
128818120|NCT04101357|463630805|FG007|Overall Study|Death|4|||
128818121|NCT04101357|463630806|FG008|Overall Study|Death|5|||
128818122|NCT04101357|463630807|FG009|Overall Study|Death|2|||
128818123|NCT04101357|463630808|FG010|Overall Study|Death|3|||
128818124|NCT04101357|463630798|FG000|Overall Study|Trial closure|0|||
128818125|NCT04101357|463630799|FG001|Overall Study|Trial closure|0|||
128818126|NCT04101357|463630800|FG002|Overall Study|Trial closure|0|||
128818127|NCT04101357|463630801|FG003|Overall Study|Trial closure|0|||
128818128|NCT04101357|463630802|FG004|Overall Study|Trial closure|0|||
128818129|NCT04101357|463630803|FG005|Overall Study|Trial closure|2|||
128818130|NCT04101357|463630804|FG006|Overall Study|Trial closure|2|||
128818131|NCT04101357|463630805|FG007|Overall Study|Trial closure|0|||
128818132|NCT04101357|463630806|FG008|Overall Study|Trial closure|0|||
128818133|NCT04101357|463630807|FG009|Overall Study|Trial closure|0|||
128818134|NCT04101357|463630808|FG010|Overall Study|Trial closure|1|||
128818135|NCT04101357|463630798|FG000|Overall Study|Lost to Follow-up|0|||
128818136|NCT04101357|463630799|FG001|Overall Study|Lost to Follow-up|0|||
128818137|NCT04101357|463630800|FG002|Overall Study|Lost to Follow-up|0|||
128818138|NCT04101357|463630801|FG003|Overall Study|Lost to Follow-up|1|||
128818139|NCT04101357|463630802|FG004|Overall Study|Lost to Follow-up|0|||
128818140|NCT04101357|463630803|FG005|Overall Study|Lost to Follow-up|0|||
128818141|NCT04101357|463630804|FG006|Overall Study|Lost to Follow-up|0|||
128818142|NCT04101357|463630805|FG007|Overall Study|Lost to Follow-up|1|||
128818143|NCT04101357|463630806|FG008|Overall Study|Lost to Follow-up|0|||
128818144|NCT04101357|463630807|FG009|Overall Study|Lost to Follow-up|0|||
128818145|NCT04101357|463630808|FG010|Overall Study|Lost to Follow-up|0|||
128818146|NCT04101357|463630798|FG000|Overall Study|Withdrawal by Subject|1|||
128818147|NCT04101357|463630799|FG001|Overall Study|Withdrawal by Subject|0|||
128818148|NCT04101357|463630800|FG002|Overall Study|Withdrawal by Subject|0|||
128818149|NCT04101357|463630801|FG003|Overall Study|Withdrawal by Subject|0|||
128818150|NCT04101357|463630802|FG004|Overall Study|Withdrawal by Subject|0|||
128818151|NCT04101357|463630803|FG005|Overall Study|Withdrawal by Subject|0|||
128818152|NCT04101357|463630804|FG006|Overall Study|Withdrawal by Subject|0|||
128818153|NCT04101357|463630805|FG007|Overall Study|Withdrawal by Subject|0|||
128818154|NCT04101357|463630806|FG008|Overall Study|Withdrawal by Subject|1|||
128818155|NCT04101357|463630807|FG009|Overall Study|Withdrawal by Subject|1|||
128818156|NCT04101357|463630808|FG010|Overall Study|Withdrawal by Subject|0|||
128818157|NCT04101357|463630798|FG000|Overall Study|Other|0|||
128818158|NCT04101357|463630799|FG001|Overall Study|Other|0|||
128818159|NCT04101357|463630800|FG002|Overall Study|Other|0|||
128818160|NCT04101357|463630801|FG003|Overall Study|Other|0|||
128818161|NCT04101357|463630802|FG004|Overall Study|Other|0|||
128818162|NCT04101357|463630803|FG005|Overall Study|Other|1|||
128818163|NCT04101357|463630804|FG006|Overall Study|Other|2|||
128818164|NCT04101357|463630805|FG007|Overall Study|Other|1|||
128818165|NCT04101357|463630806|FG008|Overall Study|Other|0|||
128818166|NCT04101357|463630807|FG009|Overall Study|Other|0|||
128818167|NCT04101357|463630808|FG010|Overall Study|Other|0|||
128818168|NCT04101357|463630798|FG000|Overall Study|Enrolled but not treated|0|||
128818169|NCT04101357|463630799|FG001|Overall Study|Enrolled but not treated|0|||
128818170|NCT04101357|463630800|FG002|Overall Study|Enrolled but not treated|0|||
128818171|NCT04101357|463630801|FG003|Overall Study|Enrolled but not treated|0|||
128818172|NCT04101357|463630802|FG004|Overall Study|Enrolled but not treated|0|||
128818173|NCT04101357|463630803|FG005|Overall Study|Enrolled but not treated|1|||
128818174|NCT04101357|463630804|FG006|Overall Study|Enrolled but not treated|1|||
128818175|NCT04101357|463630805|FG007|Overall Study|Enrolled but not treated|0|||
128818176|NCT04101357|463630806|FG008|Overall Study|Enrolled but not treated|0|||
128818177|NCT04101357|463630807|FG009|Overall Study|Enrolled but not treated|0|||
128818178|NCT04101357|463630808|FG010|Overall Study|Enrolled but not treated|0|||
128818179|NCT02296684|463630809|FG000|Overall Study|Withdrawal by Subject|0|||
128818180|NCT02296684|463630810|FG001|Overall Study|Withdrawal by Subject|1|||
128818181|NCT02296684|463630811|FG002|Overall Study|Withdrawal by Subject|1|||
128818182|NCT02296684|463630809|FG000|Overall Study|Death|2|||
128818183|NCT02296684|463630810|FG001|Overall Study|Death|0|||
128818184|NCT02296684|463630811|FG002|Overall Study|Death|0|||
128818185|NCT04786119|463630814|FG000|Overall Study|Withdrawal by Subject|2|||
128818186|NCT05828017|463630815|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
128818187|NCT05012163|463630816|FG000|Overall Study|Protocol Violation|0|||
128818188|NCT05012163|463630817|FG001|Overall Study|Protocol Violation|0|||
128818189|NCT05012163|463630818|FG002|Overall Study|Protocol Violation|1|||
128818190|NCT05012163|463630819|FG003|Overall Study|Protocol Violation|1|||
128818191|NCT05076266|463630820|FG000|Overall Study|Survey not complete - Participant refusal|2|||
128818192|NCT05076266|463630821|FG001|Overall Study|Survey not complete - Participant refusal|0|||
128818193|NCT04003246|463630824|FG000|Overall Study|Death|9|||
128818194|NCT04132518|463630830|FG000|Overall Study|Prematurely withdrawn from the study|0|||
128818195|NCT04132518|463630831|FG001|Overall Study|Prematurely withdrawn from the study|9|||
128818196|NCT04132518|463630832|FG002|Overall Study|Prematurely withdrawn from the study|1|||
128818197|NCT05524402|463630834|FG000|Overall Study|Withdrawal by Subject|3|||
128818198|NCT05524402|463630835|FG001|Overall Study|Withdrawal by Subject|1|||
128818199|NCT05524402|463630834|FG000|Overall Study|Lost to Follow-up|2|||
128818200|NCT05524402|463630835|FG001|Overall Study|Lost to Follow-up|1|||
128818201|NCT03213873|463630838|FG000|Overall Study|Withdrawal by Subject|8|||
128818202|NCT03213873|463630839|FG001|Overall Study|Withdrawal by Subject|9|||
128818203|NCT03213873|463630838|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
128818204|NCT03213873|463630839|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
128818205|NCT03213873|463630838|FG000|Overall Study|Lost to Follow-up|0|||
128818206|NCT03213873|463630839|FG001|Overall Study|Lost to Follow-up|2|||
128818207|NCT02361216|463630845|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
128818208|NCT02361216|463630846|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
128818209|NCT02361216|463630845|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
128818210|NCT02361216|463630846|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
128818211|NCT02361216|463630845|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
128818212|NCT02361216|463630846|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
128818213|NCT02361216|463630845|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
128818214|NCT02361216|463630846|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
128818215|NCT02361216|463630845|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
128818216|NCT02361216|463630846|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
128818217|NCT02361216|463630845|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
128818218|NCT02361216|463630846|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
128818219|NCT02852655|463630852|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
128818220|NCT02852655|463630853|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
128818221|NCT02852655|463630854|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
128818222|NCT02852655|463630852|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
128818223|NCT02852655|463630853|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
128818224|NCT02852655|463630854|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
128818225|NCT02852655|463630852|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
128818226|NCT02852655|463630853|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
128818227|NCT02852655|463630854|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
128818228|NCT02852655|463630852|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
128818229|NCT02852655|463630853|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
128818230|NCT02852655|463630854|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
128818231|NCT02852655|463630852|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
128818232|NCT02852655|463630853|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
128818233|NCT02852655|463630854|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
128818234|NCT02852655|463630852|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
128818235|NCT02852655|463630853|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
128818236|NCT02852655|463630854|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
128818237|NCT02852655|463630852|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
128818238|NCT02852655|463630853|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
128818239|NCT02852655|463630854|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
128818240|NCT02852655|463630852|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
128818241|NCT02852655|463630853|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
128818242|NCT02852655|463630854|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
128818243|NCT02852655|463630852|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
128818244|NCT02852655|463630853|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
128818245|NCT02852655|463630854|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
128818246|NCT04544007|463630857|FG000|Overall Study|Withdrawal by Subject|1|||
128818247|NCT04544007|463630857|FG000|Overall Study|Confirmed Progressive Disease|1|||
128818248|NCT02988661|463630858|FG000|Overall Study|Death|2|||
128818249|NCT02988661|463630859|FG001|Overall Study|Death|18|||
128818250|NCT02988661|463630858|FG000|Overall Study|Lost to Follow-up|0|||
128818251|NCT02988661|463630859|FG001|Overall Study|Lost to Follow-up|33|||
128818252|NCT02988661|463630858|FG000|Overall Study|Withdrawal by Subject|0|||
128818253|NCT02988661|463630859|FG001|Overall Study|Withdrawal by Subject|6|||
128818254|NCT02988661|463630858|FG000|Overall Study|Unable to complete the 18-month survey|1|||
128818255|NCT02988661|463630859|FG001|Overall Study|Unable to complete the 18-month survey|27|||
128818256|NCT02413489|463630875|FG000|Overall Study|Death|11|||
128818257|NCT02413489|463630876|FG001|Overall Study|Death|3|||
128818258|NCT02413489|463630877|FG002|Overall Study|Death|4|||
128818259|NCT02413489|463630875|FG000|Overall Study|Withdrawal by Subject|2|||
128818260|NCT02413489|463630876|FG001|Overall Study|Withdrawal by Subject|0|||
128818261|NCT02413489|463630877|FG002|Overall Study|Withdrawal by Subject|0|||
128818262|NCT02413489|463630875|FG000|Overall Study|Study Terminated By Sponsor|2|||
128818263|NCT02413489|463630876|FG001|Overall Study|Study Terminated By Sponsor|13|||
128818264|NCT02413489|463630877|FG002|Overall Study|Study Terminated By Sponsor|1|||
128818265|NCT02575950|463630878|FG000|Overall Study|Withdrawal by Subject|0|||
128818266|NCT02575950|463630879|FG001|Overall Study|Withdrawal by Subject|0|||
128818267|NCT02575950|463630880|FG002|Overall Study|Withdrawal by Subject|0|||
128818268|NCT02575950|463630881|FG003|Overall Study|Withdrawal by Subject|2|||
128818269|NCT02575950|463630878|FG000|Overall Study|Lost to Follow-up|0|||
128818270|NCT02575950|463630879|FG001|Overall Study|Lost to Follow-up|1|||
128818271|NCT02575950|463630880|FG002|Overall Study|Lost to Follow-up|0|||
128818272|NCT02575950|463630881|FG003|Overall Study|Lost to Follow-up|3|||
128818273|NCT04826471|463632662|FG000|Overall Study|Lost to Follow-up|2|||
128818274|NCT04826471|463632662|FG000|Overall Study|Protocol Violation|3|||
128818275|NCT04826471|463632662|FG000|Overall Study|Withdrawal by Subject|1|||
128818276|NCT04414722|463632663|FG000|Overall Study|Lost to Follow-up|3|||
128818277|NCT04414722|463632664|FG001|Overall Study|Lost to Follow-up|4|||
128818278|NCT04414722|463632665|FG002|Overall Study|Lost to Follow-up|3|||
128818279|NCT04414722|463632666|FG003|Overall Study|Lost to Follow-up|2|||
128818280|NCT04414722|463632667|FG004|Overall Study|Lost to Follow-up|3|||
128818281|NCT04414722|463632663|FG000|Overall Study|Withdrawal by Subject|6|||
128818282|NCT04414722|463632664|FG001|Overall Study|Withdrawal by Subject|3|||
128818283|NCT04414722|463632665|FG002|Overall Study|Withdrawal by Subject|1|||
128818284|NCT04414722|463632666|FG003|Overall Study|Withdrawal by Subject|5|||
128818285|NCT04414722|463632667|FG004|Overall Study|Withdrawal by Subject|1|||
128818286|NCT04414722|463632663|FG000|Overall Study|Physician Decision|0|||
128818287|NCT04414722|463632664|FG001|Overall Study|Physician Decision|1|||
128818288|NCT04414722|463632665|FG002|Overall Study|Physician Decision|2|||
128818289|NCT04414722|463632666|FG003|Overall Study|Physician Decision|0|||
128818290|NCT04414722|463632667|FG004|Overall Study|Physician Decision|0|||
128818291|NCT04414722|463632663|FG000|Overall Study|Non-participatory|0|||
128818292|NCT04414722|463632664|FG001|Overall Study|Non-participatory|1|||
128818293|NCT04414722|463632665|FG002|Overall Study|Non-participatory|1|||
128818294|NCT04414722|463632666|FG003|Overall Study|Non-participatory|0|||
128818295|NCT04414722|463632667|FG004|Overall Study|Non-participatory|0|||
128818296|NCT05218096|463632669|FG000|Primary Evaluation|Withdrawal by Subject|0|||
128818297|NCT05218096|463632670|FG001|Primary Evaluation|Withdrawal by Subject|0|||
128818298|NCT05218096|463632671|FG002|Primary Evaluation|Withdrawal by Subject|2|||
128818299|NCT05218096|463632672|FG003|Primary Evaluation|Withdrawal by Subject|0|||
128818300|NCT05218096|463632673|FG004|Primary Evaluation|Withdrawal by Subject|0|||
128818301|NCT05218096|463632669|FG000|Primary Evaluation|Physician Decision|1|||
128818302|NCT05218096|463632670|FG001|Primary Evaluation|Physician Decision|0|||
128818303|NCT05218096|463632671|FG002|Primary Evaluation|Physician Decision|0|||
128818304|NCT05218096|463632672|FG003|Primary Evaluation|Physician Decision|0|||
128818305|NCT05218096|463632673|FG004|Primary Evaluation|Physician Decision|0|||
128818306|NCT05218096|463632669|FG000|Extended Treatment|Clinical Deterioration|1|||
128818307|NCT05218096|463632670|FG001|Extended Treatment|Clinical Deterioration|1|||
128818308|NCT05218096|463632671|FG002|Extended Treatment|Clinical Deterioration|0|||
128818309|NCT05218096|463632672|FG003|Extended Treatment|Clinical Deterioration|0|||
128818310|NCT05218096|463632673|FG004|Extended Treatment|Clinical Deterioration|0|||
128818311|NCT05218096|463632669|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
128818312|NCT05218096|463632670|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
128818313|NCT05218096|463632671|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
128818314|NCT05218096|463632672|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
128818315|NCT05218096|463632673|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
128818316|NCT05218096|463632669|FG000|Extended Treatment|Withdrawal by Subject|1|||
128818317|NCT05218096|463632670|FG001|Extended Treatment|Withdrawal by Subject|3|||
128818318|NCT05218096|463632671|FG002|Extended Treatment|Withdrawal by Subject|0|||
128818319|NCT05218096|463632672|FG003|Extended Treatment|Withdrawal by Subject|2|||
128818320|NCT05218096|463632673|FG004|Extended Treatment|Withdrawal by Subject|2|||
128818321|NCT05218096|463632669|FG000|Extended Treatment|Lack of Efficacy|3|||
128818322|NCT05218096|463632670|FG001|Extended Treatment|Lack of Efficacy|0|||
128818323|NCT05218096|463632671|FG002|Extended Treatment|Lack of Efficacy|0|||
128818324|NCT05218096|463632672|FG003|Extended Treatment|Lack of Efficacy|0|||
128818325|NCT05218096|463632673|FG004|Extended Treatment|Lack of Efficacy|0|||
128818326|NCT05218096|463632669|FG000|Extended Treatment|Physician Decision|0|||
128818327|NCT05218096|463632670|FG001|Extended Treatment|Physician Decision|1|||
128818328|NCT05218096|463632671|FG002|Extended Treatment|Physician Decision|0|||
128818329|NCT05218096|463632672|FG003|Extended Treatment|Physician Decision|0|||
128818330|NCT05218096|463632673|FG004|Extended Treatment|Physician Decision|0|||
128818331|NCT05218096|463632669|FG000|Open-label Extension|Adverse Event|1|||
128818332|NCT05218096|463632670|FG001|Open-label Extension|Adverse Event|0|||
128818333|NCT05218096|463632671|FG002|Open-label Extension|Adverse Event|0|||
128818334|NCT05218096|463632672|FG003|Open-label Extension|Adverse Event|0|||
128818335|NCT05218096|463632673|FG004|Open-label Extension|Adverse Event|1|||
128818336|NCT05218096|463632669|FG000|Open-label Extension|Pregnancy|0|||
128818337|NCT05218096|463632670|FG001|Open-label Extension|Pregnancy|0|||
128818338|NCT05218096|463632671|FG002|Open-label Extension|Pregnancy|0|||
128818339|NCT05218096|463632672|FG003|Open-label Extension|Pregnancy|0|||
128818340|NCT05218096|463632673|FG004|Open-label Extension|Pregnancy|1|||
128818341|NCT05218096|463632669|FG000|Open-label Extension|Lack of Efficacy|1|||
128818342|NCT05218096|463632670|FG001|Open-label Extension|Lack of Efficacy|2|||
128818343|NCT05218096|463632671|FG002|Open-label Extension|Lack of Efficacy|0|||
128818344|NCT05218096|463632672|FG003|Open-label Extension|Lack of Efficacy|0|||
128818345|NCT05218096|463632673|FG004|Open-label Extension|Lack of Efficacy|0|||
128818346|NCT05218096|463632669|FG000|Open-label Extension|Lost to Follow-up|1|||
128818347|NCT05218096|463632670|FG001|Open-label Extension|Lost to Follow-up|0|||
128818348|NCT05218096|463632671|FG002|Open-label Extension|Lost to Follow-up|0|||
128818349|NCT05218096|463632672|FG003|Open-label Extension|Lost to Follow-up|0|||
128818350|NCT05218096|463632673|FG004|Open-label Extension|Lost to Follow-up|0|||
128818351|NCT05218096|463632669|FG000|Open-label Extension|Death|0|||
128818352|NCT05218096|463632670|FG001|Open-label Extension|Death|0|||
128818353|NCT05218096|463632671|FG002|Open-label Extension|Death|0|||
128818354|NCT05218096|463632672|FG003|Open-label Extension|Death|1|||
128818355|NCT05218096|463632673|FG004|Open-label Extension|Death|0|||
128818356|NCT05218096|463632669|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
128818357|NCT05218096|463632670|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
128818358|NCT05218096|463632671|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
128818359|NCT05218096|463632672|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
128818360|NCT05218096|463632673|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
128818361|NCT04304144|463632682|FG000|DLT Observation Period|Physician Decision|0|||
128818362|NCT04304144|463632683|FG001|DLT Observation Period|Physician Decision|1|||
128818363|NCT04304144|463632684|FG002|DLT Observation Period|Physician Decision|0|||
128818364|NCT04304144|463632685|FG003|DLT Observation Period|Physician Decision|0|||
128818365|NCT04304144|463632682|FG000|Continued Treatment Period|Adverse Event|0|||
128818366|NCT04304144|463632683|FG001|Continued Treatment Period|Adverse Event|1|||
128818367|NCT04304144|463632684|FG002|Continued Treatment Period|Adverse Event|0|||
128818368|NCT04304144|463632685|FG003|Continued Treatment Period|Adverse Event|0|||
128818369|NCT04304144|463632682|FG000|Continued Treatment Period|Death|0|||
128818370|NCT04304144|463632683|FG001|Continued Treatment Period|Death|0|||
128818371|NCT04304144|463632684|FG002|Continued Treatment Period|Death|1|||
128818372|NCT04304144|463632685|FG003|Continued Treatment Period|Death|2|||
128818373|NCT04304144|463632682|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
128818374|NCT04304144|463632683|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
128818375|NCT04304144|463632684|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
128818376|NCT04304144|463632685|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
128818377|NCT04304144|463632682|FG000|Continued Treatment Period|Other than specified|2|||
128818378|NCT04304144|463632683|FG001|Continued Treatment Period|Other than specified|0|||
128818379|NCT04304144|463632684|FG002|Continued Treatment Period|Other than specified|1|||
128818380|NCT04304144|463632685|FG003|Continued Treatment Period|Other than specified|1|||
128818381|NCT04660539|463632688|FG000|Overall Study|Adverse Event|10|||
128818382|NCT04660539|463632688|FG000|Overall Study|Lack of Efficacy|4|||
128818383|NCT04660539|463632688|FG000|Overall Study|Lost to Follow-up|5|||
128818384|NCT04660539|463632688|FG000|Overall Study|Non-Compliance With Study Drug|3|||
128818385|NCT04660539|463632688|FG000|Overall Study|Reason not Specified|12|||
128818386|NCT04660539|463632688|FG000|Overall Study|Pregnancy|2|||
128818387|NCT04660539|463632688|FG000|Overall Study|Protocol Violation|2|||
128818388|NCT04660539|463632688|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
128818389|NCT04660539|463632688|FG000|Overall Study|Withdrawal by Subject|21|||
128818390|NCT03655028|463632691|FG000|12-weeks Follow up|Death|1|||
128818391|NCT03655028|463632692|FG001|12-weeks Follow up|Death|0|||
128818392|NCT03655028|463632691|FG000|12-weeks Follow up|Physician Decision|3|||
128818393|NCT03655028|463632692|FG001|12-weeks Follow up|Physician Decision|3|||
128818394|NCT03655028|463632691|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
128818395|NCT03655028|463632692|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
128818396|NCT03655028|463632691|FG000|12-weeks Follow up|Lost to Follow-up|4|||
128818397|NCT03655028|463632692|FG001|12-weeks Follow up|Lost to Follow-up|4|||
128818398|NCT03655028|463632691|FG000|24-weeks|Lost to Follow-up|1|||
128818399|NCT03655028|463632692|FG001|24-weeks|Lost to Follow-up|1|||
128818400|NCT03655028|463632691|FG000|24-weeks|Death|0|||
128818401|NCT03655028|463632692|FG001|24-weeks|Death|1|||
128818402|NCT03513302|463632693|FG000|First Intervention (14 Days)|Screen failure|15|||
128818403|NCT03513302|463632694|FG001|First Intervention (14 Days)|Screen failure|16|||
128818404|NCT05256654|463632695|FG000|Overall Study|Adverse Event|0|||
128818405|NCT05256654|463632696|FG001|Overall Study|Adverse Event|0|||
128818406|NCT05256654|463632697|FG002|Overall Study|Adverse Event|1|||
128818407|NCT05256654|463632698|FG003|Overall Study|Adverse Event|0|||
128818408|NCT05256654|463632695|FG000|Overall Study|Lost to Follow-up|0|||
128818409|NCT05256654|463632696|FG001|Overall Study|Lost to Follow-up|0|||
128818410|NCT05256654|463632697|FG002|Overall Study|Lost to Follow-up|0|||
128818411|NCT05256654|463632698|FG003|Overall Study|Lost to Follow-up|1|||
128818412|NCT05256654|463632695|FG000|Overall Study|Withdrawal by Subject|1|||
128818413|NCT05256654|463632696|FG001|Overall Study|Withdrawal by Subject|2|||
128818414|NCT05256654|463632697|FG002|Overall Study|Withdrawal by Subject|1|||
128818415|NCT05256654|463632698|FG003|Overall Study|Withdrawal by Subject|3|||
128818416|NCT05256654|463632695|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
128818417|NCT05256654|463632696|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
128818418|NCT05256654|463632697|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
128818419|NCT05256654|463632698|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
128818420|NCT05256654|463632695|FG000|Overall Study|Other|0|||
128818421|NCT05256654|463632696|FG001|Overall Study|Other|0|||
128818422|NCT05256654|463632697|FG002|Overall Study|Other|0|||
128818423|NCT05256654|463632698|FG003|Overall Study|Other|1|||
128818424|NCT05618587|463632699|FG000|Overall Study|Lost to Follow-up|2|||
128818425|NCT05618587|463632700|FG001|Overall Study|Lost to Follow-up|0|||
128818426|NCT05167864|463632701|FG000|Overall Study|Lost to Follow-up|7|||
128818427|NCT05167864|463632702|FG001|Overall Study|Lost to Follow-up|6|||
128818428|NCT05167864|463632703|FG002|Overall Study|Lost to Follow-up|7|||
128818429|NCT05167864|463632704|FG003|Overall Study|Lost to Follow-up|9|||
128818430|NCT01254864|463632711|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
128818431|NCT01254864|463632712|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
128818432|NCT01254864|463632713|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
128818433|NCT01254864|463632711|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
128818434|NCT01254864|463632712|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
128818435|NCT01254864|463632713|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
128818436|NCT01254864|463632711|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
128818437|NCT01254864|463632712|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
128818438|NCT01254864|463632713|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
128818439|NCT01254864|463632711|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
128818440|NCT01254864|463632712|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
128818441|NCT01254864|463632713|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
128818442|NCT01254864|463632711|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
128818443|NCT01254864|463632712|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
128818444|NCT01254864|463632713|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
128818445|NCT01254864|463632711|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
128818446|NCT01254864|463632712|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
128818447|NCT01254864|463632713|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
128818448|NCT01254864|463632711|FG000|Randomization Phase|Adverse Event|0|||
128818449|NCT01254864|463632712|FG001|Randomization Phase|Adverse Event|5|||
128818450|NCT01254864|463632713|FG002|Randomization Phase|Adverse Event|17|||
128818451|NCT01254864|463632711|FG000|Randomization Phase|Death|0|||
128818452|NCT01254864|463632712|FG001|Randomization Phase|Death|1|||
128818453|NCT01254864|463632713|FG002|Randomization Phase|Death|0|||
128818454|NCT01254864|463632711|FG000|Randomization Phase|Lost to Follow-up|0|||
128818455|NCT01254864|463632712|FG001|Randomization Phase|Lost to Follow-up|0|||
128818456|NCT01254864|463632713|FG002|Randomization Phase|Lost to Follow-up|1|||
128818457|NCT01254864|463632711|FG000|Randomization Phase|Physician Decision|0|||
128818458|NCT01254864|463632712|FG001|Randomization Phase|Physician Decision|20|||
128818459|NCT01254864|463632713|FG002|Randomization Phase|Physician Decision|25|||
128818460|NCT01254864|463632711|FG000|Randomization Phase|Withdrawal by Subject|0|||
128818461|NCT01254864|463632712|FG001|Randomization Phase|Withdrawal by Subject|4|||
128818462|NCT01254864|463632713|FG002|Randomization Phase|Withdrawal by Subject|2|||
128818463|NCT01254864|463632711|FG000|Randomization Phase|Non-Compliance|0|||
128818464|NCT01254864|463632712|FG001|Randomization Phase|Non-Compliance|1|||
128818465|NCT01254864|463632713|FG002|Randomization Phase|Non-Compliance|0|||
128818466|NCT01254864|463632711|FG000|Randomization Phase|Comorbidities|0|||
128818467|NCT01254864|463632712|FG001|Randomization Phase|Comorbidities|2|||
128818468|NCT01254864|463632713|FG002|Randomization Phase|Comorbidities|1|||
128818469|NCT01828112|463632716|FG000|Treatment Phase|Adverse Event|7|||
128818470|NCT01828112|463632717|FG001|Treatment Phase|Adverse Event|8|||
128818471|NCT01828112|463632718|FG002|Treatment Phase|Adverse Event|0|||
128818472|NCT01828112|463632716|FG000|Treatment Phase|Death|9|||
128818473|NCT01828112|463632717|FG001|Treatment Phase|Death|5|||
128818474|NCT01828112|463632718|FG002|Treatment Phase|Death|0|||
128818475|NCT01828112|463632716|FG000|Treatment Phase|No longer required treatment|0|||
128818476|NCT01828112|463632717|FG001|Treatment Phase|No longer required treatment|1|||
128818477|NCT01828112|463632718|FG002|Treatment Phase|No longer required treatment|0|||
128818478|NCT01828112|463632716|FG000|Treatment Phase|Physician Decision|6|||
128818479|NCT01828112|463632717|FG001|Treatment Phase|Physician Decision|7|||
128818480|NCT01828112|463632718|FG002|Treatment Phase|Physician Decision|0|||
128818481|NCT01828112|463632716|FG000|Treatment Phase|Pregnancy|1|||
128818482|NCT01828112|463632717|FG001|Treatment Phase|Pregnancy|0|||
128818483|NCT01828112|463632718|FG002|Treatment Phase|Pregnancy|0|||
128818484|NCT01828112|463632716|FG000|Treatment Phase|Progressive disease|79|||
128818485|NCT01828112|463632717|FG001|Treatment Phase|Progressive disease|87|||
128818486|NCT01828112|463632718|FG002|Treatment Phase|Progressive disease|0|||
128818487|NCT01828112|463632716|FG000|Treatment Phase|Study terminated by sponsor|1|||
128818488|NCT01828112|463632717|FG001|Treatment Phase|Study terminated by sponsor|0|||
128818489|NCT01828112|463632718|FG002|Treatment Phase|Study terminated by sponsor|0|||
128818490|NCT01828112|463632716|FG000|Treatment Phase|Subject/guardian decision|12|||
128818491|NCT01828112|463632717|FG001|Treatment Phase|Subject/guardian decision|8|||
128818492|NCT01828112|463632718|FG002|Treatment Phase|Subject/guardian decision|0|||
128818493|NCT01828112|463632716|FG000|Extension Treatment Phase|Adverse Event|0|||
128818494|NCT01828112|463632717|FG001|Extension Treatment Phase|Adverse Event|0|||
128818495|NCT01828112|463632718|FG002|Extension Treatment Phase|Adverse Event|6|||
128818496|NCT01828112|463632716|FG000|Extension Treatment Phase|Death|0|||
128818497|NCT01828112|463632717|FG001|Extension Treatment Phase|Death|0|||
128818498|NCT01828112|463632718|FG002|Extension Treatment Phase|Death|17|||
128818499|NCT01828112|463632716|FG000|Extension Treatment Phase|Physician Decision|0|||
128818500|NCT01828112|463632717|FG001|Extension Treatment Phase|Physician Decision|0|||
128818501|NCT01828112|463632718|FG002|Extension Treatment Phase|Physician Decision|5|||
128818502|NCT01828112|463632716|FG000|Extension Treatment Phase|Progressive disease|0|||
128818503|NCT01828112|463632717|FG001|Extension Treatment Phase|Progressive disease|0|||
128818504|NCT01828112|463632718|FG002|Extension Treatment Phase|Progressive disease|46|||
128818505|NCT01828112|463632716|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
128818506|NCT01828112|463632717|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
128818507|NCT01828112|463632718|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
128818508|NCT01828112|463632716|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
128818509|NCT01828112|463632717|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
128818510|NCT01828112|463632718|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
128818511|NCT00429364|463632726|FG000|Overall Study|Withdrawal by Subject|11|||
128818512|NCT00429364|463632727|FG001|Overall Study|Withdrawal by Subject|5|||
128818513|NCT00429364|463632726|FG000|Overall Study|Physician Decision|4|||
128818514|NCT00429364|463632727|FG001|Overall Study|Physician Decision|2|||
128818515|NCT00429364|463632726|FG000|Overall Study|Lost to Follow-up|7|||
128818516|NCT00429364|463632727|FG001|Overall Study|Lost to Follow-up|6|||
128818517|NCT00429364|463632726|FG000|Overall Study|Death|0|||
128818518|NCT00429364|463632727|FG001|Overall Study|Death|1|||
128818519|NCT00429364|463632726|FG000|Overall Study|Underwent aortic root surgery|10|||
128818520|NCT00429364|463632727|FG001|Overall Study|Underwent aortic root surgery|18|||
128818521|NCT00429364|463632726|FG000|Overall Study|Pregnancy|0|||
128818522|NCT00429364|463632727|FG001|Overall Study|Pregnancy|1|||
128818523|NCT04871529|463632728|FG000|Overall Study|Withdrawal by Subject|0|||
128818524|NCT04871529|463632729|FG001|Overall Study|Withdrawal by Subject|1|||
128818525|NCT04871529|463632728|FG000|Overall Study|Death|0|||
128818526|NCT04871529|463632729|FG001|Overall Study|Death|1|||
128818527|NCT04871529|463632728|FG000|Overall Study|Not protocol specified|0|||
128818528|NCT04871529|463632729|FG001|Overall Study|Not protocol specified|1|||
128818529|NCT05184452|463632730|FG000|Overall Study|Lost to Follow-up|0|||
128818530|NCT05184452|463632731|FG001|Overall Study|Lost to Follow-up|0|||
128818531|NCT05184452|463632732|FG002|Overall Study|Lost to Follow-up|0|||
128818532|NCT05184452|463632733|FG003|Overall Study|Lost to Follow-up|0|||
128818533|NCT05184452|463632734|FG004|Overall Study|Lost to Follow-up|0|||
128818534|NCT05184452|463632735|FG005|Overall Study|Lost to Follow-up|2|||
128818535|NCT05184452|463632736|FG006|Overall Study|Lost to Follow-up|0|||
128818536|NCT05184452|463632737|FG007|Overall Study|Lost to Follow-up|0|||
128818537|NCT05184452|463632738|FG008|Overall Study|Lost to Follow-up|0|||
128818538|NCT05184452|463632739|FG009|Overall Study|Lost to Follow-up|1|||
128818539|NCT05184452|463632730|FG000|Overall Study|Withdrawal by Subject|0|||
128818540|NCT05184452|463632731|FG001|Overall Study|Withdrawal by Subject|0|||
128818541|NCT05184452|463632732|FG002|Overall Study|Withdrawal by Subject|0|||
128818542|NCT05184452|463632733|FG003|Overall Study|Withdrawal by Subject|0|||
128818543|NCT05184452|463632734|FG004|Overall Study|Withdrawal by Subject|0|||
128818544|NCT05184452|463632735|FG005|Overall Study|Withdrawal by Subject|1|||
128818545|NCT05184452|463632736|FG006|Overall Study|Withdrawal by Subject|0|||
128818546|NCT05184452|463632737|FG007|Overall Study|Withdrawal by Subject|0|||
128818547|NCT05184452|463632738|FG008|Overall Study|Withdrawal by Subject|0|||
128818548|NCT05184452|463632739|FG009|Overall Study|Withdrawal by Subject|1|||
128818549|NCT05586490|463632740|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
128818550|NCT05586490|463632741|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
128818551|NCT05586490|463632742|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
128818552|NCT05586490|463632743|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
128818553|NCT05586490|463632744|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
128818554|NCT05586490|463632740|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
128818555|NCT05586490|463632741|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
128818556|NCT05586490|463632742|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
128818557|NCT05586490|463632743|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
128818558|NCT05586490|463632744|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
128818559|NCT05586490|463632740|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
128818560|NCT05586490|463632741|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
128818561|NCT05586490|463632742|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
128818562|NCT05586490|463632743|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
128818563|NCT05586490|463632744|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
128818564|NCT05425420|463632758|FG000|Overall Study|Physician Decision|1|||
128818565|NCT05425420|463632758|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
128818566|NCT04428203|463632759|FG000|Overall Study|Adverse Event|1|||
128818567|NCT04428203|463632760|FG001|Overall Study|Adverse Event|0|||
128818568|NCT04428203|463632761|FG002|Overall Study|Adverse Event|0|||
128818569|NCT04428203|463632759|FG000|Overall Study|Withdrawal by Subject|1|||
128818570|NCT04428203|463632760|FG001|Overall Study|Withdrawal by Subject|0|||
128818571|NCT04428203|463632761|FG002|Overall Study|Withdrawal by Subject|1|||
128818572|NCT05280574|463632762|FG000|Overall Study|Withdrawal by Subject|0|||
128818573|NCT05280574|463632763|FG001|Overall Study|Withdrawal by Subject|2|||
128818574|NCT05280574|463632764|FG002|Overall Study|Withdrawal by Subject|0|||
128818575|NCT05237284|463632767|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
128818576|NCT05237284|463632768|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
128818577|NCT05237284|463632769|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
128818578|NCT05237284|463632770|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
128818579|NCT05237284|463632767|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
128818580|NCT05237284|463632768|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
128818581|NCT05237284|463632769|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
128818582|NCT05237284|463632770|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
128818583|NCT05237284|463632767|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
128818584|NCT05237284|463632768|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
128818585|NCT05237284|463632769|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
128818586|NCT05237284|463632770|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
128818587|NCT05237284|463632767|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
128818588|NCT05237284|463632768|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
128818589|NCT05237284|463632769|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
128818590|NCT05237284|463632770|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
128818591|NCT05237284|463632767|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
128818592|NCT05237284|463632768|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
128818593|NCT05237284|463632769|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
128818594|NCT05237284|463632770|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
128818595|NCT05237284|463632767|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
128818596|NCT05237284|463632768|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
128818597|NCT05237284|463632769|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
128818598|NCT05237284|463632770|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
128818599|NCT05237284|463632767|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
128818600|NCT05237284|463632768|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
128818601|NCT05237284|463632769|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
128818602|NCT05237284|463632770|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
128818603|NCT05237284|463632767|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
128818604|NCT05237284|463632768|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
128818605|NCT05237284|463632769|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
128818606|NCT05237284|463632770|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
128818607|NCT05237284|463632767|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
128818608|NCT05237284|463632768|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
128818609|NCT05237284|463632769|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
128818610|NCT05237284|463632770|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
128818611|NCT04056611|463632774|FG000|Overall Study|Physician Decision|1|||
128818612|NCT03733925|463632775|FG000|Overall Study|Lost to Follow-up|1|||
128818613|NCT03733925|463632775|FG000|Overall Study|Withdrawal by Subject|2|||
128818614|NCT03733925|463632775|FG000|Overall Study|Adverse Event|2|||
128818615|NCT03733925|463632775|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128818616|NCT02631746|463632776|FG000|Overall Study|Lack of Efficacy|3|||
128818617|NCT04571619|463632777|FG000|Phase 1|Death|22|||
128818618|NCT04571619|463632778|FG001|Phase 1|Death|18|||
128818619|NCT04571619|463632777|FG000|Phase 1|Withdrawal by Subject|7|||
128818620|NCT04571619|463632778|FG001|Phase 1|Withdrawal by Subject|2|||
128818621|NCT04571619|463632777|FG000|Phase 2|Death|13|||
128818622|NCT04571619|463632778|FG001|Phase 2|Death|16|||
128818623|NCT04571619|463632777|FG000|Phase 2|Withdrawal by Subject|6|||
128818624|NCT04571619|463632778|FG001|Phase 2|Withdrawal by Subject|4|||
128818625|NCT02224144|463632779|FG000|Overall Study|Lost to Follow-up|3|||
128818626|NCT02224144|463632780|FG001|Overall Study|Lost to Follow-up|1|||
128818627|NCT02224144|463632779|FG000|Overall Study|Death|2|||
128818628|NCT02224144|463632780|FG001|Overall Study|Death|0|||
128818629|NCT02224144|463632779|FG000|Overall Study|Withdrawal by Subject|0|||
128818630|NCT02224144|463632780|FG001|Overall Study|Withdrawal by Subject|1|||
128818631|NCT02780700|463632790|FG000|Overall Study|Progressive disease|1|||
128818632|NCT02834390|463632802|FG000|Induction Phase|Progressive disease|0|||
128818633|NCT02834390|463632803|FG001|Induction Phase|Progressive disease|1|||
128818634|NCT02834390|463632802|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
128818635|NCT02834390|463632803|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
128818636|NCT02834390|463632802|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
128818637|NCT02834390|463632803|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
128818638|NCT02834390|463632802|FG000|Consolidation Phase|Physician Decision|1|||
128818639|NCT02834390|463632803|FG001|Consolidation Phase|Physician Decision|1|||
128818640|NCT02998528|463632804|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
128818641|NCT02998528|463632805|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
128818642|NCT02998528|463632806|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
128818643|NCT02998528|463632804|FG000|Randomization Period|Participant withdrew consent|0|||
128818644|NCT02998528|463632805|FG001|Randomization Period|Participant withdrew consent|3|||
128818645|NCT02998528|463632806|FG002|Randomization Period|Participant withdrew consent|0|||
128818646|NCT02998528|463632804|FG000|Randomization Period|Participant no longer meets study criteria|1|||
128818647|NCT02998528|463632805|FG001|Randomization Period|Participant no longer meets study criteria|3|||
128818648|NCT02998528|463632806|FG002|Randomization Period|Participant no longer meets study criteria|2|||
128818649|NCT02998528|463632804|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
128818650|NCT02998528|463632805|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
128818651|NCT02998528|463632806|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
128818652|NCT02998528|463632804|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
128818653|NCT02998528|463632805|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
128818654|NCT02998528|463632806|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
128818655|NCT02998528|463632804|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
128818656|NCT02998528|463632805|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
128818657|NCT02998528|463632806|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
128818658|NCT02998528|463632804|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
128818659|NCT02998528|463632805|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
128818660|NCT02998528|463632806|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
128818661|NCT02998528|463632804|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
128818662|NCT02998528|463632805|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
128818663|NCT02998528|463632806|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
128818664|NCT02998528|463632804|FG000|Neoadjuvant Treatment Period|Death|1|||
128818665|NCT02998528|463632805|FG001|Neoadjuvant Treatment Period|Death|0|||
128818666|NCT02998528|463632806|FG002|Neoadjuvant Treatment Period|Death|0|||
128818667|NCT02998528|463632804|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
128818668|NCT02998528|463632805|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
128818669|NCT02998528|463632806|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
128818670|NCT02998528|463632804|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
128818671|NCT02998528|463632805|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
128818672|NCT02998528|463632806|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
128818673|NCT02998528|463632804|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
128818674|NCT02998528|463632805|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
128818675|NCT02998528|463632806|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
128818676|NCT02998528|463632804|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
128818677|NCT02998528|463632805|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
128818678|NCT02998528|463632806|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
128818679|NCT02998528|463632804|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
128818680|NCT02998528|463632805|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
128818681|NCT02998528|463632806|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
128818682|NCT02998528|463632804|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
128818683|NCT02998528|463632805|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
128818684|NCT02998528|463632806|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
128818685|NCT03213678|463632811|FG000|Overall Study|Death|1|||
128818686|NCT03213678|463632811|FG000|Overall Study|Physician Decision|1|||
128818687|NCT03213678|463632811|FG000|Overall Study|Progressive disease|16|||
128818688|NCT04218851|463632812|FG000|Overall Study|Death|1|||
128818689|NCT04218851|463632813|FG001|Overall Study|Death|3|||
128818690|NCT03174275|463632814|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
128818691|NCT03174275|463632814|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
128818692|NCT03174275|463632814|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
128818693|NCT03174275|463632814|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
128818694|NCT03174275|463632814|FG000|Adjuvant Chemotherapy|Progression|1|||
128818695|NCT03174275|463632814|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
128818696|NCT03174275|463632814|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
128818697|NCT03174275|463632814|FG000|Adjuvant Durvalumab|Progression|1|||
128818698|NCT03174275|463632814|FG000|Adjuvant Durvalumab|Adverse Event|3|||
128818699|NCT03174275|463632814|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
128818700|NCT03174275|463632814|FG000|Adjuvant Radiotherapy|Progression|1|||
128818701|NCT03174275|463632814|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
128818702|NCT04456296|463632815|FG000|Overall Study|Withdrawal by Subject|14|||
128818703|NCT04456296|463632816|FG001|Overall Study|Withdrawal by Subject|21|||
128818704|NCT04456296|463632817|FG002|Overall Study|Withdrawal by Subject|21|||
128818705|NCT04456296|463632815|FG000|Overall Study|Adverse Event|2|||
128818706|NCT04456296|463632816|FG001|Overall Study|Adverse Event|2|||
128818707|NCT04456296|463632817|FG002|Overall Study|Adverse Event|2|||
128818708|NCT04456296|463632815|FG000|Overall Study|Death|1|||
128818709|NCT04456296|463632816|FG001|Overall Study|Death|0|||
128818710|NCT04456296|463632817|FG002|Overall Study|Death|0|||
128818711|NCT04456296|463632815|FG000|Overall Study|Lost to Follow-up|3|||
128818712|NCT04456296|463632816|FG001|Overall Study|Lost to Follow-up|5|||
128818713|NCT04456296|463632817|FG002|Overall Study|Lost to Follow-up|6|||
128818714|NCT04456296|463632815|FG000|Overall Study|Other than specified|0|||
128818715|NCT04456296|463632816|FG001|Overall Study|Other than specified|1|||
128818716|NCT04456296|463632817|FG002|Overall Study|Other than specified|4|||
128818717|NCT04456296|463632815|FG000|Overall Study|Randomized, not treated|2|||
128818718|NCT04456296|463632816|FG001|Overall Study|Randomized, not treated|1|||
128818719|NCT04456296|463632817|FG002|Overall Study|Randomized, not treated|0|||
128818720|NCT04247802|463632818|FG000|Overall Study|Withdrawal by Subject|1|||
128818721|NCT04247802|463632819|FG001|Overall Study|Withdrawal by Subject|3|||
128818722|NCT04247802|463632818|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
128818723|NCT04247802|463632819|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
128818724|NCT04271046|463632820|FG000|Overall Study|Death|0|||
128818725|NCT04271046|463632821|FG001|Overall Study|Death|2|||
128818726|NCT04271046|463632822|FG002|Overall Study|Death|0|||
128818727|NCT04271046|463632823|FG003|Overall Study|Death|2|||
128818728|NCT04271046|463632820|FG000|Overall Study|Lost to Follow-up|12|||
128818729|NCT04271046|463632821|FG001|Overall Study|Lost to Follow-up|12|||
128818730|NCT04271046|463632822|FG002|Overall Study|Lost to Follow-up|11|||
128818731|NCT04271046|463632823|FG003|Overall Study|Lost to Follow-up|11|||
128818732|NCT04271046|463632820|FG000|Overall Study|Patient with Dementia Died|2|||
128818733|NCT04271046|463632821|FG001|Overall Study|Patient with Dementia Died|0|||
128818734|NCT04271046|463632822|FG002|Overall Study|Patient with Dementia Died|2|||
128818735|NCT04271046|463632823|FG003|Overall Study|Patient with Dementia Died|0|||
128818736|NCT04271046|463632820|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
128818737|NCT04271046|463632821|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
128818738|NCT04271046|463632822|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
128818739|NCT04271046|463632823|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
128818740|NCT04797858|463634912|FG000|Overall Study|Withdrawal by Subject|0|||
128818741|NCT04797858|463634913|FG001|Overall Study|Withdrawal by Subject|1|||
128818742|NCT04797858|463634912|FG000|Overall Study|Excluded due to administrative error|7|||
128818743|NCT04797858|463634913|FG001|Overall Study|Excluded due to administrative error|8|||
128818744|NCT03442309|463634920|FG000|Overall Study|Lost to Follow-up|1676|||
128818745|NCT03442309|463634921|FG001|Overall Study|Lost to Follow-up|1642|||
128818746|NCT04862416|463634922|FG000|Overall Study|Withdrawal by Subject|0|||
128818747|NCT04862416|463634923|FG001|Overall Study|Withdrawal by Subject|1|||
128818748|NCT04862416|463634924|FG002|Overall Study|Withdrawal by Subject|0|||
128818749|NCT04862416|463634925|FG003|Overall Study|Withdrawal by Subject|1|||
128818750|NCT04862416|463634926|FG004|Overall Study|Withdrawal by Subject|0|||
128818751|NCT04862416|463634927|FG005|Overall Study|Withdrawal by Subject|0|||
128818752|NCT04862416|463634928|FG006|Overall Study|Withdrawal by Subject|0|||
128818753|NCT04862416|463634929|FG007|Overall Study|Withdrawal by Subject|0|||
128818754|NCT03852550|463634930|FG000|Overall Study|Lost to Follow-up|4|||
128818755|NCT03852550|463634931|FG001|Overall Study|Lost to Follow-up|3|||
128818756|NCT03852550|463634930|FG000|Overall Study|Only parent outcomes completed|0|||
128818757|NCT03852550|463634931|FG001|Overall Study|Only parent outcomes completed|1|||
128818758|NCT03852550|463634930|FG000|Overall Study|Withdrawal by Subject|1|||
128818759|NCT03852550|463634931|FG001|Overall Study|Withdrawal by Subject|0|||
128818760|NCT05204654|463634932|FG000|Overall Study|Study terminated due to time restraint|2|||
128818761|NCT05204654|463634933|FG001|Overall Study|Study terminated due to time restraint|2|||
128818762|NCT05207956|463634944|FG000|Overall Study|Lost to follow up|1|||
128818763|NCT05207956|463634945|FG001|Overall Study|Lost to follow up|2|||
128818764|NCT02446236|463634946|FG000|Overall Study|Screen Failure|1|||
128818765|NCT02446236|463634947|FG001|Overall Study|Screen Failure|0|||
128818766|NCT02446236|463634948|FG002|Overall Study|Screen Failure|1|||
128818767|NCT02446236|463634946|FG000|Overall Study|Actively Receiving Therapy|0|||
128818768|NCT02446236|463634947|FG001|Overall Study|Actively Receiving Therapy|0|||
128818769|NCT02446236|463634948|FG002|Overall Study|Actively Receiving Therapy|1|||
128818770|NCT04862234|463634949|FG000|Overall Study|Surgery cancellation|1|||
128818771|NCT04862234|463634950|FG001|Overall Study|Surgery cancellation|2|||
128818772|NCT04862234|463634949|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
128818773|NCT04862234|463634950|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
128818774|NCT04862234|463634949|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
128818775|NCT04862234|463634950|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
128818776|NCT03292484|463634951|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
128818777|NCT03292484|463634951|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
128818778|NCT03292484|463634951|FG000|Overall Study|Protocol Violation|2|||
128818779|NCT03292484|463634951|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
128818780|NCT03292484|463634951|FG000|Overall Study|Sponsor decision|349|||
128818781|NCT03292484|463634951|FG000|Overall Study|Lost to Follow-up|7|||
128818782|NCT03292484|463634951|FG000|Overall Study|Coronavirus Disease 2019|1|||
128818783|NCT03292484|463634951|FG000|Overall Study|Other|20|||
128818784|NCT05290493|463634952|FG000|Overall Study|Withdrawal by Subject|2|||
128818785|NCT05290493|463634953|FG001|Overall Study|Withdrawal by Subject|2|||
128818786|NCT05290493|463634952|FG000|Overall Study|Adverse Event|1|||
128818787|NCT05290493|463634953|FG001|Overall Study|Adverse Event|0|||
128818788|NCT04615273|463634959|FG000|Overall Study|Withdrawal by Subject|3|||
128818789|NCT04615273|463634960|FG001|Overall Study|Withdrawal by Subject|1|||
128818790|NCT04615273|463634961|FG002|Overall Study|Withdrawal by Subject|2|||
128818791|NCT04615273|463634959|FG000|Overall Study|Adverse Event|1|||
128818792|NCT04615273|463634960|FG001|Overall Study|Adverse Event|0|||
128818793|NCT04615273|463634961|FG002|Overall Study|Adverse Event|1|||
128818794|NCT04615273|463634959|FG000|Overall Study|Lost to Follow-up|0|||
128818795|NCT04615273|463634960|FG001|Overall Study|Lost to Follow-up|1|||
128818796|NCT04615273|463634961|FG002|Overall Study|Lost to Follow-up|0|||
128818797|NCT04615273|463634959|FG000|Overall Study|Physician Decision|0|||
128818798|NCT04615273|463634960|FG001|Overall Study|Physician Decision|0|||
128818799|NCT04615273|463634961|FG002|Overall Study|Physician Decision|1|||
128818800|NCT04615273|463634959|FG000|Overall Study|Other|0|||
128818801|NCT04615273|463634960|FG001|Overall Study|Other|1|||
128818802|NCT04615273|463634961|FG002|Overall Study|Other|0|||
128818803|NCT04615273|463634959|FG000|Overall Study|Randomized but not treated|1|||
128818804|NCT04615273|463634960|FG001|Overall Study|Randomized but not treated|3|||
128818805|NCT04615273|463634961|FG002|Overall Study|Randomized but not treated|1|||
128818806|NCT03677141|463634965|FG000|Overall Study|Death|2|||
128818807|NCT03677141|463634966|FG001|Overall Study|Death|1|||
128818808|NCT03677141|463634967|FG002|Overall Study|Death|6|||
128818809|NCT03677141|463634968|FG003|Overall Study|Death|9|||
128818810|NCT03677141|463634969|FG004|Overall Study|Death|5|||
128818811|NCT03677141|463634970|FG005|Overall Study|Death|3|||
128818812|NCT03677141|463634965|FG000|Overall Study|Lost to Follow-up|0|||
128818813|NCT03677141|463634966|FG001|Overall Study|Lost to Follow-up|0|||
128818814|NCT03677141|463634967|FG002|Overall Study|Lost to Follow-up|0|||
128818815|NCT03677141|463634968|FG003|Overall Study|Lost to Follow-up|2|||
128818816|NCT03677141|463634969|FG004|Overall Study|Lost to Follow-up|0|||
128818817|NCT03677141|463634970|FG005|Overall Study|Lost to Follow-up|0|||
128818818|NCT03677141|463634965|FG000|Overall Study|Screen failure or enrolled in error|0|||
128818819|NCT03677141|463634966|FG001|Overall Study|Screen failure or enrolled in error|0|||
128818820|NCT03677141|463634967|FG002|Overall Study|Screen failure or enrolled in error|0|||
128818821|NCT03677141|463634968|FG003|Overall Study|Screen failure or enrolled in error|0|||
128818822|NCT03677141|463634969|FG004|Overall Study|Screen failure or enrolled in error|2|||
128818823|NCT03677141|463634970|FG005|Overall Study|Screen failure or enrolled in error|0|||
128818824|NCT03677141|463634965|FG000|Overall Study|Physician Decision|0|||
128818825|NCT03677141|463634966|FG001|Overall Study|Physician Decision|0|||
128818826|NCT03677141|463634967|FG002|Overall Study|Physician Decision|0|||
128818827|NCT03677141|463634968|FG003|Overall Study|Physician Decision|0|||
128818828|NCT03677141|463634969|FG004|Overall Study|Physician Decision|1|||
128818829|NCT03677141|463634970|FG005|Overall Study|Physician Decision|0|||
128818830|NCT03677141|463634965|FG000|Overall Study|Withdrawal by Subject|0|||
128818831|NCT03677141|463634966|FG001|Overall Study|Withdrawal by Subject|0|||
128818832|NCT03677141|463634967|FG002|Overall Study|Withdrawal by Subject|1|||
128818833|NCT03677141|463634968|FG003|Overall Study|Withdrawal by Subject|1|||
128818834|NCT03677141|463634969|FG004|Overall Study|Withdrawal by Subject|1|||
128818835|NCT03677141|463634970|FG005|Overall Study|Withdrawal by Subject|0|||
128818836|NCT05838027|463634980|FG000|Overall Study|Lost to Follow-up|5|||
128818837|NCT05838027|463634981|FG001|Overall Study|Lost to Follow-up|1|||
128818838|NCT05838027|463634980|FG000|Overall Study|Withdrawal by Subject|1|||
128818839|NCT05838027|463634981|FG001|Overall Study|Withdrawal by Subject|0|||
128818840|NCT04599634|463634982|FG000|Overall Study|Dose limiting toxicity|0|||
128818841|NCT04599634|463634983|FG001|Overall Study|Dose limiting toxicity|0|||
128818842|NCT04599634|463634984|FG002|Overall Study|Dose limiting toxicity|2|||
128818843|NCT04599634|463634985|FG003|Overall Study|Dose limiting toxicity|0|||
128818844|NCT03714815|463634986|FG000|Overall Study|Physician Decision|2|||
128818845|NCT03714815|463634986|FG000|Overall Study|Withdrawal by Subject|2|||
128818846|NCT03714815|463634986|FG000|Overall Study|Death|11|||
128818847|NCT03505008|463634988|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
128818848|NCT03505008|463634989|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
128818849|NCT03505008|463634990|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
128818850|NCT03505008|463634991|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
128818851|NCT03505008|463634988|FG000|Before Week 24 Randomization|Adverse Event|10|||
128818852|NCT03505008|463634989|FG001|Before Week 24 Randomization|Adverse Event|0|||
128818853|NCT03505008|463634990|FG002|Before Week 24 Randomization|Adverse Event|0|||
128818854|NCT03505008|463634991|FG003|Before Week 24 Randomization|Adverse Event|0|||
128818855|NCT03505008|463634988|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
128818856|NCT03505008|463634989|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
128818857|NCT03505008|463634990|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
128818858|NCT03505008|463634991|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
128818859|NCT03505008|463634988|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
128818860|NCT03505008|463634989|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
128818861|NCT03505008|463634990|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
128818862|NCT03505008|463634991|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
128818863|NCT03505008|463634988|FG000|Before Week 24 Randomization|Physician Decision|2|||
128818864|NCT03505008|463634989|FG001|Before Week 24 Randomization|Physician Decision|0|||
128818865|NCT03505008|463634990|FG002|Before Week 24 Randomization|Physician Decision|0|||
128818866|NCT03505008|463634991|FG003|Before Week 24 Randomization|Physician Decision|0|||
128818867|NCT03505008|463634988|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
128818868|NCT03505008|463634989|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
128818869|NCT03505008|463634990|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
128818870|NCT03505008|463634991|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
128818871|NCT03505008|463634988|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
128818872|NCT03505008|463634989|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
128818873|NCT03505008|463634990|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
128818874|NCT03505008|463634991|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
128818875|NCT03505008|463634988|FG000|Before Week 24 Randomization|Complication|1|||
128818876|NCT03505008|463634989|FG001|Before Week 24 Randomization|Complication|0|||
128818877|NCT03505008|463634990|FG002|Before Week 24 Randomization|Complication|0|||
128818878|NCT03505008|463634991|FG003|Before Week 24 Randomization|Complication|0|||
128818879|NCT03505008|463634988|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
128818880|NCT03505008|463634989|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
128818881|NCT03505008|463634990|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
128818882|NCT03505008|463634991|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
128818883|NCT03505008|463634988|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
128818884|NCT03505008|463634989|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
128818885|NCT03505008|463634990|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
128818886|NCT03505008|463634991|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
128818887|NCT03505008|463634988|FG000|After Week 24 Randomization|Adverse Event|0|||
128818888|NCT03505008|463634989|FG001|After Week 24 Randomization|Adverse Event|1|||
128818889|NCT03505008|463634990|FG002|After Week 24 Randomization|Adverse Event|2|||
128818890|NCT03505008|463634991|FG003|After Week 24 Randomization|Adverse Event|2|||
128818891|NCT03505008|463634988|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
128818892|NCT03505008|463634989|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
128818893|NCT03505008|463634990|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
128818894|NCT03505008|463634991|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
128818895|NCT03505008|463634988|FG000|After Week 24 Randomization|Protocol Violation|0|||
128818896|NCT03505008|463634989|FG001|After Week 24 Randomization|Protocol Violation|0|||
128818897|NCT03505008|463634990|FG002|After Week 24 Randomization|Protocol Violation|1|||
128818898|NCT03505008|463634991|FG003|After Week 24 Randomization|Protocol Violation|0|||
128818899|NCT02962076|463634994|FG000|Overall Study|MHED tracer not available|5|||
128818900|NCT02962076|463634994|FG000|Overall Study|Protocol Violation|1|||
128818901|NCT02962076|463634994|FG000|Overall Study|Physician Decision|1|||
128818902|NCT04741776|463634995|FG000|Overall Study|Withdrawal by Subject|7|||
128818903|NCT04741776|463634996|FG001|Overall Study|Withdrawal by Subject|10|||
128818904|NCT04741776|463634997|FG002|Overall Study|Withdrawal by Subject|10|||
128818905|NCT04741776|463634998|FG003|Overall Study|Withdrawal by Subject|17|||
128818906|NCT04741776|463634995|FG000|Overall Study|Death|0|||
128818907|NCT04741776|463634996|FG001|Overall Study|Death|0|||
128818908|NCT04741776|463634997|FG002|Overall Study|Death|1|||
128818909|NCT04741776|463634998|FG003|Overall Study|Death|0|||
128818910|NCT04089865|463634999|FG000|Overall Study|Withdrawal by Subject|2|||
128818911|NCT04089865|463635000|FG001|Overall Study|Withdrawal by Subject|2|||
128818912|NCT04089865|463635001|FG002|Overall Study|Withdrawal by Subject|7|||
128818913|NCT04089865|463635002|FG003|Overall Study|Withdrawal by Subject|2|||
128818914|NCT03824366|463635008|FG000|Overall Study|Death|1|||
128818915|NCT03824366|463635008|FG000|Overall Study|Previously unidentified metal artifact|1|||
128818916|NCT03824366|463635008|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
128818917|NCT03824366|463635008|FG000|Overall Study|Withdrawal by Subject|1|||
128818918|NCT05069896|463635009|FG000|Overall Study|Adverse Event|0|||
128818919|NCT05069896|463635010|FG001|Overall Study|Adverse Event|1|||
128818920|NCT05069896|463635011|FG002|Overall Study|Adverse Event|1|||
128818921|NCT05069896|463635012|FG003|Overall Study|Adverse Event|0|||
128818922|NCT05069896|463635013|FG004|Overall Study|Adverse Event|0|||
128818923|NCT05069896|463635014|FG005|Overall Study|Adverse Event|0|||
128818924|NCT05069896|463635009|FG000|Overall Study|Lost to Follow-up|0|||
128818925|NCT05069896|463635010|FG001|Overall Study|Lost to Follow-up|0|||
128818926|NCT05069896|463635011|FG002|Overall Study|Lost to Follow-up|1|||
128818927|NCT05069896|463635012|FG003|Overall Study|Lost to Follow-up|0|||
128818928|NCT05069896|463635013|FG004|Overall Study|Lost to Follow-up|1|||
128818929|NCT05069896|463635014|FG005|Overall Study|Lost to Follow-up|2|||
128818930|NCT04068831|463635015|FG000|Overall Study|Disease Progression|10|||
128818931|NCT04068831|463635016|FG001|Overall Study|Disease Progression|8|||
128818932|NCT04820322|463635017|FG000|Overall Study|Adverse Event|1|||
128818933|NCT04820322|463635018|FG001|Overall Study|Adverse Event|0|||
128818934|NCT00323856|463635019|FG000|Overall Study|Withdrawal by Subject|1|||
128818935|NCT00323856|463635019|FG000|Overall Study|Was uncooperative and noncompliant|1|||
128818936|NCT00323856|463635019|FG000|Overall Study|Reason not specified|1|||
128818937|NCT00323856|463635019|FG000|Overall Study|Missing|2|||
128818938|NCT03156465|463635020|FG000|Overall Study|Withdrawal by Subject|2|||
128818939|NCT04086121|463635030|FG000|Overall Study|Other than listed|8|||
128818940|NCT04086121|463635030|FG000|Overall Study|Withdrawal by Subject|3|||
128818941|NCT04086121|463635030|FG000|Overall Study|Lost to Follow-up|2|||
128818942|NCT04086121|463635030|FG000|Overall Study|Adverse Event|1|||
128818943|NCT04580914|463635033|FG000|Overall Study|Withdrawal by Subject|6|||
128818944|NCT04580914|463635033|FG000|Overall Study|Lost to Follow-up|2|||
128818945|NCT03580356|463635035|FG000|Treatment Period|Withdrawal by Subject|13|||
128818946|NCT03580356|463635036|FG001|Treatment Period|Withdrawal by Subject|0|||
128818947|NCT03580356|463635037|FG002|Treatment Period|Withdrawal by Subject|13|||
128818948|NCT03580356|463635038|FG003|Treatment Period|Withdrawal by Subject|1|||
128818949|NCT03580356|463635039|FG004|Treatment Period|Withdrawal by Subject|17|||
128818950|NCT03580356|463635040|FG005|Treatment Period|Withdrawal by Subject|0|||
128818951|NCT03580356|463635041|FG006|Treatment Period|Withdrawal by Subject|5|||
128818952|NCT03580356|463635042|FG007|Treatment Period|Withdrawal by Subject|0|||
128818953|NCT03580356|463635035|FG000|Treatment Period|Adverse Event|10|||
128818954|NCT03580356|463635036|FG001|Treatment Period|Adverse Event|0|||
128818955|NCT03580356|463635037|FG002|Treatment Period|Adverse Event|13|||
128818956|NCT03580356|463635038|FG003|Treatment Period|Adverse Event|0|||
128818957|NCT03580356|463635039|FG004|Treatment Period|Adverse Event|5|||
128818958|NCT03580356|463635040|FG005|Treatment Period|Adverse Event|0|||
128818959|NCT03580356|463635041|FG006|Treatment Period|Adverse Event|8|||
128818960|NCT03580356|463635042|FG007|Treatment Period|Adverse Event|0|||
128818961|NCT03580356|463635035|FG000|Treatment Period|Protocol Violation|5|||
128818962|NCT03580356|463635036|FG001|Treatment Period|Protocol Violation|0|||
128818963|NCT03580356|463635037|FG002|Treatment Period|Protocol Violation|6|||
128818964|NCT03580356|463635038|FG003|Treatment Period|Protocol Violation|1|||
128818965|NCT03580356|463635039|FG004|Treatment Period|Protocol Violation|9|||
128818966|NCT03580356|463635040|FG005|Treatment Period|Protocol Violation|1|||
128818967|NCT03580356|463635041|FG006|Treatment Period|Protocol Violation|1|||
128818968|NCT03580356|463635042|FG007|Treatment Period|Protocol Violation|0|||
128818969|NCT03580356|463635035|FG000|Treatment Period|Lack of Efficacy|6|||
128818970|NCT03580356|463635036|FG001|Treatment Period|Lack of Efficacy|0|||
128818971|NCT03580356|463635037|FG002|Treatment Period|Lack of Efficacy|2|||
128818972|NCT03580356|463635038|FG003|Treatment Period|Lack of Efficacy|0|||
128818973|NCT03580356|463635039|FG004|Treatment Period|Lack of Efficacy|3|||
128818974|NCT03580356|463635040|FG005|Treatment Period|Lack of Efficacy|0|||
128818975|NCT03580356|463635041|FG006|Treatment Period|Lack of Efficacy|3|||
128818976|NCT03580356|463635042|FG007|Treatment Period|Lack of Efficacy|0|||
128818977|NCT03580356|463635035|FG000|Treatment Period|Pregnancy|1|||
128818978|NCT03580356|463635036|FG001|Treatment Period|Pregnancy|0|||
128818979|NCT03580356|463635037|FG002|Treatment Period|Pregnancy|7|||
128818980|NCT03580356|463635038|FG003|Treatment Period|Pregnancy|0|||
128818981|NCT03580356|463635039|FG004|Treatment Period|Pregnancy|2|||
128818982|NCT03580356|463635040|FG005|Treatment Period|Pregnancy|0|||
128818983|NCT03580356|463635041|FG006|Treatment Period|Pregnancy|1|||
128818984|NCT03580356|463635042|FG007|Treatment Period|Pregnancy|0|||
128818985|NCT03580356|463635035|FG000|Treatment Period|Physician Decision|2|||
128818986|NCT03580356|463635036|FG001|Treatment Period|Physician Decision|0|||
128818987|NCT03580356|463635037|FG002|Treatment Period|Physician Decision|1|||
128818988|NCT03580356|463635038|FG003|Treatment Period|Physician Decision|0|||
128818989|NCT03580356|463635039|FG004|Treatment Period|Physician Decision|4|||
128818990|NCT03580356|463635040|FG005|Treatment Period|Physician Decision|0|||
128818991|NCT03580356|463635041|FG006|Treatment Period|Physician Decision|2|||
128818992|NCT03580356|463635042|FG007|Treatment Period|Physician Decision|0|||
128818993|NCT03580356|463635035|FG000|Treatment Period|Lost to Follow-up|1|||
128818994|NCT03580356|463635036|FG001|Treatment Period|Lost to Follow-up|1|||
128818995|NCT03580356|463635037|FG002|Treatment Period|Lost to Follow-up|1|||
128818996|NCT03580356|463635038|FG003|Treatment Period|Lost to Follow-up|0|||
128818997|NCT03580356|463635039|FG004|Treatment Period|Lost to Follow-up|3|||
128818998|NCT03580356|463635040|FG005|Treatment Period|Lost to Follow-up|0|||
128818999|NCT03580356|463635041|FG006|Treatment Period|Lost to Follow-up|1|||
128819000|NCT03580356|463635042|FG007|Treatment Period|Lost to Follow-up|0|||
128819001|NCT03580356|463635035|FG000|Treatment Period|Death|0|||
128819002|NCT03580356|463635036|FG001|Treatment Period|Death|0|||
128819003|NCT03580356|463635037|FG002|Treatment Period|Death|1|||
128819004|NCT03580356|463635038|FG003|Treatment Period|Death|0|||
128819005|NCT03580356|463635039|FG004|Treatment Period|Death|0|||
128819006|NCT03580356|463635040|FG005|Treatment Period|Death|0|||
128819007|NCT03580356|463635041|FG006|Treatment Period|Death|0|||
128819008|NCT03580356|463635042|FG007|Treatment Period|Death|0|||
128819009|NCT03580356|463635035|FG000|Treatment Period|Technical problems|0|||
128819010|NCT03580356|463635036|FG001|Treatment Period|Technical problems|0|||
128819011|NCT03580356|463635037|FG002|Treatment Period|Technical problems|0|||
128819012|NCT03580356|463635038|FG003|Treatment Period|Technical problems|0|||
128819013|NCT03580356|463635039|FG004|Treatment Period|Technical problems|1|||
128819014|NCT03580356|463635040|FG005|Treatment Period|Technical problems|0|||
128819015|NCT03580356|463635041|FG006|Treatment Period|Technical problems|0|||
128819016|NCT03580356|463635042|FG007|Treatment Period|Technical problems|0|||
128819017|NCT03580356|463635035|FG000|Treatment Period|Misrandomized, no treatment|0|||
128819018|NCT03580356|463635036|FG001|Treatment Period|Misrandomized, no treatment|0|||
128819019|NCT03580356|463635037|FG002|Treatment Period|Misrandomized, no treatment|1|||
128819020|NCT03580356|463635038|FG003|Treatment Period|Misrandomized, no treatment|0|||
128819021|NCT03580356|463635039|FG004|Treatment Period|Misrandomized, no treatment|2|||
128819022|NCT03580356|463635040|FG005|Treatment Period|Misrandomized, no treatment|0|||
128819023|NCT03580356|463635041|FG006|Treatment Period|Misrandomized, no treatment|0|||
128819024|NCT03580356|463635042|FG007|Treatment Period|Misrandomized, no treatment|0|||
128819025|NCT03580356|463635035|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
128819026|NCT03580356|463635036|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
128819027|NCT03580356|463635037|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
128819028|NCT03580356|463635038|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
128819029|NCT03580356|463635039|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
128819030|NCT03580356|463635040|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
128819031|NCT03580356|463635041|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
128819032|NCT03580356|463635042|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
128819033|NCT03580356|463635035|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
128819034|NCT03580356|463635036|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
128819035|NCT03580356|463635037|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
128819036|NCT03580356|463635038|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
128819037|NCT03580356|463635039|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
128819038|NCT03580356|463635040|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
128819039|NCT03580356|463635041|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
128819040|NCT03580356|463635042|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
128819041|NCT03580356|463635035|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
128819042|NCT03580356|463635036|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
128819043|NCT03580356|463635037|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
128819044|NCT03580356|463635038|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
128819045|NCT03580356|463635039|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
128819046|NCT03580356|463635040|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
128819047|NCT03580356|463635041|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
128819048|NCT03580356|463635042|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
128819049|NCT03580356|463635035|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
128819050|NCT03580356|463635036|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
128819051|NCT03580356|463635037|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
128819052|NCT03580356|463635038|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
128819053|NCT03580356|463635039|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
128819054|NCT03580356|463635040|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
128819055|NCT03580356|463635041|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
128819056|NCT03580356|463635042|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
128819057|NCT03580356|463635035|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
128819058|NCT03580356|463635036|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
128819059|NCT03580356|463635037|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
128819060|NCT03580356|463635038|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
128819061|NCT03580356|463635039|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
128819062|NCT03580356|463635040|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
128819063|NCT03580356|463635041|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
128819064|NCT03580356|463635042|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
128819065|NCT03580356|463635035|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
128819066|NCT03580356|463635036|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
128819067|NCT03580356|463635037|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
128819068|NCT03580356|463635038|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
128819069|NCT03580356|463635039|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
128819070|NCT03580356|463635040|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
128819071|NCT03580356|463635041|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
128819072|NCT03580356|463635042|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
128819073|NCT03580356|463635035|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
128819074|NCT03580356|463635036|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
128819075|NCT03580356|463635037|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
128819076|NCT03580356|463635038|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
128819077|NCT03580356|463635039|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
128819078|NCT03580356|463635040|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
128819079|NCT03580356|463635041|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
128819080|NCT03580356|463635042|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
128819081|NCT05715528|463635043|FG000|Overall Study|Randomized but never treated|11|||
128819082|NCT05715528|463635044|FG001|Overall Study|Randomized but never treated|13|||
128819083|NCT05715528|463635043|FG000|Overall Study|Withdrew consent|7|||
128819084|NCT05715528|463635044|FG001|Overall Study|Withdrew consent|15|||
128819085|NCT05715528|463635043|FG000|Overall Study|Lost to Follow-up|5|||
128819086|NCT05715528|463635044|FG001|Overall Study|Lost to Follow-up|13|||
128819087|NCT05715528|463635043|FG000|Overall Study|Investigator's discretion|3|||
128819088|NCT05715528|463635044|FG001|Overall Study|Investigator's discretion|1|||
128819089|NCT05715528|463635043|FG000|Overall Study|Protocol Violation|2|||
128819090|NCT05715528|463635044|FG001|Overall Study|Protocol Violation|0|||
128819091|NCT05715528|463635043|FG000|Overall Study|Non-compliance with study drug|0|||
128819092|NCT05715528|463635044|FG001|Overall Study|Non-compliance with study drug|1|||
128819093|NCT03118518|463635045|FG000|Overall Study|Early Exit after treatment|2|||
128819094|NCT03118518|463635046|FG001|Overall Study|Early Exit after treatment|8|||
128819095|NCT03118518|463635045|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
128819096|NCT03118518|463635046|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
128819097|NCT03536884|463635052|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
128819098|NCT03536884|463635053|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
128819099|NCT03536884|463635054|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819100|NCT03536884|463635055|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819101|NCT03536884|463635056|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819102|NCT03536884|463635057|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819103|NCT03536884|463635058|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819104|NCT03536884|463635059|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819105|NCT03536884|463635060|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128759353|NCT01662063|463408865|FG002|Overall Study|Lack of Efficacy|0|||
128759354|NCT01662063|463408863|FG000|Overall Study|Lost to Follow-up|0|||
128759355|NCT01662063|463408864|FG001|Overall Study|Lost to Follow-up|4|||
128759356|NCT01662063|463408865|FG002|Overall Study|Lost to Follow-up|0|||
128759357|NCT01662063|463408863|FG000|Overall Study|Protocol Violation|1|||
128759358|NCT01662063|463408864|FG001|Overall Study|Protocol Violation|0|||
128759359|NCT01662063|463408865|FG002|Overall Study|Protocol Violation|0|||
128759360|NCT01662063|463408863|FG000|Overall Study|Withdrawal by Subject|2|||
128759361|NCT01662063|463408864|FG001|Overall Study|Withdrawal by Subject|4|||
128759362|NCT01662063|463408865|FG002|Overall Study|Withdrawal by Subject|1|||
128759363|NCT01662063|463408863|FG000|Overall Study|Physician Decision|0|||
128759364|NCT01662063|463408864|FG001|Overall Study|Physician Decision|2|||
128759365|NCT01662063|463408865|FG002|Overall Study|Physician Decision|0|||
128759366|NCT01662063|463408863|FG000|Overall Study|Other|0|||
128759367|NCT01662063|463408864|FG001|Overall Study|Other|1|||
128759368|NCT01662063|463408865|FG002|Overall Study|Other|0|||
128759369|NCT00106184|463408867|FG000|Overall Study|Withdrawal by Subject|3|||
128759370|NCT00106184|463408868|FG001|Overall Study|Withdrawal by Subject|2|||
128759371|NCT02313909|463408869|FG000|Overall Study|Consent withdrawn by participant|33|||
128759372|NCT02313909|463408870|FG001|Overall Study|Consent withdrawn by participant|33|||
128759373|NCT02313909|463408869|FG000|Overall Study|Lost to Follow-up|24|||
128759374|NCT02313909|463408870|FG001|Overall Study|Lost to Follow-up|17|||
128759375|NCT00948974|463408876|FG000|Overall Study|Lost to Follow-up|23|||
128759376|NCT00948974|463408877|FG001|Overall Study|Lost to Follow-up|20|||
128759377|NCT00409682|463408885|FG000|Open-label Induction Period|Adverse Event|1|||
128759378|NCT00409682|463408886|FG001|Open-label Induction Period|Adverse Event|0|||
128759379|NCT00409682|463408887|FG002|Open-label Induction Period|Adverse Event|0|||
128759380|NCT00409682|463408885|FG000|Open-label Induction Period|Lack of Efficacy|1|||
128759381|NCT00409682|463408886|FG001|Open-label Induction Period|Lack of Efficacy|0|||
128759382|NCT00409682|463408887|FG002|Open-label Induction Period|Lack of Efficacy|0|||
128759383|NCT00409682|463408885|FG000|Open-label Induction Period|Protocol Violation|1|||
128759384|NCT00409682|463408886|FG001|Open-label Induction Period|Protocol Violation|0|||
128759385|NCT00409682|463408887|FG002|Open-label Induction Period|Protocol Violation|0|||
128759386|NCT00409682|463408885|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
128759387|NCT00409682|463408886|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
128759388|NCT00409682|463408887|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
128759389|NCT00409682|463408885|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
128759390|NCT00409682|463408886|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
128759391|NCT00409682|463408887|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
128759392|NCT00409682|463408885|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
128759393|NCT00409682|463408886|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
128759394|NCT00409682|463408887|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
128759395|NCT00409682|463408885|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
128759396|NCT00409682|463408886|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
128759397|NCT00409682|463408887|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
128759398|NCT00409682|463408885|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
128759399|NCT00409682|463408886|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
128759400|NCT00409682|463408887|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
128759401|NCT00409682|463408885|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
128759402|NCT00409682|463408886|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
128759403|NCT00409682|463408887|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
128759404|NCT00409682|463408885|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
128759405|NCT00409682|463408886|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
128759406|NCT00409682|463408887|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
128759407|NCT01896869|463408890|FG000|Overall Study|Withdrawal by Subject|0|||
128759408|NCT01896869|463408891|FG001|Overall Study|Withdrawal by Subject|6|||
128759409|NCT01896869|463408890|FG000|Overall Study|Lost to Follow-up|1|||
128759410|NCT01896869|463408891|FG001|Overall Study|Lost to Follow-up|0|||
128759411|NCT00118716|463408892|FG000|Overall Study|Adverse Event|2|||
128759412|NCT00118716|463408893|FG001|Overall Study|Adverse Event|7|||
128759413|NCT00118716|463408892|FG000|Overall Study|Protocol Violation|5|||
128759414|NCT00118716|463408893|FG001|Overall Study|Protocol Violation|4|||
128759415|NCT00118716|463408892|FG000|Overall Study|Withdrawal by Subject|0|||
128759416|NCT00118716|463408893|FG001|Overall Study|Withdrawal by Subject|1|||
128759417|NCT00118716|463408892|FG000|Overall Study|Exacerbation|2|||
128759418|NCT00118716|463408893|FG001|Overall Study|Exacerbation|2|||
128759419|NCT00118716|463408892|FG000|Overall Study|Discontinued by sponsor|1|||
128759420|NCT00118716|463408893|FG001|Overall Study|Discontinued by sponsor|1|||
128759421|NCT00118716|463408892|FG000|Overall Study|Non-compliance|1|||
128819106|NCT03536884|463635061|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819107|NCT03536884|463635062|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819108|NCT03536884|463635063|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
128819109|NCT03536884|463635052|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819110|NCT03536884|463635053|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
128819111|NCT03536884|463635054|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819112|NCT03536884|463635055|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819113|NCT03536884|463635056|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819114|NCT03536884|463635057|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819115|NCT03536884|463635058|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819116|NCT03536884|463635059|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819117|NCT03536884|463635060|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819118|NCT03536884|463635061|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819119|NCT03536884|463635062|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819120|NCT03536884|463635063|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
128819121|NCT03536884|463635052|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
128819122|NCT03536884|463635053|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
128819123|NCT03536884|463635054|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819124|NCT03536884|463635055|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819125|NCT03536884|463635056|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819126|NCT03536884|463635057|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819127|NCT03536884|463635058|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819128|NCT03536884|463635059|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819129|NCT03536884|463635060|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819130|NCT03536884|463635061|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819131|NCT03536884|463635062|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819132|NCT03536884|463635063|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
128819133|NCT03536884|463635052|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819134|NCT03536884|463635053|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
128819135|NCT03536884|463635054|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819136|NCT03536884|463635055|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819137|NCT03536884|463635056|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819138|NCT03536884|463635057|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819139|NCT03536884|463635058|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819140|NCT03536884|463635059|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819141|NCT03536884|463635060|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819142|NCT03536884|463635061|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819143|NCT03536884|463635062|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819144|NCT03536884|463635063|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
128819145|NCT03536884|463635052|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819146|NCT03536884|463635053|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
128819147|NCT03536884|463635054|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819148|NCT03536884|463635055|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819149|NCT03536884|463635056|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819150|NCT03536884|463635057|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819151|NCT03536884|463635058|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819152|NCT03536884|463635059|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819153|NCT03536884|463635060|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819154|NCT03536884|463635061|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819155|NCT03536884|463635062|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819156|NCT03536884|463635063|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
128819157|NCT03536884|463635052|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819158|NCT03536884|463635053|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
128819159|NCT03536884|463635054|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819160|NCT03536884|463635055|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819161|NCT03536884|463635056|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819162|NCT03536884|463635057|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819163|NCT03536884|463635058|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819164|NCT03536884|463635059|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819165|NCT03536884|463635060|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819166|NCT03536884|463635061|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819167|NCT03536884|463635062|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819168|NCT03536884|463635063|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
128819169|NCT03536884|463635052|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819170|NCT03536884|463635053|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819171|NCT03536884|463635054|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
128819172|NCT03536884|463635055|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819173|NCT03536884|463635056|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
128819174|NCT03536884|463635057|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819175|NCT03536884|463635058|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819176|NCT03536884|463635059|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819177|NCT03536884|463635060|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819178|NCT03536884|463635061|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819179|NCT03536884|463635062|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819180|NCT03536884|463635063|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
128819181|NCT03536884|463635052|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819182|NCT03536884|463635053|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819183|NCT03536884|463635054|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
128819184|NCT03536884|463635055|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
128819185|NCT03536884|463635056|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
128819186|NCT03536884|463635057|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819187|NCT03536884|463635058|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819188|NCT03536884|463635059|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819189|NCT03536884|463635060|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819190|NCT03536884|463635061|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819191|NCT03536884|463635062|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819192|NCT03536884|463635063|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
128819193|NCT03536884|463635052|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819194|NCT03536884|463635053|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819195|NCT03536884|463635054|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819196|NCT03536884|463635055|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
128819197|NCT03536884|463635056|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
128819198|NCT03536884|463635057|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819199|NCT03536884|463635058|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819200|NCT03536884|463635059|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819201|NCT03536884|463635060|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819202|NCT03536884|463635061|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819203|NCT03536884|463635062|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819204|NCT03536884|463635063|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
128819205|NCT03536884|463635052|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819206|NCT03536884|463635053|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819207|NCT03536884|463635054|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
128819208|NCT03536884|463635055|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
128819209|NCT03536884|463635056|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
128819210|NCT03536884|463635057|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819211|NCT03536884|463635058|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819212|NCT03536884|463635059|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819213|NCT03536884|463635060|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819214|NCT03536884|463635061|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819215|NCT03536884|463635062|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819216|NCT03536884|463635063|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
128819217|NCT03536884|463635052|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819218|NCT03536884|463635053|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819219|NCT03536884|463635054|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
128819220|NCT03536884|463635055|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
128819221|NCT03536884|463635056|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
128819222|NCT03536884|463635057|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819223|NCT03536884|463635058|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819224|NCT03536884|463635059|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819225|NCT03536884|463635060|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819226|NCT03536884|463635061|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819227|NCT03536884|463635062|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819228|NCT03536884|463635063|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
128819229|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819230|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819231|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819232|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819233|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819234|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
128819235|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
128819236|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
128819237|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
128819238|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819239|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819240|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
128819241|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819242|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819243|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819244|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819245|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819246|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
128819247|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
128819248|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
128819249|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
128819250|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819251|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819252|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
128819253|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819254|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819255|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819256|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819257|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819258|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
128819259|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819260|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
128819261|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819262|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819263|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819264|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
128819265|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819266|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819267|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819268|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819269|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819270|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
128819271|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819272|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
128819273|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
128819274|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819275|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819276|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
128819277|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819278|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819279|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819280|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819281|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819282|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
128819283|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
128819284|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
128819285|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
128819286|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819287|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819288|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
128819289|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819290|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819291|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819292|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819293|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819294|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
128819295|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819296|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819297|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819298|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819299|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819300|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
128819301|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819302|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819303|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819304|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819305|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819306|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819307|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
128819308|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819309|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819310|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819311|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819312|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
128819313|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819314|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819315|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819316|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819317|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819318|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819319|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
128819320|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819321|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819322|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819323|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819324|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
128819325|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819326|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819327|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819328|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819329|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819330|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
128819331|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819332|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819333|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819334|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819335|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819336|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
128819337|NCT03536884|463635052|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819338|NCT03536884|463635053|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819339|NCT03536884|463635054|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819340|NCT03536884|463635055|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819341|NCT03536884|463635056|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819342|NCT03536884|463635057|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819343|NCT03536884|463635058|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819344|NCT03536884|463635059|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819345|NCT03536884|463635060|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
128819346|NCT03536884|463635061|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819347|NCT03536884|463635062|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819348|NCT03536884|463635063|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
128819349|NCT03536884|463635052|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819350|NCT03536884|463635053|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819351|NCT03536884|463635054|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819352|NCT03536884|463635055|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819353|NCT03536884|463635056|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819354|NCT03536884|463635057|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819355|NCT03536884|463635058|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819356|NCT03536884|463635059|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819357|NCT03536884|463635060|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
128819358|NCT03536884|463635061|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
128819359|NCT03536884|463635062|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
128819360|NCT03536884|463635063|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
128819361|NCT03536884|463635052|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819362|NCT03536884|463635053|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819363|NCT03536884|463635054|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819364|NCT03536884|463635055|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819365|NCT03536884|463635056|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819366|NCT03536884|463635057|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819367|NCT03536884|463635058|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819368|NCT03536884|463635059|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819369|NCT03536884|463635060|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
128819370|NCT03536884|463635061|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
128819371|NCT03536884|463635062|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
128819372|NCT03536884|463635063|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
128819373|NCT03536884|463635052|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819374|NCT03536884|463635053|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819375|NCT03536884|463635054|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819376|NCT03536884|463635055|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819377|NCT03536884|463635056|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819378|NCT03536884|463635057|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819379|NCT03536884|463635058|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819380|NCT03536884|463635059|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819381|NCT03536884|463635060|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819382|NCT03536884|463635061|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819383|NCT03536884|463635062|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
128819384|NCT03536884|463635063|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
128819385|NCT03536884|463635052|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819386|NCT03536884|463635053|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819387|NCT03536884|463635054|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819388|NCT03536884|463635055|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819389|NCT03536884|463635056|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819390|NCT03536884|463635057|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819391|NCT03536884|463635058|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819392|NCT03536884|463635059|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819393|NCT03536884|463635060|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819394|NCT03536884|463635061|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819395|NCT03536884|463635062|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
128819396|NCT03536884|463635063|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
128819397|NCT03536884|463635052|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819398|NCT03536884|463635053|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819399|NCT03536884|463635054|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819400|NCT03536884|463635055|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819401|NCT03536884|463635056|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819402|NCT03536884|463635057|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819403|NCT03536884|463635058|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819404|NCT03536884|463635059|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819405|NCT03536884|463635060|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819406|NCT03536884|463635061|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819407|NCT03536884|463635062|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
128819408|NCT03536884|463635063|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
128819409|NCT03485729|463635070|FG000|Overall Study|Withdrawal by Subject|0|||
128819410|NCT03485729|463635071|FG001|Overall Study|Withdrawal by Subject|0|||
128819411|NCT03485729|463635072|FG002|Overall Study|Withdrawal by Subject|1|||
128819412|NCT03485729|463635070|FG000|Overall Study|Disease progression|8|||
128819413|NCT03485729|463635071|FG001|Overall Study|Disease progression|13|||
128819414|NCT03485729|463635072|FG002|Overall Study|Disease progression|1|||
128819415|NCT03485729|463635070|FG000|Overall Study|Hospice care|1|||
128819416|NCT03485729|463635071|FG001|Overall Study|Hospice care|0|||
128819417|NCT03485729|463635072|FG002|Overall Study|Hospice care|0|||
128819418|NCT03485729|463635070|FG000|Overall Study|Poor performance status|1|||
128819419|NCT03485729|463635071|FG001|Overall Study|Poor performance status|0|||
128819420|NCT03485729|463635072|FG002|Overall Study|Poor performance status|0|||
128819421|NCT03485729|463635070|FG000|Overall Study|Illness|0|||
128819422|NCT03485729|463635071|FG001|Overall Study|Illness|1|||
128819423|NCT03485729|463635072|FG002|Overall Study|Illness|0|||
128819424|NCT05035654|463635074|FG000|Overall Study|Physician Decision|0|||
128819425|NCT05035654|463635075|FG001|Overall Study|Physician Decision|1|||
128819426|NCT05035654|463635076|FG002|Overall Study|Physician Decision|0|||
128819427|NCT05035654|463635074|FG000|Overall Study|Adverse Event|0|||
128819428|NCT05035654|463635075|FG001|Overall Study|Adverse Event|1|||
128819429|NCT05035654|463635076|FG002|Overall Study|Adverse Event|0|||
128819430|NCT05035654|463635074|FG000|Overall Study|Withdrawal by Subject|0|||
128819431|NCT05035654|463635075|FG001|Overall Study|Withdrawal by Subject|0|||
128819432|NCT05035654|463635076|FG002|Overall Study|Withdrawal by Subject|4|||
128819433|NCT05035654|463635074|FG000|Overall Study|Bilateral Dislodgement|1|||
128819434|NCT05035654|463635075|FG001|Overall Study|Bilateral Dislodgement|0|||
128819435|NCT05035654|463635076|FG002|Overall Study|Bilateral Dislodgement|0|||
128819436|NCT02367040|463635081|FG000|Overall Study|Lost to Follow-up|1|||
128819437|NCT02367040|463635082|FG001|Overall Study|Lost to Follow-up|1|||
128819438|NCT02367040|463635081|FG000|Overall Study|Lack of Efficacy|1|||
128819439|NCT02367040|463635082|FG001|Overall Study|Lack of Efficacy|0|||
128819440|NCT02367040|463635081|FG000|Overall Study|Additional primary malignancy|0|||
128819441|NCT02367040|463635082|FG001|Overall Study|Additional primary malignancy|1|||
128819442|NCT02367040|463635081|FG000|Overall Study|AE not associated with clinical disease progression|114|||
128819443|NCT02367040|463635082|FG001|Overall Study|AE not associated with clinical disease progression|11|||
128819444|NCT02367040|463635081|FG000|Overall Study|AE associated with clinical disease progression|1|||
128819445|NCT02367040|463635082|FG001|Overall Study|AE associated with clinical disease progression|3|||
128819446|NCT02367040|463635081|FG000|Overall Study|Physician Decision|2|||
128819447|NCT02367040|463635082|FG001|Overall Study|Physician Decision|8|||
128819448|NCT02367040|463635081|FG000|Overall Study|Non-compliance with study drug|1|||
128819449|NCT02367040|463635082|FG001|Overall Study|Non-compliance with study drug|0|||
128819450|NCT02367040|463635081|FG000|Overall Study|Failure to meet continuation criteria|1|||
128819451|NCT02367040|463635082|FG001|Overall Study|Failure to meet continuation criteria|0|||
128819452|NCT02367040|463635081|FG000|Overall Study|Switching to other therapy|2|||
128819453|NCT02367040|463635082|FG001|Overall Study|Switching to other therapy|0|||
128819454|NCT02367040|463635081|FG000|Overall Study|Withdrawal by Subject|46|||
128819455|NCT02367040|463635082|FG001|Overall Study|Withdrawal by Subject|16|||
128819456|NCT02367040|463635081|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
128819457|NCT02367040|463635082|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
128819458|NCT02367040|463635081|FG000|Overall Study|Patient decision|39|||
128819459|NCT02367040|463635082|FG001|Overall Study|Patient decision|14|||
128819460|NCT02367040|463635081|FG000|Overall Study|Required procedure failed|1|||
128819461|NCT02367040|463635082|FG001|Overall Study|Required procedure failed|0|||
128819462|NCT02367040|463635081|FG000|Overall Study|Randomized by mistake with study treatment|1|||
128819463|NCT02367040|463635082|FG001|Overall Study|Randomized by mistake with study treatment|0|||
128819464|NCT02367040|463635081|FG000|Overall Study|Protocol Violation|1|||
128819465|NCT02367040|463635082|FG001|Overall Study|Protocol Violation|0|||
128819466|NCT02367040|463635081|FG000|Overall Study|Progressive disease - radiological progression|51|||
128819467|NCT02367040|463635082|FG001|Overall Study|Progressive disease - radiological progression|78|||
128819468|NCT02367040|463635081|FG000|Overall Study|Progressive disease - clinical progression|6|||
128819469|NCT02367040|463635082|FG001|Overall Study|Progressive disease - clinical progression|6|||
128819470|NCT02367040|463635081|FG000|Overall Study|Drug not administered|3|||
128819471|NCT02367040|463635082|FG001|Overall Study|Drug not administered|2|||
128819472|NCT02367040|463635081|FG000|Overall Study|Progressive disease|0|||
128819473|NCT02367040|463635082|FG001|Overall Study|Progressive disease|1|||
128819474|NCT02367040|463635081|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
128819475|NCT02367040|463635082|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
128819476|NCT02367040|463635081|FG000|Overall Study|Death|2|||
128819477|NCT02367040|463635082|FG001|Overall Study|Death|0|||
128819478|NCT05856435|463635094|FG000|Overall Study|Lost to Follow-up|6|||
128819479|NCT02323880|463635095|FG000|Overall Study|Adverse Event|2|||
128819480|NCT02323880|463635096|FG001|Overall Study|Adverse Event|0|||
128819481|NCT02323880|463635097|FG002|Overall Study|Adverse Event|1|||
128819482|NCT02323880|463635098|FG003|Overall Study|Adverse Event|1|||
128819483|NCT02323880|463635099|FG004|Overall Study|Adverse Event|1|||
128819484|NCT02323880|463635100|FG005|Overall Study|Adverse Event|0|||
128819485|NCT02323880|463635101|FG006|Overall Study|Adverse Event|1|||
128819486|NCT02323880|463635102|FG007|Overall Study|Adverse Event|0|||
128819487|NCT02323880|463635095|FG000|Overall Study|Death|0|||
128819488|NCT02323880|463635096|FG001|Overall Study|Death|0|||
128819489|NCT02323880|463635097|FG002|Overall Study|Death|0|||
128819490|NCT02323880|463635098|FG003|Overall Study|Death|0|||
128819491|NCT02323880|463635099|FG004|Overall Study|Death|0|||
128819492|NCT02323880|463635100|FG005|Overall Study|Death|1|||
128819493|NCT02323880|463635101|FG006|Overall Study|Death|0|||
128819494|NCT02323880|463635102|FG007|Overall Study|Death|0|||
128819495|NCT02323880|463635095|FG000|Overall Study|Lack of Efficacy|4|||
128819496|NCT02323880|463635096|FG001|Overall Study|Lack of Efficacy|11|||
128819497|NCT02323880|463635097|FG002|Overall Study|Lack of Efficacy|5|||
128819498|NCT02323880|463635098|FG003|Overall Study|Lack of Efficacy|5|||
128819499|NCT02323880|463635099|FG004|Overall Study|Lack of Efficacy|4|||
128819500|NCT02323880|463635100|FG005|Overall Study|Lack of Efficacy|8|||
128819501|NCT02323880|463635101|FG006|Overall Study|Lack of Efficacy|4|||
128819502|NCT02323880|463635102|FG007|Overall Study|Lack of Efficacy|6|||
128819503|NCT02323880|463635095|FG000|Overall Study|Physician Decision|0|||
128819504|NCT02323880|463635096|FG001|Overall Study|Physician Decision|0|||
128819505|NCT02323880|463635097|FG002|Overall Study|Physician Decision|0|||
128819506|NCT02323880|463635098|FG003|Overall Study|Physician Decision|0|||
128819507|NCT02323880|463635099|FG004|Overall Study|Physician Decision|1|||
128819508|NCT02323880|463635100|FG005|Overall Study|Physician Decision|1|||
128819509|NCT02323880|463635101|FG006|Overall Study|Physician Decision|1|||
128819510|NCT02323880|463635102|FG007|Overall Study|Physician Decision|0|||
128819511|NCT02323880|463635095|FG000|Overall Study|Withdrawal by Subject|0|||
128819512|NCT02323880|463635096|FG001|Overall Study|Withdrawal by Subject|2|||
128819513|NCT02323880|463635097|FG002|Overall Study|Withdrawal by Subject|0|||
128819514|NCT02323880|463635098|FG003|Overall Study|Withdrawal by Subject|0|||
128819515|NCT02323880|463635099|FG004|Overall Study|Withdrawal by Subject|0|||
128819516|NCT02323880|463635100|FG005|Overall Study|Withdrawal by Subject|0|||
128819517|NCT02323880|463635101|FG006|Overall Study|Withdrawal by Subject|0|||
128819518|NCT02323880|463635102|FG007|Overall Study|Withdrawal by Subject|0|||
128819519|NCT04934072|463635104|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
128819520|NCT04934072|463635105|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
128819521|NCT04934072|463635106|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
128819522|NCT04934072|463635107|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
128819523|NCT04934072|463635108|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
128819524|NCT04934072|463635104|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
128819525|NCT04934072|463635105|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
128819526|NCT04934072|463635106|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
128819527|NCT04934072|463635107|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
128819528|NCT04934072|463635108|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
128819529|NCT04934072|463635104|FG000|Day 0 to Week 52|Other|3|||
128819530|NCT04934072|463635105|FG001|Day 0 to Week 52|Other|1|||
128819531|NCT04934072|463635106|FG002|Day 0 to Week 52|Other|0|||
128819532|NCT04934072|463635107|FG003|Day 0 to Week 52|Other|0|||
128819533|NCT04934072|463635108|FG004|Day 0 to Week 52|Other|0|||
128819534|NCT04934072|463635104|FG000|Day 0 to Week 52|Adverse Event|1|||
128819535|NCT04934072|463635105|FG001|Day 0 to Week 52|Adverse Event|3|||
128819536|NCT04934072|463635106|FG002|Day 0 to Week 52|Adverse Event|0|||
128819537|NCT04934072|463635107|FG003|Day 0 to Week 52|Adverse Event|0|||
128819538|NCT04934072|463635108|FG004|Day 0 to Week 52|Adverse Event|0|||
128819539|NCT04934072|463635104|FG000|Week 52 to Week 78|Adverse Event|0|||
128819540|NCT04934072|463635105|FG001|Week 52 to Week 78|Adverse Event|0|||
128819541|NCT04934072|463635106|FG002|Week 52 to Week 78|Adverse Event|0|||
128819542|NCT04934072|463635107|FG003|Week 52 to Week 78|Adverse Event|1|||
128819543|NCT04934072|463635108|FG004|Week 52 to Week 78|Adverse Event|1|||
128819544|NCT04934072|463635104|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
128819545|NCT04934072|463635105|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
128819546|NCT04934072|463635106|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
128819547|NCT04934072|463635107|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
128819548|NCT04934072|463635108|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
128819549|NCT04934072|463635104|FG000|Week 52 to Week 78|Other|0|||
128819550|NCT04934072|463635105|FG001|Week 52 to Week 78|Other|0|||
128819551|NCT04934072|463635106|FG002|Week 52 to Week 78|Other|1|||
128819552|NCT04934072|463635107|FG003|Week 52 to Week 78|Other|0|||
128819553|NCT04934072|463635108|FG004|Week 52 to Week 78|Other|0|||
128819554|NCT05660434|463635112|FG000|Overall Study|Never obtained study materials|2|||
128819555|NCT05660434|463635113|FG001|Overall Study|Never obtained study materials|1|||
128819556|NCT02865538|463635123|FG000|Overall Study|Withdrawal by Subject|0|||
128819557|NCT02865538|463635124|FG001|Overall Study|Withdrawal by Subject|0|||
128819558|NCT02865538|463635125|FG002|Overall Study|Withdrawal by Subject|1|||
128819559|NCT02865538|463635126|FG003|Overall Study|Withdrawal by Subject|0|||
128819560|NCT02865538|463635127|FG004|Overall Study|Withdrawal by Subject|0|||
128819561|NCT02865538|463635123|FG000|Overall Study|Lost to Follow-up|1|||
128819562|NCT02865538|463635124|FG001|Overall Study|Lost to Follow-up|0|||
128819563|NCT02865538|463635125|FG002|Overall Study|Lost to Follow-up|0|||
128819564|NCT02865538|463635126|FG003|Overall Study|Lost to Follow-up|0|||
128819565|NCT02865538|463635127|FG004|Overall Study|Lost to Follow-up|0|||
128819566|NCT03106740|463636547|FG000|Overall Study|Lost to Follow-up|2|||
128819567|NCT03106740|463636548|FG001|Overall Study|Lost to Follow-up|2|||
128819568|NCT03106740|463636547|FG000|Overall Study|Withdrawal by Subject|2|||
128819569|NCT03106740|463636548|FG001|Overall Study|Withdrawal by Subject|4|||
128819570|NCT03106740|463636547|FG000|Overall Study|Physician Decision|0|||
128819571|NCT03106740|463636548|FG001|Overall Study|Physician Decision|1|||
128819572|NCT03106740|463636547|FG000|Overall Study|Partial data|1|||
128819573|NCT03106740|463636548|FG001|Overall Study|Partial data|0|||
128819574|NCT04565990|463636549|FG000|Overall Study|Death|5|||
128819575|NCT04565990|463636549|FG000|Overall Study|Lost to Follow-up|1|||
128819576|NCT04565990|463636549|FG000|Overall Study|Withdrawal by Subject|1|||
128819577|NCT05363163|463636554|FG000|Overall Study|Withdrawal by Subject|13|||
128819578|NCT03673501|463636555|FG000|Overall Study|Participants ongoing.|36|||
128819579|NCT03673501|463636556|FG001|Overall Study|Participants ongoing.|24|||
128819580|NCT04709419|463636557|FG000|Overall Study|Physician Decision|1|||
128819581|NCT04709419|463636558|FG001|Overall Study|Physician Decision|0|||
128819582|NCT05683340|463636559|FG000|Overall Study|Adverse Event|1|||
128819583|NCT05683340|463636560|FG001|Overall Study|Adverse Event|1|||
128819584|NCT05683340|463636559|FG000|Overall Study|Protocol Violation|1|||
128819585|NCT05683340|463636560|FG001|Overall Study|Protocol Violation|0|||
128819586|NCT05683340|463636559|FG000|Overall Study|Withdrawal by Subject|0|||
128819587|NCT05683340|463636560|FG001|Overall Study|Withdrawal by Subject|2|||
128819588|NCT02056834|463636561|FG000|Overall Study|Lost to Follow-up|7|||
128819589|NCT06106022|463636562|FG000|Overall Study|Lost to Follow-up|1|||
128819590|NCT06106022|463636563|FG001|Overall Study|Lost to Follow-up|0|||
128819591|NCT06106022|463636562|FG000|Overall Study|Voluntary Withdrawal|0|||
128819592|NCT06106022|463636563|FG001|Overall Study|Voluntary Withdrawal|2|||
128819593|NCT03276676|463636565|FG000|Overall Study|Withdrawal by Subject|2|||
128819594|NCT03276676|463636566|FG001|Overall Study|Withdrawal by Subject|1|||
128819595|NCT03926130|463636569|FG000|Overall Study|Adverse Event|9|||
128819596|NCT03926130|463636570|FG001|Overall Study|Adverse Event|11|||
128819597|NCT03926130|463636571|FG002|Overall Study|Adverse Event|2|||
128819598|NCT03926130|463636572|FG003|Overall Study|Adverse Event|0|||
128819599|NCT03926130|463636569|FG000|Overall Study|Death|2|||
128819600|NCT03926130|463636570|FG001|Overall Study|Death|0|||
128819601|NCT03926130|463636571|FG002|Overall Study|Death|1|||
128819602|NCT03926130|463636572|FG003|Overall Study|Death|0|||
128819603|NCT03926130|463636569|FG000|Overall Study|Lack of Efficacy|14|||
128819604|NCT03926130|463636570|FG001|Overall Study|Lack of Efficacy|11|||
128819605|NCT03926130|463636571|FG002|Overall Study|Lack of Efficacy|7|||
128819606|NCT03926130|463636572|FG003|Overall Study|Lack of Efficacy|1|||
128819607|NCT03926130|463636569|FG000|Overall Study|Lost to Follow-up|0|||
128819608|NCT03926130|463636570|FG001|Overall Study|Lost to Follow-up|7|||
128819609|NCT03926130|463636571|FG002|Overall Study|Lost to Follow-up|1|||
128819610|NCT03926130|463636572|FG003|Overall Study|Lost to Follow-up|0|||
128819611|NCT03926130|463636569|FG000|Overall Study|As Reported by Investigator|2|||
128819612|NCT03926130|463636570|FG001|Overall Study|As Reported by Investigator|6|||
128819613|NCT03926130|463636571|FG002|Overall Study|As Reported by Investigator|6|||
128819614|NCT03926130|463636572|FG003|Overall Study|As Reported by Investigator|0|||
128819615|NCT03926130|463636569|FG000|Overall Study|Physician Decision|3|||
128819616|NCT03926130|463636570|FG001|Overall Study|Physician Decision|2|||
128819617|NCT03926130|463636571|FG002|Overall Study|Physician Decision|1|||
128819618|NCT03926130|463636572|FG003|Overall Study|Physician Decision|0|||
128819619|NCT03926130|463636569|FG000|Overall Study|Pregnancy|2|||
128819620|NCT03926130|463636570|FG001|Overall Study|Pregnancy|2|||
128819621|NCT03926130|463636571|FG002|Overall Study|Pregnancy|1|||
128819622|NCT03926130|463636572|FG003|Overall Study|Pregnancy|0|||
128819623|NCT03926130|463636569|FG000|Overall Study|Withdrawal by Subject|20|||
128819624|NCT03926130|463636570|FG001|Overall Study|Withdrawal by Subject|28|||
128819625|NCT03926130|463636571|FG002|Overall Study|Withdrawal by Subject|18|||
128819626|NCT03926130|463636572|FG003|Overall Study|Withdrawal by Subject|1|||
128819627|NCT03926130|463636569|FG000|Overall Study|Non-Compliance|1|||
128819628|NCT03926130|463636570|FG001|Overall Study|Non-Compliance|1|||
128819629|NCT03926130|463636571|FG002|Overall Study|Non-Compliance|0|||
128819630|NCT03926130|463636572|FG003|Overall Study|Non-Compliance|0|||
128819631|NCT03926130|463636569|FG000|Overall Study|Disposition Not Captured|0|||
128819632|NCT03926130|463636570|FG001|Overall Study|Disposition Not Captured|2|||
128819633|NCT03926130|463636571|FG002|Overall Study|Disposition Not Captured|1|||
128819634|NCT03926130|463636572|FG003|Overall Study|Disposition Not Captured|0|||
128819635|NCT03583333|463636573|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
128819636|NCT03583333|463636574|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
128819637|NCT03583333|463636573|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
128819638|NCT03583333|463636574|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
128819639|NCT03583333|463636573|FG000|Overall Study|Withdrawal by Subject|9|||
128819640|NCT03583333|463636574|FG001|Overall Study|Withdrawal by Subject|5|||
128819641|NCT03583333|463636573|FG000|Overall Study|Physician Decision|3|||
128819642|NCT03583333|463636574|FG001|Overall Study|Physician Decision|2|||
128819643|NCT03583333|463636573|FG000|Overall Study|Death|12|||
128819644|NCT03583333|463636574|FG001|Overall Study|Death|7|||
129204714|NCT02079740|465046926|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
129204715|NCT02079740|465046927|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
128819647|NCT03858517|463636610|FG000|Overall Study|Adverse Event|1|||
128819648|NCT03858517|463636610|FG000|Overall Study|Lost to Follow-up|1|||
128819649|NCT03858517|463636610|FG000|Overall Study|removed for being incarcerated|1|||
128819650|NCT03858517|463636610|FG000|Overall Study|Sponsor Closure|48|||
128819651|NCT05285137|463636612|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
128819652|NCT05285137|463636613|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
128819653|NCT05285137|463636614|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
128819654|NCT05285137|463636615|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
128819655|NCT05285137|463636616|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
128819656|NCT05285137|463636617|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
128819657|NCT05285137|463636618|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
128819658|NCT05285137|463636619|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
128819659|NCT05285137|463636620|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
128819660|NCT05285137|463636612|FG000|Overall Study|Lost to Follow-up|0|||
128819661|NCT05285137|463636613|FG001|Overall Study|Lost to Follow-up|0|||
128819662|NCT05285137|463636614|FG002|Overall Study|Lost to Follow-up|1|||
128819663|NCT05285137|463636615|FG003|Overall Study|Lost to Follow-up|3|||
128819664|NCT05285137|463636616|FG004|Overall Study|Lost to Follow-up|0|||
128819665|NCT05285137|463636617|FG005|Overall Study|Lost to Follow-up|0|||
128819666|NCT05285137|463636618|FG006|Overall Study|Lost to Follow-up|1|||
128819667|NCT05285137|463636619|FG007|Overall Study|Lost to Follow-up|0|||
128819668|NCT05285137|463636620|FG008|Overall Study|Lost to Follow-up|0|||
128819669|NCT05285137|463636612|FG000|Overall Study|Physician Decision|0|||
128819670|NCT05285137|463636613|FG001|Overall Study|Physician Decision|1|||
128819671|NCT05285137|463636614|FG002|Overall Study|Physician Decision|0|||
128819672|NCT05285137|463636615|FG003|Overall Study|Physician Decision|0|||
128819673|NCT05285137|463636616|FG004|Overall Study|Physician Decision|0|||
128819674|NCT05285137|463636617|FG005|Overall Study|Physician Decision|0|||
128819675|NCT05285137|463636618|FG006|Overall Study|Physician Decision|0|||
128819676|NCT05285137|463636619|FG007|Overall Study|Physician Decision|0|||
128819677|NCT05285137|463636620|FG008|Overall Study|Physician Decision|0|||
128819678|NCT05285137|463636612|FG000|Overall Study|Pregnancy|0|||
128819679|NCT05285137|463636613|FG001|Overall Study|Pregnancy|0|||
128819680|NCT05285137|463636614|FG002|Overall Study|Pregnancy|0|||
128819681|NCT05285137|463636615|FG003|Overall Study|Pregnancy|0|||
128819682|NCT05285137|463636616|FG004|Overall Study|Pregnancy|0|||
128819683|NCT05285137|463636617|FG005|Overall Study|Pregnancy|0|||
128819684|NCT05285137|463636618|FG006|Overall Study|Pregnancy|1|||
128819685|NCT05285137|463636619|FG007|Overall Study|Pregnancy|0|||
128819686|NCT05285137|463636620|FG008|Overall Study|Pregnancy|0|||
128819687|NCT05285137|463636612|FG000|Overall Study|Withdrawal by Subject|0|||
128819688|NCT05285137|463636613|FG001|Overall Study|Withdrawal by Subject|1|||
128819689|NCT05285137|463636614|FG002|Overall Study|Withdrawal by Subject|2|||
128819690|NCT05285137|463636615|FG003|Overall Study|Withdrawal by Subject|1|||
128819691|NCT05285137|463636616|FG004|Overall Study|Withdrawal by Subject|0|||
128819692|NCT05285137|463636617|FG005|Overall Study|Withdrawal by Subject|0|||
128819693|NCT05285137|463636618|FG006|Overall Study|Withdrawal by Subject|0|||
128819694|NCT05285137|463636619|FG007|Overall Study|Withdrawal by Subject|0|||
128819695|NCT05285137|463636620|FG008|Overall Study|Withdrawal by Subject|1|||
128819696|NCT03717935|463636625|FG000|Overall Study|Withdrawal by Subject|0|||
128819697|NCT03717935|463636626|FG001|Overall Study|Withdrawal by Subject|2|||
128819698|NCT01820611|463636627|FG000|Overall Study|Death|8|||
128819699|NCT01820611|463636627|FG000|Overall Study|Adverse Event|1|||
128819700|NCT01820611|463636627|FG000|Overall Study|Withdrawal by Subject|9|||
128819701|NCT03484819|463636628|FG000|Overall Study|Death|2|||
128819702|NCT03484819|463636628|FG000|Overall Study|Adverse Event|2|||
128819703|NCT03484819|463636628|FG000|Overall Study|Physician Decision|1|||
128819704|NCT03484819|463636628|FG000|Overall Study|Withdrawal by Subject|2|||
128819705|NCT03484819|463636628|FG000|Overall Study|Disease Progression|4|||
128819706|NCT03484819|463636628|FG000|Overall Study|Complicating Condition|1|||
128819707|NCT05736458|463636629|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
128819708|NCT05736458|463636630|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
128819709|NCT05736458|463636631|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
128819710|NCT05736458|463636629|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
128819711|NCT05736458|463636630|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
128819712|NCT05736458|463636631|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
128819713|NCT05736458|463636629|FG000|TMS/fMRI #1|Physician Decision|0|||
128819714|NCT05736458|463636630|FG001|TMS/fMRI #1|Physician Decision|0|||
128819715|NCT05736458|463636631|FG002|TMS/fMRI #1|Physician Decision|2|||
128819716|NCT05736458|463636629|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
128819717|NCT05736458|463636630|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
128819718|NCT05736458|463636631|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
128819719|NCT02990338|463636632|FG000|Overall Study|Randomized and not treated|4|||
128819720|NCT02990338|463636633|FG001|Overall Study|Randomized and not treated|2|||
128819721|NCT02990338|463636632|FG000|Overall Study|Adverse Event|23|||
128819722|NCT02990338|463636633|FG001|Overall Study|Adverse Event|22|||
128819723|NCT02990338|463636632|FG000|Overall Study|Progressive disease|118|||
128819724|NCT02990338|463636633|FG001|Overall Study|Progressive disease|107|||
128819725|NCT02990338|463636632|FG000|Overall Study|Poor compliance to protocol|0|||
128819726|NCT02990338|463636633|FG001|Overall Study|Poor compliance to protocol|1|||
128819727|NCT02990338|463636632|FG000|Overall Study|Withdrawal by Subject|6|||
128819728|NCT02990338|463636633|FG001|Overall Study|Withdrawal by Subject|8|||
128819729|NCT02990338|463636632|FG000|Overall Study|Physician's decision|2|||
128819730|NCT02990338|463636633|FG001|Overall Study|Physician's decision|6|||
128819731|NCT02990338|463636632|FG000|Overall Study|Treatment extension study|0|||
128819732|NCT02990338|463636633|FG001|Overall Study|Treatment extension study|6|||
128819733|NCT02990338|463636632|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
128819734|NCT02990338|463636633|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
128819735|NCT02990338|463636632|FG000|Overall Study|Continue with therapy available commercially|0|||
128819736|NCT02990338|463636633|FG001|Overall Study|Continue with therapy available commercially|1|||
128819737|NCT04479761|463636634|FG000|Overall Study|could not perform the balance tasks|1|||
128819738|NCT04479761|463636635|FG001|Overall Study|could not perform the balance tasks|0|||
128819739|NCT04479761|463636636|FG002|Overall Study|could not perform the balance tasks|0|||
128819740|NCT04479761|463636634|FG000|Overall Study|Adverse Event|1|||
128819741|NCT04479761|463636635|FG001|Overall Study|Adverse Event|0|||
128819742|NCT04479761|463636636|FG002|Overall Study|Adverse Event|0|||
128819743|NCT04479761|463636634|FG000|Overall Study|one control did not meet screening criteria|0|||
128819744|NCT04479761|463636635|FG001|Overall Study|one control did not meet screening criteria|0|||
128819745|NCT04479761|463636636|FG002|Overall Study|one control did not meet screening criteria|1|||
128819746|NCT04479761|463636634|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
128819747|NCT04479761|463636635|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
128819748|NCT04479761|463636636|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
128819749|NCT02997202|463636640|FG000|Overall Study|Miscellaneous|2|||
128819750|NCT02997202|463636641|FG001|Overall Study|Miscellaneous|2|||
128819751|NCT02997202|463636640|FG000|Overall Study|Withdrawal by Subject|8|||
128819752|NCT02997202|463636641|FG001|Overall Study|Withdrawal by Subject|12|||
128819753|NCT02997202|463636640|FG000|Overall Study|Lost to Follow-up|5|||
128819754|NCT02997202|463636641|FG001|Overall Study|Lost to Follow-up|3|||
128819755|NCT02997202|463636640|FG000|Overall Study|Death|41|||
128819756|NCT02997202|463636641|FG001|Overall Study|Death|45|||
128819757|NCT05900154|463636646|FG000|Follow-Up Period|Lost to Follow-up|1|||
128819758|NCT05900154|463636647|FG001|Follow-Up Period|Lost to Follow-up|2|||
128819759|NCT05900154|463636648|FG002|Follow-Up Period|Lost to Follow-up|1|||
128819760|NCT05900154|463636649|FG003|Follow-Up Period|Lost to Follow-up|0|||
128819761|NCT05900154|463636650|FG004|Follow-Up Period|Lost to Follow-up|1|||
128819762|NCT05900154|463636651|FG005|Follow-Up Period|Lost to Follow-up|1|||
128819763|NCT00303459|463636653|FG000|Overall Study|Death|33|||
128819764|NCT00303459|463636654|FG001|Overall Study|Death|44|||
128819765|NCT00303459|463636653|FG000|Overall Study|Withdrawal of consent|32|||
128819766|NCT00303459|463636654|FG001|Overall Study|Withdrawal of consent|26|||
128819767|NCT00303459|463636653|FG000|Overall Study|Lost to Follow-up|5|||
128819768|NCT00303459|463636654|FG001|Overall Study|Lost to Follow-up|4|||
128819769|NCT00303459|463636653|FG000|Overall Study|Administrative reason|7|||
128819770|NCT00303459|463636654|FG001|Overall Study|Administrative reason|7|||
128819771|NCT00303459|463636653|FG000|Overall Study|Decision by the investigator|5|||
128819772|NCT00303459|463636654|FG001|Overall Study|Decision by the investigator|7|||
128819773|NCT00303459|463636653|FG000|Overall Study|Lung transplantation|1|||
128819774|NCT00303459|463636654|FG001|Overall Study|Lung transplantation|1|||
128819775|NCT04129554|463636655|FG000|Overall Study|Withdrawal by Subject|4|||
128819776|NCT04129554|463636656|FG001|Overall Study|Withdrawal by Subject|3|||
128819777|NCT04129554|463636655|FG000|Overall Study|Other|0|||
128819778|NCT04129554|463636656|FG001|Overall Study|Other|2|||
128819779|NCT02846545|463636659|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
128819780|NCT02846545|463636660|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
128819781|NCT02846545|463636659|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
128819782|NCT02846545|463636660|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
128819783|NCT02846545|463636659|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
128819784|NCT02846545|463636660|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
128819785|NCT02846545|463636659|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
128819786|NCT02846545|463636660|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
128819787|NCT02846545|463636659|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
128819788|NCT02846545|463636660|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
128819789|NCT03691298|463636663|FG000|Overall Study|Lost to Follow-up|8|||
128819790|NCT03691298|463636663|FG000|Overall Study|Sponsor terminated study|2|||
128819791|NCT02492711|463636667|FG000|Overall Study|Adverse Event|9|||
128819792|NCT02492711|463636668|FG001|Overall Study|Adverse Event|9|||
128819793|NCT02492711|463636669|FG002|Overall Study|Adverse Event|2|||
128819794|NCT02492711|463636667|FG000|Overall Study|Death|3|||
128819795|NCT02492711|463636668|FG001|Overall Study|Death|3|||
128819796|NCT02492711|463636669|FG002|Overall Study|Death|0|||
128819797|NCT02492711|463636667|FG000|Overall Study|Withdrawal by Subject|10|||
128819798|NCT02492711|463636668|FG001|Overall Study|Withdrawal by Subject|16|||
128819799|NCT02492711|463636669|FG002|Overall Study|Withdrawal by Subject|5|||
128819800|NCT02492711|463636667|FG000|Overall Study|Physician Decision|10|||
128819801|NCT02492711|463636668|FG001|Overall Study|Physician Decision|6|||
128819802|NCT02492711|463636669|FG002|Overall Study|Physician Decision|4|||
128819803|NCT02492711|463636667|FG000|Overall Study|Lost to Follow-up|0|||
128819804|NCT02492711|463636668|FG001|Overall Study|Lost to Follow-up|0|||
128819805|NCT02492711|463636669|FG002|Overall Study|Lost to Follow-up|1|||
128819806|NCT02492711|463636667|FG000|Overall Study|study treatment delay|2|||
128819807|NCT02492711|463636668|FG001|Overall Study|study treatment delay|1|||
128819808|NCT02492711|463636669|FG002|Overall Study|study treatment delay|0|||
128819809|NCT02492711|463636667|FG000|Overall Study|change in chemotherapy|0|||
128819810|NCT02492711|463636668|FG001|Overall Study|change in chemotherapy|1|||
128819811|NCT02492711|463636669|FG002|Overall Study|change in chemotherapy|0|||
128819812|NCT02492711|463636667|FG000|Overall Study|never treated|2|||
128819813|NCT02492711|463636668|FG001|Overall Study|never treated|4|||
128819814|NCT02492711|463636669|FG002|Overall Study|never treated|0|||
128819815|NCT02492711|463636667|FG000|Overall Study|Other|0|||
128819816|NCT02492711|463636668|FG001|Overall Study|Other|0|||
128819817|NCT02492711|463636669|FG002|Overall Study|Other|1|||
128819818|NCT02518048|463636673|FG000|Overall Study|Withdrawal by Subject|1|||
128819819|NCT05962814|463636674|FG000|Overall Study|failed eligibility|1|||
128819820|NCT01314105|463637886|FG000|Overall Study|Progressive Disease|6|||
128819821|NCT01314105|463637887|FG001|Overall Study|Progressive Disease|10|||
128819822|NCT01314105|463637886|FG000|Overall Study|Refused to continue taking medication|0|||
128819823|NCT01314105|463637887|FG001|Overall Study|Refused to continue taking medication|1|||
128819824|NCT01314105|463637886|FG000|Overall Study|Other Adverse Event|1|||
128819825|NCT01314105|463637887|FG001|Overall Study|Other Adverse Event|1|||
128819826|NCT05524116|463637893|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
128819827|NCT05524116|463637894|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
128819828|NCT05524116|463637893|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
128819829|NCT05524116|463637894|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
128819830|NCT05524116|463637893|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
128819831|NCT05524116|463637894|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
128819832|NCT05524116|463637893|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
128819833|NCT05524116|463637894|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
128819834|NCT05524116|463637893|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
128819835|NCT05524116|463637894|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
128819836|NCT05405985|463637895|FG000|Overall Study|Withdrawal by Subject|1|||
128819837|NCT05405985|463637896|FG001|Overall Study|Withdrawal by Subject|0|||
128819838|NCT04880733|463637897|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
128819839|NCT04880733|463637898|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
128819840|NCT04880733|463637899|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
128819841|NCT04880733|463637897|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
128819842|NCT04880733|463637898|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
128819843|NCT04880733|463637899|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
128819844|NCT04880733|463637897|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
128819845|NCT04880733|463637898|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
128819846|NCT04880733|463637899|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
128819847|NCT04880733|463637897|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
128819848|NCT04880733|463637898|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
128819849|NCT04880733|463637899|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
128819850|NCT04880733|463637897|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
128819851|NCT04880733|463637898|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
128819852|NCT04880733|463637899|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
128819853|NCT05533190|463637904|FG000|Overall Study|Lost to Follow-up|19|||
128819854|NCT05533190|463637905|FG001|Overall Study|Lost to Follow-up|7|||
128819855|NCT05533190|463637904|FG000|Overall Study|Failed to download app|1|||
128819856|NCT05533190|463637905|FG001|Overall Study|Failed to download app|0|||
128819857|NCT05533190|463637904|FG000|Overall Study|Thought app was a scam|1|||
128819858|NCT05533190|463637905|FG001|Overall Study|Thought app was a scam|0|||
128819859|NCT05533190|463637904|FG000|Overall Study|Withdrawal by Subject|2|||
128819860|NCT05533190|463637905|FG001|Overall Study|Withdrawal by Subject|0|||
128819861|NCT05552508|463637906|FG000|Overall Study|Adverse Event|3|||
128819862|NCT01917084|463637910|FG000|Overall Study|Withdrawal by Subject|1|||
128819863|NCT04451772|463637917|FG000|Overall Study|Adverse Event|1|||
128819864|NCT04451772|463637918|FG001|Overall Study|Adverse Event|0|||
128819865|NCT04451772|463637919|FG002|Overall Study|Adverse Event|1|||
128819866|NCT04451772|463637920|FG003|Overall Study|Adverse Event|1|||
128819867|NCT04451772|463637921|FG004|Overall Study|Adverse Event|0|||
128819868|NCT04451772|463637922|FG005|Overall Study|Adverse Event|3|||
128819869|NCT04451772|463637917|FG000|Overall Study|Withdrawal by Subject|2|||
128819870|NCT04451772|463637918|FG001|Overall Study|Withdrawal by Subject|7|||
128819871|NCT04451772|463637919|FG002|Overall Study|Withdrawal by Subject|2|||
128819872|NCT04451772|463637920|FG003|Overall Study|Withdrawal by Subject|1|||
128819873|NCT04451772|463637921|FG004|Overall Study|Withdrawal by Subject|1|||
128819874|NCT04451772|463637922|FG005|Overall Study|Withdrawal by Subject|0|||
128819875|NCT04451772|463637917|FG000|Overall Study|Other, not specified|1|||
128819876|NCT04451772|463637918|FG001|Overall Study|Other, not specified|2|||
128819877|NCT04451772|463637919|FG002|Overall Study|Other, not specified|1|||
128819878|NCT04451772|463637920|FG003|Overall Study|Other, not specified|0|||
128819879|NCT04451772|463637921|FG004|Overall Study|Other, not specified|0|||
128819880|NCT04451772|463637922|FG005|Overall Study|Other, not specified|1|||
128819881|NCT04451772|463637917|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
128819882|NCT04451772|463637918|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
128819883|NCT04451772|463637919|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
128819884|NCT04451772|463637920|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
128819885|NCT04451772|463637921|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
128819886|NCT04451772|463637922|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
128819887|NCT05424380|463637926|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
128819888|NCT05424380|463637927|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
128819889|NCT05424380|463637928|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
128819890|NCT05424380|463637929|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
128819891|NCT05424380|463637930|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
128819892|NCT05424380|463637931|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
128819893|NCT05424380|463637926|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
128819894|NCT05424380|463637927|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
128819895|NCT05424380|463637928|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
128819896|NCT05424380|463637929|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
128819897|NCT05424380|463637930|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
128819898|NCT05424380|463637931|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
128819899|NCT05424380|463637926|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
128819900|NCT05424380|463637927|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
128819901|NCT05424380|463637928|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
128819902|NCT05424380|463637929|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
128819903|NCT05424380|463637930|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
128819904|NCT05424380|463637931|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
128819905|NCT05424380|463637926|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
128819906|NCT05424380|463637927|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
128819907|NCT05424380|463637928|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
128819908|NCT05424380|463637929|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
128819909|NCT05424380|463637930|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
128819910|NCT05424380|463637931|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
128819911|NCT05424380|463637926|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
128819912|NCT05424380|463637927|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
128819913|NCT05424380|463637928|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
128819914|NCT05424380|463637929|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
128819915|NCT05424380|463637930|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
128819916|NCT05424380|463637931|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
128819917|NCT05424380|463637926|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
128819918|NCT05424380|463637927|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
128819919|NCT05424380|463637928|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
128819920|NCT05424380|463637929|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
128819921|NCT05424380|463637930|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
128819922|NCT05424380|463637931|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
128819923|NCT05424380|463637926|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
128819924|NCT05424380|463637927|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
128819925|NCT05424380|463637928|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
128819926|NCT05424380|463637929|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
128819927|NCT05424380|463637930|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
128819928|NCT05424380|463637931|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
128819929|NCT05424380|463637926|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
128819930|NCT05424380|463637927|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
128819931|NCT05424380|463637928|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
128819932|NCT05424380|463637929|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
128819933|NCT05424380|463637930|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
128819934|NCT05424380|463637931|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
128819935|NCT05424380|463637926|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819936|NCT05424380|463637927|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819937|NCT05424380|463637928|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819938|NCT05424380|463637929|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
128819939|NCT05424380|463637930|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819940|NCT05424380|463637931|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819941|NCT05424380|463637926|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
128819942|NCT05424380|463637927|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
128819943|NCT05424380|463637928|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
128819944|NCT05424380|463637929|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
128819945|NCT05424380|463637930|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
128819946|NCT05424380|463637931|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
128819947|NCT05424380|463637926|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
128819948|NCT05424380|463637927|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
128819949|NCT05424380|463637928|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
128819950|NCT05424380|463637929|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
128819951|NCT05424380|463637930|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
128819952|NCT05424380|463637931|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
128819953|NCT05424380|463637926|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
128819954|NCT05424380|463637927|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
128819955|NCT05424380|463637928|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
128819956|NCT05424380|463637929|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
128819957|NCT05424380|463637930|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
128819958|NCT05424380|463637931|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
128819959|NCT05424380|463637926|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819960|NCT05424380|463637927|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819961|NCT05424380|463637928|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819962|NCT05424380|463637929|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819963|NCT05424380|463637930|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
128819964|NCT05424380|463637931|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
128819965|NCT05424380|463637926|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
128819966|NCT05424380|463637927|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
128819967|NCT05424380|463637928|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
128819968|NCT05424380|463637929|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
128819969|NCT05424380|463637930|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
128819970|NCT05424380|463637931|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
128819971|NCT02909686|463637932|FG000|Overall Study|Physician Decision|3|||
128819972|NCT02909686|463637932|FG000|Overall Study|Withdrawal by Subject|2|||
128819973|NCT02828358|463637933|FG000|Overall Study|Physician Decision|7|||
128819974|NCT02828358|463637934|FG001|Overall Study|Physician Decision|1|||
128819975|NCT02828358|463637933|FG000|Overall Study|Treatment Failure|6|||
128819976|NCT02828358|463637934|FG001|Overall Study|Treatment Failure|0|||
128819977|NCT02828358|463637933|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
128819978|NCT02828358|463637934|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
128819979|NCT02828358|463637933|FG000|Overall Study|Refusal of further protocol therapy|2|||
128819980|NCT02828358|463637934|FG001|Overall Study|Refusal of further protocol therapy|0|||
128819981|NCT02828358|463637933|FG000|Overall Study|Relapse|25|||
128819982|NCT02828358|463637934|FG001|Overall Study|Relapse|0|||
128819983|NCT02828358|463637933|FG000|Overall Study|Still on therapy|5|||
128819984|NCT02828358|463637934|FG001|Overall Study|Still on therapy|0|||
128819985|NCT06037668|463637937|FG000|Overall Study|Lost to Follow-up|1|||
128819986|NCT06037668|463637938|FG001|Overall Study|Lost to Follow-up|1|||
128819987|NCT06037668|463637937|FG000|Overall Study|Protocol Violation|1|||
128819988|NCT06037668|463637938|FG001|Overall Study|Protocol Violation|0|||
128819989|NCT06037668|463637937|FG000|Overall Study|Withdrawal by Subject|1|||
128819990|NCT06037668|463637938|FG001|Overall Study|Withdrawal by Subject|0|||
128819991|NCT06037668|463637937|FG000|Overall Study|Other Study Discontinuation Reason|1|||
128819992|NCT06037668|463637938|FG001|Overall Study|Other Study Discontinuation Reason|0|||
128819993|NCT04804540|463637939|FG000|Overall Study|Adverse Event|26|||
128819994|NCT04804540|463637940|FG001|Overall Study|Adverse Event|13|||
128819995|NCT05172232|463637941|FG000|Overall Study|Lost to Follow-up|3|||
128819996|NCT01828021|463637942|FG000|Overall Study|Adverse Event|5|||
128819997|NCT01828021|463637942|FG000|Overall Study|Lack of Efficacy|17|||
128819998|NCT01828021|463637942|FG000|Overall Study|Withdrawal by Subject|2|||
128759422|NCT00118716|463408893|FG001|Overall Study|Non-compliance|3|||
128759423|NCT00118716|463408892|FG000|Overall Study|misrandomized|1|||
128759424|NCT00118716|463408893|FG001|Overall Study|misrandomized|1|||
128759425|NCT00118716|463408892|FG000|Overall Study|Expired drug use|1|||
128759426|NCT00118716|463408893|FG001|Overall Study|Expired drug use|2|||
128759427|NCT00118716|463408892|FG000|Overall Study|Investigator discretion|0|||
128759428|NCT00118716|463408893|FG001|Overall Study|Investigator discretion|1|||
128759429|NCT02436811|463408895|FG000|Overall Study|Lost to Follow-up|2|||
128759430|NCT02436811|463408896|FG001|Overall Study|Lost to Follow-up|9|||
128759431|NCT02436811|463408897|FG002|Overall Study|Lost to Follow-up|7|||
128759432|NCT03371940|463408898|FG000|Overall Study|Withdrawal by Subject|8|||
128759433|NCT03371940|463408899|FG001|Overall Study|Withdrawal by Subject|1|||
128759434|NCT03371940|463408900|FG002|Overall Study|Withdrawal by Subject|3|||
128759435|NCT03371940|463408901|FG003|Overall Study|Withdrawal by Subject|4|||
128759436|NCT05099926|463408907|FG000|Overall Study|Lost to Follow-up|1|||
128759437|NCT00724152|463408910|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
128759438|NCT00724152|463408911|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
128759439|NCT00724152|463408912|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
128759440|NCT00724152|463408910|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
128759441|NCT00724152|463408911|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
128759442|NCT00724152|463408912|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
128759443|NCT03266770|463408913|FG000|Overall Study|Physician Decision|3|||
128759444|NCT03266770|463408913|FG000|Overall Study|Insufficient study supplies|1|||
128759445|NCT03266770|463408913|FG000|Overall Study|Adverse Event|1|||
128759446|NCT00031486|463408916|FG000|Overall Study|Adverse Event|1|||
128759447|NCT00031486|463408917|FG001|Overall Study|Adverse Event|0|||
128759448|NCT00031486|463408916|FG000|Overall Study|Lost to Follow-up|0|||
128759449|NCT00031486|463408917|FG001|Overall Study|Lost to Follow-up|1|||
128759450|NCT00031486|463408916|FG000|Overall Study|Withdrawal by Subject|3|||
128759451|NCT00031486|463408917|FG001|Overall Study|Withdrawal by Subject|2|||
128759452|NCT00031486|463408916|FG000|Overall Study|Death|0|||
128759453|NCT00031486|463408917|FG001|Overall Study|Death|3|||
128759454|NCT00031486|463408916|FG000|Overall Study|Non-compliant|0|||
128759455|NCT00031486|463408917|FG001|Overall Study|Non-compliant|4|||
128759456|NCT00031486|463408916|FG000|Overall Study|Did not meet eligibility requirement|2|||
128759457|NCT00031486|463408917|FG001|Overall Study|Did not meet eligibility requirement|1|||
128759458|NCT00031486|463408916|FG000|Overall Study|Other|1|||
128759459|NCT00031486|463408917|FG001|Overall Study|Other|1|||
128759460|NCT03685591|463408918|FG000|Overall Study|Global Deterioration of Health Status|0|||
128759461|NCT03685591|463408919|FG001|Overall Study|Global Deterioration of Health Status|0|||
128759462|NCT03685591|463408920|FG002|Overall Study|Global Deterioration of Health Status|0|||
128759463|NCT03685591|463408921|FG003|Overall Study|Global Deterioration of Health Status|1|||
128759464|NCT03685591|463408922|FG004|Overall Study|Global Deterioration of Health Status|2|||
128759465|NCT03685591|463408923|FG005|Overall Study|Global Deterioration of Health Status|4|||
128759466|NCT03685591|463408924|FG006|Overall Study|Global Deterioration of Health Status|1|||
128759467|NCT03685591|463408925|FG007|Overall Study|Global Deterioration of Health Status|1|||
128759468|NCT03685591|463408926|FG008|Overall Study|Global Deterioration of Health Status|0|||
128759469|NCT03685591|463408918|FG000|Overall Study|Progressive Disease|1|||
128759470|NCT03685591|463408919|FG001|Overall Study|Progressive Disease|1|||
128759471|NCT03685591|463408920|FG002|Overall Study|Progressive Disease|0|||
128759472|NCT03685591|463408921|FG003|Overall Study|Progressive Disease|3|||
128759473|NCT03685591|463408922|FG004|Overall Study|Progressive Disease|5|||
128759474|NCT03685591|463408923|FG005|Overall Study|Progressive Disease|4|||
128759475|NCT03685591|463408924|FG006|Overall Study|Progressive Disease|3|||
128759476|NCT03685591|463408925|FG007|Overall Study|Progressive Disease|2|||
128759477|NCT03685591|463408926|FG008|Overall Study|Progressive Disease|1|||
128759478|NCT03685591|463408918|FG000|Overall Study|Other|0|||
128759479|NCT03685591|463408919|FG001|Overall Study|Other|0|||
128759480|NCT03685591|463408920|FG002|Overall Study|Other|1|||
128759481|NCT03685591|463408921|FG003|Overall Study|Other|0|||
128759482|NCT03685591|463408922|FG004|Overall Study|Other|2|||
128759483|NCT03685591|463408923|FG005|Overall Study|Other|3|||
128759484|NCT03685591|463408924|FG006|Overall Study|Other|0|||
128759485|NCT03685591|463408925|FG007|Overall Study|Other|0|||
128759486|NCT03685591|463408926|FG008|Overall Study|Other|0|||
128759487|NCT03685591|463408918|FG000|Overall Study|Withdrawal by Subject|0|||
128759488|NCT03685591|463408919|FG001|Overall Study|Withdrawal by Subject|0|||
128759489|NCT03685591|463408920|FG002|Overall Study|Withdrawal by Subject|0|||
128759490|NCT03685591|463408921|FG003|Overall Study|Withdrawal by Subject|0|||
128759491|NCT03685591|463408922|FG004|Overall Study|Withdrawal by Subject|3|||
128759492|NCT03685591|463408923|FG005|Overall Study|Withdrawal by Subject|2|||
128759493|NCT03685591|463408924|FG006|Overall Study|Withdrawal by Subject|0|||
128759494|NCT03685591|463408925|FG007|Overall Study|Withdrawal by Subject|0|||
128759495|NCT03685591|463408926|FG008|Overall Study|Withdrawal by Subject|1|||
128819999|NCT01828021|463637942|FG000|Overall Study|Ileal obstruction, unrelated|1|||
128820000|NCT04186819|463637944|FG000|Overall Study|Adverse Event|1|||
128820001|NCT04186819|463637944|FG000|Overall Study|Lost to Follow-up|1|||
128820002|NCT04186819|463637944|FG000|Overall Study|Opted for EBRT|1|||
128820003|NCT04186819|463637944|FG000|Overall Study|Opted SBRT|1|||
128820004|NCT04186819|463637944|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
128820005|NCT04186819|463637944|FG000|Overall Study|Physician Decision|1|||
128820006|NCT04186819|463637944|FG000|Overall Study|RP Delayed|1|||
128820007|NCT04186819|463637944|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
128820008|NCT04186819|463637944|FG000|Overall Study|Subject declined for financial reasons|1|||
128820009|NCT04186819|463637944|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
128820010|NCT04186819|463637944|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
128820011|NCT04186819|463637944|FG000|Overall Study|The subject opted for other treatment option|2|||
128820012|NCT04186819|463637944|FG000|Overall Study|The subject opted for other treatment options|1|||
128820013|NCT04186819|463637944|FG000|Overall Study|Withdrawal by Subject|3|||
128820014|NCT04186819|463637944|FG000|Overall Study|Reason not specified|1|||
128820015|NCT01199133|463637946|FG000|Year 1|Adverse Event|16|||
128820016|NCT01199133|463637947|FG001|Year 1|Adverse Event|4|||
128820017|NCT01199133|463637946|FG000|Year 1|Withdrawal by Subject|8|||
128820018|NCT01199133|463637947|FG001|Year 1|Withdrawal by Subject|4|||
128820019|NCT01199133|463637946|FG000|Year 1|Any other reason not above-mentioned|6|||
128820020|NCT01199133|463637947|FG001|Year 1|Any other reason not above-mentioned|7|||
128820021|NCT01199133|463637946|FG000|Year 2|Adverse Event|1|||
128820022|NCT01199133|463637947|FG001|Year 2|Adverse Event|0|||
128820023|NCT01199133|463637946|FG000|Year 2|Withdrawal by Subject|1|||
128820024|NCT01199133|463637947|FG001|Year 2|Withdrawal by Subject|1|||
128820025|NCT01199133|463637946|FG000|Year 2|Any other reason not above-mentioned|1|||
128820026|NCT01199133|463637947|FG001|Year 2|Any other reason not above-mentioned|2|||
128820027|NCT05013385|463637949|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
128820028|NCT01447719|463637950|FG000|Overall Study|Image acquisition failure|2|||
128820029|NCT01447719|463637950|FG000|Overall Study|Invalid image or not imaged|3|||
128820030|NCT01447719|463637950|FG000|Overall Study|Subject still living at end of study|79|||
128820031|NCT01447719|463637950|FG000|Overall Study|Withdrawal by Subject|2|||
128820032|NCT01447719|463637950|FG000|Overall Study|Family withdrew autopsy consent|7|||
128820033|NCT05100628|463637951|FG000|Overall Study|Progressive Disease|1|||
128820034|NCT05100628|463637952|FG001|Overall Study|Progressive Disease|0|||
128820035|NCT05100628|463637953|FG002|Overall Study|Progressive Disease|0|||
128820036|NCT05100628|463637954|FG003|Overall Study|Progressive Disease|0|||
128820037|NCT05100628|463637951|FG000|Overall Study|Study Terminated by Sponsor|0|||
128820038|NCT05100628|463637952|FG001|Overall Study|Study Terminated by Sponsor|0|||
128820039|NCT05100628|463637953|FG002|Overall Study|Study Terminated by Sponsor|3|||
128820040|NCT05100628|463637954|FG003|Overall Study|Study Terminated by Sponsor|0|||
128820041|NCT05100628|463637951|FG000|Overall Study|unkown|0|||
128820042|NCT05100628|463637952|FG001|Overall Study|unkown|1|||
128820043|NCT05100628|463637953|FG002|Overall Study|unkown|0|||
128820044|NCT05100628|463637954|FG003|Overall Study|unkown|0|||
128820045|NCT03252288|463637957|FG000|Overall Study|Death|1|||
128820046|NCT03252288|463637958|FG001|Overall Study|Death|0|||
128820047|NCT03252288|463637959|FG002|Overall Study|Death|0|||
128820048|NCT03252288|463637957|FG000|Overall Study|Death|11|||
128820049|NCT03252288|463637958|FG001|Overall Study|Death|0|||
128820050|NCT03252288|463637959|FG002|Overall Study|Death|0|||
128820051|NCT03252288|463637957|FG000|Overall Study|Withdrawal by Subject|2|||
128820052|NCT03252288|463637958|FG001|Overall Study|Withdrawal by Subject|0|||
128820053|NCT03252288|463637959|FG002|Overall Study|Withdrawal by Subject|0|||
128820054|NCT03252288|463637957|FG000|Overall Study|Lost to Follow-up|79|||
128820055|NCT03252288|463637958|FG001|Overall Study|Lost to Follow-up|0|||
128820056|NCT03252288|463637959|FG002|Overall Study|Lost to Follow-up|0|||
128820057|NCT03252288|463637957|FG000|Overall Study|Loss of baseline data on tablets|6|||
128820058|NCT03252288|463637958|FG001|Overall Study|Loss of baseline data on tablets|0|||
128820059|NCT03252288|463637959|FG002|Overall Study|Loss of baseline data on tablets|0|||
128820060|NCT02542631|463637971|FG000|Overall Study|Adverse Event|1|||
128820061|NCT02542631|463637972|FG001|Overall Study|Adverse Event|1|||
128820062|NCT02542631|463637971|FG000|Overall Study|Sponsor Termination|1|||
128820063|NCT02542631|463637972|FG001|Overall Study|Sponsor Termination|0|||
128820064|NCT02542631|463637971|FG000|Overall Study|Withdrawal by Subject|11|||
128820065|NCT02542631|463637972|FG001|Overall Study|Withdrawal by Subject|16|||
128820066|NCT02542631|463637971|FG000|Overall Study|Protocol Violation|1|||
128820067|NCT02542631|463637972|FG001|Overall Study|Protocol Violation|1|||
128820068|NCT02542631|463637971|FG000|Overall Study|Physician Decision|6|||
128820069|NCT02542631|463637972|FG001|Overall Study|Physician Decision|4|||
128820070|NCT02542631|463637971|FG000|Overall Study|Lost to Follow-up|6|||
128820071|NCT02542631|463637972|FG001|Overall Study|Lost to Follow-up|5|||
128820072|NCT02542631|463637971|FG000|Overall Study|Death|1|||
128820073|NCT02542631|463637972|FG001|Overall Study|Death|2|||
128820074|NCT02542631|463637971|FG000|Overall Study|Other|2|||
128820075|NCT02542631|463637972|FG001|Overall Study|Other|1|||
128820076|NCT02542631|463637971|FG000|Overall Study|Used Prohibited Medication|2|||
128820077|NCT02542631|463637972|FG001|Overall Study|Used Prohibited Medication|1|||
128820078|NCT02938923|463637973|FG000|Overall Study|Death|1|||
128820079|NCT02938923|463637974|FG001|Overall Study|Death|0|||
128820080|NCT02938923|463637975|FG002|Overall Study|Death|0|||
128820081|NCT02938923|463637973|FG000|Overall Study|Physician Decision|0|||
128820082|NCT02938923|463637974|FG001|Overall Study|Physician Decision|2|||
128820083|NCT02938923|463637975|FG002|Overall Study|Physician Decision|0|||
128820084|NCT02938923|463637973|FG000|Overall Study|Withdrawal by Subject|0|||
128820085|NCT02938923|463637974|FG001|Overall Study|Withdrawal by Subject|1|||
128820086|NCT02938923|463637975|FG002|Overall Study|Withdrawal by Subject|1|||
128820087|NCT00721149|463637976|FG000|Overall Study|Physician Decision|1|||
128820088|NCT00631475|463637979|FG000|Overall Study|Death|18|||
128820089|NCT00631475|463637979|FG000|Overall Study|Adverse Event|14|||
128820090|NCT00631475|463637979|FG000|Overall Study|Withdrew consent|5|||
128820091|NCT00631475|463637979|FG000|Overall Study|Preparation for lung transplant|8|||
128820092|NCT01570361|463637980|FG000|Overall Study|Subject discontinued|1|||
128820093|NCT01570361|463637981|FG001|Overall Study|Subject discontinued|2|||
128820094|NCT01570361|463637980|FG000|Overall Study|Sponsor closing the study|51|||
128820095|NCT01570361|463637981|FG001|Overall Study|Sponsor closing the study|50|||
128820096|NCT01570361|463637980|FG000|Overall Study|Subject excluded|5|||
128820097|NCT01570361|463637981|FG001|Overall Study|Subject excluded|3|||
128820098|NCT01570361|463637980|FG000|Overall Study|Subject withdrew consent|14|||
128820099|NCT01570361|463637981|FG001|Overall Study|Subject withdrew consent|9|||
128820100|NCT01570361|463637980|FG000|Overall Study|Adverse Event|2|||
128820101|NCT01570361|463637981|FG001|Overall Study|Adverse Event|1|||
128820102|NCT01570361|463637980|FG000|Overall Study|Lost to Follow-up|4|||
128820103|NCT01570361|463637981|FG001|Overall Study|Lost to Follow-up|4|||
128820104|NCT01570361|463637980|FG000|Overall Study|Death|5|||
128820105|NCT01570361|463637981|FG001|Overall Study|Death|4|||
128820106|NCT01570361|463637980|FG000|Overall Study|Other|0|||
128820107|NCT01570361|463637981|FG001|Overall Study|Other|2|||
128820108|NCT03993392|463637988|FG000|Overall Study|Withdrawal by Subject|3|||
128820109|NCT03993392|463637988|FG000|Overall Study|Lost to Follow-up|2|||
128820110|NCT03993392|463637988|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
128820111|NCT04505410|463637996|FG000|Overall Study|Adverse Event|2|||
128820112|NCT04505410|463637997|FG001|Overall Study|Adverse Event|0|||
128820113|NCT04505410|463637996|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
128820114|NCT04505410|463637997|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
128820115|NCT04505410|463637996|FG000|Overall Study|did not want to follow diet|1|||
128820116|NCT04505410|463637997|FG001|Overall Study|did not want to follow diet|0|||
128820117|NCT04505410|463637996|FG000|Overall Study|flare up of ulcerative colitis|0|||
128820118|NCT04505410|463637997|FG001|Overall Study|flare up of ulcerative colitis|1|||
128820119|NCT04505410|463637996|FG000|Overall Study|Lost to Follow-up|0|||
128820120|NCT04505410|463637997|FG001|Overall Study|Lost to Follow-up|2|||
128820121|NCT04505410|463637996|FG000|Overall Study|Lost to Follow-up|1|||
128820122|NCT04505410|463637997|FG001|Overall Study|Lost to Follow-up|0|||
128820123|NCT04505410|463637996|FG000|Overall Study|initiated another diet on their own|0|||
128820124|NCT04505410|463637997|FG001|Overall Study|initiated another diet on their own|2|||
128820125|NCT01586910|463639247|FG000|Overall Study|Death|4|||
128820126|NCT01586910|463639248|FG001|Overall Study|Death|4|||
128820127|NCT01586910|463639247|FG000|Overall Study|Withdrawal by Subject|6|||
128820128|NCT01586910|463639248|FG001|Overall Study|Withdrawal by Subject|43|||
128820129|NCT01586910|463639247|FG000|Overall Study|Physician withdrew Subject|5|||
128820130|NCT01586910|463639248|FG001|Overall Study|Physician withdrew Subject|24|||
128820131|NCT04999111|463639249|FG000|Overall Study|Lost to Follow-up|21|||
128820132|NCT04999111|463639250|FG001|Overall Study|Lost to Follow-up|16|||
128820133|NCT04999111|463639251|FG002|Overall Study|Lost to Follow-up|2|||
128820134|NCT04999111|463639252|FG003|Overall Study|Lost to Follow-up|26|||
128820135|NCT04999111|463639253|FG004|Overall Study|Lost to Follow-up|30|||
128820136|NCT04999111|463639254|FG005|Overall Study|Lost to Follow-up|6|||
128820137|NCT04999111|463639249|FG000|Overall Study|Physician Decision|1|||
128820138|NCT04999111|463639250|FG001|Overall Study|Physician Decision|3|||
128820139|NCT04999111|463639251|FG002|Overall Study|Physician Decision|0|||
128820140|NCT04999111|463639252|FG003|Overall Study|Physician Decision|1|||
128820141|NCT04999111|463639253|FG004|Overall Study|Physician Decision|2|||
128820142|NCT04999111|463639254|FG005|Overall Study|Physician Decision|0|||
128820143|NCT04999111|463639249|FG000|Overall Study|Withdrawal by Subject|23|||
128820144|NCT04999111|463639250|FG001|Overall Study|Withdrawal by Subject|29|||
128820145|NCT04999111|463639251|FG002|Overall Study|Withdrawal by Subject|15|||
128820146|NCT04999111|463639252|FG003|Overall Study|Withdrawal by Subject|30|||
128820147|NCT04999111|463639253|FG004|Overall Study|Withdrawal by Subject|35|||
128820148|NCT04999111|463639254|FG005|Overall Study|Withdrawal by Subject|10|||
128820149|NCT04999111|463639249|FG000|Overall Study|Other|6|||
128820150|NCT04999111|463639250|FG001|Overall Study|Other|6|||
128820151|NCT04999111|463639251|FG002|Overall Study|Other|3|||
128820152|NCT04999111|463639252|FG003|Overall Study|Other|8|||
128820153|NCT04999111|463639253|FG004|Overall Study|Other|8|||
128820154|NCT04999111|463639254|FG005|Overall Study|Other|5|||
128820155|NCT04999111|463639249|FG000|Overall Study|Non-compliance with study schedule|1|||
128820156|NCT04999111|463639250|FG001|Overall Study|Non-compliance with study schedule|0|||
128820157|NCT04999111|463639251|FG002|Overall Study|Non-compliance with study schedule|0|||
128820158|NCT04999111|463639252|FG003|Overall Study|Non-compliance with study schedule|1|||
128820159|NCT04999111|463639253|FG004|Overall Study|Non-compliance with study schedule|1|||
128820160|NCT04999111|463639254|FG005|Overall Study|Non-compliance with study schedule|1|||
128820161|NCT04999111|463639249|FG000|Overall Study|Randomized but not vaccinated|1|||
128820162|NCT04999111|463639250|FG001|Overall Study|Randomized but not vaccinated|2|||
128820163|NCT04999111|463639251|FG002|Overall Study|Randomized but not vaccinated|0|||
128820164|NCT04999111|463639252|FG003|Overall Study|Randomized but not vaccinated|3|||
128820165|NCT04999111|463639253|FG004|Overall Study|Randomized but not vaccinated|3|||
128820166|NCT04999111|463639254|FG005|Overall Study|Randomized but not vaccinated|0|||
128820167|NCT04999111|463639249|FG000|Overall Study|Adverse Event|1|||
128820168|NCT04999111|463639250|FG001|Overall Study|Adverse Event|1|||
128820169|NCT04999111|463639251|FG002|Overall Study|Adverse Event|0|||
128820170|NCT04999111|463639252|FG003|Overall Study|Adverse Event|0|||
128820171|NCT04999111|463639253|FG004|Overall Study|Adverse Event|0|||
128820172|NCT04999111|463639254|FG005|Overall Study|Adverse Event|0|||
128759496|NCT03685591|463408918|FG000|Overall Study|Adverse Event|0|||
128759497|NCT03685591|463408919|FG001|Overall Study|Adverse Event|0|||
128759498|NCT03685591|463408920|FG002|Overall Study|Adverse Event|0|||
128759499|NCT03685591|463408921|FG003|Overall Study|Adverse Event|1|||
128759500|NCT03685591|463408922|FG004|Overall Study|Adverse Event|1|||
128759501|NCT03685591|463408923|FG005|Overall Study|Adverse Event|4|||
128759502|NCT03685591|463408924|FG006|Overall Study|Adverse Event|0|||
128759503|NCT03685591|463408925|FG007|Overall Study|Adverse Event|1|||
128759504|NCT03685591|463408926|FG008|Overall Study|Adverse Event|1|||
128759505|NCT02220894|463408927|FG000|Overall Study|Adverse Event|127|||
128759506|NCT02220894|463408928|FG001|Overall Study|Adverse Event|74|||
128759507|NCT02220894|463408927|FG000|Overall Study|Death|418|||
128759508|NCT02220894|463408928|FG001|Overall Study|Death|508|||
128759509|NCT02220894|463408927|FG000|Overall Study|Lost to Follow-up|0|||
128759510|NCT02220894|463408928|FG001|Overall Study|Lost to Follow-up|4|||
128759511|NCT02220894|463408927|FG000|Overall Study|Site Terminated by Sponsor|2|||
128759512|NCT02220894|463408928|FG001|Overall Study|Site Terminated by Sponsor|0|||
128759513|NCT02220894|463408927|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
128759514|NCT02220894|463408928|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
128759515|NCT02220894|463408927|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128759516|NCT02220894|463408928|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
128759517|NCT02220894|463408927|FG000|Overall Study|Withdrawal by Subject|10|||
128759518|NCT02220894|463408928|FG001|Overall Study|Withdrawal by Subject|9|||
128759519|NCT00500903|463408931|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
128759520|NCT00500903|463408932|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
128759521|NCT00500903|463408933|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
128759522|NCT00500903|463408931|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
128759523|NCT00500903|463408932|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
128759524|NCT00500903|463408933|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
128759525|NCT00500903|463408931|FG000|Overall Study|Progressive Disease|41|||
128759526|NCT00500903|463408932|FG001|Overall Study|Progressive Disease|2|||
128759527|NCT00500903|463408933|FG002|Overall Study|Progressive Disease|15|||
128759528|NCT00500903|463408931|FG000|Overall Study|Patient Declined Further Treatment|0|||
128759529|NCT00500903|463408932|FG001|Overall Study|Patient Declined Further Treatment|0|||
128759530|NCT00500903|463408933|FG002|Overall Study|Patient Declined Further Treatment|3|||
128759531|NCT00500903|463408931|FG000|Overall Study|Symptomatic Deterioration|2|||
128759532|NCT00500903|463408932|FG001|Overall Study|Symptomatic Deterioration|0|||
128759533|NCT00500903|463408933|FG002|Overall Study|Symptomatic Deterioration|0|||
128759534|NCT00500903|463408931|FG000|Overall Study|Reason Not Specified|10|||
128759535|NCT00500903|463408932|FG001|Overall Study|Reason Not Specified|0|||
128759536|NCT00500903|463408933|FG002|Overall Study|Reason Not Specified|2|||
128759537|NCT00696410|463408936|FG000|Overall Study|Lost to Follow-up|2|||
128759538|NCT00696410|463408937|FG001|Overall Study|Lost to Follow-up|0|||
128759539|NCT00696410|463408936|FG000|Overall Study|Withdrawal by Subject|8|||
128759540|NCT00696410|463408937|FG001|Overall Study|Withdrawal by Subject|0|||
128759541|NCT00696410|463408936|FG000|Overall Study|Physician Decision|3|||
128759542|NCT00696410|463408937|FG001|Overall Study|Physician Decision|0|||
128759543|NCT00552084|463408940|FG000|Overall Study|Adverse Event|2|||
128759544|NCT00552084|463408941|FG001|Overall Study|Adverse Event|3|||
128759545|NCT00552084|463408940|FG000|Overall Study|Withdrawal by Subject|4|||
128759546|NCT00552084|463408941|FG001|Overall Study|Withdrawal by Subject|5|||
128759547|NCT00552084|463408940|FG000|Overall Study|Protocol Violation|1|||
128759548|NCT00552084|463408941|FG001|Overall Study|Protocol Violation|0|||
128759549|NCT00552084|463408940|FG000|Overall Study|change in anti-arrythmic drug|1|||
128759550|NCT00552084|463408941|FG001|Overall Study|change in anti-arrythmic drug|1|||
128820173|NCT04999111|463639249|FG000|Overall Study|Initiated prohibited medication|0|||
128820174|NCT04999111|463639250|FG001|Overall Study|Initiated prohibited medication|0|||
128820175|NCT04999111|463639251|FG002|Overall Study|Initiated prohibited medication|0|||
128820176|NCT04999111|463639252|FG003|Overall Study|Initiated prohibited medication|0|||
128820177|NCT04999111|463639253|FG004|Overall Study|Initiated prohibited medication|1|||
128820178|NCT04999111|463639254|FG005|Overall Study|Initiated prohibited medication|0|||
128820179|NCT02437136|463639257|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
128820180|NCT02437136|463639258|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
128820181|NCT02437136|463639259|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
128820182|NCT02437136|463639260|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
128820183|NCT02437136|463639261|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
128820184|NCT02437136|463639262|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
128820185|NCT02437136|463639263|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
128820186|NCT02437136|463639257|FG000|Expansion (Phase 2)|Death|0|||
128820187|NCT02437136|463639258|FG001|Expansion (Phase 2)|Death|0|||
128820188|NCT02437136|463639259|FG002|Expansion (Phase 2)|Death|0|||
128820189|NCT02437136|463639260|FG003|Expansion (Phase 2)|Death|6|||
128820190|NCT02437136|463639261|FG004|Expansion (Phase 2)|Death|37|||
128820191|NCT02437136|463639262|FG005|Expansion (Phase 2)|Death|29|||
128820192|NCT02437136|463639263|FG006|Expansion (Phase 2)|Death|24|||
128820193|NCT02437136|463639257|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
128820194|NCT02437136|463639258|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
128820195|NCT02437136|463639259|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
128820196|NCT02437136|463639260|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
128820197|NCT02437136|463639261|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
128820198|NCT02437136|463639262|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
128820199|NCT02437136|463639263|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
128820200|NCT02437136|463639257|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
128820201|NCT02437136|463639258|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
128820202|NCT02437136|463639259|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
128820203|NCT02437136|463639260|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
128820204|NCT02437136|463639261|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
128820205|NCT02437136|463639262|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
128820206|NCT02437136|463639263|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
128820207|NCT03640286|463639266|FG000|Overall Study|Adverse Event|6|||
128820208|NCT03640286|463639267|FG001|Overall Study|Adverse Event|6|||
128820209|NCT03640286|463639266|FG000|Overall Study|Lost to Follow-up|3|||
128820210|NCT03640286|463639267|FG001|Overall Study|Lost to Follow-up|6|||
128820211|NCT03640286|463639266|FG000|Overall Study|Pregnancy|1|||
128820212|NCT03640286|463639267|FG001|Overall Study|Pregnancy|0|||
128820213|NCT03640286|463639266|FG000|Overall Study|Withdrawal by Subject|10|||
128820214|NCT03640286|463639267|FG001|Overall Study|Withdrawal by Subject|10|||
128820215|NCT03640286|463639266|FG000|Overall Study|Non-compliance|4|||
128820216|NCT03640286|463639267|FG001|Overall Study|Non-compliance|10|||
128820217|NCT03640286|463639266|FG000|Overall Study|Medication change|1|||
128820218|NCT03640286|463639267|FG001|Overall Study|Medication change|0|||
128820219|NCT03640286|463639266|FG000|Overall Study|Other|1|||
128820220|NCT03640286|463639267|FG001|Overall Study|Other|2|||
128820221|NCT03640286|463639266|FG000|Overall Study|Joined another lifestyle program|0|||
128820222|NCT03640286|463639267|FG001|Overall Study|Joined another lifestyle program|1|||
128820223|NCT03181516|463639268|FG000|Overall Study|Withdrawal by Subject|14|||
128820224|NCT03181516|463639269|FG001|Overall Study|Withdrawal by Subject|7|||
128820225|NCT03181516|463639268|FG000|Overall Study|Lost to Follow-up|2|||
128820226|NCT03181516|463639269|FG001|Overall Study|Lost to Follow-up|2|||
128820227|NCT02839265|463639273|FG000|Overall Study|Screen Failure|2|||
128820228|NCT02839265|463639273|FG000|Overall Study|Death|1|||
128820229|NCT02839265|463639273|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
128820230|NCT03635424|463639274|FG000|Overall Study|Adverse Event|1|||
128820231|NCT03635424|463639274|FG000|Overall Study|Death|1|||
128820232|NCT03635424|463639274|FG000|Overall Study|Device not implanted|1|||
128820233|NCT02278211|463639275|FG000|Overall Study|Unable to analyse PET scan|2|||
128820234|NCT04167553|463639276|FG000|Overall Study|Withdrawal by Subject|1|||
128820235|NCT04167553|463639277|FG001|Overall Study|Withdrawal by Subject|0|||
128820236|NCT04167553|463639278|FG002|Overall Study|Withdrawal by Subject|1|||
128820237|NCT04167553|463639279|FG003|Overall Study|Withdrawal by Subject|2|||
128820238|NCT04167553|463639280|FG004|Overall Study|Withdrawal by Subject|1|||
128820239|NCT04167553|463639281|FG005|Overall Study|Withdrawal by Subject|0|||
128820240|NCT04167553|463639282|FG006|Overall Study|Withdrawal by Subject|0|||
128820241|NCT04167553|463639276|FG000|Overall Study|Physician Decision|0|||
128820242|NCT04167553|463639277|FG001|Overall Study|Physician Decision|0|||
128820243|NCT04167553|463639278|FG002|Overall Study|Physician Decision|0|||
128820244|NCT04167553|463639279|FG003|Overall Study|Physician Decision|0|||
128820245|NCT04167553|463639280|FG004|Overall Study|Physician Decision|2|||
128820246|NCT04167553|463639281|FG005|Overall Study|Physician Decision|2|||
128820247|NCT04167553|463639282|FG006|Overall Study|Physician Decision|0|||
128820248|NCT04167553|463639276|FG000|Overall Study|Lost to Follow-up|0|||
128820249|NCT04167553|463639277|FG001|Overall Study|Lost to Follow-up|0|||
128820250|NCT04167553|463639278|FG002|Overall Study|Lost to Follow-up|2|||
128820251|NCT04167553|463639279|FG003|Overall Study|Lost to Follow-up|0|||
128820252|NCT04167553|463639280|FG004|Overall Study|Lost to Follow-up|0|||
128820253|NCT04167553|463639281|FG005|Overall Study|Lost to Follow-up|0|||
128820254|NCT04167553|463639282|FG006|Overall Study|Lost to Follow-up|0|||
128820255|NCT05224544|463639285|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
128820256|NCT05224544|463639286|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
128820257|NCT00844415|463639287|FG000|Overall Study|Withdrawal by Subject|1|||
128820258|NCT02473445|463639288|FG000|Overall Study|Withdrawal by Subject|2|||
128820259|NCT02473445|463639288|FG000|Overall Study|Sponsor Decision|20|||
128820260|NCT03015532|463639289|FG000|Overall Study|Adverse Event|0|||
128820261|NCT03015532|463639290|FG001|Overall Study|Adverse Event|0|||
128820262|NCT03015532|463639291|FG002|Overall Study|Adverse Event|0|||
128820263|NCT03015532|463639292|FG003|Overall Study|Adverse Event|0|||
128820264|NCT03015532|463639293|FG004|Overall Study|Adverse Event|0|||
128820265|NCT03015532|463639294|FG005|Overall Study|Adverse Event|2|||
128820266|NCT03015532|463639295|FG006|Overall Study|Adverse Event|1|||
128820267|NCT03015532|463639296|FG007|Overall Study|Adverse Event|0|||
128820268|NCT03015532|463639289|FG000|Overall Study|Withdrawal by Subject|0|||
128820269|NCT03015532|463639290|FG001|Overall Study|Withdrawal by Subject|0|||
128820270|NCT03015532|463639291|FG002|Overall Study|Withdrawal by Subject|0|||
128820271|NCT03015532|463639292|FG003|Overall Study|Withdrawal by Subject|0|||
128820272|NCT03015532|463639293|FG004|Overall Study|Withdrawal by Subject|0|||
128820273|NCT03015532|463639294|FG005|Overall Study|Withdrawal by Subject|0|||
128820274|NCT03015532|463639295|FG006|Overall Study|Withdrawal by Subject|1|||
128820275|NCT03015532|463639296|FG007|Overall Study|Withdrawal by Subject|0|||
128820276|NCT05970861|463639297|FG000|Overall Study|Physician Decision|4|||
128820277|NCT05970861|463639298|FG001|Overall Study|Physician Decision|4|||
128820278|NCT05970861|463639297|FG000|Overall Study|Lost to Follow-up|4|||
128820279|NCT05970861|463639298|FG001|Overall Study|Lost to Follow-up|3|||
128820280|NCT03988621|463639302|FG000|Overall Study|Lost to Follow-up|16|||
128820281|NCT03988621|463639303|FG001|Overall Study|Lost to Follow-up|17|||
128820282|NCT03988621|463639302|FG000|Overall Study|Withdrawal by Subject|14|||
128820283|NCT03988621|463639303|FG001|Overall Study|Withdrawal by Subject|7|||
128820284|NCT03988621|463639302|FG000|Overall Study|Patient Lost to Follow Up|15|||
128820285|NCT03988621|463639303|FG001|Overall Study|Patient Lost to Follow Up|15|||
128820286|NCT03988621|463639302|FG000|Overall Study|Patient death|1|||
128820287|NCT03988621|463639303|FG001|Overall Study|Patient death|5|||
128820288|NCT04629339|463639304|FG000|Overall Study|Death|1|||
128820289|NCT04629339|463639305|FG001|Overall Study|Death|0|||
128820290|NCT04629339|463639306|FG002|Overall Study|Death|2|||
128820291|NCT04629339|463639307|FG003|Overall Study|Death|2|||
128820292|NCT04629339|463639308|FG004|Overall Study|Death|0|||
128820293|NCT04629339|463639304|FG000|Overall Study|Disease Progression|0|||
128820294|NCT04629339|463639305|FG001|Overall Study|Disease Progression|0|||
128820295|NCT04629339|463639306|FG002|Overall Study|Disease Progression|1|||
128820296|NCT04629339|463639307|FG003|Overall Study|Disease Progression|1|||
128820297|NCT04629339|463639308|FG004|Overall Study|Disease Progression|0|||
128820298|NCT04629339|463639304|FG000|Overall Study|Lost to Follow-up|0|||
128820299|NCT04629339|463639305|FG001|Overall Study|Lost to Follow-up|0|||
128820300|NCT04629339|463639306|FG002|Overall Study|Lost to Follow-up|0|||
128820301|NCT04629339|463639307|FG003|Overall Study|Lost to Follow-up|1|||
128820302|NCT04629339|463639308|FG004|Overall Study|Lost to Follow-up|0|||
128820303|NCT04629339|463639304|FG000|Overall Study|Physician Decision|0|||
128820304|NCT04629339|463639305|FG001|Overall Study|Physician Decision|1|||
128820305|NCT04629339|463639306|FG002|Overall Study|Physician Decision|0|||
128820306|NCT04629339|463639307|FG003|Overall Study|Physician Decision|0|||
128820307|NCT04629339|463639308|FG004|Overall Study|Physician Decision|0|||
128820308|NCT04629339|463639304|FG000|Overall Study|Study Terminated by Sponsor|0|||
128820309|NCT04629339|463639305|FG001|Overall Study|Study Terminated by Sponsor|0|||
128820310|NCT04629339|463639306|FG002|Overall Study|Study Terminated by Sponsor|0|||
128820311|NCT04629339|463639307|FG003|Overall Study|Study Terminated by Sponsor|1|||
128820312|NCT04629339|463639308|FG004|Overall Study|Study Terminated by Sponsor|0|||
128820313|NCT04629339|463639304|FG000|Overall Study|Withdrawal by Subject|0|||
128820314|NCT04629339|463639305|FG001|Overall Study|Withdrawal by Subject|0|||
128820315|NCT04629339|463639306|FG002|Overall Study|Withdrawal by Subject|2|||
128820316|NCT04629339|463639307|FG003|Overall Study|Withdrawal by Subject|2|||
128820317|NCT04629339|463639308|FG004|Overall Study|Withdrawal by Subject|0|||
128820318|NCT04158739|463639311|FG000|Overall Study|Adverse Event|1|||
128820319|NCT04158739|463639312|FG001|Overall Study|Adverse Event|0|||
128820320|NCT04158739|463639311|FG000|Overall Study|Death|0|||
128820321|NCT04158739|463639312|FG001|Overall Study|Death|1|||
128820322|NCT04158739|463639311|FG000|Overall Study|Lack of Efficacy|3|||
128820323|NCT04158739|463639312|FG001|Overall Study|Lack of Efficacy|7|||
128820324|NCT04158739|463639311|FG000|Overall Study|Physician Decision|0|||
128820325|NCT04158739|463639312|FG001|Overall Study|Physician Decision|1|||
128820326|NCT04158739|463639311|FG000|Overall Study|Withdrawal by Subject|3|||
128820327|NCT04158739|463639312|FG001|Overall Study|Withdrawal by Subject|0|||
128820328|NCT03914469|463639313|FG000|Overall Study|Lost to Follow-up|1|||
128820329|NCT03914469|463639314|FG001|Overall Study|Lost to Follow-up|4|||
128820330|NCT04778410|463639315|FG000|Safety Run-in Period|Death|5|||
128820331|NCT04778410|463639316|FG001|Safety Run-in Period|Death|6|||
128820332|NCT04778410|463639317|FG002|Safety Run-in Period|Death|0|||
128820333|NCT04778410|463639318|FG003|Safety Run-in Period|Death|0|||
128820334|NCT04778410|463639319|FG004|Safety Run-in Period|Death|0|||
128820335|NCT04778410|463639320|FG005|Safety Run-in Period|Death|0|||
128820336|NCT04778410|463639315|FG000|Phase 2 Period|Death|0|||
128820337|NCT04778410|463639316|FG001|Phase 2 Period|Death|0|||
128820338|NCT04778410|463639317|FG002|Phase 2 Period|Death|0|||
128820339|NCT04778410|463639318|FG003|Phase 2 Period|Death|5|||
128820340|NCT04778410|463639319|FG004|Phase 2 Period|Death|18|||
128820341|NCT04778410|463639320|FG005|Phase 2 Period|Death|0|||
128820342|NCT04778410|463639315|FG000|Phase 2 Period|Lost to Follow-up|0|||
128820343|NCT04778410|463639316|FG001|Phase 2 Period|Lost to Follow-up|0|||
128820344|NCT04778410|463639317|FG002|Phase 2 Period|Lost to Follow-up|0|||
128820345|NCT04778410|463639318|FG003|Phase 2 Period|Lost to Follow-up|1|||
128820346|NCT04778410|463639319|FG004|Phase 2 Period|Lost to Follow-up|1|||
128820347|NCT04778410|463639320|FG005|Phase 2 Period|Lost to Follow-up|0|||
128820348|NCT04778410|463639315|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
128820349|NCT04778410|463639316|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
128820350|NCT04778410|463639317|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
128820351|NCT04778410|463639318|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
128820352|NCT04778410|463639319|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
128820353|NCT04778410|463639320|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
128820354|NCT04778410|463639315|FG000|Phase 2 Period|Withdrew Consent|0|||
128820355|NCT04778410|463639316|FG001|Phase 2 Period|Withdrew Consent|0|||
128820356|NCT04778410|463639317|FG002|Phase 2 Period|Withdrew Consent|0|||
128820357|NCT04778410|463639318|FG003|Phase 2 Period|Withdrew Consent|0|||
128820358|NCT04778410|463639319|FG004|Phase 2 Period|Withdrew Consent|2|||
128820359|NCT04778410|463639320|FG005|Phase 2 Period|Withdrew Consent|0|||
128820360|NCT00677365|463639325|FG000|Overall Study|Adverse Event|2|||
128820361|NCT00677365|463639326|FG001|Overall Study|Adverse Event|1|||
128820362|NCT00677365|463639327|FG002|Overall Study|Adverse Event|1|||
128820363|NCT00677365|463639328|FG003|Overall Study|Adverse Event|2|||
128820364|NCT00677365|463639325|FG000|Overall Study|Withdrawal by Subject|0|||
128820365|NCT00677365|463639326|FG001|Overall Study|Withdrawal by Subject|0|||
128820366|NCT00677365|463639327|FG002|Overall Study|Withdrawal by Subject|1|||
128820367|NCT00677365|463639328|FG003|Overall Study|Withdrawal by Subject|0|||
128820368|NCT00677365|463639325|FG000|Overall Study|Other reason|0|||
128820369|NCT00677365|463639326|FG001|Overall Study|Other reason|0|||
128820370|NCT00677365|463639327|FG002|Overall Study|Other reason|0|||
128820371|NCT00677365|463639328|FG003|Overall Study|Other reason|1|||
128820372|NCT01121588|463639329|FG000|Overall Study|Death|5|||
128820373|NCT01121588|463639330|FG001|Overall Study|Death|3|||
128820374|NCT01121588|463639331|FG002|Overall Study|Death|13|||
128820375|NCT01121588|463639329|FG000|Overall Study|Study Terminated by Sponsor|1|||
128820376|NCT01121588|463639330|FG001|Overall Study|Study Terminated by Sponsor|1|||
128820377|NCT01121588|463639331|FG002|Overall Study|Study Terminated by Sponsor|0|||
128820378|NCT01121588|463639329|FG000|Overall Study|Participant Refused Further Followup|2|||
128820379|NCT01121588|463639330|FG001|Overall Study|Participant Refused Further Followup|0|||
128820380|NCT01121588|463639331|FG002|Overall Study|Participant Refused Further Followup|2|||
128820381|NCT01121588|463639329|FG000|Overall Study|Lost to Follow-up|0|||
128820382|NCT01121588|463639330|FG001|Overall Study|Lost to Follow-up|1|||
128820383|NCT01121588|463639331|FG002|Overall Study|Lost to Follow-up|1|||
128820384|NCT01121588|463639329|FG000|Overall Study|Non-Specified Reasons|9|||
128820385|NCT01121588|463639330|FG001|Overall Study|Non-Specified Reasons|4|||
128820386|NCT01121588|463639331|FG002|Overall Study|Non-Specified Reasons|2|||
128820387|NCT04583280|463639334|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
128820388|NCT04583280|463639335|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
128820389|NCT05158504|463639336|FG000|Overall Study|Lost to Follow-up|2|||
128820390|NCT05158504|463639337|FG001|Overall Study|Lost to Follow-up|3|||
128820391|NCT03606512|463639338|FG000|Overall Study|Lost to Follow-up|0|||
128820392|NCT03606512|463639339|FG001|Overall Study|Lost to Follow-up|1|||
128820393|NCT03606512|463639338|FG000|Overall Study|'moved from study area|0|||
128820394|NCT03606512|463639339|FG001|Overall Study|'moved from study area|1|||
128820395|NCT05513937|463639340|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
128820396|NCT05513937|463639341|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
128820397|NCT05513937|463639342|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
128820398|NCT05513937|463639343|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
128820399|NCT05513937|463639340|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
128820400|NCT05513937|463639341|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
128820401|NCT05513937|463639342|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
128820402|NCT05513937|463639343|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
128820403|NCT05513937|463639340|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
128820404|NCT05513937|463639341|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
128820405|NCT05513937|463639342|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
128820406|NCT05513937|463639343|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
128820407|NCT05513937|463639340|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
128820408|NCT05513937|463639341|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
128820409|NCT05513937|463639342|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
128820410|NCT05513937|463639343|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
128820411|NCT05513937|463639340|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
128820412|NCT05513937|463639341|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
128820413|NCT05513937|463639342|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
128820414|NCT05513937|463639343|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
128820415|NCT05513937|463639340|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
128820416|NCT05513937|463639341|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
128820417|NCT05513937|463639342|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
128820418|NCT05513937|463639343|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
128820419|NCT02577354|463639344|FG000|Overall Study|Lack of Efficacy|4|||
128820420|NCT02577354|463639345|FG001|Overall Study|Lack of Efficacy|4|||
128820421|NCT02577354|463639344|FG000|Overall Study|Lost to Follow-up|3|||
128820422|NCT02577354|463639345|FG001|Overall Study|Lost to Follow-up|1|||
128820423|NCT02577354|463639344|FG000|Overall Study|Missed Visit|4|||
128820424|NCT02577354|463639345|FG001|Overall Study|Missed Visit|3|||
128820425|NCT02577354|463639344|FG000|Overall Study|Adverse Event|4|||
128820426|NCT02577354|463639345|FG001|Overall Study|Adverse Event|5|||
128820427|NCT03245840|463639346|FG000|Overall Study|Adverse Event|6|||
128820428|NCT03245840|463639347|FG001|Overall Study|Adverse Event|0|||
128820429|NCT03245840|463639346|FG000|Overall Study|Death|2|||
128820430|NCT03245840|463639347|FG001|Overall Study|Death|0|||
128820431|NCT03245840|463639346|FG000|Overall Study|Withdrawal by Subject|31|||
128820432|NCT03245840|463639347|FG001|Overall Study|Withdrawal by Subject|1|||
128820433|NCT03245840|463639346|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
128820434|NCT03245840|463639347|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128820435|NCT03245840|463639346|FG000|Overall Study|Physician Decision|4|||
128820436|NCT03245840|463639347|FG001|Overall Study|Physician Decision|1|||
128820437|NCT03245840|463639346|FG000|Overall Study|Study Terminated by Sponsor|56|||
128820438|NCT03245840|463639347|FG001|Overall Study|Study Terminated by Sponsor|6|||
128820439|NCT03245840|463639346|FG000|Overall Study|Site Terminated by Sponsor|4|||
128820440|NCT03245840|463639347|FG001|Overall Study|Site Terminated by Sponsor|0|||
128820441|NCT03245840|463639346|FG000|Overall Study|Lost to Follow-up|12|||
128820442|NCT03245840|463639347|FG001|Overall Study|Lost to Follow-up|2|||
128820443|NCT03245840|463639346|FG000|Overall Study|Pregnancy|2|||
128820444|NCT03245840|463639347|FG001|Overall Study|Pregnancy|0|||
128820445|NCT03245840|463639346|FG000|Overall Study|Non-Compliance with Study Drug|2|||
128820446|NCT03245840|463639347|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128820447|NCT03245840|463639346|FG000|Overall Study|Not treated|1|||
128820448|NCT03245840|463639347|FG001|Overall Study|Not treated|1|||
128820449|NCT04109066|463639348|FG000|Pre-treatment|Participant withdrew consent|2|||
128820450|NCT04109066|463639349|FG001|Pre-treatment|Participant withdrew consent|0|||
128820451|NCT04109066|463639348|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
128820452|NCT04109066|463639349|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
128820453|NCT04109066|463639348|FG000|Treatment|Lack of Efficacy|2|||
128820454|NCT04109066|463639349|FG001|Treatment|Lack of Efficacy|4|||
128820455|NCT04109066|463639348|FG000|Treatment|Adverse Event|23|||
128820456|NCT04109066|463639349|FG001|Treatment|Adverse Event|7|||
128820457|NCT04109066|463639348|FG000|Treatment|Participant request to discontinue Study treatment|15|||
128820458|NCT04109066|463639349|FG001|Treatment|Participant request to discontinue Study treatment|14|||
128820459|NCT04109066|463639348|FG000|Treatment|Withdrawal by Subject|8|||
128820460|NCT04109066|463639349|FG001|Treatment|Withdrawal by Subject|8|||
128820461|NCT04109066|463639348|FG000|Treatment|Death|3|||
128820462|NCT04109066|463639349|FG001|Treatment|Death|0|||
128820463|NCT04109066|463639348|FG000|Treatment|Participant no longer meets study criteria|2|||
128820464|NCT04109066|463639349|FG001|Treatment|Participant no longer meets study criteria|2|||
128820465|NCT04109066|463639348|FG000|Treatment|Administrative reasons by sponsor|2|||
128820466|NCT04109066|463639349|FG001|Treatment|Administrative reasons by sponsor|3|||
128820467|NCT04109066|463639348|FG000|Treatment|Other reasons|17|||
128820468|NCT04109066|463639349|FG001|Treatment|Other reasons|23|||
128820469|NCT04109066|463639348|FG000|Treatment|Disease Progression|4|||
128820470|NCT04109066|463639349|FG001|Treatment|Disease Progression|7|||
128820471|NCT04109066|463639348|FG000|Treatment|Study drug toxicity|12|||
128820472|NCT04109066|463639349|FG001|Treatment|Study drug toxicity|5|||
128820473|NCT04109066|463639348|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
128820474|NCT04109066|463639349|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
128820475|NCT04109066|463639348|FG000|Treatment|Disease Recurrence|0|||
128820476|NCT04109066|463639349|FG001|Treatment|Disease Recurrence|2|||
128820477|NCT04109066|463639348|FG000|Treatment|Not reported|4|||
128820478|NCT04109066|463639349|FG001|Treatment|Not reported|8|||
128820479|NCT05890105|463639350|FG000|Overall Study|Adverse Event|1|||
128820480|NCT05890105|463639351|FG001|Overall Study|Adverse Event|0|||
128820481|NCT05890105|463639352|FG002|Overall Study|Adverse Event|0|||
128820482|NCT05890105|463639350|FG000|Overall Study|Other|1|||
128820483|NCT05890105|463639351|FG001|Overall Study|Other|2|||
128820484|NCT05890105|463639352|FG002|Overall Study|Other|0|||
128820540|NCT06262477|463641868|FG000|Overall Study|Withdrawal by Subject|1|||
128820541|NCT06262477|463641869|FG001|Overall Study|Withdrawal by Subject|0|||
128820542|NCT06262477|463641868|FG000|Overall Study|Adverse Event|0|||
128820543|NCT06262477|463641869|FG001|Overall Study|Adverse Event|1|||
128820544|NCT06262477|463641868|FG000|Overall Study|Lost to Follow-up|0|||
128820545|NCT06262477|463641869|FG001|Overall Study|Lost to Follow-up|1|||
128820546|NCT01064440|463641870|FG000|Overall Study|Lost to Follow-up|1|||
128820547|NCT01064440|463641871|FG001|Overall Study|Lost to Follow-up|1|||
128820548|NCT01064440|463641872|FG002|Overall Study|Lost to Follow-up|1|||
128820549|NCT01064440|463641870|FG000|Overall Study|Non-compliance|0|||
128820550|NCT01064440|463641871|FG001|Overall Study|Non-compliance|1|||
128820551|NCT01064440|463641872|FG002|Overall Study|Non-compliance|0|||
128820552|NCT01064440|463641870|FG000|Overall Study|Death|1|||
128820553|NCT01064440|463641871|FG001|Overall Study|Death|0|||
128820554|NCT01064440|463641872|FG002|Overall Study|Death|1|||
128820555|NCT01064440|463641870|FG000|Overall Study|Withdrawal by Subject|0|||
128820556|NCT01064440|463641871|FG001|Overall Study|Withdrawal by Subject|1|||
128820557|NCT01064440|463641872|FG002|Overall Study|Withdrawal by Subject|1|||
128820558|NCT01064440|463641870|FG000|Overall Study|Other: amputation|1|||
128820559|NCT01064440|463641871|FG001|Overall Study|Other: amputation|0|||
128820560|NCT01064440|463641872|FG002|Overall Study|Other: amputation|0|||
128820575|NCT04108130|463641875|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
128820576|NCT04108130|463641876|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
128820577|NCT04108130|463641875|FG000|Overall Study|Consent Withdrawn|9|||
128820578|NCT04108130|463641876|FG001|Overall Study|Consent Withdrawn|6|||
128820579|NCT04108130|463641875|FG000|Overall Study|Surgery Cancelled|4|||
128820580|NCT04108130|463641876|FG001|Overall Study|Surgery Cancelled|4|||
128820581|NCT04108130|463641875|FG000|Overall Study|Found Ineligible for Study|4|||
128820582|NCT04108130|463641876|FG001|Overall Study|Found Ineligible for Study|3|||
128820583|NCT04108130|463641875|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
128820584|NCT04108130|463641876|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
128820585|NCT04108130|463641875|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
128820586|NCT04108130|463641876|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
128820602|NCT05507333|463641889|FG000|Overall Study|Protocol Violation|1|||
128820819|NCT02585323|463641937|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
128820820|NCT02585323|463641938|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
128820821|NCT02585323|463641937|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
128820822|NCT02585323|463641938|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
128820823|NCT02585323|463641937|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
128820824|NCT02585323|463641938|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
128820825|NCT02585323|463641937|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
128820826|NCT02585323|463641938|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
128820827|NCT01130883|463641939|FG000|Overall Study|Patient Noncompliance|6|||
128820828|NCT01130883|463641939|FG000|Overall Study|Reason Unknown|1|||
128820829|NCT01130883|463641939|FG000|Overall Study|Adverse Event|3|||
128821301|NCT03972150|463644452|FG000|Overall Study|Adverse Event|0|||
128821302|NCT03972150|463644453|FG001|Overall Study|Adverse Event|1|||
128821303|NCT03972150|463644454|FG002|Overall Study|Adverse Event|1|||
128821304|NCT03972150|463644455|FG003|Overall Study|Adverse Event|0|||
128821305|NCT03972150|463644456|FG004|Overall Study|Adverse Event|0|||
128821306|NCT03972150|463644452|FG000|Overall Study|Progressive disease|3|||
128821307|NCT03972150|463644453|FG001|Overall Study|Progressive disease|5|||
128821308|NCT03972150|463644454|FG002|Overall Study|Progressive disease|2|||
128821309|NCT03972150|463644455|FG003|Overall Study|Progressive disease|2|||
128821310|NCT03972150|463644456|FG004|Overall Study|Progressive disease|3|||
128821311|NCT04183283|463644458|FG000|Period 1|Withdrawal by Subject|0|||
128821312|NCT04183283|463644459|FG001|Period 1|Withdrawal by Subject|1|||
128821313|NCT04183283|463644460|FG002|Period 1|Withdrawal by Subject|0|||
128821314|NCT04183283|463644461|FG003|Period 1|Withdrawal by Subject|0|||
128821315|NCT04183283|463644458|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
128821316|NCT04183283|463644459|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
128821317|NCT04183283|463644460|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
128821318|NCT04183283|463644461|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
128821512|NCT03981926|463644521|FG000|Overall Study|Lost to Follow-up|5|||
128821513|NCT03981926|463644522|FG001|Overall Study|Lost to Follow-up|9|||
128821550|NCT05464069|463644532|FG000|Overall Study|Protocol Violation|3|||
128821551|NCT05464069|463644533|FG001|Overall Study|Protocol Violation|2|||
128821640|NCT04136912|463644559|FG000|Overall Study|Operational reasons|0|||
128821641|NCT04136912|463644560|FG001|Overall Study|Operational reasons|0|||
128821642|NCT04136912|463644561|FG002|Overall Study|Operational reasons|2|||
128821646|NCT05976334|463644565|FG000|Part B|Death|0|||
128821647|NCT05976334|463644566|FG001|Part B|Death|1|||
128821648|NCT05976334|463644565|FG000|Part B|Study Terminated by Sponsor|0|||
128821649|NCT05976334|463644566|FG001|Part B|Study Terminated by Sponsor|1|||
128821650|NCT05976334|463644565|FG000|Part B|Reason Not Specified|0|||
128821651|NCT05976334|463644566|FG001|Part B|Reason Not Specified|1|||
128821680|NCT04526886|463644574|FG000|Overall Study|Physician Decision|4|||
128821743|NCT04632225|463644605|FG000|Overall Study|Withdrawal by Subject|2|||
128821744|NCT04632225|463644606|FG001|Overall Study|Withdrawal by Subject|2|||
128821943|NCT01475786|463645557|FG000|Overall Study|Adverse Event|0|||
128821944|NCT01475786|463645558|FG001|Overall Study|Adverse Event|1|||
128821945|NCT01475786|463645559|FG002|Overall Study|Adverse Event|0|||
128821946|NCT01475786|463645557|FG000|Overall Study|Lost to Follow-up|1|||
128821947|NCT01475786|463645558|FG001|Overall Study|Lost to Follow-up|2|||
128821948|NCT01475786|463645559|FG002|Overall Study|Lost to Follow-up|1|||
128821949|NCT01475786|463645557|FG000|Overall Study|Withdrawal by Subject|0|||
128821950|NCT01475786|463645558|FG001|Overall Study|Withdrawal by Subject|1|||
128821951|NCT01475786|463645559|FG002|Overall Study|Withdrawal by Subject|1|||
128821952|NCT01475786|463645557|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
128821953|NCT01475786|463645558|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
128821954|NCT01475786|463645559|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
129204892|NCT02469623|465046981|FG000|Overall Study|Not consented for long-term follow-up|4|||
129204893|NCT02469623|465046981|FG000|Overall Study|Lost to Follow-up|4|||
129204894|NCT02469623|465046981|FG000|Overall Study|Withdrawal by Subject|2|||
128822009|NCT02039401|463645580|FG000|Overall Study|Adverse Event|0|||
128822010|NCT02039401|463645581|FG001|Overall Study|Adverse Event|1|||
128822023|NCT03057054|463645586|FG000|Overall Study|Death|4|||
128822024|NCT03057054|463645587|FG001|Overall Study|Death|4|||
128822025|NCT03057054|463645586|FG000|Overall Study|Withdrawal by Subject|6|||
128822026|NCT03057054|463645587|FG001|Overall Study|Withdrawal by Subject|3|||
128822027|NCT03057054|463645586|FG000|Overall Study|Ineligible|1|||
128822028|NCT03057054|463645587|FG001|Overall Study|Ineligible|1|||
128822065|NCT03734029|463645606|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
128822066|NCT03734029|463645607|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
128822067|NCT03734029|463645606|FG000|Overall Study|Adverse Event|60|||
128822068|NCT03734029|463645607|FG001|Overall Study|Adverse Event|14|||
128822069|NCT03734029|463645606|FG000|Overall Study|Withdrawal by Subject|12|||
128822070|NCT03734029|463645607|FG001|Overall Study|Withdrawal by Subject|11|||
128822071|NCT03734029|463645606|FG000|Overall Study|Clinical progression by investigator|10|||
128822072|NCT03734029|463645607|FG001|Overall Study|Clinical progression by investigator|8|||
128822073|NCT03734029|463645606|FG000|Overall Study|Death|5|||
128822074|NCT03734029|463645607|FG001|Overall Study|Death|2|||
128822075|NCT03734029|463645606|FG000|Overall Study|Physician Decision|4|||
128822076|NCT03734029|463645607|FG001|Overall Study|Physician Decision|3|||
128822077|NCT03734029|463645606|FG000|Overall Study|Other|2|||
128822078|NCT03734029|463645607|FG001|Overall Study|Other|0|||
128822079|NCT03734029|463645606|FG000|Overall Study|Lost to Follow-up|0|||
128822080|NCT03734029|463645607|FG001|Overall Study|Lost to Follow-up|1|||
128822081|NCT03734029|463645606|FG000|Overall Study|Randomized, but not treated|2|||
128822082|NCT03734029|463645607|FG001|Overall Study|Randomized, but not treated|12|||
128870687|NCT02071290|463820690|FG001|Overall Study|Withdrawal by Subject|1|||
128870688|NCT02071290|463820689|FG000|Overall Study|Protocol Violation|3|||
128870689|NCT02071290|463820690|FG001|Overall Study|Protocol Violation|5|||
128870690|NCT02071290|463820689|FG000|Overall Study|Physician Decision|0|||
128870691|NCT02071290|463820690|FG001|Overall Study|Physician Decision|1|||
128870692|NCT05560243|463820692|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
128870693|NCT01072630|463820697|FG000|Overall Study|Adverse Event|11|||
128870694|NCT01072630|463820698|FG001|Overall Study|Adverse Event|19|||
128870695|NCT01072630|463820699|FG002|Overall Study|Adverse Event|2|||
128870696|NCT01072630|463820697|FG000|Overall Study|Lack of Efficacy|10|||
128870697|NCT01072630|463820698|FG001|Overall Study|Lack of Efficacy|10|||
128870698|NCT01072630|463820699|FG002|Overall Study|Lack of Efficacy|1|||
128870699|NCT01072630|463820697|FG000|Overall Study|Withdrawal by Subject|8|||
128870700|NCT01072630|463820698|FG001|Overall Study|Withdrawal by Subject|7|||
128870701|NCT01072630|463820699|FG002|Overall Study|Withdrawal by Subject|2|||
128870702|NCT01072630|463820697|FG000|Overall Study|Protocol Violation|10|||
128870703|NCT01072630|463820698|FG001|Overall Study|Protocol Violation|8|||
128870704|NCT01072630|463820699|FG002|Overall Study|Protocol Violation|4|||
128870705|NCT01072630|463820697|FG000|Overall Study|Lost to Follow-up|11|||
128870706|NCT01072630|463820698|FG001|Overall Study|Lost to Follow-up|11|||
128870707|NCT01072630|463820699|FG002|Overall Study|Lost to Follow-up|1|||
128870708|NCT01072630|463820697|FG000|Overall Study|Noncompliance with study medication|1|||
128870709|NCT01072630|463820698|FG001|Overall Study|Noncompliance with study medication|1|||
128870710|NCT01072630|463820699|FG002|Overall Study|Noncompliance with study medication|1|||
128870711|NCT01072630|463820697|FG000|Overall Study|Noncompliance with study procedures|1|||
128870712|NCT01072630|463820698|FG001|Overall Study|Noncompliance with study procedures|2|||
128870713|NCT01072630|463820699|FG002|Overall Study|Noncompliance with study procedures|1|||
128870714|NCT01072630|463820697|FG000|Overall Study|Other|3|||
128870715|NCT01072630|463820698|FG001|Overall Study|Other|2|||
128870716|NCT01072630|463820699|FG002|Overall Study|Other|1|||
128870717|NCT01232738|463820700|FG000|Overall Study|Death|3|||
128870718|NCT01232738|463820700|FG000|Overall Study|Physician Decision|2|||
128870719|NCT01232738|463820700|FG000|Overall Study|Lost to Follow-up|1|||
128870720|NCT01232738|463820700|FG000|Overall Study|Withdrawal by Subject|2|||
128822101|NCT03367156|463646441|FG000|Overall Study|Lack of interest|3|||
128822102|NCT03367156|463646442|FG001|Overall Study|Lack of interest|1|||
128822103|NCT03367156|463646441|FG000|Overall Study|Death|2|||
128822104|NCT03367156|463646442|FG001|Overall Study|Death|0|||
128822105|NCT03367156|463646441|FG000|Overall Study|Lost to Follow-up|2|||
128822106|NCT03367156|463646442|FG001|Overall Study|Lost to Follow-up|1|||
128822107|NCT03367156|463646441|FG000|Overall Study|Became ineligible|1|||
128822108|NCT03367156|463646442|FG001|Overall Study|Became ineligible|2|||
128822109|NCT03367156|463646441|FG000|Overall Study|Hospitalization|1|||
128822110|NCT03367156|463646442|FG001|Overall Study|Hospitalization|0|||
128822111|NCT03367156|463646441|FG000|Overall Study|Concerned about Treatment|11|||
128822112|NCT03367156|463646442|FG001|Overall Study|Concerned about Treatment|3|||
128822113|NCT03367156|463646441|FG000|Overall Study|Started new treatment|4|||
128822114|NCT03367156|463646442|FG001|Overall Study|Started new treatment|1|||
128822115|NCT05507437|463646443|FG000|Overall Study|Withdrawal by Subject|1|||
128822116|NCT05507437|463646444|FG001|Overall Study|Withdrawal by Subject|1|||
128822117|NCT05507437|463646443|FG000|Overall Study|Death|3|||
128822118|NCT05507437|463646444|FG001|Overall Study|Death|0|||
128822119|NCT04282980|463646446|FG000|Overall Study|Remained on treatment|6|||
128822120|NCT04282980|463646446|FG000|Overall Study|Survival follow-up|11|||
128822121|NCT04282980|463646446|FG000|Overall Study|Withdrawal of informed consent|1|||
128822122|NCT04282980|463646446|FG000|Overall Study|Lost to Follow-up|1|||
128822123|NCT03571386|463646448|FG000|Overall Study|scheduling conflict|4|||
128822124|NCT03571386|463646449|FG001|Overall Study|scheduling conflict|0|||
128822125|NCT03571386|463646448|FG000|Overall Study|Withdrawal by Subject|15|||
128822126|NCT03571386|463646449|FG001|Overall Study|Withdrawal by Subject|5|||
128822127|NCT04311632|463646450|FG000|Overall Study|Withdrawal by Subject|0|||
128822128|NCT04311632|463646451|FG001|Overall Study|Withdrawal by Subject|0|||
128822129|NCT04311632|463646452|FG002|Overall Study|Withdrawal by Subject|1|||
128822130|NCT04605159|463646453|FG000|Overall Study|Adverse Event|6|||
128822131|NCT04605159|463646454|FG001|Overall Study|Adverse Event|3|||
128822132|NCT04605159|463646455|FG002|Overall Study|Adverse Event|21|||
128822133|NCT04605159|463646456|FG003|Overall Study|Adverse Event|4|||
128822134|NCT04605159|463646453|FG000|Overall Study|Lost to Follow-up|74|||
128822135|NCT04605159|463646454|FG001|Overall Study|Lost to Follow-up|45|||
128822136|NCT04605159|463646455|FG002|Overall Study|Lost to Follow-up|119|||
128822137|NCT04605159|463646456|FG003|Overall Study|Lost to Follow-up|80|||
128822138|NCT04605159|463646453|FG000|Overall Study|Protocol Violation|4|||
128822139|NCT04605159|463646454|FG001|Overall Study|Protocol Violation|5|||
128822140|NCT04605159|463646455|FG002|Overall Study|Protocol Violation|2|||
128822141|NCT04605159|463646456|FG003|Overall Study|Protocol Violation|0|||
128822142|NCT04605159|463646453|FG000|Overall Study|Withdrawal by Subject|66|||
128822143|NCT04605159|463646454|FG001|Overall Study|Withdrawal by Subject|37|||
128822144|NCT04605159|463646455|FG002|Overall Study|Withdrawal by Subject|68|||
128822145|NCT04605159|463646456|FG003|Overall Study|Withdrawal by Subject|50|||
128822146|NCT04605159|463646453|FG000|Overall Study|Migrated / moved from the study area|32|||
128822147|NCT04605159|463646454|FG001|Overall Study|Migrated / moved from the study area|22|||
128822148|NCT04605159|463646455|FG002|Overall Study|Migrated / moved from the study area|41|||
128822149|NCT04605159|463646456|FG003|Overall Study|Migrated / moved from the study area|21|||
128822150|NCT04605159|463646453|FG000|Overall Study|Other|1|||
128822151|NCT04605159|463646454|FG001|Overall Study|Other|2|||
128822152|NCT04605159|463646455|FG002|Overall Study|Other|7|||
128822153|NCT04605159|463646456|FG003|Overall Study|Other|3|||
128822154|NCT04881461|463646457|FG000|Overall Study|Adverse Event|2|||
128822155|NCT04881461|463646458|FG001|Overall Study|Adverse Event|4|||
128822156|NCT04881461|463646457|FG000|Overall Study|Withdrawal by Subject|19|||
128822157|NCT04881461|463646458|FG001|Overall Study|Withdrawal by Subject|19|||
128822158|NCT04881461|463646457|FG000|Overall Study|Lost to Follow-up|4|||
128822159|NCT04881461|463646458|FG001|Overall Study|Lost to Follow-up|4|||
128822160|NCT04881461|463646457|FG000|Overall Study|Lack of Efficacy|1|||
128822161|NCT04881461|463646458|FG001|Overall Study|Lack of Efficacy|0|||
128822162|NCT04881461|463646457|FG000|Overall Study|"Reason stated as other in CRF"|1|||
128822163|NCT04881461|463646458|FG001|Overall Study|"Reason stated as other in CRF"|2|||
128822164|NCT05422885|463646465|FG000|Overall Study|Lost to Follow-up|1|||
128822165|NCT05422885|463646465|FG000|Overall Study|Withdrawal by Subject|2|||
128822166|NCT04084574|463646466|FG000|Overall Study|Lost to Follow-up|1|||
128822167|NCT04084574|463646467|FG001|Overall Study|Lost to Follow-up|0|||
128822168|NCT04084574|463646466|FG000|Overall Study|Physician Decision|1|||
128822169|NCT04084574|463646467|FG001|Overall Study|Physician Decision|0|||
128822170|NCT04084574|463646466|FG000|Overall Study|Relocated out of state|1|||
128822171|NCT04084574|463646467|FG001|Overall Study|Relocated out of state|0|||
128822172|NCT02944968|463646468|FG000|Overall Study|Subject excluded before study procedure|1|||
128822173|NCT02944968|463646468|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
128822174|NCT03663205|463646471|FG000|Overall Study|Death|144|||
128822175|NCT03663205|463646472|FG001|Overall Study|Death|69|||
128822176|NCT03663205|463646471|FG000|Overall Study|Sponsor decision|53|||
128822177|NCT03663205|463646472|FG001|Overall Study|Sponsor decision|19|||
128822178|NCT03663205|463646471|FG000|Overall Study|Withdrawal by Subject|8|||
128822179|NCT03663205|463646472|FG001|Overall Study|Withdrawal by Subject|11|||
128822180|NCT03663205|463646471|FG000|Overall Study|Lost to Follow-up|7|||
128822181|NCT03663205|463646472|FG001|Overall Study|Lost to Follow-up|9|||
128822182|NCT03663205|463646471|FG000|Overall Study|Transferred to long term extension study|11|||
128822183|NCT03663205|463646472|FG001|Overall Study|Transferred to long term extension study|3|||
128822184|NCT02326974|463646473|FG000|Overall Study|Withdrawal by Subject|2|||
128822185|NCT02326974|463646473|FG000|Overall Study|failed heterogenity evaluation|5|||
128822186|NCT04924400|463646481|FG000|Overall Study|Lost to Follow-up|3|||
128822187|NCT04924400|463646482|FG001|Overall Study|Lost to Follow-up|0|||
128822188|NCT04424316|463646483|FG000|Overall Study|Adverse Event|0|||
128822189|NCT04424316|463646484|FG001|Overall Study|Adverse Event|1|||
128822190|NCT04424316|463646485|FG002|Overall Study|Adverse Event|0|||
128822191|NCT04424316|463646486|FG003|Overall Study|Adverse Event|0|||
128822192|NCT04424316|463646483|FG000|Overall Study|Death|1|||
128822193|NCT04424316|463646484|FG001|Overall Study|Death|0|||
128822194|NCT04424316|463646485|FG002|Overall Study|Death|8|||
128822195|NCT04424316|463646486|FG003|Overall Study|Death|14|||
128822196|NCT04424316|463646483|FG000|Overall Study|Lost to Follow-up|93|||
128822197|NCT04424316|463646484|FG001|Overall Study|Lost to Follow-up|88|||
128822198|NCT04424316|463646485|FG002|Overall Study|Lost to Follow-up|224|||
128822199|NCT04424316|463646486|FG003|Overall Study|Lost to Follow-up|211|||
128822200|NCT04424316|463646483|FG000|Overall Study|No longer met eligibility criteria|1|||
128822201|NCT04424316|463646484|FG001|Overall Study|No longer met eligibility criteria|0|||
128822202|NCT04424316|463646485|FG002|Overall Study|No longer met eligibility criteria|0|||
128822203|NCT04424316|463646486|FG003|Overall Study|No longer met eligibility criteria|0|||
128822204|NCT04424316|463646483|FG000|Overall Study|Other|15|||
128822205|NCT04424316|463646484|FG001|Overall Study|Other|11|||
128822206|NCT04424316|463646485|FG002|Overall Study|Other|34|||
128822207|NCT04424316|463646486|FG003|Overall Study|Other|45|||
128822208|NCT04424316|463646483|FG000|Overall Study|Physician Decision|1|||
128822209|NCT04424316|463646484|FG001|Overall Study|Physician Decision|0|||
128822210|NCT04424316|463646485|FG002|Overall Study|Physician Decision|1|||
128822211|NCT04424316|463646486|FG003|Overall Study|Physician Decision|1|||
128822212|NCT04424316|463646483|FG000|Overall Study|Protocol Violation|0|||
128822213|NCT04424316|463646484|FG001|Overall Study|Protocol Violation|1|||
128822214|NCT04424316|463646485|FG002|Overall Study|Protocol Violation|0|||
128822215|NCT04424316|463646486|FG003|Overall Study|Protocol Violation|0|||
128822216|NCT04424316|463646483|FG000|Overall Study|Withdrawal by Subject|71|||
128822217|NCT04424316|463646484|FG001|Overall Study|Withdrawal by Subject|77|||
128822218|NCT04424316|463646485|FG002|Overall Study|Withdrawal by Subject|0|||
128822219|NCT04424316|463646486|FG003|Overall Study|Withdrawal by Subject|0|||
128822220|NCT04424316|463646483|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128822221|NCT04424316|463646484|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128822222|NCT04424316|463646485|FG002|Overall Study|Withdrawal by parent/guardian|74|||
128822223|NCT04424316|463646486|FG003|Overall Study|Withdrawal by parent/guardian|81|||
128822224|NCT04424316|463646483|FG000|Overall Study|Randomized but not vaccinated|13|||
128822225|NCT04424316|463646484|FG001|Overall Study|Randomized but not vaccinated|21|||
128822226|NCT04424316|463646485|FG002|Overall Study|Randomized but not vaccinated|0|||
128822227|NCT04424316|463646486|FG003|Overall Study|Randomized but not vaccinated|0|||
128822228|NCT04424316|463646483|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
128822229|NCT04424316|463646484|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
128822230|NCT04424316|463646485|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
128822231|NCT04424316|463646486|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
128822232|NCT00412607|463646489|FG000|Overall Study|Withdrawal by Subject|9|||
128822233|NCT00412607|463646489|FG000|Overall Study|Lost to Follow-up|19|||
128822234|NCT00412607|463646489|FG000|Overall Study|Death|61|||
128822235|NCT00412607|463646489|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
128822236|NCT04707768|463646490|FG000|Overall Study|Adverse Event|9|||
128822237|NCT04707768|463646491|FG001|Overall Study|Adverse Event|18|||
128822238|NCT04707768|463646492|FG002|Overall Study|Adverse Event|3|||
128822239|NCT04707768|463646490|FG000|Overall Study|Investigator's Discretion|8|||
128822240|NCT04707768|463646491|FG001|Overall Study|Investigator's Discretion|4|||
128822241|NCT04707768|463646492|FG002|Overall Study|Investigator's Discretion|3|||
128822242|NCT04707768|463646490|FG000|Overall Study|Withdrawal by Subject|6|||
128822243|NCT04707768|463646491|FG001|Overall Study|Withdrawal by Subject|8|||
128822244|NCT04707768|463646492|FG002|Overall Study|Withdrawal by Subject|2|||
128822245|NCT04707768|463646490|FG000|Overall Study|Lack of Efficacy|1|||
128822246|NCT04707768|463646491|FG001|Overall Study|Lack of Efficacy|3|||
128822247|NCT04707768|463646492|FG002|Overall Study|Lack of Efficacy|0|||
128822248|NCT04707768|463646490|FG000|Overall Study|Lost to Follow-up|0|||
128822249|NCT04707768|463646491|FG001|Overall Study|Lost to Follow-up|0|||
128822250|NCT04707768|463646492|FG002|Overall Study|Lost to Follow-up|3|||
128822251|NCT04707768|463646490|FG000|Overall Study|Death|13|||
128822252|NCT04707768|463646491|FG001|Overall Study|Death|11|||
128822253|NCT04707768|463646492|FG002|Overall Study|Death|13|||
128822254|NCT04707768|463646490|FG000|Overall Study|Protocol Violation|2|||
128822255|NCT04707768|463646491|FG001|Overall Study|Protocol Violation|1|||
128822256|NCT04707768|463646492|FG002|Overall Study|Protocol Violation|0|||
128822257|NCT04707768|463646490|FG000|Overall Study|Non Compliance with Study Drug|1|||
128822258|NCT04707768|463646491|FG001|Overall Study|Non Compliance with Study Drug|0|||
128822259|NCT04707768|463646492|FG002|Overall Study|Non Compliance with Study Drug|0|||
128822260|NCT04707768|463646490|FG000|Overall Study|Transplant|4|||
128822261|NCT04707768|463646491|FG001|Overall Study|Transplant|4|||
128822262|NCT04707768|463646492|FG002|Overall Study|Transplant|8|||
128822263|NCT04707768|463646490|FG000|Overall Study|Other|9|||
128822264|NCT04707768|463646491|FG001|Overall Study|Other|5|||
128822265|NCT04707768|463646492|FG002|Overall Study|Other|2|||
128822266|NCT04078152|463646493|FG000|Overall Study|Other|83|||
128822267|NCT04078152|463646494|FG001|Overall Study|Other|22|||
128822268|NCT04078152|463646495|FG002|Overall Study|Other|25|||
128822269|NCT04078152|463646493|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
128822270|NCT04078152|463646494|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
128822271|NCT04078152|463646495|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
128822272|NCT04078152|463646493|FG000|Overall Study|Withdrawal by Subject|5|||
128822273|NCT04078152|463646494|FG001|Overall Study|Withdrawal by Subject|0|||
128822274|NCT04078152|463646495|FG002|Overall Study|Withdrawal by Subject|1|||
128822275|NCT04078152|463646493|FG000|Overall Study|Death|10|||
128822276|NCT04078152|463646494|FG001|Overall Study|Death|2|||
128822277|NCT04078152|463646495|FG002|Overall Study|Death|12|||
128822278|NCT04078152|463646493|FG000|Overall Study|Adverse Event|1|||
128822279|NCT04078152|463646494|FG001|Overall Study|Adverse Event|0|||
128822280|NCT04078152|463646495|FG002|Overall Study|Adverse Event|0|||
128822281|NCT02510235|463646496|FG000|Overall Study|Withdrawal by Subject|1|||
128822282|NCT02510235|463646497|FG001|Overall Study|Withdrawal by Subject|0|||
128822283|NCT00450216|463646498|FG000|Overall Study|Adverse Event|38|||
128822284|NCT00450216|463646499|FG001|Overall Study|Adverse Event|23|||
128822285|NCT00450216|463646498|FG000|Overall Study|Withdrawal by Subject|48|||
128822286|NCT00450216|463646499|FG001|Overall Study|Withdrawal by Subject|26|||
128822287|NCT00450216|463646498|FG000|Overall Study|Lost to Follow-up|16|||
128822288|NCT00450216|463646499|FG001|Overall Study|Lost to Follow-up|9|||
128822289|NCT00450216|463646498|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
128822290|NCT00450216|463646499|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
128822291|NCT00450216|463646498|FG000|Overall Study|misc|21|||
128822292|NCT00450216|463646499|FG001|Overall Study|misc|20|||
128822293|NCT04206787|463646500|FG000|Overall Study|Other than listed|2|||
128822294|NCT04206787|463646500|FG000|Overall Study|Investigator decision|1|||
128822295|NCT04206787|463646500|FG000|Overall Study|Death|25|||
128822296|NCT04206787|463646500|FG000|Overall Study|Lost to Follow-up|9|||
128822297|NCT04206787|463646500|FG000|Overall Study|Withdrawal of consent|9|||
128822298|NCT00319111|463646504|FG000|Overall Study|Adverse Event|20|||
128822299|NCT00319111|463646504|FG000|Overall Study|Withdrawal of consent|11|||
128822300|NCT00319111|463646504|FG000|Overall Study|Death|9|||
128822301|NCT00319111|463646504|FG000|Overall Study|Lack of clinical improvement|4|||
128822302|NCT00319111|463646504|FG000|Overall Study|Administrative|2|||
128822303|NCT00319111|463646504|FG000|Overall Study|Treatment failure|1|||
128822304|NCT04678856|463646505|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
128822305|NCT04678856|463646506|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
128822306|NCT04678856|463646505|FG000|Overall Study|Withdrawal by Subject|5|||
128822307|NCT04678856|463646506|FG001|Overall Study|Withdrawal by Subject|1|||
128822308|NCT00942877|463647882|FG000|Overall Study|Refused further treatment|1|||
128822309|NCT00942877|463647883|FG001|Overall Study|Refused further treatment|1|||
128822310|NCT00942877|463647882|FG000|Overall Study|Patient was not treated|1|||
128822311|NCT00942877|463647883|FG001|Overall Study|Patient was not treated|0|||
128822312|NCT00942877|463647882|FG000|Overall Study|Adverse Event|1|||
128822313|NCT00942877|463647883|FG001|Overall Study|Adverse Event|0|||
128822314|NCT00942877|463647882|FG000|Overall Study|Progressive disease|42|||
128822315|NCT00942877|463647883|FG001|Overall Study|Progressive disease|3|||
128822316|NCT01385202|463647886|FG000|Overall Study|Lost to Follow-up|6|||
128822317|NCT01385202|463647886|FG000|Overall Study|Not Eligible|11|||
128822318|NCT01385202|463647886|FG000|Overall Study|Withdrawn|1|||
128822319|NCT02905331|463647887|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
128822320|NCT02905331|463647888|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
128822321|NCT02905331|463647889|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
128822322|NCT02905331|463647887|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
128822323|NCT02905331|463647888|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
128822324|NCT02905331|463647889|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
128822325|NCT02905331|463647887|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
128822326|NCT02905331|463647888|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
128822327|NCT02905331|463647889|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
128822328|NCT02905331|463647887|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
128822329|NCT02905331|463647888|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
128822330|NCT02905331|463647889|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
128822331|NCT02905331|463647887|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
128822332|NCT02905331|463647888|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
128822333|NCT02905331|463647889|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
128822334|NCT03681262|463647890|FG000|Overall Study|Continuing on study|3|||
128822335|NCT03681262|463647891|FG001|Overall Study|Continuing on study|3|||
128822336|NCT03681262|463647890|FG000|Overall Study|Lost to Follow-up|1|||
128822337|NCT03681262|463647891|FG001|Overall Study|Lost to Follow-up|0|||
128822338|NCT04102111|463647892|FG000|Overall Study|Withdrawal by Subject|2|||
128822339|NCT04102111|463647893|FG001|Overall Study|Withdrawal by Subject|3|||
128822340|NCT04102111|463647892|FG000|Overall Study|Adverse Event|1|||
128822341|NCT04102111|463647893|FG001|Overall Study|Adverse Event|1|||
128822342|NCT04102111|463647892|FG000|Overall Study|Study terminated by sponsor|1|||
128822343|NCT04102111|463647893|FG001|Overall Study|Study terminated by sponsor|3|||
128822344|NCT02782676|463647894|FG000|Overall Study|Lost to Follow-up|0|||
128822345|NCT02782676|463647895|FG001|Overall Study|Lost to Follow-up|1|||
128822346|NCT03334695|463647896|FG000|Overall Study|Lost to Follow-up|3|||
128822347|NCT03334695|463647897|FG001|Overall Study|Lost to Follow-up|3|||
128822348|NCT03334695|463647896|FG000|Overall Study|Physician Decision|1|||
128822349|NCT03334695|463647897|FG001|Overall Study|Physician Decision|2|||
128822350|NCT03334695|463647896|FG000|Overall Study|Protocol Violation|0|||
128822351|NCT03334695|463647897|FG001|Overall Study|Protocol Violation|1|||
128822352|NCT02641730|463647898|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
128822353|NCT02641730|463647899|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128822354|NCT02641730|463647900|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
128822355|NCT02641730|463647901|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
128822356|NCT02641730|463647902|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
128822357|NCT02641730|463647898|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
128822358|NCT02641730|463647899|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
128822359|NCT02641730|463647900|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
128822360|NCT02641730|463647901|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
128822361|NCT02641730|463647902|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
128822362|NCT02641730|463647898|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
128822363|NCT02641730|463647899|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
128822364|NCT02641730|463647900|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
128822365|NCT02641730|463647901|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
128822366|NCT02641730|463647902|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
128822367|NCT02641730|463647898|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
128822368|NCT02641730|463647899|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
128822369|NCT02641730|463647900|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
128822370|NCT02641730|463647901|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
128822371|NCT02641730|463647902|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
128822372|NCT02641730|463647898|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
128822373|NCT02641730|463647899|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
128822374|NCT02641730|463647900|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
128822375|NCT02641730|463647901|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
128822376|NCT02641730|463647902|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
128822377|NCT02641730|463647898|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
128822378|NCT02641730|463647899|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
128822379|NCT02641730|463647900|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
128822380|NCT02641730|463647901|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
128822381|NCT02641730|463647902|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
128822382|NCT02874742|463647903|FG000|Overall Study|Death|0|||
128822383|NCT02874742|463647904|FG001|Overall Study|Death|1|||
128822384|NCT02874742|463647905|FG002|Overall Study|Death|0|||
128822385|NCT02874742|463647903|FG000|Overall Study|Lost to Follow-up|5|||
128822386|NCT02874742|463647904|FG001|Overall Study|Lost to Follow-up|4|||
128822387|NCT02874742|463647905|FG002|Overall Study|Lost to Follow-up|1|||
128822388|NCT02874742|463647903|FG000|Overall Study|Withdrawal by Subject|17|||
128822389|NCT02874742|463647904|FG001|Overall Study|Withdrawal by Subject|8|||
128822390|NCT02874742|463647905|FG002|Overall Study|Withdrawal by Subject|0|||
128822391|NCT02874742|463647903|FG000|Overall Study|Other|4|||
128822392|NCT02874742|463647904|FG001|Overall Study|Other|1|||
128822393|NCT02874742|463647905|FG002|Overall Study|Other|0|||
128822394|NCT02874742|463647903|FG000|Overall Study|Progressive Disease|1|||
128822395|NCT02874742|463647904|FG001|Overall Study|Progressive Disease|0|||
128822396|NCT02874742|463647905|FG002|Overall Study|Progressive Disease|0|||
128822397|NCT02874742|463647903|FG000|Overall Study|Screen Failure|0|||
128822398|NCT02874742|463647904|FG001|Overall Study|Screen Failure|2|||
128822399|NCT02874742|463647905|FG002|Overall Study|Screen Failure|0|||
128822400|NCT00964392|463647906|FG000|Overall Study|Withdrawal by Subject|4|||
128822401|NCT00964392|463647907|FG001|Overall Study|Withdrawal by Subject|6|||
128822402|NCT00964392|463647906|FG000|Overall Study|Lost to Follow-up|4|||
128822403|NCT00964392|463647907|FG001|Overall Study|Lost to Follow-up|10|||
128822404|NCT00964392|463647906|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
128822405|NCT00964392|463647907|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
128822406|NCT00964392|463647906|FG000|Overall Study|Not completed|44|||
128822407|NCT00964392|463647907|FG001|Overall Study|Not completed|168|||
128822408|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
128822409|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
128822410|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
128822411|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
128822412|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
128822413|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
128822414|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
128822415|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
128822416|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
128822417|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
128822418|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
128822419|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
128822420|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
128822421|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
128822422|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
128822423|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
128822424|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
128822425|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
128822426|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
128822427|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
128822428|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
128822429|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
128822430|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
128822431|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
128822432|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
128822433|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
128822434|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
128822435|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
128822436|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
128822437|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
128822438|NCT04614948|463647908|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
128822439|NCT04614948|463647909|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
128822440|NCT04614948|463647910|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
128822441|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
128822442|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
128822443|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
128822444|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
128822445|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
128822446|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
128822447|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
128822448|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
128822449|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
128822450|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
128822451|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
128822452|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
128822453|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
128822454|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
128822455|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
128822456|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
128822457|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
128822458|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
128822459|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
128822460|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
128822461|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
128822462|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
128822463|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
128822464|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
128822465|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
128822466|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
128822467|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
128822468|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
128822469|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
128822470|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
128822471|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
128822472|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
128822473|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
128822474|NCT04614948|463647908|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
128822475|NCT04614948|463647909|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
128822476|NCT04614948|463647910|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
128822477|NCT04055012|463647911|FG000|Overall Study|Withdrawal by Subject|1|||
128822478|NCT04055012|463647912|FG001|Overall Study|Withdrawal by Subject|3|||
128822479|NCT04055012|463647913|FG002|Overall Study|Withdrawal by Subject|1|||
128822480|NCT04055012|463647914|FG003|Overall Study|Withdrawal by Subject|0|||
128822481|NCT04055012|463647911|FG000|Overall Study|Metformin Recall|1|||
128822482|NCT04055012|463647912|FG001|Overall Study|Metformin Recall|1|||
128822483|NCT04055012|463647913|FG002|Overall Study|Metformin Recall|1|||
128822484|NCT04055012|463647914|FG003|Overall Study|Metformin Recall|0|||
128822485|NCT04173247|463647923|FG000|Overall Study|Withdrawal by Subject|0|||
128822486|NCT04173247|463647924|FG001|Overall Study|Withdrawal by Subject|2|||
128822487|NCT04173247|463647923|FG000|Overall Study|Death|1|||
128822488|NCT04173247|463647924|FG001|Overall Study|Death|0|||
128822489|NCT04173247|463647923|FG000|Overall Study|Physician Decision|1|||
128822490|NCT04173247|463647924|FG001|Overall Study|Physician Decision|0|||
128822491|NCT05070741|463647925|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
128822492|NCT03582033|463647928|FG000|Part A|Other|0|||
128822493|NCT03582033|463647929|FG001|Part A|Other|0|||
128822494|NCT03582033|463647930|FG002|Part A|Other|0|||
128822495|NCT03582033|463647931|FG003|Part A|Other|0|||
128822496|NCT03582033|463647932|FG004|Part A|Other|2|||
128822497|NCT03582033|463647933|FG005|Part A|Other|0|||
128822498|NCT03582033|463647934|FG006|Part A|Other|0|||
128822499|NCT03582033|463647935|FG007|Part A|Other|0|||
128822500|NCT03582033|463647936|FG008|Part A|Other|0|||
128822501|NCT03582033|463647937|FG009|Part A|Other|0|||
128822502|NCT03582033|463647928|FG000|Part A|Death|1|||
128822503|NCT03582033|463647929|FG001|Part A|Death|1|||
128822504|NCT03582033|463647930|FG002|Part A|Death|2|||
128822505|NCT03582033|463647931|FG003|Part A|Death|4|||
128822506|NCT03582033|463647932|FG004|Part A|Death|11|||
128822507|NCT03582033|463647933|FG005|Part A|Death|0|||
128822508|NCT03582033|463647934|FG006|Part A|Death|0|||
128822509|NCT03582033|463647935|FG007|Part A|Death|0|||
128822510|NCT03582033|463647936|FG008|Part A|Death|0|||
128822511|NCT03582033|463647937|FG009|Part A|Death|0|||
128822512|NCT03582033|463647928|FG000|Part A|Lost to Follow-up|0|||
128822513|NCT03582033|463647929|FG001|Part A|Lost to Follow-up|0|||
128822514|NCT03582033|463647930|FG002|Part A|Lost to Follow-up|0|||
128822515|NCT03582033|463647931|FG003|Part A|Lost to Follow-up|0|||
128822516|NCT03582033|463647932|FG004|Part A|Lost to Follow-up|1|||
128822517|NCT03582033|463647933|FG005|Part A|Lost to Follow-up|0|||
128822518|NCT03582033|463647934|FG006|Part A|Lost to Follow-up|0|||
128822519|NCT03582033|463647935|FG007|Part A|Lost to Follow-up|0|||
128822520|NCT03582033|463647936|FG008|Part A|Lost to Follow-up|0|||
128822521|NCT03582033|463647937|FG009|Part A|Lost to Follow-up|0|||
128822522|NCT03582033|463647928|FG000|Part A|Study terminated by sponsor|0|||
128822523|NCT03582033|463647929|FG001|Part A|Study terminated by sponsor|0|||
128822524|NCT03582033|463647930|FG002|Part A|Study terminated by sponsor|0|||
128822525|NCT03582033|463647931|FG003|Part A|Study terminated by sponsor|2|||
128822526|NCT03582033|463647932|FG004|Part A|Study terminated by sponsor|1|||
128822527|NCT03582033|463647933|FG005|Part A|Study terminated by sponsor|0|||
128822528|NCT03582033|463647934|FG006|Part A|Study terminated by sponsor|0|||
128822529|NCT03582033|463647935|FG007|Part A|Study terminated by sponsor|0|||
128822530|NCT03582033|463647936|FG008|Part A|Study terminated by sponsor|0|||
128822531|NCT03582033|463647937|FG009|Part A|Study terminated by sponsor|0|||
128822532|NCT03582033|463647928|FG000|Part A|Withdrawal by Subject|1|||
128822533|NCT03582033|463647929|FG001|Part A|Withdrawal by Subject|1|||
128822534|NCT03582033|463647930|FG002|Part A|Withdrawal by Subject|0|||
128822535|NCT03582033|463647931|FG003|Part A|Withdrawal by Subject|1|||
128822536|NCT03582033|463647932|FG004|Part A|Withdrawal by Subject|7|||
128822537|NCT03582033|463647933|FG005|Part A|Withdrawal by Subject|0|||
128822538|NCT03582033|463647934|FG006|Part A|Withdrawal by Subject|0|||
128822539|NCT03582033|463647935|FG007|Part A|Withdrawal by Subject|0|||
128822540|NCT03582033|463647936|FG008|Part A|Withdrawal by Subject|0|||
128822541|NCT03582033|463647937|FG009|Part A|Withdrawal by Subject|0|||
128822542|NCT03582033|463647928|FG000|Part B|Death|0|||
128822543|NCT03582033|463647929|FG001|Part B|Death|0|||
128822544|NCT03582033|463647930|FG002|Part B|Death|0|||
128822545|NCT03582033|463647931|FG003|Part B|Death|0|||
128822546|NCT03582033|463647932|FG004|Part B|Death|0|||
128822547|NCT03582033|463647933|FG005|Part B|Death|2|||
128822548|NCT03582033|463647934|FG006|Part B|Death|0|||
128822549|NCT03582033|463647935|FG007|Part B|Death|0|||
128822550|NCT03582033|463647936|FG008|Part B|Death|0|||
128822551|NCT03582033|463647937|FG009|Part B|Death|0|||
128822552|NCT03582033|463647928|FG000|Part B|Study terminated by sponsor|0|||
128822553|NCT03582033|463647929|FG001|Part B|Study terminated by sponsor|0|||
128822554|NCT03582033|463647930|FG002|Part B|Study terminated by sponsor|0|||
128822555|NCT03582033|463647931|FG003|Part B|Study terminated by sponsor|0|||
128822556|NCT03582033|463647932|FG004|Part B|Study terminated by sponsor|0|||
128822557|NCT03582033|463647933|FG005|Part B|Study terminated by sponsor|12|||
128822558|NCT03582033|463647934|FG006|Part B|Study terminated by sponsor|0|||
128822559|NCT03582033|463647935|FG007|Part B|Study terminated by sponsor|0|||
128822560|NCT03582033|463647936|FG008|Part B|Study terminated by sponsor|0|||
128822561|NCT03582033|463647937|FG009|Part B|Study terminated by sponsor|0|||
128822562|NCT03582033|463647928|FG000|Part B|Withdrawal by Subject|0|||
128822563|NCT03582033|463647929|FG001|Part B|Withdrawal by Subject|0|||
128822564|NCT03582033|463647930|FG002|Part B|Withdrawal by Subject|0|||
128822565|NCT03582033|463647931|FG003|Part B|Withdrawal by Subject|0|||
128822566|NCT03582033|463647932|FG004|Part B|Withdrawal by Subject|0|||
128822567|NCT03582033|463647933|FG005|Part B|Withdrawal by Subject|6|||
128822568|NCT03582033|463647934|FG006|Part B|Withdrawal by Subject|0|||
128822569|NCT03582033|463647935|FG007|Part B|Withdrawal by Subject|0|||
128822570|NCT03582033|463647936|FG008|Part B|Withdrawal by Subject|0|||
128822571|NCT03582033|463647937|FG009|Part B|Withdrawal by Subject|0|||
128822572|NCT03582033|463647928|FG000|Part C|Other|0|||
128822573|NCT03582033|463647929|FG001|Part C|Other|0|||
128822574|NCT03582033|463647930|FG002|Part C|Other|0|||
128822575|NCT03582033|463647931|FG003|Part C|Other|0|||
128822576|NCT03582033|463647932|FG004|Part C|Other|0|||
128822577|NCT03582033|463647933|FG005|Part C|Other|0|||
128822578|NCT03582033|463647934|FG006|Part C|Other|2|||
128822579|NCT03582033|463647935|FG007|Part C|Other|0|||
128822580|NCT03582033|463647936|FG008|Part C|Other|0|||
128822581|NCT03582033|463647937|FG009|Part C|Other|0|||
128822582|NCT03582033|463647928|FG000|Part C|Death|0|||
128822583|NCT03582033|463647929|FG001|Part C|Death|0|||
128822584|NCT03582033|463647930|FG002|Part C|Death|0|||
128822585|NCT03582033|463647931|FG003|Part C|Death|0|||
128822586|NCT03582033|463647932|FG004|Part C|Death|0|||
128822587|NCT03582033|463647933|FG005|Part C|Death|0|||
128822588|NCT03582033|463647934|FG006|Part C|Death|6|||
128822589|NCT03582033|463647935|FG007|Part C|Death|1|||
128822590|NCT03582033|463647936|FG008|Part C|Death|2|||
128822591|NCT03582033|463647937|FG009|Part C|Death|0|||
128822592|NCT03582033|463647928|FG000|Part C|Study terminated by sponsor|0|||
128822593|NCT03582033|463647929|FG001|Part C|Study terminated by sponsor|0|||
128822594|NCT03582033|463647930|FG002|Part C|Study terminated by sponsor|0|||
128822595|NCT03582033|463647931|FG003|Part C|Study terminated by sponsor|0|||
128822596|NCT03582033|463647932|FG004|Part C|Study terminated by sponsor|0|||
128870721|NCT01232738|463820700|FG000|Overall Study|Adverse Event|5|||
128822597|NCT03582033|463647933|FG005|Part C|Study terminated by sponsor|0|||
128822598|NCT03582033|463647934|FG006|Part C|Study terminated by sponsor|3|||
128822599|NCT03582033|463647935|FG007|Part C|Study terminated by sponsor|3|||
128822600|NCT03582033|463647936|FG008|Part C|Study terminated by sponsor|2|||
128822601|NCT03582033|463647937|FG009|Part C|Study terminated by sponsor|0|||
128822602|NCT03582033|463647928|FG000|Part C|Withdrawal by Subject|0|||
128822603|NCT03582033|463647929|FG001|Part C|Withdrawal by Subject|0|||
128822604|NCT03582033|463647930|FG002|Part C|Withdrawal by Subject|0|||
128822605|NCT03582033|463647931|FG003|Part C|Withdrawal by Subject|0|||
128822606|NCT03582033|463647932|FG004|Part C|Withdrawal by Subject|0|||
128822607|NCT03582033|463647933|FG005|Part C|Withdrawal by Subject|0|||
128822608|NCT03582033|463647934|FG006|Part C|Withdrawal by Subject|1|||
128822609|NCT03582033|463647935|FG007|Part C|Withdrawal by Subject|2|||
128822610|NCT03582033|463647936|FG008|Part C|Withdrawal by Subject|1|||
128822611|NCT03582033|463647937|FG009|Part C|Withdrawal by Subject|0|||
128822612|NCT03582033|463647928|FG000|Part D|Death|0|||
128822613|NCT03582033|463647929|FG001|Part D|Death|0|||
128822614|NCT03582033|463647930|FG002|Part D|Death|0|||
128822615|NCT03582033|463647931|FG003|Part D|Death|0|||
128822616|NCT03582033|463647932|FG004|Part D|Death|0|||
128822617|NCT03582033|463647933|FG005|Part D|Death|0|||
128822618|NCT03582033|463647934|FG006|Part D|Death|0|||
128822619|NCT03582033|463647935|FG007|Part D|Death|0|||
128822620|NCT03582033|463647936|FG008|Part D|Death|0|||
128822621|NCT03582033|463647937|FG009|Part D|Death|1|||
128822622|NCT03582033|463647928|FG000|Part D|Study terminated by sponsor|0|||
128822623|NCT03582033|463647929|FG001|Part D|Study terminated by sponsor|0|||
128822624|NCT03582033|463647930|FG002|Part D|Study terminated by sponsor|0|||
128822625|NCT03582033|463647931|FG003|Part D|Study terminated by sponsor|0|||
128822626|NCT03582033|463647932|FG004|Part D|Study terminated by sponsor|0|||
128822627|NCT03582033|463647933|FG005|Part D|Study terminated by sponsor|0|||
128822628|NCT03582033|463647934|FG006|Part D|Study terminated by sponsor|0|||
128822629|NCT03582033|463647935|FG007|Part D|Study terminated by sponsor|0|||
128822630|NCT03582033|463647936|FG008|Part D|Study terminated by sponsor|0|||
128822631|NCT03582033|463647937|FG009|Part D|Study terminated by sponsor|4|||
128822632|NCT03812614|463647940|FG000|Intervention|Withdrawal by Subject|7|||
128822633|NCT03812614|463647941|FG001|Intervention|Withdrawal by Subject|2|||
128822634|NCT03812614|463647942|FG002|Intervention|Withdrawal by Subject|7|||
128822635|NCT03812614|463647943|FG003|Intervention|Withdrawal by Subject|2|||
128822636|NCT03812614|463647940|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
128822637|NCT03812614|463647941|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
128822638|NCT03812614|463647942|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
128822639|NCT03812614|463647943|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
128822640|NCT03812614|463647940|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
128822641|NCT03812614|463647941|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
128822642|NCT03812614|463647942|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
128822643|NCT03812614|463647943|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
128822644|NCT03812614|463647940|FG000|6-month Follow-up|Lost to Follow-up|0|||
128822645|NCT03812614|463647941|FG001|6-month Follow-up|Lost to Follow-up|0|||
128822646|NCT03812614|463647942|FG002|6-month Follow-up|Lost to Follow-up|12|||
128822647|NCT03812614|463647943|FG003|6-month Follow-up|Lost to Follow-up|8|||
128822648|NCT03812614|463647940|FG000|12-month Follow-up|Lost to Follow-up|18|||
128822649|NCT03812614|463647941|FG001|12-month Follow-up|Lost to Follow-up|17|||
128822650|NCT03812614|463647942|FG002|12-month Follow-up|Lost to Follow-up|5|||
128822651|NCT03812614|463647943|FG003|12-month Follow-up|Lost to Follow-up|2|||
128822652|NCT05205161|463647944|FG000|Overall Study|Study terminated by sponsor|3|||
128822653|NCT05205161|463647945|FG001|Overall Study|Study terminated by sponsor|3|||
128822654|NCT05205161|463647946|FG002|Overall Study|Study terminated by sponsor|1|||
128822655|NCT05652010|463647947|FG000|First Intervention|Withdrawal by Subject|0|||
128822656|NCT05652010|463647948|FG001|First Intervention|Withdrawal by Subject|1|||
128822657|NCT05652010|463647947|FG000|Second Intervention|Withdrawal by Subject|1|||
128822658|NCT05652010|463647948|FG001|Second Intervention|Withdrawal by Subject|0|||
128822659|NCT05741294|463647950|FG000|Overall Study|Lost to Follow-up|3|||
128822660|NCT05741294|463647950|FG000|Overall Study|Protocol deviation|3|||
128822661|NCT05741294|463647950|FG000|Overall Study|Withdrawal by Subject|1|||
128822662|NCT04163991|463647957|FG000|Overall Study|Adverse Event|0|||
128822663|NCT04163991|463647958|FG001|Overall Study|Adverse Event|0|||
128822664|NCT04163991|463647959|FG002|Overall Study|Adverse Event|0|||
128822665|NCT04163991|463647960|FG003|Overall Study|Adverse Event|1|||
128822666|NCT04163991|463647961|FG004|Overall Study|Adverse Event|0|||
128822667|NCT04163991|463647957|FG000|Overall Study|Death|0|||
128822668|NCT04163991|463647958|FG001|Overall Study|Death|0|||
128822669|NCT04163991|463647959|FG002|Overall Study|Death|1|||
128822670|NCT04163991|463647960|FG003|Overall Study|Death|0|||
128822671|NCT04163991|463647961|FG004|Overall Study|Death|0|||
128822672|NCT04163991|463647957|FG000|Overall Study|Lost to Follow-up|0|||
128822673|NCT04163991|463647958|FG001|Overall Study|Lost to Follow-up|1|||
128822674|NCT04163991|463647959|FG002|Overall Study|Lost to Follow-up|0|||
128822675|NCT04163991|463647960|FG003|Overall Study|Lost to Follow-up|0|||
128822676|NCT04163991|463647961|FG004|Overall Study|Lost to Follow-up|0|||
128822677|NCT04163991|463647957|FG000|Overall Study|Withdrawal by Subject|1|||
128822678|NCT04163991|463647958|FG001|Overall Study|Withdrawal by Subject|1|||
128822679|NCT04163991|463647959|FG002|Overall Study|Withdrawal by Subject|3|||
128822680|NCT04163991|463647960|FG003|Overall Study|Withdrawal by Subject|1|||
128822681|NCT04163991|463647961|FG004|Overall Study|Withdrawal by Subject|1|||
128822682|NCT04163991|463647957|FG000|Overall Study|Other, Not Specified|0|||
128822683|NCT04163991|463647958|FG001|Overall Study|Other, Not Specified|1|||
128822684|NCT04163991|463647959|FG002|Overall Study|Other, Not Specified|1|||
128822685|NCT04163991|463647960|FG003|Overall Study|Other, Not Specified|1|||
128822686|NCT04163991|463647961|FG004|Overall Study|Other, Not Specified|0|||
128822687|NCT04214418|463647962|FG000|Overall Study|Withdrawal by Subject|1|||
128822688|NCT04214418|463647963|FG001|Overall Study|Withdrawal by Subject|0|||
128822689|NCT04214418|463647964|FG002|Overall Study|Withdrawal by Subject|0|||
128822690|NCT04214418|463647965|FG003|Overall Study|Withdrawal by Subject|0|||
128822691|NCT04214418|463647966|FG004|Overall Study|Withdrawal by Subject|0|||
128822692|NCT04214418|463647967|FG005|Overall Study|Withdrawal by Subject|0|||
128822693|NCT04214418|463647962|FG000|Overall Study|Adverse Event|0|||
128822694|NCT04214418|463647963|FG001|Overall Study|Adverse Event|2|||
128822695|NCT04214418|463647964|FG002|Overall Study|Adverse Event|0|||
128822696|NCT04214418|463647965|FG003|Overall Study|Adverse Event|0|||
128822697|NCT04214418|463647966|FG004|Overall Study|Adverse Event|0|||
128822698|NCT04214418|463647967|FG005|Overall Study|Adverse Event|0|||
128822699|NCT04214418|463647962|FG000|Overall Study|Death|1|||
128822700|NCT04214418|463647963|FG001|Overall Study|Death|0|||
128822701|NCT04214418|463647964|FG002|Overall Study|Death|0|||
128822702|NCT04214418|463647965|FG003|Overall Study|Death|0|||
128822703|NCT04214418|463647966|FG004|Overall Study|Death|0|||
128822704|NCT04214418|463647967|FG005|Overall Study|Death|0|||
128822705|NCT04635059|463647968|FG000|Overall Study|Study terminated early.|4|||
128822706|NCT03248479|463647972|FG000|Overall Study|Death|12|||
128822707|NCT03248479|463647973|FG001|Overall Study|Death|44|||
128822708|NCT03248479|463647974|FG002|Overall Study|Death|1|||
128822709|NCT03248479|463647975|FG003|Overall Study|Death|72|||
128822710|NCT03248479|463647976|FG004|Overall Study|Death|17|||
128822711|NCT03248479|463647977|FG005|Overall Study|Death|6|||
128822712|NCT03248479|463647978|FG006|Overall Study|Death|1|||
128822713|NCT03248479|463647979|FG007|Overall Study|Death|14|||
128822714|NCT03248479|463647980|FG008|Overall Study|Death|3|||
128822715|NCT03248479|463647981|FG009|Overall Study|Death|7|||
128822716|NCT03248479|463647982|FG010|Overall Study|Death|3|||
128822717|NCT03248479|463647983|FG011|Overall Study|Death|1|||
128822718|NCT03248479|463647984|FG012|Overall Study|Death|1|||
128822719|NCT03248479|463647972|FG000|Overall Study|Study terminated by sponsor|12|||
128822720|NCT03248479|463647973|FG001|Overall Study|Study terminated by sponsor|15|||
128822721|NCT03248479|463647974|FG002|Overall Study|Study terminated by sponsor|0|||
128822722|NCT03248479|463647975|FG003|Overall Study|Study terminated by sponsor|5|||
128822723|NCT03248479|463647976|FG004|Overall Study|Study terminated by sponsor|0|||
128822724|NCT03248479|463647977|FG005|Overall Study|Study terminated by sponsor|0|||
128822725|NCT03248479|463647978|FG006|Overall Study|Study terminated by sponsor|0|||
128822726|NCT03248479|463647979|FG007|Overall Study|Study terminated by sponsor|1|||
128822727|NCT03248479|463647980|FG008|Overall Study|Study terminated by sponsor|1|||
128822728|NCT03248479|463647981|FG009|Overall Study|Study terminated by sponsor|0|||
128822729|NCT03248479|463647982|FG010|Overall Study|Study terminated by sponsor|5|||
128822730|NCT03248479|463647983|FG011|Overall Study|Study terminated by sponsor|4|||
128822731|NCT03248479|463647984|FG012|Overall Study|Study terminated by sponsor|0|||
128822732|NCT03248479|463647972|FG000|Overall Study|Consent withdrawn|6|||
128822733|NCT03248479|463647973|FG001|Overall Study|Consent withdrawn|3|||
128822734|NCT03248479|463647974|FG002|Overall Study|Consent withdrawn|0|||
128822735|NCT03248479|463647975|FG003|Overall Study|Consent withdrawn|9|||
128822736|NCT03248479|463647976|FG004|Overall Study|Consent withdrawn|1|||
128822737|NCT03248479|463647977|FG005|Overall Study|Consent withdrawn|0|||
128822738|NCT03248479|463647978|FG006|Overall Study|Consent withdrawn|0|||
128822739|NCT03248479|463647979|FG007|Overall Study|Consent withdrawn|1|||
128822740|NCT03248479|463647980|FG008|Overall Study|Consent withdrawn|0|||
128822741|NCT03248479|463647981|FG009|Overall Study|Consent withdrawn|3|||
128822742|NCT03248479|463647982|FG010|Overall Study|Consent withdrawn|1|||
128822743|NCT03248479|463647983|FG011|Overall Study|Consent withdrawn|0|||
128822744|NCT03248479|463647984|FG012|Overall Study|Consent withdrawn|1|||
128822745|NCT03248479|463647972|FG000|Overall Study|Lost to Follow-up|2|||
128822746|NCT03248479|463647973|FG001|Overall Study|Lost to Follow-up|1|||
128822747|NCT03248479|463647974|FG002|Overall Study|Lost to Follow-up|0|||
128822748|NCT03248479|463647975|FG003|Overall Study|Lost to Follow-up|0|||
128822749|NCT03248479|463647976|FG004|Overall Study|Lost to Follow-up|0|||
128822750|NCT03248479|463647977|FG005|Overall Study|Lost to Follow-up|0|||
128822751|NCT03248479|463647978|FG006|Overall Study|Lost to Follow-up|0|||
128822752|NCT03248479|463647979|FG007|Overall Study|Lost to Follow-up|0|||
128822753|NCT03248479|463647980|FG008|Overall Study|Lost to Follow-up|0|||
128822754|NCT03248479|463647981|FG009|Overall Study|Lost to Follow-up|0|||
128822755|NCT03248479|463647982|FG010|Overall Study|Lost to Follow-up|0|||
128822756|NCT03248479|463647983|FG011|Overall Study|Lost to Follow-up|0|||
128822757|NCT03248479|463647984|FG012|Overall Study|Lost to Follow-up|1|||
128822758|NCT03248479|463647972|FG000|Overall Study|Not reported|0|||
128822759|NCT03248479|463647973|FG001|Overall Study|Not reported|0|||
128822760|NCT03248479|463647974|FG002|Overall Study|Not reported|0|||
128822761|NCT03248479|463647975|FG003|Overall Study|Not reported|1|||
128822762|NCT03248479|463647976|FG004|Overall Study|Not reported|1|||
128822763|NCT03248479|463647977|FG005|Overall Study|Not reported|0|||
128822764|NCT03248479|463647978|FG006|Overall Study|Not reported|0|||
128822765|NCT03248479|463647979|FG007|Overall Study|Not reported|1|||
128822766|NCT03248479|463647980|FG008|Overall Study|Not reported|1|||
128822767|NCT03248479|463647981|FG009|Overall Study|Not reported|0|||
128822768|NCT03248479|463647982|FG010|Overall Study|Not reported|0|||
128822769|NCT03248479|463647983|FG011|Overall Study|Not reported|0|||
128822770|NCT03248479|463647984|FG012|Overall Study|Not reported|0|||
128822771|NCT03011034|463647985|FG000|Overall Study|Adverse Event|1|||
128822772|NCT03011034|463647986|FG001|Overall Study|Adverse Event|0|||
128822773|NCT03735979|463647991|FG000|Overall Study|Lost to Follow-up|1|||
128822774|NCT03735979|463647992|FG001|Overall Study|Lost to Follow-up|12|||
128822775|NCT03735979|463647993|FG002|Overall Study|Lost to Follow-up|14|||
128822776|NCT03735979|463647991|FG000|Overall Study|Withdrawal by Subject|1|||
128822777|NCT03735979|463647992|FG001|Overall Study|Withdrawal by Subject|5|||
128822778|NCT03735979|463647993|FG002|Overall Study|Withdrawal by Subject|2|||
128822779|NCT03735979|463647991|FG000|Overall Study|Not due to the above reasons|1|||
128822780|NCT03735979|463647992|FG001|Overall Study|Not due to the above reasons|0|||
128822781|NCT03735979|463647993|FG002|Overall Study|Not due to the above reasons|0|||
128822782|NCT04743973|463647994|FG000|Overall Study|Withdrawal by Subject|5|||
128822783|NCT05654662|463647995|FG000|Overall Study|Withdrawal by Subject|1|||
128822784|NCT05654662|463647996|FG001|Overall Study|Withdrawal by Subject|0|||
128822785|NCT05654662|463647995|FG000|Overall Study|A death in the family|1|||
128822786|NCT05654662|463647996|FG001|Overall Study|A death in the family|0|||
128822787|NCT03165955|463647997|FG000|Treatment|Withdrawal by Subject|3|||
128822788|NCT03165955|463647997|FG000|Treatment|Death|1|||
128822789|NCT03165955|463647997|FG000|Treatment|Adverse Event|1|||
128822790|NCT03165955|463647997|FG000|Treatment|Progressive disease|3|||
128822791|NCT00626795|463647998|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
128822792|NCT00626795|463647999|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
128822793|NCT00626795|463648000|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
128822794|NCT00626795|463647998|FG000|Blinded Treatment|Lack of Efficacy|2|||
128822795|NCT00626795|463647999|FG001|Blinded Treatment|Lack of Efficacy|0|||
128822796|NCT00626795|463648000|FG002|Blinded Treatment|Lack of Efficacy|0|||
128822797|NCT00626795|463647998|FG000|Blinded Treatment|Unacceptable adverse event|0|||
128822798|NCT00626795|463647999|FG001|Blinded Treatment|Unacceptable adverse event|0|||
128822799|NCT00626795|463648000|FG002|Blinded Treatment|Unacceptable adverse event|1|||
128822800|NCT00626795|463647998|FG000|Blinded Treatment|Protocol Violation|0|||
128822801|NCT00626795|463647999|FG001|Blinded Treatment|Protocol Violation|1|||
128822802|NCT00626795|463648000|FG002|Blinded Treatment|Protocol Violation|1|||
128822803|NCT00626795|463647998|FG000|Blinded Treatment|Withdrawal by Subject|1|||
128822804|NCT00626795|463647999|FG001|Blinded Treatment|Withdrawal by Subject|1|||
128822805|NCT00626795|463648000|FG002|Blinded Treatment|Withdrawal by Subject|0|||
128822806|NCT00626795|463647998|FG000|Blinded Treatment|Other reasons|2|||
128822807|NCT00626795|463647999|FG001|Blinded Treatment|Other reasons|0|||
128822808|NCT00626795|463648000|FG002|Blinded Treatment|Other reasons|2|||
128822809|NCT00626795|463647998|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
128822810|NCT00626795|463647999|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
128822811|NCT00626795|463648000|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
128822812|NCT04499521|463648008|FG000|Overall Study|Disease Progression|1|||
128822813|NCT04499521|463648009|FG001|Overall Study|Disease Progression|0|||
128822814|NCT05525104|463648010|FG000|Overall Study|Failed caudal analgesia|1|||
128822815|NCT05525104|463648011|FG001|Overall Study|Failed caudal analgesia|3|||
128822816|NCT05525104|463648010|FG000|Overall Study|Premedication needed|0|||
128822817|NCT05525104|463648011|FG001|Overall Study|Premedication needed|1|||
128822818|NCT05525104|463648010|FG000|Overall Study|Protocol Violation|10|||
128822819|NCT05525104|463648011|FG001|Overall Study|Protocol Violation|0|||
128822820|NCT05525104|463648010|FG000|Overall Study|Cancelled operation|1|||
128822821|NCT05525104|463648011|FG001|Overall Study|Cancelled operation|0|||
128822822|NCT03990883|463648012|FG000|Blinded Treatment Phase|Adverse Event|1|||
128822823|NCT03990883|463648013|FG001|Blinded Treatment Phase|Adverse Event|1|||
128822824|NCT03990883|463648014|FG002|Blinded Treatment Phase|Adverse Event|0|||
128822825|NCT03990883|463648012|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
128822826|NCT03990883|463648013|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
128822827|NCT03990883|463648014|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
128822828|NCT03990883|463648012|FG000|Blinded Treatment Phase|Physician Decision|1|||
128822829|NCT03990883|463648013|FG001|Blinded Treatment Phase|Physician Decision|0|||
128822830|NCT03990883|463648014|FG002|Blinded Treatment Phase|Physician Decision|0|||
128822831|NCT03990883|463648012|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
128822832|NCT03990883|463648013|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
128822833|NCT03990883|463648014|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
128822834|NCT03990883|463648012|FG000|Blinded Treatment Phase|COVID-19|3|||
128822835|NCT03990883|463648013|FG001|Blinded Treatment Phase|COVID-19|2|||
128822836|NCT03990883|463648014|FG002|Blinded Treatment Phase|COVID-19|0|||
128822837|NCT03990883|463648012|FG000|Blinded Treatment Phase|Personal Reasons|6|||
128822838|NCT03990883|463648013|FG001|Blinded Treatment Phase|Personal Reasons|3|||
128822839|NCT03990883|463648014|FG002|Blinded Treatment Phase|Personal Reasons|0|||
128822840|NCT03990883|463648012|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
128822841|NCT03990883|463648013|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
128822842|NCT03990883|463648014|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
128822843|NCT03990883|463648012|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
128822844|NCT03990883|463648013|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
128822845|NCT03990883|463648014|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
128822846|NCT03990883|463648012|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
128822847|NCT03990883|463648013|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
128822848|NCT03990883|463648014|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
128822849|NCT05247034|463649512|FG000|Overall Study|Lost to Follow-up|3|||
128822850|NCT05247034|463649513|FG001|Overall Study|Lost to Follow-up|2|||
128822851|NCT05247034|463649512|FG000|Overall Study|Organizational problems when attending appointments|1|||
128822852|NCT05247034|463649513|FG001|Overall Study|Organizational problems when attending appointments|0|||
128822853|NCT04464564|463649516|FG000|Period A (Placebo lead-in)|Other|5|||
128822854|NCT04464564|463649517|FG001|Period A (Placebo lead-in)|Other|0|||
128822855|NCT04464564|463649518|FG002|Period A (Placebo lead-in)|Other|0|||
128822856|NCT04464564|463649519|FG003|Period A (Placebo lead-in)|Other|0|||
128822857|NCT04464564|463649516|FG000|Period B (Randomization Period)|Adverse Event|0|||
128822858|NCT04464564|463649517|FG001|Period B (Randomization Period)|Adverse Event|1|||
128822859|NCT04464564|463649518|FG002|Period B (Randomization Period)|Adverse Event|2|||
128822860|NCT04464564|463649519|FG003|Period B (Randomization Period)|Adverse Event|8|||
128822861|NCT04464564|463649516|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
128822862|NCT04464564|463649517|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
128822863|NCT04464564|463649518|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
128822864|NCT04464564|463649519|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
128822865|NCT04464564|463649516|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
128822866|NCT04464564|463649517|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
128822867|NCT04464564|463649518|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
128822868|NCT04464564|463649519|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
128822869|NCT04464564|463649516|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
128822870|NCT04464564|463649517|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
128822871|NCT04464564|463649518|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
128822872|NCT04464564|463649519|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
128822873|NCT04464564|463649516|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
128822874|NCT04464564|463649517|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
128822875|NCT04464564|463649518|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
128822876|NCT04464564|463649519|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
128822877|NCT04464564|463649516|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
128822878|NCT04464564|463649517|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
128822879|NCT04464564|463649518|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
128822880|NCT04464564|463649519|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
128822881|NCT04464564|463649516|FG000|Period B (Randomization Period)|Reason not Specified|0|||
128822882|NCT04464564|463649517|FG001|Period B (Randomization Period)|Reason not Specified|3|||
128822883|NCT04464564|463649518|FG002|Period B (Randomization Period)|Reason not Specified|3|||
128822884|NCT04464564|463649519|FG003|Period B (Randomization Period)|Reason not Specified|3|||
128822885|NCT03505710|463649520|FG000|Overall Study|Progressive Disease|24|||
128822886|NCT03505710|463649521|FG001|Overall Study|Progressive Disease|17|||
128822887|NCT03505710|463649522|FG002|Overall Study|Progressive Disease|43|||
128822888|NCT03505710|463649520|FG000|Overall Study|Clinical Progression|6|||
128822889|NCT03505710|463649521|FG001|Overall Study|Clinical Progression|8|||
128822890|NCT03505710|463649522|FG002|Overall Study|Clinical Progression|3|||
128822891|NCT03505710|463649520|FG000|Overall Study|Adverse Event|12|||
128822892|NCT03505710|463649521|FG001|Overall Study|Adverse Event|6|||
128822893|NCT03505710|463649522|FG002|Overall Study|Adverse Event|28|||
128822894|NCT03505710|463649520|FG000|Overall Study|Withdrawal by Subject|1|||
128822895|NCT03505710|463649521|FG001|Overall Study|Withdrawal by Subject|3|||
128822896|NCT03505710|463649522|FG002|Overall Study|Withdrawal by Subject|7|||
128822897|NCT03505710|463649520|FG000|Overall Study|Physician Decision|1|||
128822898|NCT03505710|463649521|FG001|Overall Study|Physician Decision|1|||
128822899|NCT03505710|463649522|FG002|Overall Study|Physician Decision|2|||
128822900|NCT03505710|463649520|FG000|Overall Study|Death|4|||
128822901|NCT03505710|463649521|FG001|Overall Study|Death|5|||
128822902|NCT03505710|463649522|FG002|Overall Study|Death|6|||
128822903|NCT03505710|463649520|FG000|Overall Study|Other Reasons|1|||
128822904|NCT03505710|463649521|FG001|Overall Study|Other Reasons|1|||
128822905|NCT03505710|463649522|FG002|Overall Study|Other Reasons|1|||
128822906|NCT03505710|463649520|FG000|Overall Study|Study Terminated by Sponsor|0|||
128822907|NCT03505710|463649521|FG001|Overall Study|Study Terminated by Sponsor|0|||
128822908|NCT03505710|463649522|FG002|Overall Study|Study Terminated by Sponsor|1|||
128822909|NCT04389957|463649526|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
128822910|NCT04389957|463649527|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
128822911|NCT04389957|463649528|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
128822912|NCT04389957|463649529|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
128822913|NCT04389957|463649530|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
128822914|NCT00887198|463649535|FG000|Randomized Period|Ongoing|42|||
128822915|NCT00887198|463649536|FG001|Randomized Period|Ongoing|0|||
128822916|NCT00887198|463649537|FG002|Randomized Period|Ongoing|0|||
128822917|NCT00887198|463649535|FG000|Randomized Period|Adverse Event|50|||
128822918|NCT00887198|463649536|FG001|Randomized Period|Adverse Event|33|||
128822919|NCT00887198|463649537|FG002|Randomized Period|Adverse Event|0|||
128822920|NCT00887198|463649535|FG000|Randomized Period|Lost to Follow-up|1|||
128822921|NCT00887198|463649536|FG001|Randomized Period|Lost to Follow-up|0|||
128822922|NCT00887198|463649537|FG002|Randomized Period|Lost to Follow-up|0|||
128822923|NCT00887198|463649535|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
128822924|NCT00887198|463649536|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
128822925|NCT00887198|463649537|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
128822926|NCT00887198|463649535|FG000|Randomized Period|Withdrawal by Subject|41|||
128822927|NCT00887198|463649536|FG001|Randomized Period|Withdrawal by Subject|56|||
128822928|NCT00887198|463649537|FG002|Randomized Period|Withdrawal by Subject|0|||
128822929|NCT00887198|463649535|FG000|Randomized Period|Progressive disease|366|||
128822930|NCT00887198|463649536|FG001|Randomized Period|Progressive disease|370|||
128822931|NCT00887198|463649537|FG002|Randomized Period|Progressive disease|0|||
128822932|NCT00887198|463649535|FG000|Randomized Period|Other|42|||
128822933|NCT00887198|463649536|FG001|Randomized Period|Other|30|||
128822934|NCT00887198|463649537|FG002|Randomized Period|Other|0|||
128822935|NCT00887198|463649535|FG000|Randomized Period|Randomized, Not treated|4|||
128822936|NCT00887198|463649536|FG001|Randomized Period|Randomized, Not treated|2|||
128822937|NCT00887198|463649537|FG002|Randomized Period|Randomized, Not treated|0|||
128822938|NCT00887198|463649535|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
128822939|NCT00887198|463649536|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
128822940|NCT00887198|463649537|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
128822941|NCT00887198|463649535|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
128822942|NCT00887198|463649536|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
128822943|NCT00887198|463649537|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
128822944|NCT00887198|463649535|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
128822945|NCT00887198|463649536|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
128822946|NCT00887198|463649537|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
128822947|NCT00887198|463649535|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
128822948|NCT00887198|463649536|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
128822949|NCT00887198|463649537|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
128822950|NCT00887198|463649535|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
128822951|NCT00887198|463649536|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
128822952|NCT00887198|463649537|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
128822953|NCT00887198|463649535|FG000|Cross Over (Placebo to AA)|Other|0|||
128822954|NCT00887198|463649536|FG001|Cross Over (Placebo to AA)|Other|0|||
128822955|NCT00887198|463649537|FG002|Cross Over (Placebo to AA)|Other|19|||
128822956|NCT05007080|463649538|FG000|Overall Study|Lost to Follow-up|0|||
128822957|NCT05007080|463649539|FG001|Overall Study|Lost to Follow-up|1|||
128822958|NCT05007080|463649540|FG002|Overall Study|Lost to Follow-up|0|||
128822959|NCT05007080|463649541|FG003|Overall Study|Lost to Follow-up|1|||
128822960|NCT05007080|463649542|FG004|Overall Study|Lost to Follow-up|1|||
128822961|NCT05007080|463649543|FG005|Overall Study|Lost to Follow-up|1|||
128822962|NCT05007080|463649538|FG000|Overall Study|Death|0|||
128822963|NCT05007080|463649539|FG001|Overall Study|Death|1|||
128822964|NCT05007080|463649540|FG002|Overall Study|Death|0|||
128822965|NCT05007080|463649541|FG003|Overall Study|Death|0|||
128822966|NCT05007080|463649542|FG004|Overall Study|Death|0|||
128822967|NCT05007080|463649543|FG005|Overall Study|Death|0|||
128822968|NCT05007080|463649538|FG000|Overall Study|Withdrawal by Subject|1|||
128822969|NCT05007080|463649539|FG001|Overall Study|Withdrawal by Subject|2|||
128822970|NCT05007080|463649540|FG002|Overall Study|Withdrawal by Subject|0|||
128822971|NCT05007080|463649541|FG003|Overall Study|Withdrawal by Subject|2|||
128822972|NCT05007080|463649542|FG004|Overall Study|Withdrawal by Subject|1|||
128822973|NCT05007080|463649543|FG005|Overall Study|Withdrawal by Subject|1|||
128822974|NCT05007080|463649538|FG000|Overall Study|Other|1|||
128822975|NCT05007080|463649539|FG001|Overall Study|Other|0|||
128822976|NCT05007080|463649540|FG002|Overall Study|Other|1|||
128822977|NCT05007080|463649541|FG003|Overall Study|Other|1|||
128822978|NCT05007080|463649542|FG004|Overall Study|Other|0|||
128822979|NCT05007080|463649543|FG005|Overall Study|Other|2|||
128822980|NCT05007080|463649538|FG000|Overall Study|Randomized not vaccinated|0|||
128822981|NCT05007080|463649539|FG001|Overall Study|Randomized not vaccinated|0|||
128822982|NCT05007080|463649540|FG002|Overall Study|Randomized not vaccinated|0|||
128822983|NCT05007080|463649541|FG003|Overall Study|Randomized not vaccinated|0|||
128822984|NCT05007080|463649542|FG004|Overall Study|Randomized not vaccinated|0|||
128822985|NCT05007080|463649543|FG005|Overall Study|Randomized not vaccinated|1|||
128822986|NCT00319046|463649544|FG000|Overall Study|withdrawal of subject's consent|7|||
128822987|NCT00319046|463649544|FG000|Overall Study|administrative reason|1|||
128822988|NCT03652272|463649548|FG000|3 Month|Withdrawal by Subject|1|||
128822989|NCT03652272|463649549|FG001|3 Month|Withdrawal by Subject|1|||
128822990|NCT03652272|463649548|FG000|3 Month|Lost to Follow-up|16|||
128822991|NCT03652272|463649549|FG001|3 Month|Lost to Follow-up|14|||
128822992|NCT03884101|463649554|FG000|Overall Study|Participant Ongoing in Study|202|||
128822993|NCT03884101|463649555|FG001|Overall Study|Participant Ongoing in Study|186|||
128822994|NCT03884101|463649554|FG000|Overall Study|Death|212|||
128822995|NCT03884101|463649555|FG001|Overall Study|Death|224|||
128822996|NCT03884101|463649554|FG000|Overall Study|Lost to Follow-up|0|||
128822997|NCT03884101|463649555|FG001|Overall Study|Lost to Follow-up|1|||
128822998|NCT03884101|463649554|FG000|Overall Study|Withdrawal by Subject|6|||
128822999|NCT03884101|463649555|FG001|Overall Study|Withdrawal by Subject|11|||
128823000|NCT02938520|463649556|FG000|Overall Study|On-going at the time of analysis|258|||
128823001|NCT02938520|463649557|FG001|Overall Study|On-going at the time of analysis|261|||
128823002|NCT02938520|463649556|FG000|Overall Study|Physician Decision|2|||
128823003|NCT02938520|463649557|FG001|Overall Study|Physician Decision|5|||
128823004|NCT02938520|463649556|FG000|Overall Study|Lost to Follow-up|2|||
128823005|NCT02938520|463649557|FG001|Overall Study|Lost to Follow-up|2|||
128823006|NCT02938520|463649556|FG000|Overall Study|Withdrawal by Subject|7|||
128823007|NCT02938520|463649557|FG001|Overall Study|Withdrawal by Subject|7|||
128823008|NCT02938520|463649556|FG000|Overall Study|Protocol Violation|0|||
128823009|NCT02938520|463649557|FG001|Overall Study|Protocol Violation|1|||
128823010|NCT02938520|463649556|FG000|Overall Study|Lack of Efficacy|5|||
128823011|NCT02938520|463649557|FG001|Overall Study|Lack of Efficacy|3|||
128823012|NCT02938520|463649556|FG000|Overall Study|Adverse Event|9|||
128823013|NCT02938520|463649557|FG001|Overall Study|Adverse Event|4|||
128823014|NCT04675034|463649562|FG000|Overall Study|Lost to Follow-up|1|||
128823015|NCT04675034|463649563|FG001|Overall Study|Lost to Follow-up|1|||
128823016|NCT04675034|463649564|FG002|Overall Study|Lost to Follow-up|0|||
128823017|NCT04675034|463649565|FG003|Overall Study|Lost to Follow-up|2|||
128823018|NCT04675034|463649566|FG004|Overall Study|Lost to Follow-up|0|||
128823019|NCT04675034|463649562|FG000|Overall Study|Protocol Violation|1|||
128823020|NCT04675034|463649563|FG001|Overall Study|Protocol Violation|0|||
128823021|NCT04675034|463649564|FG002|Overall Study|Protocol Violation|0|||
128823022|NCT04675034|463649565|FG003|Overall Study|Protocol Violation|1|||
128823023|NCT04675034|463649566|FG004|Overall Study|Protocol Violation|3|||
128823024|NCT04675034|463649562|FG000|Overall Study|Withdrawal by Subject|9|||
128823025|NCT04675034|463649563|FG001|Overall Study|Withdrawal by Subject|3|||
128823026|NCT04675034|463649564|FG002|Overall Study|Withdrawal by Subject|4|||
128823027|NCT04675034|463649565|FG003|Overall Study|Withdrawal by Subject|8|||
128823028|NCT04675034|463649566|FG004|Overall Study|Withdrawal by Subject|6|||
128823029|NCT03372057|463649569|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
128823030|NCT03372057|463649570|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
128823031|NCT03372057|463649571|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
128823032|NCT03372057|463649569|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
128823033|NCT03372057|463649570|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
128823034|NCT03372057|463649571|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
128823035|NCT03372057|463649569|FG000|Dose Optimization Phase|Death|16|||
128823036|NCT03372057|463649570|FG001|Dose Optimization Phase|Death|11|||
128823037|NCT03372057|463649571|FG002|Dose Optimization Phase|Death|0|||
128823038|NCT03372057|463649569|FG000|Expansion Phase|Withdrawal by Subject|0|||
128823039|NCT03372057|463649570|FG001|Expansion Phase|Withdrawal by Subject|0|||
128823040|NCT03372057|463649571|FG002|Expansion Phase|Withdrawal by Subject|4|||
128823041|NCT03372057|463649569|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
128823042|NCT03372057|463649570|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
128823043|NCT03372057|463649571|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
128823044|NCT03372057|463649569|FG000|Expansion Phase|Death|0|||
128823045|NCT03372057|463649570|FG001|Expansion Phase|Death|0|||
128823046|NCT03372057|463649571|FG002|Expansion Phase|Death|78|||
128823047|NCT03372057|463649569|FG000|Expansion Phase|Progressive Disease|0|||
128823048|NCT03372057|463649570|FG001|Expansion Phase|Progressive Disease|0|||
128823049|NCT03372057|463649571|FG002|Expansion Phase|Progressive Disease|1|||
128823050|NCT03372057|463649569|FG000|Expansion Phase|Adverse Event|0|||
128823051|NCT03372057|463649570|FG001|Expansion Phase|Adverse Event|0|||
128823052|NCT03372057|463649571|FG002|Expansion Phase|Adverse Event|1|||
128823053|NCT05953740|463649572|FG000|Period 1|Physician Decision|0|||
128823054|NCT05953740|463649573|FG001|Period 1|Physician Decision|1|||
128823055|NCT05953740|463649574|FG002|Period 1|Physician Decision|0|||
128823056|NCT05953740|463649575|FG003|Period 1|Physician Decision|0|||
128823057|NCT05953740|463649576|FG004|Period 1|Physician Decision|0|||
128823058|NCT05953740|463649577|FG005|Period 1|Physician Decision|0|||
128823059|NCT05953740|463649578|FG006|Period 1|Physician Decision|0|||
128823060|NCT05953740|463649579|FG007|Period 1|Physician Decision|0|||
128823061|NCT05953740|463649572|FG000|Period 2|Withdrawal by Subject|0|||
128823062|NCT05953740|463649573|FG001|Period 2|Withdrawal by Subject|1|||
128823063|NCT05953740|463649574|FG002|Period 2|Withdrawal by Subject|1|||
128823064|NCT05953740|463649575|FG003|Period 2|Withdrawal by Subject|0|||
128823065|NCT05953740|463649576|FG004|Period 2|Withdrawal by Subject|0|||
128823066|NCT05953740|463649577|FG005|Period 2|Withdrawal by Subject|0|||
128823067|NCT05953740|463649578|FG006|Period 2|Withdrawal by Subject|0|||
128823068|NCT05953740|463649579|FG007|Period 2|Withdrawal by Subject|0|||
128823069|NCT03880955|463649580|FG000|Overall Study|Adverse Event|1|||
128823070|NCT03880955|463649580|FG000|Overall Study|Death|1|||
128823071|NCT03880955|463649580|FG000|Overall Study|Lost to Follow-up|12|||
128823072|NCT03880955|463649580|FG000|Overall Study|Withdrawal by Subject|4|||
128823073|NCT03880955|463649580|FG000|Overall Study|Missing- Study Site Closed|27|||
128823074|NCT05008055|463649586|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
128823075|NCT05008055|463649587|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
128823076|NCT05008055|463649588|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
128823077|NCT04679389|463649591|FG000|Overall Study|Adverse Event|1|||
128823078|NCT04679389|463649592|FG001|Overall Study|Adverse Event|0|||
128823079|NCT04679389|463649591|FG000|Overall Study|Protocol Violation|2|||
128823080|NCT04679389|463649592|FG001|Overall Study|Protocol Violation|0|||
128823081|NCT04679389|463649591|FG000|Overall Study|Physician Decision|3|||
128823082|NCT04679389|463649592|FG001|Overall Study|Physician Decision|5|||
128823083|NCT04679389|463649591|FG000|Overall Study|Withdrawal by Subject|5|||
128823084|NCT04679389|463649592|FG001|Overall Study|Withdrawal by Subject|7|||
128823085|NCT05112900|463649597|FG000|Overall Study|Withdrawal by Subject|960|||
128823086|NCT05112900|463649598|FG001|Overall Study|Withdrawal by Subject|921|||
128823087|NCT05112900|463649599|FG002|Overall Study|Withdrawal by Subject|968|||
128823088|NCT01438853|463649602|FG000|Overall Study|Death|0|||
128823089|NCT01438853|463649603|FG001|Overall Study|Death|0|||
128823090|NCT01438853|463649604|FG002|Overall Study|Death|0|||
128823091|NCT01438853|463649605|FG003|Overall Study|Death|1|||
128823092|NCT01438853|463649602|FG000|Overall Study|Withdrawal by Subject|0|||
128823093|NCT01438853|463649603|FG001|Overall Study|Withdrawal by Subject|0|||
128823094|NCT01438853|463649604|FG002|Overall Study|Withdrawal by Subject|1|||
128823095|NCT01438853|463649605|FG003|Overall Study|Withdrawal by Subject|0|||
128823096|NCT02624050|463649606|FG000|Overall Study|Physician Decision|4|||
128823097|NCT02624050|463649607|FG001|Overall Study|Physician Decision|0|||
128823098|NCT02624050|463649606|FG000|Overall Study|Protocol Violation|2|||
128823099|NCT02624050|463649607|FG001|Overall Study|Protocol Violation|0|||
128823100|NCT03904576|463649608|FG000|Washout Period|Protocol Violation|1|||
128823101|NCT03904576|463649609|FG001|Washout Period|Protocol Violation|1|||
128823102|NCT03279978|463649611|FG000|Overall Study|Withdrawal by Subject|0|||
128823103|NCT03279978|463649612|FG001|Overall Study|Withdrawal by Subject|1|||
128823104|NCT03279978|463649613|FG002|Overall Study|Withdrawal by Subject|0|||
128823105|NCT03279978|463649614|FG003|Overall Study|Withdrawal by Subject|0|||
128823106|NCT03279978|463649615|FG004|Overall Study|Withdrawal by Subject|0|||
128823107|NCT03279978|463649616|FG005|Overall Study|Withdrawal by Subject|0|||
128823108|NCT03279978|463649617|FG006|Overall Study|Withdrawal by Subject|0|||
128823109|NCT03279978|463649618|FG007|Overall Study|Withdrawal by Subject|0|||
128823110|NCT03279978|463649619|FG008|Overall Study|Withdrawal by Subject|0|||
128823111|NCT03279978|463649620|FG009|Overall Study|Withdrawal by Subject|1|||
128823112|NCT03279978|463649611|FG000|Overall Study|Lost to Follow-up|1|||
128823113|NCT03279978|463649612|FG001|Overall Study|Lost to Follow-up|0|||
128823114|NCT03279978|463649613|FG002|Overall Study|Lost to Follow-up|1|||
128823115|NCT03279978|463649614|FG003|Overall Study|Lost to Follow-up|0|||
128823116|NCT03279978|463649615|FG004|Overall Study|Lost to Follow-up|0|||
128823117|NCT03279978|463649616|FG005|Overall Study|Lost to Follow-up|0|||
128823118|NCT03279978|463649617|FG006|Overall Study|Lost to Follow-up|0|||
128823119|NCT03279978|463649618|FG007|Overall Study|Lost to Follow-up|0|||
128823120|NCT03279978|463649619|FG008|Overall Study|Lost to Follow-up|0|||
128823121|NCT03279978|463649620|FG009|Overall Study|Lost to Follow-up|0|||
128823122|NCT03279978|463649611|FG000|Overall Study|Other than stated above|0|||
128823123|NCT03279978|463649612|FG001|Overall Study|Other than stated above|0|||
128823124|NCT03279978|463649613|FG002|Overall Study|Other than stated above|0|||
128823125|NCT03279978|463649614|FG003|Overall Study|Other than stated above|0|||
128823126|NCT03279978|463649615|FG004|Overall Study|Other than stated above|0|||
128823127|NCT03279978|463649616|FG005|Overall Study|Other than stated above|0|||
128823128|NCT03279978|463649617|FG006|Overall Study|Other than stated above|1|||
128823129|NCT03279978|463649618|FG007|Overall Study|Other than stated above|0|||
128823130|NCT03279978|463649619|FG008|Overall Study|Other than stated above|0|||
128823131|NCT03279978|463649620|FG009|Overall Study|Other than stated above|0|||
128823132|NCT04330040|463649621|FG000|Overall Study|Other: Adverse event|5|||
128823133|NCT04330040|463649622|FG001|Overall Study|Other: Adverse event|0|||
128823134|NCT04330040|463649623|FG002|Overall Study|Other: Adverse event|0|||
128823135|NCT04330040|463649621|FG000|Overall Study|Disease progression|38|||
128823136|NCT04330040|463649622|FG001|Overall Study|Disease progression|10|||
128823137|NCT04330040|463649623|FG002|Overall Study|Disease progression|0|||
128823138|NCT04330040|463649621|FG000|Overall Study|Physician Decision|5|||
128823139|NCT04330040|463649622|FG001|Overall Study|Physician Decision|3|||
128823140|NCT04330040|463649623|FG002|Overall Study|Physician Decision|0|||
128823141|NCT04330040|463649621|FG000|Overall Study|Lost to Follow-up|1|||
128823142|NCT04330040|463649622|FG001|Overall Study|Lost to Follow-up|1|||
128823143|NCT04330040|463649623|FG002|Overall Study|Lost to Follow-up|0|||
128823144|NCT04330040|463649621|FG000|Overall Study|Death|2|||
128823145|NCT04330040|463649622|FG001|Overall Study|Death|1|||
128823146|NCT04330040|463649623|FG002|Overall Study|Death|0|||
128823147|NCT04330040|463649621|FG000|Overall Study|Withdrawal by Subject|3|||
128823148|NCT04330040|463649622|FG001|Overall Study|Withdrawal by Subject|3|||
128823149|NCT04330040|463649623|FG002|Overall Study|Withdrawal by Subject|0|||
128823150|NCT04330040|463649621|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
128823151|NCT04330040|463649622|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
128823152|NCT04330040|463649623|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
128823153|NCT04330040|463649621|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
128823154|NCT04330040|463649622|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
128823155|NCT04330040|463649623|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
128823156|NCT04330040|463649621|FG000|Overall Study|Other: Disease progression|1|||
128823157|NCT04330040|463649622|FG001|Overall Study|Other: Disease progression|0|||
128823158|NCT04330040|463649623|FG002|Overall Study|Other: Disease progression|0|||
128823159|NCT04330040|463649621|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
128823160|NCT04330040|463649622|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
128823161|NCT04330040|463649623|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
128823162|NCT04330040|463649621|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
128823163|NCT04330040|463649622|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
128823164|NCT04330040|463649623|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
128823165|NCT04330040|463649621|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
128823166|NCT04330040|463649622|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
128823167|NCT04330040|463649623|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
128823168|NCT04427007|463650639|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
128823169|NCT04427007|463650640|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
128823170|NCT04633278|463650641|FG000|Overall Study|Adverse Event|1|||
128823171|NCT04633278|463650642|FG001|Overall Study|Adverse Event|0|||
128823172|NCT04633278|463650641|FG000|Overall Study|Withdrawal by Subject|1|||
128823173|NCT04633278|463650642|FG001|Overall Study|Withdrawal by Subject|0|||
128823174|NCT04633278|463650641|FG000|Overall Study|Death|11|||
128823175|NCT04633278|463650642|FG001|Overall Study|Death|7|||
128823176|NCT04633278|463650641|FG000|Overall Study|Sponsor Decision|3|||
128823177|NCT04633278|463650642|FG001|Overall Study|Sponsor Decision|0|||
128823178|NCT04633278|463650641|FG000|Overall Study|Not Listed|1|||
128823179|NCT04633278|463650642|FG001|Overall Study|Not Listed|0|||
128823180|NCT03636490|463650643|FG000|Overall Study|Dropped out or incomplete data|141|||
128823181|NCT02246127|463650644|FG000|First Course Treatment|Adverse Event|9|||
128823182|NCT02246127|463650645|FG001|First Course Treatment|Adverse Event|7|||
128823183|NCT02246127|463650644|FG000|First Course Treatment|Withdrawal by Subject|6|||
128823184|NCT02246127|463650645|FG001|First Course Treatment|Withdrawal by Subject|7|||
128823185|NCT02246127|463650644|FG000|First Course Treatment|Physician Decision|9|||
128823186|NCT02246127|463650645|FG001|First Course Treatment|Physician Decision|9|||
128823187|NCT02246127|463650644|FG000|First Course Treatment|Death|3|||
128823188|NCT02246127|463650645|FG001|First Course Treatment|Death|3|||
128823189|NCT02246127|463650644|FG000|First Course Treatment|Not reported reasons|6|||
128823190|NCT02246127|463650645|FG001|First Course Treatment|Not reported reasons|7|||
128823191|NCT02246127|463650644|FG000|First Course Treatment|Not treated|3|||
128823192|NCT02246127|463650645|FG001|First Course Treatment|Not treated|3|||
128823193|NCT06262347|463650651|FG000|Overall Study|Lost to Follow-up|4|||
128823194|NCT06262347|463650652|FG001|Overall Study|Lost to Follow-up|3|||
128823195|NCT06262347|463650651|FG000|Overall Study|Withdrawal by Subject|0|||
128823196|NCT06262347|463650652|FG001|Overall Study|Withdrawal by Subject|1|||
128823197|NCT06655818|463650665|FG000|Overall Study|Withdrawal by Subject|1|||
128823198|NCT02095691|463650666|FG000|Overall Study|Physician Decision|1|||
128823199|NCT05147584|463650667|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
128823200|NCT05460871|463650668|FG000|Overall Study|Withdrawal by Subject|1|||
128823201|NCT05460871|463650669|FG001|Overall Study|Withdrawal by Subject|2|||
128823202|NCT04623775|463650680|FG000|Randomization|No Longer Meets Study Criteria|2|||
128823203|NCT04623775|463650681|FG001|Randomization|No Longer Meets Study Criteria|1|||
128823204|NCT04623775|463650682|FG002|Randomization|No Longer Meets Study Criteria|0|||
128823205|NCT04623775|463650683|FG003|Randomization|No Longer Meets Study Criteria|0|||
128823206|NCT04623775|463650680|FG000|Randomization|Withdrew Consent|0|||
128823207|NCT04623775|463650681|FG001|Randomization|Withdrew Consent|0|||
128823208|NCT04623775|463650682|FG002|Randomization|Withdrew Consent|0|||
128823209|NCT04623775|463650683|FG003|Randomization|Withdrew Consent|1|||
128823210|NCT04623775|463650680|FG000|Randomization|Other Reasons|0|||
128823211|NCT04623775|463650681|FG001|Randomization|Other Reasons|0|||
128823212|NCT04623775|463650682|FG002|Randomization|Other Reasons|0|||
128823213|NCT04623775|463650683|FG003|Randomization|Other Reasons|1|||
128823214|NCT04623775|463650680|FG000|Treatment Period|participant withdrew consent|4|||
128823215|NCT04623775|463650681|FG001|Treatment Period|participant withdrew consent|0|||
128823216|NCT04623775|463650682|FG002|Treatment Period|participant withdrew consent|1|||
128823217|NCT04623775|463650683|FG003|Treatment Period|participant withdrew consent|2|||
128823218|NCT04623775|463650680|FG000|Treatment Period|Death|3|||
128823219|NCT04623775|463650681|FG001|Treatment Period|Death|1|||
128823220|NCT04623775|463650682|FG002|Treatment Period|Death|4|||
128823221|NCT04623775|463650683|FG003|Treatment Period|Death|2|||
128823222|NCT04623775|463650680|FG000|Treatment Period|Lost to Follow-up|0|||
128823223|NCT04623775|463650681|FG001|Treatment Period|Lost to Follow-up|2|||
128823224|NCT04623775|463650682|FG002|Treatment Period|Lost to Follow-up|0|||
128823225|NCT04623775|463650683|FG003|Treatment Period|Lost to Follow-up|0|||
128823226|NCT04623775|463650680|FG000|Treatment Period|poor/non compliance|0|||
128823227|NCT04623775|463650681|FG001|Treatment Period|poor/non compliance|0|||
128823228|NCT04623775|463650682|FG002|Treatment Period|poor/non compliance|1|||
128823229|NCT04623775|463650683|FG003|Treatment Period|poor/non compliance|0|||
128823230|NCT04623775|463650680|FG000|Treatment Period|participant no longer meets study criteria|0|||
128823231|NCT04623775|463650681|FG001|Treatment Period|participant no longer meets study criteria|1|||
128823232|NCT04623775|463650682|FG002|Treatment Period|participant no longer meets study criteria|0|||
128823233|NCT04623775|463650683|FG003|Treatment Period|participant no longer meets study criteria|0|||
128823234|NCT04623775|463650680|FG000|Treatment Period|administrative reasons by sponsor|3|||
128823235|NCT04623775|463650681|FG001|Treatment Period|administrative reasons by sponsor|2|||
128823236|NCT04623775|463650682|FG002|Treatment Period|administrative reasons by sponsor|0|||
128823237|NCT04623775|463650683|FG003|Treatment Period|administrative reasons by sponsor|0|||
128823238|NCT04623775|463650680|FG000|Treatment Period|other reasons|2|||
128823239|NCT04623775|463650681|FG001|Treatment Period|other reasons|0|||
128823240|NCT04623775|463650682|FG002|Treatment Period|other reasons|1|||
128823241|NCT04623775|463650683|FG003|Treatment Period|other reasons|1|||
128823242|NCT04623775|463650680|FG000|Treatment Period|disease progression|40|||
128823243|NCT04623775|463650681|FG001|Treatment Period|disease progression|35|||
128823244|NCT04623775|463650682|FG002|Treatment Period|disease progression|63|||
128823245|NCT04623775|463650683|FG003|Treatment Period|disease progression|63|||
128823246|NCT04623775|463650680|FG000|Treatment Period|study drug toxicity|12|||
128823247|NCT04623775|463650681|FG001|Treatment Period|study drug toxicity|15|||
128823248|NCT04623775|463650682|FG002|Treatment Period|study drug toxicity|13|||
128823249|NCT04623775|463650683|FG003|Treatment Period|study drug toxicity|12|||
128823250|NCT04623775|463650680|FG000|Treatment Period|AE unrelated to study drug|4|||
128823251|NCT04623775|463650681|FG001|Treatment Period|AE unrelated to study drug|9|||
128823252|NCT04623775|463650682|FG002|Treatment Period|AE unrelated to study drug|12|||
128823253|NCT04623775|463650683|FG003|Treatment Period|AE unrelated to study drug|9|||
128823254|NCT04623775|463650680|FG000|Treatment Period|participant request to discontinue treatment|0|||
128823255|NCT04623775|463650681|FG001|Treatment Period|participant request to discontinue treatment|2|||
128823256|NCT04623775|463650682|FG002|Treatment Period|participant request to discontinue treatment|2|||
128823257|NCT04623775|463650683|FG003|Treatment Period|participant request to discontinue treatment|0|||
128823258|NCT03498521|463650684|FG000|Overall Study|Death|191|||
128823259|NCT03498521|463650685|FG001|Overall Study|Death|64|||
128823260|NCT03498521|463650686|FG002|Overall Study|Death|72|||
128823261|NCT03498521|463650684|FG000|Overall Study|Exclusion criteria|1|||
128823262|NCT03498521|463650685|FG001|Overall Study|Exclusion criteria|0|||
128823263|NCT03498521|463650686|FG002|Overall Study|Exclusion criteria|0|||
128823264|NCT03498521|463650684|FG000|Overall Study|Lost to Follow-up|3|||
128823265|NCT03498521|463650685|FG001|Overall Study|Lost to Follow-up|3|||
128823266|NCT03498521|463650686|FG002|Overall Study|Lost to Follow-up|3|||
128823267|NCT03498521|463650684|FG000|Overall Study|No profile due to technical failure|1|||
128823268|NCT03498521|463650685|FG001|Overall Study|No profile due to technical failure|0|||
128823269|NCT03498521|463650686|FG002|Overall Study|No profile due to technical failure|0|||
128823270|NCT03498521|463650684|FG000|Overall Study|Physician Decision|0|||
128823271|NCT03498521|463650685|FG001|Overall Study|Physician Decision|1|||
128823272|NCT03498521|463650686|FG002|Overall Study|Physician Decision|0|||
128823273|NCT03498521|463650684|FG000|Overall Study|Withdrawal by Subject|9|||
128823274|NCT03498521|463650685|FG001|Overall Study|Withdrawal by Subject|6|||
128823275|NCT03498521|463650686|FG002|Overall Study|Withdrawal by Subject|2|||
128823276|NCT03498521|463650684|FG000|Overall Study|Study ongoing|121|||
128823277|NCT03498521|463650685|FG001|Overall Study|Study ongoing|36|||
128823278|NCT03498521|463650686|FG002|Overall Study|Study ongoing|15|||
128823279|NCT05830799|463650688|FG000|Overall Study|Withdrawal by Subject|1|||
128823280|NCT04214834|463650689|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
128823281|NCT04214834|463650690|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
128823282|NCT04633538|463650695|FG000|Overall Study|Death|1|||
128823283|NCT04633538|463650695|FG000|Overall Study|Lost to Follow-up|3|||
128823284|NCT04633538|463650695|FG000|Overall Study|Withdrawal by Subject|1|||
128823285|NCT04631016|463650702|FG000|Overall Study|Adverse Event|3|||
128823286|NCT04631016|463650703|FG001|Overall Study|Adverse Event|0|||
128823287|NCT04631016|463650702|FG000|Overall Study|Withdrawal by Subject|5|||
128823288|NCT04631016|463650703|FG001|Overall Study|Withdrawal by Subject|4|||
128823289|NCT04631016|463650702|FG000|Overall Study|Reason unspecified|1|||
128823290|NCT04631016|463650703|FG001|Overall Study|Reason unspecified|0|||
128823291|NCT04631016|463650702|FG000|Overall Study|Failure to meet randomization criteria|2|||
128823292|NCT04631016|463650703|FG001|Overall Study|Failure to meet randomization criteria|1|||
128823293|NCT04496752|463650704|FG000|Second Assessment|Lost to Follow-up|3|||
128823294|NCT04496752|463650705|FG001|Second Assessment|Lost to Follow-up|3|||
128823295|NCT04496752|463650704|FG000|Second Assessment|Adverse Event|2|||
128823296|NCT04496752|463650705|FG001|Second Assessment|Adverse Event|0|||
128823297|NCT04967599|463650708|FG000|Overall Study|Lost to Follow-up|35|||
128823298|NCT04967599|463650709|FG001|Overall Study|Lost to Follow-up|19|||
128823299|NCT04967599|463650710|FG002|Overall Study|Lost to Follow-up|23|||
128823300|NCT04369911|463650711|FG000|Overall Study|Lost to Follow-up|3|||
128823301|NCT04369911|463650712|FG001|Overall Study|Lost to Follow-up|3|||
128823302|NCT04369911|463650711|FG000|Overall Study|Withdrawal by Subject|1|||
128823303|NCT04369911|463650712|FG001|Overall Study|Withdrawal by Subject|2|||
128823304|NCT05123027|463650718|FG000|Overall Study|Lost to Follow-up|17|||
128823305|NCT05123027|463650719|FG001|Overall Study|Lost to Follow-up|22|||
128823306|NCT05123027|463650718|FG000|Overall Study|Incarceration|3|||
128823307|NCT05123027|463650719|FG001|Overall Study|Incarceration|4|||
128823308|NCT05123027|463650718|FG000|Overall Study|Death|2|||
128823309|NCT05123027|463650719|FG001|Overall Study|Death|2|||
128823310|NCT05123027|463650718|FG000|Overall Study|Other|2|||
128823311|NCT05123027|463650719|FG001|Overall Study|Other|0|||
128823312|NCT05541484|463650727|FG000|Overall Study|Withdrawal by Subject|1|||
128823313|NCT05541484|463650728|FG001|Overall Study|Withdrawal by Subject|0|||
128823314|NCT05215054|463650733|FG000|Overall Study|Lost to Follow-up|1|||
128823315|NCT05215054|463650734|FG001|Overall Study|Lost to Follow-up|1|||
128823316|NCT05215054|463650733|FG000|Overall Study|Protocol Violation|1|||
128823317|NCT05215054|463650734|FG001|Overall Study|Protocol Violation|1|||
128823318|NCT05215054|463650733|FG000|Overall Study|Withdrawal by Subject|4|||
128823319|NCT05215054|463650734|FG001|Overall Study|Withdrawal by Subject|4|||
128823320|NCT04159519|463650735|FG000|Overall Study|Adverse Event|1|||
128823321|NCT04159519|463650736|FG001|Overall Study|Adverse Event|1|||
128823322|NCT04159519|463650735|FG000|Overall Study|Lack of Efficacy|1|||
128823323|NCT04159519|463650736|FG001|Overall Study|Lack of Efficacy|0|||
128823324|NCT04159519|463650735|FG000|Overall Study|Discontinued from study|1|||
128823325|NCT04159519|463650736|FG001|Overall Study|Discontinued from study|0|||
128823326|NCT04159519|463650735|FG000|Overall Study|Protocol Violation|1|||
128823327|NCT04159519|463650736|FG001|Overall Study|Protocol Violation|1|||
128823328|NCT04159519|463650735|FG000|Overall Study|Withdrawal by Subject|4|||
128823329|NCT04159519|463650736|FG001|Overall Study|Withdrawal by Subject|4|||
128823330|NCT01756300|463650737|FG000|Overall Study|Death|1|||
128823331|NCT01756300|463650737|FG000|Overall Study|Withdrawal by Subject|1|||
128823332|NCT02163694|463651301|FG000|Overall Study|Adverse event- related to progression|4|||
128823333|NCT02163694|463651302|FG001|Overall Study|Adverse event- related to progression|10|||
128823334|NCT02163694|463651301|FG000|Overall Study|Adverse event- not related to progression|7|||
128823335|NCT02163694|463651302|FG001|Overall Study|Adverse event- not related to progression|22|||
128823336|NCT02163694|463651301|FG000|Overall Study|Withdrew consent|13|||
128823337|NCT02163694|463651302|FG001|Overall Study|Withdrew consent|28|||
128823338|NCT02163694|463651301|FG000|Overall Study|Lost to Follow-up|2|||
128823339|NCT02163694|463651302|FG001|Overall Study|Lost to Follow-up|2|||
128823340|NCT02163694|463651301|FG000|Overall Study|Sponsor discontinued study|3|||
128823341|NCT02163694|463651302|FG001|Overall Study|Sponsor discontinued study|29|||
128823342|NCT02163694|463651301|FG000|Overall Study|Progressive disease per protocol|125|||
128823343|NCT02163694|463651302|FG001|Overall Study|Progressive disease per protocol|224|||
128823344|NCT02163694|463651301|FG000|Overall Study|Other, not specified|17|||
128823345|NCT02163694|463651302|FG001|Overall Study|Other, not specified|22|||
128823346|NCT02163694|463651301|FG000|Overall Study|Randomized but Not Treated|1|||
128823347|NCT02163694|463651302|FG001|Overall Study|Randomized but Not Treated|0|||
128823348|NCT02163694|463651301|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
128823349|NCT02163694|463651302|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
128823350|NCT03370913|463651303|FG000|Overall Study|Death|1|||
128823351|NCT03370913|463651303|FG000|Overall Study|Lost to Follow-up|1|||
128823352|NCT04560179|463651306|FG000|Overall Study|Physician Decision|1|||
128823353|NCT04560179|463651307|FG001|Overall Study|Physician Decision|0|||
128823354|NCT04560179|463651308|FG002|Overall Study|Physician Decision|0|||
128823355|NCT04560179|463651309|FG003|Overall Study|Physician Decision|0|||
128823356|NCT04560179|463651310|FG004|Overall Study|Physician Decision|0|||
128823357|NCT04560179|463651306|FG000|Overall Study|Adverse Event|0|||
128823358|NCT04560179|463651307|FG001|Overall Study|Adverse Event|0|||
128823359|NCT04560179|463651308|FG002|Overall Study|Adverse Event|0|||
128823360|NCT04560179|463651309|FG003|Overall Study|Adverse Event|1|||
128823361|NCT04560179|463651310|FG004|Overall Study|Adverse Event|0|||
128823362|NCT06010836|463651311|FG000|Overall Study|Lost to Follow-up|2|||
128823363|NCT06010836|463651312|FG001|Overall Study|Lost to Follow-up|2|||
128823364|NCT06010836|463651311|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
128823365|NCT06010836|463651312|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
128823366|NCT06010836|463651311|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
128823367|NCT06010836|463651312|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
128823368|NCT06010836|463651311|FG000|Overall Study|Did not receive intervention discussion|0|||
128823369|NCT06010836|463651312|FG001|Overall Study|Did not receive intervention discussion|4|||
128823370|NCT04524689|463651313|FG000|Overall Study|Withdrawal by Subject|1|||
128823371|NCT04524689|463651314|FG001|Overall Study|Withdrawal by Subject|1|||
128823372|NCT04524689|463651315|FG002|Overall Study|Withdrawal by Subject|0|||
128823373|NCT04524689|463651316|FG003|Overall Study|Withdrawal by Subject|0|||
128823374|NCT04524689|463651317|FG004|Overall Study|Withdrawal by Subject|1|||
128823375|NCT04524689|463651318|FG005|Overall Study|Withdrawal by Subject|0|||
128823376|NCT04524689|463651313|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
128823377|NCT04524689|463651314|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
128823378|NCT04524689|463651315|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
128823379|NCT04524689|463651316|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
128823380|NCT04524689|463651317|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
128823381|NCT04524689|463651318|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
128823382|NCT04524689|463651313|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
128823383|NCT04524689|463651314|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
128823384|NCT04524689|463651315|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
128823385|NCT04524689|463651316|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
128823386|NCT04524689|463651317|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
128823387|NCT04524689|463651318|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
128823388|NCT05451693|463651319|FG000|Overall Study|Withdrawal by Subject|1|||
128823389|NCT05451693|463651320|FG001|Overall Study|Withdrawal by Subject|1|||
128823390|NCT04490109|463651331|FG000|Overall Study|Lost to Follow-up|3|||
128823391|NCT04490109|463651332|FG001|Overall Study|Lost to Follow-up|10|||
128823392|NCT04490109|463651333|FG002|Overall Study|Lost to Follow-up|4|||
128823393|NCT04490109|463651331|FG000|Overall Study|Withdrawal by Subject|8|||
128823394|NCT04490109|463651332|FG001|Overall Study|Withdrawal by Subject|6|||
128823395|NCT04490109|463651333|FG002|Overall Study|Withdrawal by Subject|9|||
128823396|NCT04490109|463651331|FG000|Overall Study|Physician Decision|0|||
128823397|NCT04490109|463651332|FG001|Overall Study|Physician Decision|2|||
128823398|NCT04490109|463651333|FG002|Overall Study|Physician Decision|3|||
128823399|NCT04490109|463651331|FG000|Overall Study|Adverse Event|2|||
128823400|NCT04490109|463651332|FG001|Overall Study|Adverse Event|1|||
128823401|NCT04490109|463651333|FG002|Overall Study|Adverse Event|0|||
128823402|NCT04490109|463651331|FG000|Overall Study|Significant Non-Compliance|2|||
128823403|NCT04490109|463651332|FG001|Overall Study|Significant Non-Compliance|4|||
128823404|NCT04490109|463651333|FG002|Overall Study|Significant Non-Compliance|4|||
128823405|NCT04490109|463651331|FG000|Overall Study|Significant Clinical Event|0|||
128823406|NCT04490109|463651332|FG001|Overall Study|Significant Clinical Event|1|||
128823407|NCT04490109|463651333|FG002|Overall Study|Significant Clinical Event|0|||
128823408|NCT04490109|463651331|FG000|Overall Study|Other Reason|4|||
128823409|NCT04490109|463651332|FG001|Overall Study|Other Reason|1|||
128823410|NCT04490109|463651333|FG002|Overall Study|Other Reason|1|||
128823411|NCT03817983|463651336|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
128823412|NCT03817983|463651337|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
128823413|NCT03817983|463651338|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
128823414|NCT03744676|463651339|FG000|Pre-Treatment Phase|Disease related complications|2|||
128823415|NCT03744676|463651339|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
128823416|NCT03744676|463651339|FG000|Pre-Treatment Phase|Death|7|||
128823417|NCT03744676|463651339|FG000|Pre-Treatment Phase|Other Reasons|7|||
128823418|NCT03744676|463651339|FG000|Treatment Phase|Participant withdrew consent|8|||
128823419|NCT03744676|463651339|FG000|Treatment Phase|Death|33|||
128823420|NCT03744676|463651339|FG000|Treatment Phase|other reasons|6|||
128823421|NCT03884439|463651347|FG000|Overall Study|No informed consent for publication of study results|38|||
128823422|NCT03884439|463651347|FG000|Overall Study|Contract violation/deficiency|7|||
128823423|NCT03533257|463651352|FG000|Overall Study|Adverse Event|4|||
128823424|NCT03533257|463651353|FG001|Overall Study|Adverse Event|2|||
128823425|NCT03533257|463651352|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
128823426|NCT03533257|463651353|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
128823427|NCT04780581|463651354|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
128823428|NCT04780581|463651355|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
128823429|NCT04780581|463651354|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
128823430|NCT04780581|463651355|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
128823431|NCT01651000|463651356|FG000|Overall Study|Adverse Event|2|||
128823432|NCT01651000|463651357|FG001|Overall Study|Adverse Event|8|||
128823433|NCT01651000|463651356|FG000|Overall Study|Lost to Follow-up|3|||
128823434|NCT01651000|463651357|FG001|Overall Study|Lost to Follow-up|2|||
128823435|NCT01651000|463651356|FG000|Overall Study|Protocol Violation|0|||
128823436|NCT01651000|463651357|FG001|Overall Study|Protocol Violation|3|||
128823437|NCT01651000|463651356|FG000|Overall Study|Withdrawal by Subject|2|||
128823438|NCT01651000|463651357|FG001|Overall Study|Withdrawal by Subject|10|||
128823439|NCT01651000|463651356|FG000|Overall Study|Subject noncompliance|0|||
128823440|NCT01651000|463651357|FG001|Overall Study|Subject noncompliance|3|||
128823441|NCT01651000|463651356|FG000|Overall Study|Lack of Efficacy|1|||
128823442|NCT01651000|463651357|FG001|Overall Study|Lack of Efficacy|1|||
128823443|NCT01651000|463651356|FG000|Overall Study|Physician Decision|1|||
128823444|NCT01651000|463651357|FG001|Overall Study|Physician Decision|0|||
128823445|NCT01651000|463651356|FG000|Overall Study|Administrative reason|1|||
128823446|NCT01651000|463651357|FG001|Overall Study|Administrative reason|0|||
128823447|NCT01651000|463651356|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
128823448|NCT01651000|463651357|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
128823449|NCT02765412|463651358|FG000|Overall Study|Death|482|||
128823450|NCT02765412|463651359|FG001|Overall Study|Death|855|||
128823451|NCT04244175|463652454|FG000|Overall Study|Adverse Event|3|||
128823452|NCT04244175|463652455|FG001|Overall Study|Adverse Event|2|||
128823453|NCT04244175|463652456|FG002|Overall Study|Adverse Event|5|||
128823454|NCT04244175|463652454|FG000|Overall Study|Lack of Efficacy|1|||
128823455|NCT04244175|463652455|FG001|Overall Study|Lack of Efficacy|0|||
128823456|NCT04244175|463652456|FG002|Overall Study|Lack of Efficacy|1|||
128823457|NCT04244175|463652454|FG000|Overall Study|Lost to Follow-up|1|||
128823458|NCT04244175|463652455|FG001|Overall Study|Lost to Follow-up|0|||
128823459|NCT04244175|463652456|FG002|Overall Study|Lost to Follow-up|0|||
128823460|NCT04244175|463652454|FG000|Overall Study|Non-compliance with study drug|1|||
128823461|NCT04244175|463652455|FG001|Overall Study|Non-compliance with study drug|0|||
128823462|NCT04244175|463652456|FG002|Overall Study|Non-compliance with study drug|1|||
128823463|NCT04244175|463652454|FG000|Overall Study|Protocol deviation|0|||
128823464|NCT04244175|463652455|FG001|Overall Study|Protocol deviation|1|||
128823465|NCT04244175|463652456|FG002|Overall Study|Protocol deviation|0|||
128823466|NCT04244175|463652454|FG000|Overall Study|Withdrawal by Subject|1|||
128823467|NCT04244175|463652455|FG001|Overall Study|Withdrawal by Subject|3|||
128823468|NCT04244175|463652456|FG002|Overall Study|Withdrawal by Subject|1|||
128823469|NCT04244175|463652454|FG000|Overall Study|Other, not specified|0|||
128823470|NCT04244175|463652455|FG001|Overall Study|Other, not specified|1|||
128823471|NCT04244175|463652456|FG002|Overall Study|Other, not specified|2|||
128823472|NCT04595331|463652457|FG000|Overall Study|Withdrawal by Subject|0|||
128823473|NCT04595331|463652458|FG001|Overall Study|Withdrawal by Subject|1|||
128823474|NCT04595331|463652457|FG000|Overall Study|Lost to Follow-up|0|||
128823475|NCT04595331|463652458|FG001|Overall Study|Lost to Follow-up|5|||
128823476|NCT04595331|463652457|FG000|Overall Study|Medical reason|0|||
128823477|NCT04595331|463652458|FG001|Overall Study|Medical reason|1|||
128823478|NCT03781089|463652459|FG000|Overall Study|Constipation|1|||
128823479|NCT03781089|463652460|FG001|Overall Study|Constipation|0|||
128823480|NCT03781089|463652459|FG000|Overall Study|Positive pregnancy test|0|||
128823481|NCT03781089|463652460|FG001|Overall Study|Positive pregnancy test|1|||
128823482|NCT05311176|463652461|FG000|Overall Study|Death|6|||
128823483|NCT05311176|463652461|FG000|Overall Study|Sponsor discontinued the study|1|||
128823484|NCT03662022|463652472|FG000|Year 1 2019|prevalent case|83|||
128823485|NCT03662022|463652473|FG001|Year 1 2019|prevalent case|116|||
128823486|NCT03662022|463652474|FG002|Year 1 2019|prevalent case|158|||
128823487|NCT03662022|463652475|FG003|Year 1 2019|prevalent case|99|||
128823488|NCT03662022|463652472|FG000|Year 2 2020|incident case|18|||
128823489|NCT03662022|463652473|FG001|Year 2 2020|incident case|18|||
128823490|NCT03662022|463652474|FG002|Year 2 2020|incident case|16|||
128823491|NCT03662022|463652475|FG003|Year 2 2020|incident case|26|||
128823492|NCT03662022|463652472|FG000|Year 2 2020|other case|18|||
128823493|NCT03662022|463652473|FG001|Year 2 2020|other case|16|||
128823494|NCT03662022|463652474|FG002|Year 2 2020|other case|16|||
128823495|NCT03662022|463652475|FG003|Year 2 2020|other case|24|||
128823496|NCT03662022|463652472|FG000|Year 2 2020|Lost to Follow-up|1633|||
128823497|NCT03662022|463652473|FG001|Year 2 2020|Lost to Follow-up|1183|||
128823498|NCT03662022|463652474|FG002|Year 2 2020|Lost to Follow-up|1381|||
128823499|NCT03662022|463652475|FG003|Year 2 2020|Lost to Follow-up|2858|||
128823500|NCT03662022|463652472|FG000|Year 3 2021|incident case|24|||
128823501|NCT03662022|463652473|FG001|Year 3 2021|incident case|27|||
128823502|NCT03662022|463652474|FG002|Year 3 2021|incident case|24|||
128823503|NCT03662022|463652475|FG003|Year 3 2021|incident case|11|||
128823504|NCT03662022|463652472|FG000|Year 3 2021|other case|4|||
128823505|NCT03662022|463652473|FG001|Year 3 2021|other case|15|||
128823506|NCT03662022|463652474|FG002|Year 3 2021|other case|10|||
128823507|NCT03662022|463652475|FG003|Year 3 2021|other case|14|||
128823508|NCT03662022|463652472|FG000|Year 3 2021|Lost to Follow-up|179|||
128823509|NCT03662022|463652473|FG001|Year 3 2021|Lost to Follow-up|244|||
128823510|NCT03662022|463652474|FG002|Year 3 2021|Lost to Follow-up|480|||
128823511|NCT03662022|463652475|FG003|Year 3 2021|Lost to Follow-up|477|||
128823512|NCT03662022|463652472|FG000|Year 4 2022|incident case|25|||
128823513|NCT03662022|463652473|FG001|Year 4 2022|incident case|41|||
128823514|NCT03662022|463652474|FG002|Year 4 2022|incident case|28|||
128823515|NCT03662022|463652475|FG003|Year 4 2022|incident case|7|||
128823516|NCT03662022|463652472|FG000|Year 4 2022|other case|8|||
128823517|NCT03662022|463652473|FG001|Year 4 2022|other case|19|||
128823518|NCT03662022|463652474|FG002|Year 4 2022|other case|13|||
128823519|NCT03662022|463652475|FG003|Year 4 2022|other case|7|||
128823520|NCT03662022|463652472|FG000|Year 4 2022|Lost to Follow-up|986|||
128823521|NCT03662022|463652473|FG001|Year 4 2022|Lost to Follow-up|1079|||
128823522|NCT03662022|463652474|FG002|Year 4 2022|Lost to Follow-up|1236|||
128823523|NCT03662022|463652475|FG003|Year 4 2022|Lost to Follow-up|1826|||
128823524|NCT05836012|463652476|FG000|Overall Study|Lost to Follow-up|1|||
128823525|NCT05836012|463652477|FG001|Overall Study|Lost to Follow-up|0|||
128823526|NCT05836012|463652476|FG000|Overall Study|Withdrawal by Subject|1|||
128823527|NCT05836012|463652477|FG001|Overall Study|Withdrawal by Subject|3|||
128823528|NCT05836012|463652476|FG000|Overall Study|Reason not included in pre-specified categories|2|||
128823529|NCT05836012|463652477|FG001|Overall Study|Reason not included in pre-specified categories|1|||
128823530|NCT05454514|463652479|FG000|Overall Study|Withdrawal by Subject|4|||
128823531|NCT03547271|463652480|FG000|Overall Study|Adverse Event|1|||
128823532|NCT03547271|463652481|FG001|Overall Study|Adverse Event|1|||
128823533|NCT03547271|463652482|FG002|Overall Study|Adverse Event|0|||
128823534|NCT03547271|463652483|FG003|Overall Study|Adverse Event|0|||
128823535|NCT03547271|463652480|FG000|Overall Study|Protocol deviation|5|||
128823536|NCT03547271|463652481|FG001|Overall Study|Protocol deviation|7|||
128823537|NCT03547271|463652482|FG002|Overall Study|Protocol deviation|3|||
128823538|NCT03547271|463652483|FG003|Overall Study|Protocol deviation|0|||
128823539|NCT03547271|463652480|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
128823540|NCT03547271|463652481|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
128823541|NCT03547271|463652482|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
128823542|NCT03547271|463652483|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
128823543|NCT03547271|463652480|FG000|Overall Study|Lost to Follow-up|3|||
128823544|NCT03547271|463652481|FG001|Overall Study|Lost to Follow-up|3|||
128823545|NCT03547271|463652482|FG002|Overall Study|Lost to Follow-up|1|||
128823546|NCT03547271|463652483|FG003|Overall Study|Lost to Follow-up|0|||
128823547|NCT06065735|463652488|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
128823548|NCT06065735|463652489|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
128823549|NCT06065735|463652490|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
128823550|NCT06065735|463652488|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
128823551|NCT06065735|463652489|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
128823552|NCT06065735|463652490|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
128823553|NCT06065735|463652488|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
128823554|NCT06065735|463652489|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
128823555|NCT06065735|463652490|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
128823556|NCT06065735|463652488|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
128823557|NCT06065735|463652489|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
128823558|NCT06065735|463652490|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
128823559|NCT06065735|463652488|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
128823560|NCT06065735|463652489|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
128823561|NCT06065735|463652490|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
128823562|NCT02919917|463652491|FG000|Overall Study|Withdrawal by Subject|4|||
128823563|NCT02919917|463652492|FG001|Overall Study|Withdrawal by Subject|8|||
128823564|NCT03418740|463652493|FG000|Overall Study|Lost to Follow-up|13|||
128823565|NCT03418740|463652493|FG000|Overall Study|Scheduling Issues|7|||
128823566|NCT03418740|463652493|FG000|Overall Study|Withdrawal by Subject|2|||
128823567|NCT03418740|463652493|FG000|Overall Study|Unable to Continue Consent|1|||
128823568|NCT04157517|463652498|FG000|Overall Study|Death|1|||
128823569|NCT04157517|463652499|FG001|Overall Study|Death|2|||
128823570|NCT04157517|463652500|FG002|Overall Study|Death|2|||
128823571|NCT04157517|463652501|FG003|Overall Study|Death|3|||
128823572|NCT04157517|463652502|FG004|Overall Study|Death|3|||
128823573|NCT04157517|463652503|FG005|Overall Study|Death|4|||
128823574|NCT04157517|463652504|FG006|Overall Study|Death|1|||
128823575|NCT04157517|463652505|FG007|Overall Study|Death|2|||
128823576|NCT04157517|463652506|FG008|Overall Study|Death|4|||
128823577|NCT04157517|463652507|FG009|Overall Study|Death|0|||
128823578|NCT04157517|463652498|FG000|Overall Study|Withdrawal by Subject|1|||
128823579|NCT04157517|463652499|FG001|Overall Study|Withdrawal by Subject|1|||
128823580|NCT04157517|463652500|FG002|Overall Study|Withdrawal by Subject|1|||
128823581|NCT04157517|463652501|FG003|Overall Study|Withdrawal by Subject|0|||
128823582|NCT04157517|463652502|FG004|Overall Study|Withdrawal by Subject|0|||
128823583|NCT04157517|463652503|FG005|Overall Study|Withdrawal by Subject|1|||
128823584|NCT04157517|463652504|FG006|Overall Study|Withdrawal by Subject|0|||
128823585|NCT04157517|463652505|FG007|Overall Study|Withdrawal by Subject|0|||
128823586|NCT04157517|463652506|FG008|Overall Study|Withdrawal by Subject|1|||
128823587|NCT04157517|463652507|FG009|Overall Study|Withdrawal by Subject|0|||
128823588|NCT04157517|463652498|FG000|Overall Study|Other|1|||
128823589|NCT04157517|463652499|FG001|Overall Study|Other|0|||
128823590|NCT04157517|463652500|FG002|Overall Study|Other|0|||
128823591|NCT04157517|463652501|FG003|Overall Study|Other|0|||
128823592|NCT04157517|463652502|FG004|Overall Study|Other|0|||
128823593|NCT04157517|463652503|FG005|Overall Study|Other|1|||
128823594|NCT04157517|463652504|FG006|Overall Study|Other|2|||
128823595|NCT04157517|463652505|FG007|Overall Study|Other|7|||
128823596|NCT04157517|463652506|FG008|Overall Study|Other|7|||
128823597|NCT04157517|463652507|FG009|Overall Study|Other|0|||
128823598|NCT02933489|463652508|FG000|Overall Study|Ineligible|3|||
128823599|NCT02933489|463652509|FG001|Overall Study|Ineligible|3|||
128823600|NCT02933489|463652508|FG000|Overall Study|Withdrawal by Subject|27|||
128823601|NCT02933489|463652509|FG001|Overall Study|Withdrawal by Subject|18|||
128823602|NCT02933489|463652508|FG000|Overall Study|Unable to complete exams (other)|14|||
128823603|NCT02933489|463652509|FG001|Overall Study|Unable to complete exams (other)|7|||
128823604|NCT02461134|463652510|FG000|Overall Study|Adverse Event|1|||
128823605|NCT03250676|463652511|FG000|Overall Study|Adverse Event|0|||
128823606|NCT03250676|463652512|FG001|Overall Study|Adverse Event|0|||
128823607|NCT03250676|463652513|FG002|Overall Study|Adverse Event|0|||
128823608|NCT03250676|463652514|FG003|Overall Study|Adverse Event|1|||
128823609|NCT03250676|463652515|FG004|Overall Study|Adverse Event|2|||
128823610|NCT03250676|463652516|FG005|Overall Study|Adverse Event|9|||
128823611|NCT03250676|463652511|FG000|Overall Study|Withdrawal by Subject|1|||
128823612|NCT03250676|463652512|FG001|Overall Study|Withdrawal by Subject|0|||
128823613|NCT03250676|463652513|FG002|Overall Study|Withdrawal by Subject|0|||
128823614|NCT03250676|463652514|FG003|Overall Study|Withdrawal by Subject|1|||
128823615|NCT03250676|463652515|FG004|Overall Study|Withdrawal by Subject|1|||
128823616|NCT03250676|463652516|FG005|Overall Study|Withdrawal by Subject|2|||
128823617|NCT03250676|463652511|FG000|Overall Study|Physician Decision|0|||
128823618|NCT03250676|463652512|FG001|Overall Study|Physician Decision|0|||
128823619|NCT03250676|463652513|FG002|Overall Study|Physician Decision|0|||
128823620|NCT03250676|463652514|FG003|Overall Study|Physician Decision|2|||
128823621|NCT03250676|463652515|FG004|Overall Study|Physician Decision|0|||
128823622|NCT03250676|463652516|FG005|Overall Study|Physician Decision|3|||
128823623|NCT03250676|463652511|FG000|Overall Study|Withdrawal of consent|0|||
128823624|NCT03250676|463652512|FG001|Overall Study|Withdrawal of consent|0|||
128823625|NCT03250676|463652513|FG002|Overall Study|Withdrawal of consent|2|||
128823626|NCT03250676|463652514|FG003|Overall Study|Withdrawal of consent|0|||
128823627|NCT03250676|463652515|FG004|Overall Study|Withdrawal of consent|0|||
128823628|NCT03250676|463652516|FG005|Overall Study|Withdrawal of consent|2|||
128823629|NCT03250676|463652511|FG000|Overall Study|Other|1|||
128823630|NCT03250676|463652512|FG001|Overall Study|Other|0|||
128823631|NCT03250676|463652513|FG002|Overall Study|Other|0|||
128823632|NCT03250676|463652514|FG003|Overall Study|Other|0|||
128823633|NCT03250676|463652515|FG004|Overall Study|Other|0|||
128823634|NCT03250676|463652516|FG005|Overall Study|Other|0|||
128823635|NCT03250676|463652511|FG000|Overall Study|Disease progression|4|||
128823636|NCT03250676|463652512|FG001|Overall Study|Disease progression|12|||
128823637|NCT03250676|463652513|FG002|Overall Study|Disease progression|9|||
128823638|NCT03250676|463652514|FG003|Overall Study|Disease progression|7|||
128823639|NCT03250676|463652515|FG004|Overall Study|Disease progression|4|||
128823640|NCT03250676|463652516|FG005|Overall Study|Disease progression|88|||
128823641|NCT03587805|463652517|FG000|Overall Study|Adverse Event|72|||
128823642|NCT03587805|463652517|FG000|Overall Study|Death|1|||
128823643|NCT03587805|463652517|FG000|Overall Study|Lost to Follow-up|78|||
128823644|NCT03587805|463652517|FG000|Overall Study|Withdrawal by Subject|105|||
128823645|NCT03587805|463652517|FG000|Overall Study|Lack of Efficacy|119|||
128823646|NCT03587805|463652517|FG000|Overall Study|Reason unknown|26|||
128823647|NCT03587805|463652517|FG000|Overall Study|COVID_19 pandemic|4|||
128823648|NCT03587805|463652517|FG000|Overall Study|Various reasons|121|||
128823649|NCT03587805|463652517|FG000|Overall Study|Withdrawal by parent/guardian|3|||
128823650|NCT03982186|463652518|FG000|Overall Study|Lost to Follow-up|0|||
128823651|NCT03982186|463652519|FG001|Overall Study|Lost to Follow-up|1|||
128823652|NCT03982186|463652520|FG002|Overall Study|Lost to Follow-up|2|||
128823653|NCT03982186|463652521|FG003|Overall Study|Lost to Follow-up|1|||
128823654|NCT03982186|463652522|FG004|Overall Study|Lost to Follow-up|1|||
128823655|NCT03982186|463652523|FG005|Overall Study|Lost to Follow-up|0|||
128823656|NCT03982186|463652518|FG000|Overall Study|Physician Decision|0|||
128823657|NCT03982186|463652519|FG001|Overall Study|Physician Decision|1|||
128823658|NCT03982186|463652520|FG002|Overall Study|Physician Decision|0|||
128823659|NCT03982186|463652521|FG003|Overall Study|Physician Decision|0|||
128823660|NCT03982186|463652522|FG004|Overall Study|Physician Decision|0|||
128823661|NCT03982186|463652523|FG005|Overall Study|Physician Decision|0|||
128823662|NCT03982186|463652518|FG000|Overall Study|Withdrawal by Subject|3|||
128823663|NCT03982186|463652519|FG001|Overall Study|Withdrawal by Subject|4|||
128823664|NCT03982186|463652520|FG002|Overall Study|Withdrawal by Subject|1|||
128823665|NCT03982186|463652521|FG003|Overall Study|Withdrawal by Subject|7|||
128823666|NCT03982186|463652522|FG004|Overall Study|Withdrawal by Subject|2|||
128823667|NCT03982186|463652523|FG005|Overall Study|Withdrawal by Subject|0|||
128823668|NCT03982186|463652518|FG000|Overall Study|Randomized and not treated|0|||
128823669|NCT03982186|463652519|FG001|Overall Study|Randomized and not treated|0|||
128823670|NCT03982186|463652520|FG002|Overall Study|Randomized and not treated|0|||
128823671|NCT03982186|463652521|FG003|Overall Study|Randomized and not treated|1|||
128823672|NCT03982186|463652522|FG004|Overall Study|Randomized and not treated|0|||
128823673|NCT03982186|463652523|FG005|Overall Study|Randomized and not treated|0|||
128823674|NCT05020353|463653113|FG000|Overall Study|Protocol Violation|7|||
128823675|NCT05020353|463653113|FG000|Overall Study|Withdrawal by Subject|33|||
128823676|NCT03417284|463653114|FG000|Overall Study|Inadequate supply on study drug|1|||
128823677|NCT03417284|463653115|FG001|Overall Study|Inadequate supply on study drug|0|||
128823678|NCT03417284|463653116|FG002|Overall Study|Inadequate supply on study drug|0|||
128823679|NCT03417284|463653117|FG003|Overall Study|Inadequate supply on study drug|0|||
128823680|NCT03417284|463653114|FG000|Overall Study|Disease Progression|0|||
128823681|NCT03417284|463653115|FG001|Overall Study|Disease Progression|0|||
128823682|NCT03417284|463653116|FG002|Overall Study|Disease Progression|1|||
128823683|NCT03417284|463653117|FG003|Overall Study|Disease Progression|0|||
128823684|NCT05132400|463653118|FG000|Overall Study|Withdrawal by Subject|14|||
128823685|NCT05132400|463653119|FG001|Overall Study|Withdrawal by Subject|8|||
128823686|NCT05132400|463653118|FG000|Overall Study|Lost to Follow-up|132|||
128823687|NCT05132400|463653119|FG001|Overall Study|Lost to Follow-up|121|||
128823688|NCT01880515|463653120|FG000|Overall Study|Lost to Follow-up|3|||
128823689|NCT01880515|463653121|FG001|Overall Study|Lost to Follow-up|2|||
128823690|NCT01880515|463653120|FG000|Overall Study|Disease Progression|5|||
128823691|NCT01880515|463653121|FG001|Overall Study|Disease Progression|7|||
128823692|NCT03333915|463653135|FG000|Overall Study|Lost to Follow-up|0|||
128823693|NCT03333915|463653136|FG001|Overall Study|Lost to Follow-up|0|||
128823694|NCT03333915|463653137|FG002|Overall Study|Lost to Follow-up|1|||
128823695|NCT03333915|463653138|FG003|Overall Study|Lost to Follow-up|0|||
128823696|NCT03333915|463653139|FG004|Overall Study|Lost to Follow-up|0|||
128823697|NCT03333915|463653135|FG000|Overall Study|Disease Progression|0|||
128823698|NCT03333915|463653136|FG001|Overall Study|Disease Progression|1|||
128823699|NCT03333915|463653137|FG002|Overall Study|Disease Progression|0|||
128823700|NCT03333915|463653138|FG003|Overall Study|Disease Progression|0|||
128823701|NCT03333915|463653139|FG004|Overall Study|Disease Progression|0|||
128823702|NCT03333915|463653135|FG000|Overall Study|Death|0|||
128823703|NCT03333915|463653136|FG001|Overall Study|Death|0|||
128823704|NCT03333915|463653137|FG002|Overall Study|Death|0|||
128823705|NCT03333915|463653138|FG003|Overall Study|Death|37|||
128823706|NCT03333915|463653139|FG004|Overall Study|Death|18|||
128823707|NCT03333915|463653135|FG000|Overall Study|Sponsor's Decision|0|||
128823708|NCT03333915|463653136|FG001|Overall Study|Sponsor's Decision|0|||
128823709|NCT03333915|463653137|FG002|Overall Study|Sponsor's Decision|0|||
128823710|NCT03333915|463653138|FG003|Overall Study|Sponsor's Decision|48|||
128823711|NCT03333915|463653139|FG004|Overall Study|Sponsor's Decision|4|||
128823712|NCT03333915|463653135|FG000|Overall Study|Withdrawal by Subject|0|||
128823713|NCT03333915|463653136|FG001|Overall Study|Withdrawal by Subject|0|||
128823714|NCT03333915|463653137|FG002|Overall Study|Withdrawal by Subject|0|||
128823715|NCT03333915|463653138|FG003|Overall Study|Withdrawal by Subject|5|||
128823716|NCT03333915|463653139|FG004|Overall Study|Withdrawal by Subject|1|||
128823717|NCT05785130|463653141|FG000|Overall Study|Withdrawal by Subject|1|||
128823718|NCT05785130|463653142|FG001|Overall Study|Withdrawal by Subject|0|||
128823719|NCT05785130|463653141|FG000|Overall Study|Lack of Efficacy|0|||
128823720|NCT05785130|463653142|FG001|Overall Study|Lack of Efficacy|1|||
128823721|NCT02532621|463653148|FG000|Overall Study|Death|3|||
128823722|NCT02532621|463653148|FG000|Overall Study|Lost to Follow-up|3|||
128823723|NCT02532621|463653148|FG000|Overall Study|Withdrawal by Subject|6|||
128823724|NCT02532621|463653148|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
128823725|NCT02532621|463653148|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
128823726|NCT03522298|463653149|FG000|Overall Study|Adverse Event|1|||
128823727|NCT03522298|463653150|FG001|Overall Study|Adverse Event|0|||
128823728|NCT03522298|463653151|FG002|Overall Study|Adverse Event|0|||
128823729|NCT03522298|463653152|FG003|Overall Study|Adverse Event|1|||
128823730|NCT03522298|463653149|FG000|Overall Study|Death|2|||
128823731|NCT03522298|463653150|FG001|Overall Study|Death|4|||
128823732|NCT03522298|463653151|FG002|Overall Study|Death|8|||
128823733|NCT03522298|463653152|FG003|Overall Study|Death|8|||
128823734|NCT03522298|463653149|FG000|Overall Study|Patient decision|0|||
128823735|NCT03522298|463653150|FG001|Overall Study|Patient decision|2|||
128823736|NCT03522298|463653151|FG002|Overall Study|Patient decision|2|||
128823737|NCT03522298|463653152|FG003|Overall Study|Patient decision|2|||
128823738|NCT04795245|463653155|FG000|Overall Study|Unkown reason|7|||
128823739|NCT04795245|463653155|FG000|Overall Study|Death|17|||
128823740|NCT04795245|463653155|FG000|Overall Study|Other than listed|19|||
128823741|NCT04795245|463653155|FG000|Overall Study|Adverse Event|143|||
128823742|NCT04795245|463653155|FG000|Overall Study|Progressive disease|512|||
128823743|NCT04795245|463653155|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
128823744|NCT01897441|463653156|FG000|Overall Study|Lost to Follow-up|0|||
128823745|NCT01897441|463653157|FG001|Overall Study|Lost to Follow-up|0|||
128823746|NCT01897441|463653158|FG002|Overall Study|Lost to Follow-up|1|||
128823747|NCT01897441|463653159|FG003|Overall Study|Lost to Follow-up|0|||
128823748|NCT01897441|463653160|FG004|Overall Study|Lost to Follow-up|0|||
128823749|NCT01897441|463653161|FG005|Overall Study|Lost to Follow-up|0|||
128823750|NCT01897441|463653156|FG000|Overall Study|Withdrawal by Subject|0|||
128823751|NCT01897441|463653157|FG001|Overall Study|Withdrawal by Subject|0|||
128823752|NCT01897441|463653158|FG002|Overall Study|Withdrawal by Subject|0|||
128823753|NCT01897441|463653159|FG003|Overall Study|Withdrawal by Subject|0|||
128823754|NCT01897441|463653160|FG004|Overall Study|Withdrawal by Subject|1|||
128823755|NCT01897441|463653161|FG005|Overall Study|Withdrawal by Subject|0|||
128823756|NCT01897441|463653156|FG000|Overall Study|Withdrawn by Provider|0|||
128823757|NCT01897441|463653157|FG001|Overall Study|Withdrawn by Provider|2|||
128823758|NCT01897441|463653158|FG002|Overall Study|Withdrawn by Provider|0|||
128823759|NCT01897441|463653159|FG003|Overall Study|Withdrawn by Provider|0|||
128823760|NCT01897441|463653160|FG004|Overall Study|Withdrawn by Provider|0|||
128823761|NCT01897441|463653161|FG005|Overall Study|Withdrawn by Provider|0|||
128823762|NCT04761198|463653164|FG000|Overall Study|Progressive Disease|1|||
128823763|NCT04761198|463653165|FG001|Overall Study|Progressive Disease|0|||
128823764|NCT04761198|463653166|FG002|Overall Study|Progressive Disease|0|||
128823765|NCT04761198|463653167|FG003|Overall Study|Progressive Disease|1|||
128823766|NCT04761198|463653168|FG004|Overall Study|Progressive Disease|4|||
128823767|NCT04761198|463653169|FG005|Overall Study|Progressive Disease|1|||
128823768|NCT04761198|463653170|FG006|Overall Study|Progressive Disease|2|||
128823769|NCT04761198|463653164|FG000|Overall Study|Protocol Violation|0|||
128823770|NCT04761198|463653165|FG001|Overall Study|Protocol Violation|0|||
128823771|NCT04761198|463653166|FG002|Overall Study|Protocol Violation|0|||
128823772|NCT04761198|463653167|FG003|Overall Study|Protocol Violation|0|||
128823773|NCT04761198|463653168|FG004|Overall Study|Protocol Violation|1|||
128823774|NCT04761198|463653169|FG005|Overall Study|Protocol Violation|0|||
128823775|NCT04761198|463653170|FG006|Overall Study|Protocol Violation|0|||
128823776|NCT04761198|463653164|FG000|Overall Study|Death|2|||
128823777|NCT04761198|463653165|FG001|Overall Study|Death|1|||
128823778|NCT04761198|463653166|FG002|Overall Study|Death|2|||
128823779|NCT04761198|463653167|FG003|Overall Study|Death|5|||
128823780|NCT04761198|463653168|FG004|Overall Study|Death|14|||
128823781|NCT04761198|463653169|FG005|Overall Study|Death|2|||
128823782|NCT04761198|463653170|FG006|Overall Study|Death|5|||
128823783|NCT04761198|463653164|FG000|Overall Study|Lost to Follow-up|0|||
128823784|NCT04761198|463653165|FG001|Overall Study|Lost to Follow-up|0|||
128823785|NCT04761198|463653166|FG002|Overall Study|Lost to Follow-up|0|||
128823786|NCT04761198|463653167|FG003|Overall Study|Lost to Follow-up|0|||
128823787|NCT04761198|463653168|FG004|Overall Study|Lost to Follow-up|1|||
128823788|NCT04761198|463653169|FG005|Overall Study|Lost to Follow-up|0|||
128823789|NCT04761198|463653170|FG006|Overall Study|Lost to Follow-up|0|||
128823790|NCT04761198|463653164|FG000|Overall Study|Withdrawal by Subject|2|||
128823791|NCT04761198|463653165|FG001|Overall Study|Withdrawal by Subject|0|||
128823792|NCT04761198|463653166|FG002|Overall Study|Withdrawal by Subject|1|||
128823793|NCT04761198|463653167|FG003|Overall Study|Withdrawal by Subject|0|||
128823794|NCT04761198|463653168|FG004|Overall Study|Withdrawal by Subject|2|||
128823795|NCT04761198|463653169|FG005|Overall Study|Withdrawal by Subject|0|||
128823796|NCT04761198|463653170|FG006|Overall Study|Withdrawal by Subject|1|||
128823797|NCT04761198|463653164|FG000|Overall Study|Study Terminated by Sponsor|6|||
128823798|NCT04761198|463653165|FG001|Overall Study|Study Terminated by Sponsor|0|||
128823799|NCT04761198|463653166|FG002|Overall Study|Study Terminated by Sponsor|5|||
128823800|NCT04761198|463653167|FG003|Overall Study|Study Terminated by Sponsor|3|||
128823801|NCT04761198|463653168|FG004|Overall Study|Study Terminated by Sponsor|10|||
128823802|NCT04761198|463653169|FG005|Overall Study|Study Terminated by Sponsor|1|||
128823803|NCT04761198|463653170|FG006|Overall Study|Study Terminated by Sponsor|2|||
128823804|NCT02994927|463653171|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128823805|NCT02994927|463653172|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128823806|NCT02994927|463653171|FG000|Overall Study|Did not meet eligibility criteria|0|||
128823807|NCT02994927|463653172|FG001|Overall Study|Did not meet eligibility criteria|1|||
128823808|NCT02994927|463653171|FG000|Overall Study|Physician Decision|4|||
128823809|NCT02994927|463653172|FG001|Overall Study|Physician Decision|3|||
128823810|NCT02994927|463653171|FG000|Overall Study|Death|4|||
128823811|NCT02994927|463653172|FG001|Overall Study|Death|2|||
128823812|NCT02994927|463653171|FG000|Overall Study|Adverse Event|2|||
128823813|NCT02994927|463653172|FG001|Overall Study|Adverse Event|1|||
128823814|NCT02994927|463653171|FG000|Overall Study|Withdrawal by Subject|3|||
128823815|NCT02994927|463653172|FG001|Overall Study|Withdrawal by Subject|6|||
128823816|NCT02994927|463653171|FG000|Overall Study|Lost to Follow-up|2|||
128823817|NCT02994927|463653172|FG001|Overall Study|Lost to Follow-up|1|||
128823818|NCT04093869|463653180|FG000|Overall Study|Death|0|||
128823819|NCT04093869|463653181|FG001|Overall Study|Death|1|||
128823820|NCT04093869|463653180|FG000|Overall Study|Withdrawal by Subject|1|||
128823821|NCT04093869|463653181|FG001|Overall Study|Withdrawal by Subject|0|||
128823822|NCT04626427|463653182|FG000|Overall Study|Death|1|||
128823823|NCT04626427|463653182|FG000|Overall Study|Withdrawal by Subject|1|||
128823824|NCT04626427|463653182|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
128823825|NCT04626427|463653182|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
128823826|NCT01265537|463653183|FG000|Overall Study|Adverse Event|2|||
128823827|NCT01265537|463653184|FG001|Overall Study|Adverse Event|1|||
128823828|NCT01265537|463653183|FG000|Overall Study|Physician Decision|0|||
128823829|NCT01265537|463653184|FG001|Overall Study|Physician Decision|1|||
128823830|NCT05866926|463653185|FG000|Overall Study|Death|16|||
128823831|NCT05866926|463653186|FG001|Overall Study|Death|9|||
128823832|NCT05866926|463653185|FG000|Overall Study|Lost to Follow-up|0|||
128823833|NCT05866926|463653186|FG001|Overall Study|Lost to Follow-up|1|||
128823834|NCT05866926|463653185|FG000|Overall Study|Adverse Event|1|||
128823835|NCT05866926|463653186|FG001|Overall Study|Adverse Event|0|||
128823836|NCT05866926|463653185|FG000|Overall Study|Withdrawal by Subject|5|||
128823837|NCT05866926|463653186|FG001|Overall Study|Withdrawal by Subject|1|||
128823838|NCT05866926|463653185|FG000|Overall Study|Disease progression|1|||
128823839|NCT05866926|463653186|FG001|Overall Study|Disease progression|0|||
128823840|NCT05866926|463653185|FG000|Overall Study|other causes|2|||
128823841|NCT05866926|463653186|FG001|Overall Study|other causes|1|||
128823842|NCT05267639|463653603|FG000|Overall Study|Withdrawal by Subject|1|||
128823843|NCT05267639|463653604|FG001|Overall Study|Withdrawal by Subject|0|||
128823844|NCT03635567|463653610|FG000|Overall Study|Lost to Follow-up|4|||
128823845|NCT03635567|463653611|FG001|Overall Study|Lost to Follow-up|1|||
128823846|NCT03635567|463653610|FG000|Overall Study|Withdrawal by Subject|11|||
128823847|NCT03635567|463653611|FG001|Overall Study|Withdrawal by Subject|16|||
128823848|NCT03635567|463653610|FG000|Overall Study|Sponsor Decision|99|||
128823849|NCT03635567|463653611|FG001|Overall Study|Sponsor Decision|57|||
128823850|NCT03635567|463653610|FG000|Overall Study|Death|194|||
128823851|NCT03635567|463653611|FG001|Overall Study|Death|235|||
128823852|NCT00942734|463653626|FG000|Overall Study|Adverse Event|2|||
128823853|NCT00942734|463653626|FG000|Overall Study|Protocol Violation|3|||
128823854|NCT00942734|463653626|FG000|Overall Study|Disease Progression|2|||
128823855|NCT00942734|463653626|FG000|Overall Study|Physician Decision|1|||
128823856|NCT03816397|463653627|FG000|Overall Study|Censored at interim analysis date.|13|||
128823857|NCT03816397|463653628|FG001|Overall Study|Censored at interim analysis date.|6|||
128823858|NCT03816397|463653627|FG000|Overall Study|Withdrawal by Subject|1|||
128823859|NCT03816397|463653628|FG001|Overall Study|Withdrawal by Subject|1|||
128823860|NCT05985395|463653629|FG000|Overall Study|Physician Decision|2|||
128823861|NCT05985395|463653630|FG001|Overall Study|Physician Decision|1|||
128823862|NCT05985395|463653629|FG000|Overall Study|Withdrawal by Subject|1|||
128823863|NCT05985395|463653630|FG001|Overall Study|Withdrawal by Subject|0|||
128823864|NCT02777593|463653642|FG000|Overall Study|Still in study|1|||
128823865|NCT02777593|463653643|FG001|Overall Study|Still in study|32|||
128823866|NCT02777593|463653644|FG002|Overall Study|Still in study|3|||
128823867|NCT02777593|463653645|FG003|Overall Study|Still in study|6|||
128823868|NCT02777593|463653646|FG004|Overall Study|Still in study|5|||
128823869|NCT02777593|463653642|FG000|Overall Study|Death|21|||
128823870|NCT02777593|463653643|FG001|Overall Study|Death|28|||
128823871|NCT02777593|463653644|FG002|Overall Study|Death|0|||
128823872|NCT02777593|463653645|FG003|Overall Study|Death|5|||
128823873|NCT02777593|463653646|FG004|Overall Study|Death|0|||
128823874|NCT02777593|463653642|FG000|Overall Study|Withdrawal by Subject|8|||
128823875|NCT02777593|463653643|FG001|Overall Study|Withdrawal by Subject|4|||
128823876|NCT02777593|463653644|FG002|Overall Study|Withdrawal by Subject|1|||
128823877|NCT02777593|463653645|FG003|Overall Study|Withdrawal by Subject|1|||
128823878|NCT02777593|463653646|FG004|Overall Study|Withdrawal by Subject|0|||
128823879|NCT02777593|463653642|FG000|Overall Study|Lost to Follow-up|8|||
128823880|NCT02777593|463653643|FG001|Overall Study|Lost to Follow-up|16|||
128823881|NCT02777593|463653644|FG002|Overall Study|Lost to Follow-up|5|||
128823882|NCT02777593|463653645|FG003|Overall Study|Lost to Follow-up|0|||
128823883|NCT02777593|463653646|FG004|Overall Study|Lost to Follow-up|1|||
128823884|NCT02777593|463653642|FG000|Overall Study|Physician Decision|2|||
128823885|NCT02777593|463653643|FG001|Overall Study|Physician Decision|2|||
128823886|NCT02777593|463653644|FG002|Overall Study|Physician Decision|0|||
128823887|NCT02777593|463653645|FG003|Overall Study|Physician Decision|0|||
128823888|NCT02777593|463653646|FG004|Overall Study|Physician Decision|0|||
128823889|NCT02777593|463653642|FG000|Overall Study|Discontinued due to Other|1|||
128823890|NCT02777593|463653643|FG001|Overall Study|Discontinued due to Other|0|||
128823891|NCT02777593|463653644|FG002|Overall Study|Discontinued due to Other|0|||
128823892|NCT02777593|463653645|FG003|Overall Study|Discontinued due to Other|0|||
128823893|NCT02777593|463653646|FG004|Overall Study|Discontinued due to Other|0|||
128823894|NCT03493542|463653647|FG000|Base Study|Withdrawal by Subject|0|||
128823895|NCT03493542|463653648|FG001|Base Study|Withdrawal by Subject|4|||
128823896|NCT03493542|463653649|FG002|Base Study|Withdrawal by Subject|0|||
128823897|NCT03493542|463653647|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
128823898|NCT03493542|463653648|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
128823899|NCT03493542|463653649|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
128823900|NCT03493542|463653647|FG000|Extension Study|Withdrawal by Subject|0|||
128823901|NCT03493542|463653648|FG001|Extension Study|Withdrawal by Subject|0|||
128823902|NCT03493542|463653649|FG002|Extension Study|Withdrawal by Subject|25|||
128823903|NCT05485935|463653650|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
128823904|NCT05485935|463653651|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
128823905|NCT05485935|463653650|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
128823906|NCT05485935|463653651|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
128823907|NCT05485935|463653650|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
128823908|NCT05485935|463653651|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
128823909|NCT05485935|463653650|FG000|Period 2 (T2 and V3)|loss of contact|0|||
128823910|NCT05485935|463653651|FG001|Period 2 (T2 and V3)|loss of contact|1|||
128823911|NCT02806726|463653657|FG000|Overall Study|Lost to Follow-up|1|||
128823912|NCT05129501|463653658|FG000|Overall Study|Lost to Follow-up|54|||
128823913|NCT05129501|463653659|FG001|Overall Study|Lost to Follow-up|41|||
128823914|NCT04281498|463653660|FG000|Overall Study|Progression of disease|1|||
128823915|NCT04281498|463653660|FG000|Overall Study|Planned SCT|1|||
128823916|NCT04281498|463653660|FG000|Overall Study|Alternative Treatment|1|||
128823917|NCT00447980|463654187|FG000|Overall Study|Withdrawal by Subject|1|||
128823918|NCT00447980|463654188|FG001|Overall Study|Withdrawal by Subject|1|||
128823919|NCT00447980|463654189|FG002|Overall Study|Withdrawal by Subject|4|||
128823920|NCT00447980|463654190|FG003|Overall Study|Withdrawal by Subject|4|||
128823921|NCT00447980|463654187|FG000|Overall Study|Lost to Follow-up|1|||
128823922|NCT00447980|463654188|FG001|Overall Study|Lost to Follow-up|1|||
128823923|NCT00447980|463654189|FG002|Overall Study|Lost to Follow-up|0|||
128823924|NCT00447980|463654190|FG003|Overall Study|Lost to Follow-up|0|||
128823925|NCT00447980|463654187|FG000|Overall Study|Did not proceed with surgery|3|||
128823926|NCT00447980|463654188|FG001|Overall Study|Did not proceed with surgery|3|||
128823927|NCT00447980|463654189|FG002|Overall Study|Did not proceed with surgery|2|||
128823928|NCT00447980|463654190|FG003|Overall Study|Did not proceed with surgery|2|||
128823929|NCT05157841|463654193|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
128823930|NCT05157841|463654194|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
128823931|NCT05157841|463654195|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
128823932|NCT05157841|463654193|FG000|Part A (14 Days)|Adverse Event|1|||
128823933|NCT05157841|463654194|FG001|Part A (14 Days)|Adverse Event|0|||
128823934|NCT05157841|463654195|FG002|Part A (14 Days)|Adverse Event|0|||
128823935|NCT05157841|463654193|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
128823936|NCT05157841|463654194|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
128823937|NCT05157841|463654195|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
128823938|NCT02076009|463654196|FG000|Overall Study|Death|172|||
128823939|NCT02076009|463654197|FG001|Overall Study|Death|153|||
128823940|NCT02076009|463654196|FG000|Overall Study|Withdrawal by Subject|16|||
128823941|NCT02076009|463654197|FG001|Overall Study|Withdrawal by Subject|12|||
128823942|NCT02076009|463654196|FG000|Overall Study|Lost to Follow-up|4|||
128823943|NCT02076009|463654197|FG001|Overall Study|Lost to Follow-up|2|||
128823944|NCT02076009|463654196|FG000|Overall Study|Progressive Disease|1|||
128823945|NCT02076009|463654197|FG001|Overall Study|Progressive Disease|0|||
128823946|NCT02076009|463654196|FG000|Overall Study|Physician Decision|0|||
128823947|NCT02076009|463654197|FG001|Overall Study|Physician Decision|1|||
128823948|NCT02076009|463654196|FG000|Overall Study|End of data collection|90|||
128823949|NCT02076009|463654197|FG001|Overall Study|End of data collection|118|||
128823950|NCT05988398|463654199|FG000|Overall Study|Lack of time|21|||
128823951|NCT05988398|463654200|FG001|Overall Study|Lack of time|0|||
128823952|NCT05988398|463654199|FG000|Overall Study|Absent from school|0|||
128823953|NCT05988398|463654200|FG001|Overall Study|Absent from school|38|||
128823954|NCT05988398|463654199|FG000|Overall Study|Chose not to participate|0|||
128823955|NCT05988398|463654200|FG001|Overall Study|Chose not to participate|42|||
128823956|NCT05988398|463654199|FG000|Overall Study|Other commitments (e.g., sports)|0|||
128823957|NCT05988398|463654200|FG001|Overall Study|Other commitments (e.g., sports)|25|||
128823958|NCT05718687|463654212|FG000|Overall Study|Withdrawal by Subject|3|||
128823959|NCT01527188|463654216|FG000|Overall Study|Adverse Event|5|||
128823960|NCT01527188|463654217|FG001|Overall Study|Adverse Event|5|||
128823961|NCT01527188|463654218|FG002|Overall Study|Adverse Event|11|||
128823962|NCT01527188|463654219|FG003|Overall Study|Adverse Event|0|||
128823963|NCT01527188|463654216|FG000|Overall Study|Withdrawal by Subject|3|||
128823964|NCT01527188|463654217|FG001|Overall Study|Withdrawal by Subject|6|||
128823965|NCT01527188|463654218|FG002|Overall Study|Withdrawal by Subject|4|||
128823966|NCT01527188|463654219|FG003|Overall Study|Withdrawal by Subject|4|||
128823967|NCT01527188|463654216|FG000|Overall Study|Any other reason not above-mentioned|6|||
128823968|NCT01527188|463654217|FG001|Overall Study|Any other reason not above-mentioned|7|||
128823969|NCT01527188|463654218|FG002|Overall Study|Any other reason not above-mentioned|8|||
128823970|NCT01527188|463654219|FG003|Overall Study|Any other reason not above-mentioned|8|||
128823971|NCT01220531|463654222|FG000|Overall Study|Death|7|||
128823972|NCT01220531|463654222|FG000|Overall Study|Lost to Follow-up|1|||
128823973|NCT02325154|463654223|FG000|Overall Study|Physician Decision|1|||
128823974|NCT03782116|463654224|FG000|Completed Intervetion|Lost to Follow-up|11|||
128823975|NCT03782116|463654225|FG001|Completed Intervetion|Lost to Follow-up|7|||
128823976|NCT03782116|463654224|FG000|Completed Intervetion|Withdrawal by Subject|6|||
128823977|NCT03782116|463654225|FG001|Completed Intervetion|Withdrawal by Subject|5|||
128823978|NCT03782116|463654224|FG000|Included in Analysis|Protocol Violation|5|||
128823979|NCT03782116|463654225|FG001|Included in Analysis|Protocol Violation|5|||
128823980|NCT03512301|463654603|FG000|Overall Study|Protocol Violation|2|||
128823981|NCT03512301|463654603|FG000|Overall Study|Did Not Qualify|3|||
128823982|NCT03512301|463654603|FG000|Overall Study|Age-ineligible|1|||
128823983|NCT03512301|463654603|FG000|Overall Study|Inadequate fluency with the English language|3|||
128823984|NCT02611687|463654605|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
128823985|NCT02611687|463654606|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
128823986|NCT04933474|463654607|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
128823987|NCT04933474|463654608|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
128823988|NCT04933474|463654607|FG000|Overall Study|Lost to Follow-up|19|||
128823989|NCT04933474|463654608|FG001|Overall Study|Lost to Follow-up|9|||
128823990|NCT04933474|463654607|FG000|Overall Study|Life Burden - unable to participate|6|||
128823991|NCT04933474|463654608|FG001|Overall Study|Life Burden - unable to participate|2|||
128823992|NCT04933474|463654607|FG000|Overall Study|Disease Burden - unable to participate|4|||
128823993|NCT04933474|463654608|FG001|Overall Study|Disease Burden - unable to participate|1|||
128823994|NCT04933474|463654607|FG000|Overall Study|Surgery/Hospitalization|1|||
128823995|NCT04933474|463654608|FG001|Overall Study|Surgery/Hospitalization|2|||
128823996|NCT04933474|463654607|FG000|Overall Study|Dissatisfied with Intervention|1|||
128823997|NCT04933474|463654608|FG001|Overall Study|Dissatisfied with Intervention|1|||
128823998|NCT04933474|463654607|FG000|Overall Study|Withdrew interest in participation|1|||
128823999|NCT04933474|463654608|FG001|Overall Study|Withdrew interest in participation|0|||
128824000|NCT04933474|463654607|FG000|Overall Study|Had previously enrolled in the study|0|||
128824001|NCT04933474|463654608|FG001|Overall Study|Had previously enrolled in the study|1|||
128824002|NCT03242915|463654620|FG000|Overall Study|Adverse Event|5|||
128824003|NCT03242915|463654621|FG001|Overall Study|Adverse Event|1|||
128824004|NCT03242915|463654620|FG000|Overall Study|Withdrawal by Subject|0|||
128824005|NCT03242915|463654621|FG001|Overall Study|Withdrawal by Subject|2|||
128824006|NCT03242915|463654620|FG000|Overall Study|Physician Decision|4|||
128824007|NCT03242915|463654621|FG001|Overall Study|Physician Decision|1|||
128824008|NCT04908930|463654630|FG000|Overall Study|Lost to Follow-up|1|||
128824009|NCT04908930|463654631|FG001|Overall Study|Lost to Follow-up|1|||
128824010|NCT04908930|463654632|FG002|Overall Study|Lost to Follow-up|0|||
128824011|NCT04908930|463654633|FG003|Overall Study|Lost to Follow-up|0|||
128824012|NCT04908930|463654634|FG004|Overall Study|Lost to Follow-up|0|||
128824013|NCT04908930|463654630|FG000|Overall Study|hardware in mouth|1|||
128824014|NCT04908930|463654631|FG001|Overall Study|hardware in mouth|1|||
128824015|NCT04908930|463654632|FG002|Overall Study|hardware in mouth|0|||
128824016|NCT04908930|463654633|FG003|Overall Study|hardware in mouth|0|||
128824017|NCT04908930|463654634|FG004|Overall Study|hardware in mouth|0|||
128824018|NCT04908930|463654630|FG000|Overall Study|wrong team|1|||
128824019|NCT04908930|463654631|FG001|Overall Study|wrong team|0|||
128824020|NCT04908930|463654632|FG002|Overall Study|wrong team|0|||
128824021|NCT04908930|463654633|FG003|Overall Study|wrong team|0|||
128824022|NCT04908930|463654634|FG004|Overall Study|wrong team|0|||
128824023|NCT04908930|463654630|FG000|Overall Study|quit team|2|||
128824024|NCT04908930|463654631|FG001|Overall Study|quit team|4|||
128824025|NCT04908930|463654632|FG002|Overall Study|quit team|0|||
128824026|NCT04908930|463654633|FG003|Overall Study|quit team|0|||
128824027|NCT04908930|463654634|FG004|Overall Study|quit team|0|||
128824028|NCT04908930|463654630|FG000|Overall Study|Withdrawal by Subject|1|||
128824029|NCT04908930|463654631|FG001|Overall Study|Withdrawal by Subject|2|||
128824030|NCT04908930|463654632|FG002|Overall Study|Withdrawal by Subject|0|||
128824031|NCT04908930|463654633|FG003|Overall Study|Withdrawal by Subject|0|||
128824032|NCT04908930|463654634|FG004|Overall Study|Withdrawal by Subject|0|||
128824033|NCT04908930|463654630|FG000|Overall Study|parent not liking program|0|||
128824034|NCT04908930|463654631|FG001|Overall Study|parent not liking program|1|||
128824035|NCT04908930|463654632|FG002|Overall Study|parent not liking program|0|||
128824036|NCT04908930|463654633|FG003|Overall Study|parent not liking program|0|||
128824037|NCT04908930|463654634|FG004|Overall Study|parent not liking program|0|||
128824038|NCT05771467|463654636|FG000|Overall Study|Lost to Follow-up|6|||
128824039|NCT05771467|463654637|FG001|Overall Study|Lost to Follow-up|3|||
128824040|NCT00709956|463654640|FG000|Overall Study|Withdrawal by Subject|1|||
128824041|NCT00709956|463654641|FG001|Overall Study|Withdrawal by Subject|1|||
128824042|NCT00709956|463654640|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
128824043|NCT00709956|463654641|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
128824044|NCT03008382|463654642|FG000|Overall Study|Withdrawal by Subject|2|||
128824045|NCT03008382|463654643|FG001|Overall Study|Withdrawal by Subject|5|||
128824046|NCT03008382|463654644|FG002|Overall Study|Withdrawal by Subject|2|||
128824047|NCT03008382|463654645|FG003|Overall Study|Withdrawal by Subject|0|||
128824048|NCT03008382|463654642|FG000|Overall Study|Protocol Violation|1|||
128824049|NCT03008382|463654643|FG001|Overall Study|Protocol Violation|0|||
128824050|NCT03008382|463654644|FG002|Overall Study|Protocol Violation|0|||
128824051|NCT03008382|463654645|FG003|Overall Study|Protocol Violation|0|||
128824052|NCT03008382|463654642|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
128824053|NCT03008382|463654643|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
128824054|NCT03008382|463654644|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
128824055|NCT03008382|463654645|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
128824056|NCT03008382|463654642|FG000|Overall Study|Lost to Follow-up|0|||
128824057|NCT03008382|463654643|FG001|Overall Study|Lost to Follow-up|0|||
128824058|NCT03008382|463654644|FG002|Overall Study|Lost to Follow-up|1|||
128824059|NCT03008382|463654645|FG003|Overall Study|Lost to Follow-up|0|||
128824060|NCT03008382|463654642|FG000|Overall Study|Screenfail|0|||
128824061|NCT03008382|463654643|FG001|Overall Study|Screenfail|0|||
128824062|NCT03008382|463654644|FG002|Overall Study|Screenfail|2|||
128824063|NCT03008382|463654645|FG003|Overall Study|Screenfail|0|||
128824064|NCT03983382|463655364|FG000|Overall Study|Death|1|||
128824065|NCT03983382|463655364|FG000|Overall Study|Lost to Follow-up|3|||
128824066|NCT03983382|463655364|FG000|Overall Study|Physician Decision|2|||
128824067|NCT03983382|463655364|FG000|Overall Study|Withdrawal by Subject|10|||
128824068|NCT03983382|463655364|FG000|Overall Study|Change in cancer treatment|2|||
128824069|NCT04165213|463655365|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
128824070|NCT04165213|463655366|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
128824071|NCT04165213|463655365|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
128824072|NCT04165213|463655366|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
128824073|NCT04165213|463655365|FG000|Clinician Enrollment|Termination from site|0|||
128824074|NCT04165213|463655366|FG001|Clinician Enrollment|Termination from site|1|||
128824075|NCT04165213|463655365|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
128824076|NCT04165213|463655366|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
128824077|NCT04165213|463655365|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
128824078|NCT04165213|463655366|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
128824079|NCT04165213|463655365|FG000|Caregiver Enrollment|Physician Decision|1|||
128824080|NCT04165213|463655366|FG001|Caregiver Enrollment|Physician Decision|0|||
128824081|NCT04165213|463655365|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
128824082|NCT04165213|463655366|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
128824083|NCT04165213|463655365|FG000|Caregiver Enrollment|PLWD death|2|||
128824084|NCT04165213|463655366|FG001|Caregiver Enrollment|PLWD death|0|||
128824085|NCT04165213|463655365|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
128824086|NCT04165213|463655366|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
128824087|NCT04165213|463655365|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
128824088|NCT04165213|463655366|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
128824089|NCT04165213|463655365|FG000|PLWD Enrollment|Lost to Follow-up|1|||
128824090|NCT04165213|463655366|FG001|PLWD Enrollment|Lost to Follow-up|1|||
128824091|NCT04165213|463655365|FG000|PLWD Enrollment|Physician Decision|1|||
128824092|NCT04165213|463655366|FG001|PLWD Enrollment|Physician Decision|0|||
128824093|NCT04165213|463655365|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
128824094|NCT04165213|463655366|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
128824095|NCT04165213|463655365|FG000|PLWD Enrollment|Death|2|||
128824096|NCT04165213|463655366|FG001|PLWD Enrollment|Death|0|||
128824097|NCT04165213|463655365|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
128824098|NCT04165213|463655366|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
128824099|NCT04174170|463655367|FG000|Placebo Run-in Period|Not Randomized|38|||
128824100|NCT04174170|463655368|FG001|Placebo Run-in Period|Not Randomized|0|||
128824101|NCT04174170|463655369|FG002|Placebo Run-in Period|Not Randomized|0|||
128824102|NCT04174170|463655370|FG003|Placebo Run-in Period|Not Randomized|0|||
128824103|NCT04174170|463655367|FG000|Double Blind Treatment Period|Adverse Event|0|||
128824104|NCT04174170|463655368|FG001|Double Blind Treatment Period|Adverse Event|9|||
128824105|NCT04174170|463655369|FG002|Double Blind Treatment Period|Adverse Event|9|||
128824106|NCT04174170|463655370|FG003|Double Blind Treatment Period|Adverse Event|8|||
128824107|NCT04174170|463655367|FG000|Double Blind Treatment Period|Death|0|||
128824108|NCT04174170|463655368|FG001|Double Blind Treatment Period|Death|1|||
128824109|NCT04174170|463655369|FG002|Double Blind Treatment Period|Death|0|||
128824110|NCT04174170|463655370|FG003|Double Blind Treatment Period|Death|0|||
128824111|NCT04174170|463655367|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
128824112|NCT04174170|463655368|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
128824113|NCT04174170|463655369|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
128824114|NCT04174170|463655370|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
128824115|NCT04174170|463655367|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
128824116|NCT04174170|463655368|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
128824117|NCT04174170|463655369|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
128824118|NCT04174170|463655370|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
128824119|NCT04174170|463655367|FG000|Double Blind Treatment Period|Physician Decision|0|||
128824120|NCT04174170|463655368|FG001|Double Blind Treatment Period|Physician Decision|1|||
128824121|NCT04174170|463655369|FG002|Double Blind Treatment Period|Physician Decision|0|||
128824122|NCT04174170|463655370|FG003|Double Blind Treatment Period|Physician Decision|1|||
128824123|NCT04174170|463655367|FG000|Double Blind Treatment Period|Pregnancy|0|||
128824124|NCT04174170|463655368|FG001|Double Blind Treatment Period|Pregnancy|1|||
128824125|NCT04174170|463655369|FG002|Double Blind Treatment Period|Pregnancy|0|||
128824126|NCT04174170|463655370|FG003|Double Blind Treatment Period|Pregnancy|1|||
128824127|NCT04174170|463655367|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
128824128|NCT04174170|463655368|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
128824129|NCT04174170|463655369|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
128824130|NCT04174170|463655370|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
128824131|NCT04174170|463655367|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
128824132|NCT04174170|463655368|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
128824133|NCT04174170|463655369|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
128824134|NCT04174170|463655370|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
128870722|NCT00338962|463820701|FG000|Overall Study|Lost to Follow-up|3|||
129204895|NCT02469623|465046981|FG000|Overall Study|Death|3|||
128824135|NCT04174170|463655367|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
128824136|NCT04174170|463655368|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
128824137|NCT04174170|463655369|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
128824138|NCT04174170|463655370|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
128824139|NCT04772534|463655378|FG000|Overall Study|Physician Decision|1|||
128824140|NCT04772534|463655379|FG001|Overall Study|Physician Decision|0|||
128824141|NCT04772534|463655380|FG002|Overall Study|Physician Decision|0|||
128824142|NCT04772534|463655378|FG000|Overall Study|Withdrawal by Subject|3|||
128824143|NCT04772534|463655379|FG001|Overall Study|Withdrawal by Subject|0|||
128824144|NCT04772534|463655380|FG002|Overall Study|Withdrawal by Subject|1|||
128824145|NCT04194450|463655381|FG000|Overall Study|not eligible|1|||
128824146|NCT04194450|463655382|FG001|Overall Study|not eligible|0|||
128824147|NCT00308997|463655394|FG000|Overall Study|Subject feigned clinical data|0|||
128824148|NCT00308997|463655395|FG001|Overall Study|Subject feigned clinical data|1|||
128824149|NCT00308997|463655394|FG000|Overall Study|Unable to tolerate intervention|1|||
128824150|NCT00308997|463655395|FG001|Overall Study|Unable to tolerate intervention|0|||
128824151|NCT04490356|463655396|FG000|Overall Study|Lost to Follow-up|1|||
128824152|NCT03733626|463655397|FG000|Overall Study|Physician Decision|4|||
128824153|NCT03733626|463655398|FG001|Overall Study|Physician Decision|4|||
128824154|NCT04586244|463655401|FG000|Overall Study|Lost to Follow-up|1|||
128824155|NCT04586244|463655402|FG001|Overall Study|Lost to Follow-up|0|||
128824156|NCT04586244|463655403|FG002|Overall Study|Lost to Follow-up|0|||
128824157|NCT04586244|463655404|FG003|Overall Study|Lost to Follow-up|1|||
128824158|NCT04586244|463655405|FG004|Overall Study|Lost to Follow-up|0|||
128824159|NCT04586244|463655401|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
128824160|NCT04586244|463655402|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
128824161|NCT04586244|463655403|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
128824162|NCT04586244|463655404|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
128824163|NCT04586244|463655405|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
128824164|NCT04174560|463655410|FG000|Overall Study|Lost to Follow-up|1|||
128824165|NCT04174560|463655411|FG001|Overall Study|Lost to Follow-up|0|||
128824166|NCT04174560|463655412|FG002|Overall Study|Lost to Follow-up|0|||
128824167|NCT04174560|463655413|FG003|Overall Study|Lost to Follow-up|0|||
128824168|NCT04174560|463655410|FG000|Overall Study|Withdrawal by Subject|0|||
128824169|NCT04174560|463655411|FG001|Overall Study|Withdrawal by Subject|0|||
128824170|NCT04174560|463655412|FG002|Overall Study|Withdrawal by Subject|2|||
128824171|NCT04174560|463655413|FG003|Overall Study|Withdrawal by Subject|0|||
128824172|NCT05424718|463655414|FG000|Overall Study|Lost to Follow-up|5|||
128824173|NCT05424718|463655415|FG001|Overall Study|Lost to Follow-up|4|||
128824174|NCT04046549|463655416|FG000|Overall Study|Adverse Event|1|||
128824175|NCT04046549|463655416|FG000|Overall Study|Physician Decision|1|||
128824176|NCT04046549|463655416|FG000|Overall Study|Withdrawal by Subject|3|||
128824177|NCT04046549|463655416|FG000|Overall Study|Other, Not Specified|5|||
128824178|NCT03142009|463655417|FG000|Overall Study|Lost to Follow-up|45|||
128824179|NCT03142009|463655418|FG001|Overall Study|Lost to Follow-up|30|||
128824180|NCT03872466|463655419|FG000|Overall Study|Withdrawal by Subject|1|||
128824181|NCT03872466|463655420|FG001|Overall Study|Withdrawal by Subject|0|||
128824182|NCT03872466|463655419|FG000|Overall Study|Physician Decision|2|||
128824183|NCT03872466|463655420|FG001|Overall Study|Physician Decision|0|||
128824184|NCT01778686|463655421|FG000|Overall Study|Adverse Event|0|||
128824185|NCT01778686|463655422|FG001|Overall Study|Adverse Event|0|||
128824186|NCT01778686|463655423|FG002|Overall Study|Adverse Event|1|||
128824187|NCT01499368|463655424|FG000|Overall Study|Did not meet I/E criteria|8|||
128824188|NCT01499368|463655425|FG001|Overall Study|Did not meet I/E criteria|4|||
128824189|NCT01499368|463655426|FG002|Overall Study|Did not meet I/E criteria|4|||
128824190|NCT01499368|463655424|FG000|Overall Study|Prohibited Concomitant medication|1|||
128824191|NCT01499368|463655425|FG001|Overall Study|Prohibited Concomitant medication|1|||
128824192|NCT01499368|463655426|FG002|Overall Study|Prohibited Concomitant medication|0|||
128824193|NCT01499368|463655424|FG000|Overall Study|Withdrawal by Subject|11|||
128824194|NCT01499368|463655425|FG001|Overall Study|Withdrawal by Subject|10|||
128824195|NCT01499368|463655426|FG002|Overall Study|Withdrawal by Subject|8|||
128824196|NCT01499368|463655424|FG000|Overall Study|Lost to Follow-up|3|||
128824197|NCT01499368|463655425|FG001|Overall Study|Lost to Follow-up|2|||
128824198|NCT01499368|463655426|FG002|Overall Study|Lost to Follow-up|5|||
128824199|NCT01499368|463655424|FG000|Overall Study|Adverse Event|4|||
128824200|NCT01499368|463655425|FG001|Overall Study|Adverse Event|0|||
128824201|NCT01499368|463655426|FG002|Overall Study|Adverse Event|2|||
128824202|NCT01499368|463655424|FG000|Overall Study|Physician Decision|0|||
128824203|NCT01499368|463655425|FG001|Overall Study|Physician Decision|1|||
128824204|NCT01499368|463655426|FG002|Overall Study|Physician Decision|0|||
128824205|NCT01499368|463655424|FG000|Overall Study|Deviation from visit window|0|||
128824206|NCT01499368|463655425|FG001|Overall Study|Deviation from visit window|0|||
128824207|NCT01499368|463655426|FG002|Overall Study|Deviation from visit window|1|||
128824208|NCT01499368|463655424|FG000|Overall Study|Error of Prescriptions|0|||
128824209|NCT01499368|463655425|FG001|Overall Study|Error of Prescriptions|0|||
128824210|NCT01499368|463655426|FG002|Overall Study|Error of Prescriptions|1|||
128824211|NCT06059443|463655427|FG000|Overall Study|Withdrawal by Subject|2|||
128824212|NCT06059443|463655428|FG001|Overall Study|Withdrawal by Subject|0|||
128824213|NCT06059443|463655427|FG000|Overall Study|Lost to Follow-up|2|||
128824214|NCT06059443|463655428|FG001|Overall Study|Lost to Follow-up|2|||
128824215|NCT03092674|463655429|FG000|Overall Study|Adverse Event or Side Effects|1|||
128824216|NCT03092674|463655430|FG001|Overall Study|Adverse Event or Side Effects|4|||
128824217|NCT03092674|463655431|FG002|Overall Study|Adverse Event or Side Effects|4|||
128824218|NCT03092674|463655429|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
128824219|NCT03092674|463655430|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
128824220|NCT03092674|463655431|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
128824221|NCT03092674|463655429|FG000|Overall Study|Progression/Relapse|5|||
128824222|NCT03092674|463655430|FG001|Overall Study|Progression/Relapse|4|||
128824223|NCT03092674|463655431|FG002|Overall Study|Progression/Relapse|8|||
128824224|NCT03092674|463655429|FG000|Overall Study|Death|4|||
128824225|NCT03092674|463655430|FG001|Overall Study|Death|8|||
128824226|NCT03092674|463655431|FG002|Overall Study|Death|2|||
128824227|NCT03092674|463655429|FG000|Overall Study|Other - Not Protocol Specified|11|||
128824228|NCT03092674|463655430|FG001|Overall Study|Other - Not Protocol Specified|8|||
128824229|NCT03092674|463655431|FG002|Overall Study|Other - Not Protocol Specified|8|||
128824230|NCT01105091|463655433|FG000|Overall Study|Death|2|||
128824231|NCT01105091|463655434|FG001|Overall Study|Death|0|||
128824232|NCT02231749|463655824|FG000|Overall Study|Disease progression|229|||
128824233|NCT02231749|463655825|FG001|Overall Study|Disease progression|297|||
128824234|NCT02231749|463655824|FG000|Overall Study|Study Drug Toxicity|134|||
128824235|NCT02231749|463655825|FG001|Overall Study|Study Drug Toxicity|63|||
128824236|NCT02231749|463655824|FG000|Overall Study|Death|1|||
128824237|NCT02231749|463655825|FG001|Overall Study|Death|1|||
128824238|NCT02231749|463655824|FG000|Overall Study|AE unrelated to Study drug|32|||
128824239|NCT02231749|463655825|FG001|Overall Study|AE unrelated to Study drug|31|||
128824240|NCT02231749|463655824|FG000|Overall Study|Participant's request to discontinue|10|||
128824241|NCT02231749|463655825|FG001|Overall Study|Participant's request to discontinue|21|||
128824242|NCT02231749|463655824|FG000|Overall Study|Participant withdrew Consent|8|||
128824243|NCT02231749|463655825|FG001|Overall Study|Participant withdrew Consent|15|||
128824244|NCT02231749|463655824|FG000|Overall Study|Lost to Follow-up|1|||
128824245|NCT02231749|463655825|FG001|Overall Study|Lost to Follow-up|2|||
128824246|NCT02231749|463655824|FG000|Overall Study|Maximum Clinical Benefit|5|||
128824247|NCT02231749|463655825|FG001|Overall Study|Maximum Clinical Benefit|8|||
128824248|NCT02231749|463655824|FG000|Overall Study|Poor/Non-Compliance|0|||
128824249|NCT02231749|463655825|FG001|Overall Study|Poor/Non-Compliance|3|||
128824250|NCT02231749|463655824|FG000|Overall Study|Pregnancy|1|||
128824251|NCT02231749|463655825|FG001|Overall Study|Pregnancy|0|||
128824252|NCT02231749|463655824|FG000|Overall Study|other|0|||
128824253|NCT02231749|463655825|FG001|Overall Study|other|8|||
128824254|NCT02231749|463655824|FG000|Overall Study|No longer meets Study Criteria|1|||
128824255|NCT02231749|463655825|FG001|Overall Study|No longer meets Study Criteria|0|||
128824256|NCT03786926|463655826|FG000|Overall Study|Adverse Event|0|||
128824257|NCT03786926|463655827|FG001|Overall Study|Adverse Event|0|||
128824258|NCT03786926|463655828|FG002|Overall Study|Adverse Event|0|||
128824259|NCT03786926|463655829|FG003|Overall Study|Adverse Event|0|||
128824260|NCT03786926|463655830|FG004|Overall Study|Adverse Event|0|||
128824261|NCT03786926|463655831|FG005|Overall Study|Adverse Event|0|||
128824262|NCT03786926|463655832|FG006|Overall Study|Adverse Event|0|||
128824263|NCT03786926|463655833|FG007|Overall Study|Adverse Event|1|||
128824264|NCT03786926|463655834|FG008|Overall Study|Adverse Event|1|||
128824265|NCT03786926|463655835|FG009|Overall Study|Adverse Event|0|||
128824266|NCT03786926|463655836|FG010|Overall Study|Adverse Event|1|||
128824267|NCT03786926|463655826|FG000|Overall Study|Progressive disease|3|||
128824268|NCT03786926|463655827|FG001|Overall Study|Progressive disease|0|||
128824269|NCT03786926|463655828|FG002|Overall Study|Progressive disease|3|||
128824270|NCT03786926|463655829|FG003|Overall Study|Progressive disease|1|||
128824271|NCT03786926|463655830|FG004|Overall Study|Progressive disease|2|||
128824272|NCT03786926|463655831|FG005|Overall Study|Progressive disease|2|||
128824273|NCT03786926|463655832|FG006|Overall Study|Progressive disease|1|||
128824274|NCT03786926|463655833|FG007|Overall Study|Progressive disease|6|||
128824275|NCT03786926|463655834|FG008|Overall Study|Progressive disease|1|||
128824276|NCT03786926|463655835|FG009|Overall Study|Progressive disease|1|||
128824277|NCT03786926|463655836|FG010|Overall Study|Progressive disease|1|||
128824278|NCT03786926|463655826|FG000|Overall Study|Death|0|||
128824279|NCT03786926|463655827|FG001|Overall Study|Death|1|||
128824280|NCT03786926|463655828|FG002|Overall Study|Death|1|||
128824281|NCT03786926|463655829|FG003|Overall Study|Death|0|||
128824282|NCT03786926|463655830|FG004|Overall Study|Death|0|||
128824283|NCT03786926|463655831|FG005|Overall Study|Death|0|||
128824284|NCT03786926|463655832|FG006|Overall Study|Death|0|||
128824285|NCT03786926|463655833|FG007|Overall Study|Death|0|||
128824286|NCT03786926|463655834|FG008|Overall Study|Death|0|||
128824287|NCT03786926|463655835|FG009|Overall Study|Death|1|||
128824288|NCT03786926|463655836|FG010|Overall Study|Death|2|||
128824289|NCT03786926|463655826|FG000|Overall Study|Physician Decision|0|||
128824290|NCT03786926|463655827|FG001|Overall Study|Physician Decision|1|||
128824291|NCT03786926|463655828|FG002|Overall Study|Physician Decision|0|||
128824292|NCT03786926|463655829|FG003|Overall Study|Physician Decision|1|||
128824293|NCT03786926|463655830|FG004|Overall Study|Physician Decision|2|||
128824294|NCT03786926|463655831|FG005|Overall Study|Physician Decision|0|||
128824295|NCT03786926|463655832|FG006|Overall Study|Physician Decision|0|||
128824296|NCT03786926|463655833|FG007|Overall Study|Physician Decision|2|||
128824297|NCT03786926|463655834|FG008|Overall Study|Physician Decision|1|||
128824298|NCT03786926|463655835|FG009|Overall Study|Physician Decision|1|||
128824299|NCT03786926|463655836|FG010|Overall Study|Physician Decision|0|||
128824300|NCT03786926|463655826|FG000|Overall Study|Withdrawal by Subject|0|||
128824301|NCT03786926|463655827|FG001|Overall Study|Withdrawal by Subject|1|||
128824302|NCT03786926|463655828|FG002|Overall Study|Withdrawal by Subject|1|||
128824303|NCT03786926|463655829|FG003|Overall Study|Withdrawal by Subject|0|||
128824304|NCT03786926|463655830|FG004|Overall Study|Withdrawal by Subject|0|||
128824305|NCT03786926|463655831|FG005|Overall Study|Withdrawal by Subject|0|||
128824306|NCT03786926|463655832|FG006|Overall Study|Withdrawal by Subject|1|||
128824307|NCT03786926|463655833|FG007|Overall Study|Withdrawal by Subject|0|||
128824308|NCT03786926|463655834|FG008|Overall Study|Withdrawal by Subject|1|||
128824309|NCT03786926|463655835|FG009|Overall Study|Withdrawal by Subject|0|||
128824310|NCT03786926|463655836|FG010|Overall Study|Withdrawal by Subject|1|||
128824311|NCT03786926|463655826|FG000|Overall Study|Study terminated by Sponsor|0|||
128824312|NCT03786926|463655827|FG001|Overall Study|Study terminated by Sponsor|0|||
128824313|NCT03786926|463655828|FG002|Overall Study|Study terminated by Sponsor|0|||
128824314|NCT03786926|463655829|FG003|Overall Study|Study terminated by Sponsor|0|||
128824315|NCT03786926|463655830|FG004|Overall Study|Study terminated by Sponsor|1|||
128824316|NCT03786926|463655831|FG005|Overall Study|Study terminated by Sponsor|0|||
128824317|NCT03786926|463655832|FG006|Overall Study|Study terminated by Sponsor|0|||
128824318|NCT03786926|463655833|FG007|Overall Study|Study terminated by Sponsor|4|||
128824319|NCT03786926|463655834|FG008|Overall Study|Study terminated by Sponsor|0|||
128824320|NCT03786926|463655835|FG009|Overall Study|Study terminated by Sponsor|0|||
128824321|NCT03786926|463655836|FG010|Overall Study|Study terminated by Sponsor|0|||
128824322|NCT03786926|463655826|FG000|Overall Study|Anti-neoplasm treatment|0|||
128824323|NCT03786926|463655827|FG001|Overall Study|Anti-neoplasm treatment|0|||
128824324|NCT03786926|463655828|FG002|Overall Study|Anti-neoplasm treatment|0|||
128824325|NCT03786926|463655829|FG003|Overall Study|Anti-neoplasm treatment|0|||
128824326|NCT03786926|463655830|FG004|Overall Study|Anti-neoplasm treatment|1|||
128824327|NCT03786926|463655831|FG005|Overall Study|Anti-neoplasm treatment|0|||
128824328|NCT03786926|463655832|FG006|Overall Study|Anti-neoplasm treatment|1|||
128824329|NCT03786926|463655833|FG007|Overall Study|Anti-neoplasm treatment|0|||
128824330|NCT03786926|463655834|FG008|Overall Study|Anti-neoplasm treatment|0|||
128824331|NCT03786926|463655835|FG009|Overall Study|Anti-neoplasm treatment|0|||
128824332|NCT03786926|463655836|FG010|Overall Study|Anti-neoplasm treatment|0|||
128824333|NCT03786926|463655826|FG000|Overall Study|Other|0|||
128824334|NCT03786926|463655827|FG001|Overall Study|Other|0|||
128824335|NCT03786926|463655828|FG002|Overall Study|Other|0|||
128824336|NCT03786926|463655829|FG003|Overall Study|Other|1|||
128824337|NCT03786926|463655830|FG004|Overall Study|Other|0|||
128824338|NCT03786926|463655831|FG005|Overall Study|Other|1|||
128824339|NCT03786926|463655832|FG006|Overall Study|Other|0|||
128824340|NCT03786926|463655833|FG007|Overall Study|Other|0|||
128824341|NCT03786926|463655834|FG008|Overall Study|Other|2|||
128824342|NCT03786926|463655835|FG009|Overall Study|Other|0|||
128824343|NCT03786926|463655836|FG010|Overall Study|Other|0|||
128824344|NCT05875701|463655840|FG000|Overall Study|Lost to Follow-up|2|||
128824345|NCT05875701|463655841|FG001|Overall Study|Lost to Follow-up|0|||
128824346|NCT05875701|463655840|FG000|Overall Study|Withdrawal by Subject|1|||
128824347|NCT05875701|463655841|FG001|Overall Study|Withdrawal by Subject|1|||
128824348|NCT02989662|463655842|FG000|Overall Study|Lost to Follow-up|0|||
128824349|NCT02989662|463655843|FG001|Overall Study|Lost to Follow-up|0|||
128824350|NCT02989662|463655844|FG002|Overall Study|Lost to Follow-up|0|||
128824351|NCT02989662|463655845|FG003|Overall Study|Lost to Follow-up|2|||
128824352|NCT02989662|463655842|FG000|Overall Study|Physician Decision|3|||
128824353|NCT02989662|463655843|FG001|Overall Study|Physician Decision|0|||
128824354|NCT02989662|463655844|FG002|Overall Study|Physician Decision|0|||
128824355|NCT02989662|463655845|FG003|Overall Study|Physician Decision|0|||
128824356|NCT02989662|463655842|FG000|Overall Study|Withdrawal by Subject|1|||
128824357|NCT02989662|463655843|FG001|Overall Study|Withdrawal by Subject|0|||
128824358|NCT02989662|463655844|FG002|Overall Study|Withdrawal by Subject|0|||
128824359|NCT02989662|463655845|FG003|Overall Study|Withdrawal by Subject|0|||
128824360|NCT04408755|463655847|FG000|Period A (Placebo lead-in)|Other|11|||
128824361|NCT04408755|463655848|FG001|Period A (Placebo lead-in)|Other|0|||
128824362|NCT04408755|463655849|FG002|Period A (Placebo lead-in)|Other|0|||
128824363|NCT04408755|463655850|FG003|Period A (Placebo lead-in)|Other|0|||
128824364|NCT04408755|463655847|FG000|Period B (Randomization Period)|Adverse Event|0|||
128824365|NCT04408755|463655848|FG001|Period B (Randomization Period)|Adverse Event|3|||
128824366|NCT04408755|463655849|FG002|Period B (Randomization Period)|Adverse Event|0|||
128824367|NCT04408755|463655850|FG003|Period B (Randomization Period)|Adverse Event|1|||
128824368|NCT04408755|463655847|FG000|Period B (Randomization Period)|Death|0|||
128824369|NCT04408755|463655848|FG001|Period B (Randomization Period)|Death|0|||
128824370|NCT04408755|463655849|FG002|Period B (Randomization Period)|Death|1|||
128824371|NCT04408755|463655850|FG003|Period B (Randomization Period)|Death|0|||
128824372|NCT04408755|463655847|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
128824373|NCT04408755|463655848|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
128824374|NCT04408755|463655849|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
128824375|NCT04408755|463655850|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
128824376|NCT04408755|463655847|FG000|Period B (Randomization Period)|Physician Decision|0|||
128824377|NCT04408755|463655848|FG001|Period B (Randomization Period)|Physician Decision|0|||
128824378|NCT04408755|463655849|FG002|Period B (Randomization Period)|Physician Decision|1|||
128824379|NCT04408755|463655850|FG003|Period B (Randomization Period)|Physician Decision|0|||
128824380|NCT04408755|463655847|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
128824381|NCT04408755|463655848|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
128824382|NCT04408755|463655849|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
128824383|NCT04408755|463655850|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
128824384|NCT04408755|463655847|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
128824385|NCT04408755|463655848|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
128824386|NCT04408755|463655849|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
128824387|NCT04408755|463655850|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
128824388|NCT04408755|463655847|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
128824389|NCT04408755|463655848|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
128824390|NCT04408755|463655849|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
128824391|NCT04408755|463655850|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
128824392|NCT04408755|463655847|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
128824393|NCT04408755|463655848|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
128824394|NCT04408755|463655849|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
128824395|NCT04408755|463655850|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
128824396|NCT04408755|463655847|FG000|Period B (Randomization Period)|Reason not Specified|0|||
128824397|NCT04408755|463655848|FG001|Period B (Randomization Period)|Reason not Specified|1|||
128824398|NCT04408755|463655849|FG002|Period B (Randomization Period)|Reason not Specified|0|||
128824399|NCT04408755|463655850|FG003|Period B (Randomization Period)|Reason not Specified|2|||
128824400|NCT01553149|463655854|FG000|Overall Study|Adverse Event|0|||
128824401|NCT01553149|463655855|FG001|Overall Study|Adverse Event|9|||
128824402|NCT01553149|463655854|FG000|Overall Study|Physician Decision|5|||
128824403|NCT01553149|463655855|FG001|Overall Study|Physician Decision|10|||
128824404|NCT01553149|463655854|FG000|Overall Study|Ineligible|0|||
128824405|NCT01553149|463655855|FG001|Overall Study|Ineligible|1|||
128824406|NCT03215706|463655866|FG000|Randomization|Adverse Event unrelated to study drug|1|||
128824407|NCT03215706|463655867|FG001|Randomization|Adverse Event unrelated to study drug|0|||
128824408|NCT03215706|463655866|FG000|Randomization|participant withdrew consent|1|||
128824409|NCT03215706|463655867|FG001|Randomization|participant withdrew consent|3|||
128824410|NCT03215706|463655866|FG000|Randomization|no longer meets study criteria|1|||
128824411|NCT03215706|463655867|FG001|Randomization|no longer meets study criteria|4|||
128824412|NCT03215706|463655866|FG000|Randomization|other reasons|0|||
128824413|NCT03215706|463655867|FG001|Randomization|other reasons|2|||
128824414|NCT03215706|463655866|FG000|Treatment Period|Disease Progression|150|||
128824415|NCT03215706|463655867|FG001|Treatment Period|Disease Progression|142|||
128824416|NCT03215706|463655866|FG000|Treatment Period|Study Drug Toxicity|53|||
128824417|NCT03215706|463655867|FG001|Treatment Period|Study Drug Toxicity|21|||
128824418|NCT03215706|463655866|FG000|Treatment Period|Death|2|||
128824419|NCT03215706|463655867|FG001|Treatment Period|Death|1|||
128824420|NCT03215706|463655866|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
128824421|NCT03215706|463655867|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
128824422|NCT03215706|463655866|FG000|Treatment Period|Request to D/C treatment|1|||
128824423|NCT03215706|463655867|FG001|Treatment Period|Request to D/C treatment|6|||
128824424|NCT03215706|463655866|FG000|Treatment Period|Participant withdrew consent|3|||
128824425|NCT03215706|463655867|FG001|Treatment Period|Participant withdrew consent|4|||
128824426|NCT03215706|463655866|FG000|Treatment Period|Lost to Follow-up|0|||
128824427|NCT03215706|463655867|FG001|Treatment Period|Lost to Follow-up|1|||
128824428|NCT03215706|463655866|FG000|Treatment Period|Other Reasons|4|||
128824429|NCT03215706|463655867|FG001|Treatment Period|Other Reasons|5|||
128824430|NCT03215706|463655866|FG000|Treatment Period|Ongoing in the treatment period|105|||
128824431|NCT03215706|463655867|FG001|Treatment Period|Ongoing in the treatment period|43|||
128824432|NCT00945724|463655868|FG000|Overall Study|Withdrawal by Subject|2|||
128824433|NCT00945724|463655868|FG000|Overall Study|Physician Decision|1|||
128824434|NCT00945724|463655868|FG000|Overall Study|Adverse Event|5|||
128824435|NCT00945724|463655868|FG000|Overall Study|Second malignancy|1|||
128824436|NCT00994643|463656861|FG000|Overall Study|Withdrawal by Subject|1|||
128824437|NCT05412004|463656862|FG000|Overall Study|Adverse Event|0|||
128824438|NCT05412004|463656863|FG001|Overall Study|Adverse Event|2|||
128824439|NCT05412004|463656864|FG002|Overall Study|Adverse Event|1|||
128824440|NCT05412004|463656865|FG003|Overall Study|Adverse Event|5|||
128824441|NCT05412004|463656862|FG000|Overall Study|Assigned Treatment by Mistake|5|||
128824442|NCT05412004|463656863|FG001|Overall Study|Assigned Treatment by Mistake|10|||
128824443|NCT05412004|463656864|FG002|Overall Study|Assigned Treatment by Mistake|2|||
128824444|NCT05412004|463656865|FG003|Overall Study|Assigned Treatment by Mistake|5|||
128824445|NCT05412004|463656862|FG000|Overall Study|Lost to Follow-up|3|||
128824446|NCT05412004|463656863|FG001|Overall Study|Lost to Follow-up|0|||
128824447|NCT05412004|463656864|FG002|Overall Study|Lost to Follow-up|0|||
128824448|NCT05412004|463656865|FG003|Overall Study|Lost to Follow-up|0|||
128824449|NCT05412004|463656862|FG000|Overall Study|Patient could not travel to site|0|||
128824450|NCT05412004|463656863|FG001|Overall Study|Patient could not travel to site|1|||
128824451|NCT05412004|463656864|FG002|Overall Study|Patient could not travel to site|0|||
128824452|NCT05412004|463656865|FG003|Overall Study|Patient could not travel to site|0|||
128824453|NCT05412004|463656862|FG000|Overall Study|Physician Decision|0|||
128824454|NCT05412004|463656863|FG001|Overall Study|Physician Decision|1|||
128824455|NCT05412004|463656864|FG002|Overall Study|Physician Decision|0|||
128824456|NCT05412004|463656865|FG003|Overall Study|Physician Decision|0|||
128824457|NCT05412004|463656862|FG000|Overall Study|Pregnancy|0|||
128824458|NCT05412004|463656863|FG001|Overall Study|Pregnancy|1|||
128824459|NCT05412004|463656864|FG002|Overall Study|Pregnancy|0|||
128824460|NCT05412004|463656865|FG003|Overall Study|Pregnancy|0|||
128824461|NCT05412004|463656862|FG000|Overall Study|Protocol Violation|1|||
128824462|NCT05412004|463656863|FG001|Overall Study|Protocol Violation|0|||
128824463|NCT05412004|463656864|FG002|Overall Study|Protocol Violation|0|||
128824464|NCT05412004|463656865|FG003|Overall Study|Protocol Violation|0|||
128824465|NCT05412004|463656862|FG000|Overall Study|Withdrawal by Subject|4|||
128824466|NCT05412004|463656863|FG001|Overall Study|Withdrawal by Subject|19|||
128824467|NCT05412004|463656864|FG002|Overall Study|Withdrawal by Subject|4|||
128824468|NCT05412004|463656865|FG003|Overall Study|Withdrawal by Subject|14|||
128824469|NCT05412004|463656862|FG000|Overall Study|Screen Failure|0|||
128824470|NCT05412004|463656863|FG001|Overall Study|Screen Failure|0|||
128824471|NCT05412004|463656864|FG002|Overall Study|Screen Failure|0|||
128824472|NCT05412004|463656865|FG003|Overall Study|Screen Failure|1|||
128824473|NCT05412004|463656862|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
128824474|NCT05412004|463656863|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
128824475|NCT05412004|463656864|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
128824476|NCT05412004|463656865|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
128824477|NCT00968149|463656866|FG000|Overall Study|Adverse Event|5|||
128824478|NCT00968149|463656867|FG001|Overall Study|Adverse Event|1|||
128824479|NCT00968149|463656866|FG000|Overall Study|Lack of Efficacy|0|||
128824480|NCT00968149|463656867|FG001|Overall Study|Lack of Efficacy|4|||
128824481|NCT00968149|463656866|FG000|Overall Study|Lost to Follow-up|0|||
128824482|NCT00968149|463656867|FG001|Overall Study|Lost to Follow-up|1|||
128824483|NCT00968149|463656866|FG000|Overall Study|Protocol Violation|4|||
128824484|NCT00968149|463656867|FG001|Overall Study|Protocol Violation|0|||
128824485|NCT00968149|463656866|FG000|Overall Study|Withdrawal by Subject|2|||
128824486|NCT00968149|463656867|FG001|Overall Study|Withdrawal by Subject|0|||
128824487|NCT03934931|463656868|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
128824488|NCT03934931|463656869|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
128824489|NCT03934931|463656870|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
128824490|NCT02720068|463656871|FG000|Overall Study|Adverse Event|0|||
128824491|NCT02720068|463656872|FG001|Overall Study|Adverse Event|0|||
128824492|NCT02720068|463656873|FG002|Overall Study|Adverse Event|0|||
128824493|NCT02720068|463656874|FG003|Overall Study|Adverse Event|0|||
128824494|NCT02720068|463656875|FG004|Overall Study|Adverse Event|0|||
128824495|NCT02720068|463656876|FG005|Overall Study|Adverse Event|0|||
128824496|NCT02720068|463656877|FG006|Overall Study|Adverse Event|0|||
128824497|NCT02720068|463656878|FG007|Overall Study|Adverse Event|0|||
128824498|NCT02720068|463656879|FG008|Overall Study|Adverse Event|0|||
128824499|NCT02720068|463656880|FG009|Overall Study|Adverse Event|0|||
128824500|NCT02720068|463656881|FG010|Overall Study|Adverse Event|0|||
128824501|NCT02720068|463656882|FG011|Overall Study|Adverse Event|1|||
128824502|NCT02720068|463656883|FG012|Overall Study|Adverse Event|0|||
128824503|NCT02720068|463656884|FG013|Overall Study|Adverse Event|0|||
128824504|NCT02720068|463656885|FG014|Overall Study|Adverse Event|0|||
128824505|NCT02720068|463656886|FG015|Overall Study|Adverse Event|0|||
128824506|NCT02720068|463656887|FG016|Overall Study|Adverse Event|0|||
128824507|NCT02720068|463656888|FG017|Overall Study|Adverse Event|0|||
128824508|NCT02720068|463656871|FG000|Overall Study|Death|1|||
128824509|NCT02720068|463656872|FG001|Overall Study|Death|3|||
128824510|NCT02720068|463656873|FG002|Overall Study|Death|2|||
128824511|NCT02720068|463656874|FG003|Overall Study|Death|1|||
128824512|NCT02720068|463656875|FG004|Overall Study|Death|2|||
128824513|NCT02720068|463656876|FG005|Overall Study|Death|1|||
128824514|NCT02720068|463656877|FG006|Overall Study|Death|2|||
128824515|NCT02720068|463656878|FG007|Overall Study|Death|2|||
128824516|NCT02720068|463656879|FG008|Overall Study|Death|3|||
128824517|NCT02720068|463656880|FG009|Overall Study|Death|1|||
128824518|NCT02720068|463656881|FG010|Overall Study|Death|20|||
128824519|NCT02720068|463656882|FG011|Overall Study|Death|166|||
128824520|NCT02720068|463656883|FG012|Overall Study|Death|34|||
128824521|NCT02720068|463656884|FG013|Overall Study|Death|30|||
128824522|NCT02720068|463656885|FG014|Overall Study|Death|45|||
128824523|NCT02720068|463656886|FG015|Overall Study|Death|16|||
128824524|NCT02720068|463656887|FG016|Overall Study|Death|20|||
128824525|NCT02720068|463656888|FG017|Overall Study|Death|28|||
128824526|NCT02720068|463656871|FG000|Overall Study|Lost to Follow-up|0|||
128824527|NCT02720068|463656872|FG001|Overall Study|Lost to Follow-up|0|||
128824528|NCT02720068|463656873|FG002|Overall Study|Lost to Follow-up|0|||
128824529|NCT02720068|463656874|FG003|Overall Study|Lost to Follow-up|0|||
128824530|NCT02720068|463656875|FG004|Overall Study|Lost to Follow-up|0|||
128824531|NCT02720068|463656876|FG005|Overall Study|Lost to Follow-up|0|||
128824532|NCT02720068|463656877|FG006|Overall Study|Lost to Follow-up|0|||
128824533|NCT02720068|463656878|FG007|Overall Study|Lost to Follow-up|0|||
128824534|NCT02720068|463656879|FG008|Overall Study|Lost to Follow-up|0|||
128824535|NCT02720068|463656880|FG009|Overall Study|Lost to Follow-up|0|||
128824536|NCT02720068|463656881|FG010|Overall Study|Lost to Follow-up|0|||
128824537|NCT02720068|463656882|FG011|Overall Study|Lost to Follow-up|1|||
128824538|NCT02720068|463656883|FG012|Overall Study|Lost to Follow-up|0|||
128824539|NCT02720068|463656884|FG013|Overall Study|Lost to Follow-up|1|||
128824540|NCT02720068|463656885|FG014|Overall Study|Lost to Follow-up|2|||
128824541|NCT02720068|463656886|FG015|Overall Study|Lost to Follow-up|0|||
128824542|NCT02720068|463656887|FG016|Overall Study|Lost to Follow-up|0|||
128824543|NCT02720068|463656888|FG017|Overall Study|Lost to Follow-up|1|||
128824544|NCT02720068|463656871|FG000|Overall Study|Physician Decision|0|||
128824545|NCT02720068|463656872|FG001|Overall Study|Physician Decision|0|||
128824546|NCT02720068|463656873|FG002|Overall Study|Physician Decision|0|||
128824547|NCT02720068|463656874|FG003|Overall Study|Physician Decision|1|||
128824548|NCT02720068|463656875|FG004|Overall Study|Physician Decision|0|||
128824549|NCT02720068|463656876|FG005|Overall Study|Physician Decision|0|||
128824550|NCT02720068|463656877|FG006|Overall Study|Physician Decision|0|||
128824551|NCT02720068|463656878|FG007|Overall Study|Physician Decision|0|||
128824552|NCT02720068|463656879|FG008|Overall Study|Physician Decision|0|||
128824553|NCT02720068|463656880|FG009|Overall Study|Physician Decision|0|||
128824554|NCT02720068|463656881|FG010|Overall Study|Physician Decision|0|||
128824555|NCT02720068|463656882|FG011|Overall Study|Physician Decision|1|||
128824556|NCT02720068|463656883|FG012|Overall Study|Physician Decision|0|||
128824557|NCT02720068|463656884|FG013|Overall Study|Physician Decision|0|||
128824558|NCT02720068|463656885|FG014|Overall Study|Physician Decision|0|||
128824559|NCT02720068|463656886|FG015|Overall Study|Physician Decision|0|||
128824560|NCT02720068|463656887|FG016|Overall Study|Physician Decision|0|||
128824561|NCT02720068|463656888|FG017|Overall Study|Physician Decision|1|||
128824562|NCT02720068|463656871|FG000|Overall Study|Progressive Disease|2|||
128824563|NCT02720068|463656872|FG001|Overall Study|Progressive Disease|3|||
128824564|NCT02720068|463656873|FG002|Overall Study|Progressive Disease|1|||
128824565|NCT02720068|463656874|FG003|Overall Study|Progressive Disease|1|||
128824566|NCT02720068|463656875|FG004|Overall Study|Progressive Disease|1|||
128824567|NCT02720068|463656876|FG005|Overall Study|Progressive Disease|2|||
128824568|NCT02720068|463656877|FG006|Overall Study|Progressive Disease|1|||
128824569|NCT02720068|463656878|FG007|Overall Study|Progressive Disease|1|||
128824570|NCT02720068|463656879|FG008|Overall Study|Progressive Disease|0|||
128824571|NCT02720068|463656880|FG009|Overall Study|Progressive Disease|1|||
128824572|NCT02720068|463656881|FG010|Overall Study|Progressive Disease|0|||
128824573|NCT02720068|463656882|FG011|Overall Study|Progressive Disease|4|||
128824574|NCT02720068|463656883|FG012|Overall Study|Progressive Disease|1|||
128824575|NCT02720068|463656884|FG013|Overall Study|Progressive Disease|0|||
128824576|NCT02720068|463656885|FG014|Overall Study|Progressive Disease|0|||
128824577|NCT02720068|463656886|FG015|Overall Study|Progressive Disease|0|||
128824578|NCT02720068|463656887|FG016|Overall Study|Progressive Disease|0|||
128824579|NCT02720068|463656888|FG017|Overall Study|Progressive Disease|0|||
128824580|NCT02720068|463656871|FG000|Overall Study|Sponsor Decision|0|||
128824581|NCT02720068|463656872|FG001|Overall Study|Sponsor Decision|0|||
128824582|NCT02720068|463656873|FG002|Overall Study|Sponsor Decision|0|||
128824583|NCT02720068|463656874|FG003|Overall Study|Sponsor Decision|0|||
128824584|NCT02720068|463656875|FG004|Overall Study|Sponsor Decision|0|||
128824585|NCT02720068|463656876|FG005|Overall Study|Sponsor Decision|0|||
128824586|NCT02720068|463656877|FG006|Overall Study|Sponsor Decision|0|||
128824587|NCT02720068|463656878|FG007|Overall Study|Sponsor Decision|0|||
128824588|NCT02720068|463656879|FG008|Overall Study|Sponsor Decision|0|||
128824589|NCT02720068|463656880|FG009|Overall Study|Sponsor Decision|0|||
128824590|NCT02720068|463656881|FG010|Overall Study|Sponsor Decision|0|||
128824591|NCT02720068|463656882|FG011|Overall Study|Sponsor Decision|6|||
128824592|NCT02720068|463656883|FG012|Overall Study|Sponsor Decision|3|||
128824593|NCT02720068|463656884|FG013|Overall Study|Sponsor Decision|2|||
128824594|NCT02720068|463656885|FG014|Overall Study|Sponsor Decision|4|||
128824595|NCT02720068|463656886|FG015|Overall Study|Sponsor Decision|4|||
128824596|NCT02720068|463656887|FG016|Overall Study|Sponsor Decision|0|||
128824597|NCT02720068|463656888|FG017|Overall Study|Sponsor Decision|8|||
128824598|NCT02720068|463656871|FG000|Overall Study|Withdrawal by Subject|0|||
128824599|NCT02720068|463656872|FG001|Overall Study|Withdrawal by Subject|0|||
128824600|NCT02720068|463656873|FG002|Overall Study|Withdrawal by Subject|0|||
128824601|NCT02720068|463656874|FG003|Overall Study|Withdrawal by Subject|0|||
128824602|NCT02720068|463656875|FG004|Overall Study|Withdrawal by Subject|0|||
128824603|NCT02720068|463656876|FG005|Overall Study|Withdrawal by Subject|0|||
128824604|NCT02720068|463656877|FG006|Overall Study|Withdrawal by Subject|0|||
128824605|NCT02720068|463656878|FG007|Overall Study|Withdrawal by Subject|0|||
128824606|NCT02720068|463656879|FG008|Overall Study|Withdrawal by Subject|0|||
128824607|NCT02720068|463656880|FG009|Overall Study|Withdrawal by Subject|1|||
128824608|NCT02720068|463656881|FG010|Overall Study|Withdrawal by Subject|0|||
128824609|NCT02720068|463656882|FG011|Overall Study|Withdrawal by Subject|27|||
128824610|NCT02720068|463656883|FG012|Overall Study|Withdrawal by Subject|2|||
128824611|NCT02720068|463656884|FG013|Overall Study|Withdrawal by Subject|8|||
128824612|NCT02720068|463656885|FG014|Overall Study|Withdrawal by Subject|7|||
128824613|NCT02720068|463656886|FG015|Overall Study|Withdrawal by Subject|0|||
128824614|NCT02720068|463656887|FG016|Overall Study|Withdrawal by Subject|0|||
128824615|NCT02720068|463656888|FG017|Overall Study|Withdrawal by Subject|2|||
128824616|NCT02720068|463656871|FG000|Overall Study|Protocol Violation|0|||
128824617|NCT02720068|463656872|FG001|Overall Study|Protocol Violation|0|||
128824618|NCT02720068|463656873|FG002|Overall Study|Protocol Violation|0|||
128824619|NCT02720068|463656874|FG003|Overall Study|Protocol Violation|0|||
128824620|NCT02720068|463656875|FG004|Overall Study|Protocol Violation|0|||
128824621|NCT02720068|463656876|FG005|Overall Study|Protocol Violation|0|||
128824622|NCT02720068|463656877|FG006|Overall Study|Protocol Violation|0|||
128824623|NCT02720068|463656878|FG007|Overall Study|Protocol Violation|0|||
128824624|NCT02720068|463656879|FG008|Overall Study|Protocol Violation|0|||
128824625|NCT02720068|463656880|FG009|Overall Study|Protocol Violation|0|||
128824626|NCT02720068|463656881|FG010|Overall Study|Protocol Violation|1|||
128824627|NCT02720068|463656882|FG011|Overall Study|Protocol Violation|0|||
128824628|NCT02720068|463656883|FG012|Overall Study|Protocol Violation|0|||
128824629|NCT02720068|463656884|FG013|Overall Study|Protocol Violation|0|||
128824630|NCT02720068|463656885|FG014|Overall Study|Protocol Violation|1|||
128824631|NCT02720068|463656886|FG015|Overall Study|Protocol Violation|0|||
128824632|NCT02720068|463656887|FG016|Overall Study|Protocol Violation|1|||
128824633|NCT02720068|463656888|FG017|Overall Study|Protocol Violation|0|||
128824634|NCT00113360|463656889|FG000|Overall Study|Adverse Event|3|||
128824635|NCT00113360|463656889|FG000|Overall Study|Subject required surgery|1|||
128824636|NCT00113360|463656889|FG000|Overall Study|Did not meet eligibility criteria|3|||
128824637|NCT02467270|463656892|FG000|Overall Study|Participants Never Treated|0|||
128824638|NCT02467270|463656893|FG001|Overall Study|Participants Never Treated|1|||
128824639|NCT02467270|463656894|FG002|Overall Study|Participants Never Treated|0|||
128824640|NCT02467270|463656892|FG000|Overall Study|Ongoing|50|||
128824641|NCT02467270|463656893|FG001|Overall Study|Ongoing|41|||
128824642|NCT02467270|463656894|FG002|Overall Study|Ongoing|43|||
128824643|NCT02467270|463656892|FG000|Overall Study|Adverse Event|16|||
128824644|NCT02467270|463656893|FG001|Overall Study|Adverse Event|15|||
128824645|NCT02467270|463656894|FG002|Overall Study|Adverse Event|14|||
128824646|NCT02467270|463656892|FG000|Overall Study|Progressive Disease|7|||
128824647|NCT02467270|463656893|FG001|Overall Study|Progressive Disease|7|||
128824648|NCT02467270|463656894|FG002|Overall Study|Progressive Disease|4|||
128824649|NCT02467270|463656892|FG000|Overall Study|Death|2|||
128824650|NCT02467270|463656893|FG001|Overall Study|Death|0|||
128824651|NCT02467270|463656894|FG002|Overall Study|Death|2|||
128824652|NCT02467270|463656892|FG000|Overall Study|Lack of Efficacy|12|||
128824653|NCT02467270|463656893|FG001|Overall Study|Lack of Efficacy|18|||
128824654|NCT02467270|463656894|FG002|Overall Study|Lack of Efficacy|23|||
128824655|NCT02467270|463656892|FG000|Overall Study|Non-compliance With Study Drug|0|||
128824656|NCT02467270|463656893|FG001|Overall Study|Non-compliance With Study Drug|2|||
128824657|NCT02467270|463656894|FG002|Overall Study|Non-compliance With Study Drug|1|||
128824658|NCT02467270|463656892|FG000|Overall Study|Lost to Follow-up|2|||
128824659|NCT02467270|463656893|FG001|Overall Study|Lost to Follow-up|1|||
128824660|NCT02467270|463656894|FG002|Overall Study|Lost to Follow-up|0|||
128824661|NCT02467270|463656892|FG000|Overall Study|Pregnancy|0|||
128824662|NCT02467270|463656893|FG001|Overall Study|Pregnancy|1|||
128824663|NCT02467270|463656894|FG002|Overall Study|Pregnancy|0|||
128824664|NCT02467270|463656892|FG000|Overall Study|Physician Decision|0|||
128824665|NCT02467270|463656893|FG001|Overall Study|Physician Decision|4|||
128824666|NCT02467270|463656894|FG002|Overall Study|Physician Decision|1|||
128824667|NCT02467270|463656892|FG000|Overall Study|Withdrawal by Subject|4|||
128824668|NCT02467270|463656893|FG001|Overall Study|Withdrawal by Subject|3|||
128824669|NCT02467270|463656894|FG002|Overall Study|Withdrawal by Subject|5|||
128824670|NCT02467270|463656892|FG000|Overall Study|Reason not Specified|1|||
128824671|NCT02467270|463656893|FG001|Overall Study|Reason not Specified|2|||
128824672|NCT02467270|463656894|FG002|Overall Study|Reason not Specified|1|||
128824673|NCT00739908|463656895|FG000|Overall Study|Adverse Event|5|||
128824674|NCT00739908|463656896|FG001|Overall Study|Adverse Event|6|||
128824675|NCT00739908|463656895|FG000|Overall Study|Withdrawal by Subject|4|||
128824676|NCT00739908|463656896|FG001|Overall Study|Withdrawal by Subject|2|||
128824677|NCT00739908|463656895|FG000|Overall Study|Lost to Follow-up|14|||
128824678|NCT00739908|463656896|FG001|Overall Study|Lost to Follow-up|9|||
128824679|NCT00739908|463656895|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
128824680|NCT00739908|463656896|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
128824681|NCT00739908|463656895|FG000|Overall Study|Non-Compliance With Study Medication|0|||
128824682|NCT00739908|463656896|FG001|Overall Study|Non-Compliance With Study Medication|3|||
128824683|NCT00739908|463656895|FG000|Overall Study|Lack of Efficacy|0|||
128824684|NCT00739908|463656896|FG001|Overall Study|Lack of Efficacy|1|||
128824685|NCT00739908|463656895|FG000|Overall Study|Relocation|0|||
128824686|NCT00739908|463656896|FG001|Overall Study|Relocation|1|||
128824687|NCT00495677|463656897|FG000|Stage 1 (25 Days)|Adverse Event|0|||
128824688|NCT00495677|463656898|FG001|Stage 1 (25 Days)|Adverse Event|0|||
128824689|NCT00495677|463656899|FG002|Stage 1 (25 Days)|Adverse Event|1|||
128824690|NCT00495677|463656900|FG003|Stage 1 (25 Days)|Adverse Event|0|||
128824691|NCT00495677|463656901|FG004|Stage 1 (25 Days)|Adverse Event|0|||
128824692|NCT00495677|463656902|FG005|Stage 1 (25 Days)|Adverse Event|0|||
128824693|NCT00495677|463656903|FG006|Stage 1 (25 Days)|Adverse Event|0|||
128824694|NCT04129164|463656909|FG000|Overall Study|Non-compliance with procedures|0|||
128824695|NCT04129164|463656910|FG001|Overall Study|Non-compliance with procedures|0|||
128824696|NCT04129164|463656911|FG002|Overall Study|Non-compliance with procedures|2|||
128824697|NCT04129164|463656912|FG003|Overall Study|Non-compliance with procedures|0|||
128824698|NCT04129164|463656909|FG000|Overall Study|Adverse Event|0|||
128824699|NCT04129164|463656910|FG001|Overall Study|Adverse Event|0|||
128824700|NCT04129164|463656911|FG002|Overall Study|Adverse Event|2|||
128824701|NCT04129164|463656912|FG003|Overall Study|Adverse Event|0|||
128824702|NCT04129164|463656909|FG000|Overall Study|Pregnancy|0|||
128824703|NCT04129164|463656910|FG001|Overall Study|Pregnancy|0|||
128824704|NCT04129164|463656911|FG002|Overall Study|Pregnancy|0|||
128824705|NCT04129164|463656912|FG003|Overall Study|Pregnancy|1|||
128824706|NCT04129164|463656909|FG000|Overall Study|Withdrawal by Subject|3|||
128824707|NCT04129164|463656910|FG001|Overall Study|Withdrawal by Subject|2|||
128824708|NCT04129164|463656911|FG002|Overall Study|Withdrawal by Subject|4|||
128824709|NCT04129164|463656912|FG003|Overall Study|Withdrawal by Subject|6|||
128824710|NCT04129164|463656909|FG000|Overall Study|Death|0|||
128824711|NCT04129164|463656910|FG001|Overall Study|Death|1|||
128824712|NCT04129164|463656911|FG002|Overall Study|Death|0|||
128824713|NCT04129164|463656912|FG003|Overall Study|Death|0|||
128824714|NCT04129164|463656909|FG000|Overall Study|Lost to Follow-up|0|||
128824715|NCT04129164|463656910|FG001|Overall Study|Lost to Follow-up|1|||
128824716|NCT04129164|463656911|FG002|Overall Study|Lost to Follow-up|0|||
128824717|NCT04129164|463656912|FG003|Overall Study|Lost to Follow-up|0|||
128824718|NCT03868930|463656913|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
128824719|NCT03868930|463656914|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
128824720|NCT03868930|463656913|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
128824721|NCT03868930|463656914|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
128824722|NCT03868930|463656913|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
128824723|NCT03868930|463656914|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
128824724|NCT03868930|463656913|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
128824725|NCT03868930|463656914|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
128824726|NCT03868930|463656913|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
128824727|NCT03868930|463656914|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
128824728|NCT04227899|463656917|FG000|Overall Study|Withdrawal by Subject|6|||
128824729|NCT04227899|463656918|FG001|Overall Study|Withdrawal by Subject|3|||
128824730|NCT04227899|463656917|FG000|Overall Study|Death|12|||
128824731|NCT04227899|463656918|FG001|Overall Study|Death|6|||
128824732|NCT04227899|463656917|FG000|Overall Study|Lost to Follow-up|2|||
128824733|NCT04227899|463656918|FG001|Overall Study|Lost to Follow-up|1|||
128824734|NCT01773993|463656920|FG000|Overall Study|No Visit After Treatment|35|||
128824735|NCT04664881|463656921|FG000|Overall Study|Withdrawal by Subject|1|||
128824736|NCT04664881|463656922|FG001|Overall Study|Withdrawal by Subject|8|||
128824737|NCT04664881|463656921|FG000|Overall Study|Physician Decision|0|||
128824738|NCT04664881|463656922|FG001|Overall Study|Physician Decision|5|||
128824739|NCT04664881|463656921|FG000|Overall Study|Lost to Follow-up|1|||
128824740|NCT04664881|463656922|FG001|Overall Study|Lost to Follow-up|0|||
128824741|NCT00328783|463656930|FG000|Overall Study|Could not tolerate ABC|21|||
128824742|NCT00328783|463656930|FG000|Overall Study|No heart in RT field|4|||
128824743|NCT00328783|463656930|FG000|Overall Study|Withdrawal by Subject|1|||
128824744|NCT00357682|463656931|FG000|Overall Study|Did not receive allocated Treatment|10|||
128824745|NCT00357682|463656932|FG001|Overall Study|Did not receive allocated Treatment|9|||
128824746|NCT00357682|463656933|FG002|Overall Study|Did not receive allocated Treatment|9|||
128824747|NCT00357682|463656934|FG003|Overall Study|Did not receive allocated Treatment|10|||
128824748|NCT00357682|463656931|FG000|Overall Study|Withdrew consent|6|||
128824749|NCT00357682|463656932|FG001|Overall Study|Withdrew consent|6|||
128824750|NCT00357682|463656933|FG002|Overall Study|Withdrew consent|5|||
128824751|NCT00357682|463656934|FG003|Overall Study|Withdrew consent|5|||
128824752|NCT00357682|463656931|FG000|Overall Study|Lost to Follow-up|39|||
128824753|NCT00357682|463656932|FG001|Overall Study|Lost to Follow-up|33|||
128824754|NCT00357682|463656933|FG002|Overall Study|Lost to Follow-up|26|||
128824755|NCT00357682|463656934|FG003|Overall Study|Lost to Follow-up|35|||
128824756|NCT00357682|463656931|FG000|Overall Study|Adverse Event|24|||
128824757|NCT00357682|463656932|FG001|Overall Study|Adverse Event|32|||
128824758|NCT00357682|463656933|FG002|Overall Study|Adverse Event|22|||
128824759|NCT00357682|463656934|FG003|Overall Study|Adverse Event|27|||
128824760|NCT00357682|463656931|FG000|Overall Study|Physician Decision|32|||
128824761|NCT00357682|463656932|FG001|Overall Study|Physician Decision|20|||
128824762|NCT00357682|463656933|FG002|Overall Study|Physician Decision|24|||
128824763|NCT00357682|463656934|FG003|Overall Study|Physician Decision|30|||
128824764|NCT00357682|463656931|FG000|Overall Study|Patient decision|73|||
128824765|NCT00357682|463656932|FG001|Overall Study|Patient decision|80|||
128824766|NCT00357682|463656933|FG002|Overall Study|Patient decision|51|||
128824767|NCT00357682|463656934|FG003|Overall Study|Patient decision|59|||
128824768|NCT00357682|463656931|FG000|Overall Study|Other reason|157|||
128824769|NCT00357682|463656932|FG001|Overall Study|Other reason|130|||
128824770|NCT00357682|463656933|FG002|Overall Study|Other reason|114|||
128824771|NCT00357682|463656934|FG003|Overall Study|Other reason|99|||
128824772|NCT02726386|463656939|FG000|Overall Study|Adverse Event|17|||
128824773|NCT02726386|463656940|FG001|Overall Study|Adverse Event|20|||
128824774|NCT02726386|463656939|FG000|Overall Study|Withdrawal by Subject|14|||
128824775|NCT02726386|463656940|FG001|Overall Study|Withdrawal by Subject|28|||
128824776|NCT02726386|463656939|FG000|Overall Study|Other reasons|7|||
128824777|NCT02726386|463656940|FG001|Overall Study|Other reasons|8|||
128824778|NCT04012567|463656952|FG000|Overall Study|Lost to Follow-up|0|||
128824779|NCT04012567|463656953|FG001|Overall Study|Lost to Follow-up|1|||
128824780|NCT04012567|463656952|FG000|Overall Study|Withdrawal by Subject|1|||
128824781|NCT04012567|463656953|FG001|Overall Study|Withdrawal by Subject|0|||
128824782|NCT02951052|463656954|FG000|Overall Study|Adverse Event|13|||
128824783|NCT02951052|463656955|FG001|Overall Study|Adverse Event|5|||
128824784|NCT02951052|463656954|FG000|Overall Study|Withdrawal by Subject|1|||
128824785|NCT02951052|463656955|FG001|Overall Study|Withdrawal by Subject|5|||
128824786|NCT02951052|463656954|FG000|Overall Study|Physician Decision|2|||
128824787|NCT02951052|463656955|FG001|Overall Study|Physician Decision|0|||
128824788|NCT02951052|463656954|FG000|Overall Study|Lost to Follow-up|1|||
128824789|NCT02951052|463656955|FG001|Overall Study|Lost to Follow-up|1|||
128824790|NCT02951052|463656954|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
128824791|NCT02951052|463656955|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
128824792|NCT02951052|463656954|FG000|Overall Study|Protocol Violation|5|||
128824793|NCT02951052|463656955|FG001|Overall Study|Protocol Violation|3|||
128824794|NCT02951052|463656954|FG000|Overall Study|Lack of Efficacy|3|||
128824795|NCT02951052|463656955|FG001|Overall Study|Lack of Efficacy|4|||
128824796|NCT02951052|463656954|FG000|Overall Study|Ongoing|1|||
128824797|NCT02951052|463656955|FG001|Overall Study|Ongoing|0|||
128824798|NCT04644029|463657529|FG000|Overall Study|Death|1|||
128824799|NCT04644029|463657530|FG001|Overall Study|Death|0|||
128824800|NCT04644029|463657529|FG000|Overall Study|Physician Decision|1|||
128824801|NCT04644029|463657530|FG001|Overall Study|Physician Decision|2|||
128824802|NCT04644029|463657529|FG000|Overall Study|Withdrawal by Subject|21|||
128824803|NCT04644029|463657530|FG001|Overall Study|Withdrawal by Subject|19|||
128824804|NCT04644029|463657529|FG000|Overall Study|Lost to Follow-up|31|||
128824805|NCT04644029|463657530|FG001|Overall Study|Lost to Follow-up|34|||
128824806|NCT04644029|463657529|FG000|Overall Study|Study Terminated by Sponsor|308|||
128824807|NCT04644029|463657530|FG001|Overall Study|Study Terminated by Sponsor|309|||
128824808|NCT04644029|463657529|FG000|Overall Study|Randomized in Error|2|||
128824809|NCT04644029|463657530|FG001|Overall Study|Randomized in Error|1|||
128824810|NCT04644029|463657529|FG000|Overall Study|Other|0|||
128824811|NCT04644029|463657530|FG001|Overall Study|Other|1|||
128824812|NCT03286114|463657537|FG000|Overall Study|Adverse Event|6|||
128824813|NCT03286114|463657537|FG000|Overall Study|Death|3|||
128824814|NCT01046825|463657538|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
128824815|NCT01046825|463657539|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
128824816|NCT01046825|463657540|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
128824817|NCT01046825|463657541|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
128824818|NCT01046825|463657542|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
128824819|NCT01046825|463657538|FG000|Overall Study|Physician Decision|0|||
128824820|NCT01046825|463657539|FG001|Overall Study|Physician Decision|1|||
128824821|NCT01046825|463657540|FG002|Overall Study|Physician Decision|2|||
128824822|NCT01046825|463657541|FG003|Overall Study|Physician Decision|0|||
128824823|NCT01046825|463657542|FG004|Overall Study|Physician Decision|0|||
128824824|NCT01046825|463657538|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
128824825|NCT01046825|463657539|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
128824826|NCT01046825|463657540|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
128824827|NCT01046825|463657541|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
128824828|NCT01046825|463657542|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
128824829|NCT01046825|463657538|FG000|Overall Study|Found to be ineligible|0|||
128824830|NCT01046825|463657539|FG001|Overall Study|Found to be ineligible|1|||
128824831|NCT01046825|463657540|FG002|Overall Study|Found to be ineligible|0|||
128824832|NCT01046825|463657541|FG003|Overall Study|Found to be ineligible|0|||
128824833|NCT01046825|463657542|FG004|Overall Study|Found to be ineligible|0|||
128824834|NCT01046825|463657538|FG000|Overall Study|Death|0|||
128824835|NCT01046825|463657539|FG001|Overall Study|Death|0|||
128824836|NCT01046825|463657540|FG002|Overall Study|Death|0|||
128824837|NCT01046825|463657541|FG003|Overall Study|Death|1|||
128824838|NCT01046825|463657542|FG004|Overall Study|Death|0|||
128824839|NCT01046825|463657538|FG000|Overall Study|Did not submit biology samples|0|||
128824840|NCT01046825|463657539|FG001|Overall Study|Did not submit biology samples|0|||
128824841|NCT01046825|463657540|FG002|Overall Study|Did not submit biology samples|0|||
128824842|NCT01046825|463657541|FG003|Overall Study|Did not submit biology samples|0|||
128824843|NCT01046825|463657542|FG004|Overall Study|Did not submit biology samples|13|||
128824844|NCT00003222|463657552|FG000|Overall Study|Physician Decision|0|||
128824845|NCT00003222|463657553|FG001|Overall Study|Physician Decision|1|||
128824846|NCT04757753|463657554|FG000|Overall Study|Lost to Follow-up|7|||
128824847|NCT04757753|463657555|FG001|Overall Study|Lost to Follow-up|7|||
128824848|NCT04757753|463657554|FG000|Overall Study|Withdrawal by Subject|0|||
128824849|NCT04757753|463657555|FG001|Overall Study|Withdrawal by Subject|3|||
128824850|NCT04757753|463657554|FG000|Overall Study|Endodontic treatment failure|1|||
128824851|NCT04757753|463657555|FG001|Overall Study|Endodontic treatment failure|2|||
128824852|NCT04757753|463657554|FG000|Overall Study|Tooth fracture/extraction|3|||
128824853|NCT04757753|463657555|FG001|Overall Study|Tooth fracture/extraction|0|||
128824854|NCT01313559|463657556|FG000|Overall Study|Withdrawal by Subject|1|||
128824855|NCT01313559|463657557|FG001|Overall Study|Withdrawal by Subject|2|||
128824856|NCT01313559|463657556|FG000|Overall Study|Disease progression|1|||
128824857|NCT01313559|463657557|FG001|Overall Study|Disease progression|0|||
128824858|NCT01313559|463657556|FG000|Overall Study|Rising PSA|2|||
128824859|NCT01313559|463657557|FG001|Overall Study|Rising PSA|0|||
128824860|NCT03201939|463657561|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
128824861|NCT03201939|463657562|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
128824862|NCT05707351|463657565|FG000|Overall Study|Withdrawal by Subject|2|||
128824863|NCT05707351|463657565|FG000|Overall Study|Reason Not Specified|1|||
128824864|NCT02206828|463657570|FG000|Overall Study|Lost to Follow-up|7|||
128824865|NCT05795153|463658479|FG000|Overall Study|Adverse Event|2|||
128824866|NCT05795153|463658479|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128824867|NCT05795153|463658479|FG000|Overall Study|Lost to Follow-up|1|||
128824868|NCT05795153|463658479|FG000|Overall Study|Subject decision|2|||
128824869|NCT05180539|463658480|FG000|Overall Study|Lost to Follow-up|27|||
128824870|NCT05180539|463658481|FG001|Overall Study|Lost to Follow-up|30|||
128824871|NCT02566889|463658484|FG000|Overall Study|Withdrawal by Subject|3|||
128824872|NCT02566889|463658485|FG001|Overall Study|Withdrawal by Subject|1|||
128824873|NCT02566889|463658484|FG000|Overall Study|Adverse Event|4|||
128824874|NCT02566889|463658485|FG001|Overall Study|Adverse Event|2|||
128824875|NCT02566889|463658484|FG000|Overall Study|Other|6|||
128824876|NCT02566889|463658485|FG001|Overall Study|Other|2|||
128824877|NCT04518943|463658486|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
128824878|NCT04518943|463658487|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
128824879|NCT04518943|463658488|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
128824880|NCT04518943|463658489|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
128824881|NCT04518943|463658490|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
128824882|NCT04518943|463658491|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
128824883|NCT04518943|463658492|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
128824884|NCT04518943|463658493|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
128824885|NCT04518943|463658494|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
128824886|NCT04518943|463658495|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
128824887|NCT04518943|463658496|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
128824888|NCT04518943|463658497|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
128824889|NCT04518943|463658498|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
128824890|NCT04518943|463658499|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
128824891|NCT04518943|463658500|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
128824892|NCT04518943|463658501|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
128824893|NCT03699163|463658503|FG000|Overall Study|Physician Decision|12|||
128824894|NCT03699163|463658504|FG001|Overall Study|Physician Decision|0|||
128824895|NCT03699163|463658503|FG000|Overall Study|failed QC measures|205|||
128824896|NCT03699163|463658504|FG001|Overall Study|failed QC measures|206|||
128824897|NCT03705793|463658505|FG000|Overall Study|Lost to Follow-up|3|||
128824898|NCT03705793|463658506|FG001|Overall Study|Lost to Follow-up|4|||
128824899|NCT03705793|463658505|FG000|Overall Study|Withdrawal by Subject|2|||
128824900|NCT03705793|463658506|FG001|Overall Study|Withdrawal by Subject|1|||
128824901|NCT02719574|463658507|FG000|Phase 1 (Dose Escalation)|Other|0|||
128824902|NCT02719574|463658508|FG001|Phase 1 (Dose Escalation)|Other|2|||
128824903|NCT02719574|463658509|FG002|Phase 1 (Dose Escalation)|Other|1|||
128824904|NCT02719574|463658510|FG003|Phase 1 (Dose Escalation)|Other|2|||
128824905|NCT02719574|463658511|FG004|Phase 1 (Dose Escalation)|Other|2|||
128824906|NCT02719574|463658512|FG005|Phase 1 (Dose Escalation)|Other|0|||
128824907|NCT02719574|463658513|FG006|Phase 1 (Dose Escalation)|Other|0|||
128824908|NCT02719574|463658514|FG007|Phase 1 (Dose Escalation)|Other|0|||
128824909|NCT02719574|463658515|FG008|Phase 1 (Dose Escalation)|Other|0|||
128824910|NCT02719574|463658516|FG009|Phase 1 (Dose Escalation)|Other|0|||
128824911|NCT02719574|463658517|FG010|Phase 1 (Dose Escalation)|Other|0|||
128824912|NCT02719574|463658518|FG011|Phase 1 (Dose Escalation)|Other|0|||
128824913|NCT02719574|463658519|FG012|Phase 1 (Dose Escalation)|Other|0|||
128824914|NCT02719574|463658520|FG013|Phase 1 (Dose Escalation)|Other|0|||
128824915|NCT02719574|463658521|FG014|Phase 1 (Dose Escalation)|Other|0|||
128824916|NCT02719574|463658522|FG015|Phase 1 (Dose Escalation)|Other|0|||
128824917|NCT02719574|463658523|FG016|Phase 1 (Dose Escalation)|Other|0|||
128824918|NCT02719574|463658507|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
128824919|NCT02719574|463658508|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
128824920|NCT02719574|463658509|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
128824921|NCT02719574|463658510|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
128824922|NCT02719574|463658511|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
128824923|NCT02719574|463658512|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
128824924|NCT02719574|463658513|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824925|NCT02719574|463658514|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824926|NCT02719574|463658515|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824927|NCT02719574|463658516|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824928|NCT02719574|463658517|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824929|NCT02719574|463658518|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824930|NCT02719574|463658519|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824931|NCT02719574|463658520|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824932|NCT02719574|463658521|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824933|NCT02719574|463658522|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824934|NCT02719574|463658523|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
128824935|NCT02719574|463658507|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824936|NCT02719574|463658508|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
128824937|NCT02719574|463658509|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
128824938|NCT02719574|463658510|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824939|NCT02719574|463658511|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
128824940|NCT02719574|463658512|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
128824941|NCT02719574|463658513|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824942|NCT02719574|463658514|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824943|NCT02719574|463658515|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824944|NCT02719574|463658516|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824945|NCT02719574|463658517|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824946|NCT02719574|463658518|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824947|NCT02719574|463658519|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824948|NCT02719574|463658520|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824949|NCT02719574|463658521|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824950|NCT02719574|463658522|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824951|NCT02719574|463658523|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
128824952|NCT02719574|463658507|FG000|Phase 1 (Dose Escalation)|Death|2|||
128824953|NCT02719574|463658508|FG001|Phase 1 (Dose Escalation)|Death|1|||
128824954|NCT02719574|463658509|FG002|Phase 1 (Dose Escalation)|Death|1|||
128824955|NCT02719574|463658510|FG003|Phase 1 (Dose Escalation)|Death|0|||
128824956|NCT02719574|463658511|FG004|Phase 1 (Dose Escalation)|Death|0|||
128824957|NCT02719574|463658512|FG005|Phase 1 (Dose Escalation)|Death|0|||
128824958|NCT02719574|463658513|FG006|Phase 1 (Dose Escalation)|Death|0|||
128824959|NCT02719574|463658514|FG007|Phase 1 (Dose Escalation)|Death|0|||
128824960|NCT02719574|463658515|FG008|Phase 1 (Dose Escalation)|Death|0|||
128824961|NCT02719574|463658516|FG009|Phase 1 (Dose Escalation)|Death|0|||
128824962|NCT02719574|463658517|FG010|Phase 1 (Dose Escalation)|Death|0|||
128824963|NCT02719574|463658518|FG011|Phase 1 (Dose Escalation)|Death|0|||
128824964|NCT02719574|463658519|FG012|Phase 1 (Dose Escalation)|Death|0|||
128824965|NCT02719574|463658520|FG013|Phase 1 (Dose Escalation)|Death|0|||
128824966|NCT02719574|463658521|FG014|Phase 1 (Dose Escalation)|Death|0|||
128824967|NCT02719574|463658522|FG015|Phase 1 (Dose Escalation)|Death|0|||
128824968|NCT02719574|463658523|FG016|Phase 1 (Dose Escalation)|Death|0|||
128824969|NCT02719574|463658507|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824970|NCT02719574|463658508|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
128824971|NCT02719574|463658509|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824972|NCT02719574|463658510|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824973|NCT02719574|463658511|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
128824974|NCT02719574|463658512|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
128824975|NCT02719574|463658513|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824976|NCT02719574|463658514|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824977|NCT02719574|463658515|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824978|NCT02719574|463658516|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824979|NCT02719574|463658517|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824980|NCT02719574|463658518|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824981|NCT02719574|463658519|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824982|NCT02719574|463658520|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824983|NCT02719574|463658521|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824984|NCT02719574|463658522|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824985|NCT02719574|463658523|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
128824986|NCT02719574|463658507|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824987|NCT02719574|463658508|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824988|NCT02719574|463658509|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824989|NCT02719574|463658510|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824990|NCT02719574|463658511|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
128824991|NCT02719574|463658512|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
128824992|NCT02719574|463658513|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824993|NCT02719574|463658514|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824994|NCT02719574|463658515|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824995|NCT02719574|463658516|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824996|NCT02719574|463658517|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824997|NCT02719574|463658518|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824998|NCT02719574|463658519|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
128824999|NCT02719574|463658520|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
128825000|NCT02719574|463658521|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
128825001|NCT02719574|463658522|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
128825002|NCT02719574|463658523|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
128825003|NCT02719574|463658507|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825004|NCT02719574|463658508|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825005|NCT02719574|463658509|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
128825006|NCT02719574|463658510|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825007|NCT02719574|463658511|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825008|NCT02719574|463658512|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825009|NCT02719574|463658513|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825010|NCT02719574|463658514|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825011|NCT02719574|463658515|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825012|NCT02719574|463658516|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825013|NCT02719574|463658517|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825014|NCT02719574|463658518|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825015|NCT02719574|463658519|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825016|NCT02719574|463658520|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825017|NCT02719574|463658521|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825018|NCT02719574|463658522|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825019|NCT02719574|463658523|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
128825020|NCT02719574|463658507|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825021|NCT02719574|463658508|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825022|NCT02719574|463658509|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825023|NCT02719574|463658510|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825024|NCT02719574|463658511|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825025|NCT02719574|463658512|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825026|NCT02719574|463658513|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
128825027|NCT02719574|463658514|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
128825028|NCT02719574|463658515|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
128825029|NCT02719574|463658516|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825030|NCT02719574|463658517|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825031|NCT02719574|463658518|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825032|NCT02719574|463658519|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825033|NCT02719574|463658520|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825034|NCT02719574|463658521|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825035|NCT02719574|463658522|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825036|NCT02719574|463658523|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
128825037|NCT02719574|463658507|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825038|NCT02719574|463658508|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825039|NCT02719574|463658509|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825040|NCT02719574|463658510|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825041|NCT02719574|463658511|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825042|NCT02719574|463658512|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825043|NCT02719574|463658513|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
128825044|NCT02719574|463658514|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
128825045|NCT02719574|463658515|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825046|NCT02719574|463658516|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825047|NCT02719574|463658517|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825048|NCT02719574|463658518|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825049|NCT02719574|463658519|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825050|NCT02719574|463658520|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825051|NCT02719574|463658521|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825052|NCT02719574|463658522|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825053|NCT02719574|463658523|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
128825054|NCT02719574|463658507|FG000|Phase 1 (Dose Expansion)|Death|0|||
128825055|NCT02719574|463658508|FG001|Phase 1 (Dose Expansion)|Death|0|||
128825056|NCT02719574|463658509|FG002|Phase 1 (Dose Expansion)|Death|0|||
128825057|NCT02719574|463658510|FG003|Phase 1 (Dose Expansion)|Death|0|||
128825058|NCT02719574|463658511|FG004|Phase 1 (Dose Expansion)|Death|0|||
128825059|NCT02719574|463658512|FG005|Phase 1 (Dose Expansion)|Death|0|||
128825060|NCT02719574|463658513|FG006|Phase 1 (Dose Expansion)|Death|1|||
128825061|NCT02719574|463658514|FG007|Phase 1 (Dose Expansion)|Death|6|||
128825062|NCT02719574|463658515|FG008|Phase 1 (Dose Expansion)|Death|0|||
128825063|NCT02719574|463658516|FG009|Phase 1 (Dose Expansion)|Death|0|||
128825064|NCT02719574|463658517|FG010|Phase 1 (Dose Expansion)|Death|0|||
128825065|NCT02719574|463658518|FG011|Phase 1 (Dose Expansion)|Death|0|||
128825066|NCT02719574|463658519|FG012|Phase 1 (Dose Expansion)|Death|0|||
128825067|NCT02719574|463658520|FG013|Phase 1 (Dose Expansion)|Death|0|||
128825068|NCT02719574|463658521|FG014|Phase 1 (Dose Expansion)|Death|0|||
128825069|NCT02719574|463658522|FG015|Phase 1 (Dose Expansion)|Death|0|||
128825070|NCT02719574|463658523|FG016|Phase 1 (Dose Expansion)|Death|0|||
128825071|NCT02719574|463658507|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825072|NCT02719574|463658508|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825073|NCT02719574|463658509|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825074|NCT02719574|463658510|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825075|NCT02719574|463658511|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825076|NCT02719574|463658512|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825077|NCT02719574|463658513|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
128825078|NCT02719574|463658514|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
128825079|NCT02719574|463658515|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825080|NCT02719574|463658516|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825081|NCT02719574|463658517|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825082|NCT02719574|463658518|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825083|NCT02719574|463658519|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825084|NCT02719574|463658520|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825085|NCT02719574|463658521|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825086|NCT02719574|463658522|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825087|NCT02719574|463658523|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
128825088|NCT02719574|463658507|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825089|NCT02719574|463658508|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825090|NCT02719574|463658509|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825091|NCT02719574|463658510|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825092|NCT02719574|463658511|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825093|NCT02719574|463658512|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825094|NCT02719574|463658513|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
128825095|NCT02719574|463658514|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
128825096|NCT02719574|463658515|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825097|NCT02719574|463658516|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825098|NCT02719574|463658517|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825099|NCT02719574|463658518|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825100|NCT02719574|463658519|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825101|NCT02719574|463658520|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825102|NCT02719574|463658521|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825103|NCT02719574|463658522|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825104|NCT02719574|463658523|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
128825105|NCT02719574|463658507|FG000|Phase 1 (Dose Expansion)|Other|0|||
128825106|NCT02719574|463658508|FG001|Phase 1 (Dose Expansion)|Other|0|||
128825107|NCT02719574|463658509|FG002|Phase 1 (Dose Expansion)|Other|0|||
128825108|NCT02719574|463658510|FG003|Phase 1 (Dose Expansion)|Other|0|||
128825109|NCT02719574|463658511|FG004|Phase 1 (Dose Expansion)|Other|0|||
128825110|NCT02719574|463658512|FG005|Phase 1 (Dose Expansion)|Other|0|||
128825111|NCT02719574|463658513|FG006|Phase 1 (Dose Expansion)|Other|1|||
128825112|NCT02719574|463658514|FG007|Phase 1 (Dose Expansion)|Other|7|||
128825113|NCT02719574|463658515|FG008|Phase 1 (Dose Expansion)|Other|0|||
128825114|NCT02719574|463658516|FG009|Phase 1 (Dose Expansion)|Other|0|||
128825115|NCT02719574|463658517|FG010|Phase 1 (Dose Expansion)|Other|0|||
128825116|NCT02719574|463658518|FG011|Phase 1 (Dose Expansion)|Other|0|||
128825117|NCT02719574|463658519|FG012|Phase 1 (Dose Expansion)|Other|0|||
128825118|NCT02719574|463658520|FG013|Phase 1 (Dose Expansion)|Other|0|||
128825119|NCT02719574|463658521|FG014|Phase 1 (Dose Expansion)|Other|0|||
128825120|NCT02719574|463658522|FG015|Phase 1 (Dose Expansion)|Other|0|||
128825121|NCT02719574|463658523|FG016|Phase 1 (Dose Expansion)|Other|0|||
128825122|NCT02719574|463658507|FG000|Phase 2|Protocol Defined Disease Progression|0|||
128825123|NCT02719574|463658508|FG001|Phase 2|Protocol Defined Disease Progression|0|||
128825124|NCT02719574|463658509|FG002|Phase 2|Protocol Defined Disease Progression|0|||
128825125|NCT02719574|463658510|FG003|Phase 2|Protocol Defined Disease Progression|0|||
128825126|NCT02719574|463658511|FG004|Phase 2|Protocol Defined Disease Progression|0|||
128825127|NCT02719574|463658512|FG005|Phase 2|Protocol Defined Disease Progression|0|||
128825128|NCT02719574|463658513|FG006|Phase 2|Protocol Defined Disease Progression|0|||
128825129|NCT02719574|463658514|FG007|Phase 2|Protocol Defined Disease Progression|0|||
128825130|NCT02719574|463658515|FG008|Phase 2|Protocol Defined Disease Progression|0|||
128825131|NCT02719574|463658516|FG009|Phase 2|Protocol Defined Disease Progression|65|||
128825132|NCT02719574|463658517|FG010|Phase 2|Protocol Defined Disease Progression|8|||
128825133|NCT02719574|463658518|FG011|Phase 2|Protocol Defined Disease Progression|2|||
128825134|NCT02719574|463658519|FG012|Phase 2|Protocol Defined Disease Progression|4|||
128825135|NCT02719574|463658520|FG013|Phase 2|Protocol Defined Disease Progression|9|||
128825136|NCT02719574|463658521|FG014|Phase 2|Protocol Defined Disease Progression|11|||
128825137|NCT02719574|463658522|FG015|Phase 2|Protocol Defined Disease Progression|3|||
128825138|NCT02719574|463658523|FG016|Phase 2|Protocol Defined Disease Progression|4|||
128825139|NCT02719574|463658507|FG000|Phase 2|Adverse Event|0|||
128825140|NCT02719574|463658508|FG001|Phase 2|Adverse Event|0|||
128825141|NCT02719574|463658509|FG002|Phase 2|Adverse Event|0|||
128825142|NCT02719574|463658510|FG003|Phase 2|Adverse Event|0|||
128825143|NCT02719574|463658511|FG004|Phase 2|Adverse Event|0|||
128825144|NCT02719574|463658512|FG005|Phase 2|Adverse Event|0|||
128825145|NCT02719574|463658513|FG006|Phase 2|Adverse Event|0|||
128825146|NCT02719574|463658514|FG007|Phase 2|Adverse Event|0|||
128825147|NCT02719574|463658515|FG008|Phase 2|Adverse Event|0|||
128825148|NCT02719574|463658516|FG009|Phase 2|Adverse Event|27|||
128825149|NCT02719574|463658517|FG010|Phase 2|Adverse Event|0|||
128825150|NCT02719574|463658518|FG011|Phase 2|Adverse Event|1|||
128825151|NCT02719574|463658519|FG012|Phase 2|Adverse Event|1|||
128825152|NCT02719574|463658520|FG013|Phase 2|Adverse Event|1|||
128825153|NCT02719574|463658521|FG014|Phase 2|Adverse Event|2|||
128825154|NCT02719574|463658522|FG015|Phase 2|Adverse Event|2|||
128825155|NCT02719574|463658523|FG016|Phase 2|Adverse Event|3|||
128825156|NCT02719574|463658507|FG000|Phase 2|Other|0|||
128825157|NCT02719574|463658508|FG001|Phase 2|Other|0|||
128825158|NCT02719574|463658509|FG002|Phase 2|Other|0|||
128825159|NCT02719574|463658510|FG003|Phase 2|Other|0|||
128825160|NCT02719574|463658511|FG004|Phase 2|Other|0|||
128825161|NCT02719574|463658512|FG005|Phase 2|Other|0|||
128825162|NCT02719574|463658513|FG006|Phase 2|Other|0|||
128825163|NCT02719574|463658514|FG007|Phase 2|Other|0|||
128825164|NCT02719574|463658515|FG008|Phase 2|Other|0|||
128825165|NCT02719574|463658516|FG009|Phase 2|Other|20|||
128825166|NCT02719574|463658517|FG010|Phase 2|Other|7|||
128825167|NCT02719574|463658518|FG011|Phase 2|Other|0|||
128825168|NCT02719574|463658519|FG012|Phase 2|Other|5|||
128825169|NCT02719574|463658520|FG013|Phase 2|Other|7|||
128825170|NCT02719574|463658521|FG014|Phase 2|Other|0|||
128825171|NCT02719574|463658522|FG015|Phase 2|Other|1|||
128825172|NCT02719574|463658523|FG016|Phase 2|Other|4|||
128825173|NCT02719574|463658507|FG000|Phase 2|Transplant|0|||
128825174|NCT02719574|463658508|FG001|Phase 2|Transplant|0|||
128825175|NCT02719574|463658509|FG002|Phase 2|Transplant|0|||
128825176|NCT02719574|463658510|FG003|Phase 2|Transplant|0|||
128825177|NCT02719574|463658511|FG004|Phase 2|Transplant|0|||
128825178|NCT02719574|463658512|FG005|Phase 2|Transplant|0|||
128825179|NCT02719574|463658513|FG006|Phase 2|Transplant|0|||
128825180|NCT02719574|463658514|FG007|Phase 2|Transplant|0|||
128825181|NCT02719574|463658515|FG008|Phase 2|Transplant|0|||
128825182|NCT02719574|463658516|FG009|Phase 2|Transplant|15|||
128825183|NCT02719574|463658517|FG010|Phase 2|Transplant|2|||
128825184|NCT02719574|463658518|FG011|Phase 2|Transplant|0|||
128825185|NCT02719574|463658519|FG012|Phase 2|Transplant|6|||
128825186|NCT02719574|463658520|FG013|Phase 2|Transplant|1|||
128825187|NCT02719574|463658521|FG014|Phase 2|Transplant|1|||
128825188|NCT02719574|463658522|FG015|Phase 2|Transplant|0|||
128825189|NCT02719574|463658523|FG016|Phase 2|Transplant|0|||
128825190|NCT02719574|463658507|FG000|Phase 2|Death|0|||
128825191|NCT02719574|463658508|FG001|Phase 2|Death|0|||
128825192|NCT02719574|463658509|FG002|Phase 2|Death|0|||
128825193|NCT02719574|463658510|FG003|Phase 2|Death|0|||
128825194|NCT02719574|463658511|FG004|Phase 2|Death|0|||
128825195|NCT02719574|463658512|FG005|Phase 2|Death|0|||
128825196|NCT02719574|463658513|FG006|Phase 2|Death|0|||
128825197|NCT02719574|463658514|FG007|Phase 2|Death|0|||
128825198|NCT02719574|463658515|FG008|Phase 2|Death|0|||
128825199|NCT02719574|463658516|FG009|Phase 2|Death|14|||
128825200|NCT02719574|463658517|FG010|Phase 2|Death|0|||
128825201|NCT02719574|463658518|FG011|Phase 2|Death|0|||
128825202|NCT02719574|463658519|FG012|Phase 2|Death|1|||
128825203|NCT02719574|463658520|FG013|Phase 2|Death|1|||
128825204|NCT02719574|463658521|FG014|Phase 2|Death|2|||
128825205|NCT02719574|463658522|FG015|Phase 2|Death|0|||
128825206|NCT02719574|463658523|FG016|Phase 2|Death|0|||
128825207|NCT02719574|463658507|FG000|Phase 2|Investigator Decision|0|||
128825208|NCT02719574|463658508|FG001|Phase 2|Investigator Decision|0|||
128825209|NCT02719574|463658509|FG002|Phase 2|Investigator Decision|0|||
128825210|NCT02719574|463658510|FG003|Phase 2|Investigator Decision|0|||
128825211|NCT02719574|463658511|FG004|Phase 2|Investigator Decision|0|||
128825212|NCT02719574|463658512|FG005|Phase 2|Investigator Decision|0|||
128825213|NCT02719574|463658513|FG006|Phase 2|Investigator Decision|0|||
128825214|NCT02719574|463658514|FG007|Phase 2|Investigator Decision|0|||
128825215|NCT02719574|463658515|FG008|Phase 2|Investigator Decision|0|||
128825216|NCT02719574|463658516|FG009|Phase 2|Investigator Decision|6|||
128825217|NCT02719574|463658517|FG010|Phase 2|Investigator Decision|1|||
128825218|NCT02719574|463658518|FG011|Phase 2|Investigator Decision|2|||
128825219|NCT02719574|463658519|FG012|Phase 2|Investigator Decision|3|||
128825220|NCT02719574|463658520|FG013|Phase 2|Investigator Decision|1|||
128825221|NCT02719574|463658521|FG014|Phase 2|Investigator Decision|3|||
128825222|NCT02719574|463658522|FG015|Phase 2|Investigator Decision|2|||
128825223|NCT02719574|463658523|FG016|Phase 2|Investigator Decision|0|||
128825224|NCT02719574|463658507|FG000|Phase 2|Withdrawal by Subject|0|||
128825225|NCT02719574|463658508|FG001|Phase 2|Withdrawal by Subject|0|||
128825226|NCT02719574|463658509|FG002|Phase 2|Withdrawal by Subject|0|||
128825227|NCT02719574|463658510|FG003|Phase 2|Withdrawal by Subject|0|||
128825228|NCT02719574|463658511|FG004|Phase 2|Withdrawal by Subject|0|||
128825229|NCT02719574|463658512|FG005|Phase 2|Withdrawal by Subject|0|||
128825230|NCT02719574|463658513|FG006|Phase 2|Withdrawal by Subject|0|||
128825231|NCT02719574|463658514|FG007|Phase 2|Withdrawal by Subject|0|||
128825232|NCT02719574|463658515|FG008|Phase 2|Withdrawal by Subject|0|||
128825233|NCT02719574|463658516|FG009|Phase 2|Withdrawal by Subject|5|||
128825234|NCT02719574|463658517|FG010|Phase 2|Withdrawal by Subject|0|||
128825235|NCT02719574|463658518|FG011|Phase 2|Withdrawal by Subject|0|||
128825236|NCT02719574|463658519|FG012|Phase 2|Withdrawal by Subject|0|||
128825237|NCT02719574|463658520|FG013|Phase 2|Withdrawal by Subject|1|||
128825238|NCT02719574|463658521|FG014|Phase 2|Withdrawal by Subject|1|||
128825239|NCT02719574|463658522|FG015|Phase 2|Withdrawal by Subject|2|||
128825240|NCT02719574|463658523|FG016|Phase 2|Withdrawal by Subject|0|||
128825241|NCT02719574|463658507|FG000|Phase 2|Protocol Violation|0|||
128825242|NCT02719574|463658508|FG001|Phase 2|Protocol Violation|0|||
128825243|NCT02719574|463658509|FG002|Phase 2|Protocol Violation|0|||
128825244|NCT02719574|463658510|FG003|Phase 2|Protocol Violation|0|||
128825245|NCT02719574|463658511|FG004|Phase 2|Protocol Violation|0|||
128825246|NCT02719574|463658512|FG005|Phase 2|Protocol Violation|0|||
128825247|NCT02719574|463658513|FG006|Phase 2|Protocol Violation|0|||
128825248|NCT02719574|463658514|FG007|Phase 2|Protocol Violation|0|||
128825249|NCT02719574|463658515|FG008|Phase 2|Protocol Violation|0|||
128825250|NCT02719574|463658516|FG009|Phase 2|Protocol Violation|1|||
128825251|NCT02719574|463658517|FG010|Phase 2|Protocol Violation|0|||
128825252|NCT02719574|463658518|FG011|Phase 2|Protocol Violation|0|||
128825253|NCT02719574|463658519|FG012|Phase 2|Protocol Violation|0|||
128825254|NCT02719574|463658520|FG013|Phase 2|Protocol Violation|0|||
128825255|NCT02719574|463658521|FG014|Phase 2|Protocol Violation|0|||
128825256|NCT02719574|463658522|FG015|Phase 2|Protocol Violation|0|||
128825257|NCT02719574|463658523|FG016|Phase 2|Protocol Violation|0|||
128825258|NCT03875313|463658542|FG000|Overall Study|Withdrawal by Subject|1|||
128825259|NCT03875313|463658543|FG001|Overall Study|Withdrawal by Subject|3|||
128825260|NCT03875313|463658544|FG002|Overall Study|Withdrawal by Subject|0|||
128825261|NCT03875313|463658545|FG003|Overall Study|Withdrawal by Subject|0|||
128825262|NCT03875313|463658546|FG004|Overall Study|Withdrawal by Subject|0|||
128825263|NCT03875313|463658542|FG000|Overall Study|Death|0|||
128825264|NCT03875313|463658543|FG001|Overall Study|Death|0|||
128825265|NCT03875313|463658544|FG002|Overall Study|Death|0|||
128825266|NCT03875313|463658545|FG003|Overall Study|Death|0|||
128825267|NCT03875313|463658546|FG004|Overall Study|Death|1|||
128825268|NCT03875313|463658542|FG000|Overall Study|Lost to Follow-up|0|||
128825269|NCT03875313|463658543|FG001|Overall Study|Lost to Follow-up|0|||
128825270|NCT03875313|463658544|FG002|Overall Study|Lost to Follow-up|0|||
128825271|NCT03875313|463658545|FG003|Overall Study|Lost to Follow-up|0|||
128825272|NCT03875313|463658546|FG004|Overall Study|Lost to Follow-up|1|||
128825273|NCT03875313|463658542|FG000|Overall Study|Study Termination by Sponsor|0|||
128825274|NCT03875313|463658543|FG001|Overall Study|Study Termination by Sponsor|1|||
128825275|NCT03875313|463658544|FG002|Overall Study|Study Termination by Sponsor|1|||
128825276|NCT03875313|463658545|FG003|Overall Study|Study Termination by Sponsor|0|||
128825277|NCT03875313|463658546|FG004|Overall Study|Study Termination by Sponsor|1|||
128825278|NCT03875313|463658542|FG000|Overall Study|New Anticancer Treatment|0|||
128825279|NCT03875313|463658543|FG001|Overall Study|New Anticancer Treatment|1|||
128825280|NCT03875313|463658544|FG002|Overall Study|New Anticancer Treatment|2|||
128825281|NCT03875313|463658545|FG003|Overall Study|New Anticancer Treatment|1|||
128825282|NCT03875313|463658546|FG004|Overall Study|New Anticancer Treatment|0|||
128825283|NCT03875313|463658542|FG000|Overall Study|Other, Not Specified|2|||
128825284|NCT03875313|463658543|FG001|Overall Study|Other, Not Specified|11|||
128825285|NCT03875313|463658544|FG002|Overall Study|Other, Not Specified|3|||
128825286|NCT03875313|463658545|FG003|Overall Study|Other, Not Specified|3|||
128825287|NCT03875313|463658546|FG004|Overall Study|Other, Not Specified|1|||
128825288|NCT02075554|463658547|FG000|Overall Study|Lost to Follow-up|7|||
128825289|NCT02075554|463658547|FG000|Overall Study|Withdrawal by Subject|5|||
128825290|NCT02075554|463658547|FG000|Overall Study|Physician Decision|3|||
128825291|NCT04993677|463658548|FG000|Overall Study|Lost to Follow-up|1|||
128825292|NCT04993677|463658549|FG001|Overall Study|Lost to Follow-up|0|||
128825293|NCT04993677|463658550|FG002|Overall Study|Lost to Follow-up|0|||
128825294|NCT04993677|463658551|FG003|Overall Study|Lost to Follow-up|0|||
128825295|NCT04993677|463658548|FG000|Overall Study|Death|11|||
128825296|NCT04993677|463658549|FG001|Overall Study|Death|8|||
128825297|NCT04993677|463658550|FG002|Overall Study|Death|3|||
128825298|NCT04993677|463658551|FG003|Overall Study|Death|1|||
128825299|NCT04993677|463658548|FG000|Overall Study|Subject withdrawal of consent|4|||
128825300|NCT04993677|463658549|FG001|Overall Study|Subject withdrawal of consent|3|||
128825301|NCT04993677|463658550|FG002|Overall Study|Subject withdrawal of consent|0|||
128825302|NCT04993677|463658551|FG003|Overall Study|Subject withdrawal of consent|2|||
128825303|NCT04993677|463658548|FG000|Overall Study|Study termination by sponsor|3|||
128825304|NCT04993677|463658549|FG001|Overall Study|Study termination by sponsor|25|||
128825305|NCT04993677|463658550|FG002|Overall Study|Study termination by sponsor|3|||
128825306|NCT04993677|463658551|FG003|Overall Study|Study termination by sponsor|3|||
128825307|NCT04993677|463658548|FG000|Overall Study|Other|2|||
128825308|NCT04993677|463658549|FG001|Overall Study|Other|3|||
128825309|NCT04993677|463658550|FG002|Overall Study|Other|3|||
128825310|NCT04993677|463658551|FG003|Overall Study|Other|2|||
128825311|NCT03248492|463658558|FG000|Overall Study|Progressive Disease|24|||
128825312|NCT03248492|463658559|FG001|Overall Study|Progressive Disease|23|||
128825313|NCT03248492|463658560|FG002|Overall Study|Progressive Disease|11|||
128825314|NCT03248492|463658561|FG003|Overall Study|Progressive Disease|66|||
128825315|NCT03248492|463658562|FG004|Overall Study|Progressive Disease|1|||
128825316|NCT03248492|463658558|FG000|Overall Study|Adverse Event|14|||
128825317|NCT03248492|463658559|FG001|Overall Study|Adverse Event|13|||
129204896|NCT04073186|465046982|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
129204897|NCT04073186|465046982|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
129204898|NCT04073186|465046982|FG000|First Wearing Cycle|Protocol Violation|1|||
128825318|NCT03248492|463658560|FG002|Overall Study|Adverse Event|9|||
128825319|NCT03248492|463658561|FG003|Overall Study|Adverse Event|22|||
128825320|NCT03248492|463658562|FG004|Overall Study|Adverse Event|2|||
128825321|NCT03248492|463658558|FG000|Overall Study|Withdrawal by Subject|5|||
128825322|NCT03248492|463658559|FG001|Overall Study|Withdrawal by Subject|4|||
128825323|NCT03248492|463658560|FG002|Overall Study|Withdrawal by Subject|0|||
128825324|NCT03248492|463658561|FG003|Overall Study|Withdrawal by Subject|8|||
128825325|NCT03248492|463658562|FG004|Overall Study|Withdrawal by Subject|1|||
128825326|NCT03248492|463658558|FG000|Overall Study|Physician Decision|1|||
128825327|NCT03248492|463658559|FG001|Overall Study|Physician Decision|1|||
128825328|NCT03248492|463658560|FG002|Overall Study|Physician Decision|1|||
128825329|NCT03248492|463658561|FG003|Overall Study|Physician Decision|7|||
128825330|NCT03248492|463658562|FG004|Overall Study|Physician Decision|0|||
128825331|NCT03248492|463658558|FG000|Overall Study|Death|1|||
128825332|NCT03248492|463658559|FG001|Overall Study|Death|1|||
128825333|NCT03248492|463658560|FG002|Overall Study|Death|0|||
128825334|NCT03248492|463658561|FG003|Overall Study|Death|6|||
128825335|NCT03248492|463658562|FG004|Overall Study|Death|0|||
128825336|NCT03248492|463658558|FG000|Overall Study|Study Terminated by Sponsor|3|||
128825337|NCT03248492|463658559|FG001|Overall Study|Study Terminated by Sponsor|1|||
128825338|NCT03248492|463658560|FG002|Overall Study|Study Terminated by Sponsor|0|||
128825339|NCT03248492|463658561|FG003|Overall Study|Study Terminated by Sponsor|7|||
128825340|NCT03248492|463658562|FG004|Overall Study|Study Terminated by Sponsor|0|||
128825341|NCT03248492|463658558|FG000|Overall Study|Other|2|||
128825342|NCT03248492|463658559|FG001|Overall Study|Other|5|||
128825343|NCT03248492|463658560|FG002|Overall Study|Other|0|||
128825344|NCT03248492|463658561|FG003|Overall Study|Other|14|||
128825345|NCT03248492|463658562|FG004|Overall Study|Other|0|||
128825346|NCT03705390|463658563|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
128825347|NCT03705390|463658563|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
128825348|NCT02656706|463658569|FG000|Overall Study|Insurance Denial|1|||
128825349|NCT03725332|463658570|FG000|Overall Study|Adverse Event|5|||
128825350|NCT03725332|463658571|FG001|Overall Study|Adverse Event|10|||
128825351|NCT03725332|463658570|FG000|Overall Study|Death|1|||
128825352|NCT03725332|463658571|FG001|Overall Study|Death|3|||
128825353|NCT03725332|463658570|FG000|Overall Study|Lost to Follow-up|43|||
128825354|NCT03725332|463658571|FG001|Overall Study|Lost to Follow-up|122|||
128825355|NCT03725332|463658570|FG000|Overall Study|Withdrawal by Subject|0|||
128825356|NCT03725332|463658571|FG001|Overall Study|Withdrawal by Subject|1|||
128825357|NCT03725332|463658570|FG000|Overall Study|Duplicate enrollment|0|||
128825358|NCT03725332|463658571|FG001|Overall Study|Duplicate enrollment|1|||
128825359|NCT03725332|463658570|FG000|Overall Study|Did not consent|0|||
128825360|NCT03725332|463658571|FG001|Overall Study|Did not consent|1|||
128825361|NCT02701283|463658580|FG000|Overall Study|Death|25|||
128825362|NCT02701283|463658581|FG001|Overall Study|Death|29|||
128825363|NCT02701283|463658582|FG002|Overall Study|Death|19|||
128825364|NCT02701283|463658580|FG000|Overall Study|Lost to Follow-up|3|||
128825365|NCT02701283|463658581|FG001|Overall Study|Lost to Follow-up|8|||
128825366|NCT02701283|463658582|FG002|Overall Study|Lost to Follow-up|1|||
128825367|NCT02701283|463658580|FG000|Overall Study|Withdrawal by Subject|12|||
128825368|NCT02701283|463658581|FG001|Overall Study|Withdrawal by Subject|41|||
128825369|NCT02701283|463658582|FG002|Overall Study|Withdrawal by Subject|1|||
128825370|NCT02701283|463658580|FG000|Overall Study|Missed 2-year visit|22|||
128825371|NCT02701283|463658581|FG001|Overall Study|Missed 2-year visit|27|||
128825372|NCT02701283|463658582|FG002|Overall Study|Missed 2-year visit|0|||
128825373|NCT02701283|463658580|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
128825374|NCT02701283|463658581|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
128825375|NCT02701283|463658582|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
128825376|NCT01830595|463658583|FG000|First Period|Withdrawal by Subject|1|||
128825377|NCT01830595|463658584|FG001|First Period|Withdrawal by Subject|3|||
128825378|NCT01830595|463658583|FG000|Washout|Withdrawal by Subject|2|||
128825379|NCT01830595|463658584|FG001|Washout|Withdrawal by Subject|2|||
128825380|NCT04908514|463658589|FG000|Overall Study|Lost to Follow-up|2|||
128825381|NCT04908514|463658589|FG000|Overall Study|Withdrawal by Subject|1|||
128825382|NCT04121546|463659232|FG000|Overall Study|Lost to Follow-up|1|||
128825383|NCT04121546|463659233|FG001|Overall Study|Lost to Follow-up|3|||
128825384|NCT03767335|463659234|FG000|Overall Study|Physician Decision|1|||
128825385|NCT03767335|463659235|FG001|Overall Study|Physician Decision|1|||
128825386|NCT03767335|463659236|FG002|Overall Study|Physician Decision|0|||
128825387|NCT03767335|463659234|FG000|Overall Study|Withdrawal by Subject|0|||
128825388|NCT03767335|463659235|FG001|Overall Study|Withdrawal by Subject|0|||
128825389|NCT03767335|463659236|FG002|Overall Study|Withdrawal by Subject|6|||
128825390|NCT03767335|463659234|FG000|Overall Study|Participant excluded from efficacy population|0|||
128825391|NCT03767335|463659235|FG001|Overall Study|Participant excluded from efficacy population|0|||
128825392|NCT03767335|463659236|FG002|Overall Study|Participant excluded from efficacy population|1|||
128825393|NCT03767335|463659234|FG000|Overall Study|Death|0|||
128825394|NCT03767335|463659235|FG001|Overall Study|Death|0|||
128825395|NCT03767335|463659236|FG002|Overall Study|Death|2|||
128825396|NCT03767335|463659234|FG000|Overall Study|Progressive Disease|2|||
128825397|NCT03767335|463659235|FG001|Overall Study|Progressive Disease|2|||
128825398|NCT03767335|463659236|FG002|Overall Study|Progressive Disease|2|||
128825399|NCT03767335|463659234|FG000|Overall Study|Disease progression needing additional medication|0|||
128825400|NCT03767335|463659235|FG001|Overall Study|Disease progression needing additional medication|0|||
128825401|NCT03767335|463659236|FG002|Overall Study|Disease progression needing additional medication|17|||
128825402|NCT03767335|463659234|FG000|Overall Study|Sponsor decision|0|||
128825403|NCT03767335|463659235|FG001|Overall Study|Sponsor decision|0|||
128825404|NCT03767335|463659236|FG002|Overall Study|Sponsor decision|2|||
128825405|NCT03767335|463659234|FG000|Overall Study|Other Medical Reasons|0|||
128825406|NCT03767335|463659235|FG001|Overall Study|Other Medical Reasons|0|||
128825407|NCT03767335|463659236|FG002|Overall Study|Other Medical Reasons|3|||
128825408|NCT04495621|463659238|FG000|Overall Study|Withdrawal by Subject|0|||
128825409|NCT04495621|463659239|FG001|Overall Study|Withdrawal by Subject|3|||
128825410|NCT04495621|463659238|FG000|Overall Study|Death|7|||
128825411|NCT04495621|463659239|FG001|Overall Study|Death|11|||
128825412|NCT04495621|463659238|FG000|Overall Study|Investigator Decision|0|||
128825413|NCT04495621|463659239|FG001|Overall Study|Investigator Decision|7|||
128825414|NCT04495621|463659238|FG000|Overall Study|Lost to Follow-up|0|||
128825415|NCT04495621|463659239|FG001|Overall Study|Lost to Follow-up|1|||
128825416|NCT04940624|463659243|FG000|Overall Study|Adverse Event|4|||
128825417|NCT04940624|463659244|FG001|Overall Study|Adverse Event|11|||
128825418|NCT04940624|463659243|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
128825419|NCT04940624|463659244|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
128825420|NCT04940624|463659243|FG000|Overall Study|Physician Decision|1|||
128825421|NCT04940624|463659244|FG001|Overall Study|Physician Decision|0|||
128825422|NCT04940624|463659243|FG000|Overall Study|Lost to Follow-up|1|||
128825423|NCT04940624|463659244|FG001|Overall Study|Lost to Follow-up|0|||
128825424|NCT04940624|463659243|FG000|Overall Study|Reason Not Specified|1|||
128825425|NCT04940624|463659244|FG001|Overall Study|Reason Not Specified|0|||
128825426|NCT05714059|463659254|FG000|Overall Study|Withdrawal by Subject|2|||
128825427|NCT05714059|463659255|FG001|Overall Study|Withdrawal by Subject|2|||
128825428|NCT05714059|463659254|FG000|Overall Study|Adverse Event|0|||
128825429|NCT05714059|463659255|FG001|Overall Study|Adverse Event|1|||
128825430|NCT05714059|463659254|FG000|Overall Study|Lost to Follow-up|0|||
128825431|NCT05714059|463659255|FG001|Overall Study|Lost to Follow-up|1|||
128825432|NCT05714059|463659254|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
128825433|NCT05714059|463659255|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
128825434|NCT05714059|463659254|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
128825435|NCT05714059|463659255|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
128825436|NCT05116774|463659258|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
128825437|NCT05116774|463659259|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
128825438|NCT05116774|463659258|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
128825439|NCT05116774|463659259|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
128825440|NCT05116774|463659258|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
128825441|NCT05116774|463659259|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
128825442|NCT05116774|463659258|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
128825443|NCT05116774|463659259|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
128825444|NCT03150862|463659260|FG000|Overall Study|Death|2|||
128825445|NCT03150862|463659261|FG001|Overall Study|Death|7|||
128825446|NCT03150862|463659262|FG002|Overall Study|Death|8|||
128825447|NCT03150862|463659263|FG003|Overall Study|Death|27|||
128825448|NCT03150862|463659264|FG004|Overall Study|Death|4|||
128825449|NCT03150862|463659265|FG005|Overall Study|Death|8|||
128825450|NCT03150862|463659266|FG006|Overall Study|Death|6|||
128825451|NCT03150862|463659267|FG007|Overall Study|Death|21|||
128825452|NCT03150862|463659260|FG000|Overall Study|Withdrawal by Subject|1|||
128825453|NCT03150862|463659261|FG001|Overall Study|Withdrawal by Subject|1|||
128825454|NCT03150862|463659262|FG002|Overall Study|Withdrawal by Subject|0|||
128825455|NCT03150862|463659263|FG003|Overall Study|Withdrawal by Subject|3|||
128825456|NCT03150862|463659264|FG004|Overall Study|Withdrawal by Subject|1|||
128825457|NCT03150862|463659265|FG005|Overall Study|Withdrawal by Subject|1|||
128825458|NCT03150862|463659266|FG006|Overall Study|Withdrawal by Subject|1|||
128825459|NCT03150862|463659267|FG007|Overall Study|Withdrawal by Subject|3|||
128825460|NCT03150862|463659260|FG000|Overall Study|Lost to Follow-up|0|||
128825461|NCT03150862|463659261|FG001|Overall Study|Lost to Follow-up|0|||
128825462|NCT03150862|463659262|FG002|Overall Study|Lost to Follow-up|1|||
128825463|NCT03150862|463659263|FG003|Overall Study|Lost to Follow-up|0|||
128825464|NCT03150862|463659264|FG004|Overall Study|Lost to Follow-up|0|||
128825465|NCT03150862|463659265|FG005|Overall Study|Lost to Follow-up|0|||
128825466|NCT03150862|463659266|FG006|Overall Study|Lost to Follow-up|0|||
128825467|NCT03150862|463659267|FG007|Overall Study|Lost to Follow-up|2|||
128825468|NCT03150862|463659260|FG000|Overall Study|Sponsor's decision|0|||
128825469|NCT03150862|463659261|FG001|Overall Study|Sponsor's decision|0|||
128825470|NCT03150862|463659262|FG002|Overall Study|Sponsor's decision|0|||
128825471|NCT03150862|463659263|FG003|Overall Study|Sponsor's decision|10|||
128825472|NCT03150862|463659264|FG004|Overall Study|Sponsor's decision|3|||
128825473|NCT03150862|463659265|FG005|Overall Study|Sponsor's decision|0|||
128825474|NCT03150862|463659266|FG006|Overall Study|Sponsor's decision|1|||
128825475|NCT03150862|463659267|FG007|Overall Study|Sponsor's decision|1|||
128825476|NCT03150862|463659260|FG000|Overall Study|Change in Methylation status|0|||
128825477|NCT03150862|463659261|FG001|Overall Study|Change in Methylation status|0|||
128825478|NCT03150862|463659262|FG002|Overall Study|Change in Methylation status|0|||
128825479|NCT03150862|463659263|FG003|Overall Study|Change in Methylation status|0|||
128825480|NCT03150862|463659264|FG004|Overall Study|Change in Methylation status|1|||
128825481|NCT03150862|463659265|FG005|Overall Study|Change in Methylation status|0|||
128825482|NCT03150862|463659266|FG006|Overall Study|Change in Methylation status|0|||
128825483|NCT03150862|463659267|FG007|Overall Study|Change in Methylation status|0|||
128825484|NCT03150862|463659260|FG000|Overall Study|Roll over in to Long Term Extension|0|||
128825485|NCT03150862|463659261|FG001|Overall Study|Roll over in to Long Term Extension|0|||
128825486|NCT03150862|463659262|FG002|Overall Study|Roll over in to Long Term Extension|0|||
128825487|NCT03150862|463659263|FG003|Overall Study|Roll over in to Long Term Extension|0|||
128825488|NCT03150862|463659264|FG004|Overall Study|Roll over in to Long Term Extension|0|||
128825489|NCT03150862|463659265|FG005|Overall Study|Roll over in to Long Term Extension|0|||
128825490|NCT03150862|463659266|FG006|Overall Study|Roll over in to Long Term Extension|0|||
128825491|NCT03150862|463659267|FG007|Overall Study|Roll over in to Long Term Extension|1|||
128825492|NCT03150862|463659260|FG000|Overall Study|Progressive Disease|0|||
128825493|NCT03150862|463659261|FG001|Overall Study|Progressive Disease|0|||
128825494|NCT03150862|463659262|FG002|Overall Study|Progressive Disease|0|||
128825495|NCT03150862|463659263|FG003|Overall Study|Progressive Disease|0|||
128825496|NCT03150862|463659264|FG004|Overall Study|Progressive Disease|0|||
128825497|NCT03150862|463659265|FG005|Overall Study|Progressive Disease|0|||
128825498|NCT03150862|463659266|FG006|Overall Study|Progressive Disease|0|||
128825499|NCT03150862|463659267|FG007|Overall Study|Progressive Disease|2|||
128825500|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
128825501|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
128825502|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
128825503|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
128825504|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
128825505|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
128825506|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
128825507|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
128825508|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
128825509|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
128825510|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
128825511|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
128825512|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
128825513|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
128825514|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
128825515|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
128825516|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
128825517|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
128825518|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
128825519|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
128825520|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
128825521|NCT04505722|463659269|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
128825522|NCT04505722|463659270|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
128825523|NCT04505722|463659271|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
128825524|NCT04505722|463659269|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
128825525|NCT04505722|463659270|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
128825526|NCT04505722|463659271|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
128825527|NCT04505722|463659269|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
128825528|NCT04505722|463659270|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
128825529|NCT04505722|463659271|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
128825530|NCT04505722|463659269|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
128825531|NCT04505722|463659270|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
128825532|NCT04505722|463659271|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
128825533|NCT04505722|463659269|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
128825534|NCT04505722|463659270|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
128825535|NCT04505722|463659271|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
128825536|NCT04505722|463659269|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
128825537|NCT04505722|463659270|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
128825538|NCT04505722|463659271|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
128825539|NCT04505722|463659269|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
128825540|NCT04505722|463659270|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
128825541|NCT04505722|463659271|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
128825542|NCT04505722|463659269|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
128825543|NCT04505722|463659270|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
128825544|NCT04505722|463659271|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
128825545|NCT04755595|463659272|FG000|Overall Study|Lost to Follow-up|1|||
128825546|NCT00319696|463659273|FG000|Overall Study|Adverse Event|36|||
128825547|NCT00319696|463659273|FG000|Overall Study|withdrawal of consent|14|||
128825548|NCT00319696|463659273|FG000|Overall Study|administrative|7|||
128825549|NCT00319696|463659273|FG000|Overall Study|Lost to Follow-up|3|||
128825550|NCT03891758|463659275|FG000|Overall Study|Adverse Event|2|||
128825551|NCT03891758|463659276|FG001|Overall Study|Adverse Event|0|||
128825552|NCT03891758|463659275|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128825553|NCT03891758|463659276|FG001|Overall Study|Withdrawal by parent/guardian|2|||
128825554|NCT05039021|463659680|FG000|Overall Study|Death|1|||
128825555|NCT05039021|463659680|FG000|Overall Study|Lost to Follow-up|3|||
128825556|NCT02422615|463659681|FG000|Treatment Period|Progressive disease|314|||
128825557|NCT02422615|463659682|FG001|Treatment Period|Progressive disease|200|||
128825558|NCT02422615|463659681|FG000|Treatment Period|Adverse Event|51|||
128825559|NCT02422615|463659682|FG001|Treatment Period|Adverse Event|9|||
128825560|NCT02422615|463659681|FG000|Treatment Period|Physician Decision|32|||
128825561|NCT02422615|463659682|FG001|Treatment Period|Physician Decision|8|||
128825562|NCT02422615|463659681|FG000|Treatment Period|Subject/guardian decision|38|||
128825563|NCT02422615|463659682|FG001|Treatment Period|Subject/guardian decision|8|||
128825564|NCT02422615|463659681|FG000|Treatment Period|Death|2|||
128825565|NCT02422615|463659682|FG001|Treatment Period|Death|1|||
128825566|NCT02422615|463659681|FG000|Treatment Period|Technical problems|0|||
128825567|NCT02422615|463659682|FG001|Treatment Period|Technical problems|1|||
128825568|NCT02422615|463659681|FG000|Treatment Period|Protocol deviation|1|||
128825569|NCT02422615|463659682|FG001|Treatment Period|Protocol deviation|1|||
128825570|NCT02422615|463659681|FG000|Treatment Period|Study terminated as per protocol|46|||
128825571|NCT02422615|463659682|FG001|Treatment Period|Study terminated as per protocol|14|||
128825572|NCT02422615|463659681|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
128825573|NCT02422615|463659682|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128825574|NCT02422615|463659681|FG000|Post-treatment Efficacy Follow-up|Death|2|||
128825575|NCT02422615|463659682|FG001|Post-treatment Efficacy Follow-up|Death|1|||
128825576|NCT02422615|463659681|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
128825577|NCT02422615|463659682|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
128825578|NCT02422615|463659681|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
128825579|NCT02422615|463659682|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
128825580|NCT02422615|463659681|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
128825581|NCT02422615|463659682|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
128825582|NCT02422615|463659681|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
128825583|NCT02422615|463659682|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
128825584|NCT01639131|463659683|FG000|Overall Study|Disease Progression|6|||
128825585|NCT03653364|463659685|FG000|Overall Study|Withdrawal by Subject|1|||
128825586|NCT03653364|463659685|FG000|Overall Study|Enrolled in Error|1|||
128825587|NCT03653364|463659685|FG000|Overall Study|Death|1|||
128825588|NCT00087685|463659686|FG000|Overall Study|Adverse Event|5|||
128825589|NCT00087685|463659686|FG000|Overall Study|Non-Compliance|1|||
128825590|NCT00087685|463659686|FG000|Overall Study|Progressive Disease|5|||
128825591|NCT00087685|463659686|FG000|Overall Study|Withdrawal by Subject|3|||
128825592|NCT03213457|463659687|FG000|Screening Period|Withdrawal by Subject|0|||
128825593|NCT03213457|463659688|FG001|Screening Period|Withdrawal by Subject|1|||
128825594|NCT03213457|463659689|FG002|Screening Period|Withdrawal by Subject|0|||
128825595|NCT03213457|463659687|FG000|Screening Period|Other|1|||
128825596|NCT03213457|463659688|FG001|Screening Period|Other|0|||
128825597|NCT03213457|463659689|FG002|Screening Period|Other|0|||
128825598|NCT03213457|463659687|FG000|Double-Blind Period|Adverse Event|3|||
128825599|NCT03213457|463659688|FG001|Double-Blind Period|Adverse Event|2|||
128825600|NCT03213457|463659689|FG002|Double-Blind Period|Adverse Event|7|||
128825601|NCT03213457|463659687|FG000|Double-Blind Period|Withdrawal by Subject|14|||
128825602|NCT03213457|463659688|FG001|Double-Blind Period|Withdrawal by Subject|2|||
128825603|NCT03213457|463659689|FG002|Double-Blind Period|Withdrawal by Subject|14|||
128825604|NCT03213457|463659687|FG000|Double-Blind Period|Lost to Follow-up|2|||
128825605|NCT03213457|463659688|FG001|Double-Blind Period|Lost to Follow-up|3|||
128825606|NCT03213457|463659689|FG002|Double-Blind Period|Lost to Follow-up|9|||
128825607|NCT03213457|463659687|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
128825608|NCT03213457|463659688|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
128825609|NCT03213457|463659689|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
128825610|NCT03213457|463659687|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
128825611|NCT03213457|463659688|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
128825612|NCT03213457|463659689|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
128825613|NCT03213457|463659687|FG000|Double-Blind Period|Pregnancy|5|||
128825614|NCT03213457|463659688|FG001|Double-Blind Period|Pregnancy|0|||
128825615|NCT03213457|463659689|FG002|Double-Blind Period|Pregnancy|0|||
128825616|NCT03213457|463659687|FG000|Double-Blind Period|Other|10|||
128825617|NCT03213457|463659688|FG001|Double-Blind Period|Other|3|||
128825618|NCT03213457|463659689|FG002|Double-Blind Period|Other|17|||
128825619|NCT03213457|463659687|FG000|Open-Label Period|Adverse Event|1|||
128825620|NCT03213457|463659688|FG001|Open-Label Period|Adverse Event|2|||
128825621|NCT03213457|463659689|FG002|Open-Label Period|Adverse Event|2|||
128825622|NCT03213457|463659687|FG000|Open-Label Period|Withdrawal by Subject|12|||
128825623|NCT03213457|463659688|FG001|Open-Label Period|Withdrawal by Subject|5|||
128825624|NCT03213457|463659689|FG002|Open-Label Period|Withdrawal by Subject|24|||
128825625|NCT03213457|463659687|FG000|Open-Label Period|Lost to Follow-up|1|||
128825626|NCT03213457|463659688|FG001|Open-Label Period|Lost to Follow-up|2|||
128825627|NCT03213457|463659689|FG002|Open-Label Period|Lost to Follow-up|8|||
128825628|NCT03213457|463659687|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
128825629|NCT03213457|463659688|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
128825630|NCT03213457|463659689|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
128825631|NCT03213457|463659687|FG000|Open-Label Period|Non-compliance with study procedures|1|||
128825632|NCT03213457|463659688|FG001|Open-Label Period|Non-compliance with study procedures|1|||
128825633|NCT03213457|463659689|FG002|Open-Label Period|Non-compliance with study procedures|2|||
128825634|NCT03213457|463659687|FG000|Open-Label Period|Exclusionary medications|0|||
128825635|NCT03213457|463659688|FG001|Open-Label Period|Exclusionary medications|0|||
128825636|NCT03213457|463659689|FG002|Open-Label Period|Exclusionary medications|1|||
128825637|NCT03213457|463659687|FG000|Open-Label Period|Other|1|||
128825638|NCT03213457|463659688|FG001|Open-Label Period|Other|1|||
128825639|NCT03213457|463659689|FG002|Open-Label Period|Other|6|||
128825640|NCT03213457|463659687|FG000|Follow-Up Period|Adverse Event|16|||
128825641|NCT03213457|463659688|FG001|Follow-Up Period|Adverse Event|8|||
128825642|NCT03213457|463659689|FG002|Follow-Up Period|Adverse Event|37|||
128825643|NCT03213457|463659687|FG000|Follow-Up Period|Withdrawal by Subject|18|||
128825644|NCT03213457|463659688|FG001|Follow-Up Period|Withdrawal by Subject|11|||
128825645|NCT03213457|463659689|FG002|Follow-Up Period|Withdrawal by Subject|55|||
128825646|NCT03213457|463659687|FG000|Follow-Up Period|Lost to Follow-up|28|||
128825647|NCT03213457|463659688|FG001|Follow-Up Period|Lost to Follow-up|15|||
128825648|NCT03213457|463659689|FG002|Follow-Up Period|Lost to Follow-up|50|||
128825649|NCT03213457|463659687|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
128825650|NCT03213457|463659688|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
128825651|NCT03213457|463659689|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
128825652|NCT03213457|463659687|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
128825653|NCT03213457|463659688|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
128825654|NCT03213457|463659689|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
128825655|NCT03213457|463659687|FG000|Follow-Up Period|Pregnancy|7|||
128825656|NCT03213457|463659688|FG001|Follow-Up Period|Pregnancy|0|||
128825657|NCT03213457|463659689|FG002|Follow-Up Period|Pregnancy|18|||
128825658|NCT03213457|463659687|FG000|Follow-Up Period|Exclusionary medications|1|||
128825659|NCT03213457|463659688|FG001|Follow-Up Period|Exclusionary medications|1|||
128825660|NCT03213457|463659689|FG002|Follow-Up Period|Exclusionary medications|5|||
128825661|NCT03213457|463659687|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
128825662|NCT03213457|463659688|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
128825663|NCT03213457|463659689|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
128825664|NCT03213457|463659687|FG000|Follow-Up Period|Other|14|||
128825665|NCT03213457|463659688|FG001|Follow-Up Period|Other|10|||
128825666|NCT03213457|463659689|FG002|Follow-Up Period|Other|31|||
128825667|NCT05934292|463659690|FG000|Overall Study|Lost to Follow-up|0|||
128825668|NCT05934292|463659691|FG001|Overall Study|Lost to Follow-up|0|||
128825669|NCT05934292|463659692|FG002|Overall Study|Lost to Follow-up|1|||
128825670|NCT05934292|463659693|FG003|Overall Study|Lost to Follow-up|0|||
128825671|NCT04479787|463659694|FG000|Through 6 Months|Withdrawal by Subject|16|||
128825672|NCT04479787|463659695|FG001|Through 6 Months|Withdrawal by Subject|14|||
128825673|NCT04479787|463659694|FG000|Through 6 Months|Unsuccessful Trial|17|||
128825674|NCT04479787|463659695|FG001|Through 6 Months|Unsuccessful Trial|0|||
128825675|NCT04479787|463659694|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
128825676|NCT04479787|463659695|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
128825677|NCT04479787|463659694|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
128825678|NCT04479787|463659695|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
128825679|NCT04479787|463659694|FG000|Through 6 Months|Lost to Follow-up|3|||
128825680|NCT04479787|463659695|FG001|Through 6 Months|Lost to Follow-up|2|||
128825681|NCT04479787|463659694|FG000|Through 6 Months|Death|3|||
128825682|NCT04479787|463659695|FG001|Through 6 Months|Death|0|||
128825683|NCT04479787|463659694|FG000|Through 6 Months|Inclusion/Exclusion|2|||
128825684|NCT04479787|463659695|FG001|Through 6 Months|Inclusion/Exclusion|1|||
128825685|NCT04479787|463659694|FG000|Through 6 Months|Subject Became Pregnant|1|||
128825686|NCT04479787|463659695|FG001|Through 6 Months|Subject Became Pregnant|1|||
128825687|NCT04479787|463659694|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
128825688|NCT04479787|463659695|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
128825689|NCT04479787|463659694|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
128825690|NCT04479787|463659695|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
128825691|NCT04479787|463659694|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
128825692|NCT04479787|463659695|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
128825693|NCT04479787|463659694|FG000|After 6 Months|Withdrawal by Subject|3|||
128870723|NCT00338962|463820702|FG001|Overall Study|Lost to Follow-up|3|||
128825694|NCT04479787|463659695|FG001|After 6 Months|Withdrawal by Subject|13|||
128825695|NCT04479787|463659694|FG000|After 6 Months|Unsuccessful Trial|0|||
128825696|NCT04479787|463659695|FG001|After 6 Months|Unsuccessful Trial|7|||
128825697|NCT04479787|463659694|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
128825698|NCT04479787|463659695|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
128825699|NCT04479787|463659694|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
128825700|NCT04479787|463659695|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
128825701|NCT04479787|463659694|FG000|After 6 Months|Death|2|||
128825702|NCT04479787|463659695|FG001|After 6 Months|Death|0|||
128825703|NCT04479787|463659694|FG000|After 6 Months|Lost to Follow-up|1|||
128825704|NCT04479787|463659695|FG001|After 6 Months|Lost to Follow-up|1|||
128825705|NCT04479787|463659694|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
128825706|NCT04479787|463659695|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
128825707|NCT04479787|463659694|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
128825708|NCT04479787|463659695|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
128825709|NCT04479787|463659694|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
128825710|NCT04479787|463659695|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
128825711|NCT04479787|463659694|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
128825712|NCT04479787|463659695|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
128825713|NCT04899674|463659696|FG000|Test|Adverse Event|1|||
128825714|NCT03774472|463659697|FG000|Overall Study|Physician Decision|1|||
128825715|NCT03774472|463659698|FG001|Overall Study|Physician Decision|0|||
128825716|NCT03774472|463659699|FG002|Overall Study|Physician Decision|0|||
128825717|NCT03774472|463659697|FG000|Overall Study|Progression prior to 4 weeks|0|||
128825718|NCT03774472|463659698|FG001|Overall Study|Progression prior to 4 weeks|1|||
128825719|NCT03774472|463659699|FG002|Overall Study|Progression prior to 4 weeks|0|||
128825720|NCT03774472|463659697|FG000|Overall Study|Withdrawal by Subject|0|||
128825721|NCT03774472|463659698|FG001|Overall Study|Withdrawal by Subject|1|||
128825722|NCT03774472|463659699|FG002|Overall Study|Withdrawal by Subject|0|||
128825723|NCT04059406|463659700|FG000|Overall Study|Early Treatment Termination|5|||
128825724|NCT04059406|463659701|FG001|Overall Study|Early Treatment Termination|5|||
128825725|NCT04059406|463659702|FG002|Overall Study|Early Treatment Termination|15|||
128825726|NCT05155306|463659703|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
128825727|NCT05155306|463659704|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
128825728|NCT05155306|463659705|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
128825729|NCT05155306|463659706|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
128825730|NCT05155306|463659703|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
128825731|NCT05155306|463659704|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
128825732|NCT05155306|463659705|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
128825733|NCT05155306|463659706|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
128825734|NCT05601882|463659709|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
128825735|NCT05601882|463659710|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
128825736|NCT05601882|463659711|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
128825737|NCT05601882|463659712|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
128825738|NCT05601882|463659709|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
128825739|NCT05601882|463659710|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
128825740|NCT05601882|463659711|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
128825741|NCT05601882|463659712|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
128825742|NCT05601882|463659709|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
128825743|NCT05601882|463659710|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
128825744|NCT05601882|463659711|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
128825745|NCT05601882|463659712|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
128825746|NCT05601882|463659709|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
128825747|NCT05601882|463659710|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
128825748|NCT05601882|463659711|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
128825749|NCT05601882|463659712|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
128825750|NCT05601882|463659709|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
128825751|NCT05601882|463659710|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
128825752|NCT05601882|463659711|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
128825753|NCT05601882|463659712|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
128825754|NCT05601882|463659709|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
128825755|NCT05601882|463659710|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
128825756|NCT05601882|463659711|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
128825757|NCT05601882|463659712|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
128825758|NCT04158141|463659713|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
128825759|NCT04158141|463659714|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
128825760|NCT04158141|463659715|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
128825761|NCT04158141|463659713|FG000|Step 1: Registration|Adverse Event|1|||
128825762|NCT04158141|463659714|FG001|Step 1: Registration|Adverse Event|0|||
128825763|NCT04158141|463659715|FG002|Step 1: Registration|Adverse Event|0|||
128825764|NCT04158141|463659713|FG000|Step 1: Registration|Withdrawal by Subject|1|||
128825765|NCT04158141|463659714|FG001|Step 1: Registration|Withdrawal by Subject|0|||
128825766|NCT04158141|463659715|FG002|Step 1: Registration|Withdrawal by Subject|0|||
128825767|NCT04158141|463659713|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
128825768|NCT04158141|463659714|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
128825769|NCT04158141|463659715|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
128825770|NCT04977583|463660431|FG000|Overall Study|Lost to Follow-up|8|||
128825771|NCT04977583|463660432|FG001|Overall Study|Lost to Follow-up|4|||
128825772|NCT04977583|463660433|FG002|Overall Study|Lost to Follow-up|13|||
128825773|NCT04977583|463660431|FG000|Overall Study|Withdrawal by Subject|3|||
128825774|NCT04977583|463660432|FG001|Overall Study|Withdrawal by Subject|2|||
128825775|NCT04977583|463660433|FG002|Overall Study|Withdrawal by Subject|1|||
128825776|NCT00686595|463660439|FG000|Overall Study|Adverse Event|3|||
128825777|NCT00686595|463660439|FG000|Overall Study|Protocol Violation|1|||
128825778|NCT00686595|463660439|FG000|Overall Study|Lost to Follow-up|1|||
128825779|NCT00686595|463660439|FG000|Overall Study|Lack of Efficacy|1|||
128825780|NCT00686595|463660439|FG000|Overall Study|Poor Compliance|1|||
128825781|NCT06688357|463660452|FG000|Overall Study|Adverse Event|0|||
128825782|NCT06688357|463660453|FG001|Overall Study|Adverse Event|1|||
128825783|NCT04121741|463660454|FG000|Overall Study|Protocol Violation|1|||
128825784|NCT04121741|463660455|FG001|Overall Study|Protocol Violation|0|||
128825785|NCT04121741|463660456|FG002|Overall Study|Protocol Violation|0|||
128825786|NCT04121741|463660457|FG003|Overall Study|Protocol Violation|0|||
128825787|NCT04121741|463660458|FG004|Overall Study|Protocol Violation|0|||
128825788|NCT04121741|463660459|FG005|Overall Study|Protocol Violation|0|||
128825789|NCT03473223|463660460|FG000|Overall Study|Lost to Follow-up|1|||
128825790|NCT03473223|463660461|FG001|Overall Study|Lost to Follow-up|1|||
128825791|NCT03473223|463660460|FG000|Overall Study|Withdrawal by Subject|47|||
128825792|NCT03473223|463660461|FG001|Overall Study|Withdrawal by Subject|42|||
128825793|NCT03473223|463660460|FG000|Overall Study|Indirect contact|32|||
128825794|NCT03473223|463660461|FG001|Overall Study|Indirect contact|29|||
128825795|NCT03473223|463660460|FG000|Overall Study|Other (Not specified)|32|||
128825796|NCT03473223|463660461|FG001|Overall Study|Other (Not specified)|20|||
128825797|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
128825798|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
128825799|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
128825800|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
128825801|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
128825802|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
128825803|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
128825804|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
128825805|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
128825806|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
128825807|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
128825808|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
128825809|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
128825810|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
128825811|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
128825812|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
128825813|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
128825814|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
128825815|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
128825816|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
128825817|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
128825818|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
128825819|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
128825820|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
128825821|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
128825822|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
128825823|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
128825824|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
128825825|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
128825826|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
128825827|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
128825828|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
128825829|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
128825830|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
128825831|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
128870724|NCT00338962|463820703|FG002|Overall Study|Lost to Follow-up|2|||
128825832|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
128825833|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
128825834|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
128825835|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
128825836|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
128825837|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
128825838|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
128825839|NCT03524092|463660462|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
128825840|NCT03524092|463660463|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
128825841|NCT03524092|463660464|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
128825842|NCT03524092|463660465|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
128825843|NCT03524092|463660466|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
128825844|NCT03524092|463660467|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
128825845|NCT03524092|463660462|FG000|Loss of Response Rescue Period|Adverse Event|0|||
128825846|NCT03524092|463660463|FG001|Loss of Response Rescue Period|Adverse Event|0|||
128825847|NCT03524092|463660464|FG002|Loss of Response Rescue Period|Adverse Event|0|||
128825848|NCT03524092|463660465|FG003|Loss of Response Rescue Period|Adverse Event|2|||
128825849|NCT03524092|463660466|FG004|Loss of Response Rescue Period|Adverse Event|0|||
128825850|NCT03524092|463660467|FG005|Loss of Response Rescue Period|Adverse Event|0|||
128825851|NCT03524092|463660462|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
128825852|NCT03524092|463660463|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
128825853|NCT03524092|463660464|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
128825854|NCT03524092|463660465|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
128825855|NCT03524092|463660466|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
128825856|NCT03524092|463660467|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
128825857|NCT03524092|463660462|FG000|Loss of Response Rescue Period|Pregnancy|0|||
128825858|NCT03524092|463660463|FG001|Loss of Response Rescue Period|Pregnancy|0|||
128825859|NCT03524092|463660464|FG002|Loss of Response Rescue Period|Pregnancy|0|||
128825860|NCT03524092|463660465|FG003|Loss of Response Rescue Period|Pregnancy|1|||
128825861|NCT03524092|463660466|FG004|Loss of Response Rescue Period|Pregnancy|0|||
128825862|NCT03524092|463660467|FG005|Loss of Response Rescue Period|Pregnancy|0|||
128825863|NCT03524092|463660462|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
128825864|NCT03524092|463660463|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
128825865|NCT03524092|463660464|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
128825866|NCT03524092|463660465|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
128825867|NCT03524092|463660466|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
128825868|NCT03524092|463660467|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
128825869|NCT03524092|463660462|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
128825870|NCT03524092|463660463|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
128825871|NCT03524092|463660464|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
128825872|NCT03524092|463660465|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
128825873|NCT03524092|463660466|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
128825874|NCT03524092|463660467|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
128825875|NCT03524092|463660462|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
128825876|NCT03524092|463660463|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
128825877|NCT03524092|463660464|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
128825878|NCT03524092|463660465|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
128825879|NCT03524092|463660466|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
128825880|NCT03524092|463660467|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
128825881|NCT03524092|463660462|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
128825882|NCT03524092|463660463|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
128825883|NCT03524092|463660464|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
128825884|NCT03524092|463660465|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
128825885|NCT03524092|463660466|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
128825886|NCT03524092|463660467|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
128825887|NCT03524092|463660462|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
128825888|NCT03524092|463660463|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
128825889|NCT03524092|463660464|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
128825890|NCT03524092|463660465|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
128825891|NCT03524092|463660466|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
128825892|NCT03524092|463660467|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
128825893|NCT03524092|463660462|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
128825894|NCT03524092|463660463|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
128825895|NCT03524092|463660464|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
128825896|NCT03524092|463660465|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
128825897|NCT03524092|463660466|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
128825898|NCT03524092|463660467|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
128825899|NCT03524092|463660462|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
128825900|NCT03524092|463660463|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
128825901|NCT03524092|463660464|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
128825902|NCT03524092|463660465|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
128825903|NCT03524092|463660466|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
128825904|NCT03524092|463660467|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
128825905|NCT03524092|463660462|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
128825906|NCT03524092|463660463|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
128825907|NCT03524092|463660464|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
128825908|NCT03524092|463660465|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
128825909|NCT03524092|463660466|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
128825910|NCT03524092|463660467|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
128825911|NCT03524092|463660462|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
128825912|NCT03524092|463660463|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
128825913|NCT03524092|463660464|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
128825914|NCT03524092|463660465|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
128825915|NCT03524092|463660466|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
128825916|NCT03524092|463660467|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
128825917|NCT03524092|463660462|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
128825918|NCT03524092|463660463|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
128825919|NCT03524092|463660464|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
128825920|NCT03524092|463660465|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
128825921|NCT03524092|463660466|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
128825922|NCT03524092|463660467|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
128825923|NCT03524092|463660462|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
128825924|NCT03524092|463660463|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
128825925|NCT03524092|463660464|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
128825926|NCT03524092|463660465|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
128825927|NCT03524092|463660466|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
128825928|NCT03524092|463660467|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
128825929|NCT03524092|463660462|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
128825930|NCT03524092|463660463|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
128825931|NCT03524092|463660464|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
128825932|NCT03524092|463660465|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
128825933|NCT03524092|463660466|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
128825934|NCT03524092|463660467|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
128825935|NCT03834740|463660468|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
128825936|NCT03834740|463660469|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
128825937|NCT03834740|463660470|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
128825938|NCT03275285|463660473|FG000|Overall Study|Ongoing|45|||
128825939|NCT03275285|463660474|FG001|Overall Study|Ongoing|69|||
128825940|NCT06191679|463660475|FG000|Baseline|Lost to Follow-up|1|||
128825941|NCT06191679|463660476|FG001|Baseline|Lost to Follow-up|0|||
128825942|NCT06191679|463660477|FG002|Baseline|Lost to Follow-up|1|||
128825943|NCT06191679|463660478|FG003|Baseline|Lost to Follow-up|0|||
128825944|NCT06191679|463660475|FG000|Allocation to Group|Withdrawal by Subject|0|||
128825945|NCT06191679|463660476|FG001|Allocation to Group|Withdrawal by Subject|1|||
128825946|NCT06191679|463660477|FG002|Allocation to Group|Withdrawal by Subject|2|||
128825947|NCT06191679|463660478|FG003|Allocation to Group|Withdrawal by Subject|0|||
128825948|NCT06191679|463660475|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
128825949|NCT06191679|463660476|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
128825950|NCT06191679|463660477|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
128825951|NCT06191679|463660478|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
128825952|NCT06191679|463660475|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
128825953|NCT06191679|463660476|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
128825954|NCT06191679|463660477|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
128825955|NCT06191679|463660478|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
128825956|NCT06191679|463660475|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
128825957|NCT06191679|463660476|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
128825958|NCT06191679|463660477|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
128825959|NCT06191679|463660478|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
128825960|NCT00115934|463660479|FG000|Overall Study|Lost to Follow-up|1|||
128825961|NCT00115934|463660480|FG001|Overall Study|Lost to Follow-up|0|||
128825962|NCT00115934|463660479|FG000|Overall Study|Did not receive intervention|3|||
128825963|NCT00115934|463660480|FG001|Overall Study|Did not receive intervention|2|||
128825964|NCT05827068|463660481|FG000|Overall Study|Lost to Follow-up|1|||
128825965|NCT05827068|463660482|FG001|Overall Study|Lost to Follow-up|4|||
128825966|NCT05827068|463660483|FG002|Overall Study|Lost to Follow-up|1|||
128825967|NCT05827068|463660484|FG003|Overall Study|Lost to Follow-up|1|||
128825968|NCT05827068|463660485|FG004|Overall Study|Lost to Follow-up|2|||
128825969|NCT05827068|463660486|FG005|Overall Study|Lost to Follow-up|4|||
128825970|NCT05827068|463660487|FG006|Overall Study|Lost to Follow-up|1|||
128825971|NCT05827068|463660481|FG000|Overall Study|Withdrawal by Subject|4|||
128825972|NCT05827068|463660482|FG001|Overall Study|Withdrawal by Subject|0|||
128825973|NCT05827068|463660483|FG002|Overall Study|Withdrawal by Subject|1|||
128825974|NCT05827068|463660484|FG003|Overall Study|Withdrawal by Subject|2|||
128825975|NCT05827068|463660485|FG004|Overall Study|Withdrawal by Subject|3|||
128825976|NCT05827068|463660486|FG005|Overall Study|Withdrawal by Subject|0|||
128825977|NCT05827068|463660487|FG006|Overall Study|Withdrawal by Subject|1|||
128825978|NCT05827068|463660481|FG000|Overall Study|Physician Decision|0|||
128825979|NCT05827068|463660482|FG001|Overall Study|Physician Decision|0|||
128825980|NCT05827068|463660483|FG002|Overall Study|Physician Decision|0|||
128825981|NCT05827068|463660484|FG003|Overall Study|Physician Decision|0|||
128825982|NCT05827068|463660485|FG004|Overall Study|Physician Decision|1|||
128825983|NCT05827068|463660486|FG005|Overall Study|Physician Decision|0|||
128825984|NCT05827068|463660487|FG006|Overall Study|Physician Decision|1|||
128825985|NCT05827068|463660481|FG000|Overall Study|Other Than Specified|0|||
128825986|NCT05827068|463660482|FG001|Overall Study|Other Than Specified|1|||
128825987|NCT05827068|463660483|FG002|Overall Study|Other Than Specified|0|||
128825988|NCT05827068|463660484|FG003|Overall Study|Other Than Specified|0|||
128825989|NCT05827068|463660485|FG004|Overall Study|Other Than Specified|0|||
128825990|NCT05827068|463660486|FG005|Overall Study|Other Than Specified|0|||
128825991|NCT05827068|463660487|FG006|Overall Study|Other Than Specified|0|||
128825992|NCT03867201|463660488|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
128825993|NCT03867201|463660489|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
128825994|NCT03867201|463660488|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
128825995|NCT03867201|463660489|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
128825996|NCT03867201|463660488|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
128825997|NCT03867201|463660489|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
128825998|NCT03867201|463660488|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
128825999|NCT03867201|463660489|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
128826000|NCT03867201|463660488|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
128826001|NCT03867201|463660489|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
128826002|NCT03867201|463660488|FG000|Open-Label Period From Week 12|Adverse Event|5|||
128826003|NCT03867201|463660489|FG001|Open-Label Period From Week 12|Adverse Event|11|||
128826004|NCT03867201|463660488|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
128826005|NCT03867201|463660489|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
128826006|NCT03867201|463660488|FG000|Open-Label Period From Week 12|Physician Decision|6|||
128826007|NCT03867201|463660489|FG001|Open-Label Period From Week 12|Physician Decision|3|||
128826008|NCT03867201|463660488|FG000|Open-Label Period From Week 12|Pregnancy|2|||
128826009|NCT03867201|463660489|FG001|Open-Label Period From Week 12|Pregnancy|2|||
128826010|NCT03867201|463660488|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
128826011|NCT03867201|463660489|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
128826012|NCT03867201|463660488|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
128826013|NCT03867201|463660489|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
128826014|NCT03867201|463660488|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
128826015|NCT03867201|463660489|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
128826016|NCT03867201|463660488|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
128826017|NCT03867201|463660489|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
128826018|NCT00353496|463660492|FG000|Overall Study|Adverse Event|1|||
128826019|NCT00353496|463660493|FG001|Overall Study|Adverse Event|0|||
128826020|NCT00353496|463660492|FG000|Overall Study|Protocol Violation|2|||
128826021|NCT00353496|463660493|FG001|Overall Study|Protocol Violation|2|||
128826022|NCT00353496|463660492|FG000|Overall Study|Withdrawal by Subject|3|||
128826023|NCT00353496|463660493|FG001|Overall Study|Withdrawal by Subject|4|||
128826024|NCT00353496|463660492|FG000|Overall Study|Physician Decision|6|||
128826025|NCT00353496|463660493|FG001|Overall Study|Physician Decision|9|||
128826026|NCT00353496|463660492|FG000|Overall Study|Not otherwise specified|4|||
128826027|NCT00353496|463660493|FG001|Overall Study|Not otherwise specified|2|||
128826028|NCT03997474|463660494|FG000|Overall Study|Death|6|||
128826029|NCT03997474|463660495|FG001|Overall Study|Death|2|||
128826030|NCT03997474|463660496|FG002|Overall Study|Death|1|||
128826031|NCT03997474|463660494|FG000|Overall Study|Physician Decision|2|||
128826032|NCT03997474|463660495|FG001|Overall Study|Physician Decision|0|||
128826033|NCT03997474|463660496|FG002|Overall Study|Physician Decision|0|||
128826034|NCT03997474|463660494|FG000|Overall Study|study terminated by sponsor|1|||
128826035|NCT03997474|463660495|FG001|Overall Study|study terminated by sponsor|0|||
128826036|NCT03997474|463660496|FG002|Overall Study|study terminated by sponsor|1|||
128826037|NCT01470144|463660498|FG000|Overall Study|Adverse Event|2|||
128826038|NCT01470144|463660498|FG000|Overall Study|Death|1|||
128826039|NCT01470144|463660498|FG000|Overall Study|Lung transplant|6|||
128826040|NCT01470144|463660498|FG000|Overall Study|Patient's and investigator's decision|1|||
128826041|NCT02325466|463661160|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
128826042|NCT02325466|463661161|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
128826043|NCT02325466|463661162|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
128826044|NCT02325466|463661160|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
128826045|NCT02325466|463661161|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
128826046|NCT02325466|463661162|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
128826047|NCT02325466|463661160|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
128826048|NCT02325466|463661161|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
128826049|NCT02325466|463661162|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
128826050|NCT02325466|463661160|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
128826051|NCT02325466|463661161|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
128826052|NCT02325466|463661162|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
128826053|NCT02325466|463661160|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
128826054|NCT02325466|463661161|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
128826055|NCT02325466|463661162|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
128826056|NCT02325466|463661160|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
128826057|NCT02325466|463661161|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
128826058|NCT02325466|463661162|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
128826059|NCT02325466|463661160|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
128826060|NCT02325466|463661161|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
128826061|NCT02325466|463661162|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
128826062|NCT02325466|463661160|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
128826063|NCT02325466|463661161|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
128826064|NCT02325466|463661162|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
128826065|NCT02325466|463661160|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
128826066|NCT02325466|463661161|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
128826067|NCT02325466|463661162|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
128826068|NCT01596972|463661163|FG000|Overall Study|Physician Decision|1|||
128826069|NCT01596972|463661164|FG001|Overall Study|Physician Decision|9|||
128826070|NCT01596972|463661163|FG000|Overall Study|Lost to Follow-up|0|||
128826071|NCT01596972|463661164|FG001|Overall Study|Lost to Follow-up|4|||
128826072|NCT01596972|463661163|FG000|Overall Study|Withdrawal by Subject|0|||
128826073|NCT01596972|463661164|FG001|Overall Study|Withdrawal by Subject|1|||
128826074|NCT01105975|463661168|FG000|Overall Study|Adverse Event|2|||
128826075|NCT01105975|463661169|FG001|Overall Study|Adverse Event|1|||
128826076|NCT01105975|463661170|FG002|Overall Study|Adverse Event|5|||
128826077|NCT01105975|463661171|FG003|Overall Study|Adverse Event|1|||
128826078|NCT01105975|463661172|FG004|Overall Study|Adverse Event|0|||
128826079|NCT01105975|463661173|FG005|Overall Study|Adverse Event|1|||
128826080|NCT01105975|463661174|FG006|Overall Study|Adverse Event|2|||
128826081|NCT01105975|463661175|FG007|Overall Study|Adverse Event|4|||
128826082|NCT01105975|463661176|FG008|Overall Study|Adverse Event|1|||
128826083|NCT01105975|463661177|FG009|Overall Study|Adverse Event|4|||
128826084|NCT01105975|463661168|FG000|Overall Study|Withdrawal by Subject|2|||
128826085|NCT01105975|463661169|FG001|Overall Study|Withdrawal by Subject|2|||
128826086|NCT01105975|463661170|FG002|Overall Study|Withdrawal by Subject|2|||
128826087|NCT01105975|463661171|FG003|Overall Study|Withdrawal by Subject|0|||
128826088|NCT01105975|463661172|FG004|Overall Study|Withdrawal by Subject|4|||
128826089|NCT01105975|463661173|FG005|Overall Study|Withdrawal by Subject|1|||
128826090|NCT01105975|463661174|FG006|Overall Study|Withdrawal by Subject|2|||
128826091|NCT01105975|463661175|FG007|Overall Study|Withdrawal by Subject|1|||
128826092|NCT01105975|463661176|FG008|Overall Study|Withdrawal by Subject|0|||
128826093|NCT01105975|463661177|FG009|Overall Study|Withdrawal by Subject|3|||
128826094|NCT01105975|463661168|FG000|Overall Study|Lost to Follow-up|1|||
128826095|NCT01105975|463661169|FG001|Overall Study|Lost to Follow-up|0|||
128826096|NCT01105975|463661170|FG002|Overall Study|Lost to Follow-up|0|||
128826097|NCT01105975|463661171|FG003|Overall Study|Lost to Follow-up|1|||
128826098|NCT01105975|463661172|FG004|Overall Study|Lost to Follow-up|1|||
128826099|NCT01105975|463661173|FG005|Overall Study|Lost to Follow-up|0|||
128826100|NCT01105975|463661174|FG006|Overall Study|Lost to Follow-up|0|||
128826101|NCT01105975|463661175|FG007|Overall Study|Lost to Follow-up|0|||
128826102|NCT01105975|463661176|FG008|Overall Study|Lost to Follow-up|1|||
128826103|NCT01105975|463661177|FG009|Overall Study|Lost to Follow-up|0|||
128826104|NCT01105975|463661168|FG000|Overall Study|Physician Decision|0|||
128826105|NCT01105975|463661169|FG001|Overall Study|Physician Decision|0|||
128826106|NCT01105975|463661170|FG002|Overall Study|Physician Decision|0|||
128826107|NCT01105975|463661171|FG003|Overall Study|Physician Decision|0|||
128826108|NCT01105975|463661172|FG004|Overall Study|Physician Decision|0|||
128826109|NCT01105975|463661173|FG005|Overall Study|Physician Decision|0|||
128826110|NCT01105975|463661174|FG006|Overall Study|Physician Decision|2|||
128826111|NCT01105975|463661175|FG007|Overall Study|Physician Decision|0|||
128826112|NCT01105975|463661176|FG008|Overall Study|Physician Decision|0|||
128826113|NCT01105975|463661177|FG009|Overall Study|Physician Decision|0|||
128826114|NCT01105975|463661168|FG000|Overall Study|Protocol Violation|0|||
128826115|NCT01105975|463661169|FG001|Overall Study|Protocol Violation|2|||
128826116|NCT01105975|463661170|FG002|Overall Study|Protocol Violation|2|||
128826117|NCT01105975|463661171|FG003|Overall Study|Protocol Violation|0|||
128826118|NCT01105975|463661172|FG004|Overall Study|Protocol Violation|1|||
128826119|NCT01105975|463661173|FG005|Overall Study|Protocol Violation|1|||
128826120|NCT01105975|463661174|FG006|Overall Study|Protocol Violation|1|||
128826121|NCT01105975|463661175|FG007|Overall Study|Protocol Violation|1|||
128826122|NCT01105975|463661176|FG008|Overall Study|Protocol Violation|2|||
128826123|NCT01105975|463661177|FG009|Overall Study|Protocol Violation|2|||
128826124|NCT01105975|463661168|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
128826125|NCT01105975|463661169|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
128826126|NCT01105975|463661170|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
128826127|NCT01105975|463661171|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
128826128|NCT01105975|463661172|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
128826129|NCT01105975|463661173|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
128826130|NCT01105975|463661174|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
128826131|NCT01105975|463661175|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
128826132|NCT01105975|463661176|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
128826133|NCT01105975|463661177|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
128826134|NCT01260896|463661180|FG000|First Intervention|Withdrawn Due to Emesis|2|||
128826135|NCT01260896|463661181|FG001|First Intervention|Withdrawn Due to Emesis|0|||
128826136|NCT00312208|463661183|FG000|Overall Study|Adverse Event|97|||
128826137|NCT00312208|463661184|FG001|Overall Study|Adverse Event|61|||
128826138|NCT00312208|463661183|FG000|Overall Study|Protocol Violation|5|||
128826139|NCT00312208|463661184|FG001|Overall Study|Protocol Violation|3|||
128826140|NCT00312208|463661183|FG000|Overall Study|Death|2|||
128826141|NCT00312208|463661184|FG001|Overall Study|Death|1|||
128826142|NCT00312208|463661183|FG000|Overall Study|Lack of Efficacy|7|||
128826143|NCT00312208|463661184|FG001|Overall Study|Lack of Efficacy|4|||
128826144|NCT00312208|463661183|FG000|Overall Study|Lost to Follow-up|3|||
128826145|NCT00312208|463661184|FG001|Overall Study|Lost to Follow-up|5|||
128826146|NCT00312208|463661183|FG000|Overall Study|Withdrawal by Subject|53|||
128826147|NCT00312208|463661184|FG001|Overall Study|Withdrawal by Subject|42|||
128826148|NCT00312208|463661183|FG000|Overall Study|Other|5|||
128826149|NCT00312208|463661184|FG001|Overall Study|Other|7|||
128826150|NCT02284113|463661185|FG000|Overall Study|Adverse Event|1|||
128826151|NCT02284113|463661186|FG001|Overall Study|Adverse Event|0|||
128826152|NCT02284113|463661185|FG000|Overall Study|non-compliance|0|||
128826153|NCT02284113|463661186|FG001|Overall Study|non-compliance|1|||
128826154|NCT02284113|463661185|FG000|Overall Study|Withdrawal by Subject|0|||
128826155|NCT02284113|463661186|FG001|Overall Study|Withdrawal by Subject|1|||
128826156|NCT02284113|463661185|FG000|Overall Study|not provided|0|||
128826157|NCT02284113|463661186|FG001|Overall Study|not provided|1|||
128826158|NCT02284113|463661185|FG000|Overall Study|surgery cancelled|2|||
128826159|NCT02284113|463661186|FG001|Overall Study|surgery cancelled|0|||
128826160|NCT03885232|463661189|FG000|Overall Study|Lost to Follow-up|74|||
128826161|NCT03885232|463661190|FG001|Overall Study|Lost to Follow-up|32|||
128826162|NCT03885232|463661189|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
128826163|NCT03885232|463661190|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
128826164|NCT01315132|463661193|FG000|Overall Study|not treated due to disease progression|1|||
128826165|NCT03840902|463661196|FG000|Overall Study|Randomized but not treated|1|||
128826166|NCT03840902|463661197|FG001|Overall Study|Randomized but not treated|1|||
128826167|NCT03660930|463661198|FG000|Overall Study|Adverse Event|0|||
128826168|NCT03660930|463661199|FG001|Overall Study|Adverse Event|0|||
128826169|NCT03660930|463661200|FG002|Overall Study|Adverse Event|0|||
128826170|NCT03660930|463661201|FG003|Overall Study|Adverse Event|2|||
128826171|NCT03660930|463661202|FG004|Overall Study|Adverse Event|0|||
128826172|NCT03660930|463661203|FG005|Overall Study|Adverse Event|1|||
128826173|NCT03660930|463661204|FG006|Overall Study|Adverse Event|0|||
128826174|NCT03660930|463661205|FG007|Overall Study|Adverse Event|0|||
128826175|NCT03660930|463661198|FG000|Overall Study|Withdrawal by Subject|0|||
128826176|NCT03660930|463661199|FG001|Overall Study|Withdrawal by Subject|0|||
128826177|NCT03660930|463661200|FG002|Overall Study|Withdrawal by Subject|0|||
128826178|NCT03660930|463661201|FG003|Overall Study|Withdrawal by Subject|0|||
128826179|NCT03660930|463661202|FG004|Overall Study|Withdrawal by Subject|0|||
128826180|NCT03660930|463661203|FG005|Overall Study|Withdrawal by Subject|1|||
128826181|NCT03660930|463661204|FG006|Overall Study|Withdrawal by Subject|0|||
128826182|NCT03660930|463661205|FG007|Overall Study|Withdrawal by Subject|0|||
128826183|NCT05018143|463661208|FG000|Overall Study|Lost to Follow-up|5|||
128826184|NCT05018143|463661209|FG001|Overall Study|Lost to Follow-up|4|||
128826185|NCT05018143|463661208|FG000|Overall Study|Withdrawal by Subject|0|||
128826186|NCT05018143|463661209|FG001|Overall Study|Withdrawal by Subject|1|||
128826187|NCT04018495|463661210|FG000|Overall Study|Physician Decision|1|||
128826188|NCT01084863|463661213|FG000|Main Study Treatment Period|Disease progression|11|||
128826189|NCT01084863|463661214|FG001|Main Study Treatment Period|Disease progression|7|||
128826190|NCT01084863|463661213|FG000|Main Study Treatment Period|Adverse Event|5|||
128826191|NCT01084863|463661214|FG001|Main Study Treatment Period|Adverse Event|3|||
128826192|NCT01084863|463661213|FG000|Main Study Treatment Period|Other Reason|0|||
128826193|NCT01084863|463661214|FG001|Main Study Treatment Period|Other Reason|1|||
128826194|NCT01084863|463661213|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
128826195|NCT01084863|463661214|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
128826196|NCT01084863|463661213|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
128826197|NCT01084863|463661214|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
128826198|NCT01084863|463661213|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
128826199|NCT01084863|463661214|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
128826200|NCT01084863|463661213|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
128826201|NCT01084863|463661214|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
128826202|NCT01084863|463661213|FG000|Treatment Period Beyond Cycle 8|Other|0|||
128826203|NCT01084863|463661214|FG001|Treatment Period Beyond Cycle 8|Other|1|||
128826204|NCT01084863|463661213|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
128826205|NCT01084863|463661214|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
128826206|NCT02500576|463661217|FG000|Overall Study|Adverse Event|0|||
128826207|NCT02500576|463661218|FG001|Overall Study|Adverse Event|1|||
128826208|NCT02500576|463661217|FG000|Overall Study|Death|2|||
128826209|NCT02500576|463661218|FG001|Overall Study|Death|1|||
128826210|NCT02500576|463661217|FG000|Overall Study|Lack of Efficacy|5|||
128826211|NCT02500576|463661218|FG001|Overall Study|Lack of Efficacy|5|||
128826212|NCT02500576|463661217|FG000|Overall Study|Withdrawal by Subject|1|||
128826213|NCT02500576|463661218|FG001|Overall Study|Withdrawal by Subject|1|||
128826214|NCT03691493|463661224|FG000|Overall Study|Withdrawal by Subject|1|||
128826215|NCT01983683|463661225|FG000|Overall Study|Withdrawal by Subject|14|||
128826216|NCT01983683|463661226|FG001|Overall Study|Withdrawal by Subject|18|||
128826217|NCT01983683|463661225|FG000|Overall Study|Death|11|||
128826218|NCT01983683|463661226|FG001|Overall Study|Death|15|||
128826219|NCT01983683|463661225|FG000|Overall Study|Physician Decision|8|||
128826220|NCT01983683|463661226|FG001|Overall Study|Physician Decision|9|||
128826221|NCT01983683|463661225|FG000|Overall Study|Lost to Follow-up|4|||
128826222|NCT01983683|463661226|FG001|Overall Study|Lost to Follow-up|8|||
128826223|NCT01983683|463661225|FG000|Overall Study|Sponsor Decision|1|||
128826224|NCT01983683|463661226|FG001|Overall Study|Sponsor Decision|1|||
128826225|NCT04039113|463661233|FG000|Overall Study|Withdrawal by Subject|8|||
128826226|NCT04039113|463661234|FG001|Overall Study|Withdrawal by Subject|11|||
128826227|NCT04039113|463661233|FG000|Overall Study|Lost to Follow-up|1|||
128826228|NCT04039113|463661234|FG001|Overall Study|Lost to Follow-up|1|||
128826229|NCT04039113|463661233|FG000|Overall Study|Adverse Event|2|||
128826230|NCT04039113|463661234|FG001|Overall Study|Adverse Event|2|||
128826231|NCT04039113|463661233|FG000|Overall Study|Death|2|||
128826232|NCT04039113|463661234|FG001|Overall Study|Death|4|||
128826233|NCT04039113|463661233|FG000|Overall Study|Site Closure|6|||
128826234|NCT04039113|463661234|FG001|Overall Study|Site Closure|0|||
128826235|NCT04039113|463661233|FG000|Overall Study|Failure to meet randomisation criteria|4|||
128826236|NCT04039113|463661234|FG001|Overall Study|Failure to meet randomisation criteria|0|||
128826237|NCT04980300|463661235|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
128826238|NCT04980300|463661236|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
128826239|NCT04980300|463661235|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
128826240|NCT04980300|463661236|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
128826241|NCT04980300|463661235|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
128826242|NCT04980300|463661236|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
128826243|NCT04980300|463661235|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
128826244|NCT04980300|463661236|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
128826245|NCT03459196|463662323|FG000|Overall Study|Subject didn't receive study catheter|2|||
128826246|NCT03140670|463662330|FG000|Overall Study|Withdrawal by Subject|2|||
128826247|NCT03140670|463662330|FG000|Overall Study|Lost to Follow-up|1|||
128826248|NCT03140670|463662330|FG000|Overall Study|Physician Decision|1|||
128826249|NCT00220805|463662331|FG000|Overall Study|Adverse Event|1|||
128826250|NCT00220805|463662332|FG001|Overall Study|Adverse Event|3|||
128826251|NCT00220805|463662331|FG000|Overall Study|Withdrawal by Subject|3|||
128826252|NCT00220805|463662332|FG001|Overall Study|Withdrawal by Subject|0|||
128826253|NCT00220805|463662331|FG000|Overall Study|Lack of Efficacy|1|||
128826254|NCT00220805|463662332|FG001|Overall Study|Lack of Efficacy|0|||
128826255|NCT00220805|463662331|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
128826256|NCT00220805|463662332|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
128826257|NCT01288443|463662333|FG000|Overall Study|Adverse Event|0|||
128826258|NCT01288443|463662334|FG001|Overall Study|Adverse Event|0|||
128826259|NCT01288443|463662335|FG002|Overall Study|Adverse Event|1|||
128826260|NCT01288443|463662336|FG003|Overall Study|Adverse Event|1|||
128826261|NCT01288443|463662337|FG004|Overall Study|Adverse Event|3|||
128826262|NCT01288443|463662338|FG005|Overall Study|Adverse Event|1|||
128826263|NCT01288443|463662333|FG000|Overall Study|Poor compliance to protocol|0|||
128826264|NCT01288443|463662334|FG001|Overall Study|Poor compliance to protocol|0|||
128826265|NCT01288443|463662335|FG002|Overall Study|Poor compliance to protocol|0|||
128826266|NCT01288443|463662336|FG003|Overall Study|Poor compliance to protocol|0|||
128826267|NCT01288443|463662337|FG004|Overall Study|Poor compliance to protocol|0|||
128826268|NCT01288443|463662338|FG005|Overall Study|Poor compliance to protocol|1|||
128826269|NCT01288443|463662333|FG000|Overall Study|Participant Moved|0|||
128826270|NCT01288443|463662334|FG001|Overall Study|Participant Moved|0|||
128826271|NCT01288443|463662335|FG002|Overall Study|Participant Moved|0|||
128826272|NCT01288443|463662336|FG003|Overall Study|Participant Moved|1|||
128826273|NCT01288443|463662337|FG004|Overall Study|Participant Moved|2|||
128826274|NCT01288443|463662338|FG005|Overall Study|Participant Moved|1|||
128826275|NCT01288443|463662333|FG000|Overall Study|Consent withdrawn by Participant|0|||
128826276|NCT01288443|463662334|FG001|Overall Study|Consent withdrawn by Participant|0|||
128826277|NCT01288443|463662335|FG002|Overall Study|Consent withdrawn by Participant|0|||
128826278|NCT01288443|463662336|FG003|Overall Study|Consent withdrawn by Participant|0|||
128826279|NCT01288443|463662337|FG004|Overall Study|Consent withdrawn by Participant|0|||
128826280|NCT01288443|463662338|FG005|Overall Study|Consent withdrawn by Participant|1|||
128826281|NCT01288443|463662333|FG000|Overall Study|Lost to Follow-up|0|||
128826282|NCT01288443|463662334|FG001|Overall Study|Lost to Follow-up|1|||
128826283|NCT01288443|463662335|FG002|Overall Study|Lost to Follow-up|0|||
128826284|NCT01288443|463662336|FG003|Overall Study|Lost to Follow-up|0|||
128826285|NCT01288443|463662337|FG004|Overall Study|Lost to Follow-up|0|||
128826286|NCT01288443|463662338|FG005|Overall Study|Lost to Follow-up|0|||
128826287|NCT01288443|463662333|FG000|Overall Study|Study drug auto-injector administration|0|||
128826288|NCT01288443|463662334|FG001|Overall Study|Study drug auto-injector administration|0|||
128826289|NCT01288443|463662335|FG002|Overall Study|Study drug auto-injector administration|0|||
128826290|NCT01288443|463662336|FG003|Overall Study|Study drug auto-injector administration|0|||
128826291|NCT01288443|463662337|FG004|Overall Study|Study drug auto-injector administration|1|||
128826292|NCT01288443|463662338|FG005|Overall Study|Study drug auto-injector administration|1|||
128826293|NCT01288443|463662333|FG000|Overall Study|Other than above|0|||
128826294|NCT01288443|463662334|FG001|Overall Study|Other than above|0|||
128826295|NCT01288443|463662335|FG002|Overall Study|Other than above|0|||
128826296|NCT01288443|463662336|FG003|Overall Study|Other than above|2|||
128826297|NCT01288443|463662337|FG004|Overall Study|Other than above|1|||
128826298|NCT01288443|463662338|FG005|Overall Study|Other than above|0|||
128826299|NCT01964300|463662340|FG000|Overall Study|Ineligible after enrollment|0|||
128826300|NCT01964300|463662341|FG001|Overall Study|Ineligible after enrollment|1|||
128826301|NCT01964300|463662340|FG000|Overall Study|Adverse Event|1|||
128826302|NCT01964300|463662341|FG001|Overall Study|Adverse Event|1|||
128826303|NCT01964300|463662340|FG000|Overall Study|Lack of Efficacy|3|||
128826304|NCT01964300|463662341|FG001|Overall Study|Lack of Efficacy|5|||
128826305|NCT01964300|463662340|FG000|Overall Study|Withdrawal by Subject|0|||
128826306|NCT01964300|463662341|FG001|Overall Study|Withdrawal by Subject|1|||
128826307|NCT01964300|463662340|FG000|Overall Study|To receive alternative therapy|1|||
128826308|NCT01964300|463662341|FG001|Overall Study|To receive alternative therapy|2|||
128826309|NCT01964300|463662340|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
128826310|NCT01964300|463662341|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
128826311|NCT01964300|463662340|FG000|Overall Study|Weight criteria not met|0|||
128826312|NCT01964300|463662341|FG001|Overall Study|Weight criteria not met|1|||
128826313|NCT03183050|463662342|FG000|Overall Study|Lost to Follow-up|23|||
128826314|NCT02797132|463662343|FG000|Part A (15 Days)|Adverse Event|1|||
128826315|NCT02797132|463662343|FG000|Part B (24 Weeks)|Adverse Event|3|||
128826316|NCT00754065|463662347|FG000|Overall Study|Never received treatment|12|||
128826317|NCT00754065|463662348|FG001|Overall Study|Never received treatment|2|||
128826318|NCT00754065|463662347|FG000|Overall Study|Adverse Event|19|||
128826319|NCT00754065|463662348|FG001|Overall Study|Adverse Event|25|||
128826320|NCT00754065|463662347|FG000|Overall Study|Lost to Follow-up|7|||
128826321|NCT00754065|463662348|FG001|Overall Study|Lost to Follow-up|11|||
128826322|NCT00754065|463662347|FG000|Overall Study|Protocol Violation|12|||
128826323|NCT00754065|463662348|FG001|Overall Study|Protocol Violation|10|||
128826324|NCT00754065|463662347|FG000|Overall Study|Withdrawal by Subject|4|||
128826325|NCT00754065|463662348|FG001|Overall Study|Withdrawal by Subject|5|||
128826326|NCT00754065|463662347|FG000|Overall Study|Pregnancy|6|||
128826327|NCT00754065|463662348|FG001|Overall Study|Pregnancy|0|||
128826328|NCT00754065|463662347|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
128826329|NCT00754065|463662348|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
128826330|NCT01074294|463662349|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
128826331|NCT01074294|463662350|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
128826332|NCT01074294|463662351|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
128826333|NCT01074294|463662352|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
128826334|NCT01074294|463662349|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
128826335|NCT01074294|463662350|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
128826336|NCT01074294|463662351|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
128826337|NCT01074294|463662352|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
128826338|NCT01074294|463662349|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
128826339|NCT01074294|463662350|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
128826340|NCT01074294|463662351|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
128826341|NCT01074294|463662352|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
128826342|NCT01074294|463662349|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
128826343|NCT01074294|463662350|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
128826344|NCT01074294|463662351|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
128826345|NCT01074294|463662352|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
128826346|NCT01074294|463662349|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
128826347|NCT01074294|463662350|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
128826348|NCT01074294|463662351|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
128826349|NCT01074294|463662352|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
128826350|NCT01074294|463662349|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
128826351|NCT01074294|463662350|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
128826352|NCT01074294|463662351|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
128826353|NCT01074294|463662352|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
128826354|NCT01074294|463662349|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
128826355|NCT01074294|463662350|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
128826356|NCT01074294|463662351|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
128826357|NCT01074294|463662352|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
128826358|NCT01074294|463662349|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
128826359|NCT01074294|463662350|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
128826360|NCT01074294|463662351|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
128826361|NCT01074294|463662352|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
128826362|NCT01074294|463662349|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
128826363|NCT01074294|463662350|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
128826364|NCT01074294|463662351|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
128826365|NCT01074294|463662352|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
128826366|NCT01074294|463662349|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
128826367|NCT01074294|463662350|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
128826368|NCT01074294|463662351|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
128826369|NCT01074294|463662352|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
128826370|NCT01074294|463662349|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
128826371|NCT01074294|463662350|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
128826372|NCT01074294|463662351|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
128826373|NCT01074294|463662352|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
128826374|NCT01074294|463662349|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
128826375|NCT01074294|463662350|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
128826376|NCT01074294|463662351|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
128826377|NCT01074294|463662352|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
128826378|NCT01074294|463662349|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
128826379|NCT01074294|463662350|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
128826380|NCT01074294|463662351|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
128826381|NCT01074294|463662352|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
128826382|NCT00623194|463662353|FG000|Overall Study|Lack of Efficacy|1|||
128826383|NCT00623194|463662353|FG000|Overall Study|Protocol Violation|3|||
128826384|NCT00623194|463662353|FG000|Overall Study|Unclassified|1|||
128826385|NCT00982644|463662354|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
128826386|NCT00982644|463662355|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
128826387|NCT00982644|463662354|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
128826388|NCT00982644|463662355|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
128826389|NCT00982644|463662354|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
128826390|NCT00982644|463662355|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
128826391|NCT00982644|463662354|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
128826392|NCT00982644|463662355|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
128826393|NCT00982644|463662354|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
128826394|NCT00982644|463662355|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
128826395|NCT00982644|463662354|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
128826396|NCT00982644|463662355|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
128826397|NCT00982644|463662354|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
128826398|NCT00982644|463662355|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
128826399|NCT00982644|463662354|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
128826400|NCT00982644|463662355|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
128826401|NCT00982644|463662354|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
128826402|NCT00982644|463662355|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
128826403|NCT00982644|463662354|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
128826404|NCT00982644|463662355|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
128826405|NCT00943917|463662358|FG000|Stage I|Adverse Event|1|||
128826406|NCT00943917|463662359|FG001|Stage I|Adverse Event|2|||
128826407|NCT00943917|463662360|FG002|Stage I|Adverse Event|2|||
128826408|NCT00943917|463662361|FG003|Stage I|Adverse Event|0|||
128826409|NCT00943917|463662362|FG004|Stage I|Adverse Event|0|||
128826410|NCT00943917|463662363|FG005|Stage I|Adverse Event|0|||
128826411|NCT00943917|463662364|FG006|Stage I|Adverse Event|0|||
128826412|NCT00943917|463662365|FG007|Stage I|Adverse Event|0|||
128826413|NCT00943917|463662366|FG008|Stage I|Adverse Event|0|||
128826414|NCT00943917|463662367|FG009|Stage I|Adverse Event|0|||
128826415|NCT00943917|463662368|FG010|Stage I|Adverse Event|0|||
128826416|NCT00943917|463662369|FG011|Stage I|Adverse Event|0|||
128826417|NCT00943917|463662370|FG012|Stage I|Adverse Event|0|||
128826418|NCT00943917|463662371|FG013|Stage I|Adverse Event|0|||
128826419|NCT00943917|463662372|FG014|Stage I|Adverse Event|0|||
128826420|NCT00943917|463662358|FG000|Stage I|Lost to Follow-up|0|||
128826421|NCT00943917|463662359|FG001|Stage I|Lost to Follow-up|0|||
128826422|NCT00943917|463662360|FG002|Stage I|Lost to Follow-up|1|||
128826423|NCT00943917|463662361|FG003|Stage I|Lost to Follow-up|0|||
128826424|NCT00943917|463662362|FG004|Stage I|Lost to Follow-up|0|||
128826425|NCT00943917|463662363|FG005|Stage I|Lost to Follow-up|0|||
128826426|NCT00943917|463662364|FG006|Stage I|Lost to Follow-up|0|||
128826427|NCT00943917|463662365|FG007|Stage I|Lost to Follow-up|0|||
128826428|NCT00943917|463662366|FG008|Stage I|Lost to Follow-up|0|||
128826429|NCT00943917|463662367|FG009|Stage I|Lost to Follow-up|0|||
128826430|NCT00943917|463662368|FG010|Stage I|Lost to Follow-up|0|||
128826431|NCT00943917|463662369|FG011|Stage I|Lost to Follow-up|0|||
128826432|NCT00943917|463662370|FG012|Stage I|Lost to Follow-up|0|||
128826433|NCT00943917|463662371|FG013|Stage I|Lost to Follow-up|0|||
128826434|NCT00943917|463662372|FG014|Stage I|Lost to Follow-up|0|||
128826435|NCT00943917|463662358|FG000|Stage I|hyperglycemia|0|||
128826436|NCT00943917|463662359|FG001|Stage I|hyperglycemia|0|||
128826437|NCT00943917|463662360|FG002|Stage I|hyperglycemia|1|||
128826438|NCT00943917|463662361|FG003|Stage I|hyperglycemia|0|||
128826439|NCT00943917|463662362|FG004|Stage I|hyperglycemia|0|||
128826440|NCT00943917|463662363|FG005|Stage I|hyperglycemia|0|||
128826441|NCT00943917|463662364|FG006|Stage I|hyperglycemia|0|||
128826442|NCT00943917|463662365|FG007|Stage I|hyperglycemia|0|||
128826443|NCT00943917|463662366|FG008|Stage I|hyperglycemia|0|||
128826444|NCT00943917|463662367|FG009|Stage I|hyperglycemia|0|||
128826445|NCT00943917|463662368|FG010|Stage I|hyperglycemia|0|||
128826446|NCT00943917|463662369|FG011|Stage I|hyperglycemia|0|||
128826447|NCT00943917|463662370|FG012|Stage I|hyperglycemia|0|||
128826448|NCT00943917|463662371|FG013|Stage I|hyperglycemia|0|||
128826449|NCT00943917|463662372|FG014|Stage I|hyperglycemia|0|||
128826450|NCT00943917|463662358|FG000|Stage I|A1C elevation|1|||
128826451|NCT00943917|463662359|FG001|Stage I|A1C elevation|0|||
128826452|NCT00943917|463662360|FG002|Stage I|A1C elevation|0|||
128826453|NCT00943917|463662361|FG003|Stage I|A1C elevation|0|||
128826454|NCT00943917|463662362|FG004|Stage I|A1C elevation|0|||
128826455|NCT00943917|463662363|FG005|Stage I|A1C elevation|0|||
128826456|NCT00943917|463662364|FG006|Stage I|A1C elevation|0|||
128826457|NCT00943917|463662365|FG007|Stage I|A1C elevation|0|||
128826458|NCT00943917|463662366|FG008|Stage I|A1C elevation|0|||
128826459|NCT00943917|463662367|FG009|Stage I|A1C elevation|0|||
128826460|NCT00943917|463662368|FG010|Stage I|A1C elevation|0|||
128826461|NCT00943917|463662369|FG011|Stage I|A1C elevation|0|||
128826462|NCT00943917|463662370|FG012|Stage I|A1C elevation|0|||
128826463|NCT00943917|463662371|FG013|Stage I|A1C elevation|0|||
128826464|NCT00943917|463662372|FG014|Stage I|A1C elevation|0|||
128826465|NCT00943917|463662358|FG000|Stage I|Withdrawal by Subject|2|||
128826466|NCT00943917|463662359|FG001|Stage I|Withdrawal by Subject|1|||
128826467|NCT00943917|463662360|FG002|Stage I|Withdrawal by Subject|2|||
128826468|NCT00943917|463662361|FG003|Stage I|Withdrawal by Subject|0|||
128826469|NCT00943917|463662362|FG004|Stage I|Withdrawal by Subject|0|||
128826470|NCT00943917|463662363|FG005|Stage I|Withdrawal by Subject|0|||
128826471|NCT00943917|463662364|FG006|Stage I|Withdrawal by Subject|0|||
128826472|NCT00943917|463662365|FG007|Stage I|Withdrawal by Subject|0|||
128826473|NCT00943917|463662366|FG008|Stage I|Withdrawal by Subject|0|||
128826474|NCT00943917|463662367|FG009|Stage I|Withdrawal by Subject|0|||
128826475|NCT00943917|463662368|FG010|Stage I|Withdrawal by Subject|0|||
128826476|NCT00943917|463662369|FG011|Stage I|Withdrawal by Subject|0|||
128826477|NCT00943917|463662370|FG012|Stage I|Withdrawal by Subject|0|||
128826478|NCT00943917|463662371|FG013|Stage I|Withdrawal by Subject|0|||
128826479|NCT00943917|463662372|FG014|Stage I|Withdrawal by Subject|0|||
128826480|NCT00943917|463662358|FG000|Stage II|Adverse Event|0|||
128826481|NCT00943917|463662359|FG001|Stage II|Adverse Event|0|||
128826482|NCT00943917|463662360|FG002|Stage II|Adverse Event|0|||
128826483|NCT00943917|463662361|FG003|Stage II|Adverse Event|0|||
128826484|NCT00943917|463662362|FG004|Stage II|Adverse Event|0|||
128826485|NCT00943917|463662363|FG005|Stage II|Adverse Event|1|||
128826486|NCT00943917|463662364|FG006|Stage II|Adverse Event|3|||
128826487|NCT00943917|463662365|FG007|Stage II|Adverse Event|0|||
128826488|NCT00943917|463662366|FG008|Stage II|Adverse Event|1|||
128826489|NCT00943917|463662367|FG009|Stage II|Adverse Event|0|||
128826490|NCT00943917|463662368|FG010|Stage II|Adverse Event|0|||
128826491|NCT00943917|463662369|FG011|Stage II|Adverse Event|0|||
128826492|NCT00943917|463662370|FG012|Stage II|Adverse Event|0|||
128826493|NCT00943917|463662371|FG013|Stage II|Adverse Event|0|||
128826494|NCT00943917|463662372|FG014|Stage II|Adverse Event|0|||
128826495|NCT00943917|463662358|FG000|Stage II|Withdrawal by Subject|0|||
128826496|NCT00943917|463662359|FG001|Stage II|Withdrawal by Subject|0|||
128826497|NCT00943917|463662360|FG002|Stage II|Withdrawal by Subject|0|||
128826498|NCT00943917|463662361|FG003|Stage II|Withdrawal by Subject|0|||
128826499|NCT00943917|463662362|FG004|Stage II|Withdrawal by Subject|0|||
128826500|NCT00943917|463662363|FG005|Stage II|Withdrawal by Subject|1|||
128826501|NCT00943917|463662364|FG006|Stage II|Withdrawal by Subject|0|||
128826502|NCT00943917|463662365|FG007|Stage II|Withdrawal by Subject|0|||
128826503|NCT00943917|463662366|FG008|Stage II|Withdrawal by Subject|0|||
128826504|NCT00943917|463662367|FG009|Stage II|Withdrawal by Subject|0|||
128826505|NCT00943917|463662368|FG010|Stage II|Withdrawal by Subject|0|||
128826506|NCT00943917|463662369|FG011|Stage II|Withdrawal by Subject|0|||
128826507|NCT00943917|463662370|FG012|Stage II|Withdrawal by Subject|0|||
128826508|NCT00943917|463662371|FG013|Stage II|Withdrawal by Subject|0|||
128826509|NCT00943917|463662372|FG014|Stage II|Withdrawal by Subject|0|||
128826510|NCT00943917|463662358|FG000|Stage II|Pregnancy|0|||
128826511|NCT00943917|463662359|FG001|Stage II|Pregnancy|0|||
128826512|NCT00943917|463662360|FG002|Stage II|Pregnancy|0|||
128826513|NCT00943917|463662361|FG003|Stage II|Pregnancy|0|||
128826514|NCT00943917|463662362|FG004|Stage II|Pregnancy|0|||
128826515|NCT00943917|463662363|FG005|Stage II|Pregnancy|1|||
128826516|NCT00943917|463662364|FG006|Stage II|Pregnancy|0|||
128826517|NCT00943917|463662365|FG007|Stage II|Pregnancy|0|||
128826518|NCT00943917|463662366|FG008|Stage II|Pregnancy|0|||
128826519|NCT00943917|463662367|FG009|Stage II|Pregnancy|0|||
128826520|NCT00943917|463662368|FG010|Stage II|Pregnancy|0|||
128826521|NCT00943917|463662369|FG011|Stage II|Pregnancy|0|||
128826522|NCT00943917|463662370|FG012|Stage II|Pregnancy|0|||
128826523|NCT00943917|463662371|FG013|Stage II|Pregnancy|0|||
128826524|NCT00943917|463662372|FG014|Stage II|Pregnancy|0|||
128826525|NCT00943917|463662358|FG000|Stage II Continuation|Adverse Event|0|||
128826526|NCT00943917|463662359|FG001|Stage II Continuation|Adverse Event|0|||
128826527|NCT00943917|463662360|FG002|Stage II Continuation|Adverse Event|0|||
128826528|NCT00943917|463662361|FG003|Stage II Continuation|Adverse Event|0|||
128826529|NCT00943917|463662362|FG004|Stage II Continuation|Adverse Event|0|||
128826530|NCT00943917|463662363|FG005|Stage II Continuation|Adverse Event|0|||
128826531|NCT00943917|463662364|FG006|Stage II Continuation|Adverse Event|0|||
128826532|NCT00943917|463662365|FG007|Stage II Continuation|Adverse Event|0|||
128826533|NCT00943917|463662366|FG008|Stage II Continuation|Adverse Event|0|||
128826534|NCT00943917|463662367|FG009|Stage II Continuation|Adverse Event|0|||
128826535|NCT00943917|463662368|FG010|Stage II Continuation|Adverse Event|0|||
128826536|NCT00943917|463662369|FG011|Stage II Continuation|Adverse Event|1|||
128826537|NCT00943917|463662370|FG012|Stage II Continuation|Adverse Event|2|||
128826538|NCT00943917|463662371|FG013|Stage II Continuation|Adverse Event|1|||
128826539|NCT00943917|463662372|FG014|Stage II Continuation|Adverse Event|1|||
128826540|NCT00943917|463662358|FG000|Stage II Continuation|Withdrawal by Subject|0|||
128826541|NCT00943917|463662359|FG001|Stage II Continuation|Withdrawal by Subject|0|||
128826542|NCT00943917|463662360|FG002|Stage II Continuation|Withdrawal by Subject|0|||
128826543|NCT00943917|463662361|FG003|Stage II Continuation|Withdrawal by Subject|0|||
128826544|NCT00943917|463662362|FG004|Stage II Continuation|Withdrawal by Subject|0|||
128826545|NCT00943917|463662363|FG005|Stage II Continuation|Withdrawal by Subject|0|||
128826546|NCT00943917|463662364|FG006|Stage II Continuation|Withdrawal by Subject|0|||
128826547|NCT00943917|463662365|FG007|Stage II Continuation|Withdrawal by Subject|0|||
128826548|NCT00943917|463662366|FG008|Stage II Continuation|Withdrawal by Subject|0|||
128826549|NCT00943917|463662367|FG009|Stage II Continuation|Withdrawal by Subject|0|||
128826550|NCT00943917|463662368|FG010|Stage II Continuation|Withdrawal by Subject|0|||
128826551|NCT00943917|463662369|FG011|Stage II Continuation|Withdrawal by Subject|0|||
128826552|NCT00943917|463662370|FG012|Stage II Continuation|Withdrawal by Subject|0|||
128826553|NCT00943917|463662371|FG013|Stage II Continuation|Withdrawal by Subject|1|||
128826554|NCT00943917|463662372|FG014|Stage II Continuation|Withdrawal by Subject|3|||
128826555|NCT00943917|463662358|FG000|Stage II Continuation|Protocol Violation|0|||
128826556|NCT00943917|463662359|FG001|Stage II Continuation|Protocol Violation|0|||
128826557|NCT00943917|463662360|FG002|Stage II Continuation|Protocol Violation|0|||
128826558|NCT00943917|463662361|FG003|Stage II Continuation|Protocol Violation|0|||
128826559|NCT00943917|463662362|FG004|Stage II Continuation|Protocol Violation|0|||
128826560|NCT00943917|463662363|FG005|Stage II Continuation|Protocol Violation|0|||
128826561|NCT00943917|463662364|FG006|Stage II Continuation|Protocol Violation|0|||
128826562|NCT00943917|463662365|FG007|Stage II Continuation|Protocol Violation|0|||
128826563|NCT00943917|463662366|FG008|Stage II Continuation|Protocol Violation|0|||
128826564|NCT00943917|463662367|FG009|Stage II Continuation|Protocol Violation|1|||
128826565|NCT00943917|463662368|FG010|Stage II Continuation|Protocol Violation|0|||
128826566|NCT00943917|463662369|FG011|Stage II Continuation|Protocol Violation|1|||
128826567|NCT00943917|463662370|FG012|Stage II Continuation|Protocol Violation|0|||
128826568|NCT00943917|463662371|FG013|Stage II Continuation|Protocol Violation|0|||
128826569|NCT00943917|463662372|FG014|Stage II Continuation|Protocol Violation|0|||
128826570|NCT00943917|463662358|FG000|Stage II Continuation|hypoglycemia|0|||
128826571|NCT00943917|463662359|FG001|Stage II Continuation|hypoglycemia|0|||
128826572|NCT00943917|463662360|FG002|Stage II Continuation|hypoglycemia|0|||
128826573|NCT00943917|463662361|FG003|Stage II Continuation|hypoglycemia|0|||
128826574|NCT00943917|463662362|FG004|Stage II Continuation|hypoglycemia|0|||
128826575|NCT00943917|463662363|FG005|Stage II Continuation|hypoglycemia|0|||
128826576|NCT00943917|463662364|FG006|Stage II Continuation|hypoglycemia|0|||
128826577|NCT00943917|463662365|FG007|Stage II Continuation|hypoglycemia|0|||
128826578|NCT00943917|463662366|FG008|Stage II Continuation|hypoglycemia|0|||
128826579|NCT00943917|463662367|FG009|Stage II Continuation|hypoglycemia|0|||
128826580|NCT00943917|463662368|FG010|Stage II Continuation|hypoglycemia|0|||
128826581|NCT00943917|463662369|FG011|Stage II Continuation|hypoglycemia|0|||
128826582|NCT00943917|463662370|FG012|Stage II Continuation|hypoglycemia|1|||
128826583|NCT00943917|463662371|FG013|Stage II Continuation|hypoglycemia|0|||
128826584|NCT00943917|463662372|FG014|Stage II Continuation|hypoglycemia|0|||
128826585|NCT00943917|463662358|FG000|Stage II Continuation|A1C elevation|0|||
128826586|NCT00943917|463662359|FG001|Stage II Continuation|A1C elevation|0|||
128826587|NCT00943917|463662360|FG002|Stage II Continuation|A1C elevation|0|||
128826588|NCT00943917|463662361|FG003|Stage II Continuation|A1C elevation|0|||
128826589|NCT00943917|463662362|FG004|Stage II Continuation|A1C elevation|0|||
128826590|NCT00943917|463662363|FG005|Stage II Continuation|A1C elevation|0|||
128826591|NCT00943917|463662364|FG006|Stage II Continuation|A1C elevation|0|||
128826592|NCT00943917|463662365|FG007|Stage II Continuation|A1C elevation|0|||
128826593|NCT00943917|463662366|FG008|Stage II Continuation|A1C elevation|0|||
128826594|NCT00943917|463662367|FG009|Stage II Continuation|A1C elevation|0|||
128826595|NCT00943917|463662368|FG010|Stage II Continuation|A1C elevation|0|||
128826596|NCT00943917|463662369|FG011|Stage II Continuation|A1C elevation|0|||
128826597|NCT00943917|463662370|FG012|Stage II Continuation|A1C elevation|0|||
128826598|NCT00943917|463662371|FG013|Stage II Continuation|A1C elevation|1|||
128826599|NCT00943917|463662372|FG014|Stage II Continuation|A1C elevation|0|||
128826600|NCT01171976|463662373|FG000|Overall Study|Protocol Violation|0|||
128826601|NCT01171976|463662374|FG001|Overall Study|Protocol Violation|0|||
128826602|NCT01171976|463662375|FG002|Overall Study|Protocol Violation|1|||
128826603|NCT01171976|463662373|FG000|Overall Study|Death|2|||
128826604|NCT01171976|463662374|FG001|Overall Study|Death|4|||
128826605|NCT01171976|463662375|FG002|Overall Study|Death|1|||
128826606|NCT01171976|463662373|FG000|Overall Study|Lost to Follow-up|4|||
128826607|NCT01171976|463662374|FG001|Overall Study|Lost to Follow-up|0|||
128826608|NCT01171976|463662375|FG002|Overall Study|Lost to Follow-up|2|||
128826609|NCT01171976|463662373|FG000|Overall Study|Withdrawal by Subject|1|||
128826610|NCT01171976|463662374|FG001|Overall Study|Withdrawal by Subject|5|||
128826611|NCT01171976|463662375|FG002|Overall Study|Withdrawal by Subject|6|||
128826612|NCT01171976|463662373|FG000|Overall Study|Abnormal test result|1|||
128826613|NCT01171976|463662374|FG001|Overall Study|Abnormal test result|0|||
128826614|NCT01171976|463662375|FG002|Overall Study|Abnormal test result|0|||
128826615|NCT01171976|463662373|FG000|Overall Study|Adverse Event|6|||
128826616|NCT01171976|463662374|FG001|Overall Study|Adverse Event|2|||
128826617|NCT01171976|463662375|FG002|Overall Study|Adverse Event|5|||
128826618|NCT03357952|463662379|FG000|Overall Study|Withdrawal by Subject|0|||
128826619|NCT03357952|463662380|FG001|Overall Study|Withdrawal by Subject|1|||
128826620|NCT03357952|463662379|FG000|Overall Study|Sponsor Decision|9|||
128826621|NCT03357952|463662380|FG001|Overall Study|Sponsor Decision|0|||
128826622|NCT01371994|463662381|FG000|Overall Study|Adverse Event|3|||
128826623|NCT01371994|463662382|FG001|Overall Study|Adverse Event|6|||
128826624|NCT01371994|463662381|FG000|Overall Study|Lack of Efficacy|3|||
128826625|NCT01371994|463662382|FG001|Overall Study|Lack of Efficacy|0|||
128826626|NCT01371994|463662381|FG000|Overall Study|Withdrawal by Subject|13|||
128826627|NCT01371994|463662382|FG001|Overall Study|Withdrawal by Subject|7|||
128826628|NCT01371994|463662381|FG000|Overall Study|Lost to Follow-up|1|||
128826629|NCT01371994|463662382|FG001|Overall Study|Lost to Follow-up|1|||
128826630|NCT01371994|463662381|FG000|Overall Study|Protocol Violation|24|||
128826631|NCT01371994|463662382|FG001|Overall Study|Protocol Violation|17|||
128826632|NCT01371994|463662381|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
128826633|NCT01371994|463662382|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
128826634|NCT01371994|463662381|FG000|Overall Study|Physician Decision|1|||
128826635|NCT01371994|463662382|FG001|Overall Study|Physician Decision|1|||
128826636|NCT01371994|463662381|FG000|Overall Study|Miscellaneous Reasons|6|||
128826637|NCT01371994|463662382|FG001|Overall Study|Miscellaneous Reasons|4|||
128826638|NCT03280030|463662383|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
128826639|NCT03280030|463662384|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
128826640|NCT03280030|463662385|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
128826641|NCT03280030|463662383|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
128826642|NCT03280030|463662384|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
128826643|NCT03280030|463662385|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
128826644|NCT03280030|463662383|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
128826645|NCT03280030|463662384|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
128826646|NCT03280030|463662385|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
128826647|NCT03280030|463662383|FG000|Part 2 - Efficacy|Adverse Event|0|||
128826648|NCT03280030|463662384|FG001|Part 2 - Efficacy|Adverse Event|4|||
128826649|NCT03280030|463662385|FG002|Part 2 - Efficacy|Adverse Event|6|||
128826650|NCT03280030|463662383|FG000|Part 2 - Efficacy|Death|0|||
128826651|NCT03280030|463662384|FG001|Part 2 - Efficacy|Death|3|||
128826652|NCT03280030|463662385|FG002|Part 2 - Efficacy|Death|0|||
128826653|NCT03280030|463662383|FG000|Part 2 - Efficacy|Physician Decision|0|||
128826654|NCT03280030|463662384|FG001|Part 2 - Efficacy|Physician Decision|10|||
128826655|NCT03280030|463662385|FG002|Part 2 - Efficacy|Physician Decision|16|||
128826656|NCT03280030|463662383|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
128826657|NCT03280030|463662384|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
128826658|NCT03280030|463662385|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
128826659|NCT03280030|463662383|FG000|Part 2 - Efficacy|Progressive disease|0|||
128826660|NCT03280030|463662384|FG001|Part 2 - Efficacy|Progressive disease|7|||
128826661|NCT03280030|463662385|FG002|Part 2 - Efficacy|Progressive disease|5|||
128826662|NCT03222609|463662386|FG000|Overall Study|Withdrew consent|2|||
128826663|NCT03222609|463662387|FG001|Overall Study|Withdrew consent|3|||
128826664|NCT03222609|463662388|FG002|Overall Study|Withdrew consent|4|||
128826665|NCT03222609|463662389|FG003|Overall Study|Withdrew consent|2|||
128826666|NCT03222609|463662386|FG000|Overall Study|Lost to Follow-up|1|||
128826667|NCT03222609|463662387|FG001|Overall Study|Lost to Follow-up|0|||
128826668|NCT03222609|463662388|FG002|Overall Study|Lost to Follow-up|0|||
128826669|NCT03222609|463662389|FG003|Overall Study|Lost to Follow-up|0|||
128826670|NCT03222609|463662386|FG000|Overall Study|Death|16|||
128826671|NCT03222609|463662387|FG001|Overall Study|Death|13|||
128826672|NCT03222609|463662388|FG002|Overall Study|Death|9|||
128826673|NCT03222609|463662389|FG003|Overall Study|Death|6|||
128826674|NCT03222609|463662386|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
128826675|NCT03222609|463662387|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
128826676|NCT03222609|463662388|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
128826677|NCT03222609|463662389|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
128826678|NCT03656718|463662390|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
128826679|NCT03656718|463662391|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
128826680|NCT03656718|463662392|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
128826681|NCT03656718|463662393|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
128826682|NCT03656718|463662394|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
128826683|NCT03656718|463662395|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
128826684|NCT03656718|463662396|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
128826685|NCT03656718|463662390|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
128826686|NCT03656718|463662391|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
128826687|NCT03656718|463662392|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
128826688|NCT03656718|463662393|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
128826689|NCT03656718|463662394|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
128826690|NCT03656718|463662395|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
128826691|NCT03656718|463662396|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
128826692|NCT03656718|463662390|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
128826693|NCT03656718|463662391|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
128826694|NCT03656718|463662392|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
128826695|NCT03656718|463662393|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
128826696|NCT03656718|463662394|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
128826697|NCT03656718|463662395|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
128826698|NCT03656718|463662396|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
128826699|NCT03656718|463662390|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
128826700|NCT03656718|463662391|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
128826701|NCT03656718|463662392|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
128826702|NCT03656718|463662393|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
128826703|NCT03656718|463662394|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
128826704|NCT03656718|463662395|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
128826705|NCT03656718|463662396|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
128826706|NCT03656718|463662390|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
128826707|NCT03656718|463662391|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
128826708|NCT03656718|463662392|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
128826709|NCT03656718|463662393|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
128826710|NCT03656718|463662394|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
128826711|NCT03656718|463662395|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
128826712|NCT03656718|463662396|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
128826713|NCT03656718|463662390|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
128826714|NCT03656718|463662391|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
128826715|NCT03656718|463662392|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
128826716|NCT03656718|463662393|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
128826717|NCT03656718|463662394|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
128826718|NCT03656718|463662395|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
128826719|NCT03656718|463662396|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
128826720|NCT03656718|463662390|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
128826721|NCT03656718|463662391|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
128826722|NCT03656718|463662392|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
128826723|NCT03656718|463662393|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
128826724|NCT03656718|463662394|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
128826725|NCT03656718|463662395|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
128826726|NCT03656718|463662396|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
128826727|NCT03656718|463662390|FG000|Treatment Period Part C|Disease progression|0|||
128826728|NCT03656718|463662391|FG001|Treatment Period Part C|Disease progression|0|||
128826729|NCT03656718|463662392|FG002|Treatment Period Part C|Disease progression|0|||
128826730|NCT03656718|463662393|FG003|Treatment Period Part C|Disease progression|0|||
128826731|NCT03656718|463662394|FG004|Treatment Period Part C|Disease progression|12|||
128826732|NCT03656718|463662395|FG005|Treatment Period Part C|Disease progression|0|||
128826733|NCT03656718|463662396|FG006|Treatment Period Part C|Disease progression|0|||
128826734|NCT03656718|463662390|FG000|Treatment Period Part C|Death|0|||
128826735|NCT03656718|463662391|FG001|Treatment Period Part C|Death|0|||
128826736|NCT03656718|463662392|FG002|Treatment Period Part C|Death|0|||
128826737|NCT03656718|463662393|FG003|Treatment Period Part C|Death|0|||
128826738|NCT03656718|463662394|FG004|Treatment Period Part C|Death|1|||
128826739|NCT03656718|463662395|FG005|Treatment Period Part C|Death|0|||
128826740|NCT03656718|463662396|FG006|Treatment Period Part C|Death|0|||
128826741|NCT03656718|463662390|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
128826742|NCT03656718|463662391|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
128826743|NCT03656718|463662392|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
128826744|NCT03656718|463662393|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
128826745|NCT03656718|463662394|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
128826746|NCT03656718|463662395|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
128826747|NCT03656718|463662396|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
128826748|NCT03656718|463662390|FG000|Treatment Period Part C|Other reasons|0|||
128826749|NCT03656718|463662391|FG001|Treatment Period Part C|Other reasons|0|||
128826750|NCT03656718|463662392|FG002|Treatment Period Part C|Other reasons|0|||
128826751|NCT03656718|463662393|FG003|Treatment Period Part C|Other reasons|0|||
128826752|NCT03656718|463662394|FG004|Treatment Period Part C|Other reasons|1|||
128826753|NCT03656718|463662395|FG005|Treatment Period Part C|Other reasons|0|||
128826754|NCT03656718|463662396|FG006|Treatment Period Part C|Other reasons|0|||
128826755|NCT03656718|463662390|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
128826756|NCT03656718|463662391|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
128826757|NCT03656718|463662392|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
128826758|NCT03656718|463662393|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
128826759|NCT03656718|463662394|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
128826760|NCT03656718|463662395|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
128826761|NCT03656718|463662396|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
128826762|NCT03211247|463662397|FG000|Overall Study|Adverse Event|8|||
128826763|NCT03211247|463662398|FG001|Overall Study|Adverse Event|0|||
128826764|NCT03211247|463662399|FG002|Overall Study|Adverse Event|1|||
128826765|NCT03211247|463662400|FG003|Overall Study|Adverse Event|0|||
128826766|NCT03211247|463662401|FG004|Overall Study|Adverse Event|0|||
128826767|NCT03211247|463662397|FG000|Overall Study|Lost to Follow-up|2|||
128826768|NCT03211247|463662398|FG001|Overall Study|Lost to Follow-up|1|||
128826769|NCT03211247|463662399|FG002|Overall Study|Lost to Follow-up|0|||
128826770|NCT03211247|463662400|FG003|Overall Study|Lost to Follow-up|0|||
128826771|NCT03211247|463662401|FG004|Overall Study|Lost to Follow-up|0|||
128826772|NCT03211247|463662397|FG000|Overall Study|Physician Decision|1|||
128826773|NCT03211247|463662398|FG001|Overall Study|Physician Decision|2|||
128826774|NCT03211247|463662399|FG002|Overall Study|Physician Decision|0|||
128826775|NCT03211247|463662400|FG003|Overall Study|Physician Decision|0|||
128826776|NCT03211247|463662401|FG004|Overall Study|Physician Decision|0|||
128826777|NCT03211247|463662397|FG000|Overall Study|Non-compliance with study drug|2|||
128826778|NCT03211247|463662398|FG001|Overall Study|Non-compliance with study drug|0|||
128826779|NCT03211247|463662399|FG002|Overall Study|Non-compliance with study drug|0|||
128826780|NCT03211247|463662400|FG003|Overall Study|Non-compliance with study drug|0|||
128826781|NCT03211247|463662401|FG004|Overall Study|Non-compliance with study drug|0|||
128826782|NCT03211247|463662397|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
128826783|NCT03211247|463662398|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
128826784|NCT03211247|463662399|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
128826785|NCT03211247|463662400|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
128826786|NCT03211247|463662401|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
128826787|NCT03211247|463662397|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
128826788|NCT03211247|463662398|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
128826789|NCT03211247|463662399|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
128826790|NCT03211247|463662400|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
128826791|NCT03211247|463662401|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
128826792|NCT03211247|463662397|FG000|Overall Study|Protocol Violation|0|||
128826793|NCT03211247|463662398|FG001|Overall Study|Protocol Violation|1|||
128826794|NCT03211247|463662399|FG002|Overall Study|Protocol Violation|0|||
128826795|NCT03211247|463662400|FG003|Overall Study|Protocol Violation|0|||
128826796|NCT03211247|463662401|FG004|Overall Study|Protocol Violation|0|||
128826797|NCT04153890|463662402|FG000|Overall Study|Lost to Follow-up|9|||
128826798|NCT04153890|463662403|FG001|Overall Study|Lost to Follow-up|0|||
128826799|NCT04153890|463662404|FG002|Overall Study|Lost to Follow-up|9|||
128826800|NCT04153890|463662405|FG003|Overall Study|Lost to Follow-up|0|||
128826801|NCT04153890|463662402|FG000|Overall Study|Death|0|||
128826802|NCT04153890|463662403|FG001|Overall Study|Death|2|||
128826803|NCT04153890|463662404|FG002|Overall Study|Death|0|||
128826804|NCT04153890|463662405|FG003|Overall Study|Death|0|||
128826805|NCT04153890|463662402|FG000|Overall Study|Withdrawal by Subject|0|||
128826806|NCT04153890|463662403|FG001|Overall Study|Withdrawal by Subject|0|||
128826807|NCT04153890|463662404|FG002|Overall Study|Withdrawal by Subject|0|||
128826808|NCT04153890|463662405|FG003|Overall Study|Withdrawal by Subject|2|||
128826809|NCT05786612|463662406|FG000|Overall Study|Adverse Event|1|||
128826810|NCT05786612|463662407|FG001|Overall Study|Adverse Event|2|||
128826811|NCT05786612|463662406|FG000|Overall Study|one screening failure|0|||
128826812|NCT05786612|463662407|FG001|Overall Study|one screening failure|2|||
128826813|NCT00146172|463663634|FG000|Overall Study|Adverse Event|0|||
128826814|NCT00146172|463663635|FG001|Overall Study|Adverse Event|0|||
128826815|NCT00146172|463663636|FG002|Overall Study|Adverse Event|1|||
128826816|NCT00146172|463663637|FG003|Overall Study|Adverse Event|1|||
128826817|NCT00146172|463663638|FG004|Overall Study|Adverse Event|0|||
128826818|NCT00146172|463663639|FG005|Overall Study|Adverse Event|2|||
128826819|NCT00146172|463663640|FG006|Overall Study|Adverse Event|3|||
128826820|NCT00146172|463663641|FG007|Overall Study|Adverse Event|10|||
128826821|NCT00146172|463663634|FG000|Overall Study|Lost to Follow-up|0|||
128826822|NCT00146172|463663635|FG001|Overall Study|Lost to Follow-up|0|||
128826823|NCT00146172|463663636|FG002|Overall Study|Lost to Follow-up|0|||
128826824|NCT00146172|463663637|FG003|Overall Study|Lost to Follow-up|0|||
128826825|NCT00146172|463663638|FG004|Overall Study|Lost to Follow-up|0|||
128826826|NCT00146172|463663639|FG005|Overall Study|Lost to Follow-up|0|||
128826827|NCT00146172|463663640|FG006|Overall Study|Lost to Follow-up|0|||
128826828|NCT00146172|463663641|FG007|Overall Study|Lost to Follow-up|1|||
128826829|NCT00146172|463663634|FG000|Overall Study|Disease Progression|2|||
128826830|NCT00146172|463663635|FG001|Overall Study|Disease Progression|4|||
128826831|NCT00146172|463663636|FG002|Overall Study|Disease Progression|2|||
128826832|NCT00146172|463663637|FG003|Overall Study|Disease Progression|5|||
128826833|NCT00146172|463663638|FG004|Overall Study|Disease Progression|2|||
128826834|NCT00146172|463663639|FG005|Overall Study|Disease Progression|2|||
128826835|NCT00146172|463663640|FG006|Overall Study|Disease Progression|1|||
128826836|NCT00146172|463663641|FG007|Overall Study|Disease Progression|22|||
128826837|NCT00146172|463663634|FG000|Overall Study|Death|0|||
128826838|NCT00146172|463663635|FG001|Overall Study|Death|0|||
128826839|NCT00146172|463663636|FG002|Overall Study|Death|0|||
128826840|NCT00146172|463663637|FG003|Overall Study|Death|0|||
128826841|NCT00146172|463663638|FG004|Overall Study|Death|0|||
128826842|NCT00146172|463663639|FG005|Overall Study|Death|0|||
128826843|NCT00146172|463663640|FG006|Overall Study|Death|1|||
128826844|NCT00146172|463663641|FG007|Overall Study|Death|0|||
128826845|NCT00146172|463663634|FG000|Overall Study|Physician Decision|0|||
128826846|NCT00146172|463663635|FG001|Overall Study|Physician Decision|0|||
128826847|NCT00146172|463663636|FG002|Overall Study|Physician Decision|0|||
128826848|NCT00146172|463663637|FG003|Overall Study|Physician Decision|0|||
128826849|NCT00146172|463663638|FG004|Overall Study|Physician Decision|0|||
128826850|NCT00146172|463663639|FG005|Overall Study|Physician Decision|0|||
128826851|NCT00146172|463663640|FG006|Overall Study|Physician Decision|0|||
128826852|NCT00146172|463663641|FG007|Overall Study|Physician Decision|1|||
128826853|NCT00146172|463663634|FG000|Overall Study|Withdrawal by Subject|0|||
128826854|NCT00146172|463663635|FG001|Overall Study|Withdrawal by Subject|0|||
128826855|NCT00146172|463663636|FG002|Overall Study|Withdrawal by Subject|0|||
128826856|NCT00146172|463663637|FG003|Overall Study|Withdrawal by Subject|0|||
128826857|NCT00146172|463663638|FG004|Overall Study|Withdrawal by Subject|0|||
128826858|NCT00146172|463663639|FG005|Overall Study|Withdrawal by Subject|1|||
128826859|NCT00146172|463663640|FG006|Overall Study|Withdrawal by Subject|1|||
128826860|NCT00146172|463663641|FG007|Overall Study|Withdrawal by Subject|4|||
128826861|NCT00146172|463663634|FG000|Overall Study|Symptomatic Deterioration|1|||
128826862|NCT00146172|463663635|FG001|Overall Study|Symptomatic Deterioration|0|||
128826863|NCT00146172|463663636|FG002|Overall Study|Symptomatic Deterioration|1|||
128826864|NCT00146172|463663637|FG003|Overall Study|Symptomatic Deterioration|0|||
128826865|NCT00146172|463663638|FG004|Overall Study|Symptomatic Deterioration|1|||
128826866|NCT00146172|463663639|FG005|Overall Study|Symptomatic Deterioration|2|||
128826867|NCT00146172|463663640|FG006|Overall Study|Symptomatic Deterioration|0|||
128826868|NCT00146172|463663641|FG007|Overall Study|Symptomatic Deterioration|2|||
128826869|NCT03876457|463663644|FG000|Overall Study|Lost to Follow-up|1|||
128826870|NCT03876457|463663645|FG001|Overall Study|Lost to Follow-up|3|||
128826871|NCT01036724|463663646|FG000|Overall Study|Adverse Event|1|||
128826872|NCT01036724|463663647|FG001|Overall Study|Adverse Event|2|||
128826873|NCT01036724|463663646|FG000|Overall Study|Lack of Efficacy|1|||
128826874|NCT01036724|463663647|FG001|Overall Study|Lack of Efficacy|1|||
128826875|NCT01036724|463663646|FG000|Overall Study|Protocol Violation|4|||
128826876|NCT01036724|463663647|FG001|Overall Study|Protocol Violation|5|||
128826877|NCT02438137|463663649|FG000|Overall Study|Lost to Follow-up|3|||
128826878|NCT02438137|463663650|FG001|Overall Study|Lost to Follow-up|2|||
128826879|NCT02438137|463663649|FG000|Overall Study|Adverse Event|1|||
128826880|NCT02438137|463663650|FG001|Overall Study|Adverse Event|0|||
128826881|NCT02438137|463663649|FG000|Overall Study|Withdrawal by Subject|4|||
128826882|NCT02438137|463663650|FG001|Overall Study|Withdrawal by Subject|3|||
128826883|NCT02438137|463663649|FG000|Overall Study|Physician Decision|0|||
128826884|NCT02438137|463663650|FG001|Overall Study|Physician Decision|1|||
128826885|NCT01637402|463663652|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
128826886|NCT01637402|463663653|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
128826887|NCT01637402|463663652|FG000|Standard Dose Regimen|Adverse Event|1|||
128826888|NCT01637402|463663653|FG001|Standard Dose Regimen|Adverse Event|0|||
128826889|NCT01637402|463663652|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
128826890|NCT01637402|463663653|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
128826891|NCT01637402|463663652|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
128826892|NCT01637402|463663653|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
128826893|NCT01637402|463663652|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
128826894|NCT01637402|463663653|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
128826895|NCT01637402|463663652|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
128826896|NCT01637402|463663653|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
128826897|NCT02285270|463663654|FG000|Overall Study|Lost to Follow-up|1|||
128826898|NCT02285270|463663654|FG000|Overall Study|Physician Decision|3|||
128826899|NCT02285270|463663654|FG000|Overall Study|Determined to be ineligible|1|||
128826900|NCT02111096|463663655|FG000|Overall Study|Adverse Event|4|||
128826901|NCT02111096|463663656|FG001|Overall Study|Adverse Event|1|||
128826902|NCT02111096|463663657|FG002|Overall Study|Adverse Event|2|||
128826903|NCT02111096|463663655|FG000|Overall Study|Non-Compliance with Study Drug|1|||
128870725|NCT00338962|463820704|FG003|Overall Study|Lost to Follow-up|3|||
128826904|NCT02111096|463663656|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128826905|NCT02111096|463663657|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128826906|NCT02111096|463663655|FG000|Overall Study|Lost to Follow Up|1|||
128826907|NCT02111096|463663656|FG001|Overall Study|Lost to Follow Up|1|||
128826908|NCT02111096|463663657|FG002|Overall Study|Lost to Follow Up|1|||
128826909|NCT02111096|463663655|FG000|Overall Study|Physician Decision|0|||
128826910|NCT02111096|463663656|FG001|Overall Study|Physician Decision|1|||
128826911|NCT02111096|463663657|FG002|Overall Study|Physician Decision|0|||
128826912|NCT02111096|463663655|FG000|Overall Study|Protocol Violation|1|||
128826913|NCT02111096|463663656|FG001|Overall Study|Protocol Violation|0|||
128826914|NCT02111096|463663657|FG002|Overall Study|Protocol Violation|1|||
128826915|NCT02111096|463663655|FG000|Overall Study|Terminated by Sponsor|53|||
128826916|NCT02111096|463663656|FG001|Overall Study|Terminated by Sponsor|35|||
128826917|NCT02111096|463663657|FG002|Overall Study|Terminated by Sponsor|54|||
128826918|NCT02111096|463663655|FG000|Overall Study|Withdrawal by Subject|4|||
128826919|NCT02111096|463663656|FG001|Overall Study|Withdrawal by Subject|2|||
128826920|NCT02111096|463663657|FG002|Overall Study|Withdrawal by Subject|8|||
128826921|NCT03709706|463663658|FG000|Overall Study|Adverse Event|0|||
128826922|NCT03709706|463663659|FG001|Overall Study|Adverse Event|1|||
128826923|NCT03709706|463663658|FG000|Overall Study|Physician Decision|14|||
128826924|NCT03709706|463663659|FG001|Overall Study|Physician Decision|8|||
128826925|NCT03709706|463663658|FG000|Overall Study|Withdrawal by Subject|2|||
128826926|NCT03709706|463663659|FG001|Overall Study|Withdrawal by Subject|1|||
128826927|NCT03709706|463663658|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
128826928|NCT03709706|463663659|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
128826929|NCT04868617|463663660|FG000|Overall Study|Death|1|||
128826930|NCT04868617|463663661|FG001|Overall Study|Death|0|||
128826931|NCT04868617|463663660|FG000|Overall Study|Adverse Event|1|||
128826932|NCT04868617|463663661|FG001|Overall Study|Adverse Event|0|||
128826933|NCT04868617|463663660|FG000|Overall Study|Withdrawal by Subject|1|||
128826934|NCT04868617|463663661|FG001|Overall Study|Withdrawal by Subject|0|||
128826935|NCT04868617|463663660|FG000|Overall Study|Device deficiency|1|||
128826936|NCT04868617|463663661|FG001|Overall Study|Device deficiency|0|||
128826937|NCT01627561|463663662|FG000|Overall Study|Lost to Follow-up|1|||
128826938|NCT01627561|463663663|FG001|Overall Study|Lost to Follow-up|0|||
128826939|NCT01627561|463663662|FG000|Overall Study|Withdrawal by Subject|0|||
128826940|NCT01627561|463663663|FG001|Overall Study|Withdrawal by Subject|1|||
128826941|NCT01627561|463663662|FG000|Overall Study|Migrated/moved from study area|0|||
128826942|NCT01627561|463663663|FG001|Overall Study|Migrated/moved from study area|2|||
128826943|NCT01970007|463663664|FG000|Overall Study|Death|5|||
128826944|NCT01970007|463663664|FG000|Overall Study|Withdrawal by Subject|23|||
128826945|NCT01970007|463663664|FG000|Overall Study|Lost to Follow-up|24|||
128826946|NCT01970007|463663664|FG000|Overall Study|"Other endpoint"|3|||
128826947|NCT02844439|463663668|FG000|Overall Study|Withdrawal by Subject|1|||
128826948|NCT02844439|463663668|FG000|Overall Study|Lost to Follow-up|2|||
128826949|NCT02844439|463663668|FG000|Overall Study|Termination by Sponsor|4|||
128826950|NCT02844439|463663668|FG000|Overall Study|Death|28|||
128826951|NCT02844439|463663668|FG000|Overall Study|Other|5|||
128826952|NCT03170648|463663673|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
128826953|NCT03170648|463663673|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
128826954|NCT03509909|463663674|FG000|Overall Study|Withdrawal by Subject|16|||
128826955|NCT03509909|463663675|FG001|Overall Study|Withdrawal by Subject|9|||
128826956|NCT03509909|463663674|FG000|Overall Study|Lost to Follow-up|3|||
128826957|NCT03509909|463663675|FG001|Overall Study|Lost to Follow-up|4|||
128826958|NCT03509909|463663674|FG000|Overall Study|Adverse Event|2|||
128826959|NCT03509909|463663675|FG001|Overall Study|Adverse Event|0|||
128826960|NCT03500549|463663676|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
128826961|NCT03500549|463663677|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
128826962|NCT03500549|463663676|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
128826963|NCT03500549|463663677|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
128826964|NCT02754596|463663678|FG000|Overall Study|Withdrawal by Subject|3|||
128826965|NCT02754596|463663679|FG001|Overall Study|Withdrawal by Subject|4|||
128826966|NCT02754596|463663680|FG002|Overall Study|Withdrawal by Subject|0|||
128826967|NCT02754596|463663678|FG000|Overall Study|Physician Decision|1|||
128826968|NCT02754596|463663679|FG001|Overall Study|Physician Decision|1|||
128826969|NCT02754596|463663680|FG002|Overall Study|Physician Decision|1|||
128826970|NCT02754596|463663678|FG000|Overall Study|Lost to Follow-up|1|||
128826971|NCT02754596|463663679|FG001|Overall Study|Lost to Follow-up|1|||
128826972|NCT02754596|463663680|FG002|Overall Study|Lost to Follow-up|2|||
128826973|NCT02754596|463663678|FG000|Overall Study|Death|0|||
128826974|NCT02754596|463663679|FG001|Overall Study|Death|2|||
128826975|NCT02754596|463663680|FG002|Overall Study|Death|0|||
128826976|NCT02754596|463663678|FG000|Overall Study|Adverse Event|1|||
128826977|NCT02754596|463663679|FG001|Overall Study|Adverse Event|0|||
128826978|NCT02754596|463663680|FG002|Overall Study|Adverse Event|1|||
128826979|NCT02754596|463663678|FG000|Overall Study|Other|1|||
128826980|NCT02754596|463663679|FG001|Overall Study|Other|0|||
128826981|NCT02754596|463663680|FG002|Overall Study|Other|0|||
128826982|NCT02107261|463663681|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
128826983|NCT02107261|463663682|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
128826984|NCT02107261|463663681|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
128826985|NCT02107261|463663682|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
128826986|NCT04337931|463663684|FG000|Overall Study|Death|4|||
128826987|NCT04337931|463663685|FG001|Overall Study|Death|1|||
128826988|NCT04337931|463663686|FG002|Overall Study|Death|7|||
128826989|NCT04337931|463663684|FG000|Overall Study|Withdrawal by Subject|0|||
128826990|NCT04337931|463663685|FG001|Overall Study|Withdrawal by Subject|1|||
128826991|NCT04337931|463663686|FG002|Overall Study|Withdrawal by Subject|0|||
128826992|NCT04337931|463663684|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
128826993|NCT04337931|463663685|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
128826994|NCT04337931|463663686|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
128826995|NCT04337931|463663684|FG000|Overall Study|Study terminated by sponsor|3|||
128826996|NCT04337931|463663685|FG001|Overall Study|Study terminated by sponsor|6|||
128826997|NCT04337931|463663686|FG002|Overall Study|Study terminated by sponsor|2|||
128826998|NCT04337931|463663684|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
128826999|NCT04337931|463663685|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
128827000|NCT04337931|463663686|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
128827001|NCT04337931|463663684|FG000|Overall Study|Colorectal cancer treatment|1|||
128827002|NCT04337931|463663685|FG001|Overall Study|Colorectal cancer treatment|0|||
128827003|NCT04337931|463663686|FG002|Overall Study|Colorectal cancer treatment|0|||
128827004|NCT04337931|463663684|FG000|Overall Study|Participant decision|0|||
128827005|NCT04337931|463663685|FG001|Overall Study|Participant decision|1|||
128827006|NCT04337931|463663686|FG002|Overall Study|Participant decision|0|||
128827007|NCT04436289|463663687|FG000|Overall Study|Death prior to hospital discharge|8|||
128827008|NCT04436289|463663688|FG001|Overall Study|Death prior to hospital discharge|5|||
128827009|NCT04436289|463663689|FG002|Overall Study|Death prior to hospital discharge|0|||
128827010|NCT04436289|463663690|FG003|Overall Study|Death prior to hospital discharge|1|||
128827011|NCT04436289|463663687|FG000|Overall Study|Withdrawal by Subject|0|||
128827012|NCT04436289|463663688|FG001|Overall Study|Withdrawal by Subject|1|||
128827013|NCT04436289|463663689|FG002|Overall Study|Withdrawal by Subject|4|||
128827014|NCT04436289|463663690|FG003|Overall Study|Withdrawal by Subject|0|||
128827015|NCT04436289|463663687|FG000|Overall Study|Extended hospital stay|0|||
128827016|NCT04436289|463663688|FG001|Overall Study|Extended hospital stay|1|||
128827017|NCT04436289|463663689|FG002|Overall Study|Extended hospital stay|0|||
128827018|NCT04436289|463663690|FG003|Overall Study|Extended hospital stay|0|||
128827019|NCT04436289|463663687|FG000|Overall Study|Lost to Follow-up|0|||
128827020|NCT04436289|463663688|FG001|Overall Study|Lost to Follow-up|4|||
128827021|NCT04436289|463663689|FG002|Overall Study|Lost to Follow-up|1|||
128827022|NCT04436289|463663690|FG003|Overall Study|Lost to Follow-up|3|||
128827023|NCT05139992|463663693|FG000|Overall Study|Withdrawal by Subject|12|||
128827024|NCT05139992|463663693|FG000|Overall Study|Lost to Follow-up|6|||
128827025|NCT01208974|463663694|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
128827026|NCT01208974|463663695|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
128827027|NCT01208974|463663696|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
128827028|NCT01208974|463663697|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
128827029|NCT01208974|463663694|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
128827030|NCT01208974|463663695|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
128827031|NCT01208974|463663696|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
128827032|NCT01208974|463663697|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
128827033|NCT01208974|463663694|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
129204899|NCT04073186|465046982|FG000|First Wearing Cycle|Lens Discomfort|2|||
129204900|NCT04073186|465046982|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
129204901|NCT04073186|465046982|FG000|Second Wearing Cycle|Adverse Event|1|||
129204902|NCT02763644|465046983|FG000|Overall Study|Patient/guardian decision|1|||
129204903|NCT02763644|465046984|FG001|Overall Study|Patient/guardian decision|0|||
129204904|NCT02763644|465046983|FG000|Overall Study|Death|1|||
129204905|NCT02763644|465046984|FG001|Overall Study|Death|1|||
129204906|NCT02763644|465046983|FG000|Overall Study|Adverse Event|1|||
129204907|NCT02763644|465046984|FG001|Overall Study|Adverse Event|1|||
129204908|NCT00473434|465046985|FG000|Overall Study|Physician Decision|3|||
129204909|NCT00473434|465046985|FG000|Overall Study|Withdrawal by Subject|9|||
129204910|NCT00473434|465046985|FG000|Overall Study|Compliance|3|||
129204911|NCT00473434|465046985|FG000|Overall Study|Lack of Efficacy|3|||
129204912|NCT00473434|465046985|FG000|Overall Study|Adverse Event|3|||
129204913|NCT00473434|465046985|FG000|Overall Study|Patient was selling medication to others|1|||
129204914|NCT00473434|465046985|FG000|Overall Study|Safety evaluation|1|||
129204915|NCT00473434|465046985|FG000|Overall Study|Reason not specified|6|||
129204916|NCT00473434|465046985|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
129204917|NCT00473434|465046985|FG000|Overall Study|Switching to trial medication|1|||
129204918|NCT00473434|465046985|FG000|Overall Study|No longer required|1|||
129204919|NCT02356159|465046986|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129204920|NCT02356159|465046987|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129204921|NCT02356159|465046988|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129204922|NCT02356159|465046989|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129204923|NCT02356159|465046990|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129204924|NCT02356159|465046991|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
129204925|NCT00861705|465046992|FG000|Overall Study|Never Began Treatment|7|||
129204926|NCT00861705|465046993|FG001|Overall Study|Never Began Treatment|3|||
129204927|NCT00861705|465046994|FG002|Overall Study|Never Began Treatment|0|||
129204928|NCT00861705|465046995|FG003|Overall Study|Never Began Treatment|1|||
129204929|NCT06418152|465046996|FG000|Overall Study|Frequent DBS setting changes|1|||
129204930|NCT06418152|465046996|FG000|Overall Study|Withdrawal by Subject|2|||
129204931|NCT00667628|465046997|FG000|Overall Study|Lost to Follow-up|1|||
129204932|NCT00667628|465046998|FG001|Overall Study|Lost to Follow-up|0|||
129204933|NCT00667628|465046997|FG000|Overall Study|Death|6|||
129204934|NCT00667628|465046998|FG001|Overall Study|Death|6|||
129204935|NCT00667628|465046997|FG000|Overall Study|Investigator Considers in Best Interest|1|||
129204936|NCT00667628|465046998|FG001|Overall Study|Investigator Considers in Best Interest|0|||
129204937|NCT00667628|465046997|FG000|Overall Study|Sponsor Terminated Study|17|||
129204938|NCT00667628|465046998|FG001|Overall Study|Sponsor Terminated Study|21|||
129204939|NCT03360682|465046999|FG000|Overall Study|Adverse Event|3|||
129204940|NCT01962441|465047002|FG000|Randomized Period|Randomized but Never Treated|4|||
129204941|NCT01962441|465047003|FG001|Randomized Period|Randomized but Never Treated|2|||
129204942|NCT01962441|465047004|FG002|Randomized Period|Randomized but Never Treated|3|||
129204943|NCT01962441|465047002|FG000|Randomized Period|Lost to Follow-up|2|||
128827034|NCT01208974|463663695|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
128827035|NCT01208974|463663696|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
128827036|NCT01208974|463663697|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
128827037|NCT05521516|463663698|FG000|Overall Study|Withdrawal by Subject|1|||
128827038|NCT05521516|463663699|FG001|Overall Study|Withdrawal by Subject|1|||
128827039|NCT04305327|463663700|FG000|Overall Study|Study early termination|2|||
128827040|NCT04305327|463663701|FG001|Overall Study|Study early termination|5|||
128827041|NCT04305327|463663702|FG002|Overall Study|Study early termination|2|||
128827042|NCT04305327|463663703|FG003|Overall Study|Study early termination|2|||
128827043|NCT04305327|463663700|FG000|Overall Study|Withdrawal by Subject|0|||
128827044|NCT04305327|463663701|FG001|Overall Study|Withdrawal by Subject|1|||
128827045|NCT04305327|463663702|FG002|Overall Study|Withdrawal by Subject|0|||
128827046|NCT04305327|463663703|FG003|Overall Study|Withdrawal by Subject|0|||
128827047|NCT00747565|463663704|FG000|Overall Study|Withdrawal by Subject|10|||
128827048|NCT00747565|463663705|FG001|Overall Study|Withdrawal by Subject|6|||
128827049|NCT00747565|463663704|FG000|Overall Study|Lost to Follow-up|4|||
128827050|NCT00747565|463663705|FG001|Overall Study|Lost to Follow-up|1|||
128827051|NCT03777657|463663706|FG000|Overall Study|Death|397|||
128827052|NCT03777657|463663707|FG001|Overall Study|Death|431|||
128827053|NCT03777657|463663706|FG000|Overall Study|Study Closed by Sponsor|77|||
128827054|NCT03777657|463663707|FG001|Overall Study|Study Closed by Sponsor|38|||
128827055|NCT03777657|463663706|FG000|Overall Study|Withdrawal by Subject|20|||
128827056|NCT03777657|463663707|FG001|Overall Study|Withdrawal by Subject|17|||
128827057|NCT03777657|463663706|FG000|Overall Study|Lost to Follow-up|6|||
128827058|NCT03777657|463663707|FG001|Overall Study|Lost to Follow-up|10|||
128827059|NCT00545545|463663708|FG000|Overall Study|Progressive Neoplastic Disease|1|||
128827060|NCT00545545|463663709|FG001|Overall Study|Progressive Neoplastic Disease|5|||
128827061|NCT00545545|463663710|FG002|Overall Study|Progressive Neoplastic Disease|0|||
128827062|NCT00545545|463663711|FG003|Overall Study|Progressive Neoplastic Disease|4|||
128827063|NCT00545545|463663712|FG004|Overall Study|Progressive Neoplastic Disease|8|||
128827064|NCT00545545|463663713|FG005|Overall Study|Progressive Neoplastic Disease|7|||
128827065|NCT00545545|463663708|FG000|Overall Study|Withdrawal by Subject|0|||
128827066|NCT00545545|463663709|FG001|Overall Study|Withdrawal by Subject|1|||
128827067|NCT00545545|463663710|FG002|Overall Study|Withdrawal by Subject|0|||
128827068|NCT00545545|463663711|FG003|Overall Study|Withdrawal by Subject|0|||
128827069|NCT00545545|463663712|FG004|Overall Study|Withdrawal by Subject|0|||
128827070|NCT00545545|463663713|FG005|Overall Study|Withdrawal by Subject|0|||
128827071|NCT00545545|463663708|FG000|Overall Study|Physician Decision|1|||
128827072|NCT00545545|463663709|FG001|Overall Study|Physician Decision|0|||
128827073|NCT00545545|463663710|FG002|Overall Study|Physician Decision|0|||
128827074|NCT00545545|463663711|FG003|Overall Study|Physician Decision|0|||
128827075|NCT00545545|463663712|FG004|Overall Study|Physician Decision|0|||
128827076|NCT00545545|463663713|FG005|Overall Study|Physician Decision|1|||
128827077|NCT00545545|463663708|FG000|Overall Study|Irinotecan intolerance|1|||
128827078|NCT00545545|463663709|FG001|Overall Study|Irinotecan intolerance|1|||
128827079|NCT00545545|463663710|FG002|Overall Study|Irinotecan intolerance|0|||
128827080|NCT00545545|463663711|FG003|Overall Study|Irinotecan intolerance|0|||
128827081|NCT00545545|463663712|FG004|Overall Study|Irinotecan intolerance|0|||
128827082|NCT00545545|463663713|FG005|Overall Study|Irinotecan intolerance|0|||
128827083|NCT00545545|463663708|FG000|Overall Study|No target lesions to track post surgery|0|||
128827084|NCT00545545|463663709|FG001|Overall Study|No target lesions to track post surgery|0|||
128827085|NCT00545545|463663710|FG002|Overall Study|No target lesions to track post surgery|0|||
128827086|NCT00545545|463663711|FG003|Overall Study|No target lesions to track post surgery|0|||
128827087|NCT00545545|463663712|FG004|Overall Study|No target lesions to track post surgery|1|||
128827088|NCT00545545|463663713|FG005|Overall Study|No target lesions to track post surgery|1|||
128827089|NCT05464732|463663725|FG000|Overall Study|Lost to Follow-up|0|||
128827090|NCT05464732|463663726|FG001|Overall Study|Lost to Follow-up|1|||
128827091|NCT05464732|463663725|FG000|Overall Study|Adverse Event|1|||
128827092|NCT05464732|463663726|FG001|Overall Study|Adverse Event|0|||
128827093|NCT04882917|463663730|FG000|Overall Study|Adverse Event|0|||
128827094|NCT04882917|463663731|FG001|Overall Study|Adverse Event|1|||
128827095|NCT04882917|463663732|FG002|Overall Study|Adverse Event|2|||
128827096|NCT04882917|463663733|FG003|Overall Study|Adverse Event|2|||
128827097|NCT04882917|463663730|FG000|Overall Study|Withdrawal by Subject|1|||
128827098|NCT04882917|463663731|FG001|Overall Study|Withdrawal by Subject|0|||
128827099|NCT04882917|463663732|FG002|Overall Study|Withdrawal by Subject|2|||
128827100|NCT04882917|463663733|FG003|Overall Study|Withdrawal by Subject|1|||
128827101|NCT04882917|463663730|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
128827102|NCT04882917|463663731|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
128827103|NCT04882917|463663732|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
128827104|NCT04882917|463663733|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
128827105|NCT00319020|463663734|FG000|Overall Study|Death|2|||
128827106|NCT00319020|463663735|FG001|Overall Study|Death|2|||
128827107|NCT00319020|463663734|FG000|Overall Study|Withdrawal by Subject|4|||
128827108|NCT00319020|463663735|FG001|Overall Study|Withdrawal by Subject|1|||
128827109|NCT00319020|463663734|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
128827110|NCT00319020|463663735|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
128827111|NCT00319020|463663734|FG000|Overall Study|Administrative reason|0|||
128827112|NCT00319020|463663735|FG001|Overall Study|Administrative reason|5|||
128827113|NCT00319020|463663734|FG000|Overall Study|Disease progression|0|||
128827114|NCT00319020|463663735|FG001|Overall Study|Disease progression|2|||
128827115|NCT00319020|463663734|FG000|Overall Study|Transplant|0|||
128827116|NCT00319020|463663735|FG001|Overall Study|Transplant|1|||
128827117|NCT00319020|463663734|FG000|Overall Study|Treatment failure|0|||
128827118|NCT00319020|463663735|FG001|Overall Study|Treatment failure|1|||
128827119|NCT00319020|463663734|FG000|Overall Study|Adverse Event|0|||
128827120|NCT00319020|463663735|FG001|Overall Study|Adverse Event|1|||
128827121|NCT00227266|463663736|FG000|Overall Study|Withdrawal by Subject|0|||
128827122|NCT00227266|463663737|FG001|Overall Study|Withdrawal by Subject|0|||
128827123|NCT00227266|463663738|FG002|Overall Study|Withdrawal by Subject|1|||
128827124|NCT00227266|463663736|FG000|Overall Study|Protocol Violation|1|||
128827125|NCT00227266|463663737|FG001|Overall Study|Protocol Violation|0|||
128827126|NCT00227266|463663738|FG002|Overall Study|Protocol Violation|1|||
128827127|NCT00227266|463663736|FG000|Overall Study|Excessive weight gain|0|||
128827128|NCT00227266|463663737|FG001|Overall Study|Excessive weight gain|0|||
128827129|NCT00227266|463663738|FG002|Overall Study|Excessive weight gain|2|||
128827130|NCT02678689|463663739|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
128827131|NCT02678689|463663740|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
128827132|NCT03959423|463663744|FG000|Overall Study|Withdrawal by Subject|2|||
128827133|NCT03959423|463663745|FG001|Overall Study|Withdrawal by Subject|3|||
128827134|NCT03959423|463663744|FG000|Overall Study|Physician Decision|0|||
128827135|NCT03959423|463663745|FG001|Overall Study|Physician Decision|1|||
128827136|NCT03959423|463663744|FG000|Overall Study|Lost to Follow-up|1|||
128827137|NCT03959423|463663745|FG001|Overall Study|Lost to Follow-up|0|||
128827138|NCT03959423|463663744|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
128827139|NCT03959423|463663745|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
128827140|NCT04926740|463663746|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
128827141|NCT04926740|463663747|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
128827142|NCT04926740|463663746|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
128827143|NCT04926740|463663747|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
128827144|NCT02549352|463663748|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
128827145|NCT02549352|463663749|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
128827146|NCT02549352|463663748|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
128827147|NCT02549352|463663749|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
128827148|NCT02549352|463663748|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
128827149|NCT02549352|463663749|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
128827150|NCT02549352|463663748|FG000|12-month Follow-up|Withdrawal by Subject|4|||
128827151|NCT02549352|463663749|FG001|12-month Follow-up|Withdrawal by Subject|5|||
128827152|NCT02549352|463663748|FG000|12-month Follow-up|Lost to Follow-up|3|||
128827153|NCT02549352|463663749|FG001|12-month Follow-up|Lost to Follow-up|2|||
128827154|NCT02549352|463663748|FG000|12-month Follow-up|Death|0|||
128827155|NCT02549352|463663749|FG001|12-month Follow-up|Death|1|||
128827156|NCT02549352|463663748|FG000|12-month Follow-up|Protocol Violation|0|||
128827157|NCT02549352|463663749|FG001|12-month Follow-up|Protocol Violation|1|||
128827158|NCT02549352|463663748|FG000|12-month Follow-up|Other|1|||
128827159|NCT02549352|463663749|FG001|12-month Follow-up|Other|3|||
128827160|NCT00593840|463663752|FG000|Overall Study|Withdrawal by Subject|1|||
128827161|NCT04530487|463664906|FG000|Overall Study|Death|1|||
128827162|NCT00655499|463664907|FG000|Overall Study|not eligible|4|||
128827163|NCT01184326|463664908|FG000|Overall Study|Adverse Event|1|||
128827164|NCT01184326|463664909|FG001|Overall Study|Adverse Event|2|||
128827165|NCT01184326|463664910|FG002|Overall Study|Adverse Event|0|||
128827166|NCT01184326|463664908|FG000|Overall Study|Death|0|||
128827167|NCT01184326|463664909|FG001|Overall Study|Death|0|||
128827168|NCT01184326|463664910|FG002|Overall Study|Death|1|||
128827169|NCT01184326|463664908|FG000|Overall Study|Withdrawal by Subject|0|||
128827170|NCT01184326|463664909|FG001|Overall Study|Withdrawal by Subject|0|||
128827171|NCT01184326|463664910|FG002|Overall Study|Withdrawal by Subject|1|||
128827172|NCT01184326|463664908|FG000|Overall Study|Physician Decision|1|||
128827173|NCT01184326|463664909|FG001|Overall Study|Physician Decision|1|||
128827174|NCT01184326|463664910|FG002|Overall Study|Physician Decision|0|||
128827175|NCT01184326|463664908|FG000|Overall Study|Disease Progression|1|||
128827176|NCT01184326|463664909|FG001|Overall Study|Disease Progression|3|||
128827177|NCT01184326|463664910|FG002|Overall Study|Disease Progression|12|||
128827178|NCT00557492|463664917|FG000|Overall Study|Change in health insurance|1|||
128827179|NCT04213807|463664918|FG000|Overall Study|Physician Decision|0|||
128827180|NCT04213807|463664919|FG001|Overall Study|Physician Decision|0|||
128827181|NCT04213807|463664920|FG002|Overall Study|Physician Decision|1|||
128827182|NCT01574716|463664921|FG000|Part 1|Death|3|||
128827183|NCT01574716|463664922|FG001|Part 1|Death|1|||
128827184|NCT01574716|463664923|FG002|Part 1|Death|8|||
128827185|NCT01574716|463664924|FG003|Part 1|Death|0|||
128827186|NCT01574716|463664925|FG004|Part 1|Death|0|||
128827187|NCT01574716|463664921|FG000|Part 1|Discontinuation of study by sponsor|0|||
128827188|NCT01574716|463664922|FG001|Part 1|Discontinuation of study by sponsor|0|||
128827189|NCT01574716|463664923|FG002|Part 1|Discontinuation of study by sponsor|1|||
128827190|NCT01574716|463664924|FG003|Part 1|Discontinuation of study by sponsor|0|||
128827191|NCT01574716|463664925|FG004|Part 1|Discontinuation of study by sponsor|0|||
128827192|NCT01574716|463664921|FG000|Part 1|Withdrawal by Subject|0|||
128827193|NCT01574716|463664922|FG001|Part 1|Withdrawal by Subject|2|||
128827194|NCT01574716|463664923|FG002|Part 1|Withdrawal by Subject|0|||
128827195|NCT01574716|463664924|FG003|Part 1|Withdrawal by Subject|0|||
128827196|NCT01574716|463664925|FG004|Part 1|Withdrawal by Subject|0|||
128827197|NCT01574716|463664921|FG000|Part 1|Lost to Follow-up|0|||
128827198|NCT01574716|463664922|FG001|Part 1|Lost to Follow-up|1|||
128827199|NCT01574716|463664923|FG002|Part 1|Lost to Follow-up|0|||
128827200|NCT01574716|463664924|FG003|Part 1|Lost to Follow-up|0|||
128827201|NCT01574716|463664925|FG004|Part 1|Lost to Follow-up|0|||
128827202|NCT01574716|463664921|FG000|Part 2|Progressive disease|0|||
128827203|NCT01574716|463664922|FG001|Part 2|Progressive disease|0|||
128827204|NCT01574716|463664923|FG002|Part 2|Progressive disease|0|||
128827205|NCT01574716|463664924|FG003|Part 2|Progressive disease|1|||
128827206|NCT01574716|463664925|FG004|Part 2|Progressive disease|0|||
128827207|NCT01574716|463664921|FG000|Part 2|Death|0|||
128827208|NCT01574716|463664922|FG001|Part 2|Death|0|||
128827209|NCT01574716|463664923|FG002|Part 2|Death|0|||
128827210|NCT01574716|463664924|FG003|Part 2|Death|76|||
128827211|NCT01574716|463664925|FG004|Part 2|Death|35|||
128827212|NCT01574716|463664921|FG000|Part 2|Discontinuation of study by sponsor|0|||
128827213|NCT01574716|463664922|FG001|Part 2|Discontinuation of study by sponsor|0|||
128827214|NCT01574716|463664923|FG002|Part 2|Discontinuation of study by sponsor|0|||
128827215|NCT01574716|463664924|FG003|Part 2|Discontinuation of study by sponsor|51|||
128827216|NCT01574716|463664925|FG004|Part 2|Discontinuation of study by sponsor|31|||
128827217|NCT01574716|463664921|FG000|Part 2|Withdrawal by Subject|0|||
128827218|NCT01574716|463664922|FG001|Part 2|Withdrawal by Subject|0|||
128827219|NCT01574716|463664923|FG002|Part 2|Withdrawal by Subject|0|||
128827220|NCT01574716|463664924|FG003|Part 2|Withdrawal by Subject|5|||
128827221|NCT01574716|463664925|FG004|Part 2|Withdrawal by Subject|4|||
128827222|NCT01574716|463664921|FG000|Part 2|Brain metastases|0|||
128827223|NCT01574716|463664922|FG001|Part 2|Brain metastases|0|||
128827224|NCT01574716|463664923|FG002|Part 2|Brain metastases|0|||
128827225|NCT01574716|463664924|FG003|Part 2|Brain metastases|1|||
128827226|NCT01574716|463664925|FG004|Part 2|Brain metastases|0|||
128827227|NCT01574716|463664921|FG000|Part 2|Lost to Follow-up|0|||
128827228|NCT01574716|463664922|FG001|Part 2|Lost to Follow-up|0|||
128827229|NCT01574716|463664923|FG002|Part 2|Lost to Follow-up|0|||
128827230|NCT01574716|463664924|FG003|Part 2|Lost to Follow-up|3|||
128827231|NCT01574716|463664925|FG004|Part 2|Lost to Follow-up|0|||
128827232|NCT03621735|463664926|FG000|Overall Study|Withdrawal by Subject|13|||
128827233|NCT03621735|463664927|FG001|Overall Study|Withdrawal by Subject|13|||
128827234|NCT01579318|463664937|FG000|Overall Study|Disease Progression|1|||
128827235|NCT02347332|463664938|FG000|Overall Study|Not treated|5|||
128827236|NCT02347332|463664939|FG001|Overall Study|Not treated|2|||
128827237|NCT02347332|463664938|FG000|Overall Study|Progressive disease|141|||
128827238|NCT02347332|463664939|FG001|Overall Study|Progressive disease|159|||
128827239|NCT02347332|463664938|FG000|Overall Study|Adverse Event|50|||
128827240|NCT02347332|463664939|FG001|Overall Study|Adverse Event|41|||
128827241|NCT02347332|463664938|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
128827242|NCT02347332|463664939|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
128827243|NCT02347332|463664938|FG000|Overall Study|Protocol Violation|1|||
128827244|NCT02347332|463664939|FG001|Overall Study|Protocol Violation|1|||
128827245|NCT02347332|463664938|FG000|Overall Study|Lost to Follow-up|2|||
128827246|NCT02347332|463664939|FG001|Overall Study|Lost to Follow-up|1|||
128827247|NCT02347332|463664938|FG000|Overall Study|Physician Decision|4|||
128827248|NCT02347332|463664939|FG001|Overall Study|Physician Decision|3|||
128827249|NCT02347332|463664938|FG000|Overall Study|Withdrawal by Subject|20|||
128827250|NCT02347332|463664939|FG001|Overall Study|Withdrawal by Subject|14|||
128827251|NCT02347332|463664938|FG000|Overall Study|Protocol requirement|1|||
128827252|NCT02347332|463664939|FG001|Overall Study|Protocol requirement|1|||
128827253|NCT02347332|463664938|FG000|Overall Study|Switch Post-Trial program|0|||
128827254|NCT02347332|463664939|FG001|Overall Study|Switch Post-Trial program|1|||
128827255|NCT00112359|463664940|FG000|Overall Study|Unrelated adverse event|16|||
128827256|NCT00112359|463664941|FG001|Overall Study|Unrelated adverse event|8|||
128827257|NCT00112359|463664940|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
128827258|NCT00112359|463664941|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
128827259|NCT00112359|463664940|FG000|Overall Study|Related adverse event|5|||
128827260|NCT00112359|463664941|FG001|Overall Study|Related adverse event|3|||
128827261|NCT00112359|463664940|FG000|Overall Study|Lost to Follow-up|0|||
128827262|NCT00112359|463664941|FG001|Overall Study|Lost to Follow-up|1|||
128827263|NCT00112359|463664940|FG000|Overall Study|Personal/administrative|1|||
128827264|NCT00112359|463664941|FG001|Overall Study|Personal/administrative|1|||
128827265|NCT00112359|463664940|FG000|Overall Study|Other|3|||
128827266|NCT00112359|463664941|FG001|Overall Study|Other|0|||
128827267|NCT01961609|463664942|FG000|Initiation|Missing|3|||
128827268|NCT01961609|463664943|FG001|Initiation|Missing|2|||
128827269|NCT01961609|463664944|FG002|Initiation|Missing|0|||
128827270|NCT01961609|463664945|FG003|Initiation|Missing|0|||
128827271|NCT01961609|463664942|FG000|Initiation|Protocol deviation|1|||
128827272|NCT01961609|463664943|FG001|Initiation|Protocol deviation|0|||
128827273|NCT01961609|463664944|FG002|Initiation|Protocol deviation|0|||
128827274|NCT01961609|463664945|FG003|Initiation|Protocol deviation|0|||
128827275|NCT01961609|463664942|FG000|Initiation|Death|0|||
128827276|NCT01961609|463664943|FG001|Initiation|Death|1|||
128827277|NCT01961609|463664944|FG002|Initiation|Death|0|||
128827278|NCT01961609|463664945|FG003|Initiation|Death|0|||
128827279|NCT01961609|463664942|FG000|Initiation|Administrative problems|1|||
128827280|NCT01961609|463664943|FG001|Initiation|Administrative problems|0|||
128827281|NCT01961609|463664944|FG002|Initiation|Administrative problems|0|||
128827282|NCT01961609|463664945|FG003|Initiation|Administrative problems|0|||
128827283|NCT01961609|463664942|FG000|Initiation|Withdrawal by Subject|1|||
128827284|NCT01961609|463664943|FG001|Initiation|Withdrawal by Subject|2|||
128827285|NCT01961609|463664944|FG002|Initiation|Withdrawal by Subject|0|||
128827286|NCT01961609|463664945|FG003|Initiation|Withdrawal by Subject|0|||
128827287|NCT01961609|463664942|FG000|Initiation|Lack of Efficacy|2|||
128827288|NCT01961609|463664943|FG001|Initiation|Lack of Efficacy|1|||
128827289|NCT01961609|463664944|FG002|Initiation|Lack of Efficacy|0|||
128827290|NCT01961609|463664945|FG003|Initiation|Lack of Efficacy|0|||
128827291|NCT01961609|463664942|FG000|Initiation|Abnormal lab values|0|||
128827292|NCT01961609|463664943|FG001|Initiation|Abnormal lab values|1|||
128827293|NCT01961609|463664944|FG002|Initiation|Abnormal lab values|0|||
128827294|NCT01961609|463664945|FG003|Initiation|Abnormal lab values|0|||
128827295|NCT01961609|463664942|FG000|Initiation|Adverse Event|3|||
128827296|NCT01961609|463664943|FG001|Initiation|Adverse Event|5|||
128827297|NCT01961609|463664944|FG002|Initiation|Adverse Event|0|||
128827298|NCT01961609|463664945|FG003|Initiation|Adverse Event|0|||
128827299|NCT01961609|463664942|FG000|Initiation|Randomized but not treated|1|||
128827300|NCT01961609|463664943|FG001|Initiation|Randomized but not treated|1|||
128827301|NCT01961609|463664944|FG002|Initiation|Randomized but not treated|0|||
128827302|NCT01961609|463664945|FG003|Initiation|Randomized but not treated|0|||
128827303|NCT01961609|463664942|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
128827304|NCT01961609|463664943|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
128827305|NCT01961609|463664944|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
128827306|NCT01961609|463664945|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
128827307|NCT01961609|463664942|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
128827308|NCT01961609|463664943|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
128827309|NCT01961609|463664944|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
128827310|NCT01961609|463664945|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
128827311|NCT01961609|463664942|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
128827312|NCT01961609|463664943|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
128827313|NCT01961609|463664944|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
128827314|NCT01961609|463664945|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
128827315|NCT01961609|463664942|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
128827316|NCT01961609|463664943|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
128827317|NCT01961609|463664944|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
128827318|NCT01961609|463664945|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
128827319|NCT01961609|463664942|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
128827320|NCT01961609|463664943|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
128827321|NCT01961609|463664944|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
128827322|NCT01961609|463664945|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
128827323|NCT01961609|463664942|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
128827324|NCT01961609|463664943|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
128827325|NCT01961609|463664944|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
128827326|NCT01961609|463664945|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
128827327|NCT01961609|463664942|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
128827328|NCT01961609|463664943|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
128827329|NCT01961609|463664944|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
128827330|NCT01961609|463664945|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
128827331|NCT01961609|463664942|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
128827332|NCT01961609|463664943|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
128827333|NCT01961609|463664944|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
128827334|NCT01961609|463664945|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
128827335|NCT01961609|463664942|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
128827336|NCT01961609|463664943|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
128827337|NCT01961609|463664944|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
128827338|NCT01961609|463664945|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
128827339|NCT01961609|463664942|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
128827340|NCT01961609|463664943|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
128827341|NCT01961609|463664944|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
128827342|NCT01961609|463664945|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
128827343|NCT01961609|463664942|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
128827344|NCT01961609|463664943|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
128827345|NCT01961609|463664944|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
128827346|NCT01961609|463664945|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
128827347|NCT01961609|463664942|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
128827348|NCT01961609|463664943|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
128827349|NCT01961609|463664944|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
128827350|NCT01961609|463664945|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
128827351|NCT01988402|463664946|FG000|Overall Study|Adverse Event|1|||
128827352|NCT01988402|463664947|FG001|Overall Study|Adverse Event|2|||
128827353|NCT01988402|463664946|FG000|Overall Study|Withdrawal by Subject|1|||
128827354|NCT01988402|463664947|FG001|Overall Study|Withdrawal by Subject|0|||
128827355|NCT00571649|463664949|FG000|Treatment Period|Adverse Event|438|||
128827356|NCT00571649|463664950|FG001|Treatment Period|Adverse Event|385|||
128827357|NCT00571649|463664949|FG000|Treatment Period|Clinical endpoint reached|50|||
128827358|NCT00571649|463664950|FG001|Treatment Period|Clinical endpoint reached|56|||
128827359|NCT00571649|463664949|FG000|Treatment Period|Withdrawal by Subject|285|||
128827360|NCT00571649|463664950|FG001|Treatment Period|Withdrawal by Subject|255|||
128827361|NCT00571649|463664949|FG000|Treatment Period|Death|76|||
128827362|NCT00571649|463664950|FG001|Treatment Period|Death|59|||
128827363|NCT00571649|463664949|FG000|Treatment Period|Physician Decision|8|||
128827364|NCT00571649|463664950|FG001|Treatment Period|Physician Decision|9|||
128827365|NCT00571649|463664949|FG000|Treatment Period|Lost to Follow-up|43|||
128827366|NCT00571649|463664950|FG001|Treatment Period|Lost to Follow-up|41|||
128827367|NCT00571649|463664949|FG000|Treatment Period|Non-compliant with study medication|88|||
128827368|NCT00571649|463664950|FG001|Treatment Period|Non-compliant with study medication|89|||
128827369|NCT00571649|463664949|FG000|Treatment Period|Patient convenience|11|||
128827370|NCT00571649|463664950|FG001|Treatment Period|Patient convenience|13|||
128827371|NCT00571649|463664949|FG000|Treatment Period|Protocol Violation|90|||
128827372|NCT00571649|463664950|FG001|Treatment Period|Protocol Violation|92|||
128827373|NCT00571649|463664949|FG000|Treatment Period|Technical problems|3|||
128827374|NCT00571649|463664950|FG001|Treatment Period|Technical problems|5|||
128827375|NCT00571649|463664949|FG000|Follow-up Period|Adverse Event|46|||
128827376|NCT00571649|463664950|FG001|Follow-up Period|Adverse Event|40|||
128827377|NCT00571649|463664949|FG000|Follow-up Period|Clinical endpoint reached|5|||
128827378|NCT00571649|463664950|FG001|Follow-up Period|Clinical endpoint reached|2|||
128827379|NCT00571649|463664949|FG000|Follow-up Period|Withdrawal by Subject|119|||
128827380|NCT00571649|463664950|FG001|Follow-up Period|Withdrawal by Subject|115|||
128827381|NCT00571649|463664949|FG000|Follow-up Period|Death|132|||
128827382|NCT00571649|463664950|FG001|Follow-up Period|Death|133|||
128827383|NCT00571649|463664949|FG000|Follow-up Period|Physician Decision|7|||
128827384|NCT00571649|463664950|FG001|Follow-up Period|Physician Decision|13|||
128827385|NCT00571649|463664949|FG000|Follow-up Period|Lost to Follow-up|95|||
128827386|NCT00571649|463664950|FG001|Follow-up Period|Lost to Follow-up|92|||
128827387|NCT00571649|463664949|FG000|Follow-up Period|Patient convenience|136|||
128827388|NCT00571649|463664950|FG001|Follow-up Period|Patient convenience|121|||
128827389|NCT00571649|463664949|FG000|Follow-up Period|Protocol Violation|5|||
128827390|NCT00571649|463664950|FG001|Follow-up Period|Protocol Violation|12|||
128827391|NCT00582972|463664951|FG000|Overall Study|Protocol Violation|2|||
128827392|NCT01566890|463664954|FG000|Overall Study|Adverse Event|1|||
128827393|NCT01566890|463664955|FG001|Overall Study|Adverse Event|0|||
128827394|NCT01566890|463664956|FG002|Overall Study|Adverse Event|0|||
128827395|NCT01566890|463664957|FG003|Overall Study|Adverse Event|0|||
128827396|NCT01566890|463664958|FG004|Overall Study|Adverse Event|0|||
128827397|NCT01566890|463664954|FG000|Overall Study|Withdrawal by Subject|3|||
128827398|NCT01566890|463664955|FG001|Overall Study|Withdrawal by Subject|1|||
128827399|NCT01566890|463664956|FG002|Overall Study|Withdrawal by Subject|1|||
128827400|NCT01566890|463664957|FG003|Overall Study|Withdrawal by Subject|1|||
128827401|NCT01566890|463664958|FG004|Overall Study|Withdrawal by Subject|0|||
128827402|NCT01566890|463664954|FG000|Overall Study|Screen failure|6|||
128827403|NCT01566890|463664955|FG001|Overall Study|Screen failure|0|||
128827404|NCT01566890|463664956|FG002|Overall Study|Screen failure|1|||
128827405|NCT01566890|463664957|FG003|Overall Study|Screen failure|1|||
128827406|NCT01566890|463664958|FG004|Overall Study|Screen failure|0|||
128827407|NCT01566890|463664954|FG000|Overall Study|Incomplete CEU data|1|||
128827408|NCT01566890|463664955|FG001|Overall Study|Incomplete CEU data|3|||
128827409|NCT01566890|463664956|FG002|Overall Study|Incomplete CEU data|5|||
128827410|NCT01566890|463664957|FG003|Overall Study|Incomplete CEU data|8|||
128827411|NCT01566890|463664958|FG004|Overall Study|Incomplete CEU data|0|||
128827412|NCT01566890|463664954|FG000|Overall Study|Lost to Follow-up|0|||
128827413|NCT01566890|463664955|FG001|Overall Study|Lost to Follow-up|0|||
128827414|NCT01566890|463664956|FG002|Overall Study|Lost to Follow-up|4|||
128827415|NCT01566890|463664957|FG003|Overall Study|Lost to Follow-up|4|||
128827416|NCT01566890|463664958|FG004|Overall Study|Lost to Follow-up|0|||
128827417|NCT01566890|463664954|FG000|Overall Study|Other|0|||
128827418|NCT01566890|463664955|FG001|Overall Study|Other|0|||
128827419|NCT01566890|463664956|FG002|Overall Study|Other|0|||
128827420|NCT01566890|463664957|FG003|Overall Study|Other|0|||
128827421|NCT01566890|463664958|FG004|Overall Study|Other|7|||
128827422|NCT01211184|463664964|FG000|Overall Study|Withdrawal by Subject|0|||
128827423|NCT01211184|463664965|FG001|Overall Study|Withdrawal by Subject|2|||
128827424|NCT01211184|463664966|FG002|Overall Study|Withdrawal by Subject|1|||
128827425|NCT01421667|463664967|FG000|Overall Study|Withdrawal by Subject|0|||
128827426|NCT01421667|463664968|FG001|Overall Study|Withdrawal by Subject|1|||
128827427|NCT01421667|463664969|FG002|Overall Study|Withdrawal by Subject|2|||
128827428|NCT01421667|463664970|FG003|Overall Study|Withdrawal by Subject|1|||
128827429|NCT01421667|463664967|FG000|Overall Study|Lost to Follow-up|0|||
128827430|NCT01421667|463664968|FG001|Overall Study|Lost to Follow-up|1|||
128827431|NCT01421667|463664969|FG002|Overall Study|Lost to Follow-up|0|||
128827432|NCT01421667|463664970|FG003|Overall Study|Lost to Follow-up|0|||
128827433|NCT04060212|463664971|FG000|Overall Study|Withdrawal by Subject|7|||
128827434|NCT02928172|463664975|FG000|Overall Study|Device did not record data|1|||
128827435|NCT02016872|463664980|FG000|Overall Study|Withdrawal by Subject|10|||
128827436|NCT02016872|463664980|FG000|Overall Study|Death Progression|2|||
128827437|NCT02016872|463664980|FG000|Overall Study|No FMISO scan|1|||
128827438|NCT02016872|463664980|FG000|Overall Study|Ineligible|2|||
128827439|NCT02761187|463664981|FG000|Overall Study|Too ill to Participate|13|||
128827440|NCT02761187|463664982|FG001|Overall Study|Too ill to Participate|8|||
128827441|NCT02761187|463664981|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
128827442|NCT02761187|463664982|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
128827443|NCT02761187|463664981|FG000|Overall Study|Patient withdrew consent|64|||
128827444|NCT02761187|463664982|FG001|Overall Study|Patient withdrew consent|58|||
128827445|NCT02761187|463664981|FG000|Overall Study|Physician discretion|4|||
128827446|NCT02761187|463664982|FG001|Overall Study|Physician discretion|8|||
128827447|NCT02761187|463664981|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
128827448|NCT02761187|463664982|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
128827449|NCT02761187|463664981|FG000|Overall Study|On Hospice|20|||
128827450|NCT02761187|463664982|FG001|Overall Study|On Hospice|26|||
128827451|NCT02761187|463664981|FG000|Overall Study|Deceased|474|||
128827452|NCT02761187|463664982|FG001|Overall Study|Deceased|642|||
128827453|NCT02761187|463664981|FG000|Overall Study|Lost to Follow-up|73|||
128827454|NCT02761187|463664982|FG001|Overall Study|Lost to Follow-up|63|||
128827455|NCT02761187|463664981|FG000|Overall Study|Due to study discontinued at site|100|||
128827456|NCT02761187|463664982|FG001|Overall Study|Due to study discontinued at site|85|||
128827457|NCT02761187|463664981|FG000|Overall Study|Reason not Specified|1484|||
128827458|NCT02761187|463664982|FG001|Overall Study|Reason not Specified|937|||
128827459|NCT03978637|463664983|FG000|Overall Study|Death|0|||
128827460|NCT03978637|463664984|FG001|Overall Study|Death|2|||
128827461|NCT03978637|463664985|FG002|Overall Study|Death|2|||
128827462|NCT03978637|463664986|FG003|Overall Study|Death|0|||
128827463|NCT03978637|463664983|FG000|Overall Study|Withdrawal by Subject|0|||
128827464|NCT03978637|463664984|FG001|Overall Study|Withdrawal by Subject|0|||
128827465|NCT03978637|463664985|FG002|Overall Study|Withdrawal by Subject|1|||
128827466|NCT03978637|463664986|FG003|Overall Study|Withdrawal by Subject|0|||
128827467|NCT03978637|463664983|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
128827468|NCT03978637|463664984|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
128827469|NCT03978637|463664985|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
128827470|NCT03978637|463664986|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
128827471|NCT02307682|463664987|FG000|Overall Study|Adverse Event|9|||
128827472|NCT02307682|463664988|FG001|Overall Study|Adverse Event|8|||
128827473|NCT02307682|463664989|FG002|Overall Study|Adverse Event|12|||
128827474|NCT02307682|463664987|FG000|Overall Study|Lack of Efficacy|1|||
128827475|NCT02307682|463664988|FG001|Overall Study|Lack of Efficacy|0|||
128827476|NCT02307682|463664989|FG002|Overall Study|Lack of Efficacy|1|||
128827477|NCT02307682|463664987|FG000|Overall Study|Physician Decision|2|||
128827478|NCT02307682|463664988|FG001|Overall Study|Physician Decision|2|||
128827479|NCT02307682|463664989|FG002|Overall Study|Physician Decision|8|||
128827480|NCT02307682|463664987|FG000|Overall Study|Progressive Disease|1|||
128827481|NCT02307682|463664988|FG001|Overall Study|Progressive Disease|0|||
128827482|NCT02307682|463664989|FG002|Overall Study|Progressive Disease|0|||
128827483|NCT02307682|463664987|FG000|Overall Study|Withdrawal by Subject|26|||
128827484|NCT02307682|463664988|FG001|Overall Study|Withdrawal by Subject|34|||
128827485|NCT02307682|463664989|FG002|Overall Study|Withdrawal by Subject|23|||
128827486|NCT02307682|463664987|FG000|Overall Study|Death|9|||
128827487|NCT02307682|463664988|FG001|Overall Study|Death|7|||
128827488|NCT02307682|463664989|FG002|Overall Study|Death|12|||
128827489|NCT02307682|463664987|FG000|Overall Study|Lost to Follow-up|1|||
128827490|NCT02307682|463664988|FG001|Overall Study|Lost to Follow-up|5|||
128827491|NCT02307682|463664989|FG002|Overall Study|Lost to Follow-up|6|||
128827492|NCT02307682|463664987|FG000|Overall Study|Protocol Deviation|0|||
128827493|NCT02307682|463664988|FG001|Overall Study|Protocol Deviation|0|||
128827494|NCT02307682|463664989|FG002|Overall Study|Protocol Deviation|2|||
128827495|NCT02307682|463664987|FG000|Overall Study|Other|1|||
128827496|NCT02307682|463664988|FG001|Overall Study|Other|1|||
128827497|NCT02307682|463664989|FG002|Overall Study|Other|0|||
128827498|NCT05630833|463664990|FG000|Overall Study|Adverse Event|3|||
128827499|NCT05630833|463664991|FG001|Overall Study|Adverse Event|0|||
128827500|NCT05630833|463664990|FG000|Overall Study|Lack of Efficacy|0|||
128827501|NCT05630833|463664991|FG001|Overall Study|Lack of Efficacy|1|||
128827502|NCT05630833|463664990|FG000|Overall Study|Lost to Follow-up|1|||
128827503|NCT05630833|463664991|FG001|Overall Study|Lost to Follow-up|0|||
128827504|NCT05630833|463664990|FG000|Overall Study|Withdrawal by Subject|3|||
128827505|NCT05630833|463664991|FG001|Overall Study|Withdrawal by Subject|1|||
128827506|NCT03170349|463664993|FG000|From Implant to the 30-Day Visit|Death|1|||
128827507|NCT03170349|463664993|FG000|From 30-Day to 6-Month Visit|Death|3|||
128827508|NCT03170349|463664993|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
128827509|NCT03170349|463664993|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
128827510|NCT03170349|463664993|FG000|From 6-Month to 1-Year Visit|Death|6|||
128827511|NCT03170349|463664993|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
128827512|NCT03170349|463664993|FG000|From 1-Year to 2-Year Visit|Death|13|||
128827513|NCT03170349|463664993|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
128827514|NCT03170349|463664993|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
128827515|NCT03170349|463664993|FG000|From 2-Year to 3-Year Visit|Death|10|||
128827516|NCT03170349|463664993|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
128827517|NCT03170349|463664993|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
128827518|NCT03170349|463664993|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
128827519|NCT01084694|463666016|FG000|Overall Study|Withdrawal by Subject|2|||
128827520|NCT01084694|463666017|FG001|Overall Study|Withdrawal by Subject|1|||
128827521|NCT01084694|463666016|FG000|Overall Study|Death|2|||
128827522|NCT01084694|463666017|FG001|Overall Study|Death|12|||
128827523|NCT01084694|463666016|FG000|Overall Study|eligibility not maintained|2|||
128827524|NCT01084694|463666017|FG001|Overall Study|eligibility not maintained|7|||
128827525|NCT00945321|463666018|FG000|Period 1|Adverse Event|0|||
128827526|NCT00945321|463666019|FG001|Period 1|Adverse Event|0|||
128827527|NCT00945321|463666020|FG002|Period 1|Adverse Event|0|||
128827528|NCT00945321|463666021|FG003|Period 1|Adverse Event|0|||
128827529|NCT00945321|463666022|FG004|Period 1|Adverse Event|1|||
128827530|NCT00945321|463666023|FG005|Period 1|Adverse Event|0|||
128827531|NCT00945321|463666018|FG000|Period 4|Lost to Follow-up|0|||
128827532|NCT00945321|463666019|FG001|Period 4|Lost to Follow-up|0|||
128827533|NCT00945321|463666020|FG002|Period 4|Lost to Follow-up|0|||
128827534|NCT00945321|463666021|FG003|Period 4|Lost to Follow-up|0|||
128827535|NCT00945321|463666022|FG004|Period 4|Lost to Follow-up|0|||
128827536|NCT00945321|463666023|FG005|Period 4|Lost to Follow-up|1|||
128827537|NCT02633215|463666024|FG000|Overall Study|Lost to Follow-up|2|||
128827538|NCT02633215|463666025|FG001|Overall Study|Lost to Follow-up|3|||
128827539|NCT04017611|463666026|FG000|Overall Study|Withdrawn prior to completion|1|||
128827540|NCT00692913|463666027|FG000|Overall Study|Adverse Event|8|||
128827541|NCT00692913|463666028|FG001|Overall Study|Adverse Event|4|||
128827542|NCT00692913|463666027|FG000|Overall Study|Lost to Follow-up|3|||
128827543|NCT00692913|463666028|FG001|Overall Study|Lost to Follow-up|5|||
128827544|NCT00692913|463666027|FG000|Overall Study|Physician Decision|2|||
128827545|NCT00692913|463666028|FG001|Overall Study|Physician Decision|0|||
128827546|NCT00692913|463666027|FG000|Overall Study|Protocol Violation|1|||
128827547|NCT00692913|463666028|FG001|Overall Study|Protocol Violation|1|||
128827548|NCT00692913|463666027|FG000|Overall Study|Withdrawal by Subject|15|||
128827549|NCT00692913|463666028|FG001|Overall Study|Withdrawal by Subject|20|||
128827550|NCT02291913|463666029|FG000|Overall Study|Progressive Disease|32|||
128827551|NCT02291913|463666029|FG000|Overall Study|Adverse Event|11|||
128827552|NCT02291913|463666029|FG000|Overall Study|Death|2|||
128827553|NCT02291913|463666029|FG000|Overall Study|Physician Decision|1|||
128827554|NCT02291913|463666029|FG000|Overall Study|Withdrawal by Subject|1|||
128827555|NCT02291913|463666029|FG000|Overall Study|Protocol Violation|1|||
128827556|NCT02866942|463666038|FG000|Overall Study|Invalid consent|1|||
128827557|NCT01268306|463666041|FG000|Overall Study|Lost to Follow-up|1|||
128827558|NCT04334317|463666042|FG000|Overall Study|Adverse Event|1|||
128827559|NCT04334317|463666043|FG001|Overall Study|Adverse Event|2|||
128827560|NCT04334317|463666044|FG002|Overall Study|Adverse Event|0|||
128827561|NCT04334317|463666045|FG003|Overall Study|Adverse Event|0|||
128827562|NCT04334317|463666042|FG000|Overall Study|Protocol Deviation|0|||
128827563|NCT04334317|463666043|FG001|Overall Study|Protocol Deviation|1|||
128827564|NCT04334317|463666044|FG002|Overall Study|Protocol Deviation|0|||
128827565|NCT04334317|463666045|FG003|Overall Study|Protocol Deviation|0|||
128827566|NCT04334317|463666042|FG000|Overall Study|Withdrawal by Subject|2|||
128827567|NCT04334317|463666043|FG001|Overall Study|Withdrawal by Subject|2|||
128827568|NCT04334317|463666044|FG002|Overall Study|Withdrawal by Subject|0|||
128827569|NCT04334317|463666045|FG003|Overall Study|Withdrawal by Subject|0|||
128827570|NCT01128595|463666050|FG000|Treatment Period 3|Withdrawal by Subject|0|||
128827571|NCT01128595|463666051|FG001|Treatment Period 3|Withdrawal by Subject|1|||
128827572|NCT01128595|463666052|FG002|Treatment Period 3|Withdrawal by Subject|0|||
128827573|NCT01128595|463666053|FG003|Treatment Period 3|Withdrawal by Subject|0|||
128827574|NCT00605306|463666054|FG000|Overall Study|Adverse Event|0|||
128827575|NCT00605306|463666055|FG001|Overall Study|Adverse Event|1|||
128827576|NCT00372775|463666056|FG000|Overall Study|Adverse Event|8|||
128827577|NCT00372775|463666056|FG000|Overall Study|Death|15|||
128827578|NCT00372775|463666056|FG000|Overall Study|Objective progression or relapse|30|||
128827579|NCT00372775|463666056|FG000|Overall Study|Global deterioration of health status|6|||
128827580|NCT00372775|463666056|FG000|Overall Study|Withdrawal by Subject|1|||
128827581|NCT00372775|463666056|FG000|Overall Study|Other|1|||
128827582|NCT00372775|463666056|FG000|Overall Study|Not Treated|2|||
128827583|NCT02568215|463666058|FG000|Overall Study|Death|1|||
128827584|NCT02568215|463666059|FG001|Overall Study|Death|2|||
128827585|NCT02568215|463666060|FG002|Overall Study|Death|0|||
128827586|NCT02568215|463666058|FG000|Overall Study|Physician Decision|2|||
128827587|NCT02568215|463666059|FG001|Overall Study|Physician Decision|2|||
128827588|NCT02568215|463666060|FG002|Overall Study|Physician Decision|2|||
128827589|NCT02568215|463666058|FG000|Overall Study|Lost to Follow-up|29|||
128827590|NCT02568215|463666059|FG001|Overall Study|Lost to Follow-up|32|||
128827591|NCT02568215|463666060|FG002|Overall Study|Lost to Follow-up|41|||
128827592|NCT02568215|463666058|FG000|Overall Study|Withdrawal by Subject|21|||
128827593|NCT02568215|463666059|FG001|Overall Study|Withdrawal by Subject|19|||
128827594|NCT02568215|463666060|FG002|Overall Study|Withdrawal by Subject|22|||
128827595|NCT02568215|463666058|FG000|Overall Study|Protocol Violation|1|||
128827596|NCT02568215|463666059|FG001|Overall Study|Protocol Violation|1|||
128827597|NCT02568215|463666060|FG002|Overall Study|Protocol Violation|0|||
128827598|NCT02568215|463666058|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
128827599|NCT02568215|463666059|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
128827600|NCT02568215|463666060|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
128827601|NCT02568215|463666058|FG000|Overall Study|Other|0|||
128827602|NCT02568215|463666059|FG001|Overall Study|Other|1|||
128827603|NCT02568215|463666060|FG002|Overall Study|Other|4|||
128827604|NCT02185794|463666062|FG000|Overall Study|Enrolled but Never Dosed|1|||
128827605|NCT02185794|463666063|FG001|Overall Study|Enrolled but Never Dosed|6|||
128827606|NCT02185794|463666064|FG002|Overall Study|Enrolled but Never Dosed|3|||
128827607|NCT02185794|463666065|FG003|Overall Study|Enrolled but Never Dosed|1|||
128827608|NCT02185794|463666066|FG004|Overall Study|Enrolled but Never Dosed|1|||
128827609|NCT02185794|463666067|FG005|Overall Study|Enrolled but Never Dosed|0|||
128827610|NCT02185794|463666062|FG000|Overall Study|Investigator's Discretion|1|||
128827611|NCT02185794|463666063|FG001|Overall Study|Investigator's Discretion|0|||
128827612|NCT02185794|463666064|FG002|Overall Study|Investigator's Discretion|1|||
128827613|NCT02185794|463666065|FG003|Overall Study|Investigator's Discretion|2|||
128827614|NCT02185794|463666066|FG004|Overall Study|Investigator's Discretion|2|||
128827615|NCT02185794|463666067|FG005|Overall Study|Investigator's Discretion|15|||
128827616|NCT02185794|463666062|FG000|Overall Study|Withdrew Consent|2|||
128827617|NCT02185794|463666063|FG001|Overall Study|Withdrew Consent|5|||
128827618|NCT02185794|463666064|FG002|Overall Study|Withdrew Consent|10|||
128827619|NCT02185794|463666065|FG003|Overall Study|Withdrew Consent|2|||
128827620|NCT02185794|463666066|FG004|Overall Study|Withdrew Consent|0|||
128827621|NCT02185794|463666067|FG005|Overall Study|Withdrew Consent|0|||
128827622|NCT02185794|463666062|FG000|Overall Study|Lost to Follow-up|1|||
128827623|NCT02185794|463666063|FG001|Overall Study|Lost to Follow-up|2|||
128827624|NCT02185794|463666064|FG002|Overall Study|Lost to Follow-up|2|||
128827625|NCT02185794|463666065|FG003|Overall Study|Lost to Follow-up|3|||
128827626|NCT02185794|463666066|FG004|Overall Study|Lost to Follow-up|0|||
128827627|NCT02185794|463666067|FG005|Overall Study|Lost to Follow-up|1|||
128827628|NCT00336505|463666068|FG000|Overall Study|Adverse Event|10|||
128827629|NCT00336505|463666069|FG001|Overall Study|Adverse Event|9|||
128827630|NCT00336505|463666068|FG000|Overall Study|Lack of Efficacy|8|||
128827631|NCT00336505|463666069|FG001|Overall Study|Lack of Efficacy|4|||
128827632|NCT00336505|463666068|FG000|Overall Study|Lost to Follow-up|7|||
128827633|NCT00336505|463666069|FG001|Overall Study|Lost to Follow-up|4|||
128827634|NCT00336505|463666068|FG000|Overall Study|Withdrawal by Subject|5|||
128827635|NCT00336505|463666069|FG001|Overall Study|Withdrawal by Subject|3|||
128827636|NCT00336505|463666068|FG000|Overall Study|Other|7|||
128827637|NCT00336505|463666069|FG001|Overall Study|Other|7|||
128827638|NCT01092416|463666070|FG000|Enrollment|Atherectomy device not inserted|3|||
128827639|NCT01092416|463666070|FG000|30-Day Follow-up|Death|2|||
128827640|NCT01092416|463666070|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
128827641|NCT01092416|463666070|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
128827642|NCT01092416|463666070|FG000|12-Month Follow-up|Death|16|||
128827643|NCT01092416|463666070|FG000|12-Month Follow-up|Lost to Follow-up|4|||
128827644|NCT01092416|463666070|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
128827645|NCT01092416|463666070|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
128827646|NCT01092416|463666070|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
128827647|NCT00366249|463666071|FG000|Overall Study|Adverse Event|53|||
128827648|NCT00366249|463666072|FG001|Overall Study|Adverse Event|28|||
128827649|NCT00366249|463666071|FG000|Overall Study|Death|0|||
128827650|NCT00366249|463666072|FG001|Overall Study|Death|1|||
128827651|NCT00366249|463666071|FG000|Overall Study|Physician Decision|5|||
128827652|NCT00366249|463666072|FG001|Overall Study|Physician Decision|2|||
128827653|NCT00366249|463666071|FG000|Overall Study|Lost to Follow-up|2|||
128827654|NCT00366249|463666072|FG001|Overall Study|Lost to Follow-up|0|||
128827655|NCT00366249|463666071|FG000|Overall Study|Protocol Violation|1|||
128827656|NCT00366249|463666072|FG001|Overall Study|Protocol Violation|2|||
128827657|NCT00366249|463666071|FG000|Overall Study|Withdrawal by Subject|18|||
128827658|NCT00366249|463666072|FG001|Overall Study|Withdrawal by Subject|4|||
128827659|NCT00366249|463666071|FG000|Overall Study|Lack of Efficacy|21|||
128827660|NCT00366249|463666072|FG001|Overall Study|Lack of Efficacy|21|||
128827661|NCT00366249|463666071|FG000|Overall Study|Most due to osteomylitis status|31|||
128827662|NCT00366249|463666072|FG001|Overall Study|Most due to osteomylitis status|20|||
128827663|NCT01561300|463666073|FG000|Run in on Placebo|Adverse Event|1|||
128827664|NCT01561300|463666074|FG001|Run in on Placebo|Adverse Event|0|||
128827665|NCT00777049|463666075|FG000|Overall Study|Withdrawal by Subject|1|||
128827666|NCT00777049|463666076|FG001|Overall Study|Withdrawal by Subject|0|||
128827667|NCT00777049|463666075|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
128827668|NCT00777049|463666076|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
128827669|NCT00246805|463666077|FG000|Phase 1|Lost to Follow-up|1|||
128827670|NCT00246805|463666078|FG001|Phase 1|Lost to Follow-up|0|||
128827671|NCT00609869|463666079|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
128827672|NCT00609869|463666079|FG000|Overall Study|Severe hematologic toxicity|1|||
128827673|NCT00609869|463666079|FG000|Overall Study|Withdrawal by Subject|1|||
128827674|NCT00609869|463666079|FG000|Overall Study|Seizures|1|||
128827675|NCT00609869|463666079|FG000|Overall Study|Severe tumor flare reaction|1|||
128827676|NCT00609869|463666079|FG000|Overall Study|Hepatitis B infection|1|||
128827677|NCT00609869|463666079|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
128827678|NCT00609869|463666079|FG000|Overall Study|Mantle cell: not evaluable|4|||
128827679|NCT00890591|463666081|FG000|Overall Study|Lack of Efficacy|20|||
128827680|NCT00724126|463666082|FG000|Overall Study|Adverse Event|2|||
128827681|NCT00724126|463666083|FG001|Overall Study|Adverse Event|0|||
128827682|NCT00724126|463666082|FG000|Overall Study|Withdrawal by Subject|8|||
128827683|NCT00724126|463666083|FG001|Overall Study|Withdrawal by Subject|6|||
128827684|NCT00724126|463666082|FG000|Overall Study|Lost to Follow-up|6|||
128827685|NCT00724126|463666083|FG001|Overall Study|Lost to Follow-up|6|||
128827686|NCT00724126|463666082|FG000|Overall Study|Noncompliance|2|||
128827687|NCT00724126|463666083|FG001|Overall Study|Noncompliance|1|||
128827688|NCT00724126|463666082|FG000|Overall Study|Subject randomized although ineligible|1|||
128827689|NCT00724126|463666083|FG001|Overall Study|Subject randomized although ineligible|1|||
128827690|NCT00724126|463666082|FG000|Overall Study|Subject had to leave vicinity of site|0|||
128827691|NCT00724126|463666083|FG001|Overall Study|Subject had to leave vicinity of site|1|||
128827692|NCT00739934|463666084|FG000|Voriconazole IV|Adverse Event|6|||
128827693|NCT00739934|463666084|FG000|Voriconazole Oral|Other|3|||
128827694|NCT02502526|463666088|FG000|Overall Study|Lost to Follow-up|2|||
128827695|NCT02502526|463666089|FG001|Overall Study|Lost to Follow-up|2|||
128827696|NCT02502526|463666090|FG002|Overall Study|Lost to Follow-up|3|||
128827697|NCT02502526|463666088|FG000|Overall Study|Withdrawal by Subject|0|||
128827698|NCT02502526|463666089|FG001|Overall Study|Withdrawal by Subject|1|||
128827699|NCT02502526|463666090|FG002|Overall Study|Withdrawal by Subject|1|||
128827700|NCT02502526|463666088|FG000|Overall Study|Disqualified due to cataract grading|0|||
128827701|NCT02502526|463666089|FG001|Overall Study|Disqualified due to cataract grading|0|||
128827702|NCT02502526|463666090|FG002|Overall Study|Disqualified due to cataract grading|1|||
128827703|NCT02502526|463666088|FG000|Overall Study|Enrollment suspension|4|||
128827704|NCT02502526|463666089|FG001|Overall Study|Enrollment suspension|1|||
128827705|NCT02502526|463666090|FG002|Overall Study|Enrollment suspension|1|||
128827706|NCT01952366|463666091|FG000|Overall Study|Death|22|||
128827707|NCT01952366|463666091|FG000|Overall Study|Withdrawal by Subject|9|||
128827708|NCT00293397|463666094|FG000|Overall Study|Death|2|||
128827709|NCT00822120|463666095|FG000|Initial Registration|Adverse Event|1|||
128827710|NCT00822120|463666096|FG001|Initial Registration|Adverse Event|0|||
128827711|NCT00822120|463666097|FG002|Initial Registration|Adverse Event|0|||
128827712|NCT00822120|463666098|FG003|Initial Registration|Adverse Event|0|||
128827713|NCT00822120|463666099|FG004|Initial Registration|Adverse Event|0|||
128827714|NCT00822120|463666100|FG005|Initial Registration|Adverse Event|0|||
128827715|NCT00822120|463666095|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
128827716|NCT00822120|463666096|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
128827717|NCT00822120|463666097|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
128827718|NCT00822120|463666098|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
128827719|NCT00822120|463666099|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
128827720|NCT00822120|463666100|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
128827721|NCT00822120|463666095|FG000|Initial Registration|Reasons not Protocol Specified|2|||
128827722|NCT00822120|463666096|FG001|Initial Registration|Reasons not Protocol Specified|0|||
128827723|NCT00822120|463666097|FG002|Initial Registration|Reasons not Protocol Specified|0|||
128827724|NCT00822120|463666098|FG003|Initial Registration|Reasons not Protocol Specified|0|||
128827725|NCT00822120|463666099|FG004|Initial Registration|Reasons not Protocol Specified|0|||
128827726|NCT00822120|463666100|FG005|Initial Registration|Reasons not Protocol Specified|0|||
128827727|NCT00822120|463666095|FG000|Initial Registration|Ineligible|22|||
128827728|NCT00822120|463666096|FG001|Initial Registration|Ineligible|1|||
128827729|NCT00822120|463666097|FG002|Initial Registration|Ineligible|0|||
128827730|NCT00822120|463666098|FG003|Initial Registration|Ineligible|0|||
128827731|NCT00822120|463666099|FG004|Initial Registration|Ineligible|0|||
128827732|NCT00822120|463666100|FG005|Initial Registration|Ineligible|0|||
128827733|NCT00822120|463666095|FG000|PET-directed Therapy|Adverse Event|0|||
128827734|NCT00822120|463666096|FG001|PET-directed Therapy|Adverse Event|0|||
128827735|NCT00822120|463666097|FG002|PET-directed Therapy|Adverse Event|0|||
128827736|NCT00822120|463666098|FG003|PET-directed Therapy|Adverse Event|1|||
128827737|NCT00822120|463666099|FG004|PET-directed Therapy|Adverse Event|0|||
128827738|NCT00822120|463666100|FG005|PET-directed Therapy|Adverse Event|0|||
128827739|NCT00822120|463666095|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
128827740|NCT00822120|463666096|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
128827741|NCT00822120|463666097|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
128827742|NCT00822120|463666098|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
128827743|NCT00822120|463666099|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
128827744|NCT00822120|463666100|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
128827745|NCT00822120|463666095|FG000|PET-directed Therapy|Death|0|||
128827746|NCT00822120|463666096|FG001|PET-directed Therapy|Death|0|||
128827747|NCT00822120|463666097|FG002|PET-directed Therapy|Death|0|||
128827748|NCT00822120|463666098|FG003|PET-directed Therapy|Death|2|||
128827749|NCT00822120|463666099|FG004|PET-directed Therapy|Death|0|||
128827750|NCT00822120|463666100|FG005|PET-directed Therapy|Death|0|||
128827751|NCT00822120|463666095|FG000|PET-directed Therapy|Protocol Violation|0|||
128827752|NCT00822120|463666096|FG001|PET-directed Therapy|Protocol Violation|0|||
128827753|NCT00822120|463666097|FG002|PET-directed Therapy|Protocol Violation|0|||
128827754|NCT00822120|463666098|FG003|PET-directed Therapy|Protocol Violation|6|||
128827755|NCT00822120|463666099|FG004|PET-directed Therapy|Protocol Violation|0|||
128827756|NCT00822120|463666100|FG005|PET-directed Therapy|Protocol Violation|0|||
128827757|NCT00503906|463666101|FG000|Overall Study|Withdrawal by Subject|1|||
128827758|NCT01324310|463666102|FG000|Overall Study|Adverse Event|1|||
128827759|NCT01324310|463666102|FG000|Overall Study|Disease Progression|1|||
128827760|NCT02787005|463666123|FG000|Overall Study|Adverse Event|24|||
128827761|NCT02787005|463666124|FG001|Overall Study|Adverse Event|9|||
128827762|NCT02787005|463666125|FG002|Overall Study|Adverse Event|9|||
128827763|NCT02787005|463666126|FG003|Overall Study|Adverse Event|7|||
128827764|NCT02787005|463666127|FG004|Overall Study|Adverse Event|2|||
128827765|NCT02787005|463666123|FG000|Overall Study|Death|100|||
128827766|NCT02787005|463666124|FG001|Overall Study|Death|53|||
128827767|NCT02787005|463666125|FG002|Overall Study|Death|48|||
128827768|NCT02787005|463666126|FG003|Overall Study|Death|69|||
128827769|NCT02787005|463666127|FG004|Overall Study|Death|38|||
128827770|NCT02787005|463666123|FG000|Overall Study|Sponsor Decision|7|||
128827771|NCT02787005|463666124|FG001|Overall Study|Sponsor Decision|4|||
128827772|NCT02787005|463666125|FG002|Overall Study|Sponsor Decision|0|||
128827773|NCT02787005|463666126|FG003|Overall Study|Sponsor Decision|4|||
128827774|NCT02787005|463666127|FG004|Overall Study|Sponsor Decision|5|||
128827775|NCT02787005|463666123|FG000|Overall Study|Withdrawal by Subject|2|||
128827776|NCT02787005|463666124|FG001|Overall Study|Withdrawal by Subject|1|||
128827777|NCT02787005|463666125|FG002|Overall Study|Withdrawal by Subject|1|||
128827778|NCT02787005|463666126|FG003|Overall Study|Withdrawal by Subject|0|||
128827779|NCT02787005|463666127|FG004|Overall Study|Withdrawal by Subject|1|||
128827780|NCT02787005|463666123|FG000|Overall Study|Screen Failure|0|||
128827781|NCT02787005|463666124|FG001|Overall Study|Screen Failure|2|||
128827782|NCT02787005|463666125|FG002|Overall Study|Screen Failure|0|||
128827783|NCT02787005|463666126|FG003|Overall Study|Screen Failure|0|||
128827784|NCT02787005|463666127|FG004|Overall Study|Screen Failure|1|||
128827785|NCT02787005|463666123|FG000|Overall Study|Lost to Follow-up|0|||
128827786|NCT02787005|463666124|FG001|Overall Study|Lost to Follow-up|0|||
128827787|NCT02787005|463666125|FG002|Overall Study|Lost to Follow-up|0|||
128827788|NCT02787005|463666126|FG003|Overall Study|Lost to Follow-up|1|||
128827789|NCT02787005|463666127|FG004|Overall Study|Lost to Follow-up|0|||
128827790|NCT02029235|463666128|FG000|Overall Study|Non-compliance with study meds or diary|4|||
128827791|NCT02029235|463666129|FG001|Overall Study|Non-compliance with study meds or diary|1|||
128827792|NCT01387516|463666130|FG000|Overall Study|Lost to Follow-up|4|||
128827793|NCT01387516|463666131|FG001|Overall Study|Lost to Follow-up|4|||
128827794|NCT01387516|463666132|FG002|Overall Study|Lost to Follow-up|2|||
128827795|NCT01387516|463666133|FG003|Overall Study|Lost to Follow-up|3|||
128827796|NCT01387516|463666130|FG000|Overall Study|Withdrawal by Subject|1|||
128827797|NCT01387516|463666131|FG001|Overall Study|Withdrawal by Subject|1|||
128827798|NCT01387516|463666132|FG002|Overall Study|Withdrawal by Subject|2|||
128827799|NCT01387516|463666133|FG003|Overall Study|Withdrawal by Subject|0|||
128827800|NCT01387516|463666130|FG000|Overall Study|Death|0|||
128827801|NCT01387516|463666131|FG001|Overall Study|Death|0|||
128827802|NCT01387516|463666132|FG002|Overall Study|Death|0|||
128827803|NCT01387516|463666133|FG003|Overall Study|Death|1|||
128827804|NCT01738438|463666135|FG000|Overall Study|Disease Progression|32|||
128827805|NCT01738438|463666135|FG000|Overall Study|Adverse Event|3|||
128827806|NCT04066075|463666136|FG000|Overall Study|Lost to Follow-up|3|||
128827807|NCT04066075|463666137|FG001|Overall Study|Lost to Follow-up|3|||
128827808|NCT04066075|463666136|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
128827809|NCT04066075|463666137|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
128827810|NCT04066075|463666136|FG000|Overall Study|Withdrawal by Subject|2|||
128827811|NCT04066075|463666137|FG001|Overall Study|Withdrawal by Subject|2|||
128827812|NCT00309166|463666138|FG000|Overall Study|Adverse event, non-fatal|1|||
128827813|NCT00309166|463666139|FG001|Overall Study|Adverse event, non-fatal|0|||
128827814|NCT00309166|463666138|FG000|Overall Study|Withdrawal by Subject|4|||
128827815|NCT00309166|463666139|FG001|Overall Study|Withdrawal by Subject|3|||
128827816|NCT03593226|463666158|FG000|Overall Study|Disease progression|6|||
128827817|NCT03593226|463666159|FG001|Overall Study|Disease progression|13|||
128827818|NCT03593226|463666160|FG002|Overall Study|Disease progression|5|||
128827819|NCT03593226|463666161|FG003|Overall Study|Disease progression|6|||
128827820|NCT03593226|463666158|FG000|Overall Study|Adverse Event|0|||
128827821|NCT03593226|463666159|FG001|Overall Study|Adverse Event|1|||
128827822|NCT03593226|463666160|FG002|Overall Study|Adverse Event|0|||
128827823|NCT03593226|463666161|FG003|Overall Study|Adverse Event|0|||
128827824|NCT03593226|463666158|FG000|Overall Study|Withdrawal by Subject|0|||
128827825|NCT03593226|463666159|FG001|Overall Study|Withdrawal by Subject|4|||
128827826|NCT03593226|463666160|FG002|Overall Study|Withdrawal by Subject|1|||
128827827|NCT03593226|463666161|FG003|Overall Study|Withdrawal by Subject|0|||
128827828|NCT03593226|463666158|FG000|Overall Study|Physician Decision|0|||
128827829|NCT03593226|463666159|FG001|Overall Study|Physician Decision|1|||
128827830|NCT03593226|463666160|FG002|Overall Study|Physician Decision|0|||
128827831|NCT03593226|463666161|FG003|Overall Study|Physician Decision|0|||
128827832|NCT03593226|463666158|FG000|Overall Study|Clinical disease progression|0|||
128827833|NCT03593226|463666159|FG001|Overall Study|Clinical disease progression|0|||
128827834|NCT03593226|463666160|FG002|Overall Study|Clinical disease progression|1|||
128827835|NCT03593226|463666161|FG003|Overall Study|Clinical disease progression|0|||
128827836|NCT04517435|463666162|FG000|Overall Study|Withdrawal by Subject|0|||
128827837|NCT04517435|463666163|FG001|Overall Study|Withdrawal by Subject|0|||
128827838|NCT04517435|463666164|FG002|Overall Study|Withdrawal by Subject|1|||
128827839|NCT04517435|463666162|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
128827840|NCT04517435|463666163|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
128827841|NCT04517435|463666164|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
128827842|NCT03789110|463666165|FG000|Overall Study|Adverse Event|2|||
128827843|NCT03789110|463666165|FG000|Overall Study|Physician Decision|1|||
128827844|NCT03789110|463666165|FG000|Overall Study|Withdrawal by Subject|2|||
128827845|NCT03789110|463666165|FG000|Overall Study|Lack of Efficacy|22|||
128827846|NCT03789110|463666165|FG000|Overall Study|still on treatment|3|||
128827847|NCT00065182|463667680|FG000|Overall Study|Adverse Event|24|||
128827848|NCT00065182|463667681|FG001|Overall Study|Adverse Event|17|||
128827849|NCT00065182|463667680|FG000|Overall Study|Lost to Follow-up|0|||
128827850|NCT00065182|463667681|FG001|Overall Study|Lost to Follow-up|4|||
128827851|NCT00065182|463667680|FG000|Overall Study|Protocol Violation|3|||
128827852|NCT00065182|463667681|FG001|Overall Study|Protocol Violation|4|||
128827853|NCT00065182|463667680|FG000|Overall Study|Serious adverse events (SAE)|1|||
128827854|NCT00065182|463667681|FG001|Overall Study|Serious adverse events (SAE)|0|||
128827855|NCT00065182|463667680|FG000|Overall Study|Sponsor Decision|11|||
128827856|NCT00065182|463667681|FG001|Overall Study|Sponsor Decision|7|||
128827857|NCT00065182|463667680|FG000|Overall Study|Withdrawal by Subject|8|||
128827858|NCT00065182|463667681|FG001|Overall Study|Withdrawal by Subject|3|||
128827859|NCT00065182|463667680|FG000|Overall Study|No clinical benefit|1|||
128827860|NCT00065182|463667681|FG001|Overall Study|No clinical benefit|0|||
128827861|NCT00065182|463667680|FG000|Overall Study|Death|0|||
128827862|NCT00065182|463667681|FG001|Overall Study|Death|1|||
128827863|NCT00065182|463667680|FG000|Overall Study|Decline in Status|0|||
128827864|NCT00065182|463667681|FG001|Overall Study|Decline in Status|1|||
128827865|NCT03801148|463667684|FG000|Period 1 (2 Days)|Adverse Event|1|||
128827866|NCT03801148|463667685|FG001|Period 1 (2 Days)|Adverse Event|1|||
128827867|NCT03801148|463667686|FG002|Period 1 (2 Days)|Adverse Event|0|||
128827868|NCT03801148|463667687|FG003|Period 1 (2 Days)|Adverse Event|0|||
128827869|NCT03801148|463667684|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
128827870|NCT03801148|463667685|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
128827871|NCT03801148|463667686|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
128827872|NCT03801148|463667687|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
128827873|NCT03801148|463667684|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
128827874|NCT03801148|463667685|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
128827875|NCT03801148|463667686|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
128827876|NCT03801148|463667687|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
128827877|NCT03801148|463667684|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
128827878|NCT03801148|463667685|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
128827879|NCT03801148|463667686|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
128827880|NCT03801148|463667687|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
128827881|NCT01750684|463667688|FG000|Overall Study|Death|1|||
128827882|NCT01750684|463667689|FG001|Overall Study|Death|0|||
128827883|NCT01750684|463667688|FG000|Overall Study|Non-compliance with Study Drug|0|||
128827884|NCT01750684|463667689|FG001|Overall Study|Non-compliance with Study Drug|1|||
128827885|NCT01750684|463667688|FG000|Overall Study|Withdrawn by Sponsor|0|||
128827886|NCT01750684|463667689|FG001|Overall Study|Withdrawn by Sponsor|1|||
128827887|NCT01750684|463667688|FG000|Overall Study|Protocol Violation|1|||
128827888|NCT01750684|463667689|FG001|Overall Study|Protocol Violation|0|||
128827889|NCT01185600|463667690|FG000|Overall Study|Adverse Event|1|||
128827890|NCT01185600|463667691|FG001|Overall Study|Adverse Event|1|||
128827891|NCT01185600|463667690|FG000|Overall Study|Death|0|||
128827892|NCT01185600|463667691|FG001|Overall Study|Death|1|||
128827893|NCT01185600|463667690|FG000|Overall Study|Lost to Follow-up|0|||
128827894|NCT01185600|463667691|FG001|Overall Study|Lost to Follow-up|5|||
128827895|NCT01185600|463667690|FG000|Overall Study|Physician Decision|29|||
128827896|NCT01185600|463667691|FG001|Overall Study|Physician Decision|35|||
128827897|NCT01185600|463667690|FG000|Overall Study|Withdrawal by Subject|1|||
128827898|NCT01185600|463667691|FG001|Overall Study|Withdrawal by Subject|1|||
128827899|NCT01185600|463667690|FG000|Overall Study|Hold by DSMB|1|||
128827900|NCT01185600|463667691|FG001|Overall Study|Hold by DSMB|2|||
128827901|NCT03577106|463667692|FG000|Overall Study|Withdrawal by Subject|3|||
128827902|NCT01342367|463667693|FG000|Overall Study|Death|1|||
128827903|NCT01342367|463667694|FG001|Overall Study|Death|0|||
128827904|NCT01342367|463667693|FG000|Overall Study|Withdrawal by Subject|1|||
128827905|NCT01342367|463667694|FG001|Overall Study|Withdrawal by Subject|2|||
128827906|NCT00640159|463667695|FG000|Overall Study|Lost to Follow-up|2|||
128827907|NCT01500200|463667696|FG000|Stage 1|Adverse Event|1|||
128827908|NCT01500200|463667697|FG001|Stage 1|Adverse Event|4|||
128827909|NCT01500200|463667698|FG002|Stage 1|Adverse Event|5|||
128827910|NCT01500200|463667699|FG003|Stage 1|Adverse Event|0|||
128827911|NCT01500200|463667700|FG004|Stage 1|Adverse Event|0|||
128827912|NCT01500200|463667701|FG005|Stage 1|Adverse Event|0|||
128827913|NCT01500200|463667696|FG000|Stage 1|Lost to Follow-up|2|||
128827914|NCT01500200|463667697|FG001|Stage 1|Lost to Follow-up|2|||
128827915|NCT01500200|463667698|FG002|Stage 1|Lost to Follow-up|1|||
128827916|NCT01500200|463667699|FG003|Stage 1|Lost to Follow-up|0|||
128827917|NCT01500200|463667700|FG004|Stage 1|Lost to Follow-up|0|||
128827918|NCT01500200|463667701|FG005|Stage 1|Lost to Follow-up|0|||
128827919|NCT01500200|463667696|FG000|Stage 1|Withdrawal by Subject|3|||
128827920|NCT01500200|463667697|FG001|Stage 1|Withdrawal by Subject|0|||
128827921|NCT01500200|463667698|FG002|Stage 1|Withdrawal by Subject|0|||
128827922|NCT01500200|463667699|FG003|Stage 1|Withdrawal by Subject|0|||
128827923|NCT01500200|463667700|FG004|Stage 1|Withdrawal by Subject|0|||
128827924|NCT01500200|463667701|FG005|Stage 1|Withdrawal by Subject|0|||
128827925|NCT01500200|463667696|FG000|Stage 1|Noncompliance with Study Drug|1|||
128827926|NCT01500200|463667697|FG001|Stage 1|Noncompliance with Study Drug|0|||
128827927|NCT01500200|463667698|FG002|Stage 1|Noncompliance with Study Drug|0|||
128827928|NCT01500200|463667699|FG003|Stage 1|Noncompliance with Study Drug|0|||
128827929|NCT01500200|463667700|FG004|Stage 1|Noncompliance with Study Drug|0|||
128827930|NCT01500200|463667701|FG005|Stage 1|Noncompliance with Study Drug|0|||
128827931|NCT01500200|463667696|FG000|Stage 1|Physician Decision|1|||
128827932|NCT01500200|463667697|FG001|Stage 1|Physician Decision|0|||
128827933|NCT01500200|463667698|FG002|Stage 1|Physician Decision|0|||
128827934|NCT01500200|463667699|FG003|Stage 1|Physician Decision|0|||
128827935|NCT01500200|463667700|FG004|Stage 1|Physician Decision|0|||
128827936|NCT01500200|463667701|FG005|Stage 1|Physician Decision|0|||
128827937|NCT01500200|463667696|FG000|Stage 2|Adverse Event|0|||
128827938|NCT01500200|463667697|FG001|Stage 2|Adverse Event|0|||
128827939|NCT01500200|463667698|FG002|Stage 2|Adverse Event|0|||
128827940|NCT01500200|463667699|FG003|Stage 2|Adverse Event|0|||
128827941|NCT01500200|463667700|FG004|Stage 2|Adverse Event|5|||
128827942|NCT01500200|463667701|FG005|Stage 2|Adverse Event|4|||
128827943|NCT04860505|463667702|FG000|Overall Study|Lost to Follow-up|2|||
128827944|NCT03066609|463667705|FG000|INDUCTION|Pregnancy|0|||
128827945|NCT03066609|463667706|FG001|INDUCTION|Pregnancy|0|||
128827946|NCT03066609|463667707|FG002|INDUCTION|Pregnancy|1|||
128827947|NCT03066609|463667708|FG003|INDUCTION|Pregnancy|0|||
128827948|NCT03066609|463667705|FG000|INDUCTION|Lack of Efficacy|0|||
128827949|NCT03066609|463667706|FG001|INDUCTION|Lack of Efficacy|0|||
128827950|NCT03066609|463667707|FG002|INDUCTION|Lack of Efficacy|1|||
128827951|NCT03066609|463667708|FG003|INDUCTION|Lack of Efficacy|0|||
128827952|NCT03066609|463667705|FG000|INDUCTION|Adverse Event|2|||
128827953|NCT03066609|463667706|FG001|INDUCTION|Adverse Event|2|||
128827954|NCT03066609|463667707|FG002|INDUCTION|Adverse Event|0|||
128827955|NCT03066609|463667708|FG003|INDUCTION|Adverse Event|0|||
128827956|NCT03066609|463667705|FG000|MAINTENANCE|Adverse Event|0|||
128827957|NCT03066609|463667706|FG001|MAINTENANCE|Adverse Event|0|||
128827958|NCT03066609|463667707|FG002|MAINTENANCE|Adverse Event|0|||
128827959|NCT03066609|463667708|FG003|MAINTENANCE|Adverse Event|1|||
128827960|NCT03066609|463667705|FG000|MAINTENANCE|Withdrawal by Subject|4|||
128827961|NCT03066609|463667706|FG001|MAINTENANCE|Withdrawal by Subject|2|||
128827962|NCT03066609|463667707|FG002|MAINTENANCE|Withdrawal by Subject|1|||
128827963|NCT03066609|463667708|FG003|MAINTENANCE|Withdrawal by Subject|1|||
128827964|NCT03066609|463667705|FG000|MAINTENANCE|Lost to Follow-up|0|||
128827965|NCT03066609|463667706|FG001|MAINTENANCE|Lost to Follow-up|1|||
128827966|NCT03066609|463667707|FG002|MAINTENANCE|Lost to Follow-up|1|||
128827967|NCT03066609|463667708|FG003|MAINTENANCE|Lost to Follow-up|0|||
128827968|NCT03066609|463667705|FG000|MAINTENANCE|Pregnancy|1|||
128827969|NCT03066609|463667706|FG001|MAINTENANCE|Pregnancy|0|||
128827970|NCT03066609|463667707|FG002|MAINTENANCE|Pregnancy|0|||
128827971|NCT03066609|463667708|FG003|MAINTENANCE|Pregnancy|0|||
128827972|NCT03066609|463667705|FG000|MAINTENANCE|Lack of Efficacy|2|||
128827973|NCT03066609|463667706|FG001|MAINTENANCE|Lack of Efficacy|1|||
128827974|NCT03066609|463667707|FG002|MAINTENANCE|Lack of Efficacy|0|||
128827975|NCT03066609|463667708|FG003|MAINTENANCE|Lack of Efficacy|1|||
128827976|NCT03066609|463667705|FG000|OVERALL STUDY|Adverse Event|2|||
128827977|NCT03066609|463667706|FG001|OVERALL STUDY|Adverse Event|2|||
128827978|NCT03066609|463667707|FG002|OVERALL STUDY|Adverse Event|0|||
128827979|NCT03066609|463667708|FG003|OVERALL STUDY|Adverse Event|1|||
128827980|NCT03066609|463667705|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
128827981|NCT03066609|463667706|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
128827982|NCT03066609|463667707|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
128827983|NCT03066609|463667708|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
128827984|NCT03066609|463667705|FG000|OVERALL STUDY|Lost to Follow-up|1|||
128827985|NCT03066609|463667706|FG001|OVERALL STUDY|Lost to Follow-up|1|||
128827986|NCT03066609|463667707|FG002|OVERALL STUDY|Lost to Follow-up|1|||
128827987|NCT03066609|463667708|FG003|OVERALL STUDY|Lost to Follow-up|1|||
128827988|NCT03066609|463667705|FG000|OVERALL STUDY|Pregnancy|1|||
128827989|NCT03066609|463667706|FG001|OVERALL STUDY|Pregnancy|0|||
128827990|NCT03066609|463667707|FG002|OVERALL STUDY|Pregnancy|1|||
128827991|NCT03066609|463667708|FG003|OVERALL STUDY|Pregnancy|0|||
128827992|NCT03066609|463667705|FG000|OVERALL STUDY|Lack of Efficacy|2|||
128827993|NCT03066609|463667706|FG001|OVERALL STUDY|Lack of Efficacy|1|||
128827994|NCT03066609|463667707|FG002|OVERALL STUDY|Lack of Efficacy|1|||
128827995|NCT03066609|463667708|FG003|OVERALL STUDY|Lack of Efficacy|1|||
128827996|NCT03066609|463667705|FG000|OVERALL STUDY|discontinued follow up|0|||
128827997|NCT03066609|463667706|FG001|OVERALL STUDY|discontinued follow up|2|||
128827998|NCT03066609|463667707|FG002|OVERALL STUDY|discontinued follow up|0|||
128827999|NCT03066609|463667708|FG003|OVERALL STUDY|discontinued follow up|0|||
128828000|NCT00523419|463667711|FG000|Overall Study|Adverse Event|1|||
128828001|NCT00523419|463667711|FG000|Overall Study|Withdrawal by Subject|1|||
128828002|NCT00523419|463667711|FG000|Overall Study|Physician Decision|2|||
128828003|NCT00523419|463667711|FG000|Overall Study|Progressive Disease|22|||
128828004|NCT00523419|463667711|FG000|Overall Study|Death due to Study Disease|4|||
128828005|NCT00523419|463667711|FG000|Overall Study|Death due to Adverse Event|2|||
128828006|NCT01218009|463667712|FG000|Overall Study|Protocol Violation|2|||
128828007|NCT01218009|463667713|FG001|Overall Study|Protocol Violation|1|||
128828008|NCT01218009|463667712|FG000|Overall Study|Withdrawal by Subject|3|||
128828009|NCT01218009|463667713|FG001|Overall Study|Withdrawal by Subject|1|||
128828010|NCT01218009|463667712|FG000|Overall Study|Sponsor terminated study|161|||
128828011|NCT01218009|463667713|FG001|Overall Study|Sponsor terminated study|163|||
128828012|NCT03170882|463667714|FG000|Overall Study|Death|17|||
128828013|NCT03170882|463667715|FG001|Overall Study|Death|29|||
128828014|NCT03170882|463667714|FG000|Overall Study|Lost to Follow-up|0|||
128828015|NCT03170882|463667715|FG001|Overall Study|Lost to Follow-up|1|||
128828016|NCT03170882|463667714|FG000|Overall Study|Withdrawal by Subject|4|||
128828017|NCT03170882|463667715|FG001|Overall Study|Withdrawal by Subject|7|||
128828018|NCT03170882|463667714|FG000|Overall Study|Reason not Specified|28|||
128828019|NCT03170882|463667715|FG001|Overall Study|Reason not Specified|36|||
128828020|NCT00622700|463667716|FG000|Core Treatment Period|Randomized but Not Treated|0|||
128828021|NCT00622700|463667717|FG001|Core Treatment Period|Randomized but Not Treated|2|||
128828022|NCT00622700|463667718|FG002|Core Treatment Period|Randomized but Not Treated|2|||
128828023|NCT00622700|463667719|FG003|Core Treatment Period|Randomized but Not Treated|0|||
128828024|NCT00622700|463667720|FG004|Core Treatment Period|Randomized but Not Treated|0|||
128828025|NCT00622700|463667721|FG005|Core Treatment Period|Randomized but Not Treated|0|||
128828026|NCT00622700|463667722|FG006|Core Treatment Period|Randomized but Not Treated|0|||
128828027|NCT00622700|463667716|FG000|Core Treatment Period|Adverse Event|18|||
128828028|NCT00622700|463667717|FG001|Core Treatment Period|Adverse Event|25|||
128828029|NCT00622700|463667718|FG002|Core Treatment Period|Adverse Event|18|||
128828030|NCT00622700|463667719|FG003|Core Treatment Period|Adverse Event|0|||
128828031|NCT00622700|463667720|FG004|Core Treatment Period|Adverse Event|0|||
128828032|NCT00622700|463667721|FG005|Core Treatment Period|Adverse Event|0|||
128828033|NCT00622700|463667722|FG006|Core Treatment Period|Adverse Event|0|||
128828034|NCT00622700|463667716|FG000|Core Treatment Period|Lack of Efficacy|19|||
128828035|NCT00622700|463667717|FG001|Core Treatment Period|Lack of Efficacy|6|||
128828036|NCT00622700|463667718|FG002|Core Treatment Period|Lack of Efficacy|12|||
128828037|NCT00622700|463667719|FG003|Core Treatment Period|Lack of Efficacy|0|||
128828038|NCT00622700|463667720|FG004|Core Treatment Period|Lack of Efficacy|0|||
128828039|NCT00622700|463667721|FG005|Core Treatment Period|Lack of Efficacy|0|||
128828040|NCT00622700|463667722|FG006|Core Treatment Period|Lack of Efficacy|0|||
128828041|NCT00622700|463667716|FG000|Core Treatment Period|Lost to Follow-up|1|||
128828042|NCT00622700|463667717|FG001|Core Treatment Period|Lost to Follow-up|1|||
128828043|NCT00622700|463667718|FG002|Core Treatment Period|Lost to Follow-up|1|||
128828044|NCT00622700|463667719|FG003|Core Treatment Period|Lost to Follow-up|0|||
128828045|NCT00622700|463667720|FG004|Core Treatment Period|Lost to Follow-up|0|||
128828046|NCT00622700|463667721|FG005|Core Treatment Period|Lost to Follow-up|0|||
128828047|NCT00622700|463667722|FG006|Core Treatment Period|Lost to Follow-up|0|||
128828048|NCT00622700|463667716|FG000|Core Treatment Period|Death|1|||
128828049|NCT00622700|463667717|FG001|Core Treatment Period|Death|0|||
128828050|NCT00622700|463667718|FG002|Core Treatment Period|Death|0|||
128828051|NCT00622700|463667719|FG003|Core Treatment Period|Death|0|||
128828052|NCT00622700|463667720|FG004|Core Treatment Period|Death|0|||
128828053|NCT00622700|463667721|FG005|Core Treatment Period|Death|0|||
128828054|NCT00622700|463667722|FG006|Core Treatment Period|Death|0|||
128828055|NCT00622700|463667716|FG000|Core Treatment Period|Progressive Disease|3|||
128828056|NCT00622700|463667717|FG001|Core Treatment Period|Progressive Disease|1|||
128828057|NCT00622700|463667718|FG002|Core Treatment Period|Progressive Disease|0|||
128828058|NCT00622700|463667719|FG003|Core Treatment Period|Progressive Disease|0|||
128828059|NCT00622700|463667720|FG004|Core Treatment Period|Progressive Disease|0|||
128828060|NCT00622700|463667721|FG005|Core Treatment Period|Progressive Disease|0|||
128828061|NCT00622700|463667722|FG006|Core Treatment Period|Progressive Disease|0|||
128828062|NCT00622700|463667716|FG000|Core Treatment Period|Withdrawal by Subject|12|||
128828063|NCT00622700|463667717|FG001|Core Treatment Period|Withdrawal by Subject|18|||
128828064|NCT00622700|463667718|FG002|Core Treatment Period|Withdrawal by Subject|15|||
128828065|NCT00622700|463667719|FG003|Core Treatment Period|Withdrawal by Subject|0|||
128828066|NCT00622700|463667720|FG004|Core Treatment Period|Withdrawal by Subject|0|||
128828067|NCT00622700|463667721|FG005|Core Treatment Period|Withdrawal by Subject|0|||
128828068|NCT00622700|463667722|FG006|Core Treatment Period|Withdrawal by Subject|0|||
128828069|NCT00622700|463667716|FG000|Core Treatment Period|Other than specified above|2|||
128828070|NCT00622700|463667717|FG001|Core Treatment Period|Other than specified above|2|||
128828071|NCT00622700|463667718|FG002|Core Treatment Period|Other than specified above|5|||
128828072|NCT00622700|463667719|FG003|Core Treatment Period|Other than specified above|0|||
128828073|NCT00622700|463667720|FG004|Core Treatment Period|Other than specified above|0|||
128828074|NCT00622700|463667721|FG005|Core Treatment Period|Other than specified above|0|||
128828075|NCT00622700|463667722|FG006|Core Treatment Period|Other than specified above|0|||
128828076|NCT00622700|463667716|FG000|Extension Treatment Period|Adverse Event|0|||
128828077|NCT00622700|463667717|FG001|Extension Treatment Period|Adverse Event|0|||
128828078|NCT00622700|463667718|FG002|Extension Treatment Period|Adverse Event|0|||
128828079|NCT00622700|463667719|FG003|Extension Treatment Period|Adverse Event|5|||
128828080|NCT00622700|463667720|FG004|Extension Treatment Period|Adverse Event|9|||
128828081|NCT00622700|463667721|FG005|Extension Treatment Period|Adverse Event|6|||
128828082|NCT00622700|463667722|FG006|Extension Treatment Period|Adverse Event|8|||
128828083|NCT00622700|463667716|FG000|Extension Treatment Period|Lack of Efficacy|0|||
128828084|NCT00622700|463667717|FG001|Extension Treatment Period|Lack of Efficacy|0|||
128828085|NCT00622700|463667718|FG002|Extension Treatment Period|Lack of Efficacy|0|||
128828086|NCT00622700|463667719|FG003|Extension Treatment Period|Lack of Efficacy|2|||
128828087|NCT00622700|463667720|FG004|Extension Treatment Period|Lack of Efficacy|8|||
128828088|NCT00622700|463667721|FG005|Extension Treatment Period|Lack of Efficacy|1|||
128828089|NCT00622700|463667722|FG006|Extension Treatment Period|Lack of Efficacy|9|||
128828090|NCT00622700|463667716|FG000|Extension Treatment Period|Protocol Violation|0|||
128828091|NCT00622700|463667717|FG001|Extension Treatment Period|Protocol Violation|0|||
128828092|NCT00622700|463667718|FG002|Extension Treatment Period|Protocol Violation|0|||
128828093|NCT00622700|463667719|FG003|Extension Treatment Period|Protocol Violation|0|||
128828094|NCT00622700|463667720|FG004|Extension Treatment Period|Protocol Violation|0|||
128828095|NCT00622700|463667721|FG005|Extension Treatment Period|Protocol Violation|2|||
128828096|NCT00622700|463667722|FG006|Extension Treatment Period|Protocol Violation|0|||
128828097|NCT00622700|463667716|FG000|Extension Treatment Period|Lost to Follow-up|0|||
128828098|NCT00622700|463667717|FG001|Extension Treatment Period|Lost to Follow-up|0|||
128828099|NCT00622700|463667718|FG002|Extension Treatment Period|Lost to Follow-up|0|||
128828100|NCT00622700|463667719|FG003|Extension Treatment Period|Lost to Follow-up|0|||
128828101|NCT00622700|463667720|FG004|Extension Treatment Period|Lost to Follow-up|1|||
128828102|NCT00622700|463667721|FG005|Extension Treatment Period|Lost to Follow-up|0|||
128828103|NCT00622700|463667722|FG006|Extension Treatment Period|Lost to Follow-up|0|||
128828104|NCT00622700|463667716|FG000|Extension Treatment Period|Progressive Disease|0|||
128828105|NCT00622700|463667717|FG001|Extension Treatment Period|Progressive Disease|0|||
128828106|NCT00622700|463667718|FG002|Extension Treatment Period|Progressive Disease|0|||
128828107|NCT00622700|463667719|FG003|Extension Treatment Period|Progressive Disease|1|||
128828108|NCT00622700|463667720|FG004|Extension Treatment Period|Progressive Disease|2|||
128828109|NCT00622700|463667721|FG005|Extension Treatment Period|Progressive Disease|0|||
128828110|NCT00622700|463667722|FG006|Extension Treatment Period|Progressive Disease|2|||
128828111|NCT00622700|463667716|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
128828112|NCT00622700|463667717|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
128828113|NCT00622700|463667718|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
128828114|NCT00622700|463667719|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
128828115|NCT00622700|463667720|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
128828116|NCT00622700|463667721|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
128828117|NCT00622700|463667722|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
128828118|NCT00622700|463667716|FG000|Extension Treatment Period|Missing|0|||
128828119|NCT00622700|463667717|FG001|Extension Treatment Period|Missing|0|||
128828120|NCT00622700|463667718|FG002|Extension Treatment Period|Missing|0|||
128828121|NCT00622700|463667719|FG003|Extension Treatment Period|Missing|2|||
128828122|NCT00622700|463667720|FG004|Extension Treatment Period|Missing|3|||
128828123|NCT00622700|463667721|FG005|Extension Treatment Period|Missing|1|||
128828124|NCT00622700|463667722|FG006|Extension Treatment Period|Missing|0|||
128828125|NCT00622700|463667716|FG000|Extension Treatment Period|Other than specified above|0|||
128828126|NCT00622700|463667717|FG001|Extension Treatment Period|Other than specified above|0|||
128828127|NCT00622700|463667718|FG002|Extension Treatment Period|Other than specified above|0|||
128828128|NCT00622700|463667719|FG003|Extension Treatment Period|Other than specified above|0|||
128828129|NCT00622700|463667720|FG004|Extension Treatment Period|Other than specified above|0|||
128828130|NCT00622700|463667721|FG005|Extension Treatment Period|Other than specified above|1|||
128828131|NCT00622700|463667722|FG006|Extension Treatment Period|Other than specified above|1|||
128828132|NCT02646618|463667723|FG000|Overall Study|Lost to Follow-up|10|||
128828133|NCT02646618|463667724|FG001|Overall Study|Lost to Follow-up|14|||
128828134|NCT01458366|463667726|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
128828135|NCT01458366|463667727|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
128828136|NCT01458366|463667728|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
128828137|NCT01458366|463667729|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
128828138|NCT01458366|463667730|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
128828139|NCT01458366|463667726|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
128828140|NCT01458366|463667727|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
128828141|NCT01458366|463667728|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
128828142|NCT01458366|463667729|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
128828143|NCT01458366|463667730|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
128828144|NCT05580003|463667731|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828145|NCT05580003|463667732|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828146|NCT05580003|463667733|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828147|NCT05580003|463667734|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828148|NCT05580003|463667735|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828149|NCT05580003|463667736|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828150|NCT05580003|463667737|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
128828151|NCT05580003|463667738|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828152|NCT05580003|463667739|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828153|NCT05580003|463667740|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828154|NCT05580003|463667741|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828155|NCT05580003|463667742|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828156|NCT05580003|463667743|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828157|NCT05580003|463667744|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828158|NCT05580003|463667745|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828159|NCT05580003|463667746|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828160|NCT05580003|463667747|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828161|NCT05580003|463667748|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828162|NCT05580003|463667749|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828163|NCT05580003|463667750|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828164|NCT05580003|463667751|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828165|NCT05580003|463667752|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828166|NCT05580003|463667753|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828167|NCT05580003|463667754|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828168|NCT05580003|463667755|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828169|NCT05580003|463667756|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828170|NCT05580003|463667757|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828171|NCT05580003|463667758|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
128828172|NCT05580003|463667731|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828173|NCT05580003|463667732|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828174|NCT05580003|463667733|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828175|NCT05580003|463667734|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828176|NCT05580003|463667735|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828177|NCT05580003|463667736|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
128828178|NCT05580003|463667737|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828179|NCT05580003|463667738|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828180|NCT05580003|463667739|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828181|NCT05580003|463667740|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828182|NCT05580003|463667741|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828183|NCT05580003|463667742|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828184|NCT05580003|463667743|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828185|NCT05580003|463667744|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828186|NCT05580003|463667745|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828187|NCT05580003|463667746|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828188|NCT05580003|463667747|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828189|NCT05580003|463667748|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828190|NCT05580003|463667749|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828191|NCT05580003|463667750|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828192|NCT05580003|463667751|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828193|NCT05580003|463667752|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828194|NCT05580003|463667753|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828195|NCT05580003|463667754|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828196|NCT05580003|463667755|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828197|NCT05580003|463667756|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828198|NCT05580003|463667757|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828199|NCT05580003|463667758|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
128828200|NCT05580003|463667731|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828201|NCT05580003|463667732|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828202|NCT05580003|463667733|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828203|NCT05580003|463667734|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
128828204|NCT05580003|463667735|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828205|NCT05580003|463667736|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828206|NCT05580003|463667737|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828207|NCT05580003|463667738|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828208|NCT05580003|463667739|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828209|NCT05580003|463667740|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828210|NCT05580003|463667741|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828211|NCT05580003|463667742|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828212|NCT05580003|463667743|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828213|NCT05580003|463667744|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828214|NCT05580003|463667745|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828215|NCT05580003|463667746|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828216|NCT05580003|463667747|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828217|NCT05580003|463667748|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828218|NCT05580003|463667749|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828219|NCT05580003|463667750|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828220|NCT05580003|463667751|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828221|NCT05580003|463667752|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828222|NCT05580003|463667753|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828223|NCT05580003|463667754|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828224|NCT05580003|463667755|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828225|NCT05580003|463667756|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828226|NCT05580003|463667757|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828227|NCT05580003|463667758|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
128828228|NCT05580003|463667731|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828229|NCT05580003|463667732|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
128828230|NCT05580003|463667733|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828231|NCT05580003|463667734|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828232|NCT05580003|463667735|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828233|NCT05580003|463667736|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828234|NCT05580003|463667737|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828235|NCT05580003|463667738|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828236|NCT05580003|463667739|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828237|NCT05580003|463667740|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828238|NCT05580003|463667741|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828239|NCT05580003|463667742|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828240|NCT05580003|463667743|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828241|NCT05580003|463667744|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828242|NCT05580003|463667745|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828243|NCT05580003|463667746|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828244|NCT05580003|463667747|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828245|NCT05580003|463667748|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828246|NCT05580003|463667749|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828247|NCT05580003|463667750|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828248|NCT05580003|463667751|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828249|NCT05580003|463667752|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828250|NCT05580003|463667753|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828251|NCT05580003|463667754|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828252|NCT05580003|463667755|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828253|NCT05580003|463667756|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828254|NCT05580003|463667757|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828255|NCT05580003|463667758|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
128828256|NCT05580003|463667731|FG000|Part 2 (up to 10 Days)|Other|0|||
128828257|NCT05580003|463667732|FG001|Part 2 (up to 10 Days)|Other|0|||
128828258|NCT05580003|463667733|FG002|Part 2 (up to 10 Days)|Other|0|||
128828259|NCT05580003|463667734|FG003|Part 2 (up to 10 Days)|Other|0|||
128828260|NCT05580003|463667735|FG004|Part 2 (up to 10 Days)|Other|0|||
128828261|NCT05580003|463667736|FG005|Part 2 (up to 10 Days)|Other|0|||
128828262|NCT05580003|463667737|FG006|Part 2 (up to 10 Days)|Other|0|||
128828263|NCT05580003|463667738|FG007|Part 2 (up to 10 Days)|Other|0|||
128828264|NCT05580003|463667739|FG008|Part 2 (up to 10 Days)|Other|0|||
128828265|NCT05580003|463667740|FG009|Part 2 (up to 10 Days)|Other|1|||
128828266|NCT05580003|463667741|FG010|Part 2 (up to 10 Days)|Other|0|||
128828267|NCT05580003|463667742|FG011|Part 2 (up to 10 Days)|Other|0|||
128828268|NCT05580003|463667743|FG012|Part 2 (up to 10 Days)|Other|0|||
128828269|NCT05580003|463667744|FG013|Part 2 (up to 10 Days)|Other|0|||
128828270|NCT05580003|463667745|FG014|Part 2 (up to 10 Days)|Other|0|||
128828271|NCT05580003|463667746|FG015|Part 2 (up to 10 Days)|Other|0|||
128828272|NCT05580003|463667747|FG016|Part 2 (up to 10 Days)|Other|0|||
128828273|NCT05580003|463667748|FG017|Part 2 (up to 10 Days)|Other|0|||
128828274|NCT05580003|463667749|FG018|Part 2 (up to 10 Days)|Other|0|||
128828275|NCT05580003|463667750|FG019|Part 2 (up to 10 Days)|Other|0|||
128828276|NCT05580003|463667751|FG020|Part 2 (up to 10 Days)|Other|0|||
128828277|NCT05580003|463667752|FG021|Part 2 (up to 10 Days)|Other|0|||
128828278|NCT05580003|463667753|FG022|Part 2 (up to 10 Days)|Other|0|||
128828279|NCT05580003|463667754|FG023|Part 2 (up to 10 Days)|Other|0|||
128828280|NCT05580003|463667755|FG024|Part 2 (up to 10 Days)|Other|0|||
128828281|NCT05580003|463667756|FG025|Part 2 (up to 10 Days)|Other|0|||
128828282|NCT05580003|463667757|FG026|Part 2 (up to 10 Days)|Other|0|||
128828283|NCT05580003|463667758|FG027|Part 2 (up to 10 Days)|Other|0|||
128828284|NCT05580003|463667731|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828285|NCT05580003|463667732|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828286|NCT05580003|463667733|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828287|NCT05580003|463667734|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828288|NCT05580003|463667735|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828289|NCT05580003|463667736|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828290|NCT05580003|463667737|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828291|NCT05580003|463667738|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828292|NCT05580003|463667739|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828293|NCT05580003|463667740|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828294|NCT05580003|463667741|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828295|NCT05580003|463667742|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828296|NCT05580003|463667743|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828297|NCT05580003|463667744|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828298|NCT05580003|463667745|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828299|NCT05580003|463667746|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828300|NCT05580003|463667747|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828301|NCT05580003|463667748|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828302|NCT05580003|463667749|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828303|NCT05580003|463667750|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
128828304|NCT05580003|463667751|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828305|NCT05580003|463667752|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828306|NCT05580003|463667753|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828307|NCT05580003|463667754|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828308|NCT05580003|463667755|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828309|NCT05580003|463667756|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828310|NCT05580003|463667757|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828311|NCT05580003|463667758|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
128828312|NCT05580003|463667731|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828313|NCT05580003|463667732|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828314|NCT05580003|463667733|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828315|NCT05580003|463667734|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828316|NCT05580003|463667735|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828317|NCT05580003|463667736|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828318|NCT05580003|463667737|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828319|NCT05580003|463667738|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828320|NCT05580003|463667739|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828321|NCT05580003|463667740|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828322|NCT05580003|463667741|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828323|NCT05580003|463667742|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828324|NCT05580003|463667743|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828325|NCT05580003|463667744|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828326|NCT05580003|463667745|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828327|NCT05580003|463667746|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828328|NCT05580003|463667747|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828329|NCT05580003|463667748|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828330|NCT05580003|463667749|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828331|NCT05580003|463667750|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828332|NCT05580003|463667751|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
128828333|NCT05580003|463667752|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828334|NCT05580003|463667753|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828335|NCT05580003|463667754|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828336|NCT05580003|463667755|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828337|NCT05580003|463667756|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828338|NCT05580003|463667757|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828339|NCT05580003|463667758|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
128828340|NCT05580003|463667731|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828341|NCT05580003|463667732|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828342|NCT05580003|463667733|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828343|NCT05580003|463667734|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828344|NCT05580003|463667735|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828345|NCT05580003|463667736|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828346|NCT05580003|463667737|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828347|NCT05580003|463667738|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828348|NCT05580003|463667739|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828349|NCT05580003|463667740|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828350|NCT05580003|463667741|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828351|NCT05580003|463667742|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828352|NCT05580003|463667743|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828353|NCT05580003|463667744|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828354|NCT05580003|463667745|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828355|NCT05580003|463667746|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828356|NCT05580003|463667747|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828357|NCT05580003|463667748|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828358|NCT05580003|463667749|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828359|NCT05580003|463667750|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828360|NCT05580003|463667751|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828361|NCT05580003|463667752|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
128828362|NCT05580003|463667753|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828363|NCT05580003|463667754|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828364|NCT05580003|463667755|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828365|NCT05580003|463667756|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828366|NCT05580003|463667757|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828367|NCT05580003|463667758|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
128828368|NCT05580003|463667731|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828369|NCT05580003|463667732|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828370|NCT05580003|463667733|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828371|NCT05580003|463667734|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828372|NCT05580003|463667735|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828373|NCT05580003|463667736|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828374|NCT05580003|463667737|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828375|NCT05580003|463667738|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828376|NCT05580003|463667739|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828377|NCT05580003|463667740|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828378|NCT05580003|463667741|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828379|NCT05580003|463667742|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828380|NCT05580003|463667743|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828381|NCT05580003|463667744|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828382|NCT05580003|463667745|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828383|NCT05580003|463667746|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828384|NCT05580003|463667747|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828385|NCT05580003|463667748|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828386|NCT05580003|463667749|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828387|NCT05580003|463667750|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828388|NCT05580003|463667751|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828389|NCT05580003|463667752|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828390|NCT05580003|463667753|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828391|NCT05580003|463667754|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828392|NCT05580003|463667755|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828393|NCT05580003|463667756|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828394|NCT05580003|463667757|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
128828395|NCT05580003|463667758|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
128828396|NCT05580003|463667731|FG000|Part 6 Period 2 (Day 1)|Other|0|||
128828397|NCT05580003|463667732|FG001|Part 6 Period 2 (Day 1)|Other|0|||
128828398|NCT05580003|463667733|FG002|Part 6 Period 2 (Day 1)|Other|0|||
128828399|NCT05580003|463667734|FG003|Part 6 Period 2 (Day 1)|Other|0|||
128828400|NCT05580003|463667735|FG004|Part 6 Period 2 (Day 1)|Other|0|||
128828401|NCT05580003|463667736|FG005|Part 6 Period 2 (Day 1)|Other|0|||
128828402|NCT05580003|463667737|FG006|Part 6 Period 2 (Day 1)|Other|0|||
128828403|NCT05580003|463667738|FG007|Part 6 Period 2 (Day 1)|Other|0|||
128828404|NCT05580003|463667739|FG008|Part 6 Period 2 (Day 1)|Other|0|||
128828405|NCT05580003|463667740|FG009|Part 6 Period 2 (Day 1)|Other|0|||
128828406|NCT05580003|463667741|FG010|Part 6 Period 2 (Day 1)|Other|0|||
128828407|NCT05580003|463667742|FG011|Part 6 Period 2 (Day 1)|Other|0|||
128828408|NCT05580003|463667743|FG012|Part 6 Period 2 (Day 1)|Other|0|||
128828409|NCT05580003|463667744|FG013|Part 6 Period 2 (Day 1)|Other|0|||
128828410|NCT05580003|463667745|FG014|Part 6 Period 2 (Day 1)|Other|0|||
128828411|NCT05580003|463667746|FG015|Part 6 Period 2 (Day 1)|Other|0|||
128828412|NCT05580003|463667747|FG016|Part 6 Period 2 (Day 1)|Other|0|||
128828413|NCT05580003|463667748|FG017|Part 6 Period 2 (Day 1)|Other|0|||
128828414|NCT05580003|463667749|FG018|Part 6 Period 2 (Day 1)|Other|0|||
128828415|NCT05580003|463667750|FG019|Part 6 Period 2 (Day 1)|Other|0|||
128828416|NCT05580003|463667751|FG020|Part 6 Period 2 (Day 1)|Other|0|||
128828417|NCT05580003|463667752|FG021|Part 6 Period 2 (Day 1)|Other|0|||
128828418|NCT05580003|463667753|FG022|Part 6 Period 2 (Day 1)|Other|0|||
128828419|NCT05580003|463667754|FG023|Part 6 Period 2 (Day 1)|Other|0|||
128828420|NCT05580003|463667755|FG024|Part 6 Period 2 (Day 1)|Other|1|||
128828421|NCT05580003|463667756|FG025|Part 6 Period 2 (Day 1)|Other|0|||
128828422|NCT05580003|463667757|FG026|Part 6 Period 2 (Day 1)|Other|0|||
128828423|NCT05580003|463667758|FG027|Part 6 Period 2 (Day 1)|Other|0|||
128828424|NCT01753999|463667759|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
128828425|NCT01753999|463667760|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
128828426|NCT01753999|463667759|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
128828427|NCT01753999|463667760|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
128828428|NCT01753999|463667759|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
128828429|NCT01753999|463667760|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
128828430|NCT01753999|463667759|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
128828431|NCT01753999|463667760|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
128828432|NCT01753999|463667759|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
128828433|NCT01753999|463667760|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
128828434|NCT01753999|463667759|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
128828435|NCT01753999|463667760|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
128828436|NCT02392234|463667761|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
128828437|NCT02392234|463667762|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
128828438|NCT02392234|463667763|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
128828439|NCT02392234|463667764|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
128828440|NCT02392234|463667765|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
128828441|NCT02392234|463667766|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
128828442|NCT02392234|463667761|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
128828443|NCT02392234|463667762|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
128828444|NCT02392234|463667763|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
128828445|NCT02392234|463667764|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
128828446|NCT02392234|463667765|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
128828447|NCT02392234|463667766|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
128828448|NCT02392234|463667761|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128828449|NCT02392234|463667762|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128828450|NCT02392234|463667763|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128828451|NCT02392234|463667764|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128828452|NCT02392234|463667765|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
128828453|NCT02392234|463667766|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
128828454|NCT02392234|463667761|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
128828455|NCT02392234|463667762|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
128828456|NCT02392234|463667763|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
128828457|NCT02392234|463667764|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
128828458|NCT02392234|463667765|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
128828459|NCT02392234|463667766|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
128828460|NCT02392234|463667761|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
128828461|NCT02392234|463667762|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
128828462|NCT02392234|463667763|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
128828463|NCT02392234|463667764|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
128828464|NCT02392234|463667765|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
128828465|NCT02392234|463667766|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
128828466|NCT02392234|463667761|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
128828467|NCT02392234|463667762|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
128828468|NCT02392234|463667763|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
128828469|NCT02392234|463667764|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
128828470|NCT02392234|463667765|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
128828471|NCT02392234|463667766|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
128828472|NCT02392234|463667761|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
128828473|NCT02392234|463667762|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
128828474|NCT02392234|463667763|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
128828475|NCT02392234|463667764|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
128828476|NCT02392234|463667765|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
128828477|NCT02392234|463667766|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
128828478|NCT02392234|463667761|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
128828479|NCT02392234|463667762|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
128828480|NCT02392234|463667763|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
128828481|NCT02392234|463667764|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
128828482|NCT02392234|463667765|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
128828483|NCT02392234|463667766|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
128828484|NCT02052440|463667771|FG000|Overall Study|Withdrawal by Subject|0|||
128828485|NCT02052440|463667772|FG001|Overall Study|Withdrawal by Subject|1|||
128828486|NCT02130557|463667773|FG000|Overall Study|Withdrawal by Subject|12|||
128828487|NCT02130557|463667774|FG001|Overall Study|Withdrawal by Subject|12|||
128828488|NCT02130557|463667773|FG000|Overall Study|Investigator Request|0|||
128828489|NCT02130557|463667774|FG001|Overall Study|Investigator Request|2|||
128828490|NCT02130557|463667773|FG000|Overall Study|Deceased|14|||
128828491|NCT02130557|463667774|FG001|Overall Study|Deceased|14|||
128828492|NCT02130557|463667773|FG000|Overall Study|Lost to Follow-up|6|||
128828493|NCT02130557|463667774|FG001|Overall Study|Lost to Follow-up|7|||
128828494|NCT02130557|463667773|FG000|Overall Study|Other|2|||
128828495|NCT02130557|463667774|FG001|Overall Study|Other|1|||
128828496|NCT02130557|463667773|FG000|Overall Study|Missing|2|||
128828497|NCT02130557|463667774|FG001|Overall Study|Missing|1|||
128828498|NCT02408887|463667775|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
128828499|NCT02408887|463667776|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
128828500|NCT02408887|463667775|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
128828501|NCT02408887|463667776|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
128828502|NCT03333109|463667777|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
128828503|NCT03333109|463667778|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
128828504|NCT03333109|463667779|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
128828505|NCT03333109|463667777|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
128828506|NCT03333109|463667778|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
128828507|NCT03333109|463667779|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
128828508|NCT03333109|463667777|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
128828509|NCT03333109|463667778|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
128828510|NCT03333109|463667779|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
128828511|NCT03333109|463667777|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
128828512|NCT03333109|463667778|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
128828513|NCT03333109|463667779|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
128828514|NCT03333109|463667777|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
128828515|NCT03333109|463667778|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
128828516|NCT03333109|463667779|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
128828517|NCT03333109|463667777|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
128828518|NCT03333109|463667778|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
128828519|NCT03333109|463667779|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
128828520|NCT03333109|463667777|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
128828521|NCT03333109|463667778|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
128828522|NCT03333109|463667779|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
128828523|NCT03333109|463667777|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
128828524|NCT03333109|463667778|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
128828525|NCT03333109|463667779|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
128828526|NCT02415127|463667781|FG000|Overall Study|Adverse Event|1|||
128828527|NCT02415127|463667782|FG001|Overall Study|Adverse Event|0|||
128828528|NCT01855750|463667783|FG000|Overall Study|Death|78|||
128828529|NCT01855750|463667784|FG001|Overall Study|Death|78|||
128828530|NCT01855750|463667783|FG000|Overall Study|Lost to Follow-up|9|||
128828531|NCT01855750|463667784|FG001|Overall Study|Lost to Follow-up|23|||
128828532|NCT01855750|463667783|FG000|Overall Study|Withdrawal by Subject|35|||
128828533|NCT01855750|463667784|FG001|Overall Study|Withdrawal by Subject|28|||
128828534|NCT01855750|463667783|FG000|Overall Study|Sponsor ends the study|297|||
128828535|NCT01855750|463667784|FG001|Overall Study|Sponsor ends the study|290|||
128828536|NCT04300023|463667785|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
128828537|NCT04300023|463667786|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
128828538|NCT05525572|463667787|FG000|Overall Study|Lost to Follow-up|2|||
128828539|NCT04057131|463667788|FG000|Overall Study|Protocol Violation|24|||
128828540|NCT03160885|463667789|FG000|Initial Treatment Period|Not dosed|2|||
128828541|NCT03160885|463667790|FG001|Initial Treatment Period|Not dosed|0|||
128828542|NCT03160885|463667791|FG002|Initial Treatment Period|Not dosed|0|||
128828543|NCT03160885|463667792|FG003|Initial Treatment Period|Not dosed|0|||
128828544|NCT03160885|463667793|FG004|Initial Treatment Period|Not dosed|0|||
128828545|NCT03160885|463667794|FG005|Initial Treatment Period|Not dosed|0|||
128828546|NCT03160885|463667795|FG006|Initial Treatment Period|Not dosed|0|||
128828547|NCT03160885|463667789|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
128828548|NCT03160885|463667790|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
128828549|NCT03160885|463667791|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128828550|NCT03160885|463667792|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128828551|NCT03160885|463667793|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128828552|NCT03160885|463667794|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128828553|NCT03160885|463667795|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
128828554|NCT03160885|463667789|FG000|Open-label Treatment|Not dosed|0|||
128828555|NCT03160885|463667790|FG001|Open-label Treatment|Not dosed|0|||
128828556|NCT03160885|463667791|FG002|Open-label Treatment|Not dosed|0|||
128828557|NCT03160885|463667792|FG003|Open-label Treatment|Not dosed|0|||
128828558|NCT03160885|463667793|FG004|Open-label Treatment|Not dosed|0|||
128828559|NCT03160885|463667794|FG005|Open-label Treatment|Not dosed|0|||
128828560|NCT03160885|463667795|FG006|Open-label Treatment|Not dosed|2|||
128828561|NCT03160885|463667789|FG000|Open-label Treatment|Discontinued IMP|0|||
128828562|NCT03160885|463667790|FG001|Open-label Treatment|Discontinued IMP|0|||
128828563|NCT03160885|463667791|FG002|Open-label Treatment|Discontinued IMP|0|||
128828564|NCT03160885|463667792|FG003|Open-label Treatment|Discontinued IMP|0|||
128828565|NCT03160885|463667793|FG004|Open-label Treatment|Discontinued IMP|0|||
128828566|NCT03160885|463667794|FG005|Open-label Treatment|Discontinued IMP|0|||
128828567|NCT03160885|463667795|FG006|Open-label Treatment|Discontinued IMP|131|||
128828568|NCT03160885|463667789|FG000|Open-label Treatment|Completed Week 50|0|||
128828569|NCT03160885|463667790|FG001|Open-label Treatment|Completed Week 50|0|||
128828570|NCT03160885|463667791|FG002|Open-label Treatment|Completed Week 50|0|||
128828571|NCT03160885|463667792|FG003|Open-label Treatment|Completed Week 50|0|||
128828572|NCT03160885|463667793|FG004|Open-label Treatment|Completed Week 50|0|||
128828573|NCT03160885|463667794|FG005|Open-label Treatment|Completed Week 50|0|||
128828574|NCT03160885|463667795|FG006|Open-label Treatment|Completed Week 50|4|||
128828575|NCT03160885|463667789|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
128828576|NCT03160885|463667790|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
128828577|NCT03160885|463667791|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
128828578|NCT03160885|463667792|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
128828579|NCT03160885|463667793|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
128828580|NCT03160885|463667794|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
128828581|NCT03160885|463667795|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
128828582|NCT03160885|463667789|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
128828583|NCT03160885|463667790|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
128828584|NCT03160885|463667791|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
128828585|NCT03160885|463667792|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
128828586|NCT03160885|463667793|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
128828587|NCT03160885|463667794|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
128828588|NCT03160885|463667795|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
128828589|NCT03160885|463667789|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
128828590|NCT03160885|463667790|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
128828591|NCT03160885|463667791|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
128828592|NCT03160885|463667792|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
128828593|NCT03160885|463667793|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
128828594|NCT03160885|463667794|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
128828595|NCT03160885|463667795|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
128828596|NCT03160885|463667789|FG000|Maintenance Treatment Period|Completed Week 50|0|||
128828597|NCT03160885|463667790|FG001|Maintenance Treatment Period|Completed Week 50|0|||
128828598|NCT03160885|463667791|FG002|Maintenance Treatment Period|Completed Week 50|1|||
128828599|NCT03160885|463667792|FG003|Maintenance Treatment Period|Completed Week 50|0|||
128828600|NCT03160885|463667793|FG004|Maintenance Treatment Period|Completed Week 50|0|||
128828601|NCT03160885|463667794|FG005|Maintenance Treatment Period|Completed Week 50|0|||
128828602|NCT03160885|463667795|FG006|Maintenance Treatment Period|Completed Week 50|0|||
128828603|NCT03425682|463667796|FG000|Overall Study|Lost to Follow-up|2|||
128828604|NCT03425682|463667797|FG001|Overall Study|Lost to Follow-up|4|||
128828605|NCT03425682|463667796|FG000|Overall Study|Withdrawal by Subject|0|||
128828606|NCT03425682|463667797|FG001|Overall Study|Withdrawal by Subject|3|||
128828607|NCT03425682|463667796|FG000|Overall Study|Subject did not meet I/E|4|||
128828608|NCT03425682|463667797|FG001|Overall Study|Subject did not meet I/E|10|||
128828609|NCT03277989|463667804|FG000|Overall Study|Lost to Follow-up|6|||
128828610|NCT03277989|463667804|FG000|Overall Study|Adverse Event|6|||
128828611|NCT03277989|463667804|FG000|Overall Study|Withdrawal by Subject|3|||
128828612|NCT03277989|463667804|FG000|Overall Study|Didn't Receive Study Device|7|||
128828613|NCT03277989|463667804|FG000|Overall Study|Site Closure|26|||
128828614|NCT03277989|463667804|FG000|Overall Study|Sponsor Closure|107|||
128828615|NCT05704725|463667807|FG000|Overall Study|Lost to Follow-up|0|||
128828616|NCT05704725|463667808|FG001|Overall Study|Lost to Follow-up|1|||
128828617|NCT05704725|463667807|FG000|Overall Study|Withdrawal by Subject|1|||
128828618|NCT05704725|463667808|FG001|Overall Study|Withdrawal by Subject|0|||
128828619|NCT03227861|463667809|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
128828620|NCT03227861|463667809|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
128828621|NCT03227861|463667809|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
128828622|NCT03227861|463667809|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
128828623|NCT03227861|463667809|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
128828624|NCT03227861|463667809|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
128828625|NCT03227861|463667809|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
128828626|NCT03227861|463667809|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
128828627|NCT03227861|463667809|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
128828628|NCT03227861|463667809|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
128828629|NCT03516942|463667810|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
128828630|NCT03516942|463667810|FG000|Registration Through Baseline Survey Com|Death|8|||
128828631|NCT03516942|463667810|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
128828632|NCT03516942|463667810|FG000|T0: Baseline|LOST|13|||
128828633|NCT03516942|463667810|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
128828634|NCT03516942|463667810|FG000|T1: 3 Months Survey|Death|10|||
128828635|NCT03516942|463667810|FG000|T1: 3 Months Survey|Lost|163|||
128828636|NCT03516942|463667810|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
128828637|NCT03516942|463667810|FG000|T2: 6 Month Survey|Death|14|||
128828638|NCT03516942|463667810|FG000|T2: 6 Month Survey|Lost|180|||
128828639|NCT03516942|463667810|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
128828640|NCT03516942|463667810|FG000|T3: 12 Month Survey|Death|19|||
128828641|NCT03516942|463667810|FG000|T3: 12 Month Survey|Lost|209|||
128828642|NCT05613907|463667811|FG000|Overall Study|Lost to Follow-up|5|||
128828643|NCT05613907|463667811|FG000|Overall Study|Death|3|||
128828644|NCT05613907|463667811|FG000|Overall Study|Withdrawal by Subject|2|||
128828645|NCT00490139|463667813|FG000|Overall Study|Lost to Follow-up|249|||
128828646|NCT00490139|463667814|FG001|Overall Study|Lost to Follow-up|216|||
128828647|NCT00490139|463667815|FG002|Overall Study|Lost to Follow-up|205|||
128828648|NCT00490139|463667816|FG003|Overall Study|Lost to Follow-up|229|||
128828649|NCT00490139|463667813|FG000|Overall Study|Withdrawal by Subject|333|||
128828650|NCT00490139|463667814|FG001|Overall Study|Withdrawal by Subject|322|||
128828651|NCT00490139|463667815|FG002|Overall Study|Withdrawal by Subject|396|||
128828652|NCT00490139|463667816|FG003|Overall Study|Withdrawal by Subject|295|||
128828653|NCT00490139|463667813|FG000|Overall Study|Patient did not sign ICF 12|169|||
128828654|NCT00490139|463667814|FG001|Overall Study|Patient did not sign ICF 12|176|||
128828655|NCT00490139|463667815|FG002|Overall Study|Patient did not sign ICF 12|139|||
128828656|NCT00490139|463667816|FG003|Overall Study|Patient did not sign ICF 12|167|||
128828657|NCT00490139|463667813|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
128828658|NCT00490139|463667814|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
128828659|NCT00490139|463667815|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
128828660|NCT00490139|463667816|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
128828661|NCT00490139|463667813|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
128828662|NCT00490139|463667814|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
128828663|NCT00490139|463667815|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
128828664|NCT00490139|463667816|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
128828665|NCT00490139|463667813|FG000|Overall Study|Other reasons as defined per protocol|98|||
128828666|NCT00490139|463667814|FG001|Overall Study|Other reasons as defined per protocol|84|||
128828667|NCT00490139|463667815|FG002|Overall Study|Other reasons as defined per protocol|82|||
128828668|NCT00490139|463667816|FG003|Overall Study|Other reasons as defined per protocol|105|||
128828669|NCT04484623|463667817|FG000|Overall Study|Lost to Follow-up|0|||
128828670|NCT04484623|463667818|FG001|Overall Study|Lost to Follow-up|1|||
128828671|NCT04484623|463667817|FG000|Overall Study|Protocol Deviation|1|||
128828672|NCT04484623|463667818|FG001|Overall Study|Protocol Deviation|0|||
128828673|NCT04484623|463667817|FG000|Overall Study|Physician Decision|1|||
128828674|NCT04484623|463667818|FG001|Overall Study|Physician Decision|0|||
128828675|NCT04484623|463667817|FG000|Overall Study|Withdrawal by Subject|11|||
128828676|NCT04484623|463667818|FG001|Overall Study|Withdrawal by Subject|8|||
128828677|NCT04484623|463667817|FG000|Overall Study|Ongoing|94|||
128828678|NCT04484623|463667818|FG001|Overall Study|Ongoing|84|||
128828679|NCT04551066|463667819|FG000|Overall Study|Death|5|||
128828680|NCT04551066|463667820|FG001|Overall Study|Death|3|||
128828681|NCT04551066|463667819|FG000|Overall Study|Lost to Follow-up|1|||
128828682|NCT04551066|463667820|FG001|Overall Study|Lost to Follow-up|0|||
128828683|NCT04551066|463667819|FG000|Overall Study|Sponsor Decision|103|||
128828684|NCT04551066|463667820|FG001|Overall Study|Sponsor Decision|117|||
128828685|NCT04551066|463667819|FG000|Overall Study|Withdrawal by Subject|8|||
128828686|NCT04551066|463667820|FG001|Overall Study|Withdrawal by Subject|2|||
128828687|NCT04551066|463667819|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
128828688|NCT04551066|463667820|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
128828689|NCT04551066|463667819|FG000|Overall Study|Adverse Event|2|||
128828690|NCT04551066|463667820|FG001|Overall Study|Adverse Event|0|||
128828691|NCT04551066|463667819|FG000|Overall Study|Physician Decision|2|||
128828692|NCT04551066|463667820|FG001|Overall Study|Physician Decision|0|||
128828693|NCT04551066|463667819|FG000|Overall Study|Protocol Violation|1|||
128828694|NCT04551066|463667820|FG001|Overall Study|Protocol Violation|0|||
128828695|NCT04551066|463667819|FG000|Overall Study|Lack of Efficacy|0|||
128828696|NCT04551066|463667820|FG001|Overall Study|Lack of Efficacy|1|||
128828697|NCT04551066|463667819|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
128828698|NCT04551066|463667820|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
128828699|NCT05529992|463667821|FG000|Overall Study|Withdrawal by Subject|1|||
128828700|NCT02798471|463667824|FG000|Overall Study|Adverse Event|7|||
128828701|NCT02798471|463667825|FG001|Overall Study|Adverse Event|2|||
128828702|NCT02798471|463667824|FG000|Overall Study|Physician Decision|3|||
128828703|NCT02798471|463667825|FG001|Overall Study|Physician Decision|7|||
128828704|NCT02798471|463667824|FG000|Overall Study|Death|2|||
128828705|NCT02798471|463667825|FG001|Overall Study|Death|3|||
128828706|NCT02798471|463667824|FG000|Overall Study|Lost to Follow-up|0|||
128828707|NCT02798471|463667825|FG001|Overall Study|Lost to Follow-up|1|||
128828708|NCT02798471|463667824|FG000|Overall Study|Other|5|||
128828709|NCT02798471|463667825|FG001|Overall Study|Other|3|||
128828710|NCT02798471|463667824|FG000|Overall Study|Subject withdrew consent|0|||
128828711|NCT02798471|463667825|FG001|Overall Study|Subject withdrew consent|6|||
128828712|NCT02798471|463667824|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
128828713|NCT02798471|463667825|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
128828714|NCT02798471|463667824|FG000|Overall Study|Randomized, but not treated|0|||
128828715|NCT02798471|463667825|FG001|Overall Study|Randomized, but not treated|2|||
128828716|NCT04503681|463669275|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
128828717|NCT04503681|463669276|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
128828718|NCT02760654|463669278|FG000|Overall Study|Lost to Follow-up|3|||
128828719|NCT02760654|463669279|FG001|Overall Study|Lost to Follow-up|3|||
128828720|NCT02760654|463669278|FG000|Overall Study|Withdrawal by Subject|4|||
128828721|NCT02760654|463669279|FG001|Overall Study|Withdrawal by Subject|3|||
128828722|NCT00210106|463669280|FG000|Overall Study|Death|1|||
128828723|NCT00210106|463669280|FG000|Overall Study|Protocol Violation|13|||
128828724|NCT00754325|463669283|FG000|Initial Treatment|Continuing Active Treatment|4|||
128828725|NCT00754325|463669284|FG001|Initial Treatment|Continuing Active Treatment|5|||
128828726|NCT00754325|463669283|FG000|Initial Treatment|Adverse Event|7|||
128828727|NCT00754325|463669284|FG001|Initial Treatment|Adverse Event|6|||
128828728|NCT00754325|463669283|FG000|Initial Treatment|Withdrawal by Subject|2|||
128828729|NCT00754325|463669284|FG001|Initial Treatment|Withdrawal by Subject|2|||
128828730|NCT00754325|463669283|FG000|Initial Treatment|Physician Decision|2|||
128828731|NCT00754325|463669284|FG001|Initial Treatment|Physician Decision|0|||
128828732|NCT00754325|463669283|FG000|Initial Treatment|Sponsor Request|0|||
128828733|NCT00754325|463669284|FG001|Initial Treatment|Sponsor Request|1|||
128828734|NCT00754325|463669283|FG000|Initial Treatment|Disease Progression|35|||
128828735|NCT00754325|463669284|FG001|Initial Treatment|Disease Progression|35|||
128828736|NCT04876417|463669285|FG000|Overall Study|Lost to Follow-up|5|||
128828737|NCT04876417|463669286|FG001|Overall Study|Lost to Follow-up|8|||
128828738|NCT04876417|463669287|FG002|Overall Study|Lost to Follow-up|0|||
128828739|NCT04876417|463669288|FG003|Overall Study|Lost to Follow-up|0|||
128828740|NCT00439270|463669289|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
128828741|NCT00439270|463669290|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
128828742|NCT00439270|463669291|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
128828743|NCT00439270|463669292|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
128828744|NCT00439270|463669293|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
128828745|NCT00439270|463669289|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
128828746|NCT00439270|463669290|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
128828747|NCT00439270|463669291|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
128828748|NCT00439270|463669292|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
128828749|NCT00439270|463669293|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
128828750|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
128828751|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
128828752|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
128828753|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
128828754|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
128828755|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
128828756|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
128828757|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
128828758|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
128828759|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
128828760|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
128828761|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
128828762|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
128828763|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
128828764|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
128828765|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
128828766|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
128828767|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
128828768|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
128828769|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
128828770|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
128828771|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
128828772|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
128828773|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
128828774|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
128828775|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
128828776|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
128828777|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
128828778|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
128828779|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
128828780|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
128828781|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
128828782|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
128828783|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
128828784|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
128828785|NCT00439270|463669289|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
128828786|NCT00439270|463669290|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
128828787|NCT00439270|463669291|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
128828788|NCT00439270|463669292|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
128828789|NCT00439270|463669293|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
128828790|NCT03478969|463669294|FG000|Overall Study|Withdrawal by Subject|4|||
128828791|NCT03478969|463669295|FG001|Overall Study|Withdrawal by Subject|7|||
128828792|NCT03478969|463669296|FG002|Overall Study|Withdrawal by Subject|6|||
128828793|NCT03478969|463669294|FG000|Overall Study|Adverse Event|2|||
128828794|NCT03478969|463669295|FG001|Overall Study|Adverse Event|0|||
128828795|NCT03478969|463669296|FG002|Overall Study|Adverse Event|1|||
128828796|NCT03478969|463669294|FG000|Overall Study|Pregnancy|1|||
128828797|NCT03478969|463669295|FG001|Overall Study|Pregnancy|0|||
128828798|NCT03478969|463669296|FG002|Overall Study|Pregnancy|0|||
128828799|NCT03478969|463669294|FG000|Overall Study|Personal Reasons|1|||
128828800|NCT03478969|463669295|FG001|Overall Study|Personal Reasons|0|||
128828801|NCT03478969|463669296|FG002|Overall Study|Personal Reasons|1|||
128828802|NCT03478969|463669294|FG000|Overall Study|Covid-19|1|||
128828803|NCT03478969|463669295|FG001|Overall Study|Covid-19|4|||
128828804|NCT03478969|463669296|FG002|Overall Study|Covid-19|3|||
128828805|NCT03478969|463669294|FG000|Overall Study|Multiple Reasons|0|||
128828806|NCT03478969|463669295|FG001|Overall Study|Multiple Reasons|1|||
128828807|NCT03478969|463669296|FG002|Overall Study|Multiple Reasons|1|||
128828808|NCT03478969|463669294|FG000|Overall Study|Eligibility Criteria|0|||
128828809|NCT03478969|463669295|FG001|Overall Study|Eligibility Criteria|0|||
128828810|NCT03478969|463669296|FG002|Overall Study|Eligibility Criteria|5|||
128828811|NCT03478969|463669294|FG000|Overall Study|Lost to Follow-up|0|||
128828812|NCT03478969|463669295|FG001|Overall Study|Lost to Follow-up|0|||
128828813|NCT03478969|463669296|FG002|Overall Study|Lost to Follow-up|1|||
128828814|NCT02941549|463669297|FG000|Overall Study|Adverse Event|1|||
128828815|NCT02941549|463669298|FG001|Overall Study|Adverse Event|0|||
128828816|NCT02941549|463669299|FG002|Overall Study|Adverse Event|0|||
128828817|NCT02941549|463669297|FG000|Overall Study|Withdrawal by Subject|2|||
128828818|NCT02941549|463669298|FG001|Overall Study|Withdrawal by Subject|1|||
128828819|NCT02941549|463669299|FG002|Overall Study|Withdrawal by Subject|2|||
128828820|NCT01436175|463669300|FG000|Overall Study|Adverse Event|111|||
128828821|NCT01436175|463669300|FG000|Overall Study|Protocol Violation|49|||
128828822|NCT01436175|463669300|FG000|Overall Study|Withdrawal by Subject|108|||
128828823|NCT01436175|463669300|FG000|Overall Study|Lost to Follow-up|89|||
128828824|NCT01436175|463669300|FG000|Overall Study|Lack of Efficacy|24|||
128828825|NCT01436175|463669300|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
128828826|NCT01436175|463669300|FG000|Overall Study|Other|826|||
128828827|NCT05405244|463669302|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
128828828|NCT05405244|463669303|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
128828829|NCT05405244|463669302|FG000|Washout (2 Weeks)|Adverse Event|2|||
128828830|NCT05405244|463669303|FG001|Washout (2 Weeks)|Adverse Event|0|||
128828831|NCT05405244|463669302|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
128828832|NCT05405244|463669303|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
128828833|NCT03418922|463669306|FG000|Overall Study|Withdrawal by Subject|0|||
128828834|NCT03418922|463669307|FG001|Overall Study|Withdrawal by Subject|2|||
128828835|NCT03418922|463669306|FG000|Overall Study|Adverse Event|2|||
128828836|NCT03418922|463669307|FG001|Overall Study|Adverse Event|2|||
128828837|NCT03418922|463669306|FG000|Overall Study|Death|0|||
128828838|NCT03418922|463669307|FG001|Overall Study|Death|1|||
128828839|NCT03418922|463669306|FG000|Overall Study|Physician Decision|0|||
128828840|NCT03418922|463669307|FG001|Overall Study|Physician Decision|1|||
128828841|NCT03451422|463669308|FG000|Overall Study|Lost to Follow-up|0|||
128828842|NCT03451422|463669309|FG001|Overall Study|Lost to Follow-up|0|||
128828843|NCT03451422|463669310|FG002|Overall Study|Lost to Follow-up|0|||
128828844|NCT03451422|463669311|FG003|Overall Study|Lost to Follow-up|0|||
128828845|NCT03451422|463669312|FG004|Overall Study|Lost to Follow-up|0|||
128828846|NCT03451422|463669313|FG005|Overall Study|Lost to Follow-up|1|||
128828847|NCT03451422|463669308|FG000|Overall Study|Decision by sponsor|1|||
128828848|NCT03451422|463669309|FG001|Overall Study|Decision by sponsor|0|||
128828849|NCT03451422|463669310|FG002|Overall Study|Decision by sponsor|1|||
128828850|NCT03451422|463669311|FG003|Overall Study|Decision by sponsor|0|||
128828851|NCT03451422|463669312|FG004|Overall Study|Decision by sponsor|0|||
128828852|NCT03451422|463669313|FG005|Overall Study|Decision by sponsor|0|||
128828853|NCT03451422|463669308|FG000|Overall Study|Withdrawal by Subject|0|||
128828854|NCT03451422|463669309|FG001|Overall Study|Withdrawal by Subject|0|||
128828855|NCT03451422|463669310|FG002|Overall Study|Withdrawal by Subject|2|||
128828856|NCT03451422|463669311|FG003|Overall Study|Withdrawal by Subject|3|||
128828857|NCT03451422|463669312|FG004|Overall Study|Withdrawal by Subject|2|||
128828858|NCT03451422|463669313|FG005|Overall Study|Withdrawal by Subject|1|||
128828859|NCT03601715|463669314|FG000|Second Intervention|Lost to Follow-up|1|||
128828860|NCT03601715|463669315|FG001|Second Intervention|Lost to Follow-up|1|||
128828861|NCT03601715|463669316|FG002|Second Intervention|Lost to Follow-up|0|||
128828862|NCT00918333|463669319|FG000|Overall Study|Drug not taken per protocol|1|||
128828863|NCT00918333|463669320|FG001|Overall Study|Drug not taken per protocol|0|||
128828864|NCT00918333|463669319|FG000|Overall Study|Inadequate amount of drugs provided|1|||
128828865|NCT00918333|463669320|FG001|Overall Study|Inadequate amount of drugs provided|4|||
128828866|NCT00918333|463669319|FG000|Overall Study|Ineligible|1|||
128828867|NCT00918333|463669320|FG001|Overall Study|Ineligible|0|||
128828868|NCT00918333|463669319|FG000|Overall Study|Withdrawal by Subject|0|||
128828869|NCT00918333|463669320|FG001|Overall Study|Withdrawal by Subject|1|||
128828870|NCT01313884|463669322|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
128828871|NCT00263757|463669323|FG000|Overall Study|Withdrawal by Subject|5|||
128828872|NCT00263757|463669324|FG001|Overall Study|Withdrawal by Subject|4|||
128828873|NCT00263757|463669323|FG000|Overall Study|Screen failure|0|||
128828874|NCT00263757|463669324|FG001|Overall Study|Screen failure|1|||
128828875|NCT00263757|463669323|FG000|Overall Study|Adverse Event|3|||
128828876|NCT00263757|463669324|FG001|Overall Study|Adverse Event|3|||
128828877|NCT02964741|463669325|FG000|Overall Study|Protocol Violation|1|||
128828878|NCT02964741|463669326|FG001|Overall Study|Protocol Violation|0|||
128828879|NCT02964741|463669327|FG002|Overall Study|Protocol Violation|0|||
128828880|NCT02964741|463669325|FG000|Overall Study|Withdrawal by Subject|0|||
128828881|NCT02964741|463669326|FG001|Overall Study|Withdrawal by Subject|1|||
128828882|NCT02964741|463669327|FG002|Overall Study|Withdrawal by Subject|0|||
128828883|NCT02964741|463669325|FG000|Overall Study|claustrophobia|1|||
128828884|NCT02964741|463669326|FG001|Overall Study|claustrophobia|0|||
128828885|NCT02964741|463669327|FG002|Overall Study|claustrophobia|0|||
128828886|NCT01212744|463669340|FG000|Overall Study|Withdrawal by Subject|1|||
128828887|NCT02167451|463669341|FG000|Overall Study|Withdrawal by Subject|1|||
128828888|NCT01218659|463669342|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
128828889|NCT01218659|463669343|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
128828890|NCT01218659|463669344|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
128828891|NCT01218659|463669342|FG000|18-Month Randomized Period|Did not receive study drug|0|||
128828892|NCT01218659|463669343|FG001|18-Month Randomized Period|Did not receive study drug|3|||
128828893|NCT01218659|463669344|FG002|18-Month Randomized Period|Did not receive study drug|0|||
128828894|NCT01218659|463669342|FG000|12-Month OLE|Withdrawal by Subject|0|||
128828895|NCT01218659|463669343|FG001|12-Month OLE|Withdrawal by Subject|0|||
128828896|NCT01218659|463669344|FG002|12-Month OLE|Withdrawal by Subject|2|||
128828897|NCT01218659|463669342|FG000|12-Month OLE|Physician Decision|0|||
128828898|NCT01218659|463669343|FG001|12-Month OLE|Physician Decision|0|||
128828899|NCT01218659|463669344|FG002|12-Month OLE|Physician Decision|1|||
128828900|NCT01218659|463669342|FG000|12-Month OLE|Lost to Follow-up|0|||
128828901|NCT01218659|463669343|FG001|12-Month OLE|Lost to Follow-up|0|||
128828902|NCT01218659|463669344|FG002|12-Month OLE|Lost to Follow-up|1|||
128828903|NCT01218659|463669342|FG000|12-Month OLE|Pregnancy|0|||
128828904|NCT01218659|463669343|FG001|12-Month OLE|Pregnancy|0|||
128828905|NCT01218659|463669344|FG002|12-Month OLE|Pregnancy|1|||
128828906|NCT01218659|463669342|FG000|12-Month OLE|Lack of Efficacy|0|||
128828907|NCT01218659|463669343|FG001|12-Month OLE|Lack of Efficacy|0|||
128828908|NCT01218659|463669344|FG002|12-Month OLE|Lack of Efficacy|1|||
128828909|NCT01218659|463669342|FG000|12-Month OLE|Declined to participate in the OLE|0|||
128828910|NCT01218659|463669343|FG001|12-Month OLE|Declined to participate in the OLE|0|||
128828911|NCT01218659|463669344|FG002|12-Month OLE|Declined to participate in the OLE|4|||
128828912|NCT04191824|463669351|FG000|Overall Study|Death|13|||
128828913|NCT04191824|463669352|FG001|Overall Study|Death|12|||
128828914|NCT04191824|463669351|FG000|Overall Study|Lost to Follow-up|456|||
128828915|NCT04191824|463669352|FG001|Overall Study|Lost to Follow-up|435|||
128828916|NCT04191824|463669351|FG000|Overall Study|Physician Decision|2|||
128828917|NCT04191824|463669352|FG001|Overall Study|Physician Decision|1|||
128828918|NCT04191824|463669351|FG000|Overall Study|Protocol Violation|0|||
128828919|NCT04191824|463669352|FG001|Overall Study|Protocol Violation|2|||
128828920|NCT04191824|463669351|FG000|Overall Study|Withdrawal by Subject|16|||
128828921|NCT04191824|463669352|FG001|Overall Study|Withdrawal by Subject|18|||
128828922|NCT04191824|463669351|FG000|Overall Study|Early site closure|24|||
128828923|NCT04191824|463669352|FG001|Overall Study|Early site closure|22|||
128828924|NCT01499849|463669358|FG000|Overall Study|Adverse Event|28|||
128828925|NCT01499849|463669359|FG001|Overall Study|Adverse Event|32|||
128828926|NCT01499849|463669358|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
128828927|NCT01499849|463669359|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
128828928|NCT01499849|463669358|FG000|Overall Study|Withdrawal by Subject|43|||
128828929|NCT01499849|463669359|FG001|Overall Study|Withdrawal by Subject|43|||
128828930|NCT01499849|463669358|FG000|Overall Study|Death|5|||
128828931|NCT01499849|463669359|FG001|Overall Study|Death|7|||
128828932|NCT01499849|463669358|FG000|Overall Study|Disease Progression|11|||
128828933|NCT01499849|463669359|FG001|Overall Study|Disease Progression|10|||
128828934|NCT01499849|463669358|FG000|Overall Study|Protocol Violation|11|||
128828935|NCT01499849|463669359|FG001|Overall Study|Protocol Violation|11|||
128828936|NCT01499849|463669358|FG000|Overall Study|Physician Decision|20|||
128828937|NCT01499849|463669359|FG001|Overall Study|Physician Decision|19|||
128828938|NCT01499849|463669358|FG000|Overall Study|Lack of Efficacy|3|||
128828939|NCT01499849|463669359|FG001|Overall Study|Lack of Efficacy|4|||
128828940|NCT01499849|463669358|FG000|Overall Study|Lost to Follow-up|6|||
128828941|NCT01499849|463669359|FG001|Overall Study|Lost to Follow-up|3|||
128828942|NCT01499849|463669358|FG000|Overall Study|Other Reasons|27|||
128828943|NCT01499849|463669359|FG001|Overall Study|Other Reasons|30|||
128828944|NCT01437319|463669360|FG000|Phase I|Lost to Follow-up|2|||
128828945|NCT01437319|463669361|FG001|Phase I|Lost to Follow-up|0|||
128828946|NCT01437319|463669362|FG002|Phase I|Lost to Follow-up|0|||
128828947|NCT01437319|463669360|FG000|Phase I|Protocol Violation|1|||
128828948|NCT01437319|463669361|FG001|Phase I|Protocol Violation|0|||
128828949|NCT01437319|463669362|FG002|Phase I|Protocol Violation|0|||
128828950|NCT01437319|463669360|FG000|Phase I|Study related symptoms/complaints|27|||
128828951|NCT01437319|463669361|FG001|Phase I|Study related symptoms/complaints|0|||
128828952|NCT01437319|463669362|FG002|Phase I|Study related symptoms/complaints|0|||
128828953|NCT01437319|463669360|FG000|Phase I|Withdrawal by Subject|25|||
128828954|NCT01437319|463669361|FG001|Phase I|Withdrawal by Subject|0|||
128828955|NCT01437319|463669362|FG002|Phase I|Withdrawal by Subject|0|||
128828956|NCT01437319|463669360|FG000|Phase II|Withdrawal by Subject|0|||
128828957|NCT01437319|463669361|FG001|Phase II|Withdrawal by Subject|8|||
128828958|NCT01437319|463669362|FG002|Phase II|Withdrawal by Subject|16|||
128828959|NCT01437319|463669360|FG000|Phase II|Lost to Follow-up|0|||
128828960|NCT01437319|463669361|FG001|Phase II|Lost to Follow-up|7|||
128828961|NCT01437319|463669362|FG002|Phase II|Lost to Follow-up|2|||
128828962|NCT01437319|463669360|FG000|Phase II|Study related symptoms/complaints|0|||
128828963|NCT01437319|463669361|FG001|Phase II|Study related symptoms/complaints|28|||
128828964|NCT01437319|463669362|FG002|Phase II|Study related symptoms/complaints|19|||
128828965|NCT01437319|463669360|FG000|Phase II|Protocol Violation|0|||
128828966|NCT01437319|463669361|FG001|Phase II|Protocol Violation|1|||
128828967|NCT01437319|463669362|FG002|Phase II|Protocol Violation|0|||
128828968|NCT00174252|463669363|FG000|Overall Study|Protocol Violation|2|||
128828969|NCT00811941|463669364|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
128828970|NCT00811941|463669365|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
128828971|NCT00811941|463669364|FG000|All Treated Patients|Adverse Event|2|||
128828972|NCT00811941|463669365|FG001|All Treated Patients|Adverse Event|43|||
128828973|NCT00811941|463669364|FG000|All Treated Patients|Lack of Efficacy|2|||
128828974|NCT00811941|463669365|FG001|All Treated Patients|Lack of Efficacy|3|||
128828975|NCT00811941|463669364|FG000|All Treated Patients|Non-compliance|1|||
128828976|NCT00811941|463669365|FG001|All Treated Patients|Non-compliance|8|||
128828977|NCT00811941|463669364|FG000|All Treated Patients|Protocol Violation|5|||
128828978|NCT00811941|463669365|FG001|All Treated Patients|Protocol Violation|17|||
128828979|NCT00811941|463669364|FG000|All Treated Patients|Withdrawal by Subject|35|||
128828980|NCT00811941|463669365|FG001|All Treated Patients|Withdrawal by Subject|94|||
128828981|NCT00811941|463669364|FG000|All Treated Patients|Lost to Follow-up|3|||
128828982|NCT00811941|463669365|FG001|All Treated Patients|Lost to Follow-up|12|||
128828983|NCT00811941|463669364|FG000|All Treated Patients|Other Reason|4|||
128828984|NCT00811941|463669365|FG001|All Treated Patients|Other Reason|14|||
128828985|NCT03802994|463669366|FG000|Overall Study|Lost to Follow-up|0|||
128828986|NCT03802994|463669367|FG001|Overall Study|Lost to Follow-up|2|||
128828987|NCT03802994|463669368|FG002|Overall Study|Lost to Follow-up|3|||
128828988|NCT03802994|463669369|FG003|Overall Study|Lost to Follow-up|2|||
128828989|NCT03802994|463669370|FG004|Overall Study|Lost to Follow-up|2|||
128828990|NCT03611556|463669376|FG000|Overall Study|Death|7|||
128828991|NCT03611556|463669377|FG001|Overall Study|Death|7|||
128828992|NCT03611556|463669378|FG002|Overall Study|Death|3|||
128828993|NCT03611556|463669379|FG003|Overall Study|Death|8|||
128828994|NCT03611556|463669380|FG004|Overall Study|Death|47|||
128828995|NCT03611556|463669381|FG005|Overall Study|Death|32|||
128828996|NCT03611556|463669382|FG006|Overall Study|Death|53|||
128828997|NCT03611556|463669376|FG000|Overall Study|Withdrawal by Subject|0|||
128828998|NCT03611556|463669377|FG001|Overall Study|Withdrawal by Subject|0|||
128828999|NCT03611556|463669378|FG002|Overall Study|Withdrawal by Subject|0|||
128829000|NCT03611556|463669379|FG003|Overall Study|Withdrawal by Subject|0|||
128829001|NCT03611556|463669380|FG004|Overall Study|Withdrawal by Subject|4|||
128829002|NCT03611556|463669381|FG005|Overall Study|Withdrawal by Subject|2|||
128829003|NCT03611556|463669382|FG006|Overall Study|Withdrawal by Subject|4|||
128829004|NCT03611556|463669376|FG000|Overall Study|Sponsor decision|0|||
128829005|NCT03611556|463669377|FG001|Overall Study|Sponsor decision|0|||
128829006|NCT03611556|463669378|FG002|Overall Study|Sponsor decision|0|||
128829007|NCT03611556|463669379|FG003|Overall Study|Sponsor decision|0|||
128829008|NCT03611556|463669380|FG004|Overall Study|Sponsor decision|9|||
128829009|NCT03611556|463669381|FG005|Overall Study|Sponsor decision|4|||
128829010|NCT03611556|463669382|FG006|Overall Study|Sponsor decision|12|||
128829011|NCT03611556|463669376|FG000|Overall Study|Reasons|0|||
128829012|NCT03611556|463669377|FG001|Overall Study|Reasons|0|||
128829013|NCT03611556|463669378|FG002|Overall Study|Reasons|0|||
128829014|NCT03611556|463669379|FG003|Overall Study|Reasons|0|||
128829015|NCT03611556|463669380|FG004|Overall Study|Reasons|2|||
128829016|NCT03611556|463669381|FG005|Overall Study|Reasons|0|||
128829017|NCT03611556|463669382|FG006|Overall Study|Reasons|1|||
128829018|NCT00390884|463669383|FG000|Overall Study|Withdrawal by Subject|2|||
128829019|NCT00390884|463669384|FG001|Overall Study|Withdrawal by Subject|2|||
128829020|NCT04035447|463669385|FG000|Treatment Period|Lost to Follow-up|6|||
128829021|NCT04035447|463669386|FG001|Treatment Period|Lost to Follow-up|5|||
128829022|NCT04035447|463669385|FG000|Treatment Period|Physician Decision|0|||
128829023|NCT04035447|463669386|FG001|Treatment Period|Physician Decision|2|||
128829024|NCT03304587|463669387|FG000|Overall Study|Headache after intervention|0|||
128829025|NCT03304587|463669388|FG001|Overall Study|Headache after intervention|1|||
128829026|NCT03304587|463669387|FG000|Overall Study|Withdrawal by Subject|1|||
128829027|NCT03304587|463669388|FG001|Overall Study|Withdrawal by Subject|0|||
128829028|NCT02397096|463669389|FG000|Day 1 to Week 24|Adverse Event|7|||
128829029|NCT02397096|463669390|FG001|Day 1 to Week 24|Adverse Event|1|||
128829030|NCT02397096|463669389|FG000|Day 1 to Week 24|Death|1|||
128829031|NCT02397096|463669390|FG001|Day 1 to Week 24|Death|0|||
128829032|NCT02397096|463669389|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
128829033|NCT02397096|463669390|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
128829034|NCT02397096|463669389|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
128829035|NCT02397096|463669390|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
128829036|NCT02397096|463669389|FG000|Day 1 to Week 24|Physician Decision|2|||
128829037|NCT02397096|463669390|FG001|Day 1 to Week 24|Physician Decision|3|||
128829038|NCT02397096|463669389|FG000|Day 1 to Week 24|Protocol Violation|1|||
128829039|NCT02397096|463669390|FG001|Day 1 to Week 24|Protocol Violation|4|||
128829040|NCT02397096|463669389|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
128829041|NCT02397096|463669390|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
128829042|NCT02397096|463669389|FG000|Day 1 to Week 24|Randomized, not treated|3|||
128829043|NCT02397096|463669390|FG001|Day 1 to Week 24|Randomized, not treated|0|||
128829044|NCT02397096|463669389|FG000|Week 24 to Week 48|Adverse Event|6|||
128829045|NCT02397096|463669390|FG001|Week 24 to Week 48|Adverse Event|2|||
128829046|NCT02397096|463669389|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
128829047|NCT02397096|463669390|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
128829048|NCT02397096|463669389|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
128829049|NCT02397096|463669390|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
128829050|NCT02397096|463669389|FG000|Week 24 to Week 48|Physician Decision|2|||
128829051|NCT02397096|463669390|FG001|Week 24 to Week 48|Physician Decision|1|||
128829052|NCT02397096|463669389|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
128829053|NCT02397096|463669390|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
128829054|NCT02397096|463669389|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
128829055|NCT02397096|463669390|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
128829056|NCT02397096|463669389|FG000|Study Extension 1|Adverse Event|7|||
128829057|NCT02397096|463669390|FG001|Study Extension 1|Adverse Event|5|||
128829058|NCT02397096|463669389|FG000|Study Extension 1|Death|1|||
128829059|NCT02397096|463669390|FG001|Study Extension 1|Death|0|||
128829060|NCT02397096|463669389|FG000|Study Extension 1|Lack of Efficacy|2|||
128829061|NCT02397096|463669390|FG001|Study Extension 1|Lack of Efficacy|5|||
128829062|NCT02397096|463669389|FG000|Study Extension 1|Lost to Follow-up|2|||
128829063|NCT02397096|463669390|FG001|Study Extension 1|Lost to Follow-up|3|||
128829064|NCT02397096|463669389|FG000|Study Extension 1|Non-compliance with study drug|3|||
128829065|NCT02397096|463669390|FG001|Study Extension 1|Non-compliance with study drug|0|||
128829066|NCT02397096|463669389|FG000|Study Extension 1|Physician Decision|4|||
128829067|NCT02397096|463669390|FG001|Study Extension 1|Physician Decision|2|||
128829068|NCT02397096|463669389|FG000|Study Extension 1|Pregnancy|1|||
128829069|NCT02397096|463669390|FG001|Study Extension 1|Pregnancy|0|||
128829070|NCT02397096|463669389|FG000|Study Extension 1|Protocol Violation|0|||
128829071|NCT02397096|463669390|FG001|Study Extension 1|Protocol Violation|1|||
128829072|NCT02397096|463669389|FG000|Study Extension 1|Withdrawal by Subject|21|||
128829073|NCT02397096|463669390|FG001|Study Extension 1|Withdrawal by Subject|7|||
128829074|NCT02397096|463669389|FG000|Study Extension 2|Adverse Event|3|||
128829075|NCT02397096|463669390|FG001|Study Extension 2|Adverse Event|3|||
128829076|NCT02397096|463669389|FG000|Study Extension 2|Availability of study medication locally|152|||
128829077|NCT02397096|463669390|FG001|Study Extension 2|Availability of study medication locally|64|||
128829078|NCT02397096|463669389|FG000|Study Extension 2|Death|2|||
128829079|NCT02397096|463669390|FG001|Study Extension 2|Death|0|||
128829080|NCT02397096|463669389|FG000|Study Extension 2|Lack of Efficacy|1|||
128829081|NCT02397096|463669390|FG001|Study Extension 2|Lack of Efficacy|0|||
128829082|NCT02397096|463669389|FG000|Study Extension 2|Lost to Follow-up|2|||
128829083|NCT02397096|463669390|FG001|Study Extension 2|Lost to Follow-up|1|||
128829084|NCT02397096|463669389|FG000|Study Extension 2|Non-compliance with study drug|1|||
128829085|NCT02397096|463669390|FG001|Study Extension 2|Non-compliance with study drug|0|||
128829086|NCT02397096|463669389|FG000|Study Extension 2|Physician Decision|2|||
128829087|NCT02397096|463669390|FG001|Study Extension 2|Physician Decision|5|||
128829088|NCT02397096|463669389|FG000|Study Extension 2|Pregnancy|1|||
128829089|NCT02397096|463669390|FG001|Study Extension 2|Pregnancy|0|||
128829090|NCT02397096|463669389|FG000|Study Extension 2|Withdrawal by Subject|10|||
128829091|NCT02397096|463669390|FG001|Study Extension 2|Withdrawal by Subject|3|||
128829092|NCT02397096|463669389|FG000|Study Extension 3|Adverse Event|1|||
128829093|NCT02397096|463669390|FG001|Study Extension 3|Adverse Event|0|||
128829094|NCT02397096|463669389|FG000|Study Extension 3|Availability of study medication locally|11|||
128829095|NCT02397096|463669390|FG001|Study Extension 3|Availability of study medication locally|3|||
128829096|NCT02397096|463669389|FG000|Study Extension 3|Lost to Follow-up|1|||
128829097|NCT02397096|463669390|FG001|Study Extension 3|Lost to Follow-up|0|||
128829098|NCT02397096|463669389|FG000|Study Extension 3|Withdrawal by Subject|2|||
128829099|NCT02397096|463669390|FG001|Study Extension 3|Withdrawal by Subject|1|||
128829100|NCT00918203|463669394|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
128829101|NCT00918203|463669395|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
128829102|NCT00918203|463669396|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
128829103|NCT00918203|463669394|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
128829104|NCT00918203|463669395|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
128829105|NCT00918203|463669396|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
128829106|NCT00918203|463669394|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
128829107|NCT00918203|463669395|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
128829108|NCT00918203|463669396|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
128829109|NCT00918203|463669394|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
128829110|NCT00918203|463669395|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
128829111|NCT00918203|463669396|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
128829112|NCT00701701|463669399|FG000|Overall Study|Withdrawal by Subject|0|||
128829113|NCT00701701|463669400|FG001|Overall Study|Withdrawal by Subject|1|||
128829114|NCT00701701|463669399|FG000|Overall Study|Adverse Event|0|||
128829115|NCT00701701|463669400|FG001|Overall Study|Adverse Event|1|||
128829116|NCT00589875|463669401|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
128829117|NCT00589875|463669401|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
128829118|NCT03488719|463669404|FG000|Overall Study|Adverse Event|0|||
128829119|NCT03488719|463669405|FG001|Overall Study|Adverse Event|4|||
128829120|NCT03488719|463669406|FG002|Overall Study|Adverse Event|2|||
128829121|NCT03488719|463669404|FG000|Overall Study|Other|0|||
128829122|NCT03488719|463669405|FG001|Overall Study|Other|0|||
128829123|NCT03488719|463669406|FG002|Overall Study|Other|5|||
128829124|NCT03477175|463669409|FG000|Overall Study|Unable to travel due to COVID-19|0|||
128829125|NCT03477175|463669410|FG001|Overall Study|Unable to travel due to COVID-19|1|||
128829126|NCT03477175|463669409|FG000|Overall Study|Physician Decision|1|||
128829127|NCT03477175|463669410|FG001|Overall Study|Physician Decision|0|||
128829128|NCT03477175|463669409|FG000|Overall Study|Transitioned to commercial drug|6|||
128829129|NCT03477175|463669410|FG001|Overall Study|Transitioned to commercial drug|6|||
128829130|NCT03477175|463669409|FG000|Overall Study|Lost to Follow-up|1|||
128829131|NCT03477175|463669410|FG001|Overall Study|Lost to Follow-up|1|||
128829132|NCT03477175|463669409|FG000|Overall Study|Withdrawal by Subject|3|||
128829133|NCT03477175|463669410|FG001|Overall Study|Withdrawal by Subject|1|||
128829134|NCT03477175|463669409|FG000|Overall Study|Adverse Event|1|||
128829135|NCT03477175|463669410|FG001|Overall Study|Adverse Event|5|||
128829136|NCT03477175|463669409|FG000|Overall Study|Disease Progression|7|||
128829137|NCT03477175|463669410|FG001|Overall Study|Disease Progression|7|||
128829138|NCT02078648|463669411|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
128829139|NCT02078648|463669412|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
128829140|NCT02078648|463669411|FG000|Overall Study|Adverse Event|0|||
128829141|NCT02078648|463669412|FG001|Overall Study|Adverse Event|1|||
128829142|NCT02078648|463669411|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
128829143|NCT02078648|463669412|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
128829144|NCT02078648|463669411|FG000|Overall Study|Withdrawal by Subject|3|||
128829145|NCT02078648|463669412|FG001|Overall Study|Withdrawal by Subject|1|||
128829146|NCT02078648|463669411|FG000|Overall Study|Investigator Decision|5|||
128829147|NCT02078648|463669412|FG001|Overall Study|Investigator Decision|7|||
128829148|NCT02078648|463669411|FG000|Overall Study|Death|1|||
128829149|NCT02078648|463669412|FG001|Overall Study|Death|1|||
128829150|NCT02078648|463669411|FG000|Overall Study|Undefined|0|||
128829151|NCT02078648|463669412|FG001|Overall Study|Undefined|1|||
128829152|NCT04088227|463669413|FG000|Overall Study|Withdrawal by Subject|1|||
128829153|NCT04088227|463669414|FG001|Overall Study|Withdrawal by Subject|0|||
128829154|NCT04088227|463669413|FG000|Overall Study|Surgery postponed >5weeks|1|||
128829155|NCT04088227|463669414|FG001|Overall Study|Surgery postponed >5weeks|0|||
128829156|NCT03664804|463669416|FG000|Overall Study|Withdrawal by Subject|7|||
128829157|NCT04701203|463669417|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
128829158|NCT04701203|463669418|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
128829159|NCT04701203|463669419|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
128829160|NCT04701203|463669417|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
128829161|NCT04701203|463669418|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
128829162|NCT04701203|463669419|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
128829163|NCT04701203|463669417|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
128829164|NCT04701203|463669418|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
128829165|NCT04701203|463669419|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
128829166|NCT04701203|463669417|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
128829167|NCT04701203|463669418|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
128829168|NCT04701203|463669419|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
128829169|NCT06140290|463669420|FG000|Period 1|Adverse Event|1|||
128829170|NCT06140290|463669421|FG001|Period 1|Adverse Event|0|||
128829171|NCT06140290|463669420|FG000|Period 2|Assigned but not treated|0|||
128829172|NCT06140290|463669421|FG001|Period 2|Assigned but not treated|1|||
128829173|NCT06140290|463669420|FG000|Period 2|Withdrawal by Subject|0|||
128829174|NCT06140290|463669421|FG001|Period 2|Withdrawal by Subject|1|||
128829175|NCT05293717|463669423|FG000|Overall Study|Physician Decision|1|||
128829176|NCT03762850|463670964|FG000|Overall Study|Death|0|||
128829177|NCT03762850|463670965|FG001|Overall Study|Death|1|||
128829178|NCT03762850|463670964|FG000|Overall Study|Lost to Follow-up|0|||
128829179|NCT03762850|463670965|FG001|Overall Study|Lost to Follow-up|1|||
128829180|NCT03762850|463670964|FG000|Overall Study|Physician Decision|0|||
128829181|NCT03762850|463670965|FG001|Overall Study|Physician Decision|1|||
128829182|NCT03762850|463670964|FG000|Overall Study|Withdrawal by Subject|4|||
128829183|NCT03762850|463670965|FG001|Overall Study|Withdrawal by Subject|9|||
128829184|NCT03083366|463670966|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
128829185|NCT03083366|463670967|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
128829186|NCT03083366|463670966|FG000|Enrollment Period|Lack of Efficacy|1|||
128829187|NCT03083366|463670967|FG001|Enrollment Period|Lack of Efficacy|0|||
128829188|NCT02036970|463670975|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
128829189|NCT02036970|463670976|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
128829190|NCT02036970|463670977|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
128829191|NCT02036970|463670978|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
128829192|NCT02036970|463670979|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
128829193|NCT02036970|463670980|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
128829194|NCT02036970|463670981|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
128829195|NCT02036970|463670982|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
128829196|NCT02036970|463670983|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
128829197|NCT02036970|463670984|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
128829198|NCT02036970|463670975|FG000|Part 1: Day 1 Through Week 16|Death|0|||
128829199|NCT02036970|463670976|FG001|Part 1: Day 1 Through Week 16|Death|0|||
128829200|NCT02036970|463670977|FG002|Part 1: Day 1 Through Week 16|Death|0|||
128829201|NCT02036970|463670978|FG003|Part 1: Day 1 Through Week 16|Death|0|||
128829202|NCT02036970|463670979|FG004|Part 1: Day 1 Through Week 16|Death|0|||
128829203|NCT02036970|463670980|FG005|Part 1: Day 1 Through Week 16|Death|0|||
128829204|NCT02036970|463670981|FG006|Part 1: Day 1 Through Week 16|Death|0|||
128829205|NCT02036970|463670982|FG007|Part 1: Day 1 Through Week 16|Death|0|||
128829206|NCT02036970|463670983|FG008|Part 1: Day 1 Through Week 16|Death|1|||
128829207|NCT02036970|463670984|FG009|Part 1: Day 1 Through Week 16|Death|0|||
128829208|NCT02036970|463670975|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
128829209|NCT02036970|463670976|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
128829210|NCT02036970|463670977|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
128829211|NCT02036970|463670978|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
128829212|NCT02036970|463670979|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
128829213|NCT02036970|463670980|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
128829214|NCT02036970|463670981|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
128829215|NCT02036970|463670982|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
128829216|NCT02036970|463670983|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
128829217|NCT02036970|463670984|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
128829218|NCT02036970|463670975|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
128829219|NCT02036970|463670976|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
128829220|NCT02036970|463670977|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
128829221|NCT02036970|463670978|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
128829222|NCT02036970|463670979|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
128829223|NCT02036970|463670980|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
128829224|NCT02036970|463670981|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
128829225|NCT02036970|463670982|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
128829226|NCT02036970|463670983|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
128829227|NCT02036970|463670984|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
128829228|NCT02036970|463670975|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829229|NCT02036970|463670976|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829230|NCT02036970|463670977|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829231|NCT02036970|463670978|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
128829232|NCT02036970|463670979|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829233|NCT02036970|463670980|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829234|NCT02036970|463670981|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829235|NCT02036970|463670982|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829236|NCT02036970|463670983|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829237|NCT02036970|463670984|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
128829238|NCT02036970|463670975|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
128829239|NCT02036970|463670976|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
128829240|NCT02036970|463670977|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
128829241|NCT02036970|463670978|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
128829242|NCT02036970|463670979|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
128829243|NCT02036970|463670980|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
128829244|NCT02036970|463670981|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
128829245|NCT02036970|463670982|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
128829246|NCT02036970|463670983|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
128829247|NCT02036970|463670984|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
128829248|NCT02036970|463670975|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829249|NCT02036970|463670976|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829250|NCT02036970|463670977|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829251|NCT02036970|463670978|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829252|NCT02036970|463670979|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829253|NCT02036970|463670980|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829254|NCT02036970|463670981|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829255|NCT02036970|463670982|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
128829256|NCT02036970|463670983|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829257|NCT02036970|463670984|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
128829258|NCT02036970|463670975|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
128829259|NCT02036970|463670976|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
128829260|NCT02036970|463670977|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
128829261|NCT02036970|463670978|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
128829262|NCT02036970|463670979|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
128829263|NCT02036970|463670980|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
128829264|NCT02036970|463670981|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
128829265|NCT02036970|463670982|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
128829266|NCT02036970|463670983|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
128829267|NCT02036970|463670984|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
128829268|NCT02036970|463670975|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
128829269|NCT02036970|463670976|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
128829270|NCT02036970|463670977|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
128829271|NCT02036970|463670978|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
128829272|NCT02036970|463670979|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
128829273|NCT02036970|463670980|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
128829274|NCT02036970|463670981|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
128829275|NCT02036970|463670982|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
128829276|NCT02036970|463670983|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
128829277|NCT02036970|463670984|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
128829278|NCT02386098|463670987|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
128829279|NCT02386098|463670988|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
128829280|NCT02386098|463670989|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
128829281|NCT02386098|463670990|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
128829282|NCT02386098|463670991|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
128829283|NCT02386098|463670987|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
128829284|NCT02386098|463670988|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
128829285|NCT02386098|463670989|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
128829286|NCT02386098|463670990|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
128829287|NCT02386098|463670991|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
128829288|NCT02386098|463670987|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
128829289|NCT02386098|463670988|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
128829290|NCT02386098|463670989|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
128829291|NCT02386098|463670990|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
128829292|NCT02386098|463670991|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
128829293|NCT02386098|463670987|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
128829294|NCT02386098|463670988|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
128829295|NCT02386098|463670989|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
128829296|NCT02386098|463670990|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
128829297|NCT02386098|463670991|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
128829298|NCT02386098|463670987|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
128829299|NCT02386098|463670988|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
128829300|NCT02386098|463670989|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
128829301|NCT02386098|463670990|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
128829302|NCT02386098|463670991|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
128829303|NCT02386098|463670987|FG000|Stage 1 (96 Weeks)|Other|1|||
128829304|NCT02386098|463670988|FG001|Stage 1 (96 Weeks)|Other|0|||
128829305|NCT02386098|463670989|FG002|Stage 1 (96 Weeks)|Other|0|||
128829306|NCT02386098|463670990|FG003|Stage 1 (96 Weeks)|Other|0|||
128829307|NCT02386098|463670991|FG004|Stage 1 (96 Weeks)|Other|0|||
128829308|NCT02386098|463670987|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
128829309|NCT02386098|463670988|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
128829310|NCT02386098|463670989|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
128829311|NCT02386098|463670990|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
128829312|NCT02386098|463670991|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
128829313|NCT03752684|463670993|FG000|Overall Study|Lost to Follow-up|4|||
128829314|NCT03352713|463670996|FG000|Overall Study|Lost to Follow-up|8|||
128829315|NCT03352713|463670996|FG000|Overall Study|Withdrawn by investigator|5|||
128829316|NCT03352713|463670996|FG000|Overall Study|Completed 0 EMAs|8|||
128829317|NCT03352713|463670996|FG000|Overall Study|Device incompatible/stolen|5|||
128829318|NCT02722434|463670997|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
128829319|NCT02722434|463670998|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
128829320|NCT02722434|463670997|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
128829321|NCT02722434|463670998|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
128829322|NCT00360269|463670999|FG000|Overall Study|Lost to Follow-up|7|||
128829323|NCT00360269|463671000|FG001|Overall Study|Lost to Follow-up|9|||
128829324|NCT00360269|463670999|FG000|Overall Study|Physician Decision|1|||
128829325|NCT00360269|463671000|FG001|Overall Study|Physician Decision|2|||
128829326|NCT00360269|463670999|FG000|Overall Study|Adverse Event|1|||
128829327|NCT00360269|463671000|FG001|Overall Study|Adverse Event|0|||
128829328|NCT00360269|463670999|FG000|Overall Study|Withdrawal by Subject|1|||
128829329|NCT00360269|463671000|FG001|Overall Study|Withdrawal by Subject|1|||
128829330|NCT00048932|463671003|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
128829331|NCT00048932|463671004|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
128829332|NCT00048932|463671005|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
128829333|NCT00048932|463671003|FG000|Double Blind Period (DB)|Adverse Event|51|||
128829334|NCT00048932|463671004|FG001|Double Blind Period (DB)|Adverse Event|19|||
128829335|NCT00048932|463671005|FG002|Double Blind Period (DB)|Adverse Event|0|||
128829336|NCT00048932|463671003|FG000|Double Blind Period (DB)|Death|5|||
128829337|NCT00048932|463671004|FG001|Double Blind Period (DB)|Death|3|||
128829338|NCT00048932|463671005|FG002|Double Blind Period (DB)|Death|0|||
128829339|NCT00048932|463671003|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
128829340|NCT00048932|463671004|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
128829341|NCT00048932|463671005|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
128829342|NCT00048932|463671003|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
128829343|NCT00048932|463671004|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
128829344|NCT00048932|463671005|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
128829345|NCT00048932|463671003|FG000|Double Blind Period (DB)|Relocation|1|||
128829346|NCT00048932|463671004|FG001|Double Blind Period (DB)|Relocation|0|||
128829347|NCT00048932|463671005|FG002|Double Blind Period (DB)|Relocation|0|||
128829348|NCT00048932|463671003|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
128829349|NCT00048932|463671004|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
128829350|NCT00048932|463671005|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
128829351|NCT00048932|463671003|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
128829352|NCT00048932|463671004|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
128829353|NCT00048932|463671005|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
128829354|NCT00048932|463671003|FG000|Double Blind Period (DB)|Pregnancy|1|||
128829355|NCT00048932|463671004|FG001|Double Blind Period (DB)|Pregnancy|0|||
128829356|NCT00048932|463671005|FG002|Double Blind Period (DB)|Pregnancy|0|||
128829357|NCT00048932|463671003|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
128829358|NCT00048932|463671004|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
128829359|NCT00048932|463671005|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
128829360|NCT00048932|463671003|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
128829361|NCT00048932|463671004|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
128829362|NCT00048932|463671005|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
128829363|NCT00048932|463671003|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
128829364|NCT00048932|463671004|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
128829365|NCT00048932|463671005|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
128829366|NCT00048932|463671003|FG000|Open Label Period (OL)|Death|0|||
128829367|NCT00048932|463671004|FG001|Open Label Period (OL)|Death|0|||
128829368|NCT00048932|463671005|FG002|Open Label Period (OL)|Death|25|||
128829369|NCT00048932|463671003|FG000|Open Label Period (OL)|Adverse Event|0|||
128829370|NCT00048932|463671004|FG001|Open Label Period (OL)|Adverse Event|0|||
128829371|NCT00048932|463671005|FG002|Open Label Period (OL)|Adverse Event|103|||
128829372|NCT00048932|463671003|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
128829373|NCT00048932|463671004|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
128829374|NCT00048932|463671005|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
128829375|NCT00048932|463671003|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
128829376|NCT00048932|463671004|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
128829377|NCT00048932|463671005|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
128829378|NCT00048932|463671003|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
128829379|NCT00048932|463671004|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
128829380|NCT00048932|463671005|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
128829381|NCT00048932|463671003|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
128829382|NCT00048932|463671004|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
128829383|NCT00048932|463671005|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
128829384|NCT00048932|463671003|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
128829385|NCT00048932|463671004|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
128829386|NCT00048932|463671005|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
128829387|NCT00048932|463671003|FG000|Open Label Period (OL)|Pregnancy|0|||
128829388|NCT00048932|463671004|FG001|Open Label Period (OL)|Pregnancy|0|||
128829389|NCT00048932|463671005|FG002|Open Label Period (OL)|Pregnancy|6|||
128829390|NCT00048932|463671003|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
128829391|NCT00048932|463671004|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
128829392|NCT00048932|463671005|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
128829393|NCT00048932|463671003|FG000|Open Label Period (OL)|Investigator Retiring|0|||
128829394|NCT00048932|463671004|FG001|Open Label Period (OL)|Investigator Retiring|0|||
128829395|NCT00048932|463671005|FG002|Open Label Period (OL)|Investigator Retiring|2|||
128829396|NCT00048932|463671003|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
128829397|NCT00048932|463671004|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
128829398|NCT00048932|463671005|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
128829399|NCT00048932|463671003|FG000|Open Label Period (OL)|Participant Relocated|0|||
128829400|NCT00048932|463671004|FG001|Open Label Period (OL)|Participant Relocated|0|||
128829401|NCT00048932|463671005|FG002|Open Label Period (OL)|Participant Relocated|6|||
128829402|NCT00048932|463671003|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
128829403|NCT00048932|463671004|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
128829404|NCT00048932|463671005|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
128829405|NCT00048932|463671003|FG000|Open Label Period (OL)|Site Closure|0|||
128829406|NCT00048932|463671004|FG001|Open Label Period (OL)|Site Closure|0|||
128829407|NCT00048932|463671005|FG002|Open Label Period (OL)|Site Closure|3|||
128829408|NCT00048932|463671003|FG000|Open Label Period (OL)|Trial Terminated|0|||
128829409|NCT00048932|463671004|FG001|Open Label Period (OL)|Trial Terminated|0|||
128829410|NCT00048932|463671005|FG002|Open Label Period (OL)|Trial Terminated|1|||
128829411|NCT00048932|463671003|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
128829412|NCT00048932|463671004|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
128829413|NCT00048932|463671005|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
128829414|NCT00048932|463671003|FG000|Open Label Period (OL)|Patient Decision|0|||
128829415|NCT00048932|463671004|FG001|Open Label Period (OL)|Patient Decision|0|||
128829416|NCT00048932|463671005|FG002|Open Label Period (OL)|Patient Decision|4|||
128829417|NCT00048932|463671003|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
128829418|NCT00048932|463671004|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
128829419|NCT00048932|463671005|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
128829420|NCT00048932|463671003|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
128829421|NCT00048932|463671004|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
128829422|NCT00048932|463671005|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
128829423|NCT00048932|463671003|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
128829424|NCT00048932|463671004|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
128829425|NCT00048932|463671005|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
128829426|NCT00048932|463671003|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
128829427|NCT00048932|463671004|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
128829428|NCT00048932|463671005|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
128829429|NCT00048932|463671003|FG000|Open Label Period (OL)|Investigator Decision|0|||
128829430|NCT00048932|463671004|FG001|Open Label Period (OL)|Investigator Decision|0|||
128829431|NCT00048932|463671005|FG002|Open Label Period (OL)|Investigator Decision|4|||
128829432|NCT00048932|463671003|FG000|Open Label Period (OL)|Site Staff Issues|0|||
128829433|NCT00048932|463671004|FG001|Open Label Period (OL)|Site Staff Issues|0|||
128829434|NCT00048932|463671005|FG002|Open Label Period (OL)|Site Staff Issues|2|||
128829435|NCT00048932|463671003|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
128829436|NCT00048932|463671004|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
128829437|NCT00048932|463671005|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
128829438|NCT00048932|463671003|FG000|Open Label Period (OL)|Participant Surgery|0|||
128829439|NCT00048932|463671004|FG001|Open Label Period (OL)|Participant Surgery|0|||
128829440|NCT00048932|463671005|FG002|Open Label Period (OL)|Participant Surgery|1|||
128829441|NCT04989816|463671008|FG000|Overall Study|Death|77|||
128829442|NCT04989816|463671008|FG000|Overall Study|Lost to Follow-up|3|||
128829443|NCT03437733|463671009|FG000|Overall Study|Eligibility criteria not met|0|||
128829444|NCT03437733|463671010|FG001|Overall Study|Eligibility criteria not met|3|||
128829445|NCT01982682|463671011|FG000|Overall Study|Physician Decision|1|||
128829446|NCT00786864|463671012|FG000|Overall Study|Lost to Follow-up|0|||
128829447|NCT00786864|463671013|FG001|Overall Study|Lost to Follow-up|1|||
128829448|NCT00786864|463671012|FG000|Overall Study|Sustained serious back injury|1|||
128829449|NCT00786864|463671013|FG001|Overall Study|Sustained serious back injury|0|||
128829450|NCT03442777|463671017|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
128829451|NCT03442777|463671018|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
128829452|NCT03442777|463671019|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
128829453|NCT00857766|463671020|FG000|Overall Study|Adverse Event|13|||
128829454|NCT00857766|463671021|FG001|Overall Study|Adverse Event|12|||
128829455|NCT00857766|463671020|FG000|Overall Study|Protocol Violation|11|||
128829456|NCT00857766|463671021|FG001|Overall Study|Protocol Violation|11|||
128829457|NCT00857766|463671020|FG000|Overall Study|Lost to Follow-up|1|||
128829458|NCT00857766|463671021|FG001|Overall Study|Lost to Follow-up|0|||
128829459|NCT00857766|463671020|FG000|Overall Study|Investigator Discretion|2|||
128829460|NCT00857766|463671021|FG001|Overall Study|Investigator Discretion|3|||
128829461|NCT00857766|463671020|FG000|Overall Study|Participant Withdrew Consent|4|||
128829462|NCT00857766|463671021|FG001|Overall Study|Participant Withdrew Consent|4|||
128829463|NCT01640951|463671022|FG000|Overall Study|Adverse Event|8|||
128829464|NCT01640951|463671023|FG001|Overall Study|Adverse Event|3|||
128829465|NCT01640951|463671024|FG002|Overall Study|Adverse Event|10|||
128829466|NCT01640951|463671025|FG003|Overall Study|Adverse Event|6|||
128829467|NCT01640951|463671026|FG004|Overall Study|Adverse Event|1|||
128829468|NCT01640951|463671027|FG005|Overall Study|Adverse Event|11|||
128829469|NCT01640951|463671028|FG006|Overall Study|Adverse Event|1|||
128829470|NCT01640951|463671029|FG007|Overall Study|Adverse Event|3|||
128829471|NCT01640951|463671022|FG000|Overall Study|Lack of Efficacy|20|||
128829472|NCT01640951|463671023|FG001|Overall Study|Lack of Efficacy|1|||
128829473|NCT01640951|463671024|FG002|Overall Study|Lack of Efficacy|7|||
128829474|NCT01640951|463671025|FG003|Overall Study|Lack of Efficacy|14|||
128829475|NCT01640951|463671026|FG004|Overall Study|Lack of Efficacy|0|||
128829476|NCT01640951|463671027|FG005|Overall Study|Lack of Efficacy|6|||
128829477|NCT01640951|463671028|FG006|Overall Study|Lack of Efficacy|5|||
128829478|NCT01640951|463671029|FG007|Overall Study|Lack of Efficacy|6|||
128829479|NCT01640951|463671022|FG000|Overall Study|Lost to Follow-up|1|||
128829480|NCT01640951|463671023|FG001|Overall Study|Lost to Follow-up|0|||
128829481|NCT01640951|463671024|FG002|Overall Study|Lost to Follow-up|6|||
128829482|NCT01640951|463671025|FG003|Overall Study|Lost to Follow-up|2|||
128829483|NCT01640951|463671026|FG004|Overall Study|Lost to Follow-up|2|||
128829484|NCT01640951|463671027|FG005|Overall Study|Lost to Follow-up|3|||
128829485|NCT01640951|463671028|FG006|Overall Study|Lost to Follow-up|1|||
128829486|NCT01640951|463671029|FG007|Overall Study|Lost to Follow-up|1|||
128829487|NCT01640951|463671022|FG000|Overall Study|Non-compliance with study treatment|0|||
128829488|NCT01640951|463671023|FG001|Overall Study|Non-compliance with study treatment|0|||
128829489|NCT01640951|463671024|FG002|Overall Study|Non-compliance with study treatment|1|||
128829490|NCT01640951|463671025|FG003|Overall Study|Non-compliance with study treatment|1|||
128829491|NCT01640951|463671026|FG004|Overall Study|Non-compliance with study treatment|1|||
128829492|NCT01640951|463671027|FG005|Overall Study|Non-compliance with study treatment|4|||
128829493|NCT01640951|463671028|FG006|Overall Study|Non-compliance with study treatment|1|||
128829494|NCT01640951|463671029|FG007|Overall Study|Non-compliance with study treatment|0|||
128829495|NCT01640951|463671022|FG000|Overall Study|Physician Decision|2|||
128829496|NCT01640951|463671023|FG001|Overall Study|Physician Decision|5|||
128829497|NCT01640951|463671024|FG002|Overall Study|Physician Decision|2|||
128829498|NCT01640951|463671025|FG003|Overall Study|Physician Decision|2|||
128829499|NCT01640951|463671026|FG004|Overall Study|Physician Decision|2|||
128829500|NCT01640951|463671027|FG005|Overall Study|Physician Decision|3|||
128829501|NCT01640951|463671028|FG006|Overall Study|Physician Decision|3|||
128829502|NCT01640951|463671029|FG007|Overall Study|Physician Decision|0|||
128829503|NCT01640951|463671022|FG000|Overall Study|Pregnancy|3|||
128829504|NCT01640951|463671023|FG001|Overall Study|Pregnancy|0|||
128829505|NCT01640951|463671024|FG002|Overall Study|Pregnancy|0|||
128829506|NCT01640951|463671025|FG003|Overall Study|Pregnancy|4|||
128829507|NCT01640951|463671026|FG004|Overall Study|Pregnancy|0|||
128829508|NCT01640951|463671027|FG005|Overall Study|Pregnancy|0|||
128829509|NCT01640951|463671028|FG006|Overall Study|Pregnancy|2|||
128829510|NCT01640951|463671029|FG007|Overall Study|Pregnancy|0|||
128829511|NCT01640951|463671022|FG000|Overall Study|Protocol Deviation|0|||
128829512|NCT01640951|463671023|FG001|Overall Study|Protocol Deviation|1|||
128829513|NCT01640951|463671024|FG002|Overall Study|Protocol Deviation|2|||
128829514|NCT01640951|463671025|FG003|Overall Study|Protocol Deviation|1|||
128829515|NCT01640951|463671026|FG004|Overall Study|Protocol Deviation|0|||
128829516|NCT01640951|463671027|FG005|Overall Study|Protocol Deviation|1|||
128829517|NCT01640951|463671028|FG006|Overall Study|Protocol Deviation|0|||
128829518|NCT01640951|463671029|FG007|Overall Study|Protocol Deviation|0|||
128829519|NCT01640951|463671022|FG000|Overall Study|Subject/Guardian decision|12|||
128829520|NCT01640951|463671023|FG001|Overall Study|Subject/Guardian decision|4|||
128829521|NCT01640951|463671024|FG002|Overall Study|Subject/Guardian decision|13|||
128829522|NCT01640951|463671025|FG003|Overall Study|Subject/Guardian decision|15|||
128829523|NCT01640951|463671026|FG004|Overall Study|Subject/Guardian decision|7|||
128829524|NCT01640951|463671027|FG005|Overall Study|Subject/Guardian decision|19|||
128829525|NCT01640951|463671028|FG006|Overall Study|Subject/Guardian decision|5|||
128829526|NCT01640951|463671029|FG007|Overall Study|Subject/Guardian decision|4|||
128829527|NCT01640951|463671022|FG000|Overall Study|Death|0|||
128829528|NCT01640951|463671023|FG001|Overall Study|Death|1|||
128829529|NCT01640951|463671024|FG002|Overall Study|Death|1|||
128829530|NCT01640951|463671025|FG003|Overall Study|Death|0|||
128829531|NCT01640951|463671026|FG004|Overall Study|Death|0|||
128829532|NCT01640951|463671027|FG005|Overall Study|Death|0|||
128829533|NCT01640951|463671028|FG006|Overall Study|Death|0|||
128829534|NCT01640951|463671029|FG007|Overall Study|Death|2|||
128829535|NCT03355573|463671030|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
128829536|NCT03355573|463671030|FG000|Overall Study|Sponsor's decision|1|||
128829537|NCT03355573|463671030|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
128829538|NCT03355573|463671030|FG000|Overall Study|PI's decision|2|||
128829539|NCT03355573|463671030|FG000|Overall Study|Withdrawal by Subject|23|||
128829540|NCT03355573|463671030|FG000|Overall Study|Lost to Follow-up|4|||
128829541|NCT03355573|463671030|FG000|Overall Study|Lack of Efficacy|2|||
128829542|NCT03355573|463671030|FG000|Overall Study|Adverse Event, non-fatal|17|||
128829543|NCT03355573|463671030|FG000|Overall Study|Adverse Event, serious fatal|2|||
128829544|NCT01536093|463671033|FG000|Overall Study|Death|1|||
128829545|NCT01536093|463671034|FG001|Overall Study|Death|2|||
128829546|NCT01536093|463671033|FG000|Overall Study|absence of maternal colostrum|2|||
128829547|NCT01536093|463671034|FG001|Overall Study|absence of maternal colostrum|0|||
128829548|NCT01536093|463671033|FG000|Overall Study|Withdrawal by Subject|0|||
128829549|NCT01536093|463671034|FG001|Overall Study|Withdrawal by Subject|1|||
128829550|NCT00942266|463671035|FG000|Overall Study|Withdrawal by Subject|1|||
128829551|NCT00942266|463671036|FG001|Overall Study|Withdrawal by Subject|0|||
128829552|NCT00942266|463671035|FG000|Overall Study|Adverse Event|2|||
128829553|NCT00942266|463671036|FG001|Overall Study|Adverse Event|1|||
128829554|NCT00942266|463671035|FG000|Overall Study|Disease Progression|38|||
128829555|NCT00942266|463671036|FG001|Overall Study|Disease Progression|11|||
128829556|NCT00942266|463671035|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
128829557|NCT00942266|463671036|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
128829558|NCT00942266|463671035|FG000|Overall Study|Intercurrent illness|0|||
128829559|NCT00942266|463671036|FG001|Overall Study|Intercurrent illness|1|||
128829560|NCT00942266|463671035|FG000|Overall Study|Physician Decision|2|||
128829561|NCT00942266|463671036|FG001|Overall Study|Physician Decision|0|||
128829562|NCT00942266|463671035|FG000|Overall Study|medical deterioration (pneumonia)|0|||
128829563|NCT00942266|463671036|FG001|Overall Study|medical deterioration (pneumonia)|1|||
128829564|NCT00756574|463671042|FG000|Overall Study|Withdrawal by Subject|9|||
128829565|NCT00756574|463671043|FG001|Overall Study|Withdrawal by Subject|7|||
128829566|NCT00756574|463671042|FG000|Overall Study|Lost to Follow-up|4|||
128829567|NCT00756574|463671043|FG001|Overall Study|Lost to Follow-up|4|||
128829568|NCT04795167|463671044|FG000|Overall Study|Death|1|||
128829569|NCT04795167|463671045|FG001|Overall Study|Death|18|||
128829570|NCT04795167|463671046|FG002|Overall Study|Death|1|||
128829571|NCT04795167|463671044|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
128829572|NCT04795167|463671045|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
128829573|NCT04795167|463671046|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
128829574|NCT01675492|463671047|FG000|Overall Study|study completed early - product approval|42|||
128829575|NCT05025384|463671048|FG000|Overall Study|Physician Decision|5|||
128829576|NCT05025384|463671049|FG001|Overall Study|Physician Decision|6|||
128829577|NCT03610581|463671050|FG000|Overall Study|Study terminated by sponsor|2|||
128829578|NCT03610581|463671051|FG001|Overall Study|Study terminated by sponsor|0|||
128829579|NCT03610581|463671050|FG000|Overall Study|Other|0|||
128829580|NCT03610581|463671051|FG001|Overall Study|Other|1|||
128829581|NCT03610581|463671050|FG000|Overall Study|Withdrawal by Subject|1|||
128829582|NCT03610581|463671051|FG001|Overall Study|Withdrawal by Subject|0|||
128829583|NCT02401815|463671058|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829584|NCT02401815|463671059|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829585|NCT02401815|463671060|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829586|NCT02401815|463671061|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
128829587|NCT02401815|463671062|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829588|NCT02401815|463671063|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829589|NCT02401815|463671064|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829590|NCT02401815|463671065|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829591|NCT02401815|463671066|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829592|NCT02401815|463671067|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
128829593|NCT02401815|463671058|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
128829594|NCT02401815|463671059|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829595|NCT02401815|463671060|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829596|NCT02401815|463671061|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
128829597|NCT02401815|463671062|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829598|NCT02401815|463671063|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829599|NCT02401815|463671064|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829600|NCT02401815|463671065|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829601|NCT02401815|463671066|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829602|NCT02401815|463671067|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
128829603|NCT02401815|463671058|FG000|Dose Escalation (up to 670 Days)|Death|1|||
128829604|NCT02401815|463671059|FG001|Dose Escalation (up to 670 Days)|Death|2|||
128829605|NCT02401815|463671060|FG002|Dose Escalation (up to 670 Days)|Death|3|||
128829606|NCT02401815|463671061|FG003|Dose Escalation (up to 670 Days)|Death|5|||
128829607|NCT02401815|463671062|FG004|Dose Escalation (up to 670 Days)|Death|4|||
128829608|NCT02401815|463671063|FG005|Dose Escalation (up to 670 Days)|Death|0|||
128829609|NCT02401815|463671064|FG006|Dose Escalation (up to 670 Days)|Death|0|||
128829610|NCT02401815|463671065|FG007|Dose Escalation (up to 670 Days)|Death|0|||
128829611|NCT02401815|463671066|FG008|Dose Escalation (up to 670 Days)|Death|0|||
128829612|NCT02401815|463671067|FG009|Dose Escalation (up to 670 Days)|Death|0|||
128829613|NCT02401815|463671058|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829614|NCT02401815|463671059|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
128829615|NCT02401815|463671060|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829616|NCT02401815|463671061|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829617|NCT02401815|463671062|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
128829618|NCT02401815|463671063|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829619|NCT02401815|463671064|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829620|NCT02401815|463671065|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829621|NCT02401815|463671066|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829622|NCT02401815|463671067|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
128829623|NCT02401815|463671058|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
128829624|NCT02401815|463671059|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829625|NCT02401815|463671060|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829626|NCT02401815|463671061|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829627|NCT02401815|463671062|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
128829628|NCT02401815|463671063|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829629|NCT02401815|463671064|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829630|NCT02401815|463671065|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829631|NCT02401815|463671066|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829632|NCT02401815|463671067|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
128829633|NCT02401815|463671058|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829634|NCT02401815|463671059|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829635|NCT02401815|463671060|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829636|NCT02401815|463671061|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829637|NCT02401815|463671062|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829638|NCT02401815|463671063|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
128829639|NCT02401815|463671064|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829640|NCT02401815|463671065|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829641|NCT02401815|463671066|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829642|NCT02401815|463671067|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
128829643|NCT02401815|463671058|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829644|NCT02401815|463671059|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829645|NCT02401815|463671060|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829646|NCT02401815|463671061|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829647|NCT02401815|463671062|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829648|NCT02401815|463671063|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829649|NCT02401815|463671064|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
128829650|NCT02401815|463671065|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829651|NCT02401815|463671066|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829652|NCT02401815|463671067|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829653|NCT02401815|463671058|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829654|NCT02401815|463671059|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829655|NCT02401815|463671060|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829656|NCT02401815|463671061|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829657|NCT02401815|463671062|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829658|NCT02401815|463671063|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
128829659|NCT02401815|463671064|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
128829660|NCT02401815|463671065|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829661|NCT02401815|463671066|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829662|NCT02401815|463671067|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
128829663|NCT02401815|463671058|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829664|NCT02401815|463671059|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829665|NCT02401815|463671060|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829666|NCT02401815|463671061|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829667|NCT02401815|463671062|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829668|NCT02401815|463671063|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
128829669|NCT02401815|463671064|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829670|NCT02401815|463671065|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829671|NCT02401815|463671066|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829672|NCT02401815|463671067|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
128829673|NCT02401815|463671058|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
128829674|NCT02401815|463671059|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
128829675|NCT02401815|463671060|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
128829676|NCT02401815|463671061|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
128829677|NCT02401815|463671062|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
128829678|NCT02401815|463671063|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
128829679|NCT02401815|463671064|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
128829680|NCT02401815|463671065|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
128829681|NCT02401815|463671066|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
128829682|NCT02401815|463671067|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
128829683|NCT02401815|463671058|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829684|NCT02401815|463671059|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829685|NCT02401815|463671060|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829686|NCT02401815|463671061|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829687|NCT02401815|463671062|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829688|NCT02401815|463671063|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829689|NCT02401815|463671064|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829690|NCT02401815|463671065|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
128829691|NCT02401815|463671066|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
128829692|NCT02401815|463671067|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
128829693|NCT02401815|463671058|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829694|NCT02401815|463671059|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829695|NCT02401815|463671060|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829696|NCT02401815|463671061|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829697|NCT02401815|463671062|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829698|NCT02401815|463671063|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829699|NCT02401815|463671064|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829700|NCT02401815|463671065|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829701|NCT02401815|463671066|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
128829702|NCT02401815|463671067|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
128829703|NCT02401815|463671058|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829704|NCT02401815|463671059|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829705|NCT02401815|463671060|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829706|NCT02401815|463671061|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829707|NCT02401815|463671062|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829708|NCT02401815|463671063|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829709|NCT02401815|463671064|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829710|NCT02401815|463671065|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829711|NCT02401815|463671066|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
128829712|NCT02401815|463671067|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
128829713|NCT02401815|463671058|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829714|NCT02401815|463671059|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829715|NCT02401815|463671060|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829716|NCT02401815|463671061|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829717|NCT02401815|463671062|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829718|NCT02401815|463671063|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829719|NCT02401815|463671064|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829720|NCT02401815|463671065|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
128829721|NCT02401815|463671066|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
128829722|NCT02401815|463671067|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
128829723|NCT00748709|463671070|FG000|Overall Study|Progressive disease|15|||
128829724|NCT00748709|463671070|FG000|Overall Study|Drug reducing Toxity|2|||
128829725|NCT00748709|463671070|FG000|Overall Study|Other Adverse Event|1|||
128829726|NCT00748709|463671070|FG000|Overall Study|Withdrawal by Subject|1|||
128829727|NCT00748709|463671070|FG000|Overall Study|Other Reasons|1|||
128829728|NCT02751528|463671075|FG000|Overall Study|Withdrawal by Subject|1|||
128829729|NCT02751528|463671075|FG000|Overall Study|Adverse Event|1|||
128829730|NCT05485805|463671076|FG000|Overall Study|Withdrawal by Subject|1|||
128829731|NCT05485805|463671077|FG001|Overall Study|Withdrawal by Subject|2|||
128829732|NCT05485805|463671078|FG002|Overall Study|Withdrawal by Subject|2|||
128829733|NCT05485805|463671079|FG003|Overall Study|Withdrawal by Subject|0|||
128829734|NCT05485805|463671080|FG004|Overall Study|Withdrawal by Subject|2|||
128829735|NCT05485805|463671076|FG000|Overall Study|Adverse Event|0|||
128829736|NCT05485805|463671077|FG001|Overall Study|Adverse Event|1|||
128829737|NCT05485805|463671078|FG002|Overall Study|Adverse Event|0|||
128829738|NCT05485805|463671079|FG003|Overall Study|Adverse Event|0|||
128829739|NCT05485805|463671080|FG004|Overall Study|Adverse Event|0|||
128829740|NCT05485805|463671076|FG000|Overall Study|Lost to Follow-up|1|||
128829741|NCT05485805|463671077|FG001|Overall Study|Lost to Follow-up|1|||
128829742|NCT05485805|463671078|FG002|Overall Study|Lost to Follow-up|3|||
128829743|NCT05485805|463671079|FG003|Overall Study|Lost to Follow-up|1|||
128829744|NCT05485805|463671080|FG004|Overall Study|Lost to Follow-up|0|||
128829745|NCT04218357|463671081|FG000|1st Allocation|Withdrawal by Subject|1|||
128829746|NCT04218357|463671082|FG001|1st Allocation|Withdrawal by Subject|0|||
128829747|NCT05349838|463671083|FG000|Overall Study|Virological Failure|1|||
128829748|NCT05349838|463671084|FG001|Overall Study|Virological Failure|2|||
128829749|NCT05349838|463671083|FG000|Overall Study|Withdrawal by Subject|2|||
128829750|NCT05349838|463671084|FG001|Overall Study|Withdrawal by Subject|3|||
128829751|NCT05349838|463671083|FG000|Overall Study|Adverse Event|3|||
128829752|NCT05349838|463671084|FG001|Overall Study|Adverse Event|1|||
128829753|NCT05349838|463671083|FG000|Overall Study|Lost to Follow-up|1|||
128829754|NCT05349838|463671084|FG001|Overall Study|Lost to Follow-up|2|||
128829755|NCT05349838|463671083|FG000|Overall Study|Other reasons|5|||
128829756|NCT05349838|463671084|FG001|Overall Study|Other reasons|1|||
128829757|NCT05071430|463671086|FG000|Overall Study|Adverse Event|1|||
128829758|NCT05071430|463671087|FG001|Overall Study|Adverse Event|2|||
128829759|NCT05071430|463671086|FG000|Overall Study|Lost to Follow-up|4|||
128829760|NCT05071430|463671087|FG001|Overall Study|Lost to Follow-up|4|||
128829761|NCT05071430|463671086|FG000|Overall Study|Protocol Violation|1|||
128829762|NCT05071430|463671087|FG001|Overall Study|Protocol Violation|0|||
128829763|NCT05071430|463671086|FG000|Overall Study|Withdrawal by Subject|3|||
128829764|NCT05071430|463671087|FG001|Overall Study|Withdrawal by Subject|2|||
128829765|NCT05071430|463671086|FG000|Overall Study|Other|1|||
128829766|NCT05071430|463671087|FG001|Overall Study|Other|1|||
128829767|NCT01958021|463671088|FG000|Treatment|Progressive disease|206|||
128829768|NCT01958021|463671089|FG001|Treatment|Progressive disease|265|||
128829769|NCT01958021|463671088|FG000|Treatment|Adverse Event|38|||
128829770|NCT01958021|463671089|FG001|Treatment|Adverse Event|10|||
128829771|NCT01958021|463671088|FG000|Treatment|Subject/guardian decision|29|||
128829772|NCT01958021|463671089|FG001|Treatment|Subject/guardian decision|25|||
128829773|NCT01958021|463671088|FG000|Treatment|Physician Decision|28|||
128829774|NCT01958021|463671089|FG001|Treatment|Physician Decision|21|||
128829775|NCT01958021|463671088|FG000|Treatment|Death|6|||
128829776|NCT01958021|463671089|FG001|Treatment|Death|1|||
128829777|NCT01958021|463671088|FG000|Treatment|Protocol deviation|3|||
128829778|NCT01958021|463671089|FG001|Treatment|Protocol deviation|1|||
128829779|NCT01958021|463671088|FG000|Treatment|Sponsor decision|24|||
128829780|NCT01958021|463671089|FG001|Treatment|Sponsor decision|11|||
128829781|NCT01958021|463671088|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
128829782|NCT01958021|463671089|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
128829783|NCT01958021|463671088|FG000|Post-treatment Efficacy Follow-up|Death|1|||
128829784|NCT01958021|463671089|FG001|Post-treatment Efficacy Follow-up|Death|0|||
128829785|NCT01958021|463671088|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
128829786|NCT01958021|463671089|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
128829787|NCT01958021|463671088|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
128829788|NCT01958021|463671089|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
128829789|NCT01958021|463671088|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
128829790|NCT01958021|463671089|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
128829791|NCT01958021|463671088|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
128829792|NCT01958021|463671089|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
128829793|NCT01958021|463671088|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
128829794|NCT01958021|463671089|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
128829795|NCT02488408|463671091|FG000|Part A|Adverse Event|2|||
128829796|NCT02488408|463671092|FG001|Part A|Adverse Event|0|||
128829797|NCT02488408|463671093|FG002|Part A|Adverse Event|0|||
128829798|NCT02488408|463671094|FG003|Part A|Adverse Event|0|||
128829799|NCT02488408|463671095|FG004|Part A|Adverse Event|0|||
128829800|NCT02488408|463671096|FG005|Part A|Adverse Event|0|||
128829801|NCT02488408|463671097|FG006|Part A|Adverse Event|0|||
128829802|NCT02488408|463671098|FG007|Part A|Adverse Event|0|||
128829803|NCT02488408|463671099|FG008|Part A|Adverse Event|0|||
128829804|NCT02488408|463671100|FG009|Part A|Adverse Event|0|||
128829805|NCT02488408|463671091|FG000|Part A|Death|1|||
128829806|NCT02488408|463671092|FG001|Part A|Death|5|||
128829807|NCT02488408|463671093|FG002|Part A|Death|0|||
128829808|NCT02488408|463671094|FG003|Part A|Death|0|||
128829809|NCT02488408|463671095|FG004|Part A|Death|3|||
128829810|NCT02488408|463671096|FG005|Part A|Death|0|||
128829811|NCT02488408|463671097|FG006|Part A|Death|0|||
128829812|NCT02488408|463671098|FG007|Part A|Death|0|||
128829813|NCT02488408|463671099|FG008|Part A|Death|0|||
128829814|NCT02488408|463671100|FG009|Part A|Death|0|||
128829815|NCT02488408|463671091|FG000|Part A|Disease Progression|2|||
128829816|NCT02488408|463671092|FG001|Part A|Disease Progression|8|||
128829817|NCT02488408|463671093|FG002|Part A|Disease Progression|2|||
128829818|NCT02488408|463671094|FG003|Part A|Disease Progression|3|||
128829819|NCT02488408|463671095|FG004|Part A|Disease Progression|4|||
128829820|NCT02488408|463671096|FG005|Part A|Disease Progression|0|||
128829821|NCT02488408|463671097|FG006|Part A|Disease Progression|0|||
128829822|NCT02488408|463671098|FG007|Part A|Disease Progression|0|||
128829823|NCT02488408|463671099|FG008|Part A|Disease Progression|0|||
128829824|NCT02488408|463671100|FG009|Part A|Disease Progression|0|||
128829825|NCT02488408|463671091|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
128829826|NCT02488408|463671092|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
128829827|NCT02488408|463671093|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
128829828|NCT02488408|463671094|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
128829829|NCT02488408|463671095|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
128829830|NCT02488408|463671096|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
128829831|NCT02488408|463671097|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
128829832|NCT02488408|463671098|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
128829833|NCT02488408|463671099|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
128829834|NCT02488408|463671100|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
128829835|NCT02488408|463671091|FG000|Part A|Investigator Decision|0|||
128829836|NCT02488408|463671092|FG001|Part A|Investigator Decision|1|||
128829837|NCT02488408|463671093|FG002|Part A|Investigator Decision|1|||
128829838|NCT02488408|463671094|FG003|Part A|Investigator Decision|0|||
128829839|NCT02488408|463671095|FG004|Part A|Investigator Decision|0|||
128829840|NCT02488408|463671096|FG005|Part A|Investigator Decision|0|||
128829841|NCT02488408|463671097|FG006|Part A|Investigator Decision|0|||
128829842|NCT02488408|463671098|FG007|Part A|Investigator Decision|0|||
128829843|NCT02488408|463671099|FG008|Part A|Investigator Decision|0|||
128829844|NCT02488408|463671100|FG009|Part A|Investigator Decision|0|||
128829845|NCT02488408|463671091|FG000|Part A|Withdrawal by Subject|0|||
128829846|NCT02488408|463671092|FG001|Part A|Withdrawal by Subject|0|||
128829847|NCT02488408|463671093|FG002|Part A|Withdrawal by Subject|2|||
128829848|NCT02488408|463671094|FG003|Part A|Withdrawal by Subject|0|||
128829849|NCT02488408|463671095|FG004|Part A|Withdrawal by Subject|0|||
128829850|NCT02488408|463671096|FG005|Part A|Withdrawal by Subject|0|||
128829851|NCT02488408|463671097|FG006|Part A|Withdrawal by Subject|0|||
128829852|NCT02488408|463671098|FG007|Part A|Withdrawal by Subject|0|||
128829853|NCT02488408|463671099|FG008|Part A|Withdrawal by Subject|0|||
128829854|NCT02488408|463671100|FG009|Part A|Withdrawal by Subject|0|||
128829855|NCT02488408|463671091|FG000|Part A|Other|1|||
128829856|NCT02488408|463671092|FG001|Part A|Other|0|||
128829857|NCT02488408|463671093|FG002|Part A|Other|0|||
128829858|NCT02488408|463671094|FG003|Part A|Other|0|||
128829859|NCT02488408|463671095|FG004|Part A|Other|0|||
128829860|NCT02488408|463671096|FG005|Part A|Other|0|||
128829861|NCT02488408|463671097|FG006|Part A|Other|0|||
128829862|NCT02488408|463671098|FG007|Part A|Other|0|||
128829863|NCT02488408|463671099|FG008|Part A|Other|0|||
128829864|NCT02488408|463671100|FG009|Part A|Other|0|||
128829865|NCT02488408|463671091|FG000|Part B|Adverse Event|0|||
128829866|NCT02488408|463671092|FG001|Part B|Adverse Event|0|||
128829867|NCT02488408|463671093|FG002|Part B|Adverse Event|0|||
128829868|NCT02488408|463671094|FG003|Part B|Adverse Event|0|||
128829869|NCT02488408|463671095|FG004|Part B|Adverse Event|0|||
128829870|NCT02488408|463671096|FG005|Part B|Adverse Event|2|||
128829871|NCT02488408|463671097|FG006|Part B|Adverse Event|2|||
128829872|NCT02488408|463671098|FG007|Part B|Adverse Event|7|||
128829873|NCT02488408|463671099|FG008|Part B|Adverse Event|2|||
128829874|NCT02488408|463671100|FG009|Part B|Adverse Event|2|||
128829875|NCT02488408|463671091|FG000|Part B|Death|0|||
128829876|NCT02488408|463671092|FG001|Part B|Death|0|||
128829877|NCT02488408|463671093|FG002|Part B|Death|0|||
128829878|NCT02488408|463671094|FG003|Part B|Death|0|||
128829879|NCT02488408|463671095|FG004|Part B|Death|0|||
128829880|NCT02488408|463671096|FG005|Part B|Death|3|||
128829881|NCT02488408|463671097|FG006|Part B|Death|1|||
128829882|NCT02488408|463671098|FG007|Part B|Death|2|||
128829883|NCT02488408|463671099|FG008|Part B|Death|2|||
128829884|NCT02488408|463671100|FG009|Part B|Death|2|||
128829885|NCT02488408|463671091|FG000|Part B|Death due to Disease Progression|0|||
128829886|NCT02488408|463671092|FG001|Part B|Death due to Disease Progression|0|||
128829887|NCT02488408|463671093|FG002|Part B|Death due to Disease Progression|0|||
128829888|NCT02488408|463671094|FG003|Part B|Death due to Disease Progression|0|||
128829889|NCT02488408|463671095|FG004|Part B|Death due to Disease Progression|0|||
128829890|NCT02488408|463671096|FG005|Part B|Death due to Disease Progression|2|||
128829891|NCT02488408|463671097|FG006|Part B|Death due to Disease Progression|2|||
128829892|NCT02488408|463671098|FG007|Part B|Death due to Disease Progression|1|||
128829893|NCT02488408|463671099|FG008|Part B|Death due to Disease Progression|1|||
128829894|NCT02488408|463671100|FG009|Part B|Death due to Disease Progression|1|||
128829895|NCT02488408|463671091|FG000|Part B|Disease Progression|0|||
128829896|NCT02488408|463671092|FG001|Part B|Disease Progression|0|||
128829897|NCT02488408|463671093|FG002|Part B|Disease Progression|0|||
128829898|NCT02488408|463671094|FG003|Part B|Disease Progression|0|||
128829899|NCT02488408|463671095|FG004|Part B|Disease Progression|0|||
128829900|NCT02488408|463671096|FG005|Part B|Disease Progression|6|||
128829901|NCT02488408|463671097|FG006|Part B|Disease Progression|9|||
128829902|NCT02488408|463671098|FG007|Part B|Disease Progression|7|||
128829903|NCT02488408|463671099|FG008|Part B|Disease Progression|9|||
128829904|NCT02488408|463671100|FG009|Part B|Disease Progression|11|||
128829905|NCT02488408|463671091|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
128829906|NCT02488408|463671092|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
128829907|NCT02488408|463671093|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
128829908|NCT02488408|463671094|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
128829909|NCT02488408|463671095|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
128829910|NCT02488408|463671096|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
128829911|NCT02488408|463671097|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
128829912|NCT02488408|463671098|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
128829913|NCT02488408|463671099|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
128829914|NCT02488408|463671100|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
128829915|NCT02488408|463671091|FG000|Part B|Investigator Decision|0|||
128829916|NCT02488408|463671092|FG001|Part B|Investigator Decision|0|||
128829917|NCT02488408|463671093|FG002|Part B|Investigator Decision|0|||
128829918|NCT02488408|463671094|FG003|Part B|Investigator Decision|0|||
128829919|NCT02488408|463671095|FG004|Part B|Investigator Decision|0|||
128829920|NCT02488408|463671096|FG005|Part B|Investigator Decision|0|||
128829921|NCT02488408|463671097|FG006|Part B|Investigator Decision|1|||
128829922|NCT02488408|463671098|FG007|Part B|Investigator Decision|0|||
128829923|NCT02488408|463671099|FG008|Part B|Investigator Decision|2|||
128829924|NCT02488408|463671100|FG009|Part B|Investigator Decision|1|||
128829925|NCT05886777|463671103|FG000|Overall Study|Lost to Follow-up|1|||
128829926|NCT05886777|463671104|FG001|Overall Study|Lost to Follow-up|0|||
128829927|NCT05886777|463671105|FG002|Overall Study|Lost to Follow-up|2|||
128829928|NCT05886777|463671106|FG003|Overall Study|Lost to Follow-up|1|||
128829929|NCT05886777|463671107|FG004|Overall Study|Lost to Follow-up|0|||
128829930|NCT05886777|463671108|FG005|Overall Study|Lost to Follow-up|2|||
128829931|NCT05886777|463671109|FG006|Overall Study|Lost to Follow-up|0|||
128829932|NCT05886777|463671103|FG000|Overall Study|Other|0|||
128829933|NCT05886777|463671104|FG001|Overall Study|Other|2|||
128829934|NCT05886777|463671105|FG002|Overall Study|Other|1|||
128829935|NCT05886777|463671106|FG003|Overall Study|Other|0|||
128829936|NCT05886777|463671107|FG004|Overall Study|Other|0|||
128829937|NCT05886777|463671108|FG005|Overall Study|Other|0|||
128829938|NCT05886777|463671109|FG006|Overall Study|Other|0|||
128829939|NCT05886777|463671103|FG000|Overall Study|Withdrawal by Subject|1|||
128829940|NCT05886777|463671104|FG001|Overall Study|Withdrawal by Subject|0|||
128829941|NCT05886777|463671105|FG002|Overall Study|Withdrawal by Subject|1|||
128829942|NCT05886777|463671106|FG003|Overall Study|Withdrawal by Subject|4|||
128829943|NCT05886777|463671107|FG004|Overall Study|Withdrawal by Subject|3|||
128829944|NCT05886777|463671108|FG005|Overall Study|Withdrawal by Subject|1|||
128829945|NCT05886777|463671109|FG006|Overall Study|Withdrawal by Subject|1|||
128829946|NCT05886777|463671103|FG000|Overall Study|Protocol Violation|0|||
128829947|NCT05886777|463671104|FG001|Overall Study|Protocol Violation|0|||
128829948|NCT05886777|463671105|FG002|Overall Study|Protocol Violation|1|||
128829949|NCT05886777|463671106|FG003|Overall Study|Protocol Violation|0|||
128829950|NCT05886777|463671107|FG004|Overall Study|Protocol Violation|0|||
128829951|NCT05886777|463671108|FG005|Overall Study|Protocol Violation|0|||
128829952|NCT05886777|463671109|FG006|Overall Study|Protocol Violation|0|||
128829953|NCT05886777|463671103|FG000|Overall Study|No longer met eligibility criteria|0|||
128829954|NCT05886777|463671104|FG001|Overall Study|No longer met eligibility criteria|1|||
128829955|NCT05886777|463671105|FG002|Overall Study|No longer met eligibility criteria|0|||
128829956|NCT05886777|463671106|FG003|Overall Study|No longer met eligibility criteria|0|||
128829957|NCT05886777|463671107|FG004|Overall Study|No longer met eligibility criteria|0|||
128829958|NCT05886777|463671108|FG005|Overall Study|No longer met eligibility criteria|0|||
128829959|NCT05886777|463671109|FG006|Overall Study|No longer met eligibility criteria|0|||
128829960|NCT01812759|463672302|FG000|Overall Study|Physician Decision|0|||
128829961|NCT01812759|463672303|FG001|Overall Study|Physician Decision|0|||
128829962|NCT01812759|463672304|FG002|Overall Study|Physician Decision|1|||
128829963|NCT00536120|463672305|FG000|Overall Study|Lost to Follow-up|1|||
128829964|NCT00536120|463672306|FG001|Overall Study|Lost to Follow-up|0|||
128829965|NCT00536120|463672305|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
128829966|NCT00536120|463672306|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
128829967|NCT00536120|463672305|FG000|Overall Study|Non-compliance|1|||
128829968|NCT00536120|463672306|FG001|Overall Study|Non-compliance|0|||
128829969|NCT00536120|463672305|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
128829970|NCT00536120|463672306|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
128829971|NCT00536120|463672305|FG000|Overall Study|Steroid Use|0|||
128829972|NCT00536120|463672306|FG001|Overall Study|Steroid Use|2|||
128829973|NCT00536120|463672305|FG000|Overall Study|Missed Study Visit|0|||
128829974|NCT00536120|463672306|FG001|Overall Study|Missed Study Visit|1|||
128829975|NCT02232737|463672307|FG000|Overall Study|Lost to Follow-up|18|||
128829976|NCT02232737|463672308|FG001|Overall Study|Lost to Follow-up|28|||
128829977|NCT02232737|463672309|FG002|Overall Study|Lost to Follow-up|33|||
128829978|NCT02232737|463672307|FG000|Overall Study|Personal reasons|7|||
128829979|NCT02232737|463672308|FG001|Overall Study|Personal reasons|8|||
128829980|NCT02232737|463672309|FG002|Overall Study|Personal reasons|14|||
128829981|NCT02232737|463672307|FG000|Overall Study|Adverse Event|6|||
128829982|NCT02232737|463672308|FG001|Overall Study|Adverse Event|3|||
128829983|NCT02232737|463672309|FG002|Overall Study|Adverse Event|8|||
128829984|NCT02232737|463672307|FG000|Overall Study|Incarcerated|2|||
128829985|NCT02232737|463672308|FG001|Overall Study|Incarcerated|1|||
128829986|NCT02232737|463672309|FG002|Overall Study|Incarcerated|2|||
128829987|NCT02232737|463672307|FG000|Overall Study|Withdrawal by Subject|0|||
128829988|NCT02232737|463672308|FG001|Overall Study|Withdrawal by Subject|1|||
128829989|NCT02232737|463672309|FG002|Overall Study|Withdrawal by Subject|2|||
128829990|NCT02232737|463672307|FG000|Overall Study|Death|0|||
128829991|NCT02232737|463672308|FG001|Overall Study|Death|1|||
128829992|NCT02232737|463672309|FG002|Overall Study|Death|1|||
128829993|NCT02232737|463672307|FG000|Overall Study|Physician Decision|1|||
128829994|NCT02232737|463672308|FG001|Overall Study|Physician Decision|3|||
128829995|NCT02232737|463672309|FG002|Overall Study|Physician Decision|1|||
128829996|NCT02232737|463672307|FG000|Overall Study|Protocol Violation|1|||
128829997|NCT02232737|463672308|FG001|Overall Study|Protocol Violation|0|||
128829998|NCT02232737|463672309|FG002|Overall Study|Protocol Violation|1|||
128829999|NCT02232737|463672307|FG000|Overall Study|Reason unknown|1|||
128830000|NCT02232737|463672308|FG001|Overall Study|Reason unknown|0|||
128830001|NCT02232737|463672309|FG002|Overall Study|Reason unknown|0|||
128830002|NCT04559698|463672310|FG000|Overall Study|Lost to Follow-up|14|||
128830003|NCT04559698|463672311|FG001|Overall Study|Lost to Follow-up|15|||
128830004|NCT04559698|463672310|FG000|Overall Study|Withdrawal by Subject|0|||
128830005|NCT04559698|463672311|FG001|Overall Study|Withdrawal by Subject|1|||
128830006|NCT02200705|463672321|FG000|Overall Study|Excluded|12|||
128830007|NCT02200705|463672321|FG000|Overall Study|Death|21|||
128830008|NCT02200705|463672321|FG000|Overall Study|Withdrawal by Subject|22|||
128830009|NCT02200705|463672321|FG000|Overall Study|Lost to Follow-up|13|||
128830010|NCT02200705|463672321|FG000|Overall Study|Physician Decision|5|||
128830011|NCT02200705|463672321|FG000|Overall Study|Adverse Event|2|||
128830012|NCT01641900|463672326|FG000|Overall Study|Withdrawal by Subject|2|||
128830013|NCT01641900|463672327|FG001|Overall Study|Withdrawal by Subject|2|||
128830014|NCT03220724|463672333|FG000|Overall Study|Lost to Follow-up|2|||
128830015|NCT03220724|463672334|FG001|Overall Study|Lost to Follow-up|2|||
128830016|NCT03220724|463672335|FG002|Overall Study|Lost to Follow-up|0|||
128830017|NCT03220724|463672336|FG003|Overall Study|Lost to Follow-up|3|||
128830018|NCT03220724|463672337|FG004|Overall Study|Lost to Follow-up|1|||
128830019|NCT03220724|463672338|FG005|Overall Study|Lost to Follow-up|0|||
128830020|NCT03220724|463672339|FG006|Overall Study|Lost to Follow-up|2|||
128830021|NCT03220724|463672340|FG007|Overall Study|Lost to Follow-up|1|||
128830022|NCT03220724|463672341|FG008|Overall Study|Lost to Follow-up|0|||
128830023|NCT03220724|463672333|FG000|Overall Study|Withdrawal by Subject|1|||
128830024|NCT03220724|463672334|FG001|Overall Study|Withdrawal by Subject|0|||
128830025|NCT03220724|463672335|FG002|Overall Study|Withdrawal by Subject|1|||
128830026|NCT03220724|463672336|FG003|Overall Study|Withdrawal by Subject|0|||
128830027|NCT03220724|463672337|FG004|Overall Study|Withdrawal by Subject|0|||
128830028|NCT03220724|463672338|FG005|Overall Study|Withdrawal by Subject|0|||
128830029|NCT03220724|463672339|FG006|Overall Study|Withdrawal by Subject|0|||
128830030|NCT03220724|463672340|FG007|Overall Study|Withdrawal by Subject|0|||
128830031|NCT03220724|463672341|FG008|Overall Study|Withdrawal by Subject|0|||
128830032|NCT00442104|463672347|FG000|Overall Study|Adverse Event|5|||
128830033|NCT00442104|463672347|FG000|Overall Study|Death|2|||
128830034|NCT00442104|463672347|FG000|Overall Study|Lost to Follow-up|3|||
128830035|NCT00442104|463672347|FG000|Overall Study|Withdrawal by Subject|5|||
128830036|NCT00442104|463672347|FG000|Overall Study|Insufficient Clinical Response|10|||
128830037|NCT00442104|463672347|FG000|Overall Study|Other|21|||
128830038|NCT00442104|463672347|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
128830039|NCT02463448|463672350|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
128830040|NCT02463448|463672350|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
128830041|NCT02463448|463672350|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
128830042|NCT02463448|463672350|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
128830043|NCT00463229|463672354|FG000|Overall Study|Lost to Follow-up|5|||
128830044|NCT00463229|463672355|FG001|Overall Study|Lost to Follow-up|7|||
128830045|NCT00463229|463672354|FG000|Overall Study|Death|4|||
128830046|NCT00463229|463672355|FG001|Overall Study|Death|3|||
128830047|NCT01932970|463672356|FG000|Overall Study|Withdrawal by Subject|5|||
128830048|NCT01932970|463672356|FG000|Overall Study|Death|1|||
128830049|NCT01932970|463672356|FG000|Overall Study|Lost to Follow-up|2|||
128830050|NCT01932970|463672356|FG000|Overall Study|Protocol Specified Criteria|10|||
128830051|NCT01767467|463672357|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
128830052|NCT01767467|463672358|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
128830053|NCT01767467|463672357|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
128830054|NCT01767467|463672358|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
128830055|NCT01767467|463672357|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
128830056|NCT01767467|463672358|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
128830057|NCT01767467|463672357|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
128830058|NCT01767467|463672358|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
128830059|NCT01767467|463672357|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
128830060|NCT01767467|463672358|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
128830061|NCT01767467|463672357|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
128830062|NCT01767467|463672358|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
128830063|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
128830064|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
128830065|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
128830066|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
128830067|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
128830068|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
128830069|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
128830070|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
128830071|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
128830072|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
128830073|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
128830074|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
128830075|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
128830076|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
128830077|NCT01767467|463672357|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
128830078|NCT01767467|463672358|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
128830079|NCT01787032|463672363|FG000|Overall Study|Protocol Violation|0|||
128830080|NCT01787032|463672364|FG001|Overall Study|Protocol Violation|0|||
128830081|NCT01787032|463672365|FG002|Overall Study|Protocol Violation|0|||
128830082|NCT01787032|463672366|FG003|Overall Study|Protocol Violation|0|||
128830083|NCT01787032|463672367|FG004|Overall Study|Protocol Violation|1|||
128830084|NCT01787032|463672368|FG005|Overall Study|Protocol Violation|1|||
128830085|NCT00776009|463672371|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
128830086|NCT00776009|463672372|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
128830087|NCT00776009|463672373|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
128830088|NCT00776009|463672374|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
128830089|NCT00776009|463672375|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
128830090|NCT00776009|463672376|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
128830091|NCT00776009|463672371|FG000|Period 1: First Intervention|Protocol Violation|0|||
128830092|NCT00776009|463672372|FG001|Period 1: First Intervention|Protocol Violation|1|||
128830093|NCT00776009|463672373|FG002|Period 1: First Intervention|Protocol Violation|0|||
128830094|NCT00776009|463672374|FG003|Period 1: First Intervention|Protocol Violation|0|||
128830095|NCT00776009|463672375|FG004|Period 1: First Intervention|Protocol Violation|1|||
128830096|NCT00776009|463672376|FG005|Period 1: First Intervention|Protocol Violation|0|||
128830097|NCT00776009|463672371|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
128830098|NCT00776009|463672372|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
128830099|NCT00776009|463672373|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
128830100|NCT00776009|463672374|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
128830101|NCT00776009|463672375|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
128830102|NCT00776009|463672376|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
128830103|NCT00776009|463672371|FG000|Period 2: Second Intervention|Protocol Violation|1|||
128830104|NCT00776009|463672372|FG001|Period 2: Second Intervention|Protocol Violation|0|||
128830105|NCT00776009|463672373|FG002|Period 2: Second Intervention|Protocol Violation|1|||
128830106|NCT00776009|463672374|FG003|Period 2: Second Intervention|Protocol Violation|0|||
128830107|NCT00776009|463672375|FG004|Period 2: Second Intervention|Protocol Violation|0|||
128830108|NCT00776009|463672376|FG005|Period 2: Second Intervention|Protocol Violation|0|||
128830109|NCT00776009|463672371|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
128830110|NCT00776009|463672372|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
128830111|NCT00776009|463672373|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
128830112|NCT00776009|463672374|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
128830113|NCT00776009|463672375|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
128830114|NCT00776009|463672376|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
128830115|NCT04971733|463672377|FG000|Overall Study|Adverse Event|1|||
128830116|NCT04971733|463672378|FG001|Overall Study|Adverse Event|1|||
128830117|NCT04971733|463672377|FG000|Overall Study|Subject choice|2|||
128830118|NCT04971733|463672378|FG001|Overall Study|Subject choice|0|||
128830119|NCT04971733|463672377|FG000|Overall Study|Withdrawal by Subject|1|||
128830120|NCT04971733|463672378|FG001|Overall Study|Withdrawal by Subject|0|||
128830121|NCT04971733|463672377|FG000|Overall Study|Other|1|||
128830122|NCT04971733|463672378|FG001|Overall Study|Other|0|||
128830123|NCT02406092|463672379|FG000|Overall Study|Screen failure|10|||
128830124|NCT02406092|463672380|FG001|Overall Study|Screen failure|7|||
128830125|NCT02406092|463672379|FG000|Overall Study|Death|22|||
128830126|NCT02406092|463672380|FG001|Overall Study|Death|5|||
128830127|NCT02406092|463672379|FG000|Overall Study|Lost to Follow-up|4|||
128830128|NCT02406092|463672380|FG001|Overall Study|Lost to Follow-up|1|||
128830129|NCT02406092|463672379|FG000|Overall Study|Adverse Event|1|||
128830130|NCT02406092|463672380|FG001|Overall Study|Adverse Event|0|||
128830131|NCT02406092|463672379|FG000|Overall Study|Withdrawal by Subject|1|||
128830132|NCT02406092|463672380|FG001|Overall Study|Withdrawal by Subject|0|||
128830133|NCT03631407|463672381|FG000|Overall Study|Withdrawal by Subject|3|||
128830134|NCT03631407|463672382|FG001|Overall Study|Withdrawal by Subject|2|||
128830135|NCT03631407|463672381|FG000|Overall Study|Sponsor Decision|0|||
128830136|NCT03631407|463672382|FG001|Overall Study|Sponsor Decision|2|||
128830137|NCT03631407|463672381|FG000|Overall Study|Death|16|||
128830138|NCT03631407|463672382|FG001|Overall Study|Death|16|||
128830139|NCT03631407|463672381|FG000|Overall Study|Randomized by mistake without study treatment|1|||
128830140|NCT03631407|463672382|FG001|Overall Study|Randomized by mistake without study treatment|0|||
128830141|NCT01593020|463672387|FG000|Overall Study|Adverse Event|1|||
128830142|NCT01593020|463672388|FG001|Overall Study|Adverse Event|1|||
128830143|NCT01593020|463672387|FG000|Overall Study|Death|0|||
128830144|NCT01593020|463672388|FG001|Overall Study|Death|1|||
128830145|NCT01593020|463672387|FG000|Overall Study|Ineligible|1|||
128830146|NCT01593020|463672388|FG001|Overall Study|Ineligible|0|||
128830147|NCT02972359|463672394|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
128830148|NCT02972359|463672394|FG000|Overall Study|Lack of Efficacy|1|||
128830149|NCT02972359|463672394|FG000|Overall Study|Adverse Event|4|||
128830150|NCT02972359|463672394|FG000|Overall Study|Death|1|||
128830151|NCT02972359|463672394|FG000|Overall Study|Withdrawal by Subject|30|||
128830152|NCT02972359|463672394|FG000|Overall Study|Protocol Violation|1|||
128830153|NCT02972359|463672394|FG000|Overall Study|Lost to Follow-up|26|||
128830154|NCT02972359|463672394|FG000|Overall Study|Other reasons|5|||
128830155|NCT02972359|463672394|FG000|Overall Study|Missing|1|||
128830156|NCT02063659|463672395|FG000|Double-Blind Treatment Period|Adverse Event|1|||
128830157|NCT02063659|463672396|FG001|Double-Blind Treatment Period|Adverse Event|2|||
128830158|NCT02063659|463672397|FG002|Double-Blind Treatment Period|Adverse Event|0|||
128830159|NCT02063659|463672398|FG003|Double-Blind Treatment Period|Adverse Event|0|||
128830160|NCT02063659|463672395|FG000|Double-Blind Treatment Period|Physician Decision|1|||
128830161|NCT02063659|463672396|FG001|Double-Blind Treatment Period|Physician Decision|0|||
128830162|NCT02063659|463672397|FG002|Double-Blind Treatment Period|Physician Decision|0|||
128830163|NCT02063659|463672398|FG003|Double-Blind Treatment Period|Physician Decision|0|||
128830164|NCT02063659|463672395|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
128830165|NCT02063659|463672396|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
128830166|NCT02063659|463672397|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
128830167|NCT02063659|463672398|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
128830168|NCT02063659|463672395|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
128830169|NCT02063659|463672396|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
128830170|NCT02063659|463672397|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
128830171|NCT02063659|463672398|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
128830172|NCT02063659|463672395|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
128830173|NCT02063659|463672396|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
128830174|NCT02063659|463672397|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
128830175|NCT02063659|463672398|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
128830176|NCT02063659|463672395|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
128830177|NCT02063659|463672396|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
128830178|NCT02063659|463672397|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
128830179|NCT02063659|463672398|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
128830180|NCT02063659|463672395|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
128830181|NCT02063659|463672396|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
128830182|NCT02063659|463672397|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
128830183|NCT02063659|463672398|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
128830184|NCT02063659|463672395|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
128830185|NCT02063659|463672396|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
128830186|NCT02063659|463672397|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
128830187|NCT02063659|463672398|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
128830188|NCT03598907|463672403|FG000|Overall Study|Physician Decision|14|||
128830189|NCT03598907|463672404|FG001|Overall Study|Physician Decision|19|||
128830190|NCT05251363|463672405|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
128830191|NCT05251363|463672405|FG000|Overall Study After Implant Period|Death|9|||
128830192|NCT05251363|463672405|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
128830193|NCT05251363|463672405|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
128830194|NCT05251363|463672405|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
128830195|NCT05251363|463672405|FG000|Overall Study After Implant Period|Physician Decision|1|||
128830196|NCT05251363|463672405|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
128830197|NCT03835754|463672408|FG000|Overall Study|Death|4|||
128830198|NCT02830204|463672409|FG000|Overall Study|Death|9|||
128830199|NCT02830204|463672409|FG000|Overall Study|Withdrawal by Subject|1|||
128830200|NCT04686266|463672413|FG000|Overall Study|Withdrawal by Subject|0|||
128830201|NCT04686266|463672414|FG001|Overall Study|Withdrawal by Subject|1|||
128830202|NCT04306367|463672419|FG000|Overall Study|Progression of Disease|9|||
128830203|NCT04306367|463672419|FG000|Overall Study|Adverse Event|3|||
128830204|NCT04306367|463672419|FG000|Overall Study|Withdrawal by Subject|1|||
128830205|NCT05864209|463674039|FG000|Overall Study|Lost to Follow-up|2|||
128830206|NCT05864209|463674040|FG001|Overall Study|Lost to Follow-up|3|||
128830207|NCT00092534|463674043|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
128830208|NCT00092534|463674044|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
128830209|NCT00092534|463674045|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
128830210|NCT00092534|463674046|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
128830211|NCT00092534|463674047|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
128830212|NCT00092534|463674043|FG000|Base Study Vaccination Period|Adverse Event|3|||
128830213|NCT00092534|463674044|FG001|Base Study Vaccination Period|Adverse Event|1|||
128830214|NCT00092534|463674045|FG002|Base Study Vaccination Period|Adverse Event|0|||
128830215|NCT00092534|463674046|FG003|Base Study Vaccination Period|Adverse Event|0|||
128830216|NCT00092534|463674047|FG004|Base Study Vaccination Period|Adverse Event|0|||
128830217|NCT00092534|463674043|FG000|Base Study Vaccination Period|Death|5|||
128830218|NCT00092534|463674044|FG001|Base Study Vaccination Period|Death|4|||
128830219|NCT00092534|463674045|FG002|Base Study Vaccination Period|Death|0|||
128830220|NCT00092534|463674046|FG003|Base Study Vaccination Period|Death|0|||
128830221|NCT00092534|463674047|FG004|Base Study Vaccination Period|Death|0|||
128830222|NCT00092534|463674043|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
128830223|NCT00092534|463674044|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
128830224|NCT00092534|463674045|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
128830225|NCT00092534|463674046|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
128830226|NCT00092534|463674047|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
128830227|NCT00092534|463674043|FG000|Base Study Vaccination Period|Physician Decision|1|||
128830228|NCT00092534|463674044|FG001|Base Study Vaccination Period|Physician Decision|0|||
128830229|NCT00092534|463674045|FG002|Base Study Vaccination Period|Physician Decision|0|||
128830230|NCT00092534|463674046|FG003|Base Study Vaccination Period|Physician Decision|0|||
128830231|NCT00092534|463674047|FG004|Base Study Vaccination Period|Physician Decision|0|||
128830232|NCT00092534|463674043|FG000|Base Study Vaccination Period|Pregnancy|9|||
128830233|NCT00092534|463674044|FG001|Base Study Vaccination Period|Pregnancy|7|||
128830234|NCT00092534|463674045|FG002|Base Study Vaccination Period|Pregnancy|0|||
128830235|NCT00092534|463674046|FG003|Base Study Vaccination Period|Pregnancy|0|||
128830236|NCT00092534|463674047|FG004|Base Study Vaccination Period|Pregnancy|0|||
128830237|NCT00092534|463674043|FG000|Base Study Vaccination Period|Protocol Violation|2|||
128830238|NCT00092534|463674044|FG001|Base Study Vaccination Period|Protocol Violation|1|||
128830239|NCT00092534|463674045|FG002|Base Study Vaccination Period|Protocol Violation|0|||
128830240|NCT00092534|463674046|FG003|Base Study Vaccination Period|Protocol Violation|0|||
128830241|NCT00092534|463674047|FG004|Base Study Vaccination Period|Protocol Violation|0|||
128830242|NCT00092534|463674043|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
128830243|NCT00092534|463674044|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
128830244|NCT00092534|463674045|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
128830245|NCT00092534|463674046|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
128830246|NCT00092534|463674047|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
128830247|NCT00092534|463674043|FG000|Base Study Vaccination Period|Moved|14|||
128830248|NCT00092534|463674044|FG001|Base Study Vaccination Period|Moved|12|||
128830249|NCT00092534|463674045|FG002|Base Study Vaccination Period|Moved|0|||
128830250|NCT00092534|463674046|FG003|Base Study Vaccination Period|Moved|0|||
128830251|NCT00092534|463674047|FG004|Base Study Vaccination Period|Moved|0|||
128830252|NCT00092534|463674043|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
128830253|NCT00092534|463674044|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
128830254|NCT00092534|463674045|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
128830255|NCT00092534|463674046|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
128830256|NCT00092534|463674047|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
128830257|NCT00092534|463674043|FG000|Base Study Vaccination Period|Travel|1|||
128830258|NCT00092534|463674044|FG001|Base Study Vaccination Period|Travel|0|||
128830259|NCT00092534|463674045|FG002|Base Study Vaccination Period|Travel|0|||
128830260|NCT00092534|463674046|FG003|Base Study Vaccination Period|Travel|0|||
128830261|NCT00092534|463674047|FG004|Base Study Vaccination Period|Travel|0|||
128830262|NCT00092534|463674043|FG000|Base Study Vaccination Period|Site Closed|0|||
128830263|NCT00092534|463674044|FG001|Base Study Vaccination Period|Site Closed|1|||
128830264|NCT00092534|463674045|FG002|Base Study Vaccination Period|Site Closed|0|||
128830265|NCT00092534|463674046|FG003|Base Study Vaccination Period|Site Closed|0|||
128830266|NCT00092534|463674047|FG004|Base Study Vaccination Period|Site Closed|0|||
128830267|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Adverse Event|2|||
128830268|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Adverse Event|4|||
128830269|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Adverse Event|0|||
128830270|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Adverse Event|0|||
128830271|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Adverse Event|0|||
128830272|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Death|2|||
128830273|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Death|1|||
128830274|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Death|0|||
128830275|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Death|0|||
128830276|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Death|0|||
128830277|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
128830278|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
128830279|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
128830280|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
128830281|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
128830282|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Pregnancy|6|||
128830283|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Pregnancy|10|||
128830284|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Pregnancy|0|||
128830285|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Pregnancy|0|||
128830286|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Pregnancy|0|||
128830287|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
128830288|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
128830289|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
128830290|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
128830291|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
128830292|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
128830293|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
128830294|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
128830295|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
128830296|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
128830297|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Moved|62|||
128830298|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Moved|58|||
128830299|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Moved|0|||
128830300|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Moved|0|||
128830301|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Moved|0|||
128830302|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Travel|10|||
128830303|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Travel|7|||
128830304|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Travel|0|||
128830305|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Travel|0|||
128830306|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Travel|0|||
128830307|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Site Closed|0|||
128830308|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Site Closed|2|||
128830309|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Site Closed|0|||
128830310|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Site Closed|0|||
128830311|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Site Closed|0|||
128830312|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
128830313|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
128830314|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
128830315|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
128830316|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
128830317|NCT00092534|463674043|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
128830318|NCT00092534|463674044|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
128830319|NCT00092534|463674045|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
128830320|NCT00092534|463674046|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
128830321|NCT00092534|463674047|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
128830322|NCT00092534|463674043|FG000|Base Study EXT|Lost to Follow-up|0|||
128830323|NCT00092534|463674044|FG001|Base Study EXT|Lost to Follow-up|0|||
128830324|NCT00092534|463674045|FG002|Base Study EXT|Lost to Follow-up|41|||
128830325|NCT00092534|463674046|FG003|Base Study EXT|Lost to Follow-up|0|||
128830326|NCT00092534|463674047|FG004|Base Study EXT|Lost to Follow-up|0|||
128830327|NCT00092534|463674043|FG000|Base Study EXT|Physician Decision|0|||
128830328|NCT00092534|463674044|FG001|Base Study EXT|Physician Decision|0|||
128830329|NCT00092534|463674045|FG002|Base Study EXT|Physician Decision|1|||
128830330|NCT00092534|463674046|FG003|Base Study EXT|Physician Decision|0|||
128830331|NCT00092534|463674047|FG004|Base Study EXT|Physician Decision|0|||
128830332|NCT00092534|463674043|FG000|Base Study EXT|Pregnancy|0|||
128830333|NCT00092534|463674044|FG001|Base Study EXT|Pregnancy|0|||
128830334|NCT00092534|463674045|FG002|Base Study EXT|Pregnancy|12|||
128830335|NCT00092534|463674046|FG003|Base Study EXT|Pregnancy|0|||
128830336|NCT00092534|463674047|FG004|Base Study EXT|Pregnancy|0|||
128830337|NCT00092534|463674043|FG000|Base Study EXT|Withdrawal by Subject|0|||
128830338|NCT00092534|463674044|FG001|Base Study EXT|Withdrawal by Subject|0|||
128830339|NCT00092534|463674045|FG002|Base Study EXT|Withdrawal by Subject|18|||
128830340|NCT00092534|463674046|FG003|Base Study EXT|Withdrawal by Subject|0|||
128830341|NCT00092534|463674047|FG004|Base Study EXT|Withdrawal by Subject|0|||
128830342|NCT00092534|463674043|FG000|Base Study EXT|Participant moved|0|||
128830343|NCT00092534|463674044|FG001|Base Study EXT|Participant moved|0|||
128830344|NCT00092534|463674045|FG002|Base Study EXT|Participant moved|6|||
128830345|NCT00092534|463674046|FG003|Base Study EXT|Participant moved|0|||
128830346|NCT00092534|463674047|FG004|Base Study EXT|Participant moved|0|||
128830347|NCT00092534|463674043|FG000|Base Study EXT|Travel|0|||
128830348|NCT00092534|463674044|FG001|Base Study EXT|Travel|0|||
128830349|NCT00092534|463674045|FG002|Base Study EXT|Travel|2|||
128830350|NCT00092534|463674046|FG003|Base Study EXT|Travel|0|||
128830351|NCT00092534|463674047|FG004|Base Study EXT|Travel|0|||
128830352|NCT00092534|463674043|FG000|Base Study EXT|Site closed|0|||
128830353|NCT00092534|463674044|FG001|Base Study EXT|Site closed|0|||
128830354|NCT00092534|463674045|FG002|Base Study EXT|Site closed|21|||
128830355|NCT00092534|463674046|FG003|Base Study EXT|Site closed|0|||
128830356|NCT00092534|463674047|FG004|Base Study EXT|Site closed|0|||
128830357|NCT00092534|463674043|FG000|Base Study EXT|Study ended|0|||
128830358|NCT00092534|463674044|FG001|Base Study EXT|Study ended|0|||
128830359|NCT00092534|463674045|FG002|Base Study EXT|Study ended|29|||
128830360|NCT00092534|463674046|FG003|Base Study EXT|Study ended|0|||
128830361|NCT00092534|463674047|FG004|Base Study EXT|Study ended|0|||
128830362|NCT00092534|463674043|FG000|Base Study EXT|Protocol Violation|0|||
128830363|NCT00092534|463674044|FG001|Base Study EXT|Protocol Violation|0|||
128830364|NCT00092534|463674045|FG002|Base Study EXT|Protocol Violation|15|||
128830365|NCT00092534|463674046|FG003|Base Study EXT|Protocol Violation|0|||
128830366|NCT00092534|463674047|FG004|Base Study EXT|Protocol Violation|0|||
128830367|NCT00092534|463674043|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
128830368|NCT00092534|463674044|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
128830369|NCT00092534|463674045|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
128830370|NCT00092534|463674046|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
128830371|NCT00092534|463674047|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
128830372|NCT05029284|463674050|FG000|Overall Study|Lost to Follow-up|1|||
128830373|NCT04001829|463674051|FG000|Overall Study|Never start protocol therapy|5|||
128830374|NCT04001829|463674052|FG001|Overall Study|Never start protocol therapy|5|||
128830375|NCT04001829|463674051|FG000|Overall Study|Adverse Event|11|||
128830376|NCT04001829|463674052|FG001|Overall Study|Adverse Event|7|||
128830377|NCT04001829|463674051|FG000|Overall Study|Alternative therapy|1|||
128830378|NCT04001829|463674052|FG001|Overall Study|Alternative therapy|2|||
128830379|NCT04001829|463674051|FG000|Overall Study|Disease progression/relapse|2|||
128830380|NCT04001829|463674052|FG001|Overall Study|Disease progression/relapse|1|||
128830381|NCT04001829|463674051|FG000|Overall Study|Other complicating disease|1|||
128830382|NCT04001829|463674052|FG001|Overall Study|Other complicating disease|0|||
128830383|NCT04001829|463674051|FG000|Overall Study|Withdrawal by Subject|1|||
128830384|NCT04001829|463674052|FG001|Overall Study|Withdrawal by Subject|4|||
128830385|NCT04001829|463674051|FG000|Overall Study|Ineligible|2|||
128830386|NCT04001829|463674052|FG001|Overall Study|Ineligible|2|||
128830387|NCT04001829|463674051|FG000|Overall Study|Reason missing due to delinquent data|1|||
128830388|NCT04001829|463674052|FG001|Overall Study|Reason missing due to delinquent data|0|||
128830389|NCT03002194|463674055|FG000|Overall Study|Lost to Follow-up|6|||
128830390|NCT03002194|463674055|FG000|Overall Study|Adverse Event|1|||
128830391|NCT03002194|463674055|FG000|Overall Study|Lack of Efficacy|1|||
128830392|NCT03002194|463674055|FG000|Overall Study|Withdrawal by Subject|2|||
128830393|NCT00985088|463674056|FG000|Overall Study|Serious Adverse Event|1|||
128830394|NCT00985088|463674057|FG001|Overall Study|Serious Adverse Event|1|||
128830395|NCT00985088|463674058|FG002|Overall Study|Serious Adverse Event|0|||
128830396|NCT00985088|463674059|FG003|Overall Study|Serious Adverse Event|0|||
128830397|NCT00985088|463674060|FG004|Overall Study|Serious Adverse Event|0|||
128830398|NCT00985088|463674061|FG005|Overall Study|Serious Adverse Event|0|||
128830399|NCT00985088|463674062|FG006|Overall Study|Serious Adverse Event|0|||
128830400|NCT00985088|463674063|FG007|Overall Study|Serious Adverse Event|1|||
128830401|NCT00985088|463674056|FG000|Overall Study|Adverse Event|0|||
128830402|NCT00985088|463674057|FG001|Overall Study|Adverse Event|0|||
128830403|NCT00985088|463674058|FG002|Overall Study|Adverse Event|1|||
128830404|NCT00985088|463674059|FG003|Overall Study|Adverse Event|0|||
128830405|NCT00985088|463674060|FG004|Overall Study|Adverse Event|0|||
128830406|NCT00985088|463674061|FG005|Overall Study|Adverse Event|0|||
128830407|NCT00985088|463674062|FG006|Overall Study|Adverse Event|0|||
128830408|NCT00985088|463674063|FG007|Overall Study|Adverse Event|0|||
128830409|NCT00985088|463674056|FG000|Overall Study|Withdrawal by Subject|4|||
128830410|NCT00985088|463674057|FG001|Overall Study|Withdrawal by Subject|0|||
128830411|NCT00985088|463674058|FG002|Overall Study|Withdrawal by Subject|0|||
128830412|NCT00985088|463674059|FG003|Overall Study|Withdrawal by Subject|1|||
128830413|NCT00985088|463674060|FG004|Overall Study|Withdrawal by Subject|3|||
128830414|NCT00985088|463674061|FG005|Overall Study|Withdrawal by Subject|2|||
128830415|NCT00985088|463674062|FG006|Overall Study|Withdrawal by Subject|1|||
128830416|NCT00985088|463674063|FG007|Overall Study|Withdrawal by Subject|2|||
128830417|NCT00985088|463674056|FG000|Overall Study|Migrated/moved from study area|0|||
128830418|NCT00985088|463674057|FG001|Overall Study|Migrated/moved from study area|0|||
128830419|NCT00985088|463674058|FG002|Overall Study|Migrated/moved from study area|1|||
128830420|NCT00985088|463674059|FG003|Overall Study|Migrated/moved from study area|0|||
128830421|NCT00985088|463674060|FG004|Overall Study|Migrated/moved from study area|0|||
128830422|NCT00985088|463674061|FG005|Overall Study|Migrated/moved from study area|0|||
128830423|NCT00985088|463674062|FG006|Overall Study|Migrated/moved from study area|0|||
128830424|NCT00985088|463674063|FG007|Overall Study|Migrated/moved from study area|1|||
128830425|NCT00985088|463674056|FG000|Overall Study|Lost to Follow-up|6|||
128830426|NCT00985088|463674057|FG001|Overall Study|Lost to Follow-up|1|||
128830427|NCT00985088|463674058|FG002|Overall Study|Lost to Follow-up|2|||
128830428|NCT00985088|463674059|FG003|Overall Study|Lost to Follow-up|6|||
128830429|NCT00985088|463674060|FG004|Overall Study|Lost to Follow-up|6|||
128830430|NCT00985088|463674061|FG005|Overall Study|Lost to Follow-up|5|||
128830431|NCT00985088|463674062|FG006|Overall Study|Lost to Follow-up|3|||
128830432|NCT00985088|463674063|FG007|Overall Study|Lost to Follow-up|2|||
128830433|NCT01737398|463674064|FG000|Overall Study|Adverse event or SAE|16|||
128830434|NCT01737398|463674065|FG001|Overall Study|Adverse event or SAE|1|||
128830435|NCT01737398|463674064|FG000|Overall Study|Stopping rule met|2|||
128830436|NCT01737398|463674065|FG001|Overall Study|Stopping rule met|1|||
128830437|NCT01737398|463674064|FG000|Overall Study|Voluntary withdrawal|2|||
128830438|NCT01737398|463674065|FG001|Overall Study|Voluntary withdrawal|3|||
128830439|NCT01737398|463674064|FG000|Overall Study|Ineligibility|1|||
128830440|NCT01737398|463674065|FG001|Overall Study|Ineligibility|0|||
128830441|NCT01737398|463674064|FG000|Overall Study|Liver transplant|1|||
128830442|NCT01737398|463674065|FG001|Overall Study|Liver transplant|0|||
128830443|NCT01737398|463674064|FG000|Overall Study|Disease progression|2|||
128830444|NCT01737398|463674065|FG001|Overall Study|Disease progression|3|||
128830445|NCT01737398|463674064|FG000|Overall Study|Sponsor's decision|2|||
128830446|NCT01737398|463674065|FG001|Overall Study|Sponsor's decision|0|||
128830447|NCT05250115|463674066|FG000|Overall Study|Premature study end|40|||
128830448|NCT05250115|463674066|FG000|Overall Study|Adverse Event|8|||
128830449|NCT05250115|463674066|FG000|Overall Study|Lost to Follow-up|7|||
128830450|NCT05250115|463674066|FG000|Overall Study|Withdrawal by Subject|6|||
128830451|NCT05250115|463674066|FG000|Overall Study|Withdrawal of informed consent|1|||
128830452|NCT05250115|463674066|FG000|Overall Study|Other|7|||
128830453|NCT04162210|463674071|FG000|Overall Study|Lost to Follow-up|4|||
128830454|NCT04162210|463674072|FG001|Overall Study|Lost to Follow-up|1|||
128830455|NCT04162210|463674071|FG000|Overall Study|Withdrawal by Subject|17|||
128830456|NCT04162210|463674072|FG001|Overall Study|Withdrawal by Subject|9|||
128830457|NCT04162210|463674071|FG000|Overall Study|Ongoing|113|||
128830458|NCT04162210|463674072|FG001|Overall Study|Ongoing|59|||
128830459|NCT00371345|463674075|FG000|Overall Study|Disease Progression|21|||
128830460|NCT00371345|463674076|FG001|Overall Study|Disease Progression|35|||
128830461|NCT00371345|463674075|FG000|Overall Study|Study Drug Toxicity|1|||
128830462|NCT00371345|463674076|FG001|Overall Study|Study Drug Toxicity|7|||
128830463|NCT00371345|463674075|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
128830464|NCT00371345|463674076|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
128830465|NCT00371345|463674075|FG000|Overall Study|Participant Request|1|||
128830466|NCT00371345|463674076|FG001|Overall Study|Participant Request|1|||
128830467|NCT00371345|463674075|FG000|Overall Study|Participant Withdrew Consent|0|||
128830468|NCT00371345|463674076|FG001|Overall Study|Participant Withdrew Consent|1|||
128830469|NCT01478594|463674077|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
128830470|NCT01478594|463674078|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
128830471|NCT01478594|463674077|FG000|Overall Study|Death|45|||
128830472|NCT01478594|463674078|FG001|Overall Study|Death|18|||
128830473|NCT01478594|463674077|FG000|Overall Study|Lost to Follow-up|3|||
128830474|NCT01478594|463674078|FG001|Overall Study|Lost to Follow-up|1|||
128830475|NCT01478594|463674077|FG000|Overall Study|Withdrawal by Subject|9|||
128830476|NCT01478594|463674078|FG001|Overall Study|Withdrawal by Subject|3|||
128830477|NCT01478594|463674077|FG000|Overall Study|Study Closed by Sponsor|8|||
128830478|NCT01478594|463674078|FG001|Overall Study|Study Closed by Sponsor|5|||
128830479|NCT00713596|463674079|FG000|Overall Study|Study was terminated|2|||
128830480|NCT00713596|463674080|FG001|Overall Study|Study was terminated|3|||
128830481|NCT00713596|463674081|FG002|Overall Study|Study was terminated|2|||
128830482|NCT04545619|463674082|FG000|Overall Study|due to equipment challenges|1|||
128830483|NCT02788981|463674085|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
128830484|NCT02788981|463674086|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
128830485|NCT01359150|463674091|FG000|Overall Study|Lack of Efficacy|1|||
128830486|NCT01359150|463674092|FG001|Overall Study|Lack of Efficacy|1|||
128830487|NCT01359150|463674091|FG000|Overall Study|Withdrawal by Subject|1|||
128830488|NCT01359150|463674092|FG001|Overall Study|Withdrawal by Subject|1|||
128830489|NCT01359150|463674091|FG000|Overall Study|Adverse Event|4|||
128830490|NCT01359150|463674092|FG001|Overall Study|Adverse Event|3|||
128830491|NCT01359150|463674091|FG000|Overall Study|Other|1|||
128830492|NCT01359150|463674092|FG001|Overall Study|Other|0|||
128830493|NCT03113409|463674097|FG000|Overall Study|Withdrawal by Subject|5|||
128830494|NCT03113409|463674098|FG001|Overall Study|Withdrawal by Subject|0|||
128830495|NCT03113409|463674099|FG002|Overall Study|Withdrawal by Subject|0|||
128830496|NCT02040870|463674100|FG000|Overall Study|Completed treatment phase|6|||
128830497|NCT02040870|463674100|FG000|Overall Study|Adverse Event|7|||
128830498|NCT02040870|463674100|FG000|Overall Study|Progressive disease|58|||
128830499|NCT02040870|463674100|FG000|Overall Study|Physician Decision|6|||
128830500|NCT02040870|463674100|FG000|Overall Study|Subject/guardian decision|10|||
128830501|NCT02040870|463674100|FG000|Overall Study|Lost to Follow-up|3|||
128830502|NCT02040870|463674100|FG000|Overall Study|Death|13|||
128830503|NCT02275611|463674103|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
128830504|NCT02275611|463674104|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
128830505|NCT02275611|463674105|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
128830506|NCT02275611|463674106|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
128830507|NCT01759862|463674112|FG000|Overall Study|Physician Decision|3|||
128830508|NCT01759862|463674113|FG001|Overall Study|Physician Decision|1|||
128830509|NCT01759862|463674112|FG000|Overall Study|Adverse Event|0|||
128830510|NCT01759862|463674113|FG001|Overall Study|Adverse Event|1|||
128830511|NCT03041233|463674116|FG000|Overall Study|Death|5|||
128830512|NCT03041233|463674116|FG000|Overall Study|Physician Decision|1|||
128830513|NCT03041233|463674116|FG000|Overall Study|Lost to Follow-up|16|||
128830514|NCT03041233|463674116|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
128830515|NCT03041233|463674116|FG000|Overall Study|Sponsor Request|1|||
128830516|NCT03041233|463674116|FG000|Overall Study|Duplicate subject|1|||
128830517|NCT03041233|463674116|FG000|Overall Study|Re-ablation|1|||
128830518|NCT01588951|463674118|FG000|Overall Study|Ineligible in retrospect|0|||
128830519|NCT01588951|463674119|FG001|Overall Study|Ineligible in retrospect|0|||
128830520|NCT01588951|463674120|FG002|Overall Study|Ineligible in retrospect|1|||
128830521|NCT02628626|463674121|FG000|Overall Study|Withdrawal by Subject|2|||
128830522|NCT02628626|463674122|FG001|Overall Study|Withdrawal by Subject|2|||
128830523|NCT01400958|463674125|FG000|Overall Study|Physician Decision|0|||
128830524|NCT01400958|463674126|FG001|Overall Study|Physician Decision|1|||
128830525|NCT01400958|463674125|FG000|Overall Study|Withdrawal by Subject|0|||
128830526|NCT01400958|463674126|FG001|Overall Study|Withdrawal by Subject|1|||
128830527|NCT01400958|463674125|FG000|Overall Study|Adverse Event|1|||
128830528|NCT01400958|463674126|FG001|Overall Study|Adverse Event|0|||
128830529|NCT01532999|463674130|FG000|Overall Study|Lost to Follow-up|14|||
128830530|NCT01532999|463674131|FG001|Overall Study|Lost to Follow-up|8|||
128830531|NCT01532999|463674130|FG000|Overall Study|Physician Decision|1|||
128830532|NCT01532999|463674131|FG001|Overall Study|Physician Decision|2|||
128830533|NCT01532999|463674130|FG000|Overall Study|Withdrawal by Subject|5|||
128830534|NCT01532999|463674131|FG001|Overall Study|Withdrawal by Subject|0|||
128830535|NCT01532999|463674130|FG000|Overall Study|Relocated|2|||
128830536|NCT01532999|463674131|FG001|Overall Study|Relocated|0|||
128830537|NCT01532999|463674130|FG000|Overall Study|should not have been randomized|1|||
128830538|NCT01532999|463674131|FG001|Overall Study|should not have been randomized|0|||
128830539|NCT01532999|463674130|FG000|Overall Study|substantial noncompliance|2|||
128830540|NCT01532999|463674131|FG001|Overall Study|substantial noncompliance|0|||
128830541|NCT01532999|463674130|FG000|Overall Study|no show for week 9 assessments|6|||
128830542|NCT01532999|463674131|FG001|Overall Study|no show for week 9 assessments|4|||
128830543|NCT01532999|463674130|FG000|Overall Study|Adverse Event|0|||
128830544|NCT01532999|463674131|FG001|Overall Study|Adverse Event|1|||
128830545|NCT01532999|463674130|FG000|Overall Study|incarcerated|0|||
128830546|NCT01532999|463674131|FG001|Overall Study|incarcerated|1|||
128830547|NCT01532999|463674130|FG000|Overall Study|New job|0|||
128830548|NCT01532999|463674131|FG001|Overall Study|New job|2|||
128830549|NCT00914966|463674132|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
128830550|NCT00914966|463674132|FG000|Step 1: 1500 Units|Physician Decision|1|||
128830551|NCT00914966|463674132|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
128830552|NCT04021862|463674135|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
128830553|NCT04021862|463674136|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
128830554|NCT04021862|463674137|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
128830555|NCT04021862|463674138|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
128830556|NCT04021862|463674139|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
128830557|NCT04021862|463674140|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
128830558|NCT04021862|463674135|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
128830559|NCT04021862|463674136|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
128830560|NCT04021862|463674137|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
128830561|NCT04021862|463674138|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
128830562|NCT04021862|463674139|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
128830563|NCT04021862|463674140|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
128830564|NCT04021862|463674135|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
128830565|NCT04021862|463674136|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
128830566|NCT04021862|463674137|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
128830567|NCT04021862|463674138|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
128830568|NCT04021862|463674139|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
128830569|NCT04021862|463674140|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
128830570|NCT04021862|463674135|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
128830571|NCT04021862|463674136|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
128830572|NCT04021862|463674137|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
128830573|NCT04021862|463674138|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
128830574|NCT04021862|463674139|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
128830575|NCT04021862|463674140|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
128830576|NCT04021862|463674135|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
128830577|NCT04021862|463674136|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
128830578|NCT04021862|463674137|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
128830579|NCT04021862|463674138|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
128830580|NCT04021862|463674139|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
128830581|NCT04021862|463674140|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
128830582|NCT01690624|463674141|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
128830583|NCT01690624|463674142|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
128830584|NCT01690624|463674143|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
128830585|NCT01690624|463674144|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
128830586|NCT01690624|463674141|FG000|Overall Study|Adverse event (other than DLT)|3|||
128830587|NCT01690624|463674142|FG001|Overall Study|Adverse event (other than DLT)|1|||
128830588|NCT01690624|463674143|FG002|Overall Study|Adverse event (other than DLT)|1|||
128830589|NCT01690624|463674144|FG003|Overall Study|Adverse event (other than DLT)|1|||
128830590|NCT01690624|463674141|FG000|Overall Study|Withdrawal by Subject|0|||
128830591|NCT01690624|463674142|FG001|Overall Study|Withdrawal by Subject|0|||
128830592|NCT01690624|463674143|FG002|Overall Study|Withdrawal by Subject|1|||
128830593|NCT01690624|463674144|FG003|Overall Study|Withdrawal by Subject|0|||
128830594|NCT01690624|463674141|FG000|Overall Study|Sponsor is ending trial|0|||
128830595|NCT01690624|463674142|FG001|Overall Study|Sponsor is ending trial|0|||
128830596|NCT01690624|463674143|FG002|Overall Study|Sponsor is ending trial|0|||
128830597|NCT01690624|463674144|FG003|Overall Study|Sponsor is ending trial|1|||
128830598|NCT01690624|463674141|FG000|Overall Study|Physician Decision|0|||
128830599|NCT01690624|463674142|FG001|Overall Study|Physician Decision|0|||
128830600|NCT01690624|463674143|FG002|Overall Study|Physician Decision|0|||
128830601|NCT01690624|463674144|FG003|Overall Study|Physician Decision|1|||
128830602|NCT01690624|463674141|FG000|Overall Study|Withdrawal by Subject|0|||
128830603|NCT01690624|463674142|FG001|Overall Study|Withdrawal by Subject|1|||
128830604|NCT01690624|463674143|FG002|Overall Study|Withdrawal by Subject|0|||
128830605|NCT01690624|463674144|FG003|Overall Study|Withdrawal by Subject|0|||
128830606|NCT01690624|463674141|FG000|Overall Study|Lack of Efficacy|1|||
128830607|NCT01690624|463674142|FG001|Overall Study|Lack of Efficacy|1|||
128830608|NCT01690624|463674143|FG002|Overall Study|Lack of Efficacy|3|||
128830609|NCT01690624|463674144|FG003|Overall Study|Lack of Efficacy|0|||
128830610|NCT02517268|463674146|FG000|Overall Study|Withdrawal by Subject|1|||
128830611|NCT02517268|463674147|FG001|Overall Study|Withdrawal by Subject|0|||
128830612|NCT04445831|463674148|FG000|Overall Study|Withdrawal by Subject|2|||
128830613|NCT04445831|463674149|FG001|Overall Study|Withdrawal by Subject|1|||
128830614|NCT04445831|463674150|FG002|Overall Study|Withdrawal by Subject|1|||
128830615|NCT04445831|463674151|FG003|Overall Study|Withdrawal by Subject|0|||
128830616|NCT04445831|463674152|FG004|Overall Study|Withdrawal by Subject|0|||
128830617|NCT04445831|463674153|FG005|Overall Study|Withdrawal by Subject|0|||
128830618|NCT04445831|463674154|FG006|Overall Study|Withdrawal by Subject|0|||
128830619|NCT04445831|463674148|FG000|Overall Study|Subject withdrawal by caregiver|0|||
128830620|NCT04445831|463674149|FG001|Overall Study|Subject withdrawal by caregiver|1|||
128830621|NCT04445831|463674150|FG002|Overall Study|Subject withdrawal by caregiver|0|||
128830622|NCT04445831|463674151|FG003|Overall Study|Subject withdrawal by caregiver|0|||
128830623|NCT04445831|463674152|FG004|Overall Study|Subject withdrawal by caregiver|0|||
128830624|NCT04445831|463674153|FG005|Overall Study|Subject withdrawal by caregiver|0|||
128830625|NCT04445831|463674154|FG006|Overall Study|Subject withdrawal by caregiver|0|||
128830626|NCT04912856|463674155|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
128830627|NCT04912856|463674156|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
128830628|NCT04912856|463674155|FG000|Overall Study|Not reported in synoptic CSR.|0|||
128830629|NCT04912856|463674156|FG001|Overall Study|Not reported in synoptic CSR.|1|||
128830630|NCT04649047|463674163|FG000|Overall Study|Withdrawal by Subject|3|||
128830631|NCT00719888|463674164|FG000|Overall Study|Death|24|||
128830632|NCT00719888|463674165|FG001|Overall Study|Death|9|||
128830633|NCT00719888|463674164|FG000|Overall Study|Relapse|8|||
128830634|NCT00719888|463674165|FG001|Overall Study|Relapse|3|||
128830635|NCT00719888|463674164|FG000|Overall Study|Physician Decision|1|||
128830636|NCT00719888|463674165|FG001|Overall Study|Physician Decision|0|||
128830637|NCT00719888|463674164|FG000|Overall Study|Withdrawal by Subject|1|||
128830638|NCT00719888|463674165|FG001|Overall Study|Withdrawal by Subject|0|||
128830639|NCT05037513|463674166|FG000|Intervention Period|Lost to Follow-up|1|||
128830640|NCT05037513|463674167|FG001|Intervention Period|Lost to Follow-up|2|||
128830641|NCT05037513|463674166|FG000|Follow Up Period|Lost to Follow-up|16|||
128830642|NCT05037513|463674167|FG001|Follow Up Period|Lost to Follow-up|21|||
128830643|NCT05037513|463674166|FG000|Follow Up Period|Death|0|||
128830644|NCT05037513|463674167|FG001|Follow Up Period|Death|1|||
128830645|NCT05037513|463674166|FG000|Follow Up Period|Incarcerated|4|||
128830646|NCT05037513|463674167|FG001|Follow Up Period|Incarcerated|2|||
128830647|NCT03773107|463674168|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
128830648|NCT03773107|463674169|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
128830649|NCT03773107|463674170|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
128830650|NCT03773107|463674171|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
128830651|NCT02328014|463675357|FG000|Overall Study|Adverse Event|1|||
128830652|NCT02328014|463675358|FG001|Overall Study|Adverse Event|0|||
128830653|NCT02328014|463675359|FG002|Overall Study|Adverse Event|0|||
128830654|NCT02328014|463675360|FG003|Overall Study|Adverse Event|1|||
128830655|NCT02328014|463675357|FG000|Overall Study|Death|0|||
128830656|NCT02328014|463675358|FG001|Overall Study|Death|0|||
128830657|NCT02328014|463675359|FG002|Overall Study|Death|0|||
128830658|NCT02328014|463675360|FG003|Overall Study|Death|4|||
128830659|NCT02328014|463675357|FG000|Overall Study|Physician Decision|0|||
128830660|NCT02328014|463675358|FG001|Overall Study|Physician Decision|0|||
128830661|NCT02328014|463675359|FG002|Overall Study|Physician Decision|0|||
128830662|NCT02328014|463675360|FG003|Overall Study|Physician Decision|1|||
128830663|NCT02328014|463675357|FG000|Overall Study|Disease Progression|1|||
128830664|NCT02328014|463675358|FG001|Overall Study|Disease Progression|0|||
128830665|NCT02328014|463675359|FG002|Overall Study|Disease Progression|1|||
128830666|NCT02328014|463675360|FG003|Overall Study|Disease Progression|3|||
128830667|NCT02328014|463675357|FG000|Overall Study|Study Terminated by Sponsor|4|||
128830668|NCT02328014|463675358|FG001|Overall Study|Study Terminated by Sponsor|1|||
128830669|NCT02328014|463675359|FG002|Overall Study|Study Terminated by Sponsor|1|||
128830670|NCT02328014|463675360|FG003|Overall Study|Study Terminated by Sponsor|0|||
128830671|NCT02328014|463675357|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
128830672|NCT02328014|463675358|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
128830673|NCT02328014|463675359|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
128830674|NCT02328014|463675360|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
128830675|NCT02328014|463675357|FG000|Overall Study|Withdrawal by Subject|0|||
128830676|NCT02328014|463675358|FG001|Overall Study|Withdrawal by Subject|0|||
128830677|NCT02328014|463675359|FG002|Overall Study|Withdrawal by Subject|0|||
128830678|NCT02328014|463675360|FG003|Overall Study|Withdrawal by Subject|1|||
128830679|NCT01274338|463675361|FG000|Overall Study|Lack of Efficacy|72|||
128830680|NCT01274338|463675362|FG001|Overall Study|Lack of Efficacy|108|||
128830681|NCT01274338|463675363|FG002|Overall Study|Lack of Efficacy|116|||
128830682|NCT01274338|463675364|FG003|Overall Study|Lack of Efficacy|0|||
128830683|NCT01274338|463675365|FG004|Overall Study|Lack of Efficacy|0|||
128830684|NCT01274338|463675366|FG005|Overall Study|Lack of Efficacy|0|||
128830685|NCT01274338|463675361|FG000|Overall Study|Adverse Event|272|||
128830686|NCT01274338|463675362|FG001|Overall Study|Adverse Event|105|||
128830687|NCT01274338|463675363|FG002|Overall Study|Adverse Event|180|||
128830688|NCT01274338|463675364|FG003|Overall Study|Adverse Event|1|||
128830689|NCT01274338|463675365|FG004|Overall Study|Adverse Event|0|||
128830690|NCT01274338|463675366|FG005|Overall Study|Adverse Event|0|||
128830691|NCT01274338|463675361|FG000|Overall Study|Death|8|||
128830692|NCT01274338|463675362|FG001|Overall Study|Death|1|||
128830693|NCT01274338|463675363|FG002|Overall Study|Death|0|||
128830694|NCT01274338|463675364|FG003|Overall Study|Death|0|||
128830695|NCT01274338|463675365|FG004|Overall Study|Death|0|||
128830696|NCT01274338|463675366|FG005|Overall Study|Death|0|||
128830697|NCT01274338|463675361|FG000|Overall Study|Withdrawal by Subject|27|||
128830698|NCT01274338|463675362|FG001|Overall Study|Withdrawal by Subject|99|||
128830699|NCT01274338|463675363|FG002|Overall Study|Withdrawal by Subject|17|||
128830700|NCT01274338|463675364|FG003|Overall Study|Withdrawal by Subject|0|||
128830701|NCT01274338|463675365|FG004|Overall Study|Withdrawal by Subject|0|||
128830702|NCT01274338|463675366|FG005|Overall Study|Withdrawal by Subject|0|||
128830703|NCT01274338|463675361|FG000|Overall Study|Did not start treatment|8|||
128830704|NCT01274338|463675362|FG001|Overall Study|Did not start treatment|116|||
128830705|NCT01274338|463675363|FG002|Overall Study|Did not start treatment|7|||
128830706|NCT01274338|463675364|FG003|Overall Study|Did not start treatment|0|||
128830707|NCT01274338|463675365|FG004|Overall Study|Did not start treatment|0|||
128830708|NCT01274338|463675366|FG005|Overall Study|Did not start treatment|0|||
128830709|NCT01274338|463675361|FG000|Overall Study|Alternative therapy|0|||
128830710|NCT01274338|463675362|FG001|Overall Study|Alternative therapy|1|||
128830711|NCT01274338|463675363|FG002|Overall Study|Alternative therapy|0|||
128830712|NCT01274338|463675364|FG003|Overall Study|Alternative therapy|0|||
128830713|NCT01274338|463675365|FG004|Overall Study|Alternative therapy|0|||
128830714|NCT01274338|463675366|FG005|Overall Study|Alternative therapy|0|||
128830715|NCT01274338|463675361|FG000|Overall Study|Other complicating diseases|0|||
128830716|NCT01274338|463675362|FG001|Overall Study|Other complicating diseases|3|||
128830717|NCT01274338|463675363|FG002|Overall Study|Other complicating diseases|1|||
128830718|NCT01274338|463675364|FG003|Overall Study|Other complicating diseases|0|||
128830719|NCT01274338|463675365|FG004|Overall Study|Other complicating diseases|0|||
128830720|NCT01274338|463675366|FG005|Overall Study|Other complicating diseases|0|||
128830721|NCT01274338|463675361|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
128830722|NCT01274338|463675362|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
128830723|NCT01274338|463675363|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
128830724|NCT01274338|463675364|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
128830725|NCT01274338|463675365|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
128830726|NCT01274338|463675366|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
128830727|NCT01274338|463675361|FG000|Overall Study|Pregnancy|0|||
128830728|NCT01274338|463675362|FG001|Overall Study|Pregnancy|0|||
128830729|NCT01274338|463675363|FG002|Overall Study|Pregnancy|1|||
128830730|NCT01274338|463675364|FG003|Overall Study|Pregnancy|0|||
128830731|NCT01274338|463675365|FG004|Overall Study|Pregnancy|0|||
128830732|NCT01274338|463675366|FG005|Overall Study|Pregnancy|0|||
128830733|NCT01274338|463675361|FG000|Overall Study|Reason not reported|12|||
128830734|NCT01274338|463675362|FG001|Overall Study|Reason not reported|21|||
128830735|NCT01274338|463675363|FG002|Overall Study|Reason not reported|3|||
128830736|NCT01274338|463675364|FG003|Overall Study|Reason not reported|0|||
128830737|NCT01274338|463675365|FG004|Overall Study|Reason not reported|1|||
128830738|NCT01274338|463675366|FG005|Overall Study|Reason not reported|0|||
128830739|NCT05422339|463675367|FG000|Overall Study|Withdrawal by Subject|17|||
128830740|NCT05422339|463675368|FG001|Overall Study|Withdrawal by Subject|15|||
128830741|NCT06056310|463675369|FG000|Overall Study|Other Reasons|2|||
128830742|NCT06056310|463675369|FG000|Overall Study|Sponsor Request|16|||
128830743|NCT03678688|463675376|FG000|Overall Study|Reason not Specified|0|||
128830744|NCT03678688|463675377|FG001|Overall Study|Reason not Specified|0|||
128830745|NCT03678688|463675378|FG002|Overall Study|Reason not Specified|3|||
128830746|NCT03678688|463675379|FG003|Overall Study|Reason not Specified|0|||
128830747|NCT03678688|463675380|FG004|Overall Study|Reason not Specified|1|||
128830748|NCT03678688|463675381|FG005|Overall Study|Reason not Specified|0|||
128830749|NCT03678688|463675382|FG006|Overall Study|Reason not Specified|0|||
128830750|NCT03678688|463675383|FG007|Overall Study|Reason not Specified|0|||
128830751|NCT03678688|463675384|FG008|Overall Study|Reason not Specified|0|||
128830752|NCT03678688|463675376|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
128830753|NCT03678688|463675377|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
128830754|NCT03678688|463675378|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
128830755|NCT03678688|463675379|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
128830756|NCT03678688|463675380|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
128830757|NCT03678688|463675381|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
128830758|NCT03678688|463675382|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
128830759|NCT03678688|463675383|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
128830760|NCT03678688|463675384|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
128830761|NCT03678688|463675376|FG000|Overall Study|Covid Related Adverse Event|0|||
128830762|NCT03678688|463675377|FG001|Overall Study|Covid Related Adverse Event|0|||
128830763|NCT03678688|463675378|FG002|Overall Study|Covid Related Adverse Event|0|||
128830764|NCT03678688|463675379|FG003|Overall Study|Covid Related Adverse Event|0|||
128830765|NCT03678688|463675380|FG004|Overall Study|Covid Related Adverse Event|0|||
128830766|NCT03678688|463675381|FG005|Overall Study|Covid Related Adverse Event|3|||
128830767|NCT03678688|463675382|FG006|Overall Study|Covid Related Adverse Event|1|||
128830768|NCT03678688|463675383|FG007|Overall Study|Covid Related Adverse Event|1|||
128830769|NCT03678688|463675384|FG008|Overall Study|Covid Related Adverse Event|0|||
128830770|NCT03678688|463675376|FG000|Overall Study|Physician Decision|0|||
128830771|NCT03678688|463675377|FG001|Overall Study|Physician Decision|0|||
128830772|NCT03678688|463675378|FG002|Overall Study|Physician Decision|0|||
128830773|NCT03678688|463675379|FG003|Overall Study|Physician Decision|0|||
128830774|NCT03678688|463675380|FG004|Overall Study|Physician Decision|0|||
128830775|NCT03678688|463675381|FG005|Overall Study|Physician Decision|1|||
128830776|NCT03678688|463675382|FG006|Overall Study|Physician Decision|0|||
128830777|NCT03678688|463675383|FG007|Overall Study|Physician Decision|0|||
128830778|NCT03678688|463675384|FG008|Overall Study|Physician Decision|0|||
128830779|NCT03678688|463675376|FG000|Overall Study|Withdrawal by Subject|0|||
128830780|NCT03678688|463675377|FG001|Overall Study|Withdrawal by Subject|0|||
128830781|NCT03678688|463675378|FG002|Overall Study|Withdrawal by Subject|0|||
128830782|NCT03678688|463675379|FG003|Overall Study|Withdrawal by Subject|0|||
128830783|NCT03678688|463675380|FG004|Overall Study|Withdrawal by Subject|0|||
128830784|NCT03678688|463675381|FG005|Overall Study|Withdrawal by Subject|0|||
128830785|NCT03678688|463675382|FG006|Overall Study|Withdrawal by Subject|2|||
128830786|NCT03678688|463675383|FG007|Overall Study|Withdrawal by Subject|1|||
128830787|NCT03678688|463675384|FG008|Overall Study|Withdrawal by Subject|0|||
128830788|NCT01278030|463675391|FG000|Overall Study|Withdrawal by Subject|8|||
128830789|NCT01278030|463675392|FG001|Overall Study|Withdrawal by Subject|4|||
128830790|NCT00458783|463675394|FG000|Overall Study|Protocol Violation|1228|||
128830791|NCT00458783|463675395|FG001|Overall Study|Protocol Violation|1220|||
128830792|NCT05815342|463675396|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
128830793|NCT05815342|463675396|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
128830794|NCT05815342|463675396|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
128830795|NCT05815342|463675396|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
128830796|NCT05815342|463675396|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
128830797|NCT04885998|463675399|FG000|Overall Study|Withdrawal by Subject|0|||
128830798|NCT04885998|463675400|FG001|Overall Study|Withdrawal by Subject|2|||
128830799|NCT04885998|463675401|FG002|Overall Study|Withdrawal by Subject|0|||
128830800|NCT04885998|463675402|FG003|Overall Study|Withdrawal by Subject|3|||
128830801|NCT04885998|463675399|FG000|Overall Study|Lost to Follow-up|1|||
128830802|NCT04885998|463675400|FG001|Overall Study|Lost to Follow-up|1|||
128830803|NCT04885998|463675401|FG002|Overall Study|Lost to Follow-up|0|||
128830804|NCT04885998|463675402|FG003|Overall Study|Lost to Follow-up|0|||
128830805|NCT04885998|463675399|FG000|Overall Study|Death|2|||
128830806|NCT04885998|463675400|FG001|Overall Study|Death|1|||
128830807|NCT04885998|463675401|FG002|Overall Study|Death|2|||
128830808|NCT04885998|463675402|FG003|Overall Study|Death|2|||
128830809|NCT04885998|463675399|FG000|Overall Study|Decision by sponsor|1|||
128830810|NCT04885998|463675400|FG001|Overall Study|Decision by sponsor|1|||
128830811|NCT04885998|463675401|FG002|Overall Study|Decision by sponsor|0|||
128830812|NCT04885998|463675402|FG003|Overall Study|Decision by sponsor|0|||
128830813|NCT03712371|463675404|FG000|Overall Study|Lack of Efficacy|0|||
128830814|NCT03712371|463675405|FG001|Overall Study|Lack of Efficacy|0|||
128830815|NCT03712371|463675406|FG002|Overall Study|Lack of Efficacy|0|||
128830816|NCT03712371|463675407|FG003|Overall Study|Lack of Efficacy|1|||
128830817|NCT02362035|463675410|FG000|Overall Study|Death|67|||
128830818|NCT02362035|463675410|FG000|Overall Study|Lost to Follow-up|3|||
128830819|NCT02362035|463675410|FG000|Overall Study|Adverse Event|1|||
128830820|NCT02362035|463675410|FG000|Overall Study|Physician Decision|1|||
128830821|NCT02362035|463675410|FG000|Overall Study|Subject started another cancer therapy|10|||
128830822|NCT02362035|463675410|FG000|Overall Study|Study terminated by sponsor|45|||
128830823|NCT02362035|463675410|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
128830824|NCT02362035|463675410|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
128830825|NCT02362035|463675410|FG000|Overall Study|Disease progression|11|||
128830826|NCT02362035|463675410|FG000|Overall Study|Withdrawal by Subject|20|||
128830827|NCT04250194|463675413|FG000|Overall Study|Declined to schedule biopsy|6|||
128830828|NCT04250194|463675414|FG001|Overall Study|Declined to schedule biopsy|10|||
128830829|NCT04250194|463675413|FG000|Overall Study|Medically Unfit for Biopsy|2|||
128830830|NCT04250194|463675414|FG001|Overall Study|Medically Unfit for Biopsy|1|||
128830831|NCT04250194|463675413|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
128830832|NCT04250194|463675414|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
128830833|NCT04250194|463675413|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
128830834|NCT04250194|463675414|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
128830835|NCT04250194|463675413|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
128830836|NCT04250194|463675414|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
128830837|NCT00229658|463675415|FG000|Overall Study|Administrative|2|||
128830838|NCT00229658|463675416|FG001|Overall Study|Administrative|1|||
128830839|NCT00229658|463675415|FG000|Overall Study|Investigator decision|13|||
128830840|NCT00229658|463675416|FG001|Overall Study|Investigator decision|10|||
128830841|NCT00229658|463675415|FG000|Overall Study|Other|80|||
128830842|NCT00229658|463675416|FG001|Overall Study|Other|60|||
128830843|NCT00229658|463675415|FG000|Overall Study|Lost to Follow-up|82|||
128830844|NCT00229658|463675416|FG001|Overall Study|Lost to Follow-up|55|||
128830845|NCT00229658|463675415|FG000|Overall Study|Serious Adverse Event|2|||
128830846|NCT00229658|463675416|FG001|Overall Study|Serious Adverse Event|2|||
128830847|NCT00229658|463675415|FG000|Overall Study|Withdrawal of consent|46|||
128830848|NCT00229658|463675416|FG001|Overall Study|Withdrawal of consent|39|||
128830849|NCT00249769|463675417|FG000|Overall Study|Withdrawal by Subject|1|||
128830850|NCT00249769|463675418|FG001|Overall Study|Withdrawal by Subject|10|||
128830851|NCT00249769|463675419|FG002|Overall Study|Withdrawal by Subject|6|||
128830852|NCT00249769|463675417|FG000|Overall Study|Migration from Study Area|1|||
128830853|NCT00249769|463675418|FG001|Overall Study|Migration from Study Area|3|||
128830854|NCT00249769|463675419|FG002|Overall Study|Migration from Study Area|14|||
128830855|NCT00249769|463675417|FG000|Overall Study|Miscellaneous|0|||
128830856|NCT00249769|463675418|FG001|Overall Study|Miscellaneous|2|||
128830857|NCT00249769|463675419|FG002|Overall Study|Miscellaneous|2|||
128830858|NCT00249769|463675417|FG000|Overall Study|Adverse Event|0|||
128830859|NCT00249769|463675418|FG001|Overall Study|Adverse Event|0|||
128830860|NCT00249769|463675419|FG002|Overall Study|Adverse Event|1|||
128830861|NCT00249769|463675417|FG000|Overall Study|Physician Decision|0|||
128830862|NCT00249769|463675418|FG001|Overall Study|Physician Decision|0|||
128830863|NCT00249769|463675419|FG002|Overall Study|Physician Decision|2|||
128830864|NCT00249769|463675417|FG000|Overall Study|Lost to Follow-up|0|||
128830865|NCT00249769|463675418|FG001|Overall Study|Lost to Follow-up|0|||
128830866|NCT00249769|463675419|FG002|Overall Study|Lost to Follow-up|3|||
128830867|NCT01953224|463675420|FG000|Overall Study|Lost to Follow-up|1|||
128830868|NCT01953224|463675421|FG001|Overall Study|Lost to Follow-up|1|||
128830869|NCT01953224|463675420|FG000|Overall Study|Withdrawal by Subject|1|||
128830870|NCT01953224|463675421|FG001|Overall Study|Withdrawal by Subject|2|||
128830871|NCT03229408|463675422|FG000|Overall Study|Withdrawal by Subject|4|||
128830872|NCT03229408|463675423|FG001|Overall Study|Withdrawal by Subject|1|||
128830873|NCT03229408|463675422|FG000|Overall Study|Adverse Event|2|||
128830874|NCT03229408|463675423|FG001|Overall Study|Adverse Event|0|||
128830875|NCT03229408|463675422|FG000|Overall Study|Pregnancy|0|||
128830876|NCT03229408|463675423|FG001|Overall Study|Pregnancy|1|||
128830877|NCT03229408|463675422|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
128830878|NCT03229408|463675423|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
128830879|NCT04541589|463675426|FG000|Treatment Period|Adverse Event|8|||
128830880|NCT04541589|463675427|FG001|Treatment Period|Adverse Event|2|||
128830881|NCT04541589|463675426|FG000|Treatment Period|Physician Decision|3|||
128830882|NCT04541589|463675427|FG001|Treatment Period|Physician Decision|1|||
128830883|NCT04541589|463675426|FG000|Treatment Period|Subject decision|7|||
128830884|NCT04541589|463675427|FG001|Treatment Period|Subject decision|4|||
128830885|NCT04541589|463675426|FG000|Treatment Period|Withdrawal by Subject|1|||
128830886|NCT04541589|463675427|FG001|Treatment Period|Withdrawal by Subject|0|||
128830887|NCT04541589|463675426|FG000|Safety Follow-up Period|Adverse Event|2|||
128830888|NCT04541589|463675427|FG001|Safety Follow-up Period|Adverse Event|1|||
128830889|NCT04541589|463675426|FG000|Safety Follow-up Period|Physician Decision|1|||
128830890|NCT04541589|463675427|FG001|Safety Follow-up Period|Physician Decision|0|||
128830891|NCT04541589|463675426|FG000|Safety Follow-up Period|Subject decision|5|||
128830892|NCT04541589|463675427|FG001|Safety Follow-up Period|Subject decision|3|||
128830893|NCT04541589|463675426|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
128830894|NCT04541589|463675427|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
128830895|NCT03745313|463675428|FG000|At 30 Days Follow-up|Death|2|||
128830896|NCT03745313|463675428|FG000|At 6 Months Follow-up|Death|1|||
128830897|NCT03745313|463675428|FG000|At 6 Months Follow-up|Missed Visit|1|||
128830898|NCT03745313|463675428|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
128830899|NCT03745313|463675428|FG000|At 1 Year Follow-up|Death|2|||
128830900|NCT03745313|463675428|FG000|At 1 Year Follow-up|Missed Visit|2|||
128830901|NCT03745313|463675428|FG000|At 2 Year Follow-up|Missed Visit|1|||
128830902|NCT03516812|463675429|FG000|Overall Study|Adverse Event|4|||
128830903|NCT03516812|463675429|FG000|Overall Study|Lack of Efficacy|2|||
128830904|NCT03890289|463675430|FG000|Overall Study|Adverse Event|1|||
128830905|NCT03890289|463675430|FG000|Overall Study|Physician Decision|1|||
128830906|NCT03890289|463675430|FG000|Overall Study|Lack of Efficacy|2|||
128830907|NCT03389802|463675433|FG000|Overall Study|Lack of Efficacy|3|||
128830908|NCT03389802|463675434|FG001|Overall Study|Lack of Efficacy|3|||
128830909|NCT03389802|463675435|FG002|Overall Study|Lack of Efficacy|13|||
128830910|NCT03389802|463675436|FG003|Overall Study|Lack of Efficacy|6|||
128830911|NCT03389802|463675437|FG004|Overall Study|Lack of Efficacy|1|||
128830912|NCT03389802|463675433|FG000|Overall Study|Adverse Event|0|||
128830913|NCT03389802|463675434|FG001|Overall Study|Adverse Event|0|||
128830914|NCT03389802|463675435|FG002|Overall Study|Adverse Event|1|||
128830915|NCT03389802|463675436|FG003|Overall Study|Adverse Event|0|||
128830916|NCT03389802|463675437|FG004|Overall Study|Adverse Event|4|||
128830917|NCT03389802|463675433|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
128830918|NCT03389802|463675434|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
128830919|NCT03389802|463675435|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
128830920|NCT03389802|463675436|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
128830921|NCT03389802|463675437|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
128830922|NCT02426138|463675438|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
128830923|NCT02426138|463675439|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
128830924|NCT00274261|463675440|FG000|Overall Study|Adverse Event|19|||
128830925|NCT00274261|463675441|FG001|Overall Study|Adverse Event|11|||
128830926|NCT00274261|463675440|FG000|Overall Study|Pregnancy|114|||
128830927|NCT00274261|463675441|FG001|Overall Study|Pregnancy|83|||
128830928|NCT00274261|463675440|FG000|Overall Study|Withdrawal by Subject|179|||
128830929|NCT00274261|463675441|FG001|Overall Study|Withdrawal by Subject|126|||
128830930|NCT00274261|463675440|FG000|Overall Study|Protocol Violation|71|||
128830931|NCT00274261|463675441|FG001|Overall Study|Protocol Violation|42|||
128830932|NCT00274261|463675440|FG000|Overall Study|Lost to Follow-up|106|||
128830933|NCT00274261|463675441|FG001|Overall Study|Lost to Follow-up|75|||
128830934|NCT02816398|463675449|FG000|Overall Study|Death|5|||
128830935|NCT02816398|463675449|FG000|Overall Study|Lack of Efficacy|8|||
128830936|NCT02816398|463675449|FG000|Overall Study|Lost to Follow-up|1|||
128830937|NCT03362190|463675455|FG000|Overall Study|Adverse Event|0|||
128830938|NCT03362190|463675456|FG001|Overall Study|Adverse Event|0|||
128830939|NCT03362190|463675457|FG002|Overall Study|Adverse Event|0|||
128830940|NCT03362190|463675458|FG003|Overall Study|Adverse Event|1|||
128830941|NCT03362190|463675455|FG000|Overall Study|Withdrawal by Subject|0|||
128830942|NCT03362190|463675456|FG001|Overall Study|Withdrawal by Subject|0|||
128830943|NCT03362190|463675457|FG002|Overall Study|Withdrawal by Subject|0|||
128830944|NCT03362190|463675458|FG003|Overall Study|Withdrawal by Subject|1|||
128830945|NCT00687219|463675459|FG000|Overall Study|Adverse Event|8|||
128830946|NCT00687219|463675459|FG000|Overall Study|Discontinuance criteria met|7|||
128830947|NCT00687219|463675459|FG000|Overall Study|HCV-RNA positive conversion|34|||
128830948|NCT00687219|463675459|FG000|Overall Study|Withdrawal by Subject|1|||
128830949|NCT00687219|463675459|FG000|Overall Study|Lack of Efficacy|1|||
128830950|NCT01367236|463675463|FG000|Overall Study|Withdrawal by Subject|3|||
128830951|NCT01367236|463675464|FG001|Overall Study|Withdrawal by Subject|1|||
128830952|NCT02350634|463675467|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
128830953|NCT05470114|463675476|FG000|Overall Study|Withdrawal by Subject|1|||
128830954|NCT05470114|463675477|FG001|Overall Study|Withdrawal by Subject|0|||
128830955|NCT05470114|463675476|FG000|Overall Study|Lost to Follow-up|1|||
128830956|NCT05470114|463675477|FG001|Overall Study|Lost to Follow-up|0|||
128830957|NCT01563185|463675479|FG000|Overall Study|Withdrawal by Subject|1|||
128830958|NCT01563185|463675479|FG000|Overall Study|Non-Compliance with study drug|1|||
128830959|NCT04401267|463676354|FG000|Overall Study|Death|0|||
128830960|NCT04401267|463676355|FG001|Overall Study|Death|1|||
128830961|NCT04401267|463676354|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
128830962|NCT04401267|463676355|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
128830963|NCT04401267|463676354|FG000|Overall Study|Found to be Ineligible|1|||
128830964|NCT04401267|463676355|FG001|Overall Study|Found to be Ineligible|0|||
128830965|NCT03214081|463676356|FG000|Overall Study|Case Report Forms Uncollected|9|||
128830966|NCT03214081|463676356|FG000|Overall Study|Protocol Deviation|54|||
128830967|NCT02962284|463676357|FG000|Overall Study|Death|2|||
128830968|NCT02962284|463676358|FG001|Overall Study|Death|0|||
128830969|NCT02962284|463676357|FG000|Overall Study|Progressive disease|2|||
128830970|NCT02962284|463676358|FG001|Overall Study|Progressive disease|3|||
128830971|NCT02962284|463676357|FG000|Overall Study|Withdrawal by Subject|1|||
128830972|NCT02962284|463676358|FG001|Overall Study|Withdrawal by Subject|0|||
128830973|NCT00357994|463676359|FG000|Overall Study|Adverse Event|1|||
128830974|NCT00357994|463676360|FG001|Overall Study|Adverse Event|2|||
128830975|NCT00357994|463676359|FG000|Overall Study|Lack of Efficacy|0|||
128830976|NCT00357994|463676360|FG001|Overall Study|Lack of Efficacy|1|||
128830977|NCT00357994|463676359|FG000|Overall Study|Protocol Violation|1|||
128830978|NCT00357994|463676360|FG001|Overall Study|Protocol Violation|0|||
128830979|NCT00345046|463676361|FG000|Overall Study|Protocol Violation|1|||
128830980|NCT00345046|463676362|FG001|Overall Study|Protocol Violation|1|||
128830981|NCT00345046|463676363|FG002|Overall Study|Protocol Violation|2|||
128830982|NCT00790569|463676364|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
128830983|NCT00790569|463676365|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
128830984|NCT00790569|463676366|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
128830985|NCT00790569|463676364|FG000|End of Treatment (6 Month Interview)|Death|0|||
128830986|NCT00790569|463676365|FG001|End of Treatment (6 Month Interview)|Death|2|||
128830987|NCT00790569|463676366|FG002|End of Treatment (6 Month Interview)|Death|1|||
128830988|NCT00790569|463676364|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
128830989|NCT00790569|463676365|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
128830990|NCT00790569|463676366|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
128830991|NCT00790569|463676364|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
128830992|NCT00790569|463676365|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
128830993|NCT00790569|463676366|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
128830994|NCT00790569|463676364|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
128830995|NCT00790569|463676365|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
128830996|NCT00790569|463676366|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
128830997|NCT00790569|463676364|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
128830998|NCT00790569|463676365|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
128830999|NCT00790569|463676366|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
128831000|NCT03244800|463676368|FG000|Overall Study|Adverse Event|0|||
128831001|NCT03244800|463676369|FG001|Overall Study|Adverse Event|1|||
128831002|NCT03244800|463676370|FG002|Overall Study|Adverse Event|0|||
128831003|NCT03244800|463676371|FG003|Overall Study|Adverse Event|1|||
128831004|NCT03244800|463676368|FG000|Overall Study|Withdrew treatment|0|||
128831005|NCT03244800|463676369|FG001|Overall Study|Withdrew treatment|0|||
128831006|NCT03244800|463676370|FG002|Overall Study|Withdrew treatment|0|||
128831007|NCT03244800|463676371|FG003|Overall Study|Withdrew treatment|1|||
128831008|NCT05014412|463676376|FG000|Overall Study|Death|11|||
128831009|NCT05014412|463676377|FG001|Overall Study|Death|7|||
128831010|NCT05014412|463676378|FG002|Overall Study|Death|4|||
128831011|NCT05014412|463676379|FG003|Overall Study|Death|7|||
128831012|NCT05014412|463676376|FG000|Overall Study|Withdrawal by Subject|1|||
128831013|NCT05014412|463676377|FG001|Overall Study|Withdrawal by Subject|1|||
128831014|NCT05014412|463676378|FG002|Overall Study|Withdrawal by Subject|1|||
128831015|NCT05014412|463676379|FG003|Overall Study|Withdrawal by Subject|2|||
128831016|NCT05014412|463676376|FG000|Overall Study|Ongoing|21|||
128831017|NCT05014412|463676377|FG001|Overall Study|Ongoing|4|||
128831018|NCT05014412|463676378|FG002|Overall Study|Ongoing|6|||
128831019|NCT05014412|463676379|FG003|Overall Study|Ongoing|20|||
128831020|NCT01886872|463676380|FG000|Overall Study|Ineligible|7|||
128831021|NCT01886872|463676381|FG001|Overall Study|Ineligible|4|||
128831022|NCT01886872|463676382|FG002|Overall Study|Ineligible|12|||
128831023|NCT04941482|463676383|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
128831024|NCT04941482|463676384|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
128831025|NCT02454959|463676385|FG000|Overall Study|Protocol-Specified Criteria|3|||
128831026|NCT02454959|463676385|FG000|Overall Study|Physician Decision|1|||
128831027|NCT02454959|463676385|FG000|Overall Study|Withdrawal by Subject|3|||
128831028|NCT02454959|463676385|FG000|Overall Study|Adverse Event|2|||
128831029|NCT04745676|463676386|FG000|Overall Study|Death|1|||
128831030|NCT04745676|463676387|FG001|Overall Study|Death|0|||
128831031|NCT04745676|463676388|FG002|Overall Study|Death|0|||
128831032|NCT04827732|463676392|FG000|Overall Study|Did not start treatment|0|||
128831033|NCT04827732|463676393|FG001|Overall Study|Did not start treatment|1|||
128831034|NCT04827732|463676394|FG002|Overall Study|Did not start treatment|0|||
128831035|NCT04827732|463676395|FG003|Overall Study|Did not start treatment|1|||
128831036|NCT03414684|463676399|FG000|First-course Treatment|Complete response|0|||
128831037|NCT03414684|463676400|FG001|First-course Treatment|Complete response|1|||
128831038|NCT03414684|463676399|FG000|First-course Treatment|Intercurrent illness|1|||
128831039|NCT03414684|463676400|FG001|First-course Treatment|Intercurrent illness|0|||
128831040|NCT03414684|463676399|FG000|First-course Treatment|Progressive Disease|31|||
128831041|NCT03414684|463676400|FG001|First-course Treatment|Progressive Disease|32|||
128831042|NCT03414684|463676399|FG000|First-course Treatment|Adverse Event|1|||
128831043|NCT03414684|463676400|FG001|First-course Treatment|Adverse Event|2|||
128831044|NCT03414684|463676399|FG000|First-course Treatment|Physician Decision|0|||
128831045|NCT03414684|463676400|FG001|First-course Treatment|Physician Decision|1|||
128831046|NCT03414684|463676399|FG000|First-course Treatment|Withdrawal by Subject|0|||
128831047|NCT03414684|463676400|FG001|First-course Treatment|Withdrawal by Subject|1|||
128831048|NCT03414684|463676399|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
128831049|NCT03414684|463676400|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
128831050|NCT03414684|463676399|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
128831051|NCT03414684|463676400|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
128831052|NCT03414684|463676399|FG000|First-course Treatment|Still on treatment|3|||
128831053|NCT03414684|463676400|FG001|First-course Treatment|Still on treatment|0|||
128831054|NCT03414684|463676399|FG000|First-course Treatment|Never started protocol therapy|2|||
128831055|NCT03414684|463676400|FG001|First-course Treatment|Never started protocol therapy|1|||
128831056|NCT03414684|463676399|FG000|Crossover Treatment|Progressive disease|0|||
128831057|NCT03414684|463676400|FG001|Crossover Treatment|Progressive disease|12|||
128831058|NCT03414684|463676399|FG000|Crossover Treatment|Adverse Event|0|||
128831059|NCT03414684|463676400|FG001|Crossover Treatment|Adverse Event|3|||
128831060|NCT03414684|463676399|FG000|Crossover Treatment|Physician Decision|0|||
128831061|NCT03414684|463676400|FG001|Crossover Treatment|Physician Decision|1|||
128831062|NCT03414684|463676399|FG000|Crossover Treatment|Still on treatment|0|||
128831063|NCT03414684|463676400|FG001|Crossover Treatment|Still on treatment|2|||
128831064|NCT04038580|463676401|FG000|Washout 1|Death|0|||
128831065|NCT04038580|463676402|FG001|Washout 1|Death|0|||
128831066|NCT04038580|463676403|FG002|Washout 1|Death|0|||
128831067|NCT04038580|463676404|FG003|Washout 1|Death|1|||
128831068|NCT04038580|463676405|FG004|Washout 1|Death|0|||
128831069|NCT04038580|463676406|FG005|Washout 1|Death|0|||
128831070|NCT04038580|463676401|FG000|Washout 1|Withdrawal by Subject|0|||
128831071|NCT04038580|463676402|FG001|Washout 1|Withdrawal by Subject|0|||
128831072|NCT04038580|463676403|FG002|Washout 1|Withdrawal by Subject|0|||
128831073|NCT04038580|463676404|FG003|Washout 1|Withdrawal by Subject|0|||
128831074|NCT04038580|463676405|FG004|Washout 1|Withdrawal by Subject|1|||
128831075|NCT04038580|463676406|FG005|Washout 1|Withdrawal by Subject|0|||
128831076|NCT04038580|463676401|FG000|Wash-out 2|Withdrawal by Subject|1|||
128831077|NCT04038580|463676402|FG001|Wash-out 2|Withdrawal by Subject|0|||
128831078|NCT04038580|463676403|FG002|Wash-out 2|Withdrawal by Subject|0|||
128831079|NCT04038580|463676404|FG003|Wash-out 2|Withdrawal by Subject|2|||
128831080|NCT04038580|463676405|FG004|Wash-out 2|Withdrawal by Subject|0|||
128831081|NCT04038580|463676406|FG005|Wash-out 2|Withdrawal by Subject|1|||
128831082|NCT04038580|463676401|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
128831083|NCT04038580|463676402|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
128831084|NCT04038580|463676403|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
128831085|NCT04038580|463676404|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
128831086|NCT04038580|463676405|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
128831087|NCT04038580|463676406|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
128831088|NCT04038580|463676401|FG000|Wash-out 3|Withdrawal by Subject|1|||
128831089|NCT04038580|463676402|FG001|Wash-out 3|Withdrawal by Subject|0|||
128831090|NCT04038580|463676403|FG002|Wash-out 3|Withdrawal by Subject|2|||
128831091|NCT04038580|463676404|FG003|Wash-out 3|Withdrawal by Subject|0|||
128831092|NCT04038580|463676405|FG004|Wash-out 3|Withdrawal by Subject|0|||
128831093|NCT04038580|463676406|FG005|Wash-out 3|Withdrawal by Subject|0|||
128831094|NCT05810285|463676415|FG000|Overall Study|Death|4|||
128831095|NCT05810285|463676416|FG001|Overall Study|Death|21|||
128831096|NCT05810285|463676415|FG000|Overall Study|Adverse Event|18|||
128831097|NCT05810285|463676416|FG001|Overall Study|Adverse Event|16|||
128831098|NCT04577651|463676417|FG000|Overall Study|Screen Failure|7|||
128831099|NCT04577651|463676417|FG000|Overall Study|Adverse Event|1|||
128831100|NCT04577651|463676417|FG000|Overall Study|Death|1|||
128831101|NCT04577651|463676417|FG000|Overall Study|Physician Decision|1|||
128831102|NCT04577651|463676417|FG000|Overall Study|Withdrawal by Subject|3|||
128831103|NCT02278796|463677362|FG000|Overall Study|Death|2|||
128831104|NCT02278796|463677363|FG001|Overall Study|Death|3|||
128831105|NCT01372085|463677370|FG000|Washout Period 2|Physician Decision|0|||
128831106|NCT01372085|463677371|FG001|Washout Period 2|Physician Decision|0|||
128831107|NCT01372085|463677372|FG002|Washout Period 2|Physician Decision|0|||
128831108|NCT01372085|463677373|FG003|Washout Period 2|Physician Decision|0|||
128831109|NCT01372085|463677374|FG004|Washout Period 2|Physician Decision|1|||
128831110|NCT01372085|463677375|FG005|Washout Period 2|Physician Decision|0|||
128831111|NCT01372085|463677376|FG006|Washout Period 2|Physician Decision|0|||
128831112|NCT01372085|463677377|FG007|Washout Period 2|Physician Decision|0|||
128831113|NCT01372085|463677378|FG008|Washout Period 2|Physician Decision|0|||
128831114|NCT01372085|463677379|FG009|Washout Period 2|Physician Decision|0|||
128831115|NCT01372085|463677370|FG000|Washout Period 3|Withdrawal by Subject|0|||
128831116|NCT01372085|463677371|FG001|Washout Period 3|Withdrawal by Subject|0|||
128831117|NCT01372085|463677372|FG002|Washout Period 3|Withdrawal by Subject|0|||
128831118|NCT01372085|463677373|FG003|Washout Period 3|Withdrawal by Subject|0|||
128831119|NCT01372085|463677374|FG004|Washout Period 3|Withdrawal by Subject|0|||
128831120|NCT01372085|463677375|FG005|Washout Period 3|Withdrawal by Subject|2|||
128831121|NCT01372085|463677376|FG006|Washout Period 3|Withdrawal by Subject|0|||
128831122|NCT01372085|463677377|FG007|Washout Period 3|Withdrawal by Subject|0|||
128831123|NCT01372085|463677378|FG008|Washout Period 3|Withdrawal by Subject|0|||
128831124|NCT01372085|463677379|FG009|Washout Period 3|Withdrawal by Subject|0|||
128831125|NCT02824198|463677380|FG000|Overall Study|Non-compliance with the protocol|5|||
128831126|NCT02824198|463677381|FG001|Overall Study|Non-compliance with the protocol|1|||
128831127|NCT02824198|463677380|FG000|Overall Study|Lost to Follow-up|5|||
128831128|NCT02824198|463677381|FG001|Overall Study|Lost to Follow-up|2|||
128831129|NCT02824198|463677380|FG000|Overall Study|Withdrawal by Subject|5|||
128831130|NCT02824198|463677381|FG001|Overall Study|Withdrawal by Subject|0|||
128831131|NCT01613417|463677384|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
128831132|NCT01613417|463677385|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
128831133|NCT00512252|463677386|FG000|Overall Study|Lost to Follow-up|0|||
128831134|NCT00512252|463677387|FG001|Overall Study|Lost to Follow-up|0|||
128831135|NCT00512252|463677388|FG002|Overall Study|Lost to Follow-up|1|||
128831136|NCT00512252|463677386|FG000|Overall Study|Protocol Violation|0|||
128831137|NCT00512252|463677387|FG001|Overall Study|Protocol Violation|0|||
128831138|NCT00512252|463677388|FG002|Overall Study|Protocol Violation|1|||
128831139|NCT00512252|463677386|FG000|Overall Study|Death|0|||
128831140|NCT00512252|463677387|FG001|Overall Study|Death|0|||
128831141|NCT00512252|463677388|FG002|Overall Study|Death|1|||
128831142|NCT00705406|463677389|FG000|Overall Study|Lost to Follow-up|3|||
128831143|NCT00705406|463677390|FG001|Overall Study|Lost to Follow-up|3|||
128831144|NCT00705406|463677389|FG000|Overall Study|Did not receive study drug|1|||
128831145|NCT00705406|463677390|FG001|Overall Study|Did not receive study drug|2|||
128831146|NCT02357966|463677391|FG000|Overall Study|Death|0|||
128831147|NCT02357966|463677392|FG001|Overall Study|Death|0|||
128831148|NCT02357966|463677393|FG002|Overall Study|Death|1|||
128831149|NCT02357966|463677394|FG003|Overall Study|Death|0|||
128831150|NCT02357966|463677395|FG004|Overall Study|Death|2|||
128831151|NCT02357966|463677396|FG005|Overall Study|Death|0|||
128831152|NCT02357966|463677391|FG000|Overall Study|Physician Decision|1|||
128831153|NCT02357966|463677392|FG001|Overall Study|Physician Decision|0|||
128831154|NCT02357966|463677393|FG002|Overall Study|Physician Decision|0|||
128831155|NCT02357966|463677394|FG003|Overall Study|Physician Decision|0|||
128831156|NCT02357966|463677395|FG004|Overall Study|Physician Decision|1|||
128831157|NCT02357966|463677396|FG005|Overall Study|Physician Decision|0|||
128831158|NCT01079806|463677397|FG000|Day 1 to Week 96|Adverse Event|0|||
128831159|NCT01079806|463677398|FG001|Day 1 to Week 96|Adverse Event|3|||
128831160|NCT01079806|463677397|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
128831161|NCT01079806|463677398|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
128831162|NCT01079806|463677397|FG000|Day 1 to Week 96|Pregnancy|0|||
128831163|NCT01079806|463677398|FG001|Day 1 to Week 96|Pregnancy|1|||
128831164|NCT01079806|463677397|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
128831165|NCT01079806|463677398|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
128831166|NCT01079806|463677397|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
128831167|NCT01079806|463677398|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
128831168|NCT01079806|463677397|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
128831169|NCT01079806|463677398|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
128831170|NCT01079806|463677397|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
128831171|NCT01079806|463677398|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
128831172|NCT01079806|463677397|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
128831173|NCT01079806|463677398|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
128831174|NCT01079806|463677397|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
128831175|NCT01079806|463677398|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
128831176|NCT01079806|463677397|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
128831177|NCT01079806|463677398|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
128831178|NCT03732807|463677399|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
128831179|NCT03732807|463677400|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
128831180|NCT03732807|463677401|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
128831181|NCT03732807|463677402|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
128831182|NCT03732807|463677403|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
128831183|NCT03732807|463677404|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
128831184|NCT03732807|463677405|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
128831185|NCT03732807|463677399|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
128831186|NCT03732807|463677400|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
128831187|NCT03732807|463677401|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
128831188|NCT03732807|463677402|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
128831189|NCT03732807|463677403|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
128831190|NCT03732807|463677404|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
128831191|NCT03732807|463677405|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
128831192|NCT03732807|463677399|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
128831193|NCT03732807|463677400|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
128831194|NCT03732807|463677401|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
128831195|NCT03732807|463677402|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
128831196|NCT03732807|463677403|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
128831197|NCT03732807|463677404|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
128831198|NCT03732807|463677405|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
128831199|NCT03732807|463677399|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
128831200|NCT03732807|463677400|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
128831201|NCT03732807|463677401|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
128831202|NCT03732807|463677402|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
128831203|NCT03732807|463677403|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
128831204|NCT03732807|463677404|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
128831205|NCT03732807|463677405|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
128831206|NCT03732807|463677399|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
128831207|NCT03732807|463677400|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
128831208|NCT03732807|463677401|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
128831209|NCT03732807|463677402|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
128831210|NCT03732807|463677403|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
128831211|NCT03732807|463677404|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
128831212|NCT03732807|463677405|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
128831213|NCT03732807|463677399|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
128831214|NCT03732807|463677400|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
128831215|NCT03732807|463677401|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
128831216|NCT03732807|463677402|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
128831217|NCT03732807|463677403|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
128831218|NCT03732807|463677404|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
128831219|NCT03732807|463677405|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
128831220|NCT03732807|463677399|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
128831221|NCT03732807|463677400|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
128831222|NCT03732807|463677401|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
128831223|NCT03732807|463677402|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
128831224|NCT03732807|463677403|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
128831225|NCT03732807|463677404|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
128831226|NCT03732807|463677405|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
128831227|NCT03732807|463677399|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
128831228|NCT03732807|463677400|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
128831229|NCT03732807|463677401|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
128831230|NCT03732807|463677402|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
128831231|NCT03732807|463677403|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
128831232|NCT03732807|463677404|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
128831233|NCT03732807|463677405|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
128831234|NCT03732807|463677399|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
128831235|NCT03732807|463677400|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
128831236|NCT03732807|463677401|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
128831237|NCT03732807|463677402|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
128831238|NCT03732807|463677403|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
128831239|NCT03732807|463677404|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
128831240|NCT03732807|463677405|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
128831241|NCT03732807|463677399|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
128831242|NCT03732807|463677400|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
128831243|NCT03732807|463677401|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
128831244|NCT03732807|463677402|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
128831245|NCT03732807|463677403|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
128831246|NCT03732807|463677404|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
128831247|NCT03732807|463677405|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
128831248|NCT03732807|463677399|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
128831249|NCT03732807|463677400|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
128831250|NCT03732807|463677401|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
128831251|NCT03732807|463677402|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
128831252|NCT03732807|463677403|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
128831253|NCT03732807|463677404|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
128831254|NCT03732807|463677405|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
128831255|NCT03732807|463677399|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
128831256|NCT03732807|463677400|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
128831257|NCT03732807|463677401|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
128831258|NCT03732807|463677402|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
128831259|NCT03732807|463677403|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
128831260|NCT03732807|463677404|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
128831261|NCT03732807|463677405|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
128831262|NCT03732807|463677399|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
128831263|NCT03732807|463677400|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
128831264|NCT03732807|463677401|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
128831265|NCT03732807|463677402|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
128831266|NCT03732807|463677403|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
128831267|NCT03732807|463677404|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
128831268|NCT03732807|463677405|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
128831269|NCT03732807|463677399|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
128831270|NCT03732807|463677400|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
128831271|NCT03732807|463677401|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
128831272|NCT03732807|463677402|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
128831273|NCT03732807|463677403|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
128831274|NCT03732807|463677404|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
128831275|NCT03732807|463677405|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
128831276|NCT01779700|463677406|FG000|Overall Study|Adverse Event|4|||
128831277|NCT01779700|463677407|FG001|Overall Study|Adverse Event|3|||
128831278|NCT01779700|463677406|FG000|Overall Study|Withdrawal by Subject|0|||
128831279|NCT01779700|463677407|FG001|Overall Study|Withdrawal by Subject|2|||
128831280|NCT00019604|463677408|FG000|Overall Study|Death|1|||
128831281|NCT00019604|463677408|FG000|Overall Study|Progressive disease|23|||
128831282|NCT00019604|463677408|FG000|Overall Study|Refused treatment|1|||
128831283|NCT00019604|463677408|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
128831284|NCT00019604|463677408|FG000|Overall Study|Going to have liver transplant|1|||
128831285|NCT00019604|463677408|FG000|Overall Study|Move to a different study|1|||
128831286|NCT00019604|463677408|FG000|Overall Study|Non compliant on systemic CH|1|||
128831287|NCT00019604|463677408|FG000|Overall Study|Non compliant|1|||
128831288|NCT00019604|463677408|FG000|Overall Study|Resectable disease|1|||
128831289|NCT00019604|463677408|FG000|Overall Study|Started new chemo regimen|1|||
128831290|NCT00019604|463677408|FG000|Overall Study|Pt going to immunotherapy study|1|||
128831291|NCT00019604|463677408|FG000|Overall Study|Too much disease|1|||
128831292|NCT00019604|463677408|FG000|Overall Study|Unable to evaluate|1|||
128831293|NCT00019604|463677408|FG000|Overall Study|Details for other not available|4|||
128831294|NCT04652726|463677409|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
128831295|NCT04652726|463677410|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
128831296|NCT04652726|463677411|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
128831297|NCT04652726|463677409|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
128831298|NCT04652726|463677410|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
128831299|NCT04652726|463677411|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
128831300|NCT00093496|463677412|FG000|Overall Study|Protocol Violation|1|||
128831301|NCT00093496|463677413|FG001|Overall Study|Protocol Violation|3|||
128831302|NCT00683800|463677415|FG000|Overall Study|Adverse Event|195|||
128831303|NCT00683800|463677416|FG001|Overall Study|Adverse Event|102|||
128831304|NCT00683800|463677415|FG000|Overall Study|Death|0|||
128831305|NCT00683800|463677416|FG001|Overall Study|Death|1|||
128831306|NCT00683800|463677415|FG000|Overall Study|Lost to Follow-up|57|||
128831307|NCT00683800|463677416|FG001|Overall Study|Lost to Follow-up|44|||
128831308|NCT00683800|463677415|FG000|Overall Study|Other|5|||
128831309|NCT00683800|463677416|FG001|Overall Study|Other|2|||
128831310|NCT00683800|463677415|FG000|Overall Study|Protocol Violation|13|||
128831311|NCT00683800|463677416|FG001|Overall Study|Protocol Violation|16|||
128831312|NCT00683800|463677415|FG000|Overall Study|Withdrawal by Subject|66|||
128831313|NCT00683800|463677416|FG001|Overall Study|Withdrawal by Subject|64|||
128831314|NCT00683800|463677415|FG000|Overall Study|Lack of Efficacy|61|||
128831315|NCT00683800|463677416|FG001|Overall Study|Lack of Efficacy|104|||
128831316|NCT00683800|463677415|FG000|Overall Study|Randomized, not treated|35|||
128831317|NCT00683800|463677416|FG001|Overall Study|Randomized, not treated|33|||
128831318|NCT00205179|463677417|FG000|Overall Study|Death|0|||
128831319|NCT00205179|463677418|FG001|Overall Study|Death|2|||
128831320|NCT00205179|463677417|FG000|Overall Study|Physician Decision|1|||
128831321|NCT00205179|463677418|FG001|Overall Study|Physician Decision|1|||
128831322|NCT00205179|463677417|FG000|Overall Study|Adverse Event|1|||
128831323|NCT00205179|463677418|FG001|Overall Study|Adverse Event|1|||
128831324|NCT00586313|463677419|FG000|Overall Study|Lack of Efficacy|2|||
128831325|NCT02079649|463677422|FG000|Overall Study|Lost to Follow-up|0|||
128831326|NCT02079649|463677423|FG001|Overall Study|Lost to Follow-up|0|||
128831327|NCT02079649|463677424|FG002|Overall Study|Lost to Follow-up|0|||
128831328|NCT02079649|463677425|FG003|Overall Study|Lost to Follow-up|1|||
128831329|NCT02079649|463677422|FG000|Overall Study|Withdrawal by Subject|0|||
128831330|NCT02079649|463677423|FG001|Overall Study|Withdrawal by Subject|0|||
128831331|NCT02079649|463677424|FG002|Overall Study|Withdrawal by Subject|0|||
128831332|NCT02079649|463677425|FG003|Overall Study|Withdrawal by Subject|1|||
128831333|NCT02079649|463677422|FG000|Overall Study|Randomization error (prior to treatment)|1|||
128831334|NCT02079649|463677423|FG001|Overall Study|Randomization error (prior to treatment)|0|||
128831335|NCT02079649|463677424|FG002|Overall Study|Randomization error (prior to treatment)|1|||
128831336|NCT02079649|463677425|FG003|Overall Study|Randomization error (prior to treatment)|0|||
128831337|NCT02101775|463677426|FG000|Overall Study|Adverse Event|4|||
128831338|NCT02101775|463677427|FG001|Overall Study|Adverse Event|0|||
128831339|NCT02101775|463677428|FG002|Overall Study|Adverse Event|0|||
128831340|NCT02101775|463677426|FG000|Overall Study|Admission to Hospital|0|||
128831341|NCT02101775|463677427|FG001|Overall Study|Admission to Hospital|1|||
128831342|NCT02101775|463677428|FG002|Overall Study|Admission to Hospital|0|||
128831343|NCT04200664|463677431|FG000|Overall Study|Withdrawal by Subject|1|||
128831344|NCT04200664|463677432|FG001|Overall Study|Withdrawal by Subject|0|||
128831345|NCT04200664|463677433|FG002|Overall Study|Withdrawal by Subject|0|||
128831346|NCT03582475|463677439|FG000|Treatment Period|Withdrawal by Subject|0|||
128831347|NCT03582475|463677440|FG001|Treatment Period|Withdrawal by Subject|1|||
128831348|NCT03582475|463677439|FG000|Follow-up Period|Withdrawal by Subject|0|||
128831349|NCT03582475|463677440|FG001|Follow-up Period|Withdrawal by Subject|1|||
128831350|NCT02744066|463677442|FG000|Overall Study|Withdrawal by parent|0|||
128831351|NCT02744066|463677443|FG001|Overall Study|Withdrawal by parent|1|||
128831352|NCT02744066|463677442|FG000|Overall Study|Discharged from NICU prior to completion|0|||
128831353|NCT02744066|463677443|FG001|Overall Study|Discharged from NICU prior to completion|4|||
128831354|NCT05325294|463677448|FG000|Overall Study|Adverse Event|3|||
128831355|NCT05325294|463677449|FG001|Overall Study|Adverse Event|3|||
128831356|NCT05325294|463677448|FG000|Overall Study|Physician Decision|0|||
128831357|NCT05325294|463677449|FG001|Overall Study|Physician Decision|1|||
128831358|NCT05325294|463677448|FG000|Overall Study|Withdrawal by Subject|0|||
128831359|NCT05325294|463677449|FG001|Overall Study|Withdrawal by Subject|3|||
128831360|NCT05325294|463677448|FG000|Overall Study|Lost to Follow-up|1|||
128831361|NCT05325294|463677449|FG001|Overall Study|Lost to Follow-up|0|||
128831362|NCT05325294|463677448|FG000|Overall Study|Sponsor Request|0|||
128831363|NCT05325294|463677449|FG001|Overall Study|Sponsor Request|2|||
128831364|NCT00647387|463677450|FG000|Overall Study|Lost to Follow-up|6|||
128831365|NCT00647387|463677450|FG000|Overall Study|Unsuccessful implant|5|||
128831366|NCT00647387|463677450|FG000|Overall Study|Device explanted|3|||
128831367|NCT00647387|463677450|FG000|Overall Study|Other Reason|3|||
128831368|NCT00647387|463677450|FG000|Overall Study|Death|2|||
128831369|NCT02969356|463677451|FG000|Overall Study|Adverse Event|7|||
128831370|NCT02969356|463677451|FG000|Overall Study|Consent withdrawn|2|||
128831371|NCT02969356|463677451|FG000|Overall Study|Lost to Follow-up|3|||
128831372|NCT02969356|463677451|FG000|Overall Study|Did not need to be reinjected|6|||
128831373|NCT02969356|463677451|FG000|Overall Study|Personal reasons|5|||
128831374|NCT03147287|463677452|FG000|Overall Study|Randomized Not Treated|2|||
128831375|NCT03147287|463677453|FG001|Overall Study|Randomized Not Treated|1|||
128831376|NCT03147287|463677454|FG002|Overall Study|Randomized Not Treated|1|||
128831377|NCT03147287|463677452|FG000|Overall Study|Progressive Disease RECIST|31|||
128831378|NCT03147287|463677453|FG001|Overall Study|Progressive Disease RECIST|72|||
128831379|NCT03147287|463677454|FG002|Overall Study|Progressive Disease RECIST|32|||
128831380|NCT03147287|463677452|FG000|Overall Study|Progressive Disease not RECIST|13|||
128831381|NCT03147287|463677453|FG001|Overall Study|Progressive Disease not RECIST|21|||
128831382|NCT03147287|463677454|FG002|Overall Study|Progressive Disease not RECIST|13|||
128831383|NCT03147287|463677452|FG000|Overall Study|Physician Decision|1|||
128831384|NCT03147287|463677453|FG001|Overall Study|Physician Decision|2|||
128831385|NCT03147287|463677454|FG002|Overall Study|Physician Decision|1|||
128831386|NCT03147287|463677452|FG000|Overall Study|Intercurrent illness|0|||
128831387|NCT03147287|463677453|FG001|Overall Study|Intercurrent illness|1|||
128831388|NCT03147287|463677454|FG002|Overall Study|Intercurrent illness|0|||
128831389|NCT03147287|463677452|FG000|Overall Study|Withdrawal by Subject|2|||
128831390|NCT03147287|463677453|FG001|Overall Study|Withdrawal by Subject|3|||
128831391|NCT03147287|463677454|FG002|Overall Study|Withdrawal by Subject|2|||
128831392|NCT03147287|463677452|FG000|Overall Study|Patient Non-Compliance|0|||
128831393|NCT03147287|463677453|FG001|Overall Study|Patient Non-Compliance|2|||
128831394|NCT03147287|463677454|FG002|Overall Study|Patient Non-Compliance|0|||
128831395|NCT03147287|463677452|FG000|Overall Study|Patient moved|0|||
128831396|NCT03147287|463677453|FG001|Overall Study|Patient moved|1|||
128831397|NCT03147287|463677454|FG002|Overall Study|Patient moved|0|||
128831398|NCT03147287|463677452|FG000|Overall Study|Arm A crossover without PD|1|||
128831399|NCT03147287|463677453|FG001|Overall Study|Arm A crossover without PD|0|||
128831400|NCT03147287|463677454|FG002|Overall Study|Arm A crossover without PD|0|||
128831401|NCT03147287|463677452|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
128831402|NCT03147287|463677453|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
128831403|NCT03147287|463677454|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
128831404|NCT03945773|463678707|FG000|Overall Study|Consent Withdrawn|1|||
128831405|NCT03945773|463678708|FG001|Overall Study|Consent Withdrawn|1|||
128831406|NCT03945773|463678707|FG000|Overall Study|Lost to Follow-up|1|||
128831407|NCT03945773|463678708|FG001|Overall Study|Lost to Follow-up|0|||
128831408|NCT03945773|463678707|FG000|Overall Study|Death|46|||
128831409|NCT03945773|463678708|FG001|Overall Study|Death|22|||
128831410|NCT03945773|463678707|FG000|Overall Study|Physician Decision|1|||
128831411|NCT03945773|463678708|FG001|Overall Study|Physician Decision|0|||
128831412|NCT03945773|463678707|FG000|Overall Study|Other|1|||
128831413|NCT03945773|463678708|FG001|Overall Study|Other|0|||
128831414|NCT03945773|463678707|FG000|Overall Study|Ongoing at the time of DCO|4|||
128831415|NCT03945773|463678708|FG001|Overall Study|Ongoing at the time of DCO|3|||
128831416|NCT01970878|463678710|FG000|Overall Study|Withdrawal by Subject|11|||
128831417|NCT01970878|463678711|FG001|Overall Study|Withdrawal by Subject|10|||
128831418|NCT01970878|463678712|FG002|Overall Study|Withdrawal by Subject|14|||
128831419|NCT01970878|463678713|FG003|Overall Study|Withdrawal by Subject|7|||
128831420|NCT01970878|463678710|FG000|Overall Study|Lost to Follow-up|1|||
128831421|NCT01970878|463678711|FG001|Overall Study|Lost to Follow-up|3|||
128831422|NCT01970878|463678712|FG002|Overall Study|Lost to Follow-up|2|||
128831423|NCT01970878|463678713|FG003|Overall Study|Lost to Follow-up|4|||
128831424|NCT01970878|463678710|FG000|Overall Study|Administrative Reasons|1|||
128831425|NCT01970878|463678711|FG001|Overall Study|Administrative Reasons|0|||
128831426|NCT01970878|463678712|FG002|Overall Study|Administrative Reasons|0|||
128831427|NCT01970878|463678713|FG003|Overall Study|Administrative Reasons|4|||
128831428|NCT01970878|463678710|FG000|Overall Study|Lack of Efficacy|2|||
128831429|NCT01970878|463678711|FG001|Overall Study|Lack of Efficacy|1|||
128831430|NCT01970878|463678712|FG002|Overall Study|Lack of Efficacy|2|||
128831431|NCT01970878|463678713|FG003|Overall Study|Lack of Efficacy|0|||
128831432|NCT01970878|463678710|FG000|Overall Study|Adverse Event|12|||
128831433|NCT01970878|463678711|FG001|Overall Study|Adverse Event|7|||
128831434|NCT01970878|463678712|FG002|Overall Study|Adverse Event|4|||
128831435|NCT01970878|463678713|FG003|Overall Study|Adverse Event|3|||
128831436|NCT01970878|463678710|FG000|Overall Study|Protocol Specified Criteria|10|||
128831437|NCT01970878|463678711|FG001|Overall Study|Protocol Specified Criteria|4|||
128831438|NCT01970878|463678712|FG002|Overall Study|Protocol Specified Criteria|3|||
128831439|NCT01970878|463678713|FG003|Overall Study|Protocol Specified Criteria|6|||
128831440|NCT01970878|463678710|FG000|Overall Study|Physician Decision|0|||
128831441|NCT01970878|463678711|FG001|Overall Study|Physician Decision|1|||
128831442|NCT01970878|463678712|FG002|Overall Study|Physician Decision|1|||
128831443|NCT01970878|463678713|FG003|Overall Study|Physician Decision|0|||
128831444|NCT01970878|463678710|FG000|Overall Study|No Completion Status|0|||
128831445|NCT01970878|463678711|FG001|Overall Study|No Completion Status|1|||
128831446|NCT01970878|463678712|FG002|Overall Study|No Completion Status|0|||
128831447|NCT01970878|463678713|FG003|Overall Study|No Completion Status|0|||
128831448|NCT00089609|463678716|FG000|Overall Study|Withdrawal by Subject|3|||
128831449|NCT00089609|463678717|FG001|Overall Study|Withdrawal by Subject|1|||
128831450|NCT00747006|463678719|FG000|Overall Study|Adverse Event|1|||
128831451|NCT00747006|463678720|FG001|Overall Study|Adverse Event|0|||
128831452|NCT00747006|463678721|FG002|Overall Study|Adverse Event|0|||
128831453|NCT00747006|463678719|FG000|Overall Study|Lost to Follow-up|0|||
128831454|NCT00747006|463678720|FG001|Overall Study|Lost to Follow-up|1|||
128831455|NCT00747006|463678721|FG002|Overall Study|Lost to Follow-up|0|||
128831456|NCT00747006|463678719|FG000|Overall Study|Physician Decision|2|||
128831457|NCT00747006|463678720|FG001|Overall Study|Physician Decision|0|||
128831458|NCT00747006|463678721|FG002|Overall Study|Physician Decision|1|||
128831459|NCT03689946|463678722|FG000|Overall Study|Withdrawal by Subject|3|||
128831460|NCT03689946|463678722|FG000|Overall Study|Lost to Follow-up|3|||
128831461|NCT03689946|463678722|FG000|Overall Study|Data corruption|2|||
128831462|NCT04608409|463678725|FG000|Overall Study|Physician Decision|1|||
128831463|NCT04608409|463678726|FG001|Overall Study|Physician Decision|1|||
128831464|NCT04608409|463678727|FG002|Overall Study|Physician Decision|2|||
128831465|NCT00599196|463678728|FG000|Overall Study|Lack of Efficacy|22|||
128831466|NCT00599196|463678728|FG000|Overall Study|Adverse Event|93|||
128831467|NCT00599196|463678728|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
128831468|NCT00599196|463678728|FG000|Overall Study|Subject withdrew consent|43|||
128831469|NCT00599196|463678728|FG000|Overall Study|Study ended per sponsor|197|||
128831470|NCT00599196|463678728|FG000|Overall Study|Lost to Follow-up|17|||
128831471|NCT00599196|463678728|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
128831472|NCT00599196|463678728|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
128831473|NCT00599196|463678728|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
128831474|NCT00599196|463678728|FG000|Overall Study|Other: Pt Moved To Australia|1|||
128831475|NCT00599196|463678728|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
128831476|NCT00599196|463678728|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
128831477|NCT04497415|463678746|FG000|Overall Study|Lost to Follow-up|43|||
128831478|NCT04497415|463678747|FG001|Overall Study|Lost to Follow-up|27|||
128831479|NCT00734578|463678750|FG000|Overall Study|Adverse Event|4|||
128831480|NCT00734578|463678751|FG001|Overall Study|Adverse Event|6|||
128831481|NCT00734578|463678752|FG002|Overall Study|Adverse Event|1|||
128831482|NCT00734578|463678750|FG000|Overall Study|Protocol Violation|8|||
128831483|NCT00734578|463678751|FG001|Overall Study|Protocol Violation|6|||
128831484|NCT00734578|463678752|FG002|Overall Study|Protocol Violation|3|||
128831485|NCT00734578|463678750|FG000|Overall Study|Withdrawal by Subject|7|||
128831486|NCT00734578|463678751|FG001|Overall Study|Withdrawal by Subject|8|||
128831487|NCT00734578|463678752|FG002|Overall Study|Withdrawal by Subject|11|||
128831488|NCT00734578|463678750|FG000|Overall Study|Lost to Follow-up|9|||
128831489|NCT00734578|463678751|FG001|Overall Study|Lost to Follow-up|3|||
128831490|NCT00734578|463678752|FG002|Overall Study|Lost to Follow-up|5|||
128831491|NCT00734578|463678750|FG000|Overall Study|Lack of Efficacy|3|||
128831492|NCT00734578|463678751|FG001|Overall Study|Lack of Efficacy|2|||
128831493|NCT00734578|463678752|FG002|Overall Study|Lack of Efficacy|5|||
128831494|NCT00734578|463678750|FG000|Overall Study|Randomized in error|1|||
128831495|NCT00734578|463678751|FG001|Overall Study|Randomized in error|0|||
128831496|NCT00734578|463678752|FG002|Overall Study|Randomized in error|0|||
128831497|NCT00734578|463678750|FG000|Overall Study|Exclusion criteria|1|||
128831498|NCT00734578|463678751|FG001|Overall Study|Exclusion criteria|0|||
128831499|NCT00734578|463678752|FG002|Overall Study|Exclusion criteria|0|||
128831500|NCT02085941|463678756|FG000|Overall Study|Lack of Efficacy|1|||
128831501|NCT02085941|463678757|FG001|Overall Study|Lack of Efficacy|0|||
128831502|NCT02085941|463678756|FG000|Overall Study|Death|6|||
128831503|NCT02085941|463678757|FG001|Overall Study|Death|1|||
128831504|NCT02085941|463678756|FG000|Overall Study|Lost to Follow-up|1|||
128831505|NCT02085941|463678757|FG001|Overall Study|Lost to Follow-up|0|||
128831506|NCT02085941|463678756|FG000|Overall Study|Physician Decision|0|||
128831507|NCT02085941|463678757|FG001|Overall Study|Physician Decision|2|||
128831508|NCT03499964|463678758|FG000|Overall Study|Lack of Efficacy|6|||
128831509|NCT03499964|463678759|FG001|Overall Study|Lack of Efficacy|26|||
128831510|NCT03499964|463678758|FG000|Overall Study|Adverse Event|1|||
128831511|NCT03499964|463678759|FG001|Overall Study|Adverse Event|0|||
128831512|NCT03499964|463678758|FG000|Overall Study|Death|1|||
128831513|NCT03499964|463678759|FG001|Overall Study|Death|0|||
128831514|NCT03499964|463678758|FG000|Overall Study|Withdrawal by Subject|2|||
128831515|NCT03499964|463678759|FG001|Overall Study|Withdrawal by Subject|1|||
128831516|NCT03499964|463678758|FG000|Overall Study|Lost to Follow-up|1|||
128831517|NCT03499964|463678759|FG001|Overall Study|Lost to Follow-up|0|||
128831518|NCT02157116|463678765|FG000|Overall Study|Withdrawal by Subject|4|||
128831519|NCT02157116|463678765|FG000|Overall Study|Physician Decision|3|||
128831520|NCT02157116|463678765|FG000|Overall Study|Failed Screening|2|||
128831521|NCT03274076|463678767|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
128831522|NCT03274076|463678768|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
128831523|NCT03274076|463678769|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
128831524|NCT03274076|463678770|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
128831525|NCT03274076|463678767|FG000|24 Weeks Open Label|Adverse Event|0|||
128831526|NCT03274076|463678768|FG001|24 Weeks Open Label|Adverse Event|0|||
128831527|NCT03274076|463678769|FG002|24 Weeks Open Label|Adverse Event|2|||
128831528|NCT03274076|463678770|FG003|24 Weeks Open Label|Adverse Event|0|||
128831529|NCT03274076|463678767|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
128831530|NCT03274076|463678768|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
128831531|NCT03274076|463678769|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
128831532|NCT03274076|463678770|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
128831533|NCT00975585|463678771|FG000|Overall Study|Adverse Event|0|||
128831534|NCT00975585|463678772|FG001|Overall Study|Adverse Event|4|||
128831535|NCT00975585|463678771|FG000|Overall Study|Lost to Follow-up|3|||
128831536|NCT00975585|463678772|FG001|Overall Study|Lost to Follow-up|5|||
128831537|NCT00975585|463678771|FG000|Overall Study|Withdrawal by Subject|2|||
128831538|NCT00975585|463678772|FG001|Overall Study|Withdrawal by Subject|1|||
128831539|NCT00975585|463678771|FG000|Overall Study|Lens issue|2|||
128831540|NCT00975585|463678772|FG001|Overall Study|Lens issue|2|||
128831541|NCT00795184|463678773|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
128831542|NCT00795184|463678774|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
128831543|NCT00853580|463678782|FG000|Overall Study|Lost to Follow-up|3|||
128831544|NCT00853580|463678783|FG001|Overall Study|Lost to Follow-up|5|||
128831545|NCT00853580|463678782|FG000|Overall Study|Protocol Violation|2|||
128831546|NCT00853580|463678783|FG001|Overall Study|Protocol Violation|1|||
128831547|NCT00853580|463678782|FG000|Overall Study|Withdrawal by Subject|2|||
128831548|NCT00853580|463678783|FG001|Overall Study|Withdrawal by Subject|8|||
128831549|NCT00853580|463678782|FG000|Overall Study|Commenced contraindicated therapy|0|||
128831550|NCT00853580|463678783|FG001|Overall Study|Commenced contraindicated therapy|2|||
128831551|NCT01700205|463678784|FG000|Overall Study|Withdrawal by Subject|13|||
128831552|NCT01700205|463678785|FG001|Overall Study|Withdrawal by Subject|13|||
128831553|NCT01700205|463678784|FG000|Overall Study|Protocol Violation|2|||
128831554|NCT01700205|463678785|FG001|Overall Study|Protocol Violation|2|||
128831555|NCT01953692|463678788|FG000|Overall Study|Adverse Event|5|||
128831556|NCT01953692|463678789|FG001|Overall Study|Adverse Event|2|||
128831557|NCT01953692|463678790|FG002|Overall Study|Adverse Event|4|||
128831558|NCT01953692|463678791|FG003|Overall Study|Adverse Event|2|||
128831559|NCT01953692|463678792|FG004|Overall Study|Adverse Event|1|||
128831560|NCT01953692|463678793|FG005|Overall Study|Adverse Event|2|||
128831561|NCT01953692|463678794|FG006|Overall Study|Adverse Event|0|||
128831562|NCT01953692|463678795|FG007|Overall Study|Adverse Event|0|||
128831563|NCT01953692|463678796|FG008|Overall Study|Adverse Event|0|||
128831564|NCT01953692|463678788|FG000|Overall Study|Clinical Progression|0|||
128831565|NCT01953692|463678789|FG001|Overall Study|Clinical Progression|15|||
128831566|NCT01953692|463678790|FG002|Overall Study|Clinical Progression|7|||
128831567|NCT01953692|463678791|FG003|Overall Study|Clinical Progression|5|||
128831568|NCT01953692|463678792|FG004|Overall Study|Clinical Progression|0|||
128831569|NCT01953692|463678793|FG005|Overall Study|Clinical Progression|7|||
128831570|NCT01953692|463678794|FG006|Overall Study|Clinical Progression|20|||
128831571|NCT01953692|463678795|FG007|Overall Study|Clinical Progression|3|||
128831572|NCT01953692|463678796|FG008|Overall Study|Clinical Progression|3|||
128831573|NCT01953692|463678788|FG000|Overall Study|Death|5|||
128831574|NCT01953692|463678789|FG001|Overall Study|Death|0|||
128831575|NCT01953692|463678790|FG002|Overall Study|Death|2|||
128831576|NCT01953692|463678791|FG003|Overall Study|Death|2|||
128831577|NCT01953692|463678792|FG004|Overall Study|Death|1|||
128831578|NCT01953692|463678793|FG005|Overall Study|Death|3|||
128831579|NCT01953692|463678794|FG006|Overall Study|Death|6|||
128831580|NCT01953692|463678795|FG007|Overall Study|Death|2|||
128831581|NCT01953692|463678796|FG008|Overall Study|Death|1|||
128831582|NCT01953692|463678788|FG000|Overall Study|Excluded Medication|1|||
128831583|NCT01953692|463678789|FG001|Overall Study|Excluded Medication|0|||
128831584|NCT01953692|463678790|FG002|Overall Study|Excluded Medication|0|||
128831585|NCT01953692|463678791|FG003|Overall Study|Excluded Medication|0|||
128831586|NCT01953692|463678792|FG004|Overall Study|Excluded Medication|0|||
128831587|NCT01953692|463678793|FG005|Overall Study|Excluded Medication|0|||
128831588|NCT01953692|463678794|FG006|Overall Study|Excluded Medication|0|||
128831589|NCT01953692|463678795|FG007|Overall Study|Excluded Medication|0|||
128831590|NCT01953692|463678796|FG008|Overall Study|Excluded Medication|0|||
128831591|NCT01953692|463678788|FG000|Overall Study|Lost to Follow-up|1|||
128831592|NCT01953692|463678789|FG001|Overall Study|Lost to Follow-up|0|||
128831593|NCT01953692|463678790|FG002|Overall Study|Lost to Follow-up|3|||
128831594|NCT01953692|463678791|FG003|Overall Study|Lost to Follow-up|1|||
128831595|NCT01953692|463678792|FG004|Overall Study|Lost to Follow-up|0|||
128831596|NCT01953692|463678793|FG005|Overall Study|Lost to Follow-up|1|||
128831597|NCT01953692|463678794|FG006|Overall Study|Lost to Follow-up|0|||
128831598|NCT01953692|463678795|FG007|Overall Study|Lost to Follow-up|0|||
128831599|NCT01953692|463678796|FG008|Overall Study|Lost to Follow-up|0|||
128831600|NCT01953692|463678788|FG000|Overall Study|Physician Decision|11|||
128831601|NCT01953692|463678789|FG001|Overall Study|Physician Decision|4|||
128831602|NCT01953692|463678790|FG002|Overall Study|Physician Decision|2|||
128831603|NCT01953692|463678791|FG003|Overall Study|Physician Decision|2|||
128831604|NCT01953692|463678792|FG004|Overall Study|Physician Decision|1|||
128831605|NCT01953692|463678793|FG005|Overall Study|Physician Decision|2|||
128831606|NCT01953692|463678794|FG006|Overall Study|Physician Decision|4|||
128831607|NCT01953692|463678795|FG007|Overall Study|Physician Decision|1|||
128831608|NCT01953692|463678796|FG008|Overall Study|Physician Decision|0|||
128831609|NCT01953692|463678788|FG000|Overall Study|Protocol Violation|0|||
128831610|NCT01953692|463678789|FG001|Overall Study|Protocol Violation|2|||
128831611|NCT01953692|463678790|FG002|Overall Study|Protocol Violation|1|||
128831612|NCT01953692|463678791|FG003|Overall Study|Protocol Violation|0|||
128831613|NCT01953692|463678792|FG004|Overall Study|Protocol Violation|0|||
128831614|NCT01953692|463678793|FG005|Overall Study|Protocol Violation|0|||
128831615|NCT01953692|463678794|FG006|Overall Study|Protocol Violation|0|||
128831616|NCT01953692|463678795|FG007|Overall Study|Protocol Violation|1|||
128831617|NCT01953692|463678796|FG008|Overall Study|Protocol Violation|0|||
128831618|NCT01953692|463678788|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831619|NCT01953692|463678789|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831620|NCT01953692|463678790|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831621|NCT01953692|463678791|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831622|NCT01953692|463678792|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831623|NCT01953692|463678793|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831624|NCT01953692|463678794|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831625|NCT01953692|463678795|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
128831626|NCT01953692|463678796|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
128831627|NCT01953692|463678788|FG000|Overall Study|Withdrawal by Subject|4|||
128831628|NCT01953692|463678789|FG001|Overall Study|Withdrawal by Subject|2|||
128831629|NCT01953692|463678790|FG002|Overall Study|Withdrawal by Subject|1|||
128831630|NCT01953692|463678791|FG003|Overall Study|Withdrawal by Subject|2|||
128831631|NCT01953692|463678792|FG004|Overall Study|Withdrawal by Subject|0|||
128831632|NCT01953692|463678793|FG005|Overall Study|Withdrawal by Subject|3|||
128831633|NCT01953692|463678794|FG006|Overall Study|Withdrawal by Subject|2|||
128831634|NCT01953692|463678795|FG007|Overall Study|Withdrawal by Subject|1|||
128831635|NCT01953692|463678796|FG008|Overall Study|Withdrawal by Subject|1|||
128831636|NCT00983294|463678803|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
128831637|NCT00983294|463678803|FG000|Colchicine With Azithromycin|Adverse Event|1|||
128831638|NCT00853593|463678804|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
128831639|NCT00853593|463678804|FG000|Overall Study|Model 4396 lead not attempted|29|||
128831640|NCT00853593|463678804|FG000|Overall Study|Implant not attempted|4|||
128831641|NCT00600353|463678810|FG000|Overall Study|history of malignancy within 5 years|1|||
128831642|NCT00600353|463678811|FG001|Overall Study|history of malignancy within 5 years|0|||
128831643|NCT00600353|463678810|FG000|Overall Study|History of prepartive regimen|0|||
128831644|NCT00600353|463678811|FG001|Overall Study|History of prepartive regimen|1|||
128831645|NCT05966155|463678813|FG000|Overall Study|Death|1|||
128831646|NCT05966155|463678814|FG001|Overall Study|Death|2|||
128831647|NCT05966155|463678813|FG000|Overall Study|Lost to Follow-up|63|||
128831648|NCT05966155|463678814|FG001|Overall Study|Lost to Follow-up|67|||
128831649|NCT05966155|463678813|FG000|Overall Study|Protocol Violation|1|||
128831650|NCT05966155|463678814|FG001|Overall Study|Protocol Violation|0|||
128831651|NCT05966155|463678813|FG000|Overall Study|Withdrawal by Subject|8|||
128831652|NCT05966155|463678814|FG001|Overall Study|Withdrawal by Subject|9|||
128831653|NCT05966155|463678813|FG000|Overall Study|Enrolled Erroneously|0|||
128831654|NCT05966155|463678814|FG001|Overall Study|Enrolled Erroneously|1|||
128831655|NCT05966155|463678813|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
128831656|NCT05966155|463678814|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
128831657|NCT02743819|463678815|FG000|Overall Study|Lack of Efficacy|5|||
128831658|NCT02743819|463678815|FG000|Overall Study|Death|2|||
128831659|NCT02743819|463678815|FG000|Overall Study|Adverse Event|1|||
128831660|NCT01706159|463678821|FG000|Overall Study|Withdrawal Criteria|2|||
128831661|NCT01706159|463678822|FG001|Overall Study|Withdrawal Criteria|1|||
128831662|NCT01706159|463678821|FG000|Overall Study|Unclassified|6|||
128831663|NCT01706159|463678822|FG001|Overall Study|Unclassified|1|||
128831664|NCT00553332|463678827|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
128831665|NCT03775486|463678828|FG000|Initial Therapy Phase|Other reason provided|0|||
128831666|NCT03775486|463678829|FG001|Initial Therapy Phase|Other reason provided|15|||
128831667|NCT03775486|463678828|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
128831668|NCT03775486|463678829|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
128831669|NCT03775486|463678828|FG000|Initial Therapy Phase|Protocol Violation|0|||
128831670|NCT03775486|463678829|FG001|Initial Therapy Phase|Protocol Violation|2|||
128831671|NCT03775486|463678828|FG000|Initial Therapy Phase|Adverse Event|0|||
128831672|NCT03775486|463678829|FG001|Initial Therapy Phase|Adverse Event|34|||
128831673|NCT03775486|463678828|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
128831674|NCT03775486|463678829|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
128831675|NCT03775486|463678828|FG000|Maintenance Phase|Withdrawal by Subject|13|||
128831676|NCT03775486|463678829|FG001|Maintenance Phase|Withdrawal by Subject|12|||
128831677|NCT03775486|463678828|FG000|Maintenance Phase|Death|44|||
128831678|NCT03775486|463678829|FG001|Maintenance Phase|Death|45|||
128831679|NCT02235298|463678831|FG000|Overall Study|Lost to Follow-up|6|||
128831680|NCT02235298|463678832|FG001|Overall Study|Lost to Follow-up|5|||
128831681|NCT02235298|463678831|FG000|Overall Study|Adverse Event|2|||
128831682|NCT02235298|463678832|FG001|Overall Study|Adverse Event|2|||
128831683|NCT02235298|463678831|FG000|Overall Study|Withdrawal by Subject|0|||
128831684|NCT02235298|463678832|FG001|Overall Study|Withdrawal by Subject|1|||
128831685|NCT01827839|463678836|FG000|Overall Study|Adverse Event|1|||
128831686|NCT01827839|463678836|FG000|Overall Study|Consent Withdrawal|2|||
128831687|NCT00491894|463678843|FG000|Overall Study|Adverse Event|14|||
128831688|NCT00491894|463678843|FG000|Overall Study|Withdrawal by Subject|5|||
128831689|NCT00491894|463678843|FG000|Overall Study|Death|3|||
128831690|NCT00491894|463678843|FG000|Overall Study|Lost to Follow-up|3|||
128831691|NCT00491894|463678843|FG000|Overall Study|Lack of Efficacy|2|||
128831692|NCT00491894|463678843|FG000|Overall Study|Other-Failed to meet any criteria|2|||
128831693|NCT00491894|463678843|FG000|Overall Study|Physician Decision|2|||
128831694|NCT00491894|463678843|FG000|Overall Study|Protocol Violation|2|||
128831695|NCT00491894|463678843|FG000|Overall Study|Other-Intake of prohibited medication|1|||
128831696|NCT04172675|463680530|FG000|Overall Study|Withdrawal by Subject|7|||
128831697|NCT04172675|463680531|FG001|Overall Study|Withdrawal by Subject|5|||
128831698|NCT04172675|463680532|FG002|Overall Study|Withdrawal by Subject|1|||
128831699|NCT04172675|463680533|FG003|Overall Study|Withdrawal by Subject|4|||
128831700|NCT05349721|463680534|FG000|Part A (24 Weeks)|Adverse Event|9|||
128831701|NCT05349721|463680535|FG001|Part A (24 Weeks)|Adverse Event|2|||
128831702|NCT05349721|463680534|FG000|Part A (24 Weeks)|Death|8|||
128831703|NCT05349721|463680535|FG001|Part A (24 Weeks)|Death|3|||
128831704|NCT05349721|463680534|FG000|Part A (24 Weeks)|Disease Progression|1|||
128831705|NCT05349721|463680535|FG001|Part A (24 Weeks)|Disease Progression|1|||
128831706|NCT05349721|463680534|FG000|Part A (24 Weeks)|Screen Failure|2|||
128831707|NCT05349721|463680535|FG001|Part A (24 Weeks)|Screen Failure|0|||
128831708|NCT05349721|463680534|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
128831709|NCT05349721|463680535|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
128831710|NCT05349721|463680534|FG000|Part A (24 Weeks)|Other Than Specified|5|||
128831711|NCT05349721|463680535|FG001|Part A (24 Weeks)|Other Than Specified|1|||
128831712|NCT05349721|463680534|FG000|Part B (28 Weeks)|Adverse Event|3|||
128831713|NCT05349721|463680535|FG001|Part B (28 Weeks)|Adverse Event|0|||
128831714|NCT05349721|463680534|FG000|Part B (28 Weeks)|Death|21|||
128831715|NCT05349721|463680535|FG001|Part B (28 Weeks)|Death|11|||
128831716|NCT05349721|463680534|FG000|Part B (28 Weeks)|Disease Progression|2|||
128831717|NCT05349721|463680535|FG001|Part B (28 Weeks)|Disease Progression|1|||
128831718|NCT05349721|463680534|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
128831719|NCT05349721|463680535|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
128831720|NCT05349721|463680534|FG000|Part B (28 Weeks)|Physician Decision|1|||
128831721|NCT05349721|463680535|FG001|Part B (28 Weeks)|Physician Decision|0|||
128831722|NCT05349721|463680534|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
128831723|NCT05349721|463680535|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
128831724|NCT05349721|463680534|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
128831725|NCT05349721|463680535|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
128831726|NCT05349721|463680534|FG000|Part B (28 Weeks)|Other Than Specified|4|||
128831727|NCT05349721|463680535|FG001|Part B (28 Weeks)|Other Than Specified|2|||
128831728|NCT05349721|463680534|FG000|Part C (108 Weeks)|Death|0|||
128831729|NCT05349721|463680535|FG001|Part C (108 Weeks)|Death|1|||
128831730|NCT05349721|463680534|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
128831731|NCT05349721|463680535|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
128831732|NCT05349721|463680534|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
128831733|NCT05349721|463680535|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
128831734|NCT05349721|463680534|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
128831735|NCT05349721|463680535|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
128831736|NCT03070392|463680536|FG000|Overall Study|Not Treated|7|||
128831737|NCT03070392|463680537|FG001|Overall Study|Not Treated|0|||
128831738|NCT03070392|463680538|FG002|Overall Study|Not Treated|3|||
128831739|NCT03070392|463680539|FG003|Overall Study|Not Treated|12|||
128831740|NCT03070392|463680536|FG000|Overall Study|Death|3|||
128831741|NCT03070392|463680537|FG001|Overall Study|Death|0|||
128831742|NCT03070392|463680538|FG002|Overall Study|Death|0|||
128831743|NCT03070392|463680539|FG003|Overall Study|Death|1|||
128831744|NCT03070392|463680536|FG000|Overall Study|Withdrawal by Subject|7|||
128831745|NCT03070392|463680537|FG001|Overall Study|Withdrawal by Subject|0|||
128831746|NCT03070392|463680538|FG002|Overall Study|Withdrawal by Subject|0|||
128831747|NCT03070392|463680539|FG003|Overall Study|Withdrawal by Subject|3|||
128831748|NCT03070392|463680536|FG000|Overall Study|Physician Decision|1|||
128831749|NCT03070392|463680537|FG001|Overall Study|Physician Decision|0|||
128831750|NCT03070392|463680538|FG002|Overall Study|Physician Decision|0|||
128831751|NCT03070392|463680539|FG003|Overall Study|Physician Decision|2|||
128831752|NCT03070392|463680536|FG000|Overall Study|Progressive Disease|154|||
128831753|NCT03070392|463680537|FG001|Overall Study|Progressive Disease|6|||
128831754|NCT03070392|463680538|FG002|Overall Study|Progressive Disease|2|||
128831755|NCT03070392|463680539|FG003|Overall Study|Progressive Disease|70|||
128831756|NCT03070392|463680536|FG000|Overall Study|Adverse Event|6|||
128831757|NCT03070392|463680537|FG001|Overall Study|Adverse Event|1|||
128831758|NCT03070392|463680538|FG002|Overall Study|Adverse Event|1|||
128831759|NCT03070392|463680539|FG003|Overall Study|Adverse Event|3|||
128831760|NCT03070392|463680536|FG000|Overall Study|Alternate anticancer treatment|1|||
128831761|NCT03070392|463680537|FG001|Overall Study|Alternate anticancer treatment|0|||
128831762|NCT03070392|463680538|FG002|Overall Study|Alternate anticancer treatment|0|||
128831763|NCT03070392|463680539|FG003|Overall Study|Alternate anticancer treatment|1|||
128831764|NCT03070392|463680536|FG000|Overall Study|Ongoing|73|||
128831765|NCT03070392|463680537|FG001|Overall Study|Ongoing|0|||
128831766|NCT03070392|463680538|FG002|Overall Study|Ongoing|0|||
128831767|NCT03070392|463680539|FG003|Overall Study|Ongoing|11|||
128831768|NCT02972034|463680540|FG000|Overall Study|Death|11|||
128831769|NCT02972034|463680541|FG001|Overall Study|Death|1|||
128831770|NCT02972034|463680542|FG002|Overall Study|Death|3|||
128831771|NCT02972034|463680543|FG003|Overall Study|Death|3|||
128831772|NCT02972034|463680544|FG004|Overall Study|Death|2|||
128831773|NCT02972034|463680545|FG005|Overall Study|Death|2|||
128831774|NCT02972034|463680546|FG006|Overall Study|Death|3|||
128831775|NCT02972034|463680547|FG007|Overall Study|Death|4|||
128831776|NCT02972034|463680548|FG008|Overall Study|Death|8|||
128831777|NCT02972034|463680549|FG009|Overall Study|Death|11|||
128831778|NCT02972034|463680550|FG010|Overall Study|Death|3|||
128831779|NCT02972034|463680551|FG011|Overall Study|Death|2|||
128831780|NCT02972034|463680552|FG012|Overall Study|Death|11|||
128831781|NCT02972034|463680553|FG013|Overall Study|Death|10|||
128831782|NCT02972034|463680554|FG014|Overall Study|Death|9|||
128831783|NCT02972034|463680540|FG000|Overall Study|Lost to Follow-up|0|||
128831784|NCT02972034|463680541|FG001|Overall Study|Lost to Follow-up|0|||
128831785|NCT02972034|463680542|FG002|Overall Study|Lost to Follow-up|0|||
128831786|NCT02972034|463680543|FG003|Overall Study|Lost to Follow-up|0|||
128831787|NCT02972034|463680544|FG004|Overall Study|Lost to Follow-up|1|||
128831788|NCT02972034|463680545|FG005|Overall Study|Lost to Follow-up|0|||
128831789|NCT02972034|463680546|FG006|Overall Study|Lost to Follow-up|0|||
128831790|NCT02972034|463680547|FG007|Overall Study|Lost to Follow-up|1|||
128831791|NCT02972034|463680548|FG008|Overall Study|Lost to Follow-up|0|||
128831792|NCT02972034|463680549|FG009|Overall Study|Lost to Follow-up|0|||
128831793|NCT02972034|463680550|FG010|Overall Study|Lost to Follow-up|0|||
128831794|NCT02972034|463680551|FG011|Overall Study|Lost to Follow-up|0|||
128831795|NCT02972034|463680552|FG012|Overall Study|Lost to Follow-up|0|||
128831796|NCT02972034|463680553|FG013|Overall Study|Lost to Follow-up|0|||
128831797|NCT02972034|463680554|FG014|Overall Study|Lost to Follow-up|1|||
128831798|NCT02972034|463680540|FG000|Overall Study|Physician Decision|0|||
128831799|NCT02972034|463680541|FG001|Overall Study|Physician Decision|0|||
128831800|NCT02972034|463680542|FG002|Overall Study|Physician Decision|0|||
128831801|NCT02972034|463680543|FG003|Overall Study|Physician Decision|0|||
128831802|NCT02972034|463680544|FG004|Overall Study|Physician Decision|0|||
128831803|NCT02972034|463680545|FG005|Overall Study|Physician Decision|0|||
128831804|NCT02972034|463680546|FG006|Overall Study|Physician Decision|0|||
128831805|NCT02972034|463680547|FG007|Overall Study|Physician Decision|1|||
128831806|NCT02972034|463680548|FG008|Overall Study|Physician Decision|0|||
128831807|NCT02972034|463680549|FG009|Overall Study|Physician Decision|0|||
128831808|NCT02972034|463680550|FG010|Overall Study|Physician Decision|1|||
128831809|NCT02972034|463680551|FG011|Overall Study|Physician Decision|0|||
128831810|NCT02972034|463680552|FG012|Overall Study|Physician Decision|0|||
128831811|NCT02972034|463680553|FG013|Overall Study|Physician Decision|0|||
128831812|NCT02972034|463680554|FG014|Overall Study|Physician Decision|0|||
128831813|NCT02972034|463680540|FG000|Overall Study|Sponsor Decision|0|||
128831814|NCT02972034|463680541|FG001|Overall Study|Sponsor Decision|0|||
128831815|NCT02972034|463680542|FG002|Overall Study|Sponsor Decision|0|||
128831816|NCT02972034|463680543|FG003|Overall Study|Sponsor Decision|1|||
128831817|NCT02972034|463680544|FG004|Overall Study|Sponsor Decision|0|||
128831818|NCT02972034|463680545|FG005|Overall Study|Sponsor Decision|0|||
128831819|NCT02972034|463680546|FG006|Overall Study|Sponsor Decision|1|||
128831820|NCT02972034|463680547|FG007|Overall Study|Sponsor Decision|1|||
128831821|NCT02972034|463680548|FG008|Overall Study|Sponsor Decision|1|||
128831822|NCT02972034|463680549|FG009|Overall Study|Sponsor Decision|2|||
128831823|NCT02972034|463680550|FG010|Overall Study|Sponsor Decision|2|||
128831824|NCT02972034|463680551|FG011|Overall Study|Sponsor Decision|0|||
128831825|NCT02972034|463680552|FG012|Overall Study|Sponsor Decision|1|||
128831826|NCT02972034|463680553|FG013|Overall Study|Sponsor Decision|0|||
128831827|NCT02972034|463680554|FG014|Overall Study|Sponsor Decision|1|||
128831828|NCT02972034|463680540|FG000|Overall Study|Withdrawal by Subject|3|||
128831829|NCT02972034|463680541|FG001|Overall Study|Withdrawal by Subject|0|||
128831830|NCT02972034|463680542|FG002|Overall Study|Withdrawal by Subject|0|||
128831831|NCT02972034|463680543|FG003|Overall Study|Withdrawal by Subject|0|||
128831832|NCT02972034|463680544|FG004|Overall Study|Withdrawal by Subject|1|||
128831833|NCT02972034|463680545|FG005|Overall Study|Withdrawal by Subject|1|||
128831834|NCT02972034|463680546|FG006|Overall Study|Withdrawal by Subject|0|||
128831835|NCT02972034|463680547|FG007|Overall Study|Withdrawal by Subject|0|||
128831836|NCT02972034|463680548|FG008|Overall Study|Withdrawal by Subject|1|||
128831837|NCT02972034|463680549|FG009|Overall Study|Withdrawal by Subject|1|||
128831838|NCT02972034|463680550|FG010|Overall Study|Withdrawal by Subject|2|||
128831839|NCT02972034|463680551|FG011|Overall Study|Withdrawal by Subject|1|||
128831840|NCT02972034|463680552|FG012|Overall Study|Withdrawal by Subject|1|||
128831841|NCT02972034|463680553|FG013|Overall Study|Withdrawal by Subject|1|||
128831842|NCT02972034|463680554|FG014|Overall Study|Withdrawal by Subject|0|||
128831843|NCT02972034|463680540|FG000|Overall Study|Screen Failure|0|||
128831844|NCT02972034|463680541|FG001|Overall Study|Screen Failure|0|||
128831845|NCT02972034|463680542|FG002|Overall Study|Screen Failure|0|||
128831846|NCT02972034|463680543|FG003|Overall Study|Screen Failure|0|||
128831847|NCT02972034|463680544|FG004|Overall Study|Screen Failure|0|||
128831848|NCT02972034|463680545|FG005|Overall Study|Screen Failure|0|||
128831849|NCT02972034|463680546|FG006|Overall Study|Screen Failure|0|||
128831850|NCT02972034|463680547|FG007|Overall Study|Screen Failure|0|||
128831851|NCT02972034|463680548|FG008|Overall Study|Screen Failure|0|||
128831852|NCT02972034|463680549|FG009|Overall Study|Screen Failure|0|||
128831853|NCT02972034|463680550|FG010|Overall Study|Screen Failure|0|||
128831854|NCT02972034|463680551|FG011|Overall Study|Screen Failure|0|||
128831855|NCT02972034|463680552|FG012|Overall Study|Screen Failure|1|||
128831856|NCT02972034|463680553|FG013|Overall Study|Screen Failure|0|||
128831857|NCT02972034|463680554|FG014|Overall Study|Screen Failure|0|||
128831858|NCT03861052|463680555|FG000|Overall Study|Adverse Event|1|||
128831859|NCT03861052|463680556|FG001|Overall Study|Adverse Event|1|||
128831860|NCT03861052|463680557|FG002|Overall Study|Adverse Event|2|||
128831861|NCT03861052|463680558|FG003|Overall Study|Adverse Event|4|||
128831862|NCT03861052|463680555|FG000|Overall Study|Lost to Follow-up|0|||
128831863|NCT03861052|463680556|FG001|Overall Study|Lost to Follow-up|0|||
128831864|NCT03861052|463680557|FG002|Overall Study|Lost to Follow-up|0|||
128831865|NCT03861052|463680558|FG003|Overall Study|Lost to Follow-up|1|||
128831866|NCT03861052|463680555|FG000|Overall Study|Physician Decision|0|||
128831867|NCT03861052|463680556|FG001|Overall Study|Physician Decision|1|||
128831868|NCT03861052|463680557|FG002|Overall Study|Physician Decision|0|||
128831869|NCT03861052|463680558|FG003|Overall Study|Physician Decision|0|||
128831870|NCT03861052|463680555|FG000|Overall Study|Withdrawal by Subject|2|||
128831871|NCT03861052|463680556|FG001|Overall Study|Withdrawal by Subject|5|||
128831872|NCT03861052|463680557|FG002|Overall Study|Withdrawal by Subject|3|||
128831873|NCT03861052|463680558|FG003|Overall Study|Withdrawal by Subject|0|||
128831874|NCT03861052|463680555|FG000|Overall Study|Relocation to other city|1|||
128831875|NCT03861052|463680556|FG001|Overall Study|Relocation to other city|0|||
128831876|NCT03861052|463680557|FG002|Overall Study|Relocation to other city|0|||
128831877|NCT03861052|463680558|FG003|Overall Study|Relocation to other city|0|||
128831878|NCT00378898|463680559|FG000|Overall Study|Withdrawal by Subject|10|||
128831879|NCT00378898|463680560|FG001|Overall Study|Withdrawal by Subject|5|||
128831880|NCT00378898|463680559|FG000|Overall Study|Protocol Violation|1|||
128831881|NCT00378898|463680560|FG001|Overall Study|Protocol Violation|1|||
128831882|NCT02534233|463680561|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
128831883|NCT03136159|463680562|FG000|Overall Study|chorioamnionitis|2|||
128831884|NCT03136159|463680563|FG001|Overall Study|chorioamnionitis|0|||
128831885|NCT03136159|463680562|FG000|Overall Study|vertical skin incision|1|||
128831886|NCT03136159|463680563|FG001|Overall Study|vertical skin incision|0|||
128831887|NCT03136159|463680562|FG000|Overall Study|additional dressing|1|||
128831888|NCT03136159|463680563|FG001|Overall Study|additional dressing|0|||
128831889|NCT03136159|463680562|FG000|Overall Study|never got dressing placed|1|||
128831890|NCT03136159|463680563|FG001|Overall Study|never got dressing placed|0|||
128831891|NCT03823703|463680564|FG000|Overall Study|Sponsor request|0|||
128831892|NCT03823703|463680565|FG001|Overall Study|Sponsor request|3|||
128831893|NCT03823703|463680566|FG002|Overall Study|Sponsor request|4|||
128831894|NCT03823703|463680564|FG000|Overall Study|Adverse Event|3|||
128831895|NCT03823703|463680565|FG001|Overall Study|Adverse Event|1|||
128831896|NCT03823703|463680566|FG002|Overall Study|Adverse Event|0|||
128831897|NCT03823703|463680564|FG000|Overall Study|Withdrawal by Subject|0|||
128831898|NCT03823703|463680565|FG001|Overall Study|Withdrawal by Subject|1|||
128831899|NCT03823703|463680566|FG002|Overall Study|Withdrawal by Subject|0|||
128831900|NCT00925548|463680567|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
128831901|NCT00925548|463680568|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
128831902|NCT04921358|463680569|FG000|Overall Study|Withdrawal by Subject|6|||
128831903|NCT04921358|463680570|FG001|Overall Study|Withdrawal by Subject|13|||
128831904|NCT04921358|463680569|FG000|Overall Study|Lost to Follow-up|3|||
128831905|NCT04921358|463680570|FG001|Overall Study|Lost to Follow-up|6|||
128831906|NCT04921358|463680569|FG000|Overall Study|Study Terminated by Sponsor|86|||
128831907|NCT04921358|463680570|FG001|Overall Study|Study Terminated by Sponsor|89|||
128831908|NCT04921358|463680569|FG000|Overall Study|Death|92|||
128831909|NCT04921358|463680570|FG001|Overall Study|Death|82|||
128831910|NCT04926857|463680571|FG000|Overall Study|Withdrawal by Subject|40|||
128831911|NCT04926857|463680571|FG000|Overall Study|Death|9|||
128831912|NCT04926857|463680571|FG000|Overall Study|Study product no longer in use|44|||
128831913|NCT04926857|463680571|FG000|Overall Study|Inadequate data to address primary objective|16|||
128831914|NCT02372799|463680576|FG000|Treatment Period|Adverse Event|3|||
128831915|NCT02372799|463680577|FG001|Treatment Period|Adverse Event|10|||
128831916|NCT02372799|463680578|FG002|Treatment Period|Adverse Event|6|||
128831917|NCT02372799|463680576|FG000|Treatment Period|Insufficient therapeutic response|2|||
128831918|NCT02372799|463680577|FG001|Treatment Period|Insufficient therapeutic response|2|||
128831919|NCT02372799|463680578|FG002|Treatment Period|Insufficient therapeutic response|0|||
128831920|NCT02372799|463680576|FG000|Treatment Period|Withdrawal by Subject|10|||
128831921|NCT02372799|463680577|FG001|Treatment Period|Withdrawal by Subject|10|||
128831922|NCT02372799|463680578|FG002|Treatment Period|Withdrawal by Subject|2|||
128831923|NCT02372799|463680576|FG000|Treatment Period|Lost to Follow-up|11|||
128831924|NCT02372799|463680577|FG001|Treatment Period|Lost to Follow-up|5|||
128831925|NCT02372799|463680578|FG002|Treatment Period|Lost to Follow-up|3|||
128831926|NCT02372799|463680576|FG000|Treatment Period|Protocol Violation|3|||
128831927|NCT02372799|463680577|FG001|Treatment Period|Protocol Violation|0|||
128831928|NCT02372799|463680578|FG002|Treatment Period|Protocol Violation|0|||
128831929|NCT02372799|463680576|FG000|Treatment Period|Non-compliance with study drug|4|||
128831930|NCT02372799|463680577|FG001|Treatment Period|Non-compliance with study drug|4|||
128831931|NCT02372799|463680578|FG002|Treatment Period|Non-compliance with study drug|4|||
128831932|NCT02372799|463680576|FG000|Treatment Period|Miscellaneous Reasons|1|||
128831933|NCT02372799|463680577|FG001|Treatment Period|Miscellaneous Reasons|1|||
128831934|NCT02372799|463680578|FG002|Treatment Period|Miscellaneous Reasons|0|||
128831935|NCT02372799|463680576|FG000|Down-taper Period|Lost to Follow-up|1|||
128831936|NCT02372799|463680577|FG001|Down-taper Period|Lost to Follow-up|2|||
128831937|NCT02372799|463680578|FG002|Down-taper Period|Lost to Follow-up|2|||
128831938|NCT04693637|463680579|FG000|Overall Study|Death|4|||
128831939|NCT04693637|463680579|FG000|Overall Study|Withdrawal by Subject|3|||
128831940|NCT04693637|463680579|FG000|Overall Study|Physician Decision|2|||
128831941|NCT04693637|463680579|FG000|Overall Study|Lost to Follow-up|1|||
128831942|NCT01728324|463680601|FG000|Termination of DBV|Adverse Event|14|||
128831943|NCT01728324|463680602|FG001|Termination of DBV|Adverse Event|13|||
128831944|NCT01728324|463680603|FG002|Termination of DBV|Adverse Event|4|||
128831945|NCT01728324|463680601|FG000|Termination of DBV|Lack of Efficacy|14|||
128831946|NCT01728324|463680602|FG001|Termination of DBV|Lack of Efficacy|12|||
128831947|NCT01728324|463680603|FG002|Termination of DBV|Lack of Efficacy|8|||
128831948|NCT01728324|463680601|FG000|Termination of DBV|Withdrawal by Subject|9|||
128831949|NCT01728324|463680602|FG001|Termination of DBV|Withdrawal by Subject|6|||
128831950|NCT01728324|463680603|FG002|Termination of DBV|Withdrawal by Subject|2|||
128831951|NCT01728324|463680601|FG000|Termination of DBV|Other than stated|1|||
128831952|NCT01728324|463680602|FG001|Termination of DBV|Other than stated|3|||
128831953|NCT01728324|463680603|FG002|Termination of DBV|Other than stated|0|||
128831954|NCT01728324|463680601|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
128831955|NCT01728324|463680602|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
128831956|NCT01728324|463680603|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
128831957|NCT01728324|463680601|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
128831958|NCT01728324|463680602|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
128831959|NCT01728324|463680603|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
128831960|NCT01728324|463680601|FG000|Termination of FDV|Adverse Event|14|||
128831961|NCT01728324|463680602|FG001|Termination of FDV|Adverse Event|13|||
128831962|NCT01728324|463680603|FG002|Termination of FDV|Adverse Event|4|||
128831963|NCT01728324|463680601|FG000|Termination of FDV|Lack of Efficacy|14|||
128831964|NCT01728324|463680602|FG001|Termination of FDV|Lack of Efficacy|12|||
128831965|NCT01728324|463680603|FG002|Termination of FDV|Lack of Efficacy|8|||
128831966|NCT01728324|463680601|FG000|Termination of FDV|Withdrawal by Subject|9|||
128831967|NCT01728324|463680602|FG001|Termination of FDV|Withdrawal by Subject|6|||
128831968|NCT01728324|463680603|FG002|Termination of FDV|Withdrawal by Subject|2|||
128831969|NCT01728324|463680601|FG000|Termination of FDV|Other than stated|1|||
128831970|NCT01728324|463680602|FG001|Termination of FDV|Other than stated|3|||
128831971|NCT01728324|463680603|FG002|Termination of FDV|Other than stated|0|||
128831972|NCT01728324|463680601|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
128831973|NCT01728324|463680602|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
128831974|NCT01728324|463680603|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
128831975|NCT01728324|463680601|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
128831976|NCT01728324|463680602|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
128831977|NCT01728324|463680603|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
128831978|NCT01728324|463680601|FG000|Termination of RBV|Adverse Event|15|||
128831979|NCT01728324|463680602|FG001|Termination of RBV|Adverse Event|16|||
128831980|NCT01728324|463680603|FG002|Termination of RBV|Adverse Event|5|||
128831981|NCT01728324|463680601|FG000|Termination of RBV|Lack of Efficacy|14|||
128831982|NCT01728324|463680602|FG001|Termination of RBV|Lack of Efficacy|11|||
128831983|NCT01728324|463680603|FG002|Termination of RBV|Lack of Efficacy|7|||
128831984|NCT01728324|463680601|FG000|Termination of RBV|Withdrawal by Subject|9|||
128831985|NCT01728324|463680602|FG001|Termination of RBV|Withdrawal by Subject|5|||
128831986|NCT01728324|463680603|FG002|Termination of RBV|Withdrawal by Subject|2|||
128831987|NCT01728324|463680601|FG000|Termination of RBV|Other than stated|1|||
128831988|NCT01728324|463680602|FG001|Termination of RBV|Other than stated|3|||
128831989|NCT01728324|463680603|FG002|Termination of RBV|Other than stated|1|||
128831990|NCT01728324|463680601|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
128831991|NCT01728324|463680602|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
128831992|NCT01728324|463680603|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
128831993|NCT01728324|463680601|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
128831994|NCT01728324|463680602|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
128831995|NCT01728324|463680603|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
128831996|NCT03057600|463680604|FG000|Overall Study|Adverse Event|0|||
128831997|NCT03057600|463680605|FG001|Overall Study|Adverse Event|0|||
128831998|NCT03057600|463680606|FG002|Overall Study|Adverse Event|4|||
128831999|NCT03057600|463680607|FG003|Overall Study|Adverse Event|0|||
128832000|NCT03057600|463680604|FG000|Overall Study|Radiologic Disease Progression|8|||
128832001|NCT03057600|463680605|FG001|Overall Study|Radiologic Disease Progression|7|||
128832002|NCT03057600|463680606|FG002|Overall Study|Radiologic Disease Progression|13|||
128832003|NCT03057600|463680607|FG003|Overall Study|Radiologic Disease Progression|10|||
128832004|NCT03057600|463680604|FG000|Overall Study|Symptomatic Deterioration|0|||
128832005|NCT03057600|463680605|FG001|Overall Study|Symptomatic Deterioration|1|||
128832006|NCT03057600|463680606|FG002|Overall Study|Symptomatic Deterioration|1|||
128832007|NCT03057600|463680607|FG003|Overall Study|Symptomatic Deterioration|0|||
128832008|NCT03057600|463680604|FG000|Overall Study|Investigator Decision|0|||
128832009|NCT03057600|463680605|FG001|Overall Study|Investigator Decision|0|||
128832010|NCT03057600|463680606|FG002|Overall Study|Investigator Decision|1|||
128832011|NCT03057600|463680607|FG003|Overall Study|Investigator Decision|0|||
128832012|NCT03057600|463680604|FG000|Overall Study|Study Termination by Sponsor|0|||
128832013|NCT03057600|463680605|FG001|Overall Study|Study Termination by Sponsor|0|||
128832014|NCT03057600|463680606|FG002|Overall Study|Study Termination by Sponsor|0|||
128832015|NCT03057600|463680607|FG003|Overall Study|Study Termination by Sponsor|2|||
128832016|NCT03057600|463680604|FG000|Overall Study|Withdrawal by Subject|0|||
128832017|NCT03057600|463680605|FG001|Overall Study|Withdrawal by Subject|1|||
128832018|NCT03057600|463680606|FG002|Overall Study|Withdrawal by Subject|0|||
128832019|NCT03057600|463680607|FG003|Overall Study|Withdrawal by Subject|0|||
128832020|NCT03057600|463680604|FG000|Overall Study|Other, Not Specified|1|||
128832021|NCT03057600|463680605|FG001|Overall Study|Other, Not Specified|1|||
128832022|NCT03057600|463680606|FG002|Overall Study|Other, Not Specified|1|||
128832023|NCT03057600|463680607|FG003|Overall Study|Other, Not Specified|1|||
128832024|NCT01170208|463680608|FG000|Overall Study|Withdrawal by Subject|5|||
128832025|NCT01170208|463680609|FG001|Overall Study|Withdrawal by Subject|0|||
128832026|NCT01170208|463680610|FG002|Overall Study|Withdrawal by Subject|1|||
128832027|NCT01170208|463680608|FG000|Overall Study|Protocol Violation|1|||
128832028|NCT01170208|463680609|FG001|Overall Study|Protocol Violation|0|||
128832029|NCT01170208|463680610|FG002|Overall Study|Protocol Violation|1|||
128832030|NCT03335488|463680615|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
128832031|NCT03335488|463680616|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
128832032|NCT03335488|463680615|FG000|Safety Extension Period|Adverse Event|1|||
128832033|NCT03335488|463680616|FG001|Safety Extension Period|Adverse Event|0|||
128832034|NCT03335488|463680615|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
128832035|NCT03335488|463680616|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
128832036|NCT00388726|463680617|FG000|Overall Study|Adverse Event|50|||
128832037|NCT00388726|463680618|FG001|Overall Study|Adverse Event|24|||
128832038|NCT00388726|463680617|FG000|Overall Study|Progressive Disease|336|||
128832039|NCT00388726|463680618|FG001|Overall Study|Progressive Disease|153|||
128832040|NCT00388726|463680617|FG000|Overall Study|Clinical Progression|61|||
128832041|NCT00388726|463680618|FG001|Overall Study|Clinical Progression|36|||
128832042|NCT00388726|463680617|FG000|Overall Study|Withdrawal by Subject|10|||
128832043|NCT00388726|463680618|FG001|Overall Study|Withdrawal by Subject|7|||
128832044|NCT00388726|463680617|FG000|Overall Study|Administrative|6|||
128832045|NCT00388726|463680618|FG001|Overall Study|Administrative|9|||
128832046|NCT00388726|463680617|FG000|Overall Study|Physician Decision|18|||
128832047|NCT00388726|463680618|FG001|Overall Study|Physician Decision|13|||
128832048|NCT00388726|463680617|FG000|Overall Study|Death|3|||
128832049|NCT00388726|463680618|FG001|Overall Study|Death|2|||
128832050|NCT02022670|463680619|FG000|Overall Study|Adverse Event|1|||
128832051|NCT02022670|463680620|FG001|Overall Study|Adverse Event|0|||
128832052|NCT02022670|463680621|FG002|Overall Study|Adverse Event|1|||
128832053|NCT04638816|463680622|FG000|Overall Study|Withdrawal by Subject|0|||
128832054|NCT04638816|463680623|FG001|Overall Study|Withdrawal by Subject|1|||
128832055|NCT04638816|463680622|FG000|Overall Study|Lost to Follow-up|0|||
128832056|NCT04638816|463680623|FG001|Overall Study|Lost to Follow-up|1|||
128832057|NCT02251652|463680624|FG000|Overall Study|Withdrawal by Subject|1|||
128832058|NCT01160354|463680627|FG000|Overall Study|Death|0|||
128832059|NCT01160354|463680628|FG001|Overall Study|Death|1|||
128832060|NCT01160354|463680629|FG002|Overall Study|Death|1|||
128832061|NCT01822756|463680630|FG000|Overall Study|Adverse Event|0|||
128832062|NCT01822756|463680631|FG001|Overall Study|Adverse Event|0|||
128832063|NCT01822756|463680632|FG002|Overall Study|Adverse Event|0|||
128832064|NCT01822756|463680633|FG003|Overall Study|Adverse Event|2|||
128832065|NCT01822756|463680634|FG004|Overall Study|Adverse Event|0|||
128832066|NCT01822756|463680630|FG000|Overall Study|Disease progression|11|||
128832067|NCT01822756|463680631|FG001|Overall Study|Disease progression|1|||
128832068|NCT01822756|463680632|FG002|Overall Study|Disease progression|7|||
128832069|NCT01822756|463680633|FG003|Overall Study|Disease progression|2|||
128832070|NCT01822756|463680634|FG004|Overall Study|Disease progression|6|||
128832071|NCT01822756|463680630|FG000|Overall Study|Death|2|||
128832072|NCT01822756|463680631|FG001|Overall Study|Death|2|||
128832073|NCT01822756|463680632|FG002|Overall Study|Death|1|||
128832074|NCT01822756|463680633|FG003|Overall Study|Death|0|||
128832075|NCT01822756|463680634|FG004|Overall Study|Death|0|||
128832076|NCT01822756|463680630|FG000|Overall Study|Lost to Follow-up|1|||
128832077|NCT01822756|463680631|FG001|Overall Study|Lost to Follow-up|0|||
128832078|NCT01822756|463680632|FG002|Overall Study|Lost to Follow-up|1|||
128832079|NCT01822756|463680633|FG003|Overall Study|Lost to Follow-up|0|||
128832080|NCT01822756|463680634|FG004|Overall Study|Lost to Follow-up|1|||
128832081|NCT01822756|463680630|FG000|Overall Study|Physician Decision|0|||
128832082|NCT01822756|463680631|FG001|Overall Study|Physician Decision|1|||
128832083|NCT01822756|463680632|FG002|Overall Study|Physician Decision|0|||
128832084|NCT01822756|463680633|FG003|Overall Study|Physician Decision|0|||
128832085|NCT01822756|463680634|FG004|Overall Study|Physician Decision|0|||
128832086|NCT01822756|463680630|FG000|Overall Study|disease progression & patient preference|2|||
128832087|NCT01822756|463680631|FG001|Overall Study|disease progression & patient preference|0|||
128832088|NCT01822756|463680632|FG002|Overall Study|disease progression & patient preference|1|||
128832089|NCT01822756|463680633|FG003|Overall Study|disease progression & patient preference|0|||
128832090|NCT01822756|463680634|FG004|Overall Study|disease progression & patient preference|0|||
128832091|NCT01328496|463680635|FG000|Overall Study|Significant Change in Health Status|1|||
128832092|NCT01328496|463680636|FG001|Overall Study|Significant Change in Health Status|0|||
128832093|NCT03683576|463680647|FG000|Overall Study|Withdrawal by Subject|2|||
128832094|NCT03683576|463680648|FG001|Overall Study|Withdrawal by Subject|0|||
128832095|NCT03683576|463680649|FG002|Overall Study|Withdrawal by Subject|8|||
128832096|NCT03683576|463680650|FG003|Overall Study|Withdrawal by Subject|3|||
128832097|NCT03683576|463680647|FG000|Overall Study|Adverse Event|3|||
128832098|NCT03683576|463680648|FG001|Overall Study|Adverse Event|0|||
128832099|NCT03683576|463680649|FG002|Overall Study|Adverse Event|0|||
128832100|NCT03683576|463680650|FG003|Overall Study|Adverse Event|4|||
128832101|NCT03683576|463680647|FG000|Overall Study|Lack of Efficacy|1|||
128832102|NCT03683576|463680648|FG001|Overall Study|Lack of Efficacy|0|||
128832103|NCT03683576|463680649|FG002|Overall Study|Lack of Efficacy|1|||
128832104|NCT03683576|463680650|FG003|Overall Study|Lack of Efficacy|1|||
128832105|NCT03683576|463680647|FG000|Overall Study|Lost to Follow-up|0|||
128832106|NCT03683576|463680648|FG001|Overall Study|Lost to Follow-up|1|||
128832107|NCT03683576|463680649|FG002|Overall Study|Lost to Follow-up|2|||
128832108|NCT03683576|463680650|FG003|Overall Study|Lost to Follow-up|0|||
128832109|NCT03683576|463680647|FG000|Overall Study|Other, Not Specified|0|||
128832110|NCT03683576|463680648|FG001|Overall Study|Other, Not Specified|2|||
128832111|NCT03683576|463680649|FG002|Overall Study|Other, Not Specified|0|||
128832112|NCT03683576|463680650|FG003|Overall Study|Other, Not Specified|0|||
128832113|NCT03683576|463680647|FG000|Overall Study|Protocol Violation|0|||
128832114|NCT03683576|463680648|FG001|Overall Study|Protocol Violation|1|||
128832115|NCT03683576|463680649|FG002|Overall Study|Protocol Violation|1|||
128832116|NCT03683576|463680650|FG003|Overall Study|Protocol Violation|0|||
128832117|NCT03102034|463680651|FG000|Overall Study|Withdrawal by Subject|1|||
128832118|NCT03102034|463680652|FG001|Overall Study|Withdrawal by Subject|0|||
128832119|NCT03611075|463680655|FG000|Overall Study|Physician Decision|0|||
128832120|NCT03611075|463680656|FG001|Overall Study|Physician Decision|1|||
128832121|NCT03611075|463680657|FG002|Overall Study|Physician Decision|1|||
128832122|NCT03611075|463680658|FG003|Overall Study|Physician Decision|0|||
128832123|NCT03611075|463680659|FG004|Overall Study|Physician Decision|0|||
128832124|NCT03611075|463680660|FG005|Overall Study|Physician Decision|0|||
128832125|NCT03611075|463680661|FG006|Overall Study|Physician Decision|0|||
128832126|NCT03611075|463680662|FG007|Overall Study|Physician Decision|0|||
128832127|NCT03611075|463680663|FG008|Overall Study|Physician Decision|0|||
128832128|NCT03611075|463680655|FG000|Overall Study|Lost to Follow-up|1|||
128832129|NCT03611075|463680656|FG001|Overall Study|Lost to Follow-up|0|||
128832130|NCT03611075|463680657|FG002|Overall Study|Lost to Follow-up|0|||
128832131|NCT03611075|463680658|FG003|Overall Study|Lost to Follow-up|2|||
128832132|NCT03611075|463680659|FG004|Overall Study|Lost to Follow-up|0|||
128832133|NCT03611075|463680660|FG005|Overall Study|Lost to Follow-up|0|||
128832134|NCT03611075|463680661|FG006|Overall Study|Lost to Follow-up|0|||
128832135|NCT03611075|463680662|FG007|Overall Study|Lost to Follow-up|0|||
128832136|NCT03611075|463680663|FG008|Overall Study|Lost to Follow-up|0|||
128832137|NCT03611075|463680655|FG000|Overall Study|Withdrawal by Subject|0|||
128832138|NCT03611075|463680656|FG001|Overall Study|Withdrawal by Subject|1|||
128832139|NCT03611075|463680657|FG002|Overall Study|Withdrawal by Subject|1|||
128832140|NCT03611075|463680658|FG003|Overall Study|Withdrawal by Subject|1|||
128832141|NCT03611075|463680659|FG004|Overall Study|Withdrawal by Subject|0|||
128832142|NCT03611075|463680660|FG005|Overall Study|Withdrawal by Subject|0|||
128832143|NCT03611075|463680661|FG006|Overall Study|Withdrawal by Subject|1|||
128832144|NCT03611075|463680662|FG007|Overall Study|Withdrawal by Subject|0|||
128832145|NCT03611075|463680663|FG008|Overall Study|Withdrawal by Subject|0|||
128832146|NCT03611075|463680655|FG000|Overall Study|Reason unknown|0|||
128832147|NCT03611075|463680656|FG001|Overall Study|Reason unknown|0|||
128832148|NCT03611075|463680657|FG002|Overall Study|Reason unknown|0|||
128832149|NCT03611075|463680658|FG003|Overall Study|Reason unknown|1|||
128832150|NCT03611075|463680659|FG004|Overall Study|Reason unknown|0|||
128832151|NCT03611075|463680660|FG005|Overall Study|Reason unknown|0|||
128832152|NCT03611075|463680661|FG006|Overall Study|Reason unknown|1|||
128832153|NCT03611075|463680662|FG007|Overall Study|Reason unknown|0|||
128832154|NCT03611075|463680663|FG008|Overall Study|Reason unknown|0|||
128832155|NCT00676091|463680664|FG000|Infant Series|Parent or legal guardian request|10|||
128832156|NCT00676091|463680665|FG001|Infant Series|Parent or legal guardian request|8|||
128832157|NCT00676091|463680664|FG000|Infant Series|Protocol Violation|6|||
128832158|NCT00676091|463680665|FG001|Infant Series|Protocol Violation|3|||
128832159|NCT00676091|463680664|FG000|Infant Series|Adverse Event|2|||
128832160|NCT00676091|463680665|FG001|Infant Series|Adverse Event|3|||
128832161|NCT00676091|463680664|FG000|Infant Series|Failed to return|1|||
128832162|NCT00676091|463680665|FG001|Infant Series|Failed to return|3|||
128832163|NCT00676091|463680664|FG000|Infant Series|Lost to Follow-up|1|||
128832164|NCT00676091|463680665|FG001|Infant Series|Lost to Follow-up|0|||
128832165|NCT00676091|463680664|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
128832166|NCT00676091|463680665|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
128832167|NCT00676091|463680664|FG000|After Infant Series|Adverse Event|0|||
128832168|NCT00676091|463680665|FG001|After Infant Series|Adverse Event|1|||
128832169|NCT00676091|463680664|FG000|After Infant Series|Protocol Violation|0|||
128832170|NCT00676091|463680665|FG001|After Infant Series|Protocol Violation|1|||
128832171|NCT00676091|463680664|FG000|After Infant Series|Failed to return|1|||
128832172|NCT00676091|463680665|FG001|After Infant Series|Failed to return|1|||
128832173|NCT00676091|463680664|FG000|Toddler Dose|Failed to return|2|||
128832174|NCT00676091|463680665|FG001|Toddler Dose|Failed to return|0|||
128832175|NCT00676091|463680664|FG000|Toddler Dose|Parent or legal guardian request|1|||
128832176|NCT00676091|463680665|FG001|Toddler Dose|Parent or legal guardian request|0|||
128832177|NCT01701401|463680669|FG000|Overall Study|Randomized But Not Treated|3|||
128832178|NCT01701401|463680670|FG001|Overall Study|Randomized But Not Treated|1|||
128832179|NCT01701401|463680671|FG002|Overall Study|Randomized But Not Treated|0|||
128832180|NCT01701401|463680672|FG003|Overall Study|Randomized But Not Treated|1|||
128832181|NCT01701401|463680669|FG000|Overall Study|Lost to Follow-up|5|||
128832182|NCT01701401|463680670|FG001|Overall Study|Lost to Follow-up|5|||
128832183|NCT01701401|463680671|FG002|Overall Study|Lost to Follow-up|1|||
128832184|NCT01701401|463680672|FG003|Overall Study|Lost to Follow-up|3|||
128832185|NCT01701401|463680669|FG000|Overall Study|Withdrew Consent|0|||
128832186|NCT01701401|463680670|FG001|Overall Study|Withdrew Consent|3|||
128832187|NCT01701401|463680671|FG002|Overall Study|Withdrew Consent|1|||
128832188|NCT01701401|463680672|FG003|Overall Study|Withdrew Consent|2|||
128832189|NCT01701401|463680669|FG000|Overall Study|Lack of Efficacy|1|||
128832190|NCT01701401|463680670|FG001|Overall Study|Lack of Efficacy|0|||
128832191|NCT01701401|463680671|FG002|Overall Study|Lack of Efficacy|2|||
128832192|NCT01701401|463680672|FG003|Overall Study|Lack of Efficacy|0|||
128832193|NCT01701401|463680669|FG000|Overall Study|Adverse Event|1|||
128832194|NCT01701401|463680670|FG001|Overall Study|Adverse Event|0|||
128832195|NCT01701401|463680671|FG002|Overall Study|Adverse Event|0|||
128832196|NCT01701401|463680672|FG003|Overall Study|Adverse Event|0|||
128832197|NCT01701401|463680669|FG000|Overall Study|Protocol Violation|0|||
128832198|NCT01701401|463680670|FG001|Overall Study|Protocol Violation|0|||
128832199|NCT01701401|463680671|FG002|Overall Study|Protocol Violation|1|||
128832200|NCT01701401|463680672|FG003|Overall Study|Protocol Violation|0|||
128832201|NCT00933270|463680673|FG000|Overall Study|Withdrawal by Subject|26|||
128832202|NCT00933270|463680673|FG000|Overall Study|Insufficient Follow-up|10|||
128832203|NCT00933270|463680673|FG000|Overall Study|Lost to Follow-up|14|||
128832204|NCT00933270|463680673|FG000|Overall Study|Adverse Event|1|||
128832205|NCT00933270|463680673|FG000|Overall Study|Missed Visit|2|||
128832206|NCT00933270|463680673|FG000|Overall Study|Death|24|||
128832207|NCT00933270|463680673|FG000|Overall Study|Moved or would not return|10|||
128832208|NCT01000805|463680674|FG000|Overall Study|Adverse Event|21|||
128832209|NCT01000805|463680675|FG001|Overall Study|Adverse Event|9|||
128832210|NCT01000805|463680674|FG000|Overall Study|Lack of Efficacy|5|||
128832211|NCT01000805|463680675|FG001|Overall Study|Lack of Efficacy|16|||
128832212|NCT01000805|463680674|FG000|Overall Study|Lost to Follow-up|16|||
128832213|NCT01000805|463680675|FG001|Overall Study|Lost to Follow-up|21|||
128832214|NCT01000805|463680674|FG000|Overall Study|Physician Decision|0|||
128832215|NCT01000805|463680675|FG001|Overall Study|Physician Decision|1|||
128832216|NCT01000805|463680674|FG000|Overall Study|Protocol Violation|12|||
128832217|NCT01000805|463680675|FG001|Overall Study|Protocol Violation|8|||
128832218|NCT01000805|463680674|FG000|Overall Study|Withdrawal by Subject|16|||
128832219|NCT01000805|463680675|FG001|Overall Study|Withdrawal by Subject|6|||
128832220|NCT01000805|463680674|FG000|Overall Study|Sponsor Decision|0|||
128832221|NCT01000805|463680675|FG001|Overall Study|Sponsor Decision|1|||
128832222|NCT00989196|463680676|FG000|Treatment Period|Lost to Follow-up|1|||
128832223|NCT00989196|463680677|FG001|Treatment Period|Lost to Follow-up|0|||
128832224|NCT03476798|463680680|FG000|Overall Study|Death|1|||
128832225|NCT03476798|463680680|FG000|Overall Study|Withdrawal by Subject|2|||
128832226|NCT03476798|463680680|FG000|Overall Study|Protocol Violation|2|||
128832227|NCT02409680|463680685|FG000|Overall Study|Lost to Follow-up|15|||
128832228|NCT02409680|463680686|FG001|Overall Study|Lost to Follow-up|30|||
128832229|NCT03789656|463680690|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
128832230|NCT03789656|463680691|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
128832231|NCT03789656|463680692|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
128832232|NCT03789656|463680693|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
128832233|NCT03789656|463680694|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
128832234|NCT03789656|463680690|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
128832235|NCT03789656|463680691|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
128832236|NCT03789656|463680692|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
128832237|NCT03789656|463680693|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
128832238|NCT03789656|463680694|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
128832239|NCT03789656|463680690|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
128832240|NCT03789656|463680691|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
128832241|NCT03789656|463680692|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
128832242|NCT03789656|463680693|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
128832243|NCT03789656|463680694|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
128832244|NCT03789656|463680690|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
128832245|NCT03789656|463680691|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
128832246|NCT03789656|463680692|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
128832247|NCT03789656|463680693|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
128832248|NCT03789656|463680694|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
128832249|NCT02434328|463680702|FG000|Overall Study|Adverse Event|9|||
128832250|NCT02434328|463680703|FG001|Overall Study|Adverse Event|4|||
128832251|NCT02434328|463680702|FG000|Overall Study|Lack of Efficacy|0|||
128832252|NCT02434328|463680703|FG001|Overall Study|Lack of Efficacy|2|||
128832253|NCT02434328|463680702|FG000|Overall Study|Physician Decision|0|||
128832254|NCT02434328|463680703|FG001|Overall Study|Physician Decision|1|||
128832255|NCT02434328|463680702|FG000|Overall Study|Withdrawal by Subject|12|||
128832256|NCT02434328|463680703|FG001|Overall Study|Withdrawal by Subject|21|||
128832257|NCT02434328|463680702|FG000|Overall Study|Death|4|||
128832258|NCT02434328|463680703|FG001|Overall Study|Death|7|||
128832259|NCT02434328|463680702|FG000|Overall Study|Lost to Follow-up|1|||
128832260|NCT02434328|463680703|FG001|Overall Study|Lost to Follow-up|6|||
128832261|NCT02434328|463680702|FG000|Overall Study|Other|4|||
128832262|NCT02434328|463680703|FG001|Overall Study|Other|1|||
128832263|NCT05432986|463680706|FG000|Overall Study|Withdrawal by Subject|2|||
128832264|NCT05432986|463680706|FG000|Overall Study|incomplete measurement|7|||
128832265|NCT03009344|463681990|FG000|Overall Study|Lack of Efficacy|5|||
128832266|NCT03009344|463681990|FG000|Overall Study|Withdrawal by Subject|1|||
128832267|NCT03009344|463681990|FG000|Overall Study|Adverse Event|1|||
128832268|NCT03137459|463681993|FG000|2-month Assessment|Withdrawal by Subject|13|||
128832269|NCT03137459|463681994|FG001|2-month Assessment|Withdrawal by Subject|3|||
128832270|NCT03137459|463681993|FG000|2-month Assessment|Unable to reach|42|||
128832271|NCT03137459|463681994|FG001|2-month Assessment|Unable to reach|32|||
128832272|NCT03137459|463681993|FG000|2-month Assessment|Refused assessment|7|||
128832273|NCT03137459|463681994|FG001|2-month Assessment|Refused assessment|5|||
128832274|NCT03137459|463681993|FG000|2-month Assessment|Acutely ill|6|||
128832275|NCT03137459|463681994|FG001|2-month Assessment|Acutely ill|2|||
128832276|NCT03137459|463681993|FG000|4-month Assessment|Death|4|||
128832277|NCT03137459|463681994|FG001|4-month Assessment|Death|2|||
128832278|NCT03137459|463681993|FG000|4-month Assessment|Withdrawal by Subject|4|||
128832279|NCT03137459|463681994|FG001|4-month Assessment|Withdrawal by Subject|2|||
128832280|NCT03137459|463681993|FG000|4-month Assessment|Unable to reach|44|||
128832281|NCT03137459|463681994|FG001|4-month Assessment|Unable to reach|29|||
128832282|NCT03137459|463681993|FG000|4-month Assessment|Refused assessment|24|||
128832283|NCT03137459|463681994|FG001|4-month Assessment|Refused assessment|10|||
128832284|NCT03137459|463681993|FG000|4-month Assessment|Acutely ill|2|||
128832285|NCT03137459|463681994|FG001|4-month Assessment|Acutely ill|3|||
128832286|NCT03137459|463681993|FG000|6-months|Lost to Follow-up|14|||
128832287|NCT03137459|463681994|FG001|6-months|Lost to Follow-up|11|||
128832288|NCT03137459|463681993|FG000|6-months|Death|0|||
128832289|NCT03137459|463681994|FG001|6-months|Death|2|||
128832290|NCT03137459|463681993|FG000|6-months|Refused assessment|6|||
128832291|NCT03137459|463681994|FG001|6-months|Refused assessment|3|||
128832292|NCT03137459|463681993|FG000|6-months|Acutely ill|1|||
128832293|NCT03137459|463681994|FG001|6-months|Acutely ill|1|||
128832294|NCT01732757|463681995|FG000|Overall Study|Lost to Follow-up|1|||
128832295|NCT01732757|463681996|FG001|Overall Study|Lost to Follow-up|0|||
128832296|NCT01732757|463681997|FG002|Overall Study|Lost to Follow-up|0|||
128832297|NCT03116464|463681998|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
128832298|NCT00491400|463681999|FG000|Overall Study|Withdrawal by Subject|5|||
128832299|NCT00491400|463682000|FG001|Overall Study|Withdrawal by Subject|4|||
128832300|NCT00597376|463682001|FG000|Overall Study|Withdrawal by Subject|4|||
128832301|NCT00597376|463682002|FG001|Overall Study|Withdrawal by Subject|3|||
128832302|NCT00597376|463682001|FG000|Overall Study|Adverse Event|4|||
128832303|NCT00597376|463682002|FG001|Overall Study|Adverse Event|1|||
128832304|NCT00745875|463682005|FG000|Overall Study|Continuing study treatment|4|||
128832305|NCT00745875|463682006|FG001|Overall Study|Continuing study treatment|4|||
128832306|NCT01532648|463682007|FG000|Overall Study|Lost to Follow-up|3|||
128832307|NCT01532648|463682008|FG001|Overall Study|Lost to Follow-up|4|||
128832308|NCT01532648|463682007|FG000|Overall Study|Lack of Efficacy|4|||
128832309|NCT01532648|463682008|FG001|Overall Study|Lack of Efficacy|1|||
128832310|NCT01532648|463682007|FG000|Overall Study|Protocol Violation|1|||
128832311|NCT01532648|463682008|FG001|Overall Study|Protocol Violation|1|||
128832312|NCT01532648|463682007|FG000|Overall Study|Adverse Event|12|||
128832313|NCT01532648|463682008|FG001|Overall Study|Adverse Event|9|||
128832314|NCT01532648|463682007|FG000|Overall Study|Withdrawal by Subject|16|||
128832315|NCT01532648|463682008|FG001|Overall Study|Withdrawal by Subject|2|||
128832316|NCT04652869|463682013|FG000|Overall Study|Withdrawal by Subject|0|||
128832317|NCT04652869|463682014|FG001|Overall Study|Withdrawal by Subject|2|||
128832318|NCT04652869|463682015|FG002|Overall Study|Withdrawal by Subject|0|||
128832319|NCT00562094|463682016|FG000|Overall Study|Lost to Follow-up|62|||
128832320|NCT00887224|463682017|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
128832321|NCT00887224|463682018|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
128832322|NCT00887224|463682019|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
128832323|NCT00887224|463682017|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
128832324|NCT00887224|463682018|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
128832325|NCT00887224|463682019|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
128832326|NCT00887224|463682017|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
128832327|NCT00887224|463682018|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
128832328|NCT00887224|463682019|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
128832329|NCT00887224|463682017|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
128832330|NCT00887224|463682018|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
128832331|NCT00887224|463682019|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
128832332|NCT00887224|463682017|FG000|Open-label Response (OLR) Phase|Other|1|||
128832333|NCT00887224|463682018|FG001|Open-label Response (OLR) Phase|Other|0|||
128832334|NCT00887224|463682019|FG002|Open-label Response (OLR) Phase|Other|0|||
128832335|NCT00887224|463682017|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
128832336|NCT00887224|463682018|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
128832337|NCT00887224|463682019|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
128832338|NCT00887224|463682017|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
128832339|NCT00887224|463682018|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
128832340|NCT00887224|463682019|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
128832341|NCT00887224|463682017|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
128832342|NCT00887224|463682018|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
128832343|NCT00887224|463682019|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
128832344|NCT00887224|463682017|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
128832345|NCT00887224|463682018|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
128832346|NCT00887224|463682019|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
128832347|NCT00887224|463682017|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
128832348|NCT00887224|463682018|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
128832349|NCT00887224|463682019|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
128832350|NCT00887224|463682017|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
128832351|NCT00887224|463682018|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
128832352|NCT00887224|463682019|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
128832353|NCT00887224|463682017|FG000|Open-label Stability (OLS) Phase|Other|1|||
128832354|NCT00887224|463682018|FG001|Open-label Stability (OLS) Phase|Other|0|||
128832355|NCT00887224|463682019|FG002|Open-label Stability (OLS) Phase|Other|0|||
128832356|NCT00887224|463682017|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
128832357|NCT00887224|463682018|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
128832358|NCT00887224|463682019|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
128832359|NCT00887224|463682017|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
128832360|NCT00887224|463682018|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
128832361|NCT00887224|463682019|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
128832362|NCT00887224|463682017|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
128832363|NCT00887224|463682018|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
128832364|NCT00887224|463682019|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
128832365|NCT00887224|463682017|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
128832366|NCT00887224|463682018|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
128832367|NCT00887224|463682019|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
128832368|NCT00887224|463682017|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
128832369|NCT00887224|463682018|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
128832370|NCT00887224|463682019|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
128832371|NCT00887224|463682017|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
128832372|NCT00887224|463682018|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
128832373|NCT00887224|463682019|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
128832374|NCT00887224|463682017|FG000|OL Taper Phase / OL Follow Up|Other|30|||
128832375|NCT00887224|463682018|FG001|OL Taper Phase / OL Follow Up|Other|0|||
128832376|NCT00887224|463682019|FG002|OL Taper Phase / OL Follow Up|Other|0|||
128832377|NCT00887224|463682017|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
128832378|NCT00887224|463682018|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
128832379|NCT00887224|463682019|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
128832380|NCT00887224|463682017|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
128832381|NCT00887224|463682018|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
128832382|NCT00887224|463682019|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
128832383|NCT00887224|463682017|FG000|Double-blind (DB) Phase|Adverse Event|0|||
128832384|NCT00887224|463682018|FG001|Double-blind (DB) Phase|Adverse Event|7|||
128832385|NCT00887224|463682019|FG002|Double-blind (DB) Phase|Adverse Event|2|||
128832386|NCT00887224|463682017|FG000|Double-blind (DB) Phase|Failed to return|0|||
128832387|NCT00887224|463682018|FG001|Double-blind (DB) Phase|Failed to return|2|||
128832388|NCT00887224|463682019|FG002|Double-blind (DB) Phase|Failed to return|2|||
128832389|NCT00887224|463682017|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
128832390|NCT00887224|463682018|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
128832391|NCT00887224|463682019|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
128832392|NCT00887224|463682017|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
128832393|NCT00887224|463682018|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
128832394|NCT00887224|463682019|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
128832395|NCT00887224|463682017|FG000|Double-blind (DB) Phase|Other|0|||
128832396|NCT00887224|463682018|FG001|Double-blind (DB) Phase|Other|2|||
128832397|NCT00887224|463682019|FG002|Double-blind (DB) Phase|Other|0|||
128832398|NCT00887224|463682017|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
128832399|NCT00887224|463682018|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
128832400|NCT00887224|463682019|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
128832401|NCT00887224|463682017|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
128832402|NCT00887224|463682018|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
128832403|NCT00887224|463682019|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
128832404|NCT00887224|463682017|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
128832405|NCT00887224|463682018|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
128832406|NCT00887224|463682019|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
128832407|NCT00887224|463682017|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
128832408|NCT00887224|463682018|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
128832409|NCT00887224|463682019|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
128832410|NCT00887224|463682017|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
128832411|NCT00887224|463682018|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
128832412|NCT00887224|463682019|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
128832413|NCT00887224|463682017|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
128832414|NCT00887224|463682018|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
128832415|NCT00887224|463682019|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
128832416|NCT00887224|463682017|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
128832417|NCT00887224|463682018|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
128832418|NCT00887224|463682019|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
128832419|NCT00887224|463682017|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
128832420|NCT00887224|463682018|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
128832421|NCT00887224|463682019|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
128832422|NCT00887224|463682017|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
128832423|NCT00887224|463682018|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
128832424|NCT00887224|463682019|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
128832425|NCT01555138|463682022|FG000|Overall Study|Death|0|||
128832426|NCT01555138|463682023|FG001|Overall Study|Death|1|||
128832427|NCT01555138|463682022|FG000|Overall Study|Lost to Follow-up|1|||
128832428|NCT01555138|463682023|FG001|Overall Study|Lost to Follow-up|0|||
128832429|NCT01555138|463682022|FG000|Overall Study|Abnormal Lab reults|1|||
128832430|NCT01555138|463682023|FG001|Overall Study|Abnormal Lab reults|3|||
128832431|NCT01555138|463682022|FG000|Overall Study|Lack of Efficacy|2|||
128832432|NCT01555138|463682023|FG001|Overall Study|Lack of Efficacy|2|||
128832433|NCT01555138|463682022|FG000|Overall Study|Protocol Violation|5|||
128832434|NCT01555138|463682023|FG001|Overall Study|Protocol Violation|3|||
128832435|NCT01555138|463682022|FG000|Overall Study|Administrative problems|8|||
128832436|NCT01555138|463682023|FG001|Overall Study|Administrative problems|0|||
128832437|NCT01555138|463682022|FG000|Overall Study|Withdrawal by Subject|16|||
128832438|NCT01555138|463682023|FG001|Overall Study|Withdrawal by Subject|15|||
128832439|NCT01555138|463682022|FG000|Overall Study|Adverse Event|14|||
128832440|NCT01555138|463682023|FG001|Overall Study|Adverse Event|14|||
128832441|NCT03883828|463682024|FG000|Overall Study|Did not start radiotherapy|1|||
128832442|NCT03883828|463682025|FG001|Overall Study|Did not start radiotherapy|2|||
128832443|NCT01256359|463682028|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
128832444|NCT01256359|463682029|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
128832445|NCT01256359|463682028|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
128832446|NCT01256359|463682029|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
128832447|NCT02000752|463682030|FG000|Overall Study|Dystocic delivery|19|||
128832448|NCT02000752|463682031|FG001|Overall Study|Dystocic delivery|8|||
128832449|NCT02000752|463682030|FG000|Overall Study|Shift Changes|12|||
128832450|NCT02000752|463682031|FG001|Overall Study|Shift Changes|5|||
128832451|NCT04237792|463682035|FG000|Treatment (Day 1)|Adverse Event|1|||
128832452|NCT04237792|463682036|FG001|Treatment (Day 1)|Adverse Event|0|||
128832453|NCT04237792|463682037|FG002|Treatment (Day 1)|Adverse Event|0|||
128832454|NCT04237792|463682038|FG003|Treatment (Day 1)|Adverse Event|0|||
128832455|NCT04237792|463682039|FG004|Treatment (Day 1)|Adverse Event|1|||
128832456|NCT04237792|463682040|FG005|Treatment (Day 1)|Adverse Event|1|||
128832457|NCT04237792|463682035|FG000|Treatment (Day 1)|Other|0|||
128832458|NCT04237792|463682036|FG001|Treatment (Day 1)|Other|0|||
128832459|NCT04237792|463682037|FG002|Treatment (Day 1)|Other|1|||
128832460|NCT04237792|463682038|FG003|Treatment (Day 1)|Other|0|||
128832461|NCT04237792|463682039|FG004|Treatment (Day 1)|Other|0|||
128832462|NCT04237792|463682040|FG005|Treatment (Day 1)|Other|1|||
128832463|NCT04237792|463682035|FG000|Treatment (Day 1)|Not treated|1|||
128832464|NCT04237792|463682036|FG001|Treatment (Day 1)|Not treated|1|||
128832465|NCT04237792|463682037|FG002|Treatment (Day 1)|Not treated|2|||
128832466|NCT04237792|463682038|FG003|Treatment (Day 1)|Not treated|1|||
128832467|NCT04237792|463682039|FG004|Treatment (Day 1)|Not treated|0|||
128832468|NCT04237792|463682040|FG005|Treatment (Day 1)|Not treated|1|||
128832469|NCT03739866|463682042|FG000|Overall Study|Lost to Follow-up|0|||
128832470|NCT03739866|463682043|FG001|Overall Study|Lost to Follow-up|0|||
128832471|NCT03739866|463682044|FG002|Overall Study|Lost to Follow-up|0|||
128832472|NCT03739866|463682045|FG003|Overall Study|Lost to Follow-up|1|||
128832473|NCT03739866|463682046|FG004|Overall Study|Lost to Follow-up|0|||
128832474|NCT03739866|463682047|FG005|Overall Study|Lost to Follow-up|0|||
128832475|NCT03739866|463682048|FG006|Overall Study|Lost to Follow-up|0|||
128832476|NCT03739866|463682049|FG007|Overall Study|Lost to Follow-up|0|||
128832477|NCT03739866|463682042|FG000|Overall Study|Enrolled but not treated|0|||
128832478|NCT03739866|463682043|FG001|Overall Study|Enrolled but not treated|0|||
128832479|NCT03739866|463682044|FG002|Overall Study|Enrolled but not treated|1|||
128832480|NCT03739866|463682045|FG003|Overall Study|Enrolled but not treated|0|||
128832481|NCT03739866|463682046|FG004|Overall Study|Enrolled but not treated|1|||
128832482|NCT03739866|463682047|FG005|Overall Study|Enrolled but not treated|0|||
128832483|NCT03739866|463682048|FG006|Overall Study|Enrolled but not treated|0|||
128832484|NCT03739866|463682049|FG007|Overall Study|Enrolled but not treated|0|||
128832485|NCT03489369|463682050|FG000|Overall Study|Documented Progressive Disease|3|||
128832486|NCT03489369|463682051|FG001|Overall Study|Documented Progressive Disease|2|||
128832487|NCT03489369|463682052|FG002|Overall Study|Documented Progressive Disease|3|||
128832488|NCT03489369|463682053|FG003|Overall Study|Documented Progressive Disease|6|||
128832489|NCT03489369|463682050|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
128832490|NCT03489369|463682051|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
128832491|NCT03489369|463682052|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
128832492|NCT03489369|463682053|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
128832493|NCT02113449|463682054|FG000|Overall Study|Adverse Event|4|||
128832494|NCT00109031|463682057|FG000|Overall Study|Adverse Event|0|||
128832495|NCT00109031|463682058|FG001|Overall Study|Adverse Event|0|||
128832496|NCT00109031|463682059|FG002|Overall Study|Adverse Event|1|||
128832497|NCT00109031|463682060|FG003|Overall Study|Adverse Event|0|||
128832498|NCT00109031|463682057|FG000|Overall Study|Withdrawal by Subject|0|||
128832499|NCT00109031|463682058|FG001|Overall Study|Withdrawal by Subject|1|||
128832500|NCT00109031|463682059|FG002|Overall Study|Withdrawal by Subject|0|||
128832501|NCT00109031|463682060|FG003|Overall Study|Withdrawal by Subject|0|||
128832502|NCT00109031|463682057|FG000|Overall Study|Physician Decision|0|||
128832503|NCT00109031|463682058|FG001|Overall Study|Physician Decision|1|||
128832504|NCT00109031|463682059|FG002|Overall Study|Physician Decision|0|||
128832505|NCT00109031|463682060|FG003|Overall Study|Physician Decision|0|||
128832506|NCT00109031|463682057|FG000|Overall Study|Protocol Violation|0|||
128832507|NCT00109031|463682058|FG001|Overall Study|Protocol Violation|0|||
128832508|NCT00109031|463682059|FG002|Overall Study|Protocol Violation|1|||
128832509|NCT00109031|463682060|FG003|Overall Study|Protocol Violation|0|||
128832510|NCT02309294|463682061|FG000|Overall Study|Withdrawal by Subject|2|||
128832511|NCT03520036|463682062|FG000|Overall Study|Adverse Event|1|||
128832512|NCT03520036|463682063|FG001|Overall Study|Adverse Event|2|||
128832513|NCT03520036|463682064|FG002|Overall Study|Adverse Event|0|||
128832514|NCT03520036|463682062|FG000|Overall Study|Protocol Violation|1|||
128832515|NCT03520036|463682063|FG001|Overall Study|Protocol Violation|0|||
128832516|NCT03520036|463682064|FG002|Overall Study|Protocol Violation|0|||
128832517|NCT03520036|463682062|FG000|Overall Study|Withdrawal by Subject|0|||
128832518|NCT03520036|463682063|FG001|Overall Study|Withdrawal by Subject|1|||
128832519|NCT03520036|463682064|FG002|Overall Study|Withdrawal by Subject|4|||
128832520|NCT03520036|463682062|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
128832521|NCT03520036|463682063|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
128832522|NCT03520036|463682064|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
128832523|NCT02542943|463682072|FG000|Overall Study|Lost to Follow-up|1|||
128832524|NCT02542943|463682073|FG001|Overall Study|Lost to Follow-up|0|||
128832525|NCT02542943|463682074|FG002|Overall Study|Lost to Follow-up|0|||
128832526|NCT02542943|463682072|FG000|Overall Study|Withdrawal by Subject|0|||
128832527|NCT02542943|463682073|FG001|Overall Study|Withdrawal by Subject|1|||
128832528|NCT02542943|463682074|FG002|Overall Study|Withdrawal by Subject|0|||
128832529|NCT05824559|463682076|FG000|Overall Study|Adverse Event|2|||
128832530|NCT05824559|463682076|FG000|Overall Study|Physician Decision|2|||
128832531|NCT05824559|463682076|FG000|Overall Study|Progressive Disease|16|||
128832532|NCT05824559|463682076|FG000|Overall Study|Study Terminated by Sponsor|1|||
128832533|NCT05824559|463682076|FG000|Overall Study|Withdrawal by Subject|2|||
128832534|NCT05865392|463682082|FG000|Overall Study|Withdrawal by Subject|4|||
128832535|NCT05865392|463682083|FG001|Overall Study|Withdrawal by Subject|0|||
128832536|NCT05865392|463682082|FG000|Overall Study|Didn't meet inclusion criteria|4|||
128832537|NCT05865392|463682083|FG001|Overall Study|Didn't meet inclusion criteria|0|||
128832538|NCT05366751|463682084|FG000|Overall Study|Adverse Event|25|||
128832539|NCT05366751|463682084|FG000|Overall Study|Physician Decision|3|||
128832540|NCT05366751|463682084|FG000|Overall Study|Lost to Follow-up|2|||
128832541|NCT05366751|463682084|FG000|Overall Study|Withdrawal by Subject|14|||
128832542|NCT05366751|463682084|FG000|Overall Study|Study Terminated by Sponsor|50|||
128832543|NCT05366751|463682084|FG000|Overall Study|Site Terminated by Sponsor|3|||
128832544|NCT03343704|463682089|FG000|Overall Study|Refused to complete follow up|0|||
128832545|NCT03343704|463682090|FG001|Overall Study|Refused to complete follow up|1|||
128832546|NCT03343704|463682089|FG000|Overall Study|Death|0|||
128832547|NCT03343704|463682090|FG001|Overall Study|Death|1|||
128832548|NCT03343704|463682089|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
128832549|NCT03343704|463682090|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
128832550|NCT00302211|463682102|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
128832551|NCT00302211|463682103|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
128832552|NCT00302211|463682104|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
128832553|NCT00302211|463682105|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
128832554|NCT00302211|463682106|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
128832555|NCT00302211|463682102|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
128832556|NCT00302211|463682103|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
128832557|NCT00302211|463682104|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
128832558|NCT00302211|463682105|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
128832559|NCT00302211|463682106|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
128832560|NCT00302211|463682102|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
128832561|NCT00302211|463682103|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
128832562|NCT00302211|463682104|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
128832563|NCT00302211|463682105|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
128832564|NCT00302211|463682106|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
128832565|NCT00302211|463682102|FG000|Double Blind Period (New Patients)|Disease progression|0|||
128832566|NCT00302211|463682103|FG001|Double Blind Period (New Patients)|Disease progression|1|||
128832567|NCT00302211|463682104|FG002|Double Blind Period (New Patients)|Disease progression|1|||
128832568|NCT00302211|463682105|FG003|Double Blind Period (New Patients)|Disease progression|0|||
128832569|NCT00302211|463682106|FG004|Double Blind Period (New Patients)|Disease progression|0|||
128832570|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
128832571|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
128832572|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
128832573|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
128832574|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
128832575|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
128832576|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
128832577|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
128832578|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
128832579|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
128832580|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
128832581|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
128832582|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
128832583|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
128832584|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
128832585|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
128832586|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
128832587|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
128832588|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
128832589|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
128832590|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|Death|0|||
128832591|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|Death|0|||
128832592|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|Death|0|||
128832593|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|Death|1|||
128832594|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|Death|1|||
128832595|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
128832596|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
128832597|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
128832598|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
128832599|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
128832600|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
128832601|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
128832602|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
128832603|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
128832604|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
128832605|NCT00302211|463682102|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
128832606|NCT00302211|463682103|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
128832607|NCT00302211|463682104|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
128832608|NCT00302211|463682105|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
128832609|NCT00302211|463682106|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
128832610|NCT02294461|463682107|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
128832611|NCT02294461|463682108|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
128832612|NCT02294461|463682109|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
128832613|NCT02294461|463682107|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
128832614|NCT02294461|463682108|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
128832615|NCT02294461|463682109|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
128832616|NCT02294461|463682107|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
128832617|NCT02294461|463682108|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
128832618|NCT02294461|463682109|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
128832619|NCT02294461|463682107|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
128832620|NCT02294461|463682108|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
128832621|NCT02294461|463682109|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
128832622|NCT02294461|463682107|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
128832623|NCT02294461|463682108|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
128832624|NCT02294461|463682109|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
128832625|NCT02294461|463682107|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
128832626|NCT02294461|463682108|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
128832627|NCT02294461|463682109|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
128832628|NCT02294461|463682107|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
128832629|NCT02294461|463682108|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
128832630|NCT02294461|463682109|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
128832631|NCT02294461|463682107|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
128832632|NCT02294461|463682108|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
128832633|NCT02294461|463682109|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
128832634|NCT02294461|463682107|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
128832635|NCT02294461|463682108|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
128832636|NCT02294461|463682109|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
128832637|NCT02294461|463682107|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
128832638|NCT02294461|463682108|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
128832639|NCT02294461|463682109|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
128832640|NCT02294461|463682107|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
128832641|NCT02294461|463682108|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
128832642|NCT02294461|463682109|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
128832643|NCT02294461|463682107|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
128832644|NCT02294461|463682108|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
128832645|NCT02294461|463682109|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
128832646|NCT02294461|463682107|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
128832647|NCT02294461|463682108|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
128832648|NCT02294461|463682109|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
128832649|NCT02294461|463682107|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
128832650|NCT02294461|463682108|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
128832651|NCT02294461|463682109|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
128832652|NCT02637063|463683566|FG000|Overall Study|Lost to Follow-up|3|||
128832653|NCT02637063|463683567|FG001|Overall Study|Lost to Follow-up|2|||
128832654|NCT02637063|463683568|FG002|Overall Study|Lost to Follow-up|3|||
128832655|NCT02637063|463683566|FG000|Overall Study|Withdrawal by Subject|2|||
128832656|NCT02637063|463683567|FG001|Overall Study|Withdrawal by Subject|2|||
128832657|NCT02637063|463683568|FG002|Overall Study|Withdrawal by Subject|3|||
128832658|NCT01583166|463683569|FG000|Overall Study|Withdrawal by Subject|4|||
128832659|NCT01583166|463683570|FG001|Overall Study|Withdrawal by Subject|6|||
128832660|NCT01833455|463683571|FG000|Overall Study|Withdrawal by Subject|1|||
128832661|NCT01833455|463683572|FG001|Overall Study|Withdrawal by Subject|0|||
128832662|NCT04938453|463683575|FG000|Washout Period 1|Adverse Event|1|||
128832663|NCT04938453|463683576|FG001|Washout Period 1|Adverse Event|0|||
128832664|NCT04938453|463683575|FG000|Washout Period 1|Physician Decision|0|||
128832665|NCT04938453|463683576|FG001|Washout Period 1|Physician Decision|1|||
128832666|NCT04658784|463683581|FG000|6-month Follow-up|Lost to Follow-up|2|||
128832667|NCT04658784|463683582|FG001|6-month Follow-up|Lost to Follow-up|5|||
128832668|NCT00454194|463683584|FG000|Overall Study|Adverse Event|7|||
128832669|NCT00454194|463683585|FG001|Overall Study|Adverse Event|2|||
128832670|NCT00454194|463683584|FG000|Overall Study|Withdrawal by Subject|12|||
128832671|NCT00454194|463683585|FG001|Overall Study|Withdrawal by Subject|8|||
128832672|NCT00454194|463683584|FG000|Overall Study|Other Medical Problems|1|||
128832673|NCT00454194|463683585|FG001|Overall Study|Other Medical Problems|2|||
128832674|NCT00454194|463683584|FG000|Overall Study|Other Unspecified Reason|2|||
128832675|NCT00454194|463683585|FG001|Overall Study|Other Unspecified Reason|2|||
128832676|NCT02827201|463683586|FG000|Overall Study|Death|1|||
128832677|NCT02827201|463683587|FG001|Overall Study|Death|2|||
128832678|NCT02827201|463683586|FG000|Overall Study|Patients not treated|1|||
128832679|NCT02827201|463683587|FG001|Overall Study|Patients not treated|1|||
128832680|NCT00620854|463683588|FG000|Washout 1|Withdrawal by Subject|0|||
128832681|NCT00620854|463683589|FG001|Washout 1|Withdrawal by Subject|0|||
128832682|NCT00620854|463683590|FG002|Washout 1|Withdrawal by Subject|1|||
128832683|NCT00620854|463683591|FG003|Washout 1|Withdrawal by Subject|1|||
128832684|NCT00620854|463683592|FG004|Washout 1|Withdrawal by Subject|0|||
128832685|NCT00620854|463683593|FG005|Washout 1|Withdrawal by Subject|0|||
128832686|NCT03345979|463683594|FG000|Overall Study|Withdrawal by Subject|20|||
128832687|NCT03345979|463683595|FG001|Overall Study|Withdrawal by Subject|31|||
128832688|NCT03345979|463683594|FG000|Overall Study|Adverse Event|10|||
128832689|NCT03345979|463683595|FG001|Overall Study|Adverse Event|11|||
128832690|NCT03345979|463683594|FG000|Overall Study|Lost to Follow-up|8|||
128832691|NCT03345979|463683595|FG001|Overall Study|Lost to Follow-up|9|||
128832692|NCT03345979|463683594|FG000|Overall Study|Lack of Efficacy|4|||
128832693|NCT03345979|463683595|FG001|Overall Study|Lack of Efficacy|2|||
128832694|NCT03345979|463683594|FG000|Overall Study|Protocol Violation|1|||
128832695|NCT03345979|463683595|FG001|Overall Study|Protocol Violation|3|||
128832696|NCT03345979|463683594|FG000|Overall Study|Physician Decision|0|||
128832697|NCT03345979|463683595|FG001|Overall Study|Physician Decision|2|||
128832698|NCT00487240|463683598|FG000|Overall Study|Withdrawal by Subject|12|||
128832699|NCT00487240|463683599|FG001|Overall Study|Withdrawal by Subject|6|||
128832700|NCT00487240|463683598|FG000|Overall Study|Lost to Follow-up|7|||
128832701|NCT00487240|463683599|FG001|Overall Study|Lost to Follow-up|6|||
128832702|NCT00487240|463683598|FG000|Overall Study|Adverse Event|0|||
128832703|NCT00487240|463683599|FG001|Overall Study|Adverse Event|4|||
128832704|NCT00487240|463683598|FG000|Overall Study|Protocol Violation|5|||
128832705|NCT00487240|463683599|FG001|Overall Study|Protocol Violation|5|||
128832706|NCT00487240|463683598|FG000|Overall Study|Entry Criteria Not Met|3|||
128832707|NCT00487240|463683599|FG001|Overall Study|Entry Criteria Not Met|4|||
128832708|NCT00487240|463683598|FG000|Overall Study|Sponsor Decision|2|||
128832709|NCT00487240|463683599|FG001|Overall Study|Sponsor Decision|1|||
128832710|NCT00487240|463683598|FG000|Overall Study|Physician Decision|2|||
128832711|NCT00487240|463683599|FG001|Overall Study|Physician Decision|0|||
128832712|NCT02095145|463683600|FG000|Overall Study|Withdrawal by Subject|1|||
128832713|NCT02095145|463683601|FG001|Overall Study|Withdrawal by Subject|0|||
128832714|NCT02630186|463683602|FG000|Overall Study|Withdrawal by Subject|1|||
128832715|NCT00670488|463683604|FG000|Overall Study|Adverse Event|0|||
128832716|NCT00670488|463683605|FG001|Overall Study|Adverse Event|7|||
128832717|NCT00670488|463683606|FG002|Overall Study|Adverse Event|0|||
128832718|NCT00670488|463683607|FG003|Overall Study|Adverse Event|3|||
128832719|NCT00670488|463683608|FG004|Overall Study|Adverse Event|1|||
128832720|NCT00670488|463683609|FG005|Overall Study|Adverse Event|1|||
128832721|NCT00670488|463683610|FG006|Overall Study|Adverse Event|5|||
128832722|NCT00670488|463683611|FG007|Overall Study|Adverse Event|1|||
128832723|NCT00670488|463683612|FG008|Overall Study|Adverse Event|0|||
128832724|NCT00670488|463683613|FG009|Overall Study|Adverse Event|1|||
128832725|NCT00670488|463683604|FG000|Overall Study|Physician Decision|1|||
128832726|NCT00670488|463683605|FG001|Overall Study|Physician Decision|9|||
128832727|NCT00670488|463683606|FG002|Overall Study|Physician Decision|0|||
128832728|NCT00670488|463683607|FG003|Overall Study|Physician Decision|1|||
128832729|NCT00670488|463683608|FG004|Overall Study|Physician Decision|0|||
128832730|NCT00670488|463683609|FG005|Overall Study|Physician Decision|0|||
128832731|NCT00670488|463683610|FG006|Overall Study|Physician Decision|0|||
128832732|NCT00670488|463683611|FG007|Overall Study|Physician Decision|0|||
128832733|NCT00670488|463683612|FG008|Overall Study|Physician Decision|0|||
128832734|NCT00670488|463683613|FG009|Overall Study|Physician Decision|0|||
128832735|NCT00670488|463683604|FG000|Overall Study|Progressive Disease|2|||
128832736|NCT00670488|463683605|FG001|Overall Study|Progressive Disease|41|||
128832737|NCT00670488|463683606|FG002|Overall Study|Progressive Disease|3|||
128832738|NCT00670488|463683607|FG003|Overall Study|Progressive Disease|2|||
128832739|NCT00670488|463683608|FG004|Overall Study|Progressive Disease|2|||
128832740|NCT00670488|463683609|FG005|Overall Study|Progressive Disease|4|||
128832741|NCT00670488|463683610|FG006|Overall Study|Progressive Disease|11|||
128832742|NCT00670488|463683611|FG007|Overall Study|Progressive Disease|2|||
128832743|NCT00670488|463683612|FG008|Overall Study|Progressive Disease|2|||
128832744|NCT00670488|463683613|FG009|Overall Study|Progressive Disease|1|||
128832745|NCT00670488|463683604|FG000|Overall Study|Withdrawal by Subject|0|||
128832746|NCT00670488|463683605|FG001|Overall Study|Withdrawal by Subject|1|||
128832747|NCT00670488|463683606|FG002|Overall Study|Withdrawal by Subject|0|||
128832748|NCT00670488|463683607|FG003|Overall Study|Withdrawal by Subject|1|||
128832749|NCT00670488|463683608|FG004|Overall Study|Withdrawal by Subject|0|||
128832750|NCT00670488|463683609|FG005|Overall Study|Withdrawal by Subject|0|||
128832751|NCT00670488|463683610|FG006|Overall Study|Withdrawal by Subject|1|||
128832752|NCT00670488|463683611|FG007|Overall Study|Withdrawal by Subject|0|||
128832753|NCT00670488|463683612|FG008|Overall Study|Withdrawal by Subject|1|||
128832754|NCT00670488|463683613|FG009|Overall Study|Withdrawal by Subject|0|||
128832755|NCT01124045|463683617|FG000|Overall Study|Lost to Follow-up|0|||
128832756|NCT01124045|463683618|FG001|Overall Study|Lost to Follow-up|1|||
128832757|NCT01124045|463683617|FG000|Overall Study|Physician Decision|0|||
128832758|NCT01124045|463683618|FG001|Overall Study|Physician Decision|2|||
128832759|NCT05553366|463683619|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
128832760|NCT05553366|463683620|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
128832761|NCT05553366|463683621|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
128832762|NCT05553366|463683619|FG000|Overall Study|Lost to Follow-up|3|||
128832763|NCT05553366|463683620|FG001|Overall Study|Lost to Follow-up|3|||
128832764|NCT05553366|463683621|FG002|Overall Study|Lost to Follow-up|3|||
128832765|NCT05553366|463683619|FG000|Overall Study|Other non-compliance|1|||
128832766|NCT05553366|463683620|FG001|Overall Study|Other non-compliance|1|||
128832767|NCT05553366|463683621|FG002|Overall Study|Other non-compliance|0|||
128832768|NCT05553366|463683619|FG000|Overall Study|Randomized but not dosed|0|||
128832769|NCT05553366|463683620|FG001|Overall Study|Randomized but not dosed|0|||
128832770|NCT05553366|463683621|FG002|Overall Study|Randomized but not dosed|2|||
128832771|NCT03205566|463683625|FG000|Phase 1|Protocol Violation|1|||
128832772|NCT03205566|463683626|FG001|Phase 1|Protocol Violation|1|||
128832773|NCT00836498|463683627|FG000|Overall Study|Adverse Event|1|||
128832774|NCT00836498|463683628|FG001|Overall Study|Adverse Event|0|||
128832775|NCT00836498|463683627|FG000|Overall Study|Lost to Follow-up|1|||
128832776|NCT00836498|463683628|FG001|Overall Study|Lost to Follow-up|0|||
128832777|NCT00836498|463683627|FG000|Overall Study|Withdrawal by Subject|2|||
128832778|NCT00836498|463683628|FG001|Overall Study|Withdrawal by Subject|1|||
128832779|NCT01034306|463683629|FG000|Overall Study|Adverse Event|1|||
128832780|NCT01034306|463683630|FG001|Overall Study|Adverse Event|0|||
128832781|NCT01034306|463683629|FG000|Overall Study|Lost to Follow-up|0|||
128832782|NCT01034306|463683630|FG001|Overall Study|Lost to Follow-up|1|||
128832783|NCT01034306|463683629|FG000|Overall Study|Withdrawal by Subject|2|||
128832784|NCT01034306|463683630|FG001|Overall Study|Withdrawal by Subject|2|||
128832785|NCT01034306|463683629|FG000|Overall Study|hospitalized and decided to stop|1|||
128832786|NCT01034306|463683630|FG001|Overall Study|hospitalized and decided to stop|0|||
128832787|NCT01034306|463683629|FG000|Overall Study|Noncomplience|1|||
128832788|NCT01034306|463683630|FG001|Overall Study|Noncomplience|0|||
128832789|NCT01619059|463683633|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
128832790|NCT01619059|463683634|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
128832791|NCT01619059|463683633|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
128832792|NCT01619059|463683634|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
128832793|NCT01619059|463683633|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
128832794|NCT01619059|463683634|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
128832795|NCT01619059|463683633|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
128832796|NCT01619059|463683634|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
128832797|NCT01619059|463683633|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
128832798|NCT01619059|463683634|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
128832799|NCT01619059|463683633|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
128832800|NCT01619059|463683634|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
128832801|NCT01619059|463683633|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
128832802|NCT01619059|463683634|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
128832803|NCT01619059|463683633|FG000|Long-Term (LT) Treatment Period|Death|1|||
128832804|NCT01619059|463683634|FG001|Long-Term (LT) Treatment Period|Death|0|||
128832805|NCT01619059|463683633|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
128832806|NCT01619059|463683634|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
128832807|NCT01619059|463683633|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
128832808|NCT01619059|463683634|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
128832809|NCT01968967|463683637|FG000|Treatment Period|Other|22|||
128832810|NCT01968967|463683638|FG001|Treatment Period|Other|22|||
128832811|NCT01968967|463683639|FG002|Treatment Period|Other|0|||
128832812|NCT01968967|463683640|FG003|Treatment Period|Other|0|||
128832813|NCT01968967|463683641|FG004|Treatment Period|Other|0|||
128832814|NCT01968967|463683637|FG000|Treatment Period|Withdrawal by Subject|71|||
128832815|NCT01968967|463683638|FG001|Treatment Period|Withdrawal by Subject|61|||
128832816|NCT01968967|463683639|FG002|Treatment Period|Withdrawal by Subject|0|||
128832817|NCT01968967|463683640|FG003|Treatment Period|Withdrawal by Subject|0|||
128832818|NCT01968967|463683641|FG004|Treatment Period|Withdrawal by Subject|0|||
128832819|NCT01968967|463683637|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
128832820|NCT01968967|463683638|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
128832821|NCT01968967|463683639|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
128832822|NCT01968967|463683640|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
128832823|NCT01968967|463683641|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
128832824|NCT01968967|463683637|FG000|Treatment Period|Lost to Follow-up|26|||
128832825|NCT01968967|463683638|FG001|Treatment Period|Lost to Follow-up|31|||
128832826|NCT01968967|463683639|FG002|Treatment Period|Lost to Follow-up|0|||
128832827|NCT01968967|463683640|FG003|Treatment Period|Lost to Follow-up|0|||
128832828|NCT01968967|463683641|FG004|Treatment Period|Lost to Follow-up|0|||
128832829|NCT01968967|463683637|FG000|Treatment Period|Protocol Violation|1|||
128832830|NCT01968967|463683638|FG001|Treatment Period|Protocol Violation|2|||
128832831|NCT01968967|463683639|FG002|Treatment Period|Protocol Violation|0|||
128832832|NCT01968967|463683640|FG003|Treatment Period|Protocol Violation|0|||
128832833|NCT01968967|463683641|FG004|Treatment Period|Protocol Violation|0|||
128832834|NCT01968967|463683637|FG000|Treatment Period|Adverse Event|9|||
128832835|NCT01968967|463683638|FG001|Treatment Period|Adverse Event|8|||
128832836|NCT01968967|463683639|FG002|Treatment Period|Adverse Event|0|||
128832837|NCT01968967|463683640|FG003|Treatment Period|Adverse Event|0|||
128832838|NCT01968967|463683641|FG004|Treatment Period|Adverse Event|0|||
128832839|NCT01968967|463683637|FG000|Treatment Period|Death|9|||
128832840|NCT01968967|463683638|FG001|Treatment Period|Death|2|||
128832841|NCT01968967|463683639|FG002|Treatment Period|Death|0|||
128832842|NCT01968967|463683640|FG003|Treatment Period|Death|0|||
128832843|NCT01968967|463683641|FG004|Treatment Period|Death|0|||
128832844|NCT01968967|463683637|FG000|Treatment Period|Randomized Not Treated|6|||
128832845|NCT01968967|463683638|FG001|Treatment Period|Randomized Not Treated|5|||
128832846|NCT01968967|463683639|FG002|Treatment Period|Randomized Not Treated|0|||
128832847|NCT01968967|463683640|FG003|Treatment Period|Randomized Not Treated|0|||
128832848|NCT01968967|463683641|FG004|Treatment Period|Randomized Not Treated|0|||
128832849|NCT01968967|463683637|FG000|Extension Period|Withdrew Consent|0|||
128832850|NCT01968967|463683638|FG001|Extension Period|Withdrew Consent|0|||
128832851|NCT01968967|463683639|FG002|Extension Period|Withdrew Consent|2|||
128832852|NCT01968967|463683640|FG003|Extension Period|Withdrew Consent|0|||
128832853|NCT01968967|463683641|FG004|Extension Period|Withdrew Consent|5|||
128832854|NCT03418545|463683642|FG000|Overall Study|Withdrawal by Participant|2|||
128832855|NCT03418545|463683643|FG001|Overall Study|Withdrawal by Participant|4|||
128832856|NCT03418545|463683642|FG000|Overall Study|Lost to Follow-up|3|||
128832857|NCT03418545|463683643|FG001|Overall Study|Lost to Follow-up|5|||
128832858|NCT03418545|463683642|FG000|Overall Study|Reason Not Specified|0|||
128832859|NCT03418545|463683643|FG001|Overall Study|Reason Not Specified|1|||
128832860|NCT03418545|463683642|FG000|Overall Study|Missing Completion Status|0|||
128832861|NCT03418545|463683643|FG001|Overall Study|Missing Completion Status|1|||
128832862|NCT03567616|463683661|FG000|Overall Study|Disease progression|4|||
128832863|NCT03567616|463683661|FG000|Overall Study|Withdrawal by Subject|1|||
128832864|NCT03567616|463683661|FG000|Overall Study|Physician Decision|1|||
128832865|NCT03567616|463683661|FG000|Overall Study|Death|1|||
128832866|NCT03567616|463683661|FG000|Overall Study|Adverse Event|1|||
128832867|NCT01074242|463683662|FG000|Overall Study|Case report before date of contract|40|||
128832868|NCT01074242|463683662|FG000|Overall Study|Lost to Follow-up|1|||
128832869|NCT01074242|463683662|FG000|Overall Study|Case report unclear|6|||
128832870|NCT01074242|463683662|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
128832871|NCT01074242|463683662|FG000|Overall Study|Duplicate Case Report Form|5|||
128832872|NCT01957163|463683668|FG000|Overall Study|Adverse Event|5|||
128832873|NCT01957163|463683669|FG001|Overall Study|Adverse Event|2|||
128832874|NCT01957163|463683670|FG002|Overall Study|Adverse Event|4|||
128832875|NCT01957163|463683668|FG000|Overall Study|Lack of Efficacy|5|||
128832876|NCT01957163|463683669|FG001|Overall Study|Lack of Efficacy|4|||
128832877|NCT01957163|463683670|FG002|Overall Study|Lack of Efficacy|9|||
128832878|NCT01957163|463683668|FG000|Overall Study|Protocol Violation|1|||
128832879|NCT01957163|463683669|FG001|Overall Study|Protocol Violation|2|||
128832880|NCT01957163|463683670|FG002|Overall Study|Protocol Violation|0|||
128832881|NCT01957163|463683668|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
128832882|NCT01957163|463683669|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
128832883|NCT01957163|463683670|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
128832884|NCT01957163|463683668|FG000|Overall Study|Lost to Follow-up|0|||
128832885|NCT01957163|463683669|FG001|Overall Study|Lost to Follow-up|1|||
128832886|NCT01957163|463683670|FG002|Overall Study|Lost to Follow-up|0|||
128832887|NCT01957163|463683668|FG000|Overall Study|Withdrawal by Subject|4|||
128832888|NCT01957163|463683669|FG001|Overall Study|Withdrawal by Subject|2|||
128832889|NCT01957163|463683670|FG002|Overall Study|Withdrawal by Subject|4|||
128832890|NCT00641537|463683673|FG000|96-week Period|Adverse Event|0|||
128832891|NCT00641537|463683674|FG001|96-week Period|Adverse Event|1|||
128832892|NCT00641537|463683675|FG002|96-week Period|Adverse Event|3|||
128832893|NCT00641537|463683676|FG003|96-week Period|Adverse Event|0|||
128832894|NCT00641537|463683677|FG004|96-week Period|Adverse Event|2|||
128832895|NCT00641537|463683678|FG005|96-week Period|Adverse Event|0|||
128832896|NCT00641537|463683679|FG006|96-week Period|Adverse Event|0|||
128832897|NCT00641537|463683680|FG007|96-week Period|Adverse Event|0|||
128832898|NCT00641537|463683673|FG000|96-week Period|Lost to Follow-up|3|||
128832899|NCT00641537|463683674|FG001|96-week Period|Lost to Follow-up|1|||
128832900|NCT00641537|463683675|FG002|96-week Period|Lost to Follow-up|2|||
128832901|NCT00641537|463683676|FG003|96-week Period|Lost to Follow-up|2|||
128832902|NCT00641537|463683677|FG004|96-week Period|Lost to Follow-up|4|||
128832903|NCT00641537|463683678|FG005|96-week Period|Lost to Follow-up|0|||
128832904|NCT00641537|463683679|FG006|96-week Period|Lost to Follow-up|1|||
128832905|NCT00641537|463683680|FG007|96-week Period|Lost to Follow-up|0|||
128832906|NCT00641537|463683673|FG000|96-week Period|Protocol Violation|0|||
128832907|NCT00641537|463683674|FG001|96-week Period|Protocol Violation|1|||
128832908|NCT00641537|463683675|FG002|96-week Period|Protocol Violation|0|||
128832909|NCT00641537|463683676|FG003|96-week Period|Protocol Violation|1|||
128832910|NCT00641537|463683677|FG004|96-week Period|Protocol Violation|0|||
128832911|NCT00641537|463683678|FG005|96-week Period|Protocol Violation|1|||
128832912|NCT00641537|463683679|FG006|96-week Period|Protocol Violation|0|||
128832913|NCT00641537|463683680|FG007|96-week Period|Protocol Violation|0|||
128832914|NCT00641537|463683673|FG000|96-week Period|Death|2|||
128832915|NCT00641537|463683674|FG001|96-week Period|Death|0|||
128832916|NCT00641537|463683675|FG002|96-week Period|Death|1|||
128832917|NCT00641537|463683676|FG003|96-week Period|Death|0|||
128832918|NCT00641537|463683677|FG004|96-week Period|Death|0|||
128832919|NCT00641537|463683678|FG005|96-week Period|Death|0|||
128832920|NCT00641537|463683679|FG006|96-week Period|Death|0|||
128832921|NCT00641537|463683680|FG007|96-week Period|Death|0|||
128832922|NCT00641537|463683673|FG000|96-week Period|Other|4|||
128832923|NCT00641537|463683674|FG001|96-week Period|Other|7|||
128832924|NCT00641537|463683675|FG002|96-week Period|Other|14|||
128832925|NCT00641537|463683676|FG003|96-week Period|Other|9|||
128832926|NCT00641537|463683677|FG004|96-week Period|Other|11|||
128832927|NCT00641537|463683678|FG005|96-week Period|Other|6|||
128832928|NCT00641537|463683679|FG006|96-week Period|Other|4|||
128832929|NCT00641537|463683680|FG007|96-week Period|Other|6|||
128832930|NCT00641537|463683673|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
128832931|NCT00641537|463683674|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
128832932|NCT00641537|463683675|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
128832933|NCT00641537|463683676|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
128832934|NCT00641537|463683677|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
128832935|NCT00641537|463683678|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
128832936|NCT00641537|463683679|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
128832937|NCT00641537|463683680|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
128832938|NCT00641537|463683673|FG000|24-Week Supplemental Follow-up Period|Other|0|||
128832939|NCT00641537|463683674|FG001|24-Week Supplemental Follow-up Period|Other|2|||
128832940|NCT00641537|463683675|FG002|24-Week Supplemental Follow-up Period|Other|2|||
128832941|NCT00641537|463683676|FG003|24-Week Supplemental Follow-up Period|Other|1|||
128832942|NCT00641537|463683677|FG004|24-Week Supplemental Follow-up Period|Other|3|||
128832943|NCT00641537|463683678|FG005|24-Week Supplemental Follow-up Period|Other|0|||
128832944|NCT00641537|463683679|FG006|24-Week Supplemental Follow-up Period|Other|1|||
128832945|NCT00641537|463683680|FG007|24-Week Supplemental Follow-up Period|Other|1|||
128832946|NCT03697603|463683690|FG000|Overall Study|Adverse Event|3|||
128832947|NCT03697603|463683691|FG001|Overall Study|Adverse Event|18|||
128832948|NCT03697603|463683692|FG002|Overall Study|Adverse Event|3|||
128832949|NCT03697603|463683690|FG000|Overall Study|Physician Decision|1|||
128832950|NCT03697603|463683691|FG001|Overall Study|Physician Decision|0|||
128832951|NCT03697603|463683692|FG002|Overall Study|Physician Decision|2|||
128832952|NCT03697603|463683690|FG000|Overall Study|Protocol Violation|3|||
128832953|NCT03697603|463683691|FG001|Overall Study|Protocol Violation|8|||
128832954|NCT03697603|463683692|FG002|Overall Study|Protocol Violation|5|||
128832955|NCT03697603|463683690|FG000|Overall Study|Withdrawal by Subject|5|||
128832956|NCT03697603|463683691|FG001|Overall Study|Withdrawal by Subject|1|||
128832957|NCT03697603|463683692|FG002|Overall Study|Withdrawal by Subject|1|||
128832958|NCT03697603|463683690|FG000|Overall Study|Protocol Violation|0|||
128832959|NCT03697603|463683691|FG001|Overall Study|Protocol Violation|0|||
128832960|NCT03697603|463683692|FG002|Overall Study|Protocol Violation|1|||
128832961|NCT02686658|463683693|FG000|Overall Study|Adverse Event|0|||
128832962|NCT02686658|463683694|FG001|Overall Study|Adverse Event|0|||
128832963|NCT02686658|463683695|FG002|Overall Study|Adverse Event|1|||
128832964|NCT02686658|463683696|FG003|Overall Study|Adverse Event|1|||
128832965|NCT02686658|463683697|FG004|Overall Study|Adverse Event|2|||
128832966|NCT02686658|463683698|FG005|Overall Study|Adverse Event|1|||
128832967|NCT02686658|463683693|FG000|Overall Study|Investigator decision|0|||
128832968|NCT02686658|463683694|FG001|Overall Study|Investigator decision|0|||
128832969|NCT02686658|463683695|FG002|Overall Study|Investigator decision|0|||
128832970|NCT02686658|463683696|FG003|Overall Study|Investigator decision|1|||
128832971|NCT02686658|463683697|FG004|Overall Study|Investigator decision|2|||
128832972|NCT02686658|463683698|FG005|Overall Study|Investigator decision|1|||
128832973|NCT02686658|463683693|FG000|Overall Study|Sponsor decision|1|||
128832974|NCT02686658|463683694|FG001|Overall Study|Sponsor decision|2|||
128832975|NCT02686658|463683695|FG002|Overall Study|Sponsor decision|1|||
128832976|NCT02686658|463683696|FG003|Overall Study|Sponsor decision|5|||
128832977|NCT02686658|463683697|FG004|Overall Study|Sponsor decision|13|||
128832978|NCT02686658|463683698|FG005|Overall Study|Sponsor decision|2|||
128832979|NCT02686658|463683693|FG000|Overall Study|Lost to Follow-up|0|||
128832980|NCT02686658|463683694|FG001|Overall Study|Lost to Follow-up|0|||
128832981|NCT02686658|463683695|FG002|Overall Study|Lost to Follow-up|2|||
128832982|NCT02686658|463683696|FG003|Overall Study|Lost to Follow-up|0|||
128832983|NCT02686658|463683697|FG004|Overall Study|Lost to Follow-up|0|||
128832984|NCT02686658|463683698|FG005|Overall Study|Lost to Follow-up|1|||
128832985|NCT02686658|463683693|FG000|Overall Study|Death|1|||
128832986|NCT02686658|463683694|FG001|Overall Study|Death|0|||
128832987|NCT02686658|463683695|FG002|Overall Study|Death|0|||
128832988|NCT02686658|463683696|FG003|Overall Study|Death|1|||
128832989|NCT02686658|463683697|FG004|Overall Study|Death|1|||
128832990|NCT02686658|463683698|FG005|Overall Study|Death|1|||
128832991|NCT02686658|463683693|FG000|Overall Study|Withdrawal by Subject|2|||
128832992|NCT02686658|463683694|FG001|Overall Study|Withdrawal by Subject|5|||
128832993|NCT02686658|463683695|FG002|Overall Study|Withdrawal by Subject|4|||
128832994|NCT02686658|463683696|FG003|Overall Study|Withdrawal by Subject|4|||
128832995|NCT02686658|463683697|FG004|Overall Study|Withdrawal by Subject|17|||
128832996|NCT02686658|463683698|FG005|Overall Study|Withdrawal by Subject|8|||
128832997|NCT02686658|463683693|FG000|Overall Study|Placed in hospice care|0|||
128832998|NCT02686658|463683694|FG001|Overall Study|Placed in hospice care|0|||
128832999|NCT02686658|463683695|FG002|Overall Study|Placed in hospice care|1|||
128833000|NCT02686658|463683696|FG003|Overall Study|Placed in hospice care|0|||
128833001|NCT02686658|463683697|FG004|Overall Study|Placed in hospice care|0|||
128833002|NCT02686658|463683698|FG005|Overall Study|Placed in hospice care|0|||
128833003|NCT02686658|463683693|FG000|Overall Study|Participant non-compliance|0|||
128833004|NCT02686658|463683694|FG001|Overall Study|Participant non-compliance|0|||
128833005|NCT02686658|463683695|FG002|Overall Study|Participant non-compliance|0|||
128833006|NCT02686658|463683696|FG003|Overall Study|Participant non-compliance|0|||
128833007|NCT02686658|463683697|FG004|Overall Study|Participant non-compliance|0|||
128833008|NCT02686658|463683698|FG005|Overall Study|Participant non-compliance|1|||
128833009|NCT02686658|463683693|FG000|Overall Study|Concern over coronavirus disease care|0|||
128833010|NCT02686658|463683694|FG001|Overall Study|Concern over coronavirus disease care|0|||
128833011|NCT02686658|463683695|FG002|Overall Study|Concern over coronavirus disease care|0|||
128833012|NCT02686658|463683696|FG003|Overall Study|Concern over coronavirus disease care|0|||
128833013|NCT02686658|463683697|FG004|Overall Study|Concern over coronavirus disease care|2|||
128833014|NCT02686658|463683698|FG005|Overall Study|Concern over coronavirus disease care|1|||
128833015|NCT00467272|463683701|FG000|Overall Study|Pneumonia|2|||
128833016|NCT00467272|463683701|FG000|Overall Study|Thrombophlebitis|1|||
128833017|NCT00570505|463683702|FG000|Overall Study|Adverse Event|7|||
128833018|NCT00570505|463683702|FG000|Overall Study|Withdrawal by Subject|7|||
128833019|NCT00570505|463683702|FG000|Overall Study|Lost to Follow-up|23|||
128833020|NCT00570505|463683702|FG000|Overall Study|Other loss to follow-up|4|||
128833021|NCT00614614|463683705|FG000|Primary Vaccination Phase|Adverse Event|6|||
128833022|NCT00614614|463683706|FG001|Primary Vaccination Phase|Adverse Event|0|||
128833023|NCT00614614|463683707|FG002|Primary Vaccination Phase|Adverse Event|0|||
128833024|NCT00614614|463683708|FG003|Primary Vaccination Phase|Adverse Event|0|||
128833025|NCT00614614|463683709|FG004|Primary Vaccination Phase|Adverse Event|0|||
128833026|NCT00614614|463683705|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
128833027|NCT00614614|463683706|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
128833028|NCT00614614|463683707|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
128833029|NCT00614614|463683708|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
128833030|NCT00614614|463683709|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
128833031|NCT00614614|463683705|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
128833032|NCT00614614|463683706|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
128833033|NCT00614614|463683707|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
128833034|NCT00614614|463683708|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
128833035|NCT00614614|463683709|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
128833036|NCT00614614|463683705|FG000|Primary Vaccination Phase|Protocol Violation|9|||
128833037|NCT00614614|463683706|FG001|Primary Vaccination Phase|Protocol Violation|3|||
128833038|NCT00614614|463683707|FG002|Primary Vaccination Phase|Protocol Violation|0|||
128833039|NCT00614614|463683708|FG003|Primary Vaccination Phase|Protocol Violation|0|||
128833040|NCT00614614|463683709|FG004|Primary Vaccination Phase|Protocol Violation|0|||
128833041|NCT00614614|463683705|FG000|Primary Vaccination Phase|Other|4|||
128833042|NCT00614614|463683706|FG001|Primary Vaccination Phase|Other|0|||
128833043|NCT00614614|463683707|FG002|Primary Vaccination Phase|Other|0|||
128833044|NCT00614614|463683708|FG003|Primary Vaccination Phase|Other|0|||
128833045|NCT00614614|463683709|FG004|Primary Vaccination Phase|Other|0|||
128833046|NCT00614614|463683705|FG000|Booster Vaccination Phase|Adverse Event|0|||
128833047|NCT00614614|463683706|FG001|Booster Vaccination Phase|Adverse Event|0|||
128833048|NCT00614614|463683707|FG002|Booster Vaccination Phase|Adverse Event|1|||
128833049|NCT00614614|463683708|FG003|Booster Vaccination Phase|Adverse Event|1|||
128833050|NCT00614614|463683709|FG004|Booster Vaccination Phase|Adverse Event|0|||
128833051|NCT00614614|463683705|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
128833052|NCT00614614|463683706|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
128833053|NCT00614614|463683707|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
128833054|NCT00614614|463683708|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
128833055|NCT00614614|463683709|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
128833056|NCT00614614|463683705|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
128833057|NCT00614614|463683706|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
128833058|NCT00614614|463683707|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
128833059|NCT00614614|463683708|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
128833060|NCT00614614|463683709|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
128833061|NCT00614614|463683705|FG000|Booster Vaccination Phase|Protocol Violation|0|||
128833062|NCT00614614|463683706|FG001|Booster Vaccination Phase|Protocol Violation|0|||
128833063|NCT00614614|463683707|FG002|Booster Vaccination Phase|Protocol Violation|2|||
128833064|NCT00614614|463683708|FG003|Booster Vaccination Phase|Protocol Violation|3|||
128833065|NCT00614614|463683709|FG004|Booster Vaccination Phase|Protocol Violation|0|||
128833066|NCT00614614|463683705|FG000|Booster Vaccination Phase|Other|0|||
128833067|NCT00614614|463683706|FG001|Booster Vaccination Phase|Other|1|||
128833068|NCT00614614|463683707|FG002|Booster Vaccination Phase|Other|3|||
128833069|NCT00614614|463683708|FG003|Booster Vaccination Phase|Other|2|||
128833070|NCT00614614|463683709|FG004|Booster Vaccination Phase|Other|1|||
128833071|NCT05426109|463683710|FG000|Overall Study|Withdrawal by Subject|0|||
128833072|NCT05426109|463683711|FG001|Overall Study|Withdrawal by Subject|1|||
128833073|NCT05212285|463683712|FG000|Overall Study|Lack of Efficacy|12|||
128833074|NCT05212285|463683713|FG001|Overall Study|Lack of Efficacy|8|||
128833075|NCT05212285|463683712|FG000|Overall Study|Withdrawal by Subject|8|||
128833076|NCT05212285|463683713|FG001|Overall Study|Withdrawal by Subject|1|||
128833077|NCT05212285|463683712|FG000|Overall Study|Lost to Follow-up|13|||
128833078|NCT05212285|463683713|FG001|Overall Study|Lost to Follow-up|1|||
128833079|NCT05212285|463683712|FG000|Overall Study|miss data|21|||
128833080|NCT05212285|463683713|FG001|Overall Study|miss data|2|||
128833081|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
128833082|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
128833083|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
128833084|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
128833085|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
128833086|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
128833087|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
128833088|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
128833089|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
128833090|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
128833091|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
128833092|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
128833093|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
128833094|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
128833095|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
128833096|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
128833097|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
128833098|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
128833099|NCT02222493|463683714|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
128833100|NCT02222493|463683715|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
128833101|NCT02222493|463683714|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
128833102|NCT02222493|463683715|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
128833103|NCT02222493|463683714|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
128833104|NCT02222493|463683715|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
128833105|NCT02222493|463683714|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
128833106|NCT02222493|463683715|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
128833107|NCT02222493|463683714|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
128833108|NCT02222493|463683715|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
128833109|NCT02222493|463683714|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
128833110|NCT02222493|463683715|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
128833111|NCT02222493|463683714|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
128833112|NCT02222493|463683715|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
128833113|NCT02222493|463683714|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
128833114|NCT02222493|463683715|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
128833115|NCT02222493|463683714|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
128833116|NCT02222493|463683715|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
128833117|NCT02222493|463683714|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
128833118|NCT02222493|463683715|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
128833119|NCT02222493|463683714|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
128833120|NCT02222493|463683715|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
128833121|NCT02222493|463683714|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
128833122|NCT02222493|463683715|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
128833123|NCT02222493|463683714|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
128833124|NCT02222493|463683715|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
128833125|NCT03924869|463683716|FG000|Overall Study|Death|66|||
128833126|NCT03924869|463683717|FG001|Overall Study|Death|53|||
128833127|NCT03924869|463683716|FG000|Overall Study|Lost to Follow-up|2|||
128833128|NCT03924869|463683717|FG001|Overall Study|Lost to Follow-up|0|||
128833129|NCT03924869|463683716|FG000|Overall Study|Physician Decision|0|||
128833130|NCT03924869|463683717|FG001|Overall Study|Physician Decision|3|||
128833131|NCT03924869|463683716|FG000|Overall Study|Withdrawal by Subject|5|||
128833132|NCT03924869|463683717|FG001|Overall Study|Withdrawal by Subject|1|||
128833133|NCT03924869|463683716|FG000|Overall Study|Participants Ongoing|154|||
128833134|NCT03924869|463683717|FG001|Overall Study|Participants Ongoing|164|||
128833135|NCT04224272|463683720|FG000|Part 1 - Dose Finding|Death|4|||
128833136|NCT04224272|463683720|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
128833137|NCT04224272|463683720|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
128833138|NCT04224272|463683720|FG000|Part 2 - Dose Expansion|Death|10|||
128833139|NCT04224272|463683720|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
128833140|NCT02556918|463685735|FG000|Overall Study|Protocol Violation|5|||
128833141|NCT02556918|463685736|FG001|Overall Study|Protocol Violation|6|||
128833142|NCT02556918|463685735|FG000|Overall Study|Withdrawal by Subject|4|||
128833143|NCT02556918|463685736|FG001|Overall Study|Withdrawal by Subject|4|||
128833144|NCT00551421|463685747|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
128833145|NCT02634307|463685757|FG000|Overall Study|Adverse Event|50|||
128833146|NCT02634307|463685758|FG001|Overall Study|Adverse Event|24|||
128833147|NCT02634307|463685759|FG002|Overall Study|Adverse Event|14|||
128833148|NCT02634307|463685757|FG000|Overall Study|Lost to Follow-up|21|||
128833149|NCT02634307|463685758|FG001|Overall Study|Lost to Follow-up|5|||
128833150|NCT02634307|463685759|FG002|Overall Study|Lost to Follow-up|6|||
128833151|NCT02634307|463685757|FG000|Overall Study|Pregnancy|5|||
128833152|NCT02634307|463685758|FG001|Overall Study|Pregnancy|1|||
128833153|NCT02634307|463685759|FG002|Overall Study|Pregnancy|3|||
128833154|NCT02634307|463685757|FG000|Overall Study|Withdrawal by Subject|38|||
128833155|NCT02634307|463685758|FG001|Overall Study|Withdrawal by Subject|24|||
128833156|NCT02634307|463685759|FG002|Overall Study|Withdrawal by Subject|18|||
128833157|NCT02634307|463685757|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128833158|NCT02634307|463685758|FG001|Overall Study|Non-Compliance with Study Drug|2|||
128833159|NCT02634307|463685759|FG002|Overall Study|Non-Compliance with Study Drug|2|||
128833160|NCT02634307|463685757|FG000|Overall Study|Lack of Efficacy|1|||
128833161|NCT02634307|463685758|FG001|Overall Study|Lack of Efficacy|5|||
128833162|NCT02634307|463685759|FG002|Overall Study|Lack of Efficacy|3|||
128833163|NCT02634307|463685757|FG000|Overall Study|Physician Decision|7|||
128833164|NCT02634307|463685758|FG001|Overall Study|Physician Decision|5|||
128833165|NCT02634307|463685759|FG002|Overall Study|Physician Decision|5|||
128833166|NCT02634307|463685757|FG000|Overall Study|Reason not Specified|3|||
128833167|NCT02634307|463685758|FG001|Overall Study|Reason not Specified|5|||
128833168|NCT02634307|463685759|FG002|Overall Study|Reason not Specified|10|||
128833169|NCT02698475|463685760|FG000|Main Study Period|Lack of Efficacy|1|||
128833170|NCT02698475|463685760|FG000|Main Study Period|Protocol Violation|2|||
128833171|NCT02698475|463685760|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
128833172|NCT02698475|463685760|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
128833173|NCT02698475|463685760|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
128833174|NCT02698475|463685760|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
128833175|NCT02698475|463685760|FG000|Long-Term Extension Period|Other|1|||
128833176|NCT02132949|463685761|FG000|Overall Study|Death|7|||
128833177|NCT02132949|463685762|FG001|Overall Study|Death|13|||
128833178|NCT02132949|463685761|FG000|Overall Study|Lost to Follow-up|14|||
128833179|NCT02132949|463685762|FG001|Overall Study|Lost to Follow-up|4|||
128833180|NCT02132949|463685761|FG000|Overall Study|Withdrawal by Subject|6|||
128833181|NCT02132949|463685762|FG001|Overall Study|Withdrawal by Subject|5|||
128833182|NCT02132949|463685761|FG000|Overall Study|Noncompliance|5|||
128833183|NCT02132949|463685762|FG001|Overall Study|Noncompliance|1|||
128833184|NCT02132949|463685761|FG000|Overall Study|Physician Decision|3|||
128833185|NCT02132949|463685762|FG001|Overall Study|Physician Decision|1|||
128833186|NCT02132949|463685761|FG000|Overall Study|Disease Progression|3|||
128833187|NCT02132949|463685762|FG001|Overall Study|Disease Progression|0|||
128833188|NCT02132949|463685761|FG000|Overall Study|Adverse Event|2|||
128833189|NCT02132949|463685762|FG001|Overall Study|Adverse Event|1|||
128833190|NCT02132949|463685761|FG000|Overall Study|Withdrew Prior to Treatment|1|||
128833191|NCT02132949|463685762|FG001|Overall Study|Withdrew Prior to Treatment|2|||
128833192|NCT02132949|463685761|FG000|Overall Study|Reason Unspecified|0|||
128833193|NCT02132949|463685762|FG001|Overall Study|Reason Unspecified|1|||
128833194|NCT02148705|463685770|FG000|Overall Study|Death|2|||
128833195|NCT02148705|463685771|FG001|Overall Study|Death|0|||
128833196|NCT02148705|463685772|FG002|Overall Study|Death|0|||
128833197|NCT02148705|463685770|FG000|Overall Study|Lost to Follow-up|13|||
128833198|NCT02148705|463685771|FG001|Overall Study|Lost to Follow-up|4|||
128833199|NCT02148705|463685772|FG002|Overall Study|Lost to Follow-up|10|||
128833200|NCT02148705|463685770|FG000|Overall Study|Withdrawal by Subject|3|||
128833201|NCT02148705|463685771|FG001|Overall Study|Withdrawal by Subject|0|||
128833202|NCT02148705|463685772|FG002|Overall Study|Withdrawal by Subject|2|||
128833203|NCT02148705|463685770|FG000|Overall Study|Not Treated|0|||
128833204|NCT02148705|463685771|FG001|Overall Study|Not Treated|1|||
128833205|NCT02148705|463685772|FG002|Overall Study|Not Treated|5|||
128833206|NCT02310581|463685773|FG000|Overall Study|Adverse Event|1|||
128833207|NCT02310581|463685774|FG001|Overall Study|Adverse Event|1|||
128833208|NCT02310581|463685775|FG002|Overall Study|Adverse Event|1|||
128833209|NCT02310581|463685776|FG003|Overall Study|Adverse Event|0|||
128833210|NCT02310581|463685773|FG000|Overall Study|Withdrawal by Subject|2|||
128833211|NCT02310581|463685774|FG001|Overall Study|Withdrawal by Subject|1|||
128833212|NCT02310581|463685775|FG002|Overall Study|Withdrawal by Subject|0|||
128833213|NCT02310581|463685776|FG003|Overall Study|Withdrawal by Subject|1|||
128833214|NCT01673594|463685777|FG000|Overall Study|Adverse Event|3|||
128833215|NCT01673594|463685778|FG001|Overall Study|Adverse Event|1|||
128833216|NCT01673594|463685777|FG000|Overall Study|Lost to Follow-up|1|||
128833217|NCT01673594|463685778|FG001|Overall Study|Lost to Follow-up|0|||
128833218|NCT01673594|463685777|FG000|Overall Study|Physician Decision|2|||
128833219|NCT01673594|463685778|FG001|Overall Study|Physician Decision|4|||
128833220|NCT01673594|463685777|FG000|Overall Study|Withdrawal by Subject|0|||
128833221|NCT01673594|463685778|FG001|Overall Study|Withdrawal by Subject|1|||
128833222|NCT00999596|463685783|FG000|Overall Study|Statistical population not required|101|||
128833223|NCT00439218|463685786|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
128833224|NCT03176407|463685787|FG000|Overall Study|Protocol Violation|1|||
128833225|NCT03176407|463685787|FG000|Overall Study|human failure|1|||
128833226|NCT03176407|463685787|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
128833227|NCT01428583|463685790|FG000|Overall Study|Adverse Event|75|||
128833228|NCT01428583|463685790|FG000|Overall Study|Withdrawal by Subject|51|||
128833229|NCT01428583|463685790|FG000|Overall Study|Lack of Efficacy|37|||
128833230|NCT01428583|463685790|FG000|Overall Study|Lost to Follow-up|17|||
128833231|NCT01428583|463685790|FG000|Overall Study|Death|1|||
128833232|NCT01428583|463685790|FG000|Overall Study|Pregnancy|1|||
128833233|NCT01428583|463685790|FG000|Overall Study|Protocol Violation|1|||
128833234|NCT01428583|463685790|FG000|Overall Study|Physician Decision|12|||
128833235|NCT01428583|463685790|FG000|Overall Study|Non-compliant|25|||
128833236|NCT01428583|463685790|FG000|Overall Study|Confirmed positive urine drug test|8|||
128833237|NCT01428583|463685790|FG000|Overall Study|Sponsor's request|3|||
128833238|NCT01428583|463685790|FG000|Overall Study|Other|6|||
128833239|NCT02022657|463685792|FG000|Overall Study|Withdrawal by Subject|2|||
128833240|NCT02022657|463685793|FG001|Overall Study|Withdrawal by Subject|0|||
128833241|NCT02022657|463685794|FG002|Overall Study|Withdrawal by Subject|1|||
128833242|NCT02022657|463685795|FG003|Overall Study|Withdrawal by Subject|0|||
128833243|NCT02022657|463685796|FG004|Overall Study|Withdrawal by Subject|0|||
128833244|NCT02022657|463685797|FG005|Overall Study|Withdrawal by Subject|0|||
128833245|NCT02022657|463685792|FG000|Overall Study|Physician Decision|0|||
128833246|NCT02022657|463685793|FG001|Overall Study|Physician Decision|0|||
128833247|NCT02022657|463685794|FG002|Overall Study|Physician Decision|0|||
128833248|NCT02022657|463685795|FG003|Overall Study|Physician Decision|0|||
128833249|NCT02022657|463685796|FG004|Overall Study|Physician Decision|0|||
128833250|NCT02022657|463685797|FG005|Overall Study|Physician Decision|1|||
128833251|NCT02384382|463685802|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
128833252|NCT02384382|463685802|FG000|Overall Study|Death|1|||
128833253|NCT02384382|463685802|FG000|Overall Study|Adverse Event|1|||
128833254|NCT02384382|463685802|FG000|Overall Study|Disease progression|16|||
128833255|NCT00659373|463685803|FG000|Overall Study|Withdrawal by Subject|3|||
128833256|NCT00659373|463685804|FG001|Overall Study|Withdrawal by Subject|5|||
128833257|NCT00659373|463685803|FG000|Overall Study|Assessment Missed|2|||
128833258|NCT00659373|463685804|FG001|Overall Study|Assessment Missed|2|||
128833259|NCT02382640|463685805|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
128833260|NCT02382640|463685806|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
128833261|NCT02382640|463685807|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
128833262|NCT02382640|463685808|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
128833263|NCT03162614|463685811|FG000|Overall Study|Lost to Follow-up|2|||
128833264|NCT03162614|463685812|FG001|Overall Study|Lost to Follow-up|1|||
128833265|NCT03162614|463685813|FG002|Overall Study|Lost to Follow-up|1|||
128833266|NCT03162614|463685814|FG003|Overall Study|Lost to Follow-up|1|||
128833267|NCT03162614|463685815|FG004|Overall Study|Lost to Follow-up|2|||
128833268|NCT03162614|463685816|FG005|Overall Study|Lost to Follow-up|0|||
128833269|NCT03162614|463685811|FG000|Overall Study|Protocol Violation|0|||
128833270|NCT03162614|463685812|FG001|Overall Study|Protocol Violation|1|||
128833271|NCT03162614|463685813|FG002|Overall Study|Protocol Violation|0|||
128833272|NCT03162614|463685814|FG003|Overall Study|Protocol Violation|1|||
128833273|NCT03162614|463685815|FG004|Overall Study|Protocol Violation|0|||
128833274|NCT03162614|463685816|FG005|Overall Study|Protocol Violation|0|||
128833275|NCT03162614|463685811|FG000|Overall Study|Withdrawal by Subject|2|||
128833276|NCT03162614|463685812|FG001|Overall Study|Withdrawal by Subject|1|||
128833277|NCT03162614|463685813|FG002|Overall Study|Withdrawal by Subject|1|||
128833278|NCT03162614|463685814|FG003|Overall Study|Withdrawal by Subject|1|||
128833279|NCT03162614|463685815|FG004|Overall Study|Withdrawal by Subject|0|||
128833280|NCT03162614|463685816|FG005|Overall Study|Withdrawal by Subject|0|||
128833281|NCT03162614|463685811|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
128833282|NCT03162614|463685812|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
128833283|NCT03162614|463685813|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
128833284|NCT03162614|463685814|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
128833285|NCT03162614|463685815|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
128833286|NCT03162614|463685816|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
128833287|NCT05270460|463685817|FG000|Overall Study|Adverse Event|0|||
128833288|NCT05270460|463685818|FG001|Overall Study|Adverse Event|1|||
128833289|NCT05270460|463685819|FG002|Overall Study|Adverse Event|0|||
128833290|NCT05270460|463685817|FG000|Overall Study|Early Termination|0|||
128833291|NCT05270460|463685818|FG001|Overall Study|Early Termination|1|||
128833292|NCT05270460|463685819|FG002|Overall Study|Early Termination|0|||
128833293|NCT00380250|463685820|FG000|Overall Study|Withdrawal by Subject|39|||
128833294|NCT00380250|463685821|FG001|Overall Study|Withdrawal by Subject|28|||
128833295|NCT00380250|463685820|FG000|Overall Study|Adverse Event|20|||
128833296|NCT00380250|463685821|FG001|Overall Study|Adverse Event|9|||
128833297|NCT00380250|463685820|FG000|Overall Study|Lack of Efficacy|10|||
128833298|NCT00380250|463685821|FG001|Overall Study|Lack of Efficacy|8|||
128833299|NCT00380250|463685820|FG000|Overall Study|Protocol Violation|15|||
128833300|NCT00380250|463685821|FG001|Overall Study|Protocol Violation|5|||
128833301|NCT00380250|463685820|FG000|Overall Study|Lost to Follow-up|14|||
128833302|NCT00380250|463685821|FG001|Overall Study|Lost to Follow-up|5|||
128833303|NCT00380250|463685820|FG000|Overall Study|Physician Decision|1|||
128833304|NCT00380250|463685821|FG001|Overall Study|Physician Decision|0|||
128833305|NCT01065779|463685822|FG000|Overall Study|Duplicate Investigation|1|||
128833306|NCT01065779|463685822|FG000|Overall Study|Investigation Before Contract Date|37|||
128833307|NCT01065779|463685822|FG000|Overall Study|Non-enrollment Period Administration|10|||
128833308|NCT01065779|463685822|FG000|Overall Study|Not Administered With Study Drug|17|||
128833309|NCT01065779|463685822|FG000|Overall Study|Failed to Follow-up|10|||
128833310|NCT01065779|463685822|FG000|Overall Study|Inclusion Criteria Violation|7|||
128833311|NCT02630966|463685823|FG000|Overall Study|Adverse Event|1|||
128833312|NCT02630966|463685824|FG001|Overall Study|Adverse Event|3|||
128833313|NCT02630966|463685823|FG000|Overall Study|Significant Protocol Deviation|0|||
128833314|NCT02630966|463685824|FG001|Overall Study|Significant Protocol Deviation|2|||
128833315|NCT02630966|463685823|FG000|Overall Study|Voluntary Withdrawal|1|||
128833316|NCT02630966|463685824|FG001|Overall Study|Voluntary Withdrawal|1|||
128833317|NCT02630966|463685823|FG000|Overall Study|Lack of Efficacy|0|||
128833318|NCT02630966|463685824|FG001|Overall Study|Lack of Efficacy|2|||
128833319|NCT01801007|463685825|FG000|Overall Study|Adverse Event|2|||
128833320|NCT01801007|463685825|FG000|Overall Study|Lost to Follow-up|4|||
128833321|NCT01801007|463685825|FG000|Overall Study|Withdrawal by Subject|5|||
128833322|NCT00665392|463685826|FG000|Overall Study|not treated|1|||
128833323|NCT00243867|463685827|FG000|Overall Study|Adverse Event|24|||
128833324|NCT00243867|463685828|FG001|Overall Study|Adverse Event|34|||
128833325|NCT00243867|463685827|FG000|Overall Study|Lack of Efficacy|115|||
128833326|NCT00243867|463685828|FG001|Overall Study|Lack of Efficacy|78|||
128833327|NCT00243867|463685827|FG000|Overall Study|Withdrawal by Subject|11|||
128833328|NCT00243867|463685828|FG001|Overall Study|Withdrawal by Subject|23|||
128833329|NCT00243867|463685827|FG000|Overall Study|Lost to Follow-up|2|||
128833330|NCT00243867|463685828|FG001|Overall Study|Lost to Follow-up|1|||
128833331|NCT00243867|463685827|FG000|Overall Study|Physician Decision|2|||
128833332|NCT00243867|463685828|FG001|Overall Study|Physician Decision|7|||
128833333|NCT00243867|463685827|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
128833334|NCT00243867|463685828|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
128833335|NCT01321073|463685829|FG000|Overall Study|Did not attempt implant|4|||
128833336|NCT01321073|463685829|FG000|Overall Study|Death|3|||
128833337|NCT01638000|463685830|FG000|Overall Study|Randomized but Never Received Drug|7|||
128833338|NCT01638000|463685831|FG001|Overall Study|Randomized but Never Received Drug|10|||
128833339|NCT01638000|463685830|FG000|Overall Study|Adverse Event|14|||
128833340|NCT01638000|463685831|FG001|Overall Study|Adverse Event|16|||
128833341|NCT01638000|463685830|FG000|Overall Study|Lack of Efficacy|5|||
128833342|NCT01638000|463685831|FG001|Overall Study|Lack of Efficacy|6|||
128833343|NCT01638000|463685830|FG000|Overall Study|Protocol Violation|11|||
128833344|NCT01638000|463685831|FG001|Overall Study|Protocol Violation|13|||
128833345|NCT01638000|463685830|FG000|Overall Study|Withdrawal by Subject|21|||
128833346|NCT01638000|463685831|FG001|Overall Study|Withdrawal by Subject|24|||
128833347|NCT01638000|463685830|FG000|Overall Study|Miscellaneous|2|||
128833348|NCT01638000|463685831|FG001|Overall Study|Miscellaneous|2|||
128833349|NCT05352230|463685832|FG000|First Intervention (3 Months)|study terminated|2|||
128833350|NCT05352230|463685833|FG001|First Intervention (3 Months)|study terminated|2|||
128833351|NCT01683409|463685836|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
128833352|NCT01683409|463685837|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
128833353|NCT01683409|463685838|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
128833354|NCT01683409|463685839|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
128833355|NCT01683409|463685840|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
128833356|NCT01683409|463685836|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
128833357|NCT01683409|463685837|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
128833358|NCT01683409|463685838|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
128833359|NCT01683409|463685839|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
128833360|NCT01683409|463685840|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
128833361|NCT01683409|463685836|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
128833362|NCT01683409|463685837|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
128833363|NCT01683409|463685838|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
128833364|NCT01683409|463685839|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
128833365|NCT01683409|463685840|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
128833366|NCT01683409|463685836|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
128833367|NCT01683409|463685837|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
128833368|NCT01683409|463685838|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
128833369|NCT01683409|463685839|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
128833370|NCT01683409|463685840|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
128833371|NCT01683409|463685836|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
128833372|NCT01683409|463685837|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
128833373|NCT01683409|463685838|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
128833374|NCT01683409|463685839|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
128833375|NCT01683409|463685840|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
128833376|NCT01683409|463685836|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
128833377|NCT01683409|463685837|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
128833378|NCT01683409|463685838|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
128833379|NCT01683409|463685839|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
128833380|NCT01683409|463685840|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
128833381|NCT01683409|463685836|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
128833382|NCT01683409|463685837|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
128833383|NCT01683409|463685838|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
128833384|NCT01683409|463685839|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
128833385|NCT01683409|463685840|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
128833386|NCT01683409|463685836|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
128833387|NCT01683409|463685837|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
128833388|NCT01683409|463685838|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
128833389|NCT01683409|463685839|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
128833390|NCT01683409|463685840|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
128833391|NCT01683409|463685836|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
128833392|NCT01683409|463685837|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
128833393|NCT01683409|463685838|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
128833394|NCT01683409|463685839|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
128833395|NCT01683409|463685840|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
128833396|NCT01683409|463685836|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
128833397|NCT01683409|463685837|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
128833398|NCT01683409|463685838|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
128833399|NCT01683409|463685839|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
128833400|NCT01683409|463685840|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
128833401|NCT01683409|463685836|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
128833402|NCT01683409|463685837|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
128833403|NCT01683409|463685838|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
128833404|NCT01683409|463685839|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
128833405|NCT01683409|463685840|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
128833406|NCT04218864|463685841|FG000|Overall Study|Lost to Follow-up|8|||
128833407|NCT04218864|463685842|FG001|Overall Study|Lost to Follow-up|4|||
128833408|NCT04218864|463685841|FG000|Overall Study|Withdrawal by Subject|1|||
128833409|NCT04218864|463685842|FG001|Overall Study|Withdrawal by Subject|3|||
128833410|NCT01227421|463685843|FG000|Overall Study|Lost to Follow-up|6|||
128833411|NCT01227421|463685844|FG001|Overall Study|Lost to Follow-up|7|||
128833412|NCT01227421|463685845|FG002|Overall Study|Lost to Follow-up|5|||
128833413|NCT01227421|463685843|FG000|Overall Study|Adverse Event|2|||
128833414|NCT01227421|463685844|FG001|Overall Study|Adverse Event|7|||
128833415|NCT01227421|463685845|FG002|Overall Study|Adverse Event|2|||
128833416|NCT01227421|463685843|FG000|Overall Study|Withdrawal by Subject|1|||
128833417|NCT01227421|463685844|FG001|Overall Study|Withdrawal by Subject|2|||
128833418|NCT01227421|463685845|FG002|Overall Study|Withdrawal by Subject|1|||
128833419|NCT01227421|463685843|FG000|Overall Study|Protocol Violation|1|||
128833420|NCT01227421|463685844|FG001|Overall Study|Protocol Violation|1|||
128833421|NCT01227421|463685845|FG002|Overall Study|Protocol Violation|2|||
128833422|NCT01227421|463685843|FG000|Overall Study|Randomized in error|1|||
128833423|NCT01227421|463685844|FG001|Overall Study|Randomized in error|1|||
128833424|NCT01227421|463685845|FG002|Overall Study|Randomized in error|0|||
128833425|NCT02499328|463685846|FG000|Overall Study|Withdrawal by Subject|1|||
128833426|NCT02499328|463685847|FG001|Overall Study|Withdrawal by Subject|1|||
128833427|NCT02499328|463685848|FG002|Overall Study|Withdrawal by Subject|5|||
128833428|NCT02499328|463685849|FG003|Overall Study|Withdrawal by Subject|3|||
128833429|NCT02499328|463685850|FG004|Overall Study|Withdrawal by Subject|5|||
128833430|NCT02499328|463685851|FG005|Overall Study|Withdrawal by Subject|0|||
128833431|NCT02499328|463685852|FG006|Overall Study|Withdrawal by Subject|0|||
128833432|NCT02499328|463685853|FG007|Overall Study|Withdrawal by Subject|0|||
128833433|NCT02499328|463685854|FG008|Overall Study|Withdrawal by Subject|2|||
128833434|NCT02499328|463685855|FG009|Overall Study|Withdrawal by Subject|2|||
128833435|NCT02499328|463685856|FG010|Overall Study|Withdrawal by Subject|0|||
128833436|NCT02499328|463685857|FG011|Overall Study|Withdrawal by Subject|3|||
128833437|NCT02499328|463685858|FG012|Overall Study|Withdrawal by Subject|7|||
128833438|NCT02499328|463685859|FG013|Overall Study|Withdrawal by Subject|3|||
128833439|NCT02499328|463685860|FG014|Overall Study|Withdrawal by Subject|1|||
128833440|NCT02499328|463685861|FG015|Overall Study|Withdrawal by Subject|0|||
128833441|NCT02499328|463685862|FG016|Overall Study|Withdrawal by Subject|0|||
128833442|NCT02499328|463685863|FG017|Overall Study|Withdrawal by Subject|3|||
128833443|NCT02499328|463685864|FG018|Overall Study|Withdrawal by Subject|0|||
128833444|NCT02499328|463685846|FG000|Overall Study|Lost to Follow-up|0|||
128833445|NCT02499328|463685847|FG001|Overall Study|Lost to Follow-up|1|||
128833446|NCT02499328|463685848|FG002|Overall Study|Lost to Follow-up|1|||
128833447|NCT02499328|463685849|FG003|Overall Study|Lost to Follow-up|2|||
128833448|NCT02499328|463685850|FG004|Overall Study|Lost to Follow-up|0|||
128833449|NCT02499328|463685851|FG005|Overall Study|Lost to Follow-up|0|||
128833450|NCT02499328|463685852|FG006|Overall Study|Lost to Follow-up|0|||
128833451|NCT02499328|463685853|FG007|Overall Study|Lost to Follow-up|2|||
128833452|NCT02499328|463685854|FG008|Overall Study|Lost to Follow-up|3|||
128833453|NCT02499328|463685855|FG009|Overall Study|Lost to Follow-up|0|||
128833454|NCT02499328|463685856|FG010|Overall Study|Lost to Follow-up|0|||
128833455|NCT02499328|463685857|FG011|Overall Study|Lost to Follow-up|0|||
128833456|NCT02499328|463685858|FG012|Overall Study|Lost to Follow-up|0|||
128833457|NCT02499328|463685859|FG013|Overall Study|Lost to Follow-up|0|||
128833458|NCT02499328|463685860|FG014|Overall Study|Lost to Follow-up|0|||
128833459|NCT02499328|463685861|FG015|Overall Study|Lost to Follow-up|0|||
128833460|NCT02499328|463685862|FG016|Overall Study|Lost to Follow-up|0|||
128833461|NCT02499328|463685863|FG017|Overall Study|Lost to Follow-up|0|||
128833462|NCT02499328|463685864|FG018|Overall Study|Lost to Follow-up|1|||
128833463|NCT02499328|463685846|FG000|Overall Study|Death|0|||
128833464|NCT02499328|463685847|FG001|Overall Study|Death|3|||
128833465|NCT02499328|463685848|FG002|Overall Study|Death|3|||
128833466|NCT02499328|463685849|FG003|Overall Study|Death|2|||
128833467|NCT02499328|463685850|FG004|Overall Study|Death|4|||
128833468|NCT02499328|463685851|FG005|Overall Study|Death|7|||
128833469|NCT02499328|463685852|FG006|Overall Study|Death|3|||
128833470|NCT02499328|463685853|FG007|Overall Study|Death|0|||
128833471|NCT02499328|463685854|FG008|Overall Study|Death|2|||
128833472|NCT02499328|463685855|FG009|Overall Study|Death|6|||
128833473|NCT02499328|463685856|FG010|Overall Study|Death|6|||
128833474|NCT02499328|463685857|FG011|Overall Study|Death|20|||
128833475|NCT02499328|463685858|FG012|Overall Study|Death|9|||
128833476|NCT02499328|463685859|FG013|Overall Study|Death|7|||
128833477|NCT02499328|463685860|FG014|Overall Study|Death|3|||
128833478|NCT02499328|463685861|FG015|Overall Study|Death|1|||
128833479|NCT02499328|463685862|FG016|Overall Study|Death|1|||
128833480|NCT02499328|463685863|FG017|Overall Study|Death|16|||
128833481|NCT02499328|463685864|FG018|Overall Study|Death|5|||
128833482|NCT02499328|463685846|FG000|Overall Study|"Other"|2|||
128833483|NCT02499328|463685847|FG001|Overall Study|"Other"|2|||
128833484|NCT02499328|463685848|FG002|Overall Study|"Other"|1|||
128833485|NCT02499328|463685849|FG003|Overall Study|"Other"|3|||
128833486|NCT02499328|463685850|FG004|Overall Study|"Other"|6|||
128833487|NCT02499328|463685851|FG005|Overall Study|"Other"|2|||
128833488|NCT02499328|463685852|FG006|Overall Study|"Other"|3|||
128833489|NCT02499328|463685853|FG007|Overall Study|"Other"|4|||
128833490|NCT02499328|463685854|FG008|Overall Study|"Other"|6|||
128833491|NCT02499328|463685855|FG009|Overall Study|"Other"|16|||
128833492|NCT02499328|463685856|FG010|Overall Study|"Other"|13|||
128833493|NCT02499328|463685857|FG011|Overall Study|"Other"|31|||
128833494|NCT02499328|463685858|FG012|Overall Study|"Other"|8|||
128833495|NCT02499328|463685859|FG013|Overall Study|"Other"|7|||
128833496|NCT02499328|463685860|FG014|Overall Study|"Other"|6|||
128833497|NCT02499328|463685861|FG015|Overall Study|"Other"|0|||
128833498|NCT02499328|463685862|FG016|Overall Study|"Other"|0|||
128833499|NCT02499328|463685863|FG017|Overall Study|"Other"|34|||
128833500|NCT02499328|463685864|FG018|Overall Study|"Other"|43|||
128833501|NCT02499328|463685846|FG000|Overall Study|Disease Progression|0|||
128833502|NCT02499328|463685847|FG001|Overall Study|Disease Progression|0|||
128833503|NCT02499328|463685848|FG002|Overall Study|Disease Progression|0|||
128833504|NCT02499328|463685849|FG003|Overall Study|Disease Progression|0|||
128833505|NCT02499328|463685850|FG004|Overall Study|Disease Progression|0|||
128833506|NCT02499328|463685851|FG005|Overall Study|Disease Progression|0|||
128833507|NCT02499328|463685852|FG006|Overall Study|Disease Progression|1|||
128833508|NCT02499328|463685853|FG007|Overall Study|Disease Progression|0|||
128833509|NCT02499328|463685854|FG008|Overall Study|Disease Progression|1|||
128833510|NCT02499328|463685855|FG009|Overall Study|Disease Progression|0|||
128833511|NCT02499328|463685856|FG010|Overall Study|Disease Progression|1|||
128833512|NCT02499328|463685857|FG011|Overall Study|Disease Progression|0|||
128833513|NCT02499328|463685858|FG012|Overall Study|Disease Progression|0|||
128833514|NCT02499328|463685859|FG013|Overall Study|Disease Progression|0|||
128833515|NCT02499328|463685860|FG014|Overall Study|Disease Progression|0|||
128833516|NCT02499328|463685861|FG015|Overall Study|Disease Progression|0|||
128833517|NCT02499328|463685862|FG016|Overall Study|Disease Progression|0|||
128833518|NCT02499328|463685863|FG017|Overall Study|Disease Progression|2|||
128833519|NCT02499328|463685864|FG018|Overall Study|Disease Progression|0|||
128833520|NCT02499328|463685846|FG000|Overall Study|Adverse Event|1|||
128833521|NCT02499328|463685847|FG001|Overall Study|Adverse Event|0|||
128833522|NCT02499328|463685848|FG002|Overall Study|Adverse Event|0|||
128833523|NCT02499328|463685849|FG003|Overall Study|Adverse Event|1|||
128833524|NCT02499328|463685850|FG004|Overall Study|Adverse Event|0|||
128833525|NCT02499328|463685851|FG005|Overall Study|Adverse Event|0|||
128833526|NCT02499328|463685852|FG006|Overall Study|Adverse Event|0|||
128833527|NCT02499328|463685853|FG007|Overall Study|Adverse Event|0|||
128833528|NCT02499328|463685854|FG008|Overall Study|Adverse Event|0|||
128833529|NCT02499328|463685855|FG009|Overall Study|Adverse Event|0|||
128833530|NCT02499328|463685856|FG010|Overall Study|Adverse Event|0|||
128833531|NCT02499328|463685857|FG011|Overall Study|Adverse Event|0|||
128833532|NCT02499328|463685858|FG012|Overall Study|Adverse Event|1|||
128833533|NCT02499328|463685859|FG013|Overall Study|Adverse Event|0|||
128833534|NCT02499328|463685860|FG014|Overall Study|Adverse Event|0|||
128833535|NCT02499328|463685861|FG015|Overall Study|Adverse Event|0|||
128833536|NCT02499328|463685862|FG016|Overall Study|Adverse Event|0|||
128833537|NCT02499328|463685863|FG017|Overall Study|Adverse Event|0|||
128833538|NCT02499328|463685864|FG018|Overall Study|Adverse Event|0|||
128833539|NCT00145470|463685865|FG000|Overall Study|Adverse Event|19|||
128833540|NCT00145470|463685866|FG001|Overall Study|Adverse Event|25|||
128833541|NCT00145470|463685865|FG000|Overall Study|Lack of Efficacy|27|||
128833542|NCT00145470|463685866|FG001|Overall Study|Lack of Efficacy|13|||
128833543|NCT00145470|463685865|FG000|Overall Study|Withdrawal by Subject|36|||
128833544|NCT00145470|463685866|FG001|Overall Study|Withdrawal by Subject|34|||
128833545|NCT00145470|463685865|FG000|Overall Study|Lost to Follow-up|21|||
128833546|NCT00145470|463685866|FG001|Overall Study|Lost to Follow-up|17|||
128833547|NCT00145470|463685865|FG000|Overall Study|Reason Not Reported|9|||
128833548|NCT00145470|463685866|FG001|Overall Study|Reason Not Reported|9|||
128833549|NCT04602728|463685868|FG000|Overall Study|Lost to Follow-up|4|||
128833550|NCT04602728|463685869|FG001|Overall Study|Lost to Follow-up|4|||
128833551|NCT04447027|463685872|FG000|Dose Escalation|Withdrawal by Subject|1|||
128833552|NCT04447027|463685873|FG001|Dose Escalation|Withdrawal by Subject|4|||
128833553|NCT04447027|463685874|FG002|Dose Escalation|Withdrawal by Subject|3|||
128833554|NCT04447027|463685875|FG003|Dose Escalation|Withdrawal by Subject|3|||
128833555|NCT04447027|463685876|FG004|Dose Escalation|Withdrawal by Subject|1|||
128833556|NCT04447027|463685877|FG005|Dose Escalation|Withdrawal by Subject|0|||
128833557|NCT04447027|463685878|FG006|Dose Escalation|Withdrawal by Subject|0|||
128833558|NCT04447027|463685879|FG007|Dose Escalation|Withdrawal by Subject|0|||
128833559|NCT04447027|463685880|FG008|Dose Escalation|Withdrawal by Subject|0|||
128833560|NCT04447027|463685872|FG000|Dose Escalation|Refused further treatment|0|||
128833561|NCT04447027|463685873|FG001|Dose Escalation|Refused further treatment|1|||
128833562|NCT04447027|463685874|FG002|Dose Escalation|Refused further treatment|1|||
128833563|NCT04447027|463685875|FG003|Dose Escalation|Refused further treatment|0|||
128833564|NCT04447027|463685876|FG004|Dose Escalation|Refused further treatment|0|||
128833565|NCT04447027|463685877|FG005|Dose Escalation|Refused further treatment|0|||
128833566|NCT04447027|463685878|FG006|Dose Escalation|Refused further treatment|0|||
128833567|NCT04447027|463685879|FG007|Dose Escalation|Refused further treatment|0|||
128833568|NCT04447027|463685880|FG008|Dose Escalation|Refused further treatment|0|||
128833569|NCT04447027|463685872|FG000|Dose Expansion|Withdrawal by Subject|0|||
128833570|NCT04447027|463685873|FG001|Dose Expansion|Withdrawal by Subject|0|||
128833571|NCT04447027|463685874|FG002|Dose Expansion|Withdrawal by Subject|0|||
128833572|NCT04447027|463685875|FG003|Dose Expansion|Withdrawal by Subject|0|||
128833573|NCT04447027|463685876|FG004|Dose Expansion|Withdrawal by Subject|0|||
128833574|NCT04447027|463685877|FG005|Dose Expansion|Withdrawal by Subject|2|||
128833575|NCT04447027|463685878|FG006|Dose Expansion|Withdrawal by Subject|0|||
128833576|NCT04447027|463685879|FG007|Dose Expansion|Withdrawal by Subject|2|||
128833577|NCT04447027|463685880|FG008|Dose Expansion|Withdrawal by Subject|0|||
128833578|NCT02831049|463685881|FG000|Overall Study|Lost to Follow-up|0|||
128833579|NCT02831049|463685882|FG001|Overall Study|Lost to Follow-up|0|||
128833580|NCT02831049|463685883|FG002|Overall Study|Lost to Follow-up|1|||
128833581|NCT02831049|463685881|FG000|Overall Study|Withdrawal by Subject|0|||
128833582|NCT02831049|463685882|FG001|Overall Study|Withdrawal by Subject|1|||
128833583|NCT02831049|463685883|FG002|Overall Study|Withdrawal by Subject|1|||
128833584|NCT02831049|463685881|FG000|Overall Study|Pandemic shutdown|1|||
128833585|NCT02831049|463685882|FG001|Overall Study|Pandemic shutdown|0|||
128833586|NCT02831049|463685883|FG002|Overall Study|Pandemic shutdown|0|||
128833587|NCT02609048|463685884|FG000|Overall Study|Adverse Event|3|||
128833588|NCT02609048|463685885|FG001|Overall Study|Adverse Event|0|||
128833589|NCT02609048|463685886|FG002|Overall Study|Adverse Event|0|||
128833590|NCT02609048|463685884|FG000|Overall Study|Randomized but never treated|1|||
128833591|NCT02609048|463685885|FG001|Overall Study|Randomized but never treated|1|||
128833592|NCT02609048|463685886|FG002|Overall Study|Randomized but never treated|1|||
128833593|NCT02609048|463685884|FG000|Overall Study|Withdrawal of informed consent|1|||
128833594|NCT02609048|463685885|FG001|Overall Study|Withdrawal of informed consent|0|||
128833595|NCT02609048|463685886|FG002|Overall Study|Withdrawal of informed consent|0|||
128833596|NCT02609048|463685884|FG000|Overall Study|Reason not specified|6|||
128833597|NCT02609048|463685885|FG001|Overall Study|Reason not specified|9|||
128833598|NCT02609048|463685886|FG002|Overall Study|Reason not specified|9|||
128833599|NCT02485925|463685887|FG000|Overall Study|Withdrawal by Subject|3|||
128833600|NCT02485925|463685887|FG000|Overall Study|Death|1|||
128833601|NCT02485925|463685887|FG000|Overall Study|Lost to Follow-up|11|||
128833602|NCT05995977|463685888|FG000|Overall Study|Withdrawal by Subject|1|||
128833603|NCT05995977|463685889|FG001|Overall Study|Withdrawal by Subject|4|||
128833604|NCT05995977|463685888|FG000|Overall Study|Lost to Follow-up|2|||
128833605|NCT05995977|463685889|FG001|Overall Study|Lost to Follow-up|0|||
128833606|NCT04181788|463685890|FG000|TREATMENT|Adverse Event|0|||
128833607|NCT04181788|463685891|FG001|TREATMENT|Adverse Event|2|||
128833608|NCT04181788|463685892|FG002|TREATMENT|Adverse Event|1|||
128833609|NCT04181788|463685893|FG003|TREATMENT|Adverse Event|0|||
128833610|NCT04181788|463685894|FG004|TREATMENT|Adverse Event|1|||
128833611|NCT04181788|463685895|FG005|TREATMENT|Adverse Event|3|||
128833612|NCT04181788|463685890|FG000|TREATMENT|Death|0|||
128833613|NCT04181788|463685891|FG001|TREATMENT|Death|0|||
128833614|NCT04181788|463685892|FG002|TREATMENT|Death|0|||
128833615|NCT04181788|463685893|FG003|TREATMENT|Death|0|||
128833616|NCT04181788|463685894|FG004|TREATMENT|Death|8|||
128833617|NCT04181788|463685895|FG005|TREATMENT|Death|8|||
128833618|NCT04181788|463685890|FG000|TREATMENT|Physician Decision|0|||
128833619|NCT04181788|463685891|FG001|TREATMENT|Physician Decision|0|||
128833620|NCT04181788|463685892|FG002|TREATMENT|Physician Decision|0|||
128833621|NCT04181788|463685893|FG003|TREATMENT|Physician Decision|0|||
128833622|NCT04181788|463685894|FG004|TREATMENT|Physician Decision|0|||
128833623|NCT04181788|463685895|FG005|TREATMENT|Physician Decision|1|||
128833624|NCT04181788|463685890|FG000|TREATMENT|Progressive disease|3|||
128833625|NCT04181788|463685891|FG001|TREATMENT|Progressive disease|3|||
128833626|NCT04181788|463685892|FG002|TREATMENT|Progressive disease|5|||
128833627|NCT04181788|463685893|FG003|TREATMENT|Progressive disease|7|||
128833628|NCT04181788|463685894|FG004|TREATMENT|Progressive disease|20|||
128833629|NCT04181788|463685895|FG005|TREATMENT|Progressive disease|38|||
128833630|NCT04181788|463685890|FG000|TREATMENT|Global deterioration of health status|0|||
128833631|NCT04181788|463685891|FG001|TREATMENT|Global deterioration of health status|2|||
128833632|NCT04181788|463685892|FG002|TREATMENT|Global deterioration of health status|0|||
128833633|NCT04181788|463685893|FG003|TREATMENT|Global deterioration of health status|0|||
128833634|NCT04181788|463685894|FG004|TREATMENT|Global deterioration of health status|2|||
128833635|NCT04181788|463685895|FG005|TREATMENT|Global deterioration of health status|8|||
128833636|NCT04181788|463685890|FG000|TREATMENT|Withdrawal by Subject|1|||
128833637|NCT04181788|463685891|FG001|TREATMENT|Withdrawal by Subject|2|||
128833638|NCT04181788|463685892|FG002|TREATMENT|Withdrawal by Subject|0|||
128833639|NCT04181788|463685893|FG003|TREATMENT|Withdrawal by Subject|0|||
128833640|NCT04181788|463685894|FG004|TREATMENT|Withdrawal by Subject|3|||
128833641|NCT04181788|463685895|FG005|TREATMENT|Withdrawal by Subject|5|||
128833642|NCT04181788|463685890|FG000|TREATMENT|Other unspecified|0|||
128833643|NCT04181788|463685891|FG001|TREATMENT|Other unspecified|0|||
128833644|NCT04181788|463685892|FG002|TREATMENT|Other unspecified|0|||
128833645|NCT04181788|463685893|FG003|TREATMENT|Other unspecified|0|||
128833646|NCT04181788|463685894|FG004|TREATMENT|Other unspecified|0|||
128833647|NCT04181788|463685895|FG005|TREATMENT|Other unspecified|2|||
128833648|NCT04181788|463685890|FG000|TREATMENT|Ongoing|0|||
128833649|NCT04181788|463685891|FG001|TREATMENT|Ongoing|3|||
128833650|NCT04181788|463685892|FG002|TREATMENT|Ongoing|0|||
128833651|NCT04181788|463685893|FG003|TREATMENT|Ongoing|5|||
128833652|NCT04181788|463685894|FG004|TREATMENT|Ongoing|7|||
128833653|NCT04181788|463685895|FG005|TREATMENT|Ongoing|15|||
128833654|NCT04181788|463685890|FG000|FOLLOW-UP|Death|0|||
128833655|NCT04181788|463685891|FG001|FOLLOW-UP|Death|0|||
128833656|NCT04181788|463685892|FG002|FOLLOW-UP|Death|1|||
128833657|NCT04181788|463685893|FG003|FOLLOW-UP|Death|2|||
128833658|NCT04181788|463685894|FG004|FOLLOW-UP|Death|8|||
128833659|NCT04181788|463685895|FG005|FOLLOW-UP|Death|20|||
128833660|NCT04181788|463685890|FG000|FOLLOW-UP|Lost to Follow-up|0|||
128833661|NCT04181788|463685891|FG001|FOLLOW-UP|Lost to Follow-up|0|||
128833662|NCT04181788|463685892|FG002|FOLLOW-UP|Lost to Follow-up|0|||
128833663|NCT04181788|463685893|FG003|FOLLOW-UP|Lost to Follow-up|0|||
128833664|NCT04181788|463685894|FG004|FOLLOW-UP|Lost to Follow-up|0|||
128833665|NCT04181788|463685895|FG005|FOLLOW-UP|Lost to Follow-up|2|||
128833666|NCT04181788|463685890|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
128833667|NCT04181788|463685891|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
128833668|NCT04181788|463685892|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
128833669|NCT04181788|463685893|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
128833670|NCT04181788|463685894|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
128833671|NCT04181788|463685895|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
128833672|NCT04181788|463685890|FG000|FOLLOW-UP|Other unspecified|0|||
128833673|NCT04181788|463685891|FG001|FOLLOW-UP|Other unspecified|1|||
128833674|NCT04181788|463685892|FG002|FOLLOW-UP|Other unspecified|0|||
128833675|NCT04181788|463685893|FG003|FOLLOW-UP|Other unspecified|0|||
128833676|NCT04181788|463685894|FG004|FOLLOW-UP|Other unspecified|0|||
128833677|NCT04181788|463685895|FG005|FOLLOW-UP|Other unspecified|3|||
128833678|NCT04181788|463685890|FG000|FOLLOW-UP|Ongoing|0|||
128833679|NCT04181788|463685891|FG001|FOLLOW-UP|Ongoing|0|||
128833680|NCT04181788|463685892|FG002|FOLLOW-UP|Ongoing|1|||
128833681|NCT04181788|463685893|FG003|FOLLOW-UP|Ongoing|3|||
128833682|NCT04181788|463685894|FG004|FOLLOW-UP|Ongoing|2|||
128833683|NCT04181788|463685895|FG005|FOLLOW-UP|Ongoing|2|||
128833684|NCT04937504|463685896|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
128833685|NCT04937504|463685897|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
128833686|NCT04937504|463685896|FG000|9 Months Assessment|Lost to Follow-up|3|||
128833687|NCT04937504|463685897|FG001|9 Months Assessment|Lost to Follow-up|2|||
128833688|NCT04186247|463685898|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
128833689|NCT04186247|463685899|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
128833690|NCT04186247|463685900|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
128833691|NCT04186247|463685901|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
128833692|NCT04186247|463685902|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
128833693|NCT03662659|463685903|FG000|Pre-treatment|Participant no longer met study criteria|1|||
128833694|NCT03662659|463685904|FG001|Pre-treatment|Participant no longer met study criteria|1|||
128833695|NCT03662659|463685903|FG000|Pre-treatment|Other reasons|1|||
128833696|NCT03662659|463685904|FG001|Pre-treatment|Other reasons|0|||
128833697|NCT03662659|463685903|FG000|Treatment|Completed Treatment|0|||
128833698|NCT03662659|463685904|FG001|Treatment|Completed Treatment|2|||
128833699|NCT03662659|463685903|FG000|Treatment|Disease Progression|85|||
128833700|NCT03662659|463685904|FG001|Treatment|Disease Progression|97|||
128833701|NCT03662659|463685903|FG000|Treatment|Study Drug Toxicity|19|||
128833702|NCT03662659|463685904|FG001|Treatment|Study Drug Toxicity|9|||
128833703|NCT03662659|463685903|FG000|Treatment|Death|11|||
128833704|NCT03662659|463685904|FG001|Treatment|Death|9|||
128833705|NCT03662659|463685903|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
128833706|NCT03662659|463685904|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
128833707|NCT03662659|463685903|FG000|Treatment|Withdrawal by Subject|1|||
128833708|NCT03662659|463685904|FG001|Treatment|Withdrawal by Subject|1|||
128833709|NCT03662659|463685903|FG000|Treatment|Poor/Non-compliance|1|||
128833710|NCT03662659|463685904|FG001|Treatment|Poor/Non-compliance|0|||
128833711|NCT03662659|463685903|FG000|Treatment|Participant no longer meets study criteria|1|||
128833712|NCT03662659|463685904|FG001|Treatment|Participant no longer meets study criteria|0|||
128833713|NCT03662659|463685903|FG000|Treatment|Other reasons|10|||
128833714|NCT03662659|463685904|FG001|Treatment|Other reasons|8|||
128833715|NCT03662659|463685903|FG000|Treatment|Administrative reasons by sponsor|1|||
128833716|NCT03662659|463685904|FG001|Treatment|Administrative reasons by sponsor|0|||
128833717|NCT03662659|463685903|FG000|Treatment|maximum clinical benefit|0|||
128833718|NCT03662659|463685904|FG001|Treatment|maximum clinical benefit|2|||
128833719|NCT04118894|463685906|FG000|Overall Study|Lost to Follow-up|21|||
128833720|NCT04118894|463685906|FG000|Overall Study|Withdrawal by Subject|10|||
128833721|NCT04118894|463685906|FG000|Overall Study|Adverse Event|4|||
128833722|NCT04323800|463687450|FG000|Overall Study|Withdrawal by Subject|4|||
128833723|NCT04323800|463687451|FG001|Overall Study|Withdrawal by Subject|4|||
128833724|NCT04323800|463687450|FG000|Overall Study|Incomplete transfusion|1|||
128833725|NCT04323800|463687451|FG001|Overall Study|Incomplete transfusion|0|||
128833726|NCT04323800|463687450|FG000|Overall Study|Other|0|||
128833727|NCT04323800|463687451|FG001|Overall Study|Other|1|||
128833728|NCT04323800|463687450|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
128833729|NCT04323800|463687451|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
128833730|NCT00489554|463687452|FG000|Overall Study|Adverse Event|2|||
128833731|NCT00489554|463687452|FG000|Overall Study|Withdrawal by Subject|1|||
128833732|NCT00489554|463687452|FG000|Overall Study|Lost to Follow-up|1|||
128833733|NCT06571695|463687453|FG000|Overall Study|Lost to Follow-up|1|||
128833734|NCT06571695|463687454|FG001|Overall Study|Lost to Follow-up|6|||
128833735|NCT01380145|463687455|FG000|Overall Study|Progressive disease|4|||
128833736|NCT02038049|463687460|FG000|Overall Study|Lost to Follow-up|1|||
128833737|NCT02038049|463687461|FG001|Overall Study|Lost to Follow-up|0|||
128833738|NCT01808534|463687462|FG000|Overall Study|Disease progression|3|||
128833739|NCT01808534|463687462|FG000|Overall Study|Physician Decision|1|||
128833740|NCT01823224|463687463|FG000|Overall Study|Lost to Follow-up|5|||
128833741|NCT01823224|463687464|FG001|Overall Study|Lost to Follow-up|6|||
128833742|NCT01823224|463687463|FG000|Overall Study|didn't qualify|1|||
128833743|NCT01823224|463687464|FG001|Overall Study|didn't qualify|2|||
128833744|NCT01823224|463687463|FG000|Overall Study|pharmacy error|0|||
128833745|NCT01823224|463687464|FG001|Overall Study|pharmacy error|1|||
128833746|NCT01823224|463687463|FG000|Overall Study|missed med dose|0|||
128833747|NCT01823224|463687464|FG001|Overall Study|missed med dose|1|||
128833748|NCT01823224|463687463|FG000|Overall Study|Withdrawal by Subject|0|||
128833749|NCT01823224|463687464|FG001|Overall Study|Withdrawal by Subject|1|||
128833750|NCT01737021|463687470|FG000|Overall Study|Lost to Follow-up|5|||
128833751|NCT01737021|463687471|FG001|Overall Study|Lost to Follow-up|3|||
128833752|NCT03737110|463687473|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
128833753|NCT03737110|463687474|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
128833754|NCT03737110|463687475|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
128833755|NCT03737110|463687476|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
128833756|NCT03737110|463687477|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
128833757|NCT03737110|463687478|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
128833758|NCT03737110|463687473|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
128833759|NCT03737110|463687474|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
128833760|NCT03737110|463687475|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
128833761|NCT03737110|463687476|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
128833762|NCT03737110|463687477|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
128833763|NCT03737110|463687478|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
128833764|NCT03737110|463687473|FG000|Run-in (RI) Period|Adverse Event|4|||
128833765|NCT03737110|463687474|FG001|Run-in (RI) Period|Adverse Event|0|||
128833766|NCT03737110|463687475|FG002|Run-in (RI) Period|Adverse Event|0|||
128833767|NCT03737110|463687476|FG003|Run-in (RI) Period|Adverse Event|0|||
128833768|NCT03737110|463687477|FG004|Run-in (RI) Period|Adverse Event|0|||
128833769|NCT03737110|463687478|FG005|Run-in (RI) Period|Adverse Event|0|||
128833770|NCT03737110|463687473|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
128833771|NCT03737110|463687474|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
128833772|NCT03737110|463687475|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
128833773|NCT03737110|463687476|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
128833774|NCT03737110|463687477|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
128833775|NCT03737110|463687478|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
128833776|NCT03737110|463687473|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
128833777|NCT03737110|463687474|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
128833778|NCT03737110|463687475|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
128833779|NCT03737110|463687476|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
128833780|NCT03737110|463687477|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
128833781|NCT03737110|463687478|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
128833782|NCT03737110|463687473|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
128833783|NCT03737110|463687474|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
128833784|NCT03737110|463687475|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
128833785|NCT03737110|463687476|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
128833786|NCT03737110|463687477|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
128833787|NCT03737110|463687478|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
128833788|NCT03737110|463687473|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
128833789|NCT03737110|463687474|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
128833790|NCT03737110|463687475|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
128833791|NCT03737110|463687476|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
128833792|NCT03737110|463687477|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
128833793|NCT03737110|463687478|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
128833794|NCT03737110|463687473|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
128833795|NCT03737110|463687474|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
128833796|NCT03737110|463687475|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
128833797|NCT03737110|463687476|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
128833798|NCT03737110|463687477|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
128833799|NCT03737110|463687478|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
128833800|NCT02575365|463687489|FG000|Overall Study|Lost to Follow-up|4|||
128833801|NCT03865732|463687490|FG000|Overall Study|Adverse Event|0|||
128833802|NCT03865732|463687491|FG001|Overall Study|Adverse Event|1|||
128833803|NCT03392194|463687492|FG000|Overall Study|Withdrawal by Subject|1|||
128833804|NCT03392194|463687493|FG001|Overall Study|Withdrawal by Subject|2|||
128833805|NCT03392194|463687492|FG000|Overall Study|Conflicts with personal schedule|1|||
128833806|NCT03392194|463687493|FG001|Overall Study|Conflicts with personal schedule|0|||
128833807|NCT00273052|463687504|FG000|Overall Study|Withdrawal by Subject|16|||
128833808|NCT00273052|463687505|FG001|Overall Study|Withdrawal by Subject|19|||
128833809|NCT00273052|463687504|FG000|Overall Study|Adverse Event|21|||
128833810|NCT00273052|463687505|FG001|Overall Study|Adverse Event|19|||
128833811|NCT00273052|463687504|FG000|Overall Study|Protocol Violation|14|||
128833812|NCT00273052|463687505|FG001|Overall Study|Protocol Violation|18|||
128833813|NCT00273052|463687504|FG000|Overall Study|Lost to Follow-up|7|||
128833814|NCT00273052|463687505|FG001|Overall Study|Lost to Follow-up|25|||
128833815|NCT00273052|463687504|FG000|Overall Study|Lack of Efficacy|6|||
128833816|NCT00273052|463687505|FG001|Overall Study|Lack of Efficacy|4|||
128833817|NCT00273052|463687504|FG000|Overall Study|Non-Compliance|3|||
128833818|NCT00273052|463687505|FG001|Overall Study|Non-Compliance|1|||
128833819|NCT00273052|463687504|FG000|Overall Study|Other|2|||
128833820|NCT00273052|463687505|FG001|Overall Study|Other|0|||
128833821|NCT00273052|463687504|FG000|Overall Study|Worsening serum lipid levels|0|||
128833822|NCT00273052|463687505|FG001|Overall Study|Worsening serum lipid levels|2|||
128833823|NCT01951703|463687508|FG000|First Intervention|Withdrawal by Subject|1|||
128833824|NCT01951703|463687509|FG001|First Intervention|Withdrawal by Subject|0|||
128833825|NCT01951703|463687508|FG000|First Intervention|Subject was not compliant|1|||
128833826|NCT01951703|463687509|FG001|First Intervention|Subject was not compliant|1|||
128833827|NCT01951703|463687508|FG000|First Intervention|Physician Decision|1|||
128833828|NCT01951703|463687509|FG001|First Intervention|Physician Decision|0|||
128833829|NCT01951703|463687508|FG000|Second Intervention|Protocol Violation|0|||
128833830|NCT01951703|463687509|FG001|Second Intervention|Protocol Violation|1|||
128833831|NCT01951703|463687508|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
128833832|NCT01951703|463687509|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
128833833|NCT01009645|463687510|FG000|Overall Study|Lost to Follow-up|2|||
128833834|NCT01009645|463687511|FG001|Overall Study|Lost to Follow-up|8|||
128833835|NCT01009645|463687512|FG002|Overall Study|Lost to Follow-up|4|||
128833836|NCT01009645|463687513|FG003|Overall Study|Lost to Follow-up|5|||
128833837|NCT01698918|463687515|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
128833838|NCT01698918|463687515|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
128833839|NCT01698918|463687515|FG000|First Line Treatment (Core+Extension)|Death|2|||
128833840|NCT01698918|463687515|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
128833841|NCT01698918|463687515|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
128833842|NCT01698918|463687515|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
128833843|NCT01698918|463687515|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
128833844|NCT01698918|463687515|FG000|Second Line Treatment (Core+Extension)|Death|1|||
128833845|NCT01698918|463687515|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
128833846|NCT01698918|463687515|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
128833847|NCT01019135|463687516|FG000|Overall Study|Did not receive allocated intervention|12|||
128833848|NCT01019135|463687517|FG001|Overall Study|Did not receive allocated intervention|6|||
128833849|NCT01019135|463687518|FG002|Overall Study|Did not receive allocated intervention|25|||
128833850|NCT01019135|463687516|FG000|Overall Study|Did not attend CR|8|||
128833851|NCT01019135|463687517|FG001|Overall Study|Did not attend CR|13|||
128833852|NCT01019135|463687518|FG002|Overall Study|Did not attend CR|6|||
128833853|NCT05124210|463687519|FG000|Overall Study|Lost to Follow-up|1|||
128833854|NCT05124210|463687520|FG001|Overall Study|Lost to Follow-up|0|||
128833855|NCT05124210|463687519|FG000|Overall Study|Withdrawal by Subject|1|||
128833856|NCT05124210|463687520|FG001|Overall Study|Withdrawal by Subject|0|||
128833857|NCT00768755|463687523|FG000|Phase 1|Death|6|||
128833858|NCT00768755|463687524|FG001|Phase 1|Death|0|||
128833859|NCT00768755|463687525|FG002|Phase 1|Death|0|||
128833860|NCT00768755|463687526|FG003|Phase 1|Death|0|||
128833861|NCT00768755|463687523|FG000|Phase 1|Other|4|||
128833862|NCT00768755|463687524|FG001|Phase 1|Other|0|||
128833863|NCT00768755|463687525|FG002|Phase 1|Other|0|||
128833864|NCT00768755|463687526|FG003|Phase 1|Other|0|||
128833865|NCT00768755|463687523|FG000|Phase 2|Death|0|||
128833866|NCT00768755|463687524|FG001|Phase 2|Death|37|||
128833867|NCT00768755|463687525|FG002|Phase 2|Death|48|||
128833868|NCT00768755|463687526|FG003|Phase 2|Death|31|||
128833869|NCT00768755|463687523|FG000|Phase 2|Protocol Violation|0|||
128833870|NCT00768755|463687524|FG001|Phase 2|Protocol Violation|2|||
128833871|NCT00768755|463687525|FG002|Phase 2|Protocol Violation|0|||
128833872|NCT00768755|463687526|FG003|Phase 2|Protocol Violation|1|||
128833873|NCT00768755|463687523|FG000|Phase 2|Lost to Follow-up|0|||
128833874|NCT00768755|463687524|FG001|Phase 2|Lost to Follow-up|1|||
128833875|NCT00768755|463687525|FG002|Phase 2|Lost to Follow-up|1|||
128833876|NCT00768755|463687526|FG003|Phase 2|Lost to Follow-up|4|||
128833877|NCT00768755|463687523|FG000|Phase 2|Withdrawal by Subject|0|||
128833878|NCT00768755|463687524|FG001|Phase 2|Withdrawal by Subject|1|||
128833879|NCT00768755|463687525|FG002|Phase 2|Withdrawal by Subject|0|||
128833880|NCT00768755|463687526|FG003|Phase 2|Withdrawal by Subject|1|||
128833881|NCT00768755|463687523|FG000|Phase 2|Other|0|||
128833882|NCT00768755|463687524|FG001|Phase 2|Other|1|||
128833883|NCT00768755|463687525|FG002|Phase 2|Other|2|||
128833884|NCT00768755|463687526|FG003|Phase 2|Other|4|||
128833885|NCT00768755|463687523|FG000|Phase 2|Study Terminated by Sponsor|0|||
128833886|NCT00768755|463687524|FG001|Phase 2|Study Terminated by Sponsor|13|||
128833887|NCT00768755|463687525|FG002|Phase 2|Study Terminated by Sponsor|7|||
128833888|NCT00768755|463687526|FG003|Phase 2|Study Terminated by Sponsor|14|||
128833889|NCT00768755|463687523|FG000|Phase 2|Randomized but not treated|0|||
128833890|NCT00768755|463687524|FG001|Phase 2|Randomized but not treated|0|||
128833891|NCT00768755|463687525|FG002|Phase 2|Randomized but not treated|0|||
128833892|NCT00768755|463687526|FG003|Phase 2|Randomized but not treated|2|||
128833893|NCT00310037|463687527|FG000|Overall Study|Adverse Event|7|||
128833894|NCT00310037|463687528|FG001|Overall Study|Adverse Event|14|||
128833895|NCT00310037|463687527|FG000|Overall Study|Withdrawal by Subject|4|||
128833896|NCT00310037|463687528|FG001|Overall Study|Withdrawal by Subject|3|||
128833897|NCT00310037|463687527|FG000|Overall Study|Progression|6|||
128833898|NCT00310037|463687528|FG001|Overall Study|Progression|0|||
128833899|NCT00310037|463687527|FG000|Overall Study|Non-protocol treatment|1|||
128833900|NCT00310037|463687528|FG001|Overall Study|Non-protocol treatment|0|||
128833901|NCT02708498|463687529|FG000|Overall Study|Death|20|||
128833902|NCT02708498|463687530|FG001|Overall Study|Death|19|||
128833903|NCT02708498|463687531|FG002|Overall Study|Death|0|||
128833904|NCT02708498|463687532|FG003|Overall Study|Death|0|||
128833905|NCT02708498|463687533|FG004|Overall Study|Death|1|||
128833906|NCT02708498|463687534|FG005|Overall Study|Death|0|||
128833907|NCT02708498|463687535|FG006|Overall Study|Death|0|||
128833908|NCT02708498|463687536|FG007|Overall Study|Death|0|||
128833909|NCT02708498|463687529|FG000|Overall Study|Unknown reason, missing data|0|||
128833910|NCT02708498|463687530|FG001|Overall Study|Unknown reason, missing data|0|||
128833911|NCT02708498|463687531|FG002|Overall Study|Unknown reason, missing data|62|||
128833912|NCT02708498|463687532|FG003|Overall Study|Unknown reason, missing data|51|||
128833913|NCT02708498|463687533|FG004|Overall Study|Unknown reason, missing data|195|||
128833914|NCT02708498|463687534|FG005|Overall Study|Unknown reason, missing data|132|||
128833915|NCT02708498|463687535|FG006|Overall Study|Unknown reason, missing data|0|||
128833916|NCT02708498|463687536|FG007|Overall Study|Unknown reason, missing data|0|||
128833917|NCT03298087|463687540|FG000|Overall Study|Withdrawal by Subject|4|||
128833918|NCT01530334|463687544|FG000|Overall Study|Adverse Event|3|||
128833919|NCT01530334|463687544|FG000|Overall Study|unknown reason|1|||
128833920|NCT01530334|463687544|FG000|Overall Study|Progressive disease|47|||
128833921|NCT01485887|463687545|FG000|Overall Study|Withdrawal by Subject|2|||
128833922|NCT01485887|463687545|FG000|Overall Study|Adverse Event|8|||
128833923|NCT01485887|463687545|FG000|Overall Study|Deterioration of primary disease|1|||
128833924|NCT01485887|463687545|FG000|Overall Study|Primary disease markedly improved|1|||
128833925|NCT03184987|463687549|FG000|Overall Study|Withdrawal by Subject|0|||
128833926|NCT03184987|463687550|FG001|Overall Study|Withdrawal by Subject|1|||
128833927|NCT03184987|463687551|FG002|Overall Study|Withdrawal by Subject|2|||
128833928|NCT03184987|463687549|FG000|Overall Study|Physician Decision|0|||
128833929|NCT03184987|463687550|FG001|Overall Study|Physician Decision|0|||
128833930|NCT03184987|463687551|FG002|Overall Study|Physician Decision|1|||
128833931|NCT03184987|463687549|FG000|Overall Study|Adverse Event|1|||
128833932|NCT03184987|463687550|FG001|Overall Study|Adverse Event|0|||
128833933|NCT03184987|463687551|FG002|Overall Study|Adverse Event|1|||
128833934|NCT02203799|463687552|FG000|Overall Study|Withdrawal by Subject|3|||
128833935|NCT00681109|463687553|FG000|Overall Study|Lost to Follow-up|2|||
128833936|NCT00681109|463687554|FG001|Overall Study|Lost to Follow-up|6|||
128833937|NCT00681109|463687555|FG002|Overall Study|Lost to Follow-up|0|||
128833938|NCT04660799|463687556|FG000|Overall Study|Progressive Disease|1|||
128833939|NCT04660799|463687557|FG001|Overall Study|Progressive Disease|1|||
128833940|NCT04660799|463687556|FG000|Overall Study|Death|2|||
128833941|NCT04660799|463687557|FG001|Overall Study|Death|1|||
128833942|NCT04660799|463687556|FG000|Overall Study|Adverse Event|2|||
128833943|NCT04660799|463687557|FG001|Overall Study|Adverse Event|1|||
128833944|NCT04660799|463687556|FG000|Overall Study|Withdrawal by Subject|2|||
128833945|NCT04660799|463687557|FG001|Overall Study|Withdrawal by Subject|5|||
128833946|NCT00391170|463687568|FG000|Overall Study|Withdrawal by Subject|1|||
128833947|NCT00391170|463687569|FG001|Overall Study|Withdrawal by Subject|0|||
128833948|NCT00391170|463687568|FG000|Overall Study|Adverse Event|3|||
128833949|NCT00391170|463687569|FG001|Overall Study|Adverse Event|2|||
128833950|NCT00391170|463687568|FG000|Overall Study|Physician Decision|2|||
128833951|NCT00391170|463687569|FG001|Overall Study|Physician Decision|2|||
128833952|NCT03035942|463687574|FG000|Overall Study|Adverse Event|8|||
128833953|NCT03035942|463687575|FG001|Overall Study|Adverse Event|4|||
128833954|NCT03035942|463687576|FG002|Overall Study|Adverse Event|5|||
128833955|NCT04029090|463687577|FG000|Overall Study|Protocol Violation|1|||
128833956|NCT04029090|463687578|FG001|Overall Study|Protocol Violation|0|||
128833957|NCT04029090|463687579|FG002|Overall Study|Protocol Violation|0|||
128833958|NCT04029090|463687577|FG000|Overall Study|Withdrawal by Subject|0|||
128833959|NCT04029090|463687578|FG001|Overall Study|Withdrawal by Subject|1|||
128833960|NCT04029090|463687579|FG002|Overall Study|Withdrawal by Subject|0|||
128833961|NCT02157948|463687580|FG000|Overall Study|Withdrawal by Subject|4|||
128833962|NCT02157948|463687581|FG001|Overall Study|Withdrawal by Subject|5|||
128833963|NCT02157948|463687580|FG000|Overall Study|Lost to Follow-up|3|||
128833964|NCT02157948|463687581|FG001|Overall Study|Lost to Follow-up|2|||
128833965|NCT02157948|463687580|FG000|Overall Study|Protocol Specified Criteria|2|||
128833966|NCT02157948|463687581|FG001|Overall Study|Protocol Specified Criteria|1|||
128833967|NCT02157948|463687580|FG000|Overall Study|Decision by Sponsor|0|||
128833968|NCT02157948|463687581|FG001|Overall Study|Decision by Sponsor|1|||
128833969|NCT06269003|463687592|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
128833970|NCT06269003|463687593|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
128833971|NCT06269003|463687594|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
128833972|NCT06269003|463687595|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
128833973|NCT01567852|463688571|FG000|Overall Study|Withdrawal by Subject|3|||
128833974|NCT01567852|463688572|FG001|Overall Study|Withdrawal by Subject|6|||
128833975|NCT01567852|463688571|FG000|Overall Study|ECT discontinued|1|||
128833976|NCT01567852|463688572|FG001|Overall Study|ECT discontinued|1|||
128833977|NCT04809623|463688573|FG000|Overall Study|Study Terminated by Sponsor|1|||
128833978|NCT04809623|463688574|FG001|Overall Study|Study Terminated by Sponsor|0|||
128833979|NCT02660086|463688575|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
128833980|NCT02660086|463688576|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
128833981|NCT02660086|463688575|FG000|Overall Study- 12-month|Left full-time employment|12|||
128833982|NCT02660086|463688576|FG001|Overall Study- 12-month|Left full-time employment|20|||
128833983|NCT02660086|463688575|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
128833984|NCT02660086|463688576|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
128833985|NCT02660086|463688575|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
128833986|NCT02660086|463688576|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
128833987|NCT02660086|463688575|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
128833988|NCT02660086|463688576|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
128833989|NCT02660086|463688575|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
128833990|NCT02660086|463688576|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
128833991|NCT00667017|463688579|FG000|Overall Study|Withdrawal by Subject|1|||
128833992|NCT02605174|463688583|FG000|Overall Study|Adverse Event|0|||
128833993|NCT02605174|463688584|FG001|Overall Study|Adverse Event|0|||
128833994|NCT02605174|463688585|FG002|Overall Study|Adverse Event|1|||
128833995|NCT02605174|463688586|FG003|Overall Study|Adverse Event|0|||
128833996|NCT02605174|463688587|FG004|Overall Study|Adverse Event|4|||
128833997|NCT02605174|463688588|FG005|Overall Study|Adverse Event|0|||
128833998|NCT02605174|463688589|FG006|Overall Study|Adverse Event|0|||
128833999|NCT02605174|463688583|FG000|Overall Study|Lost to Follow-up|20|||
128834000|NCT02605174|463688584|FG001|Overall Study|Lost to Follow-up|7|||
128834001|NCT02605174|463688585|FG002|Overall Study|Lost to Follow-up|27|||
128834002|NCT02605174|463688586|FG003|Overall Study|Lost to Follow-up|10|||
128834003|NCT02605174|463688587|FG004|Overall Study|Lost to Follow-up|20|||
128834004|NCT02605174|463688588|FG005|Overall Study|Lost to Follow-up|10|||
128834005|NCT02605174|463688589|FG006|Overall Study|Lost to Follow-up|29|||
128834006|NCT02605174|463688583|FG000|Overall Study|Protocol Violation|10|||
128834007|NCT02605174|463688584|FG001|Overall Study|Protocol Violation|4|||
128834008|NCT02605174|463688585|FG002|Overall Study|Protocol Violation|14|||
128834009|NCT02605174|463688586|FG003|Overall Study|Protocol Violation|6|||
128834010|NCT02605174|463688587|FG004|Overall Study|Protocol Violation|7|||
128834011|NCT02605174|463688588|FG005|Overall Study|Protocol Violation|7|||
128834012|NCT02605174|463688589|FG006|Overall Study|Protocol Violation|12|||
128834013|NCT02605174|463688583|FG000|Overall Study|Pregnancy|1|||
128834014|NCT02605174|463688584|FG001|Overall Study|Pregnancy|0|||
128834015|NCT02605174|463688585|FG002|Overall Study|Pregnancy|0|||
128834016|NCT02605174|463688586|FG003|Overall Study|Pregnancy|2|||
128834017|NCT02605174|463688587|FG004|Overall Study|Pregnancy|0|||
128834018|NCT02605174|463688588|FG005|Overall Study|Pregnancy|0|||
128834019|NCT02605174|463688589|FG006|Overall Study|Pregnancy|0|||
128834020|NCT02605174|463688583|FG000|Overall Study|Withdrawal by Subject|9|||
128834021|NCT02605174|463688584|FG001|Overall Study|Withdrawal by Subject|6|||
128834022|NCT02605174|463688585|FG002|Overall Study|Withdrawal by Subject|14|||
128834023|NCT02605174|463688586|FG003|Overall Study|Withdrawal by Subject|11|||
128834024|NCT02605174|463688587|FG004|Overall Study|Withdrawal by Subject|6|||
128834025|NCT02605174|463688588|FG005|Overall Study|Withdrawal by Subject|4|||
128834026|NCT02605174|463688589|FG006|Overall Study|Withdrawal by Subject|15|||
128834027|NCT02605174|463688583|FG000|Overall Study|Physician Decision|2|||
128834028|NCT02605174|463688584|FG001|Overall Study|Physician Decision|0|||
128834029|NCT02605174|463688585|FG002|Overall Study|Physician Decision|0|||
128834030|NCT02605174|463688586|FG003|Overall Study|Physician Decision|0|||
128834031|NCT02605174|463688587|FG004|Overall Study|Physician Decision|0|||
128834032|NCT02605174|463688588|FG005|Overall Study|Physician Decision|0|||
128834033|NCT02605174|463688589|FG006|Overall Study|Physician Decision|3|||
128834034|NCT02605174|463688583|FG000|Overall Study|Randomization Failure|22|||
128834035|NCT02605174|463688584|FG001|Overall Study|Randomization Failure|6|||
128834036|NCT02605174|463688585|FG002|Overall Study|Randomization Failure|20|||
128834037|NCT02605174|463688586|FG003|Overall Study|Randomization Failure|7|||
128834038|NCT02605174|463688587|FG004|Overall Study|Randomization Failure|16|||
128834039|NCT02605174|463688588|FG005|Overall Study|Randomization Failure|11|||
128834040|NCT02605174|463688589|FG006|Overall Study|Randomization Failure|30|||
128834041|NCT03041090|463688590|FG000|Overall Study|technical error|0|||
128834042|NCT03041090|463688591|FG001|Overall Study|technical error|3|||
128834043|NCT03292406|463688594|FG000|Overall Study|Progressive Disease|6|||
128834044|NCT03292406|463688595|FG001|Overall Study|Progressive Disease|3|||
128834045|NCT03292406|463688596|FG002|Overall Study|Progressive Disease|4|||
128834046|NCT03292406|463688594|FG000|Overall Study|Adverse Event|7|||
128834047|NCT03292406|463688595|FG001|Overall Study|Adverse Event|1|||
128834048|NCT03292406|463688596|FG002|Overall Study|Adverse Event|4|||
128834049|NCT03292406|463688594|FG000|Overall Study|Withdrawal by Subject|0|||
128834050|NCT03292406|463688595|FG001|Overall Study|Withdrawal by Subject|7|||
128834051|NCT03292406|463688596|FG002|Overall Study|Withdrawal by Subject|2|||
128834052|NCT03292406|463688594|FG000|Overall Study|Protocol Violation|0|||
128834053|NCT03292406|463688595|FG001|Overall Study|Protocol Violation|1|||
128834054|NCT03292406|463688596|FG002|Overall Study|Protocol Violation|1|||
128834055|NCT03292406|463688594|FG000|Overall Study|Other|0|||
128834056|NCT03292406|463688595|FG001|Overall Study|Other|1|||
128834057|NCT03292406|463688596|FG002|Overall Study|Other|2|||
128834058|NCT00047385|463688597|FG000|Overall Study|Death before any screening|2|||
128834059|NCT00047385|463688598|FG001|Overall Study|Death before any screening|5|||
128834060|NCT00047385|463688597|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
128834061|NCT00047385|463688598|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
128834062|NCT00047385|463688597|FG000|Overall Study|Eligible for screening but had no screen|260|||
128834063|NCT00047385|463688598|FG001|Overall Study|Eligible for screening but had no screen|492|||
128834064|NCT01852045|463688599|FG000|Overall Study|Adverse Event|1|||
128834065|NCT01852045|463688600|FG001|Overall Study|Adverse Event|0|||
128834066|NCT01852045|463688601|FG002|Overall Study|Adverse Event|0|||
128834067|NCT01852045|463688599|FG000|Overall Study|Lack of Efficacy|3|||
128834068|NCT01852045|463688600|FG001|Overall Study|Lack of Efficacy|0|||
128834069|NCT01852045|463688601|FG002|Overall Study|Lack of Efficacy|0|||
128834070|NCT01852045|463688599|FG000|Overall Study|Lost to Follow-up|0|||
128834071|NCT01852045|463688600|FG001|Overall Study|Lost to Follow-up|1|||
128834072|NCT01852045|463688601|FG002|Overall Study|Lost to Follow-up|1|||
128834073|NCT01852045|463688599|FG000|Overall Study|Withdrawal by Subject|1|||
128834074|NCT01852045|463688600|FG001|Overall Study|Withdrawal by Subject|0|||
128834075|NCT01852045|463688601|FG002|Overall Study|Withdrawal by Subject|1|||
128834076|NCT01852045|463688599|FG000|Overall Study|Other Miscellaneous Reasons|1|||
128834077|NCT01852045|463688600|FG001|Overall Study|Other Miscellaneous Reasons|3|||
128834078|NCT01852045|463688601|FG002|Overall Study|Other Miscellaneous Reasons|2|||
128834079|NCT02007070|463688603|FG000|Overall Study|Adverse Event|4|||
128834080|NCT02007070|463688603|FG000|Overall Study|Clinical Progression|4|||
128834081|NCT02007070|463688603|FG000|Overall Study|Death|1|||
128834082|NCT02007070|463688603|FG000|Overall Study|Protocol Violation|2|||
128834083|NCT02007070|463688603|FG000|Overall Study|Physician Decision|1|||
128834084|NCT02007070|463688603|FG000|Overall Study|Progressive Disease|21|||
128834085|NCT03052517|463688606|FG000|Overall Study|Study Terminated By Sponsor|928|||
128834086|NCT03052517|463688607|FG001|Overall Study|Study Terminated By Sponsor|938|||
128834087|NCT03052517|463688608|FG002|Overall Study|Study Terminated By Sponsor|296|||
128834088|NCT03052517|463688606|FG000|Overall Study|Subject/Guardian Decision|50|||
128834089|NCT03052517|463688607|FG001|Overall Study|Subject/Guardian Decision|45|||
128834090|NCT03052517|463688608|FG002|Overall Study|Subject/Guardian Decision|22|||
128834091|NCT03052517|463688606|FG000|Overall Study|Lack of Efficacy|23|||
128834092|NCT03052517|463688607|FG001|Overall Study|Lack of Efficacy|14|||
128834093|NCT03052517|463688608|FG002|Overall Study|Lack of Efficacy|7|||
128834094|NCT03052517|463688606|FG000|Overall Study|Adverse Event|6|||
128834095|NCT03052517|463688607|FG001|Overall Study|Adverse Event|5|||
128834096|NCT03052517|463688608|FG002|Overall Study|Adverse Event|0|||
128834097|NCT03052517|463688606|FG000|Overall Study|Physician Decision|4|||
128834098|NCT03052517|463688607|FG001|Overall Study|Physician Decision|5|||
128834099|NCT03052517|463688608|FG002|Overall Study|Physician Decision|1|||
128834100|NCT03052517|463688606|FG000|Overall Study|Death|3|||
128834101|NCT03052517|463688607|FG001|Overall Study|Death|0|||
128834102|NCT03052517|463688608|FG002|Overall Study|Death|1|||
128834103|NCT03052517|463688606|FG000|Overall Study|Lost to Follow-up|2|||
128834104|NCT03052517|463688607|FG001|Overall Study|Lost to Follow-up|4|||
128834105|NCT03052517|463688608|FG002|Overall Study|Lost to Follow-up|0|||
128834106|NCT03052517|463688606|FG000|Overall Study|Pregnancy|1|||
128834107|NCT03052517|463688607|FG001|Overall Study|Pregnancy|0|||
128834108|NCT03052517|463688608|FG002|Overall Study|Pregnancy|1|||
128834109|NCT03052517|463688606|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
128834110|NCT03052517|463688607|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
128834111|NCT03052517|463688608|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
128834112|NCT03052517|463688606|FG000|Overall Study|Technical Problems|0|||
128834113|NCT03052517|463688607|FG001|Overall Study|Technical Problems|1|||
128834114|NCT03052517|463688608|FG002|Overall Study|Technical Problems|0|||
128834115|NCT04803734|463688609|FG000|Overall Study|Withdrawal by Subject|0|||
128834116|NCT04803734|463688610|FG001|Overall Study|Withdrawal by Subject|1|||
128834117|NCT04803734|463688609|FG000|Overall Study|Protocol Violation|0|||
128834118|NCT04803734|463688610|FG001|Overall Study|Protocol Violation|1|||
128834119|NCT01640288|463688611|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
128834120|NCT01640288|463688612|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
128834121|NCT01640288|463688611|FG000|Overall Study|Screen Failure|20|||
128834122|NCT01640288|463688612|FG001|Overall Study|Screen Failure|18|||
128834123|NCT01640288|463688611|FG000|Overall Study|Withdrawn by PI|5|||
128834124|NCT01640288|463688612|FG001|Overall Study|Withdrawn by PI|0|||
128834125|NCT01640288|463688611|FG000|Overall Study|Withdrawal by Subject|1|||
128834126|NCT01640288|463688612|FG001|Overall Study|Withdrawal by Subject|0|||
128834127|NCT00195819|463688615|FG000|Double-Blind|Withdrawal by Subject|1|||
128834128|NCT00195819|463688616|FG001|Double-Blind|Withdrawal by Subject|0|||
128834129|NCT00195819|463688615|FG000|Double-Blind|Moved|1|||
128834130|NCT00195819|463688616|FG001|Double-Blind|Moved|0|||
128834131|NCT00195819|463688615|FG000|Open-label|Adverse Event|0|||
128834132|NCT00195819|463688616|FG001|Open-label|Adverse Event|9|||
128834133|NCT00195819|463688615|FG000|Open-label|Lack of Efficacy|0|||
128834134|NCT00195819|463688616|FG001|Open-label|Lack of Efficacy|2|||
128834135|NCT00195819|463688615|FG000|Open-label|Pregnancy|0|||
128834136|NCT00195819|463688616|FG001|Open-label|Pregnancy|1|||
128834137|NCT00195819|463688615|FG000|Open-label|Protocol Violation|0|||
128834138|NCT00195819|463688616|FG001|Open-label|Protocol Violation|2|||
128834139|NCT00195819|463688615|FG000|Open-label|Moved|0|||
128834140|NCT00195819|463688616|FG001|Open-label|Moved|1|||
128834141|NCT00195819|463688615|FG000|Open-label|Withdrawal by Subject|0|||
128834142|NCT00195819|463688616|FG001|Open-label|Withdrawal by Subject|5|||
128834143|NCT01629589|463688619|FG000|Overall Study|Protocol Violation|4|||
128834144|NCT01629589|463688620|FG001|Overall Study|Protocol Violation|2|||
128834145|NCT01629589|463688619|FG000|Overall Study|Lost to Follow-up|2|||
128834146|NCT01629589|463688620|FG001|Overall Study|Lost to Follow-up|1|||
128834147|NCT01629589|463688619|FG000|Overall Study|Withdrawal by Subject|2|||
128834148|NCT01629589|463688620|FG001|Overall Study|Withdrawal by Subject|3|||
128834149|NCT01629589|463688619|FG000|Overall Study|Did not receive study vaccine|0|||
128834150|NCT01629589|463688620|FG001|Overall Study|Did not receive study vaccine|1|||
128834151|NCT03781375|463688621|FG000|Double-blind Phase|Adverse Event|0|||
128834152|NCT03781375|463688622|FG001|Double-blind Phase|Adverse Event|1|||
128834153|NCT03781375|463688621|FG000|Double-blind Phase|Lack of Response|6|||
128834154|NCT03781375|463688622|FG001|Double-blind Phase|Lack of Response|2|||
128834155|NCT03781375|463688621|FG000|Double-blind Phase|Other|1|||
128834156|NCT03781375|463688622|FG001|Double-blind Phase|Other|3|||
128834157|NCT03781375|463688621|FG000|Open-label Phase|Protocol Issues|0|||
128834158|NCT03781375|463688622|FG001|Open-label Phase|Protocol Issues|1|||
128834159|NCT03781375|463688621|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
128834160|NCT03781375|463688622|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
128834161|NCT03781375|463688621|FG000|Open-label Phase|Other|2|||
128834162|NCT03781375|463688622|FG001|Open-label Phase|Other|2|||
128834163|NCT01303510|463688623|FG000|Overall Study|Lost to Follow-up|1|||
128834164|NCT01303510|463688624|FG001|Overall Study|Lost to Follow-up|0|||
128834165|NCT00822900|463688625|FG000|Overall Study|Withdrawal by Subject|14|||
128834166|NCT00822900|463688626|FG001|Overall Study|Withdrawal by Subject|14|||
128834167|NCT00822900|463688625|FG000|Overall Study|Lost to Follow-up|9|||
128834168|NCT00822900|463688626|FG001|Overall Study|Lost to Follow-up|9|||
128834169|NCT00822900|463688625|FG000|Overall Study|Death|83|||
128834170|NCT00822900|463688626|FG001|Overall Study|Death|69|||
128834171|NCT00822900|463688625|FG000|Overall Study|Became a ward of the state|2|||
128834172|NCT00822900|463688626|FG001|Overall Study|Became a ward of the state|1|||
128834173|NCT02095678|463688627|FG000|Overall Study|Withdrawal by Subject|0|||
128834174|NCT02095678|463688628|FG001|Overall Study|Withdrawal by Subject|1|||
128834175|NCT02095678|463688627|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
128834176|NCT02095678|463688628|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
128834177|NCT02095678|463688627|FG000|Overall Study|lesion impacted by previous treatment|1|||
128834178|NCT02095678|463688628|FG001|Overall Study|lesion impacted by previous treatment|1|||
128834179|NCT02095678|463688627|FG000|Overall Study|No Confirmed Diagnosis|0|||
128834180|NCT02095678|463688628|FG001|Overall Study|No Confirmed Diagnosis|3|||
128834181|NCT02095678|463688627|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
128834182|NCT02095678|463688628|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
128834183|NCT02095678|463688627|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
128834184|NCT02095678|463688628|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
128834185|NCT00701415|463688629|FG000|Overall Study|Adverse Event|0|||
128834186|NCT00701415|463688630|FG001|Overall Study|Adverse Event|1|||
128834187|NCT00701415|463688629|FG000|Overall Study|Social/family issues and needle phobia|1|||
128834188|NCT00701415|463688630|FG001|Overall Study|Social/family issues and needle phobia|0|||
128834189|NCT02106884|463688631|FG000|Overall Study|Change of diagnosis/exclusion|0|||
128834190|NCT02106884|463688632|FG001|Overall Study|Change of diagnosis/exclusion|1|||
128834191|NCT02161458|463688633|FG000|Overall Study|Withdrawal by Subject|0|||
128834192|NCT02161458|463688634|FG001|Overall Study|Withdrawal by Subject|4|||
128834193|NCT02161458|463688635|FG002|Overall Study|Withdrawal by Subject|4|||
128834194|NCT02161458|463688636|FG003|Overall Study|Withdrawal by Subject|0|||
128834195|NCT02161458|463688633|FG000|Overall Study|Lost to Follow-up|0|||
128834196|NCT02161458|463688634|FG001|Overall Study|Lost to Follow-up|2|||
128834197|NCT02161458|463688635|FG002|Overall Study|Lost to Follow-up|1|||
128834198|NCT02161458|463688636|FG003|Overall Study|Lost to Follow-up|0|||
128834199|NCT01560429|463688637|FG000|Overall Study|Protocol Violation|3|||
128834200|NCT01560429|463688638|FG001|Overall Study|Protocol Violation|6|||
128834201|NCT00705159|463688639|FG000|Overall Study|Withdrawal by Subject|0|||
128834202|NCT00705159|463688640|FG001|Overall Study|Withdrawal by Subject|1|||
128834203|NCT00705159|463688641|FG002|Overall Study|Withdrawal by Subject|1|||
128834204|NCT00705159|463688642|FG003|Overall Study|Withdrawal by Subject|1|||
128834205|NCT00705159|463688639|FG000|Overall Study|Protocol Violation|0|||
128834206|NCT00705159|463688640|FG001|Overall Study|Protocol Violation|1|||
128834207|NCT00705159|463688641|FG002|Overall Study|Protocol Violation|0|||
128834208|NCT00705159|463688642|FG003|Overall Study|Protocol Violation|0|||
128834209|NCT00705159|463688639|FG000|Overall Study|Adverse Event|0|||
128834210|NCT00705159|463688640|FG001|Overall Study|Adverse Event|0|||
128834211|NCT00705159|463688641|FG002|Overall Study|Adverse Event|1|||
128834212|NCT00705159|463688642|FG003|Overall Study|Adverse Event|0|||
128834213|NCT00705159|463688639|FG000|Overall Study|Lost to Follow-up|0|||
128834214|NCT00705159|463688640|FG001|Overall Study|Lost to Follow-up|0|||
128834215|NCT00705159|463688641|FG002|Overall Study|Lost to Follow-up|3|||
128834216|NCT00705159|463688642|FG003|Overall Study|Lost to Follow-up|2|||
128834217|NCT00705159|463688639|FG000|Overall Study|Screen Failure|0|||
128834218|NCT00705159|463688640|FG001|Overall Study|Screen Failure|0|||
128834219|NCT00705159|463688641|FG002|Overall Study|Screen Failure|0|||
128834220|NCT00705159|463688642|FG003|Overall Study|Screen Failure|1|||
128834221|NCT03026166|463688643|FG000|Overall Study|Death|22|||
128834222|NCT03026166|463688644|FG001|Overall Study|Death|7|||
128834223|NCT03026166|463688643|FG000|Overall Study|Physician Decision|2|||
128834224|NCT03026166|463688644|FG001|Overall Study|Physician Decision|0|||
128834225|NCT03026166|463688643|FG000|Overall Study|Withdrawal by Subject|1|||
128834226|NCT03026166|463688644|FG001|Overall Study|Withdrawal by Subject|2|||
128834227|NCT03026166|463688643|FG000|Overall Study|Lost to Follow-up|1|||
128834228|NCT03026166|463688644|FG001|Overall Study|Lost to Follow-up|0|||
128834229|NCT03026166|463688643|FG000|Overall Study|Study Terminated by Sponsor|3|||
128834230|NCT03026166|463688644|FG001|Overall Study|Study Terminated by Sponsor|3|||
128834231|NCT03026166|463688643|FG000|Overall Study|Other|1|||
128834232|NCT03026166|463688644|FG001|Overall Study|Other|0|||
128834233|NCT02091752|463688647|FG000|Overall Study|Study terminated by Sponsor|2|||
128834234|NCT02091752|463688647|FG000|Overall Study|Adverse Event|1|||
128834235|NCT01604824|463688652|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
128834236|NCT01604824|463688653|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
128834237|NCT01604824|463688654|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
128834238|NCT01604824|463688655|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
128834239|NCT01604824|463688656|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
128834240|NCT01604824|463688657|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
128834241|NCT01604824|463688652|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
128834242|NCT01604824|463688653|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
128834243|NCT01604824|463688654|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
128834244|NCT01604824|463688655|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
128834245|NCT01604824|463688656|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
128834246|NCT01604824|463688657|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
128834247|NCT04821271|463688664|FG000|Period 1|Withdrawal by Subject|2|||
128834248|NCT04821271|463688665|FG001|Period 1|Withdrawal by Subject|0|||
128834249|NCT04076059|463688666|FG000|Double Blind Phase|Progressive disease|22|||
128834250|NCT04076059|463688667|FG001|Double Blind Phase|Progressive disease|26|||
128834251|NCT04076059|463688668|FG002|Double Blind Phase|Progressive disease|0|||
128834252|NCT04076059|463688666|FG000|Double Blind Phase|Withdrawal by Subject|4|||
128834253|NCT04076059|463688667|FG001|Double Blind Phase|Withdrawal by Subject|11|||
128834254|NCT04076059|463688668|FG002|Double Blind Phase|Withdrawal by Subject|0|||
128834255|NCT04076059|463688666|FG000|Double Blind Phase|Death|1|||
128834256|NCT04076059|463688667|FG001|Double Blind Phase|Death|1|||
128834257|NCT04076059|463688668|FG002|Double Blind Phase|Death|0|||
128834258|NCT04076059|463688666|FG000|Double Blind Phase|Lost to Follow-up|1|||
128834259|NCT04076059|463688667|FG001|Double Blind Phase|Lost to Follow-up|0|||
128834260|NCT04076059|463688668|FG002|Double Blind Phase|Lost to Follow-up|0|||
128834261|NCT04076059|463688666|FG000|Double Blind Phase|Adverse Event|5|||
128834262|NCT04076059|463688667|FG001|Double Blind Phase|Adverse Event|1|||
128834263|NCT04076059|463688668|FG002|Double Blind Phase|Adverse Event|0|||
128834264|NCT04076059|463688666|FG000|Double Blind Phase|Ongoing Participants|82|||
128834265|NCT04076059|463688667|FG001|Double Blind Phase|Ongoing Participants|18|||
128834266|NCT04076059|463688668|FG002|Double Blind Phase|Ongoing Participants|0|||
128834267|NCT04076059|463688666|FG000|Double Blind Phase|Miscellaneous|3|||
128834268|NCT04076059|463688667|FG001|Double Blind Phase|Miscellaneous|1|||
128834269|NCT04076059|463688668|FG002|Double Blind Phase|Miscellaneous|0|||
128834270|NCT04076059|463688666|FG000|Double Blind Phase|Protocol Deviation|1|||
128834271|NCT04076059|463688667|FG001|Double Blind Phase|Protocol Deviation|1|||
128834272|NCT04076059|463688668|FG002|Double Blind Phase|Protocol Deviation|0|||
128834273|NCT04076059|463688666|FG000|Double Blind Phase|Did not take study drug|1|||
128834274|NCT04076059|463688667|FG001|Double Blind Phase|Did not take study drug|1|||
128834275|NCT04076059|463688668|FG002|Double Blind Phase|Did not take study drug|0|||
128834276|NCT04076059|463688666|FG000|Open Label Phase|Progressive disease|0|||
128834277|NCT04076059|463688667|FG001|Open Label Phase|Progressive disease|0|||
128834278|NCT04076059|463688668|FG002|Open Label Phase|Progressive disease|7|||
128834279|NCT04076059|463688666|FG000|Open Label Phase|Withdrawal by Subject|0|||
128834280|NCT04076059|463688667|FG001|Open Label Phase|Withdrawal by Subject|0|||
128834281|NCT04076059|463688668|FG002|Open Label Phase|Withdrawal by Subject|3|||
128834282|NCT04076059|463688666|FG000|Open Label Phase|Death|0|||
128834283|NCT04076059|463688667|FG001|Open Label Phase|Death|0|||
128834284|NCT04076059|463688668|FG002|Open Label Phase|Death|2|||
128834285|NCT04076059|463688666|FG000|Open Label Phase|Ongoing Participants|0|||
128834286|NCT04076059|463688667|FG001|Open Label Phase|Ongoing Participants|0|||
128834287|NCT04076059|463688668|FG002|Open Label Phase|Ongoing Participants|11|||
128834288|NCT04535414|463688672|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
128834289|NCT04535414|463688673|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
128834290|NCT04535414|463688672|FG000|Overall Study|Cancelled appointment|1|||
128834291|NCT04535414|463688673|FG001|Overall Study|Cancelled appointment|0|||
128834292|NCT04535414|463688672|FG000|Overall Study|cancelled - food in stomach|2|||
128834293|NCT04535414|463688673|FG001|Overall Study|cancelled - food in stomach|0|||
128834294|NCT04535414|463688672|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
128834295|NCT04535414|463688673|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
128834296|NCT04535414|463688672|FG000|Overall Study|Withdrawal by Subject|0|||
128834297|NCT04535414|463688673|FG001|Overall Study|Withdrawal by Subject|1|||
128834298|NCT00949117|463689617|FG000|Overall Study|Lack of Efficacy|2|||
128834299|NCT00949117|463689618|FG001|Overall Study|Lack of Efficacy|3|||
128834300|NCT00949117|463689617|FG000|Overall Study|Protocol Violation|1|||
128834301|NCT00949117|463689618|FG001|Overall Study|Protocol Violation|1|||
128834302|NCT00949117|463689617|FG000|Overall Study|Adverse Event|0|||
128834303|NCT00949117|463689618|FG001|Overall Study|Adverse Event|1|||
128834304|NCT00799409|463689619|FG000|Overall Study|Withdrawal by Subject|1|||
128834305|NCT00799409|463689620|FG001|Overall Study|Withdrawal by Subject|0|||
128834306|NCT00799409|463689621|FG002|Overall Study|Withdrawal by Subject|0|||
128834307|NCT00799409|463689619|FG000|Overall Study|Lost to Follow-up|1|||
128834308|NCT00799409|463689620|FG001|Overall Study|Lost to Follow-up|0|||
128834309|NCT00799409|463689621|FG002|Overall Study|Lost to Follow-up|0|||
128834310|NCT00799409|463689619|FG000|Overall Study|Optimal Dose Not Achieved|2|||
128834311|NCT00799409|463689620|FG001|Overall Study|Optimal Dose Not Achieved|0|||
128834312|NCT00799409|463689621|FG002|Overall Study|Optimal Dose Not Achieved|0|||
128834313|NCT00799409|463689619|FG000|Overall Study|Failure to follow study protocol)|1|||
128834314|NCT00799409|463689620|FG001|Overall Study|Failure to follow study protocol)|0|||
128834315|NCT00799409|463689621|FG002|Overall Study|Failure to follow study protocol)|0|||
128834316|NCT00799409|463689619|FG000|Overall Study|Did not attend lab school day 1|1|||
128834317|NCT00799409|463689620|FG001|Overall Study|Did not attend lab school day 1|0|||
128834318|NCT00799409|463689621|FG002|Overall Study|Did not attend lab school day 1|0|||
128834319|NCT00799409|463689619|FG000|Overall Study|medication compliance|1|||
128834320|NCT00799409|463689620|FG001|Overall Study|medication compliance|0|||
128834321|NCT00799409|463689621|FG002|Overall Study|medication compliance|0|||
128834322|NCT03964974|463689622|FG000|Overall Study|Lost to Follow-up|3|||
128834323|NCT03964974|463689623|FG001|Overall Study|Lost to Follow-up|2|||
128834324|NCT03964974|463689622|FG000|Overall Study|Withdrawal by Subject|0|||
128834325|NCT03964974|463689623|FG001|Overall Study|Withdrawal by Subject|3|||
128834326|NCT02713594|463689624|FG000|Overall Study|Withdrawal by Subject|32|||
128834327|NCT02713594|463689625|FG001|Overall Study|Withdrawal by Subject|22|||
128834328|NCT02713594|463689624|FG000|Overall Study|Lost to Follow-up|358|||
128834329|NCT02713594|463689625|FG001|Overall Study|Lost to Follow-up|374|||
128834330|NCT00670449|463689626|FG000|Overall Study|Adverse Event|6|||
128834331|NCT00670449|463689627|FG001|Overall Study|Adverse Event|2|||
128834332|NCT00670449|463689628|FG002|Overall Study|Adverse Event|8|||
128834333|NCT00670449|463689629|FG003|Overall Study|Adverse Event|5|||
128834334|NCT00670449|463689626|FG000|Overall Study|Protocol Deviation|1|||
128834335|NCT00670449|463689627|FG001|Overall Study|Protocol Deviation|2|||
128834336|NCT00670449|463689628|FG002|Overall Study|Protocol Deviation|0|||
128834337|NCT00670449|463689629|FG003|Overall Study|Protocol Deviation|1|||
128834338|NCT00670449|463689626|FG000|Overall Study|Administrative Problems|0|||
128834339|NCT00670449|463689627|FG001|Overall Study|Administrative Problems|2|||
128834340|NCT00670449|463689628|FG002|Overall Study|Administrative Problems|0|||
128834341|NCT00670449|463689629|FG003|Overall Study|Administrative Problems|1|||
128834342|NCT00670449|463689626|FG000|Overall Study|Subject Withdrew Consent|0|||
128834343|NCT00670449|463689627|FG001|Overall Study|Subject Withdrew Consent|2|||
128834344|NCT00670449|463689628|FG002|Overall Study|Subject Withdrew Consent|0|||
128834345|NCT00670449|463689629|FG003|Overall Study|Subject Withdrew Consent|1|||
128834346|NCT00670449|463689626|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
128834347|NCT00670449|463689627|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
128834348|NCT00670449|463689628|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
128834349|NCT00670449|463689629|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
128834350|NCT00670449|463689626|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
128834351|NCT00670449|463689627|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
128834352|NCT00670449|463689628|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
128834353|NCT00670449|463689629|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
128834354|NCT02771366|463689630|FG000|Period 1|Withdrawal by Subject|0|||
128834355|NCT02771366|463689631|FG001|Period 1|Withdrawal by Subject|2|||
128834356|NCT02771366|463689630|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
128834357|NCT02771366|463689631|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
128834358|NCT01214200|463689635|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
128834359|NCT01214200|463689635|FG000|Overall Study|Withdrawal by Subject|2|||
128834360|NCT01719172|463689636|FG000|Overall Study|Lost to Follow-up|1|||
128834361|NCT01719172|463689636|FG000|Overall Study|Death|1|||
128834362|NCT00587171|463689637|FG000|Overall Study|Lost to Follow-up|1|||
128834363|NCT00587171|463689638|FG001|Overall Study|Lost to Follow-up|1|||
128834364|NCT01148017|463689639|FG000|Overall Study|Withdrawal by Subject|31|||
128834365|NCT01148017|463689640|FG001|Overall Study|Withdrawal by Subject|14|||
128834366|NCT01148017|463689641|FG002|Overall Study|Withdrawal by Subject|0|||
128834367|NCT01148017|463689642|FG003|Overall Study|Withdrawal by Subject|0|||
128834368|NCT01148017|463689639|FG000|Overall Study|Lost to Follow-up|23|||
128834369|NCT01148017|463689640|FG001|Overall Study|Lost to Follow-up|10|||
128834370|NCT01148017|463689641|FG002|Overall Study|Lost to Follow-up|0|||
128834371|NCT01148017|463689642|FG003|Overall Study|Lost to Follow-up|0|||
128834372|NCT01148017|463689639|FG000|Overall Study|Inappropriate enrollment|1|||
128834373|NCT01148017|463689640|FG001|Overall Study|Inappropriate enrollment|0|||
128834374|NCT01148017|463689641|FG002|Overall Study|Inappropriate enrollment|0|||
128834375|NCT01148017|463689642|FG003|Overall Study|Inappropriate enrollment|0|||
128834376|NCT01148017|463689639|FG000|Overall Study|Administrative reason|22|||
128834377|NCT01148017|463689640|FG001|Overall Study|Administrative reason|9|||
128834378|NCT01148017|463689641|FG002|Overall Study|Administrative reason|0|||
128834379|NCT01148017|463689642|FG003|Overall Study|Administrative reason|0|||
128834380|NCT01148017|463689639|FG000|Overall Study|Unable to classify|3|||
128834381|NCT01148017|463689640|FG001|Overall Study|Unable to classify|1|||
128834382|NCT01148017|463689641|FG002|Overall Study|Unable to classify|0|||
128834383|NCT01148017|463689642|FG003|Overall Study|Unable to classify|0|||
128834384|NCT01848483|463689643|FG000|Overall Study|Death|2|||
128834385|NCT01848483|463689644|FG001|Overall Study|Death|1|||
128834386|NCT01848483|463689643|FG000|Overall Study|Lost to Follow-up|6|||
128834387|NCT01848483|463689644|FG001|Overall Study|Lost to Follow-up|8|||
128834388|NCT01848483|463689643|FG000|Overall Study|Withdrawal by Subject|1|||
128834389|NCT01848483|463689644|FG001|Overall Study|Withdrawal by Subject|0|||
128834390|NCT01848483|463689643|FG000|Overall Study|Incarceration|2|||
128834391|NCT01848483|463689644|FG001|Overall Study|Incarceration|2|||
128834392|NCT04250636|463689647|FG000|Overall Study|Lost to Follow-up|2|||
128834393|NCT01353274|463689648|FG000|Overall Study|No case report form (CRF) collected|28|||
128834394|NCT00022672|463689650|FG000|Main Phase: 24 Months|Adverse Event|6|||
128834395|NCT00022672|463689651|FG001|Main Phase: 24 Months|Adverse Event|0|||
128834396|NCT00022672|463689650|FG000|Main Phase: 24 Months|Death|0|||
128834397|NCT00022672|463689651|FG001|Main Phase: 24 Months|Death|3|||
128834398|NCT00022672|463689650|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
128834399|NCT00022672|463689651|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
128834400|NCT00022672|463689650|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
128834401|NCT00022672|463689651|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
128834402|NCT00022672|463689650|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
128834403|NCT00022672|463689651|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
128834404|NCT00022672|463689650|FG000|Main Phase: 24 Months|Refused Treatment|3|||
128834405|NCT00022672|463689651|FG001|Main Phase: 24 Months|Refused Treatment|4|||
128834406|NCT00022672|463689650|FG000|Main Phase: 24 Months|Failure to Return|1|||
128834407|NCT00022672|463689651|FG001|Main Phase: 24 Months|Failure to Return|1|||
128834408|NCT00022672|463689650|FG000|Main Phase: 24 Months|Other|1|||
128834409|NCT00022672|463689651|FG001|Main Phase: 24 Months|Other|0|||
128834410|NCT00022672|463689650|FG000|Extension Phase|Adverse Event|1|||
128834411|NCT00022672|463689651|FG001|Extension Phase|Adverse Event|3|||
128834412|NCT00022672|463689650|FG000|Extension Phase|Death|0|||
128834413|NCT00022672|463689651|FG001|Extension Phase|Death|1|||
128834414|NCT00022672|463689650|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
128834415|NCT00022672|463689651|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
128834416|NCT00022672|463689650|FG000|Extension Phase|Refused Treatment|0|||
128834417|NCT00022672|463689651|FG001|Extension Phase|Refused Treatment|2|||
128834418|NCT00022672|463689650|FG000|Extension Phase|Other|1|||
128834419|NCT00022672|463689651|FG001|Extension Phase|Other|1|||
128834420|NCT00403494|463689652|FG000|Overall Study|Adverse Event|10|||
128834421|NCT00403494|463689653|FG001|Overall Study|Adverse Event|8|||
128834422|NCT00403494|463689652|FG000|Overall Study|Withdrew Consent|3|||
128834423|NCT00403494|463689653|FG001|Overall Study|Withdrew Consent|2|||
128834424|NCT00403494|463689652|FG000|Overall Study|Inappropriately enrolled|0|||
128834425|NCT00403494|463689653|FG001|Overall Study|Inappropriately enrolled|1|||
128834426|NCT00403494|463689652|FG000|Overall Study|Lost to Follow-up|0|||
128834427|NCT00403494|463689653|FG001|Overall Study|Lost to Follow-up|2|||
128834428|NCT00403494|463689652|FG000|Overall Study|Protocol noncompliance|0|||
128834429|NCT00403494|463689653|FG001|Overall Study|Protocol noncompliance|1|||
128834430|NCT00403494|463689652|FG000|Overall Study|Death|1|||
128834431|NCT00403494|463689653|FG001|Overall Study|Death|0|||
128834432|NCT00403494|463689652|FG000|Overall Study|Sponsor Request|1|||
128834433|NCT00403494|463689653|FG001|Overall Study|Sponsor Request|0|||
128834434|NCT03490032|463689654|FG000|Overall Study|family issue (child custody)|1|||
128834435|NCT03490032|463689655|FG001|Overall Study|family issue (child custody)|0|||
128834436|NCT03490032|463689656|FG002|Overall Study|family issue (child custody)|0|||
128834437|NCT01220999|463689666|FG000|Overall Study|Progressive disease|0|||
128834438|NCT01220999|463689667|FG001|Overall Study|Progressive disease|0|||
128834439|NCT01220999|463689668|FG002|Overall Study|Progressive disease|1|||
128834440|NCT01220999|463689669|FG003|Overall Study|Progressive disease|0|||
128834441|NCT01220999|463689670|FG004|Overall Study|Progressive disease|0|||
128834442|NCT03861234|463689671|FG000|Overall Study|Not treated|0|||
128834443|NCT03861234|463689672|FG001|Overall Study|Not treated|0|||
128834444|NCT03861234|463689673|FG002|Overall Study|Not treated|0|||
128834445|NCT03861234|463689674|FG003|Overall Study|Not treated|0|||
128834446|NCT03861234|463689675|FG004|Overall Study|Not treated|0|||
128834447|NCT03861234|463689676|FG005|Overall Study|Not treated|1|||
128834448|NCT03861234|463689677|FG006|Overall Study|Not treated|0|||
128834449|NCT03861234|463689678|FG007|Overall Study|Not treated|0|||
128834450|NCT03861234|463689671|FG000|Overall Study|Adverse Event|0|||
128834451|NCT03861234|463689672|FG001|Overall Study|Adverse Event|0|||
128834452|NCT03861234|463689673|FG002|Overall Study|Adverse Event|0|||
128834453|NCT03861234|463689674|FG003|Overall Study|Adverse Event|0|||
128834454|NCT03861234|463689675|FG004|Overall Study|Adverse Event|0|||
128834455|NCT03861234|463689676|FG005|Overall Study|Adverse Event|1|||
128834456|NCT03861234|463689677|FG006|Overall Study|Adverse Event|0|||
128834457|NCT03861234|463689678|FG007|Overall Study|Adverse Event|0|||
128834458|NCT03861234|463689671|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
128834459|NCT03861234|463689672|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
128834460|NCT03861234|463689673|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
128834461|NCT03861234|463689674|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
128834462|NCT03861234|463689675|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
128834463|NCT03861234|463689676|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
128834464|NCT03861234|463689677|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
128834465|NCT03861234|463689678|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
128834466|NCT03861234|463689671|FG000|Overall Study|As per sponsor decision|0|||
128834467|NCT03861234|463689672|FG001|Overall Study|As per sponsor decision|0|||
128834468|NCT03861234|463689673|FG002|Overall Study|As per sponsor decision|0|||
128834469|NCT03861234|463689674|FG003|Overall Study|As per sponsor decision|0|||
128834470|NCT03861234|463689675|FG004|Overall Study|As per sponsor decision|0|||
128834471|NCT03861234|463689676|FG005|Overall Study|As per sponsor decision|0|||
128834472|NCT03861234|463689677|FG006|Overall Study|As per sponsor decision|1|||
128834473|NCT03861234|463689678|FG007|Overall Study|As per sponsor decision|0|||
128834474|NCT03861234|463689671|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
128834475|NCT03861234|463689672|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
128834476|NCT03861234|463689673|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
128834477|NCT03861234|463689674|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
128834478|NCT03861234|463689675|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
128834479|NCT03861234|463689676|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
128834480|NCT03861234|463689677|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
128834481|NCT03861234|463689678|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
128834482|NCT02066636|463689679|FG000|Overall Study|Disease progression|51|||
128834483|NCT02066636|463689680|FG001|Overall Study|Disease progression|60|||
128834484|NCT02066636|463689681|FG002|Overall Study|Disease progression|700|||
128834485|NCT02066636|463689679|FG000|Overall Study|Study drug toxicity|13|||
128834486|NCT02066636|463689680|FG001|Overall Study|Study drug toxicity|2|||
128834487|NCT02066636|463689681|FG002|Overall Study|Study drug toxicity|58|||
128834488|NCT02066636|463689679|FG000|Overall Study|Death|4|||
128834489|NCT02066636|463689680|FG001|Overall Study|Death|2|||
128834490|NCT02066636|463689681|FG002|Overall Study|Death|158|||
128834491|NCT02066636|463689679|FG000|Overall Study|Adverse event unrelated to study drug|6|||
128834492|NCT02066636|463689680|FG001|Overall Study|Adverse event unrelated to study drug|4|||
128834493|NCT02066636|463689681|FG002|Overall Study|Adverse event unrelated to study drug|45|||
128834494|NCT02066636|463689679|FG000|Overall Study|Participant request to discontinue treatment|12|||
128834495|NCT02066636|463689680|FG001|Overall Study|Participant request to discontinue treatment|12|||
128834496|NCT02066636|463689681|FG002|Overall Study|Participant request to discontinue treatment|70|||
128834497|NCT02066636|463689679|FG000|Overall Study|Participant withdrew consent|10|||
128834498|NCT02066636|463689680|FG001|Overall Study|Participant withdrew consent|18|||
128834499|NCT02066636|463689681|FG002|Overall Study|Participant withdrew consent|61|||
128834500|NCT02066636|463689679|FG000|Overall Study|Lost to Follow-up|0|||
128834501|NCT02066636|463689680|FG001|Overall Study|Lost to Follow-up|2|||
128834502|NCT02066636|463689681|FG002|Overall Study|Lost to Follow-up|2|||
128834503|NCT02066636|463689679|FG000|Overall Study|Maximum clinical benefit|2|||
128834504|NCT02066636|463689680|FG001|Overall Study|Maximum clinical benefit|2|||
128834505|NCT02066636|463689681|FG002|Overall Study|Maximum clinical benefit|3|||
128834506|NCT02066636|463689679|FG000|Overall Study|Poor/non-compliance|2|||
128834507|NCT02066636|463689680|FG001|Overall Study|Poor/non-compliance|1|||
128834508|NCT02066636|463689681|FG002|Overall Study|Poor/non-compliance|1|||
128834509|NCT02066636|463689679|FG000|Overall Study|Participant no loner meets study criteria|3|||
128834510|NCT02066636|463689680|FG001|Overall Study|Participant no loner meets study criteria|2|||
128834511|NCT02066636|463689681|FG002|Overall Study|Participant no loner meets study criteria|28|||
128834512|NCT02066636|463689679|FG000|Overall Study|Administrative reasons by sponsor|8|||
128834513|NCT02066636|463689680|FG001|Overall Study|Administrative reasons by sponsor|5|||
128834514|NCT02066636|463689681|FG002|Overall Study|Administrative reasons by sponsor|0|||
128834515|NCT02066636|463689679|FG000|Overall Study|Other reasons|16|||
128834516|NCT02066636|463689680|FG001|Overall Study|Other reasons|15|||
128834517|NCT02066636|463689681|FG002|Overall Study|Other reasons|50|||
128834518|NCT01989104|463689685|FG000|Overall Study|Withdrawal by Subject|3|||
128834519|NCT01989104|463689686|FG001|Overall Study|Withdrawal by Subject|0|||
128834520|NCT01989104|463689687|FG002|Overall Study|Withdrawal by Subject|0|||
128834521|NCT01989104|463689688|FG003|Overall Study|Withdrawal by Subject|0|||
128834522|NCT01989104|463689689|FG004|Overall Study|Withdrawal by Subject|0|||
128834523|NCT02833948|463689691|FG000|Overall Study|Death|2|||
128834524|NCT02833948|463689692|FG001|Overall Study|Death|3|||
128834525|NCT02833948|463689691|FG000|Overall Study|were not scanned|8|||
128834526|NCT02833948|463689692|FG001|Overall Study|were not scanned|13|||
128834527|NCT02833948|463689691|FG000|Overall Study|scans could not be evaluated|5|||
128834528|NCT02833948|463689692|FG001|Overall Study|scans could not be evaluated|2|||
128834529|NCT02852824|463689693|FG000|Overall Study|Withdrawal by Subject|1|||
128834530|NCT02852824|463689694|FG001|Overall Study|Withdrawal by Subject|0|||
128834531|NCT02852824|463689695|FG002|Overall Study|Withdrawal by Subject|0|||
128834532|NCT02852824|463689696|FG003|Overall Study|Withdrawal by Subject|0|||
128834533|NCT02852824|463689697|FG004|Overall Study|Withdrawal by Subject|0|||
128834534|NCT02852824|463689698|FG005|Overall Study|Withdrawal by Subject|0|||
128834535|NCT02852824|463689699|FG006|Overall Study|Withdrawal by Subject|0|||
128834536|NCT02852824|463689693|FG000|Overall Study|Adverse Event|0|||
128834537|NCT02852824|463689694|FG001|Overall Study|Adverse Event|0|||
128834538|NCT02852824|463689695|FG002|Overall Study|Adverse Event|0|||
128834539|NCT02852824|463689696|FG003|Overall Study|Adverse Event|0|||
128834540|NCT02852824|463689697|FG004|Overall Study|Adverse Event|2|||
128834541|NCT02852824|463689698|FG005|Overall Study|Adverse Event|0|||
128834542|NCT02852824|463689699|FG006|Overall Study|Adverse Event|0|||
128834543|NCT03539055|463689700|FG000|Overall Study|Death|4|||
128834544|NCT03539055|463689700|FG000|Overall Study|Lost to Follow-up|1|||
128834545|NCT03539055|463689700|FG000|Overall Study|Withdrawal by Subject|2|||
128834546|NCT03539055|463689700|FG000|Overall Study|Screen Fail|7|||
128834547|NCT03539055|463689700|FG000|Overall Study|Drug Intolerance|2|||
128834548|NCT03775213|463689701|FG000|Overall Study|Withdrawal by Subject|51|||
128834549|NCT03775213|463689702|FG001|Overall Study|Withdrawal by Subject|53|||
128834550|NCT03775213|463689701|FG000|Overall Study|Incomplete Survey|7|||
128834551|NCT03775213|463689702|FG001|Overall Study|Incomplete Survey|7|||
128834552|NCT00786188|463689703|FG000|Overall Study|Adverse Event|3|||
128834553|NCT00786188|463689704|FG001|Overall Study|Adverse Event|1|||
128834554|NCT00786188|463689703|FG000|Overall Study|Withdrawal by Subject|2|||
128834555|NCT00786188|463689704|FG001|Overall Study|Withdrawal by Subject|0|||
128834556|NCT02521493|463689708|FG000|Overall Study|Death|3|||
128834557|NCT02521493|463689709|FG001|Overall Study|Death|4|||
128834558|NCT02521493|463689710|FG002|Overall Study|Death|1|||
128834559|NCT02521493|463689708|FG000|Overall Study|Physician Decision|19|||
128834560|NCT02521493|463689709|FG001|Overall Study|Physician Decision|1|||
128834561|NCT02521493|463689710|FG002|Overall Study|Physician Decision|2|||
128834562|NCT02521493|463689708|FG000|Overall Study|Withdrawal by Subject|3|||
128834563|NCT02521493|463689709|FG001|Overall Study|Withdrawal by Subject|0|||
128834564|NCT02521493|463689710|FG002|Overall Study|Withdrawal by Subject|0|||
128834565|NCT02521493|463689708|FG000|Overall Study|Ineligible|0|||
128834566|NCT02521493|463689709|FG001|Overall Study|Ineligible|1|||
128834567|NCT02521493|463689710|FG002|Overall Study|Ineligible|0|||
128834568|NCT02521493|463689708|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
128834569|NCT02521493|463689709|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
128834570|NCT02521493|463689710|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
128834571|NCT02521493|463689708|FG000|Overall Study|No MRD result|0|||
128834572|NCT02521493|463689709|FG001|Overall Study|No MRD result|0|||
128834573|NCT02521493|463689710|FG002|Overall Study|No MRD result|4|||
128834574|NCT01218594|463689711|FG000|Overall Study|Death|1|||
128834575|NCT01218594|463689711|FG000|Overall Study|Withdrawal by Subject|3|||
128834576|NCT01218594|463689711|FG000|Overall Study|Adverse Event|2|||
128834577|NCT01218594|463689711|FG000|Overall Study|Physician Decision|6|||
128834578|NCT04748341|463689712|FG000|Overall Study|Lost to Follow-up|1|||
128834579|NCT04748341|463689713|FG001|Overall Study|Lost to Follow-up|1|||
128834580|NCT00452114|463689717|FG000|Overall Study|Physician Decision|3|||
128834581|NCT00452114|463689718|FG001|Overall Study|Physician Decision|3|||
128834582|NCT00671853|463691666|FG000|Overall Study|Lack of Efficacy|3|||
128834583|NCT00671853|463691667|FG001|Overall Study|Lack of Efficacy|7|||
128834584|NCT00671853|463691666|FG000|Overall Study|Adverse Event|7|||
128834585|NCT00671853|463691667|FG001|Overall Study|Adverse Event|1|||
128834586|NCT00671853|463691666|FG000|Overall Study|Withdrawal by Subject|1|||
128834587|NCT00671853|463691667|FG001|Overall Study|Withdrawal by Subject|5|||
128834588|NCT00671853|463691666|FG000|Overall Study|Lost to Follow-up|8|||
128834589|NCT00671853|463691667|FG001|Overall Study|Lost to Follow-up|8|||
128834590|NCT00671853|463691666|FG000|Overall Study|Physician Decision|0|||
128834591|NCT00671853|463691667|FG001|Overall Study|Physician Decision|2|||
128834592|NCT00671853|463691666|FG000|Overall Study|Non-adherence with study procedures|1|||
128834593|NCT00671853|463691667|FG001|Overall Study|Non-adherence with study procedures|4|||
128834594|NCT01779050|463691669|FG000|Overall Study|Withdrawal by Subject|1|||
128834595|NCT01779050|463691670|FG001|Overall Study|Withdrawal by Subject|0|||
128834596|NCT02202317|463691671|FG000|Overall Study|Lost to Follow-up|1|||
128834597|NCT01409837|463691672|FG000|Overall Study|Withdrawal by Subject|2|||
128834598|NCT01409837|463691673|FG001|Overall Study|Withdrawal by Subject|1|||
128834599|NCT01409837|463691672|FG000|Overall Study|Lost to Follow-up|1|||
128834600|NCT01409837|463691673|FG001|Overall Study|Lost to Follow-up|0|||
128834601|NCT01409837|463691672|FG000|Overall Study|Physician Decision|0|||
128834602|NCT01409837|463691673|FG001|Overall Study|Physician Decision|1|||
128834603|NCT03960645|463691674|FG000|Overall Study|Protocol Violation|1|||
128834604|NCT03960645|463691675|FG001|Overall Study|Protocol Violation|0|||
128834605|NCT01332266|463691677|FG000|Phase 1b|Death|3|||
128834606|NCT01332266|463691678|FG001|Phase 1b|Death|3|||
128834607|NCT01332266|463691679|FG002|Phase 1b|Death|2|||
128834608|NCT01332266|463691680|FG003|Phase 1b|Death|0|||
128834609|NCT01332266|463691681|FG004|Phase 1b|Death|0|||
128834610|NCT01332266|463691677|FG000|Phase 1b|Lost to Follow-up|0|||
128834611|NCT01332266|463691678|FG001|Phase 1b|Lost to Follow-up|1|||
128834612|NCT01332266|463691679|FG002|Phase 1b|Lost to Follow-up|0|||
128834613|NCT01332266|463691680|FG003|Phase 1b|Lost to Follow-up|0|||
128834614|NCT01332266|463691681|FG004|Phase 1b|Lost to Follow-up|0|||
128834615|NCT01332266|463691677|FG000|Phase 1b|Withdrawal by Subject|1|||
128834616|NCT01332266|463691678|FG001|Phase 1b|Withdrawal by Subject|1|||
128834617|NCT01332266|463691679|FG002|Phase 1b|Withdrawal by Subject|1|||
128834618|NCT01332266|463691680|FG003|Phase 1b|Withdrawal by Subject|0|||
128834619|NCT01332266|463691681|FG004|Phase 1b|Withdrawal by Subject|0|||
128834620|NCT01332266|463691677|FG000|Phase 2|Death|0|||
128834621|NCT01332266|463691678|FG001|Phase 2|Death|0|||
128834622|NCT01332266|463691679|FG002|Phase 2|Death|0|||
128834623|NCT01332266|463691680|FG003|Phase 2|Death|33|||
128834624|NCT01332266|463691681|FG004|Phase 2|Death|36|||
128834625|NCT01332266|463691677|FG000|Phase 2|Lost to Follow-up|0|||
128834626|NCT01332266|463691678|FG001|Phase 2|Lost to Follow-up|0|||
128834627|NCT01332266|463691679|FG002|Phase 2|Lost to Follow-up|0|||
128834628|NCT01332266|463691680|FG003|Phase 2|Lost to Follow-up|2|||
128834629|NCT01332266|463691681|FG004|Phase 2|Lost to Follow-up|0|||
128834630|NCT01332266|463691677|FG000|Phase 2|Physician Decision|0|||
128834631|NCT01332266|463691678|FG001|Phase 2|Physician Decision|0|||
128834632|NCT01332266|463691679|FG002|Phase 2|Physician Decision|0|||
128834633|NCT01332266|463691680|FG003|Phase 2|Physician Decision|3|||
128834634|NCT01332266|463691681|FG004|Phase 2|Physician Decision|1|||
128834635|NCT01332266|463691677|FG000|Phase 2|Symptomatic deterioration|0|||
128834636|NCT01332266|463691678|FG001|Phase 2|Symptomatic deterioration|0|||
128834637|NCT01332266|463691679|FG002|Phase 2|Symptomatic deterioration|0|||
128834638|NCT01332266|463691680|FG003|Phase 2|Symptomatic deterioration|0|||
128834639|NCT01332266|463691681|FG004|Phase 2|Symptomatic deterioration|1|||
128834640|NCT01332266|463691677|FG000|Phase 2|Progression Disease|0|||
128834641|NCT01332266|463691678|FG001|Phase 2|Progression Disease|0|||
128834642|NCT01332266|463691679|FG002|Phase 2|Progression Disease|0|||
128834643|NCT01332266|463691680|FG003|Phase 2|Progression Disease|2|||
128834644|NCT01332266|463691681|FG004|Phase 2|Progression Disease|1|||
128834645|NCT01332266|463691677|FG000|Phase 2|Withdrawal by Subject|0|||
128834646|NCT01332266|463691678|FG001|Phase 2|Withdrawal by Subject|0|||
128834647|NCT01332266|463691679|FG002|Phase 2|Withdrawal by Subject|0|||
128834648|NCT01332266|463691680|FG003|Phase 2|Withdrawal by Subject|2|||
128834649|NCT01332266|463691681|FG004|Phase 2|Withdrawal by Subject|2|||
128834650|NCT02224755|463691684|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
128834651|NCT02224755|463691685|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
128834652|NCT02224755|463691684|FG000|Two Year Follow up Post-implant|Death|103|||
128834653|NCT02224755|463691685|FG001|Two Year Follow up Post-implant|Death|98|||
128834654|NCT02224755|463691684|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
128834655|NCT02224755|463691685|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
128834656|NCT02224755|463691684|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
128834657|NCT02224755|463691685|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
128834658|NCT02224755|463691684|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
128834659|NCT02224755|463691685|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
128834660|NCT02736188|463691686|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
128834661|NCT02736188|463691686|FG000|Overall Study|Adverse Event|1|||
128834662|NCT02736188|463691686|FG000|Overall Study|Withdrawal by Subject|1|||
128834663|NCT02736188|463691686|FG000|Overall Study|Other|6|||
128834664|NCT02128269|463691691|FG000|Treatment Period|Adverse Event|1|||
128834665|NCT02128269|463691691|FG000|Treatment Period|Physician Decision|1|||
128834666|NCT00878189|463691692|FG000|Overall Study|Death|0|||
128834667|NCT00878189|463691693|FG001|Overall Study|Death|1|||
128834668|NCT00878189|463691694|FG002|Overall Study|Death|0|||
128834669|NCT00878189|463691695|FG003|Overall Study|Death|1|||
128834670|NCT00878189|463691696|FG004|Overall Study|Death|0|||
128834671|NCT00878189|463691697|FG005|Overall Study|Death|0|||
128834672|NCT00878189|463691698|FG006|Overall Study|Death|0|||
128834673|NCT00878189|463691699|FG007|Overall Study|Death|0|||
128834674|NCT00878189|463691700|FG008|Overall Study|Death|1|||
128834675|NCT00878189|463691692|FG000|Overall Study|Participant Refused to Follow-up|0|||
128834676|NCT00878189|463691693|FG001|Overall Study|Participant Refused to Follow-up|0|||
128834677|NCT00878189|463691694|FG002|Overall Study|Participant Refused to Follow-up|0|||
128834678|NCT00878189|463691695|FG003|Overall Study|Participant Refused to Follow-up|0|||
128834679|NCT00878189|463691696|FG004|Overall Study|Participant Refused to Follow-up|0|||
128834680|NCT00878189|463691697|FG005|Overall Study|Participant Refused to Follow-up|4|||
128834681|NCT00878189|463691698|FG006|Overall Study|Participant Refused to Follow-up|0|||
128834682|NCT00878189|463691699|FG007|Overall Study|Participant Refused to Follow-up|0|||
128834683|NCT00878189|463691700|FG008|Overall Study|Participant Refused to Follow-up|0|||
128834684|NCT00878189|463691692|FG000|Overall Study|Other|3|||
128834685|NCT00878189|463691693|FG001|Overall Study|Other|2|||
128834686|NCT00878189|463691694|FG002|Overall Study|Other|4|||
128834687|NCT00878189|463691695|FG003|Overall Study|Other|7|||
128834688|NCT00878189|463691696|FG004|Overall Study|Other|4|||
128834689|NCT00878189|463691697|FG005|Overall Study|Other|18|||
128834690|NCT00878189|463691698|FG006|Overall Study|Other|15|||
128834691|NCT00878189|463691699|FG007|Overall Study|Other|3|||
128834692|NCT00878189|463691700|FG008|Overall Study|Other|4|||
128834693|NCT00878189|463691692|FG000|Overall Study|Lost to Follow-up|0|||
128834694|NCT00878189|463691693|FG001|Overall Study|Lost to Follow-up|0|||
128834695|NCT00878189|463691694|FG002|Overall Study|Lost to Follow-up|0|||
128834696|NCT00878189|463691695|FG003|Overall Study|Lost to Follow-up|0|||
128834697|NCT00878189|463691696|FG004|Overall Study|Lost to Follow-up|0|||
128834698|NCT00878189|463691697|FG005|Overall Study|Lost to Follow-up|1|||
128834699|NCT00878189|463691698|FG006|Overall Study|Lost to Follow-up|1|||
128834700|NCT00878189|463691699|FG007|Overall Study|Lost to Follow-up|0|||
128834701|NCT00878189|463691700|FG008|Overall Study|Lost to Follow-up|0|||
128834702|NCT00878189|463691692|FG000|Overall Study|Objection Progression or Relapse|0|||
128834703|NCT00878189|463691693|FG001|Overall Study|Objection Progression or Relapse|0|||
128834704|NCT00878189|463691694|FG002|Overall Study|Objection Progression or Relapse|0|||
128834705|NCT00878189|463691695|FG003|Overall Study|Objection Progression or Relapse|0|||
128834706|NCT00878189|463691696|FG004|Overall Study|Objection Progression or Relapse|0|||
128834707|NCT00878189|463691697|FG005|Overall Study|Objection Progression or Relapse|0|||
128834708|NCT00878189|463691698|FG006|Overall Study|Objection Progression or Relapse|0|||
128834709|NCT00878189|463691699|FG007|Overall Study|Objection Progression or Relapse|0|||
128834710|NCT00878189|463691700|FG008|Overall Study|Objection Progression or Relapse|3|||
128834711|NCT00703092|463691701|FG000|Overall Study|Withdrawal by Subject|2|||
128834712|NCT01021748|463691702|FG000|Overall Study|Adverse Event|2|||
128834713|NCT01021748|463691703|FG001|Overall Study|Adverse Event|1|||
128834714|NCT01021748|463691704|FG002|Overall Study|Adverse Event|2|||
128834715|NCT01021748|463691705|FG003|Overall Study|Adverse Event|0|||
128834716|NCT01021748|463691706|FG004|Overall Study|Adverse Event|2|||
128834717|NCT01021748|463691707|FG005|Overall Study|Adverse Event|0|||
128834718|NCT01021748|463691708|FG006|Overall Study|Adverse Event|1|||
128834719|NCT01021748|463691709|FG007|Overall Study|Adverse Event|0|||
128834720|NCT01021748|463691710|FG008|Overall Study|Adverse Event|7|||
128834721|NCT01021748|463691702|FG000|Overall Study|Physician Decision|1|||
128834722|NCT01021748|463691703|FG001|Overall Study|Physician Decision|0|||
128834723|NCT01021748|463691704|FG002|Overall Study|Physician Decision|1|||
128834724|NCT01021748|463691705|FG003|Overall Study|Physician Decision|1|||
128834725|NCT01021748|463691706|FG004|Overall Study|Physician Decision|0|||
128834726|NCT01021748|463691707|FG005|Overall Study|Physician Decision|0|||
128834727|NCT01021748|463691708|FG006|Overall Study|Physician Decision|1|||
128834728|NCT01021748|463691709|FG007|Overall Study|Physician Decision|1|||
128834729|NCT01021748|463691710|FG008|Overall Study|Physician Decision|2|||
128834730|NCT01021748|463691702|FG000|Overall Study|Progressive Disease|3|||
128834731|NCT01021748|463691703|FG001|Overall Study|Progressive Disease|3|||
128834732|NCT01021748|463691704|FG002|Overall Study|Progressive Disease|4|||
128834733|NCT01021748|463691705|FG003|Overall Study|Progressive Disease|6|||
128834734|NCT01021748|463691706|FG004|Overall Study|Progressive Disease|7|||
128834735|NCT01021748|463691707|FG005|Overall Study|Progressive Disease|3|||
128834736|NCT01021748|463691708|FG006|Overall Study|Progressive Disease|0|||
128834737|NCT01021748|463691709|FG007|Overall Study|Progressive Disease|5|||
128834738|NCT01021748|463691710|FG008|Overall Study|Progressive Disease|6|||
128834739|NCT01021748|463691702|FG000|Overall Study|Withdrawal by Subject|0|||
128834740|NCT01021748|463691703|FG001|Overall Study|Withdrawal by Subject|0|||
128834741|NCT01021748|463691704|FG002|Overall Study|Withdrawal by Subject|0|||
128834742|NCT01021748|463691705|FG003|Overall Study|Withdrawal by Subject|0|||
128834743|NCT01021748|463691706|FG004|Overall Study|Withdrawal by Subject|0|||
128834744|NCT01021748|463691707|FG005|Overall Study|Withdrawal by Subject|0|||
128834745|NCT01021748|463691708|FG006|Overall Study|Withdrawal by Subject|1|||
128834746|NCT01021748|463691709|FG007|Overall Study|Withdrawal by Subject|0|||
128834747|NCT01021748|463691710|FG008|Overall Study|Withdrawal by Subject|1|||
128834748|NCT01021748|463691702|FG000|Overall Study|Not Treated|0|||
128834749|NCT01021748|463691703|FG001|Overall Study|Not Treated|1|||
128834750|NCT01021748|463691704|FG002|Overall Study|Not Treated|0|||
128834751|NCT01021748|463691705|FG003|Overall Study|Not Treated|0|||
128834752|NCT01021748|463691706|FG004|Overall Study|Not Treated|0|||
128834753|NCT01021748|463691707|FG005|Overall Study|Not Treated|0|||
128834754|NCT01021748|463691708|FG006|Overall Study|Not Treated|0|||
128834755|NCT01021748|463691709|FG007|Overall Study|Not Treated|0|||
128834756|NCT01021748|463691710|FG008|Overall Study|Not Treated|0|||
128834757|NCT01829711|463691715|FG000|Overall Study|Lost to Follow-up|2|||
128834758|NCT01829711|463691715|FG000|Overall Study|Withdrawal by Subject|3|||
128834759|NCT01829711|463691715|FG000|Overall Study|Death|4|||
128834760|NCT01829711|463691715|FG000|Overall Study|Started new therapies|17|||
128834761|NCT01829711|463691715|FG000|Overall Study|Adverse Event|3|||
128834762|NCT01829711|463691715|FG000|Overall Study|Due to progression of disease|13|||
128834763|NCT01829711|463691715|FG000|Overall Study|Due to lack of response|1|||
128834764|NCT01480258|463691716|FG000|Infant Series|Protocol Violation|2|||
128834765|NCT01480258|463691717|FG001|Infant Series|Protocol Violation|0|||
128834766|NCT01480258|463691716|FG000|Infant Series|Physician Decision|0|||
128834767|NCT01480258|463691717|FG001|Infant Series|Physician Decision|1|||
128834768|NCT01480258|463691716|FG000|Infant Series|Not Vaccinated|3|||
128834769|NCT01480258|463691717|FG001|Infant Series|Not Vaccinated|0|||
128834770|NCT01480258|463691716|FG000|Infant Series|Adverse Event|1|||
128834771|NCT01480258|463691717|FG001|Infant Series|Adverse Event|1|||
128834772|NCT01480258|463691716|FG000|Infant Series|Withdrawal by Subject|1|||
128834773|NCT01480258|463691717|FG001|Infant Series|Withdrawal by Subject|6|||
128834774|NCT01480258|463691716|FG000|Interim Period|Lost to Follow-up|0|||
128834775|NCT01480258|463691717|FG001|Interim Period|Lost to Follow-up|2|||
128834776|NCT01480258|463691716|FG000|Interim Period|Physician Decision|1|||
128834777|NCT01480258|463691717|FG001|Interim Period|Physician Decision|0|||
128834778|NCT01480258|463691716|FG000|Interim Period|Protocol Violation|0|||
128834779|NCT01480258|463691717|FG001|Interim Period|Protocol Violation|1|||
128834780|NCT01480258|463691716|FG000|Interim Period|Withdrawal by Subject|9|||
128834781|NCT01480258|463691717|FG001|Interim Period|Withdrawal by Subject|6|||
128834782|NCT03316170|463691720|FG000|Overall Study|Death|1|||
128834783|NCT03316170|463691721|FG001|Overall Study|Death|0|||
128834784|NCT03316170|463691720|FG000|Overall Study|Lost to Follow-up|6|||
128834785|NCT03316170|463691721|FG001|Overall Study|Lost to Follow-up|7|||
128834786|NCT02169414|463691722|FG000|Overall Study|Withdrawal by Subject|1|||
128834787|NCT02169414|463691723|FG001|Overall Study|Withdrawal by Subject|0|||
128834788|NCT02169414|463691724|FG002|Overall Study|Withdrawal by Subject|0|||
128834789|NCT02169414|463691725|FG003|Overall Study|Withdrawal by Subject|0|||
128834790|NCT02169414|463691722|FG000|Overall Study|Adverse Event|0|||
128834791|NCT02169414|463691723|FG001|Overall Study|Adverse Event|1|||
128834792|NCT02169414|463691724|FG002|Overall Study|Adverse Event|0|||
128834793|NCT02169414|463691725|FG003|Overall Study|Adverse Event|0|||
128834794|NCT03374254|463691726|FG000|Overall Study|Death|5|||
128834795|NCT03374254|463691727|FG001|Overall Study|Death|16|||
128834796|NCT03374254|463691728|FG002|Overall Study|Death|13|||
128834797|NCT03374254|463691729|FG003|Overall Study|Death|11|||
128834798|NCT03374254|463691730|FG004|Overall Study|Death|9|||
128834799|NCT03374254|463691731|FG005|Overall Study|Death|12|||
128834800|NCT03374254|463691732|FG006|Overall Study|Death|11|||
128834801|NCT03374254|463691733|FG007|Overall Study|Death|6|||
128834802|NCT03374254|463691734|FG008|Overall Study|Death|7|||
128834803|NCT03374254|463691726|FG000|Overall Study|Lost to Follow-up|0|||
128834804|NCT03374254|463691727|FG001|Overall Study|Lost to Follow-up|0|||
128834805|NCT03374254|463691728|FG002|Overall Study|Lost to Follow-up|0|||
128834806|NCT03374254|463691729|FG003|Overall Study|Lost to Follow-up|0|||
128834807|NCT03374254|463691730|FG004|Overall Study|Lost to Follow-up|0|||
128834808|NCT03374254|463691731|FG005|Overall Study|Lost to Follow-up|0|||
128834809|NCT03374254|463691732|FG006|Overall Study|Lost to Follow-up|2|||
128834810|NCT03374254|463691733|FG007|Overall Study|Lost to Follow-up|0|||
128834811|NCT03374254|463691734|FG008|Overall Study|Lost to Follow-up|0|||
128834812|NCT03374254|463691726|FG000|Overall Study|Sponsor Decision|1|||
128834813|NCT03374254|463691727|FG001|Overall Study|Sponsor Decision|0|||
128834814|NCT03374254|463691728|FG002|Overall Study|Sponsor Decision|2|||
128834815|NCT03374254|463691729|FG003|Overall Study|Sponsor Decision|3|||
128834816|NCT03374254|463691730|FG004|Overall Study|Sponsor Decision|2|||
128834817|NCT03374254|463691731|FG005|Overall Study|Sponsor Decision|3|||
128834818|NCT03374254|463691732|FG006|Overall Study|Sponsor Decision|3|||
128834819|NCT03374254|463691733|FG007|Overall Study|Sponsor Decision|3|||
128834820|NCT03374254|463691734|FG008|Overall Study|Sponsor Decision|4|||
128834821|NCT03374254|463691726|FG000|Overall Study|Withdrawal by Subject|0|||
128834822|NCT03374254|463691727|FG001|Overall Study|Withdrawal by Subject|0|||
128834823|NCT03374254|463691728|FG002|Overall Study|Withdrawal by Subject|0|||
128834824|NCT03374254|463691729|FG003|Overall Study|Withdrawal by Subject|2|||
128834825|NCT03374254|463691730|FG004|Overall Study|Withdrawal by Subject|0|||
128834826|NCT03374254|463691731|FG005|Overall Study|Withdrawal by Subject|1|||
128834827|NCT03374254|463691732|FG006|Overall Study|Withdrawal by Subject|0|||
128834828|NCT03374254|463691733|FG007|Overall Study|Withdrawal by Subject|0|||
128834829|NCT03374254|463691734|FG008|Overall Study|Withdrawal by Subject|0|||
128834830|NCT02309515|463691735|FG000|Overall Study|Withdrawal by Subject|0|||
128834831|NCT02309515|463691736|FG001|Overall Study|Withdrawal by Subject|1|||
128834832|NCT04070105|463691737|FG000|Overall Study|Lost to Follow-up|0|||
128834833|NCT04070105|463691738|FG001|Overall Study|Lost to Follow-up|0|||
128834834|NCT04070105|463691739|FG002|Overall Study|Lost to Follow-up|0|||
128834835|NCT04070105|463691740|FG003|Overall Study|Lost to Follow-up|0|||
128834836|NCT04070105|463691741|FG004|Overall Study|Lost to Follow-up|0|||
128834837|NCT04070105|463691742|FG005|Overall Study|Lost to Follow-up|1|||
128834838|NCT00749944|463691748|FG000|Overall Study|Lost to Follow-up|2|||
128834839|NCT00749944|463691749|FG001|Overall Study|Lost to Follow-up|1|||
128834840|NCT00749944|463691748|FG000|Overall Study|Other|1|||
128834841|NCT00749944|463691749|FG001|Overall Study|Other|0|||
128834842|NCT00749944|463691748|FG000|Overall Study|Withdrawal by Subject|2|||
128834843|NCT00749944|463691749|FG001|Overall Study|Withdrawal by Subject|0|||
128834844|NCT00624377|463691752|FG000|Overall Study|Lost to Follow-up|355|||
128834845|NCT00624377|463691752|FG000|Overall Study|Withdrawal by Subject|100|||
128834846|NCT00624377|463691752|FG000|Overall Study|Adverse Event|14|||
128834847|NCT00624377|463691752|FG000|Overall Study|Other|91|||
128834848|NCT00624377|463691752|FG000|Overall Study|Non-evaluable population|84|||
128834849|NCT05260437|463691753|FG000|Overall Study|Lost to Follow-up|5|||
128834850|NCT05260437|463691754|FG001|Overall Study|Lost to Follow-up|2|||
128834851|NCT05260437|463691755|FG002|Overall Study|Lost to Follow-up|1|||
128834852|NCT05260437|463691756|FG003|Overall Study|Lost to Follow-up|2|||
128834853|NCT05260437|463691757|FG004|Overall Study|Lost to Follow-up|2|||
128834854|NCT05260437|463691753|FG000|Overall Study|Withdrawal by Subject|3|||
128834855|NCT05260437|463691754|FG001|Overall Study|Withdrawal by Subject|0|||
128834856|NCT05260437|463691755|FG002|Overall Study|Withdrawal by Subject|4|||
128834857|NCT05260437|463691756|FG003|Overall Study|Withdrawal by Subject|5|||
128834858|NCT05260437|463691757|FG004|Overall Study|Withdrawal by Subject|0|||
128834859|NCT05260437|463691753|FG000|Overall Study|Vaccine Not Administered|0|||
128834860|NCT05260437|463691754|FG001|Overall Study|Vaccine Not Administered|1|||
128834861|NCT05260437|463691755|FG002|Overall Study|Vaccine Not Administered|0|||
128834862|NCT05260437|463691756|FG003|Overall Study|Vaccine Not Administered|0|||
128834863|NCT05260437|463691757|FG004|Overall Study|Vaccine Not Administered|0|||
128834864|NCT00910962|463691758|FG000|Overall Study|Adverse Event|5|||
128834865|NCT00910962|463691759|FG001|Overall Study|Adverse Event|20|||
128834866|NCT00910962|463691760|FG002|Overall Study|Adverse Event|17|||
128834867|NCT00910962|463691758|FG000|Overall Study|Protocol Violation|1|||
128834868|NCT00910962|463691759|FG001|Overall Study|Protocol Violation|3|||
128834869|NCT00910962|463691760|FG002|Overall Study|Protocol Violation|3|||
128834870|NCT00910962|463691758|FG000|Overall Study|Lost to Follow-up|0|||
128834871|NCT00910962|463691759|FG001|Overall Study|Lost to Follow-up|3|||
128834872|NCT00910962|463691760|FG002|Overall Study|Lost to Follow-up|1|||
128834873|NCT00910962|463691758|FG000|Overall Study|Physician Decision|0|||
128834874|NCT00910962|463691759|FG001|Overall Study|Physician Decision|6|||
128834875|NCT00910962|463691760|FG002|Overall Study|Physician Decision|6|||
128834876|NCT00910962|463691758|FG000|Overall Study|Withdrawal by Subject|25|||
128834877|NCT00910962|463691759|FG001|Overall Study|Withdrawal by Subject|32|||
128834878|NCT00910962|463691760|FG002|Overall Study|Withdrawal by Subject|32|||
128834879|NCT00910962|463691758|FG000|Overall Study|Reached defined stopping criteria|12|||
128834880|NCT00910962|463691759|FG001|Overall Study|Reached defined stopping criteria|14|||
128834881|NCT00910962|463691760|FG002|Overall Study|Reached defined stopping criteria|17|||
128834882|NCT01858688|463691761|FG000|Overall Study|Withdrawal by Subject|8|||
128834883|NCT01858688|463691761|FG000|Overall Study|Participant began another therapy|3|||
128834884|NCT01858688|463691761|FG000|Overall Study|Physician Decision|2|||
128834885|NCT01858688|463691761|FG000|Overall Study|Progressive Disease|2|||
128834886|NCT01858688|463691761|FG000|Overall Study|Reason not reproted|5|||
128834887|NCT01999335|463691762|FG000|Overall Study|Discontinued before receiving treatment|0|||
128834888|NCT01999335|463691763|FG001|Overall Study|Discontinued before receiving treatment|0|||
128834889|NCT01999335|463691764|FG002|Overall Study|Discontinued before receiving treatment|0|||
128834890|NCT01999335|463691765|FG003|Overall Study|Discontinued before receiving treatment|0|||
128834891|NCT01999335|463691766|FG004|Overall Study|Discontinued before receiving treatment|2|||
128834892|NCT00787176|463691767|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
128834893|NCT00787176|463691768|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
128834894|NCT00787176|463691769|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
128834895|NCT00787176|463691770|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
128834896|NCT02404441|463691777|FG000|Phase 1 Part|Adverse Event|1|||
128834897|NCT02404441|463691778|FG001|Phase 1 Part|Adverse Event|0|||
128834898|NCT02404441|463691779|FG002|Phase 1 Part|Adverse Event|0|||
128834899|NCT02404441|463691780|FG003|Phase 1 Part|Adverse Event|0|||
128834900|NCT02404441|463691781|FG004|Phase 1 Part|Adverse Event|0|||
128834901|NCT02404441|463691782|FG005|Phase 1 Part|Adverse Event|0|||
128834902|NCT02404441|463691783|FG006|Phase 1 Part|Adverse Event|0|||
128834903|NCT02404441|463691784|FG007|Phase 1 Part|Adverse Event|0|||
128834904|NCT02404441|463691785|FG008|Phase 1 Part|Adverse Event|0|||
128834905|NCT02404441|463691786|FG009|Phase 1 Part|Adverse Event|0|||
128834906|NCT02404441|463691777|FG000|Phase 1 Part|Physician Decision|0|||
128834907|NCT02404441|463691778|FG001|Phase 1 Part|Physician Decision|1|||
128834908|NCT02404441|463691779|FG002|Phase 1 Part|Physician Decision|0|||
128834909|NCT02404441|463691780|FG003|Phase 1 Part|Physician Decision|0|||
128834910|NCT02404441|463691781|FG004|Phase 1 Part|Physician Decision|0|||
128834911|NCT02404441|463691782|FG005|Phase 1 Part|Physician Decision|0|||
128834912|NCT02404441|463691783|FG006|Phase 1 Part|Physician Decision|0|||
128834913|NCT02404441|463691784|FG007|Phase 1 Part|Physician Decision|0|||
128834914|NCT02404441|463691785|FG008|Phase 1 Part|Physician Decision|0|||
128834915|NCT02404441|463691786|FG009|Phase 1 Part|Physician Decision|0|||
128834916|NCT02404441|463691777|FG000|Phase 1 Part|Progressive Disease|14|||
128834917|NCT02404441|463691778|FG001|Phase 1 Part|Progressive Disease|11|||
128834918|NCT02404441|463691779|FG002|Phase 1 Part|Progressive Disease|7|||
128834919|NCT02404441|463691780|FG003|Phase 1 Part|Progressive Disease|6|||
128834920|NCT02404441|463691781|FG004|Phase 1 Part|Progressive Disease|9|||
128834921|NCT02404441|463691782|FG005|Phase 1 Part|Progressive Disease|0|||
128834922|NCT02404441|463691783|FG006|Phase 1 Part|Progressive Disease|0|||
128834923|NCT02404441|463691784|FG007|Phase 1 Part|Progressive Disease|0|||
128834924|NCT02404441|463691785|FG008|Phase 1 Part|Progressive Disease|0|||
128834925|NCT02404441|463691786|FG009|Phase 1 Part|Progressive Disease|0|||
128834926|NCT02404441|463691777|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
128834927|NCT02404441|463691778|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
128834928|NCT02404441|463691779|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
128834929|NCT02404441|463691780|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
128834930|NCT02404441|463691781|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
128834931|NCT02404441|463691782|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
128834932|NCT02404441|463691783|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
128834933|NCT02404441|463691784|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
128834934|NCT02404441|463691785|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
128834935|NCT02404441|463691786|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
128834936|NCT02404441|463691777|FG000|Phase 1 Part|Death|1|||
128834937|NCT02404441|463691778|FG001|Phase 1 Part|Death|1|||
128834938|NCT02404441|463691779|FG002|Phase 1 Part|Death|1|||
128834939|NCT02404441|463691780|FG003|Phase 1 Part|Death|0|||
128834940|NCT02404441|463691781|FG004|Phase 1 Part|Death|1|||
128834941|NCT02404441|463691782|FG005|Phase 1 Part|Death|0|||
128834942|NCT02404441|463691783|FG006|Phase 1 Part|Death|0|||
128834943|NCT02404441|463691784|FG007|Phase 1 Part|Death|0|||
128834944|NCT02404441|463691785|FG008|Phase 1 Part|Death|0|||
128834945|NCT02404441|463691786|FG009|Phase 1 Part|Death|0|||
128834946|NCT02404441|463691777|FG000|Phase 2 Part|Adverse Event|0|||
128834947|NCT02404441|463691778|FG001|Phase 2 Part|Adverse Event|0|||
128834948|NCT02404441|463691779|FG002|Phase 2 Part|Adverse Event|0|||
128834949|NCT02404441|463691780|FG003|Phase 2 Part|Adverse Event|0|||
128834950|NCT02404441|463691781|FG004|Phase 2 Part|Adverse Event|0|||
128834951|NCT02404441|463691782|FG005|Phase 2 Part|Adverse Event|2|||
128834952|NCT02404441|463691783|FG006|Phase 2 Part|Adverse Event|3|||
128834953|NCT02404441|463691784|FG007|Phase 2 Part|Adverse Event|3|||
128834954|NCT02404441|463691785|FG008|Phase 2 Part|Adverse Event|6|||
128834955|NCT02404441|463691786|FG009|Phase 2 Part|Adverse Event|1|||
128834956|NCT02404441|463691777|FG000|Phase 2 Part|Physician Decision|0|||
128834957|NCT02404441|463691778|FG001|Phase 2 Part|Physician Decision|0|||
128834958|NCT02404441|463691779|FG002|Phase 2 Part|Physician Decision|0|||
128834959|NCT02404441|463691780|FG003|Phase 2 Part|Physician Decision|0|||
128834960|NCT02404441|463691781|FG004|Phase 2 Part|Physician Decision|0|||
128834961|NCT02404441|463691782|FG005|Phase 2 Part|Physician Decision|7|||
128834962|NCT02404441|463691783|FG006|Phase 2 Part|Physician Decision|9|||
128834963|NCT02404441|463691784|FG007|Phase 2 Part|Physician Decision|2|||
128834964|NCT02404441|463691785|FG008|Phase 2 Part|Physician Decision|1|||
128834965|NCT02404441|463691786|FG009|Phase 2 Part|Physician Decision|3|||
128834966|NCT02404441|463691777|FG000|Phase 2 Part|Progressive disease|0|||
128834967|NCT02404441|463691778|FG001|Phase 2 Part|Progressive disease|0|||
128834968|NCT02404441|463691779|FG002|Phase 2 Part|Progressive disease|0|||
128834969|NCT02404441|463691780|FG003|Phase 2 Part|Progressive disease|0|||
128834970|NCT02404441|463691781|FG004|Phase 2 Part|Progressive disease|0|||
128834971|NCT02404441|463691782|FG005|Phase 2 Part|Progressive disease|43|||
128834972|NCT02404441|463691783|FG006|Phase 2 Part|Progressive disease|32|||
128834973|NCT02404441|463691784|FG007|Phase 2 Part|Progressive disease|31|||
128834974|NCT02404441|463691785|FG008|Phase 2 Part|Progressive disease|39|||
128834975|NCT02404441|463691786|FG009|Phase 2 Part|Progressive disease|27|||
128834976|NCT02404441|463691777|FG000|Phase 2 Part|Subject/guardian decision|0|||
128834977|NCT02404441|463691778|FG001|Phase 2 Part|Subject/guardian decision|0|||
128834978|NCT02404441|463691779|FG002|Phase 2 Part|Subject/guardian decision|0|||
128834979|NCT02404441|463691780|FG003|Phase 2 Part|Subject/guardian decision|0|||
128834980|NCT02404441|463691781|FG004|Phase 2 Part|Subject/guardian decision|0|||
128834981|NCT02404441|463691782|FG005|Phase 2 Part|Subject/guardian decision|3|||
128834982|NCT02404441|463691783|FG006|Phase 2 Part|Subject/guardian decision|9|||
128834983|NCT02404441|463691784|FG007|Phase 2 Part|Subject/guardian decision|0|||
128834984|NCT02404441|463691785|FG008|Phase 2 Part|Subject/guardian decision|3|||
128834985|NCT02404441|463691786|FG009|Phase 2 Part|Subject/guardian decision|2|||
128834986|NCT02404441|463691777|FG000|Phase 2 Part|Death|0|||
128834987|NCT02404441|463691778|FG001|Phase 2 Part|Death|0|||
128834988|NCT02404441|463691779|FG002|Phase 2 Part|Death|0|||
128834989|NCT02404441|463691780|FG003|Phase 2 Part|Death|0|||
128834990|NCT02404441|463691781|FG004|Phase 2 Part|Death|0|||
128834991|NCT02404441|463691782|FG005|Phase 2 Part|Death|4|||
128834992|NCT02404441|463691783|FG006|Phase 2 Part|Death|8|||
128834993|NCT02404441|463691784|FG007|Phase 2 Part|Death|4|||
128834994|NCT02404441|463691785|FG008|Phase 2 Part|Death|10|||
128834995|NCT02404441|463691786|FG009|Phase 2 Part|Death|9|||
128834996|NCT02234141|463691787|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
128834997|NCT02234141|463691788|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
128834998|NCT02234141|463691789|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
128834999|NCT02234141|463691790|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
128835000|NCT02234141|463691791|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
128835001|NCT02234141|463691792|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
128835002|NCT02234141|463691793|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
128835003|NCT02234141|463691787|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
128835004|NCT02234141|463691788|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
128835005|NCT02234141|463691789|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
128835006|NCT02234141|463691790|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
128835007|NCT02234141|463691791|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
128835008|NCT02234141|463691792|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
128835009|NCT02234141|463691793|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
128835010|NCT02234141|463691787|FG000|Treatment Period (24 Weeks)|Death|1|||
128835011|NCT02234141|463691788|FG001|Treatment Period (24 Weeks)|Death|2|||
128835012|NCT02234141|463691789|FG002|Treatment Period (24 Weeks)|Death|0|||
128835013|NCT02234141|463691790|FG003|Treatment Period (24 Weeks)|Death|1|||
128835014|NCT02234141|463691791|FG004|Treatment Period (24 Weeks)|Death|0|||
128835015|NCT02234141|463691792|FG005|Treatment Period (24 Weeks)|Death|0|||
128835016|NCT02234141|463691793|FG006|Treatment Period (24 Weeks)|Death|0|||
128835017|NCT02234141|463691787|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
128835018|NCT02234141|463691788|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
128835019|NCT02234141|463691789|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
128835020|NCT02234141|463691790|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
128835021|NCT02234141|463691791|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
128835022|NCT02234141|463691792|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
128835023|NCT02234141|463691793|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
128835024|NCT02234141|463691787|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
128835025|NCT02234141|463691788|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
128835026|NCT02234141|463691789|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
128835027|NCT02234141|463691790|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
128835028|NCT02234141|463691791|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
128835029|NCT02234141|463691792|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
128835030|NCT02234141|463691793|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
128835031|NCT02234141|463691787|FG000|Long-Term Treatment Period|Death|0|||
128835032|NCT02234141|463691788|FG001|Long-Term Treatment Period|Death|0|||
128835033|NCT02234141|463691789|FG002|Long-Term Treatment Period|Death|0|||
128835034|NCT02234141|463691790|FG003|Long-Term Treatment Period|Death|0|||
128835035|NCT02234141|463691791|FG004|Long-Term Treatment Period|Death|0|||
128835036|NCT02234141|463691792|FG005|Long-Term Treatment Period|Death|1|||
128835037|NCT02234141|463691793|FG006|Long-Term Treatment Period|Death|0|||
128835038|NCT02234141|463691787|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
128835039|NCT02234141|463691788|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
128835040|NCT02234141|463691789|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
128835041|NCT02234141|463691790|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
128835042|NCT02234141|463691791|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
128835043|NCT02234141|463691792|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
128835044|NCT02234141|463691793|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
128835045|NCT02234141|463691787|FG000|Long-Term Treatment Period|Adverse Event|4|||
128835046|NCT02234141|463691788|FG001|Long-Term Treatment Period|Adverse Event|0|||
128835047|NCT02234141|463691789|FG002|Long-Term Treatment Period|Adverse Event|5|||
128835048|NCT02234141|463691790|FG003|Long-Term Treatment Period|Adverse Event|0|||
128835049|NCT02234141|463691791|FG004|Long-Term Treatment Period|Adverse Event|1|||
128835050|NCT02234141|463691792|FG005|Long-Term Treatment Period|Adverse Event|1|||
128835051|NCT02234141|463691793|FG006|Long-Term Treatment Period|Adverse Event|1|||
128835052|NCT02234141|463691787|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
128835053|NCT02234141|463691788|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
128835054|NCT02234141|463691789|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
128835055|NCT02234141|463691790|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
128835056|NCT02234141|463691791|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
128835057|NCT02234141|463691792|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
128835058|NCT02234141|463691793|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
128835059|NCT02234141|463691787|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
128835060|NCT02234141|463691788|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
128835061|NCT02234141|463691789|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
128835062|NCT02234141|463691790|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
128835063|NCT02234141|463691791|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
129204944|NCT01962441|465047003|FG001|Randomized Period|Lost to Follow-up|4|||
129204945|NCT01962441|465047004|FG002|Randomized Period|Lost to Follow-up|4|||
129204946|NCT01962441|465047002|FG000|Randomized Period|Withdrew Consent|3|||
129204947|NCT01962441|465047003|FG001|Randomized Period|Withdrew Consent|3|||
128835064|NCT02234141|463691792|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
128835065|NCT02234141|463691793|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
128835066|NCT03326856|463691794|FG000|Overall Study|Lost to Follow-up|1|||
128835067|NCT03326856|463691795|FG001|Overall Study|Lost to Follow-up|1|||
128835068|NCT03326856|463691796|FG002|Overall Study|Lost to Follow-up|0|||
128835069|NCT03326856|463691797|FG003|Overall Study|Lost to Follow-up|0|||
128835070|NCT03326856|463691798|FG004|Overall Study|Lost to Follow-up|0|||
128835071|NCT02037568|463691799|FG000|Overall Study|Withdrawal by Subject|17|||
128835072|NCT02037568|463691800|FG001|Overall Study|Withdrawal by Subject|24|||
128835073|NCT02037568|463691799|FG000|Overall Study|Lost to Follow-up|16|||
128835074|NCT02037568|463691800|FG001|Overall Study|Lost to Follow-up|13|||
128835075|NCT02037568|463691799|FG000|Overall Study|Screen Failure|3|||
128835076|NCT02037568|463691800|FG001|Overall Study|Screen Failure|1|||
128835077|NCT02037568|463691799|FG000|Overall Study|Patient did not receive transplant|0|||
128835078|NCT02037568|463691800|FG001|Overall Study|Patient did not receive transplant|1|||
128835079|NCT00621842|463691801|FG000|Overall Study|Adverse Event|6|||
128835080|NCT00621842|463691801|FG000|Overall Study|Withdrawal by Subject|7|||
128835081|NCT00621842|463691801|FG000|Overall Study|Protocol Violation|4|||
128835082|NCT00621842|463691801|FG000|Overall Study|Lack of Efficacy|2|||
128835083|NCT03692871|463691805|FG000|Overall Study|Death|1|||
128835084|NCT03692871|463691806|FG001|Overall Study|Death|1|||
128835085|NCT03692871|463691805|FG000|Overall Study|Lost to Follow-up|24|||
128835086|NCT03692871|463691806|FG001|Overall Study|Lost to Follow-up|9|||
128835087|NCT03692871|463691805|FG000|Overall Study|Physician Decision|22|||
128835088|NCT03692871|463691806|FG001|Overall Study|Physician Decision|7|||
128835089|NCT03692871|463691805|FG000|Overall Study|Protocol Deviation|1|||
128835090|NCT03692871|463691806|FG001|Overall Study|Protocol Deviation|0|||
128835091|NCT03692871|463691805|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
128835092|NCT03692871|463691806|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
128835093|NCT02644122|463691807|FG000|Overall Study|Withdrawal by Subject|1|||
128835094|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
128835095|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
128835096|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
128835097|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
128835098|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
128835099|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
128835100|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
128835101|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
128835102|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
128835103|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
128835104|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
128835105|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
128835106|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
128835107|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
128835108|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
128835109|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
128835110|NCT03182244|463691808|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
128835111|NCT03182244|463691809|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
128835112|NCT03182244|463691808|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
128835113|NCT03182244|463691809|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
128835114|NCT03182244|463691808|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
128835115|NCT03182244|463691809|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
128835116|NCT03182244|463691808|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
128835117|NCT03182244|463691809|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
128835118|NCT03182244|463691808|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
129204948|NCT01962441|465047004|FG002|Randomized Period|Withdrew Consent|2|||
128835119|NCT03182244|463691809|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
128835120|NCT00680771|463691812|FG000|Overall Study|Withdrawal by Subject|1|||
128835121|NCT00680771|463691813|FG001|Overall Study|Withdrawal by Subject|0|||
128835122|NCT00680771|463691812|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
128835123|NCT00680771|463691813|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
128835124|NCT00680771|463691812|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
128835125|NCT00680771|463691813|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
128835126|NCT01316913|463691814|FG000|Overall Study|Adverse Event|17|||
128835127|NCT01316913|463691815|FG001|Overall Study|Adverse Event|20|||
128835128|NCT01316913|463691816|FG002|Overall Study|Adverse Event|15|||
128835129|NCT01316913|463691817|FG003|Overall Study|Adverse Event|11|||
128835130|NCT01316913|463691814|FG000|Overall Study|Lack of Efficacy|22|||
128835131|NCT01316913|463691815|FG001|Overall Study|Lack of Efficacy|12|||
128835132|NCT01316913|463691816|FG002|Overall Study|Lack of Efficacy|9|||
128835133|NCT01316913|463691817|FG003|Overall Study|Lack of Efficacy|13|||
128835134|NCT01316913|463691814|FG000|Overall Study|Protocol Violation|1|||
128835135|NCT01316913|463691815|FG001|Overall Study|Protocol Violation|4|||
128835136|NCT01316913|463691816|FG002|Overall Study|Protocol Violation|4|||
128835137|NCT01316913|463691817|FG003|Overall Study|Protocol Violation|1|||
128835138|NCT01316913|463691814|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
128835139|NCT01316913|463691815|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
128835140|NCT01316913|463691816|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
128835141|NCT01316913|463691817|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
128835142|NCT01316913|463691814|FG000|Overall Study|Lost to Follow-up|0|||
128835143|NCT01316913|463691815|FG001|Overall Study|Lost to Follow-up|1|||
128835144|NCT01316913|463691816|FG002|Overall Study|Lost to Follow-up|0|||
128835145|NCT01316913|463691817|FG003|Overall Study|Lost to Follow-up|2|||
128835146|NCT01316913|463691814|FG000|Overall Study|Withdrawal by Subject|10|||
128835147|NCT01316913|463691815|FG001|Overall Study|Withdrawal by Subject|9|||
128835148|NCT01316913|463691816|FG002|Overall Study|Withdrawal by Subject|10|||
128835149|NCT01316913|463691817|FG003|Overall Study|Withdrawal by Subject|6|||
128835150|NCT01668719|463691818|FG000|Phase I|On treatment|1|||
128835151|NCT01668719|463691819|FG001|Phase I|On treatment|0|||
128835152|NCT01668719|463691820|FG002|Phase I|On treatment|0|||
128835153|NCT01668719|463691818|FG000|Phase I|Adverse Event|2|||
128835154|NCT01668719|463691819|FG001|Phase I|Adverse Event|0|||
128835155|NCT01668719|463691820|FG002|Phase I|Adverse Event|0|||
128835156|NCT01668719|463691818|FG000|Phase I|Progression/relapse|1|||
128835157|NCT01668719|463691819|FG001|Phase I|Progression/relapse|0|||
128835158|NCT01668719|463691820|FG002|Phase I|Progression/relapse|0|||
128835159|NCT01668719|463691818|FG000|Phase I|not protocol specified|2|||
128835160|NCT01668719|463691819|FG001|Phase I|not protocol specified|0|||
128835161|NCT01668719|463691820|FG002|Phase I|not protocol specified|0|||
128835162|NCT01668719|463691818|FG000|Phase II|On treatment|0|||
128835163|NCT01668719|463691819|FG001|Phase II|On treatment|4|||
128835164|NCT01668719|463691820|FG002|Phase II|On treatment|3|||
128835165|NCT01668719|463691818|FG000|Phase II|Adverse Event|0|||
128835166|NCT01668719|463691819|FG001|Phase II|Adverse Event|18|||
128835167|NCT01668719|463691820|FG002|Phase II|Adverse Event|18|||
128835168|NCT01668719|463691818|FG000|Phase II|Refusal unrelated to adverse event|0|||
128835169|NCT01668719|463691819|FG001|Phase II|Refusal unrelated to adverse event|4|||
128835170|NCT01668719|463691820|FG002|Phase II|Refusal unrelated to adverse event|1|||
128835171|NCT01668719|463691818|FG000|Phase II|Progression/relapse|0|||
128835172|NCT01668719|463691819|FG001|Phase II|Progression/relapse|13|||
128835173|NCT01668719|463691820|FG002|Phase II|Progression/relapse|17|||
128835174|NCT01668719|463691818|FG000|Phase II|Death|0|||
128835175|NCT01668719|463691819|FG001|Phase II|Death|0|||
128835176|NCT01668719|463691820|FG002|Phase II|Death|2|||
128835177|NCT01668719|463691818|FG000|Phase II|not protocol specified|0|||
128835178|NCT01668719|463691819|FG001|Phase II|not protocol specified|13|||
128835179|NCT01668719|463691820|FG002|Phase II|not protocol specified|7|||
128835180|NCT02060487|463691821|FG000|Overall Study|Other|1|||
128835181|NCT02060487|463691822|FG001|Overall Study|Other|2|||
128835182|NCT02060487|463691823|FG002|Overall Study|Other|1|||
128835183|NCT02060487|463691821|FG000|Overall Study|Lack of Efficacy|0|||
128835184|NCT02060487|463691822|FG001|Overall Study|Lack of Efficacy|1|||
128835185|NCT02060487|463691823|FG002|Overall Study|Lack of Efficacy|0|||
128835186|NCT02060487|463691821|FG000|Overall Study|Withdrawal by Subject|3|||
128835187|NCT02060487|463691822|FG001|Overall Study|Withdrawal by Subject|10|||
128835188|NCT02060487|463691823|FG002|Overall Study|Withdrawal by Subject|4|||
128835189|NCT02060487|463691821|FG000|Overall Study|Study Terminated By Sponsor|87|||
128835190|NCT02060487|463691822|FG001|Overall Study|Study Terminated By Sponsor|89|||
128835191|NCT02060487|463691823|FG002|Overall Study|Study Terminated By Sponsor|100|||
128835192|NCT02060487|463691821|FG000|Overall Study|Randomized in error|1|||
128835193|NCT02060487|463691822|FG001|Overall Study|Randomized in error|0|||
128835194|NCT02060487|463691823|FG002|Overall Study|Randomized in error|0|||
128835195|NCT02060487|463691821|FG000|Overall Study|Protocol Violation|0|||
128835196|NCT02060487|463691822|FG001|Overall Study|Protocol Violation|1|||
128835197|NCT02060487|463691823|FG002|Overall Study|Protocol Violation|1|||
128835198|NCT02060487|463691821|FG000|Overall Study|Lost to Follow-up|3|||
128835199|NCT02060487|463691822|FG001|Overall Study|Lost to Follow-up|0|||
128835200|NCT02060487|463691823|FG002|Overall Study|Lost to Follow-up|2|||
128835201|NCT02060487|463691821|FG000|Overall Study|Death|34|||
128835202|NCT02060487|463691822|FG001|Overall Study|Death|25|||
128835203|NCT02060487|463691823|FG002|Overall Study|Death|19|||
128835204|NCT02060487|463691821|FG000|Overall Study|Adverse Event|0|||
128835205|NCT02060487|463691822|FG001|Overall Study|Adverse Event|0|||
128835206|NCT02060487|463691823|FG002|Overall Study|Adverse Event|1|||
128835207|NCT00875706|463691824|FG000|Overall Study|Withdrawal by Subject|1|||
128835208|NCT00875706|463691825|FG001|Overall Study|Withdrawal by Subject|0|||
128835209|NCT00875706|463691826|FG002|Overall Study|Withdrawal by Subject|0|||
128835210|NCT02950961|463691828|FG000|Overall Study|Study had to stop due to COVID.|7|||
128835211|NCT02241785|463691831|FG000|Overall Study|Sponsor Termination|43|||
128835212|NCT02241785|463691831|FG000|Overall Study|Withdrawal by Subject|1|||
128835213|NCT02241785|463691831|FG000|Overall Study|Lost to Follow-up|2|||
128835214|NCT02241785|463691831|FG000|Overall Study|Adverse Event|1|||
128835215|NCT03055988|463691832|FG000|Period 1|Adverse Event|0|||
128835216|NCT03055988|463691833|FG001|Period 1|Adverse Event|1|||
128835217|NCT03055988|463691832|FG000|Period 1|Lost to Follow-up|1|||
128835218|NCT03055988|463691833|FG001|Period 1|Lost to Follow-up|0|||
128835219|NCT03055988|463691832|FG000|Period 1|Withdrawal by Subject|0|||
128835220|NCT03055988|463691833|FG001|Period 1|Withdrawal by Subject|4|||
128835221|NCT03055988|463691832|FG000|Period 2|Adverse Event|0|||
128835222|NCT03055988|463691833|FG001|Period 2|Adverse Event|1|||
128835223|NCT03055988|463691832|FG000|Period 2|Other than listed|1|||
128835224|NCT03055988|463691833|FG001|Period 2|Other than listed|1|||
128835225|NCT00845520|463691834|FG000|Overall Study|Death|1|||
128835226|NCT00845520|463691835|FG001|Overall Study|Death|2|||
128835227|NCT00845520|463691836|FG002|Overall Study|Death|0|||
128835228|NCT00845520|463691834|FG000|Overall Study|Lost to Follow-up|1|||
128835229|NCT00845520|463691835|FG001|Overall Study|Lost to Follow-up|0|||
128835230|NCT00845520|463691836|FG002|Overall Study|Lost to Follow-up|0|||
128835231|NCT00845520|463691834|FG000|Overall Study|Adverse Event|0|||
128835232|NCT00845520|463691835|FG001|Overall Study|Adverse Event|0|||
128835233|NCT00845520|463691836|FG002|Overall Study|Adverse Event|1|||
128835234|NCT01736475|463691837|FG000|Overall Study|Adverse Event|4|||
128835235|NCT01736475|463691838|FG001|Overall Study|Adverse Event|0|||
128835236|NCT01736475|463691837|FG000|Overall Study|Withdrawal by Subject|2|||
128835237|NCT01736475|463691838|FG001|Overall Study|Withdrawal by Subject|0|||
128835238|NCT01736475|463691837|FG000|Overall Study|Protocol Violation|4|||
128835239|NCT01736475|463691838|FG001|Overall Study|Protocol Violation|0|||
128835240|NCT01736475|463691837|FG000|Overall Study|Other - Screen failure|1|||
128835241|NCT01736475|463691838|FG001|Overall Study|Other - Screen failure|0|||
128835242|NCT01736475|463691837|FG000|Overall Study|Other - Surgical procedure|1|||
128835243|NCT01736475|463691838|FG001|Overall Study|Other - Surgical procedure|0|||
128835244|NCT02807857|463691839|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
128835245|NCT02807857|463691839|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
128835246|NCT02807857|463691839|FG000|Follow-Up Set|Withdrawal by Subject|8|||
128835247|NCT02807857|463691839|FG000|Follow-Up Set|Lost to Follow-up|7|||
128835248|NCT02807857|463691839|FG000|Follow-Up Set|Physician Decision|6|||
128835249|NCT02807857|463691839|FG000|Follow-Up Set|Adverse Event|3|||
128835250|NCT02807857|463691839|FG000|Follow-Up Set|Death|27|||
128835251|NCT02807857|463691839|FG000|Follow-Up Set|Relocation|2|||
128835252|NCT02334215|463691841|FG000|Overall Study|Death|1|||
128835253|NCT02334215|463691842|FG001|Overall Study|Death|1|||
128835254|NCT02334215|463691843|FG002|Overall Study|Death|0|||
128835255|NCT02334215|463691841|FG000|Overall Study|Lost to Follow-up|1|||
128835256|NCT02334215|463691842|FG001|Overall Study|Lost to Follow-up|0|||
128835257|NCT02334215|463691843|FG002|Overall Study|Lost to Follow-up|4|||
128835258|NCT02334215|463691841|FG000|Overall Study|Withdrawal by Subject|2|||
128835259|NCT02334215|463691842|FG001|Overall Study|Withdrawal by Subject|2|||
128835260|NCT02334215|463691843|FG002|Overall Study|Withdrawal by Subject|1|||
128835261|NCT02334215|463691841|FG000|Overall Study|Not released from incarceration on time|3|||
128835262|NCT02334215|463691842|FG001|Overall Study|Not released from incarceration on time|3|||
128835263|NCT02334215|463691843|FG002|Overall Study|Not released from incarceration on time|3|||
128835264|NCT02334215|463691841|FG000|Overall Study|Incarcerated|0|||
128835265|NCT02334215|463691842|FG001|Overall Study|Incarcerated|0|||
128835266|NCT02334215|463691843|FG002|Overall Study|Incarcerated|7|||
128835267|NCT03905642|463691844|FG000|Overall Study|Withdrawal by Subject|3|||
128835268|NCT03905642|463691844|FG000|Overall Study|Pregnancy|1|||
128835269|NCT03905642|463691844|FG000|Overall Study|Adverse Event|1|||
128835270|NCT03905642|463691844|FG000|Overall Study|Lack of Efficacy|1|||
128835271|NCT03905642|463691844|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
128835272|NCT03769090|463693323|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
128835273|NCT03769090|463693324|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
128835274|NCT03769090|463693325|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
128835275|NCT03769090|463693323|FG000|Overall Study|Withdrawal by Subject|52|||
128835276|NCT03769090|463693324|FG001|Overall Study|Withdrawal by Subject|62|||
128835277|NCT03769090|463693325|FG002|Overall Study|Withdrawal by Subject|74|||
128835278|NCT03769090|463693323|FG000|Overall Study|Death|4|||
128835279|NCT03769090|463693324|FG001|Overall Study|Death|2|||
128835280|NCT03769090|463693325|FG002|Overall Study|Death|2|||
128835281|NCT03769090|463693323|FG000|Overall Study|Adverse Event|7|||
128835282|NCT03769090|463693324|FG001|Overall Study|Adverse Event|7|||
128835283|NCT03769090|463693325|FG002|Overall Study|Adverse Event|8|||
128835284|NCT03769090|463693323|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
128835285|NCT03769090|463693324|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
128835286|NCT03769090|463693325|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
128835287|NCT03769090|463693323|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
128835288|NCT03769090|463693324|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
128835289|NCT03769090|463693325|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
128835290|NCT03769090|463693323|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
128835291|NCT03769090|463693324|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
128835292|NCT03769090|463693325|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
128835293|NCT03769090|463693323|FG000|Overall Study|Protocol Violation|5|||
128835294|NCT03769090|463693324|FG001|Overall Study|Protocol Violation|6|||
128835295|NCT03769090|463693325|FG002|Overall Study|Protocol Violation|8|||
128835296|NCT03769090|463693323|FG000|Overall Study|Pregnancy|1|||
128835297|NCT03769090|463693324|FG001|Overall Study|Pregnancy|0|||
128835298|NCT03769090|463693325|FG002|Overall Study|Pregnancy|3|||
128835299|NCT03769090|463693323|FG000|Overall Study|Lost to Follow-up|19|||
128835300|NCT03769090|463693324|FG001|Overall Study|Lost to Follow-up|25|||
128835301|NCT03769090|463693325|FG002|Overall Study|Lost to Follow-up|21|||
128835302|NCT03769090|463693323|FG000|Overall Study|Condition under investigation worsened|2|||
128835303|NCT03769090|463693324|FG001|Overall Study|Condition under investigation worsened|0|||
128835304|NCT03769090|463693325|FG002|Overall Study|Condition under investigation worsened|1|||
128835305|NCT03769090|463693323|FG000|Overall Study|Lack of Efficacy|1|||
128835306|NCT03769090|463693324|FG001|Overall Study|Lack of Efficacy|2|||
128835307|NCT03769090|463693325|FG002|Overall Study|Lack of Efficacy|2|||
128835308|NCT03769090|463693323|FG000|Overall Study|Other reasons|8|||
128835309|NCT03769090|463693324|FG001|Overall Study|Other reasons|12|||
128835310|NCT03769090|463693325|FG002|Overall Study|Other reasons|15|||
128835311|NCT02014402|463693329|FG000|Overall Study|Adverse Event|1|||
128835312|NCT02014402|463693330|FG001|Overall Study|Adverse Event|0|||
128835313|NCT02014402|463693331|FG002|Overall Study|Adverse Event|0|||
128835314|NCT02014402|463693332|FG003|Overall Study|Adverse Event|0|||
128835315|NCT02014402|463693329|FG000|Overall Study|Withdrawal by Subject|1|||
128835316|NCT02014402|463693330|FG001|Overall Study|Withdrawal by Subject|2|||
128835317|NCT02014402|463693331|FG002|Overall Study|Withdrawal by Subject|2|||
128835318|NCT02014402|463693332|FG003|Overall Study|Withdrawal by Subject|1|||
128835319|NCT02014402|463693329|FG000|Overall Study|Subject did not have transportation|0|||
128835320|NCT02014402|463693330|FG001|Overall Study|Subject did not have transportation|1|||
128835321|NCT02014402|463693331|FG002|Overall Study|Subject did not have transportation|0|||
128835322|NCT02014402|463693332|FG003|Overall Study|Subject did not have transportation|0|||
128835323|NCT02014402|463693329|FG000|Overall Study|Lost to Follow-up|0|||
128835324|NCT02014402|463693330|FG001|Overall Study|Lost to Follow-up|0|||
128835325|NCT02014402|463693331|FG002|Overall Study|Lost to Follow-up|1|||
128835326|NCT02014402|463693332|FG003|Overall Study|Lost to Follow-up|2|||
128835327|NCT00443820|463693333|FG000|Overall Study|Adverse Event|1|||
128835328|NCT00443820|463693334|FG001|Overall Study|Adverse Event|1|||
128835329|NCT00443820|463693335|FG002|Overall Study|Adverse Event|0|||
128835330|NCT00443820|463693336|FG003|Overall Study|Adverse Event|0|||
128835331|NCT00443820|463693333|FG000|Overall Study|Lack of Efficacy|3|||
128835332|NCT00443820|463693334|FG001|Overall Study|Lack of Efficacy|2|||
128835333|NCT00443820|463693335|FG002|Overall Study|Lack of Efficacy|1|||
128835334|NCT00443820|463693336|FG003|Overall Study|Lack of Efficacy|1|||
128835335|NCT00443820|463693333|FG000|Overall Study|Protocol Violation|2|||
128835336|NCT00443820|463693334|FG001|Overall Study|Protocol Violation|1|||
128835337|NCT00443820|463693335|FG002|Overall Study|Protocol Violation|2|||
128835338|NCT00443820|463693336|FG003|Overall Study|Protocol Violation|1|||
128835339|NCT00443820|463693333|FG000|Overall Study|Withdrawal by Subject|6|||
128835340|NCT00443820|463693334|FG001|Overall Study|Withdrawal by Subject|7|||
128835341|NCT00443820|463693335|FG002|Overall Study|Withdrawal by Subject|8|||
128835342|NCT00443820|463693336|FG003|Overall Study|Withdrawal by Subject|9|||
128835343|NCT00443820|463693333|FG000|Overall Study|Lost to Follow-up|9|||
128835344|NCT00443820|463693334|FG001|Overall Study|Lost to Follow-up|8|||
128835345|NCT00443820|463693335|FG002|Overall Study|Lost to Follow-up|6|||
128835346|NCT00443820|463693336|FG003|Overall Study|Lost to Follow-up|5|||
128835347|NCT00443820|463693333|FG000|Overall Study|Administrative problems|0|||
128835348|NCT00443820|463693334|FG001|Overall Study|Administrative problems|0|||
128835349|NCT00443820|463693335|FG002|Overall Study|Administrative problems|0|||
128835350|NCT00443820|463693336|FG003|Overall Study|Administrative problems|1|||
128835351|NCT00443820|463693333|FG000|Overall Study|Death|0|||
128835352|NCT00443820|463693334|FG001|Overall Study|Death|0|||
128835353|NCT00443820|463693335|FG002|Overall Study|Death|1|||
128835354|NCT00443820|463693336|FG003|Overall Study|Death|0|||
128835355|NCT04633200|463693337|FG000|Overall Study|Lost to Follow-up|3|||
128835356|NCT04633200|463693338|FG001|Overall Study|Lost to Follow-up|5|||
128835357|NCT01190124|463693339|FG000|Overall Study|Death|3|||
128835358|NCT01190124|463693340|FG001|Overall Study|Death|0|||
128835359|NCT01190124|463693341|FG002|Overall Study|Death|0|||
128835360|NCT01190124|463693339|FG000|Overall Study|Therapeutic Failure|12|||
128835361|NCT01190124|463693340|FG001|Overall Study|Therapeutic Failure|0|||
128835362|NCT01190124|463693341|FG002|Overall Study|Therapeutic Failure|1|||
128835363|NCT01190124|463693339|FG000|Overall Study|Lost to Follow-up|2|||
128835364|NCT01190124|463693340|FG001|Overall Study|Lost to Follow-up|0|||
128835365|NCT01190124|463693341|FG002|Overall Study|Lost to Follow-up|0|||
128835366|NCT03493282|463693342|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
128835367|NCT03493282|463693343|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
128835368|NCT03493282|463693344|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
128835369|NCT03493282|463693342|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
128835370|NCT03493282|463693343|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
128835371|NCT03493282|463693344|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
128835372|NCT00070707|463693345|FG000|Overall Study|Adverse Event|1|||
128835373|NCT00070707|463693346|FG001|Overall Study|Adverse Event|2|||
128835374|NCT00070707|463693345|FG000|Overall Study|Lack of Efficacy|4|||
128835375|NCT00070707|463693346|FG001|Overall Study|Lack of Efficacy|1|||
128835376|NCT00070707|463693345|FG000|Overall Study|Protocol Violation|8|||
128835377|NCT00070707|463693346|FG001|Overall Study|Protocol Violation|4|||
128835378|NCT00070707|463693345|FG000|Overall Study|Unrelated to Study Medication|1|||
128835379|NCT00070707|463693346|FG001|Overall Study|Unrelated to Study Medication|0|||
128835380|NCT01523392|463693347|FG000|Treatment Period 1|Withdrawal by Subject|2|||
128835381|NCT01523392|463693348|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128835382|NCT01523392|463693347|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
128835383|NCT01523392|463693348|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
128835384|NCT01523392|463693347|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
128835385|NCT01523392|463693348|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
128835386|NCT03928743|463693350|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
128835387|NCT03928743|463693351|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
128835388|NCT03928743|463693352|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
128835389|NCT03928743|463693350|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
128835390|NCT03928743|463693351|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
128835391|NCT03928743|463693352|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
128835392|NCT03928743|463693350|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
128835393|NCT03928743|463693351|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
128835394|NCT03928743|463693352|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
128835395|NCT03928743|463693350|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
128835396|NCT03928743|463693351|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
128835397|NCT03928743|463693352|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
128835398|NCT03928743|463693350|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
128835399|NCT03928743|463693351|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
128835400|NCT03928743|463693352|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
128835401|NCT03928743|463693350|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
128835402|NCT03928743|463693351|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
128835403|NCT03928743|463693352|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
128835404|NCT03928743|463693350|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
128835405|NCT03928743|463693351|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
128835406|NCT03928743|463693352|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
128835407|NCT03928743|463693350|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
128835408|NCT03928743|463693351|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
128835409|NCT03928743|463693352|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
128835410|NCT03928743|463693350|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
128835411|NCT03928743|463693351|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
128835412|NCT03928743|463693352|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
128835413|NCT03928743|463693350|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
128835414|NCT03928743|463693351|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
128835415|NCT03928743|463693352|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
128835416|NCT03928743|463693350|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
128835417|NCT03928743|463693351|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
128835418|NCT03928743|463693352|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
128835419|NCT02236611|463693354|FG000|Overall Study|Adverse Event|10|||
128835420|NCT02236611|463693355|FG001|Overall Study|Adverse Event|16|||
128835421|NCT02236611|463693354|FG000|Overall Study|Lack of Efficacy|4|||
128835422|NCT02236611|463693355|FG001|Overall Study|Lack of Efficacy|7|||
128835423|NCT02236611|463693354|FG000|Overall Study|Lost to Follow-up|0|||
128835424|NCT02236611|463693355|FG001|Overall Study|Lost to Follow-up|2|||
128835425|NCT02236611|463693354|FG000|Overall Study|Protocol deviation|3|||
128835426|NCT02236611|463693355|FG001|Overall Study|Protocol deviation|5|||
128835427|NCT02236611|463693354|FG000|Overall Study|Withdrew consent|9|||
128835428|NCT02236611|463693355|FG001|Overall Study|Withdrew consent|4|||
128835429|NCT01450007|463693356|FG000|Overall Study|Late exclusion before treatment|2|||
128835430|NCT01450007|463693357|FG001|Overall Study|Late exclusion before treatment|3|||
128835431|NCT01450007|463693358|FG002|Overall Study|Late exclusion before treatment|2|||
128835432|NCT01450007|463693356|FG000|Overall Study|Protocol Violation|0|||
128835433|NCT01450007|463693357|FG001|Overall Study|Protocol Violation|1|||
128835434|NCT01450007|463693358|FG002|Overall Study|Protocol Violation|1|||
128835435|NCT01450007|463693356|FG000|Overall Study|Adverse Event|0|||
128835436|NCT01450007|463693357|FG001|Overall Study|Adverse Event|1|||
128835437|NCT01450007|463693358|FG002|Overall Study|Adverse Event|0|||
128835438|NCT03851094|463693360|FG000|Overall Study|Withdrawal by Subject|0|||
128835439|NCT03851094|463693361|FG001|Overall Study|Withdrawal by Subject|1|||
128835440|NCT03851094|463693360|FG000|Overall Study|Participant lost device|0|||
128835441|NCT03851094|463693361|FG001|Overall Study|Participant lost device|1|||
128835442|NCT03851094|463693360|FG000|Overall Study|Participant returned device|0|||
128835443|NCT03851094|463693361|FG001|Overall Study|Participant returned device|2|||
128835444|NCT01536704|463693362|FG000|Washout Period 1|Withdrawal by Subject|1|||
128835445|NCT01536704|463693363|FG001|Washout Period 1|Withdrawal by Subject|2|||
128835446|NCT01536704|463693364|FG002|Washout Period 1|Withdrawal by Subject|0|||
128835447|NCT01536704|463693365|FG003|Washout Period 1|Withdrawal by Subject|0|||
128835448|NCT01536704|463693362|FG000|Washout Period 2|Adverse Event|1|||
128835449|NCT01536704|463693363|FG001|Washout Period 2|Adverse Event|0|||
128835450|NCT01536704|463693364|FG002|Washout Period 2|Adverse Event|0|||
128835451|NCT01536704|463693365|FG003|Washout Period 2|Adverse Event|0|||
128835452|NCT01536704|463693362|FG000|Washout Period 2|Withdrawal by Subject|0|||
128835453|NCT01536704|463693363|FG001|Washout Period 2|Withdrawal by Subject|0|||
128835454|NCT01536704|463693364|FG002|Washout Period 2|Withdrawal by Subject|0|||
128835455|NCT01536704|463693365|FG003|Washout Period 2|Withdrawal by Subject|1|||
128835456|NCT01536704|463693362|FG000|Period 3|Adverse Event|0|||
128835457|NCT01536704|463693363|FG001|Period 3|Adverse Event|0|||
128835458|NCT01536704|463693364|FG002|Period 3|Adverse Event|0|||
128835459|NCT01536704|463693365|FG003|Period 3|Adverse Event|1|||
128835460|NCT01536704|463693362|FG000|Washout Period 3|Adverse Event|0|||
128835461|NCT01536704|463693363|FG001|Washout Period 3|Adverse Event|0|||
128835462|NCT01536704|463693364|FG002|Washout Period 3|Adverse Event|1|||
128835463|NCT01536704|463693365|FG003|Washout Period 3|Adverse Event|0|||
128835464|NCT02392507|463693366|FG000|Induction Regimen|Death|3|||
128835465|NCT02392507|463693366|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
128835466|NCT02392507|463693366|FG000|Induction Regimen|Physician Decision|1|||
128835467|NCT02392507|463693366|FG000|Induction Regimen|Withdrawal by Subject|2|||
128835468|NCT02392507|463693366|FG000|Maintenance Regimen|Death|1|||
128835469|NCT02392507|463693366|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
128835470|NCT00240994|463693367|FG000|Overall Study|Lost to Follow-up|1|||
128835471|NCT00240994|463693367|FG000|Overall Study|Protocol Violation|1|||
128835472|NCT00240994|463693367|FG000|Overall Study|Graft failure|1|||
128835473|NCT00923078|463693373|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
128835474|NCT00923078|463693374|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
128835475|NCT00923078|463693375|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
128835476|NCT00923078|463693373|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
128835477|NCT00923078|463693374|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
128835478|NCT00923078|463693375|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
128835479|NCT03547154|463693386|FG000|Overall Study|Disease Progression/Recurrence|6|||
128835480|NCT03547154|463693387|FG001|Overall Study|Disease Progression/Recurrence|14|||
128835481|NCT03547154|463693386|FG000|Overall Study|Adverse Event|26|||
128835482|NCT03547154|463693387|FG001|Overall Study|Adverse Event|31|||
128835483|NCT03547154|463693386|FG000|Overall Study|Protocol Violation|6|||
128835484|NCT03547154|463693387|FG001|Overall Study|Protocol Violation|1|||
128835485|NCT03547154|463693386|FG000|Overall Study|Physician Decision|4|||
128835486|NCT03547154|463693387|FG001|Overall Study|Physician Decision|3|||
128835487|NCT03547154|463693386|FG000|Overall Study|Insufficient Therapeutic Response|13|||
128835488|NCT03547154|463693387|FG001|Overall Study|Insufficient Therapeutic Response|10|||
128835489|NCT03547154|463693386|FG000|Overall Study|Withdrawal by Subject|10|||
128835490|NCT03547154|463693387|FG001|Overall Study|Withdrawal by Subject|6|||
128835491|NCT03547154|463693386|FG000|Overall Study|Not Selected|0|||
128835492|NCT03547154|463693387|FG001|Overall Study|Not Selected|1|||
128835493|NCT03547154|463693386|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
128835494|NCT03547154|463693387|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
129204949|NCT01962441|465047002|FG000|Randomized Period|Adverse Event|1|||
128835495|NCT04679675|463693388|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
128835496|NCT04679675|463693389|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
128835497|NCT04679675|463693390|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
128835498|NCT04679675|463693391|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
128835499|NCT04679675|463693388|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
128835500|NCT04679675|463693389|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
128835501|NCT04679675|463693390|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
128835502|NCT04679675|463693391|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
128835503|NCT00895245|463693392|FG000|Overall Study|Lack of Efficacy|6|||
128835504|NCT04248868|463693393|FG000|Overall Study|Death|1|||
128835505|NCT04248868|463693393|FG000|Overall Study|Lost to Follow-up|3|||
128835506|NCT04248868|463693393|FG000|Overall Study|Protocol Violation|2|||
128835507|NCT02706483|463693396|FG000|Overall Study|Adverse Event|97|||
128835508|NCT02706483|463693396|FG000|Overall Study|Death|1|||
128835509|NCT02706483|463693396|FG000|Overall Study|Lack of Efficacy|39|||
128835510|NCT02706483|463693396|FG000|Overall Study|Lost to Follow-up|101|||
128835511|NCT02706483|463693396|FG000|Overall Study|Non-compliance with study drug|15|||
128835512|NCT02706483|463693396|FG000|Overall Study|Physician Decision|6|||
128835513|NCT02706483|463693396|FG000|Overall Study|Pregnancy|6|||
128835514|NCT02706483|463693396|FG000|Overall Study|Protocol Violation|18|||
128835515|NCT02706483|463693396|FG000|Overall Study|Withdrawal by Subject|136|||
128835516|NCT02706483|463693396|FG000|Overall Study|Non-compliance with visits|6|||
128835517|NCT02706483|463693396|FG000|Overall Study|Site closure|4|||
128835518|NCT02706483|463693396|FG000|Overall Study|Subject moved|1|||
128835519|NCT03131713|463693397|FG000|Overall Study|Lost to Follow-up|5|||
128835520|NCT03131713|463693398|FG001|Overall Study|Lost to Follow-up|0|||
128835521|NCT01976507|463693399|FG000|Overall Study|Adverse Event|6|||
128835522|NCT01976507|463693399|FG000|Overall Study|ablation not done, drug not given|1|||
128835523|NCT02208843|463693400|FG000|Overall Study|Clinical symptoms of progression|2|||
128835524|NCT02208843|463693400|FG000|Overall Study|Progression disease according to RECIST|24|||
128835525|NCT02208843|463693400|FG000|Overall Study|Adverse Event|12|||
128835526|NCT02208843|463693400|FG000|Overall Study|Protocol Violation|1|||
128835527|NCT02208843|463693400|FG000|Overall Study|Withdrawal by Subject|1|||
128835528|NCT02208843|463693400|FG000|Overall Study|Switched to commercial afatinib|20|||
128835529|NCT01972776|463693401|FG000|Part 1|Withdrawal by Subject|0|||
128835530|NCT01972776|463693402|FG001|Part 1|Withdrawal by Subject|0|||
128835531|NCT01972776|463693403|FG002|Part 1|Withdrawal by Subject|1|||
128835532|NCT01972776|463693404|FG003|Part 1|Withdrawal by Subject|0|||
128835533|NCT01972776|463693405|FG004|Part 1|Withdrawal by Subject|0|||
128835534|NCT01972776|463693406|FG005|Part 1|Withdrawal by Subject|0|||
128835535|NCT01972776|463693401|FG000|Part 1|Adverse Event|0|||
128835536|NCT01972776|463693402|FG001|Part 1|Adverse Event|0|||
128835537|NCT01972776|463693403|FG002|Part 1|Adverse Event|1|||
128835538|NCT01972776|463693404|FG003|Part 1|Adverse Event|1|||
128835539|NCT01972776|463693405|FG004|Part 1|Adverse Event|0|||
128835540|NCT01972776|463693406|FG005|Part 1|Adverse Event|0|||
128835541|NCT01972776|463693401|FG000|Part 2|Adverse Event|0|||
128835542|NCT01972776|463693402|FG001|Part 2|Adverse Event|0|||
128835543|NCT01972776|463693403|FG002|Part 2|Adverse Event|0|||
128835544|NCT01972776|463693404|FG003|Part 2|Adverse Event|0|||
128835545|NCT01972776|463693405|FG004|Part 2|Adverse Event|3|||
128835546|NCT01972776|463693406|FG005|Part 2|Adverse Event|0|||
128835547|NCT01972776|463693401|FG000|Part 2|Administrative problems|0|||
128835548|NCT01972776|463693402|FG001|Part 2|Administrative problems|0|||
128835549|NCT01972776|463693403|FG002|Part 2|Administrative problems|0|||
128835550|NCT01972776|463693404|FG003|Part 2|Administrative problems|0|||
128835551|NCT01972776|463693405|FG004|Part 2|Administrative problems|10|||
128835552|NCT01972776|463693406|FG005|Part 2|Administrative problems|7|||
128835553|NCT00089791|463693410|FG000|Overall Study|Physician Decision|6|||
128835554|NCT00089791|463693411|FG001|Overall Study|Physician Decision|3|||
128835555|NCT00089791|463693410|FG000|Overall Study|Adverse Event|81|||
128835556|NCT00089791|463693411|FG001|Overall Study|Adverse Event|93|||
128835557|NCT00089791|463693410|FG000|Overall Study|Withdrawal by Subject|403|||
128835558|NCT00089791|463693411|FG001|Overall Study|Withdrawal by Subject|344|||
128835559|NCT00089791|463693410|FG000|Overall Study|Death|78|||
128835560|NCT00089791|463693411|FG001|Overall Study|Death|62|||
128835561|NCT00089791|463693410|FG000|Overall Study|Disease progression|7|||
128835562|NCT00089791|463693411|FG001|Overall Study|Disease progression|3|||
128835563|NCT00089791|463693410|FG000|Overall Study|Ineligibility determined|12|||
128835564|NCT00089791|463693411|FG001|Overall Study|Ineligibility determined|9|||
128835565|NCT00089791|463693410|FG000|Overall Study|Lost to Follow-up|57|||
128835566|NCT00089791|463693411|FG001|Overall Study|Lost to Follow-up|57|||
128835567|NCT00089791|463693410|FG000|Overall Study|Noncompliance|17|||
128835568|NCT00089791|463693411|FG001|Overall Study|Noncompliance|13|||
128835569|NCT00089791|463693410|FG000|Overall Study|Other|20|||
128835570|NCT00089791|463693411|FG001|Overall Study|Other|32|||
128835571|NCT00089791|463693410|FG000|Overall Study|Protocol deviation|12|||
128835572|NCT00089791|463693411|FG001|Overall Study|Protocol deviation|10|||
128835573|NCT00089791|463693410|FG000|Overall Study|Requirement for alternative therapy|7|||
128835574|NCT00089791|463693411|FG001|Overall Study|Requirement for alternative therapy|4|||
128835575|NCT00148122|463693412|FG000|Overall Study|Withdrawal by Subject|2|||
128835576|NCT03042767|463693413|FG000|Overall Study|Lost to Follow-up|1|||
128835577|NCT03042767|463693414|FG001|Overall Study|Lost to Follow-up|2|||
128835578|NCT01543204|463693415|FG000|Overall Study|Non-compliance|1|||
128835579|NCT01543204|463693415|FG000|Overall Study|Adverse Event|1|||
128835580|NCT01543204|463693415|FG000|Overall Study|Withdrawal by Subject|4|||
128835581|NCT01543204|463693415|FG000|Overall Study|Requirement for Alternative Therapy|1|||
128835582|NCT01543204|463693415|FG000|Overall Study|Lost to Follow-up|1|||
128835583|NCT02449902|463693419|FG000|Overall Study|Adverse Event|0|||
128835584|NCT02449902|463693420|FG001|Overall Study|Adverse Event|1|||
128835585|NCT02449902|463693419|FG000|Overall Study|Withdrawal by Subject|0|||
128835586|NCT02449902|463693420|FG001|Overall Study|Withdrawal by Subject|1|||
128835587|NCT02362789|463693421|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
128835588|NCT02362789|463693422|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
128835589|NCT02362789|463693423|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
128835590|NCT02362789|463693421|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
128835591|NCT02362789|463693422|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
128835592|NCT02362789|463693423|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
128835593|NCT02362789|463693421|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
128835594|NCT02362789|463693422|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
128835595|NCT02362789|463693423|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
128835596|NCT02362789|463693421|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
128835597|NCT02362789|463693422|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
128835598|NCT02362789|463693423|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
128835599|NCT02362789|463693421|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
128835600|NCT02362789|463693422|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
128835601|NCT02362789|463693423|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
128835602|NCT00721734|463693427|FG000|Overall Study|Progressive Disease|3|||
128835603|NCT00721734|463693428|FG001|Overall Study|Progressive Disease|10|||
128835604|NCT00721734|463693429|FG002|Overall Study|Progressive Disease|4|||
128835605|NCT00721734|463693430|FG003|Overall Study|Progressive Disease|5|||
128835606|NCT00721734|463693431|FG004|Overall Study|Progressive Disease|2|||
128835607|NCT00721734|463693427|FG000|Overall Study|Adverse Event|3|||
128835608|NCT00721734|463693428|FG001|Overall Study|Adverse Event|1|||
128835609|NCT00721734|463693429|FG002|Overall Study|Adverse Event|4|||
128835610|NCT00721734|463693430|FG003|Overall Study|Adverse Event|0|||
128835611|NCT00721734|463693431|FG004|Overall Study|Adverse Event|3|||
128835612|NCT00721734|463693427|FG000|Overall Study|Withdrawal by Subject|2|||
128835613|NCT00721734|463693428|FG001|Overall Study|Withdrawal by Subject|1|||
128835614|NCT00721734|463693429|FG002|Overall Study|Withdrawal by Subject|0|||
128835615|NCT00721734|463693430|FG003|Overall Study|Withdrawal by Subject|0|||
128835616|NCT00721734|463693431|FG004|Overall Study|Withdrawal by Subject|1|||
128835617|NCT00721734|463693427|FG000|Overall Study|Other|0|||
128835618|NCT00721734|463693428|FG001|Overall Study|Other|0|||
128835619|NCT00721734|463693429|FG002|Overall Study|Other|0|||
128835620|NCT00721734|463693430|FG003|Overall Study|Other|1|||
128835621|NCT00721734|463693431|FG004|Overall Study|Other|0|||
128835622|NCT01989689|463693433|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
128835623|NCT01989689|463693434|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
128835624|NCT01989689|463693433|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
128835625|NCT01989689|463693434|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
128835626|NCT00526994|463693435|FG000|Overall Study|Lost to Follow-up|98|||
128835627|NCT00526994|463693436|FG001|Overall Study|Lost to Follow-up|108|||
128835628|NCT00526994|463693437|FG002|Overall Study|Lost to Follow-up|96|||
128835629|NCT00526994|463693435|FG000|Overall Study|Death|4|||
128835630|NCT00526994|463693436|FG001|Overall Study|Death|3|||
128835631|NCT00526994|463693437|FG002|Overall Study|Death|3|||
128835632|NCT00526994|463693435|FG000|Overall Study|Withdrawal by Subject|2|||
128835633|NCT00526994|463693436|FG001|Overall Study|Withdrawal by Subject|7|||
128835634|NCT00526994|463693437|FG002|Overall Study|Withdrawal by Subject|5|||
128835635|NCT00526994|463693435|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
128835636|NCT00526994|463693436|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
128835637|NCT00526994|463693437|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
128835638|NCT03938272|463693438|FG000|Overall Study|Withdrawal by Subject|1|||
128835639|NCT03938272|463693439|FG001|Overall Study|Withdrawal by Subject|0|||
128835640|NCT03938272|463693438|FG000|Overall Study|Physician Decision|0|||
128835641|NCT03938272|463693439|FG001|Overall Study|Physician Decision|2|||
128835642|NCT03938272|463693438|FG000|Overall Study|Study termination by sponsor|10|||
128835643|NCT03938272|463693439|FG001|Overall Study|Study termination by sponsor|8|||
128835644|NCT00068107|463693442|FG000|Overall Study|end-stage renal disease|6|||
128835645|NCT00068107|463693442|FG000|Overall Study|Death|2|||
128835646|NCT00068107|463693442|FG000|Overall Study|Withdrawal by Subject|1|||
128835647|NCT01419184|463693445|FG000|Overall Study|Site data not available|3|||
128835648|NCT01419184|463693446|FG001|Overall Study|Site data not available|2|||
128835649|NCT01419184|463693445|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
128835650|NCT01419184|463693446|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
128835651|NCT01419184|463693445|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
128835652|NCT01419184|463693446|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
128835653|NCT01419184|463693445|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
128835654|NCT01419184|463693446|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
128835655|NCT01419184|463693445|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
128835656|NCT01419184|463693446|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
128835657|NCT01419184|463693445|FG000|Overall Study|Participant randomized, not treated|1|||
128835658|NCT01419184|463693446|FG001|Overall Study|Participant randomized, not treated|0|||
128835659|NCT03989232|463693449|FG000|Overall Study|Lost to Follow-up|3|||
128835660|NCT03989232|463693450|FG001|Overall Study|Lost to Follow-up|10|||
128835661|NCT03989232|463693449|FG000|Overall Study|Withdrawal by Subject|6|||
128835662|NCT03989232|463693450|FG001|Overall Study|Withdrawal by Subject|6|||
128835663|NCT03989232|463693449|FG000|Overall Study|Death|1|||
128835664|NCT03989232|463693450|FG001|Overall Study|Death|2|||
128835665|NCT05169684|463693451|FG000|Overall Study|Adverse Event|1|||
128835666|NCT05169684|463693452|FG001|Overall Study|Adverse Event|3|||
128835667|NCT05169684|463693451|FG000|Overall Study|Physician Decision|0|||
128835668|NCT05169684|463693452|FG001|Overall Study|Physician Decision|1|||
128835669|NCT05169684|463693451|FG000|Overall Study|Progressive Disease|1|||
128835670|NCT05169684|463693452|FG001|Overall Study|Progressive Disease|1|||
129204950|NCT01962441|465047003|FG001|Randomized Period|Adverse Event|1|||
129204951|NCT01962441|465047004|FG002|Randomized Period|Adverse Event|0|||
129204952|NCT01962441|465047002|FG000|Randomized Period|Death|0|||
129204953|NCT01962441|465047003|FG001|Randomized Period|Death|0|||
129204954|NCT01962441|465047004|FG002|Randomized Period|Death|2|||
129204955|NCT01962441|465047002|FG000|Randomized Period|Protocol Violation|0|||
128835671|NCT05169684|463693451|FG000|Overall Study|Participant request to discontinue treatment|0|||
128835672|NCT05169684|463693452|FG001|Overall Study|Participant request to discontinue treatment|1|||
128835673|NCT05169684|463693451|FG000|Overall Study|Other Reason|0|||
128835674|NCT05169684|463693452|FG001|Overall Study|Other Reason|1|||
128835675|NCT05484661|463693453|FG000|Overall Study|Withdrawal by Subject|1|||
128835676|NCT05484661|463693454|FG001|Overall Study|Withdrawal by Subject|0|||
128835677|NCT01856569|463693455|FG000|Overall Study|Other|1|||
128835678|NCT01856569|463693455|FG000|Overall Study|Changed Site/Structure|1|||
128835679|NCT01856569|463693455|FG000|Overall Study|Lost to Follow-up|3|||
128835680|NCT01856569|463693455|FG000|Overall Study|Did not met inclusion criteria|8|||
128835681|NCT02279732|463693457|FG000|Overall Study|Death|23|||
128835682|NCT02279732|463693458|FG001|Overall Study|Death|20|||
128835683|NCT02279732|463693457|FG000|Overall Study|Disease Progression|13|||
128835684|NCT02279732|463693458|FG001|Overall Study|Disease Progression|3|||
128835685|NCT02279732|463693457|FG000|Overall Study|Withdrawal by Subject|2|||
128835686|NCT02279732|463693458|FG001|Overall Study|Withdrawal by Subject|7|||
128835687|NCT02279732|463693457|FG000|Overall Study|Adverse Event|1|||
128835688|NCT02279732|463693458|FG001|Overall Study|Adverse Event|2|||
128835689|NCT02279732|463693457|FG000|Overall Study|Administrative Reason By Sponsor|0|||
128835690|NCT02279732|463693458|FG001|Overall Study|Administrative Reason By Sponsor|2|||
128835691|NCT02279732|463693457|FG000|Overall Study|Study Drug Toxicity|2|||
128835692|NCT02279732|463693458|FG001|Overall Study|Study Drug Toxicity|0|||
128835693|NCT02279732|463693457|FG000|Overall Study|Lost to Follow-up|0|||
128835694|NCT02279732|463693458|FG001|Overall Study|Lost to Follow-up|1|||
128835695|NCT02279732|463693457|FG000|Overall Study|Maximum Clinical Benefit|1|||
128835696|NCT02279732|463693458|FG001|Overall Study|Maximum Clinical Benefit|0|||
128835697|NCT02279732|463693457|FG000|Overall Study|Subject Requested to Discontinue|0|||
128835698|NCT02279732|463693458|FG001|Overall Study|Subject Requested to Discontinue|1|||
128835699|NCT02279732|463693457|FG000|Overall Study|Other|53|||
128835700|NCT02279732|463693458|FG001|Overall Study|Other|67|||
128835701|NCT02279732|463693457|FG000|Overall Study|Other|3|||
128835702|NCT02279732|463693458|FG001|Overall Study|Other|3|||
128835703|NCT00824408|463693459|FG000|Run-in Phase|Progressive disease|4|||
128835704|NCT00824408|463693460|FG001|Run-in Phase|Progressive disease|4|||
128835705|NCT00824408|463693461|FG002|Run-in Phase|Progressive disease|0|||
128835706|NCT00824408|463693462|FG003|Run-in Phase|Progressive disease|0|||
128835707|NCT00824408|463693463|FG004|Run-in Phase|Progressive disease|0|||
128835708|NCT00824408|463693459|FG000|Run-in Phase|Adverse Event|1|||
128835709|NCT00824408|463693460|FG001|Run-in Phase|Adverse Event|1|||
128835710|NCT00824408|463693461|FG002|Run-in Phase|Adverse Event|0|||
128835711|NCT00824408|463693462|FG003|Run-in Phase|Adverse Event|0|||
128835712|NCT00824408|463693463|FG004|Run-in Phase|Adverse Event|0|||
128835713|NCT00824408|463693459|FG000|Run-in Phase|Refused to continue medication|1|||
128835714|NCT00824408|463693460|FG001|Run-in Phase|Refused to continue medication|0|||
128835715|NCT00824408|463693461|FG002|Run-in Phase|Refused to continue medication|0|||
128835716|NCT00824408|463693462|FG003|Run-in Phase|Refused to continue medication|0|||
128835717|NCT00824408|463693463|FG004|Run-in Phase|Refused to continue medication|0|||
128835718|NCT00824408|463693459|FG000|Run-in Phase|Other reason not defined above|0|||
128835719|NCT00824408|463693460|FG001|Run-in Phase|Other reason not defined above|1|||
128835720|NCT00824408|463693461|FG002|Run-in Phase|Other reason not defined above|0|||
128835721|NCT00824408|463693462|FG003|Run-in Phase|Other reason not defined above|0|||
128835722|NCT00824408|463693463|FG004|Run-in Phase|Other reason not defined above|0|||
128835723|NCT00824408|463693459|FG000|Randomized Phase|Not treated|0|||
128835724|NCT00824408|463693460|FG001|Randomized Phase|Not treated|0|||
128835725|NCT00824408|463693461|FG002|Randomized Phase|Not treated|1|||
128835726|NCT00824408|463693462|FG003|Randomized Phase|Not treated|1|||
128835727|NCT00824408|463693463|FG004|Randomized Phase|Not treated|1|||
128835728|NCT00824408|463693459|FG000|Randomized Phase|Progressive disease|0|||
128835729|NCT00824408|463693460|FG001|Randomized Phase|Progressive disease|0|||
128835730|NCT00824408|463693461|FG002|Randomized Phase|Progressive disease|25|||
128835731|NCT00824408|463693462|FG003|Randomized Phase|Progressive disease|36|||
128835732|NCT00824408|463693463|FG004|Randomized Phase|Progressive disease|34|||
128835733|NCT00824408|463693459|FG000|Randomized Phase|Adverse Event|0|||
128835734|NCT00824408|463693460|FG001|Randomized Phase|Adverse Event|0|||
128835735|NCT00824408|463693461|FG002|Randomized Phase|Adverse Event|4|||
128835736|NCT00824408|463693462|FG003|Randomized Phase|Adverse Event|5|||
128835737|NCT00824408|463693463|FG004|Randomized Phase|Adverse Event|5|||
128835738|NCT00824408|463693459|FG000|Randomized Phase|Refused to continue medication|0|||
128835739|NCT00824408|463693460|FG001|Randomized Phase|Refused to continue medication|0|||
128835740|NCT00824408|463693461|FG002|Randomized Phase|Refused to continue medication|2|||
128835741|NCT00824408|463693462|FG003|Randomized Phase|Refused to continue medication|2|||
128835742|NCT00824408|463693463|FG004|Randomized Phase|Refused to continue medication|2|||
128835743|NCT00824408|463693459|FG000|Randomized Phase|Other reason not defined above|0|||
128835744|NCT00824408|463693460|FG001|Randomized Phase|Other reason not defined above|0|||
128835745|NCT00824408|463693461|FG002|Randomized Phase|Other reason not defined above|4|||
128835746|NCT00824408|463693462|FG003|Randomized Phase|Other reason not defined above|2|||
128835747|NCT00824408|463693463|FG004|Randomized Phase|Other reason not defined above|4|||
128835748|NCT02915783|463693468|FG000|Overall Study|Death|21|||
128835749|NCT02915783|463693468|FG000|Overall Study|Lost to Follow-up|1|||
128835750|NCT02915783|463693468|FG000|Overall Study|Withdrawal by Subject|2|||
128835751|NCT01075152|463693471|FG000|Overall Study|Withdrawal by Subject|1|||
128835752|NCT01075152|463693472|FG001|Overall Study|Withdrawal by Subject|0|||
128835753|NCT00535626|463695516|FG000|Overall Study|Death|15|||
128835754|NCT00535626|463695516|FG000|Overall Study|Lost to Follow-up|29|||
128835755|NCT00535626|463695516|FG000|Overall Study|Withdrawal by Subject|20|||
128835756|NCT00535626|463695516|FG000|Overall Study|Removal/revision of study component|8|||
128835757|NCT00535626|463695516|FG000|Overall Study|Subject terminated|31|||
128835758|NCT00535626|463695516|FG000|Overall Study|Unable to return|2|||
128835759|NCT02710669|463695517|FG000|Overall Study|Physician Decision|2|||
128835760|NCT02710669|463695518|FG001|Overall Study|Physician Decision|1|||
128835761|NCT02710669|463695519|FG002|Overall Study|Physician Decision|0|||
128835762|NCT02710669|463695517|FG000|Overall Study|Institutional delays (including COVID)|2|||
128835763|NCT02710669|463695518|FG001|Overall Study|Institutional delays (including COVID)|2|||
128835764|NCT02710669|463695519|FG002|Overall Study|Institutional delays (including COVID)|0|||
128835765|NCT02710669|463695517|FG000|Overall Study|arrived in afib/aflutter|10|||
128835766|NCT02710669|463695518|FG001|Overall Study|arrived in afib/aflutter|8|||
128835767|NCT02710669|463695519|FG002|Overall Study|arrived in afib/aflutter|2|||
128835768|NCT00731692|463695522|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
128835769|NCT00731692|463695523|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
128835770|NCT00731692|463695524|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
128835771|NCT00731692|463695522|FG000|Core Study (36 Months)|Physician Decision|1|||
128835772|NCT00731692|463695523|FG001|Core Study (36 Months)|Physician Decision|0|||
128835773|NCT00731692|463695524|FG002|Core Study (36 Months)|Physician Decision|2|||
128835774|NCT00731692|463695522|FG000|Core Study (36 Months)|Death|2|||
128835775|NCT00731692|463695523|FG001|Core Study (36 Months)|Death|1|||
128835776|NCT00731692|463695524|FG002|Core Study (36 Months)|Death|2|||
128835777|NCT00731692|463695522|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
128835778|NCT00731692|463695523|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
128835779|NCT00731692|463695524|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
128835780|NCT00731692|463695522|FG000|Core Study (36 Months)|Administrative|2|||
128835781|NCT00731692|463695523|FG001|Core Study (36 Months)|Administrative|2|||
128835782|NCT00731692|463695524|FG002|Core Study (36 Months)|Administrative|6|||
128835783|NCT00731692|463695522|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
128835784|NCT00731692|463695523|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
128835785|NCT00731692|463695524|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
128835786|NCT00731692|463695522|FG000|Core Study (36 Months)|Protocol Violation|4|||
128835787|NCT00731692|463695523|FG001|Core Study (36 Months)|Protocol Violation|5|||
128835788|NCT00731692|463695524|FG002|Core Study (36 Months)|Protocol Violation|8|||
128835789|NCT00731692|463695522|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
128835790|NCT00731692|463695523|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
128835791|NCT00731692|463695524|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
128835792|NCT00731692|463695522|FG000|Core Study (36 Months)|Adverse Event|25|||
128835793|NCT00731692|463695523|FG001|Core Study (36 Months)|Adverse Event|28|||
128835794|NCT00731692|463695524|FG002|Core Study (36 Months)|Adverse Event|29|||
128835795|NCT00731692|463695522|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
128835796|NCT00731692|463695523|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
128835797|NCT00731692|463695524|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
128835798|NCT00731692|463695522|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
128835799|NCT00731692|463695523|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
128835800|NCT00731692|463695524|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
128835801|NCT00731692|463695522|FG000|Extension Phase|Abnormal test procedure|0|||
128835802|NCT00731692|463695523|FG001|Extension Phase|Abnormal test procedure|0|||
128835803|NCT00731692|463695524|FG002|Extension Phase|Abnormal test procedure|1|||
128835804|NCT00731692|463695522|FG000|Extension Phase|Abnormal lab values|0|||
128835805|NCT00731692|463695523|FG001|Extension Phase|Abnormal lab values|0|||
128835806|NCT00731692|463695524|FG002|Extension Phase|Abnormal lab values|1|||
128835807|NCT00731692|463695522|FG000|Extension Phase|Lost to Follow-up|0|||
128835808|NCT00731692|463695523|FG001|Extension Phase|Lost to Follow-up|1|||
128835809|NCT00731692|463695524|FG002|Extension Phase|Lost to Follow-up|4|||
128835810|NCT00731692|463695522|FG000|Extension Phase|Withdrawal by Subject|4|||
128835811|NCT00731692|463695523|FG001|Extension Phase|Withdrawal by Subject|5|||
128835812|NCT00731692|463695524|FG002|Extension Phase|Withdrawal by Subject|3|||
128835813|NCT00731692|463695522|FG000|Extension Phase|Adverse Event|1|||
128835814|NCT00731692|463695523|FG001|Extension Phase|Adverse Event|1|||
128835815|NCT00731692|463695524|FG002|Extension Phase|Adverse Event|15|||
128835816|NCT03332589|463695525|FG000|Overall Study|Lack of Efficacy|2|||
128835817|NCT03332589|463695526|FG001|Overall Study|Lack of Efficacy|0|||
128835818|NCT03332589|463695527|FG002|Overall Study|Lack of Efficacy|0|||
128835819|NCT03332589|463695525|FG000|Overall Study|Adverse Event|1|||
128835820|NCT03332589|463695526|FG001|Overall Study|Adverse Event|0|||
128835821|NCT03332589|463695527|FG002|Overall Study|Adverse Event|0|||
128835822|NCT03332589|463695525|FG000|Overall Study|Death|1|||
128835823|NCT03332589|463695526|FG001|Overall Study|Death|0|||
128835824|NCT03332589|463695527|FG002|Overall Study|Death|0|||
128835825|NCT00108355|463695532|FG000|Overall Study|Peritonitis at index paracentesis|1|||
128835826|NCT00108355|463695533|FG001|Overall Study|Peritonitis at index paracentesis|1|||
128835827|NCT00108355|463695532|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
128835828|NCT00108355|463695533|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
128835829|NCT01128959|463695538|FG000|Lead in Period|Adverse Event|3|||
128835830|NCT01128959|463695538|FG000|Treatment Period|Adverse Event|3|||
128835831|NCT01128959|463695538|FG000|Treatment Period|Withdrawal by Subject|1|||
128835832|NCT02338999|463695539|FG000|First Intervention|Withdrawal by Subject|3|||
128835833|NCT02338999|463695540|FG001|First Intervention|Withdrawal by Subject|1|||
128835834|NCT02338999|463695539|FG000|Washout Period|Withdrawal by Subject|0|||
128835835|NCT02338999|463695540|FG001|Washout Period|Withdrawal by Subject|2|||
128835836|NCT02338999|463695539|FG000|Second Intervention|Withdrawal by Subject|0|||
128835837|NCT02338999|463695540|FG001|Second Intervention|Withdrawal by Subject|2|||
128835838|NCT02701296|463695541|FG000|Overall Study|Incomplete Data|0|||
128835839|NCT02701296|463695542|FG001|Overall Study|Incomplete Data|2|||
128835840|NCT00308308|463695543|FG000|Overall Study|Adverse Event|17|||
128835841|NCT00308308|463695544|FG001|Overall Study|Adverse Event|2|||
128835842|NCT00308308|463695543|FG000|Overall Study|Lost to Follow-up|5|||
128835843|NCT00308308|463695544|FG001|Overall Study|Lost to Follow-up|5|||
128835844|NCT00308308|463695543|FG000|Overall Study|Physician Decision|15|||
128835845|NCT00308308|463695544|FG001|Overall Study|Physician Decision|7|||
128835846|NCT00308308|463695543|FG000|Overall Study|Protocol Violation|3|||
128835847|NCT00308308|463695544|FG001|Overall Study|Protocol Violation|14|||
128835848|NCT00308308|463695543|FG000|Overall Study|Withdrawal by Subject|47|||
128835849|NCT00308308|463695544|FG001|Overall Study|Withdrawal by Subject|19|||
128835850|NCT00308308|463695543|FG000|Overall Study|Various|7|||
128835851|NCT00308308|463695544|FG001|Overall Study|Various|5|||
128835852|NCT00308308|463695543|FG000|Overall Study|Randomized but not dosed|8|||
128835853|NCT00308308|463695544|FG001|Overall Study|Randomized but not dosed|16|||
128835854|NCT00308308|463695543|FG000|Overall Study|Other|1|||
128835855|NCT00308308|463695544|FG001|Overall Study|Other|0|||
128835856|NCT01802333|463695545|FG000|Overall Study|Ineligible|2|||
128835857|NCT01802333|463695546|FG001|Overall Study|Ineligible|6|||
128835858|NCT01802333|463695547|FG002|Overall Study|Ineligible|8|||
128835859|NCT01802333|463695545|FG000|Overall Study|Adverse Event|1|||
128835860|NCT01802333|463695546|FG001|Overall Study|Adverse Event|8|||
128835861|NCT01802333|463695547|FG002|Overall Study|Adverse Event|8|||
128835862|NCT01802333|463695545|FG000|Overall Study|Withdrawal by Subject|6|||
128835863|NCT01802333|463695546|FG001|Overall Study|Withdrawal by Subject|6|||
128835864|NCT01802333|463695547|FG002|Overall Study|Withdrawal by Subject|5|||
128835865|NCT01802333|463695545|FG000|Overall Study|Progression/relapse|1|||
128835866|NCT01802333|463695546|FG001|Overall Study|Progression/relapse|3|||
128835867|NCT01802333|463695547|FG002|Overall Study|Progression/relapse|0|||
128835868|NCT01802333|463695545|FG000|Overall Study|Death|7|||
128835869|NCT01802333|463695546|FG001|Overall Study|Death|14|||
128835870|NCT01802333|463695547|FG002|Overall Study|Death|13|||
128835871|NCT01802333|463695545|FG000|Overall Study|Other - not protocol specified|32|||
128835872|NCT01802333|463695546|FG001|Overall Study|Other - not protocol specified|22|||
128835873|NCT01802333|463695547|FG002|Overall Study|Other - not protocol specified|24|||
128835874|NCT01802333|463695545|FG000|Overall Study|Did not start treatment|0|||
128835875|NCT01802333|463695546|FG001|Overall Study|Did not start treatment|2|||
128835876|NCT01802333|463695547|FG002|Overall Study|Did not start treatment|5|||
128835877|NCT01947491|463695548|FG000|Overall Study|Lost to Follow-up|5|||
128835878|NCT01947491|463695549|FG001|Overall Study|Lost to Follow-up|3|||
128835879|NCT01947491|463695550|FG002|Overall Study|Lost to Follow-up|1|||
128835880|NCT01947491|463695551|FG003|Overall Study|Lost to Follow-up|2|||
128835881|NCT01947491|463695548|FG000|Overall Study|Lack of Efficacy|1|||
128835882|NCT01947491|463695549|FG001|Overall Study|Lack of Efficacy|0|||
128835883|NCT01947491|463695550|FG002|Overall Study|Lack of Efficacy|0|||
128835884|NCT01947491|463695551|FG003|Overall Study|Lack of Efficacy|1|||
128835885|NCT01947491|463695548|FG000|Overall Study|Protocol Violation|1|||
128835886|NCT01947491|463695549|FG001|Overall Study|Protocol Violation|0|||
128835887|NCT01947491|463695550|FG002|Overall Study|Protocol Violation|0|||
128835888|NCT01947491|463695551|FG003|Overall Study|Protocol Violation|0|||
128835889|NCT01947491|463695548|FG000|Overall Study|Withdrawal by Subject|1|||
128835890|NCT01947491|463695549|FG001|Overall Study|Withdrawal by Subject|1|||
128835891|NCT01947491|463695550|FG002|Overall Study|Withdrawal by Subject|1|||
129204956|NCT01962441|465047003|FG001|Randomized Period|Protocol Violation|1|||
128835892|NCT01947491|463695551|FG003|Overall Study|Withdrawal by Subject|0|||
128835893|NCT01947491|463695548|FG000|Overall Study|Worsening of condition|0|||
128835894|NCT01947491|463695549|FG001|Overall Study|Worsening of condition|1|||
128835895|NCT01947491|463695550|FG002|Overall Study|Worsening of condition|0|||
128835896|NCT01947491|463695551|FG003|Overall Study|Worsening of condition|0|||
128835897|NCT01947491|463695548|FG000|Overall Study|Adverse Event|0|||
128835898|NCT01947491|463695549|FG001|Overall Study|Adverse Event|1|||
128835899|NCT01947491|463695550|FG002|Overall Study|Adverse Event|0|||
128835900|NCT01947491|463695551|FG003|Overall Study|Adverse Event|2|||
128835901|NCT02067663|463695552|FG000|Overall Study|Lost to Follow-up|13|||
128835902|NCT02067663|463695553|FG001|Overall Study|Lost to Follow-up|14|||
128835903|NCT03137784|463695554|FG000|Overall Study|Adverse Event|1|||
128835904|NCT03137784|463695555|FG001|Overall Study|Adverse Event|1|||
128835905|NCT03137784|463695556|FG002|Overall Study|Adverse Event|0|||
128835906|NCT03137784|463695557|FG003|Overall Study|Adverse Event|0|||
128835907|NCT03137784|463695558|FG004|Overall Study|Adverse Event|0|||
128835908|NCT03137784|463695559|FG005|Overall Study|Adverse Event|0|||
128835909|NCT03137784|463695554|FG000|Overall Study|Subject/guardian decision|1|||
128835910|NCT03137784|463695555|FG001|Overall Study|Subject/guardian decision|0|||
128835911|NCT03137784|463695556|FG002|Overall Study|Subject/guardian decision|0|||
128835912|NCT03137784|463695557|FG003|Overall Study|Subject/guardian decision|0|||
128835913|NCT03137784|463695558|FG004|Overall Study|Subject/guardian decision|0|||
128835914|NCT03137784|463695559|FG005|Overall Study|Subject/guardian decision|0|||
128835915|NCT03137784|463695554|FG000|Overall Study|Non-compliance with study treatment|0|||
128835916|NCT03137784|463695555|FG001|Overall Study|Non-compliance with study treatment|0|||
128835917|NCT03137784|463695556|FG002|Overall Study|Non-compliance with study treatment|0|||
128835918|NCT03137784|463695557|FG003|Overall Study|Non-compliance with study treatment|0|||
128835919|NCT03137784|463695558|FG004|Overall Study|Non-compliance with study treatment|1|||
128835920|NCT03137784|463695559|FG005|Overall Study|Non-compliance with study treatment|0|||
128835921|NCT03142932|463695560|FG000|Overall Study|Lost to Follow-up|2|||
128835922|NCT03142932|463695561|FG001|Overall Study|Lost to Follow-up|11|||
128835923|NCT02547974|463695562|FG000|Overall Study|Withdrawal by Subject|1|||
128835924|NCT02547974|463695563|FG001|Overall Study|Withdrawal by Subject|0|||
128835925|NCT02547974|463695564|FG002|Overall Study|Withdrawal by Subject|0|||
128835926|NCT02547974|463695565|FG003|Overall Study|Withdrawal by Subject|0|||
128835927|NCT04766996|463695566|FG000|Overall Study|Withdrawal by Subject|1|||
128835928|NCT04766996|463695567|FG001|Overall Study|Withdrawal by Subject|0|||
128835929|NCT04766996|463695568|FG002|Overall Study|Withdrawal by Subject|13|||
128835930|NCT02988713|463695572|FG000|Overall Study|Withdrawal by Subject|1|||
128835931|NCT02988713|463695572|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
128835932|NCT01918033|463695573|FG000|Overall Study|Adverse Event|1|||
128835933|NCT01918033|463695574|FG001|Overall Study|Adverse Event|0|||
128835934|NCT01918033|463695575|FG002|Overall Study|Adverse Event|2|||
128835935|NCT01918033|463695573|FG000|Overall Study|Lost to Follow-up|0|||
128835936|NCT01918033|463695574|FG001|Overall Study|Lost to Follow-up|1|||
128835937|NCT01918033|463695575|FG002|Overall Study|Lost to Follow-up|0|||
128835938|NCT01918033|463695573|FG000|Overall Study|Protocol Violation|2|||
128835939|NCT01918033|463695574|FG001|Overall Study|Protocol Violation|0|||
128835940|NCT01918033|463695575|FG002|Overall Study|Protocol Violation|1|||
128835941|NCT01918033|463695573|FG000|Overall Study|Withdrawal by Subject|2|||
128835942|NCT01918033|463695574|FG001|Overall Study|Withdrawal by Subject|1|||
128835943|NCT01918033|463695575|FG002|Overall Study|Withdrawal by Subject|0|||
128835944|NCT03259568|463695584|FG000|Overall Study|Participant performance was low|3|||
128835945|NCT01794299|463695586|FG000|Overall Study|ATIR manufacturing not possible|1|||
128835946|NCT01794299|463695586|FG000|Overall Study|Death|14|||
128835947|NCT01794299|463695586|FG000|Overall Study|Graft failure|1|||
128835948|NCT01794299|463695586|FG000|Overall Study|ATIR batch rejected|2|||
128835949|NCT01794299|463695586|FG000|Overall Study|Relapse|2|||
128835950|NCT01794299|463695586|FG000|Overall Study|Discontinued from active follow-up|1|||
128835951|NCT01794299|463695586|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
128835952|NCT01029704|463695587|FG000|Overall Study|Adverse Event|0|||
128835953|NCT01029704|463695588|FG001|Overall Study|Adverse Event|0|||
128835954|NCT01029704|463695589|FG002|Overall Study|Adverse Event|0|||
128835955|NCT01029704|463695590|FG003|Overall Study|Adverse Event|0|||
128835956|NCT01029704|463695591|FG004|Overall Study|Adverse Event|0|||
128835957|NCT01029704|463695592|FG005|Overall Study|Adverse Event|0|||
128835958|NCT01029704|463695593|FG006|Overall Study|Adverse Event|1|||
128835959|NCT01029704|463695594|FG007|Overall Study|Adverse Event|1|||
128835960|NCT01029704|463695595|FG008|Overall Study|Adverse Event|0|||
128835961|NCT01029704|463695587|FG000|Overall Study|Withdrawal by Subject|0|||
128835962|NCT01029704|463695588|FG001|Overall Study|Withdrawal by Subject|0|||
128835963|NCT01029704|463695589|FG002|Overall Study|Withdrawal by Subject|0|||
128835964|NCT01029704|463695590|FG003|Overall Study|Withdrawal by Subject|0|||
128835965|NCT01029704|463695591|FG004|Overall Study|Withdrawal by Subject|2|||
128835966|NCT01029704|463695592|FG005|Overall Study|Withdrawal by Subject|1|||
128835967|NCT01029704|463695593|FG006|Overall Study|Withdrawal by Subject|1|||
128835968|NCT01029704|463695594|FG007|Overall Study|Withdrawal by Subject|1|||
128835969|NCT01029704|463695595|FG008|Overall Study|Withdrawal by Subject|0|||
128835970|NCT01029704|463695587|FG000|Overall Study|Lost to Follow-up|0|||
128835971|NCT01029704|463695588|FG001|Overall Study|Lost to Follow-up|0|||
128835972|NCT01029704|463695589|FG002|Overall Study|Lost to Follow-up|0|||
128835973|NCT01029704|463695590|FG003|Overall Study|Lost to Follow-up|0|||
128835974|NCT01029704|463695591|FG004|Overall Study|Lost to Follow-up|0|||
128835975|NCT01029704|463695592|FG005|Overall Study|Lost to Follow-up|0|||
128835976|NCT01029704|463695593|FG006|Overall Study|Lost to Follow-up|1|||
128835977|NCT01029704|463695594|FG007|Overall Study|Lost to Follow-up|1|||
128835978|NCT01029704|463695595|FG008|Overall Study|Lost to Follow-up|1|||
128835979|NCT01029704|463695587|FG000|Overall Study|Lack of Efficacy|0|||
128835980|NCT01029704|463695588|FG001|Overall Study|Lack of Efficacy|0|||
128835981|NCT01029704|463695589|FG002|Overall Study|Lack of Efficacy|0|||
128835982|NCT01029704|463695590|FG003|Overall Study|Lack of Efficacy|0|||
128835983|NCT01029704|463695591|FG004|Overall Study|Lack of Efficacy|2|||
128835984|NCT01029704|463695592|FG005|Overall Study|Lack of Efficacy|3|||
128835985|NCT01029704|463695593|FG006|Overall Study|Lack of Efficacy|1|||
128835986|NCT01029704|463695594|FG007|Overall Study|Lack of Efficacy|2|||
128835987|NCT01029704|463695595|FG008|Overall Study|Lack of Efficacy|0|||
128835988|NCT01029704|463695587|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
128835989|NCT01029704|463695588|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
128835990|NCT01029704|463695589|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
128835991|NCT01029704|463695590|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
128835992|NCT01029704|463695591|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
128835993|NCT01029704|463695592|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
128835994|NCT01029704|463695593|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
128835995|NCT01029704|463695594|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
128835996|NCT01029704|463695595|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
128835997|NCT01365546|463695596|FG000|Overall Study|Withdrawal by Subject|1|||
128835998|NCT01365546|463695596|FG000|Overall Study|Screen failure|9|||
128835999|NCT01365546|463695596|FG000|Overall Study|Study termination|1|||
128836000|NCT03200574|463695602|FG000|Overall Study|Death|4|||
128836001|NCT03200574|463695602|FG000|Overall Study|Withdrawal by Subject|8|||
128836002|NCT03200574|463695602|FG000|Overall Study|Long-Term need for anticoagulation|1|||
128836003|NCT03200574|463695602|FG000|Overall Study|Relocation|2|||
128836004|NCT03200574|463695602|FG000|Overall Study|Lost to Follow-up|2|||
128836005|NCT04183491|463695603|FG000|Overall Study|Withdrawal by Subject|0|||
128836006|NCT04183491|463695604|FG001|Overall Study|Withdrawal by Subject|0|||
128836007|NCT04183491|463695605|FG002|Overall Study|Withdrawal by Subject|1|||
128836008|NCT04183491|463695606|FG003|Overall Study|Withdrawal by Subject|0|||
128836009|NCT04183491|463695607|FG004|Overall Study|Withdrawal by Subject|0|||
128836010|NCT04183491|463695608|FG005|Overall Study|Withdrawal by Subject|1|||
128836011|NCT04183491|463695609|FG006|Overall Study|Withdrawal by Subject|0|||
128836012|NCT02538094|463695610|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
128836013|NCT02538094|463695611|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
128836014|NCT02538094|463695610|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
128836015|NCT02538094|463695611|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
128836016|NCT03288506|463695612|FG000|Overall Study|Withdrawal by Subject|52|||
128836017|NCT02691702|463695619|FG000|Overall Study|Adverse Event|1|||
128836018|NCT02691702|463695620|FG001|Overall Study|Adverse Event|0|||
128836019|NCT02691702|463695621|FG002|Overall Study|Adverse Event|0|||
128836020|NCT02691702|463695622|FG003|Overall Study|Adverse Event|0|||
128836021|NCT02691702|463695623|FG004|Overall Study|Adverse Event|0|||
128836022|NCT02691702|463695624|FG005|Overall Study|Adverse Event|0|||
128836023|NCT02691702|463695625|FG006|Overall Study|Adverse Event|0|||
128836024|NCT02691702|463695626|FG007|Overall Study|Adverse Event|0|||
128836025|NCT02691702|463695627|FG008|Overall Study|Adverse Event|1|||
128836026|NCT02691702|463695628|FG009|Overall Study|Adverse Event|0|||
128836027|NCT02691702|463695629|FG010|Overall Study|Adverse Event|1|||
128836028|NCT02691702|463695619|FG000|Overall Study|Lost to Follow-up|0|||
128836029|NCT02691702|463695620|FG001|Overall Study|Lost to Follow-up|0|||
128836030|NCT02691702|463695621|FG002|Overall Study|Lost to Follow-up|1|||
128836031|NCT02691702|463695622|FG003|Overall Study|Lost to Follow-up|0|||
128836032|NCT02691702|463695623|FG004|Overall Study|Lost to Follow-up|0|||
128836033|NCT02691702|463695624|FG005|Overall Study|Lost to Follow-up|2|||
128836034|NCT02691702|463695625|FG006|Overall Study|Lost to Follow-up|0|||
128836035|NCT02691702|463695626|FG007|Overall Study|Lost to Follow-up|0|||
128836036|NCT02691702|463695627|FG008|Overall Study|Lost to Follow-up|0|||
128836037|NCT02691702|463695628|FG009|Overall Study|Lost to Follow-up|0|||
128836038|NCT02691702|463695629|FG010|Overall Study|Lost to Follow-up|1|||
128836039|NCT02691702|463695619|FG000|Overall Study|Withdrawal by Subject|1|||
128836040|NCT02691702|463695620|FG001|Overall Study|Withdrawal by Subject|1|||
128836041|NCT02691702|463695621|FG002|Overall Study|Withdrawal by Subject|0|||
128836042|NCT02691702|463695622|FG003|Overall Study|Withdrawal by Subject|0|||
128836043|NCT02691702|463695623|FG004|Overall Study|Withdrawal by Subject|0|||
128836044|NCT02691702|463695624|FG005|Overall Study|Withdrawal by Subject|1|||
128836045|NCT02691702|463695625|FG006|Overall Study|Withdrawal by Subject|2|||
128836046|NCT02691702|463695626|FG007|Overall Study|Withdrawal by Subject|0|||
128836047|NCT02691702|463695627|FG008|Overall Study|Withdrawal by Subject|0|||
128836048|NCT02691702|463695628|FG009|Overall Study|Withdrawal by Subject|0|||
128836049|NCT02691702|463695629|FG010|Overall Study|Withdrawal by Subject|0|||
128836050|NCT02691702|463695619|FG000|Overall Study|Other|0|||
128836051|NCT02691702|463695620|FG001|Overall Study|Other|0|||
128836052|NCT02691702|463695621|FG002|Overall Study|Other|0|||
128836053|NCT02691702|463695622|FG003|Overall Study|Other|0|||
128836054|NCT02691702|463695623|FG004|Overall Study|Other|0|||
128836055|NCT02691702|463695624|FG005|Overall Study|Other|0|||
128836056|NCT02691702|463695625|FG006|Overall Study|Other|1|||
128836057|NCT02691702|463695626|FG007|Overall Study|Other|0|||
128836058|NCT02691702|463695627|FG008|Overall Study|Other|1|||
128836059|NCT02691702|463695628|FG009|Overall Study|Other|0|||
128836060|NCT02691702|463695629|FG010|Overall Study|Other|0|||
128836061|NCT02691702|463695619|FG000|Overall Study|Protocol Violation|0|||
128836062|NCT02691702|463695620|FG001|Overall Study|Protocol Violation|0|||
128836063|NCT02691702|463695621|FG002|Overall Study|Protocol Violation|0|||
128836064|NCT02691702|463695622|FG003|Overall Study|Protocol Violation|0|||
128836065|NCT02691702|463695623|FG004|Overall Study|Protocol Violation|0|||
128836066|NCT02691702|463695624|FG005|Overall Study|Protocol Violation|0|||
128836067|NCT02691702|463695625|FG006|Overall Study|Protocol Violation|0|||
128836068|NCT02691702|463695626|FG007|Overall Study|Protocol Violation|0|||
128836069|NCT02691702|463695627|FG008|Overall Study|Protocol Violation|0|||
128836070|NCT02691702|463695628|FG009|Overall Study|Protocol Violation|2|||
128836071|NCT02691702|463695629|FG010|Overall Study|Protocol Violation|0|||
128836072|NCT03652610|463695635|FG000|Overall Study|Lost to Follow-up|1|||
128836073|NCT03652610|463695636|FG001|Overall Study|Lost to Follow-up|0|||
128836074|NCT03652610|463695635|FG000|Overall Study|Withdrawal by Subject|3|||
128836075|NCT03652610|463695636|FG001|Overall Study|Withdrawal by Subject|5|||
128836076|NCT00326183|463695637|FG000|Overall Study|Lost to Follow-up|104|||
128836077|NCT00326183|463695638|FG001|Overall Study|Lost to Follow-up|56|||
128836078|NCT00326183|463695637|FG000|Overall Study|Protocol Violation|6|||
128836079|NCT00326183|463695638|FG001|Overall Study|Protocol Violation|3|||
128836080|NCT00326183|463695637|FG000|Overall Study|Withdrawal by Subject|35|||
128836081|NCT00326183|463695638|FG001|Overall Study|Withdrawal by Subject|7|||
128836082|NCT00326183|463695637|FG000|Overall Study|Subject Moved|7|||
128836083|NCT00326183|463695638|FG001|Overall Study|Subject Moved|4|||
128836084|NCT00326183|463695637|FG000|Overall Study|Other|47|||
128836085|NCT00326183|463695638|FG001|Overall Study|Other|13|||
128836086|NCT00326183|463695637|FG000|Overall Study|Adverse Event|1|||
128836087|NCT00326183|463695638|FG001|Overall Study|Adverse Event|0|||
128836088|NCT02970318|463695639|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
128836089|NCT02970318|463695640|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
128836090|NCT02970318|463695641|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
128836091|NCT02970318|463695642|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
128836092|NCT02970318|463695639|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
128836093|NCT02970318|463695640|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
128836094|NCT02970318|463695641|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
128836095|NCT02970318|463695642|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
128836096|NCT02970318|463695639|FG000|Overall for Arm A & Main for Arm B|Death|41|||
128836097|NCT02970318|463695640|FG001|Overall for Arm A & Main for Arm B|Death|33|||
128836098|NCT02970318|463695641|FG002|Overall for Arm A & Main for Arm B|Death|0|||
128836099|NCT02970318|463695642|FG003|Overall for Arm A & Main for Arm B|Death|0|||
128836100|NCT02970318|463695639|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
128836101|NCT02970318|463695640|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
128836102|NCT02970318|463695641|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
128836103|NCT02970318|463695642|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
128836104|NCT02970318|463695639|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
128836105|NCT02970318|463695640|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
128836106|NCT02970318|463695641|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
128836107|NCT02970318|463695642|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
128836108|NCT02970318|463695639|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
128836109|NCT02970318|463695640|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
128836110|NCT02970318|463695641|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
128836111|NCT02970318|463695642|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
128836112|NCT02970318|463695639|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
128836113|NCT02970318|463695640|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
128836114|NCT02970318|463695641|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
128836115|NCT02970318|463695642|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
128836116|NCT01323790|463695647|FG000|Overall Study|Other|3|||
128836117|NCT01323790|463695648|FG001|Overall Study|Other|2|||
128836118|NCT01323790|463695649|FG002|Overall Study|Other|1|||
128836119|NCT01323790|463695647|FG000|Overall Study|Lost to Follow-up|11|||
128836120|NCT01323790|463695648|FG001|Overall Study|Lost to Follow-up|9|||
128836121|NCT01323790|463695649|FG002|Overall Study|Lost to Follow-up|9|||
128836122|NCT01323790|463695647|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
128836123|NCT01323790|463695648|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
128836124|NCT01323790|463695649|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
128836125|NCT01323790|463695647|FG000|Overall Study|Lack of Efficacy|3|||
128836126|NCT01323790|463695648|FG001|Overall Study|Lack of Efficacy|0|||
128836127|NCT01323790|463695649|FG002|Overall Study|Lack of Efficacy|3|||
128836128|NCT01323790|463695647|FG000|Overall Study|Adverse Event|11|||
128836129|NCT01323790|463695648|FG001|Overall Study|Adverse Event|24|||
128836130|NCT01323790|463695649|FG002|Overall Study|Adverse Event|12|||
128836131|NCT01323790|463695647|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
128836132|NCT01323790|463695648|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
128836133|NCT01323790|463695649|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
128836134|NCT01323790|463695647|FG000|Overall Study|Withdrawal by Subject|23|||
128836135|NCT01323790|463695648|FG001|Overall Study|Withdrawal by Subject|20|||
128836136|NCT01323790|463695649|FG002|Overall Study|Withdrawal by Subject|13|||
128836137|NCT01323790|463695647|FG000|Overall Study|Did Not Receive Treatment|2|||
128836138|NCT01323790|463695648|FG001|Overall Study|Did Not Receive Treatment|0|||
128836139|NCT01323790|463695649|FG002|Overall Study|Did Not Receive Treatment|1|||
128836140|NCT01323790|463695647|FG000|Overall Study|Severe non-compliance with protocol|2|||
128836141|NCT01323790|463695648|FG001|Overall Study|Severe non-compliance with protocol|2|||
128836142|NCT01323790|463695649|FG002|Overall Study|Severe non-compliance with protocol|2|||
128836143|NCT01880736|463695650|FG000|Overall Study|Adverse Event|0|||
128836144|NCT01880736|463695651|FG001|Overall Study|Adverse Event|0|||
128836145|NCT01880736|463695652|FG002|Overall Study|Adverse Event|0|||
128836146|NCT01880736|463695653|FG003|Overall Study|Adverse Event|1|||
128836147|NCT01880736|463695650|FG000|Overall Study|Withdrawal Criteria|1|||
128836148|NCT01880736|463695651|FG001|Overall Study|Withdrawal Criteria|2|||
128836149|NCT01880736|463695652|FG002|Overall Study|Withdrawal Criteria|1|||
128836150|NCT01880736|463695653|FG003|Overall Study|Withdrawal Criteria|5|||
128836151|NCT01263496|463695654|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
128836152|NCT01263496|463695655|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836153|NCT01263496|463695656|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836154|NCT01263496|463695657|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836155|NCT01263496|463695658|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836156|NCT01263496|463695659|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836157|NCT01263496|463695660|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836158|NCT01263496|463695661|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836159|NCT01263496|463695662|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
128836160|NCT01263496|463695654|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128836161|NCT01263496|463695655|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128836162|NCT01263496|463695656|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128836163|NCT01263496|463695657|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
128836164|NCT01263496|463695658|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
128836165|NCT01263496|463695659|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128836166|NCT01263496|463695660|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128836167|NCT01263496|463695661|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128836168|NCT01263496|463695662|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
128836169|NCT01263496|463695654|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
128836170|NCT01263496|463695655|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
128836171|NCT01263496|463695656|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
128836172|NCT01263496|463695657|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
128836173|NCT01263496|463695658|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
128836174|NCT01263496|463695659|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
128836175|NCT01263496|463695660|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
128836176|NCT01263496|463695661|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
128836177|NCT01263496|463695662|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
128836178|NCT01263496|463695654|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836179|NCT01263496|463695655|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
128836180|NCT01263496|463695656|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836181|NCT01263496|463695657|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836182|NCT01263496|463695658|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836183|NCT01263496|463695659|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836184|NCT01263496|463695660|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836185|NCT01263496|463695661|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836186|NCT01263496|463695662|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
128836187|NCT01263496|463695654|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
128836188|NCT01263496|463695655|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
128836189|NCT01263496|463695656|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
128836190|NCT01263496|463695657|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
128836191|NCT01263496|463695658|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
128836192|NCT01263496|463695659|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
128836193|NCT01263496|463695660|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
128836194|NCT01263496|463695661|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
128836195|NCT01263496|463695662|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
128836196|NCT01263496|463695654|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
128836197|NCT01263496|463695655|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
128836198|NCT01263496|463695656|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
128836199|NCT01263496|463695657|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
128836200|NCT01263496|463695658|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
128836201|NCT01263496|463695659|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
128836202|NCT01263496|463695660|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
128836203|NCT01263496|463695661|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
128836204|NCT01263496|463695662|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
128836205|NCT01263496|463695654|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836206|NCT01263496|463695655|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836207|NCT01263496|463695656|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836208|NCT01263496|463695657|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836209|NCT01263496|463695658|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836210|NCT01263496|463695659|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836211|NCT01263496|463695660|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836212|NCT01263496|463695661|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
128836213|NCT01263496|463695662|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128836214|NCT00266656|463695666|FG000|Overall Study|Death|1|||
128836215|NCT00266656|463695667|FG001|Overall Study|Death|0|||
128836216|NCT00266656|463695666|FG000|Overall Study|Lost to Follow-up|4|||
128836217|NCT00266656|463695667|FG001|Overall Study|Lost to Follow-up|1|||
128836218|NCT00266656|463695666|FG000|Overall Study|Withdrawal by Subject|4|||
128836219|NCT00266656|463695667|FG001|Overall Study|Withdrawal by Subject|2|||
128836220|NCT00266656|463695666|FG000|Overall Study|Did Not Reach Final Height|4|||
128836221|NCT00266656|463695667|FG001|Overall Study|Did Not Reach Final Height|8|||
128836222|NCT00266656|463695666|FG000|Overall Study|Parent/Caregiver Decision|1|||
128836223|NCT00266656|463695667|FG001|Overall Study|Parent/Caregiver Decision|2|||
128836224|NCT02203032|463695668|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
128836225|NCT02203032|463695669|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
128836226|NCT02203032|463695670|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
128836227|NCT02203032|463695671|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
128836228|NCT02203032|463695668|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
128836229|NCT02203032|463695669|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
128836230|NCT02203032|463695670|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
128836231|NCT02203032|463695671|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
128836232|NCT02203032|463695668|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
128836233|NCT02203032|463695669|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
128836234|NCT02203032|463695670|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
128836235|NCT02203032|463695671|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
128836236|NCT02203032|463695668|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
128836237|NCT02203032|463695669|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
128836238|NCT02203032|463695670|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
128836239|NCT02203032|463695671|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
128836240|NCT02203032|463695668|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
128836241|NCT02203032|463695669|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
128836242|NCT02203032|463695670|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
128836243|NCT02203032|463695671|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
128836244|NCT02203032|463695668|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
128836245|NCT02203032|463695669|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
128836246|NCT02203032|463695670|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
128836247|NCT02203032|463695671|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
128836248|NCT02203032|463695668|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
128836249|NCT02203032|463695669|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
128836250|NCT02203032|463695670|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
128836251|NCT02203032|463695671|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
128836252|NCT02203032|463695668|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
128836253|NCT02203032|463695669|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
128836254|NCT02203032|463695670|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
128836255|NCT02203032|463695671|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
128836256|NCT02203032|463695668|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
128836257|NCT02203032|463695669|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
128836258|NCT02203032|463695670|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
128836259|NCT02203032|463695671|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
128836260|NCT02203032|463695668|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
128836261|NCT02203032|463695669|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
128836262|NCT02203032|463695670|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
128836263|NCT02203032|463695671|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
128836264|NCT02203032|463695668|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
128836265|NCT02203032|463695669|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
128836266|NCT02203032|463695670|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
128836267|NCT02203032|463695671|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
128836268|NCT02203032|463695668|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
128836269|NCT02203032|463695669|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
128836270|NCT02203032|463695670|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
128836271|NCT02203032|463695671|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
128836272|NCT01915914|463695672|FG000|Acute Phase|Withdrawal by Subject|4|||
128836273|NCT01915914|463695673|FG001|Acute Phase|Withdrawal by Subject|0|||
128836274|NCT01915914|463695674|FG002|Acute Phase|Withdrawal by Subject|0|||
128836275|NCT01915914|463695675|FG003|Acute Phase|Withdrawal by Subject|0|||
128836276|NCT01915914|463695672|FG000|Acute Phase|Lost to Follow-up|4|||
128836277|NCT01915914|463695673|FG001|Acute Phase|Lost to Follow-up|0|||
128836278|NCT01915914|463695674|FG002|Acute Phase|Lost to Follow-up|0|||
128836279|NCT01915914|463695675|FG003|Acute Phase|Lost to Follow-up|0|||
128836280|NCT01915914|463695672|FG000|Acute Phase|Physician Decision|1|||
128836281|NCT01915914|463695673|FG001|Acute Phase|Physician Decision|0|||
128836282|NCT01915914|463695674|FG002|Acute Phase|Physician Decision|0|||
128836283|NCT01915914|463695675|FG003|Acute Phase|Physician Decision|0|||
128836284|NCT01915914|463695672|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
128836285|NCT01915914|463695673|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
128836286|NCT01915914|463695674|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
128836287|NCT01915914|463695675|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
128836288|NCT01915914|463695672|FG000|Acute Phase|"Not Achieved treatment success"|1|||
128836289|NCT01915914|463695673|FG001|Acute Phase|"Not Achieved treatment success"|0|||
128836290|NCT01915914|463695674|FG002|Acute Phase|"Not Achieved treatment success"|0|||
128836291|NCT01915914|463695675|FG003|Acute Phase|"Not Achieved treatment success"|0|||
128836292|NCT01915914|463695672|FG000|Acute Phase|Missing|1|||
128836293|NCT01915914|463695673|FG001|Acute Phase|Missing|0|||
128836294|NCT01915914|463695674|FG002|Acute Phase|Missing|0|||
128836295|NCT01915914|463695675|FG003|Acute Phase|Missing|0|||
128836296|NCT01915914|463695672|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128836297|NCT01915914|463695673|FG001|Maintenance Phase|Withdrawal by Subject|1|||
128836298|NCT01915914|463695674|FG002|Maintenance Phase|Withdrawal by Subject|1|||
128836299|NCT01915914|463695675|FG003|Maintenance Phase|Withdrawal by Subject|0|||
128836300|NCT01915914|463695672|FG000|Maintenance Phase|Lost to Follow-up|0|||
128836301|NCT01915914|463695673|FG001|Maintenance Phase|Lost to Follow-up|4|||
128836302|NCT01915914|463695674|FG002|Maintenance Phase|Lost to Follow-up|1|||
128836303|NCT01915914|463695675|FG003|Maintenance Phase|Lost to Follow-up|0|||
128836304|NCT01915914|463695672|FG000|Maintenance Phase|Missing|0|||
128836305|NCT01915914|463695673|FG001|Maintenance Phase|Missing|1|||
128836306|NCT01915914|463695674|FG002|Maintenance Phase|Missing|0|||
128836307|NCT01915914|463695675|FG003|Maintenance Phase|Missing|0|||
128836308|NCT01915914|463695672|FG000|Follow-up Phase|Withdrawal by Subject|0|||
128836309|NCT01915914|463695673|FG001|Follow-up Phase|Withdrawal by Subject|0|||
128836310|NCT01915914|463695674|FG002|Follow-up Phase|Withdrawal by Subject|0|||
128836311|NCT01915914|463695675|FG003|Follow-up Phase|Withdrawal by Subject|1|||
128836312|NCT01915914|463695672|FG000|Follow-up Phase|Physician Decision|0|||
128836313|NCT01915914|463695673|FG001|Follow-up Phase|Physician Decision|0|||
128836314|NCT01915914|463695674|FG002|Follow-up Phase|Physician Decision|0|||
128836315|NCT01915914|463695675|FG003|Follow-up Phase|Physician Decision|1|||
128836316|NCT01528605|463695676|FG000|Overall Study|Lost to Follow-up|1|||
128836317|NCT01528605|463695677|FG001|Overall Study|Lost to Follow-up|0|||
128836318|NCT01528605|463695678|FG002|Overall Study|Lost to Follow-up|1|||
128836319|NCT01528605|463695679|FG003|Overall Study|Lost to Follow-up|1|||
128836320|NCT01528605|463695680|FG004|Overall Study|Lost to Follow-up|0|||
128836321|NCT01528605|463695681|FG005|Overall Study|Lost to Follow-up|0|||
128836322|NCT01528605|463695676|FG000|Overall Study|Death|1|||
128836323|NCT01528605|463695677|FG001|Overall Study|Death|0|||
128836324|NCT01528605|463695678|FG002|Overall Study|Death|0|||
128836325|NCT01528605|463695679|FG003|Overall Study|Death|0|||
128836326|NCT01528605|463695680|FG004|Overall Study|Death|0|||
128836327|NCT01528605|463695681|FG005|Overall Study|Death|0|||
128836328|NCT02432274|463695682|FG000|Overall Study|Death|2|||
128836329|NCT02432274|463695683|FG001|Overall Study|Death|6|||
128836330|NCT02432274|463695684|FG002|Overall Study|Death|7|||
128836331|NCT02432274|463695685|FG003|Overall Study|Death|0|||
128836332|NCT02432274|463695686|FG004|Overall Study|Death|27|||
128836333|NCT02432274|463695687|FG005|Overall Study|Death|7|||
128836334|NCT02432274|463695688|FG006|Overall Study|Death|9|||
128836335|NCT02432274|463695689|FG007|Overall Study|Death|14|||
128836336|NCT02432274|463695682|FG000|Overall Study|Withdrawal of Consent|0|||
128836337|NCT02432274|463695683|FG001|Overall Study|Withdrawal of Consent|0|||
128836338|NCT02432274|463695684|FG002|Overall Study|Withdrawal of Consent|0|||
128836339|NCT02432274|463695685|FG003|Overall Study|Withdrawal of Consent|0|||
128836340|NCT02432274|463695686|FG004|Overall Study|Withdrawal of Consent|2|||
128836341|NCT02432274|463695687|FG005|Overall Study|Withdrawal of Consent|0|||
128836342|NCT02432274|463695688|FG006|Overall Study|Withdrawal of Consent|1|||
128836343|NCT02432274|463695689|FG007|Overall Study|Withdrawal of Consent|2|||
128836344|NCT00116649|463695690|FG000|Overall Study|Adverse Event|20|||
128836345|NCT00116649|463695690|FG000|Overall Study|Lack of Efficacy|1|||
128836346|NCT00116649|463695690|FG000|Overall Study|Lost to Follow-up|32|||
128836347|NCT00116649|463695690|FG000|Overall Study|Withdrawal by Subject|68|||
128836348|NCT00116649|463695690|FG000|Overall Study|Local Skin Reaction|9|||
128836349|NCT00116649|463695690|FG000|Overall Study|Various Reasons|18|||
128836350|NCT00116649|463695690|FG000|Overall Study|Protocol Specified|7|||
128836351|NCT00513071|463695693|FG000|Overall Study|Adverse Event|1|||
128836352|NCT00513071|463695693|FG000|Overall Study|Withdrawal by Subject|1|||
128836353|NCT00513071|463695693|FG000|Overall Study|Physician Decision|3|||
128836354|NCT01240590|463695695|FG000|Phase I|Refused further treatment|0|||
128836355|NCT01240590|463695696|FG001|Phase I|Refused further treatment|0|||
128836356|NCT01240590|463695697|FG002|Phase I|Refused further treatment|3|||
128836357|NCT01240590|463695698|FG003|Phase I|Refused further treatment|0|||
128836358|NCT01240590|463695699|FG004|Phase I|Refused further treatment|0|||
128836359|NCT01240590|463695695|FG000|Phase II|Refused further treatment|0|||
128836360|NCT01240590|463695696|FG001|Phase II|Refused further treatment|0|||
128836361|NCT01240590|463695697|FG002|Phase II|Refused further treatment|0|||
128836362|NCT01240590|463695698|FG003|Phase II|Refused further treatment|2|||
128836363|NCT01240590|463695699|FG004|Phase II|Refused further treatment|1|||
128836364|NCT02659540|463695700|FG000|Overall Study|Adverse Event|3|||
128836365|NCT02659540|463695701|FG001|Overall Study|Adverse Event|2|||
128836366|NCT02659540|463695700|FG000|Overall Study|Death|1|||
128836367|NCT02659540|463695701|FG001|Overall Study|Death|0|||
128836368|NCT02659540|463695700|FG000|Overall Study|Progressive disease|2|||
128836369|NCT02659540|463695701|FG001|Overall Study|Progressive disease|6|||
128836370|NCT02106325|463695702|FG000|Phase 1|Lost to Follow-up|2|||
128836371|NCT02106325|463695703|FG001|Phase 1|Lost to Follow-up|2|||
128836372|NCT02106325|463695702|FG000|Phase 2|Lost to Follow-up|2|||
128836373|NCT02106325|463695703|FG001|Phase 2|Lost to Follow-up|3|||
128836374|NCT02106325|463695702|FG000|Phase 3|Lost to Follow-up|2|||
128836375|NCT02106325|463695703|FG001|Phase 3|Lost to Follow-up|1|||
128836376|NCT04820491|463695704|FG000|Overall Study|Withdrawal by Subject|1|||
128836377|NCT04820491|463695705|FG001|Overall Study|Withdrawal by Subject|0|||
128836378|NCT01668355|463697179|FG000|Overall Study|Death|3|||
128836379|NCT01668355|463697180|FG001|Overall Study|Death|1|||
128836380|NCT01668355|463697179|FG000|Overall Study|Withdrawal by Subject|6|||
128836381|NCT01668355|463697180|FG001|Overall Study|Withdrawal by Subject|1|||
128836382|NCT01277302|463697181|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
128836383|NCT01277302|463697182|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
128836384|NCT01277302|463697183|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
128836385|NCT01277302|463697181|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
128836386|NCT01277302|463697182|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
128836387|NCT01277302|463697183|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
128836388|NCT01277302|463697181|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
128836389|NCT01277302|463697182|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
128836390|NCT01277302|463697183|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
128836391|NCT01277302|463697181|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
128836392|NCT01277302|463697182|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
128836393|NCT01277302|463697183|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
128836394|NCT01277302|463697181|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
128836395|NCT01277302|463697182|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
128836396|NCT01277302|463697183|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
128836397|NCT01277302|463697181|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
128836398|NCT01277302|463697182|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
128836399|NCT01277302|463697183|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
128836400|NCT01277302|463697181|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
128836401|NCT01277302|463697182|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
128836402|NCT01277302|463697183|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
128836403|NCT01277302|463697181|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
128836404|NCT01277302|463697182|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
128836405|NCT01277302|463697183|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
128836406|NCT01277302|463697181|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
128836407|NCT01277302|463697182|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
128836408|NCT01277302|463697183|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
128836409|NCT02002689|463697184|FG000|Overall Study|Disease Progression|7|||
128836410|NCT02002689|463697184|FG000|Overall Study|Adverse Event|3|||
128836411|NCT01377844|463697185|FG000|Overall Study|Withdrawal by Subject|25|||
128836412|NCT01377844|463697186|FG001|Overall Study|Withdrawal by Subject|28|||
128836413|NCT01377844|463697185|FG000|Overall Study|Protocol Violation|2|||
128836414|NCT01377844|463697186|FG001|Overall Study|Protocol Violation|3|||
128836415|NCT01377844|463697185|FG000|Overall Study|Adverse Event|3|||
128836416|NCT01377844|463697186|FG001|Overall Study|Adverse Event|0|||
128836417|NCT01377844|463697185|FG000|Overall Study|Physician Decision|6|||
128836418|NCT01377844|463697186|FG001|Overall Study|Physician Decision|3|||
128836419|NCT01377844|463697185|FG000|Overall Study|Study terminated by Sponsor|0|||
128836420|NCT01377844|463697186|FG001|Overall Study|Study terminated by Sponsor|1|||
128836421|NCT01185340|463697189|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
128836422|NCT01185340|463697190|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
128836423|NCT01185340|463697191|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
128836424|NCT01185340|463697192|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
128836425|NCT01185340|463697189|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
128836426|NCT01185340|463697190|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
128836427|NCT01185340|463697191|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
128836428|NCT01185340|463697192|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
128836429|NCT01185340|463697189|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
128836430|NCT01185340|463697190|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
128836431|NCT01185340|463697191|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
128836432|NCT01185340|463697192|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
128836433|NCT01185340|463697189|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
128836434|NCT01185340|463697190|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128836435|NCT01185340|463697191|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128836436|NCT01185340|463697192|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128836437|NCT01185340|463697189|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
128836438|NCT01185340|463697190|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128836439|NCT01185340|463697191|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128836440|NCT01185340|463697192|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128836441|NCT01185340|463697189|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
128836442|NCT01185340|463697190|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
128836443|NCT01185340|463697191|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
128836444|NCT01185340|463697192|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
128836445|NCT01185340|463697189|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
128836446|NCT01185340|463697190|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
128836447|NCT01185340|463697191|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
128836448|NCT01185340|463697192|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
128836449|NCT01185340|463697189|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
128836450|NCT01185340|463697190|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
128836451|NCT01185340|463697191|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
128836452|NCT01185340|463697192|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
128836453|NCT01185340|463697189|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
128836454|NCT01185340|463697190|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
128836455|NCT01185340|463697191|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
128836456|NCT01185340|463697192|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
128836457|NCT01185340|463697189|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
128836458|NCT01185340|463697190|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
128836459|NCT01185340|463697191|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
128836460|NCT01185340|463697192|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
128836461|NCT01185340|463697189|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
128836462|NCT01185340|463697190|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
128836463|NCT01185340|463697191|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
128836464|NCT01185340|463697192|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
128836465|NCT01185340|463697189|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
128836466|NCT01185340|463697190|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
128836467|NCT01185340|463697191|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
128836468|NCT01185340|463697192|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
128836469|NCT01185340|463697189|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
128836470|NCT01185340|463697190|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
128836471|NCT01185340|463697191|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
128836472|NCT01185340|463697192|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
128836473|NCT01185340|463697189|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
128836474|NCT01185340|463697190|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
128836475|NCT01185340|463697191|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
128836476|NCT01185340|463697192|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
128836477|NCT00087516|463697193|FG000|Overall Study|Adverse Event|10|||
128836478|NCT00087516|463697194|FG001|Overall Study|Adverse Event|10|||
128836479|NCT00087516|463697195|FG002|Overall Study|Adverse Event|3|||
128836480|NCT00087516|463697196|FG003|Overall Study|Adverse Event|6|||
128836481|NCT00087516|463697193|FG000|Overall Study|Lack of Efficacy|82|||
128836482|NCT00087516|463697194|FG001|Overall Study|Lack of Efficacy|80|||
128836483|NCT00087516|463697195|FG002|Overall Study|Lack of Efficacy|39|||
128836484|NCT00087516|463697196|FG003|Overall Study|Lack of Efficacy|29|||
128836485|NCT00087516|463697193|FG000|Overall Study|Lost to Follow-up|8|||
128836486|NCT00087516|463697194|FG001|Overall Study|Lost to Follow-up|6|||
128836487|NCT00087516|463697195|FG002|Overall Study|Lost to Follow-up|5|||
128836488|NCT00087516|463697196|FG003|Overall Study|Lost to Follow-up|5|||
128836489|NCT00087516|463697193|FG000|Overall Study|Protocol Violation|4|||
128836490|NCT00087516|463697194|FG001|Overall Study|Protocol Violation|8|||
128836491|NCT00087516|463697195|FG002|Overall Study|Protocol Violation|3|||
128836492|NCT00087516|463697196|FG003|Overall Study|Protocol Violation|6|||
128836493|NCT00087516|463697193|FG000|Overall Study|Withdrawal by Subject|16|||
128836494|NCT00087516|463697194|FG001|Overall Study|Withdrawal by Subject|27|||
128836495|NCT00087516|463697195|FG002|Overall Study|Withdrawal by Subject|11|||
128836496|NCT00087516|463697196|FG003|Overall Study|Withdrawal by Subject|12|||
128836497|NCT00087516|463697193|FG000|Overall Study|Site terminated|0|||
128836498|NCT00087516|463697194|FG001|Overall Study|Site terminated|2|||
128836499|NCT00087516|463697195|FG002|Overall Study|Site terminated|1|||
128836500|NCT00087516|463697196|FG003|Overall Study|Site terminated|0|||
128836501|NCT00087516|463697193|FG000|Overall Study|Protocol specified discontinuation|35|||
128836502|NCT00087516|463697194|FG001|Overall Study|Protocol specified discontinuation|33|||
128836503|NCT00087516|463697195|FG002|Overall Study|Protocol specified discontinuation|33|||
128836504|NCT00087516|463697196|FG003|Overall Study|Protocol specified discontinuation|26|||
128836505|NCT00087516|463697193|FG000|Overall Study|Patient moved|3|||
128836506|NCT00087516|463697194|FG001|Overall Study|Patient moved|2|||
128836507|NCT00087516|463697195|FG002|Overall Study|Patient moved|1|||
128836508|NCT00087516|463697196|FG003|Overall Study|Patient moved|0|||
128836509|NCT00087516|463697193|FG000|Overall Study|Patient was non-compliant|3|||
128836510|NCT00087516|463697194|FG001|Overall Study|Patient was non-compliant|1|||
128836511|NCT00087516|463697195|FG002|Overall Study|Patient was non-compliant|0|||
128836512|NCT00087516|463697196|FG003|Overall Study|Patient was non-compliant|0|||
128836513|NCT00087516|463697193|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
128836514|NCT00087516|463697194|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
128836515|NCT00087516|463697195|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
128836516|NCT00087516|463697196|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
128836517|NCT00087516|463697193|FG000|Overall Study|Other|0|||
128836518|NCT00087516|463697194|FG001|Overall Study|Other|0|||
128836519|NCT00087516|463697195|FG002|Overall Study|Other|1|||
128836520|NCT00087516|463697196|FG003|Overall Study|Other|0|||
128836521|NCT02065895|463697197|FG000|Overall Study|Protocol Violation|1|||
128836522|NCT02065895|463697198|FG001|Overall Study|Protocol Violation|0|||
128836523|NCT02065895|463697199|FG002|Overall Study|Protocol Violation|0|||
128836524|NCT02065895|463697200|FG003|Overall Study|Protocol Violation|1|||
128836525|NCT02065895|463697201|FG004|Overall Study|Protocol Violation|0|||
128836526|NCT02065895|463697202|FG005|Overall Study|Protocol Violation|0|||
128836527|NCT02065895|463697197|FG000|Overall Study|Scheduling conflicts|0|||
128836528|NCT02065895|463697198|FG001|Overall Study|Scheduling conflicts|1|||
128836529|NCT02065895|463697199|FG002|Overall Study|Scheduling conflicts|0|||
128836530|NCT02065895|463697200|FG003|Overall Study|Scheduling conflicts|0|||
128836531|NCT02065895|463697201|FG004|Overall Study|Scheduling conflicts|0|||
128836532|NCT02065895|463697202|FG005|Overall Study|Scheduling conflicts|0|||
128836533|NCT03403036|463697208|FG000|Overall Study|Lack of Efficacy|5|||
128836534|NCT00569166|463697213|FG000|Overall Study|Withdrawal by Subject|7|||
128836535|NCT00569166|463697214|FG001|Overall Study|Withdrawal by Subject|5|||
128836536|NCT00569166|463697215|FG002|Overall Study|Withdrawal by Subject|3|||
128836537|NCT00569166|463697213|FG000|Overall Study|Lost to Follow-up|2|||
128836538|NCT00569166|463697214|FG001|Overall Study|Lost to Follow-up|1|||
128836539|NCT00569166|463697215|FG002|Overall Study|Lost to Follow-up|1|||
128836540|NCT05005247|463697216|FG000|Overall Study|Withdrawal by Subject|0|||
128836541|NCT05005247|463697217|FG001|Overall Study|Withdrawal by Subject|1|||
128836542|NCT05005247|463697218|FG002|Overall Study|Withdrawal by Subject|0|||
128836543|NCT02958553|463697219|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
128836544|NCT02958553|463697219|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
128836545|NCT01686152|463697220|FG000|Overall Study|Withdrawal by Subject|11|||
128836546|NCT01686152|463697221|FG001|Overall Study|Withdrawal by Subject|11|||
128836547|NCT01686152|463697222|FG002|Overall Study|Withdrawal by Subject|3|||
128836548|NCT01686152|463697220|FG000|Overall Study|Drug Code Unblinded|0|||
128836549|NCT01686152|463697221|FG001|Overall Study|Drug Code Unblinded|1|||
128836550|NCT01686152|463697222|FG002|Overall Study|Drug Code Unblinded|0|||
128836551|NCT01686152|463697220|FG000|Overall Study|Protocol Violation|6|||
128836552|NCT01686152|463697221|FG001|Overall Study|Protocol Violation|1|||
128836553|NCT01686152|463697222|FG002|Overall Study|Protocol Violation|0|||
128836554|NCT01686152|463697220|FG000|Overall Study|Adverse Event|12|||
128836555|NCT01686152|463697221|FG001|Overall Study|Adverse Event|11|||
128836556|NCT01686152|463697222|FG002|Overall Study|Adverse Event|0|||
128836557|NCT01686152|463697220|FG000|Overall Study|Lack of Efficacy|0|||
128836558|NCT01686152|463697221|FG001|Overall Study|Lack of Efficacy|0|||
128836559|NCT01686152|463697222|FG002|Overall Study|Lack of Efficacy|1|||
128836560|NCT01686152|463697220|FG000|Overall Study|IP Non-compliance|5|||
128836561|NCT01686152|463697221|FG001|Overall Study|IP Non-compliance|5|||
128836562|NCT01686152|463697222|FG002|Overall Study|IP Non-compliance|0|||
128836563|NCT01686152|463697220|FG000|Overall Study|Lost to Follow-up|7|||
128836564|NCT01686152|463697221|FG001|Overall Study|Lost to Follow-up|6|||
128836565|NCT01686152|463697222|FG002|Overall Study|Lost to Follow-up|5|||
128836566|NCT00704340|463697224|FG000|Overall Study|Lost to Follow-up|2|||
128836567|NCT00704340|463697225|FG001|Overall Study|Lost to Follow-up|1|||
128836568|NCT00704340|463697224|FG000|Overall Study|Death|0|||
128836569|NCT00704340|463697225|FG001|Overall Study|Death|1|||
128836570|NCT01437540|463697226|FG000|Overall Study|Not listed below|7|||
128836571|NCT01437540|463697227|FG001|Overall Study|Not listed below|6|||
128836572|NCT01437540|463697226|FG000|Overall Study|COPD exacerbation|13|||
128836573|NCT01437540|463697227|FG001|Overall Study|COPD exacerbation|3|||
128836574|NCT01437540|463697226|FG000|Overall Study|Lost to Follow-up|3|||
128836575|NCT01437540|463697227|FG001|Overall Study|Lost to Follow-up|5|||
128836576|NCT01437540|463697226|FG000|Overall Study|Lack of Efficacy|23|||
128836577|NCT01437540|463697227|FG001|Overall Study|Lack of Efficacy|11|||
128836578|NCT01437540|463697226|FG000|Overall Study|Protocol Violation|24|||
128836579|NCT01437540|463697227|FG001|Overall Study|Protocol Violation|12|||
128836580|NCT01437540|463697226|FG000|Overall Study|Adverse Event|26|||
128836581|NCT01437540|463697227|FG001|Overall Study|Adverse Event|13|||
128836582|NCT01437540|463697226|FG000|Overall Study|Withdrawal by Subject|31|||
128836583|NCT01437540|463697227|FG001|Overall Study|Withdrawal by Subject|15|||
128836584|NCT00929526|463697229|FG000|Overall Study|Withdrawal by Subject|1|||
128836585|NCT00929526|463697230|FG001|Overall Study|Withdrawal by Subject|11|||
128836586|NCT00929526|463697229|FG000|Overall Study|Lost to Follow-up|8|||
128836587|NCT00929526|463697230|FG001|Overall Study|Lost to Follow-up|12|||
128836588|NCT00929526|463697229|FG000|Overall Study|Other|8|||
128836589|NCT00929526|463697230|FG001|Overall Study|Other|6|||
128836590|NCT01393600|463697236|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
128836591|NCT01393600|463697237|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
128836592|NCT01393600|463697238|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
128836593|NCT01393600|463697239|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
128836594|NCT01393600|463697236|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
128836595|NCT01393600|463697237|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
128836596|NCT01393600|463697238|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
128836597|NCT01393600|463697239|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
128836598|NCT01393600|463697236|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
128836599|NCT01393600|463697237|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
128836600|NCT01393600|463697238|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
128836601|NCT01393600|463697239|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
128836602|NCT01393600|463697236|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
128836603|NCT01393600|463697237|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
128836604|NCT01393600|463697238|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
128836605|NCT01393600|463697239|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
128836606|NCT01393600|463697236|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
128836607|NCT01393600|463697237|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
128836608|NCT01393600|463697238|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
128836609|NCT01393600|463697239|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
128836610|NCT01393600|463697236|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
128836611|NCT01393600|463697237|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
128836612|NCT01393600|463697238|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
128836613|NCT01393600|463697239|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
128836614|NCT01393600|463697236|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
128836615|NCT01393600|463697237|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
128836616|NCT01393600|463697238|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
128836617|NCT01393600|463697239|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
128836618|NCT00889863|463697240|FG000|Part I: Open Label|Death|1|||
128836619|NCT00889863|463697241|FG001|Part I: Open Label|Death|0|||
128836620|NCT00889863|463697240|FG000|Part I: Open Label|Adverse Event|4|||
128836621|NCT00889863|463697241|FG001|Part I: Open Label|Adverse Event|0|||
128836622|NCT00889863|463697240|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
128836623|NCT00889863|463697241|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
128836624|NCT00889863|463697240|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
128836625|NCT00889863|463697241|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
128836626|NCT00889863|463697240|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
128836627|NCT00889863|463697241|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
128836628|NCT00889863|463697240|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
128836629|NCT00889863|463697241|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
128836630|NCT00889863|463697240|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
128836631|NCT00889863|463697241|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
128836632|NCT03006393|463697250|FG000|Overall Study|Withdrawal by Subject|1|||
128836633|NCT03006393|463697251|FG001|Overall Study|Withdrawal by Subject|1|||
128836634|NCT03006393|463697250|FG000|Overall Study|Pregnancy|0|||
128836635|NCT03006393|463697251|FG001|Overall Study|Pregnancy|1|||
128836636|NCT03006393|463697250|FG000|Overall Study|Lost to Follow-up|0|||
128836637|NCT03006393|463697251|FG001|Overall Study|Lost to Follow-up|1|||
128836638|NCT03136861|463697252|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
128836639|NCT03136861|463697253|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
128836640|NCT03136861|463697254|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
128836641|NCT03136861|463697255|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
128836642|NCT03136861|463697256|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
128836643|NCT03136861|463697257|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
128836644|NCT03136861|463697258|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
128836645|NCT03136861|463697252|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
128836646|NCT03136861|463697253|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
128836647|NCT03136861|463697254|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
128836648|NCT03136861|463697255|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
128836649|NCT03136861|463697256|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
128836650|NCT03136861|463697257|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
128836651|NCT03136861|463697258|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
128836652|NCT03136861|463697252|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
128836653|NCT03136861|463697253|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
128836654|NCT03136861|463697254|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
128836655|NCT03136861|463697255|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
128836656|NCT03136861|463697256|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
128836657|NCT03136861|463697257|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
128836658|NCT03136861|463697258|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
128836659|NCT03136861|463697252|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
128836660|NCT03136861|463697253|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
128836661|NCT03136861|463697254|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
128836662|NCT03136861|463697255|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
128836663|NCT03136861|463697256|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
128836664|NCT03136861|463697257|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
128836665|NCT03136861|463697258|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
128836666|NCT03136861|463697252|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
128836667|NCT03136861|463697253|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
128836668|NCT03136861|463697254|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
128836669|NCT03136861|463697255|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
128836670|NCT03136861|463697256|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
128836671|NCT03136861|463697257|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
128836672|NCT03136861|463697258|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
128836673|NCT03136861|463697252|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
128836674|NCT03136861|463697253|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
128836675|NCT03136861|463697254|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
128836676|NCT03136861|463697255|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
128836677|NCT03136861|463697256|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
128836678|NCT03136861|463697257|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
128836679|NCT03136861|463697258|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
128836680|NCT03136861|463697252|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
128836681|NCT03136861|463697253|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
128836682|NCT03136861|463697254|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
128836683|NCT03136861|463697255|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
128836684|NCT03136861|463697256|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
128836685|NCT03136861|463697257|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
128836686|NCT03136861|463697258|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
128836687|NCT03136861|463697252|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
128836688|NCT03136861|463697253|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
128836689|NCT03136861|463697254|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
128836690|NCT03136861|463697255|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
128836691|NCT03136861|463697256|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
128836692|NCT03136861|463697257|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
128836693|NCT03136861|463697258|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
128836694|NCT01584648|463697259|FG000|Overall Study|Death|136|||
128836695|NCT01584648|463697260|FG001|Overall Study|Death|146|||
128836696|NCT01584648|463697259|FG000|Overall Study|Lost to Follow-up|9|||
128836697|NCT01584648|463697260|FG001|Overall Study|Lost to Follow-up|9|||
128836698|NCT01584648|463697259|FG000|Overall Study|Investigator discretion|3|||
128836699|NCT01584648|463697260|FG001|Overall Study|Investigator discretion|2|||
128836700|NCT01584648|463697259|FG000|Overall Study|Withdrew consent|13|||
128836701|NCT01584648|463697260|FG001|Overall Study|Withdrew consent|4|||
128836702|NCT01584648|463697259|FG000|Overall Study|Study closed/terminated|50|||
128836703|NCT01584648|463697260|FG001|Overall Study|Study closed/terminated|23|||
128836704|NCT01584648|463697259|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
128836705|NCT01584648|463697260|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
128836706|NCT05376397|463697263|FG000|Overall Study|Lost to Follow-up|1|||
128836707|NCT01328756|463697264|FG000|Overall Study|Protocol Violation|4|||
128836708|NCT01328756|463697264|FG000|Overall Study|Adverse Event|39|||
128836709|NCT01328756|463697264|FG000|Overall Study|Lack of Efficacy|5|||
128836710|NCT01328756|463697264|FG000|Overall Study|Withdrawal by Subject|41|||
128836711|NCT01328756|463697264|FG000|Overall Study|Lost to Follow-up|5|||
128836712|NCT01328756|463697264|FG000|Overall Study|Other|29|||
128836713|NCT00472082|463697268|FG000|Overall Study|Study prematurely terminated|5|||
128836714|NCT00761267|463697269|FG000|Overall Study|Death|1|||
128836715|NCT00761267|463697270|FG001|Overall Study|Death|2|||
128836716|NCT00761267|463697271|FG002|Overall Study|Death|5|||
128836717|NCT00761267|463697269|FG000|Overall Study|Lost to Follow-up|0|||
128836718|NCT00761267|463697270|FG001|Overall Study|Lost to Follow-up|0|||
128836719|NCT00761267|463697271|FG002|Overall Study|Lost to Follow-up|1|||
128836720|NCT00761267|463697269|FG000|Overall Study|Randomized but not treated|1|||
128836721|NCT00761267|463697270|FG001|Overall Study|Randomized but not treated|1|||
128836722|NCT00761267|463697271|FG002|Overall Study|Randomized but not treated|0|||
128836723|NCT00761267|463697269|FG000|Overall Study|Withdrawal by Subject|0|||
128836724|NCT00761267|463697270|FG001|Overall Study|Withdrawal by Subject|1|||
128836725|NCT00761267|463697271|FG002|Overall Study|Withdrawal by Subject|0|||
128836726|NCT04492475|463697272|FG000|Overall Study|Enrolled but not treated|8|||
128836727|NCT04492475|463697273|FG001|Overall Study|Enrolled but not treated|8|||
128836728|NCT04492475|463697272|FG000|Overall Study|Withdrawal by Subject|4|||
128836729|NCT04492475|463697273|FG001|Overall Study|Withdrawal by Subject|0|||
128836730|NCT04492475|463697272|FG000|Overall Study|Became ineligible after enrollment|2|||
128836731|NCT04492475|463697273|FG001|Overall Study|Became ineligible after enrollment|0|||
128836732|NCT03205488|463697283|FG000|Overall Study|Adverse Event|1|||
128836733|NCT03205488|463697284|FG001|Overall Study|Adverse Event|2|||
128836734|NCT03205488|463697285|FG002|Overall Study|Adverse Event|4|||
128836735|NCT03205488|463697283|FG000|Overall Study|Protocol Violation|0|||
128836736|NCT03205488|463697284|FG001|Overall Study|Protocol Violation|0|||
128836737|NCT03205488|463697285|FG002|Overall Study|Protocol Violation|1|||
128836738|NCT01860079|463697288|FG000|Overall Study|Physician Decision|14|||
128836739|NCT01860079|463697289|FG001|Overall Study|Physician Decision|22|||
128836740|NCT05445557|463697290|FG000|Double Blind Part|Lost to Follow-up|1|||
128836741|NCT00428714|463697298|FG000|Overall Study|Progressive Disease|28|||
128836742|NCT00428714|463697299|FG001|Overall Study|Progressive Disease|36|||
128836743|NCT00428714|463697298|FG000|Overall Study|Withdrawal by Subject|0|||
128836744|NCT00428714|463697299|FG001|Overall Study|Withdrawal by Subject|3|||
128836745|NCT00428714|463697298|FG000|Overall Study|Adverse Event|0|||
128836746|NCT00428714|463697299|FG001|Overall Study|Adverse Event|2|||
128836747|NCT00428714|463697298|FG000|Overall Study|Physician Decision|1|||
128836748|NCT00428714|463697299|FG001|Overall Study|Physician Decision|1|||
128836749|NCT00428714|463697298|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
128836750|NCT00428714|463697299|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
128836751|NCT00428714|463697298|FG000|Overall Study|Death due to other then PD|1|||
128836752|NCT00428714|463697299|FG001|Overall Study|Death due to other then PD|0|||
128836753|NCT01681511|463697300|FG000|Overall Study|No Treatment Received|1|||
128836754|NCT01681511|463697301|FG001|Overall Study|No Treatment Received|3|||
128836755|NCT01681511|463697300|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
128836756|NCT01681511|463697301|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
128836757|NCT01681511|463697300|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
128836758|NCT01681511|463697301|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
128836759|NCT01681511|463697300|FG000|Overall Study|No Daily Urine Sample Collected|0|||
128836760|NCT01681511|463697301|FG001|Overall Study|No Daily Urine Sample Collected|1|||
128836761|NCT01681511|463697300|FG000|Overall Study|No post-catheter sample collected|11|||
128836762|NCT01681511|463697301|FG001|Overall Study|No post-catheter sample collected|4|||
128836763|NCT01156675|463697302|FG000|Overall Study|Death|5|||
128836764|NCT01156675|463697303|FG001|Overall Study|Death|3|||
128836765|NCT01156675|463697304|FG002|Overall Study|Death|0|||
128836766|NCT01156675|463697302|FG000|Overall Study|No data|29|||
128836767|NCT01156675|463697303|FG001|Overall Study|No data|22|||
128836768|NCT01156675|463697304|FG002|Overall Study|No data|2|||
128836769|NCT02326220|463697318|FG000|Double-blind Treatment Period|Adverse Event|1|||
128836770|NCT02326220|463697319|FG001|Double-blind Treatment Period|Adverse Event|2|||
128836771|NCT02326220|463697320|FG002|Double-blind Treatment Period|Adverse Event|0|||
128836772|NCT02326220|463697318|FG000|Double-blind Treatment Period|Protocol Violation|0|||
128836773|NCT02326220|463697319|FG001|Double-blind Treatment Period|Protocol Violation|1|||
128836774|NCT02326220|463697320|FG002|Double-blind Treatment Period|Protocol Violation|0|||
128836775|NCT02326220|463697318|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
128836776|NCT02326220|463697319|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
128836777|NCT02326220|463697320|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
128836778|NCT02326220|463697318|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
128836779|NCT02326220|463697319|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
128836780|NCT02326220|463697320|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
128836781|NCT02326220|463697318|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
128836782|NCT02326220|463697319|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
128836783|NCT02326220|463697320|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
128836784|NCT02114515|463697322|FG000|Overall Study|Lost to Follow-up|52|||
128836785|NCT02114515|463697323|FG001|Overall Study|Lost to Follow-up|55|||
128836786|NCT02114515|463697322|FG000|Overall Study|Death|12|||
128836787|NCT02114515|463697323|FG001|Overall Study|Death|12|||
128836788|NCT02114515|463697322|FG000|Overall Study|Withdrawal by Subject|4|||
128836789|NCT02114515|463697323|FG001|Overall Study|Withdrawal by Subject|22|||
128836790|NCT02114515|463697322|FG000|Overall Study|Other|65|||
128836791|NCT02114515|463697323|FG001|Overall Study|Other|61|||
128836792|NCT02699099|463697324|FG000|Overall Study|Adverse Event|1|||
128836793|NCT02699099|463697325|FG001|Overall Study|Adverse Event|0|||
128836794|NCT02699099|463697326|FG002|Overall Study|Adverse Event|2|||
128836795|NCT02699099|463697324|FG000|Overall Study|Lost to Follow-up|0|||
128836796|NCT02699099|463697325|FG001|Overall Study|Lost to Follow-up|1|||
128836797|NCT02699099|463697326|FG002|Overall Study|Lost to Follow-up|0|||
128836798|NCT02699099|463697324|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
128836799|NCT02699099|463697325|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
128836800|NCT02699099|463697326|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
128836801|NCT00667732|463697327|FG000|Run -In (8 Weeks)|Adverse Event|4|||
128836802|NCT00667732|463697328|FG001|Run -In (8 Weeks)|Adverse Event|0|||
128836803|NCT00667732|463697329|FG002|Run -In (8 Weeks)|Adverse Event|0|||
128836804|NCT00667732|463697327|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
128836805|NCT00667732|463697328|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
128836806|NCT00667732|463697329|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
128836807|NCT00667732|463697327|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
128836808|NCT00667732|463697328|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
128836809|NCT00667732|463697329|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
128836810|NCT03890484|463697334|FG000|Overall Study|Lost to Follow-up|1|||
128836811|NCT03890484|463697335|FG001|Overall Study|Lost to Follow-up|1|||
128836812|NCT00824850|463697337|FG000|Overall Study|Withdrawal by Subject|0|||
128836813|NCT00824850|463697338|FG001|Overall Study|Withdrawal by Subject|1|||
128836814|NCT05184062|463697340|FG000|Overall Study|Lost to Follow-up|5|||
128836815|NCT05184062|463697341|FG001|Overall Study|Lost to Follow-up|1|||
128836816|NCT05184062|463697340|FG000|Overall Study|Withdrawal by Subject|1|||
128836817|NCT05184062|463697341|FG001|Overall Study|Withdrawal by Subject|0|||
128836818|NCT03659136|463697346|FG000|Overall Study|Not treated|2|||
128836819|NCT03659136|463697347|FG001|Overall Study|Not treated|0|||
128836820|NCT03659136|463697346|FG000|Overall Study|Covid-19 related|1|||
128836821|NCT03659136|463697347|FG001|Overall Study|Covid-19 related|1|||
128836822|NCT03659136|463697346|FG000|Overall Study|Withdrawal by Subject|1|||
128836823|NCT03659136|463697347|FG001|Overall Study|Withdrawal by Subject|6|||
128836824|NCT03659136|463697346|FG000|Overall Study|Adverse Event|4|||
128836825|NCT03659136|463697347|FG001|Overall Study|Adverse Event|6|||
128836826|NCT03659136|463697346|FG000|Overall Study|Progressive disease|37|||
128836827|NCT03659136|463697347|FG001|Overall Study|Progressive disease|31|||
128836828|NCT03659136|463697346|FG000|Overall Study|Study closure|2|||
128836829|NCT03659136|463697347|FG001|Overall Study|Study closure|2|||
128836830|NCT03659136|463697346|FG000|Overall Study|Sponsor decision/recommendation|3|||
128836831|NCT03659136|463697347|FG001|Overall Study|Sponsor decision/recommendation|2|||
128836832|NCT03659136|463697346|FG000|Overall Study|Switched to other drug/therapy|2|||
128836833|NCT03659136|463697347|FG001|Overall Study|Switched to other drug/therapy|2|||
128836834|NCT03659136|463697346|FG000|Overall Study|Lack of clinical benefit|0|||
128836835|NCT03659136|463697347|FG001|Overall Study|Lack of clinical benefit|1|||
128836836|NCT02830893|463699136|FG000|Overall Study|Relocation to out of the country|1|||
128836837|NCT02830893|463699137|FG001|Overall Study|Relocation to out of the country|0|||
128836838|NCT02830893|463699136|FG000|Overall Study|Lost to Follow-up|0|||
128836839|NCT02830893|463699137|FG001|Overall Study|Lost to Follow-up|2|||
128836840|NCT02830893|463699136|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
128836841|NCT02830893|463699137|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
128836842|NCT00647699|463699138|FG000|Overall Study|Lost to Follow-up|5|||
128836843|NCT00647699|463699139|FG001|Overall Study|Lost to Follow-up|4|||
128836844|NCT00647699|463699138|FG000|Overall Study|Withdrawal by Subject|3|||
128836845|NCT00647699|463699139|FG001|Overall Study|Withdrawal by Subject|8|||
128836846|NCT00413283|463699140|FG000|Overall Study|Withdrawal by Subject|1|||
128836847|NCT00413283|463699141|FG001|Overall Study|Withdrawal by Subject|0|||
128836848|NCT00413283|463699142|FG002|Overall Study|Withdrawal by Subject|0|||
128836849|NCT00413283|463699143|FG003|Overall Study|Withdrawal by Subject|1|||
128836850|NCT00413283|463699140|FG000|Overall Study|Death|0|||
128836851|NCT00413283|463699141|FG001|Overall Study|Death|0|||
128836852|NCT00413283|463699142|FG002|Overall Study|Death|1|||
128836853|NCT00413283|463699143|FG003|Overall Study|Death|1|||
128836854|NCT00413283|463699140|FG000|Overall Study|Adverse Event|0|||
128836855|NCT00413283|463699141|FG001|Overall Study|Adverse Event|0|||
128836856|NCT00413283|463699142|FG002|Overall Study|Adverse Event|0|||
128836857|NCT00413283|463699143|FG003|Overall Study|Adverse Event|1|||
128836858|NCT00413283|463699140|FG000|Overall Study|Ineligibility determined|0|||
128836859|NCT00413283|463699141|FG001|Overall Study|Ineligibility determined|0|||
128836860|NCT00413283|463699142|FG002|Overall Study|Ineligibility determined|0|||
128836861|NCT00413283|463699143|FG003|Overall Study|Ineligibility determined|1|||
128836862|NCT00413283|463699140|FG000|Overall Study|Protocol deviation|0|||
128836863|NCT00413283|463699141|FG001|Overall Study|Protocol deviation|1|||
128836864|NCT00413283|463699142|FG002|Overall Study|Protocol deviation|0|||
128836865|NCT00413283|463699143|FG003|Overall Study|Protocol deviation|0|||
128836866|NCT00413283|463699140|FG000|Overall Study|Requirement for alternative therapy|0|||
128836867|NCT00413283|463699141|FG001|Overall Study|Requirement for alternative therapy|2|||
128836868|NCT00413283|463699142|FG002|Overall Study|Requirement for alternative therapy|0|||
128836869|NCT00413283|463699143|FG003|Overall Study|Requirement for alternative therapy|0|||
128836870|NCT00413283|463699140|FG000|Overall Study|Other|0|||
128836871|NCT00413283|463699141|FG001|Overall Study|Other|0|||
128836872|NCT00413283|463699142|FG002|Overall Study|Other|1|||
128836873|NCT00413283|463699143|FG003|Overall Study|Other|0|||
128836874|NCT02354417|463699144|FG000|Overall Study|Physician Decision|1|||
128836875|NCT00246129|463699145|FG000|Overall Study|Lost to Follow-up|1|||
128836876|NCT00246129|463699146|FG001|Overall Study|Lost to Follow-up|0|||
128836877|NCT00246129|463699145|FG000|Overall Study|Death|2|||
128836878|NCT00246129|463699146|FG001|Overall Study|Death|1|||
128836879|NCT00246129|463699145|FG000|Overall Study|suffered primary non-function|1|||
128836880|NCT00246129|463699146|FG001|Overall Study|suffered primary non-function|0|||
128836881|NCT00246129|463699145|FG000|Overall Study|grafts failed|3|||
128836882|NCT00246129|463699146|FG001|Overall Study|grafts failed|1|||
128836883|NCT03469258|463699147|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
128836884|NCT00484198|463699151|FG000|Overall Study|Participant Withdrew Consent|12|||
128836885|NCT00484198|463699152|FG001|Overall Study|Participant Withdrew Consent|21|||
128836886|NCT00484198|463699153|FG002|Overall Study|Participant Withdrew Consent|47|||
128836887|NCT00484198|463699154|FG003|Overall Study|Participant Withdrew Consent|59|||
128836888|NCT00484198|463699151|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
128836889|NCT00484198|463699152|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
128836890|NCT00484198|463699153|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
128836891|NCT00484198|463699154|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
128836892|NCT00484198|463699151|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
128836893|NCT00484198|463699152|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
128836894|NCT00484198|463699153|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
128836895|NCT00484198|463699154|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
128836896|NCT00484198|463699151|FG000|Overall Study|Adverse Event|3|||
128836897|NCT00484198|463699152|FG001|Overall Study|Adverse Event|11|||
128836898|NCT00484198|463699153|FG002|Overall Study|Adverse Event|32|||
128836899|NCT00484198|463699154|FG003|Overall Study|Adverse Event|31|||
128836900|NCT00484198|463699151|FG000|Overall Study|Protocol Violation|0|||
128836901|NCT00484198|463699152|FG001|Overall Study|Protocol Violation|5|||
128836902|NCT00484198|463699153|FG002|Overall Study|Protocol Violation|6|||
128836903|NCT00484198|463699154|FG003|Overall Study|Protocol Violation|8|||
128836904|NCT00484198|463699151|FG000|Overall Study|Other|7|||
128836905|NCT00484198|463699152|FG001|Overall Study|Other|10|||
128836906|NCT00484198|463699153|FG002|Overall Study|Other|31|||
128836907|NCT00484198|463699154|FG003|Overall Study|Other|28|||
128836908|NCT03340961|463699155|FG000|Overall Study|Adverse Event|1|||
128836909|NCT03340961|463699156|FG001|Overall Study|Adverse Event|3|||
128836910|NCT03340961|463699157|FG002|Overall Study|Adverse Event|2|||
128836911|NCT03340961|463699158|FG003|Overall Study|Adverse Event|4|||
128836912|NCT03340961|463699155|FG000|Overall Study|Lost to Follow-up|0|||
128836913|NCT03340961|463699156|FG001|Overall Study|Lost to Follow-up|1|||
128836914|NCT03340961|463699157|FG002|Overall Study|Lost to Follow-up|0|||
128836915|NCT03340961|463699158|FG003|Overall Study|Lost to Follow-up|1|||
128836916|NCT03340961|463699155|FG000|Overall Study|Withdrawal by Subject|3|||
128836917|NCT03340961|463699156|FG001|Overall Study|Withdrawal by Subject|2|||
128836918|NCT03340961|463699157|FG002|Overall Study|Withdrawal by Subject|4|||
128836919|NCT03340961|463699158|FG003|Overall Study|Withdrawal by Subject|7|||
128836920|NCT03340961|463699155|FG000|Overall Study|Use of prohibited treatment|0|||
128836921|NCT03340961|463699156|FG001|Overall Study|Use of prohibited treatment|3|||
128836922|NCT03340961|463699157|FG002|Overall Study|Use of prohibited treatment|2|||
128836923|NCT03340961|463699158|FG003|Overall Study|Use of prohibited treatment|4|||
128836924|NCT03340961|463699155|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
128836925|NCT03340961|463699156|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
128836926|NCT03340961|463699157|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
128836927|NCT03340961|463699158|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
128836928|NCT03340961|463699155|FG000|Overall Study|Subject developed an exclusion criterion|0|||
128836929|NCT03340961|463699156|FG001|Overall Study|Subject developed an exclusion criterion|1|||
128836930|NCT03340961|463699157|FG002|Overall Study|Subject developed an exclusion criterion|0|||
128836931|NCT03340961|463699158|FG003|Overall Study|Subject developed an exclusion criterion|0|||
128836932|NCT03340961|463699155|FG000|Overall Study|Protocol Violation|1|||
128836933|NCT03340961|463699156|FG001|Overall Study|Protocol Violation|0|||
128836934|NCT03340961|463699157|FG002|Overall Study|Protocol Violation|1|||
128836935|NCT03340961|463699158|FG003|Overall Study|Protocol Violation|0|||
128836936|NCT03340961|463699155|FG000|Overall Study|Adverse Event|1|||
128836937|NCT03340961|463699156|FG001|Overall Study|Adverse Event|1|||
128836938|NCT03340961|463699157|FG002|Overall Study|Adverse Event|0|||
128836939|NCT03340961|463699158|FG003|Overall Study|Adverse Event|0|||
128836940|NCT03340961|463699155|FG000|Overall Study|Lack of Efficacy|0|||
128836941|NCT03340961|463699156|FG001|Overall Study|Lack of Efficacy|0|||
128836942|NCT03340961|463699157|FG002|Overall Study|Lack of Efficacy|0|||
128836943|NCT03340961|463699158|FG003|Overall Study|Lack of Efficacy|1|||
128836944|NCT01853384|463699159|FG000|Randomized|Adverse Event|5|||
128836945|NCT01853384|463699160|FG001|Randomized|Adverse Event|3|||
128836946|NCT01853384|463699159|FG000|Randomized|Death|1|||
128836947|NCT01853384|463699160|FG001|Randomized|Death|2|||
128836948|NCT01853384|463699159|FG000|Randomized|Lost to Follow-up|1|||
128836949|NCT01853384|463699160|FG001|Randomized|Lost to Follow-up|1|||
128836950|NCT01853384|463699159|FG000|Randomized|Withdrawal by Subject|5|||
128836951|NCT01853384|463699160|FG001|Randomized|Withdrawal by Subject|3|||
128836952|NCT01853384|463699159|FG000|Randomized|Sponsor Decision|47|||
128836953|NCT01853384|463699160|FG001|Randomized|Sponsor Decision|34|||
128836954|NCT01853384|463699159|FG000|Randomized|Other|3|||
128836955|NCT01853384|463699160|FG001|Randomized|Other|3|||
128836956|NCT01853384|463699159|FG000|Completed Follow up Visit 1|Early Termination|13|||
128836957|NCT01853384|463699160|FG001|Completed Follow up Visit 1|Early Termination|9|||
128836958|NCT01853384|463699159|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
128836959|NCT01853384|463699160|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
128836960|NCT01853384|463699159|FG000|Completed Follow up Visit 2|Adverse Event|1|||
128836961|NCT01853384|463699160|FG001|Completed Follow up Visit 2|Adverse Event|0|||
128836962|NCT01853384|463699159|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
128836963|NCT01853384|463699160|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
128836964|NCT01853384|463699159|FG000|Completed Follow up Visit 2|Death|1|||
128836965|NCT01853384|463699160|FG001|Completed Follow up Visit 2|Death|0|||
128836966|NCT01853384|463699159|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
128836967|NCT01853384|463699160|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
128836968|NCT01205126|463699161|FG000|Titration Phase|Adverse Event|5|||
128836969|NCT01205126|463699162|FG001|Titration Phase|Adverse Event|3|||
128836970|NCT01205126|463699161|FG000|Titration Phase|Withdrawal by Subject|5|||
128836971|NCT01205126|463699162|FG001|Titration Phase|Withdrawal by Subject|5|||
128836972|NCT01205126|463699161|FG000|Titration Phase|Lost to Follow-up|2|||
128836973|NCT01205126|463699162|FG001|Titration Phase|Lost to Follow-up|2|||
128836974|NCT01205126|463699161|FG000|Titration Phase|No stable titration dose|1|||
128836975|NCT01205126|463699162|FG001|Titration Phase|No stable titration dose|0|||
128836976|NCT01205126|463699161|FG000|Titration Phase|More than maximum dosage required|2|||
128836977|NCT01205126|463699162|FG001|Titration Phase|More than maximum dosage required|3|||
128836978|NCT01205126|463699161|FG000|Titration Phase|Other|8|||
128836979|NCT01205126|463699162|FG001|Titration Phase|Other|6|||
128836980|NCT01205126|463699161|FG000|Between Titration & Maintenance Phase|Other|0|||
128836981|NCT01205126|463699162|FG001|Between Titration & Maintenance Phase|Other|4|||
128836982|NCT01205126|463699161|FG000|Maintenance Phase|Adverse Event|3|||
128836983|NCT01205126|463699162|FG001|Maintenance Phase|Adverse Event|7|||
128836984|NCT01205126|463699161|FG000|Maintenance Phase|Death|4|||
128836985|NCT01205126|463699162|FG001|Maintenance Phase|Death|4|||
128836986|NCT01205126|463699161|FG000|Maintenance Phase|More than the maximum dosage required|5|||
128836987|NCT01205126|463699162|FG001|Maintenance Phase|More than the maximum dosage required|5|||
128836988|NCT01205126|463699161|FG000|Maintenance Phase|Prohibited drugs used|1|||
128836989|NCT01205126|463699162|FG001|Maintenance Phase|Prohibited drugs used|0|||
128836990|NCT01205126|463699161|FG000|Maintenance Phase|Other|11|||
128836991|NCT01205126|463699162|FG001|Maintenance Phase|Other|8|||
128836992|NCT01205126|463699161|FG000|Maintenance Phase|Lost to Follow-up|5|||
128836993|NCT01205126|463699162|FG001|Maintenance Phase|Lost to Follow-up|5|||
128836994|NCT01205126|463699161|FG000|Maintenance Phase|Withdrawal by Subject|8|||
128836995|NCT01205126|463699162|FG001|Maintenance Phase|Withdrawal by Subject|11|||
128836996|NCT00486954|463699163|FG000|Pilot Part|Adverse Event|4|||
128836997|NCT00486954|463699164|FG001|Pilot Part|Adverse Event|0|||
128836998|NCT00486954|463699165|FG002|Pilot Part|Adverse Event|5|||
128836999|NCT00486954|463699166|FG003|Pilot Part|Adverse Event|0|||
128837000|NCT00486954|463699167|FG004|Pilot Part|Adverse Event|0|||
128837001|NCT00486954|463699163|FG000|Pilot Part|Disease Progression|2|||
128837002|NCT00486954|463699164|FG001|Pilot Part|Disease Progression|0|||
128837003|NCT00486954|463699165|FG002|Pilot Part|Disease Progression|1|||
128837004|NCT00486954|463699166|FG003|Pilot Part|Disease Progression|0|||
128837005|NCT00486954|463699167|FG004|Pilot Part|Disease Progression|0|||
128837006|NCT00486954|463699163|FG000|Randomized Part|Lost to Follow-up|0|||
128837007|NCT00486954|463699164|FG001|Randomized Part|Lost to Follow-up|0|||
128837008|NCT00486954|463699165|FG002|Randomized Part|Lost to Follow-up|0|||
128837009|NCT00486954|463699166|FG003|Randomized Part|Lost to Follow-up|0|||
128837010|NCT00486954|463699167|FG004|Randomized Part|Lost to Follow-up|1|||
128837011|NCT00486954|463699163|FG000|Randomized Part|Withdrawal by Subject|0|||
128837012|NCT00486954|463699164|FG001|Randomized Part|Withdrawal by Subject|0|||
128837013|NCT00486954|463699165|FG002|Randomized Part|Withdrawal by Subject|0|||
128837014|NCT00486954|463699166|FG003|Randomized Part|Withdrawal by Subject|1|||
128837015|NCT00486954|463699167|FG004|Randomized Part|Withdrawal by Subject|0|||
128837016|NCT00486954|463699163|FG000|Randomized Part|Sponsor Terminated Study|0|||
128837017|NCT00486954|463699164|FG001|Randomized Part|Sponsor Terminated Study|0|||
128837018|NCT00486954|463699165|FG002|Randomized Part|Sponsor Terminated Study|0|||
128837019|NCT00486954|463699166|FG003|Randomized Part|Sponsor Terminated Study|19|||
128837020|NCT00486954|463699167|FG004|Randomized Part|Sponsor Terminated Study|13|||
128837021|NCT00638456|463699170|FG000|Overall Study|Withdrawal by Subject|6|||
128837022|NCT00638456|463699171|FG001|Overall Study|Withdrawal by Subject|2|||
128837023|NCT03236779|463699172|FG000|Overall Study|Lost to Follow-up|13|||
128837024|NCT03236779|463699173|FG001|Overall Study|Lost to Follow-up|21|||
128837025|NCT00805792|463699174|FG000|Overall Study|Death|3|||
128837026|NCT00805792|463699174|FG000|Overall Study|Lost to Follow-up|2|||
128837027|NCT01836523|463699175|FG000|Overall Study|Adverse Event|15|||
128837028|NCT01836523|463699176|FG001|Overall Study|Adverse Event|41|||
128837029|NCT01836523|463699177|FG002|Overall Study|Adverse Event|49|||
128837030|NCT01836523|463699178|FG003|Overall Study|Adverse Event|14|||
128837031|NCT01836523|463699175|FG000|Overall Study|Protocol Violation|6|||
128837032|NCT01836523|463699176|FG001|Overall Study|Protocol Violation|3|||
128837033|NCT01836523|463699177|FG002|Overall Study|Protocol Violation|2|||
128837034|NCT01836523|463699178|FG003|Overall Study|Protocol Violation|4|||
128837035|NCT01836523|463699175|FG000|Overall Study|Met Withdrawal Criteria|13|||
128837036|NCT01836523|463699176|FG001|Overall Study|Met Withdrawal Criteria|13|||
128837037|NCT01836523|463699177|FG002|Overall Study|Met Withdrawal Criteria|21|||
128837038|NCT01836523|463699178|FG003|Overall Study|Met Withdrawal Criteria|27|||
128837039|NCT01836523|463699175|FG000|Overall Study|Unclassified|17|||
128837040|NCT01836523|463699176|FG001|Overall Study|Unclassified|28|||
128837041|NCT01836523|463699177|FG002|Overall Study|Unclassified|19|||
128837042|NCT01836523|463699178|FG003|Overall Study|Unclassified|29|||
128837043|NCT00813709|463699182|FG000|Double Blind Period|Adverse Event|4|||
128837044|NCT00813709|463699183|FG001|Double Blind Period|Adverse Event|1|||
128837045|NCT00813709|463699184|FG002|Double Blind Period|Adverse Event|4|||
128837046|NCT00813709|463699185|FG003|Double Blind Period|Adverse Event|0|||
128837047|NCT00813709|463699186|FG004|Double Blind Period|Adverse Event|0|||
128837048|NCT00813709|463699187|FG005|Double Blind Period|Adverse Event|0|||
128837049|NCT00813709|463699182|FG000|Double Blind Period|Lost to Follow-up|3|||
128837050|NCT00813709|463699183|FG001|Double Blind Period|Lost to Follow-up|2|||
128837051|NCT00813709|463699184|FG002|Double Blind Period|Lost to Follow-up|2|||
128837052|NCT00813709|463699185|FG003|Double Blind Period|Lost to Follow-up|0|||
128837053|NCT00813709|463699186|FG004|Double Blind Period|Lost to Follow-up|0|||
128837054|NCT00813709|463699187|FG005|Double Blind Period|Lost to Follow-up|0|||
128837055|NCT00813709|463699182|FG000|Double Blind Period|Switched to open label phase|9|||
128837056|NCT00813709|463699183|FG001|Double Blind Period|Switched to open label phase|26|||
128837057|NCT00813709|463699184|FG002|Double Blind Period|Switched to open label phase|18|||
128837058|NCT00813709|463699185|FG003|Double Blind Period|Switched to open label phase|0|||
128837059|NCT00813709|463699186|FG004|Double Blind Period|Switched to open label phase|0|||
128837060|NCT00813709|463699187|FG005|Double Blind Period|Switched to open label phase|0|||
128837061|NCT00813709|463699182|FG000|Double Blind Period|Randomized but not treated|1|||
128837062|NCT00813709|463699183|FG001|Double Blind Period|Randomized but not treated|3|||
128837063|NCT00813709|463699184|FG002|Double Blind Period|Randomized but not treated|1|||
128837064|NCT00813709|463699185|FG003|Double Blind Period|Randomized but not treated|0|||
128837065|NCT00813709|463699186|FG004|Double Blind Period|Randomized but not treated|0|||
128837066|NCT00813709|463699187|FG005|Double Blind Period|Randomized but not treated|0|||
128837067|NCT00813709|463699182|FG000|Double Blind Period|Other|14|||
128837068|NCT00813709|463699183|FG001|Double Blind Period|Other|9|||
128837069|NCT00813709|463699184|FG002|Double Blind Period|Other|6|||
128837070|NCT00813709|463699185|FG003|Double Blind Period|Other|0|||
128837071|NCT00813709|463699186|FG004|Double Blind Period|Other|0|||
128837072|NCT00813709|463699187|FG005|Double Blind Period|Other|0|||
128837073|NCT00813709|463699182|FG000|Open Label Period|Adverse Event|0|||
128837074|NCT00813709|463699183|FG001|Open Label Period|Adverse Event|0|||
128837075|NCT00813709|463699184|FG002|Open Label Period|Adverse Event|0|||
128837076|NCT00813709|463699185|FG003|Open Label Period|Adverse Event|5|||
128837077|NCT00813709|463699186|FG004|Open Label Period|Adverse Event|4|||
128837078|NCT00813709|463699187|FG005|Open Label Period|Adverse Event|3|||
128837079|NCT00813709|463699182|FG000|Open Label Period|Lack of Efficacy|0|||
128837080|NCT00813709|463699183|FG001|Open Label Period|Lack of Efficacy|0|||
128837081|NCT00813709|463699184|FG002|Open Label Period|Lack of Efficacy|0|||
128837082|NCT00813709|463699185|FG003|Open Label Period|Lack of Efficacy|3|||
128837083|NCT00813709|463699186|FG004|Open Label Period|Lack of Efficacy|1|||
128837084|NCT00813709|463699187|FG005|Open Label Period|Lack of Efficacy|1|||
128837085|NCT00813709|463699182|FG000|Open Label Period|Randomized but not treated|0|||
128837086|NCT00813709|463699183|FG001|Open Label Period|Randomized but not treated|0|||
128837087|NCT00813709|463699184|FG002|Open Label Period|Randomized but not treated|0|||
128837088|NCT00813709|463699185|FG003|Open Label Period|Randomized but not treated|1|||
128837089|NCT00813709|463699186|FG004|Open Label Period|Randomized but not treated|0|||
128837090|NCT00813709|463699187|FG005|Open Label Period|Randomized but not treated|1|||
128837091|NCT00813709|463699182|FG000|Open Label Period|Other|0|||
128837092|NCT00813709|463699183|FG001|Open Label Period|Other|0|||
128837093|NCT00813709|463699184|FG002|Open Label Period|Other|0|||
128837094|NCT00813709|463699185|FG003|Open Label Period|Other|11|||
128837095|NCT00813709|463699186|FG004|Open Label Period|Other|5|||
128837096|NCT00813709|463699187|FG005|Open Label Period|Other|6|||
128837097|NCT02753075|463699188|FG000|Overall Study|Adverse Event|2|||
128837098|NCT02753075|463699189|FG001|Overall Study|Adverse Event|1|||
128837099|NCT02753075|463699190|FG002|Overall Study|Adverse Event|0|||
128837100|NCT02753075|463699188|FG000|Overall Study|Lost to Follow-up|2|||
128837101|NCT02753075|463699189|FG001|Overall Study|Lost to Follow-up|0|||
128837102|NCT02753075|463699190|FG002|Overall Study|Lost to Follow-up|0|||
128837103|NCT02753075|463699188|FG000|Overall Study|Withdrawal of Consent|1|||
128837104|NCT02753075|463699189|FG001|Overall Study|Withdrawal of Consent|1|||
128837105|NCT02753075|463699190|FG002|Overall Study|Withdrawal of Consent|3|||
128837106|NCT02753075|463699188|FG000|Overall Study|Physician Decision|3|||
128837107|NCT02753075|463699189|FG001|Overall Study|Physician Decision|1|||
128837108|NCT02753075|463699190|FG002|Overall Study|Physician Decision|0|||
128837109|NCT00603798|463699191|FG000|Overall Study|Adverse Event|4|||
128837110|NCT00603798|463699192|FG001|Overall Study|Adverse Event|2|||
128837111|NCT00603798|463699193|FG002|Overall Study|Adverse Event|1|||
128837112|NCT00603798|463699191|FG000|Overall Study|Withdrawal by Subject|4|||
128837113|NCT00603798|463699192|FG001|Overall Study|Withdrawal by Subject|3|||
128837114|NCT00603798|463699193|FG002|Overall Study|Withdrawal by Subject|4|||
128837115|NCT00603798|463699191|FG000|Overall Study|Lost to Follow-up|1|||
128837116|NCT00603798|463699192|FG001|Overall Study|Lost to Follow-up|0|||
128837117|NCT00603798|463699193|FG002|Overall Study|Lost to Follow-up|1|||
128837118|NCT00603798|463699191|FG000|Overall Study|Non-compliance with study procedures|0|||
128837119|NCT00603798|463699192|FG001|Overall Study|Non-compliance with study procedures|1|||
128837120|NCT00603798|463699193|FG002|Overall Study|Non-compliance with study procedures|0|||
128837121|NCT00603798|463699191|FG000|Overall Study|Not due to AE|1|||
128837122|NCT00603798|463699192|FG001|Overall Study|Not due to AE|1|||
128837123|NCT00603798|463699193|FG002|Overall Study|Not due to AE|4|||
128837124|NCT02245620|463699194|FG000|Overall Study|Physician Decision|1|||
128837125|NCT02245620|463699195|FG001|Overall Study|Physician Decision|1|||
128837126|NCT01102426|463699196|FG000|Overall Study|Randomized but not treated|4|||
128837127|NCT01102426|463699197|FG001|Overall Study|Randomized but not treated|1|||
128837128|NCT01102426|463699196|FG000|Overall Study|Adverse Events (treatment-related)|15|||
128837129|NCT01102426|463699197|FG001|Overall Study|Adverse Events (treatment-related)|8|||
128837130|NCT01102426|463699196|FG000|Overall Study|Physician Decision|9|||
128837131|NCT01102426|463699197|FG001|Overall Study|Physician Decision|6|||
128837132|NCT01102426|463699196|FG000|Overall Study|Progressive Disease|85|||
128837133|NCT01102426|463699197|FG001|Overall Study|Progressive Disease|44|||
128837134|NCT01102426|463699196|FG000|Overall Study|Adverse Events (unrelated to|9|||
128837135|NCT01102426|463699197|FG001|Overall Study|Adverse Events (unrelated to|1|||
128837136|NCT01102426|463699196|FG000|Overall Study|Patient Refusal|24|||
128837137|NCT01102426|463699197|FG001|Overall Study|Patient Refusal|12|||
128837138|NCT01102426|463699196|FG000|Overall Study|Death (due to adverse events|0|||
128837139|NCT01102426|463699197|FG001|Overall Study|Death (due to adverse events|1|||
128837140|NCT01102426|463699196|FG000|Overall Study|Death (non-related to the study|19|||
128837141|NCT01102426|463699197|FG001|Overall Study|Death (non-related to the study|8|||
128837142|NCT04361617|463699198|FG000|Overall Study|Withdrawal by Subject|0|||
128837143|NCT04361617|463699199|FG001|Overall Study|Withdrawal by Subject|1|||
128837144|NCT03265132|463699206|FG000|Overall Study|Adverse Event|0|||
128837145|NCT03265132|463699207|FG001|Overall Study|Adverse Event|1|||
128837146|NCT03265132|463699206|FG000|Overall Study|Lack of Efficacy|0|||
128837147|NCT03265132|463699207|FG001|Overall Study|Lack of Efficacy|2|||
128837148|NCT03265132|463699206|FG000|Overall Study|Progressive disease|0|||
128837149|NCT03265132|463699207|FG001|Overall Study|Progressive disease|2|||
128837150|NCT03265132|463699206|FG000|Overall Study|Withdrawal by Subject|0|||
128837151|NCT03265132|463699207|FG001|Overall Study|Withdrawal by Subject|1|||
128837152|NCT00088166|463699208|FG000|Overall Study|Adverse Event|11|||
128837153|NCT00088166|463699209|FG001|Overall Study|Adverse Event|9|||
128837154|NCT00088166|463699208|FG000|Overall Study|Death|3|||
128837155|NCT00088166|463699209|FG001|Overall Study|Death|1|||
128837156|NCT00088166|463699208|FG000|Overall Study|Lost to Follow-up|0|||
128837157|NCT00088166|463699209|FG001|Overall Study|Lost to Follow-up|1|||
128837158|NCT00088166|463699208|FG000|Overall Study|Physician Decision|4|||
128837159|NCT00088166|463699209|FG001|Overall Study|Physician Decision|1|||
128837160|NCT00088166|463699208|FG000|Overall Study|Protocol Violation|1|||
128837161|NCT00088166|463699209|FG001|Overall Study|Protocol Violation|5|||
128837162|NCT00088166|463699208|FG000|Overall Study|Patient deterioration|29|||
128837163|NCT00088166|463699209|FG001|Overall Study|Patient deterioration|39|||
128837164|NCT00088166|463699208|FG000|Overall Study|Withdrawal by Subject|5|||
128837165|NCT00088166|463699209|FG001|Overall Study|Withdrawal by Subject|5|||
128837166|NCT00666705|463699210|FG000|Overall Study|Withdrawal by Subject|1|||
128837167|NCT00687297|463699211|FG000|Randomization|Withdrawal by Subject|2|||
128837168|NCT00687297|463699212|FG001|Randomization|Withdrawal by Subject|0|||
128837169|NCT00687297|463699211|FG000|Randomization|Withdrew before treatment, ineligible|1|||
128837170|NCT00687297|463699212|FG001|Randomization|Withdrew before treatment, ineligible|1|||
128837171|NCT00687297|463699211|FG000|Induction|Withdrawal by Subject|4|||
128837172|NCT00687297|463699212|FG001|Induction|Withdrawal by Subject|4|||
128837173|NCT00687297|463699211|FG000|Induction|Adverse Event|16|||
128837174|NCT00687297|463699212|FG001|Induction|Adverse Event|15|||
128837175|NCT00687297|463699211|FG000|Induction|Death|7|||
128837176|NCT00687297|463699212|FG001|Induction|Death|11|||
128837177|NCT00687297|463699211|FG000|Induction|Lack of Efficacy|17|||
128837178|NCT00687297|463699212|FG001|Induction|Lack of Efficacy|21|||
128837179|NCT00687297|463699211|FG000|Induction|Ineligible|0|||
128837180|NCT00687297|463699212|FG001|Induction|Ineligible|1|||
128837181|NCT00687297|463699211|FG000|Induction|Patient Noncompliance|1|||
128837182|NCT00687297|463699212|FG001|Induction|Patient Noncompliance|0|||
128837183|NCT00687297|463699211|FG000|Induction|Physician Decision|0|||
128837184|NCT00687297|463699212|FG001|Induction|Physician Decision|2|||
128837185|NCT00687297|463699211|FG000|Induction|Other|0|||
128837186|NCT00687297|463699212|FG001|Induction|Other|1|||
128837187|NCT01109979|463699213|FG000|Overall Study|Physician Decision|2|||
128837188|NCT01109979|463699214|FG001|Overall Study|Physician Decision|0|||
128837189|NCT01109979|463699213|FG000|Overall Study|Withdrawal by Subject|0|||
128837190|NCT01109979|463699214|FG001|Overall Study|Withdrawal by Subject|1|||
128837191|NCT01228734|463699215|FG000|Overall Study|Randomized, but not treated|0|||
128837192|NCT01228734|463699216|FG001|Overall Study|Randomized, but not treated|4|||
128837193|NCT03128099|463699217|FG000|Overall Study|High dose task was too long|0|||
128837194|NCT03128099|463699218|FG001|Overall Study|High dose task was too long|4|||
128837195|NCT03128099|463699219|FG002|Overall Study|High dose task was too long|0|||
128837196|NCT03128099|463699217|FG000|Overall Study|Participant got a full time job.|1|||
128837197|NCT03128099|463699218|FG001|Overall Study|Participant got a full time job.|0|||
128837198|NCT03128099|463699219|FG002|Overall Study|Participant got a full time job.|0|||
128837199|NCT03128099|463699217|FG000|Overall Study|Became homeless and lost contact|1|||
128837200|NCT03128099|463699218|FG001|Overall Study|Became homeless and lost contact|0|||
128837201|NCT03128099|463699219|FG002|Overall Study|Became homeless and lost contact|0|||
128837202|NCT03128099|463699217|FG000|Overall Study|Did not complete all the assessments|0|||
128837203|NCT03128099|463699218|FG001|Overall Study|Did not complete all the assessments|0|||
128837204|NCT03128099|463699219|FG002|Overall Study|Did not complete all the assessments|1|||
128837205|NCT03456856|463699220|FG000|Overall Study|Lost to Follow-up|2|||
128837206|NCT03456856|463699220|FG000|Overall Study|Withdrawal by Subject|1|||
128837207|NCT02542696|463699225|FG000|Overall Study|Adverse Event|167|||
128837208|NCT02542696|463699225|FG000|Overall Study|Lack of Efficacy|26|||
128837209|NCT02542696|463699225|FG000|Overall Study|Lost to Follow-up|6|||
128837210|NCT02542696|463699225|FG000|Overall Study|Withdrawal by Subject|104|||
128837211|NCT02542696|463699225|FG000|Overall Study|Protocol Violation|5|||
128837212|NCT02542696|463699225|FG000|Overall Study|Death|8|||
128837213|NCT02542696|463699225|FG000|Overall Study|DECREASED OFF TIME|1|||
128837214|NCT02542696|463699225|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
128837215|NCT02542696|463699225|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
128837216|NCT02542696|463699225|FG000|Overall Study|MEDICAL HISTORY|1|||
128870726|NCT00338962|463820701|FG000|Overall Study|Withdrawal by Subject|1|||
128837217|NCT02542696|463699225|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
128837218|NCT02542696|463699225|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
128837219|NCT02542696|463699225|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
128837220|NCT02542696|463699225|FG000|Overall Study|SPONSOR DECISION|3|||
128837221|NCT02542696|463699225|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
128837222|NCT02542696|463699225|FG000|Overall Study|SUBJECT DECISION|2|||
128837223|NCT02137785|463699229|FG000|Overall Study|Lost to Follow-up|1|||
128837224|NCT02137785|463699230|FG001|Overall Study|Lost to Follow-up|0|||
128837225|NCT02137785|463699229|FG000|Overall Study|Withdrawal by Subject|1|||
128837226|NCT02137785|463699230|FG001|Overall Study|Withdrawal by Subject|4|||
128837227|NCT02137785|463699229|FG000|Overall Study|subject moved out of state|1|||
128837228|NCT02137785|463699230|FG001|Overall Study|subject moved out of state|0|||
128837229|NCT03390166|463699231|FG000|Overall Study|Death|0|||
128837230|NCT03390166|463699232|FG001|Overall Study|Death|1|||
128837231|NCT03390166|463699231|FG000|Overall Study|Lost to Follow-up|6|||
128837232|NCT03390166|463699232|FG001|Overall Study|Lost to Follow-up|4|||
128837233|NCT03390166|463699231|FG000|Overall Study|Physician Decision|2|||
128837234|NCT03390166|463699232|FG001|Overall Study|Physician Decision|1|||
128837235|NCT03390166|463699231|FG000|Overall Study|Move from study area|3|||
128837236|NCT03390166|463699232|FG001|Overall Study|Move from study area|2|||
128837237|NCT03390166|463699231|FG000|Overall Study|To militarycamp for conscript|1|||
128837238|NCT03390166|463699232|FG001|Overall Study|To militarycamp for conscript|0|||
128837239|NCT03390166|463699231|FG000|Overall Study|To drug therapy course|0|||
128837240|NCT03390166|463699232|FG001|Overall Study|To drug therapy course|1|||
128837241|NCT03390166|463699231|FG000|Overall Study|Move to work oversea|0|||
128837242|NCT03390166|463699232|FG001|Overall Study|Move to work oversea|1|||
128837243|NCT01137682|463699235|FG000|Overall Study|Adverse Event-CORE|2|||
128837244|NCT01137682|463699236|FG001|Overall Study|Adverse Event-CORE|4|||
128837245|NCT01137682|463699237|FG002|Overall Study|Adverse Event-CORE|0|||
128837246|NCT01137682|463699235|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
128837247|NCT01137682|463699236|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
128837248|NCT01137682|463699237|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
128837249|NCT01137682|463699235|FG000|Overall Study|Administrative problems-CORE|2|||
128837250|NCT01137682|463699236|FG001|Overall Study|Administrative problems-CORE|1|||
128837251|NCT01137682|463699237|FG002|Overall Study|Administrative problems-CORE|0|||
128837252|NCT01137682|463699235|FG000|Overall Study|Protocol Violation-CORE|0|||
128837253|NCT01137682|463699236|FG001|Overall Study|Protocol Violation-CORE|1|||
128837254|NCT01137682|463699237|FG002|Overall Study|Protocol Violation-CORE|1|||
128837255|NCT01137682|463699235|FG000|Overall Study|Adverse Event-Extension|4|||
128837256|NCT01137682|463699236|FG001|Overall Study|Adverse Event-Extension|8|||
128837257|NCT01137682|463699237|FG002|Overall Study|Adverse Event-Extension|7|||
128837258|NCT01137682|463699235|FG000|Overall Study|Lack of Efficacy-Extension|15|||
128837259|NCT01137682|463699236|FG001|Overall Study|Lack of Efficacy-Extension|9|||
128837260|NCT01137682|463699237|FG002|Overall Study|Lack of Efficacy-Extension|13|||
128837261|NCT01137682|463699235|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
128837262|NCT01137682|463699236|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
128837263|NCT01137682|463699237|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
128837264|NCT01137682|463699235|FG000|Overall Study|Lost to Follow Up-Extension|0|||
128837265|NCT01137682|463699236|FG001|Overall Study|Lost to Follow Up-Extension|1|||
128837266|NCT01137682|463699237|FG002|Overall Study|Lost to Follow Up-Extension|0|||
128837267|NCT01137682|463699235|FG000|Overall Study|Administrative problems-Extension|0|||
128837268|NCT01137682|463699236|FG001|Overall Study|Administrative problems-Extension|2|||
128837269|NCT01137682|463699237|FG002|Overall Study|Administrative problems-Extension|0|||
128837270|NCT01137682|463699235|FG000|Overall Study|Death-Extension|2|||
128837271|NCT01137682|463699236|FG001|Overall Study|Death-Extension|0|||
128837272|NCT01137682|463699237|FG002|Overall Study|Death-Extension|0|||
128837273|NCT01137682|463699235|FG000|Overall Study|Protocol Violation-Extension|2|||
128837274|NCT01137682|463699236|FG001|Overall Study|Protocol Violation-Extension|1|||
128837275|NCT01137682|463699237|FG002|Overall Study|Protocol Violation-Extension|0|||
128837276|NCT01137682|463699235|FG000|Overall Study|Did not enter extension|2|||
128837277|NCT01137682|463699236|FG001|Overall Study|Did not enter extension|3|||
128837278|NCT01137682|463699237|FG002|Overall Study|Did not enter extension|2|||
128837279|NCT01137682|463699235|FG000|Overall Study|Did not receive treatment in extension|0|||
128837280|NCT01137682|463699236|FG001|Overall Study|Did not receive treatment in extension|0|||
128837281|NCT01137682|463699237|FG002|Overall Study|Did not receive treatment in extension|1|||
128837282|NCT04617847|463699239|FG000|Overall Study|Withdrawal by Subject|1|||
128837283|NCT04617847|463699240|FG001|Overall Study|Withdrawal by Subject|0|||
128837284|NCT04617847|463699239|FG000|Overall Study|Adverse Event|0|||
128837285|NCT04617847|463699240|FG001|Overall Study|Adverse Event|2|||
128837286|NCT04617847|463699239|FG000|Overall Study|Death|0|||
128837287|NCT04617847|463699240|FG001|Overall Study|Death|1|||
128837288|NCT04617847|463699239|FG000|Overall Study|Termination of Study by Sponsor|2|||
128837289|NCT04617847|463699240|FG001|Overall Study|Termination of Study by Sponsor|21|||
128837290|NCT00244751|463699241|FG000|Overall Study|Adverse Event|7|||
128837291|NCT00244751|463699242|FG001|Overall Study|Adverse Event|7|||
128837292|NCT00244751|463699243|FG002|Overall Study|Adverse Event|5|||
128837293|NCT00244751|463699241|FG000|Overall Study|Lost to Follow-up|0|||
128837294|NCT00244751|463699242|FG001|Overall Study|Lost to Follow-up|1|||
128837295|NCT00244751|463699243|FG002|Overall Study|Lost to Follow-up|0|||
128837296|NCT00244751|463699241|FG000|Overall Study|Protocol Violation|1|||
128837297|NCT00244751|463699242|FG001|Overall Study|Protocol Violation|0|||
128837298|NCT00244751|463699243|FG002|Overall Study|Protocol Violation|1|||
128837299|NCT00244751|463699241|FG000|Overall Study|Withdrawal by Subject|7|||
128837300|NCT00244751|463699242|FG001|Overall Study|Withdrawal by Subject|5|||
128837301|NCT00244751|463699243|FG002|Overall Study|Withdrawal by Subject|3|||
128837302|NCT00244751|463699241|FG000|Overall Study|Elevated liver enzymes|1|||
128837303|NCT00244751|463699242|FG001|Overall Study|Elevated liver enzymes|0|||
128837304|NCT00244751|463699243|FG002|Overall Study|Elevated liver enzymes|0|||
128837305|NCT00244751|463699241|FG000|Overall Study|Lack of compliance with protocol|0|||
128837306|NCT00244751|463699242|FG001|Overall Study|Lack of compliance with protocol|1|||
128837307|NCT00244751|463699243|FG002|Overall Study|Lack of compliance with protocol|0|||
128837308|NCT00244751|463699241|FG000|Overall Study|Safety reasons|0|||
128837309|NCT00244751|463699242|FG001|Overall Study|Safety reasons|1|||
128837310|NCT00244751|463699243|FG002|Overall Study|Safety reasons|0|||
128837311|NCT00244751|463699241|FG000|Overall Study|Participant randomized by mistake|0|||
128837312|NCT00244751|463699242|FG001|Overall Study|Participant randomized by mistake|0|||
128837313|NCT00244751|463699243|FG002|Overall Study|Participant randomized by mistake|1|||
128837314|NCT01262456|463699245|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
128837315|NCT01262456|463699246|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
128837316|NCT01262456|463699247|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
128837317|NCT01262456|463699245|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
128837318|NCT01262456|463699246|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
128837319|NCT01262456|463699247|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
128837320|NCT01262456|463699245|FG000|3-Month Double-Blind Period|Adverse Event|6|||
128837321|NCT01262456|463699246|FG001|3-Month Double-Blind Period|Adverse Event|4|||
128837322|NCT01262456|463699247|FG002|3-Month Double-Blind Period|Adverse Event|8|||
128837323|NCT01262456|463699245|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
128837324|NCT01262456|463699246|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
128837325|NCT01262456|463699247|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
128837326|NCT01262456|463699245|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
128837327|NCT01262456|463699246|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
128837328|NCT01262456|463699247|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
128837329|NCT01262456|463699245|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
128837330|NCT01262456|463699246|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
128837331|NCT01262456|463699247|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
128837332|NCT01262456|463699245|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
128837333|NCT01262456|463699246|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
128837334|NCT01262456|463699247|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
128837335|NCT01262456|463699245|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
128837336|NCT01262456|463699246|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
128837337|NCT01262456|463699247|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
128837338|NCT01262456|463699245|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
128837339|NCT01262456|463699246|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
128837340|NCT01262456|463699247|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
128837341|NCT04085614|463699248|FG000|Overall Study|Protocol Violation|9|||
128837342|NCT04085614|463699249|FG001|Overall Study|Protocol Violation|6|||
128837343|NCT02399449|463699250|FG000|Overall Study|Withdrawal by Subject|3|||
128837344|NCT02399449|463699251|FG001|Overall Study|Withdrawal by Subject|9|||
128837345|NCT02399449|463699250|FG000|Overall Study|Physician Decision|0|||
128837346|NCT02399449|463699251|FG001|Overall Study|Physician Decision|1|||
128837347|NCT02516202|463699252|FG000|Overall Study|Withdrawal by Subject|1|||
128837348|NCT02516202|463699253|FG001|Overall Study|Withdrawal by Subject|0|||
128837349|NCT02516202|463699254|FG002|Overall Study|Withdrawal by Subject|1|||
128837350|NCT02516202|463699252|FG000|Overall Study|Lost to Follow-up|1|||
128837351|NCT02516202|463699253|FG001|Overall Study|Lost to Follow-up|1|||
128837352|NCT02516202|463699254|FG002|Overall Study|Lost to Follow-up|1|||
128837353|NCT02516202|463699252|FG000|Overall Study|Stopped Follow-up|0|||
128837354|NCT02516202|463699253|FG001|Overall Study|Stopped Follow-up|0|||
128837355|NCT02516202|463699254|FG002|Overall Study|Stopped Follow-up|1|||
128837356|NCT00337610|463699255|FG000|Overall Study|Adverse Event|2|||
128837357|NCT00337610|463699256|FG001|Overall Study|Adverse Event|2|||
128837358|NCT00337610|463699255|FG000|Overall Study|Death|0|||
128837359|NCT00337610|463699256|FG001|Overall Study|Death|1|||
128837360|NCT00337610|463699255|FG000|Overall Study|Lack of Efficacy|6|||
128837361|NCT00337610|463699256|FG001|Overall Study|Lack of Efficacy|3|||
128837362|NCT00337610|463699255|FG000|Overall Study|Lost to Follow-up|3|||
128837363|NCT00337610|463699256|FG001|Overall Study|Lost to Follow-up|3|||
128837364|NCT00337610|463699255|FG000|Overall Study|Withdrawal by Subject|6|||
128837365|NCT00337610|463699256|FG001|Overall Study|Withdrawal by Subject|5|||
128837366|NCT04867382|463699259|FG000|Overall Study|Did not complete the survey|2|||
128837367|NCT04867382|463699260|FG001|Overall Study|Did not complete the survey|1|||
128837368|NCT01079949|463699268|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
128837369|NCT01079949|463699269|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
128837370|NCT01079949|463699268|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
128837371|NCT01079949|463699269|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
128837372|NCT01079949|463699268|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
128837373|NCT01079949|463699269|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
128837374|NCT01079949|463699268|FG000|Overall Study|Randomized but not treated|1|||
128837375|NCT01079949|463699269|FG001|Overall Study|Randomized but not treated|0|||
128837376|NCT02144285|463699270|FG000|Overall Study|Withdrawal by Subject|0|||
128837377|NCT02144285|463699271|FG001|Overall Study|Withdrawal by Subject|0|||
128837378|NCT02144285|463699272|FG002|Overall Study|Withdrawal by Subject|0|||
128837379|NCT02144285|463699273|FG003|Overall Study|Withdrawal by Subject|0|||
128837380|NCT02144285|463699274|FG004|Overall Study|Withdrawal by Subject|1|||
128837381|NCT02144285|463699275|FG005|Overall Study|Withdrawal by Subject|0|||
128837382|NCT02144285|463699276|FG006|Overall Study|Withdrawal by Subject|0|||
128837383|NCT02144285|463699277|FG007|Overall Study|Withdrawal by Subject|0|||
128837384|NCT02144285|463699278|FG008|Overall Study|Withdrawal by Subject|0|||
128837385|NCT02144285|463699279|FG009|Overall Study|Withdrawal by Subject|0|||
128837386|NCT01529632|463699280|FG000|Overall Study|Administrative problem|2|||
128837387|NCT01529632|463699281|FG001|Overall Study|Administrative problem|1|||
128837388|NCT01529632|463699280|FG000|Overall Study|Protocol Violation|0|||
128837389|NCT01529632|463699281|FG001|Overall Study|Protocol Violation|1|||
128837390|NCT01529632|463699280|FG000|Overall Study|Adverse Event|1|||
128837391|NCT01529632|463699281|FG001|Overall Study|Adverse Event|1|||
128837392|NCT03786471|463699282|FG000|Overall Study|Death|254|||
128837393|NCT03786471|463699283|FG001|Overall Study|Death|223|||
128837394|NCT03786471|463699284|FG002|Overall Study|Death|37|||
128837395|NCT03786471|463699282|FG000|Overall Study|Lost to Follow-up|63|||
128837396|NCT03786471|463699283|FG001|Overall Study|Lost to Follow-up|50|||
128837397|NCT03786471|463699284|FG002|Overall Study|Lost to Follow-up|15|||
128837398|NCT03786471|463699282|FG000|Overall Study|Withdrawal by Subject|99|||
128837399|NCT03786471|463699283|FG001|Overall Study|Withdrawal by Subject|81|||
128837400|NCT03786471|463699284|FG002|Overall Study|Withdrawal by Subject|11|||
128837401|NCT00747149|463700749|FG000|Overall Study|Adverse Event|0|||
128837402|NCT00747149|463700750|FG001|Overall Study|Adverse Event|15|||
128837403|NCT00747149|463700749|FG000|Overall Study|Lost to Follow-up|0|||
128837404|NCT00747149|463700750|FG001|Overall Study|Lost to Follow-up|10|||
128837405|NCT00747149|463700749|FG000|Overall Study|Withdrawal by Subject|0|||
128837406|NCT00747149|463700750|FG001|Overall Study|Withdrawal by Subject|6|||
128837407|NCT00747149|463700749|FG000|Overall Study|Did not receive treatment|0|||
128837408|NCT00747149|463700750|FG001|Overall Study|Did not receive treatment|1|||
128837409|NCT00747149|463700749|FG000|Overall Study|Incorrect enrollment|0|||
128837410|NCT00747149|463700750|FG001|Overall Study|Incorrect enrollment|6|||
128837411|NCT00747149|463700749|FG000|Overall Study|Severe non-compliance to protocol|0|||
128837412|NCT00747149|463700750|FG001|Overall Study|Severe non-compliance to protocol|1|||
128837413|NCT00747149|463700749|FG000|Overall Study|Not reported|1|||
128837414|NCT00747149|463700750|FG001|Overall Study|Not reported|4|||
128837415|NCT01276509|463700753|FG000|Overall Study|Adverse Event|9|||
128837416|NCT01276509|463700754|FG001|Overall Study|Adverse Event|8|||
128837417|NCT01276509|463700755|FG002|Overall Study|Adverse Event|4|||
128837418|NCT01276509|463700756|FG003|Overall Study|Adverse Event|3|||
128837419|NCT01276509|463700753|FG000|Overall Study|Lack of Efficacy|2|||
128837420|NCT01276509|463700754|FG001|Overall Study|Lack of Efficacy|1|||
128837421|NCT01276509|463700755|FG002|Overall Study|Lack of Efficacy|1|||
128837422|NCT01276509|463700756|FG003|Overall Study|Lack of Efficacy|2|||
128837423|NCT01276509|463700753|FG000|Overall Study|Pregnancy|1|||
128837424|NCT01276509|463700754|FG001|Overall Study|Pregnancy|0|||
128837425|NCT01276509|463700755|FG002|Overall Study|Pregnancy|0|||
128837426|NCT01276509|463700756|FG003|Overall Study|Pregnancy|0|||
128837427|NCT01276509|463700753|FG000|Overall Study|Withdrawal by Subject|1|||
128837428|NCT01276509|463700754|FG001|Overall Study|Withdrawal by Subject|2|||
128837429|NCT01276509|463700755|FG002|Overall Study|Withdrawal by Subject|0|||
128837430|NCT01276509|463700756|FG003|Overall Study|Withdrawal by Subject|0|||
128837431|NCT01276509|463700753|FG000|Overall Study|Other|0|||
128837432|NCT01276509|463700754|FG001|Overall Study|Other|1|||
128837433|NCT01276509|463700755|FG002|Overall Study|Other|0|||
128837434|NCT01276509|463700756|FG003|Overall Study|Other|0|||
128837435|NCT02196259|463700760|FG000|Overall Study|Researcher choice|0|||
128837436|NCT02196259|463700761|FG001|Overall Study|Researcher choice|0|||
128837437|NCT02196259|463700762|FG002|Overall Study|Researcher choice|1|||
128837438|NCT02196259|463700760|FG000|Overall Study|Partial data analysis|0|||
128837439|NCT02196259|463700761|FG001|Overall Study|Partial data analysis|3|||
128837440|NCT02196259|463700762|FG002|Overall Study|Partial data analysis|0|||
128837441|NCT00215943|463700763|FG000|Overall Study|Disease Progression|3|||
128837442|NCT00215943|463700764|FG001|Overall Study|Disease Progression|5|||
128837443|NCT00215943|463700763|FG000|Overall Study|Alternate therapy|0|||
128837444|NCT00215943|463700764|FG001|Overall Study|Alternate therapy|1|||
128837445|NCT00215943|463700763|FG000|Overall Study|Adverse Event|3|||
128837446|NCT00215943|463700764|FG001|Overall Study|Adverse Event|6|||
128837447|NCT00215943|463700763|FG000|Overall Study|Other disease|0|||
128837448|NCT00215943|463700764|FG001|Overall Study|Other disease|1|||
128837449|NCT00215943|463700763|FG000|Overall Study|Other complications|3|||
128837450|NCT00215943|463700764|FG001|Overall Study|Other complications|1|||
128837451|NCT04311983|463700765|FG000|Overall Study|Lost to Follow-up|421|||
128837452|NCT04311983|463700766|FG001|Overall Study|Lost to Follow-up|456|||
128837453|NCT04311983|463700765|FG000|Overall Study|Incomplete survey|7|||
128837454|NCT04311983|463700766|FG001|Overall Study|Incomplete survey|9|||
128837455|NCT04311983|463700765|FG000|Overall Study|Death|1|||
128837456|NCT04311983|463700766|FG001|Overall Study|Death|0|||
128837457|NCT00403845|463700774|FG000|Treatment Period 1|Subject withdrew consent|1|||
128837458|NCT00403845|463700775|FG001|Treatment Period 1|Subject withdrew consent|0|||
128837459|NCT00403845|463700776|FG002|Treatment Period 1|Subject withdrew consent|0|||
128837460|NCT00403845|463700777|FG003|Treatment Period 1|Subject withdrew consent|0|||
128837461|NCT00403845|463700774|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
128837462|NCT00403845|463700775|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
128837463|NCT00403845|463700776|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
128837464|NCT00403845|463700777|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
128837465|NCT00403845|463700774|FG000|Treatment Period 2|Subject withdrew consent|1|||
128837466|NCT00403845|463700775|FG001|Treatment Period 2|Subject withdrew consent|0|||
128837467|NCT00403845|463700776|FG002|Treatment Period 2|Subject withdrew consent|0|||
128837468|NCT00403845|463700777|FG003|Treatment Period 2|Subject withdrew consent|0|||
128837469|NCT00403845|463700774|FG000|Treatment Period 3|Subject withdrew consent|0|||
128837470|NCT00403845|463700775|FG001|Treatment Period 3|Subject withdrew consent|0|||
128837471|NCT00403845|463700776|FG002|Treatment Period 3|Subject withdrew consent|0|||
128837472|NCT00403845|463700777|FG003|Treatment Period 3|Subject withdrew consent|1|||
128837473|NCT00403845|463700774|FG000|Treatment Period 3|Adverse Event|0|||
128837474|NCT00403845|463700775|FG001|Treatment Period 3|Adverse Event|0|||
128837475|NCT00403845|463700776|FG002|Treatment Period 3|Adverse Event|0|||
128837476|NCT00403845|463700777|FG003|Treatment Period 3|Adverse Event|1|||
128837477|NCT00578344|463700778|FG000|Overall Study|Insurance problems|1|||
128837478|NCT00578344|463700778|FG000|Overall Study|Graft failure|1|||
128837479|NCT02935673|463700779|FG000|Overall Study|Adverse Event|0|||
128837480|NCT02935673|463700780|FG001|Overall Study|Adverse Event|1|||
128837481|NCT02935673|463700781|FG002|Overall Study|Adverse Event|0|||
128837482|NCT02935673|463700779|FG000|Overall Study|Withdrawal by Subject|1|||
128837483|NCT02935673|463700780|FG001|Overall Study|Withdrawal by Subject|2|||
128837484|NCT02935673|463700781|FG002|Overall Study|Withdrawal by Subject|0|||
128837485|NCT04328467|463700782|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
128837486|NCT04328467|463700783|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
128837487|NCT04328467|463700784|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
128837488|NCT02152384|463700785|FG000|Period 1|Withdrawal by Subject|0|||
128837489|NCT02152384|463700786|FG001|Period 1|Withdrawal by Subject|1|||
128837490|NCT02152384|463700785|FG000|Period 1|Adverse Event|1|||
128837491|NCT02152384|463700786|FG001|Period 1|Adverse Event|1|||
128837492|NCT00930644|463700791|FG000|Overall Study|Withdrawal by Subject|4|||
128837493|NCT00930644|463700791|FG000|Overall Study|Physician Decision|2|||
128837494|NCT00930644|463700791|FG000|Overall Study|Death|1|||
128837495|NCT00930644|463700791|FG000|Overall Study|Adverse Event|16|||
128837496|NCT01393964|463700792|FG000|Overall Study|Disease Progression|4|||
128837497|NCT01393964|463700793|FG001|Overall Study|Disease Progression|3|||
128837498|NCT01393964|463700794|FG002|Overall Study|Disease Progression|5|||
128837499|NCT01393964|463700792|FG000|Overall Study|Study drug toxicity|1|||
128837500|NCT01393964|463700793|FG001|Overall Study|Study drug toxicity|0|||
128837501|NCT01393964|463700794|FG002|Overall Study|Study drug toxicity|0|||
128837502|NCT01393964|463700792|FG000|Overall Study|Withdrawal by Subject|0|||
128837503|NCT01393964|463700793|FG001|Overall Study|Withdrawal by Subject|0|||
128837504|NCT01393964|463700794|FG002|Overall Study|Withdrawal by Subject|1|||
128837505|NCT01393964|463700792|FG000|Overall Study|Adverse event unrelated to study drug|0|||
128837506|NCT01393964|463700793|FG001|Overall Study|Adverse event unrelated to study drug|3|||
128837507|NCT01393964|463700794|FG002|Overall Study|Adverse event unrelated to study drug|0|||
128837508|NCT01393964|463700792|FG000|Overall Study|Subject request stop study treatment|0|||
128837509|NCT01393964|463700793|FG001|Overall Study|Subject request stop study treatment|1|||
128837510|NCT01393964|463700794|FG002|Overall Study|Subject request stop study treatment|0|||
128837511|NCT01393964|463700792|FG000|Overall Study|Subject decided to move to transplant|1|||
128837512|NCT01393964|463700793|FG001|Overall Study|Subject decided to move to transplant|0|||
128837513|NCT01393964|463700794|FG002|Overall Study|Subject decided to move to transplant|0|||
128837514|NCT01393964|463700792|FG000|Overall Study|Subject switched to commercial supply|1|||
128837515|NCT01393964|463700793|FG001|Overall Study|Subject switched to commercial supply|0|||
128837516|NCT01393964|463700794|FG002|Overall Study|Subject switched to commercial supply|2|||
128837517|NCT01393964|463700792|FG000|Overall Study|Subject plateaued in terms of effect|1|||
128837518|NCT01393964|463700793|FG001|Overall Study|Subject plateaued in terms of effect|0|||
128837519|NCT01393964|463700794|FG002|Overall Study|Subject plateaued in terms of effect|0|||
128837520|NCT01393964|463700792|FG000|Overall Study|Investigator removed subject from study|0|||
128837521|NCT01393964|463700793|FG001|Overall Study|Investigator removed subject from study|1|||
128837522|NCT01393964|463700794|FG002|Overall Study|Investigator removed subject from study|0|||
128837523|NCT01393964|463700792|FG000|Overall Study|Subject converted to roll-over study|0|||
128837524|NCT01393964|463700793|FG001|Overall Study|Subject converted to roll-over study|1|||
128837525|NCT01393964|463700794|FG002|Overall Study|Subject converted to roll-over study|0|||
128837526|NCT01393964|463700792|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
128837527|NCT01393964|463700793|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
128837528|NCT01393964|463700794|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
128837529|NCT02671266|463700797|FG000|Overall Study|Withdrawal by Subject|1|||
128837530|NCT02671266|463700798|FG001|Overall Study|Withdrawal by Subject|1|||
128837531|NCT02825550|463700801|FG000|Overall Study|Physician Decision|1|||
128837532|NCT03349476|463700805|FG000|Overall Study|Physician Decision|3|||
128837533|NCT00795639|463700806|FG000|Overall Study|Death|1|||
128837534|NCT00795639|463700807|FG001|Overall Study|Death|6|||
128837535|NCT00795639|463700806|FG000|Overall Study|Withdrawal by Subject|1|||
128837536|NCT00795639|463700807|FG001|Overall Study|Withdrawal by Subject|3|||
128837537|NCT00795639|463700806|FG000|Overall Study|Pregnancy|1|||
128837538|NCT00795639|463700807|FG001|Overall Study|Pregnancy|0|||
128837539|NCT00795639|463700806|FG000|Overall Study|Adverse Event|5|||
128837540|NCT00795639|463700807|FG001|Overall Study|Adverse Event|2|||
128837541|NCT00795639|463700806|FG000|Overall Study|Other|0|||
128837542|NCT00795639|463700807|FG001|Overall Study|Other|2|||
128837543|NCT00795639|463700806|FG000|Overall Study|Terminated by sponsor|13|||
128837544|NCT00795639|463700807|FG001|Overall Study|Terminated by sponsor|12|||
128837545|NCT00795639|463700806|FG000|Overall Study|Randomized and not treated|0|||
128837546|NCT00795639|463700807|FG001|Overall Study|Randomized and not treated|1|||
128837547|NCT04421456|463700814|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
128837548|NCT04421456|463700815|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
128837549|NCT04421456|463700816|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
128837550|NCT04421456|463700814|FG000|Randomized Treatment Period|Adverse Event|0|||
128837551|NCT04421456|463700815|FG001|Randomized Treatment Period|Adverse Event|1|||
128837552|NCT04421456|463700816|FG002|Randomized Treatment Period|Adverse Event|0|||
128837553|NCT04421456|463700814|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
128837554|NCT04421456|463700815|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
128837555|NCT04421456|463700816|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
128837556|NCT04421456|463700814|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
128837557|NCT04421456|463700815|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
128837558|NCT04421456|463700816|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
128837559|NCT04421456|463700814|FG000|Randomized Treatment Period|Participant non-compliance|1|||
128837560|NCT04421456|463700815|FG001|Randomized Treatment Period|Participant non-compliance|1|||
128837561|NCT04421456|463700816|FG002|Randomized Treatment Period|Participant non-compliance|2|||
128837562|NCT04421456|463700814|FG000|Randomized Treatment Period|Other|0|||
128837563|NCT04421456|463700815|FG001|Randomized Treatment Period|Other|1|||
128837564|NCT04421456|463700816|FG002|Randomized Treatment Period|Other|3|||
128837565|NCT00274287|463700817|FG000|Overall Study|Withdrawal by Subject|1|||
128837566|NCT00274287|463700817|FG000|Overall Study|subject non-compliance|1|||
128837567|NCT02206607|463700820|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
128837568|NCT02206607|463700821|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
128837569|NCT02206607|463700822|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
128837570|NCT02206607|463700823|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
128837571|NCT02206607|463700824|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
128837572|NCT02206607|463700820|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
128837573|NCT02206607|463700821|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
128837574|NCT02206607|463700822|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
128837575|NCT02206607|463700823|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
128837576|NCT02206607|463700824|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
128837577|NCT00879710|463700825|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
128837578|NCT00879710|463700826|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
128837579|NCT00879710|463700827|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
128837580|NCT00879710|463700828|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
128837581|NCT00879710|463700825|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
128837582|NCT00879710|463700826|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
128837583|NCT00879710|463700827|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
128837584|NCT00879710|463700828|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
128837585|NCT03979040|463700830|FG000|Overall Study|Withdrawal by Subject|24|||
128837586|NCT03979040|463700831|FG001|Overall Study|Withdrawal by Subject|32|||
128837587|NCT03979040|463700830|FG000|Overall Study|randomized but never started treatment|32|||
128837588|NCT03979040|463700831|FG001|Overall Study|randomized but never started treatment|39|||
128837589|NCT03979040|463700830|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
128837590|NCT03979040|463700831|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
128837591|NCT03541369|463700834|FG000|Overall Study|Death|0|||
128837592|NCT03541369|463700835|FG001|Overall Study|Death|0|||
128837593|NCT03541369|463700836|FG002|Overall Study|Death|0|||
128837594|NCT03541369|463700837|FG003|Overall Study|Death|0|||
128837595|NCT03541369|463700838|FG004|Overall Study|Death|1|||
128837596|NCT03541369|463700839|FG005|Overall Study|Death|1|||
128837597|NCT03541369|463700840|FG006|Overall Study|Death|0|||
128837598|NCT03541369|463700841|FG007|Overall Study|Death|2|||
128837599|NCT03541369|463700842|FG008|Overall Study|Death|1|||
128837600|NCT03541369|463700843|FG009|Overall Study|Death|2|||
128837601|NCT03541369|463700844|FG010|Overall Study|Death|1|||
128837602|NCT03541369|463700845|FG011|Overall Study|Death|0|||
128837603|NCT03541369|463700846|FG012|Overall Study|Death|2|||
128837604|NCT03541369|463700847|FG013|Overall Study|Death|1|||
128837605|NCT03541369|463700848|FG014|Overall Study|Death|1|||
128837606|NCT03541369|463700849|FG015|Overall Study|Death|1|||
128837607|NCT03541369|463700850|FG016|Overall Study|Death|0|||
128837608|NCT03541369|463700851|FG017|Overall Study|Death|1|||
128837609|NCT03541369|463700834|FG000|Overall Study|Decision by sponsor|0|||
128837610|NCT03541369|463700835|FG001|Overall Study|Decision by sponsor|0|||
128837611|NCT03541369|463700836|FG002|Overall Study|Decision by sponsor|0|||
128837612|NCT03541369|463700837|FG003|Overall Study|Decision by sponsor|1|||
128837613|NCT03541369|463700838|FG004|Overall Study|Decision by sponsor|0|||
128837614|NCT03541369|463700839|FG005|Overall Study|Decision by sponsor|2|||
128837615|NCT03541369|463700840|FG006|Overall Study|Decision by sponsor|0|||
128837616|NCT03541369|463700841|FG007|Overall Study|Decision by sponsor|1|||
128837617|NCT03541369|463700842|FG008|Overall Study|Decision by sponsor|2|||
128837618|NCT03541369|463700843|FG009|Overall Study|Decision by sponsor|0|||
128837619|NCT03541369|463700844|FG010|Overall Study|Decision by sponsor|0|||
128837620|NCT03541369|463700845|FG011|Overall Study|Decision by sponsor|0|||
128837621|NCT03541369|463700846|FG012|Overall Study|Decision by sponsor|2|||
128837622|NCT03541369|463700847|FG013|Overall Study|Decision by sponsor|2|||
128837623|NCT03541369|463700848|FG014|Overall Study|Decision by sponsor|0|||
128837624|NCT03541369|463700849|FG015|Overall Study|Decision by sponsor|1|||
128837625|NCT03541369|463700850|FG016|Overall Study|Decision by sponsor|1|||
128837626|NCT03541369|463700851|FG017|Overall Study|Decision by sponsor|1|||
128837627|NCT03541369|463700834|FG000|Overall Study|Withdrawal by Subject|0|||
128837628|NCT03541369|463700835|FG001|Overall Study|Withdrawal by Subject|0|||
128837629|NCT03541369|463700836|FG002|Overall Study|Withdrawal by Subject|0|||
128837630|NCT03541369|463700837|FG003|Overall Study|Withdrawal by Subject|0|||
128837631|NCT03541369|463700838|FG004|Overall Study|Withdrawal by Subject|0|||
128837632|NCT03541369|463700839|FG005|Overall Study|Withdrawal by Subject|0|||
128837633|NCT03541369|463700840|FG006|Overall Study|Withdrawal by Subject|1|||
128837634|NCT03541369|463700841|FG007|Overall Study|Withdrawal by Subject|0|||
128837635|NCT03541369|463700842|FG008|Overall Study|Withdrawal by Subject|0|||
128837636|NCT03541369|463700843|FG009|Overall Study|Withdrawal by Subject|0|||
128837637|NCT03541369|463700844|FG010|Overall Study|Withdrawal by Subject|0|||
128837638|NCT03541369|463700845|FG011|Overall Study|Withdrawal by Subject|1|||
128837639|NCT03541369|463700846|FG012|Overall Study|Withdrawal by Subject|0|||
128837640|NCT03541369|463700847|FG013|Overall Study|Withdrawal by Subject|0|||
128837641|NCT03541369|463700848|FG014|Overall Study|Withdrawal by Subject|3|||
128837642|NCT03541369|463700849|FG015|Overall Study|Withdrawal by Subject|0|||
128837643|NCT03541369|463700850|FG016|Overall Study|Withdrawal by Subject|4|||
128837644|NCT03541369|463700851|FG017|Overall Study|Withdrawal by Subject|2|||
128837645|NCT03541369|463700834|FG000|Overall Study|Lost to Follow-up|0|||
128837646|NCT03541369|463700835|FG001|Overall Study|Lost to Follow-up|0|||
128837647|NCT03541369|463700836|FG002|Overall Study|Lost to Follow-up|0|||
128837648|NCT03541369|463700837|FG003|Overall Study|Lost to Follow-up|0|||
128837649|NCT03541369|463700838|FG004|Overall Study|Lost to Follow-up|1|||
128837650|NCT03541369|463700839|FG005|Overall Study|Lost to Follow-up|0|||
128837651|NCT03541369|463700840|FG006|Overall Study|Lost to Follow-up|0|||
128837652|NCT03541369|463700841|FG007|Overall Study|Lost to Follow-up|0|||
128837653|NCT03541369|463700842|FG008|Overall Study|Lost to Follow-up|1|||
128837654|NCT03541369|463700843|FG009|Overall Study|Lost to Follow-up|0|||
128837655|NCT03541369|463700844|FG010|Overall Study|Lost to Follow-up|0|||
128837656|NCT03541369|463700845|FG011|Overall Study|Lost to Follow-up|0|||
128837657|NCT03541369|463700846|FG012|Overall Study|Lost to Follow-up|1|||
128837658|NCT03541369|463700847|FG013|Overall Study|Lost to Follow-up|0|||
128837659|NCT03541369|463700848|FG014|Overall Study|Lost to Follow-up|0|||
128837660|NCT03541369|463700849|FG015|Overall Study|Lost to Follow-up|0|||
128837661|NCT03541369|463700850|FG016|Overall Study|Lost to Follow-up|0|||
128837662|NCT03541369|463700851|FG017|Overall Study|Lost to Follow-up|0|||
128837663|NCT00696241|463700852|FG000|Overall Study|Adverse Event|11|||
128837664|NCT00696241|463700853|FG001|Overall Study|Adverse Event|3|||
128837665|NCT00696241|463700854|FG002|Overall Study|Adverse Event|6|||
128837666|NCT00696241|463700855|FG003|Overall Study|Adverse Event|4|||
128837667|NCT00696241|463700856|FG004|Overall Study|Adverse Event|5|||
128837668|NCT00696241|463700852|FG000|Overall Study|Protocol Violation|1|||
128837669|NCT00696241|463700853|FG001|Overall Study|Protocol Violation|1|||
128837670|NCT00696241|463700854|FG002|Overall Study|Protocol Violation|2|||
128837671|NCT00696241|463700855|FG003|Overall Study|Protocol Violation|0|||
128837672|NCT00696241|463700856|FG004|Overall Study|Protocol Violation|3|||
128837673|NCT00696241|463700852|FG000|Overall Study|Lost to Follow-up|1|||
128837674|NCT00696241|463700853|FG001|Overall Study|Lost to Follow-up|4|||
128837675|NCT00696241|463700854|FG002|Overall Study|Lost to Follow-up|1|||
128837676|NCT00696241|463700855|FG003|Overall Study|Lost to Follow-up|2|||
128837677|NCT00696241|463700856|FG004|Overall Study|Lost to Follow-up|0|||
128837678|NCT00696241|463700852|FG000|Overall Study|Withdrawal by Subject|4|||
128837679|NCT00696241|463700853|FG001|Overall Study|Withdrawal by Subject|8|||
128837680|NCT00696241|463700854|FG002|Overall Study|Withdrawal by Subject|6|||
128837681|NCT00696241|463700855|FG003|Overall Study|Withdrawal by Subject|1|||
128837682|NCT00696241|463700856|FG004|Overall Study|Withdrawal by Subject|0|||
128837683|NCT00696241|463700852|FG000|Overall Study|Lack of Efficacy|1|||
128837684|NCT00696241|463700853|FG001|Overall Study|Lack of Efficacy|5|||
128837685|NCT00696241|463700854|FG002|Overall Study|Lack of Efficacy|4|||
128837686|NCT00696241|463700855|FG003|Overall Study|Lack of Efficacy|5|||
128837687|NCT00696241|463700856|FG004|Overall Study|Lack of Efficacy|3|||
128837688|NCT00696241|463700852|FG000|Overall Study|Other|6|||
128837689|NCT00696241|463700853|FG001|Overall Study|Other|1|||
128837690|NCT00696241|463700854|FG002|Overall Study|Other|5|||
128837691|NCT00696241|463700855|FG003|Overall Study|Other|2|||
128837692|NCT00696241|463700856|FG004|Overall Study|Other|1|||
128837693|NCT02008916|463700863|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
128837694|NCT02008916|463700864|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
128837695|NCT02008916|463700865|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
128837696|NCT02008916|463700863|FG000|Week 16 - 156|Adverse Event|4|||
128837697|NCT02008916|463700864|FG001|Week 16 - 156|Adverse Event|2|||
128837698|NCT02008916|463700865|FG002|Week 16 - 156|Adverse Event|3|||
128837699|NCT02008916|463700863|FG000|Week 16 - 156|Withdrawal by Subject|7|||
128837700|NCT02008916|463700864|FG001|Week 16 - 156|Withdrawal by Subject|3|||
128837701|NCT02008916|463700865|FG002|Week 16 - 156|Withdrawal by Subject|5|||
128837702|NCT02008916|463700863|FG000|Week 16 - 156|No longer requires treatment|0|||
128837703|NCT02008916|463700864|FG001|Week 16 - 156|No longer requires treatment|1|||
128837704|NCT02008916|463700865|FG002|Week 16 - 156|No longer requires treatment|0|||
128837705|NCT02008916|463700863|FG000|Week 16 - 156|Lost to Follow-up|5|||
128837706|NCT02008916|463700864|FG001|Week 16 - 156|Lost to Follow-up|0|||
128837707|NCT02008916|463700865|FG002|Week 16 - 156|Lost to Follow-up|0|||
128837708|NCT02008916|463700863|FG000|Week 16 - 156|Lack of Efficacy|3|||
128837709|NCT02008916|463700864|FG001|Week 16 - 156|Lack of Efficacy|5|||
128837710|NCT02008916|463700865|FG002|Week 16 - 156|Lack of Efficacy|2|||
128837711|NCT02008916|463700863|FG000|Week 16 - 156|Pregnancy|0|||
128837712|NCT02008916|463700864|FG001|Week 16 - 156|Pregnancy|1|||
128837713|NCT02008916|463700865|FG002|Week 16 - 156|Pregnancy|0|||
128837714|NCT02008916|463700863|FG000|Week 16 - 156|Physician Decision|0|||
128837715|NCT02008916|463700864|FG001|Week 16 - 156|Physician Decision|1|||
128837716|NCT02008916|463700865|FG002|Week 16 - 156|Physician Decision|0|||
128837717|NCT03803475|463700866|FG000|Overall Study|Physician Decision|1|||
128837718|NCT03347396|463700867|FG000|Part A (26 Weeks)|Adverse Event|1|||
128837719|NCT03347396|463700868|FG001|Part A (26 Weeks)|Adverse Event|0|||
128837720|NCT03347396|463700867|FG000|Part A (26 Weeks)|Death|0|||
128837721|NCT03347396|463700868|FG001|Part A (26 Weeks)|Death|1|||
128837722|NCT03347396|463700867|FG000|Part B (149 Weeks)|Adverse Event|1|||
128837723|NCT03347396|463700868|FG001|Part B (149 Weeks)|Adverse Event|1|||
128837724|NCT03347396|463700867|FG000|Part B (149 Weeks)|Death|1|||
128837725|NCT03347396|463700868|FG001|Part B (149 Weeks)|Death|0|||
128837726|NCT00392197|463700869|FG000|Overall Study|Adverse Event|4|||
128837727|NCT00392197|463700870|FG001|Overall Study|Adverse Event|12|||
128837728|NCT00392197|463700869|FG000|Overall Study|Lack of Efficacy|3|||
128837729|NCT00392197|463700870|FG001|Overall Study|Lack of Efficacy|4|||
128837730|NCT00392197|463700869|FG000|Overall Study|Lost to Follow-up|0|||
128837731|NCT00392197|463700870|FG001|Overall Study|Lost to Follow-up|1|||
128837732|NCT00392197|463700869|FG000|Overall Study|Physician Decision|3|||
128837733|NCT00392197|463700870|FG001|Overall Study|Physician Decision|2|||
128837734|NCT00392197|463700869|FG000|Overall Study|Protocol Violation|7|||
128837735|NCT00392197|463700870|FG001|Overall Study|Protocol Violation|5|||
128837736|NCT00392197|463700869|FG000|Overall Study|Withdrawal by Subject|4|||
128837737|NCT00392197|463700870|FG001|Overall Study|Withdrawal by Subject|6|||
128837738|NCT03060525|463700871|FG000|Overall Study|moved out of state|1|||
128837739|NCT03060525|463700872|FG001|Overall Study|moved out of state|1|||
128837740|NCT03060525|463700873|FG002|Overall Study|moved out of state|1|||
128837741|NCT03060525|463700874|FG003|Overall Study|moved out of state|1|||
128837742|NCT03060525|463700871|FG000|Overall Study|unable to meet time commitment required of study|2|||
128837743|NCT03060525|463700872|FG001|Overall Study|unable to meet time commitment required of study|3|||
128837744|NCT03060525|463700873|FG002|Overall Study|unable to meet time commitment required of study|3|||
128837745|NCT03060525|463700874|FG003|Overall Study|unable to meet time commitment required of study|1|||
128837746|NCT03060525|463700871|FG000|Overall Study|no longer interested in doing intervention|0|||
128837747|NCT03060525|463700872|FG001|Overall Study|no longer interested in doing intervention|0|||
128837748|NCT03060525|463700873|FG002|Overall Study|no longer interested in doing intervention|0|||
128837749|NCT03060525|463700874|FG003|Overall Study|no longer interested in doing intervention|1|||
128837750|NCT00912964|463700875|FG000|Overall Study|Eligibility criterion not met|1|||
128837751|NCT00912964|463700876|FG001|Overall Study|Eligibility criterion not met|1|||
128837752|NCT00912964|463700877|FG002|Overall Study|Eligibility criterion not met|0|||
128837753|NCT00912964|463700875|FG000|Overall Study|Adverse Event|15|||
128837754|NCT00912964|463700876|FG001|Overall Study|Adverse Event|18|||
128837755|NCT00912964|463700877|FG002|Overall Study|Adverse Event|12|||
128837756|NCT00912964|463700875|FG000|Overall Study|Lack of Efficacy|11|||
128837757|NCT00912964|463700876|FG001|Overall Study|Lack of Efficacy|4|||
128837758|NCT00912964|463700877|FG002|Overall Study|Lack of Efficacy|3|||
128837759|NCT00912964|463700875|FG000|Overall Study|Withdrawal by Subject|20|||
128837760|NCT00912964|463700876|FG001|Overall Study|Withdrawal by Subject|12|||
128837761|NCT00912964|463700877|FG002|Overall Study|Withdrawal by Subject|18|||
128837762|NCT00912964|463700875|FG000|Overall Study|Lost to Follow-up|4|||
128837763|NCT00912964|463700876|FG001|Overall Study|Lost to Follow-up|3|||
128837764|NCT00912964|463700877|FG002|Overall Study|Lost to Follow-up|3|||
128837765|NCT00912964|463700875|FG000|Overall Study|Protocol Violation|5|||
128837766|NCT00912964|463700876|FG001|Overall Study|Protocol Violation|3|||
128837767|NCT00912964|463700877|FG002|Overall Study|Protocol Violation|8|||
128837768|NCT00912964|463700875|FG000|Overall Study|Taking exclusionary medications|7|||
128837769|NCT00912964|463700876|FG001|Overall Study|Taking exclusionary medications|4|||
128837770|NCT00912964|463700877|FG002|Overall Study|Taking exclusionary medications|8|||
128837771|NCT00912964|463700875|FG000|Overall Study|Medical History|1|||
128837772|NCT00912964|463700876|FG001|Overall Study|Medical History|0|||
128837773|NCT00912964|463700877|FG002|Overall Study|Medical History|0|||
128837774|NCT00912964|463700875|FG000|Overall Study|Non-compliance with study procedures|2|||
128837775|NCT00912964|463700876|FG001|Overall Study|Non-compliance with study procedures|0|||
128837776|NCT00912964|463700877|FG002|Overall Study|Non-compliance with study procedures|0|||
128837777|NCT00912964|463700875|FG000|Overall Study|Violation of exclusion criterion|0|||
128837778|NCT00912964|463700876|FG001|Overall Study|Violation of exclusion criterion|0|||
128837779|NCT00912964|463700877|FG002|Overall Study|Violation of exclusion criterion|2|||
128837780|NCT00912964|463700875|FG000|Overall Study|Randomized but never received study drug|0|||
128837781|NCT00912964|463700876|FG001|Overall Study|Randomized but never received study drug|1|||
128837782|NCT00912964|463700877|FG002|Overall Study|Randomized but never received study drug|0|||
128837783|NCT00090519|463700878|FG000|Overall Study|Adverse Event|5|||
128837784|NCT00090519|463700879|FG001|Overall Study|Adverse Event|4|||
128837785|NCT00090519|463700878|FG000|Overall Study|Death|9|||
128837786|NCT00090519|463700879|FG001|Overall Study|Death|9|||
128837787|NCT00090519|463700878|FG000|Overall Study|Lost to Follow-up|26|||
128837788|NCT00090519|463700879|FG001|Overall Study|Lost to Follow-up|29|||
128837789|NCT00090519|463700878|FG000|Overall Study|Withdrawal by Subject|28|||
128837790|NCT00090519|463700879|FG001|Overall Study|Withdrawal by Subject|29|||
128837791|NCT00090519|463700878|FG000|Overall Study|Physician Decision|2|||
128837792|NCT00090519|463700879|FG001|Overall Study|Physician Decision|3|||
128837793|NCT00090519|463700878|FG000|Overall Study|Sponsor Decision|3|||
128837794|NCT00090519|463700879|FG001|Overall Study|Sponsor Decision|1|||
128837795|NCT02161146|463700882|FG000|Overall Study|Adverse Event|1|||
128837796|NCT02161146|463700883|FG001|Overall Study|Adverse Event|1|||
128837797|NCT02161146|463700884|FG002|Overall Study|Adverse Event|0|||
128837798|NCT02161146|463700885|FG003|Overall Study|Adverse Event|1|||
128837799|NCT02161146|463700886|FG004|Overall Study|Adverse Event|0|||
128837800|NCT02161146|463700882|FG000|Overall Study|Lost to Follow-up|0|||
128837801|NCT02161146|463700883|FG001|Overall Study|Lost to Follow-up|1|||
128837802|NCT02161146|463700884|FG002|Overall Study|Lost to Follow-up|0|||
128837803|NCT02161146|463700885|FG003|Overall Study|Lost to Follow-up|0|||
128837804|NCT02161146|463700886|FG004|Overall Study|Lost to Follow-up|0|||
128837805|NCT02161146|463700882|FG000|Overall Study|Personal Reasons|0|||
128837806|NCT02161146|463700883|FG001|Overall Study|Personal Reasons|1|||
128837807|NCT02161146|463700884|FG002|Overall Study|Personal Reasons|0|||
128837808|NCT02161146|463700885|FG003|Overall Study|Personal Reasons|2|||
128837809|NCT02161146|463700886|FG004|Overall Study|Personal Reasons|1|||
128837810|NCT02161146|463700882|FG000|Overall Study|Other Miscellaneous Reasons|0|||
128837811|NCT02161146|463700883|FG001|Overall Study|Other Miscellaneous Reasons|1|||
128837812|NCT02161146|463700884|FG002|Overall Study|Other Miscellaneous Reasons|0|||
128837813|NCT02161146|463700885|FG003|Overall Study|Other Miscellaneous Reasons|0|||
128837814|NCT02161146|463700886|FG004|Overall Study|Other Miscellaneous Reasons|0|||
128837815|NCT02189759|463700889|FG000|Overall Study|Lost to Follow-up|0|||
128837816|NCT02189759|463700890|FG001|Overall Study|Lost to Follow-up|0|||
128837817|NCT02189759|463700891|FG002|Overall Study|Lost to Follow-up|2|||
128837818|NCT02189759|463700892|FG003|Overall Study|Lost to Follow-up|5|||
128837819|NCT04919499|463700896|FG000|Overall Study|Adverse Event|0|||
128837820|NCT04919499|463700897|FG001|Overall Study|Adverse Event|0|||
128837821|NCT04919499|463700898|FG002|Overall Study|Adverse Event|0|||
128837822|NCT04919499|463700899|FG003|Overall Study|Adverse Event|0|||
128837823|NCT04919499|463700900|FG004|Overall Study|Adverse Event|2|||
128837824|NCT04919499|463700896|FG000|Overall Study|Not treated|0|||
128837825|NCT04919499|463700897|FG001|Overall Study|Not treated|0|||
128837826|NCT04919499|463700898|FG002|Overall Study|Not treated|0|||
128837827|NCT04919499|463700899|FG003|Overall Study|Not treated|1|||
128837828|NCT04919499|463700900|FG004|Overall Study|Not treated|0|||
128837829|NCT04369664|463702616|FG000|Overall Study|Physician Decision|1|||
128837830|NCT04369664|463702617|FG001|Overall Study|Physician Decision|0|||
128837831|NCT03840200|463702620|FG000|Overall Study|Death|6|||
128837832|NCT03840200|463702621|FG001|Overall Study|Death|3|||
128837833|NCT03840200|463702622|FG002|Overall Study|Death|6|||
128837834|NCT03840200|463702623|FG003|Overall Study|Death|10|||
128837835|NCT03840200|463702620|FG000|Overall Study|Reason Not Specified|2|||
128837836|NCT03840200|463702621|FG001|Overall Study|Reason Not Specified|2|||
128837837|NCT03840200|463702622|FG002|Overall Study|Reason Not Specified|1|||
128837838|NCT03840200|463702623|FG003|Overall Study|Reason Not Specified|15|||
128837839|NCT03840200|463702620|FG000|Overall Study|Physician Decision|0|||
128837840|NCT03840200|463702621|FG001|Overall Study|Physician Decision|0|||
128837841|NCT03840200|463702622|FG002|Overall Study|Physician Decision|0|||
128837842|NCT03840200|463702623|FG003|Overall Study|Physician Decision|2|||
128837843|NCT03840200|463702620|FG000|Overall Study|Progressive Disease|0|||
128837844|NCT03840200|463702621|FG001|Overall Study|Progressive Disease|0|||
128837845|NCT03840200|463702622|FG002|Overall Study|Progressive Disease|0|||
128837846|NCT03840200|463702623|FG003|Overall Study|Progressive Disease|1|||
128837847|NCT03840200|463702620|FG000|Overall Study|Withdrawal by Subject|0|||
128837848|NCT03840200|463702621|FG001|Overall Study|Withdrawal by Subject|1|||
128837849|NCT03840200|463702622|FG002|Overall Study|Withdrawal by Subject|0|||
128837850|NCT03840200|463702623|FG003|Overall Study|Withdrawal by Subject|2|||
128837851|NCT05522777|463702624|FG000|Overall Study|Lack of Efficacy|1|||
128837852|NCT05522777|463702624|FG000|Overall Study|Withdrawal by Subject|1|||
128837853|NCT05487300|463702627|FG000|Overall Study|Withdrawal by Subject|1|||
128837854|NCT05487300|463702628|FG001|Overall Study|Withdrawal by Subject|0|||
128837855|NCT05006703|463702629|FG000|Overall Study|Withdrawal by Subject|1|||
128837856|NCT05006703|463702630|FG001|Overall Study|Withdrawal by Subject|0|||
128837857|NCT05006703|463702629|FG000|Overall Study|Lost to Follow-up|13|||
128837858|NCT05006703|463702630|FG001|Overall Study|Lost to Follow-up|5|||
128837859|NCT02164578|463702632|FG000|Treatment Period|Withdrawal by Subject|3|||
128837860|NCT02164578|463702633|FG001|Treatment Period|Withdrawal by Subject|3|||
128837861|NCT02164578|463702632|FG000|Treatment Period|Adverse Event|13|||
128837862|NCT02164578|463702633|FG001|Treatment Period|Adverse Event|6|||
128837863|NCT02164578|463702632|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
128837864|NCT02164578|463702633|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
128837865|NCT02164578|463702632|FG000|Treatment Period|Protocol Violation|0|||
128837866|NCT02164578|463702633|FG001|Treatment Period|Protocol Violation|2|||
128837867|NCT02164578|463702632|FG000|Extension Period|Withdrawal by Subject|2|||
128837868|NCT02164578|463702633|FG001|Extension Period|Withdrawal by Subject|0|||
128837869|NCT02164578|463702632|FG000|Extension Period|Adverse Event|4|||
128837870|NCT02164578|463702633|FG001|Extension Period|Adverse Event|0|||
128837871|NCT02164578|463702632|FG000|Extension Period|Expiry of study medication|1|||
128837872|NCT02164578|463702633|FG001|Extension Period|Expiry of study medication|0|||
128837873|NCT02164578|463702632|FG000|Extension Period|Protocol Violation|0|||
128837874|NCT02164578|463702633|FG001|Extension Period|Protocol Violation|1|||
128837875|NCT02507297|463702634|FG000|Overall Study|Withdrawal by Subject|1|||
128837876|NCT02507297|463702635|FG001|Overall Study|Withdrawal by Subject|0|||
128837877|NCT02507297|463702634|FG000|Overall Study|Lost to Follow-up|0|||
128837878|NCT02507297|463702635|FG001|Overall Study|Lost to Follow-up|1|||
128837879|NCT01018992|463702636|FG000|Overall Study|Adverse Event|8|||
128837880|NCT01018992|463702637|FG001|Overall Study|Adverse Event|3|||
128837881|NCT01018992|463702636|FG000|Overall Study|Withdrawal by Subject|3|||
128837882|NCT01018992|463702637|FG001|Overall Study|Withdrawal by Subject|8|||
128837883|NCT01018992|463702636|FG000|Overall Study|Protocol Violation|0|||
128837884|NCT01018992|463702637|FG001|Overall Study|Protocol Violation|4|||
128837885|NCT01018992|463702636|FG000|Overall Study|Lost to Follow-up|5|||
128837886|NCT01018992|463702637|FG001|Overall Study|Lost to Follow-up|1|||
128837887|NCT03029585|463702638|FG000|Overall Study|Death|1|||
128837888|NCT03029585|463702639|FG001|Overall Study|Death|1|||
128837889|NCT03029585|463702638|FG000|Overall Study|Withdrawal by Subject|1|||
128837890|NCT03029585|463702639|FG001|Overall Study|Withdrawal by Subject|0|||
128837891|NCT01304940|463702640|FG000|Overall Study|not meet symptom severity requirement|3|||
128837892|NCT01304940|463702641|FG001|Overall Study|not meet symptom severity requirement|0|||
128837893|NCT00278395|463702642|FG000|Overall Study|Adverse Event|2|||
128837894|NCT00278395|463702642|FG000|Overall Study|Nonevaluable|1|||
128837895|NCT01286311|463702644|FG000|Overall Study|Physician did not want outreach sent|14|||
128837896|NCT01286311|463702645|FG001|Overall Study|Physician did not want outreach sent|0|||
128837897|NCT01381549|463702651|FG000|Overall Study|Ineligible: No organisms isolated|0|||
128837898|NCT01381549|463702652|FG001|Overall Study|Ineligible: No organisms isolated|0|||
128837899|NCT01381549|463702653|FG002|Overall Study|Ineligible: No organisms isolated|1|||
128837900|NCT00990184|463702656|FG000|Overall Study|Physician Decision|1|||
128837901|NCT00441168|463702657|FG000|Treatment Period|Death|3|||
128837902|NCT00441168|463702658|FG001|Treatment Period|Death|0|||
128837903|NCT00441168|463702657|FG000|Treatment Period|Adverse Event|1|||
128837904|NCT00441168|463702658|FG001|Treatment Period|Adverse Event|2|||
128837905|NCT00441168|463702657|FG000|Treatment Period|Progressive Disease|0|||
128837906|NCT00441168|463702658|FG001|Treatment Period|Progressive Disease|2|||
128837907|NCT00441168|463702657|FG000|Treatment Period|Protocol Violation|0|||
128837908|NCT00441168|463702658|FG001|Treatment Period|Protocol Violation|1|||
128837909|NCT00441168|463702657|FG000|Treatment Period|Lost to Follow-up|0|||
128837910|NCT00441168|463702658|FG001|Treatment Period|Lost to Follow-up|1|||
128837911|NCT00441168|463702657|FG000|Treatment Period|Withdrawal by Subject|3|||
128837912|NCT00441168|463702658|FG001|Treatment Period|Withdrawal by Subject|0|||
128837913|NCT00441168|463702657|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
128837914|NCT00441168|463702658|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
128837915|NCT00441168|463702657|FG000|Treatment Period|refractory disease|1|||
128837916|NCT00441168|463702658|FG001|Treatment Period|refractory disease|0|||
128837917|NCT00441168|463702657|FG000|Follow-up Period|Death|3|||
128837918|NCT00441168|463702658|FG001|Follow-up Period|Death|0|||
128837919|NCT00441168|463702657|FG000|Follow-up Period|Lost to Follow-up|5|||
128837920|NCT00441168|463702658|FG001|Follow-up Period|Lost to Follow-up|6|||
128837921|NCT00441168|463702657|FG000|Follow-up Period|Withdrawal by Subject|3|||
128837922|NCT00441168|463702658|FG001|Follow-up Period|Withdrawal by Subject|0|||
128837923|NCT00441168|463702657|FG000|Follow-up Period|Other|1|||
128837924|NCT00441168|463702658|FG001|Follow-up Period|Other|3|||
128837925|NCT03909100|463702659|FG000|Overall Study|Protocol Deviation|2|||
128837926|NCT03909100|463702659|FG000|Overall Study|Technical Problems|4|||
128837927|NCT03909100|463702659|FG000|Overall Study|Withdrawal by Subject|4|||
128837928|NCT03909100|463702659|FG000|Overall Study|Lost to Follow-up|1|||
128837929|NCT03909100|463702659|FG000|Overall Study|Reason not Specified|4|||
128837930|NCT00807599|463702660|FG000|Overall Study|Not treated on protocol study|0|||
128837931|NCT00807599|463702661|FG001|Overall Study|Not treated on protocol study|0|||
128837932|NCT00807599|463702662|FG002|Overall Study|Not treated on protocol study|2|||
128837933|NCT00807599|463702660|FG000|Overall Study|Adverse Event|0|||
128837934|NCT00807599|463702661|FG001|Overall Study|Adverse Event|0|||
128837935|NCT00807599|463702662|FG002|Overall Study|Adverse Event|5|||
128837936|NCT00807599|463702660|FG000|Overall Study|Inadequate response to induction|0|||
128837937|NCT00807599|463702661|FG001|Overall Study|Inadequate response to induction|0|||
128837938|NCT00807599|463702662|FG002|Overall Study|Inadequate response to induction|9|||
128837939|NCT00807599|463702660|FG000|Overall Study|Withdrawal by Subject|0|||
128837940|NCT00807599|463702661|FG001|Overall Study|Withdrawal by Subject|0|||
128837941|NCT00807599|463702662|FG002|Overall Study|Withdrawal by Subject|1|||
128837942|NCT01670877|463702663|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
128837943|NCT01670877|463702664|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
128837944|NCT01670877|463702665|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
128837945|NCT01670877|463702666|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
128837946|NCT01670877|463702667|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
128837947|NCT01670877|463702668|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
128837948|NCT01670877|463702663|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
128837949|NCT01670877|463702664|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
128837950|NCT01670877|463702665|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
128837951|NCT01670877|463702666|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
128837952|NCT01670877|463702667|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
128837953|NCT01670877|463702668|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
128837954|NCT01670877|463702663|FG000|Part I and Part 2|Grade 2 vomiting|0|||
128837955|NCT01670877|463702664|FG001|Part I and Part 2|Grade 2 vomiting|0|||
128837956|NCT01670877|463702665|FG002|Part I and Part 2|Grade 2 vomiting|0|||
128837957|NCT01670877|463702666|FG003|Part I and Part 2|Grade 2 vomiting|1|||
128837958|NCT01670877|463702667|FG004|Part I and Part 2|Grade 2 vomiting|0|||
128837959|NCT01670877|463702668|FG005|Part I and Part 2|Grade 2 vomiting|0|||
128837960|NCT01670877|463702663|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
128837961|NCT01670877|463702664|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
128837962|NCT01670877|463702665|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
128837963|NCT01670877|463702666|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
128837964|NCT01670877|463702667|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
128837965|NCT01670877|463702668|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
128837966|NCT01670877|463702663|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
128837967|NCT01670877|463702664|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
128837968|NCT01670877|463702665|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
128837969|NCT01670877|463702666|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
128837970|NCT01670877|463702667|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
128837971|NCT01670877|463702668|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
128837972|NCT03693989|463702669|FG000|Overall Study|Protocol Violation|3|||
128837973|NCT03693989|463702670|FG001|Overall Study|Protocol Violation|4|||
128837974|NCT03146845|463702671|FG000|Overall Study|Reference ulcer healed|1|||
128837975|NCT03146845|463702672|FG001|Overall Study|Reference ulcer healed|0|||
128837976|NCT03146845|463702671|FG000|Overall Study|Physician Decision|1|||
128837977|NCT03146845|463702672|FG001|Overall Study|Physician Decision|0|||
128837978|NCT03146845|463702671|FG000|Overall Study|Adverse Event|1|||
128837979|NCT03146845|463702672|FG001|Overall Study|Adverse Event|0|||
128837980|NCT03146845|463702671|FG000|Overall Study|Withdrawal by Subject|2|||
128837981|NCT03146845|463702672|FG001|Overall Study|Withdrawal by Subject|0|||
128837982|NCT03146845|463702671|FG000|Overall Study|Noncompliance|0|||
128837983|NCT03146845|463702672|FG001|Overall Study|Noncompliance|1|||
129204957|NCT01962441|465047004|FG002|Randomized Period|Protocol Violation|0|||
128837984|NCT03146845|463702671|FG000|Overall Study|Protocol Violation|0|||
128837985|NCT03146845|463702672|FG001|Overall Study|Protocol Violation|2|||
128837986|NCT03146845|463702671|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
128837987|NCT03146845|463702672|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
128837988|NCT00113529|463702675|FG000|Overall Study|Adverse Event|4|||
128837989|NCT00113529|463702675|FG000|Overall Study|Lack of Efficacy|20|||
128837990|NCT00113529|463702675|FG000|Overall Study|Decision of sponsor|6|||
128837991|NCT00113529|463702675|FG000|Overall Study|Withdrawal by Subject|4|||
128837992|NCT01535261|463702676|FG000|Overall Study|Physician Decision|8|||
128837993|NCT01535261|463702676|FG000|Overall Study|Protocol Violation|3|||
128837994|NCT01535261|463702676|FG000|Overall Study|Death|5|||
128837995|NCT01535261|463702676|FG000|Overall Study|Lost to Follow-up|8|||
128837996|NCT01535261|463702676|FG000|Overall Study|Withdrawal by Subject|14|||
128837997|NCT01535261|463702676|FG000|Overall Study|Adverse Event|12|||
128837998|NCT01757288|463702679|FG000|Overall Study|Consent withdrawal|0|||
128837999|NCT01757288|463702680|FG001|Overall Study|Consent withdrawal|4|||
128838000|NCT01757288|463702681|FG002|Overall Study|Consent withdrawal|4|||
128838001|NCT01757288|463702679|FG000|Overall Study|Patient off study, IRB hold.|0|||
128838002|NCT01757288|463702680|FG001|Overall Study|Patient off study, IRB hold.|0|||
128838003|NCT01757288|463702681|FG002|Overall Study|Patient off study, IRB hold.|1|||
128838004|NCT01757288|463702679|FG000|Overall Study|Patient death prior to starting treatment|0|||
128838005|NCT01757288|463702680|FG001|Overall Study|Patient death prior to starting treatment|0|||
128838006|NCT01757288|463702681|FG002|Overall Study|Patient death prior to starting treatment|1|||
128838007|NCT01757288|463702679|FG000|Overall Study|Wrong medication administered|0|||
128838008|NCT01757288|463702680|FG001|Overall Study|Wrong medication administered|1|||
128838009|NCT01757288|463702681|FG002|Overall Study|Wrong medication administered|0|||
128838010|NCT01757288|463702679|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
128838011|NCT01757288|463702680|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
128838012|NCT01757288|463702681|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
128838013|NCT01757288|463702679|FG000|Overall Study|Not meeting protocol constraints|0|||
128838014|NCT01757288|463702680|FG001|Overall Study|Not meeting protocol constraints|1|||
128838015|NCT01757288|463702681|FG002|Overall Study|Not meeting protocol constraints|1|||
128838016|NCT01757288|463702679|FG000|Overall Study|Multiple missed appointments|0|||
128838017|NCT01757288|463702680|FG001|Overall Study|Multiple missed appointments|1|||
128838018|NCT01757288|463702681|FG002|Overall Study|Multiple missed appointments|0|||
128838019|NCT01757288|463702679|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
128838020|NCT01757288|463702680|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
128838021|NCT01757288|463702681|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
128838022|NCT01757288|463702679|FG000|Overall Study|>2 weeks treatment break|0|||
128838023|NCT01757288|463702680|FG001|Overall Study|>2 weeks treatment break|0|||
128838024|NCT01757288|463702681|FG002|Overall Study|>2 weeks treatment break|1|||
128838025|NCT00042939|463702682|FG000|Overall Study|Adverse Event|6|||
128838026|NCT00042939|463702683|FG001|Overall Study|Adverse Event|7|||
128838027|NCT00042939|463702682|FG000|Overall Study|Death|3|||
128838028|NCT00042939|463702683|FG001|Overall Study|Death|2|||
128838029|NCT00042939|463702682|FG000|Overall Study|Withdrawal by Subject|3|||
128838030|NCT00042939|463702683|FG001|Overall Study|Withdrawal by Subject|4|||
128838031|NCT00042939|463702682|FG000|Overall Study|Other disease|1|||
128838032|NCT00042939|463702683|FG001|Overall Study|Other disease|0|||
128838033|NCT00042939|463702682|FG000|Overall Study|Ineligible|2|||
128838034|NCT00042939|463702683|FG001|Overall Study|Ineligible|2|||
128838035|NCT00042939|463702682|FG000|Overall Study|Deterioration of health|3|||
128838036|NCT00042939|463702683|FG001|Overall Study|Deterioration of health|4|||
128838037|NCT00042939|463702682|FG000|Overall Study|QOL diminished|1|||
128838038|NCT00042939|463702683|FG001|Overall Study|QOL diminished|0|||
128838039|NCT00042939|463702682|FG000|Overall Study|Rising ca 19-9|1|||
128838040|NCT00042939|463702683|FG001|Overall Study|Rising ca 19-9|0|||
128838041|NCT00042939|463702682|FG000|Overall Study|Patient non-compliance|1|||
128838042|NCT00042939|463702683|FG001|Overall Study|Patient non-compliance|0|||
128838043|NCT00042939|463702682|FG000|Overall Study|Still on treatment|1|||
128838044|NCT00042939|463702683|FG001|Overall Study|Still on treatment|0|||
128838045|NCT00042939|463702682|FG000|Overall Study|Treatment break > 4 weeks|0|||
128838046|NCT00042939|463702683|FG001|Overall Study|Treatment break > 4 weeks|1|||
128838047|NCT00042939|463702682|FG000|Overall Study|Did not start treatment|2|||
128838048|NCT00042939|463702683|FG001|Overall Study|Did not start treatment|1|||
128838049|NCT02525744|463702684|FG000|Period 1|Physician Decision|0|||
128838050|NCT02525744|463702685|FG001|Period 1|Physician Decision|0|||
128838051|NCT02525744|463702686|FG002|Period 1|Physician Decision|1|||
128838052|NCT02525744|463702687|FG003|Period 1|Physician Decision|0|||
128838053|NCT02525744|463702684|FG000|Period 3|Adverse Event|0|||
128838054|NCT02525744|463702685|FG001|Period 3|Adverse Event|1|||
128838055|NCT02525744|463702686|FG002|Period 3|Adverse Event|0|||
128838056|NCT02525744|463702687|FG003|Period 3|Adverse Event|0|||
128838057|NCT02525744|463702684|FG000|Period 4|Withdrawal by Subject|1|||
128838058|NCT02525744|463702685|FG001|Period 4|Withdrawal by Subject|0|||
128838059|NCT02525744|463702686|FG002|Period 4|Withdrawal by Subject|0|||
128838060|NCT02525744|463702687|FG003|Period 4|Withdrawal by Subject|0|||
128838061|NCT02525744|463702684|FG000|Period 5|Physician Decision|1|||
128838062|NCT02525744|463702685|FG001|Period 5|Physician Decision|0|||
128838063|NCT02525744|463702686|FG002|Period 5|Physician Decision|0|||
128838064|NCT02525744|463702687|FG003|Period 5|Physician Decision|0|||
128838065|NCT01777932|463702688|FG000|Overall Study|Disease progression|136|||
128838066|NCT01777932|463702688|FG000|Overall Study|Death|3|||
128838067|NCT01777932|463702688|FG000|Overall Study|Adverse Event|34|||
128838068|NCT01777932|463702688|FG000|Overall Study|Lost to Follow-up|3|||
128838069|NCT01777932|463702688|FG000|Overall Study|Investigator decision|10|||
128838070|NCT01777932|463702688|FG000|Overall Study|Reimbursement limit|9|||
128838071|NCT01777932|463702688|FG000|Overall Study|Patient refused further treatment|10|||
128838072|NCT02514824|463702693|FG000|Overall Study|Withdrawal by Subject|1|||
128838073|NCT02514824|463702694|FG001|Overall Study|Withdrawal by Subject|0|||
128838074|NCT02514824|463702695|FG002|Overall Study|Withdrawal by Subject|0|||
128838075|NCT02514824|463702696|FG003|Overall Study|Withdrawal by Subject|0|||
128838076|NCT02514824|463702693|FG000|Overall Study|Dose-Limiting Toxicity|0|||
128838077|NCT02514824|463702694|FG001|Overall Study|Dose-Limiting Toxicity|1|||
128838078|NCT02514824|463702695|FG002|Overall Study|Dose-Limiting Toxicity|0|||
128838079|NCT02514824|463702696|FG003|Overall Study|Dose-Limiting Toxicity|0|||
128838080|NCT01930188|463702697|FG000|Overall Study|unclassified|4|||
128838081|NCT01930188|463702698|FG001|Overall Study|unclassified|5|||
128838082|NCT01930188|463702699|FG002|Overall Study|unclassified|3|||
128838083|NCT01930188|463702697|FG000|Overall Study|Missing follow-up information|2|||
128838084|NCT01930188|463702698|FG001|Overall Study|Missing follow-up information|2|||
128838085|NCT01930188|463702699|FG002|Overall Study|Missing follow-up information|3|||
128838086|NCT01930188|463702697|FG000|Overall Study|Lost to Follow-up|5|||
128838087|NCT01930188|463702698|FG001|Overall Study|Lost to Follow-up|2|||
128838088|NCT01930188|463702699|FG002|Overall Study|Lost to Follow-up|2|||
128838089|NCT01930188|463702697|FG000|Overall Study|Death|2|||
128838090|NCT01930188|463702698|FG001|Overall Study|Death|1|||
128838091|NCT01930188|463702699|FG002|Overall Study|Death|3|||
128838092|NCT01930188|463702697|FG000|Overall Study|Withdrawal by Subject|9|||
128838093|NCT01930188|463702698|FG001|Overall Study|Withdrawal by Subject|11|||
128838094|NCT01930188|463702699|FG002|Overall Study|Withdrawal by Subject|8|||
128838095|NCT03150589|463702700|FG000|Overall Study|Withdrawal by Subject|16|||
128838096|NCT03150589|463702701|FG001|Overall Study|Withdrawal by Subject|9|||
128838097|NCT03150589|463702700|FG000|Overall Study|Adverse Event|7|||
128838098|NCT03150589|463702701|FG001|Overall Study|Adverse Event|6|||
128838099|NCT03150589|463702700|FG000|Overall Study|Protocol Violation|4|||
128838100|NCT03150589|463702701|FG001|Overall Study|Protocol Violation|3|||
128838101|NCT03150589|463702700|FG000|Overall Study|Lost to Follow-up|3|||
128838102|NCT03150589|463702701|FG001|Overall Study|Lost to Follow-up|3|||
128838103|NCT03150589|463702700|FG000|Overall Study|Death|2|||
128838104|NCT03150589|463702701|FG001|Overall Study|Death|3|||
128838105|NCT03150589|463702700|FG000|Overall Study|IP non-compliance and other reasons|12|||
128838106|NCT03150589|463702701|FG001|Overall Study|IP non-compliance and other reasons|3|||
128838107|NCT01020435|463702704|FG000|Overall Study|Lost to Follow-up|0|||
128838108|NCT01020435|463702705|FG001|Overall Study|Lost to Follow-up|1|||
128838109|NCT01000649|463702706|FG000|Overall Study|Adverse Event|5|||
128838110|NCT01000649|463702707|FG001|Overall Study|Adverse Event|1|||
128838111|NCT01000649|463702708|FG002|Overall Study|Adverse Event|2|||
128838112|NCT01000649|463702709|FG003|Overall Study|Adverse Event|4|||
128838113|NCT01000649|463702706|FG000|Overall Study|Lost to Follow-up|0|||
128838114|NCT01000649|463702707|FG001|Overall Study|Lost to Follow-up|2|||
128838115|NCT01000649|463702708|FG002|Overall Study|Lost to Follow-up|0|||
128838116|NCT01000649|463702709|FG003|Overall Study|Lost to Follow-up|2|||
128838117|NCT00346398|463702710|FG000|Overall Study|Lost to Follow-up|3|||
128838118|NCT00346398|463702711|FG001|Overall Study|Lost to Follow-up|0|||
128838119|NCT00346398|463702710|FG000|Overall Study|Withdrawal by Subject|0|||
128838120|NCT00346398|463702711|FG001|Overall Study|Withdrawal by Subject|2|||
128838121|NCT02607956|463702712|FG000|Double-Blinded Phase|Withdrew Consent|17|||
128838122|NCT02607956|463702713|FG001|Double-Blinded Phase|Withdrew Consent|19|||
128838123|NCT02607956|463702714|FG002|Double-Blinded Phase|Withdrew Consent|0|||
128838124|NCT02607956|463702715|FG003|Double-Blinded Phase|Withdrew Consent|0|||
128838125|NCT02607956|463702712|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
128838126|NCT02607956|463702713|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
128838127|NCT02607956|463702714|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
128838128|NCT02607956|463702715|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
128838129|NCT02607956|463702712|FG000|Double-Blinded Phase|Randomized but never treated|7|||
128838130|NCT02607956|463702713|FG001|Double-Blinded Phase|Randomized but never treated|5|||
128838131|NCT02607956|463702714|FG002|Double-Blinded Phase|Randomized but never treated|0|||
128838132|NCT02607956|463702715|FG003|Double-Blinded Phase|Randomized but never treated|0|||
128838133|NCT02607956|463702712|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
128838134|NCT02607956|463702713|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
128838135|NCT02607956|463702714|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
128838136|NCT02607956|463702715|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
128838137|NCT02607956|463702712|FG000|Double-Blinded Phase|Death|4|||
128838138|NCT02607956|463702713|FG001|Double-Blinded Phase|Death|4|||
128838139|NCT02607956|463702714|FG002|Double-Blinded Phase|Death|0|||
128838140|NCT02607956|463702715|FG003|Double-Blinded Phase|Death|0|||
128838141|NCT02607956|463702712|FG000|Double-Blinded Phase|Adverse Event|4|||
128838142|NCT02607956|463702713|FG001|Double-Blinded Phase|Adverse Event|3|||
128838143|NCT02607956|463702714|FG002|Double-Blinded Phase|Adverse Event|0|||
128838144|NCT02607956|463702715|FG003|Double-Blinded Phase|Adverse Event|0|||
128838145|NCT02607956|463702712|FG000|Double-Blinded Phase|Protocol Violation|3|||
128838146|NCT02607956|463702713|FG001|Double-Blinded Phase|Protocol Violation|1|||
128838147|NCT02607956|463702714|FG002|Double-Blinded Phase|Protocol Violation|0|||
128838148|NCT02607956|463702715|FG003|Double-Blinded Phase|Protocol Violation|0|||
128838149|NCT02607956|463702712|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
128838150|NCT02607956|463702713|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
128838151|NCT02607956|463702714|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
128838152|NCT02607956|463702715|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
128838153|NCT02607956|463702712|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
128838154|NCT02607956|463702713|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
128838155|NCT02607956|463702714|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
128838156|NCT02607956|463702715|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
128838157|NCT02607956|463702712|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
128838158|NCT02607956|463702713|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
128838159|NCT02607956|463702714|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
128838160|NCT02607956|463702715|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
128838161|NCT02607956|463702712|FG000|Open-Label Extension Phase|Death|0|||
128838162|NCT02607956|463702713|FG001|Open-Label Extension Phase|Death|0|||
128838163|NCT02607956|463702714|FG002|Open-Label Extension Phase|Death|1|||
128838164|NCT02607956|463702715|FG003|Open-Label Extension Phase|Death|3|||
128838165|NCT02607956|463702712|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
128838166|NCT02607956|463702713|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
128838167|NCT02607956|463702714|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
128838168|NCT02607956|463702715|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
128838169|NCT02607956|463702712|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
128838170|NCT02607956|463702713|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
128838171|NCT02607956|463702714|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
128838172|NCT02607956|463702715|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
128838173|NCT02607956|463702712|FG000|Open-Label Extension Phase|Protocol Violation|0|||
128838174|NCT02607956|463702713|FG001|Open-Label Extension Phase|Protocol Violation|0|||
128838175|NCT02607956|463702714|FG002|Open-Label Extension Phase|Protocol Violation|0|||
128838176|NCT02607956|463702715|FG003|Open-Label Extension Phase|Protocol Violation|2|||
128838177|NCT02607956|463702712|FG000|Open-Label Extension Phase|Pregnancy|0|||
128838178|NCT02607956|463702713|FG001|Open-Label Extension Phase|Pregnancy|0|||
128838179|NCT02607956|463702714|FG002|Open-Label Extension Phase|Pregnancy|0|||
128838180|NCT02607956|463702715|FG003|Open-Label Extension Phase|Pregnancy|1|||
128838181|NCT00103857|463702716|FG000|54-Week Base Study|Adverse Event|12|||
128838182|NCT00103857|463702717|FG001|54-Week Base Study|Adverse Event|9|||
128838183|NCT00103857|463702718|FG002|54-Week Base Study|Adverse Event|11|||
128838184|NCT00103857|463702719|FG003|54-Week Base Study|Adverse Event|6|||
128838185|NCT00103857|463702720|FG004|54-Week Base Study|Adverse Event|5|||
128838186|NCT00103857|463702721|FG005|54-Week Base Study|Adverse Event|11|||
128838187|NCT00103857|463702722|FG006|54-Week Base Study|Adverse Event|3|||
128838188|NCT00103857|463702716|FG000|54-Week Base Study|Death|0|||
128838189|NCT00103857|463702717|FG001|54-Week Base Study|Death|0|||
128838190|NCT00103857|463702718|FG002|54-Week Base Study|Death|0|||
128838191|NCT00103857|463702719|FG003|54-Week Base Study|Death|0|||
128838192|NCT00103857|463702720|FG004|54-Week Base Study|Death|1|||
128838193|NCT00103857|463702721|FG005|54-Week Base Study|Death|1|||
128838194|NCT00103857|463702722|FG006|54-Week Base Study|Death|0|||
128838195|NCT00103857|463702716|FG000|54-Week Base Study|Lack of Efficacy|11|||
128838196|NCT00103857|463702717|FG001|54-Week Base Study|Lack of Efficacy|14|||
128838197|NCT00103857|463702718|FG002|54-Week Base Study|Lack of Efficacy|8|||
128838198|NCT00103857|463702719|FG003|54-Week Base Study|Lack of Efficacy|4|||
128838199|NCT00103857|463702720|FG004|54-Week Base Study|Lack of Efficacy|3|||
128838200|NCT00103857|463702721|FG005|54-Week Base Study|Lack of Efficacy|14|||
128838201|NCT00103857|463702722|FG006|54-Week Base Study|Lack of Efficacy|19|||
128838202|NCT00103857|463702716|FG000|54-Week Base Study|Lost to Follow-up|5|||
128838203|NCT00103857|463702717|FG001|54-Week Base Study|Lost to Follow-up|4|||
128838204|NCT00103857|463702718|FG002|54-Week Base Study|Lost to Follow-up|7|||
128838205|NCT00103857|463702719|FG003|54-Week Base Study|Lost to Follow-up|5|||
128838206|NCT00103857|463702720|FG004|54-Week Base Study|Lost to Follow-up|10|||
128838207|NCT00103857|463702721|FG005|54-Week Base Study|Lost to Follow-up|9|||
128838208|NCT00103857|463702722|FG006|54-Week Base Study|Lost to Follow-up|3|||
128838209|NCT00103857|463702716|FG000|54-Week Base Study|Physician Decision|1|||
129204958|NCT01962441|465047002|FG000|Retreatment Substudy|Lack of Efficacy|1|||
129204959|NCT01962441|465047003|FG001|Retreatment Substudy|Lack of Efficacy|0|||
128838210|NCT00103857|463702717|FG001|54-Week Base Study|Physician Decision|1|||
128838211|NCT00103857|463702718|FG002|54-Week Base Study|Physician Decision|0|||
128838212|NCT00103857|463702719|FG003|54-Week Base Study|Physician Decision|0|||
128838213|NCT00103857|463702720|FG004|54-Week Base Study|Physician Decision|1|||
128838214|NCT00103857|463702721|FG005|54-Week Base Study|Physician Decision|0|||
128838215|NCT00103857|463702722|FG006|54-Week Base Study|Physician Decision|0|||
128838216|NCT00103857|463702716|FG000|54-Week Base Study|Pregnancy|1|||
128838217|NCT00103857|463702717|FG001|54-Week Base Study|Pregnancy|0|||
128838218|NCT00103857|463702718|FG002|54-Week Base Study|Pregnancy|0|||
128838219|NCT00103857|463702719|FG003|54-Week Base Study|Pregnancy|0|||
128838220|NCT00103857|463702720|FG004|54-Week Base Study|Pregnancy|1|||
128838221|NCT00103857|463702721|FG005|54-Week Base Study|Pregnancy|0|||
128838222|NCT00103857|463702722|FG006|54-Week Base Study|Pregnancy|1|||
128838223|NCT00103857|463702716|FG000|54-Week Base Study|Protocol Violation|6|||
128838224|NCT00103857|463702717|FG001|54-Week Base Study|Protocol Violation|4|||
128838225|NCT00103857|463702718|FG002|54-Week Base Study|Protocol Violation|2|||
128838226|NCT00103857|463702719|FG003|54-Week Base Study|Protocol Violation|4|||
128838227|NCT00103857|463702720|FG004|54-Week Base Study|Protocol Violation|0|||
128838228|NCT00103857|463702721|FG005|54-Week Base Study|Protocol Violation|3|||
128838229|NCT00103857|463702722|FG006|54-Week Base Study|Protocol Violation|3|||
128838230|NCT00103857|463702716|FG000|54-Week Base Study|Withdrawal by Subject|17|||
128838231|NCT00103857|463702717|FG001|54-Week Base Study|Withdrawal by Subject|16|||
128838232|NCT00103857|463702718|FG002|54-Week Base Study|Withdrawal by Subject|16|||
128838233|NCT00103857|463702719|FG003|54-Week Base Study|Withdrawal by Subject|15|||
128838234|NCT00103857|463702720|FG004|54-Week Base Study|Withdrawal by Subject|10|||
128838235|NCT00103857|463702721|FG005|54-Week Base Study|Withdrawal by Subject|15|||
128838236|NCT00103857|463702722|FG006|54-Week Base Study|Withdrawal by Subject|4|||
128838237|NCT00103857|463702716|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
128838238|NCT00103857|463702717|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
128838239|NCT00103857|463702718|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
128838240|NCT00103857|463702719|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
128838241|NCT00103857|463702720|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
128838242|NCT00103857|463702721|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
128838243|NCT00103857|463702722|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
128838244|NCT00103857|463702716|FG000|54-Week Base Study|patient moved|0|||
128838245|NCT00103857|463702717|FG001|54-Week Base Study|patient moved|1|||
128838246|NCT00103857|463702718|FG002|54-Week Base Study|patient moved|1|||
128838247|NCT00103857|463702719|FG003|54-Week Base Study|patient moved|2|||
128838248|NCT00103857|463702720|FG004|54-Week Base Study|patient moved|3|||
128838249|NCT00103857|463702721|FG005|54-Week Base Study|patient moved|1|||
128838250|NCT00103857|463702722|FG006|54-Week Base Study|patient moved|0|||
128838251|NCT00103857|463702716|FG000|54-Week Base Study|non-compliance with study procedures|1|||
128838252|NCT00103857|463702717|FG001|54-Week Base Study|non-compliance with study procedures|2|||
128838253|NCT00103857|463702718|FG002|54-Week Base Study|non-compliance with study procedures|0|||
128838254|NCT00103857|463702719|FG003|54-Week Base Study|non-compliance with study procedures|0|||
128838255|NCT00103857|463702720|FG004|54-Week Base Study|non-compliance with study procedures|0|||
128838256|NCT00103857|463702721|FG005|54-Week Base Study|non-compliance with study procedures|2|||
128838257|NCT00103857|463702722|FG006|54-Week Base Study|non-compliance with study procedures|0|||
128838258|NCT00103857|463702716|FG000|54-Week Base Study|patient incarcerated|0|||
128838259|NCT00103857|463702717|FG001|54-Week Base Study|patient incarcerated|0|||
128838260|NCT00103857|463702718|FG002|54-Week Base Study|patient incarcerated|0|||
128838261|NCT00103857|463702719|FG003|54-Week Base Study|patient incarcerated|0|||
128838262|NCT00103857|463702720|FG004|54-Week Base Study|patient incarcerated|1|||
128838263|NCT00103857|463702721|FG005|54-Week Base Study|patient incarcerated|1|||
128838264|NCT00103857|463702722|FG006|54-Week Base Study|patient incarcerated|0|||
128838265|NCT00103857|463702716|FG000|54-Week Base Study|laboratory reporting error|0|||
128838266|NCT00103857|463702717|FG001|54-Week Base Study|laboratory reporting error|0|||
128838267|NCT00103857|463702718|FG002|54-Week Base Study|laboratory reporting error|0|||
128838268|NCT00103857|463702719|FG003|54-Week Base Study|laboratory reporting error|0|||
128838269|NCT00103857|463702720|FG004|54-Week Base Study|laboratory reporting error|1|||
128838270|NCT00103857|463702721|FG005|54-Week Base Study|laboratory reporting error|0|||
128838271|NCT00103857|463702722|FG006|54-Week Base Study|laboratory reporting error|0|||
128838272|NCT00103857|463702716|FG000|54-Week Base Study|site error|0|||
128838273|NCT00103857|463702717|FG001|54-Week Base Study|site error|0|||
128838274|NCT00103857|463702718|FG002|54-Week Base Study|site error|0|||
128838275|NCT00103857|463702719|FG003|54-Week Base Study|site error|0|||
128838276|NCT00103857|463702720|FG004|54-Week Base Study|site error|0|||
128838277|NCT00103857|463702721|FG005|54-Week Base Study|site error|1|||
128838278|NCT00103857|463702722|FG006|54-Week Base Study|site error|0|||
128838279|NCT00103857|463702716|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
128838280|NCT00103857|463702717|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
128838281|NCT00103857|463702718|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
128838282|NCT00103857|463702719|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
128838283|NCT00103857|463702720|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
128838284|NCT00103857|463702721|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
128838285|NCT00103857|463702722|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
128838286|NCT00103857|463702716|FG000|50-Week Extension Study|Adverse Event|2|||
128838287|NCT00103857|463702717|FG001|50-Week Extension Study|Adverse Event|3|||
128838288|NCT00103857|463702718|FG002|50-Week Extension Study|Adverse Event|2|||
128838289|NCT00103857|463702719|FG003|50-Week Extension Study|Adverse Event|0|||
128838290|NCT00103857|463702720|FG004|50-Week Extension Study|Adverse Event|1|||
128838291|NCT00103857|463702721|FG005|50-Week Extension Study|Adverse Event|1|||
128838292|NCT00103857|463702722|FG006|50-Week Extension Study|Adverse Event|0|||
128838293|NCT00103857|463702716|FG000|50-Week Extension Study|Death|0|||
128838294|NCT00103857|463702717|FG001|50-Week Extension Study|Death|0|||
128838295|NCT00103857|463702718|FG002|50-Week Extension Study|Death|0|||
128838296|NCT00103857|463702719|FG003|50-Week Extension Study|Death|1|||
128838297|NCT00103857|463702720|FG004|50-Week Extension Study|Death|0|||
128838298|NCT00103857|463702721|FG005|50-Week Extension Study|Death|1|||
128838299|NCT00103857|463702722|FG006|50-Week Extension Study|Death|0|||
128838300|NCT00103857|463702716|FG000|50-Week Extension Study|Lack of Efficacy|26|||
128838301|NCT00103857|463702717|FG001|50-Week Extension Study|Lack of Efficacy|15|||
128838302|NCT00103857|463702718|FG002|50-Week Extension Study|Lack of Efficacy|13|||
128838303|NCT00103857|463702719|FG003|50-Week Extension Study|Lack of Efficacy|16|||
128838304|NCT00103857|463702720|FG004|50-Week Extension Study|Lack of Efficacy|8|||
128838305|NCT00103857|463702721|FG005|50-Week Extension Study|Lack of Efficacy|8|||
128838306|NCT00103857|463702722|FG006|50-Week Extension Study|Lack of Efficacy|0|||
128838307|NCT00103857|463702716|FG000|50-Week Extension Study|Lost to Follow-up|4|||
128838308|NCT00103857|463702717|FG001|50-Week Extension Study|Lost to Follow-up|0|||
128838309|NCT00103857|463702718|FG002|50-Week Extension Study|Lost to Follow-up|1|||
128838310|NCT00103857|463702719|FG003|50-Week Extension Study|Lost to Follow-up|4|||
128838311|NCT00103857|463702720|FG004|50-Week Extension Study|Lost to Follow-up|3|||
128838312|NCT00103857|463702721|FG005|50-Week Extension Study|Lost to Follow-up|3|||
128838313|NCT00103857|463702722|FG006|50-Week Extension Study|Lost to Follow-up|0|||
128838314|NCT00103857|463702716|FG000|50-Week Extension Study|Physician Decision|0|||
128838315|NCT00103857|463702717|FG001|50-Week Extension Study|Physician Decision|1|||
128838316|NCT00103857|463702718|FG002|50-Week Extension Study|Physician Decision|1|||
128838317|NCT00103857|463702719|FG003|50-Week Extension Study|Physician Decision|0|||
128838318|NCT00103857|463702720|FG004|50-Week Extension Study|Physician Decision|0|||
128838319|NCT00103857|463702721|FG005|50-Week Extension Study|Physician Decision|0|||
128838320|NCT00103857|463702722|FG006|50-Week Extension Study|Physician Decision|0|||
128838321|NCT00103857|463702716|FG000|50-Week Extension Study|Pregnancy|0|||
128838322|NCT00103857|463702717|FG001|50-Week Extension Study|Pregnancy|0|||
128838323|NCT00103857|463702718|FG002|50-Week Extension Study|Pregnancy|1|||
128838324|NCT00103857|463702719|FG003|50-Week Extension Study|Pregnancy|0|||
128838325|NCT00103857|463702720|FG004|50-Week Extension Study|Pregnancy|1|||
128838326|NCT00103857|463702721|FG005|50-Week Extension Study|Pregnancy|0|||
128838327|NCT00103857|463702722|FG006|50-Week Extension Study|Pregnancy|0|||
128838328|NCT00103857|463702716|FG000|50-Week Extension Study|Protocol Violation|1|||
128838329|NCT00103857|463702717|FG001|50-Week Extension Study|Protocol Violation|1|||
128838330|NCT00103857|463702718|FG002|50-Week Extension Study|Protocol Violation|1|||
128838331|NCT00103857|463702719|FG003|50-Week Extension Study|Protocol Violation|2|||
128838332|NCT00103857|463702720|FG004|50-Week Extension Study|Protocol Violation|0|||
128838333|NCT00103857|463702721|FG005|50-Week Extension Study|Protocol Violation|1|||
128838334|NCT00103857|463702722|FG006|50-Week Extension Study|Protocol Violation|0|||
128838335|NCT00103857|463702716|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
128838336|NCT00103857|463702717|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
128838337|NCT00103857|463702718|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
128838338|NCT00103857|463702719|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
128838339|NCT00103857|463702720|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
128838340|NCT00103857|463702721|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
128838341|NCT00103857|463702722|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
128838342|NCT00103857|463702716|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
128838343|NCT00103857|463702717|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
128838344|NCT00103857|463702718|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
128838345|NCT00103857|463702719|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
128838346|NCT00103857|463702720|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
128838347|NCT00103857|463702721|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
128838348|NCT00103857|463702722|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
128838349|NCT00103857|463702716|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
128838350|NCT00103857|463702717|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
128838351|NCT00103857|463702718|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
128838352|NCT00103857|463702719|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
128838353|NCT00103857|463702720|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
128838354|NCT00103857|463702721|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
128838355|NCT00103857|463702722|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
128838356|NCT00103857|463702716|FG000|50-Week Extension Study|patient moved|0|||
128838357|NCT00103857|463702717|FG001|50-Week Extension Study|patient moved|0|||
128838358|NCT00103857|463702718|FG002|50-Week Extension Study|patient moved|1|||
128838359|NCT00103857|463702719|FG003|50-Week Extension Study|patient moved|2|||
128838360|NCT00103857|463702720|FG004|50-Week Extension Study|patient moved|0|||
128838361|NCT00103857|463702721|FG005|50-Week Extension Study|patient moved|0|||
128838362|NCT00103857|463702722|FG006|50-Week Extension Study|patient moved|0|||
128838363|NCT00103857|463702716|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
128838364|NCT00103857|463702717|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
128838365|NCT00103857|463702718|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
128838366|NCT00103857|463702719|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
128838367|NCT00103857|463702720|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
128838368|NCT00103857|463702721|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
128838369|NCT00103857|463702722|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
128838370|NCT00103857|463702716|FG000|50-Week Extension Study|reason unspecified|0|||
128838371|NCT00103857|463702717|FG001|50-Week Extension Study|reason unspecified|0|||
128838372|NCT00103857|463702718|FG002|50-Week Extension Study|reason unspecified|0|||
128838373|NCT00103857|463702719|FG003|50-Week Extension Study|reason unspecified|0|||
128838374|NCT00103857|463702720|FG004|50-Week Extension Study|reason unspecified|1|||
128838375|NCT00103857|463702721|FG005|50-Week Extension Study|reason unspecified|0|||
128838376|NCT00103857|463702722|FG006|50-Week Extension Study|reason unspecified|0|||
128838377|NCT01005914|463702723|FG000|Overall Study|Adverse Event|4|||
128838378|NCT01005914|463702723|FG000|Overall Study|Death|4|||
128838379|NCT01005914|463702723|FG000|Overall Study|Lack of Efficacy|1|||
128838380|NCT01005914|463702723|FG000|Overall Study|Withdrawal by Subject|1|||
128838381|NCT01240785|463702725|FG000|Overall Study|Lost to Follow-up|1|||
128838382|NCT01240785|463702726|FG001|Overall Study|Lost to Follow-up|0|||
128838383|NCT01240785|463702725|FG000|Overall Study|Protocol Violation|0|||
128838384|NCT01240785|463702726|FG001|Overall Study|Protocol Violation|3|||
128838385|NCT02132195|463702729|FG000|Initial Assignment|Relapsed|14|||
128838386|NCT02132195|463702730|FG001|Initial Assignment|Relapsed|0|||
128838387|NCT02132195|463702731|FG002|Initial Assignment|Relapsed|0|||
128838388|NCT02132195|463702729|FG000|Rescue Therapy|Relapsed|0|||
128838389|NCT02132195|463702730|FG001|Rescue Therapy|Relapsed|0|||
128838390|NCT02132195|463702731|FG002|Rescue Therapy|Relapsed|7|||
128838391|NCT02132195|463702729|FG000|Rescue Therapy|Physician Decision|0|||
128838392|NCT02132195|463702730|FG001|Rescue Therapy|Physician Decision|0|||
128838393|NCT02132195|463702731|FG002|Rescue Therapy|Physician Decision|1|||
128838394|NCT02132195|463702729|FG000|Rescue Therapy|Withdrawal by Subject|0|||
128838395|NCT02132195|463702730|FG001|Rescue Therapy|Withdrawal by Subject|0|||
128838396|NCT02132195|463702731|FG002|Rescue Therapy|Withdrawal by Subject|1|||
128838397|NCT02132195|463702729|FG000|Rescue Therapy|Adverse Event|0|||
128838398|NCT02132195|463702730|FG001|Rescue Therapy|Adverse Event|0|||
128838399|NCT02132195|463702731|FG002|Rescue Therapy|Adverse Event|2|||
128838400|NCT03065400|463702734|FG000|Overall Study|Adverse Event|1|||
128838401|NCT03065400|463702734|FG000|Overall Study|Physician Decision|3|||
128838402|NCT03065400|463702734|FG000|Overall Study|Withdrawal by Subject|1|||
128838403|NCT03065400|463702734|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
128838404|NCT02102724|463702735|FG000|Overall Study|Lost to Follow-up|1|||
128838405|NCT02102724|463702736|FG001|Overall Study|Lost to Follow-up|0|||
128838406|NCT02102724|463702735|FG000|Overall Study|surgery for brain aneurysm|1|||
128838407|NCT02102724|463702736|FG001|Overall Study|surgery for brain aneurysm|1|||
128838408|NCT03072862|463702737|FG000|Overall Study|Withdrawal by Subject|4|||
128838409|NCT03072862|463702737|FG000|Overall Study|Lost to Follow-up|6|||
128838410|NCT03072862|463702737|FG000|Overall Study|Protocol Violation|4|||
128838411|NCT03072862|463702737|FG000|Overall Study|Physician Decision|2|||
128838412|NCT03072862|463702737|FG000|Overall Study|Death|1|||
128838413|NCT03072862|463702737|FG000|Overall Study|Adverse Event|1|||
128838414|NCT02203513|463702738|FG000|Overall Study|Refused further treatment|2|||
128838415|NCT02203513|463702739|FG001|Overall Study|Refused further treatment|0|||
128838416|NCT02203513|463702740|FG002|Overall Study|Refused further treatment|1|||
128838417|NCT02203513|463702741|FG003|Overall Study|Refused further treatment|0|||
128838418|NCT02203513|463702742|FG004|Overall Study|Refused further treatment|0|||
128838419|NCT02203513|463702738|FG000|Overall Study|Switched to alternative treatment|3|||
128838420|NCT02203513|463702739|FG001|Overall Study|Switched to alternative treatment|4|||
128838421|NCT02203513|463702740|FG002|Overall Study|Switched to alternative treatment|0|||
128838422|NCT02203513|463702741|FG003|Overall Study|Switched to alternative treatment|0|||
128838423|NCT02203513|463702742|FG004|Overall Study|Switched to alternative treatment|4|||
128838424|NCT02203513|463702738|FG000|Overall Study|Did not receive investigational product (IP)|0|||
128838425|NCT02203513|463702739|FG001|Overall Study|Did not receive investigational product (IP)|1|||
128838426|NCT02203513|463702740|FG002|Overall Study|Did not receive investigational product (IP)|0|||
128838427|NCT02203513|463702741|FG003|Overall Study|Did not receive investigational product (IP)|0|||
128838428|NCT02203513|463702742|FG004|Overall Study|Did not receive investigational product (IP)|0|||
128838429|NCT02203513|463702738|FG000|Overall Study|Death (unrelated to study therapy)|1|||
128838430|NCT02203513|463702739|FG001|Overall Study|Death (unrelated to study therapy)|3|||
128838431|NCT02203513|463702740|FG002|Overall Study|Death (unrelated to study therapy)|1|||
128838432|NCT02203513|463702741|FG003|Overall Study|Death (unrelated to study therapy)|0|||
128838433|NCT02203513|463702742|FG004|Overall Study|Death (unrelated to study therapy)|2|||
128838434|NCT02203513|463702738|FG000|Overall Study|Lost to Follow-up|0|||
128838435|NCT02203513|463702739|FG001|Overall Study|Lost to Follow-up|0|||
128838436|NCT02203513|463702740|FG002|Overall Study|Lost to Follow-up|1|||
128838437|NCT02203513|463702741|FG003|Overall Study|Lost to Follow-up|1|||
128838438|NCT02203513|463702742|FG004|Overall Study|Lost to Follow-up|0|||
128838439|NCT02513667|463702743|FG000|Overall Study|Withdrawal by Subject|0|||
128838440|NCT02513667|463702744|FG001|Overall Study|Withdrawal by Subject|1|||
128838441|NCT02613403|463702753|FG000|Overall Study|Lost to Follow-up|0|||
128838442|NCT02613403|463702754|FG001|Overall Study|Lost to Follow-up|1|||
128838443|NCT02613403|463702755|FG002|Overall Study|Lost to Follow-up|0|||
128838444|NCT02613403|463702756|FG003|Overall Study|Lost to Follow-up|0|||
128838445|NCT02613403|463702757|FG004|Overall Study|Lost to Follow-up|0|||
128838446|NCT02613403|463702753|FG000|Overall Study|Withdrawal by Subject|2|||
128838447|NCT02613403|463702754|FG001|Overall Study|Withdrawal by Subject|0|||
128838448|NCT02613403|463702755|FG002|Overall Study|Withdrawal by Subject|0|||
128838449|NCT02613403|463702756|FG003|Overall Study|Withdrawal by Subject|0|||
128838450|NCT02613403|463702757|FG004|Overall Study|Withdrawal by Subject|0|||
128838451|NCT01147471|463702758|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
128838452|NCT01147471|463702759|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
128838453|NCT01147471|463702758|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
128838454|NCT01147471|463702759|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
128838455|NCT01147471|463702758|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
128838456|NCT01147471|463702759|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
128838457|NCT01147471|463702758|FG000|3 Month Follow Up|Lost to Follow-up|1|||
128838458|NCT01147471|463702759|FG001|3 Month Follow Up|Lost to Follow-up|1|||
128838459|NCT01147471|463702758|FG000|3 Month Follow Up|Physician Decision|0|||
128838460|NCT01147471|463702759|FG001|3 Month Follow Up|Physician Decision|1|||
128838461|NCT01147471|463702758|FG000|6 Month Follow Up|Lost to Follow-up|4|||
128838462|NCT01147471|463702759|FG001|6 Month Follow Up|Lost to Follow-up|2|||
128838463|NCT00800176|463702764|FG000|Overall Study|Adverse Event|2|||
128838464|NCT00800176|463702765|FG001|Overall Study|Adverse Event|1|||
128838465|NCT00800176|463702766|FG002|Overall Study|Adverse Event|0|||
128838466|NCT00800176|463702767|FG003|Overall Study|Adverse Event|2|||
128838467|NCT00800176|463702768|FG004|Overall Study|Adverse Event|1|||
128838468|NCT00800176|463702769|FG005|Overall Study|Adverse Event|1|||
128838469|NCT00800176|463702764|FG000|Overall Study|Refused treatment|3|||
128838470|NCT00800176|463702765|FG001|Overall Study|Refused treatment|2|||
128838471|NCT00800176|463702766|FG002|Overall Study|Refused treatment|0|||
128838472|NCT00800176|463702767|FG003|Overall Study|Refused treatment|0|||
128838473|NCT00800176|463702768|FG004|Overall Study|Refused treatment|1|||
128838474|NCT00800176|463702769|FG005|Overall Study|Refused treatment|4|||
128838475|NCT00800176|463702764|FG000|Overall Study|Failure to return|3|||
128838476|NCT00800176|463702765|FG001|Overall Study|Failure to return|3|||
128838477|NCT00800176|463702766|FG002|Overall Study|Failure to return|0|||
128838478|NCT00800176|463702767|FG003|Overall Study|Failure to return|2|||
128838479|NCT00800176|463702768|FG004|Overall Study|Failure to return|0|||
128838480|NCT00800176|463702769|FG005|Overall Study|Failure to return|0|||
128838481|NCT00800176|463702764|FG000|Overall Study|Other|1|||
128838482|NCT00800176|463702765|FG001|Overall Study|Other|0|||
128838483|NCT00800176|463702766|FG002|Overall Study|Other|0|||
128838484|NCT00800176|463702767|FG003|Overall Study|Other|0|||
128838485|NCT00800176|463702768|FG004|Overall Study|Other|2|||
128838486|NCT00800176|463702769|FG005|Overall Study|Other|0|||
128838487|NCT01294644|463702770|FG000|Overall Study|Adverse Event|2|||
128838488|NCT01294644|463702771|FG001|Overall Study|Adverse Event|0|||
128838489|NCT01294644|463702772|FG002|Overall Study|Adverse Event|1|||
128838490|NCT01294644|463702770|FG000|Overall Study|Withdrawal by Subject|3|||
128838491|NCT01294644|463702771|FG001|Overall Study|Withdrawal by Subject|7|||
128838492|NCT01294644|463702772|FG002|Overall Study|Withdrawal by Subject|4|||
128838493|NCT01294644|463702770|FG000|Overall Study|Lost to Follow-up|3|||
128838494|NCT01294644|463702771|FG001|Overall Study|Lost to Follow-up|2|||
128838495|NCT01294644|463702772|FG002|Overall Study|Lost to Follow-up|5|||
128838496|NCT01294644|463702770|FG000|Overall Study|Miscellaneous Reason|2|||
128838497|NCT01294644|463702771|FG001|Overall Study|Miscellaneous Reason|1|||
128838498|NCT01294644|463702772|FG002|Overall Study|Miscellaneous Reason|4|||
128838499|NCT02188459|463702773|FG000|Overall Study|Lost to Follow-up|3|||
128838500|NCT02188459|463702774|FG001|Overall Study|Lost to Follow-up|4|||
128838501|NCT02188459|463702773|FG000|Overall Study|Early Termination|0|||
128838502|NCT02188459|463702774|FG001|Overall Study|Early Termination|3|||
128838503|NCT01986348|463702775|FG000|Overall Study|Death|8|||
128838504|NCT01986348|463702776|FG001|Overall Study|Death|22|||
128838505|NCT01986348|463702777|FG002|Overall Study|Death|10|||
128838506|NCT01986348|463702778|FG003|Overall Study|Death|21|||
128838507|NCT01986348|463702775|FG000|Overall Study|Lost to Follow-up|0|||
128838508|NCT01986348|463702776|FG001|Overall Study|Lost to Follow-up|0|||
128838509|NCT01986348|463702777|FG002|Overall Study|Lost to Follow-up|0|||
128838510|NCT01986348|463702778|FG003|Overall Study|Lost to Follow-up|2|||
128838511|NCT01986348|463702775|FG000|Overall Study|Physician Decision|0|||
128838512|NCT01986348|463702776|FG001|Overall Study|Physician Decision|0|||
128838513|NCT01986348|463702777|FG002|Overall Study|Physician Decision|0|||
128838514|NCT01986348|463702778|FG003|Overall Study|Physician Decision|1|||
128838515|NCT01986348|463702775|FG000|Overall Study|Progressive Disease|0|||
128838516|NCT01986348|463702776|FG001|Overall Study|Progressive Disease|0|||
128838517|NCT01986348|463702777|FG002|Overall Study|Progressive Disease|2|||
128838518|NCT01986348|463702778|FG003|Overall Study|Progressive Disease|0|||
128838519|NCT01986348|463702775|FG000|Overall Study|Withdrawal by Participant|0|||
128838520|NCT01986348|463702776|FG001|Overall Study|Withdrawal by Participant|1|||
128838521|NCT01986348|463702777|FG002|Overall Study|Withdrawal by Participant|2|||
128838522|NCT01986348|463702778|FG003|Overall Study|Withdrawal by Participant|1|||
128838523|NCT01986348|463702775|FG000|Overall Study|Study Terminated by Sponsor|0|||
128838524|NCT01986348|463702776|FG001|Overall Study|Study Terminated by Sponsor|0|||
128838525|NCT01986348|463702777|FG002|Overall Study|Study Terminated by Sponsor|0|||
128838526|NCT01986348|463702778|FG003|Overall Study|Study Terminated by Sponsor|3|||
128838527|NCT01986348|463702775|FG000|Overall Study|Other-unspecified|0|||
128838528|NCT01986348|463702776|FG001|Overall Study|Other-unspecified|1|||
128838529|NCT01986348|463702777|FG002|Overall Study|Other-unspecified|0|||
128838530|NCT01986348|463702778|FG003|Overall Study|Other-unspecified|2|||
128838531|NCT02548585|463702779|FG000|Overall Study|Withdrawal by Subject|0|||
128838532|NCT02548585|463702780|FG001|Overall Study|Withdrawal by Subject|0|||
128838533|NCT02548585|463702781|FG002|Overall Study|Withdrawal by Subject|0|||
128838534|NCT02548585|463702782|FG003|Overall Study|Withdrawal by Subject|0|||
128838535|NCT02548585|463702783|FG004|Overall Study|Withdrawal by Subject|0|||
128838536|NCT02548585|463702784|FG005|Overall Study|Withdrawal by Subject|1|||
128838537|NCT02548585|463702785|FG006|Overall Study|Withdrawal by Subject|0|||
128838538|NCT02548585|463702779|FG000|Overall Study|Lost to Follow-up|1|||
128838539|NCT02548585|463702780|FG001|Overall Study|Lost to Follow-up|0|||
128838540|NCT02548585|463702781|FG002|Overall Study|Lost to Follow-up|0|||
128838541|NCT02548585|463702782|FG003|Overall Study|Lost to Follow-up|0|||
128838542|NCT02548585|463702783|FG004|Overall Study|Lost to Follow-up|0|||
128838543|NCT02548585|463702784|FG005|Overall Study|Lost to Follow-up|0|||
128838544|NCT02548585|463702785|FG006|Overall Study|Lost to Follow-up|0|||
128838545|NCT02548585|463702779|FG000|Overall Study|Other|1|||
128838546|NCT02548585|463702780|FG001|Overall Study|Other|0|||
128838547|NCT02548585|463702781|FG002|Overall Study|Other|0|||
128838548|NCT02548585|463702782|FG003|Overall Study|Other|2|||
128838549|NCT02548585|463702783|FG004|Overall Study|Other|3|||
128838550|NCT02548585|463702784|FG005|Overall Study|Other|0|||
128838551|NCT02548585|463702785|FG006|Overall Study|Other|1|||
128838552|NCT02548585|463702779|FG000|Overall Study|Randomized but not treated|0|||
128838553|NCT02548585|463702780|FG001|Overall Study|Randomized but not treated|0|||
128838554|NCT02548585|463702781|FG002|Overall Study|Randomized but not treated|0|||
128838555|NCT02548585|463702782|FG003|Overall Study|Randomized but not treated|0|||
128838556|NCT02548585|463702783|FG004|Overall Study|Randomized but not treated|0|||
128838557|NCT02548585|463702784|FG005|Overall Study|Randomized but not treated|1|||
128838558|NCT02548585|463702785|FG006|Overall Study|Randomized but not treated|0|||
128838559|NCT02935894|463702787|FG000|Overall Study|Subject dismissed|1|||
128838560|NCT03242863|463702790|FG000|Study Week 1|Withdrawal by Subject|0|||
128838561|NCT03242863|463702791|FG001|Study Week 1|Withdrawal by Subject|1|||
128838562|NCT03242863|463702792|FG002|Study Week 1|Withdrawal by Subject|0|||
128838563|NCT03242863|463702793|FG003|Study Week 1|Withdrawal by Subject|0|||
128838564|NCT03242863|463702794|FG004|Study Week 1|Withdrawal by Subject|3|||
128838565|NCT03242863|463702795|FG005|Study Week 1|Withdrawal by Subject|0|||
128838566|NCT04620733|463704444|FG000|Overall Study|Adverse Event|4|||
128838567|NCT04620733|463704445|FG001|Overall Study|Adverse Event|3|||
128838568|NCT04620733|463704444|FG000|Overall Study|Withdrawal by Subject|2|||
128838569|NCT04620733|463704445|FG001|Overall Study|Withdrawal by Subject|5|||
128838570|NCT04620733|463704444|FG000|Overall Study|Lost to Follow-up|1|||
128838571|NCT04620733|463704445|FG001|Overall Study|Lost to Follow-up|1|||
128838572|NCT04620733|463704444|FG000|Overall Study|Protocol Deviation|1|||
128838573|NCT04620733|463704445|FG001|Overall Study|Protocol Deviation|1|||
128838574|NCT04620733|463704444|FG000|Overall Study|Reason Not Specified|0|||
128838575|NCT04620733|463704445|FG001|Overall Study|Reason Not Specified|1|||
128838576|NCT00264576|463704448|FG000|Overall Study|Lost to Follow-up|1|||
128838577|NCT00264576|463704449|FG001|Overall Study|Lost to Follow-up|1|||
128838578|NCT04783389|463704450|FG000|Overall Study|Withdrawal by Subject|2|||
128838579|NCT04783389|463704451|FG001|Overall Study|Withdrawal by Subject|0|||
128838580|NCT04783389|463704452|FG002|Overall Study|Withdrawal by Subject|0|||
128838581|NCT04783389|463704450|FG000|Overall Study|Termination of Study by Sponsor|10|||
128838582|NCT04783389|463704451|FG001|Overall Study|Termination of Study by Sponsor|12|||
128838583|NCT04783389|463704452|FG002|Overall Study|Termination of Study by Sponsor|14|||
128838584|NCT03924193|463704453|FG000|Overall Study|Adverse Event|10|||
128838585|NCT03924193|463704454|FG001|Overall Study|Adverse Event|0|||
128838586|NCT03924193|463704455|FG002|Overall Study|Adverse Event|10|||
128838587|NCT03924193|463704453|FG000|Overall Study|Withdrawal by Subject|5|||
128838588|NCT03924193|463704454|FG001|Overall Study|Withdrawal by Subject|10|||
128838589|NCT03924193|463704455|FG002|Overall Study|Withdrawal by Subject|2|||
128838590|NCT02489799|463704456|FG000|Overall Study|Lost to Follow-up|4|||
128838591|NCT02489799|463704457|FG001|Overall Study|Lost to Follow-up|1|||
128838592|NCT02489799|463704456|FG000|Overall Study|Failure to Maintain Eligibility|4|||
128838593|NCT02489799|463704457|FG001|Overall Study|Failure to Maintain Eligibility|6|||
128838594|NCT02489799|463704456|FG000|Overall Study|Withdrawal by Subject|1|||
128838595|NCT02489799|463704457|FG001|Overall Study|Withdrawal by Subject|1|||
128838596|NCT02489799|463704456|FG000|Overall Study|Death|0|||
128838597|NCT02489799|463704457|FG001|Overall Study|Death|1|||
128838598|NCT04909593|463704458|FG000|Overall Study|Withdrawal by Subject|1|||
128838599|NCT01241448|463704459|FG000|Overall Study|Adverse Event|1|||
128838600|NCT01241448|463704460|FG001|Overall Study|Adverse Event|0|||
128838601|NCT01241448|463704461|FG002|Overall Study|Adverse Event|2|||
128838602|NCT01241448|463704462|FG003|Overall Study|Adverse Event|2|||
128838603|NCT01241448|463704459|FG000|Overall Study|Lost to Follow-up|2|||
128838604|NCT01241448|463704460|FG001|Overall Study|Lost to Follow-up|1|||
128838605|NCT01241448|463704461|FG002|Overall Study|Lost to Follow-up|1|||
128838606|NCT01241448|463704462|FG003|Overall Study|Lost to Follow-up|1|||
128838607|NCT01241448|463704459|FG000|Overall Study|Physician Decision|0|||
128838608|NCT01241448|463704460|FG001|Overall Study|Physician Decision|2|||
128838609|NCT01241448|463704461|FG002|Overall Study|Physician Decision|0|||
128838610|NCT01241448|463704462|FG003|Overall Study|Physician Decision|0|||
128838611|NCT01241448|463704459|FG000|Overall Study|Protocol Violation|10|||
128838612|NCT01241448|463704460|FG001|Overall Study|Protocol Violation|5|||
128838613|NCT01241448|463704461|FG002|Overall Study|Protocol Violation|3|||
128838614|NCT01241448|463704462|FG003|Overall Study|Protocol Violation|6|||
128838615|NCT01241448|463704459|FG000|Overall Study|Sponsor Decision|17|||
128838616|NCT01241448|463704460|FG001|Overall Study|Sponsor Decision|14|||
128838617|NCT01241448|463704461|FG002|Overall Study|Sponsor Decision|12|||
128838618|NCT01241448|463704462|FG003|Overall Study|Sponsor Decision|6|||
128838619|NCT01241448|463704459|FG000|Overall Study|Withdrawal by Subject|4|||
128838620|NCT01241448|463704460|FG001|Overall Study|Withdrawal by Subject|5|||
128838621|NCT01241448|463704461|FG002|Overall Study|Withdrawal by Subject|3|||
128838622|NCT01241448|463704462|FG003|Overall Study|Withdrawal by Subject|6|||
128838623|NCT01241448|463704459|FG000|Overall Study|Excluded due to data integrity issues|3|||
128838624|NCT01241448|463704460|FG001|Overall Study|Excluded due to data integrity issues|2|||
128838625|NCT01241448|463704461|FG002|Overall Study|Excluded due to data integrity issues|2|||
128838626|NCT01241448|463704462|FG003|Overall Study|Excluded due to data integrity issues|2|||
128838627|NCT02092285|463704463|FG000|Induction Phase|Adverse Event|7|||
128838628|NCT02092285|463704463|FG000|Induction Phase|Physician Decision|4|||
128838629|NCT02092285|463704463|FG000|Induction Phase|Pregnancy|1|||
128838630|NCT02092285|463704463|FG000|Induction Phase|Relapse/Recurrence|7|||
128838631|NCT02092285|463704463|FG000|Induction Phase|Withdrawal by Subject|2|||
128838632|NCT02092285|463704463|FG000|Induction Phase|Lack of Efficacy|14|||
128838633|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
128838634|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
128838635|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
128838636|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
128838637|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
128838638|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
128838639|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
128838640|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
128838641|NCT02092285|463704463|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
128838642|NCT01825785|463704464|FG000|Overall Study|Adverse Event|0|||
128838643|NCT01825785|463704465|FG001|Overall Study|Adverse Event|0|||
128838644|NCT01825785|463704466|FG002|Overall Study|Adverse Event|0|||
128838645|NCT01825785|463704467|FG003|Overall Study|Adverse Event|0|||
128838646|NCT01825785|463704468|FG004|Overall Study|Adverse Event|1|||
128838647|NCT01825785|463704469|FG005|Overall Study|Adverse Event|0|||
128838648|NCT01825785|463704470|FG006|Overall Study|Adverse Event|0|||
128838649|NCT01825785|463704464|FG000|Overall Study|Withdrawal by Subject|0|||
128838650|NCT01825785|463704465|FG001|Overall Study|Withdrawal by Subject|0|||
128838651|NCT01825785|463704466|FG002|Overall Study|Withdrawal by Subject|0|||
128838652|NCT01825785|463704467|FG003|Overall Study|Withdrawal by Subject|0|||
128838653|NCT01825785|463704468|FG004|Overall Study|Withdrawal by Subject|1|||
128838654|NCT01825785|463704469|FG005|Overall Study|Withdrawal by Subject|1|||
128838655|NCT01825785|463704470|FG006|Overall Study|Withdrawal by Subject|0|||
128838656|NCT03740737|463704474|FG000|Overall Study|Protocol deviation|13|||
128838657|NCT03740737|463704475|FG001|Overall Study|Protocol deviation|0|||
128838658|NCT03740737|463704474|FG000|Overall Study|Adverse Event|2|||
128838659|NCT03740737|463704475|FG001|Overall Study|Adverse Event|0|||
128838660|NCT03740737|463704474|FG000|Overall Study|Lost to Follow-up|1|||
128838661|NCT03740737|463704475|FG001|Overall Study|Lost to Follow-up|0|||
128838662|NCT03740737|463704474|FG000|Overall Study|Randomization failure|1|||
128838663|NCT03740737|463704475|FG001|Overall Study|Randomization failure|0|||
128838664|NCT03740737|463704474|FG000|Overall Study|Participant withdrew consent|1|||
128838665|NCT03740737|463704475|FG001|Overall Study|Participant withdrew consent|0|||
128838666|NCT03740737|463704474|FG000|Overall Study|Participant withdrew from trial|2|||
128838667|NCT03740737|463704475|FG001|Overall Study|Participant withdrew from trial|1|||
128838668|NCT02981953|463704476|FG000|Overall Study|Death|9|||
128838669|NCT02981953|463704476|FG000|Overall Study|Withdrawal by Subject|1|||
128838670|NCT02981953|463704476|FG000|Overall Study|Withdrawal to non-compliance|1|||
128838671|NCT02889900|463704477|FG000|Overall Study|Adverse Event|11|||
128838672|NCT02889900|463704477|FG000|Overall Study|Condition under investigation worsened|32|||
128838673|NCT02889900|463704477|FG000|Overall Study|Other|5|||
128838674|NCT02889900|463704477|FG000|Overall Study|Withdrawal by Subject|7|||
128838675|NCT02889900|463704477|FG000|Overall Study|Not treated|2|||
128838676|NCT01416285|463704479|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
128838677|NCT01416285|463704480|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
128838678|NCT01655498|463704488|FG000|Overall Study|Unrelated health issue|2|||
128838679|NCT01655498|463704488|FG000|Overall Study|Protocol Violation|2|||
128838680|NCT01655498|463704488|FG000|Overall Study|Withdrawal by Subject|1|||
128838681|NCT02784834|463704489|FG000|Overall Study|Lack of Efficacy|1|||
128838682|NCT01090739|463704490|FG000|Enrollment|Withdrawal by Subject|24|||
128838683|NCT01090739|463704490|FG000|Enrollment|Protocol Violation|14|||
128838684|NCT01090739|463704490|FG000|Enrollment|Lost to Follow-up|5|||
128838685|NCT01090739|463704490|FG000|Enrollment|Physician Decision|5|||
128838686|NCT01090739|463704490|FG000|Enrollment|Sponsor termination of site|4|||
128838687|NCT01090739|463704490|FG000|Enrollment|Study implant limit reached|2|||
128838688|NCT01090739|463704490|FG000|Enrollment|Adverse Event|1|||
128838689|NCT01090739|463704490|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
128838690|NCT01090739|463704490|FG000|12 Month Follow-up|Lost to Follow-up|1|||
128838691|NCT01090739|463704490|FG000|12 Month Follow-up|Physician Decision|1|||
128838692|NCT01090739|463704490|FG000|12 Month Follow-up|Death|1|||
128838693|NCT01090739|463704490|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
128838694|NCT01090739|463704490|FG000|24 Month Follow-up|Lost to Follow-up|1|||
128838695|NCT01090739|463704490|FG000|24 Month Follow-up|Death|1|||
128838696|NCT01090739|463704490|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
128838697|NCT01090739|463704490|FG000|36 Month Follow-up|Visit still pending|17|||
128838698|NCT02410278|463704493|FG000|Run-in Period|Adverse Event|5|||
128838699|NCT02410278|463704494|FG001|Run-in Period|Adverse Event|0|||
128838700|NCT02410278|463704495|FG002|Run-in Period|Adverse Event|0|||
128838701|NCT02410278|463704493|FG000|Run-in Period|GSRS Threshold Not Met|30|||
128838702|NCT02410278|463704494|FG001|Run-in Period|GSRS Threshold Not Met|0|||
128838703|NCT02410278|463704495|FG002|Run-in Period|GSRS Threshold Not Met|0|||
128838704|NCT02410278|463704493|FG000|Run-in Period|Lost to Follow-up|1|||
128838705|NCT02410278|463704494|FG001|Run-in Period|Lost to Follow-up|0|||
128838706|NCT02410278|463704495|FG002|Run-in Period|Lost to Follow-up|0|||
128838707|NCT02410278|463704493|FG000|Run-in Period|Withdrawal by Subject|1|||
128838708|NCT02410278|463704494|FG001|Run-in Period|Withdrawal by Subject|0|||
128838709|NCT02410278|463704495|FG002|Run-in Period|Withdrawal by Subject|0|||
128838710|NCT02410278|463704493|FG000|Run-in Period|Pregnancy|1|||
128838711|NCT02410278|463704494|FG001|Run-in Period|Pregnancy|0|||
128838712|NCT02410278|463704495|FG002|Run-in Period|Pregnancy|0|||
128838713|NCT02410278|463704493|FG000|Study Treatment Period|Adverse Event|0|||
128838714|NCT02410278|463704494|FG001|Study Treatment Period|Adverse Event|6|||
128838715|NCT02410278|463704495|FG002|Study Treatment Period|Adverse Event|3|||
128838716|NCT02410278|463704493|FG000|Study Treatment Period|Physician Decision|0|||
128838717|NCT02410278|463704494|FG001|Study Treatment Period|Physician Decision|0|||
128838718|NCT02410278|463704495|FG002|Study Treatment Period|Physician Decision|1|||
128838719|NCT02410278|463704493|FG000|Study Treatment Period|Withdrawal by Subject|0|||
128838720|NCT02410278|463704494|FG001|Study Treatment Period|Withdrawal by Subject|1|||
128838721|NCT02410278|463704495|FG002|Study Treatment Period|Withdrawal by Subject|0|||
128838722|NCT02410278|463704493|FG000|Study Treatment Period|Other|0|||
128838723|NCT02410278|463704494|FG001|Study Treatment Period|Other|3|||
128838724|NCT02410278|463704495|FG002|Study Treatment Period|Other|0|||
128838725|NCT02410278|463704493|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
128838726|NCT02410278|463704494|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
128838727|NCT02410278|463704495|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
128838728|NCT03695185|463704496|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
128838729|NCT03695185|463704496|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
128838730|NCT03695185|463704496|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
128838731|NCT03695185|463704496|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
128838732|NCT03695185|463704496|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
128838733|NCT03695185|463704496|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
128838734|NCT02584257|463704497|FG000|Period 1|Withdrawal by Subject|0|||
128838735|NCT02584257|463704498|FG001|Period 1|Withdrawal by Subject|0|||
128838736|NCT02584257|463704499|FG002|Period 1|Withdrawal by Subject|0|||
128838737|NCT02584257|463704500|FG003|Period 1|Withdrawal by Subject|0|||
128838738|NCT02584257|463704501|FG004|Period 1|Withdrawal by Subject|0|||
128838739|NCT02584257|463704502|FG005|Period 1|Withdrawal by Subject|0|||
128838740|NCT02584257|463704503|FG006|Period 1|Withdrawal by Subject|1|||
128838741|NCT02584257|463704504|FG007|Period 1|Withdrawal by Subject|0|||
128838742|NCT02584257|463704505|FG008|Period 1|Withdrawal by Subject|0|||
128838743|NCT02584257|463704497|FG000|Period 2|Physician Decision|1|||
128838744|NCT02584257|463704498|FG001|Period 2|Physician Decision|0|||
128838745|NCT02584257|463704499|FG002|Period 2|Physician Decision|0|||
128838746|NCT02584257|463704500|FG003|Period 2|Physician Decision|0|||
128838747|NCT02584257|463704501|FG004|Period 2|Physician Decision|0|||
128838748|NCT02584257|463704502|FG005|Period 2|Physician Decision|0|||
128838749|NCT02584257|463704503|FG006|Period 2|Physician Decision|0|||
128838750|NCT02584257|463704504|FG007|Period 2|Physician Decision|0|||
128838751|NCT02584257|463704505|FG008|Period 2|Physician Decision|0|||
128838752|NCT02584257|463704497|FG000|Period 2|Adverse Event|0|||
128838753|NCT02584257|463704498|FG001|Period 2|Adverse Event|1|||
128838754|NCT02584257|463704499|FG002|Period 2|Adverse Event|0|||
128838755|NCT02584257|463704500|FG003|Period 2|Adverse Event|0|||
128838756|NCT02584257|463704501|FG004|Period 2|Adverse Event|0|||
128838757|NCT02584257|463704502|FG005|Period 2|Adverse Event|0|||
128838758|NCT02584257|463704503|FG006|Period 2|Adverse Event|0|||
128838759|NCT02584257|463704504|FG007|Period 2|Adverse Event|0|||
128838760|NCT02584257|463704505|FG008|Period 2|Adverse Event|0|||
128838761|NCT03031782|463704518|FG000|Treatment Period 1|Lack of Efficacy|3|||
128838762|NCT03031782|463704519|FG001|Treatment Period 1|Lack of Efficacy|0|||
128838763|NCT03031782|463704520|FG002|Treatment Period 1|Lack of Efficacy|0|||
128838764|NCT03031782|463704521|FG003|Treatment Period 1|Lack of Efficacy|0|||
128838765|NCT03031782|463704522|FG004|Treatment Period 1|Lack of Efficacy|0|||
128838766|NCT03031782|463704518|FG000|Treatment Period 2|Physician Decision|0|||
128838767|NCT03031782|463704519|FG001|Treatment Period 2|Physician Decision|1|||
128838768|NCT03031782|463704520|FG002|Treatment Period 2|Physician Decision|0|||
128838769|NCT03031782|463704521|FG003|Treatment Period 2|Physician Decision|0|||
128838770|NCT03031782|463704522|FG004|Treatment Period 2|Physician Decision|3|||
128838771|NCT03031782|463704518|FG000|Treatment Period 2|Lack of Efficacy|0|||
128838772|NCT03031782|463704519|FG001|Treatment Period 2|Lack of Efficacy|1|||
128838773|NCT03031782|463704520|FG002|Treatment Period 2|Lack of Efficacy|0|||
128838774|NCT03031782|463704521|FG003|Treatment Period 2|Lack of Efficacy|0|||
128838775|NCT03031782|463704522|FG004|Treatment Period 2|Lack of Efficacy|1|||
128838776|NCT03031782|463704518|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128838777|NCT03031782|463704519|FG001|Treatment Period 2|Withdrawal by Subject|3|||
128838778|NCT03031782|463704520|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128838779|NCT03031782|463704521|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128838780|NCT03031782|463704522|FG004|Treatment Period 2|Withdrawal by Subject|1|||
128838781|NCT03031782|463704518|FG000|Treatment Period 2|Adverse Event|0|||
128838782|NCT03031782|463704519|FG001|Treatment Period 2|Adverse Event|1|||
128838783|NCT03031782|463704520|FG002|Treatment Period 2|Adverse Event|2|||
128838784|NCT03031782|463704521|FG003|Treatment Period 2|Adverse Event|0|||
128838785|NCT03031782|463704522|FG004|Treatment Period 2|Adverse Event|0|||
128838786|NCT03031782|463704518|FG000|Treatment Period 3|Withdrawal by Subject|0|||
128838787|NCT03031782|463704519|FG001|Treatment Period 3|Withdrawal by Subject|0|||
128838788|NCT03031782|463704520|FG002|Treatment Period 3|Withdrawal by Subject|0|||
128838789|NCT03031782|463704521|FG003|Treatment Period 3|Withdrawal by Subject|1|||
128838790|NCT03031782|463704522|FG004|Treatment Period 3|Withdrawal by Subject|0|||
128838791|NCT02170207|463704525|FG000|Overall Study|Case report forms unavailable|5|||
128838792|NCT00886834|463704526|FG000|Overall Study|Protocol Violation|0|||
128838793|NCT00886834|463704527|FG001|Overall Study|Protocol Violation|3|||
128838794|NCT03122860|463704528|FG000|Overall Study|Discontinued Before Treatment|1|||
128838795|NCT03122860|463704529|FG001|Overall Study|Discontinued Before Treatment|1|||
128838796|NCT03122860|463704530|FG002|Overall Study|Discontinued Before Treatment|2|||
128838797|NCT03122860|463704531|FG003|Overall Study|Discontinued Before Treatment|0|||
128838798|NCT03122860|463704532|FG004|Overall Study|Discontinued Before Treatment|1|||
128838799|NCT03122860|463704533|FG005|Overall Study|Discontinued Before Treatment|0|||
128838800|NCT03122860|463704528|FG000|Overall Study|Adverse Event|1|||
128838801|NCT03122860|463704529|FG001|Overall Study|Adverse Event|0|||
128838802|NCT03122860|463704530|FG002|Overall Study|Adverse Event|1|||
128838803|NCT03122860|463704531|FG003|Overall Study|Adverse Event|1|||
128838804|NCT03122860|463704532|FG004|Overall Study|Adverse Event|0|||
128838805|NCT03122860|463704533|FG005|Overall Study|Adverse Event|0|||
128838806|NCT03122860|463704528|FG000|Overall Study|Lost to Follow-up|5|||
128838807|NCT03122860|463704529|FG001|Overall Study|Lost to Follow-up|2|||
128838808|NCT03122860|463704530|FG002|Overall Study|Lost to Follow-up|3|||
128838809|NCT03122860|463704531|FG003|Overall Study|Lost to Follow-up|3|||
128838810|NCT03122860|463704532|FG004|Overall Study|Lost to Follow-up|5|||
128838811|NCT03122860|463704533|FG005|Overall Study|Lost to Follow-up|4|||
128838812|NCT03122860|463704528|FG000|Overall Study|Subject Non-Compliance|0|||
128838813|NCT03122860|463704529|FG001|Overall Study|Subject Non-Compliance|0|||
128838814|NCT03122860|463704530|FG002|Overall Study|Subject Non-Compliance|1|||
128838815|NCT03122860|463704531|FG003|Overall Study|Subject Non-Compliance|0|||
128838816|NCT03122860|463704532|FG004|Overall Study|Subject Non-Compliance|0|||
128838817|NCT03122860|463704533|FG005|Overall Study|Subject Non-Compliance|0|||
128838818|NCT03122860|463704528|FG000|Overall Study|Withdrawal by Subject|3|||
128838819|NCT03122860|463704529|FG001|Overall Study|Withdrawal by Subject|2|||
128838820|NCT03122860|463704530|FG002|Overall Study|Withdrawal by Subject|5|||
128838821|NCT03122860|463704531|FG003|Overall Study|Withdrawal by Subject|7|||
128838822|NCT03122860|463704532|FG004|Overall Study|Withdrawal by Subject|9|||
128838823|NCT03122860|463704533|FG005|Overall Study|Withdrawal by Subject|8|||
128838824|NCT01138657|463704534|FG000|Overall Study|Adverse Event|3|||
128838825|NCT01138657|463704535|FG001|Overall Study|Adverse Event|10|||
128838826|NCT01138657|463704534|FG000|Overall Study|Lack of Efficacy|2|||
128838827|NCT01138657|463704535|FG001|Overall Study|Lack of Efficacy|1|||
128838828|NCT01138657|463704534|FG000|Overall Study|Lost to Follow-up|0|||
128838829|NCT01138657|463704535|FG001|Overall Study|Lost to Follow-up|3|||
128838830|NCT01138657|463704534|FG000|Overall Study|Miscellaneous Reasons|3|||
128838831|NCT01138657|463704535|FG001|Overall Study|Miscellaneous Reasons|4|||
128838832|NCT00529529|463704540|FG000|Overall Study|Adverse Event|12|||
128838833|NCT00529529|463704541|FG001|Overall Study|Adverse Event|17|||
128838834|NCT00529529|463704542|FG002|Overall Study|Adverse Event|8|||
128838835|NCT00529529|463704540|FG000|Overall Study|Subject withdrew consent|12|||
128838836|NCT00529529|463704541|FG001|Overall Study|Subject withdrew consent|9|||
128838837|NCT00529529|463704542|FG002|Overall Study|Subject withdrew consent|12|||
128838838|NCT00529529|463704540|FG000|Overall Study|Protocol deviation|8|||
128838839|NCT00529529|463704541|FG001|Overall Study|Protocol deviation|12|||
128838840|NCT00529529|463704542|FG002|Overall Study|Protocol deviation|5|||
128838841|NCT00529529|463704540|FG000|Overall Study|Lost to Follow-up|5|||
128838842|NCT00529529|463704541|FG001|Overall Study|Lost to Follow-up|3|||
128838843|NCT00529529|463704542|FG002|Overall Study|Lost to Follow-up|1|||
128838844|NCT00529529|463704540|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
128838845|NCT00529529|463704541|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128838846|NCT00529529|463704542|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
128838847|NCT00529529|463704540|FG000|Overall Study|Death|2|||
128838848|NCT00529529|463704541|FG001|Overall Study|Death|0|||
128838849|NCT00529529|463704542|FG002|Overall Study|Death|0|||
128838850|NCT00529529|463704540|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128838851|NCT00529529|463704541|FG001|Overall Study|Abnormal test procedure result(s)|0|||
128838852|NCT00529529|463704542|FG002|Overall Study|Abnormal test procedure result(s)|0|||
128838853|NCT00529529|463704540|FG000|Overall Study|Administrative problems|1|||
128838854|NCT00529529|463704541|FG001|Overall Study|Administrative problems|0|||
128838855|NCT00529529|463704542|FG002|Overall Study|Administrative problems|3|||
128838856|NCT00237809|463704543|FG000|Overall Study|Lost to Follow-up|11|||
128838857|NCT00237809|463704544|FG001|Overall Study|Lost to Follow-up|10|||
128838858|NCT00237809|463704545|FG002|Overall Study|Lost to Follow-up|9|||
128838859|NCT00237809|463704546|FG003|Overall Study|Lost to Follow-up|9|||
128838860|NCT02978716|463704547|FG000|Overall Study|Death|25|||
128838861|NCT02978716|463704548|FG001|Overall Study|Death|13|||
128838862|NCT02978716|463704549|FG002|Overall Study|Death|20|||
128838863|NCT02978716|463704547|FG000|Overall Study|Lost to Follow-up|0|||
128838864|NCT02978716|463704548|FG001|Overall Study|Lost to Follow-up|0|||
128838865|NCT02978716|463704549|FG002|Overall Study|Lost to Follow-up|1|||
128838866|NCT02978716|463704547|FG000|Overall Study|Withdrawal by Subject|6|||
128838867|NCT02978716|463704548|FG001|Overall Study|Withdrawal by Subject|4|||
128838868|NCT02978716|463704549|FG002|Overall Study|Withdrawal by Subject|5|||
128838869|NCT02978716|463704547|FG000|Overall Study|Sponsor terminated|2|||
128838870|NCT02978716|463704548|FG001|Overall Study|Sponsor terminated|13|||
128838871|NCT02978716|463704549|FG002|Overall Study|Sponsor terminated|9|||
128838872|NCT02978716|463704547|FG000|Overall Study|Other|1|||
128838873|NCT02978716|463704548|FG001|Overall Study|Other|3|||
128838874|NCT02978716|463704549|FG002|Overall Study|Other|0|||
128838875|NCT00960206|463704550|FG000|Overall Study|Death|7|||
128838876|NCT00960206|463704551|FG001|Overall Study|Death|4|||
128838877|NCT00960206|463704552|FG002|Overall Study|Death|1|||
128838878|NCT00960206|463704550|FG000|Overall Study|Unwilling/Unable to return|1|||
128838879|NCT00960206|463704551|FG001|Overall Study|Unwilling/Unable to return|2|||
128838880|NCT00960206|463704552|FG002|Overall Study|Unwilling/Unable to return|0|||
128838881|NCT00960206|463704550|FG000|Overall Study|Lost to Follow-up|8|||
128838882|NCT00960206|463704551|FG001|Overall Study|Lost to Follow-up|14|||
128838883|NCT00960206|463704552|FG002|Overall Study|Lost to Follow-up|8|||
128838884|NCT00960206|463704550|FG000|Overall Study|Withdrawal by Subject|2|||
128838885|NCT00960206|463704551|FG001|Overall Study|Withdrawal by Subject|4|||
128838886|NCT00960206|463704552|FG002|Overall Study|Withdrawal by Subject|0|||
128838887|NCT00960206|463704550|FG000|Overall Study|Revision of study component|2|||
128838888|NCT00960206|463704551|FG001|Overall Study|Revision of study component|2|||
128838889|NCT00960206|463704552|FG002|Overall Study|Revision of study component|2|||
128838890|NCT00960206|463704550|FG000|Overall Study|Missing 10 year data|20|||
128838891|NCT00960206|463704551|FG001|Overall Study|Missing 10 year data|1|||
128838892|NCT00960206|463704552|FG002|Overall Study|Missing 10 year data|1|||
128838893|NCT02470806|463704553|FG000|Overall Study|Lost to Follow-up|1|||
128838894|NCT02470806|463704554|FG001|Overall Study|Lost to Follow-up|1|||
128838895|NCT02470806|463704553|FG000|Overall Study|Adverse Event|5|||
128838896|NCT02470806|463704554|FG001|Overall Study|Adverse Event|2|||
128838897|NCT02470806|463704553|FG000|Overall Study|Protocol Violation|4|||
128838898|NCT02470806|463704554|FG001|Overall Study|Protocol Violation|11|||
128838899|NCT02470806|463704553|FG000|Overall Study|Physician Decision|0|||
128838900|NCT02470806|463704554|FG001|Overall Study|Physician Decision|3|||
128838901|NCT02470806|463704553|FG000|Overall Study|Withdrawal by Subject|3|||
128838902|NCT02470806|463704554|FG001|Overall Study|Withdrawal by Subject|10|||
128838903|NCT02470806|463704553|FG000|Overall Study|Lack of Efficacy|5|||
128838904|NCT02470806|463704554|FG001|Overall Study|Lack of Efficacy|15|||
128838905|NCT03075878|463704563|FG000|Overall Study|Physician Decision|1|||
128838906|NCT02612285|463704564|FG000|Overall Study|Withdrawal by Subject|1|||
128838907|NCT00805441|463704565|FG000|Overall Study|Adverse Event|5|||
128838908|NCT00805441|463704566|FG001|Overall Study|Adverse Event|2|||
128838909|NCT00805441|463704565|FG000|Overall Study|Lack of Efficacy|0|||
128838910|NCT00805441|463704566|FG001|Overall Study|Lack of Efficacy|2|||
128838911|NCT00805441|463704565|FG000|Overall Study|Protocol Violation|4|||
128838912|NCT00805441|463704566|FG001|Overall Study|Protocol Violation|8|||
128838913|NCT00805441|463704565|FG000|Overall Study|Lost to Follow-up|10|||
128838914|NCT00805441|463704566|FG001|Overall Study|Lost to Follow-up|13|||
128838915|NCT00805441|463704565|FG000|Overall Study|Withdrawal by Subject|15|||
128838916|NCT00805441|463704566|FG001|Overall Study|Withdrawal by Subject|9|||
128838917|NCT00805441|463704565|FG000|Overall Study|Physician Decision|0|||
128838918|NCT00805441|463704566|FG001|Overall Study|Physician Decision|1|||
128838919|NCT00805441|463704565|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
128838920|NCT00805441|463704566|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
128838921|NCT00853957|463704571|FG000|Overall Study|Adverse Event|9|||
128838922|NCT00853957|463704572|FG001|Overall Study|Adverse Event|3|||
128838923|NCT00853957|463704571|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128838924|NCT00853957|463704572|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128838925|NCT00853957|463704571|FG000|Overall Study|Subject withdrew consent|4|||
128838926|NCT00853957|463704572|FG001|Overall Study|Subject withdrew consent|5|||
128838927|NCT00853957|463704571|FG000|Overall Study|Lost to Follow-up|1|||
128838928|NCT00853957|463704572|FG001|Overall Study|Lost to Follow-up|6|||
128838929|NCT00853957|463704571|FG000|Overall Study|Protocol deviation|0|||
128838930|NCT00853957|463704572|FG001|Overall Study|Protocol deviation|3|||
128838931|NCT02158806|463704573|FG000|Overall Study|Death|2|||
128838932|NCT02158806|463704574|FG001|Overall Study|Death|0|||
129204960|NCT01962441|465047004|FG002|Retreatment Substudy|Lack of Efficacy|0|||
129204961|NCT01962441|465047002|FG000|Retreatment Substudy|Lost to Follow-up|1|||
129204962|NCT01962441|465047003|FG001|Retreatment Substudy|Lost to Follow-up|0|||
129204963|NCT01962441|465047004|FG002|Retreatment Substudy|Lost to Follow-up|0|||
129204964|NCT04908397|465047007|FG000|Overall Study|Withdrawal by Subject|2|||
129204965|NCT03100149|465047012|FG000|Overall Study|Adverse Event|0|||
129204966|NCT03100149|465047013|FG001|Overall Study|Adverse Event|1|||
129204967|NCT03100149|465047014|FG002|Overall Study|Adverse Event|0|||
128838933|NCT02158806|463704573|FG000|Overall Study|Withdrawal by Subject|2|||
128838934|NCT02158806|463704574|FG001|Overall Study|Withdrawal by Subject|0|||
128838935|NCT02158806|463704573|FG000|Overall Study|Lost to Follow-up|0|||
128838936|NCT02158806|463704574|FG001|Overall Study|Lost to Follow-up|3|||
128838937|NCT02158806|463704573|FG000|Overall Study|Moved out of area|0|||
128838938|NCT02158806|463704574|FG001|Overall Study|Moved out of area|1|||
128838939|NCT02158806|463704573|FG000|Overall Study|Transferred to palliative care|0|||
128838940|NCT02158806|463704574|FG001|Overall Study|Transferred to palliative care|1|||
128838941|NCT01898299|463704575|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
128838942|NCT01898299|463704576|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
128838943|NCT02340806|463704577|FG000|Overall Study|Protocol Violation|2|||
128838944|NCT02340806|463704578|FG001|Overall Study|Protocol Violation|0|||
128838945|NCT02340806|463704577|FG000|Overall Study|epidural catheter replaced|2|||
128838946|NCT02340806|463704578|FG001|Overall Study|epidural catheter replaced|1|||
128838947|NCT02340806|463704577|FG000|Overall Study|history of chronic pain medication|1|||
128838948|NCT02340806|463704578|FG001|Overall Study|history of chronic pain medication|0|||
128838949|NCT02340806|463704577|FG000|Overall Study|re-dose < 90 min of CSE|1|||
128838950|NCT02340806|463704578|FG001|Overall Study|re-dose < 90 min of CSE|3|||
128838951|NCT00452452|463704579|FG000|Overall Study|Protocol Violation|0|||
128838952|NCT00452452|463704580|FG001|Overall Study|Protocol Violation|0|||
128838953|NCT00452452|463704581|FG002|Overall Study|Protocol Violation|1|||
128838954|NCT00452452|463704579|FG000|Overall Study|Withdrawal by Subject|1|||
128838955|NCT00452452|463704580|FG001|Overall Study|Withdrawal by Subject|0|||
128838956|NCT00452452|463704581|FG002|Overall Study|Withdrawal by Subject|0|||
128838957|NCT00452452|463704579|FG000|Overall Study|Lost to Follow-up|1|||
128838958|NCT00452452|463704580|FG001|Overall Study|Lost to Follow-up|0|||
128838959|NCT00452452|463704581|FG002|Overall Study|Lost to Follow-up|0|||
128838960|NCT03070301|463704583|FG000|Overall Study|Progression of disease|16|||
128838961|NCT03070301|463704583|FG000|Overall Study|Physician Decision|3|||
128838962|NCT03070301|463704583|FG000|Overall Study|Withdrawal by Subject|1|||
128838963|NCT04520256|463704587|FG000|Overall Study|Lost to Follow-up|6|||
128838964|NCT04520256|463704588|FG001|Overall Study|Lost to Follow-up|4|||
128838965|NCT04520256|463704589|FG002|Overall Study|Lost to Follow-up|2|||
128838966|NCT04520256|463704590|FG003|Overall Study|Lost to Follow-up|3|||
128838967|NCT04520256|463704591|FG004|Overall Study|Lost to Follow-up|6|||
128838968|NCT04520256|463704592|FG005|Overall Study|Lost to Follow-up|6|||
128838969|NCT04520256|463704593|FG006|Overall Study|Lost to Follow-up|4|||
128838970|NCT04520256|463704594|FG007|Overall Study|Lost to Follow-up|6|||
128838971|NCT04520256|463704595|FG008|Overall Study|Lost to Follow-up|1|||
128838972|NCT04520256|463704596|FG009|Overall Study|Lost to Follow-up|3|||
128838973|NCT04520256|463704597|FG010|Overall Study|Lost to Follow-up|3|||
128838974|NCT04520256|463704598|FG011|Overall Study|Lost to Follow-up|2|||
128838975|NCT04520256|463704599|FG012|Overall Study|Lost to Follow-up|5|||
128838976|NCT04520256|463704600|FG013|Overall Study|Lost to Follow-up|3|||
128838977|NCT04520256|463704601|FG014|Overall Study|Lost to Follow-up|3|||
128838978|NCT04520256|463704602|FG015|Overall Study|Lost to Follow-up|6|||
128838979|NCT04520256|463704603|FG016|Overall Study|Lost to Follow-up|6|||
128838980|NCT04520256|463704604|FG017|Overall Study|Lost to Follow-up|4|||
128838981|NCT04520256|463704605|FG018|Overall Study|Lost to Follow-up|3|||
128838982|NCT04520256|463704606|FG019|Overall Study|Lost to Follow-up|3|||
128838983|NCT04520256|463704607|FG020|Overall Study|Lost to Follow-up|7|||
128838984|NCT04520256|463704608|FG021|Overall Study|Lost to Follow-up|3|||
128838985|NCT04520256|463704609|FG022|Overall Study|Lost to Follow-up|3|||
128838986|NCT04520256|463704610|FG023|Overall Study|Lost to Follow-up|8|||
128838987|NCT04520256|463704611|FG024|Overall Study|Lost to Follow-up|5|||
128838988|NCT04520256|463704612|FG025|Overall Study|Lost to Follow-up|4|||
128838989|NCT04520256|463704613|FG026|Overall Study|Lost to Follow-up|3|||
128838990|NCT04520256|463704614|FG027|Overall Study|Lost to Follow-up|4|||
128838991|NCT04520256|463704615|FG028|Overall Study|Lost to Follow-up|3|||
128838992|NCT04520256|463704616|FG029|Overall Study|Lost to Follow-up|4|||
128838993|NCT04520256|463704617|FG030|Overall Study|Lost to Follow-up|4|||
128838994|NCT04520256|463704618|FG031|Overall Study|Lost to Follow-up|4|||
128838995|NCT02880293|463706537|FG000|Overall Study|Inevaluable|5|||
128838996|NCT02659059|463706544|FG000|Overall Study|Other reasons|6|||
128838997|NCT02659059|463706545|FG001|Overall Study|Other reasons|1|||
128838998|NCT02659059|463706544|FG000|Overall Study|Disease Progression|143|||
128838999|NCT02659059|463706545|FG001|Overall Study|Disease Progression|16|||
128839000|NCT02659059|463706544|FG000|Overall Study|Study Drug toxicity|56|||
128839001|NCT02659059|463706545|FG001|Overall Study|Study Drug toxicity|9|||
128839002|NCT02659059|463706544|FG000|Overall Study|Death|3|||
128839003|NCT02659059|463706545|FG001|Overall Study|Death|1|||
128839004|NCT02659059|463706544|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
128839005|NCT02659059|463706545|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
128839006|NCT02659059|463706544|FG000|Overall Study|Participant request to discontinue study treatment|5|||
128839007|NCT02659059|463706545|FG001|Overall Study|Participant request to discontinue study treatment|0|||
128839008|NCT02659059|463706544|FG000|Overall Study|Participant withdrew consent|6|||
128839009|NCT02659059|463706545|FG001|Overall Study|Participant withdrew consent|1|||
128839010|NCT03976102|463706548|FG000|Overall Study|Withdrawal by Subject|4|||
128839011|NCT03976102|463706549|FG001|Overall Study|Withdrawal by Subject|4|||
128839012|NCT03976102|463706548|FG000|Overall Study|Adverse Event|2|||
128839013|NCT03976102|463706549|FG001|Overall Study|Adverse Event|4|||
128839014|NCT03976102|463706548|FG000|Overall Study|Not related to Covid-19|9|||
128839015|NCT03976102|463706549|FG001|Overall Study|Not related to Covid-19|13|||
128839016|NCT03976102|463706548|FG000|Overall Study|Lost to Follow-up|0|||
128839017|NCT03976102|463706549|FG001|Overall Study|Lost to Follow-up|2|||
128839018|NCT03976102|463706548|FG000|Overall Study|Death|3|||
128839019|NCT03976102|463706549|FG001|Overall Study|Death|2|||
128839020|NCT03976102|463706548|FG000|Overall Study|Physician Decision|1|||
128839021|NCT03976102|463706549|FG001|Overall Study|Physician Decision|1|||
128839022|NCT00092456|463706555|FG000|Overall Study|Adverse Event|0|||
128839023|NCT00092456|463706556|FG001|Overall Study|Adverse Event|0|||
128839024|NCT00092456|463706557|FG002|Overall Study|Adverse Event|1|||
128839025|NCT00092456|463706558|FG003|Overall Study|Adverse Event|1|||
128839026|NCT00092456|463706555|FG000|Overall Study|Lost to Follow-up|2|||
128839027|NCT00092456|463706556|FG001|Overall Study|Lost to Follow-up|2|||
128839028|NCT00092456|463706557|FG002|Overall Study|Lost to Follow-up|1|||
128839029|NCT00092456|463706558|FG003|Overall Study|Lost to Follow-up|2|||
128839030|NCT00092456|463706555|FG000|Overall Study|Protocol Violation|5|||
128839031|NCT00092456|463706556|FG001|Overall Study|Protocol Violation|7|||
128839032|NCT00092456|463706557|FG002|Overall Study|Protocol Violation|8|||
128839033|NCT00092456|463706558|FG003|Overall Study|Protocol Violation|6|||
128839034|NCT00092456|463706555|FG000|Overall Study|Withdrawal by Subject|13|||
128839035|NCT00092456|463706556|FG001|Overall Study|Withdrawal by Subject|5|||
128839036|NCT00092456|463706557|FG002|Overall Study|Withdrawal by Subject|16|||
128839037|NCT00092456|463706558|FG003|Overall Study|Withdrawal by Subject|6|||
128839038|NCT00092456|463706555|FG000|Overall Study|Moved|1|||
128839039|NCT00092456|463706556|FG001|Overall Study|Moved|1|||
128839040|NCT00092456|463706557|FG002|Overall Study|Moved|0|||
128839041|NCT00092456|463706558|FG003|Overall Study|Moved|1|||
128839042|NCT00092456|463706555|FG000|Overall Study|Other|4|||
128839043|NCT00092456|463706556|FG001|Overall Study|Other|2|||
128839044|NCT00092456|463706557|FG002|Overall Study|Other|3|||
128839045|NCT00092456|463706558|FG003|Overall Study|Other|0|||
128839046|NCT00451906|463706561|FG000|Overall Study|Adverse Event|515|||
128839047|NCT00451906|463706561|FG000|Overall Study|Lost to Follow-up|31|||
128839048|NCT00451906|463706561|FG000|Overall Study|Withdrawal by Subject|111|||
128839049|NCT00451906|463706561|FG000|Overall Study|Protocol Violation|21|||
128839050|NCT00451906|463706561|FG000|Overall Study|Progressive disease|1328|||
128839051|NCT00451906|463706561|FG000|Overall Study|Termination of the study|108|||
128839052|NCT00451906|463706561|FG000|Overall Study|Other Reasons|121|||
128839053|NCT00451906|463706561|FG000|Overall Study|Did not complete final visit|4|||
128839054|NCT02121808|463706566|FG000|Overall Study|Technical problem|3|||
128839055|NCT05066230|463706567|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
128839056|NCT05066230|463706568|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
128839057|NCT05066230|463706567|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
128839058|NCT05066230|463706568|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
128839059|NCT05066230|463706567|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
128839060|NCT05066230|463706568|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
128839061|NCT05066230|463706567|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
128839062|NCT05066230|463706568|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
128839063|NCT05066230|463706567|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
128839064|NCT05066230|463706568|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
128839065|NCT05066230|463706567|FG000|After Week 48|Adverse Event|1|||
128839066|NCT05066230|463706568|FG001|After Week 48|Adverse Event|0|||
128839067|NCT05066230|463706567|FG000|After Week 48|Non-compliance with study schedule|1|||
128839068|NCT05066230|463706568|FG001|After Week 48|Non-compliance with study schedule|0|||
128839069|NCT05066230|463706567|FG000|After Week 48|Withdrawal by Subject|0|||
128839070|NCT05066230|463706568|FG001|After Week 48|Withdrawal by Subject|1|||
128839071|NCT05066230|463706567|FG000|After Week 48|Lost to Follow-up|3|||
128839072|NCT05066230|463706568|FG001|After Week 48|Lost to Follow-up|3|||
128839073|NCT05066230|463706567|FG000|After Week 48|Sponsor Request|115|||
128839074|NCT05066230|463706568|FG001|After Week 48|Sponsor Request|111|||
128839075|NCT03072238|463706569|FG000|Overall Study|Withdrawal by Subject|44|||
128839076|NCT03072238|463706570|FG001|Overall Study|Withdrawal by Subject|64|||
128839077|NCT03072238|463706569|FG000|Overall Study|Lost to Follow-up|14|||
128839078|NCT03072238|463706570|FG001|Overall Study|Lost to Follow-up|5|||
128839079|NCT03072238|463706569|FG000|Overall Study|Physician Decision|4|||
128839080|NCT03072238|463706570|FG001|Overall Study|Physician Decision|6|||
128839081|NCT03072238|463706569|FG000|Overall Study|Death|351|||
128839082|NCT03072238|463706570|FG001|Overall Study|Death|318|||
128839083|NCT03072238|463706569|FG000|Overall Study|Progressive Disease|3|||
128839084|NCT03072238|463706570|FG001|Overall Study|Progressive Disease|4|||
128839085|NCT03072238|463706569|FG000|Overall Study|Reason Not Specified|138|||
128839086|NCT03072238|463706570|FG001|Overall Study|Reason Not Specified|150|||
128839087|NCT01863368|463706576|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
128839088|NCT01863368|463706577|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
128839089|NCT01863368|463706576|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
128839090|NCT01863368|463706577|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
128839091|NCT01863368|463706576|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
128839092|NCT01863368|463706577|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
128839093|NCT01863368|463706576|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
128839094|NCT01863368|463706577|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
128839095|NCT01863368|463706576|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
128839096|NCT01863368|463706577|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
128839097|NCT01863368|463706576|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
128839098|NCT01863368|463706577|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
128839099|NCT02165202|463706578|FG000|Oral Phase|Refused further participation|5|||
128839100|NCT02165202|463706579|FG001|Oral Phase|Refused further participation|1|||
128839101|NCT02165202|463706578|FG000|Oral Phase|Study product Related Toxicity|1|||
128839102|NCT02165202|463706579|FG001|Oral Phase|Study product Related Toxicity|0|||
128839103|NCT02165202|463706578|FG000|Oral Phase|Unable to contact Participant|1|||
128839104|NCT02165202|463706579|FG001|Oral Phase|Unable to contact Participant|1|||
128839105|NCT02165202|463706578|FG000|Oral Phase|Clinical reasons|1|||
128839106|NCT02165202|463706579|FG001|Oral Phase|Clinical reasons|0|||
128839107|NCT02165202|463706578|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
128839108|NCT02165202|463706579|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
128839109|NCT02165202|463706578|FG000|Oral Phase|CMC advised termination|1|||
128839110|NCT02165202|463706579|FG001|Oral Phase|CMC advised termination|0|||
128839111|NCT02165202|463706578|FG000|Oral Phase|Relocated, no follow-up planned|1|||
128839112|NCT02165202|463706579|FG001|Oral Phase|Relocated, no follow-up planned|0|||
128839113|NCT02165202|463706578|FG000|Oral Phase|Abnormal EKG|0|||
128839114|NCT02165202|463706579|FG001|Oral Phase|Abnormal EKG|1|||
128839115|NCT02165202|463706578|FG000|Injection Phase|Abnormal Lab Value|5|||
128839116|NCT02165202|463706579|FG001|Injection Phase|Abnormal Lab Value|1|||
128839117|NCT02165202|463706578|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
128839118|NCT02165202|463706579|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
128839119|NCT02165202|463706578|FG000|Injection Phase|Unable to attend within Visit Window|1|||
128839120|NCT02165202|463706579|FG001|Injection Phase|Unable to attend within Visit Window|0|||
128839121|NCT02165202|463706578|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
128839122|NCT02165202|463706579|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
128839123|NCT02165202|463706578|FG000|Injection Phase|End of Study|2|||
128839124|NCT02165202|463706579|FG001|Injection Phase|End of Study|1|||
128839125|NCT02165202|463706578|FG000|Injection Phase|Study Product related Toxicity|1|||
128839126|NCT02165202|463706579|FG001|Injection Phase|Study Product related Toxicity|0|||
128839127|NCT02165202|463706578|FG000|Injection Phase|No longer interested|0|||
128839128|NCT02165202|463706579|FG001|Injection Phase|No longer interested|1|||
128839129|NCT02165202|463706578|FG000|Injection Phase|Participant unwilling to comply|1|||
128839130|NCT02165202|463706579|FG001|Injection Phase|Participant unwilling to comply|0|||
128839131|NCT01072149|463706586|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839132|NCT01072149|463706587|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839133|NCT01072149|463706588|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
128839134|NCT01072149|463706589|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839135|NCT01072149|463706590|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839136|NCT01072149|463706591|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839137|NCT01072149|463706592|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839138|NCT01072149|463706593|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839139|NCT01072149|463706594|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839140|NCT01072149|463706595|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839141|NCT01072149|463706596|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839142|NCT01072149|463706597|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839143|NCT01072149|463706598|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839144|NCT01072149|463706599|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839145|NCT01072149|463706600|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839146|NCT01072149|463706601|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839147|NCT01072149|463706602|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839148|NCT01072149|463706603|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
128839149|NCT01072149|463706586|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839150|NCT01072149|463706587|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839151|NCT01072149|463706588|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839152|NCT01072149|463706589|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839153|NCT01072149|463706590|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839154|NCT01072149|463706591|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839155|NCT01072149|463706592|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839156|NCT01072149|463706593|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839157|NCT01072149|463706594|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839158|NCT01072149|463706595|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129204968|NCT03100149|465047012|FG000|Overall Study|Participant Moved out of Country|0|||
128839159|NCT01072149|463706596|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839160|NCT01072149|463706597|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839161|NCT01072149|463706598|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839162|NCT01072149|463706599|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839163|NCT01072149|463706600|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839164|NCT01072149|463706601|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839165|NCT01072149|463706602|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
128839166|NCT01072149|463706603|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
128839167|NCT01072149|463706586|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839168|NCT01072149|463706587|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839169|NCT01072149|463706588|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839170|NCT01072149|463706589|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839171|NCT01072149|463706590|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839172|NCT01072149|463706591|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839173|NCT01072149|463706592|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839174|NCT01072149|463706593|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839175|NCT01072149|463706594|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839176|NCT01072149|463706595|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839177|NCT01072149|463706596|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
128839178|NCT01072149|463706597|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839179|NCT01072149|463706598|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839180|NCT01072149|463706599|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839181|NCT01072149|463706600|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839182|NCT01072149|463706601|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839183|NCT01072149|463706602|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839184|NCT01072149|463706603|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
128839185|NCT01072149|463706586|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839186|NCT01072149|463706587|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
128839187|NCT01072149|463706588|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839188|NCT01072149|463706589|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839189|NCT01072149|463706590|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839190|NCT01072149|463706591|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839191|NCT01072149|463706592|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839192|NCT01072149|463706593|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839193|NCT01072149|463706594|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839194|NCT01072149|463706595|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839195|NCT01072149|463706596|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839196|NCT01072149|463706597|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839197|NCT01072149|463706598|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839198|NCT01072149|463706599|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839199|NCT01072149|463706600|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839200|NCT01072149|463706601|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839201|NCT01072149|463706602|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839202|NCT01072149|463706603|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
128839203|NCT01072149|463706586|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839204|NCT01072149|463706587|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839205|NCT01072149|463706588|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
128839206|NCT01072149|463706589|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839207|NCT01072149|463706590|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839208|NCT01072149|463706591|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839209|NCT01072149|463706592|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839210|NCT01072149|463706593|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839211|NCT01072149|463706594|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839212|NCT01072149|463706595|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839213|NCT01072149|463706596|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839214|NCT01072149|463706597|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839215|NCT01072149|463706598|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839216|NCT01072149|463706599|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839217|NCT01072149|463706600|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839218|NCT01072149|463706601|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839219|NCT01072149|463706602|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839220|NCT01072149|463706603|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
128839221|NCT01072149|463706586|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839222|NCT01072149|463706587|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839223|NCT01072149|463706588|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839224|NCT01072149|463706589|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839225|NCT01072149|463706590|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839226|NCT01072149|463706591|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839227|NCT01072149|463706592|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839228|NCT01072149|463706593|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
128839229|NCT01072149|463706594|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839230|NCT01072149|463706595|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839231|NCT01072149|463706596|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839232|NCT01072149|463706597|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839233|NCT01072149|463706598|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839234|NCT01072149|463706599|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839235|NCT01072149|463706600|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839236|NCT01072149|463706601|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839237|NCT01072149|463706602|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839238|NCT01072149|463706603|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
128839239|NCT01072149|463706586|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
128839240|NCT01072149|463706587|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
128839241|NCT01072149|463706588|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
128839242|NCT01072149|463706589|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
128839243|NCT01072149|463706590|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
128839244|NCT01072149|463706591|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
128839245|NCT01072149|463706592|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
128839246|NCT01072149|463706593|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
128839247|NCT01072149|463706594|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
128839248|NCT01072149|463706595|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
128839249|NCT01072149|463706596|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
128839250|NCT01072149|463706597|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
128839251|NCT01072149|463706598|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
128839252|NCT01072149|463706599|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
128839253|NCT01072149|463706600|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
128839254|NCT01072149|463706601|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
128839255|NCT01072149|463706602|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
128839256|NCT01072149|463706603|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
128839257|NCT01072149|463706586|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839258|NCT01072149|463706587|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839259|NCT01072149|463706588|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839260|NCT01072149|463706589|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839261|NCT01072149|463706590|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839262|NCT01072149|463706591|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839263|NCT01072149|463706592|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839264|NCT01072149|463706593|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839265|NCT01072149|463706594|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839266|NCT01072149|463706595|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839267|NCT01072149|463706596|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839268|NCT01072149|463706597|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839269|NCT01072149|463706598|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839270|NCT01072149|463706599|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839271|NCT01072149|463706600|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839272|NCT01072149|463706601|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
128839273|NCT01072149|463706602|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839274|NCT01072149|463706603|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
128839275|NCT01072149|463706586|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
128839276|NCT01072149|463706587|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
128839277|NCT01072149|463706588|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
128839278|NCT01072149|463706589|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
128839279|NCT01072149|463706590|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
128839280|NCT01072149|463706591|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
128839281|NCT01072149|463706592|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
128839282|NCT01072149|463706593|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
128839283|NCT01072149|463706594|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
128839284|NCT01072149|463706595|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
128839285|NCT01072149|463706596|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
128839286|NCT01072149|463706597|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
128839287|NCT01072149|463706598|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
128839288|NCT01072149|463706599|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
128839289|NCT01072149|463706600|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
128839290|NCT01072149|463706601|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
128839291|NCT01072149|463706602|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
128839292|NCT01072149|463706603|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
128839293|NCT01072149|463706586|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839294|NCT01072149|463706587|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839295|NCT01072149|463706588|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839296|NCT01072149|463706589|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839297|NCT01072149|463706590|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839298|NCT01072149|463706591|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839299|NCT01072149|463706592|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839300|NCT01072149|463706593|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839301|NCT01072149|463706594|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839302|NCT01072149|463706595|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839303|NCT01072149|463706596|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839304|NCT01072149|463706597|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839305|NCT01072149|463706598|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
128839306|NCT01072149|463706599|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839307|NCT01072149|463706600|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839308|NCT01072149|463706601|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839309|NCT01072149|463706602|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839310|NCT01072149|463706603|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
128839311|NCT01072149|463706586|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839312|NCT01072149|463706587|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839313|NCT01072149|463706588|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
128839314|NCT01072149|463706589|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839315|NCT01072149|463706590|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839316|NCT01072149|463706591|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839317|NCT01072149|463706592|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839318|NCT01072149|463706593|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839319|NCT01072149|463706594|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839320|NCT01072149|463706595|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839321|NCT01072149|463706596|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839322|NCT01072149|463706597|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839323|NCT01072149|463706598|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839324|NCT01072149|463706599|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
128839325|NCT01072149|463706600|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839326|NCT01072149|463706601|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839327|NCT01072149|463706602|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839328|NCT01072149|463706603|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
128839329|NCT00080119|463706604|FG000|Overall Study|Discontinued because of study closure|0|||
128839330|NCT00080119|463706605|FG001|Overall Study|Discontinued because of study closure|0|||
128839331|NCT00080119|463706606|FG002|Overall Study|Discontinued because of study closure|130|||
128839332|NCT00080119|463706607|FG003|Overall Study|Discontinued because of study closure|141|||
128839333|NCT00080119|463706604|FG000|Overall Study|Unable to get to clinic|24|||
128839334|NCT00080119|463706605|FG001|Overall Study|Unable to get to clinic|24|||
128839335|NCT00080119|463706606|FG002|Overall Study|Unable to get to clinic|7|||
128839336|NCT00080119|463706607|FG003|Overall Study|Unable to get to clinic|1|||
128839337|NCT00080119|463706604|FG000|Overall Study|Consent withdrawn|13|||
128839338|NCT00080119|463706605|FG001|Overall Study|Consent withdrawn|17|||
128839339|NCT00080119|463706606|FG002|Overall Study|Consent withdrawn|4|||
128839340|NCT00080119|463706607|FG003|Overall Study|Consent withdrawn|6|||
128839341|NCT00080119|463706604|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
128839342|NCT00080119|463706605|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
128839343|NCT00080119|463706606|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
128839344|NCT00080119|463706607|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
128839345|NCT00080119|463706604|FG000|Overall Study|Lost to Follow-up|16|||
128839346|NCT00080119|463706605|FG001|Overall Study|Lost to Follow-up|19|||
128839347|NCT00080119|463706606|FG002|Overall Study|Lost to Follow-up|19|||
128839348|NCT00080119|463706607|FG003|Overall Study|Lost to Follow-up|14|||
128839349|NCT01919489|463706609|FG000|Overall Study|Rejected the need of injections|4|||
128839350|NCT01919489|463706610|FG001|Overall Study|Rejected the need of injections|7|||
128839351|NCT01919489|463706609|FG000|Overall Study|Adverse Event|10|||
128839352|NCT01919489|463706610|FG001|Overall Study|Adverse Event|0|||
128839353|NCT01919489|463706609|FG000|Overall Study|Hospital readmission|2|||
128839354|NCT01919489|463706610|FG001|Overall Study|Hospital readmission|9|||
128839355|NCT01919489|463706609|FG000|Overall Study|Death|2|||
128839356|NCT01919489|463706610|FG001|Overall Study|Death|1|||
128839357|NCT01919489|463706609|FG000|Overall Study|Lost to Follow-up|38|||
128839358|NCT01919489|463706610|FG001|Overall Study|Lost to Follow-up|27|||
128839359|NCT01322386|463706611|FG000|Overall Study|Protocol Violation|0|||
128839360|NCT01322386|463706612|FG001|Overall Study|Protocol Violation|1|||
128839361|NCT01322386|463706611|FG000|Overall Study|Physician Decision|0|||
128839362|NCT01322386|463706612|FG001|Overall Study|Physician Decision|1|||
128839363|NCT02291861|463706617|FG000|Overall Study|Adverse Event|2|||
128839364|NCT02291861|463706618|FG001|Overall Study|Adverse Event|4|||
128839365|NCT02291861|463706619|FG002|Overall Study|Adverse Event|1|||
128839366|NCT02291861|463706620|FG003|Overall Study|Adverse Event|2|||
128839367|NCT02291861|463706617|FG000|Overall Study|Death|0|||
128839368|NCT02291861|463706618|FG001|Overall Study|Death|0|||
128839369|NCT02291861|463706619|FG002|Overall Study|Death|1|||
128839370|NCT02291861|463706620|FG003|Overall Study|Death|1|||
128839371|NCT02291861|463706617|FG000|Overall Study|Protocol Violation|1|||
128839372|NCT02291861|463706618|FG001|Overall Study|Protocol Violation|0|||
128839373|NCT02291861|463706619|FG002|Overall Study|Protocol Violation|0|||
128839374|NCT02291861|463706620|FG003|Overall Study|Protocol Violation|1|||
128839375|NCT02291861|463706617|FG000|Overall Study|Withdrawal by Subject|1|||
128839376|NCT02291861|463706618|FG001|Overall Study|Withdrawal by Subject|2|||
128839377|NCT02291861|463706619|FG002|Overall Study|Withdrawal by Subject|1|||
128839378|NCT02291861|463706620|FG003|Overall Study|Withdrawal by Subject|4|||
128839379|NCT02291861|463706617|FG000|Overall Study|Noncompliance|1|||
128839380|NCT02291861|463706618|FG001|Overall Study|Noncompliance|1|||
128839381|NCT02291861|463706619|FG002|Overall Study|Noncompliance|2|||
128839382|NCT02291861|463706620|FG003|Overall Study|Noncompliance|1|||
128839383|NCT02291861|463706617|FG000|Overall Study|Lost to Follow-up|2|||
128839384|NCT02291861|463706618|FG001|Overall Study|Lost to Follow-up|1|||
128839385|NCT02291861|463706619|FG002|Overall Study|Lost to Follow-up|4|||
128839386|NCT02291861|463706620|FG003|Overall Study|Lost to Follow-up|0|||
128839387|NCT02291861|463706617|FG000|Overall Study|Other|0|||
128839388|NCT02291861|463706618|FG001|Overall Study|Other|0|||
128839389|NCT02291861|463706619|FG002|Overall Study|Other|0|||
128839390|NCT02291861|463706620|FG003|Overall Study|Other|1|||
128839391|NCT01912599|463706626|FG000|Overall Study|Withdrawal by Subject|0|||
128839392|NCT01912599|463706627|FG001|Overall Study|Withdrawal by Subject|1|||
128839393|NCT03386344|463706628|FG000|Overall Study|Adverse Event|6|||
128839394|NCT03386344|463706629|FG001|Overall Study|Adverse Event|3|||
128839395|NCT03386344|463706630|FG002|Overall Study|Adverse Event|1|||
128839396|NCT03386344|463706628|FG000|Overall Study|Poor Compliance to Protocol|0|||
128839397|NCT03386344|463706629|FG001|Overall Study|Poor Compliance to Protocol|1|||
128839398|NCT03386344|463706630|FG002|Overall Study|Poor Compliance to Protocol|0|||
128839399|NCT03386344|463706628|FG000|Overall Study|Study Terminated by Sponsor|101|||
128839400|NCT03386344|463706629|FG001|Overall Study|Study Terminated by Sponsor|102|||
128839401|NCT03386344|463706630|FG002|Overall Study|Study Terminated by Sponsor|106|||
128839402|NCT03386344|463706628|FG000|Overall Study|Lost to Follow-up|3|||
128839403|NCT03386344|463706629|FG001|Overall Study|Lost to Follow-up|2|||
128839404|NCT03386344|463706630|FG002|Overall Study|Lost to Follow-up|1|||
128839405|NCT03386344|463706628|FG000|Overall Study|At the Participant's own Request|7|||
128839406|NCT03386344|463706629|FG001|Overall Study|At the Participant's own Request|7|||
128839407|NCT03386344|463706630|FG002|Overall Study|At the Participant's own Request|8|||
128839408|NCT03386344|463706628|FG000|Overall Study|Reason not Specified|0|||
128839409|NCT03386344|463706629|FG001|Overall Study|Reason not Specified|1|||
128839410|NCT03386344|463706630|FG002|Overall Study|Reason not Specified|0|||
128839411|NCT01280721|463706631|FG000|Overall Study|Adverse Event|4|||
128839412|NCT01280721|463706631|FG000|Overall Study|Physician Decision|3|||
128839413|NCT01280721|463706631|FG000|Overall Study|Withdrawal by Subject|6|||
128839414|NCT01280721|463706631|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
128839415|NCT01280721|463706631|FG000|Overall Study|No tolerability for the lowest dose|2|||
128839416|NCT01180400|463706632|FG000|Overall Study|Withdrawal by Subject|5|||
128839417|NCT01180400|463706633|FG001|Overall Study|Withdrawal by Subject|6|||
128839418|NCT01180400|463706632|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
128839419|NCT01180400|463706633|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
128839420|NCT01180400|463706632|FG000|Overall Study|Adverse Event|12|||
128839421|NCT01180400|463706633|FG001|Overall Study|Adverse Event|10|||
128839422|NCT01180400|463706632|FG000|Overall Study|Severe non-compliance to protocol|1|||
128839423|NCT01180400|463706633|FG001|Overall Study|Severe non-compliance to protocol|2|||
128839424|NCT01180400|463706632|FG000|Overall Study|Condition under investigation worsened|2|||
128839425|NCT01180400|463706633|FG001|Overall Study|Condition under investigation worsened|1|||
128839426|NCT01180400|463706632|FG000|Overall Study|Lack of Efficacy|2|||
128839427|NCT01180400|463706633|FG001|Overall Study|Lack of Efficacy|0|||
128839428|NCT01180400|463706632|FG000|Overall Study|Study-specific withdrawal criteria|1|||
128839429|NCT01180400|463706633|FG001|Overall Study|Study-specific withdrawal criteria|2|||
128839430|NCT01180400|463706632|FG000|Overall Study|Lost to Follow-up|2|||
128839431|NCT01180400|463706633|FG001|Overall Study|Lost to Follow-up|3|||
128839432|NCT01180400|463706632|FG000|Overall Study|Other|0|||
128839433|NCT01180400|463706633|FG001|Overall Study|Other|1|||
128839434|NCT00963924|463706634|FG000|Overall Study|Adverse Event|1|||
128839435|NCT00963924|463706635|FG001|Overall Study|Adverse Event|0|||
128839436|NCT00963924|463706634|FG000|Overall Study|Withdrawal by Subject|0|||
128839437|NCT00963924|463706635|FG001|Overall Study|Withdrawal by Subject|1|||
128839438|NCT00963924|463706634|FG000|Overall Study|Changed antipsychotic|0|||
128839439|NCT00963924|463706635|FG001|Overall Study|Changed antipsychotic|1|||
128839440|NCT00963924|463706634|FG000|Overall Study|Lost to Follow-up|0|||
128839441|NCT00963924|463706635|FG001|Overall Study|Lost to Follow-up|1|||
128839442|NCT03875729|463706636|FG000|Overall Study|Adverse Event|0|||
128839443|NCT03875729|463706637|FG001|Overall Study|Adverse Event|5|||
128839444|NCT03875729|463706636|FG000|Overall Study|Withdrawal by Subject|8|||
128839445|NCT03875729|463706637|FG001|Overall Study|Withdrawal by Subject|11|||
128839446|NCT03875729|463706636|FG000|Overall Study|Pregnancy|0|||
128839447|NCT03875729|463706637|FG001|Overall Study|Pregnancy|1|||
128839448|NCT03875729|463706636|FG000|Overall Study|Lost to Follow-up|0|||
128839449|NCT03875729|463706637|FG001|Overall Study|Lost to Follow-up|5|||
128839450|NCT03875729|463706636|FG000|Overall Study|Personal reasons|2|||
128839451|NCT03875729|463706637|FG001|Overall Study|Personal reasons|0|||
128839452|NCT01405508|463706640|FG000|Overall Study|AE, non-serious non-fatal|1|||
128839453|NCT01405508|463706641|FG001|Overall Study|AE, non-serious non-fatal|1|||
128839454|NCT01405508|463706642|FG002|Overall Study|AE, non-serious non-fatal|0|||
128839455|NCT01405508|463706643|FG003|Overall Study|AE, non-serious non-fatal|0|||
128839456|NCT00476957|463706644|FG000|Overall Study|Lost to Follow-up|176|||
128839457|NCT00476957|463706645|FG001|Overall Study|Lost to Follow-up|193|||
128839458|NCT02159352|463706646|FG000|Overall Study|Adverse Event|3|||
128839459|NCT02159352|463706647|FG001|Overall Study|Adverse Event|1|||
128839460|NCT02159352|463706646|FG000|Overall Study|Withdrawal by Subject|0|||
128839461|NCT02159352|463706647|FG001|Overall Study|Withdrawal by Subject|1|||
128839462|NCT00636168|463706654|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
128839463|NCT00636168|463706655|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
128839464|NCT00636168|463706654|FG000|Randomized to Study Drug|Adverse Event|1|||
128839465|NCT00636168|463706655|FG001|Randomized to Study Drug|Adverse Event|0|||
128839466|NCT00636168|463706654|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
128839467|NCT00636168|463706655|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
128839468|NCT00636168|463706654|FG000|Treated With Study Drug|Recurrence of disease|135|||
128839469|NCT00636168|463706655|FG001|Treated With Study Drug|Recurrence of disease|282|||
128839470|NCT00636168|463706654|FG000|Treated With Study Drug|Adverse Event|250|||
128839471|NCT00636168|463706655|FG001|Treated With Study Drug|Adverse Event|22|||
128839472|NCT00636168|463706654|FG000|Treated With Study Drug|Participant withdrew consent|16|||
128839473|NCT00636168|463706655|FG001|Treated With Study Drug|Participant withdrew consent|21|||
128839474|NCT00636168|463706654|FG000|Treated With Study Drug|Poor/non-compliance|1|||
128839475|NCT00636168|463706655|FG001|Treated With Study Drug|Poor/non-compliance|3|||
128839476|NCT00636168|463706654|FG000|Treated With Study Drug|Death|3|||
128839477|NCT00636168|463706655|FG001|Treated With Study Drug|Death|0|||
128839478|NCT00636168|463706654|FG000|Treated With Study Drug|Pregnancy|1|||
128839479|NCT00636168|463706655|FG001|Treated With Study Drug|Pregnancy|0|||
128839480|NCT00636168|463706654|FG000|Treated With Study Drug|No longer meets study criteria|1|||
128839481|NCT00636168|463706655|FG001|Treated With Study Drug|No longer meets study criteria|0|||
128839482|NCT00636168|463706654|FG000|Treated With Study Drug|Other reason|1|||
128839483|NCT00636168|463706655|FG001|Treated With Study Drug|Other reason|3|||
128839484|NCT00636168|463706654|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
128839485|NCT00636168|463706655|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
128839486|NCT00636168|463706654|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
128839487|NCT00636168|463706655|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
128839488|NCT00636168|463706654|FG000|Long Term Follow-Up|Death|8|||
128839489|NCT00636168|463706655|FG001|Long Term Follow-Up|Death|9|||
128839490|NCT00871715|463706660|FG000|Overall Study|Withdrawal by Subject|6|||
128839491|NCT00871715|463706661|FG001|Overall Study|Withdrawal by Subject|10|||
128839492|NCT00871715|463706662|FG002|Overall Study|Withdrawal by Subject|15|||
128839493|NCT00871715|463706660|FG000|Overall Study|Physician Decision|6|||
128839494|NCT00871715|463706661|FG001|Overall Study|Physician Decision|0|||
128839495|NCT00871715|463706662|FG002|Overall Study|Physician Decision|2|||
128839496|NCT00871715|463706660|FG000|Overall Study|Lost to Follow-up|3|||
128839497|NCT00871715|463706661|FG001|Overall Study|Lost to Follow-up|6|||
128839498|NCT00871715|463706662|FG002|Overall Study|Lost to Follow-up|9|||
128839499|NCT03015220|463706663|FG000|Overall Study|Withdrawal by Subject|3|||
128839500|NCT03015220|463706664|FG001|Overall Study|Withdrawal by Subject|2|||
128839501|NCT03015220|463706665|FG002|Overall Study|Withdrawal by Subject|2|||
128839502|NCT03015220|463706666|FG003|Overall Study|Withdrawal by Subject|2|||
128839503|NCT03015220|463706663|FG000|Overall Study|Lost to Follow-up|0|||
128839504|NCT03015220|463706664|FG001|Overall Study|Lost to Follow-up|0|||
128839505|NCT03015220|463706665|FG002|Overall Study|Lost to Follow-up|1|||
128839506|NCT03015220|463706666|FG003|Overall Study|Lost to Follow-up|0|||
128839507|NCT01670526|463706667|FG000|Overall Study|Withdrawal by Subject|3|||
128839508|NCT01670526|463706668|FG001|Overall Study|Withdrawal by Subject|1|||
128839509|NCT01670526|463706667|FG000|Overall Study|Lost to Follow-up|9|||
128839510|NCT01670526|463706668|FG001|Overall Study|Lost to Follow-up|5|||
128839511|NCT02291549|463706669|FG000|Overall Study|Lost to Follow-up|1|||
128839512|NCT02291549|463706670|FG001|Overall Study|Lost to Follow-up|0|||
128839513|NCT02291549|463706669|FG000|Overall Study|Withdrawal by Subject|0|||
128839514|NCT02291549|463706670|FG001|Overall Study|Withdrawal by Subject|1|||
128839515|NCT01970527|463706672|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
128839516|NCT01970527|463706673|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
128839517|NCT01970527|463706672|FG000|Treatment|Disease progression|0|||
128839518|NCT01970527|463706673|FG001|Treatment|Disease progression|1|||
128839519|NCT01970527|463706672|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
128839520|NCT01970527|463706673|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
128839521|NCT01970527|463706672|FG000|Treatment|Death|0|||
128839522|NCT01970527|463706673|FG001|Treatment|Death|1|||
128839523|NCT01970527|463706672|FG000|Follow-up Clinic Visit|Disease progression|1|||
128839524|NCT01970527|463706673|FG001|Follow-up Clinic Visit|Disease progression|1|||
128839525|NCT01970527|463706672|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
128839526|NCT01970527|463706673|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
128839527|NCT01970527|463706672|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
128839528|NCT01970527|463706673|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
128839529|NCT01964547|463706674|FG000|Overall Study|Adverse Event|8|||
128839530|NCT01964547|463706675|FG001|Overall Study|Adverse Event|2|||
128839531|NCT01964547|463706674|FG000|Overall Study|Withdrawal by Subject|4|||
128839532|NCT01964547|463706675|FG001|Overall Study|Withdrawal by Subject|7|||
128839533|NCT01964547|463706674|FG000|Overall Study|Lost to Follow-up|0|||
128839534|NCT01964547|463706675|FG001|Overall Study|Lost to Follow-up|1|||
128839535|NCT01964547|463706674|FG000|Overall Study|Withdrawal by Investigator|0|||
128839536|NCT01964547|463706675|FG001|Overall Study|Withdrawal by Investigator|1|||
128839537|NCT04447287|463706676|FG000|Period 1: Run-in Period|Adverse Event|3|||
128839538|NCT04447287|463706677|FG001|Period 1: Run-in Period|Adverse Event|0|||
128839539|NCT04447287|463706678|FG002|Period 1: Run-in Period|Adverse Event|0|||
128839540|NCT04447287|463706676|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
128839541|NCT04447287|463706677|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
128839542|NCT04447287|463706678|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
128839543|NCT04447287|463706676|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
128839544|NCT04447287|463706677|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
128839545|NCT04447287|463706678|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
128839546|NCT02147093|463706681|FG000|Period 1|Lost to Follow-up|0|||
128839547|NCT02147093|463706682|FG001|Period 1|Lost to Follow-up|1|||
128839548|NCT02147093|463706681|FG000|Period 2|Protocol Violation|2|||
128839549|NCT02147093|463706682|FG001|Period 2|Protocol Violation|0|||
128839550|NCT03246724|463706683|FG000|Overall Study|Withdrawal by Subject|5|||
128839551|NCT03246724|463706684|FG001|Overall Study|Withdrawal by Subject|2|||
128839552|NCT03246724|463706685|FG002|Overall Study|Withdrawal by Subject|4|||
128839553|NCT03246724|463706686|FG003|Overall Study|Withdrawal by Subject|2|||
128839554|NCT03246724|463706683|FG000|Overall Study|Ineligible on day of surgery|7|||
128839555|NCT03246724|463706684|FG001|Overall Study|Ineligible on day of surgery|2|||
128839556|NCT03246724|463706685|FG002|Overall Study|Ineligible on day of surgery|0|||
128839557|NCT03246724|463706686|FG003|Overall Study|Ineligible on day of surgery|3|||
128839558|NCT03246724|463706683|FG000|Overall Study|Study completed before surgical date|2|||
128839559|NCT03246724|463706684|FG001|Overall Study|Study completed before surgical date|1|||
128839560|NCT03246724|463706685|FG002|Overall Study|Study completed before surgical date|8|||
128839561|NCT03246724|463706686|FG003|Overall Study|Study completed before surgical date|1|||
128839562|NCT03246724|463706683|FG000|Overall Study|Transferred to other arm|0|||
128839563|NCT03246724|463706684|FG001|Overall Study|Transferred to other arm|0|||
128839564|NCT03246724|463706685|FG002|Overall Study|Transferred to other arm|1|||
128839565|NCT03246724|463706686|FG003|Overall Study|Transferred to other arm|0|||
128839566|NCT03246724|463706683|FG000|Overall Study|Unable to obtain medication timely|0|||
128839567|NCT03246724|463706684|FG001|Overall Study|Unable to obtain medication timely|2|||
128839568|NCT03246724|463706685|FG002|Overall Study|Unable to obtain medication timely|2|||
128839569|NCT03246724|463706686|FG003|Overall Study|Unable to obtain medication timely|1|||
128839570|NCT03246724|463706683|FG000|Overall Study|Re-consented to participate|0|||
128839571|NCT03246724|463706684|FG001|Overall Study|Re-consented to participate|0|||
128839572|NCT03246724|463706685|FG002|Overall Study|Re-consented to participate|0|||
128839573|NCT03246724|463706686|FG003|Overall Study|Re-consented to participate|1|||
128839574|NCT00655824|463706687|FG000|Overall Study|Adverse Event|3|||
128839575|NCT00655824|463706687|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
128839576|NCT00655824|463706687|FG000|Overall Study|Protocol Violation|1|||
128839577|NCT00655824|463706687|FG000|Overall Study|Withdrawal by Subject|4|||
128839578|NCT00655824|463706687|FG000|Overall Study|Deterioration of Trial Disease|2|||
128839579|NCT01662505|463706694|FG000|Overall Study|Progressive disease|6|||
128839580|NCT01662505|463706695|FG001|Overall Study|Progressive disease|1|||
128839581|NCT01662505|463706696|FG002|Overall Study|Progressive disease|5|||
128839582|NCT01662505|463706694|FG000|Overall Study|Refused cont. medication|0|||
128839583|NCT01662505|463706695|FG001|Overall Study|Refused cont. medication|0|||
128839584|NCT01662505|463706696|FG002|Overall Study|Refused cont. medication|1|||
128839585|NCT01662505|463706694|FG000|Overall Study|Not specified above|1|||
128839586|NCT01662505|463706695|FG001|Overall Study|Not specified above|3|||
128839587|NCT01662505|463706696|FG002|Overall Study|Not specified above|2|||
128839588|NCT02255474|463706697|FG000|Overall Study|Lost to Follow-up|1|||
128839589|NCT02255474|463706698|FG001|Overall Study|Lost to Follow-up|1|||
128839590|NCT02255474|463706699|FG002|Overall Study|Lost to Follow-up|3|||
128839591|NCT02255474|463706697|FG000|Overall Study|Withdrawal by Subject|1|||
128839592|NCT02255474|463706698|FG001|Overall Study|Withdrawal by Subject|1|||
128839593|NCT02255474|463706699|FG002|Overall Study|Withdrawal by Subject|0|||
128839594|NCT01229176|463706700|FG000|Overall Study|Withdrawal by Subject|0|||
128839595|NCT01229176|463706701|FG001|Overall Study|Withdrawal by Subject|0|||
128839596|NCT01229176|463706702|FG002|Overall Study|Withdrawal by Subject|0|||
128839597|NCT01229176|463706703|FG003|Overall Study|Withdrawal by Subject|1|||
128839598|NCT01229176|463706704|FG004|Overall Study|Withdrawal by Subject|1|||
128839599|NCT01229176|463706705|FG005|Overall Study|Withdrawal by Subject|1|||
128839600|NCT01229176|463706706|FG006|Overall Study|Withdrawal by Subject|0|||
128839601|NCT01229176|463706707|FG007|Overall Study|Withdrawal by Subject|1|||
128839602|NCT01229176|463706700|FG000|Overall Study|Lost to Follow-up|0|||
128839603|NCT01229176|463706701|FG001|Overall Study|Lost to Follow-up|3|||
128839604|NCT01229176|463706702|FG002|Overall Study|Lost to Follow-up|0|||
128839605|NCT01229176|463706703|FG003|Overall Study|Lost to Follow-up|0|||
128839606|NCT01229176|463706704|FG004|Overall Study|Lost to Follow-up|1|||
128839607|NCT01229176|463706705|FG005|Overall Study|Lost to Follow-up|1|||
128839608|NCT01229176|463706706|FG006|Overall Study|Lost to Follow-up|0|||
128839609|NCT01229176|463706707|FG007|Overall Study|Lost to Follow-up|2|||
128839610|NCT00882050|463706713|FG000|Overall Study|Physician Decision|1|||
128839611|NCT00882050|463706714|FG001|Overall Study|Physician Decision|0|||
128839612|NCT00882050|463706715|FG002|Overall Study|Physician Decision|0|||
128839613|NCT02367794|463706716|FG000|Overall Study|Death|252|||
128839614|NCT02367794|463706717|FG001|Overall Study|Death|245|||
128839615|NCT02367794|463706718|FG002|Overall Study|Death|243|||
128839616|NCT02367794|463706716|FG000|Overall Study|Lost to Follow-up|1|||
128839617|NCT02367794|463706717|FG001|Overall Study|Lost to Follow-up|2|||
128839618|NCT02367794|463706718|FG002|Overall Study|Lost to Follow-up|2|||
128839619|NCT02367794|463706716|FG000|Overall Study|Physician Decision|0|||
128839620|NCT02367794|463706717|FG001|Overall Study|Physician Decision|5|||
128839621|NCT02367794|463706718|FG002|Overall Study|Physician Decision|3|||
128839622|NCT02367794|463706716|FG000|Overall Study|Protocol Violation|1|||
128839623|NCT02367794|463706717|FG001|Overall Study|Protocol Violation|0|||
128839624|NCT02367794|463706718|FG002|Overall Study|Protocol Violation|1|||
128839625|NCT02367794|463706716|FG000|Overall Study|Withdrawal by Subject|25|||
128839626|NCT02367794|463706717|FG001|Overall Study|Withdrawal by Subject|12|||
128839627|NCT02367794|463706718|FG002|Overall Study|Withdrawal by Subject|20|||
128839628|NCT02367794|463706716|FG000|Overall Study|Brain metastasis|1|||
128839629|NCT02367794|463706717|FG001|Overall Study|Brain metastasis|0|||
128839630|NCT02367794|463706718|FG002|Overall Study|Brain metastasis|0|||
128839631|NCT02367794|463706716|FG000|Overall Study|Randomized in error|0|||
128839632|NCT02367794|463706717|FG001|Overall Study|Randomized in error|0|||
128839633|NCT02367794|463706718|FG002|Overall Study|Randomized in error|1|||
128839634|NCT02367794|463706716|FG000|Overall Study|Patient unable to receive carboplatin|0|||
128839635|NCT02367794|463706717|FG001|Overall Study|Patient unable to receive carboplatin|0|||
128839636|NCT02367794|463706718|FG002|Overall Study|Patient unable to receive carboplatin|1|||
128839637|NCT02367794|463706716|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
128839638|NCT02367794|463706717|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
128839639|NCT02367794|463706718|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
128839640|NCT02367794|463706716|FG000|Overall Study|Adverse Event|0|||
128839641|NCT02367794|463706717|FG001|Overall Study|Adverse Event|0|||
128839642|NCT02367794|463706718|FG002|Overall Study|Adverse Event|2|||
128839643|NCT02367794|463706716|FG000|Overall Study|Study Terminated By Sponsor|0|||
128839644|NCT02367794|463706717|FG001|Overall Study|Study Terminated By Sponsor|1|||
128839645|NCT02367794|463706718|FG002|Overall Study|Study Terminated By Sponsor|1|||
128839646|NCT02367794|463706716|FG000|Overall Study|Moved to Roll-Over Study|0|||
128839647|NCT02367794|463706717|FG001|Overall Study|Moved to Roll-Over Study|15|||
128839648|NCT02367794|463706718|FG002|Overall Study|Moved to Roll-Over Study|13|||
128839649|NCT02367794|463706716|FG000|Overall Study|Sponsor Request|60|||
128839650|NCT02367794|463706717|FG001|Overall Study|Sponsor Request|57|||
128839651|NCT02367794|463706718|FG002|Overall Study|Sponsor Request|45|||
128839652|NCT02367794|463706716|FG000|Overall Study|Moved into PTAP Study|0|||
128839653|NCT02367794|463706717|FG001|Overall Study|Moved into PTAP Study|2|||
128839654|NCT02367794|463706718|FG002|Overall Study|Moved into PTAP Study|3|||
128839655|NCT02367794|463706716|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
128839656|NCT02367794|463706717|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
128839657|NCT02367794|463706718|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
128839658|NCT02367794|463706716|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
128839659|NCT02367794|463706717|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
128839660|NCT02367794|463706718|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
128839661|NCT02367794|463706716|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
128839662|NCT02367794|463706717|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
128839663|NCT02367794|463706718|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
128839664|NCT02367794|463706716|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
128839665|NCT02367794|463706717|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
128839666|NCT02367794|463706718|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
128839667|NCT02010684|463706719|FG000|Overall Study|Lost to Follow-up|8|||
128839668|NCT02010684|463706720|FG001|Overall Study|Lost to Follow-up|18|||
128839669|NCT02010684|463706719|FG000|Overall Study|Withdrawal by Subject|4|||
128839670|NCT02010684|463706720|FG001|Overall Study|Withdrawal by Subject|5|||
128839671|NCT00091572|463706725|FG000|Overall Study|Lost to Follow-up|1|||
128839672|NCT00091572|463706726|FG001|Overall Study|Lost to Follow-up|1|||
128839673|NCT00091572|463706725|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
128839674|NCT00091572|463706726|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
128839675|NCT00091572|463706725|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
128839676|NCT00091572|463706726|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
128839677|NCT00091572|463706725|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
128839678|NCT00091572|463706726|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
128839679|NCT00091572|463706725|FG000|Overall Study|Other Reason|6|||
128839680|NCT00091572|463706726|FG001|Overall Study|Other Reason|13|||
128839681|NCT00091572|463706725|FG000|Overall Study|Ongoing (still on treatment)|8|||
128839682|NCT00091572|463706726|FG001|Overall Study|Ongoing (still on treatment)|12|||
128839683|NCT00091572|463706725|FG000|Overall Study|Major Protocol Violation|2|||
128839684|NCT00091572|463706726|FG001|Overall Study|Major Protocol Violation|0|||
128839685|NCT00091572|463706725|FG000|Overall Study|Toxicity (Related AE)|53|||
128839686|NCT00091572|463706726|FG001|Overall Study|Toxicity (Related AE)|9|||
128839687|NCT02942771|463706728|FG000|Overall Study|Adverse Event|1|||
128839688|NCT02942771|463706729|FG001|Overall Study|Adverse Event|0|||
128839689|NCT02942771|463706730|FG002|Overall Study|Adverse Event|0|||
128839690|NCT02942771|463706731|FG003|Overall Study|Adverse Event|0|||
128839691|NCT02942771|463706732|FG004|Overall Study|Adverse Event|2|||
128839692|NCT02942771|463706728|FG000|Overall Study|Lost to Follow-up|1|||
128839693|NCT02942771|463706729|FG001|Overall Study|Lost to Follow-up|0|||
128839694|NCT02942771|463706730|FG002|Overall Study|Lost to Follow-up|0|||
128839695|NCT02942771|463706731|FG003|Overall Study|Lost to Follow-up|0|||
128839696|NCT02942771|463706732|FG004|Overall Study|Lost to Follow-up|0|||
128839697|NCT02942771|463706728|FG000|Overall Study|Withdrawal by Subject|1|||
128839698|NCT02942771|463706729|FG001|Overall Study|Withdrawal by Subject|0|||
128839699|NCT02942771|463706730|FG002|Overall Study|Withdrawal by Subject|0|||
128839700|NCT02942771|463706731|FG003|Overall Study|Withdrawal by Subject|0|||
128839701|NCT02942771|463706732|FG004|Overall Study|Withdrawal by Subject|2|||
128839702|NCT01186809|463706736|FG000|Overall Study|Death|30|||
129204969|NCT03100149|465047013|FG001|Overall Study|Participant Moved out of Country|0|||
129204970|NCT03100149|465047014|FG002|Overall Study|Participant Moved out of Country|1|||
129204971|NCT03100149|465047012|FG000|Overall Study|Withdrawal by Subject|0|||
129204972|NCT03100149|465047013|FG001|Overall Study|Withdrawal by Subject|3|||
129204973|NCT03100149|465047014|FG002|Overall Study|Withdrawal by Subject|1|||
129204974|NCT04972162|465047015|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
129204975|NCT04972162|465047016|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
129204976|NCT01928927|465047017|FG000|Overall Study|Lost to Follow-up|1|||
129204977|NCT01928927|465047018|FG001|Overall Study|Lost to Follow-up|0|||
129204978|NCT01928927|465047017|FG000|Overall Study|Withdrawal by Subject|1|||
128839703|NCT04895085|463706737|FG000|Overall Study|Death|1|||
128839704|NCT04895085|463706737|FG000|Overall Study|Withdrawal by Subject|1|||
128839705|NCT04895085|463706737|FG000|Overall Study|No longer eligible: Moved from area|1|||
128839706|NCT01159600|463706742|FG000|Overall Study|Not treated|0|||
128839707|NCT01159600|463706743|FG001|Overall Study|Not treated|0|||
128839708|NCT01159600|463706744|FG002|Overall Study|Not treated|1|||
128839709|NCT01159600|463706745|FG003|Overall Study|Not treated|0|||
128839710|NCT01159600|463706746|FG004|Overall Study|Not treated|0|||
128839711|NCT01159600|463706747|FG005|Overall Study|Not treated|1|||
128839712|NCT01159600|463706748|FG006|Overall Study|Not treated|2|||
128839713|NCT01159600|463706749|FG007|Overall Study|Not treated|2|||
128839714|NCT01159600|463706742|FG000|Overall Study|Adverse Event|7|||
128839715|NCT01159600|463706743|FG001|Overall Study|Adverse Event|2|||
128839716|NCT01159600|463706744|FG002|Overall Study|Adverse Event|5|||
128839717|NCT01159600|463706745|FG003|Overall Study|Adverse Event|1|||
128839718|NCT01159600|463706746|FG004|Overall Study|Adverse Event|8|||
128839719|NCT01159600|463706747|FG005|Overall Study|Adverse Event|6|||
128839720|NCT01159600|463706748|FG006|Overall Study|Adverse Event|7|||
128839721|NCT01159600|463706749|FG007|Overall Study|Adverse Event|5|||
128839722|NCT01159600|463706742|FG000|Overall Study|Lack of Efficacy|0|||
128839723|NCT01159600|463706743|FG001|Overall Study|Lack of Efficacy|0|||
128839724|NCT01159600|463706744|FG002|Overall Study|Lack of Efficacy|0|||
128839725|NCT01159600|463706745|FG003|Overall Study|Lack of Efficacy|0|||
128839726|NCT01159600|463706746|FG004|Overall Study|Lack of Efficacy|2|||
128839727|NCT01159600|463706747|FG005|Overall Study|Lack of Efficacy|0|||
128839728|NCT01159600|463706748|FG006|Overall Study|Lack of Efficacy|0|||
128839729|NCT01159600|463706749|FG007|Overall Study|Lack of Efficacy|1|||
128839730|NCT01159600|463706742|FG000|Overall Study|Non compliant with protocol|2|||
128839731|NCT01159600|463706743|FG001|Overall Study|Non compliant with protocol|1|||
128839732|NCT01159600|463706744|FG002|Overall Study|Non compliant with protocol|0|||
128839733|NCT01159600|463706745|FG003|Overall Study|Non compliant with protocol|0|||
128839734|NCT01159600|463706746|FG004|Overall Study|Non compliant with protocol|2|||
128839735|NCT01159600|463706747|FG005|Overall Study|Non compliant with protocol|0|||
128839736|NCT01159600|463706748|FG006|Overall Study|Non compliant with protocol|2|||
128839737|NCT01159600|463706749|FG007|Overall Study|Non compliant with protocol|0|||
128839738|NCT01159600|463706742|FG000|Overall Study|Lost to Follow-up|2|||
128839739|NCT01159600|463706743|FG001|Overall Study|Lost to Follow-up|3|||
128839740|NCT01159600|463706744|FG002|Overall Study|Lost to Follow-up|4|||
128839741|NCT01159600|463706745|FG003|Overall Study|Lost to Follow-up|3|||
128839742|NCT01159600|463706746|FG004|Overall Study|Lost to Follow-up|3|||
128839743|NCT01159600|463706747|FG005|Overall Study|Lost to Follow-up|0|||
128839744|NCT01159600|463706748|FG006|Overall Study|Lost to Follow-up|3|||
128839745|NCT01159600|463706749|FG007|Overall Study|Lost to Follow-up|2|||
128839746|NCT01159600|463706742|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
128839747|NCT01159600|463706743|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
128839748|NCT01159600|463706744|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
128839749|NCT01159600|463706745|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
128839750|NCT01159600|463706746|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
128839751|NCT01159600|463706747|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
128839752|NCT01159600|463706748|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
128839753|NCT01159600|463706749|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
128839754|NCT01159600|463706742|FG000|Overall Study|Other reason not defined above|3|||
128839755|NCT01159600|463706743|FG001|Overall Study|Other reason not defined above|0|||
128839756|NCT01159600|463706744|FG002|Overall Study|Other reason not defined above|4|||
128839757|NCT01159600|463706745|FG003|Overall Study|Other reason not defined above|2|||
128839758|NCT01159600|463706746|FG004|Overall Study|Other reason not defined above|5|||
128839759|NCT01159600|463706747|FG005|Overall Study|Other reason not defined above|7|||
128839760|NCT01159600|463706748|FG006|Overall Study|Other reason not defined above|3|||
128839761|NCT01159600|463706749|FG007|Overall Study|Other reason not defined above|3|||
128839762|NCT04433091|463706750|FG000|Overall Study|Lost to Follow-up|1|||
128839763|NCT04433091|463706751|FG001|Overall Study|Lost to Follow-up|0|||
128839764|NCT04433091|463706750|FG000|Overall Study|Withdrawn .|2|||
128839765|NCT04433091|463706751|FG001|Overall Study|Withdrawn .|4|||
128839766|NCT04097535|463706752|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
128839767|NCT04820023|463708307|FG000|Overall Study|Death|0|||
128839768|NCT04820023|463708308|FG001|Overall Study|Death|0|||
128839769|NCT04820023|463708309|FG002|Overall Study|Death|0|||
128839770|NCT04820023|463708310|FG003|Overall Study|Death|0|||
128839771|NCT04820023|463708311|FG004|Overall Study|Death|0|||
128839772|NCT04820023|463708312|FG005|Overall Study|Death|0|||
128839773|NCT04820023|463708313|FG006|Overall Study|Death|1|||
128839774|NCT04820023|463708314|FG007|Overall Study|Death|0|||
128839775|NCT04820023|463708315|FG008|Overall Study|Death|1|||
128839776|NCT04820023|463708307|FG000|Overall Study|Withdrawal by Subject|1|||
128839777|NCT04820023|463708308|FG001|Overall Study|Withdrawal by Subject|2|||
128839778|NCT04820023|463708309|FG002|Overall Study|Withdrawal by Subject|2|||
128839779|NCT04820023|463708310|FG003|Overall Study|Withdrawal by Subject|1|||
128839780|NCT04820023|463708311|FG004|Overall Study|Withdrawal by Subject|4|||
128839781|NCT04820023|463708312|FG005|Overall Study|Withdrawal by Subject|3|||
128839782|NCT04820023|463708313|FG006|Overall Study|Withdrawal by Subject|3|||
128839783|NCT04820023|463708314|FG007|Overall Study|Withdrawal by Subject|6|||
128839784|NCT04820023|463708315|FG008|Overall Study|Withdrawal by Subject|5|||
128839785|NCT04820023|463708307|FG000|Overall Study|Progressive Disease|3|||
128839786|NCT04820023|463708308|FG001|Overall Study|Progressive Disease|0|||
128839787|NCT04820023|463708309|FG002|Overall Study|Progressive Disease|2|||
128839788|NCT04820023|463708310|FG003|Overall Study|Progressive Disease|2|||
128839789|NCT04820023|463708311|FG004|Overall Study|Progressive Disease|2|||
128839790|NCT04820023|463708312|FG005|Overall Study|Progressive Disease|0|||
128839791|NCT04820023|463708313|FG006|Overall Study|Progressive Disease|1|||
128839792|NCT04820023|463708314|FG007|Overall Study|Progressive Disease|1|||
128839793|NCT04820023|463708315|FG008|Overall Study|Progressive Disease|0|||
128839794|NCT04820023|463708307|FG000|Overall Study|New anti-cancer therapy|0|||
128839795|NCT04820023|463708308|FG001|Overall Study|New anti-cancer therapy|0|||
128839796|NCT04820023|463708309|FG002|Overall Study|New anti-cancer therapy|0|||
128839797|NCT04820023|463708310|FG003|Overall Study|New anti-cancer therapy|0|||
128839798|NCT04820023|463708311|FG004|Overall Study|New anti-cancer therapy|2|||
128839799|NCT04820023|463708312|FG005|Overall Study|New anti-cancer therapy|0|||
128839800|NCT04820023|463708313|FG006|Overall Study|New anti-cancer therapy|0|||
128839801|NCT04820023|463708314|FG007|Overall Study|New anti-cancer therapy|0|||
128839802|NCT04820023|463708315|FG008|Overall Study|New anti-cancer therapy|0|||
128839803|NCT04820023|463708307|FG000|Overall Study|Other|0|||
128839804|NCT04820023|463708308|FG001|Overall Study|Other|1|||
128839805|NCT04820023|463708309|FG002|Overall Study|Other|0|||
128839806|NCT04820023|463708310|FG003|Overall Study|Other|0|||
128839807|NCT04820023|463708311|FG004|Overall Study|Other|0|||
128839808|NCT04820023|463708312|FG005|Overall Study|Other|0|||
128839809|NCT04820023|463708313|FG006|Overall Study|Other|0|||
128839810|NCT04820023|463708314|FG007|Overall Study|Other|2|||
128839811|NCT04820023|463708315|FG008|Overall Study|Other|0|||
128839812|NCT00307489|463708318|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
128839813|NCT00307489|463708319|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
128839814|NCT00307489|463708318|FG000|Baseline Through Week 48|Physician Decision|1|||
128839815|NCT00307489|463708319|FG001|Baseline Through Week 48|Physician Decision|0|||
128839816|NCT00307489|463708318|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
128839817|NCT00307489|463708319|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
128839818|NCT00307489|463708318|FG000|Week 48 Through Week 168|Adverse Event|1|||
128839819|NCT00307489|463708319|FG001|Week 48 Through Week 168|Adverse Event|0|||
128839820|NCT00307489|463708318|FG000|Week 48 Through Week 168|Physician Decision|1|||
128839821|NCT00307489|463708319|FG001|Week 48 Through Week 168|Physician Decision|0|||
128839822|NCT00307489|463708318|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
128839823|NCT00307489|463708319|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
128839824|NCT00307489|463708318|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
128839825|NCT00307489|463708319|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
128839826|NCT00307489|463708318|FG000|Week 48 Through Week 168|Death|0|||
128839827|NCT00307489|463708319|FG001|Week 48 Through Week 168|Death|1|||
128839828|NCT00307489|463708318|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
128839829|NCT00307489|463708319|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
128839830|NCT00307489|463708318|FG000|Week 48 Through Week 168|Seroconversion|1|||
128839831|NCT00307489|463708319|FG001|Week 48 Through Week 168|Seroconversion|0|||
128839832|NCT01975701|463708326|FG000|Overall Study|Lost to Follow-up|1|||
128839833|NCT01975701|463708326|FG000|Overall Study|Death|23|||
128839834|NCT01975701|463708326|FG000|Overall Study|Physician Decision|1|||
128839835|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
128839836|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
128839837|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
128839838|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
128839839|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Adverse Event|7|||
128839840|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Adverse Event|8|||
128839841|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Adverse Event|8|||
128839842|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Adverse Event|9|||
128839843|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
128839844|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
128839845|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
128839846|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
128839847|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
128839848|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
128839849|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
128839850|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
128839851|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Pregnancy|0|||
128839852|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Pregnancy|2|||
128839853|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Pregnancy|2|||
128839854|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Pregnancy|0|||
128839855|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Non-compliance|1|||
128839856|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Non-compliance|0|||
128839857|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Non-compliance|0|||
128839858|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Non-compliance|3|||
128839859|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Other|3|||
128839860|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Other|0|||
128839861|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Other|3|||
128839862|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Other|2|||
128839863|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
128839864|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
128839865|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
128839866|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
128839867|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
128839868|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
128839869|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
128839870|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
128839871|NCT02143713|463708331|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
128839872|NCT02143713|463708332|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
128839873|NCT02143713|463708333|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
128839874|NCT02143713|463708334|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
128839875|NCT02143713|463708331|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
128839876|NCT02143713|463708332|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
128839877|NCT02143713|463708333|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
128839878|NCT02143713|463708334|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
128839879|NCT02143713|463708331|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
128839880|NCT02143713|463708332|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
128839881|NCT02143713|463708333|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
128839882|NCT02143713|463708334|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
128839883|NCT02143713|463708331|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
128839884|NCT02143713|463708332|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
128839885|NCT02143713|463708333|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
128839886|NCT02143713|463708334|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
128839887|NCT02143713|463708331|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
128839888|NCT02143713|463708332|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
128839889|NCT02143713|463708333|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
128839890|NCT02143713|463708334|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
128839891|NCT02143713|463708331|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
128839892|NCT02143713|463708332|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
128839893|NCT02143713|463708333|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
128839894|NCT02143713|463708334|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
128839895|NCT02143713|463708331|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
128839896|NCT02143713|463708332|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
128839897|NCT02143713|463708333|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
128839898|NCT02143713|463708334|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
128839899|NCT01768572|463708337|FG000|Overall Study|Adverse Event|7|||
128839900|NCT01768572|463708338|FG001|Overall Study|Adverse Event|8|||
128839901|NCT01768572|463708339|FG002|Overall Study|Adverse Event|4|||
128839902|NCT01768572|463708337|FG000|Overall Study|Lack of Efficacy|1|||
128839903|NCT01768572|463708338|FG001|Overall Study|Lack of Efficacy|3|||
128839904|NCT01768572|463708339|FG002|Overall Study|Lack of Efficacy|1|||
128839905|NCT01768572|463708337|FG000|Overall Study|Other, Not due to an adverse event|1|||
128839906|NCT01768572|463708338|FG001|Overall Study|Other, Not due to an adverse event|1|||
128839907|NCT01768572|463708339|FG002|Overall Study|Other, Not due to an adverse event|1|||
128839908|NCT00871494|463708343|FG000|Overall Study|Protocol Violation|5|||
128839909|NCT00871494|463708343|FG000|Overall Study|Lack of Efficacy|4|||
128839910|NCT00871494|463708343|FG000|Overall Study|Adverse Event|4|||
128839911|NCT00871494|463708343|FG000|Overall Study|Lost to Follow-up|1|||
128839912|NCT03840993|463708344|FG000|Overall Study|Adverse Event|1|||
128839913|NCT03840993|463708345|FG001|Overall Study|Adverse Event|0|||
128839914|NCT03840993|463708344|FG000|Overall Study|Lost to Follow-up|4|||
128839915|NCT03840993|463708345|FG001|Overall Study|Lost to Follow-up|0|||
128839916|NCT03840993|463708344|FG000|Overall Study|Physician Decision|0|||
128839917|NCT03840993|463708345|FG001|Overall Study|Physician Decision|1|||
128839918|NCT03840993|463708344|FG000|Overall Study|Pregnancy|0|||
128839919|NCT03840993|463708345|FG001|Overall Study|Pregnancy|1|||
128839920|NCT03840993|463708344|FG000|Overall Study|Withdrawal by Subject|1|||
128839921|NCT03840993|463708345|FG001|Overall Study|Withdrawal by Subject|3|||
128839922|NCT03840993|463708344|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
128839923|NCT03840993|463708345|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
128839924|NCT02823574|463708346|FG000|Randomization|Disease Progression|0|||
128839925|NCT02823574|463708347|FG001|Randomization|Disease Progression|0|||
128839926|NCT02823574|463708348|FG002|Randomization|Disease Progression|1|||
128839927|NCT02823574|463708349|FG003|Randomization|Disease Progression|0|||
128839928|NCT02823574|463708346|FG000|Randomization|AE unrelated to Study Drug|1|||
128839929|NCT02823574|463708347|FG001|Randomization|AE unrelated to Study Drug|0|||
128839930|NCT02823574|463708348|FG002|Randomization|AE unrelated to Study Drug|0|||
128839931|NCT02823574|463708349|FG003|Randomization|AE unrelated to Study Drug|0|||
128839932|NCT02823574|463708346|FG000|Treatment Period|Poor/Non Compliance|1|||
128839933|NCT02823574|463708347|FG001|Treatment Period|Poor/Non Compliance|0|||
128839934|NCT02823574|463708348|FG002|Treatment Period|Poor/Non Compliance|0|||
128839935|NCT02823574|463708349|FG003|Treatment Period|Poor/Non Compliance|1|||
128839936|NCT02823574|463708346|FG000|Treatment Period|Maximum Clinical Benefit|8|||
128839937|NCT02823574|463708347|FG001|Treatment Period|Maximum Clinical Benefit|4|||
128839938|NCT02823574|463708348|FG002|Treatment Period|Maximum Clinical Benefit|7|||
128839939|NCT02823574|463708349|FG003|Treatment Period|Maximum Clinical Benefit|1|||
128839940|NCT02823574|463708346|FG000|Treatment Period|Lost to Follow-up|1|||
128839941|NCT02823574|463708347|FG001|Treatment Period|Lost to Follow-up|1|||
128839942|NCT02823574|463708348|FG002|Treatment Period|Lost to Follow-up|0|||
128839943|NCT02823574|463708349|FG003|Treatment Period|Lost to Follow-up|0|||
128839944|NCT02823574|463708346|FG000|Treatment Period|Participant withdrew consent|4|||
128839945|NCT02823574|463708347|FG001|Treatment Period|Participant withdrew consent|0|||
128839946|NCT02823574|463708348|FG002|Treatment Period|Participant withdrew consent|0|||
128839947|NCT02823574|463708349|FG003|Treatment Period|Participant withdrew consent|1|||
128839948|NCT02823574|463708346|FG000|Treatment Period|Participant request to discontinue|5|||
128839949|NCT02823574|463708347|FG001|Treatment Period|Participant request to discontinue|0|||
128839950|NCT02823574|463708348|FG002|Treatment Period|Participant request to discontinue|3|||
128839951|NCT02823574|463708349|FG003|Treatment Period|Participant request to discontinue|2|||
128839952|NCT02823574|463708346|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
128839953|NCT02823574|463708347|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
128839954|NCT02823574|463708348|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
128839955|NCT02823574|463708349|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
128839956|NCT02823574|463708346|FG000|Treatment Period|Study Drug Toxicity|11|||
128839957|NCT02823574|463708347|FG001|Treatment Period|Study Drug Toxicity|2|||
128839958|NCT02823574|463708348|FG002|Treatment Period|Study Drug Toxicity|14|||
128839959|NCT02823574|463708349|FG003|Treatment Period|Study Drug Toxicity|4|||
128839960|NCT02823574|463708346|FG000|Treatment Period|Disease Progression|113|||
128839961|NCT02823574|463708347|FG001|Treatment Period|Disease Progression|64|||
128839962|NCT02823574|463708348|FG002|Treatment Period|Disease Progression|82|||
128839963|NCT02823574|463708349|FG003|Treatment Period|Disease Progression|43|||
128839964|NCT02823574|463708346|FG000|Treatment Period|Other reasons|5|||
128839965|NCT02823574|463708347|FG001|Treatment Period|Other reasons|9|||
128839966|NCT02823574|463708348|FG002|Treatment Period|Other reasons|3|||
128839967|NCT02823574|463708349|FG003|Treatment Period|Other reasons|6|||
128839968|NCT02823574|463708346|FG000|Treatment Period|Participant no longer meets study criteria|0|||
128839969|NCT02823574|463708347|FG001|Treatment Period|Participant no longer meets study criteria|0|||
128839970|NCT02823574|463708348|FG002|Treatment Period|Participant no longer meets study criteria|1|||
128839971|NCT02823574|463708349|FG003|Treatment Period|Participant no longer meets study criteria|0|||
128839972|NCT02823574|463708346|FG000|Treatment Period|Death|0|||
128839973|NCT02823574|463708347|FG001|Treatment Period|Death|0|||
128839974|NCT02823574|463708348|FG002|Treatment Period|Death|3|||
128839975|NCT02823574|463708349|FG003|Treatment Period|Death|1|||
128839976|NCT00590759|463708350|FG000|Overall Study|Death|52|||
128839977|NCT00590759|463708350|FG000|Overall Study|Lost to Follow-up|28|||
128839978|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
128839979|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
128839980|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
128839981|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
128839982|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Death|0|||
128839983|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Death|0|||
128839984|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Death|1|||
128839985|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Death|0|||
128839986|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
128839987|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
128839988|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
128839989|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
128839990|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
128839991|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
128839992|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
128839993|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
128839994|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
128839995|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
128839996|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
128839997|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
128839998|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
128839999|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
128840000|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
128840001|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
128840002|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
128840003|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
128840004|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
128840005|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
128840006|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Other|2|||
128840007|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Other|0|||
128840008|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Other|0|||
128840009|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Other|0|||
128840010|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
128840011|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
128840012|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
128840013|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
128840014|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
128840015|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
128840016|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
128840017|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
128840018|NCT03845517|463708357|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
128840019|NCT03845517|463708358|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
128840020|NCT03845517|463708359|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
128840021|NCT03845517|463708360|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
128840022|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
128840023|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
128840024|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
128840025|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
128840026|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Death|0|||
128840027|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Death|0|||
128840028|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Death|1|||
128840029|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Death|1|||
128840030|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
128840031|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
128840032|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
128840033|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
128840034|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
128840035|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
128840036|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
128840037|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
128840038|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
128840039|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
128840040|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
128840041|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
128840042|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Other|1|||
128840043|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Other|0|||
128840044|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Other|1|||
128840045|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Other|0|||
128840046|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
128840047|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
128840048|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
128840049|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
128840050|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
128840051|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
128840052|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
128840053|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
128840054|NCT03845517|463708357|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
128840055|NCT03845517|463708358|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
128840056|NCT03845517|463708359|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
128840057|NCT03845517|463708360|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
128840058|NCT00417885|463708361|FG000|Overall Study|Adverse Event|1|||
128840059|NCT00417885|463708361|FG000|Overall Study|Objective Progression or Relapse|3|||
128840060|NCT00417885|463708361|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
128840061|NCT01190436|463708362|FG000|Overall Study|Lost to Follow-up|35|||
128840062|NCT01190436|463708362|FG000|Overall Study|Other|4|||
128840063|NCT02721147|463708363|FG000|Overall Study|Lost to Follow-up|2|||
128840064|NCT02721147|463708364|FG001|Overall Study|Lost to Follow-up|0|||
128840065|NCT02721147|463708365|FG002|Overall Study|Lost to Follow-up|0|||
128840066|NCT01722097|463708367|FG000|Overall Study|Patient sheets not returned|6|||
128840067|NCT01722097|463708368|FG001|Overall Study|Patient sheets not returned|5|||
128840068|NCT02009332|463708369|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
128840069|NCT02009332|463708370|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
128840070|NCT02009332|463708371|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
128840071|NCT02009332|463708372|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
128840072|NCT02009332|463708373|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
128840073|NCT02009332|463708374|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
128840074|NCT02009332|463708369|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
128840075|NCT02009332|463708370|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
128840076|NCT02009332|463708371|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
128840077|NCT02009332|463708372|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
128840078|NCT02009332|463708373|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
128840079|NCT02009332|463708374|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
128840080|NCT02009332|463708369|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
128840081|NCT02009332|463708370|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
128840082|NCT02009332|463708371|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
128840083|NCT02009332|463708372|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
128840084|NCT02009332|463708373|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
128840085|NCT02009332|463708374|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
128840086|NCT00248794|463708376|FG000|Overall Study|Lost to Follow-up|6|||
128840087|NCT00248794|463708377|FG001|Overall Study|Lost to Follow-up|8|||
128840088|NCT00248794|463708378|FG002|Overall Study|Lost to Follow-up|3|||
128840089|NCT03449979|463708379|FG000|Overall Study|Technical difficulty|0|||
128840090|NCT03449979|463708380|FG001|Overall Study|Technical difficulty|0|||
128840091|NCT03449979|463708381|FG002|Overall Study|Technical difficulty|0|||
128840092|NCT03449979|463708382|FG003|Overall Study|Technical difficulty|1|||
128840093|NCT02632747|463708383|FG000|Wash-out Period|Adverse Event|1|||
128840094|NCT02632747|463708384|FG001|Wash-out Period|Adverse Event|0|||
128840095|NCT02069379|463708385|FG000|Baseline Measurements|Lost to Follow-up|1|||
128840096|NCT02069379|463708386|FG001|Baseline Measurements|Lost to Follow-up|0|||
128840097|NCT02069379|463708387|FG002|Baseline Measurements|Lost to Follow-up|0|||
128840098|NCT02069379|463708388|FG003|Baseline Measurements|Lost to Follow-up|0|||
128840099|NCT02069379|463708385|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
128840100|NCT02069379|463708386|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
128840101|NCT02069379|463708387|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
128840102|NCT02069379|463708388|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
128840103|NCT02069379|463708385|FG000|First Treatment Arm|Lost to Follow-up|0|||
128840104|NCT02069379|463708386|FG001|First Treatment Arm|Lost to Follow-up|1|||
128840105|NCT02069379|463708387|FG002|First Treatment Arm|Lost to Follow-up|1|||
128840106|NCT02069379|463708388|FG003|First Treatment Arm|Lost to Follow-up|0|||
128840107|NCT02069379|463708385|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
128840108|NCT02069379|463708386|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
128840109|NCT02069379|463708387|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
128840110|NCT02069379|463708388|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
128840111|NCT02069379|463708385|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
128840112|NCT02069379|463708386|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
128840113|NCT02069379|463708387|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
128840114|NCT02069379|463708388|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
128840115|NCT02069379|463708385|FG000|Second Treatment Arm|Lost to Follow-up|0|||
128840116|NCT02069379|463708386|FG001|Second Treatment Arm|Lost to Follow-up|0|||
128840117|NCT02069379|463708387|FG002|Second Treatment Arm|Lost to Follow-up|1|||
128840118|NCT02069379|463708388|FG003|Second Treatment Arm|Lost to Follow-up|0|||
128840119|NCT00700999|463708391|FG000|Overall Study|Lost to Follow-up|7|||
128840120|NCT00700999|463708392|FG001|Overall Study|Lost to Follow-up|7|||
128840121|NCT00700999|463708391|FG000|Overall Study|Excluded - did not meet study criteria|0|||
128840122|NCT00700999|463708392|FG001|Overall Study|Excluded - did not meet study criteria|1|||
128840123|NCT00700999|463708391|FG000|Overall Study|Withdrawal by Subject|8|||
128840124|NCT00700999|463708392|FG001|Overall Study|Withdrawal by Subject|1|||
128840125|NCT03481725|463708393|FG000|Overall Study|Withdrawal by Subject|1|||
128840126|NCT03481725|463708394|FG001|Overall Study|Withdrawal by Subject|0|||
128840127|NCT03651271|463708395|FG000|Overall Study|Death|4|||
128840128|NCT03651271|463708396|FG001|Overall Study|Death|37|||
128840129|NCT03651271|463708397|FG002|Overall Study|Death|0|||
128840130|NCT03651271|463708398|FG003|Overall Study|Death|2|||
128840131|NCT03651271|463708399|FG004|Overall Study|Death|6|||
128840132|NCT03651271|463708395|FG000|Overall Study|Lost to Follow-up|1|||
128840133|NCT03651271|463708396|FG001|Overall Study|Lost to Follow-up|5|||
128840134|NCT03651271|463708397|FG002|Overall Study|Lost to Follow-up|0|||
128840135|NCT03651271|463708398|FG003|Overall Study|Lost to Follow-up|1|||
128840136|NCT03651271|463708399|FG004|Overall Study|Lost to Follow-up|0|||
128840137|NCT03651271|463708395|FG000|Overall Study|Physician Decision|0|||
128840138|NCT03651271|463708396|FG001|Overall Study|Physician Decision|2|||
128840139|NCT03651271|463708397|FG002|Overall Study|Physician Decision|0|||
128840140|NCT03651271|463708398|FG003|Overall Study|Physician Decision|0|||
128840141|NCT03651271|463708399|FG004|Overall Study|Physician Decision|0|||
128840142|NCT03651271|463708395|FG000|Overall Study|Withdrawal by Subject|1|||
128840143|NCT03651271|463708396|FG001|Overall Study|Withdrawal by Subject|15|||
128840144|NCT03651271|463708397|FG002|Overall Study|Withdrawal by Subject|0|||
128840145|NCT03651271|463708398|FG003|Overall Study|Withdrawal by Subject|0|||
128840146|NCT03651271|463708399|FG004|Overall Study|Withdrawal by Subject|1|||
128840147|NCT03651271|463708395|FG000|Overall Study|Patient medically unable to continue|0|||
128840148|NCT03651271|463708396|FG001|Overall Study|Patient medically unable to continue|0|||
128840149|NCT03651271|463708397|FG002|Overall Study|Patient medically unable to continue|0|||
128840150|NCT03651271|463708398|FG003|Overall Study|Patient medically unable to continue|1|||
128840151|NCT03651271|463708399|FG004|Overall Study|Patient medically unable to continue|0|||
128840152|NCT03444155|463708402|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
128840153|NCT03444155|463708403|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
128840154|NCT02877680|463708408|FG000|Overall Study|Lost to Follow-up|1|||
128840155|NCT02877680|463708409|FG001|Overall Study|Lost to Follow-up|1|||
128840156|NCT01133678|463708410|FG000|Overall Study|Death|1|||
128840157|NCT01133678|463708411|FG001|Overall Study|Death|1|||
128840158|NCT02991118|463708418|FG000|Overall Study|Death|3|||
128840159|NCT02991118|463708419|FG001|Overall Study|Death|8|||
128840160|NCT02991118|463708418|FG000|Overall Study|Protocol Violation|0|||
128840161|NCT02991118|463708419|FG001|Overall Study|Protocol Violation|3|||
128840162|NCT02991118|463708418|FG000|Overall Study|Physician Decision|0|||
128840163|NCT02991118|463708419|FG001|Overall Study|Physician Decision|1|||
128840164|NCT02991118|463708418|FG000|Overall Study|Moved out of the country|0|||
128840165|NCT02991118|463708419|FG001|Overall Study|Moved out of the country|1|||
128840166|NCT02991118|463708418|FG000|Overall Study|Adverse Event|2|||
128840167|NCT02991118|463708419|FG001|Overall Study|Adverse Event|2|||
128840168|NCT02991118|463708418|FG000|Overall Study|Withdrawal by Subject|1|||
128840169|NCT02991118|463708419|FG001|Overall Study|Withdrawal by Subject|7|||
128840170|NCT02991118|463708418|FG000|Overall Study|Could not attend study visits|0|||
128840171|NCT02991118|463708419|FG001|Overall Study|Could not attend study visits|1|||
128840172|NCT02991118|463708418|FG000|Overall Study|Lost to Follow-up|1|||
128840173|NCT02991118|463708419|FG001|Overall Study|Lost to Follow-up|9|||
128840174|NCT00595959|463708420|FG000|Overall Study|Withdrawal by Subject|1|||
128840175|NCT00595959|463708420|FG000|Overall Study|Lost to Follow-up|1|||
128840176|NCT00446095|463708424|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
128840177|NCT00446095|463708425|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
128840178|NCT00446095|463708426|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
128840179|NCT00446095|463708427|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
128840180|NCT00446095|463708428|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
128840181|NCT00446095|463708424|FG000|Phase II (8 Weeks)|Adverse Event|0|||
128840182|NCT00446095|463708425|FG001|Phase II (8 Weeks)|Adverse Event|1|||
128840183|NCT00446095|463708426|FG002|Phase II (8 Weeks)|Adverse Event|1|||
128840184|NCT00446095|463708427|FG003|Phase II (8 Weeks)|Adverse Event|0|||
128840185|NCT00446095|463708428|FG004|Phase II (8 Weeks)|Adverse Event|0|||
128840186|NCT00446095|463708424|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
128840187|NCT00446095|463708425|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
128840188|NCT00446095|463708426|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
128840189|NCT00446095|463708427|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
128840190|NCT00446095|463708428|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
128840191|NCT00446095|463708424|FG000|Phase II (8 Weeks)|Physician Decision|1|||
128840192|NCT00446095|463708425|FG001|Phase II (8 Weeks)|Physician Decision|0|||
128840193|NCT00446095|463708426|FG002|Phase II (8 Weeks)|Physician Decision|0|||
128840194|NCT00446095|463708427|FG003|Phase II (8 Weeks)|Physician Decision|0|||
128840195|NCT00446095|463708428|FG004|Phase II (8 Weeks)|Physician Decision|0|||
128840196|NCT00446095|463708424|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
128840197|NCT00446095|463708425|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
128840198|NCT00446095|463708426|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
128840199|NCT00446095|463708427|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
128840200|NCT00446095|463708428|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
128840201|NCT00446095|463708424|FG000|Phase II (8 Weeks)|Ongoing|0|||
128840202|NCT00446095|463708425|FG001|Phase II (8 Weeks)|Ongoing|0|||
128840203|NCT00446095|463708426|FG002|Phase II (8 Weeks)|Ongoing|1|||
128840204|NCT00446095|463708427|FG003|Phase II (8 Weeks)|Ongoing|0|||
128840205|NCT00446095|463708428|FG004|Phase II (8 Weeks)|Ongoing|0|||
128840206|NCT00446095|463708424|FG000|Phase I (28 Days)|Adverse Event|0|||
128840207|NCT00446095|463708425|FG001|Phase I (28 Days)|Adverse Event|0|||
128840208|NCT00446095|463708426|FG002|Phase I (28 Days)|Adverse Event|0|||
128840209|NCT00446095|463708427|FG003|Phase I (28 Days)|Adverse Event|1|||
128840210|NCT00446095|463708428|FG004|Phase I (28 Days)|Adverse Event|0|||
128840211|NCT00446095|463708424|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
128840212|NCT00446095|463708425|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
128840213|NCT00446095|463708426|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
128840214|NCT00446095|463708427|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
128840215|NCT00446095|463708428|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
128840216|NCT02764320|463708429|FG000|Overall Study|Withdrawal by Subject|35|||
128840217|NCT02764320|463708430|FG001|Overall Study|Withdrawal by Subject|38|||
128840218|NCT02764320|463708429|FG000|Overall Study|Protocol Violation|11|||
128840219|NCT02764320|463708430|FG001|Overall Study|Protocol Violation|6|||
128840220|NCT02764320|463708429|FG000|Overall Study|Adverse Event|2|||
128840221|NCT02764320|463708430|FG001|Overall Study|Adverse Event|0|||
128840222|NCT02764320|463708429|FG000|Overall Study|Health Issues unable to continue|2|||
128840223|NCT02764320|463708430|FG001|Overall Study|Health Issues unable to continue|0|||
128840224|NCT02764320|463708429|FG000|Overall Study|Did not meet inclusion criteria|1|||
128840225|NCT02764320|463708430|FG001|Overall Study|Did not meet inclusion criteria|0|||
128840226|NCT02764320|463708429|FG000|Overall Study|Subject moved|0|||
128840227|NCT02764320|463708430|FG001|Overall Study|Subject moved|2|||
128840228|NCT02764320|463708429|FG000|Overall Study|Overused medication unavailable|0|||
128840229|NCT02764320|463708430|FG001|Overall Study|Overused medication unavailable|1|||
128840230|NCT02764320|463708429|FG000|Overall Study|Seeking care outside site|0|||
128840231|NCT02764320|463708430|FG001|Overall Study|Seeking care outside site|1|||
128840232|NCT02764320|463708429|FG000|Overall Study|Technology barriers|0|||
128840233|NCT02764320|463708430|FG001|Overall Study|Technology barriers|1|||
128840234|NCT01916109|463708431|FG000|Overall Study|Withdrawal by Subject|1|||
128840235|NCT02707952|463708434|FG000|Overall Study|Adverse Event|1|||
128840236|NCT02707952|463708435|FG001|Overall Study|Adverse Event|0|||
128840237|NCT02707952|463708436|FG002|Overall Study|Adverse Event|0|||
128840238|NCT02707952|463708437|FG003|Overall Study|Adverse Event|0|||
128840239|NCT02707952|463708434|FG000|Overall Study|Lost to Follow-up|1|||
128840240|NCT02707952|463708435|FG001|Overall Study|Lost to Follow-up|0|||
128840241|NCT02707952|463708436|FG002|Overall Study|Lost to Follow-up|0|||
128840242|NCT02707952|463708437|FG003|Overall Study|Lost to Follow-up|0|||
128840243|NCT02707952|463708434|FG000|Overall Study|Withdrawal by Subject|0|||
128840244|NCT02707952|463708435|FG001|Overall Study|Withdrawal by Subject|1|||
128840245|NCT02707952|463708436|FG002|Overall Study|Withdrawal by Subject|2|||
128840246|NCT02707952|463708437|FG003|Overall Study|Withdrawal by Subject|0|||
128840247|NCT02006641|463708438|FG000|Overall Study|Withdrawal before treatment|2|||
128840248|NCT02006641|463708439|FG001|Overall Study|Withdrawal before treatment|5|||
128840249|NCT02006641|463708440|FG002|Overall Study|Withdrawal before treatment|3|||
128840250|NCT02006641|463708438|FG000|Overall Study|Adverse Event|15|||
128840251|NCT02006641|463708439|FG001|Overall Study|Adverse Event|11|||
128840252|NCT02006641|463708440|FG002|Overall Study|Adverse Event|15|||
128840253|NCT02006641|463708438|FG000|Overall Study|Protocol Violation|0|||
128840254|NCT02006641|463708439|FG001|Overall Study|Protocol Violation|2|||
128840255|NCT02006641|463708440|FG002|Overall Study|Protocol Violation|2|||
128840256|NCT02006641|463708438|FG000|Overall Study|Lost to Follow-up|0|||
128840257|NCT02006641|463708439|FG001|Overall Study|Lost to Follow-up|1|||
128840258|NCT02006641|463708440|FG002|Overall Study|Lost to Follow-up|0|||
128840259|NCT02006641|463708438|FG000|Overall Study|Withdrawal by Subject|7|||
128840260|NCT02006641|463708439|FG001|Overall Study|Withdrawal by Subject|12|||
128840261|NCT02006641|463708440|FG002|Overall Study|Withdrawal by Subject|11|||
128840262|NCT02006641|463708438|FG000|Overall Study|Other reason: patient didn't show up|1|||
128840263|NCT02006641|463708439|FG001|Overall Study|Other reason: patient didn't show up|0|||
128840264|NCT02006641|463708440|FG002|Overall Study|Other reason: patient didn't show up|0|||
128840265|NCT02006641|463708438|FG000|Overall Study|Other reason:patient didn't want to come|0|||
128840266|NCT02006641|463708439|FG001|Overall Study|Other reason:patient didn't want to come|0|||
128840267|NCT02006641|463708440|FG002|Overall Study|Other reason:patient didn't want to come|1|||
128840268|NCT02006641|463708438|FG000|Overall Study|Other reason: patient has moved|1|||
128840269|NCT02006641|463708439|FG001|Overall Study|Other reason: patient has moved|0|||
128840270|NCT02006641|463708440|FG002|Overall Study|Other reason: patient has moved|1|||
128840271|NCT02006641|463708438|FG000|Overall Study|Other reason: caregiver in hospital|0|||
128840272|NCT02006641|463708439|FG001|Overall Study|Other reason: caregiver in hospital|1|||
128840273|NCT02006641|463708440|FG002|Overall Study|Other reason: caregiver in hospital|0|||
128840274|NCT02006641|463708438|FG000|Overall Study|Other reason: patient's wife has died|0|||
128840275|NCT02006641|463708439|FG001|Overall Study|Other reason: patient's wife has died|0|||
128840276|NCT02006641|463708440|FG002|Overall Study|Other reason: patient's wife has died|1|||
128840277|NCT02006641|463708438|FG000|Overall Study|Other reason: hospitalisation|0|||
128840278|NCT02006641|463708439|FG001|Overall Study|Other reason: hospitalisation|1|||
128840279|NCT02006641|463708440|FG002|Overall Study|Other reason: hospitalisation|0|||
128840280|NCT02006641|463708438|FG000|Overall Study|Other reason: caregiver impossibility|0|||
128840281|NCT02006641|463708439|FG001|Overall Study|Other reason: caregiver impossibility|0|||
128840282|NCT02006641|463708440|FG002|Overall Study|Other reason: caregiver impossibility|1|||
128840283|NCT02006641|463708438|FG000|Overall Study|Other reason: protocol non-compliance|0|||
128840284|NCT02006641|463708439|FG001|Overall Study|Other reason: protocol non-compliance|0|||
128840285|NCT02006641|463708440|FG002|Overall Study|Other reason: protocol non-compliance|1|||
128840286|NCT01287832|463708441|FG000|Overall Study|Adverse Event|1|||
128840287|NCT01287832|463708442|FG001|Overall Study|Adverse Event|0|||
128840288|NCT01287832|463708441|FG000|Overall Study|Death|0|||
128840289|NCT01287832|463708442|FG001|Overall Study|Death|1|||
128840290|NCT04749797|463708444|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
128840291|NCT04749797|463708445|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
128840292|NCT04749797|463708446|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
128840293|NCT01441596|463708447|FG000|Overall Study|Other reason not defined below|0|||
128840294|NCT01441596|463708448|FG001|Overall Study|Other reason not defined below|2|||
128840295|NCT01441596|463708449|FG002|Overall Study|Other reason not defined below|1|||
128840296|NCT01441596|463708447|FG000|Overall Study|Withdrawal by Subject|4|||
128840297|NCT01441596|463708448|FG001|Overall Study|Withdrawal by Subject|0|||
128840298|NCT01441596|463708449|FG002|Overall Study|Withdrawal by Subject|2|||
128840299|NCT01441596|463708447|FG000|Overall Study|Not treated|0|||
128840300|NCT01441596|463708448|FG001|Overall Study|Not treated|1|||
128840301|NCT01441596|463708449|FG002|Overall Study|Not treated|1|||
128840302|NCT01794689|463708453|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
128840303|NCT01794689|463708454|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
128840304|NCT01794689|463708455|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
128840305|NCT01794689|463708456|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
128840306|NCT01794689|463708453|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
128840307|NCT01794689|463708454|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
128840308|NCT01794689|463708455|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
128840309|NCT01794689|463708456|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
129204979|NCT01928927|465047018|FG001|Overall Study|Withdrawal by Subject|1|||
128840310|NCT01794689|463708453|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
128840311|NCT01794689|463708454|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
128840312|NCT01794689|463708455|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
128840313|NCT01794689|463708456|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
128840314|NCT01794689|463708453|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
128840315|NCT01794689|463708454|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
128840316|NCT01794689|463708455|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
128840317|NCT01794689|463708456|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
128840318|NCT01697956|463708457|FG000|Overall Study|Protocol Violation|1|||
128840319|NCT01697956|463708458|FG001|Overall Study|Protocol Violation|1|||
128840320|NCT01115309|463708459|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
128840321|NCT01115309|463708459|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
128840322|NCT01115309|463708459|FG000|Long-term Follow-up|Lost to Follow-up|6|||
128840323|NCT05700851|463708460|FG000|Overall Study|Received a kidney transplant|1|||
128840324|NCT05700851|463708460|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
128840325|NCT05700851|463708460|FG000|Overall Study|Withdrawal by Subject|1|||
128840326|NCT00589628|463708461|FG000|Overall Study|Lost to Follow-up|0|||
128840327|NCT00589628|463708462|FG001|Overall Study|Lost to Follow-up|1|||
128840328|NCT03032198|463708470|FG000|Overall Study|Screen Fail|1|||
128840329|NCT01307800|463708471|FG000|Overall Study|Adverse Event|9|||
128840330|NCT01307800|463708472|FG001|Overall Study|Adverse Event|8|||
128840331|NCT01307800|463708473|FG002|Overall Study|Adverse Event|10|||
128840332|NCT01307800|463708474|FG003|Overall Study|Adverse Event|14|||
128840333|NCT01307800|463708471|FG000|Overall Study|Entry Criteria Not Met|0|||
128840334|NCT01307800|463708472|FG001|Overall Study|Entry Criteria Not Met|0|||
128840335|NCT01307800|463708473|FG002|Overall Study|Entry Criteria Not Met|0|||
128840336|NCT01307800|463708474|FG003|Overall Study|Entry Criteria Not Met|2|||
128840337|NCT01307800|463708471|FG000|Overall Study|Lost to Follow-up|5|||
128840338|NCT01307800|463708472|FG001|Overall Study|Lost to Follow-up|6|||
128840339|NCT01307800|463708473|FG002|Overall Study|Lost to Follow-up|2|||
128840340|NCT01307800|463708474|FG003|Overall Study|Lost to Follow-up|8|||
128840341|NCT01307800|463708471|FG000|Overall Study|Perceived Lack of Efficacy|24|||
128840342|NCT01307800|463708472|FG001|Overall Study|Perceived Lack of Efficacy|23|||
128840343|NCT01307800|463708473|FG002|Overall Study|Perceived Lack of Efficacy|20|||
128840344|NCT01307800|463708474|FG003|Overall Study|Perceived Lack of Efficacy|33|||
128840345|NCT01307800|463708471|FG000|Overall Study|Protocol Violation|0|||
128840346|NCT01307800|463708472|FG001|Overall Study|Protocol Violation|3|||
128840347|NCT01307800|463708473|FG002|Overall Study|Protocol Violation|4|||
128840348|NCT01307800|463708474|FG003|Overall Study|Protocol Violation|5|||
128840349|NCT01307800|463708471|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
128840350|NCT01307800|463708472|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
128840351|NCT01307800|463708473|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
128840352|NCT01307800|463708474|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
128840353|NCT01307800|463708471|FG000|Overall Study|Sponsor Decision|6|||
128840354|NCT01307800|463708472|FG001|Overall Study|Sponsor Decision|9|||
128840355|NCT01307800|463708473|FG002|Overall Study|Sponsor Decision|12|||
128840356|NCT01307800|463708474|FG003|Overall Study|Sponsor Decision|28|||
128840357|NCT01307800|463708471|FG000|Overall Study|Withdrawal by Subject|10|||
128840358|NCT01307800|463708472|FG001|Overall Study|Withdrawal by Subject|11|||
128840359|NCT01307800|463708473|FG002|Overall Study|Withdrawal by Subject|8|||
128840360|NCT01307800|463708474|FG003|Overall Study|Withdrawal by Subject|15|||
128840361|NCT01307800|463708471|FG000|Overall Study|Participant Moved|0|||
128840362|NCT01307800|463708472|FG001|Overall Study|Participant Moved|2|||
128840363|NCT01307800|463708473|FG002|Overall Study|Participant Moved|1|||
128840364|NCT01307800|463708474|FG003|Overall Study|Participant Moved|3|||
128840365|NCT00689351|463708475|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
128840366|NCT00689351|463708476|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
128840367|NCT00689351|463708475|FG000|Infant Series of Dosing|Adverse Event|1|||
128840368|NCT00689351|463708476|FG001|Infant Series of Dosing|Adverse Event|0|||
128840369|NCT00689351|463708475|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
128840370|NCT00689351|463708476|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
128840371|NCT00689351|463708475|FG000|After Infant Series|Parent/legal guardian request|1|||
128840372|NCT00689351|463708476|FG001|After Infant Series|Parent/legal guardian request|0|||
128840373|NCT01766206|463708477|FG000|Overall Study|Withdrawal by Subject|22|||
128840374|NCT01766206|463708477|FG000|Overall Study|Lost to Follow-up|10|||
128840375|NCT01766206|463708477|FG000|Overall Study|Inappropriate enrollment|18|||
128840376|NCT01766206|463708477|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
128840377|NCT01884571|463708480|FG000|Overall Study|Adverse Event|1|||
128840378|NCT01884571|463708480|FG000|Overall Study|Death|2|||
128840379|NCT01884571|463708480|FG000|Overall Study|Withdrawal by Subject|2|||
128840380|NCT01884571|463708480|FG000|Overall Study|Disease progression|3|||
128840381|NCT02400749|463710277|FG000|Week 0 -16|Withdrawal by Subject|5|||
128840382|NCT02400749|463710278|FG001|Week 0 -16|Withdrawal by Subject|5|||
128840383|NCT02400749|463710277|FG000|Week 0 -16|Adverse Event|3|||
128840384|NCT02400749|463710278|FG001|Week 0 -16|Adverse Event|1|||
128840385|NCT02400749|463710277|FG000|Week 0 -16|Lost to Follow-up|2|||
128840386|NCT02400749|463710278|FG001|Week 0 -16|Lost to Follow-up|0|||
128840387|NCT02400749|463710277|FG000|Week 0 -16|Protocol Violation|1|||
128840388|NCT02400749|463710278|FG001|Week 0 -16|Protocol Violation|0|||
128840389|NCT02400749|463710277|FG000|Week 17 - 32|Withdrawal by Subject|3|||
128840390|NCT02400749|463710278|FG001|Week 17 - 32|Withdrawal by Subject|2|||
128840391|NCT02400749|463710277|FG000|Week 17 - 32|Adverse Event|2|||
128840392|NCT02400749|463710278|FG001|Week 17 - 32|Adverse Event|1|||
128840393|NCT04425252|463710279|FG000|Overall Study|Withdrawal by Subject|2|||
128840394|NCT04425252|463710280|FG001|Overall Study|Withdrawal by Subject|1|||
128840395|NCT04425252|463710279|FG000|Overall Study|Lost to Follow-up|1|||
128840396|NCT04425252|463710280|FG001|Overall Study|Lost to Follow-up|0|||
128840397|NCT04425252|463710279|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
128840398|NCT04425252|463710280|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
128840399|NCT02446015|463710283|FG000|Overall Study|Adverse Event|0|||
128840400|NCT02446015|463710284|FG001|Overall Study|Adverse Event|1|||
128840401|NCT02446015|463710283|FG000|Overall Study|Withdrawal by Subject|1|||
128840402|NCT02446015|463710284|FG001|Overall Study|Withdrawal by Subject|0|||
128840403|NCT03761849|463710285|FG000|Overall Study|transferred to OpenLabelExtension|35|||
128840404|NCT03761849|463710286|FG001|Overall Study|transferred to OpenLabelExtension|34|||
128840405|NCT03761849|463710287|FG002|Overall Study|transferred to OpenLabelExtension|36|||
128840406|NCT03761849|463710288|FG003|Overall Study|transferred to OpenLabelExtension|0|||
128840407|NCT03761849|463710289|FG004|Overall Study|transferred to OpenLabelExtension|0|||
128840408|NCT03761849|463710290|FG005|Overall Study|transferred to OpenLabelExtension|0|||
128840409|NCT03761849|463710285|FG000|Overall Study|Adverse Event|1|||
128840410|NCT03761849|463710286|FG001|Overall Study|Adverse Event|0|||
128840411|NCT03761849|463710287|FG002|Overall Study|Adverse Event|0|||
128840412|NCT03761849|463710288|FG003|Overall Study|Adverse Event|0|||
128840413|NCT03761849|463710289|FG004|Overall Study|Adverse Event|2|||
128840414|NCT03761849|463710290|FG005|Overall Study|Adverse Event|3|||
128840415|NCT03761849|463710285|FG000|Overall Study|Withdrawal by Subject|0|||
128840416|NCT03761849|463710286|FG001|Overall Study|Withdrawal by Subject|0|||
128840417|NCT03761849|463710287|FG002|Overall Study|Withdrawal by Subject|0|||
128840418|NCT03761849|463710288|FG003|Overall Study|Withdrawal by Subject|41|||
128840419|NCT03761849|463710289|FG004|Overall Study|Withdrawal by Subject|43|||
128840420|NCT03761849|463710290|FG005|Overall Study|Withdrawal by Subject|35|||
128840421|NCT03761849|463710285|FG000|Overall Study|Lost to Follow-up|0|||
128840422|NCT03761849|463710286|FG001|Overall Study|Lost to Follow-up|1|||
128840423|NCT03761849|463710287|FG002|Overall Study|Lost to Follow-up|0|||
128840424|NCT03761849|463710288|FG003|Overall Study|Lost to Follow-up|2|||
128840425|NCT03761849|463710289|FG004|Overall Study|Lost to Follow-up|4|||
128840426|NCT03761849|463710290|FG005|Overall Study|Lost to Follow-up|5|||
128840427|NCT03761849|463710285|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
128840428|NCT03761849|463710286|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
128840429|NCT03761849|463710287|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
128840430|NCT03761849|463710288|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
128840431|NCT03761849|463710289|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
128840432|NCT03761849|463710290|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
128840433|NCT03761849|463710285|FG000|Overall Study|Physician Decision|0|||
128840434|NCT03761849|463710286|FG001|Overall Study|Physician Decision|0|||
128840435|NCT03761849|463710287|FG002|Overall Study|Physician Decision|0|||
128840436|NCT03761849|463710288|FG003|Overall Study|Physician Decision|1|||
128840437|NCT03761849|463710289|FG004|Overall Study|Physician Decision|4|||
128840438|NCT03761849|463710290|FG005|Overall Study|Physician Decision|4|||
128840439|NCT03761849|463710285|FG000|Overall Study|Death|0|||
128840440|NCT03761849|463710286|FG001|Overall Study|Death|0|||
128840441|NCT03761849|463710287|FG002|Overall Study|Death|0|||
128840442|NCT03761849|463710288|FG003|Overall Study|Death|1|||
128840443|NCT03761849|463710289|FG004|Overall Study|Death|1|||
128840444|NCT03761849|463710290|FG005|Overall Study|Death|3|||
128840445|NCT03761849|463710285|FG000|Overall Study|Protocol Violation|0|||
128840446|NCT03761849|463710286|FG001|Overall Study|Protocol Violation|0|||
128840447|NCT03761849|463710287|FG002|Overall Study|Protocol Violation|0|||
128840448|NCT03761849|463710288|FG003|Overall Study|Protocol Violation|2|||
128840449|NCT03761849|463710289|FG004|Overall Study|Protocol Violation|2|||
128840450|NCT03761849|463710290|FG005|Overall Study|Protocol Violation|1|||
128840451|NCT03761849|463710285|FG000|Overall Study|Participant could not come to site|0|||
128840452|NCT03761849|463710286|FG001|Overall Study|Participant could not come to site|0|||
128840453|NCT03761849|463710287|FG002|Overall Study|Participant could not come to site|0|||
128840454|NCT03761849|463710288|FG003|Overall Study|Participant could not come to site|0|||
128840455|NCT03761849|463710289|FG004|Overall Study|Participant could not come to site|1|||
128840456|NCT03761849|463710290|FG005|Overall Study|Participant could not come to site|0|||
128840457|NCT03761849|463710285|FG000|Overall Study|SF- safety Finding|0|||
128840458|NCT03761849|463710286|FG001|Overall Study|SF- safety Finding|0|||
128840459|NCT03761849|463710287|FG002|Overall Study|SF- safety Finding|0|||
128840460|NCT03761849|463710288|FG003|Overall Study|SF- safety Finding|0|||
128840461|NCT03761849|463710289|FG004|Overall Study|SF- safety Finding|0|||
128840462|NCT03761849|463710290|FG005|Overall Study|SF- safety Finding|1|||
128840463|NCT03761849|463710285|FG000|Overall Study|Patient did not attend visit|0|||
128840464|NCT03761849|463710286|FG001|Overall Study|Patient did not attend visit|0|||
128840465|NCT03761849|463710287|FG002|Overall Study|Patient did not attend visit|0|||
128840466|NCT03761849|463710288|FG003|Overall Study|Patient did not attend visit|0|||
128840467|NCT03761849|463710289|FG004|Overall Study|Patient did not attend visit|0|||
128840468|NCT03761849|463710290|FG005|Overall Study|Patient did not attend visit|1|||
128840469|NCT00988429|463710291|FG000|Overall Study|Adverse Event|9|||
128840470|NCT00988429|463710292|FG001|Overall Study|Adverse Event|21|||
128840471|NCT00988429|463710293|FG002|Overall Study|Adverse Event|45|||
128840472|NCT00988429|463710291|FG000|Overall Study|Lack of Efficacy|0|||
128840473|NCT00988429|463710292|FG001|Overall Study|Lack of Efficacy|0|||
128840474|NCT00988429|463710293|FG002|Overall Study|Lack of Efficacy|1|||
128840475|NCT00988429|463710291|FG000|Overall Study|Non-Compliance with Study Drug|5|||
128840476|NCT00988429|463710292|FG001|Overall Study|Non-Compliance with Study Drug|1|||
128840477|NCT00988429|463710293|FG002|Overall Study|Non-Compliance with Study Drug|3|||
128840478|NCT00988429|463710291|FG000|Overall Study|Physician Decision|1|||
128840479|NCT00988429|463710292|FG001|Overall Study|Physician Decision|0|||
128840480|NCT00988429|463710293|FG002|Overall Study|Physician Decision|3|||
128840481|NCT00988429|463710291|FG000|Overall Study|Pregnancy|2|||
128840482|NCT00988429|463710292|FG001|Overall Study|Pregnancy|1|||
128840483|NCT00988429|463710293|FG002|Overall Study|Pregnancy|0|||
128840484|NCT00988429|463710291|FG000|Overall Study|Protocol Violation|4|||
128840485|NCT00988429|463710292|FG001|Overall Study|Protocol Violation|3|||
128840486|NCT00988429|463710293|FG002|Overall Study|Protocol Violation|3|||
128840487|NCT00988429|463710291|FG000|Overall Study|Withdrawal by Subject|7|||
128840488|NCT00988429|463710292|FG001|Overall Study|Withdrawal by Subject|7|||
128840489|NCT00988429|463710293|FG002|Overall Study|Withdrawal by Subject|12|||
128840490|NCT00988429|463710291|FG000|Overall Study|Administrative Reasons|1|||
128840491|NCT00988429|463710292|FG001|Overall Study|Administrative Reasons|2|||
128840492|NCT00988429|463710293|FG002|Overall Study|Administrative Reasons|1|||
128840493|NCT00988429|463710291|FG000|Overall Study|other reasons|8|||
128840494|NCT00988429|463710292|FG001|Overall Study|other reasons|8|||
128840495|NCT00988429|463710293|FG002|Overall Study|other reasons|1|||
128840496|NCT01074229|463710294|FG000|Overall Study|Lost to Follow-up|1|||
128840497|NCT01074229|463710295|FG001|Overall Study|Lost to Follow-up|0|||
128840498|NCT01074229|463710296|FG002|Overall Study|Lost to Follow-up|0|||
128840499|NCT01074229|463710294|FG000|Overall Study|Change to open surgical procedure|1|||
128840500|NCT01074229|463710295|FG001|Overall Study|Change to open surgical procedure|3|||
128840501|NCT01074229|463710296|FG002|Overall Study|Change to open surgical procedure|4|||
128840502|NCT02163499|463710299|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
128840503|NCT02163499|463710299|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
128840504|NCT02163499|463710299|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
128840505|NCT02163499|463710299|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
128840506|NCT02163499|463710299|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
128840507|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
128840508|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
128840509|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
128840510|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
128840511|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
128840512|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
128840513|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
128840514|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
128840515|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
128840516|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Death|8|||
128840517|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
128840518|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
128840519|NCT02163499|463710299|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
128840520|NCT01540474|463710300|FG000|Vaccination Period|Lost to Follow-up|0|||
128840521|NCT01540474|463710301|FG001|Vaccination Period|Lost to Follow-up|1|||
128840522|NCT01540474|463710302|FG002|Vaccination Period|Lost to Follow-up|0|||
128840523|NCT01540474|463710303|FG003|Vaccination Period|Lost to Follow-up|0|||
128840524|NCT00857311|463710304|FG000|Overall Study|Lost to Follow-up|1|||
128840525|NCT00857311|463710305|FG001|Overall Study|Lost to Follow-up|0|||
128840526|NCT00857311|463710306|FG002|Overall Study|Lost to Follow-up|0|||
128840527|NCT00857311|463710307|FG003|Overall Study|Lost to Follow-up|0|||
128840528|NCT01587703|463710308|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
128840529|NCT01587703|463710309|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840530|NCT01587703|463710310|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840531|NCT01587703|463710311|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840532|NCT01587703|463710312|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840533|NCT01587703|463710313|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840534|NCT01587703|463710314|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840535|NCT01587703|463710315|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840536|NCT01587703|463710316|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840537|NCT01587703|463710317|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840538|NCT01587703|463710318|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840539|NCT01587703|463710319|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840540|NCT01587703|463710320|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840541|NCT01587703|463710321|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840542|NCT01587703|463710322|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840543|NCT01587703|463710323|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840544|NCT01587703|463710324|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840545|NCT01587703|463710325|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840546|NCT01587703|463710326|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
128840547|NCT01587703|463710308|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840548|NCT01587703|463710309|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840549|NCT01587703|463710310|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840550|NCT01587703|463710311|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840551|NCT01587703|463710312|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840552|NCT01587703|463710313|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
128840553|NCT01587703|463710314|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840554|NCT01587703|463710315|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
128840555|NCT01587703|463710316|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840556|NCT01587703|463710317|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840557|NCT01587703|463710318|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840558|NCT01587703|463710319|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840559|NCT01587703|463710320|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840560|NCT01587703|463710321|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840561|NCT01587703|463710322|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840562|NCT01587703|463710323|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840563|NCT01587703|463710324|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840564|NCT01587703|463710325|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840565|NCT01587703|463710326|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
128840566|NCT01587703|463710308|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840567|NCT01587703|463710309|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840568|NCT01587703|463710310|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840569|NCT01587703|463710311|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840570|NCT01587703|463710312|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840571|NCT01587703|463710313|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840572|NCT01587703|463710314|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
128840573|NCT01587703|463710315|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840574|NCT01587703|463710316|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840575|NCT01587703|463710317|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840576|NCT01587703|463710318|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840577|NCT01587703|463710319|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840578|NCT01587703|463710320|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840579|NCT01587703|463710321|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840580|NCT01587703|463710322|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840581|NCT01587703|463710323|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840582|NCT01587703|463710324|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840583|NCT01587703|463710325|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840584|NCT01587703|463710326|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
128840585|NCT01587703|463710308|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
128840586|NCT01587703|463710309|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
128840587|NCT01587703|463710310|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
128840588|NCT01587703|463710311|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
128840589|NCT01587703|463710312|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
128840590|NCT01587703|463710313|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
128840591|NCT01587703|463710314|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
128840592|NCT01587703|463710315|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
128840593|NCT01587703|463710316|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840594|NCT01587703|463710317|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840595|NCT01587703|463710318|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840596|NCT01587703|463710319|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840597|NCT01587703|463710320|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840598|NCT01587703|463710321|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840599|NCT01587703|463710322|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840600|NCT01587703|463710323|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840601|NCT01587703|463710324|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840602|NCT01587703|463710325|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840603|NCT01587703|463710326|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
128840604|NCT01587703|463710308|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840605|NCT01587703|463710309|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840606|NCT01587703|463710310|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840607|NCT01587703|463710311|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840608|NCT01587703|463710312|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840609|NCT01587703|463710313|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840610|NCT01587703|463710314|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840611|NCT01587703|463710315|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840612|NCT01587703|463710316|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
128840613|NCT01587703|463710317|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
128840614|NCT01587703|463710318|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
128840615|NCT01587703|463710319|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840616|NCT01587703|463710320|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840617|NCT01587703|463710321|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840618|NCT01587703|463710322|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840619|NCT01587703|463710323|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840620|NCT01587703|463710324|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840621|NCT01587703|463710325|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840622|NCT01587703|463710326|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
128840623|NCT01587703|463710308|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840624|NCT01587703|463710309|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840625|NCT01587703|463710310|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840626|NCT01587703|463710311|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840627|NCT01587703|463710312|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840628|NCT01587703|463710313|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840629|NCT01587703|463710314|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840630|NCT01587703|463710315|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840631|NCT01587703|463710316|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
128840632|NCT01587703|463710317|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840633|NCT01587703|463710318|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
128840634|NCT01587703|463710319|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840635|NCT01587703|463710320|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840636|NCT01587703|463710321|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840637|NCT01587703|463710322|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840638|NCT01587703|463710323|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840639|NCT01587703|463710324|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840640|NCT01587703|463710325|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840641|NCT01587703|463710326|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
128840642|NCT01587703|463710308|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840643|NCT01587703|463710309|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840644|NCT01587703|463710310|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840645|NCT01587703|463710311|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840646|NCT01587703|463710312|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840647|NCT01587703|463710313|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840648|NCT01587703|463710314|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840649|NCT01587703|463710315|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840650|NCT01587703|463710316|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840651|NCT01587703|463710317|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
128840652|NCT01587703|463710318|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
128840653|NCT01587703|463710319|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840654|NCT01587703|463710320|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840655|NCT01587703|463710321|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840656|NCT01587703|463710322|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840657|NCT01587703|463710323|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840658|NCT01587703|463710324|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840659|NCT01587703|463710325|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840660|NCT01587703|463710326|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
128840661|NCT01587703|463710308|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840662|NCT01587703|463710309|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840663|NCT01587703|463710310|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840664|NCT01587703|463710311|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840665|NCT01587703|463710312|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840666|NCT01587703|463710313|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840667|NCT01587703|463710314|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840668|NCT01587703|463710315|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840669|NCT01587703|463710316|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
128840670|NCT01587703|463710317|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840671|NCT01587703|463710318|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840672|NCT01587703|463710319|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840673|NCT01587703|463710320|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840674|NCT01587703|463710321|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840675|NCT01587703|463710322|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840676|NCT01587703|463710323|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840677|NCT01587703|463710324|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840678|NCT01587703|463710325|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840679|NCT01587703|463710326|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
128840680|NCT01587703|463710308|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840681|NCT01587703|463710309|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840682|NCT01587703|463710310|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840683|NCT01587703|463710311|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840684|NCT01587703|463710312|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840685|NCT01587703|463710313|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840686|NCT01587703|463710314|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840687|NCT01587703|463710315|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840688|NCT01587703|463710316|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840689|NCT01587703|463710317|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840690|NCT01587703|463710318|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840691|NCT01587703|463710319|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840692|NCT01587703|463710320|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840693|NCT01587703|463710321|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840694|NCT01587703|463710322|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840695|NCT01587703|463710323|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840696|NCT01587703|463710324|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840697|NCT01587703|463710325|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
128840698|NCT01587703|463710326|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
128840699|NCT01587703|463710308|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840700|NCT01587703|463710309|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840701|NCT01587703|463710310|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840702|NCT01587703|463710311|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840703|NCT01587703|463710312|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840704|NCT01587703|463710313|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840705|NCT01587703|463710314|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840706|NCT01587703|463710315|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840707|NCT01587703|463710316|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840708|NCT01587703|463710317|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840709|NCT01587703|463710318|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840710|NCT01587703|463710319|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840711|NCT01587703|463710320|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840712|NCT01587703|463710321|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840713|NCT01587703|463710322|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840714|NCT01587703|463710323|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840715|NCT01587703|463710324|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
128840716|NCT01587703|463710325|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
128840717|NCT01587703|463710326|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
128840718|NCT01587703|463710308|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840719|NCT01587703|463710309|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840720|NCT01587703|463710310|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840721|NCT01587703|463710311|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840722|NCT01587703|463710312|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840723|NCT01587703|463710313|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840724|NCT01587703|463710314|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840725|NCT01587703|463710315|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840726|NCT01587703|463710316|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840727|NCT01587703|463710317|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840728|NCT01587703|463710318|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840729|NCT01587703|463710319|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840730|NCT01587703|463710320|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840731|NCT01587703|463710321|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840732|NCT01587703|463710322|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840733|NCT01587703|463710323|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
128840734|NCT01587703|463710324|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840735|NCT01587703|463710325|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840736|NCT01587703|463710326|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
128840737|NCT01587703|463710308|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840738|NCT01587703|463710309|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840739|NCT01587703|463710310|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840740|NCT01587703|463710311|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840741|NCT01587703|463710312|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840742|NCT01587703|463710313|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840743|NCT01587703|463710314|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840744|NCT01587703|463710315|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840745|NCT01587703|463710316|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840746|NCT01587703|463710317|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840747|NCT01587703|463710318|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840748|NCT01587703|463710319|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
128840749|NCT01587703|463710320|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840750|NCT01587703|463710321|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840751|NCT01587703|463710322|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
128840752|NCT01587703|463710323|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840753|NCT01587703|463710324|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840754|NCT01587703|463710325|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840755|NCT01587703|463710326|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
128840756|NCT01587703|463710308|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840757|NCT01587703|463710309|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840758|NCT01587703|463710310|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840759|NCT01587703|463710311|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840760|NCT01587703|463710312|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840761|NCT01587703|463710313|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840762|NCT01587703|463710314|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840763|NCT01587703|463710315|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840764|NCT01587703|463710316|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840765|NCT01587703|463710317|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840766|NCT01587703|463710318|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840767|NCT01587703|463710319|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
128840768|NCT01587703|463710320|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
128840769|NCT01587703|463710321|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
128840770|NCT01587703|463710322|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
128840771|NCT01587703|463710323|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
128840772|NCT01587703|463710324|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
128840773|NCT01587703|463710325|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840774|NCT01587703|463710326|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
128840775|NCT01587703|463710308|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840776|NCT01587703|463710309|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840777|NCT01587703|463710310|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840778|NCT01587703|463710311|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840779|NCT01587703|463710312|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840780|NCT01587703|463710313|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840781|NCT01587703|463710314|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840782|NCT01587703|463710315|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840783|NCT01587703|463710316|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840784|NCT01587703|463710317|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840785|NCT01587703|463710318|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840786|NCT01587703|463710319|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
128840787|NCT01587703|463710320|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
128840788|NCT01587703|463710321|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
128840789|NCT01587703|463710322|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
128840790|NCT01587703|463710323|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
128840791|NCT01587703|463710324|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
128840792|NCT01587703|463710325|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840793|NCT01587703|463710326|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
128840794|NCT01587703|463710308|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840795|NCT01587703|463710309|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840796|NCT01587703|463710310|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840797|NCT01587703|463710311|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840798|NCT01587703|463710312|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840799|NCT01587703|463710313|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840800|NCT01587703|463710314|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840801|NCT01587703|463710315|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840802|NCT01587703|463710316|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840803|NCT01587703|463710317|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840804|NCT01587703|463710318|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840805|NCT01587703|463710319|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
128840806|NCT01587703|463710320|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840807|NCT01587703|463710321|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840808|NCT01587703|463710322|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840809|NCT01587703|463710323|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840810|NCT01587703|463710324|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840811|NCT01587703|463710325|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840812|NCT01587703|463710326|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
128840813|NCT01799993|463710330|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
128840814|NCT01799993|463710331|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
128840815|NCT01799993|463710330|FG000|Overall Study|Death|61|||
128840816|NCT01799993|463710331|FG001|Overall Study|Death|45|||
128840817|NCT01799993|463710330|FG000|Overall Study|Withdrawal by Subject|23|||
128840818|NCT01799993|463710331|FG001|Overall Study|Withdrawal by Subject|24|||
128840819|NCT01799993|463710330|FG000|Overall Study|Lost to Follow-up|5|||
128840820|NCT01799993|463710331|FG001|Overall Study|Lost to Follow-up|8|||
128840821|NCT01799993|463710330|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
128840822|NCT01799993|463710331|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
128840823|NCT01799993|463710330|FG000|Overall Study|Protocol driven decision point|0|||
128840824|NCT01799993|463710331|FG001|Overall Study|Protocol driven decision point|3|||
128840825|NCT01799993|463710330|FG000|Overall Study|Protocol Violation|1|||
128840826|NCT01799993|463710331|FG001|Overall Study|Protocol Violation|1|||
128840827|NCT01799993|463710330|FG000|Overall Study|Deterioration of general conditions|2|||
128840828|NCT01799993|463710331|FG001|Overall Study|Deterioration of general conditions|0|||
128840829|NCT01799993|463710330|FG000|Overall Study|Screen failure|0|||
128840830|NCT01799993|463710331|FG001|Overall Study|Screen failure|1|||
128840831|NCT01799993|463710330|FG000|Overall Study|Adverse Event|1|||
128840832|NCT01799993|463710331|FG001|Overall Study|Adverse Event|0|||
128840833|NCT01799993|463710330|FG000|Overall Study|Lack of Efficacy|1|||
128840834|NCT01799993|463710331|FG001|Overall Study|Lack of Efficacy|0|||
128840835|NCT01799993|463710330|FG000|Overall Study|Recovery|0|||
128840836|NCT01799993|463710331|FG001|Overall Study|Recovery|1|||
128840837|NCT01799993|463710330|FG000|Overall Study|Logistical difficulties|1|||
128840838|NCT01799993|463710331|FG001|Overall Study|Logistical difficulties|0|||
128840839|NCT01799993|463710330|FG000|Overall Study|Protocol deviation|1|||
128840840|NCT01799993|463710331|FG001|Overall Study|Protocol deviation|0|||
128840841|NCT01799993|463710330|FG000|Overall Study|Non-compliance with medical device|1|||
128840842|NCT01799993|463710331|FG001|Overall Study|Non-compliance with medical device|0|||
128840843|NCT01799993|463710330|FG000|Overall Study|Withdrawal by parent/guardian|0|||
128840844|NCT01799993|463710331|FG001|Overall Study|Withdrawal by parent/guardian|1|||
128840845|NCT01799993|463710330|FG000|Overall Study|Other|1|||
128840846|NCT01799993|463710331|FG001|Overall Study|Other|0|||
128840847|NCT01799993|463710330|FG000|Overall Study|Subject didn't return for follow-up|0|||
128840848|NCT01799993|463710331|FG001|Overall Study|Subject didn't return for follow-up|1|||
128840849|NCT04271254|463710332|FG000|Overall Study|Withdrawal by Subject|3|||
128840850|NCT04410445|463710333|FG000|Overall Study|Lost to Follow-up|3|||
128840851|NCT04410445|463710334|FG001|Overall Study|Lost to Follow-up|9|||
128840852|NCT04410445|463710333|FG000|Overall Study|Withdrawal by Subject|27|||
128840853|NCT04410445|463710334|FG001|Overall Study|Withdrawal by Subject|15|||
128840854|NCT01123356|463710335|FG000|Overall Study|Adverse Event|2|||
128840855|NCT01123356|463710335|FG000|Overall Study|Lack of Efficacy|4|||
128840856|NCT01123356|463710335|FG000|Overall Study|Withdrawal by Subject|1|||
128840857|NCT00759681|463710336|FG000|Overall Study|Death|2|||
128840858|NCT00759681|463710337|FG001|Overall Study|Death|5|||
128840859|NCT00759681|463710336|FG000|Overall Study|Lost to Follow-up|8|||
128840860|NCT00759681|463710337|FG001|Overall Study|Lost to Follow-up|5|||
128840861|NCT00476151|463710338|FG000|Overall Study|Adverse Event|0|||
128840862|NCT00476151|463710339|FG001|Overall Study|Adverse Event|2|||
128840863|NCT00476151|463710338|FG000|Overall Study|Protocol Violation|1|||
128840864|NCT00476151|463710339|FG001|Overall Study|Protocol Violation|3|||
128840865|NCT00476151|463710338|FG000|Overall Study|Withdrawal by Subject|2|||
128840866|NCT00476151|463710339|FG001|Overall Study|Withdrawal by Subject|0|||
128840867|NCT00476151|463710338|FG000|Overall Study|Physician Decision|0|||
128840868|NCT00476151|463710339|FG001|Overall Study|Physician Decision|2|||
128840869|NCT02005484|463710346|FG000|Overall Study|Death|1|||
128840870|NCT02005484|463710346|FG000|Overall Study|Disease progression|1|||
128840871|NCT02005484|463710346|FG000|Overall Study|Changed to a Different Study|1|||
128840872|NCT02005484|463710346|FG000|Overall Study|Sponsor decision|1|||
128840873|NCT01129011|463710347|FG000|Overall Study|Adverse Event|20|||
128840874|NCT01129011|463710348|FG001|Overall Study|Adverse Event|30|||
128840875|NCT01129011|463710347|FG000|Overall Study|Withdrawal by Subject|24|||
128840876|NCT01129011|463710348|FG001|Overall Study|Withdrawal by Subject|8|||
128840877|NCT01129011|463710347|FG000|Overall Study|Lost to Follow-up|6|||
128840878|NCT01129011|463710348|FG001|Overall Study|Lost to Follow-up|7|||
128840879|NCT01129011|463710347|FG000|Overall Study|Duodenal Ulcer|2|||
128840880|NCT01129011|463710348|FG001|Overall Study|Duodenal Ulcer|8|||
128840881|NCT01129011|463710347|FG000|Overall Study|misc|7|||
128840882|NCT01129011|463710348|FG001|Overall Study|misc|4|||
128840883|NCT01113541|463710354|FG000|Overall Study|Withdrawal by Subject|1|||
128840884|NCT01113541|463710354|FG000|Overall Study|Protocol Violation|1|||
128840885|NCT01113541|463710354|FG000|Overall Study|Study Terminated by Sponsor|7|||
128840886|NCT01113541|463710354|FG000|Overall Study|Adverse Event|4|||
128840887|NCT03745651|463710355|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
128840888|NCT03745651|463710356|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
128840889|NCT03745651|463710357|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
128840890|NCT03745651|463710358|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
128840891|NCT03745651|463710359|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
128840892|NCT03745651|463710360|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
128840893|NCT03745651|463710361|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
128840894|NCT03745651|463710355|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
128840895|NCT03745651|463710356|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
128840896|NCT03745651|463710357|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
128840897|NCT03745651|463710358|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128840898|NCT03745651|463710359|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128840899|NCT03745651|463710360|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128840900|NCT03745651|463710361|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
128840901|NCT03745651|463710355|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
128840902|NCT03745651|463710356|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
128840903|NCT03745651|463710357|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
128840904|NCT03745651|463710358|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
128840905|NCT03745651|463710359|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
128840906|NCT03745651|463710360|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
128840907|NCT03745651|463710361|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
128840908|NCT03745651|463710355|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
128840909|NCT03745651|463710356|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
128840910|NCT03745651|463710357|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
128840911|NCT03745651|463710358|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
128840912|NCT03745651|463710359|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
128840913|NCT03745651|463710360|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
128840914|NCT03745651|463710361|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
128840915|NCT03745651|463710355|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
128840916|NCT03745651|463710356|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
128840917|NCT03745651|463710357|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
128840918|NCT03745651|463710358|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128840919|NCT03745651|463710359|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128840920|NCT03745651|463710360|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128840921|NCT03745651|463710361|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
128840922|NCT03745651|463710355|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
128840923|NCT03745651|463710356|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
128840924|NCT03745651|463710357|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
128840925|NCT03745651|463710358|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
128840926|NCT03745651|463710359|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
128840927|NCT03745651|463710360|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
128840928|NCT03745651|463710361|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
128840929|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
128840930|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
128840931|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
128840932|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
128840933|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
128840934|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
128840935|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
128840936|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128840937|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128840938|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128840939|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
128840940|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
128840941|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
128840942|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
128840943|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
128840944|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
128840945|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
128840946|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
128840947|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
128840948|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
128840949|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
128840950|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
128840951|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
128840952|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
128840953|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
128840954|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
128840955|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
128840956|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
128840957|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
128840958|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
128840959|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
128840960|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
128840961|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
128840962|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
128840963|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
128840964|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
128840965|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
128840966|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
128840967|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
128840968|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
128840969|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
128840970|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
128840971|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
128840972|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
128840973|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
128840974|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
128840975|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
128840976|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
128840977|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
128840978|NCT03745651|463710355|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
128840979|NCT03745651|463710356|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
128840980|NCT03745651|463710357|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
128840981|NCT03745651|463710358|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
128840982|NCT03745651|463710359|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
128840983|NCT03745651|463710360|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
128840984|NCT03745651|463710361|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
128840985|NCT01494467|463710364|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
128840986|NCT01494467|463710365|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
128840987|NCT01494467|463710364|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
128840988|NCT01494467|463710365|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
128840989|NCT01494467|463710364|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
128840990|NCT01494467|463710365|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
128840991|NCT01494467|463710364|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
128840992|NCT01494467|463710365|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
128840993|NCT01494467|463710364|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
128840994|NCT01494467|463710365|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
128840995|NCT01494467|463710364|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
128840996|NCT01494467|463710365|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
128840997|NCT01494467|463710364|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
128840998|NCT01494467|463710365|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
128840999|NCT01494467|463710364|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
128841000|NCT01494467|463710365|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
128841001|NCT01494467|463710364|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
128841002|NCT01494467|463710365|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
128841003|NCT01494467|463710364|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
128841004|NCT01494467|463710365|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
128841005|NCT01494467|463710364|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
128841006|NCT01494467|463710365|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
128841007|NCT01494467|463710364|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
128841008|NCT01494467|463710365|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
128841009|NCT01494467|463710364|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
128841010|NCT01494467|463710365|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
128841011|NCT01494467|463710364|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
128841012|NCT01494467|463710365|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
128841013|NCT02309892|463710366|FG000|Overall Study|Physician Decision|1|||
128841014|NCT02309892|463710367|FG001|Overall Study|Physician Decision|0|||
128841015|NCT02309892|463710368|FG002|Overall Study|Physician Decision|0|||
128841016|NCT02309892|463710369|FG003|Overall Study|Physician Decision|0|||
128841017|NCT02309892|463710370|FG004|Overall Study|Physician Decision|0|||
128841018|NCT02309892|463710371|FG005|Overall Study|Physician Decision|0|||
128841019|NCT02309892|463710372|FG006|Overall Study|Physician Decision|0|||
128841020|NCT02309892|463710366|FG000|Overall Study|Adverse Event|1|||
128841021|NCT02309892|463710367|FG001|Overall Study|Adverse Event|0|||
128841022|NCT02309892|463710368|FG002|Overall Study|Adverse Event|1|||
128841023|NCT02309892|463710369|FG003|Overall Study|Adverse Event|0|||
128841024|NCT02309892|463710370|FG004|Overall Study|Adverse Event|0|||
128841025|NCT02309892|463710371|FG005|Overall Study|Adverse Event|0|||
128841026|NCT02309892|463710372|FG006|Overall Study|Adverse Event|0|||
128841027|NCT02309892|463710366|FG000|Overall Study|Progressive Disease|0|||
128841028|NCT02309892|463710367|FG001|Overall Study|Progressive Disease|1|||
128841029|NCT02309892|463710368|FG002|Overall Study|Progressive Disease|0|||
128841030|NCT02309892|463710369|FG003|Overall Study|Progressive Disease|0|||
128841031|NCT02309892|463710370|FG004|Overall Study|Progressive Disease|1|||
128841032|NCT02309892|463710371|FG005|Overall Study|Progressive Disease|0|||
128841033|NCT02309892|463710372|FG006|Overall Study|Progressive Disease|0|||
128841034|NCT02309892|463710366|FG000|Overall Study|Death|0|||
128841035|NCT02309892|463710367|FG001|Overall Study|Death|0|||
128841036|NCT02309892|463710368|FG002|Overall Study|Death|0|||
128841037|NCT02309892|463710369|FG003|Overall Study|Death|0|||
128841038|NCT02309892|463710370|FG004|Overall Study|Death|0|||
128841039|NCT02309892|463710371|FG005|Overall Study|Death|1|||
128841040|NCT02309892|463710372|FG006|Overall Study|Death|0|||
128841041|NCT03262389|463710373|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
128841042|NCT03262389|463710373|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
128841043|NCT03262389|463710373|FG000|Overall Study|opted out of PET/MR|1|||
128841044|NCT01052272|463710374|FG000|Overall Study|Death|0|||
128841045|NCT01052272|463710375|FG001|Overall Study|Death|0|||
128841046|NCT01052272|463710376|FG002|Overall Study|Death|1|||
128841047|NCT01052272|463710377|FG003|Overall Study|Death|1|||
128841048|NCT01052272|463710374|FG000|Overall Study|Physician Decision|0|||
128841049|NCT01052272|463710375|FG001|Overall Study|Physician Decision|1|||
128841050|NCT01052272|463710376|FG002|Overall Study|Physician Decision|0|||
128841051|NCT01052272|463710377|FG003|Overall Study|Physician Decision|0|||
128841052|NCT01052272|463710374|FG000|Overall Study|patient refuses follow-up|5|||
128841053|NCT01052272|463710375|FG001|Overall Study|patient refuses follow-up|4|||
128841054|NCT01052272|463710376|FG002|Overall Study|patient refuses follow-up|2|||
128841055|NCT01052272|463710377|FG003|Overall Study|patient refuses follow-up|4|||
128841056|NCT01052272|463710374|FG000|Overall Study|Withdrawal by Subject|0|||
128841057|NCT01052272|463710375|FG001|Overall Study|Withdrawal by Subject|2|||
128841058|NCT01052272|463710376|FG002|Overall Study|Withdrawal by Subject|3|||
128841059|NCT01052272|463710377|FG003|Overall Study|Withdrawal by Subject|2|||
128841060|NCT01052272|463710374|FG000|Overall Study|placed in long-term care|0|||
128841061|NCT01052272|463710375|FG001|Overall Study|placed in long-term care|0|||
128841062|NCT01052272|463710376|FG002|Overall Study|placed in long-term care|1|||
128841063|NCT01052272|463710377|FG003|Overall Study|placed in long-term care|0|||
128841064|NCT01052272|463710374|FG000|Overall Study|decline in health|0|||
128841065|NCT01052272|463710375|FG001|Overall Study|decline in health|0|||
128841066|NCT01052272|463710376|FG002|Overall Study|decline in health|1|||
128841067|NCT01052272|463710377|FG003|Overall Study|decline in health|0|||
128841068|NCT04739306|463710378|FG000|Main Study Period|Adverse Event|6|||
128841069|NCT04739306|463710379|FG001|Main Study Period|Adverse Event|7|||
128841070|NCT04739306|463710378|FG000|Main Study Period|Lost to Follow-up|4|||
128841071|NCT04739306|463710379|FG001|Main Study Period|Lost to Follow-up|6|||
128841072|NCT04739306|463710378|FG000|Main Study Period|Physician Decision|1|||
128841073|NCT04739306|463710379|FG001|Main Study Period|Physician Decision|1|||
128841074|NCT04739306|463710378|FG000|Main Study Period|Withdrawal by Subject|8|||
128841075|NCT04739306|463710379|FG001|Main Study Period|Withdrawal by Subject|6|||
128841076|NCT04739306|463710378|FG000|Main Study Period|Protocol Violation|0|||
128841077|NCT04739306|463710379|FG001|Main Study Period|Protocol Violation|1|||
128841078|NCT04739306|463710378|FG000|Main Study Period|War in Ukraine|1|||
128841079|NCT04739306|463710379|FG001|Main Study Period|War in Ukraine|1|||
128841080|NCT01077284|463710380|FG000|Overall Study|Adverse Event|2|||
128841081|NCT01077284|463710381|FG001|Overall Study|Adverse Event|0|||
128841082|NCT01077284|463710382|FG002|Overall Study|Adverse Event|1|||
128841083|NCT01077284|463710380|FG000|Overall Study|Lost to Follow-up|1|||
128841084|NCT01077284|463710381|FG001|Overall Study|Lost to Follow-up|2|||
128841085|NCT01077284|463710382|FG002|Overall Study|Lost to Follow-up|0|||
128841086|NCT01077284|463710380|FG000|Overall Study|Withdrawal by Subject|2|||
128841087|NCT01077284|463710381|FG001|Overall Study|Withdrawal by Subject|3|||
128841088|NCT01077284|463710382|FG002|Overall Study|Withdrawal by Subject|1|||
128841089|NCT01077284|463710380|FG000|Overall Study|Other|0|||
128841090|NCT01077284|463710381|FG001|Overall Study|Other|0|||
128841091|NCT01077284|463710382|FG002|Overall Study|Other|1|||
128841092|NCT00096278|463710383|FG000|Overall Study|No follow-up data|15|||
128841093|NCT00096278|463710384|FG001|Overall Study|No follow-up data|18|||
128841094|NCT00096278|463710383|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
128841095|NCT00096278|463710384|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
128841096|NCT05104242|463710387|FG000|Overall Study|Withdrawal by Subject|1|||
128841097|NCT05104242|463710388|FG001|Overall Study|Withdrawal by Subject|5|||
128841098|NCT05104242|463710387|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
128841099|NCT05104242|463710388|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
128841100|NCT01864200|463710389|FG000|Overall Study|Lost to Follow-up|1|||
128841101|NCT01864200|463710390|FG001|Overall Study|Lost to Follow-up|3|||
128841102|NCT01864200|463710389|FG000|Overall Study|Protocol Violation|1|||
128841103|NCT01864200|463710390|FG001|Overall Study|Protocol Violation|0|||
128841104|NCT02077374|463710391|FG000|Overall Study|Withdrawal by Subject|0|||
128841105|NCT02077374|463710392|FG001|Overall Study|Withdrawal by Subject|1|||
128841106|NCT02077374|463710391|FG000|Overall Study|Protocol Violation|0|||
128841107|NCT02077374|463710392|FG001|Overall Study|Protocol Violation|1|||
128841108|NCT00424476|463710394|FG000|Overall Study|Withdrawal by Subject|7|||
128841109|NCT00424476|463710395|FG001|Overall Study|Withdrawal by Subject|6|||
128841110|NCT00424476|463710396|FG002|Overall Study|Withdrawal by Subject|3|||
128841111|NCT00424476|463710394|FG000|Overall Study|Adverse Event|19|||
128841112|NCT00424476|463710395|FG001|Overall Study|Adverse Event|16|||
128841113|NCT00424476|463710396|FG002|Overall Study|Adverse Event|15|||
128841114|NCT00424476|463710394|FG000|Overall Study|Lack of Efficacy|16|||
128841115|NCT00424476|463710395|FG001|Overall Study|Lack of Efficacy|12|||
128841116|NCT00424476|463710396|FG002|Overall Study|Lack of Efficacy|12|||
128841117|NCT00424476|463710394|FG000|Overall Study|Lack of Compliance|1|||
128841118|NCT00424476|463710395|FG001|Overall Study|Lack of Compliance|1|||
128841119|NCT00424476|463710396|FG002|Overall Study|Lack of Compliance|1|||
128841120|NCT00424476|463710394|FG000|Overall Study|Lost to Follow-up|4|||
128841121|NCT00424476|463710395|FG001|Overall Study|Lost to Follow-up|6|||
128841122|NCT00424476|463710396|FG002|Overall Study|Lost to Follow-up|3|||
128841123|NCT00424476|463710394|FG000|Overall Study|Protocol Violation|7|||
128841124|NCT00424476|463710395|FG001|Overall Study|Protocol Violation|2|||
128841125|NCT00424476|463710396|FG002|Overall Study|Protocol Violation|3|||
128841126|NCT00424476|463710394|FG000|Overall Study|Physician Decision|3|||
128841127|NCT00424476|463710395|FG001|Overall Study|Physician Decision|2|||
128841128|NCT00424476|463710396|FG002|Overall Study|Physician Decision|3|||
128841129|NCT00424476|463710394|FG000|Overall Study|Other|4|||
128841130|NCT00424476|463710395|FG001|Overall Study|Other|3|||
128841131|NCT00424476|463710396|FG002|Overall Study|Other|9|||
128841132|NCT00657709|463710397|FG000|Overall Study|AE or Death|7|||
128841133|NCT00657709|463710398|FG001|Overall Study|AE or Death|7|||
128841134|NCT00657709|463710399|FG002|Overall Study|AE or Death|6|||
128841135|NCT00657709|463710400|FG003|Overall Study|AE or Death|7|||
128841136|NCT00657709|463710401|FG004|Overall Study|AE or Death|1|||
128841137|NCT00657709|463710397|FG000|Overall Study|Withdrawal by Subject|7|||
128841138|NCT00657709|463710398|FG001|Overall Study|Withdrawal by Subject|15|||
128841139|NCT00657709|463710399|FG002|Overall Study|Withdrawal by Subject|15|||
128841140|NCT00657709|463710400|FG003|Overall Study|Withdrawal by Subject|5|||
128841141|NCT00657709|463710401|FG004|Overall Study|Withdrawal by Subject|9|||
128841142|NCT00657709|463710397|FG000|Overall Study|Lost to Follow-up|9|||
128841143|NCT00657709|463710398|FG001|Overall Study|Lost to Follow-up|9|||
128841144|NCT00657709|463710399|FG002|Overall Study|Lost to Follow-up|7|||
128841145|NCT00657709|463710400|FG003|Overall Study|Lost to Follow-up|1|||
128841146|NCT00657709|463710401|FG004|Overall Study|Lost to Follow-up|21|||
128841147|NCT00657709|463710397|FG000|Overall Study|Protocol Violation|0|||
128841148|NCT00657709|463710398|FG001|Overall Study|Protocol Violation|2|||
128841149|NCT00657709|463710399|FG002|Overall Study|Protocol Violation|0|||
128841150|NCT00657709|463710400|FG003|Overall Study|Protocol Violation|1|||
128841151|NCT00657709|463710401|FG004|Overall Study|Protocol Violation|2|||
128841152|NCT02574286|463710402|FG000|Overall Study|Adverse Event|3|||
128841153|NCT02574286|463710402|FG000|Overall Study|Withdrawal by Subject|2|||
128841154|NCT01280656|463710403|FG000|Overall Study|Adverse Event|1|||
128841155|NCT01280656|463710404|FG001|Overall Study|Adverse Event|14|||
128841156|NCT01280656|463710405|FG002|Overall Study|Adverse Event|13|||
128841157|NCT01280656|463710403|FG000|Overall Study|Lack of Efficacy|1|||
128841158|NCT01280656|463710404|FG001|Overall Study|Lack of Efficacy|22|||
128841159|NCT01280656|463710405|FG002|Overall Study|Lack of Efficacy|38|||
128841160|NCT01280656|463710403|FG000|Overall Study|Treatment shortening (RGT)|0|||
128841161|NCT01280656|463710404|FG001|Overall Study|Treatment shortening (RGT)|4|||
128841162|NCT01280656|463710405|FG002|Overall Study|Treatment shortening (RGT)|5|||
128841163|NCT01280656|463710403|FG000|Overall Study|Other|1|||
128841164|NCT01280656|463710404|FG001|Overall Study|Other|7|||
128841165|NCT01280656|463710405|FG002|Overall Study|Other|7|||
128841166|NCT00409747|463710406|FG000|Overall Study|Withdrawal by Subject|1|||
128841167|NCT00632736|463710412|FG000|Overall Study|Adverse Event|104|||
128841168|NCT00632736|463710412|FG000|Overall Study|Lost to Follow-up|15|||
128841169|NCT00632736|463710412|FG000|Overall Study|Protocol Violation|14|||
128841170|NCT00632736|463710412|FG000|Overall Study|Withdrawal by Subject|99|||
128841171|NCT00632736|463710412|FG000|Overall Study|Lack of Efficacy|5|||
128841172|NCT00632736|463710412|FG000|Overall Study|Sponsor terminated study|5|||
128841173|NCT00632736|463710412|FG000|Overall Study|Non-compliance|10|||
128841174|NCT00632736|463710412|FG000|Overall Study|Other|16|||
128841175|NCT02312258|463710413|FG000|Overall Study|Lost to Follow-up|8|||
128841176|NCT02312258|463710414|FG001|Overall Study|Lost to Follow-up|8|||
128841177|NCT02312258|463710413|FG000|Overall Study|Withdrawal by Patient|49|||
128841178|NCT02312258|463710414|FG001|Overall Study|Withdrawal by Patient|76|||
128841179|NCT02312258|463710413|FG000|Overall Study|Reason not Specified|107|||
128841180|NCT02312258|463710414|FG001|Overall Study|Reason not Specified|159|||
128841181|NCT02312258|463710413|FG000|Overall Study|Missing|2|||
128841182|NCT02312258|463710414|FG001|Overall Study|Missing|1|||
128841183|NCT02312258|463710413|FG000|Overall Study|Death|115|||
128841184|NCT02312258|463710414|FG001|Overall Study|Death|181|||
128841185|NCT00736502|463710420|FG000|Overall Study|Adverse Event|22|||
128841186|NCT00736502|463710420|FG000|Overall Study|Lack of Efficacy|16|||
128841187|NCT00736502|463710420|FG000|Overall Study|Lost to Follow-up|27|||
128841188|NCT03100370|463710421|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128841189|NCT03100370|463710422|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128841190|NCT03100370|463710423|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128841191|NCT03100370|463710424|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
128841192|NCT03100370|463710425|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128841193|NCT03100370|463710426|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
128841194|NCT02892019|463710427|FG000|Overall Study|randomized but not treated|0|||
128841195|NCT02892019|463710428|FG001|Overall Study|randomized but not treated|1|||
128841196|NCT02892019|463710427|FG000|Overall Study|Withdrawal by Subject|0|||
128841197|NCT02892019|463710428|FG001|Overall Study|Withdrawal by Subject|1|||
128841198|NCT02892019|463710427|FG000|Overall Study|Adverse Event|1|||
128841199|NCT02892019|463710428|FG001|Overall Study|Adverse Event|1|||
128841200|NCT01313663|463710429|FG000|Overall Study|Study Closed/Terminated|2|||
128841201|NCT01313663|463710430|FG001|Overall Study|Study Closed/Terminated|4|||
128841202|NCT01313663|463710429|FG000|Overall Study|Lost to Follow-up|0|||
128841203|NCT01313663|463710430|FG001|Overall Study|Lost to Follow-up|1|||
128841204|NCT01313663|463710429|FG000|Overall Study|Physician Decision|0|||
128841205|NCT01313663|463710430|FG001|Overall Study|Physician Decision|2|||
128841206|NCT01313663|463710429|FG000|Overall Study|Withdrawal by Subject|2|||
128841207|NCT01313663|463710430|FG001|Overall Study|Withdrawal by Subject|1|||
128841208|NCT03978130|463712370|FG000|Overall Study|Lost to Follow-up|13|||
128841209|NCT03978130|463712371|FG001|Overall Study|Lost to Follow-up|14|||
128841210|NCT03978130|463712370|FG000|Overall Study|Withdrawal by Subject|12|||
128841211|NCT03978130|463712371|FG001|Overall Study|Withdrawal by Subject|2|||
128841212|NCT03978130|463712370|FG000|Overall Study|Adverse Event|2|||
128841213|NCT03978130|463712371|FG001|Overall Study|Adverse Event|1|||
128841214|NCT01562275|463712372|FG000|Stage 1|Adverse Event|0|||
128841215|NCT01562275|463712373|FG001|Stage 1|Adverse Event|0|||
128841216|NCT01562275|463712374|FG002|Stage 1|Adverse Event|0|||
128841217|NCT01562275|463712375|FG003|Stage 1|Adverse Event|1|||
128841218|NCT01562275|463712376|FG004|Stage 1|Adverse Event|1|||
128841219|NCT01562275|463712377|FG005|Stage 1|Adverse Event|0|||
128841220|NCT01562275|463712378|FG006|Stage 1|Adverse Event|0|||
128841221|NCT01562275|463712379|FG007|Stage 1|Adverse Event|0|||
128841222|NCT01562275|463712380|FG008|Stage 1|Adverse Event|0|||
128841223|NCT01562275|463712381|FG009|Stage 1|Adverse Event|1|||
128841224|NCT01562275|463712382|FG010|Stage 1|Adverse Event|0|||
128841225|NCT01562275|463712383|FG011|Stage 1|Adverse Event|0|||
128841226|NCT01562275|463712384|FG012|Stage 1|Adverse Event|0|||
128841227|NCT01562275|463712372|FG000|Stage 1|Death|1|||
128841228|NCT01562275|463712373|FG001|Stage 1|Death|0|||
128841229|NCT01562275|463712374|FG002|Stage 1|Death|0|||
128841230|NCT01562275|463712375|FG003|Stage 1|Death|0|||
128841231|NCT01562275|463712376|FG004|Stage 1|Death|0|||
128841232|NCT01562275|463712377|FG005|Stage 1|Death|0|||
128841233|NCT01562275|463712378|FG006|Stage 1|Death|0|||
128841234|NCT01562275|463712379|FG007|Stage 1|Death|0|||
128841235|NCT01562275|463712380|FG008|Stage 1|Death|0|||
128841236|NCT01562275|463712381|FG009|Stage 1|Death|0|||
128841237|NCT01562275|463712382|FG010|Stage 1|Death|0|||
128841238|NCT01562275|463712383|FG011|Stage 1|Death|0|||
128841239|NCT01562275|463712384|FG012|Stage 1|Death|0|||
128841240|NCT01562275|463712372|FG000|Stage 1|Non Compliance|0|||
128841241|NCT01562275|463712373|FG001|Stage 1|Non Compliance|0|||
128841242|NCT01562275|463712374|FG002|Stage 1|Non Compliance|1|||
128841243|NCT01562275|463712375|FG003|Stage 1|Non Compliance|0|||
128841244|NCT01562275|463712376|FG004|Stage 1|Non Compliance|0|||
128841245|NCT01562275|463712377|FG005|Stage 1|Non Compliance|0|||
128841246|NCT01562275|463712378|FG006|Stage 1|Non Compliance|0|||
128841247|NCT01562275|463712379|FG007|Stage 1|Non Compliance|0|||
128841248|NCT01562275|463712380|FG008|Stage 1|Non Compliance|0|||
128841249|NCT01562275|463712381|FG009|Stage 1|Non Compliance|0|||
128841250|NCT01562275|463712382|FG010|Stage 1|Non Compliance|0|||
128841251|NCT01562275|463712383|FG011|Stage 1|Non Compliance|0|||
128841252|NCT01562275|463712384|FG012|Stage 1|Non Compliance|0|||
128841253|NCT01562275|463712372|FG000|Stage 1|Physician Decision|0|||
128841254|NCT01562275|463712373|FG001|Stage 1|Physician Decision|0|||
128841255|NCT01562275|463712374|FG002|Stage 1|Physician Decision|0|||
128841256|NCT01562275|463712375|FG003|Stage 1|Physician Decision|0|||
128841257|NCT01562275|463712376|FG004|Stage 1|Physician Decision|1|||
128841258|NCT01562275|463712377|FG005|Stage 1|Physician Decision|0|||
128841259|NCT01562275|463712378|FG006|Stage 1|Physician Decision|1|||
128841260|NCT01562275|463712379|FG007|Stage 1|Physician Decision|0|||
128841261|NCT01562275|463712380|FG008|Stage 1|Physician Decision|1|||
128841262|NCT01562275|463712381|FG009|Stage 1|Physician Decision|0|||
128841263|NCT01562275|463712382|FG010|Stage 1|Physician Decision|0|||
128841264|NCT01562275|463712383|FG011|Stage 1|Physician Decision|0|||
128841265|NCT01562275|463712384|FG012|Stage 1|Physician Decision|0|||
128841266|NCT01562275|463712372|FG000|Stage 1|Progression of Disease|2|||
128841267|NCT01562275|463712373|FG001|Stage 1|Progression of Disease|6|||
128841268|NCT01562275|463712374|FG002|Stage 1|Progression of Disease|2|||
128841269|NCT01562275|463712375|FG003|Stage 1|Progression of Disease|1|||
128841270|NCT01562275|463712376|FG004|Stage 1|Progression of Disease|2|||
128841271|NCT01562275|463712377|FG005|Stage 1|Progression of Disease|4|||
128841272|NCT01562275|463712378|FG006|Stage 1|Progression of Disease|1|||
128841273|NCT01562275|463712379|FG007|Stage 1|Progression of Disease|7|||
128841274|NCT01562275|463712380|FG008|Stage 1|Progression of Disease|2|||
128841275|NCT01562275|463712381|FG009|Stage 1|Progression of Disease|5|||
128841276|NCT01562275|463712382|FG010|Stage 1|Progression of Disease|3|||
128841277|NCT01562275|463712383|FG011|Stage 1|Progression of Disease|0|||
128841278|NCT01562275|463712384|FG012|Stage 1|Progression of Disease|0|||
128841279|NCT01562275|463712372|FG000|Stage 1|Withdrawal by Subject|0|||
128841280|NCT01562275|463712373|FG001|Stage 1|Withdrawal by Subject|1|||
128841281|NCT01562275|463712374|FG002|Stage 1|Withdrawal by Subject|0|||
128841282|NCT01562275|463712375|FG003|Stage 1|Withdrawal by Subject|2|||
128841283|NCT01562275|463712376|FG004|Stage 1|Withdrawal by Subject|0|||
128841284|NCT01562275|463712377|FG005|Stage 1|Withdrawal by Subject|0|||
128841285|NCT01562275|463712378|FG006|Stage 1|Withdrawal by Subject|1|||
128841286|NCT01562275|463712379|FG007|Stage 1|Withdrawal by Subject|0|||
128841287|NCT01562275|463712380|FG008|Stage 1|Withdrawal by Subject|0|||
128841288|NCT01562275|463712381|FG009|Stage 1|Withdrawal by Subject|1|||
128841289|NCT01562275|463712382|FG010|Stage 1|Withdrawal by Subject|0|||
128841290|NCT01562275|463712383|FG011|Stage 1|Withdrawal by Subject|0|||
128841291|NCT01562275|463712384|FG012|Stage 1|Withdrawal by Subject|0|||
128841292|NCT01562275|463712372|FG000|Stage 2|Death|0|||
128841293|NCT01562275|463712373|FG001|Stage 2|Death|0|||
128841294|NCT01562275|463712374|FG002|Stage 2|Death|0|||
128841295|NCT01562275|463712375|FG003|Stage 2|Death|0|||
128841296|NCT01562275|463712376|FG004|Stage 2|Death|0|||
128841297|NCT01562275|463712377|FG005|Stage 2|Death|0|||
128841298|NCT01562275|463712378|FG006|Stage 2|Death|0|||
128841299|NCT01562275|463712379|FG007|Stage 2|Death|0|||
128841300|NCT01562275|463712380|FG008|Stage 2|Death|0|||
128841301|NCT01562275|463712381|FG009|Stage 2|Death|0|||
128841302|NCT01562275|463712382|FG010|Stage 2|Death|0|||
128841303|NCT01562275|463712383|FG011|Stage 2|Death|2|||
128841304|NCT01562275|463712384|FG012|Stage 2|Death|1|||
128841305|NCT01562275|463712372|FG000|Stage 2|Progression of Disease|0|||
128841306|NCT01562275|463712373|FG001|Stage 2|Progression of Disease|0|||
128841307|NCT01562275|463712374|FG002|Stage 2|Progression of Disease|0|||
128841308|NCT01562275|463712375|FG003|Stage 2|Progression of Disease|0|||
128841309|NCT01562275|463712376|FG004|Stage 2|Progression of Disease|0|||
128841310|NCT01562275|463712377|FG005|Stage 2|Progression of Disease|0|||
128841311|NCT01562275|463712378|FG006|Stage 2|Progression of Disease|0|||
128841312|NCT01562275|463712379|FG007|Stage 2|Progression of Disease|0|||
128841313|NCT01562275|463712380|FG008|Stage 2|Progression of Disease|0|||
128841314|NCT01562275|463712381|FG009|Stage 2|Progression of Disease|0|||
128841315|NCT01562275|463712382|FG010|Stage 2|Progression of Disease|0|||
128841316|NCT01562275|463712383|FG011|Stage 2|Progression of Disease|12|||
128841317|NCT01562275|463712384|FG012|Stage 2|Progression of Disease|4|||
128841318|NCT00515112|463712386|FG000|Overall Study|Death|0|||
128841319|NCT00515112|463712387|FG001|Overall Study|Death|1|||
128841320|NCT00515112|463712386|FG000|Overall Study|The study was terminated|3|||
128841321|NCT00515112|463712387|FG001|Overall Study|The study was terminated|2|||
128841322|NCT01020487|463712388|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
128841323|NCT01020487|463712389|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
128841324|NCT01020487|463712390|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
128841325|NCT01020487|463712388|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
128841326|NCT01020487|463712389|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
128841327|NCT01020487|463712390|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
128841328|NCT01020487|463712388|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
128841329|NCT01020487|463712389|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
128841330|NCT01020487|463712390|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
128841331|NCT01020487|463712388|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
128841332|NCT01020487|463712389|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
128841333|NCT01020487|463712390|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
128841334|NCT01020487|463712388|FG000|Part 2 Open-label Period|Adverse Event|0|||
128841335|NCT01020487|463712389|FG001|Part 2 Open-label Period|Adverse Event|4|||
128841336|NCT01020487|463712390|FG002|Part 2 Open-label Period|Adverse Event|1|||
128841337|NCT04049578|463712391|FG000|Overall Study|Physician Decision|1|||
128841338|NCT00304278|463712398|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
128841339|NCT00304278|463712398|FG000|Overall Study|PT had medical condition preventing TX|1|||
128841340|NCT01945593|463712399|FG000|Overall Study|Adverse Event|0|||
128841341|NCT01945593|463712400|FG001|Overall Study|Adverse Event|0|||
128841342|NCT01945593|463712401|FG002|Overall Study|Adverse Event|0|||
128841343|NCT01945593|463712402|FG003|Overall Study|Adverse Event|5|||
128841344|NCT01945593|463712399|FG000|Overall Study|Physician Decision|0|||
128841345|NCT01945593|463712400|FG001|Overall Study|Physician Decision|0|||
128841346|NCT01945593|463712401|FG002|Overall Study|Physician Decision|1|||
128841347|NCT01945593|463712402|FG003|Overall Study|Physician Decision|1|||
128841348|NCT01945593|463712399|FG000|Overall Study|Withdrawal by Subject|0|||
128841349|NCT01945593|463712400|FG001|Overall Study|Withdrawal by Subject|2|||
128841350|NCT01945593|463712401|FG002|Overall Study|Withdrawal by Subject|0|||
128841351|NCT01945593|463712402|FG003|Overall Study|Withdrawal by Subject|4|||
128841352|NCT01945593|463712399|FG000|Overall Study|Protocol Violation|0|||
128841353|NCT01945593|463712400|FG001|Overall Study|Protocol Violation|2|||
128841354|NCT01945593|463712401|FG002|Overall Study|Protocol Violation|1|||
128841355|NCT01945593|463712402|FG003|Overall Study|Protocol Violation|3|||
128841356|NCT01945593|463712399|FG000|Overall Study|Death|0|||
128841357|NCT01945593|463712400|FG001|Overall Study|Death|0|||
128841358|NCT01945593|463712401|FG002|Overall Study|Death|1|||
128841359|NCT01945593|463712402|FG003|Overall Study|Death|0|||
128841360|NCT01945593|463712399|FG000|Overall Study|Other: Terminated|0|||
128841361|NCT01945593|463712400|FG001|Overall Study|Other: Terminated|0|||
128841362|NCT01945593|463712401|FG002|Overall Study|Other: Terminated|0|||
128841363|NCT01945593|463712402|FG003|Overall Study|Other: Terminated|1|||
128841364|NCT01945593|463712399|FG000|Overall Study|Other: Surgical Procedure|0|||
128841365|NCT01945593|463712400|FG001|Overall Study|Other: Surgical Procedure|2|||
128841366|NCT01945593|463712401|FG002|Overall Study|Other: Surgical Procedure|0|||
128841367|NCT01945593|463712402|FG003|Overall Study|Other: Surgical Procedure|6|||
128841368|NCT01945593|463712399|FG000|Overall Study|Other: Screen Failure|0|||
128841369|NCT01945593|463712400|FG001|Overall Study|Other: Screen Failure|2|||
128841370|NCT01945593|463712401|FG002|Overall Study|Other: Screen Failure|0|||
128841371|NCT01945593|463712402|FG003|Overall Study|Other: Screen Failure|0|||
128841372|NCT04025762|463712404|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
128841373|NCT04025762|463712405|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
128841374|NCT00608959|463712408|FG000|Part 1|Did not meet eligibility criteria|1|||
128841375|NCT01005602|463712411|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
128841376|NCT01005602|463712412|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
128841377|NCT01248715|463712413|FG000|Overall Study|Not influenza positive|501|||
128841378|NCT01248715|463712414|FG001|Overall Study|Not influenza positive|510|||
128841379|NCT03409276|463712420|FG000|Overall Study|Withdrawal by Subject|0|||
128841380|NCT03409276|463712421|FG001|Overall Study|Withdrawal by Subject|0|||
128841381|NCT03409276|463712422|FG002|Overall Study|Withdrawal by Subject|0|||
128841382|NCT03409276|463712423|FG003|Overall Study|Withdrawal by Subject|0|||
128841383|NCT03409276|463712424|FG004|Overall Study|Withdrawal by Subject|1|||
128841384|NCT03409276|463712420|FG000|Overall Study|Lost to Follow-up|0|||
128841385|NCT03409276|463712421|FG001|Overall Study|Lost to Follow-up|0|||
128841386|NCT03409276|463712422|FG002|Overall Study|Lost to Follow-up|0|||
128841387|NCT03409276|463712423|FG003|Overall Study|Lost to Follow-up|2|||
128841388|NCT03409276|463712424|FG004|Overall Study|Lost to Follow-up|2|||
128841389|NCT03605745|463712426|FG000|Overall Study|Study was terminated for business reasons|47|||
128841390|NCT01279447|463712427|FG000|Overall Study|Lost to Follow-up|3|||
128841391|NCT01279447|463712428|FG001|Overall Study|Lost to Follow-up|1|||
128841392|NCT01215253|463712429|FG000|Overall Study|Withdrawal by Subject|57|||
128841393|NCT01215253|463712430|FG001|Overall Study|Withdrawal by Subject|35|||
128841394|NCT01215253|463712429|FG000|Overall Study|Physician Decision|9|||
128841395|NCT01215253|463712430|FG001|Overall Study|Physician Decision|12|||
128841396|NCT01215253|463712429|FG000|Overall Study|Lost to Follow-up|6|||
128841397|NCT01215253|463712430|FG001|Overall Study|Lost to Follow-up|4|||
128841398|NCT01215253|463712429|FG000|Overall Study|Other|14|||
128841399|NCT01215253|463712430|FG001|Overall Study|Other|12|||
128841400|NCT01131325|463712437|FG000|Overall Study|Adverse Event|1|||
128841401|NCT01131325|463712437|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
128841402|NCT03344458|463712438|FG000|Overall Study|Physician Decision|1|||
128841403|NCT03344458|463712438|FG000|Overall Study|Withdrawal by Subject|16|||
128841404|NCT03344458|463712438|FG000|Overall Study|Other reasons|10|||
128841405|NCT03344458|463712438|FG000|Overall Study|Lost to Follow-up|9|||
128841406|NCT03344458|463712438|FG000|Overall Study|Protocol Violation|3|||
128841407|NCT03884478|463712439|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
128841408|NCT03884478|463712440|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
128841409|NCT03884478|463712441|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
128841410|NCT03884478|463712439|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
128841411|NCT03884478|463712440|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
128841412|NCT03884478|463712441|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
128841413|NCT03884478|463712439|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
128841414|NCT03884478|463712440|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
128841415|NCT03884478|463712441|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
128841416|NCT03884478|463712439|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
128841417|NCT03884478|463712440|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
128841418|NCT03884478|463712441|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
128841419|NCT02213094|463712442|FG000|Overall Study|Adverse Event|1|||
128841420|NCT02213094|463712443|FG001|Overall Study|Adverse Event|0|||
128841421|NCT02964234|463712444|FG000|Overall Study|Lost to Follow-up|22|||
128841422|NCT02964234|463712445|FG001|Overall Study|Lost to Follow-up|13|||
128841423|NCT04454125|463712446|FG000|Overall Study|Lost to Follow-up|0|||
128841424|NCT04454125|463712447|FG001|Overall Study|Lost to Follow-up|1|||
128841425|NCT00828139|463712453|FG000|Overall Study|Adverse Event|8|||
128841426|NCT00828139|463712454|FG001|Overall Study|Adverse Event|1|||
128841427|NCT00828139|463712455|FG002|Overall Study|Adverse Event|10|||
128841428|NCT00828139|463712456|FG003|Overall Study|Adverse Event|5|||
128841429|NCT00828139|463712453|FG000|Overall Study|Death|2|||
128841430|NCT00828139|463712454|FG001|Overall Study|Death|1|||
128841431|NCT00828139|463712455|FG002|Overall Study|Death|0|||
128841432|NCT00828139|463712456|FG003|Overall Study|Death|2|||
128841433|NCT00828139|463712453|FG000|Overall Study|Refusal unrelated to toxicity|3|||
128841434|NCT00828139|463712454|FG001|Overall Study|Refusal unrelated to toxicity|4|||
128841435|NCT00828139|463712455|FG002|Overall Study|Refusal unrelated to toxicity|5|||
128841436|NCT00828139|463712456|FG003|Overall Study|Refusal unrelated to toxicity|3|||
128841437|NCT00828139|463712453|FG000|Overall Study|Disease Progression|24|||
128841438|NCT00828139|463712454|FG001|Overall Study|Disease Progression|33|||
128841439|NCT00828139|463712455|FG002|Overall Study|Disease Progression|35|||
128841440|NCT00828139|463712456|FG003|Overall Study|Disease Progression|39|||
128841441|NCT00828139|463712453|FG000|Overall Study|Other|4|||
128841442|NCT00828139|463712454|FG001|Overall Study|Other|2|||
128841443|NCT00828139|463712455|FG002|Overall Study|Other|5|||
128841444|NCT00828139|463712456|FG003|Overall Study|Other|2|||
128841445|NCT01714947|463712457|FG000|Part B|Progressive Disease|3|||
128841446|NCT01922102|463712458|FG000|Overall Study|Withdrawal by Subject|7|||
128841447|NCT01922102|463712459|FG001|Overall Study|Withdrawal by Subject|3|||
128841448|NCT01922102|463712460|FG002|Overall Study|Withdrawal by Subject|7|||
128841449|NCT01922102|463712458|FG000|Overall Study|Physician Decision|0|||
128841450|NCT01922102|463712459|FG001|Overall Study|Physician Decision|2|||
128841451|NCT01922102|463712460|FG002|Overall Study|Physician Decision|1|||
128841452|NCT01922102|463712458|FG000|Overall Study|Adverse Event|1|||
128841453|NCT01922102|463712459|FG001|Overall Study|Adverse Event|2|||
128841454|NCT01922102|463712460|FG002|Overall Study|Adverse Event|0|||
128841455|NCT01922102|463712458|FG000|Overall Study|Lost to Follow-up|1|||
128841456|NCT01922102|463712459|FG001|Overall Study|Lost to Follow-up|0|||
128841457|NCT01922102|463712460|FG002|Overall Study|Lost to Follow-up|0|||
128841458|NCT01922102|463712458|FG000|Overall Study|Administrative problems|0|||
128841459|NCT01922102|463712459|FG001|Overall Study|Administrative problems|2|||
128841460|NCT01922102|463712460|FG002|Overall Study|Administrative problems|0|||
128841461|NCT01320683|463712462|FG000|Overall Study|Positive antibody response|1|||
128841462|NCT01894620|463712463|FG000|Overall Study|Withdrawal by Subject|0|||
128841463|NCT01894620|463712464|FG001|Overall Study|Withdrawal by Subject|1|||
128841464|NCT02959866|463712469|FG000|Overall Study|Withdrawal by Subject|1|||
128841465|NCT00952523|463712470|FG000|Overall Study|Withdrawal by Subject|7|||
128841466|NCT05265247|463712471|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
128841467|NCT05265247|463712472|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
128841468|NCT05265247|463712471|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
128841469|NCT05265247|463712472|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
128841470|NCT05265247|463712471|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
128841471|NCT05265247|463712472|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
128841472|NCT00134056|463712475|FG000|Randomization|Not eligible for assigned treatment|22|||
128841473|NCT00134056|463712476|FG001|Randomization|Not eligible for assigned treatment|20|||
128841474|NCT00134056|463712475|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
128841475|NCT00134056|463712476|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
128841476|NCT00134056|463712475|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
128841477|NCT00134056|463712476|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
128841478|NCT00134056|463712475|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
128841479|NCT00134056|463712476|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
128841480|NCT00134056|463712475|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
128841481|NCT00134056|463712476|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
128841482|NCT02555397|463712480|FG000|Overall Study|Withdrawal by Subject|1|||
128841483|NCT02555397|463712481|FG001|Overall Study|Withdrawal by Subject|0|||
128841484|NCT02555397|463712482|FG002|Overall Study|Withdrawal by Subject|0|||
128841485|NCT02555397|463712483|FG003|Overall Study|Withdrawal by Subject|0|||
128841486|NCT02555397|463712484|FG004|Overall Study|Withdrawal by Subject|0|||
128841487|NCT00537914|463712485|FG000|Overall Study|Death|1|||
128841488|NCT00537914|463712485|FG000|Overall Study|Adverse Event|7|||
128841489|NCT00537914|463712485|FG000|Overall Study|Treatment failure|10|||
128841490|NCT00537914|463712485|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
128841491|NCT00537914|463712485|FG000|Overall Study|Lost to Follow-up|19|||
128841492|NCT00537914|463712485|FG000|Overall Study|Withdrawal of informed consent|59|||
128841493|NCT01468597|463712487|FG000|Overall Study|Found ineligible|17|||
128841494|NCT01468597|463712487|FG000|Overall Study|concomitant valves|12|||
128841495|NCT01468597|463712487|FG000|Overall Study|off-pump CABG|1|||
128841496|NCT01468597|463712487|FG000|Overall Study|no platelet function data|5|||
128841497|NCT02260154|463712488|FG000|Overall Study|Screening failure|2|||
128841498|NCT02561195|463712490|FG000|Vaccination 1 to 3|Adverse Event|4|||
128841499|NCT02561195|463712491|FG001|Vaccination 1 to 3|Adverse Event|5|||
128841500|NCT02561195|463712492|FG002|Vaccination 1 to 3|Adverse Event|0|||
128841501|NCT02561195|463712493|FG003|Vaccination 1 to 3|Adverse Event|3|||
128841502|NCT02561195|463712494|FG004|Vaccination 1 to 3|Adverse Event|4|||
128841503|NCT02561195|463712495|FG005|Vaccination 1 to 3|Adverse Event|0|||
128841504|NCT02561195|463712496|FG006|Vaccination 1 to 3|Adverse Event|0|||
128841505|NCT02561195|463712497|FG007|Vaccination 1 to 3|Adverse Event|0|||
128841506|NCT02561195|463712498|FG008|Vaccination 1 to 3|Adverse Event|0|||
128841507|NCT02561195|463712499|FG009|Vaccination 1 to 3|Adverse Event|0|||
128841508|NCT02561195|463712500|FG010|Vaccination 1 to 3|Adverse Event|0|||
128841509|NCT02561195|463712501|FG011|Vaccination 1 to 3|Adverse Event|0|||
128841510|NCT02561195|463712502|FG012|Vaccination 1 to 3|Adverse Event|0|||
128841511|NCT02561195|463712503|FG013|Vaccination 1 to 3|Adverse Event|0|||
128841512|NCT02561195|463712490|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
128841513|NCT02561195|463712491|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
128841514|NCT02561195|463712492|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
128841515|NCT02561195|463712493|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
128841516|NCT02561195|463712494|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
128841517|NCT02561195|463712495|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
128841518|NCT02561195|463712496|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
128841519|NCT02561195|463712497|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
128841520|NCT02561195|463712498|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
128841521|NCT02561195|463712499|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
128841522|NCT02561195|463712500|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
128841523|NCT02561195|463712501|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
128841524|NCT02561195|463712502|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
128841525|NCT02561195|463712503|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
128841526|NCT02561195|463712490|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841527|NCT02561195|463712491|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
128841528|NCT02561195|463712492|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841529|NCT02561195|463712493|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
128841530|NCT02561195|463712494|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
128841531|NCT02561195|463712495|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
128841532|NCT02561195|463712496|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841533|NCT02561195|463712497|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841534|NCT02561195|463712498|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841535|NCT02561195|463712499|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841536|NCT02561195|463712500|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841537|NCT02561195|463712501|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841538|NCT02561195|463712502|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841539|NCT02561195|463712503|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
128841540|NCT02561195|463712490|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
128841541|NCT02561195|463712491|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
128841542|NCT02561195|463712492|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
128841543|NCT02561195|463712493|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
128841544|NCT02561195|463712494|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
128841545|NCT02561195|463712495|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
128841546|NCT02561195|463712496|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
128841547|NCT02561195|463712497|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
128841548|NCT02561195|463712498|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
128841549|NCT02561195|463712499|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
128841550|NCT02561195|463712500|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
128841551|NCT02561195|463712501|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
128841552|NCT02561195|463712502|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
128841553|NCT02561195|463712503|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
128841554|NCT02561195|463712490|FG000|Vaccination 1 to 3|Other|7|||
128841555|NCT02561195|463712491|FG001|Vaccination 1 to 3|Other|3|||
128841556|NCT02561195|463712492|FG002|Vaccination 1 to 3|Other|1|||
128841557|NCT02561195|463712493|FG003|Vaccination 1 to 3|Other|7|||
128841558|NCT02561195|463712494|FG004|Vaccination 1 to 3|Other|5|||
128841559|NCT02561195|463712495|FG005|Vaccination 1 to 3|Other|1|||
128841560|NCT02561195|463712496|FG006|Vaccination 1 to 3|Other|0|||
128841561|NCT02561195|463712497|FG007|Vaccination 1 to 3|Other|0|||
128841562|NCT02561195|463712498|FG008|Vaccination 1 to 3|Other|0|||
128841563|NCT02561195|463712499|FG009|Vaccination 1 to 3|Other|0|||
128841564|NCT02561195|463712500|FG010|Vaccination 1 to 3|Other|0|||
128841565|NCT02561195|463712501|FG011|Vaccination 1 to 3|Other|0|||
128841566|NCT02561195|463712502|FG012|Vaccination 1 to 3|Other|0|||
128841567|NCT02561195|463712503|FG013|Vaccination 1 to 3|Other|0|||
128841568|NCT02561195|463712490|FG000|Vaccination 1 to 3|Protocol Violation|1|||
128841569|NCT02561195|463712491|FG001|Vaccination 1 to 3|Protocol Violation|0|||
128841570|NCT02561195|463712492|FG002|Vaccination 1 to 3|Protocol Violation|1|||
128841571|NCT02561195|463712493|FG003|Vaccination 1 to 3|Protocol Violation|2|||
128841572|NCT02561195|463712494|FG004|Vaccination 1 to 3|Protocol Violation|5|||
128841573|NCT02561195|463712495|FG005|Vaccination 1 to 3|Protocol Violation|2|||
128841574|NCT02561195|463712496|FG006|Vaccination 1 to 3|Protocol Violation|0|||
128841575|NCT02561195|463712497|FG007|Vaccination 1 to 3|Protocol Violation|0|||
128841576|NCT02561195|463712498|FG008|Vaccination 1 to 3|Protocol Violation|0|||
128841577|NCT02561195|463712499|FG009|Vaccination 1 to 3|Protocol Violation|0|||
128841578|NCT02561195|463712500|FG010|Vaccination 1 to 3|Protocol Violation|0|||
128841579|NCT02561195|463712501|FG011|Vaccination 1 to 3|Protocol Violation|0|||
128841580|NCT02561195|463712502|FG012|Vaccination 1 to 3|Protocol Violation|0|||
128841581|NCT02561195|463712503|FG013|Vaccination 1 to 3|Protocol Violation|0|||
128841582|NCT02561195|463712490|FG000|Vaccination 1 to 3|Death|2|||
128841583|NCT02561195|463712491|FG001|Vaccination 1 to 3|Death|1|||
128841584|NCT02561195|463712492|FG002|Vaccination 1 to 3|Death|0|||
128841585|NCT02561195|463712493|FG003|Vaccination 1 to 3|Death|2|||
128841586|NCT02561195|463712494|FG004|Vaccination 1 to 3|Death|0|||
128841587|NCT02561195|463712495|FG005|Vaccination 1 to 3|Death|0|||
128841588|NCT02561195|463712496|FG006|Vaccination 1 to 3|Death|0|||
128841589|NCT02561195|463712497|FG007|Vaccination 1 to 3|Death|0|||
128841590|NCT02561195|463712498|FG008|Vaccination 1 to 3|Death|0|||
128841591|NCT02561195|463712499|FG009|Vaccination 1 to 3|Death|0|||
128841592|NCT02561195|463712500|FG010|Vaccination 1 to 3|Death|0|||
128841593|NCT02561195|463712501|FG011|Vaccination 1 to 3|Death|0|||
128841594|NCT02561195|463712502|FG012|Vaccination 1 to 3|Death|0|||
128841595|NCT02561195|463712503|FG013|Vaccination 1 to 3|Death|0|||
128841596|NCT02561195|463712490|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
128841597|NCT02561195|463712491|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
128841598|NCT02561195|463712492|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
128841599|NCT02561195|463712493|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
128841600|NCT02561195|463712494|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
128841601|NCT02561195|463712495|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841602|NCT02561195|463712496|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841603|NCT02561195|463712497|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841604|NCT02561195|463712498|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841605|NCT02561195|463712499|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841606|NCT02561195|463712500|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841607|NCT02561195|463712501|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841608|NCT02561195|463712502|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841609|NCT02561195|463712503|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
128841610|NCT02561195|463712490|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
128841611|NCT02561195|463712491|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
128841612|NCT02561195|463712492|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
128841613|NCT02561195|463712493|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
128841614|NCT02561195|463712494|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
128841615|NCT02561195|463712495|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
128841616|NCT02561195|463712496|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
128841617|NCT02561195|463712497|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
128841618|NCT02561195|463712498|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
128841619|NCT02561195|463712499|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
128841620|NCT02561195|463712500|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
128841621|NCT02561195|463712501|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
128841622|NCT02561195|463712502|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
128841623|NCT02561195|463712503|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
128841624|NCT02561195|463712490|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841625|NCT02561195|463712491|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841626|NCT02561195|463712492|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841627|NCT02561195|463712493|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841628|NCT02561195|463712494|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841629|NCT02561195|463712495|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841630|NCT02561195|463712496|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841631|NCT02561195|463712497|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841632|NCT02561195|463712498|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
128841633|NCT02561195|463712499|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
128841634|NCT02561195|463712500|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
128841635|NCT02561195|463712501|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
128841636|NCT02561195|463712502|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
128841637|NCT02561195|463712503|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
128841638|NCT02561195|463712490|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841639|NCT02561195|463712491|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841640|NCT02561195|463712492|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841641|NCT02561195|463712493|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841642|NCT02561195|463712494|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841643|NCT02561195|463712495|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841644|NCT02561195|463712496|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841645|NCT02561195|463712497|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841646|NCT02561195|463712498|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841647|NCT02561195|463712499|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841648|NCT02561195|463712500|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841649|NCT02561195|463712501|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841650|NCT02561195|463712502|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
128841651|NCT02561195|463712503|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
128841652|NCT02561195|463712490|FG000|Extension Stage (Vaccination 4)|Death|0|||
128841653|NCT02561195|463712491|FG001|Extension Stage (Vaccination 4)|Death|0|||
128841654|NCT02561195|463712492|FG002|Extension Stage (Vaccination 4)|Death|0|||
128841655|NCT02561195|463712493|FG003|Extension Stage (Vaccination 4)|Death|0|||
128841656|NCT02561195|463712494|FG004|Extension Stage (Vaccination 4)|Death|0|||
128841657|NCT02561195|463712495|FG005|Extension Stage (Vaccination 4)|Death|0|||
128841658|NCT02561195|463712496|FG006|Extension Stage (Vaccination 4)|Death|0|||
128841659|NCT02561195|463712497|FG007|Extension Stage (Vaccination 4)|Death|0|||
128841660|NCT02561195|463712498|FG008|Extension Stage (Vaccination 4)|Death|0|||
128841661|NCT02561195|463712499|FG009|Extension Stage (Vaccination 4)|Death|1|||
128841662|NCT02561195|463712500|FG010|Extension Stage (Vaccination 4)|Death|0|||
128841663|NCT02561195|463712501|FG011|Extension Stage (Vaccination 4)|Death|0|||
128841664|NCT02561195|463712502|FG012|Extension Stage (Vaccination 4)|Death|0|||
128841665|NCT02561195|463712503|FG013|Extension Stage (Vaccination 4)|Death|0|||
128841666|NCT02561195|463712490|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841667|NCT02561195|463712491|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841668|NCT02561195|463712492|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841669|NCT02561195|463712493|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841670|NCT02561195|463712494|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841671|NCT02561195|463712495|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841672|NCT02561195|463712496|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
128841673|NCT02561195|463712497|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
128841674|NCT02561195|463712498|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841675|NCT02561195|463712499|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
128841676|NCT02561195|463712500|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
128841677|NCT02561195|463712501|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
128841678|NCT02561195|463712502|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
128841679|NCT02561195|463712503|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
128841680|NCT02561195|463712490|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841681|NCT02561195|463712491|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841682|NCT02561195|463712492|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841683|NCT02561195|463712493|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841684|NCT02561195|463712494|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841685|NCT02561195|463712495|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841686|NCT02561195|463712496|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841687|NCT02561195|463712497|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841688|NCT02561195|463712498|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841689|NCT02561195|463712499|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841690|NCT02561195|463712500|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
128841691|NCT02561195|463712501|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
128841692|NCT02561195|463712502|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
128841693|NCT02561195|463712503|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
128841694|NCT02561195|463712490|FG000|Extension Stage (Vaccination 4)|Other|0|||
128841695|NCT02561195|463712491|FG001|Extension Stage (Vaccination 4)|Other|0|||
128841696|NCT02561195|463712492|FG002|Extension Stage (Vaccination 4)|Other|0|||
128841697|NCT02561195|463712493|FG003|Extension Stage (Vaccination 4)|Other|0|||
128841698|NCT02561195|463712494|FG004|Extension Stage (Vaccination 4)|Other|0|||
128841699|NCT02561195|463712495|FG005|Extension Stage (Vaccination 4)|Other|0|||
128841700|NCT02561195|463712496|FG006|Extension Stage (Vaccination 4)|Other|0|||
128841701|NCT02561195|463712497|FG007|Extension Stage (Vaccination 4)|Other|0|||
128841702|NCT02561195|463712498|FG008|Extension Stage (Vaccination 4)|Other|0|||
128841703|NCT02561195|463712499|FG009|Extension Stage (Vaccination 4)|Other|0|||
128841704|NCT02561195|463712500|FG010|Extension Stage (Vaccination 4)|Other|2|||
128841705|NCT02561195|463712501|FG011|Extension Stage (Vaccination 4)|Other|2|||
128841706|NCT02561195|463712502|FG012|Extension Stage (Vaccination 4)|Other|1|||
128841707|NCT02561195|463712503|FG013|Extension Stage (Vaccination 4)|Other|0|||
128841708|NCT02561195|463712490|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841709|NCT02561195|463712491|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841710|NCT02561195|463712492|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841711|NCT02561195|463712493|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841712|NCT02561195|463712494|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841713|NCT02561195|463712495|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841714|NCT02561195|463712496|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
128841715|NCT02561195|463712497|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841716|NCT02561195|463712498|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841717|NCT02561195|463712499|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841718|NCT02561195|463712500|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
128841719|NCT02561195|463712501|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
128841720|NCT02561195|463712502|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
128841721|NCT02561195|463712503|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
128841722|NCT03905512|463712504|FG000|Overall Study|Withdrawal by Subject|9|||
128841723|NCT03905512|463712505|FG001|Overall Study|Withdrawal by Subject|8|||
128841724|NCT03905512|463712504|FG000|Overall Study|Adverse Event|1|||
128841725|NCT03905512|463712505|FG001|Overall Study|Adverse Event|2|||
128841726|NCT03905512|463712504|FG000|Overall Study|Lost to Follow-up|4|||
128841727|NCT03905512|463712505|FG001|Overall Study|Lost to Follow-up|3|||
128841728|NCT03905512|463712504|FG000|Overall Study|Other than Specified|7|||
128841729|NCT03905512|463712505|FG001|Overall Study|Other than Specified|4|||
128841730|NCT00866619|463712506|FG000|Overall Study|Adverse Event|112|||
128841731|NCT00866619|463712507|FG001|Overall Study|Adverse Event|106|||
128841732|NCT00866619|463712508|FG002|Overall Study|Adverse Event|47|||
128841733|NCT00866619|463712509|FG003|Overall Study|Adverse Event|44|||
128841734|NCT00866619|463712506|FG000|Overall Study|Protocol Violation|2|||
128841735|NCT00866619|463712507|FG001|Overall Study|Protocol Violation|39|||
128841736|NCT00866619|463712508|FG002|Overall Study|Protocol Violation|2|||
128841737|NCT00866619|463712509|FG003|Overall Study|Protocol Violation|17|||
128841738|NCT00866619|463712506|FG000|Overall Study|Withdrawal by Subject|587|||
128841739|NCT00866619|463712507|FG001|Overall Study|Withdrawal by Subject|295|||
128841740|NCT00866619|463712508|FG002|Overall Study|Withdrawal by Subject|272|||
128841741|NCT00866619|463712509|FG003|Overall Study|Withdrawal by Subject|144|||
128841742|NCT00866619|463712506|FG000|Overall Study|Lost to Follow-up|1145|||
128841743|NCT00866619|463712507|FG001|Overall Study|Lost to Follow-up|830|||
128841744|NCT00866619|463712508|FG002|Overall Study|Lost to Follow-up|568|||
128841745|NCT00866619|463712509|FG003|Overall Study|Lost to Follow-up|425|||
128841746|NCT03560206|463712510|FG000|Overall Study|Lost to Follow-up|19|||
128841747|NCT03560206|463712511|FG001|Overall Study|Lost to Follow-up|11|||
128841748|NCT03560206|463712510|FG000|Overall Study|Withdrawal by Subject|2|||
128841749|NCT03560206|463712511|FG001|Overall Study|Withdrawal by Subject|4|||
128841750|NCT03560206|463712510|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
128841751|NCT03560206|463712511|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
128841752|NCT03560206|463712510|FG000|Overall Study|Busy schedule|14|||
128841753|NCT03560206|463712511|FG001|Overall Study|Busy schedule|2|||
128841754|NCT03560206|463712510|FG000|Overall Study|patients' new health condition such as cancer|10|||
128841755|NCT03560206|463712511|FG001|Overall Study|patients' new health condition such as cancer|1|||
128841756|NCT01199302|463712517|FG000|Overall Study|Adverse Event|1|||
128841757|NCT01199302|463712518|FG001|Overall Study|Adverse Event|1|||
128841758|NCT01199302|463712519|FG002|Overall Study|Adverse Event|2|||
128841759|NCT01199302|463712520|FG003|Overall Study|Adverse Event|0|||
128841760|NCT01199302|463712517|FG000|Overall Study|Withdrawal by Subject|2|||
128841761|NCT01199302|463712518|FG001|Overall Study|Withdrawal by Subject|2|||
128841762|NCT01199302|463712519|FG002|Overall Study|Withdrawal by Subject|3|||
128841763|NCT01199302|463712520|FG003|Overall Study|Withdrawal by Subject|0|||
128841764|NCT01199302|463712517|FG000|Overall Study|Disease Progression|3|||
128841765|NCT01199302|463712518|FG001|Overall Study|Disease Progression|4|||
128841766|NCT01199302|463712519|FG002|Overall Study|Disease Progression|4|||
128841767|NCT01199302|463712520|FG003|Overall Study|Disease Progression|2|||
128841768|NCT01199302|463712517|FG000|Overall Study|Study Termination|13|||
128841769|NCT01199302|463712518|FG001|Overall Study|Study Termination|8|||
128841770|NCT01199302|463712519|FG002|Overall Study|Study Termination|11|||
128841771|NCT01199302|463712520|FG003|Overall Study|Study Termination|9|||
128841772|NCT01199302|463712517|FG000|Overall Study|Lost to Follow-up|0|||
128841773|NCT01199302|463712518|FG001|Overall Study|Lost to Follow-up|1|||
128841774|NCT01199302|463712519|FG002|Overall Study|Lost to Follow-up|0|||
128841775|NCT01199302|463712520|FG003|Overall Study|Lost to Follow-up|0|||
128841776|NCT01199302|463712517|FG000|Overall Study|Other|1|||
128841777|NCT01199302|463712518|FG001|Overall Study|Other|0|||
128841778|NCT01199302|463712519|FG002|Overall Study|Other|0|||
128841779|NCT01199302|463712520|FG003|Overall Study|Other|0|||
128841780|NCT01634165|463712523|FG000|Period 2|Adverse Event|0|||
128841781|NCT01634165|463712524|FG001|Period 2|Adverse Event|1|||
128841782|NCT01634165|463712525|FG002|Period 2|Adverse Event|0|||
128841783|NCT01634165|463712526|FG003|Period 2|Adverse Event|0|||
128841784|NCT03820024|463712527|FG000|Overall Study|Physician Decision|1|||
128841785|NCT03820024|463712528|FG001|Overall Study|Physician Decision|2|||
128841786|NCT00946998|463713786|FG000|Overall Study|Exited prior to first outcome assessment|5|||
128841787|NCT00946998|463713787|FG001|Overall Study|Exited prior to first outcome assessment|3|||
128841788|NCT00507429|463713790|FG000|Treatment Phase|Disease Progression|12|||
128841789|NCT00507429|463713791|FG001|Treatment Phase|Disease Progression|5|||
128841790|NCT00507429|463713790|FG000|Treatment Phase|Adverse Event|12|||
128841791|NCT00507429|463713791|FG001|Treatment Phase|Adverse Event|5|||
128841792|NCT00507429|463713790|FG000|Treatment Phase|Withdrawal by Subject|3|||
128841793|NCT00507429|463713791|FG001|Treatment Phase|Withdrawal by Subject|3|||
128841794|NCT00507429|463713790|FG000|Treatment Phase|Physician Decision|4|||
128841795|NCT00507429|463713791|FG001|Treatment Phase|Physician Decision|2|||
128841796|NCT00507429|463713790|FG000|Treatment Phase|Other|6|||
128841797|NCT00507429|463713791|FG001|Treatment Phase|Other|3|||
128841798|NCT00507429|463713790|FG000|Maintenance Phase|Progressive Disease|14|||
128841799|NCT00507429|463713791|FG001|Maintenance Phase|Progressive Disease|0|||
128841800|NCT01807234|463713794|FG000|Overall Study|Lost to Follow-up|2|||
128841801|NCT01807234|463713795|FG001|Overall Study|Lost to Follow-up|5|||
128841802|NCT01807234|463713796|FG002|Overall Study|Lost to Follow-up|1|||
128841803|NCT01807234|463713797|FG003|Overall Study|Lost to Follow-up|1|||
128841804|NCT01807234|463713798|FG004|Overall Study|Lost to Follow-up|1|||
128841805|NCT01807234|463713799|FG005|Overall Study|Lost to Follow-up|2|||
128841806|NCT01807234|463713794|FG000|Overall Study|Withdrawal by Subject|3|||
128841807|NCT01807234|463713795|FG001|Overall Study|Withdrawal by Subject|1|||
128841808|NCT01807234|463713796|FG002|Overall Study|Withdrawal by Subject|1|||
128841809|NCT01807234|463713797|FG003|Overall Study|Withdrawal by Subject|1|||
128841810|NCT01807234|463713798|FG004|Overall Study|Withdrawal by Subject|2|||
128841811|NCT01807234|463713799|FG005|Overall Study|Withdrawal by Subject|1|||
128841812|NCT01807234|463713794|FG000|Overall Study|Lack of Efficacy|0|||
128841813|NCT01807234|463713795|FG001|Overall Study|Lack of Efficacy|0|||
128841814|NCT01807234|463713796|FG002|Overall Study|Lack of Efficacy|0|||
128841815|NCT01807234|463713797|FG003|Overall Study|Lack of Efficacy|0|||
128841816|NCT01807234|463713798|FG004|Overall Study|Lack of Efficacy|1|||
128841817|NCT01807234|463713799|FG005|Overall Study|Lack of Efficacy|1|||
128841818|NCT00538629|463713800|FG000|Overall Study|At subject's request|1|||
128841819|NCT00538629|463713800|FG000|Overall Study|Adverse Event|2|||
128841820|NCT00538629|463713800|FG000|Overall Study|Lack of Efficacy|12|||
128841821|NCT00538629|463713800|FG000|Overall Study|Lost to Follow-up|6|||
128841822|NCT00538629|463713800|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
128841823|NCT00555620|463713801|FG000|Overall Study|Death|0|||
128841824|NCT00555620|463713802|FG001|Overall Study|Death|1|||
128841825|NCT00555620|463713803|FG002|Overall Study|Death|0|||
128841826|NCT00555620|463713804|FG003|Overall Study|Death|0|||
128841827|NCT00555620|463713805|FG004|Overall Study|Death|0|||
128841828|NCT00555620|463713806|FG005|Overall Study|Death|1|||
128841829|NCT00555620|463713801|FG000|Overall Study|Study terminated by sponsor|0|||
128841830|NCT00555620|463713802|FG001|Overall Study|Study terminated by sponsor|0|||
128841831|NCT00555620|463713803|FG002|Overall Study|Study terminated by sponsor|1|||
128841832|NCT00555620|463713804|FG003|Overall Study|Study terminated by sponsor|0|||
128841833|NCT00555620|463713805|FG004|Overall Study|Study terminated by sponsor|0|||
128841834|NCT00555620|463713806|FG005|Overall Study|Study terminated by sponsor|0|||
128841835|NCT00555620|463713801|FG000|Overall Study|Adverse Event|0|||
128841836|NCT00555620|463713802|FG001|Overall Study|Adverse Event|0|||
128841837|NCT00555620|463713803|FG002|Overall Study|Adverse Event|1|||
128841838|NCT00555620|463713804|FG003|Overall Study|Adverse Event|5|||
128841839|NCT00555620|463713805|FG004|Overall Study|Adverse Event|0|||
128841840|NCT00555620|463713806|FG005|Overall Study|Adverse Event|1|||
128841841|NCT00555620|463713801|FG000|Overall Study|Objective progression or relapse|6|||
128841842|NCT00555620|463713802|FG001|Overall Study|Objective progression or relapse|5|||
128841843|NCT00555620|463713803|FG002|Overall Study|Objective progression or relapse|12|||
128841844|NCT00555620|463713804|FG003|Overall Study|Objective progression or relapse|17|||
128841845|NCT00555620|463713805|FG004|Overall Study|Objective progression or relapse|3|||
128841846|NCT00555620|463713806|FG005|Overall Study|Objective progression or relapse|16|||
128841847|NCT00555620|463713801|FG000|Overall Study|Participant refused treatment|0|||
128841848|NCT00555620|463713802|FG001|Overall Study|Participant refused treatment|1|||
128841849|NCT00555620|463713803|FG002|Overall Study|Participant refused treatment|1|||
128841850|NCT00555620|463713804|FG003|Overall Study|Participant refused treatment|0|||
128841851|NCT00555620|463713805|FG004|Overall Study|Participant refused treatment|0|||
128841852|NCT00555620|463713806|FG005|Overall Study|Participant refused treatment|1|||
128841853|NCT00555620|463713801|FG000|Overall Study|Other|0|||
128841854|NCT00555620|463713802|FG001|Overall Study|Other|0|||
128841855|NCT00555620|463713803|FG002|Overall Study|Other|0|||
128841856|NCT00555620|463713804|FG003|Overall Study|Other|1|||
128841857|NCT00555620|463713805|FG004|Overall Study|Other|0|||
128841858|NCT00555620|463713806|FG005|Overall Study|Other|3|||
128841859|NCT05203822|463713807|FG000|Overall Study|Adverse Event|1|||
128841860|NCT05203822|463713807|FG000|Overall Study|Withdrawal by Subject|1|||
128841861|NCT01345253|463713808|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
128841862|NCT01345253|463713809|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
128841863|NCT01345253|463713808|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
128841864|NCT01345253|463713809|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
128841865|NCT01345253|463713808|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
128841866|NCT01345253|463713809|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
128841867|NCT01345253|463713808|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
128841868|NCT01345253|463713809|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
128841869|NCT01345253|463713808|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
128841870|NCT01345253|463713809|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
128841871|NCT01345253|463713808|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
128841872|NCT01345253|463713809|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
128841873|NCT01345253|463713808|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
128841874|NCT01345253|463713809|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
128841875|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
128841876|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
128841877|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
128841878|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
128841879|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
128841880|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
128841881|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
128841882|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
128841883|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
128841884|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
128841885|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
128841886|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
128841887|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
128841888|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
128841889|NCT01345253|463713808|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
128841890|NCT01345253|463713809|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
128841891|NCT01767376|463713816|FG000|Overall Study|Lost to Follow-up|3|||
128841892|NCT01767376|463713817|FG001|Overall Study|Lost to Follow-up|2|||
128841893|NCT01767376|463713818|FG002|Overall Study|Lost to Follow-up|0|||
128841894|NCT01767376|463713816|FG000|Overall Study|Withdrawal by Subject|1|||
128841895|NCT01767376|463713817|FG001|Overall Study|Withdrawal by Subject|1|||
128841896|NCT01767376|463713818|FG002|Overall Study|Withdrawal by Subject|0|||
128841897|NCT04175834|463713820|FG000|Overall Study|Withdrawal by Subject|1|||
128841898|NCT04175834|463713821|FG001|Overall Study|Withdrawal by Subject|0|||
128841899|NCT00946088|463713822|FG000|Overall Study|Withdrawal by Subject|0|||
128841900|NCT00946088|463713823|FG001|Overall Study|Withdrawal by Subject|1|||
128841901|NCT04883541|463713824|FG000|Overall Study|Not attending regular yoga class|16|||
128841902|NCT04883541|463713825|FG001|Overall Study|Not attending regular yoga class|0|||
128841903|NCT04883541|463713824|FG000|Overall Study|Not attending the pregnancy school|0|||
128841904|NCT04883541|463713825|FG001|Overall Study|Not attending the pregnancy school|9|||
128841905|NCT00648895|463713833|FG000|Overall Study|Lack of Efficacy|0|||
128841906|NCT00648895|463713834|FG001|Overall Study|Lack of Efficacy|1|||
128841907|NCT02865083|463713835|FG000|Overall Study|Early Termination|3|||
128841908|NCT02865083|463713836|FG001|Overall Study|Early Termination|1|||
128841909|NCT00841321|463713837|FG000|Overall Study|Lost to Follow-up|1|||
128841910|NCT00841321|463713838|FG001|Overall Study|Lost to Follow-up|1|||
128841911|NCT00841321|463713837|FG000|Overall Study|Adverse Event|0|||
128841912|NCT00841321|463713838|FG001|Overall Study|Adverse Event|2|||
128841913|NCT01358175|463713839|FG000|Overall Study|Death|1|||
128841914|NCT01358175|463713840|FG001|Overall Study|Death|0|||
128841915|NCT01358175|463713841|FG002|Overall Study|Death|1|||
128841916|NCT01358175|463713839|FG000|Overall Study|Withdrawal by Subject|9|||
128841917|NCT01358175|463713840|FG001|Overall Study|Withdrawal by Subject|5|||
128841918|NCT01358175|463713841|FG002|Overall Study|Withdrawal by Subject|10|||
128841919|NCT01358175|463713839|FG000|Overall Study|Technical issues|0|||
128841920|NCT01358175|463713840|FG001|Overall Study|Technical issues|1|||
128841921|NCT01358175|463713841|FG002|Overall Study|Technical issues|0|||
128841922|NCT01358175|463713839|FG000|Overall Study|Pregnancy|0|||
128841923|NCT01358175|463713840|FG001|Overall Study|Pregnancy|1|||
128841924|NCT01358175|463713841|FG002|Overall Study|Pregnancy|0|||
128841925|NCT01358175|463713839|FG000|Overall Study|Physician Decision|1|||
128841926|NCT01358175|463713840|FG001|Overall Study|Physician Decision|0|||
128841927|NCT01358175|463713841|FG002|Overall Study|Physician Decision|0|||
128841928|NCT01358175|463713839|FG000|Overall Study|Non Compliance with Study Treatment|0|||
128841929|NCT01358175|463713840|FG001|Overall Study|Non Compliance with Study Treatment|1|||
128841930|NCT01358175|463713841|FG002|Overall Study|Non Compliance with Study Treatment|1|||
128841931|NCT01358175|463713839|FG000|Overall Study|Lost to Follow-up|1|||
128841932|NCT01358175|463713840|FG001|Overall Study|Lost to Follow-up|1|||
128841933|NCT01358175|463713841|FG002|Overall Study|Lost to Follow-up|3|||
128841934|NCT01358175|463713839|FG000|Overall Study|Lack of Efficacy|3|||
128841935|NCT01358175|463713840|FG001|Overall Study|Lack of Efficacy|8|||
128841936|NCT01358175|463713841|FG002|Overall Study|Lack of Efficacy|6|||
128841937|NCT01358175|463713839|FG000|Overall Study|Adverse Event|6|||
128841938|NCT01358175|463713840|FG001|Overall Study|Adverse Event|11|||
128841939|NCT01358175|463713841|FG002|Overall Study|Adverse Event|11|||
128841940|NCT01525875|463713842|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
128841941|NCT01525875|463713843|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
128841942|NCT01525875|463713842|FG000|Open-label Period|Lost to Follow-up|0|||
128841943|NCT01525875|463713843|FG001|Open-label Period|Lost to Follow-up|2|||
128841944|NCT02379078|463713844|FG000|Overall Study|Lost to Follow-up|33|||
128841945|NCT02379078|463713845|FG001|Overall Study|Lost to Follow-up|30|||
128841946|NCT02379078|463713844|FG000|Overall Study|Withdrawal by Subject|6|||
128841947|NCT02379078|463713845|FG001|Overall Study|Withdrawal by Subject|5|||
128841948|NCT04908488|463713846|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
128841949|NCT04908488|463713847|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
128841950|NCT04908488|463713846|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
128841951|NCT04908488|463713847|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
128841952|NCT00821093|463713850|FG000|Overall Study|Adverse Event|20|||
128841953|NCT00821093|463713851|FG001|Overall Study|Adverse Event|12|||
128841954|NCT00821093|463713850|FG000|Overall Study|Withdrawal by Subject|9|||
128841955|NCT00821093|463713851|FG001|Overall Study|Withdrawal by Subject|13|||
128841956|NCT00821093|463713850|FG000|Overall Study|Lost to Follow-up|9|||
128841957|NCT00821093|463713851|FG001|Overall Study|Lost to Follow-up|3|||
128841958|NCT00821093|463713850|FG000|Overall Study|Protocol deviation|3|||
128841959|NCT00821093|463713851|FG001|Overall Study|Protocol deviation|6|||
128841960|NCT00821093|463713850|FG000|Overall Study|Abnormal laboratory value(s)|2|||
128841961|NCT00821093|463713851|FG001|Overall Study|Abnormal laboratory value(s)|0|||
128841962|NCT00821093|463713850|FG000|Overall Study|Lack of Efficacy|2|||
128841963|NCT00821093|463713851|FG001|Overall Study|Lack of Efficacy|2|||
128841964|NCT00821093|463713850|FG000|Overall Study|Death|2|||
128841965|NCT00821093|463713851|FG001|Overall Study|Death|1|||
128841966|NCT00821093|463713850|FG000|Overall Study|Abnormal test procedure result(s)|1|||
128841967|NCT00821093|463713851|FG001|Overall Study|Abnormal test procedure result(s)|1|||
128841968|NCT00821093|463713850|FG000|Overall Study|Administrative problems|1|||
128841969|NCT00821093|463713851|FG001|Overall Study|Administrative problems|2|||
128841970|NCT01107912|463713852|FG000|Period 1|Adverse Event|0|||
128841971|NCT01107912|463713853|FG001|Period 1|Adverse Event|0|||
128841972|NCT01107912|463713854|FG002|Period 1|Adverse Event|0|||
128841973|NCT01107912|463713855|FG003|Period 1|Adverse Event|0|||
128841974|NCT01107912|463713856|FG004|Period 1|Adverse Event|2|||
128841975|NCT01107912|463713857|FG005|Period 1|Adverse Event|0|||
128841976|NCT01107912|463713852|FG000|Period 1|Physician Decision|0|||
128841977|NCT01107912|463713853|FG001|Period 1|Physician Decision|0|||
128841978|NCT01107912|463713854|FG002|Period 1|Physician Decision|0|||
128841979|NCT01107912|463713855|FG003|Period 1|Physician Decision|0|||
128841980|NCT01107912|463713856|FG004|Period 1|Physician Decision|1|||
128841981|NCT01107912|463713857|FG005|Period 1|Physician Decision|0|||
128841982|NCT01107912|463713852|FG000|Period 1|Withdrawal by Subject|1|||
128841983|NCT01107912|463713853|FG001|Period 1|Withdrawal by Subject|0|||
128841984|NCT01107912|463713854|FG002|Period 1|Withdrawal by Subject|0|||
128841985|NCT01107912|463713855|FG003|Period 1|Withdrawal by Subject|0|||
128841986|NCT01107912|463713856|FG004|Period 1|Withdrawal by Subject|0|||
128841987|NCT01107912|463713857|FG005|Period 1|Withdrawal by Subject|0|||
128841988|NCT01107912|463713852|FG000|Period 2|Physician Decision|0|||
128841989|NCT01107912|463713853|FG001|Period 2|Physician Decision|0|||
128841990|NCT01107912|463713854|FG002|Period 2|Physician Decision|1|||
128841991|NCT01107912|463713855|FG003|Period 2|Physician Decision|0|||
128841992|NCT01107912|463713856|FG004|Period 2|Physician Decision|0|||
128841993|NCT01107912|463713857|FG005|Period 2|Physician Decision|0|||
128841994|NCT01107912|463713852|FG000|Period 3|Adverse Event|0|||
128841995|NCT01107912|463713853|FG001|Period 3|Adverse Event|1|||
128841996|NCT01107912|463713854|FG002|Period 3|Adverse Event|1|||
128841997|NCT01107912|463713855|FG003|Period 3|Adverse Event|0|||
128841998|NCT01107912|463713856|FG004|Period 3|Adverse Event|0|||
128841999|NCT01107912|463713857|FG005|Period 3|Adverse Event|0|||
128842000|NCT01107912|463713852|FG000|Period 3|Withdrawal by Subject|0|||
128842001|NCT01107912|463713853|FG001|Period 3|Withdrawal by Subject|0|||
128842002|NCT01107912|463713854|FG002|Period 3|Withdrawal by Subject|0|||
128842003|NCT01107912|463713855|FG003|Period 3|Withdrawal by Subject|1|||
128842004|NCT01107912|463713856|FG004|Period 3|Withdrawal by Subject|0|||
128842005|NCT01107912|463713857|FG005|Period 3|Withdrawal by Subject|0|||
128842006|NCT01124916|463713861|FG000|Overall Study|Lost to Follow-up|3|||
128842007|NCT01124916|463713862|FG001|Overall Study|Lost to Follow-up|2|||
128842008|NCT01901302|463713863|FG000|Overall Study|Adverse Event|2|||
128842009|NCT01901302|463713864|FG001|Overall Study|Adverse Event|1|||
128842010|NCT01901302|463713863|FG000|Overall Study|Lack of Efficacy|0|||
128842011|NCT01901302|463713864|FG001|Overall Study|Lack of Efficacy|2|||
128842012|NCT01901302|463713863|FG000|Overall Study|Study Terminated by Sponsor|23|||
128842013|NCT01901302|463713864|FG001|Overall Study|Study Terminated by Sponsor|20|||
128842014|NCT01901302|463713863|FG000|Overall Study|Withdrawal by Subject|2|||
128842015|NCT01901302|463713864|FG001|Overall Study|Withdrawal by Subject|0|||
128842016|NCT01721109|463713867|FG000|Overall Study|Lack of Efficacy|1|||
128842017|NCT01721109|463713867|FG000|Overall Study|Non- Compliance with Study Drug|3|||
128842018|NCT01721109|463713867|FG000|Overall Study|Withdrew Consent|1|||
128842019|NCT01721109|463713867|FG000|Overall Study|Lost to Follow-up|2|||
128842020|NCT01536795|463713868|FG000|Overall Study|Lost to Follow-up|0|||
128842021|NCT01536795|463713869|FG001|Overall Study|Lost to Follow-up|2|||
128842022|NCT01536795|463713868|FG000|Overall Study|Lack of Efficacy|1|||
128842023|NCT01536795|463713869|FG001|Overall Study|Lack of Efficacy|0|||
128842024|NCT01699178|463713871|FG000|Overall Study|Adverse Event|1|||
128842025|NCT01699178|463713872|FG001|Overall Study|Adverse Event|5|||
128842026|NCT01699178|463713871|FG000|Overall Study|Lost to Follow-up|1|||
128842027|NCT01699178|463713872|FG001|Overall Study|Lost to Follow-up|6|||
128842028|NCT01699178|463713871|FG000|Overall Study|Non-compliance with Study Drug|3|||
128842029|NCT01699178|463713872|FG001|Overall Study|Non-compliance with Study Drug|1|||
128842030|NCT01699178|463713871|FG000|Overall Study|Physician Decision|1|||
128842031|NCT01699178|463713872|FG001|Overall Study|Physician Decision|0|||
128842032|NCT01699178|463713871|FG000|Overall Study|Withdrawal by Subject|4|||
128842033|NCT01699178|463713872|FG001|Overall Study|Withdrawal by Subject|12|||
128842034|NCT01699178|463713871|FG000|Overall Study|Hematocrit >54%|1|||
128842035|NCT01699178|463713872|FG001|Overall Study|Hematocrit >54%|1|||
128842036|NCT01699178|463713871|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
128842037|NCT01699178|463713872|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
128842038|NCT01699178|463713871|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
128842039|NCT01699178|463713872|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
128842040|NCT00321555|463713875|FG000|Overall Study|Developed antibodies|1|||
128842041|NCT00321555|463713875|FG000|Overall Study|Switched to alternative treatment|3|||
128842042|NCT00321555|463713875|FG000|Overall Study|Physician Decision|1|||
128842043|NCT00321555|463713875|FG000|Overall Study|Disease progression on study|1|||
128842044|NCT02066389|463713878|FG000|Overall Study|Adverse Event|1|||
128842045|NCT02066389|463713879|FG001|Overall Study|Adverse Event|1|||
128842046|NCT02066389|463713880|FG002|Overall Study|Adverse Event|1|||
128842047|NCT02066389|463713881|FG003|Overall Study|Adverse Event|1|||
128842048|NCT02066389|463713882|FG004|Overall Study|Adverse Event|5|||
128842049|NCT02066389|463713883|FG005|Overall Study|Adverse Event|1|||
128842050|NCT02066389|463713878|FG000|Overall Study|Withdrawal by Subject|4|||
128842051|NCT02066389|463713879|FG001|Overall Study|Withdrawal by Subject|0|||
128842052|NCT02066389|463713880|FG002|Overall Study|Withdrawal by Subject|5|||
128842053|NCT02066389|463713881|FG003|Overall Study|Withdrawal by Subject|1|||
128842054|NCT02066389|463713882|FG004|Overall Study|Withdrawal by Subject|1|||
128842055|NCT02066389|463713883|FG005|Overall Study|Withdrawal by Subject|2|||
128842056|NCT02066389|463713878|FG000|Overall Study|Lost to Follow-up|0|||
128842057|NCT02066389|463713879|FG001|Overall Study|Lost to Follow-up|0|||
128842058|NCT02066389|463713880|FG002|Overall Study|Lost to Follow-up|0|||
128842059|NCT02066389|463713881|FG003|Overall Study|Lost to Follow-up|1|||
128842060|NCT02066389|463713882|FG004|Overall Study|Lost to Follow-up|1|||
128842061|NCT02066389|463713883|FG005|Overall Study|Lost to Follow-up|1|||
128842062|NCT02066389|463713878|FG000|Overall Study|Randomized in Error|0|||
128842063|NCT02066389|463713879|FG001|Overall Study|Randomized in Error|0|||
128842064|NCT02066389|463713880|FG002|Overall Study|Randomized in Error|0|||
128842065|NCT02066389|463713881|FG003|Overall Study|Randomized in Error|0|||
128842066|NCT02066389|463713882|FG004|Overall Study|Randomized in Error|0|||
128842067|NCT02066389|463713883|FG005|Overall Study|Randomized in Error|1|||
128842068|NCT01755598|463713886|FG000|Overall Study|Other|109|||
128842069|NCT01755598|463713887|FG001|Overall Study|Other|109|||
128842070|NCT01755598|463713886|FG000|Overall Study|Lost to Follow-up|32|||
128842071|NCT01755598|463713887|FG001|Overall Study|Lost to Follow-up|43|||
128842072|NCT01755598|463713886|FG000|Overall Study|Migrated/moved from study area|76|||
128842073|NCT01755598|463713887|FG001|Overall Study|Migrated/moved from study area|65|||
128842074|NCT01755598|463713886|FG000|Overall Study|Withdrawal by Subject|22|||
128842075|NCT01755598|463713887|FG001|Overall Study|Withdrawal by Subject|31|||
128842076|NCT01755598|463713886|FG000|Overall Study|Protocol Violation|7|||
128842077|NCT01755598|463713887|FG001|Overall Study|Protocol Violation|7|||
128842078|NCT01755598|463713886|FG000|Overall Study|Adverse Event|19|||
128842079|NCT01755598|463713887|FG001|Overall Study|Adverse Event|28|||
128842080|NCT02924051|463713888|FG000|Overall Study|Withdrawal by Subject|1|||
128842081|NCT02924051|463713889|FG001|Overall Study|Withdrawal by Subject|9|||
128842082|NCT03547167|463713892|FG000|Overall Study|Withdrawal by Subject|34|||
128842083|NCT03547167|463713893|FG001|Overall Study|Withdrawal by Subject|12|||
128842084|NCT03547167|463713892|FG000|Overall Study|Screen Failure|0|||
128842085|NCT03547167|463713893|FG001|Overall Study|Screen Failure|1|||
128842086|NCT03547167|463713892|FG000|Overall Study|Lost to Follow-up|59|||
128842087|NCT03547167|463713893|FG001|Overall Study|Lost to Follow-up|15|||
128842088|NCT03547167|463713892|FG000|Overall Study|Death|4|||
128842089|NCT03547167|463713893|FG001|Overall Study|Death|2|||
128842090|NCT00645411|463713894|FG000|Overall Study|Adverse Event|0|||
128842091|NCT00645411|463713895|FG001|Overall Study|Adverse Event|0|||
128842092|NCT00645411|463713896|FG002|Overall Study|Adverse Event|0|||
128842093|NCT00645411|463713897|FG003|Overall Study|Adverse Event|2|||
128842094|NCT00645411|463713894|FG000|Overall Study|Withdrawal by Subject|2|||
128842095|NCT00645411|463713895|FG001|Overall Study|Withdrawal by Subject|1|||
128842096|NCT00645411|463713896|FG002|Overall Study|Withdrawal by Subject|19|||
128842097|NCT00645411|463713897|FG003|Overall Study|Withdrawal by Subject|21|||
128842098|NCT00645411|463713894|FG000|Overall Study|Lost to Follow-up|10|||
128842099|NCT00645411|463713895|FG001|Overall Study|Lost to Follow-up|5|||
128842100|NCT00645411|463713896|FG002|Overall Study|Lost to Follow-up|124|||
128842101|NCT00645411|463713897|FG003|Overall Study|Lost to Follow-up|75|||
128842102|NCT00645411|463713894|FG000|Overall Study|Protocol Violation|1|||
128842103|NCT00645411|463713895|FG001|Overall Study|Protocol Violation|0|||
128842104|NCT00645411|463713896|FG002|Overall Study|Protocol Violation|1|||
128842105|NCT00645411|463713897|FG003|Overall Study|Protocol Violation|0|||
128842106|NCT00645411|463713894|FG000|Overall Study|Inappropriate enrollment|0|||
128842107|NCT00645411|463713895|FG001|Overall Study|Inappropriate enrollment|0|||
128842108|NCT00645411|463713896|FG002|Overall Study|Inappropriate enrollment|4|||
128842109|NCT00645411|463713897|FG003|Overall Study|Inappropriate enrollment|1|||
128842110|NCT00645411|463713894|FG000|Overall Study|Unable to classify|0|||
128842111|NCT00645411|463713895|FG001|Overall Study|Unable to classify|0|||
128842112|NCT00645411|463713896|FG002|Overall Study|Unable to classify|3|||
128842113|NCT00645411|463713897|FG003|Overall Study|Unable to classify|4|||
128842114|NCT03987074|463713899|FG000|Overall Study|Withdrew Consent|1|||
128842115|NCT03987074|463713900|FG001|Overall Study|Withdrew Consent|1|||
128842116|NCT03987074|463713901|FG002|Overall Study|Withdrew Consent|0|||
128842117|NCT03987074|463713902|FG003|Overall Study|Withdrew Consent|2|||
128842118|NCT03987074|463713903|FG004|Overall Study|Withdrew Consent|1|||
128842119|NCT03987074|463713899|FG000|Overall Study|Adverse Event|2|||
128842120|NCT03987074|463713900|FG001|Overall Study|Adverse Event|1|||
128842121|NCT03987074|463713901|FG002|Overall Study|Adverse Event|0|||
128842122|NCT03987074|463713902|FG003|Overall Study|Adverse Event|0|||
128842123|NCT03987074|463713903|FG004|Overall Study|Adverse Event|1|||
128842124|NCT03987074|463713899|FG000|Overall Study|Lost to Follow-up|0|||
128842125|NCT03987074|463713900|FG001|Overall Study|Lost to Follow-up|0|||
128842126|NCT03987074|463713901|FG002|Overall Study|Lost to Follow-up|1|||
128842127|NCT03987074|463713902|FG003|Overall Study|Lost to Follow-up|1|||
128842128|NCT03987074|463713903|FG004|Overall Study|Lost to Follow-up|0|||
128842129|NCT03987074|463713899|FG000|Overall Study|Investigator's Discretion|0|||
128842130|NCT03987074|463713900|FG001|Overall Study|Investigator's Discretion|0|||
128842131|NCT03987074|463713901|FG002|Overall Study|Investigator's Discretion|0|||
128842132|NCT03987074|463713902|FG003|Overall Study|Investigator's Discretion|1|||
128842133|NCT03987074|463713903|FG004|Overall Study|Investigator's Discretion|0|||
128842134|NCT01334606|463713908|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
128842135|NCT02674399|463713909|FG000|Overall Study|Lost to Follow-up|2|||
128842136|NCT02674399|463713910|FG001|Overall Study|Lost to Follow-up|0|||
128842137|NCT02138838|463713911|FG000|Overall Study|Study Closure|7|||
128842138|NCT02138838|463713912|FG001|Overall Study|Study Closure|6|||
128842139|NCT02138838|463713911|FG000|Overall Study|Withdrawal by Subject|1|||
128842140|NCT02138838|463713912|FG001|Overall Study|Withdrawal by Subject|5|||
128842141|NCT02993926|463713915|FG000|Enantone Treatment Phase|Adverse Event|1|||
128842142|NCT02993926|463713916|FG001|Enantone Treatment Phase|Adverse Event|0|||
128842143|NCT02993926|463713917|FG002|Enantone Treatment Phase|Adverse Event|0|||
128842144|NCT02993926|463713915|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
128842145|NCT02993926|463713916|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
128842146|NCT02993926|463713917|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
128842147|NCT02993926|463713915|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
128842148|NCT02993926|463713916|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
128842149|NCT02993926|463713917|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
128842150|NCT02993926|463713915|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
128842151|NCT02993926|463713916|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
128842152|NCT02993926|463713917|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
128842153|NCT01084772|463713919|FG000|Baseline|Withdrawal by Subject|7|||
128842154|NCT01084772|463713920|FG001|Baseline|Withdrawal by Subject|6|||
128842155|NCT01084772|463713919|FG000|3 Months|Death|1|||
128842156|NCT01084772|463713920|FG001|3 Months|Death|0|||
128842157|NCT01084772|463713919|FG000|3 Months|Study Termination|2|||
128842158|NCT01084772|463713920|FG001|3 Months|Study Termination|2|||
128842159|NCT01084772|463713919|FG000|1 Year|Withdrawal by Subject|0|||
128842160|NCT01084772|463713920|FG001|1 Year|Withdrawal by Subject|1|||
128842161|NCT01084772|463713919|FG000|1 Year|Lost to Follow-up|3|||
128842162|NCT01084772|463713920|FG001|1 Year|Lost to Follow-up|0|||
128842163|NCT01084772|463713919|FG000|1 Year|Study Termination|0|||
128842164|NCT01084772|463713920|FG001|1 Year|Study Termination|7|||
128842165|NCT01084772|463713919|FG000|2 Years|Withdrawal by Subject|1|||
128842166|NCT01084772|463713920|FG001|2 Years|Withdrawal by Subject|0|||
128842167|NCT01084772|463713919|FG000|2 Years|Lost to Follow-up|5|||
128842168|NCT01084772|463713920|FG001|2 Years|Lost to Follow-up|2|||
128842169|NCT01084772|463713919|FG000|2 Years|Study Termination|3|||
128842170|NCT01084772|463713920|FG001|2 Years|Study Termination|2|||
128842171|NCT01867307|463713921|FG000|Overall Study|Protocol Violation|2|||
128842172|NCT01867307|463713922|FG001|Overall Study|Protocol Violation|0|||
128842173|NCT01867307|463713921|FG000|Overall Study|Other Adverse Event|1|||
128842174|NCT01867307|463713922|FG001|Overall Study|Other Adverse Event|3|||
128842175|NCT00518206|463713923|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
128842176|NCT00518206|463713924|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
128842177|NCT00518206|463713923|FG000|Overall Study|Withdrawal by Subject|2|||
128842178|NCT00518206|463713924|FG001|Overall Study|Withdrawal by Subject|0|||
128842179|NCT00518206|463713923|FG000|Overall Study|Drug Supply Issue|1|||
128842180|NCT00518206|463713924|FG001|Overall Study|Drug Supply Issue|0|||
128842181|NCT00518206|463713923|FG000|Overall Study|Reason Unknown|1|||
128842182|NCT00518206|463713924|FG001|Overall Study|Reason Unknown|0|||
128842183|NCT00518206|463713923|FG000|Overall Study|Completion Status Unknown|1|||
128842184|NCT00518206|463713924|FG001|Overall Study|Completion Status Unknown|0|||
128842185|NCT00760877|463715424|FG000|Overall Study|Protocol Violation|1|||
128842186|NCT00760877|463715425|FG001|Overall Study|Protocol Violation|0|||
128842187|NCT00760877|463715424|FG000|Overall Study|Non-compliance with protocol treatment|2|||
128842188|NCT00760877|463715425|FG001|Overall Study|Non-compliance with protocol treatment|1|||
128842189|NCT00760877|463715424|FG000|Overall Study|Pregnancy|1|||
128842190|NCT00760877|463715425|FG001|Overall Study|Pregnancy|4|||
128842191|NCT00760877|463715424|FG000|Overall Study|Death|2|||
128842192|NCT00760877|463715425|FG001|Overall Study|Death|1|||
128842193|NCT00760877|463715424|FG000|Overall Study|Withdrawal by Subject|7|||
128842194|NCT00760877|463715425|FG001|Overall Study|Withdrawal by Subject|3|||
128842195|NCT00760877|463715424|FG000|Overall Study|Adverse Event|19|||
128842196|NCT00760877|463715425|FG001|Overall Study|Adverse Event|12|||
128842197|NCT00760877|463715424|FG000|Overall Study|Participant diagnosed with AML|0|||
128842198|NCT00760877|463715425|FG001|Overall Study|Participant diagnosed with AML|1|||
128842199|NCT00760877|463715424|FG000|Overall Study|Participant not eligible to cross-over|0|||
128842200|NCT00760877|463715425|FG001|Overall Study|Participant not eligible to cross-over|1|||
128842201|NCT00760877|463715424|FG000|Overall Study|Physician Decision|1|||
128842202|NCT00760877|463715425|FG001|Overall Study|Physician Decision|2|||
128842203|NCT00760877|463715424|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
128842204|NCT00760877|463715425|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
128842205|NCT00760877|463715424|FG000|Overall Study|Treatment failure|1|||
128842206|NCT00760877|463715425|FG001|Overall Study|Treatment failure|0|||
128842207|NCT05379400|463715428|FG000|Overall Study|Lost to Follow-up|1|||
128842208|NCT05379400|463715429|FG001|Overall Study|Lost to Follow-up|1|||
128842209|NCT03020914|463715433|FG000|Overall Study|Surgery Cancelled|1|||
128842210|NCT03020914|463715434|FG001|Overall Study|Surgery Cancelled|0|||
128842211|NCT00409006|463715439|FG000|Overall Study|Death|15|||
128842212|NCT00409006|463715440|FG001|Overall Study|Death|6|||
128842213|NCT00409006|463715439|FG000|Overall Study|Lost to Follow-up|1|||
128842214|NCT00409006|463715440|FG001|Overall Study|Lost to Follow-up|2|||
128842215|NCT00409006|463715439|FG000|Overall Study|Withdrawal by Subject|3|||
128842216|NCT00409006|463715440|FG001|Overall Study|Withdrawal by Subject|2|||
128842217|NCT00409006|463715439|FG000|Overall Study|Physician Decision|1|||
128842218|NCT00409006|463715440|FG001|Overall Study|Physician Decision|2|||
128842219|NCT01877720|463715449|FG000|Overall Study|Adverse Event|1|||
128842220|NCT01877720|463715450|FG001|Overall Study|Adverse Event|0|||
128842221|NCT00447499|463715451|FG000|Overall Study|Adverse Event|1|||
128842222|NCT00447499|463715451|FG000|Overall Study|Patient Decision|4|||
128842223|NCT00447499|463715451|FG000|Overall Study|Sponsor Decision|1|||
128842224|NCT00447499|463715451|FG000|Overall Study|Physician Decision|1|||
128842225|NCT02068352|463715452|FG000|Overall Study|Lost to Follow-up|0|||
128842226|NCT02068352|463715453|FG001|Overall Study|Lost to Follow-up|2|||
128842227|NCT02068352|463715454|FG002|Overall Study|Lost to Follow-up|0|||
128842228|NCT02068352|463715452|FG000|Overall Study|Adverse Event|4|||
128842229|NCT02068352|463715453|FG001|Overall Study|Adverse Event|2|||
128842230|NCT02068352|463715454|FG002|Overall Study|Adverse Event|7|||
128842231|NCT02068352|463715452|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
128842232|NCT02068352|463715453|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
128842233|NCT02068352|463715454|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
128842234|NCT02068352|463715452|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
128842235|NCT02068352|463715453|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
128842236|NCT02068352|463715454|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
128842237|NCT02068352|463715452|FG000|Overall Study|Protocol Deviation|0|||
128842238|NCT02068352|463715453|FG001|Overall Study|Protocol Deviation|0|||
128842239|NCT02068352|463715454|FG002|Overall Study|Protocol Deviation|1|||
128842240|NCT03960437|463715455|FG000|Overall Study|Removed by PI|4|||
128842241|NCT03960437|463715455|FG000|Overall Study|Lost to Follow-up|2|||
128842242|NCT03960437|463715455|FG000|Overall Study|Withdrawal by Subject|1|||
128842243|NCT03960437|463715455|FG000|Overall Study|Death|2|||
128842244|NCT00473512|463715458|FG000|Period 1 (Phase 1)|Adverse Event|0|||
128842245|NCT00473512|463715459|FG001|Period 1 (Phase 1)|Adverse Event|0|||
128842246|NCT00473512|463715460|FG002|Period 1 (Phase 1)|Adverse Event|0|||
128842247|NCT00473512|463715461|FG003|Period 1 (Phase 1)|Adverse Event|5|||
128842248|NCT00473512|463715462|FG004|Period 1 (Phase 1)|Adverse Event|0|||
128842249|NCT00473512|463715458|FG000|Period 1 (Phase 1)|Death|0|||
128842250|NCT00473512|463715459|FG001|Period 1 (Phase 1)|Death|0|||
128842251|NCT00473512|463715460|FG002|Period 1 (Phase 1)|Death|0|||
128842252|NCT00473512|463715461|FG003|Period 1 (Phase 1)|Death|1|||
128842253|NCT00473512|463715462|FG004|Period 1 (Phase 1)|Death|0|||
128842254|NCT00473512|463715458|FG000|Period 1 (Phase 1)|Disease Progression|1|||
128842255|NCT00473512|463715459|FG001|Period 1 (Phase 1)|Disease Progression|1|||
128842256|NCT00473512|463715460|FG002|Period 1 (Phase 1)|Disease Progression|0|||
128842257|NCT00473512|463715461|FG003|Period 1 (Phase 1)|Disease Progression|10|||
128842258|NCT00473512|463715462|FG004|Period 1 (Phase 1)|Disease Progression|1|||
128842259|NCT00473512|463715458|FG000|Period 1 (Phase 1)|Other|0|||
128842260|NCT00473512|463715459|FG001|Period 1 (Phase 1)|Other|0|||
128842261|NCT00473512|463715460|FG002|Period 1 (Phase 1)|Other|0|||
128842262|NCT00473512|463715461|FG003|Period 1 (Phase 1)|Other|1|||
128842263|NCT00473512|463715462|FG004|Period 1 (Phase 1)|Other|0|||
128842264|NCT00473512|463715458|FG000|Period 2 (Phase 2)|Adverse Event|0|||
128842265|NCT00473512|463715459|FG001|Period 2 (Phase 2)|Adverse Event|0|||
128842266|NCT00473512|463715460|FG002|Period 2 (Phase 2)|Adverse Event|0|||
128842267|NCT00473512|463715461|FG003|Period 2 (Phase 2)|Adverse Event|1|||
128842268|NCT00473512|463715462|FG004|Period 2 (Phase 2)|Adverse Event|0|||
128842269|NCT00473512|463715458|FG000|Period 2 (Phase 2)|Death|0|||
128842270|NCT00473512|463715459|FG001|Period 2 (Phase 2)|Death|0|||
128842271|NCT00473512|463715460|FG002|Period 2 (Phase 2)|Death|0|||
128842272|NCT00473512|463715461|FG003|Period 2 (Phase 2)|Death|1|||
128842273|NCT00473512|463715462|FG004|Period 2 (Phase 2)|Death|1|||
128842274|NCT00473512|463715458|FG000|Period 2 (Phase 2)|Disease Progression|0|||
128842275|NCT00473512|463715459|FG001|Period 2 (Phase 2)|Disease Progression|2|||
128842276|NCT00473512|463715460|FG002|Period 2 (Phase 2)|Disease Progression|2|||
128842277|NCT00473512|463715461|FG003|Period 2 (Phase 2)|Disease Progression|17|||
128842278|NCT00473512|463715462|FG004|Period 2 (Phase 2)|Disease Progression|1|||
128842279|NCT00473512|463715458|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
128842280|NCT00473512|463715459|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
128842281|NCT00473512|463715460|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
128842282|NCT00473512|463715461|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
128842283|NCT00473512|463715462|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
128842284|NCT00473512|463715458|FG000|Period 2 (Phase 2)|Other|1|||
128842285|NCT00473512|463715459|FG001|Period 2 (Phase 2)|Other|0|||
128842286|NCT00473512|463715460|FG002|Period 2 (Phase 2)|Other|0|||
128842287|NCT00473512|463715461|FG003|Period 2 (Phase 2)|Other|3|||
128842288|NCT00473512|463715462|FG004|Period 2 (Phase 2)|Other|0|||
128842289|NCT00267956|463715463|FG000|Controlled Period|Adverse Event|4|||
128842290|NCT00267956|463715464|FG001|Controlled Period|Adverse Event|1|||
128842291|NCT00267956|463715465|FG002|Controlled Period|Adverse Event|0|||
128842292|NCT00267956|463715466|FG003|Controlled Period|Adverse Event|0|||
128842293|NCT00267956|463715463|FG000|Controlled Period|Lack of Efficacy|4|||
128842294|NCT00267956|463715464|FG001|Controlled Period|Lack of Efficacy|2|||
128842295|NCT00267956|463715465|FG002|Controlled Period|Lack of Efficacy|0|||
128842296|NCT00267956|463715466|FG003|Controlled Period|Lack of Efficacy|0|||
128842297|NCT00267956|463715463|FG000|Controlled Period|Lost to Follow-up|2|||
128842298|NCT00267956|463715464|FG001|Controlled Period|Lost to Follow-up|0|||
128842299|NCT00267956|463715465|FG002|Controlled Period|Lost to Follow-up|0|||
128842300|NCT00267956|463715466|FG003|Controlled Period|Lost to Follow-up|0|||
128842301|NCT00267956|463715463|FG000|Controlled Period|Withdrew consent|3|||
128842302|NCT00267956|463715464|FG001|Controlled Period|Withdrew consent|1|||
128842303|NCT00267956|463715465|FG002|Controlled Period|Withdrew consent|0|||
128842304|NCT00267956|463715466|FG003|Controlled Period|Withdrew consent|0|||
128842305|NCT00267956|463715463|FG000|After Controlled Period|Adverse Event|0|||
128842306|NCT00267956|463715464|FG001|After Controlled Period|Adverse Event|0|||
128842307|NCT00267956|463715465|FG002|After Controlled Period|Adverse Event|2|||
128842308|NCT00267956|463715466|FG003|After Controlled Period|Adverse Event|1|||
128842309|NCT00267956|463715463|FG000|After Controlled Period|Lack of Efficacy|0|||
128842310|NCT00267956|463715464|FG001|After Controlled Period|Lack of Efficacy|0|||
128842311|NCT00267956|463715465|FG002|After Controlled Period|Lack of Efficacy|1|||
128842312|NCT00267956|463715466|FG003|After Controlled Period|Lack of Efficacy|1|||
128842313|NCT00267956|463715463|FG000|After Controlled Period|Lost to Follow-up|0|||
128842314|NCT00267956|463715464|FG001|After Controlled Period|Lost to Follow-up|0|||
128842315|NCT00267956|463715465|FG002|After Controlled Period|Lost to Follow-up|1|||
128842316|NCT00267956|463715466|FG003|After Controlled Period|Lost to Follow-up|0|||
128842317|NCT00267956|463715463|FG000|After Controlled Period|Withdrew consent|0|||
128842318|NCT00267956|463715464|FG001|After Controlled Period|Withdrew consent|0|||
128842319|NCT00267956|463715465|FG002|After Controlled Period|Withdrew consent|1|||
128842320|NCT00267956|463715466|FG003|After Controlled Period|Withdrew consent|0|||
128842321|NCT01263223|463715467|FG000|Period 2|Withdrawal by Subject|0|||
128842322|NCT01263223|463715468|FG001|Period 2|Withdrawal by Subject|1|||
128842323|NCT01263223|463715467|FG000|7-day Follow-up|Withdrawal by Subject|0|||
128842324|NCT01263223|463715468|FG001|7-day Follow-up|Withdrawal by Subject|1|||
128842325|NCT01263223|463715467|FG000|7-day Follow-up|Lost to Follow-up|1|||
128842326|NCT01263223|463715468|FG001|7-day Follow-up|Lost to Follow-up|0|||
128842327|NCT01322347|463715469|FG000|Overall Study|Adverse Event|7|||
128842328|NCT01322347|463715470|FG001|Overall Study|Adverse Event|2|||
128842329|NCT01322347|463715469|FG000|Overall Study|Death|5|||
128842330|NCT01322347|463715470|FG001|Overall Study|Death|3|||
128842331|NCT01322347|463715469|FG000|Overall Study|Physician Decision|2|||
128842332|NCT01322347|463715470|FG001|Overall Study|Physician Decision|1|||
128842333|NCT01322347|463715469|FG000|Overall Study|Protocol Violation|5|||
128842334|NCT01322347|463715470|FG001|Overall Study|Protocol Violation|2|||
128842335|NCT01322347|463715469|FG000|Overall Study|Withdrawal by Subject|1|||
128842336|NCT01322347|463715470|FG001|Overall Study|Withdrawal by Subject|4|||
128842337|NCT01322347|463715469|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
128842338|NCT01322347|463715470|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
128842339|NCT01322347|463715469|FG000|Overall Study|blood transfusion|5|||
128842340|NCT01322347|463715470|FG001|Overall Study|blood transfusion|5|||
128842341|NCT01322347|463715469|FG000|Overall Study|sponsor decision|1|||
128842342|NCT01322347|463715470|FG001|Overall Study|sponsor decision|3|||
128842343|NCT01322347|463715469|FG000|Overall Study|ineligible|6|||
128842344|NCT01322347|463715470|FG001|Overall Study|ineligible|3|||
128842345|NCT01322347|463715469|FG000|Overall Study|kidney transplant|3|||
128842346|NCT01322347|463715470|FG001|Overall Study|kidney transplant|1|||
128842347|NCT01322347|463715469|FG000|Overall Study|study drug withheld > 12 wks|0|||
128842348|NCT01322347|463715470|FG001|Overall Study|study drug withheld > 12 wks|1|||
128842349|NCT01322347|463715469|FG000|Overall Study|moved/changed dialysis|2|||
128842350|NCT01322347|463715470|FG001|Overall Study|moved/changed dialysis|4|||
128842351|NCT01369147|463715472|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
128842352|NCT01369147|463715473|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
128842353|NCT01369147|463715474|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
128842354|NCT03184519|463715475|FG000|Overall Study|Lost to Follow-up|6|||
128842355|NCT03184519|463715475|FG000|Overall Study|Physician Decision|21|||
128842356|NCT04239911|463715476|FG000|Overall Study|Lost to Follow-up|2|||
128842357|NCT04239911|463715477|FG001|Overall Study|Lost to Follow-up|1|||
128842358|NCT00584909|463715483|FG000|Overall Study|Adverse Event|4|||
128842359|NCT03345407|463715484|FG000|Overall Study|Withdrawal by Subject|11|||
128842360|NCT03345407|463715485|FG001|Overall Study|Withdrawal by Subject|1|||
128842361|NCT03345407|463715486|FG002|Overall Study|Withdrawal by Subject|5|||
128842362|NCT03345407|463715487|FG003|Overall Study|Withdrawal by Subject|6|||
128842363|NCT03345407|463715488|FG004|Overall Study|Withdrawal by Subject|3|||
128842364|NCT03345407|463715489|FG005|Overall Study|Withdrawal by Subject|6|||
128842365|NCT03345407|463715490|FG006|Overall Study|Withdrawal by Subject|16|||
128842366|NCT03345407|463715484|FG000|Overall Study|Physician Decision|3|||
128842367|NCT03345407|463715485|FG001|Overall Study|Physician Decision|1|||
128842368|NCT03345407|463715486|FG002|Overall Study|Physician Decision|0|||
128842369|NCT03345407|463715487|FG003|Overall Study|Physician Decision|0|||
128842370|NCT03345407|463715488|FG004|Overall Study|Physician Decision|1|||
128842371|NCT03345407|463715489|FG005|Overall Study|Physician Decision|2|||
128842372|NCT03345407|463715490|FG006|Overall Study|Physician Decision|3|||
128842373|NCT03345407|463715484|FG000|Overall Study|Lost to Follow-up|2|||
128842374|NCT03345407|463715485|FG001|Overall Study|Lost to Follow-up|0|||
128842375|NCT03345407|463715486|FG002|Overall Study|Lost to Follow-up|1|||
128842376|NCT03345407|463715487|FG003|Overall Study|Lost to Follow-up|0|||
128842377|NCT03345407|463715488|FG004|Overall Study|Lost to Follow-up|1|||
128842378|NCT03345407|463715489|FG005|Overall Study|Lost to Follow-up|2|||
128842379|NCT03345407|463715490|FG006|Overall Study|Lost to Follow-up|3|||
128842380|NCT03345407|463715484|FG000|Overall Study|Protocol-defined stopping criteria|9|||
128842381|NCT03345407|463715485|FG001|Overall Study|Protocol-defined stopping criteria|0|||
128842382|NCT03345407|463715486|FG002|Overall Study|Protocol-defined stopping criteria|0|||
128842383|NCT03345407|463715487|FG003|Overall Study|Protocol-defined stopping criteria|0|||
128842384|NCT03345407|463715488|FG004|Overall Study|Protocol-defined stopping criteria|2|||
128842385|NCT03345407|463715489|FG005|Overall Study|Protocol-defined stopping criteria|1|||
128842386|NCT03345407|463715490|FG006|Overall Study|Protocol-defined stopping criteria|1|||
128842387|NCT03345407|463715484|FG000|Overall Study|Protocol Violation|2|||
128842388|NCT03345407|463715485|FG001|Overall Study|Protocol Violation|0|||
128842389|NCT03345407|463715486|FG002|Overall Study|Protocol Violation|0|||
128842390|NCT03345407|463715487|FG003|Overall Study|Protocol Violation|0|||
128842391|NCT03345407|463715488|FG004|Overall Study|Protocol Violation|1|||
128842392|NCT03345407|463715489|FG005|Overall Study|Protocol Violation|0|||
128842393|NCT03345407|463715490|FG006|Overall Study|Protocol Violation|3|||
128842394|NCT03345407|463715484|FG000|Overall Study|Lack of Efficacy|1|||
128842395|NCT03345407|463715485|FG001|Overall Study|Lack of Efficacy|1|||
128842396|NCT03345407|463715486|FG002|Overall Study|Lack of Efficacy|1|||
128842397|NCT03345407|463715487|FG003|Overall Study|Lack of Efficacy|1|||
128842398|NCT03345407|463715488|FG004|Overall Study|Lack of Efficacy|1|||
128842399|NCT03345407|463715489|FG005|Overall Study|Lack of Efficacy|0|||
128842400|NCT03345407|463715490|FG006|Overall Study|Lack of Efficacy|3|||
128842401|NCT03345407|463715484|FG000|Overall Study|Adverse Event|4|||
128842402|NCT03345407|463715485|FG001|Overall Study|Adverse Event|0|||
128842403|NCT03345407|463715486|FG002|Overall Study|Adverse Event|5|||
128842404|NCT03345407|463715487|FG003|Overall Study|Adverse Event|4|||
128842405|NCT03345407|463715488|FG004|Overall Study|Adverse Event|6|||
128842406|NCT03345407|463715489|FG005|Overall Study|Adverse Event|5|||
128842407|NCT03345407|463715490|FG006|Overall Study|Adverse Event|16|||
128842408|NCT02092909|463715493|FG000|Overall Study|Adverse Event|0|||
128842409|NCT02092909|463715494|FG001|Overall Study|Adverse Event|0|||
128842410|NCT02092909|463715495|FG002|Overall Study|Adverse Event|4|||
128842411|NCT02092909|463715496|FG003|Overall Study|Adverse Event|2|||
128842412|NCT02092909|463715493|FG000|Overall Study|Lack of Efficacy|0|||
128842413|NCT02092909|463715494|FG001|Overall Study|Lack of Efficacy|2|||
128842414|NCT02092909|463715495|FG002|Overall Study|Lack of Efficacy|1|||
128842415|NCT02092909|463715496|FG003|Overall Study|Lack of Efficacy|0|||
128842416|NCT02092909|463715493|FG000|Overall Study|Withdrawal by Subject|0|||
128842417|NCT02092909|463715494|FG001|Overall Study|Withdrawal by Subject|0|||
128842418|NCT02092909|463715495|FG002|Overall Study|Withdrawal by Subject|2|||
128842419|NCT02092909|463715496|FG003|Overall Study|Withdrawal by Subject|1|||
128842420|NCT02092909|463715493|FG000|Overall Study|Study terminated by Sponsor|0|||
128842421|NCT02092909|463715494|FG001|Overall Study|Study terminated by Sponsor|0|||
128842422|NCT02092909|463715495|FG002|Overall Study|Study terminated by Sponsor|0|||
128842423|NCT02092909|463715496|FG003|Overall Study|Study terminated by Sponsor|2|||
128842424|NCT02092909|463715493|FG000|Overall Study|Miscellaneous|1|||
128842425|NCT02092909|463715494|FG001|Overall Study|Miscellaneous|1|||
128842426|NCT02092909|463715495|FG002|Overall Study|Miscellaneous|2|||
128842427|NCT02092909|463715496|FG003|Overall Study|Miscellaneous|1|||
128842428|NCT04626128|463715497|FG000|Overall Study|Withdrawal by Subject|0|||
128842429|NCT04626128|463715498|FG001|Overall Study|Withdrawal by Subject|1|||
128842430|NCT04626128|463715499|FG002|Overall Study|Withdrawal by Subject|0|||
128842431|NCT04626128|463715500|FG003|Overall Study|Withdrawal by Subject|0|||
128842432|NCT01182285|463715501|FG000|First Intervention Week 1-10|Disease progression|1|||
128842433|NCT01182285|463715502|FG001|First Intervention Week 1-10|Disease progression|0|||
128842434|NCT01182285|463715503|FG002|First Intervention Week 1-10|Disease progression|0|||
128842435|NCT01182285|463715501|FG000|First Intervention Week 1-10|Adverse Event|1|||
128842436|NCT01182285|463715502|FG001|First Intervention Week 1-10|Adverse Event|0|||
128842437|NCT01182285|463715503|FG002|First Intervention Week 1-10|Adverse Event|0|||
128842438|NCT01182285|463715501|FG000|First Intervention Week 1-10|Non-compliance|1|||
128842439|NCT01182285|463715502|FG001|First Intervention Week 1-10|Non-compliance|0|||
128842440|NCT01182285|463715503|FG002|First Intervention Week 1-10|Non-compliance|0|||
128842441|NCT01182285|463715501|FG000|Third Intervention Week 11-52|Disease Progression|0|||
128842442|NCT01182285|463715502|FG001|Third Intervention Week 11-52|Disease Progression|0|||
128842443|NCT01182285|463715503|FG002|Third Intervention Week 11-52|Disease Progression|6|||
128842444|NCT01182285|463715501|FG000|Third Intervention Week 11-52|Other|0|||
128842445|NCT01182285|463715502|FG001|Third Intervention Week 11-52|Other|0|||
128842446|NCT01182285|463715503|FG002|Third Intervention Week 11-52|Other|2|||
128842447|NCT00379210|463715506|FG000|Overall Study|Withdrawal by Subject|10|||
128842448|NCT00379210|463715507|FG001|Overall Study|Withdrawal by Subject|7|||
128842449|NCT03209492|463715508|FG000|Overall Study|Case Report Forms Uncollected|5|||
128842450|NCT01762345|463715509|FG000|Overall Study|Adverse Event|5|||
128842451|NCT01762345|463715509|FG000|Overall Study|Protocol Violation|2|||
128842452|NCT05072795|463715510|FG000|Overall Study|Lost to Follow-up|5|||
128842453|NCT00901459|463715519|FG000|Overall Study|Withdrawal by Subject|6|||
128842454|NCT04765046|463715520|FG000|Overall Study|Screen Failure|2|||
128842455|NCT04765046|463715520|FG000|Overall Study|Withdrawal by Subject|4|||
128842456|NCT04765046|463715520|FG000|Overall Study|Physician Decision|4|||
128842457|NCT04765046|463715520|FG000|Overall Study|Surgery Cancelled|8|||
128842458|NCT00753896|463715525|FG000|Overall Study|Adverse Event|4|||
128842459|NCT00753896|463715525|FG000|Overall Study|Death|1|||
128842460|NCT00753896|463715525|FG000|Overall Study|Lost to Follow-up|2|||
128842461|NCT00753896|463715525|FG000|Overall Study|Protocol Violation|1|||
128842462|NCT00753896|463715525|FG000|Overall Study|Withdrawal by Subject|4|||
128842463|NCT00753896|463715525|FG000|Overall Study|Entry Criteria Not Met|4|||
128842464|NCT00848198|463715527|FG000|Overall Study|Incomplete Case Report Forms|15|||
128842465|NCT03708744|463715531|FG000|Overall Study|Withdrawal by Subject|0|||
128842466|NCT03708744|463715532|FG001|Overall Study|Withdrawal by Subject|0|||
128842467|NCT03708744|463715533|FG002|Overall Study|Withdrawal by Subject|1|||
128842468|NCT03708744|463715534|FG003|Overall Study|Withdrawal by Subject|0|||
128842469|NCT01029925|463715535|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
128842470|NCT01029925|463715535|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
128842471|NCT01029925|463715535|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
128842472|NCT03529942|463715536|FG000|Overall Study|Withdrawal by Subject|13|||
128842473|NCT03529942|463715536|FG000|Overall Study|Physician Decision|1|||
128842474|NCT03529942|463715536|FG000|Overall Study|Lost to Follow-up|7|||
128842475|NCT03529942|463715536|FG000|Overall Study|Needle inserted but no drug administered|1|||
128842476|NCT03529942|463715536|FG000|Overall Study|Personal reasons|1|||
128842477|NCT04930263|463715537|FG000|Overall Study|Withdrawal by Subject|3|||
128842478|NCT04930263|463715538|FG001|Overall Study|Withdrawal by Subject|5|||
128842479|NCT01989156|463715541|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
128842480|NCT01989156|463715542|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
128842481|NCT01989156|463715543|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
128842482|NCT01989156|463715541|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
128842483|NCT01989156|463715542|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
128842484|NCT01989156|463715543|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
128842485|NCT01989156|463715541|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
128842486|NCT01989156|463715542|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
128842487|NCT01989156|463715543|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
128842488|NCT01989156|463715541|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
128842489|NCT01989156|463715542|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
128842490|NCT01989156|463715543|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
128842491|NCT01989156|463715541|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
128842492|NCT01989156|463715542|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
128842493|NCT01989156|463715543|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
128842494|NCT01989156|463715541|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
128842495|NCT01989156|463715542|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
128842496|NCT01989156|463715543|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
128842497|NCT01989156|463715541|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
128842498|NCT01989156|463715542|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
128842499|NCT01989156|463715543|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
128842500|NCT01989156|463715541|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
128842501|NCT01989156|463715542|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
128842502|NCT01989156|463715543|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
128842503|NCT00850993|463715546|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
128842504|NCT00850993|463715547|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
128842505|NCT00850993|463715548|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
128842506|NCT00850993|463715549|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
128842507|NCT03839355|463715550|FG000|Overall Study|Withdrawal by Subject|1|||
128842508|NCT03839355|463715551|FG001|Overall Study|Withdrawal by Subject|0|||
128842509|NCT02009865|463715566|FG000|Overall Study|Adverse Event|0|||
128842510|NCT02009865|463715567|FG001|Overall Study|Adverse Event|2|||
128842511|NCT02009865|463715566|FG000|Overall Study|Protocol Violation|0|||
128842512|NCT02009865|463715567|FG001|Overall Study|Protocol Violation|2|||
128842513|NCT02009865|463715566|FG000|Overall Study|Withdrawal by Subject|1|||
128842514|NCT02009865|463715567|FG001|Overall Study|Withdrawal by Subject|1|||
128842515|NCT01760876|463715568|FG000|Overall Study|Non-cardiac death (head injury)|1|||
128842516|NCT01760876|463715568|FG000|Overall Study|Carcinoma of prostate|1|||
128842517|NCT01760876|463715568|FG000|Overall Study|Impaired renal function|1|||
128842518|NCT01760876|463715568|FG000|Overall Study|Major depression|1|||
128842519|NCT01760876|463715568|FG000|Overall Study|Very poor baseline OCT quality|2|||
128842520|NCT01517282|463715569|FG000|Overall Study|Consent withdrawn|0|||
128842521|NCT01517282|463715570|FG001|Overall Study|Consent withdrawn|1|||
128842522|NCT01517282|463715571|FG002|Overall Study|Consent withdrawn|1|||
128842523|NCT01517282|463715572|FG003|Overall Study|Consent withdrawn|1|||
128842524|NCT01517282|463715569|FG000|Overall Study|Physician Decision|1|||
128842525|NCT01517282|463715570|FG001|Overall Study|Physician Decision|0|||
128842526|NCT01517282|463715571|FG002|Overall Study|Physician Decision|0|||
128842527|NCT01517282|463715572|FG003|Overall Study|Physician Decision|0|||
128842528|NCT00525915|463715573|FG000|Overall Study|Non-Compliance|0|||
128842529|NCT00525915|463715574|FG001|Overall Study|Non-Compliance|1|||
128842530|NCT00525915|463715573|FG000|Overall Study|Disease Progression|5|||
128842531|NCT00525915|463715574|FG001|Overall Study|Disease Progression|6|||
128842532|NCT00525915|463715573|FG000|Overall Study|Withdrawal by Subject|1|||
128842533|NCT00525915|463715574|FG001|Overall Study|Withdrawal by Subject|0|||
128842534|NCT00525915|463715573|FG000|Overall Study|Refused Surgery|1|||
128842535|NCT00525915|463715574|FG001|Overall Study|Refused Surgery|2|||
128842536|NCT00525915|463715573|FG000|Overall Study|Unrelated illness|1|||
128842537|NCT00525915|463715574|FG001|Overall Study|Unrelated illness|0|||
128842538|NCT02332889|463715578|FG000|Overall Study|Physician Decision|1|||
128842539|NCT00711555|463716689|FG000|Overall Study|Adverse Event|3|||
128842540|NCT04914897|463716693|FG000|Overall Study|Withdrawal by Subject|3|||
128842541|NCT04914897|463716694|FG001|Overall Study|Withdrawal by Subject|1|||
128842542|NCT04914897|463716695|FG002|Overall Study|Withdrawal by Subject|1|||
128842543|NCT04914897|463716696|FG003|Overall Study|Withdrawal by Subject|1|||
128842544|NCT04914897|463716693|FG000|Overall Study|Poor compliance to protocol|0|||
128842545|NCT04914897|463716694|FG001|Overall Study|Poor compliance to protocol|0|||
128842546|NCT04914897|463716695|FG002|Overall Study|Poor compliance to protocol|1|||
128842547|NCT04914897|463716696|FG003|Overall Study|Poor compliance to protocol|0|||
128842548|NCT04914897|463716693|FG000|Overall Study|Progressive disease|5|||
128842549|NCT04914897|463716694|FG001|Overall Study|Progressive disease|14|||
128842550|NCT04914897|463716695|FG002|Overall Study|Progressive disease|30|||
128842551|NCT04914897|463716696|FG003|Overall Study|Progressive disease|21|||
128842552|NCT04914897|463716693|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
128842553|NCT04914897|463716694|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
128842554|NCT04914897|463716695|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
128842555|NCT04914897|463716696|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
128842556|NCT04914897|463716693|FG000|Overall Study|Other|1|||
128842557|NCT04914897|463716694|FG001|Overall Study|Other|0|||
128842558|NCT04914897|463716695|FG002|Overall Study|Other|0|||
128842559|NCT04914897|463716696|FG003|Overall Study|Other|1|||
128842560|NCT05356130|463716697|FG000|Overall Study|Withdrawal by Subject|0|||
128842561|NCT05356130|463716698|FG001|Overall Study|Withdrawal by Subject|0|||
128842562|NCT05356130|463716699|FG002|Overall Study|Withdrawal by Subject|3|||
128842563|NCT03141177|463716700|FG000|Overall Study|Death|62|||
128842564|NCT03141177|463716701|FG001|Overall Study|Death|13|||
128842565|NCT03141177|463716702|FG002|Overall Study|Death|84|||
128842566|NCT03141177|463716700|FG000|Overall Study|Participant withdrew consent|9|||
128842567|NCT03141177|463716701|FG001|Overall Study|Participant withdrew consent|2|||
128842568|NCT03141177|463716702|FG002|Overall Study|Participant withdrew consent|13|||
128842569|NCT03141177|463716700|FG000|Overall Study|Not reported|1|||
128842570|NCT03141177|463716701|FG001|Overall Study|Not reported|0|||
128842571|NCT03141177|463716702|FG002|Overall Study|Not reported|1|||
128842572|NCT03141177|463716700|FG000|Overall Study|Lost to Follow-up|2|||
128842573|NCT03141177|463716701|FG001|Overall Study|Lost to Follow-up|1|||
128842574|NCT03141177|463716702|FG002|Overall Study|Lost to Follow-up|1|||
128842575|NCT03141177|463716700|FG000|Overall Study|Other reasons|4|||
128842576|NCT03141177|463716701|FG001|Overall Study|Other reasons|0|||
128842577|NCT03141177|463716702|FG002|Overall Study|Other reasons|11|||
128842578|NCT03141177|463716700|FG000|Overall Study|Participants did not start treatment period|3|||
128842579|NCT03141177|463716701|FG001|Overall Study|Participants did not start treatment period|0|||
128842580|NCT03141177|463716702|FG002|Overall Study|Participants did not start treatment period|8|||
128842581|NCT00228813|463716703|FG000|Overall Study|Death|4|||
128842582|NCT00668746|463716704|FG000|Overall Study|Lost to Follow-up|2|||
128842583|NCT00668746|463716705|FG001|Overall Study|Lost to Follow-up|1|||
128842584|NCT02109172|463716706|FG000|Overall Study|Withdrawal by Subject|1|||
128842585|NCT02109172|463716707|FG001|Overall Study|Withdrawal by Subject|0|||
128842586|NCT02109172|463716708|FG002|Overall Study|Withdrawal by Subject|0|||
128842587|NCT02109172|463716709|FG003|Overall Study|Withdrawal by Subject|1|||
128842588|NCT02109172|463716710|FG004|Overall Study|Withdrawal by Subject|0|||
128842589|NCT02109172|463716711|FG005|Overall Study|Withdrawal by Subject|0|||
128842590|NCT02109172|463716706|FG000|Overall Study|Adverse Event|0|||
128842591|NCT02109172|463716707|FG001|Overall Study|Adverse Event|0|||
128842592|NCT02109172|463716708|FG002|Overall Study|Adverse Event|1|||
128842593|NCT02109172|463716709|FG003|Overall Study|Adverse Event|0|||
128842594|NCT02109172|463716710|FG004|Overall Study|Adverse Event|0|||
128842595|NCT02109172|463716711|FG005|Overall Study|Adverse Event|1|||
128842596|NCT02109172|463716706|FG000|Overall Study|Death|0|||
128842597|NCT02109172|463716707|FG001|Overall Study|Death|0|||
128842598|NCT02109172|463716708|FG002|Overall Study|Death|0|||
128842599|NCT02109172|463716709|FG003|Overall Study|Death|0|||
128842600|NCT02109172|463716710|FG004|Overall Study|Death|1|||
128842601|NCT02109172|463716711|FG005|Overall Study|Death|0|||
128842602|NCT02011568|463716712|FG000|Overall Study|Withdrawal by Subject|8|||
128842603|NCT02011568|463716713|FG001|Overall Study|Withdrawal by Subject|10|||
128842604|NCT02011568|463716712|FG000|Overall Study|Physician Decision|1|||
128842605|NCT02011568|463716713|FG001|Overall Study|Physician Decision|3|||
128842606|NCT03696342|463716717|FG000|Overall Study|Lost to Follow-up|1|||
128842607|NCT03696342|463716718|FG001|Overall Study|Lost to Follow-up|0|||
128842608|NCT05361304|463716724|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
128842609|NCT05361304|463716725|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
128842610|NCT05361304|463716724|FG000|Overall Study|COVID-19 Related|1|||
128842611|NCT05361304|463716725|FG001|Overall Study|COVID-19 Related|2|||
128842612|NCT05361304|463716724|FG000|Overall Study|Withdrawal by Subject|1|||
128842613|NCT05361304|463716725|FG001|Overall Study|Withdrawal by Subject|0|||
128842614|NCT01816165|463716726|FG000|Overall Study|Adverse Event|1|||
128842615|NCT01816165|463716727|FG001|Overall Study|Adverse Event|0|||
128842616|NCT01816165|463716728|FG002|Overall Study|Adverse Event|0|||
128842617|NCT01816165|463716729|FG003|Overall Study|Adverse Event|0|||
128842618|NCT02409732|463716730|FG000|Overall Study|Withdrawal by Subject|4|||
128842619|NCT02409732|463716730|FG000|Overall Study|Lost to Follow-up|2|||
128842620|NCT00376259|463716731|FG000|Overall Study|Sponsor request - study termination|21|||
128842621|NCT00376259|463716732|FG001|Overall Study|Sponsor request - study termination|21|||
128842622|NCT00376259|463716731|FG000|Overall Study|Patient request|1|||
128842623|NCT00376259|463716732|FG001|Overall Study|Patient request|0|||
128842624|NCT02246647|463716734|FG000|Overall Study|Withdrawal by Subject|1|||
128842625|NCT02246647|463716735|FG001|Overall Study|Withdrawal by Subject|1|||
128842626|NCT01012999|463716736|FG000|Overall Study|Protocol Violation|1|||
128842627|NCT03557307|463716737|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
128842628|NCT03557307|463716737|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
128842629|NCT03557307|463716737|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
128842630|NCT03557307|463716737|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
128842631|NCT03557307|463716737|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
128842632|NCT03557307|463716737|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
128842633|NCT03557307|463716737|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
128842634|NCT03557307|463716737|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
128842635|NCT03557307|463716737|FG000|Period 2: Maintenance Phase|Death|3|||
128842636|NCT03557307|463716737|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
128842637|NCT03557307|463716737|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
128842638|NCT03557307|463716737|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
128842639|NCT03557307|463716737|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
128842640|NCT03557307|463716737|FG000|Period 2: Maintenance Phase|other|3|||
128842641|NCT02069366|463716738|FG000|Overall Study|Lost to Follow-up|0|||
128842642|NCT02069366|463716739|FG001|Overall Study|Lost to Follow-up|0|||
128842643|NCT02069366|463716740|FG002|Overall Study|Lost to Follow-up|1|||
128842644|NCT02069366|463716741|FG003|Overall Study|Lost to Follow-up|0|||
128842645|NCT02069366|463716742|FG004|Overall Study|Lost to Follow-up|0|||
128842646|NCT02069366|463716743|FG005|Overall Study|Lost to Follow-up|2|||
128842647|NCT02069366|463716738|FG000|Overall Study|Protocol Violation|0|||
128842648|NCT02069366|463716739|FG001|Overall Study|Protocol Violation|0|||
128842649|NCT02069366|463716740|FG002|Overall Study|Protocol Violation|1|||
128842650|NCT02069366|463716741|FG003|Overall Study|Protocol Violation|0|||
128842651|NCT02069366|463716742|FG004|Overall Study|Protocol Violation|0|||
128842652|NCT02069366|463716743|FG005|Overall Study|Protocol Violation|0|||
128842653|NCT02069366|463716738|FG000|Overall Study|Withdrawal by Subject|1|||
128842654|NCT02069366|463716739|FG001|Overall Study|Withdrawal by Subject|0|||
128842655|NCT02069366|463716740|FG002|Overall Study|Withdrawal by Subject|1|||
128842656|NCT02069366|463716741|FG003|Overall Study|Withdrawal by Subject|2|||
128842657|NCT02069366|463716742|FG004|Overall Study|Withdrawal by Subject|0|||
128842658|NCT02069366|463716743|FG005|Overall Study|Withdrawal by Subject|0|||
128842659|NCT02256553|463716744|FG000|Period I|Adverse Event|5|||
128842660|NCT02256553|463716744|FG000|Period I|Protocol Violation|1|||
128842661|NCT02256553|463716744|FG000|Period II|Adverse Event|1|||
128842662|NCT02256553|463716744|FG000|Period II|Subject Moved|1|||
128842663|NCT02256553|463716744|FG000|Period III|Adverse Event|3|||
128842664|NCT03436797|463716745|FG000|Main Study|Withdrawal by Subject|2|||
128842665|NCT03436797|463716745|FG000|Main Study|Adverse Event|4|||
128842666|NCT03436797|463716745|FG000|Main Study|Lost to Follow-up|1|||
128842667|NCT03436797|463716745|FG000|Main Study|Death|1|||
128842668|NCT03436797|463716745|FG000|Main Study|Non-Specific|2|||
128842669|NCT03436797|463716745|FG000|Extended Dosing|Patient decision|1|||
128842670|NCT01951105|463716748|FG000|Overall Study|Adverse Event|0|||
128842671|NCT01951105|463716749|FG001|Overall Study|Adverse Event|5|||
128842672|NCT01951105|463716750|FG002|Overall Study|Adverse Event|0|||
128842673|NCT01951105|463716748|FG000|Overall Study|Lost to Follow-up|0|||
128842674|NCT01951105|463716749|FG001|Overall Study|Lost to Follow-up|1|||
128842675|NCT01951105|463716750|FG002|Overall Study|Lost to Follow-up|0|||
128842676|NCT01951105|463716748|FG000|Overall Study|Protocol Violation|1|||
128842677|NCT01951105|463716749|FG001|Overall Study|Protocol Violation|1|||
128842678|NCT01951105|463716750|FG002|Overall Study|Protocol Violation|1|||
128842679|NCT01951105|463716748|FG000|Overall Study|Withdrawal by Subject|0|||
128842680|NCT01951105|463716749|FG001|Overall Study|Withdrawal by Subject|3|||
128842681|NCT01951105|463716750|FG002|Overall Study|Withdrawal by Subject|1|||
128842682|NCT01601821|463716751|FG000|Overall Study|Death|2|||
128842683|NCT01601821|463716752|FG001|Overall Study|Death|5|||
128842684|NCT01601821|463716751|FG000|Overall Study|Protocol Violation|2|||
128842685|NCT01601821|463716752|FG001|Overall Study|Protocol Violation|2|||
128842686|NCT01601821|463716751|FG000|Overall Study|Lost to Follow-up|6|||
128842687|NCT01601821|463716752|FG001|Overall Study|Lost to Follow-up|14|||
128842688|NCT01601821|463716751|FG000|Overall Study|Withdrawal by Subject|1|||
128842689|NCT01601821|463716752|FG001|Overall Study|Withdrawal by Subject|0|||
128842690|NCT01601821|463716751|FG000|Overall Study|Graft Loss|6|||
128842691|NCT01601821|463716752|FG001|Overall Study|Graft Loss|6|||
128842692|NCT01601821|463716751|FG000|Overall Study|Study Events|7|||
128842693|NCT01601821|463716752|FG001|Overall Study|Study Events|1|||
128842694|NCT01601821|463716751|FG000|Overall Study|Other|5|||
128842695|NCT01601821|463716752|FG001|Overall Study|Other|1|||
128842696|NCT02469155|463716753|FG000|Overall Study|Adverse Event|6|||
128842697|NCT02469155|463716754|FG001|Overall Study|Adverse Event|0|||
128842698|NCT02469155|463716755|FG002|Overall Study|Adverse Event|1|||
128842699|NCT02469155|463716756|FG003|Overall Study|Adverse Event|10|||
128842700|NCT02469155|463716753|FG000|Overall Study|Lack of Efficacy|13|||
128842701|NCT02469155|463716754|FG001|Overall Study|Lack of Efficacy|10|||
128842702|NCT02469155|463716755|FG002|Overall Study|Lack of Efficacy|10|||
128842703|NCT02469155|463716756|FG003|Overall Study|Lack of Efficacy|8|||
128842704|NCT02469155|463716753|FG000|Overall Study|Death|0|||
128842705|NCT02469155|463716754|FG001|Overall Study|Death|0|||
128842706|NCT02469155|463716755|FG002|Overall Study|Death|0|||
128842707|NCT02469155|463716756|FG003|Overall Study|Death|1|||
128842708|NCT02469155|463716753|FG000|Overall Study|Lost to Follow-up|5|||
128842709|NCT02469155|463716754|FG001|Overall Study|Lost to Follow-up|2|||
128842710|NCT02469155|463716755|FG002|Overall Study|Lost to Follow-up|7|||
128842711|NCT02469155|463716756|FG003|Overall Study|Lost to Follow-up|2|||
128842712|NCT02469155|463716753|FG000|Overall Study|Physician Decision|0|||
128842713|NCT02469155|463716754|FG001|Overall Study|Physician Decision|0|||
128842714|NCT02469155|463716755|FG002|Overall Study|Physician Decision|1|||
128842715|NCT02469155|463716756|FG003|Overall Study|Physician Decision|0|||
128842716|NCT02469155|463716753|FG000|Overall Study|Withdrawal by Subject|34|||
128842717|NCT02469155|463716754|FG001|Overall Study|Withdrawal by Subject|30|||
128842718|NCT02469155|463716755|FG002|Overall Study|Withdrawal by Subject|20|||
128842719|NCT02469155|463716756|FG003|Overall Study|Withdrawal by Subject|37|||
128842720|NCT02469155|463716753|FG000|Overall Study|Other|3|||
128842721|NCT02469155|463716754|FG001|Overall Study|Other|3|||
128842722|NCT02469155|463716755|FG002|Overall Study|Other|2|||
128842723|NCT02469155|463716756|FG003|Overall Study|Other|10|||
128842724|NCT02469155|463716753|FG000|Overall Study|Protocol Violation|0|||
128842725|NCT02469155|463716754|FG001|Overall Study|Protocol Violation|1|||
128842726|NCT02469155|463716755|FG002|Overall Study|Protocol Violation|0|||
128842727|NCT02469155|463716756|FG003|Overall Study|Protocol Violation|1|||
128842728|NCT00442559|463716757|FG000|Overall Study|Lost to Follow-up|32|||
128842729|NCT00442559|463716758|FG001|Overall Study|Lost to Follow-up|34|||
128842730|NCT00442559|463716757|FG000|Overall Study|Protocol Violation|1|||
128842731|NCT00442559|463716758|FG001|Overall Study|Protocol Violation|1|||
128842732|NCT00442559|463716757|FG000|Overall Study|Withdrawal by Subject|1|||
128842733|NCT00442559|463716758|FG001|Overall Study|Withdrawal by Subject|0|||
128842734|NCT02604199|463716768|FG000|Overall Study|Pregnancy|0|||
128842735|NCT02604199|463716769|FG001|Overall Study|Pregnancy|0|||
128842736|NCT02604199|463716770|FG002|Overall Study|Pregnancy|0|||
128842737|NCT02604199|463716771|FG003|Overall Study|Pregnancy|1|||
128842738|NCT02604199|463716768|FG000|Overall Study|Study terminated by sponsor|0|||
128842739|NCT02604199|463716769|FG001|Overall Study|Study terminated by sponsor|2|||
128842740|NCT02604199|463716770|FG002|Overall Study|Study terminated by sponsor|0|||
128842741|NCT02604199|463716771|FG003|Overall Study|Study terminated by sponsor|2|||
128842742|NCT02604199|463716768|FG000|Overall Study|Withdrawal by Subject|0|||
128842743|NCT02604199|463716769|FG001|Overall Study|Withdrawal by Subject|1|||
128842744|NCT02604199|463716770|FG002|Overall Study|Withdrawal by Subject|0|||
128842745|NCT02604199|463716771|FG003|Overall Study|Withdrawal by Subject|0|||
128842746|NCT02812706|463716772|FG000|Phase 1|Adverse Event|0|||
128842747|NCT02812706|463716773|FG001|Phase 1|Adverse Event|2|||
128842748|NCT02812706|463716774|FG002|Phase 1|Adverse Event|0|||
128842749|NCT02812706|463716772|FG000|Phase 1|Progressive disease|3|||
128842750|NCT02812706|463716773|FG001|Phase 1|Progressive disease|3|||
128842751|NCT02812706|463716774|FG002|Phase 1|Progressive disease|0|||
128842752|NCT02812706|463716772|FG000|Phase 2|Adverse Event|0|||
128842753|NCT02812706|463716773|FG001|Phase 2|Adverse Event|0|||
128842754|NCT02812706|463716774|FG002|Phase 2|Adverse Event|2|||
128842755|NCT02812706|463716772|FG000|Phase 2|Progressive disease|0|||
128842756|NCT02812706|463716773|FG001|Phase 2|Progressive disease|0|||
128842757|NCT02812706|463716774|FG002|Phase 2|Progressive disease|22|||
128842758|NCT02812706|463716772|FG000|Phase 2|Other-Unspecified|0|||
128842759|NCT02812706|463716773|FG001|Phase 2|Other-Unspecified|0|||
128842760|NCT02812706|463716774|FG002|Phase 2|Other-Unspecified|4|||
128842761|NCT04362176|463716780|FG000|Overall Study|Lost to Follow-up|5|||
128842762|NCT04362176|463716781|FG001|Overall Study|Lost to Follow-up|8|||
128842763|NCT04362176|463716780|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
128842764|NCT04362176|463716781|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
128842765|NCT00742560|463716782|FG000|Overall Study|Adverse Event|0|||
128842766|NCT00742560|463716783|FG001|Overall Study|Adverse Event|0|||
128842767|NCT00742560|463716784|FG002|Overall Study|Adverse Event|1|||
128842768|NCT00742560|463716785|FG003|Overall Study|Adverse Event|1|||
128842769|NCT00742560|463716786|FG004|Overall Study|Adverse Event|1|||
128842770|NCT00742560|463716782|FG000|Overall Study|Death|0|||
128842771|NCT00742560|463716783|FG001|Overall Study|Death|2|||
128842772|NCT00742560|463716784|FG002|Overall Study|Death|0|||
128842773|NCT00742560|463716785|FG003|Overall Study|Death|2|||
128842774|NCT00742560|463716786|FG004|Overall Study|Death|3|||
128842775|NCT00742560|463716782|FG000|Overall Study|Subject's Decision|1|||
128842776|NCT00742560|463716783|FG001|Overall Study|Subject's Decision|0|||
128842777|NCT00742560|463716784|FG002|Overall Study|Subject's Decision|2|||
128842778|NCT00742560|463716785|FG003|Overall Study|Subject's Decision|3|||
128842779|NCT00742560|463716786|FG004|Overall Study|Subject's Decision|3|||
128842780|NCT00742560|463716782|FG000|Overall Study|Investigator's Decision|0|||
128842781|NCT00742560|463716783|FG001|Overall Study|Investigator's Decision|0|||
128842782|NCT00742560|463716784|FG002|Overall Study|Investigator's Decision|4|||
128842783|NCT00742560|463716785|FG003|Overall Study|Investigator's Decision|1|||
128842784|NCT00742560|463716786|FG004|Overall Study|Investigator's Decision|0|||
128842785|NCT00742560|463716782|FG000|Overall Study|Disease Progression|1|||
128842786|NCT00742560|463716783|FG001|Overall Study|Disease Progression|0|||
128842787|NCT00742560|463716784|FG002|Overall Study|Disease Progression|5|||
128842788|NCT00742560|463716785|FG003|Overall Study|Disease Progression|17|||
128842789|NCT00742560|463716786|FG004|Overall Study|Disease Progression|16|||
128842790|NCT00742560|463716782|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
128842791|NCT00742560|463716783|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
128842792|NCT00742560|463716784|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
128842793|NCT00742560|463716785|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
128842794|NCT00742560|463716786|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
128842795|NCT00742560|463716782|FG000|Overall Study|Other|0|||
128842796|NCT00742560|463716783|FG001|Overall Study|Other|1|||
128842797|NCT00742560|463716784|FG002|Overall Study|Other|8|||
128842798|NCT00742560|463716785|FG003|Overall Study|Other|9|||
128842799|NCT00742560|463716786|FG004|Overall Study|Other|9|||
128842800|NCT00742560|463716782|FG000|Overall Study|MIssing|0|||
128842801|NCT00742560|463716783|FG001|Overall Study|MIssing|0|||
128842802|NCT00742560|463716784|FG002|Overall Study|MIssing|0|||
128842803|NCT00742560|463716785|FG003|Overall Study|MIssing|0|||
128842804|NCT00742560|463716786|FG004|Overall Study|MIssing|1|||
128842805|NCT01426217|463716787|FG000|Overall Study|lost sample|8|||
128842806|NCT01426217|463716788|FG001|Overall Study|lost sample|14|||
128842807|NCT01812837|463716789|FG000|Overall Study|Lost to Follow-up|1|||
128842808|NCT01812837|463716790|FG001|Overall Study|Lost to Follow-up|1|||
128842809|NCT01812837|463716791|FG002|Overall Study|Lost to Follow-up|0|||
128842810|NCT01812837|463716789|FG000|Overall Study|Protocol Violation|1|||
128842811|NCT01812837|463716790|FG001|Overall Study|Protocol Violation|0|||
128842812|NCT01812837|463716791|FG002|Overall Study|Protocol Violation|0|||
128842813|NCT00658632|463716792|FG000|Overall Study|Adverse Event|13|||
128842814|NCT00658632|463716793|FG001|Overall Study|Adverse Event|11|||
128842815|NCT00658632|463716792|FG000|Overall Study|Lost to Follow-up|25|||
128842816|NCT00658632|463716793|FG001|Overall Study|Lost to Follow-up|23|||
128842817|NCT00658632|463716792|FG000|Overall Study|Withdrawal by Subject|10|||
128842818|NCT00658632|463716793|FG001|Overall Study|Withdrawal by Subject|7|||
128842819|NCT00658632|463716792|FG000|Overall Study|Lack of Efficacy|0|||
128842820|NCT00658632|463716793|FG001|Overall Study|Lack of Efficacy|1|||
128842821|NCT00658632|463716792|FG000|Overall Study|Withdrawal of consent|8|||
128842822|NCT00658632|463716793|FG001|Overall Study|Withdrawal of consent|14|||
128842823|NCT00658632|463716792|FG000|Overall Study|Pregnancy|1|||
128842824|NCT00658632|463716793|FG001|Overall Study|Pregnancy|1|||
128842825|NCT00658632|463716792|FG000|Overall Study|Other|7|||
128842826|NCT00658632|463716793|FG001|Overall Study|Other|8|||
128842827|NCT04501614|463716794|FG000|Overall Study|Study Terminated by Sponsor|6|||
128842828|NCT04501614|463716795|FG001|Overall Study|Study Terminated by Sponsor|3|||
128842829|NCT04501614|463716794|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
128842830|NCT04501614|463716795|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
128842831|NCT02991456|463716797|FG000|Overall Study|Adverse Event|2|||
128842832|NCT02991456|463716798|FG001|Overall Study|Adverse Event|0|||
128842833|NCT02991456|463716797|FG000|Overall Study|Lost to Follow-up|0|||
128842834|NCT02991456|463716798|FG001|Overall Study|Lost to Follow-up|2|||
128842835|NCT02991456|463716797|FG000|Overall Study|Withdrawal by Subject|1|||
128842836|NCT02991456|463716798|FG001|Overall Study|Withdrawal by Subject|0|||
128842837|NCT00738400|463716801|FG000|Overall Study|Adverse Event|3|||
128842838|NCT00738400|463716802|FG001|Overall Study|Adverse Event|1|||
128842839|NCT00738400|463716801|FG000|Overall Study|Withdrawal by Subject|0|||
128842840|NCT00738400|463716802|FG001|Overall Study|Withdrawal by Subject|1|||
128842841|NCT00738400|463716801|FG000|Overall Study|Lack of Efficacy|0|||
128842842|NCT00738400|463716802|FG001|Overall Study|Lack of Efficacy|1|||
128842843|NCT00738400|463716801|FG000|Overall Study|Lost to Follow-up|0|||
128842844|NCT00738400|463716802|FG001|Overall Study|Lost to Follow-up|3|||
128842845|NCT00738400|463716801|FG000|Overall Study|Protocol Violation|1|||
128842846|NCT00738400|463716802|FG001|Overall Study|Protocol Violation|0|||
128842847|NCT00738400|463716801|FG000|Overall Study|Non-compliant with study medication|0|||
128842848|NCT00738400|463716802|FG001|Overall Study|Non-compliant with study medication|1|||
128842849|NCT03138499|463716803|FG000|Overall Study|Lost to Follow-up|1|||
128842850|NCT03138499|463716804|FG001|Overall Study|Lost to Follow-up|0|||
128842851|NCT03138499|463716803|FG000|Overall Study|Participants withdrew consent|1|||
128842852|NCT03138499|463716804|FG001|Overall Study|Participants withdrew consent|0|||
128842853|NCT03138499|463716803|FG000|Overall Study|Participant discontinued study before treatment|0|||
128842854|NCT03138499|463716804|FG001|Overall Study|Participant discontinued study before treatment|1|||
128842855|NCT03138499|463716803|FG000|Overall Study|Disease Progression|2|||
128842856|NCT03138499|463716804|FG001|Overall Study|Disease Progression|6|||
128842857|NCT03138499|463716803|FG000|Overall Study|Study drug toxicity|2|||
128842858|NCT03138499|463716804|FG001|Overall Study|Study drug toxicity|2|||
128842859|NCT03138499|463716803|FG000|Overall Study|Participant request to discontinue study treatment|1|||
128842860|NCT03138499|463716804|FG001|Overall Study|Participant request to discontinue study treatment|1|||
128842861|NCT03138499|463716803|FG000|Overall Study|Other reasons|2|||
128842862|NCT03138499|463716804|FG001|Overall Study|Other reasons|0|||
128842863|NCT00508144|463716805|FG000|Overall Study|Not eligible|6|||
128842864|NCT00508144|463716805|FG000|Overall Study|Death|5|||
128842865|NCT01661972|463716806|FG000|Overall Study|Adverse Event|1|||
128842866|NCT01661972|463716807|FG001|Overall Study|Adverse Event|2|||
128842867|NCT01661972|463716806|FG000|Overall Study|Death during Treatment period|1|||
128842868|NCT01661972|463716807|FG001|Overall Study|Death during Treatment period|1|||
128842869|NCT01661972|463716806|FG000|Overall Study|Withdrawal by Subject|0|||
128842870|NCT01661972|463716807|FG001|Overall Study|Withdrawal by Subject|1|||
128842871|NCT05927753|463717543|FG000|Overall Study|Withdrawal by Subject|0|||
128842872|NCT05927753|463717544|FG001|Overall Study|Withdrawal by Subject|2|||
128842873|NCT05927753|463717543|FG000|Overall Study|Physician Decision|0|||
128842874|NCT05927753|463717544|FG001|Overall Study|Physician Decision|1|||
128842875|NCT05381948|463717546|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
128842876|NCT05381948|463717547|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
128842877|NCT05381948|463717548|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
128842878|NCT05381948|463717546|FG000|Overall Study|Adverse Event: Non-ocular|0|||
128842879|NCT05381948|463717547|FG001|Overall Study|Adverse Event: Non-ocular|1|||
128842880|NCT05381948|463717548|FG002|Overall Study|Adverse Event: Non-ocular|0|||
128842881|NCT05381948|463717546|FG000|Overall Study|Lost to Follow-up|1|||
128842882|NCT05381948|463717547|FG001|Overall Study|Lost to Follow-up|0|||
128842883|NCT05381948|463717548|FG002|Overall Study|Lost to Follow-up|0|||
128842884|NCT05381948|463717546|FG000|Overall Study|Protocol Deviation|0|||
128842885|NCT05381948|463717547|FG001|Overall Study|Protocol Deviation|2|||
128842886|NCT05381948|463717548|FG002|Overall Study|Protocol Deviation|0|||
128842887|NCT05381948|463717546|FG000|Overall Study|Withdrawal by Subject|1|||
128842888|NCT05381948|463717547|FG001|Overall Study|Withdrawal by Subject|0|||
128842889|NCT05381948|463717548|FG002|Overall Study|Withdrawal by Subject|1|||
128842890|NCT05381948|463717546|FG000|Overall Study|Death|0|||
128842891|NCT05381948|463717547|FG001|Overall Study|Death|2|||
128842892|NCT05381948|463717548|FG002|Overall Study|Death|0|||
128842893|NCT05381948|463717546|FG000|Overall Study|Discontinued study without receiving study drug|0|||
128842894|NCT05381948|463717547|FG001|Overall Study|Discontinued study without receiving study drug|0|||
128842895|NCT05381948|463717548|FG002|Overall Study|Discontinued study without receiving study drug|1|||
128842896|NCT04198428|463717549|FG000|Overall Study|Withdrawal by Subject|150|||
128842897|NCT04198428|463717550|FG001|Overall Study|Withdrawal by Subject|156|||
128842898|NCT04649359|463717554|FG000|Overall Study|Withdrawal by Subject|7|||
128842899|NCT04649359|463717555|FG001|Overall Study|Withdrawal by Subject|7|||
128842900|NCT04649359|463717554|FG000|Overall Study|Death|41|||
128842901|NCT04649359|463717555|FG001|Overall Study|Death|26|||
128842902|NCT04649359|463717554|FG000|Overall Study|Ongoing in the study|75|||
128842903|NCT04649359|463717555|FG001|Overall Study|Ongoing in the study|31|||
128842904|NCT04751929|463717556|FG000|Overall Study|Withdrawal by Subject|2|||
128842905|NCT04751929|463717557|FG001|Overall Study|Withdrawal by Subject|0|||
128842906|NCT04751929|463717558|FG002|Overall Study|Withdrawal by Subject|0|||
128842907|NCT04751929|463717559|FG003|Overall Study|Withdrawal by Subject|0|||
128842908|NCT04751929|463717556|FG000|Overall Study|Rising PSA|0|||
128842909|NCT04751929|463717557|FG001|Overall Study|Rising PSA|1|||
128842910|NCT04751929|463717558|FG002|Overall Study|Rising PSA|0|||
128842911|NCT04751929|463717559|FG003|Overall Study|Rising PSA|0|||
128842912|NCT04751929|463717556|FG000|Overall Study|Adverse Event|1|||
128842913|NCT04751929|463717557|FG001|Overall Study|Adverse Event|2|||
128842914|NCT04751929|463717558|FG002|Overall Study|Adverse Event|0|||
128842915|NCT04751929|463717559|FG003|Overall Study|Adverse Event|0|||
128842916|NCT04751929|463717556|FG000|Overall Study|Progressive Disease|3|||
128842917|NCT04751929|463717557|FG001|Overall Study|Progressive Disease|4|||
128842918|NCT04751929|463717558|FG002|Overall Study|Progressive Disease|4|||
128842919|NCT04751929|463717559|FG003|Overall Study|Progressive Disease|0|||
128842920|NCT04751929|463717556|FG000|Overall Study|Death|1|||
128842921|NCT04751929|463717557|FG001|Overall Study|Death|1|||
128842922|NCT04751929|463717558|FG002|Overall Study|Death|0|||
128842923|NCT04751929|463717559|FG003|Overall Study|Death|0|||
128842924|NCT02062827|463717561|FG000|Overall Study|Death|1|||
128842925|NCT02062827|463717562|FG001|Overall Study|Death|0|||
128842926|NCT02062827|463717563|FG002|Overall Study|Death|0|||
128842927|NCT02062827|463717564|FG003|Overall Study|Death|0|||
128842928|NCT02062827|463717565|FG004|Overall Study|Death|0|||
128842929|NCT02062827|463717566|FG005|Overall Study|Death|0|||
128842930|NCT02062827|463717567|FG006|Overall Study|Death|0|||
128842931|NCT02062827|463717568|FG007|Overall Study|Death|0|||
128842932|NCT02062827|463717561|FG000|Overall Study|Withdrawal by Subject|3|||
128842933|NCT02062827|463717562|FG001|Overall Study|Withdrawal by Subject|1|||
128842934|NCT02062827|463717563|FG002|Overall Study|Withdrawal by Subject|1|||
128842935|NCT02062827|463717564|FG003|Overall Study|Withdrawal by Subject|2|||
128842936|NCT02062827|463717565|FG004|Overall Study|Withdrawal by Subject|6|||
128842937|NCT02062827|463717566|FG005|Overall Study|Withdrawal by Subject|0|||
128842938|NCT02062827|463717567|FG006|Overall Study|Withdrawal by Subject|5|||
128842939|NCT02062827|463717568|FG007|Overall Study|Withdrawal by Subject|0|||
128842940|NCT02062827|463717561|FG000|Overall Study|Screen Fail|0|||
128842941|NCT02062827|463717562|FG001|Overall Study|Screen Fail|0|||
128842942|NCT02062827|463717563|FG002|Overall Study|Screen Fail|0|||
128842943|NCT02062827|463717564|FG003|Overall Study|Screen Fail|0|||
128842944|NCT02062827|463717565|FG004|Overall Study|Screen Fail|0|||
128842945|NCT02062827|463717566|FG005|Overall Study|Screen Fail|0|||
128842946|NCT02062827|463717567|FG006|Overall Study|Screen Fail|0|||
128842947|NCT02062827|463717568|FG007|Overall Study|Screen Fail|8|||
128842948|NCT00288353|463717570|FG000|Overall Study|Lack of Efficacy|2|||
128842949|NCT00288353|463717571|FG001|Overall Study|Lack of Efficacy|2|||
128842950|NCT00288353|463717570|FG000|Overall Study|Withdrawal by Subject|5|||
128842951|NCT00288353|463717571|FG001|Overall Study|Withdrawal by Subject|5|||
128842952|NCT05008224|463717572|FG000|Overall Study|Death|3|||
128842953|NCT05008224|463717572|FG000|Overall Study|Lost to Follow-up|2|||
128842954|NCT05008224|463717572|FG000|Overall Study|Did Not Continue on Extension Study|39|||
128842955|NCT05008224|463717572|FG000|Overall Study|Transferred to Extension Study|100|||
128842956|NCT05008224|463717572|FG000|Overall Study|Withdrawal by Subject|2|||
128842957|NCT05234632|463717573|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
128842958|NCT05234632|463717574|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
128842959|NCT05234632|463717573|FG000|Overall Study|Withdrawal by Subject|2|||
128842960|NCT05234632|463717574|FG001|Overall Study|Withdrawal by Subject|0|||
128842961|NCT05234632|463717573|FG000|Overall Study|Adverse Event|0|||
128842962|NCT05234632|463717574|FG001|Overall Study|Adverse Event|4|||
128842963|NCT05234632|463717573|FG000|Overall Study|Physician Decision|1|||
128842964|NCT05234632|463717574|FG001|Overall Study|Physician Decision|1|||
128842965|NCT05234632|463717573|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
128842966|NCT05234632|463717574|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
128842967|NCT05234632|463717573|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
128842968|NCT05234632|463717574|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
128842969|NCT04985604|463717575|FG000|Overall Study|Death|4|||
128842970|NCT04985604|463717576|FG001|Overall Study|Death|6|||
128842971|NCT04985604|463717575|FG000|Overall Study|Withdrawal by Subject|0|||
128842972|NCT04985604|463717576|FG001|Overall Study|Withdrawal by Subject|1|||
128842973|NCT02282761|463717577|FG000|Overall Study|Death|0|||
128842974|NCT02282761|463717578|FG001|Overall Study|Death|0|||
128842975|NCT02282761|463717579|FG002|Overall Study|Death|1|||
128842976|NCT02282761|463717577|FG000|Overall Study|Adverse Event|6|||
128842977|NCT02282761|463717578|FG001|Overall Study|Adverse Event|2|||
128842978|NCT02282761|463717579|FG002|Overall Study|Adverse Event|0|||
128842979|NCT02282761|463717577|FG000|Overall Study|Lack of Efficacy|11|||
128842980|NCT02282761|463717578|FG001|Overall Study|Lack of Efficacy|6|||
128842981|NCT02282761|463717579|FG002|Overall Study|Lack of Efficacy|17|||
128842982|NCT02282761|463717577|FG000|Overall Study|Lost to Follow-up|2|||
128842983|NCT02282761|463717578|FG001|Overall Study|Lost to Follow-up|2|||
128842984|NCT02282761|463717579|FG002|Overall Study|Lost to Follow-up|1|||
128842985|NCT02282761|463717577|FG000|Overall Study|Physician Decision|0|||
128842986|NCT02282761|463717578|FG001|Overall Study|Physician Decision|0|||
128842987|NCT02282761|463717579|FG002|Overall Study|Physician Decision|2|||
128842988|NCT02282761|463717577|FG000|Overall Study|Withdrawal by Subject|8|||
128842989|NCT02282761|463717578|FG001|Overall Study|Withdrawal by Subject|10|||
128842990|NCT02282761|463717579|FG002|Overall Study|Withdrawal by Subject|16|||
128842991|NCT02282761|463717577|FG000|Overall Study|Other|3|||
128842992|NCT02282761|463717578|FG001|Overall Study|Other|2|||
128842993|NCT02282761|463717579|FG002|Overall Study|Other|1|||
128842994|NCT05263492|463717580|FG000|Overall Study|Adverse Event|1|||
128842995|NCT05263492|463717580|FG000|Overall Study|Disease progression during active treatment|3|||
128842996|NCT03345420|463717583|FG000|Overall Study|Withdrawal by Subject|1|||
128842997|NCT05216835|463717584|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
128842998|NCT05216835|463717585|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
128842999|NCT05216835|463717586|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
128843000|NCT05216835|463717587|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
128843001|NCT05216835|463717588|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
128843002|NCT05216835|463717589|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
128843003|NCT05216835|463717590|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
128843004|NCT05216835|463717591|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
128843005|NCT05216835|463717584|FG000|Overall Study|Death|0|||
128843006|NCT05216835|463717585|FG001|Overall Study|Death|0|||
128843007|NCT05216835|463717586|FG002|Overall Study|Death|0|||
128843008|NCT05216835|463717587|FG003|Overall Study|Death|1|||
128843009|NCT05216835|463717588|FG004|Overall Study|Death|1|||
128843010|NCT05216835|463717589|FG005|Overall Study|Death|1|||
128843011|NCT05216835|463717590|FG006|Overall Study|Death|1|||
128843012|NCT05216835|463717591|FG007|Overall Study|Death|1|||
128843013|NCT05216835|463717584|FG000|Overall Study|Physician Decision|0|||
128843014|NCT05216835|463717585|FG001|Overall Study|Physician Decision|0|||
128843015|NCT05216835|463717586|FG002|Overall Study|Physician Decision|0|||
128843016|NCT05216835|463717587|FG003|Overall Study|Physician Decision|0|||
128843017|NCT05216835|463717588|FG004|Overall Study|Physician Decision|0|||
128843018|NCT05216835|463717589|FG005|Overall Study|Physician Decision|1|||
128843019|NCT05216835|463717590|FG006|Overall Study|Physician Decision|1|||
128843020|NCT05216835|463717591|FG007|Overall Study|Physician Decision|0|||
128843021|NCT05216835|463717584|FG000|Overall Study|Study terminated by Sponsor|0|||
128843022|NCT05216835|463717585|FG001|Overall Study|Study terminated by Sponsor|0|||
128843023|NCT05216835|463717586|FG002|Overall Study|Study terminated by Sponsor|0|||
128843024|NCT05216835|463717587|FG003|Overall Study|Study terminated by Sponsor|0|||
128843025|NCT05216835|463717588|FG004|Overall Study|Study terminated by Sponsor|0|||
128843026|NCT05216835|463717589|FG005|Overall Study|Study terminated by Sponsor|0|||
128843027|NCT05216835|463717590|FG006|Overall Study|Study terminated by Sponsor|0|||
128843028|NCT05216835|463717591|FG007|Overall Study|Study terminated by Sponsor|1|||
128843029|NCT05216835|463717584|FG000|Overall Study|Withdrawal by Subject|1|||
128843030|NCT05216835|463717585|FG001|Overall Study|Withdrawal by Subject|0|||
128843031|NCT05216835|463717586|FG002|Overall Study|Withdrawal by Subject|1|||
128843032|NCT05216835|463717587|FG003|Overall Study|Withdrawal by Subject|0|||
128843033|NCT05216835|463717588|FG004|Overall Study|Withdrawal by Subject|1|||
128843034|NCT05216835|463717589|FG005|Overall Study|Withdrawal by Subject|0|||
128843035|NCT05216835|463717590|FG006|Overall Study|Withdrawal by Subject|0|||
128843036|NCT05216835|463717591|FG007|Overall Study|Withdrawal by Subject|1|||
128843037|NCT05216835|463717584|FG000|Overall Study|Other|0|||
128843038|NCT05216835|463717585|FG001|Overall Study|Other|1|||
128843039|NCT05216835|463717586|FG002|Overall Study|Other|0|||
128843040|NCT05216835|463717587|FG003|Overall Study|Other|0|||
128843041|NCT05216835|463717588|FG004|Overall Study|Other|0|||
128843042|NCT05216835|463717589|FG005|Overall Study|Other|0|||
128843043|NCT05216835|463717590|FG006|Overall Study|Other|0|||
128843044|NCT05216835|463717591|FG007|Overall Study|Other|0|||
128843045|NCT05179603|463717592|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
128843046|NCT05179603|463717592|FG000|Overall Study|Withdrawal by Subject|1|||
128843047|NCT05179603|463717592|FG000|Overall Study|Progressive disease|4|||
128843048|NCT05179603|463717592|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
128843049|NCT04551053|463717595|FG000|Overall Study|Death|10|||
128843050|NCT04551053|463717596|FG001|Overall Study|Death|9|||
128843051|NCT04551053|463717595|FG000|Overall Study|Lost to Follow-up|0|||
128843052|NCT04551053|463717596|FG001|Overall Study|Lost to Follow-up|2|||
128843053|NCT04551053|463717595|FG000|Overall Study|Study Terminated by Sponsor|57|||
128843054|NCT04551053|463717596|FG001|Overall Study|Study Terminated by Sponsor|65|||
128843055|NCT04551053|463717595|FG000|Overall Study|Withdrawal by Subject|12|||
128843056|NCT04551053|463717596|FG001|Overall Study|Withdrawal by Subject|5|||
128843057|NCT04551053|463717595|FG000|Overall Study|Adverse Event|2|||
128843058|NCT04551053|463717596|FG001|Overall Study|Adverse Event|0|||
128843059|NCT04551053|463717595|FG000|Overall Study|Lack of Efficacy|2|||
128843060|NCT04551053|463717596|FG001|Overall Study|Lack of Efficacy|1|||
128843061|NCT04551053|463717595|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
128843062|NCT04551053|463717596|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
128843063|NCT04551053|463717595|FG000|Overall Study|Splenapendectomi|1|||
128843064|NCT04551053|463717596|FG001|Overall Study|Splenapendectomi|0|||
128843065|NCT04551053|463717595|FG000|Overall Study|Medical Decision|1|||
128843066|NCT04551053|463717596|FG001|Overall Study|Medical Decision|1|||
128843067|NCT04529941|463717597|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
128843068|NCT04529941|463717598|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
128843069|NCT04016415|463717599|FG000|Overall Study|Adverse Event|2|||
128843070|NCT04016415|463717600|FG001|Overall Study|Adverse Event|1|||
128843071|NCT04016415|463717599|FG000|Overall Study|Lost to Follow-up|6|||
128843072|NCT04016415|463717600|FG001|Overall Study|Lost to Follow-up|2|||
128843073|NCT04016415|463717599|FG000|Overall Study|Physician Decision|5|||
128843074|NCT04016415|463717600|FG001|Overall Study|Physician Decision|1|||
128843075|NCT04016415|463717599|FG000|Overall Study|Pregnancy|0|||
128843076|NCT04016415|463717600|FG001|Overall Study|Pregnancy|1|||
128843077|NCT04016415|463717599|FG000|Overall Study|Withdrawal by Subject|24|||
128843078|NCT04016415|463717600|FG001|Overall Study|Withdrawal by Subject|27|||
128843079|NCT04016415|463717599|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
128843080|NCT04016415|463717600|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
128843081|NCT02819141|463717601|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
128843082|NCT02819141|463717602|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
128843083|NCT03556891|463717603|FG000|Initial Pivotal Study|Adverse Event|4|||
128843084|NCT03556891|463717603|FG000|Initial Pivotal Study|MRI Need|3|||
128843085|NCT03556891|463717603|FG000|Initial Pivotal Study|Device Failure|1|||
128843086|NCT03556891|463717603|FG000|Initial Pivotal Study|Death|1|||
128843087|NCT03556891|463717603|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
128843088|NCT03556891|463717603|FG000|Initial Pivotal Study|Missing at random|1|||
128843089|NCT03556891|463717603|FG000|Initial Pivotal Study|Missing due to COVID|1|||
128843090|NCT03556891|463717603|FG000|Initial Pivotal Study|Protocol Violation|1|||
128843091|NCT02101554|463718020|FG000|Overall Study|Protocol Violation|0|||
128843092|NCT02101554|463718021|FG001|Overall Study|Protocol Violation|1|||
128843093|NCT02101554|463718022|FG002|Overall Study|Protocol Violation|0|||
128843094|NCT02101554|463718020|FG000|Overall Study|Insufficient Clinical Response|0|||
128843095|NCT02101554|463718021|FG001|Overall Study|Insufficient Clinical Response|2|||
128843096|NCT02101554|463718022|FG002|Overall Study|Insufficient Clinical Response|0|||
128843097|NCT02101554|463718020|FG000|Overall Study|Adverse Event|2|||
128843098|NCT02101554|463718021|FG001|Overall Study|Adverse Event|1|||
128843099|NCT02101554|463718022|FG002|Overall Study|Adverse Event|1|||
128843100|NCT02101554|463718020|FG000|Overall Study|Lost to Follow-up|0|||
128843101|NCT02101554|463718021|FG001|Overall Study|Lost to Follow-up|1|||
128843102|NCT02101554|463718022|FG002|Overall Study|Lost to Follow-up|0|||
128843103|NCT02101554|463718020|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
128843104|NCT02101554|463718021|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
128843105|NCT02101554|463718022|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
128843106|NCT04175392|463718026|FG000|Overall Study|Withdrawal by Subject|3|||
128843107|NCT04175392|463718027|FG001|Overall Study|Withdrawal by Subject|2|||
128843108|NCT02727998|463718028|FG000|Overall Study|Lost to Follow-up|3|||
128843109|NCT02727998|463718029|FG001|Overall Study|Lost to Follow-up|3|||
128843110|NCT02727998|463718028|FG000|Overall Study|Withdrawal by Subject|0|||
128843111|NCT02727998|463718029|FG001|Overall Study|Withdrawal by Subject|1|||
128843112|NCT02105688|463718030|FG000|Part A: Double-Blind|Adverse Event|1|||
128843113|NCT02105688|463718031|FG001|Part A: Double-Blind|Adverse Event|0|||
128843114|NCT02105688|463718030|FG000|Part A: Double-Blind|Death|0|||
128843115|NCT02105688|463718031|FG001|Part A: Double-Blind|Death|1|||
128843116|NCT02105688|463718030|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
128843117|NCT02105688|463718031|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
128843118|NCT02105688|463718030|FG000|Part A: Double-Blind|Physician Decision|0|||
128843119|NCT02105688|463718031|FG001|Part A: Double-Blind|Physician Decision|1|||
128843120|NCT02105688|463718030|FG000|Part A: Double-Blind|Status Unknown|0|||
128843121|NCT02105688|463718031|FG001|Part A: Double-Blind|Status Unknown|2|||
128843122|NCT02105688|463718030|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
128843123|NCT02105688|463718031|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
128843124|NCT02105688|463718030|FG000|Part B: Observational Follow-up|Death|2|||
128843125|NCT02105688|463718031|FG001|Part B: Observational Follow-up|Death|1|||
128843126|NCT02105688|463718030|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
128843127|NCT02105688|463718031|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
128843128|NCT02105688|463718030|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
128843129|NCT02105688|463718031|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
128843130|NCT02105688|463718030|FG000|Part B: Observational Follow-up|Physician Decision|3|||
128843131|NCT02105688|463718031|FG001|Part B: Observational Follow-up|Physician Decision|1|||
128843132|NCT03166215|463718035|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
128843133|NCT03166215|463718036|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
128843134|NCT03166215|463718037|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
128843135|NCT03166215|463718035|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
128843136|NCT03166215|463718036|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
128843137|NCT03166215|463718037|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
128843138|NCT02632045|463718038|FG000|Overall Study|Withdrawal by Subject|1|||
128843139|NCT02632045|463718039|FG001|Overall Study|Withdrawal by Subject|2|||
128843140|NCT05878522|463718040|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843141|NCT05878522|463718041|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843142|NCT05878522|463718042|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843143|NCT05878522|463718043|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843144|NCT05878522|463718044|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843145|NCT05878522|463718045|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843146|NCT05878522|463718046|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843147|NCT05878522|463718047|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843148|NCT05878522|463718048|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
128843149|NCT05878522|463718049|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843150|NCT05878522|463718050|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843151|NCT05878522|463718051|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
128843152|NCT05878522|463718040|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
128843153|NCT05878522|463718041|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843154|NCT05878522|463718042|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843155|NCT05878522|463718043|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843156|NCT05878522|463718044|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843157|NCT05878522|463718045|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843158|NCT05878522|463718046|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843159|NCT05878522|463718047|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843160|NCT05878522|463718048|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843161|NCT05878522|463718049|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
128843162|NCT05878522|463718050|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843163|NCT05878522|463718051|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
128843164|NCT05878522|463718040|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843165|NCT05878522|463718041|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
128843166|NCT05878522|463718042|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843167|NCT05878522|463718043|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
128843168|NCT05878522|463718044|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843169|NCT05878522|463718045|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843170|NCT05878522|463718046|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843171|NCT05878522|463718047|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843172|NCT05878522|463718048|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843173|NCT05878522|463718049|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843174|NCT05878522|463718050|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843175|NCT05878522|463718051|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
128843176|NCT05878522|463718040|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843177|NCT05878522|463718041|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843178|NCT05878522|463718042|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843179|NCT05878522|463718043|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843180|NCT05878522|463718044|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
128843181|NCT05878522|463718045|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843182|NCT05878522|463718046|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843183|NCT05878522|463718047|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843184|NCT05878522|463718048|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843185|NCT05878522|463718049|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843186|NCT05878522|463718050|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843187|NCT05878522|463718051|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
128843188|NCT02252172|463718052|FG000|Overall Study|Lost to Follow-up|3|||
128843189|NCT02252172|463718053|FG001|Overall Study|Lost to Follow-up|1|||
128843190|NCT02252172|463718052|FG000|Overall Study|Ongoing|276|||
128843191|NCT02252172|463718053|FG001|Overall Study|Ongoing|298|||
128843192|NCT05740371|463718054|FG000|Overall Study|Death|1|||
128843193|NCT05615870|463718056|FG000|Overall Study|Lost to Follow-up|10|||
128843194|NCT05615870|463718057|FG001|Overall Study|Lost to Follow-up|13|||
128843195|NCT05615870|463718056|FG000|Overall Study|Physician Decision|2|||
128843196|NCT05615870|463718057|FG001|Overall Study|Physician Decision|0|||
128843197|NCT05615870|463718056|FG000|Overall Study|Withdrawal by Subject|0|||
128843198|NCT05615870|463718057|FG001|Overall Study|Withdrawal by Subject|2|||
128843199|NCT05615870|463718056|FG000|Overall Study|Protocol Violation|0|||
128843200|NCT05615870|463718057|FG001|Overall Study|Protocol Violation|3|||
128843201|NCT05615870|463718056|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
128843202|NCT05615870|463718057|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
128843203|NCT05615870|463718056|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
128843204|NCT05615870|463718057|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
128843205|NCT05615870|463718056|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
128843206|NCT05615870|463718057|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
128843207|NCT00070317|463718058|FG000|Overall Study|Inevaluable (Never Treated)|1|||
128843208|NCT00070317|463718058|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
128843209|NCT00070317|463718058|FG000|Overall Study|Ineligible required test not done|1|||
128843210|NCT00070317|463718058|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
128843211|NCT00070317|463718058|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
128843212|NCT01885559|463718059|FG000|Overall Study|Lost to Follow-up|15|||
128843213|NCT01885559|463718060|FG001|Overall Study|Lost to Follow-up|16|||
128843214|NCT01885559|463718059|FG000|Overall Study|Less than full participation|9|||
128843215|NCT01885559|463718060|FG001|Overall Study|Less than full participation|19|||
128843216|NCT01885559|463718059|FG000|Overall Study|Protocol Violation|0|||
128843217|NCT01885559|463718060|FG001|Overall Study|Protocol Violation|1|||
128843218|NCT01549951|463718064|FG000|Overall Study|Adverse Event|15|||
128843219|NCT01549951|463718064|FG000|Overall Study|Withdrawal by Subject|2|||
128843220|NCT01549951|463718064|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
128843221|NCT01549951|463718064|FG000|Overall Study|Progressive disease|29|||
128843222|NCT01549951|463718064|FG000|Overall Study|Symptomatic deterioration|1|||
128843223|NCT01549951|463718064|FG000|Overall Study|Other|2|||
128843224|NCT02312245|463718065|FG000|Overall Study|Death|0|||
128843225|NCT02312245|463718066|FG001|Overall Study|Death|0|||
128843226|NCT02312245|463718067|FG002|Overall Study|Death|0|||
128843227|NCT02312245|463718068|FG003|Overall Study|Death|1|||
128843228|NCT02312245|463718065|FG000|Overall Study|Withdrawal by Subject|1|||
128843229|NCT02312245|463718066|FG001|Overall Study|Withdrawal by Subject|1|||
128843230|NCT02312245|463718067|FG002|Overall Study|Withdrawal by Subject|0|||
128843231|NCT02312245|463718068|FG003|Overall Study|Withdrawal by Subject|2|||
128843232|NCT02312245|463718065|FG000|Overall Study|Alternative Therapy|1|||
128843233|NCT02312245|463718066|FG001|Overall Study|Alternative Therapy|0|||
128843234|NCT02312245|463718067|FG002|Overall Study|Alternative Therapy|0|||
128843235|NCT02312245|463718068|FG003|Overall Study|Alternative Therapy|0|||
128843236|NCT02312245|463718065|FG000|Overall Study|Progression|0|||
128843237|NCT02312245|463718066|FG001|Overall Study|Progression|0|||
128843238|NCT02312245|463718067|FG002|Overall Study|Progression|0|||
128843239|NCT02312245|463718068|FG003|Overall Study|Progression|5|||
128843240|NCT02312245|463718065|FG000|Overall Study|Patient went to hospice|0|||
128843241|NCT02312245|463718066|FG001|Overall Study|Patient went to hospice|0|||
128843242|NCT02312245|463718067|FG002|Overall Study|Patient went to hospice|0|||
128843243|NCT02312245|463718068|FG003|Overall Study|Patient went to hospice|1|||
128843244|NCT02312245|463718065|FG000|Overall Study|Ineligible|1|||
128843245|NCT02312245|463718066|FG001|Overall Study|Ineligible|0|||
128843246|NCT02312245|463718067|FG002|Overall Study|Ineligible|0|||
128843247|NCT02312245|463718068|FG003|Overall Study|Ineligible|0|||
128843248|NCT01123200|463718070|FG000|Overall Study|Withdrawal by Subject|1|||
128843249|NCT01730118|463719361|FG000|Dose Escalation|Death on study|5|||
128843250|NCT01730118|463719362|FG001|Dose Escalation|Death on study|7|||
128843251|NCT01730118|463719363|FG002|Dose Escalation|Death on study|2|||
128843252|NCT01730118|463719364|FG003|Dose Escalation|Death on study|6|||
128843253|NCT01730118|463719365|FG004|Dose Escalation|Death on study|0|||
128843254|NCT01730118|463719366|FG005|Dose Escalation|Death on study|0|||
128843255|NCT01730118|463719367|FG006|Dose Escalation|Death on study|0|||
128843256|NCT01730118|463719361|FG000|Dose Escalation|Died before treatment|0|||
128843257|NCT01730118|463719362|FG001|Dose Escalation|Died before treatment|0|||
128843258|NCT01730118|463719363|FG002|Dose Escalation|Died before treatment|0|||
128843259|NCT01730118|463719364|FG003|Dose Escalation|Died before treatment|0|||
128843260|NCT01730118|463719365|FG004|Dose Escalation|Died before treatment|0|||
128843261|NCT01730118|463719366|FG005|Dose Escalation|Died before treatment|0|||
128843262|NCT01730118|463719367|FG006|Dose Escalation|Died before treatment|1|||
128843263|NCT01730118|463719361|FG000|Dose Escalation|Chose to start a different treatment|1|||
128843264|NCT01730118|463719362|FG001|Dose Escalation|Chose to start a different treatment|0|||
128843265|NCT01730118|463719363|FG002|Dose Escalation|Chose to start a different treatment|0|||
128843266|NCT01730118|463719364|FG003|Dose Escalation|Chose to start a different treatment|0|||
128843267|NCT01730118|463719365|FG004|Dose Escalation|Chose to start a different treatment|0|||
128843268|NCT01730118|463719366|FG005|Dose Escalation|Chose to start a different treatment|0|||
128843269|NCT01730118|463719367|FG006|Dose Escalation|Chose to start a different treatment|0|||
128843270|NCT01730118|463719361|FG000|Dose Escalation|Withdrawal by Subject|0|||
128843271|NCT01730118|463719362|FG001|Dose Escalation|Withdrawal by Subject|0|||
128843272|NCT01730118|463719363|FG002|Dose Escalation|Withdrawal by Subject|1|||
128843273|NCT01730118|463719364|FG003|Dose Escalation|Withdrawal by Subject|0|||
128843274|NCT01730118|463719365|FG004|Dose Escalation|Withdrawal by Subject|0|||
128843275|NCT01730118|463719366|FG005|Dose Escalation|Withdrawal by Subject|0|||
128843276|NCT01730118|463719367|FG006|Dose Escalation|Withdrawal by Subject|0|||
128843277|NCT01730118|463719361|FG000|Dose Escalation|Disease progression prior to treatment|0|||
128843278|NCT01730118|463719362|FG001|Dose Escalation|Disease progression prior to treatment|0|||
128843279|NCT01730118|463719363|FG002|Dose Escalation|Disease progression prior to treatment|0|||
128843280|NCT01730118|463719364|FG003|Dose Escalation|Disease progression prior to treatment|0|||
128843281|NCT01730118|463719365|FG004|Dose Escalation|Disease progression prior to treatment|0|||
128843282|NCT01730118|463719366|FG005|Dose Escalation|Disease progression prior to treatment|0|||
128843283|NCT01730118|463719367|FG006|Dose Escalation|Disease progression prior to treatment|1|||
128843284|NCT01730118|463719361|FG000|Dose Expansion|Death|0|||
128843285|NCT01730118|463719362|FG001|Dose Expansion|Death|0|||
128843286|NCT01730118|463719363|FG002|Dose Expansion|Death|0|||
128843287|NCT01730118|463719364|FG003|Dose Expansion|Death|0|||
128843288|NCT01730118|463719365|FG004|Dose Expansion|Death|1|||
128843289|NCT01730118|463719366|FG005|Dose Expansion|Death|0|||
128843290|NCT01730118|463719367|FG006|Dose Expansion|Death|0|||
128843291|NCT01730118|463719361|FG000|Dose Expansion|Other medical condition|0|||
128843292|NCT01730118|463719362|FG001|Dose Expansion|Other medical condition|0|||
128843293|NCT01730118|463719363|FG002|Dose Expansion|Other medical condition|0|||
128843294|NCT01730118|463719364|FG003|Dose Expansion|Other medical condition|0|||
128843295|NCT01730118|463719365|FG004|Dose Expansion|Other medical condition|1|||
128843296|NCT01730118|463719366|FG005|Dose Expansion|Other medical condition|0|||
128843297|NCT01730118|463719367|FG006|Dose Expansion|Other medical condition|0|||
128843298|NCT01730118|463719361|FG000|Dose Expansion|Withdrawal by Subject|0|||
128843299|NCT01730118|463719362|FG001|Dose Expansion|Withdrawal by Subject|0|||
128843300|NCT01730118|463719363|FG002|Dose Expansion|Withdrawal by Subject|0|||
128843301|NCT01730118|463719364|FG003|Dose Expansion|Withdrawal by Subject|0|||
128843302|NCT01730118|463719365|FG004|Dose Expansion|Withdrawal by Subject|1|||
128843303|NCT01730118|463719366|FG005|Dose Expansion|Withdrawal by Subject|0|||
128843304|NCT01730118|463719367|FG006|Dose Expansion|Withdrawal by Subject|0|||
128843305|NCT01730118|463719361|FG000|Dose Expansion|Disease progression|0|||
128843306|NCT01730118|463719362|FG001|Dose Expansion|Disease progression|0|||
128843307|NCT01730118|463719363|FG002|Dose Expansion|Disease progression|0|||
128843308|NCT01730118|463719364|FG003|Dose Expansion|Disease progression|0|||
128843309|NCT01730118|463719365|FG004|Dose Expansion|Disease progression|0|||
128843310|NCT01730118|463719366|FG005|Dose Expansion|Disease progression|1|||
128843311|NCT01730118|463719367|FG006|Dose Expansion|Disease progression|0|||
128843312|NCT01730118|463719361|FG000|Dose Expansion|Inability to return|0|||
128843313|NCT01730118|463719362|FG001|Dose Expansion|Inability to return|0|||
128843314|NCT01730118|463719363|FG002|Dose Expansion|Inability to return|0|||
128843315|NCT01730118|463719364|FG003|Dose Expansion|Inability to return|0|||
128843316|NCT01730118|463719365|FG004|Dose Expansion|Inability to return|0|||
128843317|NCT01730118|463719366|FG005|Dose Expansion|Inability to return|1|||
128843318|NCT01730118|463719367|FG006|Dose Expansion|Inability to return|0|||
128843319|NCT01730118|463719361|FG000|Dose Expansion|Physician Decision|0|||
128843320|NCT01730118|463719362|FG001|Dose Expansion|Physician Decision|0|||
128843321|NCT01730118|463719363|FG002|Dose Expansion|Physician Decision|0|||
128843322|NCT01730118|463719364|FG003|Dose Expansion|Physician Decision|0|||
128843323|NCT01730118|463719365|FG004|Dose Expansion|Physician Decision|0|||
128843324|NCT01730118|463719366|FG005|Dose Expansion|Physician Decision|1|||
128843325|NCT01730118|463719367|FG006|Dose Expansion|Physician Decision|0|||
128843326|NCT00489489|463719369|FG000|Overall Study|Not treated due to protocol violation|0|||
128843327|NCT00489489|463719370|FG001|Overall Study|Not treated due to protocol violation|1|||
128843328|NCT00489489|463719371|FG002|Overall Study|Not treated due to protocol violation|1|||
128843329|NCT00489489|463719369|FG000|Overall Study|Adverse Event|1|||
128843330|NCT00489489|463719370|FG001|Overall Study|Adverse Event|1|||
128843331|NCT00489489|463719371|FG002|Overall Study|Adverse Event|1|||
128843332|NCT00489489|463719369|FG000|Overall Study|Protocol Violation|1|||
128843333|NCT00489489|463719370|FG001|Overall Study|Protocol Violation|0|||
128843334|NCT00489489|463719371|FG002|Overall Study|Protocol Violation|1|||
128843335|NCT00489489|463719369|FG000|Overall Study|Progressive disease|0|||
128843336|NCT00489489|463719370|FG001|Overall Study|Progressive disease|1|||
128843337|NCT00489489|463719371|FG002|Overall Study|Progressive disease|0|||
128843338|NCT00489489|463719369|FG000|Overall Study|Participant did not wish to continue|1|||
128843339|NCT00489489|463719370|FG001|Overall Study|Participant did not wish to continue|1|||
128843340|NCT00489489|463719371|FG002|Overall Study|Participant did not wish to continue|0|||
128843341|NCT00489489|463719369|FG000|Overall Study|Other than above|0|||
128843342|NCT00489489|463719370|FG001|Overall Study|Other than above|1|||
128843343|NCT00489489|463719371|FG002|Overall Study|Other than above|0|||
128843344|NCT04851587|463719374|FG000|Overall Study|Lost to Follow-up|18|||
128843345|NCT01350102|463719378|FG000|Overall Study|Adverse Event|0|||
128843346|NCT01350102|463719379|FG001|Overall Study|Adverse Event|0|||
128843347|NCT01350102|463719380|FG002|Overall Study|Adverse Event|1|||
128843348|NCT01350102|463719381|FG003|Overall Study|Adverse Event|0|||
128843349|NCT04523571|463719382|FG000|Received 2 Doses|Withdrawal by Subject|0|||
128843350|NCT04523571|463719383|FG001|Received 2 Doses|Withdrawal by Subject|0|||
128843351|NCT04523571|463719384|FG002|Received 2 Doses|Withdrawal by Subject|0|||
128843352|NCT04523571|463719385|FG003|Received 2 Doses|Withdrawal by Subject|1|||
128843353|NCT04523571|463719386|FG004|Received 2 Doses|Withdrawal by Subject|1|||
128843354|NCT04523571|463719387|FG005|Received 2 Doses|Withdrawal by Subject|0|||
128843355|NCT04523571|463719382|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
128843356|NCT04523571|463719383|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
128843357|NCT04523571|463719384|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
128843358|NCT04523571|463719385|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
128843359|NCT04523571|463719386|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
128843360|NCT04523571|463719387|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
128843361|NCT04523571|463719382|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
128843362|NCT04523571|463719383|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
128843363|NCT04523571|463719384|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
128843364|NCT04523571|463719385|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
128843365|NCT04523571|463719386|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
128843366|NCT04523571|463719387|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
128843367|NCT04523571|463719382|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
128843368|NCT04523571|463719383|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
128843369|NCT04523571|463719384|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
128843370|NCT04523571|463719385|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
128843371|NCT04523571|463719386|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
128843372|NCT04523571|463719387|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
128843373|NCT04385849|463719389|FG000|Overall Study|Lost to Follow-up|1|||
128843374|NCT04385849|463719390|FG001|Overall Study|Lost to Follow-up|0|||
128843375|NCT01375777|463719391|FG000|Overall Study|Withdrawal by Subject|0|||
128843376|NCT01375777|463719392|FG001|Overall Study|Withdrawal by Subject|2|||
128843377|NCT01375777|463719393|FG002|Overall Study|Withdrawal by Subject|1|||
128843378|NCT01375777|463719394|FG003|Overall Study|Withdrawal by Subject|0|||
128843379|NCT01375777|463719395|FG004|Overall Study|Withdrawal by Subject|1|||
128843380|NCT01375777|463719396|FG005|Overall Study|Withdrawal by Subject|1|||
128843381|NCT01375777|463719397|FG006|Overall Study|Withdrawal by Subject|1|||
128843382|NCT01375777|463719398|FG007|Overall Study|Withdrawal by Subject|2|||
128843383|NCT01375777|463719399|FG008|Overall Study|Withdrawal by Subject|1|||
128843384|NCT01375777|463719391|FG000|Overall Study|Lost to Follow-up|1|||
128843385|NCT01375777|463719392|FG001|Overall Study|Lost to Follow-up|0|||
128843386|NCT01375777|463719393|FG002|Overall Study|Lost to Follow-up|0|||
128843387|NCT01375777|463719394|FG003|Overall Study|Lost to Follow-up|0|||
128843388|NCT01375777|463719395|FG004|Overall Study|Lost to Follow-up|0|||
128843389|NCT01375777|463719396|FG005|Overall Study|Lost to Follow-up|0|||
128843390|NCT01375777|463719397|FG006|Overall Study|Lost to Follow-up|1|||
128843391|NCT01375777|463719398|FG007|Overall Study|Lost to Follow-up|0|||
128843392|NCT01375777|463719399|FG008|Overall Study|Lost to Follow-up|0|||
128843393|NCT01375777|463719391|FG000|Overall Study|Other|1|||
128843394|NCT01375777|463719392|FG001|Overall Study|Other|1|||
128843395|NCT01375777|463719393|FG002|Overall Study|Other|0|||
128843396|NCT01375777|463719394|FG003|Overall Study|Other|0|||
128843397|NCT01375777|463719395|FG004|Overall Study|Other|0|||
128843398|NCT01375777|463719396|FG005|Overall Study|Other|0|||
128843399|NCT01375777|463719397|FG006|Overall Study|Other|0|||
128843400|NCT01375777|463719398|FG007|Overall Study|Other|0|||
128843401|NCT01375777|463719399|FG008|Overall Study|Other|1|||
128843402|NCT05878990|463719400|FG000|Overall Study|Lost to Follow-up|7|||
128843403|NCT05878990|463719400|FG000|Overall Study|Withdrawal by Subject|1|||
128843404|NCT01838499|463719403|FG000|Overall Study|Protocol Violation|0|||
128843405|NCT01838499|463719404|FG001|Overall Study|Protocol Violation|1|||
128843406|NCT01838499|463719403|FG000|Overall Study|Lost to Follow-up|2|||
128843407|NCT01838499|463719404|FG001|Overall Study|Lost to Follow-up|4|||
128843408|NCT01838499|463719403|FG000|Overall Study|Lack of Efficacy|1|||
128843409|NCT01838499|463719404|FG001|Overall Study|Lack of Efficacy|2|||
128843410|NCT01838499|463719403|FG000|Overall Study|Adverse Event|2|||
128843411|NCT01838499|463719404|FG001|Overall Study|Adverse Event|1|||
128843412|NCT01838499|463719403|FG000|Overall Study|Withdrawal by Subject|19|||
128843413|NCT01838499|463719404|FG001|Overall Study|Withdrawal by Subject|9|||
128843414|NCT01136733|463719405|FG000|Phase 1b|Adverse Event|0|||
128843415|NCT01136733|463719406|FG001|Phase 1b|Adverse Event|3|||
128843416|NCT01136733|463719407|FG002|Phase 1b|Adverse Event|1|||
128843417|NCT01136733|463719408|FG003|Phase 1b|Adverse Event|0|||
128843418|NCT01136733|463719409|FG004|Phase 1b|Adverse Event|0|||
128843419|NCT01136733|463719410|FG005|Phase 1b|Adverse Event|0|||
128843420|NCT01136733|463719411|FG006|Phase 1b|Adverse Event|0|||
128843421|NCT01136733|463719405|FG000|Phase 1b|Participant Choice|0|||
128843422|NCT01136733|463719406|FG001|Phase 1b|Participant Choice|0|||
128843423|NCT01136733|463719407|FG002|Phase 1b|Participant Choice|1|||
128843424|NCT01136733|463719408|FG003|Phase 1b|Participant Choice|0|||
128843425|NCT01136733|463719409|FG004|Phase 1b|Participant Choice|0|||
128843426|NCT01136733|463719410|FG005|Phase 1b|Participant Choice|0|||
128843427|NCT01136733|463719411|FG006|Phase 1b|Participant Choice|0|||
128843428|NCT01136733|463719405|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
128843429|NCT01136733|463719406|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
128843430|NCT01136733|463719407|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
128843431|NCT01136733|463719408|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
128843432|NCT01136733|463719409|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
128843433|NCT01136733|463719410|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
128843434|NCT01136733|463719411|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
128843435|NCT01136733|463719405|FG000|Phase 1b|Clinical Progression|1|||
128843436|NCT01136733|463719406|FG001|Phase 1b|Clinical Progression|1|||
128843437|NCT01136733|463719407|FG002|Phase 1b|Clinical Progression|0|||
128843438|NCT01136733|463719408|FG003|Phase 1b|Clinical Progression|0|||
128843439|NCT01136733|463719409|FG004|Phase 1b|Clinical Progression|0|||
128843440|NCT01136733|463719410|FG005|Phase 1b|Clinical Progression|0|||
128843441|NCT01136733|463719411|FG006|Phase 1b|Clinical Progression|0|||
128843442|NCT01136733|463719405|FG000|Phase 2|Disease Progression|0|||
128843443|NCT01136733|463719406|FG001|Phase 2|Disease Progression|0|||
128843444|NCT01136733|463719407|FG002|Phase 2|Disease Progression|0|||
128843445|NCT01136733|463719408|FG003|Phase 2|Disease Progression|0|||
128843446|NCT01136733|463719409|FG004|Phase 2|Disease Progression|30|||
128843447|NCT01136733|463719410|FG005|Phase 2|Disease Progression|32|||
128843448|NCT01136733|463719411|FG006|Phase 2|Disease Progression|38|||
128843449|NCT01136733|463719405|FG000|Phase 2|Adverse Event|0|||
128843450|NCT01136733|463719406|FG001|Phase 2|Adverse Event|0|||
128843451|NCT01136733|463719407|FG002|Phase 2|Adverse Event|0|||
128843452|NCT01136733|463719408|FG003|Phase 2|Adverse Event|0|||
128843453|NCT01136733|463719409|FG004|Phase 2|Adverse Event|11|||
128843454|NCT01136733|463719410|FG005|Phase 2|Adverse Event|13|||
128843455|NCT01136733|463719411|FG006|Phase 2|Adverse Event|5|||
128843456|NCT01136733|463719405|FG000|Phase 2|Participant Choice|0|||
128843457|NCT01136733|463719406|FG001|Phase 2|Participant Choice|0|||
128843458|NCT01136733|463719407|FG002|Phase 2|Participant Choice|0|||
128843459|NCT01136733|463719408|FG003|Phase 2|Participant Choice|0|||
128843460|NCT01136733|463719409|FG004|Phase 2|Participant Choice|3|||
128843461|NCT01136733|463719410|FG005|Phase 2|Participant Choice|0|||
128843462|NCT01136733|463719411|FG006|Phase 2|Participant Choice|1|||
128843463|NCT01136733|463719405|FG000|Phase 2|Administrative-Withdrew Consent|0|||
128843464|NCT01136733|463719406|FG001|Phase 2|Administrative-Withdrew Consent|0|||
128843465|NCT01136733|463719407|FG002|Phase 2|Administrative-Withdrew Consent|0|||
128843466|NCT01136733|463719408|FG003|Phase 2|Administrative-Withdrew Consent|0|||
128843467|NCT01136733|463719409|FG004|Phase 2|Administrative-Withdrew Consent|1|||
128843468|NCT01136733|463719410|FG005|Phase 2|Administrative-Withdrew Consent|0|||
128843469|NCT01136733|463719411|FG006|Phase 2|Administrative-Withdrew Consent|0|||
128843470|NCT01136733|463719405|FG000|Phase 2|Other|0|||
128843471|NCT01136733|463719406|FG001|Phase 2|Other|0|||
128843472|NCT01136733|463719407|FG002|Phase 2|Other|0|||
128843473|NCT01136733|463719408|FG003|Phase 2|Other|0|||
128843474|NCT01136733|463719409|FG004|Phase 2|Other|6|||
128843475|NCT01136733|463719410|FG005|Phase 2|Other|7|||
128843476|NCT01136733|463719411|FG006|Phase 2|Other|6|||
128843477|NCT03360071|463719413|FG000|Overall Study|Lost to Follow-up|1|||
128843478|NCT03360071|463719414|FG001|Overall Study|Lost to Follow-up|0|||
128843479|NCT05274906|463719418|FG000|Overall Study|Withdrawal by Subject|2|||
128843480|NCT05274906|463719419|FG001|Overall Study|Withdrawal by Subject|1|||
128843481|NCT02213458|463719421|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
128843482|NCT02213458|463719422|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
128843483|NCT02213458|463719421|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
128843484|NCT02213458|463719422|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
128843485|NCT02213458|463719421|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
128843486|NCT02213458|463719422|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
128843487|NCT02213458|463719421|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
128843488|NCT02213458|463719422|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
128843489|NCT02213458|463719421|FG000|Overall Study|Refused re-consent|6|||
128843490|NCT02213458|463719422|FG001|Overall Study|Refused re-consent|0|||
128843491|NCT02213458|463719421|FG000|Overall Study|Lost to Follow-up|2|||
128843492|NCT02213458|463719422|FG001|Overall Study|Lost to Follow-up|2|||
128843493|NCT02213458|463719421|FG000|Overall Study|Withdrawal by Subject|26|||
128843494|NCT02213458|463719422|FG001|Overall Study|Withdrawal by Subject|8|||
128843495|NCT00910871|463719423|FG000|Overall Study|Adverse Event|5|||
128843496|NCT00910871|463719423|FG000|Overall Study|Death|12|||
128843497|NCT00910871|463719423|FG000|Overall Study|Lost to Follow-up|8|||
128843498|NCT00910871|463719423|FG000|Overall Study|Protocol Violation|11|||
128843499|NCT00910871|463719423|FG000|Overall Study|Withdrawal by Subject|12|||
128843500|NCT00910871|463719423|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
128843501|NCT00910871|463719423|FG000|Overall Study|Undefined|1|||
128843502|NCT04043806|463719424|FG000|Overall Study|Commercial drug is available for participants|13|||
128843503|NCT04043806|463719424|FG000|Overall Study|Physician Decision|2|||
128843504|NCT04043806|463719424|FG000|Overall Study|Other|12|||
128843505|NCT04043806|463719424|FG000|Overall Study|Adverse Event|2|||
128843506|NCT04043806|463719424|FG000|Overall Study|Lost to Follow-up|6|||
128843507|NCT04043806|463719424|FG000|Overall Study|Other non-compliance|2|||
128843508|NCT04043806|463719424|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
128843509|NCT04043806|463719424|FG000|Overall Study|Never Dosed|1|||
128843510|NCT04799587|463719426|FG000|Overall Study|Withdrawal by Subject|0|||
128843511|NCT04799587|463719427|FG001|Overall Study|Withdrawal by Subject|1|||
128843512|NCT01613599|463719430|FG000|Overall Study|Death|9|||
128843513|NCT01613599|463719430|FG000|Overall Study|Lost to Follow-up|5|||
128843514|NCT01613599|463719430|FG000|Overall Study|Withdrawal by Subject|8|||
128843515|NCT01613599|463719430|FG000|Overall Study|Reason not specified|3|||
128843516|NCT01075815|463719432|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
128843517|NCT01075815|463719433|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
128843518|NCT01075815|463719432|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
128843519|NCT01075815|463719433|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
128843520|NCT01075815|463719432|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
128843521|NCT01075815|463719433|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
128843522|NCT00617708|463719436|FG000|Overall Study|Adverse Event|0|||
128843523|NCT00617708|463719437|FG001|Overall Study|Adverse Event|6|||
128843524|NCT00617708|463719438|FG002|Overall Study|Adverse Event|9|||
128843525|NCT00617708|463719436|FG000|Overall Study|Withdrawal by Subject|1|||
128843526|NCT00617708|463719437|FG001|Overall Study|Withdrawal by Subject|1|||
128843527|NCT00617708|463719438|FG002|Overall Study|Withdrawal by Subject|7|||
128843528|NCT00617708|463719436|FG000|Overall Study|Death|0|||
128843529|NCT00617708|463719437|FG001|Overall Study|Death|6|||
128843530|NCT00617708|463719438|FG002|Overall Study|Death|5|||
128843531|NCT00617708|463719436|FG000|Overall Study|Progression/Relapse|7|||
128843532|NCT00617708|463719437|FG001|Overall Study|Progression/Relapse|40|||
128843533|NCT00617708|463719438|FG002|Overall Study|Progression/Relapse|36|||
128843534|NCT00617708|463719436|FG000|Overall Study|Not protocol specified|1|||
128843535|NCT00617708|463719437|FG001|Overall Study|Not protocol specified|4|||
128843536|NCT00617708|463719438|FG002|Overall Study|Not protocol specified|2|||
128843537|NCT00617708|463719436|FG000|Overall Study|Not eligible|1|||
128843538|NCT00617708|463719437|FG001|Overall Study|Not eligible|3|||
128843539|NCT00617708|463719438|FG002|Overall Study|Not eligible|5|||
128843540|NCT02058992|463719439|FG000|Overall Study|Lost to Follow-up|4|||
128843541|NCT02058992|463719439|FG000|Overall Study|Protocol Violation|92|||
128843542|NCT02058992|463719439|FG000|Overall Study|CRF Uncollected|20|||
128843543|NCT03503188|463719440|FG000|Overall Study|Non eligible in the sub study|0|||
128843544|NCT03503188|463719441|FG001|Overall Study|Non eligible in the sub study|1|||
128843545|NCT03747575|463719448|FG000|Overall Study|Withdrawal by Subject|6|||
128843546|NCT03747575|463719449|FG001|Overall Study|Withdrawal by Subject|3|||
128843547|NCT03747575|463719448|FG000|Overall Study|Lost to Follow-up|3|||
128843548|NCT03747575|463719449|FG001|Overall Study|Lost to Follow-up|3|||
128843549|NCT03747575|463719448|FG000|Overall Study|Adverse Event|0|||
128843550|NCT03747575|463719449|FG001|Overall Study|Adverse Event|1|||
128843551|NCT03005106|463719450|FG000|Overall Study|Lost to Follow-up|16|||
128843552|NCT03005106|463719450|FG000|Overall Study|Adverse Event|1|||
128843553|NCT03005106|463719450|FG000|Overall Study|Physician Decision|1|||
128843554|NCT03005106|463719450|FG000|Overall Study|Death|2|||
128843555|NCT00321672|463719453|FG000|Overall Study|Withdrawal by Subject|5|||
128843556|NCT00321672|463719454|FG001|Overall Study|Withdrawal by Subject|1|||
128843557|NCT00321672|463719455|FG002|Overall Study|Withdrawal by Subject|2|||
128843558|NCT00321672|463719456|FG003|Overall Study|Withdrawal by Subject|0|||
128843559|NCT00321672|463719453|FG000|Overall Study|Noncompliance|1|||
128843560|NCT00321672|463719454|FG001|Overall Study|Noncompliance|2|||
128843561|NCT00321672|463719455|FG002|Overall Study|Noncompliance|1|||
128843562|NCT00321672|463719456|FG003|Overall Study|Noncompliance|0|||
128843563|NCT00321672|463719453|FG000|Overall Study|Adverse Event|1|||
128843564|NCT00321672|463719454|FG001|Overall Study|Adverse Event|1|||
128843565|NCT00321672|463719455|FG002|Overall Study|Adverse Event|0|||
128843566|NCT00321672|463719456|FG003|Overall Study|Adverse Event|0|||
128843567|NCT00321672|463719453|FG000|Overall Study|Lack of Efficacy|1|||
128843568|NCT00321672|463719454|FG001|Overall Study|Lack of Efficacy|1|||
128843569|NCT00321672|463719455|FG002|Overall Study|Lack of Efficacy|0|||
128843570|NCT00321672|463719456|FG003|Overall Study|Lack of Efficacy|0|||
128843571|NCT00321672|463719453|FG000|Overall Study|Lost to Follow-up|2|||
128843572|NCT00321672|463719454|FG001|Overall Study|Lost to Follow-up|0|||
128843573|NCT00321672|463719455|FG002|Overall Study|Lost to Follow-up|4|||
128843574|NCT00321672|463719456|FG003|Overall Study|Lost to Follow-up|2|||
128843575|NCT00321672|463719453|FG000|Overall Study|Death|1|||
128843576|NCT00321672|463719454|FG001|Overall Study|Death|0|||
128843577|NCT00321672|463719455|FG002|Overall Study|Death|0|||
128843578|NCT00321672|463719456|FG003|Overall Study|Death|0|||
128843579|NCT00321672|463719453|FG000|Overall Study|Too far to travel for visits|1|||
128843580|NCT00321672|463719454|FG001|Overall Study|Too far to travel for visits|0|||
128843581|NCT00321672|463719455|FG002|Overall Study|Too far to travel for visits|0|||
128843582|NCT00321672|463719456|FG003|Overall Study|Too far to travel for visits|0|||
128843583|NCT00321672|463719453|FG000|Overall Study|Incarcerated|0|||
128843584|NCT00321672|463719454|FG001|Overall Study|Incarcerated|0|||
128843585|NCT00321672|463719455|FG002|Overall Study|Incarcerated|2|||
128843586|NCT00321672|463719456|FG003|Overall Study|Incarcerated|0|||
128843587|NCT00321672|463719453|FG000|Overall Study|Moved out of state|0|||
128843588|NCT00321672|463719454|FG001|Overall Study|Moved out of state|1|||
128843589|NCT00321672|463719455|FG002|Overall Study|Moved out of state|1|||
128843590|NCT00321672|463719456|FG003|Overall Study|Moved out of state|0|||
128843591|NCT00321672|463719453|FG000|Overall Study|Protocol Violation|0|||
128843592|NCT00321672|463719454|FG001|Overall Study|Protocol Violation|0|||
128843593|NCT00321672|463719455|FG002|Overall Study|Protocol Violation|1|||
128843594|NCT00321672|463719456|FG003|Overall Study|Protocol Violation|0|||
128843595|NCT00321672|463719453|FG000|Overall Study|Diagnosis of testicular cancer|0|||
128843596|NCT00321672|463719454|FG001|Overall Study|Diagnosis of testicular cancer|1|||
128843597|NCT00321672|463719455|FG002|Overall Study|Diagnosis of testicular cancer|0|||
128843598|NCT00321672|463719456|FG003|Overall Study|Diagnosis of testicular cancer|0|||
128843599|NCT00321672|463719453|FG000|Overall Study|Extensive travel required for new job|0|||
128843600|NCT00321672|463719454|FG001|Overall Study|Extensive travel required for new job|1|||
128843601|NCT00321672|463719455|FG002|Overall Study|Extensive travel required for new job|0|||
128843602|NCT00321672|463719456|FG003|Overall Study|Extensive travel required for new job|0|||
128843603|NCT00512902|463719457|FG000|Overall Study|Adverse Event|7|||
128843604|NCT00512902|463719457|FG000|Overall Study|Lost to Follow-up|1|||
128843605|NCT03019289|463719458|FG000|Overall Study|Adverse Event|1|||
128843606|NCT03019289|463719459|FG001|Overall Study|Adverse Event|0|||
128843607|NCT03019289|463719460|FG002|Overall Study|Adverse Event|0|||
128843608|NCT03019289|463719461|FG003|Overall Study|Adverse Event|0|||
128843609|NCT03019289|463719462|FG004|Overall Study|Adverse Event|0|||
128843610|NCT03019289|463719463|FG005|Overall Study|Adverse Event|0|||
128843611|NCT03019289|463719464|FG006|Overall Study|Adverse Event|0|||
128843612|NCT03019289|463719465|FG007|Overall Study|Adverse Event|0|||
128843613|NCT03019289|463719466|FG008|Overall Study|Adverse Event|1|||
128843614|NCT03019289|463719458|FG000|Overall Study|Other|1|||
128843615|NCT03019289|463719459|FG001|Overall Study|Other|0|||
128843616|NCT03019289|463719460|FG002|Overall Study|Other|0|||
128843617|NCT03019289|463719461|FG003|Overall Study|Other|0|||
128843618|NCT03019289|463719462|FG004|Overall Study|Other|0|||
128843619|NCT03019289|463719463|FG005|Overall Study|Other|0|||
128843620|NCT03019289|463719464|FG006|Overall Study|Other|0|||
128843621|NCT03019289|463719465|FG007|Overall Study|Other|0|||
128843622|NCT03019289|463719466|FG008|Overall Study|Other|0|||
128843623|NCT00936065|463719467|FG000|Overall Study|Adverse Event|1|||
128843624|NCT00936065|463719468|FG001|Overall Study|Adverse Event|0|||
128843625|NCT00936065|463719469|FG002|Overall Study|Adverse Event|1|||
128843626|NCT00936065|463719467|FG000|Overall Study|Lack of Efficacy|1|||
128843627|NCT00936065|463719468|FG001|Overall Study|Lack of Efficacy|0|||
128843628|NCT00936065|463719469|FG002|Overall Study|Lack of Efficacy|1|||
128843629|NCT00936065|463719467|FG000|Overall Study|Lost to Follow-up|1|||
128843630|NCT00936065|463719468|FG001|Overall Study|Lost to Follow-up|0|||
128843631|NCT00936065|463719469|FG002|Overall Study|Lost to Follow-up|0|||
128843632|NCT00936065|463719467|FG000|Overall Study|Protocol Violation|1|||
128843633|NCT00936065|463719468|FG001|Overall Study|Protocol Violation|2|||
128843634|NCT00936065|463719469|FG002|Overall Study|Protocol Violation|1|||
128843635|NCT00936065|463719467|FG000|Overall Study|Withdrawal by Subject|0|||
128843636|NCT00936065|463719468|FG001|Overall Study|Withdrawal by Subject|2|||
128843637|NCT00936065|463719469|FG002|Overall Study|Withdrawal by Subject|4|||
128843638|NCT02389894|463719470|FG000|Overall Study|Death|4|||
128843639|NCT02389894|463719471|FG001|Overall Study|Death|5|||
128843640|NCT02389894|463719472|FG002|Overall Study|Death|3|||
128843641|NCT02389894|463719470|FG000|Overall Study|Withdrawal by Subject|2|||
128843642|NCT02389894|463719471|FG001|Overall Study|Withdrawal by Subject|4|||
128843643|NCT02389894|463719472|FG002|Overall Study|Withdrawal by Subject|5|||
128843644|NCT02389894|463719470|FG000|Overall Study|Lost to Follow-up|2|||
128843645|NCT02389894|463719471|FG001|Overall Study|Lost to Follow-up|1|||
128843646|NCT02389894|463719472|FG002|Overall Study|Lost to Follow-up|1|||
128843647|NCT01429285|463719473|FG000|Overall Study|Protocol Violation|9|||
128843648|NCT01429285|463719474|FG001|Overall Study|Protocol Violation|4|||
128843649|NCT01429285|463719473|FG000|Overall Study|Missing Data|5|||
128843650|NCT01429285|463719474|FG001|Overall Study|Missing Data|3|||
128843651|NCT01429285|463719473|FG000|Overall Study|Erroneously Enrolled Twice|8|||
128843652|NCT01429285|463719474|FG001|Overall Study|Erroneously Enrolled Twice|2|||
128843653|NCT03689452|463719480|FG000|Overall Study|Lost to Follow-up|1|||
128843654|NCT03689452|463719481|FG001|Overall Study|Lost to Follow-up|1|||
128843655|NCT02676778|463719483|FG000|Overall Study|Disease Progression|7|||
128843656|NCT02676778|463719484|FG001|Overall Study|Disease Progression|3|||
128843657|NCT02676778|463719485|FG002|Overall Study|Disease Progression|1|||
128843658|NCT02676778|463719483|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
128843659|NCT02676778|463719484|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
128843660|NCT02676778|463719485|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
128843661|NCT02676778|463719483|FG000|Overall Study|Withdrawal by Subject|3|||
128843662|NCT02676778|463719484|FG001|Overall Study|Withdrawal by Subject|2|||
128843663|NCT02676778|463719485|FG002|Overall Study|Withdrawal by Subject|0|||
128843664|NCT02676778|463719483|FG000|Overall Study|Other|4|||
128843665|NCT02676778|463719484|FG001|Overall Study|Other|3|||
128843666|NCT02676778|463719485|FG002|Overall Study|Other|0|||
128843667|NCT02676778|463719483|FG000|Overall Study|Adverse Event|2|||
128843668|NCT02676778|463719484|FG001|Overall Study|Adverse Event|3|||
128843669|NCT02676778|463719485|FG002|Overall Study|Adverse Event|0|||
128843670|NCT00732498|463719486|FG000|Overall Study|Ineligible|1|||
128843671|NCT00732498|463719486|FG000|Overall Study|Adverse Event|2|||
128843672|NCT00732498|463719486|FG000|Overall Study|Physician Decision|3|||
128843673|NCT03394508|463719492|FG000|Overall Study|Protocol Violation|0|||
128843674|NCT03394508|463719493|FG001|Overall Study|Protocol Violation|3|||
128843675|NCT03394508|463719492|FG000|Overall Study|Lost to Follow-up|1|||
128843676|NCT03394508|463719493|FG001|Overall Study|Lost to Follow-up|0|||
128843677|NCT01288729|463719494|FG000|Overall Study|Withdrawal by Subject|1|||
128843678|NCT01288729|463719495|FG001|Overall Study|Withdrawal by Subject|0|||
128843679|NCT03214198|463719496|FG000|Overall Study|Case Report Forms Uncollected|18|||
128843680|NCT03214198|463719496|FG000|Overall Study|Protocol Deviation|18|||
128843681|NCT04295499|463719497|FG000|Overall Study|moving out of state|1|||
128843682|NCT04295499|463719498|FG001|Overall Study|moving out of state|0|||
128843683|NCT04295499|463719497|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
128843684|NCT04295499|463719498|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
128843685|NCT03122548|463719499|FG000|Overall Study|Death|2|||
128843686|NCT03122548|463719499|FG000|Overall Study|Progression - subject went into hospice|1|||
128843687|NCT03122548|463719499|FG000|Overall Study|Study Terminated by Sponsor|2|||
128843688|NCT02135445|463719500|FG000|Overall Study|Lost to Follow-up|1|||
128843689|NCT02135445|463719501|FG001|Overall Study|Lost to Follow-up|0|||
128843690|NCT02135445|463719500|FG000|Overall Study|Withdrawal by Subject|1|||
128843691|NCT02135445|463719501|FG001|Overall Study|Withdrawal by Subject|0|||
128843692|NCT04448561|463719507|FG000|Overall Study|Noncompliance|1|||
128843693|NCT04448561|463719508|FG001|Overall Study|Noncompliance|0|||
128843694|NCT02136797|463720865|FG000|Overall Study|Not Treated|8|||
128843695|NCT03694210|463720866|FG000|Overall Study|Death|1|||
128843696|NCT03694210|463720866|FG000|Overall Study|Screen Failure|7|||
128843697|NCT03050372|463720867|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
128843698|NCT03050372|463720868|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
128843699|NCT03050372|463720867|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
128843700|NCT03050372|463720868|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
128843701|NCT03672188|463720871|FG000|Overall Study|Withdrawal by Subject|0|||
128843702|NCT03672188|463720872|FG001|Overall Study|Withdrawal by Subject|0|||
128843703|NCT03672188|463720873|FG002|Overall Study|Withdrawal by Subject|0|||
128843704|NCT03672188|463720874|FG003|Overall Study|Withdrawal by Subject|3|||
128843705|NCT03672188|463720875|FG004|Overall Study|Withdrawal by Subject|0|||
128843706|NCT03672188|463720876|FG005|Overall Study|Withdrawal by Subject|0|||
128843707|NCT03672188|463720877|FG006|Overall Study|Withdrawal by Subject|0|||
128843708|NCT03672188|463720878|FG007|Overall Study|Withdrawal by Subject|0|||
128843709|NCT03672188|463720879|FG008|Overall Study|Withdrawal by Subject|0|||
128843710|NCT03672188|463720880|FG009|Overall Study|Withdrawal by Subject|0|||
128843711|NCT03672188|463720881|FG010|Overall Study|Withdrawal by Subject|0|||
128843712|NCT03672188|463720882|FG011|Overall Study|Withdrawal by Subject|0|||
128843713|NCT03672188|463720883|FG012|Overall Study|Withdrawal by Subject|0|||
128843714|NCT03672188|463720884|FG013|Overall Study|Withdrawal by Subject|0|||
128843715|NCT03672188|463720885|FG014|Overall Study|Withdrawal by Subject|0|||
128843716|NCT03672188|463720871|FG000|Overall Study|Death|0|||
128843717|NCT03672188|463720872|FG001|Overall Study|Death|0|||
128843718|NCT03672188|463720873|FG002|Overall Study|Death|0|||
128843719|NCT03672188|463720874|FG003|Overall Study|Death|0|||
128843720|NCT03672188|463720875|FG004|Overall Study|Death|0|||
128843721|NCT03672188|463720876|FG005|Overall Study|Death|0|||
128843722|NCT03672188|463720877|FG006|Overall Study|Death|0|||
128843723|NCT03672188|463720878|FG007|Overall Study|Death|0|||
128843724|NCT03672188|463720879|FG008|Overall Study|Death|0|||
128843725|NCT03672188|463720880|FG009|Overall Study|Death|0|||
128843726|NCT03672188|463720881|FG010|Overall Study|Death|0|||
128843727|NCT03672188|463720882|FG011|Overall Study|Death|0|||
128843728|NCT03672188|463720883|FG012|Overall Study|Death|1|||
128843729|NCT03672188|463720884|FG013|Overall Study|Death|0|||
128843730|NCT03672188|463720885|FG014|Overall Study|Death|0|||
128843731|NCT03672188|463720871|FG000|Overall Study|Lost to Follow-up|0|||
128843732|NCT03672188|463720872|FG001|Overall Study|Lost to Follow-up|0|||
128843733|NCT03672188|463720873|FG002|Overall Study|Lost to Follow-up|1|||
128843734|NCT03672188|463720874|FG003|Overall Study|Lost to Follow-up|0|||
128843735|NCT03672188|463720875|FG004|Overall Study|Lost to Follow-up|0|||
128843736|NCT03672188|463720876|FG005|Overall Study|Lost to Follow-up|0|||
128843737|NCT03672188|463720877|FG006|Overall Study|Lost to Follow-up|0|||
128843738|NCT03672188|463720878|FG007|Overall Study|Lost to Follow-up|0|||
128843739|NCT03672188|463720879|FG008|Overall Study|Lost to Follow-up|0|||
128843740|NCT03672188|463720880|FG009|Overall Study|Lost to Follow-up|0|||
128843741|NCT03672188|463720881|FG010|Overall Study|Lost to Follow-up|0|||
128843742|NCT03672188|463720882|FG011|Overall Study|Lost to Follow-up|0|||
128843743|NCT03672188|463720883|FG012|Overall Study|Lost to Follow-up|0|||
128843744|NCT03672188|463720884|FG013|Overall Study|Lost to Follow-up|0|||
128843745|NCT03672188|463720885|FG014|Overall Study|Lost to Follow-up|0|||
128843746|NCT03320941|463720893|FG000|Overall Study|subject/guardian decision|0|||
128843747|NCT03320941|463720894|FG001|Overall Study|subject/guardian decision|0|||
128843748|NCT03320941|463720895|FG002|Overall Study|subject/guardian decision|0|||
128843749|NCT03320941|463720896|FG003|Overall Study|subject/guardian decision|1|||
128843750|NCT03320941|463720897|FG004|Overall Study|subject/guardian decision|0|||
128843751|NCT03614923|463720898|FG000|Overall Study|Withdrawal by Subject|2|||
128843752|NCT03614923|463720899|FG001|Overall Study|Withdrawal by Subject|1|||
128843753|NCT03614923|463720900|FG002|Overall Study|Withdrawal by Subject|1|||
128843754|NCT03614923|463720898|FG000|Overall Study|Adverse Event|0|||
128843755|NCT03614923|463720899|FG001|Overall Study|Adverse Event|2|||
128843756|NCT03614923|463720900|FG002|Overall Study|Adverse Event|1|||
128843757|NCT03614923|463720898|FG000|Overall Study|Lost to Follow-up|1|||
128843758|NCT03614923|463720899|FG001|Overall Study|Lost to Follow-up|0|||
128843759|NCT03614923|463720900|FG002|Overall Study|Lost to Follow-up|1|||
128843760|NCT03614923|463720898|FG000|Overall Study|Lack of Efficacy|2|||
128843761|NCT03614923|463720899|FG001|Overall Study|Lack of Efficacy|0|||
128843762|NCT03614923|463720900|FG002|Overall Study|Lack of Efficacy|1|||
128843763|NCT03614923|463720898|FG000|Overall Study|Non-compliance|0|||
128843764|NCT03614923|463720899|FG001|Overall Study|Non-compliance|1|||
128843765|NCT03614923|463720900|FG002|Overall Study|Non-compliance|0|||
128843766|NCT03614923|463720898|FG000|Overall Study|Other|0|||
128843767|NCT03614923|463720899|FG001|Overall Study|Other|1|||
128843768|NCT03614923|463720900|FG002|Overall Study|Other|1|||
128843769|NCT01107353|463720901|FG000|Overall Study|Positive Drug Screen|1|||
128843770|NCT01107353|463720902|FG001|Overall Study|Positive Drug Screen|0|||
128843771|NCT01193283|463720903|FG000|Overall Study|Death|1|||
128843772|NCT02368691|463720906|FG000|Overall Study|Death|13|||
128843773|NCT02368691|463720906|FG000|Overall Study|Lack of Efficacy|15|||
128843774|NCT02368691|463720906|FG000|Overall Study|Physician Decision|4|||
128843775|NCT03314233|463720910|FG000|Overall Study|No longer eligible at time of delivery|1|||
128843776|NCT00168805|463720912|FG000|Overall Study|Adverse Event|7|||
128843777|NCT00168805|463720913|FG001|Overall Study|Adverse Event|11|||
128843778|NCT00168805|463720914|FG002|Overall Study|Adverse Event|16|||
128843779|NCT00168805|463720912|FG000|Overall Study|Protocol Violation|12|||
128843780|NCT00168805|463720913|FG001|Overall Study|Protocol Violation|11|||
128843781|NCT00168805|463720914|FG002|Overall Study|Protocol Violation|8|||
128843782|NCT00168805|463720912|FG000|Overall Study|Lost to Follow-up|12|||
128843783|NCT00168805|463720913|FG001|Overall Study|Lost to Follow-up|17|||
128843784|NCT00168805|463720914|FG002|Overall Study|Lost to Follow-up|11|||
128843785|NCT00168805|463720912|FG000|Overall Study|Withdrawal by Subject|16|||
128843786|NCT00168805|463720913|FG001|Overall Study|Withdrawal by Subject|18|||
128843787|NCT00168805|463720914|FG002|Overall Study|Withdrawal by Subject|21|||
128843788|NCT00168805|463720912|FG000|Overall Study|Other|24|||
128843789|NCT00168805|463720913|FG001|Overall Study|Other|21|||
128843790|NCT00168805|463720914|FG002|Overall Study|Other|22|||
128843791|NCT00168805|463720912|FG000|Treatment|Adverse Event|25|||
128843792|NCT00168805|463720913|FG001|Treatment|Adverse Event|26|||
128843793|NCT00168805|463720914|FG002|Treatment|Adverse Event|32|||
128843794|NCT00168805|463720912|FG000|Treatment|Protocol Violation|3|||
128843795|NCT00168805|463720913|FG001|Treatment|Protocol Violation|5|||
128843796|NCT00168805|463720914|FG002|Treatment|Protocol Violation|5|||
128843797|NCT00168805|463720912|FG000|Treatment|Withdrawal by Subject|3|||
128843798|NCT00168805|463720913|FG001|Treatment|Withdrawal by Subject|7|||
128843799|NCT00168805|463720914|FG002|Treatment|Withdrawal by Subject|8|||
128843800|NCT00168805|463720912|FG000|Treatment|Other|18|||
128843801|NCT00168805|463720913|FG001|Treatment|Other|18|||
128843802|NCT00168805|463720914|FG002|Treatment|Other|17|||
128843803|NCT01114217|463720915|FG000|Overall Study|Adverse Event|5|||
128843804|NCT01114217|463720916|FG001|Overall Study|Adverse Event|3|||
128843805|NCT01114217|463720915|FG000|Overall Study|Lost to Follow-up|17|||
128843806|NCT01114217|463720916|FG001|Overall Study|Lost to Follow-up|33|||
128843807|NCT01114217|463720915|FG000|Overall Study|Withdrawal by Subject|21|||
128843808|NCT01114217|463720916|FG001|Overall Study|Withdrawal by Subject|28|||
128843809|NCT01114217|463720915|FG000|Overall Study|Other-Clerical Error|3|||
128843810|NCT01114217|463720916|FG001|Overall Study|Other-Clerical Error|0|||
128843811|NCT01114217|463720915|FG000|Overall Study|Other-Early termination|6|||
128843812|NCT01114217|463720916|FG001|Overall Study|Other-Early termination|10|||
128843813|NCT01114217|463720915|FG000|Overall Study|Other-Procedure|1|||
128843814|NCT01114217|463720916|FG001|Overall Study|Other-Procedure|1|||
128843815|NCT01114217|463720915|FG000|Overall Study|Other-Pregnancy|2|||
128843816|NCT01114217|463720916|FG001|Overall Study|Other-Pregnancy|4|||
128843817|NCT01114217|463720915|FG000|Overall Study|Other-Protocol Violation|1|||
128843818|NCT01114217|463720916|FG001|Overall Study|Other-Protocol Violation|3|||
128843819|NCT01114217|463720915|FG000|Overall Study|Other-Lack of Efficacy|1|||
128843820|NCT01114217|463720916|FG001|Overall Study|Other-Lack of Efficacy|0|||
128843821|NCT01114217|463720915|FG000|Overall Study|Other-Non Compliance|2|||
128843822|NCT01114217|463720916|FG001|Overall Study|Other-Non Compliance|0|||
128843823|NCT01114217|463720915|FG000|Overall Study|Other-Physician Decision|1|||
128843824|NCT01114217|463720916|FG001|Overall Study|Other-Physician Decision|1|||
128843825|NCT01114217|463720915|FG000|Overall Study|Other-Sponsor Decision|10|||
128843826|NCT01114217|463720916|FG001|Overall Study|Other-Sponsor Decision|12|||
128843827|NCT01114217|463720915|FG000|Overall Study|Other-Study Termination|0|||
128843828|NCT01114217|463720916|FG001|Overall Study|Other-Study Termination|1|||
128843829|NCT01114217|463720915|FG000|Overall Study|Other-Study Withdrawn|1|||
128843830|NCT01114217|463720916|FG001|Overall Study|Other-Study Withdrawn|1|||
128843831|NCT01114217|463720915|FG000|Overall Study|Other-Site Stopped Communicating|2|||
128843832|NCT01114217|463720916|FG001|Overall Study|Other-Site Stopped Communicating|0|||
128843833|NCT01114217|463720915|FG000|Overall Study|Other-Lost to Follow-up|1|||
128843834|NCT01114217|463720916|FG001|Overall Study|Other-Lost to Follow-up|0|||
128843835|NCT01114217|463720915|FG000|Overall Study|Other-Withdrawal by Subject|1|||
128843836|NCT01114217|463720916|FG001|Overall Study|Other-Withdrawal by Subject|1|||
128843837|NCT01183013|463720917|FG000|Overall Study|Adverse Event|6|||
128843838|NCT01183013|463720918|FG001|Overall Study|Adverse Event|8|||
128843839|NCT01183013|463720919|FG002|Overall Study|Adverse Event|5|||
128843840|NCT01183013|463720920|FG003|Overall Study|Adverse Event|5|||
128843841|NCT01183013|463720921|FG004|Overall Study|Adverse Event|10|||
128843842|NCT01183013|463720922|FG005|Overall Study|Adverse Event|10|||
128843843|NCT01183013|463720923|FG006|Overall Study|Adverse Event|6|||
128843844|NCT01183013|463720917|FG000|Overall Study|Lack of Efficacy|3|||
128843845|NCT01183013|463720918|FG001|Overall Study|Lack of Efficacy|2|||
128843846|NCT01183013|463720919|FG002|Overall Study|Lack of Efficacy|1|||
128843847|NCT01183013|463720920|FG003|Overall Study|Lack of Efficacy|2|||
128843848|NCT01183013|463720921|FG004|Overall Study|Lack of Efficacy|1|||
128843849|NCT01183013|463720922|FG005|Overall Study|Lack of Efficacy|2|||
128843850|NCT01183013|463720923|FG006|Overall Study|Lack of Efficacy|0|||
128843851|NCT01183013|463720917|FG000|Overall Study|Protocol Violation|5|||
128843852|NCT01183013|463720918|FG001|Overall Study|Protocol Violation|2|||
128843853|NCT01183013|463720919|FG002|Overall Study|Protocol Violation|4|||
128843854|NCT01183013|463720920|FG003|Overall Study|Protocol Violation|0|||
128843855|NCT01183013|463720921|FG004|Overall Study|Protocol Violation|4|||
128843856|NCT01183013|463720922|FG005|Overall Study|Protocol Violation|3|||
128843857|NCT01183013|463720923|FG006|Overall Study|Protocol Violation|3|||
128843858|NCT01183013|463720917|FG000|Overall Study|Lost to Follow-up|7|||
128843859|NCT01183013|463720918|FG001|Overall Study|Lost to Follow-up|3|||
128843860|NCT01183013|463720919|FG002|Overall Study|Lost to Follow-up|4|||
128843861|NCT01183013|463720920|FG003|Overall Study|Lost to Follow-up|3|||
128843862|NCT01183013|463720921|FG004|Overall Study|Lost to Follow-up|2|||
128843863|NCT01183013|463720922|FG005|Overall Study|Lost to Follow-up|6|||
128843864|NCT01183013|463720923|FG006|Overall Study|Lost to Follow-up|5|||
128843865|NCT01183013|463720917|FG000|Overall Study|Withdrawal by Subject|9|||
128843866|NCT01183013|463720918|FG001|Overall Study|Withdrawal by Subject|13|||
128843867|NCT01183013|463720919|FG002|Overall Study|Withdrawal by Subject|10|||
128843868|NCT01183013|463720920|FG003|Overall Study|Withdrawal by Subject|8|||
128843869|NCT01183013|463720921|FG004|Overall Study|Withdrawal by Subject|7|||
128843870|NCT01183013|463720922|FG005|Overall Study|Withdrawal by Subject|9|||
128843871|NCT01183013|463720923|FG006|Overall Study|Withdrawal by Subject|10|||
128843872|NCT01183013|463720917|FG000|Overall Study|Reasons other than stated above|15|||
128843873|NCT01183013|463720918|FG001|Overall Study|Reasons other than stated above|11|||
128843874|NCT01183013|463720919|FG002|Overall Study|Reasons other than stated above|17|||
128843875|NCT01183013|463720920|FG003|Overall Study|Reasons other than stated above|12|||
128843876|NCT01183013|463720921|FG004|Overall Study|Reasons other than stated above|12|||
128843877|NCT01183013|463720922|FG005|Overall Study|Reasons other than stated above|15|||
128843878|NCT01183013|463720923|FG006|Overall Study|Reasons other than stated above|13|||
128843879|NCT02722278|463720926|FG000|Overall Study|Withdrawal by Subject|5|||
128843880|NCT02722278|463720927|FG001|Overall Study|Withdrawal by Subject|3|||
128843881|NCT02722278|463720926|FG000|Overall Study|Adverse Event|4|||
128843882|NCT02722278|463720927|FG001|Overall Study|Adverse Event|1|||
128843883|NCT02722278|463720926|FG000|Overall Study|Lost to Follow-up|2|||
128843884|NCT02722278|463720927|FG001|Overall Study|Lost to Follow-up|0|||
128843885|NCT02722278|463720926|FG000|Overall Study|Protocol Violation|1|||
128843886|NCT02722278|463720927|FG001|Overall Study|Protocol Violation|0|||
128843887|NCT02722278|463720926|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
128843888|NCT02722278|463720927|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
128843889|NCT02722278|463720926|FG000|Overall Study|Subject declined after tx assignment|0|||
128843890|NCT02722278|463720927|FG001|Overall Study|Subject declined after tx assignment|1|||
128843891|NCT02722278|463720926|FG000|Overall Study|Site closure not study related|0|||
128843892|NCT02722278|463720927|FG001|Overall Study|Site closure not study related|1|||
128843893|NCT00472199|463720950|FG000|Overall Study|Adverse Event|19|||
128843894|NCT00472199|463720951|FG001|Overall Study|Adverse Event|23|||
128843895|NCT00472199|463720950|FG000|Overall Study|Lack of Efficacy|4|||
128843896|NCT00472199|463720951|FG001|Overall Study|Lack of Efficacy|25|||
128843897|NCT00472199|463720950|FG000|Overall Study|Lost to Follow-up|2|||
128843898|NCT00472199|463720951|FG001|Overall Study|Lost to Follow-up|4|||
128843899|NCT00472199|463720950|FG000|Overall Study|Protocol Violation|3|||
128843900|NCT00472199|463720951|FG001|Overall Study|Protocol Violation|2|||
128843901|NCT00472199|463720950|FG000|Overall Study|Withdrawal by Subject|6|||
128843902|NCT00472199|463720951|FG001|Overall Study|Withdrawal by Subject|5|||
128843903|NCT00472199|463720950|FG000|Overall Study|personal reason|0|||
128843904|NCT00472199|463720951|FG001|Overall Study|personal reason|1|||
128843905|NCT00472199|463720950|FG000|Overall Study|patient was asymptomatic|1|||
128843906|NCT00472199|463720951|FG001|Overall Study|patient was asymptomatic|0|||
128843907|NCT02446912|463720953|FG000|Overall Study|Adverse Event|3|||
128843908|NCT02446912|463720954|FG001|Overall Study|Adverse Event|13|||
128843909|NCT02446912|463720955|FG002|Overall Study|Adverse Event|5|||
128843910|NCT02446912|463720953|FG000|Overall Study|Condition under investigation worsened|0|||
128843911|NCT02446912|463720954|FG001|Overall Study|Condition under investigation worsened|1|||
128843912|NCT02446912|463720955|FG002|Overall Study|Condition under investigation worsened|1|||
128843913|NCT02446912|463720953|FG000|Overall Study|Study-specific withdrawal criteria|1|||
128843914|NCT02446912|463720954|FG001|Overall Study|Study-specific withdrawal criteria|0|||
128843915|NCT02446912|463720955|FG002|Overall Study|Study-specific withdrawal criteria|0|||
128843916|NCT02446912|463720953|FG000|Overall Study|Lack of Efficacy|1|||
128843917|NCT02446912|463720954|FG001|Overall Study|Lack of Efficacy|4|||
128843918|NCT02446912|463720955|FG002|Overall Study|Lack of Efficacy|7|||
128843919|NCT02446912|463720953|FG000|Overall Study|Lost to Follow-up|0|||
128843920|NCT02446912|463720954|FG001|Overall Study|Lost to Follow-up|0|||
128843921|NCT02446912|463720955|FG002|Overall Study|Lost to Follow-up|2|||
128843922|NCT02446912|463720953|FG000|Overall Study|Severe non-compliance to protocol|1|||
128843923|NCT02446912|463720954|FG001|Overall Study|Severe non-compliance to protocol|0|||
128843924|NCT02446912|463720955|FG002|Overall Study|Severe non-compliance to protocol|1|||
128843925|NCT02446912|463720953|FG000|Overall Study|Withdrawal by Subject|10|||
128843926|NCT02446912|463720954|FG001|Overall Study|Withdrawal by Subject|15|||
128843927|NCT02446912|463720955|FG002|Overall Study|Withdrawal by Subject|15|||
128843928|NCT02446912|463720953|FG000|Overall Study|Miscellaneous|2|||
128843929|NCT02446912|463720954|FG001|Overall Study|Miscellaneous|2|||
128843930|NCT02446912|463720955|FG002|Overall Study|Miscellaneous|4|||
128843931|NCT01268488|463720956|FG000|Overall Study|Adverse Event|3|||
128843932|NCT01268488|463720956|FG000|Overall Study|Physician Decision|2|||
128843933|NCT01757171|463720957|FG000|Overall Study|Adverse Event|5|||
128843934|NCT01757171|463720958|FG001|Overall Study|Adverse Event|1|||
128843935|NCT01757171|463720957|FG000|Overall Study|Disease Progression|1|||
128843936|NCT01757171|463720958|FG001|Overall Study|Disease Progression|0|||
128843937|NCT01757171|463720957|FG000|Overall Study|Hospitalization|1|||
128843938|NCT01757171|463720958|FG001|Overall Study|Hospitalization|0|||
128843939|NCT01757171|463720957|FG000|Overall Study|ECOG decline|1|||
128843940|NCT01757171|463720958|FG001|Overall Study|ECOG decline|0|||
128843941|NCT01014013|463720962|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
128843942|NCT01014013|463720963|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
128843943|NCT01014013|463720962|FG000|Overall Study|Clinical adverse experience|4|||
128843944|NCT01014013|463720963|FG001|Overall Study|Clinical adverse experience|2|||
128843945|NCT01014013|463720962|FG000|Overall Study|Laboratory adverse experience|1|||
128843946|NCT01014013|463720963|FG001|Overall Study|Laboratory adverse experience|1|||
128843947|NCT01014013|463720962|FG000|Overall Study|Protocol Violation|1|||
128843948|NCT01014013|463720963|FG001|Overall Study|Protocol Violation|3|||
128843949|NCT01014013|463720962|FG000|Overall Study|Withdrawal by Subject|7|||
128843950|NCT01014013|463720963|FG001|Overall Study|Withdrawal by Subject|4|||
128843951|NCT01014013|463720962|FG000|Overall Study|Clinical/microbiologic failure|1|||
128843952|NCT01014013|463720963|FG001|Overall Study|Clinical/microbiologic failure|2|||
128843953|NCT01014013|463720962|FG000|Overall Study|Pathogen culture = no growth|26|||
128843954|NCT01014013|463720963|FG001|Overall Study|Pathogen culture = no growth|34|||
128843955|NCT01014013|463720962|FG000|Overall Study|Negative urine culture|2|||
128843956|NCT01014013|463720963|FG001|Overall Study|Negative urine culture|0|||
128843957|NCT01014013|463720962|FG000|Overall Study|Pathogen resistant|7|||
128843958|NCT01014013|463720963|FG001|Overall Study|Pathogen resistant|4|||
128843959|NCT01014013|463720962|FG000|Overall Study|Physician Decision|0|||
128843960|NCT01014013|463720963|FG001|Overall Study|Physician Decision|1|||
128843961|NCT01014013|463720962|FG000|Overall Study|Another antibiotic therapy required|0|||
128843962|NCT01014013|463720963|FG001|Overall Study|Another antibiotic therapy required|1|||
128843963|NCT01014013|463720962|FG000|Overall Study|Appendectomy|1|||
128843964|NCT01014013|463720963|FG001|Overall Study|Appendectomy|0|||
128843965|NCT01014013|463720962|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
128843966|NCT01014013|463720963|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
128843967|NCT00316121|463720964|FG000|Overall Study|Death|1|||
128843968|NCT00316121|463720965|FG001|Overall Study|Death|0|||
128843969|NCT00316121|463720964|FG000|Overall Study|Lost to Follow-up|14|||
128843970|NCT00316121|463720965|FG001|Overall Study|Lost to Follow-up|8|||
128843971|NCT00316121|463720964|FG000|Overall Study|Withdrawal by Subject|2|||
128843972|NCT00316121|463720965|FG001|Overall Study|Withdrawal by Subject|0|||
128843973|NCT00316121|463720964|FG000|Overall Study|Reason is missing|1|||
128843974|NCT00316121|463720965|FG001|Overall Study|Reason is missing|0|||
128843975|NCT00316121|463720964|FG000|Overall Study|Subject relocated|1|||
128843976|NCT00316121|463720965|FG001|Overall Study|Subject relocated|1|||
128843977|NCT00316121|463720964|FG000|Overall Study|Subject refused to return|1|||
128843978|NCT00316121|463720965|FG001|Overall Study|Subject refused to return|0|||
128843979|NCT00316121|463720964|FG000|Overall Study|Subject no show for visit x 3|1|||
128843980|NCT00316121|463720965|FG001|Overall Study|Subject no show for visit x 3|0|||
128843981|NCT00316121|463720964|FG000|Overall Study|Subject did not have 24 month visit|1|||
128843982|NCT00316121|463720965|FG001|Overall Study|Subject did not have 24 month visit|0|||
128843983|NCT02305797|463720966|FG000|Overall Study|Adverse Event|11|||
128843984|NCT02305797|463720967|FG001|Overall Study|Adverse Event|2|||
128843985|NCT02305797|463720966|FG000|Overall Study|Withdrawal by Subject|9|||
128843986|NCT02305797|463720967|FG001|Overall Study|Withdrawal by Subject|10|||
128843987|NCT02305797|463720966|FG000|Overall Study|Lack of Efficacy|6|||
128843988|NCT02305797|463720967|FG001|Overall Study|Lack of Efficacy|0|||
128843989|NCT02305797|463720966|FG000|Overall Study|Lost to Follow-up|5|||
128843990|NCT02305797|463720967|FG001|Overall Study|Lost to Follow-up|11|||
128843991|NCT02305797|463720966|FG000|Overall Study|Pregnancy|0|||
128843992|NCT02305797|463720967|FG001|Overall Study|Pregnancy|2|||
128843993|NCT02305797|463720966|FG000|Overall Study|Noncompliance|14|||
128843994|NCT02305797|463720967|FG001|Overall Study|Noncompliance|12|||
128843995|NCT02305797|463720966|FG000|Overall Study|Reason not collected|0|||
128843996|NCT02305797|463720967|FG001|Overall Study|Reason not collected|1|||
128843997|NCT00460577|463720969|FG000|Overall Study|Protocol Violation|2|||
128843998|NCT00460577|463720970|FG001|Overall Study|Protocol Violation|6|||
128843999|NCT01047306|463720971|FG000|Overall Study|Withdrawal by Subject|2|||
128844000|NCT01047306|463720972|FG001|Overall Study|Withdrawal by Subject|0|||
128844001|NCT01047306|463720971|FG000|Overall Study|Lost to Follow-up|1|||
128844002|NCT01047306|463720972|FG001|Overall Study|Lost to Follow-up|0|||
128844003|NCT01878253|463720973|FG000|Overall Study|Death|1|||
128844004|NCT01878253|463720973|FG000|Overall Study|SIdus System Removal|3|||
128844005|NCT01878253|463720973|FG000|Overall Study|Withdrawal by Subject|1|||
128844006|NCT01878253|463720973|FG000|Overall Study|Lost to Follow-up|2|||
128844007|NCT01878253|463720973|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
128844008|NCT02130401|463720976|FG000|Overall Study|Poor enrollment|6|||
128844009|NCT00145496|463720979|FG000|Overall Study|Adverse Event|42|||
128844010|NCT00145496|463720980|FG001|Overall Study|Adverse Event|30|||
128844011|NCT00145496|463720979|FG000|Overall Study|Lack of Efficacy|12|||
128844012|NCT00145496|463720980|FG001|Overall Study|Lack of Efficacy|7|||
128844013|NCT00145496|463720979|FG000|Overall Study|Withdrawal by Subject|32|||
128844014|NCT00145496|463720980|FG001|Overall Study|Withdrawal by Subject|26|||
128844015|NCT00145496|463720979|FG000|Overall Study|Lost to Follow-up|12|||
128844016|NCT00145496|463720980|FG001|Overall Study|Lost to Follow-up|5|||
128844017|NCT00145496|463720979|FG000|Overall Study|Other|25|||
128844018|NCT00145496|463720980|FG001|Overall Study|Other|13|||
128844019|NCT00448344|463720981|FG000|Overall Study|Lost to Follow-up|20|||
128844020|NCT00448344|463720982|FG001|Overall Study|Lost to Follow-up|22|||
128844021|NCT00448344|463720981|FG000|Overall Study|Withdrawal by Subject|6|||
128844022|NCT00448344|463720982|FG001|Overall Study|Withdrawal by Subject|8|||
128844023|NCT00448344|463720981|FG000|Overall Study|Death|3|||
128844024|NCT00448344|463720982|FG001|Overall Study|Death|4|||
128844025|NCT00448344|463720981|FG000|Overall Study|Physician Decision|1|||
128844026|NCT00448344|463720982|FG001|Overall Study|Physician Decision|2|||
128844027|NCT01052714|463720987|FG000|Overall Study|Adverse Event|6|||
128844028|NCT01052714|463720988|FG001|Overall Study|Adverse Event|3|||
128844029|NCT01052714|463720989|FG002|Overall Study|Adverse Event|0|||
128844030|NCT01052714|463720987|FG000|Overall Study|Death|1|||
128844031|NCT01052714|463720988|FG001|Overall Study|Death|2|||
128844032|NCT01052714|463720989|FG002|Overall Study|Death|0|||
128844033|NCT01052714|463720987|FG000|Overall Study|Lost to Follow-up|2|||
128844034|NCT01052714|463720988|FG001|Overall Study|Lost to Follow-up|3|||
128844035|NCT01052714|463720989|FG002|Overall Study|Lost to Follow-up|0|||
128844036|NCT01052714|463720987|FG000|Overall Study|Physician Decision|9|||
128844037|NCT01052714|463720988|FG001|Overall Study|Physician Decision|9|||
128844038|NCT01052714|463720989|FG002|Overall Study|Physician Decision|1|||
128844039|NCT01052714|463720987|FG000|Overall Study|Withdrawal by Subject|7|||
128844040|NCT01052714|463720988|FG001|Overall Study|Withdrawal by Subject|12|||
128844041|NCT01052714|463720989|FG002|Overall Study|Withdrawal by Subject|1|||
128844042|NCT00267865|463720992|FG000|Induction Treatment|Died before completing.|2|||
128844043|NCT00267865|463720992|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
128844044|NCT03686176|463720993|FG000|Overall Study|Procedure cancelled|1|||
128844045|NCT03686176|463720994|FG001|Overall Study|Procedure cancelled|0|||
128844046|NCT03686176|463720995|FG002|Overall Study|Procedure cancelled|0|||
128844047|NCT03686176|463720993|FG000|Overall Study|VR Malfunction|1|||
128844048|NCT03686176|463720994|FG001|Overall Study|VR Malfunction|0|||
128844049|NCT03686176|463720995|FG002|Overall Study|VR Malfunction|0|||
128844050|NCT03530345|463721005|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
128844051|NCT03530345|463721006|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
128844052|NCT03530345|463721005|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
128844053|NCT03530345|463721006|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
128844054|NCT03530345|463721005|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
128844055|NCT03530345|463721006|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
128844056|NCT03530345|463721005|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
128844057|NCT03530345|463721006|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
128844058|NCT00644332|463722340|FG000|Overall Study|Adverse Event|11|||
128844059|NCT00644332|463722340|FG000|Overall Study|Withdrawal by Subject|6|||
128844060|NCT00644332|463722340|FG000|Overall Study|Completion Status Unknown|2|||
128844061|NCT00644332|463722340|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
128844062|NCT00644332|463722340|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
128844063|NCT02706834|463722341|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
128844064|NCT02706834|463722342|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
128844065|NCT02706834|463722343|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
128844066|NCT02706834|463722344|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
128844067|NCT02706834|463722345|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
128844068|NCT02706834|463722346|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
128844069|NCT02706834|463722347|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
128844070|NCT02706834|463722348|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
128844071|NCT02706834|463722349|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
128844072|NCT02706834|463722350|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
128844073|NCT02706834|463722351|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
128844074|NCT02706834|463722341|FG000|Overall Study|Lost to Follow-up|0|||
128844075|NCT02706834|463722342|FG001|Overall Study|Lost to Follow-up|0|||
128844076|NCT02706834|463722343|FG002|Overall Study|Lost to Follow-up|1|||
128844077|NCT02706834|463722344|FG003|Overall Study|Lost to Follow-up|0|||
128844078|NCT02706834|463722345|FG004|Overall Study|Lost to Follow-up|0|||
128844079|NCT02706834|463722346|FG005|Overall Study|Lost to Follow-up|0|||
128844080|NCT02706834|463722347|FG006|Overall Study|Lost to Follow-up|0|||
128844081|NCT02706834|463722348|FG007|Overall Study|Lost to Follow-up|0|||
128844082|NCT02706834|463722349|FG008|Overall Study|Lost to Follow-up|0|||
128844083|NCT02706834|463722350|FG009|Overall Study|Lost to Follow-up|0|||
128844084|NCT02706834|463722351|FG010|Overall Study|Lost to Follow-up|0|||
128844085|NCT02706834|463722341|FG000|Overall Study|Voluntary Withdrawal|1|||
128844086|NCT02706834|463722342|FG001|Overall Study|Voluntary Withdrawal|0|||
128844087|NCT02706834|463722343|FG002|Overall Study|Voluntary Withdrawal|0|||
128844088|NCT02706834|463722344|FG003|Overall Study|Voluntary Withdrawal|0|||
128844089|NCT02706834|463722345|FG004|Overall Study|Voluntary Withdrawal|0|||
128844090|NCT02706834|463722346|FG005|Overall Study|Voluntary Withdrawal|0|||
128844091|NCT02706834|463722347|FG006|Overall Study|Voluntary Withdrawal|0|||
128844092|NCT02706834|463722348|FG007|Overall Study|Voluntary Withdrawal|0|||
128844093|NCT02706834|463722349|FG008|Overall Study|Voluntary Withdrawal|0|||
128844094|NCT02706834|463722350|FG009|Overall Study|Voluntary Withdrawal|1|||
128844095|NCT02706834|463722351|FG010|Overall Study|Voluntary Withdrawal|0|||
128844096|NCT02706834|463722341|FG000|Overall Study|Other Reason Not Specified|1|||
128844097|NCT02706834|463722342|FG001|Overall Study|Other Reason Not Specified|0|||
128844098|NCT02706834|463722343|FG002|Overall Study|Other Reason Not Specified|0|||
128844099|NCT02706834|463722344|FG003|Overall Study|Other Reason Not Specified|0|||
128844100|NCT02706834|463722345|FG004|Overall Study|Other Reason Not Specified|1|||
128844101|NCT02706834|463722346|FG005|Overall Study|Other Reason Not Specified|0|||
128844102|NCT02706834|463722347|FG006|Overall Study|Other Reason Not Specified|0|||
128844103|NCT02706834|463722348|FG007|Overall Study|Other Reason Not Specified|0|||
128844104|NCT02706834|463722349|FG008|Overall Study|Other Reason Not Specified|0|||
128844105|NCT02706834|463722350|FG009|Overall Study|Other Reason Not Specified|0|||
128844106|NCT02706834|463722351|FG010|Overall Study|Other Reason Not Specified|0|||
128844107|NCT00627523|463722353|FG000|Overall Study|Lack of Efficacy|1|||
128844108|NCT00627523|463722354|FG001|Overall Study|Lack of Efficacy|0|||
128844109|NCT00627523|463722353|FG000|Overall Study|Withdrawal by Subject|0|||
128844110|NCT00627523|463722354|FG001|Overall Study|Withdrawal by Subject|2|||
128844111|NCT00627523|463722353|FG000|Overall Study|Other|1|||
128844112|NCT00627523|463722354|FG001|Overall Study|Other|0|||
128844113|NCT00355784|463722355|FG000|Overall Study|Withdrawal by Subject|0|||
128844114|NCT00355784|463722356|FG001|Overall Study|Withdrawal by Subject|0|||
128844115|NCT00355784|463722357|FG002|Overall Study|Withdrawal by Subject|2|||
128844116|NCT02543294|463722358|FG000|Overall Study|Lost to Follow-up|3|||
128844117|NCT02543294|463722358|FG000|Overall Study|Physician Decision|2|||
128844118|NCT02543294|463722358|FG000|Overall Study|Withdrawal by Subject|7|||
128844119|NCT03602053|463722362|FG000|Overall Study|Withdrawal by Subject|7|||
128844120|NCT03602053|463722363|FG001|Overall Study|Withdrawal by Subject|9|||
128844121|NCT03602053|463722364|FG002|Overall Study|Withdrawal by Subject|7|||
128844122|NCT03602053|463722362|FG000|Overall Study|Lost to Follow-up|5|||
128844123|NCT03602053|463722363|FG001|Overall Study|Lost to Follow-up|6|||
128844124|NCT03602053|463722364|FG002|Overall Study|Lost to Follow-up|0|||
128844125|NCT03602053|463722362|FG000|Overall Study|Protocol Violation|3|||
128844126|NCT03602053|463722363|FG001|Overall Study|Protocol Violation|0|||
128844127|NCT03602053|463722364|FG002|Overall Study|Protocol Violation|4|||
128844128|NCT03602053|463722362|FG000|Overall Study|Physician Decision|1|||
128844129|NCT03602053|463722363|FG001|Overall Study|Physician Decision|0|||
128844130|NCT03602053|463722364|FG002|Overall Study|Physician Decision|0|||
128844131|NCT03602053|463722362|FG000|Overall Study|migration|2|||
128844132|NCT03602053|463722363|FG001|Overall Study|migration|3|||
128844133|NCT03602053|463722364|FG002|Overall Study|migration|0|||
128844134|NCT03602053|463722362|FG000|Overall Study|Other|1|||
128844135|NCT03602053|463722363|FG001|Overall Study|Other|0|||
128844136|NCT03602053|463722364|FG002|Overall Study|Other|0|||
128844137|NCT01038128|463722365|FG000|Overall Study|Lack of Efficacy|1|||
128844138|NCT01038128|463722365|FG000|Overall Study|Lost to Follow-up|1|||
128844139|NCT01038128|463722365|FG000|Overall Study|Withdrawal by Subject|2|||
128844140|NCT00396409|463722372|FG000|Period 1 - 2007|Adverse Event|0|||
128844141|NCT00396409|463722373|FG001|Period 1 - 2007|Adverse Event|1|||
128844142|NCT00396409|463722372|FG000|Period 1 - 2007|Lack of Efficacy|0|||
128844143|NCT00396409|463722373|FG001|Period 1 - 2007|Lack of Efficacy|1|||
128844144|NCT00396409|463722372|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
128844145|NCT00396409|463722373|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
128844146|NCT00396409|463722372|FG000|Period 1 - 2007|Lost to Follow-up|2|||
128844147|NCT00396409|463722373|FG001|Period 1 - 2007|Lost to Follow-up|3|||
128844148|NCT00396409|463722372|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
128844149|NCT00396409|463722373|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
128844150|NCT00396409|463722372|FG000|Period 2 - 2008|Protocol Violation|1|||
128844151|NCT00396409|463722373|FG001|Period 2 - 2008|Protocol Violation|0|||
128844152|NCT00396409|463722372|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
128844153|NCT00396409|463722373|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
128844154|NCT00396409|463722372|FG000|Period 2 - 2008|Lost to Follow-up|3|||
128844155|NCT00396409|463722373|FG001|Period 2 - 2008|Lost to Follow-up|1|||
128844156|NCT04203199|463722376|FG000|First Intervention Period|Lost to Follow-up|0|||
128844157|NCT04203199|463722377|FG001|First Intervention Period|Lost to Follow-up|1|||
128844158|NCT04203199|463722376|FG000|Second Intervention Period|Medication change|1|||
128844159|NCT04203199|463722377|FG001|Second Intervention Period|Medication change|0|||
128844160|NCT01745380|463722378|FG000|Overall Study|Lost to Follow-up|1|||
128844161|NCT01745380|463722379|FG001|Overall Study|Lost to Follow-up|0|||
128844162|NCT01745380|463722378|FG000|Overall Study|Lack of Efficacy|0|||
128844163|NCT01745380|463722379|FG001|Overall Study|Lack of Efficacy|1|||
128844164|NCT01882088|463722380|FG000|Overall Study|Intolerance of esophageal manometry|1|||
128844165|NCT01882088|463722380|FG000|Overall Study|no possibility to place the catheter|1|||
128844166|NCT01882088|463722380|FG000|Overall Study|Protocol Violation|1|||
128844167|NCT01882088|463722380|FG000|Overall Study|inadequate pH-impedance tracings|2|||
128844168|NCT03785210|463722383|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
128844169|NCT03785210|463722384|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
128844170|NCT02720198|463722388|FG000|Overall Study|Withdrawal by Subject|0|||
128844171|NCT02720198|463722389|FG001|Overall Study|Withdrawal by Subject|1|||
128844172|NCT04879823|463722390|FG000|Overall Study|Physician Decision|3|||
128844173|NCT04879823|463722391|FG001|Overall Study|Physician Decision|1|||
128844174|NCT04879823|463722390|FG000|Overall Study|Protocol Violation|2|||
128844175|NCT04879823|463722391|FG001|Overall Study|Protocol Violation|3|||
128844176|NCT04879823|463722390|FG000|Overall Study|Lost to Follow-up|43|||
128844177|NCT04879823|463722391|FG001|Overall Study|Lost to Follow-up|35|||
128844178|NCT04468633|463722392|FG000|Overall Study|Withdrawal by Subject|4|||
128844179|NCT04468633|463722393|FG001|Overall Study|Withdrawal by Subject|0|||
128844180|NCT00460434|463722396|FG000|Overall Study|Lost to Follow-up|3|||
128844181|NCT00460434|463722397|FG001|Overall Study|Lost to Follow-up|7|||
128844182|NCT02023099|463722400|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
128844183|NCT02023099|463722401|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
128844184|NCT02023099|463722402|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
128844185|NCT02023099|463722400|FG000|Overall Study|Withdrawn Consent|3|||
128844186|NCT02023099|463722401|FG001|Overall Study|Withdrawn Consent|0|||
128844187|NCT02023099|463722402|FG002|Overall Study|Withdrawn Consent|1|||
128844188|NCT02023099|463722400|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
128844189|NCT02023099|463722401|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
128844190|NCT02023099|463722402|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
128844191|NCT00203502|463722403|FG000|Overall Study|Death|1|||
128844192|NCT04057937|463722404|FG000|Placebo-controlled Phase|Adverse Event|3|||
128844193|NCT04057937|463722405|FG001|Placebo-controlled Phase|Adverse Event|0|||
128844194|NCT04057937|463722404|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
128844195|NCT04057937|463722405|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
128844196|NCT04057937|463722404|FG000|Active-treatment Phase|Pregnancy|0|||
128844197|NCT04057937|463722405|FG001|Active-treatment Phase|Pregnancy|1|||
128844198|NCT04057937|463722404|FG000|Active-treatment Phase|Physician Decision|0|||
128844199|NCT04057937|463722405|FG001|Active-treatment Phase|Physician Decision|1|||
128844200|NCT00147745|463722408|FG000|Overall Study|Withdrawal by Subject|1|||
128844201|NCT00147745|463722409|FG001|Overall Study|Withdrawal by Subject|0|||
128844202|NCT00147745|463722410|FG002|Overall Study|Withdrawal by Subject|0|||
128844203|NCT02504502|463722411|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
128844204|NCT02504502|463722412|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
128844205|NCT02504502|463722411|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
128844206|NCT02504502|463722412|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
128844207|NCT00510783|463722421|FG000|Overall Study|Lost to Follow-up|29|||
128844208|NCT00510783|463722422|FG001|Overall Study|Lost to Follow-up|25|||
128844209|NCT00510783|463722421|FG000|Overall Study|Withdrawal by Subject|2|||
128844210|NCT00510783|463722422|FG001|Overall Study|Withdrawal by Subject|3|||
128844211|NCT00510783|463722421|FG000|Overall Study|Protocol Violation|0|||
128844212|NCT00510783|463722422|FG001|Overall Study|Protocol Violation|1|||
128844213|NCT01622088|463722423|FG000|Overall Study|Adverse Event|20|||
128844214|NCT01622088|463722423|FG000|Overall Study|Lost to Follow-up|1|||
128844215|NCT01622088|463722423|FG000|Overall Study|Withdrawal by Subject|20|||
128844216|NCT01622088|463722423|FG000|Overall Study|Investigator Decision|1|||
128844217|NCT01622088|463722423|FG000|Overall Study|Death|53|||
128844218|NCT01622088|463722423|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
128844219|NCT00274846|463722424|FG000|Overall Study|Did not receive adequate NK cells|1|||
128844220|NCT01648699|463722427|FG000|Overall Study|Death|1|||
128844221|NCT01648699|463722427|FG000|Overall Study|Lost to Follow-up|2|||
128844222|NCT01648699|463722427|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
128844223|NCT02267746|463722428|FG000|Overall Study|Adverse Event|0|||
128844224|NCT02267746|463722429|FG001|Overall Study|Adverse Event|2|||
128844225|NCT02267746|463722430|FG002|Overall Study|Adverse Event|1|||
128844226|NCT02267746|463722428|FG000|Overall Study|Protocol Violation|8|||
128844227|NCT02267746|463722429|FG001|Overall Study|Protocol Violation|7|||
128844228|NCT02267746|463722430|FG002|Overall Study|Protocol Violation|3|||
128844229|NCT02267746|463722428|FG000|Overall Study|Lack of Efficacy|11|||
128844230|NCT02267746|463722429|FG001|Overall Study|Lack of Efficacy|11|||
128844231|NCT02267746|463722430|FG002|Overall Study|Lack of Efficacy|15|||
128844232|NCT02267746|463722428|FG000|Overall Study|Protocol Violation|1|||
128844233|NCT02267746|463722429|FG001|Overall Study|Protocol Violation|2|||
128844234|NCT02267746|463722430|FG002|Overall Study|Protocol Violation|1|||
128844235|NCT02267746|463722428|FG000|Overall Study|Miscellaneous|1|||
128844236|NCT02267746|463722429|FG001|Overall Study|Miscellaneous|0|||
128844237|NCT02267746|463722430|FG002|Overall Study|Miscellaneous|1|||
128844238|NCT04598776|463722435|FG000|Overall Study|Protocol Violation|5|||
128844239|NCT04598776|463722435|FG000|Overall Study|Physician Decision|4|||
128844240|NCT00728884|463722436|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
128844241|NCT00728884|463722436|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
128844242|NCT00348283|463722437|FG000|Induction|Adverse Event|0|||
128844243|NCT00348283|463722438|FG001|Induction|Adverse Event|2|||
128844244|NCT00348283|463722437|FG000|Induction|Protocol Violation|0|||
128844245|NCT00348283|463722438|FG001|Induction|Protocol Violation|4|||
128844246|NCT00348283|463722437|FG000|Double Blind|Adverse Event|2|||
128844247|NCT00348283|463722438|FG001|Double Blind|Adverse Event|5|||
128844248|NCT00348283|463722437|FG000|Double Blind|Withdrawal by Subject|1|||
128844249|NCT00348283|463722438|FG001|Double Blind|Withdrawal by Subject|1|||
128844250|NCT00348283|463722437|FG000|Double Blind|Protocol Violation|0|||
128844251|NCT00348283|463722438|FG001|Double Blind|Protocol Violation|1|||
128844252|NCT00348283|463722437|FG000|Double Blind|Lack of Efficacy|2|||
128844253|NCT00348283|463722438|FG001|Double Blind|Lack of Efficacy|2|||
128844254|NCT00348283|463722437|FG000|Double Blind|Pregnancy|0|||
128844255|NCT00348283|463722438|FG001|Double Blind|Pregnancy|1|||
128844256|NCT00348283|463722437|FG000|Open Label|Adverse Event|0|||
128844257|NCT00348283|463722438|FG001|Open Label|Adverse Event|8|||
128844258|NCT00348283|463722437|FG000|Open Label|Withdrawal by Subject|0|||
128844259|NCT00348283|463722438|FG001|Open Label|Withdrawal by Subject|4|||
128844260|NCT00348283|463722437|FG000|Open Label|Lost to Follow-up|0|||
128844261|NCT00348283|463722438|FG001|Open Label|Lost to Follow-up|1|||
128844262|NCT00348283|463722437|FG000|Open Label|Lack of Efficacy|0|||
128844263|NCT00348283|463722438|FG001|Open Label|Lack of Efficacy|13|||
128844264|NCT00348283|463722437|FG000|Open Label|Administrative reasons|0|||
128844265|NCT00348283|463722438|FG001|Open Label|Administrative reasons|5|||
128844266|NCT00348283|463722437|FG000|Open Label|Subject moved to the United States|0|||
128844267|NCT00348283|463722438|FG001|Open Label|Subject moved to the United States|1|||
128844268|NCT00348283|463722437|FG000|Open Label|Pregnancy|0|||
128844269|NCT00348283|463722438|FG001|Open Label|Pregnancy|1|||
128844270|NCT00348283|463722437|FG000|Open Label|Sponsor decision|0|||
128844271|NCT00348283|463722438|FG001|Open Label|Sponsor decision|1|||
128844272|NCT06312566|463722446|FG000|Overall Study|Protocol Violation|0|||
128844273|NCT06312566|463722447|FG001|Overall Study|Protocol Violation|1|||
128844274|NCT04736472|463722448|FG000|Overall Study|Lost to Follow-up|1|||
128844275|NCT04736472|463722449|FG001|Overall Study|Lost to Follow-up|0|||
128844276|NCT04736472|463722450|FG002|Overall Study|Lost to Follow-up|0|||
128844277|NCT04736472|463722448|FG000|Overall Study|Withdrawal by Subject|2|||
128844278|NCT04736472|463722449|FG001|Overall Study|Withdrawal by Subject|0|||
128844279|NCT04736472|463722450|FG002|Overall Study|Withdrawal by Subject|0|||
128844280|NCT04736472|463722448|FG000|Overall Study|Protocol Violation|48|||
128844281|NCT04736472|463722449|FG001|Overall Study|Protocol Violation|0|||
128844282|NCT04736472|463722450|FG002|Overall Study|Protocol Violation|6|||
128844283|NCT03861078|463722451|FG000|Overall Study|COVID-19 shut down|4|||
128844284|NCT03861078|463722451|FG000|Overall Study|Lost to Follow-up|1|||
128844285|NCT03861078|463722451|FG000|Overall Study|Protocol Violation|2|||
128844286|NCT03861078|463722451|FG000|Overall Study|lack of venous access|1|||
128844287|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
128844288|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
128844289|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
128844290|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
128844291|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
128844292|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
128844293|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
128844294|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
128844295|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
128844296|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
128844297|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
128844298|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
128844299|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
128844300|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
128844301|NCT02971683|463722452|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
128844302|NCT02971683|463722453|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
128844303|NCT02971683|463722452|FG000|Open-Label|Lost to Follow-up|1|||
128844304|NCT02971683|463722453|FG001|Open-Label|Lost to Follow-up|0|||
128844305|NCT02971683|463722452|FG000|Open-Label|Participants withdrew consent|0|||
128844306|NCT02971683|463722453|FG001|Open-Label|Participants withdrew consent|2|||
128844307|NCT02971683|463722452|FG000|Open-Label|Participant request to discontinue study treatment|1|||
128844308|NCT02971683|463722453|FG001|Open-Label|Participant request to discontinue study treatment|0|||
128844309|NCT02971683|463722452|FG000|Open-Label|Lack of Efficacy|2|||
128844310|NCT02971683|463722453|FG001|Open-Label|Lack of Efficacy|0|||
128844311|NCT02971683|463722452|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
128844312|NCT02971683|463722453|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
128844313|NCT02971683|463722452|FG000|Long-Term Open Label|Participant withdrew consent|1|||
128844314|NCT02971683|463722453|FG001|Long-Term Open Label|Participant withdrew consent|0|||
128844315|NCT02971683|463722452|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
128844316|NCT02971683|463722453|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
128844317|NCT02971683|463722452|FG000|Long-Term Open Label|Adverse Event|1|||
128844318|NCT02971683|463722453|FG001|Long-Term Open Label|Adverse Event|2|||
128844319|NCT02971683|463722452|FG000|Long-Term Open Label|Lack of Efficacy|1|||
128844320|NCT02971683|463722453|FG001|Long-Term Open Label|Lack of Efficacy|1|||
128844321|NCT02268526|463722456|FG000|Overall Study|Adverse Event|0|||
128844322|NCT02268526|463722457|FG001|Overall Study|Adverse Event|2|||
128844323|NCT02268526|463722458|FG002|Overall Study|Adverse Event|1|||
128844324|NCT02268526|463722456|FG000|Overall Study|Death|1|||
128844325|NCT02268526|463722457|FG001|Overall Study|Death|11|||
128844326|NCT02268526|463722458|FG002|Overall Study|Death|0|||
128844327|NCT02268526|463722456|FG000|Overall Study|protocol deviation|0|||
128844328|NCT02268526|463722457|FG001|Overall Study|protocol deviation|1|||
128844329|NCT02268526|463722458|FG002|Overall Study|protocol deviation|0|||
128844330|NCT02268526|463722456|FG000|Overall Study|Physician Decision|0|||
128844331|NCT02268526|463722457|FG001|Overall Study|Physician Decision|0|||
128844332|NCT02268526|463722458|FG002|Overall Study|Physician Decision|1|||
128844333|NCT02268526|463722456|FG000|Overall Study|Subject/guardian decision|0|||
128844334|NCT02268526|463722457|FG001|Overall Study|Subject/guardian decision|7|||
128844335|NCT02268526|463722458|FG002|Overall Study|Subject/guardian decision|3|||
128844336|NCT00596960|463722459|FG000|Overall Study|Death|1|||
128844337|NCT00596960|463722460|FG001|Overall Study|Death|2|||
128844338|NCT00596960|463722459|FG000|Overall Study|Lost to Follow-up|6|||
128844339|NCT00596960|463722460|FG001|Overall Study|Lost to Follow-up|5|||
128844340|NCT00596960|463722459|FG000|Overall Study|Withdrawal by Subject|1|||
128844341|NCT00596960|463722460|FG001|Overall Study|Withdrawal by Subject|0|||
128844342|NCT00596960|463722459|FG000|Overall Study|Incarcerated|2|||
128844343|NCT00596960|463722460|FG001|Overall Study|Incarcerated|0|||
128844344|NCT00596960|463722459|FG000|Overall Study|Physician Decision|1|||
128844345|NCT00596960|463722460|FG001|Overall Study|Physician Decision|0|||
128844346|NCT00596960|463722459|FG000|Overall Study|Protocol Violation|0|||
128844347|NCT00596960|463722460|FG001|Overall Study|Protocol Violation|1|||
128844348|NCT00596960|463722459|FG000|Overall Study|No alcohol use data|0|||
128844349|NCT00596960|463722460|FG001|Overall Study|No alcohol use data|1|||
128844350|NCT02374476|463722463|FG000|VT Induced Ablation|Screening Failures|36|||
128844351|NCT02374476|463722464|FG001|VT Induced Ablation|Screening Failures|0|||
128844352|NCT02374476|463722465|FG002|VT Induced Ablation|Screening Failures|0|||
128844353|NCT02374476|463722463|FG000|Arm Assignment|Withdrawal by Subject|0|||
128844354|NCT02374476|463722464|FG001|Arm Assignment|Withdrawal by Subject|0|||
128844355|NCT02374476|463722465|FG002|Arm Assignment|Withdrawal by Subject|1|||
128844356|NCT03305458|463722466|FG000|Overall Study|Withdrawal by Subject|50|||
128844357|NCT03305458|463722467|FG001|Overall Study|Withdrawal by Subject|46|||
128844358|NCT03305458|463722468|FG002|Overall Study|Withdrawal by Subject|93|||
128844359|NCT03305458|463722466|FG000|Overall Study|Lost to Follow-up|85|||
128844360|NCT03305458|463722467|FG001|Overall Study|Lost to Follow-up|85|||
128844361|NCT03305458|463722468|FG002|Overall Study|Lost to Follow-up|35|||
128844362|NCT05431543|463722471|FG000|Overall Study|Medical History|1|||
128844363|NCT05431543|463722472|FG001|Overall Study|Medical History|0|||
128844364|NCT05431543|463722473|FG002|Overall Study|Medical History|0|||
128844365|NCT00440037|463722474|FG000|Overall Study|Withdrawal by Subject|6|||
128844366|NCT00440037|463722474|FG000|Overall Study|Administrative decision|3|||
128844367|NCT01636778|463722482|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
128844368|NCT01636778|463722483|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
128844369|NCT01636778|463722484|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
128844370|NCT01636778|463722482|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
128844371|NCT01636778|463722483|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
128844372|NCT01636778|463722484|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
128844373|NCT01636778|463722482|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
128844374|NCT01636778|463722483|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
128844375|NCT01636778|463722484|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
128844376|NCT01636778|463722482|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
128844377|NCT01636778|463722483|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
128844378|NCT01636778|463722484|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
128844379|NCT01636778|463722482|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
128844380|NCT01636778|463722483|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
128844381|NCT01636778|463722484|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
128844382|NCT01636778|463722482|FG000|Follow-up Period After Part 2|Other|0|||
128844383|NCT01636778|463722483|FG001|Follow-up Period After Part 2|Other|0|||
128844384|NCT01636778|463722484|FG002|Follow-up Period After Part 2|Other|1|||
128844385|NCT01636778|463722482|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
128844386|NCT01636778|463722483|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
128844387|NCT01636778|463722484|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
128844388|NCT01636778|463722482|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
128844389|NCT01636778|463722483|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
128844390|NCT01636778|463722484|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
128844391|NCT04212299|463722486|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
128844392|NCT00705614|463724549|FG000|Initial Intervention|Adverse Event|40|||
128844393|NCT00705614|463724550|FG001|Initial Intervention|Adverse Event|21|||
128844394|NCT00705614|463724549|FG000|Initial Intervention|Lost to Follow-up|310|||
128844395|NCT00705614|463724550|FG001|Initial Intervention|Lost to Follow-up|191|||
128844396|NCT00705614|463724549|FG000|Initial Intervention|Withdrawal by Subject|114|||
128844397|NCT00705614|463724550|FG001|Initial Intervention|Withdrawal by Subject|71|||
128844398|NCT00705614|463724549|FG000|Initial Intervention|Administrative Reason|51|||
128844399|NCT00705614|463724550|FG001|Initial Intervention|Administrative Reason|38|||
128844400|NCT00705614|463724549|FG000|Initial Intervention|Status completion unknown|3|||
128844401|NCT00705614|463724550|FG001|Initial Intervention|Status completion unknown|0|||
128844402|NCT00705614|463724549|FG000|Switch to Remicade|Adverse Event|0|||
128844403|NCT00705614|463724550|FG001|Switch to Remicade|Adverse Event|5|||
128844404|NCT00705614|463724549|FG000|Switch to Remicade|Lost to Follow-up|0|||
128844405|NCT00705614|463724550|FG001|Switch to Remicade|Lost to Follow-up|23|||
128844406|NCT00705614|463724549|FG000|Switch to Remicade|Withdrawal by Subject|0|||
128844407|NCT00705614|463724550|FG001|Switch to Remicade|Withdrawal by Subject|12|||
128844408|NCT00705614|463724549|FG000|Switch to Remicade|Administrative Reason|0|||
128844409|NCT00705614|463724550|FG001|Switch to Remicade|Administrative Reason|9|||
128844410|NCT00676195|463724553|FG000|Overall Study|Lost to Follow-up|1|||
128844411|NCT00676195|463724553|FG000|Overall Study|Adverse Event|1|||
128844412|NCT00676195|463724553|FG000|Overall Study|Physician Decision|1|||
128844413|NCT02661490|463724554|FG000|Overall Study|Lost to Follow-up|0|||
128844414|NCT02661490|463724555|FG001|Overall Study|Lost to Follow-up|1|||
128844415|NCT02661490|463724556|FG002|Overall Study|Lost to Follow-up|0|||
128844416|NCT02661490|463724557|FG003|Overall Study|Lost to Follow-up|0|||
128844417|NCT02661490|463724558|FG004|Overall Study|Lost to Follow-up|2|||
128844418|NCT02661490|463724554|FG000|Overall Study|Withdrawal by Subject|2|||
128844419|NCT02661490|463724555|FG001|Overall Study|Withdrawal by Subject|0|||
128844420|NCT02661490|463724556|FG002|Overall Study|Withdrawal by Subject|2|||
128844421|NCT02661490|463724557|FG003|Overall Study|Withdrawal by Subject|0|||
128844422|NCT02661490|463724558|FG004|Overall Study|Withdrawal by Subject|0|||
128844423|NCT02661490|463724554|FG000|Overall Study|Death|1|||
128844424|NCT02661490|463724555|FG001|Overall Study|Death|1|||
128844425|NCT02661490|463724556|FG002|Overall Study|Death|0|||
128844426|NCT02661490|463724557|FG003|Overall Study|Death|1|||
128844427|NCT02661490|463724558|FG004|Overall Study|Death|0|||
128844428|NCT02661490|463724554|FG000|Overall Study|Reason not Specified|0|||
128844429|NCT02661490|463724555|FG001|Overall Study|Reason not Specified|0|||
128844430|NCT02661490|463724556|FG002|Overall Study|Reason not Specified|0|||
128844431|NCT02661490|463724557|FG003|Overall Study|Reason not Specified|0|||
128844432|NCT02661490|463724558|FG004|Overall Study|Reason not Specified|1|||
128844433|NCT04050722|463724559|FG000|Overall Study|Withdrawal by Subject|1|||
128844434|NCT04050722|463724560|FG001|Overall Study|Withdrawal by Subject|0|||
128844435|NCT03451292|463724566|FG000|Overall Study|Death|44|||
128844436|NCT03451292|463724567|FG001|Overall Study|Death|59|||
128844437|NCT03451292|463724566|FG000|Overall Study|Withdrawal by Subject|18|||
128844438|NCT03451292|463724567|FG001|Overall Study|Withdrawal by Subject|13|||
128844439|NCT03451292|463724566|FG000|Overall Study|Transplantation|18|||
128844440|NCT03451292|463724567|FG001|Overall Study|Transplantation|12|||
128844441|NCT03451292|463724566|FG000|Overall Study|Lost to Follow-up|4|||
128844442|NCT03451292|463724567|FG001|Overall Study|Lost to Follow-up|12|||
128844443|NCT03451292|463724566|FG000|Overall Study|Physician Decision|4|||
128844444|NCT03451292|463724567|FG001|Overall Study|Physician Decision|3|||
128844445|NCT03451292|463724566|FG000|Overall Study|Adverse Event|3|||
128844446|NCT03451292|463724567|FG001|Overall Study|Adverse Event|3|||
128844447|NCT03451292|463724566|FG000|Overall Study|Non-compliance with Study Drug|2|||
128844448|NCT03451292|463724567|FG001|Overall Study|Non-compliance with Study Drug|0|||
128844449|NCT01572493|463724575|FG000|Overall Study|Physician Decision|1|||
128844450|NCT01572493|463724576|FG001|Overall Study|Physician Decision|0|||
128844451|NCT01572493|463724577|FG002|Overall Study|Physician Decision|0|||
128844452|NCT01572493|463724578|FG003|Overall Study|Physician Decision|0|||
128844453|NCT01572493|463724579|FG004|Overall Study|Physician Decision|0|||
128844454|NCT01572493|463724580|FG005|Overall Study|Physician Decision|0|||
128844455|NCT01572493|463724581|FG006|Overall Study|Physician Decision|0|||
128844456|NCT01572493|463724582|FG007|Overall Study|Physician Decision|0|||
128844457|NCT01572493|463724583|FG008|Overall Study|Physician Decision|0|||
128844458|NCT01572493|463724575|FG000|Overall Study|Switched to alternative treatment|0|||
128844459|NCT01572493|463724576|FG001|Overall Study|Switched to alternative treatment|1|||
128844460|NCT01572493|463724577|FG002|Overall Study|Switched to alternative treatment|2|||
128844461|NCT01572493|463724578|FG003|Overall Study|Switched to alternative treatment|1|||
128844462|NCT01572493|463724579|FG004|Overall Study|Switched to alternative treatment|2|||
128844463|NCT01572493|463724580|FG005|Overall Study|Switched to alternative treatment|0|||
128844464|NCT01572493|463724581|FG006|Overall Study|Switched to alternative treatment|2|||
128844465|NCT01572493|463724582|FG007|Overall Study|Switched to alternative treatment|0|||
128844466|NCT01572493|463724583|FG008|Overall Study|Switched to alternative treatment|2|||
128844467|NCT01572493|463724575|FG000|Overall Study|Death|0|||
128844468|NCT01572493|463724576|FG001|Overall Study|Death|0|||
128844469|NCT01572493|463724577|FG002|Overall Study|Death|0|||
128844470|NCT01572493|463724578|FG003|Overall Study|Death|1|||
128844471|NCT01572493|463724579|FG004|Overall Study|Death|0|||
128844472|NCT01572493|463724580|FG005|Overall Study|Death|1|||
128844473|NCT01572493|463724581|FG006|Overall Study|Death|0|||
128844474|NCT01572493|463724582|FG007|Overall Study|Death|0|||
128844475|NCT01572493|463724583|FG008|Overall Study|Death|0|||
128844476|NCT01572493|463724575|FG000|Overall Study|Adverse Event|0|||
128844477|NCT01572493|463724576|FG001|Overall Study|Adverse Event|0|||
128844478|NCT01572493|463724577|FG002|Overall Study|Adverse Event|0|||
128844479|NCT01572493|463724578|FG003|Overall Study|Adverse Event|0|||
128844480|NCT01572493|463724579|FG004|Overall Study|Adverse Event|0|||
128844481|NCT01572493|463724580|FG005|Overall Study|Adverse Event|0|||
128844482|NCT01572493|463724581|FG006|Overall Study|Adverse Event|1|||
128844483|NCT01572493|463724582|FG007|Overall Study|Adverse Event|0|||
128844484|NCT01572493|463724583|FG008|Overall Study|Adverse Event|0|||
128844485|NCT01234675|463724584|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
128844486|NCT01234675|463724585|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
128844487|NCT01234675|463724584|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
128844488|NCT01234675|463724585|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
128844489|NCT00609245|463724586|FG000|Overall Study|Adverse Event|1|||
128844490|NCT00331799|463724587|FG000|Overall Study|Withdrawal by Subject|2|||
128844491|NCT00331799|463724587|FG000|Overall Study|Sedation|1|||
128844492|NCT02889809|463724588|FG000|Overall Study|Withdrawal by Subject|30|||
128844493|NCT02889809|463724589|FG001|Overall Study|Withdrawal by Subject|21|||
128844494|NCT02889809|463724588|FG000|Overall Study|Lost to Follow-up|1|||
128844495|NCT02889809|463724589|FG001|Overall Study|Lost to Follow-up|1|||
128844496|NCT02889809|463724588|FG000|Overall Study|Site Closed|12|||
128844497|NCT02889809|463724589|FG001|Overall Study|Site Closed|11|||
128844498|NCT01090076|463724594|FG000|Overall Study|Death|1|||
128844499|NCT01090076|463724595|FG001|Overall Study|Death|1|||
128844500|NCT01090076|463724594|FG000|Overall Study|Withdrawal by Subject|0|||
128844501|NCT01090076|463724595|FG001|Overall Study|Withdrawal by Subject|1|||
128844502|NCT01870999|463724598|FG000|Overall Study|Adverse Event|0|||
128844503|NCT01870999|463724599|FG001|Overall Study|Adverse Event|4|||
128844504|NCT01870999|463724600|FG002|Overall Study|Adverse Event|1|||
128844505|NCT01870999|463724598|FG000|Overall Study|Subject met withdrawal criteria|3|||
128844506|NCT01870999|463724599|FG001|Overall Study|Subject met withdrawal criteria|2|||
128844507|NCT01870999|463724600|FG002|Overall Study|Subject met withdrawal criteria|0|||
128844508|NCT01870999|463724598|FG000|Overall Study|Subject withdrawn by Investigator|1|||
128844509|NCT01870999|463724599|FG001|Overall Study|Subject withdrawn by Investigator|0|||
128844510|NCT01870999|463724600|FG002|Overall Study|Subject withdrawn by Investigator|0|||
128844511|NCT01870999|463724598|FG000|Overall Study|Withdrawal by Subject|0|||
128844512|NCT01870999|463724599|FG001|Overall Study|Withdrawal by Subject|2|||
128844513|NCT01870999|463724600|FG002|Overall Study|Withdrawal by Subject|5|||
128844514|NCT01870999|463724598|FG000|Overall Study|Protocol Violation|0|||
128844515|NCT01870999|463724599|FG001|Overall Study|Protocol Violation|0|||
128844516|NCT01870999|463724600|FG002|Overall Study|Protocol Violation|1|||
128844517|NCT03034772|463724601|FG000|Overall Study|Adverse Event|0|||
128844518|NCT03034772|463724602|FG001|Overall Study|Adverse Event|1|||
128844519|NCT03034772|463724601|FG000|Overall Study|Withdrawal by Subject|0|||
128844520|NCT03034772|463724602|FG001|Overall Study|Withdrawal by Subject|1|||
128844521|NCT00907517|463724603|FG000|Overall Study|Progressive Disease|3|||
128844522|NCT00907517|463724604|FG001|Overall Study|Progressive Disease|3|||
128844523|NCT00907517|463724605|FG002|Overall Study|Progressive Disease|4|||
128844524|NCT00907517|463724606|FG003|Overall Study|Progressive Disease|4|||
128844525|NCT00907517|463724607|FG004|Overall Study|Progressive Disease|4|||
128844526|NCT00907517|463724603|FG000|Overall Study|Symptomatic Deterioration|0|||
128844527|NCT00907517|463724604|FG001|Overall Study|Symptomatic Deterioration|0|||
128844528|NCT00907517|463724605|FG002|Overall Study|Symptomatic Deterioration|0|||
128844529|NCT00907517|463724606|FG003|Overall Study|Symptomatic Deterioration|0|||
128844530|NCT00907517|463724607|FG004|Overall Study|Symptomatic Deterioration|1|||
128844531|NCT02660034|463724608|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
128844532|NCT02660034|463724609|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
128844533|NCT02660034|463724610|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
128844534|NCT02660034|463724611|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
128844535|NCT02660034|463724612|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
128844536|NCT02660034|463724613|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
128844537|NCT02660034|463724614|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
128844538|NCT02660034|463724615|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
128844539|NCT02660034|463724616|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
128844540|NCT02660034|463724617|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
128844541|NCT02660034|463724618|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
128844542|NCT02660034|463724619|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
128844543|NCT02660034|463724620|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
128844544|NCT02660034|463724621|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
128844545|NCT02660034|463724608|FG000|Overall Study|Progressive Disease (Clinical)|7|||
128844546|NCT02660034|463724609|FG001|Overall Study|Progressive Disease (Clinical)|8|||
128844547|NCT02660034|463724610|FG002|Overall Study|Progressive Disease (Clinical)|3|||
128844548|NCT02660034|463724611|FG003|Overall Study|Progressive Disease (Clinical)|9|||
128844549|NCT02660034|463724612|FG004|Overall Study|Progressive Disease (Clinical)|3|||
128844550|NCT02660034|463724613|FG005|Overall Study|Progressive Disease (Clinical)|0|||
128844551|NCT02660034|463724614|FG006|Overall Study|Progressive Disease (Clinical)|0|||
128844552|NCT02660034|463724615|FG007|Overall Study|Progressive Disease (Clinical)|0|||
128844553|NCT02660034|463724616|FG008|Overall Study|Progressive Disease (Clinical)|0|||
128844554|NCT02660034|463724617|FG009|Overall Study|Progressive Disease (Clinical)|0|||
128844555|NCT02660034|463724618|FG010|Overall Study|Progressive Disease (Clinical)|0|||
128844556|NCT02660034|463724619|FG011|Overall Study|Progressive Disease (Clinical)|0|||
128844557|NCT02660034|463724620|FG012|Overall Study|Progressive Disease (Clinical)|0|||
128844558|NCT02660034|463724621|FG013|Overall Study|Progressive Disease (Clinical)|0|||
128844559|NCT02660034|463724608|FG000|Overall Study|Lost to Follow-up|0|||
128844560|NCT02660034|463724609|FG001|Overall Study|Lost to Follow-up|0|||
128844561|NCT02660034|463724610|FG002|Overall Study|Lost to Follow-up|1|||
128844562|NCT02660034|463724611|FG003|Overall Study|Lost to Follow-up|1|||
128844563|NCT02660034|463724612|FG004|Overall Study|Lost to Follow-up|0|||
128844564|NCT02660034|463724613|FG005|Overall Study|Lost to Follow-up|0|||
128844565|NCT02660034|463724614|FG006|Overall Study|Lost to Follow-up|0|||
128844566|NCT02660034|463724615|FG007|Overall Study|Lost to Follow-up|0|||
128844567|NCT02660034|463724616|FG008|Overall Study|Lost to Follow-up|0|||
128844568|NCT02660034|463724617|FG009|Overall Study|Lost to Follow-up|1|||
128844569|NCT02660034|463724618|FG010|Overall Study|Lost to Follow-up|1|||
128844570|NCT02660034|463724619|FG011|Overall Study|Lost to Follow-up|1|||
128844571|NCT02660034|463724620|FG012|Overall Study|Lost to Follow-up|0|||
128844572|NCT02660034|463724621|FG013|Overall Study|Lost to Follow-up|0|||
128844573|NCT02660034|463724608|FG000|Overall Study|Participant moved into special access scheme|1|||
128844574|NCT02660034|463724609|FG001|Overall Study|Participant moved into special access scheme|2|||
128844575|NCT02660034|463724610|FG002|Overall Study|Participant moved into special access scheme|0|||
128844576|NCT02660034|463724611|FG003|Overall Study|Participant moved into special access scheme|0|||
128844577|NCT02660034|463724612|FG004|Overall Study|Participant moved into special access scheme|0|||
128844578|NCT02660034|463724613|FG005|Overall Study|Participant moved into special access scheme|0|||
128844579|NCT02660034|463724614|FG006|Overall Study|Participant moved into special access scheme|0|||
128844580|NCT02660034|463724615|FG007|Overall Study|Participant moved into special access scheme|0|||
128844581|NCT02660034|463724616|FG008|Overall Study|Participant moved into special access scheme|0|||
128844582|NCT02660034|463724617|FG009|Overall Study|Participant moved into special access scheme|0|||
128844583|NCT02660034|463724618|FG010|Overall Study|Participant moved into special access scheme|0|||
128844584|NCT02660034|463724619|FG011|Overall Study|Participant moved into special access scheme|0|||
128844585|NCT02660034|463724620|FG012|Overall Study|Participant moved into special access scheme|0|||
128844586|NCT02660034|463724621|FG013|Overall Study|Participant moved into special access scheme|0|||
128844587|NCT02660034|463724608|FG000|Overall Study|Adverse Event|1|||
128844588|NCT02660034|463724609|FG001|Overall Study|Adverse Event|0|||
128844589|NCT02660034|463724610|FG002|Overall Study|Adverse Event|0|||
128844590|NCT02660034|463724611|FG003|Overall Study|Adverse Event|0|||
128844591|NCT02660034|463724612|FG004|Overall Study|Adverse Event|0|||
128844592|NCT02660034|463724613|FG005|Overall Study|Adverse Event|0|||
128844593|NCT02660034|463724614|FG006|Overall Study|Adverse Event|0|||
128844594|NCT02660034|463724615|FG007|Overall Study|Adverse Event|0|||
128844595|NCT02660034|463724616|FG008|Overall Study|Adverse Event|0|||
128844596|NCT02660034|463724617|FG009|Overall Study|Adverse Event|0|||
128844597|NCT02660034|463724618|FG010|Overall Study|Adverse Event|0|||
128844598|NCT02660034|463724619|FG011|Overall Study|Adverse Event|0|||
128844599|NCT02660034|463724620|FG012|Overall Study|Adverse Event|0|||
128844600|NCT02660034|463724621|FG013|Overall Study|Adverse Event|0|||
128844601|NCT02660034|463724608|FG000|Overall Study|Sponsor Decision|0|||
128844602|NCT02660034|463724609|FG001|Overall Study|Sponsor Decision|1|||
128844603|NCT02660034|463724610|FG002|Overall Study|Sponsor Decision|2|||
128844604|NCT02660034|463724611|FG003|Overall Study|Sponsor Decision|2|||
128844605|NCT02660034|463724612|FG004|Overall Study|Sponsor Decision|3|||
128844606|NCT02660034|463724613|FG005|Overall Study|Sponsor Decision|0|||
128844607|NCT02660034|463724614|FG006|Overall Study|Sponsor Decision|0|||
128844608|NCT02660034|463724615|FG007|Overall Study|Sponsor Decision|0|||
128844609|NCT02660034|463724616|FG008|Overall Study|Sponsor Decision|0|||
128844610|NCT02660034|463724617|FG009|Overall Study|Sponsor Decision|0|||
128844611|NCT02660034|463724618|FG010|Overall Study|Sponsor Decision|0|||
128844612|NCT02660034|463724619|FG011|Overall Study|Sponsor Decision|0|||
128844613|NCT02660034|463724620|FG012|Overall Study|Sponsor Decision|0|||
128844614|NCT02660034|463724621|FG013|Overall Study|Sponsor Decision|1|||
128844615|NCT02660034|463724608|FG000|Overall Study|Withdrawal by Subject|0|||
128844616|NCT02660034|463724609|FG001|Overall Study|Withdrawal by Subject|0|||
128844617|NCT02660034|463724610|FG002|Overall Study|Withdrawal by Subject|0|||
128844618|NCT02660034|463724611|FG003|Overall Study|Withdrawal by Subject|0|||
128844619|NCT02660034|463724612|FG004|Overall Study|Withdrawal by Subject|0|||
128844620|NCT02660034|463724613|FG005|Overall Study|Withdrawal by Subject|0|||
128844621|NCT02660034|463724614|FG006|Overall Study|Withdrawal by Subject|1|||
128844622|NCT02660034|463724615|FG007|Overall Study|Withdrawal by Subject|1|||
128844623|NCT02660034|463724616|FG008|Overall Study|Withdrawal by Subject|1|||
128844624|NCT02660034|463724617|FG009|Overall Study|Withdrawal by Subject|0|||
128844625|NCT02660034|463724618|FG010|Overall Study|Withdrawal by Subject|0|||
128844626|NCT02660034|463724619|FG011|Overall Study|Withdrawal by Subject|1|||
128844627|NCT02660034|463724620|FG012|Overall Study|Withdrawal by Subject|2|||
128844628|NCT02660034|463724621|FG013|Overall Study|Withdrawal by Subject|0|||
128844629|NCT02660034|463724608|FG000|Overall Study|Death|0|||
128844630|NCT02660034|463724609|FG001|Overall Study|Death|0|||
128844631|NCT02660034|463724610|FG002|Overall Study|Death|0|||
128844632|NCT02660034|463724611|FG003|Overall Study|Death|0|||
128844633|NCT02660034|463724612|FG004|Overall Study|Death|0|||
128844634|NCT02660034|463724613|FG005|Overall Study|Death|13|||
128844635|NCT02660034|463724614|FG006|Overall Study|Death|14|||
128844636|NCT02660034|463724615|FG007|Overall Study|Death|10|||
128844637|NCT02660034|463724616|FG008|Overall Study|Death|9|||
128844638|NCT02660034|463724617|FG009|Overall Study|Death|21|||
128844639|NCT02660034|463724618|FG010|Overall Study|Death|17|||
128844640|NCT02660034|463724619|FG011|Overall Study|Death|15|||
128844641|NCT02660034|463724620|FG012|Overall Study|Death|18|||
128844642|NCT02660034|463724621|FG013|Overall Study|Death|7|||
128844643|NCT02660034|463724608|FG000|Overall Study|Physician Decision|0|||
128844644|NCT02660034|463724609|FG001|Overall Study|Physician Decision|0|||
128844645|NCT02660034|463724610|FG002|Overall Study|Physician Decision|0|||
128844646|NCT02660034|463724611|FG003|Overall Study|Physician Decision|0|||
128844647|NCT02660034|463724612|FG004|Overall Study|Physician Decision|0|||
128844648|NCT02660034|463724613|FG005|Overall Study|Physician Decision|0|||
128844649|NCT02660034|463724614|FG006|Overall Study|Physician Decision|0|||
128844650|NCT02660034|463724615|FG007|Overall Study|Physician Decision|0|||
128844651|NCT02660034|463724616|FG008|Overall Study|Physician Decision|0|||
128844652|NCT02660034|463724617|FG009|Overall Study|Physician Decision|0|||
128844653|NCT02660034|463724618|FG010|Overall Study|Physician Decision|0|||
128844654|NCT02660034|463724619|FG011|Overall Study|Physician Decision|0|||
128844655|NCT02660034|463724620|FG012|Overall Study|Physician Decision|0|||
128844656|NCT02660034|463724621|FG013|Overall Study|Physician Decision|1|||
128844657|NCT02660034|463724608|FG000|Overall Study|Participants transferred to LTE|0|||
128844658|NCT02660034|463724609|FG001|Overall Study|Participants transferred to LTE|0|||
128844659|NCT02660034|463724610|FG002|Overall Study|Participants transferred to LTE|0|||
128844660|NCT02660034|463724611|FG003|Overall Study|Participants transferred to LTE|0|||
128844661|NCT02660034|463724612|FG004|Overall Study|Participants transferred to LTE|0|||
128844662|NCT02660034|463724613|FG005|Overall Study|Participants transferred to LTE|10|||
128844663|NCT02660034|463724614|FG006|Overall Study|Participants transferred to LTE|8|||
128844664|NCT02660034|463724615|FG007|Overall Study|Participants transferred to LTE|8|||
128844665|NCT02660034|463724616|FG008|Overall Study|Participants transferred to LTE|10|||
128844666|NCT02660034|463724617|FG009|Overall Study|Participants transferred to LTE|1|||
128844667|NCT02660034|463724618|FG010|Overall Study|Participants transferred to LTE|2|||
128844668|NCT02660034|463724619|FG011|Overall Study|Participants transferred to LTE|4|||
128844669|NCT02660034|463724620|FG012|Overall Study|Participants transferred to LTE|1|||
128844670|NCT02660034|463724621|FG013|Overall Study|Participants transferred to LTE|1|||
128844671|NCT01797705|463724623|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
128844672|NCT01797705|463724623|FG000|Overall Study|Withdrawal by Subject|1|||
128844673|NCT01838447|463724624|FG000|Overall Study|Change in surgical plan|1|||
128844674|NCT01838447|463724625|FG001|Overall Study|Change in surgical plan|2|||
128844675|NCT01838447|463724624|FG000|Overall Study|Withdrawal by Subject|1|||
128844676|NCT01838447|463724625|FG001|Overall Study|Withdrawal by Subject|1|||
128844677|NCT01533181|463724628|FG000|Overall Study|Disease progression pre-active treatment|0|||
128844678|NCT01533181|463724629|FG001|Overall Study|Disease progression pre-active treatment|1|||
128844679|NCT01533181|463724628|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
128844680|NCT01533181|463724629|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
128844681|NCT02030847|463724630|FG000|Overall Study|Death|10|||
128844682|NCT02030847|463724630|FG000|Overall Study|Disease Progression|15|||
128844683|NCT02030847|463724630|FG000|Overall Study|New Cancer Therapy|8|||
128844684|NCT02030847|463724630|FG000|Overall Study|Physician Decision|3|||
128844685|NCT02030847|463724630|FG000|Overall Study|Withdrawal by Subject|1|||
128844686|NCT01837719|463724633|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
128844687|NCT01837719|463724633|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
128844688|NCT01703988|463724634|FG000|Overall Study|Investigator Judgment|0|||
128844689|NCT01703988|463724635|FG001|Overall Study|Investigator Judgment|0|||
128844690|NCT01703988|463724636|FG002|Overall Study|Investigator Judgment|0|||
128844691|NCT01703988|463724637|FG003|Overall Study|Investigator Judgment|1|||
128844692|NCT06247488|463724638|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
128844693|NCT06247488|463724639|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
128844694|NCT06247488|463724640|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
128844695|NCT06247488|463724641|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
128844696|NCT06247488|463724642|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
128844697|NCT06247488|463724643|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
128844698|NCT06247488|463724638|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
128844699|NCT06247488|463724639|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
128844700|NCT06247488|463724640|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
128844701|NCT06247488|463724641|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
128844702|NCT06247488|463724642|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
128844703|NCT06247488|463724643|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
128844704|NCT06247488|463724638|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
128844705|NCT06247488|463724639|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
128844706|NCT06247488|463724640|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
128844707|NCT06247488|463724641|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
128844708|NCT06247488|463724642|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
128844709|NCT06247488|463724643|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
128844710|NCT06247488|463724638|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
128844711|NCT06247488|463724639|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
128844712|NCT06247488|463724640|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
128844713|NCT06247488|463724641|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
128844714|NCT06247488|463724642|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
128844715|NCT06247488|463724643|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
128844716|NCT06247488|463724638|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
128844717|NCT06247488|463724639|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
128844718|NCT06247488|463724640|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
128844719|NCT06247488|463724641|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
128844720|NCT06247488|463724642|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
128844721|NCT06247488|463724643|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
128844722|NCT06247488|463724638|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
128844723|NCT06247488|463724639|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
128844724|NCT06247488|463724640|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
128844725|NCT06247488|463724641|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
128844726|NCT06247488|463724642|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
128844727|NCT06247488|463724643|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
128844728|NCT06247488|463724638|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
128844729|NCT06247488|463724639|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
128844730|NCT06247488|463724640|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
128844731|NCT06247488|463724641|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
128844732|NCT06247488|463724642|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
128844733|NCT06247488|463724643|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
128844734|NCT02995733|463724644|FG000|Overall Study|Study site closed|9|||
128844735|NCT02995733|463724645|FG001|Overall Study|Study site closed|10|||
128844736|NCT02995733|463724644|FG000|Overall Study|Death|3|||
128844737|NCT02995733|463724645|FG001|Overall Study|Death|4|||
128844738|NCT02995733|463724644|FG000|Overall Study|Withdrawal by Subject|6|||
128844739|NCT02995733|463724645|FG001|Overall Study|Withdrawal by Subject|2|||
128844740|NCT02995733|463724644|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
128844741|NCT02995733|463724645|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
128844742|NCT02995733|463724644|FG000|Overall Study|Lost to Follow-up|48|||
128844743|NCT02995733|463724645|FG001|Overall Study|Lost to Follow-up|37|||
128844744|NCT02995733|463724644|FG000|Overall Study|Other|0|||
128844745|NCT02995733|463724645|FG001|Overall Study|Other|1|||
128844746|NCT02465866|463724646|FG000|Period 3|Withdrawal by Subject|0|||
128844747|NCT02465866|463724647|FG001|Period 3|Withdrawal by Subject|1|||
128844748|NCT02465866|463724648|FG002|Period 3|Withdrawal by Subject|0|||
128844749|NCT02465866|463724649|FG003|Period 3|Withdrawal by Subject|0|||
128844750|NCT01469819|463724650|FG000|Overall Study|Withdrawal by Subject|1|||
128844751|NCT01469819|463724650|FG000|Overall Study|Did not meet inclusionary criteria|2|||
128844752|NCT01469819|463724650|FG000|Overall Study|Could not swallow SmartPill|2|||
128844753|NCT01469819|463724650|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
128844754|NCT00422162|463724658|FG000|Overall Study|Adverse Event|11|||
128844755|NCT00422162|463724659|FG001|Overall Study|Adverse Event|9|||
128844756|NCT00422162|463724658|FG000|Overall Study|Lack of Efficacy|4|||
128844757|NCT00422162|463724659|FG001|Overall Study|Lack of Efficacy|10|||
128844758|NCT00422162|463724658|FG000|Overall Study|Withdrawal by Subject|7|||
128844759|NCT00422162|463724659|FG001|Overall Study|Withdrawal by Subject|6|||
128844760|NCT00422162|463724658|FG000|Overall Study|Lost to Follow-up|1|||
128844761|NCT00422162|463724659|FG001|Overall Study|Lost to Follow-up|2|||
128844762|NCT00422162|463724658|FG000|Overall Study|Non-Compliant with Protocol|1|||
128844763|NCT00422162|463724659|FG001|Overall Study|Non-Compliant with Protocol|1|||
128844764|NCT00422162|463724658|FG000|Overall Study|Other|0|||
128844765|NCT00422162|463724659|FG001|Overall Study|Other|1|||
128844766|NCT00422162|463724658|FG000|Overall Study|Didn't Receive Treatment|0|||
128844767|NCT00422162|463724659|FG001|Overall Study|Didn't Receive Treatment|1|||
128844768|NCT03508830|463724660|FG000|Overall Study|Withdrawal by Subject|3|||
128844769|NCT03508830|463724661|FG001|Overall Study|Withdrawal by Subject|4|||
128844770|NCT03508830|463724660|FG000|Overall Study|Physician Decision|2|||
128844771|NCT03508830|463724661|FG001|Overall Study|Physician Decision|2|||
128844772|NCT02522299|463724662|FG000|Overall Study|Adverse Event|2|||
128844773|NCT02522299|463724663|FG001|Overall Study|Adverse Event|0|||
128844774|NCT02522299|463724662|FG000|Overall Study|Physician Decision|0|||
128844775|NCT02522299|463724663|FG001|Overall Study|Physician Decision|1|||
128844776|NCT02522299|463724662|FG000|Overall Study|Withdrawal by Subject|2|||
128844777|NCT02522299|463724663|FG001|Overall Study|Withdrawal by Subject|0|||
128844778|NCT04908800|463724666|FG000|Overall Study|Adverse Event|0|||
128844779|NCT04908800|463724667|FG001|Overall Study|Adverse Event|0|||
128844780|NCT04908800|463724668|FG002|Overall Study|Adverse Event|0|||
128844781|NCT04908800|463724669|FG003|Overall Study|Adverse Event|0|||
128844782|NCT04908800|463724670|FG004|Overall Study|Adverse Event|0|||
128844783|NCT04908800|463724671|FG005|Overall Study|Adverse Event|0|||
128844784|NCT04908800|463724672|FG006|Overall Study|Adverse Event|0|||
128844785|NCT04908800|463724673|FG007|Overall Study|Adverse Event|0|||
128844786|NCT04908800|463724674|FG008|Overall Study|Adverse Event|0|||
128844787|NCT04908800|463724675|FG009|Overall Study|Adverse Event|0|||
128844788|NCT04908800|463724676|FG010|Overall Study|Adverse Event|1|||
128844789|NCT04908800|463724677|FG011|Overall Study|Adverse Event|0|||
128844790|NCT04908800|463724678|FG012|Overall Study|Adverse Event|0|||
128844791|NCT01348763|463724680|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
128844792|NCT01348763|463724680|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
128844793|NCT03045302|463724691|FG000|Overall Study|Pre-treatment adverse event|1|||
128844794|NCT05287178|463724692|FG000|Overall Study|Lost to Follow-up|2|||
128844795|NCT02038803|463724693|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
128844796|NCT02038803|463724693|FG000|Overall Study|Lost to Follow-up|1|||
128844797|NCT02116582|463724694|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
128844798|NCT02116582|463724694|FG000|Overall Study|Adverse Event|22|||
128844799|NCT02116582|463724694|FG000|Overall Study|Death|9|||
128844800|NCT02116582|463724694|FG000|Overall Study|Progressive Disease|148|||
128844801|NCT02116582|463724694|FG000|Overall Study|Protocol Violation|3|||
128844802|NCT02116582|463724694|FG000|Overall Study|Withdrawal by Subject|8|||
128844803|NCT02116582|463724694|FG000|Overall Study|Other: Miscellaneous|11|||
128844804|NCT02116582|463724694|FG000|Overall Study|Lost to Follow-up|1|||
128844805|NCT02116582|463724694|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
128844806|NCT00498797|463724695|FG000|Overall Study|Withdrawal by Subject|4|||
128844807|NCT00498797|463724696|FG001|Overall Study|Withdrawal by Subject|2|||
128844808|NCT00498797|463724695|FG000|Overall Study|Adverse Event|12|||
128844809|NCT00498797|463724696|FG001|Overall Study|Adverse Event|5|||
128844810|NCT00498797|463724695|FG000|Overall Study|Condition under investigation worsened|19|||
128844811|NCT00498797|463724696|FG001|Overall Study|Condition under investigation worsened|21|||
128844812|NCT00498797|463724695|FG000|Overall Study|Other|3|||
128844813|NCT00498797|463724696|FG001|Overall Study|Other|1|||
128844814|NCT01855399|463724697|FG000|6 Month|Lost to Follow-up|12|||
128844815|NCT01855399|463724698|FG001|6 Month|Lost to Follow-up|9|||
128844816|NCT01855399|463724697|FG000|6 Month|Withdrawal by Subject|8|||
128844817|NCT01855399|463724698|FG001|6 Month|Withdrawal by Subject|6|||
128844818|NCT01855399|463724697|FG000|12 Month|Lost to Follow-up|7|||
128844819|NCT01855399|463724698|FG001|12 Month|Lost to Follow-up|11|||
128844820|NCT03953079|463724699|FG000|Core Study|Withdrawal by Subject|1|||
128844821|NCT03953079|463724700|FG001|Core Study|Withdrawal by Subject|2|||
128844822|NCT03953079|463724701|FG002|Core Study|Withdrawal by Subject|1|||
128844823|NCT03953079|463724699|FG000|Core Study|COVID-19|0|||
128844824|NCT03953079|463724700|FG001|Core Study|COVID-19|1|||
128844825|NCT03953079|463724701|FG002|Core Study|COVID-19|0|||
128844826|NCT03953079|463724699|FG000|Core Study|Difficulties leaving the house|0|||
128844827|NCT03953079|463724700|FG001|Core Study|Difficulties leaving the house|1|||
128844828|NCT03953079|463724701|FG002|Core Study|Difficulties leaving the house|0|||
128844829|NCT03953079|463724699|FG000|Extension Study|Withdrawal by Subject|1|||
128844830|NCT03953079|463724700|FG001|Extension Study|Withdrawal by Subject|0|||
128844831|NCT03953079|463724701|FG002|Extension Study|Withdrawal by Subject|0|||
128844832|NCT03953079|463724699|FG000|Extension Study|Received Rescue Treatment|5|||
128844833|NCT03953079|463724700|FG001|Extension Study|Received Rescue Treatment|6|||
128844834|NCT03953079|463724701|FG002|Extension Study|Received Rescue Treatment|5|||
128844835|NCT04394624|463724702|FG000|Overall Study|Adverse Event|6|||
128844836|NCT04394624|463724703|FG001|Overall Study|Adverse Event|0|||
128844837|NCT04394624|463724702|FG000|Overall Study|Progressive disease|24|||
128844838|NCT04394624|463724703|FG001|Overall Study|Progressive disease|0|||
128844839|NCT04394624|463724702|FG000|Overall Study|Not related to COVID-19|1|||
128844840|NCT04394624|463724703|FG001|Overall Study|Not related to COVID-19|0|||
128844841|NCT00141271|463724709|FG000|Overall Study|Adverse Event|31|||
128844842|NCT00141271|463724710|FG001|Overall Study|Adverse Event|19|||
128844843|NCT00141271|463724711|FG002|Overall Study|Adverse Event|17|||
128844844|NCT00141271|463724709|FG000|Overall Study|Laboratory Abnormality|2|||
128844845|NCT00141271|463724710|FG001|Overall Study|Laboratory Abnormality|1|||
128844846|NCT00141271|463724711|FG002|Overall Study|Laboratory Abnormality|1|||
128844847|NCT00141271|463724709|FG000|Overall Study|Lack of Efficacy|7|||
128844848|NCT00141271|463724710|FG001|Overall Study|Lack of Efficacy|7|||
128844849|NCT00141271|463724711|FG002|Overall Study|Lack of Efficacy|3|||
128844850|NCT00141271|463724709|FG000|Overall Study|Lost to Follow-up|15|||
128844851|NCT00141271|463724710|FG001|Overall Study|Lost to Follow-up|15|||
128844852|NCT00141271|463724711|FG002|Overall Study|Lost to Follow-up|21|||
128844853|NCT00141271|463724709|FG000|Overall Study|Withdrawal by Subject|14|||
128844854|NCT00141271|463724710|FG001|Overall Study|Withdrawal by Subject|9|||
128844855|NCT00141271|463724711|FG002|Overall Study|Withdrawal by Subject|10|||
128844856|NCT00141271|463724709|FG000|Overall Study|Other|11|||
128844857|NCT00141271|463724710|FG001|Overall Study|Other|12|||
128844858|NCT00141271|463724711|FG002|Overall Study|Other|5|||
128844859|NCT00990314|463724712|FG000|Overall Study|Death|2|||
128844860|NCT00990314|463724712|FG000|Overall Study|Adverse Event|2|||
128844861|NCT00990314|463724712|FG000|Overall Study|Withdrawal by Subject|3|||
128844862|NCT00990314|463724712|FG000|Overall Study|Non-Compliance|1|||
128844863|NCT00990314|463724712|FG000|Overall Study|Physician Decision|3|||
128844864|NCT00990314|463724712|FG000|Overall Study|Lack of Efficacy|1|||
128844865|NCT04853394|463724715|FG000|Follow-up Interviews|Lost to Follow-up|22|||
128844866|NCT04853394|463724716|FG001|Follow-up Interviews|Lost to Follow-up|15|||
128844867|NCT02442622|463724717|FG000|Overall Study|Withdrawal by Subject|3|||
128844868|NCT02442622|463724718|FG001|Overall Study|Withdrawal by Subject|1|||
128844869|NCT04413149|463726517|FG000|Overall Study|Death|10|||
128844870|NCT04413149|463726518|FG001|Overall Study|Death|5|||
128844871|NCT04413149|463726517|FG000|Overall Study|Lung transplantation|1|||
128844872|NCT04413149|463726518|FG001|Overall Study|Lung transplantation|0|||
128844873|NCT02878590|463726519|FG000|Overall Study|Withdrawal by Subject|2|||
128844874|NCT03322514|463726520|FG000|Overall Study|Withdrawal by Subject|1|||
128844875|NCT03322514|463726521|FG001|Overall Study|Withdrawal by Subject|1|||
128844876|NCT01904019|463726525|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
128844877|NCT01904019|463726525|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
128844878|NCT01904019|463726525|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
128844879|NCT01904019|463726525|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
128844880|NCT01904019|463726525|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
128844881|NCT01904019|463726525|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
128844882|NCT05335005|463726529|FG000|Overall Study|Lost to Follow-up|1|||
128844883|NCT03087851|463726533|FG000|Overall Study|Withdraw on medical grounds|0|||
128844884|NCT03087851|463726534|FG001|Overall Study|Withdraw on medical grounds|1|||
128844885|NCT03087851|463726535|FG002|Overall Study|Withdraw on medical grounds|2|||
128844886|NCT02339506|463726538|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
128844887|NCT02339506|463726539|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
128844888|NCT02339506|463726538|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
128844889|NCT02339506|463726539|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
128844890|NCT01116440|463726543|FG000|Treatment|Withdrawal by Subject|2|||
128844891|NCT01116440|463726544|FG001|Treatment|Withdrawal by Subject|2|||
128844892|NCT01116440|463726543|FG000|Treatment|Lost to Follow-up|1|||
128844893|NCT01116440|463726544|FG001|Treatment|Lost to Follow-up|1|||
128844894|NCT01116440|463726543|FG000|Treatment|Protocol Violation|0|||
128844895|NCT01116440|463726544|FG001|Treatment|Protocol Violation|2|||
128844896|NCT01116440|463726543|FG000|Treatment|Lack of Efficacy|0|||
128844897|NCT01116440|463726544|FG001|Treatment|Lack of Efficacy|1|||
128844898|NCT01116440|463726543|FG000|Treatment|Adverse Event|0|||
128844899|NCT01116440|463726544|FG001|Treatment|Adverse Event|1|||
128844900|NCT01116440|463726543|FG000|Withdrawal|Withdrawal by Subject|0|||
128844901|NCT01116440|463726544|FG001|Withdrawal|Withdrawal by Subject|1|||
128844902|NCT01116440|463726543|FG000|Withdrawal|Lost to Follow-up|0|||
128844903|NCT01116440|463726544|FG001|Withdrawal|Lost to Follow-up|1|||
128844904|NCT01116440|463726543|FG000|Follow-up|Lost to Follow-up|0|||
128844905|NCT01116440|463726544|FG001|Follow-up|Lost to Follow-up|1|||
128844906|NCT01116440|463726543|FG000|Follow-up|Withdrawal by Subject|0|||
128844907|NCT01116440|463726544|FG001|Follow-up|Withdrawal by Subject|1|||
128844908|NCT01636258|463726547|FG000|Overall Study|Lost to Follow-up|1|||
128844909|NCT01636258|463726548|FG001|Overall Study|Lost to Follow-up|0|||
128844910|NCT02798861|463726561|FG000|Overall Study|Lost to Follow-up|22|||
128844911|NCT02798861|463726561|FG000|Overall Study|Withdrawal by Subject|1|||
128844912|NCT02186015|463726562|FG000|Overall Study|Physician Decision|1|||
128844913|NCT02186015|463726563|FG001|Overall Study|Physician Decision|0|||
128844914|NCT02592434|463726566|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
128844915|NCT02592434|463726567|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
128844916|NCT02592434|463726568|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
128844917|NCT02592434|463726566|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
128844918|NCT02592434|463726567|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
128844919|NCT02592434|463726568|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
128844920|NCT02592434|463726566|FG000|Open-Label Phase (18 Weeks)|Other|3|||
128844921|NCT02592434|463726567|FG001|Open-Label Phase (18 Weeks)|Other|0|||
128844922|NCT02592434|463726568|FG002|Open-Label Phase (18 Weeks)|Other|0|||
128844923|NCT02592434|463726566|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
128844924|NCT02592434|463726567|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
128844925|NCT02592434|463726568|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
128844926|NCT02592434|463726566|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
128844927|NCT02592434|463726567|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
128844928|NCT02592434|463726568|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
128844929|NCT02592434|463726566|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
128844930|NCT02592434|463726567|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
128844931|NCT02592434|463726568|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
128844932|NCT02592434|463726566|FG000|Double Blind Phase (26 Weeks)|Other|0|||
128844933|NCT02592434|463726567|FG001|Double Blind Phase (26 Weeks)|Other|1|||
128844934|NCT02592434|463726568|FG002|Double Blind Phase (26 Weeks)|Other|0|||
128844935|NCT02592434|463726566|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
128844936|NCT02592434|463726567|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
128844937|NCT02592434|463726568|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
128844938|NCT02592434|463726566|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
128844939|NCT02592434|463726567|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
128844940|NCT02592434|463726568|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
128844941|NCT02592434|463726566|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
128844942|NCT02592434|463726567|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
128844943|NCT02592434|463726568|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
128844944|NCT00561678|463726569|FG000|Overall Study|Withdrawal by Subject|4|||
128844945|NCT00561678|463726570|FG001|Overall Study|Withdrawal by Subject|3|||
128844946|NCT00561678|463726569|FG000|Overall Study|surgery cancelled|1|||
128844947|NCT00561678|463726570|FG001|Overall Study|surgery cancelled|1|||
128844948|NCT00561678|463726569|FG000|Overall Study|surgery rescheduled to different site|2|||
128844949|NCT00561678|463726570|FG001|Overall Study|surgery rescheduled to different site|2|||
128844950|NCT00561678|463726569|FG000|Overall Study|anesthesia provider refusal|1|||
128844951|NCT00561678|463726570|FG001|Overall Study|anesthesia provider refusal|0|||
128844952|NCT01403805|463726573|FG000|Overall Study|Withdrawal by Subject|0|||
128844953|NCT01403805|463726574|FG001|Overall Study|Withdrawal by Subject|4|||
128844954|NCT01403805|463726573|FG000|Overall Study|Lost to Follow-up|0|||
128844955|NCT01403805|463726574|FG001|Overall Study|Lost to Follow-up|2|||
128844956|NCT01403805|463726573|FG000|Overall Study|Death|0|||
128844957|NCT01403805|463726574|FG001|Overall Study|Death|1|||
128844958|NCT01103141|463726575|FG000|Overall Study|Death|0|||
128844959|NCT01103141|463726576|FG001|Overall Study|Death|1|||
128844960|NCT01103141|463726575|FG000|Overall Study|Lost to Follow-up|2|||
128844961|NCT01103141|463726576|FG001|Overall Study|Lost to Follow-up|1|||
128844962|NCT01695993|463726577|FG000|Overall Study|Lost to Follow-up|2|||
128844963|NCT01695993|463726578|FG001|Overall Study|Lost to Follow-up|1|||
128844964|NCT01695993|463726579|FG002|Overall Study|Lost to Follow-up|3|||
128844965|NCT01695993|463726577|FG000|Overall Study|Withdrawal by Subject|2|||
128844966|NCT01695993|463726578|FG001|Overall Study|Withdrawal by Subject|2|||
128844967|NCT01695993|463726579|FG002|Overall Study|Withdrawal by Subject|2|||
128844968|NCT01695993|463726577|FG000|Overall Study|To ill to continue|1|||
128844969|NCT01695993|463726578|FG001|Overall Study|To ill to continue|2|||
128844970|NCT01695993|463726579|FG002|Overall Study|To ill to continue|0|||
128844971|NCT01695993|463726577|FG000|Overall Study|Changed Medical Facility|0|||
128844972|NCT01695993|463726578|FG001|Overall Study|Changed Medical Facility|0|||
128844973|NCT01695993|463726579|FG002|Overall Study|Changed Medical Facility|1|||
128844974|NCT02029521|463726580|FG000|Overall Study|Protocol Violation|1|||
128844975|NCT02029521|463726581|FG001|Overall Study|Protocol Violation|0|||
128844976|NCT02029521|463726580|FG000|Overall Study|Withdrawal by Subject|1|||
128844977|NCT02029521|463726581|FG001|Overall Study|Withdrawal by Subject|1|||
128844978|NCT01072396|463726583|FG000|Period One|Adverse Event|1|||
128844979|NCT01072396|463726584|FG001|Period One|Adverse Event|1|||
128844980|NCT01072396|463726583|FG000|Period One|Protocol Violation|2|||
128844981|NCT01072396|463726584|FG001|Period One|Protocol Violation|1|||
128844982|NCT01072396|463726583|FG000|Period One|Withdrawal by Subject|2|||
128844983|NCT01072396|463726584|FG001|Period One|Withdrawal by Subject|0|||
128844984|NCT01072396|463726583|FG000|Washout Period|Missing termination information|0|||
128844985|NCT01072396|463726584|FG001|Washout Period|Missing termination information|1|||
128844986|NCT01072396|463726583|FG000|Period Two|Adverse Event|0|||
128844987|NCT01072396|463726584|FG001|Period Two|Adverse Event|3|||
128844988|NCT01072396|463726583|FG000|Period Two|Lost to Follow-up|1|||
128844989|NCT01072396|463726584|FG001|Period Two|Lost to Follow-up|0|||
128844990|NCT01106586|463726585|FG000|Overall Study|Adverse Event|9|||
128844991|NCT01106586|463726586|FG001|Overall Study|Adverse Event|15|||
128844992|NCT01106586|463726585|FG000|Overall Study|Death|1|||
128844993|NCT01106586|463726586|FG001|Overall Study|Death|3|||
128844994|NCT01106586|463726585|FG000|Overall Study|Pregnancy|2|||
128844995|NCT01106586|463726586|FG001|Overall Study|Pregnancy|2|||
128844996|NCT01106586|463726585|FG000|Overall Study|Lack of Efficacy|1|||
128844997|NCT01106586|463726586|FG001|Overall Study|Lack of Efficacy|0|||
128844998|NCT01106586|463726585|FG000|Overall Study|Investigator's Discretion|5|||
128844999|NCT01106586|463726586|FG001|Overall Study|Investigator's Discretion|8|||
128845000|NCT01106586|463726585|FG000|Overall Study|Withdrew Consent|18|||
128845001|NCT01106586|463726586|FG001|Overall Study|Withdrew Consent|30|||
128845002|NCT01106586|463726585|FG000|Overall Study|Lost to Follow-up|24|||
128845003|NCT01106586|463726586|FG001|Overall Study|Lost to Follow-up|20|||
128845004|NCT01106586|463726585|FG000|Overall Study|Participant Noncompliance|12|||
128845005|NCT01106586|463726586|FG001|Overall Study|Participant Noncompliance|10|||
128845006|NCT01106586|463726585|FG000|Overall Study|Protocol Violation|1|||
128845007|NCT01106586|463726586|FG001|Overall Study|Protocol Violation|0|||
128845008|NCT01106586|463726585|FG000|Overall Study|Participant Transferred to Another Study|212|||
128845009|NCT01106586|463726586|FG001|Overall Study|Participant Transferred to Another Study|197|||
128845010|NCT01379521|463726587|FG000|Overall Study -Treatment Period|Adverse Event|3|||
128845011|NCT01379521|463726588|FG001|Overall Study -Treatment Period|Adverse Event|0|||
128845012|NCT01379521|463726587|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
128845013|NCT01379521|463726588|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
128845014|NCT01379521|463726587|FG000|Overall Study -Treatment Period|Disease Progression|23|||
128845015|NCT01379521|463726588|FG001|Overall Study -Treatment Period|Disease Progression|22|||
128845016|NCT01379521|463726587|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
128845017|NCT01379521|463726588|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
128845018|NCT01379521|463726587|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
128845019|NCT01379521|463726588|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
128845020|NCT01379521|463726587|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
128845021|NCT01379521|463726588|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
128845022|NCT01379521|463726587|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
128845023|NCT01379521|463726588|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
128845024|NCT01379521|463726587|FG000|Overall Study -Treatment Period|Death|2|||
128845025|NCT01379521|463726588|FG001|Overall Study -Treatment Period|Death|1|||
128845026|NCT01379521|463726587|FG000|Post-Treatment Evaluations|Disease Progression|22|||
128845027|NCT01379521|463726588|FG001|Post-Treatment Evaluations|Disease Progression|20|||
128845028|NCT01379521|463726587|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
128845029|NCT01379521|463726588|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
128845030|NCT01379521|463726587|FG000|Post-Treatment Evaluations|Death|1|||
128845031|NCT01379521|463726588|FG001|Post-Treatment Evaluations|Death|0|||
128845032|NCT00938041|463726589|FG000|Overall Study|Lost to Follow-up|6|||
128845033|NCT00938041|463726589|FG000|Overall Study|Received Alternative Therapy|1|||
128845034|NCT00938041|463726589|FG000|Overall Study|Progressive Disease|5|||
128845035|NCT00938041|463726589|FG000|Overall Study|Death|12|||
128845036|NCT00938041|463726589|FG000|Overall Study|Adrenal Insufficiency|3|||
128845037|NCT01026103|463726590|FG000|Overall Study|Physician Decision|1|||
128845038|NCT01026103|463726590|FG000|Overall Study|did not receive study device bc of error|1|||
128845039|NCT00105521|463726591|FG000|Overall Study|Other|1|||
128845040|NCT00105521|463726592|FG001|Overall Study|Other|1|||
128845041|NCT00105521|463726593|FG002|Overall Study|Other|2|||
128845042|NCT00105521|463726594|FG003|Overall Study|Other|0|||
128845043|NCT00105521|463726591|FG000|Overall Study|Adverse Event|10|||
128845044|NCT00105521|463726592|FG001|Overall Study|Adverse Event|4|||
128845045|NCT00105521|463726593|FG002|Overall Study|Adverse Event|10|||
128845046|NCT00105521|463726594|FG003|Overall Study|Adverse Event|8|||
128845047|NCT00105521|463726591|FG000|Overall Study|Withdrawal by Subject|1|||
128845048|NCT00105521|463726592|FG001|Overall Study|Withdrawal by Subject|0|||
128845049|NCT00105521|463726593|FG002|Overall Study|Withdrawal by Subject|1|||
128845050|NCT00105521|463726594|FG003|Overall Study|Withdrawal by Subject|4|||
128845051|NCT00105521|463726591|FG000|Overall Study|Lack of Efficacy|0|||
128845052|NCT00105521|463726592|FG001|Overall Study|Lack of Efficacy|0|||
128845053|NCT00105521|463726593|FG002|Overall Study|Lack of Efficacy|0|||
128845054|NCT00105521|463726594|FG003|Overall Study|Lack of Efficacy|1|||
128845055|NCT00105521|463726591|FG000|Overall Study|Protocol Violation|3|||
128845056|NCT00105521|463726592|FG001|Overall Study|Protocol Violation|5|||
128845057|NCT00105521|463726593|FG002|Overall Study|Protocol Violation|4|||
128845058|NCT00105521|463726594|FG003|Overall Study|Protocol Violation|4|||
128845059|NCT00105521|463726591|FG000|Overall Study|Lost to Follow-up|0|||
128845060|NCT00105521|463726592|FG001|Overall Study|Lost to Follow-up|1|||
128845061|NCT00105521|463726593|FG002|Overall Study|Lost to Follow-up|0|||
128845062|NCT00105521|463726594|FG003|Overall Study|Lost to Follow-up|0|||
128845063|NCT00428441|463726595|FG000|Overall Study|Lost to Follow-up|1|||
128845064|NCT02475733|463726596|FG000|Overall Study|Withdrawal by Subject|1|||
128845065|NCT02475733|463726597|FG001|Overall Study|Withdrawal by Subject|0|||
128845066|NCT02475733|463726596|FG000|Overall Study|Physician Decision|1|||
128845067|NCT02475733|463726597|FG001|Overall Study|Physician Decision|0|||
128845068|NCT00404547|463726600|FG000|Overall Study|Adverse Event|39|||
128845069|NCT00404547|463726601|FG001|Overall Study|Adverse Event|6|||
128845070|NCT00404547|463726600|FG000|Overall Study|Withdrawal by Subject|19|||
128845071|NCT00404547|463726601|FG001|Overall Study|Withdrawal by Subject|2|||
128845072|NCT00404547|463726600|FG000|Overall Study|Protocol Violation|0|||
128845073|NCT00404547|463726601|FG001|Overall Study|Protocol Violation|1|||
128845074|NCT00404547|463726600|FG000|Overall Study|Lost to Follow-up|20|||
128845075|NCT00404547|463726601|FG001|Overall Study|Lost to Follow-up|9|||
128845076|NCT00404547|463726600|FG000|Overall Study|Lack of compliance|5|||
128845077|NCT00404547|463726601|FG001|Overall Study|Lack of compliance|1|||
128845078|NCT00404547|463726600|FG000|Overall Study|Other|4|||
128845079|NCT00404547|463726601|FG001|Overall Study|Other|0|||
128845080|NCT00404547|463726600|FG000|Overall Study|Reason not stated|3|||
128845081|NCT00404547|463726601|FG001|Overall Study|Reason not stated|6|||
128845082|NCT02744898|463726602|FG000|Overall Study|Progressive Disease|2|||
128845083|NCT02744898|463726602|FG000|Overall Study|Physician Decision|1|||
128845084|NCT02744898|463726602|FG000|Overall Study|Toxicity|1|||
128845085|NCT03906240|463726603|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
128845086|NCT03906240|463726604|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
128845087|NCT03906240|463726603|FG000|Overall Study|Lost to Follow-up|1|||
128845088|NCT03906240|463726604|FG001|Overall Study|Lost to Follow-up|0|||
128845089|NCT03906240|463726603|FG000|Overall Study|Withdrawal by Subject|0|||
128845090|NCT03906240|463726604|FG001|Overall Study|Withdrawal by Subject|1|||
128845091|NCT03751280|463726611|FG000|Overall Study|Adverse Event|0|||
128845092|NCT03751280|463726612|FG001|Overall Study|Adverse Event|1|||
128845093|NCT03751280|463726611|FG000|Overall Study|Lost to Follow-up|3|||
128845094|NCT03751280|463726612|FG001|Overall Study|Lost to Follow-up|5|||
128845095|NCT03751280|463726611|FG000|Overall Study|Physician Decision|0|||
128845096|NCT03751280|463726612|FG001|Overall Study|Physician Decision|2|||
128845097|NCT03751280|463726611|FG000|Overall Study|Protocol Violation|0|||
128845098|NCT03751280|463726612|FG001|Overall Study|Protocol Violation|2|||
128845099|NCT03751280|463726611|FG000|Overall Study|Withdrawal by Subject|5|||
128845100|NCT03751280|463726612|FG001|Overall Study|Withdrawal by Subject|2|||
128845101|NCT00296504|463726613|FG000|Interim Analysis|Withdrawal by Subject|8|||
128845102|NCT00296504|463726614|FG001|Interim Analysis|Withdrawal by Subject|0|||
128845103|NCT00296504|463726615|FG002|Interim Analysis|Withdrawal by Subject|12|||
128845104|NCT00296504|463726616|FG003|Interim Analysis|Withdrawal by Subject|0|||
128845105|NCT00296504|463726617|FG004|Interim Analysis|Withdrawal by Subject|5|||
128845106|NCT00296504|463726618|FG005|Interim Analysis|Withdrawal by Subject|5|||
128845107|NCT00296504|463726619|FG006|Interim Analysis|Withdrawal by Subject|9|||
128845108|NCT00296504|463726620|FG007|Interim Analysis|Withdrawal by Subject|3|||
128845109|NCT00296504|463726621|FG008|Interim Analysis|Withdrawal by Subject|0|||
128845110|NCT00296504|463726613|FG000|Interim Analysis|Lost to Follow-up|13|||
128845111|NCT00296504|463726614|FG001|Interim Analysis|Lost to Follow-up|3|||
128845112|NCT00296504|463726615|FG002|Interim Analysis|Lost to Follow-up|26|||
128845113|NCT00296504|463726616|FG003|Interim Analysis|Lost to Follow-up|8|||
128845114|NCT00296504|463726617|FG004|Interim Analysis|Lost to Follow-up|14|||
128845115|NCT00296504|463726618|FG005|Interim Analysis|Lost to Follow-up|4|||
128845116|NCT00296504|463726619|FG006|Interim Analysis|Lost to Follow-up|11|||
128845117|NCT00296504|463726620|FG007|Interim Analysis|Lost to Follow-up|4|||
128845118|NCT00296504|463726621|FG008|Interim Analysis|Lost to Follow-up|0|||
128845119|NCT00296504|463726613|FG000|Interim Analysis|Clinical Progression|1|||
128845120|NCT00296504|463726614|FG001|Interim Analysis|Clinical Progression|0|||
128845121|NCT00296504|463726615|FG002|Interim Analysis|Clinical Progression|1|||
128845122|NCT00296504|463726616|FG003|Interim Analysis|Clinical Progression|1|||
128845123|NCT00296504|463726617|FG004|Interim Analysis|Clinical Progression|0|||
128845124|NCT00296504|463726618|FG005|Interim Analysis|Clinical Progression|2|||
128845125|NCT00296504|463726619|FG006|Interim Analysis|Clinical Progression|1|||
128845126|NCT00296504|463726620|FG007|Interim Analysis|Clinical Progression|2|||
128845127|NCT00296504|463726621|FG008|Interim Analysis|Clinical Progression|0|||
128845128|NCT00296504|463726613|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
128845129|NCT00296504|463726614|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
128845130|NCT00296504|463726615|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
128845131|NCT00296504|463726616|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
128845132|NCT00296504|463726617|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
128845133|NCT00296504|463726618|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
128845134|NCT00296504|463726619|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
128845135|NCT00296504|463726620|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
128845136|NCT00296504|463726621|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
128845137|NCT00296504|463726613|FG000|Interim Analysis|Adverse Event|0|||
128845138|NCT00296504|463726614|FG001|Interim Analysis|Adverse Event|0|||
128845139|NCT00296504|463726615|FG002|Interim Analysis|Adverse Event|13|||
128845140|NCT00296504|463726616|FG003|Interim Analysis|Adverse Event|4|||
128845141|NCT00296504|463726617|FG004|Interim Analysis|Adverse Event|6|||
128845142|NCT00296504|463726618|FG005|Interim Analysis|Adverse Event|3|||
128845143|NCT00296504|463726619|FG006|Interim Analysis|Adverse Event|4|||
128845144|NCT00296504|463726620|FG007|Interim Analysis|Adverse Event|5|||
128845145|NCT00296504|463726621|FG008|Interim Analysis|Adverse Event|0|||
128845146|NCT00296504|463726613|FG000|Interim Analysis|Protocol Violation|0|||
128845147|NCT00296504|463726614|FG001|Interim Analysis|Protocol Violation|0|||
128845148|NCT00296504|463726615|FG002|Interim Analysis|Protocol Violation|2|||
128845149|NCT00296504|463726616|FG003|Interim Analysis|Protocol Violation|0|||
128845150|NCT00296504|463726617|FG004|Interim Analysis|Protocol Violation|1|||
128845151|NCT00296504|463726618|FG005|Interim Analysis|Protocol Violation|0|||
128845152|NCT00296504|463726619|FG006|Interim Analysis|Protocol Violation|0|||
128845153|NCT00296504|463726620|FG007|Interim Analysis|Protocol Violation|1|||
128845154|NCT00296504|463726621|FG008|Interim Analysis|Protocol Violation|0|||
128845155|NCT00296504|463726613|FG000|Interim Analysis|Insufficient CD4 Response|0|||
128845156|NCT00296504|463726614|FG001|Interim Analysis|Insufficient CD4 Response|0|||
128845157|NCT00296504|463726615|FG002|Interim Analysis|Insufficient CD4 Response|0|||
128845158|NCT00296504|463726616|FG003|Interim Analysis|Insufficient CD4 Response|0|||
128845159|NCT00296504|463726617|FG004|Interim Analysis|Insufficient CD4 Response|1|||
128845160|NCT00296504|463726618|FG005|Interim Analysis|Insufficient CD4 Response|1|||
128845161|NCT00296504|463726619|FG006|Interim Analysis|Insufficient CD4 Response|0|||
128845162|NCT00296504|463726620|FG007|Interim Analysis|Insufficient CD4 Response|0|||
128845163|NCT00296504|463726621|FG008|Interim Analysis|Insufficient CD4 Response|0|||
128845164|NCT00296504|463726613|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
128845165|NCT00296504|463726614|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
128845166|NCT00296504|463726615|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
128845167|NCT00296504|463726616|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
128845168|NCT00296504|463726617|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
128845169|NCT00296504|463726618|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
128845170|NCT00296504|463726619|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
128845171|NCT00296504|463726620|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
128845172|NCT00296504|463726621|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
128845173|NCT00296504|463726613|FG000|Interim Analysis|Pregnancy|4|||
128845174|NCT00296504|463726614|FG001|Interim Analysis|Pregnancy|1|||
128845175|NCT00296504|463726615|FG002|Interim Analysis|Pregnancy|4|||
128845176|NCT00296504|463726616|FG003|Interim Analysis|Pregnancy|2|||
128845177|NCT00296504|463726617|FG004|Interim Analysis|Pregnancy|0|||
128845178|NCT00296504|463726618|FG005|Interim Analysis|Pregnancy|1|||
128845179|NCT00296504|463726619|FG006|Interim Analysis|Pregnancy|1|||
128845180|NCT00296504|463726620|FG007|Interim Analysis|Pregnancy|1|||
128845181|NCT00296504|463726621|FG008|Interim Analysis|Pregnancy|0|||
128845182|NCT00296504|463726613|FG000|Interim Analysis|Death|1|||
128845183|NCT00296504|463726614|FG001|Interim Analysis|Death|0|||
128845184|NCT00296504|463726615|FG002|Interim Analysis|Death|3|||
128845185|NCT00296504|463726616|FG003|Interim Analysis|Death|0|||
128845186|NCT00296504|463726617|FG004|Interim Analysis|Death|0|||
128845187|NCT00296504|463726618|FG005|Interim Analysis|Death|0|||
128845188|NCT00296504|463726619|FG006|Interim Analysis|Death|0|||
128845189|NCT00296504|463726620|FG007|Interim Analysis|Death|0|||
128845190|NCT00296504|463726621|FG008|Interim Analysis|Death|0|||
128845191|NCT00296504|463726613|FG000|Interim Analysis|Participant Non-compliant|0|||
128845192|NCT00296504|463726614|FG001|Interim Analysis|Participant Non-compliant|1|||
128845193|NCT00296504|463726615|FG002|Interim Analysis|Participant Non-compliant|2|||
128845194|NCT00296504|463726616|FG003|Interim Analysis|Participant Non-compliant|1|||
128845195|NCT00296504|463726617|FG004|Interim Analysis|Participant Non-compliant|1|||
128845196|NCT00296504|463726618|FG005|Interim Analysis|Participant Non-compliant|3|||
128845197|NCT00296504|463726619|FG006|Interim Analysis|Participant Non-compliant|6|||
128845198|NCT00296504|463726620|FG007|Interim Analysis|Participant Non-compliant|2|||
128845199|NCT00296504|463726621|FG008|Interim Analysis|Participant Non-compliant|0|||
128845200|NCT00296504|463726613|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
128845201|NCT00296504|463726614|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
128845202|NCT00296504|463726615|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
128845203|NCT00296504|463726616|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
128845204|NCT00296504|463726617|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
128845205|NCT00296504|463726618|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
128845206|NCT00296504|463726619|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
128845207|NCT00296504|463726620|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
128845208|NCT00296504|463726621|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
128845209|NCT00296504|463726613|FG000|Interim Analysis|To Simplify Treatment|0|||
128845210|NCT00296504|463726614|FG001|Interim Analysis|To Simplify Treatment|0|||
128845211|NCT00296504|463726615|FG002|Interim Analysis|To Simplify Treatment|1|||
128845212|NCT00296504|463726616|FG003|Interim Analysis|To Simplify Treatment|0|||
128845213|NCT00296504|463726617|FG004|Interim Analysis|To Simplify Treatment|0|||
128845214|NCT00296504|463726618|FG005|Interim Analysis|To Simplify Treatment|0|||
128845215|NCT00296504|463726619|FG006|Interim Analysis|To Simplify Treatment|2|||
128845216|NCT00296504|463726620|FG007|Interim Analysis|To Simplify Treatment|0|||
128845217|NCT00296504|463726621|FG008|Interim Analysis|To Simplify Treatment|0|||
128845218|NCT00296504|463726613|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845219|NCT00296504|463726614|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845220|NCT00296504|463726615|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
128845221|NCT00296504|463726616|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845222|NCT00296504|463726617|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845223|NCT00296504|463726618|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845224|NCT00296504|463726619|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845225|NCT00296504|463726620|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845226|NCT00296504|463726621|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
128845227|NCT00296504|463726613|FG000|Interim Analysis|Participant Moved|1|||
128845228|NCT00296504|463726614|FG001|Interim Analysis|Participant Moved|0|||
128845229|NCT00296504|463726615|FG002|Interim Analysis|Participant Moved|1|||
128845230|NCT00296504|463726616|FG003|Interim Analysis|Participant Moved|0|||
128845231|NCT00296504|463726617|FG004|Interim Analysis|Participant Moved|0|||
128845232|NCT00296504|463726618|FG005|Interim Analysis|Participant Moved|1|||
128845233|NCT00296504|463726619|FG006|Interim Analysis|Participant Moved|1|||
128845234|NCT00296504|463726620|FG007|Interim Analysis|Participant Moved|0|||
128845235|NCT00296504|463726621|FG008|Interim Analysis|Participant Moved|0|||
128845236|NCT00296504|463726613|FG000|Interim Analysis|Participant Was Incarcerated|2|||
128845237|NCT00296504|463726614|FG001|Interim Analysis|Participant Was Incarcerated|0|||
128845238|NCT00296504|463726615|FG002|Interim Analysis|Participant Was Incarcerated|1|||
128845239|NCT00296504|463726616|FG003|Interim Analysis|Participant Was Incarcerated|0|||
128845240|NCT00296504|463726617|FG004|Interim Analysis|Participant Was Incarcerated|0|||
128845241|NCT00296504|463726618|FG005|Interim Analysis|Participant Was Incarcerated|0|||
128845242|NCT00296504|463726619|FG006|Interim Analysis|Participant Was Incarcerated|0|||
128845243|NCT00296504|463726620|FG007|Interim Analysis|Participant Was Incarcerated|0|||
128845244|NCT00296504|463726621|FG008|Interim Analysis|Participant Was Incarcerated|0|||
128845245|NCT00296504|463726613|FG000|Interim Analysis|Resistance to FPV|0|||
128845246|NCT00296504|463726614|FG001|Interim Analysis|Resistance to FPV|0|||
128845247|NCT00296504|463726615|FG002|Interim Analysis|Resistance to FPV|1|||
128845248|NCT00296504|463726616|FG003|Interim Analysis|Resistance to FPV|0|||
128845249|NCT00296504|463726617|FG004|Interim Analysis|Resistance to FPV|0|||
128845250|NCT00296504|463726618|FG005|Interim Analysis|Resistance to FPV|0|||
128845251|NCT00296504|463726619|FG006|Interim Analysis|Resistance to FPV|0|||
128845252|NCT00296504|463726620|FG007|Interim Analysis|Resistance to FPV|0|||
128845253|NCT00296504|463726621|FG008|Interim Analysis|Resistance to FPV|0|||
128845254|NCT00296504|463726613|FG000|Interim Analysis|Physician Decision|0|||
128845255|NCT00296504|463726614|FG001|Interim Analysis|Physician Decision|0|||
128845256|NCT00296504|463726615|FG002|Interim Analysis|Physician Decision|1|||
128845257|NCT00296504|463726616|FG003|Interim Analysis|Physician Decision|0|||
128845258|NCT00296504|463726617|FG004|Interim Analysis|Physician Decision|0|||
128845259|NCT00296504|463726618|FG005|Interim Analysis|Physician Decision|0|||
128845260|NCT00296504|463726619|FG006|Interim Analysis|Physician Decision|0|||
128845261|NCT00296504|463726620|FG007|Interim Analysis|Physician Decision|0|||
128845262|NCT00296504|463726621|FG008|Interim Analysis|Physician Decision|0|||
128845263|NCT00296504|463726613|FG000|Interim Analysis|Principle Investigator Discretion|2|||
128845264|NCT00296504|463726614|FG001|Interim Analysis|Principle Investigator Discretion|0|||
128845265|NCT00296504|463726615|FG002|Interim Analysis|Principle Investigator Discretion|1|||
128845266|NCT00296504|463726616|FG003|Interim Analysis|Principle Investigator Discretion|1|||
128845267|NCT00296504|463726617|FG004|Interim Analysis|Principle Investigator Discretion|0|||
128845268|NCT00296504|463726618|FG005|Interim Analysis|Principle Investigator Discretion|0|||
128845269|NCT00296504|463726619|FG006|Interim Analysis|Principle Investigator Discretion|0|||
128845270|NCT00296504|463726620|FG007|Interim Analysis|Principle Investigator Discretion|0|||
128845271|NCT00296504|463726621|FG008|Interim Analysis|Principle Investigator Discretion|0|||
128845272|NCT00296504|463726613|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
128845273|NCT00296504|463726614|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
128845274|NCT00296504|463726615|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
128845275|NCT00296504|463726616|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
128845276|NCT00296504|463726617|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
128845277|NCT00296504|463726618|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
128845278|NCT00296504|463726619|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
128845279|NCT00296504|463726620|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
128845280|NCT00296504|463726621|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
128845281|NCT00296504|463726613|FG000|Interim Analysis|Non-adherence|2|||
128845282|NCT00296504|463726614|FG001|Interim Analysis|Non-adherence|0|||
128845283|NCT00296504|463726615|FG002|Interim Analysis|Non-adherence|0|||
128845284|NCT00296504|463726616|FG003|Interim Analysis|Non-adherence|0|||
128845285|NCT00296504|463726617|FG004|Interim Analysis|Non-adherence|1|||
128845286|NCT00296504|463726618|FG005|Interim Analysis|Non-adherence|0|||
128845287|NCT00296504|463726619|FG006|Interim Analysis|Non-adherence|0|||
128845288|NCT00296504|463726620|FG007|Interim Analysis|Non-adherence|1|||
128845289|NCT00296504|463726621|FG008|Interim Analysis|Non-adherence|0|||
128845290|NCT00296504|463726613|FG000|Interim Analysis|Site Closing|1|||
128845291|NCT00296504|463726614|FG001|Interim Analysis|Site Closing|0|||
128845292|NCT00296504|463726615|FG002|Interim Analysis|Site Closing|0|||
128845293|NCT00296504|463726616|FG003|Interim Analysis|Site Closing|0|||
128845294|NCT00296504|463726617|FG004|Interim Analysis|Site Closing|0|||
128845295|NCT00296504|463726618|FG005|Interim Analysis|Site Closing|1|||
128845296|NCT00296504|463726619|FG006|Interim Analysis|Site Closing|2|||
128845297|NCT00296504|463726620|FG007|Interim Analysis|Site Closing|0|||
128845298|NCT00296504|463726621|FG008|Interim Analysis|Site Closing|0|||
128845299|NCT00296504|463726613|FG000|Interim Analysis|Lack of Personnel at Site|1|||
128845300|NCT00296504|463726614|FG001|Interim Analysis|Lack of Personnel at Site|0|||
128845301|NCT00296504|463726615|FG002|Interim Analysis|Lack of Personnel at Site|0|||
128845302|NCT00296504|463726616|FG003|Interim Analysis|Lack of Personnel at Site|0|||
128845303|NCT00296504|463726617|FG004|Interim Analysis|Lack of Personnel at Site|0|||
128845304|NCT00296504|463726618|FG005|Interim Analysis|Lack of Personnel at Site|0|||
128845305|NCT00296504|463726619|FG006|Interim Analysis|Lack of Personnel at Site|0|||
128845306|NCT00296504|463726620|FG007|Interim Analysis|Lack of Personnel at Site|0|||
128845307|NCT00296504|463726621|FG008|Interim Analysis|Lack of Personnel at Site|0|||
128845308|NCT00296504|463726613|FG000|Interim Analysis|Missed Schedule Date|1|||
128845309|NCT00296504|463726614|FG001|Interim Analysis|Missed Schedule Date|0|||
128845310|NCT00296504|463726615|FG002|Interim Analysis|Missed Schedule Date|0|||
128845311|NCT00296504|463726616|FG003|Interim Analysis|Missed Schedule Date|0|||
128845312|NCT00296504|463726617|FG004|Interim Analysis|Missed Schedule Date|0|||
128845313|NCT00296504|463726618|FG005|Interim Analysis|Missed Schedule Date|0|||
128845314|NCT00296504|463726619|FG006|Interim Analysis|Missed Schedule Date|0|||
128845315|NCT00296504|463726620|FG007|Interim Analysis|Missed Schedule Date|0|||
128845316|NCT00296504|463726621|FG008|Interim Analysis|Missed Schedule Date|0|||
128845317|NCT00296504|463726613|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
128845318|NCT00296504|463726614|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
128845319|NCT00296504|463726615|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
128845320|NCT00296504|463726616|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
128845321|NCT00296504|463726617|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
128845322|NCT00296504|463726618|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
128845323|NCT00296504|463726619|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
128845324|NCT00296504|463726620|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
128845325|NCT00296504|463726621|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
128845326|NCT00296504|463726613|FG000|Interim Analysis|Participant Stopped|0|||
128845327|NCT00296504|463726614|FG001|Interim Analysis|Participant Stopped|0|||
128845328|NCT00296504|463726615|FG002|Interim Analysis|Participant Stopped|0|||
128845329|NCT00296504|463726616|FG003|Interim Analysis|Participant Stopped|0|||
128845330|NCT00296504|463726617|FG004|Interim Analysis|Participant Stopped|1|||
128845331|NCT00296504|463726618|FG005|Interim Analysis|Participant Stopped|0|||
128845332|NCT00296504|463726619|FG006|Interim Analysis|Participant Stopped|0|||
128845333|NCT00296504|463726620|FG007|Interim Analysis|Participant Stopped|0|||
128845334|NCT00296504|463726621|FG008|Interim Analysis|Participant Stopped|0|||
128845335|NCT00296504|463726613|FG000|Interim Analysis|Physician and Participant Decision|0|||
128845336|NCT00296504|463726614|FG001|Interim Analysis|Physician and Participant Decision|0|||
128845337|NCT00296504|463726615|FG002|Interim Analysis|Physician and Participant Decision|0|||
128845338|NCT00296504|463726616|FG003|Interim Analysis|Physician and Participant Decision|0|||
128845339|NCT00296504|463726617|FG004|Interim Analysis|Physician and Participant Decision|0|||
128845340|NCT00296504|463726618|FG005|Interim Analysis|Physician and Participant Decision|1|||
128845341|NCT00296504|463726619|FG006|Interim Analysis|Physician and Participant Decision|0|||
128845342|NCT00296504|463726620|FG007|Interim Analysis|Physician and Participant Decision|0|||
128845343|NCT00296504|463726621|FG008|Interim Analysis|Physician and Participant Decision|0|||
128845344|NCT00296504|463726613|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
128845345|NCT00296504|463726614|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
128845346|NCT00296504|463726615|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
128845347|NCT00296504|463726616|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
128845348|NCT00296504|463726617|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
128845349|NCT00296504|463726618|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
128845350|NCT00296504|463726619|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
128845351|NCT00296504|463726620|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
128845352|NCT00296504|463726621|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
128845353|NCT00296504|463726613|FG000|Interim Analysis|Study Ended|0|||
128845354|NCT00296504|463726614|FG001|Interim Analysis|Study Ended|0|||
128845355|NCT00296504|463726615|FG002|Interim Analysis|Study Ended|0|||
128845356|NCT00296504|463726616|FG003|Interim Analysis|Study Ended|0|||
128845357|NCT00296504|463726617|FG004|Interim Analysis|Study Ended|0|||
128845358|NCT00296504|463726618|FG005|Interim Analysis|Study Ended|0|||
128845359|NCT00296504|463726619|FG006|Interim Analysis|Study Ended|1|||
128845360|NCT00296504|463726620|FG007|Interim Analysis|Study Ended|0|||
128845361|NCT00296504|463726621|FG008|Interim Analysis|Study Ended|0|||
128845362|NCT00296504|463726613|FG000|Interim Analysis|Participant Needed Interferon|0|||
128845363|NCT00296504|463726614|FG001|Interim Analysis|Participant Needed Interferon|0|||
128845364|NCT00296504|463726615|FG002|Interim Analysis|Participant Needed Interferon|0|||
128845365|NCT00296504|463726616|FG003|Interim Analysis|Participant Needed Interferon|0|||
128845366|NCT00296504|463726617|FG004|Interim Analysis|Participant Needed Interferon|0|||
128845367|NCT00296504|463726618|FG005|Interim Analysis|Participant Needed Interferon|0|||
128845368|NCT00296504|463726619|FG006|Interim Analysis|Participant Needed Interferon|0|||
128845369|NCT00296504|463726620|FG007|Interim Analysis|Participant Needed Interferon|1|||
128845370|NCT00296504|463726621|FG008|Interim Analysis|Participant Needed Interferon|0|||
128845371|NCT00296504|463726613|FG000|Interim Analysis|Ongoing|32|||
128845372|NCT00296504|463726614|FG001|Interim Analysis|Ongoing|12|||
128845373|NCT00296504|463726615|FG002|Interim Analysis|Ongoing|16|||
128845374|NCT00296504|463726616|FG003|Interim Analysis|Ongoing|22|||
128845375|NCT00296504|463726617|FG004|Interim Analysis|Ongoing|0|||
128845376|NCT00296504|463726618|FG005|Interim Analysis|Ongoing|0|||
128845377|NCT00296504|463726619|FG006|Interim Analysis|Ongoing|30|||
128845378|NCT00296504|463726620|FG007|Interim Analysis|Ongoing|1|||
128845379|NCT00296504|463726621|FG008|Interim Analysis|Ongoing|0|||
128845380|NCT00296504|463726613|FG000|Final Analysis|Withdrawal by Subject|0|||
128845381|NCT00296504|463726614|FG001|Final Analysis|Withdrawal by Subject|0|||
128845382|NCT00296504|463726615|FG002|Final Analysis|Withdrawal by Subject|0|||
128845383|NCT00296504|463726616|FG003|Final Analysis|Withdrawal by Subject|0|||
128845384|NCT00296504|463726617|FG004|Final Analysis|Withdrawal by Subject|0|||
128845385|NCT00296504|463726618|FG005|Final Analysis|Withdrawal by Subject|0|||
128845386|NCT00296504|463726619|FG006|Final Analysis|Withdrawal by Subject|0|||
128845387|NCT00296504|463726620|FG007|Final Analysis|Withdrawal by Subject|0|||
128845388|NCT00296504|463726621|FG008|Final Analysis|Withdrawal by Subject|1|||
128845389|NCT00296504|463726613|FG000|Final Analysis|Lost to Follow-up|0|||
128845390|NCT00296504|463726614|FG001|Final Analysis|Lost to Follow-up|0|||
128845391|NCT00296504|463726615|FG002|Final Analysis|Lost to Follow-up|0|||
128845392|NCT00296504|463726616|FG003|Final Analysis|Lost to Follow-up|0|||
128845393|NCT00296504|463726617|FG004|Final Analysis|Lost to Follow-up|0|||
128845394|NCT00296504|463726618|FG005|Final Analysis|Lost to Follow-up|0|||
128845395|NCT00296504|463726619|FG006|Final Analysis|Lost to Follow-up|0|||
128845396|NCT00296504|463726620|FG007|Final Analysis|Lost to Follow-up|0|||
128845397|NCT00296504|463726621|FG008|Final Analysis|Lost to Follow-up|5|||
128845398|NCT00296504|463726613|FG000|Final Analysis|Insufficient Viral Load Response|0|||
128845399|NCT00296504|463726614|FG001|Final Analysis|Insufficient Viral Load Response|0|||
128845400|NCT00296504|463726615|FG002|Final Analysis|Insufficient Viral Load Response|0|||
128845401|NCT00296504|463726616|FG003|Final Analysis|Insufficient Viral Load Response|0|||
128845402|NCT00296504|463726617|FG004|Final Analysis|Insufficient Viral Load Response|0|||
128845403|NCT00296504|463726618|FG005|Final Analysis|Insufficient Viral Load Response|0|||
128845404|NCT00296504|463726619|FG006|Final Analysis|Insufficient Viral Load Response|0|||
128845405|NCT00296504|463726620|FG007|Final Analysis|Insufficient Viral Load Response|0|||
128845406|NCT00296504|463726621|FG008|Final Analysis|Insufficient Viral Load Response|6|||
128845407|NCT00296504|463726613|FG000|Final Analysis|Adverse Event|0|||
128845408|NCT00296504|463726614|FG001|Final Analysis|Adverse Event|0|||
128845409|NCT00296504|463726615|FG002|Final Analysis|Adverse Event|0|||
128845410|NCT00296504|463726616|FG003|Final Analysis|Adverse Event|0|||
128845411|NCT00296504|463726617|FG004|Final Analysis|Adverse Event|0|||
128845412|NCT00296504|463726618|FG005|Final Analysis|Adverse Event|0|||
128845413|NCT00296504|463726619|FG006|Final Analysis|Adverse Event|0|||
128845414|NCT00296504|463726620|FG007|Final Analysis|Adverse Event|0|||
128845415|NCT00296504|463726621|FG008|Final Analysis|Adverse Event|2|||
128845416|NCT00296504|463726613|FG000|Final Analysis|Pregnancy|0|||
128845417|NCT00296504|463726614|FG001|Final Analysis|Pregnancy|0|||
128845418|NCT00296504|463726615|FG002|Final Analysis|Pregnancy|0|||
128845419|NCT00296504|463726616|FG003|Final Analysis|Pregnancy|0|||
128845420|NCT00296504|463726617|FG004|Final Analysis|Pregnancy|0|||
128845421|NCT00296504|463726618|FG005|Final Analysis|Pregnancy|0|||
128845422|NCT00296504|463726619|FG006|Final Analysis|Pregnancy|0|||
128845423|NCT00296504|463726620|FG007|Final Analysis|Pregnancy|0|||
128845424|NCT00296504|463726621|FG008|Final Analysis|Pregnancy|4|||
128845425|NCT00296504|463726613|FG000|Final Analysis|Tuberculosis|0|||
128845426|NCT00296504|463726614|FG001|Final Analysis|Tuberculosis|0|||
128845427|NCT00296504|463726615|FG002|Final Analysis|Tuberculosis|0|||
128845428|NCT00296504|463726616|FG003|Final Analysis|Tuberculosis|0|||
128845429|NCT00296504|463726617|FG004|Final Analysis|Tuberculosis|0|||
128845430|NCT00296504|463726618|FG005|Final Analysis|Tuberculosis|0|||
128845431|NCT00296504|463726619|FG006|Final Analysis|Tuberculosis|0|||
128845432|NCT00296504|463726620|FG007|Final Analysis|Tuberculosis|0|||
128845433|NCT00296504|463726621|FG008|Final Analysis|Tuberculosis|1|||
128845434|NCT00296504|463726613|FG000|Final Analysis|Participant Moved to Another Country|0|||
128845435|NCT00296504|463726614|FG001|Final Analysis|Participant Moved to Another Country|0|||
128845436|NCT00296504|463726615|FG002|Final Analysis|Participant Moved to Another Country|0|||
128845437|NCT00296504|463726616|FG003|Final Analysis|Participant Moved to Another Country|0|||
128845438|NCT00296504|463726617|FG004|Final Analysis|Participant Moved to Another Country|0|||
128845439|NCT00296504|463726618|FG005|Final Analysis|Participant Moved to Another Country|0|||
128845440|NCT00296504|463726619|FG006|Final Analysis|Participant Moved to Another Country|0|||
128845441|NCT00296504|463726620|FG007|Final Analysis|Participant Moved to Another Country|0|||
128845442|NCT00296504|463726621|FG008|Final Analysis|Participant Moved to Another Country|1|||
128845443|NCT00296504|463726613|FG000|Final Analysis|Poor Adherence|0|||
128845444|NCT00296504|463726614|FG001|Final Analysis|Poor Adherence|0|||
128845445|NCT00296504|463726615|FG002|Final Analysis|Poor Adherence|0|||
128845446|NCT00296504|463726616|FG003|Final Analysis|Poor Adherence|0|||
128845447|NCT00296504|463726617|FG004|Final Analysis|Poor Adherence|0|||
128845448|NCT00296504|463726618|FG005|Final Analysis|Poor Adherence|0|||
128845449|NCT00296504|463726619|FG006|Final Analysis|Poor Adherence|0|||
128845450|NCT00296504|463726620|FG007|Final Analysis|Poor Adherence|0|||
128845451|NCT00296504|463726621|FG008|Final Analysis|Poor Adherence|1|||
128845452|NCT02162771|463726627|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
128845453|NCT02162771|463726628|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
128845454|NCT02162771|463726627|FG000|Core Study Period (Part 2)|Adverse Event|4|||
128845455|NCT02162771|463726628|FG001|Core Study Period (Part 2)|Adverse Event|1|||
128845456|NCT02162771|463726627|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
128845457|NCT02162771|463726628|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
128845458|NCT02162771|463726627|FG000|Core Study Period (Part 2)|Physician Decision|0|||
128845459|NCT02162771|463726628|FG001|Core Study Period (Part 2)|Physician Decision|2|||
128845460|NCT02162771|463726627|FG000|Core Study Period (Part 2)|Death|1|||
128845461|NCT02162771|463726628|FG001|Core Study Period (Part 2)|Death|0|||
128845462|NCT02162771|463726627|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
128845463|NCT02162771|463726628|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
128845464|NCT02162771|463726627|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
128845465|NCT02162771|463726628|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
128845466|NCT02162771|463726627|FG000|Maintenance Study Period (Part 2)|Death|2|||
128845467|NCT02162771|463726628|FG001|Maintenance Study Period (Part 2)|Death|1|||
128845468|NCT02162771|463726627|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
128845469|NCT02162771|463726628|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
128845470|NCT02162771|463726627|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
128845471|NCT02162771|463726628|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
128845472|NCT02162771|463726627|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
128845473|NCT02162771|463726628|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
128845474|NCT01078571|463726632|FG000|Overall Study|Adverse Event|36|||
128845475|NCT01078571|463726632|FG000|Overall Study|Lack of effectiveness|36|||
128845476|NCT01078571|463726632|FG000|Overall Study|Reason not reported|21|||
128845477|NCT01078571|463726632|FG000|Overall Study|Withdrawal by Subject|12|||
128845478|NCT01078571|463726632|FG000|Overall Study|Lost to Follow-up|8|||
128845479|NCT01078571|463726632|FG000|Overall Study|Protocol Violation|2|||
128845480|NCT01190228|463726633|FG000|Overall Study|Protocol Violation|4|||
128845481|NCT01190228|463726634|FG001|Overall Study|Protocol Violation|0|||
128845482|NCT01190228|463726635|FG002|Overall Study|Protocol Violation|0|||
128845483|NCT01190228|463726633|FG000|Overall Study|Withdrawal by Subject|1|||
128845484|NCT01190228|463726634|FG001|Overall Study|Withdrawal by Subject|0|||
128845485|NCT01190228|463726635|FG002|Overall Study|Withdrawal by Subject|0|||
128845486|NCT02588027|463726636|FG000|Overall Study|Withdrawal by Subject|1|||
128845487|NCT02588027|463726637|FG001|Overall Study|Withdrawal by Subject|3|||
128845488|NCT02588027|463726636|FG000|Overall Study|Protocol Violation|4|||
128845489|NCT02588027|463726637|FG001|Overall Study|Protocol Violation|1|||
128845490|NCT04372186|463726638|FG000|Overall Study|Death|24|||
128845491|NCT04372186|463726639|FG001|Overall Study|Death|11|||
128845492|NCT04372186|463726638|FG000|Overall Study|Transferred to a different facility for care|0|||
128845493|NCT04372186|463726639|FG001|Overall Study|Transferred to a different facility for care|2|||
128845494|NCT03219216|463726640|FG000|Overall Study|Lost to Follow-up|0|||
128845495|NCT03219216|463726641|FG001|Overall Study|Lost to Follow-up|1|||
128845496|NCT02332824|463726642|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
128845497|NCT02332824|463726643|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
128845498|NCT02332824|463726644|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
128845499|NCT02332824|463726645|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
128845500|NCT02332824|463726646|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
128845501|NCT02332824|463726647|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
128845502|NCT02332824|463726642|FG000|Overall Study|Voluntary Withdrawal|1|||
128845503|NCT02332824|463726643|FG001|Overall Study|Voluntary Withdrawal|0|||
128845504|NCT02332824|463726644|FG002|Overall Study|Voluntary Withdrawal|0|||
128845505|NCT02332824|463726645|FG003|Overall Study|Voluntary Withdrawal|0|||
128845506|NCT02332824|463726646|FG004|Overall Study|Voluntary Withdrawal|0|||
128845507|NCT02332824|463726647|FG005|Overall Study|Voluntary Withdrawal|0|||
128845508|NCT02332824|463726642|FG000|Overall Study|Inconvenient schedule|1|||
128845509|NCT02332824|463726643|FG001|Overall Study|Inconvenient schedule|1|||
128845510|NCT02332824|463726644|FG002|Overall Study|Inconvenient schedule|0|||
128845511|NCT02332824|463726645|FG003|Overall Study|Inconvenient schedule|0|||
128845512|NCT02332824|463726646|FG004|Overall Study|Inconvenient schedule|0|||
128845513|NCT02332824|463726647|FG005|Overall Study|Inconvenient schedule|0|||
128845514|NCT02332824|463726642|FG000|Overall Study|Transfer|0|||
128845515|NCT02332824|463726643|FG001|Overall Study|Transfer|0|||
128845516|NCT02332824|463726644|FG002|Overall Study|Transfer|1|||
128845517|NCT02332824|463726645|FG003|Overall Study|Transfer|1|||
128845518|NCT02332824|463726646|FG004|Overall Study|Transfer|0|||
128845519|NCT02332824|463726647|FG005|Overall Study|Transfer|0|||
128845520|NCT00914732|463726648|FG000|Overall Study|Lost to Follow-up|6|||
128845521|NCT00914732|463726649|FG001|Overall Study|Lost to Follow-up|7|||
128845522|NCT00914732|463726650|FG002|Overall Study|Lost to Follow-up|9|||
128845523|NCT00914732|463726648|FG000|Overall Study|Withdrawal by Subject|3|||
128845524|NCT00914732|463726649|FG001|Overall Study|Withdrawal by Subject|0|||
128845525|NCT00914732|463726650|FG002|Overall Study|Withdrawal by Subject|2|||
128845526|NCT00914732|463726648|FG000|Overall Study|Adverse Event|1|||
128845527|NCT00914732|463726649|FG001|Overall Study|Adverse Event|0|||
128845528|NCT00914732|463726650|FG002|Overall Study|Adverse Event|0|||
128845529|NCT03840148|463726653|FG000|Study Drug Disposition|Adverse Event|13|||
128845530|NCT03840148|463726654|FG001|Study Drug Disposition|Adverse Event|2|||
128845531|NCT03840148|463726653|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
128845532|NCT03840148|463726654|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
128845533|NCT03840148|463726653|FG000|Study Drug Disposition|Lack of Efficacy|3|||
128845534|NCT03840148|463726654|FG001|Study Drug Disposition|Lack of Efficacy|0|||
128845535|NCT03840148|463726653|FG000|Study Drug Disposition|Physician Decision|2|||
128845536|NCT03840148|463726654|FG001|Study Drug Disposition|Physician Decision|0|||
128845537|NCT03840148|463726653|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
128845538|NCT03840148|463726654|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
128845539|NCT03840148|463726653|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
128845540|NCT03840148|463726654|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
128845541|NCT03840148|463726653|FG000|Study Completion Disposition|Physician Decision|2|||
128845542|NCT03840148|463726654|FG001|Study Completion Disposition|Physician Decision|0|||
128845543|NCT03840148|463726653|FG000|Study Completion Disposition|Covid-19 related|2|||
128845544|NCT03840148|463726654|FG001|Study Completion Disposition|Covid-19 related|0|||
128845545|NCT03840148|463726653|FG000|Study Completion Disposition|Lost to Follow-up|1|||
128845546|NCT03840148|463726654|FG001|Study Completion Disposition|Lost to Follow-up|1|||
128845547|NCT03840148|463726653|FG000|Study Completion Disposition|Death|1|||
128845548|NCT03840148|463726654|FG001|Study Completion Disposition|Death|0|||
128845549|NCT03840148|463726653|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
128845550|NCT03840148|463726654|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
128845551|NCT03615404|463726655|FG000|Overall Study|Death|1|||
128845552|NCT03615404|463726655|FG000|Overall Study|vaccine did not pass quality assurance|1|||
128845553|NCT01774929|463726656|FG000|Overall Study|Adverse Event|3|||
128845554|NCT00603278|463726658|FG000|Overall Study|Lack of Efficacy|35|||
128845555|NCT00603278|463726659|FG001|Overall Study|Lack of Efficacy|10|||
128845556|NCT00603278|463726660|FG002|Overall Study|Lack of Efficacy|11|||
128845557|NCT00603278|463726661|FG003|Overall Study|Lack of Efficacy|8|||
128845558|NCT00603278|463726662|FG004|Overall Study|Lack of Efficacy|7|||
128845559|NCT00603278|463726663|FG005|Overall Study|Lack of Efficacy|14|||
128845560|NCT00603278|463726658|FG000|Overall Study|Adverse Event|0|||
128845561|NCT00603278|463726659|FG001|Overall Study|Adverse Event|3|||
128845562|NCT00603278|463726660|FG002|Overall Study|Adverse Event|1|||
128845563|NCT00603278|463726661|FG003|Overall Study|Adverse Event|0|||
128845564|NCT00603278|463726662|FG004|Overall Study|Adverse Event|2|||
128845565|NCT00603278|463726663|FG005|Overall Study|Adverse Event|1|||
128845566|NCT00603278|463726658|FG000|Overall Study|Withdrawal by Subject|2|||
128845567|NCT00603278|463726659|FG001|Overall Study|Withdrawal by Subject|3|||
128845568|NCT00603278|463726660|FG002|Overall Study|Withdrawal by Subject|1|||
128845569|NCT00603278|463726661|FG003|Overall Study|Withdrawal by Subject|2|||
128845570|NCT00603278|463726662|FG004|Overall Study|Withdrawal by Subject|1|||
128845571|NCT00603278|463726663|FG005|Overall Study|Withdrawal by Subject|2|||
128845572|NCT00603278|463726658|FG000|Overall Study|Protocol Violation|3|||
128845573|NCT00603278|463726659|FG001|Overall Study|Protocol Violation|0|||
128845574|NCT00603278|463726660|FG002|Overall Study|Protocol Violation|1|||
128845575|NCT00603278|463726661|FG003|Overall Study|Protocol Violation|1|||
128845576|NCT00603278|463726662|FG004|Overall Study|Protocol Violation|0|||
128845577|NCT00603278|463726663|FG005|Overall Study|Protocol Violation|1|||
128845578|NCT00603278|463726658|FG000|Overall Study|Physician Decision|0|||
128845579|NCT00603278|463726659|FG001|Overall Study|Physician Decision|1|||
128845580|NCT00603278|463726660|FG002|Overall Study|Physician Decision|0|||
128845581|NCT00603278|463726661|FG003|Overall Study|Physician Decision|0|||
128845582|NCT00603278|463726662|FG004|Overall Study|Physician Decision|2|||
128845583|NCT00603278|463726663|FG005|Overall Study|Physician Decision|1|||
128845584|NCT00603278|463726658|FG000|Overall Study|Lost to Follow-up|1|||
128845585|NCT00603278|463726659|FG001|Overall Study|Lost to Follow-up|0|||
128845586|NCT00603278|463726660|FG002|Overall Study|Lost to Follow-up|0|||
128845587|NCT00603278|463726661|FG003|Overall Study|Lost to Follow-up|0|||
128845588|NCT00603278|463726662|FG004|Overall Study|Lost to Follow-up|1|||
128845589|NCT00603278|463726663|FG005|Overall Study|Lost to Follow-up|0|||
128845590|NCT00990821|463726670|FG000|Overall Study|Withdrawal by Subject|0|||
128845591|NCT00990821|463726671|FG001|Overall Study|Withdrawal by Subject|2|||
128845592|NCT00990821|463726672|FG002|Overall Study|Withdrawal by Subject|0|||
128845593|NCT00990821|463726673|FG003|Overall Study|Withdrawal by Subject|0|||
128845594|NCT00990821|463726674|FG004|Overall Study|Withdrawal by Subject|3|||
128845595|NCT00990821|463726675|FG005|Overall Study|Withdrawal by Subject|3|||
128845596|NCT00990821|463726676|FG006|Overall Study|Withdrawal by Subject|1|||
128845597|NCT00990821|463726677|FG007|Overall Study|Withdrawal by Subject|0|||
128845598|NCT00990821|463726678|FG008|Overall Study|Withdrawal by Subject|0|||
128845599|NCT00990821|463726679|FG009|Overall Study|Withdrawal by Subject|1|||
128845600|NCT00990821|463726680|FG010|Overall Study|Withdrawal by Subject|3|||
128845601|NCT00990821|463726681|FG011|Overall Study|Withdrawal by Subject|5|||
128845602|NCT00990821|463726682|FG012|Overall Study|Withdrawal by Subject|2|||
128845603|NCT00990821|463726683|FG013|Overall Study|Withdrawal by Subject|1|||
128845604|NCT04150250|463726684|FG000|Overall Study|Lost to Follow-up|0|||
128845605|NCT04150250|463726685|FG001|Overall Study|Lost to Follow-up|2|||
128845606|NCT01786551|463726686|FG000|Overall Study|Participant withdrew consent|2|||
128845607|NCT01123642|463726689|FG000|Overall Study|Lost to Follow-up|23|||
128845608|NCT01123642|463726689|FG000|Overall Study|Withdrawal by Subject|9|||
128845609|NCT01123642|463726689|FG000|Overall Study|ineligible at baseline assessment|36|||
128845610|NCT01184859|463728097|FG000|Period 1: Single Dose|Insufficient urine production|0|||
128845611|NCT01184859|463728098|FG001|Period 1: Single Dose|Insufficient urine production|1|||
128845612|NCT01184859|463728099|FG002|Period 1: Single Dose|Insufficient urine production|0|||
128845613|NCT01184859|463728100|FG003|Period 1: Single Dose|Insufficient urine production|0|||
128845614|NCT01184859|463728101|FG004|Period 1: Single Dose|Insufficient urine production|0|||
128845615|NCT01184859|463728097|FG000|Period 1: Single Dose|Protocol Violation|0|||
128845616|NCT01184859|463728098|FG001|Period 1: Single Dose|Protocol Violation|1|||
128845617|NCT01184859|463728099|FG002|Period 1: Single Dose|Protocol Violation|0|||
128845618|NCT01184859|463728100|FG003|Period 1: Single Dose|Protocol Violation|0|||
128845619|NCT01184859|463728101|FG004|Period 1: Single Dose|Protocol Violation|0|||
128845620|NCT01184859|463728097|FG000|Period 1: Single Dose|Adverse Event|0|||
128845621|NCT01184859|463728098|FG001|Period 1: Single Dose|Adverse Event|0|||
128845622|NCT01184859|463728099|FG002|Period 1: Single Dose|Adverse Event|0|||
128845623|NCT01184859|463728100|FG003|Period 1: Single Dose|Adverse Event|0|||
128845624|NCT01184859|463728101|FG004|Period 1: Single Dose|Adverse Event|1|||
128845625|NCT01184859|463728097|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
128845626|NCT01184859|463728098|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
128845627|NCT01184859|463728099|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
128845628|NCT01184859|463728100|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
128845629|NCT01184859|463728101|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
128845630|NCT01184859|463728097|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
128845631|NCT01184859|463728098|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
128845632|NCT01184859|463728099|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
128845633|NCT01184859|463728100|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
128845634|NCT01184859|463728101|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
128845635|NCT00961298|463728102|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
128845636|NCT00961298|463728102|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
128845637|NCT00961298|463728102|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
128845638|NCT01232569|463728103|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
128845639|NCT01232569|463728104|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
128845640|NCT01232569|463728105|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
128845641|NCT01232569|463728106|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
128845642|NCT01232569|463728103|FG000|Double-blind Treatment Period|Escape|2|||
128845643|NCT01232569|463728104|FG001|Double-blind Treatment Period|Escape|2|||
128845644|NCT01232569|463728105|FG002|Double-blind Treatment Period|Escape|0|||
128845645|NCT01232569|463728106|FG003|Double-blind Treatment Period|Escape|0|||
128845646|NCT01232569|463728103|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
128845647|NCT01232569|463728104|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
128845648|NCT01232569|463728105|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
128845649|NCT01232569|463728106|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
128845650|NCT01232569|463728103|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
128845651|NCT01232569|463728104|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
128845652|NCT01232569|463728105|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
128845653|NCT01232569|463728106|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
128845654|NCT01232569|463728103|FG000|Double-blind Treatment Period|Physician Decision|1|||
128845655|NCT01232569|463728104|FG001|Double-blind Treatment Period|Physician Decision|0|||
128845656|NCT01232569|463728105|FG002|Double-blind Treatment Period|Physician Decision|0|||
128845657|NCT01232569|463728106|FG003|Double-blind Treatment Period|Physician Decision|0|||
128845658|NCT01232569|463728103|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
128845659|NCT01232569|463728104|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
128845660|NCT01232569|463728105|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
128845661|NCT01232569|463728106|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
128845662|NCT01232569|463728103|FG000|Double-blind Treatment Period|Death|2|||
128845663|NCT01232569|463728104|FG001|Double-blind Treatment Period|Death|0|||
128845664|NCT01232569|463728105|FG002|Double-blind Treatment Period|Death|0|||
128845665|NCT01232569|463728106|FG003|Double-blind Treatment Period|Death|0|||
128845666|NCT04044352|463728107|FG000|Overall Study|Lost to Follow-up|9|||
128845667|NCT04044352|463728107|FG000|Overall Study|Withdrawal by Subject|2|||
128845668|NCT00651937|463728108|FG000|Overall Study|Withdrawal by Subject|4|||
128845669|NCT00651937|463728109|FG001|Overall Study|Withdrawal by Subject|1|||
128845670|NCT00814632|463728110|FG000|Overall Study|Lack of Efficacy|2|||
128845671|NCT01537120|463728114|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
128845672|NCT01537120|463728114|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
128845673|NCT02514577|463728116|FG000|Overall Study|Lost to Follow-up|6|||
128845674|NCT02514577|463728117|FG001|Overall Study|Lost to Follow-up|6|||
128845675|NCT02514577|463728116|FG000|Overall Study|Protocol Violation|1|||
128845676|NCT02514577|463728117|FG001|Overall Study|Protocol Violation|0|||
128845677|NCT02514577|463728116|FG000|Overall Study|Withdrawal by Subject|6|||
128845678|NCT02514577|463728117|FG001|Overall Study|Withdrawal by Subject|6|||
128845679|NCT02514577|463728116|FG000|Overall Study|Adverse Event|1|||
128845680|NCT02514577|463728117|FG001|Overall Study|Adverse Event|1|||
128845681|NCT02388932|463728118|FG000|Overall Study|Death|1|||
128845682|NCT01503515|463728119|FG000|Overall Study|Adverse Event|4|||
128845683|NCT01503515|463728120|FG001|Overall Study|Adverse Event|5|||
128845684|NCT01503515|463728119|FG000|Overall Study|Death|0|||
128845685|NCT01503515|463728120|FG001|Overall Study|Death|1|||
128845686|NCT01503515|463728119|FG000|Overall Study|Physician Decision|14|||
128845687|NCT01503515|463728120|FG001|Overall Study|Physician Decision|23|||
128845688|NCT01503515|463728119|FG000|Overall Study|Withdrawal by Subject|0|||
128845689|NCT01503515|463728120|FG001|Overall Study|Withdrawal by Subject|1|||
128845690|NCT01503515|463728119|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
128845691|NCT01503515|463728120|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
128845692|NCT01503515|463728119|FG000|Overall Study|Ineligible|1|||
128845693|NCT01503515|463728120|FG001|Overall Study|Ineligible|1|||
128845694|NCT02123797|463728124|FG000|Baseline Intervention|Death|9|||
128845695|NCT02123797|463728125|FG001|Baseline Intervention|Death|16|||
128845696|NCT02123797|463728126|FG002|Baseline Intervention|Death|0|||
128845697|NCT02123797|463728127|FG003|Baseline Intervention|Death|0|||
128845698|NCT02123797|463728128|FG004|Baseline Intervention|Death|0|||
128845699|NCT02123797|463728124|FG000|Baseline Intervention|Withdrawal by Subject|2|||
128845700|NCT02123797|463728125|FG001|Baseline Intervention|Withdrawal by Subject|8|||
128845701|NCT02123797|463728126|FG002|Baseline Intervention|Withdrawal by Subject|0|||
128845702|NCT02123797|463728127|FG003|Baseline Intervention|Withdrawal by Subject|0|||
128845703|NCT02123797|463728128|FG004|Baseline Intervention|Withdrawal by Subject|0|||
128845704|NCT02123797|463728124|FG000|Baseline Intervention|Relocation|2|||
128845705|NCT02123797|463728125|FG001|Baseline Intervention|Relocation|0|||
128845706|NCT02123797|463728126|FG002|Baseline Intervention|Relocation|0|||
128845707|NCT02123797|463728127|FG003|Baseline Intervention|Relocation|0|||
128845708|NCT02123797|463728128|FG004|Baseline Intervention|Relocation|0|||
128845709|NCT02123797|463728124|FG000|Baseline Intervention|Out of window for initial survey|6|||
128845710|NCT02123797|463728125|FG001|Baseline Intervention|Out of window for initial survey|13|||
128845711|NCT02123797|463728126|FG002|Baseline Intervention|Out of window for initial survey|0|||
128845712|NCT02123797|463728127|FG003|Baseline Intervention|Out of window for initial survey|0|||
128845713|NCT02123797|463728128|FG004|Baseline Intervention|Out of window for initial survey|0|||
128845714|NCT02123797|463728124|FG000|Baseline Intervention|Lost to Follow-up|0|||
128845715|NCT02123797|463728125|FG001|Baseline Intervention|Lost to Follow-up|5|||
128845716|NCT02123797|463728126|FG002|Baseline Intervention|Lost to Follow-up|0|||
128845717|NCT02123797|463728127|FG003|Baseline Intervention|Lost to Follow-up|0|||
128845718|NCT02123797|463728128|FG004|Baseline Intervention|Lost to Follow-up|0|||
128845719|NCT02123797|463728124|FG000|Baseline Intervention|Other Disease|3|||
128845720|NCT02123797|463728125|FG001|Baseline Intervention|Other Disease|0|||
128845721|NCT02123797|463728126|FG002|Baseline Intervention|Other Disease|0|||
128845722|NCT02123797|463728127|FG003|Baseline Intervention|Other Disease|0|||
128845723|NCT02123797|463728128|FG004|Baseline Intervention|Other Disease|0|||
128845724|NCT02123797|463728124|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
128845725|NCT02123797|463728125|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
128845726|NCT02123797|463728126|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
128845727|NCT02123797|463728127|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
128845728|NCT02123797|463728128|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
128845729|NCT02123797|463728124|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
128845730|NCT02123797|463728125|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
128845731|NCT02123797|463728126|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
128845732|NCT02123797|463728127|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
128845733|NCT02123797|463728128|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
128845734|NCT02123797|463728124|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
128845735|NCT02123797|463728125|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
128845736|NCT02123797|463728126|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
128845737|NCT02123797|463728127|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
128845738|NCT02123797|463728128|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
128845739|NCT02123797|463728124|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
128845740|NCT02123797|463728125|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
128845741|NCT02123797|463728126|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
128845742|NCT02123797|463728127|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
128845743|NCT02123797|463728128|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
128845744|NCT02123797|463728124|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
128845745|NCT02123797|463728125|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
128845746|NCT02123797|463728126|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
128845747|NCT02123797|463728127|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
128845748|NCT02123797|463728128|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
128845749|NCT02123797|463728124|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
128845750|NCT02123797|463728125|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
128845751|NCT02123797|463728126|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
128845752|NCT02123797|463728127|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
128845753|NCT02123797|463728128|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
128845754|NCT02123797|463728124|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
128845755|NCT02123797|463728125|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
128845756|NCT02123797|463728126|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
128845757|NCT02123797|463728127|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
128845758|NCT02123797|463728128|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
128845759|NCT02123797|463728124|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
128845760|NCT02123797|463728125|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
128845761|NCT02123797|463728126|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
128845762|NCT02123797|463728127|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
128845763|NCT02123797|463728128|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
128845764|NCT02123797|463728124|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
128845765|NCT02123797|463728125|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
128845766|NCT02123797|463728126|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
128845767|NCT02123797|463728127|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
128845768|NCT02123797|463728128|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
128845769|NCT00443755|463728129|FG000|Overall Study|Withdrawal by Subject|2|||
128845770|NCT00443755|463728130|FG001|Overall Study|Withdrawal by Subject|1|||
128845771|NCT00678899|463728133|FG000|Overall Study|Adverse Event|1|||
128845772|NCT03997409|463728139|FG000|Overall Study|Protocol Violation|1|||
128845773|NCT03997409|463728140|FG001|Overall Study|Protocol Violation|1|||
128845774|NCT03997409|463728141|FG002|Overall Study|Protocol Violation|0|||
128845775|NCT03997409|463728139|FG000|Overall Study|Withdrawal by Subject|3|||
128845776|NCT03997409|463728140|FG001|Overall Study|Withdrawal by Subject|0|||
128845777|NCT03997409|463728141|FG002|Overall Study|Withdrawal by Subject|0|||
128845778|NCT03997409|463728139|FG000|Overall Study|Lost to Follow-up|0|||
128845779|NCT03997409|463728140|FG001|Overall Study|Lost to Follow-up|0|||
128845780|NCT03997409|463728141|FG002|Overall Study|Lost to Follow-up|1|||
128845781|NCT01753323|463728142|FG000|Overall Study|Lack of Efficacy|0|||
128845782|NCT01753323|463728143|FG001|Overall Study|Lack of Efficacy|0|||
128845783|NCT01753323|463728144|FG002|Overall Study|Lack of Efficacy|8|||
128845784|NCT01753323|463728142|FG000|Overall Study|Protocol deviation|1|||
128845785|NCT01753323|463728143|FG001|Overall Study|Protocol deviation|0|||
128845786|NCT01753323|463728144|FG002|Overall Study|Protocol deviation|0|||
128845787|NCT01753323|463728142|FG000|Overall Study|Adverse Event|0|||
128845788|NCT01753323|463728143|FG001|Overall Study|Adverse Event|0|||
128845789|NCT01753323|463728144|FG002|Overall Study|Adverse Event|1|||
128845790|NCT00116584|463728150|FG000|Overall Study|Withdrawal by Subject|1|||
128845791|NCT00116584|463728151|FG001|Overall Study|Withdrawal by Subject|0|||
128845792|NCT00116584|463728150|FG000|Overall Study|Protocol Violation|1|||
128845793|NCT00116584|463728151|FG001|Overall Study|Protocol Violation|1|||
128845794|NCT01498445|463728152|FG000|Overall Study|Lack of Efficacy|0|||
128845795|NCT01498445|463728153|FG001|Overall Study|Lack of Efficacy|0|||
128845796|NCT01498445|463728154|FG002|Overall Study|Lack of Efficacy|1|||
128845797|NCT01498445|463728155|FG003|Overall Study|Lack of Efficacy|2|||
128845798|NCT01498445|463728156|FG004|Overall Study|Lack of Efficacy|0|||
128845799|NCT01498445|463728157|FG005|Overall Study|Lack of Efficacy|0|||
128845800|NCT01498445|463728152|FG000|Overall Study|Screen Failure|0|||
128845801|NCT01498445|463728153|FG001|Overall Study|Screen Failure|0|||
128845802|NCT01498445|463728154|FG002|Overall Study|Screen Failure|0|||
128845803|NCT01498445|463728155|FG003|Overall Study|Screen Failure|0|||
128845804|NCT01498445|463728156|FG004|Overall Study|Screen Failure|1|||
128845805|NCT01498445|463728157|FG005|Overall Study|Screen Failure|1|||
128845806|NCT02350127|463728158|FG000|4-Month Assessment|Withdrawal by Subject|10|||
128845807|NCT02350127|463728159|FG001|4-Month Assessment|Withdrawal by Subject|9|||
128845808|NCT02350127|463728158|FG000|4-Month Assessment|Death|1|||
128845809|NCT02350127|463728159|FG001|4-Month Assessment|Death|0|||
128845810|NCT02350127|463728158|FG000|8-Month Assessment|Death|1|||
128845811|NCT02350127|463728159|FG001|8-Month Assessment|Death|1|||
128845812|NCT02350127|463728158|FG000|8-Month Assessment|Withdrawal by Subject|5|||
128845813|NCT02350127|463728159|FG001|8-Month Assessment|Withdrawal by Subject|8|||
128845814|NCT03647709|463728169|FG000|Overall Study|Lost to Follow-up|5|||
128845815|NCT03647709|463728169|FG000|Overall Study|Physician Decision|6|||
128845816|NCT03647709|463728169|FG000|Overall Study|Withdrawal by Subject|3|||
128845817|NCT00449033|463728170|FG000|Treatment Period|Adverse Event|117|||
128845818|NCT00449033|463728171|FG001|Treatment Period|Adverse Event|83|||
128845819|NCT00449033|463728170|FG000|Treatment Period|Death|21|||
128845820|NCT00449033|463728171|FG001|Treatment Period|Death|12|||
128845821|NCT00449033|463728170|FG000|Treatment Period|Lost to Follow-up|0|||
128845822|NCT00449033|463728171|FG001|Treatment Period|Lost to Follow-up|2|||
128845823|NCT00449033|463728170|FG000|Treatment Period|Physician Decision|4|||
128845824|NCT00449033|463728171|FG001|Treatment Period|Physician Decision|5|||
128845825|NCT00449033|463728170|FG000|Treatment Period|Protocol Violation|8|||
128845826|NCT00449033|463728171|FG001|Treatment Period|Protocol Violation|7|||
128845827|NCT00449033|463728170|FG000|Treatment Period|Disease Progression|231|||
128845828|NCT00449033|463728171|FG001|Treatment Period|Disease Progression|288|||
128845829|NCT00449033|463728170|FG000|Treatment Period|Consent Withdrawn|36|||
128845830|NCT00449033|463728171|FG001|Treatment Period|Consent Withdrawn|20|||
128845831|NCT00449033|463728170|FG000|Treatment Period|Amended Protocol Criteria|22|||
128845832|NCT00449033|463728171|FG001|Treatment Period|Amended Protocol Criteria|18|||
128845833|NCT00449033|463728170|FG000|Treatment Period|Non-compliance|7|||
128845834|NCT00449033|463728171|FG001|Treatment Period|Non-compliance|8|||
128845835|NCT00449033|463728170|FG000|Treatment Period|Second Malignancy|0|||
128845836|NCT00449033|463728171|FG001|Treatment Period|Second Malignancy|1|||
128845837|NCT00449033|463728170|FG000|Treatment Period|Reason Missing|0|||
128845838|NCT00449033|463728171|FG001|Treatment Period|Reason Missing|4|||
128845839|NCT00449033|463728170|FG000|Treatment Period|Treatment Ongoing|6|||
128845840|NCT00449033|463728171|FG001|Treatment Period|Treatment Ongoing|4|||
128845841|NCT00449033|463728170|FG000|Follow-up Period|Death|299|||
128845842|NCT00449033|463728171|FG001|Follow-up Period|Death|311|||
128845843|NCT00449033|463728170|FG000|Follow-up Period|Lost to Follow-up|6|||
128845844|NCT00449033|463728171|FG001|Follow-up Period|Lost to Follow-up|10|||
128845845|NCT00449033|463728170|FG000|Follow-up Period|Reason Missing|120|||
128845846|NCT00449033|463728171|FG001|Follow-up Period|Reason Missing|113|||
128845847|NCT01257698|463728174|FG000|Overall Study|Protocol Violation|4|||
128845848|NCT01257698|463728175|FG001|Overall Study|Protocol Violation|0|||
128845849|NCT04393779|463728176|FG000|Overall Study|Death|1|||
128845850|NCT04393779|463728176|FG000|Overall Study|Device reintervention or explant|4|||
128845851|NCT03802513|463728177|FG000|Overall Study|Lost to Follow-up|1|||
128845852|NCT01770509|463728191|FG000|Overall Study|Injury|0|||
128845853|NCT01770509|463728192|FG001|Overall Study|Injury|1|||
128845854|NCT01770509|463728191|FG000|Overall Study|Lost to Follow-up|1|||
128845855|NCT01770509|463728192|FG001|Overall Study|Lost to Follow-up|2|||
128845856|NCT04374253|463728193|FG000|Overall Study|Adverse Event|0|||
128845857|NCT04374253|463728194|FG001|Overall Study|Adverse Event|26|||
128845858|NCT04374253|463728195|FG002|Overall Study|Adverse Event|2|||
128845859|NCT04374253|463728196|FG003|Overall Study|Adverse Event|12|||
128845860|NCT04374253|463728193|FG000|Overall Study|Study terminated by sponsor|13|||
128845861|NCT04374253|463728194|FG001|Overall Study|Study terminated by sponsor|593|||
128845862|NCT04374253|463728195|FG002|Overall Study|Study terminated by sponsor|21|||
128845863|NCT04374253|463728196|FG003|Overall Study|Study terminated by sponsor|567|||
128845864|NCT04374253|463728193|FG000|Overall Study|Withdrawal by Subject|0|||
128845865|NCT04374253|463728194|FG001|Overall Study|Withdrawal by Subject|55|||
128845866|NCT04374253|463728195|FG002|Overall Study|Withdrawal by Subject|3|||
128845867|NCT04374253|463728196|FG003|Overall Study|Withdrawal by Subject|40|||
128845868|NCT04374253|463728193|FG000|Overall Study|Physician Decision|1|||
128845869|NCT04374253|463728194|FG001|Overall Study|Physician Decision|10|||
128845870|NCT04374253|463728195|FG002|Overall Study|Physician Decision|1|||
128845871|NCT04374253|463728196|FG003|Overall Study|Physician Decision|10|||
128845872|NCT04374253|463728193|FG000|Overall Study|Protocol Violation|0|||
128845873|NCT04374253|463728194|FG001|Overall Study|Protocol Violation|0|||
128845874|NCT04374253|463728195|FG002|Overall Study|Protocol Violation|0|||
128845875|NCT04374253|463728196|FG003|Overall Study|Protocol Violation|2|||
128845876|NCT04374253|463728193|FG000|Overall Study|Death|0|||
128845877|NCT04374253|463728194|FG001|Overall Study|Death|3|||
128845878|NCT04374253|463728195|FG002|Overall Study|Death|1|||
128845879|NCT04374253|463728196|FG003|Overall Study|Death|1|||
128845880|NCT04374253|463728193|FG000|Overall Study|Lack of Efficacy|0|||
128845881|NCT04374253|463728194|FG001|Overall Study|Lack of Efficacy|0|||
128845882|NCT04374253|463728195|FG002|Overall Study|Lack of Efficacy|0|||
128845883|NCT04374253|463728196|FG003|Overall Study|Lack of Efficacy|1|||
128845884|NCT04374253|463728193|FG000|Overall Study|Lost to Follow-up|1|||
128845885|NCT04374253|463728194|FG001|Overall Study|Lost to Follow-up|1|||
128845886|NCT04374253|463728195|FG002|Overall Study|Lost to Follow-up|0|||
128845887|NCT04374253|463728196|FG003|Overall Study|Lost to Follow-up|2|||
128845888|NCT04374253|463728193|FG000|Overall Study|Reason Not Specified|0|||
128845889|NCT04374253|463728194|FG001|Overall Study|Reason Not Specified|8|||
128845890|NCT04374253|463728195|FG002|Overall Study|Reason Not Specified|0|||
128845891|NCT04374253|463728196|FG003|Overall Study|Reason Not Specified|8|||
128845892|NCT01207453|463728197|FG000|First Intervention|Adverse Event|2|||
128845893|NCT01207453|463728198|FG001|First Intervention|Adverse Event|1|||
128845894|NCT01207453|463728197|FG000|Washout|Adverse Event|1|||
128845895|NCT01207453|463728198|FG001|Washout|Adverse Event|0|||
128845896|NCT01207453|463728197|FG000|Washout|Lost to Follow-up|1|||
128845897|NCT01207453|463728198|FG001|Washout|Lost to Follow-up|0|||
128845898|NCT01207453|463728197|FG000|2nd Intervention|Adverse Event|1|||
128845899|NCT01207453|463728198|FG001|2nd Intervention|Adverse Event|2|||
128845900|NCT01207453|463728197|FG000|2nd Intervention|Lost to Follow-up|1|||
128845901|NCT01207453|463728198|FG001|2nd Intervention|Lost to Follow-up|0|||
128845902|NCT02577315|463728204|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
128845903|NCT02577315|463728205|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
128845904|NCT00417989|463728206|FG000|Overall Study|Withdrawal by Subject|13|||
128845905|NCT00417989|463728207|FG001|Overall Study|Withdrawal by Subject|13|||
128845906|NCT00417989|463728206|FG000|Overall Study|Lost to Follow-up|1|||
128845907|NCT00417989|463728207|FG001|Overall Study|Lost to Follow-up|6|||
128845908|NCT00417989|463728206|FG000|Overall Study|Protocol Violation|1|||
128845909|NCT00417989|463728207|FG001|Overall Study|Protocol Violation|0|||
128845910|NCT00417989|463728206|FG000|Overall Study|Death|0|||
128845911|NCT00417989|463728207|FG001|Overall Study|Death|1|||
128845912|NCT00417989|463728206|FG000|Overall Study|Physician Decision|5|||
128845913|NCT00417989|463728207|FG001|Overall Study|Physician Decision|2|||
128845914|NCT01945086|463728208|FG000|Overall Study|Withdrawal by Subject|1|||
128845915|NCT01945086|463728209|FG001|Overall Study|Withdrawal by Subject|0|||
128845916|NCT01945086|463728210|FG002|Overall Study|Withdrawal by Subject|1|||
128845917|NCT01945086|463728208|FG000|Overall Study|Adverse Event|0|||
128845918|NCT01945086|463728209|FG001|Overall Study|Adverse Event|0|||
128845919|NCT01945086|463728210|FG002|Overall Study|Adverse Event|1|||
128845920|NCT00308113|463728212|FG000|Overall Study|Protocol closure|0|||
128845921|NCT00308113|463728213|FG001|Overall Study|Protocol closure|0|||
128845922|NCT00308113|463728214|FG002|Overall Study|Protocol closure|0|||
128845923|NCT00308113|463728215|FG003|Overall Study|Protocol closure|1|||
128845924|NCT00170950|463728216|FG000|Overall Study|Death|236|||
128845925|NCT00170950|463728217|FG001|Overall Study|Death|274|||
128845926|NCT00170950|463728216|FG000|Overall Study|Withdrawal by Subject|496|||
128845927|NCT00170950|463728217|FG001|Overall Study|Withdrawal by Subject|498|||
128845928|NCT00170950|463728216|FG000|Overall Study|Lost to Follow-up|134|||
128845929|NCT00170950|463728217|FG001|Overall Study|Lost to Follow-up|115|||
128845930|NCT00170950|463728216|FG000|Overall Study|Missing|2|||
128845931|NCT00170950|463728217|FG001|Overall Study|Missing|1|||
128845932|NCT00170950|463728216|FG000|Overall Study|Termination Data Not Recorded|17|||
128845933|NCT00170950|463728217|FG001|Overall Study|Termination Data Not Recorded|22|||
128845934|NCT00748098|463728218|FG000|First Treatment Intervention Period|Adverse Event|1|||
128845935|NCT00748098|463728219|FG001|First Treatment Intervention Period|Adverse Event|1|||
128845936|NCT00748098|463728218|FG000|First Treatment Intervention Period|Protocol Violation|1|||
128845937|NCT00748098|463728219|FG001|First Treatment Intervention Period|Protocol Violation|0|||
128845938|NCT00748098|463728218|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
128845939|NCT00748098|463728219|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
128845940|NCT00748098|463728218|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
128845941|NCT00748098|463728219|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
128845942|NCT00748098|463728218|FG000|First Taper Period|Protocol Violation|1|||
128845943|NCT00748098|463728219|FG001|First Taper Period|Protocol Violation|0|||
128845944|NCT00748098|463728218|FG000|First Taper Period|Withdrawal by Subject|2|||
128845945|NCT00748098|463728219|FG001|First Taper Period|Withdrawal by Subject|0|||
128845946|NCT00748098|463728218|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
128845947|NCT00748098|463728219|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
128845948|NCT00748098|463728218|FG000|1-Week Washout Period|Adverse Event|0|||
128845949|NCT00748098|463728219|FG001|1-Week Washout Period|Adverse Event|1|||
128845950|NCT00748098|463728218|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
128845951|NCT00748098|463728219|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
128845952|NCT00748098|463728218|FG000|Second Treatment Intervention Period|Adverse Event|4|||
128845953|NCT00748098|463728219|FG001|Second Treatment Intervention Period|Adverse Event|1|||
128845954|NCT00748098|463728218|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
128845955|NCT00748098|463728219|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
128845956|NCT00748098|463728218|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
128845957|NCT00748098|463728219|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
128870727|NCT00338962|463820702|FG001|Overall Study|Withdrawal by Subject|0|||
128870728|NCT00338962|463820703|FG002|Overall Study|Withdrawal by Subject|0|||
128870729|NCT00338962|463820704|FG003|Overall Study|Withdrawal by Subject|0|||
128870730|NCT00338962|463820701|FG000|Overall Study|No Transportation|2|||
128870731|NCT00338962|463820702|FG001|Overall Study|No Transportation|0|||
128870732|NCT00338962|463820703|FG002|Overall Study|No Transportation|0|||
128870733|NCT00338962|463820704|FG003|Overall Study|No Transportation|0|||
128870734|NCT00338962|463820701|FG000|Overall Study|Time Constraint|2|||
128870735|NCT00338962|463820702|FG001|Overall Study|Time Constraint|0|||
128870736|NCT00338962|463820703|FG002|Overall Study|Time Constraint|0|||
128870737|NCT00338962|463820704|FG003|Overall Study|Time Constraint|0|||
128870738|NCT00338962|463820701|FG000|Overall Study|Moved|0|||
128870739|NCT00338962|463820702|FG001|Overall Study|Moved|1|||
128870740|NCT00338962|463820703|FG002|Overall Study|Moved|0|||
128870741|NCT00338962|463820704|FG003|Overall Study|Moved|0|||
128870742|NCT00338962|463820701|FG000|Overall Study|Adverse Event|0|||
128870743|NCT00338962|463820702|FG001|Overall Study|Adverse Event|0|||
128870744|NCT00338962|463820703|FG002|Overall Study|Adverse Event|2|||
128870745|NCT00338962|463820704|FG003|Overall Study|Adverse Event|0|||
128870746|NCT00338962|463820701|FG000|Overall Study|Poor Compliance|0|||
128870747|NCT00338962|463820702|FG001|Overall Study|Poor Compliance|0|||
128870748|NCT00338962|463820703|FG002|Overall Study|Poor Compliance|2|||
128870749|NCT00338962|463820704|FG003|Overall Study|Poor Compliance|0|||
128870750|NCT03214640|463820705|FG000|Overall Study|Protocol Violation|1|||
128870751|NCT03214640|463820706|FG001|Overall Study|Protocol Violation|2|||
128870752|NCT03214640|463820707|FG002|Overall Study|Protocol Violation|1|||
128870753|NCT03214640|463820708|FG003|Overall Study|Protocol Violation|4|||
128870754|NCT03547739|463820716|FG000|Overall Study|Death|0|||
128870755|NCT03547739|463820717|FG001|Overall Study|Death|1|||
128870756|NCT03547739|463820718|FG002|Overall Study|Death|5|||
128870757|NCT03547739|463820716|FG000|Overall Study|Adverse Event|24|||
128870758|NCT03547739|463820717|FG001|Overall Study|Adverse Event|11|||
128870759|NCT03547739|463820718|FG002|Overall Study|Adverse Event|13|||
128870760|NCT03547739|463820716|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
128870761|NCT03547739|463820717|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
128870762|NCT03547739|463820718|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
128870763|NCT03547739|463820716|FG000|Overall Study|Lost to Follow-up|80|||
128870764|NCT03547739|463820717|FG001|Overall Study|Lost to Follow-up|84|||
128870765|NCT03547739|463820718|FG002|Overall Study|Lost to Follow-up|116|||
128870766|NCT00958841|463820723|FG000|Overall Study|Abnormal laboratory value(s)|1|||
128870767|NCT00958841|463820723|FG000|Overall Study|Abnormal test procedure result(s)|3|||
128870768|NCT00958841|463820723|FG000|Overall Study|Administrative problems|1|||
128870769|NCT00958841|463820723|FG000|Overall Study|Adverse Event|8|||
128870770|NCT00958841|463820723|FG000|Overall Study|New cancer therapy|5|||
128870771|NCT00958841|463820723|FG000|Overall Study|Withdrawal by Subject|1|||
128845958|NCT03568708|463729715|FG000|Overall Study|Withdrawal by Subject|1|||
128845959|NCT03568708|463729716|FG001|Overall Study|Withdrawal by Subject|1|||
128845960|NCT03568708|463729715|FG000|Overall Study|Lost to Follow-up|0|||
128845961|NCT03568708|463729716|FG001|Overall Study|Lost to Follow-up|1|||
128845962|NCT00511147|463729717|FG000|Overall Study|Withdrawal by Subject|1|||
128845963|NCT00511147|463729717|FG000|Overall Study|Disease progression|5|||
128845964|NCT00511147|463729717|FG000|Overall Study|Required platelet transfusion|1|||
128845965|NCT00809783|463729718|FG000|Overall Study|Death|1|||
128845966|NCT00809783|463729719|FG001|Overall Study|Death|0|||
128845967|NCT00809783|463729720|FG002|Overall Study|Death|0|||
128845968|NCT00809783|463729718|FG000|Overall Study|Adverse Event|34|||
128845969|NCT00809783|463729719|FG001|Overall Study|Adverse Event|52|||
128845970|NCT00809783|463729720|FG002|Overall Study|Adverse Event|71|||
128845971|NCT00809783|463729718|FG000|Overall Study|Lack of Efficacy|39|||
128845972|NCT00809783|463729719|FG001|Overall Study|Lack of Efficacy|52|||
128845973|NCT00809783|463729720|FG002|Overall Study|Lack of Efficacy|63|||
128845974|NCT00809783|463729718|FG000|Overall Study|Lost to Follow-up|0|||
128845975|NCT00809783|463729719|FG001|Overall Study|Lost to Follow-up|3|||
128845976|NCT00809783|463729720|FG002|Overall Study|Lost to Follow-up|4|||
128845977|NCT00809783|463729718|FG000|Overall Study|Withdrawal by Subject|47|||
128845978|NCT00809783|463729719|FG001|Overall Study|Withdrawal by Subject|72|||
128845979|NCT00809783|463729720|FG002|Overall Study|Withdrawal by Subject|64|||
128845980|NCT00809783|463729718|FG000|Overall Study|Protocol Violation|2|||
128845981|NCT00809783|463729719|FG001|Overall Study|Protocol Violation|6|||
128845982|NCT00809783|463729720|FG002|Overall Study|Protocol Violation|5|||
128845983|NCT00809783|463729718|FG000|Overall Study|Randomized, but not treated|3|||
128845984|NCT00809783|463729719|FG001|Overall Study|Randomized, but not treated|0|||
128845985|NCT00809783|463729720|FG002|Overall Study|Randomized, but not treated|2|||
128845986|NCT00809783|463729718|FG000|Overall Study|Study Terminated by Sponsor|378|||
128845987|NCT00809783|463729719|FG001|Overall Study|Study Terminated by Sponsor|626|||
128845988|NCT00809783|463729720|FG002|Overall Study|Study Terminated by Sponsor|565|||
128845989|NCT00809783|463729718|FG000|Overall Study|Other|21|||
128845990|NCT00809783|463729719|FG001|Overall Study|Other|21|||
128845991|NCT00809783|463729720|FG002|Overall Study|Other|16|||
128845992|NCT00126555|463729721|FG000|Overall Study|Withdrawal by Subject|1|||
128845993|NCT00126555|463729721|FG000|Overall Study|Adverse Event|2|||
128845994|NCT00126555|463729721|FG000|Overall Study|Progressive Disease|3|||
128845995|NCT00396097|463729733|FG000|Overall Study|Withdrawal by Subject|17|||
128845996|NCT00396097|463729734|FG001|Overall Study|Withdrawal by Subject|17|||
128845997|NCT00396097|463729733|FG000|Overall Study|Lost to Follow-up|4|||
128845998|NCT00396097|463729734|FG001|Overall Study|Lost to Follow-up|9|||
128845999|NCT00396097|463729733|FG000|Overall Study|Other|3|||
128846000|NCT00396097|463729734|FG001|Overall Study|Other|5|||
128846001|NCT00396097|463729733|FG000|Overall Study|Protocol Violation|0|||
128846002|NCT00396097|463729734|FG001|Overall Study|Protocol Violation|6|||
128846003|NCT00396097|463729733|FG000|Overall Study|Adverse Event|1|||
128846004|NCT00396097|463729734|FG001|Overall Study|Adverse Event|5|||
128846005|NCT00396097|463729733|FG000|Overall Study|Insufficient Clinical Response|1|||
128846006|NCT00396097|463729734|FG001|Overall Study|Insufficient Clinical Response|4|||
128846007|NCT03461211|463729735|FG000|Overall Study|Adverse Event|1|||
128846008|NCT03461211|463729736|FG001|Overall Study|Adverse Event|1|||
128846009|NCT03461211|463729735|FG000|Overall Study|Lack of Efficacy|0|||
128846010|NCT03461211|463729736|FG001|Overall Study|Lack of Efficacy|1|||
128846011|NCT01284634|463729737|FG000|Overall Study|Adverse Event|1|||
128846012|NCT01284634|463729738|FG001|Overall Study|Adverse Event|0|||
128846013|NCT01284634|463729739|FG002|Overall Study|Adverse Event|2|||
128846014|NCT01284634|463729740|FG003|Overall Study|Adverse Event|1|||
128846015|NCT01732588|463729741|FG000|First Intervention (7 Days)|Adverse Event|0|||
128846016|NCT01732588|463729742|FG001|First Intervention (7 Days)|Adverse Event|1|||
128846017|NCT01732588|463729743|FG002|First Intervention (7 Days)|Adverse Event|0|||
128846018|NCT00730925|463729754|FG000|Overall Study|Progressive Disease|21|||
128846019|NCT00730925|463729754|FG000|Overall Study|Dose reducing Event|2|||
128846020|NCT00730925|463729754|FG000|Overall Study|Other Averse Event|7|||
128846021|NCT00730925|463729754|FG000|Overall Study|Protocol Violation|1|||
128846022|NCT00730925|463729754|FG000|Overall Study|Withdrawal by Subject|1|||
128846023|NCT00730925|463729754|FG000|Overall Study|Switch to combination therapy|8|||
128846024|NCT00730925|463729754|FG000|Overall Study|Other|1|||
128846025|NCT01732627|463729755|FG000|Overall Study|Withdrawal by Subject|1|||
128846026|NCT01732627|463729756|FG001|Overall Study|Withdrawal by Subject|0|||
128846027|NCT00005908|463729759|FG000|Overall Study|Withdrawal by Subject|1|||
128846028|NCT00005908|463729760|FG001|Overall Study|Withdrawal by Subject|0|||
128846029|NCT04748445|463729763|FG000|Overall Study|No longer met eligibility criteria|12|||
128846030|NCT04748445|463729763|FG000|Overall Study|Other|36|||
128846031|NCT04748445|463729763|FG000|Overall Study|Withdrawal by Subject|553|||
128846032|NCT04748445|463729763|FG000|Overall Study|Lost to Follow-up|30|||
128846033|NCT04736602|463729764|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
128846034|NCT04736602|463729764|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
128846035|NCT02131155|463729770|FG000|Overall Study|Adverse Event|1|||
128846036|NCT02131155|463729771|FG001|Overall Study|Adverse Event|0|||
128846037|NCT02131155|463729770|FG000|Overall Study|Treatment completed|1|||
128846038|NCT02131155|463729771|FG001|Overall Study|Treatment completed|0|||
128846039|NCT02131155|463729770|FG000|Overall Study|Primary tumour recurrence|2|||
128846040|NCT02131155|463729771|FG001|Overall Study|Primary tumour recurrence|1|||
128846041|NCT02131155|463729770|FG000|Overall Study|Refused to continue study medication|1|||
128846042|NCT02131155|463729771|FG001|Overall Study|Refused to continue study medication|0|||
128846043|NCT02131155|463729770|FG000|Overall Study|Study early termination|20|||
128846044|NCT02131155|463729771|FG001|Overall Study|Study early termination|10|||
128846045|NCT01887418|463729772|FG000|Overall Study|Travelling difficulties|0|||
128846046|NCT01887418|463729773|FG001|Overall Study|Travelling difficulties|0|||
128846047|NCT01887418|463729774|FG002|Overall Study|Travelling difficulties|1|||
128846048|NCT00475735|463729775|FG000|Treatment Period 1|Adverse Event|2|||
128846049|NCT00475735|463729776|FG001|Treatment Period 1|Adverse Event|0|||
128846050|NCT00475735|463729777|FG002|Treatment Period 1|Adverse Event|0|||
128846051|NCT00475735|463729778|FG003|Treatment Period 1|Adverse Event|0|||
128846052|NCT00475735|463729779|FG004|Treatment Period 1|Adverse Event|0|||
128846053|NCT00475735|463729780|FG005|Treatment Period 1|Adverse Event|0|||
128846054|NCT00475735|463729775|FG000|Treatment Period 1|Lack of Efficacy|1|||
128846055|NCT00475735|463729776|FG001|Treatment Period 1|Lack of Efficacy|0|||
128846056|NCT00475735|463729777|FG002|Treatment Period 1|Lack of Efficacy|0|||
128846057|NCT00475735|463729778|FG003|Treatment Period 1|Lack of Efficacy|0|||
128846058|NCT00475735|463729779|FG004|Treatment Period 1|Lack of Efficacy|0|||
128846059|NCT00475735|463729780|FG005|Treatment Period 1|Lack of Efficacy|0|||
128846060|NCT00475735|463729775|FG000|Treatment Period 1|Lost to Follow-up|0|||
128846061|NCT00475735|463729776|FG001|Treatment Period 1|Lost to Follow-up|0|||
128846062|NCT00475735|463729777|FG002|Treatment Period 1|Lost to Follow-up|0|||
128846063|NCT00475735|463729778|FG003|Treatment Period 1|Lost to Follow-up|0|||
128846064|NCT00475735|463729779|FG004|Treatment Period 1|Lost to Follow-up|0|||
128846065|NCT00475735|463729780|FG005|Treatment Period 1|Lost to Follow-up|1|||
128846066|NCT00475735|463729775|FG000|Treatment Period 1|Protocol Violation|0|||
128846067|NCT00475735|463729776|FG001|Treatment Period 1|Protocol Violation|0|||
128846068|NCT00475735|463729777|FG002|Treatment Period 1|Protocol Violation|0|||
128846069|NCT00475735|463729778|FG003|Treatment Period 1|Protocol Violation|1|||
128846070|NCT00475735|463729779|FG004|Treatment Period 1|Protocol Violation|0|||
128846071|NCT00475735|463729780|FG005|Treatment Period 1|Protocol Violation|0|||
128846072|NCT00475735|463729775|FG000|Treatment Period 1|Withdrawal by Subject|1|||
128846073|NCT00475735|463729776|FG001|Treatment Period 1|Withdrawal by Subject|1|||
128846074|NCT00475735|463729777|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128846075|NCT00475735|463729778|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128846076|NCT00475735|463729779|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128846077|NCT00475735|463729780|FG005|Treatment Period 1|Withdrawal by Subject|0|||
128846078|NCT00475735|463729775|FG000|Treatment Period 1|DC due to AE but continuing|0|||
128846079|NCT00475735|463729776|FG001|Treatment Period 1|DC due to AE but continuing|0|||
128846080|NCT00475735|463729777|FG002|Treatment Period 1|DC due to AE but continuing|0|||
128846081|NCT00475735|463729778|FG003|Treatment Period 1|DC due to AE but continuing|1|||
128846082|NCT00475735|463729779|FG004|Treatment Period 1|DC due to AE but continuing|2|||
128846083|NCT00475735|463729780|FG005|Treatment Period 1|DC due to AE but continuing|2|||
128846084|NCT00475735|463729775|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
128846085|NCT00475735|463729776|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
128846086|NCT00475735|463729777|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
128846087|NCT00475735|463729778|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
128846088|NCT00475735|463729779|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
128846089|NCT00475735|463729780|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
128846090|NCT00475735|463729775|FG000|Treatment Washout|Lost to Follow-up|0|||
128846091|NCT00475735|463729776|FG001|Treatment Washout|Lost to Follow-up|1|||
128846092|NCT00475735|463729777|FG002|Treatment Washout|Lost to Follow-up|0|||
128846093|NCT00475735|463729778|FG003|Treatment Washout|Lost to Follow-up|0|||
128846094|NCT00475735|463729779|FG004|Treatment Washout|Lost to Follow-up|0|||
128846095|NCT00475735|463729780|FG005|Treatment Washout|Lost to Follow-up|0|||
128846096|NCT00475735|463729775|FG000|Treatment Washout|Protocol Violation|0|||
128846097|NCT00475735|463729776|FG001|Treatment Washout|Protocol Violation|1|||
128846098|NCT00475735|463729777|FG002|Treatment Washout|Protocol Violation|0|||
128846099|NCT00475735|463729778|FG003|Treatment Washout|Protocol Violation|0|||
128846100|NCT00475735|463729779|FG004|Treatment Washout|Protocol Violation|0|||
128846101|NCT00475735|463729780|FG005|Treatment Washout|Protocol Violation|0|||
128846102|NCT00475735|463729775|FG000|Treatment Period 2|Adverse Event|0|||
128846103|NCT00475735|463729776|FG001|Treatment Period 2|Adverse Event|1|||
128846104|NCT00475735|463729777|FG002|Treatment Period 2|Adverse Event|0|||
128846105|NCT00475735|463729778|FG003|Treatment Period 2|Adverse Event|2|||
128846106|NCT00475735|463729779|FG004|Treatment Period 2|Adverse Event|0|||
128846107|NCT00475735|463729780|FG005|Treatment Period 2|Adverse Event|0|||
128846108|NCT00475735|463729775|FG000|Treatment Period 2|Lack of Efficacy|0|||
128846109|NCT00475735|463729776|FG001|Treatment Period 2|Lack of Efficacy|0|||
128846110|NCT00475735|463729777|FG002|Treatment Period 2|Lack of Efficacy|0|||
128846111|NCT00475735|463729778|FG003|Treatment Period 2|Lack of Efficacy|0|||
128846112|NCT00475735|463729779|FG004|Treatment Period 2|Lack of Efficacy|0|||
128846113|NCT00475735|463729780|FG005|Treatment Period 2|Lack of Efficacy|1|||
128846114|NCT00475735|463729775|FG000|Treatment Period 2|Withdrawal by Subject|0|||
128846115|NCT00475735|463729776|FG001|Treatment Period 2|Withdrawal by Subject|0|||
128846116|NCT00475735|463729777|FG002|Treatment Period 2|Withdrawal by Subject|0|||
128846117|NCT00475735|463729778|FG003|Treatment Period 2|Withdrawal by Subject|0|||
128846118|NCT00475735|463729779|FG004|Treatment Period 2|Withdrawal by Subject|1|||
128846119|NCT00475735|463729780|FG005|Treatment Period 2|Withdrawal by Subject|0|||
128846120|NCT03132753|463729781|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
128846121|NCT03132753|463729782|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
128846122|NCT03132753|463729781|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
128846123|NCT03132753|463729782|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
128846124|NCT00125853|463729783|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
128846125|NCT00125853|463729784|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
128846126|NCT02097056|463729788|FG000|Overall Study|Protocol Violation|2|||
128846127|NCT02097056|463729788|FG000|Overall Study|Withdrawal by Subject|15|||
128846128|NCT02097056|463729788|FG000|Overall Study|Lost to Follow-up|2|||
128846129|NCT02097056|463729788|FG000|Overall Study|Adverse Event|37|||
128846130|NCT02097056|463729788|FG000|Overall Study|Other|2|||
128846131|NCT01446042|463729789|FG000|Overall Study|Withdrawal by Subject|12|||
128846132|NCT01446042|463729790|FG001|Overall Study|Withdrawal by Subject|2|||
128846133|NCT01446042|463729791|FG002|Overall Study|Withdrawal by Subject|4|||
128846134|NCT01446042|463729789|FG000|Overall Study|Adverse Event|1|||
128846135|NCT01446042|463729790|FG001|Overall Study|Adverse Event|0|||
128846136|NCT01446042|463729791|FG002|Overall Study|Adverse Event|4|||
128846137|NCT01446042|463729789|FG000|Overall Study|Lost to Follow-up|5|||
128846138|NCT01446042|463729790|FG001|Overall Study|Lost to Follow-up|0|||
128846139|NCT01446042|463729791|FG002|Overall Study|Lost to Follow-up|0|||
128846140|NCT01446042|463729789|FG000|Overall Study|Other reasons|2|||
128846141|NCT01446042|463729790|FG001|Overall Study|Other reasons|1|||
128846142|NCT01446042|463729791|FG002|Overall Study|Other reasons|1|||
128846143|NCT03575572|463729792|FG000|Overall Study|Withdrawal by Subject|2|||
128846144|NCT03575572|463729792|FG000|Overall Study|Physician Decision|2|||
128846145|NCT00157209|463729793|FG000|Overall Study|Ongoing at data cut-off|10|||
128846146|NCT00157209|463729794|FG001|Overall Study|Ongoing at data cut-off|0|||
128846147|NCT03023878|463729798|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
128846148|NCT03023878|463729798|FG000|Pre-Study Run-In Period|Death|1|||
128846149|NCT03023878|463729798|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
128846150|NCT03023878|463729798|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
128846151|NCT03023878|463729798|FG000|Treatment Period|Disease Progression|1|||
128846152|NCT03023878|463729798|FG000|Treatment Period|Withdrawal by Subject|1|||
128846153|NCT03023878|463729798|FG000|Treatment Period|Adverse Event|1|||
128846154|NCT03023878|463729798|FG000|Long Term Follow-Up Period|Death|2|||
128846155|NCT01247922|463729799|FG000|Overall Study|Disease progression|4|||
128846156|NCT01876823|463729802|FG000|Overall Study|Withdrawal by Subject|5|||
128846157|NCT01876823|463729802|FG000|Overall Study|Physician Decision|2|||
128846158|NCT01876823|463729802|FG000|Overall Study|Patients moved|2|||
128846159|NCT00577096|463729803|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
128846160|NCT00577096|463729804|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
128846161|NCT00577096|463729803|FG000|Short Term Participation|Withdrawal by Subject|3|||
128846162|NCT00577096|463729804|FG001|Short Term Participation|Withdrawal by Subject|5|||
128846163|NCT00577096|463729803|FG000|Short Term Participation|Death|1|||
128846164|NCT00577096|463729804|FG001|Short Term Participation|Death|1|||
128846165|NCT03928821|463729806|FG000|Overall Study|Death|0|||
128846166|NCT03928821|463729807|FG001|Overall Study|Death|1|||
128846167|NCT03928821|463729808|FG002|Overall Study|Death|0|||
128846168|NCT03928821|463729809|FG003|Overall Study|Death|0|||
128846169|NCT03928821|463729806|FG000|Overall Study|Lost to Follow-up|0|||
128846170|NCT03928821|463729807|FG001|Overall Study|Lost to Follow-up|2|||
128846171|NCT03928821|463729808|FG002|Overall Study|Lost to Follow-up|3|||
128846172|NCT03928821|463729809|FG003|Overall Study|Lost to Follow-up|0|||
128846173|NCT03928821|463729806|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
128846174|NCT03928821|463729807|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
128846175|NCT03928821|463729808|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
128846176|NCT03928821|463729809|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
128846177|NCT00985621|463729814|FG000|Overall Study|Adverse Event|2|||
128846178|NCT00985621|463729815|FG001|Overall Study|Adverse Event|3|||
128846179|NCT00985621|463729816|FG002|Overall Study|Adverse Event|4|||
128846180|NCT00985621|463729817|FG003|Overall Study|Adverse Event|16|||
128846181|NCT00985621|463729814|FG000|Overall Study|Lack of Efficacy|10|||
128846182|NCT00985621|463729815|FG001|Overall Study|Lack of Efficacy|6|||
128846183|NCT00985621|463729816|FG002|Overall Study|Lack of Efficacy|5|||
128846184|NCT00985621|463729817|FG003|Overall Study|Lack of Efficacy|12|||
128846185|NCT00985621|463729814|FG000|Overall Study|Lost to Follow-up|2|||
128846186|NCT00985621|463729815|FG001|Overall Study|Lost to Follow-up|3|||
128846187|NCT00985621|463729816|FG002|Overall Study|Lost to Follow-up|4|||
128846188|NCT00985621|463729817|FG003|Overall Study|Lost to Follow-up|4|||
128846189|NCT00985621|463729814|FG000|Overall Study|Study Terminated by Sponsor|89|||
128846190|NCT00985621|463729815|FG001|Overall Study|Study Terminated by Sponsor|108|||
128846191|NCT00985621|463729816|FG002|Overall Study|Study Terminated by Sponsor|99|||
128846192|NCT00985621|463729817|FG003|Overall Study|Study Terminated by Sponsor|92|||
128846193|NCT00985621|463729814|FG000|Overall Study|Protocol Violation|1|||
128846194|NCT00985621|463729815|FG001|Overall Study|Protocol Violation|1|||
128846195|NCT00985621|463729816|FG002|Overall Study|Protocol Violation|1|||
128846196|NCT00985621|463729817|FG003|Overall Study|Protocol Violation|0|||
128846197|NCT00985621|463729814|FG000|Overall Study|Withdrawal by Subject|8|||
128846198|NCT00985621|463729815|FG001|Overall Study|Withdrawal by Subject|10|||
128846199|NCT00985621|463729816|FG002|Overall Study|Withdrawal by Subject|8|||
128846200|NCT00985621|463729817|FG003|Overall Study|Withdrawal by Subject|12|||
128846201|NCT00985621|463729814|FG000|Overall Study|Other|1|||
128846202|NCT00985621|463729815|FG001|Overall Study|Other|0|||
128846203|NCT00985621|463729816|FG002|Overall Study|Other|0|||
128846204|NCT00985621|463729817|FG003|Overall Study|Other|0|||
128846205|NCT00985621|463729814|FG000|Overall Study|Randomized but not Treated|1|||
128846206|NCT00985621|463729815|FG001|Overall Study|Randomized but not Treated|0|||
128846207|NCT00985621|463729816|FG002|Overall Study|Randomized but not Treated|2|||
128846208|NCT00985621|463729817|FG003|Overall Study|Randomized but not Treated|1|||
128846209|NCT01911819|463729818|FG000|Overall Study|Adverse Event|0|||
128846210|NCT01911819|463729819|FG001|Overall Study|Adverse Event|1|||
128846211|NCT01911819|463729820|FG002|Overall Study|Adverse Event|0|||
128846212|NCT01911819|463729818|FG000|Overall Study|Withdrawal by Subject|1|||
128846213|NCT01911819|463729819|FG001|Overall Study|Withdrawal by Subject|1|||
128846214|NCT01911819|463729820|FG002|Overall Study|Withdrawal by Subject|0|||
128846215|NCT03849300|463729821|FG000|Overall Study|move out to different area|1|||
128846216|NCT03849300|463729822|FG001|Overall Study|move out to different area|3|||
128846217|NCT03849300|463729823|FG002|Overall Study|move out to different area|1|||
128846218|NCT03849300|463729824|FG003|Overall Study|move out to different area|4|||
128846219|NCT03849300|463729821|FG000|Overall Study|scheduling/transportation conflict|4|||
128846220|NCT03849300|463729822|FG001|Overall Study|scheduling/transportation conflict|4|||
128846221|NCT03849300|463729823|FG002|Overall Study|scheduling/transportation conflict|3|||
128846222|NCT03849300|463729824|FG003|Overall Study|scheduling/transportation conflict|2|||
128846223|NCT02418819|463729826|FG000|Overall Study|Adverse Event|0|||
128846224|NCT02418819|463729827|FG001|Overall Study|Adverse Event|0|||
128846225|NCT02418819|463729828|FG002|Overall Study|Adverse Event|1|||
128846226|NCT02418819|463729829|FG003|Overall Study|Adverse Event|0|||
128846227|NCT02418819|463729826|FG000|Overall Study|Lost to Follow-up|1|||
128846228|NCT02418819|463729827|FG001|Overall Study|Lost to Follow-up|0|||
128846229|NCT02418819|463729828|FG002|Overall Study|Lost to Follow-up|0|||
128846230|NCT02418819|463729829|FG003|Overall Study|Lost to Follow-up|0|||
128846231|NCT02418819|463729826|FG000|Overall Study|No longer meets eligibility criteria|0|||
128846232|NCT02418819|463729827|FG001|Overall Study|No longer meets eligibility criteria|0|||
128846233|NCT02418819|463729828|FG002|Overall Study|No longer meets eligibility criteria|1|||
128846234|NCT02418819|463729829|FG003|Overall Study|No longer meets eligibility criteria|0|||
128846235|NCT02418819|463729826|FG000|Overall Study|No longer willing to participate|0|||
128846236|NCT02418819|463729827|FG001|Overall Study|No longer willing to participate|0|||
128846237|NCT02418819|463729828|FG002|Overall Study|No longer willing to participate|2|||
128846238|NCT02418819|463729829|FG003|Overall Study|No longer willing to participate|1|||
128846239|NCT04743999|463729830|FG000|3-month Questionnaire|Death|1|||
128846240|NCT04743999|463729830|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
128846241|NCT04743999|463729830|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
128846242|NCT04743999|463729830|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
128846243|NCT01721759|463729831|FG000|Treatment Period|Disease Progression|85|||
128846244|NCT01721759|463729831|FG000|Treatment Period|Study drug toxicity|14|||
128846245|NCT01721759|463729831|FG000|Treatment Period|Death|1|||
128846246|NCT01721759|463729831|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
128846247|NCT01721759|463729831|FG000|Treatment Period|Participant request to withdraw|3|||
128846248|NCT01721759|463729831|FG000|Treatment Period|Other Reasons|3|||
128846249|NCT01721759|463729831|FG000|End of Study Period|Participant Withdrew Consent|5|||
128846250|NCT01721759|463729831|FG000|End of Study Period|Death|101|||
128846251|NCT01721759|463729831|FG000|End of Study Period|Lost to Follow-up|1|||
128846252|NCT01721759|463729831|FG000|End of Study Period|Other Reasons|10|||
128846253|NCT00464737|463729832|FG000|Overall Study|Adverse Event|12|||
128846254|NCT00464737|463729833|FG001|Overall Study|Adverse Event|17|||
128846255|NCT00464737|463729834|FG002|Overall Study|Adverse Event|33|||
128846256|NCT00464737|463729832|FG000|Overall Study|Lack of Efficacy|7|||
128846257|NCT00464737|463729833|FG001|Overall Study|Lack of Efficacy|7|||
128846258|NCT00464737|463729834|FG002|Overall Study|Lack of Efficacy|4|||
128846259|NCT00464737|463729832|FG000|Overall Study|Withdrawal by Subject|5|||
128846260|NCT00464737|463729833|FG001|Overall Study|Withdrawal by Subject|3|||
128846261|NCT00464737|463729834|FG002|Overall Study|Withdrawal by Subject|5|||
128846262|NCT00464737|463729832|FG000|Overall Study|Protocol Violation|1|||
128846263|NCT00464737|463729833|FG001|Overall Study|Protocol Violation|1|||
128846264|NCT00464737|463729834|FG002|Overall Study|Protocol Violation|5|||
128846265|NCT00464737|463729832|FG000|Overall Study|Non-compliance|0|||
128846266|NCT00464737|463729833|FG001|Overall Study|Non-compliance|1|||
128846267|NCT00464737|463729834|FG002|Overall Study|Non-compliance|1|||
128846268|NCT00464737|463729832|FG000|Overall Study|Lost to Follow-up|5|||
128846269|NCT00464737|463729833|FG001|Overall Study|Lost to Follow-up|2|||
128846270|NCT00464737|463729834|FG002|Overall Study|Lost to Follow-up|5|||
128846271|NCT00464737|463729832|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
128846272|NCT00464737|463729833|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
128846273|NCT00464737|463729834|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
128846274|NCT00464737|463729832|FG000|Overall Study|Other: Subject left town; family illness|1|||
128846275|NCT00464737|463729833|FG001|Overall Study|Other: Subject left town; family illness|0|||
128846276|NCT00464737|463729834|FG002|Overall Study|Other: Subject left town; family illness|0|||
128846277|NCT00464737|463729832|FG000|Overall Study|Other: Study demands too great|0|||
128846278|NCT00464737|463729833|FG001|Overall Study|Other: Study demands too great|1|||
128846279|NCT00464737|463729834|FG002|Overall Study|Other: Study demands too great|0|||
128846280|NCT00464737|463729832|FG000|Overall Study|Other: Personal family reasons|0|||
128846281|NCT00464737|463729833|FG001|Overall Study|Other: Personal family reasons|0|||
128846282|NCT00464737|463729834|FG002|Overall Study|Other: Personal family reasons|1|||
128846283|NCT00464737|463729832|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
128846284|NCT00464737|463729833|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
128846285|NCT00464737|463729834|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
128846286|NCT00676663|463729837|FG000|Overall Study|Death|43|||
128846287|NCT00676663|463729838|FG001|Overall Study|Death|27|||
128846288|NCT00676663|463729837|FG000|Overall Study|Withdrew Consent|1|||
128846289|NCT00676663|463729838|FG001|Overall Study|Withdrew Consent|8|||
128846290|NCT00676663|463729837|FG000|Overall Study|Lost to Follow-up|1|||
128846291|NCT00676663|463729838|FG001|Overall Study|Lost to Follow-up|3|||
128846292|NCT00580047|463729839|FG000|Overall Study|Lost to Follow-up|1|||
128846293|NCT00580047|463729840|FG001|Overall Study|Lost to Follow-up|1|||
128846294|NCT00580047|463729841|FG002|Overall Study|Lost to Follow-up|0|||
128846295|NCT00580047|463729839|FG000|Overall Study|Withdrawal by Subject|1|||
128846296|NCT00580047|463729840|FG001|Overall Study|Withdrawal by Subject|1|||
128846297|NCT00580047|463729841|FG002|Overall Study|Withdrawal by Subject|2|||
128846298|NCT00580047|463729839|FG000|Overall Study|Withdrawal by Subject|1|||
128846299|NCT00580047|463729840|FG001|Overall Study|Withdrawal by Subject|0|||
128846300|NCT00580047|463729841|FG002|Overall Study|Withdrawal by Subject|0|||
128846301|NCT04382053|463729842|FG000|Overall Study|Death|6|||
128846302|NCT04382053|463729843|FG001|Overall Study|Death|8|||
128846303|NCT04382053|463729842|FG000|Overall Study|Lost to Follow-up|0|||
128846304|NCT04382053|463729843|FG001|Overall Study|Lost to Follow-up|2|||
128846305|NCT04382053|463729842|FG000|Overall Study|Protocol Deviation|1|||
128846306|NCT04382053|463729843|FG001|Overall Study|Protocol Deviation|2|||
128846307|NCT04382053|463729842|FG000|Overall Study|Withdrawal by Subject|2|||
128846308|NCT04382053|463729843|FG001|Overall Study|Withdrawal by Subject|1|||
128846309|NCT01399905|463729844|FG000|Overall Study|Withdrawal by Subject|1|||
128846310|NCT01399905|463729845|FG001|Overall Study|Withdrawal by Subject|1|||
128846311|NCT00925288|463731812|FG000|Overall Study|Lost to Follow-up|9|||
128846312|NCT00925288|463731813|FG001|Overall Study|Lost to Follow-up|7|||
128846313|NCT00635570|463731816|FG000|Overall Study|Lost to Follow-up|8|||
128846314|NCT00635570|463731817|FG001|Overall Study|Lost to Follow-up|8|||
128846315|NCT00635570|463731816|FG000|Overall Study|Withdrawal by Subject|1|||
128846316|NCT00635570|463731817|FG001|Overall Study|Withdrawal by Subject|1|||
128846317|NCT00635570|463731816|FG000|Overall Study|Adverse Event|2|||
128846318|NCT00635570|463731817|FG001|Overall Study|Adverse Event|0|||
128846319|NCT00635570|463731816|FG000|Overall Study|Physician Decision|1|||
128846320|NCT00635570|463731817|FG001|Overall Study|Physician Decision|0|||
128846321|NCT00635570|463731816|FG000|Overall Study|Did not complete survey|2|||
128846322|NCT00635570|463731817|FG001|Overall Study|Did not complete survey|1|||
128846323|NCT00635570|463731816|FG000|Overall Study|Early termination(No sexual activity)|1|||
128846324|NCT00635570|463731817|FG001|Overall Study|Early termination(No sexual activity)|1|||
128846325|NCT04816708|463731827|FG000|Overall Study|Lost to Follow-up|10|||
128846326|NCT04816708|463731828|FG001|Overall Study|Lost to Follow-up|4|||
128846327|NCT05135156|463731833|FG000|Overall Study|Lost to Follow-up|0|||
128846328|NCT05135156|463731834|FG001|Overall Study|Lost to Follow-up|0|||
128846329|NCT05135156|463731835|FG002|Overall Study|Lost to Follow-up|2|||
128846330|NCT02986659|463731836|FG000|First Intervention Period|Adverse Event|3|||
128846331|NCT02986659|463731837|FG001|First Intervention Period|Adverse Event|1|||
128846332|NCT02986659|463731836|FG000|First Intervention Period|Lost to Follow-up|1|||
128846333|NCT02986659|463731837|FG001|First Intervention Period|Lost to Follow-up|0|||
128846334|NCT02986659|463731836|FG000|First Intervention Period|Withdrawal by Subject|0|||
128846335|NCT02986659|463731837|FG001|First Intervention Period|Withdrawal by Subject|1|||
128846336|NCT02986659|463731836|FG000|Second Intervention Period|Adverse Event|0|||
128846337|NCT02986659|463731837|FG001|Second Intervention Period|Adverse Event|6|||
128846338|NCT01059526|463731840|FG000|Overall Study|Patient enrolled but not treated|20|||
128846339|NCT01059526|463731841|FG001|Overall Study|Patient enrolled but not treated|17|||
128846340|NCT01059526|463731840|FG000|Overall Study|Adverse Event|2|||
128846341|NCT01059526|463731841|FG001|Overall Study|Adverse Event|2|||
128846342|NCT01059526|463731840|FG000|Overall Study|Protocol Violation|0|||
128846343|NCT01059526|463731841|FG001|Overall Study|Protocol Violation|1|||
128846344|NCT01059526|463731840|FG000|Overall Study|Withdrawal by Subject|3|||
128846345|NCT01059526|463731841|FG001|Overall Study|Withdrawal by Subject|1|||
128846346|NCT01059526|463731840|FG000|Overall Study|Lost to Follow-up|4|||
128846347|NCT01059526|463731841|FG001|Overall Study|Lost to Follow-up|1|||
128846348|NCT01059526|463731840|FG000|Overall Study|Patient found to be dermatographic|1|||
128846349|NCT01059526|463731841|FG001|Overall Study|Patient found to be dermatographic|0|||
128846350|NCT02720081|463731842|FG000|Overall Study|Adverse Event|0|||
128846351|NCT02720081|463731843|FG001|Overall Study|Adverse Event|3|||
128846352|NCT02720081|463731842|FG000|Overall Study|Protocol Violation|4|||
128846353|NCT02720081|463731843|FG001|Overall Study|Protocol Violation|1|||
128846354|NCT03772041|463731844|FG000|Overall Study|Adverse Event|8|||
128846355|NCT03772041|463731845|FG001|Overall Study|Adverse Event|3|||
128846356|NCT03772041|463731844|FG000|Overall Study|Withdrawal by Subject|0|||
128846357|NCT03772041|463731845|FG001|Overall Study|Withdrawal by Subject|2|||
128846358|NCT03772041|463731844|FG000|Overall Study|Protocol Violation|4|||
128846359|NCT03772041|463731845|FG001|Overall Study|Protocol Violation|2|||
128846360|NCT03772041|463731844|FG000|Overall Study|Physician Decision|2|||
128846361|NCT03772041|463731845|FG001|Overall Study|Physician Decision|3|||
128846362|NCT05012397|463731850|FG000|Overall Study|Death|10|||
128846363|NCT05012397|463731850|FG000|Overall Study|Physician Decision|9|||
128846364|NCT05012397|463731850|FG000|Overall Study|Withdrawal by Subject|5|||
128846365|NCT05012397|463731850|FG000|Overall Study|Lost to Follow-up|2|||
128846366|NCT03334747|463731851|FG000|Treatment Phase|Technical problems|0|||
128846367|NCT03334747|463731852|FG001|Treatment Phase|Technical problems|0|||
128846368|NCT03334747|463731853|FG002|Treatment Phase|Technical problems|0|||
128846369|NCT03334747|463731854|FG003|Treatment Phase|Technical problems|0|||
128846370|NCT03334747|463731855|FG004|Treatment Phase|Technical problems|1|||
128846371|NCT03334747|463731856|FG005|Treatment Phase|Technical problems|0|||
128846372|NCT03334747|463731857|FG006|Treatment Phase|Technical problems|0|||
128846373|NCT03334747|463731858|FG007|Treatment Phase|Technical problems|0|||
128846374|NCT03334747|463731859|FG008|Treatment Phase|Technical problems|0|||
128846375|NCT03334747|463731851|FG000|Treatment Phase|Subject/guardian decision|1|||
128846376|NCT03334747|463731852|FG001|Treatment Phase|Subject/guardian decision|0|||
128846377|NCT03334747|463731853|FG002|Treatment Phase|Subject/guardian decision|0|||
128846378|NCT03334747|463731854|FG003|Treatment Phase|Subject/guardian decision|0|||
128846379|NCT03334747|463731855|FG004|Treatment Phase|Subject/guardian decision|0|||
128846380|NCT03334747|463731856|FG005|Treatment Phase|Subject/guardian decision|1|||
128846381|NCT03334747|463731857|FG006|Treatment Phase|Subject/guardian decision|0|||
128846382|NCT03334747|463731858|FG007|Treatment Phase|Subject/guardian decision|0|||
128846383|NCT03334747|463731859|FG008|Treatment Phase|Subject/guardian decision|0|||
128846384|NCT03334747|463731851|FG000|Follow-Up Phase|Subject/guardian decision|0|||
128846385|NCT03334747|463731852|FG001|Follow-Up Phase|Subject/guardian decision|0|||
128846386|NCT03334747|463731853|FG002|Follow-Up Phase|Subject/guardian decision|0|||
128846387|NCT03334747|463731854|FG003|Follow-Up Phase|Subject/guardian decision|0|||
128846388|NCT03334747|463731855|FG004|Follow-Up Phase|Subject/guardian decision|0|||
128846389|NCT03334747|463731856|FG005|Follow-Up Phase|Subject/guardian decision|0|||
128846390|NCT03334747|463731857|FG006|Follow-Up Phase|Subject/guardian decision|1|||
128846391|NCT03334747|463731858|FG007|Follow-Up Phase|Subject/guardian decision|0|||
128846392|NCT03334747|463731859|FG008|Follow-Up Phase|Subject/guardian decision|1|||
128846393|NCT00191984|463731866|FG000|Overall Study|Disease Progression|21|||
128846394|NCT00191984|463731866|FG000|Overall Study|Adverse Event|4|||
128846395|NCT00191984|463731866|FG000|Overall Study|Death|2|||
128846396|NCT00191984|463731866|FG000|Overall Study|Entry Criteria Exclusion|1|||
128846397|NCT00191984|463731866|FG000|Overall Study|Withdrawal by Subject|7|||
128846398|NCT00191984|463731866|FG000|Overall Study|Physician Decision|4|||
128846399|NCT02567227|463731867|FG000|9 Weeks|Adverse Event|5|||
128846400|NCT02567227|463731868|FG001|9 Weeks|Adverse Event|5|||
128846401|NCT02567227|463731867|FG000|9 Weeks|Withdrawal by Subject|18|||
128846402|NCT02567227|463731868|FG001|9 Weeks|Withdrawal by Subject|8|||
128846403|NCT02567227|463731867|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
128846404|NCT02567227|463731868|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
128846405|NCT02567227|463731867|FG000|6 Month|Death|2|||
128846406|NCT02567227|463731868|FG001|6 Month|Death|0|||
128846407|NCT02567227|463731867|FG000|6 Month|Lost to Follow-up|43|||
128846408|NCT02567227|463731868|FG001|6 Month|Lost to Follow-up|40|||
128846409|NCT02567227|463731867|FG000|12 Months|Lost to Follow-up|31|||
128846410|NCT02567227|463731868|FG001|12 Months|Lost to Follow-up|32|||
128846411|NCT02567227|463731867|FG000|12 Months|Death|0|||
128846412|NCT02567227|463731868|FG001|12 Months|Death|2|||
128846413|NCT02137239|463731869|FG000|Overall Study|Discontinued Study Treatment|0|||
128846414|NCT02137239|463731870|FG001|Overall Study|Discontinued Study Treatment|3|||
128846415|NCT02137239|463731869|FG000|Overall Study|Withdrew Consent|1|||
128846416|NCT02137239|463731870|FG001|Overall Study|Withdrew Consent|1|||
128846417|NCT02137239|463731869|FG000|Overall Study|Adverse Event|2|||
128846418|NCT02137239|463731870|FG001|Overall Study|Adverse Event|2|||
128846419|NCT02498418|463731874|FG000|Overall Study|Lack of Efficacy|0|||
128846420|NCT02498418|463731875|FG001|Overall Study|Lack of Efficacy|0|||
128846421|NCT02498418|463731876|FG002|Overall Study|Lack of Efficacy|1|||
128846422|NCT02498418|463731874|FG000|Overall Study|Withdrawal by Subject|2|||
128846423|NCT02498418|463731875|FG001|Overall Study|Withdrawal by Subject|0|||
128846424|NCT02498418|463731876|FG002|Overall Study|Withdrawal by Subject|3|||
128846425|NCT02498418|463731874|FG000|Overall Study|Lost to Follow-up|0|||
128846426|NCT02498418|463731875|FG001|Overall Study|Lost to Follow-up|1|||
128846427|NCT02498418|463731876|FG002|Overall Study|Lost to Follow-up|1|||
128846428|NCT02498418|463731874|FG000|Overall Study|Participant taken prohibited medication|0|||
128846429|NCT02498418|463731875|FG001|Overall Study|Participant taken prohibited medication|1|||
128846430|NCT02498418|463731876|FG002|Overall Study|Participant taken prohibited medication|1|||
128846431|NCT00762502|463731877|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
128846432|NCT00762502|463731878|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
128846433|NCT00762502|463731879|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
128846434|NCT00762502|463731877|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
128846435|NCT00762502|463731878|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
128846436|NCT00762502|463731879|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
128846437|NCT00762502|463731877|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
128846438|NCT00762502|463731878|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
128846439|NCT00762502|463731879|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
128846440|NCT03042559|463731880|FG000|Overall Study|drop out|1|||
128846441|NCT03042559|463731881|FG001|Overall Study|drop out|1|||
128846442|NCT01536535|463731885|FG000|Overall Study|Withdrawal by Subject|10|||
128846443|NCT01536535|463731886|FG001|Overall Study|Withdrawal by Subject|5|||
128846444|NCT01536535|463731885|FG000|Overall Study|Lost to Follow-up|4|||
128846445|NCT01536535|463731886|FG001|Overall Study|Lost to Follow-up|6|||
128846446|NCT01536535|463731885|FG000|Overall Study|Physician Decision|1|||
128846447|NCT01536535|463731886|FG001|Overall Study|Physician Decision|1|||
128846448|NCT01536535|463731885|FG000|Overall Study|Participant moved|0|||
128846449|NCT01536535|463731886|FG001|Overall Study|Participant moved|1|||
128846450|NCT00385697|463731889|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
128846451|NCT00385697|463731890|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
128846452|NCT00385697|463731891|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
128846453|NCT00385697|463731892|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
128846454|NCT00385697|463731893|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
128846455|NCT00385697|463731889|FG000|Open-label Segment 1|Lost to Follow-up|1|||
128846456|NCT00385697|463731890|FG001|Open-label Segment 1|Lost to Follow-up|0|||
128846457|NCT00385697|463731891|FG002|Open-label Segment 1|Lost to Follow-up|0|||
128846458|NCT00385697|463731892|FG003|Open-label Segment 1|Lost to Follow-up|0|||
128846459|NCT00385697|463731893|FG004|Open-label Segment 1|Lost to Follow-up|0|||
128846460|NCT00385697|463731889|FG000|Double-blind Segment 2|Adverse Event|0|||
128846461|NCT00385697|463731890|FG001|Double-blind Segment 2|Adverse Event|3|||
128846462|NCT00385697|463731891|FG002|Double-blind Segment 2|Adverse Event|1|||
128846463|NCT00385697|463731892|FG003|Double-blind Segment 2|Adverse Event|0|||
128846464|NCT00385697|463731893|FG004|Double-blind Segment 2|Adverse Event|0|||
128846465|NCT00385697|463731889|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
128846466|NCT00385697|463731890|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
128846467|NCT00385697|463731891|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
128846468|NCT00385697|463731892|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
128846469|NCT00385697|463731893|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
128846470|NCT00385697|463731889|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
128846471|NCT00385697|463731890|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
128846472|NCT00385697|463731891|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
128846473|NCT00385697|463731892|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
128846474|NCT00385697|463731893|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
128846475|NCT00385697|463731889|FG000|Double-blind Segment 2|Other|0|||
128846476|NCT00385697|463731890|FG001|Double-blind Segment 2|Other|2|||
128846477|NCT00385697|463731891|FG002|Double-blind Segment 2|Other|0|||
128846478|NCT00385697|463731892|FG003|Double-blind Segment 2|Other|0|||
128846479|NCT00385697|463731893|FG004|Double-blind Segment 2|Other|0|||
128846480|NCT01485991|463731894|FG000|Overall Study|Adverse Event|0|||
128846481|NCT01485991|463731895|FG001|Overall Study|Adverse Event|4|||
128846482|NCT01485991|463731894|FG000|Overall Study|Lost to Follow-up|13|||
128846483|NCT01485991|463731895|FG001|Overall Study|Lost to Follow-up|10|||
128846484|NCT01485991|463731894|FG000|Overall Study|Withdrawal by Subject|13|||
128846485|NCT01485991|463731895|FG001|Overall Study|Withdrawal by Subject|20|||
128846486|NCT01485991|463731894|FG000|Overall Study|randomized but not treated|6|||
128846487|NCT01485991|463731895|FG001|Overall Study|randomized but not treated|2|||
128846488|NCT01475370|463731897|FG000|Overall Study|Exacerbation of primary disease|2|||
128846489|NCT01475370|463731898|FG001|Overall Study|Exacerbation of primary disease|2|||
128846490|NCT01475370|463731899|FG002|Overall Study|Exacerbation of primary disease|2|||
128846491|NCT01475370|463731897|FG000|Overall Study|Study drug administration difficult|0|||
128846492|NCT01475370|463731898|FG001|Overall Study|Study drug administration difficult|1|||
128846493|NCT01475370|463731899|FG002|Overall Study|Study drug administration difficult|1|||
128846494|NCT01475370|463731897|FG000|Overall Study|Other than specified|1|||
128846495|NCT01475370|463731898|FG001|Overall Study|Other than specified|0|||
128846496|NCT01475370|463731899|FG002|Overall Study|Other than specified|0|||
128846497|NCT02382406|463731906|FG000|Study Treatment|Disease Progression|8|||
128846498|NCT02382406|463731907|FG001|Study Treatment|Disease Progression|0|||
128846499|NCT02382406|463731908|FG002|Study Treatment|Disease Progression|20|||
128846500|NCT02382406|463731906|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
128846501|NCT02382406|463731907|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
128846502|NCT02382406|463731908|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
128846503|NCT02382406|463731906|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
128846504|NCT02382406|463731907|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
128846505|NCT02382406|463731908|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
128846506|NCT02382406|463731906|FG000|Study Treatment|symptomatic deterioration|1|||
128846507|NCT02382406|463731907|FG001|Study Treatment|symptomatic deterioration|0|||
128846508|NCT02382406|463731908|FG002|Study Treatment|symptomatic deterioration|1|||
128846509|NCT02382406|463731906|FG000|Study Treatment|Death|0|||
128846510|NCT02382406|463731907|FG001|Study Treatment|Death|0|||
128846511|NCT02382406|463731908|FG002|Study Treatment|Death|2|||
128846512|NCT02382406|463731906|FG000|Follow up|Death|11|||
128846513|NCT02382406|463731907|FG001|Follow up|Death|0|||
128846514|NCT02382406|463731908|FG002|Follow up|Death|19|||
128846515|NCT02382406|463731906|FG000|Follow up|Symptomatic deterioration|1|||
128846516|NCT02382406|463731907|FG001|Follow up|Symptomatic deterioration|0|||
128846517|NCT02382406|463731908|FG002|Follow up|Symptomatic deterioration|1|||
128846518|NCT02382406|463731906|FG000|Follow up|Patient Refused Follow-up|1|||
128846519|NCT02382406|463731907|FG001|Follow up|Patient Refused Follow-up|0|||
128846520|NCT02382406|463731908|FG002|Follow up|Patient Refused Follow-up|0|||
128846521|NCT02382406|463731906|FG000|Follow up|Study Terminated|1|||
128846522|NCT02382406|463731907|FG001|Follow up|Study Terminated|0|||
128846523|NCT02382406|463731908|FG002|Follow up|Study Terminated|8|||
128846524|NCT02382406|463731906|FG000|Follow up|Withdrawal by Subject|0|||
128846525|NCT02382406|463731907|FG001|Follow up|Withdrawal by Subject|0|||
128846526|NCT02382406|463731908|FG002|Follow up|Withdrawal by Subject|2|||
128846527|NCT03794609|463731911|FG000|Overall Study|Other|10|||
128846528|NCT03794609|463731911|FG000|Overall Study|Withdrawal by Subject|66|||
128846529|NCT03794609|463731911|FG000|Overall Study|The child is enrolled in an interventional study|70|||
128846530|NCT03794609|463731911|FG000|Overall Study|Inclusion/exclusion criteria|8|||
128846531|NCT03794609|463731911|FG000|Overall Study|At sponsor's request|151|||
128846532|NCT03794609|463731911|FG000|Overall Study|Physician Decision|1|||
128846533|NCT03794609|463731911|FG000|Overall Study|Lost to Follow-up|5|||
128846534|NCT04543942|463731912|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
128846535|NCT04543942|463731913|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
128846536|NCT04543942|463731912|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
128846537|NCT04543942|463731913|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
128846538|NCT04474691|463731920|FG000|Overall Study|Withdrawal by Subject|9|||
128846539|NCT01323309|463731921|FG000|Overall Study|Death|9|||
128846540|NCT01323309|463731922|FG001|Overall Study|Death|15|||
128846541|NCT01323309|463731923|FG002|Overall Study|Death|5|||
128846542|NCT01323309|463731921|FG000|Overall Study|Lost to Follow-up|11|||
128846543|NCT01323309|463731922|FG001|Overall Study|Lost to Follow-up|14|||
128846544|NCT01323309|463731923|FG002|Overall Study|Lost to Follow-up|24|||
128846545|NCT01323309|463731921|FG000|Overall Study|Withdrawal by Subject|14|||
128846546|NCT01323309|463731922|FG001|Overall Study|Withdrawal by Subject|14|||
128846547|NCT01323309|463731923|FG002|Overall Study|Withdrawal by Subject|18|||
128846548|NCT01323309|463731921|FG000|Overall Study|Disease progression|5|||
128846549|NCT01323309|463731922|FG001|Overall Study|Disease progression|11|||
128846550|NCT01323309|463731923|FG002|Overall Study|Disease progression|4|||
128846551|NCT03048058|463731928|FG000|Overall Study|Lost to Follow-up|4|||
128846552|NCT03048058|463731929|FG001|Overall Study|Lost to Follow-up|0|||
128846553|NCT03048058|463731928|FG000|Overall Study|Withdrawal by Subject|0|||
128846554|NCT03048058|463731929|FG001|Overall Study|Withdrawal by Subject|4|||
128846555|NCT02849509|463731954|FG000|Overall Study|Worsening of disease under study|1|||
128846556|NCT02849509|463731955|FG001|Overall Study|Worsening of disease under study|1|||
128846557|NCT02849509|463731956|FG002|Overall Study|Worsening of disease under study|1|||
128846558|NCT02849509|463731954|FG000|Overall Study|Worsening of other pre-existing disease|0|||
128846559|NCT02849509|463731955|FG001|Overall Study|Worsening of other pre-existing disease|1|||
128846560|NCT02849509|463731956|FG002|Overall Study|Worsening of other pre-existing disease|2|||
128846561|NCT02849509|463731954|FG000|Overall Study|Other adverse event|36|||
128846562|NCT02849509|463731955|FG001|Overall Study|Other adverse event|41|||
128846563|NCT02849509|463731956|FG002|Overall Study|Other adverse event|8|||
128846564|NCT02849509|463731954|FG000|Overall Study|Withdrawal by Subject|6|||
128846565|NCT02849509|463731955|FG001|Overall Study|Withdrawal by Subject|17|||
128846566|NCT02849509|463731956|FG002|Overall Study|Withdrawal by Subject|12|||
128846567|NCT02849509|463731954|FG000|Overall Study|Lost to Follow-up|27|||
128846568|NCT02849509|463731955|FG001|Overall Study|Lost to Follow-up|67|||
128846569|NCT02849509|463731956|FG002|Overall Study|Lost to Follow-up|36|||
128846570|NCT02849509|463731954|FG000|Overall Study|Other, reason not specified|14|||
128846571|NCT02849509|463731955|FG001|Overall Study|Other, reason not specified|29|||
128846572|NCT02849509|463731956|FG002|Overall Study|Other, reason not specified|25|||
128846573|NCT02849509|463731954|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
128846574|NCT02849509|463731955|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
128846575|NCT02849509|463731956|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
128846576|NCT00832650|463731959|FG000|Overall Study|Randomized but not treated|0|||
128846577|NCT00832650|463731960|FG001|Overall Study|Randomized but not treated|0|||
128846578|NCT00832650|463731961|FG002|Overall Study|Randomized but not treated|1|||
128846579|NCT00794573|463731966|FG000|Overall Study|Death|3|||
128846580|NCT00794573|463731967|FG001|Overall Study|Death|0|||
128846581|NCT00794573|463731966|FG000|Overall Study|Withdrawal by Subject|9|||
128846582|NCT00794573|463731967|FG001|Overall Study|Withdrawal by Subject|12|||
128846583|NCT00794573|463731966|FG000|Overall Study|Lost to Follow-up|26|||
128846584|NCT00794573|463731967|FG001|Overall Study|Lost to Follow-up|33|||
128846585|NCT02784535|463731968|FG000|Overall Study|Adverse Event|1|||
128846586|NCT02784535|463731969|FG001|Overall Study|Adverse Event|0|||
128846587|NCT02784535|463731968|FG000|Overall Study|Withdrawal by Subject|0|||
128846588|NCT02784535|463731969|FG001|Overall Study|Withdrawal by Subject|1|||
128846589|NCT02784535|463731968|FG000|Overall Study|Physician Decision|0|||
128846590|NCT02784535|463731969|FG001|Overall Study|Physician Decision|1|||
128846591|NCT02335242|463731970|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
128846592|NCT02335242|463731971|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
128846593|NCT02335242|463731970|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
128846594|NCT02335242|463731971|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
128846595|NCT02335242|463731970|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
128846596|NCT02335242|463731971|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
128846597|NCT00257556|463731974|FG000|Overall Study|Adverse Event|1|||
128846598|NCT00257556|463731975|FG001|Overall Study|Adverse Event|4|||
128846599|NCT00257556|463731974|FG000|Overall Study|Physician Decision|6|||
128846600|NCT00257556|463731975|FG001|Overall Study|Physician Decision|0|||
128846601|NCT00257556|463731974|FG000|Overall Study|Did not meet hCG criterion|3|||
128846602|NCT00257556|463731975|FG001|Overall Study|Did not meet hCG criterion|0|||
128846603|NCT00257556|463731974|FG000|Overall Study|other reason|4|||
128846604|NCT00257556|463731975|FG001|Overall Study|other reason|6|||
128846605|NCT00905255|463731979|FG000|Overall Study|Adverse Event|7|||
128846606|NCT00905255|463731980|FG001|Overall Study|Adverse Event|5|||
128846607|NCT00905255|463731979|FG000|Overall Study|Withdrawal by Subject|5|||
128846608|NCT00905255|463731980|FG001|Overall Study|Withdrawal by Subject|4|||
128846609|NCT00905255|463731979|FG000|Overall Study|Familial and Personal Reasons|1|||
128846610|NCT00905255|463731980|FG001|Overall Study|Familial and Personal Reasons|0|||
128846611|NCT04839289|463731983|FG000|Overall Study|Withdrawal by Subject|1|||
128846612|NCT04839289|463731984|FG001|Overall Study|Withdrawal by Subject|0|||
128846613|NCT00390806|463731988|FG000|Overall Study|Lost to Follow-up|7|||
128846614|NCT00390806|463731989|FG001|Overall Study|Lost to Follow-up|6|||
128846615|NCT00390806|463731988|FG000|Overall Study|Protocol Violation|2|||
128846616|NCT00390806|463731989|FG001|Overall Study|Protocol Violation|2|||
128846617|NCT00390806|463731988|FG000|Overall Study|Withdrawal by Subject|12|||
128846618|NCT00390806|463731989|FG001|Overall Study|Withdrawal by Subject|15|||
128846619|NCT00390806|463731988|FG000|Overall Study|Investigator Decision|4|||
128846620|NCT00390806|463731989|FG001|Overall Study|Investigator Decision|6|||
128846621|NCT00390806|463731988|FG000|Overall Study|Death|1|||
128846622|NCT00390806|463731989|FG001|Overall Study|Death|0|||
128846623|NCT00390806|463731988|FG000|Overall Study|Physician Decision|0|||
128846624|NCT00390806|463731989|FG001|Overall Study|Physician Decision|1|||
128846625|NCT00390806|463731988|FG000|Overall Study|Ongoing|4|||
128846626|NCT00390806|463731989|FG001|Overall Study|Ongoing|2|||
128846627|NCT00714688|463731990|FG000|Overall Study|Lack of Efficacy|14|||
128846628|NCT00714688|463731991|FG001|Overall Study|Lack of Efficacy|1|||
128846629|NCT00714688|463731992|FG002|Overall Study|Lack of Efficacy|4|||
128846630|NCT00714688|463731990|FG000|Overall Study|Withdrawal by Subject|4|||
128846631|NCT00714688|463731991|FG001|Overall Study|Withdrawal by Subject|3|||
128846632|NCT00714688|463731992|FG002|Overall Study|Withdrawal by Subject|3|||
128846633|NCT00714688|463731990|FG000|Overall Study|Lost to Follow-up|5|||
128846634|NCT00714688|463731991|FG001|Overall Study|Lost to Follow-up|2|||
128846635|NCT00714688|463731992|FG002|Overall Study|Lost to Follow-up|0|||
128846636|NCT00714688|463731990|FG000|Overall Study|Adverse Event|2|||
128846637|NCT00714688|463731991|FG001|Overall Study|Adverse Event|15|||
128846638|NCT00714688|463731992|FG002|Overall Study|Adverse Event|19|||
128846639|NCT00714688|463731990|FG000|Overall Study|Subject Non-compliant|3|||
128846640|NCT00714688|463731991|FG001|Overall Study|Subject Non-compliant|5|||
128846641|NCT00714688|463731992|FG002|Overall Study|Subject Non-compliant|5|||
128846642|NCT00714688|463731990|FG000|Overall Study|Ineligible to Continue the Study|0|||
128846643|NCT00714688|463731991|FG001|Overall Study|Ineligible to Continue the Study|1|||
128846644|NCT00714688|463731992|FG002|Overall Study|Ineligible to Continue the Study|1|||
128846645|NCT00714688|463731990|FG000|Overall Study|Sponsor's Decision|0|||
128846646|NCT00714688|463731991|FG001|Overall Study|Sponsor's Decision|2|||
128846647|NCT00714688|463731992|FG002|Overall Study|Sponsor's Decision|0|||
128846648|NCT00714688|463731990|FG000|Overall Study|Other|1|||
128846649|NCT00714688|463731991|FG001|Overall Study|Other|6|||
128846650|NCT00714688|463731992|FG002|Overall Study|Other|5|||
128846651|NCT01808144|463731994|FG000|Overall Study|Death|1|||
128846652|NCT01808144|463731995|FG001|Overall Study|Death|0|||
128846653|NCT01808144|463731994|FG000|Overall Study|Withdrawal by Subject|16|||
128846654|NCT01808144|463731995|FG001|Overall Study|Withdrawal by Subject|23|||
128846655|NCT01808144|463731994|FG000|Overall Study|Lost to Follow-up|6|||
128846656|NCT01808144|463731995|FG001|Overall Study|Lost to Follow-up|3|||
128846657|NCT01808144|463731994|FG000|Overall Study|Protocol Violation|6|||
128846658|NCT01808144|463731995|FG001|Overall Study|Protocol Violation|6|||
128846659|NCT01808144|463731994|FG000|Overall Study|Gout flare|0|||
128846660|NCT01808144|463731995|FG001|Overall Study|Gout flare|1|||
128846661|NCT01808144|463731994|FG000|Overall Study|Adverse Event|11|||
128846662|NCT01808144|463731995|FG001|Overall Study|Adverse Event|15|||
128846663|NCT00383500|463731996|FG000|Overall Study|Withdrawal by Subject|8|||
128846664|NCT00383500|463731997|FG001|Overall Study|Withdrawal by Subject|3|||
128846665|NCT00383500|463731998|FG002|Overall Study|Withdrawal by Subject|0|||
128846666|NCT00383500|463731996|FG000|Overall Study|Lost to Follow-up|0|||
128846667|NCT00383500|463731997|FG001|Overall Study|Lost to Follow-up|0|||
128846668|NCT00383500|463731998|FG002|Overall Study|Lost to Follow-up|2|||
128846669|NCT02176356|463733375|FG000|Overall Study|Screen Failure|14|||
128846670|NCT02176356|463733375|FG000|Overall Study|Lost to Follow-up|4|||
128846671|NCT02176356|463733375|FG000|Overall Study|Personal Reasons|3|||
128846672|NCT02176356|463733375|FG000|Overall Study|Other Miscellaneous Reasons|2|||
128846673|NCT00792259|463733376|FG000|Overall Study|Poor Quality Scans|1|||
128846674|NCT00792259|463733377|FG001|Overall Study|Poor Quality Scans|0|||
128846675|NCT00792259|463733378|FG002|Overall Study|Poor Quality Scans|0|||
128846676|NCT00332488|463733379|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
128846677|NCT00332488|463733380|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
128846678|NCT00332488|463733381|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
128846679|NCT00332488|463733379|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
128846680|NCT00332488|463733380|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
128846681|NCT00332488|463733381|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
128846682|NCT00332488|463733379|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
128846683|NCT00332488|463733380|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
128846684|NCT00332488|463733381|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
128846685|NCT00332488|463733379|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
128846686|NCT00332488|463733380|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
128846687|NCT00332488|463733381|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
128846688|NCT00332488|463733379|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
128846689|NCT00332488|463733380|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
128846690|NCT00332488|463733381|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
128846691|NCT00332488|463733379|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
128846692|NCT00332488|463733380|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
128846693|NCT00332488|463733381|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
128846694|NCT00332488|463733379|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
128846695|NCT00332488|463733380|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
128846696|NCT00332488|463733381|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
128846697|NCT00332488|463733379|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
128846698|NCT00332488|463733380|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
128846699|NCT00332488|463733381|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
128846700|NCT00332488|463733379|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
128846701|NCT00332488|463733380|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
128846702|NCT00332488|463733381|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
128846703|NCT00332488|463733379|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
128846704|NCT00332488|463733380|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
128846705|NCT00332488|463733381|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
128846706|NCT00332488|463733379|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
128846707|NCT00332488|463733380|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
128846708|NCT00332488|463733381|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
128846709|NCT00332488|463733379|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
128846710|NCT00332488|463733380|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
128846711|NCT00332488|463733381|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
128846712|NCT00371462|463733382|FG000|Overall Study|Withdrawal by Subject|1|||
128846713|NCT00371462|463733383|FG001|Overall Study|Withdrawal by Subject|0|||
128846714|NCT00371462|463733382|FG000|Overall Study|Other|7|||
128846715|NCT00371462|463733383|FG001|Overall Study|Other|8|||
128846716|NCT03721978|463733385|FG000|Overall Study|Withdrawal by Subject|6|||
128846717|NCT03721978|463733386|FG001|Overall Study|Withdrawal by Subject|1|||
128846718|NCT03721978|463733385|FG000|Overall Study|Adverse Event|1|||
128846719|NCT03721978|463733386|FG001|Overall Study|Adverse Event|1|||
128846720|NCT03721978|463733385|FG000|Overall Study|Progressive Disease|1|||
128846721|NCT03721978|463733386|FG001|Overall Study|Progressive Disease|0|||
128846722|NCT03721978|463733385|FG000|Overall Study|Lost to Follow-up|5|||
128846723|NCT03721978|463733386|FG001|Overall Study|Lost to Follow-up|1|||
128846724|NCT03721978|463733385|FG000|Overall Study|Reason not Specified|0|||
128846725|NCT03721978|463733386|FG001|Overall Study|Reason not Specified|2|||
128846726|NCT05244226|463733387|FG000|Overall Study|Adverse Event|1|||
128846727|NCT05244226|463733388|FG001|Overall Study|Adverse Event|0|||
128846728|NCT05244226|463733389|FG002|Overall Study|Adverse Event|0|||
128846729|NCT05244226|463733387|FG000|Overall Study|Lost to Follow-up|0|||
128846730|NCT05244226|463733388|FG001|Overall Study|Lost to Follow-up|0|||
128846731|NCT05244226|463733389|FG002|Overall Study|Lost to Follow-up|1|||
128846732|NCT05244226|463733387|FG000|Overall Study|Protocol Violation|0|||
128846733|NCT05244226|463733388|FG001|Overall Study|Protocol Violation|2|||
128846734|NCT05244226|463733389|FG002|Overall Study|Protocol Violation|2|||
128846735|NCT02507687|463733390|FG000|Overall Study|Adverse Event|3|||
128846736|NCT02507687|463733391|FG001|Overall Study|Adverse Event|2|||
128846737|NCT02507687|463733392|FG002|Overall Study|Adverse Event|2|||
128846738|NCT02507687|463733393|FG003|Overall Study|Adverse Event|2|||
128846739|NCT02507687|463733390|FG000|Overall Study|Withdrawal by Subject|1|||
128846740|NCT02507687|463733391|FG001|Overall Study|Withdrawal by Subject|4|||
128846741|NCT02507687|463733392|FG002|Overall Study|Withdrawal by Subject|6|||
128846742|NCT02507687|463733393|FG003|Overall Study|Withdrawal by Subject|6|||
128846743|NCT02507687|463733390|FG000|Overall Study|Protocol Violation|1|||
128846744|NCT02507687|463733391|FG001|Overall Study|Protocol Violation|0|||
128846745|NCT02507687|463733392|FG002|Overall Study|Protocol Violation|2|||
128846746|NCT02507687|463733393|FG003|Overall Study|Protocol Violation|0|||
128846747|NCT02507687|463733390|FG000|Overall Study|Lost to Follow-up|0|||
128846748|NCT02507687|463733391|FG001|Overall Study|Lost to Follow-up|0|||
128846749|NCT02507687|463733392|FG002|Overall Study|Lost to Follow-up|2|||
128846750|NCT02507687|463733393|FG003|Overall Study|Lost to Follow-up|1|||
128846751|NCT02507687|463733390|FG000|Overall Study|Screen Failure|0|||
128846752|NCT02507687|463733391|FG001|Overall Study|Screen Failure|0|||
128846753|NCT02507687|463733392|FG002|Overall Study|Screen Failure|1|||
128846754|NCT02507687|463733393|FG003|Overall Study|Screen Failure|0|||
128846755|NCT02507687|463733390|FG000|Overall Study|Other, Not Specified|0|||
128846756|NCT02507687|463733391|FG001|Overall Study|Other, Not Specified|0|||
128846757|NCT02507687|463733392|FG002|Overall Study|Other, Not Specified|2|||
128846758|NCT02507687|463733393|FG003|Overall Study|Other, Not Specified|4|||
128846759|NCT00733226|463733394|FG000|Overall Study|Withdrawal by Subject|1|||
128846760|NCT00733226|463733395|FG001|Overall Study|Withdrawal by Subject|0|||
128846761|NCT00733226|463733394|FG000|Overall Study|Lost to Follow-up|2|||
128846762|NCT00733226|463733395|FG001|Overall Study|Lost to Follow-up|0|||
128846763|NCT00733226|463733394|FG000|Overall Study|moved to another place|2|||
128846764|NCT00733226|463733395|FG001|Overall Study|moved to another place|0|||
128846765|NCT03722485|463733398|FG000|Overall Study|Withdrawal by Subject|1|||
128846766|NCT03722485|463733399|FG001|Overall Study|Withdrawal by Subject|0|||
128846767|NCT03722485|463733398|FG000|Overall Study|Adverse Event|0|||
128846768|NCT03722485|463733399|FG001|Overall Study|Adverse Event|2|||
128846769|NCT03722485|463733398|FG000|Overall Study|subject discharged prior to study completion|1|||
128846770|NCT03722485|463733399|FG001|Overall Study|subject discharged prior to study completion|5|||
128846771|NCT03722485|463733398|FG000|Overall Study|eligibility criteria not met|2|||
128846772|NCT03722485|463733399|FG001|Overall Study|eligibility criteria not met|0|||
128846773|NCT00349622|463733400|FG000|Overall Study|Death|168|||
128846774|NCT00349622|463733401|FG001|Overall Study|Death|86|||
128846775|NCT00349622|463733400|FG000|Overall Study|Lost to Follow-up|5|||
128846776|NCT00349622|463733401|FG001|Overall Study|Lost to Follow-up|1|||
128846777|NCT00349622|463733400|FG000|Overall Study|Withdrawal by Subject|5|||
128846778|NCT00349622|463733401|FG001|Overall Study|Withdrawal by Subject|9|||
128846779|NCT01902381|463733402|FG000|Overall Study|Withdrawal by Subject|1|||
128846780|NCT00755716|463733407|FG000|Overall Study|Adverse Event|1|||
128846781|NCT00755716|463733408|FG001|Overall Study|Adverse Event|4|||
128846782|NCT00755716|463733409|FG002|Overall Study|Adverse Event|1|||
128846783|NCT00755716|463733407|FG000|Overall Study|Lack of Efficacy|2|||
128846784|NCT00755716|463733408|FG001|Overall Study|Lack of Efficacy|0|||
128846785|NCT00755716|463733409|FG002|Overall Study|Lack of Efficacy|0|||
128846786|NCT00755716|463733407|FG000|Overall Study|Lost to Follow-up|5|||
128846787|NCT00755716|463733408|FG001|Overall Study|Lost to Follow-up|3|||
128846788|NCT00755716|463733409|FG002|Overall Study|Lost to Follow-up|1|||
128846789|NCT00755716|463733407|FG000|Overall Study|work schedule issues|0|||
128846790|NCT00755716|463733408|FG001|Overall Study|work schedule issues|1|||
128846791|NCT00755716|463733409|FG002|Overall Study|work schedule issues|1|||
128846792|NCT02762500|463733410|FG000|Overall Study|Lack of Efficacy|1|||
128846793|NCT02762500|463733411|FG001|Overall Study|Lack of Efficacy|0|||
128846794|NCT02762500|463733410|FG000|Overall Study|Withdrawal by Subject|1|||
128846795|NCT02762500|463733411|FG001|Overall Study|Withdrawal by Subject|1|||
128846796|NCT02762500|463733410|FG000|Overall Study|Adverse Event|0|||
128846797|NCT02762500|463733411|FG001|Overall Study|Adverse Event|2|||
128846798|NCT02229396|463733412|FG000|Overall Study|Adverse Event|6|||
128846799|NCT02229396|463733413|FG001|Overall Study|Adverse Event|12|||
128846800|NCT02229396|463733414|FG002|Overall Study|Adverse Event|12|||
128846801|NCT02229396|463733412|FG000|Overall Study|Death|2|||
128846802|NCT02229396|463733413|FG001|Overall Study|Death|3|||
128846803|NCT02229396|463733414|FG002|Overall Study|Death|1|||
128846804|NCT02229396|463733412|FG000|Overall Study|Lost to Follow-up|14|||
128846805|NCT02229396|463733413|FG001|Overall Study|Lost to Follow-up|14|||
128846806|NCT02229396|463733414|FG002|Overall Study|Lost to Follow-up|21|||
128846807|NCT02229396|463733412|FG000|Overall Study|Protocol Violation|2|||
128846808|NCT02229396|463733413|FG001|Overall Study|Protocol Violation|1|||
128846809|NCT02229396|463733414|FG002|Overall Study|Protocol Violation|0|||
128846810|NCT02229396|463733412|FG000|Overall Study|Patient Incorrectly Randomized|0|||
128846811|NCT02229396|463733413|FG001|Overall Study|Patient Incorrectly Randomized|0|||
128846812|NCT02229396|463733414|FG002|Overall Study|Patient Incorrectly Randomized|1|||
128846813|NCT02229396|463733412|FG000|Overall Study|Other|10|||
128846814|NCT02229396|463733413|FG001|Overall Study|Other|18|||
128846815|NCT02229396|463733414|FG002|Overall Study|Other|15|||
128846816|NCT02229396|463733412|FG000|Overall Study|Withdrawal by Subject|42|||
128846817|NCT02229396|463733413|FG001|Overall Study|Withdrawal by Subject|28|||
128846818|NCT02229396|463733414|FG002|Overall Study|Withdrawal by Subject|41|||
128846819|NCT02229396|463733412|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
128846820|NCT02229396|463733413|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
128846821|NCT02229396|463733414|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
128846822|NCT02229396|463733412|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
128846823|NCT02229396|463733413|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
128846824|NCT02229396|463733414|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
128846825|NCT00377312|463733427|FG000|Overall Study|Adverse Event|1|||
128846826|NCT00377312|463733428|FG001|Overall Study|Adverse Event|1|||
128846827|NCT02775214|463733429|FG000|Overall Study|Withdrawal by Subject|2|||
128846828|NCT02775214|463733430|FG001|Overall Study|Withdrawal by Subject|0|||
128846829|NCT00762723|463733431|FG000|Overall Study|Study Terminated slow enrollement|5|||
128846830|NCT00762723|463733432|FG001|Overall Study|Study Terminated slow enrollement|5|||
128846831|NCT00762723|463733433|FG002|Overall Study|Study Terminated slow enrollement|3|||
128846832|NCT01145417|463733434|FG000|Overall Study|Death|1|||
128846833|NCT01145417|463733435|FG001|Overall Study|Death|0|||
128846834|NCT01145417|463733434|FG000|Overall Study|Lost to Follow-up|2|||
128846835|NCT01145417|463733435|FG001|Overall Study|Lost to Follow-up|1|||
128846836|NCT01145417|463733434|FG000|Overall Study|Withdrawal by Subject|1|||
128846837|NCT01145417|463733435|FG001|Overall Study|Withdrawal by Subject|2|||
128846838|NCT01145417|463733434|FG000|Overall Study|Pregnancy|1|||
128846839|NCT01145417|463733435|FG001|Overall Study|Pregnancy|0|||
128846840|NCT01145417|463733434|FG000|Overall Study|Adverse Event|0|||
128846841|NCT01145417|463733435|FG001|Overall Study|Adverse Event|1|||
128846842|NCT01145417|463733434|FG000|Overall Study|Study terminated by sponsor|35|||
128846843|NCT01145417|463733435|FG001|Overall Study|Study terminated by sponsor|43|||
128846844|NCT01145417|463733434|FG000|Overall Study|Other|1|||
128846845|NCT01145417|463733435|FG001|Overall Study|Other|0|||
128846846|NCT01191697|463733436|FG000|Overall Study|Death|1|||
128846847|NCT01191697|463733436|FG000|Overall Study|Physician Decision|2|||
128846848|NCT01191697|463733436|FG000|Overall Study|Pursue chemoradiation|2|||
128846849|NCT01191697|463733436|FG000|Overall Study|Break from chemotherapy|2|||
128846850|NCT01191697|463733436|FG000|Overall Study|Withdrawal by Subject|1|||
128846851|NCT01191697|463733436|FG000|Overall Study|Surveillance|1|||
128846852|NCT01191697|463733436|FG000|Overall Study|Adverse Event|2|||
128846853|NCT01191697|463733436|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
128846854|NCT01191697|463733436|FG000|Overall Study|Not completed but analyzed|25|||
128846855|NCT01066897|463733440|FG000|Overall Study|Withdrawal by Subject|1|||
128846856|NCT01066897|463733441|FG001|Overall Study|Withdrawal by Subject|0|||
128846857|NCT01066897|463733440|FG000|Overall Study|stopped study after developing the flu.|1|||
128846858|NCT01066897|463733441|FG001|Overall Study|stopped study after developing the flu.|0|||
128846859|NCT05372913|463733450|FG000|Overall Study|Withdrawal by Subject|0|||
128846860|NCT05372913|463733451|FG001|Overall Study|Withdrawal by Subject|2|||
128846861|NCT05372913|463733450|FG000|Overall Study|Protocol Violation|2|||
128846862|NCT05372913|463733451|FG001|Overall Study|Protocol Violation|2|||
128846863|NCT05372913|463733450|FG000|Overall Study|Adverse Event|0|||
128846864|NCT05372913|463733451|FG001|Overall Study|Adverse Event|1|||
128846865|NCT03275402|463733452|FG000|Overall Study|Death|17|||
128846866|NCT03275402|463733452|FG000|Overall Study|Study terminated by sponsor|21|||
128846867|NCT03275402|463733452|FG000|Overall Study|Withdrawal by Subject|1|||
128846868|NCT02402465|463733454|FG000|Overall Study|Withdrawal by Subject|0|||
128846869|NCT02402465|463733455|FG001|Overall Study|Withdrawal by Subject|0|||
128846870|NCT02402465|463733456|FG002|Overall Study|Withdrawal by Subject|0|||
128846871|NCT02402465|463733457|FG003|Overall Study|Withdrawal by Subject|0|||
128846872|NCT02402465|463733458|FG004|Overall Study|Withdrawal by Subject|0|||
128846873|NCT02402465|463733459|FG005|Overall Study|Withdrawal by Subject|1|||
128846874|NCT02402465|463733454|FG000|Overall Study|Lost to Follow-up|0|||
128846875|NCT02402465|463733455|FG001|Overall Study|Lost to Follow-up|1|||
128846876|NCT02402465|463733456|FG002|Overall Study|Lost to Follow-up|0|||
128846877|NCT02402465|463733457|FG003|Overall Study|Lost to Follow-up|0|||
128846878|NCT02402465|463733458|FG004|Overall Study|Lost to Follow-up|1|||
128846879|NCT02402465|463733459|FG005|Overall Study|Lost to Follow-up|0|||
128846880|NCT03807700|463733460|FG000|Overall Study|Withdrawal by Subject|2|||
128846881|NCT03807700|463733461|FG001|Overall Study|Withdrawal by Subject|1|||
128846882|NCT02005029|463733463|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
128846883|NCT02005029|463733464|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
128846884|NCT01370018|463733465|FG000|Overall Study|Did not meet criteria for analysis|1|||
128846885|NCT01525641|463733466|FG000|Overall Study|Case report form not collected|25|||
128846886|NCT01525641|463733466|FG000|Overall Study|No visit since the first visit|16|||
128846887|NCT01525641|463733466|FG000|Overall Study|Adverse Event|73|||
128846888|NCT01525641|463733466|FG000|Overall Study|Lack of Efficacy|24|||
128846889|NCT01525641|463733466|FG000|Overall Study|Improvement|5|||
128846890|NCT01525641|463733466|FG000|Overall Study|Lost to follow-up (relocation)|1|||
128846891|NCT01525641|463733466|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
128846892|NCT01525641|463733466|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
128846893|NCT01525641|463733466|FG000|Overall Study|Other than stated above|7|||
128846894|NCT02538471|463733467|FG000|Overall Study|Progression of disease|2|||
128846895|NCT01675050|463733468|FG000|Period One Treatment|Withdrawal by Subject|1|||
128846896|NCT01675050|463733469|FG001|Period One Treatment|Withdrawal by Subject|0|||
128846897|NCT00084747|463733470|FG000|Overall Study|Relapsed|8|||
128846898|NCT00084747|463733470|FG000|Overall Study|Death|3|||
128846899|NCT00084747|463733470|FG000|Overall Study|Withdrawal by Subject|2|||
128846900|NCT00139659|463733471|FG000|Overall Study|Adverse Event|12|||
128846901|NCT00139659|463733472|FG001|Overall Study|Adverse Event|1|||
128846902|NCT00139659|463733471|FG000|Overall Study|Lack of Efficacy|1|||
128846903|NCT00139659|463733472|FG001|Overall Study|Lack of Efficacy|1|||
128846904|NCT00139659|463733471|FG000|Overall Study|Lost to Follow-up|7|||
128846905|NCT00139659|463733472|FG001|Overall Study|Lost to Follow-up|3|||
128846906|NCT00139659|463733471|FG000|Overall Study|Reason not Specified|6|||
128846907|NCT00139659|463733472|FG001|Overall Study|Reason not Specified|3|||
128846908|NCT00139659|463733471|FG000|Overall Study|Withdrawal by Subject|14|||
128846909|NCT00139659|463733472|FG001|Overall Study|Withdrawal by Subject|10|||
128846910|NCT02625922|463733474|FG000|Overall Study|Non-availability of IMP|1|||
128846911|NCT02625922|463733475|FG001|Overall Study|Non-availability of IMP|1|||
128846912|NCT02625922|463733474|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
128846913|NCT02625922|463733475|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
128846914|NCT02359552|463733476|FG000|Overall Study|Lost to Follow-up|3|||
128846915|NCT02359552|463733477|FG001|Overall Study|Lost to Follow-up|4|||
128846916|NCT02391116|463733480|FG000|Treatment|Withdrawal by Subject|1|||
128846917|NCT02391116|463733480|FG000|Treatment|Protocol Violation|1|||
128846918|NCT02391116|463733480|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
128846919|NCT02391116|463733480|FG000|Treatment|AE with Clinical PD|3|||
128846920|NCT02391116|463733480|FG000|Safety Follow-up|Adverse Event|1|||
128846921|NCT02391116|463733480|FG000|Safety Follow-up|Withdrawal by Subject|4|||
128846922|NCT02391116|463733480|FG000|Safety Follow-up|Switching to Other Therapy|4|||
128846923|NCT02391116|463733480|FG000|Safety Follow-up|No Follow Up|1|||
128846924|NCT02391116|463733480|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
128846925|NCT02391116|463733480|FG000|Active Follow-up|Withdrawal by Subject|1|||
128846926|NCT02391116|463733480|FG000|Active Follow-up|Switching to Other Therapy|2|||
128846927|NCT02391116|463733480|FG000|Survival Follow-up|Withdrawal by Subject|3|||
128846928|NCT02391116|463733480|FG000|Survival Follow-up|Switching to Other Therapy|1|||
128846929|NCT01395914|463733481|FG000|Overall Study|Unrelated to study drug AE|6|||
128846930|NCT01395914|463733482|FG001|Overall Study|Unrelated to study drug AE|1|||
128846931|NCT01395914|463733481|FG000|Overall Study|Death|23|||
128846932|NCT01395914|463733482|FG001|Overall Study|Death|17|||
128846933|NCT01395914|463733481|FG000|Overall Study|Other|9|||
128846934|NCT01395914|463733482|FG001|Overall Study|Other|3|||
128846935|NCT01395914|463733481|FG000|Overall Study|Withdrawal by patient|27|||
128846936|NCT01395914|463733482|FG001|Overall Study|Withdrawal by patient|14|||
128846937|NCT01395914|463733481|FG000|Overall Study|Study drug-related AE|1|||
128846938|NCT01395914|463733482|FG001|Overall Study|Study drug-related AE|0|||
128846939|NCT01395914|463733481|FG000|Overall Study|Lost to Follow-up|6|||
128846940|NCT01395914|463733482|FG001|Overall Study|Lost to Follow-up|2|||
128846941|NCT01920178|463733486|FG000|Overall Study|Lost to Follow-up|2|||
128846942|NCT01920178|463733487|FG001|Overall Study|Lost to Follow-up|1|||
128846943|NCT01261793|463733488|FG000|Overall Study|Lack of Efficacy|44|||
128846944|NCT01261793|463733489|FG001|Overall Study|Lack of Efficacy|37|||
128846945|NCT01261793|463733490|FG002|Overall Study|Lack of Efficacy|32|||
128846946|NCT01261793|463733488|FG000|Overall Study|Protocol Violation|3|||
128846947|NCT01261793|463733489|FG001|Overall Study|Protocol Violation|5|||
128846948|NCT01261793|463733490|FG002|Overall Study|Protocol Violation|6|||
128846949|NCT01261793|463733488|FG000|Overall Study|Lost to Follow-up|10|||
128846950|NCT01261793|463733489|FG001|Overall Study|Lost to Follow-up|3|||
128846951|NCT01261793|463733490|FG002|Overall Study|Lost to Follow-up|7|||
128846952|NCT01261793|463733488|FG000|Overall Study|Withdrawal by Subject|12|||
128846953|NCT01261793|463733489|FG001|Overall Study|Withdrawal by Subject|14|||
128846954|NCT01261793|463733490|FG002|Overall Study|Withdrawal by Subject|14|||
128846955|NCT01261793|463733488|FG000|Overall Study|Death|3|||
128846956|NCT01261793|463733489|FG001|Overall Study|Death|1|||
128846957|NCT01261793|463733490|FG002|Overall Study|Death|0|||
128846958|NCT01261793|463733488|FG000|Overall Study|Adverse Event|9|||
128846959|NCT01261793|463733489|FG001|Overall Study|Adverse Event|24|||
128846960|NCT01261793|463733490|FG002|Overall Study|Adverse Event|19|||
128846961|NCT01261793|463733488|FG000|Overall Study|Patient non-availability|1|||
128846962|NCT01261793|463733489|FG001|Overall Study|Patient non-availability|1|||
128846963|NCT01261793|463733490|FG002|Overall Study|Patient non-availability|1|||
128846964|NCT01261793|463733488|FG000|Overall Study|Suspected pregnancy|1|||
128846965|NCT01261793|463733489|FG001|Overall Study|Suspected pregnancy|1|||
128846966|NCT01261793|463733490|FG002|Overall Study|Suspected pregnancy|0|||
128846967|NCT01261793|463733488|FG000|Overall Study|Patient non-compliance|1|||
128846968|NCT01261793|463733489|FG001|Overall Study|Patient non-compliance|0|||
128846969|NCT01261793|463733490|FG002|Overall Study|Patient non-compliance|1|||
128846970|NCT01261793|463733488|FG000|Overall Study|Patient pregnant|1|||
128846971|NCT01261793|463733489|FG001|Overall Study|Patient pregnant|0|||
128846972|NCT01261793|463733490|FG002|Overall Study|Patient pregnant|0|||
128846973|NCT01261793|463733488|FG000|Overall Study|Outside the study area|0|||
128846974|NCT01261793|463733489|FG001|Overall Study|Outside the study area|2|||
128846975|NCT01261793|463733490|FG002|Overall Study|Outside the study area|1|||
128846976|NCT01261793|463733488|FG000|Overall Study|Lack of efficacy & patient not available|0|||
128846977|NCT01261793|463733489|FG001|Overall Study|Lack of efficacy & patient not available|1|||
128846978|NCT01261793|463733490|FG002|Overall Study|Lack of efficacy & patient not available|0|||
128846979|NCT01261793|463733488|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
128846980|NCT01261793|463733489|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
128846981|NCT01261793|463733490|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
128846982|NCT01261793|463733488|FG000|Overall Study|Randomization error|0|||
128846983|NCT01261793|463733489|FG001|Overall Study|Randomization error|1|||
128846984|NCT01261793|463733490|FG002|Overall Study|Randomization error|0|||
128846985|NCT01261793|463733488|FG000|Overall Study|Patient unable to start IV line|0|||
128846986|NCT01261793|463733489|FG001|Overall Study|Patient unable to start IV line|0|||
128846987|NCT01261793|463733490|FG002|Overall Study|Patient unable to start IV line|1|||
128846988|NCT02133131|463733494|FG000|Overall Study|Adverse Event|0|||
128846989|NCT02133131|463733495|FG001|Overall Study|Adverse Event|0|||
128846990|NCT02133131|463733496|FG002|Overall Study|Adverse Event|0|||
128846991|NCT02133131|463733497|FG003|Overall Study|Adverse Event|1|||
128846992|NCT02133131|463733498|FG004|Overall Study|Adverse Event|0|||
128846993|NCT02133131|463733499|FG005|Overall Study|Adverse Event|0|||
128846994|NCT02133131|463733500|FG006|Overall Study|Adverse Event|0|||
128846995|NCT02133131|463733494|FG000|Overall Study|Lost to Follow-up|1|||
128846996|NCT02133131|463733495|FG001|Overall Study|Lost to Follow-up|0|||
128846997|NCT02133131|463733496|FG002|Overall Study|Lost to Follow-up|0|||
128846998|NCT02133131|463733497|FG003|Overall Study|Lost to Follow-up|1|||
128846999|NCT02133131|463733498|FG004|Overall Study|Lost to Follow-up|0|||
128847000|NCT02133131|463733499|FG005|Overall Study|Lost to Follow-up|0|||
128847001|NCT02133131|463733500|FG006|Overall Study|Lost to Follow-up|0|||
128847002|NCT02133131|463733494|FG000|Overall Study|Status not recorded|4|||
128847003|NCT02133131|463733495|FG001|Overall Study|Status not recorded|5|||
128847004|NCT02133131|463733496|FG002|Overall Study|Status not recorded|1|||
128847005|NCT02133131|463733497|FG003|Overall Study|Status not recorded|4|||
128847006|NCT02133131|463733498|FG004|Overall Study|Status not recorded|0|||
128847007|NCT02133131|463733499|FG005|Overall Study|Status not recorded|0|||
128847008|NCT02133131|463733500|FG006|Overall Study|Status not recorded|0|||
128847009|NCT02133131|463733494|FG000|Overall Study|Ongoing in study|0|||
128847010|NCT02133131|463733495|FG001|Overall Study|Ongoing in study|0|||
128847011|NCT02133131|463733496|FG002|Overall Study|Ongoing in study|0|||
128847012|NCT02133131|463733497|FG003|Overall Study|Ongoing in study|0|||
128847013|NCT02133131|463733498|FG004|Overall Study|Ongoing in study|15|||
128847014|NCT02133131|463733499|FG005|Overall Study|Ongoing in study|14|||
128847015|NCT02133131|463733500|FG006|Overall Study|Ongoing in study|11|||
128847016|NCT02133131|463733494|FG000|Overall Study|Protocol Violation|0|||
128847017|NCT02133131|463733495|FG001|Overall Study|Protocol Violation|0|||
128847018|NCT02133131|463733496|FG002|Overall Study|Protocol Violation|0|||
128847019|NCT02133131|463733497|FG003|Overall Study|Protocol Violation|0|||
128847020|NCT02133131|463733498|FG004|Overall Study|Protocol Violation|0|||
128847021|NCT02133131|463733499|FG005|Overall Study|Protocol Violation|0|||
128847022|NCT02133131|463733500|FG006|Overall Study|Protocol Violation|1|||
128847023|NCT01032200|463733505|FG000|Overall Study|Death|1|||
128847024|NCT01032200|463733506|FG001|Overall Study|Death|1|||
128847025|NCT01032200|463733505|FG000|Overall Study|Withdrawal by Subject|1|||
128847026|NCT01032200|463733506|FG001|Overall Study|Withdrawal by Subject|3|||
128847027|NCT01032200|463733505|FG000|Overall Study|Toxicity|0|||
128847028|NCT01032200|463733506|FG001|Overall Study|Toxicity|2|||
128847029|NCT01032200|463733505|FG000|Overall Study|Progression|1|||
128847030|NCT01032200|463733506|FG001|Overall Study|Progression|0|||
128847031|NCT01032200|463733505|FG000|Overall Study|Multiple|1|||
128847032|NCT01032200|463733506|FG001|Overall Study|Multiple|1|||
128847033|NCT02316171|463733509|FG000|Overall Study|difficulties with urinary catheter|1|||
128847034|NCT02316171|463733510|FG001|Overall Study|difficulties with urinary catheter|0|||
128847035|NCT02316171|463733511|FG002|Overall Study|difficulties with urinary catheter|0|||
128847036|NCT02316171|463733512|FG003|Overall Study|difficulties with urinary catheter|0|||
128847037|NCT01804140|463733514|FG000|Overall Study|No sampling or biopsy procedures done|114|||
128847038|NCT01524887|463733515|FG000|Overall Study|Withdrawal by Subject|6|||
128847039|NCT01524887|463733516|FG001|Overall Study|Withdrawal by Subject|2|||
128847040|NCT01524887|463733517|FG002|Overall Study|Withdrawal by Subject|3|||
128847041|NCT01524887|463733515|FG000|Overall Study|Adverse Event|5|||
128847042|NCT01524887|463733516|FG001|Overall Study|Adverse Event|1|||
128847043|NCT01524887|463733517|FG002|Overall Study|Adverse Event|1|||
128847044|NCT01524887|463733515|FG000|Overall Study|Protocol Violation|0|||
128847045|NCT01524887|463733516|FG001|Overall Study|Protocol Violation|0|||
128847046|NCT01524887|463733517|FG002|Overall Study|Protocol Violation|1|||
128847047|NCT01524887|463733515|FG000|Overall Study|Study termination|73|||
128847048|NCT01524887|463733516|FG001|Overall Study|Study termination|87|||
128847049|NCT01524887|463733517|FG002|Overall Study|Study termination|79|||
128847050|NCT01524887|463733515|FG000|Overall Study|Withdrawal by Caregiver|0|||
128847051|NCT01524887|463733516|FG001|Overall Study|Withdrawal by Caregiver|0|||
128847052|NCT01524887|463733517|FG002|Overall Study|Withdrawal by Caregiver|2|||
128847053|NCT01524887|463733515|FG000|Overall Study|Use of prohibited medication|1|||
128847054|NCT01524887|463733516|FG001|Overall Study|Use of prohibited medication|0|||
128847055|NCT01524887|463733517|FG002|Overall Study|Use of prohibited medication|0|||
128847056|NCT02785900|463733518|FG000|Overall Study|Study Termination by Sponsor|64|||
128847057|NCT02785900|463733519|FG001|Overall Study|Study Termination by Sponsor|81|||
128847058|NCT02785900|463733518|FG000|Overall Study|Death|46|||
128847059|NCT02785900|463733519|FG001|Overall Study|Death|32|||
128847060|NCT02785900|463733518|FG000|Overall Study|Withdrawal by Subject|4|||
128847061|NCT02785900|463733519|FG001|Overall Study|Withdrawal by Subject|8|||
128847062|NCT02785900|463733518|FG000|Overall Study|Physician Decision|3|||
128847063|NCT02785900|463733519|FG001|Overall Study|Physician Decision|2|||
128847064|NCT03993054|463733520|FG000|Overall Study|PI Decision|1|||
128847065|NCT04341584|463733524|FG000|Overall Study|Withdrew consent|0|||
128847066|NCT04341584|463733525|FG001|Overall Study|Withdrew consent|2|||
128847067|NCT04341584|463733526|FG002|Overall Study|Withdrew consent|2|||
128847068|NCT04341584|463733527|FG003|Overall Study|Withdrew consent|1|||
128847069|NCT02799745|463733529|FG000|Overall Study|Participant moved out of state|1|||
128847070|NCT02799745|463733530|FG001|Overall Study|Participant moved out of state|0|||
128847071|NCT02799745|463733529|FG000|Overall Study|Discontinued due to planned surgery|1|||
128847072|NCT02799745|463733530|FG001|Overall Study|Discontinued due to planned surgery|0|||
128847073|NCT02799745|463733529|FG000|Overall Study|Withdrawal by Subject|16|||
128847074|NCT02799745|463733530|FG001|Overall Study|Withdrawal by Subject|25|||
128847075|NCT02799745|463733529|FG000|Overall Study|Protocol Deviation|4|||
128847076|NCT02799745|463733530|FG001|Overall Study|Protocol Deviation|5|||
128847077|NCT02799745|463733529|FG000|Overall Study|Progressive Disease|28|||
128847078|NCT02799745|463733530|FG001|Overall Study|Progressive Disease|38|||
128847079|NCT02799745|463733529|FG000|Overall Study|Lost to Follow-up|3|||
128847080|NCT02799745|463733530|FG001|Overall Study|Lost to Follow-up|2|||
128847081|NCT02799745|463733529|FG000|Overall Study|Death|3|||
128847082|NCT02799745|463733530|FG001|Overall Study|Death|0|||
128847083|NCT02799745|463733529|FG000|Overall Study|Adverse Event|0|||
128847084|NCT02799745|463733530|FG001|Overall Study|Adverse Event|1|||
128847085|NCT04853238|463733531|FG000|Overall Study|Death|4|||
128847086|NCT04853238|463733532|FG001|Overall Study|Death|0|||
128847087|NCT04853238|463733533|FG002|Overall Study|Death|2|||
128847088|NCT04853238|463733531|FG000|Overall Study|Lost to Follow-up|16|||
128847089|NCT04853238|463733532|FG001|Overall Study|Lost to Follow-up|2|||
128847090|NCT04853238|463733533|FG002|Overall Study|Lost to Follow-up|37|||
128847091|NCT04853238|463733531|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
128847092|NCT04853238|463733532|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
128847093|NCT04853238|463733533|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
128847094|NCT04853238|463733531|FG000|Overall Study|Withdrawal by Subject|6|||
128847095|NCT04853238|463733532|FG001|Overall Study|Withdrawal by Subject|0|||
128847096|NCT04853238|463733533|FG002|Overall Study|Withdrawal by Subject|21|||
128847097|NCT04853238|463733531|FG000|Overall Study|Physician Decision|0|||
128847098|NCT04853238|463733532|FG001|Overall Study|Physician Decision|0|||
128847099|NCT04853238|463733533|FG002|Overall Study|Physician Decision|2|||
128847100|NCT04853238|463733531|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
128847101|NCT04853238|463733532|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
128847102|NCT04853238|463733533|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
128847103|NCT01002547|463735359|FG000|Overall Study|Withdrawal by Subject|4|||
128847104|NCT01002547|463735360|FG001|Overall Study|Withdrawal by Subject|0|||
128847105|NCT01002547|463735361|FG002|Overall Study|Withdrawal by Subject|5|||
128847106|NCT01002547|463735359|FG000|Overall Study|Lost to Follow-up|2|||
128847107|NCT01002547|463735360|FG001|Overall Study|Lost to Follow-up|1|||
128847108|NCT01002547|463735361|FG002|Overall Study|Lost to Follow-up|1|||
128847109|NCT01002547|463735359|FG000|Overall Study|Physician Decision|1|||
128847110|NCT01002547|463735360|FG001|Overall Study|Physician Decision|0|||
128847111|NCT01002547|463735361|FG002|Overall Study|Physician Decision|0|||
128847112|NCT01002547|463735359|FG000|Overall Study|Death|0|||
128847113|NCT01002547|463735360|FG001|Overall Study|Death|2|||
128847114|NCT01002547|463735361|FG002|Overall Study|Death|2|||
128847115|NCT01002547|463735359|FG000|Overall Study|Adverse Event|1|||
128847116|NCT01002547|463735360|FG001|Overall Study|Adverse Event|0|||
128847117|NCT01002547|463735361|FG002|Overall Study|Adverse Event|0|||
128847118|NCT02093897|463735368|FG000|Overall Study|Physician Decision|1|||
128847119|NCT02093897|463735368|FG000|Overall Study|Planned age group closure - no's reached|17|||
128847120|NCT02093897|463735368|FG000|Overall Study|Adverse event, non-fatal|1|||
128847121|NCT00088452|463735369|FG000|Overall Study|Did not receive intervention|1|||
128847122|NCT00088452|463735370|FG001|Overall Study|Did not receive intervention|0|||
128847123|NCT00088452|463735371|FG002|Overall Study|Did not receive intervention|1|||
128847124|NCT02081196|463735373|FG000|Overall Study|Lost to Follow-up|1|||
128847125|NCT03098797|463735376|FG000|Part 2 Open Label Extension|Adverse Event|2|||
128847126|NCT03098797|463735377|FG001|Part 2 Open Label Extension|Adverse Event|0|||
128847127|NCT00434577|463735378|FG000|Months 0-3|Serious Adverse Event|0|||
128847128|NCT00434577|463735379|FG001|Months 0-3|Serious Adverse Event|0|||
128847129|NCT00434577|463735380|FG002|Months 0-3|Serious Adverse Event|1|||
128847130|NCT00434577|463735381|FG003|Months 0-3|Serious Adverse Event|0|||
128847131|NCT00434577|463735382|FG004|Months 0-3|Serious Adverse Event|0|||
128847132|NCT00434577|463735378|FG000|Months 0-3|Adverse Event|0|||
128847133|NCT00434577|463735379|FG001|Months 0-3|Adverse Event|1|||
128847134|NCT00434577|463735380|FG002|Months 0-3|Adverse Event|1|||
128847135|NCT00434577|463735381|FG003|Months 0-3|Adverse Event|0|||
128847136|NCT00434577|463735382|FG004|Months 0-3|Adverse Event|0|||
128847137|NCT00434577|463735378|FG000|Months 0-3|Lost to Follow-up|0|||
128847138|NCT00434577|463735379|FG001|Months 0-3|Lost to Follow-up|0|||
128847139|NCT00434577|463735380|FG002|Months 0-3|Lost to Follow-up|0|||
128847140|NCT00434577|463735381|FG003|Months 0-3|Lost to Follow-up|0|||
128847141|NCT00434577|463735382|FG004|Months 0-3|Lost to Follow-up|2|||
128847142|NCT00434577|463735378|FG000|Months 0-3|Protocol Violation|1|||
128847143|NCT00434577|463735379|FG001|Months 0-3|Protocol Violation|0|||
128847144|NCT00434577|463735380|FG002|Months 0-3|Protocol Violation|1|||
128847145|NCT00434577|463735381|FG003|Months 0-3|Protocol Violation|0|||
128847146|NCT00434577|463735382|FG004|Months 0-3|Protocol Violation|0|||
128847147|NCT00434577|463735378|FG000|Months 0-3|Withdrawal by Subject|2|||
128847148|NCT00434577|463735379|FG001|Months 0-3|Withdrawal by Subject|1|||
128847149|NCT00434577|463735380|FG002|Months 0-3|Withdrawal by Subject|1|||
128847150|NCT00434577|463735381|FG003|Months 0-3|Withdrawal by Subject|1|||
128847151|NCT00434577|463735382|FG004|Months 0-3|Withdrawal by Subject|1|||
128847152|NCT01589523|463735395|FG000|Overall Study|Withdrawal by Subject|1|||
128847153|NCT00961896|463735396|FG000|Overall Study|Abnormal laboratory value|0|||
128847154|NCT00961896|463735397|FG001|Overall Study|Abnormal laboratory value|0|||
128847155|NCT00961896|463735398|FG002|Overall Study|Abnormal laboratory value|1|||
128847156|NCT00506922|463735399|FG000|Overall Study|Physician Decision|0|||
128847157|NCT00506922|463735400|FG001|Overall Study|Physician Decision|0|||
128847158|NCT00506922|463735401|FG002|Overall Study|Physician Decision|0|||
128847159|NCT00506922|463735402|FG003|Overall Study|Physician Decision|2|||
128847160|NCT00506922|463735403|FG004|Overall Study|Physician Decision|0|||
128847161|NCT00506922|463735399|FG000|Overall Study|Withdrawal by Subject|0|||
128847162|NCT00506922|463735400|FG001|Overall Study|Withdrawal by Subject|0|||
128847163|NCT00506922|463735401|FG002|Overall Study|Withdrawal by Subject|0|||
128847164|NCT00506922|463735402|FG003|Overall Study|Withdrawal by Subject|0|||
128847165|NCT00506922|463735403|FG004|Overall Study|Withdrawal by Subject|1|||
128847166|NCT02675998|463735410|FG000|8-Week Treatment Period|Adverse Event|6|||
128847167|NCT02675998|463735411|FG001|8-Week Treatment Period|Adverse Event|5|||
128847168|NCT02675998|463735412|FG002|8-Week Treatment Period|Adverse Event|6|||
128847169|NCT02675998|463735413|FG003|8-Week Treatment Period|Adverse Event|0|||
128847170|NCT02675998|463735410|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
128847171|NCT02675998|463735411|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
128847172|NCT02675998|463735412|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
128847173|NCT02675998|463735413|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
128847174|NCT02675998|463735410|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
128847175|NCT02675998|463735411|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
128847176|NCT02675998|463735412|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
128847177|NCT02675998|463735413|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
128847178|NCT02675998|463735410|FG000|8-Week Treatment Period|Physician Decision|1|||
128847179|NCT02675998|463735411|FG001|8-Week Treatment Period|Physician Decision|0|||
128847180|NCT02675998|463735412|FG002|8-Week Treatment Period|Physician Decision|2|||
128847181|NCT02675998|463735413|FG003|8-Week Treatment Period|Physician Decision|0|||
128847182|NCT02675998|463735410|FG000|8-Week Treatment Period|GI side Effects|1|||
128847183|NCT02675998|463735411|FG001|8-Week Treatment Period|GI side Effects|4|||
128847184|NCT02675998|463735412|FG002|8-Week Treatment Period|GI side Effects|2|||
128847185|NCT02675998|463735413|FG003|8-Week Treatment Period|GI side Effects|0|||
128847186|NCT02675998|463735410|FG000|8-Week Treatment Period|Protocol Violation|1|||
128847187|NCT02675998|463735411|FG001|8-Week Treatment Period|Protocol Violation|1|||
128847188|NCT02675998|463735412|FG002|8-Week Treatment Period|Protocol Violation|1|||
128847189|NCT02675998|463735413|FG003|8-Week Treatment Period|Protocol Violation|0|||
128847190|NCT02675998|463735410|FG000|8-Week Treatment Period|Other|3|||
128847191|NCT02675998|463735411|FG001|8-Week Treatment Period|Other|1|||
128847192|NCT02675998|463735412|FG002|8-Week Treatment Period|Other|2|||
128847193|NCT02675998|463735413|FG003|8-Week Treatment Period|Other|0|||
128847194|NCT02675998|463735410|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
128847195|NCT02675998|463735411|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
128847196|NCT02675998|463735412|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
128847197|NCT02675998|463735413|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
128847198|NCT02675998|463735410|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
128847199|NCT02675998|463735411|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
128847200|NCT02675998|463735412|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
128847201|NCT02675998|463735413|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
128847202|NCT02675998|463735410|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
128847203|NCT02675998|463735411|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
128847204|NCT02675998|463735412|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
128847205|NCT02675998|463735413|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
128847206|NCT02675998|463735410|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
128847207|NCT02675998|463735411|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
128847208|NCT02675998|463735412|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
128847209|NCT02675998|463735413|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
128847210|NCT02675998|463735410|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
128847211|NCT02675998|463735411|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
128847212|NCT02675998|463735412|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
128847213|NCT02675998|463735413|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
128847214|NCT04357964|463735414|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
128847215|NCT04357964|463735415|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
128847216|NCT04357964|463735414|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
128847217|NCT04357964|463735415|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
128847218|NCT04357964|463735414|FG000|Overall Study|Adipose sample was insufficient quality|0|||
128847219|NCT04357964|463735415|FG001|Overall Study|Adipose sample was insufficient quality|1|||
128847220|NCT00848393|463735416|FG000|Overall Study|Protocol Violation|0|||
128847221|NCT00848393|463735417|FG001|Overall Study|Protocol Violation|0|||
128847222|NCT00848393|463735418|FG002|Overall Study|Protocol Violation|1|||
128847223|NCT00848393|463735416|FG000|Overall Study|surgical complications unrelated to stud|0|||
128847224|NCT00848393|463735417|FG001|Overall Study|surgical complications unrelated to stud|0|||
128847225|NCT00848393|463735418|FG002|Overall Study|surgical complications unrelated to stud|2|||
128847226|NCT00043186|463735421|FG000|Overall Study|Physician Decision|0|||
128847227|NCT00043186|463735422|FG001|Overall Study|Physician Decision|0|||
128847228|NCT00043186|463735423|FG002|Overall Study|Physician Decision|3|||
128847229|NCT00043186|463735424|FG003|Overall Study|Physician Decision|0|||
128847230|NCT00043186|463735425|FG004|Overall Study|Physician Decision|1|||
128847231|NCT00043186|463735426|FG005|Overall Study|Physician Decision|0|||
128847232|NCT00043186|463735427|FG006|Overall Study|Physician Decision|0|||
128847233|NCT00043186|463735428|FG007|Overall Study|Physician Decision|1|||
128847234|NCT00043186|463735429|FG008|Overall Study|Physician Decision|1|||
128847235|NCT00043186|463735421|FG000|Overall Study|Adverse Event|2|||
128847236|NCT00043186|463735422|FG001|Overall Study|Adverse Event|2|||
128847237|NCT00043186|463735423|FG002|Overall Study|Adverse Event|2|||
128847238|NCT00043186|463735424|FG003|Overall Study|Adverse Event|3|||
128847239|NCT00043186|463735425|FG004|Overall Study|Adverse Event|2|||
128847240|NCT00043186|463735426|FG005|Overall Study|Adverse Event|1|||
128847241|NCT00043186|463735427|FG006|Overall Study|Adverse Event|2|||
128847242|NCT00043186|463735428|FG007|Overall Study|Adverse Event|1|||
128847243|NCT00043186|463735429|FG008|Overall Study|Adverse Event|3|||
128847244|NCT00043186|463735421|FG000|Overall Study|Withdrawal by Subject|11|||
128847245|NCT00043186|463735422|FG001|Overall Study|Withdrawal by Subject|8|||
128847246|NCT00043186|463735423|FG002|Overall Study|Withdrawal by Subject|11|||
128847247|NCT00043186|463735424|FG003|Overall Study|Withdrawal by Subject|13|||
128847248|NCT00043186|463735425|FG004|Overall Study|Withdrawal by Subject|14|||
128847249|NCT00043186|463735426|FG005|Overall Study|Withdrawal by Subject|6|||
128847250|NCT00043186|463735427|FG006|Overall Study|Withdrawal by Subject|12|||
128847251|NCT00043186|463735428|FG007|Overall Study|Withdrawal by Subject|9|||
128847252|NCT00043186|463735429|FG008|Overall Study|Withdrawal by Subject|10|||
128847253|NCT00043186|463735421|FG000|Overall Study|Death|0|||
128847254|NCT00043186|463735422|FG001|Overall Study|Death|0|||
128847255|NCT00043186|463735423|FG002|Overall Study|Death|1|||
128847256|NCT00043186|463735424|FG003|Overall Study|Death|0|||
128847257|NCT00043186|463735425|FG004|Overall Study|Death|0|||
128847258|NCT00043186|463735426|FG005|Overall Study|Death|0|||
128847259|NCT00043186|463735427|FG006|Overall Study|Death|2|||
128847260|NCT00043186|463735428|FG007|Overall Study|Death|0|||
128847261|NCT00043186|463735429|FG008|Overall Study|Death|0|||
128847262|NCT00043186|463735421|FG000|Overall Study|Disease progression|1|||
128847263|NCT00043186|463735422|FG001|Overall Study|Disease progression|0|||
128847264|NCT00043186|463735423|FG002|Overall Study|Disease progression|0|||
128847265|NCT00043186|463735424|FG003|Overall Study|Disease progression|3|||
128847266|NCT00043186|463735425|FG004|Overall Study|Disease progression|0|||
128847267|NCT00043186|463735426|FG005|Overall Study|Disease progression|0|||
128847268|NCT00043186|463735427|FG006|Overall Study|Disease progression|0|||
128847269|NCT00043186|463735428|FG007|Overall Study|Disease progression|4|||
128847270|NCT00043186|463735429|FG008|Overall Study|Disease progression|0|||
128847271|NCT00043186|463735421|FG000|Overall Study|Ineligibility determined|0|||
128847272|NCT00043186|463735422|FG001|Overall Study|Ineligibility determined|0|||
128847273|NCT00043186|463735423|FG002|Overall Study|Ineligibility determined|0|||
128847274|NCT00043186|463735424|FG003|Overall Study|Ineligibility determined|0|||
128847275|NCT00043186|463735425|FG004|Overall Study|Ineligibility determined|0|||
128847276|NCT00043186|463735426|FG005|Overall Study|Ineligibility determined|0|||
128847277|NCT00043186|463735427|FG006|Overall Study|Ineligibility determined|0|||
128847278|NCT00043186|463735428|FG007|Overall Study|Ineligibility determined|0|||
128847279|NCT00043186|463735429|FG008|Overall Study|Ineligibility determined|1|||
128847280|NCT00043186|463735421|FG000|Overall Study|Lost to Follow-up|3|||
128847281|NCT00043186|463735422|FG001|Overall Study|Lost to Follow-up|5|||
128847282|NCT00043186|463735423|FG002|Overall Study|Lost to Follow-up|1|||
128847283|NCT00043186|463735424|FG003|Overall Study|Lost to Follow-up|1|||
128847284|NCT00043186|463735425|FG004|Overall Study|Lost to Follow-up|1|||
128847285|NCT00043186|463735426|FG005|Overall Study|Lost to Follow-up|1|||
128847286|NCT00043186|463735427|FG006|Overall Study|Lost to Follow-up|1|||
128847287|NCT00043186|463735428|FG007|Overall Study|Lost to Follow-up|1|||
128847288|NCT00043186|463735429|FG008|Overall Study|Lost to Follow-up|2|||
128847289|NCT00043186|463735421|FG000|Overall Study|Noncompliance|0|||
128847290|NCT00043186|463735422|FG001|Overall Study|Noncompliance|0|||
128847291|NCT00043186|463735423|FG002|Overall Study|Noncompliance|1|||
128847292|NCT00043186|463735424|FG003|Overall Study|Noncompliance|1|||
128847293|NCT00043186|463735425|FG004|Overall Study|Noncompliance|0|||
128847294|NCT00043186|463735426|FG005|Overall Study|Noncompliance|0|||
128847295|NCT00043186|463735427|FG006|Overall Study|Noncompliance|0|||
128847296|NCT00043186|463735428|FG007|Overall Study|Noncompliance|0|||
128847297|NCT00043186|463735429|FG008|Overall Study|Noncompliance|0|||
128847298|NCT00043186|463735421|FG000|Overall Study|Other|0|||
128847299|NCT00043186|463735422|FG001|Overall Study|Other|0|||
128847300|NCT00043186|463735423|FG002|Overall Study|Other|1|||
128847301|NCT00043186|463735424|FG003|Overall Study|Other|1|||
128847302|NCT00043186|463735425|FG004|Overall Study|Other|0|||
128847303|NCT00043186|463735426|FG005|Overall Study|Other|0|||
128847304|NCT00043186|463735427|FG006|Overall Study|Other|0|||
128847305|NCT00043186|463735428|FG007|Overall Study|Other|0|||
128847306|NCT00043186|463735429|FG008|Overall Study|Other|0|||
128847307|NCT00730847|463735431|FG000|Overall Study|Adverse Event|1|||
128847308|NCT00730847|463735431|FG000|Overall Study|Protocol Violation|2|||
128847309|NCT00730847|463735431|FG000|Overall Study|Withdrawal by Subject|16|||
128847310|NCT00730847|463735431|FG000|Overall Study|Lost to Follow-up|67|||
128847311|NCT00730847|463735431|FG000|Overall Study|Unknown completion status|21|||
128847312|NCT00730847|463735431|FG000|Overall Study|Other|24|||
128847313|NCT03022578|463735432|FG000|Overall Study|Adverse Event|1|||
128847314|NCT03022578|463735432|FG000|Overall Study|Lack of Efficacy|2|||
128847315|NCT03022578|463735432|FG000|Overall Study|Withdrawal by Subject|1|||
128847316|NCT03681353|463735433|FG000|Overall Study|Lost to Follow-up|2|||
128847317|NCT03681353|463735433|FG000|Overall Study|Withdrawal by Subject|3|||
128847318|NCT03681353|463735433|FG000|Overall Study|withdrawn by PI|2|||
128847319|NCT00726388|463735436|FG000|Overall Study|Withdrawal by Subject|5|||
128847320|NCT00726388|463735436|FG000|Overall Study|Adverse Event|3|||
128847321|NCT00726388|463735436|FG000|Overall Study|Lost to Follow-up|10|||
128847322|NCT00726388|463735436|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
128847323|NCT00726388|463735436|FG000|Overall Study|Other|5|||
128847324|NCT00726388|463735436|FG000|Overall Study|Enrolled, Not Treated|79|||
128847325|NCT00111839|463735437|FG000|Overall Study|Disease Progression|30|||
128847326|NCT00111839|463735438|FG001|Overall Study|Disease Progression|33|||
128847327|NCT00111839|463735439|FG002|Overall Study|Disease Progression|33|||
128847328|NCT00111839|463735437|FG000|Overall Study|Adverse Event|5|||
128847329|NCT00111839|463735438|FG001|Overall Study|Adverse Event|3|||
128847330|NCT00111839|463735439|FG002|Overall Study|Adverse Event|1|||
128847331|NCT00111839|463735437|FG000|Overall Study|Protocol Violation|2|||
128847332|NCT00111839|463735438|FG001|Overall Study|Protocol Violation|4|||
128847333|NCT00111839|463735439|FG002|Overall Study|Protocol Violation|2|||
128847334|NCT00111839|463735437|FG000|Overall Study|Death|1|||
128847335|NCT00111839|463735438|FG001|Overall Study|Death|1|||
128847336|NCT00111839|463735439|FG002|Overall Study|Death|6|||
128847337|NCT00111839|463735437|FG000|Overall Study|Withdrawal by Subject|2|||
128847338|NCT00111839|463735438|FG001|Overall Study|Withdrawal by Subject|2|||
128847339|NCT00111839|463735439|FG002|Overall Study|Withdrawal by Subject|2|||
128847340|NCT00111839|463735437|FG000|Overall Study|Lost to Follow-up|1|||
128847341|NCT00111839|463735438|FG001|Overall Study|Lost to Follow-up|0|||
128847342|NCT00111839|463735439|FG002|Overall Study|Lost to Follow-up|0|||
128847343|NCT00111839|463735437|FG000|Overall Study|Logistical Constraint|1|||
128847344|NCT00111839|463735438|FG001|Overall Study|Logistical Constraint|0|||
128847345|NCT00111839|463735439|FG002|Overall Study|Logistical Constraint|0|||
128847346|NCT00111839|463735437|FG000|Overall Study|Other|6|||
128847347|NCT00111839|463735438|FG001|Overall Study|Other|3|||
128847348|NCT00111839|463735439|FG002|Overall Study|Other|3|||
128847349|NCT00111839|463735437|FG000|Overall Study|Randomized but Not Treated|0|||
128847350|NCT00111839|463735438|FG001|Overall Study|Randomized but Not Treated|0|||
128847351|NCT00111839|463735439|FG002|Overall Study|Randomized but Not Treated|2|||
128847352|NCT01011049|463735440|FG000|Overall Study|Protocol Violation|0|||
128847353|NCT01011049|463735441|FG001|Overall Study|Protocol Violation|0|||
128847354|NCT01011049|463735442|FG002|Overall Study|Protocol Violation|2|||
128847355|NCT01011049|463735443|FG003|Overall Study|Protocol Violation|0|||
128847356|NCT01011049|463735440|FG000|Overall Study|Lost to Follow-up|1|||
128847357|NCT01011049|463735441|FG001|Overall Study|Lost to Follow-up|2|||
128847358|NCT01011049|463735442|FG002|Overall Study|Lost to Follow-up|1|||
128847359|NCT01011049|463735443|FG003|Overall Study|Lost to Follow-up|0|||
128847360|NCT01011049|463735440|FG000|Overall Study|Withdrawal by Subject|0|||
128847361|NCT01011049|463735441|FG001|Overall Study|Withdrawal by Subject|0|||
128847362|NCT01011049|463735442|FG002|Overall Study|Withdrawal by Subject|1|||
128847363|NCT01011049|463735443|FG003|Overall Study|Withdrawal by Subject|0|||
128847364|NCT00382408|463735444|FG000|Overall Study|Did not meet protocol requirement|3|||
128847365|NCT00382408|463735445|FG001|Overall Study|Did not meet protocol requirement|3|||
128847366|NCT00382408|463735444|FG000|Overall Study|Protocol Violation|2|||
128847367|NCT00382408|463735445|FG001|Overall Study|Protocol Violation|2|||
128847368|NCT00382408|463735444|FG000|Overall Study|Physician Decision|1|||
128847369|NCT00382408|463735445|FG001|Overall Study|Physician Decision|0|||
128847370|NCT00382408|463735444|FG000|Overall Study|Withdrawal by Subject|17|||
128847371|NCT00382408|463735445|FG001|Overall Study|Withdrawal by Subject|6|||
128847372|NCT00382408|463735444|FG000|Overall Study|Pregnancy|2|||
128847373|NCT00382408|463735445|FG001|Overall Study|Pregnancy|0|||
128847374|NCT00382408|463735444|FG000|Overall Study|Lost to Follow-up|19|||
128847375|NCT00382408|463735445|FG001|Overall Study|Lost to Follow-up|8|||
128847376|NCT00382408|463735444|FG000|Overall Study|Other|100|||
128847377|NCT00382408|463735445|FG001|Overall Study|Other|35|||
128847378|NCT00352053|463735451|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
128847379|NCT00352053|463735452|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
128847380|NCT00352053|463735451|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
128847381|NCT00352053|463735452|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
128847382|NCT00352053|463735451|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
128847383|NCT00352053|463735452|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
128847384|NCT00352053|463735451|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
128847385|NCT00352053|463735452|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
128847386|NCT00352053|463735451|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
128847387|NCT00352053|463735452|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
128847388|NCT00352053|463735451|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
128847389|NCT00352053|463735452|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
128847390|NCT00352053|463735451|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
128847391|NCT00352053|463735452|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
128847392|NCT00352053|463735451|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
128847393|NCT00352053|463735452|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
128847394|NCT00352053|463735451|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
128847395|NCT00352053|463735452|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
128847396|NCT00352053|463735451|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
128847397|NCT00352053|463735452|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
128847398|NCT00352053|463735451|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
128847399|NCT00352053|463735452|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
128847400|NCT00352053|463735451|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
128847401|NCT00352053|463735452|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
128847402|NCT00352053|463735451|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
128847403|NCT00352053|463735452|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
128847404|NCT02282917|463735454|FG000|Overall Study|Withdrawal by Subject|1|||
128847405|NCT02282917|463735454|FG000|Overall Study|Screen Failure/Not Eligible|1|||
128847406|NCT01747629|463735455|FG000|Overall Study|Adverse Event|1|||
128847407|NCT01747629|463735456|FG001|Overall Study|Adverse Event|2|||
128847408|NCT01747629|463735455|FG000|Overall Study|Withdrawal by Subject|2|||
128847409|NCT01747629|463735456|FG001|Overall Study|Withdrawal by Subject|2|||
128847410|NCT01747629|463735455|FG000|Overall Study|Noncompliance|1|||
128847411|NCT01747629|463735456|FG001|Overall Study|Noncompliance|1|||
128847412|NCT01747629|463735455|FG000|Overall Study|Inclusion criteria not met|1|||
128847413|NCT01747629|463735456|FG001|Overall Study|Inclusion criteria not met|0|||
128847414|NCT01747629|463735455|FG000|Overall Study|Not treated|1|||
128847415|NCT01747629|463735456|FG001|Overall Study|Not treated|0|||
128847416|NCT01747629|463735455|FG000|Overall Study|Other|2|||
128847417|NCT01747629|463735456|FG001|Overall Study|Other|1|||
128847418|NCT04414397|463735457|FG000|Control Period|Withdrawal by Subject|2|||
128847419|NCT04414397|463735458|FG001|Control Period|Withdrawal by Subject|2|||
128847420|NCT04414397|463735457|FG000|Control Period|Lost to Follow-up|0|||
128847421|NCT04414397|463735458|FG001|Control Period|Lost to Follow-up|4|||
128847422|NCT04414397|463735457|FG000|Control Period|Protocol deviation|0|||
128847423|NCT04414397|463735458|FG001|Control Period|Protocol deviation|1|||
128847424|NCT04414397|463735457|FG000|Post-Control Period|Withdrawal by Subject|3|||
128847425|NCT04414397|463735458|FG001|Post-Control Period|Withdrawal by Subject|6|||
128847426|NCT04414397|463735457|FG000|Post-Control Period|Lost to Follow-up|4|||
128847427|NCT04414397|463735458|FG001|Post-Control Period|Lost to Follow-up|9|||
128847428|NCT04414397|463735457|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
128847429|NCT04414397|463735458|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
128847430|NCT04414397|463735457|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
128847431|NCT04414397|463735458|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
128847432|NCT02391545|463735460|FG000|Overall Study|Death|0|||
128847433|NCT02391545|463735461|FG001|Overall Study|Death|2|||
128847434|NCT02391545|463735460|FG000|Overall Study|Lost to Follow-up|0|||
128847435|NCT02391545|463735461|FG001|Overall Study|Lost to Follow-up|1|||
128847436|NCT02391545|463735460|FG000|Overall Study|Termination of study by sponsor|20|||
128847437|NCT02391545|463735461|FG001|Overall Study|Termination of study by sponsor|20|||
128847438|NCT02391545|463735460|FG000|Overall Study|Withdrawal by Subject|0|||
128847439|NCT02391545|463735461|FG001|Overall Study|Withdrawal by Subject|1|||
128847440|NCT02391545|463735460|FG000|Overall Study|Other Reasons|6|||
128847441|NCT02391545|463735461|FG001|Overall Study|Other Reasons|4|||
128847442|NCT04754594|463735462|FG000|Blinded Period|Withdrawal by Subject|4|||
128847443|NCT04754594|463735463|FG001|Blinded Period|Withdrawal by Subject|9|||
128847444|NCT04754594|463735464|FG002|Blinded Period|Withdrawal by Subject|0|||
128847445|NCT04754594|463735465|FG003|Blinded Period|Withdrawal by Subject|0|||
128847446|NCT04754594|463735462|FG000|Blinded Period|Protocol Violation|2|||
128847447|NCT04754594|463735463|FG001|Blinded Period|Protocol Violation|2|||
128847448|NCT04754594|463735464|FG002|Blinded Period|Protocol Violation|0|||
128847449|NCT04754594|463735465|FG003|Blinded Period|Protocol Violation|0|||
128847450|NCT04754594|463735462|FG000|Blinded Period|Lost to Follow-up|1|||
128847451|NCT04754594|463735463|FG001|Blinded Period|Lost to Follow-up|1|||
128847452|NCT04754594|463735464|FG002|Blinded Period|Lost to Follow-up|0|||
128847453|NCT04754594|463735465|FG003|Blinded Period|Lost to Follow-up|0|||
128847454|NCT04754594|463735462|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
128847455|NCT04754594|463735463|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
128847456|NCT04754594|463735464|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
128847457|NCT04754594|463735465|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
128847458|NCT04754594|463735462|FG000|Unblinded Period|Withdrawal by Subject|6|||
128847459|NCT04754594|463735463|FG001|Unblinded Period|Withdrawal by Subject|8|||
128847460|NCT04754594|463735464|FG002|Unblinded Period|Withdrawal by Subject|0|||
128847461|NCT04754594|463735465|FG003|Unblinded Period|Withdrawal by Subject|0|||
128847462|NCT04754594|463735462|FG000|Unblinded Period|Lost to Follow-up|5|||
128847463|NCT04754594|463735463|FG001|Unblinded Period|Lost to Follow-up|3|||
128847464|NCT04754594|463735464|FG002|Unblinded Period|Lost to Follow-up|0|||
128847465|NCT04754594|463735465|FG003|Unblinded Period|Lost to Follow-up|0|||
128847466|NCT04754594|463735462|FG000|Unblinded Period|Protocol Violation|2|||
128847467|NCT04754594|463735463|FG001|Unblinded Period|Protocol Violation|4|||
128847468|NCT04754594|463735464|FG002|Unblinded Period|Protocol Violation|0|||
128847469|NCT04754594|463735465|FG003|Unblinded Period|Protocol Violation|0|||
128847470|NCT04754594|463735462|FG000|Unblinded Period|Other|3|||
128847471|NCT04754594|463735463|FG001|Unblinded Period|Other|0|||
128847472|NCT04754594|463735464|FG002|Unblinded Period|Other|0|||
128847473|NCT04754594|463735465|FG003|Unblinded Period|Other|0|||
128847474|NCT04754594|463735462|FG000|Infant Participants|Withdrawal by Subject|0|||
128847475|NCT04754594|463735463|FG001|Infant Participants|Withdrawal by Subject|0|||
128847476|NCT04754594|463735464|FG002|Infant Participants|Withdrawal by Subject|9|||
128847477|NCT04754594|463735465|FG003|Infant Participants|Withdrawal by Subject|17|||
128847478|NCT04754594|463735462|FG000|Infant Participants|Lost to Follow-up|0|||
128847479|NCT04754594|463735463|FG001|Infant Participants|Lost to Follow-up|0|||
128847480|NCT04754594|463735464|FG002|Infant Participants|Lost to Follow-up|4|||
128847481|NCT04754594|463735465|FG003|Infant Participants|Lost to Follow-up|10|||
128847482|NCT04754594|463735462|FG000|Infant Participants|Death|0|||
128847483|NCT04754594|463735463|FG001|Infant Participants|Death|0|||
128847484|NCT04754594|463735464|FG002|Infant Participants|Death|1|||
128847485|NCT04754594|463735465|FG003|Infant Participants|Death|1|||
128847486|NCT04754594|463735462|FG000|Infant Participants|Other|0|||
128847487|NCT04754594|463735463|FG001|Infant Participants|Other|0|||
128847488|NCT04754594|463735464|FG002|Infant Participants|Other|1|||
128847489|NCT04754594|463735465|FG003|Infant Participants|Other|1|||
128847490|NCT00655668|463735475|FG000|Overall Study|Adverse Event|6|||
128847491|NCT00655668|463735475|FG000|Overall Study|Death|5|||
128847492|NCT00655668|463735475|FG000|Overall Study|Disease Progression|27|||
128847493|NCT00655668|463735475|FG000|Overall Study|Study Terminated|9|||
128847494|NCT00655668|463735475|FG000|Overall Study|Other|1|||
128847495|NCT00655668|463735475|FG000|Overall Study|New Lymphoma Treatment Started|4|||
128847496|NCT00655668|463735475|FG000|Overall Study|Withdrawal by Subject|2|||
128847497|NCT03873038|463735476|FG000|Part 2|Withdrawal by Subject|0|||
128847498|NCT03873038|463735477|FG001|Part 2|Withdrawal by Subject|0|||
128847499|NCT03873038|463735478|FG002|Part 2|Withdrawal by Subject|0|||
128847500|NCT03873038|463735479|FG003|Part 2|Withdrawal by Subject|0|||
128847501|NCT03873038|463735480|FG004|Part 2|Withdrawal by Subject|0|||
128847502|NCT03873038|463735481|FG005|Part 2|Withdrawal by Subject|1|||
128847503|NCT03873038|463735476|FG000|Part 2|Unknon|0|||
128847504|NCT03873038|463735477|FG001|Part 2|Unknon|0|||
128847505|NCT03873038|463735478|FG002|Part 2|Unknon|0|||
128847506|NCT03873038|463735479|FG003|Part 2|Unknon|0|||
128847507|NCT03873038|463735480|FG004|Part 2|Unknon|1|||
128847508|NCT03873038|463735481|FG005|Part 2|Unknon|0|||
128847509|NCT01544153|463735482|FG000|Overall Study|Under 18|0|||
128847510|NCT01544153|463735483|FG001|Overall Study|Under 18|1|||
128847511|NCT01544153|463735484|FG002|Overall Study|Under 18|0|||
128847512|NCT01544153|463735485|FG003|Overall Study|Under 18|0|||
128847513|NCT01544153|463735482|FG000|Overall Study|Non-smoker|0|||
128847514|NCT01544153|463735483|FG001|Overall Study|Non-smoker|0|||
128847515|NCT01544153|463735484|FG002|Overall Study|Non-smoker|1|||
128847516|NCT01544153|463735485|FG003|Overall Study|Non-smoker|0|||
128847517|NCT00884793|463735486|FG000|Overall Study|Withdrawal by Subject|1|||
128847518|NCT04783519|463735487|FG000|Overall Study|Withdrawal by Subject|2|||
128847519|NCT04783519|463735488|FG001|Overall Study|Withdrawal by Subject|7|||
128847520|NCT04783519|463735489|FG002|Overall Study|Withdrawal by Subject|3|||
128847521|NCT04783519|463735487|FG000|Overall Study|Lost to Follow-up|9|||
128847522|NCT04783519|463735488|FG001|Overall Study|Lost to Follow-up|7|||
128847523|NCT04783519|463735489|FG002|Overall Study|Lost to Follow-up|6|||
128847524|NCT00645099|463735493|FG000|Overall Study|Lack of Efficacy|15|||
128847525|NCT00645099|463735494|FG001|Overall Study|Lack of Efficacy|6|||
128847526|NCT00645099|463735493|FG000|Overall Study|Withdrawal by Subject|30|||
128847527|NCT00645099|463735494|FG001|Overall Study|Withdrawal by Subject|22|||
128847528|NCT00645099|463735493|FG000|Overall Study|Lost to Follow-up|6|||
128847529|NCT00645099|463735494|FG001|Overall Study|Lost to Follow-up|4|||
128847530|NCT00645099|463735493|FG000|Overall Study|Adverse Event|11|||
128847531|NCT00645099|463735494|FG001|Overall Study|Adverse Event|5|||
128847532|NCT00645099|463735493|FG000|Overall Study|Other|9|||
128847533|NCT00645099|463735494|FG001|Overall Study|Other|5|||
128847534|NCT00497198|463735495|FG000|Overall Study|Adverse Event|4|||
128847535|NCT00497198|463735496|FG001|Overall Study|Adverse Event|2|||
128847536|NCT00497198|463735495|FG000|Overall Study|Physician Decision|1|||
128847537|NCT00497198|463735496|FG001|Overall Study|Physician Decision|2|||
128847538|NCT00497198|463735495|FG000|Overall Study|Withdrawal by Subject|0|||
128847539|NCT00497198|463735496|FG001|Overall Study|Withdrawal by Subject|1|||
128847540|NCT04267393|463735499|FG000|Randomization|Adverse Event|1|||
128847541|NCT04267393|463735500|FG001|Randomization|Adverse Event|0|||
128847542|NCT04267393|463735501|FG002|Randomization|Adverse Event|0|||
128847543|NCT04267393|463735499|FG000|Randomization|Administrative Reasons by Sponsor|0|||
128847544|NCT04267393|463735500|FG001|Randomization|Administrative Reasons by Sponsor|1|||
128847545|NCT04267393|463735501|FG002|Randomization|Administrative Reasons by Sponsor|0|||
128847546|NCT04267393|463735499|FG000|Treatment Period|Adverse Event|0|||
128847547|NCT04267393|463735500|FG001|Treatment Period|Adverse Event|2|||
128847548|NCT04267393|463735501|FG002|Treatment Period|Adverse Event|3|||
128847549|NCT04267393|463735499|FG000|Treatment Period|Participant Withdrew Consent|0|||
128847550|NCT04267393|463735500|FG001|Treatment Period|Participant Withdrew Consent|0|||
128847551|NCT04267393|463735501|FG002|Treatment Period|Participant Withdrew Consent|1|||
128847552|NCT04267393|463735499|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
128847553|NCT04267393|463735500|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
128847554|NCT04267393|463735501|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
128847555|NCT02916706|463737622|FG000|Overall Study|Adverse Event|0|||
128847556|NCT02916706|463737623|FG001|Overall Study|Adverse Event|1|||
128847557|NCT02916706|463737622|FG000|Overall Study|Lost to Follow-up|0|||
128847558|NCT02916706|463737623|FG001|Overall Study|Lost to Follow-up|1|||
128847559|NCT02916706|463737622|FG000|Overall Study|Physician Decision|1|||
128847560|NCT02916706|463737623|FG001|Overall Study|Physician Decision|0|||
128847561|NCT02916706|463737622|FG000|Overall Study|Protocol Violation|3|||
128847562|NCT02916706|463737623|FG001|Overall Study|Protocol Violation|1|||
128847563|NCT02916706|463737622|FG000|Overall Study|Withdrawal by Subject|6|||
128847564|NCT02916706|463737623|FG001|Overall Study|Withdrawal by Subject|9|||
128847565|NCT02916706|463737622|FG000|Overall Study|Other|5|||
128847566|NCT02916706|463737623|FG001|Overall Study|Other|19|||
128847567|NCT00275301|463737624|FG000|Overall Study|Adverse Event|5|||
128847568|NCT02561078|463737633|FG000|Overall Study|Adverse Event|5|||
128847569|NCT02561078|463737634|FG001|Overall Study|Adverse Event|2|||
128847570|NCT02561078|463737633|FG000|Overall Study|Death|2|||
128847571|NCT02561078|463737634|FG001|Overall Study|Death|1|||
128847572|NCT02561078|463737633|FG000|Overall Study|Lost to Follow-up|2|||
128847573|NCT02561078|463737634|FG001|Overall Study|Lost to Follow-up|6|||
128847574|NCT02561078|463737633|FG000|Overall Study|Non-Compliance with Study Drug|6|||
128847575|NCT02561078|463737634|FG001|Overall Study|Non-Compliance with Study Drug|3|||
128847576|NCT02561078|463737633|FG000|Overall Study|Physician Decision|2|||
128847577|NCT02561078|463737634|FG001|Overall Study|Physician Decision|3|||
128847578|NCT02561078|463737633|FG000|Overall Study|Withdrawal by Subject|13|||
128847579|NCT02561078|463737634|FG001|Overall Study|Withdrawal by Subject|10|||
128847580|NCT00598871|463737637|FG000|Overall Study|Adverse Event|0|||
128847581|NCT00598871|463737638|FG001|Overall Study|Adverse Event|1|||
128847582|NCT01194271|463737639|FG000|Overall Study|Withdrawal by Subject|1|||
128847583|NCT01194271|463737639|FG000|Overall Study|Ineligible, Screen Failure|1|||
128847584|NCT01194271|463737639|FG000|Overall Study|Death|1|||
128847585|NCT01983462|463737640|FG000|Overall Study|Adverse Event|1|||
128847586|NCT01983462|463737641|FG001|Overall Study|Adverse Event|0|||
128847587|NCT01983462|463737642|FG002|Overall Study|Adverse Event|0|||
128847588|NCT00381797|463737643|FG000|Overall Study|Withdrawal by Subject|1|||
128847589|NCT00381797|463737644|FG001|Overall Study|Withdrawal by Subject|1|||
128847590|NCT00381797|463737645|FG002|Overall Study|Withdrawal by Subject|0|||
128847591|NCT00381797|463737646|FG003|Overall Study|Withdrawal by Subject|0|||
128847592|NCT00381797|463737647|FG004|Overall Study|Withdrawal by Subject|2|||
128847593|NCT00381797|463737643|FG000|Overall Study|Ineligible|0|||
128847594|NCT00381797|463737644|FG001|Overall Study|Ineligible|0|||
128847595|NCT00381797|463737645|FG002|Overall Study|Ineligible|0|||
128847596|NCT00381797|463737646|FG003|Overall Study|Ineligible|1|||
128847597|NCT00381797|463737647|FG004|Overall Study|Ineligible|0|||
128847598|NCT00443898|463737648|FG000|Overall Study|Adverse Event|0|||
128847599|NCT00443898|463737649|FG001|Overall Study|Adverse Event|0|||
128847600|NCT00443898|463737650|FG002|Overall Study|Adverse Event|1|||
128847601|NCT00443898|463737651|FG003|Overall Study|Adverse Event|1|||
128847602|NCT00443898|463737648|FG000|Overall Study|Lack of Efficacy|2|||
128847603|NCT00443898|463737649|FG001|Overall Study|Lack of Efficacy|3|||
128847604|NCT00443898|463737650|FG002|Overall Study|Lack of Efficacy|3|||
128847605|NCT00443898|463737651|FG003|Overall Study|Lack of Efficacy|1|||
128847606|NCT00443898|463737648|FG000|Overall Study|Protocol Violation|1|||
128847607|NCT00443898|463737649|FG001|Overall Study|Protocol Violation|1|||
128847608|NCT00443898|463737650|FG002|Overall Study|Protocol Violation|1|||
128847609|NCT00443898|463737651|FG003|Overall Study|Protocol Violation|0|||
128847610|NCT00443898|463737648|FG000|Overall Study|Withdrawal by Subject|11|||
128847611|NCT00443898|463737649|FG001|Overall Study|Withdrawal by Subject|10|||
128847612|NCT00443898|463737650|FG002|Overall Study|Withdrawal by Subject|10|||
128847613|NCT00443898|463737651|FG003|Overall Study|Withdrawal by Subject|6|||
128847614|NCT00443898|463737648|FG000|Overall Study|Lost to Follow-up|10|||
128847615|NCT00443898|463737649|FG001|Overall Study|Lost to Follow-up|10|||
128847616|NCT00443898|463737650|FG002|Overall Study|Lost to Follow-up|14|||
128847617|NCT00443898|463737651|FG003|Overall Study|Lost to Follow-up|10|||
128847618|NCT00443898|463737648|FG000|Overall Study|Death|0|||
128847619|NCT00443898|463737649|FG001|Overall Study|Death|1|||
128847620|NCT00443898|463737650|FG002|Overall Study|Death|0|||
128847621|NCT00443898|463737651|FG003|Overall Study|Death|0|||
128847622|NCT00958711|463737652|FG000|Overall Study|Withdrawal by Subject|0|||
128847623|NCT00958711|463737653|FG001|Overall Study|Withdrawal by Subject|4|||
128847624|NCT00958711|463737652|FG000|Overall Study|Physician Decision|5|||
128847625|NCT00958711|463737653|FG001|Overall Study|Physician Decision|7|||
128847626|NCT00958711|463737652|FG000|Overall Study|Lost to Follow-up|4|||
128847627|NCT00958711|463737653|FG001|Overall Study|Lost to Follow-up|1|||
128847628|NCT00958711|463737652|FG000|Overall Study|Other|2|||
128847629|NCT00958711|463737653|FG001|Overall Study|Other|5|||
128847630|NCT00958711|463737652|FG000|Overall Study|Death|1|||
128847631|NCT00958711|463737653|FG001|Overall Study|Death|2|||
128847632|NCT00958711|463737652|FG000|Overall Study|Adverse Event|1|||
128847633|NCT00958711|463737653|FG001|Overall Study|Adverse Event|2|||
128847634|NCT00550771|463737656|FG000|Overall Study|Adverse Event|11|||
128847635|NCT00550771|463737657|FG001|Overall Study|Adverse Event|3|||
128847636|NCT00550771|463737656|FG000|Overall Study|Discontinued for study-related reasons|0|||
128847637|NCT00550771|463737657|FG001|Overall Study|Discontinued for study-related reasons|1|||
128847638|NCT00550771|463737656|FG000|Overall Study|Physician Decision|2|||
128847639|NCT00550771|463737657|FG001|Overall Study|Physician Decision|0|||
128847640|NCT00550771|463737656|FG000|Overall Study|Withdrawal by Subject|0|||
128847641|NCT00550771|463737657|FG001|Overall Study|Withdrawal by Subject|1|||
128847642|NCT00550771|463737656|FG000|Overall Study|Protocol Violation|4|||
128847643|NCT00550771|463737657|FG001|Overall Study|Protocol Violation|5|||
128847644|NCT00520403|463737659|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
128847645|NCT00520403|463737659|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
128847646|NCT00520403|463737659|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
128847647|NCT00520403|463737659|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
128847648|NCT00520403|463737659|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
128847649|NCT00520403|463737659|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
128847650|NCT00520403|463737659|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
128847651|NCT00520403|463737659|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
128847652|NCT02435381|463737660|FG000|Overall Study|Lost to Follow-up|2|||
128847653|NCT02435381|463737661|FG001|Overall Study|Lost to Follow-up|1|||
128847654|NCT00405912|463737664|FG000|Overall Study|Withdrawal by Subject|12|||
128847655|NCT00405912|463737665|FG001|Overall Study|Withdrawal by Subject|11|||
128847656|NCT00405912|463737666|FG002|Overall Study|Withdrawal by Subject|12|||
128847657|NCT00405912|463737664|FG000|Overall Study|Lost to Follow-up|4|||
128847658|NCT00405912|463737665|FG001|Overall Study|Lost to Follow-up|8|||
128847659|NCT00405912|463737666|FG002|Overall Study|Lost to Follow-up|4|||
128847660|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
128847661|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
128847662|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
128847663|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
128847664|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
128847665|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
128847666|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
128847667|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
128847668|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Death|6|||
128847669|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Death|2|||
128847670|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Death|2|||
128847671|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Death|9|||
128847672|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
128847673|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
128847674|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
128847675|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
128847676|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
128847677|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
128847678|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
128847679|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
128847680|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
128847681|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
128847682|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
128847683|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
128847684|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
128847685|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
128847686|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
128847687|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
128847688|NCT03730662|463737667|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
128847689|NCT03730662|463737668|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
128847690|NCT03730662|463737669|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
128847691|NCT03730662|463737670|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
128847692|NCT03730662|463737667|FG000|Variable Treatment Period|Adverse Event|1|||
128847693|NCT03730662|463737668|FG001|Variable Treatment Period|Adverse Event|2|||
128847694|NCT03730662|463737669|FG002|Variable Treatment Period|Adverse Event|0|||
128847695|NCT03730662|463737670|FG003|Variable Treatment Period|Adverse Event|7|||
128847696|NCT03730662|463737667|FG000|Variable Treatment Period|Death|9|||
128847697|NCT03730662|463737668|FG001|Variable Treatment Period|Death|0|||
128847698|NCT03730662|463737669|FG002|Variable Treatment Period|Death|6|||
128847699|NCT03730662|463737670|FG003|Variable Treatment Period|Death|26|||
128847700|NCT03730662|463737667|FG000|Variable Treatment Period|Lost to Follow-up|2|||
128847701|NCT03730662|463737668|FG001|Variable Treatment Period|Lost to Follow-up|1|||
128847702|NCT03730662|463737669|FG002|Variable Treatment Period|Lost to Follow-up|4|||
128847703|NCT03730662|463737670|FG003|Variable Treatment Period|Lost to Follow-up|11|||
128847704|NCT03730662|463737667|FG000|Variable Treatment Period|Personal Reason|0|||
128847705|NCT03730662|463737668|FG001|Variable Treatment Period|Personal Reason|2|||
128847706|NCT03730662|463737669|FG002|Variable Treatment Period|Personal Reason|1|||
128847707|NCT03730662|463737670|FG003|Variable Treatment Period|Personal Reason|6|||
128847708|NCT03730662|463737667|FG000|Variable Treatment Period|Physician Decision|0|||
128847709|NCT03730662|463737668|FG001|Variable Treatment Period|Physician Decision|0|||
128847710|NCT03730662|463737669|FG002|Variable Treatment Period|Physician Decision|0|||
128847711|NCT03730662|463737670|FG003|Variable Treatment Period|Physician Decision|3|||
128847712|NCT03730662|463737667|FG000|Variable Treatment Period|Protocol Violation|0|||
128847713|NCT03730662|463737668|FG001|Variable Treatment Period|Protocol Violation|1|||
128847714|NCT03730662|463737669|FG002|Variable Treatment Period|Protocol Violation|1|||
128847715|NCT03730662|463737670|FG003|Variable Treatment Period|Protocol Violation|1|||
128847716|NCT03730662|463737667|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
128847717|NCT03730662|463737668|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
128847718|NCT03730662|463737669|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
128847719|NCT03730662|463737670|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
128847720|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
128847721|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
128847722|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
128847723|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
128847724|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Death|0|||
128847725|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Death|1|||
128847726|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
128847727|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
128847728|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
128847729|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
128847730|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
128847731|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
128847732|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
128847733|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
128847734|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
128847735|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
128847736|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
128847737|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
128847738|NCT01309243|463737671|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
128847739|NCT01309243|463737672|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
128847740|NCT01309243|463737671|FG000|Extension Phase|Lost to Follow-up|6|||
128847741|NCT01309243|463737672|FG001|Extension Phase|Lost to Follow-up|0|||
128847742|NCT00632931|463737675|FG000|Part 1, Period 1|Protocol Violation|1|||
128847743|NCT00632931|463737676|FG001|Part 1, Period 1|Protocol Violation|0|||
128847744|NCT00632931|463737677|FG002|Part 1, Period 1|Protocol Violation|0|||
128847745|NCT00632931|463737675|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
128847746|NCT00632931|463737676|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
128847747|NCT00632931|463737677|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
128847748|NCT00632931|463737675|FG000|Part 2|Adverse Event|0|||
128847749|NCT00632931|463737676|FG001|Part 2|Adverse Event|0|||
128847750|NCT00632931|463737677|FG002|Part 2|Adverse Event|3|||
128847751|NCT00632931|463737675|FG000|Part 2|Death|0|||
128847752|NCT00632931|463737676|FG001|Part 2|Death|0|||
128847753|NCT00632931|463737677|FG002|Part 2|Death|1|||
128847754|NCT00632931|463737675|FG000|Part 2|Lack of Efficacy|0|||
128847755|NCT00632931|463737676|FG001|Part 2|Lack of Efficacy|0|||
128847756|NCT00632931|463737677|FG002|Part 2|Lack of Efficacy|17|||
128847757|NCT00632931|463737675|FG000|Part 2|Withdrawal by Subject|0|||
128847758|NCT00632931|463737676|FG001|Part 2|Withdrawal by Subject|0|||
128847759|NCT00632931|463737677|FG002|Part 2|Withdrawal by Subject|3|||
128847760|NCT01441583|463737680|FG000|Overall Study|Withdrawal by Subject|1|||
128847761|NCT01441583|463737681|FG001|Overall Study|Withdrawal by Subject|1|||
128847762|NCT01441583|463737682|FG002|Overall Study|Withdrawal by Subject|1|||
128847763|NCT01441583|463737680|FG000|Overall Study|Death|1|||
128847764|NCT01441583|463737681|FG001|Overall Study|Death|0|||
128847765|NCT01441583|463737682|FG002|Overall Study|Death|4|||
128847766|NCT01441583|463737680|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
128847767|NCT01441583|463737681|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
128847768|NCT01441583|463737682|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
128847769|NCT03341312|463737683|FG000|Period 1|Withdrawal by Subject|0|||
128847770|NCT03341312|463737684|FG001|Period 1|Withdrawal by Subject|1|||
128847771|NCT03341312|463737685|FG002|Period 1|Withdrawal by Subject|0|||
128847772|NCT03341312|463737686|FG003|Period 1|Withdrawal by Subject|0|||
128847773|NCT00839306|463737687|FG000|Overall Study|Adverse Event|3|||
128847774|NCT00839306|463737688|FG001|Overall Study|Adverse Event|5|||
128847775|NCT00839306|463737687|FG000|Overall Study|Lost to Follow-up|6|||
128847776|NCT00839306|463737688|FG001|Overall Study|Lost to Follow-up|9|||
128847777|NCT00839306|463737687|FG000|Overall Study|Withdrawal by Subject|5|||
128847778|NCT00839306|463737688|FG001|Overall Study|Withdrawal by Subject|7|||
128847779|NCT00839306|463737687|FG000|Overall Study|Lack of Efficacy|5|||
128847780|NCT00839306|463737688|FG001|Overall Study|Lack of Efficacy|4|||
128847781|NCT00839306|463737687|FG000|Overall Study|Other|6|||
128847782|NCT00839306|463737688|FG001|Overall Study|Other|18|||
128847783|NCT01812707|463737689|FG000|Overall Study|Adverse Event|0|||
128847784|NCT01812707|463737690|FG001|Overall Study|Adverse Event|0|||
128847785|NCT01812707|463737691|FG002|Overall Study|Adverse Event|0|||
128847786|NCT01812707|463737692|FG003|Overall Study|Adverse Event|2|||
128847787|NCT01812707|463737689|FG000|Overall Study|Poor compliance to protocol|1|||
128847788|NCT01812707|463737690|FG001|Overall Study|Poor compliance to protocol|0|||
128847789|NCT01812707|463737691|FG002|Overall Study|Poor compliance to protocol|0|||
128847790|NCT01812707|463737692|FG003|Overall Study|Poor compliance to protocol|0|||
128847791|NCT01812707|463737689|FG000|Overall Study|Consent withdrawn by participant|1|||
128847792|NCT01812707|463737690|FG001|Overall Study|Consent withdrawn by participant|0|||
128847793|NCT01812707|463737691|FG002|Overall Study|Consent withdrawn by participant|0|||
128847794|NCT01812707|463737692|FG003|Overall Study|Consent withdrawn by participant|0|||
128847795|NCT05060237|463737693|FG000|Overall Study|Withdrawal by Subject|4|||
128847796|NCT05060237|463737693|FG000|Overall Study|Screening failure|8|||
128847797|NCT01697592|463737694|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
128847798|NCT01697592|463737695|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847799|NCT01697592|463737696|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847800|NCT01697592|463737697|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847801|NCT01697592|463737698|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847802|NCT01697592|463737699|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847803|NCT01697592|463737700|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847804|NCT01697592|463737701|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847805|NCT01697592|463737702|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847806|NCT01697592|463737703|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
128847807|NCT01697592|463737694|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847808|NCT01697592|463737695|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847809|NCT01697592|463737696|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847810|NCT01697592|463737697|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847811|NCT01697592|463737698|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847812|NCT01697592|463737699|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
128847813|NCT01697592|463737700|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847814|NCT01697592|463737701|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847815|NCT01697592|463737702|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847816|NCT01697592|463737703|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
128847817|NCT01697592|463737694|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
128847818|NCT01697592|463737695|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847819|NCT01697592|463737696|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847820|NCT01697592|463737697|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847821|NCT01697592|463737698|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847822|NCT01697592|463737699|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847823|NCT01697592|463737700|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847824|NCT01697592|463737701|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847825|NCT01697592|463737702|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847826|NCT01697592|463737703|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
128847827|NCT01697592|463737694|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
128847828|NCT01697592|463737695|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
128847829|NCT01697592|463737696|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
128847830|NCT01697592|463737697|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
128847831|NCT01697592|463737698|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
128847832|NCT01697592|463737699|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
128847833|NCT01697592|463737700|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
128847834|NCT01697592|463737701|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
128847835|NCT01697592|463737702|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
128847836|NCT01697592|463737703|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
128847837|NCT01697592|463737694|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
128847838|NCT01697592|463737695|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
128847839|NCT01697592|463737696|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
128847840|NCT01697592|463737697|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
128847841|NCT01697592|463737698|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
128847842|NCT01697592|463737699|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
128847843|NCT01697592|463737700|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
128847844|NCT01697592|463737701|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
128847845|NCT01697592|463737702|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
128847846|NCT01697592|463737703|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
128847847|NCT01697592|463737694|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
128847848|NCT01697592|463737695|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847849|NCT01697592|463737696|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847850|NCT01697592|463737697|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
128847851|NCT01697592|463737698|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847852|NCT01697592|463737699|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847853|NCT01697592|463737700|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847854|NCT01697592|463737701|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847855|NCT01697592|463737702|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847856|NCT01697592|463737703|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
128847857|NCT01697592|463737694|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
128847858|NCT01697592|463737695|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
128847859|NCT01697592|463737696|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
128847860|NCT01697592|463737697|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
128847861|NCT01697592|463737698|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
128847862|NCT01697592|463737699|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
128847863|NCT01697592|463737700|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
128847864|NCT01697592|463737701|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
128847865|NCT01697592|463737702|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
128847866|NCT01697592|463737703|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
128847867|NCT01697592|463737694|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
128847868|NCT01697592|463737695|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
128847869|NCT01697592|463737696|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
128847870|NCT01697592|463737697|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
128847871|NCT01697592|463737698|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
128847872|NCT01697592|463737699|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
128847873|NCT01697592|463737700|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
128847874|NCT01697592|463737701|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
128847875|NCT01697592|463737702|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
128847876|NCT01697592|463737703|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
128847877|NCT02396758|463737704|FG000|Overall Study|Withdrawal by Subject|2|||
128847878|NCT02396758|463737705|FG001|Overall Study|Withdrawal by Subject|0|||
128847879|NCT02396758|463737706|FG002|Overall Study|Withdrawal by Subject|0|||
128847880|NCT02396758|463737707|FG003|Overall Study|Withdrawal by Subject|1|||
128847881|NCT02396758|463737704|FG000|Overall Study|Lost to Follow-up|8|||
128847882|NCT02396758|463737705|FG001|Overall Study|Lost to Follow-up|5|||
128847883|NCT02396758|463737706|FG002|Overall Study|Lost to Follow-up|3|||
128847884|NCT02396758|463737707|FG003|Overall Study|Lost to Follow-up|3|||
128847885|NCT02396758|463737704|FG000|Overall Study|Death|1|||
128847886|NCT02396758|463737705|FG001|Overall Study|Death|1|||
128847887|NCT02396758|463737706|FG002|Overall Study|Death|0|||
128847888|NCT02396758|463737707|FG003|Overall Study|Death|1|||
128847889|NCT02396758|463737704|FG000|Overall Study|Randomized but not treated|1|||
128847890|NCT02396758|463737705|FG001|Overall Study|Randomized but not treated|0|||
128847891|NCT02396758|463737706|FG002|Overall Study|Randomized but not treated|1|||
128847892|NCT02396758|463737707|FG003|Overall Study|Randomized but not treated|0|||
128847893|NCT00265096|463737708|FG000|Overall Study|Adverse Event|14|||
128847894|NCT00265096|463737709|FG001|Overall Study|Adverse Event|18|||
128847895|NCT00265096|463737710|FG002|Overall Study|Adverse Event|18|||
128847896|NCT00265096|463737708|FG000|Overall Study|Lost to Follow-up|2|||
128847897|NCT00265096|463737709|FG001|Overall Study|Lost to Follow-up|5|||
128847898|NCT00265096|463737710|FG002|Overall Study|Lost to Follow-up|3|||
128847899|NCT00265096|463737708|FG000|Overall Study|Death|0|||
128847900|NCT00265096|463737709|FG001|Overall Study|Death|1|||
128847901|NCT00265096|463737710|FG002|Overall Study|Death|2|||
128847902|NCT00265096|463737708|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
128847903|NCT00265096|463737709|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
128847904|NCT00265096|463737710|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
128847905|NCT00265096|463737708|FG000|Overall Study|Other|11|||
128847906|NCT00265096|463737709|FG001|Overall Study|Other|19|||
128847907|NCT00265096|463737710|FG002|Overall Study|Other|10|||
128847908|NCT00774306|463737711|FG000|Overall Study|Adverse Event|3|||
128847909|NCT00774306|463737712|FG001|Overall Study|Adverse Event|0|||
128847910|NCT00774306|463737713|FG002|Overall Study|Adverse Event|0|||
128847911|NCT00774306|463737714|FG003|Overall Study|Adverse Event|0|||
128847912|NCT00774306|463737711|FG000|Overall Study|Protocol Violation|2|||
128847913|NCT00774306|463737712|FG001|Overall Study|Protocol Violation|0|||
128847914|NCT00774306|463737713|FG002|Overall Study|Protocol Violation|3|||
128847915|NCT00774306|463737714|FG003|Overall Study|Protocol Violation|0|||
128847916|NCT00774306|463737711|FG000|Overall Study|Withdrawal by Subject|6|||
128847917|NCT00774306|463737712|FG001|Overall Study|Withdrawal by Subject|1|||
128847918|NCT00774306|463737713|FG002|Overall Study|Withdrawal by Subject|1|||
128847919|NCT00774306|463737714|FG003|Overall Study|Withdrawal by Subject|0|||
128847920|NCT00774306|463737711|FG000|Overall Study|Lost to Follow-up|6|||
128847921|NCT00774306|463737712|FG001|Overall Study|Lost to Follow-up|0|||
128847922|NCT00774306|463737713|FG002|Overall Study|Lost to Follow-up|4|||
128847923|NCT00774306|463737714|FG003|Overall Study|Lost to Follow-up|5|||
128847924|NCT00774306|463737711|FG000|Overall Study|Death|1|||
128847925|NCT00774306|463737712|FG001|Overall Study|Death|1|||
128847926|NCT00774306|463737713|FG002|Overall Study|Death|0|||
128847927|NCT00774306|463737714|FG003|Overall Study|Death|0|||
128847928|NCT00666835|463737717|FG000|Overall Study|Withdrawal by Subject|5|||
128847929|NCT00666835|463737718|FG001|Overall Study|Withdrawal by Subject|2|||
128847930|NCT00666835|463737717|FG000|Overall Study|Lack of Efficacy|0|||
128847931|NCT00666835|463737718|FG001|Overall Study|Lack of Efficacy|1|||
128847932|NCT00666835|463737717|FG000|Overall Study|Incl./excl. not fulfilled|7|||
128847933|NCT00666835|463737718|FG001|Overall Study|Incl./excl. not fulfilled|2|||
128847934|NCT00666835|463737717|FG000|Overall Study|Adverse Event|7|||
128847935|NCT00666835|463737718|FG001|Overall Study|Adverse Event|6|||
128847936|NCT00666835|463737717|FG000|Overall Study|Protocol Violation|2|||
128847937|NCT00666835|463737718|FG001|Overall Study|Protocol Violation|0|||
128847938|NCT00666835|463737717|FG000|Overall Study|Death|15|||
128847939|NCT00666835|463737718|FG001|Overall Study|Death|4|||
128847940|NCT00666835|463737717|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
128847941|NCT00666835|463737718|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
128847942|NCT00666835|463737717|FG000|Overall Study|Hemoglobulin concentration|4|||
128847943|NCT00666835|463737718|FG001|Overall Study|Hemoglobulin concentration|3|||
128847944|NCT00666835|463737717|FG000|Overall Study|Planned operation|2|||
128847945|NCT00666835|463737718|FG001|Overall Study|Planned operation|0|||
128847946|NCT00666835|463737717|FG000|Overall Study|Physician Decision|1|||
128847947|NCT00666835|463737718|FG001|Overall Study|Physician Decision|2|||
128847948|NCT01126879|463737719|FG000|Overall Study|Progressive Disease|3|||
128847949|NCT01126879|463737720|FG001|Overall Study|Progressive Disease|1|||
128847950|NCT01126879|463737719|FG000|Overall Study|Withdrawal by Subject|1|||
128847951|NCT01126879|463737720|FG001|Overall Study|Withdrawal by Subject|0|||
128847952|NCT01126879|463737719|FG000|Overall Study|Adverse Event|0|||
128847953|NCT01126879|463737720|FG001|Overall Study|Adverse Event|1|||
128847954|NCT01126879|463737719|FG000|Overall Study|Physician Decision|1|||
128847955|NCT01126879|463737720|FG001|Overall Study|Physician Decision|0|||
128847956|NCT03319719|463737721|FG000|Overall Study|Lost to Follow-up|1|||
128847957|NCT00498433|463737722|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
128847958|NCT00498433|463737723|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
128847959|NCT00498433|463737724|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
128847960|NCT00498433|463737722|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
128847961|NCT00498433|463737723|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
128847962|NCT00498433|463737724|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
128847963|NCT00498433|463737722|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
128847964|NCT00498433|463737723|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
128847965|NCT00498433|463737724|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
128847966|NCT00498433|463737722|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
128847967|NCT00498433|463737723|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
128847968|NCT00498433|463737724|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
128847969|NCT00744796|463737725|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
128847970|NCT03193216|463737729|FG000|Overall Study|Lost to Follow-up|1|||
128847971|NCT03193216|463737730|FG001|Overall Study|Lost to Follow-up|0|||
128847972|NCT03193216|463737729|FG000|Overall Study|Withdrawal by Subject|5|||
128847973|NCT03193216|463737730|FG001|Overall Study|Withdrawal by Subject|0|||
128847974|NCT03193216|463737729|FG000|Overall Study|Physician Decision|4|||
128847975|NCT03193216|463737730|FG001|Overall Study|Physician Decision|0|||
128847976|NCT02316847|463737731|FG000|Overall Study|Adverse Event|0|||
128847977|NCT02316847|463737732|FG001|Overall Study|Adverse Event|3|||
128847978|NCT02316847|463737731|FG000|Overall Study|Lost to Follow-up|0|||
128847979|NCT02316847|463737732|FG001|Overall Study|Lost to Follow-up|2|||
128847980|NCT02316847|463737731|FG000|Overall Study|Physician Decision|0|||
128847981|NCT02316847|463737732|FG001|Overall Study|Physician Decision|1|||
128847982|NCT02316847|463737731|FG000|Overall Study|Pregnancy|0|||
128847983|NCT02316847|463737732|FG001|Overall Study|Pregnancy|1|||
128847984|NCT02316847|463737731|FG000|Overall Study|Withdrawal by Subject|2|||
128847985|NCT02316847|463737732|FG001|Overall Study|Withdrawal by Subject|9|||
128847986|NCT02316847|463737731|FG000|Overall Study|Noncompliance with study drug|0|||
128847987|NCT02316847|463737732|FG001|Overall Study|Noncompliance with study drug|3|||
128847988|NCT02316847|463737731|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
128847989|NCT02316847|463737732|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
128847990|NCT02236598|463737736|FG000|Overall Study|Adverse Event|0|||
128847991|NCT02236598|463737737|FG001|Overall Study|Adverse Event|1|||
128847992|NCT02236598|463737736|FG000|Overall Study|Withdrawal by Subject|0|||
128847993|NCT02236598|463737737|FG001|Overall Study|Withdrawal by Subject|1|||
128847994|NCT01264887|463737739|FG000|Overall Study|Adverse Event|5|||
128847995|NCT01264887|463737739|FG000|Overall Study|Death|7|||
128847996|NCT01264887|463737739|FG000|Overall Study|Lack of Efficacy|5|||
128847997|NCT01264887|463737739|FG000|Overall Study|Physician Decision|4|||
128847998|NCT01264887|463737739|FG000|Overall Study|Withdrawal by Subject|6|||
128847999|NCT01264887|463737739|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
128848000|NCT01264887|463737739|FG000|Overall Study|Other|2|||
128848001|NCT01061775|463737740|FG000|Overall Study|Physician Decision|2|||
128848002|NCT01061775|463737740|FG000|Overall Study|Lost to Follow-up|1|||
128848003|NCT01313299|463737743|FG000|Overall Study|Adverse Event|3|||
128848004|NCT01313299|463737744|FG001|Overall Study|Adverse Event|1|||
128848005|NCT01313299|463737745|FG002|Overall Study|Adverse Event|1|||
128848006|NCT01313299|463737743|FG000|Overall Study|Lost to Follow-up|1|||
128848007|NCT01313299|463737744|FG001|Overall Study|Lost to Follow-up|0|||
128848008|NCT01313299|463737745|FG002|Overall Study|Lost to Follow-up|0|||
128848009|NCT01313299|463737743|FG000|Overall Study|Protocol Violation|2|||
128848010|NCT01313299|463737744|FG001|Overall Study|Protocol Violation|0|||
128848011|NCT01313299|463737745|FG002|Overall Study|Protocol Violation|0|||
128848012|NCT01313299|463737743|FG000|Overall Study|Withdrawal by Subject|1|||
128848013|NCT01313299|463737744|FG001|Overall Study|Withdrawal by Subject|0|||
128848014|NCT01313299|463737745|FG002|Overall Study|Withdrawal by Subject|2|||
128848015|NCT01313299|463737743|FG000|Overall Study|Family reason and moved out of state|0|||
128848016|NCT01313299|463737744|FG001|Overall Study|Family reason and moved out of state|2|||
128848017|NCT01313299|463737745|FG002|Overall Study|Family reason and moved out of state|0|||
128848018|NCT01313299|463737743|FG000|Overall Study|Lack of subject compliance|0|||
128848019|NCT01313299|463737744|FG001|Overall Study|Lack of subject compliance|0|||
128848020|NCT01313299|463737745|FG002|Overall Study|Lack of subject compliance|1|||
128848021|NCT04089332|463737749|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
128848022|NCT04089332|463737749|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
128848023|NCT04089332|463737749|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
128848024|NCT03340766|463737750|FG000|Overall Study|Withdrawal by Subject|2|||
128848025|NCT03340766|463737751|FG001|Overall Study|Withdrawal by Subject|1|||
128848026|NCT03340766|463737752|FG002|Overall Study|Withdrawal by Subject|3|||
128848027|NCT03340766|463737750|FG000|Overall Study|Lost to Follow-up|0|||
128848028|NCT03340766|463737751|FG001|Overall Study|Lost to Follow-up|0|||
128848029|NCT03340766|463737752|FG002|Overall Study|Lost to Follow-up|1|||
128848030|NCT03340766|463737750|FG000|Overall Study|Death|6|||
128848031|NCT03340766|463737751|FG001|Overall Study|Death|7|||
128848032|NCT03340766|463737752|FG002|Overall Study|Death|4|||
128848033|NCT02256488|463737755|FG000|Overall Study|Lost to Follow-up|6|||
128848034|NCT02256488|463737756|FG001|Overall Study|Lost to Follow-up|6|||
128848035|NCT02256488|463737757|FG002|Overall Study|Lost to Follow-up|9|||
128848036|NCT02256488|463737758|FG003|Overall Study|Lost to Follow-up|3|||
128848037|NCT02256488|463737755|FG000|Overall Study|OTHER|1|||
128848038|NCT02256488|463737756|FG001|Overall Study|OTHER|0|||
128848039|NCT02256488|463737757|FG002|Overall Study|OTHER|1|||
128848040|NCT02256488|463737758|FG003|Overall Study|OTHER|1|||
128848041|NCT02256488|463737755|FG000|Overall Study|Withdrawal by Subject|1|||
128848042|NCT02256488|463737756|FG001|Overall Study|Withdrawal by Subject|0|||
128848043|NCT02256488|463737757|FG002|Overall Study|Withdrawal by Subject|0|||
128848044|NCT02256488|463737758|FG003|Overall Study|Withdrawal by Subject|2|||
128848045|NCT00975130|463737762|FG000|Study Part 1|Adverse Event|150|||
128848046|NCT00975130|463737763|FG001|Study Part 1|Adverse Event|0|||
128848047|NCT00975130|463737764|FG002|Study Part 1|Adverse Event|0|||
128848048|NCT00975130|463737762|FG000|Study Part 1|Lost to Follow-up|19|||
128848049|NCT00975130|463737763|FG001|Study Part 1|Lost to Follow-up|0|||
128848050|NCT00975130|463737764|FG002|Study Part 1|Lost to Follow-up|0|||
128848051|NCT00975130|463737762|FG000|Study Part 1|Withdrawal by Subject|61|||
128848052|NCT00975130|463737763|FG001|Study Part 1|Withdrawal by Subject|0|||
128848053|NCT00975130|463737764|FG002|Study Part 1|Withdrawal by Subject|0|||
128848054|NCT00975130|463737762|FG000|Study Part 1|Protocol Violation|13|||
128848055|NCT00975130|463737763|FG001|Study Part 1|Protocol Violation|0|||
128848056|NCT00975130|463737764|FG002|Study Part 1|Protocol Violation|0|||
128848057|NCT00975130|463737762|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
128848058|NCT00975130|463737763|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
128848059|NCT00975130|463737764|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
128848060|NCT00975130|463737762|FG000|Study Part 1|Administrative|4|||
128848061|NCT00975130|463737763|FG001|Study Part 1|Administrative|0|||
128848062|NCT00975130|463737764|FG002|Study Part 1|Administrative|0|||
128848063|NCT00975130|463737762|FG000|Study Part 1|Withdrew Consent|24|||
128848064|NCT00975130|463737763|FG001|Study Part 1|Withdrew Consent|0|||
128848065|NCT00975130|463737764|FG002|Study Part 1|Withdrew Consent|0|||
128848066|NCT00975130|463737762|FG000|Study Part 2|Adverse Event|0|||
128848067|NCT00975130|463737763|FG001|Study Part 2|Adverse Event|14|||
128848068|NCT00975130|463737764|FG002|Study Part 2|Adverse Event|7|||
128848069|NCT00975130|463737762|FG000|Study Part 2|Lost to Follow-up|0|||
128848070|NCT00975130|463737763|FG001|Study Part 2|Lost to Follow-up|0|||
128848071|NCT00975130|463737764|FG002|Study Part 2|Lost to Follow-up|1|||
128848072|NCT00975130|463737762|FG000|Study Part 2|Withdrawal by Subject|0|||
128848073|NCT00975130|463737763|FG001|Study Part 2|Withdrawal by Subject|13|||
128848074|NCT00975130|463737764|FG002|Study Part 2|Withdrawal by Subject|5|||
128848075|NCT00975130|463737762|FG000|Study Part 2|Withdrew Consent|0|||
128848076|NCT00975130|463737763|FG001|Study Part 2|Withdrew Consent|6|||
128848077|NCT00975130|463737764|FG002|Study Part 2|Withdrew Consent|2|||
128848078|NCT00975130|463737762|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
128848079|NCT00975130|463737763|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
128848080|NCT00975130|463737764|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
128848081|NCT00975130|463737762|FG000|Study Part 2|Administrative|0|||
128848082|NCT00975130|463737763|FG001|Study Part 2|Administrative|1|||
128848083|NCT00975130|463737764|FG002|Study Part 2|Administrative|0|||
128848084|NCT00975130|463737762|FG000|Study Part 2|Protocol Violation|0|||
128848085|NCT00975130|463737763|FG001|Study Part 2|Protocol Violation|0|||
128848086|NCT00975130|463737764|FG002|Study Part 2|Protocol Violation|1|||
128848087|NCT00734851|463737765|FG000|Overall Study|Withdrawal by Subject|2|||
128848088|NCT00734851|463737765|FG000|Overall Study|Lost to Follow-up|1|||
128848089|NCT00734851|463737765|FG000|Overall Study|Physician Decision|18|||
128848090|NCT00818519|463737766|FG000|Overall Study|Adverse Event|2|||
128848091|NCT00818519|463737767|FG001|Overall Study|Adverse Event|2|||
128848092|NCT00818519|463737766|FG000|Overall Study|Lost to Follow-up|4|||
128848093|NCT00818519|463737767|FG001|Overall Study|Lost to Follow-up|6|||
128848094|NCT00818519|463737766|FG000|Overall Study|Protocol Violation|2|||
128848095|NCT00818519|463737767|FG001|Overall Study|Protocol Violation|1|||
128848096|NCT00818519|463737766|FG000|Overall Study|Pregnancy|0|||
128848097|NCT00818519|463737767|FG001|Overall Study|Pregnancy|1|||
128848098|NCT00818519|463737766|FG000|Overall Study|Withdrawal by Subject|4|||
128848099|NCT00818519|463737767|FG001|Overall Study|Withdrawal by Subject|9|||
128848100|NCT00818519|463737766|FG000|Overall Study|participant recovered completely|1|||
128848101|NCT00818519|463737767|FG001|Overall Study|participant recovered completely|0|||
128848102|NCT00818519|463737766|FG000|Overall Study|participant will leave for long tme|1|||
128848103|NCT00818519|463737767|FG001|Overall Study|participant will leave for long tme|0|||
128848104|NCT03562117|463737768|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
128848105|NCT03562117|463737769|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
128848106|NCT03562117|463737770|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
128848107|NCT01294358|463737771|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
128848108|NCT01294358|463737772|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
128848109|NCT01294358|463737773|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
128848110|NCT01294358|463737774|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
128848111|NCT01294358|463737775|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
128848112|NCT01294358|463737771|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
128848113|NCT01294358|463737772|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
128848114|NCT01294358|463737773|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
128848115|NCT01294358|463737774|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
128848116|NCT01294358|463737775|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
128848117|NCT01294358|463737771|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
128848118|NCT01294358|463737772|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
128848119|NCT01294358|463737773|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
128848120|NCT01294358|463737774|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
128848121|NCT01294358|463737775|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
128848122|NCT01294358|463737771|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
128848123|NCT01294358|463737772|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
128848124|NCT01294358|463737773|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
128848125|NCT01294358|463737774|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
128848126|NCT01294358|463737775|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
128848127|NCT03356145|463737776|FG000|Overall Study|Withdrawal by Subject|2|||
128848128|NCT03356145|463737777|FG001|Overall Study|Withdrawal by Subject|1|||
128848129|NCT03356145|463737776|FG000|Overall Study|Did not meet inclusion criteria|1|||
128848130|NCT03356145|463737777|FG001|Overall Study|Did not meet inclusion criteria|0|||
128848131|NCT02963922|463737778|FG000|Overall Study|Adverse Event|15|||
128848132|NCT02963922|463737779|FG001|Overall Study|Adverse Event|6|||
128848133|NCT02963922|463737778|FG000|Overall Study|Protocol deviation|6|||
128848134|NCT02963922|463737779|FG001|Overall Study|Protocol deviation|6|||
128848135|NCT02963922|463737778|FG000|Overall Study|Lack of Efficacy|1|||
128848136|NCT02963922|463737779|FG001|Overall Study|Lack of Efficacy|1|||
128848137|NCT02963922|463737778|FG000|Overall Study|Lost to Follow-up|2|||
128848138|NCT02963922|463737779|FG001|Overall Study|Lost to Follow-up|3|||
128848139|NCT02963922|463737778|FG000|Overall Study|Other|8|||
128848140|NCT02963922|463737779|FG001|Overall Study|Other|14|||
128848141|NCT03740919|463737789|FG000|Lead-in Period|Lost to Follow-up|1|||
128848142|NCT03740919|463737790|FG001|Lead-in Period|Lost to Follow-up|0|||
128848143|NCT03740919|463737791|FG002|Lead-in Period|Lost to Follow-up|0|||
128848144|NCT03740919|463737792|FG003|Lead-in Period|Lost to Follow-up|0|||
128848145|NCT03740919|463737789|FG000|Lead-in Period|Physician Decision|2|||
128848146|NCT03740919|463737790|FG001|Lead-in Period|Physician Decision|0|||
128848147|NCT03740919|463737791|FG002|Lead-in Period|Physician Decision|0|||
128848148|NCT03740919|463737792|FG003|Lead-in Period|Physician Decision|0|||
128848149|NCT03740919|463737789|FG000|Lead-in Period|Protocol Violation|1|||
128848150|NCT03740919|463737790|FG001|Lead-in Period|Protocol Violation|0|||
128848151|NCT03740919|463737791|FG002|Lead-in Period|Protocol Violation|0|||
128848152|NCT03740919|463737792|FG003|Lead-in Period|Protocol Violation|0|||
128848153|NCT03740919|463737789|FG000|Lead-in Period|Withdrawal by Subject|10|||
128848154|NCT03740919|463737790|FG001|Lead-in Period|Withdrawal by Subject|0|||
128848155|NCT03740919|463737791|FG002|Lead-in Period|Withdrawal by Subject|0|||
128848156|NCT03740919|463737792|FG003|Lead-in Period|Withdrawal by Subject|0|||
128848157|NCT03740919|463737789|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
128848158|NCT03740919|463737790|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
128848159|NCT03740919|463737791|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
128848160|NCT03740919|463737792|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
128848161|NCT03740919|463737789|FG000|Lead-in Period|Study Task Too Burdensome|1|||
128848162|NCT03740919|463737790|FG001|Lead-in Period|Study Task Too Burdensome|0|||
128848163|NCT03740919|463737791|FG002|Lead-in Period|Study Task Too Burdensome|0|||
128848164|NCT03740919|463737792|FG003|Lead-in Period|Study Task Too Burdensome|0|||
128848165|NCT03740919|463737789|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
128848166|NCT03740919|463737790|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
128848167|NCT03740919|463737791|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
128848168|NCT03740919|463737792|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
128848169|NCT03740919|463737789|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
128848170|NCT03740919|463737790|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
128848171|NCT03740919|463737791|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
128848172|NCT03740919|463737792|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
128848173|NCT03740919|463737789|FG000|Treatment Period|Adverse Event|0|||
128848174|NCT03740919|463737790|FG001|Treatment Period|Adverse Event|0|||
128848175|NCT03740919|463737791|FG002|Treatment Period|Adverse Event|2|||
128848176|NCT03740919|463737792|FG003|Treatment Period|Adverse Event|0|||
128848177|NCT03740919|463737789|FG000|Treatment Period|Protocol Violation|0|||
128848178|NCT03740919|463737790|FG001|Treatment Period|Protocol Violation|1|||
128848179|NCT03740919|463737791|FG002|Treatment Period|Protocol Violation|0|||
128848180|NCT03740919|463737792|FG003|Treatment Period|Protocol Violation|0|||
128848181|NCT03740919|463737789|FG000|Treatment Period|Withdrawal by Subject|0|||
128848182|NCT03740919|463737790|FG001|Treatment Period|Withdrawal by Subject|7|||
128848183|NCT03740919|463737791|FG002|Treatment Period|Withdrawal by Subject|6|||
128848184|NCT03740919|463737792|FG003|Treatment Period|Withdrawal by Subject|2|||
128848185|NCT03740919|463737789|FG000|Treatment Period|Terminated by Sponsor|0|||
128848186|NCT03740919|463737790|FG001|Treatment Period|Terminated by Sponsor|1|||
128848187|NCT03740919|463737791|FG002|Treatment Period|Terminated by Sponsor|0|||
128848188|NCT03740919|463737792|FG003|Treatment Period|Terminated by Sponsor|0|||
128848189|NCT03740919|463737789|FG000|Treatment Period|Issue with Insulin Pump|0|||
128848190|NCT03740919|463737790|FG001|Treatment Period|Issue with Insulin Pump|1|||
128848191|NCT03740919|463737791|FG002|Treatment Period|Issue with Insulin Pump|0|||
128848192|NCT03740919|463737792|FG003|Treatment Period|Issue with Insulin Pump|0|||
128848193|NCT03740919|463737789|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
128848194|NCT03740919|463737790|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
128848195|NCT03740919|463737791|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
128848196|NCT03740919|463737792|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
128848197|NCT03740919|463737789|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
128848198|NCT03740919|463737790|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
128848199|NCT03740919|463737791|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
128848200|NCT03740919|463737792|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
128848201|NCT03740919|463737789|FG000|Treatment Period|Not Completing Diary|0|||
128848202|NCT03740919|463737790|FG001|Treatment Period|Not Completing Diary|0|||
128848203|NCT03740919|463737791|FG002|Treatment Period|Not Completing Diary|1|||
128848204|NCT03740919|463737792|FG003|Treatment Period|Not Completing Diary|0|||
128848205|NCT03740919|463737789|FG000|Treatment Period|Insulin Painful to Participant|0|||
128848206|NCT03740919|463737790|FG001|Treatment Period|Insulin Painful to Participant|0|||
128848207|NCT03740919|463737791|FG002|Treatment Period|Insulin Painful to Participant|1|||
128848208|NCT03740919|463737792|FG003|Treatment Period|Insulin Painful to Participant|0|||
128848209|NCT00595764|463737795|FG000|Overall Study|Protocol Violation|24|||
128848210|NCT00595764|463737796|FG001|Overall Study|Protocol Violation|19|||
128848211|NCT00595764|463737795|FG000|Overall Study|Missed Medication >1 week|10|||
128848212|NCT00595764|463737796|FG001|Overall Study|Missed Medication >1 week|17|||
128848213|NCT00595764|463737795|FG000|Overall Study|Missed 3 PM visits|1|||
128848214|NCT00595764|463737796|FG001|Overall Study|Missed 3 PM visits|7|||
128848215|NCT00595764|463737795|FG000|Overall Study|Withdrawal by Subject|4|||
128848216|NCT00595764|463737796|FG001|Overall Study|Withdrawal by Subject|0|||
128848217|NCT04222088|463737797|FG000|Overall Study|Lost to Follow-up|5|||
128848218|NCT04222088|463737798|FG001|Overall Study|Lost to Follow-up|1|||
128848219|NCT04222088|463737797|FG000|Overall Study|Withdrawal by Subject|4|||
128848220|NCT04222088|463737798|FG001|Overall Study|Withdrawal by Subject|0|||
128848221|NCT01332318|463737799|FG000|Overall Study|Adverse Event|0|||
128848222|NCT01332318|463737800|FG001|Overall Study|Adverse Event|3|||
128848223|NCT01332318|463737801|FG002|Overall Study|Adverse Event|0|||
128848224|NCT01332318|463737802|FG003|Overall Study|Adverse Event|0|||
128848225|NCT01332318|463737799|FG000|Overall Study|Withdrawal by Subject|1|||
128848226|NCT01332318|463737800|FG001|Overall Study|Withdrawal by Subject|1|||
128848227|NCT01332318|463737801|FG002|Overall Study|Withdrawal by Subject|0|||
128848228|NCT01332318|463737802|FG003|Overall Study|Withdrawal by Subject|1|||
128848229|NCT01332318|463737799|FG000|Overall Study|Protocol Violation|1|||
128848230|NCT01332318|463737800|FG001|Overall Study|Protocol Violation|0|||
128848231|NCT01332318|463737801|FG002|Overall Study|Protocol Violation|1|||
128848232|NCT01332318|463737802|FG003|Overall Study|Protocol Violation|1|||
128848233|NCT02820298|463737805|FG000|Overall Study|Withdrawal by Subject|0|||
128848234|NCT02820298|463737806|FG001|Overall Study|Withdrawal by Subject|1|||
128848235|NCT02820298|463737805|FG000|Overall Study|Physician Decision|1|||
128848236|NCT02820298|463737806|FG001|Overall Study|Physician Decision|0|||
128848237|NCT02820298|463737805|FG000|Overall Study|Protocol Violation|0|||
128848238|NCT02820298|463737806|FG001|Overall Study|Protocol Violation|1|||
128848239|NCT01894256|463737807|FG000|Part A|Adverse Event|0|||
128848240|NCT01894256|463737808|FG001|Part A|Adverse Event|1|||
128848241|NCT01894256|463737809|FG002|Part A|Adverse Event|0|||
128848242|NCT01894256|463737807|FG000|Part B|Death|0|||
128848243|NCT01894256|463737808|FG001|Part B|Death|1|||
128848244|NCT01894256|463737809|FG002|Part B|Death|1|||
128848245|NCT01894256|463737807|FG000|Part B|Withdrawal by Subject|0|||
128848246|NCT01894256|463737808|FG001|Part B|Withdrawal by Subject|1|||
128848247|NCT01894256|463737809|FG002|Part B|Withdrawal by Subject|0|||
128848248|NCT01894256|463737807|FG000|Part B|Lack of Efficacy|15|||
128848249|NCT01894256|463737808|FG001|Part B|Lack of Efficacy|12|||
128848250|NCT01894256|463737809|FG002|Part B|Lack of Efficacy|13|||
128848251|NCT01780584|463737810|FG000|Overall Study|Death|1|||
128848252|NCT01780584|463737811|FG001|Overall Study|Death|0|||
128848253|NCT01780584|463737812|FG002|Overall Study|Death|1|||
128848254|NCT01780584|463737810|FG000|Overall Study|Adverse Event|0|||
128848255|NCT01780584|463737811|FG001|Overall Study|Adverse Event|1|||
128848256|NCT01780584|463737812|FG002|Overall Study|Adverse Event|0|||
128848257|NCT01780584|463737810|FG000|Overall Study|Protocol Violation|0|||
128848258|NCT01780584|463737811|FG001|Overall Study|Protocol Violation|0|||
128848259|NCT01780584|463737812|FG002|Overall Study|Protocol Violation|1|||
128848260|NCT00727259|463737813|FG000|Overall Study|Not all questionnaires completed|1055|||
128848261|NCT01021683|463737814|FG000|Overall Study|Lack of Efficacy|12|||
128848262|NCT01021683|463737814|FG000|Overall Study|Recovery of neutrophil count|51|||
128848263|NCT01021683|463737814|FG000|Overall Study|Other|8|||
128848264|NCT00500539|463737815|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
128848265|NCT00500539|463737815|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
128848266|NCT00500539|463737815|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
128848267|NCT00500539|463737815|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
128848268|NCT00500539|463737815|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
128848269|NCT00500539|463737815|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
128848270|NCT00500539|463737815|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
128848271|NCT00500539|463737815|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
128848272|NCT00500539|463737815|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
128848273|NCT00500539|463737815|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
128848274|NCT00500539|463737815|FG000|Follow-up Period (16 Weeks)|Death|1|||
128848275|NCT00500539|463737815|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
128848276|NCT00500539|463737815|FG000|Follow-up Period (16 Weeks)|Missing|3|||
128848277|NCT01201915|463737816|FG000|Overall Study|Adverse Event|2|||
128848278|NCT01201915|463737817|FG001|Overall Study|Adverse Event|1|||
128848279|NCT01201915|463737818|FG002|Overall Study|Adverse Event|1|||
128848280|NCT01201915|463737816|FG000|Overall Study|Lost to Follow-up|0|||
128848281|NCT01201915|463737817|FG001|Overall Study|Lost to Follow-up|4|||
128848282|NCT01201915|463737818|FG002|Overall Study|Lost to Follow-up|0|||
128848283|NCT01201915|463737816|FG000|Overall Study|Physician Decision|3|||
128848284|NCT01201915|463737817|FG001|Overall Study|Physician Decision|0|||
128848285|NCT01201915|463737818|FG002|Overall Study|Physician Decision|0|||
128848286|NCT01201915|463737816|FG000|Overall Study|Subject Decision|3|||
128848287|NCT01201915|463737817|FG001|Overall Study|Subject Decision|3|||
128848288|NCT01201915|463737818|FG002|Overall Study|Subject Decision|5|||
128848289|NCT01201915|463737816|FG000|Overall Study|Target Lesion Progression|0|||
128848290|NCT01201915|463737817|FG001|Overall Study|Target Lesion Progression|3|||
128848291|NCT01201915|463737818|FG002|Overall Study|Target Lesion Progression|0|||
128848292|NCT03406507|463737819|FG000|Extension Period|Lack of Efficacy|0|||
128848293|NCT03406507|463737820|FG001|Extension Period|Lack of Efficacy|1|||
128848294|NCT00663923|463737821|FG000|Overall Study|Lost to Follow-up|2|||
128848295|NCT00547300|463737824|FG000|Overall Study|Study was Administratively Terminated|25|||
128848296|NCT00547300|463737825|FG001|Overall Study|Study was Administratively Terminated|24|||
128848297|NCT00547300|463737824|FG000|Overall Study|Did not Meet Entry Criteria|0|||
128848298|NCT00547300|463737825|FG001|Overall Study|Did not Meet Entry Criteria|2|||
128848299|NCT04380688|463737826|FG000|Overall Study|Death|2|||
128848300|NCT04380688|463737827|FG001|Overall Study|Death|2|||
128848301|NCT04380688|463737826|FG000|Overall Study|Lost to Follow-up|2|||
128848302|NCT04380688|463737827|FG001|Overall Study|Lost to Follow-up|4|||
128848303|NCT04380688|463737826|FG000|Overall Study|Withdrawal by Subject|3|||
128848304|NCT04380688|463737827|FG001|Overall Study|Withdrawal by Subject|3|||
128848305|NCT01967719|463739119|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
128848306|NCT01967719|463739120|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
128848307|NCT01967719|463739121|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
128848308|NCT01967719|463739122|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
128848309|NCT01967719|463739119|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
128848310|NCT01967719|463739120|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
128848311|NCT01967719|463739121|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
128848312|NCT01967719|463739122|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
128848313|NCT02329223|463739123|FG000|Overall Study|Withdrawal by Subject|1|||
128848314|NCT02329223|463739124|FG001|Overall Study|Withdrawal by Subject|2|||
128848315|NCT02329223|463739125|FG002|Overall Study|Withdrawal by Subject|5|||
128848316|NCT02329223|463739123|FG000|Overall Study|Physician Decision|0|||
128848317|NCT02329223|463739124|FG001|Overall Study|Physician Decision|0|||
128848318|NCT02329223|463739125|FG002|Overall Study|Physician Decision|1|||
128848319|NCT02329223|463739123|FG000|Overall Study|Adverse Event|0|||
128848320|NCT02329223|463739124|FG001|Overall Study|Adverse Event|1|||
128848321|NCT02329223|463739125|FG002|Overall Study|Adverse Event|0|||
128848322|NCT00796614|463739126|FG000|Overall Study|Adverse Event|1|||
128848323|NCT00796614|463739127|FG001|Overall Study|Adverse Event|2|||
128848324|NCT00796614|463739128|FG002|Overall Study|Adverse Event|0|||
128848325|NCT00796614|463739129|FG003|Overall Study|Adverse Event|0|||
128848326|NCT00796614|463739126|FG000|Overall Study|Protocol Violation|0|||
128848327|NCT00796614|463739127|FG001|Overall Study|Protocol Violation|0|||
128848328|NCT00796614|463739128|FG002|Overall Study|Protocol Violation|2|||
128848329|NCT00796614|463739129|FG003|Overall Study|Protocol Violation|0|||
128848330|NCT00796614|463739126|FG000|Overall Study|Lost to Follow-up|2|||
128848331|NCT00796614|463739127|FG001|Overall Study|Lost to Follow-up|2|||
128848332|NCT00796614|463739128|FG002|Overall Study|Lost to Follow-up|1|||
128848333|NCT00796614|463739129|FG003|Overall Study|Lost to Follow-up|0|||
128848334|NCT00796614|463739126|FG000|Overall Study|Withdrawal by Subject|1|||
128848335|NCT00796614|463739127|FG001|Overall Study|Withdrawal by Subject|0|||
128848336|NCT00796614|463739128|FG002|Overall Study|Withdrawal by Subject|0|||
128848337|NCT00796614|463739129|FG003|Overall Study|Withdrawal by Subject|1|||
128848338|NCT00796614|463739126|FG000|Overall Study|Other than stated|1|||
128848339|NCT00796614|463739127|FG001|Overall Study|Other than stated|0|||
128848340|NCT00796614|463739128|FG002|Overall Study|Other than stated|0|||
128848341|NCT00796614|463739129|FG003|Overall Study|Other than stated|0|||
128848342|NCT00381888|463739130|FG000|Overall Study|Death|1|||
128848343|NCT00381888|463739130|FG000|Overall Study|Withdrawal by Subject|1|||
128848344|NCT00381888|463739130|FG000|Overall Study|Physician Decision|1|||
128848345|NCT00381888|463739130|FG000|Overall Study|Protocol Violation|9|||
128848346|NCT00381888|463739130|FG000|Overall Study|Had laparoscopic surgery|2|||
128848347|NCT00381888|463739130|FG000|Overall Study|Surgery was cancelled|2|||
128848348|NCT00381888|463739130|FG000|Overall Study|Adverse Event|1|||
128848349|NCT01231464|463739131|FG000|Overall Study|Adverse Event|0|||
128848350|NCT01231464|463739132|FG001|Overall Study|Adverse Event|1|||
128848351|NCT01231464|463739131|FG000|Overall Study|Protocol Violation|1|||
128848352|NCT01231464|463739132|FG001|Overall Study|Protocol Violation|2|||
128848353|NCT01231464|463739131|FG000|Overall Study|Lost to Follow-up|1|||
128848354|NCT01231464|463739132|FG001|Overall Study|Lost to Follow-up|2|||
128848355|NCT01231464|463739131|FG000|Overall Study|Withdrawal by Subject|3|||
128848356|NCT01231464|463739132|FG001|Overall Study|Withdrawal by Subject|2|||
128848357|NCT03449134|463739133|FG000|52-Week Treatment Period|Death|2|||
128848358|NCT03449134|463739134|FG001|52-Week Treatment Period|Death|1|||
128848359|NCT03449134|463739135|FG002|52-Week Treatment Period|Death|0|||
128848360|NCT03449134|463739133|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
128848361|NCT03449134|463739134|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
128848362|NCT03449134|463739135|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
128848363|NCT03449134|463739133|FG000|52-Week Treatment Period|Physician Decision|2|||
128848364|NCT03449134|463739134|FG001|52-Week Treatment Period|Physician Decision|3|||
128848365|NCT03449134|463739135|FG002|52-Week Treatment Period|Physician Decision|3|||
128848366|NCT03449134|463739133|FG000|52-Week Treatment Period|Screen Failure|1|||
128848367|NCT03449134|463739134|FG001|52-Week Treatment Period|Screen Failure|0|||
128848368|NCT03449134|463739135|FG002|52-Week Treatment Period|Screen Failure|1|||
128848369|NCT03449134|463739133|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
128848370|NCT03449134|463739134|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
128848371|NCT03449134|463739135|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
128848372|NCT03449134|463739133|FG000|52-Week Treatment Period|Site Closure|1|||
128848373|NCT03449134|463739134|FG001|52-Week Treatment Period|Site Closure|0|||
128848374|NCT03449134|463739135|FG002|52-Week Treatment Period|Site Closure|0|||
128848375|NCT00957996|463739141|FG000|Overall Study|Death|4|||
128848376|NCT00957996|463739142|FG001|Overall Study|Death|10|||
128848377|NCT00957996|463739141|FG000|Overall Study|Lost to Follow-up|4|||
128848378|NCT00957996|463739142|FG001|Overall Study|Lost to Follow-up|7|||
128848379|NCT00957996|463739141|FG000|Overall Study|Withdrawal by Subject|9|||
128848380|NCT00957996|463739142|FG001|Overall Study|Withdrawal by Subject|2|||
128848381|NCT00957996|463739141|FG000|Overall Study|Adverse Event|2|||
128848382|NCT00957996|463739142|FG001|Overall Study|Adverse Event|1|||
128848383|NCT00957996|463739141|FG000|Overall Study|Physician Decision|1|||
128848384|NCT00957996|463739142|FG001|Overall Study|Physician Decision|1|||
128848385|NCT00957996|463739141|FG000|Overall Study|Influenza-related complication|0|||
128848386|NCT00957996|463739142|FG001|Overall Study|Influenza-related complication|1|||
128848387|NCT00957996|463739141|FG000|Overall Study|Missing|1|||
128848388|NCT00957996|463739142|FG001|Overall Study|Missing|0|||
128848389|NCT00957996|463739141|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
128848390|NCT00957996|463739142|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
128848391|NCT01960348|463739148|FG000|Overall Study|Adverse event, not serious|2|||
128848392|NCT01960348|463739149|FG001|Overall Study|Adverse event, not serious|2|||
128848393|NCT01960348|463739148|FG000|Overall Study|Adverse event, serious fatal|6|||
128848394|NCT01960348|463739149|FG001|Overall Study|Adverse event, serious fatal|5|||
128848395|NCT01960348|463739148|FG000|Overall Study|Adverse event, serious non-fatal|0|||
128848396|NCT01960348|463739149|FG001|Overall Study|Adverse event, serious non-fatal|3|||
128848397|NCT01960348|463739148|FG000|Overall Study|Withdrawal by Subject|1|||
128848398|NCT01960348|463739149|FG001|Overall Study|Withdrawal by Subject|11|||
128848399|NCT01960348|463739148|FG000|Overall Study|Physician Decision|0|||
128848400|NCT01960348|463739149|FG001|Overall Study|Physician Decision|1|||
128848401|NCT01960348|463739148|FG000|Overall Study|Protocol Violation|1|||
128848402|NCT01960348|463739149|FG001|Overall Study|Protocol Violation|0|||
128848403|NCT01580995|463739150|FG000|Overall Study|Lost to Follow-up|2|||
128848404|NCT01580995|463739151|FG001|Overall Study|Lost to Follow-up|2|||
128848405|NCT01797562|463739152|FG000|Overall Study|Protocol Violation|5|||
128848406|NCT01631825|463739153|FG000|Overall Study|Adverse Event|42|||
128848407|NCT01631825|463739153|FG000|Overall Study|Lack of Efficacy|7|||
128848408|NCT01631825|463739153|FG000|Overall Study|Withdrawal by Subject|9|||
128848409|NCT01631825|463739153|FG000|Overall Study|Protocol Violation|4|||
128848410|NCT01631825|463739153|FG000|Overall Study|Discontinuation criteria|1|||
128848411|NCT01631825|463739153|FG000|Overall Study|Physician Decision|2|||
128848412|NCT05109117|463739154|FG000|Overall Study|Lost to Follow-up|1|||
128848413|NCT05109117|463739154|FG000|Overall Study|Discontinued for non-compliance|1|||
128848414|NCT03226353|463739155|FG000|Overall Study|Withdrawal by Subject|1|||
128848415|NCT03226353|463739155|FG000|Overall Study|Screen Failure|5|||
128848416|NCT01514864|463739157|FG000|Overall Study|Disease progression|7|||
128848417|NCT01514864|463739158|FG001|Overall Study|Disease progression|5|||
128848418|NCT01514864|463739157|FG000|Overall Study|Study drug toxicity|2|||
128848419|NCT01514864|463739158|FG001|Overall Study|Study drug toxicity|0|||
128848420|NCT02253147|463739160|FG000|Overall Study|Protocol Violation|30|||
128848421|NCT02253147|463739160|FG000|Overall Study|Did not consent to study extension|9|||
128848422|NCT02253147|463739160|FG000|Overall Study|Conditional re-treatment at W52|5|||
128848423|NCT02253147|463739160|FG000|Overall Study|Lost to Follow-up|2|||
128848424|NCT02253147|463739160|FG000|Overall Study|Withdrawal by Subject|1|||
128848425|NCT02254681|463739161|FG000|Overall Study|Lack of Efficacy|6|||
128848426|NCT00797511|463739162|FG000|Overall Study|Withdrawal by Subject|1|||
128848427|NCT02621047|463739163|FG000|Overall Study|Adverse Event|0|||
128848428|NCT02621047|463739164|FG001|Overall Study|Adverse Event|0|||
128848429|NCT02621047|463739165|FG002|Overall Study|Adverse Event|1|||
128848430|NCT03303521|463739170|FG000|Overall Study|Withdrawal by Subject|2|||
128848431|NCT03303521|463739171|FG001|Overall Study|Withdrawal by Subject|0|||
128848432|NCT03303521|463739170|FG000|Overall Study|Death|1|||
128848433|NCT03303521|463739171|FG001|Overall Study|Death|0|||
128848434|NCT03303521|463739170|FG000|Overall Study|Kidney transplantation|0|||
128848435|NCT03303521|463739171|FG001|Overall Study|Kidney transplantation|1|||
128848436|NCT03303521|463739170|FG000|Overall Study|Investigational product discontinuation|0|||
128848437|NCT03303521|463739171|FG001|Overall Study|Investigational product discontinuation|1|||
128848438|NCT03303521|463739170|FG000|Overall Study|Transferred to non-study dialysis center|1|||
128848439|NCT03303521|463739171|FG001|Overall Study|Transferred to non-study dialysis center|0|||
128848440|NCT03303521|463739170|FG000|Overall Study|Non-comliance to study protocol|0|||
128848441|NCT03303521|463739171|FG001|Overall Study|Non-comliance to study protocol|1|||
128848442|NCT03303521|463739170|FG000|Overall Study|Adverse Event|1|||
128848443|NCT03303521|463739171|FG001|Overall Study|Adverse Event|0|||
128848444|NCT04194541|463739172|FG000|Day 1 Through 13|Lost to Follow-up|3|||
128848445|NCT04194541|463739172|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
128848446|NCT04194541|463739172|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
128848447|NCT02642159|463739173|FG000|Overall Study|Randomized but not treated|1|||
128848448|NCT02642159|463739174|FG001|Overall Study|Randomized but not treated|0|||
128848449|NCT02642159|463739173|FG000|Overall Study|Adverse Event|10|||
128848450|NCT02642159|463739174|FG001|Overall Study|Adverse Event|4|||
128848451|NCT02642159|463739173|FG000|Overall Study|Withdrawal by Subject|9|||
128848452|NCT02642159|463739174|FG001|Overall Study|Withdrawal by Subject|1|||
128848453|NCT02642159|463739173|FG000|Overall Study|Poor compliance to study protocol|1|||
128848454|NCT02642159|463739174|FG001|Overall Study|Poor compliance to study protocol|0|||
128848455|NCT02642159|463739173|FG000|Overall Study|Other than specified above|10|||
128848456|NCT02642159|463739174|FG001|Overall Study|Other than specified above|3|||
128848457|NCT00297778|463739176|FG000|Overall Study|Adverse Event|16|||
128848458|NCT00297778|463739177|FG001|Overall Study|Adverse Event|10|||
128848459|NCT00297778|463739176|FG000|Overall Study|Withdrawal by Subject|1|||
128848460|NCT00297778|463739177|FG001|Overall Study|Withdrawal by Subject|5|||
128848461|NCT00297778|463739176|FG000|Overall Study|Lack of Efficacy|2|||
128848462|NCT00297778|463739177|FG001|Overall Study|Lack of Efficacy|1|||
128848463|NCT00297778|463739176|FG000|Overall Study|Non-compliant with trial protocol|0|||
128848464|NCT00297778|463739177|FG001|Overall Study|Non-compliant with trial protocol|3|||
128848465|NCT00297778|463739176|FG000|Overall Study|Other|0|||
128848466|NCT00297778|463739177|FG001|Overall Study|Other|1|||
128848467|NCT00679549|463739178|FG000|Overall Study|dropout|2|||
128848468|NCT00679549|463739179|FG001|Overall Study|dropout|4|||
128848469|NCT00679549|463739178|FG000|Overall Study|missing outcome echocardiograms|4|||
128848470|NCT00679549|463739179|FG001|Overall Study|missing outcome echocardiograms|5|||
128848471|NCT03280108|463739180|FG000|Overall Study|Lost to Follow-up|2|||
128848472|NCT03280108|463739181|FG001|Overall Study|Lost to Follow-up|0|||
128848473|NCT02201771|463739182|FG000|Overall Study|Death|3|||
128848474|NCT02201771|463739183|FG001|Overall Study|Death|2|||
128848475|NCT02201771|463739184|FG002|Overall Study|Death|0|||
128848476|NCT02201771|463739182|FG000|Overall Study|Protocol Violation|10|||
128848477|NCT02201771|463739183|FG001|Overall Study|Protocol Violation|8|||
128848478|NCT02201771|463739184|FG002|Overall Study|Protocol Violation|10|||
128848479|NCT01820637|463739185|FG000|Overall Study|Death|2|||
128848480|NCT01820637|463739185|FG000|Overall Study|Withdrawal by Subject|1|||
128848481|NCT00264498|463739186|FG000|Randomized Treatment|Death|0|||
128848482|NCT00264498|463739187|FG001|Randomized Treatment|Death|3|||
128848483|NCT00264498|463739186|FG000|Randomized Treatment|Withdrawal by Subject|0|||
128848484|NCT00264498|463739187|FG001|Randomized Treatment|Withdrawal by Subject|1|||
128848485|NCT00264498|463739186|FG000|Randomized Treatment|Objective disease Progression|13|||
128848486|NCT00264498|463739187|FG001|Randomized Treatment|Objective disease Progression|14|||
128848487|NCT00264498|463739186|FG000|Randomized Treatment|Physician Decision|1|||
128848488|NCT00264498|463739187|FG001|Randomized Treatment|Physician Decision|0|||
128848489|NCT00264498|463739186|FG000|Randomized Treatment|Incorrectly randomized|1|||
128848490|NCT00264498|463739187|FG001|Randomized Treatment|Incorrectly randomized|0|||
128848491|NCT00264498|463739186|FG000|Randomized Treatment|Study Closure|1|||
128848492|NCT00264498|463739187|FG001|Randomized Treatment|Study Closure|0|||
128848493|NCT00264498|463739186|FG000|Randomized Treatment|Protocol Violation|1|||
128848494|NCT00264498|463739187|FG001|Randomized Treatment|Protocol Violation|0|||
128848495|NCT00264498|463739186|FG000|Crossover Treatment|Death|1|||
128848496|NCT00264498|463739187|FG001|Crossover Treatment|Death|3|||
128848497|NCT00264498|463739186|FG000|Crossover Treatment|Objective disease progression|4|||
128848498|NCT00264498|463739187|FG001|Crossover Treatment|Objective disease progression|5|||
128848499|NCT00264498|463739186|FG000|Crossover Treatment|Study closure|0|||
128848500|NCT00264498|463739187|FG001|Crossover Treatment|Study closure|1|||
128848501|NCT00264498|463739186|FG000|Crossover Treatment|Withdrawal by Subject|1|||
128848502|NCT00264498|463739187|FG001|Crossover Treatment|Withdrawal by Subject|0|||
128848503|NCT02205476|463739188|FG000|Overall Study|Study termination by Sponsor|7|||
128848504|NCT02205476|463739189|FG001|Overall Study|Study termination by Sponsor|3|||
128848505|NCT00240097|463739190|FG000|Part I|Adverse Event|1|||
128848506|NCT00240097|463739190|FG000|Part I|Death|1|||
128848507|NCT00240097|463739190|FG000|Part I|histology|1|||
128848508|NCT00240097|463739190|FG000|Part I|unevaluable|1|||
128848509|NCT00240097|463739190|FG000|Part II|did not continue from Part I|23|||
128848510|NCT03613454|463739193|FG000|Overall Study|Protocol Violation|1|||
128848511|NCT03613454|463739194|FG001|Overall Study|Protocol Violation|0|||
128848512|NCT03613454|463739193|FG000|Overall Study|Protocol Violation|0|||
128848513|NCT03613454|463739194|FG001|Overall Study|Protocol Violation|1|||
128848514|NCT01071317|463739196|FG000|Overall Study|Lost to Follow-up|2|||
128848515|NCT01071317|463739197|FG001|Overall Study|Lost to Follow-up|2|||
128848516|NCT02040532|463739199|FG000|Overall Study|Lost to Follow-up|1|||
128848517|NCT02040532|463739199|FG000|Overall Study|Physician Decision|4|||
128848518|NCT02040532|463739199|FG000|Overall Study|Adverse Event|4|||
128848519|NCT02040532|463739199|FG000|Overall Study|Withdrawal by Subject|3|||
128848520|NCT03640754|463739202|FG000|Overall Study|Withdrawal by Subject|1|||
128848521|NCT03640754|463739203|FG001|Overall Study|Withdrawal by Subject|0|||
128848522|NCT03640754|463739202|FG000|Overall Study|Lost to Follow-up|0|||
128848523|NCT03640754|463739203|FG001|Overall Study|Lost to Follow-up|1|||
128848524|NCT01679613|463739209|FG000|Overall Study|other than stated above|0|||
128848525|NCT01679613|463739210|FG001|Overall Study|other than stated above|1|||
128848526|NCT01679613|463739211|FG002|Overall Study|other than stated above|2|||
128848527|NCT01679613|463739212|FG003|Overall Study|other than stated above|2|||
128848528|NCT03169530|463739213|FG000|Overall Study|Study ended by NIH|15|||
128848529|NCT03169530|463739214|FG001|Overall Study|Study ended by NIH|17|||
128848530|NCT02154516|463739215|FG000|Overall Study|Withdrawal by Subject|0|||
128848531|NCT02154516|463739216|FG001|Overall Study|Withdrawal by Subject|1|||
128848532|NCT02154516|463739215|FG000|Overall Study|Lost to Follow-up|1|||
128848533|NCT02154516|463739216|FG001|Overall Study|Lost to Follow-up|0|||
128848534|NCT02154516|463739215|FG000|Overall Study|Removal/revision of device|1|||
128848535|NCT02154516|463739216|FG001|Overall Study|Removal/revision of device|0|||
128848536|NCT02154516|463739215|FG000|Overall Study|Death|2|||
128848537|NCT02154516|463739216|FG001|Overall Study|Death|1|||
128848538|NCT02965599|463739217|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
128848539|NCT02965599|463739218|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
128848540|NCT00230971|463739219|FG000|Randomization|No study drug administered|3|||
128848541|NCT00230971|463739220|FG001|Randomization|No study drug administered|3|||
128848542|NCT00230971|463739219|FG000|Baseline Participants|Lost to Follow-up|5|||
128848543|NCT00230971|463739220|FG001|Baseline Participants|Lost to Follow-up|12|||
128848544|NCT00230971|463739219|FG000|Baseline Participants|Death|6|||
128848545|NCT00230971|463739220|FG001|Baseline Participants|Death|5|||
128848546|NCT00230971|463739219|FG000|Baseline Participants|Withdrawal by Subject|7|||
128848547|NCT00230971|463739220|FG001|Baseline Participants|Withdrawal by Subject|1|||
128848548|NCT00230971|463739219|FG000|Baseline Participants|Adverse Event|1|||
128848549|NCT00230971|463739220|FG001|Baseline Participants|Adverse Event|0|||
128848550|NCT00230971|463739219|FG000|Baseline Participants|No bacteria observed|1|||
128848551|NCT00230971|463739220|FG001|Baseline Participants|No bacteria observed|0|||
128848552|NCT00230971|463739219|FG000|Baseline Participants|Failure to return|1|||
128848553|NCT00230971|463739220|FG001|Baseline Participants|Failure to return|1|||
128848554|NCT00230971|463739219|FG000|Baseline Participants|Reintervention|1|||
128848555|NCT00230971|463739220|FG001|Baseline Participants|Reintervention|0|||
128848556|NCT00684203|463740714|FG000|Overall Study|Adverse Event|6|||
128848557|NCT00684203|463740715|FG001|Overall Study|Adverse Event|4|||
128848558|NCT00684203|463740716|FG002|Overall Study|Adverse Event|8|||
128848559|NCT00684203|463740717|FG003|Overall Study|Adverse Event|0|||
128848560|NCT00684203|463740718|FG004|Overall Study|Adverse Event|0|||
128848561|NCT00684203|463740719|FG005|Overall Study|Adverse Event|0|||
128848562|NCT00684203|463740714|FG000|Overall Study|Protocol-defined clinical event|3|||
128848563|NCT00684203|463740715|FG001|Overall Study|Protocol-defined clinical event|1|||
128848564|NCT00684203|463740716|FG002|Overall Study|Protocol-defined clinical event|0|||
128848565|NCT00684203|463740717|FG003|Overall Study|Protocol-defined clinical event|0|||
128848566|NCT00684203|463740718|FG004|Overall Study|Protocol-defined clinical event|0|||
128848567|NCT00684203|463740719|FG005|Overall Study|Protocol-defined clinical event|0|||
128848568|NCT00684203|463740714|FG000|Overall Study|Withdrawal by Subject|0|||
128848569|NCT00684203|463740715|FG001|Overall Study|Withdrawal by Subject|2|||
128848570|NCT00684203|463740716|FG002|Overall Study|Withdrawal by Subject|1|||
128848571|NCT00684203|463740717|FG003|Overall Study|Withdrawal by Subject|0|||
128848572|NCT00684203|463740718|FG004|Overall Study|Withdrawal by Subject|0|||
128848573|NCT00684203|463740719|FG005|Overall Study|Withdrawal by Subject|0|||
128848574|NCT00684203|463740714|FG000|Overall Study|Did not meet protocol eligibility|0|||
128848575|NCT00684203|463740715|FG001|Overall Study|Did not meet protocol eligibility|1|||
128848576|NCT00684203|463740716|FG002|Overall Study|Did not meet protocol eligibility|0|||
128848577|NCT00684203|463740717|FG003|Overall Study|Did not meet protocol eligibility|0|||
128848578|NCT00684203|463740718|FG004|Overall Study|Did not meet protocol eligibility|0|||
128848579|NCT00684203|463740719|FG005|Overall Study|Did not meet protocol eligibility|0|||
128848580|NCT00719212|463740722|FG000|Overall Study|Death|41|||
128848581|NCT00719212|463740722|FG000|Overall Study|Lost to Follow-up|2|||
128848582|NCT00719212|463740722|FG000|Overall Study|Withdrawal by Subject|1|||
128848583|NCT02151643|463740725|FG000|Overall Study|Adverse Event|2|||
128848584|NCT02151643|463740726|FG001|Overall Study|Adverse Event|0|||
128848585|NCT02151643|463740727|FG002|Overall Study|Adverse Event|1|||
128848586|NCT02151643|463740728|FG003|Overall Study|Adverse Event|4|||
128848587|NCT02151643|463740729|FG004|Overall Study|Adverse Event|0|||
128848588|NCT02151643|463740725|FG000|Overall Study|Withdrawal by Subject|0|||
128848589|NCT02151643|463740726|FG001|Overall Study|Withdrawal by Subject|1|||
128848590|NCT02151643|463740727|FG002|Overall Study|Withdrawal by Subject|1|||
128848591|NCT02151643|463740728|FG003|Overall Study|Withdrawal by Subject|1|||
128848592|NCT02151643|463740729|FG004|Overall Study|Withdrawal by Subject|1|||
128848593|NCT02151643|463740725|FG000|Overall Study|Hyperphosphataemia|1|||
128848594|NCT02151643|463740726|FG001|Overall Study|Hyperphosphataemia|0|||
128848595|NCT02151643|463740727|FG002|Overall Study|Hyperphosphataemia|0|||
128848596|NCT02151643|463740728|FG003|Overall Study|Hyperphosphataemia|0|||
128848597|NCT02151643|463740729|FG004|Overall Study|Hyperphosphataemia|1|||
128848598|NCT02151643|463740725|FG000|Overall Study|High Ferritin levels|3|||
128848599|NCT02151643|463740726|FG001|Overall Study|High Ferritin levels|3|||
128848600|NCT02151643|463740727|FG002|Overall Study|High Ferritin levels|2|||
128848601|NCT02151643|463740728|FG003|Overall Study|High Ferritin levels|2|||
128848602|NCT02151643|463740729|FG004|Overall Study|High Ferritin levels|1|||
128848603|NCT00508274|463740732|FG000|Overall Study|Adverse Event|5|||
128848604|NCT00508274|463740732|FG000|Overall Study|Death|7|||
128848605|NCT00508274|463740732|FG000|Overall Study|Disease progression|32|||
128848606|NCT00508274|463740732|FG000|Overall Study|Withdrawal by Subject|1|||
128848607|NCT00508274|463740732|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
128848608|NCT00508274|463740732|FG000|Overall Study|Missing|3|||
128848609|NCT03296566|463740733|FG000|Overall Study|Lost to Follow-up|19|||
128848610|NCT03296566|463740734|FG001|Overall Study|Lost to Follow-up|46|||
128848611|NCT03296566|463740733|FG000|Overall Study|Withdrawal by Subject|0|||
128848612|NCT03296566|463740734|FG001|Overall Study|Withdrawal by Subject|3|||
128848613|NCT01084239|463740737|FG000|28-Day Follow-up|Lost to Follow-up|4|||
128848614|NCT01084239|463740738|FG001|28-Day Follow-up|Lost to Follow-up|9|||
128848615|NCT02679079|463740739|FG000|Overall Study|Adverse Event|2|||
128848616|NCT02679079|463740740|FG001|Overall Study|Adverse Event|0|||
128848617|NCT02679079|463740741|FG002|Overall Study|Adverse Event|2|||
128848618|NCT02679079|463740739|FG000|Overall Study|Protocol Violation|0|||
128848619|NCT02679079|463740740|FG001|Overall Study|Protocol Violation|1|||
128848620|NCT02679079|463740741|FG002|Overall Study|Protocol Violation|0|||
128848621|NCT02679079|463740739|FG000|Overall Study|Withdrawal by Subject|2|||
128848622|NCT02679079|463740740|FG001|Overall Study|Withdrawal by Subject|1|||
128848623|NCT02679079|463740741|FG002|Overall Study|Withdrawal by Subject|0|||
128848624|NCT03924947|463740742|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
128848625|NCT03924947|463740743|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
128848626|NCT03924947|463740744|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
128848627|NCT03924947|463740745|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
128848628|NCT03924947|463740746|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
128848629|NCT03924947|463740747|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
128848630|NCT04150341|463740748|FG000|Overall Study|Physician Decision|0|||
128848631|NCT04150341|463740749|FG001|Overall Study|Physician Decision|0|||
128848632|NCT04150341|463740750|FG002|Overall Study|Physician Decision|1|||
128848633|NCT04150341|463740751|FG003|Overall Study|Physician Decision|0|||
128848634|NCT04150341|463740752|FG004|Overall Study|Physician Decision|0|||
128848635|NCT04150341|463740753|FG005|Overall Study|Physician Decision|0|||
128848636|NCT04150341|463740748|FG000|Overall Study|Adverse Event|0|||
128848637|NCT04150341|463740749|FG001|Overall Study|Adverse Event|0|||
128848638|NCT04150341|463740750|FG002|Overall Study|Adverse Event|0|||
128848639|NCT04150341|463740751|FG003|Overall Study|Adverse Event|0|||
128848640|NCT04150341|463740752|FG004|Overall Study|Adverse Event|1|||
128848641|NCT04150341|463740753|FG005|Overall Study|Adverse Event|0|||
128848642|NCT00899379|463740754|FG000|Overall Study|Adverse Event|2|||
128848643|NCT00899379|463740755|FG001|Overall Study|Adverse Event|2|||
128848644|NCT00899379|463740756|FG002|Overall Study|Adverse Event|1|||
128848645|NCT00899379|463740757|FG003|Overall Study|Adverse Event|1|||
128848646|NCT00899379|463740758|FG004|Overall Study|Adverse Event|2|||
128848647|NCT00899379|463740754|FG000|Overall Study|Lack of Efficacy|0|||
128848648|NCT00899379|463740755|FG001|Overall Study|Lack of Efficacy|4|||
128848649|NCT00899379|463740756|FG002|Overall Study|Lack of Efficacy|3|||
128848650|NCT00899379|463740757|FG003|Overall Study|Lack of Efficacy|0|||
128848651|NCT00899379|463740758|FG004|Overall Study|Lack of Efficacy|1|||
128848652|NCT00899379|463740754|FG000|Overall Study|Lost to Follow-up|9|||
128848653|NCT00899379|463740755|FG001|Overall Study|Lost to Follow-up|3|||
128848654|NCT00899379|463740756|FG002|Overall Study|Lost to Follow-up|0|||
128848655|NCT00899379|463740757|FG003|Overall Study|Lost to Follow-up|6|||
128848656|NCT00899379|463740758|FG004|Overall Study|Lost to Follow-up|2|||
128848657|NCT00899379|463740754|FG000|Overall Study|Protocol Violation|0|||
128848658|NCT00899379|463740755|FG001|Overall Study|Protocol Violation|0|||
128848659|NCT00899379|463740756|FG002|Overall Study|Protocol Violation|1|||
128848660|NCT00899379|463740757|FG003|Overall Study|Protocol Violation|1|||
128848661|NCT00899379|463740758|FG004|Overall Study|Protocol Violation|0|||
128848662|NCT00899379|463740754|FG000|Overall Study|Withdrawal by Subject|2|||
128848663|NCT00899379|463740755|FG001|Overall Study|Withdrawal by Subject|4|||
128848664|NCT00899379|463740756|FG002|Overall Study|Withdrawal by Subject|2|||
128848665|NCT00899379|463740757|FG003|Overall Study|Withdrawal by Subject|3|||
128848666|NCT00899379|463740758|FG004|Overall Study|Withdrawal by Subject|6|||
128848667|NCT00899379|463740754|FG000|Overall Study|Pregnancy|0|||
128848668|NCT00899379|463740755|FG001|Overall Study|Pregnancy|0|||
128848669|NCT00899379|463740756|FG002|Overall Study|Pregnancy|1|||
128848670|NCT00899379|463740757|FG003|Overall Study|Pregnancy|0|||
128848671|NCT00899379|463740758|FG004|Overall Study|Pregnancy|1|||
128848672|NCT00899379|463740754|FG000|Overall Study|Patient Uncooperative|0|||
128848673|NCT00899379|463740755|FG001|Overall Study|Patient Uncooperative|1|||
128848674|NCT00899379|463740756|FG002|Overall Study|Patient Uncooperative|0|||
128848675|NCT00899379|463740757|FG003|Overall Study|Patient Uncooperative|1|||
128848676|NCT00899379|463740758|FG004|Overall Study|Patient Uncooperative|2|||
128848677|NCT00899379|463740754|FG000|Overall Study|Abnormal Baseline ECG|0|||
128848678|NCT00899379|463740755|FG001|Overall Study|Abnormal Baseline ECG|0|||
128848679|NCT00899379|463740756|FG002|Overall Study|Abnormal Baseline ECG|0|||
128848680|NCT00899379|463740757|FG003|Overall Study|Abnormal Baseline ECG|1|||
128848681|NCT00899379|463740758|FG004|Overall Study|Abnormal Baseline ECG|0|||
128848682|NCT00899379|463740754|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
128848683|NCT00899379|463740755|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
128848684|NCT00899379|463740756|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
128848685|NCT00899379|463740757|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128848686|NCT00899379|463740758|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128848687|NCT00899379|463740754|FG000|Overall Study|Not Completed/Entered Extn|5|||
128848688|NCT00899379|463740755|FG001|Overall Study|Not Completed/Entered Extn|1|||
128848689|NCT00899379|463740756|FG002|Overall Study|Not Completed/Entered Extn|6|||
128848690|NCT00899379|463740757|FG003|Overall Study|Not Completed/Entered Extn|4|||
128848691|NCT00899379|463740758|FG004|Overall Study|Not Completed/Entered Extn|3|||
128848692|NCT00899379|463740754|FG000|Overall Study|Study Terminated|3|||
128848693|NCT00899379|463740755|FG001|Overall Study|Study Terminated|0|||
128848694|NCT00899379|463740756|FG002|Overall Study|Study Terminated|3|||
128848695|NCT00899379|463740757|FG003|Overall Study|Study Terminated|3|||
128848696|NCT00899379|463740758|FG004|Overall Study|Study Terminated|1|||
128848697|NCT00899379|463740754|FG000|Overall Study|Lost to Follow-up|3|||
128848698|NCT00899379|463740755|FG001|Overall Study|Lost to Follow-up|1|||
128848699|NCT00899379|463740756|FG002|Overall Study|Lost to Follow-up|0|||
128848700|NCT00899379|463740757|FG003|Overall Study|Lost to Follow-up|2|||
128848701|NCT00899379|463740758|FG004|Overall Study|Lost to Follow-up|5|||
128848702|NCT00899379|463740754|FG000|Overall Study|Withdrawal by Subject|4|||
128848703|NCT00899379|463740755|FG001|Overall Study|Withdrawal by Subject|7|||
128848704|NCT00899379|463740756|FG002|Overall Study|Withdrawal by Subject|4|||
128848705|NCT00899379|463740757|FG003|Overall Study|Withdrawal by Subject|7|||
128848706|NCT00899379|463740758|FG004|Overall Study|Withdrawal by Subject|2|||
128848707|NCT00899379|463740754|FG000|Overall Study|Pregnancy|1|||
128848708|NCT00899379|463740755|FG001|Overall Study|Pregnancy|0|||
128848709|NCT00899379|463740756|FG002|Overall Study|Pregnancy|0|||
128848710|NCT00899379|463740757|FG003|Overall Study|Pregnancy|0|||
128848711|NCT00899379|463740758|FG004|Overall Study|Pregnancy|0|||
128848712|NCT00899379|463740754|FG000|Overall Study|Patient Uncooperative|0|||
128848713|NCT00899379|463740755|FG001|Overall Study|Patient Uncooperative|0|||
128848714|NCT00899379|463740756|FG002|Overall Study|Patient Uncooperative|0|||
128848715|NCT00899379|463740757|FG003|Overall Study|Patient Uncooperative|1|||
128848716|NCT00899379|463740758|FG004|Overall Study|Patient Uncooperative|0|||
128848717|NCT00899379|463740754|FG000|Overall Study|Abnormal Prestudy Labs|0|||
128848718|NCT00899379|463740755|FG001|Overall Study|Abnormal Prestudy Labs|0|||
128848719|NCT00899379|463740756|FG002|Overall Study|Abnormal Prestudy Labs|0|||
128848720|NCT00899379|463740757|FG003|Overall Study|Abnormal Prestudy Labs|0|||
128848721|NCT00899379|463740758|FG004|Overall Study|Abnormal Prestudy Labs|2|||
128848722|NCT00899379|463740754|FG000|Overall Study|Abnormal Baseline ECG|0|||
128848723|NCT00899379|463740755|FG001|Overall Study|Abnormal Baseline ECG|0|||
128848724|NCT00899379|463740756|FG002|Overall Study|Abnormal Baseline ECG|1|||
128848725|NCT00899379|463740757|FG003|Overall Study|Abnormal Baseline ECG|1|||
128848726|NCT00899379|463740758|FG004|Overall Study|Abnormal Baseline ECG|0|||
128848727|NCT00899379|463740754|FG000|Overall Study|No Attack Pretreatment|3|||
128848728|NCT00899379|463740755|FG001|Overall Study|No Attack Pretreatment|5|||
128848729|NCT00899379|463740756|FG002|Overall Study|No Attack Pretreatment|5|||
128848730|NCT00899379|463740757|FG003|Overall Study|No Attack Pretreatment|6|||
128848731|NCT00899379|463740758|FG004|Overall Study|No Attack Pretreatment|4|||
128848732|NCT00899379|463740754|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
128848733|NCT00899379|463740755|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128848734|NCT00899379|463740756|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128848735|NCT00899379|463740757|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128848736|NCT00899379|463740758|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
128848737|NCT00899379|463740754|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
128848738|NCT00899379|463740755|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
128848739|NCT00899379|463740756|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
128848740|NCT00899379|463740757|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
128848741|NCT00899379|463740758|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
128848742|NCT02581189|463740763|FG000|Overall Study|Failure to return|36|||
128848743|NCT02581189|463740763|FG000|Overall Study|Withdrew consent|5|||
128848744|NCT02581189|463740763|FG000|Overall Study|Death|3|||
128848745|NCT02581189|463740763|FG000|Overall Study|Insufficient virological response|2|||
128848746|NCT02581189|463740763|FG000|Overall Study|Other, not specified|7|||
128848747|NCT00843115|463740764|FG000|Overall Study|Death|4|||
128848748|NCT00843115|463740764|FG000|Overall Study|Adverse Event|30|||
128848749|NCT00843115|463740764|FG000|Overall Study|Lost to Follow-up|4|||
128848750|NCT00843115|463740764|FG000|Overall Study|Withdrawal by Subject|17|||
128848751|NCT00843115|463740764|FG000|Overall Study|Family wanted meds stopped|1|||
128848752|NCT00843115|463740764|FG000|Overall Study|Family does not want continuation|1|||
128848753|NCT00843115|463740764|FG000|Overall Study|Patient forgot to take meds|1|||
128848754|NCT00843115|463740764|FG000|Overall Study|Does not meet entrance criteria|1|||
128848755|NCT00843115|463740764|FG000|Overall Study|Physician Decision|1|||
128848756|NCT00843115|463740764|FG000|Overall Study|Family discontinued meds|1|||
128848757|NCT00843115|463740764|FG000|Overall Study|patient took for 2 days then stopped|1|||
128848758|NCT00843115|463740764|FG000|Overall Study|patient never took the medication|1|||
128848759|NCT00843115|463740764|FG000|Overall Study|hospitalized due to deterioration|1|||
128848760|NCT00843115|463740764|FG000|Overall Study|week 12 not done|1|||
128848761|NCT00843115|463740764|FG000|Overall Study|Syndrome De Glissement|1|||
128848762|NCT03371485|463740768|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
128848763|NCT03371485|463740768|FG000|2-year Follow-up|Death|5|||
128848764|NCT02204319|463740769|FG000|Overall Study|Pregnancy|1|||
128848765|NCT02204319|463740769|FG000|Overall Study|Withdrawal by Subject|2|||
128848766|NCT01177137|463740774|FG000|Overall Study|Withdrawal by Subject|10|||
128848767|NCT01177137|463740775|FG001|Overall Study|Withdrawal by Subject|10|||
128848768|NCT01177137|463740776|FG002|Overall Study|Withdrawal by Subject|2|||
128848769|NCT02959177|463740777|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
128848770|NCT02959177|463740778|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
128848771|NCT02959177|463740779|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
128848772|NCT02959177|463740777|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
128848773|NCT02959177|463740778|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
128848774|NCT02959177|463740779|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
128848775|NCT02959177|463740777|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
128848776|NCT02959177|463740778|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
128848777|NCT02959177|463740779|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
128848778|NCT02959177|463740777|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
128848779|NCT02959177|463740778|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
128848780|NCT02959177|463740779|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
128848781|NCT02959177|463740777|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
128848782|NCT02959177|463740778|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
128848783|NCT02959177|463740779|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
128848784|NCT02959177|463740777|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
128848785|NCT02959177|463740778|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
128848786|NCT02959177|463740779|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
128848787|NCT02959177|463740777|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
128848788|NCT02959177|463740778|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
128848789|NCT02959177|463740779|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
128848790|NCT04531813|463740784|FG000|Overall Study|Protocol Violation|1|||
128848791|NCT04531813|463740784|FG000|Overall Study|Withdrawal by Subject|1|||
128848792|NCT02171130|463740785|FG000|Overall Study|Death|1|||
128848793|NCT02171130|463740785|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
128848794|NCT02171130|463740785|FG000|Overall Study|Discontinued; Site Termination|5|||
128848795|NCT02171130|463740785|FG000|Overall Study|Withdrawal by Subject|3|||
128848796|NCT02171130|463740785|FG000|Overall Study|Physician Decision|1|||
128848797|NCT02171130|463740785|FG000|Overall Study|Lost to Follow-up|1|||
128848798|NCT02171130|463740785|FG000|Overall Study|Met Exclusion Criteria|1|||
128848799|NCT02853305|463740788|FG000|Overall Study|Death|287|||
128848800|NCT02853305|463740789|FG001|Overall Study|Death|249|||
128848801|NCT02853305|463740790|FG002|Overall Study|Death|300|||
128848802|NCT02853305|463740788|FG000|Overall Study|Withdrawal by Subject|2|||
128848803|NCT02853305|463740789|FG001|Overall Study|Withdrawal by Subject|8|||
128848804|NCT02853305|463740790|FG002|Overall Study|Withdrawal by Subject|3|||
128848805|NCT02853305|463740788|FG000|Overall Study|Transferred to Extension Study|46|||
128848806|NCT02853305|463740789|FG001|Overall Study|Transferred to Extension Study|30|||
128848807|NCT02853305|463740790|FG002|Overall Study|Transferred to Extension Study|25|||
128848808|NCT02853305|463740788|FG000|Overall Study|Did Not Continue on Extension Study|16|||
128848809|NCT02853305|463740789|FG001|Overall Study|Did Not Continue on Extension Study|20|||
128848810|NCT02853305|463740790|FG002|Overall Study|Did Not Continue on Extension Study|24|||
128848811|NCT02381652|463740793|FG000|Overall Study|Withdrawal by Subject|0|||
128848812|NCT02381652|463740794|FG001|Overall Study|Withdrawal by Subject|0|||
128848813|NCT02381652|463740795|FG002|Overall Study|Withdrawal by Subject|1|||
128848814|NCT01340300|463740796|FG000|Overall Study|Lost to Follow-up|3|||
128848815|NCT01340300|463740797|FG001|Overall Study|Lost to Follow-up|0|||
128848816|NCT01340300|463740798|FG002|Overall Study|Lost to Follow-up|5|||
128848817|NCT01340300|463740799|FG003|Overall Study|Lost to Follow-up|10|||
128848818|NCT01340300|463740796|FG000|Overall Study|Withdrawal by Subject|5|||
128848819|NCT01340300|463740797|FG001|Overall Study|Withdrawal by Subject|6|||
128848820|NCT01340300|463740798|FG002|Overall Study|Withdrawal by Subject|6|||
128848821|NCT01340300|463740799|FG003|Overall Study|Withdrawal by Subject|3|||
128848822|NCT01340300|463740796|FG000|Overall Study|Adverse Event|1|||
128848823|NCT01340300|463740797|FG001|Overall Study|Adverse Event|0|||
128848824|NCT01340300|463740798|FG002|Overall Study|Adverse Event|4|||
128848825|NCT01340300|463740799|FG003|Overall Study|Adverse Event|0|||
128848826|NCT01340300|463740796|FG000|Overall Study|Physician Decision|0|||
128848827|NCT01340300|463740797|FG001|Overall Study|Physician Decision|1|||
128848828|NCT01340300|463740798|FG002|Overall Study|Physician Decision|0|||
128848829|NCT01340300|463740799|FG003|Overall Study|Physician Decision|0|||
128848830|NCT01340300|463740796|FG000|Overall Study|Unrelated sickness|0|||
128848831|NCT01340300|463740797|FG001|Overall Study|Unrelated sickness|2|||
128848832|NCT01340300|463740798|FG002|Overall Study|Unrelated sickness|0|||
128848833|NCT01340300|463740799|FG003|Overall Study|Unrelated sickness|1|||
128848834|NCT03544229|463740800|FG000|Overall Study|Adverse Event|1|||
128848835|NCT03544229|463740801|FG001|Overall Study|Adverse Event|0|||
128848836|NCT03544229|463740802|FG002|Overall Study|Adverse Event|1|||
128848837|NCT03544229|463740803|FG003|Overall Study|Adverse Event|0|||
128848838|NCT03544229|463740800|FG000|Overall Study|Protocol Deviation|0|||
128848839|NCT03544229|463740801|FG001|Overall Study|Protocol Deviation|0|||
128848840|NCT03544229|463740802|FG002|Overall Study|Protocol Deviation|1|||
128848841|NCT03544229|463740803|FG003|Overall Study|Protocol Deviation|0|||
128848842|NCT03544229|463740800|FG000|Overall Study|Lost to Follow-up|3|||
128848843|NCT03544229|463740801|FG001|Overall Study|Lost to Follow-up|0|||
128848844|NCT03544229|463740802|FG002|Overall Study|Lost to Follow-up|0|||
128848845|NCT03544229|463740803|FG003|Overall Study|Lost to Follow-up|2|||
128848846|NCT03544229|463740800|FG000|Overall Study|Voluntary Withdrawal|2|||
128848847|NCT03544229|463740801|FG001|Overall Study|Voluntary Withdrawal|1|||
128848848|NCT03544229|463740802|FG002|Overall Study|Voluntary Withdrawal|3|||
128848849|NCT03544229|463740803|FG003|Overall Study|Voluntary Withdrawal|0|||
128848850|NCT03544229|463740800|FG000|Overall Study|Lack of Efficacy|0|||
128848851|NCT03544229|463740801|FG001|Overall Study|Lack of Efficacy|1|||
128848852|NCT03544229|463740802|FG002|Overall Study|Lack of Efficacy|0|||
128848853|NCT03544229|463740803|FG003|Overall Study|Lack of Efficacy|0|||
128848854|NCT04772313|463740804|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
128848855|NCT04772313|463740804|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
128848856|NCT01836198|463740806|FG000|Part A, Period 2|Protocol Violation|0|||
128848857|NCT01836198|463740807|FG001|Part A, Period 2|Protocol Violation|1|||
128848858|NCT01836198|463740808|FG002|Part A, Period 2|Protocol Violation|0|||
128848859|NCT03187353|463740809|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
128848860|NCT03187353|463740810|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
128848861|NCT03187353|463740809|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
128848862|NCT03187353|463740810|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
128848863|NCT03187353|463740809|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
128848864|NCT03187353|463740810|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
128848865|NCT03187353|463740809|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
128848866|NCT03187353|463740810|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
128848867|NCT03187353|463740809|FG000|Washout (2 Weeks)|Adverse Event|2|||
128848868|NCT03187353|463740810|FG001|Washout (2 Weeks)|Adverse Event|0|||
128848869|NCT03187353|463740809|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
128848870|NCT03187353|463740810|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
128848871|NCT02215954|463740811|FG000|Overall Study|Adverse Event|0|||
128848872|NCT02215954|463740812|FG001|Overall Study|Adverse Event|0|||
128848873|NCT02215954|463740813|FG002|Overall Study|Adverse Event|1|||
128848874|NCT02215954|463740811|FG000|Overall Study|Withdrawal by Subject|0|||
128848875|NCT02215954|463740812|FG001|Overall Study|Withdrawal by Subject|0|||
128848876|NCT02215954|463740813|FG002|Overall Study|Withdrawal by Subject|2|||
128848877|NCT02215954|463740811|FG000|Overall Study|Not exposed|1|||
128848878|NCT02215954|463740812|FG001|Overall Study|Not exposed|1|||
128848879|NCT02215954|463740813|FG002|Overall Study|Not exposed|3|||
128848880|NCT02460562|463740814|FG000|Overall Study|Lost to Follow-up|15|||
128848881|NCT02460562|463740815|FG001|Overall Study|Lost to Follow-up|16|||
128848882|NCT01654289|463740816|FG000|Overall Study|Withdrawal by Subject|10|||
128848883|NCT01654289|463740817|FG001|Overall Study|Withdrawal by Subject|8|||
128848884|NCT01654289|463740818|FG002|Overall Study|Withdrawal by Subject|5|||
128848885|NCT01654289|463740816|FG000|Overall Study|Withdrew from intervention only|17|||
128848886|NCT01654289|463740817|FG001|Overall Study|Withdrew from intervention only|20|||
128848887|NCT01654289|463740818|FG002|Overall Study|Withdrew from intervention only|0|||
128848888|NCT03746483|463740819|FG000|Overall Study|Adverse Event|0|||
128848889|NCT03746483|463740820|FG001|Overall Study|Adverse Event|1|||
128848890|NCT03746483|463740819|FG000|Overall Study|Lack of Efficacy|3|||
128848891|NCT03746483|463740820|FG001|Overall Study|Lack of Efficacy|2|||
128848892|NCT03746483|463740819|FG000|Overall Study|Lost to Follow-up|1|||
128848893|NCT03746483|463740820|FG001|Overall Study|Lost to Follow-up|0|||
128848894|NCT03746483|463740819|FG000|Overall Study|Protocol Violation|2|||
128848895|NCT03746483|463740820|FG001|Overall Study|Protocol Violation|0|||
128848896|NCT00187135|463740821|FG000|Visit One|Withdrawal by Subject|1|||
128848897|NCT00187135|463740822|FG001|Visit One|Withdrawal by Subject|0|||
128848898|NCT00187135|463740823|FG002|Visit One|Withdrawal by Subject|0|||
128848899|NCT00187135|463740824|FG003|Visit One|Withdrawal by Subject|0|||
128848900|NCT00187135|463740825|FG004|Visit One|Withdrawal by Subject|0|||
128848901|NCT00187135|463740826|FG005|Visit One|Withdrawal by Subject|1|||
128848902|NCT00187135|463740821|FG000|Visit One|Physician Decision|3|||
128848903|NCT00187135|463740822|FG001|Visit One|Physician Decision|1|||
128848904|NCT00187135|463740823|FG002|Visit One|Physician Decision|0|||
128848905|NCT00187135|463740824|FG003|Visit One|Physician Decision|0|||
128848906|NCT00187135|463740825|FG004|Visit One|Physician Decision|0|||
128848907|NCT00187135|463740826|FG005|Visit One|Physician Decision|1|||
128848908|NCT00187135|463740821|FG000|Visit Two|Death|0|||
128848909|NCT00187135|463740822|FG001|Visit Two|Death|0|||
128848910|NCT00187135|463740823|FG002|Visit Two|Death|0|||
128848911|NCT00187135|463740824|FG003|Visit Two|Death|1|||
128848912|NCT00187135|463740825|FG004|Visit Two|Death|0|||
128848913|NCT00187135|463740826|FG005|Visit Two|Death|1|||
128848914|NCT00187135|463740821|FG000|Visit Two|Physician Decision|1|||
128848915|NCT00187135|463740822|FG001|Visit Two|Physician Decision|0|||
128848916|NCT00187135|463740823|FG002|Visit Two|Physician Decision|0|||
128848917|NCT00187135|463740824|FG003|Visit Two|Physician Decision|0|||
128848918|NCT00187135|463740825|FG004|Visit Two|Physician Decision|0|||
128848919|NCT00187135|463740826|FG005|Visit Two|Physician Decision|0|||
128848920|NCT00187135|463740821|FG000|Visit Two|Withdrawal by Subject|1|||
128848921|NCT00187135|463740822|FG001|Visit Two|Withdrawal by Subject|1|||
128848922|NCT00187135|463740823|FG002|Visit Two|Withdrawal by Subject|1|||
128848923|NCT00187135|463740824|FG003|Visit Two|Withdrawal by Subject|0|||
128848924|NCT00187135|463740825|FG004|Visit Two|Withdrawal by Subject|1|||
128848925|NCT00187135|463740826|FG005|Visit Two|Withdrawal by Subject|1|||
128848926|NCT00187135|463740821|FG000|Visit Two|Study Discontinued|3|||
128848927|NCT00187135|463740822|FG001|Visit Two|Study Discontinued|2|||
128848928|NCT00187135|463740823|FG002|Visit Two|Study Discontinued|1|||
128848929|NCT00187135|463740824|FG003|Visit Two|Study Discontinued|7|||
128848930|NCT00187135|463740825|FG004|Visit Two|Study Discontinued|5|||
128848931|NCT00187135|463740826|FG005|Visit Two|Study Discontinued|6|||
128848932|NCT00187135|463740821|FG000|Visit Three|Death|0|||
128848933|NCT00187135|463740822|FG001|Visit Three|Death|0|||
128848934|NCT00187135|463740823|FG002|Visit Three|Death|1|||
128848935|NCT00187135|463740824|FG003|Visit Three|Death|0|||
128848936|NCT00187135|463740825|FG004|Visit Three|Death|1|||
128848937|NCT00187135|463740826|FG005|Visit Three|Death|0|||
128848938|NCT00187135|463740821|FG000|Visit Three|Withdrawal by Subject|0|||
128848939|NCT00187135|463740822|FG001|Visit Three|Withdrawal by Subject|1|||
128848940|NCT00187135|463740823|FG002|Visit Three|Withdrawal by Subject|1|||
128848941|NCT00187135|463740824|FG003|Visit Three|Withdrawal by Subject|2|||
128848942|NCT00187135|463740825|FG004|Visit Three|Withdrawal by Subject|0|||
128848943|NCT00187135|463740826|FG005|Visit Three|Withdrawal by Subject|0|||
128848944|NCT00187135|463740821|FG000|Visit Three|Study Discontinued|7|||
128848945|NCT00187135|463740822|FG001|Visit Three|Study Discontinued|6|||
128848946|NCT00187135|463740823|FG002|Visit Three|Study Discontinued|7|||
128848947|NCT00187135|463740824|FG003|Visit Three|Study Discontinued|7|||
128848948|NCT00187135|463740825|FG004|Visit Three|Study Discontinued|7|||
128848949|NCT00187135|463740826|FG005|Visit Three|Study Discontinued|6|||
128848950|NCT01951261|463740827|FG000|Overall Study|Death|1|||
128848951|NCT01951261|463740828|FG001|Overall Study|Death|0|||
128848952|NCT01951261|463740827|FG000|Overall Study|Lost to Follow-up|4|||
128848953|NCT01951261|463740828|FG001|Overall Study|Lost to Follow-up|3|||
128848954|NCT01951261|463740827|FG000|Overall Study|Protocol Violation|4|||
128848955|NCT01951261|463740828|FG001|Overall Study|Protocol Violation|3|||
128848956|NCT01924806|463740829|FG000|Overall Study|Physician Decision|2|||
128848957|NCT01924806|463740830|FG001|Overall Study|Physician Decision|1|||
128848958|NCT01954771|463740831|FG000|Overall Study|Missing HbA1c of end-point|1|||
128848959|NCT01954771|463740832|FG001|Overall Study|Missing HbA1c of end-point|1|||
128848960|NCT01954771|463740833|FG002|Overall Study|Missing HbA1c of end-point|0|||
128848961|NCT01954771|463740831|FG000|Overall Study|Missing CGMS of end-point|1|||
128848962|NCT01954771|463740832|FG001|Overall Study|Missing CGMS of end-point|1|||
128848963|NCT01954771|463740833|FG002|Overall Study|Missing CGMS of end-point|0|||
128848964|NCT01954771|463740831|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
128848965|NCT01954771|463740832|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
128848966|NCT01954771|463740833|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
128848967|NCT03635775|463740836|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
128848968|NCT03635775|463740837|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
128848969|NCT03635775|463740838|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
128848970|NCT03635775|463740839|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
128848971|NCT02996097|463740841|FG000|Overall Study|Lost to Follow-up|11|||
128848972|NCT02996097|463740842|FG001|Overall Study|Lost to Follow-up|11|||
128848973|NCT00583115|463740843|FG000|Overall Study|Death|1|||
128848974|NCT01287416|463740846|FG000|Pre-post Training|Withdrawal by Subject|17|||
128848975|NCT01287416|463740847|FG001|Pre-post Training|Withdrawal by Subject|24|||
128848976|NCT01287416|463740846|FG000|Pre-post Training|Lost to Follow-up|5|||
128848977|NCT01287416|463740847|FG001|Pre-post Training|Lost to Follow-up|1|||
128848978|NCT01287416|463740846|FG000|6 Month Follow-up|Lost to Follow-up|3|||
128848979|NCT01287416|463740847|FG001|6 Month Follow-up|Lost to Follow-up|2|||
128848980|NCT02109107|463740848|FG000|Overall Study|Lost to Follow-up|2|||
128848981|NCT02506881|463740854|FG000|First Intervention (Day 1)|Protocol Violation|0|||
128848982|NCT02506881|463740855|FG001|First Intervention (Day 1)|Protocol Violation|0|||
128848983|NCT02506881|463740856|FG002|First Intervention (Day 1)|Protocol Violation|1|||
128848984|NCT02506881|463740857|FG003|First Intervention (Day 1)|Protocol Violation|0|||
128848985|NCT02506881|463740854|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
128848986|NCT02506881|463740855|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
128848987|NCT02506881|463740856|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
128848988|NCT02506881|463740857|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
128848989|NCT02506881|463740854|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
128848990|NCT02506881|463740855|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
128848991|NCT02506881|463740856|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
128848992|NCT02506881|463740857|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
128848993|NCT01919398|463740858|FG000|Overall Study|Progressive Disease|0|||
128848994|NCT01919398|463740859|FG001|Overall Study|Progressive Disease|0|||
128848995|NCT01919398|463740860|FG002|Overall Study|Progressive Disease|4|||
128848996|NCT02016690|463740863|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
128848997|NCT02016690|463740863|FG000|Overall Study|Excluded from SAS: Duplication|2|||
128848998|NCT02016690|463740863|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
128848999|NCT02016690|463740863|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
128849000|NCT02016690|463740863|FG000|Overall Study|Did not meet inclusion criteria|13|||
128849001|NCT02016690|463740863|FG000|Overall Study|Hospitalized for RSV at study start|3|||
128849002|NCT00050167|463740864|FG000|Overall Study|not eligible not invasive|1|||
128849003|NCT00050167|463740865|FG001|Overall Study|not eligible not invasive|1|||
128849004|NCT00495612|463740868|FG000|Overall Study|Lost to Follow-up|1|||
128849005|NCT00495612|463740869|FG001|Overall Study|Lost to Follow-up|0|||
128849006|NCT00495612|463740868|FG000|Overall Study|Subject's Decision to Withdraw|3|||
128849007|NCT00495612|463740869|FG001|Overall Study|Subject's Decision to Withdraw|0|||
128849008|NCT06016127|463740872|FG000|Overall Study|Withdrawal by Subject|4|||
128849009|NCT06016127|463740873|FG001|Overall Study|Withdrawal by Subject|3|||
128849010|NCT02864147|463740879|FG000|Overall Study|Withdrawal by Subject|3|||
128849011|NCT02864147|463740880|FG001|Overall Study|Withdrawal by Subject|2|||
128849012|NCT02864147|463740881|FG002|Overall Study|Withdrawal by Subject|1|||
128849013|NCT02864147|463740879|FG000|Overall Study|Lost to Follow-up|0|||
128849014|NCT02864147|463740880|FG001|Overall Study|Lost to Follow-up|4|||
128849015|NCT02864147|463740881|FG002|Overall Study|Lost to Follow-up|0|||
128849016|NCT02864147|463740879|FG000|Overall Study|Adverse Event|0|||
128849017|NCT02864147|463740880|FG001|Overall Study|Adverse Event|1|||
128849018|NCT02864147|463740881|FG002|Overall Study|Adverse Event|0|||
128849019|NCT02864147|463740879|FG000|Overall Study|Pregnancy|4|||
128849020|NCT02864147|463740880|FG001|Overall Study|Pregnancy|0|||
128849021|NCT02864147|463740881|FG002|Overall Study|Pregnancy|0|||
128849022|NCT02864147|463740879|FG000|Overall Study|Physician Decision|0|||
128849023|NCT02864147|463740880|FG001|Overall Study|Physician Decision|0|||
128849024|NCT02864147|463740881|FG002|Overall Study|Physician Decision|1|||
128849025|NCT02864147|463740879|FG000|Overall Study|Opted for excisional procedures|0|||
128849026|NCT02864147|463740880|FG001|Overall Study|Opted for excisional procedures|0|||
128849027|NCT02864147|463740881|FG002|Overall Study|Opted for excisional procedures|3|||
128849028|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
128849029|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
128849030|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
128849031|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
128849032|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
128849033|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
128849034|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
128849035|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
128849036|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
128849037|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
128849038|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
128849039|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
128849040|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
128849041|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
128849042|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
128849043|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
128849044|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
128849045|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
128849046|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
128849047|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
128849048|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
128849049|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
128849050|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
128849051|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
128849052|NCT02269917|463740882|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
128849053|NCT02269917|463740883|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
128849054|NCT02269917|463740884|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
128849055|NCT02269917|463740882|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
128849056|NCT02269917|463740883|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
128849057|NCT02269917|463740884|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
128849058|NCT02269917|463740882|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
128849059|NCT02269917|463740883|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
128849060|NCT02269917|463740884|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
128849061|NCT02269917|463740882|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
128849062|NCT02269917|463740883|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
128849063|NCT02269917|463740884|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
128849064|NCT02269917|463740882|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
128849065|NCT02269917|463740883|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
128849066|NCT02269917|463740884|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
128849067|NCT02269917|463740882|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
128849068|NCT02269917|463740883|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
128849069|NCT02269917|463740884|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
128849070|NCT02269917|463740882|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
128849071|NCT02269917|463740883|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
128849072|NCT02269917|463740884|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
128849073|NCT02269917|463740882|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
128849074|NCT02269917|463740883|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
128849075|NCT02269917|463740884|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
128849076|NCT02383927|463740885|FG000|Overall Study|Disease Progression|8|||
128849077|NCT02383927|463740886|FG001|Overall Study|Disease Progression|8|||
128849078|NCT02383927|463740887|FG002|Overall Study|Disease Progression|15|||
128849079|NCT02383927|463740888|FG003|Overall Study|Disease Progression|4|||
128849080|NCT02383927|463740885|FG000|Overall Study|Physician Decision|0|||
128849081|NCT02383927|463740886|FG001|Overall Study|Physician Decision|0|||
128849082|NCT02383927|463740887|FG002|Overall Study|Physician Decision|2|||
128849083|NCT02383927|463740888|FG003|Overall Study|Physician Decision|0|||
128849084|NCT02383927|463740885|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
128849085|NCT02383927|463740886|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
128849086|NCT02383927|463740887|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
128849087|NCT02383927|463740888|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
128849088|NCT02383927|463740885|FG000|Overall Study|Adverse Event|4|||
128849089|NCT02383927|463740886|FG001|Overall Study|Adverse Event|1|||
128849090|NCT02383927|463740887|FG002|Overall Study|Adverse Event|3|||
128849091|NCT02383927|463740888|FG003|Overall Study|Adverse Event|5|||
128849092|NCT02383927|463740885|FG000|Overall Study|Miscellaneous|1|||
128849093|NCT02383927|463740886|FG001|Overall Study|Miscellaneous|0|||
128849094|NCT02383927|463740887|FG002|Overall Study|Miscellaneous|0|||
128849095|NCT02383927|463740888|FG003|Overall Study|Miscellaneous|1|||
128849096|NCT02383927|463740885|FG000|Overall Study|Withdrawal by Subject|0|||
128849097|NCT02383927|463740886|FG001|Overall Study|Withdrawal by Subject|1|||
128849098|NCT02383927|463740887|FG002|Overall Study|Withdrawal by Subject|4|||
128849099|NCT02383927|463740888|FG003|Overall Study|Withdrawal by Subject|0|||
128849100|NCT02865135|463740889|FG000|Overall Study|Death|0|||
128849101|NCT02865135|463740890|FG001|Overall Study|Death|1|||
128849102|NCT02865135|463740891|FG002|Overall Study|Death|0|||
128849103|NCT02865135|463740889|FG000|Overall Study|Progression|6|||
128849104|NCT02865135|463740890|FG001|Overall Study|Progression|2|||
128849105|NCT02865135|463740891|FG002|Overall Study|Progression|2|||
128849106|NCT02956278|463743220|FG000|Overall Study|Withdrawal by Subject|6|||
128849107|NCT02956278|463743221|FG001|Overall Study|Withdrawal by Subject|2|||
128849108|NCT02956278|463743222|FG002|Overall Study|Withdrawal by Subject|0|||
128849109|NCT00509821|463743232|FG000|Study Period 1 (Induction)|Death|0|||
128849110|NCT00509821|463743233|FG001|Study Period 1 (Induction)|Death|1|||
128849111|NCT00509821|463743232|FG000|Study Period 1 (Induction)|Adverse Event|0|||
128849112|NCT00509821|463743233|FG001|Study Period 1 (Induction)|Adverse Event|2|||
128849113|NCT00509821|463743232|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
128849114|NCT00509821|463743233|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
128849115|NCT01816685|463743237|FG000|Overall Study|Lost to Follow-up|7|||
128849116|NCT01816685|463743238|FG001|Overall Study|Lost to Follow-up|9|||
128849117|NCT01816685|463743237|FG000|Overall Study|Surgery Cancelled|3|||
128849118|NCT01816685|463743238|FG001|Overall Study|Surgery Cancelled|2|||
128849119|NCT02720185|463743239|FG000|Overall Study|Lost to Follow-up|1|||
128849120|NCT03418493|463743240|FG000|Overall Study|Adverse Event|1|||
128849121|NCT03418493|463743241|FG001|Overall Study|Adverse Event|0|||
128849122|NCT03418493|463743242|FG002|Overall Study|Adverse Event|0|||
128849123|NCT03418493|463743243|FG003|Overall Study|Adverse Event|0|||
128849124|NCT03418493|463743244|FG004|Overall Study|Adverse Event|0|||
128849125|NCT03418493|463743245|FG005|Overall Study|Adverse Event|0|||
128849126|NCT03418493|463743246|FG006|Overall Study|Adverse Event|0|||
128849127|NCT03418493|463743247|FG007|Overall Study|Adverse Event|0|||
128849128|NCT03418493|463743248|FG008|Overall Study|Adverse Event|0|||
128849129|NCT03418493|463743249|FG009|Overall Study|Adverse Event|0|||
128849130|NCT03418493|463743250|FG010|Overall Study|Adverse Event|0|||
128849131|NCT03418493|463743240|FG000|Overall Study|Protocol Violation|0|||
128849132|NCT03418493|463743241|FG001|Overall Study|Protocol Violation|0|||
128849133|NCT03418493|463743242|FG002|Overall Study|Protocol Violation|0|||
128849134|NCT03418493|463743243|FG003|Overall Study|Protocol Violation|0|||
128849135|NCT03418493|463743244|FG004|Overall Study|Protocol Violation|0|||
128849136|NCT03418493|463743245|FG005|Overall Study|Protocol Violation|0|||
128849137|NCT03418493|463743246|FG006|Overall Study|Protocol Violation|0|||
128849138|NCT03418493|463743247|FG007|Overall Study|Protocol Violation|0|||
128849139|NCT03418493|463743248|FG008|Overall Study|Protocol Violation|0|||
128849140|NCT03418493|463743249|FG009|Overall Study|Protocol Violation|1|||
128849141|NCT03418493|463743250|FG010|Overall Study|Protocol Violation|0|||
128849142|NCT05446714|463743251|FG000|Overall Study|Lost to Follow-up|1|||
128849143|NCT05446714|463743252|FG001|Overall Study|Lost to Follow-up|3|||
128849144|NCT05446714|463743253|FG002|Overall Study|Lost to Follow-up|2|||
128849145|NCT05446714|463743251|FG000|Overall Study|Protocol Violation|2|||
128849146|NCT05446714|463743252|FG001|Overall Study|Protocol Violation|0|||
128849147|NCT05446714|463743253|FG002|Overall Study|Protocol Violation|0|||
128849148|NCT00197106|463743254|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
128849149|NCT00197106|463743255|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
128849150|NCT00197106|463743256|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
128849151|NCT00197106|463743254|FG000|Overall Treatment Period|Lack of Efficacy|0|||
128849152|NCT00197106|463743255|FG001|Overall Treatment Period|Lack of Efficacy|1|||
128849153|NCT00197106|463743256|FG002|Overall Treatment Period|Lack of Efficacy|0|||
128849154|NCT00197106|463743254|FG000|Overall Treatment Period|Lost to Follow-up|0|||
128849155|NCT00197106|463743255|FG001|Overall Treatment Period|Lost to Follow-up|0|||
128849156|NCT00197106|463743256|FG002|Overall Treatment Period|Lost to Follow-up|2|||
128849157|NCT00197106|463743254|FG000|Overall Treatment Period|Protocol Violation|0|||
128849158|NCT00197106|463743255|FG001|Overall Treatment Period|Protocol Violation|0|||
128849159|NCT00197106|463743256|FG002|Overall Treatment Period|Protocol Violation|2|||
128849160|NCT00197106|463743254|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
128849161|NCT00197106|463743255|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
128849162|NCT00197106|463743256|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
128849163|NCT01990313|463743259|FG000|Overall Study|Lost to Follow-up|1|||
128849164|NCT02396953|463743260|FG000|Overall Study|Withdrawal by Subject|0|||
128849165|NCT02396953|463743261|FG001|Overall Study|Withdrawal by Subject|0|||
128849166|NCT02396953|463743262|FG002|Overall Study|Withdrawal by Subject|1|||
128849167|NCT02396953|463743260|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
128849168|NCT02396953|463743261|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
128849169|NCT02396953|463743262|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
128849170|NCT02396953|463743260|FG000|Overall Study|Personal Reasons|1|||
128849171|NCT02396953|463743261|FG001|Overall Study|Personal Reasons|1|||
128849172|NCT02396953|463743262|FG002|Overall Study|Personal Reasons|0|||
128849173|NCT00329550|463743266|FG000|Overall Study|Adverse Event|3|||
128849174|NCT00329550|463743267|FG001|Overall Study|Adverse Event|4|||
128849175|NCT00329550|463743268|FG002|Overall Study|Adverse Event|2|||
128849176|NCT00329550|463743266|FG000|Overall Study|Withdrawal of Consent|1|||
128849177|NCT00329550|463743267|FG001|Overall Study|Withdrawal of Consent|0|||
128849178|NCT00329550|463743268|FG002|Overall Study|Withdrawal of Consent|1|||
128849179|NCT00329550|463743266|FG000|Overall Study|Due to Relocation|0|||
128849180|NCT00329550|463743267|FG001|Overall Study|Due to Relocation|0|||
128849181|NCT00329550|463743268|FG002|Overall Study|Due to Relocation|1|||
128849182|NCT00833898|463743278|FG000|Overall Study|Withdrawal by Subject|33|||
128849183|NCT00833898|463743279|FG001|Overall Study|Withdrawal by Subject|27|||
128849184|NCT00833898|463743278|FG000|Overall Study|Lost to Follow-up|7|||
128849185|NCT00833898|463743279|FG001|Overall Study|Lost to Follow-up|7|||
128849186|NCT00833898|463743278|FG000|Overall Study|Patient did not receive transplant|0|||
128849187|NCT00833898|463743279|FG001|Overall Study|Patient did not receive transplant|2|||
128849188|NCT00805285|463743280|FG000|Overall Study|Lack of Efficacy|1|||
128849189|NCT00917462|463743281|FG000|Overall Study|Clinical Deterioration|1|||
128849190|NCT01402063|463743282|FG000|Overall Study|Withdrawal by Subject|3|||
128849191|NCT01402063|463743283|FG001|Overall Study|Withdrawal by Subject|3|||
128849192|NCT02110225|463743287|FG000|Overall Study|Lost to Follow-up|0|||
128849193|NCT02110225|463743288|FG001|Overall Study|Lost to Follow-up|1|||
128849194|NCT02110225|463743289|FG002|Overall Study|Lost to Follow-up|0|||
128849195|NCT02176018|463743290|FG000|Overall Study|Adverse Event|0|||
128849196|NCT02176018|463743291|FG001|Overall Study|Adverse Event|2|||
128849197|NCT02176018|463743290|FG000|Overall Study|Lost to Follow-up|3|||
128849198|NCT02176018|463743291|FG001|Overall Study|Lost to Follow-up|1|||
128849199|NCT02176018|463743290|FG000|Overall Study|Protocol Violation|1|||
128849200|NCT02176018|463743291|FG001|Overall Study|Protocol Violation|1|||
128849201|NCT02176018|463743290|FG000|Overall Study|Withdrawal by Subject|1|||
128849202|NCT02176018|463743291|FG001|Overall Study|Withdrawal by Subject|2|||
128849203|NCT03022045|463743292|FG000|Overall Study|Adverse Event|0|||
128849204|NCT03022045|463743293|FG001|Overall Study|Adverse Event|1|||
128849205|NCT03022045|463743292|FG000|Overall Study|Withdrawal by Subject|1|||
128849206|NCT03022045|463743293|FG001|Overall Study|Withdrawal by Subject|1|||
128849207|NCT02499835|463743297|FG000|Overall Study|Withdrawal by Subject|1|||
128849208|NCT02499835|463743298|FG001|Overall Study|Withdrawal by Subject|0|||
128849209|NCT02499835|463743299|FG002|Overall Study|Withdrawal by Subject|0|||
128849210|NCT02499835|463743300|FG003|Overall Study|Withdrawal by Subject|1|||
128849211|NCT02499835|463743297|FG000|Overall Study|Physician Decision|0|||
128849212|NCT02499835|463743298|FG001|Overall Study|Physician Decision|3|||
128849213|NCT02499835|463743299|FG002|Overall Study|Physician Decision|18|||
128849214|NCT02499835|463743300|FG003|Overall Study|Physician Decision|7|||
128849215|NCT02499835|463743297|FG000|Overall Study|Adverse Event|0|||
128849216|NCT02499835|463743298|FG001|Overall Study|Adverse Event|0|||
128849217|NCT02499835|463743299|FG002|Overall Study|Adverse Event|0|||
128849218|NCT02499835|463743300|FG003|Overall Study|Adverse Event|1|||
128849219|NCT02499835|463743297|FG000|Overall Study|Disease progression|2|||
128849220|NCT02499835|463743298|FG001|Overall Study|Disease progression|1|||
128849221|NCT02499835|463743299|FG002|Overall Study|Disease progression|0|||
128849222|NCT02499835|463743300|FG003|Overall Study|Disease progression|7|||
128849223|NCT03972137|463743301|FG000|Overall Study|Lost to Follow-up|2|||
128849224|NCT03972137|463743301|FG000|Overall Study|Withdrawal by Subject|4|||
128849225|NCT03220776|463743309|FG000|Overall Study|Claustrophobia|0|||
128849226|NCT03220776|463743310|FG001|Overall Study|Claustrophobia|1|||
128849227|NCT03220776|463743311|FG002|Overall Study|Claustrophobia|1|||
128849228|NCT03220776|463743312|FG003|Overall Study|Claustrophobia|0|||
128849229|NCT03220776|463743313|FG004|Overall Study|Claustrophobia|1|||
128849230|NCT03220776|463743314|FG005|Overall Study|Claustrophobia|0|||
128849231|NCT03220776|463743309|FG000|Overall Study|MRI Equipment Failure|1|||
128849232|NCT03220776|463743310|FG001|Overall Study|MRI Equipment Failure|0|||
128849233|NCT03220776|463743311|FG002|Overall Study|MRI Equipment Failure|0|||
128849234|NCT03220776|463743312|FG003|Overall Study|MRI Equipment Failure|0|||
128849235|NCT03220776|463743313|FG004|Overall Study|MRI Equipment Failure|0|||
128849236|NCT03220776|463743314|FG005|Overall Study|MRI Equipment Failure|0|||
128849237|NCT03220776|463743309|FG000|Overall Study|Inclimate Weather|0|||
128849238|NCT03220776|463743310|FG001|Overall Study|Inclimate Weather|0|||
128849239|NCT03220776|463743311|FG002|Overall Study|Inclimate Weather|0|||
128849240|NCT03220776|463743312|FG003|Overall Study|Inclimate Weather|0|||
128849241|NCT03220776|463743313|FG004|Overall Study|Inclimate Weather|0|||
128849242|NCT03220776|463743314|FG005|Overall Study|Inclimate Weather|1|||
128849243|NCT03220776|463743309|FG000|Overall Study|Physician Decision|0|||
128849244|NCT03220776|463743310|FG001|Overall Study|Physician Decision|0|||
128849245|NCT03220776|463743311|FG002|Overall Study|Physician Decision|0|||
128849246|NCT03220776|463743312|FG003|Overall Study|Physician Decision|1|||
128849247|NCT03220776|463743313|FG004|Overall Study|Physician Decision|0|||
128849248|NCT03220776|463743314|FG005|Overall Study|Physician Decision|0|||
128849249|NCT03220776|463743309|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
128849250|NCT03220776|463743310|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
128849251|NCT03220776|463743311|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
128849252|NCT03220776|463743312|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
128849253|NCT03220776|463743313|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
128849254|NCT03220776|463743314|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
128849255|NCT03220776|463743309|FG000|Overall Study|Protocol Violation|0|||
128849256|NCT03220776|463743310|FG001|Overall Study|Protocol Violation|0|||
128849257|NCT03220776|463743311|FG002|Overall Study|Protocol Violation|0|||
128849258|NCT03220776|463743312|FG003|Overall Study|Protocol Violation|2|||
128849259|NCT03220776|463743313|FG004|Overall Study|Protocol Violation|0|||
128849260|NCT03220776|463743314|FG005|Overall Study|Protocol Violation|1|||
128849261|NCT03220776|463743309|FG000|Overall Study|Withdrawal by Subject|1|||
128849262|NCT03220776|463743310|FG001|Overall Study|Withdrawal by Subject|0|||
128849263|NCT03220776|463743311|FG002|Overall Study|Withdrawal by Subject|0|||
128849264|NCT03220776|463743312|FG003|Overall Study|Withdrawal by Subject|0|||
128849265|NCT03220776|463743313|FG004|Overall Study|Withdrawal by Subject|0|||
128849266|NCT03220776|463743314|FG005|Overall Study|Withdrawal by Subject|0|||
128849267|NCT01780545|463743316|FG000|Overall Study|Withdrawal by Subject|3|||
128849268|NCT01780545|463743317|FG001|Overall Study|Withdrawal by Subject|1|||
128849269|NCT01780545|463743316|FG000|Overall Study|Lost to Follow-up|1|||
128849270|NCT01780545|463743317|FG001|Overall Study|Lost to Follow-up|1|||
128849271|NCT03441789|463743318|FG000|Overall Study|Withdrawal by Subject|1|||
128849272|NCT03441789|463743319|FG001|Overall Study|Withdrawal by Subject|1|||
128849273|NCT03441789|463743318|FG000|Overall Study|Adverse Event|0|||
128849274|NCT03441789|463743319|FG001|Overall Study|Adverse Event|1|||
128849275|NCT03441789|463743318|FG000|Overall Study|Protocol Violation|0|||
128849276|NCT03441789|463743319|FG001|Overall Study|Protocol Violation|1|||
128849277|NCT03441789|463743318|FG000|Overall Study|Lost to Follow-up|0|||
128849278|NCT03441789|463743319|FG001|Overall Study|Lost to Follow-up|1|||
128849279|NCT04491006|463743320|FG000|Overall Study|Adverse Event|0|||
128849280|NCT04491006|463743321|FG001|Overall Study|Adverse Event|3|||
128849281|NCT04491006|463743322|FG002|Overall Study|Adverse Event|5|||
128849282|NCT04491006|463743320|FG000|Overall Study|Withdrawal by Subject|1|||
128849283|NCT04491006|463743321|FG001|Overall Study|Withdrawal by Subject|0|||
128849284|NCT04491006|463743322|FG002|Overall Study|Withdrawal by Subject|2|||
128849285|NCT01960114|463743326|FG000|Overall Study|Adverse Event|1|||
128849286|NCT01960114|463743327|FG001|Overall Study|Adverse Event|0|||
128849287|NCT01960114|463743326|FG000|Overall Study|Could not swallow study medication|0|||
128849288|NCT01960114|463743327|FG001|Overall Study|Could not swallow study medication|1|||
128849289|NCT02469077|463743328|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
128849290|NCT02469077|463743329|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
128849291|NCT02469077|463743328|FG000|Post Randomization/Intervention Period|Relocated|1|||
128849292|NCT02469077|463743329|FG001|Post Randomization/Intervention Period|Relocated|1|||
128849293|NCT02469077|463743328|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
128849294|NCT02469077|463743329|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
128849295|NCT02469077|463743328|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
128849296|NCT02469077|463743329|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
128849297|NCT01040403|463743330|FG000|Overall Study|Adverse Event|10|||
128849298|NCT01040403|463743330|FG000|Overall Study|Protocol Violation|2|||
128849299|NCT01040403|463743330|FG000|Overall Study|Lost to Follow-up|1|||
128849300|NCT01040403|463743330|FG000|Overall Study|Not treated|1|||
128849301|NCT01040403|463743330|FG000|Overall Study|Other reason not defined above|6|||
128849302|NCT01885936|463743331|FG000|Overall Study|Withdrawal by Subject|1|||
128849303|NCT01885936|463743332|FG001|Overall Study|Withdrawal by Subject|0|||
128849304|NCT03036150|463743333|FG000|Overall Study|Withdrawal by Subject|8|||
128849305|NCT03036150|463743334|FG001|Overall Study|Withdrawal by Subject|3|||
128849306|NCT03036150|463743333|FG000|Overall Study|Lost to Follow-up|2|||
128849307|NCT03036150|463743334|FG001|Overall Study|Lost to Follow-up|2|||
128849308|NCT02845375|463743335|FG000|Overall Study|upper airway obstruction|1|||
128849309|NCT02845375|463743336|FG001|Overall Study|upper airway obstruction|2|||
128849310|NCT02845375|463743337|FG002|Overall Study|upper airway obstruction|1|||
128849311|NCT01037413|463743338|FG000|Part A: Skin Testing|Adverse Event|1|||
128849312|NCT01037413|463743339|FG001|Part A: Skin Testing|Adverse Event|0|||
128849313|NCT01037413|463743338|FG000|Part A: Skin Testing|Protocol Violation|1|||
128849314|NCT01037413|463743339|FG001|Part A: Skin Testing|Protocol Violation|0|||
128849315|NCT01037413|463743338|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
128849316|NCT01037413|463743339|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
128849317|NCT01037413|463743338|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
128849318|NCT01037413|463743339|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
128849319|NCT00619983|463743343|FG000|Test Drug Alone|Withdrawal by Subject|1|||
128849320|NCT00619983|463743344|FG001|Test Drug Alone|Withdrawal by Subject|0|||
128849321|NCT00619983|463743345|FG002|Test Drug Alone|Withdrawal by Subject|0|||
128849322|NCT00619983|463743346|FG003|Test Drug Alone|Withdrawal by Subject|1|||
128849323|NCT00619983|463743343|FG000|Test Drug Alone|Failure of daily diary device|1|||
128849324|NCT00619983|463743344|FG001|Test Drug Alone|Failure of daily diary device|1|||
128849325|NCT00619983|463743345|FG002|Test Drug Alone|Failure of daily diary device|2|||
128849326|NCT00619983|463743346|FG003|Test Drug Alone|Failure of daily diary device|2|||
128849327|NCT03041701|463743354|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
128849328|NCT03041701|463743355|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
128849329|NCT03041701|463743356|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
128849330|NCT03041701|463743354|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
128849331|NCT03041701|463743355|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
128849332|NCT03041701|463743356|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
128849333|NCT03569475|463743357|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
128849334|NCT03569475|463743358|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
128849335|NCT03569475|463743359|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
128849336|NCT03569475|463743357|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
128849337|NCT03569475|463743358|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
128849338|NCT03569475|463743359|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
128849339|NCT03569475|463743357|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
128849340|NCT03569475|463743358|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
128849341|NCT03569475|463743359|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
128849342|NCT03569475|463743357|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
128849343|NCT03569475|463743358|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
128849344|NCT03569475|463743359|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
128849345|NCT03569475|463743357|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
128849346|NCT03569475|463743358|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
128849347|NCT03569475|463743359|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
128849348|NCT03569475|463743357|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
128849349|NCT03569475|463743358|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
128849350|NCT03569475|463743359|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
128849351|NCT03569475|463743357|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
128849352|NCT03569475|463743358|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
128849353|NCT03569475|463743359|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
128849354|NCT03569475|463743357|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
128849355|NCT03569475|463743358|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
128849356|NCT03569475|463743359|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
128849357|NCT03569475|463743357|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
128849358|NCT03569475|463743358|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
128849359|NCT03569475|463743359|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
128849360|NCT03638258|463743361|FG000|Overall Study|Adverse Event|1|||
128849361|NCT03638258|463743362|FG001|Overall Study|Adverse Event|0|||
128849362|NCT03638258|463743363|FG002|Overall Study|Adverse Event|2|||
128849363|NCT03638258|463743361|FG000|Overall Study|Lost to Follow-up|2|||
128849364|NCT03638258|463743362|FG001|Overall Study|Lost to Follow-up|4|||
128849365|NCT03638258|463743363|FG002|Overall Study|Lost to Follow-up|5|||
128849366|NCT03638258|463743361|FG000|Overall Study|Pregnancy|0|||
128849367|NCT03638258|463743362|FG001|Overall Study|Pregnancy|0|||
128849368|NCT03638258|463743363|FG002|Overall Study|Pregnancy|1|||
128849369|NCT03638258|463743361|FG000|Overall Study|Protocol Violation|0|||
128849370|NCT03638258|463743362|FG001|Overall Study|Protocol Violation|0|||
128849371|NCT03638258|463743363|FG002|Overall Study|Protocol Violation|1|||
128849372|NCT03638258|463743361|FG000|Overall Study|Withdrawal by Subject|4|||
128849373|NCT03638258|463743362|FG001|Overall Study|Withdrawal by Subject|5|||
128849374|NCT03638258|463743363|FG002|Overall Study|Withdrawal by Subject|12|||
128849375|NCT03638258|463743361|FG000|Overall Study|Lack of Efficacy|0|||
128849376|NCT03638258|463743362|FG001|Overall Study|Lack of Efficacy|0|||
128849377|NCT03638258|463743363|FG002|Overall Study|Lack of Efficacy|2|||
128849378|NCT02630706|463743364|FG000|Overall Study|Adverse Event|2|||
128849379|NCT02630706|463743365|FG001|Overall Study|Adverse Event|1|||
128849380|NCT02630706|463743366|FG002|Overall Study|Adverse Event|1|||
128849381|NCT02630706|463743364|FG000|Overall Study|Lost to Follow-up|0|||
128849382|NCT02630706|463743365|FG001|Overall Study|Lost to Follow-up|1|||
128849383|NCT02630706|463743366|FG002|Overall Study|Lost to Follow-up|2|||
128849384|NCT02630706|463743364|FG000|Overall Study|Physician Decision|1|||
128849385|NCT02630706|463743365|FG001|Overall Study|Physician Decision|1|||
128849386|NCT02630706|463743366|FG002|Overall Study|Physician Decision|0|||
128849387|NCT02630706|463743364|FG000|Overall Study|Pregnancy|0|||
128849388|NCT02630706|463743365|FG001|Overall Study|Pregnancy|1|||
128849389|NCT02630706|463743366|FG002|Overall Study|Pregnancy|0|||
128849390|NCT02630706|463743364|FG000|Overall Study|Withdrawal by Subject|4|||
128849391|NCT02630706|463743365|FG001|Overall Study|Withdrawal by Subject|5|||
128849392|NCT02630706|463743366|FG002|Overall Study|Withdrawal by Subject|7|||
128849393|NCT01527500|463743369|FG000|Part A|Administrative|11|||
128849394|NCT01527500|463743370|FG001|Part A|Administrative|7|||
128849395|NCT01527500|463743369|FG000|Part A|Adverse Event|4|||
128849396|NCT01527500|463743370|FG001|Part A|Adverse Event|2|||
128849397|NCT01527500|463743369|FG000|Part A|Death|4|||
128849398|NCT01527500|463743370|FG001|Part A|Death|1|||
128849399|NCT01527500|463743369|FG000|Part A|Lost to Follow-up|0|||
128849400|NCT01527500|463743370|FG001|Part A|Lost to Follow-up|1|||
128849401|NCT01527500|463743369|FG000|Part A|Protocol Deviation|9|||
128849402|NCT01527500|463743370|FG001|Part A|Protocol Deviation|2|||
128849403|NCT01527500|463743369|FG000|Part A|Withdrawal by Subject|2|||
128849404|NCT01527500|463743370|FG001|Part A|Withdrawal by Subject|0|||
128849405|NCT01527500|463743369|FG000|Part B|Adverse Event|1|||
128849406|NCT01527500|463743370|FG001|Part B|Adverse Event|0|||
128849407|NCT03078751|463743378|FG000|Overall Study|Adverse Event|4|||
128849408|NCT03078751|463743379|FG001|Overall Study|Adverse Event|0|||
128849409|NCT03078751|463743378|FG000|Overall Study|Physician Decision|1|||
128849410|NCT03078751|463743379|FG001|Overall Study|Physician Decision|0|||
128849411|NCT03078751|463743378|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
128849412|NCT03078751|463743379|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
128849413|NCT03078751|463743378|FG000|Overall Study|Subject/guardian decision|8|||
128849414|NCT03078751|463743379|FG001|Overall Study|Subject/guardian decision|1|||
128849415|NCT03078751|463743378|FG000|Overall Study|Untreated|0|||
128849416|NCT03078751|463743379|FG001|Overall Study|Untreated|4|||
128849417|NCT00607789|463743380|FG000|Overall Study|Adverse Event|3|||
128849418|NCT00607789|463743381|FG001|Overall Study|Adverse Event|0|||
128849419|NCT00607789|463743380|FG000|Overall Study|Lack of Efficacy|0|||
128849420|NCT00607789|463743381|FG001|Overall Study|Lack of Efficacy|1|||
128849421|NCT00607789|463743380|FG000|Overall Study|Inadequate adherence|3|||
128849422|NCT00607789|463743381|FG001|Overall Study|Inadequate adherence|0|||
128849423|NCT00607789|463743380|FG000|Overall Study|Lost to Follow-up|0|||
128849424|NCT00607789|463743381|FG001|Overall Study|Lost to Follow-up|5|||
128849425|NCT00607789|463743380|FG000|Overall Study|Withdrawal by Subject|1|||
128849426|NCT00607789|463743381|FG001|Overall Study|Withdrawal by Subject|0|||
128849427|NCT01209286|463743382|FG000|Overall Study|Adverse Event|4|||
128849428|NCT01209286|463743383|FG001|Overall Study|Adverse Event|3|||
128849429|NCT01209286|463743384|FG002|Overall Study|Adverse Event|1|||
128849430|NCT01209286|463743382|FG000|Overall Study|Hematological Relapse After Remission|0|||
128849431|NCT01209286|463743383|FG001|Overall Study|Hematological Relapse After Remission|1|||
128849432|NCT01209286|463743384|FG002|Overall Study|Hematological Relapse After Remission|1|||
128849433|NCT01209286|463743382|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
128849434|NCT01209286|463743383|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
128849435|NCT01209286|463743384|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
128849436|NCT01209286|463743382|FG000|Overall Study|Physician Decision|0|||
128849437|NCT01209286|463743383|FG001|Overall Study|Physician Decision|2|||
128849438|NCT01209286|463743384|FG002|Overall Study|Physician Decision|0|||
128849439|NCT01209286|463743382|FG000|Overall Study|Other|0|||
128849440|NCT01209286|463743383|FG001|Overall Study|Other|1|||
128849441|NCT01209286|463743384|FG002|Overall Study|Other|0|||
128849442|NCT03915951|463743385|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
128849443|NCT03915951|463743386|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
128849444|NCT03915951|463743385|FG000|Overall Study|Adverse Event|12|||
128849445|NCT03915951|463743386|FG001|Overall Study|Adverse Event|6|||
128849446|NCT03915951|463743385|FG000|Overall Study|Disease progression (radiological)|17|||
128849447|NCT03915951|463743386|FG001|Overall Study|Disease progression (radiological)|15|||
128849448|NCT03915951|463743385|FG000|Overall Study|Disease progression (clinical)|4|||
128849449|NCT03915951|463743386|FG001|Overall Study|Disease progression (clinical)|1|||
128849450|NCT03915951|463743385|FG000|Overall Study|Patient decision|0|||
128849451|NCT03915951|463743386|FG001|Overall Study|Patient decision|4|||
128849452|NCT03915951|463743385|FG000|Overall Study|Investigator decision|0|||
128849453|NCT03915951|463743386|FG001|Overall Study|Investigator decision|1|||
128849454|NCT03915951|463743385|FG000|Overall Study|Consent withdrawn|1|||
128849455|NCT03915951|463743386|FG001|Overall Study|Consent withdrawn|1|||
128849456|NCT03915951|463743385|FG000|Overall Study|Death|0|||
128849457|NCT03915951|463743386|FG001|Overall Study|Death|3|||
128849458|NCT01121185|463743390|FG000|Overall Study|Not infused|0|||
128849459|NCT01121185|463743391|FG001|Overall Study|Not infused|1|||
128849460|NCT01121185|463743390|FG000|Overall Study|Not transplanted|1|||
128849461|NCT01121185|463743391|FG001|Overall Study|Not transplanted|0|||
128849462|NCT01196741|463743392|FG000|Overall Study|Disease progression|34|||
128849463|NCT01196741|463743393|FG001|Overall Study|Disease progression|14|||
128849464|NCT01196741|463743392|FG000|Overall Study|Adverse Event|10|||
128849465|NCT01196741|463743393|FG001|Overall Study|Adverse Event|6|||
128849466|NCT01196741|463743392|FG000|Overall Study|Serious Adverse Event|3|||
128849467|NCT01196741|463743393|FG001|Overall Study|Serious Adverse Event|1|||
128849468|NCT01196741|463743392|FG000|Overall Study|Dose limiting Adverse Event|2|||
128849469|NCT01196741|463743393|FG001|Overall Study|Dose limiting Adverse Event|1|||
128849470|NCT01196741|463743392|FG000|Overall Study|Withdrawal by Subject|3|||
128849471|NCT01196741|463743393|FG001|Overall Study|Withdrawal by Subject|0|||
128849472|NCT01196741|463743392|FG000|Overall Study|Other reason|3|||
128849473|NCT01196741|463743393|FG001|Overall Study|Other reason|3|||
128849474|NCT01196741|463743392|FG000|Overall Study|Other|3|||
128849475|NCT01196741|463743393|FG001|Overall Study|Other|2|||
128849476|NCT01196741|463743392|FG000|Overall Study|Protocol Violation|2|||
128849477|NCT01196741|463743393|FG001|Overall Study|Protocol Violation|1|||
128849478|NCT01204775|463743397|FG000|Overall Study|Poor/non-compliance|0|||
128849479|NCT01204775|463743398|FG001|Overall Study|Poor/non-compliance|1|||
128849480|NCT01204775|463743397|FG000|Overall Study|Withdrawal by Subject|1|||
128849481|NCT01204775|463743398|FG001|Overall Study|Withdrawal by Subject|0|||
128849482|NCT02273180|463743399|FG000|Overall Study|Adverse Event|2|||
128849483|NCT02273180|463743400|FG001|Overall Study|Adverse Event|2|||
128849484|NCT02273180|463743399|FG000|Overall Study|Lack of Efficacy|1|||
128849485|NCT02273180|463743400|FG001|Overall Study|Lack of Efficacy|0|||
128849486|NCT02273180|463743399|FG000|Overall Study|Protocol Violation|1|||
128849487|NCT02273180|463743400|FG001|Overall Study|Protocol Violation|7|||
128849488|NCT02273180|463743399|FG000|Overall Study|Randomized but not treated|1|||
128849489|NCT02273180|463743400|FG001|Overall Study|Randomized but not treated|0|||
128849490|NCT02273180|463743399|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
128849491|NCT02273180|463743400|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
128849492|NCT02273180|463743399|FG000|Overall Study|Other than specified above|21|||
128849493|NCT02273180|463743400|FG001|Overall Study|Other than specified above|10|||
128849494|NCT00509925|463743401|FG000|Overall Study|Personal reasons|0|||
128849495|NCT00509925|463743402|FG001|Overall Study|Personal reasons|1|||
128849496|NCT03749616|463743405|FG000|Overall Study|Lost to Follow-up|4|||
128849497|NCT03749616|463743406|FG001|Overall Study|Lost to Follow-up|7|||
128849498|NCT03749616|463743405|FG000|Overall Study|Screen Failure|1|||
128849499|NCT03749616|463743406|FG001|Overall Study|Screen Failure|1|||
128849500|NCT03749616|463743405|FG000|Overall Study|Withdrawal by Subject|2|||
128849501|NCT03749616|463743406|FG001|Overall Study|Withdrawal by Subject|0|||
128849502|NCT04435522|463743407|FG000|Overall Study|Withdrawal by Subject|2|||
128849503|NCT00919061|463743408|FG000|Overall Study|Adverse Event|1|||
128849504|NCT00919061|463743408|FG000|Overall Study|Withdrawal by Subject|1|||
128849505|NCT05294328|463743417|FG000|Overall Study|Adverse Event|1|||
128849506|NCT05294328|463743418|FG001|Overall Study|Adverse Event|0|||
128849507|NCT05294328|463743419|FG002|Overall Study|Adverse Event|0|||
128849508|NCT05294328|463743417|FG000|Overall Study|Physician Decision|1|||
128849509|NCT05294328|463743418|FG001|Overall Study|Physician Decision|1|||
128849510|NCT05294328|463743419|FG002|Overall Study|Physician Decision|0|||
128849511|NCT05294328|463743417|FG000|Overall Study|Withdrawal by Subject|0|||
128849512|NCT05294328|463743418|FG001|Overall Study|Withdrawal by Subject|2|||
128849513|NCT05294328|463743419|FG002|Overall Study|Withdrawal by Subject|1|||
128849514|NCT05294328|463743417|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
128849515|NCT05294328|463743418|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
128849516|NCT05294328|463743419|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
128849517|NCT02056873|463743420|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
128849518|NCT01772147|463744898|FG000|Overall Study|Adverse Event|13|||
128849519|NCT01772147|463744899|FG001|Overall Study|Adverse Event|10|||
128849520|NCT01772147|463744900|FG002|Overall Study|Adverse Event|6|||
128849521|NCT01772147|463744898|FG000|Overall Study|Withdrew Consent|7|||
128849522|NCT01772147|463744899|FG001|Overall Study|Withdrew Consent|8|||
128849523|NCT01772147|463744900|FG002|Overall Study|Withdrew Consent|4|||
128849524|NCT01772147|463744898|FG000|Overall Study|Lost to Follow-up|1|||
128849525|NCT01772147|463744899|FG001|Overall Study|Lost to Follow-up|0|||
128849526|NCT01772147|463744900|FG002|Overall Study|Lost to Follow-up|1|||
128849527|NCT01772147|463744898|FG000|Overall Study|Protocol Deviation|2|||
128849528|NCT01772147|463744899|FG001|Overall Study|Protocol Deviation|1|||
128849529|NCT01772147|463744900|FG002|Overall Study|Protocol Deviation|1|||
128849530|NCT01772147|463744898|FG000|Overall Study|Lack of Efficacy|8|||
128849531|NCT01772147|463744899|FG001|Overall Study|Lack of Efficacy|6|||
128849532|NCT01772147|463744900|FG002|Overall Study|Lack of Efficacy|6|||
128849533|NCT02972242|463744901|FG000|Overall Study|Withdrawal by Subject|1|||
128849534|NCT02972242|463744902|FG001|Overall Study|Withdrawal by Subject|0|||
128849535|NCT04572997|463744903|FG000|Overall Study|Adverse Event|1|||
128849536|NCT00740597|463744904|FG000|Overall Study|insurance would not cover treatment|1|||
128849537|NCT00552513|463744905|FG000|Overall Study|Lost to Follow-up|5|||
128849538|NCT00552513|463744906|FG001|Overall Study|Lost to Follow-up|1|||
128849539|NCT01157351|463744907|FG000|Overall Study|Adverse Event|5|||
128849540|NCT01157351|463744908|FG001|Overall Study|Adverse Event|4|||
128849541|NCT01157351|463744907|FG000|Overall Study|Death|1|||
128849542|NCT01157351|463744908|FG001|Overall Study|Death|0|||
128849543|NCT01157351|463744907|FG000|Overall Study|Lost to Follow-up|53|||
128849544|NCT01157351|463744908|FG001|Overall Study|Lost to Follow-up|55|||
128849545|NCT01157351|463744907|FG000|Overall Study|Withdrawal by Subject|37|||
128849546|NCT01157351|463744908|FG001|Overall Study|Withdrawal by Subject|27|||
128849547|NCT01157351|463744907|FG000|Overall Study|Physician Decision|5|||
128849548|NCT01157351|463744908|FG001|Overall Study|Physician Decision|4|||
128849549|NCT01157351|463744907|FG000|Overall Study|Protocol Violation|0|||
128849550|NCT01157351|463744908|FG001|Overall Study|Protocol Violation|1|||
128849551|NCT01157351|463744907|FG000|Overall Study|Other|32|||
128849552|NCT01157351|463744908|FG001|Overall Study|Other|36|||
128849553|NCT01157351|463744907|FG000|Overall Study|Noncompliance with Study Drug|0|||
128849554|NCT01157351|463744908|FG001|Overall Study|Noncompliance with Study Drug|3|||
128849555|NCT01157351|463744907|FG000|Overall Study|Randomized but not Treated|4|||
128849556|NCT01157351|463744908|FG001|Overall Study|Randomized but not Treated|2|||
128849557|NCT03511378|463744911|FG000|Overall Study|Withdrawal by Subject|2|||
128849558|NCT03511378|463744912|FG001|Overall Study|Withdrawal by Subject|2|||
128849559|NCT03511378|463744911|FG000|Overall Study|Patient not coming or schedule visit|1|||
128849560|NCT03511378|463744912|FG001|Overall Study|Patient not coming or schedule visit|0|||
128849561|NCT00837096|463744913|FG000|Overall Study|Physician Decision|1|||
128849562|NCT00837096|463744914|FG001|Overall Study|Physician Decision|1|||
128849563|NCT00837096|463744913|FG000|Overall Study|Not reported|9|||
128849564|NCT00837096|463744914|FG001|Overall Study|Not reported|8|||
128849565|NCT00280683|463744915|FG000|Overall Study|Withdrawal by Subject|1|||
128849566|NCT00280683|463744916|FG001|Overall Study|Withdrawal by Subject|2|||
128849567|NCT00280683|463744915|FG000|Overall Study|Adverse Event|1|||
128849568|NCT00280683|463744916|FG001|Overall Study|Adverse Event|1|||
128849569|NCT01243411|463744917|FG000|Overall Study|Withdrawal by Subject|18|||
128849570|NCT01243411|463744917|FG000|Overall Study|Lost to Follow-up|10|||
128849571|NCT01243411|463744917|FG000|Overall Study|Adverse Event|5|||
128849572|NCT01243411|463744917|FG000|Overall Study|Other|8|||
128849573|NCT00510198|463744918|FG000|Overall Study|Withdrawal by Subject|5|||
128849574|NCT00510198|463744919|FG001|Overall Study|Withdrawal by Subject|4|||
128849575|NCT03712449|463744928|FG000|Overall Study|Withdraw Consent|0|||
128849576|NCT03712449|463744929|FG001|Overall Study|Withdraw Consent|1|||
128849577|NCT00666198|463744935|FG000|Overall Study|Protocol Violation|10|||
128849578|NCT00666198|463744935|FG000|Overall Study|No Visit After First Day of Treatment|13|||
128849579|NCT00666198|463744935|FG000|Overall Study|Safety Not Assessable|6|||
128849580|NCT00666198|463744935|FG000|Overall Study|No Drug Administration|4|||
128849581|NCT05153499|463744936|FG000|Overall Study|Withdrawal by Subject|1|||
128849582|NCT05153499|463744937|FG001|Overall Study|Withdrawal by Subject|0|||
128849583|NCT05153499|463744936|FG000|Overall Study|Clinical Hold|1|||
128849584|NCT05153499|463744937|FG001|Overall Study|Clinical Hold|0|||
128849585|NCT05153499|463744936|FG000|Overall Study|Study Termination|6|||
128849586|NCT05153499|463744937|FG001|Overall Study|Study Termination|5|||
128849587|NCT03168425|463744941|FG000|Overall Study|Lost to Follow-up|5|||
128849588|NCT03168425|463744942|FG001|Overall Study|Lost to Follow-up|8|||
128849589|NCT03168425|463744941|FG000|Overall Study|unable to confirm post op opioids|2|||
128849590|NCT03168425|463744942|FG001|Overall Study|unable to confirm post op opioids|3|||
128849591|NCT03029234|463744943|FG000|Overall Study|Sponsor Decision|1|||
128849592|NCT03029234|463744943|FG000|Overall Study|Withdrawal by Subject|5|||
128849593|NCT03029234|463744943|FG000|Overall Study|Death|91|||
128849594|NCT03029234|463744943|FG000|Overall Study|Lost to Follow-up|2|||
128849595|NCT02166047|463744944|FG000|Overall Study|Withdrawal by Participant|0|||
128849596|NCT02166047|463744945|FG001|Overall Study|Withdrawal by Participant|1|||
128849597|NCT02166047|463744946|FG002|Overall Study|Withdrawal by Participant|2|||
128849598|NCT02166047|463744947|FG003|Overall Study|Withdrawal by Participant|0|||
128849599|NCT02166047|463744948|FG004|Overall Study|Withdrawal by Participant|0|||
128849600|NCT02166047|463744949|FG005|Overall Study|Withdrawal by Participant|0|||
128849601|NCT02166047|463744950|FG006|Overall Study|Withdrawal by Participant|1|||
128849602|NCT02166047|463744951|FG007|Overall Study|Withdrawal by Participant|0|||
128849603|NCT02166047|463744952|FG008|Overall Study|Withdrawal by Participant|0|||
128849604|NCT02166047|463744953|FG009|Overall Study|Withdrawal by Participant|0|||
128849605|NCT02166047|463744954|FG010|Overall Study|Withdrawal by Participant|0|||
128849606|NCT02166047|463744955|FG011|Overall Study|Withdrawal by Participant|0|||
128849607|NCT02166047|463744944|FG000|Overall Study|Adverse Event|0|||
128849608|NCT02166047|463744945|FG001|Overall Study|Adverse Event|0|||
128849609|NCT02166047|463744946|FG002|Overall Study|Adverse Event|0|||
128849610|NCT02166047|463744947|FG003|Overall Study|Adverse Event|0|||
128849611|NCT02166047|463744948|FG004|Overall Study|Adverse Event|1|||
128849612|NCT02166047|463744949|FG005|Overall Study|Adverse Event|0|||
128849613|NCT02166047|463744950|FG006|Overall Study|Adverse Event|1|||
128849614|NCT02166047|463744951|FG007|Overall Study|Adverse Event|0|||
128849615|NCT02166047|463744952|FG008|Overall Study|Adverse Event|0|||
128849616|NCT02166047|463744953|FG009|Overall Study|Adverse Event|0|||
128849617|NCT02166047|463744954|FG010|Overall Study|Adverse Event|2|||
128849618|NCT02166047|463744955|FG011|Overall Study|Adverse Event|0|||
128849619|NCT01649297|463744956|FG000|Overall Study|Adverse Event|5|||
128849620|NCT01649297|463744957|FG001|Overall Study|Adverse Event|5|||
128849621|NCT01649297|463744958|FG002|Overall Study|Adverse Event|4|||
128849622|NCT01649297|463744959|FG003|Overall Study|Adverse Event|13|||
128849623|NCT01649297|463744960|FG004|Overall Study|Adverse Event|1|||
128849624|NCT01649297|463744956|FG000|Overall Study|Lack of Efficacy|0|||
128849625|NCT01649297|463744957|FG001|Overall Study|Lack of Efficacy|0|||
128849626|NCT01649297|463744958|FG002|Overall Study|Lack of Efficacy|0|||
128849627|NCT01649297|463744959|FG003|Overall Study|Lack of Efficacy|0|||
128849628|NCT01649297|463744960|FG004|Overall Study|Lack of Efficacy|1|||
128849629|NCT01649297|463744956|FG000|Overall Study|Non compliant with Protocol|1|||
128849630|NCT01649297|463744957|FG001|Overall Study|Non compliant with Protocol|0|||
128849631|NCT01649297|463744958|FG002|Overall Study|Non compliant with Protocol|3|||
128849632|NCT01649297|463744959|FG003|Overall Study|Non compliant with Protocol|2|||
128849633|NCT01649297|463744960|FG004|Overall Study|Non compliant with Protocol|1|||
128849634|NCT01649297|463744956|FG000|Overall Study|Lost to Follow-up|1|||
128849635|NCT01649297|463744957|FG001|Overall Study|Lost to Follow-up|1|||
128849636|NCT01649297|463744958|FG002|Overall Study|Lost to Follow-up|4|||
128849637|NCT01649297|463744959|FG003|Overall Study|Lost to Follow-up|3|||
128849638|NCT01649297|463744960|FG004|Overall Study|Lost to Follow-up|0|||
128849639|NCT01649297|463744956|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
128849640|NCT01649297|463744957|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
128849641|NCT01649297|463744958|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
128849642|NCT01649297|463744959|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
128849643|NCT01649297|463744960|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
128849644|NCT01649297|463744956|FG000|Overall Study|For other reason|4|||
128849645|NCT01649297|463744957|FG001|Overall Study|For other reason|1|||
128849646|NCT01649297|463744958|FG002|Overall Study|For other reason|2|||
128849647|NCT01649297|463744959|FG003|Overall Study|For other reason|0|||
128849648|NCT01649297|463744960|FG004|Overall Study|For other reason|0|||
128849649|NCT01685047|463744961|FG000|Overall Study|Withdrawal by Subject|20|||
128849650|NCT01685047|463744961|FG000|Overall Study|Death|26|||
128849651|NCT01685047|463744961|FG000|Overall Study|Lost to Follow-up|8|||
128849652|NCT01685047|463744961|FG000|Overall Study|Physician Decision|25|||
128849653|NCT01685047|463744961|FG000|Overall Study|Adverse Event|5|||
128849654|NCT01685047|463744961|FG000|Overall Study|patient withdrawn by sponsor|1|||
128849655|NCT02490878|463744968|FG000|Overall Study|deemed ineligible|0|||
128849656|NCT02490878|463744969|FG001|Overall Study|deemed ineligible|1|||
128849657|NCT02490878|463744968|FG000|Overall Study|progression prior to treatment|0|||
128849658|NCT02490878|463744969|FG001|Overall Study|progression prior to treatment|1|||
128849659|NCT02490878|463744968|FG000|Overall Study|only submitted baseline QOL|0|||
128849660|NCT02490878|463744969|FG001|Overall Study|only submitted baseline QOL|1|||
128849661|NCT00451555|463744970|FG000|Overall Study|Protocol Violation|2|||
128849662|NCT00451555|463744971|FG001|Overall Study|Protocol Violation|2|||
128849663|NCT00451555|463744970|FG000|Overall Study|Adverse Event|3|||
128849664|NCT00451555|463744971|FG001|Overall Study|Adverse Event|1|||
128849665|NCT00451555|463744970|FG000|Overall Study|Withdrawal by Subject|6|||
128849666|NCT00451555|463744971|FG001|Overall Study|Withdrawal by Subject|0|||
128849667|NCT00451555|463744970|FG000|Overall Study|Physician Decision|2|||
128849668|NCT00451555|463744971|FG001|Overall Study|Physician Decision|1|||
128849669|NCT00922441|463744974|FG000|Overall Study|Protocol Violation|0|||
128849670|NCT00922441|463744975|FG001|Overall Study|Protocol Violation|0|||
128849671|NCT00922441|463744976|FG002|Overall Study|Protocol Violation|2|||
128849672|NCT00922441|463744974|FG000|Overall Study|Withdrawal by Subject|0|||
128849673|NCT00922441|463744975|FG001|Overall Study|Withdrawal by Subject|0|||
128849674|NCT00922441|463744976|FG002|Overall Study|Withdrawal by Subject|1|||
128849675|NCT02973477|463744979|FG000|First Intervention|Lost to Follow-up|0|||
128849676|NCT02973477|463744980|FG001|First Intervention|Lost to Follow-up|2|||
128849677|NCT02973477|463744979|FG000|Washout|Withdrawal by Subject|1|||
128849678|NCT02973477|463744980|FG001|Washout|Withdrawal by Subject|0|||
128849679|NCT02973477|463744979|FG000|Second Intervention|Lost to Follow-up|1|||
128849680|NCT02973477|463744980|FG001|Second Intervention|Lost to Follow-up|0|||
128849681|NCT00317603|463744984|FG000|Overall Study|Progressive Disease|3|||
128849682|NCT00523549|463744987|FG000|Overall Study|Adverse Event|6|||
128849683|NCT00523549|463744988|FG001|Overall Study|Adverse Event|3|||
128849684|NCT00523549|463744987|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128849685|NCT00523549|463744988|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128849686|NCT00523549|463744987|FG000|Overall Study|Protocol Deviation|3|||
128849687|NCT00523549|463744988|FG001|Overall Study|Protocol Deviation|1|||
128849688|NCT00523549|463744987|FG000|Overall Study|Patient withdrew consent|7|||
128849689|NCT00523549|463744988|FG001|Overall Study|Patient withdrew consent|6|||
128849690|NCT00523549|463744987|FG000|Overall Study|Lost to Follow-up|3|||
128849691|NCT00523549|463744988|FG001|Overall Study|Lost to Follow-up|5|||
128849692|NCT00427778|463744993|FG000|First Intervention (4 Weeks)|no longer interested|1|||
128849693|NCT00427778|463744994|FG001|First Intervention (4 Weeks)|no longer interested|0|||
128849694|NCT00427778|463744993|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
128849695|NCT00427778|463744994|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
128849696|NCT00427778|463744993|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
128849697|NCT00427778|463744994|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
128849698|NCT00427778|463744993|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
128849699|NCT00427778|463744994|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
128849700|NCT00053352|463744995|FG000|Overall Study|Lost to Follow-up|0|||
128849701|NCT00053352|463744996|FG001|Overall Study|Lost to Follow-up|1|||
128849702|NCT00053352|463744995|FG000|Overall Study|Physician Decision|11|||
128849703|NCT00053352|463744996|FG001|Overall Study|Physician Decision|1|||
128849704|NCT00053352|463744995|FG000|Overall Study|Withdrawal by Subject|1|||
128849705|NCT00053352|463744996|FG001|Overall Study|Withdrawal by Subject|0|||
128849706|NCT00053352|463744995|FG000|Overall Study|Ineligible|8|||
128849707|NCT00053352|463744996|FG001|Overall Study|Ineligible|8|||
128849708|NCT00053352|463744995|FG000|Overall Study|Disease at new site|1|||
128849709|NCT00053352|463744996|FG001|Overall Study|Disease at new site|0|||
128849710|NCT00439647|463744997|FG000|Overall Study|Withdrawal by Subject|25|||
128849711|NCT00439647|463744998|FG001|Overall Study|Withdrawal by Subject|22|||
128849712|NCT00439647|463744997|FG000|Overall Study|Death|15|||
128849713|NCT00439647|463744998|FG001|Overall Study|Death|18|||
128849714|NCT00439647|463744997|FG000|Overall Study|Adverse Event|11|||
128849715|NCT00439647|463744998|FG001|Overall Study|Adverse Event|11|||
128849716|NCT00439647|463744997|FG000|Overall Study|Lost to Follow-up|4|||
128849717|NCT00439647|463744998|FG001|Overall Study|Lost to Follow-up|12|||
128849718|NCT00439647|463744997|FG000|Overall Study|Protocol Violation|3|||
128849719|NCT00439647|463744998|FG001|Overall Study|Protocol Violation|4|||
128849720|NCT00439647|463744997|FG000|Overall Study|Lack of Efficacy|0|||
128849721|NCT00439647|463744998|FG001|Overall Study|Lack of Efficacy|4|||
128849722|NCT00931918|463744999|FG000|Overall Study|Adverse Event|4|||
128849723|NCT00931918|463745000|FG001|Overall Study|Adverse Event|6|||
128849724|NCT00931918|463744999|FG000|Overall Study|Progressive Disease|2|||
128849725|NCT00931918|463745000|FG001|Overall Study|Progressive Disease|1|||
128849726|NCT00931918|463744999|FG000|Overall Study|Symptomatic Deterioration|1|||
128849727|NCT00931918|463745000|FG001|Overall Study|Symptomatic Deterioration|0|||
128849728|NCT00931918|463744999|FG000|Overall Study|Withdrawal by Patient|3|||
128849729|NCT00931918|463745000|FG001|Overall Study|Withdrawal by Patient|4|||
128849730|NCT00931918|463744999|FG000|Overall Study|Other Reason not Specified|4|||
128849731|NCT00931918|463745000|FG001|Overall Study|Other Reason not Specified|4|||
128849732|NCT00931918|463744999|FG000|Overall Study|Did not receive study drug|3|||
128849733|NCT00931918|463745000|FG001|Overall Study|Did not receive study drug|2|||
128849734|NCT00570921|463745001|FG000|Overall Study|Protocol Violation|1|||
128849735|NCT00570921|463745001|FG000|Overall Study|Physician Decision|1|||
128849736|NCT00784277|463745003|FG000|IR Treatment|Adverse Event|4|||
128849737|NCT00784277|463745004|FG001|IR Treatment|Adverse Event|8|||
128849738|NCT00784277|463745005|FG002|IR Treatment|Adverse Event|19|||
128849739|NCT00784277|463745006|FG003|IR Treatment|Adverse Event|35|||
128849740|NCT00784277|463745007|FG004|IR Treatment|Adverse Event|0|||
128849741|NCT00784277|463745008|FG005|IR Treatment|Adverse Event|0|||
128849742|NCT00784277|463745009|FG006|IR Treatment|Adverse Event|0|||
128849743|NCT00784277|463745003|FG000|IR Treatment|Lack of Efficacy|4|||
128849744|NCT00784277|463745004|FG001|IR Treatment|Lack of Efficacy|4|||
128849745|NCT00784277|463745005|FG002|IR Treatment|Lack of Efficacy|1|||
128849746|NCT00784277|463745006|FG003|IR Treatment|Lack of Efficacy|0|||
128849747|NCT00784277|463745007|FG004|IR Treatment|Lack of Efficacy|0|||
128849748|NCT00784277|463745008|FG005|IR Treatment|Lack of Efficacy|0|||
128849749|NCT00784277|463745009|FG006|IR Treatment|Lack of Efficacy|0|||
128849750|NCT00784277|463745003|FG000|IR Treatment|Lost to Follow-up|1|||
128849751|NCT00784277|463745004|FG001|IR Treatment|Lost to Follow-up|0|||
128849752|NCT00784277|463745005|FG002|IR Treatment|Lost to Follow-up|1|||
128849753|NCT00784277|463745006|FG003|IR Treatment|Lost to Follow-up|0|||
128849754|NCT00784277|463745007|FG004|IR Treatment|Lost to Follow-up|0|||
128849755|NCT00784277|463745008|FG005|IR Treatment|Lost to Follow-up|0|||
128849756|NCT00784277|463745009|FG006|IR Treatment|Lost to Follow-up|0|||
128849757|NCT00784277|463745003|FG000|IR Treatment|Withdrawal by Subject|5|||
128849758|NCT00784277|463745004|FG001|IR Treatment|Withdrawal by Subject|1|||
128849759|NCT00784277|463745005|FG002|IR Treatment|Withdrawal by Subject|4|||
128849760|NCT00784277|463745006|FG003|IR Treatment|Withdrawal by Subject|6|||
128849761|NCT00784277|463745007|FG004|IR Treatment|Withdrawal by Subject|0|||
128849762|NCT00784277|463745008|FG005|IR Treatment|Withdrawal by Subject|0|||
128849763|NCT00784277|463745009|FG006|IR Treatment|Withdrawal by Subject|0|||
128849764|NCT00784277|463745003|FG000|IR Treatment|Resolution Of Pain|0|||
128849765|NCT00784277|463745004|FG001|IR Treatment|Resolution Of Pain|1|||
128849766|NCT00784277|463745005|FG002|IR Treatment|Resolution Of Pain|0|||
128849767|NCT00784277|463745006|FG003|IR Treatment|Resolution Of Pain|0|||
128849768|NCT00784277|463745007|FG004|IR Treatment|Resolution Of Pain|0|||
128849769|NCT00784277|463745008|FG005|IR Treatment|Resolution Of Pain|0|||
128849770|NCT00784277|463745009|FG006|IR Treatment|Resolution Of Pain|0|||
128849771|NCT00784277|463745003|FG000|IR Treatment|Other|2|||
128849772|NCT00784277|463745004|FG001|IR Treatment|Other|3|||
128849773|NCT00784277|463745005|FG002|IR Treatment|Other|3|||
128849774|NCT00784277|463745006|FG003|IR Treatment|Other|2|||
128849775|NCT00784277|463745007|FG004|IR Treatment|Other|0|||
128849776|NCT00784277|463745008|FG005|IR Treatment|Other|0|||
128849777|NCT00784277|463745009|FG006|IR Treatment|Other|0|||
128849778|NCT00784277|463745003|FG000|ER Treatment|Adverse Event|0|||
128849779|NCT00784277|463745004|FG001|ER Treatment|Adverse Event|0|||
128849780|NCT00784277|463745005|FG002|ER Treatment|Adverse Event|0|||
128849781|NCT00784277|463745006|FG003|ER Treatment|Adverse Event|0|||
128849782|NCT00784277|463745007|FG004|ER Treatment|Adverse Event|1|||
128849783|NCT00784277|463745008|FG005|ER Treatment|Adverse Event|7|||
128849784|NCT00784277|463745009|FG006|ER Treatment|Adverse Event|7|||
128849785|NCT00784277|463745003|FG000|ER Treatment|Lack of Efficacy|0|||
128849786|NCT00784277|463745004|FG001|ER Treatment|Lack of Efficacy|0|||
128849787|NCT00784277|463745005|FG002|ER Treatment|Lack of Efficacy|0|||
128849788|NCT00784277|463745006|FG003|ER Treatment|Lack of Efficacy|0|||
128849789|NCT00784277|463745007|FG004|ER Treatment|Lack of Efficacy|3|||
128849790|NCT00784277|463745008|FG005|ER Treatment|Lack of Efficacy|4|||
128849791|NCT00784277|463745009|FG006|ER Treatment|Lack of Efficacy|0|||
128849792|NCT00784277|463745003|FG000|ER Treatment|Lost to Follow-up|0|||
128849793|NCT00784277|463745004|FG001|ER Treatment|Lost to Follow-up|0|||
128849794|NCT00784277|463745005|FG002|ER Treatment|Lost to Follow-up|0|||
128849795|NCT00784277|463745006|FG003|ER Treatment|Lost to Follow-up|0|||
128849796|NCT00784277|463745007|FG004|ER Treatment|Lost to Follow-up|0|||
128849797|NCT00784277|463745008|FG005|ER Treatment|Lost to Follow-up|2|||
128849798|NCT00784277|463745009|FG006|ER Treatment|Lost to Follow-up|0|||
128849799|NCT00784277|463745003|FG000|ER Treatment|Withdrawal by Subject|0|||
128849800|NCT00784277|463745004|FG001|ER Treatment|Withdrawal by Subject|0|||
128849801|NCT00784277|463745005|FG002|ER Treatment|Withdrawal by Subject|0|||
128849802|NCT00784277|463745006|FG003|ER Treatment|Withdrawal by Subject|0|||
128849803|NCT00784277|463745007|FG004|ER Treatment|Withdrawal by Subject|2|||
128849804|NCT00784277|463745008|FG005|ER Treatment|Withdrawal by Subject|5|||
128849805|NCT00784277|463745009|FG006|ER Treatment|Withdrawal by Subject|3|||
128849806|NCT00784277|463745003|FG000|ER Treatment|Study Medication Non-Compliant|0|||
128849807|NCT00784277|463745004|FG001|ER Treatment|Study Medication Non-Compliant|0|||
128849808|NCT00784277|463745005|FG002|ER Treatment|Study Medication Non-Compliant|0|||
128849809|NCT00784277|463745006|FG003|ER Treatment|Study Medication Non-Compliant|0|||
128849810|NCT00784277|463745007|FG004|ER Treatment|Study Medication Non-Compliant|2|||
128849811|NCT00784277|463745008|FG005|ER Treatment|Study Medication Non-Compliant|3|||
128849812|NCT00784277|463745009|FG006|ER Treatment|Study Medication Non-Compliant|3|||
128849813|NCT00784277|463745003|FG000|ER Treatment|Other|0|||
128849814|NCT00784277|463745004|FG001|ER Treatment|Other|0|||
128849815|NCT00784277|463745005|FG002|ER Treatment|Other|0|||
128849816|NCT00784277|463745006|FG003|ER Treatment|Other|0|||
128849817|NCT00784277|463745007|FG004|ER Treatment|Other|1|||
128849818|NCT00784277|463745008|FG005|ER Treatment|Other|3|||
128849819|NCT00784277|463745009|FG006|ER Treatment|Other|2|||
128849820|NCT00588341|463745010|FG000|Overall Study|Withdrawal by Subject|3|||
128849821|NCT00588341|463745010|FG000|Overall Study|Not treated due to metastatic disease|1|||
128849822|NCT00588341|463745010|FG000|Overall Study|Patient ineligible|1|||
128849823|NCT00745121|463745014|FG000|Overall Study|Death|3|||
128849824|NCT00745121|463745015|FG001|Overall Study|Death|0|||
128849825|NCT00745121|463745014|FG000|Overall Study|Adverse Event|1|||
128849826|NCT00745121|463745015|FG001|Overall Study|Adverse Event|0|||
128849827|NCT00745121|463745014|FG000|Overall Study|Lost to Follow-up|1|||
128849828|NCT00745121|463745015|FG001|Overall Study|Lost to Follow-up|0|||
128849829|NCT00745121|463745014|FG000|Overall Study|Withdrawal by Subject|4|||
128849830|NCT00745121|463745015|FG001|Overall Study|Withdrawal by Subject|2|||
128849831|NCT01363297|463745019|FG000|Overall Study|Other|0|||
128849832|NCT01363297|463745020|FG001|Overall Study|Other|0|||
128849833|NCT01363297|463745021|FG002|Overall Study|Other|0|||
128849834|NCT01363297|463745022|FG003|Overall Study|Other|0|||
128849835|NCT01363297|463745023|FG004|Overall Study|Other|1|||
128849836|NCT01363297|463745019|FG000|Overall Study|Death|3|||
128849837|NCT01363297|463745020|FG001|Overall Study|Death|6|||
128849838|NCT01363297|463745021|FG002|Overall Study|Death|6|||
128849839|NCT01363297|463745022|FG003|Overall Study|Death|10|||
128849840|NCT01363297|463745023|FG004|Overall Study|Death|30|||
128849841|NCT02515097|463745024|FG000|Overall Study|Lost to Follow-up|4|||
128849842|NCT02515097|463745025|FG001|Overall Study|Lost to Follow-up|2|||
128849843|NCT02515097|463745024|FG000|Overall Study|Withdrawal by Subject|1|||
128849844|NCT02515097|463745025|FG001|Overall Study|Withdrawal by Subject|3|||
128849845|NCT02515097|463745024|FG000|Overall Study|Adverse Event|2|||
128849846|NCT02515097|463745025|FG001|Overall Study|Adverse Event|1|||
128849847|NCT01180790|463745031|FG000|Overall Study|Adverse Event|1|||
128849848|NCT01180790|463745032|FG001|Overall Study|Adverse Event|1|||
128849849|NCT01180790|463745033|FG002|Overall Study|Adverse Event|2|||
128849850|NCT01180790|463745034|FG003|Overall Study|Adverse Event|0|||
128849851|NCT01180790|463745035|FG004|Overall Study|Adverse Event|1|||
128849852|NCT01180790|463745036|FG005|Overall Study|Adverse Event|3|||
128849853|NCT01180790|463745037|FG006|Overall Study|Adverse Event|0|||
128849854|NCT01180790|463745031|FG000|Overall Study|Withdrawal by Subject|3|||
128849855|NCT01180790|463745032|FG001|Overall Study|Withdrawal by Subject|0|||
128849856|NCT01180790|463745033|FG002|Overall Study|Withdrawal by Subject|5|||
128849857|NCT01180790|463745034|FG003|Overall Study|Withdrawal by Subject|0|||
128849858|NCT01180790|463745035|FG004|Overall Study|Withdrawal by Subject|2|||
128849859|NCT01180790|463745036|FG005|Overall Study|Withdrawal by Subject|1|||
128849860|NCT01180790|463745037|FG006|Overall Study|Withdrawal by Subject|0|||
128849861|NCT01180790|463745031|FG000|Overall Study|Lost to Follow-up|3|||
128849862|NCT01180790|463745032|FG001|Overall Study|Lost to Follow-up|1|||
128849863|NCT01180790|463745033|FG002|Overall Study|Lost to Follow-up|0|||
128849864|NCT01180790|463745034|FG003|Overall Study|Lost to Follow-up|2|||
128849865|NCT01180790|463745035|FG004|Overall Study|Lost to Follow-up|1|||
128849866|NCT01180790|463745036|FG005|Overall Study|Lost to Follow-up|0|||
128849867|NCT01180790|463745037|FG006|Overall Study|Lost to Follow-up|1|||
128849868|NCT01180790|463745031|FG000|Overall Study|Physician Decision|1|||
128849869|NCT01180790|463745032|FG001|Overall Study|Physician Decision|0|||
128849870|NCT01180790|463745033|FG002|Overall Study|Physician Decision|0|||
128849871|NCT01180790|463745034|FG003|Overall Study|Physician Decision|1|||
128849872|NCT01180790|463745035|FG004|Overall Study|Physician Decision|0|||
128849873|NCT01180790|463745036|FG005|Overall Study|Physician Decision|0|||
128849874|NCT01180790|463745037|FG006|Overall Study|Physician Decision|0|||
128849875|NCT01180790|463745031|FG000|Overall Study|Lack of Efficacy|1|||
128849876|NCT01180790|463745032|FG001|Overall Study|Lack of Efficacy|2|||
128849877|NCT01180790|463745033|FG002|Overall Study|Lack of Efficacy|5|||
128849878|NCT01180790|463745034|FG003|Overall Study|Lack of Efficacy|6|||
128849879|NCT01180790|463745035|FG004|Overall Study|Lack of Efficacy|1|||
128849880|NCT01180790|463745036|FG005|Overall Study|Lack of Efficacy|3|||
128849881|NCT01180790|463745037|FG006|Overall Study|Lack of Efficacy|0|||
128849882|NCT01180790|463745031|FG000|Overall Study|compliance|0|||
128849883|NCT01180790|463745032|FG001|Overall Study|compliance|1|||
128849884|NCT01180790|463745033|FG002|Overall Study|compliance|0|||
128849885|NCT01180790|463745034|FG003|Overall Study|compliance|0|||
128849886|NCT01180790|463745035|FG004|Overall Study|compliance|0|||
128849887|NCT01180790|463745036|FG005|Overall Study|compliance|0|||
128849888|NCT01180790|463745037|FG006|Overall Study|compliance|0|||
128849889|NCT01180790|463745031|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
128849890|NCT01180790|463745032|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
128849891|NCT01180790|463745033|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
128849892|NCT01180790|463745034|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
128849893|NCT01180790|463745035|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
128849894|NCT01180790|463745036|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
128849895|NCT01180790|463745037|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
128849896|NCT01064856|463745040|FG000|Double-blind (DB) Period|Adverse Event|1|||
128849897|NCT01064856|463745041|FG001|Double-blind (DB) Period|Adverse Event|0|||
128849898|NCT01064856|463745042|FG002|Double-blind (DB) Period|Adverse Event|0|||
128849899|NCT01064856|463745043|FG003|Double-blind (DB) Period|Adverse Event|0|||
128849900|NCT01064856|463745040|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
128849901|NCT01064856|463745041|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
128849902|NCT01064856|463745042|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
128849903|NCT01064856|463745043|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
128849904|NCT01064856|463745040|FG000|Open-label (OL) Period|Adverse Event|0|||
128849905|NCT01064856|463745041|FG001|Open-label (OL) Period|Adverse Event|0|||
128849906|NCT01064856|463745042|FG002|Open-label (OL) Period|Adverse Event|12|||
128849907|NCT01064856|463745043|FG003|Open-label (OL) Period|Adverse Event|6|||
128849908|NCT01064856|463745040|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
128849909|NCT01064856|463745041|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
128849910|NCT01064856|463745042|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
128849911|NCT01064856|463745043|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
128849912|NCT01064856|463745040|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
128849913|NCT01064856|463745041|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
128849914|NCT01064856|463745042|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
128849915|NCT01064856|463745043|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
128849916|NCT01064856|463745040|FG000|Open-label (OL) Period|Other|0|||
128849917|NCT01064856|463745041|FG001|Open-label (OL) Period|Other|0|||
128849918|NCT01064856|463745042|FG002|Open-label (OL) Period|Other|7|||
128849919|NCT01064856|463745043|FG003|Open-label (OL) Period|Other|7|||
128849920|NCT03302559|463745046|FG000|Overall Study|Adverse Event|2|||
128849921|NCT03302559|463745046|FG000|Overall Study|Lost to Follow-up|1|||
128849922|NCT03302559|463745046|FG000|Overall Study|Withdrew Consent|3|||
128849923|NCT00951171|463745047|FG000|Overall Study|Adverse Event|2|||
128849924|NCT00951171|463745048|FG001|Overall Study|Adverse Event|0|||
128849925|NCT04130061|463745049|FG000|Overall Study|OR team forgot to request membrane|1|||
128849926|NCT04130061|463745050|FG001|Overall Study|OR team forgot to request membrane|0|||
128849927|NCT01568112|463745051|FG000|Overall Study|Randomized But Not Treated|0|||
128849928|NCT01568112|463745052|FG001|Overall Study|Randomized But Not Treated|1|||
128849929|NCT01568112|463745053|FG002|Overall Study|Randomized But Not Treated|0|||
128849930|NCT01568112|463745054|FG003|Overall Study|Randomized But Not Treated|0|||
128849931|NCT01568112|463745051|FG000|Overall Study|Withdrew due to Adverse Event|2|||
128849932|NCT01568112|463745052|FG001|Overall Study|Withdrew due to Adverse Event|4|||
128849933|NCT01568112|463745053|FG002|Overall Study|Withdrew due to Adverse Event|6|||
128849934|NCT01568112|463745054|FG003|Overall Study|Withdrew due to Adverse Event|3|||
128849935|NCT01568112|463745051|FG000|Overall Study|Lost to Follow-up|0|||
128849936|NCT01568112|463745052|FG001|Overall Study|Lost to Follow-up|0|||
128849937|NCT01568112|463745053|FG002|Overall Study|Lost to Follow-up|0|||
128849938|NCT01568112|463745054|FG003|Overall Study|Lost to Follow-up|1|||
128849939|NCT01568112|463745051|FG000|Overall Study|Withdrawal by Subject|2|||
128849940|NCT01568112|463745052|FG001|Overall Study|Withdrawal by Subject|3|||
128849941|NCT01568112|463745053|FG002|Overall Study|Withdrawal by Subject|0|||
128849942|NCT01568112|463745054|FG003|Overall Study|Withdrawal by Subject|7|||
128849943|NCT01568112|463745051|FG000|Overall Study|Withdrawal by Physician|1|||
128849944|NCT01568112|463745052|FG001|Overall Study|Withdrawal by Physician|0|||
128849945|NCT01568112|463745053|FG002|Overall Study|Withdrawal by Physician|1|||
128849946|NCT01568112|463745054|FG003|Overall Study|Withdrawal by Physician|1|||
128849947|NCT00746785|463746757|FG000|Overall Study|Lost to Follow-up|29|||
128849948|NCT00746785|463746758|FG001|Overall Study|Lost to Follow-up|25|||
128849949|NCT00746785|463746759|FG002|Overall Study|Lost to Follow-up|27|||
128849950|NCT00113269|463746760|FG000|Overall Study|Not transplanted, donor issues|4|||
128849951|NCT00113269|463746761|FG001|Overall Study|Not transplanted, donor issues|0|||
128849952|NCT00113269|463746762|FG002|Overall Study|Not transplanted, donor issues|2|||
128849953|NCT00113269|463746763|FG003|Overall Study|Not transplanted, donor issues|2|||
128849954|NCT00113269|463746760|FG000|Overall Study|Not transplanted, recipient issues|2|||
128849955|NCT00113269|463746761|FG001|Overall Study|Not transplanted, recipient issues|1|||
128849956|NCT00113269|463746762|FG002|Overall Study|Not transplanted, recipient issues|7|||
128849957|NCT00113269|463746763|FG003|Overall Study|Not transplanted, recipient issues|4|||
128849958|NCT00113269|463746760|FG000|Overall Study|Early graft loss, technical|0|||
128849959|NCT00113269|463746761|FG001|Overall Study|Early graft loss, technical|0|||
128849960|NCT00113269|463746762|FG002|Overall Study|Early graft loss, technical|2|||
128849961|NCT00113269|463746763|FG003|Overall Study|Early graft loss, technical|0|||
128849962|NCT00113269|463746760|FG000|Overall Study|Death in operating room|0|||
128849963|NCT00113269|463746761|FG001|Overall Study|Death in operating room|0|||
128849964|NCT00113269|463746762|FG002|Overall Study|Death in operating room|0|||
128849965|NCT00113269|463746763|FG003|Overall Study|Death in operating room|1|||
128849966|NCT00113269|463746760|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
128849967|NCT00113269|463746761|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
128849968|NCT00113269|463746762|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
128849969|NCT00113269|463746763|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
128849970|NCT00113269|463746760|FG000|Overall Study|Adverse Event|2|||
128849971|NCT00113269|463746761|FG001|Overall Study|Adverse Event|7|||
128849972|NCT00113269|463746762|FG002|Overall Study|Adverse Event|11|||
128849973|NCT00113269|463746763|FG003|Overall Study|Adverse Event|7|||
128849974|NCT00113269|463746760|FG000|Overall Study|Withdrawal by Subject|4|||
128849975|NCT00113269|463746761|FG001|Overall Study|Withdrawal by Subject|3|||
128849976|NCT00113269|463746762|FG002|Overall Study|Withdrawal by Subject|4|||
128849977|NCT00113269|463746763|FG003|Overall Study|Withdrawal by Subject|2|||
128849978|NCT00113269|463746760|FG000|Overall Study|Graft loss|6|||
128849979|NCT00113269|463746761|FG001|Overall Study|Graft loss|6|||
128849980|NCT00113269|463746762|FG002|Overall Study|Graft loss|4|||
128849981|NCT00113269|463746763|FG003|Overall Study|Graft loss|9|||
128849982|NCT00113269|463746760|FG000|Overall Study|Protocol Violation|1|||
128849983|NCT00113269|463746761|FG001|Overall Study|Protocol Violation|0|||
128849984|NCT00113269|463746762|FG002|Overall Study|Protocol Violation|4|||
128849985|NCT00113269|463746763|FG003|Overall Study|Protocol Violation|2|||
128849986|NCT00113269|463746760|FG000|Overall Study|Lost to Follow-up|2|||
128849987|NCT00113269|463746761|FG001|Overall Study|Lost to Follow-up|3|||
128849988|NCT00113269|463746762|FG002|Overall Study|Lost to Follow-up|6|||
128849989|NCT00113269|463746763|FG003|Overall Study|Lost to Follow-up|3|||
128849990|NCT00113269|463746760|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
128849991|NCT00113269|463746761|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
128849992|NCT00113269|463746762|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
128849993|NCT00113269|463746763|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
128849994|NCT00113269|463746760|FG000|Overall Study|Discontinued due to rejection|0|||
128849995|NCT00113269|463746761|FG001|Overall Study|Discontinued due to rejection|0|||
128849996|NCT00113269|463746762|FG002|Overall Study|Discontinued due to rejection|1|||
128849997|NCT00113269|463746763|FG003|Overall Study|Discontinued due to rejection|0|||
128849998|NCT00113269|463746760|FG000|Overall Study|Moved|0|||
128849999|NCT00113269|463746761|FG001|Overall Study|Moved|1|||
128850000|NCT00113269|463746762|FG002|Overall Study|Moved|0|||
128850001|NCT00113269|463746763|FG003|Overall Study|Moved|3|||
128850002|NCT00113269|463746760|FG000|Overall Study|Received pancreas transplant|0|||
128850003|NCT00113269|463746761|FG001|Overall Study|Received pancreas transplant|0|||
128850004|NCT00113269|463746762|FG002|Overall Study|Received pancreas transplant|0|||
128850005|NCT00113269|463746763|FG003|Overall Study|Received pancreas transplant|2|||
128850006|NCT00113269|463746760|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
128850007|NCT00113269|463746761|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
128850008|NCT00113269|463746762|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
128850009|NCT00113269|463746763|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
128850010|NCT00113269|463746760|FG000|Overall Study|Did not meet eligibility criteria|1|||
128850011|NCT00113269|463746761|FG001|Overall Study|Did not meet eligibility criteria|0|||
128850012|NCT00113269|463746762|FG002|Overall Study|Did not meet eligibility criteria|0|||
128850013|NCT00113269|463746763|FG003|Overall Study|Did not meet eligibility criteria|1|||
128850014|NCT00113269|463746760|FG000|Overall Study|Unable to return for follow up|2|||
128850015|NCT00113269|463746761|FG001|Overall Study|Unable to return for follow up|1|||
128850016|NCT00113269|463746762|FG002|Overall Study|Unable to return for follow up|0|||
128850017|NCT00113269|463746763|FG003|Overall Study|Unable to return for follow up|0|||
128850018|NCT01821729|463746765|FG000|Overall Study|Withdrawal by Subject|1|||
128850019|NCT02517528|463746766|FG000|Overall Study|Withdrawal by Subject|1|||
128850020|NCT01093599|463746769|FG000|Overall Study|Lost to Follow-up|32|||
128850021|NCT01093599|463746770|FG001|Overall Study|Lost to Follow-up|46|||
128850022|NCT01703845|463746771|FG000|Overall Study|Adverse Event|1|||
128850023|NCT01703845|463746772|FG001|Overall Study|Adverse Event|0|||
128850024|NCT01703845|463746771|FG000|Overall Study|Protocol Violation|1|||
128850025|NCT01703845|463746772|FG001|Overall Study|Protocol Violation|0|||
128850026|NCT01703845|463746771|FG000|Overall Study|other than stated above|1|||
128850027|NCT01703845|463746772|FG001|Overall Study|other than stated above|0|||
128850028|NCT01644188|463746773|FG000|Overall Study|Adverse Event|44|||
128850029|NCT01644188|463746774|FG001|Overall Study|Adverse Event|20|||
128850030|NCT01644188|463746773|FG000|Overall Study|Poor compliance to protocol|26|||
128850031|NCT01644188|463746774|FG001|Overall Study|Poor compliance to protocol|14|||
128850032|NCT01644188|463746773|FG000|Overall Study|Physician Decision|1|||
128850033|NCT01644188|463746774|FG001|Overall Study|Physician Decision|3|||
128850034|NCT01644188|463746773|FG000|Overall Study|Participant moved|7|||
128850035|NCT01644188|463746774|FG001|Overall Study|Participant moved|2|||
128850036|NCT01644188|463746773|FG000|Overall Study|Related to auto-injector administration|2|||
128850037|NCT01644188|463746774|FG001|Overall Study|Related to auto-injector administration|2|||
128850038|NCT01644188|463746773|FG000|Overall Study|Consent withdrawn by participant|14|||
128850039|NCT01644188|463746774|FG001|Overall Study|Consent withdrawn by participant|7|||
128850040|NCT01644188|463746773|FG000|Overall Study|Selection criteria finally not met|2|||
128850041|NCT01644188|463746774|FG001|Overall Study|Selection criteria finally not met|0|||
128850042|NCT01644188|463746773|FG000|Overall Study|Lost to Follow-up|1|||
128850043|NCT01644188|463746774|FG001|Overall Study|Lost to Follow-up|0|||
128850044|NCT01644188|463746773|FG000|Overall Study|Death|4|||
128850045|NCT01644188|463746774|FG001|Overall Study|Death|3|||
128850046|NCT01644188|463746773|FG000|Overall Study|Last visit outside protocol visit window|14|||
128850047|NCT01644188|463746774|FG001|Overall Study|Last visit outside protocol visit window|16|||
128850048|NCT01644188|463746773|FG000|Overall Study|Site closure|1|||
128850049|NCT01644188|463746774|FG001|Overall Study|Site closure|1|||
128850050|NCT01644188|463746773|FG000|Overall Study|Other than specified above|6|||
128850051|NCT01644188|463746774|FG001|Overall Study|Other than specified above|7|||
128850052|NCT00966979|463746778|FG000|Overall Study|Death|1|||
128850053|NCT00966979|463746778|FG000|Overall Study|Lost to Follow-up|6|||
128850054|NCT00966979|463746778|FG000|Overall Study|Withdrawal by Subject|14|||
128850055|NCT00966979|463746778|FG000|Overall Study|Adverse Event|5|||
128850056|NCT00966979|463746778|FG000|Overall Study|Sponsor terminated early|49|||
128850057|NCT00966979|463746778|FG000|Overall Study|Censored because surgery not done|2|||
128850058|NCT00966979|463746778|FG000|Overall Study|Censored because study device was not implanted|14|||
128850059|NCT00966979|463746778|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
128850060|NCT04140266|463746779|FG000|Overall Study|Physician Decision|2|||
128850061|NCT04140266|463746780|FG001|Overall Study|Physician Decision|0|||
128850062|NCT04140266|463746779|FG000|Overall Study|Withdrawal by Subject|4|||
128850063|NCT04140266|463746780|FG001|Overall Study|Withdrawal by Subject|2|||
128850064|NCT03119688|463746784|FG000|Overall Study|Adverse Event|4|||
128850065|NCT03226106|463746785|FG000|Overall Study|Withdrawal by Subject|2|||
128850066|NCT03226106|463746786|FG001|Overall Study|Withdrawal by Subject|0|||
128850067|NCT03226106|463746785|FG000|Overall Study|Adverse Event|1|||
128850068|NCT03226106|463746786|FG001|Overall Study|Adverse Event|0|||
128850069|NCT03226106|463746785|FG000|Overall Study|Lost to Follow-up|2|||
128850070|NCT03226106|463746786|FG001|Overall Study|Lost to Follow-up|0|||
128850071|NCT00721214|463746787|FG000|Overall Study|Chose another center for transplant|1|||
128850072|NCT00721214|463746787|FG000|Overall Study|Death|3|||
128850073|NCT00488319|463746788|FG000|Overall Study|Adverse Event|1|||
128850074|NCT00488319|463746789|FG001|Overall Study|Adverse Event|2|||
128850075|NCT00488319|463746790|FG002|Overall Study|Adverse Event|23|||
128850076|NCT00488319|463746788|FG000|Overall Study|Lack of Efficacy|6|||
128850077|NCT00488319|463746789|FG001|Overall Study|Lack of Efficacy|12|||
128850078|NCT00488319|463746790|FG002|Overall Study|Lack of Efficacy|27|||
128850079|NCT00488319|463746788|FG000|Overall Study|Lost to Follow-up|3|||
128850080|NCT00488319|463746789|FG001|Overall Study|Lost to Follow-up|5|||
128850081|NCT00488319|463746790|FG002|Overall Study|Lost to Follow-up|16|||
128850082|NCT00488319|463746788|FG000|Overall Study|Withdrawal by Subject|5|||
128850083|NCT00488319|463746789|FG001|Overall Study|Withdrawal by Subject|20|||
128850084|NCT00488319|463746790|FG002|Overall Study|Withdrawal by Subject|44|||
128850085|NCT00488319|463746788|FG000|Overall Study|Other reasons for withdrawal|0|||
128850086|NCT00488319|463746789|FG001|Overall Study|Other reasons for withdrawal|4|||
128850087|NCT00488319|463746790|FG002|Overall Study|Other reasons for withdrawal|12|||
128850088|NCT01649557|463746791|FG000|Overall Study|Lost to Follow-up|5|||
128850089|NCT01649557|463746792|FG001|Overall Study|Lost to Follow-up|0|||
128850090|NCT01649557|463746793|FG002|Overall Study|Lost to Follow-up|3|||
128850091|NCT01649557|463746791|FG000|Overall Study|Adverse Event|7|||
128850092|NCT01649557|463746792|FG001|Overall Study|Adverse Event|5|||
128850093|NCT01649557|463746793|FG002|Overall Study|Adverse Event|1|||
128850094|NCT01649557|463746791|FG000|Overall Study|Met withdrawal criteria|4|||
128850095|NCT01649557|463746792|FG001|Overall Study|Met withdrawal criteria|0|||
128850096|NCT01649557|463746793|FG002|Overall Study|Met withdrawal criteria|0|||
128850097|NCT01649557|463746791|FG000|Overall Study|Physician Decision|8|||
128850098|NCT01649557|463746792|FG001|Overall Study|Physician Decision|2|||
128850099|NCT01649557|463746793|FG002|Overall Study|Physician Decision|1|||
128850100|NCT01649557|463746791|FG000|Overall Study|Withdrawal by Subject|15|||
128850101|NCT01649557|463746792|FG001|Overall Study|Withdrawal by Subject|5|||
128850102|NCT01649557|463746793|FG002|Overall Study|Withdrawal by Subject|4|||
128850103|NCT01649557|463746791|FG000|Overall Study|Protocol deviation|0|||
128850104|NCT01649557|463746792|FG001|Overall Study|Protocol deviation|2|||
128850105|NCT01649557|463746793|FG002|Overall Study|Protocol deviation|0|||
128850106|NCT01649557|463746791|FG000|Overall Study|Lack of Efficacy|5|||
128850107|NCT01649557|463746792|FG001|Overall Study|Lack of Efficacy|0|||
128850108|NCT01649557|463746793|FG002|Overall Study|Lack of Efficacy|0|||
128850109|NCT02544113|463746794|FG000|Overall Study|Death|3|||
128850110|NCT02544113|463746795|FG001|Overall Study|Death|4|||
128850111|NCT02847637|463746797|FG000|Overall Study|Withdrawal by Subject|0|||
128850112|NCT02847637|463746798|FG001|Overall Study|Withdrawal by Subject|1|||
128850113|NCT02847637|463746799|FG002|Overall Study|Withdrawal by Subject|1|||
128850114|NCT02847637|463746800|FG003|Overall Study|Withdrawal by Subject|0|||
128850115|NCT02847637|463746797|FG000|Overall Study|Lost to Follow-up|1|||
128850116|NCT02847637|463746798|FG001|Overall Study|Lost to Follow-up|1|||
128850117|NCT02847637|463746799|FG002|Overall Study|Lost to Follow-up|0|||
128850118|NCT02847637|463746800|FG003|Overall Study|Lost to Follow-up|0|||
128850119|NCT01746108|463746803|FG000|Overall Study|Migrated /moved from study area|0|||
128850120|NCT01746108|463746804|FG001|Overall Study|Migrated /moved from study area|1|||
128850121|NCT01746108|463746805|FG002|Overall Study|Migrated /moved from study area|0|||
128850122|NCT01746108|463746803|FG000|Overall Study|Adverse event, non-fatal|0|||
128850123|NCT01746108|463746804|FG001|Overall Study|Adverse event, non-fatal|1|||
128850124|NCT01746108|463746805|FG002|Overall Study|Adverse event, non-fatal|0|||
128850125|NCT01746108|463746803|FG000|Overall Study|Withdrawal by Subject|0|||
128850126|NCT01746108|463746804|FG001|Overall Study|Withdrawal by Subject|1|||
128850127|NCT01746108|463746805|FG002|Overall Study|Withdrawal by Subject|0|||
128850128|NCT01746108|463746803|FG000|Overall Study|Lost to Follow-up|0|||
128850129|NCT01746108|463746804|FG001|Overall Study|Lost to Follow-up|1|||
128850130|NCT01746108|463746805|FG002|Overall Study|Lost to Follow-up|0|||
128850131|NCT01388478|463746811|FG000|Overall Study|Adverse Event|4|||
128850132|NCT01388478|463746811|FG000|Overall Study|Withdrawal by Subject|1|||
128850133|NCT01990664|463746812|FG000|Overall Study|Lost to Follow-up|2|||
128850134|NCT01990664|463746813|FG001|Overall Study|Lost to Follow-up|6|||
128850135|NCT01990664|463746812|FG000|Overall Study|Withdrawal by Subject|2|||
128850136|NCT01990664|463746813|FG001|Overall Study|Withdrawal by Subject|3|||
128850137|NCT01990664|463746812|FG000|Overall Study|Protocol Violation|1|||
128850138|NCT01990664|463746813|FG001|Overall Study|Protocol Violation|0|||
128850139|NCT01990664|463746812|FG000|Overall Study|Lens Discomfort|1|||
128850140|NCT01990664|463746813|FG001|Overall Study|Lens Discomfort|1|||
128850141|NCT01990664|463746812|FG000|Overall Study|Lens Handling Difficulties|1|||
128850142|NCT01990664|463746813|FG001|Overall Study|Lens Handling Difficulties|0|||
128850143|NCT01990664|463746812|FG000|Overall Study|Unsatisfactory Visual Response|0|||
128850144|NCT01990664|463746813|FG001|Overall Study|Unsatisfactory Visual Response|1|||
128850145|NCT02025985|463746816|FG000|Overall Study|Consent withdrawn|0|||
128850146|NCT02025985|463746817|FG001|Overall Study|Consent withdrawn|0|||
128850147|NCT02025985|463746818|FG002|Overall Study|Consent withdrawn|1|||
128850148|NCT02025985|463746819|FG003|Overall Study|Consent withdrawn|0|||
128850149|NCT02025985|463746820|FG004|Overall Study|Consent withdrawn|0|||
128850150|NCT02025985|463746816|FG000|Overall Study|Termination of study by Sponsor|4|||
128850151|NCT02025985|463746817|FG001|Overall Study|Termination of study by Sponsor|3|||
128850152|NCT02025985|463746818|FG002|Overall Study|Termination of study by Sponsor|1|||
128850153|NCT02025985|463746819|FG003|Overall Study|Termination of study by Sponsor|1|||
128850154|NCT02025985|463746820|FG004|Overall Study|Termination of study by Sponsor|3|||
128850155|NCT02025985|463746816|FG000|Overall Study|Death|21|||
128850156|NCT02025985|463746817|FG001|Overall Study|Death|20|||
128850157|NCT02025985|463746818|FG002|Overall Study|Death|23|||
128850158|NCT02025985|463746819|FG003|Overall Study|Death|20|||
128850159|NCT02025985|463746820|FG004|Overall Study|Death|17|||
128850160|NCT03723915|463746822|FG000|Screening|Failed to meet screening requirements.|2|||
128850161|NCT03723915|463746822|FG000|On Treatment|Failed to meet treatment requirements|2|||
128850162|NCT01187407|463746824|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
128850163|NCT01187407|463746825|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
128850164|NCT01187407|463746826|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
128850165|NCT01187407|463746827|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
128850166|NCT01187407|463746828|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
128850167|NCT01187407|463746824|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
128850168|NCT01187407|463746825|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
128850169|NCT01187407|463746826|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
128850170|NCT01187407|463746827|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
128850171|NCT01187407|463746828|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
128850172|NCT01187407|463746824|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
128850173|NCT01187407|463746825|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
128850174|NCT01187407|463746826|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
128850175|NCT01187407|463746827|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
128850176|NCT01187407|463746828|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
128850177|NCT01187407|463746824|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
128850178|NCT01187407|463746825|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128850179|NCT01187407|463746826|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128850180|NCT01187407|463746827|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128850181|NCT01187407|463746828|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
128850182|NCT01187407|463746824|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
128850183|NCT01187407|463746825|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128850184|NCT01187407|463746826|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128850185|NCT01187407|463746827|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128850186|NCT01187407|463746828|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
128850187|NCT01187407|463746824|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
128850188|NCT01187407|463746825|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
128850189|NCT01187407|463746826|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
128850190|NCT01187407|463746827|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
128850191|NCT01187407|463746828|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
128850192|NCT01187407|463746824|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
128850193|NCT01187407|463746825|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
128850194|NCT01187407|463746826|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
128850195|NCT01187407|463746827|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
128850196|NCT01187407|463746828|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
128850197|NCT01187407|463746824|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
128850198|NCT01187407|463746825|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
128850199|NCT01187407|463746826|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
128850200|NCT01187407|463746827|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
128850201|NCT01187407|463746828|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
128850202|NCT01187407|463746824|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
128850203|NCT01187407|463746825|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
128850204|NCT01187407|463746826|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
128850205|NCT01187407|463746827|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
128850206|NCT01187407|463746828|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
128850207|NCT01187407|463746824|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
128850208|NCT01187407|463746825|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
128850209|NCT01187407|463746826|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
128850210|NCT01187407|463746827|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
128850211|NCT01187407|463746828|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
128850212|NCT01187407|463746824|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
128850213|NCT01187407|463746825|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
128850214|NCT01187407|463746826|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
128850215|NCT01187407|463746827|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
128850216|NCT01187407|463746828|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
128850217|NCT01187407|463746824|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
128850218|NCT01187407|463746825|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
128850219|NCT01187407|463746826|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
128850220|NCT01187407|463746827|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
128850221|NCT01187407|463746828|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
128850222|NCT01187407|463746824|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
128850223|NCT01187407|463746825|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
128850224|NCT01187407|463746826|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
128850225|NCT01187407|463746827|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
128850226|NCT01187407|463746828|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
128850227|NCT01187407|463746824|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
128850228|NCT01187407|463746825|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
128850229|NCT01187407|463746826|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
128850230|NCT01187407|463746827|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
128850231|NCT01187407|463746828|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
128850232|NCT01713998|463746831|FG000|Overall Study|Lost to Follow-up|2|||
128850233|NCT01713998|463746832|FG001|Overall Study|Lost to Follow-up|0|||
128850234|NCT01713998|463746833|FG002|Overall Study|Lost to Follow-up|2|||
128850235|NCT01713998|463746831|FG000|Overall Study|Withdrawal by Subject|1|||
128850236|NCT01713998|463746832|FG001|Overall Study|Withdrawal by Subject|0|||
128850237|NCT01713998|463746833|FG002|Overall Study|Withdrawal by Subject|0|||
128850238|NCT02101268|463746834|FG000|Randomized Treatment Phase|Subject Decision|8|||
128850239|NCT02101268|463746835|FG001|Randomized Treatment Phase|Subject Decision|4|||
128850240|NCT02101268|463746836|FG002|Randomized Treatment Phase|Subject Decision|0|||
128850241|NCT02101268|463746837|FG003|Randomized Treatment Phase|Subject Decision|0|||
128850242|NCT02101268|463746834|FG000|Randomized Treatment Phase|Physician Decision|4|||
128850243|NCT02101268|463746835|FG001|Randomized Treatment Phase|Physician Decision|1|||
128850244|NCT02101268|463746836|FG002|Randomized Treatment Phase|Physician Decision|0|||
128850245|NCT02101268|463746837|FG003|Randomized Treatment Phase|Physician Decision|0|||
128850246|NCT02101268|463746834|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
128850247|NCT02101268|463746835|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
128850248|NCT02101268|463746836|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
128850249|NCT02101268|463746837|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
128850250|NCT02101268|463746834|FG000|Randomized Treatment Phase|Adverse Event|6|||
128850251|NCT02101268|463746835|FG001|Randomized Treatment Phase|Adverse Event|0|||
128850252|NCT02101268|463746836|FG002|Randomized Treatment Phase|Adverse Event|0|||
128850253|NCT02101268|463746837|FG003|Randomized Treatment Phase|Adverse Event|0|||
128850254|NCT02101268|463746834|FG000|Randomized Treatment Phase|Death|5|||
128850255|NCT02101268|463746835|FG001|Randomized Treatment Phase|Death|4|||
128850256|NCT02101268|463746836|FG002|Randomized Treatment Phase|Death|0|||
128850257|NCT02101268|463746837|FG003|Randomized Treatment Phase|Death|0|||
128850258|NCT02101268|463746834|FG000|Randomized Treatment Phase|Disease Progression|4|||
128850259|NCT02101268|463746835|FG001|Randomized Treatment Phase|Disease Progression|1|||
128850260|NCT02101268|463746836|FG002|Randomized Treatment Phase|Disease Progression|0|||
128850261|NCT02101268|463746837|FG003|Randomized Treatment Phase|Disease Progression|0|||
128850262|NCT02101268|463746834|FG000|Extended Treatment Phase|Subject Decision|0|||
128850263|NCT02101268|463746835|FG001|Extended Treatment Phase|Subject Decision|0|||
128850264|NCT02101268|463746836|FG002|Extended Treatment Phase|Subject Decision|3|||
128850265|NCT02101268|463746837|FG003|Extended Treatment Phase|Subject Decision|2|||
128850266|NCT02101268|463746834|FG000|Extended Treatment Phase|Physician Decision|0|||
128850267|NCT02101268|463746835|FG001|Extended Treatment Phase|Physician Decision|0|||
128850268|NCT02101268|463746836|FG002|Extended Treatment Phase|Physician Decision|5|||
128850269|NCT02101268|463746837|FG003|Extended Treatment Phase|Physician Decision|2|||
128850270|NCT02101268|463746834|FG000|Extended Treatment Phase|Adverse Event|0|||
128850271|NCT02101268|463746835|FG001|Extended Treatment Phase|Adverse Event|0|||
128850272|NCT02101268|463746836|FG002|Extended Treatment Phase|Adverse Event|14|||
128850273|NCT02101268|463746837|FG003|Extended Treatment Phase|Adverse Event|18|||
128850274|NCT02101268|463746834|FG000|Extended Treatment Phase|Death|0|||
128850275|NCT02101268|463746835|FG001|Extended Treatment Phase|Death|0|||
128850276|NCT02101268|463746836|FG002|Extended Treatment Phase|Death|5|||
128850277|NCT02101268|463746837|FG003|Extended Treatment Phase|Death|1|||
128850278|NCT02101268|463746834|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
128850279|NCT02101268|463746835|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
128850280|NCT02101268|463746836|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
128850281|NCT02101268|463746837|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
128850282|NCT02101268|463746834|FG000|Extended Treatment Phase|Disease Progression|0|||
128850283|NCT02101268|463746835|FG001|Extended Treatment Phase|Disease Progression|0|||
128850284|NCT02101268|463746836|FG002|Extended Treatment Phase|Disease Progression|13|||
128850285|NCT02101268|463746837|FG003|Extended Treatment Phase|Disease Progression|6|||
128850286|NCT02101268|463746834|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
128850287|NCT02101268|463746835|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
128850288|NCT02101268|463746836|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
128850289|NCT02101268|463746837|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
128850290|NCT00740870|463746838|FG000|Overall Study|Not Catheterized|4|||
128850291|NCT00740870|463746838|FG000|Overall Study|Further testing contraindicated implant|17|||
128850292|NCT00839332|463746843|FG000|Phase 1|Disease Progression|38|||
128850293|NCT00839332|463746844|FG001|Phase 1|Disease Progression|0|||
128850294|NCT00839332|463746845|FG002|Phase 1|Disease Progression|0|||
128850295|NCT00839332|463746843|FG000|Phase 1|Adverse Event|6|||
128850296|NCT00839332|463746844|FG001|Phase 1|Adverse Event|0|||
128850297|NCT00839332|463746845|FG002|Phase 1|Adverse Event|0|||
128850298|NCT00839332|463746843|FG000|Phase 1|Withdrawal by Subject|4|||
128850299|NCT00839332|463746844|FG001|Phase 1|Withdrawal by Subject|0|||
128850300|NCT00839332|463746845|FG002|Phase 1|Withdrawal by Subject|0|||
128850301|NCT00839332|463746843|FG000|Phase 1|Physician Decision|2|||
128850302|NCT00839332|463746844|FG001|Phase 1|Physician Decision|0|||
128850303|NCT00839332|463746845|FG002|Phase 1|Physician Decision|0|||
128850304|NCT00839332|463746843|FG000|Phase 2|Protocol Violation|0|||
128850305|NCT00839332|463746844|FG001|Phase 2|Protocol Violation|1|||
128850306|NCT00839332|463746845|FG002|Phase 2|Protocol Violation|0|||
128850307|NCT00839332|463746843|FG000|Phase 2|Disease Progression|0|||
128850308|NCT00839332|463746844|FG001|Phase 2|Disease Progression|46|||
128850309|NCT00839332|463746845|FG002|Phase 2|Disease Progression|21|||
128850310|NCT00839332|463746843|FG000|Phase 2|Adverse Event|0|||
128850311|NCT00839332|463746844|FG001|Phase 2|Adverse Event|8|||
128850312|NCT00839332|463746845|FG002|Phase 2|Adverse Event|6|||
128850313|NCT00839332|463746843|FG000|Phase 2|Death|0|||
128850314|NCT00839332|463746844|FG001|Phase 2|Death|4|||
128850315|NCT00839332|463746845|FG002|Phase 2|Death|2|||
128850316|NCT00839332|463746843|FG000|Phase 2|Withdrawal by Subject|0|||
128850317|NCT00839332|463746844|FG001|Phase 2|Withdrawal by Subject|5|||
128850318|NCT00839332|463746845|FG002|Phase 2|Withdrawal by Subject|8|||
128850319|NCT00839332|463746843|FG000|Phase 2|Physician Decision|0|||
128850320|NCT00839332|463746844|FG001|Phase 2|Physician Decision|4|||
128850321|NCT00839332|463746845|FG002|Phase 2|Physician Decision|1|||
128850322|NCT00839332|463746843|FG000|Phase 2|Lost to Follow-up|0|||
128850323|NCT00839332|463746844|FG001|Phase 2|Lost to Follow-up|0|||
128850324|NCT00839332|463746845|FG002|Phase 2|Lost to Follow-up|1|||
128850325|NCT01200485|463746846|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
128850326|NCT01200485|463746847|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
128850327|NCT01200485|463746848|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
128850328|NCT01200485|463746846|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
128850329|NCT01200485|463746847|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
128850330|NCT01200485|463746848|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
128850331|NCT06080438|463746849|FG000|Overall Study|Lost to Follow-up|2|||
128850332|NCT01678898|463746850|FG000|PB-102-F01|Adverse Event|0|||
128850333|NCT01678898|463746851|FG001|PB-102-F01|Adverse Event|1|||
128850334|NCT01678898|463746852|FG002|PB-102-F01|Adverse Event|0|||
128850335|NCT01678898|463746850|FG000|PB-102-F01|Physician Decision|0|||
128850336|NCT01678898|463746851|FG001|PB-102-F01|Physician Decision|1|||
128850337|NCT01678898|463746852|FG002|PB-102-F01|Physician Decision|0|||
128850338|NCT00640042|463746853|FG000|Enrollment|Did not receive study drug|83|||
128850339|NCT00776984|463746854|FG000|Overall Study|Adverse Event|8|||
128850340|NCT00776984|463746855|FG001|Overall Study|Adverse Event|2|||
128850341|NCT00776984|463746854|FG000|Overall Study|Protocol Violation|4|||
128850342|NCT00776984|463746855|FG001|Overall Study|Protocol Violation|2|||
128850343|NCT00776984|463746854|FG000|Overall Study|Lost to Follow-up|2|||
128850344|NCT00776984|463746855|FG001|Overall Study|Lost to Follow-up|0|||
128850345|NCT00776984|463746854|FG000|Overall Study|Withdrawal by Subject|12|||
128850346|NCT00776984|463746855|FG001|Overall Study|Withdrawal by Subject|7|||
128850347|NCT00776984|463746854|FG000|Overall Study|Lack of Efficacy|0|||
128850348|NCT00776984|463746855|FG001|Overall Study|Lack of Efficacy|1|||
128850349|NCT00776984|463746854|FG000|Overall Study|Other|5|||
128850350|NCT00776984|463746855|FG001|Overall Study|Other|9|||
128850351|NCT02573883|463746863|FG000|Six Month Follow Up|Lost to Follow-up|1|||
128850352|NCT02573883|463746864|FG001|Six Month Follow Up|Lost to Follow-up|0|||
128850353|NCT02573883|463746865|FG002|Six Month Follow Up|Lost to Follow-up|0|||
128850354|NCT02573883|463746866|FG003|Six Month Follow Up|Lost to Follow-up|0|||
128850355|NCT02573883|463746863|FG000|One Year Follow Up|Lost to Follow-up|2|||
128850356|NCT02573883|463746864|FG001|One Year Follow Up|Lost to Follow-up|1|||
128850357|NCT02573883|463746865|FG002|One Year Follow Up|Lost to Follow-up|0|||
128850358|NCT02573883|463746866|FG003|One Year Follow Up|Lost to Follow-up|0|||
128850359|NCT01544309|463746867|FG000|Overall Study|Withdrawal by Subject|12|||
128850360|NCT01544309|463746868|FG001|Overall Study|Withdrawal by Subject|7|||
128850361|NCT01544309|463746867|FG000|Overall Study|Protocol Violation|2|||
128850362|NCT01544309|463746868|FG001|Overall Study|Protocol Violation|1|||
128850363|NCT01544309|463746867|FG000|Overall Study|Physician Decision|4|||
128850364|NCT01544309|463746868|FG001|Overall Study|Physician Decision|1|||
128850365|NCT01544309|463746867|FG000|Overall Study|Not performed pre-dose examination|1|||
128850366|NCT01544309|463746868|FG001|Overall Study|Not performed pre-dose examination|2|||
128850367|NCT01544309|463746867|FG000|Overall Study|Administered prohibit prior medication|1|||
128850368|NCT01544309|463746868|FG001|Overall Study|Administered prohibit prior medication|0|||
128850369|NCT00118703|463746869|FG000|Overall Study|Protocol Violation|1|||
128850370|NCT00118703|463746870|FG001|Overall Study|Protocol Violation|0|||
128850371|NCT00118703|463746869|FG000|Overall Study|Adverse Event|1|||
128850372|NCT00118703|463746870|FG001|Overall Study|Adverse Event|1|||
128850373|NCT00118703|463746869|FG000|Overall Study|Participant took two different treatment|0|||
128850374|NCT00118703|463746870|FG001|Overall Study|Participant took two different treatment|1|||
128850375|NCT00118703|463746869|FG000|Overall Study|Withdrawal by Subject|2|||
128850376|NCT00118703|463746870|FG001|Overall Study|Withdrawal by Subject|5|||
128850377|NCT00118703|463746869|FG000|Overall Study|Lost to Follow-up|1|||
128850378|NCT00118703|463746870|FG001|Overall Study|Lost to Follow-up|2|||
128850379|NCT03796208|463746875|FG000|Overall Study|Withdrawal by Subject|3|||
128850380|NCT03796208|463746876|FG001|Overall Study|Withdrawal by Subject|0|||
128850381|NCT03796208|463746875|FG000|Overall Study|Loss of pregnancy|1|||
128850382|NCT03796208|463746876|FG001|Overall Study|Loss of pregnancy|1|||
128850383|NCT03796208|463746875|FG000|Overall Study|Changed prenatal clinics|0|||
128850384|NCT03796208|463746876|FG001|Overall Study|Changed prenatal clinics|5|||
128850385|NCT03796208|463746875|FG000|Overall Study|Lost to Follow-up|20|||
128850386|NCT03796208|463746876|FG001|Overall Study|Lost to Follow-up|16|||
128850387|NCT02725008|463746877|FG000|Overall Study|Lost to Follow-up|7|||
128850388|NCT02725008|463746878|FG001|Overall Study|Lost to Follow-up|9|||
128850389|NCT02725008|463746877|FG000|Overall Study|Withdrawal by Subject|2|||
128850390|NCT02725008|463746878|FG001|Overall Study|Withdrawal by Subject|2|||
128850391|NCT02725008|463746877|FG000|Overall Study|Admitted to hospital|0|||
128850392|NCT02725008|463746878|FG001|Overall Study|Admitted to hospital|1|||
128850393|NCT00519285|463746879|FG000|Overall Study|Adverse Event|127|||
128850394|NCT00519285|463746880|FG001|Overall Study|Adverse Event|266|||
128850395|NCT00519285|463746879|FG000|Overall Study|Disease progression|334|||
128850396|NCT00519285|463746880|FG001|Overall Study|Disease progression|186|||
128850397|NCT00519285|463746879|FG000|Overall Study|Physician Decision|75|||
128850398|NCT00519285|463746880|FG001|Overall Study|Physician Decision|47|||
128850399|NCT00519285|463746879|FG000|Overall Study|Participant's request|53|||
128850400|NCT00519285|463746880|FG001|Overall Study|Participant's request|84|||
128850401|NCT00519285|463746879|FG000|Overall Study|Consent withdrawn|4|||
128850402|NCT00519285|463746880|FG001|Overall Study|Consent withdrawn|5|||
128850403|NCT00519285|463746879|FG000|Overall Study|Poor compliance to protocol|5|||
128850404|NCT00519285|463746880|FG001|Overall Study|Poor compliance to protocol|7|||
128850405|NCT00519285|463746879|FG000|Overall Study|Reason unspecified|5|||
128850406|NCT00519285|463746880|FG001|Overall Study|Reason unspecified|8|||
128850407|NCT00519285|463746879|FG000|Overall Study|Not treated|8|||
128850408|NCT00519285|463746880|FG001|Overall Study|Not treated|7|||
128850409|NCT00519285|463746879|FG000|Overall Study|Treatment ongoing|1|||
128850410|NCT00519285|463746880|FG001|Overall Study|Treatment ongoing|2|||
128850411|NCT02175745|463746881|FG000|Overall Study|Not Eligible|1|||
128850412|NCT04582864|463746884|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
128850413|NCT04582864|463746884|FG000|Overall Study|Death|1|||
128850414|NCT02481934|463746888|FG000|Overall Study|Death|2|||
128850415|NCT00942188|463746889|FG000|Overall Study|Adverse Event|0|||
128850416|NCT00942188|463746890|FG001|Overall Study|Adverse Event|3|||
128850417|NCT00942188|463746891|FG002|Overall Study|Adverse Event|2|||
128850418|NCT00942188|463746892|FG003|Overall Study|Adverse Event|0|||
128850419|NCT00942188|463746889|FG000|Overall Study|Lack of Efficacy|0|||
128850420|NCT00942188|463746890|FG001|Overall Study|Lack of Efficacy|0|||
128850421|NCT00942188|463746891|FG002|Overall Study|Lack of Efficacy|0|||
128850422|NCT00942188|463746892|FG003|Overall Study|Lack of Efficacy|1|||
128850423|NCT00942188|463746889|FG000|Overall Study|Protocol Violation|1|||
128850424|NCT00942188|463746890|FG001|Overall Study|Protocol Violation|1|||
128850425|NCT00942188|463746891|FG002|Overall Study|Protocol Violation|0|||
128850426|NCT00942188|463746892|FG003|Overall Study|Protocol Violation|0|||
128850427|NCT00942188|463746889|FG000|Overall Study|Lost to Follow-up|2|||
128850428|NCT00942188|463746890|FG001|Overall Study|Lost to Follow-up|1|||
128850429|NCT00942188|463746891|FG002|Overall Study|Lost to Follow-up|2|||
128850430|NCT00942188|463746892|FG003|Overall Study|Lost to Follow-up|0|||
128850431|NCT00942188|463746889|FG000|Overall Study|Withdrawal by Subject|1|||
128850432|NCT00942188|463746890|FG001|Overall Study|Withdrawal by Subject|3|||
128850433|NCT00942188|463746891|FG002|Overall Study|Withdrawal by Subject|4|||
128850434|NCT00942188|463746892|FG003|Overall Study|Withdrawal by Subject|2|||
128850435|NCT00942188|463746889|FG000|Overall Study|Physician Decision|0|||
128850436|NCT00942188|463746890|FG001|Overall Study|Physician Decision|0|||
128850437|NCT00942188|463746891|FG002|Overall Study|Physician Decision|1|||
128850438|NCT00942188|463746892|FG003|Overall Study|Physician Decision|0|||
128850439|NCT00942188|463746889|FG000|Overall Study|Sponsor Decision|0|||
128850440|NCT00942188|463746890|FG001|Overall Study|Sponsor Decision|2|||
128850441|NCT00942188|463746891|FG002|Overall Study|Sponsor Decision|0|||
128850442|NCT00942188|463746892|FG003|Overall Study|Sponsor Decision|1|||
128850443|NCT00560313|463748705|FG000|Overall Study|Adverse Events or Death|2|||
128850444|NCT00560313|463748705|FG000|Overall Study|Withdrawal by Subject|2|||
128850445|NCT00560313|463748705|FG000|Overall Study|Lost to Follow-up|1|||
128850446|NCT00560313|463748705|FG000|Overall Study|Protocol Violation|1|||
128850447|NCT05006417|463748709|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
128850448|NCT02158247|463748710|FG000|Overall Study|Invisible vocal cords|5|||
128850449|NCT00875615|463748717|FG000|Overall Study|Withdrawal by Subject|1|||
128850450|NCT01772823|463748718|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
128850451|NCT01772823|463748719|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
128850452|NCT01772823|463748718|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
128850453|NCT01772823|463748719|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
128850454|NCT01772823|463748718|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
128850455|NCT01772823|463748719|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
128850456|NCT01772823|463748718|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
128850457|NCT01772823|463748719|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
128850458|NCT01772823|463748718|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
128850459|NCT01772823|463748719|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
128850460|NCT01772823|463748718|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
128850461|NCT01772823|463748719|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
128850462|NCT01772823|463748718|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
128850463|NCT01772823|463748719|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
128850464|NCT01772823|463748718|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
128850465|NCT01772823|463748719|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
128850466|NCT01772823|463748718|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
128850467|NCT01772823|463748719|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
128850468|NCT01772823|463748718|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
128850469|NCT01772823|463748719|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
128850470|NCT01772823|463748718|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
128850471|NCT01772823|463748719|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
128850472|NCT01772823|463748718|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
128850473|NCT01772823|463748719|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
128850474|NCT01772823|463748718|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
128850475|NCT01772823|463748719|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
128850476|NCT01772823|463748718|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
128850477|NCT01772823|463748719|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
128850478|NCT01772823|463748718|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
128850479|NCT01772823|463748719|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
128850480|NCT01772823|463748718|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
128850481|NCT01772823|463748719|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
128850482|NCT02741713|463748724|FG000|Overall Study|Surgery type changed intra-operatively|2|||
128850483|NCT02741713|463748725|FG001|Overall Study|Surgery type changed intra-operatively|1|||
128850484|NCT00809341|463748728|FG000|Overall Study|Physician Decision|0|||
128850485|NCT00809341|463748729|FG001|Overall Study|Physician Decision|1|||
128850486|NCT03503162|463748730|FG000|Overall Study|did not meet eligibility|1|||
128850487|NCT02246218|463748731|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
128850488|NCT02246218|463748732|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
128850489|NCT02246218|463748731|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
128850490|NCT02246218|463748732|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
128850491|NCT02246218|463748731|FG000|Overall Study|Adverse Event|1|||
128850492|NCT02246218|463748732|FG001|Overall Study|Adverse Event|1|||
128850493|NCT02246218|463748731|FG000|Overall Study|Lost to Follow-up|1|||
128850494|NCT02246218|463748732|FG001|Overall Study|Lost to Follow-up|0|||
128850495|NCT04952701|463748733|FG000|Control Lens|Physician Decision|4|||
128850496|NCT04952701|463748733|FG000|Test Lens|Physician Decision|1|||
128850497|NCT03891641|463748734|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
128850498|NCT03891641|463748735|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
128850499|NCT01093222|463748736|FG000|Overall Study|Ineligible|6|||
128850500|NCT01093222|463748736|FG000|Overall Study|Adverse Event|7|||
128850501|NCT01093222|463748736|FG000|Overall Study|Progression/relapse|24|||
128850502|NCT01093222|463748736|FG000|Overall Study|Death|2|||
128850503|NCT01093222|463748736|FG000|Overall Study|Not protocol specified|1|||
128850504|NCT00866918|463748739|FG000|Overall Study|Death|1|||
128850505|NCT00866918|463748740|FG001|Overall Study|Death|5|||
128850506|NCT00866918|463748739|FG000|Overall Study|Lack of Efficacy|1|||
128850507|NCT00866918|463748740|FG001|Overall Study|Lack of Efficacy|1|||
128850508|NCT00866918|463748739|FG000|Overall Study|Physician Decision|10|||
128850509|NCT00866918|463748740|FG001|Overall Study|Physician Decision|2|||
128850510|NCT00866918|463748739|FG000|Overall Study|Ineligible|2|||
128850511|NCT00866918|463748740|FG001|Overall Study|Ineligible|4|||
128850512|NCT00866918|463748739|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
128850513|NCT00866918|463748740|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
128850514|NCT00866918|463748739|FG000|Overall Study|Secondary malignancy|1|||
128850515|NCT00866918|463748740|FG001|Overall Study|Secondary malignancy|0|||
128850516|NCT01281917|463748758|FG000|Overall Study|Withdrawal by Subject|1|||
128850517|NCT01978236|463748760|FG000|Overall Study|Discontinued due to study close|2|||
128850518|NCT00634920|463748762|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
128850519|NCT00634920|463748763|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
128850520|NCT00634920|463748764|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
128850521|NCT00634920|463748762|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
128850522|NCT00634920|463748763|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
128850523|NCT00634920|463748764|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
128850524|NCT00634920|463748762|FG000|Period 1 - Pre-Randomization|Rejections|0|||
128850525|NCT00634920|463748763|FG001|Period 1 - Pre-Randomization|Rejections|0|||
128850526|NCT00634920|463748764|FG002|Period 1 - Pre-Randomization|Rejections|55|||
128850527|NCT00634920|463748762|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
128850528|NCT00634920|463748763|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
128850529|NCT00634920|463748764|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
128850530|NCT00634920|463748762|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
128850531|NCT00634920|463748763|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
128850532|NCT00634920|463748764|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
128850533|NCT00634920|463748762|FG000|Period 1 - Pre-Randomization|Other issues|0|||
128850534|NCT00634920|463748763|FG001|Period 1 - Pre-Randomization|Other issues|0|||
128850535|NCT00634920|463748764|FG002|Period 1 - Pre-Randomization|Other issues|6|||
128850536|NCT00634920|463748762|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
128850537|NCT00634920|463748763|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
128850538|NCT00634920|463748764|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
128850539|NCT00634920|463748762|FG000|Period 2 - Post-Randomization|Rejection|11|||
128850540|NCT00634920|463748763|FG001|Period 2 - Post-Randomization|Rejection|5|||
128850541|NCT00634920|463748764|FG002|Period 2 - Post-Randomization|Rejection|0|||
128850542|NCT00634920|463748762|FG000|Period 2 - Post-Randomization|Death|2|||
128850543|NCT00634920|463748763|FG001|Period 2 - Post-Randomization|Death|5|||
128850544|NCT00634920|463748764|FG002|Period 2 - Post-Randomization|Death|0|||
128850545|NCT00634920|463748762|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
128850546|NCT00634920|463748763|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
128850547|NCT00634920|463748764|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
128850548|NCT00634920|463748762|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
128850549|NCT00634920|463748763|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
128850550|NCT00634920|463748764|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
128850551|NCT00819013|463748765|FG000|Overall Study|Not meeting continuing study eligibility|2|||
128850552|NCT00819013|463748766|FG001|Overall Study|Not meeting continuing study eligibility|1|||
128850553|NCT00819013|463748767|FG002|Overall Study|Not meeting continuing study eligibility|2|||
128850554|NCT00819013|463748768|FG003|Overall Study|Not meeting continuing study eligibility|1|||
128850555|NCT00819013|463748765|FG000|Overall Study|Adverse Event|0|||
128850556|NCT00819013|463748766|FG001|Overall Study|Adverse Event|0|||
128850557|NCT00819013|463748767|FG002|Overall Study|Adverse Event|1|||
128850558|NCT00819013|463748768|FG003|Overall Study|Adverse Event|0|||
128850559|NCT00819013|463748765|FG000|Overall Study|Withdrawal by Subject|1|||
128850560|NCT00819013|463748766|FG001|Overall Study|Withdrawal by Subject|0|||
128850561|NCT00819013|463748767|FG002|Overall Study|Withdrawal by Subject|1|||
128850562|NCT00819013|463748768|FG003|Overall Study|Withdrawal by Subject|0|||
128850563|NCT00819013|463748765|FG000|Overall Study|Lost to Follow-up|0|||
128850564|NCT00819013|463748766|FG001|Overall Study|Lost to Follow-up|0|||
128850565|NCT00819013|463748767|FG002|Overall Study|Lost to Follow-up|1|||
128850566|NCT00819013|463748768|FG003|Overall Study|Lost to Follow-up|2|||
128850567|NCT00819013|463748765|FG000|Overall Study|Death|0|||
128850568|NCT00819013|463748766|FG001|Overall Study|Death|0|||
128850569|NCT00819013|463748767|FG002|Overall Study|Death|0|||
128850570|NCT00819013|463748768|FG003|Overall Study|Death|1|||
128850571|NCT00607997|463748771|FG000|Overall Study|Lack of Efficacy|6|||
128850572|NCT00607997|463748772|FG001|Overall Study|Lack of Efficacy|20|||
128850573|NCT00607997|463748773|FG002|Overall Study|Lack of Efficacy|14|||
128850574|NCT00607997|463748774|FG003|Overall Study|Lack of Efficacy|10|||
128850575|NCT00607997|463748771|FG000|Overall Study|Death|8|||
128850576|NCT00607997|463748772|FG001|Overall Study|Death|5|||
128850577|NCT00607997|463748773|FG002|Overall Study|Death|2|||
128850578|NCT00607997|463748774|FG003|Overall Study|Death|5|||
128850579|NCT00607997|463748771|FG000|Overall Study|Adverse Event|3|||
128850580|NCT00607997|463748772|FG001|Overall Study|Adverse Event|1|||
128850581|NCT00607997|463748773|FG002|Overall Study|Adverse Event|2|||
128850582|NCT00607997|463748774|FG003|Overall Study|Adverse Event|0|||
128850583|NCT00607997|463748771|FG000|Overall Study|Physician Decision|4|||
128850584|NCT00607997|463748772|FG001|Overall Study|Physician Decision|1|||
128850585|NCT00607997|463748773|FG002|Overall Study|Physician Decision|0|||
128850586|NCT00607997|463748774|FG003|Overall Study|Physician Decision|0|||
128850587|NCT00607997|463748771|FG000|Overall Study|Relapse, recurrent illness|4|||
128850588|NCT00607997|463748772|FG001|Overall Study|Relapse, recurrent illness|0|||
128850589|NCT00607997|463748773|FG002|Overall Study|Relapse, recurrent illness|2|||
128850590|NCT00607997|463748774|FG003|Overall Study|Relapse, recurrent illness|0|||
128850591|NCT00607997|463748771|FG000|Overall Study|Other without explanation|2|||
128850592|NCT00607997|463748772|FG001|Overall Study|Other without explanation|0|||
128850593|NCT00607997|463748773|FG002|Overall Study|Other without explanation|4|||
128850594|NCT00607997|463748774|FG003|Overall Study|Other without explanation|1|||
128850595|NCT00576823|463748775|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
128850596|NCT00576823|463748776|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
128850597|NCT00576823|463748777|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
128850598|NCT00576823|463748775|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
128850599|NCT00576823|463748776|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
128850600|NCT00576823|463748777|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
128850601|NCT00510146|463748778|FG000|Double-Blind Treatment|Adverse Event|30|||
128850602|NCT00510146|463748779|FG001|Double-Blind Treatment|Adverse Event|13|||
128850603|NCT00510146|463748778|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
128850604|NCT00510146|463748779|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
128850605|NCT00510146|463748778|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
128850606|NCT00510146|463748779|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
128850607|NCT00510146|463748778|FG000|Double-Blind Treatment|Physician Decision|6|||
128850608|NCT00510146|463748779|FG001|Double-Blind Treatment|Physician Decision|0|||
128850609|NCT00510146|463748778|FG000|Double-Blind Treatment|Protocol Violation|1|||
128850610|NCT00510146|463748779|FG001|Double-Blind Treatment|Protocol Violation|2|||
128850611|NCT00510146|463748778|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
128850612|NCT00510146|463748779|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
128850613|NCT00510146|463748778|FG000|Double-Blind Treatment|Clinical Relapse|0|||
128850614|NCT00510146|463748779|FG001|Double-Blind Treatment|Clinical Relapse|1|||
128850615|NCT00510146|463748778|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
128850616|NCT00510146|463748779|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
128850617|NCT00510146|463748778|FG000|Open-Label Treatment|Adverse Event|22|||
128850618|NCT00510146|463748779|FG001|Open-Label Treatment|Adverse Event|8|||
128850619|NCT00510146|463748778|FG000|Open-Label Treatment|Death|1|||
128850620|NCT00510146|463748779|FG001|Open-Label Treatment|Death|1|||
128850621|NCT00510146|463748778|FG000|Open-Label Treatment|Lack of Efficacy|4|||
128850622|NCT00510146|463748779|FG001|Open-Label Treatment|Lack of Efficacy|0|||
128850623|NCT00510146|463748778|FG000|Open-Label Treatment|Lost to Follow-up|10|||
128850624|NCT00510146|463748779|FG001|Open-Label Treatment|Lost to Follow-up|1|||
128850625|NCT00510146|463748778|FG000|Open-Label Treatment|Physician Decision|3|||
128850626|NCT00510146|463748779|FG001|Open-Label Treatment|Physician Decision|1|||
128850627|NCT00510146|463748778|FG000|Open-Label Treatment|Protocol Violation|4|||
128850628|NCT00510146|463748779|FG001|Open-Label Treatment|Protocol Violation|2|||
128850629|NCT00510146|463748778|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
128850630|NCT00510146|463748779|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
128850631|NCT00510146|463748778|FG000|Open-Label Treatment|Clinical Relapse|1|||
128850632|NCT00510146|463748779|FG001|Open-Label Treatment|Clinical Relapse|1|||
128850633|NCT00510146|463748778|FG000|Open-Label Treatment|Sponsor Decision|2|||
128850634|NCT00510146|463748779|FG001|Open-Label Treatment|Sponsor Decision|0|||
128850635|NCT01930214|463748783|FG000|Overall Study|Death|4|||
128850636|NCT01930214|463748784|FG001|Overall Study|Death|4|||
128850637|NCT01930214|463748785|FG002|Overall Study|Death|11|||
128850638|NCT01930214|463748783|FG000|Overall Study|Lost to Follow-up|12|||
128850639|NCT01930214|463748784|FG001|Overall Study|Lost to Follow-up|13|||
128850640|NCT01930214|463748785|FG002|Overall Study|Lost to Follow-up|12|||
128850641|NCT01930214|463748783|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
128850642|NCT01930214|463748784|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
128850643|NCT01930214|463748785|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
128850644|NCT01930214|463748783|FG000|Overall Study|Physician Decision|2|||
128850645|NCT01930214|463748784|FG001|Overall Study|Physician Decision|0|||
128850646|NCT01930214|463748785|FG002|Overall Study|Physician Decision|0|||
128850647|NCT03589300|463748786|FG000|Overall Study|Adverse Event|2|||
128850648|NCT03589300|463748786|FG000|Overall Study|Death|4|||
128850649|NCT03589300|463748786|FG000|Overall Study|Lost to Follow-up|12|||
128850650|NCT03589300|463748786|FG000|Overall Study|Withdrawal by Subject|5|||
128850651|NCT02864342|463748791|FG000|Overall Study|Eligibility Criteria Deviation|2|||
128850652|NCT02864342|463748792|FG001|Overall Study|Eligibility Criteria Deviation|3|||
128850653|NCT02864342|463748791|FG000|Overall Study|Withdrawal by Subject|4|||
128850654|NCT02864342|463748792|FG001|Overall Study|Withdrawal by Subject|2|||
128850655|NCT02864342|463748791|FG000|Overall Study|Device Technology Issue|6|||
128850656|NCT02864342|463748792|FG001|Overall Study|Device Technology Issue|7|||
128850657|NCT02864342|463748791|FG000|Overall Study|Death|0|||
128850658|NCT02864342|463748792|FG001|Overall Study|Death|1|||
128850659|NCT02864342|463748791|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
128850660|NCT02864342|463748792|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
128850661|NCT02864342|463748791|FG000|Overall Study|Lost to Follow-up|1|||
128850662|NCT02864342|463748792|FG001|Overall Study|Lost to Follow-up|5|||
128850663|NCT02864342|463748791|FG000|Overall Study|Lost Device|1|||
128850664|NCT02864342|463748792|FG001|Overall Study|Lost Device|0|||
128850665|NCT02864342|463748791|FG000|Overall Study|Adverse Event|1|||
128850666|NCT02864342|463748792|FG001|Overall Study|Adverse Event|0|||
128850667|NCT01560585|463748797|FG000|Overall Study|Physician Decision|3|||
128850668|NCT01020747|463748802|FG000|Overall Study|Withdrawal by Subject|1|||
128850669|NCT01222078|463748803|FG000|Overall Study|Early termination of the study|1|||
128850670|NCT04688086|463748808|FG000|Overall Study|Lost to Follow-up|164|||
128850671|NCT04688086|463748808|FG000|Overall Study|Imaging error;|64|||
128850672|NCT00853021|463748811|FG000|Overall Study|Adverse Event|2|||
128850673|NCT00853021|463748811|FG000|Overall Study|Withdrawal by Subject|2|||
128850674|NCT00853021|463748811|FG000|Overall Study|Death|1|||
128850675|NCT01329419|463748812|FG000|Overall Study|Protocol Violation|235|||
128850676|NCT04522778|463748815|FG000|Overall Study|Patient did not want to wear the device|1|||
128850677|NCT04522778|463748816|FG001|Overall Study|Patient did not want to wear the device|0|||
128850678|NCT04522778|463748815|FG000|Overall Study|Lost to Follow-up|0|||
128850679|NCT04522778|463748816|FG001|Overall Study|Lost to Follow-up|1|||
128850680|NCT01225159|463748817|FG000|Overall Study|Change operation|1|||
128850681|NCT01225159|463748818|FG001|Overall Study|Change operation|0|||
128850682|NCT00981578|463748822|FG000|Overall Study|Death|1|||
128850683|NCT00981578|463748822|FG000|Overall Study|Withdrawal by Subject|2|||
128850684|NCT04206384|463748823|FG000|Overall Study|Withdrawal by Subject|8|||
128850685|NCT04206384|463748823|FG000|Overall Study|Adverse Event|2|||
128850686|NCT02212197|463748824|FG000|Overall Study|Need for radiotherapy|1|||
128850687|NCT02212197|463748825|FG001|Overall Study|Need for radiotherapy|0|||
128850688|NCT02212197|463748826|FG002|Overall Study|Need for radiotherapy|0|||
128850689|NCT03015181|463748827|FG000|Overall Study|Enrolled, but product never administered|1|||
128850690|NCT03015181|463748828|FG001|Overall Study|Enrolled, but product never administered|0|||
128850691|NCT03015181|463748829|FG002|Overall Study|Enrolled, but product never administered|0|||
128850692|NCT03015181|463748830|FG003|Overall Study|Enrolled, but product never administered|0|||
128850693|NCT03015181|463748831|FG004|Overall Study|Enrolled, but product never administered|0|||
128850694|NCT03015181|463748832|FG005|Overall Study|Enrolled, but product never administered|0|||
128850695|NCT03015181|463748833|FG006|Overall Study|Enrolled, but product never administered|0|||
128850696|NCT03015181|463748827|FG000|Overall Study|Withdrawal by Subject|0|||
128850697|NCT03015181|463748828|FG001|Overall Study|Withdrawal by Subject|0|||
128850698|NCT03015181|463748829|FG002|Overall Study|Withdrawal by Subject|0|||
128850699|NCT03015181|463748830|FG003|Overall Study|Withdrawal by Subject|0|||
128850700|NCT03015181|463748831|FG004|Overall Study|Withdrawal by Subject|0|||
128850701|NCT03015181|463748832|FG005|Overall Study|Withdrawal by Subject|1|||
128850702|NCT03015181|463748833|FG006|Overall Study|Withdrawal by Subject|0|||
128850703|NCT03015181|463748827|FG000|Overall Study|Physician Decision|0|||
128850704|NCT03015181|463748828|FG001|Overall Study|Physician Decision|0|||
128850705|NCT03015181|463748829|FG002|Overall Study|Physician Decision|0|||
128850706|NCT03015181|463748830|FG003|Overall Study|Physician Decision|0|||
128850707|NCT03015181|463748831|FG004|Overall Study|Physician Decision|0|||
128850708|NCT03015181|463748832|FG005|Overall Study|Physician Decision|0|||
128850709|NCT03015181|463748833|FG006|Overall Study|Physician Decision|1|||
128850710|NCT02551692|463748835|FG000|Overall Study|Lost to Follow-up|0|||
128850711|NCT02551692|463748836|FG001|Overall Study|Lost to Follow-up|1|||
128850712|NCT02551692|463748837|FG002|Overall Study|Lost to Follow-up|4|||
128850713|NCT02551692|463748835|FG000|Overall Study|Withdrawal by Subject|1|||
128850714|NCT02551692|463748836|FG001|Overall Study|Withdrawal by Subject|0|||
128850715|NCT02551692|463748837|FG002|Overall Study|Withdrawal by Subject|1|||
128850716|NCT01091519|463748838|FG000|Overall Study|Adverse Event|12|||
128850717|NCT01091519|463748839|FG001|Overall Study|Adverse Event|16|||
128850718|NCT01091519|463748838|FG000|Overall Study|Death|1|||
128850719|NCT01091519|463748839|FG001|Overall Study|Death|0|||
128850720|NCT01091519|463748838|FG000|Overall Study|Lack of Efficacy|16|||
128850721|NCT01091519|463748839|FG001|Overall Study|Lack of Efficacy|19|||
128850722|NCT01091519|463748838|FG000|Overall Study|Lost to Follow-up|14|||
128850723|NCT01091519|463748839|FG001|Overall Study|Lost to Follow-up|24|||
128850724|NCT01091519|463748838|FG000|Overall Study|Withdrawal by Subject|2|||
128850725|NCT01091519|463748839|FG001|Overall Study|Withdrawal by Subject|2|||
128850726|NCT01091519|463748838|FG000|Overall Study|Other|6|||
128850727|NCT01091519|463748839|FG001|Overall Study|Other|8|||
128850728|NCT01091519|463748838|FG000|Overall Study|Randomized not treated|4|||
128850729|NCT01091519|463748839|FG001|Overall Study|Randomized not treated|4|||
128850730|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
128850731|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
128850732|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
128850733|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Other|1|||
128850734|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Other|0|||
128850735|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Other|0|||
128850736|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Physician Decision|3|||
128850737|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Physician Decision|0|||
128850738|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Physician Decision|0|||
128850739|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
128850740|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
128850741|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
128850742|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
128850743|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
128850744|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
128850745|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Adverse Event|18|||
128850746|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Adverse Event|0|||
128850747|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Adverse Event|0|||
128850748|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
128850749|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
128850750|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
128850751|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
128850752|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
128850753|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
128850754|NCT03030599|463748842|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
128850755|NCT03030599|463748843|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
128850756|NCT03030599|463748844|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
128850757|NCT03030599|463748842|FG000|Stable Dose|Protocol deviation|3|||
128850758|NCT03030599|463748843|FG001|Stable Dose|Protocol deviation|0|||
128850759|NCT03030599|463748844|FG002|Stable Dose|Protocol deviation|0|||
128850760|NCT03030599|463748842|FG000|Stable Dose|Adverse Event|1|||
128850761|NCT03030599|463748843|FG001|Stable Dose|Adverse Event|0|||
128850762|NCT03030599|463748844|FG002|Stable Dose|Adverse Event|0|||
128850763|NCT03030599|463748842|FG000|Stable Dose|Lost to Follow-up|1|||
128850764|NCT03030599|463748843|FG001|Stable Dose|Lost to Follow-up|0|||
128850765|NCT03030599|463748844|FG002|Stable Dose|Lost to Follow-up|0|||
128850766|NCT03030599|463748842|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
128850767|NCT03030599|463748843|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
128850768|NCT03030599|463748844|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
128850769|NCT03030599|463748842|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
128850770|NCT03030599|463748843|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
128850771|NCT03030599|463748844|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
128850772|NCT03030599|463748842|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
128850773|NCT03030599|463748843|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
128850774|NCT03030599|463748844|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
128850775|NCT03030599|463748842|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
128850776|NCT03030599|463748843|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
128850777|NCT03030599|463748844|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
128850778|NCT03030599|463748842|FG000|Open-label Extension|Adverse Event|3|||
128850779|NCT03030599|463748843|FG001|Open-label Extension|Adverse Event|0|||
128850780|NCT03030599|463748844|FG002|Open-label Extension|Adverse Event|0|||
128850781|NCT03030599|463748842|FG000|Open-label Extension|Lost to Follow-up|2|||
128850782|NCT03030599|463748843|FG001|Open-label Extension|Lost to Follow-up|0|||
128850783|NCT03030599|463748844|FG002|Open-label Extension|Lost to Follow-up|0|||
128850784|NCT03030599|463748842|FG000|Open-label Extension|Lack of Efficacy|1|||
128850785|NCT03030599|463748843|FG001|Open-label Extension|Lack of Efficacy|0|||
128850786|NCT03030599|463748844|FG002|Open-label Extension|Lack of Efficacy|0|||
128850787|NCT03030599|463748842|FG000|Open-label Extension|Other Reason|1|||
128850788|NCT03030599|463748843|FG001|Open-label Extension|Other Reason|0|||
128850789|NCT03030599|463748844|FG002|Open-label Extension|Other Reason|0|||
128850790|NCT01177228|463748845|FG000|Overall Study|Positive tuberculosis test|0|||
128850791|NCT01177228|463748846|FG001|Overall Study|Positive tuberculosis test|1|||
128850792|NCT01177228|463748847|FG002|Overall Study|Positive tuberculosis test|0|||
128850793|NCT01177228|463748848|FG003|Overall Study|Positive tuberculosis test|0|||
128850794|NCT01177228|463748845|FG000|Overall Study|Worsening disease activity|1|||
128850795|NCT01177228|463748846|FG001|Overall Study|Worsening disease activity|0|||
128850796|NCT01177228|463748847|FG002|Overall Study|Worsening disease activity|0|||
128850797|NCT01177228|463748848|FG003|Overall Study|Worsening disease activity|0|||
128850798|NCT01177228|463748845|FG000|Overall Study|Withdrawal by Subject|0|||
128850799|NCT01177228|463748846|FG001|Overall Study|Withdrawal by Subject|1|||
128850800|NCT01177228|463748847|FG002|Overall Study|Withdrawal by Subject|0|||
128850801|NCT01177228|463748848|FG003|Overall Study|Withdrawal by Subject|0|||
128850802|NCT01592383|463748849|FG000|Overall Study|Adverse Event|1|||
128850803|NCT04167085|463748850|FG000|Baseline|Withdrawal by Subject|2|||
128850804|NCT04167085|463748851|FG001|Baseline|Withdrawal by Subject|1|||
128850805|NCT04167085|463748850|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
128850806|NCT04167085|463748851|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
128850807|NCT00006436|463748853|FG000|Overall Study|Refused further treatment|2|||
128850808|NCT00006436|463748853|FG000|Overall Study|Declined to participate (before treatment started)|1|||
128850809|NCT00316589|463748854|FG000|Overall Study|Withdrawal by Subject|0|||
128850810|NCT00316589|463748855|FG001|Overall Study|Withdrawal by Subject|5|||
128850811|NCT00316589|463748856|FG002|Overall Study|Withdrawal by Subject|0|||
128850812|NCT00316589|463748857|FG003|Overall Study|Withdrawal by Subject|1|||
128850813|NCT00316589|463748854|FG000|Overall Study|Subject unwilling/unable to comply|0|||
128850814|NCT00316589|463748855|FG001|Overall Study|Subject unwilling/unable to comply|6|||
128850815|NCT00316589|463748856|FG002|Overall Study|Subject unwilling/unable to comply|0|||
128850816|NCT00316589|463748857|FG003|Overall Study|Subject unwilling/unable to comply|2|||
128850817|NCT00316589|463748854|FG000|Overall Study|Adverse Event|1|||
128850818|NCT00316589|463748855|FG001|Overall Study|Adverse Event|0|||
128850819|NCT00316589|463748856|FG002|Overall Study|Adverse Event|0|||
128850820|NCT00316589|463748857|FG003|Overall Study|Adverse Event|1|||
128850821|NCT00316589|463748854|FG000|Overall Study|Physician Decision|0|||
128850822|NCT00316589|463748855|FG001|Overall Study|Physician Decision|1|||
128850823|NCT00316589|463748856|FG002|Overall Study|Physician Decision|0|||
128850824|NCT00316589|463748857|FG003|Overall Study|Physician Decision|0|||
128850825|NCT00316589|463748854|FG000|Overall Study|Other reason|0|||
128850826|NCT00316589|463748855|FG001|Overall Study|Other reason|12|||
128850827|NCT00316589|463748856|FG002|Overall Study|Other reason|1|||
128850828|NCT00316589|463748857|FG003|Overall Study|Other reason|1|||
128850829|NCT01482819|463748858|FG000|Overall Study|Lost to Follow-up|2|||
128850830|NCT00562484|463748859|FG000|Overall Study|Adverse Event|6|||
128850831|NCT00562484|463748860|FG001|Overall Study|Adverse Event|1|||
128850832|NCT00562484|463748859|FG000|Overall Study|Protocol Violation|11|||
128850833|NCT00562484|463748860|FG001|Overall Study|Protocol Violation|2|||
128850834|NCT00562484|463748859|FG000|Overall Study|Withdrawal by Subject|12|||
128850835|NCT00562484|463748860|FG001|Overall Study|Withdrawal by Subject|9|||
128850836|NCT00562484|463748859|FG000|Overall Study|Moved away from the study area|20|||
128850837|NCT00562484|463748860|FG001|Overall Study|Moved away from the study area|9|||
128850838|NCT00562484|463748859|FG000|Overall Study|Lost to Follow-up|132|||
128850839|NCT00562484|463748860|FG001|Overall Study|Lost to Follow-up|71|||
128850840|NCT00562484|463748859|FG000|Overall Study|Reason not provided or not specified|25|||
128850841|NCT00562484|463748860|FG001|Overall Study|Reason not provided or not specified|12|||
128850842|NCT00702520|463748861|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
128850843|NCT00702520|463748862|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
128850844|NCT00702520|463748863|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
128850845|NCT00702520|463748864|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
128850846|NCT00702520|463748861|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
128850847|NCT00702520|463748862|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
128850848|NCT00702520|463748863|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
128850849|NCT00702520|463748864|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
128850850|NCT00702520|463748861|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
128850851|NCT00702520|463748862|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
128850852|NCT00702520|463748863|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
128850853|NCT00702520|463748864|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
128850854|NCT00276016|463748865|FG000|Intervention 1|Withdrawal by Subject|0|||
128850855|NCT00276016|463748866|FG001|Intervention 1|Withdrawal by Subject|1|||
128850856|NCT00276016|463748867|FG002|Intervention 1|Withdrawal by Subject|0|||
128850857|NCT00276016|463748868|FG003|Intervention 1|Withdrawal by Subject|0|||
128850858|NCT00276016|463748869|FG004|Intervention 1|Withdrawal by Subject|0|||
128850859|NCT00276016|463748870|FG005|Intervention 1|Withdrawal by Subject|0|||
128850860|NCT05041439|463748871|FG000|Overall Study|Withdrawal by Subject|1|||
128850861|NCT05041439|463748872|FG001|Overall Study|Withdrawal by Subject|1|||
128850862|NCT05041439|463748871|FG000|Overall Study|Death|1|||
128850863|NCT05041439|463748872|FG001|Overall Study|Death|0|||
128850864|NCT01374971|463748873|FG000|Overall Study|Withdrawal by Subject|1|||
128850865|NCT00943618|463750610|FG000|Overall Study|Lost to Follow-up|38|||
128850866|NCT00943618|463750611|FG001|Overall Study|Lost to Follow-up|48|||
128850867|NCT00943618|463750612|FG002|Overall Study|Lost to Follow-up|20|||
128850868|NCT00943618|463750610|FG000|Overall Study|Discontinued Medication|17|||
128850869|NCT00943618|463750611|FG001|Overall Study|Discontinued Medication|29|||
128850870|NCT00943618|463750612|FG002|Overall Study|Discontinued Medication|11|||
128850871|NCT03713281|463750613|FG000|Overall Study|Lens handling difficuluties|2|||
128850872|NCT03713281|463750613|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
128850873|NCT00320398|463750614|FG000|Overall Study|Adverse Event|1|||
128850874|NCT00320398|463750615|FG001|Overall Study|Adverse Event|4|||
128850875|NCT00320398|463750614|FG000|Overall Study|Other|1|||
128850876|NCT00320398|463750615|FG001|Overall Study|Other|0|||
128850877|NCT00630552|463750617|FG000|Overall Study|Adverse Event|0|||
128850878|NCT00630552|463750618|FG001|Overall Study|Adverse Event|1|||
128850879|NCT00630552|463750619|FG002|Overall Study|Adverse Event|5|||
128850880|NCT00630552|463750620|FG003|Overall Study|Adverse Event|4|||
128850881|NCT00630552|463750621|FG004|Overall Study|Adverse Event|2|||
128850882|NCT00630552|463750617|FG000|Overall Study|Disease progression|5|||
128850883|NCT00630552|463750618|FG001|Overall Study|Disease progression|6|||
128850884|NCT00630552|463750619|FG002|Overall Study|Disease progression|27|||
128850885|NCT00630552|463750620|FG003|Overall Study|Disease progression|22|||
128850886|NCT00630552|463750621|FG004|Overall Study|Disease progression|31|||
128850887|NCT00630552|463750617|FG000|Overall Study|Never received IP|0|||
128850888|NCT00630552|463750618|FG001|Overall Study|Never received IP|0|||
128850889|NCT00630552|463750619|FG002|Overall Study|Never received IP|0|||
128850890|NCT00630552|463750620|FG003|Overall Study|Never received IP|2|||
128850891|NCT00630552|463750621|FG004|Overall Study|Never received IP|2|||
128850892|NCT00630552|463750617|FG000|Overall Study|Ineligibility determined|0|||
128850893|NCT00630552|463750618|FG001|Overall Study|Ineligibility determined|0|||
128850894|NCT00630552|463750619|FG002|Overall Study|Ineligibility determined|0|||
128850895|NCT00630552|463750620|FG003|Overall Study|Ineligibility determined|0|||
128850896|NCT00630552|463750621|FG004|Overall Study|Ineligibility determined|1|||
128850897|NCT00630552|463750617|FG000|Overall Study|Protocol Violation|0|||
128850898|NCT00630552|463750618|FG001|Overall Study|Protocol Violation|0|||
128850899|NCT00630552|463750619|FG002|Overall Study|Protocol Violation|0|||
128850900|NCT00630552|463750620|FG003|Overall Study|Protocol Violation|1|||
128850901|NCT00630552|463750621|FG004|Overall Study|Protocol Violation|0|||
128850902|NCT00630552|463750617|FG000|Overall Study|Physician Decision|0|||
128850903|NCT00630552|463750618|FG001|Overall Study|Physician Decision|0|||
128850904|NCT00630552|463750619|FG002|Overall Study|Physician Decision|0|||
128850905|NCT00630552|463750620|FG003|Overall Study|Physician Decision|0|||
128850906|NCT00630552|463750621|FG004|Overall Study|Physician Decision|1|||
128850907|NCT00630552|463750617|FG000|Overall Study|Death|0|||
128850908|NCT00630552|463750618|FG001|Overall Study|Death|0|||
128850909|NCT00630552|463750619|FG002|Overall Study|Death|1|||
128850910|NCT00630552|463750620|FG003|Overall Study|Death|2|||
128850911|NCT00630552|463750621|FG004|Overall Study|Death|2|||
128850912|NCT00630552|463750617|FG000|Overall Study|Withdrawal by Subject|0|||
128850913|NCT00630552|463750618|FG001|Overall Study|Withdrawal by Subject|0|||
128850914|NCT00630552|463750619|FG002|Overall Study|Withdrawal by Subject|0|||
128850915|NCT00630552|463750620|FG003|Overall Study|Withdrawal by Subject|1|||
128850916|NCT00630552|463750621|FG004|Overall Study|Withdrawal by Subject|0|||
128850917|NCT00630552|463750617|FG000|Overall Study|Other|0|||
128850918|NCT00630552|463750618|FG001|Overall Study|Other|0|||
128850919|NCT00630552|463750619|FG002|Overall Study|Other|4|||
128850920|NCT00630552|463750620|FG003|Overall Study|Other|2|||
128850921|NCT00630552|463750621|FG004|Overall Study|Other|0|||
128850922|NCT01169636|463750623|FG000|Overall Study|Adverse Event|0|||
128850923|NCT01169636|463750624|FG001|Overall Study|Adverse Event|0|||
128850924|NCT01169636|463750625|FG002|Overall Study|Adverse Event|1|||
128850925|NCT01169636|463750626|FG003|Overall Study|Adverse Event|1|||
128850926|NCT01169636|463750627|FG004|Overall Study|Adverse Event|0|||
128850927|NCT01169636|463750623|FG000|Overall Study|Screen failure|0|||
128850928|NCT01169636|463750624|FG001|Overall Study|Screen failure|0|||
128850929|NCT01169636|463750625|FG002|Overall Study|Screen failure|2|||
128850930|NCT01169636|463750626|FG003|Overall Study|Screen failure|0|||
128850931|NCT01169636|463750627|FG004|Overall Study|Screen failure|0|||
128850932|NCT01169636|463750623|FG000|Overall Study|Withdrawal by Subject|0|||
128850933|NCT01169636|463750624|FG001|Overall Study|Withdrawal by Subject|0|||
128850934|NCT01169636|463750625|FG002|Overall Study|Withdrawal by Subject|0|||
128850935|NCT01169636|463750626|FG003|Overall Study|Withdrawal by Subject|0|||
128850936|NCT01169636|463750627|FG004|Overall Study|Withdrawal by Subject|3|||
128850937|NCT02705625|463750628|FG000|Overall Study|Protocol Violation|1|||
128850938|NCT02705625|463750629|FG001|Overall Study|Protocol Violation|0|||
128850939|NCT02705625|463750630|FG002|Overall Study|Protocol Violation|0|||
128850940|NCT02705625|463750628|FG000|Overall Study|Adverse Event|6|||
128850941|NCT02705625|463750629|FG001|Overall Study|Adverse Event|5|||
128850942|NCT02705625|463750630|FG002|Overall Study|Adverse Event|2|||
128850943|NCT02705625|463750628|FG000|Overall Study|Death|0|||
128850944|NCT02705625|463750629|FG001|Overall Study|Death|0|||
128850945|NCT02705625|463750630|FG002|Overall Study|Death|1|||
128850946|NCT02705625|463750628|FG000|Overall Study|Withdrawal by Subject|1|||
128850947|NCT02705625|463750629|FG001|Overall Study|Withdrawal by Subject|4|||
128850948|NCT02705625|463750630|FG002|Overall Study|Withdrawal by Subject|5|||
128850949|NCT02705625|463750628|FG000|Overall Study|Lost to Follow-up|0|||
128850950|NCT02705625|463750629|FG001|Overall Study|Lost to Follow-up|0|||
128850951|NCT02705625|463750630|FG002|Overall Study|Lost to Follow-up|1|||
128850952|NCT02705625|463750628|FG000|Overall Study|Non-compliance|0|||
128850953|NCT02705625|463750629|FG001|Overall Study|Non-compliance|1|||
128850954|NCT02705625|463750630|FG002|Overall Study|Non-compliance|1|||
128850955|NCT02705625|463750628|FG000|Overall Study|Overdosing|0|||
128850956|NCT02705625|463750629|FG001|Overall Study|Overdosing|0|||
128850957|NCT02705625|463750630|FG002|Overall Study|Overdosing|1|||
128850958|NCT00494026|463750631|FG000|Overall Study|Sponsor Decision|4|||
128850959|NCT00468858|463750634|FG000|Overall Study|Adverse Event|0|||
128850960|NCT00468858|463750635|FG001|Overall Study|Adverse Event|1|||
128850961|NCT00468858|463750636|FG002|Overall Study|Adverse Event|0|||
128850962|NCT00468858|463750634|FG000|Overall Study|Withdrawal by Subject|7|||
128850963|NCT00468858|463750635|FG001|Overall Study|Withdrawal by Subject|4|||
128850964|NCT00468858|463750636|FG002|Overall Study|Withdrawal by Subject|5|||
128850965|NCT00468858|463750634|FG000|Overall Study|Relocation|1|||
128850966|NCT00468858|463750635|FG001|Overall Study|Relocation|3|||
128850967|NCT00468858|463750636|FG002|Overall Study|Relocation|3|||
128850968|NCT00468858|463750634|FG000|Overall Study|Lost to Follow-up|1|||
128850969|NCT00468858|463750635|FG001|Overall Study|Lost to Follow-up|2|||
128850970|NCT00468858|463750636|FG002|Overall Study|Lost to Follow-up|5|||
128850971|NCT00468858|463750634|FG000|Overall Study|Other|0|||
128850972|NCT00468858|463750635|FG001|Overall Study|Other|0|||
128850973|NCT00468858|463750636|FG002|Overall Study|Other|1|||
128850974|NCT00225277|463750643|FG000|Overall Study|Adverse Event|30|||
128850975|NCT00225277|463750644|FG001|Overall Study|Adverse Event|34|||
128850976|NCT00225277|463750643|FG000|Overall Study|Lack of Efficacy|4|||
128850977|NCT00225277|463750644|FG001|Overall Study|Lack of Efficacy|1|||
128850978|NCT00225277|463750643|FG000|Overall Study|Lost to Follow-up|4|||
128850979|NCT00225277|463750644|FG001|Overall Study|Lost to Follow-up|6|||
128850980|NCT00225277|463750643|FG000|Overall Study|Physician Decision|6|||
128850981|NCT00225277|463750644|FG001|Overall Study|Physician Decision|8|||
128850982|NCT00225277|463750643|FG000|Overall Study|Protocol Violation|6|||
128850983|NCT00225277|463750644|FG001|Overall Study|Protocol Violation|3|||
128850984|NCT00225277|463750643|FG000|Overall Study|Withdrawal by Subject|40|||
128850985|NCT00225277|463750644|FG001|Overall Study|Withdrawal by Subject|34|||
128850986|NCT00225277|463750643|FG000|Overall Study|Other|7|||
128850987|NCT00225277|463750644|FG001|Overall Study|Other|9|||
128850988|NCT04582669|463750651|FG000|Overall Study|Subject missed appointment(s).|1|||
128850989|NCT04582669|463750652|FG001|Overall Study|Subject missed appointment(s).|0|||
128850990|NCT04582669|463750653|FG002|Overall Study|Subject missed appointment(s).|1|||
128850991|NCT04582669|463750654|FG003|Overall Study|Subject missed appointment(s).|2|||
128850992|NCT04582669|463750651|FG000|Overall Study|Protocol Violation|0|||
128850993|NCT04582669|463750652|FG001|Overall Study|Protocol Violation|1|||
128850994|NCT04582669|463750653|FG002|Overall Study|Protocol Violation|1|||
128850995|NCT04582669|463750654|FG003|Overall Study|Protocol Violation|0|||
128850996|NCT00591409|463750655|FG000|Overall Study|Not Treated|0|||
128850997|NCT00591409|463750656|FG001|Overall Study|Not Treated|0|||
128850998|NCT00591409|463750657|FG002|Overall Study|Not Treated|0|||
128850999|NCT00591409|463750658|FG003|Overall Study|Not Treated|0|||
128851000|NCT00591409|463750659|FG004|Overall Study|Not Treated|1|||
128851001|NCT00591409|463750660|FG005|Overall Study|Not Treated|0|||
128851002|NCT00591409|463750661|FG006|Overall Study|Not Treated|0|||
128851003|NCT00591409|463750662|FG007|Overall Study|Not Treated|0|||
128851004|NCT00591409|463750663|FG008|Overall Study|Not Treated|0|||
128851005|NCT00591409|463750664|FG009|Overall Study|Not Treated|1|||
128851006|NCT00677092|463750665|FG000|Overall Study|Adverse Event|1|||
128851007|NCT00677092|463750665|FG000|Overall Study|Lost to Follow-up|1|||
128851008|NCT00677092|463750665|FG000|Overall Study|Withdrawal by Subject|3|||
128851009|NCT00677092|463750665|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
128851010|NCT00550446|463750666|FG000|Up To Week 12|Adverse Event|2|||
128851011|NCT00550446|463750667|FG001|Up To Week 12|Adverse Event|2|||
128851012|NCT00550446|463750668|FG002|Up To Week 12|Adverse Event|0|||
128851013|NCT00550446|463750669|FG003|Up To Week 12|Adverse Event|0|||
128851014|NCT00550446|463750670|FG004|Up To Week 12|Adverse Event|2|||
128851015|NCT00550446|463750671|FG005|Up To Week 12|Adverse Event|2|||
128851016|NCT00550446|463750672|FG006|Up To Week 12|Adverse Event|1|||
128851017|NCT00550446|463750673|FG007|Up To Week 12|Adverse Event|0|||
128851018|NCT00550446|463750674|FG008|Up To Week 12|Adverse Event|0|||
128851019|NCT00550446|463750675|FG009|Up To Week 12|Adverse Event|0|||
128851020|NCT00550446|463750676|FG010|Up To Week 12|Adverse Event|0|||
128851021|NCT00550446|463750666|FG000|Up To Week 12|Lack of Efficacy|3|||
128851022|NCT00550446|463750667|FG001|Up To Week 12|Lack of Efficacy|1|||
128851023|NCT00550446|463750668|FG002|Up To Week 12|Lack of Efficacy|0|||
128851024|NCT00550446|463750669|FG003|Up To Week 12|Lack of Efficacy|1|||
128851025|NCT00550446|463750670|FG004|Up To Week 12|Lack of Efficacy|0|||
128851026|NCT00550446|463750671|FG005|Up To Week 12|Lack of Efficacy|3|||
128851027|NCT00550446|463750672|FG006|Up To Week 12|Lack of Efficacy|3|||
128851028|NCT00550446|463750673|FG007|Up To Week 12|Lack of Efficacy|0|||
128851029|NCT00550446|463750674|FG008|Up To Week 12|Lack of Efficacy|0|||
128851030|NCT00550446|463750675|FG009|Up To Week 12|Lack of Efficacy|0|||
128851031|NCT00550446|463750676|FG010|Up To Week 12|Lack of Efficacy|0|||
128851032|NCT00550446|463750666|FG000|Up To Week 12|Lost to Follow-up|0|||
128851033|NCT00550446|463750667|FG001|Up To Week 12|Lost to Follow-up|1|||
128851034|NCT00550446|463750668|FG002|Up To Week 12|Lost to Follow-up|0|||
128851035|NCT00550446|463750669|FG003|Up To Week 12|Lost to Follow-up|0|||
128851036|NCT00550446|463750670|FG004|Up To Week 12|Lost to Follow-up|1|||
128851037|NCT00550446|463750671|FG005|Up To Week 12|Lost to Follow-up|1|||
128851038|NCT00550446|463750672|FG006|Up To Week 12|Lost to Follow-up|2|||
128851039|NCT00550446|463750673|FG007|Up To Week 12|Lost to Follow-up|0|||
128851040|NCT00550446|463750674|FG008|Up To Week 12|Lost to Follow-up|0|||
128851041|NCT00550446|463750675|FG009|Up To Week 12|Lost to Follow-up|0|||
128851042|NCT00550446|463750676|FG010|Up To Week 12|Lost to Follow-up|0|||
128851043|NCT00550446|463750666|FG000|Up To Week 12|Withdrawal by Subject|2|||
128851044|NCT00550446|463750667|FG001|Up To Week 12|Withdrawal by Subject|0|||
128851045|NCT00550446|463750668|FG002|Up To Week 12|Withdrawal by Subject|3|||
128851046|NCT00550446|463750669|FG003|Up To Week 12|Withdrawal by Subject|2|||
128851047|NCT00550446|463750670|FG004|Up To Week 12|Withdrawal by Subject|0|||
128851048|NCT00550446|463750671|FG005|Up To Week 12|Withdrawal by Subject|1|||
128851049|NCT00550446|463750672|FG006|Up To Week 12|Withdrawal by Subject|3|||
128851050|NCT00550446|463750673|FG007|Up To Week 12|Withdrawal by Subject|0|||
128851051|NCT00550446|463750674|FG008|Up To Week 12|Withdrawal by Subject|0|||
128851052|NCT00550446|463750675|FG009|Up To Week 12|Withdrawal by Subject|0|||
128851053|NCT00550446|463750676|FG010|Up To Week 12|Withdrawal by Subject|0|||
128851054|NCT00550446|463750666|FG000|Up To Week 12|Other|3|||
128851055|NCT00550446|463750667|FG001|Up To Week 12|Other|0|||
128851056|NCT00550446|463750668|FG002|Up To Week 12|Other|0|||
128851057|NCT00550446|463750669|FG003|Up To Week 12|Other|0|||
128851058|NCT00550446|463750670|FG004|Up To Week 12|Other|0|||
128851059|NCT00550446|463750671|FG005|Up To Week 12|Other|1|||
128851060|NCT00550446|463750672|FG006|Up To Week 12|Other|4|||
128851061|NCT00550446|463750673|FG007|Up To Week 12|Other|0|||
128851062|NCT00550446|463750674|FG008|Up To Week 12|Other|0|||
128851063|NCT00550446|463750675|FG009|Up To Week 12|Other|0|||
128851064|NCT00550446|463750676|FG010|Up To Week 12|Other|0|||
128851065|NCT00550446|463750666|FG000|Up To Week 12|Randomized not treated|0|||
128851066|NCT00550446|463750667|FG001|Up To Week 12|Randomized not treated|1|||
128851067|NCT00550446|463750668|FG002|Up To Week 12|Randomized not treated|1|||
128851068|NCT00550446|463750669|FG003|Up To Week 12|Randomized not treated|0|||
128851069|NCT00550446|463750670|FG004|Up To Week 12|Randomized not treated|0|||
128851070|NCT00550446|463750671|FG005|Up To Week 12|Randomized not treated|0|||
128851071|NCT00550446|463750672|FG006|Up To Week 12|Randomized not treated|0|||
128851072|NCT00550446|463750673|FG007|Up To Week 12|Randomized not treated|0|||
128851073|NCT00550446|463750674|FG008|Up To Week 12|Randomized not treated|0|||
128851074|NCT00550446|463750675|FG009|Up To Week 12|Randomized not treated|0|||
128851075|NCT00550446|463750676|FG010|Up To Week 12|Randomized not treated|0|||
128851076|NCT00550446|463750666|FG000|Post Week 12|Adverse Event|2|||
128851077|NCT00550446|463750667|FG001|Post Week 12|Adverse Event|1|||
128851078|NCT00550446|463750668|FG002|Post Week 12|Adverse Event|1|||
128851079|NCT00550446|463750669|FG003|Post Week 12|Adverse Event|1|||
128851080|NCT00550446|463750670|FG004|Post Week 12|Adverse Event|1|||
128851081|NCT00550446|463750671|FG005|Post Week 12|Adverse Event|1|||
128851082|NCT00550446|463750672|FG006|Post Week 12|Adverse Event|0|||
128851083|NCT00550446|463750673|FG007|Post Week 12|Adverse Event|0|||
128851084|NCT00550446|463750674|FG008|Post Week 12|Adverse Event|0|||
128851085|NCT00550446|463750675|FG009|Post Week 12|Adverse Event|4|||
128851086|NCT00550446|463750676|FG010|Post Week 12|Adverse Event|0|||
128851087|NCT00550446|463750666|FG000|Post Week 12|Lack of Efficacy|0|||
128851088|NCT00550446|463750667|FG001|Post Week 12|Lack of Efficacy|0|||
128851089|NCT00550446|463750668|FG002|Post Week 12|Lack of Efficacy|1|||
128851090|NCT00550446|463750669|FG003|Post Week 12|Lack of Efficacy|0|||
128851091|NCT00550446|463750670|FG004|Post Week 12|Lack of Efficacy|0|||
128851092|NCT00550446|463750671|FG005|Post Week 12|Lack of Efficacy|0|||
128851093|NCT00550446|463750672|FG006|Post Week 12|Lack of Efficacy|0|||
128851094|NCT00550446|463750673|FG007|Post Week 12|Lack of Efficacy|1|||
128851095|NCT00550446|463750674|FG008|Post Week 12|Lack of Efficacy|1|||
128851096|NCT00550446|463750675|FG009|Post Week 12|Lack of Efficacy|2|||
128851097|NCT00550446|463750676|FG010|Post Week 12|Lack of Efficacy|1|||
128851098|NCT00550446|463750666|FG000|Post Week 12|Lost to Follow-up|0|||
128851099|NCT00550446|463750667|FG001|Post Week 12|Lost to Follow-up|0|||
128851100|NCT00550446|463750668|FG002|Post Week 12|Lost to Follow-up|1|||
128851101|NCT00550446|463750669|FG003|Post Week 12|Lost to Follow-up|1|||
128851102|NCT00550446|463750670|FG004|Post Week 12|Lost to Follow-up|0|||
128851103|NCT00550446|463750671|FG005|Post Week 12|Lost to Follow-up|0|||
128851104|NCT00550446|463750672|FG006|Post Week 12|Lost to Follow-up|1|||
128851105|NCT00550446|463750673|FG007|Post Week 12|Lost to Follow-up|0|||
128851106|NCT00550446|463750674|FG008|Post Week 12|Lost to Follow-up|0|||
128851107|NCT00550446|463750675|FG009|Post Week 12|Lost to Follow-up|0|||
128851108|NCT00550446|463750676|FG010|Post Week 12|Lost to Follow-up|0|||
128851109|NCT00550446|463750666|FG000|Post Week 12|Withdrawal by Subject|0|||
128851110|NCT00550446|463750667|FG001|Post Week 12|Withdrawal by Subject|0|||
128851111|NCT00550446|463750668|FG002|Post Week 12|Withdrawal by Subject|0|||
128851112|NCT00550446|463750669|FG003|Post Week 12|Withdrawal by Subject|0|||
128851113|NCT00550446|463750670|FG004|Post Week 12|Withdrawal by Subject|1|||
128851114|NCT00550446|463750671|FG005|Post Week 12|Withdrawal by Subject|0|||
128851115|NCT00550446|463750672|FG006|Post Week 12|Withdrawal by Subject|0|||
128851116|NCT00550446|463750673|FG007|Post Week 12|Withdrawal by Subject|0|||
128851117|NCT00550446|463750674|FG008|Post Week 12|Withdrawal by Subject|0|||
128851118|NCT00550446|463750675|FG009|Post Week 12|Withdrawal by Subject|0|||
128851119|NCT00550446|463750676|FG010|Post Week 12|Withdrawal by Subject|0|||
128851120|NCT00550446|463750666|FG000|Post Week 12|Other|1|||
128851121|NCT00550446|463750667|FG001|Post Week 12|Other|1|||
128851122|NCT00550446|463750668|FG002|Post Week 12|Other|0|||
128851123|NCT00550446|463750669|FG003|Post Week 12|Other|1|||
128851124|NCT00550446|463750670|FG004|Post Week 12|Other|0|||
128851125|NCT00550446|463750671|FG005|Post Week 12|Other|0|||
128851126|NCT00550446|463750672|FG006|Post Week 12|Other|1|||
128851127|NCT00550446|463750673|FG007|Post Week 12|Other|0|||
128851128|NCT00550446|463750674|FG008|Post Week 12|Other|1|||
128851129|NCT00550446|463750675|FG009|Post Week 12|Other|1|||
128851130|NCT00550446|463750676|FG010|Post Week 12|Other|0|||
128851131|NCT02716298|463750677|FG000|First Intervention (1 Month)|Lens discomfort|1|||
128851132|NCT02716298|463750678|FG001|First Intervention (1 Month)|Lens discomfort|1|||
128851133|NCT01670188|463750681|FG000|Overall Study|Death|0|||
128851134|NCT01670188|463750682|FG001|Overall Study|Death|1|||
128851135|NCT02212301|463750683|FG000|Period 1|Lost to Follow-up|0|||
128851136|NCT02212301|463750684|FG001|Period 1|Lost to Follow-up|1|||
128851137|NCT03927222|463750685|FG000|Overall Study|Progression|3|||
128851138|NCT03927222|463750685|FG000|Overall Study|CMV testing results inconclusive|1|||
128851139|NCT03927222|463750685|FG000|Overall Study|Unable to generate enough vaccines|1|||
128851140|NCT03927222|463750685|FG000|Overall Study|Early study termination|1|||
128851141|NCT00578318|463750688|FG000|Overall Study|Lost to Follow-up|2|||
128851142|NCT00578318|463750689|FG001|Overall Study|Lost to Follow-up|0|||
128851143|NCT00578318|463750688|FG000|Overall Study|Physician Decision|1|||
128851144|NCT00578318|463750689|FG001|Overall Study|Physician Decision|0|||
128851145|NCT00527514|463750691|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
128851146|NCT00527514|463750691|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
128851147|NCT00527514|463750691|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
128851148|NCT00527514|463750691|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
128851149|NCT00527514|463750691|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
128851150|NCT00527514|463750691|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
128851151|NCT00527514|463750691|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
128851152|NCT00920699|463750694|FG000|Overall Study|Withdrawal by Subject|2|||
128851153|NCT00920699|463750695|FG001|Overall Study|Withdrawal by Subject|0|||
128851154|NCT00920699|463750696|FG002|Overall Study|Withdrawal by Subject|2|||
128851155|NCT00920699|463750694|FG000|Overall Study|no longer met eligibility|0|||
128851156|NCT00920699|463750695|FG001|Overall Study|no longer met eligibility|1|||
128851157|NCT00920699|463750696|FG002|Overall Study|no longer met eligibility|0|||
128851158|NCT00920699|463750694|FG000|Overall Study|Lost to Follow-up|0|||
128851159|NCT00920699|463750695|FG001|Overall Study|Lost to Follow-up|0|||
128851160|NCT00920699|463750696|FG002|Overall Study|Lost to Follow-up|2|||
128851161|NCT00001941|463750699|FG000|Overall Study|not treated- rapidly progressing disease|0|||
128851162|NCT00001941|463750700|FG001|Overall Study|not treated- rapidly progressing disease|0|||
128851163|NCT00001941|463750701|FG002|Overall Study|not treated- rapidly progressing disease|0|||
128851164|NCT00001941|463750702|FG003|Overall Study|not treated- rapidly progressing disease|0|||
128851165|NCT00001941|463750703|FG004|Overall Study|not treated- rapidly progressing disease|1|||
128851166|NCT03188536|463750707|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
128851167|NCT03188536|463750707|FG000|Overall Study|Not participated/met inclusion criteria|1|||
128851168|NCT02132117|463750708|FG000|Overall Study|Adverse Event|6|||
128851169|NCT02132117|463750709|FG001|Overall Study|Adverse Event|1|||
128851170|NCT02132117|463750708|FG000|Overall Study|Lost to Follow-up|2|||
128851171|NCT02132117|463750709|FG001|Overall Study|Lost to Follow-up|2|||
128851172|NCT02132117|463750708|FG000|Overall Study|Personal Reasons|1|||
128851173|NCT02132117|463750709|FG001|Overall Study|Personal Reasons|2|||
128851174|NCT02132117|463750708|FG000|Overall Study|Other Miscellaneous Reasons|2|||
128851175|NCT02132117|463750709|FG001|Overall Study|Other Miscellaneous Reasons|0|||
128851176|NCT02161185|463750714|FG000|Treatment Phase|Administrative/Other|7|||
128851177|NCT00372255|463750715|FG000|Overall Study|Withdrawn for other reasons|2|||
128851178|NCT00372255|463750716|FG001|Overall Study|Withdrawn for other reasons|1|||
128851179|NCT02970305|463750722|FG000|Overall Study|Adverse Event|10|||
128851180|NCT02970305|463750723|FG001|Overall Study|Adverse Event|6|||
128851181|NCT02970305|463750722|FG000|Overall Study|Lack of Efficacy|1|||
128851182|NCT02970305|463750723|FG001|Overall Study|Lack of Efficacy|1|||
128851183|NCT02970305|463750722|FG000|Overall Study|Noncompliance with study drug|2|||
128851184|NCT02970305|463750723|FG001|Overall Study|Noncompliance with study drug|4|||
128851185|NCT02970305|463750722|FG000|Overall Study|Protocol Violation|2|||
128851186|NCT02970305|463750723|FG001|Overall Study|Protocol Violation|2|||
128851187|NCT02970305|463750722|FG000|Overall Study|Withdrawal by Subject|12|||
128851188|NCT02970305|463750723|FG001|Overall Study|Withdrawal by Subject|11|||
128851189|NCT02970305|463750722|FG000|Overall Study|Not further specified|1|||
128851190|NCT02970305|463750723|FG001|Overall Study|Not further specified|2|||
128851191|NCT02970305|463750722|FG000|Overall Study|Lost to Follow-up|1|||
128851192|NCT02970305|463750723|FG001|Overall Study|Lost to Follow-up|2|||
128851193|NCT00983892|463750724|FG000|Overall Study|Withdrawal by Subject|10|||
128851194|NCT00983892|463750725|FG001|Overall Study|Withdrawal by Subject|12|||
128851195|NCT00808899|463750727|FG000|Overall Study|Death|1|||
128851196|NCT00808899|463750727|FG000|Overall Study|Physician Decision|3|||
128851197|NCT03120949|463750728|FG000|Overall Study|randomized in error|1|||
128851198|NCT03120949|463750729|FG001|Overall Study|randomized in error|0|||
128851199|NCT03120949|463750728|FG000|Overall Study|Death|13|||
128851200|NCT03120949|463750729|FG001|Overall Study|Death|13|||
128851201|NCT03120949|463750728|FG000|Overall Study|Lost to Follow-up|23|||
128851202|NCT03120949|463750729|FG001|Overall Study|Lost to Follow-up|13|||
128851203|NCT03120949|463750728|FG000|Overall Study|Withdrawal by Subject|139|||
128851204|NCT03120949|463750729|FG001|Overall Study|Withdrawal by Subject|124|||
128851205|NCT03120949|463750728|FG000|Overall Study|Covid-19|43|||
128851206|NCT03120949|463750729|FG001|Overall Study|Covid-19|34|||
128851207|NCT03120949|463750728|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
128851208|NCT03120949|463750729|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
128851209|NCT03120949|463750728|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
128851210|NCT03120949|463750729|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
128851211|NCT03120949|463750728|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
128851212|NCT03120949|463750729|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
128851213|NCT03120949|463750728|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
128851214|NCT03120949|463750729|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
128851215|NCT03120949|463750728|FG000|Overall Study|Site was closed|2|||
128851216|NCT03120949|463750729|FG001|Overall Study|Site was closed|3|||
128851217|NCT03120949|463750728|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
128851218|NCT03120949|463750729|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
128851219|NCT03120949|463750728|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
128851220|NCT03120949|463750729|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
128851221|NCT03120949|463750728|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
128851222|NCT03120949|463750729|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
128851223|NCT03120949|463750728|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
128851224|NCT03120949|463750729|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
128851225|NCT03120949|463750728|FG000|Overall Study|Other: Adverse Event|0|||
128851226|NCT03120949|463750729|FG001|Overall Study|Other: Adverse Event|1|||
128851227|NCT03120949|463750728|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
128851228|NCT03120949|463750729|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
128851229|NCT03120949|463750728|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
128851230|NCT03120949|463750729|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
128851231|NCT03120949|463750728|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
128851232|NCT03120949|463750729|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
128851233|NCT03120949|463750728|FG000|Overall Study|Personal Reasons|0|||
128851234|NCT03120949|463750729|FG001|Overall Study|Personal Reasons|1|||
128851235|NCT03120949|463750728|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
128851236|NCT03120949|463750729|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
128851237|NCT03120949|463750728|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
128851238|NCT03120949|463750729|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
128851239|NCT03120949|463750728|FG000|Overall Study|Compliance With Medication|0|||
128851240|NCT03120949|463750729|FG001|Overall Study|Compliance With Medication|1|||
128851241|NCT03120949|463750728|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
128851242|NCT03120949|463750729|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
128851243|NCT03120949|463750728|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
128851244|NCT03120949|463750729|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
128851245|NCT03120949|463750728|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
128851246|NCT03120949|463750729|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
128851247|NCT00988117|463750730|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
128851248|NCT00988117|463750730|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
128851249|NCT01220856|463750731|FG000|Overall Study|graft loss|3|||
128851250|NCT01220856|463750732|FG001|Overall Study|graft loss|3|||
128851251|NCT01220856|463750731|FG000|Overall Study|Lost to Follow-up|1|||
128851252|NCT01220856|463750732|FG001|Overall Study|Lost to Follow-up|0|||
128851253|NCT04088500|463750733|FG000|Overall Study|Reason unknown|1|||
128851254|NCT04088500|463750733|FG000|Overall Study|Participant withdrew consent|1|||
128851255|NCT04088500|463750733|FG000|Overall Study|Disease progression|3|||
128851256|NCT01078584|463750734|FG000|Overall Study|Final Status Unknown|1073|||
128851257|NCT01078584|463750734|FG000|Overall Study|Lost to Follow-up|670|||
128851258|NCT01078584|463750734|FG000|Overall Study|Non-serious Adverse Event|577|||
128851259|NCT01078584|463750734|FG000|Overall Study|Withdrawal of Consent|244|||
128851260|NCT01078584|463750734|FG000|Overall Study|Physician Withdrew from Study|90|||
128851261|NCT01078584|463750734|FG000|Overall Study|Non-compliance|67|||
128851262|NCT01078584|463750734|FG000|Overall Study|Blood Pressure Controlled|49|||
128851263|NCT01078584|463750734|FG000|Overall Study|Physician Switched Medication|26|||
128851264|NCT01078584|463750734|FG000|Overall Study|Physician Discontinued Patient|12|||
128851265|NCT01078584|463750734|FG000|Overall Study|Lack of Efficacy|98|||
128851266|NCT01078584|463750734|FG000|Overall Study|Protocol Violation|75|||
128851267|NCT01078584|463750734|FG000|Overall Study|Serious Adverse Event|27|||
128851268|NCT01078584|463750734|FG000|Overall Study|Multiple Reasons|2|||
128851269|NCT01208870|463750737|FG000|Overall Study|Lost to Follow-up|2|||
128851270|NCT01208870|463750738|FG001|Overall Study|Lost to Follow-up|8|||
128851271|NCT01494298|463750739|FG000|Overall Study|Protocol Violation|2|||
128851272|NCT01494298|463750740|FG001|Overall Study|Protocol Violation|8|||
128851273|NCT01904136|463752415|FG000|Overall Study|Physician Decision|0|||
128851274|NCT01904136|463752416|FG001|Overall Study|Physician Decision|0|||
128851275|NCT01904136|463752417|FG002|Overall Study|Physician Decision|0|||
128851276|NCT01904136|463752418|FG003|Overall Study|Physician Decision|0|||
128851277|NCT01904136|463752419|FG004|Overall Study|Physician Decision|0|||
128851278|NCT01904136|463752420|FG005|Overall Study|Physician Decision|1|||
128851279|NCT01904136|463752421|FG006|Overall Study|Physician Decision|0|||
128851280|NCT01904136|463752422|FG007|Overall Study|Physician Decision|0|||
128851281|NCT01904136|463752423|FG008|Overall Study|Physician Decision|0|||
128851282|NCT00853372|463752424|FG000|Overall Study|Death|30|||
128851283|NCT00853372|463752425|FG001|Overall Study|Death|26|||
128851284|NCT00853372|463752424|FG000|Overall Study|Lost to Follow-up|1|||
128851285|NCT00853372|463752425|FG001|Overall Study|Lost to Follow-up|2|||
128851286|NCT00853372|463752424|FG000|Overall Study|Full Consent Withdrawn|1|||
128851287|NCT00853372|463752425|FG001|Overall Study|Full Consent Withdrawn|1|||
128851288|NCT01268098|463752426|FG000|Overall Study|Adverse Event|1|||
128851289|NCT01268098|463752427|FG001|Overall Study|Adverse Event|0|||
128851290|NCT01929876|463752429|FG000|Period 2|Non-Compliance|1|||
128851291|NCT01845649|463752430|FG000|Overall Study|Adverse Event|7|||
128851292|NCT01845649|463752431|FG001|Overall Study|Adverse Event|10|||
128851293|NCT01845649|463752430|FG000|Overall Study|Lack of Efficacy|1|||
128851294|NCT01845649|463752431|FG001|Overall Study|Lack of Efficacy|1|||
128851295|NCT01845649|463752430|FG000|Overall Study|Lost to Follow-up|2|||
128851296|NCT01845649|463752431|FG001|Overall Study|Lost to Follow-up|2|||
128851297|NCT01845649|463752430|FG000|Overall Study|Withdrew Consent|12|||
128851298|NCT01845649|463752431|FG001|Overall Study|Withdrew Consent|4|||
128851299|NCT01845649|463752430|FG000|Overall Study|Protocol Deviation|7|||
128851300|NCT01845649|463752431|FG001|Overall Study|Protocol Deviation|4|||
128851301|NCT01845649|463752430|FG000|Overall Study|Reason not Specified|2|||
128851302|NCT01845649|463752431|FG001|Overall Study|Reason not Specified|1|||
128851303|NCT03991988|463752432|FG000|Overall Study|Withdrawal by Subject|2|||
128851304|NCT03991988|463752433|FG001|Overall Study|Withdrawal by Subject|2|||
128851305|NCT01222533|463752435|FG000|Overall Study|Adverse Event|5|||
128851306|NCT01222533|463752435|FG000|Overall Study|Withdrawal by Subject|5|||
128851307|NCT01222533|463752435|FG000|Overall Study|Other|4|||
128851308|NCT01947517|463752436|FG000|Overall Study|Withdrawal by Subject|1|||
128851309|NCT01947517|463752437|FG001|Overall Study|Withdrawal by Subject|1|||
128851310|NCT00526097|463752441|FG000|Overall Study|Adverse Event|6|||
128851311|NCT00526097|463752442|FG001|Overall Study|Adverse Event|44|||
128851312|NCT00526097|463752441|FG000|Overall Study|Protocol Violation|4|||
128851313|NCT00526097|463752442|FG001|Overall Study|Protocol Violation|10|||
128851314|NCT00526097|463752441|FG000|Overall Study|Withdrawal by Subject|3|||
128851315|NCT00526097|463752442|FG001|Overall Study|Withdrawal by Subject|1|||
128851316|NCT00526097|463752441|FG000|Overall Study|Other|2|||
128851317|NCT00526097|463752442|FG001|Overall Study|Other|1|||
128851318|NCT00460564|463752443|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
128851319|NCT00460564|463752444|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
128851320|NCT00460564|463752445|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
128851321|NCT00460564|463752446|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
128851322|NCT00460564|463752447|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
128851323|NCT00460564|463752448|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
128851324|NCT00460564|463752449|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
128851325|NCT00460564|463752450|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
128851326|NCT00460564|463752443|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
128851327|NCT00460564|463752444|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
128851328|NCT00460564|463752445|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
128851329|NCT00460564|463752446|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
128851330|NCT00460564|463752447|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
128851331|NCT00460564|463752448|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
128851332|NCT00460564|463752449|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
128851333|NCT00460564|463752450|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
128851334|NCT00460564|463752443|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
128851335|NCT00460564|463752444|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
128851336|NCT00460564|463752445|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
128851337|NCT00460564|463752446|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
128851338|NCT00460564|463752447|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
128851339|NCT00460564|463752448|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
128851340|NCT00460564|463752449|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
128851341|NCT00460564|463752450|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
128851342|NCT00460564|463752443|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
128851343|NCT00460564|463752444|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
128851344|NCT00460564|463752445|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
128851345|NCT00460564|463752446|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
128851346|NCT00460564|463752447|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
128851347|NCT00460564|463752448|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
128851348|NCT00460564|463752449|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
128851349|NCT00460564|463752450|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
128851350|NCT00460564|463752443|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
128851351|NCT00460564|463752444|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
128851352|NCT00460564|463752445|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
128851353|NCT00460564|463752446|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
128851354|NCT00460564|463752447|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
128851355|NCT00460564|463752448|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
128851356|NCT00460564|463752449|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
128851357|NCT00460564|463752450|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
128851358|NCT00487552|463752465|FG000|Overall Study|Unsuccessful magnet placements|3|||
128851359|NCT00487552|463752465|FG000|Overall Study|Death due to progressive malignancy|2|||
128851360|NCT00487552|463752465|FG000|Overall Study|Stent not placed|1|||
128851361|NCT02412111|463752466|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
128851362|NCT02412111|463752467|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
128851363|NCT02412111|463752468|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
128851364|NCT02412111|463752466|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
128851365|NCT02412111|463752467|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
128851366|NCT02412111|463752468|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
128851367|NCT02412111|463752466|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
128851368|NCT02412111|463752467|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
128851369|NCT02412111|463752468|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
128851370|NCT02412111|463752466|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
128851371|NCT02412111|463752467|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
128851372|NCT02412111|463752468|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
128851373|NCT02412111|463752466|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
128851374|NCT02412111|463752467|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
128851375|NCT02412111|463752468|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
128851376|NCT02412111|463752466|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
128851377|NCT02412111|463752467|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
128851378|NCT02412111|463752468|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
128851379|NCT02412111|463752466|FG000|Active Comparator Period (8 Weeks)|Other|0|||
128851380|NCT02412111|463752467|FG001|Active Comparator Period (8 Weeks)|Other|0|||
128851381|NCT02412111|463752468|FG002|Active Comparator Period (8 Weeks)|Other|2|||
128851382|NCT04349644|463752469|FG000|Allocation/Pretest|Lost to pretest|0|||
128851383|NCT04349644|463752470|FG001|Allocation/Pretest|Lost to pretest|3|||
128851384|NCT04349644|463752469|FG000|Posttest|Lost to posttest|0|||
128851385|NCT04349644|463752470|FG001|Posttest|Lost to posttest|8|||
128851386|NCT04349644|463752469|FG000|Posttest|Discontinued intervention|6|||
128851387|NCT04349644|463752470|FG001|Posttest|Discontinued intervention|0|||
128851388|NCT04349644|463752469|FG000|Follow-up|Lost to Follow-up|0|||
128851389|NCT04349644|463752470|FG001|Follow-up|Lost to Follow-up|2|||
128851390|NCT00983905|463752471|FG000|Theophylline Alone|Adverse Event|1|||
128851391|NCT00983905|463752471|FG000|Colchicine Alone|Adverse Event|2|||
128851392|NCT01057251|463752473|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
128851393|NCT01057251|463752474|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
128851394|NCT01057251|463752473|FG000|Overall Study|Adverse Event|4|||
128851395|NCT01057251|463752474|FG001|Overall Study|Adverse Event|2|||
128851396|NCT01057251|463752473|FG000|Overall Study|Lack of Efficacy|2|||
128851397|NCT01057251|463752474|FG001|Overall Study|Lack of Efficacy|11|||
128851398|NCT01057251|463752473|FG000|Overall Study|Protocol Violation|6|||
128851399|NCT01057251|463752474|FG001|Overall Study|Protocol Violation|2|||
128851400|NCT01057251|463752473|FG000|Overall Study|Withdrawal by Subject|4|||
128851401|NCT01057251|463752474|FG001|Overall Study|Withdrawal by Subject|5|||
128851402|NCT01057251|463752473|FG000|Overall Study|Lost to Follow-up|7|||
128851403|NCT01057251|463752474|FG001|Overall Study|Lost to Follow-up|6|||
128851404|NCT01057251|463752473|FG000|Overall Study|Other Reason|1|||
128851405|NCT01057251|463752474|FG001|Overall Study|Other Reason|1|||
128851406|NCT00784147|463752475|FG000|Overall Study|Lost to Follow-up|2|||
128851407|NCT00784147|463752476|FG001|Overall Study|Lost to Follow-up|4|||
128851408|NCT00784147|463752475|FG000|Overall Study|Withdrawal by Subject|1|||
128851409|NCT00784147|463752476|FG001|Overall Study|Withdrawal by Subject|3|||
128851410|NCT00784147|463752475|FG000|Overall Study|Physician Decision|2|||
128851411|NCT00784147|463752476|FG001|Overall Study|Physician Decision|1|||
128851412|NCT00784147|463752475|FG000|Overall Study|Protocol Violation|1|||
128851413|NCT00784147|463752476|FG001|Overall Study|Protocol Violation|1|||
128851414|NCT00784147|463752475|FG000|Overall Study|Death|2|||
128851415|NCT00784147|463752476|FG001|Overall Study|Death|0|||
128851416|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
128851417|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
128851418|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
128851419|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
128851420|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
128851421|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
128851422|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
128851423|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
128851424|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
128851425|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
128851426|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
128851427|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
128851428|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
128851429|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
128851430|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
128851431|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
128851432|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
128851433|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
128851434|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
128851435|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
128851436|NCT02637856|463752477|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
128851437|NCT02637856|463752478|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
128851438|NCT02637856|463752477|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
128851439|NCT02637856|463752478|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
128851440|NCT02637856|463752477|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
128851441|NCT02637856|463752478|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
128851442|NCT04544865|463752482|FG000|Overall Study|Death|0|||
128851443|NCT04544865|463752483|FG001|Overall Study|Death|2|||
128851444|NCT04544865|463752482|FG000|Overall Study|Lost to Follow-up|11|||
128851445|NCT04544865|463752483|FG001|Overall Study|Lost to Follow-up|7|||
128851446|NCT04544865|463752482|FG000|Overall Study|Withdrawal by Subject|0|||
128851447|NCT04544865|463752483|FG001|Overall Study|Withdrawal by Subject|1|||
128851448|NCT04544865|463752482|FG000|Overall Study|Other|0|||
128851449|NCT04544865|463752483|FG001|Overall Study|Other|1|||
128851450|NCT02815735|463752484|FG000|First Intervention (4 Weeks)|Discomfort|1|||
128851451|NCT02815735|463752485|FG001|First Intervention (4 Weeks)|Discomfort|0|||
128851452|NCT02815735|463752484|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
128851453|NCT02815735|463752485|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
128851454|NCT02815735|463752484|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
128851455|NCT02815735|463752485|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
128851456|NCT02815735|463752484|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
128851457|NCT02815735|463752485|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
128851458|NCT01732926|463752487|FG000|Overall Study|Study Terminated by Sponsor|168|||
128851459|NCT01732926|463752488|FG001|Overall Study|Study Terminated by Sponsor|80|||
128851460|NCT01732926|463752487|FG000|Overall Study|Withdrawal by Subject|46|||
128851461|NCT01732926|463752488|FG001|Overall Study|Withdrawal by Subject|8|||
128851462|NCT01732926|463752487|FG000|Overall Study|Physician Decision|24|||
128851463|NCT01732926|463752488|FG001|Overall Study|Physician Decision|11|||
128851464|NCT01732926|463752487|FG000|Overall Study|Other Reason|21|||
128851465|NCT01732926|463752488|FG001|Overall Study|Other Reason|4|||
128851466|NCT01732926|463752487|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
128851467|NCT01732926|463752488|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
128851468|NCT01732926|463752487|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
128851469|NCT01732926|463752488|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
128851470|NCT02262364|463752490|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
128851471|NCT01049984|463752491|FG000|Overall Study|Withdrawal by Subject|1|||
128851472|NCT01049984|463752492|FG001|Overall Study|Withdrawal by Subject|5|||
128851473|NCT01049984|463752491|FG000|Overall Study|Protocol Violation|3|||
128851474|NCT01049984|463752492|FG001|Overall Study|Protocol Violation|4|||
128851475|NCT01049984|463752491|FG000|Overall Study|Lost to Follow-up|2|||
128851476|NCT01049984|463752492|FG001|Overall Study|Lost to Follow-up|1|||
128851477|NCT01049984|463752491|FG000|Overall Study|Adverse Event|13|||
128851478|NCT01049984|463752492|FG001|Overall Study|Adverse Event|7|||
128851479|NCT01049984|463752491|FG000|Overall Study|Treatment failure|0|||
128851480|NCT01049984|463752492|FG001|Overall Study|Treatment failure|2|||
128851481|NCT04191148|463752498|FG000|Overall Study|Withdrawal by Subject|1|||
128851482|NCT04191148|463752499|FG001|Overall Study|Withdrawal by Subject|0|||
128851483|NCT04191148|463752498|FG000|Overall Study|Adverse Event|1|||
128851484|NCT04191148|463752499|FG001|Overall Study|Adverse Event|0|||
128851485|NCT01274559|463752502|FG000|Overall Study|Adverse Event|57|||
128851486|NCT01274559|463752503|FG001|Overall Study|Adverse Event|13|||
128851487|NCT01274559|463752502|FG000|Overall Study|Death|1|||
128851488|NCT01274559|463752503|FG001|Overall Study|Death|1|||
128851489|NCT01274559|463752502|FG000|Overall Study|Lost to Follow-up|3|||
128851490|NCT01274559|463752503|FG001|Overall Study|Lost to Follow-up|3|||
128851491|NCT01274559|463752502|FG000|Overall Study|Non-compliance with Study Drug|2|||
128851492|NCT01274559|463752503|FG001|Overall Study|Non-compliance with Study Drug|4|||
128851493|NCT01274559|463752502|FG000|Overall Study|Physician Decision|2|||
128851494|NCT01274559|463752503|FG001|Overall Study|Physician Decision|1|||
128851495|NCT01274559|463752502|FG000|Overall Study|Protocol Violation|28|||
128851496|NCT01274559|463752503|FG001|Overall Study|Protocol Violation|23|||
128851497|NCT01274559|463752502|FG000|Overall Study|Study Terminated by Sponsor|79|||
128851498|NCT01274559|463752503|FG001|Overall Study|Study Terminated by Sponsor|87|||
128851499|NCT01274559|463752502|FG000|Overall Study|Withdrawal by Subject|25|||
128851500|NCT01274559|463752503|FG001|Overall Study|Withdrawal by Subject|13|||
128851501|NCT02560389|463752504|FG000|Overall Study|Lost to Follow-up|1|||
128851502|NCT02560389|463752505|FG001|Overall Study|Lost to Follow-up|2|||
128851503|NCT02560389|463752506|FG002|Overall Study|Lost to Follow-up|2|||
128851504|NCT02560389|463752504|FG000|Overall Study|Tested positive for illicit substance|0|||
128851505|NCT02560389|463752505|FG001|Overall Study|Tested positive for illicit substance|1|||
128851506|NCT02560389|463752506|FG002|Overall Study|Tested positive for illicit substance|0|||
128851507|NCT03409731|463752508|FG000|Overall Study|Withdrawal by Subject|17|||
128851508|NCT03409731|463752508|FG000|Overall Study|Death|4|||
128851509|NCT02287883|463752517|FG000|Overall Study|Death|8|||
128851510|NCT02287883|463752518|FG001|Overall Study|Death|7|||
128851511|NCT02287883|463752517|FG000|Overall Study|No longer eligible|222|||
128851512|NCT02287883|463752518|FG001|Overall Study|No longer eligible|182|||
128851513|NCT02287883|463752517|FG000|Overall Study|Non-response to survey|229|||
128851514|NCT02287883|463752518|FG001|Overall Study|Non-response to survey|237|||
128851515|NCT00802438|463752519|FG000|Overall Study|Screen Failure|20|||
128851516|NCT00802438|463752519|FG000|Overall Study|Withdrawal by Subject|7|||
128851517|NCT00802438|463752519|FG000|Overall Study|Physician Decision|1|||
128851518|NCT03175198|463752520|FG000|Overall Study|Adverse Event|480|||
128851519|NCT03175198|463752520|FG000|Overall Study|No actual visit|120|||
128851520|NCT03175198|463752520|FG000|Overall Study|Registration rule not followed|4|||
128851521|NCT03175198|463752520|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
128851522|NCT03175198|463752520|FG000|Overall Study|Other personal reason|509|||
128851523|NCT03175198|463752520|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
128851524|NCT03175198|463752520|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
128851525|NCT03175198|463752520|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
128851526|NCT03175198|463752520|FG000|Overall Study|To conduct invasive treatment of operation|53|||
128851527|NCT03175198|463752520|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
128851528|NCT00363649|463752522|FG000|Overall Study|Withdrawal by Subject|1|||
128851529|NCT00363649|463752523|FG001|Overall Study|Withdrawal by Subject|1|||
128851530|NCT00363649|463752522|FG000|Overall Study|Adverse Event|6|||
128851531|NCT00363649|463752523|FG001|Overall Study|Adverse Event|0|||
128851532|NCT04947436|463752526|FG000|Overall Study|Lost to Follow-up|3|||
128851533|NCT04947436|463752527|FG001|Overall Study|Lost to Follow-up|7|||
128851534|NCT04947436|463752528|FG002|Overall Study|Lost to Follow-up|5|||
128851535|NCT04947436|463752526|FG000|Overall Study|Death|1|||
128851536|NCT04947436|463752527|FG001|Overall Study|Death|1|||
128851537|NCT04947436|463752528|FG002|Overall Study|Death|1|||
128851538|NCT00312845|463752529|FG000|Overall Study|Adverse Event|19|||
128851539|NCT00312845|463752530|FG001|Overall Study|Adverse Event|5|||
128851540|NCT00312845|463752529|FG000|Overall Study|Death|2|||
128851541|NCT00312845|463752530|FG001|Overall Study|Death|2|||
128851542|NCT00312845|463752529|FG000|Overall Study|Withdrawal by Subject|14|||
128851543|NCT00312845|463752530|FG001|Overall Study|Withdrawal by Subject|6|||
128851544|NCT00312845|463752529|FG000|Overall Study|Disease Progression|56|||
128851545|NCT00312845|463752530|FG001|Overall Study|Disease Progression|77|||
128851546|NCT00312845|463752529|FG000|Overall Study|Lost to Follow-up|2|||
128851547|NCT00312845|463752530|FG001|Overall Study|Lost to Follow-up|0|||
128851548|NCT00312845|463752529|FG000|Overall Study|Other|6|||
128851549|NCT00312845|463752530|FG001|Overall Study|Other|5|||
128851550|NCT00496834|463752534|FG000|Overall Study|Withdrawal by Subject|4|||
128851551|NCT00496834|463752535|FG001|Overall Study|Withdrawal by Subject|6|||
128851552|NCT00496834|463752534|FG000|Overall Study|Contraindicated medication administered|0|||
128851553|NCT00496834|463752535|FG001|Overall Study|Contraindicated medication administered|1|||
128851554|NCT00496834|463752534|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
128851555|NCT00496834|463752535|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
128851556|NCT00496834|463752534|FG000|Overall Study|Adverse Event|5|||
128851557|NCT00496834|463752535|FG001|Overall Study|Adverse Event|3|||
128851558|NCT00496834|463752534|FG000|Overall Study|IP administration violation|2|||
128851559|NCT00496834|463752535|FG001|Overall Study|IP administration violation|0|||
128851560|NCT00496834|463752534|FG000|Overall Study|Lost to Follow-up|2|||
128851561|NCT00496834|463752535|FG001|Overall Study|Lost to Follow-up|0|||
128851562|NCT00496834|463752534|FG000|Overall Study|Blood Pressure control failure|2|||
128851563|NCT00496834|463752535|FG001|Overall Study|Blood Pressure control failure|1|||
128851564|NCT01227928|463752536|FG000|Overall Study|Lost to Follow-up|4|||
128851565|NCT01227928|463752537|FG001|Overall Study|Lost to Follow-up|2|||
128851566|NCT01227928|463752536|FG000|Overall Study|Withdrawal by Subject|4|||
128851567|NCT01227928|463752537|FG001|Overall Study|Withdrawal by Subject|3|||
128851568|NCT01227928|463752536|FG000|Overall Study|Death|14|||
128851569|NCT01227928|463752537|FG001|Overall Study|Death|12|||
128851570|NCT04159805|463752540|FG000|Overall Study|Withdrawal by Subject|0|||
128851571|NCT04159805|463752541|FG001|Overall Study|Withdrawal by Subject|2|||
128851572|NCT04159805|463752542|FG002|Overall Study|Withdrawal by Subject|2|||
128851573|NCT02930837|463752543|FG000|Overall Study|Adverse Event|6|||
128851574|NCT02930837|463752543|FG000|Overall Study|Lost to Follow-up|5|||
128851575|NCT02930837|463752543|FG000|Overall Study|Withdrawal by Subject|1|||
128851576|NCT01393613|463752544|FG000|Overall Study|Adverse Event|11|||
128851577|NCT01393613|463752545|FG001|Overall Study|Adverse Event|11|||
128851578|NCT01393613|463752546|FG002|Overall Study|Adverse Event|13|||
128851579|NCT01393613|463752547|FG003|Overall Study|Adverse Event|22|||
128851580|NCT01393613|463752544|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
128851581|NCT01393613|463752545|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
128851582|NCT01393613|463752546|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
128851583|NCT01393613|463752547|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
128851584|NCT01393613|463752544|FG000|Overall Study|Physician Decision|2|||
128851585|NCT01393613|463752545|FG001|Overall Study|Physician Decision|0|||
128851586|NCT01393613|463752546|FG002|Overall Study|Physician Decision|0|||
128851587|NCT01393613|463752547|FG003|Overall Study|Physician Decision|1|||
128851588|NCT01393613|463752544|FG000|Overall Study|Withdrawal by Subject|15|||
128851589|NCT01393613|463752545|FG001|Overall Study|Withdrawal by Subject|25|||
128851590|NCT01393613|463752546|FG002|Overall Study|Withdrawal by Subject|23|||
128851591|NCT01393613|463752547|FG003|Overall Study|Withdrawal by Subject|21|||
128851592|NCT01393613|463752544|FG000|Overall Study|Protocol Deviation|2|||
128851593|NCT01393613|463752545|FG001|Overall Study|Protocol Deviation|1|||
128851594|NCT01393613|463752546|FG002|Overall Study|Protocol Deviation|0|||
128851595|NCT01393613|463752547|FG003|Overall Study|Protocol Deviation|0|||
128851596|NCT01393613|463752544|FG000|Overall Study|Lack of Efficacy|9|||
128851597|NCT01393613|463752545|FG001|Overall Study|Lack of Efficacy|20|||
128851598|NCT01393613|463752546|FG002|Overall Study|Lack of Efficacy|16|||
128851599|NCT01393613|463752547|FG003|Overall Study|Lack of Efficacy|21|||
128851600|NCT03821064|463752548|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
128851601|NCT01283971|463752549|FG000|Overall Study|Adverse Event|3|||
128851602|NCT01283971|463752550|FG001|Overall Study|Adverse Event|5|||
128851603|NCT01283971|463752549|FG000|Overall Study|Insufficient therapeutic responses|3|||
128851604|NCT01283971|463752550|FG001|Overall Study|Insufficient therapeutic responses|3|||
128851605|NCT01283971|463752549|FG000|Overall Study|Protocol Violation|5|||
128851606|NCT01283971|463752550|FG001|Overall Study|Protocol Violation|1|||
128851607|NCT01283971|463752549|FG000|Overall Study|Refused treatment|3|||
128851608|NCT01283971|463752550|FG001|Overall Study|Refused treatment|1|||
128851609|NCT01283971|463752549|FG000|Overall Study|Failure to return|0|||
128851610|NCT01283971|463752550|FG001|Overall Study|Failure to return|1|||
128851611|NCT01283971|463752549|FG000|Overall Study|Administrative reasons|1|||
128851612|NCT01283971|463752550|FG001|Overall Study|Administrative reasons|1|||
128851613|NCT02598934|463752559|FG000|Overall Study|Adverse Event|11|||
128851614|NCT02598934|463752560|FG001|Overall Study|Adverse Event|13|||
128851615|NCT02598934|463752559|FG000|Overall Study|Failure to Return|3|||
128851616|NCT02598934|463752560|FG001|Overall Study|Failure to Return|3|||
128851617|NCT02598934|463752559|FG000|Overall Study|Withdrawal by Subject|2|||
128851618|NCT02598934|463752560|FG001|Overall Study|Withdrawal by Subject|3|||
128851619|NCT02598934|463752559|FG000|Overall Study|Administrative|2|||
128851620|NCT02598934|463752560|FG001|Overall Study|Administrative|1|||
128851621|NCT02598934|463752559|FG000|Overall Study|Protocol Violation|1|||
128851622|NCT02598934|463752560|FG001|Overall Study|Protocol Violation|2|||
128851623|NCT03325608|463752563|FG000|Overall Study|Lost to Follow-up|23|||
128851624|NCT03325608|463752564|FG001|Overall Study|Lost to Follow-up|23|||
128851625|NCT03325608|463752565|FG002|Overall Study|Lost to Follow-up|30|||
128851626|NCT03325608|463752566|FG003|Overall Study|Lost to Follow-up|30|||
128851627|NCT03325608|463752563|FG000|Overall Study|Death of Caregiver|0|||
128851628|NCT03325608|463752564|FG001|Overall Study|Death of Caregiver|0|||
128851629|NCT03325608|463752565|FG002|Overall Study|Death of Caregiver|2|||
128851630|NCT03325608|463752566|FG003|Overall Study|Death of Caregiver|2|||
128851631|NCT03325608|463752563|FG000|Overall Study|Death of Care Recipient|34|||
128851632|NCT03325608|463752564|FG001|Overall Study|Death of Care Recipient|34|||
128851633|NCT03325608|463752565|FG002|Overall Study|Death of Care Recipient|28|||
128851634|NCT03325608|463752566|FG003|Overall Study|Death of Care Recipient|28|||
128851635|NCT03325608|463752563|FG000|Overall Study|Withdrawal by Subject|49|||
128851636|NCT03325608|463752564|FG001|Overall Study|Withdrawal by Subject|49|||
128851637|NCT03325608|463752565|FG002|Overall Study|Withdrawal by Subject|35|||
128851638|NCT03325608|463752566|FG003|Overall Study|Withdrawal by Subject|35|||
128851639|NCT03325608|463752563|FG000|Overall Study|Ineligible|7|||
128851640|NCT03325608|463752564|FG001|Overall Study|Ineligible|7|||
128851641|NCT03325608|463752565|FG002|Overall Study|Ineligible|5|||
128851642|NCT03325608|463752566|FG003|Overall Study|Ineligible|5|||
128851643|NCT02154347|463752567|FG000|Double-blind Period|Adverse Event|1|||
128851644|NCT02154347|463752568|FG001|Double-blind Period|Adverse Event|2|||
128851645|NCT02154347|463752567|FG000|Double-blind Period|Lack of Efficacy|1|||
128851646|NCT02154347|463752568|FG001|Double-blind Period|Lack of Efficacy|0|||
128851647|NCT02154347|463752567|FG000|Double-blind Period|Physician Decision|0|||
128851648|NCT02154347|463752568|FG001|Double-blind Period|Physician Decision|1|||
128851649|NCT02154347|463752567|FG000|Double-blind Period|Withdrawal by Subject|1|||
128851650|NCT02154347|463752568|FG001|Double-blind Period|Withdrawal by Subject|1|||
128851651|NCT02154347|463752567|FG000|Open-label Period|Adverse Event|3|||
128851652|NCT02154347|463752568|FG001|Open-label Period|Adverse Event|4|||
128851653|NCT02154347|463752567|FG000|Open-label Period|Lack of Efficacy|4|||
128851654|NCT02154347|463752568|FG001|Open-label Period|Lack of Efficacy|19|||
128851655|NCT02154347|463752567|FG000|Open-label Period|Protocol Violation|0|||
128851656|NCT02154347|463752568|FG001|Open-label Period|Protocol Violation|1|||
128851657|NCT02154347|463752567|FG000|Open-label Period|Withdrawal by Subject|0|||
128851658|NCT02154347|463752568|FG001|Open-label Period|Withdrawal by Subject|1|||
128851659|NCT02188784|463752569|FG000|Overall Study|Death|3|||
128851660|NCT02188784|463752570|FG001|Overall Study|Death|1|||
128851661|NCT02188784|463752569|FG000|Overall Study|Lost to Follow-up|1|||
128851662|NCT02188784|463752570|FG001|Overall Study|Lost to Follow-up|0|||
128851663|NCT02188784|463752569|FG000|Overall Study|Withdrawal by Subject|3|||
128851664|NCT02188784|463752570|FG001|Overall Study|Withdrawal by Subject|9|||
128851665|NCT02188784|463752569|FG000|Overall Study|Physician Decision|2|||
128851666|NCT02188784|463752570|FG001|Overall Study|Physician Decision|3|||
128851667|NCT02473913|463752572|FG000|Overall Study|Lost to Follow-up|3|||
128851668|NCT02473913|463752573|FG001|Overall Study|Lost to Follow-up|3|||
128851669|NCT01190449|463752576|FG000|Overall Study|Ineligible|0|||
128851670|NCT01190449|463752577|FG001|Overall Study|Ineligible|4|||
128851671|NCT04944784|463752578|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
128851672|NCT04944784|463752579|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
128851673|NCT04944784|463752580|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
128851674|NCT04944784|463752581|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
128851675|NCT04944784|463752578|FG000|Double-blind Period|Adverse Event|20|||
128851676|NCT04944784|463752579|FG001|Double-blind Period|Adverse Event|4|||
128851677|NCT04944784|463752580|FG002|Double-blind Period|Adverse Event|0|||
128851678|NCT04944784|463752581|FG003|Double-blind Period|Adverse Event|0|||
128851679|NCT04944784|463752578|FG000|Double-blind Period|Withdrawal by Subject|15|||
128851680|NCT04944784|463752579|FG001|Double-blind Period|Withdrawal by Subject|4|||
128851681|NCT04944784|463752580|FG002|Double-blind Period|Withdrawal by Subject|0|||
128851682|NCT04944784|463752581|FG003|Double-blind Period|Withdrawal by Subject|0|||
128851683|NCT04944784|463752578|FG000|Double-blind Period|Death|7|||
128851684|NCT04944784|463752579|FG001|Double-blind Period|Death|2|||
128851685|NCT04944784|463752580|FG002|Double-blind Period|Death|0|||
128851686|NCT04944784|463752581|FG003|Double-blind Period|Death|0|||
128851687|NCT04944784|463752578|FG000|Double-blind Period|Physician Decision|2|||
128851688|NCT04944784|463752579|FG001|Double-blind Period|Physician Decision|1|||
128851689|NCT04944784|463752580|FG002|Double-blind Period|Physician Decision|0|||
128851690|NCT04944784|463752581|FG003|Double-blind Period|Physician Decision|0|||
128851691|NCT04944784|463752578|FG000|Double-blind Period|Lack of Efficacy|0|||
128851692|NCT04944784|463752579|FG001|Double-blind Period|Lack of Efficacy|1|||
128851693|NCT04944784|463752580|FG002|Double-blind Period|Lack of Efficacy|0|||
128851694|NCT04944784|463752581|FG003|Double-blind Period|Lack of Efficacy|0|||
128851695|NCT04944784|463752578|FG000|Double-blind Period|Sponsor Request|2|||
128851696|NCT04944784|463752579|FG001|Double-blind Period|Sponsor Request|1|||
128851697|NCT04944784|463752580|FG002|Double-blind Period|Sponsor Request|0|||
128851698|NCT04944784|463752581|FG003|Double-blind Period|Sponsor Request|0|||
128851699|NCT04944784|463752578|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
128851700|NCT04944784|463752579|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
128851701|NCT04944784|463752580|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
128851702|NCT04944784|463752581|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
128851703|NCT04944784|463752578|FG000|Double-blind Period|Participant Choice|1|||
128851704|NCT04944784|463752579|FG001|Double-blind Period|Participant Choice|1|||
128851705|NCT04944784|463752580|FG002|Double-blind Period|Participant Choice|0|||
128851706|NCT04944784|463752581|FG003|Double-blind Period|Participant Choice|0|||
128851707|NCT04944784|463752578|FG000|Double-blind Period|Progressive Disease|2|||
128851708|NCT04944784|463752579|FG001|Double-blind Period|Progressive Disease|2|||
128851709|NCT04944784|463752580|FG002|Double-blind Period|Progressive Disease|0|||
128851710|NCT04944784|463752581|FG003|Double-blind Period|Progressive Disease|0|||
128851711|NCT04944784|463752578|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
128851712|NCT04944784|463752579|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
128851713|NCT04944784|463752580|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
128851714|NCT04944784|463752581|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
128851715|NCT04944784|463752578|FG000|Active Drug Period|Adverse Event|0|||
128851716|NCT04944784|463752579|FG001|Active Drug Period|Adverse Event|0|||
128851717|NCT04944784|463752580|FG002|Active Drug Period|Adverse Event|3|||
128851718|NCT04944784|463752581|FG003|Active Drug Period|Adverse Event|6|||
128851719|NCT04944784|463752578|FG000|Active Drug Period|Withdrawal by Subject|0|||
128851720|NCT04944784|463752579|FG001|Active Drug Period|Withdrawal by Subject|0|||
128851721|NCT04944784|463752580|FG002|Active Drug Period|Withdrawal by Subject|4|||
128851722|NCT04944784|463752581|FG003|Active Drug Period|Withdrawal by Subject|7|||
128851723|NCT04944784|463752578|FG000|Active Drug Period|Death|0|||
128851724|NCT04944784|463752579|FG001|Active Drug Period|Death|0|||
128851725|NCT04944784|463752580|FG002|Active Drug Period|Death|3|||
128851726|NCT04944784|463752581|FG003|Active Drug Period|Death|4|||
128851727|NCT04944784|463752578|FG000|Active Drug Period|Lack of Efficacy|0|||
128851728|NCT04944784|463752579|FG001|Active Drug Period|Lack of Efficacy|0|||
128851729|NCT04944784|463752580|FG002|Active Drug Period|Lack of Efficacy|2|||
128851730|NCT04944784|463752581|FG003|Active Drug Period|Lack of Efficacy|2|||
128851731|NCT04944784|463752578|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
128851732|NCT04944784|463752579|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
128851733|NCT04944784|463752580|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
128851734|NCT04944784|463752581|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
128851735|NCT04944784|463752578|FG000|Active Drug Period|Participant Choice|0|||
128851736|NCT04944784|463752579|FG001|Active Drug Period|Participant Choice|0|||
128851737|NCT04944784|463752580|FG002|Active Drug Period|Participant Choice|0|||
128851738|NCT04944784|463752581|FG003|Active Drug Period|Participant Choice|1|||
128851739|NCT04944784|463752578|FG000|Active Drug Period|Progressive Disease|0|||
128851740|NCT04944784|463752579|FG001|Active Drug Period|Progressive Disease|0|||
128851741|NCT04944784|463752580|FG002|Active Drug Period|Progressive Disease|4|||
128851742|NCT04944784|463752581|FG003|Active Drug Period|Progressive Disease|4|||
128851743|NCT04944784|463752578|FG000|Active Drug Period|Lost to Follow-up|0|||
128851744|NCT04944784|463752579|FG001|Active Drug Period|Lost to Follow-up|0|||
128851745|NCT04944784|463752580|FG002|Active Drug Period|Lost to Follow-up|0|||
128851746|NCT04944784|463752581|FG003|Active Drug Period|Lost to Follow-up|1|||
128851747|NCT02210208|463754436|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
128851748|NCT02210208|463754436|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
128851749|NCT02210208|463754436|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
128851750|NCT01171183|463754437|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
128851751|NCT01171183|463754438|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
128851752|NCT01171183|463754437|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
128851753|NCT01171183|463754438|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
128851754|NCT01171183|463754437|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
128851755|NCT01171183|463754438|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
128851756|NCT01171183|463754437|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
128851757|NCT01171183|463754438|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
128851758|NCT01171183|463754437|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
128851759|NCT01171183|463754438|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
128851760|NCT01171183|463754437|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
128851761|NCT01171183|463754438|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
128851762|NCT01066936|463754439|FG000|Overall Study|Death|2|||
128851763|NCT01066936|463754439|FG000|Overall Study|Device revised/removed|1|||
128851764|NCT01066936|463754439|FG000|Overall Study|Lost to Follow-up|3|||
128851765|NCT01066936|463754439|FG000|Overall Study|Withdrawal by Subject|4|||
128851766|NCT02418845|463754444|FG000|Overall Study|Lost to Follow-up|7|||
128851767|NCT02418845|463754445|FG001|Overall Study|Lost to Follow-up|2|||
128851768|NCT02418845|463754444|FG000|Overall Study|Lack of Efficacy|0|||
128851769|NCT02418845|463754445|FG001|Overall Study|Lack of Efficacy|3|||
128851770|NCT02418845|463754444|FG000|Overall Study|Physician Decision|5|||
128851771|NCT02418845|463754445|FG001|Overall Study|Physician Decision|5|||
128851772|NCT02418845|463754444|FG000|Overall Study|Protocol Violation|1|||
128851773|NCT02418845|463754445|FG001|Overall Study|Protocol Violation|0|||
128851774|NCT02418845|463754444|FG000|Overall Study|Withdrawal by Subject|3|||
128851775|NCT02418845|463754445|FG001|Overall Study|Withdrawal by Subject|2|||
128851776|NCT04984239|463754446|FG000|Overall Study|Lost to Follow-up|1|||
128851777|NCT04190225|463754447|FG000|Overall Study|Lost to Follow-up|2|||
128851778|NCT04190225|463754448|FG001|Overall Study|Lost to Follow-up|3|||
128851779|NCT04190225|463754447|FG000|Overall Study|Withdrawal by Subject|3|||
128851780|NCT04190225|463754448|FG001|Overall Study|Withdrawal by Subject|2|||
128851781|NCT04190225|463754447|FG000|Overall Study|Unrelated health condition|2|||
128851782|NCT04190225|463754448|FG001|Overall Study|Unrelated health condition|0|||
128851783|NCT01114139|463754450|FG000|Overall Study|Adverse Event|3|||
128851784|NCT01114139|463754451|FG001|Overall Study|Adverse Event|2|||
128851785|NCT01114139|463754450|FG000|Overall Study|Lost to Follow-up|15|||
128851786|NCT01114139|463754451|FG001|Overall Study|Lost to Follow-up|3|||
128851787|NCT01114139|463754450|FG000|Overall Study|Withdrawal by Subject|17|||
128851788|NCT01114139|463754451|FG001|Overall Study|Withdrawal by Subject|6|||
128851789|NCT01114139|463754450|FG000|Overall Study|Other-Missed 1 visit|1|||
128851790|NCT01114139|463754451|FG001|Overall Study|Other-Missed 1 visit|0|||
128851791|NCT01114139|463754450|FG000|Overall Study|Other-Protocol Violation|1|||
128851792|NCT01114139|463754451|FG001|Overall Study|Other-Protocol Violation|0|||
128851793|NCT01114139|463754450|FG000|Overall Study|Other-Out of window for study drug dose|1|||
128851794|NCT01114139|463754451|FG001|Overall Study|Other-Out of window for study drug dose|0|||
128851795|NCT01114139|463754450|FG000|Overall Study|Other-Participant falsified records|0|||
128851796|NCT01114139|463754451|FG001|Overall Study|Other-Participant falsified records|1|||
128851797|NCT01114139|463754450|FG000|Overall Study|Other-Participant went on hospice|0|||
128851798|NCT01114139|463754451|FG001|Overall Study|Other-Participant went on hospice|1|||
128851799|NCT01114139|463754450|FG000|Overall Study|Other-Physician changed treatment|1|||
128851800|NCT01114139|463754451|FG001|Overall Study|Other-Physician changed treatment|0|||
128851801|NCT01114139|463754450|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
128851802|NCT01114139|463754451|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
128851803|NCT02994784|463754452|FG000|6 Months Follow-up|Lost to Follow-up|3|||
128851804|NCT02466243|463754454|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
128851805|NCT02466243|463754455|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
128851806|NCT02466243|463754454|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
128851807|NCT02466243|463754455|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
128851808|NCT02466243|463754454|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
128851809|NCT02466243|463754455|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
128851810|NCT02466243|463754454|FG000|Part B Open-label Treatment Period|Missing|2|||
128851811|NCT02466243|463754455|FG001|Part B Open-label Treatment Period|Missing|2|||
128851812|NCT00477464|463754456|FG000|Overall Study|Lost to Follow-up|1|||
128851813|NCT00477464|463754456|FG000|Overall Study|Death|36|||
128851814|NCT00477464|463754456|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
128851815|NCT00639769|463754457|FG000|Overall Study|Death|2|||
128851816|NCT00639769|463754457|FG000|Overall Study|Adverse Event|7|||
128851817|NCT00639769|463754457|FG000|Overall Study|Lack of Efficacy|1|||
128851818|NCT00639769|463754457|FG000|Overall Study|Disease progression|26|||
128851819|NCT00639769|463754457|FG000|Overall Study|Withdrawal by Subject|4|||
128851820|NCT00863798|463754458|FG000|Overall Study|Adverse Event|5|||
128851821|NCT00863798|463754459|FG001|Overall Study|Adverse Event|2|||
128851822|NCT00863798|463754460|FG002|Overall Study|Adverse Event|4|||
128851823|NCT00863798|463754458|FG000|Overall Study|Participant failed to return|2|||
128851824|NCT00863798|463754459|FG001|Overall Study|Participant failed to return|1|||
128851825|NCT00863798|463754460|FG002|Overall Study|Participant failed to return|0|||
128851826|NCT00863798|463754458|FG000|Overall Study|Investigator request|1|||
128851827|NCT00863798|463754459|FG001|Overall Study|Investigator request|2|||
128851828|NCT00863798|463754460|FG002|Overall Study|Investigator request|1|||
128851829|NCT00863798|463754458|FG000|Overall Study|Lack of Efficacy|4|||
128851830|NCT00863798|463754459|FG001|Overall Study|Lack of Efficacy|3|||
128851831|NCT00863798|463754460|FG002|Overall Study|Lack of Efficacy|6|||
128851832|NCT00863798|463754458|FG000|Overall Study|Lost to Follow-up|6|||
128851833|NCT00863798|463754459|FG001|Overall Study|Lost to Follow-up|9|||
128851834|NCT00863798|463754460|FG002|Overall Study|Lost to Follow-up|5|||
128851835|NCT00863798|463754458|FG000|Overall Study|Other|2|||
128851836|NCT00863798|463754459|FG001|Overall Study|Other|3|||
128851837|NCT00863798|463754460|FG002|Overall Study|Other|1|||
128851838|NCT00863798|463754458|FG000|Overall Study|Protocol Violation|0|||
128851839|NCT00863798|463754459|FG001|Overall Study|Protocol Violation|1|||
128851840|NCT00863798|463754460|FG002|Overall Study|Protocol Violation|1|||
128851841|NCT00863798|463754458|FG000|Overall Study|Withdrawal by Subject|8|||
128851842|NCT00863798|463754459|FG001|Overall Study|Withdrawal by Subject|7|||
128851843|NCT00863798|463754460|FG002|Overall Study|Withdrawal by Subject|4|||
128851844|NCT00863798|463754458|FG000|Overall Study|Randomized not treated|4|||
128851845|NCT00863798|463754459|FG001|Overall Study|Randomized not treated|2|||
128851846|NCT00863798|463754460|FG002|Overall Study|Randomized not treated|3|||
128851847|NCT04238520|463754461|FG000|Overall Study|Withdrawal by Subject|1|||
128851848|NCT04238520|463754462|FG001|Overall Study|Withdrawal by Subject|1|||
128851849|NCT04238520|463754461|FG000|Overall Study|Lost to Follow-up|1|||
128851850|NCT04238520|463754462|FG001|Overall Study|Lost to Follow-up|2|||
128851851|NCT04238520|463754461|FG000|Overall Study|Death|0|||
128851852|NCT04238520|463754462|FG001|Overall Study|Death|2|||
128851853|NCT04238520|463754461|FG000|Overall Study|Unsafe home environment for research staff|0|||
128851854|NCT04238520|463754462|FG001|Overall Study|Unsafe home environment for research staff|1|||
128851855|NCT01470599|463754463|FG000|Overall Study|Did not meet entrance criteria|1|||
128851856|NCT01470599|463754464|FG001|Overall Study|Did not meet entrance criteria|0|||
128851857|NCT01470599|463754463|FG000|Overall Study|Lost to Follow-up|2|||
128851858|NCT01470599|463754464|FG001|Overall Study|Lost to Follow-up|1|||
128851859|NCT01470599|463754463|FG000|Overall Study|Withdrawal by Subject|3|||
128851860|NCT01470599|463754464|FG001|Overall Study|Withdrawal by Subject|4|||
128851861|NCT01470599|463754463|FG000|Overall Study|Other|1|||
128851862|NCT01470599|463754464|FG001|Overall Study|Other|0|||
128851863|NCT01470599|463754463|FG000|Overall Study|Protocol Violation|3|||
128851864|NCT01470599|463754464|FG001|Overall Study|Protocol Violation|1|||
128851865|NCT01470599|463754463|FG000|Overall Study|Adverse event related to study drug|2|||
128851866|NCT01470599|463754464|FG001|Overall Study|Adverse event related to study drug|5|||
128851867|NCT01470599|463754463|FG000|Overall Study|Insufficient clinical response|6|||
128851868|NCT01470599|463754464|FG001|Overall Study|Insufficient clinical response|27|||
128851869|NCT01470599|463754463|FG000|Overall Study|Adverse event not related to study drug|1|||
128851870|NCT01470599|463754464|FG001|Overall Study|Adverse event not related to study drug|5|||
128851871|NCT00195442|463754465|FG000|Overall Study|Less than expected therapeutic effect|38|||
128851872|NCT00195442|463754465|FG000|Overall Study|Lost to Follow-up|27|||
128851873|NCT00195442|463754465|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
128851874|NCT00195442|463754465|FG000|Overall Study|Intermittent product shortage|21|||
128851875|NCT00195442|463754465|FG000|Overall Study|Death|7|||
128851876|NCT00195442|463754465|FG000|Overall Study|No reason specified|4|||
128851877|NCT00195442|463754465|FG000|Overall Study|Poor cooperation|2|||
128851878|NCT00195442|463754465|FG000|Overall Study|Other|14|||
128851879|NCT01917006|463754466|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
128851880|NCT01917006|463754467|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
128851881|NCT01917006|463754468|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
128851882|NCT01917006|463754469|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
128851883|NCT01917006|463754470|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
128851884|NCT01917006|463754471|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
128851885|NCT01917006|463754472|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
128851886|NCT01917006|463754473|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
128851887|NCT01917006|463754466|FG000|Randomized-treatment Period|Personal Reasons|0|||
128851888|NCT01917006|463754467|FG001|Randomized-treatment Period|Personal Reasons|0|||
128851889|NCT01917006|463754468|FG002|Randomized-treatment Period|Personal Reasons|0|||
128851890|NCT01917006|463754469|FG003|Randomized-treatment Period|Personal Reasons|0|||
128851891|NCT01917006|463754470|FG004|Randomized-treatment Period|Personal Reasons|0|||
128851892|NCT01917006|463754471|FG005|Randomized-treatment Period|Personal Reasons|1|||
128851893|NCT01917006|463754472|FG006|Randomized-treatment Period|Personal Reasons|0|||
128851894|NCT01917006|463754473|FG007|Randomized-treatment Period|Personal Reasons|0|||
128851895|NCT01917006|463754466|FG000|Randomized-treatment Period|Protocol Violation|1|||
128851896|NCT01917006|463754467|FG001|Randomized-treatment Period|Protocol Violation|0|||
128851897|NCT01917006|463754468|FG002|Randomized-treatment Period|Protocol Violation|0|||
128851898|NCT01917006|463754469|FG003|Randomized-treatment Period|Protocol Violation|0|||
128851899|NCT01917006|463754470|FG004|Randomized-treatment Period|Protocol Violation|0|||
128851900|NCT01917006|463754471|FG005|Randomized-treatment Period|Protocol Violation|0|||
128851901|NCT01917006|463754472|FG006|Randomized-treatment Period|Protocol Violation|0|||
128851902|NCT01917006|463754473|FG007|Randomized-treatment Period|Protocol Violation|0|||
128851903|NCT01917006|463754466|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
128851904|NCT01917006|463754467|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
128851905|NCT01917006|463754468|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
128851906|NCT01917006|463754469|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
128851907|NCT01917006|463754470|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
128851908|NCT01917006|463754471|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
128851909|NCT01917006|463754472|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
128851910|NCT01917006|463754473|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
128851911|NCT01917006|463754466|FG000|Open-label Period|Adverse Event|0|||
128851912|NCT01917006|463754467|FG001|Open-label Period|Adverse Event|0|||
128851913|NCT01917006|463754468|FG002|Open-label Period|Adverse Event|0|||
128851914|NCT01917006|463754469|FG003|Open-label Period|Adverse Event|0|||
128851915|NCT01917006|463754470|FG004|Open-label Period|Adverse Event|0|||
128851916|NCT01917006|463754471|FG005|Open-label Period|Adverse Event|0|||
128851917|NCT01917006|463754472|FG006|Open-label Period|Adverse Event|0|||
128851918|NCT01917006|463754473|FG007|Open-label Period|Adverse Event|1|||
128851919|NCT01917006|463754466|FG000|Open-label Period|Lost to Follow-up|0|||
128851920|NCT01917006|463754467|FG001|Open-label Period|Lost to Follow-up|0|||
128851921|NCT01917006|463754468|FG002|Open-label Period|Lost to Follow-up|0|||
128851922|NCT01917006|463754469|FG003|Open-label Period|Lost to Follow-up|0|||
128851923|NCT01917006|463754470|FG004|Open-label Period|Lost to Follow-up|0|||
128851924|NCT01917006|463754471|FG005|Open-label Period|Lost to Follow-up|0|||
128851925|NCT01917006|463754472|FG006|Open-label Period|Lost to Follow-up|0|||
128851926|NCT01917006|463754473|FG007|Open-label Period|Lost to Follow-up|1|||
128851927|NCT00847132|463754476|FG000|Overall Study|Death|1|||
128851928|NCT00847132|463754477|FG001|Overall Study|Death|1|||
128851929|NCT03596242|463754478|FG000|Overall Study|Lost to Follow-up|2|||
128851930|NCT03596242|463754479|FG001|Overall Study|Lost to Follow-up|2|||
128851931|NCT02509312|463754480|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
128851932|NCT02509312|463754481|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
128851933|NCT02509312|463754480|FG000|Overall Study|Obstetrician refusal|0|||
128851934|NCT02509312|463754481|FG001|Overall Study|Obstetrician refusal|1|||
128851935|NCT02509312|463754480|FG000|Overall Study|Patient elected for TOLAC|1|||
128851936|NCT02509312|463754481|FG001|Overall Study|Patient elected for TOLAC|0|||
128851937|NCT02509312|463754480|FG000|Overall Study|Cesarean deemed stat|1|||
128851938|NCT02509312|463754481|FG001|Overall Study|Cesarean deemed stat|0|||
128851939|NCT02509312|463754480|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
128851940|NCT02509312|463754481|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
128851941|NCT02973802|463754487|FG000|Overall Study|Lost to Follow-up|1|||
128851942|NCT02973802|463754487|FG000|Overall Study|Withdrawal by Subject|1|||
128851943|NCT03357471|463754488|FG000|Overall Study|Adverse Event|1|||
128851944|NCT03357471|463754489|FG001|Overall Study|Adverse Event|0|||
128851945|NCT03357471|463754488|FG000|Overall Study|Lost to Follow-up|1|||
128851946|NCT03357471|463754489|FG001|Overall Study|Lost to Follow-up|0|||
128851947|NCT00706914|463754490|FG000|Overall Study|Lack of Efficacy|0|||
128851948|NCT00706914|463754491|FG001|Overall Study|Lack of Efficacy|1|||
128851949|NCT00706914|463754492|FG002|Overall Study|Lack of Efficacy|0|||
128851950|NCT00706914|463754490|FG000|Overall Study|Lost to Follow-up|1|||
128851951|NCT00706914|463754491|FG001|Overall Study|Lost to Follow-up|0|||
128851952|NCT00706914|463754492|FG002|Overall Study|Lost to Follow-up|0|||
128851953|NCT00706914|463754490|FG000|Overall Study|Adverse Event|2|||
128851954|NCT00706914|463754491|FG001|Overall Study|Adverse Event|2|||
128851955|NCT00706914|463754492|FG002|Overall Study|Adverse Event|0|||
128851956|NCT00706914|463754490|FG000|Overall Study|Protocol Violation|3|||
128851957|NCT00706914|463754491|FG001|Overall Study|Protocol Violation|1|||
128851958|NCT00706914|463754492|FG002|Overall Study|Protocol Violation|1|||
128851959|NCT00702650|463754494|FG000|Overall Study|Withdrawal by Subject|9|||
128851960|NCT00702650|463754494|FG000|Overall Study|Non-Compliance of Study Drug|3|||
128851961|NCT00702650|463754494|FG000|Overall Study|Lost to Follow-up|2|||
128851962|NCT00702650|463754494|FG000|Overall Study|Non-Compliance with Site Directives|1|||
128851963|NCT00702650|463754494|FG000|Overall Study|Sponsor Request|1|||
128851964|NCT00702650|463754494|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
128851965|NCT00702650|463754494|FG000|Overall Study|Adverse Event|3|||
128851966|NCT01751165|463754495|FG000|Overall Study|Adverse event, serious fatal|1|||
128851967|NCT01751165|463754496|FG001|Overall Study|Adverse event, serious fatal|0|||
128851968|NCT01751165|463754497|FG002|Overall Study|Adverse event, serious fatal|1|||
128851969|NCT01751165|463754495|FG000|Overall Study|Withdrawal by Subject|0|||
128851970|NCT01751165|463754496|FG001|Overall Study|Withdrawal by Subject|0|||
128851971|NCT01751165|463754497|FG002|Overall Study|Withdrawal by Subject|1|||
128851972|NCT01751165|463754495|FG000|Overall Study|Serious adverse event|0|||
128851973|NCT01751165|463754496|FG001|Overall Study|Serious adverse event|2|||
128851974|NCT01751165|463754497|FG002|Overall Study|Serious adverse event|0|||
128851975|NCT01751165|463754495|FG000|Overall Study|Lost to Follow-up|1|||
128851976|NCT01751165|463754496|FG001|Overall Study|Lost to Follow-up|1|||
128851977|NCT01751165|463754497|FG002|Overall Study|Lost to Follow-up|1|||
128851978|NCT00988533|463754502|FG000|Overall Study|Lost to Follow-up|3|||
128851979|NCT00943722|463754505|FG000|Base Study|Adverse Event|0|||
128851980|NCT00943722|463754506|FG001|Base Study|Adverse Event|0|||
128851981|NCT00943722|463754507|FG002|Base Study|Adverse Event|0|||
128851982|NCT00943722|463754508|FG003|Base Study|Adverse Event|1|||
128851983|NCT00943722|463754509|FG004|Base Study|Adverse Event|0|||
128851984|NCT00943722|463754510|FG005|Base Study|Adverse Event|0|||
128851985|NCT00943722|463754511|FG006|Base Study|Adverse Event|0|||
128851986|NCT00943722|463754505|FG000|Base Study|Lost to Follow-up|12|||
128851987|NCT00943722|463754506|FG001|Base Study|Lost to Follow-up|8|||
128851988|NCT00943722|463754507|FG002|Base Study|Lost to Follow-up|10|||
128851989|NCT00943722|463754508|FG003|Base Study|Lost to Follow-up|8|||
128851990|NCT00943722|463754509|FG004|Base Study|Lost to Follow-up|11|||
128851991|NCT00943722|463754510|FG005|Base Study|Lost to Follow-up|0|||
128851992|NCT00943722|463754511|FG006|Base Study|Lost to Follow-up|0|||
128851993|NCT00943722|463754505|FG000|Base Study|Physician Decision|1|||
128851994|NCT00943722|463754506|FG001|Base Study|Physician Decision|0|||
128851995|NCT00943722|463754507|FG002|Base Study|Physician Decision|0|||
128851996|NCT00943722|463754508|FG003|Base Study|Physician Decision|0|||
128851997|NCT00943722|463754509|FG004|Base Study|Physician Decision|1|||
128851998|NCT00943722|463754510|FG005|Base Study|Physician Decision|0|||
128851999|NCT00943722|463754511|FG006|Base Study|Physician Decision|0|||
128852000|NCT00943722|463754505|FG000|Base Study|Pregnancy|0|||
128852001|NCT00943722|463754506|FG001|Base Study|Pregnancy|0|||
128852002|NCT00943722|463754507|FG002|Base Study|Pregnancy|1|||
128852003|NCT00943722|463754508|FG003|Base Study|Pregnancy|0|||
128852004|NCT00943722|463754509|FG004|Base Study|Pregnancy|2|||
128852005|NCT00943722|463754510|FG005|Base Study|Pregnancy|0|||
128852006|NCT00943722|463754511|FG006|Base Study|Pregnancy|0|||
128852007|NCT00943722|463754505|FG000|Base Study|Protocol Violation|0|||
128852008|NCT00943722|463754506|FG001|Base Study|Protocol Violation|1|||
128852009|NCT00943722|463754507|FG002|Base Study|Protocol Violation|0|||
128852010|NCT00943722|463754508|FG003|Base Study|Protocol Violation|0|||
128852011|NCT00943722|463754509|FG004|Base Study|Protocol Violation|2|||
128852012|NCT00943722|463754510|FG005|Base Study|Protocol Violation|0|||
128852013|NCT00943722|463754511|FG006|Base Study|Protocol Violation|0|||
128852014|NCT00943722|463754505|FG000|Base Study|Withdrawal by Subject|12|||
128852015|NCT00943722|463754506|FG001|Base Study|Withdrawal by Subject|13|||
128852016|NCT00943722|463754507|FG002|Base Study|Withdrawal by Subject|2|||
128852017|NCT00943722|463754508|FG003|Base Study|Withdrawal by Subject|13|||
128852018|NCT00943722|463754509|FG004|Base Study|Withdrawal by Subject|8|||
128852019|NCT00943722|463754510|FG005|Base Study|Withdrawal by Subject|0|||
128852020|NCT00943722|463754511|FG006|Base Study|Withdrawal by Subject|0|||
128852021|NCT00943722|463754505|FG000|Base Study|Month 12 visit not completed|0|||
128852022|NCT00943722|463754506|FG001|Base Study|Month 12 visit not completed|0|||
128852023|NCT00943722|463754507|FG002|Base Study|Month 12 visit not completed|0|||
128852024|NCT00943722|463754508|FG003|Base Study|Month 12 visit not completed|0|||
128852025|NCT00943722|463754509|FG004|Base Study|Month 12 visit not completed|2|||
128852026|NCT00943722|463754510|FG005|Base Study|Month 12 visit not completed|0|||
128852027|NCT00943722|463754511|FG006|Base Study|Month 12 visit not completed|0|||
128852028|NCT00943722|463754505|FG000|First Extension Study: EXT 1|Adverse Event|0|||
128852029|NCT00943722|463754506|FG001|First Extension Study: EXT 1|Adverse Event|0|||
128852030|NCT00943722|463754507|FG002|First Extension Study: EXT 1|Adverse Event|0|||
128852031|NCT00943722|463754508|FG003|First Extension Study: EXT 1|Adverse Event|0|||
128852032|NCT00943722|463754509|FG004|First Extension Study: EXT 1|Adverse Event|0|||
128852033|NCT00943722|463754510|FG005|First Extension Study: EXT 1|Adverse Event|1|||
128852034|NCT00943722|463754511|FG006|First Extension Study: EXT 1|Adverse Event|0|||
128852035|NCT00943722|463754505|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
128852036|NCT00943722|463754506|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
128852037|NCT00943722|463754507|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
128852038|NCT00943722|463754508|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
128852039|NCT00943722|463754509|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
128852040|NCT00943722|463754510|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
128852041|NCT00943722|463754511|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
128852042|NCT00943722|463754505|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
128852043|NCT00943722|463754506|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
128852044|NCT00943722|463754507|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
128852045|NCT00943722|463754508|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
128852046|NCT00943722|463754509|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
128852047|NCT00943722|463754510|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
128852048|NCT00943722|463754511|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
128852049|NCT00943722|463754505|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
128852050|NCT00943722|463754506|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
128852051|NCT00943722|463754507|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
128852052|NCT00943722|463754508|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
128852053|NCT00943722|463754509|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
128852054|NCT00943722|463754510|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
128852055|NCT00943722|463754511|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
128852056|NCT00943722|463754505|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
128852057|NCT00943722|463754506|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
128852058|NCT00943722|463754507|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
128852059|NCT00943722|463754508|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
128852060|NCT00943722|463754509|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
128852061|NCT00943722|463754510|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
128852062|NCT00943722|463754511|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
128852063|NCT00943722|463754505|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
128852064|NCT00943722|463754506|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
128852065|NCT00943722|463754507|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
128852066|NCT00943722|463754508|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
128852067|NCT00943722|463754509|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
128852068|NCT00943722|463754510|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
128852069|NCT00943722|463754511|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
128852070|NCT00943722|463754505|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
128852071|NCT00943722|463754506|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
128852072|NCT00943722|463754507|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
128852073|NCT00943722|463754508|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
128852074|NCT00943722|463754509|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
128852075|NCT00943722|463754510|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
128852076|NCT00943722|463754511|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
128852077|NCT00943722|463754505|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
128852078|NCT00943722|463754506|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
128852079|NCT00943722|463754507|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
128852080|NCT00943722|463754508|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
128852081|NCT00943722|463754509|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
128852082|NCT00943722|463754510|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
128852083|NCT00943722|463754511|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
128852084|NCT00943722|463754505|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
128852085|NCT00943722|463754506|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
128852086|NCT00943722|463754507|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
128852087|NCT00943722|463754508|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
128852088|NCT00943722|463754509|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
128852089|NCT00943722|463754510|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
128852090|NCT00943722|463754511|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
128852091|NCT01036165|463754516|FG000|Overall Study|Adverse Event|6|||
128852092|NCT01036165|463754516|FG000|Overall Study|Lost to Follow-up|2|||
128852093|NCT01036165|463754516|FG000|Overall Study|Withdrawal by Subject|3|||
128852094|NCT01036165|463754516|FG000|Overall Study|Device Related Issues|3|||
128852095|NCT01036165|463754516|FG000|Overall Study|Problems finding proper area to inject|1|||
128852096|NCT00913523|463754523|FG000|Overall Study|Withdrawal by Subject|3|||
128852097|NCT00913523|463754524|FG001|Overall Study|Withdrawal by Subject|2|||
128852098|NCT00913523|463754525|FG002|Overall Study|Withdrawal by Subject|2|||
128852099|NCT00913523|463754523|FG000|Overall Study|Lost to Follow-up|1|||
128852100|NCT00913523|463754524|FG001|Overall Study|Lost to Follow-up|1|||
128852101|NCT00913523|463754525|FG002|Overall Study|Lost to Follow-up|1|||
128852102|NCT00913523|463754523|FG000|Overall Study|Adverse Event|1|||
128852103|NCT00913523|463754524|FG001|Overall Study|Adverse Event|0|||
128852104|NCT00913523|463754525|FG002|Overall Study|Adverse Event|0|||
128852105|NCT00913523|463754523|FG000|Overall Study|Protocol Violation|5|||
128852106|NCT00913523|463754524|FG001|Overall Study|Protocol Violation|8|||
128852107|NCT00913523|463754525|FG002|Overall Study|Protocol Violation|8|||
128852108|NCT00913523|463754523|FG000|Overall Study|Pregnancy|1|||
128852109|NCT00913523|463754524|FG001|Overall Study|Pregnancy|3|||
128852110|NCT00913523|463754525|FG002|Overall Study|Pregnancy|0|||
128852111|NCT00913523|463754523|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
128852112|NCT00913523|463754524|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
128852113|NCT00913523|463754525|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
128852114|NCT00916305|463754526|FG000|Overall Study|Lost to Follow-up|21|||
128852115|NCT00916305|463754527|FG001|Overall Study|Lost to Follow-up|27|||
128852116|NCT00916305|463754526|FG000|Overall Study|Withdrawal by Subject|0|||
128852117|NCT00916305|463754527|FG001|Overall Study|Withdrawal by Subject|1|||
128852118|NCT01844726|463754528|FG000|Overall Study|Withdrawal by Subject|0|||
128852119|NCT01844726|463754529|FG001|Overall Study|Withdrawal by Subject|1|||
128852120|NCT01844726|463754528|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
128852121|NCT01844726|463754529|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
128852122|NCT00307164|463754530|FG000|Overall Study|Death|1|||
128852123|NCT00307164|463754531|FG001|Overall Study|Death|0|||
128852124|NCT00307164|463754530|FG000|Overall Study|Severe debilitation, unable to continue|1|||
128852125|NCT00307164|463754531|FG001|Overall Study|Severe debilitation, unable to continue|0|||
128852126|NCT00307164|463754530|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
128852127|NCT00307164|463754531|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
128852128|NCT00307164|463754530|FG000|Overall Study|Withdrawal by Subject|1|||
128852129|NCT00307164|463754531|FG001|Overall Study|Withdrawal by Subject|8|||
128852130|NCT00307164|463754530|FG000|Overall Study|Not compliant with requirements|4|||
128852131|NCT00307164|463754531|FG001|Overall Study|Not compliant with requirements|4|||
128852132|NCT00307164|463754530|FG000|Overall Study|Lost to Follow-up|6|||
128852133|NCT00307164|463754531|FG001|Overall Study|Lost to Follow-up|1|||
128852134|NCT02512861|463754537|FG000|Overall Study|Protocol Violation|3|||
128852135|NCT02512861|463754538|FG001|Overall Study|Protocol Violation|7|||
128852136|NCT02512861|463754537|FG000|Overall Study|Physician Decision|3|||
128852137|NCT02512861|463754538|FG001|Overall Study|Physician Decision|1|||
128852138|NCT02512861|463754537|FG000|Overall Study|Withdrawal by Subject|0|||
128852139|NCT02512861|463754538|FG001|Overall Study|Withdrawal by Subject|1|||
128852140|NCT03214250|463754541|FG000|Overall Study|Death|5|||
128852141|NCT03214250|463754542|FG001|Overall Study|Death|5|||
128852142|NCT03214250|463754543|FG002|Overall Study|Death|7|||
128852143|NCT03214250|463754544|FG003|Overall Study|Death|4|||
128852144|NCT03214250|463754545|FG004|Overall Study|Death|23|||
128852145|NCT03214250|463754546|FG005|Overall Study|Death|23|||
128852146|NCT03214250|463754547|FG006|Overall Study|Death|24|||
128852147|NCT03214250|463754541|FG000|Overall Study|Lost to Follow-up|0|||
128852148|NCT03214250|463754542|FG001|Overall Study|Lost to Follow-up|0|||
128852149|NCT03214250|463754543|FG002|Overall Study|Lost to Follow-up|0|||
128852150|NCT03214250|463754544|FG003|Overall Study|Lost to Follow-up|1|||
128852151|NCT03214250|463754545|FG004|Overall Study|Lost to Follow-up|1|||
128852152|NCT03214250|463754546|FG005|Overall Study|Lost to Follow-up|2|||
128852153|NCT03214250|463754547|FG006|Overall Study|Lost to Follow-up|0|||
128852154|NCT03214250|463754541|FG000|Overall Study|Other|0|||
128852155|NCT03214250|463754542|FG001|Overall Study|Other|0|||
128852156|NCT03214250|463754543|FG002|Overall Study|Other|0|||
128852157|NCT03214250|463754544|FG003|Overall Study|Other|0|||
128852158|NCT03214250|463754545|FG004|Overall Study|Other|1|||
128852159|NCT03214250|463754546|FG005|Overall Study|Other|1|||
128852160|NCT03214250|463754547|FG006|Overall Study|Other|2|||
128852161|NCT03214250|463754541|FG000|Overall Study|Remains on Study|2|||
128852162|NCT03214250|463754542|FG001|Overall Study|Remains on Study|2|||
128852163|NCT03214250|463754543|FG002|Overall Study|Remains on Study|0|||
128852164|NCT03214250|463754544|FG003|Overall Study|Remains on Study|1|||
128852165|NCT03214250|463754545|FG004|Overall Study|Remains on Study|7|||
128852166|NCT03214250|463754546|FG005|Overall Study|Remains on Study|5|||
128852167|NCT03214250|463754547|FG006|Overall Study|Remains on Study|3|||
128852168|NCT03214250|463754541|FG000|Overall Study|Withdrawal by Subject|0|||
128852169|NCT03214250|463754542|FG001|Overall Study|Withdrawal by Subject|0|||
128852170|NCT03214250|463754543|FG002|Overall Study|Withdrawal by Subject|1|||
128852171|NCT03214250|463754544|FG003|Overall Study|Withdrawal by Subject|2|||
128852172|NCT03214250|463754545|FG004|Overall Study|Withdrawal by Subject|5|||
128852173|NCT03214250|463754546|FG005|Overall Study|Withdrawal by Subject|0|||
128852174|NCT03214250|463754547|FG006|Overall Study|Withdrawal by Subject|2|||
128852175|NCT00292981|463754551|FG000|Overall Study|Adverse Event|1|||
128852176|NCT00292981|463754551|FG000|Overall Study|Lost to Follow-up|13|||
128852177|NCT00292981|463754551|FG000|Overall Study|Withdrawal by Subject|22|||
128852178|NCT00292981|463754551|FG000|Overall Study|Other|3|||
128852179|NCT00594178|463754552|FG000|Overall Study|Physician Decision|5|||
128852180|NCT02971228|463754555|FG000|Overall Study|Withdrawal by Subject|1|||
128852181|NCT02971228|463754556|FG001|Overall Study|Withdrawal by Subject|1|||
128852182|NCT02971228|463754557|FG002|Overall Study|Withdrawal by Subject|0|||
128852183|NCT02971228|463754558|FG003|Overall Study|Withdrawal by Subject|0|||
128852184|NCT02971228|463754559|FG004|Overall Study|Withdrawal by Subject|0|||
128852185|NCT02971228|463754555|FG000|Overall Study|Logistical challenges|0|||
128852186|NCT02971228|463754556|FG001|Overall Study|Logistical challenges|1|||
128852187|NCT02971228|463754557|FG002|Overall Study|Logistical challenges|0|||
128852188|NCT02971228|463754558|FG003|Overall Study|Logistical challenges|0|||
128852189|NCT02971228|463754559|FG004|Overall Study|Logistical challenges|0|||
128852190|NCT00827775|463754569|FG000|Overall Study|Withdrawal by Subject|0|||
128852191|NCT00827775|463754570|FG001|Overall Study|Withdrawal by Subject|5|||
128852192|NCT04016805|463754571|FG000|Overall Study|Sponsor's Discretion|30|||
128852193|NCT04016805|463754572|FG001|Overall Study|Sponsor's Discretion|6|||
128852194|NCT04016805|463754573|FG002|Overall Study|Sponsor's Discretion|5|||
128852195|NCT00545571|463754574|FG000|Overall Study|Administrative Reasons|1|||
128852196|NCT00545571|463754574|FG000|Overall Study|Adverse Event|2|||
128852197|NCT00545571|463754574|FG000|Overall Study|Death|5|||
128852198|NCT00545571|463754574|FG000|Overall Study|Lack of Efficacy|1|||
128852199|NCT00545571|463754574|FG000|Overall Study|Protocol Violation|2|||
128852200|NCT00545571|463754574|FG000|Overall Study|Refused Treatment|1|||
128852201|NCT00545571|463754574|FG000|Overall Study|Screen Failure|16|||
128852202|NCT00545571|463754574|FG000|Overall Study|Transfusion|12|||
128852203|NCT00545571|463754574|FG000|Overall Study|Early Termination of Study|24|||
128852204|NCT00545571|463754574|FG000|Overall Study|Kidney Transplantation|3|||
128852205|NCT01193218|463754575|FG000|0-12 Weeks|Adverse Event|6|||
128852206|NCT01193218|463754576|FG001|0-12 Weeks|Adverse Event|0|||
128852207|NCT01193218|463754577|FG002|0-12 Weeks|Adverse Event|1|||
128852208|NCT01193218|463754578|FG003|0-12 Weeks|Adverse Event|0|||
128852209|NCT01193218|463754579|FG004|0-12 Weeks|Adverse Event|0|||
128852210|NCT01193218|463754580|FG005|0-12 Weeks|Adverse Event|2|||
128852211|NCT01193218|463754581|FG006|0-12 Weeks|Adverse Event|2|||
128852212|NCT01193218|463754582|FG007|0-12 Weeks|Adverse Event|0|||
128852213|NCT01193218|463754575|FG000|0-12 Weeks|Protocol Violation|0|||
128852214|NCT01193218|463754576|FG001|0-12 Weeks|Protocol Violation|0|||
128852215|NCT01193218|463754577|FG002|0-12 Weeks|Protocol Violation|0|||
128852216|NCT01193218|463754578|FG003|0-12 Weeks|Protocol Violation|0|||
128852217|NCT01193218|463754579|FG004|0-12 Weeks|Protocol Violation|1|||
128852218|NCT01193218|463754580|FG005|0-12 Weeks|Protocol Violation|1|||
128852219|NCT01193218|463754581|FG006|0-12 Weeks|Protocol Violation|0|||
128852220|NCT01193218|463754582|FG007|0-12 Weeks|Protocol Violation|0|||
128852221|NCT01193218|463754575|FG000|0-12 Weeks|Withdrawal by Subject|3|||
128852222|NCT01193218|463754576|FG001|0-12 Weeks|Withdrawal by Subject|0|||
128852223|NCT01193218|463754577|FG002|0-12 Weeks|Withdrawal by Subject|2|||
128852224|NCT01193218|463754578|FG003|0-12 Weeks|Withdrawal by Subject|0|||
128852225|NCT01193218|463754579|FG004|0-12 Weeks|Withdrawal by Subject|0|||
128852226|NCT01193218|463754580|FG005|0-12 Weeks|Withdrawal by Subject|0|||
128852227|NCT01193218|463754581|FG006|0-12 Weeks|Withdrawal by Subject|1|||
128852228|NCT01193218|463754582|FG007|0-12 Weeks|Withdrawal by Subject|0|||
128852229|NCT01193218|463754575|FG000|12-52 Weeks|Adverse Event|1|||
128852230|NCT01193218|463754576|FG001|12-52 Weeks|Adverse Event|0|||
128852231|NCT01193218|463754577|FG002|12-52 Weeks|Adverse Event|1|||
128852232|NCT01193218|463754578|FG003|12-52 Weeks|Adverse Event|2|||
128852233|NCT01193218|463754579|FG004|12-52 Weeks|Adverse Event|3|||
128852234|NCT01193218|463754580|FG005|12-52 Weeks|Adverse Event|3|||
128852235|NCT01193218|463754581|FG006|12-52 Weeks|Adverse Event|1|||
128852236|NCT01193218|463754582|FG007|12-52 Weeks|Adverse Event|2|||
128852237|NCT01193218|463754575|FG000|12-52 Weeks|Lack of Efficacy|0|||
128852238|NCT01193218|463754576|FG001|12-52 Weeks|Lack of Efficacy|0|||
128852239|NCT01193218|463754577|FG002|12-52 Weeks|Lack of Efficacy|0|||
128852240|NCT01193218|463754578|FG003|12-52 Weeks|Lack of Efficacy|0|||
128852241|NCT01193218|463754579|FG004|12-52 Weeks|Lack of Efficacy|0|||
128852242|NCT01193218|463754580|FG005|12-52 Weeks|Lack of Efficacy|0|||
128852243|NCT01193218|463754581|FG006|12-52 Weeks|Lack of Efficacy|1|||
128852244|NCT01193218|463754582|FG007|12-52 Weeks|Lack of Efficacy|0|||
128852245|NCT01193218|463754575|FG000|12-52 Weeks|Withdrawal by Subject|3|||
128852246|NCT01193218|463754576|FG001|12-52 Weeks|Withdrawal by Subject|0|||
128852247|NCT01193218|463754577|FG002|12-52 Weeks|Withdrawal by Subject|3|||
128852248|NCT01193218|463754578|FG003|12-52 Weeks|Withdrawal by Subject|0|||
128852249|NCT01193218|463754579|FG004|12-52 Weeks|Withdrawal by Subject|0|||
128852250|NCT01193218|463754580|FG005|12-52 Weeks|Withdrawal by Subject|2|||
128852251|NCT01193218|463754581|FG006|12-52 Weeks|Withdrawal by Subject|1|||
128852252|NCT01193218|463754582|FG007|12-52 Weeks|Withdrawal by Subject|2|||
128852253|NCT01193218|463754575|FG000|12-52 Weeks|Other reason than above|1|||
128852254|NCT01193218|463754576|FG001|12-52 Weeks|Other reason than above|0|||
128852255|NCT01193218|463754577|FG002|12-52 Weeks|Other reason than above|0|||
128852256|NCT01193218|463754578|FG003|12-52 Weeks|Other reason than above|1|||
128852257|NCT01193218|463754579|FG004|12-52 Weeks|Other reason than above|1|||
128852258|NCT01193218|463754580|FG005|12-52 Weeks|Other reason than above|0|||
128852259|NCT01193218|463754581|FG006|12-52 Weeks|Other reason than above|0|||
128852260|NCT01193218|463754582|FG007|12-52 Weeks|Other reason than above|0|||
128852261|NCT00338949|463754583|FG000|Subject Screening|Screen failures|11|||
128852262|NCT00338949|463754584|FG001|Subject Screening|Screen failures|11|||
128852263|NCT00338949|463754583|FG000|Randomization|Withdrawal by Subject|1|||
128852264|NCT00338949|463754584|FG001|Randomization|Withdrawal by Subject|0|||
128852265|NCT00338949|463754583|FG000|Randomization|Adverse Event|0|||
128852266|NCT00338949|463754584|FG001|Randomization|Adverse Event|5|||
128852267|NCT03811834|463754585|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
128852268|NCT00025662|463754586|FG000|Overall Study|Withdrawal by Subject|2|||
128852269|NCT00025662|463754586|FG000|Overall Study|Technical failure of manipulation|1|||
128852270|NCT01215032|463754587|FG000|Overall Study|Adverse Event|3|||
128852271|NCT01215032|463754587|FG000|Overall Study|Lack of Efficacy|17|||
128852272|NCT01424189|463754588|FG000|Overall Study|Adverse Event|1|||
128852273|NCT01424189|463754589|FG001|Overall Study|Adverse Event|0|||
128852274|NCT01424189|463754588|FG000|Overall Study|Lost to Follow-up|4|||
128852275|NCT01424189|463754589|FG001|Overall Study|Lost to Follow-up|1|||
128852276|NCT01424189|463754588|FG000|Overall Study|Withdrawal by Subject|4|||
128852277|NCT01424189|463754589|FG001|Overall Study|Withdrawal by Subject|4|||
128852278|NCT01424189|463754588|FG000|Overall Study|Subject moved|1|||
128852279|NCT01424189|463754589|FG001|Overall Study|Subject moved|0|||
128852280|NCT01424189|463754588|FG000|Overall Study|Death|3|||
128852281|NCT01424189|463754589|FG001|Overall Study|Death|1|||
128852282|NCT01203956|463754592|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
128852283|NCT01203956|463754593|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
128852284|NCT00069277|463754594|FG000|Overall Study|Adverse Event|3|||
128852285|NCT00069277|463754594|FG000|Overall Study|Withdrawal by Subject|1|||
128852286|NCT00069277|463754594|FG000|Overall Study|Progressive Disease|15|||
128852287|NCT00069277|463754594|FG000|Overall Study|Physician Decision|2|||
128852288|NCT02230306|463754595|FG000|Overall Study|Did not receive study treatment|1|||
128852289|NCT00361842|463754598|FG000|Overall Study|Withdrawal by Subject|2|||
128852290|NCT00361842|463754599|FG001|Overall Study|Withdrawal by Subject|3|||
128852291|NCT00361842|463754598|FG000|Overall Study|Death|2|||
128852292|NCT00361842|463754599|FG001|Overall Study|Death|1|||
128852293|NCT00361842|463754598|FG000|Overall Study|Disease progression|19|||
128852294|NCT00361842|463754599|FG001|Overall Study|Disease progression|20|||
128852295|NCT00361842|463754598|FG000|Overall Study|Adverse Event|2|||
128852296|NCT00361842|463754599|FG001|Overall Study|Adverse Event|3|||
128852297|NCT00361842|463754598|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
128852298|NCT00361842|463754599|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
128852299|NCT00361842|463754598|FG000|Overall Study|Other|1|||
128852300|NCT00361842|463754599|FG001|Overall Study|Other|0|||
128852301|NCT00361842|463754598|FG000|Overall Study|Other|0|||
128852302|NCT00361842|463754599|FG001|Overall Study|Other|2|||
128852303|NCT03512288|463754600|FG000|Overall Study|Adverse Event|1|||
128852304|NCT03512288|463754601|FG001|Overall Study|Adverse Event|0|||
128852305|NCT03512288|463754600|FG000|Overall Study|Lost to Follow-up|12|||
128852306|NCT03512288|463754601|FG001|Overall Study|Lost to Follow-up|15|||
128852307|NCT03512288|463754600|FG000|Overall Study|Physician Decision|0|||
128852308|NCT03512288|463754601|FG001|Overall Study|Physician Decision|2|||
128852309|NCT03512288|463754600|FG000|Overall Study|Protocol Violation|6|||
128852310|NCT03512288|463754601|FG001|Overall Study|Protocol Violation|4|||
128852311|NCT03512288|463754600|FG000|Overall Study|Medication error without associated adverse event|1|||
128852312|NCT03512288|463754601|FG001|Overall Study|Medication error without associated adverse event|0|||
128852313|NCT03512288|463754600|FG000|Overall Study|No longer met eligibility criteria|5|||
128852314|NCT03512288|463754601|FG001|Overall Study|No longer met eligibility criteria|2|||
128852315|NCT03512288|463754600|FG000|Overall Study|Withdrawal by parent/guardian|14|||
128852316|NCT03512288|463754601|FG001|Overall Study|Withdrawal by parent/guardian|18|||
128852317|NCT03512288|463754600|FG000|Overall Study|Other|1|||
128852318|NCT03512288|463754601|FG001|Overall Study|Other|1|||
128852319|NCT03512288|463754600|FG000|Overall Study|Randomized but not treated|1|||
128852320|NCT03512288|463754601|FG001|Overall Study|Randomized but not treated|1|||
128852321|NCT01077622|463754602|FG000|Overall Study|Physician Decision|2|||
128852322|NCT01077622|463754602|FG000|Overall Study|Withdrawal by Subject|1|||
128852323|NCT00424177|463754603|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
128852324|NCT00424177|463754603|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
128852325|NCT00424177|463754603|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
128852326|NCT00424177|463754603|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
128852327|NCT00424177|463754603|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
128852328|NCT00424177|463754603|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
128852329|NCT00424177|463754603|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
128852330|NCT00424177|463754603|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
128852331|NCT00424177|463754603|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
128852332|NCT00424177|463754603|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
128852333|NCT01260142|463754604|FG000|Treatment Period 1|Study on hold|1|||
128852334|NCT01260142|463754605|FG001|Treatment Period 1|Study on hold|1|||
128852335|NCT01260142|463754606|FG002|Treatment Period 1|Study on hold|0|||
128852336|NCT01260142|463754607|FG003|Treatment Period 1|Study on hold|0|||
128852337|NCT01260142|463754608|FG004|Treatment Period 1|Study on hold|1|||
128852338|NCT01260142|463754609|FG005|Treatment Period 1|Study on hold|2|||
128852339|NCT01260142|463754604|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
128852340|NCT01260142|463754605|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
128852341|NCT01260142|463754606|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
128852342|NCT01260142|463754607|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
128852343|NCT01260142|463754608|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
128852344|NCT01260142|463754609|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
128852345|NCT01260142|463754604|FG000|Treatment Period 1|Withdrawal by Subject|0|||
128852346|NCT01260142|463754605|FG001|Treatment Period 1|Withdrawal by Subject|0|||
128852347|NCT01260142|463754606|FG002|Treatment Period 1|Withdrawal by Subject|0|||
128852348|NCT01260142|463754607|FG003|Treatment Period 1|Withdrawal by Subject|0|||
128852349|NCT01260142|463754608|FG004|Treatment Period 1|Withdrawal by Subject|0|||
128852350|NCT01260142|463754609|FG005|Treatment Period 1|Withdrawal by Subject|1|||
128852351|NCT01502371|463754614|FG000|Overall Study|Withdrawal by Subject|1|||
128852352|NCT01502371|463754615|FG001|Overall Study|Withdrawal by Subject|2|||
128852353|NCT01502371|463754616|FG002|Overall Study|Withdrawal by Subject|1|||
128852354|NCT01502371|463754617|FG003|Overall Study|Withdrawal by Subject|1|||
128852355|NCT01502371|463754618|FG004|Overall Study|Withdrawal by Subject|1|||
128852356|NCT01502371|463754614|FG000|Overall Study|Adverse Event|2|||
128852357|NCT01502371|463754615|FG001|Overall Study|Adverse Event|1|||
128852358|NCT01502371|463754616|FG002|Overall Study|Adverse Event|0|||
128852359|NCT01502371|463754617|FG003|Overall Study|Adverse Event|4|||
128852360|NCT01502371|463754618|FG004|Overall Study|Adverse Event|3|||
128852361|NCT01502371|463754614|FG000|Overall Study|Treatment Failure|22|||
128852362|NCT01502371|463754615|FG001|Overall Study|Treatment Failure|20|||
128852363|NCT01502371|463754616|FG002|Overall Study|Treatment Failure|12|||
128852364|NCT01502371|463754617|FG003|Overall Study|Treatment Failure|19|||
128852365|NCT01502371|463754618|FG004|Overall Study|Treatment Failure|30|||
128852366|NCT01502371|463754614|FG000|Overall Study|Lack of Efficacy|3|||
128852367|NCT01502371|463754615|FG001|Overall Study|Lack of Efficacy|3|||
128852368|NCT01502371|463754616|FG002|Overall Study|Lack of Efficacy|2|||
128852369|NCT01502371|463754617|FG003|Overall Study|Lack of Efficacy|2|||
128852370|NCT01502371|463754618|FG004|Overall Study|Lack of Efficacy|4|||
128852371|NCT01502371|463754614|FG000|Overall Study|Physician Decision|3|||
128852372|NCT01502371|463754615|FG001|Overall Study|Physician Decision|0|||
128852373|NCT01502371|463754616|FG002|Overall Study|Physician Decision|0|||
128852374|NCT01502371|463754617|FG003|Overall Study|Physician Decision|0|||
128852375|NCT01502371|463754618|FG004|Overall Study|Physician Decision|1|||
128852376|NCT01502371|463754614|FG000|Overall Study|Noncompliance with Study Drug|0|||
128852377|NCT01502371|463754615|FG001|Overall Study|Noncompliance with Study Drug|0|||
128852378|NCT01502371|463754616|FG002|Overall Study|Noncompliance with Study Drug|1|||
128852379|NCT01502371|463754617|FG003|Overall Study|Noncompliance with Study Drug|2|||
128852380|NCT01502371|463754618|FG004|Overall Study|Noncompliance with Study Drug|1|||
128852381|NCT01502371|463754614|FG000|Overall Study|Technical Problems|1|||
128852382|NCT01502371|463754615|FG001|Overall Study|Technical Problems|0|||
128852383|NCT01502371|463754616|FG002|Overall Study|Technical Problems|2|||
128852384|NCT01502371|463754617|FG003|Overall Study|Technical Problems|4|||
128852385|NCT01502371|463754618|FG004|Overall Study|Technical Problems|1|||
128852386|NCT01502371|463754614|FG000|Overall Study|Protocol Violation|9|||
128852387|NCT01502371|463754615|FG001|Overall Study|Protocol Violation|5|||
128852388|NCT01502371|463754616|FG002|Overall Study|Protocol Violation|6|||
128852389|NCT01502371|463754617|FG003|Overall Study|Protocol Violation|5|||
128852390|NCT01502371|463754618|FG004|Overall Study|Protocol Violation|10|||
128852391|NCT01502371|463754614|FG000|Overall Study|Excluded Medication|0|||
128852392|NCT01502371|463754615|FG001|Overall Study|Excluded Medication|1|||
128852393|NCT01502371|463754616|FG002|Overall Study|Excluded Medication|1|||
128852394|NCT01502371|463754617|FG003|Overall Study|Excluded Medication|0|||
128852395|NCT01502371|463754618|FG004|Overall Study|Excluded Medication|1|||
128852396|NCT04156399|463756003|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
128852397|NCT04156399|463756003|FG000|Overall Study|study suspension due to COVID pandemic|3|||
128852398|NCT03440047|463756004|FG000|Overall Study|Withdrawal by Subject|2|||
128852399|NCT00478647|463756005|FG000|Overall Study|Adverse Event|1|||
128852400|NCT00478647|463756005|FG000|Overall Study|Withdrawal by Subject|1|||
128852401|NCT00511836|463756006|FG000|Double-blind Period|Lost to Follow-up|1|||
128852402|NCT00511836|463756007|FG001|Double-blind Period|Lost to Follow-up|0|||
128852403|NCT01850823|463756014|FG000|Overall Study|Early Visit Window|0|||
128852404|NCT01850823|463756015|FG001|Overall Study|Early Visit Window|1|||
128852405|NCT01850823|463756016|FG002|Overall Study|Early Visit Window|4|||
128852406|NCT01850823|463756014|FG000|Overall Study|Enrolled in Error|0|||
128852407|NCT01850823|463756015|FG001|Overall Study|Enrolled in Error|1|||
128852408|NCT01850823|463756016|FG002|Overall Study|Enrolled in Error|2|||
128852409|NCT01850823|463756014|FG000|Overall Study|Lack of Efficacy|1|||
128852410|NCT01850823|463756015|FG001|Overall Study|Lack of Efficacy|0|||
128852411|NCT01850823|463756016|FG002|Overall Study|Lack of Efficacy|0|||
128852412|NCT01850823|463756014|FG000|Overall Study|Lost to Follow-up|0|||
128852413|NCT01850823|463756015|FG001|Overall Study|Lost to Follow-up|0|||
128852414|NCT01850823|463756016|FG002|Overall Study|Lost to Follow-up|1|||
128852415|NCT01850823|463756014|FG000|Overall Study|Restricted Medication|0|||
128852416|NCT01850823|463756015|FG001|Overall Study|Restricted Medication|0|||
128852417|NCT01850823|463756016|FG002|Overall Study|Restricted Medication|2|||
128852418|NCT01850823|463756014|FG000|Overall Study|Significant worstening of SAR|0|||
128852419|NCT01850823|463756015|FG001|Overall Study|Significant worstening of SAR|1|||
128852420|NCT01850823|463756016|FG002|Overall Study|Significant worstening of SAR|0|||
128852421|NCT01850823|463756014|FG000|Overall Study|Withdrawal by Subject|2|||
128852422|NCT01850823|463756015|FG001|Overall Study|Withdrawal by Subject|0|||
128852423|NCT01850823|463756016|FG002|Overall Study|Withdrawal by Subject|1|||
128852424|NCT02895360|463756017|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
128852425|NCT02895360|463756018|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
128852426|NCT02895360|463756019|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
128852427|NCT02895360|463756020|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
128852428|NCT02895360|463756021|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
128852429|NCT02895360|463756022|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
128852430|NCT02895360|463756017|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
128852431|NCT02895360|463756018|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
128852432|NCT02895360|463756019|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
128852433|NCT02895360|463756020|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
128852434|NCT02895360|463756021|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
128852435|NCT02895360|463756022|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
128852436|NCT02895360|463756017|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
128852437|NCT02895360|463756018|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
128852438|NCT02895360|463756019|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
128852439|NCT02895360|463756020|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
128852440|NCT02895360|463756021|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
128852441|NCT02895360|463756022|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
128852442|NCT02895360|463756017|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
128852443|NCT02895360|463756018|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
128852444|NCT02895360|463756019|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
128852445|NCT02895360|463756020|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
128852446|NCT02895360|463756021|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
128852447|NCT02895360|463756022|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
128852448|NCT02895360|463756017|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
128852449|NCT02895360|463756018|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
128852450|NCT02895360|463756019|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
128852451|NCT02895360|463756020|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
128852452|NCT02895360|463756021|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
128852453|NCT02895360|463756022|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
128852454|NCT02895360|463756017|FG000|Phase 2a|Adverse Event|0|||
128852455|NCT02895360|463756018|FG001|Phase 2a|Adverse Event|0|||
128852456|NCT02895360|463756019|FG002|Phase 2a|Adverse Event|0|||
128852457|NCT02895360|463756020|FG003|Phase 2a|Adverse Event|0|||
128852458|NCT02895360|463756021|FG004|Phase 2a|Adverse Event|0|||
128852459|NCT02895360|463756022|FG005|Phase 2a|Adverse Event|1|||
128852460|NCT02895360|463756017|FG000|Phase 2a|Progressive disease|0|||
128852461|NCT02895360|463756018|FG001|Phase 2a|Progressive disease|0|||
128852462|NCT02895360|463756019|FG002|Phase 2a|Progressive disease|0|||
128852463|NCT02895360|463756020|FG003|Phase 2a|Progressive disease|0|||
128852464|NCT02895360|463756021|FG004|Phase 2a|Progressive disease|11|||
128852465|NCT02895360|463756022|FG005|Phase 2a|Progressive disease|11|||
128852466|NCT01475461|463756025|FG000|Run-in Period|Not meet eligibility criteria|16|||
128852467|NCT01475461|463756026|FG001|Run-in Period|Not meet eligibility criteria|0|||
128852468|NCT01475461|463756027|FG002|Run-in Period|Not meet eligibility criteria|0|||
128852469|NCT01475461|463756028|FG003|Run-in Period|Not meet eligibility criteria|0|||
128852470|NCT01475461|463756029|FG004|Run-in Period|Not meet eligibility criteria|0|||
128852471|NCT01475461|463756030|FG005|Run-in Period|Not meet eligibility criteria|0|||
128852472|NCT01475461|463756031|FG006|Run-in Period|Not meet eligibility criteria|0|||
128852473|NCT01475461|463756025|FG000|Run-in Period|Lost to Follow-up|7|||
128852474|NCT01475461|463756026|FG001|Run-in Period|Lost to Follow-up|0|||
128852475|NCT01475461|463756027|FG002|Run-in Period|Lost to Follow-up|0|||
128852476|NCT01475461|463756028|FG003|Run-in Period|Lost to Follow-up|0|||
128852477|NCT01475461|463756029|FG004|Run-in Period|Lost to Follow-up|0|||
128852478|NCT01475461|463756030|FG005|Run-in Period|Lost to Follow-up|0|||
128852479|NCT01475461|463756031|FG006|Run-in Period|Lost to Follow-up|0|||
128852480|NCT01475461|463756025|FG000|Run-in Period|Withdrawal by Subject|11|||
128852481|NCT01475461|463756026|FG001|Run-in Period|Withdrawal by Subject|0|||
128852482|NCT01475461|463756027|FG002|Run-in Period|Withdrawal by Subject|0|||
128852483|NCT01475461|463756028|FG003|Run-in Period|Withdrawal by Subject|0|||
128852484|NCT01475461|463756029|FG004|Run-in Period|Withdrawal by Subject|0|||
128852485|NCT01475461|463756030|FG005|Run-in Period|Withdrawal by Subject|0|||
128852486|NCT01475461|463756031|FG006|Run-in Period|Withdrawal by Subject|0|||
128852487|NCT01475461|463756025|FG000|Run-in Period|Other|3|||
128852488|NCT01475461|463756026|FG001|Run-in Period|Other|0|||
128852489|NCT01475461|463756027|FG002|Run-in Period|Other|0|||
128852490|NCT01475461|463756028|FG003|Run-in Period|Other|0|||
128852491|NCT01475461|463756029|FG004|Run-in Period|Other|0|||
128852492|NCT01475461|463756030|FG005|Run-in Period|Other|0|||
128852493|NCT01475461|463756031|FG006|Run-in Period|Other|0|||
128852494|NCT01475461|463756025|FG000|Run-in Period|Protocol Violation|4|||
128852495|NCT01475461|463756026|FG001|Run-in Period|Protocol Violation|0|||
128852496|NCT01475461|463756027|FG002|Run-in Period|Protocol Violation|0|||
128852497|NCT01475461|463756028|FG003|Run-in Period|Protocol Violation|0|||
128852498|NCT01475461|463756029|FG004|Run-in Period|Protocol Violation|0|||
128852499|NCT01475461|463756030|FG005|Run-in Period|Protocol Violation|0|||
128852500|NCT01475461|463756031|FG006|Run-in Period|Protocol Violation|0|||
128852501|NCT01475461|463756025|FG000|Treatment Period|Death|0|||
128852502|NCT01475461|463756026|FG001|Treatment Period|Death|0|||
128852503|NCT01475461|463756027|FG002|Treatment Period|Death|0|||
128852504|NCT01475461|463756028|FG003|Treatment Period|Death|1|||
128852505|NCT01475461|463756029|FG004|Treatment Period|Death|0|||
128852506|NCT01475461|463756030|FG005|Treatment Period|Death|0|||
128852507|NCT01475461|463756031|FG006|Treatment Period|Death|0|||
128852508|NCT01475461|463756025|FG000|Treatment Period|Lost to Follow-up|0|||
128852509|NCT01475461|463756026|FG001|Treatment Period|Lost to Follow-up|3|||
128852510|NCT01475461|463756027|FG002|Treatment Period|Lost to Follow-up|2|||
128852511|NCT01475461|463756028|FG003|Treatment Period|Lost to Follow-up|3|||
128852512|NCT01475461|463756029|FG004|Treatment Period|Lost to Follow-up|1|||
128852513|NCT01475461|463756030|FG005|Treatment Period|Lost to Follow-up|2|||
128852514|NCT01475461|463756031|FG006|Treatment Period|Lost to Follow-up|1|||
128852515|NCT01475461|463756025|FG000|Treatment Period|Withdrawal by Subject|0|||
128852516|NCT01475461|463756026|FG001|Treatment Period|Withdrawal by Subject|2|||
128852517|NCT01475461|463756027|FG002|Treatment Period|Withdrawal by Subject|2|||
128852518|NCT01475461|463756028|FG003|Treatment Period|Withdrawal by Subject|0|||
128852519|NCT01475461|463756029|FG004|Treatment Period|Withdrawal by Subject|2|||
128852520|NCT01475461|463756030|FG005|Treatment Period|Withdrawal by Subject|2|||
128852521|NCT01475461|463756031|FG006|Treatment Period|Withdrawal by Subject|0|||
128852522|NCT01475461|463756025|FG000|Treatment Period|Other|0|||
128852523|NCT01475461|463756026|FG001|Treatment Period|Other|1|||
128852524|NCT01475461|463756027|FG002|Treatment Period|Other|0|||
128852525|NCT01475461|463756028|FG003|Treatment Period|Other|0|||
128852526|NCT01475461|463756029|FG004|Treatment Period|Other|0|||
128852527|NCT01475461|463756030|FG005|Treatment Period|Other|0|||
128852528|NCT01475461|463756031|FG006|Treatment Period|Other|0|||
128852529|NCT01475461|463756025|FG000|Treatment Period|Protocol Violation|0|||
128852530|NCT01475461|463756026|FG001|Treatment Period|Protocol Violation|1|||
128852531|NCT01475461|463756027|FG002|Treatment Period|Protocol Violation|0|||
128852532|NCT01475461|463756028|FG003|Treatment Period|Protocol Violation|0|||
128852533|NCT01475461|463756029|FG004|Treatment Period|Protocol Violation|0|||
128852534|NCT01475461|463756030|FG005|Treatment Period|Protocol Violation|0|||
128852535|NCT01475461|463756031|FG006|Treatment Period|Protocol Violation|1|||
128852536|NCT01475461|463756025|FG000|Treatment Period|Lack of Efficacy|0|||
128852537|NCT01475461|463756026|FG001|Treatment Period|Lack of Efficacy|2|||
128852538|NCT01475461|463756027|FG002|Treatment Period|Lack of Efficacy|0|||
128852539|NCT01475461|463756028|FG003|Treatment Period|Lack of Efficacy|2|||
128852540|NCT01475461|463756029|FG004|Treatment Period|Lack of Efficacy|1|||
128852541|NCT01475461|463756030|FG005|Treatment Period|Lack of Efficacy|1|||
128852542|NCT01475461|463756031|FG006|Treatment Period|Lack of Efficacy|0|||
128852543|NCT01475461|463756025|FG000|Treatment Period|Medication Error|0|||
128852544|NCT01475461|463756026|FG001|Treatment Period|Medication Error|0|||
128852545|NCT01475461|463756027|FG002|Treatment Period|Medication Error|0|||
128852546|NCT01475461|463756028|FG003|Treatment Period|Medication Error|1|||
128852547|NCT01475461|463756029|FG004|Treatment Period|Medication Error|0|||
128852548|NCT01475461|463756030|FG005|Treatment Period|Medication Error|0|||
128852549|NCT01475461|463756031|FG006|Treatment Period|Medication Error|0|||
128852550|NCT01475461|463756025|FG000|Treatment Period|Adverse Event|0|||
128852551|NCT01475461|463756026|FG001|Treatment Period|Adverse Event|0|||
128852552|NCT01475461|463756027|FG002|Treatment Period|Adverse Event|0|||
128852553|NCT01475461|463756028|FG003|Treatment Period|Adverse Event|1|||
128852554|NCT01475461|463756029|FG004|Treatment Period|Adverse Event|0|||
128852555|NCT01475461|463756030|FG005|Treatment Period|Adverse Event|0|||
128852556|NCT01475461|463756031|FG006|Treatment Period|Adverse Event|0|||
128852557|NCT00496626|463756034|FG000|Overall Study|Lost to Follow-up|0|||
128852558|NCT00496626|463756035|FG001|Overall Study|Lost to Follow-up|1|||
128852559|NCT00496626|463756034|FG000|Overall Study|Protocol Violation|1|||
128852560|NCT00496626|463756035|FG001|Overall Study|Protocol Violation|0|||
128852561|NCT00496626|463756034|FG000|Overall Study|Withdrawal by Subject|5|||
128852562|NCT00496626|463756035|FG001|Overall Study|Withdrawal by Subject|4|||
128852563|NCT00496626|463756034|FG000|Overall Study|Relocated|0|||
128852564|NCT00496626|463756035|FG001|Overall Study|Relocated|1|||
128852565|NCT00727415|463756036|FG000|Phase I|Dose Limiting Toxicity|2|||
128852566|NCT01233999|463756038|FG000|Overall Study|Withdrawal by Subject|1|||
128852567|NCT01233999|463756038|FG000|Overall Study|Lost to Follow-up|1|||
128852568|NCT01167192|463756039|FG000|Overall Study|Adverse Event|1|||
128852569|NCT01167192|463756039|FG000|Overall Study|Death|1|||
128852570|NCT01167192|463756039|FG000|Overall Study|Withdrawal by Subject|1|||
128852571|NCT01167192|463756039|FG000|Overall Study|Insurance denial|1|||
128852572|NCT00129649|463756049|FG000|Overall Study|Withdrawal by Subject|76|||
128852573|NCT00129649|463756050|FG001|Overall Study|Withdrawal by Subject|65|||
128852574|NCT00025506|463756051|FG000|Overall Study|Ineligible: clerical error|1|||
128852575|NCT00025506|463756051|FG000|Overall Study|Ineligible: wrong cell type|5|||
128852576|NCT00025506|463756051|FG000|Overall Study|Ineligible: inadequate pathology|2|||
128852577|NCT00025506|463756051|FG000|Overall Study|Never Treated|2|||
128852578|NCT01321723|463756052|FG000|Overall Study|Adverse Event|3|||
128852579|NCT01321723|463756053|FG001|Overall Study|Adverse Event|5|||
128852580|NCT01321723|463756054|FG002|Overall Study|Adverse Event|2|||
128852581|NCT01321723|463756052|FG000|Overall Study|Withdrawal by Subject|2|||
128852582|NCT01321723|463756053|FG001|Overall Study|Withdrawal by Subject|0|||
128852583|NCT01321723|463756054|FG002|Overall Study|Withdrawal by Subject|2|||
128852584|NCT00713206|463756055|FG000|Overall Study|Lost to Follow-up|4|||
128852585|NCT00713206|463756056|FG001|Overall Study|Lost to Follow-up|4|||
128852586|NCT00713206|463756055|FG000|Overall Study|Death|1|||
128852587|NCT00713206|463756056|FG001|Overall Study|Death|0|||
128852588|NCT02561806|463756057|FG000|Induction Period|Adverse Event|0|||
128852589|NCT02561806|463756058|FG001|Induction Period|Adverse Event|2|||
128852590|NCT02561806|463756057|FG000|Induction Period|Lack of Efficacy|1|||
128852591|NCT02561806|463756058|FG001|Induction Period|Lack of Efficacy|0|||
128852592|NCT02561806|463756057|FG000|Induction Period|Withdrawal by Subject|0|||
128852593|NCT02561806|463756058|FG001|Induction Period|Withdrawal by Subject|2|||
128852594|NCT02561806|463756057|FG000|Induction Period|Site staff became unblinded|1|||
128852595|NCT02561806|463756058|FG001|Induction Period|Site staff became unblinded|0|||
128852596|NCT02561806|463756057|FG000|Induction Period|Randomized but not treated|0|||
128852597|NCT02561806|463756058|FG001|Induction Period|Randomized but not treated|1|||
128852598|NCT02561806|463756057|FG000|Maintenance Period|Adverse Event|2|||
128852599|NCT02561806|463756058|FG001|Maintenance Period|Adverse Event|1|||
128852600|NCT02561806|463756057|FG000|Maintenance Period|Lack of Efficacy|3|||
128852601|NCT02561806|463756058|FG001|Maintenance Period|Lack of Efficacy|1|||
128852602|NCT02561806|463756057|FG000|Maintenance Period|Lost to Follow-up|2|||
128852603|NCT02561806|463756058|FG001|Maintenance Period|Lost to Follow-up|2|||
128852604|NCT02561806|463756057|FG000|Maintenance Period|Protocol Violation|1|||
128852605|NCT02561806|463756058|FG001|Maintenance Period|Protocol Violation|0|||
128852606|NCT02561806|463756057|FG000|Maintenance Period|Withdrawal by Subject|5|||
128852607|NCT02561806|463756058|FG001|Maintenance Period|Withdrawal by Subject|3|||
128852608|NCT02561806|463756057|FG000|Maintenance Period|Site staff became unblinded|0|||
128852609|NCT02561806|463756058|FG001|Maintenance Period|Site staff became unblinded|1|||
128852610|NCT02561806|463756057|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
128852611|NCT02561806|463756058|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
128852612|NCT02561806|463756057|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
128852613|NCT02561806|463756058|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
128852614|NCT02547441|463756059|FG000|Double-Blind Study Period|Adverse Event|4|||
128852615|NCT02547441|463756060|FG001|Double-Blind Study Period|Adverse Event|9|||
128852616|NCT02547441|463756059|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
128852617|NCT02547441|463756060|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
128852618|NCT02547441|463756059|FG000|Double-Blind Study Period|Physician Decision|1|||
128852619|NCT02547441|463756060|FG001|Double-Blind Study Period|Physician Decision|0|||
128852620|NCT02547441|463756059|FG000|Double-Blind Study Period|Protocol Violation|1|||
128852621|NCT02547441|463756060|FG001|Double-Blind Study Period|Protocol Violation|2|||
128852622|NCT02547441|463756059|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
128852623|NCT02547441|463756060|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
128852624|NCT02547441|463756059|FG000|Double-Blind Study Period|Sponsor Decision|1|||
128852625|NCT02547441|463756060|FG001|Double-Blind Study Period|Sponsor Decision|0|||
128852626|NCT02547441|463756059|FG000|Open-Label Study Period|Adverse Event|10|||
128852627|NCT02547441|463756060|FG001|Open-Label Study Period|Adverse Event|11|||
128852628|NCT02547441|463756059|FG000|Open-Label Study Period|Lack of Efficacy|3|||
128852629|NCT02547441|463756060|FG001|Open-Label Study Period|Lack of Efficacy|2|||
128852630|NCT02547441|463756059|FG000|Open-Label Study Period|Lost to Follow-up|7|||
128852631|NCT02547441|463756060|FG001|Open-Label Study Period|Lost to Follow-up|8|||
128852632|NCT02547441|463756059|FG000|Open-Label Study Period|Physician Decision|1|||
128852633|NCT02547441|463756060|FG001|Open-Label Study Period|Physician Decision|0|||
128852634|NCT02547441|463756059|FG000|Open-Label Study Period|Protocol Violation|2|||
128852635|NCT02547441|463756060|FG001|Open-Label Study Period|Protocol Violation|0|||
128852636|NCT02547441|463756059|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
128852637|NCT02547441|463756060|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
128852638|NCT02547441|463756059|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
128852639|NCT02547441|463756060|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
128852640|NCT01322009|463756062|FG000|Overall Study|Death|0|||
128852641|NCT01322009|463756063|FG001|Overall Study|Death|1|||
128852642|NCT01322009|463756062|FG000|Overall Study|Adverse Event|0|||
128852643|NCT01322009|463756063|FG001|Overall Study|Adverse Event|1|||
128852644|NCT01322009|463756062|FG000|Overall Study|ng tube discontinued|0|||
128852645|NCT01322009|463756063|FG001|Overall Study|ng tube discontinued|1|||
128852646|NCT00394589|463756064|FG000|Overall Study|Adverse Event|2|||
128852647|NCT00394589|463756065|FG001|Overall Study|Adverse Event|1|||
128852648|NCT00394589|463756066|FG002|Overall Study|Adverse Event|2|||
128852649|NCT00394589|463756064|FG000|Overall Study|Lack of Efficacy|2|||
128852650|NCT00394589|463756065|FG001|Overall Study|Lack of Efficacy|2|||
128852651|NCT00394589|463756066|FG002|Overall Study|Lack of Efficacy|3|||
128852652|NCT00394589|463756064|FG000|Overall Study|Protocol Violation|4|||
128852653|NCT00394589|463756065|FG001|Overall Study|Protocol Violation|0|||
128852654|NCT00394589|463756066|FG002|Overall Study|Protocol Violation|2|||
128852655|NCT04081389|463756067|FG000|Overall Study|Withdrawal by Subject|0|||
128852656|NCT04081389|463756068|FG001|Overall Study|Withdrawal by Subject|0|||
128852657|NCT04081389|463756069|FG002|Overall Study|Withdrawal by Subject|1|||
128852658|NCT04081389|463756070|FG003|Overall Study|Withdrawal by Subject|0|||
128852659|NCT01013740|463756078|FG000|Overall Study|Lost to Follow-up|3|||
128852660|NCT01013740|463756079|FG001|Overall Study|Lost to Follow-up|5|||
128852661|NCT01013740|463756078|FG000|Overall Study|Physician Decision|2|||
128852662|NCT01013740|463756079|FG001|Overall Study|Physician Decision|0|||
128852663|NCT01013740|463756078|FG000|Overall Study|Withdrawal by Subject|2|||
128852664|NCT01013740|463756079|FG001|Overall Study|Withdrawal by Subject|10|||
128852665|NCT01013740|463756078|FG000|Overall Study|study close / terminated : done in error|2|||
128852666|NCT01013740|463756079|FG001|Overall Study|study close / terminated : done in error|1|||
128852667|NCT01013740|463756078|FG000|Overall Study|Missing|2|||
128852668|NCT01013740|463756079|FG001|Overall Study|Missing|1|||
128852669|NCT01013740|463756078|FG000|Overall Study|Ongoing: Study records not completed|0|||
128852670|NCT01013740|463756079|FG001|Overall Study|Ongoing: Study records not completed|2|||
128852671|NCT01242371|463756080|FG000|Overall Study|Withdrawal by Subject|2|||
128852672|NCT01242371|463756081|FG001|Overall Study|Withdrawal by Subject|2|||
128852673|NCT01242371|463756080|FG000|Overall Study|Protocol Violation|0|||
128852674|NCT01242371|463756081|FG001|Overall Study|Protocol Violation|3|||
128852675|NCT00582114|463756082|FG000|Overall Study|Death|4|||
128852676|NCT00582114|463756083|FG001|Overall Study|Death|4|||
128852677|NCT00582114|463756082|FG000|Overall Study|Kidney Transplant|3|||
128852678|NCT00582114|463756083|FG001|Overall Study|Kidney Transplant|1|||
128852679|NCT00582114|463756082|FG000|Overall Study|Lost to Follow-up|7|||
128852680|NCT00582114|463756083|FG001|Overall Study|Lost to Follow-up|6|||
128852681|NCT00582114|463756082|FG000|Overall Study|Withdrawal by Subject|8|||
128852682|NCT00582114|463756083|FG001|Overall Study|Withdrawal by Subject|16|||
128852683|NCT00582114|463756082|FG000|Overall Study|Adverse Event|1|||
128852684|NCT00582114|463756083|FG001|Overall Study|Adverse Event|1|||
128852685|NCT00582114|463756082|FG000|Overall Study|Physician Decision|0|||
128852686|NCT00582114|463756083|FG001|Overall Study|Physician Decision|6|||
128852687|NCT00582114|463756082|FG000|Overall Study|Stopped by data safety monitoring board|19|||
128852688|NCT00582114|463756083|FG001|Overall Study|Stopped by data safety monitoring board|20|||
128852689|NCT02604342|463756084|FG000|Overall Study|Death|32|||
128852690|NCT02604342|463756085|FG001|Overall Study|Death|16|||
128852691|NCT02604342|463756084|FG000|Overall Study|Progression of disease|1|||
128852692|NCT02604342|463756085|FG001|Overall Study|Progression of disease|0|||
128852693|NCT02604342|463756084|FG000|Overall Study|Withdrawal by Subject|5|||
128852694|NCT02604342|463756085|FG001|Overall Study|Withdrawal by Subject|6|||
128852695|NCT02604342|463756084|FG000|Overall Study|Other|1|||
128852696|NCT02604342|463756085|FG001|Overall Study|Other|0|||
128852697|NCT02604342|463756084|FG000|Overall Study|Study Termination by Sponsor|1|||
128852698|NCT02604342|463756085|FG001|Overall Study|Study Termination by Sponsor|0|||
128852699|NCT02604342|463756084|FG000|Overall Study|Lost to Follow-up|1|||
128852700|NCT02604342|463756085|FG001|Overall Study|Lost to Follow-up|1|||
128852701|NCT02604342|463756084|FG000|Overall Study|Physician Decision|2|||
128852702|NCT02604342|463756085|FG001|Overall Study|Physician Decision|0|||
128852703|NCT00130728|463756086|FG000|Overall Study|Death|258|||
128852704|NCT00130728|463756087|FG001|Overall Study|Death|258|||
128852705|NCT00130728|463756086|FG000|Overall Study|Lost to Follow-up|4|||
128852706|NCT00130728|463756087|FG001|Overall Study|Lost to Follow-up|0|||
128852707|NCT00130728|463756086|FG000|Overall Study|Withdrawal by Subject|0|||
128852708|NCT00130728|463756087|FG001|Overall Study|Withdrawal by Subject|2|||
128852709|NCT01349036|463756088|FG000|Overall Study|Disease progression|13|||
128852710|NCT01349036|463756089|FG001|Overall Study|Disease progression|22|||
128852711|NCT01349036|463756088|FG000|Overall Study|Other|1|||
128852712|NCT01349036|463756089|FG001|Overall Study|Other|0|||
128852713|NCT01349036|463756088|FG000|Overall Study|Withdrawal by Subject|0|||
128852714|NCT01349036|463756089|FG001|Overall Study|Withdrawal by Subject|2|||
128852715|NCT00746356|463756090|FG000|Overall Study|Withdrawal by Subject|2|||
128852716|NCT00746356|463756091|FG001|Overall Study|Withdrawal by Subject|3|||
128852717|NCT00746356|463756090|FG000|Overall Study|Death|7|||
128852718|NCT00746356|463756091|FG001|Overall Study|Death|3|||
128852719|NCT00746356|463756090|FG000|Overall Study|Lost to Follow-up|1|||
128852720|NCT00746356|463756091|FG001|Overall Study|Lost to Follow-up|0|||
128852721|NCT00746356|463756090|FG000|Overall Study|Removal of Device|0|||
128852722|NCT00746356|463756091|FG001|Overall Study|Removal of Device|1|||
128852723|NCT00746356|463756090|FG000|Overall Study|Patient relocated|1|||
128852724|NCT00746356|463756091|FG001|Overall Study|Patient relocated|0|||
128852725|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
128852726|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
128852727|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
128852728|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
128852729|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
128852730|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
128852731|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
128852732|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
128852733|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
128852734|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
128852735|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
128852736|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
128852737|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
128852738|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
128852739|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
128852740|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
128852741|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
128852742|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
128852743|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
128852744|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
128852745|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
128852746|NCT01125566|463756096|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
128852747|NCT01125566|463756097|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
128852748|NCT01125566|463756098|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
128852749|NCT01125566|463756096|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
128852750|NCT01125566|463756097|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
128852751|NCT01125566|463756098|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
128852752|NCT01125566|463756096|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
128852753|NCT01125566|463756097|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
128852754|NCT01125566|463756098|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
128852755|NCT01125566|463756096|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
128852756|NCT01125566|463756097|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
128852757|NCT01125566|463756098|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
128852758|NCT01125566|463756096|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
128852759|NCT01125566|463756097|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
128852760|NCT01125566|463756098|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
128852761|NCT02881047|463756099|FG000|Overall Study|Adverse Event|1|||
128852762|NCT02881047|463756099|FG000|Overall Study|Withdrawal by Subject|1|||
128852763|NCT03028012|463756100|FG000|Overall Study|Lost to Follow-up|2|||
128852764|NCT03028012|463756101|FG001|Overall Study|Lost to Follow-up|3|||
128852765|NCT03028012|463756102|FG002|Overall Study|Lost to Follow-up|3|||
128852766|NCT02484547|463756111|FG000|Placebo-Controlled Period|Adverse Event|10|||
128852767|NCT02484547|463756112|FG001|Placebo-Controlled Period|Adverse Event|13|||
128852768|NCT02484547|463756113|FG002|Placebo-Controlled Period|Adverse Event|20|||
128852769|NCT02484547|463756114|FG003|Placebo-Controlled Period|Adverse Event|0|||
128852770|NCT02484547|463756115|FG004|Placebo-Controlled Period|Adverse Event|0|||
128852771|NCT02484547|463756116|FG005|Placebo-Controlled Period|Adverse Event|0|||
128852772|NCT02484547|463756117|FG006|Placebo-Controlled Period|Adverse Event|0|||
128852773|NCT02484547|463756111|FG000|Placebo-Controlled Period|Change of Treatment|0|||
128852774|NCT02484547|463756112|FG001|Placebo-Controlled Period|Change of Treatment|0|||
128852775|NCT02484547|463756113|FG002|Placebo-Controlled Period|Change of Treatment|1|||
128852776|NCT02484547|463756114|FG003|Placebo-Controlled Period|Change of Treatment|0|||
128852777|NCT02484547|463756115|FG004|Placebo-Controlled Period|Change of Treatment|0|||
128852778|NCT02484547|463756116|FG005|Placebo-Controlled Period|Change of Treatment|0|||
128852779|NCT02484547|463756117|FG006|Placebo-Controlled Period|Change of Treatment|0|||
128852780|NCT02484547|463756111|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
128852781|NCT02484547|463756112|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
128852782|NCT02484547|463756113|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
128852783|NCT02484547|463756114|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
128852784|NCT02484547|463756115|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
128852785|NCT02484547|463756116|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
128852786|NCT02484547|463756117|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
128852787|NCT02484547|463756111|FG000|Placebo-Controlled Period|Death|5|||
128852788|NCT02484547|463756112|FG001|Placebo-Controlled Period|Death|0|||
128852789|NCT02484547|463756113|FG002|Placebo-Controlled Period|Death|6|||
128852790|NCT02484547|463756114|FG003|Placebo-Controlled Period|Death|0|||
128852791|NCT02484547|463756115|FG004|Placebo-Controlled Period|Death|0|||
128852792|NCT02484547|463756116|FG005|Placebo-Controlled Period|Death|0|||
128852793|NCT02484547|463756117|FG006|Placebo-Controlled Period|Death|0|||
128852794|NCT02484547|463756111|FG000|Placebo-Controlled Period|Disease Progression|2|||
128852795|NCT02484547|463756112|FG001|Placebo-Controlled Period|Disease Progression|0|||
128852796|NCT02484547|463756113|FG002|Placebo-Controlled Period|Disease Progression|1|||
128852797|NCT02484547|463756114|FG003|Placebo-Controlled Period|Disease Progression|0|||
128852798|NCT02484547|463756115|FG004|Placebo-Controlled Period|Disease Progression|0|||
128852799|NCT02484547|463756116|FG005|Placebo-Controlled Period|Disease Progression|0|||
128852800|NCT02484547|463756117|FG006|Placebo-Controlled Period|Disease Progression|0|||
128852801|NCT02484547|463756111|FG000|Placebo-Controlled Period|Investigator Decision|2|||
128852802|NCT02484547|463756112|FG001|Placebo-Controlled Period|Investigator Decision|2|||
128852803|NCT02484547|463756113|FG002|Placebo-Controlled Period|Investigator Decision|5|||
128852804|NCT02484547|463756114|FG003|Placebo-Controlled Period|Investigator Decision|0|||
128852805|NCT02484547|463756115|FG004|Placebo-Controlled Period|Investigator Decision|0|||
128852806|NCT02484547|463756116|FG005|Placebo-Controlled Period|Investigator Decision|0|||
128852807|NCT02484547|463756117|FG006|Placebo-Controlled Period|Investigator Decision|0|||
128852808|NCT02484547|463756111|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
128852809|NCT02484547|463756112|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
128852810|NCT02484547|463756113|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
128852811|NCT02484547|463756114|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
128852812|NCT02484547|463756115|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
128852813|NCT02484547|463756116|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
128852814|NCT02484547|463756117|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
128852815|NCT02484547|463756111|FG000|Placebo-Controlled Period|Relocation|1|||
128852816|NCT02484547|463756112|FG001|Placebo-Controlled Period|Relocation|1|||
128852817|NCT02484547|463756113|FG002|Placebo-Controlled Period|Relocation|1|||
128852818|NCT02484547|463756114|FG003|Placebo-Controlled Period|Relocation|0|||
128852819|NCT02484547|463756115|FG004|Placebo-Controlled Period|Relocation|0|||
128852820|NCT02484547|463756116|FG005|Placebo-Controlled Period|Relocation|0|||
128852821|NCT02484547|463756117|FG006|Placebo-Controlled Period|Relocation|0|||
128852822|NCT02484547|463756111|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
128852823|NCT02484547|463756112|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
128852824|NCT02484547|463756113|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
128852825|NCT02484547|463756114|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
128852826|NCT02484547|463756115|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
128852827|NCT02484547|463756116|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
128852828|NCT02484547|463756117|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
128852829|NCT02484547|463756111|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
128852830|NCT02484547|463756112|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
128852831|NCT02484547|463756113|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
128852832|NCT02484547|463756114|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128852833|NCT02484547|463756115|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128852834|NCT02484547|463756116|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128852835|NCT02484547|463756117|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
128852836|NCT02484547|463756111|FG000|Placebo-Controlled Period|Reason not Specified|216|||
128852837|NCT02484547|463756112|FG001|Placebo-Controlled Period|Reason not Specified|194|||
128852838|NCT02484547|463756113|FG002|Placebo-Controlled Period|Reason not Specified|183|||
128852839|NCT02484547|463756114|FG003|Placebo-Controlled Period|Reason not Specified|0|||
128852840|NCT02484547|463756115|FG004|Placebo-Controlled Period|Reason not Specified|0|||
128852841|NCT02484547|463756116|FG005|Placebo-Controlled Period|Reason not Specified|0|||
128852842|NCT02484547|463756117|FG006|Placebo-Controlled Period|Reason not Specified|0|||
128852843|NCT02484547|463756111|FG000|Long-Term Extension Period|Adverse Event|0|||
128852844|NCT02484547|463756112|FG001|Long-Term Extension Period|Adverse Event|0|||
128852845|NCT02484547|463756113|FG002|Long-Term Extension Period|Adverse Event|0|||
128852846|NCT02484547|463756114|FG003|Long-Term Extension Period|Adverse Event|0|||
128852847|NCT02484547|463756115|FG004|Long-Term Extension Period|Adverse Event|1|||
128852848|NCT02484547|463756116|FG005|Long-Term Extension Period|Adverse Event|3|||
128852849|NCT02484547|463756117|FG006|Long-Term Extension Period|Adverse Event|2|||
128852850|NCT02484547|463756111|FG000|Long-Term Extension Period|Death|0|||
128852851|NCT02484547|463756112|FG001|Long-Term Extension Period|Death|0|||
128852852|NCT02484547|463756113|FG002|Long-Term Extension Period|Death|0|||
128852853|NCT02484547|463756114|FG003|Long-Term Extension Period|Death|0|||
128852854|NCT02484547|463756115|FG004|Long-Term Extension Period|Death|0|||
128852855|NCT02484547|463756116|FG005|Long-Term Extension Period|Death|3|||
128852856|NCT02484547|463756117|FG006|Long-Term Extension Period|Death|0|||
128852857|NCT02484547|463756111|FG000|Long-Term Extension Period|Disease Progression|0|||
128852858|NCT02484547|463756112|FG001|Long-Term Extension Period|Disease Progression|0|||
128852859|NCT02484547|463756113|FG002|Long-Term Extension Period|Disease Progression|0|||
128852860|NCT02484547|463756114|FG003|Long-Term Extension Period|Disease Progression|0|||
128852861|NCT02484547|463756115|FG004|Long-Term Extension Period|Disease Progression|2|||
128852862|NCT02484547|463756116|FG005|Long-Term Extension Period|Disease Progression|4|||
128852863|NCT02484547|463756117|FG006|Long-Term Extension Period|Disease Progression|0|||
128852864|NCT02484547|463756111|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
128852865|NCT02484547|463756112|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
128852866|NCT02484547|463756113|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
128852867|NCT02484547|463756114|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
128852868|NCT02484547|463756115|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
128852869|NCT02484547|463756116|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
128852870|NCT02484547|463756117|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
128852871|NCT02484547|463756111|FG000|Long-Term Extension Period|Loss of Capacity|0|||
128852872|NCT02484547|463756112|FG001|Long-Term Extension Period|Loss of Capacity|0|||
128852873|NCT02484547|463756113|FG002|Long-Term Extension Period|Loss of Capacity|0|||
128852874|NCT02484547|463756114|FG003|Long-Term Extension Period|Loss of Capacity|0|||
128852875|NCT02484547|463756115|FG004|Long-Term Extension Period|Loss of Capacity|1|||
128852876|NCT02484547|463756116|FG005|Long-Term Extension Period|Loss of Capacity|0|||
128852877|NCT02484547|463756117|FG006|Long-Term Extension Period|Loss of Capacity|0|||
128852878|NCT02484547|463756111|FG000|Long-Term Extension Period|Change of Treatment|0|||
128852879|NCT02484547|463756112|FG001|Long-Term Extension Period|Change of Treatment|0|||
128852880|NCT02484547|463756113|FG002|Long-Term Extension Period|Change of Treatment|0|||
128852881|NCT02484547|463756114|FG003|Long-Term Extension Period|Change of Treatment|0|||
128852882|NCT02484547|463756115|FG004|Long-Term Extension Period|Change of Treatment|0|||
128852883|NCT02484547|463756116|FG005|Long-Term Extension Period|Change of Treatment|0|||
128852884|NCT02484547|463756117|FG006|Long-Term Extension Period|Change of Treatment|1|||
128852885|NCT02484547|463756111|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
128852886|NCT02484547|463756112|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
128852887|NCT02484547|463756113|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
128852888|NCT02484547|463756114|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
128852889|NCT02484547|463756115|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
128852890|NCT02484547|463756116|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
128852891|NCT02484547|463756117|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
128852892|NCT02484547|463756111|FG000|Long-Term Extension Period|Investigator Decision|0|||
128852893|NCT02484547|463756112|FG001|Long-Term Extension Period|Investigator Decision|0|||
128852894|NCT02484547|463756113|FG002|Long-Term Extension Period|Investigator Decision|0|||
128852895|NCT02484547|463756114|FG003|Long-Term Extension Period|Investigator Decision|2|||
128852896|NCT02484547|463756115|FG004|Long-Term Extension Period|Investigator Decision|1|||
128852897|NCT02484547|463756116|FG005|Long-Term Extension Period|Investigator Decision|0|||
128852898|NCT02484547|463756117|FG006|Long-Term Extension Period|Investigator Decision|1|||
128852899|NCT02484547|463756111|FG000|Long-Term Extension Period|Relocation|0|||
128852900|NCT02484547|463756112|FG001|Long-Term Extension Period|Relocation|0|||
128852901|NCT02484547|463756113|FG002|Long-Term Extension Period|Relocation|0|||
128852902|NCT02484547|463756114|FG003|Long-Term Extension Period|Relocation|1|||
128852903|NCT02484547|463756115|FG004|Long-Term Extension Period|Relocation|1|||
128852904|NCT02484547|463756116|FG005|Long-Term Extension Period|Relocation|0|||
128852905|NCT02484547|463756117|FG006|Long-Term Extension Period|Relocation|0|||
128852906|NCT02484547|463756111|FG000|Long-Term Extension Period|Study Visit Burden|0|||
128852907|NCT02484547|463756112|FG001|Long-Term Extension Period|Study Visit Burden|0|||
128852908|NCT02484547|463756113|FG002|Long-Term Extension Period|Study Visit Burden|0|||
128852909|NCT02484547|463756114|FG003|Long-Term Extension Period|Study Visit Burden|2|||
128852910|NCT02484547|463756115|FG004|Long-Term Extension Period|Study Visit Burden|0|||
128852911|NCT02484547|463756116|FG005|Long-Term Extension Period|Study Visit Burden|0|||
128852912|NCT02484547|463756117|FG006|Long-Term Extension Period|Study Visit Burden|3|||
128852913|NCT02484547|463756111|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
128852914|NCT02484547|463756112|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
128852915|NCT02484547|463756113|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
128852916|NCT02484547|463756114|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
128852917|NCT02484547|463756115|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
128852918|NCT02484547|463756116|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
128852919|NCT02484547|463756117|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
128852920|NCT02484547|463756111|FG000|Long-Term Extension Period|Reason not Specified|0|||
128852921|NCT02484547|463756112|FG001|Long-Term Extension Period|Reason not Specified|0|||
128852922|NCT02484547|463756113|FG002|Long-Term Extension Period|Reason not Specified|0|||
128852923|NCT02484547|463756114|FG003|Long-Term Extension Period|Reason not Specified|119|||
128852924|NCT02484547|463756115|FG004|Long-Term Extension Period|Reason not Specified|117|||
128852925|NCT02484547|463756116|FG005|Long-Term Extension Period|Reason not Specified|223|||
128852926|NCT02484547|463756117|FG006|Long-Term Extension Period|Reason not Specified|231|||
128852927|NCT01813305|463756118|FG000|Overall Study|Withdrawal by Subject|12|||
128852928|NCT01813305|463756119|FG001|Overall Study|Withdrawal by Subject|5|||
128852929|NCT01813305|463756118|FG000|Overall Study|Safety Concern|4|||
128852930|NCT01813305|463756119|FG001|Overall Study|Safety Concern|0|||
128852931|NCT01813305|463756118|FG000|Overall Study|Ulcer became worse|4|||
128852932|NCT01813305|463756119|FG001|Overall Study|Ulcer became worse|0|||
128852933|NCT01813305|463756118|FG000|Overall Study|Physician Decision|4|||
128852934|NCT01813305|463756119|FG001|Overall Study|Physician Decision|0|||
128852935|NCT01813305|463756118|FG000|Overall Study|Lost to Follow-up|3|||
128852936|NCT01813305|463756119|FG001|Overall Study|Lost to Follow-up|1|||
128852937|NCT01813305|463756118|FG000|Overall Study|Protocol Violation|1|||
128852938|NCT01813305|463756119|FG001|Overall Study|Protocol Violation|0|||
128852939|NCT01813305|463756118|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
128852940|NCT01813305|463756119|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
128852941|NCT01665599|463756123|FG000|Overall Study|Adverse Event|1|||
128852942|NCT01665599|463756123|FG000|Overall Study|Consent Withdrawn|1|||
128852943|NCT01665599|463756123|FG000|Overall Study|Investigator/Sponsor decision|1|||
128852944|NCT01665599|463756123|FG000|Overall Study|Death|1|||
128852945|NCT01665599|463756123|FG000|Overall Study|Lost to Follow-up|2|||
128852946|NCT01665599|463756123|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
128852947|NCT01665599|463756123|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
128852948|NCT01705145|463756124|FG000|Part B|Adverse Event|1|||
128852949|NCT04814992|463756130|FG000|Overall Study|Withdrawal by Subject|6|||
128852950|NCT04814992|463756131|FG001|Overall Study|Withdrawal by Subject|3|||
128852951|NCT04814992|463756130|FG000|Overall Study|Lost to Follow-up|1|||
128852952|NCT04814992|463756131|FG001|Overall Study|Lost to Follow-up|4|||
128852953|NCT00691678|463756132|FG000|Overall Study|Adverse Event|5|||
128852954|NCT00691678|463756132|FG000|Overall Study|life events, pain|11|||
128852955|NCT01503164|463756136|FG000|Overall Study|Withdrawal by Subject|2|||
128852956|NCT01503164|463756137|FG001|Overall Study|Withdrawal by Subject|1|||
128852957|NCT01831726|463756138|FG000|Overall Study|Adverse Event|16|||
128852958|NCT01831726|463756138|FG000|Overall Study|Death|7|||
128852959|NCT01831726|463756138|FG000|Overall Study|Disease Progression|49|||
128852960|NCT01831726|463756138|FG000|Overall Study|Physician Decision|1|||
128852961|NCT01831726|463756138|FG000|Overall Study|Subject/guardian decision|7|||
128852962|NCT03049306|463756139|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
128852963|NCT03049306|463756140|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
128852964|NCT03151551|463756141|FG000|Open-Label Treatment Period|Adverse Event|0|||
128852965|NCT03151551|463756142|FG001|Open-Label Treatment Period|Adverse Event|2|||
128852966|NCT03151551|463756141|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
128852967|NCT03151551|463756142|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
128852968|NCT03151551|463756141|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
128852969|NCT03151551|463756142|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
128852970|NCT03151551|463756141|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
128852971|NCT03151551|463756142|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
128852972|NCT03151551|463756141|FG000|Open-Label Treatment Period|Physician Decision|3|||
128852973|NCT03151551|463756142|FG001|Open-Label Treatment Period|Physician Decision|0|||
128852974|NCT03151551|463756141|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
128852975|NCT03151551|463756142|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
128852976|NCT03151551|463756141|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
128852977|NCT03151551|463756142|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
128852978|NCT03151551|463756141|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
128852979|NCT03151551|463756142|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
128852980|NCT03151551|463756141|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
128852981|NCT03151551|463756142|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
128852982|NCT03151551|463756141|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
128852983|NCT03151551|463756142|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
128852984|NCT00514813|463756147|FG000|Overall Study|Study terminated|14|||
128852985|NCT00514813|463756148|FG001|Overall Study|Study terminated|74|||
128852986|NCT00514813|463756149|FG002|Overall Study|Study terminated|40|||
128852987|NCT00514813|463756150|FG003|Overall Study|Study terminated|2|||
128852988|NCT00514813|463756147|FG000|Overall Study|Adverse Event|0|||
128852989|NCT00514813|463756148|FG001|Overall Study|Adverse Event|2|||
128852990|NCT00514813|463756149|FG002|Overall Study|Adverse Event|2|||
128852991|NCT00514813|463756150|FG003|Overall Study|Adverse Event|0|||
128852992|NCT00514813|463756147|FG000|Overall Study|Protocol Violation|1|||
128852993|NCT00514813|463756148|FG001|Overall Study|Protocol Violation|0|||
128852994|NCT00514813|463756149|FG002|Overall Study|Protocol Violation|0|||
128852995|NCT00514813|463756150|FG003|Overall Study|Protocol Violation|0|||
128852996|NCT00514813|463756147|FG000|Overall Study|Withdrawal by Subject|0|||
128852997|NCT00514813|463756148|FG001|Overall Study|Withdrawal by Subject|1|||
128852998|NCT00514813|463756149|FG002|Overall Study|Withdrawal by Subject|0|||
128852999|NCT00514813|463756150|FG003|Overall Study|Withdrawal by Subject|0|||
128853000|NCT00514813|463756147|FG000|Overall Study|Lack of Efficacy|0|||
128853001|NCT00514813|463756148|FG001|Overall Study|Lack of Efficacy|1|||
128853002|NCT00514813|463756149|FG002|Overall Study|Lack of Efficacy|0|||
128853003|NCT00514813|463756150|FG003|Overall Study|Lack of Efficacy|0|||
128853004|NCT00514813|463756147|FG000|Overall Study|Kidney transplant|0|||
128853005|NCT00514813|463756148|FG001|Overall Study|Kidney transplant|6|||
128853006|NCT00514813|463756149|FG002|Overall Study|Kidney transplant|2|||
128853007|NCT00514813|463756150|FG003|Overall Study|Kidney transplant|0|||
128853008|NCT00514813|463756147|FG000|Overall Study|Death|0|||
128853009|NCT00514813|463756148|FG001|Overall Study|Death|2|||
128853010|NCT00514813|463756149|FG002|Overall Study|Death|3|||
128853011|NCT00514813|463756150|FG003|Overall Study|Death|2|||
128853012|NCT02979613|463756151|FG000|Double-Blind Phase|Withdrew Consent|2|||
128853013|NCT02979613|463756152|FG001|Double-Blind Phase|Withdrew Consent|4|||
128853014|NCT02979613|463756151|FG000|Double-Blind Phase|Pregnancy|2|||
128853015|NCT02979613|463756152|FG001|Double-Blind Phase|Pregnancy|2|||
128853016|NCT02979613|463756151|FG000|Double-Blind Phase|Adverse Event|2|||
128853017|NCT02979613|463756152|FG001|Double-Blind Phase|Adverse Event|0|||
128853018|NCT02979613|463756151|FG000|Double-Blind Phase|Lost to Follow-up|1|||
128853019|NCT02979613|463756152|FG001|Double-Blind Phase|Lost to Follow-up|1|||
128853020|NCT02979613|463756151|FG000|Double-Blind Phase|Protocol Violation|1|||
128853021|NCT02979613|463756152|FG001|Double-Blind Phase|Protocol Violation|1|||
128853022|NCT02979613|463756151|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
128853023|NCT02979613|463756152|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
128853024|NCT02979613|463756151|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
128853025|NCT02979613|463756152|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
128853026|NCT02979613|463756151|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
128853027|NCT02979613|463756152|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
128853028|NCT02979613|463756151|FG000|Open-Label Extension (OLE) Phase|Death|0|||
128853029|NCT02979613|463756152|FG001|Open-Label Extension (OLE) Phase|Death|1|||
128853030|NCT02979613|463756151|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
128853031|NCT02979613|463756152|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
128853032|NCT03282799|463756155|FG000|Overall Study|Pregnancy|1|||
128853033|NCT03282799|463756156|FG001|Overall Study|Pregnancy|0|||
128853034|NCT03282799|463756155|FG000|Overall Study|Physician Decision|1|||
128853035|NCT03282799|463756156|FG001|Overall Study|Physician Decision|0|||
128853036|NCT00143598|463756161|FG000|Overall Study|Lost to Follow-up|23|||
128853037|NCT00143598|463756162|FG001|Overall Study|Lost to Follow-up|21|||
128853038|NCT00143598|463756161|FG000|Overall Study|Withdrawal by Subject|33|||
128853039|NCT00143598|463756162|FG001|Overall Study|Withdrawal by Subject|37|||
128853040|NCT00143598|463756161|FG000|Overall Study|Death|36|||
128853041|NCT00143598|463756162|FG001|Overall Study|Death|36|||
128853042|NCT00605566|463757595|FG000|Overall Study|Adverse Event|1|||
128853043|NCT00605566|463757595|FG000|Overall Study|Clinical deterioration|1|||
128853044|NCT00605566|463757595|FG000|Overall Study|Poor compliance in run-in period|1|||
128853045|NCT00695136|463757600|FG000|Overall Study|Withdrawal by Subject|1|||
128853046|NCT00695136|463757600|FG000|Overall Study|unrelated adverse event|1|||
128853047|NCT01726049|463757602|FG000|Overall Study|Death|1|||
128853048|NCT01726049|463757603|FG001|Overall Study|Death|1|||
128853049|NCT01726049|463757602|FG000|Overall Study|Adverse Event|4|||
128853050|NCT01726049|463757603|FG001|Overall Study|Adverse Event|1|||
128853051|NCT01726049|463757602|FG000|Overall Study|refused second HC|0|||
128853052|NCT01726049|463757603|FG001|Overall Study|refused second HC|2|||
128853053|NCT02806505|463757605|FG000|Overall Study|Adverse event/intercurrent illness|1|||
128853054|NCT02806505|463757606|FG001|Overall Study|Adverse event/intercurrent illness|3|||
128853055|NCT02806505|463757605|FG000|Overall Study|Death|4|||
128853056|NCT02806505|463757606|FG001|Overall Study|Death|0|||
128853057|NCT02806505|463757605|FG000|Overall Study|Did not cooperate/refused treatment|3|||
128853058|NCT02806505|463757606|FG001|Overall Study|Did not cooperate/refused treatment|3|||
128853059|NCT02806505|463757605|FG000|Overall Study|Failure to return|0|||
128853060|NCT02806505|463757606|FG001|Overall Study|Failure to return|1|||
128853061|NCT02806505|463757605|FG000|Overall Study|Insufficient therapeutic response|2|||
128853062|NCT02806505|463757606|FG001|Overall Study|Insufficient therapeutic response|4|||
128853063|NCT01181609|463757613|FG000|Overall Study|Adverse Event|1|||
128853064|NCT01181609|463757613|FG000|Overall Study|Withdrawal by Subject|1|||
128853065|NCT01181609|463757613|FG000|Overall Study|Lost to Follow-up|1|||
128853066|NCT01181609|463757613|FG000|Overall Study|Death|50|||
128853067|NCT01722045|463757614|FG000|Overall Study|Adverse Event|8|||
128853068|NCT01722045|463757614|FG000|Overall Study|Death|3|||
128853069|NCT01722045|463757614|FG000|Overall Study|Withdrawal by Subject|8|||
128853070|NCT01722045|463757614|FG000|Overall Study|Lost to Follow-up|4|||
128853071|NCT01722045|463757614|FG000|Overall Study|Protocol Deviation|1|||
128853072|NCT01722045|463757614|FG000|Overall Study|Physician Decision|3|||
128853073|NCT01722045|463757614|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
128853074|NCT03834623|463757624|FG000|Overall Study|Progression|0|||
128853075|NCT03834623|463757625|FG001|Overall Study|Progression|1|||
128853076|NCT01755546|463757628|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
128853077|NCT01755546|463757628|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
128853078|NCT01755546|463757628|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
128853079|NCT01755546|463757628|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
128853080|NCT01755546|463757628|FG000|Titration Phase|Adverse Event|11|||
128853081|NCT01755546|463757628|FG000|Titration Phase|Lack of Efficacy|18|||
128853082|NCT01755546|463757628|FG000|Titration Phase|Protocol Violation|9|||
128853083|NCT01755546|463757628|FG000|Titration Phase|Lost to Follow-up|2|||
128853084|NCT01755546|463757628|FG000|Titration Phase|Other and Continuing|22|||
128853085|NCT01755546|463757628|FG000|Titration Phase|Withdrawal by Subject|8|||
128853086|NCT01755546|463757628|FG000|Long Term Treatment|Adverse Event|12|||
128853087|NCT01755546|463757628|FG000|Long Term Treatment|Lack of Efficacy|6|||
128853088|NCT01755546|463757628|FG000|Long Term Treatment|Protocol Violation|10|||
128853089|NCT01755546|463757628|FG000|Long Term Treatment|Withdrawal by Subject|35|||
128853090|NCT01755546|463757628|FG000|Long Term Treatment|Lost to Follow-up|17|||
128853091|NCT01755546|463757628|FG000|Long Term Treatment|other and ongoing|41|||
128853092|NCT00362375|463757629|FG000|Overall Study|Lost to Follow-up|40|||
128853093|NCT00362375|463757630|FG001|Overall Study|Lost to Follow-up|35|||
128853094|NCT03294941|463757633|FG000|Overall Study|Withdrawal by Subject|0|||
128853095|NCT03294941|463757634|FG001|Overall Study|Withdrawal by Subject|2|||
128853096|NCT03927690|463757635|FG000|Overall Study|Withdrawal by Subject|3|||
128853097|NCT03927690|463757636|FG001|Overall Study|Withdrawal by Subject|1|||
128853098|NCT03927690|463757637|FG002|Overall Study|Withdrawal by Subject|1|||
128853099|NCT03927690|463757635|FG000|Overall Study|Adverse Event|1|||
128853100|NCT03927690|463757636|FG001|Overall Study|Adverse Event|0|||
128853101|NCT03927690|463757637|FG002|Overall Study|Adverse Event|0|||
128853102|NCT03927690|463757635|FG000|Overall Study|Death|1|||
128853103|NCT03927690|463757636|FG001|Overall Study|Death|0|||
128853104|NCT03927690|463757637|FG002|Overall Study|Death|0|||
128853105|NCT03927690|463757635|FG000|Overall Study|Lost to Follow-up|2|||
128853106|NCT03927690|463757636|FG001|Overall Study|Lost to Follow-up|2|||
128853107|NCT03927690|463757637|FG002|Overall Study|Lost to Follow-up|1|||
128853108|NCT04051242|463757643|FG000|Overall Study|Withdrawal by Subject|1|||
128853109|NCT04051242|463757643|FG000|Overall Study|Physician Decision|1|||
128853110|NCT00337285|463757645|FG000|Overall Study|Withdrawal by Subject|42|||
128853111|NCT00337285|463757645|FG000|Overall Study|Lost to Follow-up|41|||
128853112|NCT00337285|463757645|FG000|Overall Study|Adverse Event|28|||
128853113|NCT00337285|463757645|FG000|Overall Study|Protocol Violation|27|||
128853114|NCT00337285|463757645|FG000|Overall Study|Lack of Efficacy|11|||
128853115|NCT00337285|463757645|FG000|Overall Study|Death|1|||
128853116|NCT00337285|463757645|FG000|Overall Study|Physician Decision|1|||
128853117|NCT00337285|463757645|FG000|Overall Study|Lack of protocol compliance|7|||
128853118|NCT01774019|463757646|FG000|Overall Study|No longer meets protocol criteria|2|||
128853119|NCT01774019|463757647|FG001|Overall Study|No longer meets protocol criteria|0|||
128853120|NCT01774019|463757646|FG000|Overall Study|Withdrawal by Subject|1|||
128853121|NCT01774019|463757647|FG001|Overall Study|Withdrawal by Subject|0|||
128853122|NCT01774019|463757646|FG000|Overall Study|Surgery delayed > 120 days|1|||
128853123|NCT01774019|463757647|FG001|Overall Study|Surgery delayed > 120 days|0|||
128853124|NCT01774019|463757646|FG000|Overall Study|Patient refused surgery|1|||
128853125|NCT01774019|463757647|FG001|Overall Study|Patient refused surgery|1|||
128853126|NCT01774019|463757646|FG000|Overall Study|Unable to implant study device|1|||
128853127|NCT01774019|463757647|FG001|Overall Study|Unable to implant study device|0|||
128853128|NCT01774019|463757646|FG000|Overall Study|Lost to Follow-up|0|||
128853129|NCT01774019|463757647|FG001|Overall Study|Lost to Follow-up|3|||
128853130|NCT01004185|463757648|FG000|Overall Study|Adverse Event|1|||
128853131|NCT01004185|463757649|FG001|Overall Study|Adverse Event|1|||
128853132|NCT01004185|463757648|FG000|Overall Study|Lost to Follow-up|0|||
128853133|NCT01004185|463757649|FG001|Overall Study|Lost to Follow-up|1|||
128853134|NCT01004185|463757648|FG000|Overall Study|Lack of Efficacy|2|||
128853135|NCT01004185|463757649|FG001|Overall Study|Lack of Efficacy|1|||
128853136|NCT01004185|463757648|FG000|Overall Study|Sponsor Terminated Study|4|||
128853137|NCT01004185|463757649|FG001|Overall Study|Sponsor Terminated Study|5|||
128853138|NCT01004185|463757648|FG000|Overall Study|Withdrawal by Subject|2|||
128853139|NCT01004185|463757649|FG001|Overall Study|Withdrawal by Subject|1|||
128853140|NCT03481556|463757652|FG000|Overall Study|Adverse Event|1|||
128853141|NCT03481556|463757653|FG001|Overall Study|Adverse Event|0|||
128853142|NCT03481556|463757654|FG002|Overall Study|Adverse Event|0|||
128853143|NCT03481556|463757655|FG003|Overall Study|Adverse Event|0|||
128853144|NCT03481556|463757652|FG000|Overall Study|Death|4|||
128853145|NCT03481556|463757653|FG001|Overall Study|Death|2|||
128853146|NCT03481556|463757654|FG002|Overall Study|Death|3|||
128853147|NCT03481556|463757655|FG003|Overall Study|Death|16|||
128853148|NCT03481556|463757652|FG000|Overall Study|Study Terminated by Sponsor|10|||
128853149|NCT03481556|463757653|FG001|Overall Study|Study Terminated by Sponsor|5|||
128853150|NCT03481556|463757654|FG002|Overall Study|Study Terminated by Sponsor|2|||
128853151|NCT03481556|463757655|FG003|Overall Study|Study Terminated by Sponsor|9|||
128853152|NCT03463577|463757656|FG000|Overall Study|Lost to Follow-up|238|||
128853153|NCT03463577|463757657|FG001|Overall Study|Lost to Follow-up|435|||
128853154|NCT03463577|463757658|FG002|Overall Study|Lost to Follow-up|0|||
128853155|NCT03463577|463757659|FG003|Overall Study|Lost to Follow-up|0|||
128853156|NCT03463577|463757660|FG004|Overall Study|Lost to Follow-up|0|||
128853157|NCT03463577|463757661|FG005|Overall Study|Lost to Follow-up|0|||
128853158|NCT03463577|463757656|FG000|Overall Study|With unknown pregnancy outcome|0|||
128853159|NCT03463577|463757657|FG001|Overall Study|With unknown pregnancy outcome|5|||
128853160|NCT03463577|463757658|FG002|Overall Study|With unknown pregnancy outcome|0|||
128853161|NCT03463577|463757659|FG003|Overall Study|With unknown pregnancy outcome|0|||
128853162|NCT03463577|463757660|FG004|Overall Study|With unknown pregnancy outcome|0|||
128853163|NCT03463577|463757661|FG005|Overall Study|With unknown pregnancy outcome|0|||
128853164|NCT03463577|463757656|FG000|Overall Study|Maternal death|2|||
128853165|NCT03463577|463757657|FG001|Overall Study|Maternal death|0|||
128853166|NCT03463577|463757658|FG002|Overall Study|Maternal death|0|||
128853167|NCT03463577|463757659|FG003|Overall Study|Maternal death|0|||
128853168|NCT03463577|463757660|FG004|Overall Study|Maternal death|0|||
128853169|NCT03463577|463757661|FG005|Overall Study|Maternal death|0|||
128853170|NCT03463577|463757656|FG000|Overall Study|Neonatal death|0|||
128853171|NCT03463577|463757657|FG001|Overall Study|Neonatal death|0|||
128853172|NCT03463577|463757658|FG002|Overall Study|Neonatal death|0|||
128853173|NCT03463577|463757659|FG003|Overall Study|Neonatal death|15|||
128853174|NCT03463577|463757660|FG004|Overall Study|Neonatal death|17|||
128853175|NCT03463577|463757661|FG005|Overall Study|Neonatal death|0|||
128853176|NCT01101997|463757663|FG000|Overall Study|Withdrawal by Subject|2|||
128853177|NCT02172950|463757666|FG000|Overall Study|Physician Decision|3|||
128853178|NCT02172950|463757667|FG001|Overall Study|Physician Decision|3|||
128853179|NCT02172950|463757666|FG000|Overall Study|Lack of Efficacy|1|||
128853180|NCT02172950|463757667|FG001|Overall Study|Lack of Efficacy|0|||
128853181|NCT02172950|463757666|FG000|Overall Study|Adverse Event|4|||
128853182|NCT02172950|463757667|FG001|Overall Study|Adverse Event|1|||
128853183|NCT02172950|463757666|FG000|Overall Study|Withdrawal by Subject|10|||
128853184|NCT02172950|463757667|FG001|Overall Study|Withdrawal by Subject|0|||
128853185|NCT02172950|463757666|FG000|Overall Study|Protocol Violation|1|||
128853186|NCT02172950|463757667|FG001|Overall Study|Protocol Violation|0|||
128853187|NCT02172950|463757666|FG000|Overall Study|Lost to Follow-up|1|||
128853188|NCT02172950|463757667|FG001|Overall Study|Lost to Follow-up|0|||
128853189|NCT02172950|463757666|FG000|Overall Study|Death|1|||
128853190|NCT02172950|463757667|FG001|Overall Study|Death|0|||
128853191|NCT02172950|463757666|FG000|Overall Study|Patient traveling|1|||
128853192|NCT02172950|463757667|FG001|Overall Study|Patient traveling|0|||
128853193|NCT02172950|463757666|FG000|Overall Study|Patient went to other country|1|||
128853194|NCT02172950|463757667|FG001|Overall Study|Patient went to other country|0|||
128853195|NCT02172950|463757666|FG000|Overall Study|Patient relocated overseas|1|||
128853196|NCT02172950|463757667|FG001|Overall Study|Patient relocated overseas|1|||
128853197|NCT02172950|463757666|FG000|Overall Study|Patient moving|1|||
128853198|NCT02172950|463757667|FG001|Overall Study|Patient moving|0|||
128853199|NCT00611715|463757668|FG000|Overall Study|Disease Progression|24|||
128853200|NCT00611715|463757669|FG001|Overall Study|Disease Progression|4|||
128853201|NCT00611715|463757668|FG000|Overall Study|Withdrawal by Subject|5|||
128853202|NCT00611715|463757669|FG001|Overall Study|Withdrawal by Subject|1|||
128853203|NCT00611715|463757668|FG000|Overall Study|Adverse Event|9|||
128853204|NCT00611715|463757669|FG001|Overall Study|Adverse Event|1|||
128853205|NCT00611715|463757668|FG000|Overall Study|Death|1|||
128853206|NCT00611715|463757669|FG001|Overall Study|Death|0|||
128853207|NCT00611715|463757668|FG000|Overall Study|two patients are still on treatment|2|||
128853208|NCT00611715|463757669|FG001|Overall Study|two patients are still on treatment|0|||
128853209|NCT00107978|463757670|FG000|Overall Study|Adverse Event|1|||
128853210|NCT00107978|463757671|FG001|Overall Study|Adverse Event|5|||
128853211|NCT00107978|463757670|FG000|Overall Study|Death|3|||
128853212|NCT00107978|463757671|FG001|Overall Study|Death|3|||
128853213|NCT00107978|463757670|FG000|Overall Study|Lost to Follow-up|20|||
128853214|NCT00107978|463757671|FG001|Overall Study|Lost to Follow-up|28|||
128853215|NCT00107978|463757670|FG000|Overall Study|Withdrawal by Subject|4|||
128853216|NCT00107978|463757671|FG001|Overall Study|Withdrawal by Subject|9|||
128853217|NCT00107978|463757670|FG000|Overall Study|Protocol Violation|0|||
128853218|NCT00107978|463757671|FG001|Overall Study|Protocol Violation|1|||
128853219|NCT00107978|463757670|FG000|Overall Study|Other|5|||
128853220|NCT00107978|463757671|FG001|Overall Study|Other|4|||
128853221|NCT00704171|463757674|FG000|Overall Study|Withdrawal by Subject|1|||
128853222|NCT00704171|463757675|FG001|Overall Study|Withdrawal by Subject|0|||
128853223|NCT01874665|463757676|FG000|Overall Study|Adverse Event|6|||
128853224|NCT01874665|463757677|FG001|Overall Study|Adverse Event|2|||
128853225|NCT01874665|463757676|FG000|Overall Study|Withdrawal by Subject|4|||
128853226|NCT01874665|463757677|FG001|Overall Study|Withdrawal by Subject|1|||
128853227|NCT01874665|463757676|FG000|Overall Study|Physician Decision|3|||
128853228|NCT01874665|463757677|FG001|Overall Study|Physician Decision|0|||
128853229|NCT01874665|463757676|FG000|Overall Study|Clinical Progressive Disease|4|||
128853230|NCT01874665|463757677|FG001|Overall Study|Clinical Progressive Disease|3|||
128853231|NCT01874665|463757676|FG000|Overall Study|Study Terminated by Sponsor|0|||
128853232|NCT01874665|463757677|FG001|Overall Study|Study Terminated by Sponsor|2|||
128853233|NCT01874665|463757676|FG000|Overall Study|Documented Progressive Disease|11|||
128853234|NCT01874665|463757677|FG001|Overall Study|Documented Progressive Disease|7|||
128853235|NCT01874665|463757676|FG000|Overall Study|Other|2|||
128853236|NCT01874665|463757677|FG001|Overall Study|Other|0|||
128853237|NCT00350298|463757678|FG000|Overall Study|Death|7|||
128853238|NCT00350298|463757679|FG001|Overall Study|Death|8|||
128853239|NCT00350298|463757678|FG000|Overall Study|Lost to Follow-up|1|||
128853240|NCT00350298|463757679|FG001|Overall Study|Lost to Follow-up|2|||
128853241|NCT00350298|463757678|FG000|Overall Study|Withdrawal by Subject|1|||
128853242|NCT00350298|463757679|FG001|Overall Study|Withdrawal by Subject|3|||
128853243|NCT03634839|463757680|FG000|First Intervention (2 Hours)|Adverse Event|0|||
128853244|NCT03634839|463757681|FG001|First Intervention (2 Hours)|Adverse Event|2|||
128853245|NCT02447432|463757686|FG000|Epoch 001|Adverse Event|1|||
128853246|NCT02447432|463757687|FG001|Epoch 001|Adverse Event|1|||
128853247|NCT02447432|463757686|FG000|Epoch 001|Withdrawal by Subject|0|||
128853248|NCT02447432|463757687|FG001|Epoch 001|Withdrawal by Subject|4|||
128853249|NCT02447432|463757686|FG000|Epoch 001|Migrated/moved from study area|3|||
128853250|NCT02447432|463757687|FG001|Epoch 001|Migrated/moved from study area|5|||
128853251|NCT02447432|463757686|FG000|Epoch 001|Lost to Follow-up|1|||
128853252|NCT02447432|463757687|FG001|Epoch 001|Lost to Follow-up|3|||
128853253|NCT00233389|463757688|FG000|Overall Study|Adverse Event|5|||
128853254|NCT00233389|463757689|FG001|Overall Study|Adverse Event|5|||
128853255|NCT00233389|463757688|FG000|Overall Study|Lack of Efficacy|11|||
128853256|NCT00233389|463757689|FG001|Overall Study|Lack of Efficacy|8|||
128853257|NCT00233389|463757688|FG000|Overall Study|Lost to Follow-up|1|||
128853258|NCT00233389|463757689|FG001|Overall Study|Lost to Follow-up|1|||
128853259|NCT00233389|463757688|FG000|Overall Study|Physician Decision|1|||
128853260|NCT00233389|463757689|FG001|Overall Study|Physician Decision|0|||
128853261|NCT00233389|463757688|FG000|Overall Study|Protocol Violation|0|||
128853262|NCT00233389|463757689|FG001|Overall Study|Protocol Violation|1|||
128853263|NCT00233389|463757688|FG000|Overall Study|Withdrawal by Subject|0|||
128853264|NCT00233389|463757689|FG001|Overall Study|Withdrawal by Subject|1|||
128853265|NCT04962698|463757694|FG000|Motor Imagery|Technical difficulty|1|||
128853266|NCT04962698|463757695|FG001|Motor Imagery|Technical difficulty|0|||
128853267|NCT04962698|463757694|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
128853268|NCT04962698|463757695|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
128853269|NCT04962698|463757694|FG000|Kinesthetic MI|Technical difficulty|1|||
128853270|NCT04962698|463757695|FG001|Kinesthetic MI|Technical difficulty|0|||
128853271|NCT04962698|463757694|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
128853272|NCT04962698|463757695|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
128853273|NCT04962698|463757694|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
128853274|NCT04962698|463757695|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
128853275|NCT04962698|463757694|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
128853276|NCT04962698|463757695|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
128853277|NCT04962698|463757694|FG000|Virtual-hand Interaction|Technical difficulty|1|||
128853278|NCT04962698|463757695|FG001|Virtual-hand Interaction|Technical difficulty|0|||
128853279|NCT04962698|463757694|FG000|Robotic Action Observation|Technical difficulty|1|||
128853280|NCT04962698|463757695|FG001|Robotic Action Observation|Technical difficulty|0|||
128853281|NCT04962698|463757694|FG000|Rest|Technical difficulty|1|||
128853282|NCT04962698|463757695|FG001|Rest|Technical difficulty|0|||
128853283|NCT04962698|463757694|FG000|Rest|Exclusion criteria met after enrollment|0|||
128853284|NCT04962698|463757695|FG001|Rest|Exclusion criteria met after enrollment|2|||
128853285|NCT00853229|463757696|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
128853286|NCT00853229|463757697|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
128853287|NCT03201900|463757701|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
128853288|NCT03201900|463757701|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
128853289|NCT03201900|463757701|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
128853290|NCT03201900|463757701|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
128853291|NCT03201900|463757701|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
128853292|NCT03201900|463757701|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
128853293|NCT03201900|463757701|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
128853294|NCT03201900|463757701|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
128853295|NCT03201900|463757701|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
128853296|NCT03201900|463757701|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
128853297|NCT03201900|463757701|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
128853298|NCT03201900|463757701|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
128853299|NCT03201900|463757701|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
128853300|NCT00776659|463757720|FG000|Overall Study|Lost to Follow-up|15|||
128853301|NCT00776659|463757720|FG000|Overall Study|Withdrawal by Subject|10|||
128853302|NCT00776659|463757720|FG000|Overall Study|Study Terminated by Sponsor|1|||
128853303|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
128853304|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
128853305|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
128853306|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
128853307|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
128853308|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
128853309|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
128853310|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
128853311|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
128853312|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
128853313|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
128853314|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
128853315|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
128853316|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
128853317|NCT01664923|463757721|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
128853318|NCT01664923|463757722|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
128853319|NCT01664923|463757721|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
128853320|NCT01664923|463757722|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
128853321|NCT01664923|463757721|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
128853322|NCT01664923|463757722|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
128853323|NCT01664923|463757721|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
128853324|NCT01664923|463757722|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
128853325|NCT01664923|463757721|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
128853326|NCT01664923|463757722|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
128853327|NCT01664923|463757721|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
128853328|NCT01664923|463757722|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
128853329|NCT01664923|463757721|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
128853330|NCT01664923|463757722|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
128853331|NCT00905034|463757725|FG000|Overall Study|Withdrawal by Subject|1|||
128853332|NCT01710800|463757726|FG000|Overall Study|Withdrawal by Subject|21|||
128853333|NCT01710800|463757726|FG000|Overall Study|Protocol Violation|1|||
128853334|NCT02427958|463757727|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
128853335|NCT02427958|463757727|FG000|Overall Study|Lost to Follow-up|6|||
128853336|NCT02427958|463757727|FG000|Overall Study|Withdrawal by Subject|14|||
128853337|NCT02427958|463757727|FG000|Overall Study|Lack of Efficacy|1|||
128853338|NCT00511797|463757728|FG000|Overall Study|Adverse Event|1|||
128853339|NCT00511797|463757729|FG001|Overall Study|Adverse Event|2|||
128853340|NCT00511797|463757730|FG002|Overall Study|Adverse Event|2|||
128853341|NCT00511797|463757731|FG003|Overall Study|Adverse Event|2|||
128853342|NCT00511797|463757728|FG000|Overall Study|Lost to Follow-up|1|||
128853343|NCT00511797|463757729|FG001|Overall Study|Lost to Follow-up|0|||
128853344|NCT00511797|463757730|FG002|Overall Study|Lost to Follow-up|0|||
128853345|NCT00511797|463757731|FG003|Overall Study|Lost to Follow-up|1|||
128853346|NCT00511797|463757728|FG000|Overall Study|Pregnancy|0|||
128853347|NCT00511797|463757729|FG001|Overall Study|Pregnancy|0|||
128853348|NCT00511797|463757730|FG002|Overall Study|Pregnancy|0|||
128853349|NCT00511797|463757731|FG003|Overall Study|Pregnancy|1|||
128853350|NCT00511797|463757728|FG000|Overall Study|Protocol Violation|0|||
128853351|NCT00511797|463757729|FG001|Overall Study|Protocol Violation|2|||
128853352|NCT00511797|463757730|FG002|Overall Study|Protocol Violation|2|||
128853353|NCT00511797|463757731|FG003|Overall Study|Protocol Violation|3|||
128853354|NCT00511797|463757728|FG000|Overall Study|Withdrawal by Subject|3|||
128853355|NCT00511797|463757729|FG001|Overall Study|Withdrawal by Subject|3|||
128853356|NCT00511797|463757730|FG002|Overall Study|Withdrawal by Subject|4|||
128853357|NCT00511797|463757731|FG003|Overall Study|Withdrawal by Subject|2|||
128853358|NCT00511797|463757728|FG000|Overall Study|Never dispensed|1|||
128853359|NCT00511797|463757729|FG001|Overall Study|Never dispensed|0|||
128853360|NCT00511797|463757730|FG002|Overall Study|Never dispensed|1|||
128853361|NCT00511797|463757731|FG003|Overall Study|Never dispensed|3|||
128853362|NCT00511797|463757728|FG000|Overall Study|Study drug not taken|0|||
128853363|NCT00511797|463757729|FG001|Overall Study|Study drug not taken|1|||
128853364|NCT00511797|463757730|FG002|Overall Study|Study drug not taken|0|||
128853365|NCT00511797|463757731|FG003|Overall Study|Study drug not taken|1|||
128853366|NCT00511797|463757728|FG000|Overall Study|Partially missing diary|0|||
128853367|NCT00511797|463757729|FG001|Overall Study|Partially missing diary|0|||
128853368|NCT00511797|463757730|FG002|Overall Study|Partially missing diary|1|||
128853369|NCT00511797|463757731|FG003|Overall Study|Partially missing diary|0|||
128853370|NCT00511797|463757728|FG000|Overall Study|Other (moving etc)|1|||
128853371|NCT00511797|463757729|FG001|Overall Study|Other (moving etc)|0|||
128853372|NCT00511797|463757730|FG002|Overall Study|Other (moving etc)|1|||
128853373|NCT00511797|463757731|FG003|Overall Study|Other (moving etc)|2|||
128853374|NCT03974100|463757732|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
128853375|NCT03974100|463757733|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
128853376|NCT03974100|463757734|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
128853377|NCT03974100|463757735|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
128853378|NCT03974100|463757736|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
128853379|NCT03974100|463757732|FG000|TP1 - Day 1 to Week 52|Death|1|||
128853380|NCT03974100|463757733|FG001|TP1 - Day 1 to Week 52|Death|0|||
128853381|NCT03974100|463757734|FG002|TP1 - Day 1 to Week 52|Death|0|||
128853382|NCT03974100|463757735|FG003|TP1 - Day 1 to Week 52|Death|0|||
128853383|NCT03974100|463757736|FG004|TP1 - Day 1 to Week 52|Death|0|||
128853384|NCT03974100|463757732|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
128853385|NCT03974100|463757733|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
128853386|NCT03974100|463757734|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
128853387|NCT03974100|463757735|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
128853388|NCT03974100|463757736|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
128853389|NCT03974100|463757732|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
128853390|NCT03974100|463757733|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
128853391|NCT03974100|463757734|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
128853392|NCT03974100|463757735|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
128853393|NCT03974100|463757736|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
128853394|NCT03974100|463757732|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
128853395|NCT03974100|463757733|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
128853396|NCT03974100|463757734|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
128853397|NCT03974100|463757735|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
128853398|NCT03974100|463757736|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
128853399|NCT03974100|463757732|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
128853400|NCT03974100|463757733|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
128853401|NCT03974100|463757734|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
128853402|NCT03974100|463757735|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
128853403|NCT03974100|463757736|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
128853404|NCT03974100|463757732|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
128853405|NCT03974100|463757733|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
128853406|NCT03974100|463757734|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
128853407|NCT03974100|463757735|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
128853408|NCT03974100|463757736|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
128853409|NCT01560871|463757739|FG000|Overall Study|transportation issues|2|||
128853410|NCT01560871|463757740|FG001|Overall Study|transportation issues|1|||
128853411|NCT01560871|463757739|FG000|Overall Study|relocation|1|||
128853412|NCT01560871|463757740|FG001|Overall Study|relocation|0|||
128853413|NCT01560871|463757739|FG000|Overall Study|readmission to a hospital|2|||
128853414|NCT01560871|463757740|FG001|Overall Study|readmission to a hospital|1|||
128853415|NCT01560871|463757739|FG000|Overall Study|Lost to Follow-up|1|||
128853416|NCT01560871|463757740|FG001|Overall Study|Lost to Follow-up|0|||
128853417|NCT02024750|463757741|FG000|Overall Study|Withdrawal by Subject|2|||
128853418|NCT02024750|463757742|FG001|Overall Study|Withdrawal by Subject|1|||
128853419|NCT00934700|463757749|FG000|Overall Study|missing scan|5|||
128853420|NCT00934700|463757750|FG001|Overall Study|missing scan|9|||
128853421|NCT00934700|463757749|FG000|Overall Study|Death|8|||
128853422|NCT00934700|463757750|FG001|Overall Study|Death|3|||
128853423|NCT03900715|463757753|FG000|Overall Study|Protocol Deviation|1|||
128853424|NCT03900715|463757753|FG000|Overall Study|Lack of Efficacy|1|||
128853425|NCT03900715|463757753|FG000|Overall Study|Progressive Disease|6|||
128853426|NCT03900715|463757753|FG000|Overall Study|Adverse Event|2|||
128853427|NCT03900715|463757753|FG000|Overall Study|Other reasons|11|||
128853428|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
128853429|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
128853430|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
128853431|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
128853432|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
128853433|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
128853434|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
128853435|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
128853436|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
128853437|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
128853438|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
128853439|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
128853440|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
128853441|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
128853442|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
128853443|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
128853444|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
128853445|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
128853446|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
128853447|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
128853448|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
128853449|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
128853450|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
128853451|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
128853452|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
128853453|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
128853454|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
128853455|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
128853456|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
128853457|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
128853458|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
128853459|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
128853460|NCT00092521|463759782|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
128853461|NCT00092521|463759783|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
128853462|NCT00092521|463759784|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
128853463|NCT00092521|463759785|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
128853464|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
128853465|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
128853466|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
128853467|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
128853468|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
128853469|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
128853470|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
128853471|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
128853472|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
128853473|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
128853474|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
128853475|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
128853476|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Death|2|||
128853477|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Death|0|||
128853478|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Death|1|||
128853479|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Death|0|||
128853480|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
128853481|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
128853482|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
128853483|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
128853484|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
128853485|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
128853486|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
128853487|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
128853488|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
128853489|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
128853490|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
128853491|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
128853492|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Moved|32|||
128853493|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Moved|2|||
128853494|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Moved|28|||
128853495|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Moved|0|||
128853496|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
128853497|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
128853498|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
128853499|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
128853500|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Travel|2|||
128853501|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Travel|0|||
128853502|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Travel|0|||
128853503|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Travel|0|||
128853504|NCT00092521|463759782|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
128853505|NCT00092521|463759783|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
128853506|NCT00092521|463759784|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
128853507|NCT00092521|463759785|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
128853508|NCT00092521|463759782|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
128853509|NCT00092521|463759783|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
128853510|NCT00092521|463759784|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
128853511|NCT00092521|463759785|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
128853512|NCT00092521|463759782|FG000|Extension Study (Group 4)|Adverse Event|0|||
128853513|NCT00092521|463759783|FG001|Extension Study (Group 4)|Adverse Event|0|||
128853514|NCT00092521|463759784|FG002|Extension Study (Group 4)|Adverse Event|0|||
128853515|NCT00092521|463759785|FG003|Extension Study (Group 4)|Adverse Event|2|||
128853516|NCT00092521|463759782|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
128853517|NCT00092521|463759783|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
128853518|NCT00092521|463759784|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
128853519|NCT00092521|463759785|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
128853520|NCT00092521|463759782|FG000|Extension Study (Group 4)|Pregnancy|0|||
128853521|NCT00092521|463759783|FG001|Extension Study (Group 4)|Pregnancy|0|||
128853522|NCT00092521|463759784|FG002|Extension Study (Group 4)|Pregnancy|0|||
128853523|NCT00092521|463759785|FG003|Extension Study (Group 4)|Pregnancy|4|||
128853524|NCT00092521|463759782|FG000|Extension Study (Group 4)|Protocol Violation|0|||
128853525|NCT00092521|463759783|FG001|Extension Study (Group 4)|Protocol Violation|0|||
128853526|NCT00092521|463759784|FG002|Extension Study (Group 4)|Protocol Violation|0|||
128853527|NCT00092521|463759785|FG003|Extension Study (Group 4)|Protocol Violation|2|||
128853528|NCT00092521|463759782|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
128853529|NCT00092521|463759783|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
128853530|NCT00092521|463759784|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
128853531|NCT00092521|463759785|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
128853532|NCT00092521|463759782|FG000|Extension Study (Group 4)|Moved|0|||
128853533|NCT00092521|463759783|FG001|Extension Study (Group 4)|Moved|0|||
128853534|NCT00092521|463759784|FG002|Extension Study (Group 4)|Moved|0|||
128853535|NCT00092521|463759785|FG003|Extension Study (Group 4)|Moved|16|||
128853536|NCT00092521|463759782|FG000|Extension Study (Group 4)|Site Terminated|0|||
128853537|NCT00092521|463759783|FG001|Extension Study (Group 4)|Site Terminated|0|||
128853538|NCT00092521|463759784|FG002|Extension Study (Group 4)|Site Terminated|0|||
128853539|NCT00092521|463759785|FG003|Extension Study (Group 4)|Site Terminated|4|||
128853540|NCT00092521|463759782|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
128853541|NCT00092521|463759783|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
128853542|NCT00092521|463759784|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
128853543|NCT00092521|463759785|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
128853544|NCT03464383|463759786|FG000|Overall Study|Lost to Follow-up|1|||
128853545|NCT03464383|463759787|FG001|Overall Study|Lost to Follow-up|0|||
128853546|NCT03464383|463759788|FG002|Overall Study|Lost to Follow-up|0|||
128853547|NCT03464383|463759786|FG000|Overall Study|Withdrawal by Subject|0|||
128853548|NCT03464383|463759787|FG001|Overall Study|Withdrawal by Subject|1|||
128853549|NCT03464383|463759788|FG002|Overall Study|Withdrawal by Subject|0|||
128853550|NCT01333111|463759792|FG000|Overall Study|patient undergoing major surgery|0|||
128853551|NCT01333111|463759793|FG001|Overall Study|patient undergoing major surgery|2|||
128853552|NCT01333111|463759794|FG002|Overall Study|patient undergoing major surgery|0|||
128853553|NCT01333111|463759792|FG000|Overall Study|personal reasons|0|||
128853554|NCT01333111|463759793|FG001|Overall Study|personal reasons|0|||
128853555|NCT01333111|463759794|FG002|Overall Study|personal reasons|1|||
128853556|NCT01333111|463759792|FG000|Overall Study|unclassified|1|||
128853557|NCT01333111|463759793|FG001|Overall Study|unclassified|0|||
128853558|NCT01333111|463759794|FG002|Overall Study|unclassified|0|||
128853559|NCT01333111|463759792|FG000|Overall Study|withdrawal criteria|0|||
128853560|NCT01333111|463759793|FG001|Overall Study|withdrawal criteria|1|||
128853561|NCT01333111|463759794|FG002|Overall Study|withdrawal criteria|0|||
128853562|NCT01333111|463759792|FG000|Overall Study|Non-compliance|1|||
128853563|NCT01333111|463759793|FG001|Overall Study|Non-compliance|0|||
128853564|NCT01333111|463759794|FG002|Overall Study|Non-compliance|0|||
128853565|NCT01333111|463759792|FG000|Overall Study|Ineffective therapy|0|||
128853566|NCT01333111|463759793|FG001|Overall Study|Ineffective therapy|0|||
128853567|NCT01333111|463759794|FG002|Overall Study|Ineffective therapy|1|||
128853568|NCT02161406|463759795|FG000|Overall Study|Death|2|||
128853569|NCT02161406|463759796|FG001|Overall Study|Death|1|||
128853570|NCT02161406|463759795|FG000|Overall Study|Lost to Follow-up|2|||
128853571|NCT02161406|463759796|FG001|Overall Study|Lost to Follow-up|1|||
128853572|NCT02161406|463759795|FG000|Overall Study|Withdrawal by Subject|2|||
128853573|NCT02161406|463759796|FG001|Overall Study|Withdrawal by Subject|4|||
128853574|NCT02161406|463759795|FG000|Overall Study|investigator withdrew subject|3|||
128853575|NCT02161406|463759796|FG001|Overall Study|investigator withdrew subject|1|||
128853576|NCT02161406|463759795|FG000|Overall Study|Lack of Efficacy|1|||
128853577|NCT02161406|463759796|FG001|Overall Study|Lack of Efficacy|1|||
128853578|NCT02161406|463759795|FG000|Overall Study|relocation|0|||
128853579|NCT02161406|463759796|FG001|Overall Study|relocation|1|||
128853580|NCT04732871|463759797|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
128853581|NCT04732871|463759798|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
128853582|NCT04732871|463759799|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
128853583|NCT04732871|463759797|FG000|Overall Study|Lost to Follow-up|7|||
128853584|NCT04732871|463759798|FG001|Overall Study|Lost to Follow-up|4|||
128853585|NCT04732871|463759799|FG002|Overall Study|Lost to Follow-up|3|||
128853586|NCT04732871|463759797|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
128853587|NCT04732871|463759798|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
128853588|NCT04732871|463759799|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
128853589|NCT04732871|463759797|FG000|Overall Study|Migrated / moved from the study area|5|||
128853590|NCT04732871|463759798|FG001|Overall Study|Migrated / moved from the study area|0|||
128853591|NCT04732871|463759799|FG002|Overall Study|Migrated / moved from the study area|0|||
128853592|NCT04732871|463759797|FG000|Overall Study|Other|1|||
128853593|NCT04732871|463759798|FG001|Overall Study|Other|0|||
128853594|NCT04732871|463759799|FG002|Overall Study|Other|1|||
128853595|NCT04732871|463759797|FG000|Overall Study|Ongoing|6|||
128853596|NCT04732871|463759798|FG001|Overall Study|Ongoing|0|||
128853597|NCT04732871|463759799|FG002|Overall Study|Ongoing|1|||
128853598|NCT04732871|463759797|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
128853599|NCT04732871|463759798|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
128853600|NCT04732871|463759799|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
128853601|NCT03458728|463759802|FG000|Overall Study|Adverse Event|1|||
128853602|NCT03458728|463759803|FG001|Overall Study|Adverse Event|0|||
128853603|NCT03458728|463759802|FG000|Overall Study|Physician Decision|1|||
128853604|NCT03458728|463759803|FG001|Overall Study|Physician Decision|0|||
128853605|NCT03458728|463759802|FG000|Overall Study|Progressive disease - clinical assessment|1|||
128853606|NCT03458728|463759803|FG001|Overall Study|Progressive disease - clinical assessment|0|||
128853607|NCT03458728|463759802|FG000|Overall Study|Progressive disease - radiological progression|21|||
128853608|NCT03458728|463759803|FG001|Overall Study|Progressive disease - radiological progression|6|||
128853609|NCT03458728|463759802|FG000|Overall Study|Withdrawal by Subject|0|||
128853610|NCT03458728|463759803|FG001|Overall Study|Withdrawal by Subject|1|||
128853611|NCT00908349|463759804|FG000|Overall Study|Adverse Event|10|||
128853612|NCT00908349|463759804|FG000|Overall Study|Withdrawal by Subject|9|||
128853613|NCT00908349|463759804|FG000|Overall Study|Physician Decision|5|||
128853614|NCT00908349|463759804|FG000|Overall Study|Lost to Follow-up|5|||
128853615|NCT00908349|463759804|FG000|Overall Study|Various|6|||
128853616|NCT04606199|463759807|FG000|Overall Study|Withdrawal by Subject|2|||
128853617|NCT02624869|463759810|FG000|Overall Study|Lost to Follow-up|0|||
128853618|NCT02624869|463759811|FG001|Overall Study|Lost to Follow-up|0|||
128853619|NCT02624869|463759812|FG002|Overall Study|Lost to Follow-up|1|||
128853620|NCT02624869|463759810|FG000|Overall Study|Withdrawal by Subject|1|||
128853621|NCT02624869|463759811|FG001|Overall Study|Withdrawal by Subject|3|||
128853622|NCT02624869|463759812|FG002|Overall Study|Withdrawal by Subject|1|||
128853623|NCT01202409|463759813|FG000|Overall Study|Adverse Event|1|||
128853624|NCT01202409|463759813|FG000|Overall Study|Ineligible - KRAS mutants|7|||
128853625|NCT00553605|463759814|FG000|Overall Study|Did not meet entrance criteria|1|||
128853626|NCT00553605|463759815|FG001|Overall Study|Did not meet entrance criteria|3|||
128853627|NCT00553605|463759814|FG000|Overall Study|Did not receive full dose|1|||
128853628|NCT00553605|463759815|FG001|Overall Study|Did not receive full dose|0|||
128853629|NCT00553605|463759814|FG000|Overall Study|Randomized but not treated|2|||
128853630|NCT00553605|463759815|FG001|Overall Study|Randomized but not treated|0|||
128853631|NCT01085812|463759818|FG000|Open-Label Period|Adverse Event|0|||
128853632|NCT01085812|463759819|FG001|Open-Label Period|Adverse Event|80|||
128853633|NCT01085812|463759818|FG000|Open-Label Period|Lack of Efficacy|0|||
128853634|NCT01085812|463759819|FG001|Open-Label Period|Lack of Efficacy|26|||
128853635|NCT01085812|463759818|FG000|Open-Label Period|Protocol Violation|0|||
128853636|NCT01085812|463759819|FG001|Open-Label Period|Protocol Violation|39|||
128853637|NCT01085812|463759818|FG000|Open-Label Period|Withdrawal by Subject|0|||
128853638|NCT01085812|463759819|FG001|Open-Label Period|Withdrawal by Subject|53|||
128853639|NCT01085812|463759818|FG000|Open-Label Period|Lost to Follow-up|0|||
128853640|NCT01085812|463759819|FG001|Open-Label Period|Lost to Follow-up|42|||
128853641|NCT01085812|463759818|FG000|Double-Blind Period|Adverse Event|3|||
128853642|NCT01085812|463759819|FG001|Double-Blind Period|Adverse Event|8|||
128853643|NCT01085812|463759818|FG000|Double-Blind Period|Protocol Violation|2|||
128853644|NCT01085812|463759819|FG001|Double-Blind Period|Protocol Violation|7|||
128853645|NCT01085812|463759818|FG000|Double-Blind Period|Withdrawal by Subject|11|||
128853646|NCT01085812|463759819|FG001|Double-Blind Period|Withdrawal by Subject|24|||
128853647|NCT01085812|463759818|FG000|Double-Blind Period|Lost to Follow-up|5|||
128853648|NCT01085812|463759819|FG001|Double-Blind Period|Lost to Follow-up|17|||
128853649|NCT01085812|463759818|FG000|Double-Blind Period|Other Reasons|0|||
128853650|NCT01085812|463759819|FG001|Double-Blind Period|Other Reasons|2|||
128853651|NCT01085812|463759818|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
128853652|NCT01085812|463759819|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
128853653|NCT01085812|463759818|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
128853654|NCT01085812|463759819|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
128853655|NCT01085812|463759818|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
128853656|NCT01085812|463759819|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
128853657|NCT01085812|463759818|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
128853658|NCT01085812|463759819|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
128853659|NCT01085812|463759818|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
128853660|NCT01085812|463759819|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
128853661|NCT01172639|463759820|FG000|Overall Study|Death|1|||
128853662|NCT01172639|463759821|FG001|Overall Study|Death|1|||
128853663|NCT01172639|463759822|FG002|Overall Study|Death|0|||
128853664|NCT01172639|463759823|FG003|Overall Study|Death|0|||
128853665|NCT01172639|463759824|FG004|Overall Study|Death|0|||
128853666|NCT01172639|463759820|FG000|Overall Study|Lost to Follow-up|9|||
128853667|NCT01172639|463759821|FG001|Overall Study|Lost to Follow-up|7|||
128853668|NCT01172639|463759822|FG002|Overall Study|Lost to Follow-up|11|||
128853669|NCT01172639|463759823|FG003|Overall Study|Lost to Follow-up|6|||
128853670|NCT01172639|463759824|FG004|Overall Study|Lost to Follow-up|6|||
128853671|NCT01172639|463759820|FG000|Overall Study|Withdrawal by Subject|3|||
128853672|NCT01172639|463759821|FG001|Overall Study|Withdrawal by Subject|3|||
128853673|NCT01172639|463759822|FG002|Overall Study|Withdrawal by Subject|5|||
128853674|NCT01172639|463759823|FG003|Overall Study|Withdrawal by Subject|5|||
128853675|NCT01172639|463759824|FG004|Overall Study|Withdrawal by Subject|0|||
128853676|NCT00469456|463759825|FG000|Overall Study|Adverse Event|4|||
128853677|NCT00469456|463759826|FG001|Overall Study|Adverse Event|3|||
128853678|NCT00469456|463759825|FG000|Overall Study|Protocol Violation|1|||
128853679|NCT00469456|463759826|FG001|Overall Study|Protocol Violation|0|||
128853680|NCT00469456|463759825|FG000|Overall Study|Withdrawal by Subject|4|||
128853681|NCT00469456|463759826|FG001|Overall Study|Withdrawal by Subject|1|||
128853682|NCT02669407|463759829|FG000|Overall Study|Physician Decision|3|||
128853683|NCT02647788|463759833|FG000|Overall Study|Lost to Follow-up|13|||
128853684|NCT02647788|463759834|FG001|Overall Study|Lost to Follow-up|11|||
128853685|NCT02647788|463759833|FG000|Overall Study|Did not want opiate|0|||
128853686|NCT02647788|463759834|FG001|Overall Study|Did not want opiate|1|||
128853687|NCT02647788|463759833|FG000|Overall Study|Withdrawal by Subject|1|||
128853688|NCT02647788|463759834|FG001|Overall Study|Withdrawal by Subject|0|||
128853689|NCT02647788|463759833|FG000|Overall Study|Felt itchy with assigned medication|1|||
128853690|NCT02647788|463759834|FG001|Overall Study|Felt itchy with assigned medication|0|||
128853691|NCT02647788|463759833|FG000|Overall Study|Felt nauseous with assigned medication|1|||
128853692|NCT02647788|463759834|FG001|Overall Study|Felt nauseous with assigned medication|1|||
128853693|NCT00302159|463759840|FG000|Overall Study|pt declined before treatment started|1|||
128853694|NCT00302159|463759840|FG000|Overall Study|pt started Avastin|1|||
128853695|NCT03245619|463759841|FG000|Part A (Up to Day 22)|Physician Decision|4|||
128853696|NCT03245619|463759842|FG001|Part A (Up to Day 22)|Physician Decision|6|||
128853697|NCT03245619|463759843|FG002|Part A (Up to Day 22)|Physician Decision|6|||
128853698|NCT03245619|463759844|FG003|Part A (Up to Day 22)|Physician Decision|0|||
128853699|NCT03245619|463759845|FG004|Part A (Up to Day 22)|Physician Decision|0|||
128853700|NCT03245619|463759846|FG005|Part A (Up to Day 22)|Physician Decision|0|||
128853701|NCT03245619|463759847|FG006|Part A (Up to Day 22)|Physician Decision|0|||
128853702|NCT03245619|463759848|FG007|Part A (Up to Day 22)|Physician Decision|0|||
128853703|NCT03245619|463759849|FG008|Part A (Up to Day 22)|Physician Decision|0|||
128853704|NCT03245619|463759850|FG009|Part A (Up to Day 22)|Physician Decision|0|||
128853705|NCT03245619|463759851|FG010|Part A (Up to Day 22)|Physician Decision|0|||
128853706|NCT03245619|463759852|FG011|Part A (Up to Day 22)|Physician Decision|0|||
128853707|NCT03245619|463759853|FG012|Part A (Up to Day 22)|Physician Decision|0|||
128853708|NCT03245619|463759854|FG013|Part A (Up to Day 22)|Physician Decision|0|||
128853709|NCT03245619|463759855|FG014|Part A (Up to Day 22)|Physician Decision|0|||
128853710|NCT03245619|463759856|FG015|Part A (Up to Day 22)|Physician Decision|0|||
128853711|NCT03245619|463759857|FG016|Part A (Up to Day 22)|Physician Decision|0|||
128853712|NCT02835092|463759860|FG000|Overall Study|Withdrawal by Subject|3|||
128853713|NCT02835092|463759861|FG001|Overall Study|Withdrawal by Subject|6|||
128853714|NCT02835092|463759862|FG002|Overall Study|Withdrawal by Subject|3|||
128853715|NCT02835092|463759860|FG000|Overall Study|Lost to Follow-up|0|||
128853716|NCT02835092|463759861|FG001|Overall Study|Lost to Follow-up|2|||
128853717|NCT02835092|463759862|FG002|Overall Study|Lost to Follow-up|0|||
128853718|NCT01657877|463759864|FG000|Overall Study|Withdrawal by Subject|4|||
128853719|NCT01657877|463759864|FG000|Overall Study|Protocol Violation|6|||
128853720|NCT01657877|463759864|FG000|Overall Study|Adverse Event|2|||
128853721|NCT01657877|463759864|FG000|Overall Study|Other Reason|2|||
128853722|NCT01114672|463759866|FG000|Overall Study|Death|0|||
128853723|NCT01114672|463759867|FG001|Overall Study|Death|1|||
128853724|NCT01114672|463759866|FG000|Overall Study|Withdrawal by Subject|2|||
128853725|NCT01114672|463759867|FG001|Overall Study|Withdrawal by Subject|1|||
128853726|NCT01114672|463759866|FG000|Overall Study|Lost to Follow-up|1|||
128853727|NCT01114672|463759867|FG001|Overall Study|Lost to Follow-up|0|||
128853728|NCT01114672|463759866|FG000|Overall Study|transplanted|1|||
128853729|NCT01114672|463759867|FG001|Overall Study|transplanted|0|||
128853730|NCT02586415|463759872|FG000|Overall Study|Death|13|||
128853731|NCT02586415|463759873|FG001|Overall Study|Death|23|||
128853732|NCT02586415|463759872|FG000|Overall Study|Lost to Follow-up|1|||
128853733|NCT02586415|463759873|FG001|Overall Study|Lost to Follow-up|2|||
128853734|NCT02872311|463759874|FG000|Overall Study|Death|2|||
128853735|NCT02872311|463759875|FG001|Overall Study|Death|0|||
128853736|NCT02872311|463759876|FG002|Overall Study|Death|0|||
128853737|NCT02872311|463759877|FG003|Overall Study|Death|0|||
128853738|NCT02872311|463759878|FG004|Overall Study|Death|0|||
128853739|NCT02872311|463759874|FG000|Overall Study|Lost to Follow-up|2|||
128853740|NCT02872311|463759875|FG001|Overall Study|Lost to Follow-up|0|||
128853741|NCT02872311|463759876|FG002|Overall Study|Lost to Follow-up|0|||
128853742|NCT02872311|463759877|FG003|Overall Study|Lost to Follow-up|0|||
128853743|NCT02872311|463759878|FG004|Overall Study|Lost to Follow-up|0|||
128853744|NCT02872311|463759874|FG000|Overall Study|Protocol Violation|0|||
128853745|NCT02872311|463759875|FG001|Overall Study|Protocol Violation|2|||
128853746|NCT02872311|463759876|FG002|Overall Study|Protocol Violation|1|||
128853747|NCT02872311|463759877|FG003|Overall Study|Protocol Violation|0|||
128853748|NCT02872311|463759878|FG004|Overall Study|Protocol Violation|0|||
128853749|NCT04545476|463759879|FG000|Overall Study|Lost to Follow-up|1|||
128853750|NCT04545476|463759880|FG001|Overall Study|Lost to Follow-up|1|||
128853751|NCT04545476|463759881|FG002|Overall Study|Lost to Follow-up|0|||
128853752|NCT04545476|463759882|FG003|Overall Study|Lost to Follow-up|0|||
128853753|NCT00690378|463759883|FG000|Overall Study|Adverse Event|1|||
128853754|NCT00690378|463759884|FG001|Overall Study|Adverse Event|0|||
128853755|NCT00690378|463759883|FG000|Overall Study|Withdrawal by Subject|2|||
128853756|NCT00690378|463759884|FG001|Overall Study|Withdrawal by Subject|0|||
128853757|NCT00690378|463759883|FG000|Overall Study|Protocol Violation|1|||
128853758|NCT00690378|463759884|FG001|Overall Study|Protocol Violation|0|||
128853759|NCT00690378|463759883|FG000|Overall Study|Lost to Follow-up|2|||
128853760|NCT00690378|463759884|FG001|Overall Study|Lost to Follow-up|3|||
128853761|NCT00690378|463759883|FG000|Overall Study|Did not meet inc/exc criteria|13|||
128853762|NCT00690378|463759884|FG001|Overall Study|Did not meet inc/exc criteria|11|||
128853763|NCT00690378|463759883|FG000|Overall Study|Social problem|1|||
128853764|NCT00690378|463759884|FG001|Overall Study|Social problem|0|||
128853765|NCT02019641|463759885|FG000|10-Week Follow up|Withdrawal by investigator|2|||
128853766|NCT02019641|463759886|FG001|10-Week Follow up|Withdrawal by investigator|0|||
128853767|NCT02019641|463759887|FG002|10-Week Follow up|Withdrawal by investigator|0|||
128853768|NCT02019641|463759885|FG000|10-Week Follow up|Withdrawal by Subject|1|||
128853769|NCT02019641|463759886|FG001|10-Week Follow up|Withdrawal by Subject|1|||
128853770|NCT02019641|463759887|FG002|10-Week Follow up|Withdrawal by Subject|0|||
128853771|NCT02019641|463759885|FG000|20-Week Follow up|Withdrawal by investigator|0|||
128853772|NCT02019641|463759886|FG001|20-Week Follow up|Withdrawal by investigator|0|||
128853773|NCT02019641|463759887|FG002|20-Week Follow up|Withdrawal by investigator|1|||
128853774|NCT03318783|463759888|FG000|Overall Study|Withdrawal by Subject|0|||
128853775|NCT03318783|463759889|FG001|Overall Study|Withdrawal by Subject|1|||
128853776|NCT03318783|463759888|FG000|Overall Study|Death|0|||
128853777|NCT03318783|463759889|FG001|Overall Study|Death|1|||
128853778|NCT03410108|463759892|FG000|Overall Study|Ongoing|41|||
128853779|NCT03410108|463759892|FG000|Overall Study|Adverse Event|4|||
128853780|NCT03410108|463759892|FG000|Overall Study|Progressive Disease|58|||
128853781|NCT03410108|463759892|FG000|Overall Study|Withdrawal by Subject|1|||
128853782|NCT04035577|463759896|FG000|Overall Study|Lost to Follow-up|1|||
128853783|NCT04035577|463759896|FG000|Overall Study|Withdrawal by Subject|1|||
128853784|NCT03269695|463759897|FG000|Overall Study|Adverse Event|2|||
128853785|NCT03269695|463759898|FG001|Overall Study|Adverse Event|1|||
128853786|NCT03269695|463759897|FG000|Overall Study|Lack of Efficacy|0|||
128853787|NCT03269695|463759898|FG001|Overall Study|Lack of Efficacy|1|||
128853788|NCT03269695|463759897|FG000|Overall Study|Withdrawal by Subject|0|||
128853789|NCT03269695|463759898|FG001|Overall Study|Withdrawal by Subject|1|||
128853790|NCT01313624|463759900|FG000|Double-Blind Phase|Adverse Event|27|||
128853791|NCT01313624|463759901|FG001|Double-Blind Phase|Adverse Event|4|||
128853792|NCT01313624|463759900|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
128853793|NCT01313624|463759901|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
128853794|NCT01313624|463759900|FG000|Double-Blind Phase|Lost to Follow-up|0|||
128853795|NCT01313624|463759901|FG001|Double-Blind Phase|Lost to Follow-up|2|||
128853796|NCT01313624|463759900|FG000|Double-Blind Phase|Physician Decision|1|||
128853797|NCT01313624|463759901|FG001|Double-Blind Phase|Physician Decision|0|||
128853798|NCT01313624|463759900|FG000|Double-Blind Phase|Lack of Efficacy|1|||
128853799|NCT01313624|463759901|FG001|Double-Blind Phase|Lack of Efficacy|0|||
128853800|NCT01313624|463759900|FG000|Open-Label Phase|Adverse Event|1|||
128853801|NCT01313624|463759901|FG001|Open-Label Phase|Adverse Event|10|||
128853802|NCT01313624|463759900|FG000|Open-Label Phase|Withdrawal by Subject|2|||
128853803|NCT01313624|463759901|FG001|Open-Label Phase|Withdrawal by Subject|2|||
128853804|NCT01313624|463759900|FG000|Open-Label Phase|Lost to Follow-up|1|||
128853805|NCT01313624|463759901|FG001|Open-Label Phase|Lost to Follow-up|1|||
128853806|NCT00104637|463759902|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
128853807|NCT00104637|463759903|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
128853808|NCT00505414|463759904|FG000|Titration Phase|Adverse Event|0|||
128853809|NCT00505414|463759905|FG001|Titration Phase|Adverse Event|0|||
128853810|NCT00505414|463759906|FG002|Titration Phase|Adverse Event|0|||
128853811|NCT00505414|463759907|FG003|Titration Phase|Adverse Event|8|||
128853812|NCT00505414|463759908|FG004|Titration Phase|Adverse Event|3|||
128853813|NCT00505414|463759904|FG000|Titration Phase|Death|0|||
128853814|NCT00505414|463759905|FG001|Titration Phase|Death|0|||
128853815|NCT00505414|463759906|FG002|Titration Phase|Death|0|||
128853816|NCT00505414|463759907|FG003|Titration Phase|Death|2|||
128853817|NCT00505414|463759908|FG004|Titration Phase|Death|0|||
128853818|NCT00505414|463759904|FG000|Titration Phase|Lack of Efficacy|0|||
128853819|NCT00505414|463759905|FG001|Titration Phase|Lack of Efficacy|0|||
128853820|NCT00505414|463759906|FG002|Titration Phase|Lack of Efficacy|0|||
128853821|NCT00505414|463759907|FG003|Titration Phase|Lack of Efficacy|10|||
128853822|NCT00505414|463759908|FG004|Titration Phase|Lack of Efficacy|1|||
128853823|NCT00505414|463759904|FG000|Titration Phase|Protocol Violation|0|||
128853824|NCT00505414|463759905|FG001|Titration Phase|Protocol Violation|0|||
128853825|NCT00505414|463759906|FG002|Titration Phase|Protocol Violation|0|||
128853826|NCT00505414|463759907|FG003|Titration Phase|Protocol Violation|0|||
128853827|NCT00505414|463759908|FG004|Titration Phase|Protocol Violation|1|||
128853828|NCT00505414|463759904|FG000|Titration Phase|Withdrawal by Subject|0|||
128853829|NCT00505414|463759905|FG001|Titration Phase|Withdrawal by Subject|0|||
128853830|NCT00505414|463759906|FG002|Titration Phase|Withdrawal by Subject|0|||
128853831|NCT00505414|463759907|FG003|Titration Phase|Withdrawal by Subject|3|||
128853832|NCT00505414|463759908|FG004|Titration Phase|Withdrawal by Subject|4|||
128853833|NCT00505414|463759904|FG000|Titration Phase|Underlying disease and therapy required|0|||
128853834|NCT00505414|463759905|FG001|Titration Phase|Underlying disease and therapy required|0|||
128853835|NCT00505414|463759906|FG002|Titration Phase|Underlying disease and therapy required|0|||
128853836|NCT00505414|463759907|FG003|Titration Phase|Underlying disease and therapy required|7|||
128853837|NCT00505414|463759908|FG004|Titration Phase|Underlying disease and therapy required|3|||
128853838|NCT00505414|463759904|FG000|Maintenance Phase|Adverse Event|2|||
128853839|NCT00505414|463759905|FG001|Maintenance Phase|Adverse Event|2|||
128853840|NCT00505414|463759906|FG002|Maintenance Phase|Adverse Event|3|||
128853841|NCT00505414|463759907|FG003|Maintenance Phase|Adverse Event|0|||
128853842|NCT00505414|463759908|FG004|Maintenance Phase|Adverse Event|0|||
128853843|NCT00505414|463759904|FG000|Maintenance Phase|Death|2|||
128853844|NCT00505414|463759905|FG001|Maintenance Phase|Death|0|||
128853845|NCT00505414|463759906|FG002|Maintenance Phase|Death|1|||
128853846|NCT00505414|463759907|FG003|Maintenance Phase|Death|0|||
128853847|NCT00505414|463759908|FG004|Maintenance Phase|Death|0|||
128853848|NCT00505414|463759904|FG000|Maintenance Phase|Lack of Efficacy|2|||
128853849|NCT00505414|463759905|FG001|Maintenance Phase|Lack of Efficacy|1|||
128853850|NCT00505414|463759906|FG002|Maintenance Phase|Lack of Efficacy|1|||
128853851|NCT00505414|463759907|FG003|Maintenance Phase|Lack of Efficacy|0|||
128853852|NCT00505414|463759908|FG004|Maintenance Phase|Lack of Efficacy|0|||
128853853|NCT00505414|463759904|FG000|Maintenance Phase|Withdrawal by Subject|0|||
128853854|NCT00505414|463759905|FG001|Maintenance Phase|Withdrawal by Subject|0|||
128853855|NCT00505414|463759906|FG002|Maintenance Phase|Withdrawal by Subject|1|||
128853856|NCT00505414|463759907|FG003|Maintenance Phase|Withdrawal by Subject|0|||
128853857|NCT00505414|463759908|FG004|Maintenance Phase|Withdrawal by Subject|0|||
128853858|NCT00505414|463759904|FG000|Maintenance Phase|underlying disease and therapy required|0|||
128853859|NCT00505414|463759905|FG001|Maintenance Phase|underlying disease and therapy required|2|||
128853860|NCT00505414|463759906|FG002|Maintenance Phase|underlying disease and therapy required|2|||
128853861|NCT00505414|463759907|FG003|Maintenance Phase|underlying disease and therapy required|0|||
128853862|NCT00505414|463759908|FG004|Maintenance Phase|underlying disease and therapy required|0|||
128853863|NCT00846768|463759909|FG000|Overall Study|Adverse Event|0|||
128853864|NCT00846768|463759910|FG001|Overall Study|Adverse Event|1|||
128853865|NCT00846768|463759911|FG002|Overall Study|Adverse Event|0|||
128853866|NCT00846768|463759912|FG003|Overall Study|Adverse Event|0|||
128853867|NCT00644878|463759913|FG000|Overall Study|Adverse Event|2|||
128853868|NCT00644878|463759913|FG000|Overall Study|Abnormal laboratory value|3|||
128853869|NCT00644878|463759913|FG000|Overall Study|Protocol deviation|2|||
128853870|NCT00644878|463759913|FG000|Overall Study|Treatment duration completed as per protocol|11|||
128853871|NCT00591591|463759918|FG000|Overall Study|Withdrawal by Subject|1|||
128853872|NCT00591591|463759919|FG001|Overall Study|Withdrawal by Subject|37|||
128853873|NCT00591591|463759918|FG000|Overall Study|Lack of Efficacy|10|||
128853874|NCT00591591|463759919|FG001|Overall Study|Lack of Efficacy|2|||
128853875|NCT01841112|463759923|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
128853876|NCT01841112|463759924|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
128853877|NCT01841112|463759925|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
128853878|NCT01841112|463759926|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
128853879|NCT01841112|463759927|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
128853880|NCT00878553|463759928|FG000|Sleep Study|Withdrawal by Subject|2|||
128853881|NCT00878553|463759929|FG001|Sleep Study|Withdrawal by Subject|0|||
128853882|NCT00878553|463759930|FG002|Sleep Study|Withdrawal by Subject|0|||
128853883|NCT00878553|463759931|FG003|Sleep Study|Withdrawal by Subject|0|||
128853884|NCT00878553|463759932|FG004|Sleep Study|Withdrawal by Subject|0|||
128853885|NCT00878553|463759928|FG000|Sleep Study|Lost to Follow-up|1|||
128853886|NCT00878553|463759929|FG001|Sleep Study|Lost to Follow-up|0|||
128853887|NCT00878553|463759930|FG002|Sleep Study|Lost to Follow-up|0|||
128853888|NCT00878553|463759931|FG003|Sleep Study|Lost to Follow-up|0|||
128853889|NCT00878553|463759932|FG004|Sleep Study|Lost to Follow-up|0|||
128853890|NCT00878553|463759928|FG000|Sleep Study|car accident|1|||
128853891|NCT00878553|463759929|FG001|Sleep Study|car accident|0|||
128853892|NCT00878553|463759930|FG002|Sleep Study|car accident|0|||
128853893|NCT00878553|463759931|FG003|Sleep Study|car accident|0|||
128853894|NCT00878553|463759932|FG004|Sleep Study|car accident|0|||
128853895|NCT00878553|463759928|FG000|Sleep Study|family emergency|1|||
128853896|NCT00878553|463759929|FG001|Sleep Study|family emergency|0|||
128853897|NCT00878553|463759930|FG002|Sleep Study|family emergency|0|||
128853898|NCT00878553|463759931|FG003|Sleep Study|family emergency|0|||
128853899|NCT00878553|463759932|FG004|Sleep Study|family emergency|0|||
128853900|NCT00878553|463759928|FG000|PK Study|Withdrawal by Subject|0|||
128853901|NCT00878553|463759929|FG001|PK Study|Withdrawal by Subject|0|||
128853902|NCT00878553|463759930|FG002|PK Study|Withdrawal by Subject|0|||
128853903|NCT00878553|463759931|FG003|PK Study|Withdrawal by Subject|1|||
128853904|NCT00878553|463759932|FG004|PK Study|Withdrawal by Subject|0|||
128853905|NCT00912223|463759933|FG000|Overall Study|Withdrawal by Subject|1|||
128853906|NCT00912223|463759933|FG000|Overall Study|Not transplanted|1|||
128853907|NCT00912223|463759933|FG000|Overall Study|Transformed disease|1|||
128853908|NCT00461123|463759934|FG000|Overall Study|Adverse Event|1|||
128853909|NCT00461123|463759935|FG001|Overall Study|Adverse Event|0|||
128853910|NCT00461123|463759934|FG000|Overall Study|Lost to Follow-up|1|||
128853911|NCT00461123|463759935|FG001|Overall Study|Lost to Follow-up|1|||
128853912|NCT00461123|463759934|FG000|Overall Study|Protocol Violation|3|||
128853913|NCT00461123|463759935|FG001|Overall Study|Protocol Violation|2|||
128853914|NCT00461123|463759934|FG000|Overall Study|Withdrawal by Subject|1|||
128853915|NCT00461123|463759935|FG001|Overall Study|Withdrawal by Subject|3|||
128853916|NCT00927901|463759936|FG000|Treatment Period 1|Subject withdrew consent|0|||
128853917|NCT00927901|463759937|FG001|Treatment Period 1|Subject withdrew consent|0|||
128853918|NCT00927901|463759938|FG002|Treatment Period 1|Subject withdrew consent|1|||
128853919|NCT00927901|463759939|FG003|Treatment Period 1|Subject withdrew consent|0|||
128853920|NCT00927901|463759936|FG000|Treatment Period 4|Adverse Event|0|||
128853921|NCT00927901|463759937|FG001|Treatment Period 4|Adverse Event|0|||
128853922|NCT00927901|463759938|FG002|Treatment Period 4|Adverse Event|0|||
128853923|NCT00927901|463759939|FG003|Treatment Period 4|Adverse Event|1|||
128853924|NCT00927901|463759936|FG000|Treatment Period 4|Subject withdrew consent|0|||
128853925|NCT00927901|463759937|FG001|Treatment Period 4|Subject withdrew consent|0|||
128853926|NCT00927901|463759938|FG002|Treatment Period 4|Subject withdrew consent|1|||
128853927|NCT00927901|463759939|FG003|Treatment Period 4|Subject withdrew consent|0|||
128853928|NCT03029819|463759940|FG000|Overall Study|Lost to Follow-up|3|||
128853929|NCT03029819|463759941|FG001|Overall Study|Lost to Follow-up|5|||
128853930|NCT03029819|463759940|FG000|Overall Study|Removed due to disruptive behavior|0|||
128853931|NCT03029819|463759941|FG001|Overall Study|Removed due to disruptive behavior|1|||
128853932|NCT03605368|463759944|FG000|Overall Study|Lost to Follow-up|2|||
128853933|NCT03605368|463759945|FG001|Overall Study|Lost to Follow-up|1|||
128853934|NCT03605368|463759946|FG002|Overall Study|Lost to Follow-up|3|||
128853935|NCT03605368|463759947|FG003|Overall Study|Lost to Follow-up|2|||
128853936|NCT03605368|463759944|FG000|Overall Study|Withdrawal by Subject|0|||
128853937|NCT03605368|463759945|FG001|Overall Study|Withdrawal by Subject|0|||
128853938|NCT03605368|463759946|FG002|Overall Study|Withdrawal by Subject|4|||
128853939|NCT03605368|463759947|FG003|Overall Study|Withdrawal by Subject|3|||
128853940|NCT02650466|463759949|FG000|Overall Study|Physician Decision|1|||
128853941|NCT02650466|463759949|FG000|Overall Study|Withdrawal by Subject|5|||
128853942|NCT02650466|463759949|FG000|Overall Study|Lost to Follow-up|1|||
128853943|NCT01837797|463759950|FG000|Period 1|Adverse Event|9|||
128853944|NCT01837797|463759951|FG001|Period 1|Adverse Event|0|||
128853945|NCT01837797|463759952|FG002|Period 1|Adverse Event|0|||
128853946|NCT01837797|463759953|FG003|Period 1|Adverse Event|0|||
128853947|NCT01837797|463759954|FG004|Period 1|Adverse Event|0|||
128853948|NCT01837797|463759950|FG000|Period 1|Withdrawal by Subject|6|||
128853949|NCT01837797|463759951|FG001|Period 1|Withdrawal by Subject|0|||
128853950|NCT01837797|463759952|FG002|Period 1|Withdrawal by Subject|0|||
128853951|NCT01837797|463759953|FG003|Period 1|Withdrawal by Subject|0|||
128853952|NCT01837797|463759954|FG004|Period 1|Withdrawal by Subject|0|||
128853953|NCT01837797|463759950|FG000|Period 1|Administrative reasons|76|||
128853954|NCT01837797|463759951|FG001|Period 1|Administrative reasons|0|||
128853955|NCT01837797|463759952|FG002|Period 1|Administrative reasons|0|||
128853956|NCT01837797|463759953|FG003|Period 1|Administrative reasons|0|||
128853957|NCT01837797|463759954|FG004|Period 1|Administrative reasons|0|||
128853958|NCT01837797|463759950|FG000|Period 1|Withdrawal of consent before treatment|1|||
128853959|NCT01837797|463759951|FG001|Period 1|Withdrawal of consent before treatment|0|||
128853960|NCT01837797|463759952|FG002|Period 1|Withdrawal of consent before treatment|0|||
128853961|NCT01837797|463759953|FG003|Period 1|Withdrawal of consent before treatment|0|||
128853962|NCT01837797|463759954|FG004|Period 1|Withdrawal of consent before treatment|0|||
128853963|NCT01837797|463759950|FG000|Period 1|Other|10|||
128853964|NCT01837797|463759951|FG001|Period 1|Other|0|||
128853965|NCT01837797|463759952|FG002|Period 1|Other|0|||
128853966|NCT01837797|463759953|FG003|Period 1|Other|0|||
128853967|NCT01837797|463759954|FG004|Period 1|Other|0|||
128853968|NCT01837797|463759950|FG000|Period 2|Administrative or other reasons|0|||
128853969|NCT01837797|463759951|FG001|Period 2|Administrative or other reasons|5|||
128853970|NCT01837797|463759952|FG002|Period 2|Administrative or other reasons|2|||
128853971|NCT01837797|463759953|FG003|Period 2|Administrative or other reasons|4|||
128853972|NCT01837797|463759954|FG004|Period 2|Administrative or other reasons|0|||
128853973|NCT01837797|463759950|FG000|Period 2|Adverse Event|0|||
128853974|NCT01837797|463759951|FG001|Period 2|Adverse Event|0|||
128853975|NCT01837797|463759952|FG002|Period 2|Adverse Event|0|||
128853976|NCT01837797|463759953|FG003|Period 2|Adverse Event|1|||
128853977|NCT01837797|463759954|FG004|Period 2|Adverse Event|0|||
128853978|NCT01837797|463759950|FG000|Period 3|Adverse Event|0|||
128853979|NCT01837797|463759951|FG001|Period 3|Adverse Event|0|||
128853980|NCT01837797|463759952|FG002|Period 3|Adverse Event|0|||
128853981|NCT01837797|463759953|FG003|Period 3|Adverse Event|0|||
128853982|NCT01837797|463759954|FG004|Period 3|Adverse Event|1|||
128853983|NCT01837797|463759950|FG000|Period 3|Administrative reasons|0|||
128853984|NCT01837797|463759951|FG001|Period 3|Administrative reasons|0|||
128853985|NCT01837797|463759952|FG002|Period 3|Administrative reasons|0|||
128853986|NCT01837797|463759953|FG003|Period 3|Administrative reasons|0|||
128853987|NCT01837797|463759954|FG004|Period 3|Administrative reasons|20|||
128853988|NCT01837797|463759950|FG000|Period 3|Other|0|||
128853989|NCT01837797|463759951|FG001|Period 3|Other|0|||
128853990|NCT01837797|463759952|FG002|Period 3|Other|0|||
128853991|NCT01837797|463759953|FG003|Period 3|Other|0|||
128853992|NCT01837797|463759954|FG004|Period 3|Other|2|||
128853993|NCT04088136|463759956|FG000|Overall Study|Withdrawal by Subject|5|||
128853994|NCT04088136|463759957|FG001|Overall Study|Withdrawal by Subject|0|||
128853995|NCT04088136|463759956|FG000|Overall Study|Lack of Efficacy|0|||
128853996|NCT04088136|463759957|FG001|Overall Study|Lack of Efficacy|1|||
128853997|NCT01075100|463759958|FG000|Overall Study|Adverse Event|15|||
128853998|NCT01075100|463759959|FG001|Overall Study|Adverse Event|18|||
128853999|NCT01075100|463759958|FG000|Overall Study|Patient Request|4|||
128854000|NCT01075100|463759959|FG001|Overall Study|Patient Request|4|||
128854001|NCT01075100|463759958|FG000|Overall Study|Investigator Request|2|||
128854002|NCT01075100|463759959|FG001|Overall Study|Investigator Request|1|||
128854003|NCT01075100|463759958|FG000|Overall Study|Disease Progression|25|||
128854004|NCT01075100|463759959|FG001|Overall Study|Disease Progression|29|||
128854005|NCT01075100|463759958|FG000|Overall Study|Other|3|||
128854006|NCT01075100|463759959|FG001|Overall Study|Other|1|||
128854007|NCT02250183|463759960|FG000|Overall Study|Withdrawal by Subject|2|||
128854008|NCT02250183|463759960|FG000|Overall Study|Adverse Event|5|||
128854009|NCT02250183|463759960|FG000|Overall Study|Lost to Follow-up|1|||
128854010|NCT05896696|463759961|FG000|Overall Study|Screening Failure|7|||
128854011|NCT05896696|463759961|FG000|Overall Study|Withdrawal by Subject|2|||
128854012|NCT01878383|463762108|FG000|Overall Study|Lost to Follow-up|0|||
128854013|NCT01878383|463762109|FG001|Overall Study|Lost to Follow-up|1499|||
128854014|NCT03475056|463762110|FG000|Overall Study|Lost to Follow-up|0|||
128854015|NCT03475056|463762111|FG001|Overall Study|Lost to Follow-up|1|||
128854016|NCT03475056|463762110|FG000|Overall Study|Moved from Area|0|||
128854017|NCT03475056|463762111|FG001|Overall Study|Moved from Area|2|||
128854018|NCT01932762|463762114|FG000|Overall Study|Withdrawal by Subject|1|||
128854019|NCT01932762|463762115|FG001|Overall Study|Withdrawal by Subject|2|||
128854020|NCT01932762|463762116|FG002|Overall Study|Withdrawal by Subject|0|||
128854021|NCT01932762|463762117|FG003|Overall Study|Withdrawal by Subject|0|||
128854022|NCT01932762|463762114|FG000|Overall Study|Lost to Follow-up|4|||
128854023|NCT01932762|463762115|FG001|Overall Study|Lost to Follow-up|0|||
128854024|NCT01932762|463762116|FG002|Overall Study|Lost to Follow-up|0|||
128854025|NCT01932762|463762117|FG003|Overall Study|Lost to Follow-up|1|||
128854026|NCT01932762|463762114|FG000|Overall Study|Physician Decision|1|||
128854027|NCT01932762|463762115|FG001|Overall Study|Physician Decision|0|||
128854028|NCT01932762|463762116|FG002|Overall Study|Physician Decision|0|||
128854029|NCT01932762|463762117|FG003|Overall Study|Physician Decision|0|||
128854030|NCT02080403|463762120|FG000|Overall Study|Adverse Event|5|||
128854031|NCT02080403|463762121|FG001|Overall Study|Adverse Event|1|||
128854032|NCT02080403|463762120|FG000|Overall Study|Death|0|||
128854033|NCT02080403|463762121|FG001|Overall Study|Death|2|||
128854034|NCT02080403|463762120|FG000|Overall Study|Lost to Follow-up|2|||
128854035|NCT02080403|463762121|FG001|Overall Study|Lost to Follow-up|0|||
128854036|NCT02080403|463762120|FG000|Overall Study|Pregnancy|0|||
128854037|NCT02080403|463762121|FG001|Overall Study|Pregnancy|1|||
128854038|NCT02080403|463762120|FG000|Overall Study|Protocol Violation|3|||
128854039|NCT02080403|463762121|FG001|Overall Study|Protocol Violation|7|||
128854040|NCT02080403|463762120|FG000|Overall Study|Withdrawal by Subject|5|||
128854041|NCT02080403|463762121|FG001|Overall Study|Withdrawal by Subject|1|||
128854042|NCT01101334|463762122|FG000|Overall Study|Adverse Event|9|||
128854043|NCT01101334|463762123|FG001|Overall Study|Adverse Event|4|||
128854044|NCT01101334|463762122|FG000|Overall Study|Death|7|||
128854045|NCT01101334|463762123|FG001|Overall Study|Death|1|||
128854046|NCT01101334|463762122|FG000|Overall Study|Withdrawal by Subject|4|||
128854047|NCT01101334|463762123|FG001|Overall Study|Withdrawal by Subject|3|||
128854048|NCT01101334|463762122|FG000|Overall Study|Withdrawal by Sponsor|1|||
128854049|NCT01101334|463762123|FG001|Overall Study|Withdrawal by Sponsor|1|||
128854050|NCT01101334|463762122|FG000|Overall Study|Progressive Disease|22|||
128854051|NCT01101334|463762123|FG001|Overall Study|Progressive Disease|35|||
128854052|NCT01101334|463762122|FG000|Overall Study|Other|2|||
128854053|NCT01101334|463762123|FG001|Overall Study|Other|1|||
128854054|NCT03864341|463762126|FG000|Overall Study|Withdrawal by Subject|1|||
128854055|NCT02826798|463762128|FG000|Overall Study|Withdrawal by Subject|0|||
128854056|NCT02826798|463762129|FG001|Overall Study|Withdrawal by Subject|1|||
128854057|NCT02826798|463762130|FG002|Overall Study|Withdrawal by Subject|0|||
128854058|NCT02826798|463762131|FG003|Overall Study|Withdrawal by Subject|1|||
128854059|NCT02826798|463762132|FG004|Overall Study|Withdrawal by Subject|0|||
128854060|NCT00664105|463762135|FG000|Overall Study|Death|3|||
128854061|NCT00664105|463762135|FG000|Overall Study|Withdrawal by Subject|5|||
128854062|NCT00664105|463762135|FG000|Overall Study|Adverse Event|9|||
128854063|NCT00664105|463762135|FG000|Overall Study|Disease progression|7|||
128854064|NCT00263211|463762136|FG000|Overall Study|Death|1|||
128854065|NCT00263211|463762137|FG001|Overall Study|Death|0|||
128854066|NCT00263211|463762136|FG000|Overall Study|Withdrawal by Subject|3|||
128854067|NCT00263211|463762137|FG001|Overall Study|Withdrawal by Subject|0|||
128854068|NCT00263211|463762136|FG000|Overall Study|Protocol Violation|1|||
128854069|NCT00263211|463762137|FG001|Overall Study|Protocol Violation|0|||
128854070|NCT00263211|463762136|FG000|Overall Study|Disease Progression|0|||
128854071|NCT00263211|463762137|FG001|Overall Study|Disease Progression|1|||
128854072|NCT02034162|463762138|FG000|Double-blind|Lost to Follow-up|3|||
128854073|NCT02034162|463762139|FG001|Double-blind|Lost to Follow-up|0|||
128854074|NCT02034162|463762140|FG002|Double-blind|Lost to Follow-up|0|||
128854075|NCT02034162|463762138|FG000|Double-blind|Physician Decision|1|||
128854076|NCT02034162|463762139|FG001|Double-blind|Physician Decision|0|||
128854077|NCT02034162|463762140|FG002|Double-blind|Physician Decision|0|||
128854078|NCT02034162|463762138|FG000|Double-blind|Protocol Violation|0|||
128854079|NCT02034162|463762139|FG001|Double-blind|Protocol Violation|1|||
128854080|NCT02034162|463762140|FG002|Double-blind|Protocol Violation|0|||
128854081|NCT02034162|463762138|FG000|Double-blind|Withdrawal by Subject|5|||
128854082|NCT02034162|463762139|FG001|Double-blind|Withdrawal by Subject|7|||
128854083|NCT02034162|463762140|FG002|Double-blind|Withdrawal by Subject|0|||
128854084|NCT00760513|463762141|FG000|Overall Study|Withdrawal by Subject|5|||
128854085|NCT00760513|463762142|FG001|Overall Study|Withdrawal by Subject|7|||
128854086|NCT01468077|463762147|FG000|Overall Study|Adverse Event|2|||
128854087|NCT01468077|463762148|FG001|Overall Study|Adverse Event|2|||
128854088|NCT01468077|463762147|FG000|Overall Study|Lack of Efficacy|1|||
128854089|NCT01468077|463762148|FG001|Overall Study|Lack of Efficacy|1|||
128854090|NCT01468077|463762147|FG000|Overall Study|Physician Decision|1|||
128854091|NCT01468077|463762148|FG001|Overall Study|Physician Decision|0|||
128854092|NCT00761956|463762149|FG000|Overall Study|Lost to Follow-up|6|||
128854093|NCT00761956|463762150|FG001|Overall Study|Lost to Follow-up|11|||
128854094|NCT00761956|463762149|FG000|Overall Study|Withdrawal by Subject|3|||
128854095|NCT00761956|463762150|FG001|Overall Study|Withdrawal by Subject|8|||
128854096|NCT00761956|463762149|FG000|Overall Study|Death|0|||
128854097|NCT00761956|463762150|FG001|Overall Study|Death|1|||
128854098|NCT00761956|463762149|FG000|Overall Study|Adverse Event|26|||
128854099|NCT00761956|463762150|FG001|Overall Study|Adverse Event|34|||
128854100|NCT03024996|463762151|FG000|Overall Study|Death|57|||
128854101|NCT03024996|463762152|FG001|Overall Study|Death|55|||
128854102|NCT03024996|463762151|FG000|Overall Study|Disease relapse|1|||
128854103|NCT03024996|463762152|FG001|Overall Study|Disease relapse|0|||
128854104|NCT03024996|463762151|FG000|Overall Study|Lost to Follow-up|5|||
128854105|NCT03024996|463762152|FG001|Overall Study|Lost to Follow-up|10|||
128854106|NCT03024996|463762151|FG000|Overall Study|Other|3|||
128854107|NCT03024996|463762152|FG001|Overall Study|Other|3|||
128854108|NCT03024996|463762151|FG000|Overall Study|Physician Decision|0|||
128854109|NCT03024996|463762152|FG001|Overall Study|Physician Decision|1|||
128854110|NCT03024996|463762151|FG000|Overall Study|Study terminated by sponsor|303|||
128854111|NCT03024996|463762152|FG001|Overall Study|Study terminated by sponsor|283|||
128854112|NCT03024996|463762151|FG000|Overall Study|Withdrawal by Subject|21|||
128854113|NCT03024996|463762152|FG001|Overall Study|Withdrawal by Subject|36|||
128854114|NCT01951378|463762156|FG000|Overall Study|Study Terminated-Not completed|23|||
128854115|NCT01951378|463762157|FG001|Overall Study|Study Terminated-Not completed|17|||
128854116|NCT00464945|463762158|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
128854117|NCT00464945|463762159|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
128854118|NCT00464945|463762158|FG000|Infant Series|Protocol Violation|1|||
128854119|NCT00464945|463762159|FG001|Infant Series|Protocol Violation|0|||
128854120|NCT00464945|463762158|FG000|Infant Series|Lost to Follow-up|1|||
128854121|NCT00464945|463762159|FG001|Infant Series|Lost to Follow-up|0|||
128854122|NCT00464945|463762158|FG000|After Infant Series|Withdrawal by Subject|0|||
128854123|NCT00464945|463762159|FG001|After Infant Series|Withdrawal by Subject|2|||
128854124|NCT00464945|463762158|FG000|Toddler Dose|Lost to Follow-up|0|||
128854125|NCT00464945|463762159|FG001|Toddler Dose|Lost to Follow-up|1|||
128854126|NCT03065933|463762162|FG000|Overall Study|study terminated|5|||
128854127|NCT02536742|463762163|FG000|Overall Study|Did not start protocol therapy|1|||
128854128|NCT02536742|463762163|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
128854129|NCT04629443|463762164|FG000|Overall Study|Adverse Event|2|||
128854130|NCT04629443|463762165|FG001|Overall Study|Adverse Event|1|||
128854131|NCT04629443|463762166|FG002|Overall Study|Adverse Event|2|||
128854132|NCT04629443|463762164|FG000|Overall Study|Progressive Disease|2|||
128854133|NCT04629443|463762165|FG001|Overall Study|Progressive Disease|3|||
128854134|NCT04629443|463762166|FG002|Overall Study|Progressive Disease|3|||
128854135|NCT04629443|463762164|FG000|Overall Study|Physician Decision|1|||
128854136|NCT04629443|463762165|FG001|Overall Study|Physician Decision|3|||
128854137|NCT04629443|463762166|FG002|Overall Study|Physician Decision|0|||
128854138|NCT01547117|463762168|FG000|Overall Study|Physician Decision|0|||
128854139|NCT01547117|463762169|FG001|Overall Study|Physician Decision|1|||
128854140|NCT01547117|463762170|FG002|Overall Study|Physician Decision|1|||
128854141|NCT01547117|463762171|FG003|Overall Study|Physician Decision|3|||
128854142|NCT01547117|463762168|FG000|Overall Study|Withdrawal by Subject|1|||
128854143|NCT01547117|463762169|FG001|Overall Study|Withdrawal by Subject|2|||
128854144|NCT01547117|463762170|FG002|Overall Study|Withdrawal by Subject|1|||
128854145|NCT01547117|463762171|FG003|Overall Study|Withdrawal by Subject|2|||
128854146|NCT03491215|463762174|FG000|Overall Study|Death|6|||
128854147|NCT03491215|463762175|FG001|Overall Study|Death|2|||
128854148|NCT03491215|463762176|FG002|Overall Study|Death|1|||
128854149|NCT03491215|463762177|FG003|Overall Study|Death|0|||
128854150|NCT03491215|463762174|FG000|Overall Study|Physician Decision|1|||
128854151|NCT03491215|463762175|FG001|Overall Study|Physician Decision|0|||
128854152|NCT03491215|463762176|FG002|Overall Study|Physician Decision|0|||
128854153|NCT03491215|463762177|FG003|Overall Study|Physician Decision|0|||
128854154|NCT01588366|463762184|FG000|Overall Study|Adverse Event|0|||
128854155|NCT01588366|463762185|FG001|Overall Study|Adverse Event|1|||
128854156|NCT01588366|463762186|FG002|Overall Study|Adverse Event|0|||
128854157|NCT01588366|463762187|FG003|Overall Study|Adverse Event|1|||
128854158|NCT01588366|463762188|FG004|Overall Study|Adverse Event|0|||
128854159|NCT01588366|463762189|FG005|Overall Study|Adverse Event|2|||
128854160|NCT00719043|463762190|FG000|Overall Study|Adverse Event|5|||
128854161|NCT00719043|463762191|FG001|Overall Study|Adverse Event|1|||
128854162|NCT00719043|463762192|FG002|Overall Study|Adverse Event|2|||
128854163|NCT00719043|463762193|FG003|Overall Study|Adverse Event|2|||
128854164|NCT00719043|463762194|FG004|Overall Study|Adverse Event|1|||
128854165|NCT00719043|463762195|FG005|Overall Study|Adverse Event|4|||
128854166|NCT00719043|463762196|FG006|Overall Study|Adverse Event|4|||
128854167|NCT00719043|463762190|FG000|Overall Study|Lost to Follow-up|14|||
128854168|NCT00719043|463762191|FG001|Overall Study|Lost to Follow-up|10|||
128854169|NCT00719043|463762192|FG002|Overall Study|Lost to Follow-up|8|||
128854170|NCT00719043|463762193|FG003|Overall Study|Lost to Follow-up|9|||
128854171|NCT00719043|463762194|FG004|Overall Study|Lost to Follow-up|10|||
128854172|NCT00719043|463762195|FG005|Overall Study|Lost to Follow-up|9|||
128854173|NCT00719043|463762196|FG006|Overall Study|Lost to Follow-up|9|||
128854174|NCT00719043|463762190|FG000|Overall Study|Protocol Violation|0|||
128854175|NCT00719043|463762191|FG001|Overall Study|Protocol Violation|0|||
128854176|NCT00719043|463762192|FG002|Overall Study|Protocol Violation|0|||
128854177|NCT00719043|463762193|FG003|Overall Study|Protocol Violation|0|||
128854178|NCT00719043|463762194|FG004|Overall Study|Protocol Violation|0|||
128854179|NCT00719043|463762195|FG005|Overall Study|Protocol Violation|1|||
128854180|NCT00719043|463762196|FG006|Overall Study|Protocol Violation|0|||
128854181|NCT00719043|463762190|FG000|Overall Study|Other|1|||
128854182|NCT00719043|463762191|FG001|Overall Study|Other|0|||
128854183|NCT00719043|463762192|FG002|Overall Study|Other|1|||
128854184|NCT00719043|463762193|FG003|Overall Study|Other|2|||
128854185|NCT00719043|463762194|FG004|Overall Study|Other|0|||
128854186|NCT00719043|463762195|FG005|Overall Study|Other|2|||
128854187|NCT00719043|463762196|FG006|Overall Study|Other|1|||
128854188|NCT00719043|463762190|FG000|Overall Study|Withdrawal by Subject|12|||
128854189|NCT00719043|463762191|FG001|Overall Study|Withdrawal by Subject|14|||
128854190|NCT00719043|463762192|FG002|Overall Study|Withdrawal by Subject|9|||
128854191|NCT00719043|463762193|FG003|Overall Study|Withdrawal by Subject|10|||
128854192|NCT00719043|463762194|FG004|Overall Study|Withdrawal by Subject|16|||
128854193|NCT00719043|463762195|FG005|Overall Study|Withdrawal by Subject|18|||
128854194|NCT00719043|463762196|FG006|Overall Study|Withdrawal by Subject|14|||
128854195|NCT01336205|463762197|FG000|Overall Study|Other|22|||
128854196|NCT01336205|463762198|FG001|Overall Study|Other|9|||
128854197|NCT01336205|463762197|FG000|Overall Study|Lost to Follow-up|40|||
128854198|NCT01336205|463762198|FG001|Overall Study|Lost to Follow-up|20|||
128854199|NCT01336205|463762197|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
128854200|NCT01336205|463762198|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
128854201|NCT01336205|463762197|FG000|Overall Study|Lack of Efficacy|4|||
128854202|NCT01336205|463762198|FG001|Overall Study|Lack of Efficacy|0|||
128854203|NCT01336205|463762197|FG000|Overall Study|Severe noncompliance with protocol|9|||
128854204|NCT01336205|463762198|FG001|Overall Study|Severe noncompliance with protocol|2|||
128854205|NCT01336205|463762197|FG000|Overall Study|Adverse Event|56|||
128854206|NCT01336205|463762198|FG001|Overall Study|Adverse Event|6|||
128854207|NCT01336205|463762197|FG000|Overall Study|Death|1|||
128854208|NCT01336205|463762198|FG001|Overall Study|Death|1|||
128854209|NCT01336205|463762197|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
128854210|NCT01336205|463762198|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
128854211|NCT01336205|463762197|FG000|Overall Study|Withdrawal by Subject|72|||
128854212|NCT01336205|463762198|FG001|Overall Study|Withdrawal by Subject|38|||
128854213|NCT01336205|463762197|FG000|Overall Study|Did not receive treatment|4|||
128854214|NCT01336205|463762198|FG001|Overall Study|Did not receive treatment|0|||
128854215|NCT01006616|463762199|FG000|Period 1 (6 Months)|Adverse Event|10|||
128854216|NCT01006616|463762200|FG001|Period 1 (6 Months)|Adverse Event|31|||
128854217|NCT01006616|463762201|FG002|Period 1 (6 Months)|Adverse Event|37|||
128854218|NCT01006616|463762202|FG003|Period 1 (6 Months)|Adverse Event|9|||
128854219|NCT01006616|463762199|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
128854220|NCT01006616|463762200|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
128854221|NCT01006616|463762201|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
128854222|NCT01006616|463762202|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
128854223|NCT01006616|463762199|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
128854224|NCT01006616|463762200|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
128854225|NCT01006616|463762201|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
128854226|NCT01006616|463762202|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
128854227|NCT01006616|463762199|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
128854228|NCT01006616|463762200|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
128854229|NCT01006616|463762201|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
128854230|NCT01006616|463762202|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
128854231|NCT01006616|463762199|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
128854232|NCT01006616|463762200|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
128854233|NCT01006616|463762201|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
128854234|NCT01006616|463762202|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
128854235|NCT01006616|463762199|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
128854236|NCT01006616|463762200|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
128854237|NCT01006616|463762201|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
128854238|NCT01006616|463762202|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
128854239|NCT01006616|463762199|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
128854240|NCT01006616|463762200|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
128854241|NCT01006616|463762201|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
128854242|NCT01006616|463762202|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
128854243|NCT01006616|463762199|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
128854244|NCT01006616|463762200|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
128854245|NCT01006616|463762201|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
128854246|NCT01006616|463762202|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
128854247|NCT01006616|463762199|FG000|Period 1 (6 Months)|Not Treated|0|||
128854248|NCT01006616|463762200|FG001|Period 1 (6 Months)|Not Treated|0|||
128854249|NCT01006616|463762201|FG002|Period 1 (6 Months)|Not Treated|1|||
128854250|NCT01006616|463762202|FG003|Period 1 (6 Months)|Not Treated|1|||
128854251|NCT01006616|463762199|FG000|Period 2 (18 Months)|Adverse Event|6|||
128854252|NCT01006616|463762200|FG001|Period 2 (18 Months)|Adverse Event|6|||
128854253|NCT01006616|463762201|FG002|Period 2 (18 Months)|Adverse Event|6|||
128854254|NCT01006616|463762202|FG003|Period 2 (18 Months)|Adverse Event|4|||
128854255|NCT01006616|463762199|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
128854256|NCT01006616|463762200|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
128854257|NCT01006616|463762201|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
128854258|NCT01006616|463762202|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
128854259|NCT01006616|463762199|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
128854260|NCT01006616|463762200|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
128854261|NCT01006616|463762201|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
128854262|NCT01006616|463762202|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
128854263|NCT01006616|463762199|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
128854264|NCT01006616|463762200|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
128854265|NCT01006616|463762201|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
128854266|NCT01006616|463762202|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
128854267|NCT01006616|463762199|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
128854268|NCT01006616|463762200|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
128854269|NCT01006616|463762201|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
128854270|NCT01006616|463762202|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
128854271|NCT01006616|463762199|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
128854272|NCT01006616|463762200|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
128854273|NCT01006616|463762201|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
128854274|NCT01006616|463762202|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
128854275|NCT01006616|463762199|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
128854276|NCT01006616|463762200|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
128854277|NCT01006616|463762201|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
128854278|NCT01006616|463762202|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
128854279|NCT01006616|463762199|FG000|Period 2 (18 Months)|Study Terminated|63|||
128854280|NCT01006616|463762200|FG001|Period 2 (18 Months)|Study Terminated|46|||
128854281|NCT01006616|463762201|FG002|Period 2 (18 Months)|Study Terminated|44|||
128854282|NCT01006616|463762202|FG003|Period 2 (18 Months)|Study Terminated|70|||
128854283|NCT03672175|463762203|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
128854284|NCT03672175|463762204|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
128854285|NCT03672175|463762205|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
128854286|NCT03672175|463762203|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
128854287|NCT03672175|463762204|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
128854288|NCT03672175|463762205|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
128854289|NCT03672175|463762203|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
128854290|NCT03672175|463762204|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
128854291|NCT03672175|463762205|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
128854292|NCT03672175|463762203|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
128854293|NCT03672175|463762204|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
128854294|NCT03672175|463762205|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
128854295|NCT03672175|463762203|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
128854296|NCT03672175|463762204|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
128854297|NCT03672175|463762205|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
128854298|NCT03672175|463762203|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
128854299|NCT03672175|463762204|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
128854300|NCT03672175|463762205|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
128854301|NCT03672175|463762203|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
128854302|NCT03672175|463762204|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
128854303|NCT03672175|463762205|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
128854304|NCT03672175|463762203|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
128854305|NCT03672175|463762204|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
128854306|NCT03672175|463762205|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
128854307|NCT03672175|463762203|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
128854308|NCT03672175|463762204|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
128854309|NCT03672175|463762205|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
128854310|NCT03672175|463762203|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
128854311|NCT03672175|463762204|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
128854312|NCT03672175|463762205|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
128854313|NCT03672175|463762203|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
128854314|NCT03672175|463762204|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
128854315|NCT03672175|463762205|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
128854316|NCT03672175|463762203|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
128854317|NCT03672175|463762204|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
128854318|NCT03672175|463762205|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
128854319|NCT02482935|463762206|FG000|Period 1|Withdrawal by Subject|1|||
128854320|NCT02482935|463762207|FG001|Period 1|Withdrawal by Subject|0|||
128854321|NCT03414047|463762208|FG000|Overall Study|Adverse Event|0|||
128854322|NCT03414047|463762209|FG001|Overall Study|Adverse Event|0|||
128854323|NCT03414047|463762210|FG002|Overall Study|Adverse Event|1|||
128854324|NCT03414047|463762211|FG003|Overall Study|Adverse Event|1|||
128854325|NCT03414047|463762208|FG000|Overall Study|Physician Decision|1|||
128854326|NCT03414047|463762209|FG001|Overall Study|Physician Decision|0|||
128854327|NCT03414047|463762210|FG002|Overall Study|Physician Decision|0|||
128854328|NCT03414047|463762211|FG003|Overall Study|Physician Decision|1|||
128854329|NCT03414047|463762208|FG000|Overall Study|Withdrawal by Subject|1|||
128854330|NCT03414047|463762209|FG001|Overall Study|Withdrawal by Subject|0|||
128854331|NCT03414047|463762210|FG002|Overall Study|Withdrawal by Subject|2|||
128854332|NCT03414047|463762211|FG003|Overall Study|Withdrawal by Subject|0|||
128854333|NCT01585298|463762214|FG000|Overall Study|Study completion was not documented.|1|||
128854334|NCT01585298|463762214|FG000|Overall Study|Protocol deviation|1|||
128854335|NCT01585298|463762214|FG000|Overall Study|Administrative problems|4|||
128854336|NCT01585298|463762214|FG000|Overall Study|Lost to Follow-up|2|||
128854337|NCT01585298|463762214|FG000|Overall Study|Withdrawal by Subject|4|||
128854338|NCT01585298|463762214|FG000|Overall Study|Abnormal test procedure results|1|||
128854339|NCT01585298|463762214|FG000|Overall Study|Adverse Event|24|||
128854340|NCT02777242|463762218|FG000|Overall Study|Other|2|||
128854341|NCT02777242|463762218|FG000|Overall Study|Lost to Follow-up|1|||
128854342|NCT02777242|463762218|FG000|Overall Study|Multiple|1|||
128854343|NCT02777242|463762218|FG000|Overall Study|Sponsor's request|1|||
128854344|NCT02777242|463762218|FG000|Overall Study|Withdrawal by Subject|1|||
128854345|NCT01898442|463762219|FG000|Overall Study|Hemolysis/technical problems|1|||
128854346|NCT01898442|463762220|FG001|Overall Study|Hemolysis/technical problems|2|||
128854347|NCT01898442|463762221|FG002|Overall Study|Hemolysis/technical problems|2|||
128854348|NCT01898442|463762219|FG000|Overall Study|Patient vomited pills|0|||
128854349|NCT01898442|463762220|FG001|Overall Study|Patient vomited pills|0|||
128854350|NCT01898442|463762221|FG002|Overall Study|Patient vomited pills|1|||
128854351|NCT05178979|463762222|FG000|Overall Study|Death|0|||
128854352|NCT05178979|463762223|FG001|Overall Study|Death|5|||
128854353|NCT05178979|463762224|FG002|Overall Study|Death|0|||
128854354|NCT05178979|463762225|FG003|Overall Study|Death|3|||
128854355|NCT05178979|463762222|FG000|Overall Study|Adverse Event|0|||
128854356|NCT05178979|463762223|FG001|Overall Study|Adverse Event|1|||
128854357|NCT05178979|463762224|FG002|Overall Study|Adverse Event|0|||
128854358|NCT05178979|463762225|FG003|Overall Study|Adverse Event|0|||
128854359|NCT05178979|463762222|FG000|Overall Study|Lost to Follow-up|1|||
128854360|NCT05178979|463762223|FG001|Overall Study|Lost to Follow-up|8|||
128854361|NCT05178979|463762224|FG002|Overall Study|Lost to Follow-up|3|||
128854362|NCT05178979|463762225|FG003|Overall Study|Lost to Follow-up|8|||
128854363|NCT01704547|463762232|FG000|Overall Study|Physician Decision|4|||
128854364|NCT01704547|463762232|FG000|Overall Study|Withdrawal by Subject|1|||
128854365|NCT01099579|463762243|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
128854366|NCT01099579|463762244|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
128854367|NCT01099579|463762245|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
128854368|NCT01099579|463762243|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
128854369|NCT01099579|463762244|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
128854370|NCT01099579|463762245|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
128854371|NCT01099579|463762243|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
128854372|NCT01099579|463762244|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
128854373|NCT01099579|463762245|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
128854374|NCT01099579|463762243|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
128854375|NCT01099579|463762244|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
128854376|NCT01099579|463762245|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
128854377|NCT01099579|463762243|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
128854378|NCT01099579|463762244|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
128854379|NCT01099579|463762245|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
128854380|NCT01099579|463762243|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
128854381|NCT01099579|463762244|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
128854382|NCT01099579|463762245|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
128854383|NCT01099579|463762243|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
128854384|NCT01099579|463762244|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
128854385|NCT01099579|463762245|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
128854386|NCT01099579|463762243|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
128854387|NCT01099579|463762244|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
128854388|NCT01099579|463762245|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
128854389|NCT01099579|463762243|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
128854390|NCT01099579|463762244|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
128854391|NCT01099579|463762245|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
128854392|NCT01099579|463762243|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
128854393|NCT01099579|463762244|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
128854394|NCT01099579|463762245|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
128854395|NCT00909532|463762246|FG000|Overall Study|Adverse Event|4|||
128854396|NCT00909532|463762247|FG001|Overall Study|Adverse Event|1|||
128854397|NCT00909532|463762246|FG000|Overall Study|Pregnancy|0|||
128854398|NCT00909532|463762247|FG001|Overall Study|Pregnancy|1|||
128854399|NCT00909532|463762246|FG000|Overall Study|Prohibited Medication|2|||
128854400|NCT00909532|463762247|FG001|Overall Study|Prohibited Medication|1|||
128854401|NCT00909532|463762246|FG000|Overall Study|Withdrawal of Consent|1|||
128854402|NCT00909532|463762247|FG001|Overall Study|Withdrawal of Consent|1|||
128854403|NCT00909532|463762246|FG000|Overall Study|Noncompliance with Study Requirements|0|||
128854404|NCT00909532|463762247|FG001|Overall Study|Noncompliance with Study Requirements|2|||
128854405|NCT00909532|463762246|FG000|Overall Study|Physician Decision|1|||
128854406|NCT00909532|463762247|FG001|Overall Study|Physician Decision|0|||
128854407|NCT00909532|463762246|FG000|Overall Study|Wrong Genotype|1|||
128854408|NCT00909532|463762247|FG001|Overall Study|Wrong Genotype|0|||
128854409|NCT00909532|463762246|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
128854410|NCT00909532|463762247|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
128854411|NCT01726517|463762253|FG000|Overall Study|Withdrawal by Subject|0|||
128854412|NCT01726517|463762254|FG001|Overall Study|Withdrawal by Subject|0|||
128854413|NCT01726517|463762255|FG002|Overall Study|Withdrawal by Subject|1|||
128854414|NCT01726517|463762256|FG003|Overall Study|Withdrawal by Subject|0|||
128854415|NCT01726517|463762257|FG004|Overall Study|Withdrawal by Subject|0|||
128854416|NCT00573651|463762258|FG000|Overall Study|Lost to Follow-up|3|||
128854417|NCT00573651|463762258|FG000|Overall Study|Withdrawal by Subject|1|||
128854418|NCT03797989|463762279|FG000|VAC069A|Withdrawal by Subject|0|||
128854419|NCT03797989|463762280|FG001|VAC069A|Withdrawal by Subject|0|||
128854420|NCT03797989|463762281|FG002|VAC069A|Withdrawal by Subject|1|||
128854421|NCT03797989|463762282|FG003|VAC069A|Withdrawal by Subject|0|||
128854422|NCT03797989|463762283|FG004|VAC069A|Withdrawal by Subject|0|||
128854423|NCT03797989|463762284|FG005|VAC069A|Withdrawal by Subject|0|||
128854424|NCT03797989|463762285|FG006|VAC069A|Withdrawal by Subject|0|||
128854425|NCT03797989|463762286|FG007|VAC069A|Withdrawal by Subject|0|||
128854426|NCT03797989|463762287|FG008|VAC069A|Withdrawal by Subject|0|||
128854427|NCT03797989|463762288|FG009|VAC069A|Withdrawal by Subject|0|||
128854428|NCT03797989|463762289|FG010|VAC069A|Withdrawal by Subject|0|||
128854429|NCT03797989|463762290|FG011|VAC069A|Withdrawal by Subject|0|||
128854430|NCT04052997|463762291|FG000|Overall Study|Withdrawal by Subject|17|||
128854431|NCT04052997|463762291|FG000|Overall Study|Physician Decision|50|||
128854432|NCT04052997|463762291|FG000|Overall Study|Death|43|||
128854433|NCT04052997|463762291|FG000|Overall Study|Lost to Follow-up|5|||
128854434|NCT04052997|463762291|FG000|Overall Study|Progression of Disease|1|||
128854435|NCT01024036|463762292|FG000|Blinded Treatment|Adverse Event|1|||
128854436|NCT01024036|463762293|FG001|Blinded Treatment|Adverse Event|1|||
128854437|NCT01024036|463762292|FG000|Blinded Treatment|Lack of Efficacy|16|||
128854438|NCT01024036|463762293|FG001|Blinded Treatment|Lack of Efficacy|14|||
128854439|NCT01024036|463762292|FG000|Blinded Treatment|Physician Decision|1|||
128854440|NCT01024036|463762293|FG001|Blinded Treatment|Physician Decision|0|||
128854441|NCT01024036|463762292|FG000|Blinded Treatment|Death|0|||
128854442|NCT01024036|463762293|FG001|Blinded Treatment|Death|2|||
128854443|NCT01024036|463762292|FG000|Blinded Treatment|Withdrawal by Subject|4|||
128854444|NCT01024036|463762293|FG001|Blinded Treatment|Withdrawal by Subject|3|||
128854445|NCT01024036|463762292|FG000|Unblinded Treatment|Adverse Event|0|||
128854446|NCT01024036|463762293|FG001|Unblinded Treatment|Adverse Event|1|||
128854447|NCT01024036|463762292|FG000|Unblinded Treatment|Lack of Efficacy|0|||
128854448|NCT01024036|463762293|FG001|Unblinded Treatment|Lack of Efficacy|2|||
128854449|NCT01024036|463762292|FG000|Follow-Up Period|Lost to Follow-up|1|||
128854450|NCT01024036|463762293|FG001|Follow-Up Period|Lost to Follow-up|1|||
128854451|NCT01024036|463762292|FG000|Follow-Up Period|Withdrawal by Subject|0|||
128854452|NCT01024036|463762293|FG001|Follow-Up Period|Withdrawal by Subject|1|||
128854453|NCT01024036|463762292|FG000|Follow-Up Period|Adverse Event|4|||
128854454|NCT01024036|463762293|FG001|Follow-Up Period|Adverse Event|1|||
128854455|NCT00604188|463762298|FG000|Overall Study|Adverse Event|1|||
128854456|NCT00604188|463762299|FG001|Overall Study|Adverse Event|4|||
128854457|NCT00604188|463762298|FG000|Overall Study|Lost to Follow-up|17|||
128854458|NCT00604188|463762299|FG001|Overall Study|Lost to Follow-up|15|||
128854459|NCT00604188|463762298|FG000|Overall Study|Withdrawal by Subject|5|||
128854460|NCT00604188|463762299|FG001|Overall Study|Withdrawal by Subject|1|||
128854461|NCT00604188|463762298|FG000|Overall Study|Non-compliance with protocol|4|||
128854462|NCT00604188|463762299|FG001|Overall Study|Non-compliance with protocol|4|||
128854463|NCT00604188|463762298|FG000|Overall Study|Did not receive study drug|0|||
128854464|NCT00604188|463762299|FG001|Overall Study|Did not receive study drug|1|||
128854465|NCT00356759|463762302|FG000|Overall Study|Death|5|||
128854466|NCT00356759|463762303|FG001|Overall Study|Death|2|||
128854467|NCT00356759|463762302|FG000|Overall Study|Withdrawal by Subject|2|||
128854468|NCT00356759|463762303|FG001|Overall Study|Withdrawal by Subject|2|||
128854469|NCT00356759|463762302|FG000|Overall Study|Adverse Event|1|||
128854470|NCT00356759|463762303|FG001|Overall Study|Adverse Event|3|||
128854471|NCT00356759|463762302|FG000|Overall Study|Lost to Follow-up|1|||
128854472|NCT00356759|463762303|FG001|Overall Study|Lost to Follow-up|1|||
128854473|NCT00356759|463762302|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
128854474|NCT00356759|463762303|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
128854475|NCT01999972|463764337|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
128854476|NCT01999972|463764338|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
128854477|NCT01999972|463764339|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
128854478|NCT01999972|463764340|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
128854479|NCT01999972|463764341|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
128854480|NCT01999972|463764342|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
128854481|NCT01999972|463764337|FG000|Dose Escalation Part|Death|0|||
128854482|NCT01999972|463764338|FG001|Dose Escalation Part|Death|1|||
128854483|NCT01999972|463764339|FG002|Dose Escalation Part|Death|0|||
128854484|NCT01999972|463764340|FG003|Dose Escalation Part|Death|0|||
128854485|NCT01999972|463764341|FG004|Dose Escalation Part|Death|0|||
128854486|NCT01999972|463764342|FG005|Dose Escalation Part|Death|0|||
128854487|NCT01999972|463764337|FG000|Dose Escalation Part|Enrolled but not treated|0|||
128854488|NCT01999972|463764338|FG001|Dose Escalation Part|Enrolled but not treated|0|||
128854489|NCT01999972|463764339|FG002|Dose Escalation Part|Enrolled but not treated|1|||
128854490|NCT01999972|463764340|FG003|Dose Escalation Part|Enrolled but not treated|1|||
128854491|NCT01999972|463764341|FG004|Dose Escalation Part|Enrolled but not treated|0|||
128854492|NCT01999972|463764342|FG005|Dose Escalation Part|Enrolled but not treated|0|||
128854493|NCT01999972|463764337|FG000|Dose Escalation Part|Disease progression|3|||
128854494|NCT01999972|463764338|FG001|Dose Escalation Part|Disease progression|2|||
128854495|NCT01999972|463764339|FG002|Dose Escalation Part|Disease progression|3|||
128854496|NCT01999972|463764340|FG003|Dose Escalation Part|Disease progression|6|||
128854497|NCT01999972|463764341|FG004|Dose Escalation Part|Disease progression|0|||
128854498|NCT01999972|463764342|FG005|Dose Escalation Part|Disease progression|0|||
128854499|NCT01999972|463764337|FG000|Dose Escalation Part|Adverse Event|0|||
128854500|NCT01999972|463764338|FG001|Dose Escalation Part|Adverse Event|0|||
128854501|NCT01999972|463764339|FG002|Dose Escalation Part|Adverse Event|0|||
128854502|NCT01999972|463764340|FG003|Dose Escalation Part|Adverse Event|2|||
128854503|NCT01999972|463764341|FG004|Dose Escalation Part|Adverse Event|0|||
128854504|NCT01999972|463764342|FG005|Dose Escalation Part|Adverse Event|0|||
128854505|NCT01999972|463764337|FG000|Dose Escalation Part|Global deterioration of health status|1|||
128854506|NCT01999972|463764338|FG001|Dose Escalation Part|Global deterioration of health status|0|||
128854507|NCT01999972|463764339|FG002|Dose Escalation Part|Global deterioration of health status|0|||
128854508|NCT01999972|463764340|FG003|Dose Escalation Part|Global deterioration of health status|1|||
128854509|NCT01999972|463764341|FG004|Dose Escalation Part|Global deterioration of health status|0|||
128854510|NCT01999972|463764342|FG005|Dose Escalation Part|Global deterioration of health status|0|||
128854511|NCT01999972|463764337|FG000|Dose Expansion Part|Death|0|||
128854512|NCT01999972|463764338|FG001|Dose Expansion Part|Death|0|||
128854513|NCT01999972|463764339|FG002|Dose Expansion Part|Death|0|||
128854514|NCT01999972|463764340|FG003|Dose Expansion Part|Death|0|||
128854515|NCT01999972|463764341|FG004|Dose Expansion Part|Death|2|||
128854516|NCT01999972|463764342|FG005|Dose Expansion Part|Death|1|||
128854517|NCT01999972|463764337|FG000|Dose Expansion Part|Disease progression|0|||
128854518|NCT01999972|463764338|FG001|Dose Expansion Part|Disease progression|0|||
128854519|NCT01999972|463764339|FG002|Dose Expansion Part|Disease progression|0|||
128854520|NCT01999972|463764340|FG003|Dose Expansion Part|Disease progression|0|||
128854521|NCT01999972|463764341|FG004|Dose Expansion Part|Disease progression|9|||
128854522|NCT01999972|463764342|FG005|Dose Expansion Part|Disease progression|3|||
128854523|NCT01999972|463764337|FG000|Dose Expansion Part|Sponsor decision|0|||
128854524|NCT01999972|463764338|FG001|Dose Expansion Part|Sponsor decision|0|||
128854525|NCT01999972|463764339|FG002|Dose Expansion Part|Sponsor decision|0|||
128854526|NCT01999972|463764340|FG003|Dose Expansion Part|Sponsor decision|0|||
128854527|NCT01999972|463764341|FG004|Dose Expansion Part|Sponsor decision|1|||
128854528|NCT01999972|463764342|FG005|Dose Expansion Part|Sponsor decision|0|||
128854529|NCT01999972|463764337|FG000|Dose Expansion Part|Adverse Event|0|||
128854530|NCT01999972|463764338|FG001|Dose Expansion Part|Adverse Event|0|||
128854531|NCT01999972|463764339|FG002|Dose Expansion Part|Adverse Event|0|||
128854532|NCT01999972|463764340|FG003|Dose Expansion Part|Adverse Event|0|||
128854533|NCT01999972|463764341|FG004|Dose Expansion Part|Adverse Event|4|||
128854534|NCT01999972|463764342|FG005|Dose Expansion Part|Adverse Event|2|||
128854535|NCT01999972|463764337|FG000|Dose Expansion Part|Participant's non-compliance|0|||
128854536|NCT01999972|463764338|FG001|Dose Expansion Part|Participant's non-compliance|0|||
128854537|NCT01999972|463764339|FG002|Dose Expansion Part|Participant's non-compliance|0|||
128854538|NCT01999972|463764340|FG003|Dose Expansion Part|Participant's non-compliance|0|||
128854539|NCT01999972|463764341|FG004|Dose Expansion Part|Participant's non-compliance|0|||
128854540|NCT01999972|463764342|FG005|Dose Expansion Part|Participant's non-compliance|1|||
128854541|NCT01999972|463764337|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
128854542|NCT01999972|463764338|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
128854543|NCT01999972|463764339|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
128854544|NCT01999972|463764340|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
128854545|NCT01999972|463764341|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
128854546|NCT01999972|463764342|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
128854547|NCT01999972|463764337|FG000|Dose Expansion Part|Changed to standard of care|0|||
128854548|NCT01999972|463764338|FG001|Dose Expansion Part|Changed to standard of care|0|||
128854549|NCT01999972|463764339|FG002|Dose Expansion Part|Changed to standard of care|0|||
128854550|NCT01999972|463764340|FG003|Dose Expansion Part|Changed to standard of care|0|||
128854551|NCT01999972|463764341|FG004|Dose Expansion Part|Changed to standard of care|1|||
128854552|NCT01999972|463764342|FG005|Dose Expansion Part|Changed to standard of care|0|||
128854553|NCT02202109|463764343|FG000|Overall Study|Lost to Follow-up|88|||
128854554|NCT02202109|463764344|FG001|Overall Study|Lost to Follow-up|87|||
128854555|NCT02202109|463764343|FG000|Overall Study|Withdrawal by Subject|2|||
128854556|NCT02202109|463764344|FG001|Overall Study|Withdrawal by Subject|0|||
128854557|NCT00612352|463764346|FG000|Overall Study|Adverse Event|1|||
128854558|NCT00612352|463764347|FG001|Overall Study|Adverse Event|0|||
128854559|NCT00612352|463764346|FG000|Overall Study|Withdrawal by Subject|3|||
128854560|NCT00612352|463764347|FG001|Overall Study|Withdrawal by Subject|5|||
128854561|NCT00612352|463764346|FG000|Overall Study|moved out of state|1|||
128854562|NCT00612352|463764347|FG001|Overall Study|moved out of state|0|||
128854563|NCT00612352|463764346|FG000|Overall Study|didn't return calls/show up on test date|4|||
128854564|NCT00612352|463764347|FG001|Overall Study|didn't return calls/show up on test date|1|||
128854565|NCT01986114|463764348|FG000|Overall Study|Adverse Event|59|||
128854566|NCT01986114|463764348|FG000|Overall Study|Lack of Efficacy|23|||
128854567|NCT01986114|463764348|FG000|Overall Study|Withdrawal by Subject|58|||
128854568|NCT01986114|463764348|FG000|Overall Study|Noncompliance|3|||
128854569|NCT01986114|463764348|FG000|Overall Study|Protocol Violation|1|||
128854570|NCT01986114|463764348|FG000|Overall Study|Lost to Follow-up|5|||
128854571|NCT01986114|463764348|FG000|Overall Study|Other reason|7|||
128854572|NCT02106195|463764349|FG000|Overall Study|Adverse Event|2|||
128854573|NCT02106195|463764349|FG000|Overall Study|Protocol Violation|1|||
128854574|NCT00408928|463764350|FG000|Overall Study|Withdrawal by Subject|1|||
128854575|NCT00408928|463764350|FG000|Overall Study|Death|1|||
128854576|NCT00408928|463764350|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
128854577|NCT04469465|463764351|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
128854578|NCT04469465|463764352|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
128854579|NCT04469465|463764351|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
128854580|NCT04469465|463764352|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
128854581|NCT04469465|463764351|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
128854582|NCT04469465|463764352|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
128854583|NCT04469465|463764351|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
128854584|NCT04469465|463764352|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
128854585|NCT04469465|463764351|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
128854586|NCT04469465|463764352|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
128854587|NCT04469465|463764351|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
128854588|NCT04469465|463764352|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
128854589|NCT04469465|463764351|FG000|Long-Term Extension (LTE)|Death|0|||
128854590|NCT04469465|463764352|FG001|Long-Term Extension (LTE)|Death|1|||
128854591|NCT04469465|463764351|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
128854592|NCT04469465|463764352|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
128854593|NCT03194867|463764353|FG000|Overall Study|Incorrect completion of end of study form|0|||
128854594|NCT03194867|463764354|FG001|Overall Study|Incorrect completion of end of study form|0|||
128854595|NCT03194867|463764355|FG002|Overall Study|Incorrect completion of end of study form|1|||
128854596|NCT03194867|463764356|FG003|Overall Study|Incorrect completion of end of study form|0|||
128854597|NCT03305809|463764357|FG000|Overall Study|Adverse Event|2|||
128854598|NCT03305809|463764358|FG001|Overall Study|Adverse Event|2|||
128854599|NCT03305809|463764359|FG002|Overall Study|Adverse Event|6|||
128854600|NCT03305809|463764360|FG003|Overall Study|Adverse Event|6|||
128854601|NCT03305809|463764357|FG000|Overall Study|Death|0|||
128854602|NCT03305809|463764358|FG001|Overall Study|Death|0|||
128854603|NCT03305809|463764359|FG002|Overall Study|Death|1|||
128854604|NCT03305809|463764360|FG003|Overall Study|Death|1|||
128854605|NCT03305809|463764357|FG000|Overall Study|Lost to Follow-up|1|||
128854606|NCT03305809|463764358|FG001|Overall Study|Lost to Follow-up|2|||
128854607|NCT03305809|463764359|FG002|Overall Study|Lost to Follow-up|0|||
128854608|NCT03305809|463764360|FG003|Overall Study|Lost to Follow-up|0|||
128854609|NCT03305809|463764357|FG000|Overall Study|Sponsor Decision|1|||
128854610|NCT03305809|463764358|FG001|Overall Study|Sponsor Decision|0|||
128854611|NCT03305809|463764359|FG002|Overall Study|Sponsor Decision|1|||
128854612|NCT03305809|463764360|FG003|Overall Study|Sponsor Decision|8|||
128854613|NCT03305809|463764357|FG000|Overall Study|Physician Decision|0|||
128854614|NCT03305809|463764358|FG001|Overall Study|Physician Decision|0|||
128854615|NCT03305809|463764359|FG002|Overall Study|Physician Decision|2|||
128854616|NCT03305809|463764360|FG003|Overall Study|Physician Decision|4|||
128854617|NCT03305809|463764357|FG000|Overall Study|Progressive Disease|0|||
128854618|NCT03305809|463764358|FG001|Overall Study|Progressive Disease|0|||
128854619|NCT03305809|463764359|FG002|Overall Study|Progressive Disease|1|||
128854620|NCT03305809|463764360|FG003|Overall Study|Progressive Disease|0|||
128854621|NCT03305809|463764357|FG000|Overall Study|Protocol Violation|1|||
128854622|NCT03305809|463764358|FG001|Overall Study|Protocol Violation|0|||
128854623|NCT03305809|463764359|FG002|Overall Study|Protocol Violation|2|||
128854624|NCT03305809|463764360|FG003|Overall Study|Protocol Violation|3|||
128854625|NCT03305809|463764357|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
128854626|NCT03305809|463764358|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
128854627|NCT03305809|463764359|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
128854628|NCT03305809|463764360|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
128854629|NCT03305809|463764357|FG000|Overall Study|Withdrawal by Subject|2|||
128854630|NCT03305809|463764358|FG001|Overall Study|Withdrawal by Subject|4|||
128854631|NCT03305809|463764359|FG002|Overall Study|Withdrawal by Subject|5|||
128854632|NCT03305809|463764360|FG003|Overall Study|Withdrawal by Subject|2|||
128854633|NCT03305809|463764357|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
128854634|NCT03305809|463764358|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
128854635|NCT03305809|463764359|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
128854636|NCT03305809|463764360|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
128854637|NCT00816556|463764361|FG000|Overall Study|Adverse Event|1|||
128854638|NCT00816556|463764362|FG001|Overall Study|Adverse Event|1|||
128854639|NCT00816556|463764363|FG002|Overall Study|Adverse Event|1|||
128854640|NCT00816556|463764361|FG000|Overall Study|Withdrawal by Subject|1|||
128854641|NCT00816556|463764362|FG001|Overall Study|Withdrawal by Subject|1|||
128854642|NCT00816556|463764363|FG002|Overall Study|Withdrawal by Subject|1|||
128854643|NCT00816556|463764361|FG000|Overall Study|Lost to Follow-up|0|||
128854644|NCT00816556|463764362|FG001|Overall Study|Lost to Follow-up|0|||
128854645|NCT00816556|463764363|FG002|Overall Study|Lost to Follow-up|1|||
128854646|NCT03546816|463764364|FG000|Overall Study|Adverse Event|5|||
128854647|NCT03546816|463764365|FG001|Overall Study|Adverse Event|3|||
128854648|NCT03546816|463764364|FG000|Overall Study|Lack of Efficacy|2|||
128854649|NCT03546816|463764365|FG001|Overall Study|Lack of Efficacy|4|||
128854650|NCT03546816|463764364|FG000|Overall Study|Pregnancy|1|||
128854651|NCT03546816|463764365|FG001|Overall Study|Pregnancy|0|||
128854652|NCT03546816|463764364|FG000|Overall Study|Physician Decision|2|||
128854653|NCT03546816|463764365|FG001|Overall Study|Physician Decision|0|||
128854654|NCT03546816|463764364|FG000|Overall Study|Withdrawal by Subject|8|||
128854655|NCT03546816|463764365|FG001|Overall Study|Withdrawal by Subject|10|||
128854656|NCT03546816|463764364|FG000|Overall Study|Lost to Follow-up|3|||
128854657|NCT03546816|463764365|FG001|Overall Study|Lost to Follow-up|2|||
128854658|NCT02438371|463764366|FG000|Overall Study|Lost to Follow-up|3|||
128854659|NCT02438371|463764367|FG001|Overall Study|Lost to Follow-up|2|||
128854660|NCT02438371|463764366|FG000|Overall Study|Withdrawal by Subject|1|||
128854661|NCT02438371|463764367|FG001|Overall Study|Withdrawal by Subject|1|||
128854662|NCT01161446|463764368|FG000|Overall Study|Lost to Follow-up|18|||
128854663|NCT01161446|463764369|FG001|Overall Study|Lost to Follow-up|14|||
128854664|NCT01161446|463764368|FG000|Overall Study|Withdrawal by Subject|0|||
128854665|NCT01161446|463764369|FG001|Overall Study|Withdrawal by Subject|1|||
128854666|NCT01660256|463764372|FG000|Overall Study|Adverse Event|4|||
128854667|NCT01660256|463764373|FG001|Overall Study|Adverse Event|0|||
128854668|NCT01660256|463764374|FG002|Overall Study|Adverse Event|2|||
128854669|NCT01660256|463764372|FG000|Overall Study|Withdrawal by Subject|1|||
128854670|NCT01660256|463764373|FG001|Overall Study|Withdrawal by Subject|0|||
128854671|NCT01660256|463764374|FG002|Overall Study|Withdrawal by Subject|2|||
128854672|NCT01162135|463764376|FG000|Overall Study|Withdrawal by Subject|1|||
128854673|NCT01162135|463764376|FG000|Overall Study|Severe back pain|1|||
128854674|NCT01162135|463764376|FG000|Overall Study|Ineligible|1|||
128854675|NCT02088554|463764377|FG000|Overall Study|Exited before procedure|130|||
128854676|NCT02088554|463764377|FG000|Overall Study|Attempted but not implanted|31|||
128854677|NCT02088554|463764377|FG000|Overall Study|Implant not attempted|19|||
128854678|NCT02088554|463764377|FG000|Overall Study|Pending next visit|532|||
128854679|NCT02088554|463764377|FG000|Overall Study|Death|170|||
128854680|NCT02088554|463764377|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
128854681|NCT02088554|463764377|FG000|Overall Study|Lost to Follow-up|23|||
128854682|NCT02088554|463764377|FG000|Overall Study|Explanted|32|||
128854683|NCT02088554|463764377|FG000|Overall Study|Any other reason not covered by previous categories|11|||
128854684|NCT00551135|463764378|FG000|Overall Study|Adverse Event|1|||
128854685|NCT00551135|463764379|FG001|Overall Study|Adverse Event|0|||
128854686|NCT00551135|463764380|FG002|Overall Study|Adverse Event|1|||
128854687|NCT00551135|463764381|FG003|Overall Study|Adverse Event|1|||
128854688|NCT00551135|463764378|FG000|Overall Study|Lost to Follow-up|0|||
128854689|NCT00551135|463764379|FG001|Overall Study|Lost to Follow-up|0|||
128854690|NCT00551135|463764380|FG002|Overall Study|Lost to Follow-up|0|||
128854691|NCT00551135|463764381|FG003|Overall Study|Lost to Follow-up|1|||
128854692|NCT00551135|463764378|FG000|Overall Study|Other|3|||
128854693|NCT00551135|463764379|FG001|Overall Study|Other|2|||
128854694|NCT00551135|463764380|FG002|Overall Study|Other|1|||
128854695|NCT00551135|463764381|FG003|Overall Study|Other|2|||
128854696|NCT00551135|463764378|FG000|Overall Study|Withdrawal by Subject|1|||
128854697|NCT00551135|463764379|FG001|Overall Study|Withdrawal by Subject|0|||
128854698|NCT00551135|463764380|FG002|Overall Study|Withdrawal by Subject|3|||
128854699|NCT00551135|463764381|FG003|Overall Study|Withdrawal by Subject|1|||
128854700|NCT00858247|463764382|FG000|Baseline Assessment|Withdrawal by Subject|1|||
128854701|NCT00858247|463764383|FG001|Baseline Assessment|Withdrawal by Subject|1|||
128854702|NCT00858247|463764382|FG000|Baseline Assessment|Poor IV access|1|||
128854703|NCT00858247|463764383|FG001|Baseline Assessment|Poor IV access|0|||
128854704|NCT00858247|463764382|FG000|Baseline Assessment|Protocol Violation|0|||
128854705|NCT00858247|463764383|FG001|Baseline Assessment|Protocol Violation|1|||
128854706|NCT00858247|463764382|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
128854707|NCT00858247|463764383|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
128854708|NCT03898960|463764386|FG000|Overall Study|Death|10|||
128854709|NCT00548847|463764387|FG000|Overall Study|Disease progression|7|||
128854710|NCT01379703|463764388|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
128854711|NCT01379703|463764389|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
128854712|NCT01379703|463764390|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
128854713|NCT01379703|463764388|FG000|Study Start Through 9 Months|Adverse Event|0|||
128854714|NCT01379703|463764389|FG001|Study Start Through 9 Months|Adverse Event|14|||
128854715|NCT01379703|463764390|FG002|Study Start Through 9 Months|Adverse Event|10|||
128854716|NCT01379703|463764388|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
128854717|NCT01379703|463764389|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
128854718|NCT01379703|463764390|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
128854719|NCT01379703|463764388|FG000|Study Start Through 9 Months|Treatment Failure|0|||
128854720|NCT01379703|463764389|FG001|Study Start Through 9 Months|Treatment Failure|2|||
128854721|NCT01379703|463764390|FG002|Study Start Through 9 Months|Treatment Failure|2|||
128854722|NCT01379703|463764388|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
128854723|NCT01379703|463764389|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
128854724|NCT01379703|463764390|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
128854725|NCT01379703|463764388|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
128854726|NCT01379703|463764389|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
128854727|NCT01379703|463764390|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
128854728|NCT01379703|463764388|FG000|Study Start Through 9 Months|Medication not available|0|||
128854729|NCT01379703|463764389|FG001|Study Start Through 9 Months|Medication not available|2|||
128854730|NCT01379703|463764390|FG002|Study Start Through 9 Months|Medication not available|1|||
128854731|NCT01379703|463764388|FG000|Study Start Through 9 Months|Poor general condition|0|||
128854732|NCT01379703|463764389|FG001|Study Start Through 9 Months|Poor general condition|1|||
128854733|NCT01379703|463764390|FG002|Study Start Through 9 Months|Poor general condition|0|||
128854734|NCT01379703|463764388|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
128854735|NCT01379703|463764389|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
128854736|NCT01379703|463764390|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
128854737|NCT01379703|463764388|FG000|Study Start Through 9 Months|Reason unknown|2|||
128854738|NCT01379703|463764389|FG001|Study Start Through 9 Months|Reason unknown|31|||
128854739|NCT01379703|463764390|FG002|Study Start Through 9 Months|Reason unknown|24|||
128854740|NCT01379703|463764388|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
128854741|NCT01379703|463764389|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
128854742|NCT01379703|463764390|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
128854743|NCT01379703|463764388|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
128854744|NCT01379703|463764389|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
128854745|NCT01379703|463764390|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
128854746|NCT01379703|463764388|FG000|9 Months Through 18 Months|Adverse Event|0|||
128854747|NCT01379703|463764389|FG001|9 Months Through 18 Months|Adverse Event|6|||
128854748|NCT01379703|463764390|FG002|9 Months Through 18 Months|Adverse Event|0|||
128854749|NCT01379703|463764388|FG000|9 Months Through 18 Months|Treatment failure|0|||
128854750|NCT01379703|463764389|FG001|9 Months Through 18 Months|Treatment failure|5|||
128854751|NCT01379703|463764390|FG002|9 Months Through 18 Months|Treatment failure|0|||
128854752|NCT01379703|463764388|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
128854753|NCT01379703|463764389|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
128854754|NCT01379703|463764390|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
128854755|NCT01379703|463764388|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
128854756|NCT01379703|463764389|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
128854757|NCT01379703|463764390|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
128854758|NCT01379703|463764388|FG000|9 Months Through 18 Months|Fatigue|0|||
128854759|NCT01379703|463764389|FG001|9 Months Through 18 Months|Fatigue|1|||
128854760|NCT01379703|463764390|FG002|9 Months Through 18 Months|Fatigue|0|||
128854761|NCT01379703|463764388|FG000|9 Months Through 18 Months|Reason Unknown|0|||
128854762|NCT01379703|463764389|FG001|9 Months Through 18 Months|Reason Unknown|23|||
128854763|NCT01379703|463764390|FG002|9 Months Through 18 Months|Reason Unknown|0|||
128854764|NCT01316887|463764391|FG000|Overall Study|Adverse Event|13|||
128854765|NCT01316887|463764392|FG001|Overall Study|Adverse Event|21|||
128854766|NCT01316887|463764393|FG002|Overall Study|Adverse Event|17|||
128854767|NCT01316887|463764391|FG000|Overall Study|Lack of Efficacy|9|||
128854768|NCT01316887|463764392|FG001|Overall Study|Lack of Efficacy|3|||
128854769|NCT01316887|463764393|FG002|Overall Study|Lack of Efficacy|1|||
128854770|NCT01316887|463764391|FG000|Overall Study|Protocol Violation|2|||
128854771|NCT01316887|463764392|FG001|Overall Study|Protocol Violation|6|||
128854772|NCT01316887|463764393|FG002|Overall Study|Protocol Violation|6|||
128854773|NCT01316887|463764391|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
128854774|NCT01316887|463764392|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
128854775|NCT01316887|463764393|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
128854776|NCT01316887|463764391|FG000|Overall Study|Study Closed/Terminated|2|||
128854777|NCT01316887|463764392|FG001|Overall Study|Study Closed/Terminated|4|||
128854778|NCT01316887|463764393|FG002|Overall Study|Study Closed/Terminated|3|||
128854779|NCT01316887|463764391|FG000|Overall Study|Lost to Follow-up|1|||
128854780|NCT01316887|463764392|FG001|Overall Study|Lost to Follow-up|7|||
128854781|NCT01316887|463764393|FG002|Overall Study|Lost to Follow-up|5|||
128854782|NCT01316887|463764391|FG000|Overall Study|Withdrawal by Subject|8|||
128854783|NCT01316887|463764392|FG001|Overall Study|Withdrawal by Subject|16|||
128854784|NCT01316887|463764393|FG002|Overall Study|Withdrawal by Subject|15|||
128854785|NCT00813098|463764396|FG000|Overall Study|Adverse Event|2|||
128854786|NCT00813098|463764397|FG001|Overall Study|Adverse Event|4|||
128854787|NCT00813098|463764398|FG002|Overall Study|Adverse Event|1|||
128854788|NCT00813098|463764396|FG000|Overall Study|Withdrawal by Subject|0|||
128854789|NCT00813098|463764397|FG001|Overall Study|Withdrawal by Subject|1|||
128854790|NCT00813098|463764398|FG002|Overall Study|Withdrawal by Subject|0|||
128854791|NCT00813098|463764396|FG000|Overall Study|Inability to complete study procedures|1|||
128854792|NCT00813098|463764397|FG001|Overall Study|Inability to complete study procedures|0|||
128854793|NCT00813098|463764398|FG002|Overall Study|Inability to complete study procedures|0|||
128854794|NCT00813098|463764396|FG000|Overall Study|Lost to Follow-up|0|||
128854795|NCT00813098|463764397|FG001|Overall Study|Lost to Follow-up|1|||
128854796|NCT00813098|463764398|FG002|Overall Study|Lost to Follow-up|0|||
128854797|NCT00813098|463764396|FG000|Overall Study|Protocol Violation|0|||
128854798|NCT00813098|463764397|FG001|Overall Study|Protocol Violation|0|||
128854799|NCT00813098|463764398|FG002|Overall Study|Protocol Violation|1|||
128854800|NCT00813098|463764396|FG000|Overall Study|Principal Investigator decision|0|||
128854801|NCT00813098|463764397|FG001|Overall Study|Principal Investigator decision|1|||
128854802|NCT00813098|463764398|FG002|Overall Study|Principal Investigator decision|0|||
128854803|NCT00813098|463764396|FG000|Overall Study|Withdrew Consent|0|||
128854804|NCT00813098|463764397|FG001|Overall Study|Withdrew Consent|1|||
128854805|NCT00813098|463764398|FG002|Overall Study|Withdrew Consent|0|||
128854806|NCT03470545|463764401|FG000|Overall Study|Death|0|||
128854807|NCT03470545|463764402|FG001|Overall Study|Death|1|||
128854808|NCT03470545|463764401|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
128854809|NCT03470545|463764402|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
128854810|NCT03470545|463764401|FG000|Overall Study|Adverse Event|2|||
128854811|NCT03470545|463764402|FG001|Overall Study|Adverse Event|0|||
128854812|NCT03470545|463764401|FG000|Overall Study|Withdrawal by Subject|1|||
128854813|NCT03470545|463764402|FG001|Overall Study|Withdrawal by Subject|1|||
128854814|NCT03470545|463764401|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
128854815|NCT03470545|463764402|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
128854816|NCT00585975|463764403|FG000|Overall Study|Withdrawal by Subject|3|||
128854817|NCT00585975|463764404|FG001|Overall Study|Withdrawal by Subject|3|||
128854818|NCT00585975|463764403|FG000|Overall Study|Lost to Follow-up|2|||
128854819|NCT00585975|463764404|FG001|Overall Study|Lost to Follow-up|1|||
128854820|NCT00585975|463764403|FG000|Overall Study|Enrollment met/over-enrolled|10|||
128854821|NCT00585975|463764404|FG001|Overall Study|Enrollment met/over-enrolled|9|||
128854822|NCT01192776|463764405|FG000|Overall Study|Death|8|||
128854823|NCT01192776|463764406|FG001|Overall Study|Death|15|||
128854824|NCT01192776|463764407|FG002|Overall Study|Death|18|||
128854825|NCT01192776|463764408|FG003|Overall Study|Death|15|||
128854826|NCT01192776|463764405|FG000|Overall Study|Lost to Follow-up|3|||
128854827|NCT01192776|463764406|FG001|Overall Study|Lost to Follow-up|6|||
128854828|NCT01192776|463764407|FG002|Overall Study|Lost to Follow-up|3|||
128854829|NCT01192776|463764408|FG003|Overall Study|Lost to Follow-up|5|||
128854830|NCT01747837|463764411|FG000|Overall Study|Lost to Follow-up|5|||
128854831|NCT01747837|463764412|FG001|Overall Study|Lost to Follow-up|2|||
128854832|NCT01747837|463764411|FG000|Overall Study|Death|4|||
128854833|NCT01747837|463764412|FG001|Overall Study|Death|4|||
128854834|NCT00817336|463764414|FG000|Overall Study|Withdrawal by Subject|1|||
128854835|NCT00817336|463764415|FG001|Overall Study|Withdrawal by Subject|1|||
128854836|NCT01435798|463764416|FG000|Overall Study|Withdrawal by Subject|1|||
128854837|NCT01253447|463764417|FG000|Overall Study|Adverse Event|2|||
128854838|NCT00937521|463764421|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
128854839|NCT00937521|463764422|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
128854840|NCT00937521|463764423|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
128854841|NCT00937521|463764424|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
128854842|NCT00937521|463764425|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
128854843|NCT00937521|463764426|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
128854844|NCT00937521|463764427|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
128854845|NCT00937521|463764428|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
128854846|NCT00937521|463764421|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
128854847|NCT00937521|463764422|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
128854848|NCT00937521|463764423|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
128854849|NCT00937521|463764424|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
128854850|NCT00937521|463764425|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
128854851|NCT00937521|463764426|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
128854852|NCT00937521|463764427|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
128854853|NCT00937521|463764428|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
128854854|NCT00937521|463764421|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
128854855|NCT00937521|463764422|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
128854856|NCT00937521|463764423|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
128854857|NCT00937521|463764424|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
128854858|NCT00937521|463764425|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
128854859|NCT00937521|463764426|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
128854860|NCT00937521|463764427|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
128854861|NCT00937521|463764428|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
128854862|NCT00937521|463764421|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
128854863|NCT00937521|463764422|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
128854864|NCT00937521|463764423|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
128854865|NCT00937521|463764424|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
128854866|NCT00937521|463764425|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
128854867|NCT00937521|463764426|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
128854868|NCT00937521|463764427|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
128854869|NCT00937521|463764428|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
128854870|NCT00937521|463764421|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
128854871|NCT00937521|463764422|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
128854872|NCT00937521|463764423|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
128854873|NCT00937521|463764424|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
128854874|NCT00937521|463764425|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
128854875|NCT00937521|463764426|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
128854876|NCT00937521|463764427|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
128854877|NCT00937521|463764428|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
128854878|NCT00937521|463764421|FG000|Booster Phase|Adverse Event|0|||
128854879|NCT00937521|463764422|FG001|Booster Phase|Adverse Event|0|||
128854880|NCT00937521|463764423|FG002|Booster Phase|Adverse Event|0|||
128854881|NCT00937521|463764424|FG003|Booster Phase|Adverse Event|0|||
128854882|NCT00937521|463764425|FG004|Booster Phase|Adverse Event|0|||
128854883|NCT00937521|463764426|FG005|Booster Phase|Adverse Event|0|||
128854884|NCT00937521|463764427|FG006|Booster Phase|Adverse Event|1|||
128854885|NCT00937521|463764428|FG007|Booster Phase|Adverse Event|0|||
128854886|NCT00937521|463764421|FG000|Booster Phase|Withdrawal by Subject|1|||
128854887|NCT00937521|463764422|FG001|Booster Phase|Withdrawal by Subject|0|||
128854888|NCT00937521|463764423|FG002|Booster Phase|Withdrawal by Subject|0|||
128854889|NCT00937521|463764424|FG003|Booster Phase|Withdrawal by Subject|1|||
128854890|NCT00937521|463764425|FG004|Booster Phase|Withdrawal by Subject|0|||
128854891|NCT00937521|463764426|FG005|Booster Phase|Withdrawal by Subject|0|||
128854892|NCT00937521|463764427|FG006|Booster Phase|Withdrawal by Subject|0|||
128854893|NCT00937521|463764428|FG007|Booster Phase|Withdrawal by Subject|2|||
128854894|NCT00937521|463764421|FG000|Booster Phase|Lost to Follow-up|2|||
128854895|NCT00937521|463764422|FG001|Booster Phase|Lost to Follow-up|2|||
128854896|NCT00937521|463764423|FG002|Booster Phase|Lost to Follow-up|4|||
128854897|NCT00937521|463764424|FG003|Booster Phase|Lost to Follow-up|2|||
128854898|NCT00937521|463764425|FG004|Booster Phase|Lost to Follow-up|4|||
128854899|NCT00937521|463764426|FG005|Booster Phase|Lost to Follow-up|4|||
128854900|NCT00937521|463764427|FG006|Booster Phase|Lost to Follow-up|3|||
128854901|NCT00937521|463764428|FG007|Booster Phase|Lost to Follow-up|0|||
128854902|NCT00937521|463764421|FG000|Booster Phase|Administrative Reason|0|||
128854903|NCT00937521|463764422|FG001|Booster Phase|Administrative Reason|0|||
128854904|NCT00937521|463764423|FG002|Booster Phase|Administrative Reason|1|||
128854905|NCT00937521|463764424|FG003|Booster Phase|Administrative Reason|0|||
128854906|NCT00937521|463764425|FG004|Booster Phase|Administrative Reason|1|||
128854907|NCT00937521|463764426|FG005|Booster Phase|Administrative Reason|1|||
128854908|NCT00937521|463764427|FG006|Booster Phase|Administrative Reason|0|||
128854909|NCT00937521|463764428|FG007|Booster Phase|Administrative Reason|0|||
128854910|NCT00937521|463764421|FG000|Booster Phase|Protocol Deviation|0|||
128854911|NCT00937521|463764422|FG001|Booster Phase|Protocol Deviation|0|||
128854912|NCT00937521|463764423|FG002|Booster Phase|Protocol Deviation|0|||
128854913|NCT00937521|463764424|FG003|Booster Phase|Protocol Deviation|0|||
128854914|NCT00937521|463764425|FG004|Booster Phase|Protocol Deviation|0|||
128854915|NCT00937521|463764426|FG005|Booster Phase|Protocol Deviation|0|||
128854916|NCT00937521|463764427|FG006|Booster Phase|Protocol Deviation|1|||
128854917|NCT00937521|463764428|FG007|Booster Phase|Protocol Deviation|0|||
128854918|NCT01721746|463764429|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
128854919|NCT01721746|463764430|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
128854920|NCT01721746|463764429|FG000|Pre-Treatment|Withdrawal by Subject|1|||
128854921|NCT01721746|463764430|FG001|Pre-Treatment|Withdrawal by Subject|16|||
128854922|NCT01721746|463764429|FG000|Pre-Treatment|Poor/Non-compliance|1|||
128854923|NCT01721746|463764430|FG001|Pre-Treatment|Poor/Non-compliance|0|||
128854924|NCT01721746|463764429|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
128854925|NCT01721746|463764430|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
128854926|NCT01721746|463764429|FG000|Treatment|Disease Progression|192|||
128854927|NCT01721746|463764430|FG001|Treatment|Disease Progression|74|||
128854928|NCT01721746|463764429|FG000|Treatment|Study Drug Toxicity|19|||
128854929|NCT01721746|463764430|FG001|Treatment|Study Drug Toxicity|11|||
128854930|NCT01721746|463764429|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
128854931|NCT01721746|463764430|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
128854932|NCT01721746|463764429|FG000|Treatment|Participant request to discontinue Study treatment|26|||
128854933|NCT01721746|463764430|FG001|Treatment|Participant request to discontinue Study treatment|7|||
128854934|NCT01721746|463764429|FG000|Treatment|Participant withdrew consent|4|||
128854935|NCT01721746|463764430|FG001|Treatment|Participant withdrew consent|2|||
128854936|NCT01721746|463764429|FG000|Treatment|Maximum Clinical Benefit|9|||
128854937|NCT01721746|463764430|FG001|Treatment|Maximum Clinical Benefit|3|||
128854938|NCT01721746|463764429|FG000|Treatment|Poor/Non-compliance|2|||
128854939|NCT01721746|463764430|FG001|Treatment|Poor/Non-compliance|0|||
128854940|NCT01721746|463764429|FG000|Treatment|Participant no longer met Study criteria|4|||
128854941|NCT01721746|463764430|FG001|Treatment|Participant no longer met Study criteria|0|||
128854942|NCT01721746|463764429|FG000|Treatment|Other reasons|6|||
128854943|NCT01721746|463764430|FG001|Treatment|Other reasons|2|||
128854944|NCT04358068|463764431|FG000|Overall Study|Did not initiate study treatment|2|||
128854945|NCT04358068|463764432|FG001|Overall Study|Did not initiate study treatment|2|||
128854946|NCT02447718|463764433|FG000|Overall Study|Lost to Follow-up|8|||
128854947|NCT02447718|463764434|FG001|Overall Study|Lost to Follow-up|0|||
128854948|NCT02447718|463764433|FG000|Overall Study|Withdrawal by Subject|3|||
128854949|NCT02447718|463764434|FG001|Overall Study|Withdrawal by Subject|0|||
128854950|NCT02447718|463764433|FG000|Overall Study|Screen Failure|1|||
128854951|NCT02447718|463764434|FG001|Overall Study|Screen Failure|0|||
128854952|NCT00239681|463764435|FG000|Overall Study|Adverse Event|100|||
128854953|NCT00239681|463764436|FG001|Overall Study|Adverse Event|99|||
128854954|NCT00239681|463764435|FG000|Overall Study|Withdrawal by Subject|458|||
128854955|NCT00239681|463764436|FG001|Overall Study|Withdrawal by Subject|489|||
128854956|NCT00239681|463764435|FG000|Overall Study|Lost to Follow-up|28|||
128854957|NCT00239681|463764436|FG001|Overall Study|Lost to Follow-up|22|||
128854958|NCT00239681|463764435|FG000|Overall Study|Protocol Violation|4|||
128854959|NCT00239681|463764436|FG001|Overall Study|Protocol Violation|4|||
128854960|NCT00239681|463764435|FG000|Overall Study|Physician Decision|13|||
128854961|NCT00239681|463764436|FG001|Overall Study|Physician Decision|17|||
128854962|NCT00239681|463764435|FG000|Overall Study|No information chacked on CaseReportForm|90|||
128854963|NCT00239681|463764436|FG001|Overall Study|No information chacked on CaseReportForm|84|||
128854964|NCT03599622|463764437|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
128854965|NCT03599622|463764438|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
128854966|NCT03599622|463764439|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
128854967|NCT03599622|463764440|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
128854968|NCT03599622|463764437|FG000|Pre-Treatment Period|Other reasons|1|||
128854969|NCT03599622|463764438|FG001|Pre-Treatment Period|Other reasons|1|||
128854970|NCT03599622|463764439|FG002|Pre-Treatment Period|Other reasons|1|||
128854971|NCT03599622|463764440|FG003|Pre-Treatment Period|Other reasons|0|||
128854972|NCT03599622|463764437|FG000|Treatment Period|Adverse Event|11|||
128854973|NCT03599622|463764438|FG001|Treatment Period|Adverse Event|20|||
128854974|NCT03599622|463764439|FG002|Treatment Period|Adverse Event|18|||
128854975|NCT03599622|463764440|FG003|Treatment Period|Adverse Event|2|||
128854976|NCT03599622|463764437|FG000|Treatment Period|Lack of Efficacy|18|||
128854977|NCT03599622|463764438|FG001|Treatment Period|Lack of Efficacy|12|||
128854978|NCT03599622|463764439|FG002|Treatment Period|Lack of Efficacy|13|||
128854979|NCT03599622|463764440|FG003|Treatment Period|Lack of Efficacy|2|||
128854980|NCT03599622|463764437|FG000|Treatment Period|Withdrawal by Subject|5|||
128854981|NCT03599622|463764438|FG001|Treatment Period|Withdrawal by Subject|11|||
128854982|NCT03599622|463764439|FG002|Treatment Period|Withdrawal by Subject|16|||
128854983|NCT03599622|463764440|FG003|Treatment Period|Withdrawal by Subject|1|||
128854984|NCT03599622|463764437|FG000|Treatment Period|Other reasons|4|||
128854985|NCT03599622|463764438|FG001|Treatment Period|Other reasons|6|||
128854986|NCT03599622|463764439|FG002|Treatment Period|Other reasons|7|||
128854987|NCT03599622|463764440|FG003|Treatment Period|Other reasons|0|||
128854988|NCT03599622|463764437|FG000|Treatment Period|Lost to Follow-up|1|||
128854989|NCT03599622|463764438|FG001|Treatment Period|Lost to Follow-up|0|||
128854990|NCT03599622|463764439|FG002|Treatment Period|Lost to Follow-up|0|||
128854991|NCT03599622|463764440|FG003|Treatment Period|Lost to Follow-up|0|||
128854992|NCT03599622|463764437|FG000|Treatment Period|Study terminated by sponsor|7|||
128854993|NCT03599622|463764438|FG001|Treatment Period|Study terminated by sponsor|20|||
128854994|NCT03599622|463764439|FG002|Treatment Period|Study terminated by sponsor|15|||
128854995|NCT03599622|463764440|FG003|Treatment Period|Study terminated by sponsor|0|||
128854996|NCT03599622|463764437|FG000|Treatment Period|Site terminated by sponsor|0|||
128854997|NCT03599622|463764438|FG001|Treatment Period|Site terminated by sponsor|1|||
128854998|NCT03599622|463764439|FG002|Treatment Period|Site terminated by sponsor|0|||
128854999|NCT03599622|463764440|FG003|Treatment Period|Site terminated by sponsor|0|||
128855000|NCT00770588|463764441|FG000|Overall Study|Adverse Event|9|||
128855001|NCT00770588|463764442|FG001|Overall Study|Adverse Event|2|||
128855002|NCT00770588|463764441|FG000|Overall Study|Death caused by progression of disease|70|||
128855003|NCT00770588|463764442|FG001|Overall Study|Death caused by progression of disease|91|||
128855004|NCT00770588|463764441|FG000|Overall Study|Lost to Follow-up|1|||
128855005|NCT00770588|463764442|FG001|Overall Study|Lost to Follow-up|1|||
128855006|NCT00770588|463764441|FG000|Overall Study|Withdrawal by Subject|1|||
128855007|NCT00770588|463764442|FG001|Overall Study|Withdrawal by Subject|1|||
128855008|NCT00468130|463764444|FG000|Overall Study|Adverse Event|2|||
128855009|NCT00468130|463764445|FG001|Overall Study|Adverse Event|1|||
128855010|NCT00468130|463764444|FG000|Overall Study|Withdrawal by Subject|0|||
128855011|NCT00468130|463764445|FG001|Overall Study|Withdrawal by Subject|1|||
128855012|NCT00436956|463764446|FG000|Overall Study|Not evaluable|1|||
128855013|NCT00436956|463764447|FG001|Overall Study|Not evaluable|0|||
128855014|NCT01006889|463764448|FG000|Overall Study|Withdrawal by Subject|3|||
128855015|NCT02143063|463764449|FG000|Overall Study|Lost to Follow-up|16|||
128855016|NCT02143063|463764450|FG001|Overall Study|Lost to Follow-up|28|||
128855017|NCT02143063|463764451|FG002|Overall Study|Lost to Follow-up|29|||
128855018|NCT02143063|463764449|FG000|Overall Study|Withdrawal by Subject|0|||
128855019|NCT02143063|463764450|FG001|Overall Study|Withdrawal by Subject|1|||
128855020|NCT02143063|463764451|FG002|Overall Study|Withdrawal by Subject|0|||
128855021|NCT02143063|463764449|FG000|Overall Study|Death|0|||
128855022|NCT02143063|463764450|FG001|Overall Study|Death|1|||
128855023|NCT02143063|463764451|FG002|Overall Study|Death|1|||
128855024|NCT00623363|463764454|FG000|Overall Study|Adverse Event|2|||
128855025|NCT00623363|463764455|FG001|Overall Study|Adverse Event|2|||
128855026|NCT01130168|463764457|FG000|Period 1|Withdrawal by Subject|0|||
128855027|NCT01130168|463764458|FG001|Period 1|Withdrawal by Subject|1|||
128855028|NCT01130168|463764459|FG002|Period 1|Withdrawal by Subject|0|||
128855029|NCT01130168|463764460|FG003|Period 1|Withdrawal by Subject|1|||
128855030|NCT01130168|463764461|FG004|Period 1|Withdrawal by Subject|0|||
128855031|NCT01130168|463764462|FG005|Period 1|Withdrawal by Subject|0|||
128855032|NCT01130168|463764457|FG000|Period 1|Discontinued For Other Reason|0|||
128855033|NCT01130168|463764458|FG001|Period 1|Discontinued For Other Reason|0|||
128855034|NCT01130168|463764459|FG002|Period 1|Discontinued For Other Reason|1|||
128855035|NCT01130168|463764460|FG003|Period 1|Discontinued For Other Reason|1|||
128855036|NCT01130168|463764461|FG004|Period 1|Discontinued For Other Reason|0|||
128855037|NCT01130168|463764462|FG005|Period 1|Discontinued For Other Reason|0|||
128855038|NCT01130168|463764457|FG000|Period 1|Adverse Event|0|||
128855039|NCT01130168|463764458|FG001|Period 1|Adverse Event|0|||
128855040|NCT01130168|463764459|FG002|Period 1|Adverse Event|0|||
128855041|NCT01130168|463764460|FG003|Period 1|Adverse Event|1|||
128855042|NCT01130168|463764461|FG004|Period 1|Adverse Event|0|||
128855043|NCT01130168|463764462|FG005|Period 1|Adverse Event|0|||
128855044|NCT01157377|463764465|FG000|Overall Study|Lost to Follow-up|0|||
128855045|NCT01157377|463764466|FG001|Overall Study|Lost to Follow-up|0|||
128855046|NCT01157377|463764467|FG002|Overall Study|Lost to Follow-up|1|||
128855047|NCT01157377|463764468|FG003|Overall Study|Lost to Follow-up|0|||
128855048|NCT01157377|463764469|FG004|Overall Study|Lost to Follow-up|1|||
128855049|NCT01157377|463764470|FG005|Overall Study|Lost to Follow-up|1|||
128855050|NCT01157377|463764471|FG006|Overall Study|Lost to Follow-up|0|||
128855051|NCT01157377|463764465|FG000|Overall Study|Personal Reasons|2|||
128855052|NCT01157377|463764466|FG001|Overall Study|Personal Reasons|1|||
128855053|NCT01157377|463764467|FG002|Overall Study|Personal Reasons|0|||
128855054|NCT01157377|463764468|FG003|Overall Study|Personal Reasons|1|||
128855055|NCT01157377|463764469|FG004|Overall Study|Personal Reasons|0|||
128855056|NCT01157377|463764470|FG005|Overall Study|Personal Reasons|0|||
128855057|NCT01157377|463764471|FG006|Overall Study|Personal Reasons|0|||
128855058|NCT01157377|463764465|FG000|Overall Study|Protocol Violation|0|||
128855059|NCT01157377|463764466|FG001|Overall Study|Protocol Violation|0|||
128855060|NCT01157377|463764467|FG002|Overall Study|Protocol Violation|0|||
128855061|NCT01157377|463764468|FG003|Overall Study|Protocol Violation|0|||
128855062|NCT01157377|463764469|FG004|Overall Study|Protocol Violation|0|||
128855063|NCT01157377|463764470|FG005|Overall Study|Protocol Violation|1|||
128855064|NCT01157377|463764471|FG006|Overall Study|Protocol Violation|0|||
128855065|NCT01157377|463764465|FG000|Overall Study|Lack of Efficacy|0|||
128855066|NCT01157377|463764466|FG001|Overall Study|Lack of Efficacy|0|||
128855067|NCT01157377|463764467|FG002|Overall Study|Lack of Efficacy|0|||
128855068|NCT01157377|463764468|FG003|Overall Study|Lack of Efficacy|0|||
128855069|NCT01157377|463764469|FG004|Overall Study|Lack of Efficacy|0|||
128855070|NCT01157377|463764470|FG005|Overall Study|Lack of Efficacy|0|||
128855071|NCT01157377|463764471|FG006|Overall Study|Lack of Efficacy|1|||
128855072|NCT01157377|463764465|FG000|Overall Study|Other Miscellaneous Reasons|0|||
128855073|NCT01157377|463764466|FG001|Overall Study|Other Miscellaneous Reasons|2|||
128855074|NCT01157377|463764467|FG002|Overall Study|Other Miscellaneous Reasons|0|||
128855075|NCT01157377|463764468|FG003|Overall Study|Other Miscellaneous Reasons|0|||
128855076|NCT01157377|463764469|FG004|Overall Study|Other Miscellaneous Reasons|1|||
128855077|NCT01157377|463764470|FG005|Overall Study|Other Miscellaneous Reasons|1|||
128855078|NCT01157377|463764471|FG006|Overall Study|Other Miscellaneous Reasons|1|||
128855079|NCT02760485|463764472|FG000|Phase 1|Death|3|||
128855080|NCT02760485|463764473|FG001|Phase 1|Death|6|||
128855081|NCT02760485|463764474|FG002|Phase 1|Death|0|||
128855082|NCT02760485|463764472|FG000|Phase 1|Withdrawal by Subject|2|||
128855083|NCT02760485|463764473|FG001|Phase 1|Withdrawal by Subject|0|||
128855084|NCT02760485|463764474|FG002|Phase 1|Withdrawal by Subject|0|||
128855085|NCT02760485|463764472|FG000|Phase 1|Progressive Disease|1|||
128855086|NCT02760485|463764473|FG001|Phase 1|Progressive Disease|0|||
128855087|NCT02760485|463764474|FG002|Phase 1|Progressive Disease|0|||
128855088|NCT02760485|463764472|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
128855089|NCT02760485|463764473|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
128855090|NCT02760485|463764474|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
128855091|NCT02760485|463764472|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
128855092|NCT02760485|463764473|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
128855093|NCT02760485|463764474|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
128855094|NCT02760485|463764472|FG000|Phase 2|Death|0|||
128855095|NCT02760485|463764473|FG001|Phase 2|Death|0|||
128855096|NCT02760485|463764474|FG002|Phase 2|Death|12|||
128855097|NCT02760485|463764472|FG000|Phase 2|Withdrawal by Subject|0|||
128855098|NCT02760485|463764473|FG001|Phase 2|Withdrawal by Subject|0|||
128855099|NCT02760485|463764474|FG002|Phase 2|Withdrawal by Subject|3|||
128855100|NCT02760485|463764472|FG000|Phase 2|Progressive Disease|0|||
128855101|NCT02760485|463764473|FG001|Phase 2|Progressive Disease|0|||
128855102|NCT02760485|463764474|FG002|Phase 2|Progressive Disease|1|||
128855103|NCT02760485|463764472|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
128855104|NCT02760485|463764473|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
128855105|NCT02760485|463764474|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
128855106|NCT02261285|463764475|FG000|Overall Study|Disease progression|0|||
128855107|NCT02261285|463764476|FG001|Overall Study|Disease progression|0|||
128855108|NCT02261285|463764477|FG002|Overall Study|Disease progression|1|||
128855109|NCT01702519|463764478|FG000|Washout Period|Lost to Follow-up|1|||
128855110|NCT01702519|463764479|FG001|Washout Period|Lost to Follow-up|0|||
128855111|NCT01702519|463764478|FG000|Washout Period|Withdrawal by Subject|0|||
128855112|NCT01702519|463764479|FG001|Washout Period|Withdrawal by Subject|2|||
128855113|NCT03738397|463764480|FG000|Overall Study|Adverse Event|3|||
128855114|NCT03738397|463764481|FG001|Overall Study|Adverse Event|7|||
128855115|NCT03738397|463764480|FG000|Overall Study|Withdrawal by Subject|8|||
128855116|NCT03738397|463764481|FG001|Overall Study|Withdrawal by Subject|11|||
128855117|NCT03738397|463764480|FG000|Overall Study|Lost to Follow-up|7|||
128855118|NCT03738397|463764481|FG001|Overall Study|Lost to Follow-up|5|||
128855119|NCT03738397|463764480|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
128855120|NCT03738397|463764481|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
128855121|NCT03738397|463764480|FG000|Overall Study|Other|4|||
128855122|NCT03738397|463764481|FG001|Overall Study|Other|6|||
128855123|NCT00904722|463764484|FG000|Overall Study|Physician Decision|1|||
128855124|NCT01087814|463764485|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
128855125|NCT01087814|463764486|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
128855126|NCT01087814|463764485|FG000|Second Intervention (5 Days)|Physician Decision|1|||
128855127|NCT01087814|463764486|FG001|Second Intervention (5 Days)|Physician Decision|0|||
128855128|NCT01891890|463764487|FG000|Overall Study|Lost to Follow-up|0|||
128855129|NCT01891890|463764488|FG001|Overall Study|Lost to Follow-up|0|||
128855130|NCT01891890|463764489|FG002|Overall Study|Lost to Follow-up|1|||
128855131|NCT01891890|463764487|FG000|Overall Study|Study ended before endpoint reached|7|||
128855132|NCT01891890|463764488|FG001|Overall Study|Study ended before endpoint reached|3|||
128855133|NCT01891890|463764489|FG002|Overall Study|Study ended before endpoint reached|6|||
128855134|NCT01263925|463764496|FG000|Overall Study|Protocol Violation|1|||
128855135|NCT01263925|463764497|FG001|Overall Study|Protocol Violation|0|||
128855136|NCT01263925|463764496|FG000|Overall Study|Lack of Efficacy|0|||
128855137|NCT01263925|463764497|FG001|Overall Study|Lack of Efficacy|1|||
128855138|NCT01263925|463764496|FG000|Overall Study|Adverse Event|23|||
128855139|NCT01263925|463764497|FG001|Overall Study|Adverse Event|22|||
128855140|NCT01263925|463764496|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
128855141|NCT01263925|463764497|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
128855142|NCT01263925|463764496|FG000|Overall Study|Withdrawal by Subject|6|||
128855143|NCT01263925|463764497|FG001|Overall Study|Withdrawal by Subject|8|||
128855144|NCT01263925|463764496|FG000|Overall Study|Other|4|||
128855145|NCT01263925|463764497|FG001|Overall Study|Other|4|||
128855146|NCT01263925|463764496|FG000|Overall Study|Lost to Follow-up|3|||
128855147|NCT01263925|463764497|FG001|Overall Study|Lost to Follow-up|1|||
128855148|NCT01263925|463764496|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
128855149|NCT01263925|463764497|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
128855150|NCT01263925|463764496|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
128855151|NCT01263925|463764497|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
128855152|NCT01263925|463764496|FG000|Overall Study|AE/ Withdrawal|1|||
128855153|NCT01263925|463764497|FG001|Overall Study|AE/ Withdrawal|4|||
128855154|NCT01263925|463764496|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
128855155|NCT01263925|463764497|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
128855156|NCT01263925|463764496|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
128855157|NCT01263925|463764497|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
128855158|NCT01263925|463764496|FG000|Overall Study|Withdrawal/ Not specified|0|||
128855159|NCT01263925|463764497|FG001|Overall Study|Withdrawal/ Not specified|1|||
128855160|NCT03765164|463764502|FG000|Pre-intervention|Withdrawal by Subject|5|||
128855161|NCT03765164|463764503|FG001|Pre-intervention|Withdrawal by Subject|6|||
128855162|NCT03448536|463764505|FG000|Overall Study|Protocol Violation|2|||
128855163|NCT03448536|463764506|FG001|Overall Study|Protocol Violation|0|||
128855164|NCT03448536|463764505|FG000|Overall Study|Pregnancy|1|||
128855165|NCT03448536|463764506|FG001|Overall Study|Pregnancy|0|||
128855166|NCT03448536|463764505|FG000|Overall Study|Withdrawal by Subject|1|||
128855167|NCT03448536|463764506|FG001|Overall Study|Withdrawal by Subject|2|||
128855168|NCT03448536|463764505|FG000|Overall Study|Lost to Follow-up|3|||
128855169|NCT03448536|463764506|FG001|Overall Study|Lost to Follow-up|2|||
128855170|NCT03448536|463764505|FG000|Overall Study|Inadequate pain reporter|1|||
128855171|NCT03448536|463764506|FG001|Overall Study|Inadequate pain reporter|0|||
128855172|NCT03448536|463764505|FG000|Overall Study|Other|3|||
128855173|NCT03448536|463764506|FG001|Overall Study|Other|0|||
128855174|NCT03448536|463764505|FG000|Overall Study|Physician Decision|1|||
128855175|NCT03448536|463764506|FG001|Overall Study|Physician Decision|0|||
128855176|NCT00474383|463764512|FG000|Main Study|Adverse Event|11|||
128855177|NCT00474383|463764513|FG001|Main Study|Adverse Event|0|||
128855178|NCT00474383|463764512|FG000|Main Study|Symptomatic Deterioration|1|||
128855179|NCT00474383|463764513|FG001|Main Study|Symptomatic Deterioration|0|||
128855180|NCT00474383|463764512|FG000|Main Study|Progressive Disease|23|||
128855181|NCT00474383|463764513|FG001|Main Study|Progressive Disease|0|||
128855182|NCT00474383|463764512|FG000|Main Study|Other|1|||
128855183|NCT00474383|463764513|FG001|Main Study|Other|0|||
128855184|NCT00474383|463764512|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
128855185|NCT00474383|463764513|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
128855186|NCT00474383|463764512|FG000|Extension|Progressive Disease|0|||
128855187|NCT00474383|463764513|FG001|Extension|Progressive Disease|5|||
128855188|NCT02998918|463764514|FG000|Overall Study|Withdrawal by Subject|1|||
128855189|NCT02998918|463764515|FG001|Overall Study|Withdrawal by Subject|0|||
128855190|NCT00443599|463764523|FG000|Overall Study|Physician Decision|2|||
128855191|NCT00443599|463764524|FG001|Overall Study|Physician Decision|1|||
128855192|NCT00443599|463764523|FG000|Overall Study|Death|1|||
128855193|NCT00443599|463764524|FG001|Overall Study|Death|1|||
128855194|NCT00443599|463764523|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
128855195|NCT00443599|463764524|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
128855196|NCT04811339|463764525|FG000|Overall Study|lack of transportation not wanting to return|4|||
128855197|NCT04811339|463764526|FG001|Overall Study|lack of transportation not wanting to return|8|||
128855198|NCT04811339|463764527|FG002|Overall Study|lack of transportation not wanting to return|0|||
128855199|NCT04811339|463764525|FG000|Overall Study|Adverse Event|3|||
128855200|NCT04811339|463764526|FG001|Overall Study|Adverse Event|0|||
128855201|NCT04811339|463764527|FG002|Overall Study|Adverse Event|0|||
128855202|NCT04811339|463764525|FG000|Overall Study|Lost to Follow-up|1|||
128855203|NCT04811339|463764526|FG001|Overall Study|Lost to Follow-up|0|||
128855204|NCT04811339|463764527|FG002|Overall Study|Lost to Follow-up|0|||
128855205|NCT04811339|463764525|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
128855206|NCT04811339|463764526|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
128855207|NCT04811339|463764527|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
128855208|NCT04811339|463764525|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
128855209|NCT04811339|463764526|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
128855210|NCT04811339|463764527|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
128855211|NCT04811339|463764525|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
128855212|NCT04811339|463764526|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
128855213|NCT04811339|463764527|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
128855214|NCT04811339|463764525|FG000|Overall Study|Withdrawal by Subject|0|||
128855215|NCT04811339|463764526|FG001|Overall Study|Withdrawal by Subject|3|||
128855216|NCT04811339|463764527|FG002|Overall Study|Withdrawal by Subject|0|||
128855217|NCT04811339|463764525|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
128855218|NCT04811339|463764526|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
128855219|NCT04811339|463764527|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
128855220|NCT04811339|463764525|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
128855221|NCT04811339|463764526|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
128855222|NCT04811339|463764527|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
128855223|NCT00497874|463766150|FG000|Overall Study|Withdrawal by Subject|48|||
128855224|NCT00497874|463766151|FG001|Overall Study|Withdrawal by Subject|17|||
128855225|NCT00497874|463766150|FG000|Overall Study|Illness|8|||
128855226|NCT00497874|463766151|FG001|Overall Study|Illness|4|||
128855227|NCT00497874|463766150|FG000|Overall Study|Death|2|||
128855228|NCT00497874|463766151|FG001|Overall Study|Death|4|||
128855229|NCT00497874|463766150|FG000|Overall Study|Unable to contact|52|||
128855230|NCT00497874|463766151|FG001|Overall Study|Unable to contact|67|||
128855231|NCT00497874|463766150|FG000|Overall Study|Unable to schedule|37|||
128855232|NCT00497874|463766151|FG001|Overall Study|Unable to schedule|24|||
128855233|NCT01256671|463766155|FG000|Overall Study|Adverse Event|29|||
128855234|NCT01256671|463766155|FG000|Overall Study|Lost to Follow-up|16|||
128855235|NCT01256671|463766155|FG000|Overall Study|Withdrawal by Subject|31|||
128855236|NCT01256671|463766155|FG000|Overall Study|Physician Decision|3|||
128855237|NCT01256671|463766155|FG000|Overall Study|Lack of Efficacy|4|||
128855238|NCT01256671|463766155|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
128855239|NCT04843579|463766162|FG000|Overall Study|Adverse Event|1|||
128855240|NCT04843579|463766162|FG000|Overall Study|Disease Progression|1|||
128855241|NCT04009629|463766163|FG000|Overall Study|Withdrawal by Subject|2|||
128855242|NCT04009629|463766164|FG001|Overall Study|Withdrawal by Subject|0|||
128855243|NCT02808975|463766166|FG000|Overall Study|Adverse Event|3|||
128855244|NCT02808975|463766167|FG001|Overall Study|Adverse Event|4|||
128855245|NCT02808975|463766166|FG000|Overall Study|Withdrew consent|9|||
128855246|NCT02808975|463766167|FG001|Overall Study|Withdrew consent|8|||
128855247|NCT02808975|463766166|FG000|Overall Study|Lost to Follow-up|4|||
128855248|NCT02808975|463766167|FG001|Overall Study|Lost to Follow-up|6|||
128855249|NCT02808975|463766166|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
128855250|NCT02808975|463766167|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
128855251|NCT02808975|463766166|FG000|Overall Study|Other, not specified|5|||
128855252|NCT02808975|463766167|FG001|Overall Study|Other, not specified|1|||
128855253|NCT03602586|463766168|FG000|Overall Study|Withdrawal by Subject|3|||
128855254|NCT00030823|463766171|FG000|Overall Study|Withdrawal by Subject|1|||
128855255|NCT04333147|463766173|FG000|Overall Study|Adverse Event|43|||
128855256|NCT04333147|463766174|FG001|Overall Study|Adverse Event|40|||
128855257|NCT04333147|463766173|FG000|Overall Study|Lack of Efficacy|49|||
128855258|NCT04333147|463766174|FG001|Overall Study|Lack of Efficacy|48|||
128855259|NCT04333147|463766173|FG000|Overall Study|Lost to Follow-up|19|||
128855260|NCT04333147|463766174|FG001|Overall Study|Lost to Follow-up|16|||
128855261|NCT04333147|463766173|FG000|Overall Study|Physician Decision|17|||
128855262|NCT04333147|463766174|FG001|Overall Study|Physician Decision|20|||
128855263|NCT04333147|463766173|FG000|Overall Study|Withdrawal by Subject|65|||
128855264|NCT04333147|463766174|FG001|Overall Study|Withdrawal by Subject|68|||
128855265|NCT04333147|463766173|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
128855266|NCT04333147|463766174|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
128855267|NCT04333147|463766173|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
128855268|NCT04333147|463766174|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
128855269|NCT04333147|463766173|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
128855270|NCT04333147|463766174|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
128855271|NCT03062449|463766175|FG000|Overall Study|Withdrawal by Subject|7|||
128855272|NCT03062449|463766176|FG001|Overall Study|Withdrawal by Subject|1|||
128855273|NCT04702893|463766178|FG000|Overall Study|Other reasons than listed|11|||
128855274|NCT04702893|463766178|FG000|Overall Study|Withdrawal by Subject|3|||
128855275|NCT04702893|463766178|FG000|Overall Study|Lost to Follow-up|7|||
128855276|NCT04702893|463766178|FG000|Overall Study|Death|10|||
128855277|NCT04702893|463766178|FG000|Overall Study|Not treated|6|||
128855278|NCT03568812|463766179|FG000|Overall Study|Physician Decision|0|||
128855279|NCT03568812|463766180|FG001|Overall Study|Physician Decision|1|||
128855280|NCT04014790|463766181|FG000|Overall Study|Death|4|||
128855281|NCT04014790|463766181|FG000|Overall Study|Adverse Event|1|||
128855282|NCT04014790|463766181|FG000|Overall Study|Withdrawal by Subject|1|||
128855283|NCT01010204|463766182|FG000|Overall Study|Lost to Follow-up|2|||
128855284|NCT01010204|463766183|FG001|Overall Study|Lost to Follow-up|2|||
128855285|NCT01010204|463766182|FG000|Overall Study|Adverse Event|1|||
128855286|NCT01010204|463766183|FG001|Overall Study|Adverse Event|3|||
128855287|NCT01010204|463766182|FG000|Overall Study|Withdrawal by Subject|2|||
128855288|NCT01010204|463766183|FG001|Overall Study|Withdrawal by Subject|3|||
128855289|NCT01010204|463766182|FG000|Overall Study|psychiatric hospitalization|2|||
128855290|NCT01010204|463766183|FG001|Overall Study|psychiatric hospitalization|1|||
128855291|NCT02330562|463766184|FG000|Overall Study|Adverse Event|0|||
128855292|NCT02330562|463766185|FG001|Overall Study|Adverse Event|0|||
128855293|NCT02330562|463766186|FG002|Overall Study|Adverse Event|3|||
128855294|NCT02330562|463766187|FG003|Overall Study|Adverse Event|0|||
128855295|NCT02330562|463766188|FG004|Overall Study|Adverse Event|3|||
128855296|NCT02330562|463766189|FG005|Overall Study|Adverse Event|1|||
128855297|NCT02330562|463766190|FG006|Overall Study|Adverse Event|0|||
128855298|NCT02330562|463766191|FG007|Overall Study|Adverse Event|0|||
128855299|NCT02330562|463766192|FG008|Overall Study|Adverse Event|0|||
128855300|NCT02330562|463766193|FG009|Overall Study|Adverse Event|1|||
128855301|NCT02330562|463766194|FG010|Overall Study|Adverse Event|1|||
128855302|NCT02330562|463766184|FG000|Overall Study|Participant decision|1|||
128855303|NCT02330562|463766185|FG001|Overall Study|Participant decision|0|||
128855304|NCT02330562|463766186|FG002|Overall Study|Participant decision|4|||
128855305|NCT02330562|463766187|FG003|Overall Study|Participant decision|1|||
128855306|NCT02330562|463766188|FG004|Overall Study|Participant decision|5|||
128855307|NCT02330562|463766189|FG005|Overall Study|Participant decision|2|||
128855308|NCT02330562|463766190|FG006|Overall Study|Participant decision|0|||
128855309|NCT02330562|463766191|FG007|Overall Study|Participant decision|0|||
128855310|NCT02330562|463766192|FG008|Overall Study|Participant decision|0|||
128855311|NCT02330562|463766193|FG009|Overall Study|Participant decision|3|||
128855312|NCT02330562|463766194|FG010|Overall Study|Participant decision|0|||
128855313|NCT02330562|463766184|FG000|Overall Study|Disease progression|5|||
128855314|NCT02330562|463766185|FG001|Overall Study|Disease progression|3|||
128855315|NCT02330562|463766186|FG002|Overall Study|Disease progression|20|||
128855316|NCT02330562|463766187|FG003|Overall Study|Disease progression|28|||
128855317|NCT02330562|463766188|FG004|Overall Study|Disease progression|23|||
128855318|NCT02330562|463766189|FG005|Overall Study|Disease progression|7|||
128855319|NCT02330562|463766190|FG006|Overall Study|Disease progression|1|||
128855320|NCT02330562|463766191|FG007|Overall Study|Disease progression|1|||
128855321|NCT02330562|463766192|FG008|Overall Study|Disease progression|1|||
128855322|NCT02330562|463766193|FG009|Overall Study|Disease progression|0|||
128855323|NCT02330562|463766194|FG010|Overall Study|Disease progression|5|||
128855324|NCT02330562|463766184|FG000|Overall Study|Other reasons|0|||
128855325|NCT02330562|463766185|FG001|Overall Study|Other reasons|0|||
128855326|NCT02330562|463766186|FG002|Overall Study|Other reasons|0|||
128855327|NCT02330562|463766187|FG003|Overall Study|Other reasons|1|||
128855328|NCT02330562|463766188|FG004|Overall Study|Other reasons|0|||
128855329|NCT02330562|463766189|FG005|Overall Study|Other reasons|0|||
128855330|NCT02330562|463766190|FG006|Overall Study|Other reasons|0|||
128855331|NCT02330562|463766191|FG007|Overall Study|Other reasons|0|||
128855332|NCT02330562|463766192|FG008|Overall Study|Other reasons|0|||
128855333|NCT02330562|463766193|FG009|Overall Study|Other reasons|0|||
128855334|NCT02330562|463766194|FG010|Overall Study|Other reasons|0|||
128855335|NCT02330562|463766184|FG000|Overall Study|Withdrawal by Subject|0|||
128855336|NCT02330562|463766185|FG001|Overall Study|Withdrawal by Subject|0|||
128855337|NCT02330562|463766186|FG002|Overall Study|Withdrawal by Subject|0|||
128855338|NCT02330562|463766187|FG003|Overall Study|Withdrawal by Subject|0|||
128855339|NCT02330562|463766188|FG004|Overall Study|Withdrawal by Subject|0|||
128855340|NCT02330562|463766189|FG005|Overall Study|Withdrawal by Subject|0|||
128855341|NCT02330562|463766190|FG006|Overall Study|Withdrawal by Subject|0|||
128855342|NCT02330562|463766191|FG007|Overall Study|Withdrawal by Subject|0|||
128855343|NCT02330562|463766192|FG008|Overall Study|Withdrawal by Subject|0|||
128855344|NCT02330562|463766193|FG009|Overall Study|Withdrawal by Subject|1|||
128855345|NCT02330562|463766194|FG010|Overall Study|Withdrawal by Subject|0|||
128855346|NCT01657799|463766195|FG000|Overall Study|Adverse Event Related to progression|6|||
128855347|NCT01657799|463766196|FG001|Overall Study|Adverse Event Related to progression|8|||
128855348|NCT01657799|463766197|FG002|Overall Study|Adverse Event Related to progression|12|||
128855349|NCT01657799|463766195|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
128855350|NCT01657799|463766196|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
128855351|NCT01657799|463766197|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
128855352|NCT01657799|463766195|FG000|Overall Study|Withdrawal by Subject|13|||
128855353|NCT01657799|463766196|FG001|Overall Study|Withdrawal by Subject|10|||
128855354|NCT01657799|463766197|FG002|Overall Study|Withdrawal by Subject|10|||
128855355|NCT01657799|463766195|FG000|Overall Study|Lost to Follow-up|1|||
128855356|NCT01657799|463766196|FG001|Overall Study|Lost to Follow-up|0|||
128855357|NCT01657799|463766197|FG002|Overall Study|Lost to Follow-up|1|||
128855358|NCT01657799|463766195|FG000|Overall Study|Disease Progression|2|||
128855359|NCT01657799|463766196|FG001|Overall Study|Disease Progression|4|||
128855360|NCT01657799|463766197|FG002|Overall Study|Disease Progression|4|||
128855361|NCT01657799|463766195|FG000|Overall Study|Progressive Disease Clinical|7|||
128855362|NCT01657799|463766196|FG001|Overall Study|Progressive Disease Clinical|4|||
128855363|NCT01657799|463766197|FG002|Overall Study|Progressive Disease Clinical|7|||
128855364|NCT01657799|463766195|FG000|Overall Study|Radiographic & Clinical Progression|16|||
128855365|NCT01657799|463766196|FG001|Overall Study|Radiographic & Clinical Progression|11|||
128855366|NCT01657799|463766197|FG002|Overall Study|Radiographic & Clinical Progression|15|||
128855367|NCT01657799|463766195|FG000|Overall Study|Other|52|||
128855368|NCT01657799|463766196|FG001|Overall Study|Other|62|||
128855369|NCT01657799|463766197|FG002|Overall Study|Other|49|||
128855370|NCT03021551|463766198|FG000|Overall Study|Equipment Issues|2|||
128855371|NCT03021551|463766198|FG000|Overall Study|Protocol Violation|1|||
128855372|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
128855373|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
128855374|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
128855375|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
128855376|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
128855377|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
128855378|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
128855379|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
128855380|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
128855381|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
128855382|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
128855383|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
128855384|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
128855385|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
128855386|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
128855387|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
128855388|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
128855389|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
128855390|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
128855391|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
128855392|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
128855393|NCT04599855|463766201|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
128855394|NCT04599855|463766202|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
128855395|NCT04599855|463766203|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
128855396|NCT04599855|463766201|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
128855397|NCT04599855|463766202|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
128855398|NCT04599855|463766203|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
128855399|NCT04599855|463766201|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
128855400|NCT04599855|463766202|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
128855401|NCT04599855|463766203|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
128855402|NCT04599855|463766201|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
128855403|NCT04599855|463766202|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
128855404|NCT04599855|463766203|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
128855405|NCT04599855|463766201|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
128855406|NCT04599855|463766202|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
128855407|NCT04599855|463766203|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
128855408|NCT04599855|463766201|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
128855409|NCT04599855|463766202|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
128855410|NCT04599855|463766203|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
128855411|NCT04599855|463766201|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
128855412|NCT04599855|463766202|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
128855413|NCT04599855|463766203|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
128855414|NCT00236184|463766204|FG000|Overall Study|Adverse Event|5|||
128855415|NCT00236184|463766205|FG001|Overall Study|Adverse Event|2|||
128855416|NCT00236184|463766204|FG000|Overall Study|Lack of Efficacy|0|||
128855417|NCT00236184|463766205|FG001|Overall Study|Lack of Efficacy|1|||
128855418|NCT00236184|463766204|FG000|Overall Study|Lost to Follow-up|3|||
128855419|NCT00236184|463766205|FG001|Overall Study|Lost to Follow-up|4|||
128855420|NCT00236184|463766204|FG000|Overall Study|Physician Decision|1|||
128855421|NCT00236184|463766205|FG001|Overall Study|Physician Decision|1|||
128855422|NCT00236184|463766204|FG000|Overall Study|Withdrawal by Subject|3|||
128855423|NCT00236184|463766205|FG001|Overall Study|Withdrawal by Subject|0|||
128855424|NCT00236184|463766204|FG000|Overall Study|Protocol Violation|3|||
128855425|NCT00236184|463766205|FG001|Overall Study|Protocol Violation|0|||
128855426|NCT00236184|463766204|FG000|Overall Study|non-compliance with study drug|2|||
128855427|NCT00236184|463766205|FG001|Overall Study|non-compliance with study drug|1|||
128855428|NCT00236184|463766204|FG000|Overall Study|other|1|||
128855429|NCT00236184|463766205|FG001|Overall Study|other|2|||
128855430|NCT02312206|463766206|FG000|Overall Study|Adverse Event|3|||
128855431|NCT02312206|463766207|FG001|Overall Study|Adverse Event|6|||
128855432|NCT02312206|463766206|FG000|Overall Study|Withdrawal by Subject|6|||
128855433|NCT02312206|463766207|FG001|Overall Study|Withdrawal by Subject|6|||
128855434|NCT02312206|463766206|FG000|Overall Study|Physician Decision|7|||
128855435|NCT02312206|463766207|FG001|Overall Study|Physician Decision|6|||
128855436|NCT02312206|463766206|FG000|Overall Study|Death|31|||
128855437|NCT02312206|463766207|FG001|Overall Study|Death|36|||
128855438|NCT02312206|463766206|FG000|Overall Study|Study Terminated by Sponsor|81|||
128855439|NCT02312206|463766207|FG001|Overall Study|Study Terminated by Sponsor|74|||
128855440|NCT02312206|463766206|FG000|Overall Study|Patient transferred to hospice|0|||
128855441|NCT02312206|463766207|FG001|Overall Study|Patient transferred to hospice|1|||
128855442|NCT02312206|463766206|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
128855443|NCT02312206|463766207|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
128855444|NCT02312206|463766206|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
128855445|NCT02312206|463766207|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
128855446|NCT02312206|463766206|FG000|Overall Study|Disease Progression|1|||
128855447|NCT02312206|463766207|FG001|Overall Study|Disease Progression|0|||
128855448|NCT03082612|463766208|FG000|Overall Study|Lost to Follow-up|2|||
128855449|NCT03082612|463766209|FG001|Overall Study|Lost to Follow-up|0|||
128855450|NCT01772563|463766210|FG000|Cycle 1|Dose limiting toxicity|2|||
128855451|NCT01772563|463766210|FG000|Cycle 1|Progressive disease|2|||
128855452|NCT01772563|463766210|FG000|Cycle 2 and Beyond|Progressive disease|17|||
128855453|NCT01772563|463766210|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
128855454|NCT01772563|463766210|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
128855455|NCT01086384|463766213|FG000|2-week Run-in Period|Adverse Event|1|||
128855456|NCT01086384|463766214|FG001|2-week Run-in Period|Adverse Event|0|||
128855457|NCT01086384|463766215|FG002|2-week Run-in Period|Adverse Event|0|||
128855458|NCT01086384|463766213|FG000|2-week Run-in Period|Protocol Violation|1|||
128855459|NCT01086384|463766214|FG001|2-week Run-in Period|Protocol Violation|0|||
128855460|NCT01086384|463766215|FG002|2-week Run-in Period|Protocol Violation|0|||
128855461|NCT01086384|463766213|FG000|2-week Run-in Period|Lost to Follow-up|1|||
128855462|NCT01086384|463766214|FG001|2-week Run-in Period|Lost to Follow-up|0|||
128855463|NCT01086384|463766215|FG002|2-week Run-in Period|Lost to Follow-up|0|||
128855464|NCT01086384|463766213|FG000|2-week Run-in Period|Physician Decision|6|||
128855465|NCT01086384|463766214|FG001|2-week Run-in Period|Physician Decision|0|||
128855466|NCT01086384|463766215|FG002|2-week Run-in Period|Physician Decision|0|||
128855467|NCT01086384|463766213|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
128855468|NCT01086384|463766214|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
128855469|NCT01086384|463766215|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
128855470|NCT01086384|463766213|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
128855471|NCT01086384|463766214|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
128855472|NCT01086384|463766215|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
128855473|NCT01086384|463766213|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
128855474|NCT01086384|463766214|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
128855475|NCT01086384|463766215|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
128855476|NCT01086384|463766213|FG000|2-week Run-in Period|Randomized in Error|1|||
128855477|NCT01086384|463766214|FG001|2-week Run-in Period|Randomized in Error|0|||
128855478|NCT01086384|463766215|FG002|2-week Run-in Period|Randomized in Error|0|||
128855479|NCT01086384|463766213|FG000|Treatment Period|Withdrawal by Subject|0|||
128855480|NCT01086384|463766214|FG001|Treatment Period|Withdrawal by Subject|53|||
128855481|NCT01086384|463766215|FG002|Treatment Period|Withdrawal by Subject|55|||
128855482|NCT01086384|463766213|FG000|Treatment Period|Protocol Violation|0|||
128855483|NCT01086384|463766214|FG001|Treatment Period|Protocol Violation|26|||
128855484|NCT01086384|463766215|FG002|Treatment Period|Protocol Violation|17|||
128855485|NCT01086384|463766213|FG000|Treatment Period|Lack of Efficacy|0|||
128855486|NCT01086384|463766214|FG001|Treatment Period|Lack of Efficacy|22|||
128855487|NCT01086384|463766215|FG002|Treatment Period|Lack of Efficacy|13|||
128855488|NCT01086384|463766213|FG000|Treatment Period|Adverse Event|0|||
128855489|NCT01086384|463766214|FG001|Treatment Period|Adverse Event|19|||
128855490|NCT01086384|463766215|FG002|Treatment Period|Adverse Event|15|||
128855491|NCT01086384|463766213|FG000|Treatment Period|Lost to Follow-up|0|||
128855492|NCT01086384|463766214|FG001|Treatment Period|Lost to Follow-up|11|||
128855493|NCT01086384|463766215|FG002|Treatment Period|Lost to Follow-up|9|||
128855494|NCT01086384|463766213|FG000|Treatment Period|Physician Decision|0|||
128855495|NCT01086384|463766214|FG001|Treatment Period|Physician Decision|9|||
128855496|NCT01086384|463766215|FG002|Treatment Period|Physician Decision|6|||
128855497|NCT01086384|463766213|FG000|Treatment Period|Study Closed/Terminated|0|||
128855498|NCT01086384|463766214|FG001|Treatment Period|Study Closed/Terminated|7|||
128855499|NCT01086384|463766215|FG002|Treatment Period|Study Closed/Terminated|8|||
128855500|NCT01086384|463766213|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
128855501|NCT01086384|463766214|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
128855502|NCT01086384|463766215|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
128855503|NCT01086384|463766213|FG000|Treatment Period|Received Treatment in Error|0|||
128855504|NCT01086384|463766214|FG001|Treatment Period|Received Treatment in Error|1|||
128855505|NCT01086384|463766215|FG002|Treatment Period|Received Treatment in Error|0|||
128855506|NCT00832000|463766219|FG000|Overall Study|Adverse Event|2|||
128855507|NCT00832000|463766220|FG001|Overall Study|Adverse Event|0|||
128855508|NCT00832000|463766219|FG000|Overall Study|Withdrawal by Subject|1|||
128855509|NCT00832000|463766220|FG001|Overall Study|Withdrawal by Subject|0|||
128855510|NCT00832000|463766219|FG000|Overall Study|No calls to IVR in either period|1|||
128855511|NCT00832000|463766220|FG001|Overall Study|No calls to IVR in either period|1|||
128855512|NCT00832000|463766219|FG000|Overall Study|No calls to IVR in period 2|2|||
128855513|NCT00832000|463766220|FG001|Overall Study|No calls to IVR in period 2|0|||
128855514|NCT00255944|463766221|FG000|Overall Study|Lost to Follow-up|797|||
128855515|NCT00255944|463766222|FG001|Overall Study|Lost to Follow-up|834|||
128855516|NCT01129115|463766223|FG000|Overall Study|Adverse Event|1|||
128855517|NCT01129115|463766224|FG001|Overall Study|Adverse Event|2|||
128855518|NCT01129115|463766225|FG002|Overall Study|Adverse Event|3|||
128855519|NCT01129115|463766226|FG003|Overall Study|Adverse Event|3|||
128855520|NCT01129115|463766223|FG000|Overall Study|Withdrawal by Subject|1|||
128855521|NCT01129115|463766224|FG001|Overall Study|Withdrawal by Subject|3|||
128855522|NCT01129115|463766225|FG002|Overall Study|Withdrawal by Subject|1|||
128855523|NCT01129115|463766226|FG003|Overall Study|Withdrawal by Subject|4|||
128855524|NCT01129115|463766223|FG000|Overall Study|Protocol Violation|0|||
128855525|NCT01129115|463766224|FG001|Overall Study|Protocol Violation|2|||
128855526|NCT01129115|463766225|FG002|Overall Study|Protocol Violation|2|||
128855527|NCT01129115|463766226|FG003|Overall Study|Protocol Violation|2|||
128855528|NCT02299427|463766228|FG000|Overall Study|Withdrawal by Subject|1|||
128855529|NCT02299427|463766229|FG001|Overall Study|Withdrawal by Subject|0|||
128855530|NCT02299427|463766228|FG000|Overall Study|Lost to Follow-up|1|||
128855531|NCT02299427|463766229|FG001|Overall Study|Lost to Follow-up|3|||
128855532|NCT02299427|463766228|FG000|Overall Study|not adherent to dog website use|21|||
128855533|NCT02299427|463766229|FG001|Overall Study|not adherent to dog website use|0|||
128855534|NCT02108652|463766230|FG000|Overall Study|Death|253|||
128855535|NCT02108652|463766230|FG000|Overall Study|Lost to Follow-up|2|||
128855536|NCT02108652|463766230|FG000|Overall Study|Withdrawal by Subject|16|||
128855537|NCT02108652|463766230|FG000|Overall Study|Study Terminated By Sponsor|31|||
128855538|NCT02108652|463766230|FG000|Overall Study|Non-Compliance|1|||
128855539|NCT02108652|463766230|FG000|Overall Study|Physician Decision|6|||
128855540|NCT02108652|463766230|FG000|Overall Study|Progression Of Disease|1|||
128855541|NCT01121913|463766231|FG000|First Intervention Period|Adverse Event|0|||
128855542|NCT01121913|463766232|FG001|First Intervention Period|Adverse Event|0|||
128855543|NCT01121913|463766233|FG002|First Intervention Period|Adverse Event|1|||
128855544|NCT01121913|463766234|FG003|First Intervention Period|Adverse Event|0|||
128855545|NCT01121913|463766231|FG000|First Washout Period|Withdrawal by Subject|1|||
128855546|NCT01121913|463766232|FG001|First Washout Period|Withdrawal by Subject|0|||
128855547|NCT01121913|463766233|FG002|First Washout Period|Withdrawal by Subject|0|||
128855548|NCT01121913|463766234|FG003|First Washout Period|Withdrawal by Subject|0|||
128855549|NCT01121913|463766231|FG000|Second Intervention Period|Adverse Event|0|||
128855550|NCT01121913|463766232|FG001|Second Intervention Period|Adverse Event|0|||
128855551|NCT01121913|463766233|FG002|Second Intervention Period|Adverse Event|1|||
128855552|NCT01121913|463766234|FG003|Second Intervention Period|Adverse Event|0|||
128855553|NCT01121913|463766231|FG000|Second Washout Period|Withdrawal by Subject|0|||
128855554|NCT01121913|463766232|FG001|Second Washout Period|Withdrawal by Subject|0|||
128855555|NCT01121913|463766233|FG002|Second Washout Period|Withdrawal by Subject|1|||
128855556|NCT01121913|463766234|FG003|Second Washout Period|Withdrawal by Subject|0|||
128855557|NCT01121913|463766231|FG000|Third Washout Period|Adverse Event|1|||
128855558|NCT01121913|463766232|FG001|Third Washout Period|Adverse Event|0|||
128855559|NCT01121913|463766233|FG002|Third Washout Period|Adverse Event|0|||
128855560|NCT01121913|463766234|FG003|Third Washout Period|Adverse Event|0|||
128855561|NCT02564718|463766237|FG000|Overall Study|Withdrew from treatment|0|||
128855562|NCT02564718|463766238|FG001|Overall Study|Withdrew from treatment|1|||
128855563|NCT00935259|463766239|FG000|Period 1|Administrative (scheduling conflict)|1|||
128855564|NCT00935259|463766240|FG001|Period 1|Administrative (scheduling conflict)|1|||
128855565|NCT01017263|463766241|FG000|Overall Study|not eligible|12|||
128855566|NCT02980705|463766242|FG000|Overall Study|Adverse Event|0|||
128855567|NCT02980705|463766243|FG001|Overall Study|Adverse Event|1|||
128855568|NCT02980705|463766242|FG000|Overall Study|Withdrawal by Subject|6|||
128855569|NCT02980705|463766243|FG001|Overall Study|Withdrawal by Subject|9|||
128855570|NCT02980705|463766242|FG000|Overall Study|withdrew participation|0|||
128855571|NCT02980705|463766243|FG001|Overall Study|withdrew participation|1|||
128855572|NCT02980705|463766242|FG000|Overall Study|Lost to Follow-up|2|||
128855573|NCT02980705|463766243|FG001|Overall Study|Lost to Follow-up|0|||
128855574|NCT04353817|463766244|FG000|Overall Study|Adverse Event|0|||
128855575|NCT04353817|463766245|FG001|Overall Study|Adverse Event|1|||
128855576|NCT00002597|463766246|FG000|Overall Study|Protocol Violation|19|||
128855577|NCT00002597|463766247|FG001|Overall Study|Protocol Violation|17|||
128855578|NCT00002597|463766246|FG000|Overall Study|Withdrawal by Subject|7|||
128855579|NCT00002597|463766247|FG001|Overall Study|Withdrawal by Subject|6|||
128855580|NCT02654132|463766248|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
128855581|NCT02654132|463766249|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
128855582|NCT02654132|463766248|FG000|Treatment Period|Disease progression|43|||
128855583|NCT02654132|463766249|FG001|Treatment Period|Disease progression|38|||
128855584|NCT02654132|463766248|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
128855585|NCT02654132|463766249|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
128855586|NCT02654132|463766248|FG000|Treatment Period|Other reasons|4|||
128855587|NCT02654132|463766249|FG001|Treatment Period|Other reasons|2|||
128855588|NCT02654132|463766248|FG000|Treatment Period|Study drug toxicity|2|||
128855589|NCT02654132|463766249|FG001|Treatment Period|Study drug toxicity|2|||
128855590|NCT02654132|463766248|FG000|Treatment Period|Withdrawal by Subject|2|||
128855591|NCT02654132|463766249|FG001|Treatment Period|Withdrawal by Subject|1|||
128855592|NCT02654132|463766248|FG000|Treatment Period|Maximum Clinical Benefit|0|||
128855593|NCT02654132|463766249|FG001|Treatment Period|Maximum Clinical Benefit|2|||
128855594|NCT02654132|463766248|FG000|Treatment Period|Participant request to discontinue|2|||
128855595|NCT02654132|463766249|FG001|Treatment Period|Participant request to discontinue|0|||
128855596|NCT02654132|463766248|FG000|Treatment Period|Administrative reasons by sponsor|0|||
128855597|NCT02654132|463766249|FG001|Treatment Period|Administrative reasons by sponsor|1|||
128855598|NCT02654132|463766248|FG000|Treatment Period|Death|1|||
128855599|NCT02654132|463766249|FG001|Treatment Period|Death|0|||
128855600|NCT02485899|463766251|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
128855601|NCT02485899|463766252|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
128855602|NCT02485899|463766251|FG000|Overall Study|Withdrawal by Subject|1|||
128855603|NCT02485899|463766252|FG001|Overall Study|Withdrawal by Subject|0|||
128855604|NCT02485899|463766251|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
128855605|NCT02485899|463766252|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
128855606|NCT01918371|463766253|FG000|Overall Study|Missing Data|1|||
128855607|NCT01918371|463766254|FG001|Overall Study|Missing Data|1|||
128855608|NCT00823836|463766255|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
128855609|NCT00823836|463766256|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
128855610|NCT00823836|463766255|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
128855611|NCT00823836|463766256|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
128855612|NCT00823836|463766255|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
128855613|NCT00823836|463766256|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
128855614|NCT00823836|463766255|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
128855615|NCT00823836|463766256|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
128855616|NCT00823836|463766255|FG000|Long-term Phase|Adverse Event|3|||
128855617|NCT00823836|463766256|FG001|Long-term Phase|Adverse Event|2|||
128855618|NCT00823836|463766255|FG000|Long-term Phase|Physician Decision|1|||
128855619|NCT00823836|463766256|FG001|Long-term Phase|Physician Decision|2|||
128855620|NCT00823836|463766255|FG000|Long-term Phase|Withdrawal by Subject|1|||
128855621|NCT00823836|463766256|FG001|Long-term Phase|Withdrawal by Subject|1|||
128855622|NCT01880437|463766257|FG000|Overall Study|Death|12|||
128855623|NCT01880437|463766258|FG001|Overall Study|Death|4|||
128855624|NCT01880437|463766259|FG002|Overall Study|Death|17|||
128855625|NCT01880437|463766257|FG000|Overall Study|Study terminated by Sponsor|3|||
128855626|NCT01880437|463766258|FG001|Overall Study|Study terminated by Sponsor|0|||
128855627|NCT01880437|463766259|FG002|Overall Study|Study terminated by Sponsor|2|||
128855628|NCT02725528|463766265|FG000|Overall Study|Lost to Follow-up|1|||
128855629|NCT02725528|463766266|FG001|Overall Study|Lost to Follow-up|4|||
128855630|NCT02725528|463766265|FG000|Overall Study|Withdrawal by Subject|0|||
128855631|NCT02725528|463766266|FG001|Overall Study|Withdrawal by Subject|1|||
128855632|NCT02569957|463766267|FG000|Overall Study|Withdrawal by Subject|0|||
128855633|NCT02569957|463766268|FG001|Overall Study|Withdrawal by Subject|1|||
128855634|NCT04354168|463766270|FG000|Overall Study|Lost to Follow-up|22|||
128855635|NCT01438840|463766273|FG000|Core Study|Adverse Event|0|||
128855636|NCT01438840|463766274|FG001|Core Study|Adverse Event|3|||
128855637|NCT01438840|463766275|FG002|Core Study|Adverse Event|0|||
128855638|NCT01438840|463766273|FG000|Core Study|Lack of Efficacy|15|||
128855639|NCT01438840|463766274|FG001|Core Study|Lack of Efficacy|7|||
128855640|NCT01438840|463766275|FG002|Core Study|Lack of Efficacy|0|||
128855641|NCT01438840|463766273|FG000|Core Study|Withdrawal of consent|1|||
128855642|NCT01438840|463766274|FG001|Core Study|Withdrawal of consent|0|||
128855643|NCT01438840|463766275|FG002|Core Study|Withdrawal of consent|0|||
128855644|NCT01438840|463766273|FG000|Extension Phase|Adverse Event|0|||
128855645|NCT01438840|463766274|FG001|Extension Phase|Adverse Event|0|||
128855646|NCT01438840|463766275|FG002|Extension Phase|Adverse Event|3|||
128855647|NCT01438840|463766273|FG000|Extension Phase|Lost to Follow-up|0|||
128855648|NCT01438840|463766274|FG001|Extension Phase|Lost to Follow-up|0|||
128855649|NCT01438840|463766275|FG002|Extension Phase|Lost to Follow-up|1|||
128855650|NCT01438840|463766273|FG000|Extension Phase|Withdrawal by Subject|0|||
128855651|NCT01438840|463766274|FG001|Extension Phase|Withdrawal by Subject|0|||
128855652|NCT01438840|463766275|FG002|Extension Phase|Withdrawal by Subject|3|||
128855653|NCT01438840|463766273|FG000|Extension Phase|Lack of Efficacy|0|||
128855654|NCT01438840|463766274|FG001|Extension Phase|Lack of Efficacy|0|||
128855655|NCT01438840|463766275|FG002|Extension Phase|Lack of Efficacy|2|||
128855656|NCT01438840|463766273|FG000|Extension Phase|Other|0|||
128855657|NCT01438840|463766274|FG001|Extension Phase|Other|0|||
128855658|NCT01438840|463766275|FG002|Extension Phase|Other|1|||
128855659|NCT02062645|463766278|FG000|Overall Study|Adverse Event|2|||
128855660|NCT02062645|463766278|FG000|Overall Study|Protocol Violation|8|||
128855661|NCT02062645|463766278|FG000|Overall Study|Lost to Follow-up|5|||
128855662|NCT02804399|463766279|FG000|Period 2|Adverse Event|0|||
128855663|NCT02804399|463766280|FG001|Period 2|Adverse Event|1|||
128855664|NCT01774305|463766281|FG000|Overall Study|Physician Decision|1|||
128855665|NCT01774305|463766282|FG001|Overall Study|Physician Decision|0|||
128855666|NCT04211389|463766283|FG000|Overall Study|Adverse Event|1|||
128855667|NCT04211389|463766284|FG001|Overall Study|Adverse Event|2|||
128855668|NCT04211389|463766283|FG000|Overall Study|Lost to Follow-up|15|||
128855669|NCT04211389|463766284|FG001|Overall Study|Lost to Follow-up|7|||
128855670|NCT04211389|463766283|FG000|Overall Study|Protocol Violation|0|||
128855671|NCT04211389|463766284|FG001|Overall Study|Protocol Violation|1|||
128855672|NCT04211389|463766283|FG000|Overall Study|Withdrawal by Subject|10|||
128855673|NCT04211389|463766284|FG001|Overall Study|Withdrawal by Subject|11|||
128855674|NCT01062971|463766290|FG000|Overall Study|Protocol Violation|1|||
128855675|NCT01062971|463766291|FG001|Overall Study|Protocol Violation|3|||
128855676|NCT01062971|463766290|FG000|Overall Study|Lost to Follow-up|3|||
128855677|NCT01062971|463766291|FG001|Overall Study|Lost to Follow-up|4|||
128855678|NCT01530087|463766292|FG000|Overall Study|Physician Decision|2|||
128855679|NCT05523219|463766293|FG000|Overall Study|Wrong inclusion|1|||
128855680|NCT05523219|463766293|FG000|Overall Study|Lost to Follow-up|7|||
128855681|NCT01182207|463766294|FG000|First Intervention|Positive Hepatitis Results|0|||
128855682|NCT01182207|463766295|FG001|First Intervention|Positive Hepatitis Results|1|||
128855683|NCT01182207|463766294|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
128855684|NCT01182207|463766295|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
128855685|NCT04680637|463766296|FG000|Overall Study|Lost to Follow-up|0|||
128855686|NCT04680637|463766297|FG001|Overall Study|Lost to Follow-up|1|||
128855687|NCT04680637|463766298|FG002|Overall Study|Lost to Follow-up|0|||
128855688|NCT04680637|463766299|FG003|Overall Study|Lost to Follow-up|1|||
128855689|NCT04680637|463766296|FG000|Overall Study|Death|1|||
128855690|NCT04680637|463766297|FG001|Overall Study|Death|0|||
128855691|NCT04680637|463766298|FG002|Overall Study|Death|0|||
128855692|NCT04680637|463766299|FG003|Overall Study|Death|0|||
128855693|NCT04680637|463766296|FG000|Overall Study|Withdrawal by Subject|7|||
128855694|NCT04680637|463766297|FG001|Overall Study|Withdrawal by Subject|10|||
128855695|NCT04680637|463766298|FG002|Overall Study|Withdrawal by Subject|17|||
128855696|NCT04680637|463766299|FG003|Overall Study|Withdrawal by Subject|15|||
128855697|NCT04680637|463766296|FG000|Overall Study|Decision by Sponsor|21|||
128855698|NCT04680637|463766297|FG001|Overall Study|Decision by Sponsor|15|||
128855699|NCT04680637|463766298|FG002|Overall Study|Decision by Sponsor|7|||
128855700|NCT04680637|463766299|FG003|Overall Study|Decision by Sponsor|32|||
128855701|NCT02037256|463766302|FG000|Overall Study|Protocol Violation|0|||
128855702|NCT02037256|463766303|FG001|Overall Study|Protocol Violation|1|||
128855703|NCT02037256|463766302|FG000|Overall Study|Withdrawn prior to Velcade|0|||
128855704|NCT02037256|463766303|FG001|Overall Study|Withdrawn prior to Velcade|2|||
128855705|NCT04398368|463768287|FG000|Overall Study|Withdrawal by Subject|2|||
128855706|NCT00891046|463768292|FG000|Overall Study|Protocol Violation|1|||
128855707|NCT00891046|463768293|FG001|Overall Study|Protocol Violation|1|||
128855708|NCT00891046|463768294|FG002|Overall Study|Protocol Violation|0|||
128855709|NCT00891046|463768295|FG003|Overall Study|Protocol Violation|0|||
128855710|NCT00891046|463768296|FG004|Overall Study|Protocol Violation|1|||
128855711|NCT00891046|463768292|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
128855712|NCT00891046|463768293|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
128855713|NCT00891046|463768294|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
128855714|NCT00891046|463768295|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
128855715|NCT00891046|463768296|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
128855716|NCT00891046|463768292|FG000|Overall Study|Administrative problems|0|||
128855717|NCT00891046|463768293|FG001|Overall Study|Administrative problems|0|||
128855718|NCT00891046|463768294|FG002|Overall Study|Administrative problems|0|||
128855719|NCT00891046|463768295|FG003|Overall Study|Administrative problems|0|||
128855720|NCT00891046|463768296|FG004|Overall Study|Administrative problems|1|||
128855721|NCT00891046|463768292|FG000|Overall Study|Participant no longer required drug|0|||
128855722|NCT00891046|463768293|FG001|Overall Study|Participant no longer required drug|2|||
128855723|NCT00891046|463768294|FG002|Overall Study|Participant no longer required drug|0|||
128855724|NCT00891046|463768295|FG003|Overall Study|Participant no longer required drug|0|||
128855725|NCT00891046|463768296|FG004|Overall Study|Participant no longer required drug|1|||
128855726|NCT00891046|463768292|FG000|Overall Study|Adverse Event|4|||
128855727|NCT00891046|463768293|FG001|Overall Study|Adverse Event|3|||
128855728|NCT00891046|463768294|FG002|Overall Study|Adverse Event|2|||
128855729|NCT00891046|463768295|FG003|Overall Study|Adverse Event|0|||
128855730|NCT00891046|463768296|FG004|Overall Study|Adverse Event|14|||
128855731|NCT00891046|463768292|FG000|Overall Study|Withdrawal by Subject|2|||
128855732|NCT00891046|463768293|FG001|Overall Study|Withdrawal by Subject|1|||
128855733|NCT00891046|463768294|FG002|Overall Study|Withdrawal by Subject|2|||
128855734|NCT00891046|463768295|FG003|Overall Study|Withdrawal by Subject|1|||
128855735|NCT00891046|463768296|FG004|Overall Study|Withdrawal by Subject|1|||
128855736|NCT00891046|463768292|FG000|Overall Study|Lost to Follow-up|0|||
128855737|NCT00891046|463768293|FG001|Overall Study|Lost to Follow-up|0|||
128855738|NCT00891046|463768294|FG002|Overall Study|Lost to Follow-up|0|||
128855739|NCT00891046|463768295|FG003|Overall Study|Lost to Follow-up|0|||
128855740|NCT00891046|463768296|FG004|Overall Study|Lost to Follow-up|1|||
128855741|NCT04523207|463768299|FG000|Overall Study|Adverse Event|5|||
128855742|NCT04523207|463768300|FG001|Overall Study|Adverse Event|1|||
128855743|NCT04523207|463768299|FG000|Overall Study|Lost to Follow-up|2|||
128855744|NCT04523207|463768300|FG001|Overall Study|Lost to Follow-up|0|||
128855745|NCT04523207|463768299|FG000|Overall Study|Withdrawal by Subject|2|||
128855746|NCT04523207|463768300|FG001|Overall Study|Withdrawal by Subject|0|||
128855747|NCT04523207|463768299|FG000|Overall Study|Progressive Disease|2|||
128855748|NCT04523207|463768300|FG001|Overall Study|Progressive Disease|1|||
128855749|NCT04523207|463768299|FG000|Overall Study|Other|7|||
128855750|NCT04523207|463768300|FG001|Overall Study|Other|1|||
128855751|NCT03113383|463768301|FG000|Overall Study|Death|4|||
128855752|NCT03113383|463768302|FG001|Overall Study|Death|0|||
128855753|NCT01519778|463768306|FG000|Overall Study|Withdrawal by Subject|3|||
128855754|NCT01519778|463768306|FG000|Overall Study|Lost to Follow-up|10|||
128855755|NCT01519778|463768306|FG000|Overall Study|Physician Decision|1|||
128855756|NCT00412880|463768307|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
128855757|NCT00412880|463768307|FG000|Overall Study|Consent withdrawn|1|||
128855758|NCT00412880|463768307|FG000|Overall Study|Adverse Event|1|||
128855759|NCT00412880|463768307|FG000|Overall Study|Progressive disease|20|||
128855760|NCT01288209|463768308|FG000|Overall Study|Withdrawal by Subject|1|||
128855761|NCT01288209|463768309|FG001|Overall Study|Withdrawal by Subject|3|||
128855762|NCT01288209|463768308|FG000|Overall Study|Other|1|||
128855763|NCT01288209|463768309|FG001|Overall Study|Other|0|||
128855764|NCT01496365|463768310|FG000|Overall Study|Adverse Event|2|||
128855765|NCT01496365|463768311|FG001|Overall Study|Adverse Event|3|||
128855766|NCT01496365|463768312|FG002|Overall Study|Adverse Event|3|||
128855767|NCT01496365|463768313|FG003|Overall Study|Adverse Event|2|||
128855768|NCT01496365|463768314|FG004|Overall Study|Adverse Event|5|||
128855769|NCT01496365|463768315|FG005|Overall Study|Adverse Event|6|||
128855770|NCT01496365|463768316|FG006|Overall Study|Adverse Event|4|||
128855771|NCT01496365|463768310|FG000|Overall Study|Withdrawal by Subject|6|||
128855772|NCT01496365|463768311|FG001|Overall Study|Withdrawal by Subject|6|||
128855773|NCT01496365|463768312|FG002|Overall Study|Withdrawal by Subject|0|||
128855774|NCT01496365|463768313|FG003|Overall Study|Withdrawal by Subject|1|||
128855775|NCT01496365|463768314|FG004|Overall Study|Withdrawal by Subject|3|||
128855776|NCT01496365|463768315|FG005|Overall Study|Withdrawal by Subject|2|||
128855777|NCT01496365|463768316|FG006|Overall Study|Withdrawal by Subject|1|||
128855778|NCT01496365|463768310|FG000|Overall Study|Protocol Violation|2|||
128855779|NCT01496365|463768311|FG001|Overall Study|Protocol Violation|1|||
128855780|NCT01496365|463768312|FG002|Overall Study|Protocol Violation|1|||
128855781|NCT01496365|463768313|FG003|Overall Study|Protocol Violation|0|||
128855782|NCT01496365|463768314|FG004|Overall Study|Protocol Violation|0|||
128855783|NCT01496365|463768315|FG005|Overall Study|Protocol Violation|1|||
128855784|NCT01496365|463768316|FG006|Overall Study|Protocol Violation|0|||
128855785|NCT01496365|463768310|FG000|Overall Study|Lack of Efficacy|1|||
128855786|NCT01496365|463768311|FG001|Overall Study|Lack of Efficacy|0|||
128855787|NCT01496365|463768312|FG002|Overall Study|Lack of Efficacy|0|||
128855788|NCT01496365|463768313|FG003|Overall Study|Lack of Efficacy|0|||
128855789|NCT01496365|463768314|FG004|Overall Study|Lack of Efficacy|0|||
128855790|NCT01496365|463768315|FG005|Overall Study|Lack of Efficacy|1|||
128855791|NCT01496365|463768316|FG006|Overall Study|Lack of Efficacy|0|||
128855792|NCT01496365|463768310|FG000|Overall Study|Lost to Follow-up|0|||
128855793|NCT01496365|463768311|FG001|Overall Study|Lost to Follow-up|1|||
128855794|NCT01496365|463768312|FG002|Overall Study|Lost to Follow-up|0|||
128855795|NCT01496365|463768313|FG003|Overall Study|Lost to Follow-up|0|||
128855796|NCT01496365|463768314|FG004|Overall Study|Lost to Follow-up|2|||
128855797|NCT01496365|463768315|FG005|Overall Study|Lost to Follow-up|0|||
128855798|NCT01496365|463768316|FG006|Overall Study|Lost to Follow-up|0|||
128855799|NCT01496365|463768310|FG000|Overall Study|Other|4|||
128855800|NCT01496365|463768311|FG001|Overall Study|Other|4|||
128855801|NCT01496365|463768312|FG002|Overall Study|Other|2|||
128855802|NCT01496365|463768313|FG003|Overall Study|Other|1|||
128855803|NCT01496365|463768314|FG004|Overall Study|Other|3|||
128855804|NCT01496365|463768315|FG005|Overall Study|Other|0|||
128855805|NCT01496365|463768316|FG006|Overall Study|Other|1|||
128855806|NCT01015677|463768317|FG000|Overall Study|Adverse Event|0|||
128855807|NCT01015677|463768318|FG001|Overall Study|Adverse Event|1|||
128855808|NCT01015677|463768319|FG002|Overall Study|Adverse Event|0|||
128855809|NCT01015677|463768317|FG000|Overall Study|Lack of Efficacy|0|||
128855810|NCT01015677|463768318|FG001|Overall Study|Lack of Efficacy|1|||
128855811|NCT01015677|463768319|FG002|Overall Study|Lack of Efficacy|0|||
128855812|NCT01015677|463768317|FG000|Overall Study|Protocol Violation|0|||
128855813|NCT01015677|463768318|FG001|Overall Study|Protocol Violation|1|||
128855814|NCT01015677|463768319|FG002|Overall Study|Protocol Violation|0|||
128855815|NCT01015677|463768317|FG000|Overall Study|Withdrawal by Subject|1|||
128855816|NCT01015677|463768318|FG001|Overall Study|Withdrawal by Subject|1|||
128855817|NCT01015677|463768319|FG002|Overall Study|Withdrawal by Subject|0|||
128855818|NCT01646385|463768322|FG000|Overall Study|Death|202|||
128855819|NCT01646385|463768323|FG001|Overall Study|Death|222|||
128855820|NCT01646385|463768322|FG000|Overall Study|Switched to alternate biologic|636|||
128855821|NCT01646385|463768323|FG001|Overall Study|Switched to alternate biologic|649|||
128855822|NCT01843777|463768324|FG000|Overall Study|Withdrawal by Subject|1|||
128855823|NCT01843777|463768325|FG001|Overall Study|Withdrawal by Subject|0|||
128855824|NCT02165397|463768333|FG000|Overall Study|Death|7|||
128855825|NCT02165397|463768334|FG001|Overall Study|Death|10|||
128855826|NCT02165397|463768335|FG002|Overall Study|Death|8|||
128855827|NCT02165397|463768333|FG000|Overall Study|Lost to Follow-up|1|||
128855828|NCT02165397|463768334|FG001|Overall Study|Lost to Follow-up|3|||
128855829|NCT02165397|463768335|FG002|Overall Study|Lost to Follow-up|0|||
128855830|NCT02165397|463768333|FG000|Overall Study|Withdrawal by Subject|6|||
128855831|NCT02165397|463768334|FG001|Overall Study|Withdrawal by Subject|6|||
128855832|NCT02165397|463768335|FG002|Overall Study|Withdrawal by Subject|1|||
128855833|NCT02165397|463768333|FG000|Overall Study|Other, Not Specified|0|||
128855834|NCT02165397|463768334|FG001|Overall Study|Other, Not Specified|0|||
128855835|NCT02165397|463768335|FG002|Overall Study|Other, Not Specified|1|||
128855836|NCT04799418|463768336|FG000|Overall Study|Death|1|||
128855837|NCT04799418|463768337|FG001|Overall Study|Death|1|||
128855838|NCT04799418|463768336|FG000|Overall Study|Lack of Efficacy|14|||
128855839|NCT04799418|463768337|FG001|Overall Study|Lack of Efficacy|14|||
128855840|NCT04799418|463768336|FG000|Overall Study|Withdrawal by Subject|10|||
128855841|NCT04799418|463768337|FG001|Overall Study|Withdrawal by Subject|7|||
128855842|NCT04799418|463768336|FG000|Overall Study|Adverse Event|3|||
128855843|NCT04799418|463768337|FG001|Overall Study|Adverse Event|2|||
128855844|NCT03297398|463768338|FG000|Overall Study|Sponsor's decision|6|||
128855845|NCT03297398|463768339|FG001|Overall Study|Sponsor's decision|9|||
128855846|NCT03297398|463768340|FG002|Overall Study|Sponsor's decision|7|||
128855847|NCT03297398|463768338|FG000|Overall Study|Adverse Event|1|||
128855848|NCT03297398|463768339|FG001|Overall Study|Adverse Event|4|||
128855849|NCT03297398|463768340|FG002|Overall Study|Adverse Event|4|||
128855850|NCT03297398|463768338|FG000|Overall Study|Withdrawal by Subject|1|||
128855851|NCT03297398|463768339|FG001|Overall Study|Withdrawal by Subject|2|||
128855852|NCT03297398|463768340|FG002|Overall Study|Withdrawal by Subject|2|||
128855853|NCT03297398|463768338|FG000|Overall Study|Protocol Violation|0|||
128855854|NCT03297398|463768339|FG001|Overall Study|Protocol Violation|2|||
128855855|NCT03297398|463768340|FG002|Overall Study|Protocol Violation|0|||
128855856|NCT03297398|463768338|FG000|Overall Study|Physician Decision|0|||
128855857|NCT03297398|463768339|FG001|Overall Study|Physician Decision|0|||
128855858|NCT03297398|463768340|FG002|Overall Study|Physician Decision|1|||
128855859|NCT03297398|463768338|FG000|Overall Study|Lost to Follow-up|0|||
128855860|NCT03297398|463768339|FG001|Overall Study|Lost to Follow-up|0|||
128855861|NCT03297398|463768340|FG002|Overall Study|Lost to Follow-up|1|||
128855862|NCT03732820|463768355|FG000|Overall Study|Death|168|||
128855863|NCT03732820|463768356|FG001|Overall Study|Death|203|||
128855864|NCT03732820|463768355|FG000|Overall Study|Other|2|||
128855865|NCT03732820|463768356|FG001|Overall Study|Other|2|||
128855866|NCT03732820|463768355|FG000|Overall Study|Failure to meet randomisation criteria|1|||
128855867|NCT03732820|463768356|FG001|Overall Study|Failure to meet randomisation criteria|1|||
128855868|NCT03732820|463768355|FG000|Overall Study|Patient decision|14|||
128855869|NCT03732820|463768356|FG001|Overall Study|Patient decision|10|||
128855870|NCT03732820|463768355|FG000|Overall Study|Screen failure|0|||
128855871|NCT03732820|463768356|FG001|Overall Study|Screen failure|1|||
128855872|NCT03732820|463768355|FG000|Overall Study|Patients ongoing study at data cut off|210|||
128855873|NCT03732820|463768356|FG001|Overall Study|Patients ongoing study at data cut off|178|||
128855874|NCT03732820|463768355|FG000|Overall Study|Lost to Follow-up|4|||
128855875|NCT03732820|463768356|FG001|Overall Study|Lost to Follow-up|2|||
128855876|NCT00992992|463768357|FG000|Overall Study|Lost to Follow-up|3|||
128855877|NCT00992992|463768357|FG000|Overall Study|Death|16|||
128855878|NCT00992992|463768357|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
128855879|NCT00992992|463768357|FG000|Overall Study|Sponsor Closed the Study|4|||
128855880|NCT02250534|463768358|FG000|Overall Study|Lost to Follow-up|18|||
128855881|NCT02250534|463768359|FG001|Overall Study|Lost to Follow-up|28|||
128855882|NCT02250534|463768360|FG002|Overall Study|Lost to Follow-up|33|||
128855883|NCT02250534|463768358|FG000|Overall Study|Personal reasons|7|||
128855884|NCT02250534|463768359|FG001|Overall Study|Personal reasons|8|||
128855885|NCT02250534|463768360|FG002|Overall Study|Personal reasons|14|||
128855886|NCT02250534|463768358|FG000|Overall Study|Adverse Event|6|||
128855887|NCT02250534|463768359|FG001|Overall Study|Adverse Event|3|||
128855888|NCT02250534|463768360|FG002|Overall Study|Adverse Event|8|||
128855889|NCT02250534|463768358|FG000|Overall Study|incarcerated|2|||
128855890|NCT02250534|463768359|FG001|Overall Study|incarcerated|1|||
128855891|NCT02250534|463768360|FG002|Overall Study|incarcerated|2|||
128855892|NCT02250534|463768358|FG000|Overall Study|Withdrawal by Subject|0|||
128855893|NCT02250534|463768359|FG001|Overall Study|Withdrawal by Subject|1|||
128855894|NCT02250534|463768360|FG002|Overall Study|Withdrawal by Subject|2|||
128855895|NCT02250534|463768358|FG000|Overall Study|Death|0|||
128855896|NCT02250534|463768359|FG001|Overall Study|Death|1|||
128855897|NCT02250534|463768360|FG002|Overall Study|Death|1|||
128855898|NCT02250534|463768358|FG000|Overall Study|Physician Decision|1|||
128855899|NCT02250534|463768359|FG001|Overall Study|Physician Decision|3|||
128855900|NCT02250534|463768360|FG002|Overall Study|Physician Decision|1|||
128855901|NCT02250534|463768358|FG000|Overall Study|Protocol Violation|1|||
128855902|NCT02250534|463768359|FG001|Overall Study|Protocol Violation|0|||
128855903|NCT02250534|463768360|FG002|Overall Study|Protocol Violation|1|||
128855904|NCT02250534|463768358|FG000|Overall Study|Reason unknown|1|||
128855905|NCT02250534|463768359|FG001|Overall Study|Reason unknown|0|||
128855906|NCT02250534|463768360|FG002|Overall Study|Reason unknown|0|||
128855907|NCT00217022|463768361|FG000|Overall Study|Withdrawal by Subject|1|||
128855908|NCT00217022|463768362|FG001|Overall Study|Withdrawal by Subject|1|||
128855909|NCT02725567|463768364|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
128855910|NCT02725567|463768365|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
128855911|NCT02725567|463768364|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
128855912|NCT02725567|463768365|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
128855913|NCT02725567|463768364|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
128855914|NCT02725567|463768365|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
128855915|NCT01182181|463768366|FG000|First Intervention|Adverse Event|1|||
128855916|NCT01182181|463768367|FG001|First Intervention|Adverse Event|0|||
128855917|NCT01182181|463768366|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
128855918|NCT01182181|463768367|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
128855919|NCT03845075|463768368|FG000|Part 1 - DB|Withdrawal by Subject|1|||
128855920|NCT03845075|463768369|FG001|Part 1 - DB|Withdrawal by Subject|1|||
128855921|NCT03845075|463768370|FG002|Part 1 - DB|Withdrawal by Subject|0|||
128855922|NCT03845075|463768371|FG003|Part 1 - DB|Withdrawal by Subject|0|||
128855923|NCT03845075|463768368|FG000|Part 1 - DB|Adverse Event|0|||
128855924|NCT03845075|463768369|FG001|Part 1 - DB|Adverse Event|1|||
128855925|NCT03845075|463768370|FG002|Part 1 - DB|Adverse Event|0|||
128855926|NCT03845075|463768371|FG003|Part 1 - DB|Adverse Event|0|||
128855927|NCT03845075|463768368|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
128855928|NCT03845075|463768369|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
128855929|NCT03845075|463768370|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
128855930|NCT03845075|463768371|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
128855931|NCT03856047|463768372|FG000|Overall Study|Withdrawal by Subject|0|||
128855932|NCT03856047|463768373|FG001|Overall Study|Withdrawal by Subject|1|||
128855933|NCT03856047|463768374|FG002|Overall Study|Withdrawal by Subject|1|||
128855934|NCT03856047|463768375|FG003|Overall Study|Withdrawal by Subject|0|||
128855935|NCT03856047|463768376|FG004|Overall Study|Withdrawal by Subject|3|||
128855936|NCT03856047|463768377|FG005|Overall Study|Withdrawal by Subject|0|||
128855937|NCT03856047|463768378|FG006|Overall Study|Withdrawal by Subject|2|||
128855938|NCT03856047|463768372|FG000|Overall Study|Lost to Follow-up|4|||
128855939|NCT03856047|463768373|FG001|Overall Study|Lost to Follow-up|2|||
128855940|NCT03856047|463768374|FG002|Overall Study|Lost to Follow-up|3|||
128855941|NCT03856047|463768375|FG003|Overall Study|Lost to Follow-up|1|||
128855942|NCT03856047|463768376|FG004|Overall Study|Lost to Follow-up|4|||
128855943|NCT03856047|463768377|FG005|Overall Study|Lost to Follow-up|4|||
128855944|NCT03856047|463768378|FG006|Overall Study|Lost to Follow-up|4|||
128855945|NCT00874497|463768382|FG000|Overall Study|Lost to Follow-up|2|||
128855946|NCT00874497|463768383|FG001|Overall Study|Lost to Follow-up|4|||
128855947|NCT00874497|463768382|FG000|Overall Study|Adverse Event|9|||
128855948|NCT00874497|463768383|FG001|Overall Study|Adverse Event|4|||
128855949|NCT00874497|463768382|FG000|Overall Study|Sponsor Discontinued Trial|7|||
128855950|NCT00874497|463768383|FG001|Overall Study|Sponsor Discontinued Trial|3|||
128855951|NCT00874497|463768382|FG000|Overall Study|Met Withdrawal Criteria|4|||
128855952|NCT00874497|463768383|FG001|Overall Study|Met Withdrawal Criteria|2|||
128855953|NCT00874497|463768382|FG000|Overall Study|Physician Decision|1|||
128855954|NCT00874497|463768383|FG001|Overall Study|Physician Decision|1|||
128855955|NCT00874497|463768382|FG000|Overall Study|Withdrawal by Subject|5|||
128855956|NCT00874497|463768383|FG001|Overall Study|Withdrawal by Subject|4|||
128855957|NCT00263575|463768384|FG000|Titration Period|Adverse Event|14|||
128855958|NCT00263575|463768384|FG000|Titration Period|Withdrawal by Subject|10|||
128855959|NCT00263575|463768384|FG000|Titration Period|Protocol Violation|9|||
128855960|NCT00263575|463768384|FG000|Titration Period|Sponsor Decision|2|||
128855961|NCT00263575|463768384|FG000|Titration Period|Other|2|||
128855962|NCT00263575|463768384|FG000|Titration Period|Lack of Efficacy|6|||
128855963|NCT00263575|463768384|FG000|Maintence Period|Adverse Event|23|||
128855964|NCT00263575|463768384|FG000|Maintence Period|Withdrawal by Subject|8|||
128855965|NCT00263575|463768384|FG000|Maintence Period|Protocol Violation|4|||
128855966|NCT00263575|463768384|FG000|Maintence Period|Lack of Efficacy|4|||
128855967|NCT00263575|463768384|FG000|Maintence Period|Physician Decision|6|||
128855968|NCT00263575|463768384|FG000|Maintence Period|Lost to Follow-up|1|||
128855969|NCT00263575|463768384|FG000|Maintence Period|Sponsor Decision|24|||
128855970|NCT00263575|463768384|FG000|Maintence Period|Other|7|||
128855971|NCT00665223|463768389|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
128855972|NCT00665223|463768390|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
128855973|NCT00665223|463768391|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
128855974|NCT00665223|463768389|FG000|Randomized Phase (26 Weeks)|Death|0|||
128855975|NCT00665223|463768390|FG001|Randomized Phase (26 Weeks)|Death|0|||
128855976|NCT00665223|463768391|FG002|Randomized Phase (26 Weeks)|Death|1|||
128855977|NCT00665223|463768389|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
128855978|NCT00665223|463768390|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
128855979|NCT00665223|463768391|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
128855980|NCT00665223|463768389|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
128855981|NCT00665223|463768390|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
128855982|NCT00665223|463768391|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
128855983|NCT00665223|463768389|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
128855984|NCT00665223|463768390|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
128855985|NCT00665223|463768391|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
128855986|NCT00665223|463768389|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
128855987|NCT00665223|463768390|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
128855988|NCT00665223|463768391|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
128855989|NCT00665223|463768389|FG000|Open-Label Period (26 Weeks)|Death|0|||
128855990|NCT00665223|463768390|FG001|Open-Label Period (26 Weeks)|Death|1|||
128855991|NCT00665223|463768391|FG002|Open-Label Period (26 Weeks)|Death|0|||
128855992|NCT00665223|463768389|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
128855993|NCT00665223|463768390|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
128855994|NCT00665223|463768391|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
128855995|NCT00665223|463768389|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
128855996|NCT00665223|463768390|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
128855997|NCT00665223|463768391|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
128855998|NCT00665223|463768389|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
128855999|NCT00665223|463768390|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
128856000|NCT00665223|463768391|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
128856001|NCT00665223|463768389|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
128856002|NCT00665223|463768390|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
128856003|NCT00665223|463768391|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
128856004|NCT01278615|463768392|FG000|Overall Study|Withdrawal by Subject|2|||
128856005|NCT00905359|463768393|FG000|Overall Study|Lost to Follow-up|17|||
128856006|NCT00905359|463768394|FG001|Overall Study|Lost to Follow-up|10|||
128856007|NCT00905359|463768393|FG000|Overall Study|Death|2|||
128856008|NCT00905359|463768394|FG001|Overall Study|Death|0|||
128856009|NCT00905359|463768393|FG000|Overall Study|Withdrawal consent|5|||
128856010|NCT00905359|463768394|FG001|Overall Study|Withdrawal consent|6|||
128856011|NCT02138253|463768395|FG000|Overall Study|Adverse Event|3|||
128856012|NCT02138253|463768396|FG001|Overall Study|Adverse Event|3|||
128856013|NCT02138253|463768395|FG000|Overall Study|Lost to Follow-up|2|||
128856014|NCT02138253|463768396|FG001|Overall Study|Lost to Follow-up|1|||
128856015|NCT02138253|463768395|FG000|Overall Study|Physician Decision|2|||
128856016|NCT02138253|463768396|FG001|Overall Study|Physician Decision|0|||
128856017|NCT02138253|463768395|FG000|Overall Study|Non compliance|1|||
128856018|NCT02138253|463768396|FG001|Overall Study|Non compliance|0|||
128856019|NCT02138253|463768395|FG000|Overall Study|Withdrawal by Subject|1|||
128856020|NCT02138253|463768396|FG001|Overall Study|Withdrawal by Subject|0|||
128856021|NCT01426113|463768397|FG000|Overall Study|Study Discontinued|1|||
128856022|NCT01426113|463768398|FG001|Overall Study|Study Discontinued|1|||
128856023|NCT01426113|463768397|FG000|Overall Study|Adverse Event|0|||
128856024|NCT01426113|463768398|FG001|Overall Study|Adverse Event|1|||
128856025|NCT02872012|463768399|FG000|Overall Study|Withdrawal by Subject|1|||
128856026|NCT02872012|463768400|FG001|Overall Study|Withdrawal by Subject|0|||
128856027|NCT02872012|463768401|FG002|Overall Study|Withdrawal by Subject|0|||
128856028|NCT02872012|463768402|FG003|Overall Study|Withdrawal by Subject|0|||
128856029|NCT02872012|463768403|FG004|Overall Study|Withdrawal by Subject|0|||
128856030|NCT01728623|463768404|FG000|Overall Study|Disease progression|26|||
128856031|NCT01728623|463768404|FG000|Overall Study|Adverse Event|1|||
128856032|NCT01728623|463768404|FG000|Overall Study|Withdrawal by Subject|1|||
128856033|NCT00243022|463768405|FG000|Overall Study|Withdrawal by Subject|1|||
128856034|NCT00243022|463768406|FG001|Overall Study|Withdrawal by Subject|0|||
128856035|NCT00243022|463768405|FG000|Overall Study|Death|1|||
128856036|NCT00243022|463768406|FG001|Overall Study|Death|0|||
128856037|NCT00243022|463768405|FG000|Overall Study|Difficult Travel Distance|0|||
128856038|NCT00243022|463768406|FG001|Overall Study|Difficult Travel Distance|1|||
128856039|NCT03517111|463768411|FG000|Enrolled|Withdrawal by Subject|0|||
128856040|NCT03517111|463768412|FG001|Enrolled|Withdrawal by Subject|1|||
128856041|NCT03517111|463768413|FG002|Enrolled|Withdrawal by Subject|0|||
128856042|NCT03517111|463768411|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
128856043|NCT03517111|463768412|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
128856044|NCT03517111|463768413|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
128856045|NCT03517111|463768411|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
128856046|NCT03517111|463768412|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
128856047|NCT03517111|463768413|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
128856048|NCT03517111|463768411|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
128856049|NCT03517111|463768412|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
128856050|NCT03517111|463768413|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
128856051|NCT03517111|463768411|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
128856052|NCT03517111|463768412|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
128856053|NCT03517111|463768413|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
128856054|NCT00621192|463768414|FG000|Overall Study|Withdrawal by Subject|0|||
128856055|NCT00621192|463768415|FG001|Overall Study|Withdrawal by Subject|0|||
128856056|NCT00621192|463768416|FG002|Overall Study|Withdrawal by Subject|2|||
128856057|NCT00621192|463768417|FG003|Overall Study|Withdrawal by Subject|0|||
128856058|NCT00621192|463768414|FG000|Overall Study|Physician Decision|1|||
128856059|NCT00621192|463768415|FG001|Overall Study|Physician Decision|3|||
128856060|NCT00621192|463768416|FG002|Overall Study|Physician Decision|0|||
128856061|NCT00621192|463768417|FG003|Overall Study|Physician Decision|0|||
128856062|NCT00621192|463768414|FG000|Overall Study|Protocol Violation|1|||
128856063|NCT00621192|463768415|FG001|Overall Study|Protocol Violation|0|||
128856064|NCT00621192|463768416|FG002|Overall Study|Protocol Violation|0|||
128856065|NCT00621192|463768417|FG003|Overall Study|Protocol Violation|1|||
128856066|NCT00621192|463768414|FG000|Overall Study|Adverse Event|0|||
128856067|NCT00621192|463768415|FG001|Overall Study|Adverse Event|1|||
128856068|NCT00621192|463768416|FG002|Overall Study|Adverse Event|0|||
128856069|NCT00621192|463768417|FG003|Overall Study|Adverse Event|1|||
128856070|NCT00621192|463768414|FG000|Overall Study|Death|2|||
128856071|NCT00621192|463768415|FG001|Overall Study|Death|5|||
128856072|NCT00621192|463768416|FG002|Overall Study|Death|0|||
128856073|NCT00621192|463768417|FG003|Overall Study|Death|0|||
128856074|NCT00621192|463768414|FG000|Overall Study|Final Assessments not Completed|0|||
128856075|NCT00621192|463768415|FG001|Overall Study|Final Assessments not Completed|0|||
128856076|NCT00621192|463768416|FG002|Overall Study|Final Assessments not Completed|3|||
128856077|NCT00621192|463768417|FG003|Overall Study|Final Assessments not Completed|1|||
128856078|NCT04706793|463768418|FG000|Treatment|Disease worsening|10|||
128856079|NCT04706793|463768419|FG001|Treatment|Disease worsening|10|||
128856080|NCT04706793|463768418|FG000|Follow-up|Lack of Efficacy|1|||
128856081|NCT04706793|463768419|FG001|Follow-up|Lack of Efficacy|0|||
128856082|NCT04706793|463768418|FG000|Follow-up|Disease worsening|8|||
128856083|NCT04706793|463768419|FG001|Follow-up|Disease worsening|10|||
128856084|NCT04706793|463768418|FG000|Follow-up|Adverse Event|1|||
128856085|NCT04706793|463768419|FG001|Follow-up|Adverse Event|0|||
128856086|NCT03713320|463768422|FG000|Randomized Period|Adverse Event|1|||
128856087|NCT03713320|463768423|FG001|Randomized Period|Adverse Event|5|||
128856088|NCT03713320|463768424|FG002|Randomized Period|Adverse Event|0|||
128856089|NCT03713320|463768422|FG000|Randomized Period|Physician Decision|1|||
128856090|NCT03713320|463768423|FG001|Randomized Period|Physician Decision|1|||
128856091|NCT03713320|463768424|FG002|Randomized Period|Physician Decision|0|||
128856092|NCT03713320|463768422|FG000|Randomized Period|Withdrawal by Subject|4|||
128856093|NCT03713320|463768423|FG001|Randomized Period|Withdrawal by Subject|0|||
128856094|NCT03713320|463768424|FG002|Randomized Period|Withdrawal by Subject|0|||
128856095|NCT03713320|463768422|FG000|Randomized Period|Participant decision|3|||
128856096|NCT03713320|463768423|FG001|Randomized Period|Participant decision|1|||
128856097|NCT03713320|463768424|FG002|Randomized Period|Participant decision|0|||
128856098|NCT03713320|463768422|FG000|Randomized Period|Study terminated by sponsor|6|||
128856099|NCT03713320|463768423|FG001|Randomized Period|Study terminated by sponsor|3|||
128856100|NCT03713320|463768424|FG002|Randomized Period|Study terminated by sponsor|0|||
128856101|NCT03713320|463768422|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
128856102|NCT03713320|463768423|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
128856103|NCT03713320|463768424|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
128856104|NCT03713320|463768422|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
128856105|NCT03713320|463768423|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
128856106|NCT03713320|463768424|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
128856107|NCT01781832|463768425|FG000|Overall Study|Withdrawal by Subject|1|||
128856108|NCT02719743|463768426|FG000|Overall Study|Consent withdrawal|0|||
128856109|NCT02719743|463768427|FG001|Overall Study|Consent withdrawal|2|||
128856110|NCT02719743|463768428|FG002|Overall Study|Consent withdrawal|0|||
128856111|NCT02719743|463768429|FG003|Overall Study|Consent withdrawal|1|||
128856112|NCT02719743|463768430|FG004|Overall Study|Consent withdrawal|0|||
128856113|NCT02719743|463768426|FG000|Overall Study|Migrated/moved from study area|0|||
128856114|NCT02719743|463768427|FG001|Overall Study|Migrated/moved from study area|0|||
128856115|NCT02719743|463768428|FG002|Overall Study|Migrated/moved from study area|0|||
128856116|NCT02719743|463768429|FG003|Overall Study|Migrated/moved from study area|0|||
128856117|NCT02719743|463768430|FG004|Overall Study|Migrated/moved from study area|2|||
128856118|NCT02719743|463768426|FG000|Overall Study|Lost to Follow-up|1|||
128856119|NCT02719743|463768427|FG001|Overall Study|Lost to Follow-up|1|||
128856120|NCT02719743|463768428|FG002|Overall Study|Lost to Follow-up|0|||
128856121|NCT02719743|463768429|FG003|Overall Study|Lost to Follow-up|0|||
128856122|NCT02719743|463768430|FG004|Overall Study|Lost to Follow-up|0|||
128856123|NCT01209598|463768431|FG000|Overall Study|Withdrawal by Subject|1|||
128856124|NCT01209598|463768432|FG001|Overall Study|Withdrawal by Subject|0|||
128856125|NCT02601209|463768433|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
128856126|NCT02601209|463768434|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
128856127|NCT02601209|463768435|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
128856128|NCT02601209|463768436|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
128856129|NCT02601209|463768437|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
128856130|NCT02601209|463768438|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
128856131|NCT02601209|463768439|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
128856132|NCT02601209|463768440|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
128856133|NCT02601209|463768441|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
128856134|NCT02601209|463768433|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
128856135|NCT02601209|463768434|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
128856136|NCT02601209|463768435|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
128856137|NCT02601209|463768436|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
128856138|NCT02601209|463768437|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
128856139|NCT02601209|463768438|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
128856140|NCT02601209|463768439|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
128856141|NCT02601209|463768440|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
128856142|NCT02601209|463768441|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
128856143|NCT03636373|463768442|FG000|Overall Study|Study closure due to Covid-19|1|||
128856144|NCT03636373|463768443|FG001|Overall Study|Study closure due to Covid-19|0|||
128856145|NCT00572533|463768444|FG000|Overall Study|Death|4|||
128856146|NCT00572533|463768445|FG001|Overall Study|Death|1|||
128856147|NCT00572533|463768444|FG000|Overall Study|Received Kidney Transplant|2|||
128856148|NCT00572533|463768445|FG001|Overall Study|Received Kidney Transplant|1|||
128856149|NCT00572533|463768444|FG000|Overall Study|Social Issues|1|||
128856150|NCT00572533|463768445|FG001|Overall Study|Social Issues|0|||
128856151|NCT00572533|463768444|FG000|Overall Study|Transfer out of Facility|0|||
128856152|NCT00572533|463768445|FG001|Overall Study|Transfer out of Facility|1|||
128856153|NCT00798304|463768446|FG000|Overall Study|Adverse Event|0|||
128856154|NCT00798304|463768447|FG001|Overall Study|Adverse Event|1|||
128856155|NCT00798304|463768448|FG002|Overall Study|Adverse Event|1|||
128856156|NCT00798304|463768446|FG000|Overall Study|Discontinuation by Sponsor|14|||
128856157|NCT00798304|463768447|FG001|Overall Study|Discontinuation by Sponsor|21|||
128856158|NCT00798304|463768448|FG002|Overall Study|Discontinuation by Sponsor|9|||
128856159|NCT01161628|463768455|FG000|Overall Study|Death|6|||
128856160|NCT01161628|463768455|FG000|Overall Study|Lack of Efficacy|2|||
128856161|NCT00715117|463768456|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
128856162|NCT00715117|463768457|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
128856163|NCT01482429|463768458|FG000|Care Usual|Protocol Violation|0|||
128856164|NCT01482429|463768459|FG001|Care Usual|Protocol Violation|172|||
128856165|NCT01482429|463768458|FG000|Care Usual|Lost to Follow-up|0|||
128856166|NCT01482429|463768459|FG001|Care Usual|Lost to Follow-up|1|||
128856167|NCT01482429|463768458|FG000|Protocol|Protocol Violation|275|||
128856168|NCT01482429|463768459|FG001|Protocol|Protocol Violation|0|||
128856169|NCT00416598|463770188|FG000|Induction & Intensification|Adverse Event|38|||
128856170|NCT00416598|463770188|FG000|Induction & Intensification|Death|32|||
128856171|NCT00416598|463770188|FG000|Induction & Intensification|Withdrawal by Subject|46|||
128856172|NCT00416598|463770188|FG000|Induction & Intensification|Alternative Treatment|135|||
128856173|NCT00416598|463770188|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
128856174|NCT00416598|463770188|FG000|Induction & Intensification|Relapse/progression|29|||
128856175|NCT00416598|463770188|FG000|Induction & Intensification|Failed induction|87|||
128856176|NCT00416598|463770188|FG000|Decitabine Maintenance|Adverse Event|5|||
128856177|NCT00416598|463770188|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
128856178|NCT00416598|463770188|FG000|Decitabine Maintenance|Progression/relapse|38|||
128856179|NCT00416598|463770188|FG000|Decitabine Maintenance|Alternative treatment|2|||
128856180|NCT00416598|463770188|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
128856181|NCT02166476|463770195|FG000|Overall Study|Withdrawal by Subject|5|||
128856182|NCT02166476|463770196|FG001|Overall Study|Withdrawal by Subject|7|||
128856183|NCT02166476|463770195|FG000|Overall Study|Adverse Event|3|||
128856184|NCT02166476|463770196|FG001|Overall Study|Adverse Event|3|||
128856185|NCT02166476|463770195|FG000|Overall Study|Lost to Follow-up|5|||
128856186|NCT02166476|463770196|FG001|Overall Study|Lost to Follow-up|10|||
128856187|NCT02166476|463770195|FG000|Overall Study|Physician Decision|1|||
128856188|NCT02166476|463770196|FG001|Overall Study|Physician Decision|0|||
128856189|NCT02166476|463770195|FG000|Overall Study|Unable to Come for Visit|0|||
128856190|NCT02166476|463770196|FG001|Overall Study|Unable to Come for Visit|3|||
128856191|NCT02053610|463770200|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
128856192|NCT02053610|463770201|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
128856193|NCT02053610|463770200|FG000|Overall Study|Withdrew Consent|2|||
128856194|NCT02053610|463770201|FG001|Overall Study|Withdrew Consent|9|||
128856195|NCT02053610|463770200|FG000|Overall Study|Death|5|||
128856196|NCT02053610|463770201|FG001|Overall Study|Death|5|||
128856197|NCT02053610|463770200|FG000|Overall Study|Administrative/Other|1|||
128856198|NCT02053610|463770201|FG001|Overall Study|Administrative/Other|1|||
128856199|NCT02053610|463770200|FG000|Overall Study|Disease Progression|2|||
128856200|NCT02053610|463770201|FG001|Overall Study|Disease Progression|3|||
128856201|NCT02053610|463770200|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
128856202|NCT02053610|463770201|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
128856203|NCT02053610|463770200|FG000|Overall Study|Did not Receive Treatment|4|||
128856204|NCT02053610|463770201|FG001|Overall Study|Did not Receive Treatment|2|||
128856205|NCT02053610|463770200|FG000|Overall Study|Insufficient Therapeutic Response|1|||
128856206|NCT02053610|463770201|FG001|Overall Study|Insufficient Therapeutic Response|1|||
128856207|NCT02053610|463770200|FG000|Overall Study|Violation of Selection Criteria|1|||
128856208|NCT02053610|463770201|FG001|Overall Study|Violation of Selection Criteria|0|||
128856209|NCT00543062|463770207|FG000|Overall Study|Withdrawal by Subject|1|||
128856210|NCT00543062|463770208|FG001|Overall Study|Withdrawal by Subject|0|||
128856211|NCT00543062|463770209|FG002|Overall Study|Withdrawal by Subject|2|||
128856212|NCT00543062|463770210|FG003|Overall Study|Withdrawal by Subject|0|||
128856213|NCT00543062|463770207|FG000|Overall Study|Adverse Event|0|||
128856214|NCT00543062|463770208|FG001|Overall Study|Adverse Event|1|||
128856215|NCT00543062|463770209|FG002|Overall Study|Adverse Event|1|||
128856216|NCT00543062|463770210|FG003|Overall Study|Adverse Event|1|||
128856217|NCT00543062|463770207|FG000|Overall Study|Protocol Violation|1|||
128856218|NCT00543062|463770208|FG001|Overall Study|Protocol Violation|0|||
128856219|NCT00543062|463770209|FG002|Overall Study|Protocol Violation|0|||
128856220|NCT00543062|463770210|FG003|Overall Study|Protocol Violation|0|||
128856221|NCT00328562|463770213|FG000|Overall Study|Disease progression|1|||
128856222|NCT01513330|463770214|FG000|SenSura Mio First,|Adverse Event|2|||
128856223|NCT01513330|463770215|FG001|SenSura Mio First,|Adverse Event|0|||
128856224|NCT01513330|463770214|FG000|SenSura Mio First,|Lack of Efficacy|0|||
128856225|NCT01513330|463770215|FG001|SenSura Mio First,|Lack of Efficacy|1|||
128856226|NCT01513330|463770214|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
128856227|NCT01513330|463770215|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
128856228|NCT01513330|463770214|FG000|SenSura Mio First,|Other|1|||
128856229|NCT01513330|463770215|FG001|SenSura Mio First,|Other|0|||
128856230|NCT01513330|463770214|FG000|Standard Care First,|Lack of Efficacy|2|||
128856231|NCT01513330|463770215|FG001|Standard Care First,|Lack of Efficacy|2|||
128856232|NCT01513330|463770214|FG000|Standard Care First,|Withdrawal by Subject|1|||
128856233|NCT01513330|463770215|FG001|Standard Care First,|Withdrawal by Subject|2|||
128856234|NCT01513330|463770214|FG000|Standard Care First,|Other|1|||
128856235|NCT01513330|463770215|FG001|Standard Care First,|Other|0|||
128856236|NCT04486313|463770216|FG000|Overall Study|Lost to Follow-up|7|||
128856237|NCT04486313|463770217|FG001|Overall Study|Lost to Follow-up|9|||
128856238|NCT04486313|463770216|FG000|Overall Study|Withdrawal by Subject|8|||
128856239|NCT04486313|463770217|FG001|Overall Study|Withdrawal by Subject|6|||
128856240|NCT04486313|463770216|FG000|Overall Study|Physician Decision|1|||
128856241|NCT04486313|463770217|FG001|Overall Study|Physician Decision|1|||
128856242|NCT04486313|463770216|FG000|Overall Study|Death|2|||
128856243|NCT04486313|463770217|FG001|Overall Study|Death|0|||
128856244|NCT04486313|463770216|FG000|Overall Study|Protocol Violation|1|||
128856245|NCT04486313|463770217|FG001|Overall Study|Protocol Violation|1|||
128856246|NCT02232399|463770222|FG000|Overall Study|Adverse Event|1|||
128856247|NCT02232399|463770223|FG001|Overall Study|Adverse Event|0|||
128856248|NCT02232399|463770222|FG000|Overall Study|Withdrawal by Subject|0|||
128856249|NCT02232399|463770223|FG001|Overall Study|Withdrawal by Subject|1|||
128856250|NCT01777334|463770224|FG000|Overall Study|Adverse Event|18|||
128856251|NCT01777334|463770225|FG001|Overall Study|Adverse Event|14|||
128856252|NCT01777334|463770224|FG000|Overall Study|Lack of Efficacy|15|||
128856253|NCT01777334|463770225|FG001|Overall Study|Lack of Efficacy|29|||
128856254|NCT01777334|463770224|FG000|Overall Study|Protocol Violation|3|||
128856255|NCT01777334|463770225|FG001|Overall Study|Protocol Violation|7|||
128856256|NCT01777334|463770224|FG000|Overall Study|Lost to Follow-up|3|||
128856257|NCT01777334|463770225|FG001|Overall Study|Lost to Follow-up|2|||
128856258|NCT01777334|463770224|FG000|Overall Study|Withdrawal by Subject|14|||
128856259|NCT01777334|463770225|FG001|Overall Study|Withdrawal by Subject|11|||
128856260|NCT00632021|463770237|FG000|Overall Study|Withdrawal/death|4|||
128856261|NCT00632021|463770238|FG001|Overall Study|Withdrawal/death|7|||
128856262|NCT00952848|463770241|FG000|Overall Study|Withdrawal by Subject|4|||
128856263|NCT00458393|463770242|FG000|Overall Study|Withdrawal by Subject|67|||
128856264|NCT00458393|463770243|FG001|Overall Study|Withdrawal by Subject|80|||
128856265|NCT00458393|463770242|FG000|Overall Study|Physician Decision|31|||
128856266|NCT00458393|463770243|FG001|Overall Study|Physician Decision|22|||
128856267|NCT00458393|463770242|FG000|Overall Study|Relocated|77|||
128856268|NCT00458393|463770243|FG001|Overall Study|Relocated|81|||
128856269|NCT00458393|463770242|FG000|Overall Study|Lost to Follow-up|115|||
128856270|NCT00458393|463770243|FG001|Overall Study|Lost to Follow-up|92|||
128856271|NCT00458393|463770242|FG000|Overall Study|Sites marked other on the form.|19|||
128856272|NCT00458393|463770243|FG001|Overall Study|Sites marked other on the form.|20|||
128856273|NCT00857233|463770246|FG000|Overall Study|Adverse Event|24|||
128856274|NCT00857233|463770246|FG000|Overall Study|Lack of Efficacy|1|||
128856275|NCT00857233|463770246|FG000|Overall Study|Non-compliance|1|||
128856276|NCT00857233|463770246|FG000|Overall Study|Withdrawal of Consent|9|||
128856277|NCT00857233|463770246|FG000|Overall Study|Lost to Follow-up|4|||
128856278|NCT00857233|463770246|FG000|Overall Study|Nursing Home Placement|14|||
128856279|NCT00857233|463770246|FG000|Overall Study|Other Reasons|2|||
128856280|NCT01587118|463770247|FG000|Overall Study|Adverse Event|3|||
128856281|NCT01587118|463770247|FG000|Overall Study|Lost to Follow-up|2|||
128856282|NCT01587118|463770247|FG000|Overall Study|Relocation|1|||
128856283|NCT01587118|463770247|FG000|Overall Study|nonresponse|1|||
128856284|NCT00537329|463770248|FG000|Overall Study|Death|10|||
128856285|NCT00537329|463770248|FG000|Overall Study|Adverse Event|3|||
128856286|NCT00537329|463770248|FG000|Overall Study|Lack of Efficacy|2|||
128856287|NCT00537329|463770248|FG000|Overall Study|Lost to Follow-up|6|||
128856288|NCT00537329|463770248|FG000|Overall Study|Withdrawal by Subject|4|||
128856289|NCT00537329|463770248|FG000|Overall Study|Other|1|||
128856290|NCT02287233|463770250|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
128856291|NCT02287233|463770251|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
128856292|NCT02287233|463770252|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
128856293|NCT02287233|463770250|FG000|Overall Study|Adverse Event Related to Progression|0|||
128856294|NCT02287233|463770251|FG001|Overall Study|Adverse Event Related to Progression|2|||
128856295|NCT02287233|463770252|FG002|Overall Study|Adverse Event Related to Progression|8|||
128856296|NCT02287233|463770250|FG000|Overall Study|Physician Decision|1|||
128856297|NCT02287233|463770251|FG001|Overall Study|Physician Decision|2|||
128856298|NCT02287233|463770252|FG002|Overall Study|Physician Decision|4|||
128856299|NCT02287233|463770250|FG000|Overall Study|Progressive Disease with Death|0|||
128856300|NCT02287233|463770251|FG001|Overall Study|Progressive Disease with Death|0|||
128856301|NCT02287233|463770252|FG002|Overall Study|Progressive Disease with Death|10|||
128856302|NCT02287233|463770250|FG000|Overall Study|Progressive Disease Without Death|2|||
128856303|NCT02287233|463770251|FG001|Overall Study|Progressive Disease Without Death|3|||
128856304|NCT02287233|463770252|FG002|Overall Study|Progressive Disease Without Death|20|||
128856305|NCT02287233|463770250|FG000|Overall Study|Withdrawal by Subject|1|||
128856306|NCT02287233|463770251|FG001|Overall Study|Withdrawal by Subject|1|||
128856307|NCT02287233|463770252|FG002|Overall Study|Withdrawal by Subject|7|||
128856308|NCT02287233|463770250|FG000|Overall Study|Other|3|||
128856309|NCT02287233|463770251|FG001|Overall Study|Other|0|||
128856310|NCT02287233|463770252|FG002|Overall Study|Other|15|||
128856311|NCT02287233|463770250|FG000|Overall Study|Did Not Receive Treatment|0|||
128856312|NCT02287233|463770251|FG001|Overall Study|Did Not Receive Treatment|0|||
128856313|NCT02287233|463770252|FG002|Overall Study|Did Not Receive Treatment|2|||
128856314|NCT03432390|463770255|FG000|Apnea Period|Protocol Violation|2|||
128856315|NCT03432390|463770256|FG001|Apnea Period|Protocol Violation|2|||
128856316|NCT02168478|463770258|FG000|Overall Study|Withdrawal by Subject|1|||
128856317|NCT02168478|463770258|FG000|Overall Study|Did Not Consent to Participation|2|||
128856318|NCT02168478|463770258|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
128856319|NCT00661713|463770267|FG000|Overall Study|Death|1|||
128856320|NCT00661713|463770268|FG001|Overall Study|Death|0|||
128856321|NCT00661713|463770269|FG002|Overall Study|Death|0|||
128856322|NCT00661713|463770270|FG003|Overall Study|Death|0|||
128856323|NCT00661713|463770271|FG004|Overall Study|Death|1|||
128856324|NCT00661713|463770272|FG005|Overall Study|Death|0|||
128856325|NCT00661713|463770273|FG006|Overall Study|Death|0|||
128856326|NCT00661713|463770274|FG007|Overall Study|Death|0|||
128856327|NCT00661713|463770267|FG000|Overall Study|Unable to Classify|1|||
128856328|NCT00661713|463770268|FG001|Overall Study|Unable to Classify|0|||
128856329|NCT00661713|463770269|FG002|Overall Study|Unable to Classify|0|||
128856330|NCT00661713|463770270|FG003|Overall Study|Unable to Classify|0|||
128856331|NCT00661713|463770271|FG004|Overall Study|Unable to Classify|0|||
128856332|NCT00661713|463770272|FG005|Overall Study|Unable to Classify|0|||
128856333|NCT00661713|463770273|FG006|Overall Study|Unable to Classify|0|||
128856334|NCT00661713|463770274|FG007|Overall Study|Unable to Classify|0|||
128856335|NCT00661713|463770267|FG000|Overall Study|Protocol Violation|1|||
128856336|NCT00661713|463770268|FG001|Overall Study|Protocol Violation|6|||
128856337|NCT00661713|463770269|FG002|Overall Study|Protocol Violation|3|||
128856338|NCT00661713|463770270|FG003|Overall Study|Protocol Violation|3|||
128856339|NCT00661713|463770271|FG004|Overall Study|Protocol Violation|0|||
128856340|NCT00661713|463770272|FG005|Overall Study|Protocol Violation|2|||
128856341|NCT00661713|463770273|FG006|Overall Study|Protocol Violation|2|||
128856342|NCT00661713|463770274|FG007|Overall Study|Protocol Violation|1|||
128856343|NCT00661713|463770267|FG000|Overall Study|Withdrawal by Subject|11|||
128856344|NCT00661713|463770268|FG001|Overall Study|Withdrawal by Subject|25|||
128856345|NCT00661713|463770269|FG002|Overall Study|Withdrawal by Subject|12|||
128856346|NCT00661713|463770270|FG003|Overall Study|Withdrawal by Subject|21|||
128856347|NCT00661713|463770271|FG004|Overall Study|Withdrawal by Subject|12|||
128856348|NCT00661713|463770272|FG005|Overall Study|Withdrawal by Subject|26|||
128856349|NCT00661713|463770273|FG006|Overall Study|Withdrawal by Subject|45|||
128856350|NCT00661713|463770274|FG007|Overall Study|Withdrawal by Subject|9|||
128856351|NCT00661713|463770267|FG000|Overall Study|Lost to Follow-up|2|||
128856352|NCT00661713|463770268|FG001|Overall Study|Lost to Follow-up|7|||
128856353|NCT00661713|463770269|FG002|Overall Study|Lost to Follow-up|2|||
128856354|NCT00661713|463770270|FG003|Overall Study|Lost to Follow-up|2|||
128856355|NCT00661713|463770271|FG004|Overall Study|Lost to Follow-up|5|||
128856356|NCT00661713|463770272|FG005|Overall Study|Lost to Follow-up|7|||
128856357|NCT00661713|463770273|FG006|Overall Study|Lost to Follow-up|14|||
128856358|NCT00661713|463770274|FG007|Overall Study|Lost to Follow-up|1|||
128856359|NCT00661713|463770267|FG000|Overall Study|Administrative Reason|0|||
128856360|NCT00661713|463770268|FG001|Overall Study|Administrative Reason|1|||
128856361|NCT00661713|463770269|FG002|Overall Study|Administrative Reason|0|||
128856362|NCT00661713|463770270|FG003|Overall Study|Administrative Reason|2|||
128856363|NCT00661713|463770271|FG004|Overall Study|Administrative Reason|2|||
128856364|NCT00661713|463770272|FG005|Overall Study|Administrative Reason|2|||
128856365|NCT00661713|463770273|FG006|Overall Study|Administrative Reason|1|||
128856366|NCT00661713|463770274|FG007|Overall Study|Administrative Reason|0|||
128856367|NCT00661713|463770267|FG000|Overall Study|Adverse Event|0|||
128856368|NCT00661713|463770268|FG001|Overall Study|Adverse Event|0|||
128856369|NCT00661713|463770269|FG002|Overall Study|Adverse Event|0|||
128856370|NCT00661713|463770270|FG003|Overall Study|Adverse Event|0|||
128856371|NCT00661713|463770271|FG004|Overall Study|Adverse Event|0|||
128856372|NCT00661713|463770272|FG005|Overall Study|Adverse Event|0|||
128856373|NCT00661713|463770273|FG006|Overall Study|Adverse Event|1|||
128856374|NCT00661713|463770274|FG007|Overall Study|Adverse Event|0|||
128856375|NCT00661713|463770267|FG000|Overall Study|Inappropriate Enrollment|0|||
128856376|NCT00661713|463770268|FG001|Overall Study|Inappropriate Enrollment|0|||
128856377|NCT00661713|463770269|FG002|Overall Study|Inappropriate Enrollment|0|||
128856378|NCT00661713|463770270|FG003|Overall Study|Inappropriate Enrollment|0|||
128856379|NCT00661713|463770271|FG004|Overall Study|Inappropriate Enrollment|0|||
128856380|NCT00661713|463770272|FG005|Overall Study|Inappropriate Enrollment|0|||
128856381|NCT00661713|463770273|FG006|Overall Study|Inappropriate Enrollment|1|||
128856382|NCT00661713|463770274|FG007|Overall Study|Inappropriate Enrollment|0|||
128856383|NCT02658175|463770277|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
128856384|NCT02658175|463770278|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
128856385|NCT02658175|463770279|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
128856386|NCT02658175|463770277|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
128856387|NCT02658175|463770278|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
128856388|NCT02658175|463770279|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
128856389|NCT02658175|463770277|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
128856390|NCT02658175|463770278|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
128856391|NCT02658175|463770279|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
128856392|NCT02658175|463770277|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
128856393|NCT02658175|463770278|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
128856394|NCT02658175|463770279|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
128856395|NCT02658175|463770277|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
128856396|NCT02658175|463770278|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
128856397|NCT02658175|463770279|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
128856398|NCT02658175|463770277|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
128856399|NCT02658175|463770278|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
128856400|NCT02658175|463770279|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
128856401|NCT02658175|463770277|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
128856402|NCT02658175|463770278|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
128856403|NCT02658175|463770279|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
128856404|NCT02658175|463770277|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
128856405|NCT02658175|463770278|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
128856406|NCT02658175|463770279|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
128856407|NCT02658175|463770277|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
128856408|NCT02658175|463770278|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
128856409|NCT02658175|463770279|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
128856410|NCT02658175|463770277|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
128856411|NCT02658175|463770278|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
128856412|NCT02658175|463770279|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
128856413|NCT01801982|463770281|FG000|Overall Study|Lost to Follow-up|1|||
128856414|NCT02918292|463770282|FG000|Study Enrollment Prior to Transplant|Death|1|||
128856415|NCT02918292|463770282|FG000|Study Follow up After Transplant|Death|6|||
128856416|NCT01185171|463770283|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
128856417|NCT01185171|463770283|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
128856418|NCT01185171|463770283|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
128856419|NCT01185171|463770283|FG000|Maintenance|Elevated liver transaminases|3|||
128856420|NCT01185171|463770283|FG000|Maintenance|Rush|2|||
128856421|NCT01185171|463770283|FG000|Maintenance|Diarrhea|1|||
128856422|NCT01185171|463770283|FG000|Maintenance|Xerostomia|1|||
128856423|NCT01185171|463770283|FG000|Maintenance|Nausea|1|||
128856424|NCT01185171|463770283|FG000|Maintenance|Comorbid Illness|2|||
128856425|NCT01185171|463770283|FG000|Maintenance|Withdrawal by Subject|1|||
128856426|NCT01185171|463770283|FG000|Maintenance|Disease Recurrence|1|||
128856427|NCT00727506|463770284|FG000|Overall Study|Adverse Event|0|||
128856428|NCT00727506|463770285|FG001|Overall Study|Adverse Event|0|||
128856429|NCT00727506|463770286|FG002|Overall Study|Adverse Event|4|||
128856430|NCT00727506|463770287|FG003|Overall Study|Adverse Event|4|||
128856431|NCT00727506|463770288|FG004|Overall Study|Adverse Event|1|||
128856432|NCT00727506|463770289|FG005|Overall Study|Adverse Event|8|||
128856433|NCT00727506|463770284|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
128856434|NCT00727506|463770285|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128856435|NCT00727506|463770286|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
128856436|NCT00727506|463770287|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128856437|NCT00727506|463770288|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128856438|NCT00727506|463770289|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
128856439|NCT00727506|463770284|FG000|Overall Study|Progressive disease|4|||
128856440|NCT00727506|463770285|FG001|Overall Study|Progressive disease|7|||
128856441|NCT00727506|463770286|FG002|Overall Study|Progressive disease|9|||
128856442|NCT00727506|463770287|FG003|Overall Study|Progressive disease|28|||
128856443|NCT00727506|463770288|FG004|Overall Study|Progressive disease|38|||
128856444|NCT00727506|463770289|FG005|Overall Study|Progressive disease|28|||
128856445|NCT00727506|463770284|FG000|Overall Study|Refused to continue medication|0|||
128856446|NCT00727506|463770285|FG001|Overall Study|Refused to continue medication|1|||
128856447|NCT00727506|463770286|FG002|Overall Study|Refused to continue medication|2|||
128856448|NCT00727506|463770287|FG003|Overall Study|Refused to continue medication|3|||
128856449|NCT00727506|463770288|FG004|Overall Study|Refused to continue medication|1|||
128856450|NCT00727506|463770289|FG005|Overall Study|Refused to continue medication|2|||
128856451|NCT00727506|463770284|FG000|Overall Study|Other reason not described above|0|||
128856452|NCT00727506|463770285|FG001|Overall Study|Other reason not described above|0|||
128856453|NCT00727506|463770286|FG002|Overall Study|Other reason not described above|1|||
128856454|NCT00727506|463770287|FG003|Overall Study|Other reason not described above|4|||
128856455|NCT00727506|463770288|FG004|Overall Study|Other reason not described above|1|||
128856456|NCT00727506|463770289|FG005|Overall Study|Other reason not described above|1|||
128856457|NCT03561597|463770290|FG000|Overall Study|Lost to Follow-up|20|||
128856458|NCT03783689|463770292|FG000|Overall Study|Adverse Event|2|||
128856459|NCT03783689|463770293|FG001|Overall Study|Adverse Event|0|||
128856460|NCT03783689|463770292|FG000|Overall Study|Lost to Follow-up|2|||
128856461|NCT03783689|463770293|FG001|Overall Study|Lost to Follow-up|1|||
128856462|NCT03783689|463770292|FG000|Overall Study|Physician Decision|2|||
128856463|NCT03783689|463770293|FG001|Overall Study|Physician Decision|1|||
128856464|NCT03783689|463770292|FG000|Overall Study|Withdrawal by Subject|3|||
128856465|NCT03783689|463770293|FG001|Overall Study|Withdrawal by Subject|3|||
128856466|NCT02581059|463770296|FG000|Study Treatment|Disease Progression|1|||
128856467|NCT02581059|463770297|FG001|Study Treatment|Disease Progression|1|||
128856468|NCT02581059|463770296|FG000|Study Treatment|Adverse Event|2|||
128856469|NCT02581059|463770297|FG001|Study Treatment|Adverse Event|1|||
128856470|NCT02581059|463770296|FG000|Study Treatment|Death|1|||
128856471|NCT02581059|463770297|FG001|Study Treatment|Death|1|||
128856472|NCT02581059|463770296|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
128856473|NCT02581059|463770297|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
128856474|NCT02581059|463770296|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
128856475|NCT02581059|463770297|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
128856476|NCT02581059|463770296|FG000|Follow up|Death|1|||
128856477|NCT02581059|463770297|FG001|Follow up|Death|3|||
128856478|NCT02581059|463770296|FG000|Follow up|study terminated|1|||
128856479|NCT02581059|463770297|FG001|Follow up|study terminated|1|||
128856480|NCT02581059|463770296|FG000|Follow up|screen failure|0|||
128856481|NCT02581059|463770297|FG001|Follow up|screen failure|1|||
128856482|NCT02581059|463770296|FG000|Follow up|Patient started new clinical trial|1|||
128856483|NCT02581059|463770297|FG001|Follow up|Patient started new clinical trial|0|||
128856484|NCT02392104|463770298|FG000|Overall Study|discontinuation of warfarin|3|||
128856485|NCT02392104|463770298|FG000|Overall Study|bleeding event|1|||
128856486|NCT02392104|463770298|FG000|Overall Study|transferred care to another doctor|2|||
128856487|NCT02392104|463770298|FG000|Overall Study|INR goal range changed|1|||
128856488|NCT02392104|463770298|FG000|Overall Study|admitted to skilled nursing facility|3|||
128856489|NCT02392104|463770298|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
128856490|NCT04887506|463770301|FG000|Overall Study|Death|1|||
128856491|NCT04887506|463770302|FG001|Overall Study|Death|1|||
128856492|NCT04887506|463770301|FG000|Overall Study|Withdrawal by Subject|0|||
128856493|NCT04887506|463770302|FG001|Overall Study|Withdrawal by Subject|3|||
128856494|NCT04887506|463770301|FG000|Overall Study|Adverse Event|4|||
128856495|NCT04887506|463770302|FG001|Overall Study|Adverse Event|3|||
128856496|NCT04887506|463770301|FG000|Overall Study|Other - Not Reported|1|||
128856497|NCT04887506|463770302|FG001|Overall Study|Other - Not Reported|1|||
128856498|NCT02394665|463770305|FG000|Overall Study|Physician Decision|1|||
128856499|NCT02394665|463770306|FG001|Overall Study|Physician Decision|0|||
128856500|NCT02394665|463770307|FG002|Overall Study|Physician Decision|0|||
128856501|NCT02636608|463770308|FG000|Overall Study|Failure to Return|4|||
128856502|NCT02636608|463770308|FG000|Overall Study|Insufficient Virological Response|1|||
128856503|NCT02636608|463770308|FG000|Overall Study|Death|3|||
128856504|NCT02636608|463770308|FG000|Overall Study|Other|2|||
128856505|NCT02636608|463770308|FG000|Overall Study|Did Not Receive Treatment|1|||
128856506|NCT01255761|463770309|FG000|Overall Study|Adverse Event|29|||
128856507|NCT01255761|463770310|FG001|Overall Study|Adverse Event|43|||
128856508|NCT01255761|463770309|FG000|Overall Study|Lack of Efficacy|86|||
128856509|NCT01255761|463770310|FG001|Overall Study|Lack of Efficacy|74|||
128856510|NCT01255761|463770309|FG000|Overall Study|Protocol Violation|9|||
128856511|NCT01255761|463770310|FG001|Overall Study|Protocol Violation|5|||
128856512|NCT01255761|463770309|FG000|Overall Study|Lost to Follow-up|10|||
128856513|NCT01255761|463770310|FG001|Overall Study|Lost to Follow-up|8|||
128856514|NCT01255761|463770309|FG000|Overall Study|Withdrawal by Subject|11|||
128856515|NCT01255761|463770310|FG001|Overall Study|Withdrawal by Subject|27|||
128856516|NCT01255761|463770309|FG000|Overall Study|Other Reasons|37|||
128856517|NCT01255761|463770310|FG001|Overall Study|Other Reasons|18|||
128856518|NCT05613088|463770313|FG000|Treatment|Ongoing Study Treatment|9|||
128856519|NCT05613088|463770314|FG001|Treatment|Ongoing Study Treatment|2|||
128856520|NCT05613088|463770313|FG000|Treatment|Adverse Event|3|||
128856521|NCT05613088|463770314|FG001|Treatment|Adverse Event|1|||
128856522|NCT05613088|463770313|FG000|Treatment|Other Reasons|0|||
128856523|NCT05613088|463770314|FG001|Treatment|Other Reasons|1|||
128856524|NCT05613088|463770313|FG000|Treatment|Progressive Disease|58|||
128856525|NCT05613088|463770314|FG001|Treatment|Progressive Disease|26|||
128856526|NCT05613088|463770313|FG000|Treatment|Withdrawal by Subject|0|||
128856527|NCT05613088|463770314|FG001|Treatment|Withdrawal by Subject|4|||
128856528|NCT03912532|463770316|FG000|Overall Study|Adverse Event|3|||
128856529|NCT03912532|463770317|FG001|Overall Study|Adverse Event|3|||
128856530|NCT03912532|463770318|FG002|Overall Study|Adverse Event|2|||
128856531|NCT03912532|463770319|FG003|Overall Study|Adverse Event|2|||
128856532|NCT03912532|463770316|FG000|Overall Study|Lost to Follow-up|3|||
128856533|NCT03912532|463770317|FG001|Overall Study|Lost to Follow-up|2|||
128856534|NCT03912532|463770318|FG002|Overall Study|Lost to Follow-up|1|||
128856535|NCT03912532|463770319|FG003|Overall Study|Lost to Follow-up|2|||
128856536|NCT03912532|463770316|FG000|Overall Study|Withdrawal by Subject|1|||
128856537|NCT03912532|463770317|FG001|Overall Study|Withdrawal by Subject|1|||
128856538|NCT03912532|463770318|FG002|Overall Study|Withdrawal by Subject|2|||
128856539|NCT03912532|463770319|FG003|Overall Study|Withdrawal by Subject|0|||
128856540|NCT03912532|463770316|FG000|Overall Study|Physician Decision|1|||
128856541|NCT03912532|463770317|FG001|Overall Study|Physician Decision|0|||
128856542|NCT03912532|463770318|FG002|Overall Study|Physician Decision|0|||
128856543|NCT03912532|463770319|FG003|Overall Study|Physician Decision|3|||
128856544|NCT03912532|463770316|FG000|Overall Study|Other|0|||
128856545|NCT03912532|463770317|FG001|Overall Study|Other|1|||
128856546|NCT03912532|463770318|FG002|Overall Study|Other|1|||
128856547|NCT03912532|463770319|FG003|Overall Study|Other|0|||
128856548|NCT03783871|463770324|FG000|Overall Study|Withdrawal by Subject|15|||
128856549|NCT03783871|463770324|FG000|Overall Study|Death|13|||
128856550|NCT03783871|463770324|FG000|Overall Study|Lost to Follow-up|2|||
128856551|NCT03569891|463770326|FG000|Lead-in|Ineligible during lead-in|8|||
128856552|NCT03569891|463770326|FG000|Lead-in|Withdrawal by Subject|3|||
128856553|NCT03569891|463770326|FG000|Lead-in|Risks related to COVID-19|2|||
128856554|NCT03569891|463770326|FG000|AMT-061|Adverse Event|1|||
128856555|NCT04594733|463770327|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
128856556|NCT04594733|463770328|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
128856557|NCT04594733|463770327|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
128856558|NCT04594733|463770328|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
128856559|NCT04594733|463770327|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
128856560|NCT04594733|463770328|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
128856561|NCT02647645|463770331|FG000|Overall Study|Lost to Follow-up|2|||
128856562|NCT02647645|463770332|FG001|Overall Study|Lost to Follow-up|1|||
128856563|NCT00356811|463770333|FG000|Overall Study|Death|35|||
128856564|NCT00356811|463770333|FG000|Overall Study|Lost to Follow-up|2|||
128856565|NCT00356811|463770333|FG000|Overall Study|Withdrawal by Subject|6|||
128856566|NCT00356811|463770333|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
128856567|NCT00356811|463770333|FG000|Overall Study|Study Is Terminating|3|||
128856568|NCT00356811|463770333|FG000|Overall Study|Site Closed during Follow-up|2|||
128856569|NCT02386839|463770334|FG000|Overall Study|Death|1|||
128856570|NCT02386839|463770335|FG001|Overall Study|Death|0|||
128856571|NCT02386839|463770334|FG000|Overall Study|Withdrawal by Subject|9|||
128856572|NCT02386839|463770335|FG001|Overall Study|Withdrawal by Subject|10|||
128856573|NCT02386839|463770334|FG000|Overall Study|Lost to Follow-up|4|||
128856574|NCT02386839|463770335|FG001|Overall Study|Lost to Follow-up|4|||
128856575|NCT02386839|463770334|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
128856576|NCT02386839|463770335|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
128856577|NCT02386839|463770334|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
128856578|NCT02386839|463770335|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
128856579|NCT02386839|463770334|FG000|Overall Study|Other (unspecified)|1|||
128856580|NCT02386839|463770335|FG001|Overall Study|Other (unspecified)|0|||
128856581|NCT02101983|463770336|FG000|Overall Study|Physician Decision|1|||
128856582|NCT02101983|463770337|FG001|Overall Study|Physician Decision|0|||
128856583|NCT00826228|463771963|FG000|Overall Study|Withdrawal by Subject|1|||
128856584|NCT03614676|463771964|FG000|Overall Study|Delivery before planned visit|2|||
128856585|NCT03614676|463771965|FG001|Overall Study|Delivery before planned visit|0|||
128856586|NCT03614676|463771964|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
128856587|NCT03614676|463771965|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
128856588|NCT03614676|463771964|FG000|Overall Study|Migrated / moved from the study area|30|||
128856589|NCT03614676|463771965|FG001|Overall Study|Migrated / moved from the study area|22|||
128856590|NCT03614676|463771964|FG000|Overall Study|Lost to Follow-up|17|||
128856591|NCT03614676|463771965|FG001|Overall Study|Lost to Follow-up|42|||
128856592|NCT03614676|463771964|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
128856593|NCT03614676|463771965|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
128856594|NCT03614676|463771964|FG000|Overall Study|Other|16|||
128856595|NCT03614676|463771965|FG001|Overall Study|Other|47|||
128856596|NCT03614676|463771964|FG000|Overall Study|Protocol Violation|0|||
128856597|NCT03614676|463771965|FG001|Overall Study|Protocol Violation|2|||
128856598|NCT03614676|463771964|FG000|Overall Study|Neonatal event of interest|0|||
128856599|NCT03614676|463771965|FG001|Overall Study|Neonatal event of interest|6|||
128856600|NCT03614676|463771964|FG000|Overall Study|Death in infant greater than 28 days old|0|||
128856601|NCT03614676|463771965|FG001|Overall Study|Death in infant greater than 28 days old|12|||
128856602|NCT03614676|463771964|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
128856603|NCT03614676|463771965|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
128856604|NCT00903760|463771966|FG000|Overall Study|Disease Progression/Death|8|||
128856605|NCT00903760|463771967|FG001|Overall Study|Disease Progression/Death|6|||
128856606|NCT00903760|463771966|FG000|Overall Study|Stem Cell Transplant|8|||
128856607|NCT00903760|463771967|FG001|Overall Study|Stem Cell Transplant|4|||
128856608|NCT00903760|463771966|FG000|Overall Study|Physician Decision|1|||
128856609|NCT00903760|463771967|FG001|Overall Study|Physician Decision|2|||
128856610|NCT00903760|463771966|FG000|Overall Study|Death|0|||
128856611|NCT00903760|463771967|FG001|Overall Study|Death|1|||
128856612|NCT00903760|463771966|FG000|Overall Study|Lost to Follow-up|1|||
128856613|NCT00903760|463771967|FG001|Overall Study|Lost to Follow-up|0|||
128856614|NCT00903760|463771966|FG000|Overall Study|Withdrawal by Subject|1|||
128856615|NCT00903760|463771967|FG001|Overall Study|Withdrawal by Subject|2|||
128856616|NCT00903760|463771966|FG000|Overall Study|Off treatment for long period|0|||
128856617|NCT00903760|463771967|FG001|Overall Study|Off treatment for long period|1|||
128856618|NCT02388347|463771968|FG000|Overall Study|Withdrawal by Subject|0|||
128856619|NCT02388347|463771969|FG001|Overall Study|Withdrawal by Subject|0|||
128856620|NCT02388347|463771970|FG002|Overall Study|Withdrawal by Subject|1|||
128856621|NCT02388347|463771971|FG003|Overall Study|Withdrawal by Subject|0|||
128856622|NCT02388347|463771972|FG004|Overall Study|Withdrawal by Subject|0|||
128856623|NCT02825251|463771973|FG000|Overall Study|Adverse Event|0|||
128856624|NCT02825251|463771974|FG001|Overall Study|Adverse Event|1|||
128856625|NCT02825251|463771973|FG000|Overall Study|Lost to Follow-up|0|||
128856626|NCT02825251|463771974|FG001|Overall Study|Lost to Follow-up|1|||
128856627|NCT02825251|463771973|FG000|Overall Study|Withdrawal by Subject|1|||
128856628|NCT02825251|463771974|FG001|Overall Study|Withdrawal by Subject|4|||
128856629|NCT02825251|463771973|FG000|Overall Study|Unclassified|2|||
128856630|NCT02825251|463771974|FG001|Overall Study|Unclassified|0|||
128856631|NCT01845805|463771975|FG000|Overall Study|Withdrawal by Subject|1|||
128856632|NCT01845805|463771976|FG001|Overall Study|Withdrawal by Subject|2|||
128856633|NCT01845805|463771975|FG000|Overall Study|Disease Progression|13|||
128856634|NCT01845805|463771976|FG001|Overall Study|Disease Progression|14|||
128856635|NCT01845805|463771975|FG000|Overall Study|Drug-related Toxicity|4|||
128856636|NCT01845805|463771976|FG001|Overall Study|Drug-related Toxicity|0|||
128856637|NCT02820597|463771978|FG000|Overall Study|Lost to Follow-up|12|||
128856638|NCT00575042|463771979|FG000|Overall Study|Adverse Event|2|||
128856639|NCT00575042|463771979|FG000|Overall Study|Lost to Follow-up|1|||
128856640|NCT04795336|463771980|FG000|Overall Study|Withdrawal by Subject|3|||
128856641|NCT04795336|463771981|FG001|Overall Study|Withdrawal by Subject|4|||
128856642|NCT04795336|463771982|FG002|Overall Study|Withdrawal by Subject|3|||
128856643|NCT04795336|463771983|FG003|Overall Study|Withdrawal by Subject|12|||
128856644|NCT04795336|463771980|FG000|Overall Study|Lost study logs|0|||
128856645|NCT04795336|463771981|FG001|Overall Study|Lost study logs|1|||
128856646|NCT04795336|463771982|FG002|Overall Study|Lost study logs|0|||
128856647|NCT04795336|463771983|FG003|Overall Study|Lost study logs|2|||
128856648|NCT04795336|463771980|FG000|Overall Study|Did not take study medication|2|||
128856649|NCT04795336|463771981|FG001|Overall Study|Did not take study medication|0|||
128856650|NCT04795336|463771982|FG002|Overall Study|Did not take study medication|0|||
128856651|NCT04795336|463771983|FG003|Overall Study|Did not take study medication|0|||
128856652|NCT03898700|463771984|FG000|Overall Study|Withdrawal by Subject|2|||
128856653|NCT02666664|463771985|FG000|Overall Study|Physician Decision|0|||
128856654|NCT02666664|463771986|FG001|Overall Study|Physician Decision|1|||
128856655|NCT02666664|463771985|FG000|Overall Study|Protocol Violation|0|||
128856656|NCT02666664|463771986|FG001|Overall Study|Protocol Violation|2|||
128856657|NCT02666664|463771985|FG000|Overall Study|Other|0|||
128856658|NCT02666664|463771986|FG001|Overall Study|Other|1|||
128856659|NCT02666664|463771985|FG000|Overall Study|Adverse Event|12|||
128856660|NCT02666664|463771986|FG001|Overall Study|Adverse Event|37|||
128856661|NCT02666664|463771985|FG000|Overall Study|Withdrawal by participant|23|||
128856662|NCT02666664|463771986|FG001|Overall Study|Withdrawal by participant|40|||
128856663|NCT02666664|463771985|FG000|Overall Study|Sponsor decision|0|||
128856664|NCT02666664|463771986|FG001|Overall Study|Sponsor decision|1|||
128856665|NCT02666664|463771985|FG000|Overall Study|Lost to Follow-up|1|||
128856666|NCT02666664|463771986|FG001|Overall Study|Lost to Follow-up|2|||
128856667|NCT03616964|463771987|FG000|Overall Study|Adverse Event|15|||
128856668|NCT03616964|463771988|FG001|Overall Study|Adverse Event|10|||
128856669|NCT03616964|463771989|FG002|Overall Study|Adverse Event|16|||
128856670|NCT03616964|463771987|FG000|Overall Study|Death|3|||
128856671|NCT03616964|463771988|FG001|Overall Study|Death|0|||
128856672|NCT03616964|463771989|FG002|Overall Study|Death|4|||
128856673|NCT03616964|463771987|FG000|Overall Study|Lack of Efficacy|4|||
128856674|NCT03616964|463771988|FG001|Overall Study|Lack of Efficacy|8|||
128856675|NCT03616964|463771989|FG002|Overall Study|Lack of Efficacy|8|||
128856676|NCT03616964|463771987|FG000|Overall Study|Lost to Follow-up|2|||
128856677|NCT03616964|463771988|FG001|Overall Study|Lost to Follow-up|1|||
128856678|NCT03616964|463771989|FG002|Overall Study|Lost to Follow-up|3|||
128856679|NCT03616964|463771987|FG000|Overall Study|Withdrawal by Subject|18|||
128856680|NCT03616964|463771988|FG001|Overall Study|Withdrawal by Subject|14|||
128856681|NCT03616964|463771989|FG002|Overall Study|Withdrawal by Subject|21|||
128856682|NCT03616964|463771987|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
128856683|NCT03616964|463771988|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
128856684|NCT03616964|463771989|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
128856685|NCT03616964|463771987|FG000|Overall Study|Sponsor's Decision|1|||
128856686|NCT03616964|463771988|FG001|Overall Study|Sponsor's Decision|0|||
128856687|NCT03616964|463771989|FG002|Overall Study|Sponsor's Decision|0|||
128856688|NCT03616964|463771987|FG000|Overall Study|Physician Decision|0|||
128856689|NCT03616964|463771988|FG001|Overall Study|Physician Decision|2|||
128856690|NCT03616964|463771989|FG002|Overall Study|Physician Decision|0|||
128856691|NCT03616964|463771987|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
128856692|NCT03616964|463771988|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
128856693|NCT03616964|463771989|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
128856694|NCT03616964|463771987|FG000|Overall Study|Protocol Violation|0|||
128856695|NCT03616964|463771988|FG001|Overall Study|Protocol Violation|1|||
128856696|NCT03616964|463771989|FG002|Overall Study|Protocol Violation|0|||
128856697|NCT03616964|463771987|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
128856698|NCT03616964|463771988|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
128856699|NCT03616964|463771989|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
128856700|NCT03616964|463771987|FG000|Overall Study|Randomized but Never Treated|1|||
128856701|NCT03616964|463771988|FG001|Overall Study|Randomized but Never Treated|1|||
128856702|NCT03616964|463771989|FG002|Overall Study|Randomized but Never Treated|1|||
128856703|NCT00971997|463771990|FG000|Overall Study|Adverse Event|2|||
128856704|NCT00971997|463771990|FG000|Overall Study|Death|1|||
128856705|NCT00971997|463771990|FG000|Overall Study|Protocol Violation|4|||
128856706|NCT00971997|463771990|FG000|Overall Study|Withdrawal by Subject|5|||
128856707|NCT00971997|463771990|FG000|Overall Study|Physician Decision|7|||
128856708|NCT01266018|463771996|FG000|Overall Study|Physician Decision|1|||
128856709|NCT01266018|463771997|FG001|Overall Study|Physician Decision|0|||
128856710|NCT01266018|463771996|FG000|Overall Study|Progressive disease|0|||
128856711|NCT01266018|463771997|FG001|Overall Study|Progressive disease|1|||
128856712|NCT03167151|463771998|FG000|Overall Study|Withdrawal by Subject|1|||
128856713|NCT03167151|463771999|FG001|Overall Study|Withdrawal by Subject|0|||
128856714|NCT03167151|463772000|FG002|Overall Study|Withdrawal by Subject|0|||
128856715|NCT03167151|463771998|FG000|Overall Study|No evidence of tumour at surgery|0|||
128856716|NCT03167151|463771999|FG001|Overall Study|No evidence of tumour at surgery|1|||
128856717|NCT03167151|463772000|FG002|Overall Study|No evidence of tumour at surgery|1|||
128856718|NCT00634842|463772003|FG000|Overall Study|Adverse Event|2|||
128856719|NCT00634842|463772004|FG001|Overall Study|Adverse Event|3|||
128856720|NCT00634842|463772003|FG000|Overall Study|Protocol Violation|8|||
128856721|NCT00634842|463772004|FG001|Overall Study|Protocol Violation|4|||
128856722|NCT00634842|463772003|FG000|Overall Study|Move to another state|1|||
128856723|NCT00634842|463772004|FG001|Overall Study|Move to another state|0|||
128856724|NCT00634842|463772003|FG000|Overall Study|Inclusion criteria were not met|1|||
128856725|NCT00634842|463772004|FG001|Overall Study|Inclusion criteria were not met|0|||
128856726|NCT00634842|463772003|FG000|Overall Study|Lost to Follow-up|1|||
128856727|NCT00634842|463772004|FG001|Overall Study|Lost to Follow-up|2|||
128856728|NCT00634842|463772003|FG000|Overall Study|Physician Decision|1|||
128856729|NCT00634842|463772004|FG001|Overall Study|Physician Decision|0|||
128856730|NCT00634842|463772003|FG000|Overall Study|Withdrawal by Subject|1|||
128856731|NCT00634842|463772004|FG001|Overall Study|Withdrawal by Subject|3|||
128856732|NCT00634842|463772003|FG000|Overall Study|Lack of time and intolerance to drug|0|||
128856733|NCT00634842|463772004|FG001|Overall Study|Lack of time and intolerance to drug|1|||
128856734|NCT00634842|463772003|FG000|Overall Study|Discontinued due to injection|0|||
128856735|NCT00634842|463772004|FG001|Overall Study|Discontinued due to injection|2|||
128856736|NCT00634842|463772003|FG000|Overall Study|No need of study drug to treat diabetes|0|||
128856737|NCT00634842|463772004|FG001|Overall Study|No need of study drug to treat diabetes|1|||
128856738|NCT00634842|463772003|FG000|Overall Study|No wish to keep taking Avandia|0|||
128856739|NCT00634842|463772004|FG001|Overall Study|No wish to keep taking Avandia|1|||
128856740|NCT00634842|463772003|FG000|Overall Study|Subject off study drug for too long|0|||
128856741|NCT00634842|463772004|FG001|Overall Study|Subject off study drug for too long|1|||
128856742|NCT00810342|463772007|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
128856743|NCT00810342|463772008|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
128856744|NCT00810342|463772007|FG000|Month 1 Follow-up|Pregnancy|1|||
128856745|NCT00810342|463772008|FG001|Month 1 Follow-up|Pregnancy|0|||
128856746|NCT00810342|463772007|FG000|6-month Follow-up|Lost to Follow-up|18|||
128856747|NCT00810342|463772008|FG001|6-month Follow-up|Lost to Follow-up|6|||
128856748|NCT00810342|463772007|FG000|6-month Follow-up|Pregnancy|6|||
128856749|NCT00810342|463772008|FG001|6-month Follow-up|Pregnancy|2|||
128856750|NCT00810342|463772007|FG000|12-month Followup|Pregnancy|9|||
128856751|NCT00810342|463772008|FG001|12-month Followup|Pregnancy|10|||
128856752|NCT00810342|463772007|FG000|12-month Followup|Lost to Follow-up|3|||
128856753|NCT00810342|463772008|FG001|12-month Followup|Lost to Follow-up|1|||
128856754|NCT04504630|463772010|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
128856755|NCT04504630|463772011|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
128856756|NCT04504630|463772010|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
128856757|NCT04504630|463772011|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
128856758|NCT02229578|463772031|FG000|Overall Study|Withdrawal by Subject|1|||
128856759|NCT02229578|463772032|FG001|Overall Study|Withdrawal by Subject|3|||
128856760|NCT02229578|463772031|FG000|Overall Study|Protocol Violation|2|||
128856761|NCT02229578|463772032|FG001|Overall Study|Protocol Violation|0|||
128856762|NCT00943787|463772033|FG000|Overall Study|Physician Decision|4|||
128856763|NCT00943787|463772033|FG000|Overall Study|Withdrawal by Subject|3|||
128856764|NCT02706951|463772035|FG000|Period 1|Adverse Event|1|||
128856765|NCT02706951|463772036|FG001|Period 1|Adverse Event|5|||
128856766|NCT02706951|463772037|FG002|Period 1|Adverse Event|3|||
128856767|NCT02706951|463772038|FG003|Period 1|Adverse Event|0|||
128856768|NCT02706951|463772039|FG004|Period 1|Adverse Event|0|||
128856769|NCT02706951|463772035|FG000|Period 1|Withdrawal by Subject|10|||
128856770|NCT02706951|463772036|FG001|Period 1|Withdrawal by Subject|6|||
128856771|NCT02706951|463772037|FG002|Period 1|Withdrawal by Subject|6|||
128856772|NCT02706951|463772038|FG003|Period 1|Withdrawal by Subject|0|||
128856773|NCT02706951|463772039|FG004|Period 1|Withdrawal by Subject|0|||
128856774|NCT02706951|463772035|FG000|Period 1|Lost to Follow-up|0|||
128856775|NCT02706951|463772036|FG001|Period 1|Lost to Follow-up|4|||
128856776|NCT02706951|463772037|FG002|Period 1|Lost to Follow-up|1|||
128856777|NCT02706951|463772038|FG003|Period 1|Lost to Follow-up|0|||
128856778|NCT02706951|463772039|FG004|Period 1|Lost to Follow-up|0|||
128856779|NCT02706951|463772035|FG000|Period 1|Other|2|||
128856780|NCT02706951|463772036|FG001|Period 1|Other|1|||
128856781|NCT02706951|463772037|FG002|Period 1|Other|0|||
128856782|NCT02706951|463772038|FG003|Period 1|Other|0|||
128856783|NCT02706951|463772039|FG004|Period 1|Other|0|||
128856784|NCT02706951|463772035|FG000|Period 2|Adverse Event|0|||
128856785|NCT02706951|463772036|FG001|Period 2|Adverse Event|0|||
128856786|NCT02706951|463772037|FG002|Period 2|Adverse Event|0|||
128856787|NCT02706951|463772038|FG003|Period 2|Adverse Event|25|||
128856788|NCT02706951|463772039|FG004|Period 2|Adverse Event|34|||
128856789|NCT02706951|463772035|FG000|Period 2|Withdrawal by Subject|0|||
128856790|NCT02706951|463772036|FG001|Period 2|Withdrawal by Subject|0|||
128856791|NCT02706951|463772037|FG002|Period 2|Withdrawal by Subject|0|||
128856792|NCT02706951|463772038|FG003|Period 2|Withdrawal by Subject|38|||
128856793|NCT02706951|463772039|FG004|Period 2|Withdrawal by Subject|44|||
128856794|NCT02706951|463772035|FG000|Period 2|Lost to Follow-up|0|||
128856795|NCT02706951|463772036|FG001|Period 2|Lost to Follow-up|0|||
128856796|NCT02706951|463772037|FG002|Period 2|Lost to Follow-up|0|||
128856797|NCT02706951|463772038|FG003|Period 2|Lost to Follow-up|17|||
128856798|NCT02706951|463772039|FG004|Period 2|Lost to Follow-up|9|||
128856799|NCT02706951|463772035|FG000|Period 2|COVID-19 Related|0|||
128856800|NCT02706951|463772036|FG001|Period 2|COVID-19 Related|0|||
128856801|NCT02706951|463772037|FG002|Period 2|COVID-19 Related|0|||
128856802|NCT02706951|463772038|FG003|Period 2|COVID-19 Related|1|||
128856803|NCT02706951|463772039|FG004|Period 2|COVID-19 Related|2|||
128856804|NCT02706951|463772035|FG000|Period 2|Other|0|||
128856805|NCT02706951|463772036|FG001|Period 2|Other|0|||
128856806|NCT02706951|463772037|FG002|Period 2|Other|0|||
128856807|NCT02706951|463772038|FG003|Period 2|Other|37|||
128856808|NCT02706951|463772039|FG004|Period 2|Other|31|||
128856809|NCT01216072|463772040|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
128856810|NCT01216072|463772041|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
128856811|NCT01216072|463772040|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
128856812|NCT01216072|463772041|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
128856813|NCT01216072|463772040|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
128856814|NCT01216072|463772041|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
128856815|NCT01216072|463772040|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
128856816|NCT01216072|463772041|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
128856817|NCT01216072|463772040|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
128856818|NCT01216072|463772041|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
128856819|NCT01216072|463772040|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
128856820|NCT01216072|463772041|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
128856821|NCT01216072|463772040|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
128856822|NCT01216072|463772041|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
128856823|NCT01216072|463772040|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
128856824|NCT01216072|463772041|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
128856825|NCT01216072|463772040|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
128856826|NCT01216072|463772041|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
128856827|NCT01216072|463772040|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
128856828|NCT01216072|463772041|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
128856829|NCT04294667|463772042|FG000|Overall Study|Lack of Efficacy|4|||
128856830|NCT04294667|463772043|FG001|Overall Study|Lack of Efficacy|4|||
128856831|NCT04294667|463772042|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
128856832|NCT04294667|463772043|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
128856833|NCT04294667|463772042|FG000|Overall Study|Patient has a Renal Flare|1|||
128856834|NCT04294667|463772043|FG001|Overall Study|Patient has a Renal Flare|0|||
128856835|NCT04294667|463772042|FG000|Overall Study|SLE Worsening|0|||
128856836|NCT04294667|463772043|FG001|Overall Study|SLE Worsening|1|||
128856837|NCT04294667|463772042|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
128856838|NCT04294667|463772043|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
128856839|NCT04294667|463772042|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
128856840|NCT04294667|463772043|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
128856841|NCT04294667|463772042|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
128856842|NCT04294667|463772043|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
128856843|NCT04294667|463772042|FG000|Overall Study|Subject Moved to Another State|0|||
128856844|NCT04294667|463772043|FG001|Overall Study|Subject Moved to Another State|1|||
128856845|NCT04294667|463772042|FG000|Overall Study|Adverse event, serious fatal|0|||
128856846|NCT04294667|463772043|FG001|Overall Study|Adverse event, serious fatal|1|||
128856847|NCT04294667|463772042|FG000|Overall Study|Adverse event, non-fatal|3|||
128856848|NCT04294667|463772043|FG001|Overall Study|Adverse event, non-fatal|4|||
128856849|NCT02599688|463772044|FG000|Overall Study|Lack of Efficacy|1|||
128856850|NCT02599688|463772044|FG000|Overall Study|Withdrawal by Subject|1|||
128856851|NCT02599688|463772044|FG000|Overall Study|Termination by Sponsor|2|||
128856852|NCT01841697|463772045|FG000|Overall Study|Death|0|||
128856853|NCT01841697|463772046|FG001|Overall Study|Death|1|||
128856854|NCT01841697|463772045|FG000|Overall Study|Lost to Follow-up|4|||
128856855|NCT01841697|463772046|FG001|Overall Study|Lost to Follow-up|1|||
128856856|NCT01841697|463772045|FG000|Overall Study|Withdrawal by Subject|16|||
128856857|NCT01841697|463772046|FG001|Overall Study|Withdrawal by Subject|16|||
128856858|NCT00756457|463772047|FG000|Overall Study|Lost to Follow-up|1|||
128856859|NCT00756457|463772048|FG001|Overall Study|Lost to Follow-up|2|||
128856860|NCT01777490|463772049|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
128856861|NCT01777490|463772050|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
128856862|NCT01777490|463772051|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
128856863|NCT01777490|463772052|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
128856864|NCT01101061|463772053|FG000|Overall Study|Adverse Event|0|||
128856865|NCT01101061|463772054|FG001|Overall Study|Adverse Event|0|||
128856866|NCT01101061|463772055|FG002|Overall Study|Adverse Event|1|||
128856867|NCT01101061|463772056|FG003|Overall Study|Adverse Event|0|||
128856868|NCT01101061|463772057|FG004|Overall Study|Adverse Event|0|||
128856869|NCT01101061|463772058|FG005|Overall Study|Adverse Event|0|||
128856870|NCT05043883|463772059|FG000|Overall Study|Minimum required measurements could not be taken|4|||
128856871|NCT01390441|463772060|FG000|Treatment Period|Protocol Violation|0|||
128856872|NCT01390441|463772061|FG001|Treatment Period|Protocol Violation|1|||
128856873|NCT01390441|463772062|FG002|Treatment Period|Protocol Violation|0|||
128856874|NCT01390441|463772063|FG003|Treatment Period|Protocol Violation|0|||
128856875|NCT01390441|463772064|FG004|Treatment Period|Protocol Violation|0|||
128856876|NCT01390441|463772060|FG000|Treatment Period|Physician Decision|0|||
128856877|NCT01390441|463772061|FG001|Treatment Period|Physician Decision|0|||
128856878|NCT01390441|463772062|FG002|Treatment Period|Physician Decision|0|||
128856879|NCT01390441|463772063|FG003|Treatment Period|Physician Decision|1|||
128856880|NCT01390441|463772064|FG004|Treatment Period|Physician Decision|0|||
128856881|NCT01390441|463772060|FG000|Treatment Period|Lack of Efficacy|0|||
128856882|NCT01390441|463772061|FG001|Treatment Period|Lack of Efficacy|0|||
128856883|NCT01390441|463772062|FG002|Treatment Period|Lack of Efficacy|0|||
128856884|NCT01390441|463772063|FG003|Treatment Period|Lack of Efficacy|0|||
128856885|NCT01390441|463772064|FG004|Treatment Period|Lack of Efficacy|1|||
128856886|NCT01390441|463772060|FG000|Treatment Period|Unknown due to early stopping of study|0|||
128856887|NCT01390441|463772061|FG001|Treatment Period|Unknown due to early stopping of study|0|||
128856888|NCT01390441|463772062|FG002|Treatment Period|Unknown due to early stopping of study|8|||
128856889|NCT01390441|463772063|FG003|Treatment Period|Unknown due to early stopping of study|11|||
128856890|NCT01390441|463772064|FG004|Treatment Period|Unknown due to early stopping of study|7|||
128856891|NCT01390441|463772060|FG000|Treatment Period|Adverse Event|0|||
128856892|NCT01390441|463772061|FG001|Treatment Period|Adverse Event|0|||
128856893|NCT01390441|463772062|FG002|Treatment Period|Adverse Event|1|||
128856894|NCT01390441|463772063|FG003|Treatment Period|Adverse Event|1|||
128856895|NCT01390441|463772064|FG004|Treatment Period|Adverse Event|2|||
128856896|NCT01390441|463772060|FG000|Treatment Period|Withdrawal by Subject|0|||
128856897|NCT01390441|463772061|FG001|Treatment Period|Withdrawal by Subject|0|||
128856898|NCT01390441|463772062|FG002|Treatment Period|Withdrawal by Subject|1|||
128856899|NCT01390441|463772063|FG003|Treatment Period|Withdrawal by Subject|0|||
128856900|NCT01390441|463772064|FG004|Treatment Period|Withdrawal by Subject|1|||
128856901|NCT01390441|463772060|FG000|Treatment Period|Lost to Follow-up|1|||
128856902|NCT01390441|463772061|FG001|Treatment Period|Lost to Follow-up|0|||
128856903|NCT01390441|463772062|FG002|Treatment Period|Lost to Follow-up|0|||
128856904|NCT01390441|463772063|FG003|Treatment Period|Lost to Follow-up|0|||
128856905|NCT01390441|463772064|FG004|Treatment Period|Lost to Follow-up|0|||
128856906|NCT01390441|463772060|FG000|Extension Period|Protocol Violation|3|||
128856907|NCT01390441|463772061|FG001|Extension Period|Protocol Violation|1|||
128856908|NCT01390441|463772062|FG002|Extension Period|Protocol Violation|0|||
128856909|NCT01390441|463772063|FG003|Extension Period|Protocol Violation|1|||
128856910|NCT01390441|463772064|FG004|Extension Period|Protocol Violation|0|||
128856911|NCT02635386|463772065|FG000|Overall Study|Pregnancy|2|||
128856912|NCT02635386|463772066|FG001|Overall Study|Pregnancy|0|||
128856913|NCT02635386|463772067|FG002|Overall Study|Pregnancy|0|||
128856914|NCT02635386|463772068|FG003|Overall Study|Pregnancy|0|||
128856915|NCT02635386|463772069|FG004|Overall Study|Pregnancy|2|||
128856916|NCT02635386|463772065|FG000|Overall Study|Withdrawal by Subject|1|||
128856917|NCT02635386|463772066|FG001|Overall Study|Withdrawal by Subject|1|||
128856918|NCT02635386|463772067|FG002|Overall Study|Withdrawal by Subject|0|||
128856919|NCT02635386|463772068|FG003|Overall Study|Withdrawal by Subject|1|||
128856920|NCT02635386|463772069|FG004|Overall Study|Withdrawal by Subject|0|||
128856921|NCT02635386|463772065|FG000|Overall Study|Physician Decision|0|||
128856922|NCT02635386|463772066|FG001|Overall Study|Physician Decision|1|||
128856923|NCT02635386|463772067|FG002|Overall Study|Physician Decision|0|||
128856924|NCT02635386|463772068|FG003|Overall Study|Physician Decision|0|||
128856925|NCT02635386|463772069|FG004|Overall Study|Physician Decision|0|||
128856926|NCT02635386|463772065|FG000|Overall Study|Moved Out of State|0|||
128856927|NCT02635386|463772066|FG001|Overall Study|Moved Out of State|1|||
128856928|NCT02635386|463772067|FG002|Overall Study|Moved Out of State|0|||
128856929|NCT02635386|463772068|FG003|Overall Study|Moved Out of State|0|||
128856930|NCT02635386|463772069|FG004|Overall Study|Moved Out of State|0|||
128856931|NCT02635386|463772065|FG000|Overall Study|Noncompliant|0|||
128856932|NCT02635386|463772066|FG001|Overall Study|Noncompliant|2|||
128856933|NCT02635386|463772067|FG002|Overall Study|Noncompliant|1|||
128856934|NCT02635386|463772068|FG003|Overall Study|Noncompliant|1|||
128856935|NCT02635386|463772069|FG004|Overall Study|Noncompliant|1|||
128856936|NCT02635386|463772065|FG000|Overall Study|side effects|0|||
128856937|NCT02635386|463772066|FG001|Overall Study|side effects|0|||
128856938|NCT02635386|463772067|FG002|Overall Study|side effects|1|||
128856939|NCT02635386|463772068|FG003|Overall Study|side effects|4|||
128856940|NCT02635386|463772069|FG004|Overall Study|side effects|6|||
128856941|NCT02635386|463772065|FG000|Overall Study|needed other major surgery|0|||
128856942|NCT02635386|463772066|FG001|Overall Study|needed other major surgery|1|||
128856943|NCT02635386|463772067|FG002|Overall Study|needed other major surgery|0|||
128856944|NCT02635386|463772068|FG003|Overall Study|needed other major surgery|0|||
128856945|NCT02635386|463772069|FG004|Overall Study|needed other major surgery|0|||
128856946|NCT02635386|463772065|FG000|Overall Study|Other medical problems not drug related|0|||
128856947|NCT02635386|463772066|FG001|Overall Study|Other medical problems not drug related|0|||
128856948|NCT02635386|463772067|FG002|Overall Study|Other medical problems not drug related|0|||
128856949|NCT02635386|463772068|FG003|Overall Study|Other medical problems not drug related|1|||
128856950|NCT02635386|463772069|FG004|Overall Study|Other medical problems not drug related|0|||
128856951|NCT00085566|463772073|FG000|Overall Study|Adverse Event|0|||
128856952|NCT00085566|463772074|FG001|Overall Study|Adverse Event|0|||
128856953|NCT00085566|463772075|FG002|Overall Study|Adverse Event|10|||
128856954|NCT00085566|463772073|FG000|Overall Study|Patient Not treated|0|||
128856955|NCT00085566|463772074|FG001|Overall Study|Patient Not treated|0|||
128856956|NCT00085566|463772075|FG002|Overall Study|Patient Not treated|3|||
128856957|NCT00085566|463772073|FG000|Overall Study|Clinical progression|0|||
128856958|NCT00085566|463772074|FG001|Overall Study|Clinical progression|0|||
128856959|NCT00085566|463772075|FG002|Overall Study|Clinical progression|1|||
128856960|NCT03174782|463772076|FG000|Overall Study|Protocol Violation|1|||
128856961|NCT03174782|463772077|FG001|Overall Study|Protocol Violation|0|||
128856962|NCT03174782|463772076|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
128856963|NCT03174782|463772077|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
128856964|NCT03178045|463772078|FG000|Overall Study|Withdrawal by Subject|5|||
128856965|NCT03178045|463772079|FG001|Overall Study|Withdrawal by Subject|7|||
128856966|NCT03178045|463772078|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
128856967|NCT03178045|463772079|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
128856968|NCT03178045|463772078|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
128856969|NCT03178045|463772079|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
128856970|NCT01163474|463772080|FG000|Overall Study|Withdrawal by Subject|1|||
128856971|NCT01163474|463772080|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
128856972|NCT01163474|463772080|FG000|Overall Study|Lost to Follow-up|3|||
128856973|NCT02706847|463772083|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
128856974|NCT02706847|463772084|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
128856975|NCT02706847|463772085|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
128856976|NCT02706847|463772086|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
128856977|NCT02706847|463772083|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
128856978|NCT02706847|463772084|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
128856979|NCT02706847|463772085|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
128856980|NCT02706847|463772086|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
128856981|NCT02706847|463772083|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
128856982|NCT02706847|463772084|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
128856983|NCT02706847|463772085|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
128856984|NCT02706847|463772086|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
128856985|NCT02706847|463772083|FG000|Period 1: Day 1 to Week 12|Other|4|||
128856986|NCT02706847|463772084|FG001|Period 1: Day 1 to Week 12|Other|4|||
128856987|NCT02706847|463772085|FG002|Period 1: Day 1 to Week 12|Other|2|||
128856988|NCT02706847|463772086|FG003|Period 1: Day 1 to Week 12|Other|2|||
128856989|NCT02706847|463772083|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
128856990|NCT02706847|463772084|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
128856991|NCT02706847|463772085|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
128856992|NCT02706847|463772086|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
128856993|NCT02706847|463772083|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
128856994|NCT02706847|463772084|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
128856995|NCT02706847|463772085|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
128856996|NCT02706847|463772086|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
128856997|NCT02706847|463772083|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
128856998|NCT02706847|463772084|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
128856999|NCT02706847|463772085|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
128857000|NCT02706847|463772086|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
128857001|NCT02706847|463772083|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
128857002|NCT02706847|463772084|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
128857003|NCT02706847|463772085|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
128857004|NCT02706847|463772086|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
128857005|NCT02706847|463772083|FG000|Period 1: Week 12 to Week 24|Other|1|||
128857006|NCT02706847|463772084|FG001|Period 1: Week 12 to Week 24|Other|0|||
128857007|NCT02706847|463772085|FG002|Period 1: Week 12 to Week 24|Other|1|||
128857008|NCT02706847|463772086|FG003|Period 1: Week 12 to Week 24|Other|4|||
128857009|NCT02706847|463772083|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
128857010|NCT02706847|463772084|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
128857011|NCT02706847|463772085|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
128857012|NCT02706847|463772086|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
128857013|NCT02706847|463772083|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
128857014|NCT02706847|463772084|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
128857015|NCT02706847|463772085|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
128857016|NCT02706847|463772086|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
128857017|NCT02706847|463772083|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
128857018|NCT02706847|463772084|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
128857019|NCT02706847|463772085|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
128857020|NCT02706847|463772086|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
128857021|NCT02706847|463772083|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
128857022|NCT02706847|463772084|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
128857023|NCT02706847|463772085|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
128857024|NCT02706847|463772086|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
128857025|NCT02706847|463772083|FG000|Period 2: Week 24 to Week 260|Other|8|||
128857026|NCT02706847|463772084|FG001|Period 2: Week 24 to Week 260|Other|5|||
128857027|NCT02706847|463772085|FG002|Period 2: Week 24 to Week 260|Other|15|||
128857028|NCT02706847|463772086|FG003|Period 2: Week 24 to Week 260|Other|15|||
128857029|NCT02689453|463772093|FG000|Overall Study|Progressive disease|0|||
128857030|NCT02689453|463772094|FG001|Overall Study|Progressive disease|1|||
128857031|NCT02689453|463772095|FG002|Overall Study|Progressive disease|1|||
128857032|NCT04206085|463772096|FG000|Overall Study|Lost to Follow-up|0|||
128857033|NCT04206085|463772097|FG001|Overall Study|Lost to Follow-up|1|||
128857034|NCT04206085|463772098|FG002|Overall Study|Lost to Follow-up|0|||
128857035|NCT04206085|463772096|FG000|Overall Study|Lost to Follow-up|0|||
128857036|NCT04206085|463772097|FG001|Overall Study|Lost to Follow-up|0|||
128857037|NCT04206085|463772098|FG002|Overall Study|Lost to Follow-up|1|||
128857038|NCT00763451|463772099|FG000|Overall Study|Adverse Event|4|||
128857039|NCT00763451|463772100|FG001|Overall Study|Adverse Event|6|||
128857040|NCT00763451|463772101|FG002|Overall Study|Adverse Event|19|||
128857041|NCT00763451|463772102|FG003|Overall Study|Adverse Event|14|||
128857042|NCT00763451|463772099|FG000|Overall Study|Lack of Efficacy|1|||
128857043|NCT00763451|463772100|FG001|Overall Study|Lack of Efficacy|4|||
128857044|NCT00763451|463772101|FG002|Overall Study|Lack of Efficacy|3|||
128857045|NCT00763451|463772102|FG003|Overall Study|Lack of Efficacy|2|||
128857046|NCT00763451|463772099|FG000|Overall Study|Withdrawal by Subject|1|||
128857047|NCT00763451|463772100|FG001|Overall Study|Withdrawal by Subject|6|||
128857048|NCT00763451|463772101|FG002|Overall Study|Withdrawal by Subject|9|||
128857049|NCT00763451|463772102|FG003|Overall Study|Withdrawal by Subject|7|||
128857050|NCT00763451|463772099|FG000|Overall Study|Protocol Violation|0|||
128857051|NCT00763451|463772100|FG001|Overall Study|Protocol Violation|0|||
128857052|NCT00763451|463772101|FG002|Overall Study|Protocol Violation|1|||
128857053|NCT00763451|463772102|FG003|Overall Study|Protocol Violation|0|||
128857054|NCT00763451|463772099|FG000|Overall Study|Poor Compliance to Protocol|1|||
128857055|NCT00763451|463772100|FG001|Overall Study|Poor Compliance to Protocol|1|||
128857056|NCT00763451|463772101|FG002|Overall Study|Poor Compliance to Protocol|2|||
128857057|NCT00763451|463772102|FG003|Overall Study|Poor Compliance to Protocol|2|||
128857058|NCT00763451|463772099|FG000|Overall Study|Familial and Personal Reasons|5|||
128857059|NCT00763451|463772100|FG001|Overall Study|Familial and Personal Reasons|3|||
128857060|NCT00763451|463772101|FG002|Overall Study|Familial and Personal Reasons|5|||
128857061|NCT00763451|463772102|FG003|Overall Study|Familial and Personal Reasons|4|||
128857062|NCT00763451|463772099|FG000|Overall Study|Randomized but not Treated|1|||
128857063|NCT00763451|463772100|FG001|Overall Study|Randomized but not Treated|1|||
128857064|NCT00763451|463772101|FG002|Overall Study|Randomized but not Treated|0|||
128857065|NCT00763451|463772102|FG003|Overall Study|Randomized but not Treated|0|||
128857066|NCT00763451|463772099|FG000|Overall Study|Study Site Reason|0|||
128857067|NCT00763451|463772100|FG001|Overall Study|Study Site Reason|1|||
128857068|NCT00763451|463772101|FG002|Overall Study|Study Site Reason|1|||
128857069|NCT00763451|463772102|FG003|Overall Study|Study Site Reason|1|||
128857070|NCT00725543|463772106|FG000|Overall Study|Adverse Event|10|||
128857071|NCT00725543|463772106|FG000|Overall Study|Lack of Efficacy|3|||
128857072|NCT00725543|463772106|FG000|Overall Study|Withdrawal by Subject|10|||
128857073|NCT00725543|463772106|FG000|Overall Study|Physician Decision|5|||
128857074|NCT00725543|463772106|FG000|Overall Study|Lost to Follow-up|4|||
128857075|NCT00725543|463772106|FG000|Overall Study|Non-compliance|2|||
128857076|NCT00725543|463772106|FG000|Overall Study|Other|119|||
128857077|NCT05594589|463772107|FG000|Overall Study|Other|0|||
128857078|NCT05594589|463772108|FG001|Overall Study|Other|1|||
128857079|NCT05594589|463772109|FG002|Overall Study|Other|0|||
128857080|NCT00087555|463772116|FG000|Overall Study|Adverse Event|3|||
128857081|NCT00087555|463772117|FG001|Overall Study|Adverse Event|6|||
128857082|NCT00087555|463772118|FG002|Overall Study|Adverse Event|14|||
128857083|NCT00087555|463772116|FG000|Overall Study|Lost to Follow-up|0|||
128857084|NCT00087555|463772117|FG001|Overall Study|Lost to Follow-up|1|||
128857085|NCT00087555|463772118|FG002|Overall Study|Lost to Follow-up|1|||
128857086|NCT00087555|463772116|FG000|Overall Study|Non - Compliance|1|||
128857087|NCT00087555|463772117|FG001|Overall Study|Non - Compliance|0|||
128857088|NCT00087555|463772118|FG002|Overall Study|Non - Compliance|0|||
128857089|NCT00087555|463772116|FG000|Overall Study|Protocol Violation|0|||
128857090|NCT00087555|463772117|FG001|Overall Study|Protocol Violation|0|||
128857091|NCT00087555|463772118|FG002|Overall Study|Protocol Violation|2|||
128857092|NCT00087555|463772116|FG000|Overall Study|Screen Failure|1|||
128857093|NCT00087555|463772117|FG001|Overall Study|Screen Failure|1|||
128857094|NCT00087555|463772118|FG002|Overall Study|Screen Failure|0|||
128857095|NCT00087555|463772116|FG000|Overall Study|Pregnancy|0|||
128857096|NCT00087555|463772117|FG001|Overall Study|Pregnancy|1|||
128857097|NCT00087555|463772118|FG002|Overall Study|Pregnancy|1|||
128857098|NCT00087555|463772116|FG000|Overall Study|Withdrawal by Subject|3|||
128857099|NCT00087555|463772117|FG001|Overall Study|Withdrawal by Subject|2|||
128857100|NCT00087555|463772118|FG002|Overall Study|Withdrawal by Subject|1|||
128857101|NCT00087555|463772116|FG000|Overall Study|Lack of Efficacy|2|||
128857102|NCT00087555|463772117|FG001|Overall Study|Lack of Efficacy|0|||
128857103|NCT00087555|463772118|FG002|Overall Study|Lack of Efficacy|1|||
128857104|NCT00087555|463772116|FG000|Overall Study|Non Compliance|0|||
128857105|NCT00087555|463772117|FG001|Overall Study|Non Compliance|0|||
128857106|NCT00087555|463772118|FG002|Overall Study|Non Compliance|1|||
128857107|NCT00087555|463772116|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
128857108|NCT00087555|463772117|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
128857109|NCT00087555|463772118|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
128857110|NCT00087555|463772116|FG000|Overall Study|Patient wanted to go back on Med|1|||
128857111|NCT00087555|463772117|FG001|Overall Study|Patient wanted to go back on Med|0|||
128857112|NCT00087555|463772118|FG002|Overall Study|Patient wanted to go back on Med|0|||
128857113|NCT02344173|463772119|FG000|Procedure|Ablation Procedure Not Performed|7|||
128857114|NCT02344173|463772119|FG000|12-month Visit|Death|8|||
128857115|NCT02344173|463772119|FG000|12-month Visit|Withdrawal by Subject|30|||
128857116|NCT02344173|463772119|FG000|12-month Visit|Lost to Follow-up|58|||
128857117|NCT03845023|463772120|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
128857118|NCT03845023|463772121|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
128857119|NCT03845023|463772122|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
128857120|NCT03845023|463772123|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
128857121|NCT03845023|463772120|FG000|Follow-Up (14 Days)|Adverse Event|0|||
128857122|NCT03845023|463772121|FG001|Follow-Up (14 Days)|Adverse Event|0|||
128857123|NCT03845023|463772122|FG002|Follow-Up (14 Days)|Adverse Event|1|||
128857124|NCT03845023|463772123|FG003|Follow-Up (14 Days)|Adverse Event|1|||
128857125|NCT03772613|463772124|FG000|Overall Study|Lost to Follow-up|0|||
128857126|NCT03772613|463772125|FG001|Overall Study|Lost to Follow-up|1|||
128857127|NCT03772613|463772126|FG002|Overall Study|Lost to Follow-up|1|||
128857128|NCT01427738|463772127|FG000|Overall Study|Death|12|||
128857129|NCT01427738|463772128|FG001|Overall Study|Death|9|||
128857130|NCT01427738|463772127|FG000|Overall Study|Severe debilitation, unable to continue|0|||
128857131|NCT01427738|463772128|FG001|Overall Study|Severe debilitation, unable to continue|1|||
128857132|NCT01427738|463772127|FG000|Overall Study|Subject unable to get to clinic|5|||
128857133|NCT01427738|463772128|FG001|Overall Study|Subject unable to get to clinic|2|||
128857134|NCT01427738|463772127|FG000|Overall Study|Withdrawal by Subject|0|||
128857135|NCT01427738|463772128|FG001|Overall Study|Withdrawal by Subject|2|||
128857136|NCT01427738|463772127|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
128857137|NCT01427738|463772128|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
128857138|NCT01427738|463772127|FG000|Overall Study|Lost to Follow-up|1|||
128857139|NCT01427738|463772128|FG001|Overall Study|Lost to Follow-up|5|||
128857140|NCT05314374|463772129|FG000|Overall Study|Adverse Event|2|||
128857141|NCT05314374|463772130|FG001|Overall Study|Adverse Event|2|||
128857142|NCT02554383|463772131|FG000|Overall Study|Ineligible|3|||
128857143|NCT02554383|463772132|FG001|Overall Study|Ineligible|2|||
128857144|NCT02554383|463772131|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
128857145|NCT02554383|463772132|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
128857146|NCT02554383|463772131|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
128857147|NCT02554383|463772132|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
128857148|NCT02554383|463772131|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
128857149|NCT02554383|463772132|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
128857150|NCT01214421|463772135|FG000|Overall Study|Lost to Follow-up|7|||
128857151|NCT01214421|463772136|FG001|Overall Study|Lost to Follow-up|3|||
128857152|NCT01214421|463772137|FG002|Overall Study|Lost to Follow-up|7|||
128857153|NCT01214421|463772138|FG003|Overall Study|Lost to Follow-up|3|||
128857154|NCT01214421|463772135|FG000|Overall Study|Adverse Event|16|||
128857155|NCT01214421|463772136|FG001|Overall Study|Adverse Event|35|||
128857156|NCT01214421|463772137|FG002|Overall Study|Adverse Event|14|||
128857157|NCT01214421|463772138|FG003|Overall Study|Adverse Event|3|||
128857158|NCT01214421|463772135|FG000|Overall Study|Sponsor Discontinued Site|1|||
128857159|NCT01214421|463772136|FG001|Overall Study|Sponsor Discontinued Site|2|||
128857160|NCT01214421|463772137|FG002|Overall Study|Sponsor Discontinued Site|0|||
128857161|NCT01214421|463772138|FG003|Overall Study|Sponsor Discontinued Site|0|||
128857162|NCT01214421|463772135|FG000|Overall Study|Withdrawal Criteria Met|3|||
128857163|NCT01214421|463772136|FG001|Overall Study|Withdrawal Criteria Met|0|||
128857164|NCT01214421|463772137|FG002|Overall Study|Withdrawal Criteria Met|2|||
128857165|NCT01214421|463772138|FG003|Overall Study|Withdrawal Criteria Met|1|||
128857166|NCT01214421|463772135|FG000|Overall Study|Physician Decision|2|||
128857167|NCT01214421|463772136|FG001|Overall Study|Physician Decision|0|||
128857168|NCT01214421|463772137|FG002|Overall Study|Physician Decision|4|||
128857169|NCT01214421|463772138|FG003|Overall Study|Physician Decision|0|||
128857170|NCT01214421|463772135|FG000|Overall Study|Withdrawal by Subject|21|||
128857171|NCT01214421|463772136|FG001|Overall Study|Withdrawal by Subject|18|||
128857172|NCT01214421|463772137|FG002|Overall Study|Withdrawal by Subject|11|||
128857173|NCT01214421|463772138|FG003|Overall Study|Withdrawal by Subject|2|||
128857174|NCT04650698|463774017|FG000|Overall Study|Protocol Violation|2|||
128857175|NCT04650698|463774018|FG001|Overall Study|Protocol Violation|1|||
128857176|NCT04650698|463774017|FG000|Overall Study|Withdrawal by Subject|0|||
128857177|NCT04650698|463774018|FG001|Overall Study|Withdrawal by Subject|1|||
128857178|NCT00307047|463774019|FG000|Overall Study|Lost to Follow-up|35|||
128857179|NCT00307047|463774020|FG001|Overall Study|Lost to Follow-up|24|||
128857180|NCT00307047|463774019|FG000|Overall Study|Withdrawal by Subject|6|||
128857181|NCT00307047|463774020|FG001|Overall Study|Withdrawal by Subject|6|||
128857182|NCT00307047|463774019|FG000|Overall Study|Physician Decision|1|||
128857183|NCT00307047|463774020|FG001|Overall Study|Physician Decision|2|||
128857184|NCT00307047|463774019|FG000|Overall Study|Lost to follow-up for other reasons|0|||
128857185|NCT00307047|463774020|FG001|Overall Study|Lost to follow-up for other reasons|1|||
128857186|NCT00307047|463774019|FG000|Overall Study|All death, all MI, all Revascularization|27|||
128857187|NCT00307047|463774020|FG001|Overall Study|All death, all MI, all Revascularization|16|||
128857188|NCT03778294|463774021|FG000|Overall Study|Death|1|||
128857189|NCT03778294|463774021|FG000|Overall Study|Issues with insurance|1|||
128857190|NCT03778294|463774021|FG000|Overall Study|disease progression before treatment|2|||
128857191|NCT00487825|463774025|FG000|Overall Study|Adverse Event|2|||
128857192|NCT00487825|463774026|FG001|Overall Study|Adverse Event|2|||
128857193|NCT00487825|463774025|FG000|Overall Study|Lack of Efficacy|1|||
128857194|NCT00487825|463774026|FG001|Overall Study|Lack of Efficacy|1|||
128857195|NCT00487825|463774025|FG000|Overall Study|Other|3|||
128857196|NCT00487825|463774026|FG001|Overall Study|Other|2|||
128857197|NCT02104505|463774027|FG000|First Intervention (14 Days)|Adverse Event|2|||
128857198|NCT02104505|463774028|FG001|First Intervention (14 Days)|Adverse Event|0|||
128857199|NCT02104505|463774027|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
128857200|NCT02104505|463774028|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
128857201|NCT02104505|463774027|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
128857202|NCT02104505|463774028|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
128857203|NCT02104505|463774027|FG000|First Intervention (14 Days)|exclusionary condition|0|||
128857204|NCT02104505|463774028|FG001|First Intervention (14 Days)|exclusionary condition|1|||
128857205|NCT02104505|463774027|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
128857206|NCT02104505|463774028|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
128857207|NCT02104505|463774027|FG000|Second Intervention (14 Days)|Adverse Event|2|||
128857208|NCT02104505|463774028|FG001|Second Intervention (14 Days)|Adverse Event|0|||
128857209|NCT01639742|463774031|FG000|Overall Study|Study Ongoing|17|||
128857210|NCT01639742|463774031|FG000|Overall Study|Lost to Follow-up|1|||
128857211|NCT01190644|463774032|FG000|Overall Study|Death|2|||
128857212|NCT01190644|463774032|FG000|Overall Study|Disease progression|1|||
128857213|NCT02366143|463774033|FG000|Overall Study|Death|307|||
128857214|NCT02366143|463774034|FG001|Overall Study|Death|278|||
128857215|NCT02366143|463774035|FG002|Overall Study|Death|280|||
128857216|NCT02366143|463774033|FG000|Overall Study|Lost to Follow-up|2|||
128857217|NCT02366143|463774034|FG001|Overall Study|Lost to Follow-up|4|||
128857218|NCT02366143|463774035|FG002|Overall Study|Lost to Follow-up|2|||
128857219|NCT02366143|463774033|FG000|Overall Study|Physician Decision|1|||
128857220|NCT02366143|463774034|FG001|Overall Study|Physician Decision|2|||
128857221|NCT02366143|463774035|FG002|Overall Study|Physician Decision|1|||
128857222|NCT02366143|463774033|FG000|Overall Study|Protocol Violation|0|||
128857223|NCT02366143|463774034|FG001|Overall Study|Protocol Violation|0|||
128857224|NCT02366143|463774035|FG002|Overall Study|Protocol Violation|2|||
128857225|NCT02366143|463774033|FG000|Overall Study|Withdrawal by Subject|16|||
128857226|NCT02366143|463774034|FG001|Overall Study|Withdrawal by Subject|17|||
128857227|NCT02366143|463774035|FG002|Overall Study|Withdrawal by Subject|22|||
128857228|NCT02366143|463774033|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
128857229|NCT02366143|463774034|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
128857230|NCT02366143|463774035|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
128857231|NCT02366143|463774033|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
128857232|NCT02366143|463774034|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
128857233|NCT02366143|463774035|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
128857234|NCT02366143|463774033|FG000|Overall Study|Randomization Error|1|||
128857235|NCT02366143|463774034|FG001|Overall Study|Randomization Error|0|||
128857236|NCT02366143|463774035|FG002|Overall Study|Randomization Error|0|||
128857237|NCT02366143|463774033|FG000|Overall Study|PI Move and Site Closure|1|||
128857238|NCT02366143|463774034|FG001|Overall Study|PI Move and Site Closure|0|||
128857239|NCT02366143|463774035|FG002|Overall Study|PI Move and Site Closure|1|||
128857240|NCT02366143|463774033|FG000|Overall Study|Study Terminated By Sponsor|0|||
128857241|NCT02366143|463774034|FG001|Overall Study|Study Terminated By Sponsor|0|||
128857242|NCT02366143|463774035|FG002|Overall Study|Study Terminated By Sponsor|2|||
128857243|NCT02366143|463774033|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
128857244|NCT02366143|463774034|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
128857245|NCT02366143|463774035|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
128857246|NCT02366143|463774033|FG000|Overall Study|Patient moved to roll-over study|1|||
128857247|NCT02366143|463774034|FG001|Overall Study|Patient moved to roll-over study|19|||
128857248|NCT02366143|463774035|FG002|Overall Study|Patient moved to roll-over study|28|||
128857249|NCT02366143|463774033|FG000|Overall Study|Patient moved to commercial stock|0|||
128857250|NCT02366143|463774034|FG001|Overall Study|Patient moved to commercial stock|0|||
128857251|NCT02366143|463774035|FG002|Overall Study|Patient moved to commercial stock|1|||
128857252|NCT02366143|463774033|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
128857253|NCT02366143|463774034|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
128857254|NCT02366143|463774035|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
128857255|NCT02366143|463774033|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
128857256|NCT02366143|463774034|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
128857257|NCT02366143|463774035|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
128857258|NCT02366143|463774033|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
128857259|NCT02366143|463774034|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
128857260|NCT02366143|463774035|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
128857261|NCT02366143|463774033|FG000|Overall Study|Requester's instructions|1|||
128857262|NCT02366143|463774034|FG001|Overall Study|Requester's instructions|1|||
128857263|NCT02366143|463774035|FG002|Overall Study|Requester's instructions|1|||
128857264|NCT02366143|463774033|FG000|Overall Study|Uneligible|0|||
128857265|NCT02366143|463774034|FG001|Overall Study|Uneligible|1|||
128857266|NCT02366143|463774035|FG002|Overall Study|Uneligible|0|||
128857267|NCT02366143|463774033|FG000|Overall Study|Post Trial Migration|0|||
128857268|NCT02366143|463774034|FG001|Overall Study|Post Trial Migration|1|||
128857269|NCT02366143|463774035|FG002|Overall Study|Post Trial Migration|0|||
128857270|NCT02366143|463774033|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
128857271|NCT02366143|463774034|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
128857272|NCT02366143|463774035|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
128857273|NCT02366143|463774033|FG000|Overall Study|Patient switched to PTAP|0|||
128857274|NCT02366143|463774034|FG001|Overall Study|Patient switched to PTAP|1|||
128857275|NCT02366143|463774035|FG002|Overall Study|Patient switched to PTAP|0|||
128857276|NCT02366143|463774033|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
128857277|NCT02366143|463774034|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
128857278|NCT02366143|463774035|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
128857279|NCT04411186|463774036|FG000|Overall Study|Withdrawn due to protocol violation|0|||
128857280|NCT04411186|463774037|FG001|Overall Study|Withdrawn due to protocol violation|1|||
128857281|NCT01053247|463774038|FG000|Overall Study|Withdrawal by Subject|9|||
128857282|NCT01053247|463774039|FG001|Overall Study|Withdrawal by Subject|4|||
128857283|NCT01053247|463774040|FG002|Overall Study|Withdrawal by Subject|15|||
128857284|NCT01053247|463774038|FG000|Overall Study|Lack of Efficacy|1|||
128857285|NCT01053247|463774039|FG001|Overall Study|Lack of Efficacy|0|||
128857286|NCT01053247|463774040|FG002|Overall Study|Lack of Efficacy|1|||
128857287|NCT01053247|463774038|FG000|Overall Study|Protocol Violation|2|||
128857288|NCT01053247|463774039|FG001|Overall Study|Protocol Violation|1|||
128857289|NCT01053247|463774040|FG002|Overall Study|Protocol Violation|2|||
128857290|NCT01053247|463774038|FG000|Overall Study|Lost to Follow-up|8|||
128857291|NCT01053247|463774039|FG001|Overall Study|Lost to Follow-up|5|||
128857292|NCT01053247|463774040|FG002|Overall Study|Lost to Follow-up|7|||
128857293|NCT01053247|463774038|FG000|Overall Study|Adverse Event|0|||
128857294|NCT01053247|463774039|FG001|Overall Study|Adverse Event|9|||
128857295|NCT01053247|463774040|FG002|Overall Study|Adverse Event|3|||
128857296|NCT00701909|463774043|FG000|Overall Study|Withdrawal by Subject|0|||
128857297|NCT00701909|463774044|FG001|Overall Study|Withdrawal by Subject|1|||
128857298|NCT03023722|463774049|FG000|Overall Study|No follow-up assessment|4|||
128857299|NCT01385748|463774050|FG000|Overall Study|Withdrawal by Subject|7|||
128857300|NCT01385748|463774051|FG001|Overall Study|Withdrawal by Subject|4|||
128857301|NCT01385748|463774052|FG002|Overall Study|Withdrawal by Subject|5|||
128857302|NCT01385748|463774050|FG000|Overall Study|Noncompliance|3|||
128857303|NCT01385748|463774051|FG001|Overall Study|Noncompliance|1|||
128857304|NCT01385748|463774052|FG002|Overall Study|Noncompliance|6|||
128857305|NCT01385748|463774050|FG000|Overall Study|Other|1|||
128857306|NCT01385748|463774051|FG001|Overall Study|Other|7|||
128857307|NCT01385748|463774052|FG002|Overall Study|Other|1|||
128857308|NCT01385748|463774050|FG000|Overall Study|Adverse Event|4|||
128857309|NCT01385748|463774051|FG001|Overall Study|Adverse Event|2|||
128857310|NCT01385748|463774052|FG002|Overall Study|Adverse Event|1|||
128857311|NCT01458522|463774055|FG000|Overall Study|Withdrawal by Subject|2|||
128857312|NCT01458522|463774056|FG001|Overall Study|Withdrawal by Subject|2|||
128857313|NCT01458522|463774055|FG000|Overall Study|Physician Decision|1|||
128857314|NCT01458522|463774056|FG001|Overall Study|Physician Decision|9|||
128857315|NCT02684123|463774057|FG000|Phase 1|Lack of Efficacy|5|||
128857316|NCT02684123|463774058|FG001|Phase 1|Lack of Efficacy|0|||
128857317|NCT02684123|463774057|FG000|Phase 1|Adverse Event|3|||
128857318|NCT02684123|463774058|FG001|Phase 1|Adverse Event|0|||
128857319|NCT02684123|463774057|FG000|Phase 1|Lost to Follow-up|0|||
128857320|NCT02684123|463774058|FG001|Phase 1|Lost to Follow-up|1|||
128857321|NCT02684123|463774057|FG000|Phase 2|Lack of Efficacy|1|||
128857322|NCT02684123|463774058|FG001|Phase 2|Lack of Efficacy|8|||
128857323|NCT00516139|463774059|FG000|Overall Study|Adverse Event|27|||
128857324|NCT00516139|463774059|FG000|Overall Study|Lost to Follow-up|1|||
128857325|NCT00516139|463774059|FG000|Overall Study|Protocol Violation|1|||
128857326|NCT00516139|463774059|FG000|Overall Study|Withdrawal by Subject|8|||
128857327|NCT00516139|463774059|FG000|Overall Study|Lack of Efficacy|1|||
128857328|NCT00589303|463774064|FG000|Overall Study|Withdrawal by Subject|2|||
128857329|NCT00589303|463774065|FG001|Overall Study|Withdrawal by Subject|1|||
128857330|NCT04367480|463774066|FG000|Overall Study|Adverse Event|1|||
128857331|NCT04367480|463774067|FG001|Overall Study|Adverse Event|1|||
128857332|NCT04367480|463774066|FG000|Overall Study|Death|1|||
128857333|NCT04367480|463774067|FG001|Overall Study|Death|0|||
128857334|NCT04367480|463774066|FG000|Overall Study|Lost to Follow-up|1|||
128857335|NCT04367480|463774067|FG001|Overall Study|Lost to Follow-up|1|||
128857336|NCT04367480|463774066|FG000|Overall Study|Withdrawal by Subject|0|||
128857337|NCT04367480|463774067|FG001|Overall Study|Withdrawal by Subject|3|||
128857338|NCT04367480|463774066|FG000|Overall Study|App glitch during the study|1|||
128857339|NCT04367480|463774067|FG001|Overall Study|App glitch during the study|0|||
128857340|NCT04367480|463774066|FG000|Overall Study|Device Distribution Error|0|||
128857341|NCT04367480|463774067|FG001|Overall Study|Device Distribution Error|2|||
128857342|NCT04367480|463774066|FG000|Overall Study|Ineligible after Randomization|0|||
128857343|NCT04367480|463774067|FG001|Overall Study|Ineligible after Randomization|1|||
128857344|NCT04367480|463774066|FG000|Overall Study|Other Medical Reasons|0|||
128857345|NCT04367480|463774067|FG001|Overall Study|Other Medical Reasons|2|||
128857346|NCT00730015|463774071|FG000|Overall Study|Adverse Event|11|||
128857347|NCT00730015|463774072|FG001|Overall Study|Adverse Event|10|||
128857348|NCT00730015|463774073|FG002|Overall Study|Adverse Event|8|||
128857349|NCT00730015|463774071|FG000|Overall Study|Protocol Violation|2|||
128857350|NCT00730015|463774072|FG001|Overall Study|Protocol Violation|6|||
128857351|NCT00730015|463774073|FG002|Overall Study|Protocol Violation|4|||
128857352|NCT00730015|463774071|FG000|Overall Study|Withdrawal by Subject|12|||
128857353|NCT00730015|463774072|FG001|Overall Study|Withdrawal by Subject|12|||
128857354|NCT00730015|463774073|FG002|Overall Study|Withdrawal by Subject|8|||
128857355|NCT00730015|463774071|FG000|Overall Study|Lost to Follow-up|4|||
128857356|NCT00730015|463774072|FG001|Overall Study|Lost to Follow-up|10|||
128857357|NCT00730015|463774073|FG002|Overall Study|Lost to Follow-up|3|||
128857358|NCT00730015|463774071|FG000|Overall Study|Lack of Efficacy|1|||
128857359|NCT00730015|463774072|FG001|Overall Study|Lack of Efficacy|2|||
128857360|NCT00730015|463774073|FG002|Overall Study|Lack of Efficacy|8|||
128857361|NCT00730015|463774071|FG000|Overall Study|Other Reason|1|||
128857362|NCT00730015|463774072|FG001|Overall Study|Other Reason|0|||
128857363|NCT00730015|463774073|FG002|Overall Study|Other Reason|1|||
128857364|NCT04120376|463774074|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
128857365|NCT04120376|463774075|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
128857366|NCT02641587|463774076|FG000|Confinement Period|Adverse Event|1|||
128857367|NCT02641587|463774077|FG001|Confinement Period|Adverse Event|0|||
128857368|NCT02641587|463774076|FG000|Confinement Period|Withdrawal by Subject|2|||
128857369|NCT02641587|463774077|FG001|Confinement Period|Withdrawal by Subject|1|||
128857370|NCT02641587|463774076|FG000|Ambulatory Period|Withdrawal by Subject|1|||
128857371|NCT02641587|463774077|FG001|Ambulatory Period|Withdrawal by Subject|0|||
128857372|NCT01165177|463774078|FG000|Overall Study|Serious Adverse Event|227|||
128857373|NCT01165177|463774079|FG001|Overall Study|Serious Adverse Event|235|||
128857374|NCT01165177|463774078|FG000|Overall Study|Withdrawal by Subject|368|||
128857375|NCT01165177|463774079|FG001|Overall Study|Withdrawal by Subject|354|||
128857376|NCT01165177|463774078|FG000|Overall Study|Protocol Violation|19|||
128857377|NCT01165177|463774079|FG001|Overall Study|Protocol Violation|21|||
128857378|NCT01165177|463774078|FG000|Overall Study|Non-serious adverse event|30|||
128857379|NCT01165177|463774079|FG001|Overall Study|Non-serious adverse event|18|||
128857380|NCT01165177|463774078|FG000|Overall Study|Other unspecified reasons|47|||
128857381|NCT01165177|463774079|FG001|Overall Study|Other unspecified reasons|35|||
128857382|NCT01165177|463774078|FG000|Overall Study|Suspected HZ episode|0|||
128857383|NCT01165177|463774079|FG001|Overall Study|Suspected HZ episode|2|||
128857384|NCT01165177|463774078|FG000|Overall Study|Lost to Follow-up|183|||
128857385|NCT01165177|463774079|FG001|Overall Study|Lost to Follow-up|194|||
128857386|NCT01165177|463774078|FG000|Overall Study|Migrated/ moved from study area|48|||
128857387|NCT01165177|463774079|FG001|Overall Study|Migrated/ moved from study area|43|||
128857388|NCT01663506|463774080|FG000|Overall Study|Lack of Efficacy|3|||
128857389|NCT01663506|463774080|FG000|Overall Study|Consent Withdrawal by Subject|1|||
128857390|NCT01663506|463774080|FG000|Overall Study|Lost to Follow-up|1|||
128857391|NCT01663506|463774080|FG000|Overall Study|Adverse Event|1|||
128857392|NCT01663506|463774080|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
128857393|NCT04351269|463774081|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
128857394|NCT04351269|463774082|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
128857395|NCT04351269|463774083|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
128857396|NCT04351269|463774081|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
128857397|NCT04351269|463774082|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
128857398|NCT04351269|463774083|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
128857399|NCT04351269|463774081|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
128857400|NCT04351269|463774082|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
128857401|NCT04351269|463774083|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
128857402|NCT04351269|463774081|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
128857403|NCT04351269|463774082|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
128857404|NCT04351269|463774083|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
128857405|NCT04351269|463774081|FG000|Overall Study|Lost to Follow-up|1|||
128857406|NCT04351269|463774082|FG001|Overall Study|Lost to Follow-up|3|||
128857407|NCT04351269|463774083|FG002|Overall Study|Lost to Follow-up|0|||
128857408|NCT03210519|463774084|FG000|Overall Study|Adverse Event|2|||
128857409|NCT03210519|463774085|FG001|Overall Study|Adverse Event|0|||
128857410|NCT02270671|463774088|FG000|Overall Study|Withdrawal by Subject|1|||
128857411|NCT02270671|463774089|FG001|Overall Study|Withdrawal by Subject|1|||
128857412|NCT02270671|463774088|FG000|Overall Study|Protocol Violation|0|||
128857413|NCT02270671|463774089|FG001|Overall Study|Protocol Violation|1|||
128857414|NCT02270671|463774088|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
128857415|NCT02270671|463774089|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
128857416|NCT02270671|463774088|FG000|Overall Study|Lost to Follow-up|2|||
128857417|NCT02270671|463774089|FG001|Overall Study|Lost to Follow-up|1|||
128857418|NCT00822770|463774106|FG000|Overall Study|Not treated|1|||
128857419|NCT00822770|463774107|FG001|Overall Study|Not treated|0|||
128857420|NCT00822770|463774106|FG000|Overall Study|Complication/Incomplete treatment|1|||
128857421|NCT00822770|463774107|FG001|Overall Study|Complication/Incomplete treatment|0|||
128857422|NCT00822770|463774106|FG000|Overall Study|Death|1|||
128857423|NCT00822770|463774107|FG001|Overall Study|Death|1|||
128857424|NCT02818998|463774108|FG000|Overall Study|Adverse Event|3|||
128857425|NCT02818998|463774109|FG001|Overall Study|Adverse Event|2|||
128857426|NCT02818998|463774110|FG002|Overall Study|Adverse Event|1|||
128857427|NCT02818998|463774108|FG000|Overall Study|Lost to Follow-up|4|||
128857428|NCT02818998|463774109|FG001|Overall Study|Lost to Follow-up|1|||
128857429|NCT02818998|463774110|FG002|Overall Study|Lost to Follow-up|2|||
128857430|NCT02818998|463774108|FG000|Overall Study|Withdrawal by sponsor|0|||
128857431|NCT02818998|463774109|FG001|Overall Study|Withdrawal by sponsor|1|||
128857432|NCT02818998|463774110|FG002|Overall Study|Withdrawal by sponsor|1|||
128857433|NCT02818998|463774108|FG000|Overall Study|Death|3|||
128857434|NCT02818998|463774109|FG001|Overall Study|Death|6|||
128857435|NCT02818998|463774110|FG002|Overall Study|Death|8|||
128857436|NCT02818998|463774108|FG000|Overall Study|Withdrawal by Subject|7|||
128857437|NCT02818998|463774109|FG001|Overall Study|Withdrawal by Subject|6|||
128857438|NCT02818998|463774110|FG002|Overall Study|Withdrawal by Subject|6|||
128857439|NCT02818998|463774108|FG000|Overall Study|Physician Decision|1|||
128857440|NCT02818998|463774109|FG001|Overall Study|Physician Decision|0|||
128857441|NCT02818998|463774110|FG002|Overall Study|Physician Decision|0|||
128857442|NCT02049515|463774111|FG000|Overall Study|Adverse Event|46|||
128857443|NCT02049515|463774112|FG001|Overall Study|Adverse Event|2|||
128857444|NCT02049515|463774111|FG000|Overall Study|Protocol-specified Disease Progression|23|||
128857445|NCT02049515|463774112|FG001|Overall Study|Protocol-specified Disease Progression|2|||
128857446|NCT02049515|463774111|FG000|Overall Study|Death|6|||
128857447|NCT02049515|463774112|FG001|Overall Study|Death|0|||
128857448|NCT02049515|463774111|FG000|Overall Study|Physician Decision|5|||
128857449|NCT02049515|463774112|FG001|Overall Study|Physician Decision|1|||
128857450|NCT02049515|463774111|FG000|Overall Study|Withdrawal by Subject|3|||
128857451|NCT02049515|463774112|FG001|Overall Study|Withdrawal by Subject|0|||
128857452|NCT02049515|463774111|FG000|Overall Study|Termination of the Study by Sponsor|2|||
128857453|NCT02049515|463774112|FG001|Overall Study|Termination of the Study by Sponsor|0|||
128857454|NCT02049515|463774111|FG000|Overall Study|Protocol Violation|1|||
128857455|NCT02049515|463774112|FG001|Overall Study|Protocol Violation|1|||
128857456|NCT02049515|463774111|FG000|Overall Study|Clinical Deterioration|1|||
128857457|NCT02049515|463774112|FG001|Overall Study|Clinical Deterioration|0|||
128857458|NCT02049515|463774111|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
128857459|NCT02049515|463774112|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
128857460|NCT02049515|463774111|FG000|Overall Study|Treatment Interruption >42 Days|1|||
128857461|NCT02049515|463774112|FG001|Overall Study|Treatment Interruption >42 Days|0|||
128857462|NCT02049515|463774111|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
128857463|NCT02049515|463774112|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
128857464|NCT00224029|463774114|FG000|Overall Study|Lost to Follow-up|1|||
128857465|NCT00224029|463774114|FG000|Overall Study|Withdrawal by Subject|4|||
128857466|NCT00224029|463774114|FG000|Overall Study|Other|1|||
128857467|NCT01407276|463774115|FG000|Overall Study|Withdrawal by Subject|0|||
128857468|NCT01407276|463774116|FG001|Overall Study|Withdrawal by Subject|0|||
128857469|NCT01407276|463774117|FG002|Overall Study|Withdrawal by Subject|0|||
128857470|NCT01407276|463774118|FG003|Overall Study|Withdrawal by Subject|0|||
128857471|NCT01407276|463774119|FG004|Overall Study|Withdrawal by Subject|0|||
128857472|NCT01407276|463774120|FG005|Overall Study|Withdrawal by Subject|0|||
128857473|NCT01407276|463774121|FG006|Overall Study|Withdrawal by Subject|0|||
128857474|NCT01407276|463774122|FG007|Overall Study|Withdrawal by Subject|1|||
128857475|NCT00778921|463774123|FG000|Overall Study|Adverse Event|9|||
128857476|NCT00778921|463774124|FG001|Overall Study|Adverse Event|10|||
128857477|NCT00778921|463774125|FG002|Overall Study|Adverse Event|14|||
128857478|NCT00778921|463774123|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
128857479|NCT00778921|463774124|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
128857480|NCT00778921|463774125|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
128857481|NCT00778921|463774123|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
128857482|NCT00778921|463774124|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
128857483|NCT00778921|463774125|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
128857484|NCT00778921|463774123|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
128857485|NCT00778921|463774124|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
128857486|NCT00778921|463774125|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
128857487|NCT00778921|463774123|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
128857488|NCT00778921|463774124|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
128857489|NCT00778921|463774125|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
128857490|NCT00778921|463774123|FG000|Overall Study|Patient withdrew request|3|||
128857491|NCT00778921|463774124|FG001|Overall Study|Patient withdrew request|1|||
128857492|NCT00778921|463774125|FG002|Overall Study|Patient withdrew request|6|||
128857493|NCT00778921|463774123|FG000|Overall Study|Lost to Follow-up|0|||
128857494|NCT00778921|463774124|FG001|Overall Study|Lost to Follow-up|2|||
128857495|NCT00778921|463774125|FG002|Overall Study|Lost to Follow-up|1|||
128857496|NCT00778921|463774123|FG000|Overall Study|Administrative Problems|1|||
128857497|NCT00778921|463774124|FG001|Overall Study|Administrative Problems|2|||
128857498|NCT00778921|463774125|FG002|Overall Study|Administrative Problems|0|||
128857499|NCT00778921|463774123|FG000|Overall Study|Protocol Violation|3|||
128857500|NCT00778921|463774124|FG001|Overall Study|Protocol Violation|0|||
128857501|NCT00778921|463774125|FG002|Overall Study|Protocol Violation|2|||
128857502|NCT00778921|463774123|FG000|Overall Study|Not treated|0|||
128857503|NCT00778921|463774124|FG001|Overall Study|Not treated|2|||
128857504|NCT00778921|463774125|FG002|Overall Study|Not treated|2|||
128857505|NCT04805073|463774126|FG000|Overall Study|study personnel not available|2|||
128857506|NCT04805073|463774127|FG001|Overall Study|study personnel not available|0|||
128857507|NCT04805073|463774126|FG000|Overall Study|spinal anesthesia failure|0|||
128857508|NCT04805073|463774127|FG001|Overall Study|spinal anesthesia failure|1|||
128857509|NCT04805073|463774126|FG000|Overall Study|Lost to Follow-up|0|||
128857510|NCT04805073|463774127|FG001|Overall Study|Lost to Follow-up|2|||
128857511|NCT01078922|463774135|FG000|Overall Study|Adverse Event|1|||
128857512|NCT01174264|463774136|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
128857513|NCT01174264|463774137|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
128857514|NCT01174264|463774138|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
128857515|NCT01174264|463774136|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
128857516|NCT01174264|463774137|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
128857517|NCT01174264|463774138|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
128857518|NCT01174264|463774136|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
128857519|NCT01174264|463774137|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
128857520|NCT01174264|463774138|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
128857521|NCT02058836|463774142|FG000|Overall Study|Withdrawal by Subject|1|||
128857522|NCT02058836|463774143|FG001|Overall Study|Withdrawal by Subject|1|||
128857523|NCT00267098|463774144|FG000|Overall Study|Death|0|||
128857524|NCT00267098|463774145|FG001|Overall Study|Death|0|||
128857525|NCT00267098|463774146|FG002|Overall Study|Death|57|||
128857526|NCT00267098|463774147|FG003|Overall Study|Death|66|||
128857527|NCT00267098|463774148|FG004|Overall Study|Death|14|||
128857528|NCT00267098|463774149|FG005|Overall Study|Death|23|||
128857529|NCT00267098|463774150|FG006|Overall Study|Death|28|||
128857530|NCT00267098|463774151|FG007|Overall Study|Death|9|||
128857531|NCT00267098|463774144|FG000|Overall Study|Lost to Follow-up|0|||
128857532|NCT00267098|463774145|FG001|Overall Study|Lost to Follow-up|0|||
128857533|NCT00267098|463774146|FG002|Overall Study|Lost to Follow-up|6|||
128857534|NCT00267098|463774147|FG003|Overall Study|Lost to Follow-up|5|||
128857535|NCT00267098|463774148|FG004|Overall Study|Lost to Follow-up|2|||
128857536|NCT00267098|463774149|FG005|Overall Study|Lost to Follow-up|3|||
128857537|NCT00267098|463774150|FG006|Overall Study|Lost to Follow-up|1|||
128857538|NCT00267098|463774151|FG007|Overall Study|Lost to Follow-up|1|||
128857539|NCT00267098|463774144|FG000|Overall Study|Withdrawal by Subject|8|||
128857540|NCT00267098|463774145|FG001|Overall Study|Withdrawal by Subject|0|||
128857541|NCT00267098|463774146|FG002|Overall Study|Withdrawal by Subject|24|||
128857542|NCT00267098|463774147|FG003|Overall Study|Withdrawal by Subject|21|||
128857543|NCT00267098|463774148|FG004|Overall Study|Withdrawal by Subject|12|||
128857544|NCT00267098|463774149|FG005|Overall Study|Withdrawal by Subject|9|||
128857545|NCT00267098|463774150|FG006|Overall Study|Withdrawal by Subject|12|||
128857546|NCT00267098|463774151|FG007|Overall Study|Withdrawal by Subject|5|||
128857547|NCT00267098|463774144|FG000|Overall Study|Physician Decision|5|||
128857548|NCT00267098|463774145|FG001|Overall Study|Physician Decision|0|||
128857549|NCT00267098|463774146|FG002|Overall Study|Physician Decision|7|||
128857550|NCT00267098|463774147|FG003|Overall Study|Physician Decision|11|||
128857551|NCT00267098|463774148|FG004|Overall Study|Physician Decision|5|||
128857552|NCT00267098|463774149|FG005|Overall Study|Physician Decision|4|||
128857553|NCT00267098|463774150|FG006|Overall Study|Physician Decision|3|||
128857554|NCT00267098|463774151|FG007|Overall Study|Physician Decision|0|||
128857555|NCT00267098|463774144|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
128857556|NCT00267098|463774145|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128857557|NCT00267098|463774146|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128857558|NCT00267098|463774147|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128857559|NCT00267098|463774148|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
128857560|NCT00267098|463774149|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128857561|NCT00267098|463774150|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128857562|NCT00267098|463774151|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
128857563|NCT00267098|463774144|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
128857564|NCT00267098|463774145|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
128857565|NCT00267098|463774146|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
128857566|NCT00267098|463774147|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
128857567|NCT00267098|463774148|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
128857568|NCT00267098|463774149|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
128857569|NCT00267098|463774150|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
128857570|NCT00267098|463774151|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
128857571|NCT00267098|463774144|FG000|Overall Study|Site closure|0|||
128857572|NCT00267098|463774145|FG001|Overall Study|Site closure|0|||
128857573|NCT00267098|463774146|FG002|Overall Study|Site closure|0|||
128857574|NCT00267098|463774147|FG003|Overall Study|Site closure|1|||
128857575|NCT00267098|463774148|FG004|Overall Study|Site closure|0|||
128857576|NCT00267098|463774149|FG005|Overall Study|Site closure|1|||
128857577|NCT00267098|463774150|FG006|Overall Study|Site closure|1|||
128857578|NCT00267098|463774151|FG007|Overall Study|Site closure|0|||
128857579|NCT00267098|463774144|FG000|Overall Study|Explanted Medtronic device|0|||
128857580|NCT00267098|463774145|FG001|Overall Study|Explanted Medtronic device|0|||
128857581|NCT00267098|463774146|FG002|Overall Study|Explanted Medtronic device|0|||
128857582|NCT00267098|463774147|FG003|Overall Study|Explanted Medtronic device|1|||
128857583|NCT00267098|463774148|FG004|Overall Study|Explanted Medtronic device|0|||
128857584|NCT00267098|463774149|FG005|Overall Study|Explanted Medtronic device|0|||
128857585|NCT00267098|463774150|FG006|Overall Study|Explanted Medtronic device|0|||
128857586|NCT00267098|463774151|FG007|Overall Study|Explanted Medtronic device|0|||
128857587|NCT00267098|463774144|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
128857588|NCT00267098|463774145|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
128857589|NCT00267098|463774146|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
128857590|NCT00267098|463774147|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
128857591|NCT00267098|463774148|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
128857592|NCT00267098|463774149|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
128857593|NCT00267098|463774150|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
128857594|NCT00267098|463774151|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
128857595|NCT00267098|463774144|FG000|Overall Study|Subject listed for heart transplant|0|||
128857596|NCT00267098|463774145|FG001|Overall Study|Subject listed for heart transplant|0|||
128857597|NCT00267098|463774146|FG002|Overall Study|Subject listed for heart transplant|0|||
128857598|NCT00267098|463774147|FG003|Overall Study|Subject listed for heart transplant|0|||
128857599|NCT00267098|463774148|FG004|Overall Study|Subject listed for heart transplant|0|||
128857600|NCT00267098|463774149|FG005|Overall Study|Subject listed for heart transplant|0|||
128857601|NCT00267098|463774150|FG006|Overall Study|Subject listed for heart transplant|1|||
128857602|NCT00267098|463774151|FG007|Overall Study|Subject listed for heart transplant|0|||
128857603|NCT00267098|463774144|FG000|Overall Study|Sponsor withdrew subject|0|||
128857604|NCT00267098|463774145|FG001|Overall Study|Sponsor withdrew subject|0|||
128857605|NCT00267098|463774146|FG002|Overall Study|Sponsor withdrew subject|0|||
128857606|NCT00267098|463774147|FG003|Overall Study|Sponsor withdrew subject|1|||
128857607|NCT00267098|463774148|FG004|Overall Study|Sponsor withdrew subject|0|||
128857608|NCT00267098|463774149|FG005|Overall Study|Sponsor withdrew subject|0|||
128857609|NCT00267098|463774150|FG006|Overall Study|Sponsor withdrew subject|0|||
128857610|NCT00267098|463774151|FG007|Overall Study|Sponsor withdrew subject|0|||
128857611|NCT00547534|463774152|FG000|Overall Study|Adverse Event|7|||
128857612|NCT00547534|463774152|FG000|Overall Study|Disease Progression|4|||
128857613|NCT02688530|463774154|FG000|Overall Study|Withdrawal by Subject|0|||
128857614|NCT02688530|463774155|FG001|Overall Study|Withdrawal by Subject|1|||
128857615|NCT02688530|463774156|FG002|Overall Study|Withdrawal by Subject|0|||
128857616|NCT02688530|463774157|FG003|Overall Study|Withdrawal by Subject|0|||
128857617|NCT02688530|463774154|FG000|Overall Study|Lost to Follow-up|0|||
128857618|NCT02688530|463774155|FG001|Overall Study|Lost to Follow-up|0|||
128857619|NCT02688530|463774156|FG002|Overall Study|Lost to Follow-up|2|||
128857620|NCT02688530|463774157|FG003|Overall Study|Lost to Follow-up|0|||
128857621|NCT00115336|463774158|FG000|Overall Study|Hospital discharge before study drug|0|||
128857622|NCT00115336|463774159|FG001|Overall Study|Hospital discharge before study drug|1|||
128857623|NCT04199052|463774162|FG000|Overall Study|Lost to Follow-up|11|||
128857624|NCT04199052|463774163|FG001|Overall Study|Lost to Follow-up|18|||
128857625|NCT00815919|463774164|FG000|Overall Study|Unrelated Fungal Infection|1|||
128857626|NCT00815919|463774164|FG000|Overall Study|AML Relapse|1|||
128857627|NCT00815919|463774164|FG000|Overall Study|Lack of Efficacy|2|||
128857628|NCT04599907|463774167|FG000|Overall Study|Withdrawal by Subject|1|||
128857629|NCT04599907|463774168|FG001|Overall Study|Withdrawal by Subject|7|||
128857630|NCT04599907|463774169|FG002|Overall Study|Withdrawal by Subject|6|||
128857631|NCT04599907|463774167|FG000|Overall Study|Lost to Follow-up|0|||
128857632|NCT04599907|463774168|FG001|Overall Study|Lost to Follow-up|1|||
128857633|NCT04599907|463774169|FG002|Overall Study|Lost to Follow-up|0|||
128857634|NCT01466790|463774172|FG000|Overall Study|Adverse Event|1|||
128857635|NCT01466790|463774173|FG001|Overall Study|Adverse Event|0|||
128857636|NCT01466790|463774174|FG002|Overall Study|Adverse Event|0|||
128857637|NCT01466790|463774175|FG003|Overall Study|Adverse Event|0|||
128857638|NCT01466790|463774176|FG004|Overall Study|Adverse Event|2|||
128857639|NCT01466790|463774177|FG005|Overall Study|Adverse Event|0|||
128857640|NCT01466790|463774178|FG006|Overall Study|Adverse Event|0|||
128857641|NCT01466790|463774179|FG007|Overall Study|Adverse Event|0|||
128857642|NCT01466790|463774172|FG000|Overall Study|Lost to Follow-up|2|||
128857643|NCT01466790|463774173|FG001|Overall Study|Lost to Follow-up|0|||
128857644|NCT01466790|463774174|FG002|Overall Study|Lost to Follow-up|0|||
128857645|NCT01466790|463774175|FG003|Overall Study|Lost to Follow-up|0|||
128857646|NCT01466790|463774176|FG004|Overall Study|Lost to Follow-up|0|||
128857647|NCT01466790|463774177|FG005|Overall Study|Lost to Follow-up|0|||
128857648|NCT01466790|463774178|FG006|Overall Study|Lost to Follow-up|0|||
128857649|NCT01466790|463774179|FG007|Overall Study|Lost to Follow-up|0|||
128857650|NCT01466790|463774172|FG000|Overall Study|Withdrawal by Subject|1|||
128857651|NCT01466790|463774173|FG001|Overall Study|Withdrawal by Subject|1|||
128857652|NCT01466790|463774174|FG002|Overall Study|Withdrawal by Subject|0|||
128857653|NCT01466790|463774175|FG003|Overall Study|Withdrawal by Subject|0|||
128857654|NCT01466790|463774176|FG004|Overall Study|Withdrawal by Subject|1|||
128857655|NCT01466790|463774177|FG005|Overall Study|Withdrawal by Subject|0|||
128857656|NCT01466790|463774178|FG006|Overall Study|Withdrawal by Subject|1|||
128857657|NCT01466790|463774179|FG007|Overall Study|Withdrawal by Subject|1|||
128857658|NCT01251887|463774181|FG000|Overall Study|Scheduling conflict|1|||
128857659|NCT01251887|463774182|FG001|Overall Study|Scheduling conflict|2|||
128857660|NCT01251887|463774183|FG002|Overall Study|Scheduling conflict|2|||
128857661|NCT01251887|463774181|FG000|Overall Study|Physician Decision|0|||
128857662|NCT01251887|463774182|FG001|Overall Study|Physician Decision|1|||
128857663|NCT01251887|463774183|FG002|Overall Study|Physician Decision|0|||
128857664|NCT03668223|463774184|FG000|Overall Study|Death|10|||
128857665|NCT03668223|463774185|FG001|Overall Study|Death|5|||
128857666|NCT03668223|463774184|FG000|Overall Study|Lost to Follow-up|12|||
128857667|NCT03668223|463774185|FG001|Overall Study|Lost to Follow-up|12|||
128857668|NCT03668223|463774184|FG000|Overall Study|Withdrawal by Subject|8|||
128857669|NCT03668223|463774185|FG001|Overall Study|Withdrawal by Subject|3|||
128857670|NCT01103232|463774186|FG000|Overall Study|Withdrawal by Subject|1|||
128857671|NCT01103232|463774187|FG001|Overall Study|Withdrawal by Subject|1|||
128857672|NCT01103232|463774186|FG000|Overall Study|Protocol Violation|0|||
128857673|NCT01103232|463774187|FG001|Overall Study|Protocol Violation|1|||
128857674|NCT02094898|463775660|FG000|Overall Study|Clinical Worsening|2|||
128857675|NCT02094898|463775660|FG000|Overall Study|Adverse Event|2|||
128857676|NCT02094898|463775660|FG000|Overall Study|Lack of Efficacy|1|||
128857677|NCT01234883|463775661|FG000|Overall Study|Early treatment release|8|||
128857678|NCT01234883|463775662|FG001|Overall Study|Early treatment release|10|||
128857679|NCT01234883|463775661|FG000|Overall Study|Parent/guardian withdrew consent|1|||
128857680|NCT01234883|463775662|FG001|Overall Study|Parent/guardian withdrew consent|2|||
128857681|NCT01234883|463775661|FG000|Overall Study|Technical difficulties with IV infusion|0|||
128857682|NCT01234883|463775662|FG001|Overall Study|Technical difficulties with IV infusion|1|||
128857683|NCT01234883|463775661|FG000|Overall Study|Inclusion/exclusion failure|1|||
128857684|NCT01234883|463775662|FG001|Overall Study|Inclusion/exclusion failure|0|||
128857685|NCT00174447|463775665|FG000|Overall Study|Adverse Event|19|||
128857686|NCT00174447|463775665|FG000|Overall Study|Withdrawal by Subject|15|||
128857687|NCT00174447|463775665|FG000|Overall Study|Protocol Violation|1|||
128857688|NCT00174447|463775665|FG000|Overall Study|Lack of Efficacy|1|||
128857689|NCT00174447|463775665|FG000|Overall Study|Administrative reason/Other|2|||
128857690|NCT01437423|463775666|FG000|Overall Study|Lost to Follow-up|12|||
128857691|NCT01437423|463775666|FG000|Overall Study|Off label usage|3|||
128857692|NCT05878873|463775667|FG000|Overall Study|Lost to Follow-up|2|||
128857693|NCT05878873|463775668|FG001|Overall Study|Lost to Follow-up|0|||
128857694|NCT00633945|463775670|FG000|Overall Study|Physician Decision|2|||
128857695|NCT00882115|463775671|FG000|Overall Study|Withdrawal by Subject|3|||
128857696|NCT00882115|463775671|FG000|Overall Study|did not respond to DEP challe|6|||
128857697|NCT01271504|463775672|FG000|Overall Study|Death|7|||
128857698|NCT01271504|463775673|FG001|Overall Study|Death|6|||
128857699|NCT01271504|463775674|FG002|Overall Study|Death|32|||
128857700|NCT01271504|463775675|FG003|Overall Study|Death|32|||
128857701|NCT01271504|463775672|FG000|Overall Study|Lost to Follow-up|0|||
128857702|NCT01271504|463775673|FG001|Overall Study|Lost to Follow-up|1|||
128857703|NCT01271504|463775674|FG002|Overall Study|Lost to Follow-up|3|||
128857704|NCT01271504|463775675|FG003|Overall Study|Lost to Follow-up|1|||
128857705|NCT01271504|463775672|FG000|Overall Study|Protocol Violation|0|||
128857706|NCT01271504|463775673|FG001|Overall Study|Protocol Violation|0|||
128857707|NCT01271504|463775674|FG002|Overall Study|Protocol Violation|0|||
128857708|NCT01271504|463775675|FG003|Overall Study|Protocol Violation|2|||
128857709|NCT01271504|463775672|FG000|Overall Study|Administrative Reasons|0|||
128857710|NCT01271504|463775673|FG001|Overall Study|Administrative Reasons|0|||
128857711|NCT01271504|463775674|FG002|Overall Study|Administrative Reasons|6|||
128857712|NCT01271504|463775675|FG003|Overall Study|Administrative Reasons|5|||
128857713|NCT01271504|463775672|FG000|Overall Study|Withdrawal by Subject|0|||
128857714|NCT01271504|463775673|FG001|Overall Study|Withdrawal by Subject|0|||
128857715|NCT01271504|463775674|FG002|Overall Study|Withdrawal by Subject|1|||
128857716|NCT01271504|463775675|FG003|Overall Study|Withdrawal by Subject|3|||
128857717|NCT01271504|463775672|FG000|Overall Study|Other|0|||
128857718|NCT01271504|463775673|FG001|Overall Study|Other|1|||
128857719|NCT01271504|463775674|FG002|Overall Study|Other|2|||
128857720|NCT01271504|463775675|FG003|Overall Study|Other|0|||
128857721|NCT03865953|463775676|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
128857722|NCT03865953|463775677|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
128857723|NCT03865953|463775676|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
128857724|NCT03865953|463775677|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
128857725|NCT03865953|463775676|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
128857726|NCT03865953|463775677|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
128857727|NCT02552147|463775678|FG000|First Intervention (7 Days)|Protocol Violation|1|||
128857728|NCT02552147|463775679|FG001|First Intervention (7 Days)|Protocol Violation|0|||
128857729|NCT02552147|463775678|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
128857730|NCT02552147|463775679|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
128857731|NCT01547598|463775680|FG000|Overall Study|Withdrew consent|1|||
128857732|NCT01547598|463775681|FG001|Overall Study|Withdrew consent|1|||
128857733|NCT01547598|463775680|FG000|Overall Study|Lost to Follow-up|1|||
128857734|NCT01547598|463775681|FG001|Overall Study|Lost to Follow-up|1|||
128857735|NCT01547598|463775680|FG000|Overall Study|Adverse Event|1|||
128857736|NCT01547598|463775681|FG001|Overall Study|Adverse Event|1|||
128857737|NCT01547598|463775680|FG000|Overall Study|Protocol Violation|1|||
128857738|NCT01547598|463775681|FG001|Overall Study|Protocol Violation|1|||
128857739|NCT01547598|463775680|FG000|Overall Study|Other Miscellaneous Reasons|2|||
128857740|NCT01547598|463775681|FG001|Overall Study|Other Miscellaneous Reasons|1|||
128857741|NCT02229227|463775682|FG000|Overall Study|Adverse Event|14|||
128857742|NCT02229227|463775683|FG001|Overall Study|Adverse Event|9|||
128857743|NCT02229227|463775682|FG000|Overall Study|Lack of Efficacy|3|||
128857744|NCT02229227|463775683|FG001|Overall Study|Lack of Efficacy|3|||
128857745|NCT02229227|463775682|FG000|Overall Study|Protocol Violation|6|||
128857746|NCT02229227|463775683|FG001|Overall Study|Protocol Violation|8|||
128857747|NCT02229227|463775682|FG000|Overall Study|Protocol defined stopping criteria|1|||
128857748|NCT02229227|463775683|FG001|Overall Study|Protocol defined stopping criteria|3|||
128857749|NCT02229227|463775682|FG000|Overall Study|Lost to Follow-up|3|||
128857750|NCT02229227|463775683|FG001|Overall Study|Lost to Follow-up|3|||
128857751|NCT02229227|463775682|FG000|Overall Study|Study terminated by sponsor|11|||
128857752|NCT02229227|463775683|FG001|Overall Study|Study terminated by sponsor|11|||
128857753|NCT02229227|463775682|FG000|Overall Study|Withdrawal by Subject|8|||
128857754|NCT02229227|463775683|FG001|Overall Study|Withdrawal by Subject|12|||
128857755|NCT02229227|463775682|FG000|Overall Study|Other|0|||
128857756|NCT02229227|463775683|FG001|Overall Study|Other|1|||
128857757|NCT02229227|463775682|FG000|Overall Study|Physician Decision|5|||
128857758|NCT02229227|463775683|FG001|Overall Study|Physician Decision|12|||
128857759|NCT04071301|463775684|FG000|Overall Study|Withdrawal by Subject|6|||
128857760|NCT04071301|463775684|FG000|Overall Study|Death|1|||
128857761|NCT02125279|463775685|FG000|Overall Study|Lack of Efficacy|2|||
128857762|NCT02125279|463775685|FG000|Overall Study|Withdrawal by Subject|6|||
128857763|NCT02125279|463775685|FG000|Overall Study|Protocol Violation|1|||
128857764|NCT02125279|463775685|FG000|Overall Study|Lost to Follow-up|4|||
128857765|NCT01850589|463775691|FG000|Overall Study|Withdrawal by Subject|8|||
128857766|NCT01850589|463775692|FG001|Overall Study|Withdrawal by Subject|0|||
128857767|NCT04468230|463775697|FG000|Overall Study|Adverse Event|2|||
128857768|NCT03721705|463775700|FG000|Overall Study|Adverse Event|2|||
128857769|NCT03721705|463775701|FG001|Overall Study|Adverse Event|0|||
128857770|NCT03721705|463775700|FG000|Overall Study|Withdrawal by Subject|4|||
128857771|NCT03721705|463775701|FG001|Overall Study|Withdrawal by Subject|10|||
128857772|NCT03721705|463775700|FG000|Overall Study|No Suitable Study Partner|1|||
128857773|NCT03721705|463775701|FG001|Overall Study|No Suitable Study Partner|0|||
128857774|NCT03721705|463775700|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
128857775|NCT03721705|463775701|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
128857776|NCT03721705|463775700|FG000|Overall Study|Death|0|||
128857777|NCT03721705|463775701|FG001|Overall Study|Death|1|||
128857778|NCT01790295|463775702|FG000|Overall Study|Adverse Event|1|||
128857779|NCT01790295|463775702|FG000|Overall Study|Death|4|||
128857780|NCT01790295|463775702|FG000|Overall Study|Lack of Efficacy|2|||
128857781|NCT01790295|463775702|FG000|Overall Study|Study closure|4|||
128857782|NCT01080326|463775705|FG000|Overall Study|Patient deterioration prior to procedure|3|||
128857783|NCT01080326|463775705|FG000|Overall Study|Surgeon decision|1|||
128857784|NCT01318876|463775706|FG000|Day 8 Survey|email address invalid|96|||
128857785|NCT01318876|463775706|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
128857786|NCT01318876|463775706|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
128857787|NCT01296555|463775707|FG000|Overall Study|Adverse Event|0|||
128857788|NCT01296555|463775708|FG001|Overall Study|Adverse Event|0|||
128857789|NCT01296555|463775709|FG002|Overall Study|Adverse Event|1|||
128857790|NCT01296555|463775710|FG003|Overall Study|Adverse Event|1|||
128857791|NCT01296555|463775711|FG004|Overall Study|Adverse Event|2|||
128857792|NCT01296555|463775712|FG005|Overall Study|Adverse Event|4|||
128857793|NCT01296555|463775713|FG006|Overall Study|Adverse Event|1|||
128857794|NCT01296555|463775714|FG007|Overall Study|Adverse Event|4|||
128857795|NCT01296555|463775715|FG008|Overall Study|Adverse Event|3|||
128857796|NCT01296555|463775716|FG009|Overall Study|Adverse Event|1|||
128857797|NCT01296555|463775717|FG010|Overall Study|Adverse Event|0|||
128857798|NCT01296555|463775718|FG011|Overall Study|Adverse Event|4|||
128857799|NCT01296555|463775719|FG012|Overall Study|Adverse Event|1|||
128857800|NCT01296555|463775720|FG013|Overall Study|Adverse Event|4|||
128857801|NCT01296555|463775721|FG014|Overall Study|Adverse Event|0|||
128857802|NCT01296555|463775722|FG015|Overall Study|Adverse Event|0|||
128857803|NCT01296555|463775723|FG016|Overall Study|Adverse Event|0|||
128857804|NCT01296555|463775724|FG017|Overall Study|Adverse Event|0|||
128857805|NCT01296555|463775725|FG018|Overall Study|Adverse Event|0|||
128857806|NCT01296555|463775726|FG019|Overall Study|Adverse Event|1|||
128857807|NCT01296555|463775727|FG020|Overall Study|Adverse Event|0|||
128857808|NCT01296555|463775728|FG021|Overall Study|Adverse Event|0|||
128857809|NCT01296555|463775729|FG022|Overall Study|Adverse Event|0|||
128857810|NCT01296555|463775730|FG023|Overall Study|Adverse Event|0|||
128857811|NCT01296555|463775731|FG024|Overall Study|Adverse Event|0|||
128857812|NCT01296555|463775732|FG025|Overall Study|Adverse Event|0|||
128857813|NCT01296555|463775733|FG026|Overall Study|Adverse Event|0|||
128857814|NCT01296555|463775734|FG027|Overall Study|Adverse Event|0|||
128857815|NCT01296555|463775735|FG028|Overall Study|Adverse Event|0|||
128857816|NCT01296555|463775707|FG000|Overall Study|Reason Not Specified|0|||
128857817|NCT01296555|463775708|FG001|Overall Study|Reason Not Specified|0|||
128857818|NCT01296555|463775709|FG002|Overall Study|Reason Not Specified|0|||
128857819|NCT01296555|463775710|FG003|Overall Study|Reason Not Specified|0|||
128857820|NCT01296555|463775711|FG004|Overall Study|Reason Not Specified|0|||
128857821|NCT01296555|463775712|FG005|Overall Study|Reason Not Specified|0|||
128857822|NCT01296555|463775713|FG006|Overall Study|Reason Not Specified|0|||
128857823|NCT01296555|463775714|FG007|Overall Study|Reason Not Specified|0|||
128857824|NCT01296555|463775715|FG008|Overall Study|Reason Not Specified|0|||
128857825|NCT01296555|463775716|FG009|Overall Study|Reason Not Specified|0|||
128857826|NCT01296555|463775717|FG010|Overall Study|Reason Not Specified|0|||
128857827|NCT01296555|463775718|FG011|Overall Study|Reason Not Specified|0|||
128857828|NCT01296555|463775719|FG012|Overall Study|Reason Not Specified|0|||
128857829|NCT01296555|463775720|FG013|Overall Study|Reason Not Specified|1|||
128857830|NCT01296555|463775721|FG014|Overall Study|Reason Not Specified|2|||
128857831|NCT01296555|463775722|FG015|Overall Study|Reason Not Specified|3|||
128857832|NCT01296555|463775723|FG016|Overall Study|Reason Not Specified|7|||
128857833|NCT01296555|463775724|FG017|Overall Study|Reason Not Specified|4|||
128857834|NCT01296555|463775725|FG018|Overall Study|Reason Not Specified|3|||
128857835|NCT01296555|463775726|FG019|Overall Study|Reason Not Specified|7|||
128857836|NCT01296555|463775727|FG020|Overall Study|Reason Not Specified|11|||
128857837|NCT01296555|463775728|FG021|Overall Study|Reason Not Specified|5|||
128857838|NCT01296555|463775729|FG022|Overall Study|Reason Not Specified|5|||
128857839|NCT01296555|463775730|FG023|Overall Study|Reason Not Specified|7|||
128857840|NCT01296555|463775731|FG024|Overall Study|Reason Not Specified|2|||
128857841|NCT01296555|463775732|FG025|Overall Study|Reason Not Specified|2|||
128857842|NCT01296555|463775733|FG026|Overall Study|Reason Not Specified|19|||
128857843|NCT01296555|463775734|FG027|Overall Study|Reason Not Specified|11|||
128857844|NCT01296555|463775735|FG028|Overall Study|Reason Not Specified|9|||
128857845|NCT01296555|463775707|FG000|Overall Study|Physician Decision|0|||
128857846|NCT01296555|463775708|FG001|Overall Study|Physician Decision|0|||
128857847|NCT01296555|463775709|FG002|Overall Study|Physician Decision|0|||
128857848|NCT01296555|463775710|FG003|Overall Study|Physician Decision|0|||
128857849|NCT01296555|463775711|FG004|Overall Study|Physician Decision|1|||
128857850|NCT01296555|463775712|FG005|Overall Study|Physician Decision|0|||
128857851|NCT01296555|463775713|FG006|Overall Study|Physician Decision|0|||
128857852|NCT01296555|463775714|FG007|Overall Study|Physician Decision|0|||
128857853|NCT01296555|463775715|FG008|Overall Study|Physician Decision|0|||
128857854|NCT01296555|463775716|FG009|Overall Study|Physician Decision|0|||
128857855|NCT01296555|463775717|FG010|Overall Study|Physician Decision|0|||
128857856|NCT01296555|463775718|FG011|Overall Study|Physician Decision|0|||
128857857|NCT01296555|463775719|FG012|Overall Study|Physician Decision|0|||
128857858|NCT01296555|463775720|FG013|Overall Study|Physician Decision|1|||
128857859|NCT01296555|463775721|FG014|Overall Study|Physician Decision|0|||
128857860|NCT01296555|463775722|FG015|Overall Study|Physician Decision|0|||
128857861|NCT01296555|463775723|FG016|Overall Study|Physician Decision|0|||
128857862|NCT01296555|463775724|FG017|Overall Study|Physician Decision|0|||
128857863|NCT01296555|463775725|FG018|Overall Study|Physician Decision|0|||
128857864|NCT01296555|463775726|FG019|Overall Study|Physician Decision|1|||
128857865|NCT01296555|463775727|FG020|Overall Study|Physician Decision|0|||
128857866|NCT01296555|463775728|FG021|Overall Study|Physician Decision|0|||
128857867|NCT01296555|463775729|FG022|Overall Study|Physician Decision|0|||
128857868|NCT01296555|463775730|FG023|Overall Study|Physician Decision|0|||
128857869|NCT01296555|463775731|FG024|Overall Study|Physician Decision|0|||
128857870|NCT01296555|463775732|FG025|Overall Study|Physician Decision|0|||
128857871|NCT01296555|463775733|FG026|Overall Study|Physician Decision|0|||
128857872|NCT01296555|463775734|FG027|Overall Study|Physician Decision|0|||
128857873|NCT01296555|463775735|FG028|Overall Study|Physician Decision|0|||
128857874|NCT01296555|463775707|FG000|Overall Study|Progressive Disease|6|||
128857875|NCT01296555|463775708|FG001|Overall Study|Progressive Disease|3|||
128857876|NCT01296555|463775709|FG002|Overall Study|Progressive Disease|3|||
128857877|NCT01296555|463775710|FG003|Overall Study|Progressive Disease|7|||
128857878|NCT01296555|463775711|FG004|Overall Study|Progressive Disease|6|||
128857879|NCT01296555|463775712|FG005|Overall Study|Progressive Disease|16|||
128857880|NCT01296555|463775713|FG006|Overall Study|Progressive Disease|16|||
128857881|NCT01296555|463775714|FG007|Overall Study|Progressive Disease|8|||
128857882|NCT01296555|463775715|FG008|Overall Study|Progressive Disease|7|||
128857883|NCT01296555|463775716|FG009|Overall Study|Progressive Disease|18|||
128857884|NCT01296555|463775717|FG010|Overall Study|Progressive Disease|7|||
128857885|NCT01296555|463775718|FG011|Overall Study|Progressive Disease|14|||
128857886|NCT01296555|463775719|FG012|Overall Study|Progressive Disease|5|||
128857887|NCT01296555|463775720|FG013|Overall Study|Progressive Disease|12|||
128857888|NCT01296555|463775721|FG014|Overall Study|Progressive Disease|1|||
128857889|NCT01296555|463775722|FG015|Overall Study|Progressive Disease|1|||
128857890|NCT01296555|463775723|FG016|Overall Study|Progressive Disease|0|||
128857891|NCT01296555|463775724|FG017|Overall Study|Progressive Disease|0|||
128857892|NCT01296555|463775725|FG018|Overall Study|Progressive Disease|0|||
128857893|NCT01296555|463775726|FG019|Overall Study|Progressive Disease|1|||
128857894|NCT01296555|463775727|FG020|Overall Study|Progressive Disease|0|||
128857895|NCT01296555|463775728|FG021|Overall Study|Progressive Disease|0|||
128857896|NCT01296555|463775729|FG022|Overall Study|Progressive Disease|0|||
128857897|NCT01296555|463775730|FG023|Overall Study|Progressive Disease|0|||
128857898|NCT01296555|463775731|FG024|Overall Study|Progressive Disease|1|||
128857899|NCT01296555|463775732|FG025|Overall Study|Progressive Disease|0|||
128857900|NCT01296555|463775733|FG026|Overall Study|Progressive Disease|5|||
128857901|NCT01296555|463775734|FG027|Overall Study|Progressive Disease|1|||
128857902|NCT01296555|463775735|FG028|Overall Study|Progressive Disease|0|||
128857903|NCT01296555|463775707|FG000|Overall Study|Protocol Violation|0|||
128857904|NCT01296555|463775708|FG001|Overall Study|Protocol Violation|0|||
128857905|NCT01296555|463775709|FG002|Overall Study|Protocol Violation|0|||
128857906|NCT01296555|463775710|FG003|Overall Study|Protocol Violation|0|||
128857907|NCT01296555|463775711|FG004|Overall Study|Protocol Violation|0|||
128857908|NCT01296555|463775712|FG005|Overall Study|Protocol Violation|0|||
128857909|NCT01296555|463775713|FG006|Overall Study|Protocol Violation|0|||
128857910|NCT01296555|463775714|FG007|Overall Study|Protocol Violation|0|||
128857911|NCT01296555|463775715|FG008|Overall Study|Protocol Violation|0|||
128857912|NCT01296555|463775716|FG009|Overall Study|Protocol Violation|0|||
128857913|NCT01296555|463775717|FG010|Overall Study|Protocol Violation|0|||
128857914|NCT01296555|463775718|FG011|Overall Study|Protocol Violation|0|||
128857915|NCT01296555|463775719|FG012|Overall Study|Protocol Violation|0|||
128857916|NCT01296555|463775720|FG013|Overall Study|Protocol Violation|1|||
128857917|NCT01296555|463775721|FG014|Overall Study|Protocol Violation|0|||
128857918|NCT01296555|463775722|FG015|Overall Study|Protocol Violation|0|||
128857919|NCT01296555|463775723|FG016|Overall Study|Protocol Violation|0|||
128857920|NCT01296555|463775724|FG017|Overall Study|Protocol Violation|0|||
128857921|NCT01296555|463775725|FG018|Overall Study|Protocol Violation|0|||
128857922|NCT01296555|463775726|FG019|Overall Study|Protocol Violation|0|||
128857923|NCT01296555|463775727|FG020|Overall Study|Protocol Violation|0|||
128857924|NCT01296555|463775728|FG021|Overall Study|Protocol Violation|0|||
128857925|NCT01296555|463775729|FG022|Overall Study|Protocol Violation|0|||
128857926|NCT01296555|463775730|FG023|Overall Study|Protocol Violation|0|||
128857927|NCT01296555|463775731|FG024|Overall Study|Protocol Violation|0|||
128857928|NCT01296555|463775732|FG025|Overall Study|Protocol Violation|0|||
128857929|NCT01296555|463775733|FG026|Overall Study|Protocol Violation|0|||
128857930|NCT01296555|463775734|FG027|Overall Study|Protocol Violation|0|||
128857931|NCT01296555|463775735|FG028|Overall Study|Protocol Violation|0|||
128857932|NCT01296555|463775707|FG000|Overall Study|Study Terminated By Sponsor|0|||
128857933|NCT01296555|463775708|FG001|Overall Study|Study Terminated By Sponsor|0|||
128857934|NCT01296555|463775709|FG002|Overall Study|Study Terminated By Sponsor|0|||
128857935|NCT01296555|463775710|FG003|Overall Study|Study Terminated By Sponsor|0|||
128857936|NCT01296555|463775711|FG004|Overall Study|Study Terminated By Sponsor|0|||
128857937|NCT01296555|463775712|FG005|Overall Study|Study Terminated By Sponsor|0|||
128857938|NCT01296555|463775713|FG006|Overall Study|Study Terminated By Sponsor|0|||
128857939|NCT01296555|463775714|FG007|Overall Study|Study Terminated By Sponsor|0|||
128857940|NCT01296555|463775715|FG008|Overall Study|Study Terminated By Sponsor|0|||
128857941|NCT01296555|463775716|FG009|Overall Study|Study Terminated By Sponsor|0|||
128857942|NCT01296555|463775717|FG010|Overall Study|Study Terminated By Sponsor|0|||
128857943|NCT01296555|463775718|FG011|Overall Study|Study Terminated By Sponsor|0|||
128857944|NCT01296555|463775719|FG012|Overall Study|Study Terminated By Sponsor|0|||
128857945|NCT01296555|463775720|FG013|Overall Study|Study Terminated By Sponsor|0|||
128857946|NCT01296555|463775721|FG014|Overall Study|Study Terminated By Sponsor|0|||
128857947|NCT01296555|463775722|FG015|Overall Study|Study Terminated By Sponsor|0|||
128857948|NCT01296555|463775723|FG016|Overall Study|Study Terminated By Sponsor|0|||
128857949|NCT01296555|463775724|FG017|Overall Study|Study Terminated By Sponsor|0|||
128857950|NCT01296555|463775725|FG018|Overall Study|Study Terminated By Sponsor|0|||
128857951|NCT01296555|463775726|FG019|Overall Study|Study Terminated By Sponsor|0|||
128857952|NCT01296555|463775727|FG020|Overall Study|Study Terminated By Sponsor|0|||
128857953|NCT01296555|463775728|FG021|Overall Study|Study Terminated By Sponsor|0|||
128857954|NCT01296555|463775729|FG022|Overall Study|Study Terminated By Sponsor|0|||
128857955|NCT01296555|463775730|FG023|Overall Study|Study Terminated By Sponsor|0|||
128857956|NCT01296555|463775731|FG024|Overall Study|Study Terminated By Sponsor|0|||
128857957|NCT01296555|463775732|FG025|Overall Study|Study Terminated By Sponsor|1|||
128857958|NCT01296555|463775733|FG026|Overall Study|Study Terminated By Sponsor|0|||
128857959|NCT01296555|463775734|FG027|Overall Study|Study Terminated By Sponsor|0|||
128857960|NCT01296555|463775735|FG028|Overall Study|Study Terminated By Sponsor|0|||
128857961|NCT01296555|463775707|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857962|NCT01296555|463775708|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857963|NCT01296555|463775709|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857964|NCT01296555|463775710|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857965|NCT01296555|463775711|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857966|NCT01296555|463775712|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857967|NCT01296555|463775713|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857968|NCT01296555|463775714|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857969|NCT01296555|463775715|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857970|NCT01296555|463775716|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857971|NCT01296555|463775717|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857972|NCT01296555|463775718|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857973|NCT01296555|463775719|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857974|NCT01296555|463775720|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857975|NCT01296555|463775721|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857976|NCT01296555|463775722|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857977|NCT01296555|463775723|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857978|NCT01296555|463775724|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857979|NCT01296555|463775725|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857980|NCT01296555|463775726|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
128857981|NCT01296555|463775727|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857982|NCT01296555|463775728|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857983|NCT01296555|463775729|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857984|NCT01296555|463775730|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857985|NCT01296555|463775731|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857986|NCT01296555|463775732|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857987|NCT01296555|463775733|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857988|NCT01296555|463775734|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857989|NCT01296555|463775735|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
128857990|NCT01296555|463775707|FG000|Overall Study|Death|0|||
128857991|NCT01296555|463775708|FG001|Overall Study|Death|0|||
128857992|NCT01296555|463775709|FG002|Overall Study|Death|0|||
128857993|NCT01296555|463775710|FG003|Overall Study|Death|2|||
128857994|NCT01296555|463775711|FG004|Overall Study|Death|1|||
128857995|NCT01296555|463775712|FG005|Overall Study|Death|0|||
128857996|NCT01296555|463775713|FG006|Overall Study|Death|2|||
128857997|NCT01296555|463775714|FG007|Overall Study|Death|0|||
128857998|NCT01296555|463775715|FG008|Overall Study|Death|0|||
128857999|NCT01296555|463775716|FG009|Overall Study|Death|1|||
128858000|NCT01296555|463775717|FG010|Overall Study|Death|0|||
128858001|NCT01296555|463775718|FG011|Overall Study|Death|1|||
128858002|NCT01296555|463775719|FG012|Overall Study|Death|0|||
128858003|NCT01296555|463775720|FG013|Overall Study|Death|2|||
128858004|NCT01296555|463775721|FG014|Overall Study|Death|27|||
128858005|NCT01296555|463775722|FG015|Overall Study|Death|15|||
128858006|NCT01296555|463775723|FG016|Overall Study|Death|11|||
128858007|NCT01296555|463775724|FG017|Overall Study|Death|11|||
128858008|NCT01296555|463775725|FG018|Overall Study|Death|17|||
128858009|NCT01296555|463775726|FG019|Overall Study|Death|12|||
128858010|NCT01296555|463775727|FG020|Overall Study|Death|13|||
128858011|NCT01296555|463775728|FG021|Overall Study|Death|12|||
128858012|NCT01296555|463775729|FG022|Overall Study|Death|12|||
128858013|NCT01296555|463775730|FG023|Overall Study|Death|13|||
128858014|NCT01296555|463775731|FG024|Overall Study|Death|7|||
128858015|NCT01296555|463775732|FG025|Overall Study|Death|7|||
128858016|NCT01296555|463775733|FG026|Overall Study|Death|35|||
128858017|NCT01296555|463775734|FG027|Overall Study|Death|92|||
128858018|NCT01296555|463775735|FG028|Overall Study|Death|44|||
128858019|NCT01296555|463775707|FG000|Overall Study|Lost to Follow-up|0|||
128858020|NCT01296555|463775708|FG001|Overall Study|Lost to Follow-up|0|||
128858021|NCT01296555|463775709|FG002|Overall Study|Lost to Follow-up|0|||
128858022|NCT01296555|463775710|FG003|Overall Study|Lost to Follow-up|0|||
128858023|NCT01296555|463775711|FG004|Overall Study|Lost to Follow-up|0|||
128858024|NCT01296555|463775712|FG005|Overall Study|Lost to Follow-up|0|||
128858025|NCT01296555|463775713|FG006|Overall Study|Lost to Follow-up|0|||
128858026|NCT01296555|463775714|FG007|Overall Study|Lost to Follow-up|0|||
128858027|NCT01296555|463775715|FG008|Overall Study|Lost to Follow-up|0|||
128858028|NCT01296555|463775716|FG009|Overall Study|Lost to Follow-up|0|||
128858029|NCT01296555|463775717|FG010|Overall Study|Lost to Follow-up|0|||
128858030|NCT01296555|463775718|FG011|Overall Study|Lost to Follow-up|0|||
128858031|NCT01296555|463775719|FG012|Overall Study|Lost to Follow-up|0|||
128858032|NCT01296555|463775720|FG013|Overall Study|Lost to Follow-up|0|||
128858033|NCT01296555|463775721|FG014|Overall Study|Lost to Follow-up|2|||
128858034|NCT01296555|463775722|FG015|Overall Study|Lost to Follow-up|1|||
128858035|NCT01296555|463775723|FG016|Overall Study|Lost to Follow-up|0|||
128858036|NCT01296555|463775724|FG017|Overall Study|Lost to Follow-up|2|||
128858037|NCT01296555|463775725|FG018|Overall Study|Lost to Follow-up|0|||
128858038|NCT01296555|463775726|FG019|Overall Study|Lost to Follow-up|2|||
128858039|NCT01296555|463775727|FG020|Overall Study|Lost to Follow-up|3|||
128858040|NCT01296555|463775728|FG021|Overall Study|Lost to Follow-up|2|||
128858041|NCT01296555|463775729|FG022|Overall Study|Lost to Follow-up|0|||
128858042|NCT01296555|463775730|FG023|Overall Study|Lost to Follow-up|0|||
128858043|NCT01296555|463775731|FG024|Overall Study|Lost to Follow-up|0|||
128858044|NCT01296555|463775732|FG025|Overall Study|Lost to Follow-up|0|||
128858045|NCT01296555|463775733|FG026|Overall Study|Lost to Follow-up|3|||
128858046|NCT01296555|463775734|FG027|Overall Study|Lost to Follow-up|13|||
128858047|NCT01296555|463775735|FG028|Overall Study|Lost to Follow-up|5|||
128858048|NCT01296555|463775707|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128858049|NCT01296555|463775708|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128858050|NCT01296555|463775709|FG002|Overall Study|Non-Compliance With Study Drug|0|||
128858051|NCT01296555|463775710|FG003|Overall Study|Non-Compliance With Study Drug|0|||
128858052|NCT01296555|463775711|FG004|Overall Study|Non-Compliance With Study Drug|0|||
128858053|NCT01296555|463775712|FG005|Overall Study|Non-Compliance With Study Drug|0|||
128858054|NCT01296555|463775713|FG006|Overall Study|Non-Compliance With Study Drug|0|||
128858055|NCT01296555|463775714|FG007|Overall Study|Non-Compliance With Study Drug|1|||
128858056|NCT01296555|463775715|FG008|Overall Study|Non-Compliance With Study Drug|0|||
128858057|NCT01296555|463775716|FG009|Overall Study|Non-Compliance With Study Drug|0|||
128858058|NCT01296555|463775717|FG010|Overall Study|Non-Compliance With Study Drug|0|||
128858059|NCT01296555|463775718|FG011|Overall Study|Non-Compliance With Study Drug|0|||
128858060|NCT01296555|463775719|FG012|Overall Study|Non-Compliance With Study Drug|0|||
128858061|NCT01296555|463775720|FG013|Overall Study|Non-Compliance With Study Drug|0|||
128858062|NCT01296555|463775721|FG014|Overall Study|Non-Compliance With Study Drug|0|||
128858063|NCT01296555|463775722|FG015|Overall Study|Non-Compliance With Study Drug|0|||
128858064|NCT01296555|463775723|FG016|Overall Study|Non-Compliance With Study Drug|0|||
128858065|NCT01296555|463775724|FG017|Overall Study|Non-Compliance With Study Drug|0|||
128858066|NCT01296555|463775725|FG018|Overall Study|Non-Compliance With Study Drug|0|||
128858067|NCT01296555|463775726|FG019|Overall Study|Non-Compliance With Study Drug|0|||
128858068|NCT01296555|463775727|FG020|Overall Study|Non-Compliance With Study Drug|0|||
128858069|NCT01296555|463775728|FG021|Overall Study|Non-Compliance With Study Drug|0|||
128858070|NCT01296555|463775729|FG022|Overall Study|Non-Compliance With Study Drug|0|||
128858071|NCT01296555|463775730|FG023|Overall Study|Non-Compliance With Study Drug|0|||
128858072|NCT01296555|463775731|FG024|Overall Study|Non-Compliance With Study Drug|0|||
128858073|NCT01296555|463775732|FG025|Overall Study|Non-Compliance With Study Drug|0|||
128858074|NCT01296555|463775733|FG026|Overall Study|Non-Compliance With Study Drug|0|||
128858075|NCT01296555|463775734|FG027|Overall Study|Non-Compliance With Study Drug|0|||
128858076|NCT01296555|463775735|FG028|Overall Study|Non-Compliance With Study Drug|0|||
128858077|NCT01296555|463775707|FG000|Overall Study|Withdrawal by Subject|0|||
128858078|NCT01296555|463775708|FG001|Overall Study|Withdrawal by Subject|0|||
128858079|NCT01296555|463775709|FG002|Overall Study|Withdrawal by Subject|0|||
128858080|NCT01296555|463775710|FG003|Overall Study|Withdrawal by Subject|0|||
128858081|NCT01296555|463775711|FG004|Overall Study|Withdrawal by Subject|1|||
128858082|NCT01296555|463775712|FG005|Overall Study|Withdrawal by Subject|0|||
128858083|NCT01296555|463775713|FG006|Overall Study|Withdrawal by Subject|1|||
128858084|NCT01296555|463775714|FG007|Overall Study|Withdrawal by Subject|0|||
128858085|NCT01296555|463775715|FG008|Overall Study|Withdrawal by Subject|0|||
128858086|NCT01296555|463775716|FG009|Overall Study|Withdrawal by Subject|0|||
128858087|NCT01296555|463775717|FG010|Overall Study|Withdrawal by Subject|1|||
128858088|NCT01296555|463775718|FG011|Overall Study|Withdrawal by Subject|1|||
128858089|NCT01296555|463775719|FG012|Overall Study|Withdrawal by Subject|0|||
128858090|NCT01296555|463775720|FG013|Overall Study|Withdrawal by Subject|0|||
128858091|NCT01296555|463775721|FG014|Overall Study|Withdrawal by Subject|3|||
128858092|NCT01296555|463775722|FG015|Overall Study|Withdrawal by Subject|0|||
128858093|NCT01296555|463775723|FG016|Overall Study|Withdrawal by Subject|2|||
128858094|NCT01296555|463775724|FG017|Overall Study|Withdrawal by Subject|1|||
128858095|NCT01296555|463775725|FG018|Overall Study|Withdrawal by Subject|0|||
128858096|NCT01296555|463775726|FG019|Overall Study|Withdrawal by Subject|1|||
128858097|NCT01296555|463775727|FG020|Overall Study|Withdrawal by Subject|1|||
128858098|NCT01296555|463775728|FG021|Overall Study|Withdrawal by Subject|1|||
128858099|NCT01296555|463775729|FG022|Overall Study|Withdrawal by Subject|3|||
128858100|NCT01296555|463775730|FG023|Overall Study|Withdrawal by Subject|0|||
128858101|NCT01296555|463775731|FG024|Overall Study|Withdrawal by Subject|0|||
128858102|NCT01296555|463775732|FG025|Overall Study|Withdrawal by Subject|0|||
128858103|NCT01296555|463775733|FG026|Overall Study|Withdrawal by Subject|8|||
128858104|NCT01296555|463775734|FG027|Overall Study|Withdrawal by Subject|4|||
128858105|NCT01296555|463775735|FG028|Overall Study|Withdrawal by Subject|2|||
128858106|NCT03000348|463775739|FG000|Overall Study|Adverse Event|1|||
128858107|NCT03000348|463775740|FG001|Overall Study|Adverse Event|1|||
128858108|NCT03000348|463775741|FG002|Overall Study|Adverse Event|1|||
128858109|NCT03000348|463775742|FG003|Overall Study|Adverse Event|1|||
128858110|NCT03000348|463775743|FG004|Overall Study|Adverse Event|1|||
128858111|NCT03000348|463775744|FG005|Overall Study|Adverse Event|1|||
128858112|NCT03000348|463775739|FG000|Overall Study|Lost to Follow-up|0|||
128858113|NCT03000348|463775740|FG001|Overall Study|Lost to Follow-up|0|||
128858114|NCT03000348|463775741|FG002|Overall Study|Lost to Follow-up|1|||
128858115|NCT03000348|463775742|FG003|Overall Study|Lost to Follow-up|0|||
128858116|NCT03000348|463775743|FG004|Overall Study|Lost to Follow-up|0|||
128858117|NCT03000348|463775744|FG005|Overall Study|Lost to Follow-up|0|||
128858118|NCT03000348|463775739|FG000|Overall Study|Withdrawal by Subject|0|||
128858119|NCT03000348|463775740|FG001|Overall Study|Withdrawal by Subject|1|||
128858120|NCT03000348|463775741|FG002|Overall Study|Withdrawal by Subject|0|||
128858121|NCT03000348|463775742|FG003|Overall Study|Withdrawal by Subject|0|||
128858122|NCT03000348|463775743|FG004|Overall Study|Withdrawal by Subject|0|||
128858123|NCT03000348|463775744|FG005|Overall Study|Withdrawal by Subject|0|||
128858124|NCT03000348|463775739|FG000|Overall Study|Consent|0|||
128858125|NCT03000348|463775740|FG001|Overall Study|Consent|0|||
128858126|NCT03000348|463775741|FG002|Overall Study|Consent|0|||
128858127|NCT03000348|463775742|FG003|Overall Study|Consent|0|||
128858128|NCT03000348|463775743|FG004|Overall Study|Consent|1|||
128858129|NCT03000348|463775744|FG005|Overall Study|Consent|0|||
128858130|NCT03000348|463775739|FG000|Overall Study|Failure to expectorate sputum|1|||
128858131|NCT03000348|463775740|FG001|Overall Study|Failure to expectorate sputum|0|||
128858132|NCT03000348|463775741|FG002|Overall Study|Failure to expectorate sputum|1|||
128858133|NCT03000348|463775742|FG003|Overall Study|Failure to expectorate sputum|0|||
128858134|NCT03000348|463775743|FG004|Overall Study|Failure to expectorate sputum|1|||
128858135|NCT03000348|463775744|FG005|Overall Study|Failure to expectorate sputum|0|||
128858136|NCT03000348|463775739|FG000|Overall Study|No gram negative|1|||
128858137|NCT03000348|463775740|FG001|Overall Study|No gram negative|2|||
128858138|NCT03000348|463775741|FG002|Overall Study|No gram negative|1|||
128858139|NCT03000348|463775742|FG003|Overall Study|No gram negative|1|||
128858140|NCT03000348|463775743|FG004|Overall Study|No gram negative|1|||
128858141|NCT03000348|463775744|FG005|Overall Study|No gram negative|1|||
128858142|NCT03000348|463775739|FG000|Overall Study|Patient had no transport|0|||
128858143|NCT03000348|463775740|FG001|Overall Study|Patient had no transport|0|||
128858144|NCT03000348|463775741|FG002|Overall Study|Patient had no transport|0|||
128858145|NCT03000348|463775742|FG003|Overall Study|Patient had no transport|1|||
128858146|NCT03000348|463775743|FG004|Overall Study|Patient had no transport|0|||
128858147|NCT03000348|463775744|FG005|Overall Study|Patient had no transport|0|||
128858148|NCT03000348|463775739|FG000|Overall Study|Dosing|0|||
128858149|NCT03000348|463775740|FG001|Overall Study|Dosing|0|||
128858150|NCT03000348|463775741|FG002|Overall Study|Dosing|0|||
128858151|NCT03000348|463775742|FG003|Overall Study|Dosing|0|||
128858152|NCT03000348|463775743|FG004|Overall Study|Dosing|1|||
128858153|NCT03000348|463775744|FG005|Overall Study|Dosing|0|||
128858154|NCT04042077|463775745|FG000|Overall Study|Adverse Event|0|||
128858155|NCT04042077|463775746|FG001|Overall Study|Adverse Event|1|||
128858156|NCT04042077|463775745|FG000|Overall Study|Death|2|||
128858157|NCT04042077|463775746|FG001|Overall Study|Death|1|||
128858158|NCT04042077|463775745|FG000|Overall Study|Physician Decision|2|||
128858159|NCT04042077|463775746|FG001|Overall Study|Physician Decision|0|||
128858160|NCT04042077|463775745|FG000|Overall Study|Withdrawal by Subject|3|||
128858161|NCT04042077|463775746|FG001|Overall Study|Withdrawal by Subject|2|||
128858162|NCT04042077|463775745|FG000|Overall Study|Lack of Efficacy|0|||
128858163|NCT04042077|463775746|FG001|Overall Study|Lack of Efficacy|1|||
128858164|NCT00745498|463775748|FG000|Overall Study|Lost to Follow-up|1|||
128858165|NCT00745498|463775749|FG001|Overall Study|Lost to Follow-up|1|||
128858166|NCT00745498|463775750|FG002|Overall Study|Lost to Follow-up|3|||
128858167|NCT00745498|463775748|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
128858168|NCT00745498|463775749|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
128858169|NCT00745498|463775750|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
128858170|NCT00745498|463775748|FG000|Overall Study|Non-PDR related VH|0|||
128858171|NCT00745498|463775749|FG001|Overall Study|Non-PDR related VH|1|||
128858172|NCT00745498|463775750|FG002|Overall Study|Non-PDR related VH|1|||
128858173|NCT00745498|463775748|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
128858174|NCT00745498|463775749|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
128858175|NCT00745498|463775750|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
128858176|NCT02031536|463775754|FG000|Overall Study|ineligible|1|||
128858177|NCT02031536|463775755|FG001|Overall Study|ineligible|0|||
128858178|NCT01658020|463775757|FG000|Overall Study|Adverse Event|3|||
128858179|NCT01658020|463775758|FG001|Overall Study|Adverse Event|3|||
128858180|NCT01658020|463775757|FG000|Overall Study|Lost to Follow-up|1|||
128858181|NCT01658020|463775758|FG001|Overall Study|Lost to Follow-up|0|||
128858182|NCT01658020|463775757|FG000|Overall Study|Withdrawal by Subject|4|||
128858183|NCT01658020|463775758|FG001|Overall Study|Withdrawal by Subject|5|||
128858184|NCT01658020|463775757|FG000|Overall Study|Protocol Violation|0|||
128858185|NCT01658020|463775758|FG001|Overall Study|Protocol Violation|1|||
128858186|NCT02353871|463775759|FG000|Overall Study|Protocol deviation|0|||
128858187|NCT02353871|463775760|FG001|Overall Study|Protocol deviation|1|||
128858188|NCT02353871|463775759|FG000|Overall Study|Consent withdrawn|1|||
128858189|NCT02353871|463775760|FG001|Overall Study|Consent withdrawn|8|||
128858190|NCT02353871|463775759|FG000|Overall Study|Lost to Follow-up|2|||
128858191|NCT02353871|463775760|FG001|Overall Study|Lost to Follow-up|0|||
128858192|NCT01191008|463775772|FG000|Overall Study|Protocol Violation|7|||
128858193|NCT01191008|463775772|FG000|Overall Study|Lost to Follow-up|8|||
128858194|NCT00838929|463775779|FG000|Overall Study|Protocol Violation|0|||
128858195|NCT00838929|463775780|FG001|Overall Study|Protocol Violation|1|||
128858196|NCT00838929|463775781|FG002|Overall Study|Protocol Violation|0|||
128858197|NCT00838929|463775779|FG000|Overall Study|Disease progression|0|||
128858198|NCT00838929|463775780|FG001|Overall Study|Disease progression|2|||
128858199|NCT00838929|463775781|FG002|Overall Study|Disease progression|1|||
128858200|NCT04913948|463775789|FG000|Overall Study|Withdrawal by Subject|2|||
128858201|NCT04913948|463775789|FG000|Overall Study|Sample processing issues|1|||
128870772|NCT00958841|463820723|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
128858202|NCT04913948|463775789|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
128858203|NCT01068210|463775792|FG000|Overall Study|Lost to Follow-up|1|||
128858204|NCT01068210|463775793|FG001|Overall Study|Lost to Follow-up|2|||
128858205|NCT01068210|463775794|FG002|Overall Study|Lost to Follow-up|2|||
128858206|NCT01068210|463775795|FG003|Overall Study|Lost to Follow-up|1|||
128858207|NCT01068210|463775792|FG000|Overall Study|Second cancer|0|||
128858208|NCT01068210|463775793|FG001|Overall Study|Second cancer|1|||
128858209|NCT01068210|463775794|FG002|Overall Study|Second cancer|0|||
128858210|NCT01068210|463775795|FG003|Overall Study|Second cancer|0|||
128858211|NCT01068210|463775792|FG000|Overall Study|Disease progression|0|||
128858212|NCT01068210|463775793|FG001|Overall Study|Disease progression|0|||
128858213|NCT01068210|463775794|FG002|Overall Study|Disease progression|0|||
128858214|NCT01068210|463775795|FG003|Overall Study|Disease progression|2|||
128858215|NCT00699842|463775796|FG000|Overall Study|Death|0|||
128858216|NCT00699842|463775797|FG001|Overall Study|Death|1|||
128858217|NCT00699842|463775798|FG002|Overall Study|Death|0|||
128858218|NCT03522389|463775799|FG000|Overall Study|Lost to Follow-up|1|||
128858219|NCT03522389|463775800|FG001|Overall Study|Lost to Follow-up|1|||
128858220|NCT03522389|463775801|FG002|Overall Study|Lost to Follow-up|2|||
128858221|NCT03522389|463775799|FG000|Overall Study|had herniated nucleus pulposus|0|||
128858222|NCT03522389|463775800|FG001|Overall Study|had herniated nucleus pulposus|1|||
128858223|NCT03522389|463775801|FG002|Overall Study|had herniated nucleus pulposus|0|||
128858224|NCT03522389|463775799|FG000|Overall Study|go to work in other province|1|||
128858225|NCT03522389|463775800|FG001|Overall Study|go to work in other province|0|||
128858226|NCT03522389|463775801|FG002|Overall Study|go to work in other province|0|||
128858227|NCT02257918|463775802|FG000|Overall Study|Lost to Follow-up|4|||
128858228|NCT02257918|463775803|FG001|Overall Study|Lost to Follow-up|1|||
128858229|NCT02257918|463775804|FG002|Overall Study|Lost to Follow-up|0|||
128858230|NCT02257918|463775802|FG000|Overall Study|Withdrawal by Subject|0|||
128858231|NCT02257918|463775803|FG001|Overall Study|Withdrawal by Subject|0|||
128858232|NCT02257918|463775804|FG002|Overall Study|Withdrawal by Subject|1|||
128858233|NCT02257918|463775802|FG000|Overall Study|Pregnancy|0|||
128858234|NCT02257918|463775803|FG001|Overall Study|Pregnancy|0|||
128858235|NCT02257918|463775804|FG002|Overall Study|Pregnancy|1|||
128858236|NCT03371823|463775808|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
128858237|NCT03371823|463775809|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
128858238|NCT01263054|463775813|FG000|Overall Study|Death|1|||
128858239|NCT01263054|463775814|FG001|Overall Study|Death|0|||
128858240|NCT01263054|463775813|FG000|Overall Study|Lost to Follow-up|2|||
128858241|NCT01263054|463775814|FG001|Overall Study|Lost to Follow-up|2|||
128858242|NCT01263054|463775813|FG000|Overall Study|Withdrawal by Subject|1|||
128858243|NCT01263054|463775814|FG001|Overall Study|Withdrawal by Subject|3|||
128858244|NCT01263054|463775813|FG000|Overall Study|Qualification Violation|1|||
128858245|NCT01263054|463775814|FG001|Overall Study|Qualification Violation|0|||
128858246|NCT01263054|463775813|FG000|Overall Study|Other|0|||
128858247|NCT01263054|463775814|FG001|Overall Study|Other|1|||
128858248|NCT02242643|463775815|FG000|Overall Study|Protocol Violation|1|||
128858249|NCT02242643|463775816|FG001|Overall Study|Protocol Violation|2|||
128858250|NCT02242643|463775815|FG000|Overall Study|Withdrawal by Subject|15|||
128858251|NCT02242643|463775816|FG001|Overall Study|Withdrawal by Subject|10|||
128858252|NCT02242643|463775815|FG000|Overall Study|Migrated/moved from study area|1|||
128858253|NCT02242643|463775816|FG001|Overall Study|Migrated/moved from study area|3|||
128858254|NCT02242643|463775815|FG000|Overall Study|Lost to Follow-up|54|||
128858255|NCT02242643|463775816|FG001|Overall Study|Lost to Follow-up|61|||
128858256|NCT02242643|463775815|FG000|Overall Study|Child placed in foster care by family|0|||
128858257|NCT02242643|463775816|FG001|Overall Study|Child placed in foster care by family|1|||
128858258|NCT02242643|463775815|FG000|Overall Study|Non-compliance|1|||
128858259|NCT02242643|463775816|FG001|Overall Study|Non-compliance|0|||
128858260|NCT02242643|463775815|FG000|Overall Study|Consent withdrawal by parent|1|||
128858261|NCT02242643|463775816|FG001|Overall Study|Consent withdrawal by parent|0|||
128858262|NCT02242643|463775815|FG000|Overall Study|Protocol requirements not followed|1|||
128858263|NCT02242643|463775816|FG001|Overall Study|Protocol requirements not followed|0|||
128858264|NCT02242643|463775815|FG000|Overall Study|Language barrier|1|||
128858265|NCT02242643|463775816|FG001|Overall Study|Language barrier|0|||
128858266|NCT02242643|463775815|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
128858267|NCT02242643|463775816|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
128858268|NCT02282059|463775823|FG000|Overall Study|Other|15|||
128858269|NCT02282059|463775824|FG001|Overall Study|Other|3|||
128858270|NCT02282059|463775823|FG000|Overall Study|Participant refused further follow-up|8|||
128858271|NCT02282059|463775824|FG001|Overall Study|Participant refused further follow-up|4|||
128858272|NCT02282059|463775823|FG000|Overall Study|Lost to Follow-up|19|||
128858273|NCT02282059|463775824|FG001|Overall Study|Lost to Follow-up|3|||
128858274|NCT02282059|463775823|FG000|Overall Study|Death|40|||
128858275|NCT02282059|463775824|FG001|Overall Study|Death|8|||
128858276|NCT05093504|463775825|FG000|Overall Study|Death|0|||
128858277|NCT05093504|463775826|FG001|Overall Study|Death|1|||
128858278|NCT05347485|463775833|FG000|Overall Study|Death|14|||
128858279|NCT05347485|463775833|FG000|Overall Study|Lost to Follow-up|2|||
128858280|NCT05347485|463775833|FG000|Overall Study|Withdrawal by Subject|13|||
128858281|NCT05347485|463775833|FG000|Overall Study|Progressive Disease|1|||
128858282|NCT05347485|463775833|FG000|Overall Study|Study Terminated by Sponsor|49|||
128858283|NCT05347485|463775833|FG000|Overall Study|Other|1|||
128858284|NCT05347485|463775833|FG000|Overall Study|Enrolled (consented) but not treated|4|||
128858285|NCT05347485|463775833|FG000|Overall Study|Disease Relapse|2|||
128858286|NCT04886518|463775834|FG000|Overall Study|Noncompliance with study drug|1|||
128858287|NCT04886518|463775835|FG001|Overall Study|Noncompliance with study drug|0|||
128858288|NCT04886518|463775836|FG002|Overall Study|Noncompliance with study drug|0|||
128858289|NCT04886518|463775834|FG000|Overall Study|Adverse Event|0|||
128858290|NCT04886518|463775835|FG001|Overall Study|Adverse Event|1|||
128858291|NCT04886518|463775836|FG002|Overall Study|Adverse Event|0|||
128858292|NCT04886518|463775834|FG000|Overall Study|Withdrawal by Subject|1|||
128858293|NCT04886518|463775835|FG001|Overall Study|Withdrawal by Subject|0|||
128858294|NCT04886518|463775836|FG002|Overall Study|Withdrawal by Subject|0|||
128858295|NCT03733899|463775837|FG000|Period 1|Protocol Violation|0|||
128858296|NCT03733899|463775838|FG001|Period 1|Protocol Violation|0|||
128858297|NCT03733899|463775839|FG002|Period 1|Protocol Violation|0|||
128858298|NCT03733899|463775840|FG003|Period 1|Protocol Violation|0|||
128858299|NCT03733899|463775841|FG004|Period 1|Protocol Violation|0|||
128858300|NCT03733899|463775842|FG005|Period 1|Protocol Violation|1|||
128858301|NCT03733899|463775837|FG000|Period 2|Unscuccessful Treatment|0|||
128858302|NCT03733899|463775838|FG001|Period 2|Unscuccessful Treatment|1|||
128858303|NCT03733899|463775839|FG002|Period 2|Unscuccessful Treatment|0|||
128858304|NCT03733899|463775840|FG003|Period 2|Unscuccessful Treatment|0|||
128858305|NCT03733899|463775841|FG004|Period 2|Unscuccessful Treatment|0|||
128858306|NCT03733899|463775842|FG005|Period 2|Unscuccessful Treatment|0|||
128858307|NCT03733899|463775837|FG000|Period 3|Withdrawal by Subject|1|||
128858308|NCT03733899|463775838|FG001|Period 3|Withdrawal by Subject|0|||
128858309|NCT03733899|463775839|FG002|Period 3|Withdrawal by Subject|0|||
128858310|NCT03733899|463775840|FG003|Period 3|Withdrawal by Subject|0|||
128858311|NCT03733899|463775841|FG004|Period 3|Withdrawal by Subject|0|||
128858312|NCT03733899|463775842|FG005|Period 3|Withdrawal by Subject|0|||
128858313|NCT02035696|463778230|FG000|Overall Study|Lost to Follow-up|0|||
128858314|NCT02035696|463778231|FG001|Overall Study|Lost to Follow-up|3|||
128858315|NCT02035696|463778232|FG002|Overall Study|Lost to Follow-up|1|||
128858316|NCT02035696|463778233|FG003|Overall Study|Lost to Follow-up|2|||
128858317|NCT02035696|463778230|FG000|Overall Study|Withdrawal by Subject|3|||
128858318|NCT02035696|463778231|FG001|Overall Study|Withdrawal by Subject|0|||
128858319|NCT02035696|463778232|FG002|Overall Study|Withdrawal by Subject|2|||
128858320|NCT02035696|463778233|FG003|Overall Study|Withdrawal by Subject|1|||
128858321|NCT01090011|463778234|FG000|Overall Study|Progressive disease|128|||
128858322|NCT01090011|463778234|FG000|Overall Study|Adverse Event|32|||
128858323|NCT01090011|463778234|FG000|Overall Study|Protocol Violation|1|||
128858324|NCT01090011|463778234|FG000|Overall Study|Refusal to start/continue medication|5|||
128858325|NCT01090011|463778234|FG000|Overall Study|Other reason not defined above|5|||
128858326|NCT00379769|463778235|FG000|Main Study|Death|57|||
128858327|NCT00379769|463778236|FG001|Main Study|Death|67|||
128858328|NCT00379769|463778237|FG002|Main Study|Death|54|||
128858329|NCT00379769|463778238|FG003|Main Study|Death|72|||
128858330|NCT00379769|463778239|FG004|Main Study|Death|0|||
128858331|NCT00379769|463778240|FG005|Main Study|Death|0|||
128858332|NCT00379769|463778235|FG000|Main Study|Adverse Event|5|||
128858333|NCT00379769|463778236|FG001|Main Study|Adverse Event|8|||
128858334|NCT00379769|463778237|FG002|Main Study|Adverse Event|10|||
128858335|NCT00379769|463778238|FG003|Main Study|Adverse Event|11|||
128858336|NCT00379769|463778239|FG004|Main Study|Adverse Event|0|||
128858337|NCT00379769|463778240|FG005|Main Study|Adverse Event|0|||
128858338|NCT00379769|463778235|FG000|Main Study|Lost to Follow-up|29|||
128858339|NCT00379769|463778236|FG001|Main Study|Lost to Follow-up|29|||
128858340|NCT00379769|463778237|FG002|Main Study|Lost to Follow-up|25|||
128858341|NCT00379769|463778238|FG003|Main Study|Lost to Follow-up|26|||
128858342|NCT00379769|463778239|FG004|Main Study|Lost to Follow-up|0|||
128858343|NCT00379769|463778240|FG005|Main Study|Lost to Follow-up|0|||
128858344|NCT00379769|463778235|FG000|Main Study|Withdrawal by Subject|46|||
128858345|NCT00379769|463778236|FG001|Main Study|Withdrawal by Subject|56|||
128858346|NCT00379769|463778237|FG002|Main Study|Withdrawal by Subject|72|||
128858347|NCT00379769|463778238|FG003|Main Study|Withdrawal by Subject|70|||
128858348|NCT00379769|463778239|FG004|Main Study|Withdrawal by Subject|0|||
128858349|NCT00379769|463778240|FG005|Main Study|Withdrawal by Subject|0|||
128858350|NCT00379769|463778235|FG000|Main Study|Moved to survival status follow-up only|27|||
128858351|NCT00379769|463778236|FG001|Main Study|Moved to survival status follow-up only|25|||
128858352|NCT00379769|463778237|FG002|Main Study|Moved to survival status follow-up only|32|||
128858353|NCT00379769|463778238|FG003|Main Study|Moved to survival status follow-up only|36|||
128858354|NCT00379769|463778239|FG004|Main Study|Moved to survival status follow-up only|0|||
128858355|NCT00379769|463778240|FG005|Main Study|Moved to survival status follow-up only|0|||
128858356|NCT00379769|463778235|FG000|Main Study|Participant moved|3|||
128858357|NCT00379769|463778236|FG001|Main Study|Participant moved|2|||
128858358|NCT00379769|463778237|FG002|Main Study|Participant moved|3|||
128858359|NCT00379769|463778238|FG003|Main Study|Participant moved|3|||
128858360|NCT00379769|463778239|FG004|Main Study|Participant moved|0|||
128858361|NCT00379769|463778240|FG005|Main Study|Participant moved|0|||
128858362|NCT00379769|463778235|FG000|Main Study|Poor compliance|3|||
128858363|NCT00379769|463778236|FG001|Main Study|Poor compliance|2|||
128858364|NCT00379769|463778237|FG002|Main Study|Poor compliance|2|||
128858365|NCT00379769|463778238|FG003|Main Study|Poor compliance|1|||
128858366|NCT00379769|463778239|FG004|Main Study|Poor compliance|0|||
128858367|NCT00379769|463778240|FG005|Main Study|Poor compliance|0|||
128858368|NCT00379769|463778235|FG000|Main Study|Prohibited glucose lowering medication|0|||
128858369|NCT00379769|463778236|FG001|Main Study|Prohibited glucose lowering medication|3|||
128858370|NCT00379769|463778237|FG002|Main Study|Prohibited glucose lowering medication|0|||
128858371|NCT00379769|463778238|FG003|Main Study|Prohibited glucose lowering medication|1|||
128858372|NCT00379769|463778239|FG004|Main Study|Prohibited glucose lowering medication|0|||
128858373|NCT00379769|463778240|FG005|Main Study|Prohibited glucose lowering medication|0|||
128858374|NCT00379769|463778235|FG000|Main Study|Site closed|4|||
128858375|NCT00379769|463778236|FG001|Main Study|Site closed|4|||
128858376|NCT00379769|463778237|FG002|Main Study|Site closed|4|||
128858377|NCT00379769|463778238|FG003|Main Study|Site closed|8|||
128858378|NCT00379769|463778239|FG004|Main Study|Site closed|0|||
128858379|NCT00379769|463778240|FG005|Main Study|Site closed|0|||
128858380|NCT00379769|463778235|FG000|Main Study|Entry criteria violation|0|||
128858381|NCT00379769|463778236|FG001|Main Study|Entry criteria violation|0|||
128858382|NCT00379769|463778237|FG002|Main Study|Entry criteria violation|1|||
128858383|NCT00379769|463778238|FG003|Main Study|Entry criteria violation|1|||
128858384|NCT00379769|463778239|FG004|Main Study|Entry criteria violation|0|||
128858385|NCT00379769|463778240|FG005|Main Study|Entry criteria violation|0|||
128858386|NCT00379769|463778235|FG000|Main Study|Participant did not take study drug|0|||
128858387|NCT00379769|463778236|FG001|Main Study|Participant did not take study drug|0|||
128858388|NCT00379769|463778237|FG002|Main Study|Participant did not take study drug|1|||
128858389|NCT00379769|463778238|FG003|Main Study|Participant did not take study drug|0|||
128858390|NCT00379769|463778239|FG004|Main Study|Participant did not take study drug|0|||
128858391|NCT00379769|463778240|FG005|Main Study|Participant did not take study drug|0|||
128858392|NCT00379769|463778235|FG000|Main Study|Physician Decision|2|||
128858393|NCT00379769|463778236|FG001|Main Study|Physician Decision|2|||
128858394|NCT00379769|463778237|FG002|Main Study|Physician Decision|1|||
128858395|NCT00379769|463778238|FG003|Main Study|Physician Decision|1|||
128858396|NCT00379769|463778239|FG004|Main Study|Physician Decision|0|||
128858397|NCT00379769|463778240|FG005|Main Study|Physician Decision|0|||
128858398|NCT00379769|463778235|FG000|Main Study|Participant completed study at visit 27|1|||
128858399|NCT00379769|463778236|FG001|Main Study|Participant completed study at visit 27|0|||
128858400|NCT00379769|463778237|FG002|Main Study|Participant completed study at visit 27|0|||
128858401|NCT00379769|463778238|FG003|Main Study|Participant completed study at visit 27|0|||
128858402|NCT00379769|463778239|FG004|Main Study|Participant completed study at visit 27|0|||
128858403|NCT00379769|463778240|FG005|Main Study|Participant completed study at visit 27|0|||
128858404|NCT00379769|463778235|FG000|Main Study|Personal reasons|1|||
128858405|NCT00379769|463778236|FG001|Main Study|Personal reasons|0|||
128858406|NCT00379769|463778237|FG002|Main Study|Personal reasons|0|||
128858407|NCT00379769|463778238|FG003|Main Study|Personal reasons|0|||
128858408|NCT00379769|463778239|FG004|Main Study|Personal reasons|0|||
128858409|NCT00379769|463778240|FG005|Main Study|Personal reasons|0|||
128858410|NCT00379769|463778235|FG000|Main Study|Risk of heart failure|0|||
128858411|NCT00379769|463778236|FG001|Main Study|Risk of heart failure|1|||
128858412|NCT00379769|463778237|FG002|Main Study|Risk of heart failure|0|||
128858413|NCT00379769|463778238|FG003|Main Study|Risk of heart failure|0|||
128858414|NCT00379769|463778239|FG004|Main Study|Risk of heart failure|0|||
128858415|NCT00379769|463778240|FG005|Main Study|Risk of heart failure|0|||
128858416|NCT00379769|463778235|FG000|Main Study|Investigator refused to log temperature|0|||
128858417|NCT00379769|463778236|FG001|Main Study|Investigator refused to log temperature|0|||
128858418|NCT00379769|463778237|FG002|Main Study|Investigator refused to log temperature|1|||
128858419|NCT00379769|463778238|FG003|Main Study|Investigator refused to log temperature|0|||
128858420|NCT00379769|463778239|FG004|Main Study|Investigator refused to log temperature|0|||
128858421|NCT00379769|463778240|FG005|Main Study|Investigator refused to log temperature|0|||
128858422|NCT00379769|463778235|FG000|Main Study|Reason unspecified|0|||
128858423|NCT00379769|463778236|FG001|Main Study|Reason unspecified|0|||
128858424|NCT00379769|463778237|FG002|Main Study|Reason unspecified|1|||
128858425|NCT00379769|463778238|FG003|Main Study|Reason unspecified|0|||
128858426|NCT00379769|463778239|FG004|Main Study|Reason unspecified|0|||
128858427|NCT00379769|463778240|FG005|Main Study|Reason unspecified|0|||
128858428|NCT00379769|463778235|FG000|Observational Follow-up|Death|0|||
128858429|NCT00379769|463778236|FG001|Observational Follow-up|Death|0|||
128858430|NCT00379769|463778237|FG002|Observational Follow-up|Death|0|||
128858431|NCT00379769|463778238|FG003|Observational Follow-up|Death|0|||
128858432|NCT00379769|463778239|FG004|Observational Follow-up|Death|78|||
128858433|NCT00379769|463778240|FG005|Observational Follow-up|Death|70|||
128858434|NCT00379769|463778235|FG000|Observational Follow-up|Adverse Event|0|||
128858435|NCT00379769|463778236|FG001|Observational Follow-up|Adverse Event|0|||
128858436|NCT00379769|463778237|FG002|Observational Follow-up|Adverse Event|0|||
128858437|NCT00379769|463778238|FG003|Observational Follow-up|Adverse Event|0|||
128858438|NCT00379769|463778239|FG004|Observational Follow-up|Adverse Event|1|||
128858439|NCT00379769|463778240|FG005|Observational Follow-up|Adverse Event|0|||
128858440|NCT00379769|463778235|FG000|Observational Follow-up|Lost to Follow-up|0|||
128858441|NCT00379769|463778236|FG001|Observational Follow-up|Lost to Follow-up|0|||
128858442|NCT00379769|463778237|FG002|Observational Follow-up|Lost to Follow-up|0|||
128858443|NCT00379769|463778238|FG003|Observational Follow-up|Lost to Follow-up|0|||
128858444|NCT00379769|463778239|FG004|Observational Follow-up|Lost to Follow-up|25|||
128858445|NCT00379769|463778240|FG005|Observational Follow-up|Lost to Follow-up|27|||
128858446|NCT00379769|463778235|FG000|Observational Follow-up|Withdrawal by Subject|0|||
128858447|NCT00379769|463778236|FG001|Observational Follow-up|Withdrawal by Subject|0|||
128858448|NCT00379769|463778237|FG002|Observational Follow-up|Withdrawal by Subject|0|||
128858449|NCT00379769|463778238|FG003|Observational Follow-up|Withdrawal by Subject|0|||
128858450|NCT00379769|463778239|FG004|Observational Follow-up|Withdrawal by Subject|12|||
128858451|NCT00379769|463778240|FG005|Observational Follow-up|Withdrawal by Subject|12|||
128858452|NCT00379769|463778235|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
128858453|NCT00379769|463778236|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
128858454|NCT00379769|463778237|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
128858455|NCT00379769|463778238|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
128858456|NCT00379769|463778239|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
128858457|NCT00379769|463778240|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
128858458|NCT00379769|463778235|FG000|Observational Follow-up|Physician Decision|0|||
128858459|NCT00379769|463778236|FG001|Observational Follow-up|Physician Decision|0|||
128858460|NCT00379769|463778237|FG002|Observational Follow-up|Physician Decision|0|||
128858461|NCT00379769|463778238|FG003|Observational Follow-up|Physician Decision|0|||
128858462|NCT00379769|463778239|FG004|Observational Follow-up|Physician Decision|8|||
128858463|NCT00379769|463778240|FG005|Observational Follow-up|Physician Decision|8|||
128858464|NCT00379769|463778235|FG000|Observational Follow-up|Site Closed Early|0|||
128858465|NCT00379769|463778236|FG001|Observational Follow-up|Site Closed Early|0|||
128858466|NCT00379769|463778237|FG002|Observational Follow-up|Site Closed Early|0|||
128858467|NCT00379769|463778238|FG003|Observational Follow-up|Site Closed Early|0|||
128858468|NCT00379769|463778239|FG004|Observational Follow-up|Site Closed Early|6|||
128858469|NCT00379769|463778240|FG005|Observational Follow-up|Site Closed Early|7|||
128858470|NCT00379769|463778235|FG000|Observational Follow-up|Participant Moved|0|||
128858471|NCT00379769|463778236|FG001|Observational Follow-up|Participant Moved|0|||
128858472|NCT00379769|463778237|FG002|Observational Follow-up|Participant Moved|0|||
128858473|NCT00379769|463778238|FG003|Observational Follow-up|Participant Moved|0|||
128858474|NCT00379769|463778239|FG004|Observational Follow-up|Participant Moved|0|||
128858475|NCT00379769|463778240|FG005|Observational Follow-up|Participant Moved|1|||
128858476|NCT00379769|463778235|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
128858477|NCT00379769|463778236|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
128858478|NCT00379769|463778237|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
128858479|NCT00379769|463778238|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
128858480|NCT00379769|463778239|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
128858481|NCT00379769|463778240|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
128858482|NCT01689363|463778245|FG000|Overall Study|Protocol Violation|0|||
128858483|NCT01689363|463778246|FG001|Overall Study|Protocol Violation|1|||
128858484|NCT01689363|463778247|FG002|Overall Study|Protocol Violation|0|||
128858485|NCT01689363|463778248|FG003|Overall Study|Protocol Violation|0|||
128858486|NCT01689363|463778249|FG004|Overall Study|Protocol Violation|0|||
128858487|NCT01689363|463778250|FG005|Overall Study|Protocol Violation|0|||
128858488|NCT01689363|463778251|FG006|Overall Study|Protocol Violation|0|||
128858489|NCT01689363|463778252|FG007|Overall Study|Protocol Violation|0|||
128858490|NCT02859064|463778253|FG000|Overall Study|Progressive Disease|3|||
128858491|NCT02859064|463778253|FG000|Overall Study|Physician Decision|1|||
128858492|NCT02859064|463778253|FG000|Overall Study|Withdrawal by Subject|1|||
128858493|NCT02859064|463778253|FG000|Overall Study|Death|1|||
128858494|NCT00321685|463778254|FG000|Overall Study|Adverse Event|18|||
128858495|NCT00321685|463778254|FG000|Overall Study|Death|2|||
128858496|NCT00321685|463778254|FG000|Overall Study|Withdrawal by Subject|8|||
128858497|NCT00321685|463778254|FG000|Overall Study|Alternative therapy|1|||
128858498|NCT00321685|463778254|FG000|Overall Study|Complicating disese|1|||
128858499|NCT00321685|463778254|FG000|Overall Study|Other|5|||
128858500|NCT00321685|463778254|FG000|Overall Study|Not start protocol therapy|2|||
128858501|NCT00321685|463778254|FG000|Overall Study|Ineligible|2|||
128858502|NCT00127842|463778255|FG000|Overall Study|Adverse Event|15|||
128858503|NCT00127842|463778255|FG000|Overall Study|Withdrawal by Subject|3|||
128858504|NCT00127842|463778255|FG000|Overall Study|Lost to Follow-up|1|||
128858505|NCT00127842|463778255|FG000|Overall Study|Lack of Efficacy|12|||
128858506|NCT00127842|463778255|FG000|Overall Study|Noncompliance|2|||
128858507|NCT00127842|463778255|FG000|Overall Study|Protocol Violation|1|||
128858508|NCT00127842|463778255|FG000|Overall Study|Other|5|||
128858509|NCT01638390|463778258|FG000|Overall Study|screening failures|21|||
128858510|NCT01536587|463778259|FG000|Overall Study|Adverse Event|2|||
128858511|NCT02354651|463778260|FG000|Overall Study|Withdrawal by Subject|2|||
128858512|NCT02354651|463778260|FG000|Overall Study|Physician Decision|1|||
128858513|NCT01377389|463778261|FG000|Overall Study|Withdrawal by Subject|1|||
128858514|NCT01377389|463778261|FG000|Overall Study|Screen failure|2|||
128858515|NCT03382561|463778262|FG000|Overall Study|Disease progression|47|||
128858516|NCT03382561|463778263|FG001|Overall Study|Disease progression|6|||
128858517|NCT03382561|463778262|FG000|Overall Study|Adverse Event|10|||
128858518|NCT03382561|463778263|FG001|Overall Study|Adverse Event|2|||
128858519|NCT03382561|463778262|FG000|Overall Study|Death|8|||
128858520|NCT03382561|463778263|FG001|Overall Study|Death|3|||
128858521|NCT03382561|463778262|FG000|Overall Study|Withdrawal by Subject|6|||
128858522|NCT03382561|463778263|FG001|Overall Study|Withdrawal by Subject|5|||
128858523|NCT03382561|463778262|FG000|Overall Study|Alternative therapy|2|||
128858524|NCT03382561|463778263|FG001|Overall Study|Alternative therapy|8|||
128858525|NCT03382561|463778262|FG000|Overall Study|Never started treatment|3|||
128858526|NCT03382561|463778263|FG001|Overall Study|Never started treatment|6|||
128858527|NCT03382561|463778262|FG000|Overall Study|Lack of Efficacy|0|||
128858528|NCT03382561|463778263|FG001|Overall Study|Lack of Efficacy|1|||
128858529|NCT03382561|463778262|FG000|Overall Study|Physician Decision|0|||
128858530|NCT03382561|463778263|FG001|Overall Study|Physician Decision|1|||
128858531|NCT03382561|463778262|FG000|Overall Study|Other complicating disease|0|||
128858532|NCT03382561|463778263|FG001|Overall Study|Other complicating disease|1|||
128858533|NCT01131104|463778264|FG000|Overall Study|Withdrawal by Subject|3|||
128858534|NCT01131104|463778264|FG000|Overall Study|Physician Decision|4|||
128858535|NCT01131104|463778264|FG000|Overall Study|Information Not Available|5|||
128858536|NCT01131104|463778264|FG000|Overall Study|No Information on Index Date of Onset|1|||
128858537|NCT01245140|463778265|FG000|Overall Study|Adverse Event|1|||
128858538|NCT01245140|463778266|FG001|Overall Study|Adverse Event|3|||
128858539|NCT01245140|463778265|FG000|Overall Study|Lack of Efficacy|2|||
128858540|NCT01245140|463778266|FG001|Overall Study|Lack of Efficacy|4|||
128858541|NCT01245140|463778265|FG000|Overall Study|Protocol Violation|0|||
128858542|NCT01245140|463778266|FG001|Overall Study|Protocol Violation|1|||
128858543|NCT01245140|463778265|FG000|Overall Study|Withdrawal by Subject|0|||
128858544|NCT01245140|463778266|FG001|Overall Study|Withdrawal by Subject|1|||
128858545|NCT01245140|463778265|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
128858546|NCT01245140|463778266|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
128858547|NCT04836559|463778267|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
128858548|NCT04836559|463778268|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
128858549|NCT04836559|463778269|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
128858550|NCT04836559|463778270|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
128858551|NCT04836559|463778271|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
128858552|NCT04836559|463778272|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
128858553|NCT04836559|463778273|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
128858554|NCT04836559|463778274|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
128858555|NCT04836559|463778267|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
128858556|NCT04836559|463778268|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
128858557|NCT04836559|463778269|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
128858558|NCT04836559|463778270|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
128858559|NCT04836559|463778271|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
128858560|NCT04836559|463778272|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
128858561|NCT04836559|463778273|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
128858562|NCT04836559|463778274|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
128858563|NCT04836559|463778267|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
128858564|NCT04836559|463778268|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
128858565|NCT04836559|463778269|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
128858566|NCT04836559|463778270|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
128858567|NCT04836559|463778271|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
128858568|NCT04836559|463778272|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
128858569|NCT04836559|463778273|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
128858570|NCT04836559|463778274|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
128858571|NCT04836559|463778267|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
128858572|NCT04836559|463778268|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
128858573|NCT04836559|463778269|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
128858574|NCT04836559|463778270|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
128858575|NCT04836559|463778271|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
128858576|NCT04836559|463778272|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
128858577|NCT04836559|463778273|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
128858578|NCT04836559|463778274|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
128858579|NCT04836559|463778267|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
128858580|NCT04836559|463778268|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
128858581|NCT04836559|463778269|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
128858582|NCT04836559|463778270|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
128858583|NCT04836559|463778271|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
128858584|NCT04836559|463778272|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
128858585|NCT04836559|463778273|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
128858586|NCT04836559|463778274|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
128858587|NCT04836559|463778267|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
128858588|NCT04836559|463778268|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
128858589|NCT04836559|463778269|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
128858590|NCT04836559|463778270|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
128858591|NCT04836559|463778271|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
128858592|NCT04836559|463778272|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
128858593|NCT04836559|463778273|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
128858594|NCT04836559|463778274|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
128858595|NCT04836559|463778267|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
128858596|NCT04836559|463778268|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
128858597|NCT04836559|463778269|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
128858598|NCT04836559|463778270|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
128858599|NCT04836559|463778271|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
128858600|NCT04836559|463778272|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
128858601|NCT04836559|463778273|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
128858602|NCT04836559|463778274|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
128858603|NCT04836559|463778267|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
128858604|NCT04836559|463778268|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
128858605|NCT04836559|463778269|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
128858606|NCT04836559|463778270|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
128858607|NCT04836559|463778271|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
128858608|NCT04836559|463778272|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
128858609|NCT04836559|463778273|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
128858610|NCT04836559|463778274|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
128858611|NCT04836559|463778267|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
128858612|NCT04836559|463778268|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
128858613|NCT04836559|463778269|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
128858614|NCT04836559|463778270|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
128858615|NCT04836559|463778271|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
128858616|NCT04836559|463778272|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
128858617|NCT04836559|463778273|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
128858618|NCT04836559|463778274|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
128858619|NCT00334542|463778275|FG000|Overall Study|Adverse Event|3|||
128858620|NCT00334542|463778275|FG000|Overall Study|Withdrawal by Subject|1|||
128858621|NCT00334542|463778275|FG000|Overall Study|New cancer diagnosis|1|||
128858622|NCT02370251|463778276|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
128858623|NCT02370251|463778276|FG000|Overall Study|Death|4|||
128858624|NCT05765435|463778277|FG000|Overall Study|Lost to Follow-up|0|||
128858625|NCT05765435|463778278|FG001|Overall Study|Lost to Follow-up|1|||
128858626|NCT05765435|463778279|FG002|Overall Study|Lost to Follow-up|0|||
128858627|NCT05765435|463778277|FG000|Overall Study|Withdrawal by Subject|0|||
128858628|NCT05765435|463778278|FG001|Overall Study|Withdrawal by Subject|0|||
128858629|NCT05765435|463778279|FG002|Overall Study|Withdrawal by Subject|1|||
128858630|NCT04698915|463778288|FG000|Overall Study|Adverse Event|2|||
128858631|NCT04698915|463778289|FG001|Overall Study|Adverse Event|0|||
128858632|NCT04698915|463778288|FG000|Overall Study|Death|23|||
128858633|NCT04698915|463778289|FG001|Overall Study|Death|20|||
128858634|NCT04698915|463778288|FG000|Overall Study|Physician Decision|1|||
128858635|NCT04698915|463778289|FG001|Overall Study|Physician Decision|1|||
128858636|NCT04698915|463778288|FG000|Overall Study|Lost to Follow-up|1|||
128858637|NCT04698915|463778289|FG001|Overall Study|Lost to Follow-up|0|||
128858638|NCT04698915|463778288|FG000|Overall Study|Study Terminated by Sponsor|55|||
128858639|NCT04698915|463778289|FG001|Overall Study|Study Terminated by Sponsor|60|||
128858640|NCT04698915|463778288|FG000|Overall Study|Withdrawal by Subject|2|||
128858641|NCT04698915|463778289|FG001|Overall Study|Withdrawal by Subject|3|||
128858642|NCT01150045|463778290|FG000|Overall Study|Protocol Violation|0|||
128858643|NCT01150045|463778291|FG001|Overall Study|Protocol Violation|1|||
128858644|NCT01150045|463778292|FG002|Overall Study|Protocol Violation|0|||
128858645|NCT01150045|463778293|FG003|Overall Study|Protocol Violation|1|||
128858646|NCT03520075|463778300|FG000|Phase 1 (Dose Escalation)|Death|2|||
128858647|NCT03520075|463778301|FG001|Phase 1 (Dose Escalation)|Death|2|||
128858648|NCT03520075|463778302|FG002|Phase 1 (Dose Escalation)|Death|3|||
128858649|NCT03520075|463778303|FG003|Phase 1 (Dose Escalation)|Death|2|||
128858650|NCT03520075|463778304|FG004|Phase 1 (Dose Escalation)|Death|6|||
128858651|NCT03520075|463778305|FG005|Phase 1 (Dose Escalation)|Death|5|||
128858652|NCT03520075|463778306|FG006|Phase 1 (Dose Escalation)|Death|3|||
128858653|NCT03520075|463778307|FG007|Phase 1 (Dose Escalation)|Death|2|||
128858654|NCT03520075|463778308|FG008|Phase 1 (Dose Escalation)|Death|3|||
128858655|NCT03520075|463778309|FG009|Phase 1 (Dose Escalation)|Death|1|||
128858656|NCT03520075|463778310|FG010|Phase 1 (Dose Escalation)|Death|5|||
128858657|NCT03520075|463778311|FG011|Phase 1 (Dose Escalation)|Death|7|||
128858658|NCT03520075|463778312|FG012|Phase 1 (Dose Escalation)|Death|11|||
128858659|NCT03520075|463778313|FG013|Phase 1 (Dose Escalation)|Death|0|||
128858660|NCT03520075|463778314|FG014|Phase 1 (Dose Escalation)|Death|0|||
128858661|NCT03520075|463778315|FG015|Phase 1 (Dose Escalation)|Death|0|||
128858662|NCT03520075|463778316|FG016|Phase 1 (Dose Escalation)|Death|0|||
128858663|NCT03520075|463778317|FG017|Phase 1 (Dose Escalation)|Death|0|||
128858664|NCT03520075|463778318|FG018|Phase 1 (Dose Escalation)|Death|0|||
128858665|NCT03520075|463778300|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
128858666|NCT03520075|463778301|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858667|NCT03520075|463778302|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858668|NCT03520075|463778303|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
128858669|NCT03520075|463778304|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
128858670|NCT03520075|463778305|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
128858671|NCT03520075|463778306|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858672|NCT03520075|463778307|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
128858673|NCT03520075|463778308|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858674|NCT03520075|463778309|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
128858675|NCT03520075|463778310|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858676|NCT03520075|463778311|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858677|NCT03520075|463778312|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
128858678|NCT03520075|463778313|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858679|NCT03520075|463778314|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858680|NCT03520075|463778315|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858681|NCT03520075|463778316|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858682|NCT03520075|463778317|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858683|NCT03520075|463778318|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
128858684|NCT03520075|463778300|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858685|NCT03520075|463778301|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
128858686|NCT03520075|463778302|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858687|NCT03520075|463778303|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
128858688|NCT03520075|463778304|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
128858689|NCT03520075|463778305|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858690|NCT03520075|463778306|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858691|NCT03520075|463778307|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858692|NCT03520075|463778308|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858693|NCT03520075|463778309|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858694|NCT03520075|463778310|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
128858695|NCT03520075|463778311|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858696|NCT03520075|463778312|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
128858697|NCT03520075|463778313|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858698|NCT03520075|463778314|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858699|NCT03520075|463778315|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858700|NCT03520075|463778316|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858701|NCT03520075|463778317|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858702|NCT03520075|463778318|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
128858703|NCT03520075|463778300|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858704|NCT03520075|463778301|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858705|NCT03520075|463778302|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858706|NCT03520075|463778303|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858707|NCT03520075|463778304|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858708|NCT03520075|463778305|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858709|NCT03520075|463778306|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858710|NCT03520075|463778307|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858711|NCT03520075|463778308|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858712|NCT03520075|463778309|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
128858713|NCT03520075|463778310|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858714|NCT03520075|463778311|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858715|NCT03520075|463778312|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
128858716|NCT03520075|463778313|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858717|NCT03520075|463778314|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858718|NCT03520075|463778315|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858719|NCT03520075|463778316|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858720|NCT03520075|463778317|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858721|NCT03520075|463778318|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
128858722|NCT03520075|463778300|FG000|Phase 2 (Dose Expansion)|Death|0|||
128858723|NCT03520075|463778301|FG001|Phase 2 (Dose Expansion)|Death|0|||
128858724|NCT03520075|463778302|FG002|Phase 2 (Dose Expansion)|Death|0|||
128858725|NCT03520075|463778303|FG003|Phase 2 (Dose Expansion)|Death|0|||
128858726|NCT03520075|463778304|FG004|Phase 2 (Dose Expansion)|Death|0|||
128858727|NCT03520075|463778305|FG005|Phase 2 (Dose Expansion)|Death|0|||
128858728|NCT03520075|463778306|FG006|Phase 2 (Dose Expansion)|Death|0|||
128858729|NCT03520075|463778307|FG007|Phase 2 (Dose Expansion)|Death|0|||
128858730|NCT03520075|463778308|FG008|Phase 2 (Dose Expansion)|Death|0|||
128858731|NCT03520075|463778309|FG009|Phase 2 (Dose Expansion)|Death|0|||
128858732|NCT03520075|463778310|FG010|Phase 2 (Dose Expansion)|Death|0|||
128858733|NCT03520075|463778311|FG011|Phase 2 (Dose Expansion)|Death|0|||
128858734|NCT03520075|463778312|FG012|Phase 2 (Dose Expansion)|Death|0|||
128858735|NCT03520075|463778313|FG013|Phase 2 (Dose Expansion)|Death|20|||
128858736|NCT03520075|463778314|FG014|Phase 2 (Dose Expansion)|Death|13|||
128858737|NCT03520075|463778315|FG015|Phase 2 (Dose Expansion)|Death|9|||
128858738|NCT03520075|463778316|FG016|Phase 2 (Dose Expansion)|Death|5|||
128858739|NCT03520075|463778317|FG017|Phase 2 (Dose Expansion)|Death|14|||
128858740|NCT03520075|463778318|FG018|Phase 2 (Dose Expansion)|Death|12|||
128858741|NCT03520075|463778300|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858742|NCT03520075|463778301|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858743|NCT03520075|463778302|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858744|NCT03520075|463778303|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858745|NCT03520075|463778304|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858746|NCT03520075|463778305|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858747|NCT03520075|463778306|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858748|NCT03520075|463778307|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858749|NCT03520075|463778308|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858750|NCT03520075|463778309|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858751|NCT03520075|463778310|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858752|NCT03520075|463778311|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858753|NCT03520075|463778312|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858754|NCT03520075|463778313|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
128858755|NCT03520075|463778314|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
128858756|NCT03520075|463778315|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
128858757|NCT03520075|463778316|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
128858758|NCT03520075|463778317|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
128858759|NCT03520075|463778318|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
128858760|NCT03520075|463778300|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858761|NCT03520075|463778301|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858762|NCT03520075|463778302|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858763|NCT03520075|463778303|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858764|NCT03520075|463778304|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858765|NCT03520075|463778305|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858766|NCT03520075|463778306|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858767|NCT03520075|463778307|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858768|NCT03520075|463778308|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858769|NCT03520075|463778309|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858770|NCT03520075|463778310|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858771|NCT03520075|463778311|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858772|NCT03520075|463778312|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858773|NCT03520075|463778313|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858774|NCT03520075|463778314|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
128858775|NCT03520075|463778315|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
128858776|NCT03520075|463778316|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858777|NCT03520075|463778317|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
128858778|NCT03520075|463778318|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
128858779|NCT03520075|463778300|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858780|NCT03520075|463778301|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858781|NCT03520075|463778302|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858782|NCT03520075|463778303|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858783|NCT03520075|463778304|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858784|NCT03520075|463778305|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858785|NCT03520075|463778306|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128870852|NCT00283244|463820743|FG001|Overall Study|Physician Decision|0|||
128858786|NCT03520075|463778307|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858787|NCT03520075|463778308|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858788|NCT03520075|463778309|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858789|NCT03520075|463778310|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858790|NCT03520075|463778311|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858791|NCT03520075|463778312|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858792|NCT03520075|463778313|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
128858793|NCT03520075|463778314|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858794|NCT03520075|463778315|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858795|NCT03520075|463778316|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
128858796|NCT03520075|463778317|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
128858797|NCT03520075|463778318|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
128858798|NCT01432626|463778319|FG000|Overall Study|LV function recovered|2|||
128858799|NCT01432626|463778319|FG000|Overall Study|Withdrawal by Subject|2|||
128858800|NCT01432626|463778319|FG000|Overall Study|Only 1 image competed|2|||
128858801|NCT01432626|463778319|FG000|Overall Study|Imaging agent not available|1|||
128858802|NCT05382039|463778320|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
128858803|NCT05382039|463778321|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
128858804|NCT05382039|463778322|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
128858805|NCT05382039|463778320|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
128858806|NCT05382039|463778321|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
128858807|NCT05382039|463778322|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
128858808|NCT05382039|463778320|FG000|Overall Study|waiting for confirmation|0|||
128858809|NCT05382039|463778321|FG001|Overall Study|waiting for confirmation|0|||
128858810|NCT05382039|463778322|FG002|Overall Study|waiting for confirmation|1|||
128858811|NCT00126659|463778323|FG000|Overall Study|Adverse Event|0|||
128858812|NCT00126659|463778324|FG001|Overall Study|Adverse Event|0|||
128858813|NCT00126659|463778325|FG002|Overall Study|Adverse Event|2|||
128858814|NCT02367352|463778326|FG000|Overall Study|Progressive disease|7|||
128858815|NCT02367352|463778327|FG001|Overall Study|Progressive disease|0|||
128858816|NCT02367352|463778328|FG002|Overall Study|Progressive disease|0|||
128858817|NCT02367352|463778326|FG000|Overall Study|Participant Received Alternative Therapy|1|||
128858818|NCT02367352|463778327|FG001|Overall Study|Participant Received Alternative Therapy|0|||
128858819|NCT02367352|463778328|FG002|Overall Study|Participant Received Alternative Therapy|0|||
128858820|NCT02367352|463778326|FG000|Overall Study|Adverse Event|1|||
128858821|NCT02367352|463778327|FG001|Overall Study|Adverse Event|0|||
128858822|NCT02367352|463778328|FG002|Overall Study|Adverse Event|0|||
128858823|NCT01375751|463778329|FG000|Overall Study|Other|0|||
128858824|NCT01375751|463778330|FG001|Overall Study|Other|1|||
128858825|NCT01375751|463778331|FG002|Overall Study|Other|0|||
128858826|NCT02980523|463778332|FG000|Overall Study|Lost to Follow-up|1|||
128858827|NCT02980523|463778333|FG001|Overall Study|Lost to Follow-up|4|||
128858828|NCT02980523|463778334|FG002|Overall Study|Lost to Follow-up|1|||
128858829|NCT02980523|463778335|FG003|Overall Study|Lost to Follow-up|2|||
128858830|NCT02980523|463778336|FG004|Overall Study|Lost to Follow-up|1|||
128858831|NCT02980523|463778332|FG000|Overall Study|Excluded from analysis|1|||
128858832|NCT02980523|463778333|FG001|Overall Study|Excluded from analysis|3|||
128858833|NCT02980523|463778334|FG002|Overall Study|Excluded from analysis|1|||
128858834|NCT02980523|463778335|FG003|Overall Study|Excluded from analysis|1|||
128858835|NCT02980523|463778336|FG004|Overall Study|Excluded from analysis|1|||
128858836|NCT02980523|463778332|FG000|Overall Study|Lack of Efficacy|1|||
128858837|NCT02980523|463778333|FG001|Overall Study|Lack of Efficacy|4|||
128858838|NCT02980523|463778334|FG002|Overall Study|Lack of Efficacy|4|||
128858839|NCT02980523|463778335|FG003|Overall Study|Lack of Efficacy|5|||
128858840|NCT02980523|463778336|FG004|Overall Study|Lack of Efficacy|8|||
128858841|NCT02980523|463778332|FG000|Overall Study|Did not receive intervention|0|||
128858842|NCT02980523|463778333|FG001|Overall Study|Did not receive intervention|0|||
128858843|NCT02980523|463778334|FG002|Overall Study|Did not receive intervention|0|||
128858844|NCT02980523|463778335|FG003|Overall Study|Did not receive intervention|1|||
128858845|NCT02980523|463778336|FG004|Overall Study|Did not receive intervention|0|||
128858846|NCT02375347|463778337|FG000|Overall Study|Protocol Violation|1|||
128858847|NCT05186311|463778338|FG000|Part A: Serum|Withdrawal by Subject|1|||
128858848|NCT03721172|463778343|FG000|Placebo-controlled Phase|Adverse Event|7|||
128858849|NCT03721172|463778344|FG001|Placebo-controlled Phase|Adverse Event|7|||
128858850|NCT03721172|463778345|FG002|Placebo-controlled Phase|Adverse Event|0|||
128858851|NCT03721172|463778343|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
128858852|NCT03721172|463778344|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
128858853|NCT03721172|463778345|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
128858854|NCT03721172|463778343|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
128858855|NCT03721172|463778344|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
128858856|NCT03721172|463778345|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
128858857|NCT03721172|463778343|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
128858858|NCT03721172|463778344|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
128858859|NCT03721172|463778345|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
128858860|NCT03721172|463778343|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
128858861|NCT03721172|463778344|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
128858862|NCT03721172|463778345|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
128858863|NCT03721172|463778343|FG000|Placebo-controlled Phase|Other|3|||
128858864|NCT03721172|463778344|FG001|Placebo-controlled Phase|Other|0|||
128858865|NCT03721172|463778345|FG002|Placebo-controlled Phase|Other|0|||
128858866|NCT03721172|463778343|FG000|Apremilast Extension Phase|Adverse Event|0|||
128858867|NCT03721172|463778344|FG001|Apremilast Extension Phase|Adverse Event|0|||
128858868|NCT03721172|463778345|FG002|Apremilast Extension Phase|Adverse Event|10|||
128858869|NCT03721172|463778343|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
128858870|NCT03721172|463778344|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
128858871|NCT03721172|463778345|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
128858872|NCT03721172|463778343|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
128858873|NCT03721172|463778344|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
128858874|NCT03721172|463778345|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
128858875|NCT03721172|463778343|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
128858876|NCT03721172|463778344|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
128858877|NCT03721172|463778345|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
128858878|NCT03721172|463778343|FG000|Apremilast Extension Phase|Protocol Violation|0|||
128858879|NCT03721172|463778344|FG001|Apremilast Extension Phase|Protocol Violation|0|||
128858880|NCT03721172|463778345|FG002|Apremilast Extension Phase|Protocol Violation|1|||
128858881|NCT03721172|463778343|FG000|Apremilast Extension Phase|Physician Decision|0|||
128858882|NCT03721172|463778344|FG001|Apremilast Extension Phase|Physician Decision|0|||
128858883|NCT03721172|463778345|FG002|Apremilast Extension Phase|Physician Decision|1|||
128858884|NCT03721172|463778343|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
128858885|NCT03721172|463778344|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
128858886|NCT03721172|463778345|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
128858887|NCT03721172|463778343|FG000|Apremilast Extension Phase|Other|0|||
128858888|NCT03721172|463778344|FG001|Apremilast Extension Phase|Other|0|||
128858889|NCT03721172|463778345|FG002|Apremilast Extension Phase|Other|3|||
128858890|NCT03721172|463778343|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
128858891|NCT03721172|463778344|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
128858892|NCT03721172|463778345|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
128858893|NCT02402322|463778347|FG000|Pretreatment|Withdrawal by Subject|3|||
128858894|NCT02402322|463778348|FG001|Pretreatment|Withdrawal by Subject|1|||
128858895|NCT02402322|463778349|FG002|Pretreatment|Withdrawal by Subject|1|||
128858896|NCT02402322|463778347|FG000|Follow-up|Withdrawal by Subject|6|||
128858897|NCT02402322|463778348|FG001|Follow-up|Withdrawal by Subject|3|||
128858898|NCT02402322|463778349|FG002|Follow-up|Withdrawal by Subject|24|||
128858899|NCT04593823|463778350|FG000|Overall Study|Withdrawal by Subject|1|||
128858900|NCT04593823|463778351|FG001|Overall Study|Withdrawal by Subject|1|||
128858901|NCT04593823|463778350|FG000|Overall Study|Lost to Follow-up|0|||
128858902|NCT04593823|463778351|FG001|Overall Study|Lost to Follow-up|1|||
128858903|NCT02472145|463778352|FG000|Overall Study|Death|10|||
128858904|NCT02472145|463778353|FG001|Overall Study|Death|101|||
128858905|NCT02472145|463778354|FG002|Overall Study|Death|99|||
128858906|NCT02472145|463778352|FG000|Overall Study|Lost to Follow-up|0|||
128858907|NCT02472145|463778353|FG001|Overall Study|Lost to Follow-up|1|||
128858908|NCT02472145|463778354|FG002|Overall Study|Lost to Follow-up|0|||
128858909|NCT02472145|463778352|FG000|Overall Study|Withdrawal by Subject|0|||
128858910|NCT02472145|463778353|FG001|Overall Study|Withdrawal by Subject|9|||
128858911|NCT02472145|463778354|FG002|Overall Study|Withdrawal by Subject|13|||
128858912|NCT02472145|463778352|FG000|Overall Study|Sponsor decision|0|||
128858913|NCT02472145|463778353|FG001|Overall Study|Sponsor decision|3|||
128858914|NCT02472145|463778354|FG002|Overall Study|Sponsor decision|2|||
128858915|NCT02472145|463778352|FG000|Overall Study|Other|0|||
128858916|NCT02472145|463778353|FG001|Overall Study|Other|45|||
128858917|NCT02472145|463778354|FG002|Overall Study|Other|43|||
128858918|NCT01236352|463778356|FG000|Overall Study|Death|0|||
128858919|NCT01236352|463778357|FG001|Overall Study|Death|0|||
128858920|NCT01236352|463778358|FG002|Overall Study|Death|0|||
128858921|NCT01236352|463778359|FG003|Overall Study|Death|0|||
128858922|NCT01236352|463778360|FG004|Overall Study|Death|0|||
128858923|NCT01236352|463778361|FG005|Overall Study|Death|0|||
128858924|NCT01236352|463778362|FG006|Overall Study|Death|0|||
128858925|NCT01236352|463778363|FG007|Overall Study|Death|1|||
128858926|NCT01236352|463778364|FG008|Overall Study|Death|0|||
128858927|NCT01236352|463778365|FG009|Overall Study|Death|0|||
128858928|NCT01236352|463778366|FG010|Overall Study|Death|0|||
128858929|NCT01236352|463778356|FG000|Overall Study|Withdrawal by Subject|0|||
128858930|NCT01236352|463778357|FG001|Overall Study|Withdrawal by Subject|0|||
128858931|NCT01236352|463778358|FG002|Overall Study|Withdrawal by Subject|0|||
128858932|NCT01236352|463778359|FG003|Overall Study|Withdrawal by Subject|0|||
128870853|NCT00283244|463820744|FG002|Overall Study|Physician Decision|1|||
128858933|NCT01236352|463778360|FG004|Overall Study|Withdrawal by Subject|0|||
128858934|NCT01236352|463778361|FG005|Overall Study|Withdrawal by Subject|0|||
128858935|NCT01236352|463778362|FG006|Overall Study|Withdrawal by Subject|0|||
128858936|NCT01236352|463778363|FG007|Overall Study|Withdrawal by Subject|0|||
128858937|NCT01236352|463778364|FG008|Overall Study|Withdrawal by Subject|0|||
128858938|NCT01236352|463778365|FG009|Overall Study|Withdrawal by Subject|2|||
128858939|NCT01236352|463778366|FG010|Overall Study|Withdrawal by Subject|1|||
128858940|NCT01236352|463778356|FG000|Overall Study|Adverse Event|0|||
128858941|NCT01236352|463778357|FG001|Overall Study|Adverse Event|0|||
128858942|NCT01236352|463778358|FG002|Overall Study|Adverse Event|0|||
128858943|NCT01236352|463778359|FG003|Overall Study|Adverse Event|0|||
128858944|NCT01236352|463778360|FG004|Overall Study|Adverse Event|0|||
128858945|NCT01236352|463778361|FG005|Overall Study|Adverse Event|0|||
128858946|NCT01236352|463778362|FG006|Overall Study|Adverse Event|2|||
128858947|NCT01236352|463778363|FG007|Overall Study|Adverse Event|0|||
128858948|NCT01236352|463778364|FG008|Overall Study|Adverse Event|0|||
128858949|NCT01236352|463778365|FG009|Overall Study|Adverse Event|4|||
128858950|NCT01236352|463778366|FG010|Overall Study|Adverse Event|1|||
128858951|NCT01236352|463778356|FG000|Overall Study|Study drug toxicity|0|||
128858952|NCT01236352|463778357|FG001|Overall Study|Study drug toxicity|0|||
128858953|NCT01236352|463778358|FG002|Overall Study|Study drug toxicity|0|||
128858954|NCT01236352|463778359|FG003|Overall Study|Study drug toxicity|0|||
128858955|NCT01236352|463778360|FG004|Overall Study|Study drug toxicity|0|||
128858956|NCT01236352|463778361|FG005|Overall Study|Study drug toxicity|1|||
128858957|NCT01236352|463778362|FG006|Overall Study|Study drug toxicity|1|||
128858958|NCT01236352|463778363|FG007|Overall Study|Study drug toxicity|0|||
128858959|NCT01236352|463778364|FG008|Overall Study|Study drug toxicity|0|||
128858960|NCT01236352|463778365|FG009|Overall Study|Study drug toxicity|2|||
128858961|NCT01236352|463778366|FG010|Overall Study|Study drug toxicity|2|||
128858962|NCT01236352|463778356|FG000|Overall Study|Disease progression|1|||
128858963|NCT01236352|463778357|FG001|Overall Study|Disease progression|2|||
128858964|NCT01236352|463778358|FG002|Overall Study|Disease progression|1|||
128858965|NCT01236352|463778359|FG003|Overall Study|Disease progression|2|||
128858966|NCT01236352|463778360|FG004|Overall Study|Disease progression|2|||
128858967|NCT01236352|463778361|FG005|Overall Study|Disease progression|2|||
128858968|NCT01236352|463778362|FG006|Overall Study|Disease progression|1|||
128858969|NCT01236352|463778363|FG007|Overall Study|Disease progression|3|||
128858970|NCT01236352|463778364|FG008|Overall Study|Disease progression|2|||
128858971|NCT01236352|463778365|FG009|Overall Study|Disease progression|2|||
128858972|NCT01236352|463778366|FG010|Overall Study|Disease progression|2|||
128858973|NCT01236352|463778356|FG000|Overall Study|Poor/Non-compliance|1|||
128858974|NCT01236352|463778357|FG001|Overall Study|Poor/Non-compliance|0|||
128858975|NCT01236352|463778358|FG002|Overall Study|Poor/Non-compliance|0|||
128858976|NCT01236352|463778359|FG003|Overall Study|Poor/Non-compliance|0|||
128858977|NCT01236352|463778360|FG004|Overall Study|Poor/Non-compliance|0|||
128858978|NCT01236352|463778361|FG005|Overall Study|Poor/Non-compliance|0|||
128858979|NCT01236352|463778362|FG006|Overall Study|Poor/Non-compliance|0|||
128858980|NCT01236352|463778363|FG007|Overall Study|Poor/Non-compliance|0|||
128858981|NCT01236352|463778364|FG008|Overall Study|Poor/Non-compliance|0|||
128858982|NCT01236352|463778365|FG009|Overall Study|Poor/Non-compliance|0|||
128858983|NCT01236352|463778366|FG010|Overall Study|Poor/Non-compliance|0|||
128858984|NCT01236352|463778356|FG000|Overall Study|Maximum clinical benefit|1|||
128858985|NCT01236352|463778357|FG001|Overall Study|Maximum clinical benefit|1|||
128858986|NCT01236352|463778358|FG002|Overall Study|Maximum clinical benefit|1|||
128858987|NCT01236352|463778359|FG003|Overall Study|Maximum clinical benefit|0|||
128858988|NCT01236352|463778360|FG004|Overall Study|Maximum clinical benefit|2|||
128858989|NCT01236352|463778361|FG005|Overall Study|Maximum clinical benefit|0|||
128858990|NCT01236352|463778362|FG006|Overall Study|Maximum clinical benefit|3|||
128858991|NCT01236352|463778363|FG007|Overall Study|Maximum clinical benefit|1|||
128858992|NCT01236352|463778364|FG008|Overall Study|Maximum clinical benefit|1|||
128858993|NCT01236352|463778365|FG009|Overall Study|Maximum clinical benefit|4|||
128858994|NCT01236352|463778366|FG010|Overall Study|Maximum clinical benefit|2|||
128858995|NCT01236352|463778356|FG000|Overall Study|Subject request to discontinue treatment|0|||
128858996|NCT01236352|463778357|FG001|Overall Study|Subject request to discontinue treatment|0|||
128858997|NCT01236352|463778358|FG002|Overall Study|Subject request to discontinue treatment|1|||
128858998|NCT01236352|463778359|FG003|Overall Study|Subject request to discontinue treatment|1|||
128858999|NCT01236352|463778360|FG004|Overall Study|Subject request to discontinue treatment|0|||
128859000|NCT01236352|463778361|FG005|Overall Study|Subject request to discontinue treatment|1|||
128859001|NCT01236352|463778362|FG006|Overall Study|Subject request to discontinue treatment|0|||
128859002|NCT01236352|463778363|FG007|Overall Study|Subject request to discontinue treatment|0|||
128859003|NCT01236352|463778364|FG008|Overall Study|Subject request to discontinue treatment|0|||
128859004|NCT01236352|463778365|FG009|Overall Study|Subject request to discontinue treatment|1|||
128859005|NCT01236352|463778366|FG010|Overall Study|Subject request to discontinue treatment|4|||
128859006|NCT01236352|463778356|FG000|Overall Study|Subject to receive drug via EAP|1|||
128859007|NCT01236352|463778357|FG001|Overall Study|Subject to receive drug via EAP|1|||
128859008|NCT01236352|463778358|FG002|Overall Study|Subject to receive drug via EAP|1|||
128859009|NCT01236352|463778359|FG003|Overall Study|Subject to receive drug via EAP|0|||
128859010|NCT01236352|463778360|FG004|Overall Study|Subject to receive drug via EAP|0|||
128859011|NCT01236352|463778361|FG005|Overall Study|Subject to receive drug via EAP|0|||
128859012|NCT01236352|463778362|FG006|Overall Study|Subject to receive drug via EAP|0|||
128859013|NCT01236352|463778363|FG007|Overall Study|Subject to receive drug via EAP|2|||
128859014|NCT01236352|463778364|FG008|Overall Study|Subject to receive drug via EAP|0|||
128859015|NCT01236352|463778365|FG009|Overall Study|Subject to receive drug via EAP|4|||
128859016|NCT01236352|463778366|FG010|Overall Study|Subject to receive drug via EAP|0|||
128859017|NCT01236352|463778356|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
128859018|NCT01236352|463778357|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
128859019|NCT01236352|463778358|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
128859020|NCT01236352|463778359|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
128859021|NCT01236352|463778360|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
128859022|NCT01236352|463778361|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
128859023|NCT01236352|463778362|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
128859024|NCT01236352|463778363|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
128859025|NCT01236352|463778364|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
128859026|NCT01236352|463778365|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
128859027|NCT01236352|463778366|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
128859028|NCT01236352|463778356|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859029|NCT01236352|463778357|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859030|NCT01236352|463778358|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859031|NCT01236352|463778359|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859032|NCT01236352|463778360|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859033|NCT01236352|463778361|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859034|NCT01236352|463778362|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859035|NCT01236352|463778363|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859036|NCT01236352|463778364|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859037|NCT01236352|463778365|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
128859038|NCT01236352|463778366|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
128859039|NCT01236352|463778356|FG000|Overall Study|Lack of response to drug|0|||
128859040|NCT01236352|463778357|FG001|Overall Study|Lack of response to drug|0|||
128859041|NCT01236352|463778358|FG002|Overall Study|Lack of response to drug|0|||
128859042|NCT01236352|463778359|FG003|Overall Study|Lack of response to drug|0|||
128859043|NCT01236352|463778360|FG004|Overall Study|Lack of response to drug|0|||
128859044|NCT01236352|463778361|FG005|Overall Study|Lack of response to drug|0|||
128859045|NCT01236352|463778362|FG006|Overall Study|Lack of response to drug|0|||
128859046|NCT01236352|463778363|FG007|Overall Study|Lack of response to drug|0|||
128859047|NCT01236352|463778364|FG008|Overall Study|Lack of response to drug|0|||
128859048|NCT01236352|463778365|FG009|Overall Study|Lack of response to drug|1|||
128859049|NCT01236352|463778366|FG010|Overall Study|Lack of response to drug|1|||
128859050|NCT01236352|463778356|FG000|Overall Study|Patient transferred to IST|0|||
128859051|NCT01236352|463778357|FG001|Overall Study|Patient transferred to IST|0|||
128859052|NCT01236352|463778358|FG002|Overall Study|Patient transferred to IST|0|||
128859053|NCT01236352|463778359|FG003|Overall Study|Patient transferred to IST|0|||
128859054|NCT01236352|463778360|FG004|Overall Study|Patient transferred to IST|0|||
128859055|NCT01236352|463778361|FG005|Overall Study|Patient transferred to IST|0|||
128859056|NCT01236352|463778362|FG006|Overall Study|Patient transferred to IST|0|||
128859057|NCT01236352|463778363|FG007|Overall Study|Patient transferred to IST|0|||
128859058|NCT01236352|463778364|FG008|Overall Study|Patient transferred to IST|0|||
128859059|NCT01236352|463778365|FG009|Overall Study|Patient transferred to IST|2|||
128859060|NCT01236352|463778366|FG010|Overall Study|Patient transferred to IST|6|||
128859061|NCT01827046|463778370|FG000|Overall Study|Lost to Follow-up|1|||
128859062|NCT01827046|463778371|FG001|Overall Study|Lost to Follow-up|5|||
128859063|NCT01827046|463778370|FG000|Overall Study|Withdrawal by Subject|0|||
128859064|NCT01827046|463778371|FG001|Overall Study|Withdrawal by Subject|4|||
128859065|NCT02734004|463778372|FG000|Overall Study|Death|36|||
128859066|NCT02734004|463778373|FG001|Overall Study|Death|24|||
128859067|NCT02734004|463778374|FG002|Overall Study|Death|26|||
128859068|NCT02734004|463778375|FG003|Overall Study|Death|35|||
128859069|NCT02734004|463778376|FG004|Overall Study|Death|13|||
128859070|NCT02734004|463778377|FG005|Overall Study|Death|17|||
128859071|NCT02734004|463778378|FG006|Overall Study|Death|20|||
128859072|NCT02734004|463778372|FG000|Overall Study|Lost to Follow-up|1|||
128859073|NCT02734004|463778373|FG001|Overall Study|Lost to Follow-up|1|||
128859074|NCT02734004|463778374|FG002|Overall Study|Lost to Follow-up|0|||
128859075|NCT02734004|463778375|FG003|Overall Study|Lost to Follow-up|0|||
128859076|NCT02734004|463778376|FG004|Overall Study|Lost to Follow-up|1|||
128859077|NCT02734004|463778377|FG005|Overall Study|Lost to Follow-up|0|||
128859078|NCT02734004|463778378|FG006|Overall Study|Lost to Follow-up|0|||
128859079|NCT02734004|463778372|FG000|Overall Study|Withdrawal by Subject|3|||
128859080|NCT02734004|463778373|FG001|Overall Study|Withdrawal by Subject|1|||
128859081|NCT02734004|463778374|FG002|Overall Study|Withdrawal by Subject|1|||
128859082|NCT02734004|463778375|FG003|Overall Study|Withdrawal by Subject|1|||
128859083|NCT02734004|463778376|FG004|Overall Study|Withdrawal by Subject|3|||
128859084|NCT02734004|463778377|FG005|Overall Study|Withdrawal by Subject|0|||
128859085|NCT02734004|463778378|FG006|Overall Study|Withdrawal by Subject|2|||
128859086|NCT02734004|463778372|FG000|Overall Study|Other|0|||
128859087|NCT02734004|463778373|FG001|Overall Study|Other|8|||
128859088|NCT02734004|463778374|FG002|Overall Study|Other|7|||
128859089|NCT02734004|463778375|FG003|Overall Study|Other|4|||
128859090|NCT02734004|463778376|FG004|Overall Study|Other|34|||
128859091|NCT02734004|463778377|FG005|Overall Study|Other|14|||
128859092|NCT02734004|463778378|FG006|Overall Study|Other|10|||
128859093|NCT01294436|463778379|FG000|Overall Study|Adverse Event|10|||
128859094|NCT01294436|463778380|FG001|Overall Study|Adverse Event|17|||
128859095|NCT01294436|463778379|FG000|Overall Study|Withdrawal by Subject|11|||
128859096|NCT01294436|463778380|FG001|Overall Study|Withdrawal by Subject|28|||
128859097|NCT01294436|463778379|FG000|Overall Study|subject no longer meets study criteria|5|||
128859098|NCT01294436|463778380|FG001|Overall Study|subject no longer meets study criteria|20|||
128859099|NCT01294436|463778379|FG000|Overall Study|poor/non-compliance|2|||
128859100|NCT01294436|463778380|FG001|Overall Study|poor/non-compliance|5|||
128859101|NCT01536171|463778383|FG000|Overall Study|Withdrawal by Subject|1|||
128859102|NCT00585078|463778384|FG000|Overall Study|Withdrawal by Subject|4|||
128859103|NCT00585078|463778384|FG000|Overall Study|Poor performance status|1|||
128859104|NCT00585078|463778384|FG000|Overall Study|Disease Progression|24|||
128859105|NCT00585078|463778384|FG000|Overall Study|Adverse Event|10|||
128859106|NCT00585078|463778384|FG000|Overall Study|Death|1|||
128859107|NCT01018732|463778385|FG000|Overall Study|Lost to Follow-up|0|||
128859108|NCT01018732|463778386|FG001|Overall Study|Lost to Follow-up|0|||
128859109|NCT01018732|463778387|FG002|Overall Study|Lost to Follow-up|3|||
128859110|NCT01018732|463778385|FG000|Overall Study|Protocol Violation|1|||
128859111|NCT01018732|463778386|FG001|Overall Study|Protocol Violation|1|||
128859112|NCT01018732|463778387|FG002|Overall Study|Protocol Violation|0|||
128859113|NCT01018732|463778385|FG000|Overall Study|Inappropriate Enrollment|0|||
128859114|NCT01018732|463778386|FG001|Overall Study|Inappropriate Enrollment|1|||
128859115|NCT01018732|463778387|FG002|Overall Study|Inappropriate Enrollment|0|||
128859116|NCT01018732|463778385|FG000|Overall Study|Unable to Classify|0|||
128859117|NCT01018732|463778386|FG001|Overall Study|Unable to Classify|0|||
128859118|NCT01018732|463778387|FG002|Overall Study|Unable to Classify|1|||
128859119|NCT02781311|463778390|FG000|Overall Study|Adverse Event|2|||
128859120|NCT02781311|463778391|FG001|Overall Study|Adverse Event|6|||
128859121|NCT02781311|463778392|FG002|Overall Study|Adverse Event|1|||
128859122|NCT02781311|463778390|FG000|Overall Study|Withdrawal of Consent|11|||
128859123|NCT02781311|463778391|FG001|Overall Study|Withdrawal of Consent|12|||
128859124|NCT02781311|463778392|FG002|Overall Study|Withdrawal of Consent|2|||
128859125|NCT02781311|463778390|FG000|Overall Study|Lost to Follow-up|11|||
128859126|NCT02781311|463778391|FG001|Overall Study|Lost to Follow-up|8|||
128859127|NCT02781311|463778392|FG002|Overall Study|Lost to Follow-up|1|||
128859128|NCT02781311|463778390|FG000|Overall Study|Non-Compliance with Study Drug|2|||
128859129|NCT02781311|463778391|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128859130|NCT02781311|463778392|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128859131|NCT01056263|463778395|FG000|Overall Study|Adverse Event|12|||
128859132|NCT01056263|463778395|FG000|Overall Study|Death|1|||
128859133|NCT01056263|463778395|FG000|Overall Study|Withdrawal by Subject|1|||
128859134|NCT01056263|463778395|FG000|Overall Study|Lack of Efficacy|29|||
128859135|NCT01056263|463778395|FG000|Overall Study|Progressive disease|2|||
128859136|NCT01056263|463778395|FG000|Overall Study|Neoplasm progression|1|||
128859137|NCT01056263|463778395|FG000|Overall Study|Objective progression or relapse|1|||
128859138|NCT01056263|463778395|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
128859139|NCT04905849|463778396|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
128859140|NCT04905849|463778397|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
128859141|NCT05990387|463778398|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
128859142|NCT05990387|463778399|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
128859143|NCT04750577|463778400|FG000|Overall Study|Adverse Event|2|||
128859144|NCT04750577|463778401|FG001|Overall Study|Adverse Event|10|||
128859145|NCT04750577|463778402|FG002|Overall Study|Adverse Event|8|||
128859146|NCT04750577|463778403|FG003|Overall Study|Adverse Event|1|||
128859147|NCT04750577|463778400|FG000|Overall Study|Change of residence|0|||
128859148|NCT04750577|463778401|FG001|Overall Study|Change of residence|0|||
128859149|NCT04750577|463778402|FG002|Overall Study|Change of residence|1|||
128859150|NCT04750577|463778403|FG003|Overall Study|Change of residence|0|||
128859151|NCT04750577|463778400|FG000|Overall Study|Burden of study procedures|0|||
128859152|NCT04750577|463778401|FG001|Overall Study|Burden of study procedures|2|||
128859153|NCT04750577|463778402|FG002|Overall Study|Burden of study procedures|2|||
128859154|NCT04750577|463778403|FG003|Overall Study|Burden of study procedures|0|||
128859155|NCT04750577|463778400|FG000|Overall Study|Prematurely discontinued|0|||
128859156|NCT04750577|463778401|FG001|Overall Study|Prematurely discontinued|0|||
128859157|NCT04750577|463778402|FG002|Overall Study|Prematurely discontinued|0|||
128859158|NCT04750577|463778403|FG003|Overall Study|Prematurely discontinued|2|||
128859159|NCT04750577|463778400|FG000|Overall Study|Protocol deviation|1|||
128859160|NCT04750577|463778401|FG001|Overall Study|Protocol deviation|1|||
128859161|NCT04750577|463778402|FG002|Overall Study|Protocol deviation|1|||
128859162|NCT04750577|463778403|FG003|Overall Study|Protocol deviation|1|||
128859163|NCT04750577|463778400|FG000|Overall Study|Other than listed|3|||
128859164|NCT04750577|463778401|FG001|Overall Study|Other than listed|2|||
128859165|NCT04750577|463778402|FG002|Overall Study|Other than listed|2|||
128859166|NCT04750577|463778403|FG003|Overall Study|Other than listed|1|||
128859167|NCT04750577|463778400|FG000|Overall Study|Not treated|0|||
128859168|NCT04750577|463778401|FG001|Overall Study|Not treated|0|||
128859169|NCT04750577|463778402|FG002|Overall Study|Not treated|0|||
128859170|NCT04750577|463778403|FG003|Overall Study|Not treated|2|||
128859171|NCT01806389|463778406|FG000|Overall Study|Withdrawal by Subject|4|||
128859172|NCT01310699|463778409|FG000|Overall Study|Patients did not complete tandem.|4|||
128859173|NCT01310699|463778410|FG001|Overall Study|Patients did not complete tandem.|6|||
128859174|NCT00936598|463778411|FG000|Overall Study|Withdrawal by Subject|1|||
128859175|NCT00936598|463778412|FG001|Overall Study|Withdrawal by Subject|0|||
128859176|NCT00936598|463778411|FG000|Overall Study|Ineligible after consent|1|||
128859177|NCT00936598|463778412|FG001|Overall Study|Ineligible after consent|0|||
128859178|NCT00926575|463778413|FG000|Overall Study|Adverse Event|1|||
128859179|NCT00926575|463778414|FG001|Overall Study|Adverse Event|1|||
128859180|NCT00926575|463778413|FG000|Overall Study|Death|4|||
128859181|NCT00926575|463778414|FG001|Overall Study|Death|4|||
128859182|NCT00926575|463778413|FG000|Overall Study|Lost to Follow-up|1|||
128859183|NCT00926575|463778414|FG001|Overall Study|Lost to Follow-up|1|||
128859184|NCT00926575|463778413|FG000|Overall Study|Physician Decision|1|||
128859185|NCT00926575|463778414|FG001|Overall Study|Physician Decision|2|||
128859186|NCT00926575|463778413|FG000|Overall Study|Protocol Violation|1|||
128859187|NCT00926575|463778414|FG001|Overall Study|Protocol Violation|0|||
128859188|NCT00926575|463778413|FG000|Overall Study|Withdrawal by Subject|8|||
128859189|NCT00926575|463778414|FG001|Overall Study|Withdrawal by Subject|9|||
128859190|NCT02201901|463778417|FG000|Overall Study|Randomized but never treated|0|||
128859191|NCT02201901|463778418|FG001|Overall Study|Randomized but never treated|1|||
128859192|NCT02201901|463778419|FG002|Overall Study|Randomized but never treated|0|||
128859193|NCT02201901|463778417|FG000|Overall Study|Lack of Efficacy|7|||
128859194|NCT02201901|463778418|FG001|Overall Study|Lack of Efficacy|1|||
128859195|NCT02201901|463778419|FG002|Overall Study|Lack of Efficacy|6|||
128859196|NCT02201901|463778417|FG000|Overall Study|Death|3|||
128859197|NCT02201901|463778418|FG001|Overall Study|Death|3|||
128859198|NCT02201901|463778419|FG002|Overall Study|Death|3|||
128859199|NCT02201901|463778417|FG000|Overall Study|Lost to Follow-up|2|||
128859200|NCT02201901|463778418|FG001|Overall Study|Lost to Follow-up|3|||
128859201|NCT02201901|463778419|FG002|Overall Study|Lost to Follow-up|2|||
128859202|NCT02201901|463778417|FG000|Overall Study|Withdrew Consent|2|||
128859203|NCT02201901|463778418|FG001|Overall Study|Withdrew Consent|0|||
128859204|NCT02201901|463778419|FG002|Overall Study|Withdrew Consent|2|||
128859205|NCT02201901|463778417|FG000|Overall Study|Adverse Event|1|||
128859206|NCT02201901|463778418|FG001|Overall Study|Adverse Event|1|||
128859207|NCT02201901|463778419|FG002|Overall Study|Adverse Event|0|||
128859208|NCT02633397|463778421|FG000|Overall Study|Adverse Event|8|||
128859209|NCT02633397|463778422|FG001|Overall Study|Adverse Event|8|||
128859210|NCT02633397|463778421|FG000|Overall Study|Study Burden|4|||
128859211|NCT02633397|463778422|FG001|Overall Study|Study Burden|1|||
128859212|NCT02633397|463778421|FG000|Overall Study|Treatment interruption|2|||
128859213|NCT02633397|463778422|FG001|Overall Study|Treatment interruption|5|||
128859214|NCT02633397|463778421|FG000|Overall Study|Death|2|||
128859215|NCT02633397|463778422|FG001|Overall Study|Death|2|||
128859216|NCT02633397|463778421|FG000|Overall Study|Physician Decision|0|||
128859217|NCT02633397|463778422|FG001|Overall Study|Physician Decision|1|||
128859218|NCT03595878|463778423|FG000|Overall Study|Death|2|||
128859219|NCT03595878|463778424|FG001|Overall Study|Death|1|||
128859220|NCT03595878|463778425|FG002|Overall Study|Death|0|||
128859221|NCT03595878|463778423|FG000|Overall Study|Disease progression|2|||
128859222|NCT03595878|463778424|FG001|Overall Study|Disease progression|1|||
128859223|NCT03595878|463778425|FG002|Overall Study|Disease progression|2|||
128859224|NCT03494985|463778426|FG000|Overall Study|Adverse Event|3|||
128859225|NCT03494985|463778427|FG001|Overall Study|Adverse Event|2|||
128859226|NCT03494985|463778428|FG002|Overall Study|Adverse Event|3|||
128859227|NCT03494985|463778429|FG003|Overall Study|Adverse Event|0|||
128859228|NCT03494985|463778426|FG000|Overall Study|Other (Withdrawal of consent)|2|||
128859229|NCT03494985|463778427|FG001|Overall Study|Other (Withdrawal of consent)|3|||
128859230|NCT03494985|463778428|FG002|Overall Study|Other (Withdrawal of consent)|2|||
128859231|NCT03494985|463778429|FG003|Overall Study|Other (Withdrawal of consent)|5|||
128859232|NCT03494985|463778426|FG000|Overall Study|Other (Not specified)|0|||
128859233|NCT03494985|463778427|FG001|Overall Study|Other (Not specified)|1|||
128859234|NCT03494985|463778428|FG002|Overall Study|Other (Not specified)|1|||
128859235|NCT03494985|463778429|FG003|Overall Study|Other (Not specified)|0|||
128859236|NCT03036124|463778430|FG000|Overall Study|Lost to Follow-up|0|||
128859237|NCT03036124|463778431|FG001|Overall Study|Lost to Follow-up|2|||
128859238|NCT03036124|463778430|FG000|Overall Study|Withdrawal by Subject|5|||
128859239|NCT03036124|463778431|FG001|Overall Study|Withdrawal by Subject|4|||
128859240|NCT02394925|463778432|FG000|Overall Study|Adverse Event|1|||
128859241|NCT02394925|463778432|FG000|Overall Study|Lens Discomfort|3|||
128859242|NCT02394925|463778432|FG000|Overall Study|Lens handling difficulities|5|||
128859243|NCT02394925|463778432|FG000|Overall Study|Lost to Follow-up|9|||
128859244|NCT02394925|463778432|FG000|Overall Study|Protocol Violation|5|||
128859245|NCT02394925|463778432|FG000|Overall Study|No longer meet eligibility criteria|1|||
128859246|NCT02394925|463778432|FG000|Overall Study|Unsatisfactory Visual Response|5|||
128859247|NCT00966264|463779951|FG000|Overall Study|Lost to Follow-up|4|||
128859248|NCT00966264|463779952|FG001|Overall Study|Lost to Follow-up|3|||
128859249|NCT01246999|463779953|FG000|Overall Study|Lost to Follow-up|0|||
128859250|NCT01246999|463779954|FG001|Overall Study|Lost to Follow-up|1|||
128859251|NCT01246999|463779955|FG002|Overall Study|Lost to Follow-up|0|||
128859252|NCT01246999|463779956|FG003|Overall Study|Lost to Follow-up|0|||
128859253|NCT01246999|463779953|FG000|Overall Study|Withdrawal by Subject|0|||
128859254|NCT01246999|463779954|FG001|Overall Study|Withdrawal by Subject|0|||
128859255|NCT01246999|463779955|FG002|Overall Study|Withdrawal by Subject|0|||
128859256|NCT01246999|463779956|FG003|Overall Study|Withdrawal by Subject|2|||
128859257|NCT01867047|463779957|FG000|Overall Study|Lost to Follow-up|3|||
128859258|NCT01867047|463779958|FG001|Overall Study|Lost to Follow-up|3|||
128859259|NCT01867047|463779957|FG000|Overall Study|Withdrawal by Subject|2|||
128859260|NCT01867047|463779958|FG001|Overall Study|Withdrawal by Subject|0|||
128859261|NCT01867047|463779957|FG000|Overall Study|Physician Decision|2|||
128859262|NCT01867047|463779958|FG001|Overall Study|Physician Decision|0|||
128859263|NCT01867047|463779957|FG000|Overall Study|surgery not indicated in protocol|1|||
128859264|NCT01867047|463779958|FG001|Overall Study|surgery not indicated in protocol|2|||
128859265|NCT04596995|463779959|FG000|Overall Study|Lack of Efficacy|8|||
128859266|NCT04596995|463779959|FG000|Overall Study|Lost to Follow-up|3|||
128859267|NCT04596995|463779959|FG000|Overall Study|Withdrawal by Subject|12|||
128859268|NCT04596995|463779959|FG000|Overall Study|Sponsor decision|3|||
128859269|NCT04596995|463779959|FG000|Overall Study|Enrolled in managed access program|3|||
128859270|NCT00590564|463779961|FG000|Overall Study|Withdrawal by Subject|4|||
128859271|NCT00590564|463779961|FG000|Overall Study|Lost to Follow-up|6|||
128859272|NCT00590564|463779961|FG000|Overall Study|Protocol Violation|1|||
128859273|NCT00590564|463779961|FG000|Overall Study|Patient Found to be Ineligible|1|||
128859274|NCT00590564|463779961|FG000|Overall Study|Patient Non-compliance|6|||
128859275|NCT01434680|463779962|FG000|Overall Study|Withdrawal by Subject|1|||
128859276|NCT01434680|463779963|FG001|Overall Study|Withdrawal by Subject|0|||
128859277|NCT01434680|463779964|FG002|Overall Study|Withdrawal by Subject|2|||
128859278|NCT01434680|463779965|FG003|Overall Study|Withdrawal by Subject|0|||
128859279|NCT01434680|463779962|FG000|Overall Study|Lost to Follow-up|1|||
128859280|NCT01434680|463779963|FG001|Overall Study|Lost to Follow-up|1|||
128859281|NCT01434680|463779964|FG002|Overall Study|Lost to Follow-up|0|||
128859282|NCT01434680|463779965|FG003|Overall Study|Lost to Follow-up|0|||
128859283|NCT01434680|463779962|FG000|Overall Study|Protocol Violation|1|||
128859284|NCT01434680|463779963|FG001|Overall Study|Protocol Violation|1|||
128859285|NCT01434680|463779964|FG002|Overall Study|Protocol Violation|0|||
128859286|NCT01434680|463779965|FG003|Overall Study|Protocol Violation|0|||
128859287|NCT00781937|463779974|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
128859288|NCT00781937|463779975|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
128859289|NCT00781937|463779974|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
128859290|NCT00781937|463779975|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
128859291|NCT00781937|463779974|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
128859292|NCT00781937|463779975|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
128859293|NCT00781937|463779974|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
128859294|NCT00781937|463779975|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
128859295|NCT00781937|463779974|FG000|Main Trial Period Through Week 56|Unclassified|10|||
128859296|NCT00781937|463779975|FG001|Main Trial Period Through Week 56|Unclassified|15|||
128859297|NCT00781937|463779974|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
128859298|NCT00781937|463779975|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
128859299|NCT00781937|463779974|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
128859300|NCT00781937|463779975|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
128859301|NCT00013611|463779976|FG000|Overall Study|Lost to Follow-up|91|||
128859302|NCT00013611|463779977|FG001|Overall Study|Lost to Follow-up|100|||
128859303|NCT01013961|463779981|FG000|Overall Study|Adverse Event|2|||
128859304|NCT01013961|463779982|FG001|Overall Study|Adverse Event|2|||
128859305|NCT01013961|463779981|FG000|Overall Study|Withdrawal by Subject|1|||
128859306|NCT01013961|463779982|FG001|Overall Study|Withdrawal by Subject|0|||
128859307|NCT01013961|463779981|FG000|Overall Study|Physician Decision|0|||
128859308|NCT01013961|463779982|FG001|Overall Study|Physician Decision|1|||
128859309|NCT00420784|463779999|FG000|Overall Study|Adverse Event|11|||
128859310|NCT00420784|463780000|FG001|Overall Study|Adverse Event|29|||
128859311|NCT00420784|463780001|FG002|Overall Study|Adverse Event|10|||
128859312|NCT00420784|463780002|FG003|Overall Study|Adverse Event|5|||
128859313|NCT00420784|463779999|FG000|Overall Study|Withdrawal by Subject|0|||
128859314|NCT00420784|463780000|FG001|Overall Study|Withdrawal by Subject|1|||
128859315|NCT00420784|463780001|FG002|Overall Study|Withdrawal by Subject|0|||
128859316|NCT00420784|463780002|FG003|Overall Study|Withdrawal by Subject|0|||
128859317|NCT00420784|463779999|FG000|Overall Study|Lost to Follow-up|0|||
128859318|NCT00420784|463780000|FG001|Overall Study|Lost to Follow-up|0|||
128859319|NCT00420784|463780001|FG002|Overall Study|Lost to Follow-up|2|||
128859320|NCT00420784|463780002|FG003|Overall Study|Lost to Follow-up|1|||
128859321|NCT00420784|463779999|FG000|Overall Study|Virologic Stopping Rule|17|||
128859322|NCT00420784|463780000|FG001|Overall Study|Virologic Stopping Rule|26|||
128859323|NCT00420784|463780001|FG002|Overall Study|Virologic Stopping Rule|41|||
128859324|NCT00420784|463780002|FG003|Overall Study|Virologic Stopping Rule|67|||
128859325|NCT00420784|463779999|FG000|Overall Study|Other|1|||
128859326|NCT00420784|463780000|FG001|Overall Study|Other|2|||
128859327|NCT00420784|463780001|FG002|Overall Study|Other|0|||
128859328|NCT00420784|463780002|FG003|Overall Study|Other|5|||
128859329|NCT02417441|463780005|FG000|Overall Study|Inconclusive due to missing data|52|||
128859330|NCT02417441|463780006|FG001|Overall Study|Inconclusive due to missing data|19|||
128859331|NCT00983853|463780009|FG000|Overall Study|Lost to Follow-up|1|||
128859332|NCT00983853|463780010|FG001|Overall Study|Lost to Follow-up|1|||
128859333|NCT00983853|463780011|FG002|Overall Study|Lost to Follow-up|2|||
128859334|NCT00983853|463780012|FG003|Overall Study|Lost to Follow-up|2|||
128859335|NCT00983853|463780013|FG004|Overall Study|Lost to Follow-up|2|||
128859336|NCT00983853|463780014|FG005|Overall Study|Lost to Follow-up|1|||
128859337|NCT00983853|463780009|FG000|Overall Study|Withdrawal by Subject|0|||
128859338|NCT00983853|463780010|FG001|Overall Study|Withdrawal by Subject|0|||
128859339|NCT00983853|463780011|FG002|Overall Study|Withdrawal by Subject|1|||
128859340|NCT00983853|463780012|FG003|Overall Study|Withdrawal by Subject|0|||
128859341|NCT00983853|463780013|FG004|Overall Study|Withdrawal by Subject|1|||
128859342|NCT00983853|463780014|FG005|Overall Study|Withdrawal by Subject|0|||
128859343|NCT00983853|463780009|FG000|Overall Study|Unable to come to study follow-up visits|0|||
128859344|NCT00983853|463780010|FG001|Overall Study|Unable to come to study follow-up visits|1|||
128859345|NCT00983853|463780011|FG002|Overall Study|Unable to come to study follow-up visits|0|||
128859346|NCT00983853|463780012|FG003|Overall Study|Unable to come to study follow-up visits|0|||
128859347|NCT00983853|463780013|FG004|Overall Study|Unable to come to study follow-up visits|0|||
128859348|NCT00983853|463780014|FG005|Overall Study|Unable to come to study follow-up visits|0|||
128859349|NCT03603639|463780015|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
128859350|NCT03603639|463780016|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
128859351|NCT03603639|463780017|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
128859352|NCT03603639|463780018|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
128859353|NCT03603639|463780019|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
128859354|NCT03603639|463780020|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
128859355|NCT03603639|463780015|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
128859356|NCT03603639|463780016|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
128859357|NCT03603639|463780017|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
128859358|NCT03603639|463780018|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
128859359|NCT03603639|463780019|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
128859360|NCT03603639|463780020|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
128859361|NCT03016598|463780028|FG000|Overall Study|Lost to Follow-up|0|||
128859362|NCT03016598|463780029|FG001|Overall Study|Lost to Follow-up|2|||
128859363|NCT02947100|463780030|FG000|Overall Study|study terminated early|3|||
128859364|NCT02947100|463780030|FG000|Overall Study|did not meet inclusion criteria|1|||
128859365|NCT00742326|463780033|FG000|Overall Study|Physician Decision|0|||
128859366|NCT00742326|463780034|FG001|Overall Study|Physician Decision|1|||
128859367|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
128859368|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
128859369|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
128859370|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
128859371|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
128859372|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
128859373|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
128859374|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
128859375|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
128859376|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
128859377|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
128859378|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
128859379|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
128859380|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
128859381|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
128859382|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
128859383|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
128859384|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
128859385|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Missing|2|||
128859386|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Missing|1|||
128859387|NCT00443209|463780036|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
128859388|NCT00443209|463780037|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
128859389|NCT00443209|463780036|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
128859390|NCT00443209|463780037|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
128859391|NCT00443209|463780036|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
128859392|NCT00443209|463780037|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
128859393|NCT00443209|463780036|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
128859394|NCT00443209|463780037|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
128859395|NCT00443209|463780036|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
128859396|NCT00443209|463780037|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
128859397|NCT00443209|463780036|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
128859398|NCT00443209|463780037|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
128859399|NCT00443209|463780036|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
128859400|NCT00443209|463780037|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
128859401|NCT01628692|463780038|FG000|Overall Study|Lack of Efficacy|4|||
128859402|NCT01628692|463780039|FG001|Overall Study|Lack of Efficacy|4|||
128859403|NCT01628692|463780040|FG002|Overall Study|Lack of Efficacy|5|||
128859404|NCT01628692|463780041|FG003|Overall Study|Lack of Efficacy|1|||
128859405|NCT01628692|463780042|FG004|Overall Study|Lack of Efficacy|4|||
128859406|NCT01628692|463780043|FG005|Overall Study|Lack of Efficacy|7|||
128859407|NCT01628692|463780038|FG000|Overall Study|Adverse Event|2|||
128859408|NCT01628692|463780039|FG001|Overall Study|Adverse Event|0|||
128859409|NCT01628692|463780040|FG002|Overall Study|Adverse Event|2|||
128859410|NCT01628692|463780041|FG003|Overall Study|Adverse Event|0|||
128859411|NCT01628692|463780042|FG004|Overall Study|Adverse Event|0|||
128859412|NCT01628692|463780043|FG005|Overall Study|Adverse Event|0|||
128859413|NCT01628692|463780038|FG000|Overall Study|Withdrawal by Subject|0|||
128859414|NCT01628692|463780039|FG001|Overall Study|Withdrawal by Subject|1|||
128859415|NCT01628692|463780040|FG002|Overall Study|Withdrawal by Subject|1|||
128859416|NCT01628692|463780041|FG003|Overall Study|Withdrawal by Subject|0|||
128859417|NCT01628692|463780042|FG004|Overall Study|Withdrawal by Subject|0|||
128859418|NCT01628692|463780043|FG005|Overall Study|Withdrawal by Subject|0|||
128859419|NCT01628692|463780038|FG000|Overall Study|Death|0|||
128859420|NCT01628692|463780039|FG001|Overall Study|Death|1|||
128859421|NCT01628692|463780040|FG002|Overall Study|Death|0|||
128859422|NCT01628692|463780041|FG003|Overall Study|Death|0|||
128859423|NCT01628692|463780042|FG004|Overall Study|Death|0|||
128859424|NCT01628692|463780043|FG005|Overall Study|Death|0|||
128859425|NCT01628692|463780038|FG000|Overall Study|Poor compliance/noncompliance|1|||
128859426|NCT01628692|463780039|FG001|Overall Study|Poor compliance/noncompliance|0|||
128859427|NCT01628692|463780040|FG002|Overall Study|Poor compliance/noncompliance|0|||
128859428|NCT01628692|463780041|FG003|Overall Study|Poor compliance/noncompliance|0|||
128859429|NCT01628692|463780042|FG004|Overall Study|Poor compliance/noncompliance|0|||
128859430|NCT01628692|463780043|FG005|Overall Study|Poor compliance/noncompliance|0|||
128859431|NCT01628692|463780038|FG000|Overall Study|Administrative reason by sponsor|0|||
128859432|NCT01628692|463780039|FG001|Overall Study|Administrative reason by sponsor|0|||
128859433|NCT01628692|463780040|FG002|Overall Study|Administrative reason by sponsor|0|||
128859434|NCT01628692|463780041|FG003|Overall Study|Administrative reason by sponsor|0|||
128859435|NCT01628692|463780042|FG004|Overall Study|Administrative reason by sponsor|0|||
128859436|NCT01628692|463780043|FG005|Overall Study|Administrative reason by sponsor|1|||
128859437|NCT01628692|463780038|FG000|Overall Study|Completed 12 Week only|0|||
128859438|NCT01628692|463780039|FG001|Overall Study|Completed 12 Week only|0|||
128859439|NCT01628692|463780040|FG002|Overall Study|Completed 12 Week only|0|||
128859440|NCT01628692|463780041|FG003|Overall Study|Completed 12 Week only|0|||
128859441|NCT01628692|463780042|FG004|Overall Study|Completed 12 Week only|0|||
128859442|NCT01628692|463780043|FG005|Overall Study|Completed 12 Week only|1|||
128859443|NCT00409409|463780044|FG000|Overall Study|Adverse Event|7|||
128859444|NCT00409409|463780045|FG001|Overall Study|Adverse Event|2|||
128859445|NCT00409409|463780044|FG000|Overall Study|Withdrawal by Subject|1|||
128859446|NCT00409409|463780045|FG001|Overall Study|Withdrawal by Subject|1|||
128859447|NCT00409409|463780044|FG000|Overall Study|Any other reason not above-mentioned|0|||
128859448|NCT00409409|463780045|FG001|Overall Study|Any other reason not above-mentioned|1|||
128859449|NCT03635086|463780050|FG000|Overall Study|Withdrawal of consent|0|||
128859450|NCT03635086|463780051|FG001|Overall Study|Withdrawal of consent|0|||
128859451|NCT03635086|463780052|FG002|Overall Study|Withdrawal of consent|1|||
128859452|NCT03635086|463780053|FG003|Overall Study|Withdrawal of consent|0|||
128859453|NCT03635086|463780054|FG004|Overall Study|Withdrawal of consent|0|||
128859454|NCT03635086|463780050|FG000|Overall Study|Adverse Event|0|||
128859455|NCT03635086|463780051|FG001|Overall Study|Adverse Event|1|||
128859456|NCT03635086|463780052|FG002|Overall Study|Adverse Event|0|||
128859457|NCT03635086|463780053|FG003|Overall Study|Adverse Event|0|||
128859458|NCT03635086|463780054|FG004|Overall Study|Adverse Event|0|||
128859459|NCT03635086|463780050|FG000|Overall Study|Lost to Follow-up|1|||
128859460|NCT03635086|463780051|FG001|Overall Study|Lost to Follow-up|0|||
128859461|NCT03635086|463780052|FG002|Overall Study|Lost to Follow-up|0|||
128859462|NCT03635086|463780053|FG003|Overall Study|Lost to Follow-up|0|||
128859463|NCT03635086|463780054|FG004|Overall Study|Lost to Follow-up|0|||
128859464|NCT00723125|463780055|FG000|Overall Study|Met Dx|1|||
128859465|NCT00723125|463780056|FG001|Overall Study|Met Dx|0|||
128859466|NCT00723125|463780055|FG000|Overall Study|Withdrawal by Subject|15|||
128859467|NCT00723125|463780056|FG001|Overall Study|Withdrawal by Subject|6|||
128859468|NCT00723125|463780055|FG000|Overall Study|Adverse Event|2|||
128859469|NCT00723125|463780056|FG001|Overall Study|Adverse Event|0|||
128859470|NCT02196077|463780057|FG000|Overall Study|Adverse Event|4|||
128859471|NCT02196077|463780057|FG000|Overall Study|Lack of Efficacy|1|||
128859472|NCT02196077|463780057|FG000|Overall Study|Withdrawal by Subject|14|||
128859473|NCT02196077|463780057|FG000|Overall Study|Physician Decision|1|||
128859474|NCT02196077|463780057|FG000|Overall Study|Lost to Follow-up|3|||
128859475|NCT02196077|463780057|FG000|Overall Study|Protocol Violation|24|||
128859476|NCT00003477|463780072|FG000|Overall Study|Not evalauable|4|||
128859477|NCT01575873|463780073|FG000|Overall Study|Withdrawal by Subject|15|||
128859478|NCT01575873|463780074|FG001|Overall Study|Withdrawal by Subject|20|||
128859479|NCT01575873|463780075|FG002|Overall Study|Withdrawal by Subject|34|||
128859480|NCT01575873|463780076|FG003|Overall Study|Withdrawal by Subject|34|||
128859481|NCT01575873|463780073|FG000|Overall Study|Adverse Event|7|||
128859482|NCT01575873|463780074|FG001|Overall Study|Adverse Event|7|||
128859483|NCT01575873|463780075|FG002|Overall Study|Adverse Event|9|||
128859484|NCT01575873|463780076|FG003|Overall Study|Adverse Event|12|||
128859485|NCT01575873|463780073|FG000|Overall Study|Lost to Follow-up|1|||
128859486|NCT01575873|463780074|FG001|Overall Study|Lost to Follow-up|3|||
128859487|NCT01575873|463780075|FG002|Overall Study|Lost to Follow-up|13|||
128859488|NCT01575873|463780076|FG003|Overall Study|Lost to Follow-up|5|||
128859489|NCT01575873|463780073|FG000|Overall Study|Death|3|||
128859490|NCT01575873|463780074|FG001|Overall Study|Death|2|||
128859491|NCT01575873|463780075|FG002|Overall Study|Death|8|||
128859492|NCT01575873|463780076|FG003|Overall Study|Death|9|||
128859493|NCT01575873|463780073|FG000|Overall Study|Noncompliance|1|||
128859494|NCT01575873|463780074|FG001|Overall Study|Noncompliance|2|||
128859495|NCT01575873|463780075|FG002|Overall Study|Noncompliance|4|||
128859496|NCT01575873|463780076|FG003|Overall Study|Noncompliance|3|||
128859497|NCT01575873|463780073|FG000|Overall Study|Administrative decision|1|||
128859498|NCT01575873|463780074|FG001|Overall Study|Administrative decision|1|||
128859499|NCT01575873|463780075|FG002|Overall Study|Administrative decision|1|||
128859500|NCT01575873|463780076|FG003|Overall Study|Administrative decision|0|||
128859501|NCT01575873|463780073|FG000|Overall Study|Protocol deviation|0|||
128859502|NCT01575873|463780074|FG001|Overall Study|Protocol deviation|1|||
128859503|NCT01575873|463780075|FG002|Overall Study|Protocol deviation|0|||
128859504|NCT01575873|463780076|FG003|Overall Study|Protocol deviation|1|||
128859505|NCT01575873|463780073|FG000|Overall Study|Requirement for Alternative Therapy|0|||
128859506|NCT01575873|463780074|FG001|Overall Study|Requirement for Alternative Therapy|0|||
128859507|NCT01575873|463780075|FG002|Overall Study|Requirement for Alternative Therapy|1|||
128859508|NCT01575873|463780076|FG003|Overall Study|Requirement for Alternative Therapy|1|||
128859509|NCT01575873|463780073|FG000|Overall Study|Other|0|||
128859510|NCT01575873|463780074|FG001|Overall Study|Other|0|||
128859511|NCT01575873|463780075|FG002|Overall Study|Other|4|||
128859512|NCT01575873|463780076|FG003|Overall Study|Other|2|||
128859513|NCT02638103|463780077|FG000|Overall Study|Adverse Event|13|||
128859514|NCT02638103|463780078|FG001|Overall Study|Adverse Event|12|||
128859515|NCT02638103|463780079|FG002|Overall Study|Adverse Event|19|||
128859516|NCT02638103|463780080|FG003|Overall Study|Adverse Event|12|||
128859517|NCT02638103|463780077|FG000|Overall Study|Withdrawal by Subject|43|||
128859518|NCT02638103|463780078|FG001|Overall Study|Withdrawal by Subject|53|||
128859519|NCT02638103|463780079|FG002|Overall Study|Withdrawal by Subject|30|||
128859520|NCT02638103|463780080|FG003|Overall Study|Withdrawal by Subject|61|||
128859521|NCT02638103|463780077|FG000|Overall Study|Protocol Violation|1|||
128859522|NCT02638103|463780078|FG001|Overall Study|Protocol Violation|2|||
128859523|NCT02638103|463780079|FG002|Overall Study|Protocol Violation|1|||
128859524|NCT02638103|463780080|FG003|Overall Study|Protocol Violation|4|||
128859525|NCT02638103|463780077|FG000|Overall Study|Pregnancy|2|||
128859526|NCT02638103|463780078|FG001|Overall Study|Pregnancy|3|||
128859527|NCT02638103|463780079|FG002|Overall Study|Pregnancy|0|||
128859528|NCT02638103|463780080|FG003|Overall Study|Pregnancy|1|||
128859529|NCT02638103|463780077|FG000|Overall Study|Non-compliance to Study Procedures|2|||
128859530|NCT02638103|463780078|FG001|Overall Study|Non-compliance to Study Procedures|1|||
128859531|NCT02638103|463780079|FG002|Overall Study|Non-compliance to Study Procedures|1|||
128859532|NCT02638103|463780080|FG003|Overall Study|Non-compliance to Study Procedures|1|||
128859533|NCT02638103|463780077|FG000|Overall Study|Lost to Follow-up|26|||
128859534|NCT02638103|463780078|FG001|Overall Study|Lost to Follow-up|33|||
128859535|NCT02638103|463780079|FG002|Overall Study|Lost to Follow-up|20|||
128859536|NCT02638103|463780080|FG003|Overall Study|Lost to Follow-up|37|||
128859537|NCT02638103|463780077|FG000|Overall Study|Lack of Efficacy|14|||
128859538|NCT02638103|463780078|FG001|Overall Study|Lack of Efficacy|10|||
128859539|NCT02638103|463780079|FG002|Overall Study|Lack of Efficacy|12|||
128859540|NCT02638103|463780080|FG003|Overall Study|Lack of Efficacy|22|||
128859541|NCT02638103|463780077|FG000|Overall Study|Other than specified|5|||
128859542|NCT02638103|463780078|FG001|Overall Study|Other than specified|4|||
128859543|NCT02638103|463780079|FG002|Overall Study|Other than specified|2|||
128859544|NCT02638103|463780080|FG003|Overall Study|Other than specified|4|||
128859545|NCT01262092|463780083|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
128859546|NCT01262092|463780084|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
128859547|NCT01262092|463780083|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
128859548|NCT01262092|463780084|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
128859549|NCT01262092|463780083|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
128859550|NCT01262092|463780084|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
128859551|NCT01262092|463780083|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
128859552|NCT01262092|463780084|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
128859553|NCT03784820|463780085|FG000|Overall Study|Lost to Follow-up|5|||
128859554|NCT03784820|463780086|FG001|Overall Study|Lost to Follow-up|5|||
128859555|NCT03784820|463780087|FG002|Overall Study|Lost to Follow-up|3|||
128859556|NCT03784820|463780088|FG003|Overall Study|Lost to Follow-up|3|||
128859557|NCT04147858|463780089|FG000|Overall Study|Adverse Event|6|||
128859558|NCT04147858|463780090|FG001|Overall Study|Adverse Event|6|||
128859559|NCT04147858|463780091|FG002|Overall Study|Adverse Event|6|||
128859560|NCT04147858|463780089|FG000|Overall Study|Lack of Efficacy|3|||
128859561|NCT04147858|463780090|FG001|Overall Study|Lack of Efficacy|3|||
128859562|NCT04147858|463780091|FG002|Overall Study|Lack of Efficacy|1|||
128859563|NCT04147858|463780089|FG000|Overall Study|Lost to Follow-up|1|||
128859564|NCT04147858|463780090|FG001|Overall Study|Lost to Follow-up|6|||
128859565|NCT04147858|463780091|FG002|Overall Study|Lost to Follow-up|2|||
128859566|NCT04147858|463780089|FG000|Overall Study|Withdrawal by Subject|3|||
128859567|NCT04147858|463780090|FG001|Overall Study|Withdrawal by Subject|4|||
128859568|NCT04147858|463780091|FG002|Overall Study|Withdrawal by Subject|10|||
128859569|NCT04147858|463780089|FG000|Overall Study|Subject Noncompliance, Other|4|||
128859570|NCT04147858|463780090|FG001|Overall Study|Subject Noncompliance, Other|3|||
128859571|NCT04147858|463780091|FG002|Overall Study|Subject Noncompliance, Other|1|||
128859572|NCT00365547|463780098|FG000|Overall Study|Insurance did not cover Avastin|1|||
128859573|NCT00365547|463780098|FG000|Overall Study|Screen failure|1|||
128859574|NCT00365547|463780098|FG000|Overall Study|Withdrawal by Subject|1|||
128859575|NCT04428476|463780099|FG000|Overall Study|Withdrawal by Subject|1|||
128859576|NCT04428476|463780099|FG000|Overall Study|Still on treatment|12|||
128859577|NCT03023423|463780100|FG000|Overall Study|Death|5|||
128859578|NCT03023423|463780101|FG001|Overall Study|Death|12|||
128859579|NCT03023423|463780102|FG002|Overall Study|Death|20|||
128859580|NCT03023423|463780100|FG000|Overall Study|Other|0|||
128859581|NCT03023423|463780101|FG001|Overall Study|Other|2|||
128859582|NCT03023423|463780102|FG002|Overall Study|Other|2|||
128859583|NCT03023423|463780100|FG000|Overall Study|Ongoing|2|||
128859584|NCT03023423|463780101|FG001|Overall Study|Ongoing|32|||
128859585|NCT03023423|463780102|FG002|Overall Study|Ongoing|24|||
128859586|NCT03512197|463780103|FG000|Overall Study|Guardian decision|1|||
128859587|NCT03512197|463780104|FG001|Overall Study|Guardian decision|1|||
128859588|NCT03512197|463780103|FG000|Overall Study|Lack of Efficacy|19|||
128859589|NCT03512197|463780104|FG001|Overall Study|Lack of Efficacy|11|||
128859590|NCT03512197|463780103|FG000|Overall Study|New Therapy for Study Indication|16|||
128859591|NCT03512197|463780104|FG001|Overall Study|New Therapy for Study Indication|16|||
128859592|NCT03512197|463780103|FG000|Overall Study|Physician Decision|60|||
128859593|NCT03512197|463780104|FG001|Overall Study|Physician Decision|60|||
128859594|NCT03512197|463780103|FG000|Overall Study|Protocol Violation|0|||
128859595|NCT03512197|463780104|FG001|Overall Study|Protocol Violation|2|||
128859596|NCT03512197|463780103|FG000|Overall Study|Terminated by Sponsored|46|||
128859597|NCT03512197|463780104|FG001|Overall Study|Terminated by Sponsored|50|||
128859598|NCT03512197|463780103|FG000|Overall Study|Subject Decision|15|||
128859599|NCT03512197|463780104|FG001|Overall Study|Subject Decision|12|||
128859600|NCT03512197|463780103|FG000|Overall Study|Withdrawal of informed consent|20|||
128859601|NCT03512197|463780104|FG001|Overall Study|Withdrawal of informed consent|14|||
128859602|NCT03512197|463780103|FG000|Overall Study|Adverse Event|30|||
128859603|NCT03512197|463780104|FG001|Overall Study|Adverse Event|34|||
128859604|NCT03512197|463780103|FG000|Overall Study|Death|14|||
128859605|NCT03512197|463780104|FG001|Overall Study|Death|9|||
128859606|NCT03512197|463780103|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
128859607|NCT03512197|463780104|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
128859608|NCT03512197|463780103|FG000|Overall Study|Missing|3|||
128859609|NCT03512197|463780104|FG001|Overall Study|Missing|13|||
128859610|NCT03842436|463780105|FG000|Overall Study|Lost to Follow-up|1|||
128859611|NCT00490698|463780106|FG000|Overall Study|Withdrawal by Subject|1|||
128859612|NCT00490698|463780106|FG000|Overall Study|Disease Progression|7|||
128859613|NCT00490698|463780106|FG000|Overall Study|Physician Decision|2|||
128859614|NCT01431950|463780108|FG000|Overall Study|Study Site Closed/Terminated|7|||
128859615|NCT01431950|463780109|FG001|Overall Study|Study Site Closed/Terminated|3|||
128859616|NCT01431950|463780108|FG000|Overall Study|Withdrawal by Subject|4|||
128859617|NCT01431950|463780109|FG001|Overall Study|Withdrawal by Subject|3|||
128859618|NCT01431950|463780108|FG000|Overall Study|Protocol Violation|2|||
128859619|NCT01431950|463780109|FG001|Overall Study|Protocol Violation|3|||
128859620|NCT01431950|463780108|FG000|Overall Study|Adverse Event|2|||
128859621|NCT01431950|463780109|FG001|Overall Study|Adverse Event|2|||
128859622|NCT01431950|463780108|FG000|Overall Study|Physician Decision|2|||
128859623|NCT01431950|463780109|FG001|Overall Study|Physician Decision|1|||
128859624|NCT01431950|463780108|FG000|Overall Study|Lack of Efficacy|2|||
128859625|NCT01431950|463780109|FG001|Overall Study|Lack of Efficacy|1|||
128859626|NCT01431950|463780108|FG000|Overall Study|Lost to Follow-up|0|||
128859627|NCT01431950|463780109|FG001|Overall Study|Lost to Follow-up|1|||
128859628|NCT01431950|463780108|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
128859629|NCT01431950|463780109|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
128859630|NCT03020069|463782116|FG000|Overall Study|Lost to Follow-up|0|||
128859631|NCT03020069|463782117|FG001|Overall Study|Lost to Follow-up|1|||
128859632|NCT01439867|463782118|FG000|Overall Study|Non-compliance|0|||
128859633|NCT01439867|463782119|FG001|Overall Study|Non-compliance|1|||
128859634|NCT01439867|463782118|FG000|Overall Study|Withdrawal by Subject|1|||
128859635|NCT01439867|463782119|FG001|Overall Study|Withdrawal by Subject|2|||
128859636|NCT01439867|463782118|FG000|Overall Study|Administrative Decision|4|||
128859637|NCT01439867|463782119|FG001|Overall Study|Administrative Decision|5|||
128859638|NCT01439867|463782118|FG000|Overall Study|Protocol-specified Criteria|1|||
128859639|NCT01439867|463782119|FG001|Overall Study|Protocol-specified Criteria|0|||
128859640|NCT00863512|463782120|FG000|Overall Study|Adverse Event|2|||
128859641|NCT00863512|463782121|FG001|Overall Study|Adverse Event|0|||
128859642|NCT00863512|463782120|FG000|Overall Study|Withdrawal by Subject|11|||
128859643|NCT00863512|463782121|FG001|Overall Study|Withdrawal by Subject|0|||
128859644|NCT00863512|463782120|FG000|Overall Study|Physician Decision|1|||
128859645|NCT00863512|463782121|FG001|Overall Study|Physician Decision|0|||
128859646|NCT02037477|463782122|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
128859647|NCT02037477|463782123|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
128859648|NCT02037477|463782124|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
128859649|NCT02037477|463782125|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
128859650|NCT02635360|463782126|FG000|Overall Study|Adverse Event|0|||
128859651|NCT02635360|463782127|FG001|Overall Study|Adverse Event|3|||
128859652|NCT02635360|463782126|FG000|Overall Study|Withdrawal by Subject|2|||
128859653|NCT02635360|463782127|FG001|Overall Study|Withdrawal by Subject|0|||
128859654|NCT02635360|463782126|FG000|Overall Study|Non-Compliance|3|||
128859655|NCT02635360|463782127|FG001|Overall Study|Non-Compliance|1|||
128859656|NCT02635360|463782126|FG000|Overall Study|Disease Progression|0|||
128859657|NCT02635360|463782127|FG001|Overall Study|Disease Progression|2|||
128859658|NCT02635360|463782126|FG000|Overall Study|Lost to Follow-up|1|||
128859659|NCT02635360|463782127|FG001|Overall Study|Lost to Follow-up|1|||
128859660|NCT04978350|463782128|FG000|Overall Study|Lost to Follow-up|6|||
128859661|NCT00983749|463782131|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
128859662|NCT00983749|463782132|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
128859663|NCT01952847|463782133|FG000|Overall Study|Ineligible|1|||
128859664|NCT01952847|463782134|FG001|Overall Study|Ineligible|0|||
128859665|NCT01952847|463782135|FG002|Overall Study|Ineligible|0|||
128859666|NCT01952847|463782136|FG003|Overall Study|Ineligible|0|||
128859667|NCT01952847|463782133|FG000|Overall Study|Lack of Insurance Coverage|0|||
128859668|NCT01952847|463782134|FG001|Overall Study|Lack of Insurance Coverage|1|||
128859669|NCT01952847|463782135|FG002|Overall Study|Lack of Insurance Coverage|0|||
128859670|NCT01952847|463782136|FG003|Overall Study|Lack of Insurance Coverage|0|||
128859671|NCT01952847|463782133|FG000|Overall Study|Withdrawal by Subject|1|||
128859672|NCT01952847|463782134|FG001|Overall Study|Withdrawal by Subject|1|||
128859673|NCT01952847|463782135|FG002|Overall Study|Withdrawal by Subject|0|||
128859674|NCT01952847|463782136|FG003|Overall Study|Withdrawal by Subject|1|||
128859675|NCT01907906|463782137|FG000|Overall Study|Withdrawal by Subject|1|||
128859676|NCT01907906|463782138|FG001|Overall Study|Withdrawal by Subject|0|||
128859677|NCT01907906|463782137|FG000|Overall Study|Physician Decision|3|||
128859678|NCT01907906|463782138|FG001|Overall Study|Physician Decision|1|||
128859679|NCT02577003|463782141|FG000|Overall Study|Adverse Event|2|||
128859680|NCT02577003|463782142|FG001|Overall Study|Adverse Event|4|||
128859681|NCT02577003|463782141|FG000|Overall Study|Withdrawal by Subject|0|||
128859682|NCT02577003|463782142|FG001|Overall Study|Withdrawal by Subject|1|||
128859683|NCT02786004|463782143|FG000|Overall Study|Withdrawal by Subject|0|||
128859684|NCT02786004|463782144|FG001|Overall Study|Withdrawal by Subject|1|||
128859685|NCT00490945|463782146|FG000|Overall Study|Adverse Event|0|||
128859686|NCT00490945|463782147|FG001|Overall Study|Adverse Event|1|||
128859687|NCT00490945|463782148|FG002|Overall Study|Adverse Event|0|||
128859688|NCT00490945|463782149|FG003|Overall Study|Adverse Event|0|||
128859689|NCT00490945|463782150|FG004|Overall Study|Adverse Event|0|||
128859690|NCT03334253|463782151|FG000|Overall Study|Withdrawal by Subject|1|||
128859691|NCT03334253|463782152|FG001|Overall Study|Withdrawal by Subject|0|||
128859692|NCT03334253|463782151|FG000|Overall Study|Lost to Follow-up|4|||
128859693|NCT03334253|463782152|FG001|Overall Study|Lost to Follow-up|3|||
128859694|NCT03334253|463782151|FG000|Overall Study|Moved residence|2|||
128859695|NCT03334253|463782152|FG001|Overall Study|Moved residence|2|||
128859696|NCT00203047|463782153|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
128859697|NCT00203047|463782154|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
128859698|NCT00203047|463782153|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
128859699|NCT00203047|463782154|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
128859700|NCT00203047|463782153|FG000|Overall Study|Withdrawal by Subject|13|||
128859701|NCT00203047|463782154|FG001|Overall Study|Withdrawal by Subject|47|||
128859702|NCT00203047|463782153|FG000|Overall Study|Teva requested participant withdrawal|1|||
128859703|NCT00203047|463782154|FG001|Overall Study|Teva requested participant withdrawal|1|||
128859704|NCT00203047|463782153|FG000|Overall Study|Physician Decision|8|||
128859705|NCT00203047|463782154|FG001|Overall Study|Physician Decision|7|||
128859706|NCT00203047|463782153|FG000|Overall Study|Non-compliance|4|||
128859707|NCT00203047|463782154|FG001|Overall Study|Non-compliance|8|||
128859708|NCT00203047|463782153|FG000|Overall Study|Protocol Violation|1|||
128859709|NCT00203047|463782154|FG001|Overall Study|Protocol Violation|0|||
128859710|NCT00203047|463782153|FG000|Overall Study|Lost to Follow-up|11|||
128859711|NCT00203047|463782154|FG001|Overall Study|Lost to Follow-up|5|||
128859712|NCT00203047|463782153|FG000|Overall Study|Adverse Event|8|||
128859713|NCT00203047|463782154|FG001|Overall Study|Adverse Event|18|||
128859714|NCT00203047|463782153|FG000|Overall Study|Death|1|||
128859715|NCT00203047|463782154|FG001|Overall Study|Death|2|||
128859716|NCT00203047|463782153|FG000|Overall Study|Pregnancy|3|||
128859717|NCT00203047|463782154|FG001|Overall Study|Pregnancy|0|||
128859718|NCT00203047|463782153|FG000|Overall Study|Other|5|||
128859719|NCT00203047|463782154|FG001|Overall Study|Other|5|||
128859720|NCT00340704|463782157|FG000|PK Study|Adverse Event|0|||
128859721|NCT00340704|463782158|FG001|PK Study|Adverse Event|1|||
128859722|NCT00340704|463782159|FG002|PK Study|Adverse Event|0|||
128859723|NCT00340704|463782160|FG003|PK Study|Adverse Event|0|||
128859724|NCT00340704|463782161|FG004|PK Study|Adverse Event|0|||
128859725|NCT00340704|463782162|FG005|PK Study|Adverse Event|0|||
128859726|NCT00340704|463782163|FG006|PK Study|Adverse Event|0|||
128859727|NCT00340704|463782164|FG007|PK Study|Adverse Event|0|||
128859728|NCT00340704|463782165|FG008|PK Study|Adverse Event|0|||
128859729|NCT00340704|463782157|FG000|PK Study|Not treated|0|||
128859730|NCT00340704|463782158|FG001|PK Study|Not treated|0|||
128859731|NCT00340704|463782159|FG002|PK Study|Not treated|1|||
128859732|NCT00340704|463782160|FG003|PK Study|Not treated|0|||
128859733|NCT00340704|463782161|FG004|PK Study|Not treated|0|||
128859734|NCT00340704|463782162|FG005|PK Study|Not treated|0|||
128859735|NCT00340704|463782163|FG006|PK Study|Not treated|0|||
128859736|NCT00340704|463782164|FG007|PK Study|Not treated|0|||
128859737|NCT00340704|463782165|FG008|PK Study|Not treated|0|||
128859738|NCT00340704|463782157|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
128859739|NCT00340704|463782158|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
128859740|NCT00340704|463782159|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
128859741|NCT00340704|463782160|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
128859742|NCT00340704|463782161|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
128859743|NCT00340704|463782162|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
128859744|NCT00340704|463782163|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
128859745|NCT00340704|463782164|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
128859746|NCT00340704|463782165|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
128859747|NCT00340704|463782157|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859748|NCT00340704|463782158|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859749|NCT00340704|463782159|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859750|NCT00340704|463782160|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859751|NCT00340704|463782161|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859752|NCT00340704|463782162|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
128859753|NCT00340704|463782163|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859754|NCT00340704|463782164|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859755|NCT00340704|463782165|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
128859756|NCT00340704|463782157|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
128859757|NCT00340704|463782158|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
128859758|NCT00340704|463782159|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
128859759|NCT00340704|463782160|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
128859760|NCT00340704|463782161|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
128859761|NCT00340704|463782162|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
128859762|NCT00340704|463782163|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
128859763|NCT00340704|463782164|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
128859764|NCT00340704|463782165|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
128859765|NCT00340704|463782157|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
128859766|NCT00340704|463782158|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
128859767|NCT00340704|463782159|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
128859768|NCT00340704|463782160|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
128859769|NCT00340704|463782161|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
128859770|NCT00340704|463782162|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
128859771|NCT00340704|463782163|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
128859772|NCT00340704|463782164|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
128859773|NCT00340704|463782165|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
128859774|NCT00121667|463782166|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
128859775|NCT00121667|463782167|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
128859776|NCT00121667|463782168|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
128859777|NCT00121667|463782169|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
128859778|NCT00121667|463782166|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
128859779|NCT00121667|463782167|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
128859780|NCT00121667|463782168|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
128859781|NCT00121667|463782169|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
128859782|NCT00121667|463782166|FG000|Short Term (ST) Period|Adverse Event|5|||
128859783|NCT00121667|463782167|FG001|Short Term (ST) Period|Adverse Event|6|||
128859784|NCT00121667|463782168|FG002|Short Term (ST) Period|Adverse Event|5|||
128859785|NCT00121667|463782169|FG003|Short Term (ST) Period|Adverse Event|3|||
128859786|NCT00121667|463782166|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
128859787|NCT00121667|463782167|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
128859788|NCT00121667|463782168|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
128859789|NCT00121667|463782169|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
128859790|NCT00121667|463782166|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
128859791|NCT00121667|463782167|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
128859792|NCT00121667|463782168|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
128859793|NCT00121667|463782169|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
128859794|NCT00121667|463782166|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
128859795|NCT00121667|463782167|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
128859796|NCT00121667|463782168|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
128859797|NCT00121667|463782169|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
128859798|NCT00121667|463782166|FG000|Short Term (ST) Period|Other Reason|3|||
128859799|NCT00121667|463782167|FG001|Short Term (ST) Period|Other Reason|0|||
128859800|NCT00121667|463782168|FG002|Short Term (ST) Period|Other Reason|0|||
128859801|NCT00121667|463782169|FG003|Short Term (ST) Period|Other Reason|0|||
128859802|NCT00121667|463782166|FG000|Short Term (ST) Period|Death|0|||
128859803|NCT00121667|463782167|FG001|Short Term (ST) Period|Death|0|||
128859804|NCT00121667|463782168|FG002|Short Term (ST) Period|Death|0|||
128859805|NCT00121667|463782169|FG003|Short Term (ST) Period|Death|1|||
128859806|NCT00121667|463782166|FG000|Short Term (ST) Period|Pregnancy|0|||
128859807|NCT00121667|463782167|FG001|Short Term (ST) Period|Pregnancy|0|||
128859808|NCT00121667|463782168|FG002|Short Term (ST) Period|Pregnancy|0|||
128859809|NCT00121667|463782169|FG003|Short Term (ST) Period|Pregnancy|1|||
128859810|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
128859811|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
128859812|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
128859813|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
128859814|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
128859815|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
128859816|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
128859817|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
128859818|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
128859819|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
128859820|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
128859821|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
128859822|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
128859823|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
128859824|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
128859825|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
128859826|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
128859827|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
128859828|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
128859829|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
128859830|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
128859831|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
128859832|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
128859833|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
128859834|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
128859835|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
128859836|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
128859837|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
128859838|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
128859839|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
128859840|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
128859841|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
128859842|NCT00121667|463782166|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
128859843|NCT00121667|463782167|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
128859844|NCT00121667|463782168|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
128859845|NCT00121667|463782169|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
128859846|NCT01453023|463782170|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
128859847|NCT01453023|463782171|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
128859848|NCT01453023|463782170|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
128859849|NCT01453023|463782171|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
128859850|NCT01453023|463782170|FG000|Treatment Period 2|Protocol Violation|0|||
128859851|NCT01453023|463782171|FG001|Treatment Period 2|Protocol Violation|1|||
128859852|NCT02879383|463782172|FG000|First 24 Weeks|Physician Decision|0|||
128859853|NCT02879383|463782173|FG001|First 24 Weeks|Physician Decision|1|||
128859854|NCT02879383|463782174|FG002|First 24 Weeks|Physician Decision|0|||
128859855|NCT02879383|463782175|FG003|First 24 Weeks|Physician Decision|0|||
128859856|NCT02413593|463782189|FG000|Overall Study|Lost to Follow-up|3|||
128859857|NCT02413593|463782189|FG000|Overall Study|Adverse Event|1|||
128859858|NCT00478205|463782190|FG000|Overall Study|Adverse Event|182|||
128859859|NCT00478205|463782191|FG001|Overall Study|Adverse Event|39|||
128859860|NCT00478205|463782190|FG000|Overall Study|Medication Non-compliance|9|||
128859861|NCT00478205|463782191|FG001|Overall Study|Medication Non-compliance|4|||
128859862|NCT00478205|463782190|FG000|Overall Study|Protocol Violation|15|||
128859863|NCT00478205|463782191|FG001|Overall Study|Protocol Violation|5|||
128859864|NCT00478205|463782190|FG000|Overall Study|Request of Investigator or Sponsor|4|||
128859865|NCT00478205|463782191|FG001|Overall Study|Request of Investigator or Sponsor|5|||
128859866|NCT00478205|463782190|FG000|Overall Study|Withdrawal by Subject|61|||
128859867|NCT00478205|463782191|FG001|Overall Study|Withdrawal by Subject|22|||
128859868|NCT00478205|463782190|FG000|Overall Study|Lack of Efficacy|1|||
128859869|NCT00478205|463782191|FG001|Overall Study|Lack of Efficacy|0|||
128859870|NCT00478205|463782190|FG000|Overall Study|Other|24|||
128859871|NCT00478205|463782191|FG001|Overall Study|Other|12|||
128859872|NCT03513068|463782192|FG000|Overall Study|Death|1|||
128859873|NCT03513068|463782193|FG001|Overall Study|Death|0|||
128859874|NCT03513068|463782192|FG000|Overall Study|Withdrawal by Subject|4|||
128859875|NCT03513068|463782193|FG001|Overall Study|Withdrawal by Subject|6|||
128859876|NCT01012947|463782194|FG000|Overall Study|Lost to Follow-up|131|||
128859877|NCT01012947|463782195|FG001|Overall Study|Lost to Follow-up|135|||
128859878|NCT01012947|463782196|FG002|Overall Study|Lost to Follow-up|130|||
128859879|NCT01012947|463782197|FG003|Overall Study|Lost to Follow-up|118|||
128859880|NCT01012947|463782198|FG004|Overall Study|Lost to Follow-up|142|||
128859881|NCT01791413|463782199|FG000|Overall Study|Lost to Follow-up|5|||
128859882|NCT01791413|463782200|FG001|Overall Study|Lost to Follow-up|1|||
128859883|NCT04016272|463782203|FG000|Overall Study|Withdrawal by Subject|1|||
128859884|NCT04016272|463782204|FG001|Overall Study|Withdrawal by Subject|2|||
128859885|NCT00825305|463782205|FG000|Overall Study|Adverse Event|1|||
128859886|NCT00825305|463782206|FG001|Overall Study|Adverse Event|1|||
128859887|NCT00825305|463782205|FG000|Overall Study|Withdrawal by Subject|6|||
128859888|NCT00825305|463782206|FG001|Overall Study|Withdrawal by Subject|12|||
128859889|NCT00825305|463782205|FG000|Overall Study|Inappropriate inclusion|1|||
128859890|NCT00825305|463782206|FG001|Overall Study|Inappropriate inclusion|0|||
128859891|NCT00825305|463782205|FG000|Overall Study|Protocol Violation|9|||
128859892|NCT00825305|463782206|FG001|Overall Study|Protocol Violation|9|||
128859893|NCT00825305|463782205|FG000|Overall Study|Can not be classified|0|||
128859894|NCT00825305|463782206|FG001|Overall Study|Can not be classified|1|||
128859895|NCT00965497|463782209|FG000|Overall Study|Physician Decision|1|||
128859896|NCT00246090|463782214|FG000|Overall Study|Adverse Event|25|||
128859897|NCT00246090|463782214|FG000|Overall Study|Withdrawal by Subject|7|||
128859898|NCT00246090|463782214|FG000|Overall Study|Progressive Disease|212|||
128859899|NCT00246090|463782214|FG000|Overall Study|Clinical Progression|30|||
128859900|NCT00246090|463782214|FG000|Overall Study|Physician Decision|11|||
128859901|NCT00246090|463782214|FG000|Overall Study|Not Otherwise Specified|10|||
128859902|NCT02165826|463782222|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
128859903|NCT02165826|463782223|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
128859904|NCT02165826|463782224|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
128859905|NCT02165826|463782222|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
128859906|NCT02165826|463782223|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
128859907|NCT02165826|463782224|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
128859908|NCT02165826|463782222|FG000|Main Treatment Period|Lost to Follow-up|4|||
128859909|NCT02165826|463782223|FG001|Main Treatment Period|Lost to Follow-up|2|||
128859910|NCT02165826|463782224|FG002|Main Treatment Period|Lost to Follow-up|1|||
128859911|NCT02165826|463782222|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
128859912|NCT02165826|463782223|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
128859913|NCT02165826|463782224|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
128859914|NCT02165826|463782222|FG000|Main Treatment Period|Lack of Efficacy|2|||
128859915|NCT02165826|463782223|FG001|Main Treatment Period|Lack of Efficacy|0|||
128859916|NCT02165826|463782224|FG002|Main Treatment Period|Lack of Efficacy|0|||
128859917|NCT02165826|463782222|FG000|Main Treatment Period|Reason Not Specified|8|||
128859918|NCT02165826|463782223|FG001|Main Treatment Period|Reason Not Specified|5|||
128859919|NCT02165826|463782224|FG002|Main Treatment Period|Reason Not Specified|16|||
128859920|NCT02165826|463782222|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
128859921|NCT02165826|463782223|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
128859922|NCT02165826|463782224|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
128859923|NCT02165826|463782222|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
128859924|NCT02165826|463782223|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
128859925|NCT02165826|463782224|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
128859926|NCT02165826|463782222|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
128859927|NCT02165826|463782223|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
128859928|NCT02165826|463782224|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
128859929|NCT02165826|463782222|FG000|Down-Titration Period|Reason Not Specified|1|||
128859930|NCT02165826|463782223|FG001|Down-Titration Period|Reason Not Specified|0|||
128859931|NCT02165826|463782224|FG002|Down-Titration Period|Reason Not Specified|2|||
128859932|NCT04547023|463782227|FG000|Overall Study|Did Not Receive Intervention|3|||
128859933|NCT04547023|463782228|FG001|Overall Study|Did Not Receive Intervention|2|||
128859934|NCT04547023|463782227|FG000|Overall Study|Lost to Follow-up|1|||
128859935|NCT04547023|463782228|FG001|Overall Study|Lost to Follow-up|1|||
128859936|NCT00250432|463782229|FG000|Overall Study|Adverse Event|25|||
128859937|NCT00250432|463782230|FG001|Overall Study|Adverse Event|29|||
128859938|NCT00250432|463782229|FG000|Overall Study|Lack of Efficacy|2|||
128859939|NCT00250432|463782230|FG001|Overall Study|Lack of Efficacy|1|||
128859940|NCT00250432|463782229|FG000|Overall Study|Lost to Follow-up|6|||
128859941|NCT00250432|463782230|FG001|Overall Study|Lost to Follow-up|5|||
128859942|NCT00250432|463782229|FG000|Overall Study|Patient Moved|0|||
128859943|NCT00250432|463782230|FG001|Overall Study|Patient Moved|1|||
128859944|NCT00250432|463782229|FG000|Overall Study|Protocol Violation|0|||
128859945|NCT00250432|463782230|FG001|Overall Study|Protocol Violation|3|||
128859946|NCT00250432|463782229|FG000|Overall Study|Withdrawal by Subject|6|||
128859947|NCT00250432|463782230|FG001|Overall Study|Withdrawal by Subject|2|||
128859948|NCT00250432|463782229|FG000|Overall Study|Pt died out of posttherapy report period|6|||
128859949|NCT00250432|463782230|FG001|Overall Study|Pt died out of posttherapy report period|5|||
128859950|NCT00250432|463782229|FG000|Overall Study|Pt was considered untreatable|0|||
128859951|NCT00250432|463782230|FG001|Overall Study|Pt was considered untreatable|1|||
128859952|NCT00658606|463782231|FG000|Overall Study|Adverse Event|2|||
128859953|NCT00658606|463782232|FG001|Overall Study|Adverse Event|1|||
128859954|NCT00658606|463782231|FG000|Overall Study|Lack of Efficacy|6|||
128859955|NCT00658606|463782232|FG001|Overall Study|Lack of Efficacy|3|||
128859956|NCT00658606|463782231|FG000|Overall Study|Lost to Follow-up|1|||
128859957|NCT00658606|463782232|FG001|Overall Study|Lost to Follow-up|0|||
128859958|NCT00658606|463782231|FG000|Overall Study|Withdrawal by Subject|7|||
128859959|NCT00658606|463782232|FG001|Overall Study|Withdrawal by Subject|16|||
128859960|NCT00658606|463782231|FG000|Overall Study|Lack of Compliance|0|||
128859961|NCT00658606|463782232|FG001|Overall Study|Lack of Compliance|3|||
128859962|NCT03170518|463782233|FG000|Overall Study|Lost to Follow-up|4|||
128859963|NCT03170518|463782234|FG001|Overall Study|Lost to Follow-up|1|||
128859964|NCT03170518|463782235|FG002|Overall Study|Lost to Follow-up|0|||
128859965|NCT03170518|463782233|FG000|Overall Study|Physician Decision|1|||
128859966|NCT03170518|463782234|FG001|Overall Study|Physician Decision|0|||
128859967|NCT03170518|463782235|FG002|Overall Study|Physician Decision|0|||
128859968|NCT03170518|463782233|FG000|Overall Study|Withdrawal by Subject|4|||
128859969|NCT03170518|463782234|FG001|Overall Study|Withdrawal by Subject|5|||
128859970|NCT03170518|463782235|FG002|Overall Study|Withdrawal by Subject|2|||
128859971|NCT03170518|463782233|FG000|Overall Study|Site terminated by sponsor|0|||
128859972|NCT03170518|463782234|FG001|Overall Study|Site terminated by sponsor|1|||
128859973|NCT03170518|463782235|FG002|Overall Study|Site terminated by sponsor|0|||
128859974|NCT03170518|463782233|FG000|Overall Study|Non-compliance with study drug|1|||
128859975|NCT03170518|463782234|FG001|Overall Study|Non-compliance with study drug|0|||
128859976|NCT03170518|463782235|FG002|Overall Study|Non-compliance with study drug|1|||
128859977|NCT03170518|463782233|FG000|Overall Study|Withdrawal by parent/guardian|2|||
128859978|NCT03170518|463782234|FG001|Overall Study|Withdrawal by parent/guardian|0|||
128859979|NCT03170518|463782235|FG002|Overall Study|Withdrawal by parent/guardian|0|||
128859980|NCT00546078|463782236|FG000|Overall Study|Lost to Follow-up|1|||
128859981|NCT00546078|463782237|FG001|Overall Study|Lost to Follow-up|3|||
128859982|NCT00546078|463782236|FG000|Overall Study|Withdrawal by Subject|2|||
128859983|NCT00546078|463782237|FG001|Overall Study|Withdrawal by Subject|3|||
128859984|NCT00546078|463782236|FG000|Overall Study|Other reason|1|||
128859985|NCT00546078|463782237|FG001|Overall Study|Other reason|1|||
128859986|NCT03358238|463782244|FG000|Overall Study|Withdrawal by Subject|0|||
128859987|NCT03358238|463782245|FG001|Overall Study|Withdrawal by Subject|1|||
128859988|NCT00583947|463782246|FG000|Cross-over Period|Adverse Event|2|||
128859989|NCT00583947|463782247|FG001|Cross-over Period|Adverse Event|0|||
128859990|NCT00583947|463782246|FG000|Cross-over Period|Withdrawal by Subject|2|||
128859991|NCT00583947|463782247|FG001|Cross-over Period|Withdrawal by Subject|0|||
128859992|NCT00583947|463782246|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
128859993|NCT00583947|463782247|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
128859994|NCT00583947|463782246|FG000|Cross-over Period|Other|1|||
128859995|NCT00583947|463782247|FG001|Cross-over Period|Other|1|||
128859996|NCT01740154|463782249|FG000|Overall Study|Adverse Event|1|||
128859997|NCT00469859|463782250|FG000|Overall Study|Inevaluable|0|||
128859998|NCT00469859|463782251|FG001|Overall Study|Inevaluable|2|||
128859999|NCT02520310|463782252|FG000|At 6 Months Clinical Follow-up|Death|1|||
128860000|NCT02520310|463782252|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
128860001|NCT02520310|463782252|FG000|AT 3 Year Clinical Follow-up|Death|2|||
128860002|NCT02520310|463782252|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
128860003|NCT02520310|463782252|FG000|AT 4 Year Clinical Follow-up|Death|1|||
128860004|NCT02520310|463782252|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
128860005|NCT01340014|463782253|FG000|Period 1, First 7 Days|Adverse Event|1|||
128860006|NCT01340014|463782254|FG001|Period 1, First 7 Days|Adverse Event|0|||
128860007|NCT01340014|463782253|FG000|Period 1, First 7 Days|Personal Reasons|1|||
128860008|NCT01340014|463782254|FG001|Period 1, First 7 Days|Personal Reasons|0|||
128860009|NCT01340014|463782253|FG000|Period 2, Second 7 Days|Adverse Event|0|||
128860010|NCT01340014|463782254|FG001|Period 2, Second 7 Days|Adverse Event|1|||
128860011|NCT04535544|463782256|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
128860012|NCT04535544|463782257|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
128860013|NCT04535544|463782258|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
128860014|NCT04535544|463782259|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
128860015|NCT04535544|463782256|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
128860016|NCT04535544|463782257|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
128860017|NCT04535544|463782258|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
128860018|NCT04535544|463782259|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
128860019|NCT04535544|463782256|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
128860020|NCT04535544|463782257|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
128860021|NCT04535544|463782258|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
128860022|NCT04535544|463782259|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
128860023|NCT04535544|463782256|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
128860024|NCT04535544|463782257|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
128860025|NCT04535544|463782258|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
128860026|NCT04535544|463782259|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
128860027|NCT04535544|463782256|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
128860028|NCT04535544|463782257|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
128860029|NCT04535544|463782258|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
128860030|NCT04535544|463782259|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
128860031|NCT04535544|463782256|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
128860032|NCT04535544|463782257|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
128860033|NCT04535544|463782258|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
128860034|NCT04535544|463782259|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
128860035|NCT04535544|463782256|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
128860036|NCT04535544|463782257|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
128860037|NCT04535544|463782258|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
128860038|NCT04535544|463782259|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
128860039|NCT04535544|463782256|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
128860040|NCT04535544|463782257|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
128860041|NCT04535544|463782258|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
128860042|NCT04535544|463782259|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
128860043|NCT05131477|463782266|FG000|PART 1|Withdrawal by Subject|2|||
128860044|NCT05131477|463782267|FG001|PART 1|Withdrawal by Subject|9|||
128860045|NCT05131477|463782268|FG002|PART 1|Withdrawal by Subject|6|||
128860046|NCT05131477|463782269|FG003|PART 1|Withdrawal by Subject|2|||
128860047|NCT05131477|463782270|FG004|PART 1|Withdrawal by Subject|8|||
128860048|NCT05131477|463782271|FG005|PART 1|Withdrawal by Subject|0|||
128860049|NCT05131477|463782272|FG006|PART 1|Withdrawal by Subject|0|||
128860050|NCT05131477|463782273|FG007|PART 1|Withdrawal by Subject|0|||
128860051|NCT05131477|463782274|FG008|PART 1|Withdrawal by Subject|0|||
128860052|NCT05131477|463782275|FG009|PART 1|Withdrawal by Subject|0|||
128860053|NCT05131477|463782276|FG010|PART 1|Withdrawal by Subject|0|||
128860054|NCT05131477|463782277|FG011|PART 1|Withdrawal by Subject|0|||
128860055|NCT05131477|463782278|FG012|PART 1|Withdrawal by Subject|0|||
128860056|NCT05131477|463782279|FG013|PART 1|Withdrawal by Subject|0|||
128860057|NCT05131477|463782266|FG000|PART 1|Physician Decision|1|||
128860058|NCT05131477|463782267|FG001|PART 1|Physician Decision|0|||
128860059|NCT05131477|463782268|FG002|PART 1|Physician Decision|0|||
128860060|NCT05131477|463782269|FG003|PART 1|Physician Decision|0|||
128860061|NCT05131477|463782270|FG004|PART 1|Physician Decision|0|||
128860062|NCT05131477|463782271|FG005|PART 1|Physician Decision|0|||
128860063|NCT05131477|463782272|FG006|PART 1|Physician Decision|0|||
128860064|NCT05131477|463782273|FG007|PART 1|Physician Decision|0|||
128860065|NCT05131477|463782274|FG008|PART 1|Physician Decision|0|||
128860066|NCT05131477|463782275|FG009|PART 1|Physician Decision|0|||
128860067|NCT05131477|463782276|FG010|PART 1|Physician Decision|0|||
128860068|NCT05131477|463782277|FG011|PART 1|Physician Decision|0|||
128860069|NCT05131477|463782278|FG012|PART 1|Physician Decision|0|||
128860070|NCT05131477|463782279|FG013|PART 1|Physician Decision|0|||
128860071|NCT05131477|463782266|FG000|PART 1|Adverse Event|3|||
128860072|NCT05131477|463782267|FG001|PART 1|Adverse Event|5|||
128860073|NCT05131477|463782268|FG002|PART 1|Adverse Event|1|||
128860074|NCT05131477|463782269|FG003|PART 1|Adverse Event|6|||
128860075|NCT05131477|463782270|FG004|PART 1|Adverse Event|4|||
128860076|NCT05131477|463782271|FG005|PART 1|Adverse Event|0|||
128860077|NCT05131477|463782272|FG006|PART 1|Adverse Event|0|||
128860078|NCT05131477|463782273|FG007|PART 1|Adverse Event|0|||
128860079|NCT05131477|463782274|FG008|PART 1|Adverse Event|0|||
128860080|NCT05131477|463782275|FG009|PART 1|Adverse Event|0|||
128860081|NCT05131477|463782276|FG010|PART 1|Adverse Event|0|||
128860082|NCT05131477|463782277|FG011|PART 1|Adverse Event|0|||
128860083|NCT05131477|463782278|FG012|PART 1|Adverse Event|0|||
128860084|NCT05131477|463782279|FG013|PART 1|Adverse Event|0|||
128860085|NCT05131477|463782266|FG000|PART 1|unclassified|1|||
128860086|NCT05131477|463782267|FG001|PART 1|unclassified|1|||
128860087|NCT05131477|463782268|FG002|PART 1|unclassified|0|||
128860088|NCT05131477|463782269|FG003|PART 1|unclassified|0|||
128860089|NCT05131477|463782270|FG004|PART 1|unclassified|4|||
128860090|NCT05131477|463782271|FG005|PART 1|unclassified|0|||
128860091|NCT05131477|463782272|FG006|PART 1|unclassified|0|||
128860092|NCT05131477|463782273|FG007|PART 1|unclassified|0|||
128860093|NCT05131477|463782274|FG008|PART 1|unclassified|0|||
128860094|NCT05131477|463782275|FG009|PART 1|unclassified|0|||
128860095|NCT05131477|463782276|FG010|PART 1|unclassified|0|||
128860096|NCT05131477|463782277|FG011|PART 1|unclassified|0|||
128860097|NCT05131477|463782278|FG012|PART 1|unclassified|0|||
128860098|NCT05131477|463782279|FG013|PART 1|unclassified|0|||
128860099|NCT05131477|463782266|FG000|PART 1|Randomized and not treated|0|||
128860100|NCT05131477|463782267|FG001|PART 1|Randomized and not treated|0|||
128860101|NCT05131477|463782268|FG002|PART 1|Randomized and not treated|0|||
128860102|NCT05131477|463782269|FG003|PART 1|Randomized and not treated|1|||
128860103|NCT05131477|463782270|FG004|PART 1|Randomized and not treated|1|||
128860104|NCT05131477|463782271|FG005|PART 1|Randomized and not treated|0|||
128860105|NCT05131477|463782272|FG006|PART 1|Randomized and not treated|0|||
128860106|NCT05131477|463782273|FG007|PART 1|Randomized and not treated|0|||
128860107|NCT05131477|463782274|FG008|PART 1|Randomized and not treated|0|||
128860108|NCT05131477|463782275|FG009|PART 1|Randomized and not treated|0|||
128860109|NCT05131477|463782276|FG010|PART 1|Randomized and not treated|0|||
128860110|NCT05131477|463782277|FG011|PART 1|Randomized and not treated|0|||
128860111|NCT05131477|463782278|FG012|PART 1|Randomized and not treated|0|||
128860112|NCT05131477|463782279|FG013|PART 1|Randomized and not treated|0|||
128860113|NCT05131477|463782266|FG000|PART 1|Protocol Violation|2|||
128860114|NCT05131477|463782267|FG001|PART 1|Protocol Violation|0|||
128860115|NCT05131477|463782268|FG002|PART 1|Protocol Violation|0|||
128860116|NCT05131477|463782269|FG003|PART 1|Protocol Violation|1|||
128860117|NCT05131477|463782270|FG004|PART 1|Protocol Violation|0|||
128860118|NCT05131477|463782271|FG005|PART 1|Protocol Violation|0|||
128860119|NCT05131477|463782272|FG006|PART 1|Protocol Violation|0|||
128860120|NCT05131477|463782273|FG007|PART 1|Protocol Violation|0|||
128860121|NCT05131477|463782274|FG008|PART 1|Protocol Violation|0|||
128860122|NCT05131477|463782275|FG009|PART 1|Protocol Violation|0|||
128860123|NCT05131477|463782276|FG010|PART 1|Protocol Violation|0|||
128860124|NCT05131477|463782277|FG011|PART 1|Protocol Violation|0|||
128860125|NCT05131477|463782278|FG012|PART 1|Protocol Violation|0|||
128860126|NCT05131477|463782279|FG013|PART 1|Protocol Violation|0|||
128860127|NCT05131477|463782266|FG000|PART 1|Lack of Efficacy|0|||
128860128|NCT05131477|463782267|FG001|PART 1|Lack of Efficacy|1|||
128860129|NCT05131477|463782268|FG002|PART 1|Lack of Efficacy|1|||
128860130|NCT05131477|463782269|FG003|PART 1|Lack of Efficacy|2|||
128860131|NCT05131477|463782270|FG004|PART 1|Lack of Efficacy|5|||
128860132|NCT05131477|463782271|FG005|PART 1|Lack of Efficacy|0|||
128860133|NCT05131477|463782272|FG006|PART 1|Lack of Efficacy|0|||
128860134|NCT05131477|463782273|FG007|PART 1|Lack of Efficacy|0|||
128860135|NCT05131477|463782274|FG008|PART 1|Lack of Efficacy|0|||
128860136|NCT05131477|463782275|FG009|PART 1|Lack of Efficacy|0|||
128860137|NCT05131477|463782276|FG010|PART 1|Lack of Efficacy|0|||
128860138|NCT05131477|463782277|FG011|PART 1|Lack of Efficacy|0|||
128860139|NCT05131477|463782278|FG012|PART 1|Lack of Efficacy|0|||
128860140|NCT05131477|463782279|FG013|PART 1|Lack of Efficacy|0|||
128860141|NCT05131477|463782266|FG000|PART 2|Withdrawal by Subject|0|||
128860142|NCT05131477|463782267|FG001|PART 2|Withdrawal by Subject|0|||
128860143|NCT05131477|463782268|FG002|PART 2|Withdrawal by Subject|0|||
128860144|NCT05131477|463782269|FG003|PART 2|Withdrawal by Subject|0|||
128860145|NCT05131477|463782270|FG004|PART 2|Withdrawal by Subject|0|||
128860146|NCT05131477|463782271|FG005|PART 2|Withdrawal by Subject|0|||
128860147|NCT05131477|463782272|FG006|PART 2|Withdrawal by Subject|2|||
128860148|NCT05131477|463782273|FG007|PART 2|Withdrawal by Subject|0|||
128860149|NCT05131477|463782274|FG008|PART 2|Withdrawal by Subject|0|||
128860150|NCT05131477|463782275|FG009|PART 2|Withdrawal by Subject|0|||
128860151|NCT05131477|463782276|FG010|PART 2|Withdrawal by Subject|2|||
128860152|NCT05131477|463782277|FG011|PART 2|Withdrawal by Subject|0|||
128860153|NCT05131477|463782278|FG012|PART 2|Withdrawal by Subject|2|||
128860154|NCT05131477|463782279|FG013|PART 2|Withdrawal by Subject|2|||
128860155|NCT05131477|463782266|FG000|PART 2|Other|0|||
128860156|NCT05131477|463782267|FG001|PART 2|Other|0|||
128860157|NCT05131477|463782268|FG002|PART 2|Other|0|||
128860158|NCT05131477|463782269|FG003|PART 2|Other|0|||
128860159|NCT05131477|463782270|FG004|PART 2|Other|0|||
128860160|NCT05131477|463782271|FG005|PART 2|Other|0|||
128860161|NCT05131477|463782272|FG006|PART 2|Other|0|||
128860162|NCT05131477|463782273|FG007|PART 2|Other|0|||
128860163|NCT05131477|463782274|FG008|PART 2|Other|1|||
128860164|NCT05131477|463782275|FG009|PART 2|Other|1|||
128860165|NCT05131477|463782276|FG010|PART 2|Other|0|||
128860166|NCT05131477|463782277|FG011|PART 2|Other|0|||
128860167|NCT05131477|463782278|FG012|PART 2|Other|1|||
128860168|NCT05131477|463782279|FG013|PART 2|Other|0|||
128860169|NCT05131477|463782266|FG000|PART 2|Lack of Efficacy|0|||
128860170|NCT05131477|463782267|FG001|PART 2|Lack of Efficacy|0|||
128860171|NCT05131477|463782268|FG002|PART 2|Lack of Efficacy|0|||
128860172|NCT05131477|463782269|FG003|PART 2|Lack of Efficacy|0|||
128860173|NCT05131477|463782270|FG004|PART 2|Lack of Efficacy|0|||
128860174|NCT05131477|463782271|FG005|PART 2|Lack of Efficacy|1|||
128860175|NCT05131477|463782272|FG006|PART 2|Lack of Efficacy|1|||
128860176|NCT05131477|463782273|FG007|PART 2|Lack of Efficacy|0|||
128860177|NCT05131477|463782274|FG008|PART 2|Lack of Efficacy|3|||
128860178|NCT05131477|463782275|FG009|PART 2|Lack of Efficacy|0|||
128860179|NCT05131477|463782276|FG010|PART 2|Lack of Efficacy|1|||
128860180|NCT05131477|463782277|FG011|PART 2|Lack of Efficacy|0|||
128860181|NCT05131477|463782278|FG012|PART 2|Lack of Efficacy|2|||
128860182|NCT05131477|463782279|FG013|PART 2|Lack of Efficacy|0|||
128860183|NCT05131477|463782266|FG000|PART 2|Unclassified|0|||
128860184|NCT05131477|463782267|FG001|PART 2|Unclassified|0|||
128860185|NCT05131477|463782268|FG002|PART 2|Unclassified|0|||
128860186|NCT05131477|463782269|FG003|PART 2|Unclassified|0|||
128860187|NCT05131477|463782270|FG004|PART 2|Unclassified|0|||
128860188|NCT05131477|463782271|FG005|PART 2|Unclassified|0|||
128860189|NCT05131477|463782272|FG006|PART 2|Unclassified|0|||
128860190|NCT05131477|463782273|FG007|PART 2|Unclassified|0|||
128860191|NCT05131477|463782274|FG008|PART 2|Unclassified|0|||
128860192|NCT05131477|463782275|FG009|PART 2|Unclassified|0|||
128860193|NCT05131477|463782276|FG010|PART 2|Unclassified|1|||
128860194|NCT05131477|463782277|FG011|PART 2|Unclassified|0|||
128860195|NCT05131477|463782278|FG012|PART 2|Unclassified|0|||
128860196|NCT05131477|463782279|FG013|PART 2|Unclassified|0|||
128860197|NCT05131477|463782266|FG000|PART 2|Re-randomized and not treated|0|||
128860198|NCT05131477|463782267|FG001|PART 2|Re-randomized and not treated|0|||
128860199|NCT05131477|463782268|FG002|PART 2|Re-randomized and not treated|0|||
128860200|NCT05131477|463782269|FG003|PART 2|Re-randomized and not treated|0|||
128860201|NCT05131477|463782270|FG004|PART 2|Re-randomized and not treated|0|||
128860202|NCT05131477|463782271|FG005|PART 2|Re-randomized and not treated|0|||
128860203|NCT05131477|463782272|FG006|PART 2|Re-randomized and not treated|0|||
128860204|NCT05131477|463782273|FG007|PART 2|Re-randomized and not treated|1|||
128860205|NCT05131477|463782274|FG008|PART 2|Re-randomized and not treated|0|||
128860206|NCT05131477|463782275|FG009|PART 2|Re-randomized and not treated|0|||
128860207|NCT05131477|463782276|FG010|PART 2|Re-randomized and not treated|1|||
128860208|NCT05131477|463782277|FG011|PART 2|Re-randomized and not treated|0|||
128860209|NCT05131477|463782278|FG012|PART 2|Re-randomized and not treated|1|||
128860210|NCT05131477|463782279|FG013|PART 2|Re-randomized and not treated|1|||
128860211|NCT02194829|463782280|FG000|Overall Study|Adverse Event|2|||
128860212|NCT02194829|463782281|FG001|Overall Study|Adverse Event|2|||
128860213|NCT02194829|463782280|FG000|Overall Study|Death|0|||
128860214|NCT02194829|463782281|FG001|Overall Study|Death|1|||
128860215|NCT02194829|463782280|FG000|Overall Study|Disease progression|0|||
128860216|NCT02194829|463782281|FG001|Overall Study|Disease progression|1|||
128860217|NCT02194829|463782280|FG000|Overall Study|Withdrawal by Subject|0|||
128860218|NCT02194829|463782281|FG001|Overall Study|Withdrawal by Subject|1|||
128860219|NCT02194829|463782280|FG000|Overall Study|Never started protocol therapy|0|||
128860220|NCT02194829|463782281|FG001|Overall Study|Never started protocol therapy|1|||
128860221|NCT05992922|463782284|FG000|Overall Study|Adverse Event|6|||
128860222|NCT05992922|463782285|FG001|Overall Study|Adverse Event|0|||
128860223|NCT05992922|463782284|FG000|Overall Study|Sponsor Termination of Study|14|||
128860224|NCT05992922|463782285|FG001|Overall Study|Sponsor Termination of Study|20|||
128860225|NCT02172911|463783572|FG000|Overall Study|Serious Adverse Event|0|||
128860226|NCT02172911|463783573|FG001|Overall Study|Serious Adverse Event|1|||
128860227|NCT02172911|463783572|FG000|Overall Study|Progression of Disease|0|||
128860228|NCT02172911|463783573|FG001|Overall Study|Progression of Disease|1|||
128860229|NCT02172911|463783572|FG000|Overall Study|Loss of insurance coverage|1|||
128860230|NCT02172911|463783573|FG001|Overall Study|Loss of insurance coverage|0|||
128860231|NCT02737826|463783574|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
128860232|NCT02737826|463783575|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
128860233|NCT02737826|463783576|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
128860234|NCT02056626|463783577|FG000|Overall Study|patient did not follow directions|3|||
128860235|NCT02056626|463783578|FG001|Overall Study|patient did not follow directions|1|||
128860236|NCT02056626|463783579|FG002|Overall Study|patient did not follow directions|0|||
128860237|NCT02056626|463783580|FG003|Overall Study|patient did not follow directions|0|||
128860238|NCT01454739|463783581|FG000|Overall Study|Protocol Violation|2|||
128860239|NCT01454739|463783582|FG001|Overall Study|Protocol Violation|3|||
128860240|NCT01454739|463783581|FG000|Overall Study|Withdrawal by Subject|2|||
128860241|NCT01454739|463783582|FG001|Overall Study|Withdrawal by Subject|6|||
128860242|NCT01454739|463783581|FG000|Overall Study|Other|3|||
128860243|NCT01454739|463783582|FG001|Overall Study|Other|5|||
128860244|NCT01454739|463783581|FG000|Overall Study|Physician Decision|0|||
128860245|NCT01454739|463783582|FG001|Overall Study|Physician Decision|5|||
128860246|NCT01454739|463783581|FG000|Overall Study|Lost to Follow-up|0|||
128860247|NCT01454739|463783582|FG001|Overall Study|Lost to Follow-up|1|||
128860248|NCT01454739|463783581|FG000|Overall Study|Adverse Event|0|||
128860249|NCT01454739|463783582|FG001|Overall Study|Adverse Event|1|||
128860250|NCT01784523|463783585|FG000|Overall Study|Study closed early|7|||
128860251|NCT01784523|463783586|FG001|Overall Study|Study closed early|4|||
128860252|NCT04340947|463783587|FG000|7-day Washout Period|Lost to Follow-up|5|||
128860253|NCT04340947|463783588|FG001|7-day Washout Period|Lost to Follow-up|4|||
128860254|NCT01124097|463783592|FG000|Overall Study|Withdrawal by Subject|4|||
128860255|NCT01124097|463783593|FG001|Overall Study|Withdrawal by Subject|3|||
128860256|NCT01124097|463783594|FG002|Overall Study|Withdrawal by Subject|2|||
128860257|NCT01124097|463783595|FG003|Overall Study|Withdrawal by Subject|3|||
128860258|NCT01124097|463783592|FG000|Overall Study|Lack of Efficacy|2|||
128860259|NCT01124097|463783593|FG001|Overall Study|Lack of Efficacy|3|||
128860260|NCT01124097|463783594|FG002|Overall Study|Lack of Efficacy|1|||
128860261|NCT01124097|463783595|FG003|Overall Study|Lack of Efficacy|3|||
128860262|NCT01124097|463783592|FG000|Overall Study|Adverse Event|24|||
128860263|NCT01124097|463783593|FG001|Overall Study|Adverse Event|15|||
128860264|NCT01124097|463783594|FG002|Overall Study|Adverse Event|15|||
128860265|NCT01124097|463783595|FG003|Overall Study|Adverse Event|7|||
128860266|NCT01124097|463783592|FG000|Overall Study|Protocol Violation|2|||
128860267|NCT01124097|463783593|FG001|Overall Study|Protocol Violation|0|||
128860268|NCT01124097|463783594|FG002|Overall Study|Protocol Violation|2|||
128860269|NCT01124097|463783595|FG003|Overall Study|Protocol Violation|1|||
128860270|NCT01124097|463783592|FG000|Overall Study|Physician Decision|2|||
128860271|NCT01124097|463783593|FG001|Overall Study|Physician Decision|1|||
128860272|NCT01124097|463783594|FG002|Overall Study|Physician Decision|0|||
128860273|NCT01124097|463783595|FG003|Overall Study|Physician Decision|0|||
128860274|NCT01677299|463783596|FG000|Overall Study|Adverse Event|0|||
128860275|NCT01677299|463783597|FG001|Overall Study|Adverse Event|2|||
128860276|NCT01677299|463783598|FG002|Overall Study|Adverse Event|1|||
128860277|NCT01677299|463783599|FG003|Overall Study|Adverse Event|0|||
128860278|NCT01677299|463783596|FG000|Overall Study|Withdrawal by Subject|0|||
128860279|NCT01677299|463783597|FG001|Overall Study|Withdrawal by Subject|1|||
128860280|NCT01677299|463783598|FG002|Overall Study|Withdrawal by Subject|0|||
128860281|NCT01677299|463783599|FG003|Overall Study|Withdrawal by Subject|1|||
128860282|NCT00193479|463783600|FG000|Induction Chemotherapy|Adverse Event|2|||
128860283|NCT00193479|463783600|FG000|Induction Chemotherapy|Disease Progression|1|||
128860284|NCT00193479|463783600|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
128860285|NCT00193479|463783600|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
128860286|NCT00559377|463783602|FG000|Overall Study|Withdrawal by Subject|9|||
128860287|NCT00940875|463783603|FG000|Treatment Phase|Adverse Event|9|||
128860288|NCT00940875|463783604|FG001|Treatment Phase|Adverse Event|3|||
128860289|NCT00940875|463783603|FG000|Treatment Phase|Death|3|||
128860290|NCT00940875|463783604|FG001|Treatment Phase|Death|5|||
128860291|NCT00940875|463783603|FG000|Treatment Phase|Lack of Efficacy|1|||
128860292|NCT00940875|463783604|FG001|Treatment Phase|Lack of Efficacy|0|||
128860293|NCT00940875|463783603|FG000|Treatment Phase|Withdrawal by Subject|3|||
128860294|NCT00940875|463783604|FG001|Treatment Phase|Withdrawal by Subject|0|||
128860295|NCT00940875|463783603|FG000|Treatment Phase|Disease progression|9|||
128860296|NCT00940875|463783604|FG001|Treatment Phase|Disease progression|11|||
128860297|NCT00940875|463783603|FG000|Treatment Phase|Physician Decision|1|||
128860298|NCT00940875|463783604|FG001|Treatment Phase|Physician Decision|0|||
128860299|NCT00940875|463783603|FG000|Post-Study Treatment|Death|0|||
128860300|NCT00940875|463783604|FG001|Post-Study Treatment|Death|1|||
128860301|NCT00940875|463783603|FG000|Post-Study Treatment|Disease Progression|0|||
128860302|NCT00940875|463783604|FG001|Post-Study Treatment|Disease Progression|2|||
128860303|NCT00872001|463783605|FG000|Overall Study|Adverse Event|34|||
128860304|NCT00872001|463783606|FG001|Overall Study|Adverse Event|23|||
128860305|NCT00872001|463783605|FG000|Overall Study|Protocol Defined Clinical Event|5|||
128860306|NCT00872001|463783606|FG001|Overall Study|Protocol Defined Clinical Event|7|||
128860307|NCT00872001|463783605|FG000|Overall Study|Lost to Follow-up|13|||
128860308|NCT00872001|463783606|FG001|Overall Study|Lost to Follow-up|12|||
128860309|NCT00872001|463783605|FG000|Overall Study|Withdrawal by Subject|18|||
128860310|NCT00872001|463783606|FG001|Overall Study|Withdrawal by Subject|30|||
128860311|NCT00872001|463783605|FG000|Overall Study|Protocol Violation|5|||
128860312|NCT00872001|463783606|FG001|Overall Study|Protocol Violation|8|||
128860313|NCT00872001|463783605|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
128860314|NCT00872001|463783606|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
128860315|NCT00872001|463783605|FG000|Overall Study|Administrative|23|||
128860316|NCT00872001|463783606|FG001|Overall Study|Administrative|15|||
128860317|NCT02030002|463783607|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
128860318|NCT02030002|463783607|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
128860319|NCT02030002|463783607|FG000|Follow-up|Lost to Follow-up|2|||
128860320|NCT03482752|463783615|FG000|Overall Study|Withdrawal by Subject|2|||
128860321|NCT03482752|463783615|FG000|Overall Study|Lost to Follow-up|1|||
128860322|NCT03482752|463783615|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
128860323|NCT01807182|463783616|FG000|Overall Study|Death|1|||
128860324|NCT01807182|463783616|FG000|Overall Study|New therapy|1|||
128860325|NCT01807182|463783616|FG000|Overall Study|Moved to hospice care|1|||
128860326|NCT01080300|463783617|FG000|Overall Study|Adverse Event|49|||
128860327|NCT01080300|463783618|FG001|Overall Study|Adverse Event|35|||
128860328|NCT01080300|463783617|FG000|Overall Study|Lack of Efficacy|12|||
128860329|NCT01080300|463783618|FG001|Overall Study|Lack of Efficacy|15|||
128860330|NCT01080300|463783617|FG000|Overall Study|Protocol Violation|7|||
128860331|NCT01080300|463783618|FG001|Overall Study|Protocol Violation|13|||
128860332|NCT01080300|463783617|FG000|Overall Study|Lost to Follow-up|10|||
128860333|NCT01080300|463783618|FG001|Overall Study|Lost to Follow-up|6|||
128860334|NCT01080300|463783617|FG000|Overall Study|Death|0|||
128860335|NCT01080300|463783618|FG001|Overall Study|Death|1|||
128860336|NCT01080300|463783617|FG000|Overall Study|Withdrawal by Subject|12|||
128860337|NCT01080300|463783618|FG001|Overall Study|Withdrawal by Subject|28|||
128860338|NCT01080300|463783617|FG000|Overall Study|Reasons not specified|4|||
128860339|NCT01080300|463783618|FG001|Overall Study|Reasons not specified|6|||
128860340|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
128860341|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
128860342|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
128860343|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
128860344|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
128860345|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
128860346|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
128860347|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
128860348|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
128860349|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
128860350|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
128860351|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
128860352|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
128860353|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
128860354|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
128860355|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
128860356|NCT04210843|463783620|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
128860357|NCT04210843|463783621|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
128860358|NCT04210843|463783620|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
128860359|NCT04210843|463783621|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
128860360|NCT04210843|463783620|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
128860361|NCT04210843|463783621|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
128860362|NCT04210843|463783620|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
128860363|NCT04210843|463783621|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
128860364|NCT04210843|463783620|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
128860365|NCT04210843|463783621|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
128860366|NCT04210843|463783620|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
128860367|NCT04210843|463783621|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
128860368|NCT04210843|463783620|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
128860369|NCT04210843|463783621|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
128860370|NCT04210843|463783620|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
128860371|NCT04210843|463783621|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
128860372|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
128860373|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
128860374|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
128860375|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
128860376|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
128860377|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
128860378|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
128860379|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
128860380|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
128860381|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
128860382|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
128860383|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
128860384|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
128860385|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
128860386|NCT04210843|463783620|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
128860387|NCT04210843|463783621|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
128860388|NCT01776008|463783622|FG000|Overall Study|ineligible|2|||
128860389|NCT00150618|463783625|FG000|Overall Study|Adverse Event|2|||
128860390|NCT00150618|463783626|FG001|Overall Study|Adverse Event|2|||
128860391|NCT00150618|463783627|FG002|Overall Study|Adverse Event|6|||
128860392|NCT00150618|463783628|FG003|Overall Study|Adverse Event|9|||
128860393|NCT00150618|463783629|FG004|Overall Study|Adverse Event|5|||
128860394|NCT00150618|463783625|FG000|Overall Study|Withdrawal by Subject|6|||
128860395|NCT00150618|463783626|FG001|Overall Study|Withdrawal by Subject|8|||
128860396|NCT00150618|463783627|FG002|Overall Study|Withdrawal by Subject|8|||
128860397|NCT00150618|463783628|FG003|Overall Study|Withdrawal by Subject|4|||
128860398|NCT00150618|463783629|FG004|Overall Study|Withdrawal by Subject|5|||
128860399|NCT00150618|463783625|FG000|Overall Study|Lost to Follow-up|4|||
128860400|NCT00150618|463783626|FG001|Overall Study|Lost to Follow-up|1|||
128860401|NCT00150618|463783627|FG002|Overall Study|Lost to Follow-up|5|||
128860402|NCT00150618|463783628|FG003|Overall Study|Lost to Follow-up|8|||
128860403|NCT00150618|463783629|FG004|Overall Study|Lost to Follow-up|4|||
128860404|NCT00150618|463783625|FG000|Overall Study|Protocol Violation|1|||
128860405|NCT00150618|463783626|FG001|Overall Study|Protocol Violation|0|||
128860406|NCT00150618|463783627|FG002|Overall Study|Protocol Violation|0|||
128860407|NCT00150618|463783628|FG003|Overall Study|Protocol Violation|0|||
128860408|NCT00150618|463783629|FG004|Overall Study|Protocol Violation|1|||
128860409|NCT00150618|463783625|FG000|Overall Study|Lack of Efficacy|1|||
128860410|NCT00150618|463783626|FG001|Overall Study|Lack of Efficacy|4|||
128860411|NCT00150618|463783627|FG002|Overall Study|Lack of Efficacy|7|||
128860412|NCT00150618|463783628|FG003|Overall Study|Lack of Efficacy|4|||
128860413|NCT00150618|463783629|FG004|Overall Study|Lack of Efficacy|6|||
128860414|NCT00150618|463783625|FG000|Overall Study|No study meds|0|||
128860415|NCT00150618|463783626|FG001|Overall Study|No study meds|0|||
128860416|NCT00150618|463783627|FG002|Overall Study|No study meds|0|||
128860417|NCT00150618|463783628|FG003|Overall Study|No study meds|0|||
128860418|NCT00150618|463783629|FG004|Overall Study|No study meds|2|||
128860419|NCT00150618|463783625|FG000|Overall Study|Physician Decision|0|||
128860420|NCT00150618|463783626|FG001|Overall Study|Physician Decision|2|||
128860421|NCT00150618|463783627|FG002|Overall Study|Physician Decision|0|||
128860422|NCT00150618|463783628|FG003|Overall Study|Physician Decision|0|||
128860423|NCT00150618|463783629|FG004|Overall Study|Physician Decision|1|||
128860424|NCT00150618|463783625|FG000|Overall Study|Lack of compliance|2|||
128860425|NCT00150618|463783626|FG001|Overall Study|Lack of compliance|1|||
128860426|NCT00150618|463783627|FG002|Overall Study|Lack of compliance|1|||
128860427|NCT00150618|463783628|FG003|Overall Study|Lack of compliance|0|||
128860428|NCT00150618|463783629|FG004|Overall Study|Lack of compliance|1|||
128860429|NCT00150618|463783625|FG000|Overall Study|Abnormal ECG|1|||
128860430|NCT00150618|463783626|FG001|Overall Study|Abnormal ECG|0|||
128860431|NCT00150618|463783627|FG002|Overall Study|Abnormal ECG|0|||
128860432|NCT00150618|463783628|FG003|Overall Study|Abnormal ECG|0|||
128860433|NCT00150618|463783629|FG004|Overall Study|Abnormal ECG|0|||
128860434|NCT00150618|463783625|FG000|Overall Study|Sponsor's decision|0|||
128860435|NCT00150618|463783626|FG001|Overall Study|Sponsor's decision|0|||
128860436|NCT00150618|463783627|FG002|Overall Study|Sponsor's decision|0|||
128860437|NCT00150618|463783628|FG003|Overall Study|Sponsor's decision|1|||
128860438|NCT00150618|463783629|FG004|Overall Study|Sponsor's decision|0|||
128860439|NCT01850030|463783630|FG000|Overall Study|Adverse Event|64|||
128860440|NCT01850030|463783631|FG001|Overall Study|Adverse Event|82|||
128860441|NCT01850030|463783630|FG000|Overall Study|Lack of Efficacy|3|||
128860442|NCT01850030|463783631|FG001|Overall Study|Lack of Efficacy|1|||
128860443|NCT01850030|463783630|FG000|Overall Study|Lost to Follow-up|5|||
128860444|NCT01850030|463783631|FG001|Overall Study|Lost to Follow-up|5|||
128860445|NCT01850030|463783630|FG000|Overall Study|Withdrawal by Subject|3|||
128860446|NCT01850030|463783631|FG001|Overall Study|Withdrawal by Subject|4|||
128860447|NCT01850030|463783630|FG000|Overall Study|Protocol Violation|24|||
128860448|NCT01850030|463783631|FG001|Overall Study|Protocol Violation|28|||
128860449|NCT01850030|463783630|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
128860450|NCT01850030|463783631|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
128860451|NCT00762476|463783632|FG000|Overall Study|Adverse Event|7|||
128860452|NCT00762476|463783633|FG001|Overall Study|Adverse Event|1|||
128860453|NCT00762476|463783632|FG000|Overall Study|Lost to Follow-up|2|||
128860454|NCT00762476|463783633|FG001|Overall Study|Lost to Follow-up|0|||
128860455|NCT00762476|463783632|FG000|Overall Study|Protocol Violation|5|||
128860456|NCT00762476|463783633|FG001|Overall Study|Protocol Violation|6|||
128860457|NCT00762476|463783632|FG000|Overall Study|Physician Decision|2|||
128860458|NCT00762476|463783633|FG001|Overall Study|Physician Decision|14|||
128860459|NCT00762476|463783632|FG000|Overall Study|Withdrawal by Subject|6|||
128860460|NCT00762476|463783633|FG001|Overall Study|Withdrawal by Subject|12|||
128860461|NCT00762476|463783632|FG000|Overall Study|antibiotic use|0|||
128860462|NCT00762476|463783633|FG001|Overall Study|antibiotic use|1|||
128860463|NCT00762476|463783632|FG000|Overall Study|non-compliance with study visits|0|||
128860464|NCT00762476|463783633|FG001|Overall Study|non-compliance with study visits|2|||
128860465|NCT00762476|463783632|FG000|Overall Study|Seasonal allergies|1|||
128860466|NCT00762476|463783633|FG001|Overall Study|Seasonal allergies|0|||
128860467|NCT02878603|463783634|FG000|Overall Study|Lost to Follow-up|4|||
128860468|NCT02878603|463783635|FG001|Overall Study|Lost to Follow-up|1|||
128860469|NCT02878603|463783634|FG000|Overall Study|Withdrawal by Subject|1|||
128860470|NCT02878603|463783635|FG001|Overall Study|Withdrawal by Subject|1|||
128860471|NCT02878603|463783634|FG000|Overall Study|Death|1|||
128860472|NCT02878603|463783635|FG001|Overall Study|Death|0|||
128860473|NCT02878603|463783634|FG000|Overall Study|Physician Decision|0|||
128860474|NCT02878603|463783635|FG001|Overall Study|Physician Decision|3|||
128860475|NCT04674189|463783636|FG000|Overall Study|Adverse Event|0|||
128860476|NCT04674189|463783637|FG001|Overall Study|Adverse Event|0|||
128860477|NCT04674189|463783638|FG002|Overall Study|Adverse Event|1|||
128860478|NCT04674189|463783636|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
128860479|NCT04674189|463783637|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
128860480|NCT04674189|463783638|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
128860481|NCT04674189|463783636|FG000|Overall Study|Physician Decision|1|||
128860482|NCT04674189|463783637|FG001|Overall Study|Physician Decision|0|||
128860483|NCT04674189|463783638|FG002|Overall Study|Physician Decision|0|||
128860484|NCT04674189|463783636|FG000|Overall Study|Withdrawal by Participant|83|||
128860485|NCT04674189|463783637|FG001|Overall Study|Withdrawal by Participant|71|||
128860486|NCT04674189|463783638|FG002|Overall Study|Withdrawal by Participant|142|||
128860487|NCT04674189|463783636|FG000|Overall Study|Lost to Follow-up|55|||
128860488|NCT04674189|463783637|FG001|Overall Study|Lost to Follow-up|53|||
128860489|NCT04674189|463783638|FG002|Overall Study|Lost to Follow-up|44|||
128860490|NCT04674189|463783636|FG000|Overall Study|Miscellaneous|27|||
128860491|NCT04674189|463783637|FG001|Overall Study|Miscellaneous|23|||
128860492|NCT04674189|463783638|FG002|Overall Study|Miscellaneous|207|||
128860493|NCT04674189|463783636|FG000|Overall Study|Did Not Receive Treatment|3|||
128860494|NCT04674189|463783637|FG001|Overall Study|Did Not Receive Treatment|1|||
128860495|NCT04674189|463783638|FG002|Overall Study|Did Not Receive Treatment|2|||
128860496|NCT02838134|463783639|FG000|Overall Study|Lost to Follow-up|1|||
128860497|NCT02838134|463783640|FG001|Overall Study|Lost to Follow-up|2|||
128860498|NCT02838134|463783639|FG000|Overall Study|logistic problems|1|||
128860499|NCT02838134|463783640|FG001|Overall Study|logistic problems|1|||
128860500|NCT01564277|463783641|FG000|Overall Study|Protocol Violation|0|||
128860501|NCT01564277|463783642|FG001|Overall Study|Protocol Violation|1|||
128860502|NCT01564277|463783641|FG000|Overall Study|Physician Decision|1|||
128860503|NCT01564277|463783642|FG001|Overall Study|Physician Decision|0|||
128860504|NCT01637077|463783643|FG000|Overall Study|Cancel|1|||
128860505|NCT01637077|463783644|FG001|Overall Study|Cancel|1|||
128860506|NCT01637077|463783643|FG000|Overall Study|Withdrawal by Subject|1|||
128860507|NCT01637077|463783644|FG001|Overall Study|Withdrawal by Subject|0|||
128860508|NCT01637077|463783643|FG000|Overall Study|No cycle 1 questionnaire data|2|||
128860509|NCT01637077|463783644|FG001|Overall Study|No cycle 1 questionnaire data|0|||
128860510|NCT02595372|463783645|FG000|Overall Study|Adverse Event|6|||
128860511|NCT02595372|463783645|FG000|Overall Study|Physician Decision|2|||
128860512|NCT02595372|463783645|FG000|Overall Study|Disease Progression|1|||
128860513|NCT00794924|463783646|FG000|Overall Study|Lost to Follow-up|6|||
128860514|NCT00794924|463783647|FG001|Overall Study|Lost to Follow-up|8|||
128860515|NCT00794924|463783646|FG000|Overall Study|Withdrawal by Subject|48|||
128860516|NCT00794924|463783647|FG001|Overall Study|Withdrawal by Subject|60|||
128860517|NCT00794924|463783646|FG000|Overall Study|Adverse Event|6|||
128860518|NCT00794924|463783647|FG001|Overall Study|Adverse Event|2|||
128860519|NCT01594970|463783648|FG000|Overall Study|Non-Adverse Event Related|4|||
128860520|NCT01594970|463783649|FG001|Overall Study|Non-Adverse Event Related|5|||
128860521|NCT01594970|463783650|FG002|Overall Study|Non-Adverse Event Related|6|||
128860522|NCT01594970|463783648|FG000|Overall Study|Adverse Event|17|||
128860523|NCT01594970|463783649|FG001|Overall Study|Adverse Event|23|||
128860524|NCT01594970|463783650|FG002|Overall Study|Adverse Event|23|||
128860525|NCT01594970|463783648|FG000|Overall Study|Lost to Follow-up|54|||
128860526|NCT01594970|463783649|FG001|Overall Study|Lost to Follow-up|54|||
128860527|NCT01594970|463783650|FG002|Overall Study|Lost to Follow-up|37|||
128860528|NCT00953615|463783651|FG000|Overall Study|Adverse Event|1|||
128860529|NCT01299480|463783652|FG000|Overall Study|No longer willing to participate|19|||
128860530|NCT01299480|463783653|FG001|Overall Study|No longer willing to participate|17|||
128860531|NCT01299480|463783654|FG002|Overall Study|No longer willing to participate|14|||
128860532|NCT01299480|463783655|FG003|Overall Study|No longer willing to participate|13|||
128860533|NCT01299480|463783656|FG004|Overall Study|No longer willing to participate|10|||
128860534|NCT01299480|463783652|FG000|Overall Study|Protocol Violation|7|||
128860535|NCT01299480|463783653|FG001|Overall Study|Protocol Violation|5|||
128860536|NCT01299480|463783654|FG002|Overall Study|Protocol Violation|8|||
128860537|NCT01299480|463783655|FG003|Overall Study|Protocol Violation|1|||
128860538|NCT01299480|463783656|FG004|Overall Study|Protocol Violation|1|||
128860539|NCT01299480|463783652|FG000|Overall Study|Withdrawal by Subject|3|||
128860540|NCT01299480|463783653|FG001|Overall Study|Withdrawal by Subject|4|||
128860541|NCT01299480|463783654|FG002|Overall Study|Withdrawal by Subject|7|||
128860542|NCT01299480|463783655|FG003|Overall Study|Withdrawal by Subject|3|||
128860543|NCT01299480|463783656|FG004|Overall Study|Withdrawal by Subject|4|||
128860544|NCT01299480|463783652|FG000|Overall Study|Adverse Event|6|||
128860545|NCT01299480|463783653|FG001|Overall Study|Adverse Event|4|||
128860546|NCT01299480|463783654|FG002|Overall Study|Adverse Event|5|||
128860547|NCT01299480|463783655|FG003|Overall Study|Adverse Event|4|||
128860548|NCT01299480|463783656|FG004|Overall Study|Adverse Event|0|||
128860549|NCT01299480|463783652|FG000|Overall Study|Withdrawal due to pregnancy|0|||
128860550|NCT01299480|463783653|FG001|Overall Study|Withdrawal due to pregnancy|1|||
128860551|NCT01299480|463783654|FG002|Overall Study|Withdrawal due to pregnancy|1|||
128860552|NCT01299480|463783655|FG003|Overall Study|Withdrawal due to pregnancy|0|||
128860553|NCT01299480|463783656|FG004|Overall Study|Withdrawal due to pregnancy|0|||
128860554|NCT01299480|463783652|FG000|Overall Study|Physician Decision|1|||
128860555|NCT01299480|463783653|FG001|Overall Study|Physician Decision|1|||
128860556|NCT01299480|463783654|FG002|Overall Study|Physician Decision|0|||
128860557|NCT01299480|463783655|FG003|Overall Study|Physician Decision|2|||
128860558|NCT01299480|463783656|FG004|Overall Study|Physician Decision|0|||
128860559|NCT01299480|463783652|FG000|Overall Study|Lost to Follow-up|3|||
128860560|NCT01299480|463783653|FG001|Overall Study|Lost to Follow-up|1|||
128860561|NCT01299480|463783654|FG002|Overall Study|Lost to Follow-up|2|||
128860562|NCT01299480|463783655|FG003|Overall Study|Lost to Follow-up|1|||
128860563|NCT01299480|463783656|FG004|Overall Study|Lost to Follow-up|2|||
128860564|NCT01299480|463783652|FG000|Overall Study|Other|3|||
128860565|NCT01299480|463783653|FG001|Overall Study|Other|2|||
128860566|NCT01299480|463783654|FG002|Overall Study|Other|3|||
128860567|NCT01299480|463783655|FG003|Overall Study|Other|0|||
128860568|NCT01299480|463783656|FG004|Overall Study|Other|3|||
128860569|NCT01299480|463783652|FG000|Overall Study|Started, but not vaccinated|0|||
128860570|NCT01299480|463783653|FG001|Overall Study|Started, but not vaccinated|0|||
128860571|NCT01299480|463783654|FG002|Overall Study|Started, but not vaccinated|1|||
128860572|NCT01299480|463783655|FG003|Overall Study|Started, but not vaccinated|1|||
128860573|NCT01299480|463783656|FG004|Overall Study|Started, but not vaccinated|0|||
128860574|NCT02296892|463783657|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
128860575|NCT02296892|463783658|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
128860576|NCT02296892|463783659|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
128860577|NCT02296892|463783657|FG000|Overall Study|Lost to Follow-up|5|||
128860578|NCT02296892|463783658|FG001|Overall Study|Lost to Follow-up|0|||
128860579|NCT02296892|463783659|FG002|Overall Study|Lost to Follow-up|1|||
128860580|NCT04277507|463783662|FG000|Overall Study|Lost to Follow-up|17|||
128860581|NCT04277507|463783662|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
128860582|NCT04277507|463783662|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
128860583|NCT04277507|463783662|FG000|Overall Study|Withdrawal by Subject|3|||
128860584|NCT04277507|463783662|FG000|Overall Study|Death due to COVID-19|1|||
128860585|NCT04277507|463783662|FG000|Overall Study|Data missing for full evaluation|5|||
128860586|NCT02559310|463783666|FG000|Overall Study|Death|4|||
128860587|NCT02559310|463783667|FG001|Overall Study|Death|3|||
128860588|NCT02559310|463783666|FG000|Overall Study|Lost to Follow-up|5|||
128860589|NCT02559310|463783667|FG001|Overall Study|Lost to Follow-up|3|||
128860590|NCT02559310|463783666|FG000|Overall Study|Physician Decision|2|||
128860591|NCT02559310|463783667|FG001|Overall Study|Physician Decision|1|||
128860592|NCT02559310|463783666|FG000|Overall Study|Withdrawal by Subject|13|||
128860593|NCT02559310|463783667|FG001|Overall Study|Withdrawal by Subject|9|||
128860594|NCT02559310|463783666|FG000|Overall Study|Sponsor Decision|0|||
128860595|NCT02559310|463783667|FG001|Overall Study|Sponsor Decision|1|||
128860596|NCT02559310|463783666|FG000|Overall Study|Randomized but not treated|3|||
128860597|NCT02559310|463783667|FG001|Overall Study|Randomized but not treated|2|||
128860598|NCT05226130|463783668|FG000|Overall Study|Lost to Follow-up|0|||
128860599|NCT05226130|463783669|FG001|Overall Study|Lost to Follow-up|1|||
128860600|NCT05226130|463783668|FG000|Overall Study|Not treatment adherent|0|||
128860601|NCT05226130|463783669|FG001|Overall Study|Not treatment adherent|2|||
128860602|NCT03358472|463783670|FG000|Overall Study|Death|6|||
128860603|NCT03358472|463783671|FG001|Overall Study|Death|3|||
128860604|NCT03358472|463783672|FG002|Overall Study|Death|10|||
128860605|NCT03358472|463783670|FG000|Overall Study|Physician Decision|0|||
128860606|NCT03358472|463783671|FG001|Overall Study|Physician Decision|1|||
128860607|NCT03358472|463783672|FG002|Overall Study|Physician Decision|0|||
128860608|NCT03358472|463783670|FG000|Overall Study|Withdrawal by Subject|0|||
128860609|NCT03358472|463783671|FG001|Overall Study|Withdrawal by Subject|0|||
128860610|NCT03358472|463783672|FG002|Overall Study|Withdrawal by Subject|1|||
128860611|NCT03358472|463783670|FG000|Overall Study|On-going at clinical cut off date|9|||
128860612|NCT03358472|463783671|FG001|Overall Study|On-going at clinical cut off date|6|||
128860613|NCT03358472|463783672|FG002|Overall Study|On-going at clinical cut off date|5|||
128860614|NCT05101993|463783675|FG000|Overall Study|Withdrawal by Subject|1|||
128860615|NCT04577573|463783676|FG000|Overall Study|Technical - invalid protocol|0|||
128860616|NCT04577573|463783677|FG001|Overall Study|Technical - invalid protocol|2|||
128860617|NCT04577573|463783678|FG002|Overall Study|Technical - invalid protocol|0|||
128860618|NCT01124838|463783679|FG000|Overall Study|Miscellaneous|4|||
128860619|NCT01124838|463783680|FG001|Overall Study|Miscellaneous|2|||
128860620|NCT01124838|463783679|FG000|Overall Study|Adverse Event|7|||
128860621|NCT01124838|463783680|FG001|Overall Study|Adverse Event|11|||
128860622|NCT01124838|463783679|FG000|Overall Study|Lack of Efficacy|2|||
128860623|NCT01124838|463783680|FG001|Overall Study|Lack of Efficacy|0|||
128860624|NCT01124838|463783679|FG000|Overall Study|Withdrawal by Subject|3|||
128860625|NCT01124838|463783680|FG001|Overall Study|Withdrawal by Subject|2|||
128860626|NCT01124838|463783679|FG000|Overall Study|Lost to Follow-up|2|||
128860627|NCT01124838|463783680|FG001|Overall Study|Lost to Follow-up|0|||
128860628|NCT04297618|463783681|FG000|Overall Study|Adverse Event|1|||
128860629|NCT04297618|463783681|FG000|Overall Study|Withdrawal by Subject|1|||
128860630|NCT06719986|463783682|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
128860631|NCT06719986|463783683|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
128860632|NCT06719986|463783684|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
128860633|NCT06719986|463783682|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
128860634|NCT06719986|463783683|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
128860635|NCT06719986|463783684|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
128860636|NCT02600897|463783686|FG000|Overall Study|Death|1|||
128860637|NCT02600897|463783687|FG001|Overall Study|Death|2|||
128860638|NCT02600897|463783688|FG002|Overall Study|Death|1|||
128860639|NCT02600897|463783689|FG003|Overall Study|Death|2|||
128860640|NCT02600897|463783690|FG004|Overall Study|Death|3|||
128860641|NCT02600897|463783691|FG005|Overall Study|Death|2|||
128860642|NCT02600897|463783692|FG006|Overall Study|Death|10|||
128860643|NCT02600897|463783693|FG007|Overall Study|Death|7|||
128860644|NCT02600897|463783694|FG008|Overall Study|Death|20|||
128860645|NCT02600897|463783686|FG000|Overall Study|Lost to Follow-up|1|||
128860646|NCT02600897|463783687|FG001|Overall Study|Lost to Follow-up|0|||
128860647|NCT02600897|463783688|FG002|Overall Study|Lost to Follow-up|0|||
128860648|NCT02600897|463783689|FG003|Overall Study|Lost to Follow-up|0|||
128860649|NCT02600897|463783690|FG004|Overall Study|Lost to Follow-up|0|||
128860650|NCT02600897|463783691|FG005|Overall Study|Lost to Follow-up|0|||
128860651|NCT02600897|463783692|FG006|Overall Study|Lost to Follow-up|0|||
128860652|NCT02600897|463783693|FG007|Overall Study|Lost to Follow-up|1|||
128860653|NCT02600897|463783694|FG008|Overall Study|Lost to Follow-up|0|||
128860654|NCT02600897|463783686|FG000|Overall Study|Withdrawal by Subject|0|||
128860655|NCT02600897|463783687|FG001|Overall Study|Withdrawal by Subject|0|||
128860656|NCT02600897|463783688|FG002|Overall Study|Withdrawal by Subject|0|||
128860657|NCT02600897|463783689|FG003|Overall Study|Withdrawal by Subject|0|||
128860658|NCT02600897|463783690|FG004|Overall Study|Withdrawal by Subject|0|||
128860659|NCT02600897|463783691|FG005|Overall Study|Withdrawal by Subject|0|||
128860660|NCT02600897|463783692|FG006|Overall Study|Withdrawal by Subject|0|||
128860661|NCT02600897|463783693|FG007|Overall Study|Withdrawal by Subject|4|||
128860662|NCT02600897|463783694|FG008|Overall Study|Withdrawal by Subject|2|||
128860663|NCT02600897|463783686|FG000|Overall Study|Reason Not Specified|0|||
128860664|NCT02600897|463783687|FG001|Overall Study|Reason Not Specified|0|||
128860665|NCT02600897|463783688|FG002|Overall Study|Reason Not Specified|0|||
128860666|NCT02600897|463783689|FG003|Overall Study|Reason Not Specified|0|||
128860667|NCT02600897|463783690|FG004|Overall Study|Reason Not Specified|0|||
128860668|NCT02600897|463783691|FG005|Overall Study|Reason Not Specified|0|||
128860669|NCT02600897|463783692|FG006|Overall Study|Reason Not Specified|0|||
128860670|NCT02600897|463783693|FG007|Overall Study|Reason Not Specified|0|||
128860671|NCT02600897|463783694|FG008|Overall Study|Reason Not Specified|1|||
128860672|NCT02726945|463783695|FG000|Overall Study|Withdrawal by Subject|0|||
128860673|NCT02726945|463783696|FG001|Overall Study|Withdrawal by Subject|0|||
128860674|NCT02726945|463783697|FG002|Overall Study|Withdrawal by Subject|1|||
128860675|NCT02726945|463783695|FG000|Overall Study|Elected to have total knee replacement|0|||
128860676|NCT02726945|463783696|FG001|Overall Study|Elected to have total knee replacement|1|||
128860677|NCT02726945|463783697|FG002|Overall Study|Elected to have total knee replacement|0|||
128860678|NCT00129935|463785239|FG000|Overall Study|Adverse Event|18|||
128860679|NCT00129935|463785240|FG001|Overall Study|Adverse Event|56|||
128860680|NCT00129935|463785239|FG000|Overall Study|Death|1|||
128860681|NCT00129935|463785240|FG001|Overall Study|Death|1|||
128860682|NCT00129935|463785239|FG000|Overall Study|Withdrawal by Subject|7|||
128860683|NCT00129935|463785240|FG001|Overall Study|Withdrawal by Subject|20|||
128860684|NCT00129935|463785239|FG000|Overall Study|Protocol Violation|0|||
128860685|NCT00129935|463785240|FG001|Overall Study|Protocol Violation|4|||
128860686|NCT00129935|463785239|FG000|Overall Study|Physician Decision|3|||
128860687|NCT00129935|463785240|FG001|Overall Study|Physician Decision|4|||
128860688|NCT00129935|463785239|FG000|Overall Study|Recurrence|1|||
128860689|NCT00129935|463785240|FG001|Overall Study|Recurrence|3|||
128860690|NCT00129935|463785239|FG000|Overall Study|Second primary|0|||
128860691|NCT00129935|463785240|FG001|Overall Study|Second primary|1|||
128860692|NCT00129935|463785239|FG000|Overall Study|Other|3|||
128860693|NCT00129935|463785240|FG001|Overall Study|Other|2|||
128860694|NCT00129935|463785239|FG000|Overall Study|Crossed to the other arm|2|||
128860695|NCT00129935|463785240|FG001|Overall Study|Crossed to the other arm|1|||
128860696|NCT00129935|463785239|FG000|Overall Study|Incorrect study treatment|1|||
128860697|NCT00129935|463785240|FG001|Overall Study|Incorrect study treatment|0|||
128860698|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
128860699|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
128860700|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
128860701|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Death|4|||
128860702|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Death|2|||
128860703|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Death|3|||
128860704|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
128860705|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
128860706|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
128860707|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
128860708|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
128860709|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
128860710|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
128860711|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
128860712|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
128860713|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
128860714|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
128860715|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
128860716|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
128860717|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
128860718|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
128860719|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
128860720|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
128860721|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
128860722|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
128860723|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
128860724|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
128860725|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
128860726|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
128860727|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
128860728|NCT02783573|463785241|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
128860729|NCT02783573|463785242|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
128860730|NCT02783573|463785243|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
128860731|NCT02783573|463785241|FG000|Delayed-Start Period|Sponsor Decision|0|||
128860732|NCT02783573|463785242|FG001|Delayed-Start Period|Sponsor Decision|17|||
128860733|NCT02783573|463785243|FG002|Delayed-Start Period|Sponsor Decision|12|||
128860734|NCT00233480|463785244|FG000|Overall Study|Underwent status II heart transplant|0|||
128860735|NCT00233480|463785245|FG001|Overall Study|Underwent status II heart transplant|1|||
128860736|NCT00581893|463785246|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
128860737|NCT00581893|463785247|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
128860738|NCT02797522|463785255|FG000|Overall Study|Study Terminated by Sponsor|0|||
128860739|NCT02797522|463785256|FG001|Overall Study|Study Terminated by Sponsor|0|||
128860740|NCT02797522|463785257|FG002|Overall Study|Study Terminated by Sponsor|0|||
128860741|NCT02797522|463785258|FG003|Overall Study|Study Terminated by Sponsor|0|||
128860742|NCT02797522|463785259|FG004|Overall Study|Study Terminated by Sponsor|0|||
128860743|NCT02797522|463785260|FG005|Overall Study|Study Terminated by Sponsor|0|||
128860744|NCT02797522|463785261|FG006|Overall Study|Study Terminated by Sponsor|0|||
128860745|NCT02797522|463785262|FG007|Overall Study|Study Terminated by Sponsor|4|||
128860746|NCT02797522|463785263|FG008|Overall Study|Study Terminated by Sponsor|2|||
128860747|NCT02797522|463785264|FG009|Overall Study|Study Terminated by Sponsor|4|||
128860748|NCT02797522|463785265|FG010|Overall Study|Study Terminated by Sponsor|1|||
128860749|NCT00725712|463785266|FG000|Overall Study|Withdrawal by Subject|2|||
128860750|NCT00725712|463785267|FG001|Overall Study|Withdrawal by Subject|1|||
128860751|NCT00725712|463785266|FG000|Overall Study|Protocol Violation|1|||
128860752|NCT00725712|463785267|FG001|Overall Study|Protocol Violation|0|||
128860753|NCT00725712|463785266|FG000|Overall Study|Progressive disease|37|||
128860754|NCT00725712|463785267|FG001|Overall Study|Progressive disease|16|||
128860755|NCT00725712|463785266|FG000|Overall Study|Clinical progression not based on RECIST|0|||
128860756|NCT00725712|463785267|FG001|Overall Study|Clinical progression not based on RECIST|3|||
128860757|NCT00725712|463785266|FG000|Overall Study|Adverse Event|5|||
128860758|NCT00725712|463785267|FG001|Overall Study|Adverse Event|5|||
128860759|NCT00725712|463785266|FG000|Overall Study|Death|2|||
128860760|NCT00725712|463785267|FG001|Overall Study|Death|0|||
128860761|NCT00725712|463785266|FG000|Overall Study|Other: Death|1|||
128860762|NCT00725712|463785267|FG001|Overall Study|Other: Death|0|||
128860763|NCT00725712|463785266|FG000|Overall Study|Hospitalized, unable to continue|0|||
128860764|NCT00725712|463785267|FG001|Overall Study|Hospitalized, unable to continue|1|||
128860765|NCT00132678|463785270|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
128860766|NCT00132678|463785271|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
128860767|NCT00132678|463785272|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
128860768|NCT00132678|463785270|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
128860769|NCT00132678|463785271|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
128860770|NCT00132678|463785272|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
128860771|NCT00132678|463785270|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
128860772|NCT00132678|463785271|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
128860773|NCT00132678|463785272|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
128860774|NCT00132678|463785270|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
128860775|NCT00132678|463785271|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
128860776|NCT00132678|463785272|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
128860777|NCT00132678|463785270|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
128860778|NCT00132678|463785271|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
128860779|NCT00132678|463785272|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
128860780|NCT00132678|463785270|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
128860781|NCT00132678|463785271|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
128860782|NCT00132678|463785272|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
128860783|NCT00132678|463785270|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
128860784|NCT00132678|463785271|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
128860785|NCT00132678|463785272|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
128860786|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Death|2|||
128860787|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Death|0|||
128860788|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Death|0|||
128860789|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
128860790|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
128860791|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
128860792|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
128860793|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
128860794|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
128860795|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
128860796|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
128860797|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
128860798|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
128860799|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
128860800|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
128860801|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
128860802|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
128860803|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
128860804|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
128860805|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
128860806|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
128860807|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
128860808|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
128860809|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
128860810|NCT00132678|463785270|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
128860811|NCT00132678|463785271|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
128860812|NCT00132678|463785272|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
128860813|NCT00132678|463785270|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
128860814|NCT00132678|463785271|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
128860815|NCT00132678|463785272|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
128860816|NCT00132678|463785270|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
128860817|NCT00132678|463785271|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
128860818|NCT00132678|463785272|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
128860819|NCT00132678|463785270|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
128860820|NCT00132678|463785271|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
128860821|NCT00132678|463785272|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
128860822|NCT00132678|463785270|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
128860823|NCT00132678|463785271|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
128860824|NCT00132678|463785272|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
128860825|NCT00132678|463785270|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
128860826|NCT00132678|463785271|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
128860827|NCT00132678|463785272|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
128860828|NCT00132678|463785270|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
128860829|NCT00132678|463785271|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
128860830|NCT00132678|463785272|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
128860831|NCT00132678|463785270|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
128860832|NCT00132678|463785271|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
128860833|NCT00132678|463785272|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
128860834|NCT01367847|463785273|FG000|Overall Study|Withdrawal by Subject|2|||
128860835|NCT01367847|463785274|FG001|Overall Study|Withdrawal by Subject|2|||
128860836|NCT00592293|463785278|FG000|Overall Study|Withdrawal by Subject|1|||
128860837|NCT01606319|463785279|FG000|Overall Study|Lost to Follow-up|17|||
128860838|NCT01606319|463785280|FG001|Overall Study|Lost to Follow-up|14|||
128860839|NCT01606319|463785279|FG000|Overall Study|Withdrawal by Subject|9|||
128860840|NCT01606319|463785280|FG001|Overall Study|Withdrawal by Subject|12|||
128860841|NCT01606319|463785279|FG000|Overall Study|Physician Decision|1|||
128860842|NCT01606319|463785280|FG001|Overall Study|Physician Decision|2|||
128860843|NCT01606319|463785279|FG000|Overall Study|Lack of Efficacy|6|||
128860844|NCT01606319|463785280|FG001|Overall Study|Lack of Efficacy|8|||
128860845|NCT01606319|463785279|FG000|Overall Study|Adverse Event|1|||
128860846|NCT01606319|463785280|FG001|Overall Study|Adverse Event|4|||
128860847|NCT01821937|463785282|FG000|Overall Study|Adverse Event|0|||
128860848|NCT01821937|463785283|FG001|Overall Study|Adverse Event|3|||
128860849|NCT00609947|463785284|FG000|Overall Study|Death|1|||
128860850|NCT02406248|463785285|FG000|Overall Study|Death|7|||
128860851|NCT02406248|463785285|FG000|Overall Study|Withdrawal by Subject|2|||
128860852|NCT01304498|463785286|FG000|Overall Study|Adverse Event|1|||
128860853|NCT01304498|463785287|FG001|Overall Study|Adverse Event|1|||
128860854|NCT01304498|463785286|FG000|Overall Study|Withdrawal by Subject|2|||
128860855|NCT01304498|463785287|FG001|Overall Study|Withdrawal by Subject|3|||
128860856|NCT01304498|463785286|FG000|Overall Study|Protocol Violation|1|||
128860857|NCT01304498|463785287|FG001|Overall Study|Protocol Violation|0|||
128860858|NCT01304498|463785286|FG000|Overall Study|Lost to Follow-up|2|||
128860859|NCT01304498|463785287|FG001|Overall Study|Lost to Follow-up|1|||
128860860|NCT01834586|463785289|FG000|Overall Study|Adverse Event|1|||
128860861|NCT01667549|463785290|FG000|Overall Study|Withdrawal by Subject|3|||
128860862|NCT01667549|463785291|FG001|Overall Study|Withdrawal by Subject|5|||
128860863|NCT01667549|463785292|FG002|Overall Study|Withdrawal by Subject|7|||
128860864|NCT01667549|463785293|FG003|Overall Study|Withdrawal by Subject|6|||
128860865|NCT01667549|463785294|FG004|Overall Study|Withdrawal by Subject|1|||
128860866|NCT02844777|463785295|FG000|Overall Study|Withdrawal by Subject|2|||
128860867|NCT02844777|463785296|FG001|Overall Study|Withdrawal by Subject|0|||
128860868|NCT02844777|463785297|FG002|Overall Study|Withdrawal by Subject|0|||
128860869|NCT02493946|463785298|FG000|DB Period|Withdrawal by Subject|8|||
128860870|NCT02493946|463785299|FG001|DB Period|Withdrawal by Subject|5|||
128860871|NCT02493946|463785300|FG002|DB Period|Withdrawal by Subject|0|||
128860872|NCT02493946|463785298|FG000|Open Label Period|Withdrawal by Subject|0|||
128860873|NCT02493946|463785299|FG001|Open Label Period|Withdrawal by Subject|0|||
128860874|NCT02493946|463785300|FG002|Open Label Period|Withdrawal by Subject|74|||
128860875|NCT02493946|463785298|FG000|Open Label Period|Adverse Event|0|||
128860876|NCT02493946|463785299|FG001|Open Label Period|Adverse Event|0|||
128860877|NCT02493946|463785300|FG002|Open Label Period|Adverse Event|4|||
128860878|NCT02493946|463785298|FG000|Open Label Period|Lost to Follow-up|0|||
128860879|NCT02493946|463785299|FG001|Open Label Period|Lost to Follow-up|0|||
128860880|NCT02493946|463785300|FG002|Open Label Period|Lost to Follow-up|1|||
128860881|NCT02493946|463785298|FG000|Open Label Period|Investigator decision, non-compliance|0|||
128860882|NCT02493946|463785299|FG001|Open Label Period|Investigator decision, non-compliance|0|||
128860883|NCT02493946|463785300|FG002|Open Label Period|Investigator decision, non-compliance|2|||
128860884|NCT02493946|463785298|FG000|Open Label Period|Investigator decision, non-availability|0|||
128860885|NCT02493946|463785299|FG001|Open Label Period|Investigator decision, non-availability|0|||
128860886|NCT02493946|463785300|FG002|Open Label Period|Investigator decision, non-availability|1|||
128860887|NCT02493946|463785298|FG000|Open Label Period|Pregnancy|0|||
128860888|NCT02493946|463785299|FG001|Open Label Period|Pregnancy|0|||
128860889|NCT02493946|463785300|FG002|Open Label Period|Pregnancy|3|||
128860890|NCT02493946|463785298|FG000|Open Label Period|Site error|0|||
128860891|NCT02493946|463785299|FG001|Open Label Period|Site error|0|||
128860892|NCT02493946|463785300|FG002|Open Label Period|Site error|1|||
128860893|NCT03017742|463785304|FG000|Overall Study|Protocol Violation|36|||
128860894|NCT03017742|463785304|FG000|Overall Study|Withdrawal by Subject|37|||
128860895|NCT01727505|463785306|FG000|First 24 Hours|Adverse Event|0|||
128860896|NCT01727505|463785307|FG001|First 24 Hours|Adverse Event|1|||
128860897|NCT01727505|463785306|FG000|Second 24 Hours|Missing data|0|||
128860898|NCT01727505|463785307|FG001|Second 24 Hours|Missing data|1|||
128860899|NCT02389764|463785314|FG000|Overall Study|Lack of Efficacy|9|||
128860900|NCT01814072|463785315|FG000|Overall Study|Lost to Follow-up|2|||
128860901|NCT01814072|463785316|FG001|Overall Study|Lost to Follow-up|2|||
128860902|NCT01814072|463785317|FG002|Overall Study|Lost to Follow-up|2|||
128860903|NCT01814072|463785318|FG003|Overall Study|Lost to Follow-up|0|||
128860904|NCT01814072|463785319|FG004|Overall Study|Lost to Follow-up|2|||
128860905|NCT01814072|463785320|FG005|Overall Study|Lost to Follow-up|3|||
128860906|NCT01814072|463785321|FG006|Overall Study|Lost to Follow-up|3|||
128860907|NCT01814072|463785322|FG007|Overall Study|Lost to Follow-up|1|||
128860908|NCT01814072|463785323|FG008|Overall Study|Lost to Follow-up|2|||
128860909|NCT01814072|463785324|FG009|Overall Study|Lost to Follow-up|3|||
128860910|NCT01814072|463785325|FG010|Overall Study|Lost to Follow-up|1|||
128860911|NCT01814072|463785326|FG011|Overall Study|Lost to Follow-up|2|||
128860912|NCT01814072|463785327|FG012|Overall Study|Lost to Follow-up|2|||
128860913|NCT01814072|463785328|FG013|Overall Study|Lost to Follow-up|1|||
128860914|NCT01814072|463785329|FG014|Overall Study|Lost to Follow-up|2|||
128860915|NCT01814072|463785330|FG015|Overall Study|Lost to Follow-up|1|||
128860916|NCT01814072|463785331|FG016|Overall Study|Lost to Follow-up|3|||
128860917|NCT01814072|463785332|FG017|Overall Study|Lost to Follow-up|1|||
128860918|NCT01814072|463785333|FG018|Overall Study|Lost to Follow-up|3|||
128860919|NCT01814072|463785334|FG019|Overall Study|Lost to Follow-up|3|||
128860920|NCT01814072|463785335|FG020|Overall Study|Lost to Follow-up|2|||
128860921|NCT01814072|463785336|FG021|Overall Study|Lost to Follow-up|1|||
128860922|NCT01814072|463785337|FG022|Overall Study|Lost to Follow-up|3|||
128860923|NCT01814072|463785338|FG023|Overall Study|Lost to Follow-up|1|||
128860924|NCT01814072|463785339|FG024|Overall Study|Lost to Follow-up|4|||
128860925|NCT01814072|463785340|FG025|Overall Study|Lost to Follow-up|1|||
128860926|NCT01814072|463785341|FG026|Overall Study|Lost to Follow-up|1|||
128860927|NCT01814072|463785342|FG027|Overall Study|Lost to Follow-up|2|||
128860928|NCT01814072|463785343|FG028|Overall Study|Lost to Follow-up|3|||
128860929|NCT01814072|463785344|FG029|Overall Study|Lost to Follow-up|3|||
128860930|NCT01814072|463785345|FG030|Overall Study|Lost to Follow-up|2|||
128860931|NCT01814072|463785346|FG031|Overall Study|Lost to Follow-up|0|||
128860932|NCT01814072|463785315|FG000|Overall Study|Withdrawal by Subject|2|||
128860933|NCT01814072|463785316|FG001|Overall Study|Withdrawal by Subject|0|||
128860934|NCT01814072|463785317|FG002|Overall Study|Withdrawal by Subject|1|||
128860935|NCT01814072|463785318|FG003|Overall Study|Withdrawal by Subject|0|||
128860936|NCT01814072|463785319|FG004|Overall Study|Withdrawal by Subject|2|||
128860937|NCT01814072|463785320|FG005|Overall Study|Withdrawal by Subject|3|||
128860938|NCT01814072|463785321|FG006|Overall Study|Withdrawal by Subject|1|||
128860939|NCT01814072|463785322|FG007|Overall Study|Withdrawal by Subject|0|||
128860940|NCT01814072|463785323|FG008|Overall Study|Withdrawal by Subject|1|||
128860941|NCT01814072|463785324|FG009|Overall Study|Withdrawal by Subject|2|||
128860942|NCT01814072|463785325|FG010|Overall Study|Withdrawal by Subject|0|||
128860943|NCT01814072|463785326|FG011|Overall Study|Withdrawal by Subject|0|||
128860944|NCT01814072|463785327|FG012|Overall Study|Withdrawal by Subject|1|||
128860945|NCT01814072|463785328|FG013|Overall Study|Withdrawal by Subject|1|||
128860946|NCT01814072|463785329|FG014|Overall Study|Withdrawal by Subject|1|||
128860947|NCT01814072|463785330|FG015|Overall Study|Withdrawal by Subject|1|||
128860948|NCT01814072|463785331|FG016|Overall Study|Withdrawal by Subject|0|||
128860949|NCT01814072|463785332|FG017|Overall Study|Withdrawal by Subject|0|||
128860950|NCT01814072|463785333|FG018|Overall Study|Withdrawal by Subject|0|||
128860951|NCT01814072|463785334|FG019|Overall Study|Withdrawal by Subject|2|||
128860952|NCT01814072|463785335|FG020|Overall Study|Withdrawal by Subject|0|||
128860953|NCT01814072|463785336|FG021|Overall Study|Withdrawal by Subject|0|||
128860954|NCT01814072|463785337|FG022|Overall Study|Withdrawal by Subject|1|||
128860955|NCT01814072|463785338|FG023|Overall Study|Withdrawal by Subject|0|||
128860956|NCT01814072|463785339|FG024|Overall Study|Withdrawal by Subject|2|||
128860957|NCT01814072|463785340|FG025|Overall Study|Withdrawal by Subject|1|||
128860958|NCT01814072|463785341|FG026|Overall Study|Withdrawal by Subject|1|||
128860959|NCT01814072|463785342|FG027|Overall Study|Withdrawal by Subject|2|||
128860960|NCT01814072|463785343|FG028|Overall Study|Withdrawal by Subject|1|||
128860961|NCT01814072|463785344|FG029|Overall Study|Withdrawal by Subject|0|||
128860962|NCT01814072|463785345|FG030|Overall Study|Withdrawal by Subject|0|||
128860963|NCT01814072|463785346|FG031|Overall Study|Withdrawal by Subject|0|||
128860964|NCT01011868|463785347|FG000|After Week 18 Follow-up|Adverse Event|8|||
128860965|NCT01011868|463785348|FG001|After Week 18 Follow-up|Adverse Event|6|||
128860966|NCT01011868|463785349|FG002|After Week 18 Follow-up|Adverse Event|13|||
128860967|NCT01011868|463785347|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
128860968|NCT01011868|463785348|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
128860969|NCT01011868|463785349|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
128860970|NCT01011868|463785347|FG000|After Week 18 Follow-up|Protocol Violation|1|||
128860971|NCT01011868|463785348|FG001|After Week 18 Follow-up|Protocol Violation|1|||
128860972|NCT01011868|463785349|FG002|After Week 18 Follow-up|Protocol Violation|1|||
128860973|NCT01011868|463785347|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
128860974|NCT01011868|463785348|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
128860975|NCT01011868|463785349|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
128860976|NCT01011868|463785347|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
128860977|NCT01011868|463785348|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
128860978|NCT01011868|463785349|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
128860979|NCT01011868|463785347|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
128860980|NCT01011868|463785348|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
128860981|NCT01011868|463785349|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
128860982|NCT01011868|463785347|FG000|After Week 78 Follow-up|Adverse Event|14|||
128860983|NCT01011868|463785348|FG001|After Week 78 Follow-up|Adverse Event|18|||
128860984|NCT01011868|463785349|FG002|After Week 78 Follow-up|Adverse Event|21|||
128860985|NCT01011868|463785347|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
128860986|NCT01011868|463785348|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
128860987|NCT01011868|463785349|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
128860988|NCT01011868|463785347|FG000|After Week 78 Follow-up|Protocol Violation|9|||
128860989|NCT01011868|463785348|FG001|After Week 78 Follow-up|Protocol Violation|1|||
128860990|NCT01011868|463785349|FG002|After Week 78 Follow-up|Protocol Violation|2|||
128860991|NCT01011868|463785347|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
128860992|NCT01011868|463785348|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
128860993|NCT01011868|463785349|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
128860994|NCT01011868|463785347|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
128860995|NCT01011868|463785348|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
128860996|NCT01011868|463785349|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
128860997|NCT01011868|463785347|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
128860998|NCT01011868|463785348|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
128860999|NCT01011868|463785349|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
128861000|NCT02336425|463785350|FG000|Overall Study|Study terminated.|2|||
128861001|NCT02336425|463785351|FG001|Overall Study|Study terminated.|2|||
128861002|NCT02336425|463785352|FG002|Overall Study|Study terminated.|3|||
128861003|NCT02336425|463785353|FG003|Overall Study|Study terminated.|3|||
128861004|NCT00978562|463785354|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
128861005|NCT01782690|463785355|FG000|Overall Study|Not reported|7|||
128861006|NCT01782690|463785355|FG000|Overall Study|Toxicity of gemcitabine|1|||
128861007|NCT01782690|463785355|FG000|Overall Study|Toxicity of erlotinib|1|||
128861008|NCT01782690|463785355|FG000|Overall Study|Lost to Follow-up|31|||
128861009|NCT01782690|463785355|FG000|Overall Study|Withdrawal of informed consent|2|||
128861010|NCT01782690|463785355|FG000|Overall Study|Absent rash|9|||
128861011|NCT01782690|463785355|FG000|Overall Study|Physician Decision|13|||
128861012|NCT01782690|463785355|FG000|Overall Study|Patient's wish|21|||
128861013|NCT01782690|463785355|FG000|Overall Study|Tumor progression|74|||
128861014|NCT01782690|463785355|FG000|Overall Study|Death|133|||
128861015|NCT01782690|463785355|FG000|Overall Study|Study completion unknown|7|||
128861016|NCT04946942|463785357|FG000|Overall Study|Lost to Follow-up|6|||
128861017|NCT04946942|463785358|FG001|Overall Study|Lost to Follow-up|2|||
128861018|NCT04946942|463785359|FG002|Overall Study|Lost to Follow-up|0|||
128861019|NCT04907357|463785360|FG000|Overall Study|Death|0|||
128861020|NCT04907357|463785361|FG001|Overall Study|Death|1|||
128861021|NCT04907357|463785360|FG000|Overall Study|Lost to Follow-up|9|||
128861022|NCT04907357|463785361|FG001|Overall Study|Lost to Follow-up|18|||
128861023|NCT04907357|463785360|FG000|Overall Study|Physician Decision|1|||
128861024|NCT04907357|463785361|FG001|Overall Study|Physician Decision|0|||
128861025|NCT04907357|463785360|FG000|Overall Study|Withdrawal by Subject|0|||
128861026|NCT04907357|463785361|FG001|Overall Study|Withdrawal by Subject|1|||
128861027|NCT04907357|463785360|FG000|Overall Study|Unable to attend visits|1|||
128861028|NCT04907357|463785361|FG001|Overall Study|Unable to attend visits|0|||
128861029|NCT04907357|463785360|FG000|Overall Study|Incarcerated|1|||
128861030|NCT04907357|463785361|FG001|Overall Study|Incarcerated|1|||
128861031|NCT01948076|463785362|FG000|Overall Study|Withdrawal by Subject|0|||
128861032|NCT01948076|463785363|FG001|Overall Study|Withdrawal by Subject|1|||
128861033|NCT00738283|463785367|FG000|Overall Study|Death|1|||
128861034|NCT00738283|463785367|FG000|Overall Study|Transfer to another facility|2|||
128861035|NCT00738283|463785367|FG000|Overall Study|Discharge home prior to end of study|1|||
128861036|NCT00486252|463785368|FG000|Overall Study|Adverse Event|7|||
128861037|NCT00486252|463785368|FG000|Overall Study|Lack of Efficacy|9|||
128861038|NCT00486252|463785368|FG000|Overall Study|Lost to Follow-up|24|||
128861039|NCT00486252|463785368|FG000|Overall Study|Other|18|||
128861040|NCT01261247|463785371|FG000|Overall Study|Ineligible|2|||
128861041|NCT01210651|463785372|FG000|Overall Study|Lost to Follow-up|1|||
128861042|NCT01210651|463785373|FG001|Overall Study|Lost to Follow-up|1|||
128861043|NCT01210651|463785372|FG000|Overall Study|schedule conflicts|1|||
128861044|NCT01210651|463785373|FG001|Overall Study|schedule conflicts|5|||
128861045|NCT01210651|463785372|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
128861046|NCT01210651|463785373|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
128861047|NCT01210651|463785372|FG000|Overall Study|Withdrawal by Subject|1|||
128861048|NCT01210651|463785373|FG001|Overall Study|Withdrawal by Subject|1|||
128861049|NCT01210651|463785372|FG000|Overall Study|Injury outside study|2|||
128861050|NCT01210651|463785373|FG001|Overall Study|Injury outside study|0|||
128861051|NCT02592707|463785377|FG000|Overall Study|Consent Withdrawn|0|||
128861052|NCT02592707|463785378|FG001|Overall Study|Consent Withdrawn|1|||
128861053|NCT02592707|463785379|FG002|Overall Study|Consent Withdrawn|2|||
128861054|NCT02592707|463785380|FG003|Overall Study|Consent Withdrawn|0|||
128861055|NCT02592707|463785377|FG000|Overall Study|Death|1|||
128861056|NCT02592707|463785378|FG001|Overall Study|Death|0|||
128861057|NCT02592707|463785379|FG002|Overall Study|Death|0|||
128861058|NCT02592707|463785380|FG003|Overall Study|Death|0|||
128861059|NCT02592707|463785377|FG000|Overall Study|Progressive Disease|4|||
128861060|NCT02592707|463785378|FG001|Overall Study|Progressive Disease|4|||
128861061|NCT02592707|463785379|FG002|Overall Study|Progressive Disease|3|||
128861062|NCT02592707|463785380|FG003|Overall Study|Progressive Disease|3|||
128861063|NCT02592707|463785377|FG000|Overall Study|Other|0|||
128861064|NCT02592707|463785378|FG001|Overall Study|Other|0|||
128861065|NCT02592707|463785379|FG002|Overall Study|Other|1|||
128861066|NCT02592707|463785380|FG003|Overall Study|Other|2|||
128861067|NCT02592707|463785377|FG000|Overall Study|Never entered LTFU period|1|||
128861068|NCT02592707|463785378|FG001|Overall Study|Never entered LTFU period|0|||
128861069|NCT02592707|463785379|FG002|Overall Study|Never entered LTFU period|0|||
128861070|NCT02592707|463785380|FG003|Overall Study|Never entered LTFU period|2|||
128861071|NCT04124471|463785381|FG000|Overall Study|screen failure|1|||
128861072|NCT04855734|463785382|FG000|Overall Study|Lost to Follow-up|2|||
128861073|NCT04855734|463785383|FG001|Overall Study|Lost to Follow-up|2|||
128861074|NCT03732677|463785384|FG000|Overall Study|Terminated the study|154|||
128861075|NCT03732677|463785385|FG001|Overall Study|Terminated the study|197|||
128861076|NCT03732677|463785384|FG000|Overall Study|Continuing study off treatment|379|||
128861077|NCT03732677|463785385|FG001|Overall Study|Continuing study off treatment|333|||
128861078|NCT04013971|463785386|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
128861079|NCT04013971|463785387|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
128861080|NCT04013971|463785386|FG000|Overall Study|Missing biomechanical data|0|||
128861081|NCT04013971|463785387|FG001|Overall Study|Missing biomechanical data|1|||
128861082|NCT00344032|463785393|FG000|Overall Study|Adverse Event|0|||
128861083|NCT00344032|463785394|FG001|Overall Study|Adverse Event|1|||
128861084|NCT00344032|463785393|FG000|Overall Study|Withdrawal by Subject|6|||
128861085|NCT00344032|463785394|FG001|Overall Study|Withdrawal by Subject|2|||
128861086|NCT00344032|463785393|FG000|Overall Study|Lost to Follow-up|4|||
128861087|NCT00344032|463785394|FG001|Overall Study|Lost to Follow-up|6|||
128861088|NCT00344032|463785393|FG000|Overall Study|Physician Decision|4|||
128861089|NCT00344032|463785394|FG001|Overall Study|Physician Decision|1|||
128861090|NCT02065882|463785395|FG000|Part I: PK/PD|Screening failure|5|||
128861091|NCT02065882|463785395|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
128861092|NCT02065882|463785395|FG000|Part I: PK/PD|Adverse Event|1|||
128861093|NCT02065882|463785395|FG000|Part II: Clinical Efficacy|Screening failure|7|||
128861094|NCT02065882|463785395|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
128861095|NCT02065882|463785395|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
128861096|NCT02065882|463785395|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
128861097|NCT02065882|463785395|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
128861098|NCT02065882|463785395|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
128861099|NCT06840769|463785396|FG000|Overall Study|Withdrawal by Subject|1|||
128861100|NCT06840769|463785397|FG001|Overall Study|Withdrawal by Subject|0|||
128861101|NCT06840769|463785398|FG002|Overall Study|Withdrawal by Subject|0|||
128861102|NCT06840769|463785399|FG003|Overall Study|Withdrawal by Subject|0|||
128861103|NCT06840769|463785400|FG004|Overall Study|Withdrawal by Subject|0|||
128861104|NCT03192462|463787962|FG000|Overall Study|Death|13|||
128861105|NCT03192462|463787963|FG001|Overall Study|Death|11|||
128861106|NCT03192462|463787964|FG002|Overall Study|Death|9|||
128861107|NCT03192462|463787962|FG000|Overall Study|Lost to Follow-up|0|||
128861108|NCT03192462|463787963|FG001|Overall Study|Lost to Follow-up|1|||
128861109|NCT03192462|463787964|FG002|Overall Study|Lost to Follow-up|0|||
128861110|NCT03192462|463787962|FG000|Overall Study|On follow up|0|||
128861111|NCT03192462|463787963|FG001|Overall Study|On follow up|0|||
128861112|NCT03192462|463787964|FG002|Overall Study|On follow up|3|||
128861113|NCT02419417|463787965|FG000|Overall Study|Disease progression|5|||
128861114|NCT02419417|463787966|FG001|Overall Study|Disease progression|4|||
128861115|NCT02419417|463787967|FG002|Overall Study|Disease progression|13|||
128861116|NCT02419417|463787968|FG003|Overall Study|Disease progression|10|||
128861117|NCT02419417|463787969|FG004|Overall Study|Disease progression|10|||
128861118|NCT02419417|463787970|FG005|Overall Study|Disease progression|3|||
128861119|NCT02419417|463787971|FG006|Overall Study|Disease progression|4|||
128861120|NCT02419417|463787972|FG007|Overall Study|Disease progression|5|||
128861121|NCT02419417|463787973|FG008|Overall Study|Disease progression|13|||
128861122|NCT02419417|463787974|FG009|Overall Study|Disease progression|9|||
128861123|NCT02419417|463787975|FG010|Overall Study|Disease progression|0|||
128861124|NCT02419417|463787965|FG000|Overall Study|Study drug toxicity|0|||
128861125|NCT02419417|463787966|FG001|Overall Study|Study drug toxicity|0|||
128861126|NCT02419417|463787967|FG002|Overall Study|Study drug toxicity|0|||
128861127|NCT02419417|463787968|FG003|Overall Study|Study drug toxicity|0|||
128861128|NCT02419417|463787969|FG004|Overall Study|Study drug toxicity|1|||
128861129|NCT02419417|463787970|FG005|Overall Study|Study drug toxicity|0|||
128861130|NCT02419417|463787971|FG006|Overall Study|Study drug toxicity|0|||
128861131|NCT02419417|463787972|FG007|Overall Study|Study drug toxicity|0|||
128861132|NCT02419417|463787973|FG008|Overall Study|Study drug toxicity|0|||
128861133|NCT02419417|463787974|FG009|Overall Study|Study drug toxicity|0|||
128861134|NCT02419417|463787975|FG010|Overall Study|Study drug toxicity|0|||
128861135|NCT02419417|463787965|FG000|Overall Study|Adverse event unrelated to study drug|0|||
128861136|NCT02419417|463787966|FG001|Overall Study|Adverse event unrelated to study drug|0|||
128861137|NCT02419417|463787967|FG002|Overall Study|Adverse event unrelated to study drug|0|||
128861138|NCT02419417|463787968|FG003|Overall Study|Adverse event unrelated to study drug|0|||
128861139|NCT02419417|463787969|FG004|Overall Study|Adverse event unrelated to study drug|2|||
128861140|NCT02419417|463787970|FG005|Overall Study|Adverse event unrelated to study drug|1|||
128861141|NCT02419417|463787971|FG006|Overall Study|Adverse event unrelated to study drug|0|||
128861142|NCT02419417|463787972|FG007|Overall Study|Adverse event unrelated to study drug|1|||
128861143|NCT02419417|463787973|FG008|Overall Study|Adverse event unrelated to study drug|0|||
128861144|NCT02419417|463787974|FG009|Overall Study|Adverse event unrelated to study drug|0|||
128861145|NCT02419417|463787975|FG010|Overall Study|Adverse event unrelated to study drug|0|||
128861146|NCT02419417|463787965|FG000|Overall Study|Participant request to discontinue|0|||
128861147|NCT02419417|463787966|FG001|Overall Study|Participant request to discontinue|0|||
128861148|NCT02419417|463787967|FG002|Overall Study|Participant request to discontinue|0|||
128861149|NCT02419417|463787968|FG003|Overall Study|Participant request to discontinue|0|||
128861150|NCT02419417|463787969|FG004|Overall Study|Participant request to discontinue|0|||
128861151|NCT02419417|463787970|FG005|Overall Study|Participant request to discontinue|0|||
128861152|NCT02419417|463787971|FG006|Overall Study|Participant request to discontinue|0|||
128861153|NCT02419417|463787972|FG007|Overall Study|Participant request to discontinue|0|||
128861154|NCT02419417|463787973|FG008|Overall Study|Participant request to discontinue|0|||
128861155|NCT02419417|463787974|FG009|Overall Study|Participant request to discontinue|1|||
128861156|NCT02419417|463787975|FG010|Overall Study|Participant request to discontinue|0|||
128861157|NCT02419417|463787965|FG000|Overall Study|Withdrawal by Subject|0|||
128861158|NCT02419417|463787966|FG001|Overall Study|Withdrawal by Subject|0|||
128861159|NCT02419417|463787967|FG002|Overall Study|Withdrawal by Subject|0|||
128861160|NCT02419417|463787968|FG003|Overall Study|Withdrawal by Subject|0|||
128861161|NCT02419417|463787969|FG004|Overall Study|Withdrawal by Subject|0|||
128861162|NCT02419417|463787970|FG005|Overall Study|Withdrawal by Subject|0|||
128861163|NCT02419417|463787971|FG006|Overall Study|Withdrawal by Subject|0|||
128861164|NCT02419417|463787972|FG007|Overall Study|Withdrawal by Subject|0|||
128861165|NCT02419417|463787973|FG008|Overall Study|Withdrawal by Subject|0|||
128861166|NCT02419417|463787974|FG009|Overall Study|Withdrawal by Subject|0|||
128861167|NCT02419417|463787975|FG010|Overall Study|Withdrawal by Subject|1|||
128861168|NCT00078377|463787976|FG000|Overall Study|Adverse Event|2|||
128861169|NCT00078377|463787977|FG001|Overall Study|Adverse Event|5|||
128861170|NCT00078377|463787978|FG002|Overall Study|Adverse Event|1|||
128861171|NCT00078377|463787976|FG000|Overall Study|Lack of Efficacy|2|||
128861172|NCT00078377|463787977|FG001|Overall Study|Lack of Efficacy|0|||
128861173|NCT00078377|463787978|FG002|Overall Study|Lack of Efficacy|2|||
128861174|NCT00078377|463787976|FG000|Overall Study|Lost to Follow-up|0|||
128861175|NCT00078377|463787977|FG001|Overall Study|Lost to Follow-up|1|||
128861176|NCT00078377|463787978|FG002|Overall Study|Lost to Follow-up|1|||
128861177|NCT00078377|463787976|FG000|Overall Study|Physician Decision|2|||
128861178|NCT00078377|463787977|FG001|Overall Study|Physician Decision|0|||
128861179|NCT00078377|463787978|FG002|Overall Study|Physician Decision|0|||
128861180|NCT00078377|463787976|FG000|Overall Study|Withdrawal by Subject|3|||
128861181|NCT00078377|463787977|FG001|Overall Study|Withdrawal by Subject|4|||
128861182|NCT00078377|463787978|FG002|Overall Study|Withdrawal by Subject|4|||
128861183|NCT00078377|463787976|FG000|Overall Study|Miscellaneous|2|||
128861184|NCT00078377|463787977|FG001|Overall Study|Miscellaneous|6|||
128861185|NCT00078377|463787978|FG002|Overall Study|Miscellaneous|1|||
128861186|NCT00953147|463787979|FG000|Overall Study|Adverse Event|8|||
128861187|NCT00953147|463787980|FG001|Overall Study|Adverse Event|16|||
128861188|NCT00953147|463787981|FG002|Overall Study|Adverse Event|6|||
128861189|NCT00953147|463787979|FG000|Overall Study|Protocol Violation|2|||
128861190|NCT00953147|463787980|FG001|Overall Study|Protocol Violation|8|||
128861191|NCT00953147|463787981|FG002|Overall Study|Protocol Violation|4|||
128861192|NCT00953147|463787979|FG000|Overall Study|Withdrawal by Subject|13|||
128861193|NCT00953147|463787980|FG001|Overall Study|Withdrawal by Subject|15|||
128861194|NCT00953147|463787981|FG002|Overall Study|Withdrawal by Subject|12|||
128861195|NCT00953147|463787979|FG000|Overall Study|Lost to Follow-up|8|||
128861196|NCT00953147|463787980|FG001|Overall Study|Lost to Follow-up|9|||
128861197|NCT00953147|463787981|FG002|Overall Study|Lost to Follow-up|4|||
128861198|NCT00953147|463787979|FG000|Overall Study|Physician Decision|2|||
128861199|NCT00953147|463787980|FG001|Overall Study|Physician Decision|7|||
128861200|NCT00953147|463787981|FG002|Overall Study|Physician Decision|3|||
128861201|NCT00953147|463787979|FG000|Overall Study|Other|4|||
128861202|NCT00953147|463787980|FG001|Overall Study|Other|11|||
128861203|NCT00953147|463787981|FG002|Overall Study|Other|13|||
128861204|NCT00790400|463787982|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
128861205|NCT00790400|463787983|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
128861206|NCT00790400|463787982|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
128861207|NCT00790400|463787983|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
128861208|NCT00790400|463787982|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
128861209|NCT00790400|463787983|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
128861210|NCT00790400|463787982|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
128861211|NCT00790400|463787983|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
128861212|NCT00790400|463787982|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
128861213|NCT00790400|463787983|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
128861214|NCT00790400|463787982|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
128861215|NCT00790400|463787983|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
128861216|NCT00790400|463787982|FG000|Double-blind Period (Core Phase)|Death|1|||
128861217|NCT00790400|463787983|FG001|Double-blind Period (Core Phase)|Death|0|||
128861218|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
128861219|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
128861220|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
128861221|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
128861222|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
128861223|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
128861224|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
128861225|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
128861226|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
128861227|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
128861228|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Death|1|||
128861229|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Death|0|||
128861230|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
128861231|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
128861232|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
128861233|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
128861234|NCT00790400|463787982|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
128861235|NCT00790400|463787983|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
128861236|NCT00078338|463787984|FG000|Overall Study|Adverse Event|31|||
128861237|NCT00078338|463787985|FG001|Overall Study|Adverse Event|24|||
128861238|NCT00078338|463787984|FG000|Overall Study|Lost to Follow-up|17|||
128861239|NCT00078338|463787985|FG001|Overall Study|Lost to Follow-up|2|||
128861240|NCT00078338|463787984|FG000|Overall Study|Protocol Violation|2|||
128861241|NCT00078338|463787985|FG001|Overall Study|Protocol Violation|2|||
128861242|NCT00078338|463787984|FG000|Overall Study|Disease Progression|4|||
128861243|NCT00078338|463787985|FG001|Overall Study|Disease Progression|7|||
128861244|NCT00078338|463787984|FG000|Overall Study|Other|28|||
128861245|NCT00078338|463787985|FG001|Overall Study|Other|16|||
128861246|NCT00078338|463787984|FG000|Overall Study|Subjects randomized, but not treated|3|||
128861247|NCT00078338|463787985|FG001|Overall Study|Subjects randomized, but not treated|3|||
128861248|NCT03258723|463787986|FG000|Overall Study|COVID Interruption of study|54|||
128861249|NCT03258723|463787986|FG000|Overall Study|Lost to Follow-up|8|||
128861250|NCT01594827|463787990|FG000|Overall Study|Adverse Event|1|||
128861251|NCT01594827|463787991|FG001|Overall Study|Adverse Event|0|||
128861252|NCT01594827|463787990|FG000|Overall Study|Physician Decision|3|||
128861253|NCT01594827|463787991|FG001|Overall Study|Physician Decision|0|||
128861254|NCT02153905|463787992|FG000|Overall Study|Death|1|||
128861255|NCT02153905|463787993|FG001|Overall Study|Death|0|||
128861256|NCT01516749|463787998|FG000|Active Therapy|Lost to Follow-up|1|||
128861257|NCT01516749|463787998|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
128861258|NCT00351377|463787999|FG000|Overall Study|Adverse Event|5|||
128861259|NCT00351377|463787999|FG000|Overall Study|Death|1|||
128861260|NCT00351377|463787999|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
128861261|NCT01607879|463788000|FG000|Overall Study|Death|1|||
128861262|NCT01607879|463788001|FG001|Overall Study|Death|0|||
128861263|NCT03845140|463788004|FG000|Overall Study|Participant travelled outside study area|0|||
128861264|NCT03845140|463788005|FG001|Overall Study|Participant travelled outside study area|1|||
128861265|NCT03845140|463788006|FG002|Overall Study|Participant travelled outside study area|0|||
128861266|NCT03845140|463788007|FG003|Overall Study|Participant travelled outside study area|0|||
128861267|NCT03845140|463788008|FG004|Overall Study|Participant travelled outside study area|0|||
128861268|NCT03845140|463788009|FG005|Overall Study|Participant travelled outside study area|0|||
128861269|NCT01592045|463788015|FG000|Overall Study|Disease Progression|1|||
128861270|NCT01592045|463788016|FG001|Overall Study|Disease Progression|1|||
128861271|NCT01592045|463788015|FG000|Overall Study|Adverse Event|1|||
128861272|NCT01592045|463788016|FG001|Overall Study|Adverse Event|1|||
128861273|NCT01592045|463788015|FG000|Overall Study|Withdrawal by Subject|1|||
128861274|NCT01592045|463788016|FG001|Overall Study|Withdrawal by Subject|0|||
128861275|NCT01592045|463788015|FG000|Overall Study|Moved out of country|2|||
128861276|NCT01592045|463788016|FG001|Overall Study|Moved out of country|0|||
128861277|NCT03994731|463788017|FG000|Pegloticase + IMM Period|Death|2|||
128861278|NCT03994731|463788018|FG001|Pegloticase + IMM Period|Death|0|||
128861279|NCT03994731|463788017|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
128861280|NCT03994731|463788018|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
128861281|NCT03994731|463788017|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
128861282|NCT03994731|463788018|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
128861283|NCT03812029|463788026|FG000|Overall Study|Protocol Violation|1|||
128861284|NCT03812029|463788027|FG001|Overall Study|Protocol Violation|0|||
128861285|NCT03812029|463788028|FG002|Overall Study|Protocol Violation|0|||
128861286|NCT03812029|463788029|FG003|Overall Study|Protocol Violation|1|||
128861287|NCT03812029|463788030|FG004|Overall Study|Protocol Violation|0|||
128861288|NCT03812029|463788026|FG000|Overall Study|Withdrawal by Subject|1|||
128861289|NCT03812029|463788027|FG001|Overall Study|Withdrawal by Subject|0|||
128861290|NCT03812029|463788028|FG002|Overall Study|Withdrawal by Subject|0|||
128861291|NCT03812029|463788029|FG003|Overall Study|Withdrawal by Subject|2|||
128861292|NCT03812029|463788030|FG004|Overall Study|Withdrawal by Subject|2|||
128861293|NCT03812029|463788026|FG000|Overall Study|Stopping rules|0|||
128861294|NCT03812029|463788027|FG001|Overall Study|Stopping rules|1|||
128861295|NCT03812029|463788028|FG002|Overall Study|Stopping rules|0|||
128861296|NCT03812029|463788029|FG003|Overall Study|Stopping rules|0|||
128861297|NCT03812029|463788030|FG004|Overall Study|Stopping rules|0|||
128861298|NCT03812029|463788026|FG000|Overall Study|Adverse Event|0|||
128861299|NCT03812029|463788027|FG001|Overall Study|Adverse Event|9|||
128861300|NCT03812029|463788028|FG002|Overall Study|Adverse Event|0|||
128861301|NCT03812029|463788029|FG003|Overall Study|Adverse Event|3|||
128861302|NCT03812029|463788030|FG004|Overall Study|Adverse Event|5|||
128861303|NCT03812029|463788026|FG000|Overall Study|Lost to Follow-up|0|||
128861304|NCT03812029|463788027|FG001|Overall Study|Lost to Follow-up|0|||
128861305|NCT03812029|463788028|FG002|Overall Study|Lost to Follow-up|0|||
128861306|NCT03812029|463788029|FG003|Overall Study|Lost to Follow-up|0|||
128861307|NCT03812029|463788030|FG004|Overall Study|Lost to Follow-up|3|||
128861308|NCT03149042|463788031|FG000|Overall Study|Invasive FFR not performed|21|||
128861309|NCT03149042|463788031|FG000|Overall Study|Poor CT Image Quality|1|||
128861310|NCT03149042|463788031|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
128861311|NCT00790205|463788032|FG000|Overall Study|Lost to Follow-up|61|||
128861312|NCT00790205|463788033|FG001|Overall Study|Lost to Follow-up|71|||
128861313|NCT00790205|463788032|FG000|Overall Study|Withdrawal by Subject|299|||
128861314|NCT00790205|463788033|FG001|Overall Study|Withdrawal by Subject|363|||
128861315|NCT02643628|463788034|FG000|Overall Study|Lost to Follow-up|1|||
128861316|NCT02643628|463788035|FG001|Overall Study|Lost to Follow-up|4|||
128861317|NCT02643628|463788034|FG000|Overall Study|Withdrawal by Subject|0|||
128861318|NCT02643628|463788035|FG001|Overall Study|Withdrawal by Subject|1|||
128861319|NCT02643628|463788034|FG000|Overall Study|Relocated out of state|0|||
128861320|NCT02643628|463788035|FG001|Overall Study|Relocated out of state|1|||
128861321|NCT04092452|463788043|FG000|Overall Study|Adverse Event|1|||
128861322|NCT04092452|463788044|FG001|Overall Study|Adverse Event|3|||
128861323|NCT04092452|463788045|FG002|Overall Study|Adverse Event|3|||
128861324|NCT04092452|463788046|FG003|Overall Study|Adverse Event|7|||
128861325|NCT04092452|463788043|FG000|Overall Study|Lack of Efficacy|1|||
128861326|NCT04092452|463788044|FG001|Overall Study|Lack of Efficacy|1|||
128861327|NCT04092452|463788045|FG002|Overall Study|Lack of Efficacy|1|||
128861328|NCT04092452|463788046|FG003|Overall Study|Lack of Efficacy|0|||
128861329|NCT04092452|463788043|FG000|Overall Study|Lost to Follow-up|4|||
128861330|NCT04092452|463788044|FG001|Overall Study|Lost to Follow-up|3|||
128861331|NCT04092452|463788045|FG002|Overall Study|Lost to Follow-up|5|||
128861332|NCT04092452|463788046|FG003|Overall Study|Lost to Follow-up|1|||
128861333|NCT04092452|463788043|FG000|Overall Study|Non-Compliance With Study Drug|0|||
128861334|NCT04092452|463788044|FG001|Overall Study|Non-Compliance With Study Drug|0|||
128861335|NCT04092452|463788045|FG002|Overall Study|Non-Compliance With Study Drug|1|||
128861336|NCT04092452|463788046|FG003|Overall Study|Non-Compliance With Study Drug|1|||
128861337|NCT04092452|463788043|FG000|Overall Study|Physician Decision|1|||
128861338|NCT04092452|463788044|FG001|Overall Study|Physician Decision|0|||
128861339|NCT04092452|463788045|FG002|Overall Study|Physician Decision|1|||
128861340|NCT04092452|463788046|FG003|Overall Study|Physician Decision|0|||
128861341|NCT04092452|463788043|FG000|Overall Study|Pregnancy|2|||
128861342|NCT04092452|463788044|FG001|Overall Study|Pregnancy|0|||
128861343|NCT04092452|463788045|FG002|Overall Study|Pregnancy|0|||
128861344|NCT04092452|463788046|FG003|Overall Study|Pregnancy|0|||
128861345|NCT04092452|463788043|FG000|Overall Study|Protocol Deviation|1|||
128861346|NCT04092452|463788044|FG001|Overall Study|Protocol Deviation|0|||
128861347|NCT04092452|463788045|FG002|Overall Study|Protocol Deviation|0|||
128861348|NCT04092452|463788046|FG003|Overall Study|Protocol Deviation|0|||
128861349|NCT04092452|463788043|FG000|Overall Study|Withdrawal by Subject|3|||
128861350|NCT04092452|463788044|FG001|Overall Study|Withdrawal by Subject|10|||
128861351|NCT04092452|463788045|FG002|Overall Study|Withdrawal by Subject|3|||
128861352|NCT04092452|463788046|FG003|Overall Study|Withdrawal by Subject|5|||
128861353|NCT04092452|463788043|FG000|Overall Study|Other|0|||
128861354|NCT04092452|463788044|FG001|Overall Study|Other|0|||
128861355|NCT04092452|463788045|FG002|Overall Study|Other|1|||
128861356|NCT04092452|463788046|FG003|Overall Study|Other|2|||
128861357|NCT02127125|463788047|FG000|Overall Study|Lost to Follow-up|0|||
128861358|NCT02127125|463788048|FG001|Overall Study|Lost to Follow-up|0|||
128861359|NCT02127125|463788049|FG002|Overall Study|Lost to Follow-up|0|||
128861360|NCT02127125|463788050|FG003|Overall Study|Lost to Follow-up|0|||
128861361|NCT02127125|463788051|FG004|Overall Study|Lost to Follow-up|2|||
128861362|NCT02127125|463788052|FG005|Overall Study|Lost to Follow-up|1|||
128861363|NCT02127125|463788053|FG006|Overall Study|Lost to Follow-up|0|||
128861364|NCT02127125|463788054|FG007|Overall Study|Lost to Follow-up|0|||
128861365|NCT02127125|463788055|FG008|Overall Study|Lost to Follow-up|0|||
128861366|NCT02127125|463788047|FG000|Overall Study|Withdrawal by Subject|0|||
128861367|NCT02127125|463788048|FG001|Overall Study|Withdrawal by Subject|0|||
128861368|NCT02127125|463788049|FG002|Overall Study|Withdrawal by Subject|0|||
128861369|NCT02127125|463788050|FG003|Overall Study|Withdrawal by Subject|1|||
128861370|NCT02127125|463788051|FG004|Overall Study|Withdrawal by Subject|0|||
128861371|NCT02127125|463788052|FG005|Overall Study|Withdrawal by Subject|0|||
128861372|NCT02127125|463788053|FG006|Overall Study|Withdrawal by Subject|0|||
128861373|NCT02127125|463788054|FG007|Overall Study|Withdrawal by Subject|0|||
128861374|NCT02127125|463788055|FG008|Overall Study|Withdrawal by Subject|0|||
128861375|NCT02127125|463788047|FG000|Overall Study|Physician Decision|0|||
128861376|NCT02127125|463788048|FG001|Overall Study|Physician Decision|0|||
128861377|NCT02127125|463788049|FG002|Overall Study|Physician Decision|1|||
128861378|NCT02127125|463788050|FG003|Overall Study|Physician Decision|0|||
128861379|NCT02127125|463788051|FG004|Overall Study|Physician Decision|1|||
128861380|NCT02127125|463788052|FG005|Overall Study|Physician Decision|2|||
128861381|NCT02127125|463788053|FG006|Overall Study|Physician Decision|0|||
128861382|NCT02127125|463788054|FG007|Overall Study|Physician Decision|0|||
128861383|NCT02127125|463788055|FG008|Overall Study|Physician Decision|0|||
128861384|NCT02353468|463788057|FG000|Overall Study|Study terminated|3|||
128861385|NCT00848484|463788058|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
128861386|NCT00848484|463788059|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
128861387|NCT00848484|463788058|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
128861388|NCT00848484|463788059|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
128861389|NCT00848484|463788058|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
128861390|NCT00848484|463788059|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
128861391|NCT00848484|463788058|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
128861392|NCT00848484|463788059|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
128861393|NCT00848484|463788058|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
128861394|NCT00848484|463788059|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
128861395|NCT03355209|463788062|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
128861396|NCT03355209|463788063|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
128861397|NCT03355209|463788064|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
128861398|NCT03355209|463788065|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
128861399|NCT03355209|463788066|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
128861400|NCT03355209|463788067|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
128861401|NCT03355209|463788062|FG000|Part 1: Double-Blind Period|Death|0|||
128861402|NCT03355209|463788063|FG001|Part 1: Double-Blind Period|Death|0|||
128861403|NCT03355209|463788064|FG002|Part 1: Double-Blind Period|Death|1|||
128861404|NCT03355209|463788065|FG003|Part 1: Double-Blind Period|Death|0|||
128861405|NCT03355209|463788066|FG004|Part 1: Double-Blind Period|Death|0|||
128861406|NCT03355209|463788067|FG005|Part 1: Double-Blind Period|Death|0|||
128861407|NCT03355209|463788062|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
128861408|NCT03355209|463788063|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
128861409|NCT03355209|463788064|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
128861410|NCT03355209|463788065|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
128861411|NCT03355209|463788066|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
128861412|NCT03355209|463788067|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
128861413|NCT03355209|463788062|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
128861414|NCT03355209|463788063|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
128861415|NCT03355209|463788064|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
128861416|NCT03355209|463788065|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
128861417|NCT03355209|463788066|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
128861418|NCT03355209|463788067|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
128861419|NCT03355209|463788062|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
128861420|NCT03355209|463788063|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
128861421|NCT03355209|463788064|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
128861422|NCT03355209|463788065|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
128861423|NCT03355209|463788066|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
128861424|NCT03355209|463788067|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
128861425|NCT03355209|463788062|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
128861426|NCT03355209|463788063|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
128861427|NCT03355209|463788064|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
128861428|NCT03355209|463788065|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
128861429|NCT03355209|463788066|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
128861430|NCT03355209|463788067|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
128861431|NCT03355209|463788062|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
128861432|NCT03355209|463788063|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
128861433|NCT03355209|463788064|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
128861434|NCT03355209|463788065|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
128861435|NCT03355209|463788066|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
128861436|NCT03355209|463788067|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
128861437|NCT03355209|463788062|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
128861438|NCT03355209|463788063|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
128861439|NCT03355209|463788064|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
128861440|NCT03355209|463788065|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
128861441|NCT03355209|463788066|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
128861442|NCT03355209|463788067|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
128861443|NCT03355209|463788062|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
128861444|NCT03355209|463788063|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
128861445|NCT03355209|463788064|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
128861446|NCT03355209|463788065|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128861447|NCT03355209|463788066|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
128861448|NCT03355209|463788067|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
128861449|NCT03355209|463788062|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
128861450|NCT03355209|463788063|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
128861451|NCT03355209|463788064|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
128861452|NCT03355209|463788065|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
128861453|NCT03355209|463788066|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
128861454|NCT03355209|463788067|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
128861455|NCT03355209|463788062|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
128861456|NCT03355209|463788063|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
128861457|NCT03355209|463788064|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
128861458|NCT03355209|463788065|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
128861459|NCT03355209|463788066|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
128861460|NCT03355209|463788067|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
128861461|NCT02975102|463788070|FG000|Overall Study|Adverse Event|2|||
128861462|NCT02975102|463788071|FG001|Overall Study|Adverse Event|1|||
128861463|NCT01441635|463788075|FG000|Overall Study|Adverse Event|4|||
128861464|NCT01441635|463788076|FG001|Overall Study|Adverse Event|3|||
128861465|NCT01441635|463788077|FG002|Overall Study|Adverse Event|1|||
128861466|NCT01441635|463788078|FG003|Overall Study|Adverse Event|5|||
128861467|NCT01441635|463788079|FG004|Overall Study|Adverse Event|1|||
128861468|NCT01441635|463788080|FG005|Overall Study|Adverse Event|2|||
128861469|NCT01441635|463788081|FG006|Overall Study|Adverse Event|2|||
128861470|NCT01441635|463788082|FG007|Overall Study|Adverse Event|2|||
128861471|NCT01441635|463788083|FG008|Overall Study|Adverse Event|1|||
128861472|NCT01441635|463788084|FG009|Overall Study|Adverse Event|0|||
128861473|NCT01441635|463788075|FG000|Overall Study|Withdrawal by Subject|1|||
128861474|NCT01441635|463788076|FG001|Overall Study|Withdrawal by Subject|1|||
128861475|NCT01441635|463788077|FG002|Overall Study|Withdrawal by Subject|0|||
128861476|NCT01441635|463788078|FG003|Overall Study|Withdrawal by Subject|1|||
128861477|NCT01441635|463788079|FG004|Overall Study|Withdrawal by Subject|0|||
128861478|NCT01441635|463788080|FG005|Overall Study|Withdrawal by Subject|0|||
128861479|NCT01441635|463788081|FG006|Overall Study|Withdrawal by Subject|2|||
128861480|NCT01441635|463788082|FG007|Overall Study|Withdrawal by Subject|0|||
128861481|NCT01441635|463788083|FG008|Overall Study|Withdrawal by Subject|1|||
128861482|NCT01441635|463788084|FG009|Overall Study|Withdrawal by Subject|1|||
128861483|NCT01441635|463788075|FG000|Overall Study|Lost to Follow-up|0|||
128861484|NCT01441635|463788076|FG001|Overall Study|Lost to Follow-up|1|||
128861485|NCT01441635|463788077|FG002|Overall Study|Lost to Follow-up|1|||
128861486|NCT01441635|463788078|FG003|Overall Study|Lost to Follow-up|1|||
128861487|NCT01441635|463788079|FG004|Overall Study|Lost to Follow-up|1|||
128861488|NCT01441635|463788080|FG005|Overall Study|Lost to Follow-up|3|||
128861489|NCT01441635|463788081|FG006|Overall Study|Lost to Follow-up|1|||
128861490|NCT01441635|463788082|FG007|Overall Study|Lost to Follow-up|1|||
128861491|NCT01441635|463788083|FG008|Overall Study|Lost to Follow-up|0|||
128861492|NCT01441635|463788084|FG009|Overall Study|Lost to Follow-up|1|||
128861493|NCT01441635|463788075|FG000|Overall Study|Noncompliance|0|||
128861494|NCT01441635|463788076|FG001|Overall Study|Noncompliance|1|||
128861495|NCT01441635|463788077|FG002|Overall Study|Noncompliance|0|||
128861496|NCT01441635|463788078|FG003|Overall Study|Noncompliance|0|||
128861497|NCT01441635|463788079|FG004|Overall Study|Noncompliance|0|||
128861498|NCT01441635|463788080|FG005|Overall Study|Noncompliance|0|||
128861499|NCT01441635|463788081|FG006|Overall Study|Noncompliance|1|||
128861500|NCT01441635|463788082|FG007|Overall Study|Noncompliance|0|||
128861501|NCT01441635|463788083|FG008|Overall Study|Noncompliance|0|||
128861502|NCT01441635|463788084|FG009|Overall Study|Noncompliance|0|||
128861503|NCT01441635|463788075|FG000|Overall Study|Surgery or Invasive Intervention|0|||
128861504|NCT01441635|463788076|FG001|Overall Study|Surgery or Invasive Intervention|0|||
128861505|NCT01441635|463788077|FG002|Overall Study|Surgery or Invasive Intervention|1|||
128861506|NCT01441635|463788078|FG003|Overall Study|Surgery or Invasive Intervention|0|||
128861507|NCT01441635|463788079|FG004|Overall Study|Surgery or Invasive Intervention|0|||
128861508|NCT01441635|463788080|FG005|Overall Study|Surgery or Invasive Intervention|0|||
128861509|NCT01441635|463788081|FG006|Overall Study|Surgery or Invasive Intervention|0|||
128861510|NCT01441635|463788082|FG007|Overall Study|Surgery or Invasive Intervention|0|||
128861511|NCT01441635|463788083|FG008|Overall Study|Surgery or Invasive Intervention|0|||
128861512|NCT01441635|463788084|FG009|Overall Study|Surgery or Invasive Intervention|0|||
128861513|NCT01441635|463788075|FG000|Overall Study|Received Exclusionary Medication|1|||
128861514|NCT01441635|463788076|FG001|Overall Study|Received Exclusionary Medication|0|||
128861515|NCT01441635|463788077|FG002|Overall Study|Received Exclusionary Medication|0|||
128861516|NCT01441635|463788078|FG003|Overall Study|Received Exclusionary Medication|0|||
128861517|NCT01441635|463788079|FG004|Overall Study|Received Exclusionary Medication|0|||
128861518|NCT01441635|463788080|FG005|Overall Study|Received Exclusionary Medication|0|||
128861519|NCT01441635|463788081|FG006|Overall Study|Received Exclusionary Medication|0|||
128861520|NCT01441635|463788082|FG007|Overall Study|Received Exclusionary Medication|0|||
128861521|NCT01441635|463788083|FG008|Overall Study|Received Exclusionary Medication|0|||
128861522|NCT01441635|463788084|FG009|Overall Study|Received Exclusionary Medication|0|||
128861523|NCT01441635|463788075|FG000|Overall Study|Other|0|||
128861524|NCT01441635|463788076|FG001|Overall Study|Other|0|||
128861525|NCT01441635|463788077|FG002|Overall Study|Other|0|||
128861526|NCT01441635|463788078|FG003|Overall Study|Other|0|||
128861527|NCT01441635|463788079|FG004|Overall Study|Other|0|||
128861528|NCT01441635|463788080|FG005|Overall Study|Other|0|||
128861529|NCT01441635|463788081|FG006|Overall Study|Other|0|||
128861530|NCT01441635|463788082|FG007|Overall Study|Other|1|||
128861531|NCT01441635|463788083|FG008|Overall Study|Other|0|||
128861532|NCT01441635|463788084|FG009|Overall Study|Other|0|||
128861533|NCT01825577|463788085|FG000|Overall Study|Physician Decision|2|||
128861534|NCT01825577|463788085|FG000|Overall Study|Withdrawal by Subject|1|||
128861535|NCT01825577|463788085|FG000|Overall Study|Withdrawn by family members|2|||
128861536|NCT01825577|463788085|FG000|Overall Study|Lack of Efficacy|3|||
128861537|NCT00358644|463788086|FG000|Overall Study|Progressive Disease|21|||
128861538|NCT00358644|463788086|FG000|Overall Study|Adverse Event|7|||
128861539|NCT00358644|463788086|FG000|Overall Study|Death|11|||
128861540|NCT00358644|463788086|FG000|Overall Study|Withdrawal by Subject|4|||
128861541|NCT00358644|463788086|FG000|Overall Study|Physician Decision|6|||
128861542|NCT00358644|463788086|FG000|Overall Study|Patient not eligible for study|1|||
128861543|NCT01358331|463788087|FG000|Overall Study|Lost to Follow-up|0|||
128861544|NCT01358331|463788088|FG001|Overall Study|Lost to Follow-up|0|||
128861545|NCT01358331|463788089|FG002|Overall Study|Lost to Follow-up|0|||
128861546|NCT01358331|463788090|FG003|Overall Study|Lost to Follow-up|1|||
128861547|NCT01358331|463788091|FG004|Overall Study|Lost to Follow-up|0|||
128861548|NCT01358331|463788092|FG005|Overall Study|Lost to Follow-up|0|||
128861549|NCT01358331|463788087|FG000|Overall Study|Withdrawal by Subject|0|||
128861550|NCT01358331|463788088|FG001|Overall Study|Withdrawal by Subject|0|||
128861551|NCT01358331|463788089|FG002|Overall Study|Withdrawal by Subject|0|||
128861552|NCT01358331|463788090|FG003|Overall Study|Withdrawal by Subject|1|||
128861553|NCT01358331|463788091|FG004|Overall Study|Withdrawal by Subject|1|||
128861554|NCT01358331|463788092|FG005|Overall Study|Withdrawal by Subject|1|||
128861555|NCT01358331|463788087|FG000|Overall Study|Adverse Events|1|||
128861556|NCT01358331|463788088|FG001|Overall Study|Adverse Events|1|||
128861557|NCT01358331|463788089|FG002|Overall Study|Adverse Events|1|||
128861558|NCT01358331|463788090|FG003|Overall Study|Adverse Events|0|||
128861559|NCT01358331|463788091|FG004|Overall Study|Adverse Events|1|||
128861560|NCT01358331|463788092|FG005|Overall Study|Adverse Events|5|||
128861561|NCT01358331|463788087|FG000|Overall Study|Symptomatic Deterioration|0|||
128861562|NCT01358331|463788088|FG001|Overall Study|Symptomatic Deterioration|0|||
128861563|NCT01358331|463788089|FG002|Overall Study|Symptomatic Deterioration|0|||
128861564|NCT01358331|463788090|FG003|Overall Study|Symptomatic Deterioration|0|||
128861565|NCT01358331|463788091|FG004|Overall Study|Symptomatic Deterioration|1|||
128861566|NCT01358331|463788092|FG005|Overall Study|Symptomatic Deterioration|0|||
128861567|NCT01358331|463788087|FG000|Overall Study|Participants did not wish to continue|0|||
128861568|NCT01358331|463788088|FG001|Overall Study|Participants did not wish to continue|0|||
128861569|NCT01358331|463788089|FG002|Overall Study|Participants did not wish to continue|0|||
128861570|NCT01358331|463788090|FG003|Overall Study|Participants did not wish to continue|0|||
128861571|NCT01358331|463788091|FG004|Overall Study|Participants did not wish to continue|1|||
128861572|NCT01358331|463788092|FG005|Overall Study|Participants did not wish to continue|0|||
128861573|NCT01358331|463788087|FG000|Overall Study|Progress of disease under investigation|1|||
128861574|NCT01358331|463788088|FG001|Overall Study|Progress of disease under investigation|2|||
128861575|NCT01358331|463788089|FG002|Overall Study|Progress of disease under investigation|3|||
128861576|NCT01358331|463788090|FG003|Overall Study|Progress of disease under investigation|1|||
128861577|NCT01358331|463788091|FG004|Overall Study|Progress of disease under investigation|3|||
128861578|NCT01358331|463788092|FG005|Overall Study|Progress of disease under investigation|0|||
128861579|NCT03327831|463788093|FG000|Overall Study|Lost to Follow-up|2|||
128861580|NCT03274895|463788096|FG000|Overall Study|Lack of Efficacy|1|||
128861581|NCT03274895|463788097|FG001|Overall Study|Lack of Efficacy|0|||
128861582|NCT03274895|463788096|FG000|Overall Study|Adverse Event|8|||
128861583|NCT03274895|463788097|FG001|Overall Study|Adverse Event|7|||
128861584|NCT03274895|463788096|FG000|Overall Study|Lost to Follow-up|1|||
128861585|NCT03274895|463788097|FG001|Overall Study|Lost to Follow-up|0|||
128861586|NCT03274895|463788096|FG000|Overall Study|Diagnosis not confirmed|3|||
128861587|NCT03274895|463788097|FG001|Overall Study|Diagnosis not confirmed|4|||
128861588|NCT03332784|463788101|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861589|NCT03332784|463788102|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
128861590|NCT03332784|463788103|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861591|NCT03332784|463788104|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861592|NCT03332784|463788105|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861593|NCT03332784|463788106|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861594|NCT03332784|463788107|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861595|NCT03332784|463788108|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861596|NCT03332784|463788109|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861597|NCT03332784|463788110|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861598|NCT03332784|463788111|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861599|NCT03332784|463788112|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861600|NCT03332784|463788113|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861601|NCT03332784|463788114|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861602|NCT03332784|463788115|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
128861603|NCT03332784|463788116|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861604|NCT03332784|463788117|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861605|NCT03332784|463788118|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861606|NCT03332784|463788119|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861607|NCT03332784|463788120|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
128861608|NCT00401258|463788121|FG000|Overall Study|Adverse Event|7|||
128861609|NCT01969851|463788126|FG000|Overall Study|Adverse Event|0|||
128861610|NCT01969851|463788127|FG001|Overall Study|Adverse Event|0|||
128861611|NCT01969851|463788128|FG002|Overall Study|Adverse Event|3|||
128861612|NCT01969851|463788126|FG000|Overall Study|Lack of Efficacy|0|||
128861613|NCT01969851|463788127|FG001|Overall Study|Lack of Efficacy|3|||
128861614|NCT01969851|463788128|FG002|Overall Study|Lack of Efficacy|1|||
128861615|NCT01969851|463788126|FG000|Overall Study|Withdrawal by Subject|1|||
128861616|NCT01969851|463788127|FG001|Overall Study|Withdrawal by Subject|0|||
128861617|NCT01969851|463788128|FG002|Overall Study|Withdrawal by Subject|1|||
128861618|NCT01969851|463788126|FG000|Overall Study|No effective dose in Titration period|0|||
128861619|NCT01969851|463788127|FG001|Overall Study|No effective dose in Titration period|0|||
128861620|NCT01969851|463788128|FG002|Overall Study|No effective dose in Titration period|1|||
128861621|NCT01969851|463788126|FG000|Overall Study|Sponsor decision|0|||
128861622|NCT01969851|463788127|FG001|Overall Study|Sponsor decision|0|||
128861623|NCT01969851|463788128|FG002|Overall Study|Sponsor decision|1|||
128861624|NCT01430468|463788136|FG000|Overall Study|Physician Decision|2|||
128861625|NCT01430468|463788137|FG001|Overall Study|Physician Decision|1|||
128861626|NCT01430468|463788136|FG000|Overall Study|Withdrawal by Subject|5|||
128861627|NCT01430468|463788137|FG001|Overall Study|Withdrawal by Subject|5|||
128861628|NCT00617929|463788145|FG000|Overall Study|Physician Decision|1|||
128861629|NCT02498236|463788146|FG000|Overall Study|Did not show for testing|1|||
128861630|NCT02498236|463788147|FG001|Overall Study|Did not show for testing|0|||
128861631|NCT02498236|463788148|FG002|Overall Study|Did not show for testing|0|||
128861632|NCT02498236|463788149|FG003|Overall Study|Did not show for testing|0|||
128861633|NCT02498236|463788150|FG004|Overall Study|Did not show for testing|0|||
128861634|NCT02498236|463788151|FG005|Overall Study|Did not show for testing|0|||
128861635|NCT02498236|463788152|FG006|Overall Study|Did not show for testing|0|||
128861636|NCT02498236|463788153|FG007|Overall Study|Did not show for testing|1|||
128861637|NCT02498236|463788146|FG000|Overall Study|Equipment failure|0|||
128861638|NCT02498236|463788147|FG001|Overall Study|Equipment failure|0|||
128861639|NCT02498236|463788148|FG002|Overall Study|Equipment failure|0|||
128861640|NCT02498236|463788149|FG003|Overall Study|Equipment failure|0|||
128861641|NCT02498236|463788150|FG004|Overall Study|Equipment failure|0|||
128861642|NCT02498236|463788151|FG005|Overall Study|Equipment failure|0|||
128861643|NCT02498236|463788152|FG006|Overall Study|Equipment failure|1|||
128861644|NCT02498236|463788153|FG007|Overall Study|Equipment failure|0|||
128861645|NCT02498236|463788146|FG000|Overall Study|Withdrawal by Subject|0|||
128861646|NCT02498236|463788147|FG001|Overall Study|Withdrawal by Subject|0|||
128861647|NCT02498236|463788148|FG002|Overall Study|Withdrawal by Subject|0|||
128861648|NCT02498236|463788149|FG003|Overall Study|Withdrawal by Subject|0|||
128861649|NCT02498236|463788150|FG004|Overall Study|Withdrawal by Subject|1|||
128861650|NCT02498236|463788151|FG005|Overall Study|Withdrawal by Subject|0|||
128861651|NCT02498236|463788152|FG006|Overall Study|Withdrawal by Subject|0|||
128861652|NCT02498236|463788153|FG007|Overall Study|Withdrawal by Subject|0|||
128861653|NCT00383123|463788154|FG000|Overall Study|Adverse Event|1|||
128861654|NCT00383123|463788155|FG001|Overall Study|Adverse Event|0|||
128861655|NCT00383123|463788154|FG000|Overall Study|Lost to Follow-up|68|||
128861656|NCT00383123|463788155|FG001|Overall Study|Lost to Follow-up|61|||
128861657|NCT00383123|463788154|FG000|Overall Study|Protocol Violation|5|||
128861658|NCT00383123|463788155|FG001|Overall Study|Protocol Violation|1|||
128861659|NCT00383123|463788154|FG000|Overall Study|Withdrawal by Subject|27|||
128861660|NCT00383123|463788155|FG001|Overall Study|Withdrawal by Subject|18|||
128861661|NCT00383123|463788154|FG000|Overall Study|Other reason|10|||
128861662|NCT00383123|463788155|FG001|Overall Study|Other reason|6|||
128861663|NCT03566979|463788156|FG000|Overall Study|Withdrawal by Subject|2|||
128861664|NCT03566979|463788157|FG001|Overall Study|Withdrawal by Subject|0|||
128861665|NCT03566979|463788158|FG002|Overall Study|Withdrawal by Subject|1|||
128861666|NCT03566979|463788159|FG003|Overall Study|Withdrawal by Subject|1|||
128861667|NCT03566979|463788156|FG000|Overall Study|Lost to Follow-up|2|||
128861668|NCT03566979|463788157|FG001|Overall Study|Lost to Follow-up|7|||
128861669|NCT03566979|463788158|FG002|Overall Study|Lost to Follow-up|9|||
128861670|NCT03566979|463788159|FG003|Overall Study|Lost to Follow-up|5|||
128861671|NCT03566979|463788156|FG000|Overall Study|Adverse Event|1|||
128861672|NCT03566979|463788157|FG001|Overall Study|Adverse Event|0|||
128861673|NCT03566979|463788158|FG002|Overall Study|Adverse Event|0|||
128861674|NCT03566979|463788159|FG003|Overall Study|Adverse Event|0|||
128861675|NCT04982575|463788162|FG000|Overall Study|Withdrawal by Subject|2|||
128861676|NCT04982575|463788163|FG001|Overall Study|Withdrawal by Subject|0|||
128861677|NCT04982575|463788164|FG002|Overall Study|Withdrawal by Subject|2|||
128861678|NCT01151423|463788165|FG000|Overall Study|Study terminated by Sponsor|9|||
128861679|NCT01151423|463788166|FG001|Overall Study|Study terminated by Sponsor|10|||
128861680|NCT01151423|463788165|FG000|Overall Study|Protocol Violation|0|||
128861681|NCT01151423|463788166|FG001|Overall Study|Protocol Violation|1|||
128861682|NCT01151423|463788165|FG000|Overall Study|Physician Decision|1|||
128861683|NCT01151423|463788166|FG001|Overall Study|Physician Decision|1|||
128861684|NCT01151423|463788165|FG000|Overall Study|Pregnancy|0|||
128861685|NCT01151423|463788166|FG001|Overall Study|Pregnancy|1|||
128861686|NCT01151423|463788165|FG000|Overall Study|Death|0|||
128861687|NCT01151423|463788166|FG001|Overall Study|Death|1|||
128861688|NCT01151423|463788165|FG000|Overall Study|Adverse Event|3|||
128861689|NCT01151423|463788166|FG001|Overall Study|Adverse Event|0|||
128861690|NCT01151423|463788165|FG000|Overall Study|Withdrawal by Subject|1|||
128861691|NCT01151423|463788166|FG001|Overall Study|Withdrawal by Subject|3|||
128861692|NCT01151423|463788165|FG000|Overall Study|Lost to Follow-up|1|||
128861693|NCT01151423|463788166|FG001|Overall Study|Lost to Follow-up|0|||
128861694|NCT01151423|463788165|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
128861695|NCT01151423|463788166|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
128861696|NCT01151423|463788165|FG000|Overall Study|Participated in other clinical trial|1|||
128861697|NCT01151423|463788166|FG001|Overall Study|Participated in other clinical trial|0|||
128861698|NCT04949802|463790373|FG000|Overall Study|Lost to Follow-up|3|||
128861699|NCT02473965|463790374|FG000|Overall Study|Adverse Event|6|||
128861700|NCT02473965|463790375|FG001|Overall Study|Adverse Event|4|||
128861701|NCT02473965|463790374|FG000|Overall Study|MG worsening|4|||
128861702|NCT02473965|463790375|FG001|Overall Study|MG worsening|1|||
128861703|NCT02473965|463790374|FG000|Overall Study|Withdrawal by Subject|2|||
128861704|NCT02473965|463790375|FG001|Overall Study|Withdrawal by Subject|3|||
128861705|NCT02473965|463790374|FG000|Overall Study|Physician Decision|0|||
128861706|NCT02473965|463790375|FG001|Overall Study|Physician Decision|2|||
128861707|NCT03816761|463790376|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
128861708|NCT03816761|463790377|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
128861709|NCT03816761|463790378|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
128861710|NCT03816761|463790379|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
128861711|NCT03816761|463790380|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
128861712|NCT03816761|463790381|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
128861713|NCT03816761|463790376|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
128861714|NCT03816761|463790377|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
128861715|NCT03816761|463790378|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
128861716|NCT03816761|463790379|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
128861717|NCT03816761|463790380|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
128861718|NCT03816761|463790381|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
128861719|NCT01240551|463790382|FG000|Overall Study|Refused further treatment|3|||
128861720|NCT01240551|463790383|FG001|Overall Study|Refused further treatment|2|||
128861721|NCT01240551|463790382|FG000|Overall Study|Lost to Follow-up|1|||
128861722|NCT01240551|463790383|FG001|Overall Study|Lost to Follow-up|1|||
128861723|NCT02568397|463790387|FG000|Period 2|Withdrawal by Subject|0|||
128861724|NCT02568397|463790388|FG001|Period 2|Withdrawal by Subject|1|||
128861725|NCT02568397|463790387|FG000|Period 2|Physician Decision|0|||
128861726|NCT02568397|463790388|FG001|Period 2|Physician Decision|1|||
128861727|NCT01200342|463790389|FG000|Overall Study|Disease Progression|1|||
128861728|NCT04546217|463790392|FG000|Overall Study|Withdrawal by Subject|2|||
128861729|NCT04546217|463790393|FG001|Overall Study|Withdrawal by Subject|0|||
128861730|NCT04546217|463790392|FG000|Overall Study|Uncontrolled hypertension|1|||
128861731|NCT04546217|463790393|FG001|Overall Study|Uncontrolled hypertension|0|||
128861732|NCT02550938|463790394|FG000|Overall Study|Lost to Follow-up|8|||
128861733|NCT02550938|463790395|FG001|Overall Study|Lost to Follow-up|7|||
128861734|NCT02550938|463790396|FG002|Overall Study|Lost to Follow-up|12|||
128861735|NCT02550938|463790397|FG003|Overall Study|Lost to Follow-up|11|||
128861736|NCT01484431|463790398|FG000|Period 1: High Dose|Physician Decision|0|||
128861737|NCT01484431|463790399|FG001|Period 1: High Dose|Physician Decision|1|||
128861738|NCT01484431|463790400|FG002|Period 1: High Dose|Physician Decision|0|||
128861739|NCT01484431|463790398|FG000|Period 2|Death|0|||
128861740|NCT01484431|463790399|FG001|Period 2|Death|1|||
128861741|NCT01484431|463790400|FG002|Period 2|Death|1|||
128861742|NCT01484431|463790398|FG000|Period 2|Physician Decision|0|||
128861743|NCT01484431|463790399|FG001|Period 2|Physician Decision|0|||
128861744|NCT01484431|463790400|FG002|Period 2|Physician Decision|1|||
128861745|NCT01484431|463790398|FG000|Period 2|Non-Compliance with Study Drug|1|||
128861746|NCT01484431|463790399|FG001|Period 2|Non-Compliance with Study Drug|0|||
128861747|NCT01484431|463790400|FG002|Period 2|Non-Compliance with Study Drug|0|||
128861748|NCT02514239|463790404|FG000|Overall Study|Refused to continue trial medication|0|||
128861749|NCT02514239|463790405|FG001|Overall Study|Refused to continue trial medication|0|||
128861750|NCT02514239|463790406|FG002|Overall Study|Refused to continue trial medication|0|||
128861751|NCT02514239|463790407|FG003|Overall Study|Refused to continue trial medication|0|||
128861752|NCT02514239|463790408|FG004|Overall Study|Refused to continue trial medication|0|||
128861753|NCT02514239|463790409|FG005|Overall Study|Refused to continue trial medication|0|||
128861754|NCT02514239|463790410|FG006|Overall Study|Refused to continue trial medication|0|||
128861755|NCT02514239|463790411|FG007|Overall Study|Refused to continue trial medication|0|||
128861756|NCT02514239|463790412|FG008|Overall Study|Refused to continue trial medication|0|||
128861757|NCT02514239|463790413|FG009|Overall Study|Refused to continue trial medication|1|||
128861758|NCT02514239|463790404|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861759|NCT02514239|463790405|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861760|NCT02514239|463790406|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861761|NCT02514239|463790407|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861762|NCT02514239|463790408|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861763|NCT02514239|463790409|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861764|NCT02514239|463790410|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861765|NCT02514239|463790411|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
128861766|NCT02514239|463790412|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
128861767|NCT02514239|463790413|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
128861768|NCT02514239|463790404|FG000|Overall Study|Not treated|0|||
128861769|NCT02514239|463790405|FG001|Overall Study|Not treated|1|||
128861770|NCT02514239|463790406|FG002|Overall Study|Not treated|0|||
128861771|NCT02514239|463790407|FG003|Overall Study|Not treated|0|||
128861772|NCT02514239|463790408|FG004|Overall Study|Not treated|0|||
128861773|NCT02514239|463790409|FG005|Overall Study|Not treated|0|||
128861774|NCT02514239|463790410|FG006|Overall Study|Not treated|0|||
128861775|NCT02514239|463790411|FG007|Overall Study|Not treated|0|||
128861776|NCT02514239|463790412|FG008|Overall Study|Not treated|0|||
128861777|NCT02514239|463790413|FG009|Overall Study|Not treated|0|||
128861778|NCT02514239|463790404|FG000|Overall Study|Other Adverse Events|2|||
128861779|NCT02514239|463790405|FG001|Overall Study|Other Adverse Events|0|||
128861780|NCT02514239|463790406|FG002|Overall Study|Other Adverse Events|0|||
128861781|NCT02514239|463790407|FG003|Overall Study|Other Adverse Events|1|||
128861782|NCT02514239|463790408|FG004|Overall Study|Other Adverse Events|0|||
128861783|NCT02514239|463790409|FG005|Overall Study|Other Adverse Events|1|||
128861784|NCT02514239|463790410|FG006|Overall Study|Other Adverse Events|0|||
128861785|NCT02514239|463790411|FG007|Overall Study|Other Adverse Events|1|||
128861786|NCT02514239|463790412|FG008|Overall Study|Other Adverse Events|2|||
128861787|NCT02514239|463790413|FG009|Overall Study|Other Adverse Events|0|||
128861788|NCT02514239|463790404|FG000|Overall Study|Progressive disease|3|||
128861789|NCT02514239|463790405|FG001|Overall Study|Progressive disease|3|||
128861790|NCT02514239|463790406|FG002|Overall Study|Progressive disease|2|||
128861791|NCT02514239|463790407|FG003|Overall Study|Progressive disease|2|||
128861792|NCT02514239|463790408|FG004|Overall Study|Progressive disease|3|||
128861793|NCT02514239|463790409|FG005|Overall Study|Progressive disease|3|||
128861794|NCT02514239|463790410|FG006|Overall Study|Progressive disease|4|||
128861795|NCT02514239|463790411|FG007|Overall Study|Progressive disease|2|||
128861796|NCT02514239|463790412|FG008|Overall Study|Progressive disease|5|||
128861797|NCT02514239|463790413|FG009|Overall Study|Progressive disease|0|||
128861798|NCT01888874|463790416|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
128861799|NCT01888874|463790417|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
128861800|NCT01888874|463790418|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
128861801|NCT01888874|463790419|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
128861802|NCT01888874|463790420|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
128861803|NCT01888874|463790421|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
128861804|NCT01888874|463790422|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
128861805|NCT01888874|463790416|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
128861806|NCT01888874|463790417|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
128861807|NCT01888874|463790418|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
128861808|NCT01888874|463790419|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
128861809|NCT01888874|463790420|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
128861810|NCT01888874|463790421|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
128861811|NCT01888874|463790422|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
128861812|NCT01888874|463790416|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
128861813|NCT01888874|463790417|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
128861814|NCT01888874|463790418|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
128861815|NCT01888874|463790419|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
128861816|NCT01888874|463790420|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
128861817|NCT01888874|463790421|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
128861818|NCT01888874|463790422|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
128861819|NCT01888874|463790416|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
128861820|NCT01888874|463790417|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
128861821|NCT01888874|463790418|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
128861822|NCT01888874|463790419|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
128861823|NCT01888874|463790420|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
128861824|NCT01888874|463790421|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
128861825|NCT01888874|463790422|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
128861826|NCT01888874|463790416|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128861827|NCT01888874|463790417|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128861828|NCT01888874|463790418|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128861829|NCT01888874|463790419|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128861830|NCT01888874|463790420|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
128861831|NCT01888874|463790421|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128861832|NCT01888874|463790422|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
128861833|NCT01888874|463790416|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
128861834|NCT01888874|463790417|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
128861835|NCT01888874|463790418|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
128861836|NCT01888874|463790419|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
128861837|NCT01888874|463790420|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
128861838|NCT01888874|463790421|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
128861839|NCT01888874|463790422|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
128861840|NCT01888874|463790416|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
128861841|NCT01888874|463790417|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
128861842|NCT01888874|463790418|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
128861843|NCT01888874|463790419|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
128861844|NCT01888874|463790420|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
128861845|NCT01888874|463790421|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
128861846|NCT01888874|463790422|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
128861847|NCT01888874|463790416|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
128861848|NCT01888874|463790417|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
128861849|NCT01888874|463790418|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
128861850|NCT01888874|463790419|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
128861851|NCT01888874|463790420|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
128861852|NCT01888874|463790421|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
128861853|NCT01888874|463790422|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
128861854|NCT01888874|463790416|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
128861855|NCT01888874|463790417|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
128861856|NCT01888874|463790418|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
128861857|NCT01888874|463790419|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
128861858|NCT01888874|463790420|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
128861859|NCT01888874|463790421|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
128861860|NCT01888874|463790422|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
128861861|NCT01888874|463790416|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
128861862|NCT01888874|463790417|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
128861863|NCT01888874|463790418|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
128861864|NCT01888874|463790419|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
128861865|NCT01888874|463790420|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
128861866|NCT01888874|463790421|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
128861867|NCT01888874|463790422|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
128861868|NCT01888874|463790416|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
128861869|NCT01888874|463790417|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
128861870|NCT01888874|463790418|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
128861871|NCT01888874|463790419|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
128861872|NCT01888874|463790420|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
128861873|NCT01888874|463790421|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
128861874|NCT01888874|463790422|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
128861875|NCT01888874|463790416|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
128861876|NCT01888874|463790417|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
128861877|NCT01888874|463790418|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
128861878|NCT01888874|463790419|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
128861879|NCT01888874|463790420|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
128861880|NCT01888874|463790421|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
128861881|NCT01888874|463790422|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
128861882|NCT01888874|463790416|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
128861883|NCT01888874|463790417|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
128861884|NCT01888874|463790418|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
128861885|NCT01888874|463790419|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
128861886|NCT01888874|463790420|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
128861887|NCT01888874|463790421|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
128861888|NCT01888874|463790422|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
128861889|NCT02763215|463790423|FG000|Overall Study|Participants withdrew from study|3|||
128861890|NCT02763215|463790423|FG000|Overall Study|Missed visit|1|||
128861891|NCT02763215|463790423|FG000|Overall Study|Visit outside visit-window|1|||
128861892|NCT02763215|463790423|FG000|Overall Study|Death|1|||
128861893|NCT02763215|463790423|FG000|Overall Study|Lost to Follow-up|1|||
128861894|NCT00475644|463790425|FG000|Overall Study|Protocol Violation|13|||
128861895|NCT01411241|463790426|FG000|Overall Study|Protocol Violation|0|||
128861896|NCT01411241|463790427|FG001|Overall Study|Protocol Violation|5|||
128861897|NCT01411241|463790426|FG000|Overall Study|Withdrawal by Subject|9|||
128861898|NCT01411241|463790427|FG001|Overall Study|Withdrawal by Subject|10|||
128861899|NCT01411241|463790426|FG000|Overall Study|Serious Adverse Event|0|||
128861900|NCT01411241|463790427|FG001|Overall Study|Serious Adverse Event|3|||
128861901|NCT01411241|463790426|FG000|Overall Study|Lost to Follow-up|2|||
128861902|NCT01411241|463790427|FG001|Overall Study|Lost to Follow-up|4|||
128861903|NCT02980042|463790432|FG000|Overall Study|Lost to Follow-up|5|||
128861904|NCT02980042|463790433|FG001|Overall Study|Lost to Follow-up|0|||
128861905|NCT02980042|463790432|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
128861906|NCT02980042|463790433|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
128861907|NCT01483144|463790436|FG000|Overall Study|Adverse Event|9|||
128861908|NCT01483144|463790437|FG001|Overall Study|Adverse Event|4|||
128861909|NCT01483144|463790438|FG002|Overall Study|Adverse Event|6|||
128861910|NCT01483144|463790436|FG000|Overall Study|Withdrawal by Subject|0|||
128861911|NCT01483144|463790437|FG001|Overall Study|Withdrawal by Subject|2|||
128861912|NCT01483144|463790438|FG002|Overall Study|Withdrawal by Subject|5|||
128861913|NCT01483144|463790436|FG000|Overall Study|Physician Decision|1|||
128861914|NCT01483144|463790437|FG001|Overall Study|Physician Decision|0|||
128861915|NCT01483144|463790438|FG002|Overall Study|Physician Decision|0|||
128861916|NCT01483144|463790436|FG000|Overall Study|Lost to Follow-up|2|||
128861917|NCT01483144|463790437|FG001|Overall Study|Lost to Follow-up|4|||
128861918|NCT01483144|463790438|FG002|Overall Study|Lost to Follow-up|1|||
128861919|NCT01483144|463790436|FG000|Overall Study|Protocol Violation|3|||
128861920|NCT01483144|463790437|FG001|Overall Study|Protocol Violation|3|||
128861921|NCT01483144|463790438|FG002|Overall Study|Protocol Violation|3|||
128861922|NCT01107899|463790444|FG000|Overall Study|Physician Decision|5|||
128861923|NCT01107899|463790445|FG001|Overall Study|Physician Decision|0|||
128861924|NCT01107899|463790446|FG002|Overall Study|Physician Decision|3|||
128861925|NCT01107899|463790444|FG000|Overall Study|Withdrawal by Subject|0|||
128861926|NCT01107899|463790445|FG001|Overall Study|Withdrawal by Subject|0|||
128861927|NCT01107899|463790446|FG002|Overall Study|Withdrawal by Subject|1|||
128861928|NCT00974259|463790447|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
128861929|NCT00974259|463790448|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
128861930|NCT00944229|463790451|FG000|Overall Study|Withdrawal by Subject|11|||
128861931|NCT00944229|463790451|FG000|Overall Study|Physician Decision|14|||
128861932|NCT04292470|463790452|FG000|Overall Study|Withdrawal by Subject|0|||
128861933|NCT04292470|463790453|FG001|Overall Study|Withdrawal by Subject|1|||
128861934|NCT02906020|463790471|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
128861935|NCT02906020|463790472|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
128861936|NCT02906020|463790473|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
128861937|NCT02906020|463790474|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
128861938|NCT02906020|463790475|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
128861939|NCT02906020|463790476|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
128861940|NCT02906020|463790477|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
128861941|NCT02906020|463790478|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
128861942|NCT02906020|463790479|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
128861943|NCT02906020|463790480|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
128861944|NCT02906020|463790481|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
128861945|NCT02906020|463790482|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
128861946|NCT02906020|463790483|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
128861947|NCT02906020|463790484|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
128861948|NCT02906020|463790485|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
128861949|NCT02906020|463790486|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
128861950|NCT02906020|463790471|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861951|NCT02906020|463790472|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861952|NCT02906020|463790473|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861953|NCT02906020|463790474|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861954|NCT02906020|463790475|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861955|NCT02906020|463790476|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861956|NCT02906020|463790477|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861957|NCT02906020|463790478|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861958|NCT02906020|463790479|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
128861959|NCT02906020|463790480|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
128861960|NCT02906020|463790481|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861961|NCT02906020|463790482|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861962|NCT02906020|463790483|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861963|NCT02906020|463790484|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861964|NCT02906020|463790485|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861965|NCT02906020|463790486|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
128861966|NCT02906020|463790471|FG000|Part 2: Double-blind Treatment Period|Other|0|||
128861967|NCT02906020|463790472|FG001|Part 2: Double-blind Treatment Period|Other|0|||
128861968|NCT02906020|463790473|FG002|Part 2: Double-blind Treatment Period|Other|0|||
128861969|NCT02906020|463790474|FG003|Part 2: Double-blind Treatment Period|Other|0|||
128861970|NCT02906020|463790475|FG004|Part 2: Double-blind Treatment Period|Other|0|||
128861971|NCT02906020|463790476|FG005|Part 2: Double-blind Treatment Period|Other|0|||
128861972|NCT02906020|463790477|FG006|Part 2: Double-blind Treatment Period|Other|0|||
128861973|NCT02906020|463790478|FG007|Part 2: Double-blind Treatment Period|Other|0|||
128861974|NCT02906020|463790479|FG008|Part 2: Double-blind Treatment Period|Other|6|||
128861975|NCT02906020|463790480|FG009|Part 2: Double-blind Treatment Period|Other|10|||
128861976|NCT02906020|463790481|FG010|Part 2: Double-blind Treatment Period|Other|0|||
128861977|NCT02906020|463790482|FG011|Part 2: Double-blind Treatment Period|Other|0|||
128861978|NCT02906020|463790483|FG012|Part 2: Double-blind Treatment Period|Other|0|||
128861979|NCT02906020|463790484|FG013|Part 2: Double-blind Treatment Period|Other|0|||
128861980|NCT02906020|463790485|FG014|Part 2: Double-blind Treatment Period|Other|0|||
128861981|NCT02906020|463790486|FG015|Part 2: Double-blind Treatment Period|Other|0|||
128861982|NCT02906020|463790471|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861983|NCT02906020|463790472|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861984|NCT02906020|463790473|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861985|NCT02906020|463790474|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861986|NCT02906020|463790475|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861987|NCT02906020|463790476|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861988|NCT02906020|463790477|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861989|NCT02906020|463790478|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861990|NCT02906020|463790479|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861991|NCT02906020|463790480|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861992|NCT02906020|463790481|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861993|NCT02906020|463790482|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861994|NCT02906020|463790483|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
128861995|NCT02906020|463790484|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
128861996|NCT02906020|463790485|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861997|NCT02906020|463790486|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
128861998|NCT02906020|463790471|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128861999|NCT02906020|463790472|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862000|NCT02906020|463790473|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862001|NCT02906020|463790474|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862002|NCT02906020|463790475|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862003|NCT02906020|463790476|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862004|NCT02906020|463790477|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862005|NCT02906020|463790478|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862006|NCT02906020|463790479|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862007|NCT02906020|463790480|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862008|NCT02906020|463790481|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862009|NCT02906020|463790482|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862010|NCT02906020|463790483|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
128862011|NCT02906020|463790484|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
128862012|NCT02906020|463790485|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
128862013|NCT02906020|463790486|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
128862014|NCT02906020|463790471|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862015|NCT02906020|463790472|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862016|NCT02906020|463790473|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862017|NCT02906020|463790474|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862018|NCT02906020|463790475|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862019|NCT02906020|463790476|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862020|NCT02906020|463790477|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862021|NCT02906020|463790478|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862022|NCT02906020|463790479|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862023|NCT02906020|463790480|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862024|NCT02906020|463790481|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862025|NCT02906020|463790482|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862026|NCT02906020|463790483|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
128862027|NCT02906020|463790484|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
128862028|NCT02906020|463790485|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862029|NCT02906020|463790486|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
128862030|NCT02906020|463790471|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862031|NCT02906020|463790472|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862032|NCT02906020|463790473|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862033|NCT02906020|463790474|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862034|NCT02906020|463790475|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862035|NCT02906020|463790476|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862036|NCT02906020|463790477|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862037|NCT02906020|463790478|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862038|NCT02906020|463790479|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862039|NCT02906020|463790480|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862040|NCT02906020|463790481|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862041|NCT02906020|463790482|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862042|NCT02906020|463790483|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
128862043|NCT02906020|463790484|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
128862044|NCT02906020|463790485|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862045|NCT02906020|463790486|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
128862046|NCT02906020|463790471|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862047|NCT02906020|463790472|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862048|NCT02906020|463790473|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862049|NCT02906020|463790474|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862050|NCT02906020|463790475|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862051|NCT02906020|463790476|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862052|NCT02906020|463790477|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862053|NCT02906020|463790478|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862054|NCT02906020|463790479|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862055|NCT02906020|463790480|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862056|NCT02906020|463790481|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862057|NCT02906020|463790482|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
128862058|NCT02906020|463790483|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
128862059|NCT02906020|463790484|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
128862060|NCT02906020|463790485|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
128862061|NCT02906020|463790486|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
128862062|NCT02906020|463790471|FG000|Part 2: Long-term Follow-up Period|Other|0|||
128862063|NCT02906020|463790472|FG001|Part 2: Long-term Follow-up Period|Other|0|||
128862064|NCT02906020|463790473|FG002|Part 2: Long-term Follow-up Period|Other|0|||
128862065|NCT02906020|463790474|FG003|Part 2: Long-term Follow-up Period|Other|0|||
128862066|NCT02906020|463790475|FG004|Part 2: Long-term Follow-up Period|Other|0|||
128862067|NCT02906020|463790476|FG005|Part 2: Long-term Follow-up Period|Other|0|||
128862068|NCT02906020|463790477|FG006|Part 2: Long-term Follow-up Period|Other|0|||
128862069|NCT02906020|463790478|FG007|Part 2: Long-term Follow-up Period|Other|0|||
128862070|NCT02906020|463790479|FG008|Part 2: Long-term Follow-up Period|Other|0|||
128862071|NCT02906020|463790480|FG009|Part 2: Long-term Follow-up Period|Other|0|||
128862072|NCT02906020|463790481|FG010|Part 2: Long-term Follow-up Period|Other|0|||
128862073|NCT02906020|463790482|FG011|Part 2: Long-term Follow-up Period|Other|0|||
128862074|NCT02906020|463790483|FG012|Part 2: Long-term Follow-up Period|Other|13|||
128862075|NCT02906020|463790484|FG013|Part 2: Long-term Follow-up Period|Other|8|||
128862076|NCT02906020|463790485|FG014|Part 2: Long-term Follow-up Period|Other|3|||
128862077|NCT02906020|463790486|FG015|Part 2: Long-term Follow-up Period|Other|2|||
128862078|NCT01810939|463790487|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
128862079|NCT01810939|463790488|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
128862080|NCT01810939|463790489|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
128862081|NCT01810939|463790487|FG000|Part A Treatment Period|Protocol Violation|2|||
128862082|NCT01810939|463790488|FG001|Part A Treatment Period|Protocol Violation|0|||
128862083|NCT01810939|463790489|FG002|Part A Treatment Period|Protocol Violation|0|||
128862084|NCT01810939|463790487|FG000|Part A Treatment Period|Adverse Event|10|||
128862085|NCT01810939|463790488|FG001|Part A Treatment Period|Adverse Event|0|||
128862086|NCT01810939|463790489|FG002|Part A Treatment Period|Adverse Event|0|||
128862087|NCT01810939|463790487|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
128862088|NCT01810939|463790488|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
128862089|NCT01810939|463790489|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
128862090|NCT01810939|463790487|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
128862091|NCT01810939|463790488|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
128862092|NCT01810939|463790489|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
128862093|NCT01810939|463790487|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
128862094|NCT01810939|463790488|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
128862095|NCT01810939|463790489|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
128862096|NCT01810939|463790487|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
128862097|NCT01810939|463790488|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
128862098|NCT01810939|463790489|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
128862099|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
128862100|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
128862101|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
128862102|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
128862103|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
128862104|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
128862105|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
128862106|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
128862107|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
128862108|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
128862109|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
128862110|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
128862111|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
128862112|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
128862113|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
128862114|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
128862115|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
128862116|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
128862117|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
128862118|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
128862119|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
128862120|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
128862121|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
128862122|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
128862123|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
128862124|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
128862125|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
128862126|NCT01810939|463790487|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
128862127|NCT01810939|463790488|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
128862128|NCT01810939|463790489|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
128862129|NCT01375673|463790490|FG000|Overall Study|Withdrawal by Subject|0|||
128862130|NCT01375673|463790491|FG001|Overall Study|Withdrawal by Subject|1|||
128862131|NCT02179177|463790492|FG000|Overall Study|Lost to Follow-up|1|||
128862132|NCT02179177|463790493|FG001|Overall Study|Lost to Follow-up|1|||
128862133|NCT02179177|463790492|FG000|Overall Study|Withdrawal by Subject|1|||
128862134|NCT02179177|463790493|FG001|Overall Study|Withdrawal by Subject|1|||
128862135|NCT00884650|463790496|FG000|Overall Study|Did not return complete pain diaries|7|||
128862136|NCT00884650|463790497|FG001|Overall Study|Did not return complete pain diaries|7|||
128862137|NCT00884650|463790496|FG000|Overall Study|Admitted Post-Op|1|||
128862138|NCT00884650|463790497|FG001|Overall Study|Admitted Post-Op|0|||
128862139|NCT00884650|463790496|FG000|Overall Study|Femoral Stress Fracture|1|||
128862140|NCT00884650|463790497|FG001|Overall Study|Femoral Stress Fracture|0|||
128862141|NCT00884650|463790496|FG000|Overall Study|Pain Pump Complication|0|||
128862142|NCT00884650|463790497|FG001|Overall Study|Pain Pump Complication|1|||
128862143|NCT00979953|463790498|FG000|Overall Study|Adverse Event|5|||
128862144|NCT00979953|463790499|FG001|Overall Study|Adverse Event|2|||
128862145|NCT00979953|463790500|FG002|Overall Study|Adverse Event|17|||
128862146|NCT00979953|463790501|FG003|Overall Study|Adverse Event|4|||
128862147|NCT00979953|463790498|FG000|Overall Study|Lack of Efficacy|1|||
128862148|NCT00979953|463790499|FG001|Overall Study|Lack of Efficacy|2|||
128862149|NCT00979953|463790500|FG002|Overall Study|Lack of Efficacy|0|||
128862150|NCT00979953|463790501|FG003|Overall Study|Lack of Efficacy|0|||
128862151|NCT00979953|463790498|FG000|Overall Study|Lost to Follow-up|1|||
128862152|NCT00979953|463790499|FG001|Overall Study|Lost to Follow-up|1|||
128862153|NCT00979953|463790500|FG002|Overall Study|Lost to Follow-up|1|||
128862154|NCT00979953|463790501|FG003|Overall Study|Lost to Follow-up|0|||
128862155|NCT00979953|463790498|FG000|Overall Study|Withdrawal by Subject|0|||
128862156|NCT00979953|463790499|FG001|Overall Study|Withdrawal by Subject|0|||
128862157|NCT00979953|463790500|FG002|Overall Study|Withdrawal by Subject|2|||
128862158|NCT00979953|463790501|FG003|Overall Study|Withdrawal by Subject|1|||
128862159|NCT00979953|463790498|FG000|Overall Study|Protocol Violation|1|||
128862160|NCT00979953|463790499|FG001|Overall Study|Protocol Violation|0|||
128862161|NCT00979953|463790500|FG002|Overall Study|Protocol Violation|2|||
128862162|NCT00979953|463790501|FG003|Overall Study|Protocol Violation|2|||
128862163|NCT04829747|463790506|FG000|Overall Study|Protocol Violation|1|||
128862164|NCT03274453|463790509|FG000|Overall Study|Lost to Follow-up|2|||
128862165|NCT03274453|463790510|FG001|Overall Study|Lost to Follow-up|5|||
128862166|NCT03274453|463790511|FG002|Overall Study|Lost to Follow-up|4|||
128862167|NCT03274453|463790512|FG003|Overall Study|Lost to Follow-up|1|||
128862168|NCT03274453|463790509|FG000|Overall Study|Physician Decision|2|||
128862169|NCT03274453|463790510|FG001|Overall Study|Physician Decision|0|||
128862170|NCT03274453|463790511|FG002|Overall Study|Physician Decision|0|||
128862171|NCT03274453|463790512|FG003|Overall Study|Physician Decision|3|||
128862172|NCT03274453|463790509|FG000|Overall Study|Surgery Cancelled|0|||
128862173|NCT03274453|463790510|FG001|Overall Study|Surgery Cancelled|1|||
128862174|NCT03274453|463790511|FG002|Overall Study|Surgery Cancelled|0|||
128862175|NCT03274453|463790512|FG003|Overall Study|Surgery Cancelled|0|||
128862176|NCT01732549|463790514|FG000|Overall Study|Adverse Event|13|||
128862177|NCT01732549|463790515|FG001|Overall Study|Adverse Event|3|||
128862178|NCT01732549|463790514|FG000|Overall Study|Consent withdrawn|13|||
128862179|NCT01732549|463790515|FG001|Overall Study|Consent withdrawn|6|||
128862180|NCT01732549|463790514|FG000|Overall Study|Disease progression|37|||
128862181|NCT01732549|463790515|FG001|Overall Study|Disease progression|50|||
128862182|NCT01732549|463790514|FG000|Overall Study|Other|8|||
128862183|NCT01732549|463790515|FG001|Overall Study|Other|14|||
128862184|NCT01681992|463790519|FG000|Overall Study|Adverse Event|3|||
128862185|NCT01681992|463790520|FG001|Overall Study|Adverse Event|2|||
128862186|NCT01681992|463790521|FG002|Overall Study|Adverse Event|3|||
128862187|NCT01681992|463790519|FG000|Overall Study|Lost to Follow-up|36|||
128862188|NCT01681992|463790520|FG001|Overall Study|Lost to Follow-up|38|||
128862189|NCT01681992|463790521|FG002|Overall Study|Lost to Follow-up|53|||
128862190|NCT01681992|463790519|FG000|Overall Study|As Per Sponsor Decision|0|||
128862191|NCT01681992|463790520|FG001|Overall Study|As Per Sponsor Decision|0|||
128862192|NCT01681992|463790521|FG002|Overall Study|As Per Sponsor Decision|1|||
128862193|NCT01681992|463790519|FG000|Overall Study|Protocol Violation|0|||
128862194|NCT01681992|463790520|FG001|Overall Study|Protocol Violation|0|||
128862195|NCT01681992|463790521|FG002|Overall Study|Protocol Violation|1|||
128862196|NCT01681992|463790519|FG000|Overall Study|Withdrawal by Subject|27|||
128862197|NCT01681992|463790520|FG001|Overall Study|Withdrawal by Subject|30|||
128862198|NCT01681992|463790521|FG002|Overall Study|Withdrawal by Subject|25|||
128862199|NCT02344342|463790532|FG000|Overall Study|Industry partner dropped out|11|||
128862200|NCT02344342|463790533|FG001|Overall Study|Industry partner dropped out|9|||
128862201|NCT02344342|463790534|FG002|Overall Study|Industry partner dropped out|14|||
128862202|NCT02344342|463790535|FG003|Overall Study|Industry partner dropped out|10|||
128862203|NCT03690427|463790540|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
128862204|NCT03690427|463790541|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
128862205|NCT02609672|463790545|FG000|Overall Study|Lost to Follow-up|3|||
128862206|NCT02609672|463790546|FG001|Overall Study|Lost to Follow-up|1|||
128862207|NCT02956837|463790548|FG000|Overall Study|Serious Adverse Events|0|||
128862208|NCT02956837|463790549|FG001|Overall Study|Serious Adverse Events|1|||
128862209|NCT02956837|463790550|FG002|Overall Study|Serious Adverse Events|0|||
128862210|NCT02956837|463790551|FG003|Overall Study|Serious Adverse Events|0|||
128862211|NCT02956837|463790548|FG000|Overall Study|Withdrawal by Subject|0|||
128862212|NCT02956837|463790549|FG001|Overall Study|Withdrawal by Subject|1|||
128862213|NCT02956837|463790550|FG002|Overall Study|Withdrawal by Subject|0|||
128862214|NCT02956837|463790551|FG003|Overall Study|Withdrawal by Subject|3|||
128862215|NCT02956837|463790548|FG000|Overall Study|Lost to Follow-up|0|||
128862216|NCT02956837|463790549|FG001|Overall Study|Lost to Follow-up|1|||
128862217|NCT02956837|463790550|FG002|Overall Study|Lost to Follow-up|2|||
128862218|NCT02956837|463790551|FG003|Overall Study|Lost to Follow-up|0|||
128862219|NCT02597712|463790552|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
128862220|NCT02597712|463790553|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
128862221|NCT02597712|463790552|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
128862222|NCT02597712|463790553|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
128862223|NCT02597712|463790552|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
128862224|NCT02597712|463790553|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
128862225|NCT02637323|463790554|FG000|Overall Study|Lost to Follow-up|2|||
128862226|NCT02637323|463790555|FG001|Overall Study|Lost to Follow-up|0|||
128862227|NCT02637323|463790554|FG000|Overall Study|Protocol Violation|0|||
128862228|NCT02637323|463790555|FG001|Overall Study|Protocol Violation|1|||
128862229|NCT00513708|463790556|FG000|Overall Study|Lost to Follow-up|4|||
128862230|NCT00513708|463790557|FG001|Overall Study|Lost to Follow-up|4|||
128862231|NCT00513708|463790558|FG002|Overall Study|Lost to Follow-up|4|||
128862232|NCT00760747|463790565|FG000|Study Period II|Adverse Event|3|||
128862233|NCT00760747|463790566|FG001|Study Period II|Adverse Event|4|||
128862234|NCT00760747|463790565|FG000|Study Period II|Lack of Efficacy|0|||
128862235|NCT00760747|463790566|FG001|Study Period II|Lack of Efficacy|6|||
128862236|NCT00760747|463790565|FG000|Study Period II|Parent/Caregiver Decision|3|||
128862237|NCT00760747|463790566|FG001|Study Period II|Parent/Caregiver Decision|0|||
128862238|NCT00760747|463790565|FG000|Study Period II|Protocol Violation|6|||
128862239|NCT00760747|463790566|FG001|Study Period II|Protocol Violation|3|||
128862240|NCT00760747|463790565|FG000|Study Period II|Withdrawal by Subject|1|||
128862241|NCT00760747|463790566|FG001|Study Period II|Withdrawal by Subject|0|||
128862242|NCT00760747|463790565|FG000|Study Period II|No drug administered|0|||
128862243|NCT00760747|463790566|FG001|Study Period II|No drug administered|1|||
128862244|NCT00760747|463790565|FG000|Study Period III|Adverse Event|1|||
128862245|NCT00760747|463790566|FG001|Study Period III|Adverse Event|0|||
128862246|NCT00760747|463790565|FG000|Study Period III|Lack of Efficacy|1|||
128862247|NCT00760747|463790566|FG001|Study Period III|Lack of Efficacy|0|||
128862248|NCT00760747|463790565|FG000|Study Period III|Parent/Caregiver Decision|0|||
128862249|NCT00760747|463790566|FG001|Study Period III|Parent/Caregiver Decision|1|||
128862250|NCT00760747|463790565|FG000|Study Period III|Protocol Violation|1|||
128862251|NCT00760747|463790566|FG001|Study Period III|Protocol Violation|1|||
128862252|NCT00760747|463790565|FG000|Study Period III|Physician Decision|0|||
128862253|NCT00760747|463790566|FG001|Study Period III|Physician Decision|1|||
128862254|NCT01443923|463790567|FG000|Overall Study|Adverse Event|1|||
128862255|NCT01443923|463790568|FG001|Overall Study|Adverse Event|0|||
128862256|NCT00108745|463790569|FG000|Overall Study|Withdrawal by Subject|19|||
128862257|NCT00108745|463790570|FG001|Overall Study|Withdrawal by Subject|12|||
128862258|NCT00108745|463790571|FG002|Overall Study|Withdrawal by Subject|12|||
128862259|NCT00108745|463790569|FG000|Overall Study|Never Treated|8|||
128862260|NCT00108745|463790570|FG001|Overall Study|Never Treated|10|||
128862261|NCT00108745|463790571|FG002|Overall Study|Never Treated|12|||
128862262|NCT00108745|463790569|FG000|Overall Study|Ineligible|7|||
128862263|NCT00108745|463790570|FG001|Overall Study|Ineligible|13|||
128862264|NCT00108745|463790571|FG002|Overall Study|Ineligible|13|||
128862265|NCT01889069|463790572|FG000|Overall Study|Death|18|||
128862266|NCT01889069|463790572|FG000|Overall Study|Progression of Disease|14|||
128862267|NCT01889069|463790572|FG000|Overall Study|Lost to Follow-up|6|||
128862268|NCT01889069|463790572|FG000|Overall Study|Other|4|||
128862269|NCT01889069|463790572|FG000|Overall Study|Consent Withdrawal|3|||
128862270|NCT01426347|463790574|FG000|Overall Study|Lost to Follow-up|0|||
128862271|NCT01426347|463790575|FG001|Overall Study|Lost to Follow-up|3|||
128862272|NCT01426347|463790574|FG000|Overall Study|Protocol Violation|2|||
128862273|NCT01426347|463790575|FG001|Overall Study|Protocol Violation|0|||
128862274|NCT01426347|463790574|FG000|Overall Study|Withdrawal by Subject|5|||
128862275|NCT01426347|463790575|FG001|Overall Study|Withdrawal by Subject|0|||
128862276|NCT00455741|463790576|FG000|Overall Study|Physician Decision|0|||
128862277|NCT00455741|463790577|FG001|Overall Study|Physician Decision|1|||
128862278|NCT01245374|463790580|FG000|Overall Study|Protocol Violation|1|||
128862279|NCT01245374|463790580|FG000|Overall Study|Withdrawal by Subject|3|||
128862280|NCT00935532|463790581|FG000|Overall Study|Adverse Event|11|||
128862281|NCT00935532|463790582|FG001|Overall Study|Adverse Event|6|||
128862282|NCT00935532|463790581|FG000|Overall Study|Death|1|||
128862283|NCT00935532|463790582|FG001|Overall Study|Death|0|||
128862284|NCT00935532|463790581|FG000|Overall Study|Lost to Follow-up|1|||
128862285|NCT00935532|463790582|FG001|Overall Study|Lost to Follow-up|0|||
128862286|NCT00935532|463790581|FG000|Overall Study|Physician Decision|1|||
128862287|NCT00935532|463790582|FG001|Overall Study|Physician Decision|2|||
128862288|NCT00935532|463790581|FG000|Overall Study|Protocol Violation|2|||
128862289|NCT00935532|463790582|FG001|Overall Study|Protocol Violation|1|||
128862290|NCT00935532|463790581|FG000|Overall Study|Subject Decision|2|||
128862291|NCT00935532|463790582|FG001|Overall Study|Subject Decision|1|||
128862292|NCT00935532|463790581|FG000|Overall Study|Sponsor Decision|0|||
128862293|NCT00935532|463790582|FG001|Overall Study|Sponsor Decision|1|||
128862294|NCT00935532|463790581|FG000|Overall Study|Loss Glucose Control|4|||
128862295|NCT00935532|463790582|FG001|Overall Study|Loss Glucose Control|0|||
128862296|NCT04954326|463790583|FG000|Overall Study|Protocol Violation|0|||
128862297|NCT04954326|463790584|FG001|Overall Study|Protocol Violation|1|||
128862298|NCT04954326|463790583|FG000|Overall Study|Death|0|||
128862299|NCT04954326|463790584|FG001|Overall Study|Death|2|||
128862300|NCT04954326|463790583|FG000|Overall Study|Physician Decision|0|||
128862301|NCT04954326|463790584|FG001|Overall Study|Physician Decision|1|||
128862302|NCT00475228|463790585|FG000|Overall Study|Lost to Follow-up|17|||
128862303|NCT00475228|463790586|FG001|Overall Study|Lost to Follow-up|17|||
128862304|NCT01183390|463792386|FG000|First Intervention|Adverse Event|0|||
128862305|NCT01183390|463792387|FG001|First Intervention|Adverse Event|1|||
128862306|NCT01730950|463792390|FG000|Overall Study|Protocol Violation|6|||
128862307|NCT01730950|463792391|FG001|Overall Study|Protocol Violation|6|||
128862308|NCT00667459|463792392|FG000|Overall Study|Death|0|||
128862309|NCT00667459|463792393|FG001|Overall Study|Death|2|||
128862310|NCT00667459|463792392|FG000|Overall Study|Lost to Follow-up|8|||
128862311|NCT00667459|463792393|FG001|Overall Study|Lost to Follow-up|43|||
128862312|NCT00474526|463792394|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
128862313|NCT00474526|463792395|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
128862314|NCT00474526|463792396|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
128862315|NCT00474526|463792397|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
128862316|NCT00474526|463792398|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
128862317|NCT00474526|463792399|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
128862318|NCT00474526|463792400|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
128862319|NCT00474526|463792401|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
128862320|NCT00474526|463792402|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
128862321|NCT00474526|463792403|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
128862322|NCT00474526|463792404|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
128862323|NCT00474526|463792405|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
128862324|NCT00474526|463792406|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
128862325|NCT00474526|463792407|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
128862326|NCT00474526|463792408|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
128862327|NCT00474526|463792409|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
128862328|NCT00474526|463792410|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
128862329|NCT00474526|463792394|FG000|Overall Study|Adverse Event|2|||
128862330|NCT00474526|463792395|FG001|Overall Study|Adverse Event|0|||
128862331|NCT00474526|463792396|FG002|Overall Study|Adverse Event|2|||
128862332|NCT00474526|463792397|FG003|Overall Study|Adverse Event|4|||
128862333|NCT00474526|463792398|FG004|Overall Study|Adverse Event|2|||
128862334|NCT00474526|463792399|FG005|Overall Study|Adverse Event|1|||
128862335|NCT00474526|463792400|FG006|Overall Study|Adverse Event|1|||
128862336|NCT00474526|463792401|FG007|Overall Study|Adverse Event|0|||
128862337|NCT00474526|463792402|FG008|Overall Study|Adverse Event|0|||
128862338|NCT00474526|463792403|FG009|Overall Study|Adverse Event|0|||
128862339|NCT00474526|463792404|FG010|Overall Study|Adverse Event|0|||
128862340|NCT00474526|463792405|FG011|Overall Study|Adverse Event|0|||
128862341|NCT00474526|463792406|FG012|Overall Study|Adverse Event|0|||
128862342|NCT00474526|463792407|FG013|Overall Study|Adverse Event|0|||
128862343|NCT00474526|463792408|FG014|Overall Study|Adverse Event|1|||
128862344|NCT00474526|463792409|FG015|Overall Study|Adverse Event|1|||
128862345|NCT00474526|463792410|FG016|Overall Study|Adverse Event|0|||
128862346|NCT00474526|463792394|FG000|Overall Study|Death|0|||
128862347|NCT00474526|463792395|FG001|Overall Study|Death|0|||
128862348|NCT00474526|463792396|FG002|Overall Study|Death|0|||
128862349|NCT00474526|463792397|FG003|Overall Study|Death|0|||
128862350|NCT00474526|463792398|FG004|Overall Study|Death|0|||
128862351|NCT00474526|463792399|FG005|Overall Study|Death|0|||
128862352|NCT00474526|463792400|FG006|Overall Study|Death|0|||
128862353|NCT00474526|463792401|FG007|Overall Study|Death|0|||
128862354|NCT00474526|463792402|FG008|Overall Study|Death|0|||
128862355|NCT00474526|463792403|FG009|Overall Study|Death|0|||
128862356|NCT00474526|463792404|FG010|Overall Study|Death|0|||
128862357|NCT00474526|463792405|FG011|Overall Study|Death|0|||
128862358|NCT00474526|463792406|FG012|Overall Study|Death|0|||
128862359|NCT00474526|463792407|FG013|Overall Study|Death|3|||
128862360|NCT00474526|463792408|FG014|Overall Study|Death|0|||
128862361|NCT00474526|463792409|FG015|Overall Study|Death|0|||
128862362|NCT00474526|463792410|FG016|Overall Study|Death|0|||
128862363|NCT00474526|463792394|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862364|NCT00474526|463792395|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
128862365|NCT00474526|463792396|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862366|NCT00474526|463792397|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
128862367|NCT00474526|463792398|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
128862368|NCT00474526|463792399|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862369|NCT00474526|463792400|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862370|NCT00474526|463792401|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862371|NCT00474526|463792402|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862372|NCT00474526|463792403|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862373|NCT00474526|463792404|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862374|NCT00474526|463792405|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862375|NCT00474526|463792406|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862376|NCT00474526|463792407|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
128862377|NCT00474526|463792408|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
128862378|NCT00474526|463792409|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862379|NCT00474526|463792410|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
128862380|NCT00474526|463792394|FG000|Overall Study|Lost to Follow-up|8|||
128862381|NCT00474526|463792395|FG001|Overall Study|Lost to Follow-up|6|||
128862382|NCT00474526|463792396|FG002|Overall Study|Lost to Follow-up|13|||
128862383|NCT00474526|463792397|FG003|Overall Study|Lost to Follow-up|29|||
128862384|NCT00474526|463792398|FG004|Overall Study|Lost to Follow-up|11|||
128862385|NCT00474526|463792399|FG005|Overall Study|Lost to Follow-up|5|||
128862386|NCT00474526|463792400|FG006|Overall Study|Lost to Follow-up|8|||
128862387|NCT00474526|463792401|FG007|Overall Study|Lost to Follow-up|1|||
128862388|NCT00474526|463792402|FG008|Overall Study|Lost to Follow-up|0|||
128862389|NCT00474526|463792403|FG009|Overall Study|Lost to Follow-up|6|||
128862390|NCT00474526|463792404|FG010|Overall Study|Lost to Follow-up|2|||
128862391|NCT00474526|463792405|FG011|Overall Study|Lost to Follow-up|4|||
128862392|NCT00474526|463792406|FG012|Overall Study|Lost to Follow-up|6|||
128862393|NCT00474526|463792407|FG013|Overall Study|Lost to Follow-up|74|||
128862394|NCT00474526|463792408|FG014|Overall Study|Lost to Follow-up|29|||
128862395|NCT00474526|463792409|FG015|Overall Study|Lost to Follow-up|4|||
128862396|NCT00474526|463792410|FG016|Overall Study|Lost to Follow-up|5|||
128862397|NCT00474526|463792394|FG000|Overall Study|Protocol Violation|2|||
128862398|NCT00474526|463792395|FG001|Overall Study|Protocol Violation|6|||
128862399|NCT00474526|463792396|FG002|Overall Study|Protocol Violation|4|||
128862400|NCT00474526|463792397|FG003|Overall Study|Protocol Violation|12|||
128862401|NCT00474526|463792398|FG004|Overall Study|Protocol Violation|3|||
128862402|NCT00474526|463792399|FG005|Overall Study|Protocol Violation|1|||
128862403|NCT00474526|463792400|FG006|Overall Study|Protocol Violation|3|||
128862404|NCT00474526|463792401|FG007|Overall Study|Protocol Violation|0|||
128862405|NCT00474526|463792402|FG008|Overall Study|Protocol Violation|0|||
128862406|NCT00474526|463792403|FG009|Overall Study|Protocol Violation|4|||
128862407|NCT00474526|463792404|FG010|Overall Study|Protocol Violation|2|||
128862408|NCT00474526|463792405|FG011|Overall Study|Protocol Violation|2|||
128862409|NCT00474526|463792406|FG012|Overall Study|Protocol Violation|4|||
128862410|NCT00474526|463792407|FG013|Overall Study|Protocol Violation|19|||
128862411|NCT00474526|463792408|FG014|Overall Study|Protocol Violation|9|||
128862412|NCT00474526|463792409|FG015|Overall Study|Protocol Violation|6|||
128862413|NCT00474526|463792410|FG016|Overall Study|Protocol Violation|2|||
128862414|NCT00474526|463792394|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
128862415|NCT00474526|463792395|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
128862416|NCT00474526|463792396|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
128862417|NCT00474526|463792397|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
128862418|NCT00474526|463792398|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
128862419|NCT00474526|463792399|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
128862420|NCT00474526|463792400|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
128862421|NCT00474526|463792401|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
128862422|NCT00474526|463792402|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
128862423|NCT00474526|463792403|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
128862424|NCT00474526|463792404|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
128862425|NCT00474526|463792405|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
128862426|NCT00474526|463792406|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
128862427|NCT00474526|463792407|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
128862428|NCT00474526|463792408|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
128862429|NCT00474526|463792409|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
128862430|NCT00474526|463792410|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
128862431|NCT00474526|463792394|FG000|Overall Study|Withdrawal by Subject|9|||
128862432|NCT00474526|463792395|FG001|Overall Study|Withdrawal by Subject|24|||
128862433|NCT00474526|463792396|FG002|Overall Study|Withdrawal by Subject|21|||
128862434|NCT00474526|463792397|FG003|Overall Study|Withdrawal by Subject|52|||
128862435|NCT00474526|463792398|FG004|Overall Study|Withdrawal by Subject|38|||
128862436|NCT00474526|463792399|FG005|Overall Study|Withdrawal by Subject|6|||
128862437|NCT00474526|463792400|FG006|Overall Study|Withdrawal by Subject|12|||
128862438|NCT00474526|463792401|FG007|Overall Study|Withdrawal by Subject|4|||
128862439|NCT00474526|463792402|FG008|Overall Study|Withdrawal by Subject|4|||
128862440|NCT00474526|463792403|FG009|Overall Study|Withdrawal by Subject|13|||
128862441|NCT00474526|463792404|FG010|Overall Study|Withdrawal by Subject|5|||
128862442|NCT00474526|463792405|FG011|Overall Study|Withdrawal by Subject|4|||
128862443|NCT00474526|463792406|FG012|Overall Study|Withdrawal by Subject|4|||
128862444|NCT00474526|463792407|FG013|Overall Study|Withdrawal by Subject|37|||
128862445|NCT00474526|463792408|FG014|Overall Study|Withdrawal by Subject|22|||
128862446|NCT00474526|463792409|FG015|Overall Study|Withdrawal by Subject|1|||
128862447|NCT00474526|463792410|FG016|Overall Study|Withdrawal by Subject|1|||
128862448|NCT01251770|463792411|FG000|Overall Study|Protocol Violation|13|||
128862449|NCT01251770|463792412|FG001|Overall Study|Protocol Violation|7|||
128862450|NCT01020877|463792416|FG000|Second Intervention|Withdrawal by Subject|1|||
128862451|NCT01020877|463792417|FG001|Second Intervention|Withdrawal by Subject|0|||
128862452|NCT02460575|463792419|FG000|Overall Study|Lost to Follow-up|1|||
128862453|NCT02460575|463792420|FG001|Overall Study|Lost to Follow-up|0|||
128862454|NCT05543174|463792421|FG000|Overall Study|Ongoing|7|||
128862455|NCT01270828|463792422|FG000|Pregabalin CR SB|Reason Unspecified|0|||
128862456|NCT01270828|463792423|FG001|Pregabalin CR SB|Reason Unspecified|0|||
128862457|NCT01270828|463792424|FG002|Pregabalin CR SB|Reason Unspecified|8|||
128862458|NCT01270828|463792422|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
128862459|NCT01270828|463792423|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
128862460|NCT01270828|463792424|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
128862461|NCT01270828|463792422|FG000|Pregabalin CR SB|Related adverse event|0|||
128862462|NCT01270828|463792423|FG001|Pregabalin CR SB|Related adverse event|0|||
128862463|NCT01270828|463792424|FG002|Pregabalin CR SB|Related adverse event|46|||
128862464|NCT01270828|463792422|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
128862465|NCT01270828|463792423|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
128862466|NCT01270828|463792424|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
128862467|NCT01270828|463792422|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
128862468|NCT01270828|463792423|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
128862469|NCT01270828|463792424|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
128862470|NCT01270828|463792422|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
128862471|NCT01270828|463792423|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
128862472|NCT01270828|463792424|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
128862473|NCT01270828|463792422|FG000|Pregabalin CR SB|Unrelated AE|0|||
128862474|NCT01270828|463792423|FG001|Pregabalin CR SB|Unrelated AE|0|||
128862475|NCT01270828|463792424|FG002|Pregabalin CR SB|Unrelated AE|8|||
128862476|NCT01270828|463792422|FG000|Pregabalin CR SB|Protocol Violation|0|||
128862477|NCT01270828|463792423|FG001|Pregabalin CR SB|Protocol Violation|0|||
128862478|NCT01270828|463792424|FG002|Pregabalin CR SB|Protocol Violation|8|||
128862479|NCT01270828|463792422|FG000|Double Blind Phase|Death|0|||
128862480|NCT01270828|463792423|FG001|Double Blind Phase|Death|1|||
128862481|NCT01270828|463792424|FG002|Double Blind Phase|Death|0|||
128862482|NCT01270828|463792422|FG000|Double Blind Phase|Protocol Violation|0|||
128862483|NCT01270828|463792423|FG001|Double Blind Phase|Protocol Violation|1|||
128862484|NCT01270828|463792424|FG002|Double Blind Phase|Protocol Violation|0|||
128862485|NCT01270828|463792422|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
128862486|NCT01270828|463792423|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
128862487|NCT01270828|463792424|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
128862488|NCT01270828|463792422|FG000|Double Blind Phase|Reason Unspecified|7|||
128862489|NCT01270828|463792423|FG001|Double Blind Phase|Reason Unspecified|4|||
128862490|NCT01270828|463792424|FG002|Double Blind Phase|Reason Unspecified|0|||
128862491|NCT01270828|463792422|FG000|Double Blind Phase|Withdrawal by Subject|6|||
128862492|NCT01270828|463792423|FG001|Double Blind Phase|Withdrawal by Subject|15|||
128862493|NCT01270828|463792424|FG002|Double Blind Phase|Withdrawal by Subject|0|||
128862494|NCT01270828|463792422|FG000|Double Blind Phase|Lost to Follow-up|1|||
128862495|NCT01270828|463792423|FG001|Double Blind Phase|Lost to Follow-up|2|||
128862496|NCT01270828|463792424|FG002|Double Blind Phase|Lost to Follow-up|0|||
128862497|NCT01270828|463792422|FG000|Double Blind Phase|Lack of Efficacy|2|||
128862498|NCT01270828|463792423|FG001|Double Blind Phase|Lack of Efficacy|11|||
128862499|NCT01270828|463792424|FG002|Double Blind Phase|Lack of Efficacy|0|||
128862500|NCT01270828|463792422|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
128862501|NCT01270828|463792423|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
128862502|NCT01270828|463792424|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
128862503|NCT01270828|463792422|FG000|Double Blind Phase|Adverse event related to study drug|5|||
128862504|NCT01270828|463792423|FG001|Double Blind Phase|Adverse event related to study drug|7|||
128862505|NCT01270828|463792424|FG002|Double Blind Phase|Adverse event related to study drug|0|||
128862506|NCT02963090|463792425|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
128862507|NCT02963090|463792426|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
128862508|NCT04497389|463792429|FG000|Overall Study|Withdrawal by Subject|1|||
128862509|NCT04497389|463792430|FG001|Overall Study|Withdrawal by Subject|0|||
128862510|NCT03322540|463792432|FG000|Overall Study|Death|21|||
128862511|NCT03322540|463792433|FG001|Overall Study|Death|28|||
128862512|NCT03322540|463792432|FG000|Overall Study|Lost to Follow-up|0|||
128862513|NCT03322540|463792433|FG001|Overall Study|Lost to Follow-up|1|||
128862514|NCT03322540|463792432|FG000|Overall Study|Physician Decision|7|||
128862515|NCT03322540|463792433|FG001|Overall Study|Physician Decision|6|||
128862516|NCT03322540|463792432|FG000|Overall Study|Withdrawal by Subject|3|||
128862517|NCT03322540|463792433|FG001|Overall Study|Withdrawal by Subject|1|||
128862518|NCT03322540|463792432|FG000|Overall Study|Study terminated by sponsor|0|||
128862519|NCT03322540|463792433|FG001|Overall Study|Study terminated by sponsor|1|||
128862520|NCT04052425|463792434|FG000|24-Week Double-blind Period|Adverse Event|0|||
128862521|NCT04052425|463792435|FG001|24-Week Double-blind Period|Adverse Event|1|||
128862522|NCT04052425|463792436|FG002|24-Week Double-blind Period|Adverse Event|0|||
128862523|NCT04052425|463792437|FG003|24-Week Double-blind Period|Adverse Event|0|||
128862524|NCT04052425|463792434|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
128862525|NCT04052425|463792435|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
128862526|NCT04052425|463792436|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
128862527|NCT04052425|463792437|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
128862528|NCT04052425|463792434|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
128862529|NCT04052425|463792435|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
128862530|NCT04052425|463792436|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
128862531|NCT04052425|463792437|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
128862532|NCT04052425|463792434|FG000|24-Week Double-blind Period|Physician Decision|1|||
128862533|NCT04052425|463792435|FG001|24-Week Double-blind Period|Physician Decision|0|||
128862534|NCT04052425|463792436|FG002|24-Week Double-blind Period|Physician Decision|0|||
128862535|NCT04052425|463792437|FG003|24-Week Double-blind Period|Physician Decision|0|||
128862536|NCT04052425|463792434|FG000|24-Week Double-blind Period|Protocol Violation|1|||
128862537|NCT04052425|463792435|FG001|24-Week Double-blind Period|Protocol Violation|0|||
128862538|NCT04052425|463792436|FG002|24-Week Double-blind Period|Protocol Violation|0|||
128862539|NCT04052425|463792437|FG003|24-Week Double-blind Period|Protocol Violation|0|||
128862540|NCT04052425|463792434|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
128862541|NCT04052425|463792435|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
128862542|NCT04052425|463792436|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
128862543|NCT04052425|463792437|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
128862544|NCT04052425|463792434|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
128862545|NCT04052425|463792435|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
128862546|NCT04052425|463792436|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
128862547|NCT04052425|463792437|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
128862548|NCT04052425|463792434|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
128862549|NCT04052425|463792435|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
128862550|NCT04052425|463792436|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
128862551|NCT04052425|463792437|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
128862552|NCT04052425|463792434|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
128862553|NCT04052425|463792435|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
128862554|NCT04052425|463792436|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
128862555|NCT04052425|463792437|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
128862556|NCT04052425|463792434|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
128862557|NCT04052425|463792435|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
128862558|NCT04052425|463792436|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
128862559|NCT04052425|463792437|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
128862560|NCT04052425|463792434|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
128862561|NCT04052425|463792435|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
128862562|NCT04052425|463792436|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
128862563|NCT04052425|463792437|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
128862564|NCT04052425|463792434|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
128862565|NCT04052425|463792435|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
128862566|NCT04052425|463792436|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
128862567|NCT04052425|463792437|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
128862568|NCT04052425|463792434|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
128862569|NCT04052425|463792435|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
128862570|NCT04052425|463792436|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
128862571|NCT04052425|463792437|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
128862572|NCT04052425|463792434|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
128862573|NCT04052425|463792435|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
128862574|NCT04052425|463792436|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
128862575|NCT04052425|463792437|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
128862576|NCT04334278|463792438|FG000|Overall Study|Lost to Follow-up|0|||
128862577|NCT04334278|463792439|FG001|Overall Study|Lost to Follow-up|3|||
128862578|NCT04334278|463792438|FG000|Overall Study|Withdrawal by Subject|4|||
128862579|NCT04334278|463792439|FG001|Overall Study|Withdrawal by Subject|2|||
128862580|NCT02615509|463792440|FG000|Overall Study|Lost to Follow-up|134|||
128862581|NCT02615509|463792440|FG000|Overall Study|Death|4|||
128862582|NCT02615509|463792440|FG000|Overall Study|Withdrawal by Subject|8|||
128862583|NCT00425607|463792441|FG000|Overall Study|Death|1|||
128862584|NCT00425607|463792441|FG000|Overall Study|Withdrawal by Subject|1|||
128862585|NCT00079339|463792442|FG000|Overall Study|Adverse Event|1|||
128862586|NCT00079339|463792443|FG001|Overall Study|Adverse Event|7|||
128862587|NCT00079339|463792444|FG002|Overall Study|Adverse Event|2|||
128862588|NCT00079339|463792442|FG000|Overall Study|Death|1|||
128862589|NCT00079339|463792443|FG001|Overall Study|Death|0|||
128862590|NCT00079339|463792444|FG002|Overall Study|Death|0|||
128862591|NCT00079339|463792442|FG000|Overall Study|Non-compliance|0|||
128862592|NCT00079339|463792443|FG001|Overall Study|Non-compliance|0|||
128862593|NCT00079339|463792444|FG002|Overall Study|Non-compliance|1|||
128862594|NCT00079339|463792442|FG000|Overall Study|Withdrawal by Subject|0|||
128862595|NCT00079339|463792443|FG001|Overall Study|Withdrawal by Subject|4|||
128862596|NCT00079339|463792444|FG002|Overall Study|Withdrawal by Subject|1|||
128862597|NCT00079339|463792442|FG000|Overall Study|Disease progression|3|||
128862598|NCT00079339|463792443|FG001|Overall Study|Disease progression|28|||
128862599|NCT00079339|463792444|FG002|Overall Study|Disease progression|2|||
128862600|NCT02563548|463792445|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
128862601|NCT02563548|463792446|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
128862602|NCT02563548|463792447|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
128862603|NCT02563548|463792448|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
128862604|NCT02563548|463792449|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
128862605|NCT02563548|463792450|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
128862606|NCT02563548|463792445|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
128862607|NCT02563548|463792446|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
128862608|NCT02563548|463792447|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
128862609|NCT02563548|463792448|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
128862610|NCT02563548|463792449|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
128862611|NCT02563548|463792450|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
128862612|NCT02563548|463792445|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
128862613|NCT02563548|463792446|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
128862614|NCT02563548|463792447|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
128862615|NCT02563548|463792448|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
128862616|NCT02563548|463792449|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
128862617|NCT02563548|463792450|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
128862618|NCT02563548|463792445|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
128862619|NCT02563548|463792446|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
128862620|NCT02563548|463792447|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
128862621|NCT02563548|463792448|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
128862622|NCT02563548|463792449|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
128862623|NCT02563548|463792450|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
128862624|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
128862625|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
128862626|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
128862627|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
128862628|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
128862629|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
128862630|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
128862631|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
128862632|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
128862633|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
128862634|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
128862635|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
128862636|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
128862637|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
128862638|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
128862639|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
128862640|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
128862641|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
128862642|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
128862643|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
128862644|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
128862645|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
128862646|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
128862647|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
128862648|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
128862649|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
128862650|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
128862651|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
128862652|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
128862653|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
128862654|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
128862655|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
128862656|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
128862657|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
128862658|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
128862659|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
128862660|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
128862661|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
128862662|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
128862663|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
128862664|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
128862665|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
128862666|NCT02563548|463792445|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
128862667|NCT02563548|463792446|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
128862668|NCT02563548|463792447|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
128862669|NCT02563548|463792448|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
128862670|NCT02563548|463792449|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
128862671|NCT02563548|463792450|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
128862672|NCT00520845|463792451|FG000|Overall Study|Death|3|||
128862673|NCT00520845|463792451|FG000|Overall Study|Adverse Event|4|||
128862674|NCT00520845|463792451|FG000|Overall Study|Disease Progression, relapse|13|||
128862675|NCT00520845|463792451|FG000|Overall Study|Withdrawal by Subject|1|||
128862676|NCT00520845|463792451|FG000|Overall Study|Alternative Therapy|1|||
128862677|NCT00945672|463792455|FG000|Overall Study|Withdrawal by Subject|0|||
128862678|NCT00945672|463792456|FG001|Overall Study|Withdrawal by Subject|0|||
128862679|NCT00945672|463792457|FG002|Overall Study|Withdrawal by Subject|0|||
128862680|NCT00945672|463792458|FG003|Overall Study|Withdrawal by Subject|1|||
128862681|NCT03054337|463792463|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
128862682|NCT03054337|463792464|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
128862683|NCT03054337|463792465|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
128862684|NCT03054337|463792466|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
128862685|NCT03054337|463792467|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
128862686|NCT03054337|463792468|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
128862687|NCT00447590|463792470|FG000|Overall Study|Withdrawal by Subject|26|||
128862688|NCT00447590|463792470|FG000|Overall Study|Lost to Follow-up|24|||
128862689|NCT00447590|463792470|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
128862690|NCT01967069|463792471|FG000|Overall Study|Adverse Event|2|||
128862691|NCT01967069|463792472|FG001|Overall Study|Adverse Event|2|||
128862692|NCT01967069|463792471|FG000|Overall Study|Lost to Follow-up|5|||
128862693|NCT01967069|463792472|FG001|Overall Study|Lost to Follow-up|2|||
128862694|NCT01967069|463792471|FG000|Overall Study|Withdrawal by Subject|1|||
128862695|NCT01967069|463792472|FG001|Overall Study|Withdrawal by Subject|3|||
128862696|NCT01967069|463792471|FG000|Overall Study|Lack of Efficacy|0|||
128862697|NCT01967069|463792472|FG001|Overall Study|Lack of Efficacy|1|||
128862698|NCT01661205|463792476|FG000|Overall Study|Physician Decision|2|||
128862699|NCT03111095|463792480|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
128862700|NCT03111095|463792481|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
128862701|NCT03111095|463792480|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
128862702|NCT03111095|463792481|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
128862703|NCT00504075|463792482|FG000|Overall Study|Adverse Event|1|||
128862704|NCT00504075|463792482|FG000|Overall Study|Lost to Follow-up|5|||
128862705|NCT00504075|463792482|FG000|Overall Study|Withdrawal by Subject|1|||
128862706|NCT00504075|463792482|FG000|Overall Study|Required other therapeutic intervention|1|||
128862707|NCT04245345|463792490|FG000|Overall Study|Death|1|||
128862708|NCT04245345|463792490|FG000|Overall Study|Exited prior to implant|5|||
128862709|NCT04245345|463792490|FG000|Overall Study|Exited prior to 1-month|9|||
128862710|NCT04245345|463792490|FG000|Overall Study|Missed 1-month visit|3|||
128862711|NCT04245345|463792490|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
128862712|NCT04245345|463792490|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
128862713|NCT00732992|463792491|FG000|Overall Study|Adverse Event|1|||
128862714|NCT00732992|463792492|FG001|Overall Study|Adverse Event|1|||
128862715|NCT00732992|463792491|FG000|Overall Study|Objective Progression or Relapse|3|||
128862716|NCT00732992|463792492|FG001|Overall Study|Objective Progression or Relapse|5|||
128862717|NCT00732992|463792491|FG000|Overall Study|Global Deterioration of Health Status|1|||
128862718|NCT00732992|463792492|FG001|Overall Study|Global Deterioration of Health Status|0|||
128862719|NCT00732992|463792491|FG000|Overall Study|Withdrawal by Subject|1|||
128862720|NCT00732992|463792492|FG001|Overall Study|Withdrawal by Subject|0|||
128862721|NCT03004404|463792495|FG000|Period 2|Adverse Event|0|||
128862722|NCT03004404|463792496|FG001|Period 2|Adverse Event|0|||
128862723|NCT03004404|463792497|FG002|Period 2|Adverse Event|0|||
128862724|NCT03004404|463792498|FG003|Period 2|Adverse Event|0|||
128862725|NCT03004404|463792499|FG004|Period 2|Adverse Event|0|||
128862726|NCT03004404|463792500|FG005|Period 2|Adverse Event|0|||
128862727|NCT03004404|463792501|FG006|Period 2|Adverse Event|0|||
128862728|NCT03004404|463792502|FG007|Period 2|Adverse Event|0|||
128862729|NCT03004404|463792503|FG008|Period 2|Adverse Event|1|||
128862730|NCT03004404|463792504|FG009|Period 2|Adverse Event|0|||
128862731|NCT03004404|463792505|FG010|Period 2|Adverse Event|0|||
128862732|NCT03004404|463792506|FG011|Period 2|Adverse Event|0|||
128862733|NCT03004404|463792507|FG012|Period 2|Adverse Event|0|||
128862734|NCT03004404|463792508|FG013|Period 2|Adverse Event|0|||
128862735|NCT03004404|463792509|FG014|Period 2|Adverse Event|0|||
128862736|NCT03004404|463792510|FG015|Period 2|Adverse Event|1|||
128862737|NCT00706654|463792511|FG000|Conversion Phase|Lost to Follow-up|4|||
128862738|NCT00706654|463792512|FG001|Conversion Phase|Lost to Follow-up|0|||
128862739|NCT00706654|463792513|FG002|Conversion Phase|Lost to Follow-up|0|||
128862740|NCT00706654|463792514|FG003|Conversion Phase|Lost to Follow-up|0|||
128862741|NCT00706654|463792511|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
128862742|NCT00706654|463792512|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
128862743|NCT00706654|463792513|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
128862744|NCT00706654|463792514|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
128862745|NCT00706654|463792511|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
128862746|NCT00706654|463792512|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
128862747|NCT00706654|463792513|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
128862748|NCT00706654|463792514|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
128862749|NCT00706654|463792511|FG000|Conversion Phase|Withdrawn by Investigator|14|||
128862750|NCT00706654|463792512|FG001|Conversion Phase|Withdrawn by Investigator|0|||
128862751|NCT00706654|463792513|FG002|Conversion Phase|Withdrawn by Investigator|0|||
128862752|NCT00706654|463792514|FG003|Conversion Phase|Withdrawn by Investigator|0|||
128862753|NCT00706654|463792511|FG000|Conversion Phase|Withdrew Consent|38|||
128862754|NCT00706654|463792512|FG001|Conversion Phase|Withdrew Consent|0|||
128862755|NCT00706654|463792513|FG002|Conversion Phase|Withdrew Consent|0|||
128862756|NCT00706654|463792514|FG003|Conversion Phase|Withdrew Consent|0|||
128862757|NCT00706654|463792511|FG000|Conversion Phase|Adverse Event|18|||
128862758|NCT00706654|463792512|FG001|Conversion Phase|Adverse Event|0|||
128862759|NCT00706654|463792513|FG002|Conversion Phase|Adverse Event|0|||
128862760|NCT00706654|463792514|FG003|Conversion Phase|Adverse Event|0|||
128862761|NCT00706654|463792511|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
128862762|NCT00706654|463792512|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
128862763|NCT00706654|463792513|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
128862764|NCT00706654|463792514|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
128862765|NCT00706654|463792511|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
128862766|NCT00706654|463792512|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
128862767|NCT00706654|463792513|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
128862768|NCT00706654|463792514|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
128862769|NCT00706654|463792511|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
128862770|NCT00706654|463792512|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
128862771|NCT00706654|463792513|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
128862772|NCT00706654|463792514|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
128862773|NCT00706654|463792511|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
128862774|NCT00706654|463792512|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
128862775|NCT00706654|463792513|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
128862776|NCT00706654|463792514|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
128862777|NCT00706654|463792511|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
128862778|NCT00706654|463792512|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
128862779|NCT00706654|463792513|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
128862780|NCT00706654|463792514|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
128862781|NCT00706654|463792511|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
128862782|NCT00706654|463792512|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
128862783|NCT00706654|463792513|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
128862784|NCT00706654|463792514|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
128862785|NCT00706654|463792511|FG000|Oral Stabilization Phase|Withdrew consent|55|||
128862786|NCT00706654|463792512|FG001|Oral Stabilization Phase|Withdrew consent|0|||
128862787|NCT00706654|463792513|FG002|Oral Stabilization Phase|Withdrew consent|0|||
128862788|NCT00706654|463792514|FG003|Oral Stabilization Phase|Withdrew consent|0|||
128862789|NCT00706654|463792511|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
128862790|NCT00706654|463792512|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
128862791|NCT00706654|463792513|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
128862792|NCT00706654|463792514|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
128862793|NCT00706654|463792511|FG000|Oral Stabilization Phase|Adverse Event|21|||
128862794|NCT00706654|463792512|FG001|Oral Stabilization Phase|Adverse Event|0|||
128862795|NCT00706654|463792513|FG002|Oral Stabilization Phase|Adverse Event|0|||
128862796|NCT00706654|463792514|FG003|Oral Stabilization Phase|Adverse Event|0|||
128862797|NCT00706654|463792511|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
128862798|NCT00706654|463792512|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
128862799|NCT00706654|463792513|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
128862800|NCT00706654|463792514|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
128862801|NCT00706654|463792511|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
128862802|NCT00706654|463792512|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
128862803|NCT00706654|463792513|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
128862804|NCT00706654|463792514|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
128862805|NCT00706654|463792511|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
128862806|NCT00706654|463792512|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
128862807|NCT00706654|463792513|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
128862808|NCT00706654|463792514|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
128862809|NCT00706654|463792511|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
128862810|NCT00706654|463792512|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
128862811|NCT00706654|463792513|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
128862812|NCT00706654|463792514|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
128862813|NCT00706654|463792511|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
128862814|NCT00706654|463792512|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
128862815|NCT00706654|463792513|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
128862816|NCT00706654|463792514|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
128862817|NCT00706654|463792511|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
128862818|NCT00706654|463792512|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
128862819|NCT00706654|463792513|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
128862820|NCT00706654|463792514|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
128862821|NCT00706654|463792511|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
128862822|NCT00706654|463792512|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
128862823|NCT00706654|463792513|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
128862824|NCT00706654|463792514|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
128862825|NCT00706654|463792511|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
128862826|NCT00706654|463792512|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
128862827|NCT00706654|463792513|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
128862828|NCT00706654|463792514|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
128862829|NCT00706654|463792511|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
128862830|NCT00706654|463792512|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
128862831|NCT00706654|463792513|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
128862832|NCT00706654|463792514|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
128862833|NCT00706654|463792511|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
128862834|NCT00706654|463792512|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
128862835|NCT00706654|463792513|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
128862836|NCT00706654|463792514|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
128862837|NCT01001390|463792517|FG000|Overall Study|Failure to wear AFO device|2|||
128862838|NCT01001390|463792518|FG001|Overall Study|Failure to wear AFO device|0|||
128862839|NCT01151215|463792519|FG000|Overall Study|Worsening of condition under study|1|||
128862840|NCT01151215|463792520|FG001|Overall Study|Worsening of condition under study|1|||
128862841|NCT01151215|463792521|FG002|Overall Study|Worsening of condition under study|1|||
128862842|NCT01151215|463792519|FG000|Overall Study|Death|16|||
128862843|NCT01151215|463792520|FG001|Overall Study|Death|20|||
128862844|NCT01151215|463792521|FG002|Overall Study|Death|11|||
128862845|NCT01151215|463792519|FG000|Overall Study|Lost to Follow-up|0|||
128862846|NCT01151215|463792520|FG001|Overall Study|Lost to Follow-up|0|||
128862847|NCT01151215|463792521|FG002|Overall Study|Lost to Follow-up|3|||
128862848|NCT01151215|463792519|FG000|Overall Study|Withdrawal by Subject|3|||
128862849|NCT01151215|463792520|FG001|Overall Study|Withdrawal by Subject|1|||
128862850|NCT01151215|463792521|FG002|Overall Study|Withdrawal by Subject|2|||
128862851|NCT01151215|463792519|FG000|Overall Study|Disease progression|0|||
128862852|NCT01151215|463792520|FG001|Overall Study|Disease progression|1|||
128862853|NCT01151215|463792521|FG002|Overall Study|Disease progression|1|||
128862854|NCT01151215|463792519|FG000|Overall Study|Safety as judged by the investigator|0|||
128862855|NCT01151215|463792520|FG001|Overall Study|Safety as judged by the investigator|0|||
128862856|NCT01151215|463792521|FG002|Overall Study|Safety as judged by the investigator|1|||
128862857|NCT01721954|463792524|FG000|Overall Study|Death|58|||
128862858|NCT01721954|463792525|FG001|Overall Study|Death|64|||
128862859|NCT01721954|463792524|FG000|Overall Study|Withdrawal by Subject|8|||
128862860|NCT01721954|463792525|FG001|Overall Study|Withdrawal by Subject|4|||
128862861|NCT01721954|463792524|FG000|Overall Study|Adverse Event|2|||
128862862|NCT01721954|463792525|FG001|Overall Study|Adverse Event|0|||
128862863|NCT01721954|463792524|FG000|Overall Study|Lost to Follow-up|2|||
128862864|NCT01721954|463792525|FG001|Overall Study|Lost to Follow-up|1|||
128862865|NCT03392168|463792526|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
128862866|NCT03392168|463792527|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
128862867|NCT03392168|463792528|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
128862868|NCT03392168|463792529|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
128862869|NCT03392168|463792526|FG000|Period 2: Cohort 2|Other|0|||
128862870|NCT03392168|463792527|FG001|Period 2: Cohort 2|Other|1|||
128862871|NCT03392168|463792528|FG002|Period 2: Cohort 2|Other|0|||
128862872|NCT03392168|463792529|FG003|Period 2: Cohort 2|Other|0|||
128862873|NCT01162486|463792534|FG000|Overall Study|low ANC|1|||
128862874|NCT01162486|463792535|FG001|Overall Study|low ANC|0|||
128862875|NCT01162486|463792536|FG002|Overall Study|low ANC|0|||
128862876|NCT01162486|463792537|FG003|Overall Study|low ANC|0|||
128862877|NCT01162486|463792538|FG004|Overall Study|low ANC|0|||
128862878|NCT01162486|463792534|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
128862879|NCT01162486|463792535|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
128862880|NCT01162486|463792536|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
128862881|NCT01162486|463792537|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
128862882|NCT01162486|463792538|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
128862883|NCT01162486|463792534|FG000|Overall Study|elevated LFTs|0|||
128862884|NCT01162486|463792535|FG001|Overall Study|elevated LFTs|0|||
128862885|NCT01162486|463792536|FG002|Overall Study|elevated LFTs|1|||
128862886|NCT01162486|463792537|FG003|Overall Study|elevated LFTs|0|||
128862887|NCT01162486|463792538|FG004|Overall Study|elevated LFTs|0|||
128862888|NCT01162486|463792534|FG000|Overall Study|Pregnancy|0|||
128862889|NCT01162486|463792535|FG001|Overall Study|Pregnancy|0|||
128862890|NCT01162486|463792536|FG002|Overall Study|Pregnancy|0|||
128862891|NCT01162486|463792537|FG003|Overall Study|Pregnancy|1|||
128862892|NCT01162486|463792538|FG004|Overall Study|Pregnancy|0|||
128862893|NCT04160988|463792541|FG000|Overall Study|poor image quality|28|||
128862894|NCT00844597|463792542|FG000|Overall Study|Adverse Event|0|||
128862895|NCT00844597|463792543|FG001|Overall Study|Adverse Event|0|||
128862896|NCT00844597|463792544|FG002|Overall Study|Adverse Event|0|||
128862897|NCT00844597|463792545|FG003|Overall Study|Adverse Event|1|||
128862898|NCT00844597|463792546|FG004|Overall Study|Adverse Event|0|||
128862899|NCT00844597|463792547|FG005|Overall Study|Adverse Event|0|||
128862900|NCT02670122|463792548|FG000|Overall Study|Lost to Follow-up|4|||
128862901|NCT02762903|463792554|FG000|Overall Study|Lost to Follow-up|0|||
128862902|NCT02762903|463792555|FG001|Overall Study|Lost to Follow-up|1|||
128862903|NCT01228175|463792556|FG000|Overall Study|Lost to Follow-up|64|||
128862904|NCT01228175|463792557|FG001|Overall Study|Lost to Follow-up|50|||
128862905|NCT01228175|463792556|FG000|Overall Study|Withdrawal by Subject|1|||
128862906|NCT01228175|463792557|FG001|Overall Study|Withdrawal by Subject|2|||
128862907|NCT01228175|463792556|FG000|Overall Study|Physician Decision|1|||
128862908|NCT01228175|463792557|FG001|Overall Study|Physician Decision|1|||
128862909|NCT00243074|463792558|FG000|Overall Study|Ineligible|6|||
128862910|NCT00243074|463792558|FG000|Overall Study|Adverse Event|6|||
128862911|NCT00243074|463792558|FG000|Overall Study|Withdrawal by Subject|2|||
128862912|NCT00243074|463792558|FG000|Overall Study|Lack of Efficacy|36|||
128862913|NCT00243074|463792558|FG000|Overall Study|Death|2|||
128862914|NCT00243074|463792558|FG000|Overall Study|not protocol specified|1|||
128862915|NCT00243074|463792558|FG000|Overall Study|Did not receive any treatment|1|||
128862916|NCT00664534|463792559|FG000|Overall Study|Adverse Event|2|||
128862917|NCT00664534|463792560|FG001|Overall Study|Adverse Event|3|||
128862918|NCT00664534|463792559|FG000|Overall Study|Lost to Follow-up|6|||
128862919|NCT00664534|463792560|FG001|Overall Study|Lost to Follow-up|10|||
128862920|NCT00664534|463792559|FG000|Overall Study|Protocol Violation|10|||
128862921|NCT00664534|463792560|FG001|Overall Study|Protocol Violation|8|||
128862922|NCT00664534|463792559|FG000|Overall Study|Withdrawal by Subject|7|||
128862923|NCT00664534|463792560|FG001|Overall Study|Withdrawal by Subject|6|||
128862924|NCT00664534|463792559|FG000|Overall Study|Physician Decision|8|||
128862925|NCT00664534|463792560|FG001|Overall Study|Physician Decision|0|||
128862926|NCT00664534|463792559|FG000|Overall Study|Sponsor decision|8|||
128862927|NCT00664534|463792560|FG001|Overall Study|Sponsor decision|6|||
128862928|NCT03041792|463792563|FG000|Overall Study|Adverse Event|4|||
128862929|NCT03041792|463792564|FG001|Overall Study|Adverse Event|0|||
128862930|NCT03041792|463792563|FG000|Overall Study|Death in the family|0|||
128862931|NCT03041792|463792564|FG001|Overall Study|Death in the family|2|||
128862932|NCT03041792|463792563|FG000|Overall Study|Randomized but not treated|0|||
128862933|NCT03041792|463792564|FG001|Overall Study|Randomized but not treated|1|||
128862934|NCT02227992|463792565|FG000|Overall Study|Lost to Follow-up|1|||
128862935|NCT02227992|463792566|FG001|Overall Study|Lost to Follow-up|1|||
128862936|NCT02358668|463794818|FG000|Overall Study|Adverse Event|2|||
128862937|NCT02358668|463794819|FG001|Overall Study|Adverse Event|0|||
128862938|NCT02358668|463794820|FG002|Overall Study|Adverse Event|0|||
128862939|NCT02358668|463794818|FG000|Overall Study|Withdrawal by Subject|0|||
128862940|NCT02358668|463794819|FG001|Overall Study|Withdrawal by Subject|1|||
128862941|NCT02358668|463794820|FG002|Overall Study|Withdrawal by Subject|0|||
128862942|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Adverse Event|2|||
128862943|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Adverse Event|0|||
128862944|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Adverse Event|0|||
128862945|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Adverse Event|0|||
128862946|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
128862947|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
128862948|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
128862949|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
128862950|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
128862951|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
128862952|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
128862953|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
128862954|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Physician Decision|1|||
128862955|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Physician Decision|0|||
128862956|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Physician Decision|0|||
128862957|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Physician Decision|0|||
128862958|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Pregnancy|1|||
128862959|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Pregnancy|0|||
128862960|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Pregnancy|0|||
128862961|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Pregnancy|0|||
128862962|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
128862963|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
128862964|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
128862965|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
128862966|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
128862967|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
128862968|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
128862969|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
128862970|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
128862971|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
128862972|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
128862973|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
128862974|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
128862975|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
128862976|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
128862977|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
128862978|NCT04057573|463794821|FG000|24-Week Double-Blind Period|Not Treated|1|||
128862979|NCT04057573|463794822|FG001|24-Week Double-Blind Period|Not Treated|0|||
128862980|NCT04057573|463794823|FG002|24-Week Double-Blind Period|Not Treated|0|||
128862981|NCT04057573|463794824|FG003|24-Week Double-Blind Period|Not Treated|0|||
128862982|NCT04057573|463794821|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
128862983|NCT04057573|463794822|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
128862984|NCT04057573|463794823|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
128862985|NCT04057573|463794824|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
128862986|NCT04057573|463794821|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
128862987|NCT04057573|463794822|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
128862988|NCT04057573|463794823|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
128862989|NCT04057573|463794824|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
128862990|NCT04057573|463794821|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
128862991|NCT04057573|463794822|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
128862992|NCT04057573|463794823|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
128862993|NCT04057573|463794824|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
128862994|NCT04057573|463794821|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
128862995|NCT04057573|463794822|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
128862996|NCT04057573|463794823|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
128862997|NCT04057573|463794824|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
128862998|NCT04057573|463794821|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
128862999|NCT04057573|463794822|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
128863000|NCT04057573|463794823|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
128863001|NCT04057573|463794824|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
128863002|NCT01317875|463794827|FG000|Overall Study|Other|0|||
128863003|NCT01317875|463794828|FG001|Overall Study|Other|0|||
128863004|NCT01317875|463794829|FG002|Overall Study|Other|1|||
128863005|NCT01317875|463794830|FG003|Overall Study|Other|0|||
128863006|NCT01317875|463794831|FG004|Overall Study|Other|0|||
128863007|NCT01317875|463794832|FG005|Overall Study|Other|0|||
128863008|NCT01317875|463794833|FG006|Overall Study|Other|0|||
128863009|NCT01317875|463794834|FG007|Overall Study|Other|0|||
128863010|NCT01317875|463794835|FG008|Overall Study|Other|0|||
128863011|NCT01317875|463794836|FG009|Overall Study|Other|0|||
128863012|NCT01317875|463794827|FG000|Overall Study|Noncompliance with study drug|0|||
128863013|NCT01317875|463794828|FG001|Overall Study|Noncompliance with study drug|0|||
128863014|NCT01317875|463794829|FG002|Overall Study|Noncompliance with study drug|1|||
128863015|NCT01317875|463794830|FG003|Overall Study|Noncompliance with study drug|0|||
128863016|NCT01317875|463794831|FG004|Overall Study|Noncompliance with study drug|0|||
128863017|NCT01317875|463794832|FG005|Overall Study|Noncompliance with study drug|0|||
128863018|NCT01317875|463794833|FG006|Overall Study|Noncompliance with study drug|0|||
128863019|NCT01317875|463794834|FG007|Overall Study|Noncompliance with study drug|0|||
128863020|NCT01317875|463794835|FG008|Overall Study|Noncompliance with study drug|0|||
128863021|NCT01317875|463794836|FG009|Overall Study|Noncompliance with study drug|0|||
128863022|NCT01317875|463794827|FG000|Overall Study|Progressive Disease|1|||
128863023|NCT01317875|463794828|FG001|Overall Study|Progressive Disease|0|||
128863024|NCT01317875|463794829|FG002|Overall Study|Progressive Disease|2|||
128863025|NCT01317875|463794830|FG003|Overall Study|Progressive Disease|0|||
128863026|NCT01317875|463794831|FG004|Overall Study|Progressive Disease|1|||
128863027|NCT01317875|463794832|FG005|Overall Study|Progressive Disease|0|||
128863028|NCT01317875|463794833|FG006|Overall Study|Progressive Disease|0|||
128863029|NCT01317875|463794834|FG007|Overall Study|Progressive Disease|1|||
128863030|NCT01317875|463794835|FG008|Overall Study|Progressive Disease|0|||
128863031|NCT01317875|463794836|FG009|Overall Study|Progressive Disease|0|||
128863032|NCT01317875|463794827|FG000|Overall Study|Withdrawal by Subject|0|||
128863033|NCT01317875|463794828|FG001|Overall Study|Withdrawal by Subject|0|||
128863034|NCT01317875|463794829|FG002|Overall Study|Withdrawal by Subject|0|||
128863035|NCT01317875|463794830|FG003|Overall Study|Withdrawal by Subject|0|||
128863036|NCT01317875|463794831|FG004|Overall Study|Withdrawal by Subject|1|||
128863037|NCT01317875|463794832|FG005|Overall Study|Withdrawal by Subject|0|||
128863038|NCT01317875|463794833|FG006|Overall Study|Withdrawal by Subject|0|||
128863039|NCT01317875|463794834|FG007|Overall Study|Withdrawal by Subject|3|||
128863040|NCT01317875|463794835|FG008|Overall Study|Withdrawal by Subject|0|||
128863041|NCT01317875|463794836|FG009|Overall Study|Withdrawal by Subject|0|||
128863042|NCT01317875|463794827|FG000|Overall Study|Physician Decision|0|||
128863043|NCT01317875|463794828|FG001|Overall Study|Physician Decision|1|||
128863044|NCT01317875|463794829|FG002|Overall Study|Physician Decision|1|||
128863045|NCT01317875|463794830|FG003|Overall Study|Physician Decision|0|||
128863046|NCT01317875|463794831|FG004|Overall Study|Physician Decision|2|||
128863047|NCT01317875|463794832|FG005|Overall Study|Physician Decision|0|||
128863048|NCT01317875|463794833|FG006|Overall Study|Physician Decision|0|||
128863049|NCT01317875|463794834|FG007|Overall Study|Physician Decision|2|||
128863050|NCT01317875|463794835|FG008|Overall Study|Physician Decision|0|||
128863051|NCT01317875|463794836|FG009|Overall Study|Physician Decision|0|||
128863052|NCT01317875|463794827|FG000|Overall Study|Death|0|||
128863053|NCT01317875|463794828|FG001|Overall Study|Death|0|||
128863054|NCT01317875|463794829|FG002|Overall Study|Death|2|||
128863055|NCT01317875|463794830|FG003|Overall Study|Death|1|||
128863056|NCT01317875|463794831|FG004|Overall Study|Death|0|||
128863057|NCT01317875|463794832|FG005|Overall Study|Death|1|||
128863058|NCT01317875|463794833|FG006|Overall Study|Death|0|||
128863059|NCT01317875|463794834|FG007|Overall Study|Death|4|||
128863060|NCT01317875|463794835|FG008|Overall Study|Death|0|||
128863061|NCT01317875|463794836|FG009|Overall Study|Death|0|||
128863062|NCT01317875|463794827|FG000|Overall Study|Adverse Event|2|||
128863063|NCT01317875|463794828|FG001|Overall Study|Adverse Event|1|||
128863064|NCT01317875|463794829|FG002|Overall Study|Adverse Event|2|||
128863065|NCT01317875|463794830|FG003|Overall Study|Adverse Event|1|||
128863066|NCT01317875|463794831|FG004|Overall Study|Adverse Event|5|||
128863067|NCT01317875|463794832|FG005|Overall Study|Adverse Event|1|||
128863068|NCT01317875|463794833|FG006|Overall Study|Adverse Event|2|||
128863069|NCT01317875|463794834|FG007|Overall Study|Adverse Event|5|||
128863070|NCT01317875|463794835|FG008|Overall Study|Adverse Event|0|||
128863071|NCT01317875|463794836|FG009|Overall Study|Adverse Event|0|||
128863072|NCT01381575|463794837|FG000|Overall Study|Serious Adverse Event|1|||
128863073|NCT01381575|463794838|FG001|Overall Study|Serious Adverse Event|0|||
128863074|NCT01381575|463794839|FG002|Overall Study|Serious Adverse Event|0|||
128863075|NCT01381575|463794837|FG000|Overall Study|Non-Serious Adverse Event|0|||
128863076|NCT01381575|463794838|FG001|Overall Study|Non-Serious Adverse Event|0|||
128863077|NCT01381575|463794839|FG002|Overall Study|Non-Serious Adverse Event|1|||
128863078|NCT01381575|463794837|FG000|Overall Study|Protocol Violation|0|||
128863079|NCT01381575|463794838|FG001|Overall Study|Protocol Violation|1|||
128863080|NCT01381575|463794839|FG002|Overall Study|Protocol Violation|1|||
128863081|NCT01381575|463794837|FG000|Overall Study|Withdrawal by Subject|15|||
128863082|NCT01381575|463794838|FG001|Overall Study|Withdrawal by Subject|9|||
128863083|NCT01381575|463794839|FG002|Overall Study|Withdrawal by Subject|7|||
128863084|NCT01381575|463794837|FG000|Overall Study|Migrated/moved from study area|2|||
128863085|NCT01381575|463794838|FG001|Overall Study|Migrated/moved from study area|12|||
128863086|NCT01381575|463794839|FG002|Overall Study|Migrated/moved from study area|2|||
128863087|NCT01381575|463794837|FG000|Overall Study|Lost to Follow-up|8|||
128863088|NCT01381575|463794838|FG001|Overall Study|Lost to Follow-up|17|||
128863089|NCT01381575|463794839|FG002|Overall Study|Lost to Follow-up|9|||
128863090|NCT01443403|463794840|FG000|Overall Study|Adverse Event|1|||
128863091|NCT01443403|463794841|FG001|Overall Study|Adverse Event|1|||
128863092|NCT01443403|463794842|FG002|Overall Study|Adverse Event|4|||
128863093|NCT01443403|463794843|FG003|Overall Study|Adverse Event|5|||
128863094|NCT01443403|463794840|FG000|Overall Study|Withdrawal by Subject|0|||
128863095|NCT01443403|463794841|FG001|Overall Study|Withdrawal by Subject|1|||
128863096|NCT01443403|463794842|FG002|Overall Study|Withdrawal by Subject|2|||
128863097|NCT01443403|463794843|FG003|Overall Study|Withdrawal by Subject|1|||
128863098|NCT01443403|463794840|FG000|Overall Study|Lost to Follow-up|0|||
128863099|NCT01443403|463794841|FG001|Overall Study|Lost to Follow-up|0|||
128863100|NCT01443403|463794842|FG002|Overall Study|Lost to Follow-up|0|||
128863101|NCT01443403|463794843|FG003|Overall Study|Lost to Follow-up|1|||
128863102|NCT01443403|463794840|FG000|Overall Study|Protocol Violation|2|||
128863103|NCT01443403|463794841|FG001|Overall Study|Protocol Violation|1|||
128863104|NCT01443403|463794842|FG002|Overall Study|Protocol Violation|1|||
128863105|NCT01443403|463794843|FG003|Overall Study|Protocol Violation|1|||
128863106|NCT01443403|463794840|FG000|Overall Study|Use of Prohibited Treatment|2|||
128863107|NCT01443403|463794841|FG001|Overall Study|Use of Prohibited Treatment|3|||
128863108|NCT01443403|463794842|FG002|Overall Study|Use of Prohibited Treatment|0|||
128863109|NCT01443403|463794843|FG003|Overall Study|Use of Prohibited Treatment|0|||
128863110|NCT01443403|463794840|FG000|Overall Study|Other - Miscellaneous|1|||
128863111|NCT01443403|463794841|FG001|Overall Study|Other - Miscellaneous|0|||
128863112|NCT01443403|463794842|FG002|Overall Study|Other - Miscellaneous|0|||
128863113|NCT01443403|463794843|FG003|Overall Study|Other - Miscellaneous|1|||
128863114|NCT04307940|463794847|FG000|Overall Study|Adverse Event|1|||
128863115|NCT04307940|463794848|FG001|Overall Study|Adverse Event|0|||
128863116|NCT04307940|463794849|FG002|Overall Study|Adverse Event|0|||
128863117|NCT04307940|463794847|FG000|Overall Study|Withdrawal by Subject|2|||
128863118|NCT04307940|463794848|FG001|Overall Study|Withdrawal by Subject|3|||
128863119|NCT04307940|463794849|FG002|Overall Study|Withdrawal by Subject|1|||
128863120|NCT04307940|463794847|FG000|Overall Study|Lost to Follow-up|2|||
128863121|NCT04307940|463794848|FG001|Overall Study|Lost to Follow-up|0|||
128863122|NCT04307940|463794849|FG002|Overall Study|Lost to Follow-up|1|||
128863123|NCT00953771|463794850|FG000|Overall Study|Death|1|||
128863124|NCT00953771|463794851|FG001|Overall Study|Death|0|||
128863125|NCT03374488|463794852|FG000|Overall Study|Death|13|||
128863126|NCT03374488|463794853|FG001|Overall Study|Death|13|||
128863127|NCT03374488|463794852|FG000|Overall Study|Withdrawal by Subject|3|||
128863128|NCT03374488|463794853|FG001|Overall Study|Withdrawal by Subject|1|||
128863129|NCT03374488|463794852|FG000|Overall Study|Physician Decision|3|||
128863130|NCT03374488|463794853|FG001|Overall Study|Physician Decision|0|||
128863131|NCT03104075|463794854|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
128863132|NCT03104075|463794855|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
128863133|NCT04024462|463794856|FG000|Overall Study|Withdrawal by Subject|6|||
128863134|NCT04024462|463794857|FG001|Overall Study|Withdrawal by Subject|7|||
128863135|NCT04024462|463794856|FG000|Overall Study|Progressive Disease|0|||
128863136|NCT04024462|463794857|FG001|Overall Study|Progressive Disease|1|||
128863137|NCT04024462|463794856|FG000|Overall Study|Adverse Event|0|||
128863138|NCT04024462|463794857|FG001|Overall Study|Adverse Event|1|||
128863139|NCT04024462|463794856|FG000|Overall Study|Death|0|||
128863140|NCT04024462|463794857|FG001|Overall Study|Death|1|||
128863141|NCT04024462|463794856|FG000|Overall Study|Lost to Follow-up|1|||
128863142|NCT04024462|463794857|FG001|Overall Study|Lost to Follow-up|0|||
128863143|NCT04024462|463794856|FG000|Overall Study|Ongoing in the Study|94|||
128863144|NCT04024462|463794857|FG001|Overall Study|Ongoing in the Study|89|||
128863145|NCT04896008|463794858|FG000|Overall Study|Ongoing|70|||
128863146|NCT04896008|463794859|FG001|Overall Study|Ongoing|38|||
128863147|NCT04896008|463794858|FG000|Overall Study|Adverse Event|0|||
128863148|NCT04896008|463794859|FG001|Overall Study|Adverse Event|2|||
128863149|NCT04896008|463794858|FG000|Overall Study|Death|5|||
128863150|NCT04896008|463794859|FG001|Overall Study|Death|10|||
128863151|NCT04896008|463794858|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
128863152|NCT04896008|463794859|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
128863153|NCT04896008|463794858|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
128863154|NCT04896008|463794859|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
128863155|NCT04896008|463794858|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
128863156|NCT04896008|463794859|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
128863157|NCT04896008|463794858|FG000|Overall Study|Withdrawal by Subject|1|||
128863158|NCT04896008|463794859|FG001|Overall Study|Withdrawal by Subject|4|||
128863159|NCT04896008|463794858|FG000|Overall Study|Investigator Decision|2|||
128863160|NCT04896008|463794859|FG001|Overall Study|Investigator Decision|0|||
128863161|NCT04896008|463794858|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
128863162|NCT04896008|463794859|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
128863163|NCT00709228|463794871|FG000|Overall Study|Not treated|14|||
128863164|NCT00709228|463794871|FG000|Overall Study|Eligibility criteria not met|281|||
128863165|NCT00709228|463794871|FG000|Overall Study|Adverse events|2|||
128863166|NCT00709228|463794871|FG000|Overall Study|Discontinued treatment|14|||
128863167|NCT00709228|463794871|FG000|Overall Study|Did not enter follow-up|4|||
128863168|NCT00709228|463794871|FG000|Overall Study|Discontinued follow-up|5|||
128863169|NCT00709228|463794871|FG000|Overall Study|Disease progression|1|||
128863170|NCT00709228|463794871|FG000|Overall Study|Lost to Follow-up|6|||
128863171|NCT00709228|463794871|FG000|Overall Study|Non-compliance|5|||
128863172|NCT02870972|463794872|FG000|Overall Study|Adverse Event|1|||
128863173|NCT02870972|463794873|FG001|Overall Study|Adverse Event|0|||
128863174|NCT02870972|463794874|FG002|Overall Study|Adverse Event|0|||
128863175|NCT02870972|463794875|FG003|Overall Study|Adverse Event|0|||
128863176|NCT02870972|463794876|FG004|Overall Study|Adverse Event|0|||
128863177|NCT00789360|463794879|FG000|Overall Study|Protocol Violation|3|||
128863178|NCT00789360|463794880|FG001|Overall Study|Protocol Violation|1|||
128863179|NCT04400487|463794881|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
128863180|NCT04400487|463794881|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
128863181|NCT04400487|463794881|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
128863182|NCT00022659|463794882|FG000|Overall Study|Ineligible: wrong primary|1|||
128863183|NCT00022659|463794882|FG000|Overall Study|Never treated|1|||
128863184|NCT03559062|463794883|FG000|Overall Study|Other|0|||
128863185|NCT03559062|463794884|FG001|Overall Study|Other|1|||
128863186|NCT03559062|463794885|FG002|Overall Study|Other|0|||
128863187|NCT03445533|463794886|FG000|Overall Study|Progressive Disease|48|||
128863188|NCT03445533|463794887|FG001|Overall Study|Progressive Disease|81|||
128863189|NCT03445533|463794886|FG000|Overall Study|Adverse Event|60|||
128863190|NCT03445533|463794887|FG001|Overall Study|Adverse Event|64|||
128863191|NCT03445533|463794886|FG000|Overall Study|Death|9|||
128863192|NCT03445533|463794887|FG001|Overall Study|Death|19|||
128863193|NCT03445533|463794886|FG000|Overall Study|Miscellaneous|0|||
128863194|NCT03445533|463794887|FG001|Overall Study|Miscellaneous|16|||
128863195|NCT03445533|463794886|FG000|Overall Study|Withdrawal by Subject|3|||
128863196|NCT03445533|463794887|FG001|Overall Study|Withdrawal by Subject|4|||
128863197|NCT03445533|463794886|FG000|Overall Study|Physician Decision|1|||
128863198|NCT03445533|463794887|FG001|Overall Study|Physician Decision|3|||
128863199|NCT03445533|463794886|FG000|Overall Study|Sponsor Decision|0|||
128863200|NCT03445533|463794887|FG001|Overall Study|Sponsor Decision|1|||
128863201|NCT03445533|463794886|FG000|Overall Study|Lost to Follow-up|0|||
128863202|NCT03445533|463794887|FG001|Overall Study|Lost to Follow-up|1|||
128863203|NCT03445533|463794886|FG000|Overall Study|Never Received any Study Treatment|7|||
128863204|NCT03445533|463794887|FG001|Overall Study|Never Received any Study Treatment|4|||
128863205|NCT00968526|463794888|FG000|Overall Study|Adverse Event|2|||
128863206|NCT00968526|463794889|FG001|Overall Study|Adverse Event|0|||
128863207|NCT00968526|463794888|FG000|Overall Study|Migrated/moved from study area|1|||
128863208|NCT00968526|463794889|FG001|Overall Study|Migrated/moved from study area|0|||
128863209|NCT02493062|463794890|FG000|Overall Study|Physician Decision|12|||
128863210|NCT03926195|463794891|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
128863211|NCT03926195|463794892|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
128863212|NCT03926195|463794891|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
128863213|NCT03926195|463794892|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
128863214|NCT03926195|463794891|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
128863215|NCT03926195|463794892|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
128863216|NCT03926195|463794891|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
128863217|NCT03926195|463794892|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
128863218|NCT03926195|463794891|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
128863219|NCT03926195|463794892|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
128863220|NCT03926195|463794891|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
128863221|NCT03926195|463794892|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
128863222|NCT01327612|463794894|FG000|Overall Study|Withdrawal by Subject|0|||
128863223|NCT01327612|463794895|FG001|Overall Study|Withdrawal by Subject|0|||
128863224|NCT01327612|463794896|FG002|Overall Study|Withdrawal by Subject|0|||
128863225|NCT01327612|463794897|FG003|Overall Study|Withdrawal by Subject|0|||
128863226|NCT01327612|463794898|FG004|Overall Study|Withdrawal by Subject|0|||
128863227|NCT01327612|463794899|FG005|Overall Study|Withdrawal by Subject|1|||
128863228|NCT01327612|463794900|FG006|Overall Study|Withdrawal by Subject|0|||
128863229|NCT01327612|463794894|FG000|Overall Study|Disease Progression|1|||
128863230|NCT01327612|463794895|FG001|Overall Study|Disease Progression|1|||
128863231|NCT01327612|463794896|FG002|Overall Study|Disease Progression|1|||
128863232|NCT01327612|463794897|FG003|Overall Study|Disease Progression|0|||
128863233|NCT01327612|463794898|FG004|Overall Study|Disease Progression|1|||
128863234|NCT01327612|463794899|FG005|Overall Study|Disease Progression|2|||
128863235|NCT01327612|463794900|FG006|Overall Study|Disease Progression|2|||
128863236|NCT01327612|463794894|FG000|Overall Study|Administrative Decision|0|||
128863237|NCT01327612|463794895|FG001|Overall Study|Administrative Decision|0|||
128863238|NCT01327612|463794896|FG002|Overall Study|Administrative Decision|0|||
128863239|NCT01327612|463794897|FG003|Overall Study|Administrative Decision|1|||
128863240|NCT01327612|463794898|FG004|Overall Study|Administrative Decision|0|||
128863241|NCT01327612|463794899|FG005|Overall Study|Administrative Decision|0|||
128863242|NCT01327612|463794900|FG006|Overall Study|Administrative Decision|0|||
128863243|NCT01327612|463794894|FG000|Overall Study|Death|0|||
128863244|NCT01327612|463794895|FG001|Overall Study|Death|0|||
128863245|NCT01327612|463794896|FG002|Overall Study|Death|0|||
128863246|NCT01327612|463794897|FG003|Overall Study|Death|0|||
128863247|NCT01327612|463794898|FG004|Overall Study|Death|1|||
128863248|NCT01327612|463794899|FG005|Overall Study|Death|0|||
128863249|NCT01327612|463794900|FG006|Overall Study|Death|0|||
128863250|NCT00426127|463794901|FG000|Overall Study|Adverse Event|1|||
128863251|NCT00426127|463794901|FG000|Overall Study|Removed due to disease progression|1|||
128863252|NCT05569421|463794902|FG000|Overall Study|Withdrawal by Subject|1|||
128863253|NCT05569421|463794903|FG001|Overall Study|Withdrawal by Subject|0|||
128863254|NCT05569421|463794904|FG002|Overall Study|Withdrawal by Subject|0|||
128863255|NCT01689857|463794905|FG000|Overall Study|Lost to Follow-up|5|||
128863256|NCT01689857|463794906|FG001|Overall Study|Lost to Follow-up|2|||
128863257|NCT05105087|463794907|FG000|Overall Study|Withdrawal by Subject|2|||
128863258|NCT05105087|463794907|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
128863259|NCT03738475|463794908|FG000|Overall Study|Participant Non-Compliance|1|||
128863260|NCT03738475|463794909|FG001|Overall Study|Participant Non-Compliance|0|||
128863261|NCT00737477|463794910|FG000|Overall Study|Adverse Event|9|||
128863262|NCT00737477|463794910|FG000|Overall Study|Death|9|||
128863263|NCT00737477|463794910|FG000|Overall Study|Treatment Refusal|1|||
128863264|NCT00737477|463794910|FG000|Overall Study|Withdrawal by Subject|1|||
128863265|NCT00737477|463794910|FG000|Overall Study|Renal Transplantation|10|||
128863266|NCT00737477|463794910|FG000|Overall Study|Other|4|||
128863267|NCT00581477|463794911|FG000|Overall Study|Physician Decision|2|||
128863268|NCT03106753|463794912|FG000|Overall Study|Withdrawal by Subject|0|||
128863269|NCT03106753|463794913|FG001|Overall Study|Withdrawal by Subject|1|||
128863270|NCT01853475|463794914|FG000|Overall Study|Withdrawal by Subject|0|||
128863271|NCT01853475|463794915|FG001|Overall Study|Withdrawal by Subject|1|||
128863272|NCT01853475|463794916|FG002|Overall Study|Withdrawal by Subject|0|||
128863273|NCT02803593|463794920|FG000|Overall Study|Lost to Follow-up|17|||
128863274|NCT02803593|463794921|FG001|Overall Study|Lost to Follow-up|35|||
128863275|NCT05143138|463794922|FG000|Overall Study|Death|5|||
128863276|NCT05143138|463794923|FG001|Overall Study|Death|35|||
128863277|NCT05143138|463794924|FG002|Overall Study|Death|1|||
128863278|NCT05143138|463794922|FG000|Overall Study|Lost to Follow-up|2|||
128863279|NCT05143138|463794923|FG001|Overall Study|Lost to Follow-up|4|||
128863280|NCT05143138|463794924|FG002|Overall Study|Lost to Follow-up|0|||
128863281|NCT05143138|463794922|FG000|Overall Study|withdrawal|1|||
128863282|NCT05143138|463794923|FG001|Overall Study|withdrawal|1|||
128863283|NCT05143138|463794924|FG002|Overall Study|withdrawal|0|||
128863284|NCT03443414|463794927|FG000|Overall Study|Adverse Event|6|||
128863285|NCT03443414|463794928|FG001|Overall Study|Adverse Event|0|||
128863286|NCT03443414|463794929|FG002|Overall Study|Adverse Event|4|||
128863287|NCT03443414|463794930|FG003|Overall Study|Adverse Event|2|||
128863288|NCT03443414|463794931|FG004|Overall Study|Adverse Event|3|||
128863289|NCT03443414|463794927|FG000|Overall Study|Withdrawal by Subject|3|||
128863290|NCT03443414|463794928|FG001|Overall Study|Withdrawal by Subject|2|||
128863291|NCT03443414|463794929|FG002|Overall Study|Withdrawal by Subject|2|||
128863292|NCT03443414|463794930|FG003|Overall Study|Withdrawal by Subject|2|||
128863293|NCT03443414|463794931|FG004|Overall Study|Withdrawal by Subject|1|||
128863294|NCT03443414|463794927|FG000|Overall Study|Death|0|||
128863295|NCT03443414|463794928|FG001|Overall Study|Death|1|||
128863296|NCT03443414|463794929|FG002|Overall Study|Death|0|||
128863297|NCT03443414|463794930|FG003|Overall Study|Death|1|||
128863298|NCT03443414|463794931|FG004|Overall Study|Death|0|||
128863299|NCT03443414|463794927|FG000|Overall Study|Reason not specified|2|||
128863300|NCT03443414|463794928|FG001|Overall Study|Reason not specified|0|||
128863301|NCT03443414|463794929|FG002|Overall Study|Reason not specified|0|||
128863302|NCT03443414|463794930|FG003|Overall Study|Reason not specified|0|||
128863303|NCT03443414|463794931|FG004|Overall Study|Reason not specified|1|||
128863304|NCT03933462|463794932|FG000|Overall Study|Adverse Event|2|||
128863305|NCT03933462|463794933|FG001|Overall Study|Adverse Event|0|||
128863306|NCT02522728|463794937|FG000|Overall Study|Withdrawal by Subject|6|||
128863307|NCT02522728|463794938|FG001|Overall Study|Withdrawal by Subject|6|||
128863308|NCT02522728|463794937|FG000|Overall Study|Death|4|||
128863309|NCT02522728|463794938|FG001|Overall Study|Death|3|||
128863310|NCT02522728|463794937|FG000|Overall Study|Adverse Event|2|||
128863311|NCT02522728|463794938|FG001|Overall Study|Adverse Event|1|||
128863312|NCT02522728|463794937|FG000|Overall Study|Did not receive randomized study device|0|||
128863313|NCT02522728|463794938|FG001|Overall Study|Did not receive randomized study device|1|||
128863314|NCT01099917|463794940|FG000|Overall Study|Adverse Event|3|||
128863315|NCT01099917|463794940|FG000|Overall Study|Not Treated|24|||
128863316|NCT00422734|463794952|FG000|Overall Study|Physician Decision|1|||
128863317|NCT00422734|463794953|FG001|Overall Study|Physician Decision|1|||
128863318|NCT00422734|463794952|FG000|Overall Study|Protocol Violation|1|||
128863319|NCT00422734|463794953|FG001|Overall Study|Protocol Violation|6|||
128863320|NCT00422734|463794952|FG000|Overall Study|Withdrawal by Subject|12|||
128863321|NCT00422734|463794953|FG001|Overall Study|Withdrawal by Subject|8|||
128863322|NCT00422734|463794952|FG000|Overall Study|Adverse Event|0|||
128863323|NCT00422734|463794953|FG001|Overall Study|Adverse Event|3|||
128863324|NCT00422734|463794952|FG000|Overall Study|Partner Decision|0|||
128863325|NCT00422734|463794953|FG001|Overall Study|Partner Decision|3|||
128863326|NCT00368875|463794957|FG000|Overall Study|Adverse Event|0|||
128863327|NCT00368875|463794958|FG001|Overall Study|Adverse Event|12|||
128863328|NCT00368875|463794957|FG000|Overall Study|Progressive disease|3|||
128863329|NCT00368875|463794958|FG001|Overall Study|Progressive disease|27|||
128863330|NCT00368875|463794957|FG000|Overall Study|Withdrawal by Subject|2|||
128863331|NCT00368875|463794958|FG001|Overall Study|Withdrawal by Subject|6|||
128863332|NCT00368875|463794957|FG000|Overall Study|Other Reason|0|||
128863333|NCT00368875|463794958|FG001|Overall Study|Other Reason|2|||
128863334|NCT00368875|463794957|FG000|Overall Study|Alternative Therapy|1|||
128863335|NCT00368875|463794958|FG001|Overall Study|Alternative Therapy|1|||
128863336|NCT01305239|463794959|FG000|Overall Study|Adverse Event|22|||
128863337|NCT01305239|463794959|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
128863338|NCT03229486|463794960|FG000|Overall Study|Protocol Violation|0|||
128863339|NCT03229486|463794961|FG001|Overall Study|Protocol Violation|1|||
128863340|NCT01461005|463794965|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
128863341|NCT04978090|463794968|FG000|Overall Study|unable to adequately fit device|2|||
128863342|NCT00996606|463794971|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
128863343|NCT00996606|463794971|FG000|Overall Study|Insufficient Therapeutic Response|2|||
128863344|NCT00996606|463794971|FG000|Overall Study|Protocol Violation|1|||
128863345|NCT00996606|463794971|FG000|Overall Study|Withdrawal by Subject|3|||
128863346|NCT00632502|463794973|FG000|Overall Study|Adverse Event|0|||
128863347|NCT00632502|463794974|FG001|Overall Study|Adverse Event|1|||
128863348|NCT00632502|463794973|FG000|Overall Study|Randomized not treated|3|||
128863349|NCT00632502|463794974|FG001|Overall Study|Randomized not treated|0|||
128863350|NCT03075527|463794975|FG000|Overall Study|Death|1|||
128863351|NCT03075527|463794975|FG000|Overall Study|Withdrawal by Subject|1|||
128863352|NCT03075527|463794975|FG000|Overall Study|Physician Decision|3|||
128863353|NCT03075527|463794975|FG000|Overall Study|Progression/Relapse|14|||
128863354|NCT00681668|463794976|FG000|Overall Study|Protocol Violation|1|||
128863355|NCT00681668|463794976|FG000|Overall Study|Withdrawal by Subject|1|||
128863356|NCT02209181|463794977|FG000|Overall Study|Adverse Event|1|||
128863357|NCT02209181|463794978|FG001|Overall Study|Adverse Event|0|||
128863358|NCT02209181|463794979|FG002|Overall Study|Adverse Event|1|||
128863359|NCT02209181|463794980|FG003|Overall Study|Adverse Event|0|||
128863360|NCT02209181|463794977|FG000|Overall Study|Withdrawal by Subject|0|||
128863361|NCT02209181|463794978|FG001|Overall Study|Withdrawal by Subject|1|||
128863362|NCT02209181|463794979|FG002|Overall Study|Withdrawal by Subject|0|||
128863363|NCT02209181|463794980|FG003|Overall Study|Withdrawal by Subject|0|||
128863364|NCT04641962|463794986|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
128863365|NCT04641962|463794987|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
128863366|NCT04641962|463794988|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
128863367|NCT04641962|463794989|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
128863368|NCT04641962|463794990|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
128863369|NCT04641962|463794986|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
128863370|NCT04641962|463794987|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
128863371|NCT04641962|463794988|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
128863372|NCT04641962|463794989|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
128863373|NCT04641962|463794990|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
128863374|NCT04641962|463794986|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
128863375|NCT04641962|463794987|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
128863376|NCT04641962|463794988|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
128863377|NCT04641962|463794989|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
128863378|NCT04641962|463794990|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
128863379|NCT04641962|463794986|FG000|DBT Period: Up to 52 Weeks|Death|1|||
128863380|NCT04641962|463794987|FG001|DBT Period: Up to 52 Weeks|Death|0|||
128863381|NCT04641962|463794988|FG002|DBT Period: Up to 52 Weeks|Death|0|||
128863382|NCT04641962|463794989|FG003|DBT Period: Up to 52 Weeks|Death|0|||
128863383|NCT04641962|463794990|FG004|DBT Period: Up to 52 Weeks|Death|0|||
128863384|NCT04641962|463794986|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
128863385|NCT04641962|463794987|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
128863386|NCT04641962|463794988|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
128863387|NCT04641962|463794989|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
128863388|NCT04641962|463794990|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
128863389|NCT04641962|463794986|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
128863390|NCT04641962|463794987|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
128863391|NCT04641962|463794988|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
128863392|NCT04641962|463794989|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
128863393|NCT04641962|463794990|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
128863394|NCT04641962|463794986|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
128863395|NCT04641962|463794987|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
128863396|NCT04641962|463794988|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
128863397|NCT04641962|463794989|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
128863398|NCT04641962|463794990|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
128863399|NCT00862836|463794991|FG000|Overall Study|Withdrawal by Subject|1|||
128863400|NCT06926673|463794992|FG000|Overall Study|Lost to Follow-up|0|||
128863401|NCT06926673|463794993|FG001|Overall Study|Lost to Follow-up|0|||
128863402|NCT06926673|463794994|FG002|Overall Study|Lost to Follow-up|0|||
128863403|NCT06926673|463794995|FG003|Overall Study|Lost to Follow-up|1|||
128863404|NCT06926673|463794996|FG004|Overall Study|Lost to Follow-up|0|||
128863405|NCT06926673|463794997|FG005|Overall Study|Lost to Follow-up|0|||
128863406|NCT06926673|463794998|FG006|Overall Study|Lost to Follow-up|0|||
128863407|NCT06926673|463794992|FG000|Overall Study|Physician Decision|0|||
128863408|NCT06926673|463794993|FG001|Overall Study|Physician Decision|0|||
128863409|NCT06926673|463794994|FG002|Overall Study|Physician Decision|0|||
128863410|NCT06926673|463794995|FG003|Overall Study|Physician Decision|0|||
128863411|NCT06926673|463794996|FG004|Overall Study|Physician Decision|0|||
128863412|NCT06926673|463794997|FG005|Overall Study|Physician Decision|0|||
128863413|NCT06926673|463794998|FG006|Overall Study|Physician Decision|1|||
128863414|NCT06926673|463794992|FG000|Overall Study|Withdrawal by Subject|0|||
128863415|NCT06926673|463794993|FG001|Overall Study|Withdrawal by Subject|3|||
128863416|NCT06926673|463794994|FG002|Overall Study|Withdrawal by Subject|2|||
128863417|NCT06926673|463794995|FG003|Overall Study|Withdrawal by Subject|1|||
128863418|NCT06926673|463794996|FG004|Overall Study|Withdrawal by Subject|0|||
128863419|NCT06926673|463794997|FG005|Overall Study|Withdrawal by Subject|2|||
128863420|NCT06926673|463794998|FG006|Overall Study|Withdrawal by Subject|0|||
128863421|NCT01920477|463796673|FG000|Overall Study|Adverse Event|0|||
128863422|NCT01920477|463796674|FG001|Overall Study|Adverse Event|1|||
128863423|NCT01920477|463796673|FG000|Overall Study|Lack of Efficacy|1|||
128863424|NCT01920477|463796674|FG001|Overall Study|Lack of Efficacy|0|||
128863425|NCT01920477|463796673|FG000|Overall Study|Study closed/terminated|14|||
128863426|NCT01920477|463796674|FG001|Overall Study|Study closed/terminated|15|||
128863427|NCT01920477|463796673|FG000|Overall Study|Withdrawal by Subject|0|||
128863428|NCT01920477|463796674|FG001|Overall Study|Withdrawal by Subject|1|||
128863429|NCT01681277|463796675|FG000|Overall Study|Adverse Event|1|||
128863430|NCT01681277|463796676|FG001|Overall Study|Adverse Event|0|||
128863431|NCT01681277|463796677|FG002|Overall Study|Adverse Event|0|||
128863432|NCT01681277|463796678|FG003|Overall Study|Adverse Event|0|||
128863433|NCT01681277|463796679|FG004|Overall Study|Adverse Event|0|||
128863434|NCT02113124|463796680|FG000|Overall Study|Unable to retrieve blood sample|1|||
128863435|NCT02113124|463796681|FG001|Overall Study|Unable to retrieve blood sample|1|||
128863436|NCT02271984|463796687|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863437|NCT02271984|463796688|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863438|NCT02271984|463796689|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863439|NCT02271984|463796690|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863440|NCT02271984|463796691|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863441|NCT02271984|463796692|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
128863442|NCT02271984|463796693|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863443|NCT02271984|463796694|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
128863444|NCT02271984|463796695|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863445|NCT02271984|463796696|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863446|NCT02271984|463796697|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863447|NCT02271984|463796698|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
128863448|NCT04624243|463796699|FG000|Overall Study|Death|0|||
128863449|NCT04624243|463796700|FG001|Overall Study|Death|1|||
128863450|NCT04624243|463796701|FG002|Overall Study|Death|0|||
128863451|NCT04624243|463796702|FG003|Overall Study|Death|0|||
128863452|NCT04624243|463796703|FG004|Overall Study|Death|0|||
128863453|NCT04624243|463796699|FG000|Overall Study|Lost to Follow-up|2|||
128863454|NCT04624243|463796700|FG001|Overall Study|Lost to Follow-up|3|||
128863455|NCT04624243|463796701|FG002|Overall Study|Lost to Follow-up|7|||
128863456|NCT04624243|463796702|FG003|Overall Study|Lost to Follow-up|1|||
128863457|NCT04624243|463796703|FG004|Overall Study|Lost to Follow-up|3|||
128863458|NCT04624243|463796699|FG000|Overall Study|Physician Decision|3|||
128863459|NCT04624243|463796700|FG001|Overall Study|Physician Decision|8|||
128863460|NCT04624243|463796701|FG002|Overall Study|Physician Decision|15|||
128863461|NCT04624243|463796702|FG003|Overall Study|Physician Decision|2|||
128863462|NCT04624243|463796703|FG004|Overall Study|Physician Decision|11|||
128863463|NCT04624243|463796699|FG000|Overall Study|Withdrawal by Subject|19|||
128863464|NCT04624243|463796700|FG001|Overall Study|Withdrawal by Subject|44|||
128863465|NCT04624243|463796701|FG002|Overall Study|Withdrawal by Subject|40|||
128863466|NCT04624243|463796702|FG003|Overall Study|Withdrawal by Subject|21|||
128863467|NCT04624243|463796703|FG004|Overall Study|Withdrawal by Subject|39|||
128863468|NCT04624243|463796699|FG000|Overall Study|Miscellaneous|3|||
128863469|NCT04624243|463796700|FG001|Overall Study|Miscellaneous|12|||
128863470|NCT04624243|463796701|FG002|Overall Study|Miscellaneous|9|||
128863471|NCT04624243|463796702|FG003|Overall Study|Miscellaneous|4|||
128863472|NCT04624243|463796703|FG004|Overall Study|Miscellaneous|6|||
128863473|NCT05048238|463796706|FG000|Overall Study|Withdrawal by Subject|1|||
128863474|NCT01730378|463796707|FG000|Overall Study|Lost to Follow-up|1|||
128863475|NCT01730378|463796708|FG001|Overall Study|Lost to Follow-up|0|||
128863476|NCT00955708|463796709|FG000|Overall Study|Death|269|||
128863477|NCT00955708|463796709|FG000|Overall Study|Lost to Follow-up|72|||
128863478|NCT00955708|463796709|FG000|Overall Study|Physician Decision|36|||
128863479|NCT00955708|463796709|FG000|Overall Study|Protocol Violation|134|||
128863480|NCT00955708|463796709|FG000|Overall Study|Registry Conclusion|186|||
128863481|NCT00955708|463796709|FG000|Overall Study|Product removed from service|94|||
128863482|NCT00955708|463796709|FG000|Overall Study|Patient Refused to participate further|116|||
128863483|NCT00955708|463796709|FG000|Overall Study|Closure of study location|60|||
128863484|NCT00955708|463796709|FG000|Overall Study|Patient changed care provider/moved|91|||
128863485|NCT01016262|463796710|FG000|Double-blind Phase|Adverse Event|0|||
128863486|NCT01016262|463796711|FG001|Double-blind Phase|Adverse Event|0|||
128863487|NCT01016262|463796712|FG002|Double-blind Phase|Adverse Event|1|||
128863488|NCT01016262|463796713|FG003|Double-blind Phase|Adverse Event|0|||
128863489|NCT01016262|463796714|FG004|Double-blind Phase|Adverse Event|0|||
128863490|NCT01016262|463796715|FG005|Double-blind Phase|Adverse Event|0|||
128863491|NCT01016262|463796710|FG000|Double-blind Phase|Lack of Efficacy|1|||
128863492|NCT01016262|463796711|FG001|Double-blind Phase|Lack of Efficacy|0|||
128863493|NCT01016262|463796712|FG002|Double-blind Phase|Lack of Efficacy|5|||
128863494|NCT01016262|463796713|FG003|Double-blind Phase|Lack of Efficacy|0|||
128863495|NCT01016262|463796714|FG004|Double-blind Phase|Lack of Efficacy|0|||
128863496|NCT01016262|463796715|FG005|Double-blind Phase|Lack of Efficacy|0|||
128863497|NCT01016262|463796710|FG000|Double-blind Phase|Disease Progression|0|||
128863498|NCT01016262|463796711|FG001|Double-blind Phase|Disease Progression|1|||
128863499|NCT01016262|463796712|FG002|Double-blind Phase|Disease Progression|2|||
128863500|NCT01016262|463796713|FG003|Double-blind Phase|Disease Progression|0|||
128863501|NCT01016262|463796714|FG004|Double-blind Phase|Disease Progression|0|||
128863502|NCT01016262|463796715|FG005|Double-blind Phase|Disease Progression|0|||
128863503|NCT01016262|463796710|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
128863504|NCT01016262|463796711|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
128863505|NCT01016262|463796712|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
128863506|NCT01016262|463796713|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
128863507|NCT01016262|463796714|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
128863508|NCT01016262|463796715|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
128863509|NCT01016262|463796710|FG000|Open-Label Phase|Adverse Event|0|||
128863510|NCT01016262|463796711|FG001|Open-Label Phase|Adverse Event|0|||
128863511|NCT01016262|463796712|FG002|Open-Label Phase|Adverse Event|0|||
128863512|NCT01016262|463796713|FG003|Open-Label Phase|Adverse Event|1|||
128863513|NCT01016262|463796714|FG004|Open-Label Phase|Adverse Event|0|||
128863514|NCT01016262|463796715|FG005|Open-Label Phase|Adverse Event|0|||
128863515|NCT01016262|463796710|FG000|Open-Label Phase|Lost to Follow-up|0|||
128863516|NCT01016262|463796711|FG001|Open-Label Phase|Lost to Follow-up|0|||
128863517|NCT01016262|463796712|FG002|Open-Label Phase|Lost to Follow-up|0|||
128863518|NCT01016262|463796713|FG003|Open-Label Phase|Lost to Follow-up|0|||
128863519|NCT01016262|463796714|FG004|Open-Label Phase|Lost to Follow-up|1|||
128863520|NCT01016262|463796715|FG005|Open-Label Phase|Lost to Follow-up|0|||
128863521|NCT01016262|463796710|FG000|Open-Label Phase|Lack of Efficacy|0|||
128863522|NCT01016262|463796711|FG001|Open-Label Phase|Lack of Efficacy|0|||
128863523|NCT01016262|463796712|FG002|Open-Label Phase|Lack of Efficacy|0|||
128863524|NCT01016262|463796713|FG003|Open-Label Phase|Lack of Efficacy|1|||
128863525|NCT01016262|463796714|FG004|Open-Label Phase|Lack of Efficacy|0|||
128863526|NCT01016262|463796715|FG005|Open-Label Phase|Lack of Efficacy|0|||
128863527|NCT01016262|463796710|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
128863528|NCT01016262|463796711|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
128863529|NCT01016262|463796712|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
128863530|NCT01016262|463796713|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
128863531|NCT01016262|463796714|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
128863532|NCT01016262|463796715|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
128863533|NCT01736540|463796716|FG000|Overall Study|Did not complete scan within 45 days|2|||
128863534|NCT01736540|463796716|FG000|Overall Study|Death|1|||
128863535|NCT01736540|463796716|FG000|Overall Study|Abnormal test procedure|1|||
128863536|NCT01736540|463796716|FG000|Overall Study|Withdrawal by Subject|5|||
128863537|NCT01736540|463796716|FG000|Overall Study|Protocol Violation|1|||
128863538|NCT01736540|463796716|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
128863539|NCT01736540|463796716|FG000|Overall Study|No show for MRI appointment|1|||
128863540|NCT01736540|463796716|FG000|Overall Study|Unable to make MRI appointment|3|||
128863541|NCT00479882|463796717|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
128863542|NCT00479882|463796718|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
128863543|NCT00479882|463796719|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
128863544|NCT00479882|463796720|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
128863545|NCT00479882|463796717|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
128863546|NCT00479882|463796718|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
128863547|NCT00479882|463796719|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
128863548|NCT00479882|463796720|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
128863549|NCT00479882|463796717|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
128863550|NCT00479882|463796718|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
128863551|NCT00479882|463796719|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
128863552|NCT00479882|463796720|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
128863553|NCT00479882|463796717|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
128863554|NCT00479882|463796718|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
128863555|NCT00479882|463796719|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
128863556|NCT00479882|463796720|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
128863557|NCT00479882|463796717|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
128863558|NCT00479882|463796718|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
128863559|NCT00479882|463796719|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
128863560|NCT00479882|463796720|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
128863561|NCT00479882|463796717|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
128863562|NCT00479882|463796718|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
128863563|NCT00479882|463796719|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
128863564|NCT00479882|463796720|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
128863565|NCT00479882|463796717|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
128863566|NCT00479882|463796718|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
128863567|NCT00479882|463796719|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
128863568|NCT00479882|463796720|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
128863569|NCT00479882|463796717|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
128863570|NCT00479882|463796718|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
128863571|NCT00479882|463796719|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
128863572|NCT00479882|463796720|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
128863573|NCT00479882|463796717|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
128863574|NCT00479882|463796718|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
128863575|NCT00479882|463796719|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
128863576|NCT00479882|463796720|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
128863577|NCT00479882|463796717|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
128863578|NCT00479882|463796718|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
128863579|NCT00479882|463796719|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
128863580|NCT00479882|463796720|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
128863581|NCT00479882|463796717|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
128863582|NCT00479882|463796718|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
128863583|NCT00479882|463796719|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
128863584|NCT00479882|463796720|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
128863585|NCT00479882|463796717|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
128863586|NCT00479882|463796718|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
128863587|NCT00479882|463796719|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
128863588|NCT00479882|463796720|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
128863589|NCT00479882|463796717|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
128863590|NCT00479882|463796718|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
128863591|NCT00479882|463796719|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
128863592|NCT00479882|463796720|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
128863593|NCT00479882|463796717|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
128863594|NCT00479882|463796718|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
128863595|NCT00479882|463796719|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
128863596|NCT00479882|463796720|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
128863597|NCT01370655|463796721|FG000|Period 1|Adverse Event|2|||
128863598|NCT01370655|463796722|FG001|Period 1|Adverse Event|0|||
128863599|NCT01370655|463796723|FG002|Period 1|Adverse Event|0|||
128863600|NCT01370655|463796724|FG003|Period 1|Adverse Event|0|||
128863601|NCT01370655|463796725|FG004|Period 1|Adverse Event|0|||
128863602|NCT01370655|463796726|FG005|Period 1|Adverse Event|0|||
128863603|NCT01370655|463796727|FG006|Period 1|Adverse Event|1|||
128863604|NCT01370655|463796728|FG007|Period 1|Adverse Event|0|||
128863605|NCT01370655|463796729|FG008|Period 1|Adverse Event|0|||
128863606|NCT01370655|463796730|FG009|Period 1|Adverse Event|0|||
128863607|NCT01370655|463796731|FG010|Period 1|Adverse Event|0|||
128863608|NCT01370655|463796732|FG011|Period 1|Adverse Event|0|||
128863609|NCT01370655|463796721|FG000|Period 2|Adverse Event|0|||
128863610|NCT01370655|463796722|FG001|Period 2|Adverse Event|0|||
128863611|NCT01370655|463796723|FG002|Period 2|Adverse Event|1|||
128863612|NCT01370655|463796724|FG003|Period 2|Adverse Event|0|||
128863613|NCT01370655|463796725|FG004|Period 2|Adverse Event|1|||
128863614|NCT01370655|463796726|FG005|Period 2|Adverse Event|0|||
128863615|NCT01370655|463796727|FG006|Period 2|Adverse Event|0|||
128863616|NCT01370655|463796728|FG007|Period 2|Adverse Event|1|||
128863617|NCT01370655|463796729|FG008|Period 2|Adverse Event|0|||
128863618|NCT01370655|463796730|FG009|Period 2|Adverse Event|0|||
128863619|NCT01370655|463796731|FG010|Period 2|Adverse Event|0|||
128863620|NCT01370655|463796732|FG011|Period 2|Adverse Event|0|||
128863621|NCT01370655|463796721|FG000|Period 2|met protocol specified stopping criteria|0|||
128863622|NCT01370655|463796722|FG001|Period 2|met protocol specified stopping criteria|0|||
128863623|NCT01370655|463796723|FG002|Period 2|met protocol specified stopping criteria|1|||
128863624|NCT01370655|463796724|FG003|Period 2|met protocol specified stopping criteria|0|||
128863625|NCT01370655|463796725|FG004|Period 2|met protocol specified stopping criteria|0|||
128863626|NCT01370655|463796726|FG005|Period 2|met protocol specified stopping criteria|0|||
128863627|NCT01370655|463796727|FG006|Period 2|met protocol specified stopping criteria|1|||
128863628|NCT01370655|463796728|FG007|Period 2|met protocol specified stopping criteria|0|||
128863629|NCT01370655|463796729|FG008|Period 2|met protocol specified stopping criteria|1|||
128863630|NCT01370655|463796730|FG009|Period 2|met protocol specified stopping criteria|0|||
128863631|NCT01370655|463796731|FG010|Period 2|met protocol specified stopping criteria|1|||
128863632|NCT01370655|463796732|FG011|Period 2|met protocol specified stopping criteria|0|||
128863633|NCT01370655|463796721|FG000|Period 2|Withdrawal by Subject|0|||
128863634|NCT01370655|463796722|FG001|Period 2|Withdrawal by Subject|0|||
128863635|NCT01370655|463796723|FG002|Period 2|Withdrawal by Subject|0|||
128863636|NCT01370655|463796724|FG003|Period 2|Withdrawal by Subject|0|||
128863637|NCT01370655|463796725|FG004|Period 2|Withdrawal by Subject|0|||
128863638|NCT01370655|463796726|FG005|Period 2|Withdrawal by Subject|0|||
128863639|NCT01370655|463796727|FG006|Period 2|Withdrawal by Subject|0|||
128863640|NCT01370655|463796728|FG007|Period 2|Withdrawal by Subject|0|||
128863641|NCT01370655|463796729|FG008|Period 2|Withdrawal by Subject|1|||
128863642|NCT01370655|463796730|FG009|Period 2|Withdrawal by Subject|0|||
128863643|NCT01370655|463796731|FG010|Period 2|Withdrawal by Subject|0|||
128863644|NCT01370655|463796732|FG011|Period 2|Withdrawal by Subject|0|||
128863645|NCT02057575|463796737|FG000|Overall Study|Adverse Event|0|||
128863646|NCT02057575|463796738|FG001|Overall Study|Adverse Event|2|||
128863647|NCT02057575|463796739|FG002|Overall Study|Adverse Event|0|||
128863648|NCT02057575|463796740|FG003|Overall Study|Adverse Event|1|||
128863649|NCT02057575|463796737|FG000|Overall Study|Withdrawal by Subject|1|||
128863650|NCT02057575|463796738|FG001|Overall Study|Withdrawal by Subject|0|||
128863651|NCT02057575|463796739|FG002|Overall Study|Withdrawal by Subject|0|||
128863652|NCT02057575|463796740|FG003|Overall Study|Withdrawal by Subject|0|||
128863653|NCT02057575|463796737|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
128863654|NCT02057575|463796738|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
128863655|NCT02057575|463796739|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
128863656|NCT02057575|463796740|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
128863657|NCT02057575|463796737|FG000|Overall Study|Protocol Violation|0|||
128863658|NCT02057575|463796738|FG001|Overall Study|Protocol Violation|1|||
128863659|NCT02057575|463796739|FG002|Overall Study|Protocol Violation|0|||
128863660|NCT02057575|463796740|FG003|Overall Study|Protocol Violation|0|||
128863661|NCT00332462|463796741|FG000|Overall Study|Adverse Event|5|||
128863662|NCT00332462|463796741|FG000|Overall Study|Abnormal Lab Value|1|||
128863663|NCT00332462|463796741|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
128863664|NCT00332462|463796741|FG000|Overall Study|no longer requires study drug|1|||
128863665|NCT00332462|463796741|FG000|Overall Study|Death|3|||
128863666|NCT00332462|463796741|FG000|Overall Study|Graft Loss|2|||
128863667|NCT01643044|463796742|FG000|Overall Study|Lost to Follow-up|1|||
128863668|NCT01643044|463796743|FG001|Overall Study|Lost to Follow-up|1|||
128863669|NCT01643044|463796742|FG000|Overall Study|Miscarried baby|2|||
128863670|NCT01643044|463796743|FG001|Overall Study|Miscarried baby|2|||
128863671|NCT01643044|463796742|FG000|Overall Study|Delivered outside of hospital|1|||
128863672|NCT01643044|463796743|FG001|Overall Study|Delivered outside of hospital|2|||
128863673|NCT01735175|463796747|FG000|Overall Study|Withdrawal by Subject|9|||
128863674|NCT01735175|463796748|FG001|Overall Study|Withdrawal by Subject|2|||
128863675|NCT01735175|463796747|FG000|Overall Study|Lost to Follow-up|4|||
128863676|NCT01735175|463796748|FG001|Overall Study|Lost to Follow-up|2|||
128863677|NCT01735175|463796747|FG000|Overall Study|Death|3|||
128863678|NCT01735175|463796748|FG001|Overall Study|Death|2|||
128863679|NCT01735175|463796747|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
128863680|NCT01735175|463796748|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
128863681|NCT01023958|463796751|FG000|Overall Study|Progressive disease|48|||
128863682|NCT01023958|463796751|FG000|Overall Study|Other adverse event|1|||
128863683|NCT01023958|463796751|FG000|Overall Study|Refused to continue medication|1|||
128863684|NCT02159040|463796752|FG000|Overall Study|Death|1|||
128863685|NCT03080493|463796753|FG000|Overall Study|Did not provide NRS pain results|1|||
128863686|NCT03080493|463796754|FG001|Overall Study|Did not provide NRS pain results|0|||
128863687|NCT03080493|463796753|FG000|Overall Study|Adverse Event|0|||
128863688|NCT03080493|463796754|FG001|Overall Study|Adverse Event|1|||
128863689|NCT03080493|463796753|FG000|Overall Study|Randomization error (parity group)|0|||
128863690|NCT03080493|463796754|FG001|Overall Study|Randomization error (parity group)|1|||
128863691|NCT00755417|463796755|FG000|Overall Study|Adverse Event|28|||
128863692|NCT00755417|463796756|FG001|Overall Study|Adverse Event|20|||
128863693|NCT00755417|463796757|FG002|Overall Study|Adverse Event|7|||
128863694|NCT00755417|463796755|FG000|Overall Study|Lack of Efficacy|8|||
128863695|NCT00755417|463796756|FG001|Overall Study|Lack of Efficacy|4|||
128863696|NCT00755417|463796757|FG002|Overall Study|Lack of Efficacy|9|||
128863697|NCT00755417|463796755|FG000|Overall Study|Protocol Violation|2|||
128863698|NCT00755417|463796756|FG001|Overall Study|Protocol Violation|1|||
128863699|NCT00755417|463796757|FG002|Overall Study|Protocol Violation|1|||
128863700|NCT00755417|463796755|FG000|Overall Study|Lost to Follow-up|3|||
128863701|NCT00755417|463796756|FG001|Overall Study|Lost to Follow-up|0|||
128863702|NCT00755417|463796757|FG002|Overall Study|Lost to Follow-up|1|||
128863703|NCT00755417|463796755|FG000|Overall Study|Withdrawal by Subject|12|||
128863704|NCT00755417|463796756|FG001|Overall Study|Withdrawal by Subject|12|||
128863705|NCT00755417|463796757|FG002|Overall Study|Withdrawal by Subject|12|||
128863706|NCT00755417|463796755|FG000|Overall Study|Not specified or missing data|9|||
128863707|NCT00755417|463796756|FG001|Overall Study|Not specified or missing data|18|||
128863708|NCT00755417|463796757|FG002|Overall Study|Not specified or missing data|12|||
128863709|NCT02362503|463796759|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
128863710|NCT02362503|463796760|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
128863711|NCT02362503|463796761|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
128863712|NCT02362503|463796759|FG000|Double-blind Period-Up to 8 Days|Death|1|||
128863713|NCT02362503|463796760|FG001|Double-blind Period-Up to 8 Days|Death|0|||
128863714|NCT02362503|463796761|FG002|Double-blind Period-Up to 8 Days|Death|0|||
128863715|NCT02362503|463796759|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
128863716|NCT02362503|463796760|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
128863717|NCT02362503|463796761|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
128863718|NCT02362503|463796759|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
128863719|NCT02362503|463796760|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
128863720|NCT02362503|463796761|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
128863721|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
128863722|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
128863723|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
128863724|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
128863725|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
128863726|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
128863727|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
128863728|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
128863729|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
128863730|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
128863731|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
128863732|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
128863733|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
128863734|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
128863735|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
128863736|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
128863737|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
128863738|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
128863739|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
128863740|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
128863741|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
128863742|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
128863743|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
128863744|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
128863745|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
128863746|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
128863747|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
128863748|NCT02362503|463796759|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
128863749|NCT02362503|463796760|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
128863750|NCT02362503|463796761|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
128863751|NCT02195479|463796762|FG000|Overall Study|Lost to Follow-up|18|||
128863752|NCT02195479|463796763|FG001|Overall Study|Lost to Follow-up|15|||
128863753|NCT02195479|463796762|FG000|Overall Study|Death|217|||
128863754|NCT02195479|463796763|FG001|Overall Study|Death|171|||
128863755|NCT02195479|463796762|FG000|Overall Study|Physician Decision|1|||
128863756|NCT02195479|463796763|FG001|Overall Study|Physician Decision|0|||
128863757|NCT02195479|463796762|FG000|Overall Study|Withdrawal by Subject|30|||
128863758|NCT02195479|463796763|FG001|Overall Study|Withdrawal by Subject|30|||
128863759|NCT02195479|463796762|FG000|Overall Study|Other|3|||
128863760|NCT02195479|463796763|FG001|Overall Study|Other|4|||
128863761|NCT02195479|463796762|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
128863762|NCT02195479|463796763|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
128863763|NCT03325777|463796768|FG000|Overall Study|Lost to Follow-up|9|||
128863764|NCT03325777|463796769|FG001|Overall Study|Lost to Follow-up|12|||
128863765|NCT01266161|463796772|FG000|Overall Study|Ineligible|1|||
128863766|NCT01266161|463796773|FG001|Overall Study|Ineligible|0|||
128863767|NCT01266161|463796772|FG000|Overall Study|Lack of Efficacy|0|||
128863768|NCT01266161|463796773|FG001|Overall Study|Lack of Efficacy|1|||
128863769|NCT01266161|463796772|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
128863770|NCT01266161|463796773|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
128863771|NCT01436305|463796775|FG000|Overall Study|Death|1|||
128863772|NCT01436305|463796776|FG001|Overall Study|Death|0|||
128863773|NCT01436305|463796777|FG002|Overall Study|Death|0|||
128863774|NCT01436305|463796775|FG000|Overall Study|Lost to Follow-up|0|||
128863775|NCT01436305|463796776|FG001|Overall Study|Lost to Follow-up|1|||
128863776|NCT01436305|463796777|FG002|Overall Study|Lost to Follow-up|0|||
128863777|NCT01436305|463796775|FG000|Overall Study|Withdrawal by Subject|1|||
128863778|NCT01436305|463796776|FG001|Overall Study|Withdrawal by Subject|3|||
128863779|NCT01436305|463796777|FG002|Overall Study|Withdrawal by Subject|0|||
128863780|NCT01485120|463796778|FG000|Overall Study|Withdrawal by Subject|2|||
128863781|NCT01081886|463796779|FG000|Overall Study|Study termination|11|||
128863782|NCT01081886|463796780|FG001|Overall Study|Study termination|13|||
128863783|NCT02567708|463796781|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
128863784|NCT02567708|463796782|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
128863785|NCT02567708|463796781|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
128863786|NCT02567708|463796782|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
128863787|NCT02567708|463796781|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
128863788|NCT02567708|463796782|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
128863789|NCT02567708|463796781|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
128863790|NCT02567708|463796782|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
128863791|NCT04148651|463796785|FG000|Overall Study|Lost to Follow-up|2|||
128863792|NCT05262751|463796786|FG000|Washout Period 2|Adverse Event|1|||
128863793|NCT05262751|463796787|FG001|Washout Period 2|Adverse Event|0|||
128863794|NCT05262751|463796788|FG002|Washout Period 2|Adverse Event|0|||
128863795|NCT05262751|463796789|FG003|Washout Period 2|Adverse Event|0|||
128863796|NCT05262751|463796790|FG004|Washout Period 2|Adverse Event|0|||
128863797|NCT05262751|463796791|FG005|Washout Period 2|Adverse Event|0|||
128863798|NCT05262751|463796786|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
128863799|NCT05262751|463796787|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
128863800|NCT05262751|463796788|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
128863801|NCT05262751|463796789|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
128863802|NCT05262751|463796790|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
128863803|NCT05262751|463796791|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
128863804|NCT01154140|463796793|FG000|Overall Study|Death|71|||
128863805|NCT01154140|463796794|FG001|Overall Study|Death|81|||
128863806|NCT01154140|463796793|FG000|Overall Study|Lost to Follow-up|4|||
128863807|NCT01154140|463796794|FG001|Overall Study|Lost to Follow-up|5|||
128863808|NCT01154140|463796793|FG000|Overall Study|Withdrawal by Subject|12|||
128863809|NCT01154140|463796794|FG001|Overall Study|Withdrawal by Subject|13|||
128863810|NCT01154140|463796793|FG000|Overall Study|Other|3|||
128863811|NCT01154140|463796794|FG001|Overall Study|Other|1|||
128863812|NCT01154140|463796793|FG000|Overall Study|Randomized but not treated|1|||
128863813|NCT01154140|463796794|FG001|Overall Study|Randomized but not treated|2|||
128863814|NCT02992691|463796802|FG000|Overall Study|Adverse Event|2|||
128863815|NCT02992691|463796802|FG000|Overall Study|Withdrawal by Subject|1|||
128863816|NCT04276051|463796803|FG000|Overall Study|Lost to Follow-up|0|||
128863817|NCT04276051|463796804|FG001|Overall Study|Lost to Follow-up|1|||
128863818|NCT04276051|463796803|FG000|Overall Study|Physician Decision|0|||
128863819|NCT04276051|463796804|FG001|Overall Study|Physician Decision|1|||
128863820|NCT04276051|463796803|FG000|Overall Study|Withdrawal by Subject|1|||
128863821|NCT04276051|463796804|FG001|Overall Study|Withdrawal by Subject|1|||
128863822|NCT00392925|463796805|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
128863823|NCT00392925|463796806|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
128863824|NCT00392925|463796807|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
128863825|NCT00392925|463796808|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
128863826|NCT00392925|463796805|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
128863827|NCT00392925|463796806|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
128863828|NCT00392925|463796807|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
128863829|NCT00392925|463796808|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
128863830|NCT00392925|463796805|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
128863831|NCT00392925|463796806|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
128863832|NCT00392925|463796807|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
128863833|NCT00392925|463796808|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
128863834|NCT00392925|463796805|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
128863835|NCT00392925|463796806|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
128863836|NCT00392925|463796807|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
128863837|NCT00392925|463796808|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
128863838|NCT00392925|463796805|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
128863839|NCT00392925|463796806|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
128863840|NCT00392925|463796807|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
128863841|NCT00392925|463796808|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
128863842|NCT00392925|463796805|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
128863843|NCT00392925|463796806|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
128863844|NCT00392925|463796807|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
128863845|NCT00392925|463796808|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
128863846|NCT00392925|463796805|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
128863847|NCT00392925|463796806|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
128863848|NCT00392925|463796807|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
128863849|NCT00392925|463796808|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
128863850|NCT00392925|463796805|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
128863851|NCT00392925|463796806|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
128863852|NCT00392925|463796807|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
128863853|NCT00392925|463796808|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
128863854|NCT00392925|463796805|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
128863855|NCT00392925|463796806|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
128863856|NCT00392925|463796807|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
128863857|NCT00392925|463796808|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
128863858|NCT02579772|463796809|FG000|Overall Study|Withdrawal by Subject|0|||
128863859|NCT02579772|463796810|FG001|Overall Study|Withdrawal by Subject|1|||
128863860|NCT02579772|463796809|FG000|Overall Study|Usage of additional antioxidants|1|||
128863861|NCT02579772|463796810|FG001|Overall Study|Usage of additional antioxidants|0|||
128863862|NCT02579772|463796809|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
128863863|NCT02579772|463796810|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
128863864|NCT03128671|463796811|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
128863865|NCT03128671|463796812|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
128863866|NCT03128671|463796811|FG000|Allocation|Death|1|||
128863867|NCT03128671|463796812|FG001|Allocation|Death|0|||
128863868|NCT03128671|463796811|FG000|Allocation|Withdrawal by Subject|4|||
128863869|NCT03128671|463796812|FG001|Allocation|Withdrawal by Subject|0|||
128863870|NCT03128671|463796811|FG000|Intervention|Withdrawal by Subject|11|||
128863871|NCT03128671|463796812|FG001|Intervention|Withdrawal by Subject|10|||
128863872|NCT03128671|463796811|FG000|Intervention|Palliative/hospice care initiated|9|||
128863873|NCT03128671|463796812|FG001|Intervention|Palliative/hospice care initiated|10|||
128863874|NCT03128671|463796811|FG000|Intervention|Death|13|||
128863875|NCT03128671|463796812|FG001|Intervention|Death|11|||
128863876|NCT03128671|463796811|FG000|Intervention|Interrupted by hurricane|1|||
128863877|NCT03128671|463796812|FG001|Intervention|Interrupted by hurricane|0|||
128863878|NCT03128671|463796811|FG000|Intervention|Physician Decision|2|||
128863879|NCT03128671|463796812|FG001|Intervention|Physician Decision|3|||
128863880|NCT04463680|463796813|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
128863881|NCT04463680|463796813|FG000|Overall Study|Not eligible due to implant duration of use|1|||
128863882|NCT04463680|463796813|FG000|Overall Study|Withdrawal by Subject|3|||
128863883|NCT05239598|463796816|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
128863884|NCT05239598|463796817|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
128863885|NCT05239598|463796816|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
128863886|NCT05239598|463796817|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
128863887|NCT04147195|463796822|FG000|Overall Study|Adverse Event|0|||
128863888|NCT04147195|463796823|FG001|Overall Study|Adverse Event|3|||
128863889|NCT04147195|463796822|FG000|Overall Study|Study Terminated by Sponsor|4|||
128863890|NCT04147195|463796823|FG001|Overall Study|Study Terminated by Sponsor|2|||
128863891|NCT04147195|463796822|FG000|Overall Study|Withdrawal by Subject|0|||
128863892|NCT04147195|463796823|FG001|Overall Study|Withdrawal by Subject|1|||
128863893|NCT05823012|463796824|FG000|Titration Period|Adverse Event|1|||
128863894|NCT05823012|463796824|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
128863895|NCT05823012|463796824|FG000|Maintenance Period|Adverse Event|1|||
128863896|NCT05823012|463796824|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
128863897|NCT05823012|463796824|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
128863898|NCT01424813|463796825|FG000|Overall Study|Withdrawal by Subject|3|||
128863899|NCT01424813|463796826|FG001|Overall Study|Withdrawal by Subject|0|||
128863900|NCT01424813|463796825|FG000|Overall Study|Protocol Violation|1|||
128863901|NCT01424813|463796826|FG001|Overall Study|Protocol Violation|0|||
128863902|NCT01424813|463796825|FG000|Overall Study|Other|1|||
128863903|NCT01424813|463796826|FG001|Overall Study|Other|2|||
128863904|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Adverse Event|10|||
128863905|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Adverse Event|9|||
128863906|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Adverse Event|7|||
128863907|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
128863908|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
128863909|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
128863910|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
128863911|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
128863912|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
128863913|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Physician Decision|7|||
128863914|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Physician Decision|3|||
128863915|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Physician Decision|2|||
128863916|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Pregnancy|2|||
128863917|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Pregnancy|1|||
128863918|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Pregnancy|3|||
128863919|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
128863920|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
128863921|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
128863922|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
128863923|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
128863924|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
128863925|NCT02614183|463796827|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
128863926|NCT02614183|463796828|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
128863927|NCT02614183|463796829|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
128863928|NCT02614183|463796827|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
128863929|NCT02614183|463796828|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
128863930|NCT02614183|463796829|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
128863931|NCT02614183|463796827|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
128863932|NCT02614183|463796828|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
128863933|NCT02614183|463796829|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
128863934|NCT02614183|463796827|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
128863935|NCT02614183|463796828|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
128863936|NCT02614183|463796829|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
128863937|NCT02614183|463796827|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
128863938|NCT02614183|463796828|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
128863939|NCT02614183|463796829|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
128863940|NCT04991753|463798659|FG000|Overall Study|Withdrawal by Subject|0|||
128863941|NCT04991753|463798660|FG001|Overall Study|Withdrawal by Subject|1|||
128863942|NCT03299049|463798663|FG000|Overall Study|On-going|486|||
128863943|NCT03299049|463798664|FG001|Overall Study|On-going|481|||
128863944|NCT03299049|463798663|FG000|Overall Study|Withdrawal by Subject|6|||
128863945|NCT03299049|463798664|FG001|Overall Study|Withdrawal by Subject|21|||
128863946|NCT03299049|463798663|FG000|Overall Study|Physician Decision|5|||
128863947|NCT03299049|463798664|FG001|Overall Study|Physician Decision|1|||
128863948|NCT03299049|463798663|FG000|Overall Study|Lost to Follow-up|2|||
128863949|NCT03299049|463798664|FG001|Overall Study|Lost to Follow-up|0|||
128863950|NCT03299049|463798663|FG000|Overall Study|Pregnancy|1|||
128863951|NCT03299049|463798664|FG001|Overall Study|Pregnancy|3|||
128863952|NCT03299049|463798663|FG000|Overall Study|Protocol Violation|1|||
128863953|NCT03299049|463798664|FG001|Overall Study|Protocol Violation|1|||
128863954|NCT03299049|463798663|FG000|Overall Study|Lack of Efficacy|9|||
128863955|NCT03299049|463798664|FG001|Overall Study|Lack of Efficacy|3|||
128863956|NCT03299049|463798663|FG000|Overall Study|Adverse Event|12|||
128863957|NCT03299049|463798664|FG001|Overall Study|Adverse Event|13|||
128863958|NCT01901419|463798665|FG000|Overall Study|Protocol Violation|2|||
128863959|NCT01901419|463798666|FG001|Overall Study|Protocol Violation|6|||
128863960|NCT01901419|463798665|FG000|Overall Study|unavailable researchers|6|||
128863961|NCT01901419|463798666|FG001|Overall Study|unavailable researchers|3|||
128863962|NCT01667926|463798671|FG000|Overall Study|Withdrawal by Subject|1|||
128863963|NCT01667926|463798672|FG001|Overall Study|Withdrawal by Subject|2|||
128863964|NCT01667926|463798673|FG002|Overall Study|Withdrawal by Subject|2|||
128863965|NCT01667926|463798671|FG000|Overall Study|Physician Decision|0|||
128863966|NCT01667926|463798672|FG001|Overall Study|Physician Decision|0|||
128863967|NCT01667926|463798673|FG002|Overall Study|Physician Decision|1|||
128863968|NCT01667926|463798671|FG000|Overall Study|Time committment|0|||
128863969|NCT01667926|463798672|FG001|Overall Study|Time committment|0|||
128863970|NCT01667926|463798673|FG002|Overall Study|Time committment|2|||
128863971|NCT01667926|463798671|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
128863972|NCT01667926|463798672|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
128863973|NCT01667926|463798673|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
128863974|NCT01667926|463798671|FG000|Overall Study|Lost to Follow-up|1|||
128863975|NCT01667926|463798672|FG001|Overall Study|Lost to Follow-up|2|||
128863976|NCT01667926|463798673|FG002|Overall Study|Lost to Follow-up|1|||
128863977|NCT01667926|463798671|FG000|Overall Study|Side effects|3|||
128863978|NCT01667926|463798672|FG001|Overall Study|Side effects|0|||
128863979|NCT01667926|463798673|FG002|Overall Study|Side effects|0|||
128863980|NCT02412735|463798674|FG000|Overall Study|Adverse Event|0|||
128863981|NCT02412735|463798675|FG001|Overall Study|Adverse Event|1|||
128863982|NCT02412735|463798676|FG002|Overall Study|Adverse Event|2|||
128863983|NCT02412735|463798674|FG000|Overall Study|Withdrawal by Subject|23|||
128863984|NCT02412735|463798675|FG001|Overall Study|Withdrawal by Subject|27|||
128863985|NCT02412735|463798676|FG002|Overall Study|Withdrawal by Subject|22|||
128863986|NCT02412735|463798674|FG000|Overall Study|Investigator Decision|3|||
128863987|NCT02412735|463798675|FG001|Overall Study|Investigator Decision|3|||
128863988|NCT02412735|463798676|FG002|Overall Study|Investigator Decision|2|||
128863989|NCT02412735|463798674|FG000|Overall Study|Lost to Follow-up|17|||
128863990|NCT02412735|463798675|FG001|Overall Study|Lost to Follow-up|11|||
128863991|NCT02412735|463798676|FG002|Overall Study|Lost to Follow-up|18|||
128863992|NCT02412735|463798674|FG000|Overall Study|Reason not Specified|3|||
128863993|NCT02412735|463798675|FG001|Overall Study|Reason not Specified|2|||
128863994|NCT02412735|463798676|FG002|Overall Study|Reason not Specified|2|||
128863995|NCT04043143|463798677|FG000|Overall Study|Lost to Follow-up|5|||
128863996|NCT04043143|463798678|FG001|Overall Study|Lost to Follow-up|5|||
128863997|NCT04043143|463798677|FG000|Overall Study|screen failure|1|||
128863998|NCT04043143|463798678|FG001|Overall Study|screen failure|0|||
128863999|NCT02521363|463798679|FG000|Overall Study|Withdrawal by Subject|1|||
128864000|NCT02521363|463798680|FG001|Overall Study|Withdrawal by Subject|2|||
128864001|NCT01923662|463798681|FG000|Overall Study|Withdrawal by Subject|1|||
128864002|NCT01939353|463798682|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
128864003|NCT01939353|463798682|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
128864004|NCT01939353|463798682|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
128864005|NCT01939353|463798682|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
128864006|NCT01939353|463798682|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
128864007|NCT00874731|463798688|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
128864008|NCT00874731|463798689|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
128864009|NCT00874731|463798690|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
128864010|NCT00874731|463798688|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
128864011|NCT00874731|463798689|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
128864012|NCT00874731|463798690|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
128864013|NCT00874731|463798688|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
128864014|NCT00874731|463798689|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
128864015|NCT00874731|463798690|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
128864016|NCT01132820|463798697|FG000|Overall Study|Ineligible: wrong cell type|1|||
128864017|NCT01132820|463798697|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
128864018|NCT01132820|463798697|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
128864019|NCT01132820|463798697|FG000|Overall Study|Never treated|1|||
128864020|NCT01132820|463798697|FG000|Overall Study|Inadequate data|1|||
128864021|NCT05000216|463798701|FG000|Stage 1|Lost to Follow-up|0|||
128864022|NCT05000216|463798702|FG001|Stage 1|Lost to Follow-up|0|||
128864023|NCT05000216|463798703|FG002|Stage 1|Lost to Follow-up|0|||
128864024|NCT05000216|463798704|FG003|Stage 1|Lost to Follow-up|0|||
128864025|NCT05000216|463798705|FG004|Stage 1|Lost to Follow-up|0|||
128864026|NCT05000216|463798706|FG005|Stage 1|Lost to Follow-up|0|||
128864027|NCT05000216|463798707|FG006|Stage 1|Lost to Follow-up|1|||
128864028|NCT05000216|463798708|FG007|Stage 1|Lost to Follow-up|1|||
128864029|NCT05000216|463798709|FG008|Stage 1|Lost to Follow-up|0|||
128864030|NCT05000216|463798710|FG009|Stage 1|Lost to Follow-up|2|||
128864031|NCT05000216|463798711|FG010|Stage 1|Lost to Follow-up|3|||
128864032|NCT05000216|463798712|FG011|Stage 1|Lost to Follow-up|0|||
128864033|NCT05000216|463798713|FG012|Stage 1|Lost to Follow-up|0|||
128864034|NCT05000216|463798714|FG013|Stage 1|Lost to Follow-up|0|||
128864035|NCT05000216|463798715|FG014|Stage 1|Lost to Follow-up|0|||
128864036|NCT05000216|463798716|FG015|Stage 1|Lost to Follow-up|0|||
128864037|NCT05000216|463798717|FG016|Stage 1|Lost to Follow-up|0|||
128864038|NCT05000216|463798718|FG017|Stage 1|Lost to Follow-up|0|||
128864039|NCT05000216|463798719|FG018|Stage 1|Lost to Follow-up|0|||
128864040|NCT05000216|463798720|FG019|Stage 1|Lost to Follow-up|0|||
128864041|NCT05000216|463798721|FG020|Stage 1|Lost to Follow-up|0|||
128864042|NCT05000216|463798722|FG021|Stage 1|Lost to Follow-up|0|||
128864043|NCT05000216|463798701|FG000|Stage 1|Physician Decision|0|||
128864044|NCT05000216|463798702|FG001|Stage 1|Physician Decision|0|||
128864045|NCT05000216|463798703|FG002|Stage 1|Physician Decision|0|||
128864046|NCT05000216|463798704|FG003|Stage 1|Physician Decision|0|||
128864047|NCT05000216|463798705|FG004|Stage 1|Physician Decision|0|||
128864048|NCT05000216|463798706|FG005|Stage 1|Physician Decision|0|||
128864049|NCT05000216|463798707|FG006|Stage 1|Physician Decision|0|||
128864050|NCT05000216|463798708|FG007|Stage 1|Physician Decision|1|||
128864051|NCT05000216|463798709|FG008|Stage 1|Physician Decision|1|||
128864052|NCT05000216|463798710|FG009|Stage 1|Physician Decision|0|||
128864053|NCT05000216|463798711|FG010|Stage 1|Physician Decision|0|||
128864054|NCT05000216|463798712|FG011|Stage 1|Physician Decision|0|||
128864055|NCT05000216|463798713|FG012|Stage 1|Physician Decision|0|||
128864056|NCT05000216|463798714|FG013|Stage 1|Physician Decision|0|||
128864057|NCT05000216|463798715|FG014|Stage 1|Physician Decision|0|||
128864058|NCT05000216|463798716|FG015|Stage 1|Physician Decision|0|||
128864059|NCT05000216|463798717|FG016|Stage 1|Physician Decision|0|||
128864060|NCT05000216|463798718|FG017|Stage 1|Physician Decision|0|||
128864061|NCT05000216|463798719|FG018|Stage 1|Physician Decision|0|||
128864062|NCT05000216|463798720|FG019|Stage 1|Physician Decision|0|||
128864063|NCT05000216|463798721|FG020|Stage 1|Physician Decision|0|||
128864064|NCT05000216|463798722|FG021|Stage 1|Physician Decision|0|||
128864065|NCT05000216|463798701|FG000|Stage 1|Withdrawal by Subject|0|||
128864066|NCT05000216|463798702|FG001|Stage 1|Withdrawal by Subject|1|||
128864067|NCT05000216|463798703|FG002|Stage 1|Withdrawal by Subject|0|||
128864068|NCT05000216|463798704|FG003|Stage 1|Withdrawal by Subject|0|||
128864069|NCT05000216|463798705|FG004|Stage 1|Withdrawal by Subject|0|||
128864070|NCT05000216|463798706|FG005|Stage 1|Withdrawal by Subject|0|||
128864071|NCT05000216|463798707|FG006|Stage 1|Withdrawal by Subject|0|||
128864072|NCT05000216|463798708|FG007|Stage 1|Withdrawal by Subject|0|||
128864073|NCT05000216|463798709|FG008|Stage 1|Withdrawal by Subject|0|||
128864074|NCT05000216|463798710|FG009|Stage 1|Withdrawal by Subject|3|||
128864075|NCT05000216|463798711|FG010|Stage 1|Withdrawal by Subject|10|||
128864076|NCT05000216|463798712|FG011|Stage 1|Withdrawal by Subject|0|||
128864077|NCT05000216|463798713|FG012|Stage 1|Withdrawal by Subject|0|||
128864078|NCT05000216|463798714|FG013|Stage 1|Withdrawal by Subject|0|||
128864079|NCT05000216|463798715|FG014|Stage 1|Withdrawal by Subject|0|||
128864080|NCT05000216|463798716|FG015|Stage 1|Withdrawal by Subject|0|||
128864081|NCT05000216|463798717|FG016|Stage 1|Withdrawal by Subject|0|||
128864082|NCT05000216|463798718|FG017|Stage 1|Withdrawal by Subject|0|||
128864083|NCT05000216|463798719|FG018|Stage 1|Withdrawal by Subject|0|||
128864084|NCT05000216|463798720|FG019|Stage 1|Withdrawal by Subject|0|||
128864085|NCT05000216|463798721|FG020|Stage 1|Withdrawal by Subject|0|||
128864086|NCT05000216|463798722|FG021|Stage 1|Withdrawal by Subject|0|||
128864087|NCT05000216|463798701|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
128864088|NCT05000216|463798702|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
128864089|NCT05000216|463798703|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
128864090|NCT05000216|463798704|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
128864091|NCT05000216|463798705|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
128864092|NCT05000216|463798706|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
128864093|NCT05000216|463798707|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
128864094|NCT05000216|463798708|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
128864095|NCT05000216|463798709|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
128864096|NCT05000216|463798710|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
128864097|NCT05000216|463798711|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
128864098|NCT05000216|463798712|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
128864099|NCT05000216|463798713|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
128864100|NCT05000216|463798714|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
128864101|NCT05000216|463798715|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
128864102|NCT05000216|463798716|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
128864103|NCT05000216|463798717|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
128864104|NCT05000216|463798718|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
128864105|NCT05000216|463798719|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
128864106|NCT05000216|463798720|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
128864107|NCT05000216|463798721|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
128864108|NCT05000216|463798722|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
128864109|NCT05000216|463798701|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864110|NCT05000216|463798702|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864111|NCT05000216|463798703|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864112|NCT05000216|463798704|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864113|NCT05000216|463798705|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864114|NCT05000216|463798706|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864115|NCT05000216|463798707|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864116|NCT05000216|463798708|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864117|NCT05000216|463798709|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
128864118|NCT05000216|463798710|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864119|NCT05000216|463798711|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864120|NCT05000216|463798712|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864121|NCT05000216|463798713|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864122|NCT05000216|463798714|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864123|NCT05000216|463798715|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864124|NCT05000216|463798716|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864125|NCT05000216|463798717|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864126|NCT05000216|463798718|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864127|NCT05000216|463798719|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864128|NCT05000216|463798720|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864129|NCT05000216|463798721|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864130|NCT05000216|463798722|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
128864131|NCT05000216|463798701|FG000|Stage 1|Other|0|||
128864132|NCT05000216|463798702|FG001|Stage 1|Other|0|||
128864133|NCT05000216|463798703|FG002|Stage 1|Other|0|||
128864134|NCT05000216|463798704|FG003|Stage 1|Other|0|||
128864135|NCT05000216|463798705|FG004|Stage 1|Other|1|||
128864136|NCT05000216|463798706|FG005|Stage 1|Other|0|||
128864137|NCT05000216|463798707|FG006|Stage 1|Other|0|||
128864138|NCT05000216|463798708|FG007|Stage 1|Other|2|||
128864139|NCT05000216|463798709|FG008|Stage 1|Other|0|||
128864140|NCT05000216|463798710|FG009|Stage 1|Other|0|||
128864141|NCT05000216|463798711|FG010|Stage 1|Other|1|||
128864142|NCT05000216|463798712|FG011|Stage 1|Other|1|||
128864143|NCT05000216|463798713|FG012|Stage 1|Other|0|||
128864144|NCT05000216|463798714|FG013|Stage 1|Other|0|||
128864145|NCT05000216|463798715|FG014|Stage 1|Other|0|||
128864146|NCT05000216|463798716|FG015|Stage 1|Other|0|||
128864147|NCT05000216|463798717|FG016|Stage 1|Other|0|||
128864148|NCT05000216|463798718|FG017|Stage 1|Other|0|||
128864149|NCT05000216|463798719|FG018|Stage 1|Other|0|||
128864150|NCT05000216|463798720|FG019|Stage 1|Other|0|||
128864151|NCT05000216|463798721|FG020|Stage 1|Other|0|||
128864152|NCT05000216|463798722|FG021|Stage 1|Other|0|||
128864153|NCT05000216|463798701|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
128864154|NCT05000216|463798702|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
128864155|NCT05000216|463798703|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
128864156|NCT05000216|463798704|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
128864157|NCT05000216|463798705|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
128864158|NCT05000216|463798706|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
128864159|NCT05000216|463798707|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
128864160|NCT05000216|463798708|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
128864161|NCT05000216|463798709|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
128864162|NCT05000216|463798710|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
128864163|NCT05000216|463798711|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
128864164|NCT05000216|463798712|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
128864165|NCT05000216|463798713|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
128864166|NCT05000216|463798714|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
128864167|NCT05000216|463798715|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
128864168|NCT05000216|463798716|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
128864169|NCT05000216|463798717|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
128864170|NCT05000216|463798718|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
128864171|NCT05000216|463798719|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
128864172|NCT05000216|463798720|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
128864173|NCT05000216|463798721|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
128864174|NCT05000216|463798722|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
128864175|NCT05000216|463798701|FG000|Stage 2|Lost to Follow-up|0|||
128864176|NCT05000216|463798702|FG001|Stage 2|Lost to Follow-up|0|||
128864177|NCT05000216|463798703|FG002|Stage 2|Lost to Follow-up|0|||
128864178|NCT05000216|463798704|FG003|Stage 2|Lost to Follow-up|0|||
128864179|NCT05000216|463798705|FG004|Stage 2|Lost to Follow-up|0|||
128864180|NCT05000216|463798706|FG005|Stage 2|Lost to Follow-up|0|||
128864181|NCT05000216|463798707|FG006|Stage 2|Lost to Follow-up|0|||
128864182|NCT05000216|463798708|FG007|Stage 2|Lost to Follow-up|0|||
128864183|NCT05000216|463798709|FG008|Stage 2|Lost to Follow-up|0|||
128864184|NCT05000216|463798710|FG009|Stage 2|Lost to Follow-up|0|||
128864185|NCT05000216|463798711|FG010|Stage 2|Lost to Follow-up|0|||
128864186|NCT05000216|463798712|FG011|Stage 2|Lost to Follow-up|0|||
128864187|NCT05000216|463798713|FG012|Stage 2|Lost to Follow-up|0|||
128864188|NCT05000216|463798714|FG013|Stage 2|Lost to Follow-up|0|||
128864189|NCT05000216|463798715|FG014|Stage 2|Lost to Follow-up|0|||
128864190|NCT05000216|463798716|FG015|Stage 2|Lost to Follow-up|0|||
128864191|NCT05000216|463798717|FG016|Stage 2|Lost to Follow-up|4|||
128864192|NCT05000216|463798718|FG017|Stage 2|Lost to Follow-up|0|||
128864193|NCT05000216|463798719|FG018|Stage 2|Lost to Follow-up|0|||
128864194|NCT05000216|463798720|FG019|Stage 2|Lost to Follow-up|0|||
128864195|NCT05000216|463798721|FG020|Stage 2|Lost to Follow-up|0|||
128864196|NCT05000216|463798722|FG021|Stage 2|Lost to Follow-up|0|||
128864197|NCT05000216|463798701|FG000|Stage 2|Physician Decision|0|||
128864198|NCT05000216|463798702|FG001|Stage 2|Physician Decision|0|||
128864199|NCT05000216|463798703|FG002|Stage 2|Physician Decision|0|||
128864200|NCT05000216|463798704|FG003|Stage 2|Physician Decision|0|||
128864201|NCT05000216|463798705|FG004|Stage 2|Physician Decision|0|||
128864202|NCT05000216|463798706|FG005|Stage 2|Physician Decision|0|||
128864203|NCT05000216|463798707|FG006|Stage 2|Physician Decision|0|||
128864204|NCT05000216|463798708|FG007|Stage 2|Physician Decision|0|||
128864205|NCT05000216|463798709|FG008|Stage 2|Physician Decision|0|||
128864206|NCT05000216|463798710|FG009|Stage 2|Physician Decision|0|||
128864207|NCT05000216|463798711|FG010|Stage 2|Physician Decision|0|||
128864208|NCT05000216|463798712|FG011|Stage 2|Physician Decision|0|||
128864209|NCT05000216|463798713|FG012|Stage 2|Physician Decision|1|||
128864210|NCT05000216|463798714|FG013|Stage 2|Physician Decision|0|||
128864211|NCT05000216|463798715|FG014|Stage 2|Physician Decision|0|||
128864212|NCT05000216|463798716|FG015|Stage 2|Physician Decision|0|||
128864213|NCT05000216|463798717|FG016|Stage 2|Physician Decision|0|||
128864214|NCT05000216|463798718|FG017|Stage 2|Physician Decision|0|||
128864215|NCT05000216|463798719|FG018|Stage 2|Physician Decision|0|||
128864216|NCT05000216|463798720|FG019|Stage 2|Physician Decision|0|||
128864217|NCT05000216|463798721|FG020|Stage 2|Physician Decision|0|||
128864218|NCT05000216|463798722|FG021|Stage 2|Physician Decision|0|||
128864219|NCT05000216|463798701|FG000|Stage 2|Withdrawal by Subject|0|||
128864220|NCT05000216|463798702|FG001|Stage 2|Withdrawal by Subject|0|||
128864221|NCT05000216|463798703|FG002|Stage 2|Withdrawal by Subject|0|||
128864222|NCT05000216|463798704|FG003|Stage 2|Withdrawal by Subject|0|||
128864223|NCT05000216|463798705|FG004|Stage 2|Withdrawal by Subject|0|||
128864224|NCT05000216|463798706|FG005|Stage 2|Withdrawal by Subject|0|||
128864225|NCT05000216|463798707|FG006|Stage 2|Withdrawal by Subject|0|||
128864226|NCT05000216|463798708|FG007|Stage 2|Withdrawal by Subject|0|||
128864227|NCT05000216|463798709|FG008|Stage 2|Withdrawal by Subject|0|||
128864228|NCT05000216|463798710|FG009|Stage 2|Withdrawal by Subject|0|||
128864229|NCT05000216|463798711|FG010|Stage 2|Withdrawal by Subject|0|||
128864230|NCT05000216|463798712|FG011|Stage 2|Withdrawal by Subject|0|||
128864231|NCT05000216|463798713|FG012|Stage 2|Withdrawal by Subject|0|||
128864232|NCT05000216|463798714|FG013|Stage 2|Withdrawal by Subject|0|||
128864233|NCT05000216|463798715|FG014|Stage 2|Withdrawal by Subject|2|||
128864234|NCT05000216|463798716|FG015|Stage 2|Withdrawal by Subject|0|||
128864235|NCT05000216|463798717|FG016|Stage 2|Withdrawal by Subject|9|||
128864236|NCT05000216|463798718|FG017|Stage 2|Withdrawal by Subject|0|||
128864237|NCT05000216|463798719|FG018|Stage 2|Withdrawal by Subject|0|||
128864238|NCT05000216|463798720|FG019|Stage 2|Withdrawal by Subject|0|||
128864239|NCT05000216|463798721|FG020|Stage 2|Withdrawal by Subject|0|||
128864240|NCT05000216|463798722|FG021|Stage 2|Withdrawal by Subject|0|||
128864241|NCT05000216|463798701|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
128864242|NCT05000216|463798702|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
128864243|NCT05000216|463798703|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
128864244|NCT05000216|463798704|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
128864245|NCT05000216|463798705|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
128864246|NCT05000216|463798706|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
128864247|NCT05000216|463798707|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
128864248|NCT05000216|463798708|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
128864249|NCT05000216|463798709|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
128864250|NCT05000216|463798710|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
128864251|NCT05000216|463798711|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
128864252|NCT05000216|463798712|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
128864253|NCT05000216|463798713|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
128864254|NCT05000216|463798714|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
128864255|NCT05000216|463798715|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
128864256|NCT05000216|463798716|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
128864257|NCT05000216|463798717|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
128864258|NCT05000216|463798718|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
128864259|NCT05000216|463798719|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
128864260|NCT05000216|463798720|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
128864261|NCT05000216|463798721|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
128864262|NCT05000216|463798722|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
128864263|NCT05000216|463798701|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864264|NCT05000216|463798702|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864265|NCT05000216|463798703|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864266|NCT05000216|463798704|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864267|NCT05000216|463798705|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864268|NCT05000216|463798706|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864269|NCT05000216|463798707|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864270|NCT05000216|463798708|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864271|NCT05000216|463798709|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864272|NCT05000216|463798710|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864273|NCT05000216|463798711|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864274|NCT05000216|463798712|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864275|NCT05000216|463798713|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864276|NCT05000216|463798714|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864277|NCT05000216|463798715|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
128864278|NCT05000216|463798716|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864279|NCT05000216|463798717|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
128864280|NCT05000216|463798718|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864281|NCT05000216|463798719|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864282|NCT05000216|463798720|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864283|NCT05000216|463798721|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864284|NCT05000216|463798722|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
128864285|NCT05000216|463798701|FG000|Stage 2|Other reason|0|||
128864286|NCT05000216|463798702|FG001|Stage 2|Other reason|0|||
128864287|NCT05000216|463798703|FG002|Stage 2|Other reason|0|||
128864288|NCT05000216|463798704|FG003|Stage 2|Other reason|0|||
128864289|NCT05000216|463798705|FG004|Stage 2|Other reason|0|||
128864290|NCT05000216|463798706|FG005|Stage 2|Other reason|0|||
128864291|NCT05000216|463798707|FG006|Stage 2|Other reason|0|||
128864292|NCT05000216|463798708|FG007|Stage 2|Other reason|0|||
128864293|NCT05000216|463798709|FG008|Stage 2|Other reason|0|||
128864294|NCT05000216|463798710|FG009|Stage 2|Other reason|0|||
128864295|NCT05000216|463798711|FG010|Stage 2|Other reason|0|||
128864296|NCT05000216|463798712|FG011|Stage 2|Other reason|0|||
128864297|NCT05000216|463798713|FG012|Stage 2|Other reason|0|||
128864298|NCT05000216|463798714|FG013|Stage 2|Other reason|0|||
128864299|NCT05000216|463798715|FG014|Stage 2|Other reason|0|||
128864300|NCT05000216|463798716|FG015|Stage 2|Other reason|0|||
128864301|NCT05000216|463798717|FG016|Stage 2|Other reason|1|||
128864302|NCT05000216|463798718|FG017|Stage 2|Other reason|0|||
128864303|NCT05000216|463798719|FG018|Stage 2|Other reason|0|||
128864304|NCT05000216|463798720|FG019|Stage 2|Other reason|0|||
128864305|NCT05000216|463798721|FG020|Stage 2|Other reason|0|||
128864306|NCT05000216|463798722|FG021|Stage 2|Other reason|0|||
128864307|NCT05000216|463798701|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
128864308|NCT05000216|463798702|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
128864309|NCT05000216|463798703|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
128864310|NCT05000216|463798704|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
128864311|NCT05000216|463798705|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
128864312|NCT05000216|463798706|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
128864313|NCT05000216|463798707|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
128864314|NCT05000216|463798708|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
128864315|NCT05000216|463798709|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
128864316|NCT05000216|463798710|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
128864317|NCT05000216|463798711|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
128864318|NCT05000216|463798712|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
128864319|NCT05000216|463798713|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
128864320|NCT05000216|463798714|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
128864321|NCT05000216|463798715|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
128864322|NCT05000216|463798716|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
128864323|NCT05000216|463798717|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
128864324|NCT05000216|463798718|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
128864325|NCT05000216|463798719|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
128864326|NCT05000216|463798720|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
128864327|NCT05000216|463798721|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
128864328|NCT05000216|463798722|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
128864329|NCT05000216|463798701|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864330|NCT05000216|463798702|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864331|NCT05000216|463798703|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864332|NCT05000216|463798704|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864333|NCT05000216|463798705|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864334|NCT05000216|463798706|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864335|NCT05000216|463798707|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864336|NCT05000216|463798708|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864337|NCT05000216|463798709|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864338|NCT05000216|463798710|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864339|NCT05000216|463798711|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864340|NCT05000216|463798712|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864341|NCT05000216|463798713|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864342|NCT05000216|463798714|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864343|NCT05000216|463798715|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864344|NCT05000216|463798716|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
128864345|NCT05000216|463798717|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864346|NCT05000216|463798718|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864347|NCT05000216|463798719|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864348|NCT05000216|463798720|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864349|NCT05000216|463798721|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864350|NCT05000216|463798722|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
128864351|NCT05000216|463798701|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864352|NCT05000216|463798702|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864353|NCT05000216|463798703|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864354|NCT05000216|463798704|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864355|NCT05000216|463798705|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864356|NCT05000216|463798706|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864357|NCT05000216|463798707|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864358|NCT05000216|463798708|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864359|NCT05000216|463798709|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864360|NCT05000216|463798710|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864361|NCT05000216|463798711|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864362|NCT05000216|463798712|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864363|NCT05000216|463798713|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864364|NCT05000216|463798714|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
128864365|NCT05000216|463798715|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864366|NCT05000216|463798716|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
128864367|NCT05000216|463798717|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864368|NCT05000216|463798718|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864369|NCT05000216|463798719|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
128864370|NCT05000216|463798720|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864371|NCT05000216|463798721|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864372|NCT05000216|463798722|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
128864373|NCT05071053|463798723|FG000|Overall Study|Progressive disease|30|||
128864374|NCT05071053|463798723|FG000|Overall Study|Adverse Event|5|||
128864375|NCT01602510|463798724|FG000|Open Label Phase|Adverse Event|46|||
128864376|NCT01602510|463798725|FG001|Open Label Phase|Adverse Event|0|||
128864377|NCT01602510|463798726|FG002|Open Label Phase|Adverse Event|0|||
128864378|NCT01602510|463798724|FG000|Open Label Phase|Lack of Efficacy|22|||
128864379|NCT01602510|463798725|FG001|Open Label Phase|Lack of Efficacy|0|||
128864380|NCT01602510|463798726|FG002|Open Label Phase|Lack of Efficacy|0|||
128864381|NCT01602510|463798724|FG000|Open Label Phase|Protocol Violation|15|||
128864382|NCT01602510|463798725|FG001|Open Label Phase|Protocol Violation|0|||
128864383|NCT01602510|463798726|FG002|Open Label Phase|Protocol Violation|0|||
128864384|NCT01602510|463798724|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
128864385|NCT01602510|463798725|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
128864386|NCT01602510|463798726|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
128864387|NCT01602510|463798724|FG000|Open Label Phase|Lost to Follow-up|22|||
128864388|NCT01602510|463798725|FG001|Open Label Phase|Lost to Follow-up|0|||
128864389|NCT01602510|463798726|FG002|Open Label Phase|Lost to Follow-up|0|||
128864390|NCT01602510|463798724|FG000|Open Label Phase|Physician Decision|19|||
128864391|NCT01602510|463798725|FG001|Open Label Phase|Physician Decision|0|||
128864392|NCT01602510|463798726|FG002|Open Label Phase|Physician Decision|0|||
128864393|NCT01602510|463798724|FG000|Open Label Phase|Withdrawal by Subject|57|||
128864394|NCT01602510|463798725|FG001|Open Label Phase|Withdrawal by Subject|0|||
128864395|NCT01602510|463798726|FG002|Open Label Phase|Withdrawal by Subject|0|||
128864396|NCT01602510|463798724|FG000|Randomized Phase|Adverse Event|0|||
128864397|NCT01602510|463798725|FG001|Randomized Phase|Adverse Event|2|||
128864398|NCT01602510|463798726|FG002|Randomized Phase|Adverse Event|6|||
128864399|NCT01602510|463798724|FG000|Randomized Phase|Lack of Efficacy|0|||
128864400|NCT01602510|463798725|FG001|Randomized Phase|Lack of Efficacy|4|||
128864401|NCT01602510|463798726|FG002|Randomized Phase|Lack of Efficacy|4|||
128864402|NCT01602510|463798724|FG000|Randomized Phase|Protocol Violation|0|||
128864403|NCT01602510|463798725|FG001|Randomized Phase|Protocol Violation|3|||
128864404|NCT01602510|463798726|FG002|Randomized Phase|Protocol Violation|3|||
128864405|NCT01602510|463798724|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
128864406|NCT01602510|463798725|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
128864407|NCT01602510|463798726|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
128864408|NCT01602510|463798724|FG000|Randomized Phase|Lost to Follow-up|0|||
128864409|NCT01602510|463798725|FG001|Randomized Phase|Lost to Follow-up|1|||
128864410|NCT01602510|463798726|FG002|Randomized Phase|Lost to Follow-up|3|||
128864411|NCT01602510|463798724|FG000|Randomized Phase|Physician Decision|0|||
128864412|NCT01602510|463798725|FG001|Randomized Phase|Physician Decision|0|||
128864413|NCT01602510|463798726|FG002|Randomized Phase|Physician Decision|2|||
128864414|NCT01602510|463798724|FG000|Randomized Phase|Withdrawal by Subject|0|||
128864415|NCT01602510|463798725|FG001|Randomized Phase|Withdrawal by Subject|6|||
128864416|NCT01602510|463798726|FG002|Randomized Phase|Withdrawal by Subject|7|||
128864417|NCT03519204|463798727|FG000|Overall Study|Lost to Follow-up|3|||
128864418|NCT03519204|463798728|FG001|Overall Study|Lost to Follow-up|8|||
128864419|NCT03519204|463798727|FG000|Overall Study|Withdrawal by Subject|9|||
128864420|NCT03519204|463798728|FG001|Overall Study|Withdrawal by Subject|7|||
128864421|NCT03519204|463798727|FG000|Overall Study|Other Miscellaneous Reasons|1|||
128864422|NCT03519204|463798728|FG001|Overall Study|Other Miscellaneous Reasons|0|||
128864423|NCT01572740|463798729|FG000|Overall Study|Adverse Event|1|||
128864424|NCT01572740|463798730|FG001|Overall Study|Adverse Event|1|||
128864425|NCT01572740|463798729|FG000|Overall Study|Withdrawal by Subject|1|||
128864426|NCT01572740|463798730|FG001|Overall Study|Withdrawal by Subject|1|||
128864427|NCT01572740|463798729|FG000|Overall Study|unclassified|4|||
128864428|NCT01572740|463798730|FG001|Overall Study|unclassified|3|||
128864429|NCT01289210|463798731|FG000|Overall Study|Adverse Event|1|||
128864430|NCT01818531|463798732|FG000|Overall Study|Withdrawn for case delay after block|1|||
128864431|NCT01818531|463798733|FG001|Overall Study|Withdrawn for case delay after block|0|||
128864432|NCT01818531|463798732|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
128864433|NCT01818531|463798733|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
128864434|NCT01818531|463798732|FG000|Overall Study|Withdrawn for failure to place block|0|||
128864435|NCT01818531|463798733|FG001|Overall Study|Withdrawn for failure to place block|1|||
128864436|NCT01110408|463798736|FG000|Overall Study|Protocol Violation|1|||
128864437|NCT01110408|463798737|FG001|Overall Study|Protocol Violation|0|||
128864438|NCT01465763|463798738|FG000|Overall Study|Withdrawal by Subject|4|||
128864439|NCT01465763|463798739|FG001|Overall Study|Withdrawal by Subject|0|||
128864440|NCT01465763|463798740|FG002|Overall Study|Withdrawal by Subject|1|||
128864441|NCT01465763|463798738|FG000|Overall Study|Insufficient Clinical Response|11|||
128864442|NCT01465763|463798739|FG001|Overall Study|Insufficient Clinical Response|0|||
128864443|NCT01465763|463798740|FG002|Overall Study|Insufficient Clinical Response|1|||
128864444|NCT01465763|463798738|FG000|Overall Study|Adverse Event|9|||
128864445|NCT01465763|463798739|FG001|Overall Study|Adverse Event|0|||
128864446|NCT01465763|463798740|FG002|Overall Study|Adverse Event|1|||
128864447|NCT01465763|463798738|FG000|Overall Study|Other|2|||
128864448|NCT01465763|463798739|FG001|Overall Study|Other|0|||
128864449|NCT01465763|463798740|FG002|Overall Study|Other|0|||
128864450|NCT01465763|463798738|FG000|Overall Study|Protocol Violation|4|||
128864451|NCT01465763|463798739|FG001|Overall Study|Protocol Violation|1|||
128864452|NCT01465763|463798740|FG002|Overall Study|Protocol Violation|1|||
128864453|NCT01465763|463798738|FG000|Overall Study|Death|1|||
128864454|NCT01465763|463798739|FG001|Overall Study|Death|0|||
128864455|NCT01465763|463798740|FG002|Overall Study|Death|0|||
128864456|NCT01646177|463798741|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
128864457|NCT01646177|463798742|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
128864458|NCT01646177|463798743|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
128864459|NCT01646177|463798744|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
128864460|NCT01646177|463798745|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864461|NCT01646177|463798746|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864462|NCT01646177|463798747|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864463|NCT01646177|463798748|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864464|NCT01646177|463798749|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864465|NCT01646177|463798750|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864466|NCT01646177|463798751|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864467|NCT01646177|463798752|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
128864468|NCT01646177|463798741|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
128864469|NCT01646177|463798742|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
128864470|NCT01646177|463798743|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
128864471|NCT01646177|463798744|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
128864472|NCT01646177|463798745|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864473|NCT01646177|463798746|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864474|NCT01646177|463798747|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864475|NCT01646177|463798748|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864476|NCT01646177|463798749|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864477|NCT01646177|463798750|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864478|NCT01646177|463798751|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864479|NCT01646177|463798752|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
128864480|NCT01646177|463798741|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
128864481|NCT01646177|463798742|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
128864482|NCT01646177|463798743|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
128864483|NCT01646177|463798744|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
128864484|NCT01646177|463798745|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864485|NCT01646177|463798746|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864486|NCT01646177|463798747|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864487|NCT01646177|463798748|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864488|NCT01646177|463798749|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864489|NCT01646177|463798750|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864490|NCT01646177|463798751|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864491|NCT01646177|463798752|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
128864492|NCT01646177|463798741|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
128864493|NCT01646177|463798742|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
128864494|NCT01646177|463798743|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
128864495|NCT01646177|463798744|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
128864496|NCT01646177|463798745|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864497|NCT01646177|463798746|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864498|NCT01646177|463798747|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864499|NCT01646177|463798748|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864500|NCT01646177|463798749|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864501|NCT01646177|463798750|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864502|NCT01646177|463798751|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864503|NCT01646177|463798752|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
128864504|NCT01646177|463798741|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864505|NCT01646177|463798742|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864506|NCT01646177|463798743|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
128864507|NCT01646177|463798744|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
128864508|NCT01646177|463798745|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864509|NCT01646177|463798746|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864510|NCT01646177|463798747|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864511|NCT01646177|463798748|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864512|NCT01646177|463798749|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864513|NCT01646177|463798750|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864514|NCT01646177|463798751|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864515|NCT01646177|463798752|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
128864516|NCT01646177|463798741|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
128864517|NCT01646177|463798742|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
128864518|NCT01646177|463798743|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
128864519|NCT01646177|463798744|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864520|NCT01646177|463798745|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864521|NCT01646177|463798746|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864522|NCT01646177|463798747|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864523|NCT01646177|463798748|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864524|NCT01646177|463798749|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864525|NCT01646177|463798750|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864526|NCT01646177|463798751|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864527|NCT01646177|463798752|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
128864528|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864529|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864530|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864531|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864532|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
128864533|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
128864534|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
128864535|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
128864536|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864537|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864538|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864539|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
128864540|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864541|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864542|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864543|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864544|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
128864545|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
128864546|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
128864547|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
128864548|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864549|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864550|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864551|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
128864552|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864553|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864554|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864555|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864556|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
128864557|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
128864558|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
128864559|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
128864560|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864561|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864562|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864563|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
128864564|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864565|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864566|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864567|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864568|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
128864569|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
128864570|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
128864571|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
128864572|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864573|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864574|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864575|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
128864576|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864577|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864578|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864579|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864580|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
128864581|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
128864582|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
128864583|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
128864584|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864585|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864586|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864587|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
128864588|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864589|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864590|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864591|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864592|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
128864593|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
128864594|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864595|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
128864596|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864597|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864598|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864599|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
128864600|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864601|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864602|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864603|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864604|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
128864605|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
128864606|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
128864607|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
128864608|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864609|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864610|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864611|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
128864612|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
128864613|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
128864614|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
128864615|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
128864616|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
128864617|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
128864618|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
128864619|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
128864620|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
128864621|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
128864622|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
128864623|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
128864624|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864625|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864626|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864627|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864628|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
128864629|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
128864630|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
128864631|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
128864632|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864633|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864634|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864635|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
128864636|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864637|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864638|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864639|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864640|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864641|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864642|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864643|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
128864644|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864645|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864646|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864647|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
128864648|NCT01646177|463798741|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864649|NCT01646177|463798742|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864650|NCT01646177|463798743|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864651|NCT01646177|463798744|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864652|NCT01646177|463798745|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864653|NCT01646177|463798746|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
128864654|NCT01646177|463798747|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
128864655|NCT01646177|463798748|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
128864656|NCT01646177|463798749|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864657|NCT01646177|463798750|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864658|NCT01646177|463798751|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864659|NCT01646177|463798752|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
128864660|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864661|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864662|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864663|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864664|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864665|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864666|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864667|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
128864668|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
128864669|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
128864670|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
128864671|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
128864672|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864673|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864674|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864675|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864676|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864677|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864678|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864679|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
128864680|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
128864681|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
128864682|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
128864683|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
128864684|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864685|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864686|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864687|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864688|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864689|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864690|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864691|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
128864692|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
128864693|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
128864694|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
128864695|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
128864696|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864697|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864698|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864699|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864700|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864701|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864702|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864703|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
128864704|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
128864705|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
128864706|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
128864707|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
128864708|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864709|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864710|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864711|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864712|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864713|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864714|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864715|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
128864716|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
128864717|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
128864718|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
128864719|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
128864720|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864721|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864722|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864723|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864724|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864725|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864726|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864727|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
128864728|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
128864729|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
128864730|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
128864731|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
128864732|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864733|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864734|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864735|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864736|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864737|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864738|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864739|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864740|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
128864741|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
128864742|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
128864743|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
128864744|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864745|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864746|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864747|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864748|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864749|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864750|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864751|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864752|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
128864753|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
128864754|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
128864755|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
128864756|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864757|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864758|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864759|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864760|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864761|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864762|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864763|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864764|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
128864765|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
128864766|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
128864767|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
128864768|NCT01646177|463798741|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864769|NCT01646177|463798742|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864770|NCT01646177|463798743|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864771|NCT01646177|463798744|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864772|NCT01646177|463798745|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864773|NCT01646177|463798746|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864774|NCT01646177|463798747|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864775|NCT01646177|463798748|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864776|NCT01646177|463798749|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864777|NCT01646177|463798750|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
128864778|NCT01646177|463798751|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
128864779|NCT01646177|463798752|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
128864780|NCT02920970|463798753|FG000|First Intervention|Protocol Violation|0|||
128864781|NCT02920970|463798754|FG001|First Intervention|Protocol Violation|1|||
128864782|NCT02920970|463798753|FG000|First Intervention|Adverse Event|0|||
128864783|NCT02920970|463798754|FG001|First Intervention|Adverse Event|1|||
128864784|NCT02920970|463798753|FG000|Second Intervention|Poor Lens Fit|1|||
128864785|NCT02920970|463798754|FG001|Second Intervention|Poor Lens Fit|0|||
128864786|NCT01711853|463798757|FG000|Overall Study|Not treated|3|||
128864787|NCT00755105|463798761|FG000|Overall Study|Withdrawal by Subject|9|||
128864788|NCT00755105|463798762|FG001|Overall Study|Withdrawal by Subject|11|||
128864789|NCT00755105|463798763|FG002|Overall Study|Withdrawal by Subject|4|||
128864790|NCT01281839|463798764|FG000|Overall Study|Lost to Follow-up|6|||
128864791|NCT01281839|463798765|FG001|Overall Study|Lost to Follow-up|3|||
128864792|NCT01281839|463798764|FG000|Overall Study|Withdrawal by Subject|4|||
128864793|NCT01281839|463798765|FG001|Overall Study|Withdrawal by Subject|10|||
128864794|NCT01281839|463798764|FG000|Overall Study|Reason not specified|0|||
128864795|NCT01281839|463798765|FG001|Overall Study|Reason not specified|1|||
128864796|NCT01509547|463798768|FG000|Overall Study|Lost to Follow-up|24|||
128864797|NCT01509547|463798769|FG001|Overall Study|Lost to Follow-up|14|||
128864798|NCT01509547|463798768|FG000|Overall Study|Withdrawal by Subject|11|||
128864799|NCT01509547|463798769|FG001|Overall Study|Withdrawal by Subject|24|||
128864800|NCT01509547|463798768|FG000|Overall Study|Physician Decision|0|||
128864801|NCT01509547|463798769|FG001|Overall Study|Physician Decision|1|||
128864802|NCT00402051|463798772|FG000|Overall Study|Progressive Disease|13|||
128864803|NCT00402051|463798773|FG001|Overall Study|Progressive Disease|20|||
128864804|NCT00402051|463798772|FG000|Overall Study|Adverse Event|11|||
128864805|NCT00402051|463798773|FG001|Overall Study|Adverse Event|4|||
128864806|NCT00402051|463798772|FG000|Overall Study|Physician Decision|7|||
128864807|NCT00402051|463798773|FG001|Overall Study|Physician Decision|3|||
128864808|NCT00402051|463798772|FG000|Overall Study|Withdrawal by Subject|3|||
128864809|NCT00402051|463798773|FG001|Overall Study|Withdrawal by Subject|3|||
128864810|NCT00402051|463798772|FG000|Overall Study|Death - Related to Study Drug|1|||
128864811|NCT00402051|463798773|FG001|Overall Study|Death - Related to Study Drug|2|||
128864812|NCT00402051|463798772|FG000|Overall Study|Death Due to Study Disease|2|||
128864813|NCT00402051|463798773|FG001|Overall Study|Death Due to Study Disease|1|||
128864814|NCT00402051|463798772|FG000|Overall Study|Death Due to Adverse Event|0|||
128864815|NCT00402051|463798773|FG001|Overall Study|Death Due to Adverse Event|2|||
128864816|NCT00402051|463798772|FG000|Overall Study|Lost to Follow-up|1|||
128864817|NCT00402051|463798773|FG001|Overall Study|Lost to Follow-up|0|||
128864818|NCT00570908|463798788|FG000|Overall Study|Adverse Event|5|||
128864819|NCT00570908|463798788|FG000|Overall Study|Withdrawal by Subject|2|||
128864820|NCT01213524|463798789|FG000|Baseline|Withdrawal by Subject|5|||
128864821|NCT01213524|463798789|FG000|Baseline|high breath alcohol levels|1|||
128864822|NCT01213524|463798789|FG000|Baseline|Physician Decision|1|||
128864823|NCT01213524|463798789|FG000|Session 2|Withdrawal by Subject|5|||
128864824|NCT01213524|463798789|FG000|Session 3|Withdrawal by Subject|4|||
128864825|NCT01213524|463798789|FG000|Session 4|Physician Decision|1|||
128864826|NCT01213524|463798789|FG000|Session 4|Withdrawal by Subject|2|||
128864827|NCT06152224|463798795|FG000|Overall Study|Withdrawal by Subject|1|||
128864828|NCT06152224|463798796|FG001|Overall Study|Withdrawal by Subject|0|||
128864829|NCT06152224|463798795|FG000|Overall Study|Lost to Follow-up|0|||
128864830|NCT06152224|463798796|FG001|Overall Study|Lost to Follow-up|1|||
128864831|NCT06152224|463798795|FG000|Overall Study|On Follow Up|18|||
128864832|NCT06152224|463798796|FG001|Overall Study|On Follow Up|18|||
128864833|NCT00281320|463798799|FG000|Overall Study|Adverse Event|12|||
128864834|NCT00281320|463798800|FG001|Overall Study|Adverse Event|9|||
128864835|NCT00281320|463798799|FG000|Overall Study|Lack of Efficacy|4|||
128864836|NCT00281320|463798800|FG001|Overall Study|Lack of Efficacy|3|||
128864837|NCT00281320|463798799|FG000|Overall Study|Withdrawal by Subject|5|||
128864838|NCT00281320|463798800|FG001|Overall Study|Withdrawal by Subject|6|||
128864839|NCT00281320|463798799|FG000|Overall Study|Lost to Follow-up|1|||
128864840|NCT00281320|463798800|FG001|Overall Study|Lost to Follow-up|2|||
128864841|NCT00281320|463798799|FG000|Overall Study|Other|3|||
128864842|NCT00281320|463798800|FG001|Overall Study|Other|1|||
128864843|NCT01447576|463798809|FG000|Overall Study|Lost to Follow-up|52|||
128864844|NCT01447576|463798809|FG000|Overall Study|Adverse Event|127|||
128864845|NCT01447576|463798809|FG000|Overall Study|Participant met withdrawal criteria|40|||
128864846|NCT01447576|463798809|FG000|Overall Study|Withdrawal by Subject|100|||
128864847|NCT01447576|463798809|FG000|Overall Study|Protocol deviation|83|||
128864848|NCT01447576|463798809|FG000|Overall Study|Lack of Efficacy|68|||
128864849|NCT01447576|463798809|FG000|Overall Study|Physician Decision|6|||
128864850|NCT00975676|463798810|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
128864851|NCT00975676|463798811|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
128864852|NCT02548078|463798812|FG000|Overall Study|Serious adverse event/Adverse event|1|||
128864853|NCT02548078|463798813|FG001|Overall Study|Serious adverse event/Adverse event|0|||
128864854|NCT02548078|463798812|FG000|Overall Study|Moved from study area|3|||
128864855|NCT02548078|463798813|FG001|Overall Study|Moved from study area|3|||
128864856|NCT02548078|463798812|FG000|Overall Study|Lost to Follow-up|1|||
128864857|NCT02548078|463798813|FG001|Overall Study|Lost to Follow-up|3|||
128864858|NCT01088984|463801135|FG000|Phase 1|Death|2|||
128864859|NCT01088984|463801136|FG001|Phase 1|Death|1|||
128864860|NCT01088984|463801135|FG000|Phase 1|Disease Progression|2|||
128864861|NCT01088984|463801136|FG001|Phase 1|Disease Progression|4|||
128864862|NCT01088984|463801135|FG000|Phase 1|Other|1|||
128864863|NCT01088984|463801136|FG001|Phase 1|Other|1|||
128864864|NCT01088984|463801135|FG000|Phase 2|Death|0|||
128864865|NCT01088984|463801136|FG001|Phase 2|Death|5|||
128864866|NCT01088984|463801135|FG000|Phase 2|Withdrawal by Subject|0|||
128864867|NCT01088984|463801136|FG001|Phase 2|Withdrawal by Subject|1|||
128864868|NCT01088984|463801135|FG000|Phase 2|DIsease Progression|0|||
128864869|NCT01088984|463801136|FG001|Phase 2|DIsease Progression|25|||
128864870|NCT01088984|463801135|FG000|Phase 2|Other|0|||
128864871|NCT01088984|463801136|FG001|Phase 2|Other|1|||
128864872|NCT04707664|463801137|FG000|Overall Study|Adverse Event|2|||
128864873|NCT04707664|463801138|FG001|Overall Study|Adverse Event|0|||
128864874|NCT04707664|463801137|FG000|Overall Study|Death|1|||
128864875|NCT04707664|463801138|FG001|Overall Study|Death|2|||
128864876|NCT04707664|463801137|FG000|Overall Study|Withdrawal by Subject|13|||
128864877|NCT04707664|463801138|FG001|Overall Study|Withdrawal by Subject|21|||
128864878|NCT04707664|463801137|FG000|Overall Study|Lost to Follow-up|11|||
128864879|NCT04707664|463801138|FG001|Overall Study|Lost to Follow-up|13|||
128864880|NCT04707664|463801137|FG000|Overall Study|Not treated|2|||
128864881|NCT04707664|463801138|FG001|Overall Study|Not treated|0|||
128864882|NCT00699153|463801139|FG000|Overall Study|Lost to Follow-up|1|||
128864883|NCT00699153|463801140|FG001|Overall Study|Lost to Follow-up|0|||
128864884|NCT00699153|463801139|FG000|Overall Study|Adverse Event|0|||
128864885|NCT00699153|463801140|FG001|Overall Study|Adverse Event|2|||
128864886|NCT00699153|463801139|FG000|Overall Study|Protocol Violation|1|||
128864887|NCT00699153|463801140|FG001|Overall Study|Protocol Violation|0|||
128864888|NCT00699153|463801139|FG000|Overall Study|Travel Problem|1|||
128864889|NCT00699153|463801140|FG001|Overall Study|Travel Problem|0|||
128864890|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
128864891|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
128864892|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
128864893|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
128864894|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Death|13|||
128864895|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Death|12|||
128864896|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Progression|257|||
128864897|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Progression|218|||
128864898|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
128864899|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
128864900|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
128864901|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
128864902|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
128864903|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
128864904|NCT01006980|463801143|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
128864905|NCT01006980|463801144|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
128864906|NCT01006980|463801143|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
128864907|NCT01006980|463801144|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
128864908|NCT01006980|463801143|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
128864909|NCT01006980|463801144|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
128864910|NCT01006980|463801143|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
128864911|NCT01006980|463801144|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
128864912|NCT01006980|463801143|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
128864913|NCT01006980|463801144|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
128864914|NCT01006980|463801143|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
128864915|NCT01006980|463801144|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
128864916|NCT02706405|463801149|FG000|Overall Study|Death|3|||
128864917|NCT02706405|463801150|FG001|Overall Study|Death|2|||
128864918|NCT02706405|463801151|FG002|Overall Study|Death|0|||
128864919|NCT02706405|463801152|FG003|Overall Study|Death|1|||
128864920|NCT02706405|463801153|FG004|Overall Study|Death|0|||
128864921|NCT02706405|463801154|FG005|Overall Study|Death|0|||
128864922|NCT02706405|463801155|FG006|Overall Study|Death|3|||
128864923|NCT02706405|463801156|FG007|Overall Study|Death|4|||
128864924|NCT02706405|463801149|FG000|Overall Study|Disease progression|0|||
128864925|NCT02706405|463801150|FG001|Overall Study|Disease progression|0|||
128864926|NCT02706405|463801151|FG002|Overall Study|Disease progression|0|||
128864927|NCT02706405|463801152|FG003|Overall Study|Disease progression|0|||
128864928|NCT02706405|463801153|FG004|Overall Study|Disease progression|0|||
128864929|NCT02706405|463801154|FG005|Overall Study|Disease progression|0|||
128864930|NCT02706405|463801155|FG006|Overall Study|Disease progression|0|||
128864931|NCT02706405|463801156|FG007|Overall Study|Disease progression|1|||
128864932|NCT02706405|463801149|FG000|Overall Study|Pt moved to new therapy|0|||
128864933|NCT02706405|463801150|FG001|Overall Study|Pt moved to new therapy|0|||
128864934|NCT02706405|463801151|FG002|Overall Study|Pt moved to new therapy|0|||
128864935|NCT02706405|463801152|FG003|Overall Study|Pt moved to new therapy|0|||
128864936|NCT02706405|463801153|FG004|Overall Study|Pt moved to new therapy|0|||
128864937|NCT02706405|463801154|FG005|Overall Study|Pt moved to new therapy|1|||
128864938|NCT02706405|463801155|FG006|Overall Study|Pt moved to new therapy|0|||
128864939|NCT02706405|463801156|FG007|Overall Study|Pt moved to new therapy|1|||
128864940|NCT02706405|463801149|FG000|Overall Study|Physician Decision|1|||
128864941|NCT02706405|463801150|FG001|Overall Study|Physician Decision|0|||
128864942|NCT02706405|463801151|FG002|Overall Study|Physician Decision|0|||
128864943|NCT02706405|463801152|FG003|Overall Study|Physician Decision|0|||
128864944|NCT02706405|463801153|FG004|Overall Study|Physician Decision|0|||
128864945|NCT02706405|463801154|FG005|Overall Study|Physician Decision|0|||
128864946|NCT02706405|463801155|FG006|Overall Study|Physician Decision|0|||
128864947|NCT02706405|463801156|FG007|Overall Study|Physician Decision|0|||
128864948|NCT01228318|463801157|FG000|Overall Study|Clinic no show to receive intervention|1|||
128864949|NCT01228318|463801158|FG001|Overall Study|Clinic no show to receive intervention|0|||
128864950|NCT01228318|463801157|FG000|Overall Study|Unable to contact|2|||
128864951|NCT01228318|463801158|FG001|Overall Study|Unable to contact|5|||
128864952|NCT01228318|463801157|FG000|Overall Study|Moved|0|||
128864953|NCT01228318|463801158|FG001|Overall Study|Moved|2|||
128864954|NCT01228318|463801157|FG000|Overall Study|Incarcerated|1|||
128864955|NCT01228318|463801158|FG001|Overall Study|Incarcerated|0|||
128864956|NCT01182441|463801163|FG000|Overall Study|Patient Still in Follow-up|152|||
128864957|NCT01182441|463801164|FG001|Overall Study|Patient Still in Follow-up|72|||
128864958|NCT01182441|463801163|FG000|Overall Study|Death|37|||
128864959|NCT01182441|463801164|FG001|Overall Study|Death|25|||
128864960|NCT01182441|463801163|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
128864961|NCT01182441|463801164|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
128864962|NCT01182441|463801163|FG000|Overall Study|Lost to Follow-up|5|||
128864963|NCT01182441|463801164|FG001|Overall Study|Lost to Follow-up|8|||
128864964|NCT01182441|463801163|FG000|Overall Study|Withdrawal by Subject|6|||
128864965|NCT01182441|463801164|FG001|Overall Study|Withdrawal by Subject|13|||
128864966|NCT01182441|463801163|FG000|Overall Study|Implant Not Attempted|4|||
128864967|NCT01182441|463801164|FG001|Overall Study|Implant Not Attempted|0|||
128864968|NCT01182441|463801163|FG000|Overall Study|Adverse Event|2|||
128864969|NCT01182441|463801164|FG001|Overall Study|Adverse Event|0|||
128864970|NCT01182441|463801163|FG000|Overall Study|Physician Decision|1|||
128864971|NCT01182441|463801164|FG001|Overall Study|Physician Decision|1|||
128864972|NCT00603525|463801165|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
128864973|NCT00603525|463801166|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
128864974|NCT00603525|463801167|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
128864975|NCT00603525|463801165|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
128864976|NCT00603525|463801166|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
128864977|NCT00603525|463801167|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
128864978|NCT00603525|463801165|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
128864979|NCT00603525|463801166|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
128864980|NCT00603525|463801167|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
128864981|NCT00603525|463801165|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
128864982|NCT00603525|463801166|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
128864983|NCT00603525|463801167|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
128864984|NCT00603525|463801165|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
128864985|NCT00603525|463801166|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
128864986|NCT00603525|463801167|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
128864987|NCT00603525|463801165|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
128864988|NCT00603525|463801166|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
128864989|NCT00603525|463801167|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
128864990|NCT00603525|463801165|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
128864991|NCT00603525|463801166|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
128864992|NCT00603525|463801167|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
128864993|NCT00603525|463801165|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
128864994|NCT00603525|463801166|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
128864995|NCT00603525|463801167|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
128864996|NCT00603525|463801165|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
128864997|NCT00603525|463801166|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
128864998|NCT00603525|463801167|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
128864999|NCT00603525|463801165|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
128865000|NCT00603525|463801166|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
128865001|NCT00603525|463801167|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
128865002|NCT00603525|463801165|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
128865003|NCT00603525|463801166|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
128865004|NCT00603525|463801167|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
128865005|NCT00603525|463801165|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
128865006|NCT00603525|463801166|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
128865007|NCT00603525|463801167|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
128865008|NCT00603525|463801165|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
128865009|NCT00603525|463801166|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
128865010|NCT00603525|463801167|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
128865011|NCT00603525|463801165|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
128865012|NCT00603525|463801166|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
128865013|NCT00603525|463801167|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
128865014|NCT00603525|463801165|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
128865015|NCT00603525|463801166|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
128865016|NCT00603525|463801167|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
128865017|NCT02304705|463801168|FG000|Overall Study|Withdrawal by Subject|2|||
128865018|NCT02304705|463801169|FG001|Overall Study|Withdrawal by Subject|0|||
128865019|NCT02304705|463801168|FG000|Overall Study|Physician Decision|2|||
128865020|NCT02304705|463801169|FG001|Overall Study|Physician Decision|4|||
128865021|NCT02304705|463801168|FG000|Overall Study|Death|0|||
128865022|NCT02304705|463801169|FG001|Overall Study|Death|1|||
128865023|NCT02304705|463801168|FG000|Overall Study|Lost to Follow-up|0|||
128865024|NCT02304705|463801169|FG001|Overall Study|Lost to Follow-up|2|||
128865025|NCT02124811|463801170|FG000|Overall Study|Early termination|2|||
128865026|NCT02124811|463801171|FG001|Overall Study|Early termination|2|||
128865027|NCT02124811|463801170|FG000|Overall Study|Withdrawal by Subject|1|||
128865028|NCT02124811|463801171|FG001|Overall Study|Withdrawal by Subject|0|||
128865029|NCT03480932|463801172|FG000|Overall Study|Death|1|||
128865030|NCT03480932|463801173|FG001|Overall Study|Death|1|||
128865031|NCT03480932|463801174|FG002|Overall Study|Death|0|||
128865032|NCT03480932|463801172|FG000|Overall Study|Lost to Follow-up|0|||
128865033|NCT03480932|463801173|FG001|Overall Study|Lost to Follow-up|2|||
128865034|NCT03480932|463801174|FG002|Overall Study|Lost to Follow-up|3|||
128865035|NCT03480932|463801172|FG000|Overall Study|Incarcerated|2|||
128865036|NCT03480932|463801173|FG001|Overall Study|Incarcerated|2|||
128865037|NCT03480932|463801174|FG002|Overall Study|Incarcerated|2|||
128865038|NCT01757197|463801180|FG000|Overall Study|Death|2|||
128865039|NCT01174446|463801184|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
128865040|NCT01174446|463801185|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
128865041|NCT01174446|463801186|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
128865042|NCT01174446|463801187|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
128865043|NCT01174446|463801184|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
128865044|NCT01174446|463801185|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
128865045|NCT01174446|463801186|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
128865046|NCT01174446|463801187|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
128865047|NCT01174446|463801184|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
128865048|NCT01174446|463801185|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
128865049|NCT01174446|463801186|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
128865050|NCT01174446|463801187|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
128865051|NCT01174446|463801184|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
128865052|NCT01174446|463801185|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
128865053|NCT01174446|463801186|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
128865054|NCT01174446|463801187|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
128865055|NCT01077128|463801188|FG000|Overall Study|Adverse Event|8|||
128865056|NCT01077128|463801188|FG000|Overall Study|Lack of Efficacy|1|||
128865057|NCT01077128|463801188|FG000|Overall Study|Disease exacerbation|1|||
128865058|NCT01077128|463801188|FG000|Overall Study|Adverse event and consent withdrawal|1|||
128865059|NCT01077128|463801188|FG000|Overall Study|Adverse event and disease exacerbation|1|||
128865060|NCT01077128|463801188|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
128865061|NCT01077128|463801188|FG000|Overall Study|Other|54|||
128865062|NCT00847626|463801191|FG000|Overall Study|Adverse Event|10|||
128865063|NCT00847626|463801192|FG001|Overall Study|Adverse Event|10|||
128865064|NCT00847626|463801193|FG002|Overall Study|Adverse Event|6|||
128865065|NCT00847626|463801194|FG003|Overall Study|Adverse Event|19|||
128865066|NCT00847626|463801195|FG004|Overall Study|Adverse Event|11|||
128865067|NCT00847626|463801196|FG005|Overall Study|Adverse Event|22|||
128865068|NCT00847626|463801197|FG006|Overall Study|Adverse Event|4|||
128865069|NCT00847626|463801198|FG007|Overall Study|Adverse Event|6|||
128865070|NCT00847626|463801199|FG008|Overall Study|Adverse Event|3|||
128865071|NCT00847626|463801200|FG009|Overall Study|Adverse Event|6|||
128865072|NCT00847626|463801201|FG010|Overall Study|Adverse Event|6|||
128865073|NCT00847626|463801191|FG000|Overall Study|Protocol Violation|2|||
128865074|NCT00847626|463801192|FG001|Overall Study|Protocol Violation|1|||
128865075|NCT00847626|463801193|FG002|Overall Study|Protocol Violation|2|||
128865076|NCT00847626|463801194|FG003|Overall Study|Protocol Violation|1|||
128865077|NCT00847626|463801195|FG004|Overall Study|Protocol Violation|1|||
128865078|NCT00847626|463801196|FG005|Overall Study|Protocol Violation|1|||
128865079|NCT00847626|463801197|FG006|Overall Study|Protocol Violation|1|||
128865080|NCT00847626|463801198|FG007|Overall Study|Protocol Violation|1|||
128865081|NCT00847626|463801199|FG008|Overall Study|Protocol Violation|0|||
128865082|NCT00847626|463801200|FG009|Overall Study|Protocol Violation|1|||
128865083|NCT00847626|463801201|FG010|Overall Study|Protocol Violation|1|||
128865084|NCT00847626|463801191|FG000|Overall Study|Lost to Follow-up|0|||
128865085|NCT00847626|463801192|FG001|Overall Study|Lost to Follow-up|1|||
128865086|NCT00847626|463801193|FG002|Overall Study|Lost to Follow-up|1|||
128865087|NCT00847626|463801194|FG003|Overall Study|Lost to Follow-up|1|||
128865088|NCT00847626|463801195|FG004|Overall Study|Lost to Follow-up|0|||
128865089|NCT00847626|463801196|FG005|Overall Study|Lost to Follow-up|3|||
128865090|NCT00847626|463801197|FG006|Overall Study|Lost to Follow-up|1|||
128865091|NCT00847626|463801198|FG007|Overall Study|Lost to Follow-up|3|||
128865092|NCT00847626|463801199|FG008|Overall Study|Lost to Follow-up|1|||
128865093|NCT00847626|463801200|FG009|Overall Study|Lost to Follow-up|0|||
128865094|NCT00847626|463801201|FG010|Overall Study|Lost to Follow-up|1|||
128865095|NCT00847626|463801191|FG000|Overall Study|Withdrawal by Subject|5|||
128865096|NCT00847626|463801192|FG001|Overall Study|Withdrawal by Subject|5|||
128865097|NCT00847626|463801193|FG002|Overall Study|Withdrawal by Subject|3|||
128865098|NCT00847626|463801194|FG003|Overall Study|Withdrawal by Subject|8|||
128865099|NCT00847626|463801195|FG004|Overall Study|Withdrawal by Subject|12|||
128865100|NCT00847626|463801196|FG005|Overall Study|Withdrawal by Subject|9|||
128865101|NCT00847626|463801197|FG006|Overall Study|Withdrawal by Subject|8|||
128865102|NCT00847626|463801198|FG007|Overall Study|Withdrawal by Subject|4|||
128865103|NCT00847626|463801199|FG008|Overall Study|Withdrawal by Subject|4|||
128865104|NCT00847626|463801200|FG009|Overall Study|Withdrawal by Subject|5|||
128865105|NCT00847626|463801201|FG010|Overall Study|Withdrawal by Subject|2|||
128865106|NCT00847626|463801191|FG000|Overall Study|Lack of Efficacy|3|||
128865107|NCT00847626|463801192|FG001|Overall Study|Lack of Efficacy|1|||
128865108|NCT00847626|463801193|FG002|Overall Study|Lack of Efficacy|0|||
128865109|NCT00847626|463801194|FG003|Overall Study|Lack of Efficacy|1|||
128865110|NCT00847626|463801195|FG004|Overall Study|Lack of Efficacy|2|||
128865111|NCT00847626|463801196|FG005|Overall Study|Lack of Efficacy|0|||
128865112|NCT00847626|463801197|FG006|Overall Study|Lack of Efficacy|6|||
128865113|NCT00847626|463801198|FG007|Overall Study|Lack of Efficacy|2|||
128865114|NCT00847626|463801199|FG008|Overall Study|Lack of Efficacy|5|||
128865115|NCT00847626|463801200|FG009|Overall Study|Lack of Efficacy|1|||
128865116|NCT00847626|463801201|FG010|Overall Study|Lack of Efficacy|7|||
128865117|NCT00847626|463801191|FG000|Overall Study|Other|1|||
128865118|NCT00847626|463801192|FG001|Overall Study|Other|5|||
128865119|NCT00847626|463801193|FG002|Overall Study|Other|4|||
128865120|NCT00847626|463801194|FG003|Overall Study|Other|1|||
128865121|NCT00847626|463801195|FG004|Overall Study|Other|2|||
128865122|NCT00847626|463801196|FG005|Overall Study|Other|2|||
128865123|NCT00847626|463801197|FG006|Overall Study|Other|2|||
128865124|NCT00847626|463801198|FG007|Overall Study|Other|3|||
128865125|NCT00847626|463801199|FG008|Overall Study|Other|1|||
128865126|NCT00847626|463801200|FG009|Overall Study|Other|1|||
128865127|NCT00847626|463801201|FG010|Overall Study|Other|3|||
128865128|NCT03057847|463801202|FG000|Overall Study|Lost to Follow-up|16|||
128865129|NCT01706705|463801203|FG000|Overall Study|Death|1|||
128865130|NCT01706705|463801203|FG000|Overall Study|Lack of Efficacy|13|||
128865131|NCT01706705|463801203|FG000|Overall Study|Non-clinical|6|||
128865132|NCT04703192|463801204|FG000|Overall Study|Withdrawal by Subject|2|||
128865133|NCT04703192|463801205|FG001|Overall Study|Withdrawal by Subject|0|||
128865134|NCT04703192|463801204|FG000|Overall Study|Death|3|||
128865135|NCT04703192|463801205|FG001|Overall Study|Death|1|||
128865136|NCT04703192|463801204|FG000|Overall Study|Adverse Event|13|||
128865137|NCT04703192|463801205|FG001|Overall Study|Adverse Event|2|||
128865138|NCT04703192|463801204|FG000|Overall Study|Progressive or Relapsed Disease|46|||
128865139|NCT04703192|463801205|FG001|Overall Study|Progressive or Relapsed Disease|7|||
128865140|NCT04703192|463801204|FG000|Overall Study|Clinical Progression|19|||
128865141|NCT04703192|463801205|FG001|Overall Study|Clinical Progression|8|||
128865142|NCT04703192|463801204|FG000|Overall Study|Lost to Follow-up|1|||
128865143|NCT04703192|463801205|FG001|Overall Study|Lost to Follow-up|0|||
128865144|NCT04703192|463801204|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
128865145|NCT04703192|463801205|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
128865146|NCT04703192|463801204|FG000|Overall Study|Other|5|||
128865147|NCT04703192|463801205|FG001|Overall Study|Other|1|||
128865148|NCT05627258|463801206|FG000|Overall Study|Lost to Follow-up|1|||
128865149|NCT05627258|463801207|FG001|Overall Study|Lost to Follow-up|0|||
128865150|NCT05627258|463801208|FG002|Overall Study|Lost to Follow-up|0|||
128865151|NCT05627258|463801209|FG003|Overall Study|Lost to Follow-up|0|||
128865152|NCT05627258|463801210|FG004|Overall Study|Lost to Follow-up|0|||
128865153|NCT05627258|463801211|FG005|Overall Study|Lost to Follow-up|0|||
128865154|NCT05627258|463801206|FG000|Overall Study|Withdrawal by Subject|0|||
128865155|NCT05627258|463801207|FG001|Overall Study|Withdrawal by Subject|0|||
128865156|NCT05627258|463801208|FG002|Overall Study|Withdrawal by Subject|0|||
128865157|NCT05627258|463801209|FG003|Overall Study|Withdrawal by Subject|0|||
128865158|NCT05627258|463801210|FG004|Overall Study|Withdrawal by Subject|2|||
128865159|NCT05627258|463801211|FG005|Overall Study|Withdrawal by Subject|0|||
128865160|NCT05627258|463801206|FG000|Overall Study|Enrolled, but product not administered|1|||
128865161|NCT05627258|463801207|FG001|Overall Study|Enrolled, but product not administered|0|||
128865162|NCT05627258|463801208|FG002|Overall Study|Enrolled, but product not administered|0|||
128865163|NCT05627258|463801209|FG003|Overall Study|Enrolled, but product not administered|0|||
128865164|NCT05627258|463801210|FG004|Overall Study|Enrolled, but product not administered|0|||
128865165|NCT05627258|463801211|FG005|Overall Study|Enrolled, but product not administered|0|||
128865166|NCT05627258|463801206|FG000|Overall Study|Other subject illness/injury|1|||
128865167|NCT05627258|463801207|FG001|Overall Study|Other subject illness/injury|0|||
128865168|NCT05627258|463801208|FG002|Overall Study|Other subject illness/injury|0|||
128865169|NCT05627258|463801209|FG003|Overall Study|Other subject illness/injury|0|||
128865170|NCT05627258|463801210|FG004|Overall Study|Other subject illness/injury|0|||
128865171|NCT05627258|463801211|FG005|Overall Study|Other subject illness/injury|0|||
128865172|NCT05627258|463801206|FG000|Overall Study|Subject moved from area|0|||
128865173|NCT05627258|463801207|FG001|Overall Study|Subject moved from area|0|||
128865174|NCT05627258|463801208|FG002|Overall Study|Subject moved from area|1|||
128865175|NCT05627258|463801209|FG003|Overall Study|Subject moved from area|0|||
128865176|NCT05627258|463801210|FG004|Overall Study|Subject moved from area|0|||
128865177|NCT05627258|463801211|FG005|Overall Study|Subject moved from area|0|||
128865178|NCT02138786|463801212|FG000|Overall Study|Adverse Event|0|||
128865179|NCT02138786|463801213|FG001|Overall Study|Adverse Event|2|||
128865180|NCT02138786|463801214|FG002|Overall Study|Adverse Event|1|||
128865181|NCT02138786|463801212|FG000|Overall Study|Death|1|||
128865182|NCT02138786|463801213|FG001|Overall Study|Death|7|||
128865183|NCT02138786|463801214|FG002|Overall Study|Death|2|||
128865184|NCT02138786|463801212|FG000|Overall Study|Disease Progression|1|||
128865185|NCT02138786|463801213|FG001|Overall Study|Disease Progression|1|||
128865186|NCT02138786|463801214|FG002|Overall Study|Disease Progression|3|||
128865187|NCT02138786|463801212|FG000|Overall Study|Withdrawal by Subject|1|||
128865188|NCT02138786|463801213|FG001|Overall Study|Withdrawal by Subject|2|||
128865189|NCT02138786|463801214|FG002|Overall Study|Withdrawal by Subject|0|||
128865190|NCT02138786|463801212|FG000|Overall Study|Patient's Wish|0|||
128865191|NCT02138786|463801213|FG001|Overall Study|Patient's Wish|2|||
128865192|NCT02138786|463801214|FG002|Overall Study|Patient's Wish|0|||
128865193|NCT02138786|463801212|FG000|Overall Study|Sponsor Terminated Study|0|||
128865194|NCT02138786|463801213|FG001|Overall Study|Sponsor Terminated Study|1|||
128865195|NCT02138786|463801214|FG002|Overall Study|Sponsor Terminated Study|1|||
128865196|NCT02138786|463801212|FG000|Overall Study|Non-Compliance|0|||
128865197|NCT02138786|463801213|FG001|Overall Study|Non-Compliance|0|||
128865198|NCT02138786|463801214|FG002|Overall Study|Non-Compliance|1|||
128865199|NCT02088957|463801215|FG000|Overall Study|Lack of Efficacy|1|||
128865200|NCT02088957|463801216|FG001|Overall Study|Lack of Efficacy|0|||
128865201|NCT01199068|463801217|FG000|Overall Study|Unacceptable toxicity|0|||
128865202|NCT01199068|463801218|FG001|Overall Study|Unacceptable toxicity|0|||
128865203|NCT01199068|463801219|FG002|Overall Study|Unacceptable toxicity|2|||
128865204|NCT01199068|463801217|FG000|Overall Study|Progressive disease|3|||
128865205|NCT01199068|463801218|FG001|Overall Study|Progressive disease|3|||
128865206|NCT01199068|463801219|FG002|Overall Study|Progressive disease|6|||
128865207|NCT01199068|463801217|FG000|Overall Study|Withdrawal by Subject|0|||
128865208|NCT01199068|463801218|FG001|Overall Study|Withdrawal by Subject|0|||
128865209|NCT01199068|463801219|FG002|Overall Study|Withdrawal by Subject|1|||
128865210|NCT01294397|463801220|FG000|Overall Study|Withdrawal by Subject|1|||
128865211|NCT01294397|463801220|FG000|Overall Study|Administrative Decision|1|||
128865212|NCT00678301|463801221|FG000|Overall Study|Non-compliance with study procedures|0|||
128865213|NCT00678301|463801222|FG001|Overall Study|Non-compliance with study procedures|1|||
128865214|NCT00678301|463801221|FG000|Overall Study|Adverse Event|1|||
128865215|NCT00678301|463801222|FG001|Overall Study|Adverse Event|0|||
128865216|NCT00678301|463801221|FG000|Overall Study|Withdrawal by Subject|4|||
128865217|NCT00678301|463801222|FG001|Overall Study|Withdrawal by Subject|0|||
128865218|NCT00678301|463801221|FG000|Overall Study|Lost to Follow-up|3|||
128865219|NCT00678301|463801222|FG001|Overall Study|Lost to Follow-up|1|||
128865220|NCT02687035|463801224|FG000|Overall Study|Withdrawal by Subject|1|||
128865221|NCT02687035|463801224|FG000|Overall Study|Death|87|||
128865222|NCT02687035|463801224|FG000|Overall Study|Lost to Follow-up|1|||
128865223|NCT02687035|463801224|FG000|Overall Study|Missed Visit|87|||
128865224|NCT02687035|463801224|FG000|Overall Study|Did not receive Study Device|8|||
128865225|NCT00667394|463801225|FG000|Overall Study|Adverse Event|3|||
128865226|NCT00667394|463801226|FG001|Overall Study|Adverse Event|0|||
128865227|NCT00667394|463801225|FG000|Overall Study|Progressive disease|1|||
128865228|NCT00667394|463801226|FG001|Overall Study|Progressive disease|0|||
128865229|NCT04076943|463801228|FG000|Overall Study|Withdrawal by Subject|12|||
128865230|NCT04076943|463801228|FG000|Overall Study|Adverse Event|1|||
128865231|NCT04076943|463801228|FG000|Overall Study|Progressive Disease|2|||
128865232|NCT04076943|463801228|FG000|Overall Study|Death|13|||
128865233|NCT04076943|463801228|FG000|Overall Study|Other than specified|6|||
128865234|NCT02224703|463801234|FG000|Overall Study|Adverse Event|0|||
128865235|NCT02224703|463801235|FG001|Overall Study|Adverse Event|5|||
128865236|NCT02224703|463801236|FG002|Overall Study|Adverse Event|0|||
128865237|NCT02224703|463801234|FG000|Overall Study|Withdrawn by investigator|1|||
128865238|NCT02224703|463801235|FG001|Overall Study|Withdrawn by investigator|0|||
128865239|NCT02224703|463801236|FG002|Overall Study|Withdrawn by investigator|0|||
128865240|NCT02224703|463801234|FG000|Overall Study|Advised by medical monitor|1|||
128865241|NCT02224703|463801235|FG001|Overall Study|Advised by medical monitor|0|||
128865242|NCT02224703|463801236|FG002|Overall Study|Advised by medical monitor|0|||
128865243|NCT02224703|463801234|FG000|Overall Study|Withdrawn by parent/guardian|0|||
128865244|NCT02224703|463801235|FG001|Overall Study|Withdrawn by parent/guardian|1|||
128865245|NCT02224703|463801236|FG002|Overall Study|Withdrawn by parent/guardian|0|||
128865246|NCT02224703|463801234|FG000|Overall Study|Lack of Efficacy|1|||
128865247|NCT02224703|463801235|FG001|Overall Study|Lack of Efficacy|0|||
128865248|NCT02224703|463801236|FG002|Overall Study|Lack of Efficacy|0|||
128865249|NCT02922023|463801237|FG000|Overall Study|Lost to Follow-up|2|||
128865250|NCT02922023|463801238|FG001|Overall Study|Lost to Follow-up|0|||
128865251|NCT00659880|463801239|FG000|Overall Study|Lost to Follow-up|5|||
128865252|NCT01886287|463801246|FG000|Overall Study|Radiographic disease progression|1|||
128865253|NCT01886287|463801246|FG000|Overall Study|Clinical progression due to disease|1|||
128865254|NCT03596762|463801247|FG000|Overall Study|Protocol Violation|0|||
128865255|NCT03596762|463801248|FG001|Overall Study|Protocol Violation|0|||
128865256|NCT03596762|463801249|FG002|Overall Study|Protocol Violation|0|||
128865257|NCT03596762|463801250|FG003|Overall Study|Protocol Violation|0|||
128865258|NCT03596762|463801251|FG004|Overall Study|Protocol Violation|1|||
128865259|NCT03596762|463801247|FG000|Overall Study|Adverse Event|2|||
128865260|NCT03596762|463801248|FG001|Overall Study|Adverse Event|0|||
128865261|NCT03596762|463801249|FG002|Overall Study|Adverse Event|1|||
128865262|NCT03596762|463801250|FG003|Overall Study|Adverse Event|0|||
128865263|NCT03596762|463801251|FG004|Overall Study|Adverse Event|5|||
128865264|NCT03596762|463801247|FG000|Overall Study|Withdrawal by Subject|2|||
128865265|NCT03596762|463801248|FG001|Overall Study|Withdrawal by Subject|1|||
128865266|NCT03596762|463801249|FG002|Overall Study|Withdrawal by Subject|0|||
128865267|NCT03596762|463801250|FG003|Overall Study|Withdrawal by Subject|1|||
128865268|NCT03596762|463801251|FG004|Overall Study|Withdrawal by Subject|1|||
128865269|NCT01031628|463801252|FG000|Overall Study|Study terminated early|0|||
128865270|NCT01031628|463801253|FG001|Overall Study|Study terminated early|1|||
128865271|NCT01031628|463801254|FG002|Overall Study|Study terminated early|3|||
128865272|NCT01031628|463801255|FG003|Overall Study|Study terminated early|0|||
128865273|NCT01263509|463801256|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
128865274|NCT01263509|463801257|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
128865275|NCT01263509|463801258|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
128865276|NCT01263509|463801259|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
128865277|NCT01263509|463801256|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
128865278|NCT01263509|463801257|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
128865279|NCT01263509|463801258|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
128865280|NCT01263509|463801259|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
128865281|NCT01263509|463801256|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
128865282|NCT01263509|463801257|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
128865283|NCT01263509|463801258|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
128865284|NCT01263509|463801259|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
128865285|NCT01263509|463801256|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
128865286|NCT01263509|463801257|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
128865287|NCT01263509|463801258|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128865288|NCT01263509|463801259|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
128865289|NCT01263509|463801256|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
128865290|NCT01263509|463801257|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
128865291|NCT01263509|463801258|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
128865292|NCT01263509|463801259|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
128865293|NCT02990468|463801260|FG000|Phase 2: MTD|Change in treatment|0|||
128865294|NCT02990468|463801261|FG001|Phase 2: MTD|Change in treatment|0|||
128865295|NCT02990468|463801262|FG002|Phase 2: MTD|Change in treatment|1|||
128865296|NCT02593123|463801265|FG000|Overall Study|Physician Decision|2|||
128865297|NCT02593123|463801266|FG001|Overall Study|Physician Decision|1|||
128865298|NCT02593123|463801265|FG000|Overall Study|Relapse|1|||
128865299|NCT02593123|463801266|FG001|Overall Study|Relapse|1|||
128865300|NCT00477490|463801269|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
128865301|NCT00477490|463801270|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
128865302|NCT00477490|463801271|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
128865303|NCT00477490|463801272|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
128865304|NCT00477490|463801273|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
128865305|NCT00477490|463801274|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
128865306|NCT00477490|463801275|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
128865307|NCT00477490|463801276|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
128865308|NCT00477490|463801277|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
128865309|NCT00477490|463801269|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
128865310|NCT00477490|463801270|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
128865311|NCT00477490|463801271|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
128865312|NCT00477490|463801272|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
128865313|NCT00477490|463801273|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
128865314|NCT00477490|463801274|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
128865315|NCT00477490|463801275|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
128865316|NCT00477490|463801276|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
128865317|NCT00477490|463801277|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
128865318|NCT00477490|463801269|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
128865319|NCT00477490|463801270|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
128865320|NCT00477490|463801271|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
128865321|NCT00477490|463801272|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
128865322|NCT00477490|463801273|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
128865323|NCT00477490|463801274|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
128865324|NCT00477490|463801275|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
128865325|NCT00477490|463801276|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
128865326|NCT00477490|463801277|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
128865327|NCT00477490|463801269|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
128865328|NCT00477490|463801270|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
128865329|NCT00477490|463801271|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
128865330|NCT00477490|463801272|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
128865331|NCT00477490|463801273|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
128865332|NCT00477490|463801274|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
128865333|NCT00477490|463801275|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
128865334|NCT00477490|463801276|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
128865335|NCT00477490|463801277|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
128865336|NCT00477490|463801269|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
128865337|NCT00477490|463801270|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
128865338|NCT00477490|463801271|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
128865339|NCT00477490|463801272|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
128865340|NCT00477490|463801273|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
128865341|NCT00477490|463801274|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
128865342|NCT00477490|463801275|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
128865343|NCT00477490|463801276|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
128865344|NCT00477490|463801277|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
128865345|NCT00477490|463801269|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
128865346|NCT00477490|463801270|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
128865347|NCT00477490|463801271|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
128865348|NCT00477490|463801272|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
128865349|NCT00477490|463801273|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
128865350|NCT00477490|463801274|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
128865351|NCT00477490|463801275|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
128865352|NCT00477490|463801276|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
128865353|NCT00477490|463801277|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
128865354|NCT00477490|463801269|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
128865355|NCT00477490|463801270|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
128865356|NCT00477490|463801271|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
128865357|NCT00477490|463801272|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
128865358|NCT00477490|463801273|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
128865359|NCT00477490|463801274|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
128865360|NCT00477490|463801275|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
128865361|NCT00477490|463801276|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
128865362|NCT00477490|463801277|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
128865363|NCT00477490|463801269|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
128865364|NCT00477490|463801270|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
128865365|NCT00477490|463801271|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
128865366|NCT00477490|463801272|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
128865367|NCT00477490|463801273|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
128865368|NCT00477490|463801274|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
128865369|NCT00477490|463801275|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
128865370|NCT00477490|463801276|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
128865371|NCT00477490|463801277|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
128865372|NCT00477490|463801269|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
128865373|NCT00477490|463801270|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
128865374|NCT00477490|463801271|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
128865375|NCT00477490|463801272|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
128865376|NCT00477490|463801273|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
128865377|NCT00477490|463801274|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
128865378|NCT00477490|463801275|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
128865379|NCT00477490|463801276|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
128865380|NCT00477490|463801277|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
128865381|NCT00477490|463801269|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
128865382|NCT00477490|463801270|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
128865383|NCT00477490|463801271|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
128865384|NCT00477490|463801272|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
128865385|NCT00477490|463801273|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
128865386|NCT00477490|463801274|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
128865387|NCT00477490|463801275|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
128865388|NCT00477490|463801276|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
128865389|NCT00477490|463801277|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
128865390|NCT00477490|463801269|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
128865391|NCT00477490|463801270|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
128865392|NCT00477490|463801271|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
128865393|NCT00477490|463801272|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
128865394|NCT00477490|463801273|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
128865395|NCT00477490|463801274|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
128865396|NCT00477490|463801275|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
128865397|NCT00477490|463801276|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
128865398|NCT00477490|463801277|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
128865399|NCT00477490|463801269|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865400|NCT00477490|463801270|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
128865401|NCT00477490|463801271|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865402|NCT00477490|463801272|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865403|NCT00477490|463801273|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865404|NCT00477490|463801274|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865405|NCT00477490|463801275|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865406|NCT00477490|463801276|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865407|NCT00477490|463801277|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
128865408|NCT00477490|463801269|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
128865409|NCT00477490|463801270|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
128865410|NCT00477490|463801271|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
128865411|NCT00477490|463801272|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
128865412|NCT00477490|463801273|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
128865413|NCT00477490|463801274|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
128865414|NCT00477490|463801275|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
128865415|NCT00477490|463801276|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
128865416|NCT00477490|463801277|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
128865417|NCT00477490|463801269|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
128865418|NCT00477490|463801270|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
128865419|NCT00477490|463801271|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
128865420|NCT00477490|463801272|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
128865421|NCT00477490|463801273|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
128865422|NCT00477490|463801274|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
128865423|NCT00477490|463801275|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
128865424|NCT00477490|463801276|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
128865425|NCT00477490|463801277|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
128865426|NCT01427725|463801280|FG000|Overall Study|Lost to Follow-up|17|||
128865427|NCT01427725|463801280|FG000|Overall Study|Protocol Violation|1|||
128865428|NCT01427725|463801280|FG000|Overall Study|Drug not administered|1|||
128865429|NCT01427725|463801280|FG000|Overall Study|Failure to visit|7|||
128865430|NCT01427725|463801280|FG000|Overall Study|Adverse Event|46|||
128865431|NCT01427725|463801280|FG000|Overall Study|Failure to visit after administration|40|||
128865432|NCT01427725|463801280|FG000|Overall Study|Patient's rejection|27|||
128865433|NCT01427725|463801280|FG000|Overall Study|Transfer to a different hospital|17|||
128865434|NCT01427725|463801280|FG000|Overall Study|Lack of Efficacy|8|||
128865435|NCT01427725|463801280|FG000|Overall Study|Death|7|||
128865436|NCT01427725|463801280|FG000|Overall Study|Symptom improvement|6|||
128865437|NCT01427725|463801280|FG000|Overall Study|AE and Patient's rejection|5|||
128865438|NCT01427725|463801280|FG000|Overall Study|Physician Decision|5|||
128865439|NCT01427725|463801280|FG000|Overall Study|Exacerbation of underlying disease|5|||
128865440|NCT01427725|463801280|FG000|Overall Study|Oral feeding difficulty|5|||
128865441|NCT01427725|463801280|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
128865442|NCT01427725|463801280|FG000|Overall Study|Forgetting prescription|1|||
128865443|NCT01427725|463801280|FG000|Overall Study|Other|2|||
128865444|NCT02269423|463801284|FG000|Overall Study|Discontinued due to change in residence|0|||
128865445|NCT02269423|463801285|FG001|Overall Study|Discontinued due to change in residence|1|||
128865446|NCT02269423|463801286|FG002|Overall Study|Discontinued due to change in residence|0|||
128865447|NCT02269423|463801287|FG003|Overall Study|Discontinued due to change in residence|1|||
128865448|NCT01277887|463801289|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
128865449|NCT01277887|463801290|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
128865450|NCT01277887|463801289|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
128865451|NCT01277887|463801290|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
128865452|NCT01277887|463801289|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
128865453|NCT01277887|463801290|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
128865454|NCT00415051|463801291|FG000|Overall Study|Protocol Violation|1|||
128865455|NCT00203268|463801292|FG000|Early Treatment|only treated one headache|2|||
128865456|NCT00203268|463801292|FG000|Early Treatment|Lost to Follow-up|1|||
128865457|NCT00203268|463801292|FG000|Early Treatment|Withdrawal by Subject|1|||
128865458|NCT00600613|463801293|FG000|Overall Study|Protocol Deviation|1|||
128865459|NCT02514551|463801296|FG000|Overall Study|Lost to Follow-up|0|||
128865460|NCT02514551|463801297|FG001|Overall Study|Lost to Follow-up|1|||
128865461|NCT02514551|463801296|FG000|Overall Study|Participant Never Treated|0|||
128865462|NCT02514551|463801297|FG001|Overall Study|Participant Never Treated|2|||
128865463|NCT05415748|463801303|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
128865464|NCT05415748|463801304|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
128865465|NCT05415748|463801305|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
128865466|NCT05415748|463801306|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
128865467|NCT05415748|463801303|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
128865468|NCT05415748|463801304|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
128865469|NCT05415748|463801305|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
128865470|NCT05415748|463801306|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
128865471|NCT02819024|463801308|FG000|Overall Study|Withdrawal by Subject|1|||
128865472|NCT00792948|463801309|FG000|Overall Study|Adverse Event|6|||
128865473|NCT00792948|463801309|FG000|Overall Study|Death|4|||
128865474|NCT00792948|463801309|FG000|Overall Study|Withdrawal by Subject|3|||
128865475|NCT00792948|463801309|FG000|Overall Study|Ineligible|2|||
128865476|NCT00792948|463801309|FG000|Overall Study|Insurance denial - not treated|1|||
128865477|NCT00792948|463801309|FG000|Overall Study|Physician Decision|11|||
128865478|NCT00792948|463801309|FG000|Overall Study|Protocol Violation|1|||
128865479|NCT03832595|463801317|FG000|Overall Study|Death|142|||
128865480|NCT03832595|463801318|FG001|Overall Study|Death|130|||
128865481|NCT03832595|463801317|FG000|Overall Study|Medical management without dialysis|37|||
128865482|NCT03832595|463801318|FG001|Overall Study|Medical management without dialysis|1|||
128865483|NCT03277352|463801319|FG000|Overall Study|Study Terminated By Sponsor|2|||
128865484|NCT03277352|463801319|FG000|Overall Study|Withdrawal by Subject|4|||
128865485|NCT03277352|463801319|FG000|Overall Study|Death|4|||
128865486|NCT03838731|463802529|FG000|Overall Study|Pregnancy|0|||
128865487|NCT03838731|463802530|FG001|Overall Study|Pregnancy|1|||
128865488|NCT03838731|463802529|FG000|Overall Study|Withdrawal of consent|1|||
128865489|NCT03838731|463802530|FG001|Overall Study|Withdrawal of consent|0|||
128865490|NCT01195948|463802536|FG000|Overall Study|Lost to Follow-up|0|||
128865491|NCT01195948|463802537|FG001|Overall Study|Lost to Follow-up|1|||
128865492|NCT01195948|463802538|FG002|Overall Study|Lost to Follow-up|2|||
128865493|NCT00770029|463802539|FG000|Overall Study|Lost to Follow-up|2|||
128865494|NCT00770029|463802540|FG001|Overall Study|Lost to Follow-up|0|||
128865495|NCT00770029|463802539|FG000|Overall Study|Withdrawal by Subject|3|||
128865496|NCT00770029|463802540|FG001|Overall Study|Withdrawal by Subject|3|||
128865497|NCT00770029|463802539|FG000|Overall Study|Adverse Event|1|||
128865498|NCT00770029|463802540|FG001|Overall Study|Adverse Event|0|||
128865499|NCT00895895|463802543|FG000|Period 1|Adverse Event|7|||
128865500|NCT00895895|463802544|FG001|Period 1|Adverse Event|6|||
128865501|NCT00895895|463802545|FG002|Period 1|Adverse Event|4|||
128865502|NCT00895895|463802546|FG003|Period 1|Adverse Event|6|||
128865503|NCT00895895|463802547|FG004|Period 1|Adverse Event|7|||
128865504|NCT00895895|463802543|FG000|Period 1|Death|0|||
128865505|NCT00895895|463802544|FG001|Period 1|Death|0|||
128865506|NCT00895895|463802545|FG002|Period 1|Death|0|||
128865507|NCT00895895|463802546|FG003|Period 1|Death|0|||
128865508|NCT00895895|463802547|FG004|Period 1|Death|1|||
128865509|NCT00895895|463802543|FG000|Period 1|discontinued by sponsor|2|||
128865510|NCT00895895|463802544|FG001|Period 1|discontinued by sponsor|1|||
128865511|NCT00895895|463802545|FG002|Period 1|discontinued by sponsor|2|||
128865512|NCT00895895|463802546|FG003|Period 1|discontinued by sponsor|1|||
128865513|NCT00895895|463802547|FG004|Period 1|discontinued by sponsor|1|||
128865514|NCT00895895|463802543|FG000|Period 1|failed to return|0|||
128865515|NCT00895895|463802544|FG001|Period 1|failed to return|0|||
128865516|NCT00895895|463802545|FG002|Period 1|failed to return|1|||
128865517|NCT00895895|463802546|FG003|Period 1|failed to return|0|||
128865518|NCT00895895|463802547|FG004|Period 1|failed to return|1|||
128865519|NCT00895895|463802543|FG000|Period 1|investigator request|0|||
128865520|NCT00895895|463802544|FG001|Period 1|investigator request|1|||
128865521|NCT00895895|463802545|FG002|Period 1|investigator request|0|||
128865522|NCT00895895|463802546|FG003|Period 1|investigator request|0|||
128865523|NCT00895895|463802547|FG004|Period 1|investigator request|0|||
128865524|NCT00895895|463802543|FG000|Period 1|Lost to Follow-up|2|||
128865525|NCT00895895|463802544|FG001|Period 1|Lost to Follow-up|1|||
128865526|NCT00895895|463802545|FG002|Period 1|Lost to Follow-up|3|||
128865527|NCT00895895|463802546|FG003|Period 1|Lost to Follow-up|2|||
128865528|NCT00895895|463802547|FG004|Period 1|Lost to Follow-up|3|||
128865529|NCT00895895|463802543|FG000|Period 1|Other|1|||
128865530|NCT00895895|463802544|FG001|Period 1|Other|2|||
128865531|NCT00895895|463802545|FG002|Period 1|Other|1|||
128865532|NCT00895895|463802546|FG003|Period 1|Other|1|||
128865533|NCT00895895|463802547|FG004|Period 1|Other|1|||
128865534|NCT00895895|463802543|FG000|Period 1|Protocol Violation|0|||
128865535|NCT00895895|463802544|FG001|Period 1|Protocol Violation|1|||
128865536|NCT00895895|463802545|FG002|Period 1|Protocol Violation|0|||
128865537|NCT00895895|463802546|FG003|Period 1|Protocol Violation|0|||
128865538|NCT00895895|463802547|FG004|Period 1|Protocol Violation|0|||
128865539|NCT00895895|463802543|FG000|Period 1|Withdrawal by Subject|6|||
128865540|NCT00895895|463802544|FG001|Period 1|Withdrawal by Subject|6|||
128865541|NCT00895895|463802545|FG002|Period 1|Withdrawal by Subject|8|||
128865542|NCT00895895|463802546|FG003|Period 1|Withdrawal by Subject|2|||
128865543|NCT00895895|463802547|FG004|Period 1|Withdrawal by Subject|4|||
128865544|NCT00895895|463802543|FG000|Period 1|unsatisfactory response-efficacy|2|||
128865545|NCT00895895|463802544|FG001|Period 1|unsatisfactory response-efficacy|0|||
128865546|NCT00895895|463802545|FG002|Period 1|unsatisfactory response-efficacy|0|||
128865547|NCT00895895|463802546|FG003|Period 1|unsatisfactory response-efficacy|0|||
128865548|NCT00895895|463802547|FG004|Period 1|unsatisfactory response-efficacy|0|||
128865549|NCT00895895|463802543|FG000|Period 1|randomized and not treated|1|||
128865550|NCT00895895|463802544|FG001|Period 1|randomized and not treated|3|||
128865551|NCT00895895|463802545|FG002|Period 1|randomized and not treated|1|||
128865552|NCT00895895|463802546|FG003|Period 1|randomized and not treated|1|||
128865553|NCT00895895|463802547|FG004|Period 1|randomized and not treated|2|||
128865554|NCT00895895|463802543|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
128865555|NCT00895895|463802544|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
128865556|NCT00895895|463802545|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
128865557|NCT00895895|463802546|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
128865558|NCT00895895|463802547|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
128865559|NCT00895895|463802543|FG000|After Period 1, Prior to Period 2|Other|0|||
128865560|NCT00895895|463802544|FG001|After Period 1, Prior to Period 2|Other|0|||
128865561|NCT00895895|463802545|FG002|After Period 1, Prior to Period 2|Other|1|||
128865562|NCT00895895|463802546|FG003|After Period 1, Prior to Period 2|Other|0|||
128865563|NCT00895895|463802547|FG004|After Period 1, Prior to Period 2|Other|0|||
128865564|NCT00895895|463802543|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
128865565|NCT00895895|463802544|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
128865566|NCT00895895|463802545|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
128865567|NCT00895895|463802546|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
128865568|NCT00895895|463802547|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
128865569|NCT00895895|463802543|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
128865570|NCT00895895|463802544|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
128865571|NCT00895895|463802545|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
128865572|NCT00895895|463802546|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
128865573|NCT00895895|463802547|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
128865574|NCT00895895|463802543|FG000|Period 2|Adverse Event|3|||
128865575|NCT00895895|463802544|FG001|Period 2|Adverse Event|3|||
128865576|NCT00895895|463802545|FG002|Period 2|Adverse Event|5|||
128865577|NCT00895895|463802546|FG003|Period 2|Adverse Event|2|||
128865578|NCT00895895|463802547|FG004|Period 2|Adverse Event|5|||
128865579|NCT00895895|463802543|FG000|Period 2|Death|0|||
128865580|NCT00895895|463802544|FG001|Period 2|Death|0|||
128865581|NCT00895895|463802545|FG002|Period 2|Death|1|||
128865582|NCT00895895|463802546|FG003|Period 2|Death|0|||
128865583|NCT00895895|463802547|FG004|Period 2|Death|0|||
128865584|NCT00895895|463802543|FG000|Period 2|discontinued by sponsor|44|||
128865585|NCT00895895|463802544|FG001|Period 2|discontinued by sponsor|44|||
128865586|NCT00895895|463802545|FG002|Period 2|discontinued by sponsor|38|||
128865587|NCT00895895|463802546|FG003|Period 2|discontinued by sponsor|46|||
128865588|NCT00895895|463802547|FG004|Period 2|discontinued by sponsor|37|||
128865589|NCT00895895|463802543|FG000|Period 2|failed to return|2|||
128865590|NCT00895895|463802544|FG001|Period 2|failed to return|0|||
128865591|NCT00895895|463802545|FG002|Period 2|failed to return|0|||
128865592|NCT00895895|463802546|FG003|Period 2|failed to return|0|||
128865593|NCT00895895|463802547|FG004|Period 2|failed to return|0|||
128865594|NCT00895895|463802543|FG000|Period 2|investigator request|2|||
128865595|NCT00895895|463802544|FG001|Period 2|investigator request|0|||
128865596|NCT00895895|463802545|FG002|Period 2|investigator request|0|||
128865597|NCT00895895|463802546|FG003|Period 2|investigator request|0|||
128865598|NCT00895895|463802547|FG004|Period 2|investigator request|0|||
128865599|NCT00895895|463802543|FG000|Period 2|Lost to Follow-up|1|||
128865600|NCT00895895|463802544|FG001|Period 2|Lost to Follow-up|2|||
128865601|NCT00895895|463802545|FG002|Period 2|Lost to Follow-up|1|||
128865602|NCT00895895|463802546|FG003|Period 2|Lost to Follow-up|1|||
128865603|NCT00895895|463802547|FG004|Period 2|Lost to Follow-up|0|||
128865604|NCT00895895|463802543|FG000|Period 2|Other|1|||
128865605|NCT00895895|463802544|FG001|Period 2|Other|1|||
128865606|NCT00895895|463802545|FG002|Period 2|Other|3|||
128865607|NCT00895895|463802546|FG003|Period 2|Other|1|||
128865608|NCT00895895|463802547|FG004|Period 2|Other|1|||
128865609|NCT00895895|463802543|FG000|Period 2|Protocol Violation|1|||
128865610|NCT00895895|463802544|FG001|Period 2|Protocol Violation|0|||
128865611|NCT00895895|463802545|FG002|Period 2|Protocol Violation|1|||
128865612|NCT00895895|463802546|FG003|Period 2|Protocol Violation|1|||
128865613|NCT00895895|463802547|FG004|Period 2|Protocol Violation|1|||
128865614|NCT00895895|463802543|FG000|Period 2|Withdrawal by Subject|0|||
128865615|NCT00895895|463802544|FG001|Period 2|Withdrawal by Subject|2|||
128865616|NCT00895895|463802545|FG002|Period 2|Withdrawal by Subject|0|||
128865617|NCT00895895|463802546|FG003|Period 2|Withdrawal by Subject|3|||
128865618|NCT00895895|463802547|FG004|Period 2|Withdrawal by Subject|5|||
128865619|NCT00895895|463802543|FG000|Period 2|unsatisfactory response-efficacy|2|||
128865620|NCT00895895|463802544|FG001|Period 2|unsatisfactory response-efficacy|1|||
128865621|NCT00895895|463802545|FG002|Period 2|unsatisfactory response-efficacy|0|||
128865622|NCT00895895|463802546|FG003|Period 2|unsatisfactory response-efficacy|0|||
128865623|NCT00895895|463802547|FG004|Period 2|unsatisfactory response-efficacy|0|||
128865624|NCT01261000|463802548|FG000|Overall Study|Screen failure|1|||
128865625|NCT00504777|463802549|FG000|Overall Study|Adverse Event|1|||
128865626|NCT00669877|463802550|FG000|Overall Study|Disease Progression/Death|4|||
128865627|NCT01374568|463802553|FG000|Overall Study|Lab unable to analyze BTM|0|||
128865628|NCT01374568|463802554|FG001|Overall Study|Lab unable to analyze BTM|2|||
128865629|NCT01912404|463802555|FG000|Overall Study|Due to personal reasons|1|||
128865630|NCT01912404|463802556|FG001|Overall Study|Due to personal reasons|0|||
128865631|NCT00820170|463802558|FG000|Overall Study|Adverse Event|0|||
128865632|NCT00820170|463802559|FG001|Overall Study|Adverse Event|0|||
128865633|NCT00820170|463802560|FG002|Overall Study|Adverse Event|0|||
128865634|NCT00820170|463802561|FG003|Overall Study|Adverse Event|0|||
128865635|NCT00820170|463802562|FG004|Overall Study|Adverse Event|2|||
128865636|NCT00820170|463802558|FG000|Overall Study|Progressive Disease|0|||
128865637|NCT00820170|463802559|FG001|Overall Study|Progressive Disease|0|||
128865638|NCT00820170|463802560|FG002|Overall Study|Progressive Disease|0|||
128865639|NCT00820170|463802561|FG003|Overall Study|Progressive Disease|0|||
128865640|NCT00820170|463802562|FG004|Overall Study|Progressive Disease|2|||
128865641|NCT03538938|463802563|FG000|Overall Study|Death|0|||
128865642|NCT03538938|463802564|FG001|Overall Study|Death|0|||
128865643|NCT03538938|463802565|FG002|Overall Study|Death|2|||
128865644|NCT03538938|463802566|FG003|Overall Study|Death|0|||
128865645|NCT03538938|463802567|FG004|Overall Study|Death|0|||
128865646|NCT03538938|463802568|FG005|Overall Study|Death|1|||
128865647|NCT03538938|463802569|FG006|Overall Study|Death|0|||
128865648|NCT03538938|463802570|FG007|Overall Study|Death|1|||
128865649|NCT03538938|463802571|FG008|Overall Study|Death|1|||
128865650|NCT03538938|463802572|FG009|Overall Study|Death|1|||
128865651|NCT03538938|463802573|FG010|Overall Study|Death|0|||
128865652|NCT03538938|463802574|FG011|Overall Study|Death|0|||
128865653|NCT03538938|463802575|FG012|Overall Study|Death|1|||
128865654|NCT03538938|463802576|FG013|Overall Study|Death|1|||
128865655|NCT03538938|463802577|FG014|Overall Study|Death|0|||
128865656|NCT03538938|463802578|FG015|Overall Study|Death|1|||
128865657|NCT03538938|463802563|FG000|Overall Study|Withdrawal by Subject|4|||
128865658|NCT03538938|463802564|FG001|Overall Study|Withdrawal by Subject|6|||
128865659|NCT03538938|463802565|FG002|Overall Study|Withdrawal by Subject|5|||
128865660|NCT03538938|463802566|FG003|Overall Study|Withdrawal by Subject|3|||
128865661|NCT03538938|463802567|FG004|Overall Study|Withdrawal by Subject|0|||
128865662|NCT03538938|463802568|FG005|Overall Study|Withdrawal by Subject|0|||
128865663|NCT03538938|463802569|FG006|Overall Study|Withdrawal by Subject|3|||
128865664|NCT03538938|463802570|FG007|Overall Study|Withdrawal by Subject|1|||
128865665|NCT03538938|463802571|FG008|Overall Study|Withdrawal by Subject|5|||
128865666|NCT03538938|463802572|FG009|Overall Study|Withdrawal by Subject|1|||
128865667|NCT03538938|463802573|FG010|Overall Study|Withdrawal by Subject|2|||
128865668|NCT03538938|463802574|FG011|Overall Study|Withdrawal by Subject|1|||
128865669|NCT03538938|463802575|FG012|Overall Study|Withdrawal by Subject|3|||
128865670|NCT03538938|463802576|FG013|Overall Study|Withdrawal by Subject|0|||
128865671|NCT03538938|463802577|FG014|Overall Study|Withdrawal by Subject|2|||
128865672|NCT03538938|463802578|FG015|Overall Study|Withdrawal by Subject|4|||
128865673|NCT03538938|463802563|FG000|Overall Study|Incarcerated|0|||
128865674|NCT03538938|463802564|FG001|Overall Study|Incarcerated|0|||
128865675|NCT03538938|463802565|FG002|Overall Study|Incarcerated|0|||
128865676|NCT03538938|463802566|FG003|Overall Study|Incarcerated|0|||
128865677|NCT03538938|463802567|FG004|Overall Study|Incarcerated|0|||
128865678|NCT03538938|463802568|FG005|Overall Study|Incarcerated|0|||
128865679|NCT03538938|463802569|FG006|Overall Study|Incarcerated|0|||
128865680|NCT03538938|463802570|FG007|Overall Study|Incarcerated|0|||
128865681|NCT03538938|463802571|FG008|Overall Study|Incarcerated|0|||
128865682|NCT03538938|463802572|FG009|Overall Study|Incarcerated|0|||
128865683|NCT03538938|463802573|FG010|Overall Study|Incarcerated|0|||
128865684|NCT03538938|463802574|FG011|Overall Study|Incarcerated|1|||
128865685|NCT03538938|463802575|FG012|Overall Study|Incarcerated|0|||
128865686|NCT03538938|463802576|FG013|Overall Study|Incarcerated|0|||
128865687|NCT03538938|463802577|FG014|Overall Study|Incarcerated|0|||
128865688|NCT03538938|463802578|FG015|Overall Study|Incarcerated|0|||
128865689|NCT03995316|463802579|FG000|Overall Study|Lost to Follow-up|10|||
128865690|NCT03995316|463802580|FG001|Overall Study|Lost to Follow-up|3|||
128865691|NCT01361594|463802581|FG000|Overall Study|Withdrawal by Subject|1|||
128865692|NCT01361594|463802582|FG001|Overall Study|Withdrawal by Subject|2|||
128865693|NCT00780559|463802586|FG000|Overall Study|Lost to Follow-up|2|||
128865694|NCT00780559|463802587|FG001|Overall Study|Lost to Follow-up|7|||
128865695|NCT00780559|463802586|FG000|Overall Study|Death|1|||
128865696|NCT00780559|463802587|FG001|Overall Study|Death|0|||
128865697|NCT01518153|463802590|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
128865698|NCT01518153|463802591|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
128865699|NCT01518153|463802592|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
128865700|NCT01518153|463802590|FG000|Stem Cell Transplant|Death|2|||
128865701|NCT01518153|463802591|FG001|Stem Cell Transplant|Death|0|||
128865702|NCT01518153|463802592|FG002|Stem Cell Transplant|Death|0|||
128865703|NCT01518153|463802590|FG000|Stem Cell Transplant|Secondary graft failure|1|||
128865704|NCT01518153|463802591|FG001|Stem Cell Transplant|Secondary graft failure|0|||
128865705|NCT01518153|463802592|FG002|Stem Cell Transplant|Secondary graft failure|0|||
128865706|NCT01518153|463802590|FG000|Stem Cell Transplant|Adverse Event|1|||
128865707|NCT01518153|463802591|FG001|Stem Cell Transplant|Adverse Event|0|||
128865708|NCT01518153|463802592|FG002|Stem Cell Transplant|Adverse Event|0|||
128865709|NCT01518153|463802590|FG000|Donor Lymphocyte Infusion|Death|0|||
128865710|NCT01518153|463802591|FG001|Donor Lymphocyte Infusion|Death|2|||
128865711|NCT01518153|463802592|FG002|Donor Lymphocyte Infusion|Death|1|||
128865712|NCT01754753|463802593|FG000|Overall Study|Study close|43|||
128865713|NCT01754753|463802594|FG001|Overall Study|Study close|44|||
128865714|NCT01754753|463802593|FG000|Overall Study|Lost to Follow-up|9|||
128865715|NCT01754753|463802594|FG001|Overall Study|Lost to Follow-up|5|||
128865716|NCT00856245|463802597|FG000|Overall Study|Was not transplanted|5|||
128865717|NCT01250509|463802598|FG000|Overall Study|Lost to Follow-up|5|||
128865718|NCT01250509|463802599|FG001|Overall Study|Lost to Follow-up|2|||
128865719|NCT00839956|463802609|FG000|Overall Study|Adverse Event|2|||
128865720|NCT00839956|463802609|FG000|Overall Study|Lack of Efficacy|6|||
128865721|NCT00839956|463802609|FG000|Overall Study|Physician Decision|1|||
128865722|NCT00839956|463802609|FG000|Overall Study|Withdrawal by Subject|3|||
128865723|NCT02807883|463802612|FG000|Overall Study|Withdrawal by Subject|2|||
128865724|NCT01371708|463802613|FG000|Overall Study|Insufficient clinical response|3|||
128865725|NCT01371708|463802614|FG001|Overall Study|Insufficient clinical response|2|||
128865726|NCT01371708|463802615|FG002|Overall Study|Insufficient clinical response|0|||
128865727|NCT01371708|463802613|FG000|Overall Study|Lost to Follow-up|5|||
128865728|NCT01371708|463802614|FG001|Overall Study|Lost to Follow-up|9|||
128865729|NCT01371708|463802615|FG002|Overall Study|Lost to Follow-up|7|||
128865730|NCT01371708|463802613|FG000|Overall Study|Protocol Violation|2|||
128865731|NCT01371708|463802614|FG001|Overall Study|Protocol Violation|1|||
128865732|NCT01371708|463802615|FG002|Overall Study|Protocol Violation|2|||
128865733|NCT01371708|463802613|FG000|Overall Study|No longer willing to participate|7|||
128865734|NCT01371708|463802614|FG001|Overall Study|No longer willing to participate|7|||
128865735|NCT01371708|463802615|FG002|Overall Study|No longer willing to participate|13|||
128865736|NCT01371708|463802613|FG000|Overall Study|Medication error/not related to AE|0|||
128865737|NCT01371708|463802614|FG001|Overall Study|Medication error/not related to AE|1|||
128865738|NCT01371708|463802615|FG002|Overall Study|Medication error/not related to AE|0|||
128865739|NCT01371708|463802613|FG000|Overall Study|Other|3|||
128865740|NCT01371708|463802614|FG001|Overall Study|Other|2|||
128865741|NCT01371708|463802615|FG002|Overall Study|Other|4|||
128865742|NCT01371708|463802613|FG000|Overall Study|Adverse Event|5|||
128865743|NCT01371708|463802614|FG001|Overall Study|Adverse Event|8|||
128865744|NCT01371708|463802615|FG002|Overall Study|Adverse Event|12|||
128865745|NCT01371708|463802613|FG000|Overall Study|Started but did not receive treatment|1|||
128865746|NCT01371708|463802614|FG001|Overall Study|Started but did not receive treatment|0|||
128865747|NCT01371708|463802615|FG002|Overall Study|Started but did not receive treatment|1|||
128865748|NCT01399918|463802619|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
128865749|NCT03197766|463802624|FG000|Overall Study|Withdrawal by Subject|2|||
128865750|NCT03197766|463802625|FG001|Overall Study|Withdrawal by Subject|0|||
128865751|NCT00972322|463802627|FG000|Overall Study|Adverse Event|2|||
128865752|NCT00972322|463802628|FG001|Overall Study|Adverse Event|1|||
128865753|NCT00972322|463802627|FG000|Overall Study|Positive drug screen|0|||
128865754|NCT00972322|463802628|FG001|Overall Study|Positive drug screen|1|||
128865755|NCT00972322|463802627|FG000|Overall Study|Lost to Follow-up|0|||
128865756|NCT00972322|463802628|FG001|Overall Study|Lost to Follow-up|1|||
128865757|NCT00972322|463802627|FG000|Overall Study|Consistently high glucose values|1|||
128865758|NCT00972322|463802628|FG001|Overall Study|Consistently high glucose values|0|||
128865759|NCT00277095|463802631|FG000|Overall Study|Death|2|||
128865760|NCT00277095|463802631|FG000|Overall Study|Explanted|7|||
128865761|NCT00277095|463802631|FG000|Overall Study|Lost to Follow-up|2|||
128865762|NCT00277095|463802631|FG000|Overall Study|Missed Follow-up|9|||
128865763|NCT00277095|463802631|FG000|Overall Study|Physician Decision|1|||
128865764|NCT05140915|463802633|FG000|Overall Study|Lost to Follow-up|2|||
128865765|NCT05140915|463802634|FG001|Overall Study|Lost to Follow-up|1|||
128865766|NCT04520659|463802635|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
128865767|NCT04520659|463802636|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
128865768|NCT04520659|463802637|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
128865769|NCT04520659|463802638|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
128865770|NCT03361865|463802643|FG000|Overall Study|Death|17|||
128865771|NCT03361865|463802644|FG001|Overall Study|Death|18|||
128865772|NCT03361865|463802643|FG000|Overall Study|Physician Decision|1|||
128865773|NCT03361865|463802644|FG001|Overall Study|Physician Decision|9|||
128865774|NCT03361865|463802643|FG000|Overall Study|Withdrawal by Subject|1|||
128865775|NCT03361865|463802644|FG001|Overall Study|Withdrawal by Subject|0|||
128865776|NCT03852719|463802645|FG000|Overall Study|Withdrawal of consent|8|||
128865777|NCT03852719|463802646|FG001|Overall Study|Withdrawal of consent|8|||
128865778|NCT03852719|463802647|FG002|Overall Study|Withdrawal of consent|9|||
128865779|NCT03852719|463802645|FG000|Overall Study|Physician Decision|5|||
128865780|NCT03852719|463802646|FG001|Overall Study|Physician Decision|4|||
128865781|NCT03852719|463802647|FG002|Overall Study|Physician Decision|1|||
128865782|NCT03852719|463802645|FG000|Overall Study|Pregnancy|2|||
128865783|NCT03852719|463802646|FG001|Overall Study|Pregnancy|1|||
128865784|NCT03852719|463802647|FG002|Overall Study|Pregnancy|0|||
128865785|NCT03852719|463802645|FG000|Overall Study|Death|1|||
128865786|NCT03852719|463802646|FG001|Overall Study|Death|0|||
128865787|NCT03852719|463802647|FG002|Overall Study|Death|0|||
128865788|NCT03852719|463802645|FG000|Overall Study|Reason not Specified|3|||
128865789|NCT03852719|463802646|FG001|Overall Study|Reason not Specified|3|||
128865790|NCT03852719|463802647|FG002|Overall Study|Reason not Specified|5|||
128865791|NCT03852719|463802645|FG000|Overall Study|Adverse Event|2|||
128865792|NCT03852719|463802646|FG001|Overall Study|Adverse Event|1|||
128865793|NCT03852719|463802647|FG002|Overall Study|Adverse Event|4|||
128865794|NCT03852719|463802645|FG000|Overall Study|Progressive disease|1|||
128865795|NCT03852719|463802646|FG001|Overall Study|Progressive disease|4|||
128865796|NCT03852719|463802647|FG002|Overall Study|Progressive disease|1|||
128865797|NCT03852719|463802645|FG000|Overall Study|Lost to Follow-up|1|||
128865798|NCT03852719|463802646|FG001|Overall Study|Lost to Follow-up|0|||
128865799|NCT03852719|463802647|FG002|Overall Study|Lost to Follow-up|0|||
128865800|NCT05543187|463802648|FG000|Overall Study|Ongoing|3|||
128865801|NCT05543187|463802649|FG001|Overall Study|Ongoing|2|||
128865802|NCT04777864|463802650|FG000|Overall Study|Lost to Follow-up|8|||
128865803|NCT04777864|463802651|FG001|Overall Study|Lost to Follow-up|19|||
128865804|NCT03086655|463802652|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
128865805|NCT03086655|463802653|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
128865806|NCT03086655|463802652|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
128865807|NCT03086655|463802653|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
128865808|NCT03086655|463802652|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
128865809|NCT03086655|463802653|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
128865810|NCT03086655|463802652|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
128865811|NCT03086655|463802653|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
128865812|NCT03086655|463802652|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
128865813|NCT03086655|463802653|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
128865814|NCT03086655|463802652|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
128865815|NCT03086655|463802653|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
128865816|NCT03086655|463802652|FG000|12 Month Follow-up = Final Assessment|Death|0|||
128865817|NCT03086655|463802653|FG001|12 Month Follow-up = Final Assessment|Death|1|||
128865818|NCT03633799|463802661|FG000|Overall Study|Adverse Event|349|||
128865819|NCT03633799|463802661|FG000|Overall Study|Withdrawal by Subject|288|||
128865820|NCT03633799|463802661|FG000|Overall Study|Lost to Follow-up|97|||
128865821|NCT03633799|463802661|FG000|Overall Study|Physician Decision|9|||
128865822|NCT03633799|463802661|FG000|Overall Study|Protocol Violation|4|||
128865823|NCT03633799|463802661|FG000|Overall Study|Pregnancy|20|||
128865824|NCT03633799|463802661|FG000|Overall Study|other|39|||
128865825|NCT03633799|463802661|FG000|Overall Study|ongoing within third year of study|106|||
128865826|NCT03633799|463802661|FG000|Overall Study|unsuccessful study drug placement|19|||
128865827|NCT02998476|463802662|FG000|Overall Study|Lost to Follow-up|1|||
128865828|NCT02998476|463802663|FG001|Overall Study|Lost to Follow-up|0|||
128865829|NCT02998476|463802662|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
128865830|NCT02998476|463802663|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
128865831|NCT02998476|463802662|FG000|Overall Study|Withdrawal by Subject|1|||
128865832|NCT02998476|463802663|FG001|Overall Study|Withdrawal by Subject|2|||
128865833|NCT02998476|463802662|FG000|Overall Study|Death|45|||
128865834|NCT02998476|463802663|FG001|Overall Study|Death|2|||
128865835|NCT02998476|463802662|FG000|Overall Study|Other|6|||
128865836|NCT02998476|463802663|FG001|Overall Study|Other|1|||
128865837|NCT02397447|463802664|FG000|Overall Study|Lost to Follow-up|2|||
128865838|NCT02397447|463802665|FG001|Overall Study|Lost to Follow-up|2|||
128865839|NCT01435772|463802666|FG000|Overall Study|Adverse Event|1|||
128865840|NCT01435772|463802667|FG001|Overall Study|Adverse Event|0|||
128865841|NCT01435772|463802668|FG002|Overall Study|Adverse Event|2|||
128865842|NCT01435772|463802666|FG000|Overall Study|Withdrawal by Subject|0|||
128865843|NCT01435772|463802667|FG001|Overall Study|Withdrawal by Subject|1|||
128865844|NCT01435772|463802668|FG002|Overall Study|Withdrawal by Subject|3|||
128865845|NCT01435772|463802666|FG000|Overall Study|Other - study termination|2|||
128865846|NCT01435772|463802667|FG001|Overall Study|Other - study termination|2|||
128865847|NCT01435772|463802668|FG002|Overall Study|Other - study termination|10|||
128865848|NCT03238963|463802669|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
128865849|NCT03238963|463802670|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
128865850|NCT03238963|463802669|FG000|Overall Study|Withdrawal by Subject|1|||
128865851|NCT03238963|463802670|FG001|Overall Study|Withdrawal by Subject|1|||
128865852|NCT03238963|463802669|FG000|Overall Study|Lost to Follow-up|1|||
128865853|NCT03238963|463802670|FG001|Overall Study|Lost to Follow-up|0|||
128865854|NCT03238963|463802669|FG000|Overall Study|Protocol Violation|1|||
128865855|NCT03238963|463802670|FG001|Overall Study|Protocol Violation|1|||
128865856|NCT03238963|463802669|FG000|Overall Study|Adverse Event|1|||
128865857|NCT03238963|463802670|FG001|Overall Study|Adverse Event|0|||
128865858|NCT04942366|463804827|FG000|Overall Study|Withdrawal by Subject|5|||
128865859|NCT04942366|463804828|FG001|Overall Study|Withdrawal by Subject|5|||
128865860|NCT04996004|463804829|FG000|Phase I|Death|1|||
128865861|NCT04996004|463804830|FG001|Phase I|Death|2|||
128865862|NCT04996004|463804831|FG002|Phase I|Death|1|||
128865863|NCT04996004|463804832|FG003|Phase I|Death|0|||
128865864|NCT04996004|463804833|FG004|Phase I|Death|0|||
128865865|NCT04996004|463804834|FG005|Phase I|Death|0|||
128865866|NCT04996004|463804829|FG000|Phase I|Study terminated by sponsor|2|||
128865867|NCT04996004|463804830|FG001|Phase I|Study terminated by sponsor|1|||
128865868|NCT04996004|463804831|FG002|Phase I|Study terminated by sponsor|2|||
128865869|NCT04996004|463804832|FG003|Phase I|Study terminated by sponsor|0|||
128865870|NCT04996004|463804833|FG004|Phase I|Study terminated by sponsor|0|||
128865871|NCT04996004|463804834|FG005|Phase I|Study terminated by sponsor|0|||
128865872|NCT04996004|463804829|FG000|Phase II|Study terminated by sponsor|0|||
128865873|NCT04996004|463804830|FG001|Phase II|Study terminated by sponsor|0|||
128865874|NCT04996004|463804831|FG002|Phase II|Study terminated by sponsor|0|||
128865875|NCT04996004|463804832|FG003|Phase II|Study terminated by sponsor|20|||
128865876|NCT04996004|463804833|FG004|Phase II|Study terminated by sponsor|10|||
128865877|NCT04996004|463804834|FG005|Phase II|Study terminated by sponsor|10|||
128865878|NCT04996004|463804829|FG000|Phase II|Withdrawal by Subject|0|||
128865879|NCT04996004|463804830|FG001|Phase II|Withdrawal by Subject|0|||
128865880|NCT04996004|463804831|FG002|Phase II|Withdrawal by Subject|0|||
128865881|NCT04996004|463804832|FG003|Phase II|Withdrawal by Subject|0|||
128865882|NCT04996004|463804833|FG004|Phase II|Withdrawal by Subject|1|||
128865883|NCT04996004|463804834|FG005|Phase II|Withdrawal by Subject|2|||
128865884|NCT04996004|463804829|FG000|Phase II|Death|0|||
128865885|NCT04996004|463804830|FG001|Phase II|Death|0|||
128865886|NCT04996004|463804831|FG002|Phase II|Death|0|||
128865887|NCT04996004|463804832|FG003|Phase II|Death|12|||
128865888|NCT04996004|463804833|FG004|Phase II|Death|2|||
128865889|NCT04996004|463804834|FG005|Phase II|Death|9|||
128865890|NCT04996004|463804829|FG000|Phase II|Other|0|||
128865891|NCT04996004|463804830|FG001|Phase II|Other|0|||
128865892|NCT04996004|463804831|FG002|Phase II|Other|0|||
128865893|NCT04996004|463804832|FG003|Phase II|Other|0|||
128865894|NCT04996004|463804833|FG004|Phase II|Other|0|||
128865895|NCT04996004|463804834|FG005|Phase II|Other|1|||
128865896|NCT02942277|463804835|FG000|Year 1|Withdrawal by Subject|0|||
128865897|NCT02942277|463804836|FG001|Year 1|Withdrawal by Subject|0|||
128865898|NCT02942277|463804837|FG002|Year 1|Withdrawal by Subject|0|||
128865899|NCT02942277|463804838|FG003|Year 1|Withdrawal by Subject|0|||
128865900|NCT02942277|463804839|FG004|Year 1|Withdrawal by Subject|1|||
128865901|NCT02942277|463804840|FG005|Year 1|Withdrawal by Subject|3|||
128865902|NCT02942277|463804841|FG006|Year 1|Withdrawal by Subject|0|||
128865903|NCT02942277|463804842|FG007|Year 1|Withdrawal by Subject|1|||
128865904|NCT02942277|463804843|FG008|Year 1|Withdrawal by Subject|0|||
128865905|NCT02942277|463804844|FG009|Year 1|Withdrawal by Subject|0|||
128865906|NCT02942277|463804845|FG010|Year 1|Withdrawal by Subject|3|||
128865907|NCT02942277|463804835|FG000|Year 1|Travel|0|||
128865908|NCT02942277|463804836|FG001|Year 1|Travel|1|||
128865909|NCT02942277|463804837|FG002|Year 1|Travel|0|||
128865910|NCT02942277|463804838|FG003|Year 1|Travel|0|||
128865911|NCT02942277|463804839|FG004|Year 1|Travel|4|||
128865912|NCT02942277|463804840|FG005|Year 1|Travel|5|||
128865913|NCT02942277|463804841|FG006|Year 1|Travel|0|||
128865914|NCT02942277|463804842|FG007|Year 1|Travel|0|||
128865915|NCT02942277|463804843|FG008|Year 1|Travel|0|||
128865916|NCT02942277|463804844|FG009|Year 1|Travel|0|||
128865917|NCT02942277|463804845|FG010|Year 1|Travel|8|||
128865918|NCT02942277|463804835|FG000|Year 1|Joined Army|0|||
128865919|NCT02942277|463804836|FG001|Year 1|Joined Army|1|||
128865920|NCT02942277|463804837|FG002|Year 1|Joined Army|0|||
128865921|NCT02942277|463804838|FG003|Year 1|Joined Army|0|||
128865922|NCT02942277|463804839|FG004|Year 1|Joined Army|0|||
128865923|NCT02942277|463804840|FG005|Year 1|Joined Army|0|||
128865924|NCT02942277|463804841|FG006|Year 1|Joined Army|0|||
128865925|NCT02942277|463804842|FG007|Year 1|Joined Army|0|||
128865926|NCT02942277|463804843|FG008|Year 1|Joined Army|0|||
128865927|NCT02942277|463804844|FG009|Year 1|Joined Army|0|||
128865928|NCT02942277|463804845|FG010|Year 1|Joined Army|0|||
128865929|NCT02942277|463804835|FG000|Year 1|Subject met withdrawal criteria|0|||
128865930|NCT02942277|463804836|FG001|Year 1|Subject met withdrawal criteria|0|||
128865931|NCT02942277|463804837|FG002|Year 1|Subject met withdrawal criteria|0|||
128865932|NCT02942277|463804838|FG003|Year 1|Subject met withdrawal criteria|1|||
128865933|NCT02942277|463804839|FG004|Year 1|Subject met withdrawal criteria|0|||
128865934|NCT02942277|463804840|FG005|Year 1|Subject met withdrawal criteria|0|||
128865935|NCT02942277|463804841|FG006|Year 1|Subject met withdrawal criteria|0|||
128865936|NCT02942277|463804842|FG007|Year 1|Subject met withdrawal criteria|0|||
128865937|NCT02942277|463804843|FG008|Year 1|Subject met withdrawal criteria|0|||
128865938|NCT02942277|463804844|FG009|Year 1|Subject met withdrawal criteria|0|||
128865939|NCT02942277|463804845|FG010|Year 1|Subject met withdrawal criteria|0|||
128865940|NCT02942277|463804835|FG000|Year 1|Lost to Follow-up|0|||
128865941|NCT02942277|463804836|FG001|Year 1|Lost to Follow-up|0|||
128865942|NCT02942277|463804837|FG002|Year 1|Lost to Follow-up|0|||
128865943|NCT02942277|463804838|FG003|Year 1|Lost to Follow-up|0|||
128865944|NCT02942277|463804839|FG004|Year 1|Lost to Follow-up|1|||
128865945|NCT02942277|463804840|FG005|Year 1|Lost to Follow-up|0|||
128865946|NCT02942277|463804841|FG006|Year 1|Lost to Follow-up|0|||
128865947|NCT02942277|463804842|FG007|Year 1|Lost to Follow-up|0|||
128865948|NCT02942277|463804843|FG008|Year 1|Lost to Follow-up|0|||
128865949|NCT02942277|463804844|FG009|Year 1|Lost to Follow-up|0|||
128865950|NCT02942277|463804845|FG010|Year 1|Lost to Follow-up|2|||
128865951|NCT02942277|463804835|FG000|Year 1|Protocol Violation|0|||
128865952|NCT02942277|463804836|FG001|Year 1|Protocol Violation|0|||
128865953|NCT02942277|463804837|FG002|Year 1|Protocol Violation|0|||
128865954|NCT02942277|463804838|FG003|Year 1|Protocol Violation|0|||
128865955|NCT02942277|463804839|FG004|Year 1|Protocol Violation|1|||
128865956|NCT02942277|463804840|FG005|Year 1|Protocol Violation|1|||
128865957|NCT02942277|463804841|FG006|Year 1|Protocol Violation|0|||
128865958|NCT02942277|463804842|FG007|Year 1|Protocol Violation|0|||
128865959|NCT02942277|463804843|FG008|Year 1|Protocol Violation|0|||
128865960|NCT02942277|463804844|FG009|Year 1|Protocol Violation|0|||
128865961|NCT02942277|463804845|FG010|Year 1|Protocol Violation|2|||
128865962|NCT02942277|463804835|FG000|Year 1|Pregnancy|0|||
128865963|NCT02942277|463804836|FG001|Year 1|Pregnancy|0|||
128865964|NCT02942277|463804837|FG002|Year 1|Pregnancy|0|||
128865965|NCT02942277|463804838|FG003|Year 1|Pregnancy|0|||
128865966|NCT02942277|463804839|FG004|Year 1|Pregnancy|0|||
128865967|NCT02942277|463804840|FG005|Year 1|Pregnancy|1|||
128865968|NCT02942277|463804841|FG006|Year 1|Pregnancy|0|||
128865969|NCT02942277|463804842|FG007|Year 1|Pregnancy|0|||
128865970|NCT02942277|463804843|FG008|Year 1|Pregnancy|0|||
128865971|NCT02942277|463804844|FG009|Year 1|Pregnancy|0|||
128865972|NCT02942277|463804845|FG010|Year 1|Pregnancy|0|||
128865973|NCT02942277|463804835|FG000|Year 2|Lost to Follow-up|0|||
128865974|NCT02942277|463804836|FG001|Year 2|Lost to Follow-up|0|||
128865975|NCT02942277|463804837|FG002|Year 2|Lost to Follow-up|0|||
128865976|NCT02942277|463804838|FG003|Year 2|Lost to Follow-up|0|||
128865977|NCT02942277|463804839|FG004|Year 2|Lost to Follow-up|2|||
128865978|NCT02942277|463804840|FG005|Year 2|Lost to Follow-up|1|||
128865979|NCT02942277|463804841|FG006|Year 2|Lost to Follow-up|0|||
128865980|NCT02942277|463804842|FG007|Year 2|Lost to Follow-up|0|||
128865981|NCT02942277|463804843|FG008|Year 2|Lost to Follow-up|0|||
128865982|NCT02942277|463804844|FG009|Year 2|Lost to Follow-up|0|||
128865983|NCT02942277|463804845|FG010|Year 2|Lost to Follow-up|0|||
128865984|NCT02942277|463804835|FG000|Year 2|Did not rescreen|0|||
128865985|NCT02942277|463804836|FG001|Year 2|Did not rescreen|0|||
128865986|NCT02942277|463804837|FG002|Year 2|Did not rescreen|1|||
128865987|NCT02942277|463804838|FG003|Year 2|Did not rescreen|1|||
128865988|NCT02942277|463804839|FG004|Year 2|Did not rescreen|9|||
128865989|NCT02942277|463804840|FG005|Year 2|Did not rescreen|6|||
128865990|NCT02942277|463804841|FG006|Year 2|Did not rescreen|0|||
128865991|NCT02942277|463804842|FG007|Year 2|Did not rescreen|1|||
128865992|NCT02942277|463804843|FG008|Year 2|Did not rescreen|0|||
128865993|NCT02942277|463804844|FG009|Year 2|Did not rescreen|0|||
128865994|NCT02942277|463804845|FG010|Year 2|Did not rescreen|21|||
128865995|NCT02942277|463804835|FG000|Year 2|Met withdrawal criteria|0|||
128865996|NCT02942277|463804836|FG001|Year 2|Met withdrawal criteria|0|||
128865997|NCT02942277|463804837|FG002|Year 2|Met withdrawal criteria|0|||
128865998|NCT02942277|463804838|FG003|Year 2|Met withdrawal criteria|0|||
128865999|NCT02942277|463804839|FG004|Year 2|Met withdrawal criteria|1|||
128866000|NCT02942277|463804840|FG005|Year 2|Met withdrawal criteria|2|||
128866001|NCT02942277|463804841|FG006|Year 2|Met withdrawal criteria|0|||
128866002|NCT02942277|463804842|FG007|Year 2|Met withdrawal criteria|0|||
128866003|NCT02942277|463804843|FG008|Year 2|Met withdrawal criteria|0|||
128866004|NCT02942277|463804844|FG009|Year 2|Met withdrawal criteria|0|||
128866005|NCT02942277|463804845|FG010|Year 2|Met withdrawal criteria|1|||
128866006|NCT02942277|463804835|FG000|Year 2|Travel|0|||
128866007|NCT02942277|463804836|FG001|Year 2|Travel|1|||
128866008|NCT02942277|463804837|FG002|Year 2|Travel|0|||
128866009|NCT02942277|463804838|FG003|Year 2|Travel|0|||
128866010|NCT02942277|463804839|FG004|Year 2|Travel|0|||
128866011|NCT02942277|463804840|FG005|Year 2|Travel|1|||
128866012|NCT02942277|463804841|FG006|Year 2|Travel|0|||
128866013|NCT02942277|463804842|FG007|Year 2|Travel|0|||
128866014|NCT02942277|463804843|FG008|Year 2|Travel|0|||
128866015|NCT02942277|463804844|FG009|Year 2|Travel|1|||
128866016|NCT02942277|463804845|FG010|Year 2|Travel|3|||
128866017|NCT02942277|463804835|FG000|Year 2|Non-compliant|0|||
128866018|NCT02942277|463804836|FG001|Year 2|Non-compliant|0|||
128866019|NCT02942277|463804837|FG002|Year 2|Non-compliant|0|||
128866020|NCT02942277|463804838|FG003|Year 2|Non-compliant|0|||
128866021|NCT02942277|463804839|FG004|Year 2|Non-compliant|1|||
128866022|NCT02942277|463804840|FG005|Year 2|Non-compliant|1|||
128866023|NCT02942277|463804841|FG006|Year 2|Non-compliant|0|||
128866024|NCT02942277|463804842|FG007|Year 2|Non-compliant|0|||
128866025|NCT02942277|463804843|FG008|Year 2|Non-compliant|0|||
128866026|NCT02942277|463804844|FG009|Year 2|Non-compliant|0|||
128866027|NCT02942277|463804845|FG010|Year 2|Non-compliant|0|||
128866028|NCT02942277|463804835|FG000|Year 2|Withdrawal by Subject|0|||
128866029|NCT02942277|463804836|FG001|Year 2|Withdrawal by Subject|0|||
128866030|NCT02942277|463804837|FG002|Year 2|Withdrawal by Subject|0|||
128866031|NCT02942277|463804838|FG003|Year 2|Withdrawal by Subject|0|||
128866032|NCT02942277|463804839|FG004|Year 2|Withdrawal by Subject|0|||
128866033|NCT02942277|463804840|FG005|Year 2|Withdrawal by Subject|0|||
128866034|NCT02942277|463804841|FG006|Year 2|Withdrawal by Subject|1|||
128866035|NCT02942277|463804842|FG007|Year 2|Withdrawal by Subject|0|||
128866036|NCT02942277|463804843|FG008|Year 2|Withdrawal by Subject|0|||
128866037|NCT02942277|463804844|FG009|Year 2|Withdrawal by Subject|0|||
128866038|NCT02942277|463804845|FG010|Year 2|Withdrawal by Subject|0|||
128866039|NCT05577715|463804846|FG000|Overall Study|Withdrawal by Subject|1|||
128866040|NCT05577715|463804846|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
128866041|NCT05577715|463804846|FG000|Overall Study|Lost to Follow-up|1|||
128866042|NCT05577715|463804846|FG000|Overall Study|Death|6|||
128866043|NCT03809039|463804852|FG000|Part 1|Withdrawal by Subject|1|||
128866044|NCT03809039|463804853|FG001|Part 1|Withdrawal by Subject|0|||
128866045|NCT03809039|463804854|FG002|Part 1|Withdrawal by Subject|0|||
128866046|NCT03809039|463804855|FG003|Part 1|Withdrawal by Subject|1|||
128866047|NCT03809039|463804856|FG004|Part 1|Withdrawal by Subject|0|||
128866048|NCT03809039|463804857|FG005|Part 1|Withdrawal by Subject|0|||
128866049|NCT03809039|463804858|FG006|Part 1|Withdrawal by Subject|0|||
128866050|NCT03809039|463804859|FG007|Part 1|Withdrawal by Subject|0|||
128866051|NCT03809039|463804860|FG008|Part 1|Withdrawal by Subject|0|||
128866052|NCT03809039|463804852|FG000|Part 3|Withdrawn by study termination|0|||
128866053|NCT03809039|463804853|FG001|Part 3|Withdrawn by study termination|0|||
128866054|NCT03809039|463804854|FG002|Part 3|Withdrawn by study termination|0|||
128866055|NCT03809039|463804855|FG003|Part 3|Withdrawn by study termination|0|||
128866056|NCT03809039|463804856|FG004|Part 3|Withdrawn by study termination|0|||
128866057|NCT03809039|463804857|FG005|Part 3|Withdrawn by study termination|0|||
128866058|NCT03809039|463804858|FG006|Part 3|Withdrawn by study termination|0|||
128866059|NCT03809039|463804859|FG007|Part 3|Withdrawn by study termination|2|||
128866060|NCT03809039|463804860|FG008|Part 3|Withdrawn by study termination|6|||
128866061|NCT01250925|463804863|FG000|Overall Study|Lost to Follow-up|1|||
128866062|NCT01250925|463804864|FG001|Overall Study|Lost to Follow-up|1|||
128866063|NCT01250925|463804865|FG002|Overall Study|Lost to Follow-up|0|||
128866064|NCT01250925|463804863|FG000|Overall Study|Withdrawal by Subject|2|||
128866065|NCT01250925|463804864|FG001|Overall Study|Withdrawal by Subject|0|||
128866066|NCT01250925|463804865|FG002|Overall Study|Withdrawal by Subject|0|||
128866067|NCT01250925|463804863|FG000|Overall Study|Protocol Violation|2|||
128866068|NCT01250925|463804864|FG001|Overall Study|Protocol Violation|0|||
128866069|NCT01250925|463804865|FG002|Overall Study|Protocol Violation|0|||
128866070|NCT01250925|463804863|FG000|Overall Study|Physician Decision|0|||
128866071|NCT01250925|463804864|FG001|Overall Study|Physician Decision|2|||
128866072|NCT01250925|463804865|FG002|Overall Study|Physician Decision|1|||
128866073|NCT01250925|463804863|FG000|Overall Study|Adverse Event|0|||
128866074|NCT01250925|463804864|FG001|Overall Study|Adverse Event|0|||
128866075|NCT01250925|463804865|FG002|Overall Study|Adverse Event|1|||
128866076|NCT03338296|463804866|FG000|Overall Study|Adverse Event|0|||
128866077|NCT03338296|463804867|FG001|Overall Study|Adverse Event|1|||
128866078|NCT03338296|463804866|FG000|Overall Study|Withdrawal by Subject|14|||
128866079|NCT03338296|463804867|FG001|Overall Study|Withdrawal by Subject|13|||
128866080|NCT03338296|463804866|FG000|Overall Study|Lost to Follow-up|10|||
128866081|NCT03338296|463804867|FG001|Overall Study|Lost to Follow-up|10|||
128866082|NCT03338296|463804866|FG000|Overall Study|Study Terminated by Sponsor|77|||
128866083|NCT03338296|463804867|FG001|Overall Study|Study Terminated by Sponsor|76|||
128866084|NCT03338296|463804866|FG000|Overall Study|Other|2|||
128866085|NCT03338296|463804867|FG001|Overall Study|Other|7|||
128866086|NCT03338296|463804866|FG000|Overall Study|Missing|0|||
128866087|NCT03338296|463804867|FG001|Overall Study|Missing|1|||
128866088|NCT04421950|463804868|FG000|Overall Study|Dropped or lost to follow up|4|||
128866089|NCT04421950|463804869|FG001|Overall Study|Dropped or lost to follow up|2|||
128866090|NCT01252355|463804870|FG000|Overall Study|Adverse Event|9|||
128866091|NCT01252355|463804871|FG001|Overall Study|Adverse Event|17|||
128866092|NCT01252355|463804872|FG002|Overall Study|Adverse Event|22|||
128866093|NCT01252355|463804870|FG000|Overall Study|Lack of Efficacy|6|||
128866094|NCT01252355|463804871|FG001|Overall Study|Lack of Efficacy|4|||
128866095|NCT01252355|463804872|FG002|Overall Study|Lack of Efficacy|2|||
128866096|NCT01252355|463804870|FG000|Overall Study|Lost to Follow-up|0|||
128866097|NCT01252355|463804871|FG001|Overall Study|Lost to Follow-up|0|||
128866098|NCT01252355|463804872|FG002|Overall Study|Lost to Follow-up|1|||
128866099|NCT01252355|463804870|FG000|Overall Study|Poor Compliance to Protocol|1|||
128866100|NCT01252355|463804871|FG001|Overall Study|Poor Compliance to Protocol|1|||
128866101|NCT01252355|463804872|FG002|Overall Study|Poor Compliance to Protocol|1|||
128866102|NCT01252355|463804870|FG000|Overall Study|Progressive Disease|2|||
128866103|NCT01252355|463804871|FG001|Overall Study|Progressive Disease|0|||
128866104|NCT01252355|463804872|FG002|Overall Study|Progressive Disease|0|||
128866105|NCT01252355|463804870|FG000|Overall Study|Sponsor Early Termination of Study|149|||
128866106|NCT01252355|463804871|FG001|Overall Study|Sponsor Early Termination of Study|149|||
128866107|NCT01252355|463804872|FG002|Overall Study|Sponsor Early Termination of Study|146|||
128866108|NCT01252355|463804870|FG000|Overall Study|Randomized but not Treated|2|||
128866109|NCT01252355|463804871|FG001|Overall Study|Randomized but not Treated|0|||
128866110|NCT01252355|463804872|FG002|Overall Study|Randomized but not Treated|0|||
128866111|NCT01252355|463804870|FG000|Overall Study|Other Than Above|8|||
128866112|NCT01252355|463804871|FG001|Overall Study|Other Than Above|7|||
128866113|NCT01252355|463804872|FG002|Overall Study|Other Than Above|7|||
128866114|NCT00335140|463804875|FG000|Overall Study|Ineligible|1|||
128866115|NCT04546425|463804876|FG000|Overall Study|Protocol Violation|1|||
128866116|NCT04546425|463804877|FG001|Overall Study|Protocol Violation|1|||
128866117|NCT04546425|463804878|FG002|Overall Study|Protocol Violation|0|||
128866118|NCT04546425|463804879|FG003|Overall Study|Protocol Violation|0|||
128866119|NCT04546425|463804876|FG000|Overall Study|Adverse Event|3|||
128866120|NCT04546425|463804877|FG001|Overall Study|Adverse Event|0|||
128866121|NCT04546425|463804878|FG002|Overall Study|Adverse Event|0|||
128866122|NCT04546425|463804879|FG003|Overall Study|Adverse Event|0|||
128866123|NCT04546425|463804876|FG000|Overall Study|Lost to Follow-up|5|||
128866124|NCT04546425|463804877|FG001|Overall Study|Lost to Follow-up|4|||
128866125|NCT04546425|463804878|FG002|Overall Study|Lost to Follow-up|0|||
128866126|NCT04546425|463804879|FG003|Overall Study|Lost to Follow-up|0|||
128866127|NCT04546425|463804876|FG000|Overall Study|No Longer met eligibility criteria|3|||
128866128|NCT04546425|463804877|FG001|Overall Study|No Longer met eligibility criteria|3|||
128866129|NCT04546425|463804878|FG002|Overall Study|No Longer met eligibility criteria|1|||
128866130|NCT04546425|463804879|FG003|Overall Study|No Longer met eligibility criteria|1|||
128866131|NCT04546425|463804876|FG000|Overall Study|Withdrawal by parent/guardian|6|||
128866132|NCT04546425|463804877|FG001|Overall Study|Withdrawal by parent/guardian|5|||
128866133|NCT04546425|463804878|FG002|Overall Study|Withdrawal by parent/guardian|1|||
128866134|NCT04546425|463804879|FG003|Overall Study|Withdrawal by parent/guardian|1|||
128866135|NCT01725126|463804880|FG000|Overall Study|Protocol Violation|0|||
128866136|NCT01725126|463804881|FG001|Overall Study|Protocol Violation|1|||
128866137|NCT01725126|463804882|FG002|Overall Study|Protocol Violation|0|||
128866138|NCT01725126|463804883|FG003|Overall Study|Protocol Violation|0|||
128866139|NCT01725126|463804884|FG004|Overall Study|Protocol Violation|0|||
128866140|NCT01725126|463804885|FG005|Overall Study|Protocol Violation|0|||
128866141|NCT01725126|463804880|FG000|Overall Study|Withdrawal by Subject|0|||
128866142|NCT01725126|463804881|FG001|Overall Study|Withdrawal by Subject|0|||
128866143|NCT01725126|463804882|FG002|Overall Study|Withdrawal by Subject|0|||
128866144|NCT01725126|463804883|FG003|Overall Study|Withdrawal by Subject|1|||
128866145|NCT01725126|463804884|FG004|Overall Study|Withdrawal by Subject|0|||
128866146|NCT01725126|463804885|FG005|Overall Study|Withdrawal by Subject|0|||
128866147|NCT00677534|463804889|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
128866148|NCT00677534|463804889|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
128866149|NCT00677534|463804889|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
128866150|NCT00863681|463804897|FG000|Overall Study|Other|2|||
128866151|NCT00863681|463804898|FG001|Overall Study|Other|0|||
128866152|NCT00863681|463804899|FG002|Overall Study|Other|0|||
128866153|NCT00863681|463804897|FG000|Overall Study|Missing|1|||
128866154|NCT00863681|463804898|FG001|Overall Study|Missing|0|||
128866155|NCT00863681|463804899|FG002|Overall Study|Missing|0|||
128866156|NCT00863681|463804897|FG000|Overall Study|Death|40|||
128866157|NCT00863681|463804898|FG001|Overall Study|Death|23|||
128866158|NCT00863681|463804899|FG002|Overall Study|Death|6|||
128866159|NCT00863681|463804897|FG000|Overall Study|Withdrawal by Subject|12|||
128866160|NCT00863681|463804898|FG001|Overall Study|Withdrawal by Subject|5|||
128866161|NCT00863681|463804899|FG002|Overall Study|Withdrawal by Subject|2|||
128866162|NCT00863681|463804897|FG000|Overall Study|Protocol Violation|2|||
128866163|NCT00863681|463804898|FG001|Overall Study|Protocol Violation|0|||
128866164|NCT00863681|463804899|FG002|Overall Study|Protocol Violation|0|||
128866165|NCT00863681|463804897|FG000|Overall Study|Lost to Follow-up|3|||
128866166|NCT00863681|463804898|FG001|Overall Study|Lost to Follow-up|0|||
128866167|NCT00863681|463804899|FG002|Overall Study|Lost to Follow-up|3|||
128866168|NCT00863681|463804897|FG000|Overall Study|Adverse Event|28|||
128866169|NCT00863681|463804898|FG001|Overall Study|Adverse Event|10|||
128866170|NCT00863681|463804899|FG002|Overall Study|Adverse Event|6|||
128866171|NCT00863681|463804897|FG000|Overall Study|Lack of Efficacy|2|||
128866172|NCT00863681|463804898|FG001|Overall Study|Lack of Efficacy|2|||
128866173|NCT00863681|463804899|FG002|Overall Study|Lack of Efficacy|1|||
128866174|NCT00863681|463804897|FG000|Overall Study|Non-compliance with study drug|1|||
128866175|NCT00863681|463804898|FG001|Overall Study|Non-compliance with study drug|3|||
128866176|NCT00863681|463804899|FG002|Overall Study|Non-compliance with study drug|0|||
128866177|NCT03031496|463804900|FG000|Period 1|Adverse Event|2|||
128866178|NCT03031496|463804901|FG001|Period 1|Adverse Event|0|||
128866179|NCT03031496|463804900|FG000|Period 1|Withdrawal by Subject|0|||
128866180|NCT03031496|463804901|FG001|Period 1|Withdrawal by Subject|2|||
128866181|NCT02979249|463804903|FG000|Overall Study|Lost to Follow-up|2|||
128866182|NCT02979249|463804903|FG000|Overall Study|Withdrawal by Subject|4|||
128866183|NCT01125046|463804904|FG000|First 6 Months of Treatment|Death|1|||
128866184|NCT01125046|463804904|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
128866185|NCT01125046|463804904|FG000|First 6 Months of Treatment|Non-compliance|1|||
128866186|NCT01125046|463804904|FG000|First 6 Months of Treatment|Surgery|1|||
128866187|NCT01125046|463804904|FG000|First 6 Months of Treatment|Progressive Disease|7|||
128866188|NCT01125046|463804904|FG000|First 6 Months of Treatment|Adverse Event|2|||
128866189|NCT01125046|463804904|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
128866190|NCT01125046|463804904|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
128866191|NCT01125046|463804904|FG000|Follow-up/Data Cut Off Point|Death|29|||
128866192|NCT01125046|463804904|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
128866193|NCT01685229|463804906|FG000|Overall Study|Subjects missing Study Exit form|3|||
128866194|NCT01685229|463804907|FG001|Overall Study|Subjects missing Study Exit form|1|||
128866195|NCT01685229|463804906|FG000|Overall Study|Lost to Follow-up|16|||
128866196|NCT01685229|463804907|FG001|Overall Study|Lost to Follow-up|10|||
128866197|NCT01685229|463804906|FG000|Overall Study|Withdrawal by Subject|6|||
128866198|NCT01685229|463804907|FG001|Overall Study|Withdrawal by Subject|5|||
128866199|NCT01685229|463804906|FG000|Overall Study|Death|1|||
128866200|NCT01685229|463804907|FG001|Overall Study|Death|0|||
128866201|NCT02766777|463804912|FG000|Overall Study|Adverse Event|12|||
128866202|NCT02766777|463804912|FG000|Overall Study|Lost to Follow-up|16|||
128866203|NCT02766777|463804912|FG000|Overall Study|Non-Compliance With Study Drug|1|||
128866204|NCT02766777|463804912|FG000|Overall Study|Protocol Violation|1|||
128866205|NCT02766777|463804912|FG000|Overall Study|Withdrawal by Subject|4|||
128866206|NCT00967005|463804915|FG000|Overall Study|Lost to Follow-up|7|||
128866207|NCT00967005|463804916|FG001|Overall Study|Lost to Follow-up|10|||
128866208|NCT03019640|463804917|FG000|Overall Study|Screen Failures|4|||
128866209|NCT03019640|463804917|FG000|Overall Study|Adverse Event|3|||
128866210|NCT03019640|463804917|FG000|Overall Study|Participant Relapsed|1|||
128866211|NCT01162863|463804918|FG000|Overall Study|Lack of Efficacy|1|||
128866212|NCT01162863|463804919|FG001|Overall Study|Lack of Efficacy|0|||
128866213|NCT01162863|463804920|FG002|Overall Study|Lack of Efficacy|0|||
128866214|NCT01162863|463804918|FG000|Overall Study|Adverse Event|0|||
128866215|NCT01162863|463804919|FG001|Overall Study|Adverse Event|1|||
128866216|NCT01162863|463804920|FG002|Overall Study|Adverse Event|0|||
128866217|NCT00588692|463804921|FG000|Overall Study|Withdrawal by Subject|4|||
128866218|NCT00588692|463804922|FG001|Overall Study|Withdrawal by Subject|2|||
128866219|NCT00588692|463804921|FG000|Overall Study|Hip Surgery|0|||
128866220|NCT00588692|463804922|FG001|Overall Study|Hip Surgery|1|||
128866221|NCT00588692|463804921|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
128866222|NCT00588692|463804922|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
128866223|NCT00588692|463804921|FG000|Overall Study|Cancer|1|||
128866224|NCT00588692|463804922|FG001|Overall Study|Cancer|0|||
128866225|NCT00588692|463804921|FG000|Overall Study|Death|1|||
128866226|NCT00588692|463804922|FG001|Overall Study|Death|0|||
128866227|NCT03552523|463804923|FG000|Overall Study|Withdrawal by Subject|1|||
128866228|NCT03552523|463804924|FG001|Overall Study|Withdrawal by Subject|1|||
128866229|NCT04462289|463804925|FG000|Overall Study|Lost to Follow-up|4|||
128866230|NCT04462289|463804926|FG001|Overall Study|Lost to Follow-up|5|||
128866231|NCT04462289|463804925|FG000|Overall Study|Death|0|||
128866232|NCT04462289|463804926|FG001|Overall Study|Death|3|||
128866233|NCT04462289|463804925|FG000|Overall Study|Withdrawal by Subject|1|||
128866234|NCT04462289|463804926|FG001|Overall Study|Withdrawal by Subject|3|||
128866235|NCT01077518|463804927|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
128866236|NCT01077518|463804928|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
128866237|NCT01077518|463804929|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
128866238|NCT01077518|463804927|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
128866239|NCT01077518|463804928|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
128866240|NCT01077518|463804929|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
128866241|NCT01077518|463804927|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
128866242|NCT01077518|463804928|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
128866243|NCT01077518|463804929|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
128866244|NCT01077518|463804927|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
128866245|NCT01077518|463804928|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
128866246|NCT01077518|463804929|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
128866247|NCT01077518|463804927|FG000|Optional Ofa Phase|Physician Decision|0|||
128866248|NCT01077518|463804928|FG001|Optional Ofa Phase|Physician Decision|0|||
128866249|NCT01077518|463804929|FG002|Optional Ofa Phase|Physician Decision|1|||
128866250|NCT01077518|463804927|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
128866251|NCT01077518|463804928|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
128866252|NCT01077518|463804929|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
128866253|NCT01077518|463804927|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
128866254|NCT01077518|463804928|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
128866255|NCT01077518|463804929|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
128866256|NCT01495598|463804930|FG000|Overall Study|Death during follow up period|2|||
128866257|NCT01495598|463804930|FG000|Overall Study|Death on study|1|||
128866258|NCT01495598|463804930|FG000|Overall Study|Lost to Follow-up|3|||
128866259|NCT01495598|463804930|FG000|Overall Study|Physician Decision|8|||
128866260|NCT05511038|463804934|FG000|Overall|Withdrawal by Subject|5|||
128866261|NCT05511038|463804935|FG001|Overall|Withdrawal by Subject|3|||
128866262|NCT05511038|463804934|FG000|Overall|Screen Failure|20|||
128866263|NCT05511038|463804935|FG001|Overall|Screen Failure|1|||
128866264|NCT05511038|463804934|FG000|Overall|Physician Decision|3|||
128866265|NCT05511038|463804935|FG001|Overall|Physician Decision|0|||
128866266|NCT05511038|463804934|FG000|Overall|Lost to Follow-up|3|||
128866267|NCT05511038|463804935|FG001|Overall|Lost to Follow-up|0|||
128866268|NCT05511038|463804934|FG000|Overall|Death|1|||
128866269|NCT05511038|463804935|FG001|Overall|Death|0|||
128866270|NCT05511038|463804934|FG000|Screening|Withdrawal by Subject|1|||
128866271|NCT05511038|463804935|FG001|Screening|Withdrawal by Subject|0|||
128866272|NCT05511038|463804934|FG000|Screening|Lost to Follow Up (1 participant)|1|||
128866273|NCT05511038|463804935|FG001|Screening|Lost to Follow Up (1 participant)|0|||
128866274|NCT05511038|463804934|FG000|Screening|Screen Failure|3|||
128866275|NCT05511038|463804935|FG001|Screening|Screen Failure|0|||
128866276|NCT05511038|463804934|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
128866277|NCT05511038|463804935|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
128866278|NCT05511038|463804934|FG000|Treatment|Withdrawal by Subject|5|||
128866279|NCT05511038|463804935|FG001|Treatment|Withdrawal by Subject|3|||
128866280|NCT05511038|463804934|FG000|Treatment|Physician Decision|4|||
128866281|NCT05511038|463804935|FG001|Treatment|Physician Decision|0|||
128866282|NCT05511038|463804934|FG000|Treatment|Lost to Follow-up|2|||
128866283|NCT05511038|463804935|FG001|Treatment|Lost to Follow-up|0|||
128866284|NCT05511038|463804934|FG000|Treatment|Death|1|||
128866285|NCT05511038|463804935|FG001|Treatment|Death|0|||
128866286|NCT05511038|463804934|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
128866287|NCT05511038|463804935|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
128866288|NCT05511038|463804934|FG000|Treatment|Refuse by subject|1|||
128866289|NCT05511038|463804935|FG001|Treatment|Refuse by subject|0|||
128866290|NCT05511038|463804934|FG000|Treatment|Subject did not go to the site for visit|1|||
128866291|NCT05511038|463804935|FG001|Treatment|Subject did not go to the site for visit|0|||
128866292|NCT04485611|463804936|FG000|Prehabilitation|Physician Decision|1|||
128866293|NCT04879849|463804937|FG000|Overall Study|Lost to Follow-up|0|||
128866294|NCT04879849|463804938|FG001|Overall Study|Lost to Follow-up|0|||
128866295|NCT04879849|463804939|FG002|Overall Study|Lost to Follow-up|0|||
128866296|NCT04879849|463804940|FG003|Overall Study|Lost to Follow-up|1|||
128866297|NCT04879849|463804941|FG004|Overall Study|Lost to Follow-up|0|||
128866298|NCT04879849|463804942|FG005|Overall Study|Lost to Follow-up|0|||
128866299|NCT04879849|463804943|FG006|Overall Study|Lost to Follow-up|0|||
128866300|NCT04879849|463804944|FG007|Overall Study|Lost to Follow-up|0|||
128866301|NCT04879849|463804937|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
128866302|NCT04879849|463804938|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
128866303|NCT04879849|463804939|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
128866304|NCT04879849|463804940|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
128866305|NCT04879849|463804941|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
128866306|NCT04879849|463804942|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
128866307|NCT04879849|463804943|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
128866308|NCT04879849|463804944|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
128866309|NCT04879849|463804937|FG000|Overall Study|Withdrawal by Subject|0|||
128866310|NCT04879849|463804938|FG001|Overall Study|Withdrawal by Subject|0|||
128866311|NCT04879849|463804939|FG002|Overall Study|Withdrawal by Subject|0|||
128866312|NCT04879849|463804940|FG003|Overall Study|Withdrawal by Subject|0|||
128866313|NCT04879849|463804941|FG004|Overall Study|Withdrawal by Subject|2|||
128866314|NCT04879849|463804942|FG005|Overall Study|Withdrawal by Subject|0|||
128866315|NCT04879849|463804943|FG006|Overall Study|Withdrawal by Subject|1|||
128866316|NCT04879849|463804944|FG007|Overall Study|Withdrawal by Subject|0|||
128866317|NCT04879849|463804937|FG000|Overall Study|Progressive Disease|0|||
128866318|NCT04879849|463804938|FG001|Overall Study|Progressive Disease|0|||
128866319|NCT04879849|463804939|FG002|Overall Study|Progressive Disease|1|||
128866320|NCT04879849|463804940|FG003|Overall Study|Progressive Disease|0|||
128866321|NCT04879849|463804941|FG004|Overall Study|Progressive Disease|0|||
128866322|NCT04879849|463804942|FG005|Overall Study|Progressive Disease|0|||
128866323|NCT04879849|463804943|FG006|Overall Study|Progressive Disease|0|||
128866324|NCT04879849|463804944|FG007|Overall Study|Progressive Disease|0|||
128866325|NCT04879849|463804937|FG000|Overall Study|Death|0|||
128866326|NCT04879849|463804938|FG001|Overall Study|Death|0|||
128866327|NCT04879849|463804939|FG002|Overall Study|Death|1|||
128866328|NCT04879849|463804940|FG003|Overall Study|Death|1|||
128866329|NCT04879849|463804941|FG004|Overall Study|Death|1|||
128866330|NCT04879849|463804942|FG005|Overall Study|Death|2|||
128866331|NCT04879849|463804943|FG006|Overall Study|Death|1|||
128866332|NCT04879849|463804944|FG007|Overall Study|Death|2|||
128866333|NCT04879849|463804937|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
128866334|NCT04879849|463804938|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
128866335|NCT04879849|463804939|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
128866336|NCT04879849|463804940|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
128866337|NCT04879849|463804941|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
128866338|NCT04879849|463804942|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
128866339|NCT04879849|463804943|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
128866340|NCT04879849|463804944|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
128866341|NCT04879849|463804937|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
128866342|NCT04879849|463804938|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
128866343|NCT04879849|463804939|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
128866344|NCT04879849|463804940|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
128866345|NCT04879849|463804941|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
128866346|NCT04879849|463804942|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
128866347|NCT04879849|463804943|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
128866348|NCT04879849|463804944|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
128866349|NCT04879849|463804937|FG000|Overall Study|Reason Not Specified|1|||
128866350|NCT04879849|463804938|FG001|Overall Study|Reason Not Specified|0|||
128866351|NCT04879849|463804939|FG002|Overall Study|Reason Not Specified|0|||
128866352|NCT04879849|463804940|FG003|Overall Study|Reason Not Specified|0|||
128866353|NCT04879849|463804941|FG004|Overall Study|Reason Not Specified|0|||
128866354|NCT04879849|463804942|FG005|Overall Study|Reason Not Specified|0|||
128866355|NCT04879849|463804943|FG006|Overall Study|Reason Not Specified|0|||
128866356|NCT04879849|463804944|FG007|Overall Study|Reason Not Specified|0|||
128866357|NCT03810235|463804947|FG000|Overall Study|Withdrawal by Subject|2|||
128866358|NCT03810235|463804948|FG001|Overall Study|Withdrawal by Subject|0|||
128866359|NCT01647542|463804949|FG000|Overall Study|Major Protocol Deviation|1|||
128866360|NCT01647542|463804950|FG001|Overall Study|Major Protocol Deviation|0|||
128866361|NCT01647542|463804951|FG002|Overall Study|Major Protocol Deviation|0|||
128866362|NCT01647542|463804949|FG000|Overall Study|Adverse Event|4|||
128866363|NCT01647542|463804950|FG001|Overall Study|Adverse Event|5|||
128866364|NCT01647542|463804951|FG002|Overall Study|Adverse Event|4|||
128866365|NCT01647542|463804949|FG000|Overall Study|Lost to Follow-up|0|||
128866366|NCT01647542|463804950|FG001|Overall Study|Lost to Follow-up|2|||
128866367|NCT01647542|463804951|FG002|Overall Study|Lost to Follow-up|2|||
128866368|NCT01647542|463804949|FG000|Overall Study|Withdrawal by Subject|6|||
128866369|NCT01647542|463804950|FG001|Overall Study|Withdrawal by Subject|4|||
128866370|NCT01647542|463804951|FG002|Overall Study|Withdrawal by Subject|0|||
128866371|NCT01647542|463804949|FG000|Overall Study|Study Termination|64|||
128866372|NCT01647542|463804950|FG001|Overall Study|Study Termination|61|||
128866373|NCT01647542|463804951|FG002|Overall Study|Study Termination|65|||
128866374|NCT01647542|463804949|FG000|Overall Study|Lack of Efficacy|1|||
128866375|NCT01647542|463804950|FG001|Overall Study|Lack of Efficacy|1|||
128866376|NCT01647542|463804951|FG002|Overall Study|Lack of Efficacy|0|||
128866377|NCT01647542|463804949|FG000|Overall Study|Death|0|||
128866378|NCT01647542|463804950|FG001|Overall Study|Death|0|||
128866379|NCT01647542|463804951|FG002|Overall Study|Death|1|||
128866380|NCT05576662|463804952|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
128866381|NCT05576662|463804953|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
128866382|NCT05576662|463804952|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
128866383|NCT05576662|463804953|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
128866384|NCT05576662|463804952|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
128866385|NCT05576662|463804953|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
128866386|NCT05576662|463804952|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
128866387|NCT05576662|463804953|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
128866388|NCT03008005|463804954|FG000|Overall Study|Physician Decision|1|||
128866389|NCT03008005|463804955|FG001|Overall Study|Physician Decision|0|||
128866390|NCT03008005|463804956|FG002|Overall Study|Physician Decision|0|||
128866391|NCT03008005|463804954|FG000|Overall Study|Withdrawal by Subject|1|||
128866392|NCT03008005|463804955|FG001|Overall Study|Withdrawal by Subject|0|||
128866393|NCT03008005|463804956|FG002|Overall Study|Withdrawal by Subject|0|||
128866394|NCT03008005|463804954|FG000|Overall Study|Ineligible|0|||
128866395|NCT03008005|463804955|FG001|Overall Study|Ineligible|1|||
128866396|NCT03008005|463804956|FG002|Overall Study|Ineligible|0|||
128866397|NCT01040169|463804969|FG000|Overall Study|Lost to Follow-up|3|||
128866398|NCT01040169|463804970|FG001|Overall Study|Lost to Follow-up|8|||
128866399|NCT00350727|463804971|FG000|Phase I: Dose Escalation|Adverse Event|4|||
128866400|NCT00350727|463804972|FG001|Phase I: Dose Escalation|Adverse Event|0|||
128866401|NCT00350727|463804973|FG002|Phase I: Dose Escalation|Adverse Event|0|||
128866402|NCT00350727|463804971|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
128866403|NCT00350727|463804972|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
128866404|NCT00350727|463804973|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
128866405|NCT00350727|463804971|FG000|Phase I: Dose Escalation|Death|1|||
128866406|NCT00350727|463804972|FG001|Phase I: Dose Escalation|Death|0|||
128866407|NCT00350727|463804973|FG002|Phase I: Dose Escalation|Death|0|||
128866408|NCT00350727|463804971|FG000|Phase I: Dose Escalation|Physician Decision|1|||
128866409|NCT00350727|463804972|FG001|Phase I: Dose Escalation|Physician Decision|0|||
128866410|NCT00350727|463804973|FG002|Phase I: Dose Escalation|Physician Decision|0|||
128866411|NCT00350727|463804971|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
128866412|NCT00350727|463804972|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
128866413|NCT00350727|463804973|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
128866414|NCT00350727|463804971|FG000|Phase II|Disease Progression|0|||
128866415|NCT00350727|463804972|FG001|Phase II|Disease Progression|15|||
128866416|NCT00350727|463804973|FG002|Phase II|Disease Progression|16|||
128866417|NCT00350727|463804971|FG000|Phase II|Clinical Deterioration|0|||
128866418|NCT00350727|463804972|FG001|Phase II|Clinical Deterioration|1|||
128866419|NCT00350727|463804973|FG002|Phase II|Clinical Deterioration|0|||
128866420|NCT00350727|463804971|FG000|Phase II|Withdrawal by Subject|0|||
128866421|NCT00350727|463804972|FG001|Phase II|Withdrawal by Subject|2|||
128866422|NCT00350727|463804973|FG002|Phase II|Withdrawal by Subject|1|||
128866423|NCT00350727|463804971|FG000|Phase II|Adverse Event|0|||
128866424|NCT00350727|463804972|FG001|Phase II|Adverse Event|1|||
128866425|NCT00350727|463804973|FG002|Phase II|Adverse Event|1|||
128866426|NCT00350727|463804971|FG000|Phase II|Death|0|||
128866427|NCT00350727|463804972|FG001|Phase II|Death|0|||
128866428|NCT00350727|463804973|FG002|Phase II|Death|2|||
128866429|NCT00350727|463804971|FG000|Phase II|Sponsor Terminated Study|0|||
128866430|NCT00350727|463804972|FG001|Phase II|Sponsor Terminated Study|0|||
128866431|NCT00350727|463804973|FG002|Phase II|Sponsor Terminated Study|1|||
128866432|NCT00350727|463804971|FG000|Phase II|Enrolled in Rollover Study|0|||
128866433|NCT00350727|463804972|FG001|Phase II|Enrolled in Rollover Study|0|||
128866434|NCT00350727|463804973|FG002|Phase II|Enrolled in Rollover Study|1|||
128866435|NCT03551691|463804974|FG000|Overall Study|Withdrawal by Subject|3|||
128866436|NCT03551691|463804975|FG001|Overall Study|Withdrawal by Subject|3|||
128866437|NCT03520712|463804976|FG000|Overall Study|Early termination of the study by Sponsor|2|||
128866438|NCT05855967|463804977|FG000|Overall Study|Withdrawal by Subject|7|||
128866439|NCT05855967|463804978|FG001|Overall Study|Withdrawal by Subject|5|||
128866440|NCT05855967|463804977|FG000|Overall Study|Lost to Follow-up|2|||
128866441|NCT05855967|463804978|FG001|Overall Study|Lost to Follow-up|1|||
128866442|NCT02446821|463804979|FG000|Overall Study|Adverse Event|28|||
128866443|NCT02446821|463804979|FG000|Overall Study|Withdrawal by Subject|6|||
128866444|NCT02446821|463804979|FG000|Overall Study|Lost to Follow-up|22|||
128866445|NCT02446821|463804979|FG000|Overall Study|other|9|||
128866446|NCT02446821|463804979|FG000|Overall Study|insertion failure|3|||
128866447|NCT02284009|463804981|FG000|Overall Study|Adverse Event|3|||
128866448|NCT02284009|463804982|FG001|Overall Study|Adverse Event|0|||
128866449|NCT02284009|463804981|FG000|Overall Study|Lost to Follow-up|1|||
128866450|NCT02284009|463804982|FG001|Overall Study|Lost to Follow-up|3|||
128866451|NCT02284009|463804981|FG000|Overall Study|Physician Decision|0|||
128866452|NCT02284009|463804982|FG001|Overall Study|Physician Decision|2|||
128866453|NCT02284009|463804981|FG000|Overall Study|Withdrawal by Subject|2|||
128866454|NCT02284009|463804982|FG001|Overall Study|Withdrawal by Subject|5|||
128866455|NCT01876082|463806289|FG000|Overall Study|Withdrawal by Subject|0|||
128866456|NCT01876082|463806290|FG001|Overall Study|Withdrawal by Subject|2|||
128866457|NCT01876082|463806289|FG000|Overall Study|Protocol Violation|1|||
128866458|NCT01876082|463806290|FG001|Overall Study|Protocol Violation|0|||
128866459|NCT01876082|463806289|FG000|Overall Study|Adverse Event|1|||
128866460|NCT01876082|463806290|FG001|Overall Study|Adverse Event|1|||
128866461|NCT01876082|463806289|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
128866462|NCT01876082|463806290|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
128866463|NCT04427280|463806291|FG000|Overall Study|Withdrawal by Subject|0|||
128866464|NCT04427280|463806292|FG001|Overall Study|Withdrawal by Subject|2|||
128866465|NCT05282121|463806293|FG000|Overall Study|Adverse Event|1|||
128866466|NCT05282121|463806294|FG001|Overall Study|Adverse Event|1|||
128866467|NCT05282121|463806295|FG002|Overall Study|Adverse Event|4|||
128866468|NCT05282121|463806296|FG003|Overall Study|Adverse Event|1|||
128866469|NCT05282121|463806293|FG000|Overall Study|Study Terminated by Sponsor|1|||
128866470|NCT05282121|463806294|FG001|Overall Study|Study Terminated by Sponsor|2|||
128866471|NCT05282121|463806295|FG002|Overall Study|Study Terminated by Sponsor|2|||
128866472|NCT05282121|463806296|FG003|Overall Study|Study Terminated by Sponsor|2|||
128866473|NCT05282121|463806293|FG000|Overall Study|Other than listed|0|||
128866474|NCT05282121|463806294|FG001|Overall Study|Other than listed|0|||
128866475|NCT05282121|463806295|FG002|Overall Study|Other than listed|1|||
128866476|NCT05282121|463806296|FG003|Overall Study|Other than listed|0|||
128866477|NCT05282121|463806293|FG000|Overall Study|No reason available|0|||
128866478|NCT05282121|463806294|FG001|Overall Study|No reason available|0|||
128866479|NCT05282121|463806295|FG002|Overall Study|No reason available|1|||
128866480|NCT05282121|463806296|FG003|Overall Study|No reason available|0|||
128866481|NCT01736189|463806297|FG000|Overall Study|Violation of registration criteria|41|||
128866482|NCT01736189|463806297|FG000|Overall Study|Protocol Violation|4|||
128866483|NCT01736189|463806297|FG000|Overall Study|Criteria and protocol violations|1|||
128866484|NCT03301155|463806298|FG000|Overall Study|Сompliance with exclusion criteria|8|||
128866485|NCT03301155|463806299|FG001|Overall Study|Сompliance with exclusion criteria|7|||
128866486|NCT00384189|463806300|FG000|Overall Study|Reason Not Specified|50|||
128866487|NCT00384189|463806301|FG001|Overall Study|Reason Not Specified|57|||
128866488|NCT00384189|463806302|FG002|Overall Study|Reason Not Specified|58|||
128866489|NCT00384189|463806303|FG003|Overall Study|Reason Not Specified|40|||
128866490|NCT00608868|463806304|FG000|Overall Study|Withdrawal by Subject|7|||
128866491|NCT00608868|463806304|FG000|Overall Study|Protocol Violation|3|||
128866492|NCT00608868|463806304|FG000|Overall Study|Lost to Follow-up|2|||
128866493|NCT00608868|463806304|FG000|Overall Study|Adverse Event|1|||
128866494|NCT00608868|463806304|FG000|Overall Study|Physician Decision|2|||
128866495|NCT03868787|463806309|FG000|Overall Study|Withdrawal by Subject|2|||
128866496|NCT03868787|463806310|FG001|Overall Study|Withdrawal by Subject|1|||
128866497|NCT01399697|463806323|FG000|Overall Study|Adverse Event|13|||
128866498|NCT01399697|463806324|FG001|Overall Study|Adverse Event|3|||
128866499|NCT01399697|463806325|FG002|Overall Study|Adverse Event|1|||
128866500|NCT01399697|463806323|FG000|Overall Study|Lost to Follow-up|2|||
128866501|NCT01399697|463806324|FG001|Overall Study|Lost to Follow-up|0|||
128866502|NCT01399697|463806325|FG002|Overall Study|Lost to Follow-up|0|||
128866503|NCT01399697|463806323|FG000|Overall Study|Withdrawal by Subject|8|||
128866504|NCT01399697|463806324|FG001|Overall Study|Withdrawal by Subject|0|||
128866505|NCT01399697|463806325|FG002|Overall Study|Withdrawal by Subject|0|||
128866506|NCT01399697|463806323|FG000|Overall Study|Investigator Decisión|1|||
128866507|NCT01399697|463806324|FG001|Overall Study|Investigator Decisión|0|||
128866508|NCT01399697|463806325|FG002|Overall Study|Investigator Decisión|2|||
128866509|NCT01399697|463806323|FG000|Overall Study|Lack of Efficacy|9|||
128866510|NCT01399697|463806324|FG001|Overall Study|Lack of Efficacy|0|||
128866511|NCT01399697|463806325|FG002|Overall Study|Lack of Efficacy|1|||
128866512|NCT01399697|463806323|FG000|Overall Study|Protocol Violation|2|||
128866513|NCT01399697|463806324|FG001|Overall Study|Protocol Violation|0|||
128866514|NCT01399697|463806325|FG002|Overall Study|Protocol Violation|0|||
128866515|NCT01399697|463806323|FG000|Overall Study|Non-Compliant|1|||
128866516|NCT01399697|463806324|FG001|Overall Study|Non-Compliant|0|||
128866517|NCT01399697|463806325|FG002|Overall Study|Non-Compliant|0|||
128866518|NCT01399697|463806323|FG000|Overall Study|Inclusion Error|2|||
128866519|NCT01399697|463806324|FG001|Overall Study|Inclusion Error|0|||
128866520|NCT01399697|463806325|FG002|Overall Study|Inclusion Error|0|||
128866521|NCT01399697|463806323|FG000|Overall Study|Positive result for hepatitis B|1|||
128866522|NCT01399697|463806324|FG001|Overall Study|Positive result for hepatitis B|0|||
128866523|NCT01399697|463806325|FG002|Overall Study|Positive result for hepatitis B|0|||
128866524|NCT01399697|463806323|FG000|Overall Study|Clinical RA remission|1|||
128866525|NCT01399697|463806324|FG001|Overall Study|Clinical RA remission|0|||
128866526|NCT01399697|463806325|FG002|Overall Study|Clinical RA remission|0|||
128866527|NCT01399697|463806323|FG000|Overall Study|Sponsor Decision|1|||
128866528|NCT01399697|463806324|FG001|Overall Study|Sponsor Decision|0|||
128866529|NCT01399697|463806325|FG002|Overall Study|Sponsor Decision|0|||
128866530|NCT04313608|463806326|FG000|Overall Study|Death|12|||
128866531|NCT04313608|463806327|FG001|Overall Study|Death|3|||
128866532|NCT01371825|463806331|FG000|Overall Study|Death|4|||
128866533|NCT02440425|463806335|FG000|Overall Study|Death likely due to disease progression|1|||
128866534|NCT02440425|463806335|FG000|Overall Study|Withdrawal by Subject|2|||
128866535|NCT02440425|463806335|FG000|Overall Study|Adverse Event|1|||
128866536|NCT02440425|463806335|FG000|Overall Study|Adverse Event/Ineligible|1|||
128866537|NCT01068665|463806336|FG000|Overall Study|Adverse Event|5|||
128866538|NCT01068665|463806337|FG001|Overall Study|Adverse Event|4|||
128866539|NCT01068665|463806336|FG000|Overall Study|Lack of Efficacy|0|||
128866540|NCT01068665|463806337|FG001|Overall Study|Lack of Efficacy|2|||
128866541|NCT01068665|463806336|FG000|Overall Study|Protocol Violation|5|||
128866542|NCT01068665|463806337|FG001|Overall Study|Protocol Violation|2|||
128866543|NCT01068665|463806336|FG000|Overall Study|Withdrawal Criteria|3|||
128866544|NCT01068665|463806337|FG001|Overall Study|Withdrawal Criteria|9|||
128866545|NCT01068665|463806336|FG000|Overall Study|Other|17|||
128866546|NCT01068665|463806337|FG001|Overall Study|Other|12|||
128866547|NCT02807272|463806338|FG000|Overall Study|Death|9|||
128866548|NCT02807272|463806339|FG001|Overall Study|Death|5|||
128866549|NCT02807272|463806340|FG002|Overall Study|Death|2|||
128866550|NCT02807272|463806341|FG003|Overall Study|Death|0|||
128866551|NCT02807272|463806342|FG004|Overall Study|Death|1|||
128866552|NCT02807272|463806338|FG000|Overall Study|Lost to Follow-up|1|||
128866553|NCT02807272|463806339|FG001|Overall Study|Lost to Follow-up|0|||
128866554|NCT02807272|463806340|FG002|Overall Study|Lost to Follow-up|0|||
128866555|NCT02807272|463806341|FG003|Overall Study|Lost to Follow-up|0|||
128866556|NCT02807272|463806342|FG004|Overall Study|Lost to Follow-up|0|||
128866557|NCT02807272|463806338|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
128866558|NCT02807272|463806339|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
128866559|NCT02807272|463806340|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
128866560|NCT02807272|463806341|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
128866561|NCT02807272|463806342|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
128866562|NCT02807272|463806338|FG000|Overall Study|Protocol-defined Disease Progression|0|||
128866563|NCT02807272|463806339|FG001|Overall Study|Protocol-defined Disease Progression|1|||
128866564|NCT02807272|463806340|FG002|Overall Study|Protocol-defined Disease Progression|0|||
128866565|NCT02807272|463806341|FG003|Overall Study|Protocol-defined Disease Progression|0|||
128866566|NCT02807272|463806342|FG004|Overall Study|Protocol-defined Disease Progression|1|||
128866567|NCT02807272|463806338|FG000|Overall Study|Study Terminated by Sponsor|1|||
128866568|NCT02807272|463806339|FG001|Overall Study|Study Terminated by Sponsor|0|||
128866569|NCT02807272|463806340|FG002|Overall Study|Study Terminated by Sponsor|0|||
128866570|NCT02807272|463806341|FG003|Overall Study|Study Terminated by Sponsor|1|||
128866571|NCT02807272|463806342|FG004|Overall Study|Study Terminated by Sponsor|0|||
128866572|NCT02807272|463806338|FG000|Overall Study|Other|1|||
128866573|NCT02807272|463806339|FG001|Overall Study|Other|0|||
128866574|NCT02807272|463806340|FG002|Overall Study|Other|0|||
128866575|NCT02807272|463806341|FG003|Overall Study|Other|0|||
128866576|NCT02807272|463806342|FG004|Overall Study|Other|1|||
128866577|NCT01038427|463806343|FG000|Overall Study|Lost to follow up|1|||
128866578|NCT01038427|463806344|FG001|Overall Study|Lost to follow up|1|||
128866579|NCT01038427|463806345|FG002|Overall Study|Lost to follow up|0|||
128866580|NCT01038427|463806343|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
128866581|NCT01038427|463806344|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
128866582|NCT01038427|463806345|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
128866583|NCT01038427|463806343|FG000|Overall Study|Withdrew consent|0|||
128866584|NCT01038427|463806344|FG001|Overall Study|Withdrew consent|0|||
128866585|NCT01038427|463806345|FG002|Overall Study|Withdrew consent|1|||
128866586|NCT01038427|463806343|FG000|Overall Study|Adverse Event|2|||
128866587|NCT01038427|463806344|FG001|Overall Study|Adverse Event|2|||
128866588|NCT01038427|463806345|FG002|Overall Study|Adverse Event|1|||
128866589|NCT01038427|463806343|FG000|Overall Study|Enrolled in error|0|||
128866590|NCT01038427|463806344|FG001|Overall Study|Enrolled in error|1|||
128866591|NCT01038427|463806345|FG002|Overall Study|Enrolled in error|1|||
128866592|NCT01038427|463806343|FG000|Overall Study|Other|0|||
128866593|NCT01038427|463806344|FG001|Overall Study|Other|2|||
128866594|NCT01038427|463806345|FG002|Overall Study|Other|0|||
128866595|NCT00604708|463806346|FG000|Overall Study|Withdrawal by Subject|9|||
128866596|NCT00604708|463806347|FG001|Overall Study|Withdrawal by Subject|10|||
128866597|NCT00604708|463806346|FG000|Overall Study|Protocol Violation|2|||
128866598|NCT00604708|463806347|FG001|Overall Study|Protocol Violation|8|||
128866599|NCT00604708|463806346|FG000|Overall Study|Lost to Follow-up|5|||
128866600|NCT00604708|463806347|FG001|Overall Study|Lost to Follow-up|5|||
128866601|NCT00604708|463806346|FG000|Overall Study|administrative reasons|9|||
128866602|NCT00604708|463806347|FG001|Overall Study|administrative reasons|11|||
128866603|NCT00604708|463806346|FG000|Overall Study|Adverse Event|6|||
128866604|NCT00604708|463806347|FG001|Overall Study|Adverse Event|6|||
128866605|NCT02202785|463806348|FG000|Overall Study|Study Terminated by Sponsor|1|||
128866606|NCT02202785|463806349|FG001|Overall Study|Study Terminated by Sponsor|6|||
128866607|NCT02202785|463806350|FG002|Overall Study|Study Terminated by Sponsor|4|||
128866608|NCT02202785|463806348|FG000|Overall Study|Withdrawal by Subject|0|||
128866609|NCT02202785|463806349|FG001|Overall Study|Withdrawal by Subject|1|||
128866610|NCT02202785|463806350|FG002|Overall Study|Withdrawal by Subject|0|||
128866611|NCT02202785|463806348|FG000|Overall Study|Lost to Follow-up|0|||
128866612|NCT02202785|463806349|FG001|Overall Study|Lost to Follow-up|1|||
128866613|NCT02202785|463806350|FG002|Overall Study|Lost to Follow-up|0|||
128866614|NCT02202785|463806348|FG000|Overall Study|Reason not Specified|10|||
128866615|NCT02202785|463806349|FG001|Overall Study|Reason not Specified|7|||
128866616|NCT02202785|463806350|FG002|Overall Study|Reason not Specified|13|||
128866617|NCT01137578|463806351|FG000|Overall Study|Participant requested to Discontinue|3|||
128866618|NCT01137578|463806352|FG001|Overall Study|Participant requested to Discontinue|0|||
128866619|NCT01137578|463806353|FG002|Overall Study|Participant requested to Discontinue|0|||
128866620|NCT01137578|463806351|FG000|Overall Study|Withdrawal by Subject|1|||
128866621|NCT01137578|463806352|FG001|Overall Study|Withdrawal by Subject|0|||
128866622|NCT01137578|463806353|FG002|Overall Study|Withdrawal by Subject|0|||
128866623|NCT01137578|463806351|FG000|Overall Study|Other|12|||
128866624|NCT01137578|463806352|FG001|Overall Study|Other|2|||
128866625|NCT01137578|463806353|FG002|Overall Study|Other|6|||
128866626|NCT04145700|463806354|FG000|Overall Study|Withdrawal by Subject|8|||
128866627|NCT04145700|463806355|FG001|Overall Study|Withdrawal by Subject|3|||
128866628|NCT01327846|463806358|FG000|Core Phase|Subject decision (vital status: missing)|1|||
128866629|NCT01327846|463806359|FG001|Core Phase|Subject decision (vital status: missing)|2|||
128866630|NCT01327846|463806360|FG002|Core Phase|Subject decision (vital status: missing)|2|||
128866631|NCT01327846|463806361|FG003|Core Phase|Subject decision (vital status: missing)|1|||
128866632|NCT01327846|463806358|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
128866633|NCT01327846|463806359|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
128866634|NCT01327846|463806360|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
128866635|NCT01327846|463806361|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
128866636|NCT01327846|463806358|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
128866637|NCT01327846|463806359|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
128866638|NCT01327846|463806360|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
128866639|NCT01327846|463806361|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
128866640|NCT01327846|463806358|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
128866641|NCT01327846|463806359|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
128866642|NCT01327846|463806360|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
128866643|NCT01327846|463806361|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
128866644|NCT01327846|463806358|FG000|Core Phase|Lost to Follow-up|3|||
128866645|NCT01327846|463806359|FG001|Core Phase|Lost to Follow-up|3|||
128866646|NCT01327846|463806360|FG002|Core Phase|Lost to Follow-up|4|||
128866647|NCT01327846|463806361|FG003|Core Phase|Lost to Follow-up|5|||
128866648|NCT01327846|463806358|FG000|Extension Phase|Study terminated by sponsor|1073|||
128866649|NCT01327846|463806359|FG001|Extension Phase|Study terminated by sponsor|1124|||
128866650|NCT01327846|463806360|FG002|Extension Phase|Study terminated by sponsor|1067|||
128866651|NCT01327846|463806361|FG003|Extension Phase|Study terminated by sponsor|1660|||
128866652|NCT01327846|463806358|FG000|Extension Phase|Withdrawal by Subject|20|||
128866653|NCT01327846|463806359|FG001|Extension Phase|Withdrawal by Subject|13|||
128866654|NCT01327846|463806360|FG002|Extension Phase|Withdrawal by Subject|19|||
128866655|NCT01327846|463806361|FG003|Extension Phase|Withdrawal by Subject|37|||
128866656|NCT01327846|463806358|FG000|Extension Phase|Lost to Follow-up|4|||
128866657|NCT01327846|463806359|FG001|Extension Phase|Lost to Follow-up|3|||
128866658|NCT01327846|463806360|FG002|Extension Phase|Lost to Follow-up|4|||
128866659|NCT01327846|463806361|FG003|Extension Phase|Lost to Follow-up|7|||
128866660|NCT01327846|463806358|FG000|Extension Phase|Technical Problems|2|||
128866661|NCT01327846|463806359|FG001|Extension Phase|Technical Problems|4|||
128866662|NCT01327846|463806360|FG002|Extension Phase|Technical Problems|2|||
128866663|NCT01327846|463806361|FG003|Extension Phase|Technical Problems|2|||
128866664|NCT04343976|463806362|FG000|Overall Study|Withdrawal by Subject|0|||
128866665|NCT04343976|463806363|FG001|Overall Study|Withdrawal by Subject|1|||
128866666|NCT00594880|463806364|FG000|Overall Study|Withdrawal by Subject|1|||
128866667|NCT00594880|463806365|FG001|Overall Study|Withdrawal by Subject|1|||
128866668|NCT00594880|463806364|FG000|Overall Study|Lost to Follow-up|1|||
128866669|NCT00594880|463806365|FG001|Overall Study|Lost to Follow-up|0|||
128866670|NCT00694109|463806366|FG000|Overall Study|Physician Decision|3|||
128866671|NCT00694109|463806366|FG000|Overall Study|Adverse Event|74|||
128866672|NCT00694109|463806366|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
128866673|NCT00694109|463806366|FG000|Overall Study|Lack of Efficacy|2|||
128866674|NCT00694109|463806366|FG000|Overall Study|Withdrawal by Subject|13|||
128866675|NCT00694109|463806366|FG000|Overall Study|Pregnancy|1|||
128866676|NCT00694109|463806366|FG000|Overall Study|Enrolled but not treated|1|||
128866677|NCT00694109|463806366|FG000|Overall Study|Other|2|||
128866678|NCT00694109|463806366|FG000|Overall Study|Consented but no additional treatment|3|||
128866679|NCT00846807|463806367|FG000|Overall Study|Adverse Event|270|||
128866680|NCT00846807|463806367|FG000|Overall Study|Lost to Follow-up|94|||
128866681|NCT00846807|463806367|FG000|Overall Study|Withdrawal by Subject|56|||
128866682|NCT00846807|463806367|FG000|Overall Study|Non compliant with European label|7|||
128866683|NCT00846807|463806367|FG000|Overall Study|Switch to other anticoagulants|89|||
128866684|NCT00846807|463806367|FG000|Overall Study|No prescription after hospital discharge|56|||
128866685|NCT00846807|463806367|FG000|Overall Study|Other|60|||
128866686|NCT00245960|463806368|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
128866687|NCT00245960|463806369|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
128866688|NCT00245960|463806368|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
128866689|NCT00245960|463806369|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
128866690|NCT00245960|463806368|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
128866691|NCT00245960|463806369|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
128866692|NCT00245960|463806368|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
128866693|NCT00245960|463806369|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
128866694|NCT00245960|463806368|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
128866695|NCT00245960|463806369|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
128866696|NCT00245960|463806368|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
128866697|NCT00245960|463806369|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
128866698|NCT00245960|463806368|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
128866699|NCT00245960|463806369|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
128866700|NCT00245960|463806368|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
128866701|NCT00245960|463806369|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
128866702|NCT00245960|463806368|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
128866703|NCT00245960|463806369|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
128866704|NCT00245960|463806368|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
128866705|NCT00245960|463806369|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
128866706|NCT00245960|463806368|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
128866707|NCT00245960|463806369|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
128866708|NCT00245960|463806368|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
128866709|NCT00245960|463806369|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
128866710|NCT00737698|463806370|FG000|Overall Study|Withdrawal by Subject|6|||
128866711|NCT00737698|463806371|FG001|Overall Study|Withdrawal by Subject|5|||
128866712|NCT00737698|463806372|FG002|Overall Study|Withdrawal by Subject|3|||
128866713|NCT00737698|463806370|FG000|Overall Study|Death|0|||
128866714|NCT00737698|463806371|FG001|Overall Study|Death|0|||
128866715|NCT00737698|463806372|FG002|Overall Study|Death|1|||
128866716|NCT01067846|463806373|FG000|Overall Study|Lost to Follow-up|17|||
128866717|NCT01067846|463806374|FG001|Overall Study|Lost to Follow-up|19|||
128866718|NCT01067846|463806373|FG000|Overall Study|Withdrawal by Subject|1|||
128866719|NCT01067846|463806374|FG001|Overall Study|Withdrawal by Subject|0|||
128866720|NCT01067846|463806373|FG000|Overall Study|participation in other tx study|1|||
128866721|NCT01067846|463806374|FG001|Overall Study|participation in other tx study|0|||
128866722|NCT02817906|463806375|FG000|Overall Study|Adverse Event|3|||
128866723|NCT02817906|463806376|FG001|Overall Study|Adverse Event|0|||
128866724|NCT02817906|463806375|FG000|Overall Study|Lack of Efficacy|1|||
128866725|NCT02817906|463806376|FG001|Overall Study|Lack of Efficacy|0|||
128866726|NCT02817906|463806375|FG000|Overall Study|Protocol Violation|1|||
128866727|NCT02817906|463806376|FG001|Overall Study|Protocol Violation|1|||
128866728|NCT02817906|463806375|FG000|Overall Study|Study Terminated by Sponsor|2|||
128866729|NCT02817906|463806376|FG001|Overall Study|Study Terminated by Sponsor|2|||
128866730|NCT02817906|463806375|FG000|Overall Study|Withdrawal by Subject|7|||
128866731|NCT02817906|463806376|FG001|Overall Study|Withdrawal by Subject|0|||
128866732|NCT02817906|463806375|FG000|Overall Study|Other|2|||
128866733|NCT02817906|463806376|FG001|Overall Study|Other|2|||
128866734|NCT03686423|463806378|FG000|Overall Study|Withdrawal by Subject|9|||
128866735|NCT03686423|463806378|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
128866736|NCT04608773|463806379|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
128866737|NCT04608773|463806380|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
128866738|NCT04608773|463806379|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
128866739|NCT04608773|463806380|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
128866740|NCT04608773|463806379|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
128866741|NCT04608773|463806380|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
128866742|NCT04608773|463806379|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
128866743|NCT04608773|463806380|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
128866744|NCT04608773|463806379|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
128866745|NCT04608773|463806380|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
128866746|NCT02833077|463806381|FG000|Overall Study|Adverse Event|1|||
128866747|NCT02833077|463806382|FG001|Overall Study|Adverse Event|2|||
128866748|NCT02833077|463806381|FG000|Overall Study|Lost to Follow-up|10|||
128866749|NCT02833077|463806382|FG001|Overall Study|Lost to Follow-up|1|||
128866750|NCT02833077|463806381|FG000|Overall Study|Personal Reasons|6|||
128866751|NCT02833077|463806382|FG001|Overall Study|Personal Reasons|4|||
128866752|NCT02833077|463806381|FG000|Overall Study|Protocol Deviation|0|||
128866753|NCT02833077|463806382|FG001|Overall Study|Protocol Deviation|1|||
128866754|NCT02387970|463806383|FG000|Overall Study|Did not complete 1-year follow up|1|||
128866755|NCT02387970|463806384|FG001|Overall Study|Did not complete 1-year follow up|2|||
128866756|NCT01436253|463806389|FG000|Overall Study|Lost to Follow-up|182|||
128866757|NCT01436253|463806389|FG000|Overall Study|Not meeting all eligibility criteria|117|||
128866758|NCT02671500|463806391|FG000|Overall Study|Lack of Efficacy|12|||
128866759|NCT02671500|463806391|FG000|Overall Study|Lost to Follow-up|2|||
128866760|NCT05292586|463806394|FG000|Overall Study|Withdrawal by Subject|3|||
128866761|NCT05292586|463806395|FG001|Overall Study|Withdrawal by Subject|10|||
128866762|NCT05292586|463806394|FG000|Overall Study|Randomization error|3|||
128866763|NCT05292586|463806395|FG001|Overall Study|Randomization error|7|||
128866764|NCT05292586|463806394|FG000|Overall Study|Adverse Event|3|||
128866765|NCT05292586|463806395|FG001|Overall Study|Adverse Event|0|||
128866766|NCT05292586|463806394|FG000|Overall Study|Lost to Follow-up|0|||
128866767|NCT05292586|463806395|FG001|Overall Study|Lost to Follow-up|1|||
128866768|NCT05292586|463806394|FG000|Overall Study|Patient refused treatment|1|||
128866769|NCT05292586|463806395|FG001|Overall Study|Patient refused treatment|0|||
128866770|NCT05292586|463806394|FG000|Overall Study|Patient could not travel to the study site|1|||
128866771|NCT05292586|463806395|FG001|Overall Study|Patient could not travel to the study site|0|||
128866772|NCT05292586|463806394|FG000|Overall Study|Technical issues with the masterscope|0|||
128866773|NCT05292586|463806395|FG001|Overall Study|Technical issues with the masterscope|3|||
128866774|NCT05292586|463806394|FG000|Overall Study|Patient moved to a different state|0|||
128866775|NCT05292586|463806395|FG001|Overall Study|Patient moved to a different state|1|||
128866776|NCT03682185|463806398|FG000|Overall Study|Lost to Follow-up|4|||
128866777|NCT03682185|463806399|FG001|Overall Study|Lost to Follow-up|7|||
128866778|NCT03682185|463806400|FG002|Overall Study|Lost to Follow-up|4|||
128866779|NCT03682185|463806401|FG003|Overall Study|Lost to Follow-up|7|||
128866780|NCT03682185|463806402|FG004|Overall Study|Lost to Follow-up|1|||
128866781|NCT03682185|463806398|FG000|Overall Study|Withdrawal by Subject|7|||
128866782|NCT03682185|463806399|FG001|Overall Study|Withdrawal by Subject|3|||
128866783|NCT03682185|463806400|FG002|Overall Study|Withdrawal by Subject|7|||
128866784|NCT03682185|463806401|FG003|Overall Study|Withdrawal by Subject|3|||
128866785|NCT03682185|463806402|FG004|Overall Study|Withdrawal by Subject|0|||
128866786|NCT04908631|463806403|FG000|Overall Study|Lost to Follow-up|1|||
128866787|NCT04908631|463806403|FG000|Overall Study|Physician Decision|1|||
128866788|NCT04908631|463806403|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
128866789|NCT04531982|463806404|FG000|Overall Study|Withdrawal by Subject|10|||
128866790|NCT04531982|463806405|FG001|Overall Study|Withdrawal by Subject|11|||
128866791|NCT04531982|463806404|FG000|Overall Study|Adverse Event|6|||
128866792|NCT04531982|463806405|FG001|Overall Study|Adverse Event|14|||
128866793|NCT04531982|463806404|FG000|Overall Study|Protocol Violation|6|||
128866794|NCT04531982|463806405|FG001|Overall Study|Protocol Violation|9|||
128866795|NCT04531982|463806404|FG000|Overall Study|Non-compliance with study drug|3|||
128866796|NCT04531982|463806405|FG001|Overall Study|Non-compliance with study drug|2|||
128866797|NCT04531982|463806404|FG000|Overall Study|Use of prohibited medication|2|||
128866798|NCT04531982|463806405|FG001|Overall Study|Use of prohibited medication|0|||
128866799|NCT04531982|463806404|FG000|Overall Study|Lost to Follow-up|0|||
128866800|NCT04531982|463806405|FG001|Overall Study|Lost to Follow-up|1|||
128866801|NCT04531982|463806404|FG000|Overall Study|Geopolitical conflict|2|||
128866802|NCT04531982|463806405|FG001|Overall Study|Geopolitical conflict|0|||
128866803|NCT04531982|463806404|FG000|Overall Study|Lack of Efficacy|3|||
128866804|NCT04531982|463806405|FG001|Overall Study|Lack of Efficacy|1|||
128866805|NCT04047862|463806412|FG000|Overall Study|Death|0|||
128866806|NCT04047862|463806413|FG001|Overall Study|Death|0|||
128866807|NCT04047862|463806414|FG002|Overall Study|Death|4|||
128866808|NCT04047862|463806415|FG003|Overall Study|Death|7|||
128866809|NCT04047862|463806416|FG004|Overall Study|Death|2|||
128866810|NCT04047862|463806417|FG005|Overall Study|Death|4|||
128866811|NCT04047862|463806418|FG006|Overall Study|Death|3|||
128866812|NCT04047862|463806419|FG007|Overall Study|Death|24|||
128866813|NCT04047862|463806420|FG008|Overall Study|Death|24|||
128866814|NCT04047862|463806421|FG009|Overall Study|Death|22|||
128866815|NCT04047862|463806422|FG010|Overall Study|Death|35|||
128866816|NCT04047862|463806423|FG011|Overall Study|Death|18|||
128866817|NCT04047862|463806424|FG012|Overall Study|Death|14|||
128866818|NCT04047862|463806425|FG013|Overall Study|Death|6|||
128866819|NCT04047862|463806426|FG014|Overall Study|Death|19|||
128866820|NCT04047862|463806427|FG015|Overall Study|Death|42|||
128866821|NCT04047862|463806428|FG016|Overall Study|Death|9|||
128866822|NCT04047862|463806429|FG017|Overall Study|Death|8|||
128866823|NCT04047862|463806430|FG018|Overall Study|Death|10|||
128866824|NCT04047862|463806412|FG000|Overall Study|Withdrawal by Subject|0|||
128866825|NCT04047862|463806413|FG001|Overall Study|Withdrawal by Subject|0|||
128866826|NCT04047862|463806414|FG002|Overall Study|Withdrawal by Subject|0|||
128866827|NCT04047862|463806415|FG003|Overall Study|Withdrawal by Subject|5|||
128866828|NCT04047862|463806416|FG004|Overall Study|Withdrawal by Subject|2|||
128866829|NCT04047862|463806417|FG005|Overall Study|Withdrawal by Subject|0|||
128866830|NCT04047862|463806418|FG006|Overall Study|Withdrawal by Subject|1|||
128866831|NCT04047862|463806419|FG007|Overall Study|Withdrawal by Subject|0|||
128866832|NCT04047862|463806420|FG008|Overall Study|Withdrawal by Subject|4|||
128866833|NCT04047862|463806421|FG009|Overall Study|Withdrawal by Subject|4|||
128866834|NCT04047862|463806422|FG010|Overall Study|Withdrawal by Subject|4|||
128866835|NCT04047862|463806423|FG011|Overall Study|Withdrawal by Subject|2|||
128866836|NCT04047862|463806424|FG012|Overall Study|Withdrawal by Subject|3|||
128866837|NCT04047862|463806425|FG013|Overall Study|Withdrawal by Subject|0|||
128866838|NCT04047862|463806426|FG014|Overall Study|Withdrawal by Subject|9|||
128866839|NCT04047862|463806427|FG015|Overall Study|Withdrawal by Subject|5|||
128866840|NCT04047862|463806428|FG016|Overall Study|Withdrawal by Subject|1|||
128866841|NCT04047862|463806429|FG017|Overall Study|Withdrawal by Subject|3|||
128866842|NCT04047862|463806430|FG018|Overall Study|Withdrawal by Subject|1|||
128866843|NCT04047862|463806412|FG000|Overall Study|Lost to Follow-up|0|||
128866844|NCT04047862|463806413|FG001|Overall Study|Lost to Follow-up|0|||
128866845|NCT04047862|463806414|FG002|Overall Study|Lost to Follow-up|1|||
128866846|NCT04047862|463806415|FG003|Overall Study|Lost to Follow-up|0|||
128866847|NCT04047862|463806416|FG004|Overall Study|Lost to Follow-up|0|||
128866848|NCT04047862|463806417|FG005|Overall Study|Lost to Follow-up|0|||
128866849|NCT04047862|463806418|FG006|Overall Study|Lost to Follow-up|0|||
128866850|NCT04047862|463806419|FG007|Overall Study|Lost to Follow-up|1|||
128866851|NCT04047862|463806420|FG008|Overall Study|Lost to Follow-up|0|||
128866852|NCT04047862|463806421|FG009|Overall Study|Lost to Follow-up|1|||
128866853|NCT04047862|463806422|FG010|Overall Study|Lost to Follow-up|0|||
128866854|NCT04047862|463806423|FG011|Overall Study|Lost to Follow-up|3|||
128866855|NCT04047862|463806424|FG012|Overall Study|Lost to Follow-up|0|||
128866856|NCT04047862|463806425|FG013|Overall Study|Lost to Follow-up|0|||
128866857|NCT04047862|463806426|FG014|Overall Study|Lost to Follow-up|2|||
128866858|NCT04047862|463806427|FG015|Overall Study|Lost to Follow-up|2|||
128866859|NCT04047862|463806428|FG016|Overall Study|Lost to Follow-up|1|||
128866860|NCT04047862|463806429|FG017|Overall Study|Lost to Follow-up|0|||
128866861|NCT04047862|463806430|FG018|Overall Study|Lost to Follow-up|0|||
128866862|NCT04047862|463806412|FG000|Overall Study|Physician Decision|0|||
128866863|NCT04047862|463806413|FG001|Overall Study|Physician Decision|0|||
128866864|NCT04047862|463806414|FG002|Overall Study|Physician Decision|0|||
128866865|NCT04047862|463806415|FG003|Overall Study|Physician Decision|1|||
128866866|NCT04047862|463806416|FG004|Overall Study|Physician Decision|0|||
128866867|NCT04047862|463806417|FG005|Overall Study|Physician Decision|0|||
128866868|NCT04047862|463806418|FG006|Overall Study|Physician Decision|0|||
128866869|NCT04047862|463806419|FG007|Overall Study|Physician Decision|0|||
128866870|NCT04047862|463806420|FG008|Overall Study|Physician Decision|0|||
128866871|NCT04047862|463806421|FG009|Overall Study|Physician Decision|0|||
128866872|NCT04047862|463806422|FG010|Overall Study|Physician Decision|0|||
128866873|NCT04047862|463806423|FG011|Overall Study|Physician Decision|0|||
128866874|NCT04047862|463806424|FG012|Overall Study|Physician Decision|0|||
128866875|NCT04047862|463806425|FG013|Overall Study|Physician Decision|0|||
128866876|NCT04047862|463806426|FG014|Overall Study|Physician Decision|1|||
128866877|NCT04047862|463806427|FG015|Overall Study|Physician Decision|0|||
128866878|NCT04047862|463806428|FG016|Overall Study|Physician Decision|1|||
128866879|NCT04047862|463806429|FG017|Overall Study|Physician Decision|0|||
128866880|NCT04047862|463806430|FG018|Overall Study|Physician Decision|0|||
128866881|NCT04047862|463806412|FG000|Overall Study|Completed all Assessments|1|||
128866882|NCT04047862|463806413|FG001|Overall Study|Completed all Assessments|3|||
128866883|NCT04047862|463806414|FG002|Overall Study|Completed all Assessments|1|||
128866884|NCT04047862|463806415|FG003|Overall Study|Completed all Assessments|3|||
128866885|NCT04047862|463806416|FG004|Overall Study|Completed all Assessments|2|||
128866886|NCT04047862|463806417|FG005|Overall Study|Completed all Assessments|5|||
128866887|NCT04047862|463806418|FG006|Overall Study|Completed all Assessments|7|||
128866888|NCT04047862|463806419|FG007|Overall Study|Completed all Assessments|0|||
128866889|NCT04047862|463806420|FG008|Overall Study|Completed all Assessments|0|||
128866890|NCT04047862|463806421|FG009|Overall Study|Completed all Assessments|0|||
128866891|NCT04047862|463806422|FG010|Overall Study|Completed all Assessments|0|||
128866892|NCT04047862|463806423|FG011|Overall Study|Completed all Assessments|0|||
128866893|NCT04047862|463806424|FG012|Overall Study|Completed all Assessments|0|||
128866894|NCT04047862|463806425|FG013|Overall Study|Completed all Assessments|0|||
128866895|NCT04047862|463806426|FG014|Overall Study|Completed all Assessments|0|||
128866896|NCT04047862|463806427|FG015|Overall Study|Completed all Assessments|0|||
128866897|NCT04047862|463806428|FG016|Overall Study|Completed all Assessments|0|||
128866898|NCT04047862|463806429|FG017|Overall Study|Completed all Assessments|0|||
128866899|NCT04047862|463806430|FG018|Overall Study|Completed all Assessments|0|||
128866900|NCT04047862|463806412|FG000|Overall Study|Sponsor Decision|0|||
128866901|NCT04047862|463806413|FG001|Overall Study|Sponsor Decision|0|||
128866902|NCT04047862|463806414|FG002|Overall Study|Sponsor Decision|0|||
128866903|NCT04047862|463806415|FG003|Overall Study|Sponsor Decision|0|||
128866904|NCT04047862|463806416|FG004|Overall Study|Sponsor Decision|0|||
128866905|NCT04047862|463806417|FG005|Overall Study|Sponsor Decision|0|||
128866906|NCT04047862|463806418|FG006|Overall Study|Sponsor Decision|0|||
128866907|NCT04047862|463806419|FG007|Overall Study|Sponsor Decision|13|||
128866908|NCT04047862|463806420|FG008|Overall Study|Sponsor Decision|10|||
128866909|NCT04047862|463806421|FG009|Overall Study|Sponsor Decision|18|||
128866910|NCT04047862|463806422|FG010|Overall Study|Sponsor Decision|3|||
128866911|NCT04047862|463806423|FG011|Overall Study|Sponsor Decision|3|||
128866912|NCT04047862|463806424|FG012|Overall Study|Sponsor Decision|4|||
128866913|NCT04047862|463806425|FG013|Overall Study|Sponsor Decision|0|||
128866914|NCT04047862|463806426|FG014|Overall Study|Sponsor Decision|7|||
128866915|NCT04047862|463806427|FG015|Overall Study|Sponsor Decision|8|||
128866916|NCT04047862|463806428|FG016|Overall Study|Sponsor Decision|9|||
128866917|NCT04047862|463806429|FG017|Overall Study|Sponsor Decision|7|||
128866918|NCT04047862|463806430|FG018|Overall Study|Sponsor Decision|8|||
128866919|NCT04047862|463806412|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866920|NCT04047862|463806413|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866921|NCT04047862|463806414|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866922|NCT04047862|463806415|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866923|NCT04047862|463806416|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866924|NCT04047862|463806417|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866925|NCT04047862|463806418|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866926|NCT04047862|463806419|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
128866927|NCT04047862|463806420|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
128866928|NCT04047862|463806421|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866929|NCT04047862|463806422|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
128866930|NCT04047862|463806423|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866931|NCT04047862|463806424|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866932|NCT04047862|463806425|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
128866933|NCT04047862|463806426|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
128866934|NCT04047862|463806427|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
128866935|NCT04047862|463806428|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
128866936|NCT04047862|463806429|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
128866937|NCT04047862|463806430|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
128866938|NCT04047862|463806412|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866939|NCT04047862|463806413|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866940|NCT04047862|463806414|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866941|NCT04047862|463806415|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866942|NCT04047862|463806416|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866943|NCT04047862|463806417|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866944|NCT04047862|463806418|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866945|NCT04047862|463806419|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866946|NCT04047862|463806420|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866947|NCT04047862|463806421|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866948|NCT04047862|463806422|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866949|NCT04047862|463806423|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866950|NCT04047862|463806424|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866951|NCT04047862|463806425|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866952|NCT04047862|463806426|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866953|NCT04047862|463806427|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
128866954|NCT04047862|463806428|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866955|NCT04047862|463806429|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
128866956|NCT04047862|463806430|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
128866957|NCT04047862|463806412|FG000|Overall Study|Other|0|||
128866958|NCT04047862|463806413|FG001|Overall Study|Other|0|||
128866959|NCT04047862|463806414|FG002|Overall Study|Other|0|||
128866960|NCT04047862|463806415|FG003|Overall Study|Other|0|||
128866961|NCT04047862|463806416|FG004|Overall Study|Other|0|||
128866962|NCT04047862|463806417|FG005|Overall Study|Other|0|||
128866963|NCT04047862|463806418|FG006|Overall Study|Other|0|||
128866964|NCT04047862|463806419|FG007|Overall Study|Other|0|||
128866965|NCT04047862|463806420|FG008|Overall Study|Other|0|||
128866966|NCT04047862|463806421|FG009|Overall Study|Other|0|||
128866967|NCT04047862|463806422|FG010|Overall Study|Other|0|||
128866968|NCT04047862|463806423|FG011|Overall Study|Other|0|||
128866969|NCT04047862|463806424|FG012|Overall Study|Other|0|||
128866970|NCT04047862|463806425|FG013|Overall Study|Other|0|||
128866971|NCT04047862|463806426|FG014|Overall Study|Other|2|||
128866972|NCT04047862|463806427|FG015|Overall Study|Other|1|||
128866973|NCT04047862|463806428|FG016|Overall Study|Other|1|||
128866974|NCT04047862|463806429|FG017|Overall Study|Other|1|||
128866975|NCT04047862|463806430|FG018|Overall Study|Other|0|||
128866976|NCT03829501|463807905|FG000|Overall Study|Withdrawal of Consent|2|||
128866977|NCT03829501|463807906|FG001|Overall Study|Withdrawal of Consent|0|||
128866978|NCT03829501|463807907|FG002|Overall Study|Withdrawal of Consent|3|||
128866979|NCT03829501|463807908|FG003|Overall Study|Withdrawal of Consent|0|||
128866980|NCT03829501|463807909|FG004|Overall Study|Withdrawal of Consent|1|||
128866981|NCT03829501|463807910|FG005|Overall Study|Withdrawal of Consent|1|||
128866982|NCT03829501|463807911|FG006|Overall Study|Withdrawal of Consent|0|||
128866983|NCT03829501|463807912|FG007|Overall Study|Withdrawal of Consent|10|||
128866984|NCT03829501|463807913|FG008|Overall Study|Withdrawal of Consent|10|||
128866985|NCT03829501|463807914|FG009|Overall Study|Withdrawal of Consent|3|||
128866986|NCT03829501|463807915|FG010|Overall Study|Withdrawal of Consent|4|||
128866987|NCT03829501|463807916|FG011|Overall Study|Withdrawal of Consent|4|||
128866988|NCT03829501|463807917|FG012|Overall Study|Withdrawal of Consent|4|||
128866989|NCT03829501|463807918|FG013|Overall Study|Withdrawal of Consent|0|||
128866990|NCT03829501|463807919|FG014|Overall Study|Withdrawal of Consent|3|||
128866991|NCT03829501|463807920|FG015|Overall Study|Withdrawal of Consent|0|||
128866992|NCT03829501|463807921|FG016|Overall Study|Withdrawal of Consent|1|||
128866993|NCT03829501|463807922|FG017|Overall Study|Withdrawal of Consent|1|||
128866994|NCT03829501|463807923|FG018|Overall Study|Withdrawal of Consent|0|||
128866995|NCT03829501|463807924|FG019|Overall Study|Withdrawal of Consent|0|||
128866996|NCT03829501|463807925|FG020|Overall Study|Withdrawal of Consent|3|||
128866997|NCT03829501|463807926|FG021|Overall Study|Withdrawal of Consent|0|||
128866998|NCT03829501|463807927|FG022|Overall Study|Withdrawal of Consent|1|||
128866999|NCT03829501|463807905|FG000|Overall Study|PD|0|||
128867000|NCT03829501|463807906|FG001|Overall Study|PD|0|||
128867001|NCT03829501|463807907|FG002|Overall Study|PD|0|||
128867002|NCT03829501|463807908|FG003|Overall Study|PD|2|||
128867003|NCT03829501|463807909|FG004|Overall Study|PD|0|||
128867004|NCT03829501|463807910|FG005|Overall Study|PD|0|||
128867005|NCT03829501|463807911|FG006|Overall Study|PD|0|||
128867006|NCT03829501|463807912|FG007|Overall Study|PD|0|||
128867007|NCT03829501|463807913|FG008|Overall Study|PD|0|||
128867008|NCT03829501|463807914|FG009|Overall Study|PD|0|||
128867009|NCT03829501|463807915|FG010|Overall Study|PD|0|||
128867010|NCT03829501|463807916|FG011|Overall Study|PD|0|||
128867011|NCT03829501|463807917|FG012|Overall Study|PD|0|||
128867012|NCT03829501|463807918|FG013|Overall Study|PD|0|||
128867013|NCT03829501|463807919|FG014|Overall Study|PD|0|||
128867014|NCT03829501|463807920|FG015|Overall Study|PD|1|||
128867015|NCT03829501|463807921|FG016|Overall Study|PD|0|||
128867016|NCT03829501|463807922|FG017|Overall Study|PD|0|||
128867017|NCT03829501|463807923|FG018|Overall Study|PD|0|||
128867018|NCT03829501|463807924|FG019|Overall Study|PD|0|||
128867019|NCT03829501|463807925|FG020|Overall Study|PD|1|||
128867020|NCT03829501|463807926|FG021|Overall Study|PD|0|||
128867021|NCT03829501|463807927|FG022|Overall Study|PD|0|||
128867022|NCT03829501|463807905|FG000|Overall Study|Study Terminated by Sponsor|0|||
128867023|NCT03829501|463807906|FG001|Overall Study|Study Terminated by Sponsor|0|||
128867024|NCT03829501|463807907|FG002|Overall Study|Study Terminated by Sponsor|0|||
128867025|NCT03829501|463807908|FG003|Overall Study|Study Terminated by Sponsor|0|||
128867026|NCT03829501|463807909|FG004|Overall Study|Study Terminated by Sponsor|0|||
128867027|NCT03829501|463807910|FG005|Overall Study|Study Terminated by Sponsor|0|||
128867028|NCT03829501|463807911|FG006|Overall Study|Study Terminated by Sponsor|0|||
128867029|NCT03829501|463807912|FG007|Overall Study|Study Terminated by Sponsor|3|||
128867030|NCT03829501|463807913|FG008|Overall Study|Study Terminated by Sponsor|1|||
128867031|NCT03829501|463807914|FG009|Overall Study|Study Terminated by Sponsor|0|||
128867032|NCT03829501|463807915|FG010|Overall Study|Study Terminated by Sponsor|0|||
128867033|NCT03829501|463807916|FG011|Overall Study|Study Terminated by Sponsor|0|||
128867034|NCT03829501|463807917|FG012|Overall Study|Study Terminated by Sponsor|0|||
128867035|NCT03829501|463807918|FG013|Overall Study|Study Terminated by Sponsor|0|||
128867036|NCT03829501|463807919|FG014|Overall Study|Study Terminated by Sponsor|3|||
128867037|NCT03829501|463807920|FG015|Overall Study|Study Terminated by Sponsor|2|||
128867038|NCT03829501|463807921|FG016|Overall Study|Study Terminated by Sponsor|2|||
128867039|NCT03829501|463807922|FG017|Overall Study|Study Terminated by Sponsor|0|||
128867040|NCT03829501|463807923|FG018|Overall Study|Study Terminated by Sponsor|0|||
128867041|NCT03829501|463807924|FG019|Overall Study|Study Terminated by Sponsor|0|||
128867042|NCT03829501|463807925|FG020|Overall Study|Study Terminated by Sponsor|1|||
128867043|NCT03829501|463807926|FG021|Overall Study|Study Terminated by Sponsor|0|||
128867044|NCT03829501|463807927|FG022|Overall Study|Study Terminated by Sponsor|3|||
128867045|NCT03829501|463807905|FG000|Overall Study|Lost to Follow Up|0|||
128867046|NCT03829501|463807906|FG001|Overall Study|Lost to Follow Up|0|||
128867047|NCT03829501|463807907|FG002|Overall Study|Lost to Follow Up|0|||
128867048|NCT03829501|463807908|FG003|Overall Study|Lost to Follow Up|0|||
128867049|NCT03829501|463807909|FG004|Overall Study|Lost to Follow Up|1|||
128867050|NCT03829501|463807910|FG005|Overall Study|Lost to Follow Up|0|||
128867051|NCT03829501|463807911|FG006|Overall Study|Lost to Follow Up|0|||
128867052|NCT03829501|463807912|FG007|Overall Study|Lost to Follow Up|2|||
128867053|NCT03829501|463807913|FG008|Overall Study|Lost to Follow Up|2|||
128867054|NCT03829501|463807914|FG009|Overall Study|Lost to Follow Up|0|||
128867055|NCT03829501|463807915|FG010|Overall Study|Lost to Follow Up|2|||
128867056|NCT03829501|463807916|FG011|Overall Study|Lost to Follow Up|1|||
128867057|NCT03829501|463807917|FG012|Overall Study|Lost to Follow Up|0|||
128867058|NCT03829501|463807918|FG013|Overall Study|Lost to Follow Up|1|||
128867059|NCT03829501|463807919|FG014|Overall Study|Lost to Follow Up|1|||
128867060|NCT03829501|463807920|FG015|Overall Study|Lost to Follow Up|0|||
128867061|NCT03829501|463807921|FG016|Overall Study|Lost to Follow Up|0|||
128867062|NCT03829501|463807922|FG017|Overall Study|Lost to Follow Up|0|||
128867063|NCT03829501|463807923|FG018|Overall Study|Lost to Follow Up|0|||
128867064|NCT03829501|463807924|FG019|Overall Study|Lost to Follow Up|0|||
128867065|NCT03829501|463807925|FG020|Overall Study|Lost to Follow Up|0|||
128867066|NCT03829501|463807926|FG021|Overall Study|Lost to Follow Up|0|||
128867067|NCT03829501|463807927|FG022|Overall Study|Lost to Follow Up|1|||
128867068|NCT03829501|463807905|FG000|Overall Study|Death|2|||
128867069|NCT03829501|463807906|FG001|Overall Study|Death|4|||
128867070|NCT03829501|463807907|FG002|Overall Study|Death|5|||
128867071|NCT03829501|463807908|FG003|Overall Study|Death|6|||
128867072|NCT03829501|463807909|FG004|Overall Study|Death|5|||
128867073|NCT03829501|463807910|FG005|Overall Study|Death|4|||
128867074|NCT03829501|463807911|FG006|Overall Study|Death|5|||
128867075|NCT03829501|463807912|FG007|Overall Study|Death|24|||
128867076|NCT03829501|463807913|FG008|Overall Study|Death|22|||
128867077|NCT03829501|463807914|FG009|Overall Study|Death|6|||
128867078|NCT03829501|463807915|FG010|Overall Study|Death|3|||
128867079|NCT03829501|463807916|FG011|Overall Study|Death|10|||
128867080|NCT03829501|463807917|FG012|Overall Study|Death|10|||
128867081|NCT03829501|463807918|FG013|Overall Study|Death|5|||
128867082|NCT03829501|463807919|FG014|Overall Study|Death|7|||
128867083|NCT03829501|463807920|FG015|Overall Study|Death|2|||
128867084|NCT03829501|463807921|FG016|Overall Study|Death|2|||
128867085|NCT03829501|463807922|FG017|Overall Study|Death|1|||
128867086|NCT03829501|463807923|FG018|Overall Study|Death|1|||
128867087|NCT03829501|463807924|FG019|Overall Study|Death|1|||
128867088|NCT03829501|463807925|FG020|Overall Study|Death|1|||
128867089|NCT03829501|463807926|FG021|Overall Study|Death|2|||
128867090|NCT03829501|463807927|FG022|Overall Study|Death|3|||
128867091|NCT03829501|463807905|FG000|Overall Study|Miscellaneous|0|||
128867092|NCT03829501|463807906|FG001|Overall Study|Miscellaneous|0|||
128867093|NCT03829501|463807907|FG002|Overall Study|Miscellaneous|1|||
128867094|NCT03829501|463807908|FG003|Overall Study|Miscellaneous|0|||
128867095|NCT03829501|463807909|FG004|Overall Study|Miscellaneous|0|||
128867096|NCT03829501|463807910|FG005|Overall Study|Miscellaneous|0|||
128867097|NCT03829501|463807911|FG006|Overall Study|Miscellaneous|0|||
128867098|NCT03829501|463807912|FG007|Overall Study|Miscellaneous|1|||
128867099|NCT03829501|463807913|FG008|Overall Study|Miscellaneous|0|||
128867100|NCT03829501|463807914|FG009|Overall Study|Miscellaneous|0|||
128867101|NCT03829501|463807915|FG010|Overall Study|Miscellaneous|0|||
128867102|NCT03829501|463807916|FG011|Overall Study|Miscellaneous|0|||
128867103|NCT03829501|463807917|FG012|Overall Study|Miscellaneous|0|||
128867104|NCT03829501|463807918|FG013|Overall Study|Miscellaneous|0|||
128867105|NCT03829501|463807919|FG014|Overall Study|Miscellaneous|0|||
128867106|NCT03829501|463807920|FG015|Overall Study|Miscellaneous|0|||
128867107|NCT03829501|463807921|FG016|Overall Study|Miscellaneous|0|||
128867108|NCT03829501|463807922|FG017|Overall Study|Miscellaneous|0|||
128867109|NCT03829501|463807923|FG018|Overall Study|Miscellaneous|0|||
128867110|NCT03829501|463807924|FG019|Overall Study|Miscellaneous|0|||
128867111|NCT03829501|463807925|FG020|Overall Study|Miscellaneous|0|||
128867112|NCT03829501|463807926|FG021|Overall Study|Miscellaneous|0|||
128867113|NCT03829501|463807927|FG022|Overall Study|Miscellaneous|1|||
128867114|NCT01123070|463807928|FG000|Part B Double Blind Period|Protocol Violation|0|||
128867115|NCT01123070|463807929|FG001|Part B Double Blind Period|Protocol Violation|0|||
128867116|NCT01123070|463807930|FG002|Part B Double Blind Period|Protocol Violation|0|||
128867117|NCT01123070|463807931|FG003|Part B Double Blind Period|Protocol Violation|1|||
128867118|NCT01123070|463807928|FG000|Part B Double Blind Period|Adverse Event|0|||
128867119|NCT01123070|463807929|FG001|Part B Double Blind Period|Adverse Event|0|||
128867120|NCT01123070|463807930|FG002|Part B Double Blind Period|Adverse Event|2|||
128867121|NCT01123070|463807931|FG003|Part B Double Blind Period|Adverse Event|0|||
128867122|NCT01123070|463807928|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
128867123|NCT01123070|463807929|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
128867124|NCT01123070|463807930|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
128867125|NCT01123070|463807931|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
128867126|NCT03284229|463807932|FG000|Overall Study|Lost to Follow-up|3|||
128867127|NCT01332630|463807933|FG000|Overall Study|Withdrawal by Subject|3|||
128867128|NCT03140280|463807934|FG000|Overall Study|Physician Decision|5|||
128867129|NCT01977677|463807943|FG000|Overall Study|Unrelated Adverse Event|0|||
128867130|NCT01977677|463807944|FG001|Overall Study|Unrelated Adverse Event|0|||
128867131|NCT01977677|463807945|FG002|Overall Study|Unrelated Adverse Event|1|||
128867132|NCT01498887|463807946|FG000|Overall Study|Administrative problems|1|||
128867133|NCT01498887|463807947|FG001|Overall Study|Administrative problems|0|||
128867134|NCT01498887|463807946|FG000|Overall Study|Lost to Follow-up|1|||
128867135|NCT01498887|463807947|FG001|Overall Study|Lost to Follow-up|1|||
128867136|NCT01498887|463807946|FG000|Overall Study|Withdrawal by Subject|1|||
128867137|NCT01498887|463807947|FG001|Overall Study|Withdrawal by Subject|0|||
128867138|NCT01498887|463807946|FG000|Overall Study|Protocol Violation|1|||
128867139|NCT01498887|463807947|FG001|Overall Study|Protocol Violation|3|||
128867140|NCT01498887|463807946|FG000|Overall Study|Lack of Efficacy|5|||
128867141|NCT01498887|463807947|FG001|Overall Study|Lack of Efficacy|3|||
128867142|NCT01498887|463807946|FG000|Overall Study|Abnormal result from test procedure|1|||
128867143|NCT01498887|463807947|FG001|Overall Study|Abnormal result from test procedure|1|||
128867144|NCT01498887|463807946|FG000|Overall Study|Abnormal laboratory value|2|||
128867145|NCT01498887|463807947|FG001|Overall Study|Abnormal laboratory value|2|||
128867146|NCT01498887|463807946|FG000|Overall Study|Adverse Event|4|||
128867147|NCT01498887|463807947|FG001|Overall Study|Adverse Event|1|||
128867148|NCT00667225|463807950|FG000|Overall Study|Subject had no more lesions to treat.|1|||
128867149|NCT00667225|463807951|FG001|Overall Study|Subject had no more lesions to treat.|0|||
128867150|NCT00667225|463807950|FG000|Overall Study|Lost to Follow-up|0|||
128867151|NCT00667225|463807951|FG001|Overall Study|Lost to Follow-up|1|||
128867152|NCT05262517|463807952|FG000|Overall Study|Randomized but not treated|5|||
128867153|NCT05262517|463807953|FG001|Overall Study|Randomized but not treated|11|||
128867154|NCT00626197|463807957|FG000|Overall Study|Did not cooperate|2|||
128867155|NCT00626197|463807958|FG001|Overall Study|Did not cooperate|6|||
128867156|NCT00626197|463807959|FG002|Overall Study|Did not cooperate|1|||
128867157|NCT00626197|463807957|FG000|Overall Study|Failure to return|6|||
128867158|NCT00626197|463807958|FG001|Overall Study|Failure to return|5|||
128867159|NCT00626197|463807959|FG002|Overall Study|Failure to return|6|||
128867160|NCT00626197|463807957|FG000|Overall Study|Adverse event, serious fatal|3|||
128867161|NCT00626197|463807958|FG001|Overall Study|Adverse event, serious fatal|6|||
128867162|NCT00626197|463807959|FG002|Overall Study|Adverse event, serious fatal|6|||
128867163|NCT00626197|463807957|FG000|Overall Study|Adverse Event|1|||
128867164|NCT00626197|463807958|FG001|Overall Study|Adverse Event|1|||
128867165|NCT00626197|463807959|FG002|Overall Study|Adverse Event|2|||
128867166|NCT00626197|463807957|FG000|Overall Study|Withdrawal by Subject|17|||
128867167|NCT00626197|463807958|FG001|Overall Study|Withdrawal by Subject|17|||
128867168|NCT00626197|463807959|FG002|Overall Study|Withdrawal by Subject|7|||
128867169|NCT00626197|463807957|FG000|Overall Study|Administrative reasons|15|||
128867170|NCT00626197|463807958|FG001|Overall Study|Administrative reasons|19|||
128867171|NCT00626197|463807959|FG002|Overall Study|Administrative reasons|55|||
128867172|NCT04833127|463807960|FG000|Overall Study|Lost to Follow-up|1|||
128867173|NCT04833127|463807961|FG001|Overall Study|Lost to Follow-up|1|||
128867174|NCT04552899|463807964|FG000|Overall Study|Adverse Event|4|||
128867175|NCT04552899|463807965|FG001|Overall Study|Adverse Event|3|||
128867176|NCT04552899|463807964|FG000|Overall Study|Death|4|||
128867177|NCT04552899|463807965|FG001|Overall Study|Death|4|||
128867178|NCT04552899|463807964|FG000|Overall Study|Lost to Follow-up|8|||
128867179|NCT04552899|463807965|FG001|Overall Study|Lost to Follow-up|13|||
128867180|NCT04552899|463807964|FG000|Overall Study|Lung Transplant|4|||
128867181|NCT04552899|463807965|FG001|Overall Study|Lung Transplant|3|||
128867182|NCT04552899|463807964|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
128867183|NCT04552899|463807965|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
128867184|NCT04552899|463807964|FG000|Overall Study|Physician Decision|3|||
128867185|NCT04552899|463807965|FG001|Overall Study|Physician Decision|4|||
128867186|NCT04552899|463807964|FG000|Overall Study|Study Terminated By Sponsor|237|||
128867187|NCT04552899|463807965|FG001|Overall Study|Study Terminated By Sponsor|239|||
128867188|NCT04552899|463807964|FG000|Overall Study|Withdrawal by Subject|15|||
128867189|NCT04552899|463807965|FG001|Overall Study|Withdrawal by Subject|17|||
128867190|NCT00461981|463807969|FG000|Overall Study|Lost to Follow-up|9|||
128867191|NCT00461981|463807970|FG001|Overall Study|Lost to Follow-up|6|||
128867192|NCT00461981|463807969|FG000|Overall Study|Withdrawal by Subject|2|||
128867193|NCT00461981|463807970|FG001|Overall Study|Withdrawal by Subject|3|||
128867194|NCT00731133|463807974|FG000|Overall Study|Withdrawal by Subject|10|||
128867195|NCT03510455|463807975|FG000|Overall Study|Physician Decision|1|||
128867196|NCT04958642|463807982|FG000|Overall Study|Transferred to OLEX program|3|||
128867197|NCT04958642|463807983|FG001|Overall Study|Transferred to OLEX program|0|||
128867198|NCT04958642|463807984|FG002|Overall Study|Transferred to OLEX program|5|||
128867199|NCT04958642|463807982|FG000|Overall Study|Death|0|||
128867200|NCT04958642|463807983|FG001|Overall Study|Death|0|||
128867201|NCT04958642|463807984|FG002|Overall Study|Death|1|||
128867202|NCT04958642|463807982|FG000|Overall Study|Withdrawal by Subject|4|||
128867203|NCT04958642|463807983|FG001|Overall Study|Withdrawal by Subject|9|||
128867204|NCT04958642|463807984|FG002|Overall Study|Withdrawal by Subject|13|||
128867205|NCT04958642|463807982|FG000|Overall Study|Investigator's Decision|0|||
128867206|NCT04958642|463807983|FG001|Overall Study|Investigator's Decision|0|||
128867207|NCT04958642|463807984|FG002|Overall Study|Investigator's Decision|1|||
128867208|NCT04958642|463807982|FG000|Overall Study|Adverse Event|1|||
128867209|NCT04958642|463807983|FG001|Overall Study|Adverse Event|0|||
128867210|NCT04958642|463807984|FG002|Overall Study|Adverse Event|1|||
128867211|NCT04958642|463807982|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
128867212|NCT04958642|463807983|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
128867213|NCT04958642|463807984|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
128867214|NCT04958642|463807982|FG000|Overall Study|Lost to Follow-up|1|||
128867215|NCT04958642|463807983|FG001|Overall Study|Lost to Follow-up|0|||
128867216|NCT04958642|463807984|FG002|Overall Study|Lost to Follow-up|0|||
128867217|NCT04958642|463807982|FG000|Overall Study|Transferred to EAP following study termination|0|||
128867218|NCT04958642|463807983|FG001|Overall Study|Transferred to EAP following study termination|0|||
128867219|NCT04958642|463807984|FG002|Overall Study|Transferred to EAP following study termination|1|||
128867220|NCT04958642|463807982|FG000|Overall Study|Transferred to Expanded Access Program|1|||
128867221|NCT04958642|463807983|FG001|Overall Study|Transferred to Expanded Access Program|0|||
128867222|NCT04958642|463807984|FG002|Overall Study|Transferred to Expanded Access Program|0|||
128867223|NCT03853551|463807988|FG000|Overall Study|Death|2|||
128867224|NCT03853551|463807988|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
128867225|NCT02476175|463807989|FG000|Overall Study|Adverse Event|2|||
128867226|NCT02964325|463807992|FG000|Overall Study|Lost to Follow-up|3|||
128867227|NCT02964325|463807993|FG001|Overall Study|Lost to Follow-up|3|||
128867228|NCT02964325|463807992|FG000|Overall Study|Physician Decision|5|||
128867229|NCT02964325|463807993|FG001|Overall Study|Physician Decision|4|||
128867230|NCT02964325|463807992|FG000|Overall Study|Death|1|||
128867231|NCT02964325|463807993|FG001|Overall Study|Death|3|||
128867232|NCT02964325|463807992|FG000|Overall Study|Withdrawal by Subject|2|||
128867233|NCT02964325|463807993|FG001|Overall Study|Withdrawal by Subject|1|||
128867234|NCT02964325|463807992|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
128867235|NCT02964325|463807993|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
128867236|NCT02510040|463807994|FG000|Overall Study|Deemed no longer eligible|18|||
128867237|NCT02510040|463807995|FG001|Overall Study|Deemed no longer eligible|3|||
128867238|NCT02510040|463807996|FG002|Overall Study|Deemed no longer eligible|1|||
128867239|NCT00534495|463808003|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
128867240|NCT00534495|463808004|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
128867241|NCT00534495|463808005|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
128867242|NCT00534495|463808003|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
128867243|NCT00534495|463808004|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
128867244|NCT00534495|463808005|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
128867245|NCT00534495|463808003|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
128867246|NCT00534495|463808004|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
128867247|NCT00534495|463808005|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
128867248|NCT00534495|463808003|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
128867249|NCT00534495|463808004|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
128867250|NCT00534495|463808005|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
128867251|NCT00534495|463808003|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
128867252|NCT00534495|463808004|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
128867253|NCT00534495|463808005|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
128867254|NCT00534495|463808003|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
128867255|NCT00534495|463808004|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
128867256|NCT00534495|463808005|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
128867257|NCT00534495|463808003|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
128867258|NCT00534495|463808004|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
128867259|NCT00534495|463808005|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
128867260|NCT00534495|463808003|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
128867261|NCT00534495|463808004|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
128867262|NCT00534495|463808005|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
128867263|NCT00534495|463808003|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
128867264|NCT00534495|463808004|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
128867265|NCT00534495|463808005|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
128867266|NCT04230122|463808006|FG000|Overall Study|Lost to Follow-up|1|||
128867267|NCT04230122|463808007|FG001|Overall Study|Lost to Follow-up|0|||
128867268|NCT00818779|463808008|FG000|Overall Study|Protocol Violation|1|||
128867269|NCT00818779|463808009|FG001|Overall Study|Protocol Violation|0|||
128867270|NCT00818779|463808008|FG000|Overall Study|Lost to Follow-up|1|||
128867271|NCT00818779|463808009|FG001|Overall Study|Lost to Follow-up|0|||
128867272|NCT00818779|463808008|FG000|Overall Study|Adverse Event|4|||
128867273|NCT00818779|463808009|FG001|Overall Study|Adverse Event|1|||
128867274|NCT04978493|463808010|FG000|Overall Study|No reason available|0|||
128867275|NCT04978493|463808011|FG001|Overall Study|No reason available|1|||
128867276|NCT04978493|463808010|FG000|Overall Study|Adverse Event|1|||
128867277|NCT04978493|463808011|FG001|Overall Study|Adverse Event|0|||
128867278|NCT01254747|463808012|FG000|Overall Study|Unacceptable subjective vision|0|||
128867279|NCT01254747|463808013|FG001|Overall Study|Unacceptable subjective vision|0|||
128867280|NCT01254747|463808014|FG002|Overall Study|Unacceptable subjective vision|0|||
128867281|NCT01254747|463808015|FG003|Overall Study|Unacceptable subjective vision|2|||
128867282|NCT01254747|463808012|FG000|Overall Study|Difficult removal handling|0|||
128867283|NCT01254747|463808013|FG001|Overall Study|Difficult removal handling|0|||
128867284|NCT01254747|463808014|FG002|Overall Study|Difficult removal handling|1|||
128867285|NCT01254747|463808015|FG003|Overall Study|Difficult removal handling|0|||
128867286|NCT01254747|463808012|FG000|Overall Study|Symptoms and problems|0|||
128867287|NCT01254747|463808013|FG001|Overall Study|Symptoms and problems|2|||
128867288|NCT01254747|463808014|FG002|Overall Study|Symptoms and problems|1|||
128867289|NCT01254747|463808015|FG003|Overall Study|Symptoms and problems|0|||
128867290|NCT01254747|463808012|FG000|Overall Study|Lost to Follow-up|0|||
128867291|NCT01254747|463808013|FG001|Overall Study|Lost to Follow-up|0|||
128867292|NCT01254747|463808014|FG002|Overall Study|Lost to Follow-up|1|||
128867293|NCT01254747|463808015|FG003|Overall Study|Lost to Follow-up|0|||
128867294|NCT01254747|463808012|FG000|Overall Study|Biomicroscopy|0|||
128867295|NCT01254747|463808013|FG001|Overall Study|Biomicroscopy|0|||
128867296|NCT01254747|463808014|FG002|Overall Study|Biomicroscopy|1|||
128867297|NCT01254747|463808015|FG003|Overall Study|Biomicroscopy|0|||
128867298|NCT01254747|463808012|FG000|Overall Study|Discomfort|0|||
128867299|NCT01254747|463808013|FG001|Overall Study|Discomfort|4|||
128867300|NCT01254747|463808014|FG002|Overall Study|Discomfort|0|||
128867301|NCT01254747|463808015|FG003|Overall Study|Discomfort|0|||
128867302|NCT00316017|463808016|FG000|Overall Study|Protocol Violation|11|||
128867303|NCT00316017|463808017|FG001|Overall Study|Protocol Violation|13|||
128867304|NCT00316017|463808018|FG002|Overall Study|Protocol Violation|19|||
128867305|NCT01217437|463808019|FG000|Overall Study|Adverse Event|0|||
128867306|NCT01217437|463808020|FG001|Overall Study|Adverse Event|8|||
128867307|NCT01217437|463808019|FG000|Overall Study|Death|5|||
128867308|NCT01217437|463808020|FG001|Overall Study|Death|0|||
128867309|NCT01217437|463808019|FG000|Overall Study|Lack of Efficacy|29|||
128867310|NCT01217437|463808020|FG001|Overall Study|Lack of Efficacy|25|||
128867311|NCT01217437|463808019|FG000|Overall Study|Physician Decision|8|||
128867312|NCT01217437|463808020|FG001|Overall Study|Physician Decision|5|||
128867313|NCT01217437|463808019|FG000|Overall Study|Withdrawal by Subject|0|||
128867314|NCT01217437|463808020|FG001|Overall Study|Withdrawal by Subject|2|||
128867315|NCT01217437|463808019|FG000|Overall Study|Ineligible|1|||
128867316|NCT01217437|463808020|FG001|Overall Study|Ineligible|1|||
128867317|NCT03841526|463808021|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
128867318|NCT03841526|463808022|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
128867319|NCT03841526|463808023|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
128867320|NCT03841526|463808024|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
128867321|NCT03841526|463808025|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
128867322|NCT03841526|463808026|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
128867323|NCT03841526|463808021|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
128867324|NCT03841526|463808022|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
128867325|NCT03841526|463808023|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
128867326|NCT03841526|463808024|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
128867327|NCT03841526|463808025|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
128867328|NCT03841526|463808026|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
128867329|NCT03841526|463808021|FG000|Outpatient Phase Treatment|Physician Decision|0|||
128867330|NCT03841526|463808022|FG001|Outpatient Phase Treatment|Physician Decision|1|||
128867331|NCT03841526|463808023|FG002|Outpatient Phase Treatment|Physician Decision|0|||
128867332|NCT03841526|463808024|FG003|Outpatient Phase Treatment|Physician Decision|0|||
128867333|NCT03841526|463808025|FG004|Outpatient Phase Treatment|Physician Decision|0|||
128867334|NCT03841526|463808026|FG005|Outpatient Phase Treatment|Physician Decision|0|||
128867335|NCT03841526|463808021|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
128867336|NCT03841526|463808022|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
128867337|NCT03841526|463808023|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
128867338|NCT03841526|463808024|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
128867339|NCT03841526|463808025|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
128867340|NCT03841526|463808026|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
128867341|NCT06748729|463808028|FG000|Overall Study|Withdrawal by Subject|1|||
128867342|NCT04165031|463809282|FG000|Overall Study|Adverse Event|1|||
128867343|NCT04165031|463809283|FG001|Overall Study|Adverse Event|1|||
128867344|NCT04165031|463809284|FG002|Overall Study|Adverse Event|0|||
128867345|NCT04165031|463809285|FG003|Overall Study|Adverse Event|0|||
128867346|NCT04165031|463809286|FG004|Overall Study|Adverse Event|0|||
128867347|NCT04165031|463809287|FG005|Overall Study|Adverse Event|0|||
128867348|NCT04165031|463809282|FG000|Overall Study|Withdrawal by Subject|0|||
128867349|NCT04165031|463809283|FG001|Overall Study|Withdrawal by Subject|0|||
128867350|NCT04165031|463809284|FG002|Overall Study|Withdrawal by Subject|1|||
128867351|NCT04165031|463809285|FG003|Overall Study|Withdrawal by Subject|0|||
128867352|NCT04165031|463809286|FG004|Overall Study|Withdrawal by Subject|0|||
128867353|NCT04165031|463809287|FG005|Overall Study|Withdrawal by Subject|0|||
128867354|NCT00663702|463809292|FG000|Overall Study|Adverse Event|8|||
128867355|NCT00663702|463809293|FG001|Overall Study|Adverse Event|4|||
128867356|NCT00663702|463809292|FG000|Overall Study|Withdrawal by Subject|3|||
128867357|NCT00663702|463809293|FG001|Overall Study|Withdrawal by Subject|1|||
128867358|NCT00663702|463809292|FG000|Overall Study|Pregnancy|0|||
128867359|NCT00663702|463809293|FG001|Overall Study|Pregnancy|1|||
128867360|NCT00663702|463809292|FG000|Overall Study|Lost to Follow-up|3|||
128867361|NCT00663702|463809293|FG001|Overall Study|Lost to Follow-up|0|||
128867362|NCT00663702|463809292|FG000|Overall Study|Death|1|||
128867363|NCT00663702|463809293|FG001|Overall Study|Death|1|||
128867364|NCT00663702|463809292|FG000|Overall Study|Lack of Efficacy|3|||
128867365|NCT00663702|463809293|FG001|Overall Study|Lack of Efficacy|3|||
128867366|NCT02993406|463809296|FG000|Overall Study|Withdrawal by Subject|170|||
128867367|NCT02993406|463809297|FG001|Overall Study|Withdrawal by Subject|196|||
128867368|NCT02993406|463809296|FG000|Overall Study|Physician Decision|3|||
128867369|NCT02993406|463809297|FG001|Overall Study|Physician Decision|5|||
128867370|NCT02993406|463809296|FG000|Overall Study|Lost to Follow-up|12|||
128867371|NCT02993406|463809297|FG001|Overall Study|Lost to Follow-up|13|||
128867372|NCT02993406|463809296|FG000|Overall Study|Unclassifiable Response|105|||
128867373|NCT02993406|463809297|FG001|Overall Study|Unclassifiable Response|139|||
128867374|NCT02993406|463809296|FG000|Overall Study|Administrative decision|1|||
128867375|NCT02993406|463809297|FG001|Overall Study|Administrative decision|0|||
128867376|NCT02993406|463809296|FG000|Overall Study|Sponsor decision|4|||
128867377|NCT02993406|463809297|FG001|Overall Study|Sponsor decision|5|||
128867378|NCT02248818|463809298|FG000|Screening|Protocol Violation|0|||
128867379|NCT02248818|463809299|FG001|Screening|Protocol Violation|0|||
128867380|NCT02248818|463809300|FG002|Screening|Protocol Violation|0|||
128867381|NCT02248818|463809301|FG003|Screening|Protocol Violation|0|||
128867382|NCT02248818|463809302|FG004|Screening|Protocol Violation|0|||
128867383|NCT02248818|463809303|FG005|Screening|Protocol Violation|0|||
128867384|NCT02248818|463809304|FG006|Screening|Protocol Violation|0|||
128867385|NCT02248818|463809305|FG007|Screening|Protocol Violation|0|||
128867386|NCT02248818|463809306|FG008|Screening|Protocol Violation|7|||
128867387|NCT02248818|463809298|FG000|Screening|Study fully enrolled|0|||
128867388|NCT02248818|463809299|FG001|Screening|Study fully enrolled|0|||
128867389|NCT02248818|463809300|FG002|Screening|Study fully enrolled|0|||
128867390|NCT02248818|463809301|FG003|Screening|Study fully enrolled|0|||
128867391|NCT02248818|463809302|FG004|Screening|Study fully enrolled|0|||
128867392|NCT02248818|463809303|FG005|Screening|Study fully enrolled|0|||
128867393|NCT02248818|463809304|FG006|Screening|Study fully enrolled|0|||
128867394|NCT02248818|463809305|FG007|Screening|Study fully enrolled|0|||
128867395|NCT02248818|463809306|FG008|Screening|Study fully enrolled|14|||
128867396|NCT02248818|463809298|FG000|Screening|Physician Decision|0|||
128867397|NCT02248818|463809299|FG001|Screening|Physician Decision|0|||
128867398|NCT02248818|463809300|FG002|Screening|Physician Decision|0|||
128867399|NCT02248818|463809301|FG003|Screening|Physician Decision|0|||
128867400|NCT02248818|463809302|FG004|Screening|Physician Decision|0|||
128867401|NCT02248818|463809303|FG005|Screening|Physician Decision|0|||
128867402|NCT02248818|463809304|FG006|Screening|Physician Decision|0|||
128867403|NCT02248818|463809305|FG007|Screening|Physician Decision|0|||
128867404|NCT02248818|463809306|FG008|Screening|Physician Decision|73|||
128867405|NCT02248818|463809298|FG000|Screening|Withdrawal by Subject|0|||
128867406|NCT02248818|463809299|FG001|Screening|Withdrawal by Subject|0|||
128867407|NCT02248818|463809300|FG002|Screening|Withdrawal by Subject|0|||
128867408|NCT02248818|463809301|FG003|Screening|Withdrawal by Subject|0|||
128867409|NCT02248818|463809302|FG004|Screening|Withdrawal by Subject|0|||
128867410|NCT02248818|463809303|FG005|Screening|Withdrawal by Subject|0|||
128867411|NCT02248818|463809304|FG006|Screening|Withdrawal by Subject|0|||
128867412|NCT02248818|463809305|FG007|Screening|Withdrawal by Subject|0|||
128867413|NCT02248818|463809306|FG008|Screening|Withdrawal by Subject|6|||
128867414|NCT02248818|463809298|FG000|Screening|Lost to Follow-up|0|||
128867415|NCT02248818|463809299|FG001|Screening|Lost to Follow-up|0|||
128867416|NCT02248818|463809300|FG002|Screening|Lost to Follow-up|0|||
128867417|NCT02248818|463809301|FG003|Screening|Lost to Follow-up|0|||
128867418|NCT02248818|463809302|FG004|Screening|Lost to Follow-up|0|||
128867419|NCT02248818|463809303|FG005|Screening|Lost to Follow-up|0|||
128867420|NCT02248818|463809304|FG006|Screening|Lost to Follow-up|0|||
128867421|NCT02248818|463809305|FG007|Screening|Lost to Follow-up|0|||
128867422|NCT02248818|463809306|FG008|Screening|Lost to Follow-up|7|||
128867423|NCT02248818|463809298|FG000|Randomised Study|Administrative - randomization error|0|||
128867424|NCT02248818|463809299|FG001|Randomised Study|Administrative - randomization error|0|||
128867425|NCT02248818|463809300|FG002|Randomised Study|Administrative - randomization error|0|||
128867426|NCT02248818|463809301|FG003|Randomised Study|Administrative - randomization error|0|||
128867427|NCT02248818|463809302|FG004|Randomised Study|Administrative - randomization error|0|||
128867428|NCT02248818|463809303|FG005|Randomised Study|Administrative - randomization error|8|||
128867429|NCT02248818|463809304|FG006|Randomised Study|Administrative - randomization error|0|||
128867430|NCT02248818|463809305|FG007|Randomised Study|Administrative - randomization error|0|||
128867431|NCT02248818|463809306|FG008|Randomised Study|Administrative - randomization error|0|||
128867432|NCT04325282|463809307|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
128867433|NCT04325282|463809308|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
128867434|NCT04325282|463809307|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
128867435|NCT04325282|463809308|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
128867436|NCT01283152|463809312|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
128867437|NCT01283152|463809313|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
128867438|NCT01283152|463809312|FG000|Overall Study|Refused HESA|1|||
128867439|NCT01283152|463809313|FG001|Overall Study|Refused HESA|0|||
128867440|NCT02643303|463809318|FG000|Overall Study|Progressive Disease|4|||
128867441|NCT02643303|463809319|FG001|Overall Study|Progressive Disease|4|||
128867442|NCT02643303|463809320|FG002|Overall Study|Progressive Disease|1|||
128867443|NCT02643303|463809321|FG003|Overall Study|Progressive Disease|12|||
128867444|NCT02643303|463809322|FG004|Overall Study|Progressive Disease|6|||
128867445|NCT02643303|463809323|FG005|Overall Study|Progressive Disease|4|||
128867446|NCT02643303|463809324|FG006|Overall Study|Progressive Disease|8|||
128867447|NCT02643303|463809325|FG007|Overall Study|Progressive Disease|2|||
128867448|NCT02643303|463809326|FG008|Overall Study|Progressive Disease|6|||
128867449|NCT02643303|463809318|FG000|Overall Study|Adverse Event|0|||
128867450|NCT02643303|463809319|FG001|Overall Study|Adverse Event|1|||
128867451|NCT02643303|463809320|FG002|Overall Study|Adverse Event|0|||
128867452|NCT02643303|463809321|FG003|Overall Study|Adverse Event|0|||
128867453|NCT02643303|463809322|FG004|Overall Study|Adverse Event|1|||
128867454|NCT02643303|463809323|FG005|Overall Study|Adverse Event|0|||
128867455|NCT02643303|463809324|FG006|Overall Study|Adverse Event|0|||
128867456|NCT02643303|463809325|FG007|Overall Study|Adverse Event|0|||
128867457|NCT02643303|463809326|FG008|Overall Study|Adverse Event|0|||
128867458|NCT02643303|463809318|FG000|Overall Study|Withdrawal by Subject|0|||
128867459|NCT02643303|463809319|FG001|Overall Study|Withdrawal by Subject|0|||
128867460|NCT02643303|463809320|FG002|Overall Study|Withdrawal by Subject|0|||
128867461|NCT02643303|463809321|FG003|Overall Study|Withdrawal by Subject|1|||
128867462|NCT02643303|463809322|FG004|Overall Study|Withdrawal by Subject|0|||
128867463|NCT02643303|463809323|FG005|Overall Study|Withdrawal by Subject|0|||
128867464|NCT02643303|463809324|FG006|Overall Study|Withdrawal by Subject|1|||
128867465|NCT02643303|463809325|FG007|Overall Study|Withdrawal by Subject|1|||
128867466|NCT02643303|463809326|FG008|Overall Study|Withdrawal by Subject|1|||
128867467|NCT01499303|463809333|FG000|Overall Study|Ongoing|2|||
128867468|NCT01499303|463809334|FG001|Overall Study|Ongoing|1|||
128867469|NCT01499303|463809333|FG000|Overall Study|Withdrawal by Subject|0|||
128867470|NCT01499303|463809334|FG001|Overall Study|Withdrawal by Subject|1|||
128867471|NCT01499303|463809333|FG000|Overall Study|Adverse Event|1|||
128867472|NCT01499303|463809334|FG001|Overall Study|Adverse Event|4|||
128867473|NCT01499303|463809333|FG000|Overall Study|Other|0|||
128867474|NCT01499303|463809334|FG001|Overall Study|Other|1|||
128867475|NCT04939701|463809337|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
128867476|NCT04939701|463809338|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
128867477|NCT04939701|463809339|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
128867478|NCT04939701|463809337|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
128867479|NCT04939701|463809338|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
128867480|NCT04939701|463809339|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
128867481|NCT04939701|463809337|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
128867482|NCT04939701|463809338|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
128867483|NCT04939701|463809339|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
128867484|NCT04939701|463809337|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
128867485|NCT04939701|463809338|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
128867486|NCT04939701|463809339|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
128867487|NCT04939701|463809337|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
128867488|NCT04939701|463809338|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
128867489|NCT04939701|463809339|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
128867490|NCT04939701|463809337|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
128867491|NCT04939701|463809338|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
128867492|NCT04939701|463809339|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
128867493|NCT04939701|463809337|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
128867494|NCT04939701|463809338|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
128867495|NCT04939701|463809339|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
128867496|NCT02383940|463809340|FG000|Overall Study|Adverse Event|1|||
128867497|NCT02383940|463809341|FG001|Overall Study|Adverse Event|0|||
128867498|NCT02383940|463809340|FG000|Overall Study|Lost to Follow-up|2|||
128867499|NCT02383940|463809341|FG001|Overall Study|Lost to Follow-up|2|||
128867500|NCT02383940|463809340|FG000|Overall Study|Physician Decision|2|||
128867501|NCT02383940|463809341|FG001|Overall Study|Physician Decision|0|||
128867502|NCT02383940|463809340|FG000|Overall Study|Withdrawal by Subject|1|||
128867503|NCT02383940|463809341|FG001|Overall Study|Withdrawal by Subject|1|||
128867504|NCT02383940|463809340|FG000|Overall Study|Randomized but not treated|2|||
128867505|NCT02383940|463809341|FG001|Overall Study|Randomized but not treated|0|||
128867506|NCT02383940|463809340|FG000|Overall Study|Other than specified above|1|||
128867507|NCT02383940|463809341|FG001|Overall Study|Other than specified above|0|||
128867508|NCT02672852|463809343|FG000|Part A1|Disease Worsening|1|||
128867509|NCT02672852|463809344|FG001|Part A1|Disease Worsening|0|||
128867510|NCT02672852|463809345|FG002|Part A1|Disease Worsening|0|||
128867511|NCT02672852|463809346|FG003|Part A1|Disease Worsening|0|||
128867512|NCT02672852|463809347|FG004|Part A1|Disease Worsening|0|||
128867513|NCT02672852|463809348|FG005|Part A1|Disease Worsening|0|||
128867514|NCT02672852|463809349|FG006|Part A1|Disease Worsening|0|||
128867515|NCT02672852|463809343|FG000|Part A1|Adverse Event|0|||
128867516|NCT02672852|463809344|FG001|Part A1|Adverse Event|1|||
128867517|NCT02672852|463809345|FG002|Part A1|Adverse Event|0|||
128867518|NCT02672852|463809346|FG003|Part A1|Adverse Event|0|||
128867519|NCT02672852|463809347|FG004|Part A1|Adverse Event|0|||
128867520|NCT02672852|463809348|FG005|Part A1|Adverse Event|0|||
128867521|NCT02672852|463809349|FG006|Part A1|Adverse Event|0|||
128867522|NCT02672852|463809343|FG000|Part A1|Lost to Follow-up|1|||
128867523|NCT02672852|463809344|FG001|Part A1|Lost to Follow-up|2|||
128867524|NCT02672852|463809345|FG002|Part A1|Lost to Follow-up|0|||
128867525|NCT02672852|463809346|FG003|Part A1|Lost to Follow-up|0|||
128867526|NCT02672852|463809347|FG004|Part A1|Lost to Follow-up|0|||
128867527|NCT02672852|463809348|FG005|Part A1|Lost to Follow-up|0|||
128867528|NCT02672852|463809349|FG006|Part A1|Lost to Follow-up|0|||
128867529|NCT02672852|463809343|FG000|Part A1|Withdrawal by Subject|1|||
128867530|NCT02672852|463809344|FG001|Part A1|Withdrawal by Subject|1|||
128867531|NCT02672852|463809345|FG002|Part A1|Withdrawal by Subject|0|||
128867532|NCT02672852|463809346|FG003|Part A1|Withdrawal by Subject|0|||
128867533|NCT02672852|463809347|FG004|Part A1|Withdrawal by Subject|0|||
128867534|NCT02672852|463809348|FG005|Part A1|Withdrawal by Subject|0|||
128867535|NCT02672852|463809349|FG006|Part A1|Withdrawal by Subject|0|||
128867536|NCT02672852|463809343|FG000|Part A2|Disease worsening|0|||
128867537|NCT02672852|463809344|FG001|Part A2|Disease worsening|0|||
128867538|NCT02672852|463809345|FG002|Part A2|Disease worsening|1|||
128867539|NCT02672852|463809346|FG003|Part A2|Disease worsening|0|||
128867540|NCT02672852|463809347|FG004|Part A2|Disease worsening|0|||
128867541|NCT02672852|463809348|FG005|Part A2|Disease worsening|0|||
128867542|NCT02672852|463809349|FG006|Part A2|Disease worsening|0|||
128867543|NCT02672852|463809343|FG000|Part A2|Adverse Event|0|||
128867544|NCT02672852|463809344|FG001|Part A2|Adverse Event|0|||
128867545|NCT02672852|463809345|FG002|Part A2|Adverse Event|3|||
128867546|NCT02672852|463809346|FG003|Part A2|Adverse Event|0|||
128867547|NCT02672852|463809347|FG004|Part A2|Adverse Event|0|||
128867548|NCT02672852|463809348|FG005|Part A2|Adverse Event|0|||
128867549|NCT02672852|463809349|FG006|Part A2|Adverse Event|0|||
128867550|NCT02672852|463809343|FG000|Part A2|Lost to Follow-up|0|||
128867551|NCT02672852|463809344|FG001|Part A2|Lost to Follow-up|0|||
128867552|NCT02672852|463809345|FG002|Part A2|Lost to Follow-up|2|||
128867553|NCT02672852|463809346|FG003|Part A2|Lost to Follow-up|0|||
128867554|NCT02672852|463809347|FG004|Part A2|Lost to Follow-up|0|||
128867555|NCT02672852|463809348|FG005|Part A2|Lost to Follow-up|0|||
128867556|NCT02672852|463809349|FG006|Part A2|Lost to Follow-up|0|||
128867557|NCT02672852|463809343|FG000|Part A2|Withdrawal by Subject|0|||
128867558|NCT02672852|463809344|FG001|Part A2|Withdrawal by Subject|0|||
128867559|NCT02672852|463809345|FG002|Part A2|Withdrawal by Subject|1|||
128867560|NCT02672852|463809346|FG003|Part A2|Withdrawal by Subject|0|||
128867561|NCT02672852|463809347|FG004|Part A2|Withdrawal by Subject|0|||
128867562|NCT02672852|463809348|FG005|Part A2|Withdrawal by Subject|0|||
128867563|NCT02672852|463809349|FG006|Part A2|Withdrawal by Subject|0|||
128867564|NCT02672852|463809343|FG000|Part A2|Other|0|||
128867565|NCT02672852|463809344|FG001|Part A2|Other|0|||
128867566|NCT02672852|463809345|FG002|Part A2|Other|3|||
128867567|NCT02672852|463809346|FG003|Part A2|Other|0|||
128867568|NCT02672852|463809347|FG004|Part A2|Other|0|||
128867569|NCT02672852|463809348|FG005|Part A2|Other|0|||
128867570|NCT02672852|463809349|FG006|Part A2|Other|0|||
128867571|NCT02672852|463809343|FG000|Part A2|Not entered in Part B|0|||
128867572|NCT02672852|463809344|FG001|Part A2|Not entered in Part B|0|||
128867573|NCT02672852|463809345|FG002|Part A2|Not entered in Part B|0|||
128867574|NCT02672852|463809346|FG003|Part A2|Not entered in Part B|4|||
128867575|NCT02672852|463809347|FG004|Part A2|Not entered in Part B|0|||
128867576|NCT02672852|463809348|FG005|Part A2|Not entered in Part B|0|||
128867577|NCT02672852|463809349|FG006|Part A2|Not entered in Part B|0|||
128867578|NCT02672852|463809343|FG000|Part B|Disease worsening|0|||
128867579|NCT02672852|463809344|FG001|Part B|Disease worsening|0|||
128867580|NCT02672852|463809345|FG002|Part B|Disease worsening|0|||
128867581|NCT02672852|463809346|FG003|Part B|Disease worsening|0|||
128867582|NCT02672852|463809347|FG004|Part B|Disease worsening|1|||
128867583|NCT02672852|463809348|FG005|Part B|Disease worsening|0|||
128867584|NCT02672852|463809349|FG006|Part B|Disease worsening|1|||
128867585|NCT02672852|463809343|FG000|Part B|Worsening pre-existing condition|0|||
128867586|NCT02672852|463809344|FG001|Part B|Worsening pre-existing condition|0|||
128867587|NCT02672852|463809345|FG002|Part B|Worsening pre-existing condition|0|||
128867588|NCT02672852|463809346|FG003|Part B|Worsening pre-existing condition|0|||
128867589|NCT02672852|463809347|FG004|Part B|Worsening pre-existing condition|0|||
128867590|NCT02672852|463809348|FG005|Part B|Worsening pre-existing condition|1|||
128867591|NCT02672852|463809349|FG006|Part B|Worsening pre-existing condition|0|||
128867592|NCT02672852|463809343|FG000|Part B|Other adverse event|0|||
128867593|NCT02672852|463809344|FG001|Part B|Other adverse event|0|||
128867594|NCT02672852|463809345|FG002|Part B|Other adverse event|0|||
128867595|NCT02672852|463809346|FG003|Part B|Other adverse event|0|||
128867596|NCT02672852|463809347|FG004|Part B|Other adverse event|3|||
128867597|NCT02672852|463809348|FG005|Part B|Other adverse event|5|||
128867598|NCT02672852|463809349|FG006|Part B|Other adverse event|1|||
128867599|NCT02672852|463809343|FG000|Part B|Lost to Follow-up|0|||
128867600|NCT02672852|463809344|FG001|Part B|Lost to Follow-up|0|||
128867601|NCT02672852|463809345|FG002|Part B|Lost to Follow-up|0|||
128867602|NCT02672852|463809346|FG003|Part B|Lost to Follow-up|0|||
128867603|NCT02672852|463809347|FG004|Part B|Lost to Follow-up|3|||
128867604|NCT02672852|463809348|FG005|Part B|Lost to Follow-up|4|||
128867605|NCT02672852|463809349|FG006|Part B|Lost to Follow-up|1|||
128867606|NCT02672852|463809343|FG000|Part B|Withdrawal by Subject|0|||
128867607|NCT02672852|463809344|FG001|Part B|Withdrawal by Subject|0|||
128867608|NCT02672852|463809345|FG002|Part B|Withdrawal by Subject|0|||
128867609|NCT02672852|463809346|FG003|Part B|Withdrawal by Subject|0|||
128867610|NCT02672852|463809347|FG004|Part B|Withdrawal by Subject|5|||
128867611|NCT02672852|463809348|FG005|Part B|Withdrawal by Subject|0|||
128867612|NCT02672852|463809349|FG006|Part B|Withdrawal by Subject|7|||
128867613|NCT02672852|463809343|FG000|Part B|Other|0|||
128867614|NCT02672852|463809344|FG001|Part B|Other|0|||
128867615|NCT02672852|463809345|FG002|Part B|Other|0|||
128867616|NCT02672852|463809346|FG003|Part B|Other|0|||
128867617|NCT02672852|463809347|FG004|Part B|Other|4|||
128867618|NCT02672852|463809348|FG005|Part B|Other|1|||
128867619|NCT02672852|463809349|FG006|Part B|Other|2|||
128867620|NCT01876901|463809351|FG000|Overall Study|Protocol Violation|10|||
128867621|NCT01876901|463809352|FG001|Overall Study|Protocol Violation|2|||
128867622|NCT01876901|463809351|FG000|Overall Study|No or other surgical intervention|7|||
128867623|NCT01876901|463809352|FG001|Overall Study|No or other surgical intervention|5|||
128867624|NCT01598662|463809353|FG000|Overall Study|Lost to Follow-up|10|||
128867625|NCT01598662|463809354|FG001|Overall Study|Lost to Follow-up|17|||
128867626|NCT01598662|463809353|FG000|Overall Study|Physician Decision|1|||
128867627|NCT01598662|463809354|FG001|Overall Study|Physician Decision|2|||
128867628|NCT01598662|463809353|FG000|Overall Study|IUD expelled before month 6|0|||
128867629|NCT01598662|463809354|FG001|Overall Study|IUD expelled before month 6|2|||
128867630|NCT00643617|463809355|FG000|Overall Study|Death|6|||
128867631|NCT00643617|463809356|FG001|Overall Study|Death|9|||
128867632|NCT00643617|463809355|FG000|Overall Study|Lost to Follow-up|42|||
128867633|NCT00643617|463809356|FG001|Overall Study|Lost to Follow-up|51|||
128867634|NCT02683785|463809359|FG000|Overall Study|Withdrawal by Subject|1|||
128867635|NCT02683785|463809360|FG001|Overall Study|Withdrawal by Subject|1|||
128867636|NCT02683785|463809359|FG000|Overall Study|Lost to Follow-up|0|||
128867637|NCT02683785|463809360|FG001|Overall Study|Lost to Follow-up|1|||
128867638|NCT02683785|463809359|FG000|Overall Study|Adverse Event|0|||
128867639|NCT02683785|463809360|FG001|Overall Study|Adverse Event|2|||
128867640|NCT02233803|463809365|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
128867641|NCT02233803|463809366|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
128867642|NCT02233803|463809365|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
128867643|NCT02233803|463809366|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
128867644|NCT02233803|463809365|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
128867645|NCT02233803|463809366|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
128867646|NCT02233803|463809365|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
128867647|NCT02233803|463809366|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
128867648|NCT02233803|463809365|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
128867649|NCT02233803|463809366|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
128867650|NCT02233803|463809365|FG000|Washout Period (4-Wks)|Physician Decision|1|||
128867651|NCT02233803|463809366|FG001|Washout Period (4-Wks)|Physician Decision|0|||
128867652|NCT02233803|463809365|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
128867653|NCT02233803|463809366|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
128867654|NCT02233803|463809365|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
128867655|NCT02233803|463809366|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
128867656|NCT02233803|463809365|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
128867657|NCT02233803|463809366|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
128867658|NCT03635099|463809367|FG000|Period 1|Adverse Event|1|||
128867659|NCT03635099|463809368|FG001|Period 1|Adverse Event|0|||
128867660|NCT03635099|463809369|FG002|Period 1|Adverse Event|0|||
128867661|NCT03635099|463809370|FG003|Period 1|Adverse Event|1|||
128867662|NCT03635099|463809371|FG004|Period 1|Adverse Event|0|||
128867663|NCT03635099|463809372|FG005|Period 1|Adverse Event|0|||
128867664|NCT03635099|463809373|FG006|Period 1|Adverse Event|0|||
128867665|NCT03635099|463809374|FG007|Period 1|Adverse Event|0|||
128867666|NCT03635099|463809367|FG000|Period 1|Protocol Violation|0|||
128867667|NCT03635099|463809368|FG001|Period 1|Protocol Violation|0|||
128867668|NCT03635099|463809369|FG002|Period 1|Protocol Violation|1|||
128867669|NCT03635099|463809370|FG003|Period 1|Protocol Violation|0|||
128867670|NCT03635099|463809371|FG004|Period 1|Protocol Violation|0|||
128867671|NCT03635099|463809372|FG005|Period 1|Protocol Violation|0|||
128867672|NCT03635099|463809373|FG006|Period 1|Protocol Violation|0|||
128867673|NCT03635099|463809374|FG007|Period 1|Protocol Violation|0|||
128867674|NCT03635099|463809367|FG000|Period 1|Lost to Follow-up|0|||
128867675|NCT03635099|463809368|FG001|Period 1|Lost to Follow-up|0|||
128867676|NCT03635099|463809369|FG002|Period 1|Lost to Follow-up|1|||
128867677|NCT03635099|463809370|FG003|Period 1|Lost to Follow-up|2|||
128867678|NCT03635099|463809371|FG004|Period 1|Lost to Follow-up|1|||
128867679|NCT03635099|463809372|FG005|Period 1|Lost to Follow-up|0|||
128867680|NCT03635099|463809373|FG006|Period 1|Lost to Follow-up|1|||
128867681|NCT03635099|463809374|FG007|Period 1|Lost to Follow-up|2|||
128867682|NCT03635099|463809367|FG000|Period 1|Withdrawal by Subject|3|||
128867683|NCT03635099|463809368|FG001|Period 1|Withdrawal by Subject|3|||
128867684|NCT03635099|463809369|FG002|Period 1|Withdrawal by Subject|5|||
128867685|NCT03635099|463809370|FG003|Period 1|Withdrawal by Subject|2|||
128867686|NCT03635099|463809371|FG004|Period 1|Withdrawal by Subject|2|||
128867687|NCT03635099|463809372|FG005|Period 1|Withdrawal by Subject|0|||
128867688|NCT03635099|463809373|FG006|Period 1|Withdrawal by Subject|3|||
128867689|NCT03635099|463809374|FG007|Period 1|Withdrawal by Subject|0|||
128867690|NCT03635099|463809367|FG000|Period 1|History of suicidal ideation|0|||
128867691|NCT03635099|463809368|FG001|Period 1|History of suicidal ideation|0|||
128867692|NCT03635099|463809369|FG002|Period 1|History of suicidal ideation|1|||
128867693|NCT03635099|463809370|FG003|Period 1|History of suicidal ideation|0|||
128867694|NCT03635099|463809371|FG004|Period 1|History of suicidal ideation|0|||
128867695|NCT03635099|463809372|FG005|Period 1|History of suicidal ideation|0|||
128867696|NCT03635099|463809373|FG006|Period 1|History of suicidal ideation|0|||
128867697|NCT03635099|463809374|FG007|Period 1|History of suicidal ideation|0|||
128867698|NCT03635099|463809367|FG000|Period 1|pursue other treatment options|0|||
128867699|NCT03635099|463809368|FG001|Period 1|pursue other treatment options|0|||
128867700|NCT03635099|463809369|FG002|Period 1|pursue other treatment options|0|||
128867701|NCT03635099|463809370|FG003|Period 1|pursue other treatment options|0|||
128867702|NCT03635099|463809371|FG004|Period 1|pursue other treatment options|0|||
128867703|NCT03635099|463809372|FG005|Period 1|pursue other treatment options|1|||
128867704|NCT03635099|463809373|FG006|Period 1|pursue other treatment options|0|||
128867705|NCT03635099|463809374|FG007|Period 1|pursue other treatment options|0|||
128867706|NCT03635099|463809367|FG000|Not Eligible for Period 2|Pregnancy|0|||
128867707|NCT03635099|463809368|FG001|Not Eligible for Period 2|Pregnancy|0|||
128867708|NCT03635099|463809369|FG002|Not Eligible for Period 2|Pregnancy|0|||
128867709|NCT03635099|463809370|FG003|Not Eligible for Period 2|Pregnancy|1|||
128867710|NCT03635099|463809371|FG004|Not Eligible for Period 2|Pregnancy|0|||
128867711|NCT03635099|463809372|FG005|Not Eligible for Period 2|Pregnancy|0|||
128867712|NCT03635099|463809373|FG006|Not Eligible for Period 2|Pregnancy|0|||
128867713|NCT03635099|463809374|FG007|Not Eligible for Period 2|Pregnancy|0|||
128867714|NCT03635099|463809367|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
128867715|NCT03635099|463809368|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
128867716|NCT03635099|463809369|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
128867717|NCT03635099|463809370|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
128867718|NCT03635099|463809371|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
128867719|NCT03635099|463809372|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
128867720|NCT03635099|463809373|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
128867721|NCT03635099|463809374|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
128867722|NCT03635099|463809367|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
128867723|NCT03635099|463809368|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
128867724|NCT03635099|463809369|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
128867725|NCT03635099|463809370|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
128867726|NCT03635099|463809371|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
128867727|NCT03635099|463809372|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
128867728|NCT03635099|463809373|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
128867729|NCT03635099|463809374|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
128867730|NCT03635099|463809367|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
128867731|NCT03635099|463809368|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
128867732|NCT03635099|463809369|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
128867733|NCT03635099|463809370|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
128867734|NCT03635099|463809371|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
128867735|NCT03635099|463809372|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
128867736|NCT03635099|463809373|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
128867737|NCT03635099|463809374|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
128867738|NCT03635099|463809367|FG000|Period 2|Adverse Event|0|||
128867739|NCT03635099|463809368|FG001|Period 2|Adverse Event|0|||
128867740|NCT03635099|463809369|FG002|Period 2|Adverse Event|1|||
128867741|NCT03635099|463809370|FG003|Period 2|Adverse Event|0|||
128867742|NCT03635099|463809371|FG004|Period 2|Adverse Event|1|||
128867743|NCT03635099|463809372|FG005|Period 2|Adverse Event|0|||
128867744|NCT03635099|463809373|FG006|Period 2|Adverse Event|0|||
128867745|NCT03635099|463809374|FG007|Period 2|Adverse Event|0|||
128867746|NCT03635099|463809367|FG000|Period 2|Lost to Follow-up|0|||
128867747|NCT03635099|463809368|FG001|Period 2|Lost to Follow-up|0|||
128867748|NCT03635099|463809369|FG002|Period 2|Lost to Follow-up|1|||
128867749|NCT03635099|463809370|FG003|Period 2|Lost to Follow-up|0|||
128867750|NCT03635099|463809371|FG004|Period 2|Lost to Follow-up|4|||
128867751|NCT03635099|463809372|FG005|Period 2|Lost to Follow-up|0|||
128867752|NCT03635099|463809373|FG006|Period 2|Lost to Follow-up|0|||
128867753|NCT03635099|463809374|FG007|Period 2|Lost to Follow-up|0|||
128867754|NCT03635099|463809367|FG000|Period 2|Withdrawal by Subject|0|||
128867755|NCT03635099|463809368|FG001|Period 2|Withdrawal by Subject|0|||
128867756|NCT03635099|463809369|FG002|Period 2|Withdrawal by Subject|7|||
128867757|NCT03635099|463809370|FG003|Period 2|Withdrawal by Subject|4|||
128867758|NCT03635099|463809371|FG004|Period 2|Withdrawal by Subject|7|||
128867759|NCT03635099|463809372|FG005|Period 2|Withdrawal by Subject|0|||
128867760|NCT03635099|463809373|FG006|Period 2|Withdrawal by Subject|0|||
128867761|NCT03635099|463809374|FG007|Period 2|Withdrawal by Subject|0|||
128867762|NCT04191616|463809377|FG000|Pre-assignment Period|Did not receive study treatment|2|||
128867763|NCT04191616|463809377|FG000|Treatment Period|Death|37|||
128867764|NCT04191616|463809377|FG000|Treatment Period|Sponsor decision|11|||
128867765|NCT04191616|463809377|FG000|Treatment Period|Withdrawal by Subject|4|||
128867766|NCT02180243|463809378|FG000|Overall Study|Withdrawal by Subject|12|||
128867767|NCT02180243|463809379|FG001|Overall Study|Withdrawal by Subject|12|||
128867768|NCT02180243|463809378|FG000|Overall Study|Lost to Follow-up|12|||
128867769|NCT02180243|463809379|FG001|Overall Study|Lost to Follow-up|2|||
128867770|NCT01840410|463809383|FG000|Overall Study|Physician Decision|1|||
128867771|NCT01840410|463809384|FG001|Overall Study|Physician Decision|2|||
128867772|NCT01840410|463809383|FG000|Overall Study|Pregnancy|1|||
128867773|NCT01840410|463809384|FG001|Overall Study|Pregnancy|0|||
128867774|NCT01840410|463809383|FG000|Overall Study|Protocol deviation|1|||
128867775|NCT01840410|463809384|FG001|Overall Study|Protocol deviation|0|||
128867776|NCT01840410|463809383|FG000|Overall Study|Lost to Follow-up|1|||
128867777|NCT01840410|463809384|FG001|Overall Study|Lost to Follow-up|0|||
128867778|NCT01840410|463809383|FG000|Overall Study|Withdrawal by Subject|2|||
128867779|NCT01840410|463809384|FG001|Overall Study|Withdrawal by Subject|1|||
128867780|NCT01840410|463809383|FG000|Overall Study|Adverse Event|1|||
128867781|NCT01840410|463809384|FG001|Overall Study|Adverse Event|1|||
128867782|NCT05235269|463809391|FG000|Overall Study|Adverse Event|1|||
128867783|NCT05235269|463809391|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
128867784|NCT05235269|463809391|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
128867785|NCT00798434|463809392|FG000|Double-Blind|Adverse Event|22|||
128867786|NCT00798434|463809393|FG001|Double-Blind|Adverse Event|46|||
128867787|NCT00798434|463809392|FG000|Double-Blind|Death|0|||
128867788|NCT00798434|463809393|FG001|Double-Blind|Death|1|||
128867789|NCT00798434|463809392|FG000|Double-Blind|Lost to Follow-up|1|||
128867790|NCT00798434|463809393|FG001|Double-Blind|Lost to Follow-up|0|||
128867791|NCT00798434|463809392|FG000|Double-Blind|Lack of Efficacy|8|||
128867792|NCT00798434|463809393|FG001|Double-Blind|Lack of Efficacy|12|||
128867793|NCT00798434|463809392|FG000|Double-Blind|Withdrawal by Subject|17|||
128867794|NCT00798434|463809393|FG001|Double-Blind|Withdrawal by Subject|14|||
128867795|NCT00798434|463809392|FG000|Double-Blind|Protocol Violation|1|||
128867796|NCT00798434|463809393|FG001|Double-Blind|Protocol Violation|4|||
128867797|NCT00798434|463809392|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
128867798|NCT00798434|463809393|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
128867799|NCT00798434|463809392|FG000|Double-Blind|Other|1|||
128867800|NCT00798434|463809393|FG001|Double-Blind|Other|0|||
128867801|NCT00798434|463809392|FG000|Double-Blind|Not Treated|3|||
128867802|NCT00798434|463809393|FG001|Double-Blind|Not Treated|6|||
128867803|NCT00798434|463809392|FG000|Open-Label|Adverse Event|33|||
128867804|NCT00798434|463809393|FG001|Open-Label|Adverse Event|11|||
128867805|NCT00798434|463809392|FG000|Open-Label|Lack of Efficacy|5|||
128867806|NCT00798434|463809393|FG001|Open-Label|Lack of Efficacy|11|||
128867807|NCT00798434|463809392|FG000|Open-Label|Withdrawal by Subject|2|||
128867808|NCT00798434|463809393|FG001|Open-Label|Withdrawal by Subject|7|||
128867809|NCT00798434|463809392|FG000|Open-Label|Protocol Violation|1|||
128867810|NCT00798434|463809393|FG001|Open-Label|Protocol Violation|0|||
128867811|NCT00798434|463809392|FG000|Open-Label|Other|1|||
128867812|NCT00798434|463809393|FG001|Open-Label|Other|2|||
128867813|NCT00798434|463809392|FG000|Open-Label|Not Treated|0|||
128867814|NCT00798434|463809393|FG001|Open-Label|Not Treated|1|||
128867815|NCT03898167|463809394|FG000|Overall Study|Terminated phone call early|7|||
128867816|NCT03898167|463809395|FG001|Overall Study|Terminated phone call early|0|||
128867817|NCT03898167|463809396|FG002|Overall Study|Terminated phone call early|0|||
128867818|NCT03898167|463809394|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
128867819|NCT03898167|463809395|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
128867820|NCT03898167|463809396|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
128867821|NCT05177354|463809397|FG000|Implant to 30-day Visit|Physician Decision|1|||
128867822|NCT05177354|463809397|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
128867823|NCT05177354|463809397|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
128867824|NCT05177354|463809397|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
128867825|NCT03548220|463809399|FG000|Overall Study|Lost to Follow-up|1|||
128867826|NCT03548220|463809400|FG001|Overall Study|Lost to Follow-up|0|||
128867827|NCT03548220|463809401|FG002|Overall Study|Lost to Follow-up|0|||
128867828|NCT03548220|463809402|FG003|Overall Study|Lost to Follow-up|0|||
128867829|NCT03570892|463809403|FG000|Overall Study|Death|51|||
128867830|NCT03570892|463809404|FG001|Overall Study|Death|45|||
128867831|NCT03570892|463809403|FG000|Overall Study|Subject decision|5|||
128867832|NCT03570892|463809404|FG001|Overall Study|Subject decision|3|||
128867833|NCT03570892|463809403|FG000|Overall Study|Protocol Violation|1|||
128867834|NCT03570892|463809404|FG001|Overall Study|Protocol Violation|4|||
128867835|NCT03570892|463809403|FG000|Overall Study|Physician Decision|0|||
128867836|NCT03570892|463809404|FG001|Overall Study|Physician Decision|2|||
128867837|NCT01099215|463810623|FG000|Overall Study|Withdrawal by Subject|1|||
128867838|NCT01099215|463810624|FG001|Overall Study|Withdrawal by Subject|0|||
128867839|NCT01099215|463810623|FG000|Overall Study|Adverse Event|0|||
128867840|NCT01099215|463810624|FG001|Overall Study|Adverse Event|1|||
128867841|NCT00747227|463810626|FG000|Overall Study|Death|3|||
128867842|NCT00747227|463810627|FG001|Overall Study|Death|1|||
128867843|NCT00747227|463810626|FG000|Overall Study|Withdrawal by Subject|1|||
128867844|NCT00747227|463810627|FG001|Overall Study|Withdrawal by Subject|0|||
128867845|NCT00747227|463810626|FG000|Overall Study|Lost to Follow-up|1|||
128867846|NCT00747227|463810627|FG001|Overall Study|Lost to Follow-up|2|||
128867847|NCT00747227|463810626|FG000|Overall Study|Illness|1|||
128867848|NCT00747227|463810627|FG001|Overall Study|Illness|1|||
128867849|NCT03554629|463810628|FG000|Overall Study|Inadequate data|6|||
128867850|NCT00515671|463810635|FG000|Overall Study|Lost to Follow-up|13|||
128867851|NCT00515671|463810636|FG001|Overall Study|Lost to Follow-up|10|||
128867852|NCT00515671|463810635|FG000|Overall Study|Withdrawal by Subject|3|||
128867853|NCT00515671|463810636|FG001|Overall Study|Withdrawal by Subject|5|||
128867854|NCT00515671|463810635|FG000|Overall Study|incarcerated|1|||
128867855|NCT00515671|463810636|FG001|Overall Study|incarcerated|2|||
128867856|NCT00288639|463810639|FG000|Overall Study|Adverse Event|5|||
128867857|NCT00288639|463810639|FG000|Overall Study|Lack of Efficacy|4|||
128867858|NCT00288639|463810639|FG000|Overall Study|Withdrawal by Subject|2|||
128867859|NCT00288639|463810639|FG000|Overall Study|Other|1|||
128867860|NCT01014208|463810648|FG000|Overall Study|Lost to Follow-up|2|||
128867861|NCT01014208|463810649|FG001|Overall Study|Lost to Follow-up|5|||
128867862|NCT01014208|463810648|FG000|Overall Study|Participant Withdrew Consent|12|||
128867863|NCT01014208|463810649|FG001|Overall Study|Participant Withdrew Consent|12|||
128867864|NCT01014208|463810648|FG000|Overall Study|Did Not Receive Study Drug|2|||
128867865|NCT01014208|463810649|FG001|Overall Study|Did Not Receive Study Drug|0|||
128867866|NCT01014208|463810648|FG000|Overall Study|Study Closed/terminated|78|||
128867867|NCT01014208|463810649|FG001|Overall Study|Study Closed/terminated|83|||
128867868|NCT04020185|463810650|FG000|Overall Study|Death|0|||
128867869|NCT04020185|463810651|FG001|Overall Study|Death|0|||
128867870|NCT04020185|463810652|FG002|Overall Study|Death|1|||
128867871|NCT04020185|463810653|FG003|Overall Study|Death|2|||
128867872|NCT04020185|463810654|FG004|Overall Study|Death|1|||
128867873|NCT04020185|463810655|FG005|Overall Study|Death|0|||
128867874|NCT04020185|463810656|FG006|Overall Study|Death|1|||
128867875|NCT04020185|463810657|FG007|Overall Study|Death|0|||
128867876|NCT04020185|463810650|FG000|Overall Study|Consent withdrawn|1|||
128867877|NCT04020185|463810651|FG001|Overall Study|Consent withdrawn|0|||
128867878|NCT04020185|463810652|FG002|Overall Study|Consent withdrawn|0|||
128867879|NCT04020185|463810653|FG003|Overall Study|Consent withdrawn|0|||
128867880|NCT04020185|463810654|FG004|Overall Study|Consent withdrawn|2|||
128867881|NCT04020185|463810655|FG005|Overall Study|Consent withdrawn|0|||
128867882|NCT04020185|463810656|FG006|Overall Study|Consent withdrawn|1|||
128867883|NCT04020185|463810657|FG007|Overall Study|Consent withdrawn|1|||
128867884|NCT04020185|463810650|FG000|Overall Study|Patient in hospice|0|||
128867885|NCT04020185|463810651|FG001|Overall Study|Patient in hospice|1|||
128867886|NCT04020185|463810652|FG002|Overall Study|Patient in hospice|0|||
128867887|NCT04020185|463810653|FG003|Overall Study|Patient in hospice|0|||
128867888|NCT04020185|463810654|FG004|Overall Study|Patient in hospice|0|||
128867889|NCT04020185|463810655|FG005|Overall Study|Patient in hospice|0|||
128867890|NCT04020185|463810656|FG006|Overall Study|Patient in hospice|0|||
128867891|NCT04020185|463810657|FG007|Overall Study|Patient in hospice|0|||
128867892|NCT04020185|463810650|FG000|Overall Study|Continuing on expanded access|0|||
128867893|NCT04020185|463810651|FG001|Overall Study|Continuing on expanded access|0|||
128867894|NCT04020185|463810652|FG002|Overall Study|Continuing on expanded access|0|||
128867895|NCT04020185|463810653|FG003|Overall Study|Continuing on expanded access|0|||
128867896|NCT04020185|463810654|FG004|Overall Study|Continuing on expanded access|0|||
128867897|NCT04020185|463810655|FG005|Overall Study|Continuing on expanded access|0|||
128867898|NCT04020185|463810656|FG006|Overall Study|Continuing on expanded access|1|||
128867899|NCT04020185|463810657|FG007|Overall Study|Continuing on expanded access|1|||
128867900|NCT00527787|463810659|FG000|Overall Study|Adverse Event|14|||
128867901|NCT00527787|463810660|FG001|Overall Study|Adverse Event|24|||
128867902|NCT00527787|463810659|FG000|Overall Study|Withdrawal by Subject|13|||
128867903|NCT00527787|463810660|FG001|Overall Study|Withdrawal by Subject|25|||
128867904|NCT00527787|463810659|FG000|Overall Study|Lost to Follow-up|5|||
128867905|NCT00527787|463810660|FG001|Overall Study|Lost to Follow-up|2|||
128867906|NCT00527787|463810659|FG000|Overall Study|Duodenal Ulcer|1|||
128867907|NCT00527787|463810660|FG001|Overall Study|Duodenal Ulcer|10|||
128867908|NCT00527787|463810659|FG000|Overall Study|misc|5|||
128867909|NCT00527787|463810660|FG001|Overall Study|misc|2|||
128867910|NCT03433677|463810661|FG000|Period 1|Protocol Violation|1|||
128867911|NCT03433677|463810662|FG001|Period 1|Protocol Violation|0|||
128867912|NCT03433677|463810661|FG000|Period 2|Withdrawal by Subject|1|||
128867913|NCT03433677|463810662|FG001|Period 2|Withdrawal by Subject|1|||
128867914|NCT04308590|463810663|FG000|Overall Study|Adverse Event|12|||
128867915|NCT04308590|463810664|FG001|Overall Study|Adverse Event|2|||
128867916|NCT04308590|463810663|FG000|Overall Study|Withdrawal by Subject|10|||
128867917|NCT04308590|463810664|FG001|Overall Study|Withdrawal by Subject|4|||
128867918|NCT04308590|463810663|FG000|Overall Study|Death|1|||
128867919|NCT04308590|463810664|FG001|Overall Study|Death|0|||
128867920|NCT04308590|463810663|FG000|Overall Study|Lost to Follow-up|1|||
128867921|NCT04308590|463810664|FG001|Overall Study|Lost to Follow-up|1|||
128867922|NCT04308590|463810663|FG000|Overall Study|Physician Decision|1|||
128867923|NCT04308590|463810664|FG001|Overall Study|Physician Decision|0|||
128867924|NCT04308590|463810663|FG000|Overall Study|Subject does not want to continue with Pi|0|||
128867925|NCT04308590|463810664|FG001|Overall Study|Subject does not want to continue with Pi|1|||
128867926|NCT05487586|463810665|FG000|Overall Study|Death|22|||
128867927|NCT05487586|463810665|FG000|Overall Study|Physician Decision|1|||
128867928|NCT05487586|463810665|FG000|Overall Study|Transfer to another hospital|4|||
128867929|NCT05487586|463810665|FG000|Overall Study|Other|1|||
128867930|NCT00565773|463810666|FG000|Overall Study|Withdrawal by Subject|1|||
128867931|NCT00565773|463810666|FG000|Overall Study|Physician Decision|1|||
128867932|NCT04798781|463810667|FG000|Overall Study|Withdrawal by Subject|1|||
128867933|NCT00702962|463810668|FG000|Overall Study|Progressive disease|0|||
128867934|NCT00702962|463810669|FG001|Overall Study|Progressive disease|1|||
128867935|NCT00702962|463810668|FG000|Overall Study|Hospitalized for other health disorder|1|||
128867936|NCT00702962|463810669|FG001|Overall Study|Hospitalized for other health disorder|0|||
128867937|NCT02175641|463810672|FG000|Overall Study|Death|3|||
128867938|NCT02175641|463810673|FG001|Overall Study|Death|4|||
128867939|NCT02175641|463810672|FG000|Overall Study|Lost to Follow-up|4|||
128867940|NCT02175641|463810673|FG001|Overall Study|Lost to Follow-up|4|||
128867941|NCT02175641|463810672|FG000|Overall Study|Withdrawal by Subject|7|||
128867942|NCT02175641|463810673|FG001|Overall Study|Withdrawal by Subject|4|||
128867943|NCT02175641|463810672|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
128867944|NCT02175641|463810673|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
128867945|NCT02175641|463810672|FG000|Overall Study|Developed Contraindicated Condition|8|||
128867946|NCT02175641|463810673|FG001|Overall Study|Developed Contraindicated Condition|0|||
128867947|NCT01923467|463810674|FG000|Overall Study|Lost to Follow-up|62|||
128867948|NCT01923467|463810674|FG000|Overall Study|Subject non-interest|479|||
128867949|NCT03921723|463810675|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
128867950|NCT03921723|463810675|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
128867951|NCT03015129|463810676|FG000|Overall Study|Death|2|||
128867952|NCT03015129|463810677|FG001|Overall Study|Death|2|||
128867953|NCT03015129|463810676|FG000|Overall Study|Lost to Follow-up|0|||
128867954|NCT03015129|463810677|FG001|Overall Study|Lost to Follow-up|1|||
128867955|NCT03015129|463810676|FG000|Overall Study|Progression of disease|38|||
128867956|NCT03015129|463810677|FG001|Overall Study|Progression of disease|33|||
128867957|NCT03015129|463810676|FG000|Overall Study|Adverse Event|0|||
128867958|NCT03015129|463810677|FG001|Overall Study|Adverse Event|4|||
128867959|NCT02242097|463810678|FG000|Ibrutinib Treatment|Adverse Event|16|||
128867960|NCT02242097|463810678|FG000|Ibrutinib Treatment|Physician Decision|1|||
128867961|NCT02242097|463810678|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
128867962|NCT02242097|463810678|FG000|Ibrutinib Treatment|Death|1|||
128867963|NCT02242097|463810678|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
128867964|NCT02242097|463810678|FG000|Post Therapy Follow Up|Death|3|||
128867965|NCT02242097|463810678|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
128867966|NCT02574845|463810681|FG000|Overall Study|Consent withdrawn further participation|0|||
128867967|NCT02574845|463810682|FG001|Overall Study|Consent withdrawn further participation|0|||
128867968|NCT02574845|463810683|FG002|Overall Study|Consent withdrawn further participation|0|||
128867969|NCT02574845|463810684|FG003|Overall Study|Consent withdrawn further participation|0|||
128867970|NCT02574845|463810685|FG004|Overall Study|Consent withdrawn further participation|1|||
128867971|NCT02574845|463810686|FG005|Overall Study|Consent withdrawn further participation|0|||
128867972|NCT02574845|463810681|FG000|Overall Study|Adverse Event|0|||
128867973|NCT02574845|463810682|FG001|Overall Study|Adverse Event|1|||
128867974|NCT02574845|463810683|FG002|Overall Study|Adverse Event|0|||
128867975|NCT02574845|463810684|FG003|Overall Study|Adverse Event|0|||
128867976|NCT02574845|463810685|FG004|Overall Study|Adverse Event|0|||
128867977|NCT02574845|463810686|FG005|Overall Study|Adverse Event|1|||
128867978|NCT03435692|463810688|FG000|Overall Study|Lack of Efficacy|2|||
128867979|NCT03435692|463810689|FG001|Overall Study|Lack of Efficacy|2|||
128867980|NCT03435692|463810690|FG002|Overall Study|Lack of Efficacy|0|||
128867981|NCT01712061|463810695|FG000|Overall Study|Adverse Event|4|||
128867982|NCT01712061|463810696|FG001|Overall Study|Adverse Event|9|||
128867983|NCT01712061|463810697|FG002|Overall Study|Adverse Event|5|||
128867984|NCT01712061|463810695|FG000|Overall Study|Death|0|||
128867985|NCT01712061|463810696|FG001|Overall Study|Death|0|||
128867986|NCT01712061|463810697|FG002|Overall Study|Death|1|||
128867987|NCT01712061|463810695|FG000|Overall Study|Lost to Follow-up|1|||
128867988|NCT01712061|463810696|FG001|Overall Study|Lost to Follow-up|0|||
128867989|NCT01712061|463810697|FG002|Overall Study|Lost to Follow-up|1|||
128867990|NCT01712061|463810695|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
128867991|NCT01712061|463810696|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
128867992|NCT01712061|463810697|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
128867993|NCT01712061|463810695|FG000|Overall Study|Medication Error Without Associated AE|0|||
128867994|NCT01712061|463810696|FG001|Overall Study|Medication Error Without Associated AE|1|||
128867995|NCT01712061|463810697|FG002|Overall Study|Medication Error Without Associated AE|0|||
128867996|NCT01712061|463810695|FG000|Overall Study|Withdrawal by Subject|1|||
128867997|NCT01712061|463810696|FG001|Overall Study|Withdrawal by Subject|7|||
128867998|NCT01712061|463810697|FG002|Overall Study|Withdrawal by Subject|1|||
128867999|NCT01712061|463810695|FG000|Overall Study|Other|0|||
128868000|NCT01712061|463810696|FG001|Overall Study|Other|3|||
128868001|NCT01712061|463810697|FG002|Overall Study|Other|0|||
128868002|NCT00879775|463810698|FG000|Overall Study|Lost to Follow-up|2|||
128868003|NCT00879775|463810699|FG001|Overall Study|Lost to Follow-up|1|||
128868004|NCT01401153|463810701|FG000|First Test Day|Learning disabilities; illness|1|||
128868005|NCT01401153|463810702|FG001|First Test Day|Learning disabilities; illness|10|||
128868006|NCT01401153|463810701|FG000|Second Test Day|illness|0|||
128868007|NCT01401153|463810702|FG001|Second Test Day|illness|5|||
128868008|NCT00214019|463810703|FG000|Overall Study|Lost to Follow-up|11|||
128868009|NCT00214019|463810703|FG000|Overall Study|Withdrawal by Subject|2|||
128868010|NCT00214019|463810703|FG000|Overall Study|Screen Failed prior to randomization|17|||
128868011|NCT01677767|463810706|FG000|Overall Study|Adverse Event|1|||
128868012|NCT01677767|463810706|FG000|Overall Study|Death|4|||
128868013|NCT01677767|463810706|FG000|Overall Study|Protocol Violation|4|||
128868014|NCT01677767|463810706|FG000|Overall Study|Withdrawal by Subject|10|||
128868015|NCT01677767|463810706|FG000|Overall Study|Non-compliance by the participants|3|||
128868016|NCT03846453|463810707|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
128868017|NCT03846453|463810708|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
128868018|NCT03846453|463810709|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
128868019|NCT03846453|463810707|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
128868020|NCT03846453|463810708|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
128868021|NCT03846453|463810709|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
128868022|NCT03846453|463810707|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
128868023|NCT03846453|463810708|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
128868024|NCT03846453|463810709|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
128868025|NCT03846453|463810707|FG000|Placebo Run-in (14 Days)|Other|2|||
128868026|NCT03846453|463810708|FG001|Placebo Run-in (14 Days)|Other|0|||
128868027|NCT03846453|463810709|FG002|Placebo Run-in (14 Days)|Other|0|||
128868028|NCT03846453|463810707|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
128868029|NCT03846453|463810708|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
128868030|NCT03846453|463810709|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
128868031|NCT03846453|463810707|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
128868032|NCT03846453|463810708|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
128868033|NCT03846453|463810709|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
128868034|NCT03846453|463810707|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
128868035|NCT03846453|463810708|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
128868036|NCT03846453|463810709|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
128868037|NCT03846453|463810707|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
128868038|NCT03846453|463810708|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
128868039|NCT03846453|463810709|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
128868040|NCT03846453|463810707|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
128868041|NCT03846453|463810708|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
128868042|NCT03846453|463810709|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
128868043|NCT00757627|463810710|FG000|Overall Study|Adverse Event|15|||
128868044|NCT00757627|463810710|FG000|Overall Study|Lack of Efficacy|10|||
128868045|NCT00757627|463810710|FG000|Overall Study|Lost to Follow-up|28|||
128868046|NCT00757627|463810710|FG000|Overall Study|Withdrawal by Subject|27|||
128868047|NCT00757627|463810710|FG000|Overall Study|Other|1|||
128868048|NCT00468143|463810711|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
128868049|NCT00468143|463810712|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
128868050|NCT00468143|463810711|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
128868051|NCT00468143|463810712|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
128868052|NCT01606670|463810713|FG000|Overall Study|Adverse Event|6|||
128868053|NCT01606670|463810713|FG000|Overall Study|Lack of Efficacy|2|||
128868054|NCT01606670|463810713|FG000|Overall Study|Lost to Follow-up|3|||
128868055|NCT01606670|463810713|FG000|Overall Study|Withdrawal by Subject|3|||
128868056|NCT01606670|463810713|FG000|Overall Study|Other Reason|2|||
128868057|NCT02906007|463810719|FG000|Overall Study|Physician Decision|0|||
128868058|NCT02906007|463810720|FG001|Overall Study|Physician Decision|0|||
128868059|NCT02906007|463810721|FG002|Overall Study|Physician Decision|1|||
128868060|NCT02906007|463810719|FG000|Overall Study|Died|1|||
128868061|NCT02906007|463810720|FG001|Overall Study|Died|0|||
128868062|NCT02906007|463810721|FG002|Overall Study|Died|0|||
128868063|NCT01946529|463810722|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
128868064|NCT01946529|463810723|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
128868065|NCT01946529|463810724|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
128868066|NCT01946529|463810722|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
128868067|NCT01946529|463810723|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
128868068|NCT01946529|463810724|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
128868069|NCT06655558|463810725|FG000|Overall Study|Protocol Violation|1|||
128868070|NCT03578887|463810734|FG000|Overall Study|Withdrawal by Subject|7|||
128868071|NCT03578887|463810735|FG001|Overall Study|Withdrawal by Subject|2|||
128868072|NCT03578887|463810736|FG002|Overall Study|Withdrawal by Subject|1|||
128868073|NCT03578887|463810734|FG000|Overall Study|Lost to Follow-up|13|||
128868074|NCT03578887|463810735|FG001|Overall Study|Lost to Follow-up|1|||
128868075|NCT03578887|463810736|FG002|Overall Study|Lost to Follow-up|4|||
128868076|NCT03578887|463810734|FG000|Overall Study|Physician Decision|0|||
128868077|NCT03578887|463810735|FG001|Overall Study|Physician Decision|1|||
128868078|NCT03578887|463810736|FG002|Overall Study|Physician Decision|1|||
128868079|NCT05602727|463812835|FG000|Overall Study|Physician Decision|0|||
128868080|NCT05602727|463812836|FG001|Overall Study|Physician Decision|1|||
128868081|NCT05602727|463812837|FG002|Overall Study|Physician Decision|0|||
128868082|NCT05602727|463812835|FG000|Overall Study|Randomized by mistake without study medication|1|||
128868083|NCT05602727|463812836|FG001|Overall Study|Randomized by mistake without study medication|0|||
128868084|NCT05602727|463812837|FG002|Overall Study|Randomized by mistake without study medication|0|||
128868085|NCT05602727|463812835|FG000|Overall Study|Study termination by Sponsor|18|||
128868086|NCT05602727|463812836|FG001|Overall Study|Study termination by Sponsor|15|||
128868087|NCT05602727|463812837|FG002|Overall Study|Study termination by Sponsor|19|||
128868088|NCT05602727|463812835|FG000|Overall Study|Withdrawal by Subject|2|||
128868089|NCT05602727|463812836|FG001|Overall Study|Withdrawal by Subject|1|||
128868090|NCT05602727|463812837|FG002|Overall Study|Withdrawal by Subject|1|||
128868091|NCT05602727|463812835|FG000|Overall Study|Various reasons|1|||
128868092|NCT05602727|463812836|FG001|Overall Study|Various reasons|6|||
128868093|NCT05602727|463812837|FG002|Overall Study|Various reasons|1|||
128868094|NCT03330405|463812838|FG000|Overall Study|Other|1|||
128868095|NCT03330405|463812839|FG001|Overall Study|Other|3|||
128868096|NCT03330405|463812840|FG002|Overall Study|Other|1|||
128868097|NCT03330405|463812841|FG003|Overall Study|Other|0|||
128868098|NCT03330405|463812842|FG004|Overall Study|Other|2|||
128868099|NCT03330405|463812843|FG005|Overall Study|Other|0|||
128868100|NCT03330405|463812844|FG006|Overall Study|Other|1|||
128868101|NCT03330405|463812845|FG007|Overall Study|Other|0|||
128868102|NCT03330405|463812846|FG008|Overall Study|Other|0|||
128868103|NCT03330405|463812847|FG009|Overall Study|Other|0|||
128868104|NCT03330405|463812848|FG010|Overall Study|Other|0|||
128868105|NCT03330405|463812838|FG000|Overall Study|Progressive disease|8|||
128868106|NCT03330405|463812839|FG001|Overall Study|Progressive disease|27|||
128868107|NCT03330405|463812840|FG002|Overall Study|Progressive disease|4|||
128868108|NCT03330405|463812841|FG003|Overall Study|Progressive disease|18|||
128868109|NCT03330405|463812842|FG004|Overall Study|Progressive disease|16|||
128868110|NCT03330405|463812843|FG005|Overall Study|Progressive disease|14|||
128868111|NCT03330405|463812844|FG006|Overall Study|Progressive disease|7|||
128868112|NCT03330405|463812845|FG007|Overall Study|Progressive disease|29|||
128868113|NCT03330405|463812846|FG008|Overall Study|Progressive disease|9|||
128868114|NCT03330405|463812847|FG009|Overall Study|Progressive disease|11|||
128868115|NCT03330405|463812848|FG010|Overall Study|Progressive disease|5|||
128868116|NCT03330405|463812838|FG000|Overall Study|Withdrawal by Subject|1|||
128868117|NCT03330405|463812839|FG001|Overall Study|Withdrawal by Subject|4|||
128868118|NCT03330405|463812840|FG002|Overall Study|Withdrawal by Subject|0|||
128868119|NCT03330405|463812841|FG003|Overall Study|Withdrawal by Subject|1|||
128868120|NCT03330405|463812842|FG004|Overall Study|Withdrawal by Subject|1|||
128868121|NCT03330405|463812843|FG005|Overall Study|Withdrawal by Subject|1|||
128868122|NCT03330405|463812844|FG006|Overall Study|Withdrawal by Subject|0|||
128868123|NCT03330405|463812845|FG007|Overall Study|Withdrawal by Subject|2|||
128868124|NCT03330405|463812846|FG008|Overall Study|Withdrawal by Subject|2|||
128868125|NCT03330405|463812847|FG009|Overall Study|Withdrawal by Subject|1|||
128868126|NCT03330405|463812848|FG010|Overall Study|Withdrawal by Subject|1|||
128868127|NCT03330405|463812838|FG000|Overall Study|Global deterioration of health status|2|||
128868128|NCT03330405|463812839|FG001|Overall Study|Global deterioration of health status|3|||
128868129|NCT03330405|463812840|FG002|Overall Study|Global deterioration of health status|0|||
128868130|NCT03330405|463812841|FG003|Overall Study|Global deterioration of health status|2|||
128868131|NCT03330405|463812842|FG004|Overall Study|Global deterioration of health status|3|||
128868132|NCT03330405|463812843|FG005|Overall Study|Global deterioration of health status|3|||
128868133|NCT03330405|463812844|FG006|Overall Study|Global deterioration of health status|0|||
128868134|NCT03330405|463812845|FG007|Overall Study|Global deterioration of health status|2|||
128868135|NCT03330405|463812846|FG008|Overall Study|Global deterioration of health status|8|||
128868136|NCT03330405|463812847|FG009|Overall Study|Global deterioration of health status|4|||
128868137|NCT03330405|463812848|FG010|Overall Study|Global deterioration of health status|1|||
128868138|NCT03330405|463812838|FG000|Overall Study|Adverse Event|0|||
128868139|NCT03330405|463812839|FG001|Overall Study|Adverse Event|1|||
128868140|NCT03330405|463812840|FG002|Overall Study|Adverse Event|0|||
128868141|NCT03330405|463812841|FG003|Overall Study|Adverse Event|1|||
128868142|NCT03330405|463812842|FG004|Overall Study|Adverse Event|1|||
128868143|NCT03330405|463812843|FG005|Overall Study|Adverse Event|1|||
128868144|NCT03330405|463812844|FG006|Overall Study|Adverse Event|3|||
128868145|NCT03330405|463812845|FG007|Overall Study|Adverse Event|4|||
128868146|NCT03330405|463812846|FG008|Overall Study|Adverse Event|2|||
128868147|NCT03330405|463812847|FG009|Overall Study|Adverse Event|2|||
128868148|NCT03330405|463812848|FG010|Overall Study|Adverse Event|2|||
128868149|NCT03330405|463812838|FG000|Overall Study|Death|0|||
128868150|NCT03330405|463812839|FG001|Overall Study|Death|4|||
128868151|NCT03330405|463812840|FG002|Overall Study|Death|0|||
128868152|NCT03330405|463812841|FG003|Overall Study|Death|0|||
128868153|NCT03330405|463812842|FG004|Overall Study|Death|0|||
128868154|NCT03330405|463812843|FG005|Overall Study|Death|1|||
128868155|NCT03330405|463812844|FG006|Overall Study|Death|0|||
128868156|NCT03330405|463812845|FG007|Overall Study|Death|2|||
128868157|NCT03330405|463812846|FG008|Overall Study|Death|0|||
128868158|NCT03330405|463812847|FG009|Overall Study|Death|0|||
128868159|NCT03330405|463812848|FG010|Overall Study|Death|0|||
128868160|NCT03330405|463812838|FG000|Overall Study|Physician Decision|0|||
128868161|NCT03330405|463812839|FG001|Overall Study|Physician Decision|0|||
128868162|NCT03330405|463812840|FG002|Overall Study|Physician Decision|0|||
128868163|NCT03330405|463812841|FG003|Overall Study|Physician Decision|0|||
128868164|NCT03330405|463812842|FG004|Overall Study|Physician Decision|0|||
128868165|NCT03330405|463812843|FG005|Overall Study|Physician Decision|0|||
128868166|NCT03330405|463812844|FG006|Overall Study|Physician Decision|0|||
128868167|NCT03330405|463812845|FG007|Overall Study|Physician Decision|1|||
128868168|NCT03330405|463812846|FG008|Overall Study|Physician Decision|0|||
128868169|NCT03330405|463812847|FG009|Overall Study|Physician Decision|0|||
128868170|NCT03330405|463812848|FG010|Overall Study|Physician Decision|0|||
128868171|NCT03889704|463812849|FG000|Overall Study|Study terminated due to pandemic|1|||
128868172|NCT03482466|463812850|FG000|Overall Study|Protocol Violation|2|||
128868173|NCT03268603|463812851|FG000|Overall Study|Withdrawal by Subject|6|||
128868174|NCT03268603|463812851|FG000|Overall Study|Physician Decision|1|||
128868175|NCT03268603|463812851|FG000|Overall Study|Withdrawn due to disease progression|2|||
128868176|NCT02060370|463812852|FG000|Overall Study|Physician Decision|1|||
128868177|NCT00356408|463812853|FG000|Overall Study|Adverse Event|9|||
128868178|NCT00356408|463812853|FG000|Overall Study|Lack of Efficacy|36|||
128868179|NCT00356408|463812853|FG000|Overall Study|Lost to Follow-up|2|||
128868180|NCT00356408|463812853|FG000|Overall Study|Withdrawal by Subject|6|||
128868181|NCT00356408|463812853|FG000|Overall Study|Other: Principal investigator discretion|3|||
128868182|NCT00356408|463812853|FG000|Overall Study|Other: Sponsor request|1|||
128868183|NCT00356408|463812853|FG000|Overall Study|Other: Azathioprine stopped|1|||
128868184|NCT00356408|463812853|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
128868185|NCT00356408|463812853|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
128868186|NCT01493427|463812855|FG000|Overall Study|Adverse Event|10|||
128868187|NCT01493427|463812855|FG000|Overall Study|Personal Reasons|4|||
128868188|NCT01493427|463812855|FG000|Overall Study|Lost to Follow-up|2|||
128868189|NCT01493427|463812855|FG000|Overall Study|Inability to Follow Instructions|2|||
128868190|NCT01493427|463812855|FG000|Overall Study|Other|2|||
128868191|NCT05775991|463812856|FG000|Overall Study|Withdrawal by Subject|0|||
128868192|NCT05775991|463812857|FG001|Overall Study|Withdrawal by Subject|0|||
128868193|NCT05775991|463812858|FG002|Overall Study|Withdrawal by Subject|2|||
128868194|NCT01461811|463812859|FG000|Overall Study|Adverse Event|2|||
128868195|NCT01461811|463812860|FG001|Overall Study|Adverse Event|1|||
128868196|NCT01461811|463812859|FG000|Overall Study|Subject decision unrelated to an AE|1|||
128868197|NCT01461811|463812860|FG001|Overall Study|Subject decision unrelated to an AE|1|||
128868198|NCT01461811|463812859|FG000|Overall Study|Noncompliance|1|||
128868199|NCT01461811|463812860|FG001|Overall Study|Noncompliance|1|||
128868200|NCT01075958|463812861|FG000|Overall Study|Blood sample could not be obtained|44|||
128868201|NCT03733314|463812862|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
128868202|NCT03733314|463812863|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
128868203|NCT03733314|463812862|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
128868204|NCT03733314|463812863|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
128868205|NCT03733314|463812862|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
128868206|NCT03733314|463812863|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
128868207|NCT03733314|463812862|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
128868208|NCT03733314|463812863|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
128868209|NCT03733314|463812862|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
128868210|NCT03733314|463812863|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
128868211|NCT03733314|463812862|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
128868212|NCT03733314|463812863|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
128868213|NCT01240915|463812864|FG000|Overall Study|Adverse Event|0|||
128868214|NCT01240915|463812865|FG001|Overall Study|Adverse Event|0|||
128868215|NCT01240915|463812866|FG002|Overall Study|Adverse Event|0|||
128868216|NCT01240915|463812867|FG003|Overall Study|Adverse Event|1|||
128868217|NCT01240915|463812868|FG004|Overall Study|Adverse Event|0|||
128868218|NCT01240915|463812869|FG005|Overall Study|Adverse Event|2|||
128868219|NCT01240915|463812870|FG006|Overall Study|Adverse Event|0|||
128868220|NCT01240915|463812871|FG007|Overall Study|Adverse Event|0|||
128868221|NCT01240915|463812872|FG008|Overall Study|Adverse Event|1|||
128868222|NCT01240915|463812864|FG000|Overall Study|Lost to Follow-up|0|||
128868223|NCT01240915|463812865|FG001|Overall Study|Lost to Follow-up|0|||
128868224|NCT01240915|463812866|FG002|Overall Study|Lost to Follow-up|0|||
128868225|NCT01240915|463812867|FG003|Overall Study|Lost to Follow-up|0|||
128868226|NCT01240915|463812868|FG004|Overall Study|Lost to Follow-up|1|||
128868227|NCT01240915|463812869|FG005|Overall Study|Lost to Follow-up|1|||
128868228|NCT01240915|463812870|FG006|Overall Study|Lost to Follow-up|0|||
128868229|NCT01240915|463812871|FG007|Overall Study|Lost to Follow-up|1|||
128868230|NCT01240915|463812872|FG008|Overall Study|Lost to Follow-up|1|||
128868231|NCT01240915|463812864|FG000|Overall Study|Withdrawal by Subject|2|||
128868232|NCT01240915|463812865|FG001|Overall Study|Withdrawal by Subject|1|||
128868233|NCT01240915|463812866|FG002|Overall Study|Withdrawal by Subject|0|||
128868234|NCT01240915|463812867|FG003|Overall Study|Withdrawal by Subject|2|||
128868235|NCT01240915|463812868|FG004|Overall Study|Withdrawal by Subject|0|||
128868236|NCT01240915|463812869|FG005|Overall Study|Withdrawal by Subject|4|||
128868237|NCT01240915|463812870|FG006|Overall Study|Withdrawal by Subject|2|||
128868238|NCT01240915|463812871|FG007|Overall Study|Withdrawal by Subject|3|||
128868239|NCT01240915|463812872|FG008|Overall Study|Withdrawal by Subject|3|||
128868240|NCT01240915|463812864|FG000|Overall Study|Other|0|||
128868241|NCT01240915|463812865|FG001|Overall Study|Other|0|||
128868242|NCT01240915|463812866|FG002|Overall Study|Other|0|||
128868243|NCT01240915|463812867|FG003|Overall Study|Other|0|||
128868244|NCT01240915|463812868|FG004|Overall Study|Other|2|||
128868245|NCT01240915|463812869|FG005|Overall Study|Other|0|||
128868246|NCT01240915|463812870|FG006|Overall Study|Other|0|||
128868247|NCT01240915|463812871|FG007|Overall Study|Other|0|||
128868248|NCT01240915|463812872|FG008|Overall Study|Other|0|||
128868249|NCT01240915|463812864|FG000|Overall Study|Insufficient Clinical Response|0|||
128868250|NCT01240915|463812865|FG001|Overall Study|Insufficient Clinical Response|0|||
128868251|NCT01240915|463812866|FG002|Overall Study|Insufficient Clinical Response|0|||
128868252|NCT01240915|463812867|FG003|Overall Study|Insufficient Clinical Response|0|||
128868253|NCT01240915|463812868|FG004|Overall Study|Insufficient Clinical Response|1|||
128868254|NCT01240915|463812869|FG005|Overall Study|Insufficient Clinical Response|3|||
128868255|NCT01240915|463812870|FG006|Overall Study|Insufficient Clinical Response|6|||
128868256|NCT01240915|463812871|FG007|Overall Study|Insufficient Clinical Response|0|||
128868257|NCT01240915|463812872|FG008|Overall Study|Insufficient Clinical Response|3|||
128868258|NCT04514510|463812873|FG000|Overall Study|Lost to Follow-up|0|||
128868259|NCT04514510|463812874|FG001|Overall Study|Lost to Follow-up|1|||
128868260|NCT04514510|463812873|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
128868261|NCT04514510|463812874|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
128868262|NCT00406692|463812875|FG000|Overall Study|Withdrawal by Subject|4|||
128868263|NCT00406692|463812875|FG000|Overall Study|Physician Decision|1|||
128868264|NCT00406692|463812875|FG000|Overall Study|Adverse Event|1|||
128868265|NCT00406692|463812875|FG000|Overall Study|Lack of Efficacy|1|||
128868266|NCT00821587|463812876|FG000|Overall Study|Physician Decision|0|||
128868267|NCT00821587|463812877|FG001|Overall Study|Physician Decision|1|||
128868268|NCT02781090|463812880|FG000|3-Month Follow-Up|Missed Visit|20|||
128868269|NCT02781090|463812881|FG001|3-Month Follow-Up|Missed Visit|20|||
128868270|NCT02781090|463812880|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
128868271|NCT02781090|463812881|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
128868272|NCT02781090|463812880|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
128868273|NCT02781090|463812881|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
128868274|NCT02781090|463812880|FG000|3-Month Follow-Up|Death|1|||
128868275|NCT02781090|463812881|FG001|3-Month Follow-Up|Death|0|||
128868276|NCT02781090|463812880|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
128868277|NCT02781090|463812881|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
128868278|NCT02781090|463812880|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
128868279|NCT02781090|463812881|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
128868280|NCT02781090|463812880|FG000|6-Month Follow-Up|Death|0|||
128868281|NCT02781090|463812881|FG001|6-Month Follow-Up|Death|1|||
128868282|NCT01145898|463812882|FG000|3-year Treatment|medication change by treating physician|3|||
128868283|NCT01145898|463812883|FG001|3-year Treatment|medication change by treating physician|16|||
128868284|NCT01195623|463812886|FG000|Overall Study|Lost to Follow-up|35|||
128868285|NCT01195623|463812887|FG001|Overall Study|Lost to Follow-up|37|||
128868286|NCT00842244|463812888|FG000|Overall Study|Death|3|||
128868287|NCT00842244|463812888|FG000|Overall Study|Withdrawal by Subject|1|||
128868288|NCT00842244|463812888|FG000|Overall Study|Other|17|||
128868289|NCT00635661|463812893|FG000|Overall Study|Withdrawal by Subject|4|||
128868290|NCT02636725|463812896|FG000|Overall Study|Adverse Event|1|||
128868291|NCT05330676|463812897|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
128868292|NCT05330676|463812898|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
128868293|NCT01559129|463812900|FG000|Treatment Phase|Adverse Event|0|||
128868294|NCT01559129|463812901|FG001|Treatment Phase|Adverse Event|2|||
128868295|NCT01559129|463812900|FG000|Treatment Phase|Progressive Disease|1|||
128868296|NCT01559129|463812901|FG001|Treatment Phase|Progressive Disease|1|||
128868297|NCT01559129|463812900|FG000|Treatment Phase|Lack of Efficacy|0|||
128868298|NCT01559129|463812901|FG001|Treatment Phase|Lack of Efficacy|1|||
128868299|NCT01559129|463812900|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
128868300|NCT01559129|463812901|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
128868301|NCT01559129|463812900|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
128868302|NCT01559129|463812901|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
128868303|NCT01559129|463812900|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
128868304|NCT01559129|463812901|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
128868305|NCT01559129|463812900|FG000|Open-label Extension Period|Adverse Event|1|||
128868306|NCT01559129|463812901|FG001|Open-label Extension Period|Adverse Event|0|||
128868307|NCT01559129|463812900|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
128868308|NCT01559129|463812901|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
128868309|NCT00368927|463812902|FG000|Overall Study|Lost to Follow-up|2|||
128868310|NCT00368927|463812903|FG001|Overall Study|Lost to Follow-up|0|||
128868311|NCT00368927|463812902|FG000|Overall Study|Adverse Event|1|||
128868312|NCT00368927|463812903|FG001|Overall Study|Adverse Event|1|||
128868313|NCT00368927|463812902|FG000|Overall Study|Withdrawal by Subject|1|||
128868314|NCT00368927|463812903|FG001|Overall Study|Withdrawal by Subject|2|||
128868315|NCT00368927|463812902|FG000|Overall Study|Physician Decision|1|||
128868316|NCT00368927|463812903|FG001|Overall Study|Physician Decision|0|||
128868317|NCT03525392|463812904|FG000|Overall Study|Adverse Event|1|||
128868318|NCT03525392|463812905|FG001|Overall Study|Adverse Event|0|||
128868319|NCT03525392|463812906|FG002|Overall Study|Adverse Event|2|||
128868320|NCT03525392|463812907|FG003|Overall Study|Adverse Event|0|||
128868321|NCT03525392|463812908|FG004|Overall Study|Adverse Event|0|||
128868322|NCT03525392|463812904|FG000|Overall Study|Progressive disease|0|||
128868323|NCT03525392|463812905|FG001|Overall Study|Progressive disease|1|||
128868324|NCT03525392|463812906|FG002|Overall Study|Progressive disease|1|||
128868325|NCT03525392|463812907|FG003|Overall Study|Progressive disease|3|||
128868326|NCT03525392|463812908|FG004|Overall Study|Progressive disease|1|||
128868327|NCT03284203|463812911|FG000|Overall Study|Lost to Follow-up|3|||
128868328|NCT02229851|463812912|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
128868329|NCT02229851|463812913|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
128868330|NCT02229851|463812914|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
128868331|NCT02229851|463812915|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
128868332|NCT02229851|463812916|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
128868333|NCT02229851|463812917|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
128868334|NCT02229851|463812918|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
128868335|NCT02229851|463812912|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
128868336|NCT02229851|463812913|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
128868337|NCT02229851|463812914|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
128868338|NCT02229851|463812915|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
128868339|NCT02229851|463812916|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
128868340|NCT02229851|463812917|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
128868341|NCT02229851|463812918|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
128868342|NCT02229851|463812912|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
128868343|NCT02229851|463812913|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
128868344|NCT02229851|463812914|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
128868345|NCT02229851|463812915|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
128868346|NCT02229851|463812916|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
128868347|NCT02229851|463812917|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
128868348|NCT02229851|463812918|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
128868349|NCT02229851|463812912|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
128868350|NCT02229851|463812913|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
128868351|NCT02229851|463812914|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
128868352|NCT02229851|463812915|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
128868353|NCT02229851|463812916|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
128868354|NCT02229851|463812917|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
128868355|NCT02229851|463812918|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
128868356|NCT02229851|463812912|FG000|Main Phase (Double-blind Phase)|Death|1|||
128868357|NCT02229851|463812913|FG001|Main Phase (Double-blind Phase)|Death|1|||
128868358|NCT02229851|463812914|FG002|Main Phase (Double-blind Phase)|Death|0|||
128868359|NCT02229851|463812915|FG003|Main Phase (Double-blind Phase)|Death|0|||
128868360|NCT02229851|463812916|FG004|Main Phase (Double-blind Phase)|Death|0|||
128868361|NCT02229851|463812917|FG005|Main Phase (Double-blind Phase)|Death|0|||
128868362|NCT02229851|463812918|FG006|Main Phase (Double-blind Phase)|Death|0|||
128868363|NCT02229851|463812912|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
128868364|NCT02229851|463812913|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
128868365|NCT02229851|463812914|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
128868366|NCT02229851|463812915|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
128868367|NCT02229851|463812916|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
128868368|NCT02229851|463812917|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
128868369|NCT02229851|463812918|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
128868370|NCT02229851|463812912|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
128868371|NCT02229851|463812913|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
128868372|NCT02229851|463812914|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
128868373|NCT02229851|463812915|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
128868374|NCT02229851|463812916|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
128868375|NCT02229851|463812917|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
128868376|NCT02229851|463812918|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
128868377|NCT02229851|463812912|FG000|Extension Phase (Open-label Phase)|Death|0|||
128868378|NCT02229851|463812913|FG001|Extension Phase (Open-label Phase)|Death|0|||
128868379|NCT02229851|463812914|FG002|Extension Phase (Open-label Phase)|Death|0|||
128868380|NCT02229851|463812915|FG003|Extension Phase (Open-label Phase)|Death|1|||
128868381|NCT02229851|463812916|FG004|Extension Phase (Open-label Phase)|Death|0|||
128868382|NCT02229851|463812917|FG005|Extension Phase (Open-label Phase)|Death|1|||
128868383|NCT02229851|463812918|FG006|Extension Phase (Open-label Phase)|Death|1|||
128868384|NCT01111240|463812919|FG000|Overall Study|Adverse Event|190|||
128868385|NCT01111240|463812919|FG000|Overall Study|Lack of Efficacy|545|||
128868386|NCT01111240|463812919|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
128868387|NCT01111240|463812919|FG000|Overall Study|Other|312|||
128868388|NCT04187326|463812920|FG000|Overall Study|Lost to Follow-up|2|||
128868389|NCT04187326|463812921|FG001|Overall Study|Lost to Follow-up|1|||
128868390|NCT04187326|463812920|FG000|Overall Study|Computer error- task was only partially completed.|0|||
128868391|NCT04187326|463812921|FG001|Overall Study|Computer error- task was only partially completed.|1|||
128868392|NCT01607476|463812922|FG000|Overall Study|Withdrawal by Subject|1|||
128868393|NCT01607476|463812923|FG001|Overall Study|Withdrawal by Subject|0|||
128868394|NCT01607476|463812924|FG002|Overall Study|Withdrawal by Subject|1|||
128868395|NCT01607476|463812922|FG000|Overall Study|Lost to Follow-up|0|||
128868396|NCT01607476|463812923|FG001|Overall Study|Lost to Follow-up|0|||
128868397|NCT01607476|463812924|FG002|Overall Study|Lost to Follow-up|2|||
128868398|NCT04958200|463812927|FG000|Overall Study|Withdrawal by Subject|0|||
128868399|NCT04958200|463812928|FG001|Overall Study|Withdrawal by Subject|2|||
128868400|NCT04958200|463812927|FG000|Overall Study|Lost to Follow-up|3|||
128868401|NCT04958200|463812928|FG001|Overall Study|Lost to Follow-up|2|||
128868402|NCT04531098|463812929|FG000|Stage I|Adverse Event|0|||
128868403|NCT04531098|463812930|FG001|Stage I|Adverse Event|0|||
128868404|NCT04531098|463812931|FG002|Stage I|Adverse Event|3|||
128868405|NCT04531098|463812929|FG000|Stage I|Protocol Violation|0|||
128868406|NCT04531098|463812930|FG001|Stage I|Protocol Violation|0|||
128868407|NCT04531098|463812931|FG002|Stage I|Protocol Violation|5|||
128868408|NCT04531098|463812929|FG000|Stage I|Withdrawal by Subject|0|||
128868409|NCT04531098|463812930|FG001|Stage I|Withdrawal by Subject|5|||
128868410|NCT04531098|463812931|FG002|Stage I|Withdrawal by Subject|10|||
128868411|NCT04531098|463812929|FG000|Stage II|Adverse Event|1|||
128868412|NCT04531098|463812930|FG001|Stage II|Adverse Event|2|||
128868413|NCT04531098|463812931|FG002|Stage II|Adverse Event|0|||
128868414|NCT04531098|463812929|FG000|Stage II|Protocol Violation|1|||
128868415|NCT04531098|463812930|FG001|Stage II|Protocol Violation|2|||
128868416|NCT04531098|463812931|FG002|Stage II|Protocol Violation|0|||
128868417|NCT04531098|463812929|FG000|Stage II|Withdrawal by Subject|3|||
128868418|NCT04531098|463812930|FG001|Stage II|Withdrawal by Subject|1|||
128868419|NCT04531098|463812931|FG002|Stage II|Withdrawal by Subject|0|||
128868420|NCT04531098|463812929|FG000|Stage II|Moved from study area|8|||
128868421|NCT04531098|463812930|FG001|Stage II|Moved from study area|5|||
128868422|NCT04531098|463812931|FG002|Stage II|Moved from study area|0|||
128868423|NCT02628028|463812932|FG000|Dosing Period|Withdrawal by Subject|0|||
128868424|NCT02628028|463812933|FG001|Dosing Period|Withdrawal by Subject|0|||
128868425|NCT02628028|463812934|FG002|Dosing Period|Withdrawal by Subject|1|||
128868426|NCT02628028|463812935|FG003|Dosing Period|Withdrawal by Subject|0|||
128868427|NCT02628028|463812936|FG004|Dosing Period|Withdrawal by Subject|2|||
128868428|NCT02628028|463812937|FG005|Dosing Period|Withdrawal by Subject|4|||
128868429|NCT02628028|463812938|FG006|Dosing Period|Withdrawal by Subject|1|||
128868430|NCT02628028|463812939|FG007|Dosing Period|Withdrawal by Subject|1|||
128868431|NCT02628028|463812932|FG000|Dosing Period|Adverse Event|0|||
128868432|NCT02628028|463812933|FG001|Dosing Period|Adverse Event|0|||
128868433|NCT02628028|463812934|FG002|Dosing Period|Adverse Event|0|||
128868434|NCT02628028|463812935|FG003|Dosing Period|Adverse Event|0|||
128868435|NCT02628028|463812936|FG004|Dosing Period|Adverse Event|2|||
128868436|NCT02628028|463812937|FG005|Dosing Period|Adverse Event|1|||
128868437|NCT02628028|463812938|FG006|Dosing Period|Adverse Event|3|||
128868438|NCT02628028|463812939|FG007|Dosing Period|Adverse Event|2|||
128868439|NCT02628028|463812932|FG000|Dosing Period|Death|0|||
128868440|NCT02628028|463812933|FG001|Dosing Period|Death|0|||
128868441|NCT02628028|463812934|FG002|Dosing Period|Death|0|||
128868442|NCT02628028|463812935|FG003|Dosing Period|Death|0|||
128868443|NCT02628028|463812936|FG004|Dosing Period|Death|0|||
128868444|NCT02628028|463812937|FG005|Dosing Period|Death|0|||
128868445|NCT02628028|463812938|FG006|Dosing Period|Death|0|||
128868446|NCT02628028|463812939|FG007|Dosing Period|Death|1|||
128868447|NCT02628028|463812932|FG000|Dosing Period|Lack of Efficacy|0|||
128868448|NCT02628028|463812933|FG001|Dosing Period|Lack of Efficacy|0|||
128868449|NCT02628028|463812934|FG002|Dosing Period|Lack of Efficacy|0|||
128868450|NCT02628028|463812935|FG003|Dosing Period|Lack of Efficacy|0|||
128868451|NCT02628028|463812936|FG004|Dosing Period|Lack of Efficacy|3|||
128868452|NCT02628028|463812937|FG005|Dosing Period|Lack of Efficacy|0|||
128868453|NCT02628028|463812938|FG006|Dosing Period|Lack of Efficacy|1|||
128868454|NCT02628028|463812939|FG007|Dosing Period|Lack of Efficacy|0|||
128868455|NCT02628028|463812932|FG000|Dosing Period|Study Terminated by Sponsor|0|||
128868456|NCT02628028|463812933|FG001|Dosing Period|Study Terminated by Sponsor|0|||
128868457|NCT02628028|463812934|FG002|Dosing Period|Study Terminated by Sponsor|0|||
128868458|NCT02628028|463812935|FG003|Dosing Period|Study Terminated by Sponsor|0|||
128868459|NCT02628028|463812936|FG004|Dosing Period|Study Terminated by Sponsor|7|||
128868460|NCT02628028|463812937|FG005|Dosing Period|Study Terminated by Sponsor|6|||
128868461|NCT02628028|463812938|FG006|Dosing Period|Study Terminated by Sponsor|7|||
128868462|NCT02628028|463812939|FG007|Dosing Period|Study Terminated by Sponsor|7|||
128868463|NCT02628028|463812932|FG000|Dosing Period|Physician Decision|0|||
128868464|NCT02628028|463812933|FG001|Dosing Period|Physician Decision|0|||
128868465|NCT02628028|463812934|FG002|Dosing Period|Physician Decision|0|||
128868466|NCT02628028|463812935|FG003|Dosing Period|Physician Decision|0|||
128868467|NCT02628028|463812936|FG004|Dosing Period|Physician Decision|0|||
128868468|NCT02628028|463812937|FG005|Dosing Period|Physician Decision|1|||
128868469|NCT02628028|463812938|FG006|Dosing Period|Physician Decision|0|||
128868470|NCT02628028|463812939|FG007|Dosing Period|Physician Decision|0|||
128868471|NCT02628028|463812932|FG000|Dosing Period|Site Terminated by Sponsor|0|||
128868472|NCT02628028|463812933|FG001|Dosing Period|Site Terminated by Sponsor|0|||
128868473|NCT02628028|463812934|FG002|Dosing Period|Site Terminated by Sponsor|0|||
128868474|NCT02628028|463812935|FG003|Dosing Period|Site Terminated by Sponsor|0|||
128868475|NCT02628028|463812936|FG004|Dosing Period|Site Terminated by Sponsor|0|||
128868476|NCT02628028|463812937|FG005|Dosing Period|Site Terminated by Sponsor|1|||
128868477|NCT02628028|463812938|FG006|Dosing Period|Site Terminated by Sponsor|1|||
128868478|NCT02628028|463812939|FG007|Dosing Period|Site Terminated by Sponsor|0|||
128868479|NCT02628028|463812932|FG000|Dosing Period|Lost to Follow-up|0|||
128868480|NCT02628028|463812933|FG001|Dosing Period|Lost to Follow-up|0|||
128868481|NCT02628028|463812934|FG002|Dosing Period|Lost to Follow-up|0|||
128868482|NCT02628028|463812935|FG003|Dosing Period|Lost to Follow-up|0|||
128868483|NCT02628028|463812936|FG004|Dosing Period|Lost to Follow-up|0|||
128868484|NCT02628028|463812937|FG005|Dosing Period|Lost to Follow-up|0|||
128868485|NCT02628028|463812938|FG006|Dosing Period|Lost to Follow-up|1|||
128868486|NCT02628028|463812939|FG007|Dosing Period|Lost to Follow-up|0|||
128868487|NCT02628028|463812932|FG000|Dosing Period|Other|0|||
128868488|NCT02628028|463812933|FG001|Dosing Period|Other|0|||
128868489|NCT02628028|463812934|FG002|Dosing Period|Other|0|||
128868490|NCT02628028|463812935|FG003|Dosing Period|Other|0|||
128868491|NCT02628028|463812936|FG004|Dosing Period|Other|2|||
128868492|NCT02628028|463812937|FG005|Dosing Period|Other|1|||
128868493|NCT02628028|463812938|FG006|Dosing Period|Other|2|||
128868494|NCT02628028|463812939|FG007|Dosing Period|Other|4|||
128868495|NCT02628028|463812932|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
128868496|NCT02628028|463812933|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
128868497|NCT02628028|463812934|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
128868498|NCT02628028|463812935|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
128868499|NCT02628028|463812936|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
128868500|NCT02628028|463812937|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
128868501|NCT02628028|463812938|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
128868502|NCT02628028|463812939|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
128868503|NCT02628028|463812932|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
128868504|NCT02628028|463812933|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
128868505|NCT02628028|463812934|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
128868506|NCT02628028|463812935|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
128868507|NCT02628028|463812936|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
128868508|NCT02628028|463812937|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
128868509|NCT02628028|463812938|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
128868510|NCT02628028|463812939|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
128868511|NCT02628028|463812932|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
128868512|NCT02628028|463812933|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
128868513|NCT02628028|463812934|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
128868514|NCT02628028|463812935|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
128868515|NCT02628028|463812936|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
128868516|NCT02628028|463812937|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
128868517|NCT02628028|463812938|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
128868518|NCT02628028|463812939|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
128868519|NCT02628028|463812932|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
128868520|NCT02628028|463812933|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
128868521|NCT02628028|463812934|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
128868522|NCT02628028|463812935|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
128868523|NCT02628028|463812936|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
128868524|NCT02628028|463812937|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
128868525|NCT02628028|463812938|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
128868526|NCT02628028|463812939|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
128868527|NCT02628028|463812932|FG000|Long-term Extension (LTE) Period|Other|0|||
128868528|NCT02628028|463812933|FG001|Long-term Extension (LTE) Period|Other|0|||
128868529|NCT02628028|463812934|FG002|Long-term Extension (LTE) Period|Other|0|||
128868530|NCT02628028|463812935|FG003|Long-term Extension (LTE) Period|Other|0|||
128868531|NCT02628028|463812936|FG004|Long-term Extension (LTE) Period|Other|0|||
128868532|NCT02628028|463812937|FG005|Long-term Extension (LTE) Period|Other|3|||
128868533|NCT02628028|463812938|FG006|Long-term Extension (LTE) Period|Other|4|||
128868534|NCT02628028|463812939|FG007|Long-term Extension (LTE) Period|Other|3|||
128868535|NCT02145468|463812940|FG000|Overall Study|Withdrawal by Subject|5|||
128868536|NCT02145468|463812941|FG001|Overall Study|Withdrawal by Subject|8|||
128868537|NCT04157400|463812942|FG000|Overall Study|Withdrawal by Subject|1|||
128868538|NCT04157400|463812942|FG000|Overall Study|Lost to Follow-up|3|||
128868539|NCT00623805|463812943|FG000|Overall Study|Adverse Event|9|||
128868540|NCT00623805|463812944|FG001|Overall Study|Adverse Event|6|||
128868541|NCT00623805|463812943|FG000|Overall Study|Death|2|||
128868542|NCT00623805|463812944|FG001|Overall Study|Death|0|||
128868543|NCT00623805|463812943|FG000|Overall Study|Lack of Efficacy|3|||
128868544|NCT00623805|463812944|FG001|Overall Study|Lack of Efficacy|7|||
128868545|NCT00623805|463812943|FG000|Overall Study|Lost to Follow-up|2|||
128868546|NCT00623805|463812944|FG001|Overall Study|Lost to Follow-up|2|||
128868547|NCT00623805|463812943|FG000|Overall Study|Protocol Violation|1|||
128868548|NCT00623805|463812944|FG001|Overall Study|Protocol Violation|1|||
128868549|NCT00623805|463812943|FG000|Overall Study|Reason not Specified|3|||
128868550|NCT00623805|463812944|FG001|Overall Study|Reason not Specified|6|||
128868551|NCT04655027|463812960|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
128868552|NCT04655027|463812961|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
128868553|NCT03519997|463812964|FG000|Overall Study|Adverse Event|4|||
128868554|NCT03519997|463812964|FG000|Overall Study|Withdrawal by Subject|2|||
128868555|NCT03519997|463812964|FG000|Overall Study|Protocol Violation|1|||
128868556|NCT05543707|463812965|FG000|Overall Study|Study drug non-compliance/|5|||
128868557|NCT05543707|463812966|FG001|Overall Study|Study drug non-compliance/|0|||
128868558|NCT05543707|463812965|FG000|Overall Study|Withdrawal by Subject|1|||
128868559|NCT05543707|463812966|FG001|Overall Study|Withdrawal by Subject|1|||
128868560|NCT05543707|463812965|FG000|Overall Study|Adverse Event|1|||
128868561|NCT05543707|463812966|FG001|Overall Study|Adverse Event|0|||
128868562|NCT05543707|463812965|FG000|Overall Study|concurrent illness|0|||
128868563|NCT05543707|463812966|FG001|Overall Study|concurrent illness|1|||
128868564|NCT05543707|463812965|FG000|Overall Study|Pregnancy|1|||
128868565|NCT05543707|463812966|FG001|Overall Study|Pregnancy|1|||
128868566|NCT00186888|463812967|FG000|Overall Study|Toxicity|0|||
128868567|NCT00186888|463812968|FG001|Overall Study|Toxicity|1|||
128868568|NCT00186888|463812969|FG002|Overall Study|Toxicity|0|||
128868569|NCT00186888|463812967|FG000|Overall Study|Relapse or progression of disease|4|||
128868570|NCT00186888|463812968|FG001|Overall Study|Relapse or progression of disease|2|||
128868571|NCT00186888|463812969|FG002|Overall Study|Relapse or progression of disease|0|||
128868572|NCT02336451|463812970|FG000|Overall Study|Adverse Event|1|||
128868573|NCT02336451|463812971|FG001|Overall Study|Adverse Event|2|||
128868574|NCT02336451|463812972|FG002|Overall Study|Adverse Event|0|||
128868575|NCT02336451|463812973|FG003|Overall Study|Adverse Event|6|||
128868576|NCT02336451|463812974|FG004|Overall Study|Adverse Event|4|||
128868577|NCT02336451|463812970|FG000|Overall Study|Death|6|||
128868578|NCT02336451|463812971|FG001|Overall Study|Death|2|||
128868579|NCT02336451|463812972|FG002|Overall Study|Death|3|||
128868580|NCT02336451|463812973|FG003|Overall Study|Death|6|||
128868581|NCT02336451|463812974|FG004|Overall Study|Death|6|||
128868582|NCT02336451|463812970|FG000|Overall Study|Physician Decision|9|||
128868583|NCT02336451|463812971|FG001|Overall Study|Physician Decision|6|||
128868584|NCT02336451|463812972|FG002|Overall Study|Physician Decision|7|||
128868585|NCT02336451|463812973|FG003|Overall Study|Physician Decision|16|||
128868586|NCT02336451|463812974|FG004|Overall Study|Physician Decision|3|||
128868587|NCT02336451|463812970|FG000|Overall Study|Progressive disease|23|||
128868588|NCT02336451|463812971|FG001|Overall Study|Progressive disease|26|||
128868589|NCT02336451|463812972|FG002|Overall Study|Progressive disease|2|||
128868590|NCT02336451|463812973|FG003|Overall Study|Progressive disease|14|||
128868591|NCT02336451|463812974|FG004|Overall Study|Progressive disease|4|||
128868592|NCT02336451|463812970|FG000|Overall Study|Protocol Violation|1|||
128868593|NCT02336451|463812971|FG001|Overall Study|Protocol Violation|0|||
128868594|NCT02336451|463812972|FG002|Overall Study|Protocol Violation|0|||
128868595|NCT02336451|463812973|FG003|Overall Study|Protocol Violation|0|||
128868596|NCT02336451|463812974|FG004|Overall Study|Protocol Violation|0|||
128868597|NCT02336451|463812970|FG000|Overall Study|Patient/guardian decision|2|||
128868598|NCT02336451|463812971|FG001|Overall Study|Patient/guardian decision|4|||
128868599|NCT02336451|463812972|FG002|Overall Study|Patient/guardian decision|0|||
128868600|NCT02336451|463812973|FG003|Overall Study|Patient/guardian decision|2|||
128868601|NCT02336451|463812974|FG004|Overall Study|Patient/guardian decision|1|||
128868602|NCT02344290|463812982|FG000|Overall Study|Withdrawal by Subject|315|||
128868603|NCT02344290|463812983|FG001|Overall Study|Withdrawal by Subject|324|||
128868604|NCT02344290|463812982|FG000|Overall Study|Lost to Follow-up|258|||
128868605|NCT02344290|463812983|FG001|Overall Study|Lost to Follow-up|249|||
128868606|NCT02344290|463812982|FG000|Overall Study|Unable to get to clinic|69|||
128868607|NCT02344290|463812983|FG001|Overall Study|Unable to get to clinic|60|||
128868608|NCT02344290|463812982|FG000|Overall Study|Physician Decision|25|||
128868609|NCT02344290|463812983|FG001|Overall Study|Physician Decision|25|||
128868610|NCT02344290|463812982|FG000|Overall Study|Site Closure|15|||
128868611|NCT02344290|463812983|FG001|Overall Study|Site Closure|19|||
128868612|NCT02344290|463812982|FG000|Overall Study|Other|5|||
128868613|NCT02344290|463812983|FG001|Overall Study|Other|3|||
128868614|NCT04998812|463812984|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
128868615|NCT04998812|463812985|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
128868616|NCT04998812|463812984|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
128868617|NCT04998812|463812985|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
128868618|NCT04998812|463812984|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
128868619|NCT04998812|463812985|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
128868620|NCT04998812|463812984|FG000|Vaccination Period|Ongoing in study|23|||
128868621|NCT04998812|463812985|FG001|Vaccination Period|Ongoing in study|23|||
128868622|NCT05718466|463814556|FG000|Overall Study|Withdrawal by Subject|1|||
128868623|NCT05718466|463814557|FG001|Overall Study|Withdrawal by Subject|2|||
128868624|NCT05718466|463814556|FG000|Overall Study|Death|0|||
128868625|NCT05718466|463814557|FG001|Overall Study|Death|1|||
128868626|NCT00387426|463814559|FG000|Overall Study|Lack of Response|7|||
128868627|NCT00387426|463814559|FG000|Overall Study|Toxicities|4|||
128868628|NCT00387426|463814559|FG000|Overall Study|Disease Progression|3|||
128868629|NCT01253135|463814566|FG000|Original Protocol|Protocol Amendment|15|||
128868630|NCT01253135|463814566|FG000|Amended Protocol|Non-compliance|1|||
128868631|NCT01901432|463814571|FG000|Overall Study|Adverse Event|0|||
128868632|NCT01901432|463814572|FG001|Overall Study|Adverse Event|1|||
128868633|NCT01901432|463814573|FG002|Overall Study|Adverse Event|1|||
128868634|NCT01901432|463814574|FG003|Overall Study|Adverse Event|0|||
128868635|NCT01901432|463814575|FG004|Overall Study|Adverse Event|1|||
128868636|NCT01901432|463814571|FG000|Overall Study|Withdrawal by Subject|0|||
128868637|NCT01901432|463814572|FG001|Overall Study|Withdrawal by Subject|0|||
128868638|NCT01901432|463814573|FG002|Overall Study|Withdrawal by Subject|1|||
128868639|NCT01901432|463814574|FG003|Overall Study|Withdrawal by Subject|0|||
128868640|NCT01901432|463814575|FG004|Overall Study|Withdrawal by Subject|5|||
128868641|NCT01901432|463814571|FG000|Overall Study|Physician Decision|0|||
128868642|NCT01901432|463814572|FG001|Overall Study|Physician Decision|0|||
128868643|NCT01901432|463814573|FG002|Overall Study|Physician Decision|0|||
128868644|NCT01901432|463814574|FG003|Overall Study|Physician Decision|0|||
128868645|NCT01901432|463814575|FG004|Overall Study|Physician Decision|2|||
128868646|NCT01901432|463814571|FG000|Overall Study|Patient decision to stop study drug|0|||
128868647|NCT01901432|463814572|FG001|Overall Study|Patient decision to stop study drug|0|||
128868648|NCT01901432|463814573|FG002|Overall Study|Patient decision to stop study drug|0|||
128868649|NCT01901432|463814574|FG003|Overall Study|Patient decision to stop study drug|0|||
128868650|NCT01901432|463814575|FG004|Overall Study|Patient decision to stop study drug|1|||
128868651|NCT00379288|463814578|FG000|Overall Study|Adverse Event|5|||
128868652|NCT00379288|463814579|FG001|Overall Study|Adverse Event|6|||
128868653|NCT00379288|463814580|FG002|Overall Study|Adverse Event|2|||
128868654|NCT00379288|463814581|FG003|Overall Study|Adverse Event|0|||
128868655|NCT00379288|463814578|FG000|Overall Study|Treatment Failure|0|||
128868656|NCT00379288|463814579|FG001|Overall Study|Treatment Failure|1|||
128868657|NCT00379288|463814580|FG002|Overall Study|Treatment Failure|0|||
128868658|NCT00379288|463814581|FG003|Overall Study|Treatment Failure|1|||
128868659|NCT00379288|463814578|FG000|Overall Study|Lost to Follow-up|3|||
128868660|NCT00379288|463814579|FG001|Overall Study|Lost to Follow-up|3|||
128868661|NCT00379288|463814580|FG002|Overall Study|Lost to Follow-up|2|||
128868662|NCT00379288|463814581|FG003|Overall Study|Lost to Follow-up|0|||
128868663|NCT00379288|463814578|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
128868664|NCT00379288|463814579|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
128868665|NCT00379288|463814580|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
128868666|NCT00379288|463814581|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
128868667|NCT00379288|463814578|FG000|Overall Study|Subject withdrew-related to study drug|1|||
128868668|NCT00379288|463814579|FG001|Overall Study|Subject withdrew-related to study drug|0|||
128868669|NCT00379288|463814580|FG002|Overall Study|Subject withdrew-related to study drug|0|||
128868670|NCT00379288|463814581|FG003|Overall Study|Subject withdrew-related to study drug|1|||
128868671|NCT00379288|463814578|FG000|Overall Study|Noncompliance with protocol|8|||
128868672|NCT00379288|463814579|FG001|Overall Study|Noncompliance with protocol|6|||
128868673|NCT00379288|463814580|FG002|Overall Study|Noncompliance with protocol|2|||
128868674|NCT00379288|463814581|FG003|Overall Study|Noncompliance with protocol|1|||
128868675|NCT00379288|463814578|FG000|Overall Study|Did not meet protocol eligibility|0|||
128868676|NCT00379288|463814579|FG001|Overall Study|Did not meet protocol eligibility|1|||
128868677|NCT00379288|463814580|FG002|Overall Study|Did not meet protocol eligibility|0|||
128868678|NCT00379288|463814581|FG003|Overall Study|Did not meet protocol eligibility|2|||
128868679|NCT00379288|463814578|FG000|Overall Study|Administrative|2|||
128868680|NCT00379288|463814579|FG001|Overall Study|Administrative|2|||
128868681|NCT00379288|463814580|FG002|Overall Study|Administrative|0|||
128868682|NCT00379288|463814581|FG003|Overall Study|Administrative|1|||
128868683|NCT00918879|463814582|FG000|Overall Study|Withdrawal by Subject|4|||
128868684|NCT00918879|463814583|FG001|Overall Study|Withdrawal by Subject|4|||
128868685|NCT00918879|463814582|FG000|Overall Study|Lost to Follow-up|1|||
128868686|NCT00918879|463814583|FG001|Overall Study|Lost to Follow-up|1|||
128868687|NCT00918879|463814582|FG000|Overall Study|Severe non-compliance to protocol|1|||
128868688|NCT00918879|463814583|FG001|Overall Study|Severe non-compliance to protocol|1|||
128868689|NCT00833261|463814586|FG000|Overall Study|Withdrawal by Subject|4|||
128868690|NCT00357110|463814587|FG000|Overall Study|Early study termination|5|||
128868691|NCT00357110|463814588|FG001|Overall Study|Early study termination|5|||
128868692|NCT01008553|463814589|FG000|Period 1 (Titration Period)|Physician Decision|2|||
128868693|NCT01008553|463814590|FG001|Period 1 (Titration Period)|Physician Decision|0|||
128868694|NCT01008553|463814591|FG002|Period 1 (Titration Period)|Physician Decision|0|||
128868695|NCT01008553|463814589|FG000|Period 1 (Titration Period)|Adverse Event|33|||
128868696|NCT01008553|463814590|FG001|Period 1 (Titration Period)|Adverse Event|0|||
128868697|NCT01008553|463814591|FG002|Period 1 (Titration Period)|Adverse Event|0|||
128868698|NCT01008553|463814589|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
128868699|NCT01008553|463814590|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
128868700|NCT01008553|463814591|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
128868701|NCT01008553|463814589|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
128868702|NCT01008553|463814590|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
128868703|NCT01008553|463814591|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
128868704|NCT01008553|463814589|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
128868705|NCT01008553|463814590|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
128868706|NCT01008553|463814591|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
128868707|NCT01008553|463814589|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
128868708|NCT01008553|463814590|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
128868709|NCT01008553|463814591|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
128868710|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
128868711|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
128868712|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
128868713|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
128868714|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
128868715|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
128868716|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
128868717|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
128868718|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
128868719|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
128868720|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
128868721|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
128868722|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
128868723|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
128868724|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
128868725|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
128868726|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
128868727|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
128868728|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
128868729|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
128868730|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
128868731|NCT01008553|463814589|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
128868732|NCT01008553|463814590|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
128868733|NCT01008553|463814591|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
128868734|NCT01008410|463814593|FG000|Overall Study|Adverse Event|13|||
128868735|NCT01008410|463814594|FG001|Overall Study|Adverse Event|7|||
128868736|NCT01008410|463814593|FG000|Overall Study|Withdrawal by Subject|6|||
128868737|NCT01008410|463814594|FG001|Overall Study|Withdrawal by Subject|2|||
128868738|NCT01008410|463814593|FG000|Overall Study|Lost to Follow-up|1|||
128868739|NCT01008410|463814594|FG001|Overall Study|Lost to Follow-up|0|||
128868740|NCT01008410|463814593|FG000|Overall Study|Noncompliance|1|||
128868741|NCT01008410|463814594|FG001|Overall Study|Noncompliance|0|||
128868742|NCT01008410|463814593|FG000|Overall Study|Low Cortisol|2|||
128868743|NCT01008410|463814594|FG001|Overall Study|Low Cortisol|0|||
128868744|NCT01008410|463814593|FG000|Overall Study|Lack of Efficacy|2|||
128868745|NCT01008410|463814594|FG001|Overall Study|Lack of Efficacy|6|||
128868746|NCT01008410|463814593|FG000|Overall Study|Met Exclusion Criterion|0|||
128868747|NCT01008410|463814594|FG001|Overall Study|Met Exclusion Criterion|1|||
128868748|NCT03056300|463814597|FG000|Overall Study|Surgical reason per study protocol|3|||
128868749|NCT03563157|463814598|FG000|Overall Study|Progressive Disease|2|||
128868750|NCT02187159|463814599|FG000|Overall Study|Protocol Violation|4|||
128868751|NCT02187159|463814600|FG001|Overall Study|Protocol Violation|6|||
128868752|NCT02187159|463814601|FG002|Overall Study|Protocol Violation|3|||
128868753|NCT02187159|463814602|FG003|Overall Study|Protocol Violation|4|||
128868754|NCT02187159|463814599|FG000|Overall Study|Lack of Efficacy|10|||
128868755|NCT02187159|463814600|FG001|Overall Study|Lack of Efficacy|5|||
128868756|NCT02187159|463814601|FG002|Overall Study|Lack of Efficacy|4|||
128868757|NCT02187159|463814602|FG003|Overall Study|Lack of Efficacy|7|||
128868758|NCT02187159|463814599|FG000|Overall Study|Adverse Event|28|||
128868759|NCT02187159|463814600|FG001|Overall Study|Adverse Event|33|||
128868760|NCT02187159|463814601|FG002|Overall Study|Adverse Event|42|||
128868761|NCT02187159|463814602|FG003|Overall Study|Adverse Event|50|||
128868762|NCT02187159|463814599|FG000|Overall Study|Withdrawal by Subject|24|||
128868763|NCT02187159|463814600|FG001|Overall Study|Withdrawal by Subject|28|||
128868764|NCT02187159|463814601|FG002|Overall Study|Withdrawal by Subject|25|||
128868765|NCT02187159|463814602|FG003|Overall Study|Withdrawal by Subject|26|||
128868766|NCT02187159|463814599|FG000|Overall Study|Other|3|||
128868767|NCT02187159|463814600|FG001|Overall Study|Other|7|||
128868768|NCT02187159|463814601|FG002|Overall Study|Other|3|||
128868769|NCT02187159|463814602|FG003|Overall Study|Other|9|||
128868770|NCT00567567|463814603|FG000|Overall Study|Adverse Event|0|||
128868771|NCT00567567|463814604|FG001|Overall Study|Adverse Event|2|||
128868772|NCT00567567|463814605|FG002|Overall Study|Adverse Event|5|||
128868773|NCT00567567|463814603|FG000|Overall Study|Death|8|||
128868774|NCT00567567|463814604|FG001|Overall Study|Death|1|||
128868775|NCT00567567|463814605|FG002|Overall Study|Death|5|||
128868776|NCT00567567|463814603|FG000|Overall Study|Lack of Efficacy|16|||
128868777|NCT00567567|463814604|FG001|Overall Study|Lack of Efficacy|17|||
128868778|NCT00567567|463814605|FG002|Overall Study|Lack of Efficacy|48|||
128868779|NCT00567567|463814603|FG000|Overall Study|Lost to Follow-up|0|||
128868780|NCT00567567|463814604|FG001|Overall Study|Lost to Follow-up|0|||
128868781|NCT00567567|463814605|FG002|Overall Study|Lost to Follow-up|1|||
128868782|NCT00567567|463814603|FG000|Overall Study|Physician Decision|16|||
128868783|NCT00567567|463814604|FG001|Overall Study|Physician Decision|18|||
128868784|NCT00567567|463814605|FG002|Overall Study|Physician Decision|84|||
128868785|NCT00567567|463814603|FG000|Overall Study|Withdrawal by Subject|0|||
128868786|NCT00567567|463814604|FG001|Overall Study|Withdrawal by Subject|0|||
128868787|NCT00567567|463814605|FG002|Overall Study|Withdrawal by Subject|2|||
128868788|NCT00567567|463814603|FG000|Overall Study|Ineligible|4|||
128868789|NCT00567567|463814604|FG001|Overall Study|Ineligible|0|||
128868790|NCT00567567|463814605|FG002|Overall Study|Ineligible|9|||
128868791|NCT00567567|463814603|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
128868792|NCT00567567|463814604|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
128868793|NCT00567567|463814605|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
128868794|NCT00567567|463814603|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
128868795|NCT00567567|463814604|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
128868796|NCT00567567|463814605|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
128868797|NCT00567567|463814603|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
128868798|NCT00567567|463814604|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
128868799|NCT00567567|463814605|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
128868800|NCT04335591|463814606|FG000|Overall Study|Adverse Event|5|||
128868801|NCT04335591|463814607|FG001|Overall Study|Adverse Event|2|||
128868802|NCT04335591|463814608|FG002|Overall Study|Adverse Event|3|||
128868803|NCT04335591|463814609|FG003|Overall Study|Adverse Event|2|||
128868804|NCT04335591|463814606|FG000|Overall Study|Protocol Violation|1|||
128868805|NCT04335591|463814607|FG001|Overall Study|Protocol Violation|0|||
128868806|NCT04335591|463814608|FG002|Overall Study|Protocol Violation|0|||
128868807|NCT04335591|463814609|FG003|Overall Study|Protocol Violation|0|||
128868808|NCT04335591|463814606|FG000|Overall Study|Withdrawal by Subject|8|||
128868809|NCT04335591|463814607|FG001|Overall Study|Withdrawal by Subject|4|||
128868810|NCT04335591|463814608|FG002|Overall Study|Withdrawal by Subject|4|||
128868811|NCT04335591|463814609|FG003|Overall Study|Withdrawal by Subject|5|||
128868812|NCT04335591|463814606|FG000|Overall Study|Subject planning pregnancy|0|||
128868813|NCT04335591|463814607|FG001|Overall Study|Subject planning pregnancy|1|||
128868814|NCT04335591|463814608|FG002|Overall Study|Subject planning pregnancy|0|||
128868815|NCT04335591|463814609|FG003|Overall Study|Subject planning pregnancy|0|||
128868816|NCT04335591|463814606|FG000|Overall Study|Ukrainian Russian war conflict|4|||
128868817|NCT04335591|463814607|FG001|Overall Study|Ukrainian Russian war conflict|5|||
128868818|NCT04335591|463814608|FG002|Overall Study|Ukrainian Russian war conflict|2|||
128868819|NCT04335591|463814609|FG003|Overall Study|Ukrainian Russian war conflict|0|||
128868820|NCT03248882|463814610|FG000|Overall Study|Adverse Event|3|||
128868821|NCT03248882|463814611|FG001|Overall Study|Adverse Event|3|||
128868822|NCT03248882|463814612|FG002|Overall Study|Adverse Event|2|||
128868823|NCT03248882|463814613|FG003|Overall Study|Adverse Event|6|||
128868824|NCT03248882|463814614|FG004|Overall Study|Adverse Event|9|||
128868825|NCT03248882|463814610|FG000|Overall Study|Lost to Follow-up|0|||
128868826|NCT03248882|463814611|FG001|Overall Study|Lost to Follow-up|0|||
128868827|NCT03248882|463814612|FG002|Overall Study|Lost to Follow-up|0|||
128868828|NCT03248882|463814613|FG003|Overall Study|Lost to Follow-up|0|||
128868829|NCT03248882|463814614|FG004|Overall Study|Lost to Follow-up|1|||
128868830|NCT03248882|463814610|FG000|Overall Study|Protocol Violation|2|||
128868831|NCT03248882|463814611|FG001|Overall Study|Protocol Violation|0|||
128868832|NCT03248882|463814612|FG002|Overall Study|Protocol Violation|2|||
128868833|NCT03248882|463814613|FG003|Overall Study|Protocol Violation|0|||
128868834|NCT03248882|463814614|FG004|Overall Study|Protocol Violation|1|||
128868835|NCT03248882|463814610|FG000|Overall Study|Withdrawal by Subject|2|||
128868836|NCT03248882|463814611|FG001|Overall Study|Withdrawal by Subject|2|||
128868837|NCT03248882|463814612|FG002|Overall Study|Withdrawal by Subject|3|||
128868838|NCT03248882|463814613|FG003|Overall Study|Withdrawal by Subject|4|||
128868839|NCT03248882|463814614|FG004|Overall Study|Withdrawal by Subject|2|||
128868840|NCT01156376|463814617|FG000|Overall Study|Adverse Event|1|||
128868841|NCT01156376|463814618|FG001|Overall Study|Adverse Event|0|||
128868842|NCT01156376|463814619|FG002|Overall Study|Adverse Event|1|||
128868843|NCT01156376|463814617|FG000|Overall Study|Withdrawal by Subject|0|||
128868844|NCT01156376|463814618|FG001|Overall Study|Withdrawal by Subject|0|||
128868845|NCT01156376|463814619|FG002|Overall Study|Withdrawal by Subject|3|||
128868846|NCT01867333|463814620|FG000|Overall Study|Withdrawal by Subject|1|||
128868847|NCT01867333|463814621|FG001|Overall Study|Withdrawal by Subject|0|||
128868848|NCT01867333|463814620|FG000|Overall Study|Adverse Event|1|||
128868849|NCT01867333|463814621|FG001|Overall Study|Adverse Event|0|||
128868850|NCT01867333|463814620|FG000|Overall Study|Participant choice|1|||
128868851|NCT01867333|463814621|FG001|Overall Study|Participant choice|2|||
128868852|NCT01867333|463814620|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
128868853|NCT01867333|463814621|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
128868854|NCT01867333|463814620|FG000|Overall Study|Death|0|||
128868855|NCT01867333|463814621|FG001|Overall Study|Death|1|||
128868856|NCT01867333|463814620|FG000|Overall Study|Physician Decision|3|||
128868857|NCT01867333|463814621|FG001|Overall Study|Physician Decision|2|||
128868858|NCT01867333|463814620|FG000|Overall Study|Switched to alternative treatment|1|||
128868859|NCT01867333|463814621|FG001|Overall Study|Switched to alternative treatment|0|||
128868860|NCT00403767|463814625|FG000|Overall Study|Adverse Event|993|||
128868861|NCT00403767|463814626|FG001|Overall Study|Adverse Event|919|||
128868862|NCT00403767|463814625|FG000|Overall Study|Non-compliant with study medication|134|||
128868863|NCT00403767|463814626|FG001|Overall Study|Non-compliant with study medication|164|||
128868864|NCT00403767|463814625|FG000|Overall Study|Consent withdrawn|671|||
128868865|NCT00403767|463814626|FG001|Overall Study|Consent withdrawn|673|||
128868866|NCT00403767|463814625|FG000|Overall Study|Investigator dec./not protocol-related|191|||
128868867|NCT00403767|463814626|FG001|Overall Study|Investigator dec./not protocol-related|178|||
128868868|NCT00403767|463814625|FG000|Overall Study|Lost to Follow-up|6|||
128868869|NCT00403767|463814626|FG001|Overall Study|Lost to Follow-up|8|||
128868870|NCT00403767|463814625|FG000|Overall Study|Protocol Violation|142|||
128868871|NCT00403767|463814626|FG001|Overall Study|Protocol Violation|124|||
128868872|NCT00403767|463814625|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
128868873|NCT00403767|463814626|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
128868874|NCT00403767|463814625|FG000|Overall Study|Study terminated by sponsor|82|||
128868875|NCT00403767|463814626|FG001|Overall Study|Study terminated by sponsor|69|||
128868876|NCT00403767|463814625|FG000|Overall Study|Missing/incomplete data|1|||
128868877|NCT00403767|463814626|FG001|Overall Study|Missing/incomplete data|1|||
128868878|NCT01696955|463814627|FG000|Main Study|Protocol Violation|1|||
128868879|NCT01696955|463814628|FG001|Main Study|Protocol Violation|0|||
128868880|NCT01696955|463814627|FG000|Main Study|Withdrawal by Subject|1|||
128868881|NCT01696955|463814628|FG001|Main Study|Withdrawal by Subject|1|||
128868882|NCT03192475|463814629|FG000|Overall Study|Death|0|||
128868883|NCT03192475|463814630|FG001|Overall Study|Death|1|||
128868884|NCT03192475|463814629|FG000|Overall Study|Lost to Follow-up|13|||
128868885|NCT03192475|463814630|FG001|Overall Study|Lost to Follow-up|8|||
128868886|NCT00436605|463814633|FG000|Overall Study|Protocol Violation|3|||
128868887|NCT01696045|463814636|FG000|Overall Study|Study drug toxicity|1|||
128868888|NCT01696045|463814637|FG001|Overall Study|Study drug toxicity|5|||
128868889|NCT01696045|463814636|FG000|Overall Study|Disease progression|2|||
128868890|NCT01696045|463814637|FG001|Overall Study|Disease progression|2|||
128868891|NCT00573859|463814638|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
128868892|NCT00573859|463814638|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
128868893|NCT03541200|463814647|FG000|Overall Study|Adverse Event|19|||
128868894|NCT03541200|463814647|FG000|Overall Study|Death|1|||
128868895|NCT03541200|463814647|FG000|Overall Study|Lost to Follow-up|10|||
128868896|NCT03541200|463814647|FG000|Overall Study|Physician Decision|1|||
128868897|NCT03541200|463814647|FG000|Overall Study|Protocol Violation|51|||
128868898|NCT03541200|463814647|FG000|Overall Study|Withdrawal by Subject|23|||
128868899|NCT03541200|463814647|FG000|Overall Study|other|8|||
128868900|NCT01204710|463814649|FG000|Randomization Treatment|Lost to Follow-up|1|||
128868901|NCT01204710|463814650|FG001|Randomization Treatment|Lost to Follow-up|0|||
128868902|NCT01204710|463814649|FG000|Randomization Treatment|Withdrawal by Subject|6|||
128868903|NCT01204710|463814650|FG001|Randomization Treatment|Withdrawal by Subject|5|||
128868904|NCT01204710|463814649|FG000|Randomization Treatment|Physician Decision|3|||
128868905|NCT01204710|463814650|FG001|Randomization Treatment|Physician Decision|2|||
128868906|NCT01204710|463814649|FG000|Randomization Treatment|Entry criteria not met|0|||
128868907|NCT01204710|463814650|FG001|Randomization Treatment|Entry criteria not met|1|||
128868908|NCT01204710|463814649|FG000|Randomization Treatment|Adverse Event|4|||
128868909|NCT01204710|463814650|FG001|Randomization Treatment|Adverse Event|2|||
128868910|NCT01204710|463814649|FG000|Randomization Treatment|Sponsor Decision|0|||
128868911|NCT01204710|463814650|FG001|Randomization Treatment|Sponsor Decision|1|||
128868912|NCT01204710|463814649|FG000|Randomization Treatment|Worsening of General condition|0|||
128868913|NCT01204710|463814650|FG001|Randomization Treatment|Worsening of General condition|1|||
128868914|NCT01204710|463814649|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
128868915|NCT01204710|463814650|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
128868916|NCT01204710|463814649|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
128868917|NCT01204710|463814650|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
128868918|NCT01204710|463814649|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
128868919|NCT01204710|463814650|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
128868920|NCT01204710|463814649|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
128868921|NCT01204710|463814650|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
128868922|NCT01276379|463814651|FG000|Overall Study|Screening failure|40|||
128868923|NCT00864253|463814652|FG000|Overall Study|Adverse Event|56|||
128868924|NCT00864253|463814653|FG001|Overall Study|Adverse Event|11|||
128868925|NCT00864253|463814652|FG000|Overall Study|Unrelated Adverse Event|3|||
128868926|NCT00864253|463814653|FG001|Overall Study|Unrelated Adverse Event|1|||
128868927|NCT00864253|463814652|FG000|Overall Study|Physician Decision|11|||
128868928|NCT00864253|463814653|FG001|Overall Study|Physician Decision|15|||
128868929|NCT00864253|463814652|FG000|Overall Study|Protocol Violation|0|||
128868930|NCT00864253|463814653|FG001|Overall Study|Protocol Violation|2|||
128868931|NCT00864253|463814652|FG000|Overall Study|Lost to Follow-up|1|||
128868932|NCT00864253|463814653|FG001|Overall Study|Lost to Follow-up|1|||
128868933|NCT00864253|463814652|FG000|Overall Study|Withdrawal by Subject|18|||
128868934|NCT00864253|463814653|FG001|Overall Study|Withdrawal by Subject|18|||
128868935|NCT00864253|463814652|FG000|Overall Study|Death|1|||
128868936|NCT00864253|463814653|FG001|Overall Study|Death|0|||
128868937|NCT00864253|463814652|FG000|Overall Study|Ongoing|2|||
128868938|NCT00864253|463814653|FG001|Overall Study|Ongoing|3|||
128868939|NCT00864253|463814652|FG000|Overall Study|Untreated|7|||
128868940|NCT00864253|463814653|FG001|Overall Study|Untreated|7|||
128868941|NCT01896726|463814654|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
128868942|NCT01896726|463814654|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
128868943|NCT01128114|463814655|FG000|Overall Study|Treatment Withdrawn|6|||
128868944|NCT01128114|463814655|FG000|Overall Study|Screening Failed|2|||
128868945|NCT00208325|463814656|FG000|Overall Study|Death|18|||
128868946|NCT00208325|463814657|FG001|Overall Study|Death|19|||
128868947|NCT00208325|463814658|FG002|Overall Study|Death|7|||
128868948|NCT00208325|463814659|FG003|Overall Study|Death|5|||
128868949|NCT00208325|463814656|FG000|Overall Study|Withdrawal by Subject|0|||
128868950|NCT00208325|463814657|FG001|Overall Study|Withdrawal by Subject|1|||
128868951|NCT00208325|463814658|FG002|Overall Study|Withdrawal by Subject|0|||
128868952|NCT00208325|463814659|FG003|Overall Study|Withdrawal by Subject|0|||
128868953|NCT00208325|463814656|FG000|Overall Study|Revision|4|||
128868954|NCT00208325|463814657|FG001|Overall Study|Revision|1|||
128868955|NCT00208325|463814658|FG002|Overall Study|Revision|0|||
128868956|NCT00208325|463814659|FG003|Overall Study|Revision|4|||
128868957|NCT00208325|463814656|FG000|Overall Study|Lost to Follow-up|1|||
128868958|NCT00208325|463814657|FG001|Overall Study|Lost to Follow-up|0|||
128868959|NCT00208325|463814658|FG002|Overall Study|Lost to Follow-up|2|||
128868960|NCT00208325|463814659|FG003|Overall Study|Lost to Follow-up|0|||
128868961|NCT00208325|463814656|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
128868962|NCT00208325|463814657|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
128868963|NCT00208325|463814658|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
128868964|NCT00208325|463814659|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
128868965|NCT00208325|463814656|FG000|Overall Study|Does not wish to Continue in Study|5|||
128868966|NCT00208325|463814657|FG001|Overall Study|Does not wish to Continue in Study|8|||
128868967|NCT00208325|463814658|FG002|Overall Study|Does not wish to Continue in Study|3|||
128868968|NCT00208325|463814659|FG003|Overall Study|Does not wish to Continue in Study|2|||
128868969|NCT00208325|463814656|FG000|Overall Study|Other|2|||
128868970|NCT00208325|463814657|FG001|Overall Study|Other|1|||
128868971|NCT00208325|463814658|FG002|Overall Study|Other|1|||
128868972|NCT00208325|463814659|FG003|Overall Study|Other|0|||
128868973|NCT00208325|463814656|FG000|Overall Study|Mis-Randomized|17|||
128868974|NCT00208325|463814657|FG001|Overall Study|Mis-Randomized|20|||
128868975|NCT00208325|463814658|FG002|Overall Study|Mis-Randomized|0|||
128868976|NCT00208325|463814659|FG003|Overall Study|Mis-Randomized|0|||
128868977|NCT02206061|463814660|FG000|Overall Study|Withdrawal by Subject|4|||
128868978|NCT02206061|463814661|FG001|Overall Study|Withdrawal by Subject|7|||
128868979|NCT02206061|463814662|FG002|Overall Study|Withdrawal by Subject|1|||
128868980|NCT02206061|463814660|FG000|Overall Study|Lost to Follow-up|14|||
128868981|NCT02206061|463814661|FG001|Overall Study|Lost to Follow-up|7|||
128868982|NCT02206061|463814662|FG002|Overall Study|Lost to Follow-up|20|||
128868983|NCT04445987|463814663|FG000|Overall Study|Adverse Event|0|||
128868984|NCT04445987|463814664|FG001|Overall Study|Adverse Event|0|||
128868985|NCT04445987|463814665|FG002|Overall Study|Adverse Event|1|||
128868986|NCT04445987|463814666|FG003|Overall Study|Adverse Event|0|||
128868987|NCT04445987|463814667|FG004|Overall Study|Adverse Event|4|||
128868988|NCT04445987|463814668|FG005|Overall Study|Adverse Event|0|||
128868989|NCT04445987|463814663|FG000|Overall Study|Lost to Follow-up|4|||
128868990|NCT04445987|463814664|FG001|Overall Study|Lost to Follow-up|3|||
128868991|NCT04445987|463814665|FG002|Overall Study|Lost to Follow-up|1|||
128868992|NCT04445987|463814666|FG003|Overall Study|Lost to Follow-up|1|||
128868993|NCT04445987|463814667|FG004|Overall Study|Lost to Follow-up|29|||
128868994|NCT04445987|463814668|FG005|Overall Study|Lost to Follow-up|0|||
128868995|NCT04445987|463814663|FG000|Overall Study|Physician Decision|0|||
128868996|NCT04445987|463814664|FG001|Overall Study|Physician Decision|0|||
128868997|NCT04445987|463814665|FG002|Overall Study|Physician Decision|0|||
128868998|NCT04445987|463814666|FG003|Overall Study|Physician Decision|0|||
128868999|NCT04445987|463814667|FG004|Overall Study|Physician Decision|1|||
128869000|NCT04445987|463814668|FG005|Overall Study|Physician Decision|0|||
128869001|NCT04445987|463814663|FG000|Overall Study|Protocol Violation|1|||
128869002|NCT04445987|463814664|FG001|Overall Study|Protocol Violation|0|||
128869003|NCT04445987|463814665|FG002|Overall Study|Protocol Violation|0|||
128869004|NCT04445987|463814666|FG003|Overall Study|Protocol Violation|0|||
128869005|NCT04445987|463814667|FG004|Overall Study|Protocol Violation|2|||
128869006|NCT04445987|463814668|FG005|Overall Study|Protocol Violation|0|||
128869007|NCT04445987|463814663|FG000|Overall Study|Withdrawal by Subject|4|||
128869008|NCT04445987|463814664|FG001|Overall Study|Withdrawal by Subject|0|||
128869009|NCT04445987|463814665|FG002|Overall Study|Withdrawal by Subject|1|||
128869010|NCT04445987|463814666|FG003|Overall Study|Withdrawal by Subject|0|||
128869011|NCT04445987|463814667|FG004|Overall Study|Withdrawal by Subject|18|||
128869012|NCT04445987|463814668|FG005|Overall Study|Withdrawal by Subject|1|||
128869013|NCT04445987|463814663|FG000|Overall Study|Other reason|0|||
128869014|NCT04445987|463814664|FG001|Overall Study|Other reason|0|||
128869015|NCT04445987|463814665|FG002|Overall Study|Other reason|1|||
128869016|NCT04445987|463814666|FG003|Overall Study|Other reason|0|||
128869017|NCT04445987|463814667|FG004|Overall Study|Other reason|2|||
128869018|NCT04445987|463814668|FG005|Overall Study|Other reason|0|||
128869019|NCT03826030|463814680|FG000|Overall Study|Withdrawal by Subject|2|||
128869020|NCT03826030|463814681|FG001|Overall Study|Withdrawal by Subject|0|||
128869021|NCT03826030|463814682|FG002|Overall Study|Withdrawal by Subject|1|||
128869022|NCT03826030|463814680|FG000|Overall Study|Lost to Follow-up|1|||
128869023|NCT03826030|463814681|FG001|Overall Study|Lost to Follow-up|1|||
128869024|NCT03826030|463814682|FG002|Overall Study|Lost to Follow-up|1|||
128869025|NCT03826030|463814680|FG000|Overall Study|Too busy to return for visits|1|||
128869026|NCT03826030|463814681|FG001|Overall Study|Too busy to return for visits|0|||
128869027|NCT03826030|463814682|FG002|Overall Study|Too busy to return for visits|0|||
128869028|NCT04893460|463814687|FG000|Overall Study|Lost to Follow-up|18|||
128869029|NCT03820947|463814690|FG000|Overall Study|Physician Decision|0|||
128869030|NCT03820947|463814691|FG001|Overall Study|Physician Decision|1|||
128869031|NCT03820947|463814692|FG002|Overall Study|Physician Decision|1|||
128869032|NCT03820947|463814693|FG003|Overall Study|Physician Decision|0|||
128869033|NCT03820947|463814694|FG004|Overall Study|Physician Decision|3|||
128869034|NCT03820947|463814690|FG000|Overall Study|Withdrawal by Subject|6|||
128869035|NCT03820947|463814691|FG001|Overall Study|Withdrawal by Subject|10|||
128869036|NCT03820947|463814692|FG002|Overall Study|Withdrawal by Subject|3|||
128869037|NCT03820947|463814693|FG003|Overall Study|Withdrawal by Subject|8|||
128869038|NCT03820947|463814694|FG004|Overall Study|Withdrawal by Subject|5|||
128869039|NCT03820947|463814690|FG000|Overall Study|Procedure Not Attempted|0|||
128869040|NCT03820947|463814691|FG001|Overall Study|Procedure Not Attempted|2|||
128869041|NCT03820947|463814692|FG002|Overall Study|Procedure Not Attempted|1|||
128869042|NCT03820947|463814693|FG003|Overall Study|Procedure Not Attempted|0|||
128869043|NCT03820947|463814694|FG004|Overall Study|Procedure Not Attempted|0|||
128869044|NCT03820947|463814690|FG000|Overall Study|Other Exit|1|||
128869045|NCT03820947|463814691|FG001|Overall Study|Other Exit|3|||
128869046|NCT03820947|463814692|FG002|Overall Study|Other Exit|3|||
128869047|NCT03820947|463814693|FG003|Overall Study|Other Exit|3|||
128869048|NCT03820947|463814694|FG004|Overall Study|Other Exit|0|||
128869049|NCT03820947|463814690|FG000|Overall Study|Follow-up Not Done|10|||
128869050|NCT03820947|463814691|FG001|Overall Study|Follow-up Not Done|13|||
128869051|NCT03820947|463814692|FG002|Overall Study|Follow-up Not Done|2|||
128869052|NCT03820947|463814693|FG003|Overall Study|Follow-up Not Done|3|||
128869053|NCT03820947|463814694|FG004|Overall Study|Follow-up Not Done|12|||
128869054|NCT03820947|463814690|FG000|Overall Study|Death|0|||
128869055|NCT03820947|463814691|FG001|Overall Study|Death|0|||
128869056|NCT03820947|463814692|FG002|Overall Study|Death|0|||
128869057|NCT03820947|463814693|FG003|Overall Study|Death|0|||
128869058|NCT03820947|463814694|FG004|Overall Study|Death|9|||
128869059|NCT03820947|463814690|FG000|Overall Study|Lost to Follow-up|4|||
128869060|NCT03820947|463814691|FG001|Overall Study|Lost to Follow-up|6|||
128869061|NCT03820947|463814692|FG002|Overall Study|Lost to Follow-up|0|||
128869062|NCT03820947|463814693|FG003|Overall Study|Lost to Follow-up|0|||
128869063|NCT03820947|463814694|FG004|Overall Study|Lost to Follow-up|9|||
128869064|NCT02218606|463816923|FG000|Overall Study|Adverse Event|1|||
128869065|NCT02218606|463816924|FG001|Overall Study|Adverse Event|1|||
128869066|NCT02218606|463816923|FG000|Overall Study|Death|15|||
128869067|NCT02218606|463816924|FG001|Overall Study|Death|28|||
128869068|NCT02218606|463816923|FG000|Overall Study|Physician Decision|0|||
128869069|NCT02218606|463816924|FG001|Overall Study|Physician Decision|1|||
128869070|NCT02218606|463816923|FG000|Overall Study|Withdrawal by Subject|4|||
128869071|NCT02218606|463816924|FG001|Overall Study|Withdrawal by Subject|0|||
128869072|NCT02218606|463816923|FG000|Overall Study|Noncompliance|1|||
128869073|NCT02218606|463816924|FG001|Overall Study|Noncompliance|0|||
128869074|NCT02218606|463816923|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
128869075|NCT02218606|463816924|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
128869076|NCT02218606|463816923|FG000|Overall Study|Other|2|||
128869077|NCT02218606|463816924|FG001|Overall Study|Other|1|||
128869078|NCT02218606|463816923|FG000|Overall Study|Never started treatment|0|||
128869079|NCT02218606|463816924|FG001|Overall Study|Never started treatment|1|||
128869080|NCT03203473|463816925|FG000|Induction Phase|Never started primary treatment|2|||
128869081|NCT03203473|463816926|FG001|Induction Phase|Never started primary treatment|0|||
128869082|NCT03203473|463816927|FG002|Induction Phase|Never started primary treatment|0|||
128869083|NCT03203473|463816925|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
128869084|NCT03203473|463816926|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
128869085|NCT03203473|463816927|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
128869086|NCT03203473|463816925|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
128869087|NCT03203473|463816926|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
128869088|NCT03203473|463816927|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
128869089|NCT03203473|463816925|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
128869090|NCT03203473|463816926|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
128869091|NCT03203473|463816927|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
128869092|NCT03203473|463816925|FG000|Arm Allocation Phase|started salvage therapy|0|||
128869093|NCT03203473|463816926|FG001|Arm Allocation Phase|started salvage therapy|5|||
128869094|NCT03203473|463816927|FG002|Arm Allocation Phase|started salvage therapy|0|||
128869095|NCT03203473|463816925|FG000|Arm Allocation Phase|Disease progression|0|||
128869096|NCT03203473|463816926|FG001|Arm Allocation Phase|Disease progression|0|||
128869097|NCT03203473|463816927|FG002|Arm Allocation Phase|Disease progression|37|||
128869098|NCT03203473|463816925|FG000|Arm Allocation Phase|Adverse Event|0|||
128869099|NCT03203473|463816926|FG001|Arm Allocation Phase|Adverse Event|0|||
128869100|NCT03203473|463816927|FG002|Arm Allocation Phase|Adverse Event|11|||
128869101|NCT03203473|463816925|FG000|Arm Allocation Phase|Physician Decision|0|||
128869102|NCT03203473|463816926|FG001|Arm Allocation Phase|Physician Decision|0|||
128869103|NCT03203473|463816927|FG002|Arm Allocation Phase|Physician Decision|3|||
128869104|NCT03203473|463816925|FG000|Arm Allocation Phase|Death|0|||
128869105|NCT03203473|463816926|FG001|Arm Allocation Phase|Death|0|||
128869106|NCT03203473|463816927|FG002|Arm Allocation Phase|Death|1|||
128869107|NCT03203473|463816925|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
128869108|NCT03203473|463816926|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
128869109|NCT03203473|463816927|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
128869110|NCT03203473|463816925|FG000|Arm Allocation Phase|Intercurrent illness|0|||
128869111|NCT03203473|463816926|FG001|Arm Allocation Phase|Intercurrent illness|0|||
128869112|NCT03203473|463816927|FG002|Arm Allocation Phase|Intercurrent illness|1|||
128869113|NCT03203473|463816925|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
128869114|NCT03203473|463816926|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
128869115|NCT03203473|463816927|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
128869116|NCT01732822|463816932|FG000|Overall Study|Withdrawal by Subject|123|||
128869117|NCT01732822|463816933|FG001|Overall Study|Withdrawal by Subject|113|||
128869118|NCT01183260|463816934|FG000|Overall Study|Intraop screen failure|2|||
128869119|NCT01183260|463816935|FG001|Overall Study|Intraop screen failure|0|||
128869120|NCT01183260|463816934|FG000|Overall Study|Withdrawal by Subject|1|||
128869121|NCT01183260|463816935|FG001|Overall Study|Withdrawal by Subject|1|||
128869122|NCT01183260|463816934|FG000|Overall Study|Revised within 30 days|0|||
128869123|NCT01183260|463816935|FG001|Overall Study|Revised within 30 days|1|||
128869124|NCT01183260|463816934|FG000|Overall Study|Death|1|||
128869125|NCT01183260|463816935|FG001|Overall Study|Death|0|||
128869126|NCT01255631|463816936|FG000|Overall Study|poor enrollment, no data analyzed|9|||
128869127|NCT01255631|463816937|FG001|Overall Study|poor enrollment, no data analyzed|6|||
128869128|NCT00568178|463816947|FG000|Double Blind Base Study|Adverse Event|0|||
128869129|NCT00568178|463816948|FG001|Double Blind Base Study|Adverse Event|2|||
128869130|NCT00568178|463816949|FG002|Double Blind Base Study|Adverse Event|1|||
128869131|NCT00568178|463816950|FG003|Double Blind Base Study|Adverse Event|2|||
128869132|NCT00568178|463816951|FG004|Double Blind Base Study|Adverse Event|0|||
128869133|NCT00568178|463816952|FG005|Double Blind Base Study|Adverse Event|0|||
128869134|NCT00568178|463816947|FG000|Double Blind Base Study|Lost to Follow-up|1|||
128869135|NCT00568178|463816948|FG001|Double Blind Base Study|Lost to Follow-up|0|||
128869136|NCT00568178|463816949|FG002|Double Blind Base Study|Lost to Follow-up|0|||
128869137|NCT00568178|463816950|FG003|Double Blind Base Study|Lost to Follow-up|1|||
128869138|NCT00568178|463816951|FG004|Double Blind Base Study|Lost to Follow-up|0|||
128869139|NCT00568178|463816952|FG005|Double Blind Base Study|Lost to Follow-up|0|||
128869140|NCT00568178|463816947|FG000|Double Blind Base Study|Physician Decision|1|||
128869141|NCT00568178|463816948|FG001|Double Blind Base Study|Physician Decision|1|||
128869142|NCT00568178|463816949|FG002|Double Blind Base Study|Physician Decision|0|||
128869143|NCT00568178|463816950|FG003|Double Blind Base Study|Physician Decision|1|||
128869144|NCT00568178|463816951|FG004|Double Blind Base Study|Physician Decision|0|||
128869145|NCT00568178|463816952|FG005|Double Blind Base Study|Physician Decision|0|||
128869146|NCT00568178|463816947|FG000|Double Blind Base Study|Protocol Violation|3|||
128869147|NCT00568178|463816948|FG001|Double Blind Base Study|Protocol Violation|2|||
128869148|NCT00568178|463816949|FG002|Double Blind Base Study|Protocol Violation|0|||
128869149|NCT00568178|463816950|FG003|Double Blind Base Study|Protocol Violation|0|||
128869150|NCT00568178|463816951|FG004|Double Blind Base Study|Protocol Violation|0|||
128869151|NCT00568178|463816952|FG005|Double Blind Base Study|Protocol Violation|0|||
128869152|NCT00568178|463816947|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
128869153|NCT00568178|463816948|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
128869154|NCT00568178|463816949|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
128869155|NCT00568178|463816950|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
128869156|NCT00568178|463816951|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
128869157|NCT00568178|463816952|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
128869158|NCT00568178|463816947|FG000|Double Blind Base Study|Progressive Disease|0|||
128869159|NCT00568178|463816948|FG001|Double Blind Base Study|Progressive Disease|0|||
128869160|NCT00568178|463816949|FG002|Double Blind Base Study|Progressive Disease|0|||
128869161|NCT00568178|463816950|FG003|Double Blind Base Study|Progressive Disease|1|||
128869162|NCT00568178|463816951|FG004|Double Blind Base Study|Progressive Disease|0|||
128869163|NCT00568178|463816952|FG005|Double Blind Base Study|Progressive Disease|0|||
128869164|NCT00568178|463816947|FG000|Open Label Extension|Adverse Event|0|||
128869165|NCT00568178|463816948|FG001|Open Label Extension|Adverse Event|0|||
128869166|NCT00568178|463816949|FG002|Open Label Extension|Adverse Event|0|||
128869167|NCT00568178|463816950|FG003|Open Label Extension|Adverse Event|0|||
128869168|NCT00568178|463816951|FG004|Open Label Extension|Adverse Event|11|||
128869169|NCT00568178|463816952|FG005|Open Label Extension|Adverse Event|8|||
128869170|NCT00568178|463816947|FG000|Open Label Extension|Protocol Violation|0|||
128869171|NCT00568178|463816948|FG001|Open Label Extension|Protocol Violation|0|||
128869172|NCT00568178|463816949|FG002|Open Label Extension|Protocol Violation|0|||
128869173|NCT00568178|463816950|FG003|Open Label Extension|Protocol Violation|0|||
128869174|NCT00568178|463816951|FG004|Open Label Extension|Protocol Violation|1|||
128869175|NCT00568178|463816952|FG005|Open Label Extension|Protocol Violation|0|||
128869176|NCT00568178|463816947|FG000|Open Label Extension|Lost to Follow-up|0|||
128869177|NCT00568178|463816948|FG001|Open Label Extension|Lost to Follow-up|0|||
128869178|NCT00568178|463816949|FG002|Open Label Extension|Lost to Follow-up|0|||
128869179|NCT00568178|463816950|FG003|Open Label Extension|Lost to Follow-up|0|||
128869180|NCT00568178|463816951|FG004|Open Label Extension|Lost to Follow-up|6|||
128869181|NCT00568178|463816952|FG005|Open Label Extension|Lost to Follow-up|11|||
128869182|NCT00568178|463816947|FG000|Open Label Extension|Physician Decision|0|||
128869183|NCT00568178|463816948|FG001|Open Label Extension|Physician Decision|0|||
128869184|NCT00568178|463816949|FG002|Open Label Extension|Physician Decision|0|||
128869185|NCT00568178|463816950|FG003|Open Label Extension|Physician Decision|0|||
128869186|NCT00568178|463816951|FG004|Open Label Extension|Physician Decision|9|||
128869187|NCT00568178|463816952|FG005|Open Label Extension|Physician Decision|8|||
128869188|NCT00568178|463816947|FG000|Open Label Extension|Pregnancy|0|||
128869189|NCT00568178|463816948|FG001|Open Label Extension|Pregnancy|0|||
128869190|NCT00568178|463816949|FG002|Open Label Extension|Pregnancy|0|||
128869191|NCT00568178|463816950|FG003|Open Label Extension|Pregnancy|0|||
128869192|NCT00568178|463816951|FG004|Open Label Extension|Pregnancy|0|||
128869193|NCT00568178|463816952|FG005|Open Label Extension|Pregnancy|1|||
128869194|NCT00568178|463816947|FG000|Open Label Extension|Progressive Disease|0|||
128869195|NCT00568178|463816948|FG001|Open Label Extension|Progressive Disease|0|||
128869196|NCT00568178|463816949|FG002|Open Label Extension|Progressive Disease|0|||
128869197|NCT00568178|463816950|FG003|Open Label Extension|Progressive Disease|0|||
128869198|NCT00568178|463816951|FG004|Open Label Extension|Progressive Disease|3|||
128869199|NCT00568178|463816952|FG005|Open Label Extension|Progressive Disease|1|||
128869200|NCT00568178|463816947|FG000|Open Label Extension|Termination of Trial|0|||
128869201|NCT00568178|463816948|FG001|Open Label Extension|Termination of Trial|0|||
128869202|NCT00568178|463816949|FG002|Open Label Extension|Termination of Trial|0|||
128869203|NCT00568178|463816950|FG003|Open Label Extension|Termination of Trial|0|||
128869204|NCT00568178|463816951|FG004|Open Label Extension|Termination of Trial|45|||
128869205|NCT00568178|463816952|FG005|Open Label Extension|Termination of Trial|47|||
128869206|NCT00568178|463816947|FG000|Open Label Extension|Withdrawal by Subject|0|||
128869207|NCT00568178|463816948|FG001|Open Label Extension|Withdrawal by Subject|0|||
128869208|NCT00568178|463816949|FG002|Open Label Extension|Withdrawal by Subject|0|||
128869209|NCT00568178|463816950|FG003|Open Label Extension|Withdrawal by Subject|0|||
128869210|NCT00568178|463816951|FG004|Open Label Extension|Withdrawal by Subject|4|||
128869211|NCT00568178|463816952|FG005|Open Label Extension|Withdrawal by Subject|4|||
128869212|NCT01531673|463816953|FG000|Overall Study|Non-Compliance|0|||
128869213|NCT01531673|463816954|FG001|Overall Study|Non-Compliance|0|||
128869214|NCT01531673|463816955|FG002|Overall Study|Non-Compliance|0|||
128869215|NCT01531673|463816956|FG003|Overall Study|Non-Compliance|0|||
128869216|NCT01531673|463816957|FG004|Overall Study|Non-Compliance|0|||
128869217|NCT01531673|463816958|FG005|Overall Study|Non-Compliance|1|||
128869218|NCT01531673|463816959|FG006|Overall Study|Non-Compliance|0|||
128869219|NCT01531673|463816960|FG007|Overall Study|Non-Compliance|0|||
128869220|NCT01531673|463816961|FG008|Overall Study|Non-Compliance|0|||
128869221|NCT01531673|463816962|FG009|Overall Study|Non-Compliance|0|||
128869222|NCT01531673|463816963|FG010|Overall Study|Non-Compliance|0|||
128869223|NCT01531673|463816964|FG011|Overall Study|Non-Compliance|0|||
128869224|NCT01531673|463816965|FG012|Overall Study|Non-Compliance|0|||
128869225|NCT01531673|463816953|FG000|Overall Study|Adverse Event|0|||
128869226|NCT01531673|463816954|FG001|Overall Study|Adverse Event|1|||
128869227|NCT01531673|463816955|FG002|Overall Study|Adverse Event|0|||
128869228|NCT01531673|463816956|FG003|Overall Study|Adverse Event|0|||
128869229|NCT01531673|463816957|FG004|Overall Study|Adverse Event|0|||
128869230|NCT01531673|463816958|FG005|Overall Study|Adverse Event|0|||
128869231|NCT01531673|463816959|FG006|Overall Study|Adverse Event|0|||
128869232|NCT01531673|463816960|FG007|Overall Study|Adverse Event|0|||
128869233|NCT01531673|463816961|FG008|Overall Study|Adverse Event|0|||
128869234|NCT01531673|463816962|FG009|Overall Study|Adverse Event|0|||
128869235|NCT01531673|463816963|FG010|Overall Study|Adverse Event|0|||
128869236|NCT01531673|463816964|FG011|Overall Study|Adverse Event|0|||
128869237|NCT01531673|463816965|FG012|Overall Study|Adverse Event|0|||
128869238|NCT01531673|463816953|FG000|Overall Study|Lost to Follow-up|0|||
128869239|NCT01531673|463816954|FG001|Overall Study|Lost to Follow-up|0|||
128869240|NCT01531673|463816955|FG002|Overall Study|Lost to Follow-up|0|||
128869241|NCT01531673|463816956|FG003|Overall Study|Lost to Follow-up|0|||
128869242|NCT01531673|463816957|FG004|Overall Study|Lost to Follow-up|1|||
128869243|NCT01531673|463816958|FG005|Overall Study|Lost to Follow-up|0|||
128869244|NCT01531673|463816959|FG006|Overall Study|Lost to Follow-up|0|||
128869245|NCT01531673|463816960|FG007|Overall Study|Lost to Follow-up|0|||
128869246|NCT01531673|463816961|FG008|Overall Study|Lost to Follow-up|0|||
128869247|NCT01531673|463816962|FG009|Overall Study|Lost to Follow-up|0|||
128869248|NCT01531673|463816963|FG010|Overall Study|Lost to Follow-up|0|||
128869249|NCT01531673|463816964|FG011|Overall Study|Lost to Follow-up|0|||
128869250|NCT01531673|463816965|FG012|Overall Study|Lost to Follow-up|0|||
128869251|NCT01531673|463816953|FG000|Overall Study|Other|0|||
128869252|NCT01531673|463816954|FG001|Overall Study|Other|0|||
128869253|NCT01531673|463816955|FG002|Overall Study|Other|0|||
128869254|NCT01531673|463816956|FG003|Overall Study|Other|1|||
128869255|NCT01531673|463816957|FG004|Overall Study|Other|0|||
128869256|NCT01531673|463816958|FG005|Overall Study|Other|0|||
128869257|NCT01531673|463816959|FG006|Overall Study|Other|0|||
128869258|NCT01531673|463816960|FG007|Overall Study|Other|0|||
128869259|NCT01531673|463816961|FG008|Overall Study|Other|0|||
128869260|NCT01531673|463816962|FG009|Overall Study|Other|1|||
128869261|NCT01531673|463816963|FG010|Overall Study|Other|0|||
128869262|NCT01531673|463816964|FG011|Overall Study|Other|0|||
128869263|NCT01531673|463816965|FG012|Overall Study|Other|0|||
128869264|NCT02815579|463816966|FG000|Overall Study|Non-payment of loan down-payment|16|||
128869265|NCT02815579|463816967|FG001|Overall Study|Non-payment of loan down-payment|0|||
128869266|NCT02815579|463816966|FG000|Overall Study|Withdrawal by Subject|7|||
128869267|NCT02815579|463816967|FG001|Overall Study|Withdrawal by Subject|1|||
128869268|NCT02815579|463816966|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
128869269|NCT02815579|463816967|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
128869270|NCT02815579|463816966|FG000|Overall Study|Lost to Follow-up|7|||
128869271|NCT02815579|463816967|FG001|Overall Study|Lost to Follow-up|4|||
128869272|NCT02815579|463816966|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
128869273|NCT02815579|463816967|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
128869274|NCT02815579|463816966|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
128869275|NCT02815579|463816967|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
128869276|NCT02815579|463816966|FG000|Overall Study|Death|5|||
128869277|NCT02815579|463816967|FG001|Overall Study|Death|4|||
128869278|NCT02815579|463816966|FG000|Overall Study|Imprisoned|0|||
128869279|NCT02815579|463816967|FG001|Overall Study|Imprisoned|2|||
128869280|NCT02815579|463816966|FG000|Overall Study|Did not meet enrollment criteria|0|||
128869281|NCT02815579|463816967|FG001|Overall Study|Did not meet enrollment criteria|1|||
128869282|NCT00264303|463816968|FG000|Overall Study|Adverse Event|4|||
128869283|NCT00264303|463816969|FG001|Overall Study|Adverse Event|3|||
128869284|NCT00264303|463816968|FG000|Overall Study|Lack of Efficacy|10|||
128869285|NCT00264303|463816969|FG001|Overall Study|Lack of Efficacy|13|||
128869286|NCT00264303|463816968|FG000|Overall Study|Lost to Follow-up|3|||
128869287|NCT00264303|463816969|FG001|Overall Study|Lost to Follow-up|3|||
128869288|NCT00264303|463816968|FG000|Overall Study|Withdrawal by Subject|2|||
128869289|NCT00264303|463816969|FG001|Overall Study|Withdrawal by Subject|3|||
128869290|NCT00264303|463816968|FG000|Overall Study|Various reasons listed in study report|6|||
128869291|NCT00264303|463816969|FG001|Overall Study|Various reasons listed in study report|7|||
128869292|NCT02389452|463816970|FG000|Overall Study|Lost to Follow-up|13|||
128869293|NCT02389452|463816970|FG000|Overall Study|Adverse Event|1|||
128869294|NCT02389452|463816970|FG000|Overall Study|Withdrawal by Subject|5|||
128869295|NCT02389452|463816970|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
128869296|NCT02311673|463816971|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
128869297|NCT02311673|463816972|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
128869298|NCT02311673|463816973|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
128869299|NCT02311673|463816974|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
128869300|NCT00414908|463816984|FG000|Overall Study|Protocol Violation|1|||
128869301|NCT00414908|463816985|FG001|Overall Study|Protocol Violation|1|||
128869302|NCT01076153|463816986|FG000|Overall Study|Symptoms improved/resolved|10|||
128869303|NCT01076153|463816986|FG000|Overall Study|Adverse Event|1|||
128869304|NCT00818168|463816987|FG000|Overall Study|Lack of Efficacy|18|||
128869305|NCT00818168|463816987|FG000|Overall Study|Pregnancy|2|||
128869306|NCT00818168|463816987|FG000|Overall Study|Withdrawal by Subject|16|||
128869307|NCT00818168|463816987|FG000|Overall Study|Lost to Follow-up|7|||
128869308|NCT00818168|463816987|FG000|Overall Study|Adverse Event|19|||
128869309|NCT00818168|463816987|FG000|Overall Study|Reason for Non-completion Not reported|6|||
128869310|NCT00818168|463816987|FG000|Overall Study|Participant Moved|2|||
128869311|NCT02040259|463816988|FG000|Overall Study|Death|280|||
128869312|NCT02040259|463816988|FG000|Overall Study|Lost to Follow-up|76|||
128869313|NCT02040259|463816988|FG000|Overall Study|Assessment not completed|3|||
128869314|NCT02040259|463816988|FG000|Overall Study|Withdrawal by Subject|4|||
128869315|NCT04476251|463816989|FG000|Overall Study|Not treated|1|||
128869316|NCT00316602|463817000|FG000|Overall Study|Withdrawal by Subject|3|||
128869317|NCT00316602|463817001|FG001|Overall Study|Withdrawal by Subject|2|||
128869318|NCT00316602|463817000|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
128869319|NCT00316602|463817001|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
128869320|NCT00316602|463817000|FG000|Overall Study|Adverse Event|1|||
128869321|NCT00316602|463817001|FG001|Overall Study|Adverse Event|0|||
128869322|NCT00316602|463817000|FG000|Overall Study|Other|3|||
128869323|NCT00316602|463817001|FG001|Overall Study|Other|6|||
128869324|NCT00626990|463817004|FG000|Overall Study|Lack of Efficacy|6|||
128869325|NCT00626990|463817005|FG001|Overall Study|Lack of Efficacy|7|||
128869326|NCT00626990|463817006|FG002|Overall Study|Lack of Efficacy|49|||
128869327|NCT00626990|463817007|FG003|Overall Study|Lack of Efficacy|40|||
128869328|NCT00626990|463817004|FG000|Overall Study|Adverse Event|1|||
128869329|NCT00626990|463817005|FG001|Overall Study|Adverse Event|7|||
128869330|NCT00626990|463817006|FG002|Overall Study|Adverse Event|14|||
128869331|NCT00626990|463817007|FG003|Overall Study|Adverse Event|28|||
128869332|NCT00626990|463817004|FG000|Overall Study|Death|0|||
128869333|NCT00626990|463817005|FG001|Overall Study|Death|1|||
128869334|NCT00626990|463817006|FG002|Overall Study|Death|0|||
128869335|NCT00626990|463817007|FG003|Overall Study|Death|0|||
128869336|NCT00626990|463817004|FG000|Overall Study|Withdrawal by Subject|3|||
128869337|NCT00626990|463817005|FG001|Overall Study|Withdrawal by Subject|1|||
128869338|NCT00626990|463817006|FG002|Overall Study|Withdrawal by Subject|5|||
128869339|NCT00626990|463817007|FG003|Overall Study|Withdrawal by Subject|11|||
128869340|NCT00626990|463817004|FG000|Overall Study|Protocol Violation|0|||
128869341|NCT00626990|463817005|FG001|Overall Study|Protocol Violation|1|||
128869342|NCT00626990|463817006|FG002|Overall Study|Protocol Violation|1|||
128869343|NCT00626990|463817007|FG003|Overall Study|Protocol Violation|0|||
128869344|NCT00626990|463817004|FG000|Overall Study|Various different reasons/missing|4|||
128869345|NCT00626990|463817005|FG001|Overall Study|Various different reasons/missing|8|||
128869346|NCT00626990|463817006|FG002|Overall Study|Various different reasons/missing|8|||
128869347|NCT00626990|463817007|FG003|Overall Study|Various different reasons/missing|16|||
128869348|NCT04138576|463817012|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
128869349|NCT00297427|463817013|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
128869350|NCT00297427|463817014|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
128869351|NCT00297427|463817013|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
128869352|NCT00297427|463817014|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
128869353|NCT00297427|463817013|FG000|Phase 1: Initial Intervention|Death|0|||
128869354|NCT00297427|463817014|FG001|Phase 1: Initial Intervention|Death|1|||
128869355|NCT00297427|463817013|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
128869356|NCT00297427|463817014|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
128869357|NCT00297427|463817013|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
128869358|NCT00297427|463817014|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
128869359|NCT00297427|463817013|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
128869360|NCT00297427|463817014|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
128869361|NCT00297427|463817013|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
128869362|NCT00297427|463817014|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
128869363|NCT00297427|463817013|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
128869364|NCT00297427|463817014|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
128869365|NCT01656200|463817015|FG000|Overall Study|Withdrawal by Subject|1|||
128869366|NCT04155047|463817021|FG000|Overall Study|Adverse Event|1|||
128869367|NCT04155047|463817022|FG001|Overall Study|Adverse Event|0|||
128869368|NCT04155047|463817021|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
128869369|NCT04155047|463817022|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
128869370|NCT04488770|463817026|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869371|NCT04488770|463817027|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869372|NCT04488770|463817028|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869373|NCT04488770|463817029|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
128869374|NCT04488770|463817030|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869375|NCT04488770|463817031|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869376|NCT04488770|463817032|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869377|NCT04488770|463817033|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869378|NCT04488770|463817034|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869379|NCT04488770|463817035|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869380|NCT04488770|463817036|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869381|NCT04488770|463817037|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869382|NCT04488770|463817038|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
128869383|NCT04488770|463817026|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
128869384|NCT04488770|463817027|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869385|NCT04488770|463817028|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869386|NCT04488770|463817029|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869387|NCT04488770|463817030|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869388|NCT04488770|463817031|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869389|NCT04488770|463817032|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869390|NCT04488770|463817033|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869391|NCT04488770|463817034|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869392|NCT04488770|463817035|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869393|NCT04488770|463817036|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869394|NCT04488770|463817037|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869395|NCT04488770|463817038|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
128869396|NCT04488770|463817026|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869397|NCT04488770|463817027|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869398|NCT04488770|463817028|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869399|NCT04488770|463817029|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869400|NCT04488770|463817030|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869401|NCT04488770|463817031|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
128869402|NCT04488770|463817032|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
128869403|NCT04488770|463817033|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869404|NCT04488770|463817034|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869405|NCT04488770|463817035|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869406|NCT04488770|463817036|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869407|NCT04488770|463817037|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869408|NCT04488770|463817038|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
128869409|NCT04488770|463817026|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869410|NCT04488770|463817027|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869411|NCT04488770|463817028|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869412|NCT04488770|463817029|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869413|NCT04488770|463817030|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
128869414|NCT04488770|463817031|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869415|NCT04488770|463817032|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869416|NCT04488770|463817033|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869417|NCT04488770|463817034|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869418|NCT04488770|463817035|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869419|NCT04488770|463817036|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869420|NCT04488770|463817037|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869421|NCT04488770|463817038|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
128869422|NCT03174431|463817039|FG000|Overall Study|Withdrawal by Subject|14|||
128869423|NCT03174431|463817040|FG001|Overall Study|Withdrawal by Subject|11|||
128869424|NCT03174431|463817039|FG000|Overall Study|alternative treatment|2|||
128869425|NCT03174431|463817040|FG001|Overall Study|alternative treatment|0|||
128869426|NCT03174431|463817039|FG000|Overall Study|Lost to Follow-up|1|||
128869427|NCT03174431|463817040|FG001|Overall Study|Lost to Follow-up|5|||
128869428|NCT02075073|463817041|FG000|Overall Study|Withdrawal by Subject|0|||
128869429|NCT02075073|463817042|FG001|Overall Study|Withdrawal by Subject|1|||
128869430|NCT02075073|463817043|FG002|Overall Study|Withdrawal by Subject|0|||
128869431|NCT02797080|463817049|FG000|Overall Study|Lost to Follow-up|1|||
128869432|NCT02797080|463817049|FG000|Overall Study|Withdrawal by Subject|1|||
128869433|NCT00951015|463817052|FG000|Randomization Phase 96 Week|Adverse Event|1|||
128869434|NCT00951015|463817053|FG001|Randomization Phase 96 Week|Adverse Event|1|||
128869435|NCT00951015|463817054|FG002|Randomization Phase 96 Week|Adverse Event|2|||
128869436|NCT00951015|463817055|FG003|Randomization Phase 96 Week|Adverse Event|5|||
128869437|NCT00951015|463817056|FG004|Randomization Phase 96 Week|Adverse Event|0|||
128869438|NCT00951015|463817052|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
128869439|NCT00951015|463817053|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
128869440|NCT00951015|463817054|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
128869441|NCT00951015|463817055|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
128869442|NCT00951015|463817056|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
128869443|NCT00951015|463817052|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
128869444|NCT00951015|463817053|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
128869445|NCT00951015|463817054|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
128869446|NCT00951015|463817055|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
128869447|NCT00951015|463817056|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
128869448|NCT00951015|463817052|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
128869449|NCT00951015|463817053|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
128869450|NCT00951015|463817054|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
128869451|NCT00951015|463817055|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
128869452|NCT00951015|463817056|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
128869453|NCT00951015|463817052|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
128869454|NCT00951015|463817053|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
128869455|NCT00951015|463817054|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
128869456|NCT00951015|463817055|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
128869457|NCT00951015|463817056|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
128869458|NCT00951015|463817052|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
128869459|NCT00951015|463817053|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
128869460|NCT00951015|463817054|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
128869461|NCT00951015|463817055|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
128869462|NCT00951015|463817056|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
128869463|NCT00951015|463817052|FG000|Open-label Phase|Adverse Event|0|||
128869464|NCT00951015|463817053|FG001|Open-label Phase|Adverse Event|0|||
128869465|NCT00951015|463817054|FG002|Open-label Phase|Adverse Event|0|||
128869466|NCT00951015|463817055|FG003|Open-label Phase|Adverse Event|0|||
128869467|NCT00951015|463817056|FG004|Open-label Phase|Adverse Event|3|||
128869468|NCT00951015|463817052|FG000|Open-label Phase|Lack of Efficacy|0|||
128869469|NCT00951015|463817053|FG001|Open-label Phase|Lack of Efficacy|0|||
128869470|NCT00951015|463817054|FG002|Open-label Phase|Lack of Efficacy|0|||
128869471|NCT00951015|463817055|FG003|Open-label Phase|Lack of Efficacy|0|||
128869472|NCT00951015|463817056|FG004|Open-label Phase|Lack of Efficacy|1|||
128869473|NCT00951015|463817052|FG000|Open-label Phase|Protocol Violation|0|||
128869474|NCT00951015|463817053|FG001|Open-label Phase|Protocol Violation|0|||
128869475|NCT00951015|463817054|FG002|Open-label Phase|Protocol Violation|0|||
128869476|NCT00951015|463817055|FG003|Open-label Phase|Protocol Violation|0|||
128869477|NCT00951015|463817056|FG004|Open-label Phase|Protocol Violation|12|||
128869478|NCT00951015|463817052|FG000|Open-label Phase|Lost to Follow-up|0|||
128869479|NCT00951015|463817053|FG001|Open-label Phase|Lost to Follow-up|0|||
128869480|NCT00951015|463817054|FG002|Open-label Phase|Lost to Follow-up|0|||
128869481|NCT00951015|463817055|FG003|Open-label Phase|Lost to Follow-up|0|||
128869482|NCT00951015|463817056|FG004|Open-label Phase|Lost to Follow-up|12|||
128869483|NCT00951015|463817052|FG000|Open-label Phase|Withdrawal by Subject|0|||
128869484|NCT00951015|463817053|FG001|Open-label Phase|Withdrawal by Subject|0|||
128869485|NCT00951015|463817054|FG002|Open-label Phase|Withdrawal by Subject|0|||
128869486|NCT00951015|463817055|FG003|Open-label Phase|Withdrawal by Subject|0|||
128869487|NCT00951015|463817056|FG004|Open-label Phase|Withdrawal by Subject|14|||
128869488|NCT00951015|463817052|FG000|Open-label Phase|Physician Decision|0|||
128869489|NCT00951015|463817053|FG001|Open-label Phase|Physician Decision|0|||
128869490|NCT00951015|463817054|FG002|Open-label Phase|Physician Decision|0|||
128869491|NCT00951015|463817055|FG003|Open-label Phase|Physician Decision|0|||
128869492|NCT00951015|463817056|FG004|Open-label Phase|Physician Decision|8|||
128869493|NCT01208103|463817058|FG000|Overall Study|Adverse Event|1|||
128869494|NCT01208103|463817058|FG000|Overall Study|Withdrawal by Subject|1|||
128869495|NCT03819634|463817059|FG000|Overall Study|Physician Decision|2|||
128869496|NCT00299494|463817060|FG000|Overall Study|Withdrawal by Subject|0|||
128869497|NCT00299494|463817061|FG001|Overall Study|Withdrawal by Subject|0|||
128869498|NCT00299494|463817062|FG002|Overall Study|Withdrawal by Subject|0|||
128869499|NCT00299494|463817063|FG003|Overall Study|Withdrawal by Subject|3|||
128869500|NCT00299494|463817064|FG004|Overall Study|Withdrawal by Subject|1|||
128869501|NCT00299494|463817065|FG005|Overall Study|Withdrawal by Subject|4|||
128869502|NCT00299494|463817060|FG000|Overall Study|Physician Decision|0|||
128869503|NCT00299494|463817061|FG001|Overall Study|Physician Decision|0|||
128869504|NCT00299494|463817062|FG002|Overall Study|Physician Decision|0|||
128869505|NCT00299494|463817063|FG003|Overall Study|Physician Decision|0|||
128869506|NCT00299494|463817064|FG004|Overall Study|Physician Decision|1|||
128869507|NCT00299494|463817065|FG005|Overall Study|Physician Decision|0|||
128869508|NCT00299494|463817060|FG000|Overall Study|Death|3|||
128869509|NCT00299494|463817061|FG001|Overall Study|Death|1|||
128869510|NCT00299494|463817062|FG002|Overall Study|Death|4|||
128869511|NCT00299494|463817063|FG003|Overall Study|Death|6|||
128869512|NCT00299494|463817064|FG004|Overall Study|Death|18|||
128869513|NCT00299494|463817065|FG005|Overall Study|Death|19|||
128869514|NCT00299494|463817060|FG000|Overall Study|Lost to Follow-up|0|||
128869515|NCT00299494|463817061|FG001|Overall Study|Lost to Follow-up|0|||
128869516|NCT00299494|463817062|FG002|Overall Study|Lost to Follow-up|0|||
128869517|NCT00299494|463817063|FG003|Overall Study|Lost to Follow-up|0|||
128869518|NCT00299494|463817064|FG004|Overall Study|Lost to Follow-up|3|||
128869519|NCT00299494|463817065|FG005|Overall Study|Lost to Follow-up|1|||
128869520|NCT00299494|463817060|FG000|Overall Study|Other - Unspecified|0|||
128869521|NCT00299494|463817061|FG001|Overall Study|Other - Unspecified|0|||
128869522|NCT00299494|463817062|FG002|Overall Study|Other - Unspecified|0|||
128869523|NCT00299494|463817063|FG003|Overall Study|Other - Unspecified|0|||
128869524|NCT00299494|463817064|FG004|Overall Study|Other - Unspecified|3|||
128869525|NCT00299494|463817065|FG005|Overall Study|Other - Unspecified|1|||
128869526|NCT00299494|463817060|FG000|Overall Study|Other - site closure|0|||
128869527|NCT00299494|463817061|FG001|Overall Study|Other - site closure|0|||
128869528|NCT00299494|463817062|FG002|Overall Study|Other - site closure|0|||
128869529|NCT00299494|463817063|FG003|Overall Study|Other - site closure|1|||
128869530|NCT00299494|463817064|FG004|Overall Study|Other - site closure|1|||
128869531|NCT00299494|463817065|FG005|Overall Study|Other - site closure|1|||
128869532|NCT01417104|463817068|FG000|Overall Study|Withdrawal by Subject|5|||
128869533|NCT01417104|463817069|FG001|Overall Study|Withdrawal by Subject|1|||
128869534|NCT01417104|463817068|FG000|Overall Study|Failure to make contact|0|||
128869535|NCT01417104|463817069|FG001|Overall Study|Failure to make contact|1|||
128869536|NCT01417104|463817068|FG000|Overall Study|Adverse Event|1|||
128869537|NCT01417104|463817069|FG001|Overall Study|Adverse Event|0|||
128869538|NCT03361605|463817070|FG000|Overall Study|Analyzable data not available|3|||
128869539|NCT03101462|463817071|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
128869540|NCT03101462|463817072|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
128869541|NCT01641159|463817073|FG000|Overall Study|Lost to Follow-up|2|||
128869542|NCT01641159|463817074|FG001|Overall Study|Lost to Follow-up|1|||
128869543|NCT01641159|463817073|FG000|Overall Study|Withdrawal by Subject|0|||
128869544|NCT01641159|463817074|FG001|Overall Study|Withdrawal by Subject|1|||
128869545|NCT03653208|463817078|FG000|Overall Study|Withdrawal by Subject|0|||
128869546|NCT03653208|463817079|FG001|Overall Study|Withdrawal by Subject|0|||
128869547|NCT03653208|463817080|FG002|Overall Study|Withdrawal by Subject|0|||
128869548|NCT03653208|463817081|FG003|Overall Study|Withdrawal by Subject|0|||
128869549|NCT03653208|463817082|FG004|Overall Study|Withdrawal by Subject|1|||
128869550|NCT03653208|463817083|FG005|Overall Study|Withdrawal by Subject|0|||
128869551|NCT03653208|463817084|FG006|Overall Study|Withdrawal by Subject|0|||
128869552|NCT03653208|463817085|FG007|Overall Study|Withdrawal by Subject|1|||
128869553|NCT03653208|463817086|FG008|Overall Study|Withdrawal by Subject|1|||
128869554|NCT03752970|463817087|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
128869555|NCT03752970|463817088|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
128869556|NCT03752970|463817089|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
128869557|NCT03752970|463817087|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
128869558|NCT03752970|463817088|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
128869559|NCT03752970|463817089|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
128869560|NCT03752970|463817087|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
128869561|NCT03752970|463817088|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
128869562|NCT03752970|463817089|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
128869563|NCT03752970|463817087|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
128869564|NCT03752970|463817088|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
128869565|NCT03752970|463817089|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
128869566|NCT03752970|463817087|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
128869567|NCT03752970|463817088|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
128869568|NCT03752970|463817089|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
128869569|NCT01114880|463817090|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
128869570|NCT01114880|463817091|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
128869571|NCT01114880|463817090|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
128869572|NCT01114880|463817091|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
128869573|NCT01114880|463817090|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
128869574|NCT01114880|463817091|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
128869575|NCT01114880|463817090|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
128869576|NCT01114880|463817091|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
128869577|NCT01114880|463817090|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
128869578|NCT01114880|463817091|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
128869579|NCT01114880|463817090|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
128869580|NCT01114880|463817091|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
128869581|NCT02001064|463817092|FG000|Overall Study|Withdrawal by Subject|2|||
128869582|NCT02001064|463817093|FG001|Overall Study|Withdrawal by Subject|1|||
128869583|NCT02108964|463817096|FG000|Overall Study|Progressive disease|15|||
128869584|NCT02108964|463817097|FG001|Overall Study|Progressive disease|31|||
128869585|NCT02108964|463817098|FG002|Overall Study|Progressive disease|54|||
128869586|NCT02108964|463817099|FG003|Overall Study|Progressive disease|7|||
128869587|NCT02108964|463817100|FG004|Overall Study|Progressive disease|20|||
128869588|NCT02108964|463817101|FG005|Overall Study|Progressive disease|4|||
128869589|NCT02108964|463817102|FG006|Overall Study|Progressive disease|6|||
128869590|NCT02108964|463817103|FG007|Overall Study|Progressive disease|33|||
128869591|NCT02108964|463817096|FG000|Overall Study|Physician Decision|1|||
128869592|NCT02108964|463817097|FG001|Overall Study|Physician Decision|5|||
128869593|NCT02108964|463817098|FG002|Overall Study|Physician Decision|7|||
128869594|NCT02108964|463817099|FG003|Overall Study|Physician Decision|1|||
128869595|NCT02108964|463817100|FG004|Overall Study|Physician Decision|2|||
128869596|NCT02108964|463817101|FG005|Overall Study|Physician Decision|1|||
128869597|NCT02108964|463817102|FG006|Overall Study|Physician Decision|1|||
128869598|NCT02108964|463817103|FG007|Overall Study|Physician Decision|3|||
128869599|NCT02108964|463817096|FG000|Overall Study|Adverse Event|0|||
128869600|NCT02108964|463817097|FG001|Overall Study|Adverse Event|0|||
128869601|NCT02108964|463817098|FG002|Overall Study|Adverse Event|4|||
128869602|NCT02108964|463817099|FG003|Overall Study|Adverse Event|0|||
128869603|NCT02108964|463817100|FG004|Overall Study|Adverse Event|1|||
128869604|NCT02108964|463817101|FG005|Overall Study|Adverse Event|0|||
128869605|NCT02108964|463817102|FG006|Overall Study|Adverse Event|3|||
128869606|NCT02108964|463817103|FG007|Overall Study|Adverse Event|2|||
128869607|NCT02108964|463817096|FG000|Overall Study|Death|1|||
128869608|NCT02108964|463817097|FG001|Overall Study|Death|1|||
128869609|NCT02108964|463817098|FG002|Overall Study|Death|4|||
128869610|NCT02108964|463817099|FG003|Overall Study|Death|0|||
128869611|NCT02108964|463817100|FG004|Overall Study|Death|3|||
128869612|NCT02108964|463817101|FG005|Overall Study|Death|0|||
128869613|NCT02108964|463817102|FG006|Overall Study|Death|0|||
128869614|NCT02108964|463817103|FG007|Overall Study|Death|2|||
128869615|NCT02108964|463817096|FG000|Overall Study|Subject/Guardian decision|0|||
128869616|NCT02108964|463817097|FG001|Overall Study|Subject/Guardian decision|1|||
128869617|NCT02108964|463817098|FG002|Overall Study|Subject/Guardian decision|4|||
128869618|NCT02108964|463817099|FG003|Overall Study|Subject/Guardian decision|0|||
128869619|NCT02108964|463817100|FG004|Overall Study|Subject/Guardian decision|2|||
128869620|NCT02108964|463817101|FG005|Overall Study|Subject/Guardian decision|0|||
128869621|NCT02108964|463817102|FG006|Overall Study|Subject/Guardian decision|1|||
128869622|NCT02108964|463817103|FG007|Overall Study|Subject/Guardian decision|2|||
128869623|NCT02108964|463817096|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
128869624|NCT02108964|463817097|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
128869625|NCT02108964|463817098|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
128869626|NCT02108964|463817099|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
128869627|NCT02108964|463817100|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
128869628|NCT02108964|463817101|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
128869629|NCT02108964|463817102|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
128869630|NCT02108964|463817103|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
128869631|NCT03006848|463817104|FG000|Overall Study|Adverse Event|1|||
128869632|NCT03006848|463817104|FG000|Overall Study|Physician Decision|1|||
128869633|NCT03006848|463817104|FG000|Overall Study|Lack of Efficacy|16|||
128869634|NCT00384397|463817105|FG000|Overall Study|Adverse Event|0|||
128869635|NCT00384397|463817106|FG001|Overall Study|Adverse Event|1|||
128869636|NCT00384397|463817107|FG002|Overall Study|Adverse Event|2|||
128869637|NCT00384397|463817105|FG000|Overall Study|Protocol Violation|7|||
128869638|NCT00384397|463817106|FG001|Overall Study|Protocol Violation|15|||
128869639|NCT00384397|463817107|FG002|Overall Study|Protocol Violation|13|||
128869640|NCT00384397|463817105|FG000|Overall Study|Lost to Follow-up|11|||
128869641|NCT00384397|463817106|FG001|Overall Study|Lost to Follow-up|13|||
128869642|NCT00384397|463817107|FG002|Overall Study|Lost to Follow-up|3|||
128869643|NCT00384397|463817105|FG000|Overall Study|Withdrawal by Subject|14|||
128869644|NCT00384397|463817106|FG001|Overall Study|Withdrawal by Subject|17|||
128869645|NCT00384397|463817107|FG002|Overall Study|Withdrawal by Subject|15|||
128869646|NCT01214642|463817108|FG000|Overall Study|Progressive Disease|3|||
128869647|NCT01214642|463817109|FG001|Overall Study|Progressive Disease|2|||
128869648|NCT01214642|463817110|FG002|Overall Study|Progressive Disease|3|||
128869649|NCT01214642|463817111|FG003|Overall Study|Progressive Disease|5|||
128869650|NCT01214642|463817112|FG004|Overall Study|Progressive Disease|5|||
128869651|NCT01214642|463817113|FG005|Overall Study|Progressive Disease|3|||
128869652|NCT01214642|463817114|FG006|Overall Study|Progressive Disease|5|||
128869653|NCT01214642|463817115|FG007|Overall Study|Progressive Disease|3|||
128869654|NCT01214642|463817116|FG008|Overall Study|Progressive Disease|10|||
128869655|NCT01214642|463817117|FG009|Overall Study|Progressive Disease|2|||
128869656|NCT01214642|463817118|FG010|Overall Study|Progressive Disease|1|||
128869657|NCT01214642|463817119|FG011|Overall Study|Progressive Disease|4|||
128869658|NCT01214642|463817108|FG000|Overall Study|Adverse Event|0|||
128869659|NCT01214642|463817109|FG001|Overall Study|Adverse Event|1|||
128869660|NCT01214642|463817110|FG002|Overall Study|Adverse Event|0|||
128869661|NCT01214642|463817111|FG003|Overall Study|Adverse Event|0|||
128869662|NCT01214642|463817112|FG004|Overall Study|Adverse Event|0|||
128869663|NCT01214642|463817113|FG005|Overall Study|Adverse Event|0|||
128869664|NCT01214642|463817114|FG006|Overall Study|Adverse Event|1|||
128869665|NCT01214642|463817115|FG007|Overall Study|Adverse Event|0|||
128869666|NCT01214642|463817116|FG008|Overall Study|Adverse Event|0|||
128869667|NCT01214642|463817117|FG009|Overall Study|Adverse Event|1|||
128869668|NCT01214642|463817118|FG010|Overall Study|Adverse Event|1|||
128869669|NCT01214642|463817119|FG011|Overall Study|Adverse Event|0|||
128869670|NCT01214642|463817108|FG000|Overall Study|Death|0|||
128869671|NCT01214642|463817109|FG001|Overall Study|Death|0|||
128869672|NCT01214642|463817110|FG002|Overall Study|Death|1|||
128869673|NCT01214642|463817111|FG003|Overall Study|Death|0|||
128869674|NCT01214642|463817112|FG004|Overall Study|Death|0|||
128869675|NCT01214642|463817113|FG005|Overall Study|Death|0|||
128869676|NCT01214642|463817114|FG006|Overall Study|Death|0|||
128869677|NCT01214642|463817115|FG007|Overall Study|Death|0|||
128869678|NCT01214642|463817116|FG008|Overall Study|Death|0|||
128869679|NCT01214642|463817117|FG009|Overall Study|Death|0|||
128869680|NCT01214642|463817118|FG010|Overall Study|Death|1|||
128869681|NCT01214642|463817119|FG011|Overall Study|Death|0|||
128869682|NCT01214642|463817108|FG000|Overall Study|Withdrawal by Subject|0|||
128869683|NCT01214642|463817109|FG001|Overall Study|Withdrawal by Subject|0|||
128869684|NCT01214642|463817110|FG002|Overall Study|Withdrawal by Subject|1|||
128869685|NCT01214642|463817111|FG003|Overall Study|Withdrawal by Subject|0|||
128869686|NCT01214642|463817112|FG004|Overall Study|Withdrawal by Subject|0|||
128869687|NCT01214642|463817113|FG005|Overall Study|Withdrawal by Subject|0|||
128869688|NCT01214642|463817114|FG006|Overall Study|Withdrawal by Subject|0|||
128869689|NCT01214642|463817115|FG007|Overall Study|Withdrawal by Subject|0|||
128869690|NCT01214642|463817116|FG008|Overall Study|Withdrawal by Subject|3|||
128869691|NCT01214642|463817117|FG009|Overall Study|Withdrawal by Subject|1|||
128869692|NCT01214642|463817118|FG010|Overall Study|Withdrawal by Subject|1|||
128869693|NCT01214642|463817119|FG011|Overall Study|Withdrawal by Subject|0|||
128869694|NCT01214642|463817108|FG000|Overall Study|Physician Decision|0|||
128869695|NCT01214642|463817109|FG001|Overall Study|Physician Decision|0|||
128869696|NCT01214642|463817110|FG002|Overall Study|Physician Decision|1|||
128869697|NCT01214642|463817111|FG003|Overall Study|Physician Decision|1|||
128869698|NCT01214642|463817112|FG004|Overall Study|Physician Decision|1|||
128869699|NCT01214642|463817113|FG005|Overall Study|Physician Decision|0|||
128869700|NCT01214642|463817114|FG006|Overall Study|Physician Decision|0|||
128869701|NCT01214642|463817115|FG007|Overall Study|Physician Decision|0|||
128869702|NCT01214642|463817116|FG008|Overall Study|Physician Decision|0|||
128869703|NCT01214642|463817117|FG009|Overall Study|Physician Decision|0|||
128869704|NCT01214642|463817118|FG010|Overall Study|Physician Decision|0|||
128869705|NCT01214642|463817119|FG011|Overall Study|Physician Decision|2|||
128869706|NCT04372121|463817120|FG000|Overall Study|Lost to Follow-up|0|||
128869707|NCT04372121|463817121|FG001|Overall Study|Lost to Follow-up|0|||
128869708|NCT04372121|463817122|FG002|Overall Study|Lost to Follow-up|0|||
128869709|NCT04372121|463817123|FG003|Overall Study|Lost to Follow-up|1|||
128869710|NCT04372121|463817120|FG000|Overall Study|Protocol Violation|0|||
128869711|NCT04372121|463817121|FG001|Overall Study|Protocol Violation|0|||
128869712|NCT04372121|463817122|FG002|Overall Study|Protocol Violation|1|||
128869713|NCT04372121|463817123|FG003|Overall Study|Protocol Violation|0|||
128869714|NCT04372121|463817120|FG000|Overall Study|Withdrawal by Subject|3|||
128869715|NCT04372121|463817121|FG001|Overall Study|Withdrawal by Subject|1|||
128869716|NCT04372121|463817122|FG002|Overall Study|Withdrawal by Subject|0|||
128869717|NCT04372121|463817123|FG003|Overall Study|Withdrawal by Subject|0|||
128869718|NCT04372121|463817120|FG000|Overall Study|Study termination|6|||
128869719|NCT04372121|463817121|FG001|Overall Study|Study termination|5|||
128869720|NCT04372121|463817122|FG002|Overall Study|Study termination|1|||
128869721|NCT04372121|463817123|FG003|Overall Study|Study termination|1|||
128869722|NCT04372121|463817120|FG000|Overall Study|Hysterectomy planned|1|||
128869723|NCT04372121|463817121|FG001|Overall Study|Hysterectomy planned|0|||
128869724|NCT04372121|463817122|FG002|Overall Study|Hysterectomy planned|0|||
128869725|NCT04372121|463817123|FG003|Overall Study|Hysterectomy planned|0|||
128869726|NCT04500769|463818624|FG000|Overall Study|Withdrawal by Subject|5|||
128869727|NCT01967147|463818625|FG000|Overall Study|Adverse Event|5|||
128869728|NCT01967147|463818626|FG001|Overall Study|Adverse Event|2|||
128869729|NCT01967147|463818625|FG000|Overall Study|Lack of Efficacy|1|||
128869730|NCT01967147|463818626|FG001|Overall Study|Lack of Efficacy|4|||
128869731|NCT01967147|463818625|FG000|Overall Study|Lost to Follow-up|1|||
128869732|NCT01967147|463818626|FG001|Overall Study|Lost to Follow-up|2|||
128869733|NCT01967147|463818625|FG000|Overall Study|Withdrawal by Subject|2|||
128869734|NCT01967147|463818626|FG001|Overall Study|Withdrawal by Subject|4|||
128869735|NCT01967147|463818625|FG000|Overall Study|Non-compliance with Study Drug|0|||
128869736|NCT01967147|463818626|FG001|Overall Study|Non-compliance with Study Drug|3|||
128869737|NCT01967147|463818625|FG000|Overall Study|Other|4|||
128869738|NCT01967147|463818626|FG001|Overall Study|Other|5|||
128869739|NCT00890695|463818627|FG000|Overall Study|Protocol Violation|1|||
128869740|NCT00890695|463818628|FG001|Overall Study|Protocol Violation|0|||
128869741|NCT02314780|463818629|FG000|Overall Study|organizational reasons|0|||
128869742|NCT02314780|463818630|FG001|Overall Study|organizational reasons|2|||
128869743|NCT02314780|463818631|FG002|Overall Study|organizational reasons|0|||
128869744|NCT02314780|463818629|FG000|Overall Study|Adverse Event|0|||
128869745|NCT02314780|463818630|FG001|Overall Study|Adverse Event|1|||
128869746|NCT02314780|463818631|FG002|Overall Study|Adverse Event|0|||
128869747|NCT00215137|463818635|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
128869748|NCT00215137|463818636|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
128869749|NCT00215137|463818637|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
128869750|NCT00215137|463818635|FG000|Randomization Period|Lost to Follow-up|0|||
128869751|NCT00215137|463818636|FG001|Randomization Period|Lost to Follow-up|1|||
128869752|NCT00215137|463818637|FG002|Randomization Period|Lost to Follow-up|0|||
128869753|NCT00215137|463818635|FG000|Randomization Period|Withdrawal by Subject|0|||
128869754|NCT00215137|463818636|FG001|Randomization Period|Withdrawal by Subject|1|||
128869755|NCT00215137|463818637|FG002|Randomization Period|Withdrawal by Subject|0|||
128869756|NCT03002220|463818639|FG000|Overall Study|Lack of Efficacy|2|||
128869757|NCT03002220|463818639|FG000|Overall Study|Withdrawal by Subject|3|||
128869758|NCT03002220|463818639|FG000|Overall Study|Adverse Event|2|||
128869759|NCT03002220|463818639|FG000|Overall Study|Disease progression|13|||
128869760|NCT03002220|463818639|FG000|Overall Study|Physician Decision|1|||
128869761|NCT01142232|463818645|FG000|Overall Study|Adverse Event|1|||
128869762|NCT01142232|463818646|FG001|Overall Study|Adverse Event|2|||
128869763|NCT01142232|463818647|FG002|Overall Study|Adverse Event|1|||
128869764|NCT01142232|463818648|FG003|Overall Study|Adverse Event|0|||
128869765|NCT01142232|463818649|FG004|Overall Study|Adverse Event|4|||
128869766|NCT01142232|463818645|FG000|Overall Study|Death|0|||
128869767|NCT01142232|463818646|FG001|Overall Study|Death|0|||
128869768|NCT01142232|463818647|FG002|Overall Study|Death|0|||
128869769|NCT01142232|463818648|FG003|Overall Study|Death|0|||
128869770|NCT01142232|463818649|FG004|Overall Study|Death|1|||
128869771|NCT01142232|463818645|FG000|Overall Study|Disease Progression|2|||
128869772|NCT01142232|463818646|FG001|Overall Study|Disease Progression|0|||
128869773|NCT01142232|463818647|FG002|Overall Study|Disease Progression|1|||
128869774|NCT01142232|463818648|FG003|Overall Study|Disease Progression|2|||
128869775|NCT01142232|463818649|FG004|Overall Study|Disease Progression|12|||
128869776|NCT01142232|463818645|FG000|Overall Study|Withdrawal by Subject|0|||
128869777|NCT01142232|463818646|FG001|Overall Study|Withdrawal by Subject|0|||
128869778|NCT01142232|463818647|FG002|Overall Study|Withdrawal by Subject|0|||
128869779|NCT01142232|463818648|FG003|Overall Study|Withdrawal by Subject|1|||
128869780|NCT01142232|463818649|FG004|Overall Study|Withdrawal by Subject|3|||
128869781|NCT01142232|463818645|FG000|Overall Study|Physician Decision|0|||
128869782|NCT01142232|463818646|FG001|Overall Study|Physician Decision|1|||
128869783|NCT01142232|463818647|FG002|Overall Study|Physician Decision|0|||
128869784|NCT01142232|463818648|FG003|Overall Study|Physician Decision|2|||
128869785|NCT01142232|463818649|FG004|Overall Study|Physician Decision|10|||
128869786|NCT01142232|463818645|FG000|Overall Study|Alternative Therapy|0|||
128869787|NCT01142232|463818646|FG001|Overall Study|Alternative Therapy|1|||
128869788|NCT01142232|463818647|FG002|Overall Study|Alternative Therapy|1|||
128869789|NCT01142232|463818648|FG003|Overall Study|Alternative Therapy|0|||
128869790|NCT01142232|463818649|FG004|Overall Study|Alternative Therapy|1|||
128869791|NCT01142232|463818645|FG000|Overall Study|Off Trt for other complicating disease|0|||
128869792|NCT01142232|463818646|FG001|Overall Study|Off Trt for other complicating disease|0|||
128869793|NCT01142232|463818647|FG002|Overall Study|Off Trt for other complicating disease|0|||
128869794|NCT01142232|463818648|FG003|Overall Study|Off Trt for other complicating disease|0|||
128869795|NCT01142232|463818649|FG004|Overall Study|Off Trt for other complicating disease|1|||
128869796|NCT01142232|463818645|FG000|Overall Study|Noncompliance|0|||
128869797|NCT01142232|463818646|FG001|Overall Study|Noncompliance|0|||
128869798|NCT01142232|463818647|FG002|Overall Study|Noncompliance|0|||
128869799|NCT01142232|463818648|FG003|Overall Study|Noncompliance|0|||
128869800|NCT01142232|463818649|FG004|Overall Study|Noncompliance|2|||
128869801|NCT02787044|463818652|FG000|Overall Study|Lost to Follow-up|15|||
128869802|NCT02787044|463818653|FG001|Overall Study|Lost to Follow-up|19|||
128869803|NCT01517295|463818655|FG000|Overall Study|Physician Decision|1|||
128869804|NCT01517295|463818656|FG001|Overall Study|Physician Decision|0|||
128869805|NCT02182947|463818657|FG000|Overall Study|Withdrawal by Subject|7|||
128869806|NCT02182947|463818657|FG000|Overall Study|Lost to Follow-up|3|||
128869807|NCT02182947|463818657|FG000|Overall Study|Failed screening activities|8|||
128869808|NCT00730275|463818660|FG000|Overall Study|Withdrawal by Subject|0|||
128869809|NCT00730275|463818661|FG001|Overall Study|Withdrawal by Subject|0|||
128869810|NCT00730275|463818662|FG002|Overall Study|Withdrawal by Subject|0|||
128869811|NCT00730275|463818663|FG003|Overall Study|Withdrawal by Subject|1|||
128869812|NCT00939822|463818664|FG000|Overall Study|Lost to Follow-up|1|||
128869813|NCT00939822|463818665|FG001|Overall Study|Lost to Follow-up|0|||
128869814|NCT00939822|463818664|FG000|Overall Study|withdrew from study due to busy schedule|1|||
128869815|NCT00939822|463818665|FG001|Overall Study|withdrew from study due to busy schedule|1|||
128869816|NCT00939822|463818664|FG000|Overall Study|Mental health issues|0|||
128869817|NCT00939822|463818665|FG001|Overall Study|Mental health issues|2|||
128869818|NCT03046121|463818668|FG000|Overall Study|Death|32|||
128869819|NCT03046121|463818669|FG001|Overall Study|Death|60|||
128869820|NCT03046121|463818668|FG000|Overall Study|Withdrawal by Subject|14|||
128869821|NCT03046121|463818669|FG001|Overall Study|Withdrawal by Subject|12|||
128869822|NCT00910039|463818670|FG000|Overall Study|Physician Decision|1|||
128869823|NCT04035499|463818673|FG000|Overall Study|Death|2|||
128869824|NCT04035499|463818673|FG000|Overall Study|Withdrawal by Subject|1|||
128869825|NCT00416195|463818674|FG000|Overall Study|Adverse Event|1|||
128869826|NCT00416195|463818675|FG001|Overall Study|Adverse Event|2|||
128869827|NCT00416195|463818674|FG000|Overall Study|Protocol Violation|1|||
128869828|NCT00416195|463818675|FG001|Overall Study|Protocol Violation|1|||
128869829|NCT00416195|463818674|FG000|Overall Study|Other|0|||
128869830|NCT00416195|463818675|FG001|Overall Study|Other|1|||
128869831|NCT01305408|463818681|FG000|Overall Study|Adverse Event|10|||
128869832|NCT01305408|463818682|FG001|Overall Study|Adverse Event|7|||
128869833|NCT01305408|463818681|FG000|Overall Study|Lack of Efficacy|3|||
128869834|NCT01305408|463818682|FG001|Overall Study|Lack of Efficacy|4|||
128869835|NCT01305408|463818681|FG000|Overall Study|Withdrawal by Subject|9|||
128869836|NCT01305408|463818682|FG001|Overall Study|Withdrawal by Subject|9|||
128869837|NCT01305408|463818681|FG000|Overall Study|Protocol Violation|4|||
128869838|NCT01305408|463818682|FG001|Overall Study|Protocol Violation|6|||
128869839|NCT01305408|463818681|FG000|Overall Study|Lost to Follow-up|5|||
128869840|NCT01305408|463818682|FG001|Overall Study|Lost to Follow-up|3|||
128869841|NCT01305408|463818681|FG000|Overall Study|Noncompliance with study medication|0|||
128869842|NCT01305408|463818682|FG001|Overall Study|Noncompliance with study medication|1|||
128869843|NCT01305408|463818681|FG000|Overall Study|Noncompliance with study procedures|0|||
128869844|NCT01305408|463818682|FG001|Overall Study|Noncompliance with study procedures|1|||
128869845|NCT01305408|463818681|FG000|Overall Study|Other|1|||
128869846|NCT01305408|463818682|FG001|Overall Study|Other|0|||
128869847|NCT02530970|463818683|FG000|Overall Study|Adverse Event|8|||
128869848|NCT02530970|463818683|FG000|Overall Study|Lost to Follow-up|88|||
128869849|NCT02530970|463818683|FG000|Overall Study|Physician Decision|5|||
128869850|NCT02530970|463818683|FG000|Overall Study|Withdrawal by Subject|14|||
128869851|NCT02530970|463818683|FG000|Overall Study|Death|6|||
128869852|NCT02530970|463818683|FG000|Overall Study|Hospitalization|1|||
128869853|NCT02530970|463818683|FG000|Overall Study|Insurance|2|||
128869854|NCT02530970|463818683|FG000|Overall Study|Explant|2|||
128869855|NCT02530970|463818683|FG000|Overall Study|Change in Provider|5|||
128869856|NCT02530970|463818683|FG000|Overall Study|Relocation|3|||
128869857|NCT02770612|463818685|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
128869858|NCT02003222|463818691|FG000|Induction|Never started treatment|0|||
128869859|NCT02003222|463818692|FG001|Induction|Never started treatment|0|||
128869860|NCT02003222|463818693|FG002|Induction|Never started treatment|0|||
128869861|NCT02003222|463818694|FG003|Induction|Never started treatment|0|||
128869862|NCT02003222|463818695|FG004|Induction|Never started treatment|8|||
128869863|NCT02003222|463818691|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
128869864|NCT02003222|463818692|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
128869865|NCT02003222|463818693|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
128869866|NCT02003222|463818694|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
128869867|NCT02003222|463818695|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
128869868|NCT02003222|463818691|FG000|Induction|Adverse Event|0|||
128869869|NCT02003222|463818692|FG001|Induction|Adverse Event|0|||
128869870|NCT02003222|463818693|FG002|Induction|Adverse Event|0|||
128869871|NCT02003222|463818694|FG003|Induction|Adverse Event|0|||
128869872|NCT02003222|463818695|FG004|Induction|Adverse Event|13|||
128869873|NCT02003222|463818691|FG000|Induction|Alternative therapy|0|||
128869874|NCT02003222|463818692|FG001|Induction|Alternative therapy|0|||
128869875|NCT02003222|463818693|FG002|Induction|Alternative therapy|0|||
128869876|NCT02003222|463818694|FG003|Induction|Alternative therapy|0|||
128869877|NCT02003222|463818695|FG004|Induction|Alternative therapy|12|||
128869878|NCT02003222|463818691|FG000|Induction|Disease progression|0|||
128869879|NCT02003222|463818692|FG001|Induction|Disease progression|0|||
128869880|NCT02003222|463818693|FG002|Induction|Disease progression|0|||
128869881|NCT02003222|463818694|FG003|Induction|Disease progression|0|||
128869882|NCT02003222|463818695|FG004|Induction|Disease progression|22|||
128869883|NCT02003222|463818691|FG000|Induction|Death|0|||
128869884|NCT02003222|463818692|FG001|Induction|Death|0|||
128869885|NCT02003222|463818693|FG002|Induction|Death|0|||
128869886|NCT02003222|463818694|FG003|Induction|Death|0|||
128869887|NCT02003222|463818695|FG004|Induction|Death|3|||
128869888|NCT02003222|463818691|FG000|Induction|Withdrawal by Subject|0|||
128869889|NCT02003222|463818692|FG001|Induction|Withdrawal by Subject|0|||
128869890|NCT02003222|463818693|FG002|Induction|Withdrawal by Subject|0|||
128869891|NCT02003222|463818694|FG003|Induction|Withdrawal by Subject|0|||
128869892|NCT02003222|463818695|FG004|Induction|Withdrawal by Subject|8|||
128869893|NCT02003222|463818691|FG000|Induction|Other reasons|0|||
128869894|NCT02003222|463818692|FG001|Induction|Other reasons|0|||
128869895|NCT02003222|463818693|FG002|Induction|Other reasons|0|||
128869896|NCT02003222|463818694|FG003|Induction|Other reasons|0|||
128869897|NCT02003222|463818695|FG004|Induction|Other reasons|22|||
128869898|NCT02003222|463818691|FG000|Intensification|Never started treatment|0|||
128869899|NCT02003222|463818692|FG001|Intensification|Never started treatment|0|||
128869900|NCT02003222|463818693|FG002|Intensification|Never started treatment|0|||
128869901|NCT02003222|463818694|FG003|Intensification|Never started treatment|0|||
128869902|NCT02003222|463818695|FG004|Intensification|Never started treatment|2|||
128869903|NCT02003222|463818691|FG000|Intensification|Adverse Event|0|||
128869904|NCT02003222|463818692|FG001|Intensification|Adverse Event|0|||
128869905|NCT02003222|463818693|FG002|Intensification|Adverse Event|0|||
128869906|NCT02003222|463818694|FG003|Intensification|Adverse Event|0|||
128869907|NCT02003222|463818695|FG004|Intensification|Adverse Event|6|||
128869908|NCT02003222|463818691|FG000|Intensification|Alternative therapy|0|||
128869909|NCT02003222|463818692|FG001|Intensification|Alternative therapy|0|||
128869910|NCT02003222|463818693|FG002|Intensification|Alternative therapy|0|||
128869911|NCT02003222|463818694|FG003|Intensification|Alternative therapy|0|||
128869912|NCT02003222|463818695|FG004|Intensification|Alternative therapy|8|||
128869913|NCT02003222|463818691|FG000|Intensification|Disease progression|0|||
128869914|NCT02003222|463818692|FG001|Intensification|Disease progression|0|||
128869915|NCT02003222|463818693|FG002|Intensification|Disease progression|0|||
128869916|NCT02003222|463818694|FG003|Intensification|Disease progression|0|||
128869917|NCT02003222|463818695|FG004|Intensification|Disease progression|18|||
128869918|NCT02003222|463818691|FG000|Intensification|Withdrawal by Subject|0|||
128869919|NCT02003222|463818692|FG001|Intensification|Withdrawal by Subject|0|||
128869920|NCT02003222|463818693|FG002|Intensification|Withdrawal by Subject|0|||
128869921|NCT02003222|463818694|FG003|Intensification|Withdrawal by Subject|0|||
128869922|NCT02003222|463818695|FG004|Intensification|Withdrawal by Subject|5|||
128869923|NCT02003222|463818691|FG000|Intensification|Other reasons|0|||
128869924|NCT02003222|463818692|FG001|Intensification|Other reasons|0|||
128869925|NCT02003222|463818693|FG002|Intensification|Other reasons|0|||
128869926|NCT02003222|463818694|FG003|Intensification|Other reasons|0|||
128869927|NCT02003222|463818695|FG004|Intensification|Other reasons|8|||
128869928|NCT01365481|463818696|FG000|Overall Study|Adverse Event|6|||
128869929|NCT01365481|463818697|FG001|Overall Study|Adverse Event|9|||
128869930|NCT01365481|463818698|FG002|Overall Study|Adverse Event|0|||
128869931|NCT01365481|463818699|FG003|Overall Study|Adverse Event|2|||
128869932|NCT01365481|463818696|FG000|Overall Study|Withdrawal by Subject|0|||
128869933|NCT01365481|463818697|FG001|Overall Study|Withdrawal by Subject|2|||
128869934|NCT01365481|463818698|FG002|Overall Study|Withdrawal by Subject|1|||
128869935|NCT01365481|463818699|FG003|Overall Study|Withdrawal by Subject|1|||
128869936|NCT01365481|463818696|FG000|Overall Study|Lost to Follow-up|1|||
128869937|NCT01365481|463818697|FG001|Overall Study|Lost to Follow-up|1|||
128869938|NCT01365481|463818698|FG002|Overall Study|Lost to Follow-up|2|||
128869939|NCT01365481|463818699|FG003|Overall Study|Lost to Follow-up|3|||
128869940|NCT01365481|463818696|FG000|Overall Study|Abnormal laboratory value(s)|0|||
128869941|NCT01365481|463818697|FG001|Overall Study|Abnormal laboratory value(s)|1|||
128869942|NCT01365481|463818698|FG002|Overall Study|Abnormal laboratory value(s)|0|||
128869943|NCT01365481|463818699|FG003|Overall Study|Abnormal laboratory value(s)|0|||
128869944|NCT01365481|463818696|FG000|Overall Study|Administrative problems|0|||
128869945|NCT01365481|463818697|FG001|Overall Study|Administrative problems|1|||
128869946|NCT01365481|463818698|FG002|Overall Study|Administrative problems|0|||
128869947|NCT01365481|463818699|FG003|Overall Study|Administrative problems|0|||
128869948|NCT01365481|463818696|FG000|Overall Study|Protocol deviation|0|||
128869949|NCT01365481|463818697|FG001|Overall Study|Protocol deviation|1|||
128869950|NCT01365481|463818698|FG002|Overall Study|Protocol deviation|0|||
128869951|NCT01365481|463818699|FG003|Overall Study|Protocol deviation|1|||
128869952|NCT01365481|463818696|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128869953|NCT01365481|463818697|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
128869954|NCT01365481|463818698|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
128869955|NCT01365481|463818699|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
128869956|NCT03014011|463818711|FG000|First Intervention|Withdrawal by Subject|1|||
128869957|NCT03014011|463818712|FG001|First Intervention|Withdrawal by Subject|0|||
128869958|NCT03014011|463818711|FG000|Washout|Withdrawal by Subject|1|||
128869959|NCT03014011|463818712|FG001|Washout|Withdrawal by Subject|0|||
128869960|NCT02416453|463818714|FG000|Overall Study|Adverse Event|0|||
128869961|NCT02416453|463818715|FG001|Overall Study|Adverse Event|0|||
128869962|NCT02416453|463818716|FG002|Overall Study|Adverse Event|0|||
128869963|NCT02416453|463818717|FG003|Overall Study|Adverse Event|2|||
128869964|NCT02416453|463818718|FG004|Overall Study|Adverse Event|0|||
128869965|NCT02416453|463818719|FG005|Overall Study|Adverse Event|1|||
128869966|NCT02416453|463818720|FG006|Overall Study|Adverse Event|0|||
128869967|NCT02416453|463818721|FG007|Overall Study|Adverse Event|0|||
128869968|NCT02416453|463818722|FG008|Overall Study|Adverse Event|0|||
128869969|NCT02416453|463818723|FG009|Overall Study|Adverse Event|0|||
128869970|NCT02416453|463818724|FG010|Overall Study|Adverse Event|0|||
128869971|NCT02416453|463818714|FG000|Overall Study|Lost to Follow-up|1|||
128869972|NCT02416453|463818715|FG001|Overall Study|Lost to Follow-up|3|||
128869973|NCT02416453|463818716|FG002|Overall Study|Lost to Follow-up|0|||
128869974|NCT02416453|463818717|FG003|Overall Study|Lost to Follow-up|8|||
128869975|NCT02416453|463818718|FG004|Overall Study|Lost to Follow-up|0|||
128869976|NCT02416453|463818719|FG005|Overall Study|Lost to Follow-up|5|||
128869977|NCT02416453|463818720|FG006|Overall Study|Lost to Follow-up|1|||
128869978|NCT02416453|463818721|FG007|Overall Study|Lost to Follow-up|3|||
128869979|NCT02416453|463818722|FG008|Overall Study|Lost to Follow-up|1|||
128869980|NCT02416453|463818723|FG009|Overall Study|Lost to Follow-up|0|||
128869981|NCT02416453|463818724|FG010|Overall Study|Lost to Follow-up|0|||
128869982|NCT02416453|463818714|FG000|Overall Study|Physician Decision|0|||
128869983|NCT02416453|463818715|FG001|Overall Study|Physician Decision|0|||
128869984|NCT02416453|463818716|FG002|Overall Study|Physician Decision|0|||
128869985|NCT02416453|463818717|FG003|Overall Study|Physician Decision|0|||
128869986|NCT02416453|463818718|FG004|Overall Study|Physician Decision|0|||
128869987|NCT02416453|463818719|FG005|Overall Study|Physician Decision|1|||
128869988|NCT02416453|463818720|FG006|Overall Study|Physician Decision|1|||
128869989|NCT02416453|463818721|FG007|Overall Study|Physician Decision|1|||
128869990|NCT02416453|463818722|FG008|Overall Study|Physician Decision|0|||
128869991|NCT02416453|463818723|FG009|Overall Study|Physician Decision|0|||
128869992|NCT02416453|463818724|FG010|Overall Study|Physician Decision|0|||
128869993|NCT02416453|463818714|FG000|Overall Study|Withdrawal by Subject|2|||
128869994|NCT02416453|463818715|FG001|Overall Study|Withdrawal by Subject|0|||
128869995|NCT02416453|463818716|FG002|Overall Study|Withdrawal by Subject|0|||
128869996|NCT02416453|463818717|FG003|Overall Study|Withdrawal by Subject|5|||
128869997|NCT02416453|463818718|FG004|Overall Study|Withdrawal by Subject|1|||
128869998|NCT02416453|463818719|FG005|Overall Study|Withdrawal by Subject|8|||
128869999|NCT02416453|463818720|FG006|Overall Study|Withdrawal by Subject|0|||
128870000|NCT02416453|463818721|FG007|Overall Study|Withdrawal by Subject|8|||
128870001|NCT02416453|463818722|FG008|Overall Study|Withdrawal by Subject|4|||
128870002|NCT02416453|463818723|FG009|Overall Study|Withdrawal by Subject|0|||
128870003|NCT02416453|463818724|FG010|Overall Study|Withdrawal by Subject|0|||
128870004|NCT02416453|463818714|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870005|NCT02416453|463818715|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870006|NCT02416453|463818716|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
128870007|NCT02416453|463818717|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870008|NCT02416453|463818718|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870009|NCT02416453|463818719|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870010|NCT02416453|463818720|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870011|NCT02416453|463818721|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870012|NCT02416453|463818722|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870013|NCT02416453|463818723|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870014|NCT02416453|463818724|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
128870015|NCT02416453|463818714|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870016|NCT02416453|463818715|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870017|NCT02416453|463818716|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870018|NCT02416453|463818717|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870019|NCT02416453|463818718|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870020|NCT02416453|463818719|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
128870021|NCT02416453|463818720|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870022|NCT02416453|463818721|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870023|NCT02416453|463818722|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870024|NCT02416453|463818723|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870025|NCT02416453|463818724|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
128870026|NCT01152814|463818726|FG000|Overall Study|Lost to Follow-up|2|||
128870027|NCT00831129|463818734|FG000|Overall Study|Adverse Event|0|||
128870028|NCT00831129|463818735|FG001|Overall Study|Adverse Event|1|||
128870029|NCT00831129|463818734|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
128870030|NCT00831129|463818735|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
128870031|NCT01877239|463818736|FG000|Overall Study|Adverse Event|4|||
128870032|NCT01877239|463818736|FG000|Overall Study|Disease Remission|1|||
128870033|NCT01877239|463818736|FG000|Overall Study|Withdrawal by Subject|4|||
128870034|NCT01877239|463818736|FG000|Overall Study|Other|2|||
128870035|NCT01877239|463818736|FG000|Overall Study|Lack of Efficacy|4|||
128870036|NCT01877239|463818736|FG000|Overall Study|Data not available|35|||
128870037|NCT01669577|463818740|FG000|Overall Study|Death|22|||
128870038|NCT01669577|463818740|FG000|Overall Study|Lost to Follow-up|78|||
128870039|NCT01669577|463818740|FG000|Overall Study|Physician Decision|34|||
128870040|NCT01283516|463818741|FG000|Overall Study|Adverse Event|0|||
128870041|NCT01283516|463818742|FG001|Overall Study|Adverse Event|0|||
128870042|NCT01283516|463818743|FG002|Overall Study|Adverse Event|0|||
128870043|NCT01283516|463818744|FG003|Overall Study|Adverse Event|0|||
128870044|NCT01283516|463818745|FG004|Overall Study|Adverse Event|0|||
128870045|NCT01283516|463818746|FG005|Overall Study|Adverse Event|0|||
128870046|NCT01283516|463818747|FG006|Overall Study|Adverse Event|2|||
128870047|NCT01283516|463818748|FG007|Overall Study|Adverse Event|0|||
128870048|NCT01283516|463818749|FG008|Overall Study|Adverse Event|28|||
128870049|NCT01283516|463818741|FG000|Overall Study|Death|0|||
128870050|NCT01283516|463818742|FG001|Overall Study|Death|0|||
128870051|NCT01283516|463818743|FG002|Overall Study|Death|0|||
128870052|NCT01283516|463818744|FG003|Overall Study|Death|0|||
128870053|NCT01283516|463818745|FG004|Overall Study|Death|0|||
128870054|NCT01283516|463818746|FG005|Overall Study|Death|1|||
128870055|NCT01283516|463818747|FG006|Overall Study|Death|0|||
128870056|NCT01283516|463818748|FG007|Overall Study|Death|1|||
128870057|NCT01283516|463818749|FG008|Overall Study|Death|12|||
128870058|NCT01283516|463818741|FG000|Overall Study|Disease Progression|2|||
128870059|NCT01283516|463818742|FG001|Overall Study|Disease Progression|2|||
128870060|NCT01283516|463818743|FG002|Overall Study|Disease Progression|3|||
128870061|NCT01283516|463818744|FG003|Overall Study|Disease Progression|3|||
128870062|NCT01283516|463818745|FG004|Overall Study|Disease Progression|13|||
128870063|NCT01283516|463818746|FG005|Overall Study|Disease Progression|8|||
128870064|NCT01283516|463818747|FG006|Overall Study|Disease Progression|6|||
128870065|NCT01283516|463818748|FG007|Overall Study|Disease Progression|3|||
128870066|NCT01283516|463818749|FG008|Overall Study|Disease Progression|139|||
128870067|NCT01283516|463818741|FG000|Overall Study|Withdrawal by Subject|0|||
128870068|NCT01283516|463818742|FG001|Overall Study|Withdrawal by Subject|0|||
128870069|NCT01283516|463818743|FG002|Overall Study|Withdrawal by Subject|0|||
128870070|NCT01283516|463818744|FG003|Overall Study|Withdrawal by Subject|0|||
128870071|NCT01283516|463818745|FG004|Overall Study|Withdrawal by Subject|1|||
128870072|NCT01283516|463818746|FG005|Overall Study|Withdrawal by Subject|0|||
128870073|NCT01283516|463818747|FG006|Overall Study|Withdrawal by Subject|1|||
128870074|NCT01283516|463818748|FG007|Overall Study|Withdrawal by Subject|0|||
128870075|NCT01283516|463818749|FG008|Overall Study|Withdrawal by Subject|36|||
128870076|NCT01283516|463818741|FG000|Overall Study|Administrative problems|0|||
128870077|NCT01283516|463818742|FG001|Overall Study|Administrative problems|0|||
128870078|NCT01283516|463818743|FG002|Overall Study|Administrative problems|0|||
128870079|NCT01283516|463818744|FG003|Overall Study|Administrative problems|0|||
128870080|NCT01283516|463818745|FG004|Overall Study|Administrative problems|0|||
128870081|NCT01283516|463818746|FG005|Overall Study|Administrative problems|1|||
128870082|NCT01283516|463818747|FG006|Overall Study|Administrative problems|1|||
128870083|NCT01283516|463818748|FG007|Overall Study|Administrative problems|1|||
128870084|NCT01283516|463818749|FG008|Overall Study|Administrative problems|39|||
128870085|NCT01283516|463818741|FG000|Overall Study|Lost to Follow-up|0|||
128870086|NCT01283516|463818742|FG001|Overall Study|Lost to Follow-up|0|||
128870087|NCT01283516|463818743|FG002|Overall Study|Lost to Follow-up|0|||
128870088|NCT01283516|463818744|FG003|Overall Study|Lost to Follow-up|0|||
128870089|NCT01283516|463818745|FG004|Overall Study|Lost to Follow-up|0|||
128870090|NCT01283516|463818746|FG005|Overall Study|Lost to Follow-up|0|||
128870091|NCT01283516|463818747|FG006|Overall Study|Lost to Follow-up|0|||
128870092|NCT01283516|463818748|FG007|Overall Study|Lost to Follow-up|0|||
128870093|NCT01283516|463818749|FG008|Overall Study|Lost to Follow-up|1|||
128870094|NCT00132873|463818758|FG000|Overall Study|Adverse Event|3|||
128870095|NCT00132873|463818758|FG000|Overall Study|Lost to Follow-up|1|||
128870096|NCT00132873|463818758|FG000|Overall Study|Lack of Efficacy|1|||
128870097|NCT00132873|463818758|FG000|Overall Study|Withdrawal by Subject|3|||
128870098|NCT00132873|463818758|FG000|Overall Study|Planned Pregnancy|1|||
128870099|NCT02045875|463818759|FG000|Overall Study|Lost to Follow-up|3|||
128870100|NCT02045875|463818760|FG001|Overall Study|Lost to Follow-up|0|||
128870101|NCT02045875|463818759|FG000|Overall Study|Withdrawal by Subject|4|||
128870102|NCT02045875|463818760|FG001|Overall Study|Withdrawal by Subject|3|||
128870103|NCT00444275|463818761|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
128870104|NCT00444275|463818762|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
128870105|NCT00444275|463818763|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
128870106|NCT00444275|463818764|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
128870107|NCT00444275|463818765|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
128870108|NCT00444275|463818761|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
128870109|NCT00444275|463818762|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
128870110|NCT00444275|463818763|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
128870111|NCT00444275|463818764|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
128870112|NCT00444275|463818765|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
128870113|NCT00444275|463818761|FG000|Maintenance Treatment Phase|Adverse Event|0|||
128870114|NCT00444275|463818762|FG001|Maintenance Treatment Phase|Adverse Event|0|||
128870115|NCT00444275|463818763|FG002|Maintenance Treatment Phase|Adverse Event|3|||
128870116|NCT00444275|463818764|FG003|Maintenance Treatment Phase|Adverse Event|2|||
128870117|NCT00444275|463818765|FG004|Maintenance Treatment Phase|Adverse Event|13|||
128870118|NCT00444275|463818761|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
128870119|NCT00444275|463818762|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
128870120|NCT00444275|463818763|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
128870121|NCT00444275|463818764|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
128870122|NCT00444275|463818765|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
128870123|NCT00444275|463818761|FG000|Maintenance Treatment Phase|Patient's wish|0|||
128870124|NCT00444275|463818762|FG001|Maintenance Treatment Phase|Patient's wish|0|||
128870125|NCT00444275|463818763|FG002|Maintenance Treatment Phase|Patient's wish|19|||
128870126|NCT00444275|463818764|FG003|Maintenance Treatment Phase|Patient's wish|9|||
128870127|NCT00444275|463818765|FG004|Maintenance Treatment Phase|Patient's wish|20|||
128870128|NCT00444275|463818761|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
128870129|NCT00444275|463818762|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
128870130|NCT00444275|463818763|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
128870131|NCT00444275|463818764|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
128870132|NCT00444275|463818765|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
128870133|NCT00444275|463818761|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
128870134|NCT00444275|463818762|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
128870135|NCT00444275|463818763|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
128870136|NCT00444275|463818764|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
128870137|NCT00444275|463818765|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
128870138|NCT00586612|463818769|FG000|Primary Phase|Protocol Violation|1|||
128870139|NCT00586612|463818770|FG001|Primary Phase|Protocol Violation|0|||
128870140|NCT00586612|463818769|FG000|Primary Phase|Lost to Follow-up|0|||
128870141|NCT00586612|463818770|FG001|Primary Phase|Lost to Follow-up|1|||
128870142|NCT00586612|463818769|FG000|Primary Phase|Withdrawal by Subject|0|||
128870143|NCT00586612|463818770|FG001|Primary Phase|Withdrawal by Subject|2|||
128870144|NCT00586612|463818769|FG000|Booster Phase|Lost to Follow-up|3|||
128870145|NCT00586612|463818770|FG001|Booster Phase|Lost to Follow-up|1|||
128870146|NCT02738853|463818771|FG000|Enrollment|Inclusion/Exclusion not met|21|||
128870147|NCT02738853|463818771|FG000|Enrollment|Withdrawal by Subject|3|||
128870148|NCT02738853|463818771|FG000|Enrollment|Subject treated with commercially available device|6|||
128870149|NCT02738853|463818771|FG000|Enrollment|Study Enrollment Closed|3|||
128870150|NCT02738853|463818771|FG000|Procedure|Death|1|||
128870151|NCT02738853|463818771|FG000|1 Month|Death|2|||
128870152|NCT02738853|463818771|FG000|6 Month|Death|4|||
128870153|NCT02738853|463818771|FG000|6 Month|Withdrawal by Subject|2|||
128870154|NCT02738853|463818771|FG000|1 Year|Death|6|||
128870155|NCT02738853|463818771|FG000|1 Year|Withdrawal by Subject|1|||
128870156|NCT02738853|463818771|FG000|2 Year|Death|2|||
128870157|NCT02738853|463818771|FG000|2 Year|Lost to Follow-up|1|||
128870158|NCT02738853|463818771|FG000|3 Year|Death|2|||
128870159|NCT02738853|463818771|FG000|3 Year|Withdrawal by Subject|1|||
128870160|NCT02738853|463818771|FG000|4 Year|Death|9|||
128870161|NCT02738853|463818771|FG000|5 Year|Lost to Follow-up|4|||
128870162|NCT01803282|463818772|FG000|Overall Study|Progressive Disease|4|||
128870163|NCT01803282|463818773|FG001|Overall Study|Progressive Disease|3|||
128870164|NCT01803282|463818774|FG002|Overall Study|Progressive Disease|6|||
128870165|NCT01803282|463818775|FG003|Overall Study|Progressive Disease|22|||
128870166|NCT01803282|463818776|FG004|Overall Study|Progressive Disease|5|||
128870167|NCT01803282|463818777|FG005|Overall Study|Progressive Disease|8|||
128870168|NCT01803282|463818778|FG006|Overall Study|Progressive Disease|23|||
128870169|NCT01803282|463818779|FG007|Overall Study|Progressive Disease|24|||
128870170|NCT01803282|463818780|FG008|Overall Study|Progressive Disease|3|||
128870171|NCT01803282|463818781|FG009|Overall Study|Progressive Disease|29|||
128870172|NCT01803282|463818782|FG010|Overall Study|Progressive Disease|6|||
128870173|NCT01803282|463818783|FG011|Overall Study|Progressive Disease|11|||
128870174|NCT01803282|463818772|FG000|Overall Study|Death|0|||
128870175|NCT01803282|463818773|FG001|Overall Study|Death|0|||
128870176|NCT01803282|463818774|FG002|Overall Study|Death|0|||
128870177|NCT01803282|463818775|FG003|Overall Study|Death|0|||
128870178|NCT01803282|463818776|FG004|Overall Study|Death|2|||
128870179|NCT01803282|463818777|FG005|Overall Study|Death|1|||
128870180|NCT01803282|463818778|FG006|Overall Study|Death|1|||
128870181|NCT01803282|463818779|FG007|Overall Study|Death|5|||
128870182|NCT01803282|463818780|FG008|Overall Study|Death|1|||
128870183|NCT01803282|463818781|FG009|Overall Study|Death|1|||
128870184|NCT01803282|463818782|FG010|Overall Study|Death|0|||
128870185|NCT01803282|463818783|FG011|Overall Study|Death|0|||
128870186|NCT01803282|463818772|FG000|Overall Study|Withdrew Consent|0|||
128870187|NCT01803282|463818773|FG001|Overall Study|Withdrew Consent|0|||
128870188|NCT01803282|463818774|FG002|Overall Study|Withdrew Consent|0|||
128870189|NCT01803282|463818775|FG003|Overall Study|Withdrew Consent|6|||
128870190|NCT01803282|463818776|FG004|Overall Study|Withdrew Consent|1|||
128870191|NCT01803282|463818777|FG005|Overall Study|Withdrew Consent|0|||
128870192|NCT01803282|463818778|FG006|Overall Study|Withdrew Consent|8|||
128870193|NCT01803282|463818779|FG007|Overall Study|Withdrew Consent|3|||
128870194|NCT01803282|463818780|FG008|Overall Study|Withdrew Consent|1|||
128870195|NCT01803282|463818781|FG009|Overall Study|Withdrew Consent|5|||
128870196|NCT01803282|463818782|FG010|Overall Study|Withdrew Consent|0|||
128870197|NCT01803282|463818783|FG011|Overall Study|Withdrew Consent|1|||
128870198|NCT01803282|463818772|FG000|Overall Study|Investigator's Discretion|0|||
128870199|NCT01803282|463818773|FG001|Overall Study|Investigator's Discretion|0|||
128870200|NCT01803282|463818774|FG002|Overall Study|Investigator's Discretion|0|||
128870201|NCT01803282|463818775|FG003|Overall Study|Investigator's Discretion|7|||
128870202|NCT01803282|463818776|FG004|Overall Study|Investigator's Discretion|2|||
128870203|NCT01803282|463818777|FG005|Overall Study|Investigator's Discretion|1|||
128870204|NCT01803282|463818778|FG006|Overall Study|Investigator's Discretion|7|||
128870205|NCT01803282|463818779|FG007|Overall Study|Investigator's Discretion|10|||
128870206|NCT01803282|463818780|FG008|Overall Study|Investigator's Discretion|6|||
128870207|NCT01803282|463818781|FG009|Overall Study|Investigator's Discretion|7|||
128870208|NCT01803282|463818782|FG010|Overall Study|Investigator's Discretion|1|||
128870209|NCT01803282|463818783|FG011|Overall Study|Investigator's Discretion|0|||
128870210|NCT01803282|463818772|FG000|Overall Study|Adverse Event|0|||
128870211|NCT01803282|463818773|FG001|Overall Study|Adverse Event|0|||
128870212|NCT01803282|463818774|FG002|Overall Study|Adverse Event|0|||
128870213|NCT01803282|463818775|FG003|Overall Study|Adverse Event|0|||
128870214|NCT01803282|463818776|FG004|Overall Study|Adverse Event|0|||
128870215|NCT01803282|463818777|FG005|Overall Study|Adverse Event|0|||
128870216|NCT01803282|463818778|FG006|Overall Study|Adverse Event|1|||
128870217|NCT01803282|463818779|FG007|Overall Study|Adverse Event|2|||
128870218|NCT01803282|463818780|FG008|Overall Study|Adverse Event|0|||
128870219|NCT01803282|463818781|FG009|Overall Study|Adverse Event|1|||
128870220|NCT01803282|463818782|FG010|Overall Study|Adverse Event|0|||
128870221|NCT01803282|463818783|FG011|Overall Study|Adverse Event|3|||
128870222|NCT01803282|463818772|FG000|Overall Study|Non-Compliance with Study Drug|0|||
128870223|NCT01803282|463818773|FG001|Overall Study|Non-Compliance with Study Drug|0|||
128870224|NCT01803282|463818774|FG002|Overall Study|Non-Compliance with Study Drug|0|||
128870225|NCT01803282|463818775|FG003|Overall Study|Non-Compliance with Study Drug|1|||
128870226|NCT01803282|463818776|FG004|Overall Study|Non-Compliance with Study Drug|0|||
128870227|NCT01803282|463818777|FG005|Overall Study|Non-Compliance with Study Drug|0|||
128870228|NCT01803282|463818778|FG006|Overall Study|Non-Compliance with Study Drug|0|||
128870229|NCT01803282|463818779|FG007|Overall Study|Non-Compliance with Study Drug|0|||
128870230|NCT01803282|463818780|FG008|Overall Study|Non-Compliance with Study Drug|0|||
128870231|NCT01803282|463818781|FG009|Overall Study|Non-Compliance with Study Drug|0|||
128870232|NCT01803282|463818782|FG010|Overall Study|Non-Compliance with Study Drug|0|||
128870233|NCT01803282|463818783|FG011|Overall Study|Non-Compliance with Study Drug|0|||
128870234|NCT01803282|463818772|FG000|Overall Study|Unknown Reason|0|||
128870235|NCT01803282|463818773|FG001|Overall Study|Unknown Reason|0|||
128870236|NCT01803282|463818774|FG002|Overall Study|Unknown Reason|0|||
128870237|NCT01803282|463818775|FG003|Overall Study|Unknown Reason|0|||
128870238|NCT01803282|463818776|FG004|Overall Study|Unknown Reason|0|||
128870239|NCT01803282|463818777|FG005|Overall Study|Unknown Reason|0|||
128870240|NCT01803282|463818778|FG006|Overall Study|Unknown Reason|0|||
128870241|NCT01803282|463818779|FG007|Overall Study|Unknown Reason|1|||
128870242|NCT01803282|463818780|FG008|Overall Study|Unknown Reason|0|||
128870243|NCT01803282|463818781|FG009|Overall Study|Unknown Reason|0|||
128870244|NCT01803282|463818782|FG010|Overall Study|Unknown Reason|0|||
128870245|NCT01803282|463818783|FG011|Overall Study|Unknown Reason|0|||
128870246|NCT01803282|463818772|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
128870247|NCT01803282|463818773|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
128870248|NCT01803282|463818774|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
128870249|NCT01803282|463818775|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
128870250|NCT01803282|463818776|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
128870251|NCT01803282|463818777|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
128870252|NCT01803282|463818778|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
128870253|NCT01803282|463818779|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
128870254|NCT01803282|463818780|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
128870255|NCT01803282|463818781|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
128870256|NCT01803282|463818782|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
128870257|NCT01803282|463818783|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
128870258|NCT01803282|463818772|FG000|Overall Study|Enrolled but Never Treated|0|||
128870259|NCT01803282|463818773|FG001|Overall Study|Enrolled but Never Treated|0|||
128870260|NCT01803282|463818774|FG002|Overall Study|Enrolled but Never Treated|0|||
128870261|NCT01803282|463818775|FG003|Overall Study|Enrolled but Never Treated|0|||
128870262|NCT01803282|463818776|FG004|Overall Study|Enrolled but Never Treated|1|||
128870263|NCT01803282|463818777|FG005|Overall Study|Enrolled but Never Treated|0|||
128870264|NCT01803282|463818778|FG006|Overall Study|Enrolled but Never Treated|1|||
128870265|NCT01803282|463818779|FG007|Overall Study|Enrolled but Never Treated|1|||
128870266|NCT01803282|463818780|FG008|Overall Study|Enrolled but Never Treated|0|||
128870267|NCT01803282|463818781|FG009|Overall Study|Enrolled but Never Treated|1|||
128870268|NCT01803282|463818782|FG010|Overall Study|Enrolled but Never Treated|0|||
128870269|NCT01803282|463818783|FG011|Overall Study|Enrolled but Never Treated|0|||
128870270|NCT01743989|463818784|FG000|Treatment Phase|Unstable MR4.0|0|||
128870271|NCT01743989|463818785|FG001|Treatment Phase|Unstable MR4.0|6|||
128870272|NCT01743989|463818786|FG002|Treatment Phase|Unstable MR4.0|263|||
128870273|NCT01743989|463818784|FG000|Treatment Phase|Adverse Event|0|||
128870274|NCT01743989|463818785|FG001|Treatment Phase|Adverse Event|4|||
128870275|NCT01743989|463818786|FG002|Treatment Phase|Adverse Event|67|||
128870276|NCT01743989|463818784|FG000|Treatment Phase|Withdrawal by Subject|1|||
128870277|NCT01743989|463818785|FG001|Treatment Phase|Withdrawal by Subject|3|||
128870278|NCT01743989|463818786|FG002|Treatment Phase|Withdrawal by Subject|28|||
128870279|NCT01743989|463818784|FG000|Treatment Phase|Death|0|||
128870280|NCT01743989|463818785|FG001|Treatment Phase|Death|1|||
128870281|NCT01743989|463818786|FG002|Treatment Phase|Death|3|||
128870282|NCT01743989|463818784|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
128870283|NCT01743989|463818785|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
128870284|NCT01743989|463818786|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
128870285|NCT01743989|463818784|FG000|Treatment Phase|Protocol deviation|0|||
128870286|NCT01743989|463818785|FG001|Treatment Phase|Protocol deviation|0|||
128870287|NCT01743989|463818786|FG002|Treatment Phase|Protocol deviation|3|||
128870288|NCT01743989|463818784|FG000|Treatment Phase|Pregnancy|0|||
128870289|NCT01743989|463818785|FG001|Treatment Phase|Pregnancy|0|||
128870290|NCT01743989|463818786|FG002|Treatment Phase|Pregnancy|2|||
128870291|NCT01743989|463818784|FG000|Treatment Phase|Lost to Follow-up|0|||
128870292|NCT01743989|463818785|FG001|Treatment Phase|Lost to Follow-up|0|||
128870293|NCT01743989|463818786|FG002|Treatment Phase|Lost to Follow-up|2|||
128870294|NCT01743989|463818784|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
128870295|NCT01743989|463818785|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
128870296|NCT01743989|463818786|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
128870297|NCT01743989|463818784|FG000|Treatment Phase|Administrative problems|0|||
128870298|NCT01743989|463818785|FG001|Treatment Phase|Administrative problems|0|||
128870299|NCT01743989|463818786|FG002|Treatment Phase|Administrative problems|1|||
128870300|NCT01743989|463818784|FG000|Treatment Phase|New cancer (CML) therapy|0|||
128870301|NCT01743989|463818785|FG001|Treatment Phase|New cancer (CML) therapy|1|||
128870302|NCT01743989|463818786|FG002|Treatment Phase|New cancer (CML) therapy|0|||
128870303|NCT01743989|463818784|FG000|Treatment Phase|Physician Decision|0|||
128870304|NCT01743989|463818785|FG001|Treatment Phase|Physician Decision|0|||
128870305|NCT01743989|463818786|FG002|Treatment Phase|Physician Decision|3|||
128870306|NCT01743989|463818784|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
128870307|NCT01743989|463818785|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
128870308|NCT01743989|463818786|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
128870309|NCT01743989|463818784|FG000|Treatment Phase|Not randomized by mistake|0|||
128870310|NCT01743989|463818785|FG001|Treatment Phase|Not randomized by mistake|0|||
128870311|NCT01743989|463818786|FG002|Treatment Phase|Not randomized by mistake|1|||
128870312|NCT01743989|463818784|FG000|Treatment Phase|Included by mistake|0|||
128870313|NCT01743989|463818785|FG001|Treatment Phase|Included by mistake|0|||
128870314|NCT01743989|463818786|FG002|Treatment Phase|Included by mistake|1|||
128870315|NCT01743989|463818784|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
128870316|NCT01743989|463818785|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
128870317|NCT01743989|463818786|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
128870318|NCT01743989|463818784|FG000|TFR Phase|Adverse Event|0|||
128870319|NCT01743989|463818785|FG001|TFR Phase|Adverse Event|1|||
128870320|NCT01743989|463818786|FG002|TFR Phase|Adverse Event|0|||
128870321|NCT01743989|463818784|FG000|TFR Phase|Lost to Follow-up|0|||
128870322|NCT01743989|463818785|FG001|TFR Phase|Lost to Follow-up|2|||
128870323|NCT01743989|463818786|FG002|TFR Phase|Lost to Follow-up|0|||
128870324|NCT01743989|463818784|FG000|TFR Phase|Physician Decision|0|||
128870325|NCT01743989|463818785|FG001|TFR Phase|Physician Decision|1|||
128870326|NCT01743989|463818786|FG002|TFR Phase|Physician Decision|0|||
128870327|NCT01743989|463818784|FG000|TFR Phase|Logistical problems|0|||
128870328|NCT01743989|463818785|FG001|TFR Phase|Logistical problems|2|||
128870329|NCT01743989|463818786|FG002|TFR Phase|Logistical problems|0|||
128870330|NCT01743989|463818784|FG000|TFR Phase|Protocol deviation|0|||
128870331|NCT01743989|463818785|FG001|TFR Phase|Protocol deviation|1|||
128870332|NCT01743989|463818786|FG002|TFR Phase|Protocol deviation|0|||
128870333|NCT01743989|463818784|FG000|TFR Phase|Withdrawal by Subject|0|||
128870334|NCT01743989|463818785|FG001|TFR Phase|Withdrawal by Subject|2|||
128870335|NCT01743989|463818786|FG002|TFR Phase|Withdrawal by Subject|0|||
128870336|NCT01743989|463818784|FG000|Re-treatment Phase|Adverse Event|8|||
128870337|NCT01743989|463818785|FG001|Re-treatment Phase|Adverse Event|4|||
128870338|NCT01743989|463818786|FG002|Re-treatment Phase|Adverse Event|0|||
128870339|NCT01743989|463818784|FG000|Re-treatment Phase|Death|1|||
128870340|NCT01743989|463818785|FG001|Re-treatment Phase|Death|1|||
128870341|NCT01743989|463818786|FG002|Re-treatment Phase|Death|0|||
128870342|NCT01743989|463818784|FG000|Re-treatment Phase|Administrative problems|1|||
128870343|NCT01743989|463818785|FG001|Re-treatment Phase|Administrative problems|1|||
128870344|NCT01743989|463818786|FG002|Re-treatment Phase|Administrative problems|0|||
128870345|NCT01743989|463818784|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
128870346|NCT01743989|463818785|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
128870347|NCT01743989|463818786|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
128870348|NCT01743989|463818784|FG000|Re-treatment Phase|Unstable MR|1|||
128870349|NCT01743989|463818785|FG001|Re-treatment Phase|Unstable MR|0|||
128870350|NCT01743989|463818786|FG002|Re-treatment Phase|Unstable MR|0|||
128870351|NCT01743989|463818784|FG000|Re-treatment Phase|Physician Decision|0|||
128870352|NCT01743989|463818785|FG001|Re-treatment Phase|Physician Decision|1|||
128870353|NCT01743989|463818786|FG002|Re-treatment Phase|Physician Decision|0|||
128870354|NCT01743989|463818784|FG000|Re-treatment Phase|Lost to Follow-up|0|||
128870355|NCT01743989|463818785|FG001|Re-treatment Phase|Lost to Follow-up|1|||
128870356|NCT01743989|463818786|FG002|Re-treatment Phase|Lost to Follow-up|0|||
128870357|NCT02235311|463818791|FG000|Overall Study|Lost to Follow-up|0|||
128870358|NCT02235311|463818792|FG001|Overall Study|Lost to Follow-up|1|||
128870359|NCT02235311|463818791|FG000|Overall Study|Protocol Violation|0|||
128870360|NCT02235311|463818792|FG001|Overall Study|Protocol Violation|1|||
128870361|NCT02626455|463818793|FG000|Overall Study|Other|1|||
128870362|NCT02626455|463818794|FG001|Overall Study|Other|1|||
128870363|NCT02626455|463818795|FG002|Overall Study|Other|0|||
128870364|NCT02626455|463818796|FG003|Overall Study|Other|0|||
128870365|NCT02626455|463818797|FG004|Overall Study|Other|0|||
128870366|NCT02626455|463818798|FG005|Overall Study|Other|17|||
128870367|NCT02626455|463818799|FG006|Overall Study|Other|23|||
128870368|NCT02626455|463818793|FG000|Overall Study|Withdrawal by Subject|1|||
128870369|NCT02626455|463818794|FG001|Overall Study|Withdrawal by Subject|0|||
128870370|NCT02626455|463818795|FG002|Overall Study|Withdrawal by Subject|0|||
128870371|NCT02626455|463818796|FG003|Overall Study|Withdrawal by Subject|0|||
128870372|NCT02626455|463818797|FG004|Overall Study|Withdrawal by Subject|0|||
128870373|NCT02626455|463818798|FG005|Overall Study|Withdrawal by Subject|10|||
128870374|NCT02626455|463818799|FG006|Overall Study|Withdrawal by Subject|6|||
128870375|NCT02626455|463818793|FG000|Overall Study|Physician Decision|0|||
128870376|NCT02626455|463818794|FG001|Overall Study|Physician Decision|2|||
128870377|NCT02626455|463818795|FG002|Overall Study|Physician Decision|2|||
128870378|NCT02626455|463818796|FG003|Overall Study|Physician Decision|2|||
128870379|NCT02626455|463818797|FG004|Overall Study|Physician Decision|1|||
128870380|NCT02626455|463818798|FG005|Overall Study|Physician Decision|10|||
128870381|NCT02626455|463818799|FG006|Overall Study|Physician Decision|3|||
128870382|NCT02626455|463818793|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
128870383|NCT02626455|463818794|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
128870384|NCT02626455|463818795|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
128870385|NCT02626455|463818796|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
128870386|NCT02626455|463818797|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
128870387|NCT02626455|463818798|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
128870388|NCT02626455|463818799|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
128870389|NCT02626455|463818793|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
128870390|NCT02626455|463818794|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
128870391|NCT02626455|463818795|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
128870392|NCT02626455|463818796|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
128870393|NCT02626455|463818797|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
128870394|NCT02626455|463818798|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
128870395|NCT02626455|463818799|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
128870396|NCT02626455|463818793|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
128870397|NCT02626455|463818794|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
128870398|NCT02626455|463818795|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
128870399|NCT02626455|463818796|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
128870400|NCT02626455|463818797|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
128870401|NCT02626455|463818798|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
128870402|NCT02626455|463818799|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
128870403|NCT02626455|463818793|FG000|Overall Study|Patient decision|0|||
128870404|NCT02626455|463818794|FG001|Overall Study|Patient decision|1|||
128870405|NCT02626455|463818795|FG002|Overall Study|Patient decision|0|||
128870406|NCT02626455|463818796|FG003|Overall Study|Patient decision|0|||
128870407|NCT02626455|463818797|FG004|Overall Study|Patient decision|1|||
128870408|NCT02626455|463818798|FG005|Overall Study|Patient decision|36|||
128870409|NCT02626455|463818799|FG006|Overall Study|Patient decision|22|||
128870410|NCT02626455|463818793|FG000|Overall Study|Protocol Violation|0|||
128870411|NCT02626455|463818794|FG001|Overall Study|Protocol Violation|0|||
128870412|NCT02626455|463818795|FG002|Overall Study|Protocol Violation|0|||
128870413|NCT02626455|463818796|FG003|Overall Study|Protocol Violation|0|||
128870414|NCT02626455|463818797|FG004|Overall Study|Protocol Violation|0|||
128870415|NCT02626455|463818798|FG005|Overall Study|Protocol Violation|0|||
128870416|NCT02626455|463818799|FG006|Overall Study|Protocol Violation|1|||
128870417|NCT02626455|463818793|FG000|Overall Study|Progressive disease - radiological progression|0|||
128870418|NCT02626455|463818794|FG001|Overall Study|Progressive disease - radiological progression|0|||
128870419|NCT02626455|463818795|FG002|Overall Study|Progressive disease - radiological progression|0|||
128870420|NCT02626455|463818796|FG003|Overall Study|Progressive disease - radiological progression|0|||
128870421|NCT02626455|463818797|FG004|Overall Study|Progressive disease - radiological progression|0|||
128870422|NCT02626455|463818798|FG005|Overall Study|Progressive disease - radiological progression|11|||
128870423|NCT02626455|463818799|FG006|Overall Study|Progressive disease - radiological progression|22|||
128870424|NCT02626455|463818793|FG000|Overall Study|Progressive disease - clinical progression|0|||
128870425|NCT02626455|463818794|FG001|Overall Study|Progressive disease - clinical progression|0|||
128870426|NCT02626455|463818795|FG002|Overall Study|Progressive disease - clinical progression|0|||
128870427|NCT02626455|463818796|FG003|Overall Study|Progressive disease - clinical progression|0|||
128870428|NCT02626455|463818797|FG004|Overall Study|Progressive disease - clinical progression|0|||
128870429|NCT02626455|463818798|FG005|Overall Study|Progressive disease - clinical progression|1|||
128870430|NCT02626455|463818799|FG006|Overall Study|Progressive disease - clinical progression|2|||
128870431|NCT02626455|463818793|FG000|Overall Study|Lost to Follow-up|0|||
128870432|NCT02626455|463818794|FG001|Overall Study|Lost to Follow-up|0|||
128870433|NCT02626455|463818795|FG002|Overall Study|Lost to Follow-up|0|||
128870434|NCT02626455|463818796|FG003|Overall Study|Lost to Follow-up|0|||
128870435|NCT02626455|463818797|FG004|Overall Study|Lost to Follow-up|0|||
128870436|NCT02626455|463818798|FG005|Overall Study|Lost to Follow-up|1|||
128870437|NCT02626455|463818799|FG006|Overall Study|Lost to Follow-up|0|||
128870438|NCT02626455|463818793|FG000|Overall Study|AE not associated with clinical disease progression|1|||
128870439|NCT02626455|463818794|FG001|Overall Study|AE not associated with clinical disease progression|1|||
128870440|NCT02626455|463818795|FG002|Overall Study|AE not associated with clinical disease progression|0|||
128870441|NCT02626455|463818796|FG003|Overall Study|AE not associated with clinical disease progression|2|||
128870442|NCT02626455|463818797|FG004|Overall Study|AE not associated with clinical disease progression|1|||
128870443|NCT02626455|463818798|FG005|Overall Study|AE not associated with clinical disease progression|65|||
128870444|NCT02626455|463818799|FG006|Overall Study|AE not associated with clinical disease progression|21|||
128870445|NCT02626455|463818793|FG000|Overall Study|AE associated with clinical disease progression|0|||
128870446|NCT02626455|463818794|FG001|Overall Study|AE associated with clinical disease progression|0|||
128870447|NCT02626455|463818795|FG002|Overall Study|AE associated with clinical disease progression|0|||
128870448|NCT02626455|463818796|FG003|Overall Study|AE associated with clinical disease progression|0|||
128870449|NCT02626455|463818797|FG004|Overall Study|AE associated with clinical disease progression|0|||
128870450|NCT02626455|463818798|FG005|Overall Study|AE associated with clinical disease progression|1|||
128870451|NCT02626455|463818799|FG006|Overall Study|AE associated with clinical disease progression|2|||
128870452|NCT02626455|463818793|FG000|Overall Study|Study intervention never administered|0|||
128870453|NCT02626455|463818794|FG001|Overall Study|Study intervention never administered|0|||
128870454|NCT02626455|463818795|FG002|Overall Study|Study intervention never administered|0|||
128870455|NCT02626455|463818796|FG003|Overall Study|Study intervention never administered|0|||
128870456|NCT02626455|463818797|FG004|Overall Study|Study intervention never administered|0|||
128870457|NCT02626455|463818798|FG005|Overall Study|Study intervention never administered|1|||
128870458|NCT02626455|463818799|FG006|Overall Study|Study intervention never administered|3|||
128870459|NCT03345576|463818802|FG000|Overall Study|Withdrawal by Subject|2|||
128870460|NCT03345576|463818803|FG001|Overall Study|Withdrawal by Subject|2|||
128870461|NCT03345576|463818802|FG000|Overall Study|Adverse Event|1|||
128870462|NCT03345576|463818803|FG001|Overall Study|Adverse Event|0|||
128870463|NCT01302080|463820629|FG000|Overall Study|Withdrew Consent|92|||
128870464|NCT01302080|463820630|FG001|Overall Study|Withdrew Consent|39|||
128870465|NCT01302080|463820629|FG000|Overall Study|Patient/Family Moved|28|||
128870466|NCT01302080|463820630|FG001|Overall Study|Patient/Family Moved|3|||
128870467|NCT01302080|463820629|FG000|Overall Study|Lost to Follow-up|192|||
128870468|NCT01302080|463820630|FG001|Overall Study|Lost to Follow-up|93|||
128870469|NCT01302080|463820629|FG000|Overall Study|Death|1|||
128870470|NCT01302080|463820630|FG001|Overall Study|Death|0|||
128870471|NCT01302080|463820629|FG000|Overall Study|Other|52|||
128870472|NCT01302080|463820630|FG001|Overall Study|Other|8|||
128870473|NCT01302080|463820629|FG000|Overall Study|Reason Missing For Discontinuation|1|||
128870474|NCT01302080|463820630|FG001|Overall Study|Reason Missing For Discontinuation|0|||
128870475|NCT00503139|463820633|FG000|Overall Study|Case Report Forms were not collected|4|||
128870476|NCT00503139|463820633|FG000|Overall Study|Protocol Violation|4|||
128870477|NCT02735577|463820634|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
128870478|NCT02735577|463820634|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
128870479|NCT00833833|463820635|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
128870480|NCT00833833|463820636|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
128870481|NCT00833833|463820637|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
128870482|NCT00833833|463820638|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
128870483|NCT00833833|463820639|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
128870484|NCT00833833|463820640|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
128870485|NCT00833833|463820635|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
128870486|NCT00833833|463820636|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
128870487|NCT00833833|463820637|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
128870488|NCT00833833|463820638|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
128870489|NCT00833833|463820639|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
128870490|NCT00833833|463820640|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
128870491|NCT00833833|463820635|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
128870492|NCT00833833|463820636|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
128870493|NCT00833833|463820637|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
128870494|NCT00833833|463820638|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
128870495|NCT00833833|463820639|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
128870496|NCT00833833|463820640|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
128870497|NCT00833833|463820635|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
128870498|NCT00833833|463820636|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
128870499|NCT00833833|463820637|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
128870500|NCT00833833|463820638|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
128870501|NCT00833833|463820639|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
128870502|NCT00833833|463820640|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
128870503|NCT00833833|463820635|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
128870504|NCT00833833|463820636|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870505|NCT00833833|463820637|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
128870506|NCT00833833|463820638|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870507|NCT00833833|463820639|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870508|NCT00833833|463820640|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870509|NCT00833833|463820635|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
128870510|NCT00833833|463820636|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
128870511|NCT00833833|463820637|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
128870512|NCT00833833|463820638|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
128870513|NCT00833833|463820639|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
128870514|NCT00833833|463820640|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
128870515|NCT00833833|463820635|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
128870516|NCT00833833|463820636|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
128870517|NCT00833833|463820637|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
128870518|NCT00833833|463820638|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
128870519|NCT00833833|463820639|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
128870520|NCT00833833|463820640|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
128870521|NCT00833833|463820635|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
128870522|NCT00833833|463820636|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
128870523|NCT00833833|463820637|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
128870524|NCT00833833|463820638|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
128870525|NCT00833833|463820639|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
128870526|NCT00833833|463820640|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
128870527|NCT00833833|463820635|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
128870528|NCT00833833|463820636|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
128870529|NCT00833833|463820637|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
128870530|NCT00833833|463820638|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
128870531|NCT00833833|463820639|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
128870532|NCT00833833|463820640|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
128870533|NCT00833833|463820635|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870534|NCT00833833|463820636|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870535|NCT00833833|463820637|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870536|NCT00833833|463820638|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
128870537|NCT00833833|463820639|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
128870538|NCT00833833|463820640|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
128870539|NCT00833833|463820635|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
128870540|NCT00833833|463820636|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
128870541|NCT00833833|463820637|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
128870542|NCT00833833|463820638|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
128870543|NCT00833833|463820639|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
128870544|NCT00833833|463820640|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
128870545|NCT00833833|463820635|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
128870546|NCT00833833|463820636|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
128870547|NCT00833833|463820637|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
128870548|NCT00833833|463820638|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
128870549|NCT00833833|463820639|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
128870550|NCT00833833|463820640|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
128870551|NCT00833833|463820635|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
128870552|NCT00833833|463820636|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
128870553|NCT00833833|463820637|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
128870554|NCT00833833|463820638|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
128870555|NCT00833833|463820639|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
128870556|NCT00833833|463820640|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
128870557|NCT01994837|463820641|FG000|Overall Study|Progressive disease per protocol|23|||
128870558|NCT01994837|463820641|FG000|Overall Study|Adv event related to progressive disease|3|||
128870559|NCT01994837|463820641|FG000|Overall Study|Fatal progressive disease|2|||
128870560|NCT01994837|463820641|FG000|Overall Study|Adverse event not related to progression|1|||
128870561|NCT01994837|463820641|FG000|Overall Study|Chose palliative care|1|||
128870562|NCT01994837|463820641|FG000|Overall Study|Proceeded to transplant|1|||
128870563|NCT01994837|463820641|FG000|Overall Study|Removed from study due to no response|1|||
128870564|NCT01127893|463820642|FG000|Overall Study|Study Termination by the Sponsor|1|||
128870565|NCT00574873|463820643|FG000|Overall Study|Withdrawal by Subject|18|||
128870566|NCT00574873|463820644|FG001|Overall Study|Withdrawal by Subject|19|||
128870567|NCT00574873|463820643|FG000|Overall Study|Investigator request|18|||
128870568|NCT00574873|463820644|FG001|Overall Study|Investigator request|8|||
128870569|NCT00574873|463820643|FG000|Overall Study|Death|15|||
128870570|NCT00574873|463820644|FG001|Overall Study|Death|14|||
128870571|NCT00574873|463820643|FG000|Overall Study|Lost to Follow-up|14|||
128870572|NCT00574873|463820644|FG001|Overall Study|Lost to Follow-up|5|||
128870573|NCT00574873|463820643|FG000|Overall Study|Other|40|||
128870574|NCT00574873|463820644|FG001|Overall Study|Other|4|||
128870575|NCT00574873|463820643|FG000|Overall Study|Discontinuation of study by sponsor|5|||
128870576|NCT00574873|463820644|FG001|Overall Study|Discontinuation of study by sponsor|199|||
128870577|NCT00574873|463820643|FG000|Overall Study|Blank, site closed per local regulations|2|||
128870578|NCT00574873|463820644|FG001|Overall Study|Blank, site closed per local regulations|2|||
128870579|NCT00574873|463820643|FG000|Overall Study|Extension Study|126|||
128870580|NCT00574873|463820644|FG001|Overall Study|Extension Study|0|||
128870581|NCT03568318|463820648|FG000|Overall Study|Adverse Event|3|||
128870582|NCT03568318|463820649|FG001|Overall Study|Adverse Event|1|||
128870583|NCT03568318|463820650|FG002|Overall Study|Adverse Event|1|||
128870584|NCT03568318|463820651|FG003|Overall Study|Adverse Event|0|||
128870585|NCT03568318|463820652|FG004|Overall Study|Adverse Event|1|||
128870586|NCT03568318|463820653|FG005|Overall Study|Adverse Event|0|||
128870587|NCT03568318|463820648|FG000|Overall Study|Withdrawal by Subject|6|||
128870588|NCT03568318|463820649|FG001|Overall Study|Withdrawal by Subject|5|||
128870589|NCT03568318|463820650|FG002|Overall Study|Withdrawal by Subject|2|||
128870590|NCT03568318|463820651|FG003|Overall Study|Withdrawal by Subject|1|||
128870591|NCT03568318|463820652|FG004|Overall Study|Withdrawal by Subject|0|||
128870592|NCT03568318|463820653|FG005|Overall Study|Withdrawal by Subject|0|||
128870593|NCT03568318|463820648|FG000|Overall Study|Lost to Follow-up|3|||
128870594|NCT03568318|463820649|FG001|Overall Study|Lost to Follow-up|2|||
128870595|NCT03568318|463820650|FG002|Overall Study|Lost to Follow-up|2|||
128870596|NCT03568318|463820651|FG003|Overall Study|Lost to Follow-up|2|||
128870597|NCT03568318|463820652|FG004|Overall Study|Lost to Follow-up|1|||
128870598|NCT03568318|463820653|FG005|Overall Study|Lost to Follow-up|0|||
128870599|NCT03568318|463820648|FG000|Overall Study|Other|3|||
128870600|NCT03568318|463820649|FG001|Overall Study|Other|1|||
128870601|NCT03568318|463820650|FG002|Overall Study|Other|3|||
128870602|NCT03568318|463820651|FG003|Overall Study|Other|0|||
128870603|NCT03568318|463820652|FG004|Overall Study|Other|0|||
128870604|NCT03568318|463820653|FG005|Overall Study|Other|0|||
128870605|NCT03568318|463820648|FG000|Overall Study|Ongoing at Time of Analysis|5|||
128870606|NCT03568318|463820649|FG001|Overall Study|Ongoing at Time of Analysis|3|||
128870607|NCT03568318|463820650|FG002|Overall Study|Ongoing at Time of Analysis|2|||
128870608|NCT03568318|463820651|FG003|Overall Study|Ongoing at Time of Analysis|1|||
128870609|NCT03568318|463820652|FG004|Overall Study|Ongoing at Time of Analysis|0|||
128870610|NCT03568318|463820653|FG005|Overall Study|Ongoing at Time of Analysis|0|||
128870611|NCT01638429|463820656|FG000|Overall Study|Withdrawal by Subject|1|||
128870612|NCT03207451|463820657|FG000|Overall Study|scheduling conflict|1|||
128870613|NCT03207451|463820658|FG001|Overall Study|scheduling conflict|0|||
128870614|NCT03207451|463820659|FG002|Overall Study|scheduling conflict|2|||
128870615|NCT03207451|463820660|FG003|Overall Study|scheduling conflict|2|||
128870616|NCT03207451|463820657|FG000|Overall Study|Adverse Event|0|||
128870617|NCT03207451|463820658|FG001|Overall Study|Adverse Event|0|||
128870618|NCT03207451|463820659|FG002|Overall Study|Adverse Event|0|||
128870619|NCT03207451|463820660|FG003|Overall Study|Adverse Event|1|||
128870620|NCT02040584|463820662|FG000|Overall Study|Adverse Event|13|||
128870621|NCT02040584|463820663|FG001|Overall Study|Adverse Event|6|||
128870622|NCT02040584|463820662|FG000|Overall Study|Protocol Violation|9|||
128870623|NCT02040584|463820663|FG001|Overall Study|Protocol Violation|11|||
128870624|NCT02040584|463820662|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
128870625|NCT02040584|463820663|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
128870626|NCT02040584|463820662|FG000|Overall Study|Death|6|||
128870627|NCT02040584|463820663|FG001|Overall Study|Death|3|||
128870628|NCT02040584|463820662|FG000|Overall Study|Transplant rejection/retransplant|0|||
128870629|NCT02040584|463820663|FG001|Overall Study|Transplant rejection/retransplant|1|||
128870630|NCT02040584|463820662|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
128870631|NCT02040584|463820663|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
128870632|NCT01802567|463820664|FG000|Overall Study|Withdrawal by Subject|2|||
128870633|NCT01802567|463820664|FG000|Overall Study|Physician Decision|1|||
128870634|NCT01802567|463820664|FG000|Overall Study|Lack of Efficacy|7|||
128870635|NCT01802567|463820664|FG000|Overall Study|Consented but did not start therapy|7|||
128870636|NCT01802567|463820664|FG000|Overall Study|Protocol Violation|1|||
128870637|NCT02591953|463820667|FG000|Overall Study|Lost to Follow-up|6|||
128870638|NCT02591953|463820668|FG001|Overall Study|Lost to Follow-up|6|||
128870639|NCT03167359|463820671|FG000|Overall Study|Physician Decision|1|||
128870640|NCT03167359|463820671|FG000|Overall Study|Lost to Follow-up|1|||
128870641|NCT03339583|463820672|FG000|First Intervention (14 Days)|Adverse Event|1|||
128870642|NCT03339583|463820673|FG001|First Intervention (14 Days)|Adverse Event|0|||
128870643|NCT03339583|463820672|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
128870644|NCT03339583|463820673|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
128870645|NCT03339583|463820672|FG000|Second Intervention (14 Days)|Adverse Event|0|||
128870646|NCT03339583|463820673|FG001|Second Intervention (14 Days)|Adverse Event|1|||
128870647|NCT03339583|463820672|FG000|Follow-up (14 Days)|Physician Decision|6|||
128870648|NCT03339583|463820673|FG001|Follow-up (14 Days)|Physician Decision|3|||
128870649|NCT01896557|463820674|FG000|Clopidogrel Alone|Adverse Event|1|||
128870650|NCT01896557|463820675|FG001|Clopidogrel Alone|Adverse Event|0|||
128870651|NCT01896557|463820674|FG000|Clopidogrel + GI Protector|low adherence|1|||
128870652|NCT01896557|463820675|FG001|Clopidogrel + GI Protector|low adherence|1|||
128870653|NCT01896557|463820674|FG000|Clopidogrel + GI Protector|Reading error|1|||
128870654|NCT01896557|463820675|FG001|Clopidogrel + GI Protector|Reading error|3|||
128870655|NCT00734591|463820676|FG000|Screening for Prospective Period|Site did not participate|1604|||
128870656|NCT00734591|463820677|FG001|Screening for Prospective Period|Site did not participate|1488|||
128870657|NCT00734591|463820676|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
128870658|NCT00734591|463820677|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
128870659|NCT00734591|463820676|FG000|Prospective Period|Withdrawal by Subject|11|||
128870660|NCT00734591|463820677|FG001|Prospective Period|Withdrawal by Subject|9|||
128870661|NCT00734591|463820676|FG000|Prospective Period|Lost to Follow-up|37|||
128870662|NCT00734591|463820677|FG001|Prospective Period|Lost to Follow-up|33|||
128870663|NCT00734591|463820676|FG000|Prospective Period|Study Terminated|1|||
128870664|NCT00734591|463820677|FG001|Prospective Period|Study Terminated|0|||
128870665|NCT00734591|463820676|FG000|Prospective Period|Other|2|||
128870666|NCT00734591|463820677|FG001|Prospective Period|Other|2|||
128870667|NCT02236988|463820678|FG000|Overall Study|Lost to Follow-up|0|||
128870668|NCT02236988|463820679|FG001|Overall Study|Lost to Follow-up|0|||
128870669|NCT02236988|463820680|FG002|Overall Study|Lost to Follow-up|0|||
128870670|NCT02236988|463820681|FG003|Overall Study|Lost to Follow-up|1|||
128870671|NCT02236988|463820678|FG000|Overall Study|Unable to Comply with Study Visits|0|||
128870672|NCT02236988|463820679|FG001|Overall Study|Unable to Comply with Study Visits|0|||
128870673|NCT02236988|463820680|FG002|Overall Study|Unable to Comply with Study Visits|0|||
128870674|NCT02236988|463820681|FG003|Overall Study|Unable to Comply with Study Visits|2|||
128870675|NCT04032613|463820682|FG000|Overall Study|Did not complete post-program assessment|5|||
128870676|NCT04032613|463820683|FG001|Overall Study|Did not complete post-program assessment|2|||
128870677|NCT01659853|463820684|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
128870678|NCT01659853|463820685|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
128870679|NCT01659853|463820684|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
128870680|NCT01659853|463820685|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
128870681|NCT03053518|463820688|FG000|Overall Study|Withdrawal by Subject|3|||
128870682|NCT03053518|463820688|FG000|Overall Study|Lost to Follow-up|2|||
128870683|NCT03053518|463820688|FG000|Overall Study|Ineligible|5|||
128870684|NCT02071290|463820689|FG000|Overall Study|Death|1|||
128870685|NCT02071290|463820690|FG001|Overall Study|Death|0|||
128870686|NCT02071290|463820689|FG000|Overall Study|Withdrawal by Subject|0|||
128870773|NCT00958841|463820723|FG000|Overall Study|Completed M6/did not enter extension|27|||
128870774|NCT00958841|463820723|FG000|Overall Study|Discontinued prior to M*|28|||
128870775|NCT00743431|463820724|FG000|Overall Study|Toxicity|6|||
128870776|NCT00743431|463820724|FG000|Overall Study|Tumor progression|56|||
128870777|NCT00743431|463820724|FG000|Overall Study|Withdrawal by Subject|13|||
128870778|NCT00743431|463820724|FG000|Overall Study|Death|9|||
128870779|NCT00743431|463820724|FG000|Overall Study|Reason for discontinuation not specified|29|||
128870780|NCT00743431|463820724|FG000|Overall Study|No documentation available|13|||
128870781|NCT03291288|463820725|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
128870782|NCT03291288|463820726|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
128870783|NCT03291288|463820725|FG000|Drug-drug Interaction Phase|Disease progression|1|||
128870784|NCT03291288|463820726|FG001|Drug-drug Interaction Phase|Disease progression|0|||
128870785|NCT03291288|463820725|FG000|Drug-drug Interaction Phase|Other|3|||
128870786|NCT03291288|463820726|FG001|Drug-drug Interaction Phase|Other|0|||
128870787|NCT03291288|463820725|FG000|Pexidartinib Only|Ongoing|0|||
128870788|NCT03291288|463820726|FG001|Pexidartinib Only|Ongoing|2|||
128870789|NCT04276415|463820727|FG000|Overall Study|Adverse Event|0|||
128870790|NCT04276415|463820728|FG001|Overall Study|Adverse Event|0|||
128870791|NCT04276415|463820729|FG002|Overall Study|Adverse Event|0|||
128870792|NCT04276415|463820730|FG003|Overall Study|Adverse Event|3|||
128870793|NCT04276415|463820731|FG004|Overall Study|Adverse Event|0|||
128870794|NCT04276415|463820732|FG005|Overall Study|Adverse Event|0|||
128870795|NCT04276415|463820727|FG000|Overall Study|Clinical progression|1|||
128870796|NCT04276415|463820728|FG001|Overall Study|Clinical progression|1|||
128870797|NCT04276415|463820729|FG002|Overall Study|Clinical progression|0|||
128870798|NCT04276415|463820730|FG003|Overall Study|Clinical progression|0|||
128870799|NCT04276415|463820731|FG004|Overall Study|Clinical progression|1|||
128870800|NCT04276415|463820732|FG005|Overall Study|Clinical progression|0|||
128870801|NCT04276415|463820727|FG000|Overall Study|Other|0|||
128870802|NCT04276415|463820728|FG001|Overall Study|Other|0|||
128870803|NCT04276415|463820729|FG002|Overall Study|Other|0|||
128870804|NCT04276415|463820730|FG003|Overall Study|Other|1|||
128870805|NCT04276415|463820731|FG004|Overall Study|Other|0|||
128870806|NCT04276415|463820732|FG005|Overall Study|Other|0|||
128870807|NCT04276415|463820727|FG000|Overall Study|Physician Decision|0|||
128870808|NCT04276415|463820728|FG001|Overall Study|Physician Decision|0|||
128870809|NCT04276415|463820729|FG002|Overall Study|Physician Decision|1|||
128870810|NCT04276415|463820730|FG003|Overall Study|Physician Decision|3|||
128870811|NCT04276415|463820731|FG004|Overall Study|Physician Decision|2|||
128870812|NCT04276415|463820732|FG005|Overall Study|Physician Decision|0|||
128870813|NCT04276415|463820727|FG000|Overall Study|Progressive disease|3|||
128870814|NCT04276415|463820728|FG001|Overall Study|Progressive disease|3|||
128870815|NCT04276415|463820729|FG002|Overall Study|Progressive disease|4|||
128870816|NCT04276415|463820730|FG003|Overall Study|Progressive disease|5|||
128870817|NCT04276415|463820731|FG004|Overall Study|Progressive disease|1|||
128870818|NCT04276415|463820732|FG005|Overall Study|Progressive disease|2|||
128870819|NCT04276415|463820727|FG000|Overall Study|Withdrawal by patient|0|||
128870820|NCT04276415|463820728|FG001|Overall Study|Withdrawal by patient|0|||
128870821|NCT04276415|463820729|FG002|Overall Study|Withdrawal by patient|0|||
128870822|NCT04276415|463820730|FG003|Overall Study|Withdrawal by patient|1|||
128870823|NCT04276415|463820731|FG004|Overall Study|Withdrawal by patient|2|||
128870824|NCT04276415|463820732|FG005|Overall Study|Withdrawal by patient|0|||
128870825|NCT03309813|463820733|FG000|Main Randomized Study|Withdrawal by Subject|1|||
128870826|NCT03309813|463820734|FG001|Main Randomized Study|Withdrawal by Subject|0|||
128870827|NCT01989169|463820737|FG000|Period 2|Adverse Event|0|||
128870828|NCT01989169|463820738|FG001|Period 2|Adverse Event|1|||
128870829|NCT02406677|463820739|FG000|Overall Study|Death|16|||
128870830|NCT02406677|463820740|FG001|Overall Study|Death|8|||
128870831|NCT02406677|463820739|FG000|Overall Study|Discharged without P2Y12|1|||
128870832|NCT02406677|463820740|FG001|Overall Study|Discharged without P2Y12|3|||
128870833|NCT02406677|463820739|FG000|Overall Study|Discharged on prasugrel|283|||
128870834|NCT02406677|463820740|FG001|Overall Study|Discharged on prasugrel|587|||
128870835|NCT02406677|463820739|FG000|Overall Study|Withdrawal by Subject|1|||
128870836|NCT02406677|463820740|FG001|Overall Study|Withdrawal by Subject|0|||
128870837|NCT04531904|463820741|FG000|Overall Study|Lost to Follow-up|1|||
128870838|NCT04531904|463820741|FG000|Overall Study|Death|14|||
128870839|NCT00283244|463820742|FG000|Overall Study|Adverse Event|0|||
128870840|NCT00283244|463820743|FG001|Overall Study|Adverse Event|8|||
128870841|NCT00283244|463820744|FG002|Overall Study|Adverse Event|11|||
128870842|NCT00283244|463820742|FG000|Overall Study|Death|4|||
128870843|NCT00283244|463820743|FG001|Overall Study|Death|3|||
128870844|NCT00283244|463820744|FG002|Overall Study|Death|2|||
128870845|NCT00283244|463820742|FG000|Overall Study|Lack of Efficacy|8|||
128870846|NCT00283244|463820743|FG001|Overall Study|Lack of Efficacy|32|||
128870847|NCT00283244|463820744|FG002|Overall Study|Lack of Efficacy|26|||
128870848|NCT00283244|463820742|FG000|Overall Study|Withdrawal by Subject|1|||
128870849|NCT00283244|463820743|FG001|Overall Study|Withdrawal by Subject|2|||
128870850|NCT00283244|463820744|FG002|Overall Study|Withdrawal by Subject|2|||
128870851|NCT00283244|463820742|FG000|Overall Study|Physician Decision|0|||
128870854|NCT00283244|463820742|FG000|Overall Study|Medical illness (other complicating dz)|4|||
128870855|NCT00283244|463820743|FG001|Overall Study|Medical illness (other complicating dz)|3|||
128870856|NCT00283244|463820744|FG002|Overall Study|Medical illness (other complicating dz)|6|||
128870857|NCT00283244|463820742|FG000|Overall Study|Clinical deterioration|1|||
128870858|NCT00283244|463820743|FG001|Overall Study|Clinical deterioration|3|||
128870859|NCT00283244|463820744|FG002|Overall Study|Clinical deterioration|3|||
128870860|NCT01609062|463820745|FG000|Extension Phase|Terminated by Sponsor|14|||
128870861|NCT01609062|463820746|FG001|Extension Phase|Terminated by Sponsor|9|||
128870862|NCT01609062|463820745|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
128870863|NCT01609062|463820746|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
128870864|NCT01609062|463820745|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
128870865|NCT01609062|463820746|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
128870866|NCT00658788|463820747|FG000|Overall Study|Adverse Event|11|||
128870867|NCT00658788|463820747|FG000|Overall Study|Withdrawal by Subject|13|||
128870868|NCT00658788|463820747|FG000|Overall Study|Lost to Follow-up|18|||
128870869|NCT00658788|463820747|FG000|Overall Study|Treatment Discontinuation|32|||
128870870|NCT00653523|463820748|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
128870871|NCT00653523|463820748|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
128870872|NCT00653523|463820748|FG000|Overall Study|Adverse Event|7|||
128870873|NCT00653523|463820748|FG000|Overall Study|Withdrawal by Subject|6|||
128870874|NCT00653523|463820748|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
128870875|NCT00653523|463820748|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
128870876|NCT02425904|463820749|FG000|Overall Study|Lost to Follow-up|1|||
128870877|NCT02425904|463820750|FG001|Overall Study|Lost to Follow-up|0|||
128870878|NCT02425904|463820749|FG000|Overall Study|Withdrawal by Subject|2|||
128870879|NCT02425904|463820750|FG001|Overall Study|Withdrawal by Subject|0|||
128870880|NCT02425904|463820749|FG000|Overall Study|Death|0|||
128870881|NCT02425904|463820750|FG001|Overall Study|Death|3|||
128870882|NCT05384938|463820752|FG000|Overall Study|Withdrawal by Subject|8|||
128870883|NCT05384938|463820752|FG000|Overall Study|Lost to Follow-up|6|||
128870884|NCT05384938|463820752|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
